recombinant amphiregulin
percutaneous coronary intervention for st elevation myocardial infarction - stable - over 12 hours from symptom onset
percutaneous coronary intervention for st elevation myocardial infarction - stable after successful full - dose thrombolytic therapy
percutaneous coronary intervention for st elevation myocardial infarction - unstable - over 12 hours from symptom onset
percutaneous mitral valve repair
pericardial stripping
post - cardiac transplant evaluation
pre - operative evaluation for non - cardiovascular surgery
previously implanted cardiac lead
rescue percutaneous coronary intervention for st elevation myocardial infarction after failed full - dose thrombolytic therapy
reused cardiac lead
conpadri - i regimen
right cardiac ventricle assist device procedure
right cardiac ventricle pacing malfunction
severe cardiac valve regurgitation
severe cardiac valve stenosis
spontaneous sustained ventricular tachycardia by ecg finding
staged percutaneous coronary intervention
subject delay in providing consent
surgical maze procedure
syncope with high risk cardiac characteristics
syncope with inducible ventricular tachycardia by ecg finding
three vessel coronary disease
thrombolysis in myocardial infarction flow
transcatheter aortic valve implantation
two vessel coronary disease
typical coronary artery disease symptom
unable to obtain acceptable pacing thresholds
unable to obtain satisfactory coronary sinus access
unable to obtain satisfactory vascular access
unable to position lead due to coronary sinus dissection
unable to position lead in tributary vein of coronary sinus
upgrade to cardiac device with additional pacing capabilities
urgent procedure
american college of cardiology / american heart association lesion complexity class
cardiac arrest / arrhythmia etiology unknown
cardiac lead dislodgement requiring reposition / reoperation
faulty device connector / header
idiopathic primary ventricular tachycardia / ventricular flutter by ecg finding
american college of cardiology / american heart association lesion complexity score a
american college of cardiology / american heart association lesion complexity score b
american college of cardiology / american heart association lesion complexity score c
thrombolysis in myocardial infarction flow - 0
thrombolysis in myocardial infarction flow - 1
thrombolysis in myocardial infarction flow - 2
thrombolysis in myocardial infarction flow - 3
pulmonic valvuloplasty
manufacturer recall
evaux spring water - based topical spray
file transfer protocol
secure file transfer protocol
transfer of images and data
needle free injection
renal cell carcinoma associated with neuroblastoma
needle free injection dosing unit
sinus node functional assessment
conjunctival primary acquired melanosis
immigrant
arterial access site
arterial access closure
pre - procedure
post - procedure
intrinsic qrs duration
paced ventricular rhythm without intrinsic ventricular complexes
chronic total coronary artery occlusion
coronary vessel lesion
coronary artery graft
coronary lesion complexity
coronary reperfusion procedure
cardiac ablation
cardiac valve injury
cytabom regimen
coronary venous dissection
cardiac computerized tomographic angiography
coronary culprit lesion
cardiac stress test
cardiac ischemic risk score
non - invasive cardiac stress test
sinus rhythm
luminal carotid thrombus
transplant waiting list
smoking tobacco
cardiac stent placement
in stent restenosis
guidewire across lesion
coronary artery perforation
cardiac diagnostic procedure
coronary angiography
coronary artery dominance
intra - aortic balloon pump
bifocal
eosinophil lysophospholipase
fistulagram
central nervous system nongerminomatous germ cell tumor
hgnc_id
lichenoid
oral mucositis rating scale
ginger flavor
synthetic breast cancer peptides - tetanus toxoid - poly iclc vaccine
rintatolimod
hpv e1 / e2 interaction inhibitor gel ap611074
naratuximab emtansine
adenovirus / cytomegalovirus / epstein - barr virus - specific allogeneic cytotoxic t lymphocytes
cellular sheet dosage form
sign or symptom
adas - cog cdisc version questionnaire question
bpi questionnaire question
bpi short form questionnaire question
bprs - a clinical classification question
cdisc questionnaire terminology
cgi questionnaire question
comm questionnaire question
c - ssrs baseline questionnaire question
eq - 5d - 3l questionnaire question
fpsr questionnaire question
kps scale questionnaire question
mds - updrs questionnaire question
mmse functional test question
mnsi questionnaire question
npi questionnaire question
pdqualif questionnaire question
pepsinogen measurement
rdq questionnaire question
short - form mpq - 2 questionnaire question
soapp - r questionnaire question
updrs questionnaire question
hamd - 17 questionnaire question
partner
cdisc questionnaire category terminology
cdisc sdtm relationship to subject terminology
cdisc questionnaire adas - cog cdisc version test name terminology
cdisc questionnaire adas - cog cdisc version test code terminology
cdisc clinical classification bprs - a test name terminology
cdisc clinical classification bprs - a test code terminology
cdisc questionnaire eq - 5d - 3l test name terminology
cdisc questionnaire eq - 5d - 3l test code terminology
cdisc clinical classification hamd 17 test name terminology
cdisc clinical classification hamd 17 test code terminology
cdisc questionnaire mds - updrs test name terminology
cdisc questionnaire mds - updrs test code terminology
cdisc functional test mmse test name terminology
cdisc functional test mmse test code terminology
cdisc questionnaire npi test name terminology
cdisc questionnaire npi test code terminology
cdisc questionnaire pdqualif test name terminology
cdisc questionnaire pdqualif test code terminology
cdisc questionnaire updrs test name terminology
cdisc questionnaire updrs test code terminology
cdisc questionnaire cgi test name terminology
cdisc questionnaire cgi test code terminology
cdisc questionnaire mnsi test name terminology
cdisc questionnaire mnsi test code terminology
cdisc questionnaire fpsr test name terminology
cdisc questionnaire fpsr test code terminology
cdisc questionnaire short - form mpq - 2 test name terminology
cdisc questionnaire short - form mpq - 2 test code terminology
cdisc questionnaire comm test name terminology
cdisc questionnaire comm test code terminology
cdisc questionnaire soapp - r test name terminology
cdisc questionnaire soapp - r test code terminology
cdisc questionnaire bpi test name terminology
cdisc questionnaire bpi test code terminology
cdisc questionnaire bpi short form test name terminology
cdisc questionnaire bpi short form test code terminology
cdisc questionnaire rdq test name terminology
cdisc questionnaire rdq test code terminology
cdisc questionnaire c - ssrs baseline test name terminology
cdisc questionnaire c - ssrs baseline test code terminology
cdisc questionnaire kps scale test name terminology
cdisc questionnaire kps scale test code terminology
sf36 v1 .0 standard questionnaire question
wpai:shp v2 .0 questionnaire question
cdisc questionnaire wpai:shp v2 .0 test name terminology
cdisc questionnaire wpai:shp v2 .0 test code terminology
cdisc adas - cog  -  word recall average score
cdisc adas - cog  -  word recall trial 1 subscore
cdisc adas - cog  -  word recall trial 2 subscore
cdisc adas - cog  -  word recall trial 3 subscore
cdisc adas - cog  -  word recall: word 1
cdisc adas - cog  -  word recall: word 2
cdisc adas - cog  -  word recall: word 3
cdisc adas - cog  -  word recall: word 4
cdisc adas - cog  -  word recall: word 5
cdisc adas - cog  -  word recall: word 6
cdisc adas - cog  -  word recall: word 7
cdisc adas - cog  -  word recall: word 8
cdisc adas - cog  -  word recall: word 9
dzapo regimen
cdisc adas - cog  -  word recall: word 10
cdisc adas - cog  -  naming objects and fingers summary score
cdisc adas - cog  -  naming objects and fingers: 1
cdisc adas - cog  -  naming objects and fingers: 2
cdisc adas - cog  -  naming objects and fingers: 3
cdisc adas - cog  -  naming objects and fingers: 4
cdisc adas - cog  -  naming objects and fingers: 5
cdisc adas - cog  -  naming objects and fingers: 6
cdisc adas - cog  -  naming objects and fingers: 7
cdisc adas - cog  -  naming objects and fingers: 8
recombinant angiogenin
cdisc adas - cog  -  naming objects and fingers: 9
cdisc adas - cog  -  naming objects and fingers: 10
cdisc adas - cog  -  naming objects and fingers: 11
cdisc adas - cog  -  naming objects and fingers: 12
cdisc adas - cog  -  naming objects and fingers: thumb
cdisc adas - cog  -  naming objects and fingers: pointer
cdisc adas - cog  -  naming objects and fingers: middle
cdisc adas - cog  -  naming objects and fingers: ring
cdisc adas - cog  -  naming objects and fingers: pinky
cdisc adas - cog  -  commands summary score
cdisc adas - cog  -  commands: fist
cdisc adas - cog  -  commands: ceiling
cdisc adas - cog  -  commands: pencil
cdisc adas - cog  -  commands: watch
cdisc adas - cog  -  commands: shoulder
cdisc adas - cog  -  delayed word recall summary score
cdisc adas - cog  -  delayed word recall: word 1
cdisc adas - cog  -  delayed word recall: word 2
cdisc adas - cog  -  delayed word recall: word 3
cdisc adas - cog  -  delayed word recall: word 4
cdisc adas - cog  -  delayed word recall: word 5
cdisc adas - cog  -  delayed word recall: word 6
cdisc adas - cog  -  delayed word recall: word 7
cdisc adas - cog  -  delayed word recall: word 8
cdisc adas - cog  -  delayed word recall: word 9
cdisc adas - cog  -  delayed word recall: word 10
cdisc adas - cog  -  constructional praxis summary score
cdisc adas - cog  -  constructional praxis: circle
cdisc adas - cog  -  constructional praxis: 2 rectangles
cdisc adas - cog  -  constructional praxis: diamond
doxorubicin / mitomycin / tegafur regimen
cdisc adas - cog  -  constructional praxis: cube
cdisc adas - cog  -  attempt to draw
cdisc adas - cog  -  ideational praxis summary score
cdisc adas - cog  -  ideational praxis: fold
cdisc adas - cog  -  ideational praxis: insert
cdisc adas - cog  -  ideational praxis: seal
cdisc adas - cog  -  ideational praxis: address
cdisc adas - cog  -  ideational praxis: stamp
cdisc adas - cog  -  orientation summary score
cdisc adas - cog  -  orientation: full name
asparaginase / methotrexate regimen
cdisc adas - cog  -  orientation: month
cdisc adas - cog  -  orientation: date
cdisc adas - cog  -  orientation: year
cdisc adas - cog  -  orientation: day of week
cdisc adas - cog  -  orientation: season
cdisc adas - cog  -  orientation: place
cdisc adas - cog  -  orientation: time
cdisc adas - cog  -  word recognition summary score
cdisc adas - cog  -  word recognition trial 1 summary score
cdisc adas - cog  -  word recognition trial 2 summary score
cdisc adas - cog  -  word recognition trial 3 summary score
cdisc adas - cog  -  word recognition: word 1
cdisc adas - cog  -  word recognition: word 2
cdisc adas - cog  -  word recognition: word 3
cdisc adas - cog  -  word recognition: word 4
cdisc adas - cog  -  word recognition: word 5
cdisc adas - cog  -  word recognition: word 6
cdisc adas - cog  -  word recognition: word 7
cdisc adas - cog  -  word recognition: word 8
cdisc adas - cog  -  word recognition: word 9
cdisc adas - cog  -  word recognition: word 10
cdisc adas - cog  -  word recognition: word 11
cdisc adas - cog  -  word recognition: word 12
cdisc adas - cog  -  word recognition: word 13
cdisc adas - cog  -  word recognition: word 14
cdisc adas - cog  -  word recognition: word 15
cdisc adas - cog  -  word recognition: word 16
cdisc adas - cog  -  word recognition: word 17
cdisc adas - cog  -  word recognition: word 18
cdisc adas - cog  -  word recognition: word 19
cdisc adas - cog  -  word recognition: word 20
cdisc adas - cog  -  word recognition: word 21
cdisc adas - cog  -  word recognition: word 22
cdisc adas - cog  -  word recognition: word 23
cdisc adas - cog  -  word recognition: word 24
cdisc adas - cog  -  remembering test instructions
cdisc adas - cog  -  spoken language ability
cdisc adas - cog  -  word difficulty in spontaneous speech
cdisc adas - cog  -  comprehension
cdisc adas - cog  -  concentration / distractibility
mcbp regimen
cdisc adas - cog  -  number cancellation summary score
cdisc adas - cog  -  number cancellation: correct
cdisc adas - cog  -  number cancellation: errors
cdisc adas - cog  -  number cancellation: remind
cdisc adas - cog  -  executive function maze summary score
cdisc adas - cog  -  executive function maze: errors
cdisc adas - cog  -  executive function maze: time
bpi  -  marital status
bpi  -  education
bpi  -  professional degree
bpi  -  current occupation
bpi  -  spouse's occupation
bpi  -  current job status
bpi  -  how long since diagnosis
bpi  -  pain due to present disease
bpi  -  pain as a symptom
bpi  -  surgery in past month
bpi  -  kind of surgery in past month
bpi  -  pain other than everyday kinds
bpi  -  pain medications in the last 7 days
ansamycin antineoplastic antibiotic
doxorubicin / semustine regimen
bpi  -  pain requires medication daily
bpi  -  areas of pain
bpi  -  area hurts most
bpi  -  pain at its worst in last week
bpi  -  pain at its least in last week
bpi  -  pain on the average
bpi  -  pain right now
bpi  -  things that make pain feel better
bpi  -  things that make your pain worse
bpi  -  treatments receiving for pain
dactinomycin / doxorubicin / methotrexate / vincristine regimen
bpi  -  relief pain treatments provided
bpi  -  hours before pain returns
bpi  -  pain due to effects of treatment
bpi  -  pain due to primary disease
bpi  -  pain due to unrelated medical condition
bpi  -  describe unrelated medical condition
bpi  -  aching
bpi  -  throbbing
bpi  -  shooting
bpi  -  stabbing
bpi  -  gnawing
bpi  -  sharp
bpi  -  tender
bpi  -  burning
bpi  -  exhausting
bpi  -  tiring
bpi  -  penetrating
bpi  -  nagging
bpi  -  numb
bpi  -  miserable
bpi  -  unbearable
bpi  -  pain interfered with general activity
bpi  -  pain interfered with mood
bpi  -  pain interfered with walking ability
bpi  -  pain interfered with normal work
bpi  -  pain interfered with relations
bpi  -  pain interfered with sleep
bpi  -  pain interfered with enjoyment of life
bpi  -  prefer to take pain medicine
bpi  -  take my pain medicine
bpi  -  need stronger type of pain medication
bpi  -  need more pain medication than prescribed
bpi  -  concerned with too much pain medication use
bpi  -  why concerned with too much pain medication use
bpi  -  problems with side effects pain medication
bpi  -  what side effects from pain medication
bpi  -  need further information about pain medication
bpi  -  warm compresses to relieve pain
bpi  -  cold compresses to relieve pain
bpi  -  relaxation techniques relieve pain
bpi  -  distraction to relieve pain
bpi  -  biofeedback to relieve pain
bpi  -  hypnosis to relieve pain
bpi  -  other methods to relieve pain
bpi  -  specified other method to relieve pain
bpi  -  medications not prescribed taken for pain
bpi short form  -  pain other than everyday kinds
bpi short form  -  areas of pain
bpi short form  -  area that hurts most
bpi short form  -  pain at its worst in last 24 hours
roap regimen
bpi short form  -  pain at its least in last 24 hours
bpi short form  -  pain on the average
bpi short form  -  pain right now
bpi short form  -  treatments or medications receiving for pain
bpi short form  -  relief from pain treatments provided
bpi short form  -  pain interfered with general activity
bpi short form  -  pain interfered with mood
bpi short form  -  pain interfered with walking ability
bpi short form  -  pain interfered with normal work
bpi short form  -  pain interfered with relations
bpi short form  -  pain interfered with sleep
bpi short form  -  pain interfered with enjoyment of life
bprs - a  -  somatic concern
bprs - a  -  anxiety
bprs - a  -  emotional withdrawal
bprs - a  -  conceptual disorganization
bprs - a  -  guilt feelings
bprs - a  -  tension
bprs - a  -  mannerisms and posturing
bprs - a  -  grandiosity
bprs - a  -  depressive mood
bprs - a  -  hostility
bprs - a  -  suspiciousness
bprs - a  -  hallucinatory behavior
bprs - a  -  motor retardation
bprs - a  -  uncooperativeness
bprs - a  -  unusual thought content
bprs - a  -  blunted affect
bprs - a  -  excitement
bprs - a  -  disorientation
mean qrs duration ventricular paced
corrected qt interval
eq - 5d - 3l  -  mobility
eq - 5d - 3l  -  self - care
eq - 5d - 3l  -  usual activities
eq - 5d - 3l  -  pain or discomfort
eq - 5d - 3l  -  anxiety or depression
eq - 5d - 3l  -  eq vas score
hamd - 17  -  depressed mood
hamd - 17  -  feelings of guilt
antineoplaston a10
hamd - 17  -  suicide
hamd - 17  -  insomnia  -  early night
hamd - 17  -  insomnia  -  middle night
hamd - 17  -  insomnia  -  early morning
hamd - 17  -  work and activities
hamd - 17  -  retardation
hamd - 17  -  agitation
hamd - 17  -  psychic anxiety
hamd - 17  -  somatic anxiety
hamd - 17  -  gastrointestinal somatic symptoms
hamd - 17  -  general somatic symptoms
hamd - 17  -  genital symptoms
hamd - 17  -  hypochondriasis
hamd - 17  -  loss of weight according to patient
hamd - 17  -  loss of weight according to weekly measurements
hamd - 17  -  insight
hamd - 17  -  total score
kps scale  -  karnofsky performance status
sideroblast measurement
ring sideroblast measurement
tricyclic antidepressant measurement
ecarin clotting time measurement
ch50 measurement
platelet hematocrit measurement
hdl cholesterol to ldl cholesterol ratio measurement
apolipoprotein c2 measurement
apolipoprotein j measurement
alpha - 1 acid glycoprotein measurement
alanine aminopeptidase measurement
chemokine receptor cxcr3 measurement
ceruloplasmin measurement
kidney injury molecule - 1 measurement
non - prostatic acid phosphatase measurement
prealbumin measurement
protein s measurement
retinol binding protein measurement
soluble transferrin receptor measurement
iohexol clearance
edta clearance
diethylene triamine pentaacetic acid clearance
immature neutrophils to leukocytes ratio measurement
immature lymphocytes to leukocytes ratio measurement
immature lymphocytes measurement
immature granulocytes to leukocytes ratio measurement
proerythroblast measurement
homeostatic model assessment of insulin resistance
free glycerol measurement
glomerular filtration rate from beta - trace protein adjusted for bsa measurement
glomerular filtration rate from b - 2 microglobulin adjusted for bsa measurement
ova and parasite measurement
plasmodium measurement
liver kidney microsomal type 1 igg antibody measurement
liver kidney microsomal type 1 igm antibody measurement
liver kidney microsomal type 1 iga antibody measurement
ribonucleoprotein antibody measurement
scl - 70 antibody measurement
jo - 1 antibody measurement
hla - b27 antigen measurement
alpha - 1 microglobulin measurement
alpha - 1 microglobulin to creatinine ratio measurement
dnase - b antibody measurement
chlamydia trachomatis iga antibody measurement
chlamydia trachomatis igm antibody measurement
chlamydia trachomatis igg antibody measurement
pepsinogen i measurement
pepsinogen ii measurement
pepsinogen a measurement
pepsinogen c measurement
activated protein c resistance measurement
beta carotene measurement
mds - updrs  -  cognitive impairment
mds - updrs  -  hallucinations and psychosis
mds - updrs  -  depressed mood
mds - updrs  -  anxious mood
mds - updrs  -  apathy
mds - updrs  -  features of dopamine dysregulation syndrome
mds - updrs  -  sleep problems
mds - updrs  -  daytime sleepiness
mds - updrs  -  pain and other sensations
mds - updrs  -  urinary problems
mds - updrs  -  constipation problems
mds - updrs  -  lightheadedness on standing
mds - updrs  -  fatigue
mds - updrs  -  speech
mds - updrs  -  saliva and drooling
mds - updrs  -  chewing and swallowing
mds - updrs  -  eating tasks
mds - updrs  -  dressing
mds - updrs  -  hygiene
mds - updrs  -  handwriting
mds - updrs  -  doing hobbies and other activities
mds - updrs  -  turning in bed
mds - updrs  -  tremor
mds - updrs  -  walking and balance
mds - updrs  -  freezing
mds - updrs  -  medication for parkinson's disease
mds - updrs  -  clinical state on medication
arsenic trioxide
mds - updrs  -  taking levodopa
mds - updrs  -  minutes since levodopa dose
mds - updrs  -  speech problems
mds - updrs  -  facial expression
mds - updrs  -  rigidity neck
mds - updrs  -  rigidity right upper extremity
mds - updrs  -  rigidity left upper extremity
mds - updrs  -  rigidity right lower extremity
mds - updrs  -  rigidity left lower extremity
mds - updrs  -  right finger tapping
mds - updrs  -  left finger tapping
mds - updrs  -  right hand movements
mds - updrs  -  left hand movements
mds - updrs  -  pronanation - supination movement of right hand
mds - updrs  -  pronanation - supination movement of left hand
mds - updrs  -  right toe tapping
mds - updrs  -  left toe tapping
mds - updrs  -  right leg agility
mds - updrs  -  left leg agility
mds - updrs  -  arising from chair
mds - updrs  -  gait
mds - updrs  -  freezing of gait
mds - updrs  -  postural stability
mds - updrs  -  posture
mds - updrs  -  body bradykinesia
mds - updrs  -  postural tremor of right hand
mds - updrs  -  kinetic tremor of left hand
mds - updrs  -  rest tremor amplitude right upper extremity
mds - updrs  -  rest tremor amplitude left upper extremity
mds - updrs  -  rest tremor amplitude right lower extremity
cafp regimen
mds - updrs  -  rest tremor amplitude left lower extremity
mds - updrs  -  rest tremor amplitude lip or jaw
mds - updrs  -  consistency of rest tremor
mds - updrs  -  dyskinesias during exam
mds - updrs  -  movements interfere with ratings
mds - updrs  -  hoehn and yahr stage
mds - updrs  -  time spent with dyskinesias
mds - updrs  -  functional impact of dyskinesias
mds - updrs  -  time spent in the off state
mds - updrs  -  functional impact of fluctuations
mds - updrs  -  complexity of motor fluctuations
mds - updrs  -  painful off - state dystonia
mmse  -  question 1
mmse  -  what is the year
mmse  -  what is the season
mmse  -  what is the date
mmse  -  what is the day of week
mmse  -  what is the month of year
mmse  -  question 2
mmse  -  what is the state
mmse  -  what is the county
mmse  -  what is the city or town
mmse  -  what is the building
mmse  -  what is the floor
mmse  -  question 3
mmse  -  repeat word 1
mmse  -  repeat word 2
mmse  -  repeat word 3
mmse  -  question 4
mmse  -  what is 100 take away 7
mmse  -  keep subtracting 7 step 2
mmse  -  keep subtracting 7 step 3
mmse  -  keep subtracting 7 step 4
mmse  -  keep subtracting 7 step 5
mmse  -  question 4c
mmse  -  spell backward letter 1
mmse  -  spell backward letter 2
mmse  -  spell backward letter 3
mmse  -  spell backward letter 4
mmse  -  spell backward letter 5
mmse  -  attention and calculation subtotal
mmse  -  question 5
mmse  -  recall word 1
mmse  -  recall word 2
mmse  -  recall word 3
mmse  -  question 6
mmse  -  naming object 1
mmse  -  naming object 2
mmse  -  repeat what i say
mmse  -  question 8
altretamine / cisplatin / cyclophosphamide / fluorouracil regimen
mmse  -  take in right hand
mmse  -  fold in half
mmse  -  put on floor or table
mmse  -  read this and do what it says
mmse  -  write a sentence
mmse  -  copy this design
mmse  -  total score
mnsi  -  legs and / or feet numb
mnsi  -  burning pain legs / feet
mnsi  -  feet too sensitive to touch
mnsi  -  muscle cramps legs / feet
mnsi  -  prickling feelings legs / feet
mnsi  -  hurt when bed covers touch skin
mnsi  -  able to tell hot from cold water
mnsi  -  open sore on foot
mnsi  -  doctor says diabetic neuropathy
mnsi  -  feel weak all over most times
mnsi  -  symptoms worse at night
mnsi  -  legs hurt when walking
mnsi  -  able to sense feet when walking
ammonium trichlorotellurate
mnsi  -  skin so dry that feet crack open
mnsi  -  ever had amputation
mnsi  -  history total
mnsi  -  right foot appears normal
mnsi  -  right foot deformities
mnsi  -  right foot infection
mnsi  -  right foot fissure
mnsi  -  right foot other abnormal specify
mnsi  -  left foot appears normal
mnsi  -  left foot deformities
mnsi  -  left foot infection
mnsi  -  left foot fissure
mnsi  -  left foot other abnormal specify
mnsi  -  right foot ulceration
mnsi  -  left foot ulceration
mnsi  -  right ankle reflexes
mnsi  -  left ankle reflexes
mnsi  -  right foot vibration great toe
mnsi  -  left foot vibration great toe
mnsi  -  right foot monofilament
mnsi  -  left foot monofilament
mnsi  -  physical assessment total score
npi  -  have beliefs that you know are not true
npi  -  he / she is in danger
npi  -  others are stealing from him / her
npi  -  his / her spouse is having an affair
npi  -  unwelcome guests are living in his / her house
npi  -  his / her spouse or others are not who they claim to be
npi  -  his / her house is not his / her home
npi  -  family members plan to abandon him / her
npi  -  television or magazine figures are actually present in the home
npi  -  any other unusual things that i haven't asked about
npi  -  hallucinations such as seeing false visions or hearing false voices
npi  -  describe hearing voices or act as if he / she hears voices
npi  -  talk to people who are not there
npi  -  describe seeing things not seen by others
npi  -  report smelling odors not smelled by others
npi  -  describe feeling things on his / her skin
npi  -  describe tastes that are without any known cause
npi  -  describe any other unusual sensory experiences
npi  -  periods when he / she refuses to cooperate
npi  -  get upset with those trying to care for him / her
npi  -  stubborn
npi  -  uncooperative
npi  -  any other behaviors that make him / her hard to handle
npi  -  shout or curse angrily
npi  -  slam doors ,  kick furniture ,  throw things
npi  -  attempt to hurt or hit others
npi  -  any other aggressive or agitated behaviors
npi  -  seem sad or depressed
npi  -  periods of tearfulness or sobbing
npi  -  say ,  or act as if he / she is sad or in low spirits
npi  -  put him / herself down or say that he / she feels like a failure
npi  -  say that he / she is a bad person
npi  -  seem very discouraged
npi  -  say he / she is a burden to the family
npi  -  express a wish for death
npi  -  show any other signs of depression or sadness
npi  -  very nervous ,  worried ,  or frightened for no apparent reason
npi  -  say that he / she is worried about planned events
npi  -  periods of feeling shaky ,  unable to relax ,  or feeling excessively tense
npi  -  periods of shortness of breath ,  gasping ,  or sighing for no apparent reason
npi  -  complain of butterflies ,  racing or pounding heart
npi  -  avoid certain places or situations that make him / her more nervous
npi  -  become nervous and upset when separated from you
npi  -  show any other signs of anxiety
npi  -  seem too cheerful or too happy for no reason
npi  -  appear to feel good or to be too happy
npi  -  fine humor and laugh at things that others do not find funny
npi  -  seem to have a childish sense of humor
npi  -  tell jokes or make remarks that are not funny to others
npi  -  play childish pranks
npi  -  talk big or claim to have more abilities or wealth than is true
npi  -  show any other signs of feeling too good or being too happy
npi  -  lost interest in the world around him / her
npi  -  seem less spontaneous and less active than usual
npi  -  less likely initiate to initiate a conversation
npi  -  less affectionate or lacking in emotions
npi  -  contribute less to household chores
npi  -  less interested in the activities and plans of others
npi  -  lost interest in friends and family members
npi  -  less enthusiastic about his / her usual interests
npi  -  show any other signs that he / she doesn't care about doing new things
npi  -  seem to act impulsively without thinking
npi  -  act impulsively without appearing to consider the consequences
npi  -  talk to total strangers as if he / she knew them
npi  -  say things to people that are insensitive
npi  -  say crude things or make sexual remarks
npi  -  talk openly about very personal or private matters
npi  -  take liberties or touch or hug others
npi  -  show any other signs of loss of control of his / her impulses
npi  -  get irritated and easily disturbed
npi  -  bad temper ,  flying 'off the handle' easily over little things
npi  -  rapidly change moods from one to another
npi  -  sudden flares of anger
npi  -  impatient ,  having trouble coping with delays
npi  -  cranky and irritable
npi  -  argumentative and difficult to get along with
npi  -  show any other signs of irritability
npi  -  pace ,  do things over and over ,  repeatedly pick at things
azapicyl
facvp regimen
npi  -  pace around the house without apparent purpose
npi  -  rummage around opening and unpacking drawers or closets
npi  -  repeatedly put on and take off clothing
npi  -  repetitive activities or 'habits'
npi  -  engage in repetitive activities
npi  -  fidget excessively ,  seem unable to sit still
npi  -  do any other activities over and over
npi  -  difficulty sleeping
npi  -  difficulty falling asleep
npi  -  get up during the night
cyclophosphamide / mercaptopurine / prednisone / vincristine regimen
npi  -  wander ,  pace or get involved in inappropriate activities at night
npi  -  awaken you during the night
npi  -  wake up at night ,  dress ,  and plan to go out
npi  -  awaken too early in morning
npi  -  sleep excessively during the day
npi  -  any other nighttime behaviors that bother you
npi  -  change in appetite ,  weight ,  or eating habits
npi  -  loss of appetite
npi  -  increase in appetite
npi  -  loss of weight
npi  -  gained weight
npi  -  change in eating behavior
npi  -  change in kind of food he / she likes
npi  -  developed eating behaviors such as eating exactly the same types of food
npi  -  any other changes in appetite or eating
pdqualif  -  lightheadedness
pdqualif  -  imbalance
pdqualif  -  swallowing difficulty
pdqualif  -  communication
pdqualif  -  nocturia
pdqualif  -  sexual ability
pdqualif  -  neuropathy in hands or feet
pdqualif  -  bladder control difficulty
pdqualif  -  constipation
pdqualif  -  trouble with sleep initiation or waking early
pdqualif  -  trouble with sleep maintenance
pdqualif  -  positive outlook difficult
pdqualif  -  burden to others
pdqualif  -  social life affected
pdqualif  -  worry about future
pdqualif  -  difficulty in asking for help
pdqualif  -  important to maintain independence
pdqualif  -  difficulty in adjusting to change
pdqualif  -  social life not affected
pdqualif  -  travel important
pdqualif  -  family relationship affected
pdqualif  -  social isolation
pdqualif  -  self concept change
pdqualif  -  sexual desirability
pdqualif  -  independent hygiene in past 7 days
pdqualif  -  independent food preparation in past 7 days
pdqualif  -  problem with communication in the past 7 days
pdqualif  -  fatigue in past 7 days
pdqualif  -  house work in past 7 days
pdqualif  -  sleep with partner in past 7 days
pdqualif  -  driving in past 7 days
pdqualif  -  financial strain in past 7 days
pdqualif  -  parkinson's symptoms
lateral decubitus position
brief pain inventory questionnaire
brief pain inventory short form questionnaire
brief psychiatric rating scale a clinical classification
alzheimer's disease assessment scale - cognitive cdisc version questionnaire
clinical global impression original version questionnaire
current opioid misuse measure questionnaire
columbia - suicide severity rating scale baseline questionnaire
faces pain scale revised questionnaire
hamilton depression rating scale 17 item clinical classification
karnofsky performance status scale questionnaire
movement disorder society unified parkinson's disease rating scale questionnaire
michigan neuropathy screening instrument questionnaire
neuropsychiatric inventory questionnaire
parkinson's disease quality of life scale questionnaire
roland morris disability questionnaire
short form 36 health survey standard ,  us version 1 .0 questionnaire
short - form mcgill pain questionnaire - 2
screener and opioid assessment for patients with pain revised questionnaire
unified parkinson's disease rating scale questionnaire
work productivity and activity impairment specific health problems version 2 .0 questionnaire
rdq  -  stay at home
rdq  -  change position frequently
rdq  -  walk more slowly
rdq  -  not do any usual house jobs
rdq  -  use handrail to get upstairs
rdq  -  lie down to rest more often
rdq  -  hold on to get out of a chair
rdq  -  get other people to do things
rdq  -  get dressed more slowly
rdq  -  only stand for short periods
rdq  -  try not to bend or kneel
rdq  -  difficult to get out of a chair
rdq  -  painful almost all the time
rdq  -  difficult to turn over in bed
rdq  -  appetite is not very good
rdq  -  trouble putting on socks or stockings
rdq  -  only walk short distances
rdq  -  sleep less well
rdq  -  get dressed with help
rdq  -  sit down most of the day
azaribine
rdq  -  avoid heavy jobs
rdq  -  more irritable with people
rdq  -  go upstairs more slowly
rdq  -  stay in bed
rdq  -  total derived score
biological grandchild
biological grandparent
biological child
third degree relative
biological sibling
organ donor
pregnancy partner
sexual partner
sf36 v1 .0 standard  -  question 1
sf36 v1 .0 standard  -  question 2
sf36 v1 .0 standard  -  question 3a
sf36 v1 .0 standard  -  question 3b
sf36 v1 .0 standard  -  question 3c
sf36 v1 .0 standard  -  question 3d
sf36 v1 .0 standard  -  question 3e
sf36 v1 .0 standard  -  question 3f
sf36 v1 .0 standard  -  question 3g
sf36 v1 .0 standard  -  question 3h
sf36 v1 .0 standard  -  question 3i
sf36 v1 .0 standard  -  question 3j
sf36 v1 .0 standard  -  question 4a
sf36 v1 .0 standard  -  question 4b
sf36 v1 .0 standard  -  question 4c
sf36 v1 .0 standard  -  question 4d
sf36 v1 .0 standard  -  question 5a
fuvac regimen
sf36 v1 .0 standard  -  question 5b
sf36 v1 .0 standard  -  question 5c
sf36 v1 .0 standard  -  question 6
sf36 v1 .0 standard  -  question 7
sf36 v1 .0 standard  -  question 8
sf36 v1 .0 standard  -  question 9a
sf36 v1 .0 standard  -  question 9b
sf36 v1 .0 standard  -  question 9c
sf36 v1 .0 standard  -  question 9d
sf36 v1 .0 standard  -  question 9e
sf36 v1 .0 standard  -  question 9f
sf36 v1 .0 standard  -  question 9g
sf36 v1 .0 standard  -  question 9h
sf36 v1 .0 standard  -  question 9i
sf36 v1 .0 standard  -  question 10
sf36 v1 .0 standard  -  question 11a
sf36 v1 .0 standard  -  question 11b
sf36 v1 .0 standard  -  question 11c
sf36 v1 .0 standard  -  question 11d
sf - mpq - 2  -  throbbing pain
sf - mpq - 2  -  shooting pain
sf - mpq - 2  -  stabbing pain
sf - mpq - 2  -  sharp pain
sf - mpq - 2  -  cramping pain
sf - mpq - 2  -  gnawing pain
sf - mpq - 2  -  hot - burning pain
sf - mpq - 2  -  aching pain
sf - mpq - 2  -  heavy pain
sf - mpq - 2  -  tender
sf - mpq - 2  -  splitting pain
sf - mpq - 2  -  tiring - exhausting
sf - mpq - 2  -  sickening
sf - mpq - 2  -  fearful
sf - mpq - 2  -  punishing - cruel
sf - mpq - 2  -  electric - shock pain
sf - mpq - 2  -  cold - freezing pain
sf - mpq - 2  -  piercing
sf - mpq - 2  -  pain caused by light touch
sf - mpq - 2  -  itching
sf - mpq - 2  -  numbness
soapp - r  -  how often mood swings
soapp - r  -  need higher doses of medication
soapp - r  -  felt impatient with doctors
soapp - r  -  felt that things are overwhelming
soapp - r  -  how often tension at home
soapp - r  -  how often counted pain pills
soapp - r  -  concerned people will judge you
soapp - r  -  how often feel bored
soapp - r  -  how often taken more pain medication
soapp - r  -  worried about being left alone
soapp - r  -  felt craving for medication
soapp - r  -  others expressed concern over medication use
soapp - r  -  how often friends had problem
soapp - r  -  others told you bad temper
soapp - r  -  felt consumed to get pain medication
soapp - r  -  run out of pain medication early
soapp - r  -  others kept you from what you deserve
soapp - r  -  legal problems or arrested
soapp - r  -  attended aa or na meeting
soapp - r  -  argument where someone got hurt
soapp - r  -  how often sexually abused
soapp - r  -  others suggested drug or alcohol problem
soapp - r  -  how often borrowed pain medication
soapp - r  -  treated for alcohol or drug problem
soapp - r  -  any additional information
soapp - r  -  score
prostatic fluid
thousand copies per milliliter
million copies per milliliter
diopter
ethyleneimine
copies per milliliter
updrs  -  mentation ,  behavior and mood: intellectual impairment
updrs  -  mentation ,  behavior and mood: thought disorder
updrs  -  mentation ,  behavior and mood: depression
updrs  -  mentation ,  behavior and mood: motivation / initiative
updrs  -  activities of daily living: speech
updrs  -  activities of daily living: salivation
updrs  -  activities of daily living: swallowing
updrs  -  activities of daily living: handwriting
updrs  -  activities of daily living: cutting food and handling utensils
updrs  -  activities of daily living: dressing
updrs  -  activities of daily living: hygiene
updrs  -  activities of daily living: turning in bed and adjusting bed clothes
updrs  -  activities of daily living: falling
updrs  -  activities of daily living: freezing when walking
updrs  -  activities of daily living: walking
updrs  -  activities of daily living: tremor
updrs  -  activities of daily living: sensory complaints related to parkinsonism
updrs  -  motor examination: speech
updrs  -  motor examination: facial expression
updrs  -  motor examination: tremor at rest
updrs  -  motor examination: action or postural tremor of hand
updrs  -  motor examination: rigidity
updrs  -  motor examination: finger taps
updrs  -  motor examination: hand movements
updrs  -  motor examination: rapid alternating movements of hands
updrs  -  motor examination: leg agility
updrs  -  motor examination: arising from chair
updrs  -  motor examination: posture
updrs  -  motor examination: gait
updrs  -  motor examination: postural stability
updrs  -  motor examination: body bradykinesia and hypokinesia
updrs  -  complications of therapy: dyskinesias  -  duration
updrs  -  complications of therapy: dyskinesias  -  disability
updrs  -  complications of therapy: dyskinesias  -  painful dyskinesias
updrs  -  complications of therapy: dyskinesias  -  presence of early morning dystonia
updrs  -  complications of therapy: clinical fluctuations  -  off periods predictable
updrs  -  complications of therapy: clinical fluctuations  -  off periods unpredictable
updrs  -  complications of therapy: clinical fluctuations  -  off periods sudden
updrs  -  complications of therapy: clinical fluctuations  -  average off periods per day
updrs  -  complications of therapy: other complications  -  anorexia ,  nausea ,  or vomiting
updrs  -  complications of therapy: other complications  -  sleep disturbances
updrs  -  complications of therapy: other complications  -  symptomatic orthostasis
updrs  -  modified hoehn and yahr staging
updrs  -  schwab and england activities of daily living scale
pulse pressure
forearm circumference
hip circumference
waist circumference
wpai:shp v2 .0  -  currently employed
wpai:shp v2 .0  -  missed work hours due to problem
wpai:shp v2 .0  -  missed work hours due to other reasons
wpai:shp v2 .0  -  hours actually worked
wpai:shp v2 .0  -  problem affects productivity
wpai:shp v2 .0  -  problem affects regular daily activity
cgi  -  severity of illness
cgi  -  global improvement
cgi  -  efficacy index
comm  -  trouble thinking clearly or memory problems
comm  -  complaints not completing tasks
comm  -  other sources for pain medication
comm  -  taken medications other than prescribed
comm  -  seriously thought of hurting self
comm  -  time spent thinking about opioids
comm  -  been in an argument
comm  -  trouble controlling anger
comm  -  take medications belonging to others
comm  -  worry about handling medications
comm  -  others worry about your medications
comm  -  emergency phone call or clinic visit
comm  -  gotten angry with people
comm  -  take more medication than prescribed
comm  -  borrowed medication from others
comm  -  used pain medicine for other symptoms
comm  -  visit emergency room
comm  -  score
c - ssrs baseline  -  wish to be dead or go to sleep and not wake up
c - ssrs baseline  -  description of wish to be dead
c - ssrs baseline  -  non - specific suicidal thought
c - ssrs baseline  -  description of non - specific suicide thought
c - ssrs baseline  -  suicidal ideation - no intent
c - ssrs baseline  -  description of suicidal ideation - no intent
c - ssrs baseline  -  ideation with plan / intent
c - ssrs baseline  -  description of ideation with plan and intent
c - ssrs baseline  -  most severe ideation
c - ssrs baseline  -  describe most severe ideation
c - ssrs baseline  -  frequency of most severe ideation
c - ssrs baseline  -  duration of most severe ideation
c - ssrs baseline  -  control over most severe ideation
c - ssrs baseline  -  deterrents to most severe ideation
c - ssrs baseline  -  reasons for most severe ideation
c - ssrs baseline  -  actual suicide attempt
c - ssrs baseline  -  number of actual suicide attempts
c - ssrs baseline  -  description of actual suicide attempts
c - ssrs baseline  -  non - suicidal self - injurious behavior
c - ssrs baseline  -  interrupted suicide attempt
c - ssrs baseline  -  number of interrupted suicide attempts
c - ssrs baseline  -  description of interrupted suicide attempt
c - ssrs baseline  -  aborted suicide attempt
c - ssrs baseline  -  number of aborted suicide attempts
nafazatrom
cmft regimen
c - ssrs baseline  -  description of aborted suicide attempt
c - ssrs baseline  -  preparatory acts or behaviors toward suicide attempt
c - ssrs baseline  -  description of preparatory acts or behaviors toward suicide attempt
c - ssrs baseline  -  suicidal behavior
c - ssrs baseline  -  most recent suicide attempt date
c - ssrs baseline  -  most recent suicide attempt damage
c - ssrs baseline  -  most recent suicide attempt potential
c - ssrs baseline  -  most lethal suicide attempt date
c - ssrs baseline  -  most lethal suicide attempt damage
c - ssrs baseline  -  most lethal suicide attempt potential
c - ssrs baseline  -  first suicide attempt date
c - ssrs baseline  -  first suicide attempt damage
c - ssrs baseline  -  first suicide attempt potential
fpsr  -  how much do you hurt
c - ssrs baseline  -  ideation with intent ,  no plan
c - ssrs baseline  -  description of ideation with intent ,  no plan
carbohydrate - deficient transferrin measurement
3 , 4 - dihydroxyphenylglycol measurement
mds - updrs  -  get out of bed ,  car ,  or deep chair
mnsi  -  right foot dry skin ,  callus
mnsi  -  left foot dry skin ,  callus
sf - mpq - 2  -  tingling or 'pins and needles'
cerebral arterial aneurysm
cerebral venous aneurysm
colon atresia
duodenal atresia
ileal atresia
jejunal atresia
neonatal aspiration of amniotic fluid
atrioventricular septal defect
complete atrioventricular canal defect balanced
complete atrioventricular canal defect unbalanced
dextrocardia situs solitus
functional bowel obstruction
intentional trauma
neonatal injury related to birth
retinopathy of prematurity with plus disease
transient tachypnea of the newborn
lethal multiple pterygium syndrome
escobar syndrome
total colonic aganglionosis
short segment hirschsprung disease
steroid 21 - monooxygenase deficiency
methemoglobin reductase deficiency
spina bifida occulta
drug induced methemoglobinemia
atic / alk fusion gene
atic / alk fusion protein
bcr / jak2 fusion gene
bcr / jak2 fusion protein
aortopulmonary window
cbfb / myh11 fusion gene
cbfb / myh11 fusion protein
col1a2 / plag1 fusion gene
has2 / plag1 fusion gene
fus / creb3l1 fusion gene
fus / creb3l1 fusion protein
mll / ell fusion gene
mll / ell fusion protein
msn / alk fusion gene
msn / alk fusion protein
nono / tfe3 fusion gene
nono / tfe3 fusion protein
npm1 / rara short fusion gene
npm1 / rara long fusion gene
npm1 / rara short fusion protein
npm1 / rara long fusion protein
pax3 / foxo4 fusion gene
pax3 / foxo4 fusion protein
pax3 / ncoa1 fusion gene
pax3 / ncoa1 fusion protein
rpn1 / mecom fusion gene
ss18l1 / ssx1 fusion gene
ss18l1 / ssx1 fusion protein
total intestinal aganglionosis
tfg / alk fusion gene
tfg / alk fusion protein
tfg / alk short form fusion gene
tfg / alk long form fusion gene
tfg / alk extra long form fusion gene
tfg / alk short form fusion protein
tfg / alk long form fusion protein
tfg / alk extra long form fusion protein
tpm3 / alk fusion gene
tpm3 / alk fusion protein
tpm4 / alk fusion gene
tpm4 / alk fusion protein
arid2 gene
arid2 wt allele
at - rich interactive domain - containing protein 2
bcor gene
bcor wt allele
bcl - 6 corepressor
trivalent live - attenuated influenza vaccine
cdk12 gene
cdk12 wt allele
cyclin - dependent kinase 12
nutm2a gene
nutm2a wt allele
beauvericin
cytarabine / daunorubicin / prednisone / thioguanine regimen
nut family member 2a
nutm2b gene
nutm2b wt allele
nut family member 2b
fbxo11 gene
fbxo11 wt allele
f - box only protein 11
hey1 gene
hey1 wt allele
hairy / enhancer - of - split related with yrpw motif protein 1
srsf2 gene
srsf2 wt allele
serine / arginine - rich splicing factor 2
u2af1 gene
u2af1 wt allele
splicing factor u2af 35 kda subunit
ywhae gene
ywhae wt allele
14 - 3 - 3 protein epsilon
geometric shape
zrsr2 gene
zrsr2 wt allele
u2 small nuclear ribonucleoprotein auxiliary factor 35 kda subunit - related protein 2
annotation collection
worklist
discordance
stil gene
stil wt allele
scl - interrupting locus protein
task
conjugated estrogens / cyclophosphamide / doxorubicin / fluorouracil / methotrexate / tamoxifen
guarana supplement
elsiglutide
mtor1 / 2 kinase inhibitor me - 344
zirconium zr 89 desferrioxamine b monoclonal antibody huj591
entity statement
image annotation statement
milliampere second
dose length product
computed tomography dose index volume
egfr nm_005228 .3:c .334_1137del804
egfr np_005219 .2:p .k29_n298insg
lysozyme immunohistochemistry
research use only
viral small rna
syp gene
syp wt allele
synaptophysin
cd57 antigen
dsg3 gene
dsg3 wt allele
desmoglein - 3
spn gene
spn wt allele
leukosialin
cd9 gene
cd9 wt allele
cd9 antigen
hla - dra gene
hla - dra wt allele
hla class ii histocompatibility antigen ,  dr alpha chain
agonizing pain
annoying pain
killing pain
miserable pain
nagging pain
sickening pain
terrifying pain
tiring pain
torturing pain
troublesome pain
unbearable pain
burning pain
cramping pain
crushing pain
dull pain
hurting pain
pressing pain
radiating pain
sharp pain
shooting pain
splitting pain
stabbing pain
tearing pain
painometer
dextro - transposition of the great vessels with intact ventricular septum
dextro - transposition of the great vessels with ventricular septal defect
bilateral anophthalmos
unilateral anophthalmos
bilateral microphthalmos
unilateral microphthalmos
acquired bilateral cataracts
acquired unilateral cataract
bilateral cataracts
congenital bilateral cataracts
congenital unilateral cataract
congenital ventricular tachycardia
congenital supraventricular tachycardia
congenital facial nerve palsy
congenital phrenic nerve palsy
benzodiazepine
neonatal alloimmune thrombocytopenia
myelomeningocele
cervical myelomeningocele
lumbar myelomeningocele
indefinite
debond procedure
circumferential supracrestal fiberotomy
sacral myelomeningocele
thoracic myelomeningocele
spinal meningocele
cervical meningocele
lumbar meningocele
sacral meningocele
thoracic meningocele
spina bifida
mullerian inhibiting factor deficiency
myopathy
retinal examination
hemolytic anemia due to membrane defect
bilateral renal agenesis
tpdcv regimen
unilateral renal agenesis
birth head circumference
complete trisomy 21 syndrome
complete trisomy 13 syndrome
bonaire ,  sint eustatius and saba
curacao
sint maarten  ( dutch part )
hsp90 inhibitor pu - h71
bilateral glaucoma
hypernatremic dehydration
triage status
medical device deployment
intracoronary device
coronary vessel bifurcation lesion
cardiac rehabilitation
exercise counseling
defibrillation threshold
upper limit of vulnerability for induction of ventricular fibrillation
cardiac lead function indicator
in situ existing lead
in situ lead status
lead dislodgement
reimplantation
substance adverse event
tobacco cessation counseling
antitachycardia pacing
perforation due to lead
appropriate treatment
explantation
peripheral embolus
peripheral nerve injury
cardioverter defibrillator shock therapy
venous obstruction
aorta disease
renal artery disease
aldosterone receptor antagonist
glycoprotein iib / iiia antagonist
igf - 1r antisense oligodeoxynucleotide - treated autologous glioma cells
cd19car - cd3zeta - 4 - 1bb - expressing allogeneic t - lymphocyte cells
pegylated recombinant l - asparaginase erwinia chrysanthemi
multifunctional / multitargeted anticancer agent omn54
bevacizumab - irdye 800cw
liposomal muc1 / pet - lipid a vaccine ont - 10
sofosbuvir
tubulin polymerization inhibitor ckd - 516
bovine lactoferrin supplement
random periareolar fine - needle aspiration
estrogen receptor and / or progesterone receptor positive
bilateral optic nerve hypoplasia
unilateral optic nerve hypoplasia
kernicterus related to isoimmunization
perinatal central nervous system depression
spinal cord infarct during birth
suspected necrotizing enterocolitis
traumatic chylothorax
duodenal band
ileal band
jejunal band
spinal injury related to birth
laryngeal agenesis
has_data_element
have
pik3r2 gene
pik3r2 wt allele
phosphatidylinositol 3 - kinase regulatory subunit beta
ralbp1 gene
ralbp1 wt allele
rala - binding protein 1
integrin alpham / beta2
atmin gene
atmin wt allele
atm interactor
next generation sequencing
whole genome sequencing
whole exome sequencing
exome
tspyl2 gene
tspyl2 wt allele
testis - specific y - encoded - like protein 2
benznidazole
cdc34 gene
cdc34 wt allele
therapeutic area
ubiquitin - conjugating enzyme e2 r1
hemolytic disease of the newborn
colonic band
nlrp6 gene
nlrp6 wt allele
nacht ,  lrr and pyd domains - containing protein 6
htra1 gene
htra1 wt allele
serine protease htra1
immature retinopathy of prematurity
bilateral renal dysplasia
coronary anomaly
colonic web
facial nerve palsy related to trauma
fracture of long bone related to birth
fracture of skull related to birth
transient leukemoid reaction of the newborn
perinatal blood aspiration syndrome
neonatal drug withdrawal
complete atrioventricular septal defect with tetralogy of fallot
perinatal intraventricular hemorrhage
heterotaxy syndrome with polysplenia
heterotaxy syndrome with asplenia
pericardial anomaly
mitochondrial myopathy
congenital malformation syndrome related to known exogenous cause
neonatal resuscitation
respiratory failure related to neuromuscular disorder
respiratory failure related to central nervous system disorder
coagulation disorder related to liver dysfunction
organic acid metabolism disorder
rnasel gene
rnasel wt allele
2 - 5a - dependent ribonuclease
arterial thrombosis related to vascular access complication
venous thrombosis related to vascular access complication
arvcf gene
arvcf wt allele
armadillo repeat protein deleted in velo - cardio - facial syndrome
cry1 gene
cry1 wt allele
cryptochrome - 1
stag2 gene
stag2 wt allele
cohesin subunit sa - 2
ubqln2 gene
ubqln2 wt allele
ubiquilin - 2
gpr183 gene
gpr183 wt allele
g - protein coupled receptor 183
phlpp1 gene
phlpp1 wt allele
ph domain leucine - rich repeat - containing protein phosphatase 1
arhgap29 gene
temp regimen
arhgap29 wt allele
rho gtpase - activating protein 29
complete trisomy 18 syndrome
kcnma1 gene
kcnma1 wt allele
calcium - activated potassium channel subunit alpha - 1
anti - cd40 monoclonal antibody chi lob 7 / 4
cd - expressing bifidobacterium aps001f
danvatirsen
gallium ga 68 - edotreotide
immunomodulatory agent cc - 11006
lentivirus vector rhiv7 - shi - tar - ccr5rz - transduced hematopoietic progenitor cells
tiaf1 gene
tiaf1 wt allele
tgfb1 - induced anti - apoptotic factor 1
sh3bp5 gene
sh3bp5 wt allele
sh3 domain - binding protein 5
thbd gene
thbd wt allele
thrombomodulin
nisch gene
nisch wt allele
nischarin
unc45a gene
unc45a wt allele
protein unc - 45 homolog a
pulsatility index
tpt1 gene
tpt1 wt allele
translationally - controlled tumor protein
esrra gene
esrra wt allele
steroid hormone receptor err1
catsperz gene
catsperz wt allele
cation channel sperm - associated protein subunit zeta
c9orf72 gene
c9orf72 wt allele
verteporfin
uncharacterized protein c9orf72
grn gene
grn wt allele
granulins
gpc6 gene
gpc6 wt allele
glypican - 6
tll1 gene
tll1 wt allele
tolloid - like protein 1
foxo6 gene
foxo6 wt allele
forkhead box protein o6
aicda gene
aicda wt allele
single - stranded dna cytosine deaminase
lin28b gene
lin28b wt allele
protein lin - 28 homolog b
ddx58 gene
ddx58 wt allele
probable atp - dependent rna helicase ddx58
postn gene
postn wt allele
periostin
kif5b gene
kif5b wt allele
kinesin - 1 heavy chain
wdcp gene
wdcp wt allele
wd repeat and coiled - coil - containing protein
sdc4 gene
sdc4 wt allele
syndecan - 4
slc34a2 gene
slc34a2 wt allele
sodium - dependent phosphate transport protein 2b
sh3bp2 gene
sh3bp2 wt allele
sh3 domain - binding protein 2
camta1 gene
camta1 wt allele
calmodulin - binding transcription activator 1
h3 - 3a gene
h3 - 3a wt allele
histone h3 .3
lrig3 gene
lrig3 wt allele
leucine - rich repeats and immunoglobulin - like domains protein 3
phf6 gene
phf6 wt allele
phd finger protein 6
ect2l gene
ect2l wt allele
epithelial cell - transforming sequence 2 oncogene - like
mast1 gene
mast1 wt allele
microtubule - associated serine / threonine - protein kinase 1
mast2 gene
mast2 wt allele
microtubule - associated serine / threonine - protein kinase 2
obsolete procedure_has_target_disease
obsolete procedure_uses_manufactured_object
znf700 gene
znf700 wt allele
zinc finger protein 700
gpbp1l1 gene
gpbp1l1 wt allele
vasculin - like protein 1
tada2a gene
tada2a wt allele
transcriptional adapter 2 - alpha
sec16a gene
sec16a wt allele
protein transport protein sec16a
sec31a gene
sec31a wt allele
protein transport protein sec31a
sec22b gene
sec22b wt allele
vesicle - trafficking protein sec22b
gabbr2 gene
gabbr2 wt allele
gamma - aminobutyric acid type b receptor subunit 2
lgr5 gene
lgr5 wt allele
leucine - rich repeat - containing g - protein coupled receptor 5
nup107 gene
nup107 wt allele
nuclear pore complex protein nup107
bemp regimen
sqstm1 gene
sqstm1 wt allele
sequestosome - 1
ppfibp1 gene
ppfibp1 wt allele
liprin - beta - 1
esrp1 gene
esrp1 wt allele
epithelial splicing regulatory protein 1
ubenimex
agtrap gene
agtrap wt allele
type - 1 angiotensin ii receptor - associated protein
ssbp2 gene
ssbp2 wt allele
single - stranded dna - binding protein 2
fchsd1 gene
fchsd1 wt allele
f - bar and double sh3 domains protein 1
api / fdf analytical testing site
fdf manufacture
clinical bioequivalence or bioavailability study
in vitro bioequivalence or bioanalytical testing
transarterial chemoembolization
transarterial
palliative
gamma - delta tocotrienol
tocotrienol - rich fraction
edicotinib
flt3 / kit kinase inhibitor akn - 028
anti - dll4 monoclonal antibody medi0639
indium in 111 anti - cd45 monoclonal antibody bc8
hypoxia - activated prodrug th - 4000
indusatumab vedotin
trpv6 calcium channel inhibitor sor - c13
treatment epoch
interphalangeal joint
proximal interphalangeal joint
distal interphalangeal joint
folate binding protein e39 peptide vaccine
mek inhibitor wx - 554
unapproved drug for use in drug shortage
cicletanine hydrochloride
molibresib
stage i differentiated thyroid gland carcinoma under 45 years ajcc v7
stage i differentiated thyroid gland carcinoma 45 years and older ajcc v7
stage ii differentiated thyroid gland carcinoma under 45 years ajcc v7
stage ii differentiated thyroid gland carcinoma 45 years and older ajcc v7
egln1 gene
egln1 wt allele
egl nine homolog 1
tyk2 gene
tyk2 wt allele
non - receptor tyrosine - protein kinase tyk2
p4ha2 gene
p4ha2 wt allele
prolyl 4 - hydroxylase subunit alpha - 2
mx2 gene
mx2 wt allele
interferon - induced gtp - binding protein mx2
lgals13 gene
lgals13 wt allele
galactoside - binding soluble lectin 13
tumor bed
sgk1 gene
sgk1 wt allele
serine / threonine - protein kinase sgk1
sirt2 gene
sirt2 wt allele
nad - dependent deacetylase sirtuin - 2
ddx3x gene
ddx3x wt allele
atp - dependent rna helicase ddx3x
uba2 gene
uba2 wt allele
sumo - activating enzyme subunit 2
sae1 gene
sae1 wt allele
sumo - activating enzyme subunit 1
usp9x gene
usp9x wt allele
probable ubiquitin carboxyl - terminal hydrolase faf - x
ccr2 gene
ccr2 wt allele
c - c chemokine receptor type 2
foxm1 gene
foxm1 wt allele
forkhead box protein m1
tdg gene
tdg wt allele
g / t mismatch - specific thymine dna glycosylase
sting1 gene
sting1 wt allele
stimulator of interferon genes protein
myocardial infarction by ecg finding
vacad regimen
hoxb9 gene
hoxb9 wt allele
homeobox protein hox - b9
deptor gene
deptor wt allele
dep domain - containing mtor - interacting protein
acute myocardial infarction by ecg finding
old myocardial infarction by ecg finding
silent myocardial infarction by ecg finding
atf5 gene
beta - carotene
atf5 wt allele
cyclic amp - dependent transcription factor atf - 5
rnh1 gene
rnh1 wt allele
ribonuclease inhibitor
fscn1 gene
fscn1 wt allele
fascin
dtl gene
dtl wt allele
denticleless protein homolog
sharpin gene
sharpin wt allele
sharpin
akt1s1 gene
akt1s1 wt allele
proline - rich akt1 substrate 1
zmym3 gene
zmym3 wt allele
zinc finger mym - type protein 3
prrt2 gene
prrt2 wt allele
proline - rich transmembrane protein 2
ms4a2 gene
ms4a2 wt allele
high affinity immunoglobulin epsilon receptor subunit beta
pitpnc1 gene
pitpnc1 wt allele
cytoplasmic phosphatidylinositol transfer protein 1
gas6 gene
gas6 wt allele
growth arrest - specific protein 6
swi5 gene
swi5 wt allele
dna repair protein swi5 homolog
numb gene
numb wt allele
protein numb homolog
tbx3 gene
tbx3 wt allele
t - box transcription factor tbx3
palb2 gene mutation
adjuvant radiotherapy
serpinf1 gene
serpinf1 wt allele
pigment epithelium - derived factor
foxa1 gene
foxa1 wt allele
hepatocyte nuclear factor 3 - alpha
gdf3 gene
gdf3 wt allele
growth / differentiation factor 3
golim4 gene
golim4 wt allele
golgi integral membrane protein 4
rgs4 gene
rgs4 wt allele
regulator of g - protein signaling 4
tmem138 gene
tmem138 wt allele
transmembrane protein 138
tmem216 gene
tmem216 wt allele
transmembrane protein 216
mir375 gene
mir375 wt allele
mir375 pre - mirna
actively marketed
medical device brand name family
manufacturing date production identifier
expiration date production identifier
serial number production identifier
lot or batch number production identifier
labeled as containing natural rubber latex
human cells or tissue product
no longer marketed
packaged as sterile
fda device listing number
direct marking device identifier
excepted from direct marking
french catheter gauge
recommended handling atmospheric pressure
recommended handling humidity
recommended handling temperature
device labeler
inner diameter
medical device model family
needle gauge
never marketed
hydrogen peroxide sterilization
ozone sterilization
chlorine dioxide sterilization
ethylene oxide - in - a - bag sterilization
high intensity light or pulse light sterilization
microwave radiation sterilization
sound wave sterilization
ultraviolet light sterilization
vaporized peracetic acid sterilization
primary package identifier
glucuronidase inhibitor
reason for direct part exempt marking
labeler regulatory contact for fda
second greatest diameter
special storage condition
recommended storage atmospheric pressure
recommended storage humidity
recommended storage temperature
device labeler customer contact
third greatest diameter
third party regulatory information submitter
to be marketed
dry heat sterilization
ethylene oxide sterilization
moist heat or steam sterilization
radiation sterilization
global unique device identification database submission
unit of use device identifier
hpn gene
hpn wt allele
serine protease hepsin
eed gene
primary device identifier
eed wt allele
secondary device identifier
polycomb protein eed
rbbp4 gene
rbbp4 wt allele
histone - binding protein rbbp4
errfi1 gene
errfi1 wt allele
erbb receptor feedback inhibitor 1
h3c2 gene
h3c2 wt allele
histone h3 .1
amh gene
amh wt allele
muellerian - inhibiting factor
nr1d1 gene
nr1d1 wt allele
nuclear receptor subfamily 1 group d member 1
nr1d2 gene
nr1d2 wt allele
nuclear receptor subfamily 1 group d member 2
snx18 gene
snx18 wt allele
sorting nexin - 18
ffar1 gene
ffar1 wt allele
free fatty acid receptor 1
klrk1 gene
klrk1 wt allele
nkg2 - d type ii integral membrane protein
cdh23 gene
cdh23 wt allele
cadherin - 23
ttn gene
ttn wt allele
titin
mmp10 gene
vbmf regimen
mmp10 wt allele
stromelysin - 2
b3gat1 gene
lavandula angustifolia
b3gat1 wt allele
galactosylgalactosylxylosylprotein 3 - beta - glucuronosyltransferase 1
ppargc1b gene
ppargc1b wt allele
peroxisome proliferator - activated receptor gamma coactivator 1 - beta
tff3 gene
tff3 wt allele
trefoil factor 3
respiratory arrest
mesothelin - specific chimeric antigen receptor - engineered peripheral blood lymphocytes
il33 gene
il33 wt allele
iobenguane i - 124
multi - epitope folate receptor alpha peptide vaccine
lipegfilgrastim
interleukin - 33
arhgef2 gene
arhgef2 wt allele
rho guanine nucleotide exchange factor 2
ect2 gene
ect2 wt allele
protein ect2
multi - agc kinase inhibitor at13148
til 1383i t cell receptor - transduced autologous t cells
lipopolysaccharide
adenoviral transduced hil - 12 - expressing autologous dendritic cells inxn - 3001 plus activator ligand inxn - 1001
alectinib
olmutinib
linoleyl carbonate - paclitaxel
topical calcitriol
aerosolized aldesleukin
torc1 / 2 kinase inhibitor ds - 3078a
allogeneic adenovirus - specific cytotoxic t lymphocytes
abraxas1 gene
abraxas1 wt allele
brca1 - a complex subunit abraxas 1
klebsiella pneumoniae glycoprotein
tfcp2 gene
tfcp2 wt allele
alpha - globin transcription factor cp2
f2 gene product
des - gamma carboxyprothrombin
cdisc clinical classification aims test code terminology
cdisc clinical classification aims test name terminology
cdisc functional test adni avlt test code terminology
cdisc functional test adni avlt test name terminology
cdisc questionnaire bars test code terminology
cdisc questionnaire bars test name terminology
cdisc questionnaire cdr test code terminology
cdisc questionnaire cdr test name terminology
cdisc questionnaire cows test code terminology
cdisc questionnaire cows test name terminology
cdisc clinical classification ecog test code terminology
cdisc clinical classification ecog test name terminology
cdisc questionnaire eq - 5d - 5l test code terminology
cdisc questionnaire eq - 5d - 5l test name terminology
cdisc clinical classification hama test code terminology
cdisc clinical classification hama test name terminology
cdisc clinical classification hamd 21 test code terminology
cdisc clinical classification hamd 21 test name terminology
cdisc questionnaire sf36 v1 .0 acute test code terminology
cdisc questionnaire sf36 v1 .0 acute test name terminology
cdisc questionnaire sf36 v2 .0 acute test name terminology
cdisc questionnaire sf36 v2 .0 standard test code terminology
cdisc questionnaire sf36 v2 .0 standard test name terminology
cdisc questionnaire sows subjective test code terminology
cdisc questionnaire sows subjective test name terminology
cdisc questionnaire ymrs test code terminology
cdisc questionnaire ymrs test name terminology
cdisc sdtm findings about test code terminology
cdisc sdtm findings about test name terminology
cdisc sdtm normal abnormal response terminology
cdisc sdtm findings about object terminology
cdisc clinical data element glossary terminology
cdisc sdtm consensus cardiac classification systems test name terminology
cdisc sdtm consensus cardiac classification systems test code terminology
cdisc sdtm new york heart association class responses terminology
cdisc sdtm killip class responses terminology
cdisc sdtm thrombolysis in myocardial infarction flow responses terminology
cdisc sdtm canadian cardiovascular society classification terminology
cdisc sdtm coronary artery disease presentation terminology
cdisc sdtm coronary artery disease symptoms terminology
cdisc sdtm mechanical circulatory support placement timing terminology
cdisc sdtm cardiovascular test name terminology
cdisc sdtm cardiovascular test code terminology
cdisc sdtm risk assessment terminology
cdisc sdtm coronary artery disease risk terminology
cdisc sdtm coronary vessel disease extent terminology
cdisc sdtm location of most severe stenosis within a graft terminology
cdisc sdtm sudden death syndrome type terminology
cdisc sdtm cardiac valvular regurgitation severity terminology
cdisc sdtm cardiac valvular stenosis severity terminology
cdisc sdtm non - system reason for pci delay terminology
cdisc sdtm procedure urgency status terminology
cdisc sdtm diabetes therapy terminology
cdisc sdtm procedure terminology
cdisc sdtm cardiac procedure indication terminology
cdisc sdtm coronary artery dominance terminology
cdisc sdtm lesion complexity terminology
cdisc sdtm lead abnormality terminology
cdisc sdtm discharge disposition terminology
cdisc sdtm reason coronary sinus access or left ventricular lead not implanted terminology
cdisc sdtm acute coronary syndrome presentation category terminology
cdisc sdtm cardiac rhythm device failure manifestation terminology
cdisc sdtm lead status terminology
cdisc sdtm left ventricular ejection fraction measurement result terminology
aims clinical classification question
adni - avlt questionnaire question
bars questionnaire question
cdr questionnaire question
cows questionnaire question
ecog clinical classification question
eq - 5d - 5l questionnaire question
hama questionnaire question
hamd 21 questionnaire question
sf36 v1 0 acute questionnaire question
sf36 v2 0 standard questionnaire question
sf36 v2 0 acute questionnaire question
sows subjective questionnaire question
ymrs questionnaire question
cdisc questionnaire sf36 v2 .0 acute test code terminology
spl business operation qualifier terminology
manufactures non - generics
not tested
st elevation myocardial infarction by ecg finding
epha2 - targeting dopc - encapsulated sirna
epidermal growth factor ointment
allogeneic gm - csf - secreting tumor vaccine panc 6 .03 pcdna - 1 / gm - neo
allogeneic gm - csf - secreting tumor vaccine panc 10 .05 pcdna - 1 / gm - neo
hla - a*2402 - restricted multipeptide vaccine s - 488410
poly - alendronate dextran - guanidine conjugate
elgemtumab
adni avlt  -  list a recall 1 word 1
adni avlt  -  list a recall 1 word 2
adni avlt  -  list a recall 1 word 3
adni avlt  -  list a recall 1 word 4
bisantrene
adni avlt  -  list a recall 1 word 5
adni avlt  -  list a recall 1 word 6
adni avlt  -  list a recall 1 word 7
adni avlt  -  list a recall 1 word 8
adni avlt  -  list a recall 1 word 9
adni avlt  -  list a recall 1 word 10
adni avlt  -  list a recall 1 word 11
adni avlt  -  list a recall 1 word 12
adni avlt  -  list a recall 1 word 13
adni avlt  -  list a recall 1 word 14
adni avlt  -  list a recall 1 word 15
adni avlt  -  list a recall 1 total
adni avlt  -  list a intrusions 1
adni avlt  -  list a recall 2 word 1
adni avlt  -  list a recall 2 word 2
adni avlt  -  list a recall 2 word 3
adni avlt  -  list a recall 2 word 4
adni avlt  -  list a recall 2 word 5
adni avlt  -  list a recall 2 word 6
adni avlt  -  list a recall 2 word 7
adni avlt  -  list a recall 2 word 8
adni avlt  -  list a recall 2 word 9
adni avlt  -  list a recall 2 word 10
adni avlt  -  list a recall 2 word 11
adni avlt  -  list a recall 2 word 12
adni avlt  -  list a recall 2 word 13
adni avlt  -  list a recall 2 word 14
adni avlt  -  list a recall 2 word 15
adni avlt  -  list a recall 2 total
adni avlt  -  list a intrusions 2
adni avlt  -  list a recall 3 word 1
adni avlt  -  list a recall 3 word 2
adni avlt  -  list a recall 3 word 3
adni avlt  -  list a recall 3 word 4
adni avlt  -  list a recall 3 word 5
adni avlt  -  list a recall 3 word 6
adni avlt  -  list a recall 3 word 7
adni avlt  -  list a recall 3 word 8
adni avlt  -  list a recall 3 word 9
adni avlt  -  list a recall 3 word 10
adni avlt  -  list a recall 3 word 11
adni avlt  -  list a recall 3 word 12
adni avlt  -  list a recall 3 word 13
adni avlt  -  list a recall 3 word 14
adni avlt  -  list a recall 3 word 15
adni avlt  -  list a recall 3 total
adni avlt  -  list a intrusions 3
adni avlt  -  list a recall 4 word 1
adni avlt  -  list a recall 4 word 2
adni avlt  -  list a recall 4 word 3
adni avlt  -  list a recall 4 word 4
adni avlt  -  list a recall 4 word 5
adni avlt  -  list a recall 4 word 6
adni avlt  -  list a recall 4 word 7
adni avlt  -  list a recall 4 word 8
adni avlt  -  list a recall 4 word 9
adni avlt  -  list a recall 4 word 10
adni avlt  -  list a recall 4 word 11
adni avlt  -  list a recall 4 word 12
adni avlt  -  list a recall 4 word 13
adni avlt  -  list a recall 4 word 14
adni avlt  -  list a recall 4 word 15
adni avlt  -  list a recall 4 total
adni avlt  -  list a intrusions 4
adni avlt  -  list a recall 5 word 1
adni avlt  -  list a recall 5 word 2
adni avlt  -  list a recall 5 word 3
adni avlt  -  list a recall 5 word 4
adni avlt  -  list a recall 5 word 5
adni avlt  -  list a recall 5 word 6
adni avlt  -  list a recall 5 word 7
adni avlt  -  list a recall 5 word 8
adni avlt  -  list a recall 5 word 9
adni avlt  -  list a recall 5 word 10
adni avlt  -  list a recall 5 word 11
adni avlt  -  list a recall 5 word 12
adni avlt  -  list a recall 5 word 13
adni avlt  -  list a recall 5 word 14
adni avlt  -  list a recall 5 word 15
adni avlt  -  list a recall 5 total
adni avlt  -  list a intrusions 5
adni avlt  -  list a recall 6  ( after b )  word 1
adni avlt  -  list a recall 6  ( after b )  word 2
adni avlt  -  list a recall 6  ( after b )  word 3
adni avlt  -  list a recall 6  ( after b )  word 4
adni avlt  -  list a recall 6  ( after b )  word 5
adni avlt  -  list a recall 6  ( after b )  word 6
adni avlt  -  list a recall 6  ( after b )  word 7
adni avlt  -  list a recall 6  ( after b )  word 8
adni avlt  -  list a recall 6  ( after b )  word 9
adni avlt  -  list a recall 6  ( after b )  word 10
adni avlt  -  list a recall 6  ( after b )  word 11
adni avlt  -  list a recall 6  ( after b )  word 12
adni avlt  -  list a recall 6  ( after b )  word 13
adni avlt  -  list a recall 6  ( after b )  word 14
adni avlt  -  list a recall 6  ( after b )  word 15
adni avlt  -  list a recall 6  ( after b )  total
adni avlt  -  list a intrusions 6
adni avlt  -  list b recall word 1
adni avlt  -  list b recall word 2
bismuth subsalicylate
adni avlt  -  list b recall word 3
adni avlt  -  list b recall word 4
adni avlt  -  list b recall word 5
adni avlt  -  list b recall word 6
adni avlt  -  list b recall word 7
adni avlt  -  list b recall word 8
adni avlt  -  list b recall word 9
adni avlt  -  list b recall word 10
adni avlt  -  list b recall word 11
adni avlt  -  list b recall word 12
cytarabine / hydrocortisone / methotrexate regimen
adni avlt  -  list b recall word 13
adni avlt  -  list b recall word 14
adni avlt  -  list b recall word 15
adni avlt  -  list b recall total
adni avlt  -  list b intrusions
adni avlt  -  list a 30 min delay recall word 1
adni avlt  -  list a 30 min delay recall word 2
adni avlt  -  list a 30 min delay recall word 3
adni avlt  -  list a 30 min delay recall word 4
adni avlt  -  list a 30 min delay recall word 5
adni avlt  -  list a 30 min delay recall word 6
adni avlt  -  list a 30 min delay recall word 7
adni avlt  -  list a 30 min delay recall word 8
adni avlt  -  list a 30 min delay recall word 9
adni avlt  -  list a 30 min delay recall word 10
adni avlt  -  list a 30 min delay recall word 11
adni avlt  -  list a 30 min delay recall word 12
adni avlt  -  list a 30 min delay recall word 13
adni avlt  -  list a 30 min delay recall word 14
adni avlt  -  list a 30 min delay recall word 15
adni avlt  -  list a 30 min delay recall total
adni avlt  -  list a 30 min delay intrusions
adni avlt  -  list a recognition total
adni avlt  -  list a recognition intrusions
aims  -  muscles of facial expression
aims  -  lips and perioral area
aims  -  jaw
aims  -  tongue
aims  -  upper extremities
aims  -  lower extremities
aims  -  neck ,  shoulders ,  hips
aims  -  severity of abnormal movements
aims  -  incapacitation due to abnormal movements
aims  -  patient's awareness of abnormal movements
aims  -  current teeth / dentures problems
aims  -  patient usually wears dentures
bars  -  objective
bars  -  subjective ,  awareness
bars  -  subjective ,  distress
bars  -  global clinical assessment
cdr  -  memory
cdr  -  orientation
cdr  -  judgment and problem solving
cdr  -  community affairs
cdr  -  home and hobbies
cdr  -  personal care
cows  -  resting pulse rate
cows  -  sweating
cows  -  restlessness
cows  -  pupil size
cows  -  bone or joint aches
cows  -  runny nose or tearing
cows  -  gi upset
cows  -  tremor
cows  -  yawning
cows  -  anxiety or irritability
cows  -  gooseflesh skin
eq - 5d - 5l  -  mobility
eq - 5d - 5l  -  self - care
eq - 5d - 5l  -  usual activities
eq - 5d - 5l  -  pain or discomfort
eq - 5d - 5l  -  anxiety or depression
eq - 5d - 5l  -  eq vas score
hama  -  anxious mood
hama  -  tension
hama  -  fears
hama  -  insomnia
hama  -  intellectual
hama  -  depressed mood
hama  -  somatic  ( muscular )
hama  -  somatic  ( sensory )
hama  -  cardiovascular symptoms
hama  -  respiratory symptoms
hama  -  gastrointestinal symptoms
hama  -  genitourinary symptoms
hama  -  autonomic symptoms
hama  -  behavior at interview
hamd - 21  -  depressed mood
hamd - 21  -  feelings of guilt
hamd - 21  -  suicide
hamd - 21  -  insomnia early
hamd - 21  -  insomnia middle
hamd - 21  -  insomnia late
hamd - 21  -  work and activities
hamd - 21  -  retardation
hamd - 21  -  agitation
hamd - 21  -  anxiety psychological
hamd - 21  -  anxiety somatic
hamd - 21  -  somatic symptoms gastro - intestinal
hamd - 21  -  somatic symptoms general
batanopride
hamd - 21  -  genital symptoms
hamd - 21  -  hypochondriasis
hamd - 21  -  loss of weight by history
hamd - 21  -  loss of weight measured
hamd - 21  -  insight
hamd - 21  -  diurnal variation
hamd - 21  -  diurnal variation severity
hamd - 21  -  depersonalization and derealization
hamd - 21  -  paranoid symptoms
hamd - 21  -  obsessional and compulsive symptoms
cyclophosphamide / mitoxantrone / prednisone / vincristine
hamd - 21  -  total score
abnormal involuntary movement scale clinical classification
alzheimer's disease neuroimaging initiative auditory verbal learning test functional test
barnes akathisia rating scale questionnaire
clinical dementia rating questionnaire
clinical opiate withdrawal scale questionnaire
european quality of life five dimension five level scale questionnaire
hamilton anxiety rating scale clinical classification
hamilton depression rating scale 21 - item clinical classification
short form 36 health survey acute ,  us version 1 .0 questionnaire
short form 36 health survey acute ,  us version 2 .0 questionnaire
short form 36 health survey standard ,  us version 2 .0 questionnaire
subjective opiate withdrawal scale questionnaire
young mania rating scale questionnaire
sf - 36 v1 .0 acute  -  question 1
sf - 36 v1 .0 acute  -  question 2
sf - 36 v1 .0 acute  -  question 3a
sf - 36 v1 .0 acute  -  question 3b
sf - 36 v1 .0 acute  -  question 3c
sf - 36 v1 .0 acute  -  question 3d
sf - 36 v1 .0 acute  -  question 3e
sf - 36 v1 .0 acute  -  question 3f
sf - 36 v1 .0 acute  -  question 3g
sf - 36 v1 .0 acute  -  question 3h
sf - 36 v1 .0 acute  -  question 3i
sf - 36 v1 .0 acute  -  question 3j
sf - 36 v1 .0 acute  -  question 4a
sf - 36 v1 .0 acute  -  question 4b
sf - 36 v1 .0 acute  -  question 4c
cyclophosphamide / fluorouracil / fluoxymesterone / methotrexate regimen
sf - 36 v1 .0 acute  -  question 4d
sf - 36 v1 .0 acute  -  question 5a
sf - 36 v1 .0 acute  -  question 5b
sf - 36 v1 .0 acute  -  question 5c
sf - 36 v1 .0 acute  -  question 6
sf - 36 v1 .0 acute  -  question 7
sf - 36 v1 .0 acute  -  question 8
sf - 36 v1 .0 acute  -  question 9a
sf - 36 v1 .0 acute  -  question 9b
sf - 36 v1 .0 acute  -  question 9c
sf - 36 v1 .0 acute  -  question 9d
sf - 36 v1 .0 acute  -  question 9e
sf - 36 v1 .0 acute  -  question 9f
sf - 36 v1 .0 acute  -  question 9g
sf - 36 v1 .0 acute  -  question 9h
sf - 36 v1 .0 acute  -  question 9i
sf - 36 v1 .0 acute  -  question 10
sf - 36 v1 .0 acute  -  question 11a
sf - 36 v1 .0 acute  -  question 11b
sf - 36 v1 .0 acute  -  question 11c
sf - 36 v1 .0 acute  -  question 11d
sf - 36 v2 .0 acute  -  question 1
sf - 36 v2 .0 acute  -  question 2
sf - 36 v2 .0 acute  -  question 3a
sf - 36 v2 .0 acute  -  question 3b
sf - 36 v2 .0 acute  -  question 3c
sf - 36 v2 .0 acute  -  question 3d
sf - 36 v2 .0 acute  -  question 3e
sf - 36 v2 .0 acute  -  question 3f
sf - 36 v2 .0 acute  -  question 3g
sf - 36 v2 .0 acute  -  question 3h
sf - 36 v2 .0 acute  -  question 3i
sf - 36 v2 .0 acute  -  question 3j
sf - 36 v2 .0 acute  -  question 4a
sf - 36 v2 .0 acute  -  question 4b
sf - 36 v2 .0 acute  -  question 4c
sf - 36 v2 .0 acute  -  question 4d
sf - 36 v2 .0 acute  -  question 5a
sf - 36 v2 .0 acute  -  question 5b
sf - 36 v2 .0 acute  -  question 5c
sf - 36 v2 .0 acute  -  question 6
sf - 36 v2 .0 acute  -  question 7
sf - 36 v2 .0 acute  -  question 8
sf - 36 v2 .0 acute  -  question 9a
sf - 36 v2 .0 acute  -  question 9b
sf - 36 v2 .0 acute  -  question 9c
sf - 36 v2 .0 acute  -  question 9d
sf - 36 v2 .0 acute  -  question 9e
sf - 36 v2 .0 acute  -  question 9f
sf - 36 v2 .0 acute  -  question 9g
sf - 36 v2 .0 acute  -  question 9h
sf - 36 v2 .0 acute  -  question 9i
sf - 36 v2 .0 acute  -  question 10
sf - 36 v2 .0 acute  -  question 11a
sf - 36 v2 .0 acute  -  question 11b
sf - 36 v2 .0 acute  -  question 11c
sf - 36 v2 .0 acute  -  question 11d
sf - 36 v2 .0 standard  -  question 1
sf - 36 v2 .0 standard  -  question 2
sf - 36 v2 .0 standard  -  question 3a
emitefur
bleomycin / vinblastine regimen
sf - 36 v2 .0 standard  -  question 3b
sf - 36 v2 .0 standard  -  question 3c
sf - 36 v2 .0 standard  -  question 3d
sf - 36 v2 .0 standard  -  question 3e
sf - 36 v2 .0 standard  -  question 3f
sf - 36 v2 .0 standard  -  question 3g
sf - 36 v2 .0 standard  -  question 3h
sf - 36 v2 .0 standard  -  question 3i
sf - 36 v2 .0 standard  -  question 3j
sf - 36 v2 .0 standard  -  question 4a
sf - 36 v2 .0 standard  -  question 4b
sf - 36 v2 .0 standard  -  question 4c
sf - 36 v2 .0 standard  -  question 4d
sf - 36 v2 .0 standard  -  question 5a
sf - 36 v2 .0 standard  -  question 5b
sf - 36 v2 .0 standard  -  question 5c
sf - 36 v2 .0 standard  -  question 6
sf - 36 v2 .0 standard  -  question 7
sf - 36 v2 .0 standard  -  question 8
sf - 36 v2 .0 standard  -  question 9a
sf - 36 v2 .0 standard  -  question 9b
sf - 36 v2 .0 standard  -  question 9c
sf - 36 v2 .0 standard  -  question 9d
sf - 36 v2 .0 standard  -  question 9e
sf - 36 v2 .0 standard  -  question 9f
sf - 36 v2 .0 standard  -  question 9g
sf - 36 v2 .0 standard  -  question 9h
sf - 36 v2 .0 standard  -  question 9i
sf - 36 v2 .0 standard  -  question 10
sf - 36 v2 .0 standard  -  question 11a
flac regimen
sf - 36 v2 .0 standard  -  question 11b
sf - 36 v2 .0 standard  -  question 11c
sf - 36 v2 .0 standard  -  question 11d
ymrs  -  elevated mood
ymrs  -  increased motor activity - energy
ymrs  -  sexual interest
ymrs  -  sleep
ymrs  -  irritability
ymrs  -  speech  ( rate and amount )
ymrs  -  language - thought disorder
ymrs  -  content
ymrs  -  disruptive - aggressive behaviour
ymrs  -  appearance
ymrs  -  insight
cardiac valvular regurgitation severity
cardiac valvular stenosis severity
oral medication
institution not defined
short term general hospital
median heart rate
median pr duration
median qrs duration
median qt duration
median qtcf
median rr duration
blinded treatment epoch
open label treatment epoch
adenosine diphosphate measurement
antiphospholipid antibody measurement
arachidonic acid measurement
cd34 measurement
clue cell count
dextroamphetamine measurement
endogenous thrombin potential area under curve measurement
endogenous thrombin potential lag time measurement
endogenous thrombin potential lag time relative measurement
endogenous thrombin potential measurement
endogenous thrombin potential peak height measurement
endogenous thrombin potential peak height relative measurement
endogenous thrombin potential time to peak measurement
endogenous thrombin potential time to peak relative measurement
factor v leiden measurement
factor xiv measurement
hematocrit corrected reticulocyte count
hematocrit corrected reticulocytes to erythrocytes ratio measurement
hydrogen measurement
immature reticulocyte fraction measurement
lupus anticoagulant sensitive aptt measurement
lymphoblast count
p50 oxygen measurement
cisplatin / paclitaxel
soluble interleukin 2 receptor activity measurement
sperm motility measurement
urine conductivity
extracted lead
reused lead
acute marginal artery
circumflex artery and its branches
circumflex artery av groove continuation artery
costochondral joint 1
costochondral joint 7
distal circumflex artery
distal interphalangeal joint 2
distal interphalangeal joint 3
distal interphalangeal joint 4
distal interphalangeal joint 5
distal left anterior descending artery
distal right coronary artery conduit
first diagonal branch artery
first left posterolateral branch artery
first obtuse marginal branch artery
amoxicillin - clavulanate potassium
first right posterolateral artery
interphalangeal joint 1
interphalangeal joint 2
interphalangeal joint 3
interphalangeal joint 4
interphalangeal joint 5
interphalangeal thumb joint
lateral first diagonal branch artery
lateral first obtuse marginal branch artery
lateral ramus intermedius artery
lateral second diagonal branch artery
lateral second obtuse marginal branch artery
lateral third diagonal branch artery
left anterior descending septal perforator artery
left posterolateral descending artery
left ventricular epicardium
metacarpophalangeal joint 1
metacarpophalangeal joint 2
metacarpophalangeal joint 3
metacarpophalangeal joint 4
metacarpophalangeal joint 5
metatarsophalangeal joint 1
metatarsophalangeal joint 2
metatarsophalangeal joint 3
metatarsophalangeal joint 4
metatarsophalangeal joint 5
mid - circumflex artery
mid - distal left anterior descending coronary artery and all diagonal coronary branches
mid - left anterior descending artery
mid - right coronary artery conduit
perihilar lymph node
proximal circumflex artery
proximal interphalangeal joint 2
proximal interphalangeal joint 3
proximal interphalangeal joint 4
proximal interphalangeal joint 5
proximal left anterior descending artery
proximal right coronary artery conduit
ramus intermedius artery
right atrial endocardium
vab - 6 regimen
right coronary artery and its branches
right posterior atrioventricular artery
right posterior descending artery
right ventricular endocardium
second diagonal branch artery
second left posterolateral branch artery
second obtuse marginal branch artery
second right posterolateral artery
septal perforator artery
sublingual region
third diagonal branch artery
third obtuse marginal branch artery
third posterolateral descending artery
third right posterolateral artery
transverse tarsal joint
study subject withdrawal by parent or guardian
accumulation ratio area under the curve
accumulation ratio cmax
accumulation ratio cmin
amount recovered from t1 to t2
amount recovered from t1 to t2 normalized by body mass index
amount recovered from t1 to t2 normalized by surface area
amount recovered from t1 to t2 normalized by weight
amount recovered over dosing interval
amount recovered over dosing interval normalized by body mass index
amount recovered over dosing interval normalized by surface area
amount recovered over dosing interval normalized by weight
concentration divided by body mass index
concentration divided by dose
concentration divided by surface area
concentration divided by weight
initial volume of distribution
initial volume of distribution normalized by body mass index
initial volume of distribution normalized by dose
initial volume of distribution normalized by surface area
initial volume of distribution normalized by weight
nonrenal clearance
observed steady state volume of distribution normalized by body mass index
observed steady state volume of distribution normalized by dose
observed steady state volume of distribution normalized by surface area
observed steady state volume of distribution normalized by weight
peak trough ratio
percent recovered from t1 to t2
percent recovered from t1 to t2 normalized by body mass index
percent recovered from t1 to t2 normalized by surface area
percent recovered from t1 to t2 normalized by weight
percent recovered over dosing interval
percent recovered over dosing interval normalized by body mass index
percent recovered over dosing interval normalized by surface area
percent recovered over dosing interval normalized by weight
cyve regimen
predicted steady state volume of distribution normalized by body mass index
predicted steady state volume of distribution normalized by dose
predicted steady state volume of distribution normalized by surface area
predicted steady state volume of distribution normalized by weight
trough concentration
trough concentration divided by body mass index
trough concentration divided by dose
trough concentration divided by surface area
trough concentration divided by weight
intrajejunal route of administration
bropirimine
intrapalatal route of administration
high risk
intermediate risk
low risk
application dosing unit
capful dosing unit
centimeter per second
decibel
ecog  -  performance status
sows subjective  ( handelsman )   -  i feel anxious
sows subjective  ( handelsman )   -  i feel like yawning
sows subjective  ( handelsman )   -  i'm perspiring
sows subjective  ( handelsman )   -  my eyes are tearing
sows subjective  ( handelsman )   -  my nose is running
sows subjective  ( handelsman )   -  i have goose flesh
sows subjective  ( handelsman )   -  i am shaking
sows subjective  ( handelsman )   -  i have hot flashes
sows subjective  ( handelsman )   -  i have cold flashes
sows subjective  ( handelsman )   -  my bones and muscles ache
sows subjective  ( handelsman )   -  i feel restless
sows subjective  ( handelsman )   -  i feel nauseous
sows subjective  ( handelsman )   -  i feel like vomiting
sows subjective  ( handelsman )   -  my muscles twitch
sows subjective  ( handelsman )   -  i have cramps in my stomach
sows subjective  ( handelsman )   -  i feel like shooting up now
lateral third obtuse marginal branch artery
accumulation ratio ctrough
khdrbs1 gene
khdrbs1 wt allele
kh domain - containing ,  rna - binding ,  signal transduction - associated protein 1
vaccine provider
funding source for product
private funding
military funding
public funding
required emergency room or doctor visit
s100a4 gene
s100a4 wt allele
protein s100 - a4
chd8 gene
chd8 wt allele
chromodomain - helicase - dna - binding protein 8
number of hospitalization days
scn2a gene
scn2a wt allele
sodium channel protein type 2 subunit alpha
scn1a gene
scn1a wt allele
sodium channel protein type 1 subunit alpha
resulted in prolongation of hospitalization
disability or permanent damage
katnal2 gene
katnal2 wt allele
katanin p60 atpase - containing subunit a - like 2
ntng1 gene
ntng1 wt allele
netrin - g1
grin2b gene
grin2b wt allele
glutamate receptor ionotropic ,  nmda 2b
scarb1 gene
scarb1 wt allele
scavenger receptor class b member 1
cd151 gene
cd151 wt allele
cd151 antigen
other vaccinations given within four weeks
illness at time of vaccination
number of siblings
adverse event following immunization
yy1 gene
yy1 wt allele
transcriptional repressor protein yy1
mlxipl gene
mlxipl wt allele
carbohydrate - responsive element - binding protein
mgat4c gene
mgat4c wt allele
alpha - 1 , 3 - mannosyl - glycoprotein 4 - beta - n - acetylglucosaminyltransferase c
unc119 gene
unc119 wt allele
protein unc - 119 homolog a
fkbp1a gene
fkbp1a wt allele
peptidyl - prolyl cis - trans isomerase fkbp1a
trpc4 gene
trpc4 wt allele
short transient receptor potential channel 4
hdac7 gene
hdac7 wt allele
histone deacetylase 7
hdac9 gene
hdac9 wt allele
histone deacetylase 9
cdk5r1 gene
cdk5r1 wt allele
cyclin - dependent kinase 5 activator 1
s1pr1 gene
s1pr1 wt allele
bruceantin
sphingosine 1 - phosphate receptor 1
klf5 gene
klf5 wt allele
krueppel - like factor 5
qpct gene
qpct wt allele
glutaminyl - peptide cyclotransferase
foxa3 gene
foxa3 wt allele
hepatocyte nuclear factor 3 - gamma
nkx2 - 5 gene
nkx2 - 5 wt allele
homeobox protein nkx - 2 .5
slc12a2 gene
slc12a2 wt allele
solute carrier family 12 member 2
image plane
prex2 gene
prex2 wt allele
phosphatidylinositol 3 , 4 , 5 - trisphosphate - dependent rac exchanger 2 protein
arid1b gene
arid1b wt allele
at - rich interactive domain - containing protein 1b
map3k13 gene
map3k13 wt allele
mitogen - activated protein kinase kinase kinase 13
ace2 gene
ace2 wt allele
stomach cramp
angiotensin - converting enzyme 2
pulmonary infiltrate
lymphoid hyperplasia
myopia
spop gene
anti - erbb3 monoclonal antibody av - 203
hyaluronic acid - based hydrating vaginal gel
spop wt allele
speckle - type poz protein
water - based vaginal lubricant
mvt regimen
lactoperoxidase / lysozyme / lactoferrin - based prebiotic vaginal lubricant
adenovirus - psa prostate cancer vaccine
f2rl3 gene
f2rl3 wt allele
proteinase - activated receptor 4
recombinant vesicular stomatitis virus - expressing interferon - beta
selinexor
beta - hydroxy - beta - methylbutyrate supplement
padi4 gene
padi4 wt allele
protein - arginine deiminase type - 4
hs6st2 gene
hs6st2 wt allele
heparan - sulfate 6 - o - sulfotransferase 2
trifluridine and tipiracil hydrochloride
r1 cooling gel plus r2 moisturizing / sun protecting lotion
low interval point in time date data type
planned occurrence
visit end time
performed medical condition result
mercaptopurine / methotrexate regimen
favorable
unfavorable
international neuroblastoma pathology classification
international neuroblastoma risk group classification system
capivasertib
ipafricept
mirvetuximab soravtansine
saccharomyces boulardii probiotic supplement
docetaxel lipid microspheres
recombinant ephb4 - hsa fusion protein
uterine ligament adenosarcoma
epoetin zeta
tuberculosis contact
ventricular repolarization abnormality
cdisc sdtm contact case investigation contact type terminology
cdisc sdtm directly observed therapy location terminology
cdisc sdtm drug resistance status terminology
cdisc sdtm disease outcome terminology
cdisc sdtm supporting evidence for re - treatment terminology
cdisc sdtm laboratory test standard character result terminology
cdisc sdtm microbial identification certainty terminology
cdisc sdtm priority of tuberculosis contact terminology
cdisc sdtm reason for treatment interruption terminology
cdisc sdtm reason for treatment terminology
cdisc sdtm treatment failure reason terminology
cdisc sdtm reason treatment not administered terminology
cdisc sdtm social risk factor terminology
cdisc sdtm contact setting terminology
cdisc sdtm treatment episode terminology
cdisc sdtm vaccination evidence source terminology
acute anterolateral myocardial infarction by ecg finding
acute anteroseptal myocardial infarction by ecg finding
acute high lateral myocardial infarction by ecg finding
acute right ventricular myocardial infarction by ecg finding
acute septal myocardial infarction by ecg finding
atrial bigeminy by ecg finding
atrial couplet by ecg finding
atrial trigeminy by ecg finding
auramine staining method
bryostatin 1
bacteriological cure
bacteriological failure
bacteriological finding
blocked atrial premature complex by ecg finding
blocked ventricular premature complex by ecg finding
cardiovascular system findings domain
casual contact
clinical cure
clinical failure
contact with exposure during medical procedure
contact with exposure in crowd setting
contact with medical risk factor
country of potential disease exposure
current or recent employee or volunteer in homeless shelter
current or recent employee or volunteer in jail or prison
current or recent employee or volunteer in nursing home
device events domain
device exposure domain
device identifiers domain
device properties domain
device to subject relationship domain
device tracking and disposition domain
device - in - use domain
dextrocardia by ecg finding
directly observed therapy
disease contact investigation
drug resistance status
dural venous sinus
early r wave transition by ecg finding
early repolarization
endocrine system findings domain
entry date from country of potential disease exposure
enzyme - linked immunosorbent spot assay
extensively drug resistance process
extreme right axis deviation
failure after first treatment
failure after multiple treatments
fetal findings domain
forgot to take medication dose
fusion complex
digestive system findings domain
hematopoietic system findings domain
high grade atrioventricular block by ecg finding
high lateral myocardial infarction by ecg finding
high - priority tuberculosis subject
homeless during past year
household contact
household environment
immigrant from high tuberculosis prevalent area
immune system findings domain
in the field
integumentary system findings domain
junctional premature complex by ecg finding
late r wave transition by ecg finding
left ventricular aneurysm
left ventricular hypertrophy with strain by ecg finding
line probe assay
lived in refugee camp
log10 colony forming units per gram
log10 colony forming units per milliliter
long - term facility resident
loop - mediated isothermal amplification
low - priority tuberculosis subject
medication lost
medication misplaced
medium - priority tuberculosis subject
member of high risk population
microbial identification certainty
microbial liquid culture
microbial solid culture
migratory worker
morphology findings domain
multifocal atrial premature complex by ecg finding
multifocal ventricular premature complex by ecg finding
musculoskeletal findings ,  connective and soft tissue findings domain
myocardial ischemia by ecg finding
myocardial perfusion imaging
nervous system findings domain
nonclinical pregnancy results domain
non - household environment
non - sustained atrial tachycardia by ecg finding
normal sinus rhythm
not offered
observed volume of distribution normalized by dose
old or age indeterminate anterior myocardial infarction by ecg finding
old or age indeterminate anterolateral myocardial infarction by ecg finding
old or age indeterminate anteroseptal myocardial infarction by ecg finding
old or age indeterminate extensive anterior myocardial infarction by ecg finding
old or age indeterminate high lateral myocardial infarction by ecg finding
old or age indeterminate inferior myocardial infarction by ecg finding
old or age indeterminate lateral myocardial infarction by ecg finding
old or age indeterminate posterior myocardial infarction by ecg finding
old or age indeterminate right ventricular myocardial infarction by ecg finding
old or age indeterminate septal myocardial infarction by ecg finding
pairing events domain
per 100 high powered fields
predicted volume of distribution normalized by dose
presumptive
previous patient noncompliance
priority of disease contact
patco regimen
procedure domain
qrs axis indeterminate
reason for treatment
reason for treatment interruption
reason treatment not administered
refugee from high tuberculosis prevalent area
repolarization abnormality secondary to ventricular hypertrophy
reproductive system findings domain
setting of disease contact
short qtc interval
site of directly observed therapy
social risk factor
social setting
source case investigation
subject in contact with tuberculosis source
sub - therapeutic drug level
superficial lymph node
supporting evidence for retreatment
t wave alternans by ecg finding
travel to high burden tuberculosis country
treatment episode indicator
treatment failure reason
tumor response domain
type of contagion contact
unifocal atrial premature complex by ecg finding
unifocal ventricular premature complex by ecg finding
urinary system findings domain
vaccination evidence source
ventricular parasystole by ecg finding
volume of distribution of fraction dose observed normalized by dose
volume of distribution of fraction dose predicted normalized by dose
new myocardial infarction by ecg finding
new anterior myocardial infarction by ecg finding
new anterolateral myocardial infarction by ecg finding
new anteroseptal myocardial infarction by ecg finding
new extensive anterior myocardial infarction by ecg finding
new high lateral myocardial infarction by ecg finding
new inferior myocardial infarction by ecg finding
new lateral myocardial infarction by ecg finding
new septal myocardial infarction by ecg finding
clinical observation subcategory
clinical observation result category
death diagnosis result category
interstitial photodynamic therapy
extended release bupivacaine hydrochloride resorbable matrix formulation
parp / tankyrase inhibitor 2x - 121
pled - based mnsod mimetic
vaccinium myrtillus / macleaya cordata / echinacea angustifolia extract granules
heparan sulfate glycosaminoglycan mimetic m402
zirconium zr 89 - labeled anti - plgf monoclonal antibody ro5323441
wt1 peptide vaccine wt2725
fosgemcitabine palabenamide
adenovirus encoding tyrosinase / mart - 1 / magea6 - transduced autologous dendritic cell vaccine
ensartinib
ulimorelin hydrochloride
sheng - mai san
allodepleted haploidentical t cells - expressing inducible caspase 9
tisagenlecleucel
lactobacillus plantarum 299v / lactobacillus acidophilus / bifidobacterium lactis probiotic supplement
srpk1 gene
srpk1 wt allele
srsf protein kinase 1
cervical cerclage
zfpm2 gene
zfpm2 wt allele
zinc finger protein zfpm2
cd37 gene
cd37 wt allele
leukocyte antigen cd37
sirt7 gene
sirt7 wt allele
nad - dependent protein deacetylase sirtuin - 7
amd1 gene
amd1 wt allele
s - adenosylmethionine decarboxylase proenzyme
scd gene
scd wt allele
acyl - coa desaturase
sarm1 gene
doxorubicin / etoposide / methotrexate regimen
sarm1 wt allele
sterile alpha and tir motif - containing protein 1
recombinant human muc1 - oxidized polymannose - pulsed autologous dendritic cell vaccine
sacituzumab govitecan
talacotuzumab
iodine i 124 anti - phosphatidylserine monoclonal antibody pgn650
rivipansel
hpv e6 / e7 dna vaccine gx - 188e
deuterated phenanthrene
inducible cd4 + cd25 +  regulatory t cells
foam regimen
hand2 gene
hand2 wt allele
heart -  and neural crest derivatives - expressed protein 2
lilrb2 gene
lilrb2 wt allele
leukocyte immunoglobulin - like receptor subfamily b member 2
dnm2 gene
dnm2 wt allele
dynamin - 2
reln gene
butein
doxorubicin / fluorouracil / semustine regimen
reln wt allele
reelin
sh2b3 gene
sh2b3 wt allele
sh2b adapter protein 3
kansl1 gene
kansl1 wt allele
kat8 regulatory nsl complex subunit 1
pfkfb3 gene
pfkfb3 wt allele
6 - phosphofructo - 2 - kinase / fructose - 2 , 6 - biphosphatase 3
ptgfrn gene
ptgfrn wt allele
prostaglandin f2 receptor negative regulator
znf678 gene
znf678 wt allele
zinc finger protein 678
trim36 gene
trim36 wt allele
e3 ubiquitin - protein ligase trim36
chronic endometritis
spred1 gene
spred1 wt allele
sprouty - related ,  evh1 domain - containing protein 1
proc gene
proc wt allele
vitamin k - dependent protein c
eif2ak3 gene
eif2ak3 wt allele
eukaryotic translation initiation factor 2 - alpha kinase 3
hnrnpd gene
hnrnpd wt allele
heterogeneous nuclear ribonucleoprotein d0
spl combination product type terminology
usual
extreme
stage 2a neuroblastoma
stage 2b neuroblastoma
carmustine sustained - release implant wafer
absorbable adhesion barrier gel
ck2 - targeting synthetic peptide cigb - 300
naphthalimide analogue unbs5162
ulinastatin
fruquintinib
anti - tgf - beta rii monoclonal antibody imc - tr1
efbemalenograstim alfa
cyp17 / cyp11b2 inhibitor lae001
gemcitabine prodrug ly2334737
recursive partitioning assessment
low interval integer data type
low interval point in time date and time data type
interval quantity data type
negation indicator
long acting myeloid growth factor
short acting myeloid growth factor
significant intercurrent illness
diammonium glycyrrhizinate
hopkins verbal learning test revised
analysis of data log
aspirin / simvastatin / atenolol / ramipril / thiazide capsule
international neuroblastoma response criteria
ovarian non - dysgerminomatous germ cell tumor
primary central nervous system neoplasm
pharyngeal squamous cell carcinoma
teacher
hpv - 16 e6 peptides vaccine / candida albicans extract
nanoparticle - encapsulated doxorubicin hydrochloride
tirabrutinib
olinvacimab
boanmycin hydrochloride
htert / survivin / cmv multipeptide vaccine
everolimus tablets for oral suspension
thioureidobutyronitrile
uniformly - labeled  [ 13c ] glucose
miscellaneous neoplasm
human papillomavirus - related malignant neoplasm in aids patient
ldb1 gene
ldb1 wt allele
lim domain - binding protein 1
ctdnep1 gene
ctdnep1 wt allele
ctd nuclear envelope phosphatase 1
sox10 gene
sox10 wt allele
transcription factor sox - 10
tasp1 gene
tasp1 wt allele
threonine aspartase 1
high grade astrocytic tumor
mtch2 gene
mtch2 wt allele
buthionine sulfoximine
mitochondrial carrier homolog 2
ppp6c gene
ppp6c wt allele
serine / threonine - protein phosphatase 6 catalytic subunit
human papillomavirus - 31
nci ctep simplified disease classification terminology
snx31 gene
snx31 wt allele
sorting nexin - 31
stk19 gene
stk19 wt allele
serine / threonine - protein kinase 19
usp44 gene
usp44 wt allele
ubiquitin carboxyl - terminal hydrolase 44
rnf20 gene
rnf20 wt allele
e3 ubiquitin - protein ligase bre1a
spdef gene
spdef wt allele
sam pointed domain - containing ets transcription factor
mmp13 gene
mmp13 wt allele
collagenase 3
tbr1 gene
tbr1 wt allele
t - box brain protein 1
eomes gene
eomes wt allele
eomesodermin homolog
dnajb6 gene
dnajb6 wt allele
dnaj homolog subfamily b member 6
lclat1 gene
lclat1 wt allele
lysocardiolipin acyltransferase 1
sncaip gene
sncaip wt allele
synphilin - 1
cd99 gene
cd99 wt allele
cd99 antigen
pik3c2b gene
pik3c2b wt allele
phosphatidylinositol 4 - phosphate 3 - kinase c2 domain - containing subunit beta
pik3c2g gene
pik3c2g wt allele
phosphatidylinositol 4 - phosphate 3 - kinase c2 domain - containing subunit gamma
cd109 gene
cd109 wt allele
cd109 antigen
otx2 gene
otx2 wt allele
homeobox protein otx2
systemic arterial hypertensive disorder
great blood vessel
hipk2 gene
hipk2 wt allele
homeodomain - interacting protein kinase 2
wrap53 gene
wrap53 wt allele
telomerase cajal body protein 1
zfp36 gene
zfp36 wt allele
tristetraprolin
wnt16 gene
wnt16 wt allele
protein wnt - 16
id3 gene
id3 wt allele
dna - binding protein inhibitor id - 3
cardiac resuscitation
mrpl45 gene
mrpl45 wt allele
39s ribosomal protein l45 ,  mitochondrial
fracture of clavicle related to birth
src / abl kinase inhibitor azd0424
meconium peritonitis
apoptotic autologous tumor cells - pulsed alpha - type - 1 polarized dendritic cells
congenital hydronephrosis
anti - enpp3 antibody - drug conjugate ags - 16c3f
iodine i 131 rituximab
gag:267 - 274 peptide vaccine
pbn derivative okn - 007
congenital ileal stenosis
congenital jejunal stenosis
somatotropin deficiency
testosterone biosynthesis deficiency
patient reported outcomes measurement information system
promis adult sleep - related impairment item bank
brachial plexus palsy related to birth
list of threatening experiences questionnaire
fungemia
bacteremia
immunohematological
human papillomavirus - 26
human papillomavirus - 33
human papillomavirus - 35
human papillomavirus - 39
human papillomavirus - 45
butocin
human papillomavirus - 51
human papillomavirus - 52
human papillomavirus - 53
human papillomavirus - 56
human papillomavirus - 58
human papillomavirus - 59
human papillomavirus - 66
human papillomavirus - 68
human papillomavirus - 73
human papillomavirus - 82
nci ctep sdc cns neoplasm  ( primary tumor )  category terminology
nci ctep sdc aids - related malignancy and condition category terminology
nci ctep sdc bone neoplasm category terminology
nci ctep sdc breast neoplasm category terminology
nci ctep sdc cns - excluded nervous system neoplasm and disorder category terminology
nci ctep sdc endocrine neoplasm category terminology
nci ctep sdc eye neoplasm category terminology
nci ctep sdc gastrointestinal neoplasm category terminology
nci ctep sdc germ cell neoplasm category terminology
nci ctep sdc head and neck neoplasm category terminology
nci ctep sdc hematopoietic neoplasm  ( excluding leukemia ,  lymphoma and myeloma )  category terminology
nci ctep sdc immune disorder  ( excluding aids and malignancy )  category terminology
nci ctep sdc kidney neoplasm category terminology
nci ctep sdc lung ,  mediastinal and pleural neoplasm category terminology
nci ctep sdc miscellaneous neoplasm category terminology
nci ctep sdc non - neoplastic disorder category terminology
nci ctep sdc reproductive system neoplasm ,  female category terminology
nci ctep sdc reproductive system neoplasm ,  male category terminology
nci ctep sdc skin neoplasm category terminology
nci ctep sdc soft tissue neoplasm category terminology
cdb regimen
nci ctep sdc urothelial tract neoplasm category terminology
nci ctep sdc astrocytoma ,  high grade sub - category terminology
nci ctep sdc aids - related human papillomavirus sub - category terminology
nci ctep sdc aids - related kaposi sarcoma sub - category terminology
nci ctep sdc aids - related lymphoma sub - category terminology
nci ctep sdc aids - related malignancy and condition ,  miscellaneous sub - category terminology
nci ctep sdc bone neoplasm ,  miscellaneous sub - category terminology
nci ctep sdc chondrosarcoma sub - category terminology
nci ctep sdc ewing sarcoma sub - category terminology
nci ctep sdc osteosarcoma sub - category terminology
nci ctep sdc breast cancer  -  in situ sub - category terminology
nci ctep sdc breast cancer  -  invasive sub - category terminology
nci ctep sdc breast neoplasm ,  miscellaneous sub - category terminology
nci ctep sdc astrocytoma ,  low grade sub - category terminology
nci ctep sdc choroid plexus tumors sub - category terminology
nci ctep sdc cns neoplasm  ( primary tumor )  ,  miscellaneous sub - category terminology
nci ctep sdc embryonal tumors of the cns sub - category terminology
nci ctep sdc ependymal tumors sub - category terminology
nci ctep sdc germ cell tumors of the cns sub - category terminology
nci ctep sdc meningeal tumors sub - category terminology
nci ctep sdc oligodendroglial tumors sub - category terminology
nci ctep sdc tumors of the sellar region sub - category terminology
nci ctep sdc cns - excluded nervous system neoplasm ,  miscellaneous sub - category terminology
nci ctep sdc neuroblastoma sub - category terminology
nci ctep sdc neurofibromatosis sub - category terminology
nci ctep sdc adrenal cancer sub - category terminology
nci ctep sdc endocrine neoplasm ,  miscellaneous sub - category terminology
nci ctep sdc neuroendocrine cancer sub - category terminology
nci ctep sdc parathyroid cancer sub - category terminology
nci ctep sdc thyroid cancer sub - category terminology
nci ctep sdc malignant eye neoplasm ,  miscellaneous sub - category terminology
nci ctep sdc retinoblastoma sub - category terminology
nci ctep sdc anal cancer sub - category terminology
nci ctep sdc colorectal cancer sub - category terminology
nci ctep sdc gastroesophageal cancer sub - category terminology
nci ctep sdc gastrointestinal neoplasm ,  miscellaneous sub - category terminology
nci ctep sdc liver and hepatobiliary cancer sub - category terminology
nci ctep sdc pancreatic cancer  ( excluding islets )  sub - category terminology
nci ctep sdc small intestine cancer sub - category terminology
nci ctep sdc extragonadal germ cell cancer  ( excluding gestational trophoblastic disease and germ cell tumors of the cns )  sub - category terminology
nci ctep sdc germ cell neoplasm ,  miscellaneous sub - category terminology
nci ctep sdc ovarian germ cell cancer sub - category terminology
nci ctep sdc testicular germ cell cancer sub - category terminology
nci ctep sdc head and neck neoplasm ,  miscellaneous sub - category terminology
nci ctep sdc head and neck precancerous condition sub - category terminology
nci ctep sdc head and neck squamous cell carcinoma sub - category terminology
nci ctep sdc nasopharyngeal cancer sub - category terminology
nci ctep sdc salivary gland cancer sub - category terminology
nci ctep sdc hematopoietic neoplasm ,  miscellaneous sub - category terminology
nci ctep sdc mastocytosis sub - category terminology
nci ctep sdc immune disorder  ( excluding aids and malignancy )  ,  miscellaneous sub - category terminology
nci ctep sdc immunodeficiency and immunosuppression disorder sub - category terminology
nci ctep sdc clear cell sarcoma of the kidney sub - category terminology
nci ctep sdc kidney neoplasm ,  miscellaneous sub - category terminology
nci ctep sdc renal cell carcinoma sub - category terminology
nci ctep sdc rhabdoid tumor of the kidney sub - category terminology
nci ctep sdc wilms tumor sub - category terminology
nci ctep sdc lung ,  mediastinal and pleural neoplasm ,  miscellaneous sub - category terminology
nci ctep sdc mediastinal cancer sub - category terminology
nci ctep sdc mesothelioma sub - category terminology
nci ctep sdc non - small cell lung cancer sub - category terminology
nci ctep sdc small cell lung cancer sub - category terminology
nci ctep sdc carcinoma ,  miscellaneous sub - category terminology
nci ctep sdc metastases ,  distant  ( excluding specified site of origin )  sub - category terminology
nci ctep sdc miscellaneous neoplasm sub - category terminology
nci ctep sdc solid tumor ,  miscellaneous sub - category terminology
nci ctep sdc vascular tumor ,  miscellaneous sub - category terminology
nci ctep sdc non - neoplastic disorder ,  miscellaneous sub - category terminology
nci ctep sdc cervical cancer sub - category terminology
nci ctep sdc cervical intraepithelial neoplasia  ( cin )  sub - category terminology
piritrexim
nci ctep sdc female reproductive system neoplasm ,  miscellaneous sub - category terminology
nci ctep sdc gestational trophoblastic disease sub - category terminology
nci ctep sdc ovarian cancer  ( excluding ovarian germ cell cancer )  sub - category terminology
nci ctep sdc uterine cancer sub - category terminology
nci ctep sdc vaginal cancer sub - category terminology
nci ctep sdc vaginal intraepithelial neoplasia  ( vin )  sub - category terminology
nci ctep sdc vulvar cancer sub - category terminology
nci ctep sdc male reproductive system neoplasm ,  miscellaneous sub - category terminology
nci ctep sdc penile cancer sub - category terminology
nci ctep sdc prostate cancer sub - category terminology
nci ctep sdc prostatic intraepithelial neoplasia  ( pin )  sub - category terminology
nci ctep sdc testicular cancer  ( excluding testicular germ cell cancer )  sub - category terminology
nci ctep sdc basal cell carcinoma sub - category terminology
nci ctep sdc melanoma sub - category terminology
nci ctep sdc merkel cell tumor sub - category terminology
nci ctep sdc skin neoplasm ,  miscellaneous sub - category terminology
nci ctep sdc squamous cell carcinoma of the skin sub - category terminology
nci ctep sdc non - rhabdomyosarcoma soft tissue sarcoma sub - category terminology
nci ctep sdc rhabdomyosarcoma sub - category terminology
nci ctep sdc soft tissue neoplasm ,  miscellaneous sub - category terminology
nci ctep sdc hematopoietic neoplasm / lymphoma category terminology
nci ctep sdc hematopoietic neoplasm / leukemia category terminology
nci ctep sdc hematopoietic neoplasm / myeloma category terminology
nci ctep sdc acute lymphoblastic leukemia sub - category terminology
nci ctep sdc acute myeloid leukemia sub - category terminology
nci ctep sdc chronic lymphoid leukemia sub - category terminology
nci ctep sdc chronic myeloproliferative disease sub - category terminology
nci ctep sdc leukemia ,  miscellaneous sub - category terminology
nci ctep sdc myelodysplastic syndrome sub - category terminology
nci ctep sdc myelodysplastic / myeloproliferative disease sub - category terminology
nci ctep sdc myeloma sub - category terminology
nci ctep sdc urothelial tract / bladder cancer sub - category terminology
nci ctep sdc urothelial tract / bladder neoplasm ,  miscellaneous sub - category terminology
nci ctep sdc non - hodgkin lymphoma sub - category terminology
nci ctep sdc b - cell proliferations of uncertain malignant potential sub - category terminology
nci ctep sdc hodgkin lymphoma sub - category terminology
nci ctep sdc lymphoma ,  miscellaneous sub - category terminology
anaerobic
nih consensus response criteria for chronic gvhd
complete response in cgvhd
partial response in cgvhd
less than partial response in cgvhd
stable cgvhd
exacerbation of cgvhd
perlman syndrome
progressive cgvhd
mixed response in cgvhd
venetoclax
s - adenosylhomocysteine
3 - chlorotyrosine
hematopoietic cell transplant relapse
hematopoietic cell transplant relapse low risk rate
hematopoietic cell transplant relapse standard risk rate
hematopoietic cell transplant relapse high risk rate
congenital phrenic nerve injury
cardiac compression during initial resuscitation
bioassay measurement
data collection
subject exclusion reason
planned treatment regimen
related record
study treatment causality
subject pool
subject visit type
portion or totality
data origin
fda toxicity measure type terminology
fda act type terminology
postnatal drug withdrawal
recurrent laryngeal nerve injury
congenital bleeding disorder
age at time of vaccination
equipment qualification
unused subset concept
requalification
beta - elemene
modified citrus pectin supplement
pinometostat
data standard
soy lecithin / glycerol dioleate - based oral spray
cdisc domain
in utero drug withdrawal
genu recurvatum
congenital reproductive system abnormality
sexual differentiation disorder
perinatal subependymal hemorrhage with intraventricular and intracerebral extension
acquired phrenic nerve injury
acquired phrenic nerve palsy
perinatal respiratory distress
perinatal cyanotic attack
plasmacytoid dendritic cell vaccine
tumor - cells apoptosis factor hormone - peptide
durvalumab
lexaptepid pegol
fluorine f 18 4 - l - fluoroglutamine  ( 2s , 4r )
identification of medicinal products terminology
racemate
organism part
cactinomycin
organism part location
optical rotation
dextrorotatory
levorotatory
nonrotatory
chemical substance excluding protein or nucleic acid
structurally diverse substance
chiral
achiral
epimeric
meso compound
square planar 1 molecular geometry
square planar 2 molecular geometry
square planar 3 molecular geometry
square planar 4 molecular geometry
tetrahedral molecular geometry
octahedral 12 molecular geometry
octahedral 22 molecular geometry
octahedral 21 molecular geometry
cahn - ingold - prelog priority system
axial r
axial s
popliteal fossa
genetic finding
ischemic necrosis
pulmonary trunk hypoplasia
protein / peptide substance
perinatal jaundice related to inspissated bile syndrome
photoacoustic spectroscopy
phellodendron amurense bark extract
brachial plexus injury
cathepsin s
cystic fibrosis with meconium ileus
ctss gene
ctss wt allele
fetal neurodevelopmental disorder
decant
antecubital fossa
total proctocolectomy
chemical structure
substance dispersity
endoscopic mucosal resection
mixture component
cryomold
cryovial
chemical moiety
assessment of survivor concerns
worry about future diagnostic tests
worry about another type of cancer
worry about my cancer coming back
worry about my health
worry about my children's health
promis global health questionnaire
in general would you say your health is
in general would you say your quality of life is
in general how would you rate your physical health
in general how would you rate your mental health including your mood and ability to think
in general how would you rate your satisfaction with your social activities and relationships
in general please rate how well you carry out your usual social activities and roles
to what extent are you able to carry out your everyday physical activities such as walking climbing stairs carrying groceries or moving a chair
in the past 7 days how often have you been bothered by emotional problems such as feeling anxious depressed or irritable
in the past 7 days how would you rate your fatigue on average
in the past 7 days how would you rate your pain on average
tissue source site
macrodissection
congenital aortic arch hypoplasia
narrow surgical margin
hand assisted laparoscopy
endorectal
consent waiver
largetrifoliolious bugbane rhizome supplement
nitroglycerin transdermal patch
erdafitinib
brontictuzumab
lactobacillus acidophilus / streptococcus thermophilus / bifidobacterium lactis / l . rhamnosus / b . longum / b . bifidum - based probiotic supplement
pegylated liposomal mitomycin c lipid - based prodrug
acalisib
fluorine f 18 d - fmau
peg - 3350 / sodium sulfate / sodium chloride / potassium chloride / sodium ascorbate / ascorbic acid - based laxative
cytarabine / hydroxyurea regimen
body image scale
religious group
sephardic jew
buddhist
muslim
roman catholic
protestant christian
eastern orthodox christian
seventh day adventist
fluorouracil / hydroxyurea
mormon
hindu
feel self - conscious about appearance
feel physically less attractive as result of disease or treatment
serious clinical event type
clinical event pattern type
aids - related human papillomavirus infection
nucleolin antagonist ipp - 204106n
birabresib
peg - based laxative ner1006
caffeine citrate
ginsenoside rg3 capsule
dissatisfaction with appearance when dressed
feel less feminine due to disease or treatment
difficult to look at self naked
feel less sexually attractive due to disease or treatment
avoid people due to physical appearance
feel that treatment has left body less whole
feel dissatisfied with body
dissatisfied with appearance of scar
very good partial response in neuroblastoma
complete response in neuroblastoma
partial response in neuroblastoma
no response in neuroblastoma
mixed response in neuroblastoma
multidimensional body - self relations questionnaire appearance orientation
before going out in public i notice my looks
careful to buy clothes that make me look good
check my appearance in mirror whenever
before going out i spend time preparing
important that i look good
use very few grooming products
self - conscious if grooming is wrong
wear whatever is handy without care
do not care what others think of my appearance
special care with hair grooming
never think about appearance
always trying to improve physical appearance
cdisc define - xml general observation class terminology
cdisc sdtm subject characteristic test name terminology
breast cancer treatment outcomes scale - cosmetic status
breast size difference since cancer treatment
breast texture difference since cancer treatment
nipple appearance difference since breast cancer treatment
breast shape difference since cancer treatment
breast elevation difference since cancer treatment
fit of bra difference since breast cancer treatment
fit of clothing difference since breast cancer treatment
pretreatment
papillary carcinoma of the penis ,  not otherwise specified
pretreatment period
very good
prostaglandin measurement
11 - dehydro - thromboxane b2 measurement
3 , 4 - dihydroxyphenylacetic acid measurement
abdominal skinfold thickness
absolute change from nadir
activated coagulation time
alpha tocopherol measurement
alpha tocopherol to vitamin e ratio measurement
alpha - 2 antiplasmin measurement
amyloid beta 1 - 38 measurement
amyloid beta 1 - 40 measurement
apolipoprotein a4 measurement
apolipoprotein a5 measurement
apolipoprotein b to apolipoprotein a1 ratio measurement
beta catenin measurement
beta - 2 glycoprotein 1 igg antibody measurement
beta - 2 glycoprotein 1 igm antibody measurement
calcium and phosphorus product measurement
cancer antigen 1 measurement
cancer antigen 15 - 3 measurement
cardiolipin igm antibody measurement
cd1 expressing cell measurement
cd14 expressing cell measurement
cd2 expressing cell measurement
cd2 expressing cell to lymphocyte ratio measurement
cd20 expressing cell measurement
cd5 expressing cell measurement
cd56 expressing cell measurement
cdisc basic data structure dataset
cdisc events class
cdisc findings class
cdisc interventions class
cdisc other adam dataset
cdisc relationship class
cdisc special purpose class
cdisc subject level analysis dataset
cdisc trial design class
cholesteryl ester transfer protein activity measurement
clostridium difficile toxin measurement
clostridium tetani igg antibody measurement
collagen type iv measurement
common iliac lymph node
complete response with incomplete bone marrow recovery
dilute russell's viper venom time to control ratio measurement
dipeptidyl peptidase - 4 activity measurement
diphtheria igg antibody measurement
every eight weeks
every five weeks
experimental organism benign basalioma
experimental organism benign bone osteofibroma
experimental organism malignant hepatocholangiocellular carcinoma
experimental organism malignant hibernoma
factor ix activity measurement
factor v activity measurement
factor vii activity measurement
factor viia activity measurement
factor viii activity measurement
heparin calcium
fdg - positron emission tomography
flt - positron emission tomography
hdl particle size measurement
helicobacter pylori igg antibody measurement
hepatitis b dna measurement
human albumin antibody measurement
human anti - mouse antibody measurement
immunoblast count
influenza a igg antibody measurement
influenza b igg antibody measurement
isoleucine measurement
lavage fluid
ldl particle size measurement
leukotriene b4 measurement
leukotriene d4 measurement
leukotriene e4 measurement
measured tumor identification
median or lower cervical lymph node
myelin antibodies measurement
n - acetyl - beta - d - glucosaminidase measurement
new lesion progression
new tumor confirmation
nodular partial response
non - measurable tumor identification
not all lesions evaluated
not measured tumor identification
paratracheal lymph node
platelet aggregation measurement
posterior cervical lymph node
preauricular lymph node
procalcitonin measurement
prostaglandin d2 measurement
prostaglandin d2 synthase measurement
prostaglandin e synthase measurement
prostaglandin e1 measurement
prostaglandin e2 measurement
prostaglandin f1 alpha measurement
prostaglandin f2 alpha measurement
rectosigmoid colon
retrocrural lymph node
rubella igg antibody measurement
sum of diameters of non lymph node tumors
target extra nodal tumor identification
target nodal tumor identification
target nodule tumor identification
thromboxane b2 measurement
thyroglobulin measurement
upper cervical lymph node
vitamin e to cholesterol ratio measurement
vitamin k1 measurement
ice regimen
vldl particle size measurement
whole parathyroid hormone measurement
per milliliter
albumin to total protein ratio measurement
iliac fossa
ischiorectal fossa
occipital scalp
very severe
cdisc questionnaire adcs - cgic test name terminology
cdisc questionnaire adcs - cgic test code terminology
cdisc questionnaire c - ssrs since last visit test name terminology
cdisc questionnaire c - ssrs since last visit test code terminology
cdisc questionnaire ess test name terminology
cdisc questionnaire ess test code terminology
cdisc questionnaire fiqr test name terminology
cdisc questionnaire fiqr test code terminology
cdisc questionnaire gad - 7 test name terminology
cdisc questionnaire gad - 7 test code terminology
cdisc questionnaire hads test name terminology
cdisc questionnaire hads test code terminology
cdisc questionnaire iief test name terminology
cdisc questionnaire iief test code terminology
cdisc questionnaire nps test name terminology
cdisc questionnaire nps test code terminology
cdisc questionnaire oab - q test name terminology
cdisc questionnaire oab - q test code terminology
cdisc questionnaire oab - q short form test name terminology
cdisc questionnaire oab - q short form test code terminology
cdisc questionnaire odi v2 .1a test name terminology
cdisc questionnaire odi v2 .1a test code terminology
cdisc questionnaire phq - 9 test name terminology
cdisc questionnaire phq - 9 test code terminology
cdisc questionnaire phq - 15 test name terminology
cdisc questionnaire phq - 15 test code terminology
cdisc questionnaire siqr test name terminology
cdisc questionnaire siqr test code terminology
cdisc questionnaire sows short test name terminology
cdisc questionnaire sows short test code terminology
cdisc questionnaire ups test name terminology
cdisc questionnaire ups test code terminology
adcs - cgic questionnaire question
c - ssrs since last visit questionnaire question
ess questionnaire question
fiqr questionnaire question
gad - 7 questionnaire question
hads questionnaire question
iief questionnaire question
nps questionnaire question
oab - q questionnaire question
oab - q short form questionnaire question
calicheamicin gamma 1i
odi v2 .1a questionnaire question
phq - 9 questionnaire question
phq - 15 questionnaire question
siqr questionnaire question
sows short questionnaire question
ups questionnaire question
likert score 1
likert score 6
likert score 7
likert score 8
likert score 9
worst imaginable pain
positron emission tomography and computed tomography scan
high performance liquid chromatography mass spectrometry
positron emission tomography and magnetic resonance imaging
alzheimer's disease cooperative study - clinical global impression of change questionnaire
columbia - suicide severity rating scale since last visit questionnaire
epworth sleepiness scale questionnaire
revised fibromyalgia impact questionnaire
generalized anxiety disorder  -  7 questionnaire
hospital anxiety and depression scale questionnaire
international index of erectile function questionnaire
neuropathic pain scale questionnaire
the overactive bladder questionnaire
the overactive bladder questionnaire short form
the oswestry disability index version 2 .1a questionnaire
patient health questionnaire  -  9 item
patient health questionnaire  -  15 item
symptom impact questionnaire
short opiate withdrawal scale questionnaire
urgency perception scale questionnaire
adcs - cgic  -  clinical impression of change from baseline
c - ssrs since last visit  -  suicide
c - ssrs since last visit  -  most lethal attempt date
c - ssrs since last visit  -  most lethal actual attempt lethality / medical damage
c - ssrs since last visit  -  most lethal actual attempt potential lethality
ess  -  sitting and reading
ess  -  watching tv
ess  -  sitting ,  inactive in a public place
ess  -  as a passenger in a car for an hour without a break
ess  -  lying down to rest in the afternoon when circumstances permit
ess  -  sitting and talking to someone
ess  -  sitting quietly after a lunch without alcohol
ess  -  in a car ,  while stopped for a few minutes in the traffic
fiqr  -  brush or comb your hair
fiqr  -  walk continuously for 20 minutes
fiqr  -  prepare a homemade meal
fiqr  -  vacuum scrub or sweep floors
fiqr  -  lift and carry a bag full of groceries
fiqr  -  climb one flight of stairs
fiqr  -  change bed sheets
fiqr  -  sit in a chair for 45 minutes
fiqr  -  go shopping for groceries
fiqr  -  fibromyalgia prevented me from accomplishing goals for the week
fiqr  -  i was completely overwhelmed by my fibromyalgia symptoms
fiqr  -  pain
fiqr  -  energy
fiqr  -  stiffness
fiqr  -  your sleep
fiqr  -  depression
fiqr  -  memory problems
fiqr  -  anxiety
fiqr  -  tenderness to touch
fiqr  -  balance problems
fiqr  -  sensitivity to loud noises ,  bright lights ,  odors and cold
gad - 7  -  feeling nervous anxious or on edge
gad - 7  -  not being able to stop or control worrying
gad - 7  -  worrying too much about different things
gad - 7  -  trouble relaxing
gad - 7  -  being so restless that it is hard to sit still
gad - 7  -  becoming easily annoyed or irritable
gad - 7  -  feel afraid as if something awful might happen
gad - 7  -  problems made it difficult to work ,  take care of things ,  or get along with other people
hads  -  i feel tense or wound up
hads  -  i still enjoy the things i used to enjoy
hads  -  i get a frightened feeling something awful is about to happen
hads  -  i can laugh and see funny side of things
hads  -  worrying thoughts go through my mind
hads  -  i feel cheerful
hads  -  i can sit at ease and feel relaxed
hads  -  i feel as if i am slowed down
hads  -  i get frightened feeling like butterflies in the stomach
hads  -  i have lost interest in my appearance
hads  -  i feel restless as if i have to be on the move
hads  -  i look forward with enjoyment to things
hads  -  i get sudden feelings of panic
hads  -  i can enjoy a good book or radio or television programme
iief  -  able to get an erection during sexual activity
iief  -  erections hard enough for penetration
iief  -  able to penetrate your partner
iief  -  able to maintain your erection after you had penetrated your partner
iief  -  maintain your erection to completion of intercourse
iief  -  how many times have you attempted sexual intercourse
iief  -  how often was it satisfactory for you
iief  -  how much have you enjoyed sexual intercourse
iief  -  how often did you ejaculate
iief  -  did you have feeling of orgasm with or without ejaculation
iief  -  how often have you felt sexual desire
iief  -  rate your level of sexual desire
iief  -  satisfied with overall sex life
canola oil
iief  -  satisfied with your sexual relationship with your partner
iief  -  your confidence to get and keep an erection
npi  -  delusions frequency
npi  -  delusions severity
npi  -  delusions distress
npi  -  hallucinations frequency
npi  -  hallucinations severity
npi  -  hallucinations distress
npi  -  agitation / aggression frequency
npi  -  agitation / aggression severity
npi  -  agitation / aggression distress
npi  -  depression / dysphoria frequency
npi  -  depression / dysphoria severity
npi  -  depression / dysphoria distress
npi  -  anxiety frequency
npi  -  anxiety severity
npi  -  anxiety distress
npi  -  elation / euphoria frequency
npi  -  elation / euphoria severity
npi  -  elation / euphoria distress
npi  -  apathy / indifference frequency
npi  -  apathy / indifference severity
npi  -  apathy / indifference distress
npi  -  disinhibition frequency
npi  -  disinhibition severity
npi  -  disinhibition distress
npi  -  irritability / lability frequency
npi  -  irritability / lability severity
npi  -  irritability / lability distress
npi  -  aberrant motor behavior frequency
npi  -  aberrant motor behavior severity
npi  -  aberrant motor behavior distress
npi  -  sleep and nighttime behavior disorders frequency
npi  -  sleep and nighttime behavior disorders severity
npi  -  sleep and nighttime behavior disorders distress
npi  -  appetite and eating disorders frequency
npi  -  appetite and eating disorders severity
npi  -  appetite and eating disorders distress
nps  -  tell us how intense your pain is
nps  -  tell us how sharp your pain feels
nps  -  tell us how hot your pain feels
nps  -  tell us how dull your pain feels
nps  -  tell us how cold your pain feels
nps  -  tell us how sensitive your skin is to light touch or clothing
nps  -  tell us how itchy your pain feels
nps  -  describe the time quality of your pain
nps  -  describe the background pain
nps  -  describe the flare - up pain
nps  -  describe the single type of pain all time
nps  -  describe the occasional pain
nps  -  tell us overall how unpleasant your pain is to you
nps  -  how intense is your deep pain
nps  -  how intense is your surface pain
oab - q  -  frequent urination during the daytime
oab - q  -  uncomfortable urge to urinate
oab - q  -  sudden urge to urinate with little or no warning
oab - q  -  accidental loss of urine
oab - q  -  nighttime urination
oab - q  -  waking up at night because you had to urinate
oab - q  -  uncontrollable urge to urinate
oab - q  -  urine loss associated with a strong desire to urinate
oab - q  -  carefully plan your commute
oab - q  -  feel drowsy or sleepy during the day
oab - q  -  plan 'escape routes' to restrooms
oab - q  -  caused you distress
oab - q  -  frustrated you
oab - q  -  feel like there is something wrong with you
oab - q  -  interfered with a good night's rest
oab - q  -  decrease your physical activities
oab - q  -  prevented you from feeling rested upon waking
oab - q  -  frustrated your family and friends
oab - q  -  caused you anxiety or worry
oab - q  -  stay home more often than you would prefer
oab - q  -  adjust your travel plans so that you are always near a restroom
oab - q  -  avoid activities away from restrooms
oab - q  -  frustrated or annoyed about the amount of time you spend in the restroom
oab - q  -  awakened you during sleep
oab - q  -  made you worry about odor or hygiene
oab - q  -  uncomfortable while traveling with others
oab - q  -  affected your relationships with family and friends
oab - q  -  decrease participating in social gatherings
oab - q  -  caused you embarrassment
oab - q  -  interfered with getting sleep
oab - q  -  caused problems with your partner or spouse
oab - q  -  plan activities more carefully
oab - q  -  locate closest restroom as soon as you arrive
oab - q short form  -  uncomfortable urge to urinate
oab - q short form  -  sudden urge to urinate with little or no warning
oab - q short form  -  accidental loss of urine
oab - q short form  -  nighttime urination
oab - q short form  -  waking up at night because you had to urinate
oab - q short form  -  urine loss associated with a strong desire to urinate
oab - q short form  -  plan 'escape routes' to restrooms
oab - q short form  -  feel like there is something wrong with you
oab - q short form  -  interfered with a good night's rest
oab - q short form  -  frustrated or annoyed about the amount of time you spend in the restroom
oab - q short form  -  avoid activities away from restrooms
oab - q short form  -  awakened you during sleep
oab - q short form  -  decrease your physical activities
oab - q short form  -  caused problems with your partner or spouse
caracemide
oab - q short form  -  uncomfortable while traveling with others
oab - q short form  -  affected your relationships with family and friends
oab - q short form  -  interfered with getting sleep
oab - q short form  -  caused you embarrassment
oab - q short form  -  locate closest restroom as soon as you arrive
phq - 9  -  little interest or pleasure in doing things
phq - 9  -  feeling down ,  depressed ,  or hopeless
phq - 9  -  trouble falling or staying asleep ,  or sleeping too much
phq - 9  -  feeling tired or having little energy
phq - 9  -  poor appetite or overeating
phq - 9  -  feeling bad about yourself
phq - 9  -  trouble concentrating on things
phq - 9  -  moving or speaking slowly or the opposite being fidgety or restless
phq - 9  -  thoughts that you would be better off dead
phq - 9  -  how difficult have problems made it for you to work ,  take care of things ,  or get along with other people
phq - 15  -  stomach pain
phq - 15  -  back pain
phq - 15  -  pain in your arms ,  legs ,  or joints
phq - 15  -  menstrual cramp or other problems with your periods
phq - 15  -  headaches
phq - 15  -  chest pain
phq - 15  -  dizziness
phq - 15  -  fainting spells
phq - 15  -  feeling your heart pound or race
phq - 15  -  shortness of breath
phq - 15  -  pain or problems during sexual intercourse
phq - 15  -  constipation ,  loose bowels ,  or diarrhea
phq - 15  -  nausea ,  gas ,  or indigestion
phq - 15  -  feeling tired or having low energy
phq - 15  -  trouble sleeping
siqr  -  brush or comb your hair
siqr  -  walk continuously for 20 minutes
siqr  -  prepare a homemade meal
siqr  -  vacuum scrub or sweep floors
siqr  -  lift and carry a bag full of groceries
siqr  -  climb one flight of stairs
siqr  -  change bed sheets
siqr  -  sit in a chair for 45 minutes
siqr  -  go shopping for groceries
siqr  -  my medical problem prevented me from accomplishing goals for the week
siqr  -  i was completely overwhelmed by my medical problem
siqr  -  pain
siqr  -  energy
siqr  -  stiffness
siqr  -  your sleep
siqr  -  depression
siqr  -  memory problems
siqr  -  anxiety
siqr  -  tenderness to touch
siqr  -  balance problems
siqr  -  sensitivity to loud noises ,  bright lights ,  odors and cold
sows short  -  feeling sick
sows short  -  stomach cramps
sows short  -  muscle spasms / twitching
sows short  -  feelings of coldness
sows short  -  heart pounding
sows short  -  muscular tension
sows short  -  aches and pains
sows short  -  yawning
sows short  -  runny eyes
sows short  -  insomnia / problems sleeping
ups  -  describe your experience when you desire to urinate
odi v2 .1a  -  pain intensity
odi v2 .1a  -  personal care
odi v2 .1a  -  lifting
odi v2 .1a  -  walking
odi v2 .1a  -  sitting
odi v2 .1a  -  standing
odi v2 .1a  -  sleeping
odi v2 .1a  -  sex life
odi v2 .1a  -  social life
odi v2 .1a  -  travelling
c - ssrs since last visit  -  wish to be dead or go to sleep and not wake up
c - ssrs since last visit  -  description of wish to be dead
c - ssrs since last visit  -  non - specific suicidal thought
c - ssrs since last visit  -  description of non - specific suicide thought
c - ssrs since last visit  -  suicidal ideation - no intent
c - ssrs since last visit  -  description of suicidal ideation - no intent
c - ssrs since last visit  -  description of ideation with plan and intent
c - ssrs since last visit  -  most severe ideation
c - ssrs since last visit  -  describe most severe ideation
c - ssrs since last visit  -  frequency of most severe ideation
c - ssrs since last visit  -  duration of most severe ideation
c - ssrs since last visit  -  control over most severe ideation
c - ssrs since last visit  -  deterrents to most severe ideation
c - ssrs since last visit  -  reasons for most severe ideation
c - ssrs since last visit  -  actual suicide attempt
c - ssrs since last visit  -  number of actual suicide attempts
c - ssrs since last visit  -  description of actual suicide attempts
c - ssrs since last visit  -  non - suicidal self - injurious behavior
c - ssrs since last visit  -  interrupted suicide attempt
c - ssrs since last visit  -  number of interrupted suicide attempts
c - ssrs since last visit  -  description of interrupted suicide attempt
c - ssrs since last visit  -  aborted suicide attempt
c - ssrs since last visit  -  number of aborted suicide attempts
c - ssrs since last visit  -  description of aborted suicide attempt
c - ssrs since last visit  -  preparatory acts or behaviors toward suicide attempt
c - ssrs since last visit  -  description of preparatory acts or behaviors toward suicide attempt
c - ssrs since last visit  -  suicidal behavior
c - ssrs since last visit  -  ideation with intent ,  no plan
carbogen
c - ssrs since last visit  -  description of ideation with intent ,  no plan
c - ssrs since last visit  -  ideation with plan / intent
definitely disagree
mostly disagree
neither agree or disagree
mostly agree
definitely agree
slight
cd19 expressing cell count
cd3 expressing cell count
cd4 expressing cell count
cd8 expressing cell count
cd19 cell to lymphocyte ratio measurement
cd3 cell to lymphocyte ratio measurement
cd4 cell to cd8 cell ratio measurement
cd4 cell to lymphocyte ratio measurement
cd8 cell to lymphocyte ratio measurement
hereditary prostate carcinoma
iliac crest
carbon c 11 erlotinib hydrochloride
lirilumab
amnion - derived cellular cytokine solution
injectable astragalus membranaceus polysaccharide
xbp1 - us / xbp1 - sp / cd138 / cs1 multipeptide vaccine pvx - 410
oxycodone hydrochloride / naloxone hydrochloride prolonged - release tablet
smac mimetic gdc - 0917
taladegib
pasotuxizumab
galectin - 1 inhibitor otx008
fap - specific cd8 - positive t cells
recombinant human hsp110 - gp100 chaperone complex vaccine
fluorine f 18 fmdht
fact - p questionnaire
losing weight
aches and pains bother me
have painful body parts
satisfied with present comfort level
feel like a man
trouble moving bowels
difficulty urinating
unusual frequent urination
activities limited by urination problems
have and maintain an erection
patient reported outcomes version of ctcae
worst severity last seven days breast enlargement or tenderness
hemoglobin variant measurement
retrocrural
portacaval
preauricular
pittsburgh sleep quality index
fact - cognitive function
regardless
extra - adrenal
biopathology center
seattle cancer care alliance
eflapegrastim
anti - grp78 monoclonal antibody pat - sm6
internalized - arginylglycylaspartic acid cyclic peptide
anti - erbb3 monoclonal antibody regn1400
anti - hla - dr monoclonal antibody immu - 114
pi3k alpha / beta inhibitor bay1082439
allogeneic irradiated melanoma cell vaccine csf470
istiratumab
gallium ga 68 - labeled dota di - hsg peptide imp - 288
autologous bone marrow - derived cd34 / cxcr4 - positive stem cells amr - 001
high - titer rsv immune globulin ri - 001
norepinephrine - secreting
normetanephrine - secreting
epinephrine - secreting
metanephrine - secreting
dopamine - secreting
methoxytyramine - secreting
sdha gene
sdha wt allele
succinate dehydrogenase  [ ubiquinone ]  flavoprotein subunit ,  mitochondrial
abca5 gene
abca5 wt allele
atp - binding cassette sub - family a member 5
abcc4 gene
abcc4 wt allele
multidrug resistance - associated protein 4
abcc2 gene
abcc2 wt allele
canalicular multispecific organic anion transporter 1
acaca gene
acaca wt allele
acetyl - coa carboxylase 1
acer1 gene
tnfrsf8 gene product
soluble tumor necrosis factor receptor superfamily member 8
acer1 wt allele
alkaline ceramidase 1
acer2 gene
acer2 wt allele
alkaline ceramidase 2
acer3 gene
acer3 wt allele
alkaline ceramidase 3
asah1 gene
carbovir
asah1 wt allele
acid ceramidase
asah2 gene
asah2 wt allele
neutral ceramidase
asah2b gene
asah2b wt allele
putative inactive neutral ceramidase b
asah2c gene
asah2c wt allele
putative neutral ceramidase c
imaging quality assurance review center
carpometacarpal joint 1
carpometacarpal joint 2
carpometacarpal joint 3
carpometacarpal joint 4
carpometacarpal joint 5
right aortic arch
microcystic renal disease
solitary multilocular kidney cyst
hemoglobin barts
lissencephaly
congenital hydroureter
congenital postural scoliosis
alox12 gene
alox12 wt allele
arachidonate 12 - lipoxygenase ,  12s - type
arg1 gene
arg1 wt allele
arginase - 1
arsa gene
arsa wt allele
arylsulfatase a
automotive occupations
welding occupations
congenital pulmonary valve insufficiency
congenital aortic valve insufficiency
b4galt6 gene
b4galt6 wt allele
beta - 1 , 4 - galactosyltransferase 6
fpgs gene
fpgs wt allele
folylpolyglutamate synthase ,  mitochondrial
ggh gene
ggh wt allele
gamma - glutamyl hydrolase
slc19a1 gene
slc19a1 wt allele
folate transporter 1
abcc5 gene
abcc5 wt allele
multidrug resistance - associated protein 5
plvap gene
plvap wt allele
plasmalemma vesicle - associated protein
bccip gene
coloboma of the retina
bccip wt allele
brca2 and cdkn1a - interacting protein
atf3 gene
atf3 wt allele
cyclic amp - dependent transcription factor atf - 3
anln gene
anln wt allele
anillin
actb gene
actb wt allele
pain keeps me from doing things i want to do
pyruvate dehydrogenase deficiency
actin ,  cytoplasmic 1
acta2 gene
acta2 wt allele
actin ,  aortic smooth muscle
adipor1 gene
adipor1 wt allele
adiponectin receptor protein 1
adipor2 gene
adipor2 wt allele
adiponectin receptor protein 2
zglp1 gene
zglp1 wt allele
gata - type zinc finger protein 1
voluntary report
nqo2 gene
nqo2 wt allele
ribosyldihydronicotinamide dehydrogenase  [ quinone ]
cbr3 gene
cbr3 wt allele
carbonyl reductase  [ nadph ]  3
human anti - human antibody
baalc gene
baalc wt allele
brain and acute leukemia cytoplasmic protein
mtap gene
mtap wt allele
s - methyl - 5' - thioadenosine phosphorylase
hspa1a gene
hspa1b gene
hspa1a wt allele
carzinophilin
hspa1b wt allele
heat shock 70 kda protein 1a / 1b
deoxyuridine triphosphate
congenital hematological disorder
topical cocaine hydrochloride
pegfilgrastim biosimilar la - ep2006
anti - cd20 - car - cd3zeta - 4 - 1bb - expressing autologous t - lymphocyte cells
technetium tc 99m - 3prgd2
fimepinostat
mcpyv tag - specific polyclonal autologous cd8 - positive t cells
zirconium zr 89 - labeled ro5479599
nuclear grade iii or iv
luspatercept
cytoplasm presence of less than or equal to twenty five percent
weiss system
weiss criteria
ensat staging finding v7
pathologic ensat staging finding v7
pathologic primary tumor ensat staging finding v7
pt1 ensat staging finding v7
pt2 ensat staging finding v7
pt3 ensat staging finding v7
pt4 ensat staging finding v7
pathologic lymph nodes ensat staging finding v7
pn0 ensat staging finding v7
pn1 ensat staging finding v7
clinical ensat staging finding v7
clinical distant metastasis ensat staging finding v7
cm0 ensat staging finding v7
cm1 ensat staging finding v7
adrenal cortex carcinoma by ensat stage
ensat stage i adrenal cortex carcinoma
ensat stage ii adrenal cortex carcinoma
ensat stage iii adrenal cortex carcinoma
ensat stage iv adrenal cortex carcinoma
hsd17b1 gene
hsd17b1 wt allele
estradiol 17 - beta - dehydrogenase 1
bcl2a1 gene
bcl2a1 wt allele
bcl2 - related protein a1
camk2n1 gene
camk2n1 wt allele
calcium / calmodulin - dependent protein kinase ii inhibitor 1
hot flash related daily inference scale
erk inhibitor mk - 8353
ctag2 gene
ctag2 wt allele
itraconazole dispersion in polymer matrix
cancer / testis antigen 2
ca9 gene
ca9 wt allele
carbonic anhydrase 9
ctsg gene
ctsg wt allele
telapristone acetate
cathepsin g
telapristone
lumretuzumab
slamf1 gene
slamf1 wt allele
signaling lymphocytic activation molecule
cd163 gene
cd163 wt allele
scavenger receptor cysteine - rich type 1 protein m130
cd226 gene
cd226 wt allele
cd226 antigen
cd244 gene
cd244 wt allele
natural killer cell receptor 2b4
cd27 gene
cd27 wt allele
cd27 antigen
cd69 gene
cd69 wt allele
early activation antigen cd69
cd70 gene
cd70 wt allele
cd70 antigen
enjoyment of life
naive t - lymphocyte
memory t - lymphocyte
effector t - lymphocyte
ndrg2 gene
ndrg2 wt allele
protein ndrg2
esm1 gene
esm1 wt allele
endothelial cell - specific molecule 1
plxdc1 gene
plxdc1 wt allele
plexin domain - containing protein 1
antxr1 gene
antxr1 wt allele
anthrax toxin receptor 1
apln gene
apln wt allele
apelin
glycogen synthase kinase 3
cefepime hydrochloride
pancreastatin
parp1 gene product
poly  [ adp - ribose ]  polymerase 1 p85
leisure activity
ugt1a7 gene
ugt1a7 wt allele
udp - glucuronosyltransferase 1 - 7
cd8a gene
cd8a wt allele
t - cell surface glycoprotein cd8 alpha chain
cdc20 gene
cdc20 wt allele
cell division cycle protein 20 homolog
ceacam1 gene
ceacam1 wt allele
carcinoembryonic antigen - related cell adhesion molecule 1
cebpb gene
cebpb wt allele
ccaat / enhancer binding protein beta
cep55 gene
cep55 wt allele
centrosomal protein of 55 kda
cerkl gene
cerkl wt allele
ceramide kinase - like protein
cers5 gene
cers5 wt allele
ceramide synthase 5
ccr7 gene
ccr7 wt allele
c - c chemokine receptor type 7
clec4c gene
clec4c wt allele
c - type lectin domain family 4 member c
cdc25c gene
cdc25c wt allele
m - phase inducer phosphatase 3
cp gene
cp wt allele
ceruloplasmin
crbn gene
crbn wt allele
protein cereblon
cxcl16 gene
cxcl16 wt allele
c - x - c motif chemokine 16
cyp24a1 gene
cyp24a1 wt allele
1 , 25 - dihydroxyvitamin d ( 3 )  24 - hydroxylase ,  mitochondrial
cyp27a1 gene
cyp27a1 wt allele
sterol 26 - hydroxylase ,  mitochondrial
folfiri - cetuximab regimen
polatuzumab vedotin
circulating cell - free rna
cllu1 gene
cllu1 wt allele
chronic lymphocytic leukemia up - regulated protein 1
bmf gene
bmf wt allele
bcl - 2 - modifying factor
kif23 gene
kif23 wt allele
kinesin - like protein kif23
tubb gene
tubb wt allele
tubulin beta chain
pinatuzumab vedotin
tuba3c gene
tuba3c wt allele
tubulin alpha - 3c / d chain
crtam gene
crtam wt allele
cytotoxic and regulatory t - cell molecule
degs1 gene
degs1 wt allele
sphingolipid delta ( 4 )  - desaturase des1
degs2 gene
degs2 wt allele
sphingolipid delta ( 4 )  - desaturase / c4 - hydroxylase des2
dcaf7 gene
dcaf7 wt allele
ddb - 1 and cul4 - associated factor 7
ddit4 gene
ddit4 wt allele
dna damage - inducible transcript 4 protein
eif2s1 gene
eif2s1 wt allele
eukaryotic translation initiation factor 2 subunit 1
eif4a1 gene
eif4a1 wt allele
eukaryotic initiation factor 4a - i
lactate dehydrogenase isoenzyme 5
cyclin d
elane gene
elane wt allele
cyclin e
neutrophil elastase
i - kappa - b kinase
cetirizine
type iii procollagen n - terminal peptide
ganglioside gq
oligodendrocyte marker o4
eno1 gene
eno1 wt allele
alpha - enolase
pxn gene
pxn wt allele
paxillin
enpp2 gene
enpp2 wt allele
ectonucleotide pyrophosphatase / phosphodiesterase family member 2
ptpn13 gene
ptpn13 wt allele
tyrosine - protein phosphatase non - receptor type 13
f12 gene
tnnt2 gene
f12 wt allele
tnnt2 wt allele
coagulation factor xii
troponin t ,  cardiac muscle
fbxo32 gene
fbxo32 wt allele
tnni3 gene
tnni3 wt allele
f - box only protein 32
troponin i ,  cardiac muscle
ccna1 gene
ccna1 wt allele
cyclin - a1
alpl gene
alpl wt allele
alkaline phosphatase ,  tissue - nonspecific isozyme
cyp1b1 gene
fcgr1a gene
cyp1b1 wt allele
fcgr1a wt allele
cytochrome p450 1b1
high affinity immunoglobulin gamma fc receptor i
rad23b gene
rad23b wt allele
uv excision repair protein rad23 homolog b
tubb3 gene
tubb3 wt allele
tubulin beta - 3 chain
rorc gene
rorc wt allele
nuclear receptor ror - gamma
tbx21 gene
tbx21 wt allele
t - box transcription factor tbx21
itgb7 gene
itgb7 wt allele
integrin beta - 7
dll3 gene
dll3 wt allele
delta - like protein 3
hes4 gene
hes4 wt allele
transcription factor hes - 4
imalumab
eloquent brain areas
gzmb gene
ak 3012
derazantinib
granzyme b
fluorine f 18 - labeled s -  ( 3 - fluoropropyl ) homocysteine hydrochloride
iridium ir 192
hamp gene
hamp wt allele
fish oil / glycerol / egg lecithin - based emulsion
hepcidin
licartin
havcr2 gene
havcr2 wt allele
hepatitis a virus cellular receptor 2
trouble doing strenuous activities like carrying a heavy shopping bag or suitcase
p53 / hdm2 interaction inhibitor cgm097
trouble taking long walk
trouble taking short walk outside house
stay in bed or chair during day
need help with eating ,  dressing ,  washing or toilet
limited in doing work or daily activities
limited in pursuing hobbies or leisure activities
hdac11 gene
hdac11 wt allele
histone deacetylase 11
cisplatin / cyclophosphamide / doxorubicin / prednisone regimen
anti - tissue factor monoclonal antibody morab - 066
panulisib
need rest
trouble sleeping
feel weak
lacks appetite
have emesis
have constipation
cgp - 6809
have diarrhea
feel tired
feel tense
epas1 gene
feel worry
epas1 wt allele
endothelial pas domain - containing protein 1
difficulty concentrating reading newspaper or watching television
feel irritable
feel depressed
interference with family life due to physical condition or medical treatment
interference with social activities due to physical condition or medical treatment
financial difficulties due to physical condition or medical treatment
overall health rating during past week
overall quality of life rating during past week
very poor
hla - g gene
hla - g wt allele
have hot flushes
quality of life questionnaire  -  gastrointestinal neuroendocrine tumors 21
look flushed or red
have night sweats
have abdominal discomfort
feel abdomen is bloated
have problem with flatulence
have heartburn
have difficulty eating
hla class i histocompatibility antigen ,  alpha chain g
have side effects from treatment
have problem with repeated injections
worry about tumor recurrence in other body areas
hoxa3 gene
hoxa3 wt allele
divergent differentiation
homeobox protein hox - a3
hoxb6 gene
hoxb6 wt allele
homeobox protein hox - b6
hspd1 gene
hspd1 wt allele
60 kda heat shock protein ,  mitochondrial
il20 gene
il20 wt allele
interleukin - 20
il21 gene
il21 wt allele
interleukin - 21
ifnl2 gene
ifnl2 wt allele
interferon lambda - 2
ifnl1 gene
ifnl1 wt allele
interferon lambda - 1
gzmb wt allele
european organization for research and treatment of cancer quality of life questionnaire core 30
kif2c gene
kif2c wt allele
kinesin - like protein kif2c
kir3dl1 gene
kir3dl1 wt allele
killer cell immunoglobulin - like receptor 3dl1
klrc1 gene
klrc1 wt allele
nkg2 - a / nkg2 - b type ii integral membrane protein
concern about home life disruption
worry about future health
distress about illness or treatment to those close to you
have weight loss problem
have weight gain problem
worry about test results
have aches or pains in muscles or bones
have limited ability to travel
pseudoangiomatous stromal hyperplasia
have problem receiving adequate disease and treatment information
feel disease or treatment adversely affects sex life
gage2a gene
gage2a wt allele
g antigen 2a
fgd4 gene
fgd4 wt allele
fyve ,  rhogef and ph domain - containing protein 4
fgf23 gene
fgf23 wt allele
fibroblast growth factor 23
vegfd gene
vegfd wt allele
vascular endothelial growth factor d
fkbp8 gene
fkbp8 wt allele
peptidyl - prolyl cis - trans isomerase fkbp8
fmod gene
fmod wt allele
fibromodulin
foxp3 gene
foxp3 wt allele
forkhead box protein p3
fshb gene
fshb wt allele
follitropin subunit beta
fadrozole hydrochloride
fut4 gene
fut4 wt allele
alpha -  ( 1 , 3 )  - fucosyltransferase 4
fzd8 gene
fzd8 wt allele
frizzled - 8
lgals1 gene
lgals1 wt allele
galectin - 1
gapdh gene
gapdh wt allele
glyceraldehyde - 3 - phosphate dehydrogenase
roneparstat
umbralisib
geranylgeranyltransferase i inhibitor
gene - modified hiv - protected hematopoietic stem cells
gata6 gene
gata6 wt allele
transcription factor gata - 6
autologous gm - csf - secreting lethally irradiated leukemia cell vaccine
zirconium zr 89 dfo - mstp2109a
gba gene
gba wt allele
glucosylceramidase
gba2 gene
gba2 wt allele
non - lysosomal glucosylceramidase
ghrl gene
ghrl wt allele
appetite - regulating hormone
gip gene
gip wt allele
gastric inhibitory polypeptide
glutathione peroxidase 2
gpx2 gene
gpx2 wt allele
treatment emergent flag
ce mark
first in human
standard time
non - reason code
distinct product count
md anderson dysphagia inventory
ability to swallow limits daily activities
embarassed by my eating habits
feel like people have difficulty cooking for me
swallowing more difficult at end of day
does not feel self - conscious when eating
upset by swallowing problem
swallowing takes great effort
does not go out due to swallowing problem
swallowing difficulty causes lost income
takes longer to eat due to swallowing problem
asked why unable to eat something
others irritated by my eating problem
cough when drinking liquids
exosome
swallowing problems limit social and personal life
bid gene product
truncated bid
gage8 gene
feel free to go out to eat with friends ,  neighbors and relatives
gage8 wt allele
limit food intake due to swallowing difficulty
unable to maintain weight due to swallowing problem
have low self - esteem due to swallowing problem
feel like swallowing huge amount of food
feel excluded due to eating habits
g antigen 2d
gage7 gene
gage7 wt allele
g antigen 7
gage6 gene
gage6 wt allele
strongly agree
strongly disagree
g antigen 6
agree
disagree
gage5 gene
gage5 wt allele
g antigen 5
gage4 gene
g antigen 4
gage4 wt allele
gage3 gene
gage3 wt allele
g antigen 3
gage1 gene
gage1 wt allele
g antigen 1
bage gene
bage wt allele
b melanoma antigen 1
other race
magea10 gene
magea10 wt allele
melanoma - associated antigen 10
magea2 gene
chamomile
magea2 wt allele
melanoma - associated antigen 2
septin4 gene
septin4 wt allele
batch number
septin - 4
hdac10 gene
hdac10 wt allele
histone deacetylase 10
magea1 gene
magea1 wt allele
melanoma - associated antigen 1
magea4 gene
magea4 wt allele
tnfrsf10c gene
melanoma - associated antigen 4
tnfrsf10c wt allele
magea6 gene
magea6 wt allele
melanoma - associated antigen 6
pmfac regimen
tumor necrosis factor receptor superfamily member 10c
mageb18 gene
mageb18 wt allele
melanoma - associated antigen b18
magec1 gene
magec1 wt allele
melanoma - associated antigen c1
magec2 gene
magec2 wt allele
melanoma - associated antigen c2
hes3 gene
hes3 wt allele
transcription factor hes - 3
hes6 gene
hes6 wt allele
transcription cofactor hes - 6
hey2 gene
hey2 wt allele
nlrp1 gene
nlrp1 wt allele
hairy / enhancer - of - split related with yrpw motif protein 2
nacht ,  lrr and pyd domains - containing protein 1
slc29a2 gene
ncr2 gene
ncr2 wt allele
slc29a2 wt allele
natural cytotoxicity triggering receptor 2
equilibrative nucleoside transporter 2
ncr3 gene
ncr3 wt allele
vip - b regimen
natural cytotoxicity triggering receptor 3
tbl2 gene
tbl2 wt allele
transducin beta - like protein 2
irf8 gene
irf8 wt allele
interferon regulatory factor 8
nes gene
rab40b gene
rab40b wt allele
ras - related protein rab - 40b
nes wt allele
nestin
ncf2 gene
ncf2 wt allele
neutrophil cytosolic factor 2
nnmt gene
nnmt wt allele
nicotinamide n - methyltransferase
homer3 gene
nox4 gene
nox4 wt allele
nadph oxidase 4
homer3 wt allele
homer protein homolog 3
trib2 gene
trib2 wt allele
tribbles homolog 2
serpinb9 gene
serpinb9 wt allele
serpin b9
pelo gene
pelo wt allele
protein pelota homolog
nsmaf gene
nsmaf wt allele
protein fan
nt5c2 gene
nt5c2 wt allele
cytosolic purine 5' - nucleotidase
bglap gene
bglap wt allele
osteocalcin
linear analogue self - assessment
overall quality of life
overall intellectual well - being
overall physical well - being
overall emotional well - being
level of social activity
overall spiritual well - being
chaparrinone
frequency of pain
average severity of pain
average level of fatigue
level of support from friends and family
concern about finances
concern about legal matters  -  will and advanced directives
constant concern
no concerns
highest level of support
as good as it can be
as bad as it can be
map1lc3a gene
map1lc3a wt allele
microtubule - associated proteins 1a / 1b light chain 3a
lpl gene
lpl wt allele
lipoprotein lipase
lrrc19 gene
lrrc19 wt allele
leucine - rich repeat - containing protein 19
lag3 gene
lag3 wt allele
total body water measurement
lymphocyte activation gene 3 protein
lypla1 gene
lypla1 wt allele
acyl - protein thioesterase 1
lamp1 gene
lamp1 wt allele
lysosome - associated membrane glycoprotein 1
mr1 gene
mr1 wt allele
major histocompatibility complex class i - related gene protein
mrc1 gene
mrc1 wt allele
macrophage mannose receptor 1
map4 gene
map4 wt allele
microtubule - associated protein 4
capg gene
capg wt allele
macrophage - capping protein
mdc1 gene
mdc1 wt allele
mediator of dna damage checkpoint protein 1
mrc2 gene
mrc2 wt allele
c - type mannose receptor 2
micb gene
micb wt allele
mhc class i polypeptide - related sequence b
mib1 gene
mib1 wt allele
e3 ubiquitin - protein ligase mib1
irf9 gene
irf9 wt allele
interferon regulatory factor 9
isg15 gene
isg15 wt allele
ubiquitin - like protein isg15
eif5 gene
eif5 wt allele
eukaryotic translation initiation factor 5
dnaj protein
epstein - barr nuclear antigen 2
mir382 gene
mir382 wt allele
mir382 pre - mirna
kit exon 11 mutation
mst1l gene
mst1l wt allele
putative macrophage - stimulating protein mstp9
kit exon 9 mutation
kit exon 13 mutation
genome - wide dna copy number
fc - gamma receptor
tenascin family
microtubule - associated proteins 1a / 1b light chain 3
killer - cell immunoglobulin - like receptor
interleukin - 2 receptor
ancestry - informative marker
serpinc1 gene
serpinc1 wt allele
antithrombin - iii
celf2 gene
celf2 wt allele
cugbp elav - like family member 2
meis2 gene
meis2 wt allele
homeobox protein meis2
nfya gene
nfya wt allele
nuclear transcription factor y subunit alpha
stra6 gene
stra6 wt allele
stimulated by retinoic acid gene 6 protein homolog
tob2 gene
tob2 wt allele
protein tob2
cxadr gene
chlornaphazine
cxadr wt allele
coxsackievirus and adenovirus receptor
mvp gene
mvp wt allele
major vault protein
camk2a gene
camk2a wt allele
calcium / calmodulin - dependent protein kinase type ii subunit alpha
rad50 gene
rad50 wt allele
dna repair protein rad50
rad51 gene
rad51 wt allele
dna repair protein rad51 homolog 1
park7 gene
park7 wt allele
protein dj - 1
parp2 gene
parp2 wt allele
rassf5 gene
poly  [ adp - ribose ]  polymerase 2
rassf5 wt allele
ras association domain - containing protein 5
rpp40 gene
rpp40 wt allele
ribonuclease p protein subunit p40
rps14 gene
rps14 wt allele
40s ribosomal protein s14
pbxip1 gene
pbxip1 wt allele
technetium tc 99 hydrazinonicotinamide - tricine - linked interleukin - 2
savolitinib
pre - b - cell leukemia transcription factor - interacting protein 1
wt1 235 - 243 peptide vaccine
rictor gene
rictor wt allele
wt1 247 - 261 peptide vaccine
wt1 124 - 138 peptide vaccine
pde2a gene
rapamycin - insensitive companion of mtor
pde2a wt allele
cgmp - dependent 3' , 5' - cyclic phosphodiesterase
nadofaragene firadenovec / syn3
ulixertinib
amcasertib
igf - 1r inhibitor pl225b
uv1 telomerase peptide vaccine
darolutamide
pdgfc gene
pdgfc wt allele
platelet - derived growth factor c
rlf gene
rlf wt allele
zinc finger protein rlf
rpa1 gene
rpa1 wt allele
replication protein a 70 kda dna - binding subunit
pdk1 gene
pdk1 wt allele
rpl13a gene
 [ pyruvate dehydrogenase  [ lipoamide ]  ]  kinase isozyme 1 ,  mitochondrial
rpl13a wt allele
60s ribosomal protein l13a
rps6ka1 gene
rps6ka1 wt allele
ribosomal protein s6 kinase alpha - 1
rptor gene
rptor wt allele
regulatory - associated protein of mtor
rrm2b gene
rrm2b wt allele
ribonucleoside - diphosphate reductase subunit m2 b
s1pr2 gene
s1pr2 wt allele
sphingosine 1 - phosphate receptor 2
s1pr3 gene
s1pr3 wt allele
sphingosine 1 - phosphate receptor 3
s1pr4 gene
s1pr4 wt allele
sphingosine 1 - phosphate receptor 4
s1pr5 gene
s1pr5 wt allele
sphingosine 1 - phosphate receptor 5
pdpn gene
pdpn wt allele
podoplanin
position
pfkm gene
pfkm wt allele
6 - phosphofructokinase ,  muscle type
pigf gene
pigf wt allele
phosphatidylinositol - glycan biosynthesis class f protein
pias1 gene
pias1 wt allele
e3 sumo - protein ligase pias1
pim2 gene
pim2 wt allele
chloroaluminum phthalocyanine
serine / threonine - protein kinase pim - 2
prkci gene
prkci wt allele
protein kinase c iota type
prune2 gene
prune2 wt allele
protein prune homolog 2
psenen gene
psenen wt allele
gamma - secretase subunit pen - 2
pyy gene
pyy wt allele
peptide yy
branchial cleft remnant
rab5c gene
rab5c wt allele
ras - related protein rab - 5c
rac3 gene
rac3 wt allele
ras - related c3 botulinum toxin substrate 3
wireless communication problem
plcg1 gene
plcg1 wt allele
1 - phosphatidylinositol 4 , 5 - bisphosphate phosphodiesterase gamma - 1
apba1 gene
apba1 wt allele
amyloid beta a4 precursor protein - binding family a member 1
camk2b gene
camk2b wt allele
calcium / calmodulin - dependent protein kinase type ii subunit beta
camk2g gene
camk2g wt allele
calcium / calmodulin - dependent protein kinase type ii subunit gamma
cdc25b gene
cdc25b wt allele
m - phase inducer phosphatase 2
nanos3 gene
nanos3 wt allele
nanos homolog 3
nek3 gene
apba2 gene
nek3 wt allele
apba2 wt allele
serine / threonine - protein kinase nek3
amyloid beta a4 precursor protein - binding family a member 2
apba3 gene
apba3 wt allele
amyloid beta a4 precursor protein - binding family a member 3
b4galt1 gene
b4galt1 wt allele
beta - 1 , 4 - galactosyltransferase 1
snurf gene
snurf wt allele
snrpn upstream reading frame protein
lgals3 gene
lgals3 wt allele
galectin - 3
tle1 gene
tle1 wt allele
transducin - like enhancer protein 1
ahcy gene
ahcy wt allele
sesn3 gene
adenosylhomocysteinase
sesn3 wt allele
sestrin - 3
bhmt gene
bhmt wt allele
megavoltage planar imaging
betaine - homocysteine s - methyltransferase 1
kilovoltage planar imaging
cyp26b1 gene
cyp26b1 wt allele
cytochrome p450 26b1
megavoltage cone beam computed tomography
dnd1 gene
dnd1 wt allele
kilovoltage cone beam computed tomography
bhmt2 gene
dead end protein homolog 1
bhmt2 wt allele
s - methylmethionine - homocysteine s - methyltransferase bhmt2
chat gene
chat wt allele
choline o - acetyltransferase
ct on rails
dst gene
dst wt allele
dystonin
fact - hep questionnaire
e2f6 gene
e2f6 wt allele
chdh gene
transcription factor e2f6
chdh wt allele
choline dehydrogenase ,  mitochondrial
psmg2 gene
chlorozotocin
psmg2 wt allele
proteasome assembly chaperone 2
have swelling or cramps in stomach
stra8 gene
stra8 wt allele
stimulated by retinoic acid gene 8 protein
have control of bowels
radio beacon transponder system
digests food well
chpt1 gene
unhappy with change in appearance
chpt1 wt allele
cholinephosphotransferase 1
folr2 gene
photon beam radiation therapy
folr2 wt allele
folate receptor beta
have back pain
bothered by constipation
cobalt - 60 radiation therapy
mthfd1 gene
able to perform usual activities
mthfd1 wt allele
c - 1 - tetrahydrofolate synthase ,  cytoplasmic
crabp2 gene
bothered by jaundice or yellow skin color
crabp2 wt allele
cellular retinoic acid - binding protein 2
cbfa2t2 gene
have fever
cbfa2t2 wt allele
have itch
protein cbfa2t2
volume modulated arc therapy
notice change in the way food tastes
have chills
crip2 gene
have dry mouth
crip2 wt allele
have discomfort or pain in stomach
cysteine - rich protein 2
scanning proton beam therapy
scattering proton beam therapy
mthfd2 gene
mthfd2 wt allele
bifunctional methylenetetrahydrofolate dehydrogenase / cyclohydrolase ,  mitochondrial
mtr gene
mr - based treatment machine
mtr wt allele
methionine synthase
crlf1 gene
crlf1 wt allele
cytokine receptor - like factor 1
pcyt1a gene
pcyt1a wt allele
lhx3 gene
lhx3 wt allele
choline - phosphate cytidylyltransferase a
lim / homeobox protein lhx3
znf423 gene
znf423 wt allele
zinc finger protein 423
atg5 gene
atg5 wt allele
autophagy protein 5
pemt gene
pemt wt allele
phosphatidylethanolamine n - methyltransferase
shmt1 gene
shmt1 wt allele
serine hydroxymethyltransferase ,  cytosolic
pla2g1b gene
pla2g1b wt allele
phospholipase a2
gsta1 gene
gsta1 wt allele
glutathione s - transferase a1
cr2 gene
cr2 wt allele
complement receptor type 2
cks1b gene
cks1b wt allele
cyclin - dependent kinases regulatory subunit 1
pyridinoline
protein tyrosine phosphatase type iva
inpp5d gene product
phosphatidylinositol 3 , 4 , 5 - trisphosphate 5 - phosphatase 1 isoform 3
hla class ii histocompatibility antigen ,  dq alpha 1 chain
palliative radiation therapy for metastatic cancer
retreatment of progressive local disease with external beam radiation
retreatment of progressive local disease with brachytherapy
retreatment of progressive local disease with cryotherapy and hifu
rectal balloon
film portal imaging
electronic portal imaging
scgb3a1 gene
scgb3a1 wt allele
secretoglobin family 3a member 1
sdc2 gene
sdc2 wt allele
asulacrine isethionate
syndecan - 2
sfrp2 gene
sfrp2 wt allele
secreted frizzled - related protein 2
sfrp5 gene
sfrp5 wt allele
secreted frizzled - related protein 5
sel1l gene
sel1l wt allele
protein sel - 1 homolog 1
serpina1 gene
serpina1 wt allele
alpha - 1 - antitrypsin
setmar gene
setmar wt allele
histone - lysine n - methyltransferase setmar
sgms1 gene
sgms1 wt allele
phosphatidylcholine:ceramide cholinephosphotransferase 1
smpd1 gene
smpd1 wt allele
sphingomyelin phosphodiesterase
smpd2 gene
smpd2 wt allele
sgms2 gene
sgms2 wt allele
sphingomyelin phosphodiesterase 2
phosphatidylcholine:ceramide cholinephosphotransferase 2
sgpl1 gene
smpd3 gene
sgpl1 wt allele
smpd3 wt allele
sphingomyelin phosphodiesterase 3
sphingosine - 1 - phosphate lyase 1
fact - h&n questionnaire
smpd4 gene
smpd4 wt allele
sgpp1 gene
sgpp1 wt allele
sphingomyelin phosphodiesterase 4
sphingosine - 1 - phosphate phosphatase 1
able to eat liked food
have trouble breathing
sgpp2 gene
voice has usual quality and strength
sgpp2 wt allele
able to eat as much food as desired
sphingosine - 1 - phosphate phosphatase 2
unhappy with face and neck appearance
swallowing naturally and easily
smoke cigarettes or other tobacco products
drinks alcohol such as beer or wine
able to communicate with others
able to eat solid food
have pain in mouth ,  throat or neck
slamf6 gene
slamf6 wt allele
slam family member 6
slc1a4 gene
slc1a4 wt allele
neutral amino acid transporter a
slc29a1 gene
slc29a1 wt allele
equilibrative nucleoside transporter 1
slc4a1 gene
slc4a1 wt allele
band 3 anion transport protein
slc4a3 gene
slc4a3 wt allele
anion exchange protein 3
slc18a2 gene
slc18a2 wt allele
synaptic vesicular amine transporter
slc22a1 gene
slc22a1 wt allele
solute carrier family 22 member 1
sost gene
sost wt allele
sclerostin
sox11 gene
sox11 wt allele
transcription factor sox - 11
spry4 gene
spry4 wt allele
protein sprouty homolog 4
srebf1 gene
srebf1 wt allele
sterol regulatory element - binding protein 1
sulf2 gene
sulf2 wt allele
extracellular sulfatase sulf - 2
tbxa2r gene
tbxa2r wt allele
thromboxane a2 receptor
tdp1 gene
tdp1 wt allele
tyrosyl - dna phosphodiesterase 1
nelfcd gene
nelfcd wt allele
negative elongation factor c / d
cilostazol
tmpo gene
tmpo wt allele
lamina - associated polypeptide 2 ,  isoform alpha
lamina - associated polypeptide 2 ,  isoforms beta / gamma
tmpo gene product
tmem204 gene
tmem204 wt allele
transmembrane protein 204
traf1 gene
traf1 wt allele
tnf receptor - associated factor 1
tnfrsf9 gene
tnfrsf9 wt allele
tumor necrosis factor receptor superfamily member 9
ptges2 gene
ptges2 wt allele
prostaglandin e synthase 2
mapkap1 gene
mapkap1 wt allele
target of rapamycin complex 2 subunit mapkap1
tnfaip1 gene
tnfaip1 wt allele
btb / poz domain - containing adapter for cul3 - mediated rhoa degradation protein 2
eif4e gene
eif4e wt allele
eukaryotic translation initiation factor 4e
mtrr gene
mtrr wt allele
methionine synthase reductase
cdisc questionnaire dad test name terminology
cdisc questionnaire dad test code terminology
cdisc questionnaire c - ssrs baseline / screening version phase 1 study version 1 / 14 / 09 test name terminology
cdisc questionnaire c - ssrs baseline / screening version phase 1 study version 1 / 14 / 09 test code terminology
cdisc questionnaire pi v1 test name terminology
cdisc questionnaire pi v1 test code terminology
cdisc questionnaire pr v1 test name terminology
cdisc questionnaire pr v1 test code terminology
cdisc questionnaire gcgi v1 test name terminology
cdisc questionnaire gcgi v1 test code terminology
cdisc questionnaire adcs - adl test name terminology
cdisc questionnaire adcs - adl test code terminology
c - ssrs baseline / screening version phase 1 study version 1 / 14 / 09 questionnaire question
dad questionnaire question
pi questionnaire question
pr questionnaire question
gcgi questionnaire question
adcs - adl questionnaire question
cathepsin - activatable cy5 fluorescent imaging probe lum015
hsd17b3 gene
hsd17b3 wt allele
denintuzumab mafodotin
testosterone 17 - beta - dehydrogenase 3
hsd17b6 gene
hsd17b6 wt allele
17 - beta - hydroxysteroid dehydrogenase type 6
hsd3b2 gene
hsd3b2 wt allele
3 beta - hydroxysteroid dehydrogenase / delta 5 -  > 4 - isomerase type 2
srd5a1 gene
srd5a1 wt allele
3 - oxo - 5 - alpha - steroid 4 - dehydrogenase 1
srd5a3 gene
srd5a3 wt allele
probable polyprenol reductase
columbia - suicide severity rating scale baseline / screening version phase 1 study 1 / 14 / 09 questionnaire
disability assessment for dementia questionnaire
alzheimer's disease cooperative study activities of daily living inventory questionnaire
standards pain intensity questionnaire
standards pain relief questionnaire
standards general clinical global impressions questionnaire
dad  -  decide to wash or take a bath or shower
dad  -  decide to brush teeth or care for dentures
dad  -  decide to care for his / her hair
dad  -  prepare the water ,  towels ,  and soap for washing ,  taking a bath or shower
dad  -  wash and dry all parts of body safely and completely
dad  -  brush teeth or take care of dentures appropriately
dad  -  take care of his / her hair
dad  -  decide to dress himself / herself
dad  -  choose appropriate clothing
dad  -  dress in the appropriate order
dad  -  dress himself / herself completely
dad  -  undress himself / herself completely
dad  -  decide to use the toilet at appropriate times
dad  -  use the toilet without accidents
dad  -  decide that he / she needs to eat
dad  -  choose appropriate utensils and seasonings when eating
dad  -  eat meals at a normal pace and with appropriate manners
dad  -  decide to prepare a light meal or snack for himself / herself
dad  -  adequately plan a light meal or snack
dad  -  safely prepare or cook a light meal or snack
dad  -  attempt to telephone someone at a suitable time
dad  -  find and dial a telephone number correctly
dad  -  carry out an appropriate telephone conversation
dad  -  write and convey a telephone message adequately
dad  -  decide to go out at an appropriate time
dad  -  adequately organize an outing with respect to transportation ,  keys ,  destination ,  weather ,  money ,  shopping list
dad  -  go out and reach a familiar destination without getting lost
dad  -  safely take the adequate mode of transportation
dad  -  return from the store with appropriate items
dad  -  show an interest in personal affairs such as finances and written correspondence
cl 246738
dad  -  organize finances to pay bills
dad  -  adequately organize correspondence
dad  -  handle money adequately
dad  -  decide to take medications at the correct time
dad  -  take medications as prescribed
dad  -  show an interest in leisure activities
dad  -  take an interest in household chores as in the past
dad  -  plan and organize adequately household chores as in the past
dad  -  complete household chores adequately as in the past
dad  -  stay safely at home when needed
c - ssrs baseline / screening version phase 1 study  -  wish to be dead  ( lifetime )
c - ssrs baseline / screening version phase 1 study  -  wish to be dead  ( past 6 months )
c - ssrs baseline / screening version phase 1 study  -  description of wish to be dead  ( lifetime )
c - ssrs baseline / screening version phase 1 study  -  non - specific active suicidal thoughts  ( lifetime )
c - ssrs baseline / screening version phase 1 study  -  non - specific active suicidal thoughts  ( past 6 months )
c - ssrs baseline / screening version phase 1 study  -  description of non - specific active suicidal thoughts  ( lifetime )
c - ssrs baseline / screening version phase 1 study  -  active suicidal ideation with any methods  ( not plan )  without intent to act  ( lifetime )
c - ssrs baseline / screening version phase 1 study  -  active suicidal ideation with any methods  ( not plan )  without intent to act  ( past 6 months )
c - ssrs baseline / screening version phase 1 study  -  description of active suicidal ideation with any methods  ( not plan )  without intent to act  ( lifetime )
c - ssrs baseline / screening version phase 1 study  -  active suicidal ideation with some intent to act ,  without specific plan  ( lifetime )
c - ssrs baseline / screening version phase 1 study  -  active suicidal ideation with some intent to act ,  without specific plan  ( past 6 months )
c - ssrs baseline / screening version phase 1 study  -  description of active suicidal ideation with some intent to act ,  without specific plan  ( lifetime )
c - ssrs baseline / screening version phase 1 study  -  active suicidal ideation with specific plan and intent  ( lifetime )
c - ssrs baseline / screening version phase 1 study  -  active suicidal ideation with specific plan and intent  ( past 6 months )
c - ssrs baseline / screening version phase 1 study  -  description of active suicidal ideation with specific plan and intent  ( lifetime )
c - ssrs baseline / screening version phase 1 study  -  most severe ideation  ( lifetime )
c - ssrs baseline / screening version phase 1 study  -  describe most severe ideation  ( lifetime )
c - ssrs baseline / screening version phase 1 study  -  most severe ideation  ( past 6 months )
c - ssrs baseline / screening version phase 1 study  -  describe most severe ideation  ( past 6 months )
c - ssrs baseline / screening version phase 1 study  -  frequency of most severe ideation  ( lifetime )
c - ssrs baseline / screening version phase 1 study  -  frequency of most severe ideation  ( past 6 months )
c - ssrs baseline / screening version phase 1 study  -  duration of most severe ideation  ( lifetime )
c - ssrs baseline / screening version phase 1 study  -  duration of most severe ideation  ( past 6 months )
c - ssrs baseline / screening version phase 1 study  -  controllability of most severe ideation  ( lifetime )
c - ssrs baseline / screening version phase 1 study  -  controllability of most severe ideation  ( past 6 months )
c - ssrs baseline / screening version phase 1 study  -  deterrents to most severe ideation  ( lifetime )
c - ssrs baseline / screening version phase 1 study  -  deterrents to most severe ideation  ( past 6 months )
c - ssrs baseline / screening version phase 1 study  -  reasons for most severe ideation  ( lifetime )
c - ssrs baseline / screening version phase 1 study  -  reasons for most severe ideation  ( past 6 months )
c - ssrs baseline / screening version phase 1 study  -  actual suicide attempt
c - ssrs baseline / screening version phase 1 study  -  number of actual suicide attempts
c - ssrs baseline / screening version phase 1 study  -  description of actual suicide attempt
c - ssrs baseline / screening version phase 1 study  -  non - suicidal self - injurious behavior
c - ssrs baseline / screening version phase 1 study  -  interrupted suicide attempt
c - ssrs baseline / screening version phase 1 study  -  number of interrupted suicide attempts
c - ssrs baseline / screening version phase 1 study  -  description of interrupted suicide attempt
c - ssrs baseline / screening version phase 1 study  -  aborted suicide attempt
c - ssrs baseline / screening version phase 1 study  -  number of aborted suicide attempts
c - ssrs baseline / screening version phase 1 study  -  description of aborted suicide attempt
c - ssrs baseline / screening version phase 1 study  -  preparatory acts or behaviors toward suicide attempt
c - ssrs baseline / screening version phase 1 study  -  description of preparatory acts or behaviors toward suicide attempt
c - ssrs baseline / screening version phase 1 study  -  suicidal behavior
c - ssrs baseline / screening version phase 1 study  -  most recent suicide attempt date
c - ssrs baseline / screening version phase 1 study  -  most recent suicide attempt actual lethality / medical damage
c - ssrs baseline / screening version phase 1 study  -  most recent suicide attempt potential lethality
c - ssrs baseline / screening version phase 1 study  -  most lethal suicide attempt date
c - ssrs baseline / screening version phase 1 study  -  most lethal suicide attempt actual lethality / medical damage
c - ssrs baseline / screening version phase 1 study  -  most lethal suicide attempt potential lethality
c - ssrs baseline / screening version phase 1 study  -  first suicide attempt date
c - ssrs baseline / screening version phase 1 study  -  first suicide attempt actual lethality / medical damage
c - ssrs baseline / screening version phase 1 study  -  first suicide attempt potential lethality
pi  -  pain intensity for various time periods of evaluation
pi  -  average pain intensity for various time periods of evaluation
pi  -  minimum pain intensity for various time periods of evaluation
pi  -  maximum pain intensity for various time periods of evaluation
pi  -  least pain intensity for various time periods of evaluation
pi  -  worst pain intensity for various time periods of evaluation
pr  -  pain relief for various time periods of evaluation
pr  -  average pain relief for various time periods of evaluation
pr  -  minimum pain relief for various time periods of evaluation
pr  -  maximum pain relief for various time periods of evaluation
pr  -  least pain relief for various time periods of evaluation
pr  -  worst pain relief for various time periods of evaluation
pr  -  starting pain half gone
pr  -  was there perceptible pain relief
pr  -  time to perceptible pain relief
pr  -  was there meaningful pain relief
pr  -  time to meaningful pain relief
gcgi  -  global severity of pain
gcgi  -  global improvement of pain
gcgi  -  global disease status of pain
gcgi  -  pain treatment preference
gcgi  -  global rating of pain medication
adcs - adl  -  description of usual performance of eating
adcs - adl  -  description of optimal performance of walking
adcs - adl  -  usual bowel and bladder function at toilet
adcs - adl  -  description of usual performance of bathing
adcs - adl  -  description of optimal performance of grooming
adcs - adl  -  select first clothes for the day
adcs - adl  -  description of usual performance of dressing
adcs - adl  -  description of usual performance of physically getting dressed
adcs - adl  -  use a telephone
adcs - adl  -  description of highest performance of telephone use
adcs - adl  -  watch television
adcs - adl  -  select or ask for television program
adcs - adl  -  talk about tv content while watching
adcs - adl  -  talk about tv content within a day after watching
adcs - adl  -  pay attention to conversation
adcs - adl  -  usual conversation participation
adcs - adl  -  clear dishes after meal or snack
zeniplatin
adcs - adl  -  description of usual performance of clearing dishes
adcs - adl  -  find personal belongings at home
adcs - adl  -  description of usual performance of finding personal belonging at home
adcs - adl  -  obtain beverage for self
adcs - adl  -  description of highest performance of obtaining beverage
adcs - adl  -  make a meal or snack at home
adcs - adl  -  highest level of food preparation
adcs - adl  -  dispose of garbage in appropriate place at home
adcs - adl  -  description of usual performance of garbage disposal
adcs - adl  -  get around outside home
adcs - adl  -  description of optimal performance of getting around outside of home
adcs - adl  -  go shopping
adcs - adl  -  how subject usually selects items
adcs - adl  -  pay for items without supervision or physical help
adcs - adl  -  keep appointments or meetings with others
adcs - adl  -  description of awareness of appointment ahead of time
adcs - adl  -  subject left on their own
adcs - adl  -  left away from home for fifteen minutes or longer
adcs - adl  -  left at home for one hour or longer
adcs - adl  -  left at home for less than one hour
adcs - adl  -  talk about current events
adcs - adl  -  talk about events on tv that subject did not take part in
adcs - adl  -  talk about events outside of home that subject took part in
adcs - adl  -  talk about events at home that subject took part in or watched
adcs - adl  -  read for more than five minutes
adcs - adl  -  talk about what subject read less than one hour after reading
adcs - adl  -  talk about what subject read more than one hour after reading
adcs - adl  -  write things down
adcs - adl  -  description of most complicated writings
adcs - adl  -  perform pastime ,  hobby or game
vm regimen
adcs - adl  -  pastime: card or board games
adcs - adl  -  pastime: bingo
adcs - adl  -  pastime: crosswords
adcs - adl  -  pastime: art
adcs - adl  -  pastime: musical instrument
adcs - adl  -  pastime: knitting
adcs - adl  -  pastime: sewing
adcs - adl  -  pastime: reading
adcs - adl  -  pastime: gardening
adcs - adl  -  pastime: golf
adcs - adl  -  pastime: tennis
adcs - adl  -  pastime: workshop
adcs - adl  -  pastime: fishing
adcs - adl  -  pastime: other
adcs - adl  -  pastime: other specify
adcs - adl  -  performed hobbies only at day care
adcs - adl  -  description of usual performance of common pastimes
adcs - adl  -  use household appliance to do chores
adcs - adl  -  appliance: washer
adcs - adl  -  appliance: dryer
adcs - adl  -  appliance: vacuum
adcs - adl  -  appliance: dishwasher
adcs - adl  -  appliance: toaster
adcs - adl  -  appliance: toaster oven
adcs - adl  -  appliance: range
adcs - adl  -  appliance: microwave
adcs - adl  -  appliance: food processor
adcs - adl  -  appliance: other
adcs - adl  -  appliance: other specify
adcs - adl  -  description of usual use of commonly used appliances
adcs - adl  -  total score
adcs - adl  -  number of 'don't know' responses
apoe*4 allele
apoe gene product
apolipoprotein e4
microrna 29b
kir ligand
ntrk1 gene product
high affinity nerve growth factor receptor isoform trka - iii
6q11 - q27
bacterial 16s rna
mir518e gene
mir518e wt allele
mir518e pre - mirna
ngf gene
ngf wt allele
anxa2 gene
anxa2 wt allele
annexin a2
c1qa gene
c1qa wt allele
complement c1q subcomponent subunit a
reg3a gene
reg3a wt allele
regenerating islet - derived protein 3 - alpha
st2 gene
uchl1 gene
uchl1 wt allele
ubiquitin carboxyl - terminal hydrolase isozyme l1
pi3 gene
pi3 wt allele
elafin
phenethyl isothiocyanate - containing watercress juice
ccnc gene
ccnc wt allele
rivogenlecleucel
cyclin - c
mt1g gene
mt1g wt allele
monocarboxylate transporter 1 inhibitor azd3965
clarithromycin
metallothionein - 1g
2 - hydroxyoleic acid
entospletinib
lutetium lu 177 dota - tetulomab
npy1r gene
npy1r wt allele
neuropeptide y receptor type 1
glossopharyngeal sulcus
npy2r gene
npy2r wt allele
neuropeptide y receptor type 2
npy5r gene
npy5r wt allele
neuropeptide y receptor type 5
s100a10 gene
s100a10 wt allele
protein s100 - a10
akr1c1 gene
akr1c1 wt allele
aldo - keto reductase family 1 member c1
ugt2b15 gene
ugt2b15 wt allele
udp - glucuronosyltransferase 2b15
ugt2b17 gene
ugt2b17 wt allele
udp - glucuronosyltransferase 2b17
akr1c2 gene
akr1c2 wt allele
aldo - keto reductase family 1 member c2
slco2b1 gene
slco2b1 wt allele
solute carrier organic anion transporter family member 2b1
hoxa7 gene
hoxa7 wt allele
homeobox protein hox - a7
hoxb4 gene
hoxb4 wt allele
homeobox protein hox - b4
amyloid beta precursor protein measurement
cd11a expressing cell count
cd11b expressing cell count
cystine measurement
factor xiv activity measurement
fibrotest score measurement
lymphoblast to leukocyte ratio measurement
theophylline measurement
ischial tuberosity
sacral tuberosity
failure to meet randomization criteria
excretion rate from t1 to t2
excretion rate from t1 to t2 normalized by bmi
excretion rate from t1 to t2 normalized by dose
excretion rate from t1 to t2 normalized by sa
excretion rate from t1 to t2 normalized by wt
nonrenal clearance normalized by bmi
nonrenal clearance normalized by dose
nonrenal clearance normalized by sa
nonrenal clearance normalized by wt
renal clearance normalized by bmi
renal clearance normalized by dose
renal clearance normalized by sa
renal clearance normalized by wt
gram per milliliter per milligram per kilogram
gram per milliliter per milligram per kilogram per day
hour times gram per milliliter per milligram per kilogram
hour times gram per milliliter per milligram per kilogram per day
hour times microgram per milliliter per milligram per kilogram
hour times microgram per milliliter per milligram per kilogram per day
hour times milligram per milliliter per milligram per kilogram
hour times milligram per milliliter per milligram per kilogram per day
hour times nanogram per milliliter per milligram per kilogram per day
hour times picogram per milliliter per milligram per kilogram
hour times picogram per milliliter per milligram per kilogram per day
microgram per milliliter per milligram per kilogram
microgram per milliliter per milligram per kilogram per day
milligram per milliliter per milligram per kilogram
milligram per milliliter per milligram per kilogram per day
nanogram per milliliter per milligram per kilogram
nanogram per milliliter per milligram per kilogram per day
picogram per milliliter per milligram per kilogram
picogram per milliliter per milligram per kilogram per day
centimeter per minute
centisecond
decamole per liter
fraction of 1
gram per gram of creatinine
gram per mole of creatinine
hectopascal
hundred billion per liter
hundred million per liter
hundred thousand per liter
kilodalton
kilopascal per liter per second
kilosecond
liter per hour per square meter
liter per liter
liter per minute per square meter
microgram equivalent
micromole per liter per second
microvolt second
custirsen sodium
mile per hour
milliequivalent per gram of creatinine
milligram per gram of creatinine
milliliter per centimeter
milliliter per deciliter
milliliter per second per 1 .73 meter squared
millimeter mercury per liter per minute
millimeter per minute
millimeter per second
millimeter per two hours
millimole per gram of creatinine
millimole per mole of creatinine
millivolt minute
nanounit per centiliter
per deciliter
per liter
per visual field
ten billion per liter
tera international unit per liter
thousand per liter
unit per centiliter
unit per deciliter
unit per gram hemoglobin
unit per gram of creatinine
volt per second
ret gene product
egfr gene product
pain at its worst
fatigue at its worst
nausea at its worst
disturbed sleep at its worst
being distressed at its worst
shortness of breath at its worst
problem with remembering things at its worst
problem with lack of appetite at its worst
feeling drowsy at its worst
dry mouth at its worst
feeling sad at its worst
vomiting at its worst
numbness or tingling at its worst
mucus in mouth and throat at its worst
swallowing or chewing difficulties at its worst
voice or speech difficulties at its worst
choking or coughing  -  food or liquids going down the wrong pipe at its worst
constipation at its worst
problem tasting food at its worst
symptoms interfere with life
problem with teeth or gums at its worst
skin pain or burning or rash at its worst
work including work around the house
mouth or throat sores at its worst
md anderson symptom inventory  -  head and neck
timeline followback method
crack cocaine
hallucinogen
high grade ovarian serous adenocarcinoma
low grade ovarian serous adenocarcinoma
tpi1 gene
tpi1 wt allele
triosephosphate isomerase
trdmt1 gene
trdmt1 wt allele
trna  ( cytosine ( 38 )  - c ( 5 )  )  - methyltransferase
tsc22d3 gene
tsc22d3 wt allele
tsc22 domain family protein 3
tnfrsf18 gene
tnfrsf18 wt allele
tumor necrosis factor receptor superfamily member 18
tnfrsf21 gene
tnfrsf21 wt allele
tumor necrosis factor receptor superfamily member 21
ugt1a6 gene
ugt1a6 wt allele
udp - glucuronosyltransferase 1 - 6
ugt2b7 gene
ugt2b7 wt allele
udp - glucuronosyltransferase 2b7
cannabinoid
intrathoracic
ulbp1 gene
ulbp1 wt allele
nkg2d ligand 1
ulbp2 gene
ulbp2 wt allele
glucose measurement
cholesterol measurement
high density lipoprotein cholesterol measurement
low density lipoprotein cholesterol measurement
very low density lipoprotein cholesterol measurement
ammonium biurate crystals measurement
nkg2d ligand 2
ulbp3 gene
ulbp3 wt allele
nkg2d ligand 3
meningocele
vegfb gene
vegfb wt allele
vascular endothelial growth factor b
vps18 gene
copovithane
vps18 wt allele
vacuolar protein sorting - associated protein 18
wnk1 gene
wnk1 wt allele
serine / threonine - protein kinase wnk1
zeb1 gene
zeb1 wt allele
zinc finger e - box - binding homeobox 1
zmynd8 gene
zmynd8 wt allele
protein kinase c - binding protein 1
copper cu 62 ethylglyoxal bis ( thiosemicarbazone )
depatuxizumab mafodotin
gemcitabine hydrochloride emulsion
autologous cd19car - cd28 - cd3zeta - egfrt - expressing tcm - enriched t cells
alk inhibitor ro5424802
astragalus - based formulation qing shu yi qi tang
magnesium isoglycyrrhizinate
therapeutic hepatitis c immune globulin
as bad as you can imagine
alvin j siteman cancer center
cancer therapy and research center
dan l duncan cancer center
harold c simmons cancer center
hollings cancer center
sanford - burnham medical research institute
stanford cancer institute
the university of kansas cancer center
university of maryland marlene and stewart greenebaum cancer center
university of new mexico cancer center
winship cancer institute
spl substance indexing terminology
left thigh
left arm
left deltoid
right deltoid
right arm
right thigh
left gluteus medius
right gluteus medius
left vastus lateralis
right vastus lateralis
left lower forearm
right lower forearm
microtubule - associated proteins 1a / 1b light chain 3 - ii
dna replication timing
mll / mllt11 fusion gene
mll / mllt11 fusion protein
xage1 family gene
cancer / testis antigen family 47 gene
c - circle
diablo gene
diablo wt allele
diablo homolog ,  mitochondrial
lage3 gene
lage3 wt allele
l antigen family member 3
itsn1 gene
itsn1 wt allele
intersectin - 1
allelic imbalance
ncl gene
ncl wt allele
nucleolin
gstm4 gene
gstm4 wt allele
glutathione s - transferase mu 4
aria oncology information system
mosaiq oncology information management system
oncochart management tool
meditech health record system
mckesson health record system
epic health record system
nextgen healthcare record system
brainlab iplan
varian eclipse
nucletron oncentra
philips pinnacle
elekta xio
krt5 gene
krt5 wt allele
keratin ,  type ii cytoskeletal 5
krt72 gene
krt72 wt allele
keratin ,  type ii cytoskeletal 72
emergency medicine
neonatology
neurosurgery
obstetrics and gynecology
physical medicine and rehabilitation
podiatry
vaccination site on body icsr terminology
pulmonary medicine
sports medicine
general surgery
pdlim2 gene
pdlim2 wt allele
pdz and lim domain protein 2
hand surgery
vascular surgery
cordycepin
urological surgery
detection limit
pgbd5 gene
pgbd5 wt allele
molecular density
unit density
serum or plasma
karnofsky performance status 100
piggybac transposable element - derived protein 5
karnofsky performance status 90
karnofsky performance status 80
karnofsky performance status 70
karnofsky performance status 60
karnofsky performance status 50
karnofsky performance status 40
karnofsky performance status 30
karnofsky performance status 20
dact2 gene
karnofsky performance status 10
dact2 wt allele
karnofsky performance status 0
ecog performance status
ecog performance status 0
ecog performance status 1
dapper homolog 2
ecog performance status 2
ecog performance status 3
ecog performance status 4
ecog performance status 5
dad1 gene
dad1 wt allele
stranded seed implant
loose seed implant
whole - pelvis
dolichyl - diphosphooligosaccharide - protein glycosyltransferase subunit dad1
homicide and legal intervention
accidents and adverse effects
selenop gene
selenop wt allele
selenoprotein p
treatment completed as prescribed
treatment terminated due to toxicity
non - academic hospital
free - standing clinic
sediment analysis
breast lymphedema symptom survey
breast appears or feels swollen
how much does it bother you
breast feels heavy
breast appears redder
have pain ,  tenderness or discomfort in breast
have axillary fullness or numbness
study element
toxicity grade scale type terminology
human clinical subject data section
non - human clinical subject data section
serious adverse event reason
serious adverse event reason type terminology
biospecimen usability
subject trial set
clinical event pattern
true false response terminology
anterior tonsillar pillar
lymphedema and breast cancer questionnaire
have limited movement of shoulder
have limited movement of elbow
have limited movement of wrist
have limited movement of fingers
feel weakness in arm or hand
have tenderness
have swelling
have swelling with pitting
have redness
have blistering
have firmness or tightness
have increased temperature in arm
have heaviness
have numbness
have stiffness
have aching
have chest wall swelling
have breast swelling
have pockets of fluid develop
have other symptoms
axillary lymph node dissection without prior sentinel lymph node biopsy
fifty
ninety
ninety nine
eighty
eighty nine
seventy
seventy nine
sixty
sixty nine
fifty nine
forty
forty nine
thirty
thirty nine
twenty
cortisone acetate
twenty nine
nineteen
liposome - encapsulated mir - 34 mimic mrx34
andecaliximab
fms / trk tyrosine kinase inhibitor plx7486 tosylate
anti - cd19 monoclonal antibody di - b4
autologous sarcoma lysate - pulsed dendritic cell vaccine
autologous sarcoma cell lysate
indium in 111 pertuzumab
adgmcaix - transduced autologous dendritic cells
autologous glioma cell lysate
ad - hcmv - tk
ad - hcmv - flt3l
one hundred
nup98 / kdm5a fusion gene
nup98 / kdm5a fusion protein
mnx1 / etv6 fusion gene
mnx1 / etv6 fusion protein
cbfa2t3 / glis2 fusion gene
cbfa2t3 / glis2 fusion protein
hoxa gene family
hoxb gene family
braf np_004324 .2:p .v600x
adrenergic receptor
protein carbonyl content
8 - oxoguanine
12 - methyltetradecanoic acid
13 - methyltetradecanoic acid
fkbp5 gene
fkbp5 wt allele
peptidyl - prolyl cis - trans isomerase fkbp5
neil3 gene
neil3 wt allele
endonuclease 8 - like 3
atp5f1e gene
atp5f1e wt allele
atp synthase subunit epsilon ,  mitochondrial
bgn gene
bgn wt allele
biglycan
efnb2 gene
efnb2 wt allele
ephrin - b2
gadd45b gene
gadd45b wt allele
growth arrest and dna damage - inducible protein gadd45 beta
mad2l1 gene
mad2l1 wt allele
mitotic spindle assembly checkpoint protein mad2a
 [ 18f ] l - fmac
zotiraciclib citrate
pgk1 gene
ralimetinib mesylate
pgk1 wt allele
phosphoglycerate kinase 1
cacna1g gene
cacna1g wt allele
voltage - dependent t - type calcium channel subunit alpha - 1g
neurog1 gene
neurog1 wt allele
neurogenin - 1
ugt1a9 gene
ugt1a9 wt allele
udp - glucuronosyltransferase 1 - 9
lbp gene
lbp wt allele
lipopolysaccharide - binding protein
htr1a gene
htr1a wt allele
5 - hydroxytryptamine receptor 1a
tph1 gene
tph1 wt allele
tryptophan 5 - hydroxylase 1
slc6a4 gene
slc6a4 wt allele
sodium - dependent serotonin transporter
clcn7 gene
clcn7 wt allele
h (  +  )  / cl (  -  )  exchange transporter 7
concerned about keeping my job ,  including work at home
feel distant from people
worry the transplant will not work
treatment effects are worse than imagined
like my body appearance
able to get around by myself
interested in sex
concern about ability to have children
have confidence in nurse
regret having bone marrow transplant
able to remember
able to concentrate
have blurry eyesight
bothered by food taste change
have tremor
bothered by skin problems
have bowel trouble
illness is personal hardship for close family members
treatment cost is a burden to me or my family
have frequent colds /  infections
cyproterone acetate
glis2 gene
glis2 wt allele
zinc finger protein glis2
ppbp gene product
lauren classification
cytochrome p450 2a6
jak2 protein variant
claudin - low
jak2 np_004963 .1:p .v617f
jak2 nm_004972 .3:c .1848_1849deltginsct
jak2 nm_004972 .3:c .1849g > t
jak2 nm_004972 .3:c .2792a > g
jak2 np_004963 .1:p .y931c
jak2 np_004963 .1:p .e985k
jak2 np_004963 .1:p .g935r
jak2 np_004963 .1:p .i960v
jak2 np_004963 .1:p .m929i
jak2 np_004963 .1:p .r938l
epgn gene
epgn wt allele
epigen
5p15
a2m gene
a2m wt allele
alpha - 2 - macroglobulin
tmtc1 gene
tmtc1 wt allele
protein o - mannosyl - transferase tmtc1
ednrb gene
ednrb wt allele
endothelin receptor type b
fgd5 gene
fgd5 wt allele
fyve ,  rhogef and ph domain - containing protein 5
ldb2 gene
ldb2 wt allele
lim domain - binding protein 2
palmd gene
palmd wt allele
palmdelphin
serum amyloid a
plpp3 gene
plpp3 wt allele
phospholipid phosphatase 3
spry1 gene
spry1 wt allele
protein sprouty homolog 1
mitogen - activated protein kinase kinase
3 - hydroxycotinine
homocysteine
arabinofuranosylcytosine triphosphate
deoxyribonucleotide triphosphate
apolipoprotein a
synpo gene
synpo wt allele
synaptopodin
tcf4 gene
tcf4 wt allele
transcription factor 4
excision repair cross - complementing family
dna ligase
il22 gene
il22 wt allele
interleukin - 22
rwdd3 gene
rwdd3 wt allele
rwd domain - containing protein 3
tnfsf13 gene
tnfsf13 wt allele
tumor necrosis factor ligand superfamily member 13
calprotectin
il13ra2 gene
il13ra2 wt allele
hla - dr15 antigen
interleukin - 13 receptor subunit alpha - 2
hla class i histocompatibility antigen ,  a - 24 alpha chain
krt17 gene
krt17 wt allele
5 - ht3 receptor
keratin ,  type i cytoskeletal 17
krt14 gene
krt14 wt allele
keratin ,  type i cytoskeletal 14
f1 .2
mir150 gene
mir150 wt allele
mir150 pre - mirna
mir191 gene
mir191 wt allele
mir191 pre - mirna
sult1e1 gene
sult1e1 wt allele
estrogen sulfotransferase
bag3 gene
bag3 wt allele
bag family molecular chaperone regulator 3
relb gene
relb wt allele
transcription factor relb
daidzein
serpina7 gene
steap1 gene
steap1 wt allele
metalloreductase steap1
serpina7 wt allele
thyroxine - binding globulin
il1rl1 gene
sema3f gene
sema3f wt allele
il1rl1 wt allele
semaphorin - 3f
interleukin - 1 receptor - like 1
lrrc32 gene
lrrc32 wt allele
leucine - rich repeat - containing protein 32
serpina9 gene
serpina9 wt allele
serpin a9
sptbn2 gene
sptbn2 wt allele
spectrin beta chain ,  non - erythrocytic 2
abcc3 gene
abcc3 wt allele
canalicular multispecific organic anion transporter 2
dusp6 gene
dusp6 wt allele
dual specificity protein phosphatase 6
spry2 gene
spry2 wt allele
protein sprouty homolog 2
apob gene
apob wt allele
apolipoprotein b - 100
trim16 gene
trim16 wt allele
tripartite motif - containing protein 16
percutaneous fluoroscopic gastrostomy
pre - dose measure
not made with natural rubber latex
fda cdrh gudid terminology
percutaneous endoscopic gastrostomy
device size text
distant lymph node
natural rubber
magnetic resonance imaging safety labeling information
magnetic resonance safe
magnetic resonance conditional
magnetic resonance unsafe
chromatin immunoprecipitation
chip - seq
chip - on - chip
faire - seq
dnase - seq
nome - seq
bisulfite sequencing
methylc - seq
mnase sequencing
methylome
phf20 gene
phf20 wt allele
phd finger protein 20
nek9 gene
nek9 wt allele
serine / threonine - protein kinase nek9
sparcl1 gene
sparcl1 wt allele
sparc - like protein 1
rspo2 gene
rspo2 wt allele
r - spondin - 2
rras gene
rras wt allele
ras - related protein r - ras
double strand brachytherapy
fletcher - suit brachytherapy
manchester ovoid
tandem brachytherapy
mini ovoid brachytherapy
mesh brachytherapy
vaginal cylinder
rhoj gene
rhoj wt allele
rho - related gtp - binding protein rhoj
piezo1 gene
piezo1 wt allele
piezo - type mechanosensitive ion channel component 1
piezo2 gene
piezo2 wt allele
piezo - type mechanosensitive ion channel component 2
psmc2 gene
psmc2 wt allele
26s protease regulatory subunit 7
kir2ds1 gene
kir2ds1 wt allele
killer cell immunoglobulin - like receptor 2ds1
vamp1 gene
vamp1 wt allele
vesicle - associated membrane protein 1
fam83a gene
fam83a wt allele
daunorubicin - dna complex
protein fam83a
absence of signs or symptoms
sensate
pharyngeal residue
plant - based natural product
plant or plant part extract
cib1 gene
cib1 wt allele
calcium and integrin - binding protein 1
ptprd gene
ptprd wt allele
receptor - type tyrosine - protein phosphatase delta
ptprk gene
ptprk wt allele
receptor - type tyrosine - protein phosphatase kappa
cusatuzumab
t1e28z car - expressing autologous cd4 - positive t lymphocytes
xentuzumab
sofituzumab vedotin
p53 - hdm2 interaction inhibitor mi - 773
glutathione pegylated liposomal doxorubicin hydrochloride formulation 2b3 - 101
clinical fellow  -  speech language pathologist
ic9 - gd2 - cd28 - ox40 - expressing t lymphocytes
poly - gamma glutamic acid
certificate of clinical competence  -  speech language pathologist
mek / aurora kinase inhibitor bi 847325
board recognized specialist  -  swallowing
animal - based natural product
marine - based natural product
venom
fungus - based natural product
venom protein
fda classified non - traditional sterilization method
clinical variant
analysis project
chaf1a gene
chaf1a wt allele
chromatin assembly factor 1 subunit a
cry2 gene
cry2 wt allele
cryptochrome - 2
dclre1a gene
dclre1a wt allele
dna cross - link repair 1a protein
mexican state
veracruz
zacatecas
michoacan
morelos
nayarit
nuevo leon
oaxaca
puebla
queretaro
quintana roo
sinaloa
san luis potosi
sonora
tabasco
tamaulipas
tlaxcala
mbd4 gene
baja california
mbd4 wt allele
baja california sur
chiapas
coahuila
methyl - cpg - binding domain protein 4
colima
guerrero
guanajuato
hidalgo
jalisco
mexican city
durango
distrito federal of mexico
micronization
extended release depot dosage form
month of the year
january
february
march
april
may
june
july
august
september
october
nthl1 gene
november
december
nthl1 wt allele
endonuclease iii - like protein 1
aguascalientes
campeche
chihuahua
gper1 gene
gper1 wt allele
duborimycin
g - protein coupled estrogen receptor 1
interdigital region
ureterovesical junction
ureteropelvic junction
crenolanib besylate
drospirenone / ethinyl estradiol
ldha gene
ldha wt allele
l - lactate dehydrogenase a chain
atp6ap1 gene
atp6ap1 wt allele
v - type proton atpase subunit s1
ager gene
ager wt allele
advanced glycosylation end product - specific receptor
wt1 - as gene
wt1 - as wt allele
wilms tumor - associated antisense rna
taok3 gene
taok3 wt allele
serine / threonine - protein kinase tao3
vtcn1 gene
vtcn1 wt allele
v - set domain - containing t - cell activation inhibitor 1
pold1 gene
pold1 wt allele
dna polymerase delta catalytic subunit
pold3 gene
pold3 wt allele
dna polymerase delta subunit 3
cmet car - mrna electroporated autologous t lymphocytes
mrna - derived prostate cancer vaccine cv9104
pole gene
pole wt allele
olive oil extract / curcumin - based capsule
brilanestrant
dna polymerase epsilon catalytic subunit a
poli gene
poli wt allele
dna polymerase iota
polk gene
polk wt allele
adenovector - transduced ap1903 - inducible myd88 / cd40 - expressing autologous psma - specific prostate cancer vaccine bpx - 201
dna polymerase kappa
rad18 gene
rad18 wt allele
e3 ubiquitin - protein ligase rad18
autologous cd19 - 28z chimeric antigen receptor - expressing t - lymphocytes
anti - amyloid monoclonal antibody neod001
rad23a gene
atezolizumab
rad23a wt allele
uv excision repair protein rad23 homolog a
cxcr4 peptide antagonist ly2510924
pan - raf kinase inhibitor tak - 580
rbm4 gene
antibody - drug conjugate dfrf4539a
wt1 peptide vaccine ocv - 501
rbm4 wt allele
pim kinase inhibitor lgh447
rna - binding protein 4
pi3k - beta inhibitor gsk2636771
anti - c - met monoclonal antibody abt - 700
rad52 gene
rad52 wt allele
dna repair protein rad52 homolog
anti - cd27l antibody - drug conjugate amg 172
brachyury - expressing yeast vaccine gi - 6301
cadm1 gene
cadm1 wt allele
liposome - encapsulated rb94 plasmid dna gene therapy agent sgt - 94
cell adhesion molecule 1
abo hemolytic disease of the newborn
pax1 gene
pax1 wt allele
paired box protein pax - 1
rad9a gene
rad9a wt allele
cell cycle checkpoint control protein rad9a
rad9b gene
rad9b wt allele
cell cycle checkpoint control protein rad9b
rev1 gene
rev1 wt allele
dna repair protein rev1
nprl3 gene
nprl3 wt allele
gator complex protein nprl3
sumo1 gene
sumo1 wt allele
small ubiquitin - related modifier 1
tnp1 gene
tnp1 wt allele
spermatid nuclear transition protein 1
trpc2 gene
macrometastasis
clinical classification for oncology
ube2a gene
any t
defensins
ube2a wt allele
isolated tumor cells
ubiquitin - conjugating enzyme e2 a
tumor size measurement
tumor regression grade
pleural / elastic layer invasion
ung gene
ung wt allele
uracil - dna glycosylase
wrnip1 gene
wrnip1 wt allele
atpase wrnip1
advanced glycation end product
rorc gene product
nuclear receptor ror - gamma t
hyperploidy
dna hydroxymethylation
mitosis - karyorrhexis index
3p14
peripheral lymph node addressin
total skin - sparing mastectomy
tbx4 gene
tbx4 wt allele
t - box transcription factor tbx4
spl lot distribution data  -  distribution codes terminology
quantity distributed per reporting interval
quantity distributed anticipated total
inpp4b gene
quantity final containers returned
inpp4b wt allele
inositol polyphosphate 4 - phosphatase type ii
slc27a3 gene
slc27a3 wt allele
long - chain fatty acid transport protein 3
slc27a4 gene
slc27a4 wt allele
long - chain fatty acid transport protein 4
ube2l3 gene
ube2l3 wt allele
ubiquitin - conjugating enzyme e2 l3
fam131b gene
fam131b wt allele
protein fam131b
klc1 gene
klc1 wt allele
kinesin light chain 1
efemp1 gene
efemp1 wt allele
egf - containing fibulin - like extracellular matrix protein 1
ciz1 gene
ciz1 wt allele
cip1 - interacting zinc finger protein
sdcbp gene
sdcbp wt allele
syntenin - 1
ifnl3 gene
ifnl3 wt allele
interferon lambda - 3
znf444 gene
znf444 wt allele
doxorubicin / vinorelbine regimen
zinc finger protein 444
scarf1 gene
scarf1 wt allele
scavenger receptor class f member 1
baiap2l1 gene
baiap2l1 wt allele
brain - specific angiogenesis inhibitor 1 - associated protein 2 - like protein 1
zirconium zr 89 - labeled monoclonal antibody mmot0530a
s1p receptor agonist krp203
simmitecan hydrochloride
c - met inhibitor msc2156119j
alpha - lipoic acid - palladium / vitamin / mineral supplement
international bone marrow transplant registry
chest tube flutter valve
charlson comorbidity index chart review version
had a myocardial infarction
hospitalized or treated for heart failure
has peripheral vascular disease
has a cerebrovascular accident or transient ischemic disease
has hemiplegia
has asthma ,  chronic lung disease ,  chronic bronchitis or emphysema
has diabetes that requires treatment
has end organ damage from diabetes
has moderate or severe renal disease
has chronic liver disease
has moderate or severe liver disease
has gastric or peptic ulcer
has cancer other than basal cell skin cancer
has metastatic solid tumor
has alzheimer's ,  dementia from any etiology or any serious cognitive impairment
has any rheumatic or connective tissue disease
has hiv or aids
has hypertension
has decubitus ulcer ,  peripheral skin ulcer or repeated episodes of cellulitis
has depression
using warfarin or coumadin
center for international blood and marrow transplant research
european group for blood and marrow transplantation
pulmonary hygiene
nasoduodenal tube
defibrotide sodium
fact - l questionnaire
bothered by hair loss
feels tightness in the chest
breathing is easy
has ever smoked
regrets smoking
spermine
microrna 124
non - receptor type protein tyrosine phosphatase
receptor - type protein tyrosine phosphatase gene
carboxymethylcellulose sodium - containing eye drop
ptpre gene product
cpe gene product
atrip gene
atrip wt allele
atr - interacting protein
atp2a2 gene
atp2a2 wt allele
sarcoplasmic / endoplasmic reticulum calcium atpase 2
hcrt gene
hcrt wt allele
orexin
gan gene
gan wt allele
gigaxonin
pdcd11 gene
pdcd11 wt allele
protein rrp5 homolog
anlotinib hydrochloride
pbtl cd19car - 28 / cd137 / zeta
protein phosphatase 2a inhibitor lb - 100
topical menthol cream
pembrolizumab
ddx52 gene
ddx52 wt allele
probable atp - dependent rna helicase ddx52
notch3 gene
notch3 wt allele
neurogenic locus notch homolog protein 3
psap gene
psap wt allele
proactivator polypeptide
dhh gene
dhh wt allele
desert hedgehog protein
ihh gene
ihh wt allele
podxl gene
indian hedgehog protein
podxl wt allele
podocalyxin
gas1 gene
gas1 wt allele
triap1 gene
growth arrest - specific protein 1
triap1 wt allele
tp53 - regulated inhibitor of apoptosis 1
rab23 gene
rab23 wt allele
ras - related protein rab - 23
brdt gene
unable to accommodate disability or language
brdt wt allele
bromodomain testis - specific protein
not returned
dtx2 gene
dtx2 wt allele
patient did not complete study
probable e3 ubiquitin - protein ligase dtx2
booklet return not requested
treatment on hold
scheduled by mistake
angptl1 gene
incorrect booklet given
angptl1 wt allele
angiopoietin - related protein 1
protocol misinterpreted
staff error
cdisc sdtm reproductive system findings test name terminology
cdisc sdtm reproductive system findings test code terminology
cdisc sdtm device identifier parameter long name terminology
cdisc sdtm device identifier parameter short name terminology
cdisc sdtm device - in - use test name terminology
cdisc sdtm device - in - use test code terminology
infranatant
supernatant
staff not available
no reason given
angpt4 gene
angpt4 wt allele
patient did not like question content
angiopoietin - 4
individual physical condition
cd1d gene
cd1d wt allele
antigen - presenting glycoprotein cd1d
acute extensive anterior wall myocardial infarction by ecg finding
age at menopause
alanine aminotransferase to aspartate aminotransferase ratio measurement
alpha fetoprotein activity measurement
desmethylmisonidazole
anesthetized exsanguination and perfusion euthanasia
birth control method
biventricular hypertrophy by ecg finding
brugada syndrome pattern by ecg finding
budding yeast measurement
cancer antigen 72 - 4 measurement
captive bolt and exsanguination euthanasia
carbon dioxide and exsanguination euthanasia
childbearing potential
chloride clearance measurement
coil strength
corticosterone to creatinine ratio measurement
cortisol to creatinine ratio measurement
cystatin c to creatinine ratio measurement
cytokeratin 19 fragment 21 - 1 measurement
dialysis fluid
dipstick
elastography
epstein - barr nuclear antigen 1 igg ab measurement
epstein - barr virus infection status
extensive anterior wall myocardial infarction by ecg finding
fatty acid binding protein 3 measurement
fetal measurements domain
flame photometry
frames per second
hemoglobin distribution width measurement
hepatitis e virus igg antibody measurement
hiv antibody measurement
hour squared times micromole per liter
hour squared times picomole per liter
cisplatin / topotecan
hour times millimole per liter per gram
hour times mole per liter per gram
hour times picomole per liter per gram
image acquisition matrix size
image slice thickness
immunoblasts to lymphocytes ratio measurement
immunoturbidimetry
intact glucose - dependent insulinotropic peptide measurement
lewis ,  rat strain
lipocalin - 2 measurement
lipocalin - 2 to creatinine ratio measurement
menopause status
milliliters per millimeter of mercury
minute times picomole per liter
monocytes to macrocytes ratio measurement
multi - slice spiral computed tomography
myoglobin to creatinine ratio measurement
myosin light chain 3 measurement
new posterior wall myocardial infarction by ecg finding
nih minipig
cyclophosphamide / paclitaxel
number of abortions
number of pregnancies
pharmacogenomics biomarker domain
phosphate clearance measurement
plasma infranatant
plasma supernatant
platelet - poor plasma
platelet - rich plasma
pleural fluid infranatant
pleural fluid supernatant
potassium clearance measurement
pregnant during the study
pulse sequence
receiver bandwidth
reconstruction filter type
serum infranatant
serum supernatant
single - slice spiral computed tomography
sodium clearance measurement
specimen weight measurement
stereotactic surgery frame type
subject biomarker domain
suffolk sheep
swiss webster mouse
thrombin to antithrombin ratio measurement
tissue inhibitor of metalloproteinase 1 to creatinine ratio measurement
trial site terminated by sponsor
tumor identifier domain
tumor results domain
u wave abnormality by ecg finding
unplanned terminal sacrifice
viral resistance domain
dll1 gene
dll1 wt allele
alkbh7 gene
alkbh7 wt allele
delta - like protein 1
alpha - ketoglutarate - dependent dioxygenase alkb homolog 7
slc7a5 gene
slc7a5 wt allele
large neutral amino acids transporter small subunit 1
cd63 gene
cd63 wt allele
cd63 antigen
cybb gene
cybb wt allele
cytochrome b - 245 heavy chain
nr2c2 gene
nr2c2 wt allele
nuclear receptor subfamily 2 group c member 2
detorubicin
bpi gene
bpi wt allele
bactericidal permeability - increasing protein
macc1 gene
macc1 wt allele
metastasis - associated in colon cancer protein 1
map2k2 gene
map2k2 wt allele
sema4d gene
sema4d wt allele
semaphorin - 4d
smad1 gene
smad1 wt allele
mothers against decapentaplegic homolog 1
slco1b1 gene
slco1b1 wt allele
solute carrier organic anion transporter family member 1b1
slco1b3 gene
slco1b3 wt allele
solute carrier organic anion transporter family member 1b3
map3k5 gene
fatigue severity scale
map3k5 wt allele
mitogen - activated protein kinase kinase kinase 5
visual analogue fatigue scale
motivation lower when fatigued
exercise brings on fatigue
easily fatigued
fatigue interferes with physical functioning
fatigue causes frequent problems
fatigue prevents sustained physical functioning
fatigue interferes with certain duties and responsibilities
fatigue among most disabling symptoms
dual specificity mitogen - activated protein kinase kinase 2
fatigue interferes with work ,  family ,  or social life
setbp1 gene
setbp1 wt allele
set - binding protein
cgas gene
cgas wt allele
cyclic gmp - amp synthase
naxe gene
naxe wt allele
human prescription drug manufacturing
nad ( p ) h - hydrate epimerase
human over - the - counter drug manufacturing
would never doze
slight chance of dozing
moderate chance of dozing
high chance of dozing
cdisc questionnaire adcs - adl mci test name terminology
cdisc questionnaire adcs - adl mci test code terminology
cdisc questionnaire adcs - adl severe dementia test name terminology
cdisc questionnaire adcs - adl severe dementia test code terminology
cdisc clinical classification bdi test name terminology
cdisc clinical classification bdi test code terminology
cdisc clinical classification tdi test name terminology
cdisc clinical classification tdi test code terminology
cdisc questionnaire c - ssrs already enrolled subjects test name terminology
cdisc questionnaire c - ssrs already enrolled subjects test code terminology
cdisc questionnaire c - ssrs baseline / screening version test name terminology
cdisc questionnaire c - ssrs baseline / screening version test code terminology
cdisc questionnaire gds test name terminology
cdisc questionnaire gds test code terminology
cdisc questionnaire gds - sf test name terminology
cdisc questionnaire gds - sf test code terminology
cdisc questionnaire haq - di with vas test name terminology
cdisc questionnaire haq - di with vas test code terminology
cdisc questionnaire mmrc test name terminology
cdisc questionnaire mmrc test code terminology
cdisc questionnaire sgrq - c test name terminology
cdisc questionnaire sgrq - c test code terminology
adcs - adl mci questionnaire question
adcs - adl severe dementia questionnaire question
bdi clinical classification question
tdi clinical classification question
c - ssrs already enrolled subjects questionnaire question
c - ssrs baseline / screening version questionnaire question
gds questionnaire question
gds - sf questionnaire question
haq - di questionnaire question
mmrc questionnaire question
sgrq - c questionnaire question
time - consuming
sitting and reading
watching tv
sitting inactive in public place
passenger in car for hour without break
lying down for afternoon rest when circumstances permit
sitting and talking to someone
sitting quietly after lunch without alcohol
stopped in car for few minutes in traffic
doze or fall asleep
baseline dyspnea index clinical classification
transition dyspnea index clinical classification
columbia - suicide severity rating scale already enrolled subjects questionnaire
columbia - suicide severity rating scale baseline / screening version questionnaire
geriatric depression scale questionnaire
geriatric depression scale short form questionnaire
health assessment questionnaire disability index with pain visual analog scale questionnaire
dexamethasone acetate
modified medical research council dyspnea scale questionnaire
bdi  -  functional impairment
bdi  -  magnitude of task
bdi  -  magnitude of effort
tdi  -  change in functional impairment
tdi  -  change in magnitude of task
tdi  -  change in magnitude of effort
c - ssrs baseline / screening version  -  wish to be dead  ( lifetime )
c - ssrs baseline / screening version  -  wish to be dead  ( past x months )
c - ssrs baseline / screening version  -  description of wish to be dead
c - ssrs baseline / screening version  -  non - specific active suicidal thoughts  ( lifetime )
c - ssrs baseline / screening version  -  non - specific active suicidal thoughts  ( past x months )
c - ssrs baseline / screening version  -  description of non - specific active suicidal thoughts
c - ssrs baseline / screening version  -  active suicidal ideation with any methods  ( not plan )  without intent to act  ( lifetime )
c - ssrs baseline / screening version  -  active suicidal ideation with any methods  ( not plan )  without intent to act  ( past x months )
c - ssrs baseline / screening version  -  description of active suicidal ideation with any methods  ( not plan )  without intent to act
c - ssrs baseline / screening version  -  active suicidal ideation with specific plan and intent  ( lifetime )
c - ssrs baseline / screening version  -  active suicidal ideation with specific plan and intent  ( past x months )
c - ssrs baseline / screening version  -  description of active suicidal ideation with specific plan and intent
c - ssrs baseline / screening version  -  most severe ideation  ( lifetime )
c - ssrs baseline / screening version  -  describe most severe ideation  ( lifetime )
c - ssrs baseline / screening version  -  most severe ideation  ( past x months )
c - ssrs baseline / screening version  -  describe most severe ideation  ( past x months )
c - ssrs baseline / screening version  -  frequency of most severe ideation  ( lifetime )
c - ssrs baseline / screening version  -  frequency of most severe ideation  ( past x months )
c - ssrs baseline / screening version  -  duration of most severe ideation  ( lifetime )
c - ssrs baseline / screening version  -  duration of most severe ideation  ( past x months )
c - ssrs baseline / screening version  -  controllability of most severe ideation  ( lifetime )
c - ssrs baseline / screening version  -  controllability of most severe ideation  ( past x months )
c - ssrs baseline / screening version  -  reasons for most severe ideation  ( lifetime )
c - ssrs baseline / screening version  -  reasons for most severe ideation  ( past x months )
c - ssrs baseline / screening version  -  number of actual suicide attempts  ( lifetime )
c - ssrs baseline / screening version  -  number of actual suicide attempts  ( past x years )
c - ssrs baseline / screening version  -  description of actual suicide attempt
c - ssrs baseline / screening version  -  non - suicidal self - injurious behavior  ( lifetime )
c - ssrs baseline / screening version  -  non - suicidal self - injurious behavior  ( past x years )
c - ssrs baseline / screening version  -  interrupted suicide attempt  ( lifetime )
c - ssrs baseline / screening version  -  interrupted suicide attempt  ( past x years )
c - ssrs baseline / screening version  -  number of interrupted suicide attempts  ( lifetime )
c - ssrs baseline / screening version  -  number of interrupted suicide attempts  ( past x years )
c - ssrs baseline / screening version  -  description of interrupted suicide attempt
c - ssrs baseline / screening version  -  aborted suicide attempt  ( lifetime )
c - ssrs baseline / screening version  -  aborted suicide attempt  ( past x years )
c - ssrs baseline / screening version  -  number of aborted suicide attempts  ( lifetime )
c - ssrs baseline / screening version  -  number of aborted suicide attempts  ( past x years )
c - ssrs baseline / screening version  -  description of aborted suicide attempt
c - ssrs baseline / screening version  -  preparatory acts or behaviors toward suicide attempt  ( lifetime )
c - ssrs baseline / screening version  -  preparatory acts or behaviors toward suicide attempt  ( past x years )
c - ssrs baseline / screening version  -  description of preparatory acts or behaviors toward suicide attempt
c - ssrs baseline / screening version  -  suicidal behavior  ( lifetime )
c - ssrs baseline / screening version  -  suicidal behavior  ( past x years )
c - ssrs baseline / screening version  -  most recent suicide attempt date
c - ssrs baseline / screening version  -  most recent suicide attempt actual lethality / medical damage
c - ssrs baseline / screening version  -  most recent suicide attempt potential lethality
c - ssrs baseline / screening version  -  most lethal suicide attempt date
c - ssrs baseline / screening version  -  most lethal suicide attempt actual lethality / medical damage
c - ssrs baseline / screening version  -  most lethal suicide attempt potential lethality
c - ssrs baseline / screening version  -  first suicide attempt date
c - ssrs baseline / screening version  -  first suicide attempt actual lethality / medical damage
c - ssrs baseline / screening version  -  first suicide attempt potential lethality
gds  -  basically satisfied with life
gds  -  dropped activities and interests
gds  -  feel life is empty
gds  -  often get bored
gds  -  hopeful about future
gds  -  bothered by thoughts
gds  -  good spirits most of time
gds  -  afraid of something bad happening
gds  -  feel happy most of time
gds  -  often feel helpless
gds  -  get restless and fidgety
gds  -  prefer to stay home
gds  -  frequently worry about future
gds  -  more memory problems than most
gds  -  think wonderful to be alive
gds  -  feel downhearted and blue
gds  -  feel worthless
gds  -  worry about the past
gds  -  find life exciting
gds  -  hard to start new projects
gds  -  feel full of energy
gds  -  feel situation is hopeless
gds  -  think most people better off than you
gds  -  often upset over little things
gds  -  frequently feel like crying
gds  -  have trouble concentrating
gds  -  enjoy getting up in the morning
gds  -  prefer to avoid social gatherings
gds  -  easy to make decisions
gds  -  mind as clear as it used to be
gds - sf  -  basically satisfied with life
gds - sf  -  dropped activities and interests
gds - sf  -  feel life is empty
gds - sf  -  often get bored
gds - sf  -  good spirits most of time
gds - sf  -  afraid of something bad happening
anguidine
gds - sf  -  feel happy most of time
gds - sf  -  often feel helpless
gds - sf  -  prefer to stay home
gds - sf  -  more memory problems than most
gds - sf  -  think wonderful to be alive
gds - sf  -  feel worthless
gds - sf  -  feel full of energy
gds - sf  -  feel situation is hopeless
gds - sf  -  think most people better off than you
haq - di with vas  -  able to dress yourself
haq - di with vas  -  able to shampoo hair
haq - di with vas  -  able to stand up from chair
haq - di with vas  -  able to get in and out of bed
haq - di with vas  -  able to cut meat
haq - di with vas  -  able to lift cup or glass to mouth
haq - di with vas  -  able to open milk carton
haq - di with vas  -  able to walk outdoors on flat ground
haq - di with vas  -  able to climb up steps
haq - di with vas  -  aids or devices  -  cane
haq - di with vas  -  aids or devices  -  walker
haq - di with vas  -  aids or devices  -  crutches
haq - di with vas  -  aids or devices  -  wheelchair
haq - di with vas  -  aids or devices  -  used for dressing
haq - di with vas  -  aids or devices  -  built up or special utensils
haq - di with vas  -  aids or devices  -  special or built up chair
haq - di with vas  -  aids or devices for dress / arising / eat / walk - other
haq - di with vas  -  aids or devices for dress / arising / eat / walk - specify
haq - di with vas  -  help from another person  -  dressing and grooming
haq - di with vas  -  help from another person  -  arising
haq - di with vas  -  help from another person  -  eating
haq - di with vas  -  help from another person  -  walking
haq - di with vas  -  able to wash and dry body
haq - di with vas  -  able to take tub bath
haq - di with vas  -  able to get on and off toilet
haq - di with vas  -  able to reach and get down object from above head
haq - di with vas  -  able to bend down and pick up clothing from floor
haq - di with vas  -  able to open car doors
haq - di with vas  -  able to open previously opened jars
haq - di with vas  -  able to turn faucets on and off
haq - di with vas  -  able to run errands and shop
haq - di with vas  -  able to get in and out of car
haq - di with vas  -  able to do chores  -  vacuuming or yardwork
haq - di with vas  -  aids or devices  -  raised toilet seat
haq - di with vas  -  aids or devices  -  bathtub seat
haq - di with vas  -  aids or devices  -  bathtub bar
haq - di with vas  -  aids or devices  -  long - handled appliances for reach
haq - di with vas  -  aids or devices  -  long - handled appliances in bathroom
haq - di with vas  -  help from another person  -  hygiene
haq - di with vas  -  help from another person  -  reach
haq - di with vas  -  help from another person  -  gripping and opening things
haq - di with vas  -  help from another person  -  errands and chores
haq - di with vas  -  severity of pain in the past week
sgrq - c  -  description of your current health
sgrq - c  -  cough
sgrq - c  -  bring up phlegm
sgrq - c  -  have shortness of breath
sgrq - c  -  have attacks of wheezing
sgrq - c  -  number of respiratory attacks last year
sgrq - c  -  good days with few respiratory problems
sgrq - c  -  wheezing worse in the morning
sgrq - c  -  description of your respiratory problems
sgrq - c  -  feel breathless washing or dressing yourself
sgrq - c  -  feel breathless walking around the house
sgrq - c  -  feel breathless walking outside on level ground
sgrq - c  -  feel breathless walking up a flight of stairs
sgrq - c  -  feel breathless walking up hills
sgrq - c  -  coughing hurts
sgrq - c  -  coughing makes me tired
sgrq - c  -  short of breath when talk
sgrq - c  -  short of breath when bend over
sgrq - c  -  coughing disturbs my sleep
sgrq - c  -  get exhausted easily
sgrq - c  -  cough is embarrassing in public
sgrq - c  -  afraid or panic when cannot catch breath
sgrq - c  -  not in control of respiratory problems
sgrq - c  -  become frail because of respiratory problems
sgrq - c  -  exercise is not safe for me
sgrq - c  -  everything seems too much effort
sgrq - c  -  take a long time to get washed or dressed
sgrq - c  -  cannot take a bath or shower
sgrq - c  -  walk slower than other people my age
sgrq - c  -  jobs take a long time
sgrq - c  -  walk up flight of stairs slowly
sgrq - c  -  if walk fast have to stop
sgrq - c  -  difficult to walk up hills
sgrq - c  -  difficult to carry heavy loads
sgrq - c  -  how respiratory problems affect you
alzheimer's disease cooperative study - activities of daily living inventory mild cognitive impairment questionnaire
alzheimer's disease cooperative study - activities of daily living inventory severe dementia questionnaire
st . george's respiratory questionnaire for chronic obstructive pulmonary disease patients
adcs - adl mci  -  find personal belongings
adcs - adl mci  -  description of usual performance of finding belongings
adcs - adl mci  -  select first clothes for the day
adcs - adl mci  -  description of usual performance of selecting first clothes for the day
adcs - adl mci  -  description of usual performance of physically getting dressed
adcs - adl mci  -  clean room
adcs - adl mci  -  description of usual performance of cleaning room
adcs - adl mci  -  balance checkbook
adcs - adl mci  -  description of usual performance of balancing checkbook
dibenzo  ( a , l )  pyrene
adcs - adl mci  -  write things down
adcs - adl mci  -  description of usual performance of most complicated things written
adcs - adl mci  -  clean laundry
adcs - adl mci  -  description of usual performance of clean laundry
adcs - adl mci  -  keep appointments
adcs - adl mci  -  description of awareness of the meeting ahead of time
adcs - adl mci  -  use a telephone
adcs - adl mci  -  description of highest level of performance of telephone use
adcs - adl mci  -  make a meal or snack
adcs - adl mci  -  description of highest level of food preparation
adcs - adl mci  -  travel outside home
adcs - adl mci  -  description of optimal performance of travelling outside home
adcs - adl mci  -  talk about current events
adcs - adl mci  -  talk about regional ,  national or international events
adcs - adl mci  -  talk about outside home events
adcs - adl mci  -  talk about at home events
adcs - adl mci  -  converse without repeating
adcs - adl mci  -  read more than 5 minutes
adcs - adl mci  -  select or ask for something to read
adcs - adl mci  -  talk within 1 hour after reading
adcs - adl mci  -  talk within 24 hours after reading
adcs - adl mci  -  watch television
adcs - adl mci  -  select or ask for programs or show
adcs - adl mci  -  talk about content of program while watching
adcs - adl mci  -  talk about content of program after watching within a day
adcs - adl mci  -  go shopping at a store
adcs - adl mci  -  select correct items without help
adcs - adl mci  -  pay for items on his or her own
adcs - adl mci  -  left on his or her own
adcs - adl mci  -  left away from home longer than 15 minutes
cisplatin / fluorouracil / paclitaxel regimen
adcs - adl mci  -  left at home longer than an hour
adcs - adl mci  -  left at home less than an hour
adcs - adl mci  -  use household appliance
adcs - adl mci  -  use household appliance: dishwasher
adcs - adl mci  -  use household appliance: power tools
adcs - adl mci  -  use household appliance: toaster oven
adcs - adl mci  -  use household appliance: range
adcs - adl mci  -  use household appliance: microwave
adcs - adl mci  -  use household appliance: food processor
adcs - adl mci  -  use household appliance: other
adcs - adl mci  -  use household appliance: other specify
adcs - adl mci  -  description of usual use of commonly used appliances
adcs - adl mci  -  perform pastime ,  hobby or game
adcs - adl mci  -  perform pastime ,  hobby or game: card or board games
adcs - adl mci  -  perform pastime ,  hobby or game: bingo
adcs - adl mci  -  perform pastime ,  hobby or game: crosswords
adcs - adl mci  -  perform pastime ,  hobby or game: art
adcs - adl mci  -  perform pastime ,  hobby or game: musical instrument
adcs - adl mci  -  perform pastime ,  hobby or game: knitting
adcs - adl mci  -  perform pastime ,  hobby or game: sewing
adcs - adl mci  -  perform pastime ,  hobby or game: reading
adcs - adl mci  -  perform pastime ,  hobby or game: gardening
adcs - adl mci  -  perform pastime ,  hobby or game: golf
adcs - adl mci  -  perform pastime ,  hobby or game: tennis
adcs - adl mci  -  perform pastime ,  hobby or game: workshop
adcs - adl mci  -  perform pastime ,  hobby or game: fishing
adcs - adl mci  -  perform pastime ,  hobby or game: other
adcs - adl mci  -  perform pastime ,  hobby or game: other specify
adcs - adl mci  -  require help to perform hobbies
adcs - adl mci  -  list hobbies lost ability to perform
adcs - adl mci  -  drive a car
adcs - adl mci  -  description of optimal performance of driving car
adcs - adl mci  -  take medications regularly
adcs - adl mci  -  description of taking medications regularly
adcs - adl mci  -  carry through complex activities to completion
adcs - adl mci  -  description of extent needing reminder
adcs - adl mci  -  initiate complex daily activities
adcs - adl mci  -  time taken to complete complex activities
adcs - adl mci  -  extenuating circumstance
adcs - adl mci  -  explain extenuating circumstance
adcs - adl mci  -  subscore for items 1 to 3
adcs - adl mci  -  subscore for items 4 to 7
adcs - adl mci  -  subscore for items 8 to 10
adcs - adl mci  -  subscore for items 11 to 12
adcs - adl mci  -  subscore for items 13 to 14
adcs - adl mci  -  subscore for items 15 to 16
adcs - adl mci  -  subscore for item 17
adcs - adl mci  -  subscore for item 18
adcs - adl mci  -  adl total score
adcs - adl severe dementia  -  description of usual performance of eating
adcs - adl severe dementia  -  description of optimal performance of walking
adcs - adl severe dementia  -  usual bowel and bladder function at toilet
adcs - adl severe dementia  -  description of usual performance of bathing
adcs - adl severe dementia  -  description of optimal performance of grooming
adcs - adl severe dementia  -  use a telephone
adcs - adl severe dementia  -  description of highest performance of telephone use
adcs - adl severe dementia  -  watch television
adcs - adl severe dementia  -  select or ask for television program
adcs - adl severe dementia  -  talk about tv content while watching
adcs - adl severe dementia  -  talk about tv content within a day after watching
adcs - adl severe dementia  -  pay attention to conversation
adcs - adl severe dementia  -  usual conversation participation
adcs - adl severe dementia  -  clear dishes after meal or snack
adcs - adl severe dementia  -  description of usual performance of clearing dishes
adcs - adl severe dementia  -  find personal belongings at home
adcs - adl severe dementia  -  description of usual performance of finding personal belonging at home
adcs - adl severe dementia  -  obtain beverage for self
adcs - adl severe dementia  -  description of highest performance of obtaining beverage
adcs - adl severe dementia  -  dispose of garbage in appropriate place at home
iproplatin
adcs - adl severe dementia  -  description of usual performance of garbage disposal
adcs - adl severe dementia  -  get around outside home
adcs - adl severe dementia  -  description of optimal performance of getting around outside of home
adcs - adl severe dementia  -  subject left on their own
adcs - adl severe dementia  -  alone away from home for fifteen minutes or longer
adcs - adl severe dementia  -  alone at home for one hour or longer
adcs - adl severe dementia  -  alone at home for less than one hour
adcs - adl severe dementia  -  turn on faucet to wash without help
adcs - adl severe dementia  -  turn off faucet after wash without help
adcs - adl severe dementia  -  turn on light without help entering room
bicalutamide / leuprolide regimen
adcs - adl severe dementia  -  turn off light without help leaving room
adcs - adl severe dementia  -  sum of items 1 - 5
adcs - adl severe dementia  -  sum of items 6 - 8
adcs - adl severe dementia  -  sum of items 9 - 12
adcs - adl severe dementia  -  sum of items 13 - 15
adcs - adl severe dementia  -  sum of items 16 - 19
adcs - adl severe dementia  -  total score
c - ssrs baseline / screening version  -  active suicidal ideation with some intent to act ,  without specific plan  ( lifetime )
c - ssrs baseline / screening version  -  active suicidal ideation with some intent to act ,  without specific plan  ( past x months )
c - ssrs baseline / screening version  -  description of active suicidal ideation with some intent to act ,  without specific plan
bicalutamide / goserelin regimen
haq - di with vas  -  aids or devices  -  jar opener  ( jars previously opened )
sgrq - c  -  respiratory problems a nuisance to family ,  friends or neighbours
sgrq - c  -  respiratory problems affect daily life: cannot play sports
sgrq - c  -  respiratory problems affect daily life: cannot go out for entertainment
sgrq - c  -  respiratory problems affect daily life: cannot go out to do shopping
sgrq - c  -  respiratory problems affect daily life: cannot do household chores
sgrq - c  -  respiratory problems affect daily life: cannot move far from bed
c - ssrs already enrolled subjects  -  wish to be dead  ( prior to study entry )
c - ssrs already enrolled subjects  -  wish to be dead  ( since study start )
c - ssrs already enrolled subjects  -  description of wish to be dead
c - ssrs already enrolled subjects  -  non - specific active suicidal thoughts  ( prior to study entry )
c - ssrs already enrolled subjects  -  non - specific active suicidal thoughts  ( since study start )
c - ssrs already enrolled subjects  -  description of non - specific active suicidal thoughts
c - ssrs already enrolled subjects  -  active suicidal ideation with any methods  ( not plan )  without intent to act  ( prior to study entry )
c - ssrs already enrolled subjects  -  active suicidal ideation with any methods  ( not plan )  without intent to act  ( since study start )
c - ssrs already enrolled subjects  -  description of active suicidal ideation with any methods  ( not plan )  without intent to act
c - ssrs already enrolled subjects  -  active suicidal ideation with some intent to act ,  without specific plan  ( prior to study entry )
c - ssrs already enrolled subjects  -  active suicidal ideation with some intent to act ,  without specific plan  ( since study start )
c - ssrs already enrolled subjects  -  description of active suicidal ideation with some intent to act ,  without specific plan
c - ssrs already enrolled subjects  -  active suicidal ideation with specific plan and intent  ( prior to study entry )
c - ssrs already enrolled subjects  -  active suicidal ideation with specific plan and intent  ( since study start )
c - ssrs already enrolled subjects  -  description of active suicidal ideation with specific plan and intent
c - ssrs already enrolled subjects  -  most severe ideation  ( prior to study entry )
c - ssrs already enrolled subjects  -  describe most severe ideation  ( prior to study entry )
c - ssrs already enrolled subjects  -  most severe ideation  ( since study start )
c - ssrs already enrolled subjects  -  describe most severe ideation  ( since study start )
c - ssrs already enrolled subjects  -  frequency of most severe ideation  ( prior to study entry )
c - ssrs already enrolled subjects  -  frequency of most severe ideation  ( since study start )
c - ssrs already enrolled subjects  -  duration of most severe ideation  ( prior to study entry )
c - ssrs already enrolled subjects  -  duration of most severe ideation  ( since study start )
c - ssrs already enrolled subjects  -  controllability of most severe ideation  ( prior to study entry )
c - ssrs already enrolled subjects  -  controllability of most severe ideation  ( since study start )
c - ssrs already enrolled subjects  -  deterrents to most severe ideation  ( prior to study entry )
c - ssrs already enrolled subjects  -  deterrents to most severe ideation  ( since study start )
c - ssrs already enrolled subjects  -  reasons for most severe ideation  ( prior to study entry )
c - ssrs already enrolled subjects  -  reasons for most severe ideation  ( since study start )
c - ssrs already enrolled subjects  -  actual suicide attempt  ( prior to study entry )
c - ssrs already enrolled subjects  -  actual suicide attempt  ( since study start )
c - ssrs already enrolled subjects  -  number of actual suicide attempts  ( prior to study entry )
c - ssrs already enrolled subjects  -  number of actual suicide attempts  ( since study start )
c - ssrs already enrolled subjects  -  description of actual suicide attempt
c - ssrs already enrolled subjects  -  non - suicidal self - injurious behavior  ( prior to study entry )
c - ssrs already enrolled subjects  -  non - suicidal self - injurious behavior  ( since study start )
c - ssrs already enrolled subjects  -  interrupted suicide attempt  ( prior to study entry )
c - ssrs already enrolled subjects  -  interrupted suicide attempt  ( since study start )
c - ssrs already enrolled subjects  -  number of interrupted suicide attempts  ( prior to study entry )
c - ssrs already enrolled subjects  -  number of interrupted suicide attempts  ( since study start )
c - ssrs already enrolled subjects  -  description of interrupted suicide attempt
c - ssrs already enrolled subjects  -  aborted suicide attempt  ( prior to study entry )
c - ssrs already enrolled subjects  -  aborted suicide attempt  ( since study start )
c - ssrs already enrolled subjects  -  number of aborted suicide attempts  ( prior to study entry )
c - ssrs already enrolled subjects  -  number of aborted suicide attempts  ( since study start )
c - ssrs already enrolled subjects  -  description of aborted suicide attempt
c - ssrs already enrolled subjects  -  preparatory acts or behaviors toward suicide attempt  ( prior to study entry )
c - ssrs already enrolled subjects  -  preparatory acts or behaviors toward suicide attempt  ( since study start )
c - ssrs already enrolled subjects  -  description of preparatory acts or behaviors toward suicide attempt
c - ssrs already enrolled subjects  -  suicidal behavior  ( prior to study entry )
c - ssrs already enrolled subjects  -  suicidal behavior  ( since study start )
c - ssrs already enrolled subjects  -  completed suicide  ( prior to study entry )
c - ssrs already enrolled subjects  -  completed suicide  ( since study start )
c - ssrs already enrolled subjects  -  most recent suicide attempt date
c - ssrs already enrolled subjects  -  most recent suicide attempt actual lethality / medical damage
c - ssrs already enrolled subjects  -  most recent suicide attempt potential lethality
c - ssrs already enrolled subjects  -  most lethal suicide attempt date
c - ssrs already enrolled subjects  -  most lethal suicide attempt actual lethality / medical damage
c - ssrs already enrolled subjects  -  most lethal suicide attempt potential lethality
c - ssrs already enrolled subjects  -  first suicide attempt date
c - ssrs already enrolled subjects  -  first suicide attempt actual lethality / medical damage
c - ssrs already enrolled subjects  -  first suicide attempt potential lethality
adcs - adl mci  -  use household appliance: washer
adcs - adl mci  -  use household appliance: dryer
adcs - adl mci  -  use household appliance: vacuum
adcs - adl mci  -  points for questions  ( 1 - 18 )  answered 'don't know'
haq - di with vas  -  aids or devices for hygiene / reach / grip / act - other
haq - di with vas  -  aids or devices for hygiene / reach / grip / act - specify
allogeneic conditioning
autologous conditioning
disease response domain
qtcb prolongation
qtcf prolongation
porfimer sodium
interpolated premature ventricular complex by ecg finding
anaphylaxis
agranulocytosis
sudden death
nid2 gene
nid2 wt allele
nidogen - 2
acly gene
acly wt allele
atp - citrate synthase
mgst2 gene
mgst2 wt allele
microsomal glutathione s - transferase 2
col7a1 gene
col7a1 wt allele
collagen alpha - 1 ( vii )  chain
gabarapl2 gene
gabarapl2 wt allele
gamma - aminobutyric acid receptor - associated protein - like 2
chd1 gene
chd1 wt allele
chromodomain - helicase - dna - binding protein 1
dab2ip gene
dab2ip wt allele
disabled homolog 2 - interacting protein
phlpp2 gene
phlpp2 wt allele
ph domain leucine - rich repeat - containing protein phosphatase 2
itgae gene
itgae wt allele
integrin alpha - e
fst gene
fst wt allele
follistatin
ndn gene
ndn wt allele
necdin
kinome response profile
17 - alpha - hydroxypregnenolone
kinome
phenanthrene tetraol
crotonaldehyde
s - phenyl - n - acetylcysteine
monohydroxybutylmercapturic acid
3 - hydroxypropylmercapturic acid
4 - hydroxybut - 2 - ylmercapturic acid
n - acetyl - s -  ( 2 - hydroxyethyl ) cysteine
glutathione s - transferase alpha
glutathione s - transferase mu
amp - activated protein kinase beta
organic anion transporter protein
histone h3 dimethyl lys27
histone h3 dimethyl lys4
histone h3 trimethyl lys4
egfr np_005219 .2:p .g719x
androstanedione
nccn guidelines distress management distress thermometer screening tool version 1 .2011
nccn guidelines distress management problem list screening tool version 1 .2011
distressed during the past week on a scale of 0 to 10
mart - 1 / gp100 / tyrosinase / mage - a3 peptides - loaded irradiated allogeneic plasmacytoid dendritic cells
oncolytic adenovirus icovir5 - infected autologous mesenchymal stem cells
heparan sulfate glycosaminoglycan mimetic nanopolymer mouthwash
distress over practical problem with child care
gallium ga 68 - labeled affibody aby - 025
benzaldehyde dimethane sulfonate
carbohydrate supplement drink
pbcar3 phosphopeptide - tetanus peptide vaccine
pirs2 phosphopeptide - tetanus peptide vaccine
pbcar3 / pirs2 - phosphopeptide - tetanus peptide vaccine
allogeneic hla - a2 / 4 - 1bb ligand - expressing melanoma vaccine
distress over practical problem with housing
distress over practical problem with insurance or finances
distress over practical problem with transportation
distress over practical problem with work or school
distress over practical problem with treatment decisions
distress over family problem of dealing with children
distress over family problem of dealing with partner
distress over family problem with ability to have children
distress over family problem with family health issues
distress over emotional problem with depression
distress over emotional problem with fear
distress over emotional problem with nervousness
distress over emotional problem with sadness
distress over emotional problem with worry
distress over emotional problem with loss of interest in usual activities
distress over spiritual or religious concerns
distress over physical problem with appearance
distress over physical problem with bathing or dressing
mucoadhesive paclitaxel formulation
distress over physical problem with breathing
cd33car - cd3zeta - 4 - 1bb - expressing autologous t - lymphocytes
egfr car - cd3zeta - 4 - 1bb - expressing autologous t - lymphocytes
distress over physical problem with changes in urination
distress over physical problem with constipation
distress over physical problem with diarrhea
distress over physical problem with eating
distress over physical problem with fatigue
distress over physical problem with feeling swollen
distress over physical problem with fevers
distress over physical problem with getting around
1 , 1 - dimethylhydrazine
distress over physical problem with indigestion
distress over physical problem with memory or concentration
distress over physical problem with mouth sores
distress over physical problem with nausea
distress over physical problem with dry or congested nose
distress over physical problem with pain
distress over physical problem with sexual activity
distress over physical problem with dry or itchy skin
distress over physical problem with sleep
distress over physical problem with tingling in hands or feet
distress over other problem
skin - sparing mastectomy
oncoplastic partial mastectomy / lumpectomy with oncoplastic closure
dose escalation
little interest or pleasure in doing things
poor appetite or overeating
feeling bad about yourself or feeling like a failure or have let yourself or your family down
moving or speaking so slowly that other people could have noticed
so fidgety or restless that you have been moving around more
thoughts you would be better off dead or hurting yourself some way
problems made it difficult to do work ,  take care of things at home ,  or get along with other people
several
nearly
more than half the days
braf v600 mutation
augmentation mammoplasty
neck dissection impairment index
bothered by neck or shoulder pain or discomfort
bothered by shoulder stiffness
bothered by difficulty with self - care activities because of neck or shoulder
limited in ability to lift light objects because of shoulder or neck
limited in ability to lift heavy objects because of shoulder or neck
limited in ability to reach above for objects because of shoulder or neck
bothered by overall activity level because of shoulder or neck
treatment of neck affected participation in social activities
limited in ability to do leisure or recreational activities because of neck or shoulder
limited in ability to do work because of neck or shoulder
fak inhibitor vs - 4718
fact complex - targeting curaxin cbl0137
l - methylfolate
erk inhibitor gdc - 0994
cd19car - cd28zeta - 4 - 1bb - expressing allogeneic t lymphocytes
pep - cmv vaccine
topical sirolimus
agerafenib
how often bothered by problems
feeling nervous ,  anxious or on edge
not able to stop or control worrying
worrying too much about different things
trouble relaxing
being so restless it is hard to sit still
becoming easily annoyed or irritable
feeling afraid as if something awful might happen
how difficult have problems made it to do work ,  take care of things at home ,  or get along with other people
abies sachalinensis var . sachalinensis oil
abies sibirica leaf oil
achillea millefolium oil
aesculus hippocastanum seed fluid extract
almond oil
ambrette seed oil
amomum villosum leaf oil
angelica root oil
angelica seed oil
apricot kernel oil
argan oil
asafetida oil
avocado oil
backhousia citriodora leaf oil
balsam peru oil
bay fruit oil
bay leaf oil
bitter almond oil
bitter fennel fruit oil
brassica napus oil
camelina sativa seed oil
canaga oil
carapa guianensis seed oil
caraway oil
cardamom oil
carrot seed oil
cashew oil
cedrus deodara seed oil
cervus elaphus horn oil
chamaecyparis obtusa wood oil
chamaemelum nobile flower oil
chilean hazelnut oil
chinese cinnamon leaf oil
cinnamomum loureirii bark extract
cinnamomum zeylanicum bark extract
cinnamon leaf oil
citrus bergamia extract
citrus sinensis flower oil
clary sage oil
coix lacryma - jobi oil
cucumber seed oil
cumin oil
curcuma aromatica root oil
curcuma xanthorrhiza oil
cymbopogon schoenanthus oil
dimethylmyleran
davana oil
dianthus caryophyllus flower oil
dill seed oil
dill weed oil
east indian lemongrass oil
emu oil
european hazelnut oil
fenugreek seed oil
fish liver oil
geranium oil algerian type
ginger oil
grape seed oil
grapefruit seed oil
halibut liver oil
hippophae rhamnoides fruit oil
hops oil
horehound oil
indian frankincense oil
jojoba oil
kanuka oil
lanolin oil
lemon oil
levant cottonseed oil
lime oil
linseed oil
lovage oil
mace oil
mango seed oil
manuka oil
melaleuca quinquenervia leaf oil
menhaden oil
mentha arvensis flower oil
mustard oil
myrtle leaf oil
neatsfoot oil
nigella sativa seed oil
nutmeg oil
orange oil extract
oregano leaf oil
origanum majorana leaf extract
orris root extract
palmarosa oil
parsley seed oil
pelargonium capitatum oil
pelargonium odoratissimum oil
pelargonium radens oil
pelargonium roseum oil
perilla frutescens leaf oil
pine needle oil pinus mugo
pistachio oil
pomegranate seed oil
pumpkin seed oil
rhododendron dauricum leaf oil
ribes nigurm seed
rice germ oil
rosa alba flower extract
rosa centifolia flower oil
rosa damascena flower oil
rosa gallica flower oil
rosa moschata oil
rosemary oil
saffron oil
saigon cinnamon leaf oil
sambucus canadensis flower oil
sambucus nigra flower oil
sandalwood oil
santalum spicatum oil
thyme oil
turmeric oil
turpentine oil
walnut oil
west indian lemongrass oil
wheat germ oil
white pine oil
wild thyme oil
zedoary oil
pediatric non - congenital ventricular tachycardia
musculoskeletal disorder
md anderson symptom inventory  -  core
md anderson symptom inventory  -  lung chemoradiation
coughing at its worst
sore throat at its worst
difficulty swallowing at its worst
pedicle tram flap procedure
milademetan tosylate
ultra low temperature freezer
pi3k inhibitor wx - 037
bp - cx1 - platinum complex bp - c1
anti - 5t4 antibody - drug conjugate pf - 06263507
monosialotetrahexosylganglioside
asbestos mining
edmonton symptom assessment system
worst possible pain
worst possible tiredness
worst possible nausea
worst possible depression
worst possible anxiety
feel drowsy
worst possible appetite
worst possible feeling of overall well - being
dinoprost tromethamine
overall well - being
worst possible symptom
worst severity past seven days fatigue ,  tiredness ,  or lack of energy
past seven days how much fatigue ,  tiredness ,  or lack of energy interfered with usual or daily activities
worst severity past seven days numbness or tingling in hands or feet
past seven days numbness or tingling in hands or feet interfering with usual or daily activities
past seven days frequency of pain
worst severity past seven days pain
past seven days pain interfering with usual or daily activities
worst severity past seven days constipation
worst severity past seven days problems with concentration
past seven days problems with concentration interfering with usual or daily activities
past seven days frequency of tremors
worst severity past seven days tremors
past seven days other symptoms to report
worst severity past seven days other symptom
nitrogen dioxide sterilization
supercritical carbon dioxide sterilization
liquid chemical sterilization
high - level disinfectant sterilization
dcaf1 gene
dcaf1 wt allele
ddb1 -  and cul4 - associated factor 1
mageb2 gene
social security death index
mageb2 wt allele
obituary
histone h3 lysine 4
melanoma - associated antigen b2
histone h3 lysine 9
human anti - ricin antibody
macrovessel density
dna fragmentation
phosphodiesterase type 4
twenty one
fractional excretion of sodium
glb1 gene
glb1 wt allele
beta - galactosidase
tetrahydrobiopterin
calcitroic acid
sult1a1 gene
sult1a1 wt allele
sulfotransferase 1a1
csnk2b gene
csnk2b wt allele
casein kinase ii subunit beta
gabrg1 gene
gabrg1 wt allele
gamma - aminobutyric acid receptor subunit gamma - 1
67 kda laminin receptor
ddx31 gene
ddx31 wt allele
probable atp - dependent rna helicase ddx31
gab1 gene
gab1 wt allele
grb2 - associated - binding protein 1
atf4 gene
atf4 wt allele
cyclic amp - dependent transcription factor atf - 4
slc16a1 gene
slc16a1 wt allele
monocarboxylate transporter 1
slc16a4 gene
slc16a4 wt allele
monocarboxylate transporter 5
slc46a1 gene
slc46a1 wt allele
proton - coupled folate transporter
ceacam6 gene
ceacam6 wt allele
carcinoembryonic antigen - related cell adhesion molecule 6
nr1i3 gene
nr1i3 wt allele
nuclear receptor subfamily 1 group i member 3
elavl1 gene
elavl1 wt allele
elav - like protein 1
kras np_004976 .2:p .q61x
kras np_004976 .2:p .a146x
pik3ca np_006209 .2:p .e542x
pik3ca np_006209 .2:p .e545x
pik3ca np_006209 .2:p .h1047x
nras np_002515 .1:p .g12x
nras np_002515 .1:p .g13x
nras np_002515 .1:p .q61x
tumor microenvironment of metastasis density
alpp gene
triphasic
australia - modified karnofsky performance scale
australia - modified karnofsky performance status 40
australia - modified karnofsky performance status 30
australia - modified karnofsky performance status 20
australia - modified karnofsky performance status 10
auto - triggered
anti - drug antibody
neutralizing anti - drug antibody
convenient
useful
sickness
doxorubicin - dna complex
iodine i 124 phospholipid ether analogue clr1404
aloe / anise / ascorbic acid / clove / peppermint / spearmint / thyme - based mouthwash
glioblastoma cancer vaccine erc1671
nogapendekin alfa
recombinant human adenovirus type 5 h101
cd138car - cd137 / tcrzeta - expressing t lymphocytes
tazemetostat
multinational association of supportive care in cancer antiemesis tool
baseline nausea and vomiting
vomiting in the last 24 hours
how often vomited during this period
nausea in the last 24 hours
how much nausea in the last 24 hours
nausea and vomiting during the first 24 hours after chemotherapy
vomiting in the 24 hours since chemotherapy
how often vomited in the 24 hours since chemotherapy
nausea in the 24 hours since chemotherapy
delayed nausea and vomiting
vomiting during this period
nausea during this period
how much nausea during this period
as much as possible
did you take any medication except the study drug for vomiting in the past 24 hours
did you take any medication except the study drug for nausea in the past 24 hours
scheduled by doctor
needed help
concerned i would develop symptoms
pregnancy - related nausea and / or vomiting
chemotherapy - related nausea and / or vomiting
pillow
hepatojugular
pancreatic stellate cell
osoba nausea and emesis module
nausea interfered with appetite during past 24 hours
nausea affected sleep during past 24 hours
nausea interfered with physical activities during past 24 hours
nausea interfered with social life during past 24 hours
nausea interfered with enjoyment of life during past 24 hours
vomiting or dry heaves interfered with appetite during past 24 hours
vomiting or dry heaves affected sleep during past 24 hours
vomiting or dry heaves interfered with physical activities during past 24 hours
vomiting or dry heaves interfered with social life during past 24 hours
vomiting or dry heaves interfered with enjoyment of life during past 24 hours
treatment satisfaction questionnaire for medication
satisfaction with ability of medication to prevent or treat condition
satisfaction with way medication relieves symptoms
satisfaction with time it takes medication to start working
ease of using medication in its present form
ease of planning when to use medication each time
convenience of taking medication as instructed
confidence that taking medication is a good thing
certainty that good outweighs the bad things about medication
satisfaction with medication
alpp wt allele
alkaline phosphatase ,  placental type
bufalin
metanephrine
cyp3a gene locus
b - cell receptor complex
casein kinase 2
thromboxane b2
certain
angiotensin - 2
fibrin monomer
s - nitroso - hemoglobin
alpha - amylase
cancer / testis antigen
c - telopeptide of type i collagen generated by matrix metalloproteinases
pdgfra nm_006206 .4:c .2525a > t
pdgfra protein variant
pdgfra np_006197 .1:p .d842v
pros1 gene
pros1 wt allele
vitamin k - dependent protein s
slc22a2 gene
slc22a2 wt allele
solute carrier family 22 member 2
slc18a1 gene
slc18a1 wt allele
fgfr2 gene mutation
chromaffin granule amine transporter
fgfr2 protein variant
il10ra gene
fgfr2 nm_000141 .4:c .755c > g
il10ra wt allele
fgfr2 np_000132 .3:p .s252w
interleukin - 10 receptor subunit alpha
failure to thrive
interleukin - 8 receptor
cxcr4 inhibitor
fgfr2 nm_000141 .4:c .758c > g
fgfr2 np_000132 .3:p .p253r
fgfr2 nm_000141 .4:c .1115c > g
fgfr2 np_000132 .3:p .s372c
fgfr2 nm_000141 .4:c .1124a > g
fgfr2 np_000132 .3:p .y375c
fgfr2 nm_000141 .4:c .1144t > c
fgfr2 np_000132 .3:p .c382r
fgfr2 nm_000141 .4:c .1647t > a
fgfr2 nm_000141 .4:c .1647t > g
dromostanolone
fgfr2 np_000132 .3:p .n549k
other asian
other pacific islander
fgfr2 nm_000141 .4:c .1645a > c
fgfr2 np_000132 .3:p .n549h
fgfr2 nm_000141 .4:c .1975a > g
fgfr2 np_000132 .3:p .k659e
mexican or mexican american
cuban
other hispanic or latino ( a )
spint1 gene
spint1 wt allele
kunitz - type protease inhibitor 1
adra2c gene
adra2c wt allele
alpha - 2c adrenergic receptor
txnrd1 gene
txnrd1 wt allele
thioredoxin reductase 1 ,  cytoplasmic
txnrd2 gene
txnrd2 wt allele
thioredoxin reductase 2 ,  mitochondrial
ttf1 gene
ttf1 wt allele
transcription termination factor 1
krt13 gene
krt13 wt allele
keratin ,  type i cytoskeletal 13
did you take any medication except the study drug for vomiting during this period
did you take any medication except the study drug for nausea during this period
expanded prostate cancer index composite
expanded prostate cancer index composite ,  sexual medications / devices supplement
have penile prosthesis
used medications or devices to aid or improve erections
medicine or device tried or currently used to improve erection
penile injection therapy
vacuum erection device
have not tried it
tried it but not helpful
helped but not using it now
helped and using it sometimes
helped and using it always
describe usual quality of erections without assistance of medicines or devices during last 4 weeks
not firm enough for sexual activity
firm enough for masturbation and foreplay only
firm enough for intercourse
traf7 gene
traf7 wt allele
e3 ubiquitin - protein ligase traf7
rnf43 gene
rnf43 wt allele
e3 ubiquitin - protein ligase rnf43
rpl5 gene
rpl5 wt allele
60s ribosomal protein l5
pot1 gene
pot1 wt allele
protection of telomeres protein 1
cnot3 gene
cnot3 wt allele
ccr4 - not transcription complex subunit 3
strn gene
strn wt allele
striatin
irf2bp2 gene
irf2bp2 wt allele
interferon regulatory factor 2 - binding protein 2
cdx1 gene
cdx1 wt allele
homeobox protein cdx - 1
adjustable dose pre - filled pen syringe
mucin - depleted foci of the mouse intestinal tract
intramucosal carcinoma of the mouse intestinal tract
serrated lesion of the mouse intestinal tract
metastatic carcinoma of the mouse intestinal tract
spl race terminology
dicycloplatin
aav - dc - ctl tumor cell targeting therapy
rovalpituzumab tesirine
liposomal rhenium re 186
melphalan flufenamide
allogeneic autophagosome - enriched vaccine dpv - 001
substance p - saporin
aprutumab
pi3kbeta inhibitor azd8186
bc - 819 plasmid / polyethylenimine complex
dezapelisib
us county
dromostanolone propionate
brequinar sodium
bleomycin / cyclophosphamide / doxorubicin / prednisolone / vindesine regimen
dynemicin a
elsamitrucin
district of columbia ,  dc
cyclophosphamide / methotrexate regimen
eutectic mixture of local anesthetics
enocitabine
cytarabine / topotecan regimen
staphylococcal enterotoxin a
fluorouracil / irinotecan / leucovorin calcium
staphylococcal enterotoxin b
staphylococcal enterotoxin c
toxic shock syndrome toxin - 1
cyclophosphamide / doxorubicin / etoposide / prednisone
apaziquone
epigallocatechin gallate
epitiostanol
leuprolide / tamoxifen regimen
estradiol valerate
estrone sulfate
etanidazole
carboxyamidotriazole / paclitaxel
etoposide phosphate
fludarabine
pyrimethamine - sulfadoxine
fazarabine
exemestane
fenretinide
finasteride
cefixime
mitoflaxone
fludarabine phosphate
fludrocortisone acetate
fluosol - da
fosfestrol
fotemustine
fumonisin b1
gabapentin
bold regimen
gallium nitrate
midway islands ,  um
chorioretinitis
single chamber power injector
physiologic hyperbilirubinemia
6 - item orientation - memory - concentration test
what year is it
what month is it
about what time is it
count backwards from 20 to 1
say the months in reverse order
repeat the memory phrase
estimated glomerular filtration rate
toxic methemoglobinemia with cyanosis
musculoskeletal finding
tachyarrhythmia
plantar grasp reflex
panhypopituitarism
allantoic cyst
congenital anomaly of pulmonary veins
musculoskeletal injury
dual chamber power injector
saline flush
older americans resource scale multidimensional functional assessment questionnaire
activities of daily living dimension of functioning questionnaire
use the telephone
get to places out of walking distance
go shopping for groceries or clothes
prepare your meals
do housework
take your medicines
handle your money
have current illness
without help
with some help
completely unable
not answered
bone marrow aplasia
index lesion
non - index lesion
bcr - abl tki - resistant mutation
not meeting criteria
medical outcomes study physical functioning scale
instrumental activities of daily living
older americans resources and services comorbidity scale
medical outcomes study social activities
medical outcomes study social support survey
organ procurement and transplantation network
limited by health
united network for organ sharing
vigorous activities such as running ,  lifting heavy objects ,  or participating in strenuous sports
moderate activities such as moving a table ,  pushing a vacuum cleaner ,  bowling ,  or playing golf
lifting or carrying groceries
climbing several flights of stairs
climbing one flight of stairs
bending ,  kneeling ,  or stooping
walking more than a mile
walking several blocks
walking one block
bathing or dressing yourself
limited a lot
limited a little
not limited at all
past 4 weeks
past 6 months
physical health or emotional problems
interference with social activities
all of the time
most of the time
some of the time
a little of the time
none of the time
much less socially active than before
somewhat less socially active than before
about as socially active as before
somewhat more socially active as before
much more socially active than before
ganglioside gd2
much more limited than others
somewhat more limited than others
about the same as others
somewhat less limited than others
much less limited than others
someone to help you if you were confined to bed
someone you can count on to listen to you when you need to talk
someone to give you good advice about a crisis
someone to take you to the doctor if you needed it
someone to give you information to help you understand a situation
someone to confide in or talk to about yourself or your problem
someone to prepare your meals if you were unable to do it yourself
someone whose advice you really want
someone to help you with daily chores if you were sick
someone to share your most private worries and fears with
someone to turn to for suggestions about how to deal with a personal problem
someone who understands your problems
amber
hazel
violet
class 1 uveal melanoma
class 2 uveal melanoma
class 1a uveal melanoma
class 1b uveal melanoma
presence of extravascular matrix patterns
extravascular matrix loops
loops forming networks
tumor infiltrating macrophages
extrascleral extension of uveal melanoma
mushroom - shaped lesion
genetic carrier
antecubital region
carpal region
minimal aneuploidy
oral rehydration solution os - 1
multi - peptide cmv - modified vaccinia ankara vaccine
synthetic long e6 / e7 peptides vaccine hpv - 01
anti - vegfr2 - car retroviral vector - transduced autologous t - lymphocytes
vadastuximab talirine
zirconium zr 89 df - iab2m
anti - cd19 - car fmc63 - 28z retroviral vector - transduced allogeneic t - lymphocytes
stat3 inhibitor wp1066
have had seizures
can remember new things
trimebutine 3 - thiocarbamoylbenzenesulfonate
get frustrated that i cannot do things i used to
afraid of having a seizure
have trouble with eyesight
feel independent
have trouble hearing
able to find the right words to say
difficulty expressing thoughts
bothered by change in personality
able to make decisions and take responsibility
bothered by drop in contribution to the family
able to put thoughts together
need help in caring for self
able to put thoughts into actions
able to read like they used to
able to write like they used to
able to drive a vehicle
have trouble feeling sensations in limbs
have weakness in limbs
trouble with coordination
get headaches
orchiopexy
testicular cancer serum markers test result
sx
s0
s1
s2
s3
international germ cell consensus classification
micro
arrhythmia by ecg finding
us counties terminology
human prescription drug distribution
human over - the - counter drug distribution
critical organ volume
cloth
emancipated minor
modified overall immune related response criterion
modified overall immune related response criterion ,  new non - measurable lesion
modified overall immune related response criterion ,  complete remission
modified overall immune related response criterion ,  partial response
modified overall immune related response criterion ,  stable disease
modified overall immune related response criterion ,  progressive disease
av block first degree by ecg finding
av block second degree mobitz type i by ecg finding
av block third degree by ecg finding
atrial fibrillation by ecg finding
software version
atrial flutter by ecg finding
clot detection
colorimetry
sinus bradycardia by ecg finding
slackia
wautersiella
supraventricular tachycardia by ecg finding
ventricular arrhythmia by ecg finding
ventricular fibrillation by ecg finding
ventricular tachycardia by ecg finding
sinus tachycardia by ecg finding
atrial tachycardia by ecg finding
cdisc sdtm respiratory test code terminology
cdisc sdtm respiratory test name terminology
cdisc sdtm employment status terminology
cdisc sdtm device events category terminology
cdisc sdtm device events action taken with device terminology
cdisc sdtm device properties test code terminology
cdisc sdtm device properties test name terminology
cdisc send domain abbreviation terminology
cdisc sdtm genetic sample type terminology
ventricular flutter by ecg finding
diffusion weighted imaging
arterial embolus
atrial thrombus
av block second degree
neostriatum
a proliferation - inducing ligand measurement
abnormal cell count
adenovirus antibody measurement
alpha hydroxybutyrate dehydrogenase measurement
aluminum measurement
angiopoietin 1 measurement
antibody unit
apolipoprotein j to creatinine ratio measurement
atrioventricular conduction ecg assessment
axis and voltage ecg assessment
bacteroides dorei
bacteroides faecis
b - cell activating factor measurement
bence - jones protein measurement
biospecimen domain
biospecimen events domain
biscuit dosing unit
block unit of distance
bursa of fabricius
butyrylcholinesterase measurement
cancer antigen 27 - 29 measurement
cardiolipin igg antibody measurement
cartilage oligomeric matrix protein measurement
cd10 expressing cell count
cd13 expressing cell count
cd22 expressing cell count
cd23 expressing cell count
paclitaxel / vinorelbine
cd33 expressing cell count
cd38 expressing cell count
cd79a expressing cell count
cellularity measurement
centromere b antibody measurement
chamber hypertrophy or enlargement ecg assessment
cheek pouch
chemical ablation
chloroplast dna
chymotrypsin measurement
coccidioides antibody measurement
copper measurement
crop
cross - linking and immunoprecipitation
cryoglobulin measurement
cyclic guanosine monophosphate measurement
cytoplasmic basophilia neutrophil count
day times femtogram per milliliter per kilogram per meter squared
day times femtogram per milliliter per meter squared
day times gram per milliliter per kilogram per meter squared
day times gram per milliliter per meter squared
day times microgram per milliliter per kilogram per meter squared
day times microgram per milliliter per meter squared
day times micromole per liter per kilogram per meter squared
day times micromole per liter per meter squared
day times milligram per milliliter per kilogram per meter squared
day times milligram per milliliter per meter squared
day times millimole per liter per kilogram per meter squared
day times millimole per liter per meter squared
day times mole per liter per kilogram per meter squared
day times mole per liter per meter squared
day times nanogram per milliliter per kilogram per meter squared
day times nanogram per milliliter per meter squared
day times nanomole per liter per kilogram per meter squared
day times nanomole per liter per meter squared
day times picogram per milliliter per kilogram per meter squared
day times picogram per milliliter per meter squared
day times picomole per liter
day times picomole per liter per kilogram per meter squared
day times picomole per liter per meter squared
degenerated leukocyte count
electrical lead locking type
electrocauterization
electrochemiluminescence
electrochemiluminescence immunoassay
enzymatic colorimetry
enzyme multiplied immunoassay technique
erythrocyte agglutination measurement
experimental organism basal cell adenoma
experimental organism basal cell carcinoma
geldanamycin
expiratory reserve volume
full brother
full sister
gas chromatography mass spectrometry
granulicatella elegans
hansel staining method
heinz body to erythrocyte ratio measurement
hemoglobin a1c to hemoglobin ratio measurement
hemolytic index
histone antibody measurement
hour times femtogram per milliliter per kilogram per meter squared
hour times femtogram per milliliter per meter squared
hour times gram per milliliter per kilogram per meter squared
hour times gram per milliliter per meter squared
hour times microgram per milliliter per kilogram per meter squared
hour times microgram per milliliter per meter squared
hour times micromole per liter per kilogram per meter squared
hour times micromole per liter per meter squared
hour times milligram per milliliter per kilogram per meter squared
hour times milligram per milliliter per meter squared
hour times millimole per liter per kilogram per meter squared
hour times millimole per liter per meter squared
hour times mole per liter per kilogram per meter squared
hour times mole per liter per meter squared
hour times nanogram per milliliter per kilogram per meter squared
hour times nanogram per milliliter per meter squared
hour times nanomole per liter per kilogram per meter squared
hour times nanomole per liter per meter squared
hour times picogram per milliliter per kilogram per meter squared
hour times picogram per milliliter per meter squared
hour times picomole per liter per kilogram per meter squared
hour times picomole per liter per meter squared
icteric index
igg igm iga total measurement
immature cell to total cell ratio measurement
immunochemiluminometric assay
immunoradiometric assay
inspiratory reserve volume
intraventricular and intraatrial conduction ecg assessment
ketone body measurement
kinetic microparticle immunoassay
laser ablation
lipemic index
macroamylase measurement
macrophage to total cell ratio measurement
manual clot detection
mast cell count
mast cell to total cell ratio measurement
maternal biological grandparent
mechanical clot detection
meningeal cell count
meningeal cell to total cell ratio measurement
microparticle enzyme immunoassay
millimole per mole
minute times femtogram per milliliter per kilogram per meter squared
minute times femtogram per milliliter per meter squared
minute times gram per milliliter per kilogram per meter squared
minute times gram per milliliter per meter squared
minute times microgram per milliliter per kilogram per meter squared
minute times microgram per milliliter per meter squared
minute times micromole per liter per kilogram per meter squared
minute times micromole per liter per meter squared
minute times milligram per milliliter per kilogram per meter squared
minute times milligram per milliliter per meter squared
minute times millimole per liter per kilogram per meter squared
minute times millimole per liter per meter squared
minute times mole per liter per kilogram per meter squared
minute times mole per liter per meter squared
minute times nanogram per milliliter per kilogram per meter squared
minute times nanogram per milliliter per meter squared
minute times nanomole per liter per kilogram per meter squared
minute times nanomole per liter per meter squared
minute times picogram per milliliter per kilogram per meter squared
minute times picogram per milliliter per meter squared
minute times picomole per liter per kilogram per meter squared
minute times picomole per liter per meter squared
monocytoid cell count
monocytoid cell to total cell ratio measurement
msdrna
multicopy single - stranded dna
myocardial infarction ecg assessment
nephelometry
non - compliant adam datasets domain
nucleated thrombocyte count
oxygen measurement
pacemaker ecg assessment
paternal biological grandparent
periurethral region
pharmacogenomics findings domain
pharmacogenomics trial characteristics domain
photometric clot detection
platelet activating factor measurement
platelet aggregation amplitude measurement
platelet component distribution width measurement
platelet function closure time measurement
platelet morphology measurement
positron emission tomography and single photon emission computed tomography scan
precursor mrna
proinsulin to insulin ratio measurement
genistein
protocol summary for pharmacogenomic assessments domain
proventriculus
ralstonia mannitolilytica
reconstruction of raw data type
refractometry
renin activity measurement
reprogram
rhythm not otherwise specified ecg assessment
scapulohumeral joint
scheduled maintenance
semi - recumbent
single - stranded dna
sinus node rhythm and arrhythmia ecg assessment
slackia exigua
slice number
slow vital capacity
small nucleolar rna
smooth muscle antibody measurement
step unit of distance
supraventricular arrhythmia ecg assessment
supraventricular tachyarrhythmia ecg assessment
surfactant protein d measurement
syrinx
tidal volume
total lung capacity
transmammary route of administration
troponin measurement
turbidimetry
vacuolated lymphocyte count
ventricular arrhythmia ecg assessment
ventricular tachyarrhythmia ecg assessment
volume of distribution for dosing interval
wautersiella falsenii
cdisc questionnaire c - ssrs children's baseline test name terminology
cdisc questionnaire c - ssrs children's baseline test code terminology
cdisc questionnaire c - ssrs children's baseline / screening test name terminology
cdisc questionnaire c - ssrs children's baseline / screening test code terminology
cdisc questionnaire c - ssrs children's since last visit test name terminology
tamoxifen / letrozole regimen
cdisc questionnaire c - ssrs children's since last visit test code terminology
cdisc questionnaire c - ssrs screening test name terminology
cdisc questionnaire c - ssrs screening test code terminology
cdisc questionnaire faq test name terminology
cdisc questionnaire faq test code terminology
cdisc questionnaire faq - nacc version test name terminology
cdisc questionnaire faq - nacc version test code terminology
cdisc questionnaire mrs test name terminology
cdisc questionnaire mrs test code terminology
cdisc questionnaire sds test name terminology
cdisc questionnaire sds test code terminology
c - ssrs children's baseline questionnaire question
c - ssrs children's baseline / screening questionnaire question
c - ssrs children's since last visit questionnaire question
c - ssrs screening questionnaire question
faq questionnaire question
faq - nacc version questionnaire question
mrs questionnaire question
sds questionnaire question
forced expiratory volume in 1 second to forced vital capacity ratio measurement
forced inspiratory volume in 1 second
forced vital capacity
inspiratory capacity
st segment ,  t wave ,  and u wave ecg assessment
volume of distribution for dosing interval by fraction
volume of distribution for dosing interval by fraction normalized by body mass index
volume of distribution for dosing interval by fraction normalized by dose
volume of distribution for dosing interval by fraction normalized by surface area
volume of distribution for dosing interval by fraction normalized by weight
volume of distribution for dosing interval normalized by body mass index
volume of distribution for dosing interval normalized by dose
volume of distribution for dosing interval normalized by surface area
volume of distribution for dosing interval normalized by weight
cyp3a4 inhibitor
cyp3a4 inducer
chlorhexidine gluconate cleansing
control cleansing
columbia - suicide severity rating scale children's baseline questionnaire
columbia - suicide severity rating scale children's baseline / screening questionnaire
columbia - suicide severity rating scale children's since last visit questionnaire
columbia - suicide severity rating scale screening questionnaire
functional activities questionnaire
functional activities questionnaire - nacc version
modified rankin scale questionnaire
sheehan disability scale questionnaire
c - ssrs children's baseline / screening  -  wish to be dead  ( lifetime )
c - ssrs children's baseline / screening  -  wish to be dead  ( past 6 months )
c - ssrs children's baseline / screening  -  description of wish to be dead
c - ssrs children's baseline / screening  -  non - specific active suicidal thoughts  ( lifetime )
c - ssrs children's baseline / screening  -  non - specific active suicidal thoughts  ( past 6 months )
c - ssrs children's baseline / screening  -  description of non - specific active suicidal thoughts
c - ssrs children's baseline / screening  -  active suicidal ideation with any methods  ( not plan )  without intent to act  ( lifetime )
c - ssrs children's baseline / screening  -  active suicidal ideation with any methods  ( not plan )  without intent to act  ( past 6 months )
c - ssrs children's baseline / screening  -  description of active suicidal ideation with any methods  ( not plan )  without intent to act
c - ssrs children's baseline / screening  -  active suicidal ideation with some intent to act ,  without specific plan  ( lifetime )
c - ssrs children's baseline / screening  -  active suicidal ideation with some intent to act ,  without specific plan  ( past 6 months )
c - ssrs children's baseline / screening  -  description of active suicidal ideation with some intent to act ,  without specific plan
c - ssrs children's baseline / screening  -  active suicidal ideation with specific plan and intent  ( lifetime )
c - ssrs children's baseline / screening  -  active suicidal ideation with specific plan and intent  ( past 6 months )
c - ssrs children's baseline / screening  -  description of active suicidal ideation with specific plan and intent
glaucarubolone
c - ssrs children's baseline / screening  -  most severe ideation
c - ssrs children's baseline / screening  -  describe most severe ideation
c - ssrs children's baseline / screening  -  frequency of most severe ideation  ( lifetime )
c - ssrs children's baseline / screening  -  frequency of most severe ideation  ( past 6 months )
c - ssrs children's baseline / screening  -  frequency ,  write response
c - ssrs children's baseline / screening  -  actual suicide attempt
c - ssrs children's baseline / screening  -  number of actual suicide attempts
c - ssrs children's baseline / screening  -  description of actual suicide attempt
c - ssrs children's baseline / screening  -  non - suicidal self - injurious behavior
c - ssrs children's baseline / screening  -  self - injurious behavior ,  intent unknown
c - ssrs children's baseline / screening  -  interrupted suicide attempt
c - ssrs children's baseline / screening  -  number of interrupted suicide attempts
c - ssrs children's baseline / screening  -  description of interrupted suicide attempt
c - ssrs children's baseline / screening  -  aborted suicide attempt
c - ssrs children's baseline / screening  -  number of aborted suicide attempts
c - ssrs children's baseline / screening  -  description of aborted suicide attempt
c - ssrs children's baseline / screening  -  preparatory acts or behaviors toward suicide attempt
c - ssrs children's baseline / screening  -  description of preparatory acts or behaviors toward suicide attempt
c - ssrs children's baseline / screening  -  suicidal behavior
c - ssrs children's baseline / screening  -  most recent suicide attempt date
c - ssrs children's baseline / screening  -  most recent suicide attempt actual lethality / medical damage
c - ssrs children's baseline / screening  -  most recent suicide attempt potential lethality
c - ssrs children's baseline / screening  -  most lethal suicide attempt date
c - ssrs children's baseline / screening  -  most lethal suicide attempt actual lethality / medical damage
c - ssrs children's baseline / screening  -  most lethal suicide attempt potential lethality
c - ssrs children's baseline / screening  -  first suicide attempt date
c - ssrs children's baseline / screening  -  first suicide attempt actual lethality / medical damage
c - ssrs children's baseline / screening  -  first suicide attempt potential lethality
c - ssrs children's since last visit  -  wish to be dead
c - ssrs children's since last visit  -  description of wish to be dead
c - ssrs children's since last visit  -  non - specific active suicidal thoughts
c - ssrs children's since last visit  -  description of non - specific active suicidal thoughts
c - ssrs children's since last visit  -  active suicidal ideation with any methods  ( not plan )  without intent to act
c - ssrs children's since last visit  -  description of active suicidal ideation with any methods  ( not plan )  without intent to act
c - ssrs children's since last visit  -  active suicidal ideation with some intent to act ,  without specific plan
c - ssrs children's since last visit  -  description of active suicidal ideation with some intent to act ,  without specific plan
c - ssrs children's since last visit  -  active suicidal ideation with specific plan and intent
c - ssrs children's since last visit  -  description of active suicidal ideation with specific plan and intent
c - ssrs children's since last visit  -  most severe ideation
c - ssrs children's since last visit  -  describe most severe ideation
c - ssrs children's since last visit  -  frequency of most severe ideation
c - ssrs children's since last visit  -  frequency ,  write response
c - ssrs children's since last visit  -  actual suicide attempt
c - ssrs children's since last visit  -  number of actual suicide attempts
c - ssrs children's since last visit  -  description of actual suicide attempt
c - ssrs children's since last visit  -  non - suicidal self - injurious behavior
c - ssrs children's since last visit  -  self - injurious behavior ,  intent unknown
c - ssrs children's since last visit  -  interrupted suicide attempt
c - ssrs children's since last visit  -  number of interrupted suicide attempts
c - ssrs children's since last visit  -  description of interrupted suicide attempt
c - ssrs children's since last visit  -  aborted or self - interrupted suicide attempt
c - ssrs children's since last visit  -  number of aborted or self - interrupted suicide attempts
c - ssrs children's since last visit  -  description of aborted or self - interrupted suicide attempt
c - ssrs children's since last visit  -  preparatory acts or behaviors toward suicide attempt
c - ssrs children's since last visit  -  description of preparatory acts or behaviors toward suicide attempt
c - ssrs children's since last visit  -  suicidal behavior
c - ssrs children's since last visit  -  suicide
c - ssrs children's since last visit  -  most lethal suicide attempt date
c - ssrs children's since last visit  -  most lethal suicide attempt actual lethality / medical damage
c - ssrs children's since last visit  -  most lethal suicide attempt potential lethality
c - ssrs screening  -  wish to be dead
c - ssrs screening  -  description of wish to be dead
c - ssrs screening  -  non - specific active suicidal thoughts
c - ssrs screening  -  description of non - specific active suicidal thoughts
c - ssrs screening  -  active suicidal ideation with any methods  ( not plan )  without intent to act
c - ssrs screening  -  description of active suicidal ideation with any methods  ( not plan )  without intent to act
c - ssrs screening  -  active suicidal ideation with some intent to act ,  without specific plan
c - ssrs screening  -  description of active suicidal ideation with some intent to act ,  without specific plan
c - ssrs screening  -  active suicidal ideation with specific plan and intent
c - ssrs screening  -  description of active suicidal ideation with specific plan and intent
c - ssrs screening  -  most severe ideation
c - ssrs screening  -  describe most severe ideation
c - ssrs screening  -  frequency of most severe ideation
c - ssrs screening  -  duration of most severe ideation
c - ssrs screening  -  controllability of most severe ideation
c - ssrs screening  -  deterrents to most severe ideation
c - ssrs screening  -  reasons for most severe ideation
c - ssrs screening  -  actual suicide attempt
c - ssrs screening  -  number of actual suicide attempts
c - ssrs screening  -  description of actual suicide attempt
c - ssrs screening  -  non - suicidal self - injurious behavior
c - ssrs screening  -  interrupted suicide attempt
c - ssrs screening  -  number of interrupted suicide attempts
c - ssrs screening  -  description of interrupted suicide attempt
c - ssrs screening  -  aborted suicide attempt
c - ssrs screening  -  number of aborted suicide attempts
c - ssrs screening  -  description of aborted suicide attempt
c - ssrs screening  -  preparatory acts or behaviors toward suicide attempt
c - ssrs screening  -  description of preparatory acts or behaviors toward suicide attempt
c - ssrs screening  -  suicidal behavior
c - ssrs screening  -  most recent suicide attempt date
c - ssrs screening  -  most recent suicide attempt actual lethality / medical damage
c - ssrs screening  -  most recent suicide attempt potential lethality
c - ssrs screening  -  most lethal suicide attempt date
c - ssrs screening  -  most lethal suicide attempt actual lethality / medical damage
c - ssrs screening  -  most lethal suicide attempt potential lethality
c - ssrs screening  -  first suicide attempt date
c - ssrs screening  -  first suicide attempt actual lethality / medical damage
c - ssrs screening  -  first suicide attempt potential lethality
faq  -  write checks ,  pay bills ,  balance checkbook
faq  -  assemble
faq  -  shop alone
faq  -  play game of skill ,  work on hobby
faq  -  heat water ,  make coffee ,  turn off stove
faq  -  prepare a meal
faq  -  keep track of current events
faq  -  pay attention ,  understand ,  discuss
faq  -  remember
faq  -  travel
faq  -  total score
faq - nacc version  -  write checks ,  pay bills ,  balance checkbook
faq - nacc version  -  assemble
faq - nacc version  -  shop alone
faq - nacc version  -  play game of skill ,  work on hobby
faq - nacc version  -  heat water ,  make coffee ,  turn off stove
faq - nacc version  -  prepare a meal
faq - nacc version  -  keep track of current events
faq - nacc version  -  pay attention ,  understand ,  discuss
faq - nacc version  -  remember
faq - nacc version  -  travel
mrs  -  modified rankin scale score
sds  -  symptoms disrupted work / school work
sds  -  not worked / studied in past week for reason unrelated to disorder
sds  -  symptoms disrupted social life / leisure activities
sds  -  symptoms disrupted family life / home responsibilities
sds  -  days lost
sds  -  days unproductive
c - ssrs children's baseline  -  wish to be dead
c - ssrs children's baseline  -  description of wish to be dead
c - ssrs children's baseline  -  non - specific active suicidal thoughts
c - ssrs children's baseline  -  description of non - specific active suicidal thoughts
c - ssrs children's baseline  -  active suicidal ideation with any methods  ( not plan )  without intent to act
c - ssrs children's baseline  -  description of active suicidal ideation with any methods  ( not plan )  without intent to act
c - ssrs children's baseline  -  active suicidal ideation with some intent to act ,  without specific plan
c - ssrs children's baseline  -  description of active suicidal ideation with some intent to act ,  without specific plan
c - ssrs children's baseline  -  active suicidal ideation with specific plan and intent
c - ssrs children's baseline  -  description of active suicidal ideation with specific plan and intent
c - ssrs children's baseline  -  most severe ideation
c - ssrs children's baseline  -  describe most severe ideation
c - ssrs children's baseline  -  frequency of most severe ideation
c - ssrs children's baseline  -  frequency ,  write response
c - ssrs children's baseline  -  actual suicide attempt
c - ssrs children's baseline  -  number of actual suicide attempts
c - ssrs children's baseline  -  description of actual suicide attempt
c - ssrs children's baseline  -  non - suicidal self - injurious behavior
c - ssrs children's baseline  -  self - injurious behavior ,  intent unknown
c - ssrs children's baseline  -  interrupted suicide attempt
c - ssrs children's baseline  -  number of interrupted suicide attempts
c - ssrs children's baseline  -  description of interrupted suicide attempt
c - ssrs children's baseline  -  aborted suicide attempt
c - ssrs children's baseline  -  number of aborted suicide attempts
c - ssrs children's baseline  -  description of aborted suicide attempt
c - ssrs children's baseline  -  preparatory acts or behaviors toward suicide attempt
c - ssrs children's baseline  -  description of preparatory acts or behaviors toward suicide attempt
c - ssrs children's baseline  -  suicidal behavior
c - ssrs children's baseline  -  most recent suicide attempt date
c - ssrs children's baseline  -  most recent suicide attempt actual lethality / medical damage
c - ssrs children's baseline  -  most recent suicide attempt potential lethality
c - ssrs children's baseline  -  most lethal suicide attempt date
c - ssrs children's baseline  -  most lethal suicide attempt actual lethality / medical damage
c - ssrs children's baseline  -  most lethal suicide attempt potential lethality
c - ssrs children's baseline  -  first suicide attempt date
c - ssrs children's baseline  -  first suicide attempt actual lethality / medical damage
c - ssrs children's baseline  -  first suicide attempt potential lethality
multi - drug resistant organism
anti - egfrviii car - transduced allogeneic t - lymphocytes
carbon c 14 - labeled ixazomib
detectable
undetectable
melk inhibitor ots167
nanosomal docetaxel lipid suspension
spanlecortemlocel
carbon c 14 oxaliplatin
enasidenib
mrna - derived lung cancer vaccine bi 1361849
akt 1 / 2 inhibitor bay1125976
fluorine f 18 ski - 249380
dad  -  sub - total initiation
dad  -  total initiation number of applicable items
dad  -  sub - total planning and organization
dad  -  sub - total effective performance
dad  -  sub - total effective performance number of applicable items
dad  -  total score
dad  -  total number of applicable items
dad  -  total percent
updrs  -  motor examination: tremor at rest ,  face ,  lips ,  chin
updrs  -  motor examination: tremor at rest ,  hands ,  right
updrs  -  motor examination: tremor at rest ,  hands ,  left
updrs  -  motor examination: tremor at rest ,  feet ,  right
updrs  -  motor examination: tremor at rest ,  feet ,  left
updrs  -  motor examination: action tremor ,  hand ,  right
updrs  -  motor examination: action tremor ,  hand ,  left
updrs  -  motor examination: rigidity neck
updrs  -  motor examination: rigidity upper extremity ,  right
updrs  -  motor examination: rigidity upper extremity ,  left
updrs  -  motor examination: rigidity lower extremity ,  right
updrs  -  motor examination: rigidity lower extremity ,  left
updrs  -  motor examination: finger taps ,  right
updrs  -  motor examination: finger taps ,  left
updrs  -  motor examination: hand grips ,  right
glycosylphosphatidylinositol
updrs  -  motor examination: hand grips ,  left
updrs  -  motor examination: hand pronate / supinate ,  right
updrs  -  motor examination: hand pronate / supinate ,  left
updrs  -  motor examination: leg agility ,  right
updrs  -  motor examination: leg agility ,  left
updrs  -  symptomatic orthostasis: blood pressure ,  seated
updrs  -  symptomatic orthostasis: blood pressure ,  supine
updrs  -  symptomatic orthostasis: blood pressure ,  standing
updrs  -  symptomatic orthostasis: weight
updrs  -  symptomatic orthostasis: pulse ,  seated
updrs  -  symptomatic orthostasis: pulse ,  standing
updrs  -  schwab and england % adl score  ( pd )
updrs  -  schwab and england % adl  ( with dyskinesia )
updrs  -  mentation ,  behavior and mood sub - total
updrs  -  activities of daily living sub - total
updrs  -  motor examination sub - total
updrs  -  updrs total
dad  -  plan and organize number of applicable items
epstein - barr virus early rna
alk break apart fish probe kit
fact - taxane questionnaire
have numbness or tingling in hands
have numbness or tingling in feet
feel discomfort in hands
feel discomfort in feet
have joint pain or muscle cramps
get ringing or buzzing in ears
have trouble buttoning buttons
have trouble feeling shape of small objects in hand
have trouble walking
feel bloated
hands are swollen
legs or feet are swollen
have pain in fingertips
bothered by look of hands or nails
fact - np questionnaire
difficulty moving neck and shoulders due to stiffness
bothered by ringing in ears
bothered by worsening eyesight
have trouble smelling
can enjoy taste of food
bothered by blocked nose
device embolization
ectopia cordis
hemopericardium
inferior vena cava stenosis
junctional ectopic tachycardia
levocardia
polymorphic ventricular tachycardia
post - pericardiotomy syndrome
prosthetic valve dysfunction
pulmonary vein obstruction
vascular shunt thrombosis
superior vena cava stenosis
venous embolism
ventricular dysfunction
twin reversed arterial perfusion sequence malformation
desquamation
rigor
poor weight gain
spl equivalence codes terminology
spl contributing factor - general terminology
no problems walking
some problems walking
confined to bed
no problems with self - care
some problems with washing and dressing
unable to wash or dress
no problems performing usual activities
some problems performing usual activities
unable to perform usual activities
no pain or discomfort
moderate pain or discomfort
extreme pain or discomfort
not anxious or depressed
moderately anxious or depressed
extremely anxious or depressed
health state thermometer scale
worst imaginable health
best imaginable health
sorghum bicolor supplement
fluorine f 18 5 - fluoro - 2 - deoxycytidine
mart - 1 reactive cd8 +  t - lymphocytes
imisopasem manganese
alk - fak inhibitor cep - 37440
rice bran
navy bean powder
liposomal hpv - 16 e6 / e7 multipeptide vaccine pds0101
hla - a*0201 restricted tert ( 572y )  / tert ( 572 )  peptides vaccine vx - 001
immunoglobulin heavy chain locus variable region mutation
glioblastoma by gene expression profile
proneural glioblastoma
neural glioblastoma
classical glioblastoma
mesenchymal glioblastoma
your health state today
medical outcomes study your feelings questionnaire
how happy ,  satisfied ,  or pleased are you with your personal life
radionuclide specific activity
glycyrrhizin
how often did you feel there were people you were close to
how often has feeling depressed interfered with what you usually do
how much of the time
did you have difficulty reasoning and solving problems
have you generally enjoyed the things you do
have you had reason to wonder if you were losing your mind ,  or losing control over the way you act ,  talk ,  think ,  feel ,  or of your memory
has your daily life been full of things that were interesting to you
have you felt loved and wanted
have you been a very nervous person
did you have difficulty doing activities involving concentration and thinking
have you been in firm control of your behavior ,  thoughts ,  emotions ,  and feelings
did you become confused and start several actions at a time
did you feel that you had nothing to look forward to
have you felt calm and peaceful
have you felt emotionally stable
have you felt downhearted and blue
have you felt like crying
feel left out
did you forget things that happened recently or where you put things or appointments
did you feel that others would be better off if you were dead
did you feel that your love relationships were full and complete
have you been bothered by nervousness or your nerves
has living been a wonderful adventure
have you felt so down in the dumps that nothing could cheer you up
did you ever think about taking your own life
have you felt restless ,  fidgety ,  or impatient
have you been moody or brooded about things
did you get rattled ,  upset ,  or flustered
did you have trouble keeping your attention on any activity for long
have you been anxious or worried
have you been a happy person
did you find yourself having difficulty trying to calm down
have you been in low or very low spirits
have you felt cheerful or lighthearted
how depressed have you felt at its worst
did you react slowly to things that were said or done
feel isolated from others
adverse event emergency room visit
adverse event doctor visit
extremely happy
very happy
generally satisfied or pleased
sometimes fairly satisfied
generally dissatisfied and unhappy
very dissatisfied and unhappy
a good bit of the time
not enough to be concerned or worried
a little concerned
quite concerned
very much concerned
extremely bothered
bothered very much
bothered quite a bit
bothered some
bothered a little
not bothered at all
absent fetal heart rate variability
mercaptopurine oral suspension
mitochondrial oxidative phosphorylation inhibitor atr - 101
activated marrow infiltrating lymphocytes
fentanyl citrate - containing nasal spray
jak inhibitor incb047986
triptolide analog
carbon c 14 selumetinib
selatinib ditosilate
marked baseline fetal heart rate variability
fetal arrhythmia
minimal baseline fetal heart rate variability
sinusoidal fetal heart rate pattern
fetal tachyarrhythmia
fetal bradyarrhythmia
normal continuous cardiotocography pattern
indeterminate continuous cardiotocography pattern
abnormal continuous cardiotocography pattern
fetal heart rate pattern
periodic fetal heart rate pattern
episodic fetal heart rate pattern
moderate baseline fetal heart rate variability
recurrent variable fetal heart rate deceleration
ductus venosus agenesis
antepartum obstetric air embolism
postpartum obstetric air embolism
antepartum obstetric septic embolism
antepartum obstetric thromboembolism
done
ductopenia
ductal or ductular proliferation
concentric fibrosis of intrahepatic duct
minimal response of multiple myeloma
inv ( 3 )
lamin b
pgp gene
pgp wt allele
phosphoglycolate phosphatase
notch receptor intracellular domain
tnfrsf13c gene
tnfrsf13c wt allele
tumor necrosis factor receptor superfamily member 13c
eighteen
tg3 antibody
gossypol acetic acid
six2 gene
il7 antibody
dyskeratosis congenita
six2 wt allele
homeobox protein six2
six4 gene
mart1 antibody
six4 wt allele
ctag2 antibody
nlrp4 antibody
homeobox protein six4
tsga10 antibody
six5 gene
six5 wt allele
griscelli syndrome type 2
shakes
homeobox protein six5
hyperpyrexia
ctcfl gene
ctcfl wt allele
slc2a3p1 gene
htc2 gene
adh1c gene
transcriptional repressor ctcfl
adh1c wt allele
emsy gene
alcohol dehydrogenase 1c
emsy wt allele
protein emsy
adh4 gene
lrp1b gene
adh4 wt allele
lrp1b wt allele
alcohol dehydrogenase 4
low - density lipoprotein receptor - related protein 1b
prkcg gene
prkcg wt allele
protein kinase c gamma type
ndrg4 gene
ndrg4 wt allele
protein ndrg4
epha7 gene
tfpi2 gene
epha7 wt allele
ephrin type - a receptor 7
tfpi2 wt allele
tissue factor pathway inhibitor 2
slc38a3 gene
slc38a3 wt allele
sodium - coupled neutral amino acid transporter 3
zmynd10 gene
zmynd10 wt allele
zinc finger mynd domain - containing protein 10
sudden unexplained infant death
sudden unexplained death in childhood
neonatal neutropenia
disseminated intravascular coagulation in newborn
hemorrhagic disease of newborn
direct maternal death
indirect maternal death
maternal mortality
postpartum obstetric septic embolism
dusp5 gene
dusp5 wt allele
dual specificity protein phosphatase 5
postpartum obstetric thromboembolism
krt18 gene
krt18 wt allele
keratin ,  type i cytoskeletal 18
sec14l1 gene
sec14l1 wt allele
sec14 - like protein 1
alas1 gene
alas1 wt allele
5 - aminolevulinate synthase ,  nonspecific ,  mitochondrial
atoh1 gene
atoh1 wt allele
protein atonal homolog 1
dkk2 gene
dkk2 wt allele
dickkopf - related protein 2
dkk4 gene
dkk4 wt allele
dickkopf - related protein 4
exanthem
dermatographism
diaper dermatitis
candida diaper dermatitis
seborrheic dermatitis
naranjo adverse drug reaction probability scale
objective evidence
carbon c 14 telotristat etiprate
peg - proline - interferon alfa - 2b
oncolytic herpes simplex virus - 1 - encoding gm - csf
donor regulatory t - lymphocytes
pyrotinib
olive oil / soya oil / egg lecithin - based emulsion
yangzheng xiaoji extract
bimiralisib
liposomal eribulin mesylate
ondansetron
autologous melanoma lysate / ny - eso - 1 - pulsed autologous dendritic cell vaccine
bet inhibitor cpi - 0610
lenti - d / abcd1 - transduced autologous hematopoietic stem cells
cmvpp65 / gb plasmid vaccine asp0113
immune hydrops fetalis
non - immune hydrops fetalis
laprituximab emtansine
ho / 02 / 02
angiotensin converting enzyme inhibitor fetopathy
diabetic fetopathy
fetal virilization
amniotic fluid embolism
chromatin assembly factor i
pre - gestational diabetes
postpartum endometritis
severe sepsis
nlrp4 gene
nlrp4 wt allele
nacht ,  lrr and pyd domains - containing protein 4
nlrp2 gene
nlrp2 wt allele
nacht ,  lrr and pyd domains - containing protein 2
tsga10 gene
tsga10 wt allele
testis - specific gene 10 protein
cftr gene
cftr wt allele
cystic fibrosis transmembrane conductance regulator
ubr5 gene
ubr5 wt allele
e3 ubiquitin - protein ligase ubr5
rnf130 gene
rnf130 wt allele
e3 ubiquitin - protein ligase rnf130
mkrn1 gene
mkrn1 wt allele
e3 ubiquitin - protein ligase makorin - 1
qki gene
qki wt allele
protein quaking
nacc2 gene
nacc2 wt allele
nucleus accumbens - associated protein 2
clinical chorioamnionitis
histologic chorioamnionitis
deciduitis
group b streptococcus risk
positive gbs risk status
negative gbs risk status
unknown gbs risk status
pregnancy with intrauterine device
nulliparous
clcn6 gene
clcn6 wt allele
chloride transport protein 6
epc1 gene
epc1 wt allele
triplet pregnancy
enhancer of polycomb homolog 1
quadruplet pregnancy
meaf6 gene
meaf6 wt allele
chromatin modification - related protein meaf6
neurodermatitis
sustained engraftment
sustained engraftment at day 100
primary graft failure after hematopoietic cell transplantation
pustular eruption
secondary graft failure after hematopoietic cell transplantation
skin vesicle
folfox regimen
bulla
annular lesion
targetoid lesion
mbtd1 gene
lichenification
mbtd1 wt allele
mbt domain - containing protein 1
ezhip gene
ezhip wt allele
ezh inhibitory protein
zc3h7b gene
zc3h7b wt allele
zinc finger ccch domain - containing protein 7b
haploidentical
pump dosing unit
time of flight
fixed drug eruption
skin fissure
fgfr inhibitor debio 1347
autologous ic9 - gd2 - car - expressing vzv - specific t lymphocytes
polo - like kinase 4 inhibitor cfi - 400945 fumarate
autologous gm - csf - secreting lethally irradiated colorectal cancer cell vaccine
tgfbdnrii - transduced autologous tumor infiltrating lymphocytes
ceralasertib
encequidar
anti - slitrk6 monoclonal antibody - mmae conjugate ags15e
autologous cultured acute myeloid leukemia - specific cytotoxic t lymphocytes
anti - her3 monoclonal antibody gsk2849330
live - attenuated listeria monocytogenes - encoding egfrviii - ny - eso - 1 vaccine adu - 623
relatlimab
halofuginone
oraxol
ladiratuzumab vedotin
cebranopadol
neoantigen - based melanoma - poly - iclc vaccine
p70s6k / akt inhibitor msc2363318a
adenovirus 5 - human guanylyl cyclase c - padre vaccine
thymoma by masaoka - koga stage
masaoka - koga stage i
masaoka - koga stage iia
masaoka - koga stage iib
masaoka - koga stage iii
masaoka - koga stage iva
masaoka - koga stage ivb
myasthenia classification system
myasthenia class i
myasthenia class ii
myasthenia class iii
myasthenia class iv
myasthenia class v
surgical site infection
superficial incision
deep incision
surgical organ or space
cdisc sdtm skin response test name terminology
cdisc sdtm skin response test code terminology
reoviridae
rhabdoviridae
bunyaviridae
sapovirus
alphavirus
filoviridae
amount recovered infinity observed
amount recovered infinity predicted
percent recovered infinity observed
percent recovered infinity predicted
dengue virus
cdisc sdtm device tracking and disposition event dictionary derived term terminology
trial indication
recent thymic emigrant
anthocyanin
urolithin
prostaglandin e2
tn antigen
replication competent retrovirus
furanocoumarin
glucosinolate
delta13c
succinate dehydrogenase
3 - hydroxyacyl - coa dehydrogenase
carboxylesterase
macrophage inflammatory protein
casc1 gene
casc1 wt allele
bcg antibody
protein casc1
psa antibody
acpp antibody
folh1 antibody
psca antibody
cflar gene product
washc5 gene
washc5 wt allele
casp8 and fadd - like apoptosis regulator isoform 2
wash complex subunit strumpellin
stip1 gene
stip1 wt allele
stress - induced - phosphoprotein 1
cthrc1 gene
cthrc1 wt allele
collagen triple helix repeat - containing protein 1
gstm3 gene
gstm3 wt allele
glutathione s - transferase mu 3
psmb8 gene
psmb8 wt allele
proteasome subunit beta type - 8
psmb10 gene
psmb10 wt allele
proteasome subunit beta type - 10
slc44a1 gene
slc44a1 wt allele
choline transporter - like protein 1
lpar3 gene
lpar3 wt allele
lysophosphatidic acid receptor 3
intent to compound 506e drug
fam49b gene
fam49b wt allele
protein fam49b
no intent to compound 506e drug
compounding from bulk ingredient
not compounding from bulk ingredient
compounding sterile product
not compounding sterile product
utp23 gene
utp23 wt allele
rrna - processing protein utp23 homolog
canx gene
hc - toxin
docetaxel / epirubicin regimen
canx wt allele
akr1a1 gene
akr1a1 wt allele
calnexin
alcohol dehydrogenase  [ nadp (  +  )  ]
keap1 gene
keap1 wt allele
kelch - like ech - associated protein 1
ptges gene
ptges wt allele
skin sloughing
prostaglandin e synthase
panniculitis
human drug compounding outsourcing facility
skin necrosis
chronic decubitus
eosinophilic fasciitis
vascular malformation
pdia3 gene
umbilical granuloma
pdia3 wt allele
protein disulfide - isomerase a3
acute generalized exanthematous pustulosis
lgals9 gene
pseudoporphyria
lgals9 wt allele
galectin - 9
dusp4 gene
dusp4 wt allele
dual specificity protein phosphatase 4
myh1 gene
myh1 wt allele
myosin - 1
myh2 gene
myh2 wt allele
myosin - 2
l1cam gene
l1cam wt allele
neural cell adhesion molecule l1
tapbp gene
tapbp wt allele
tapasin
vasp gene
vasp wt allele
vasodilator - stimulated phosphoprotein
lor gene
lor wt allele
loricrin
flg gene
flg wt allele
filaggrin
krt10 gene
krt10 wt allele
keratin ,  type i cytoskeletal 10
c1galt1 gene
c1galt1 wt allele
glycoprotein - n - acetylgalactosamine 3 - beta - galactosyltransferase 1
c1galt1c1 gene
c1galt1c1 wt allele
c1galt1 - specific chaperone 1
type 0: not a combination product
worst severity past seven days insomnia
worst severity past seven days vomiting
worst severity past seven days palmar - plantar erythrodysthesia
worst severity past seven days decreased appetite
worst severity past seven days mouth or throat sores
worst severity past seven days nausea
past seven days insomnia interfering with usual or daily activities
past seven days palmar - plantar erythrodysthesia interfering with usual or daily activities
past seven days decreased appetite interfering with usual or daily activities
past seven days frequency of vomiting
past seven days frequency of diarrhea
past seven days frequency of nausea
past seven days rash
skin bruise
angioedema
blanching
hdac inhibitor cxd101
fluorine f 18 galacto - rgd peptide
anti - cd19 - car - cd3zeta - 4 - 1bb - expressing allogenic natural killer cells
docetaxel / doxorubicin regimen
acral erythema
tinea infection
toxic erythema of chemotherapy
blepharitis
have pain other than everyday kind of pain
pain at its least
pain right now
treatment or medication received for pain
how much relief received from treatment or medication
bulbar conjunctivitis
hidradenitis
pain interferes with general activity
pain interferes with mood
pain interferes with walking ability
pain interferes with relations with other people
pain interferes with sleep
pain interferes with enjoyment of life
enanthem
angular cheilitis
glossitis
recombinant hepatocyte growth factor
telogen effluvium
polymorphous light eruption
red man syndrome
drug induced cutaneous lupus erythematosus
drug induced cutaneous vasculitis
rogaratinib
autologous tumor cell proteoliposome chronic lymphocytic leukemia vaccine
bivalent hpv16 / 18 therapeutic cervical cancer vaccine
drug hypersensitivity syndrome
anticonvulsant hypersensitivity syndrome
cutaneous vasculitis
neutrophilic eccrine hidradenitis
onycholysis
onychodystrophy
onychomycosis
paronychial inflammation
pain relief
5 - hydroxyindoleacetic acid measurement
absolute change from nadir in sum of diameter
active ghrelin measurement
aggrecan chondroitin sulfate epitope 846 measurement
allergen skin response index
allergen skin response intensity
amount recovered infinity observed normalized by body mass index
amount recovered infinity observed normalized by surface area
amount recovered infinity observed normalized by weight
amount recovered infinity predicted normalized by body mass index
amount recovered infinity predicted normalized by surface area
amount recovered infinity predicted normalized by weight
aphthovirus
arbovirus
astroviridae
barmah forest virus
breast fed indicator
bulbospongiosus
capillary blood
chemokine  ( c - c motif )  ligand 17 measurement
chemokine  ( c - c motif )  ligand 18 measurement
chemokine  ( c - x - c motif )  ligand 10 measurement
coagulation index measurement
colorado tick fever virus
count of unspecified cells
coxsackie a virus
coxsackie b virus
day times femtogram per milliliter per gram
day times femtogram per milliliter per kilogram
day times gram per milliliter per gram
day times gram per milliliter per kilogram
day times microgram per milliliter per gram
day times microgram per milliliter per kilogram
day times micromole per liter per gram
day times micromole per liter per kilogram
day times milligram per milliliter per gram
day times milligram per milliliter per kilogram
day times millimole per liter per gram
day times millimole per liter per kilogram
day times mole per liter per gram
day times mole per liter per kilogram
day times nanogram per milliliter per gram
day times nanogram per milliliter per kilogram
day times nanomole per liter per gram
day times nanomole per liter per kilogram
day times picogram per milliliter per gram
day times picogram per milliliter per kilogram
day times picomole per liter per gram
day times picomole per liter per kilogram
dengue virus 1
dengue virus 2
dengue virus 3
dengue virus 4
destroyed medical device
ebola virus
echovirus
epidermal growth factor receptor measurement
estrogen receptor measurement
experimental organism benign polyp
experimental organism benign seminoma
factor xiii measurement
fda device classification
fda unique device identifier
fibroblast growth factor 21 measurement
antigenic skin flare longest diameter
antigenic skin flare mean diameter
antigenic skin flare size
flow microscopy
forced expiratory volume in 1 second reversibility
ghrelin measurement
hemodialysis clearance
hemoglobin c crystals measurement
hendra virus
henipavirus
soluble her2 antigen measurement
herpes simplex virus 6 antibody measurement
histone 1 antibody measurement
histone 2a antibody measurement
histone 2b antibody measurement
histone 3 antibody measurement
histone 4 antibody measurement
hour times femtogram per milliliter per gram
hour times femtogram per milliliter per kilogram
hepsulfam
hour times gram per milliliter per gram
hour times gram per milliliter per kilogram
hour times microgram per milliliter per gram
hour times microgram per milliliter per kilogram
hour times micromole per liter per kilogram
hour times milligram per milliliter per gram
hour times milligram per milliliter per kilogram
hour times millimole per liter per kilogram
hour times mole per liter per kilogram
hour times nanomole per liter per kilogram
hour times picogram per milliliter per gram
hour times picomole per liter per kilogram
human epidermal growth factor receptor 2 measurement
human herpesvirus 2
human herpesvirus 5
human herpesvirus 7
human parainfluenza virus 2
human parainfluenza virus 3
human parainfluenza virus 4
hyaluronic acid measurement
immunogenicity specimen assessments domain
inspiratory capacity reversibility
insulin - like growth factor binding protein 3 measurement
interleukin 1 beta measurement
interleukin 1 receptor antagonist measurement
intermediate density lipoprotein cholesterol measurement
jc virus antibody measurement
l2 - l3 intervertebral space
l3 - l4 intervertebral space
lost medical device
lyssavirus
marburgvirus
material pore size
maximum forced inspiratory flow
minute times femtogram per milliliter per gram
minute times femtogram per milliliter per kilogram
minute times gram per milliliter per gram
minute times gram per milliliter per kilogram
minute times microgram per milliliter per gram
minute times microgram per milliliter per kilogram
minute times micromole per liter per gram
minute times micromole per liter per kilogram
minute times milligram per milliliter per gram
minute times milligram per milliliter per kilogram
minute times millimole per liter per gram
minute times millimole per liter per kilogram
minute times mole per liter per gram
minute times mole per liter per kilogram
minute times nanogram per milliliter per gram
minute times nanogram per milliliter per kilogram
minute times nanomole per liter per gram
minute times nanomole per liter per kilogram
minute times picogram per milliliter per gram
minute times picogram per milliliter per kilogram
minute times picomole per liter per gram
minute times picomole per liter per kilogram
molluscipoxvirus
molluscum contagiosum virus
nairovirus
nipah virus
nitric oxide measurement
non - study device issue
norovirus
norwalk virus
number of coil channels
orbivirus
orthobunyavirus
parapoxvirus
peak expiratory flow reversibility
percent change from baseline in sum of area
percent change from baseline in sum of diameter
percent change from baseline in sum of longest diameter
percent change from baseline in sum of volume
percent change from nadir in sum of diameter
percent change from nadir in sum of longest diameter
percent predicted expiratory reserve volume
percent predicted forced expiratory volume in 1 second
percent predicted forced expiratory volume in 1 second divided by forced vital capacity
percent predicted forced expiratory volume in 6 seconds
percent predicted forced inspiratory flow maximum
percent predicted forced inspiratory volume in 1 second
percent predicted forced vital capacity
percent predicted inspiratory capacity
percent predicted inspiratory reserve volume
percent predicted peak expiratory flow
percent predicted residual volume
percent predicted slow vital capacity
percent predicted tidal volume
percent predicted total lung capacity
percent recovered infinity observed normalized by body mass index
percent recovered infinity observed normalized by surface area
percent recovered infinity observed normalized by weight
percent recovered infinity predicted normalized by body mass index
percent recovered infinity predicted normalized by surface area
percent recovered infinity predicted normalized by weight
periostin measurement
perivenous route of administration
phlebovirus
pneumovirus
precuneus
herbimycin
premature birth indicator
pseudocowpox virus
qtcb shortened
qtcf shortened
quadrate lobe of liver
rabies virus
reagent lot number
rhinovirus a
rhinovirus b
rhinovirus c
roseolovirus
ross river virus
rubeola igg antibody measurement
rubeola igm antibody measurement
rubivirus
sapporo virus
signal amplitude
signal frequency
signal width
herpes simplex virus
skin response domain
surgical mesh open area
tick - borne encephalitis virus
torr
twin type
tympanic bulla
varicellovirus
wheal longest diameter
wheal mean diameter
wheal size
levator ani / bulbospongiosus
oncogenicity
sars coronavirus
shockwave dosing unit
cdisc questionnaire aq20 test name terminology
cdisc questionnaire aq20 test code terminology
cdisc clinical classification ds test name terminology
cdisc clinical classification ds test code terminology
cdisc clinical classification edss test name terminology
cdisc clinical classification edss test code terminology
cdisc questionnaire fams test name terminology
cdisc questionnaire fams test code terminology
cdisc questionnaire kfss test name terminology
cdisc questionnaire kfss test code terminology
cdisc questionnaire mhis - nacc test name terminology
cdisc questionnaire mhis - nacc test code terminology
cdisc questionnaire pdds test name terminology
cdisc questionnaire pdds test code terminology
cdisc questionnaire sgrq past 3 months version test name terminology
cdisc questionnaire sgrq past 3 months version test code terminology
cdisc questionnaire sgrq past 4 weeks version test name terminology
cdisc questionnaire sgrq past 4 weeks version test code terminology
cdisc questionnaire vfq25 - interviewer administered format test name terminology
cdisc questionnaire vfq25 - interviewer administered format test code terminology
cdisc questionnaire vfq25 - self administered format test name terminology
cdisc questionnaire vfq25 - self administered format test code terminology
aq20 questionnaire question
ds clinical classification question
edss clinical classification question
fams questionnaire question
kfss questionnaire question
mhis - nacc questionnaire question
pdds questionnaire question
st george's respiratory questionnaire past 3 months version questionnaire question
st george's respiratory questionnaire past 4 weeks version questionnaire question
vfq25 - interviewer administered format questionnaire question
vfq25 - self administered format questionnaire question
cows  -  resting pulse rate: beats / minute
cows  -  total score
npi  -  delusions fxs score
npi  -  hallucinations fxs score
npi  -  agitation / aggression fxs score
npi  -  depression / dysphoria fxs score
npi  -  anxiety fxs score
npi  -  elation / euphoria fxs score
npi  -  apathy / indifference fxs score
npi  -  disinhibition fxs score
npi  -  irritability / lability fxs score
npi  -  aberrant motor behavior fxs score
npi  -  sleep / night behavior disorder fxs score
npi  -  appetite / eating disorders fxs score
npi  -  npi total score
npi  -  npi total distress score
mir22 gene
mir22 wt allele
mir22 pre - mirna
p2ry2 gene
p2ry2 wt allele
p2y purinoceptor 2
ccser1 gene
ccser1 wt allele
serine - rich coiled - coil domain - containing protein 1
ucp1 gene
ucp1 wt allele
mitochondrial brown fat uncoupling protein 1
autologous lymphoid effector cells specific against tumor cells
fluorine f 18 fdht
pi3k / mtor kinase inhibitor vs - 5584
extended release flucytosine
cetuximab - irdye 800cw
hexamethylene bisacetamide
bet inhibitor ro6870810
dgka gene
dgka wt allele
diacylglycerol kinase alpha
msr1 gene
msr1 wt allele
daylight - savings time
macrophage scavenger receptor types i and ii
water bath
electric warmer
nr5a2 gene
nr5a2 wt allele
nuclear receptor subfamily 5 group a member 2
npr1 gene
npr1 wt allele
atrial natriuretic peptide receptor 1
endoscopic ultrasound biopsy
ultrasound - guided transesophageal endoscopic fine - needle aspiration
airway questionnaire 20
disease steps clinical classification
eniluracil / 5 - fu combination tablet
kurtzke expanded disability status scale clinical classification
functional assessment of multiple sclerosis questionnaire
kurtzke functional systems scores questionnaire
modified hachinski ischemic scale - nacc version questionnaire
patient determined disease steps questionnaire
st . george's respiratory questionnaire past 3 months version
st . george's respiratory questionnaire past 4 weeks version
visual functioning questionnaire 25 - interviewer administered format version 2000
visual functioning questionnaire 25 - self administered format version 2000
aq20  -  cough often during the day
aq20  -  chest trouble make you feel restless
aq20  -  gardening make you breathless
aq20  -  worry when going to friend house something will upset your chest
aq20  -  get chest problems when contact with strong smells
aq20  -  partner find your chest trouble upsetting
aq20  -  feel breathless when trying to sleep
aq20  -  worry about long term effects of drugs for chest trouble
aq20  -  getting emotionally upset make chest trouble worse
aq20  -  difficulty getting around the house because of chest trouble
aq20  -  chest problem make you breathless at work
aq20  -  walking upstairs make you breathless
aq20  -  get breathless doing housework
aq20  -  chest trouble make you go home sooner than others
aq20  -  suffer from breathlessness when laugh
aq20  -  chest trouble make you feel impatient
aq20  -  fullness of life is limited by chest trouble
aq20  -  feel drained after a cold because of chest trouble
aq20  -  feeling of chest heaviness
aq20  -  worry a lot about chest trouble
ds  -  disease steps classification
edss  -  expanded disability score
fams  -  have trouble meeting needs of family because of my condition
fams  -  i am able to work
fams  -  i have trouble walking
fams  -  limit social activity because of condition
fams  -  i have strength in my legs
fams  -  trouble getting around in public places
fams  -  have to take condition into account when making plans
fams  -  i have nausea
fams  -  i have pain
fams  -  i feel ill
fams  -  i feel weak all over
fams  -  i have pain in my joints
fams  -  bothered by headaches
fams  -  bothered by muscle pains
fams  -  i feel sad
fams  -  losing hope in fight against my illness
fams  -  i am able to enjoy life
fams  -  feel trapped by my condition
fams  -  depressed about my condition
fams  -  i feel useless
fams  -  feel overwhelmed by my condition
fams  -  my work is fulfilling
fams  -  i have accepted my illness
fams  -  enjoying things i usually do for fun
fams  -  content with quality of my life now
fams  -  i am frustrated by my condition
fams  -  feel sense of purpose in my life
fams  -  feel motivated to do things
fams  -  have a lack of energy
fams  -  i feel tired
fams  -  trouble starting things because i am tired
fams  -  trouble finishing things because i am tired
fams  -  need to rest during the day
fams  -  trouble remembering things
fams  -  trouble concentrating
fams  -  my thinking is slower than before
fams  -  trouble learning new tasks or directions
fams  -  feel close to my friends
fams  -  get emotional support from family
fams  -  get support from friends
fams  -  family has accepted my illness
fams  -  satisfied with family communication about my illness
fams  -  family has trouble understanding when my condition gets worse
fams  -  feel left out of things
fams  -  bothered by side effects of treatment
fams  -  forced to spend time in bed
fams  -  feel close to my partner
fams  -  satisfied with my sex life
fams  -  satisfied with how i am coping with illness
haemophilus influenzae b vaccine
fams  -  i feel nervous
fams  -  worry my condition will get worse
fams  -  i am sleeping well
fams  -  heat worsens my symptoms
fams  -  trouble controlling my urine
fams  -  urinate more frequently than usual
fams  -  bothered by chills
fams  -  bothered by fevers
fams  -  bothered by muscle spasms
kfss  -  pyramidal functions
kfss  -  cerebellar functions
kfss  -  weakness interferes with testing
kfss  -  brain stem functions
kfss  -  sensory functions
kfss  -  bowel and bladder functions
kfss  -  visual  ( or optic )  functions
kfss  -  presence of temporal pallor
kfss  -  cerebral  ( or mental )  functions
mhis - nacc  -  abrupt onset
mhis - nacc  -  stepwise deterioration
mhis - nacc  -  emotional incontinence
mhis - nacc  -  history or presence of hypertension
mhis - nacc  -  history of stroke
mhis - nacc  -  focal neurological symptoms
mhis - nacc  -  focal neurological signs
mhis - nacc  -  total score
pdds  -  category describing situation
sgrq past 3 months version  -  describe your current health
sgrq past 3 months version  -  i have coughed
sgrq past 3 months version  -  i have brought up phlegm
sgrq past 3 months version  -  i have had shortness of breath
sgrq past 3 months version  -  i have had wheezing attacks
sgrq past 3 months version  -  times suffered from severe respiratory attacks
sgrq past 3 months version  -  how long did worst respiratory attack last
sgrq past 3 months version  -  how many good days you had
sgrq past 3 months version  -  wheeze worse when get up in the morning
sgrq past 3 months version  -  describe your respiratory condition
sgrq past 3 months version  -  held a job
sgrq past 3 months version  -  sitting or lying still
sgrq past 3 months version  -  washing or dressing yourself
sgrq past 3 months version  -  walking around the house
sgrq past 3 months version  -  walking outside on level ground
sgrq past 3 months version  -  walking up a flight of stairs
sgrq past 3 months version  -  walking up hills
sgrq past 3 months version  -  playing sports or other physical activities
sgrq past 3 months version  -  coughing hurts
sgrq past 3 months version  -  coughing makes me tired
sgrq past 3 months version  -  short of breath when i talk
sgrq past 3 months version  -  short of breath when bend over
sgrq past 3 months version  -  coughing disturbs my sleep
sgrq past 3 months version  -  i get exhausted easily
sgrq past 3 months version  -  my cough is embarrassing in public
sgrq past 3 months version  -  respiratory problems a nuisance to family
sgrq past 3 months version  -  get afraid when cannot catch my breath
sgrq past 3 months version  -  not in control of my respiratory problems
sgrq past 3 months version  -  not expect respiratory problems get better
sgrq past 3 months version  -  become frail or invalid because of my respiratory problems
sgrq past 3 months version  -  exercise is not safe for me
sgrq past 3 months version  -  everything too much effort
sgrq past 3 months version  -  treatment does not help me much
etoposide / ifosfamide / mesna regimen
sgrq past 3 months version  -  embarrassed using medication in public
sgrq past 3 months version  -  unpleasant side effects from medication
sgrq past 3 months version  -  treatment interferes with my life
sgrq past 3 months version  -  take long time to get washed or dressed
sgrq past 3 months version  -  cannot take a bath or shower
sgrq past 3 months version  -  walk slower than other people my age
sgrq past 3 months version  -  jobs take long time or i have to stop
sgrq past 3 months version  -  if walk up one flight of stairs i have to go slow
sgrq past 3 months version  -  if walk fast i have to stop or slow down
sgrq past 3 months version  -  breathing makes difficult to walk up hills
sgrq past 3 months version  -  breathing makes difficult to carry heavy loads
sgrq past 3 months version  -  breathing makes difficult to do heavy manual work
sgrq past 3 months version  -  cannot play sports or do physical activities
sgrq past 3 months version  -  cannot go out for entertainment
sgrq past 3 months version  -  cannot go out to do shopping
sgrq past 3 months version  -  cannot do household chores
sgrq past 3 months version  -  cannot move far from bed or chair
sgrq past 3 months version  -  how respiratory problems affect you
sgrq past 4 weeks version  -  describe your current health
sgrq past 4 weeks version  -  i have coughed
sgrq past 4 weeks version  -  i have brought up phlegm
sgrq past 4 weeks version  -  i have had shortness of breath
sgrq past 4 weeks version  -  i have had wheezing attacks
sgrq past 4 weeks version  -  times suffered from severe respiratory attacks
sgrq past 4 weeks version  -  how long did worst respiratory attack last
sgrq past 4 weeks version  -  how many good days you had
sgrq past 4 weeks version  -  wheeze worse when get up in the morning
sgrq past 4 weeks version  -  describe your respiratory condition
sgrq past 4 weeks version  -  held a job
sgrq past 4 weeks version  -  sitting or lying still
sgrq past 4 weeks version  -  washing or dressing yourself
sgrq past 4 weeks version  -  walking around the house
sgrq past 4 weeks version  -  walking outside on level ground
sgrq past 4 weeks version  -  walking up a flight of stairs
sgrq past 4 weeks version  -  walking up hills
sgrq past 4 weeks version  -  playing sports or other physical activities
sgrq past 4 weeks version  -  coughing hurts
sgrq past 4 weeks version  -  coughing makes me tired
sgrq past 4 weeks version  -  short of breath when i talk
sgrq past 4 weeks version  -  short of breath when bend over
omacetaxine mepesuccinate
sgrq past 4 weeks version  -  coughing disturbs my sleep
sgrq past 4 weeks version  -  i get exhausted easily
sgrq past 4 weeks version  -  my cough is embarrassing in public
sgrq past 4 weeks version  -  respiratory problems a nuisance to family
sgrq past 4 weeks version  -  get afraid when cannot catch my breath
sgrq past 4 weeks version  -  not in control of my respiratory problems
sgrq past 4 weeks version  -  not expect respiratory problems get better
sgrq past 4 weeks version  -  become frail or invalid because of my respiratory problems
sgrq past 4 weeks version  -  exercise is not safe for me
sgrq past 4 weeks version  -  everything too much effort
sgrq past 4 weeks version  -  treatment does not help me much
sgrq past 4 weeks version  -  embarrassed using medication in public
sgrq past 4 weeks version  -  unpleasant side effects from medication
sgrq past 4 weeks version  -  treatment interferes with my life
sgrq past 4 weeks version  -  take long time to get washed or dressed
sgrq past 4 weeks version  -  cannot take a bath or shower
sgrq past 4 weeks version  -  walk slower than other people my age
sgrq past 4 weeks version  -  jobs take long time or i have to stop
sgrq past 4 weeks version  -  if walk up one flight of stairs i have to go slow
sgrq past 4 weeks version  -  if walk fast i have to stop or slow down
sgrq past 4 weeks version  -  breathing makes difficult to walk up hills
sgrq past 4 weeks version  -  breathing makes difficult to carry heavy loads
sgrq past 4 weeks version  -  breathing makes difficult to do heavy manual work
sgrq past 4 weeks version  -  cannot play sports or do physical activities
sgrq past 4 weeks version  -  cannot go out for entertainment
sgrq past 4 weeks version  -  cannot go out to do shopping
sgrq past 4 weeks version  -  cannot do household chores
sgrq past 4 weeks version  -  cannot move far from bed or chair
sgrq past 4 weeks version  -  how respiratory problems affect you
vfq25 - interviewer administered format  -  overall health
vfq25 - interviewer administered format  -  eyesight using both eyes
vfq25 - interviewer administered format  -  time spent worry about eyesight
vfq25 - interviewer administered format  -  pain or discomfort you had in and around eyes
vfq25 - interviewer administered format  -  difficulty reading ordinary print in newspapers
vfq25 - interviewer administered format  -  difficulty doing work or hobbies
vfq25 - interviewer administered format  -  difficulty finding something on a shelf
vfq25 - interviewer administered format  -  difficulty reading street signs
vfq25 - interviewer administered format  -  difficulty going down steps at night
vfq25 - interviewer administered format  -  difficulty noticing objects off to the side while walking
vfq25 - interviewer administered format  -  difficulty seeing how people react
vfq25 - interviewer administered format  -  difficulty picking out and matching own clothes
vfq25 - interviewer administered format  -  difficulty visiting people
vfq25 - interviewer administered format  -  difficulty going out to see movies
vfq25 - interviewer administered format  -  are you currently driving
vfq25 - interviewer administered format  -  never driven or given up driving
vfq25 - interviewer administered format  -  main reason you gave up driving
vfq25 - interviewer administered format  -  difficulty driving during daytime
vfq25 - interviewer administered format  -  difficulty driving at night
vfq25 - interviewer administered format  -  driving in difficult condition
vfq25 - interviewer administered format  -  accomplish less because of vision
vfq25 - interviewer administered format  -  limited in how long you can work because of vision
vfq25 - interviewer administered format  -  pain in eyes keep you from doing what you like
vfq25 - interviewer administered format  -  stay home because of eyesight
vfq25 - interviewer administered format  -  feel frustrated because of eyesight
vfq25 - interviewer administered format  -  have less control because of eyesight
vfq25 - interviewer administered format  -  have to rely on other people because of eyesight
vfq25 - interviewer administered format  -  need help from others because of eyesight
vfq25 - interviewer administered format  -  worry about embarrass myself or others because of eyesight
vfq25 - interviewer administered format  -  rate your overall health
vfq25 - interviewer administered format  -  rate your eyesight now
vfq25 - interviewer administered format  -  difficulty reading small print
vfq25 - interviewer administered format  -  difficulty figure out bill accuracy
vfq25 - interviewer administered format  -  difficulty shaving or styling hair or putting on makeup
vfq25 - interviewer administered format  -  difficulty recognizing people you know
vfq25 - interviewer administered format  -  difficulty taking part in sports or outdoor activities
vfq25 - interviewer administered format  -  difficulty seeing and enjoying programs on tv
vfq25 - interviewer administered format  -  difficulty entertaining friends and family in home
vfq25 - interviewer administered format  -  do you have more help from others
vfq25 - interviewer administered format  -  limited in kinds of things can do
vfq25 - interviewer administered format  -  often irritable because of eyesight
vfq25 - interviewer administered format  -  don't go out of home alone because of eyesight
vfq25 - self administered format  -  overall health
vfq25 - self administered format  -  eyesight using both eyes
vfq25 - self administered format  -  time spent worry about eyesight
vfq25 - self administered format  -  pain or discomfort you had in and around eyes
vfq25 - self administered format  -  difficulty reading ordinary print in newspapers
vfq25 - self administered format  -  difficulty doing work or hobbies
vfq25 - self administered format  -  difficulty finding something on a shelf
vfq25 - self administered format  -  difficulty reading street signs
vfq25 - self administered format  -  difficulty going down steps at night
vfq25 - self administered format  -  difficulty noticing objects off to the side while walking
vfq25 - self administered format  -  difficulty seeing how people react
vfq25 - self administered format  -  difficulty picking out and matching own clothes
vfq25 - self administered format  -  difficulty visiting people
vfq25 - self administered format  -  difficulty going out to see movies
vfq25 - self administered format  -  are you currently driving
vfq25 - self administered format  -  never driven or given up driving
vfq25 - self administered format  -  main reason you gave up driving
vfq25 - self administered format  -  difficulty driving during daytime
vfq25 - self administered format  -  difficulty driving at night
vfq25 - self administered format  -  driving in difficult condition
vfq25 - self administered format  -  accomplish less because of vision
vfq25 - self administered format  -  limited in how long you can work because of vision
vfq25 - self administered format  -  pain in eyes keep you from doing what you like
vfq25 - self administered format  -  stay home because of eyesight
vfq25 - self administered format  -  feel frustrated because of eyesight
vfq25 - self administered format  -  have less control because of eyesight
vfq25 - self administered format  -  have to rely on other people because of eyesight
vfq25 - self administered format  -  need help from others because of eyesight
vfq25 - self administered format  -  worry about embarrass myself or others because of eyesight
leflunomide
vfq25 - self administered format  -  rate your overall health
vfq25 - self administered format  -  rate your eyesight now
vfq25 - self administered format  -  difficulty reading small print
vfq25 - self administered format  -  difficulty figure out bill accuracy
vfq25 - self administered format  -  difficulty shaving or styling hair or putting on makeup
vfq25 - self administered format  -  difficulty recognizing people you know
vfq25 - self administered format  -  difficulty taking part in sports or outdoor activities
vfq25 - self administered format  -  difficulty seeing and enjoying programs on tv
vfq25 - self administered format  -  difficulty entertaining friends and family in home
vfq25 - self administered format  -  do you have more help from others
vfq25 - self administered format  -  limited in kinds of things can do
vfq25 - self administered format  -  often irritable because of eyesight
vfq25 - self administered format  -  don't go out of home alone because of eyesight
mhis - nacc  -  somatic complaints
horizontal nail ridging
leukonychia
dose volume histogram
depigmentation
monitor unit
cumulative meterset weight
leukoderma
hoxb13 gene
hoxb13 wt allele
melasma
serum separator tube
homeobox protein hox - b13
phrynoderma
cpne1 gene
harlequin reaction
cpne1 wt allele
ichthyosis acquisita
copine - 1
tinea versicolor
growth hormone excess
growth hormone deficiency
thyroid storm
qprt gene
qprt wt allele
nicotinate - nucleotide pyrophosphorylase  [ carboxylating ]
adrenal crisis
chronic maternal hypertension
chronic maternal hypertension with superimposed preeclampsia
severe preeclampsia
gestational diabetes mellitus ,  a1
gestational diabetes mellitus ,  a2
chronic villitis
maternal weight gain in pregnancy
excessive weight gain in pregnancy
low weight gain in pregnancy
symphysis pubis dysfunction
post term pregnancy
twin pregnancy
monochorionic monoamniotic twin pregnancy
monochorionic diamniotic twin pregnancy
dichorionic diamniotic twin pregnancy
non - cesarean uterine surgical scarring
threatened abortion
early pregnancy loss
peri - implantational loss
pre - embryonic loss
embryonic loss
early fetal death
late fetal death
spontaneous preterm birth
transient myocardial ischemia of newborn
control point
zim2 gene
zim2 wt allele
zinc finger imprinted 2
peg3 gene
peg3 wt allele
paternally - expressed gene 3 protein
dcn gene
dcn wt allele
decorin
ide gene
ide wt allele
insulin - degrading enzyme
iapp gene
iapp wt allele
islet amyloid polypeptide
anti - cd2 monoclonal antibody
anti - cd3 monoclonal antibody
anti - cd4 monoclonal antibody
anti - cd5 monoclonal antibody
anti - cd6 monoclonal antibody
anti - cd7 monoclonal antibody
anti - cd8 monoclonal antibody
anti - cd19 monoclonal antibody
bace2 gene
bace2 wt allele
beta - secretase 2
bace1 gene
bace1 wt allele
beta - secretase 1
terf2ip gene
terf2ip wt allele
telomeric repeat - binding factor 2 - interacting protein 1
pagr1 gene
hydrazine sulfate
pagr1 wt allele
paxip1 - associated glutamate - rich protein 1
paxip1 gene
paxip1 wt allele
pax - interacting protein 1
sall4 gene
fda emanufacturing terminology
sall4 wt allele
sal - like protein 4
alpha - beta t - cell receptor antibody
treated volume
irradiated volume
clinical target volume
gross target volume
radiotherapy bolus
hexim1 gene
hexim1 wt allele
protein hexim1
accessory
sox4 gene
sox4 wt allele
transcription factor sox - 4
cell culture - based biosynthesis
drying method
filling method
granulation
particle sizing
production
red blood cell processing
animal blood product - derived intermediate paste production
antigen reagent production
anti - human globulin preparation
blood product collection
bone marrow collection
cell separation by density gradient centrifugation
collection of non - human source plasma
harvest of product from cell media
harvest of product from whole cell lysate
human blood product - derived intermediate paste production
plasma protein cold ethanol fractionation
plasma protein cryoprecipitation
preparation of blood products grouping reagent
production of blood serological test device
sample purification from cell culture
sample recovery from cell culture ,  not otherwise specified
sedimentation sample separation from cell culture
sterile cell culture product processing
tissue decellularization
recovery of plasma from blood products
mineral sources
cell bank characterization
cell bank maintenance
cell culture pooling
disposable bag culture
flask or bottle culture
perfusion culture
scaffold seeding
feeder layer
bioreactor culture biosynthesis
cell culture - based biosynthesis ,  not otherwise specified
disposable bag culture biosynthesis
perfusion culture biosynthesis
shaker flask or roller bottle culture biosynthesis
cell or vector cryopreservation
design and specification of software platform or architecture for in vitro diagnostics device
blood product distribution
cell product encapsulation
coating of device with immunologic reagents
compression formulation process
die cutting formulation process
drug formulation process ,  not otherwise specified
fluidized bed coating method
lamination formulation process
laser drill formulation process
molded formulation process
roller coating method
rotating pan coating method
vapor disposition coating method
drying method ,  not otherwise specified
flash drying method
fluid bed drying method
moving bed drying method
radiant heating drying method
spray heating drying method
stationary bed heating drying method
tissue protein extraction
isolated aseptic liquid filling method
isolated aseptic powder filling method
liquid filling method ,  not otherwise specified
manual aseptic liquid filling method
estramustine / etoposide / paclitaxel regimen
manual aseptic powder filling method
non - sterile augur powder filling method
non - sterile dosing disk powder filling method
non - sterile medical gas filling method
non - sterile piston powder filling method
non - sterile vacuum powder filling method
non - sterile vibratory powder filling method
non - sterile volumetric powder filling method
powder filling method ,  not otherwise specified
pressurized liquid filling method
hydroxyl radical
kave regimen
centrifugal filtration
moving filter filtration
stationary filter filtration
immunological flow cytometry
radioisotope formation
dry roller compaction granulation
dry slugging granulation
extrusion granulation
fluid bed granulation
fluidized hot melt granulation
granulation ,  not otherwise specified
high shear granulation
low shear granulation
spray granulation
final harvest and pooling of viral vectors
human cell or tissue harvest
container / closure labeling
labeling ,  not otherwise specified
device or device component manufacturing
manufacture or assemble software platform or architecture for in vitro diagnostics device
recombinant protein manufacture
laboratory testing for bacteria ,  virus ,  or mycoplasma
working cell bank release laboratory testing
dissolution mixing
dry powder conditioning mixing
dry powder convection mixing
dry powder diffusion mixing
dry powder pneumatic mixing
high shear wet milling mixing
low shear mixing
miscible liquids mixing
mixing ,  not otherwise specified
operation ,  not otherwise specified
container / closure packaging
packaging other
repackaging
secondary packaging
air classification particle sizing
cooling / congealing particle sizing
particle sizing ,  not otherwise specified
screening particle sizing
size reduction particle sizing
wet milling particle sizing
plasmapheresis for human source plasma
coating of solid phase with antigen ,  antibody ,  or nucleic acid for in vitro diagnostics device
nanoparticle production
plasmid production
polysaccharide preparation from bacterial cells
production of immunoassay detection reagent
production of in vitro diagnostics
production of individual vaccine component
production of nucleic acid detection reagent
production of nucleic acid extraction reagent
stem cell isolation
synthetic scaffold production
viral vector preparation
tissue processing
viral vector expansion and production
blood or viral antigen purification
crystallization purification
evaporation purification
extraction purification
medical gas purification
oligonucleotide purification
polyclonal antisera purification
protein precipitation
protein purification
purification ,  not otherwise specified
synthetic peptide purification
whole organism lysate purification
red blood cell reagent preparation
terminal sterilization
blood product storage
derivation ,  not otherwise specified
oligonucleotide synthesis
synthetic peptide synthesis
analytical laboratory testing ,  not otherwise specified
blood products laboratory testing
chemical laboratory testing
physical laboratory testing
code writing of software platform or architecture for in vitro diagnostics device
mapkapk5 gene
mapkapk5 wt allele
map kinase - activated protein kinase 5
clockwise
counterclockwise
nod1 gene
nod1 wt allele
nucleotide - binding oligomerization domain - containing protein 1
md anderson symptom inventory  -  brain tumor
weakness on one side of the body at its worst
difficulty understanding at its worst
difficulty speaking at its worst
seizure at its worst
difficulty concentrating at its worst
vision at its worst
change in appearance at its worst
change in bowel pattern at its worst
irritability at its worst
pediatric failure to thrive
tropisetron
growth failure
insulin resistance
hyperglucagonemia
fish - mouth papilla with mucin hypersecretion
hyperinsulinemia
extended template biopsy
injectable foam dosage form
ubash3b gene
ubash3b wt allele
ubiquitin - associated and sh3 domain - containing protein b
cptp gene
cptp wt allele
ceramide - 1 - phosphate transfer protein
arterial hypervascularization
gpnmb gene
gpnmb wt allele
transmembrane glycoprotein nmb
ogfr gene
ogfr wt allele
opioid growth factor receptor
doxorubicin / gemcitabine regimen
hepatitis c rna measurement
tpm1 gene
blood collection tube
tpm1 wt allele
evacuated blood specimen collection tube
tropomyosin alpha - 1 chain
exoc7 gene
hypoechoic focus
exoc7 wt allele
exocyst complex component 7
naf1 gene
naf1 wt allele
h / aca ribonucleoprotein complex non - core subunit naf1
cisd1 gene
cisd1 wt allele
cdgsh iron - sulfur domain - containing protein 1
dilation
helq gene
helq wt allele
helicase polq - like
morc3 gene
morc3 wt allele
morc family cw - type zinc finger protein 3
primary hypothyroidism
central hypothyroidism
primary hyperthyroidism
central hyperthyroidism
hashitoxicosis
fetal blood loss
fetal - maternal hemorrhage
rhesus isoimmunization
fetal acidosis
short umbilical cord
nuchal cord
umbilical cord occlusion
meconium stained amniotic fluid
transient myocardial dysfunction of newborn
btnl2 gene
btnl2 wt allele
pneumonitis
butyrophilin - like protein 2
autologous peripheral blood lymphocytes cotransduced with retroviral vectors encoding inducible il - 12 and anti - ny - eso - 1 tcr
mivavotinib
recombinant cell - surface anchored sialidase das181
tisotumab vedotin
hsd11b1 gene
hsd11b1 wt allele
corticosteroid 11 - beta - dehydrogenase isozyme 1
hyperprolactinemia
insulin resistance syndrome
sick euthyroid syndrome
transient hypothyroxinemia of prematurity
primary adrenal insufficiency
cerdulatinib
autologous ct7 / mage - a3 / wt1 mrna - electroporated langerhans - type dendritic cells
dach - platin micelle nc - 4016
folate receptor - targeted tubulysin conjugate ec1456
recombinant human serum amyloid p / pentraxin 2
difficulty swallowing solid foods
difficulty swallowing soft or mashed foods
difficulty swallowing liquids
pain in chest when swallowing
choke when swallowing
able to enjoy meals with family or friends
wake at night because of coughing
fact - ga questionnaire
fact - c questionnaire
fact - an questionnaire
fact - leu questionnaire
bothered by reflux or heartburn
discomfort or pain when eating
have feeling of fullness or heaviness in stomach area
have trouble swallowing food
bothered by a change in eating habits
digestive problems interfere with usual activities
avoid going out to eat because of illness
have stomach problems that worry me
bothered by gas or flatulence
have difficulty planning for future due to illness
hyperechoic focus
imreg - 1
hyperechoic strand
flaviviridae
hepacivirus
adrenal androgen deficiency
coronaviridae
hypoaldosteronemia
betacoronavirus
hypercortisolemia
adrenal androgen excess
cushing disease
hypocortisolemia
hyperaldosteronemia
hyperaldosteronism
primary hypoparathyroidism
androgen excess
txnip gene
gonadotropin - dependent precocious puberty
txnip wt allele
gonadotropin - independent precocious puberty
thioredoxin - interacting protein
uvrag gene
uvrag wt allele
uv radiation resistance - associated gene protein
wasl gene
wasl wt allele
neural wiskott - aldrich syndrome protein
mfn2 gene
mfn2 wt allele
mitofusin - 2
mir31 gene
mir31 wt allele
mir31 pre - mirna
mysm1 gene
mysm1 wt allele
histone h2a deubiquitinase mysm1
quinolinic acid
absolute blood lymphocyte count
uterine carcinosarcoma ,  homologous type
uterine carcinosarcoma ,  heterologous type
cobblestone area - forming cells
colony - forming unit - fibroblasts
minimal disseminated disease
circulating tumor - derived dna
cpg antibody
creatine kinase
angiokine
ephrin - a
receptor - activated smad
grp gene product
pre - progastrin - releasing peptide
neuromedin - c
klrc2 gene
klrc2 wt allele
nkg2 - c type ii integral membrane protein
eci2 gene
eci2 wt allele
enoyl - coa delta isomerase 2 ,  mitochondrial
artn gene
artn wt allele
artemin
vcan gene
vcan wt allele
versican core protein
adm gene
adm wt allele
adm
papilla
volume doubling time
lipg gene
lipg wt allele
milligray - centimeter
endothelial lipase
wdr66 gene
wdr66 wt allele
cilia -  and flagella - associated protein 251
psat1 gene
psat1 wt allele
phosphoserine aminotransferase
b9d2 gene
b9d2 wt allele
b9 domain - containing protein 2
wbp1l gene
wbp1l wt allele
ww domain binding protein 1 - like
elac2 gene
elac2 wt allele
zinc phosphodiesterase elac protein 2
prostate saturation biopsy
hot lesion
exosc5 gene
exosc5 wt allele
exosome complex component rrp46
p - p68 inhibitor rx - 5902
metatinib tromethamine
pegilodecakin
allogeneic glioblastoma stem - like cell line lysate - pulsed autologous dendritic cell vaccine
radix angelicae sinensis / radix astragali herbal supplement
circulating proteasome
lrp2 gene
imuvert
lrp2 wt allele
faact questionnaire
low - density lipoprotein receptor - related protein 2
adipose tissue deposition
who classification of tumors
marchf9 gene
marchf9 wt allele
embedding medium
e3 ubiquitin - protein ligase march9
mx1 gene
mx1 wt allele
interferon - induced gtp - binding protein mx1
pou5f1b gene
pou5f1b wt allele
putative pou domain ,  class 5 ,  transcription factor 1b
ccn1 gene
ccn1 wt allele
ccn family member 1
slc28a2 gene
slc28a2 wt allele
sodium / nucleoside cotransporter 2
slc28a3 gene
slc28a3 wt allele
solute carrier family 28 member 3
cald1 gene
cald1 wt allele
caldesmon
abcf2 gene
abcf2 wt allele
atp - binding cassette sub - family f member 2
braf inhibitor plx8394
dkk1 - neutralizing monoclonal antibody dkn - 01
anti - pd - 1 monoclonal antibody medi0680
anti - erbb3 monoclonal antibody cdx - 3379
histone - lysine n - methyltransferase ezh2 inhibitor gsk2816126
secondary hyperparathyroidism
pubertal failure
premature adrenarche
premature menarche
primary amenorrhea
secondary amenorrhea
oligomenorrhea
premature thelarche
galactorrhea
hyperestrogenism
hyperprogesteronism
hypoprogesteronism
hypogonadotropic hypogonadism
hypergonadotropic hypogonadism
testosterone excess
spl sex terminology
ovarian failure
primary ovarian failure
exposure planned occurrence
clinical events completion status
concomitant medication pre - specified
drug accountability date
drug accountability completion status
exposure reference identifier
findings about events or interventions baseline flag
findings about events or interventions collection date time
findings about events or interventions data collection day
findings about events or interventions evaluator
findings about events or interventions location
findings about events or interventions original result
findings about events or interventions original result unit
findings about events or interventions reason not done
findings about events or interventions completion status
findings about events or interventions character result in standard format
findings about events or interventions numeric result in standard unit
findings about events or interventions result standard unit
laboratory data completion status
microbiology completion status
microbiology susceptibility completion status
pharmacokinetic concentration completion status
physical exam method
physical exam performed
pharmacokinetic parameters completion status
pharmacokinetic parameters result standard unit
subject characteristic performed
disabling adverse event
antepartum stillbirth
intrapartum stillbirth
indicated preterm birth
placenta increta
placenta percreta
low - lying placenta
duration of rupture of membrane
number of centimeters dilated on admission
blood in stool
whole blood collection tube
personal contact
model for end - stage liver disease
feeding intolerance
infantile gastroesophageal reflux
sandifer's syndrome
melena neonatorum
scarff - bloom - richardson grading system
indicine - n - oxide
hepatorenal syndrome
healthy volunteer medical history questionnaire
have undergone a transplant
have chronic infection
have had cold sores
have autoimmune or inflammatory condition
have arthritis ,  rheumatism ,  bursitis ,  lupus or sjogren syndrome
have diabetes
have history of opportunistic or frequent infection
have immunodeficiency
have had a tumor ,  growth ,  cyst ,  or cancer
have allergy
have had severe tooth or gum trouble
have adequate moisture in mouth
quantitative trait locus
expression quantitative trait locus
consideration
nap
car ride
housemate
nerve - sparing surgery
gray baby syndrome
diethylstilbestrol syndrome
labor after cesarean
threatened preterm labor
eleven
twelve
thirteen
fourteen
fifteen
vacop - b regimen
sixteen
seventeen
ny - eso - 1 / gla - se vaccine id - g305
tenalisib
parsaclisib
wnt - 5a mimic hexapeptide foxy - 5
american urological association symptom score
dusquetide
efs - ada lentiviral vector - transduced cd34 - positive autologous lymphocytes
anti - psma monoclonal antibody mdx1201 - a488
copper cu 62 - ptsm
copper cu 62 - atsm
acalabrutinib
omaveloxolone
cytidine analog rx - 3117
ever
international prostate symptom score
megamonas
dexamethasone symptom questionnaire
dexamethasone symptom questionnaire - chronic
have indigestion ,  heartburn ,  reflux ,  or discomfort in upper abdomen
have increased appetite
have hiccups
gaining weight
have rash or acne on face
have thrush
depression after stopping dexamethasone
have increased roundness of face
have low mood ,  sadness ,  or depression
have increased anger or irritability
have difficulty standing from a seated position or walking up stairs
have problem with fragile skin or bruising
diabetes diagnosis since steroid treatment
have trouble controlling blood sugar
have problems attributed to steroids
most bothersome symptom attributed to steroids
platinum - group metal
hearing handicap inventory for the elderly ,  screening version
esophageal dysphagia
hearing problem causes embarrassment when meeting new people
hearing problem causes frustration when talking with family
difficulty hearing a whisper
feel handicapped by hearing problem
hearing problem causes difficulty when visiting with people
hearing problem causes problem attending religious services
hearing problem causes arguments with family
hearing problem causes difficulty when listening to tv or radio
hearing problem limits personal or social life
hearing problem causes difficulty in a restaurant
projectile vomiting
infantile colic
abdominal migraine
malabsorption
intussusception
diabetic embryopathy
fetal macrosomia
non - rh blood group isoimmunization
braxton - hicks contraction
time of onset of labor
spontaneous onset of labor
precipitous birth
dysfunctional labor
tetanic contraction
funic presentation
brow presentation
neonatal hyperglycemia
terminology value set
aica - ribotide
point
indole - 3 - carbinol
prepared material
sarcosine
regulatory b cell
immature myeloid cell
t ( 14 ; 16 )  ( q32 ; q23 )
t ( 9 ; 11 )
absence of biallelic tcrgamma deletion
mll partial tandem duplication
cytomegalovirus microrna
cytomegalovirus mrna
ror1 antibody
tmprss2 / ets family fusion gene
igh / crlf2 fusion gene
hla - a gene product
hla class i histocompatibility antigen ,  a - 2402 alpha chain
bone specific alkaline phosphatase
ins gene product
proinsulin
scgb2a2 gene
apply
scgb2a2 wt allele
mammaglobin - a
jchain gene
jchain wt allele
slc6a3 gene
immunoglobulin j chain
spats2l gene
slc6a3 wt allele
spats2l wt allele
spats2 - like protein
sodium - dependent dopamine transporter
ca6 gene
ca6 wt allele
scgb1d2 gene
carbonic anhydrase 6
scgb1d2 wt allele
nrxn3 gene
secretoglobin family 1d member 2
nrxn3 wt allele
neurexin - 3
gpr101 gene
gpr101 wt allele
probable g - protein coupled receptor 101
adgrf1 gene
adgrf1 wt allele
adhesion g protein - coupled receptor f1
ugt8 gene
chn2 gene
chn2 wt allele
ugt8 wt allele
2 - hydroxyacylsphingosine 1 - beta - galactosyltransferase
beta - chimaerin
sema6a gene
sema6a wt allele
semaphorin - 6a
pon2 gene
pon2 wt allele
serum paraoxonase / arylesterase 2
s100z gene
s100z wt allele
protein s100 - z
slc22a3 gene
slc22a3 wt allele
solute carrier family 22 member 3
slc47a1 gene
slc47a1 wt allele
multidrug and toxin extrusion protein 1
slc47a2 gene
slc47a2 wt allele
multidrug and toxin extrusion protein 2
slc29a4 gene
slc29a4 wt allele
equilibrative nucleoside transporter 4
cd177 gene
cd177 wt allele
cd177 antigen
rgl4 gene
rgl4 wt allele
ral - gds - related protein
entpd1 gene
entpd1 wt allele
ectonucleoside triphosphate diphosphohydrolase 1
cpa1 gene
cpa1 wt allele
carboxypeptidase a1
flna gene
flna wt allele
filamin - a
oropharyngeal dysphagia
ren gene
ren wt allele
renin
olfm4 gene
olfm4 wt allele
olfactomedin - 4
eif2ak4 gene
eif2ak4 wt allele
eukaryotic translation initiation factor 2 - alpha kinase 4
abcg1 gene
cul - de - sac
inosine dialdehyde
abcg1 wt allele
atp - binding cassette sub - family g member 1
hjv gene
hjv wt allele
hemojuvelin
hdac8 gene
hdac8 wt allele
histone deacetylase 8
nrarp gene
chronic liver disease
nrarp wt allele
notch - regulated ankyrin repeat - containing protein
ern1 gene
ern1 wt allele
serine / threonine - protein kinase / endoribonuclease ire1
proctalgia fugax
atf6 gene
atf6 wt allele
cyclic amp - dependent transcription factor atf - 6 alpha
dkc1 gene
dkc1 wt allele
h / aca ribonucleoprotein complex subunit 4
macroh2a1 gene
macroh2a1 wt allele
core histone macro - h2a .1
plxnc1 gene
plxnc1 wt allele
plexin - c1
pik3cd gene
pik3cd wt allele
loss of appetite
phosphatidylinositol 4 , 5 - bisphosphate 3 - kinase catalytic subunit delta isoform
ugt1a4 gene
ugt1a4 wt allele
udp - glucuronosyltransferase 1 - 4
serpind1 gene
serpind1 wt allele
heparin cofactor 2
basp1 gene
basp1 wt allele
brain acid soluble protein 1
retn gene
retn wt allele
resistin
person role title
lactobacillus rhamnosus / l . jensenii / l . crispatus / l . gasseri oral supplement
lsd1 inhibitor gsk2879552
alpha - 1 , 3 - galactosyltransferase - expressing allogeneic renal cell carcinoma vaccine
contrast agent cs - 1000
tlr4 agonist g100
ivac mutanome vaccine
ovapuldencel - t
seviteronel
vesigenurtucel - l
midazolam - containing buccal liquid
lorlatinib
long - acting release pasireotide
carboxylesterase - expressing allogeneic neural stem cells
immediate - release tablet afuresertib
anti - cd98 monoclonal antibody ign523
folate binding protein j65 peptide vaccine
coffee dietary supplement
twenty five
main duct pancreatic intraductal papillary - mucinous neoplasm
branch duct pancreatic intraductal papillary - mucinous neoplasm
wrong
mixed type pancreatic intraductal papillary - mucinous neoplasm
branch duct
disseminated bacillus calmette - guerin infection
hypotonic - hyporesponsive episode
vaccine - associated paralytic poliomyelitis
disseminated oka varicella zoster virus infection
reactive airway disease
cadaver
serum collection tube
complete blood count collection tube
sediment
coal dust
diesel exhaust
flare - up
skin tattoo
hard
abrupt
indwelling device
judgment
haus7 gene
decimal point
haus7 wt allele
haus augmin - like complex subunit 7
heparin potassium
child - pugh class a
child - pugh class b
nppb gene product
child - pugh class c
inferior mediastinal lymph node
fetal bovine serum
delight
terrible
roche diagnostics free psa test
iopromide
hybritech psa test
bayer immuno - 1 psa test
methanol / water - based buffered preservative solution
alcohol / polyethylene glycol - based cytology fixative
tosoh bioscience
abbott diagnostics
beckman coulter ,  inc
roche diagnostics
fecal occult blood
tortuous colon
reticulocytopenia
erythrocytosis
eosinophilopenia
basophilopenia
monocytopenia
scattered microscopic foci
low anterior resection
end organ damage from diabetes
ground glass opacity
part - solid ground - glass pulmonary nodule
abnormal colorectal exam ,  suspicious for malignancy
abnormal colorectal exam ,  highly suspicious for malignancy
scleroderma polymyositis overlap syndrome
unable to draw blood
undiagnosed
unable to collect voided urine
transurethral incision of the prostate
balloon dilation
grade b
grade x
non - necrotizing granuloma
necrotizing granuloma
paneth cell - like change
poorly formed pattern
transition zone - like
retention cyst
advia centaur
dimension with heterogeneous module
immulite
hyperfibrinogenemia
vitros eci
excessive bleeding
excessive bruising
homogenate
cell pellet
dried blood spot
buccal swab
chart abstraction
acute hemorrhagic edema of infancy
hyperphosphatemia
transaminitis
twenty four
granulomatosis
hyperamylasemia
pleocytosis
prss1 gene
prss1 wt allele
trypsin - 1
h3 - 3b gene
h3 - 3b wt allele
atp1a1 gene
atp1a1 wt allele
sodium / potassium - transporting atpase subunit alpha - 1
atp2b3 gene
atp2b3 wt allele
plasma membrane calcium - transporting atpase 3
direct hyperbilirubinemia
cacna1d gene
cacna1d wt allele
voltage - dependent l - type calcium channel subunit alpha - 1d
positive number
transthoracic needle biopsy
nickel peroxidase method
magnetic resonance cholangiopancreatography
punctate
waiver
off - site
timely
live in own home
live in assisted living facility
live in a nursing home
live with child or children
live with friends
indirect hyperbilirubinemia
enadenotucirev
6 - phosphofructo - 2 - kinase / fructose - 2 , 6 - bisphosphatases isoform 3 inhibitor act - pfk - 158
uae inhibitor tak - 243
igf - methotrexate conjugate
ph20 hyaluronidase - expressing adenovirus vcn - 01
wheatgrass juice
akt / erk inhibitor onc201
navoximod
cd133 antigen peptide - pulsed autologous dendritic cell vaccine
immediate - release onapristone
anti - von willebrand factor nanobody
extended - release onapristone
recombinant globulin component macrophage - activating factor
uncaria tomentosa extract
itraconazole
oxidized avidin
lutetium lu 177 dota - biotin
anti - c - met monoclonal antibody argx - 111
autologous mesenchymal stem cells apceth_101
sulforaphane - cyclodextrin complex
gallium ga 68 - labeled mln6907
carbon c11 temozolomide
dlk1 / epha2 / hbb / nrp1 / rgs5 / tem1 peptide - pulsed alpha - type - 1 polarized dendritic cell vaccine
monoclonal band
oligoclonal bands
high sensitivity troponin t assay
extended - field radiation therapy
involved - field radiation therapy
involved node radiation therapy
autoimmune primary adrenal insufficiency
t helper 17 cell
2 - hydroxyestrogen
16 - hydroxyestrogen
hpx gene
hpx wt allele
hemopexin
ahsg gene
ahsg wt allele
alpha - 2 - hs - glycoprotein
twin - twin transfusion syndrome
vanishing twin syndrome
bortezomib / cyclophosphamide / dexamethasone regimen
rvd regimen
bortezomib / dexamethasone / pegylated liposomal doxorubicin regimen
discordant twin
ephb4 gene
ephb4 wt allele
ephrin type - b receptor 4
fetal hypoxemia
il31 gene
il31 wt allele
interleukin - 31
notch family
hypoxia inducible factor family
brachyury protein antibody
melanoma - associated antigen family
enhancing lesion
donation identification number production identifier
labeling does not contain mri safety information
cdisc questionnaire borg cr10 test name terminology
cdisc questionnaire borg cr10 test code terminology
cdisc questionnaire c - ssrs pediatric / cognitively impaired lifetime / recent test name terminology
cdisc questionnaire c - ssrs pediatric / cognitively impaired lifetime / recent test code terminology
cdisc questionnaire fatigue severity scale test name terminology
cdisc questionnaire fatigue severity scale test code terminology
cdisc questionnaire bladder control scale test name terminology
cdisc questionnaire bladder control scale test code terminology
cdisc questionnaire bowel control scale test name terminology
cdisc questionnaire bowel control scale test code terminology
cdisc questionnaire impact of visual impairment scale test name terminology
cdisc questionnaire impact of visual impairment scale test code terminology
cdisc questionnaire modified fatigue impact scale test name terminology
cdisc questionnaire modified fatigue impact scale test code terminology
cdisc questionnaire multiple sclerosis quality of life - 54 instrument test name terminology
cdisc questionnaire multiple sclerosis quality of life - 54 instrument test code terminology
cdisc questionnaire rand 36 - item health survey 1 .0 test name terminology
cdisc questionnaire rand 36 - item health survey 1 .0 test code terminology
borg cr10 questionnaire question
c - ssrs pediatric cognitively impaired lifetime recent questionnaire question
fss questionnaire question
blcs questionnaire question
bwcs questionnaire question
ivis questionnaire question
mfis questionnaire question
msqol - 54 questionnaire question
rand - 36 questionnaire question
borg category - ratio 10 scale questionnaire
columbia - suicide severity rating scale pediatric / cognitively impaired lifetime / recent questionnaire
bladder control scale questionnaire
bowel control scale questionnaire
impact of visual impairment scale questionnaire
modified fatigue impact scale questionnaire
multiple sclerosis quality of life - 54 instrument questionnaire
rand 36 - item health survey 1 .0 questionnaire
cdr  -  sum of boxes
cdr  -  global cdr
mds - updrs  -  postural tremor of left hand
mds - updrs  -  kinetic tremor of right hand
kfss  -  other functions
kfss  -  other functions specify
gad - 7  -  total score
phq - 9  -  total score
borg cr10  -  rating
c - ssrs pediatric / cognitively impaired lifetime / recent  -  wish to be dead  ( lifetime )
c - ssrs pediatric / cognitively impaired lifetime / recent  -  wish to be dead  ( past 1 month )
c - ssrs pediatric / cognitively impaired lifetime / recent  -  description of wish to be dead
c - ssrs pediatric / cognitively impaired lifetime / recent  -  non - specific active suicidal thoughts  ( lifetime )
c - ssrs pediatric / cognitively impaired lifetime / recent  -  non - specific active suicidal thoughts  ( past 1 month )
c - ssrs pediatric / cognitively impaired lifetime / recent  -  description of non - specific active suicidal thoughts
c - ssrs pediatric / cognitively impaired lifetime / recent  -  active suicidal ideation with any methods  ( not plan )  without intent to act  ( lifetime )
c - ssrs pediatric / cognitively impaired lifetime / recent  -  active suicidal ideation with any methods  ( not plan )  without intent to act  ( past 1 month )
c - ssrs pediatric / cognitively impaired lifetime / recent  -  description of active suicidal ideation with any methods  ( not plan )  without intent to act
c - ssrs pediatric / cognitively impaired lifetime / recent  -  active suicidal ideation with some intent to act ,  without specific plan  ( lifetime )
c - ssrs pediatric / cognitively impaired lifetime / recent  -  active suicidal ideation with some intent to act ,  without specific plan  ( past 1 month )
keyhole limpet hemocyanin
c - ssrs pediatric / cognitively impaired lifetime / recent  -  description of active suicidal ideation with some intent to act ,  without specific plan
c - ssrs pediatric / cognitively impaired lifetime / recent  -  active suicidal ideation with specific plan and intent  ( lifetime )
c - ssrs pediatric / cognitively impaired lifetime / recent  -  active suicidal ideation with specific plan and intent  ( past 1 month )
c - ssrs pediatric / cognitively impaired lifetime / recent  -  description of active suicidal ideation with specific plan and intent
c - ssrs pediatric / cognitively impaired lifetime / recent  -  most severe ideation  ( lifetime )
c - ssrs pediatric / cognitively impaired lifetime / recent  -  describe most severe ideation  ( lifetime )
c - ssrs pediatric / cognitively impaired lifetime / recent  -  most severe ideation  ( past 1 month )
c - ssrs pediatric / cognitively impaired lifetime / recent  -  describe most severe ideation  ( past 1 month )
c - ssrs pediatric / cognitively impaired lifetime / recent  -  frequency  ( lifetime )
c - ssrs pediatric / cognitively impaired lifetime / recent  -  frequency  ( past 1 month )
c - ssrs pediatric / cognitively impaired lifetime / recent  -  frequency write response
c - ssrs pediatric / cognitively impaired lifetime / recent  -  actual suicide attempt  ( lifetime )
c - ssrs pediatric / cognitively impaired lifetime / recent  -  actual suicide attempt  ( past 3 month )
c - ssrs pediatric / cognitively impaired lifetime / recent  -  number of actual suicide attempts  ( lifetime )
c - ssrs pediatric / cognitively impaired lifetime / recent  -  number of actual suicide attempts  ( past 3 months )
c - ssrs pediatric / cognitively impaired lifetime / recent  -  description of actual suicide attempt
c - ssrs pediatric / cognitively impaired lifetime / recent  -  non - suicidal self - injurious behavior  ( lifetime )
c - ssrs pediatric / cognitively impaired lifetime / recent  -  non - suicidal self - injurious behavior  ( past 3 months )
c - ssrs pediatric / cognitively impaired lifetime / recent  -  self - injurious behavior ,  intent unknown  ( lifetime )
c - ssrs pediatric / cognitively impaired lifetime / recent  -  self - injurious behavior ,  intent unknown  ( past 3 months )
c - ssrs pediatric / cognitively impaired lifetime / recent  -  interrupted suicide attempt  ( lifetime )
c - ssrs pediatric / cognitively impaired lifetime / recent  -  interrupted suicide attempt  ( past 3 months )
c - ssrs pediatric / cognitively impaired lifetime / recent  -  number of interrupted suicide attempts  ( lifetime )
c - ssrs pediatric / cognitively impaired lifetime / recent  -  number of interrupted suicide attempts  ( past 3 months )
c - ssrs pediatric / cognitively impaired lifetime / recent  -  description of interrupted suicide attempt
c - ssrs pediatric / cognitively impaired lifetime / recent  -  aborted or self - interrupted suicide attempt  ( lifetime )
c - ssrs pediatric / cognitively impaired lifetime / recent  -  aborted or self - interrupted suicide attempt  ( past 3 months )
c - ssrs pediatric / cognitively impaired lifetime / recent  -  number of aborted or self - interrupted suicide attempt  ( lifetime )
c - ssrs pediatric / cognitively impaired lifetime / recent  -  number of aborted or self - interrupted suicide attempt  ( past 3 months )
c - ssrs pediatric / cognitively impaired lifetime / recent  -  description of aborted suicide attempt
c - ssrs pediatric / cognitively impaired lifetime / recent  -  preparatory acts or behaviors toward suicide attempt  ( lifetime )
c - ssrs pediatric / cognitively impaired lifetime / recent  -  preparatory acts or behaviors toward suicide attempt  ( past 3 months )
c - ssrs pediatric / cognitively impaired lifetime / recent  -  description of preparatory acts or behaviors toward suicide attempt
c - ssrs pediatric / cognitively impaired lifetime / recent  -  suicidal behavior  ( lifetime )
c - ssrs pediatric / cognitively impaired lifetime / recent  -  suicidal behavior  ( past 3 months )
c - ssrs pediatric / cognitively impaired lifetime / recent  -  most recent suicide attempt date
c - ssrs pediatric / cognitively impaired lifetime / recent  -  most recent suicide attempt actual lethality / medical damage
c - ssrs pediatric / cognitively impaired lifetime / recent  -  most recent suicide attempt potential lethality
c - ssrs pediatric / cognitively impaired lifetime / recent  -  most lethal suicide attempt date
c - ssrs pediatric / cognitively impaired lifetime / recent  -  most lethal suicide attempt actual lethality / medical damage
c - ssrs pediatric / cognitively impaired lifetime / recent  -  most lethal suicide attempt potential lethality
c - ssrs pediatric / cognitively impaired lifetime / recent  -  first suicide attempt date
c - ssrs pediatric / cognitively impaired lifetime / recent  -  first suicide attempt actual lethality / medical damage
c - ssrs pediatric / cognitively impaired lifetime / recent  -  first suicide attempt potential lethality
fss  -  motivation is lower when fatigued
fss  -  exercise brings on my fatigue
fss  -  i am easily fatigued
fss  -  fatigue interferes with physical functioning
fss  -  fatigue causes frequent problems
fss  -  fatigue prevents sustained physical functioning
fss  -  fatigue interferes with carrying out duties
fss  -  fatigue is among most disabling symptoms
fss  -  fatigue interferes with work
blcs  -  lost control of your bladder
blcs  -  almost lost control of your bladder
blcs  -  altered activities because bladder problems
blcs  -  bladder problems restrict overall lifestyle
bwcs  -  been constipated
bwcs  -  lost control of your bowels
bwcs  -  almost lost control of your bowels
bwcs  -  altered activities because bowel control problems
bwcs  -  bowel problems restrict overall lifestyle
ivis  -  read or access personal letters
ivis  -  read or access printed materials
ivis  -  read or access dials
ivis  -  watch tv or identify faces from distance
ivis  -  identify house numbers or street signs
mfis  -  have been less alert
mfis  -  have difficulty paying attention for long time
mfis  -  unable to think clearly
mfis  -  have been clumsy and uncoordinated
mfis  -  have been forgetful
mfis  -  pace myself in physical activities
mfis  -  less motivated to do anything that requires physical effort
mfis  -  less motivated to participate in social activities
mfis  -  limited in my abilities to do things away from home
mfis  -  have trouble maintain physical effort
mfis  -  have difficulty making decisions
mfis  -  less motivated to do anything that requires thinking
mfis  -  muscles have felt weak
mfis  -  been physically uncomfortable
mfis  -  have trouble finishing tasks that require thinking
mfis  -  difficulty organizing my thoughts
mfis  -  less able to complete tasks that require physical effort
mfis  -  my thinking has been slowed down
mfis  -  have trouble concentrating
mfis  -  have limited my physical activities
mfis  -  need to rest more often or longer
msqol - 54  -  would you say your health is
msqol - 54  -  health now compared to one year ago
msqol - 54  -  health limit vigorous activities
msqol - 54  -  health limit moderate activities
msqol - 54  -  health limit lifting or carrying groceries
msqol - 54  -  health limit climbing several stairs
msqol - 54  -  health limit climbing one stair
msqol - 54  -  health limit bending ,  kneeling or stooping
msqol - 54  -  health limit walking more than a mile
msqol - 54  -  health limit walking several blocks
msqol - 54  -  health limit walking one block
msqol - 54  -  health limit bathing and dressing yourself
mitomycin c analog kw - 2149
msqol - 54  -  physical health cut down time on work
msqol - 54  -  physical health accomplish less
msqol - 54  -  physical health limited in the kind of work
msqol - 54  -  physical health difficulty perform work
msqol - 54  -  emotional problem cut down time on work
msqol - 54  -  emotional problem accomplish less
msqol - 54  -  emotional problem did not do work carefully
msqol - 54  -  extend physical health or emotional problem interfere with social activities
msqol - 54  -  bodily pain
msqol - 54  -  pain interfere with normal work
msqol - 54  -  feel full of pep
msqol - 54  -  been a nervous person
msqol - 54  -  felt so down nothing could cheer you up
msqol - 54  -  felt calm and peaceful
msqol - 54  -  have a lot of energy
msqol - 54  -  felt downhearted and blue
msqol - 54  -  feel worn out
msqol - 54  -  been a happy person
msqol - 54  -  feel tired
msqol - 54  -  feel rested waking in the morning
msqol - 54  -  time physical health or emotional problem interfere with social activities
msqol - 54  -  get sick easier than other
msqol - 54  -  as healthy as anybody
msqol - 54  -  expect health to get worse
msqol - 54  -  health is excellent
msqol - 54  -  discouraged by health problem
msqol - 54  -  frustrated with health
msqol - 54  -  health a worry in life
msqol - 54  -  feel weighed down by health problem
msqol - 54  -  difficulty concentrating and thinking
msqol - 54  -  trouble keep attention for long
msqol - 54  -  trouble with memory
msqol - 54  -  others notice your problems with memory or concentration
msqol - 54  -  lack of sexual interest
msqol - 54  -  difficulty keeping an erection
msqol - 54  -  inadequate lubrication
msqol - 54  -  difficulty having orgasm
msqol - 54  -  ability to satisfy sexual partner
msqol - 54  -  satisfied with sexual function
msqol - 54  -  bowel or bladder function interfere with social activities
msqol - 54  -  pain interfere enjoyment of life
msqol - 54  -  rate your own quality of life
msqol - 54  -  describe how you feel about your life
rand - 36  -  rate your health
rand - 36  -  rate your health compared to one year ago
rand - 36  -  health limit vigorous activities
rand - 36  -  health limit moderate activities
rand - 36  -  health limit lifting groceries
rand - 36  -  health limit climbing several flights
rand - 36  -  health limit climbing one flight
rand - 36  -  health limit bending or stooping
rand - 36  -  health limit walking more than a mile
rand - 36  -  health limit walking several blocks
rand - 36  -  health limit walking one block
rand - 36  -  health limit bathing or dressing
rand - 36  -  physical health cut down time spent on work
rand - 36  -  physical health accomplished less
rand - 36  -  physical health limited in the kind of work
rand - 36  -  physical health difficulty performing work
rand - 36  -  emotional problem cut down time spent on work
rand - 36  -  emotional problem accomplished less
rand - 36  -  emotional problem did not do work as carefully
rand - 36  -  extend physical health or emotional problems interfere with social activities
rand - 36  -  bodily pain
rand - 36  -  pain interfere with normal work
rand - 36  -  feel full of pep
rand - 36  -  been a nervous person
rand - 36  -  felt nothing could cheer you up
rand - 36  -  felt calm and peaceful
rand - 36  -  have a lot of energy
rand - 36  -  felt downhearted and blue
rand - 36  -  feel worn out
rand - 36  -  been a happy person
rand - 36  -  feel tired
rand - 36  -  time physical health or emotional problems interfere with social activities
rand - 36  -  get sick easier than other
rand - 36  -  as healthy as anybody
rand - 36  -  expect health to get worse
rand - 36  -  my health is excellent
fetal echocardiography
fetal doppler velocimetry
fetal doppler monitoring
chlorophyta
internal fetal heart rate monitoring
intrapartum fetal stimulation
vibroacoustic stimulation
allis clamp fetal scalp stimulation
digital fetal scalp stimulation
conception age
corrected age
postmenstrual age
live birth
late preterm birth
term birth
early term birth
full term birth
late term birth
post term birth
intermittent auscultation
intrauterine resuscitation
carboxyamidotriazole
fetal scalp sampling
off regimen
spontaneous labor and birth
transdermal 4 - hydroxytestosterone
first degree perineal laceration
second degree perineal laceration
third degree perineal laceration
fourth degree perineal laceration
experimental organism islet cell adenoma neoplasm
experimental organism acidophil carcinoma
experimental organism histiocytic lymphoma neoplasm
experimental organism mixed lymphoma neoplasm
experimental organism lymphosarcoma neoplasm
experimental organism benign stromal tumor neoplasm
experimental organism benign teratoma neoplasm
experimental organism benign thymoma neoplasm
cdisc sdtm morphology test name terminology
cdisc sdtm morphology test code terminology
cdisc sdtm protocol milestone terminology
cdisc sdtm pharmacogenomics biomarker medical statement terminology
ecg recording quality
total body clearance by fraction of dose for dose interval
total body clearance for dose interval
kluyveromyces
yarrowia
wickerhamomyces
magnusiomyces
filobasidium
prototheca
trichosporon
placental retention
antenatal steroid therapy initiated
augmentation of labor
manual fetal rotation
spontaneous vertex delivery
spontaneous breech delivery
breech extraction
assisted breech delivery
trial of birth labor after cesarean
primary cesarean birth
carboplatin / gemcitabine / paclitaxel regimen
repeat cesarean birth
elective cesarean delivery
indicated cesarean delivery
delivery by destructive operation
controlled oral word association test
electrical stimulation electrode type
explanted medical device
baseline wander by ecg finding
muscle tremor artifact
alternating current noise by ecg finding
interchanged limb electrodes by ecg finding
disconnected limb electrodes by ecg finding
interchanged precordial electrodes by ecg finding
disconnected precordial electrode v1 by ecg finding
disconnected precordial electrode v2 by ecg finding
disconnected precordial electrode v3 by ecg finding
disconnected precordial electrode v4 by ecg finding
disconnected precordial electrode v5 by ecg finding
disconnected precordial electrode v6 by ecg finding
all precordial electrodes are disconnected by ecg finding
incorrectly positioned precordial electrodes by ecg finding
quality problem not otherwise specified by ecg finding
artifact lead signal by ecg finding
ecg waveforms not present
60 hertz noise by ecg finding
50 hertz noise by ecg finding
low amplitude qrs complex by ecg finding
incomplete ecg
incorrectly scaled ecg
incompletely digitized ecg leads
inability to digitize ecg leads
invalid ecg waveforms
poor quality ecg
suspicion of limb electrodes reversal but interpretation assumes no reversal by ecg finding
suspicion of limb electrodes reversal but interpretation assumes reversal by ecg finding
ecg acquired with precordial electrodes placed on the right chest
other incorrect electrode placement
insufficient number of beats for complete ecg evaluation
ecg evaluation not performed due to unknown ecg amplitude gain or recording speed
incomplete ecg measurements due to truncation of qrs complexes
ecg evaluation not performed due to poor quality of printed ecg
ecg evaluation not performed due to corrupted digital ecg file
dominant hand
boundary shift integral
mri without contrast
polysomnography
femoral condyle
humeral epicondyle
distal interphalangeal joint 2 of the hand
distal interphalangeal joint 3 of the hand
interphalangeal joint 2 of the hand
interphalangeal joint 3 of the hand
interphalangeal joint 4 of the hand
interphalangeal joint 5 of the hand
proximal interphalangeal joint 2 of the hand
proximal interphalangeal joint 3 of the hand
proximal interphalangeal joint 4 of the hand
proximal interphalangeal joint 5 of the hand
distal interphalangeal joint 2 of the foot
distal interphalangeal joint 3 of the foot
lavendustin a
interphalangeal joint 1 of the foot
interphalangeal joint 2 of the foot
interphalangeal joint 3 of the foot
interphalangeal joint 4 of the foot
interphalangeal joint 5 of the foot
proximal interphalangeal joint 2 of the foot
proximal interphalangeal joint 3 of the foot
proximal interphalangeal joint 4 of the foot
proximal interphalangeal joint 5 of the foot
subject is randomized
platelet aggregometry curve type
platelet aggregometry mean amplitude
platelet aggregometry mean curve type
nuclear swelling measurement
mean platelet dry mass
reticulocyte mean corpuscular volume
eosinophil band form count
eosinophil band form to leukocyte ratio
reticulocyte distribution width
fractional excretion of calcium
fractional excretion of chloride
fractional excretion of phosphate
fractional excretion of potassium
sialyl ssea - 1 antigen measurement
sulfur dioxide measurement
unspecified cells to total cell ratio measurement
total body clearance by fraction of dose for dose interval normalized by dose
total body clearance by fraction of dose for dose interval normalized by body mass index
total body clearance by fraction of dose for dose interval normalized by surface area
total body clearance by fraction of dose for dose interval normalized by weight
total body clearance for dose interval normalized by dose
total body clearance for dose interval normalized by body mass index
total body clearance for dose interval normalized by surface area
total body clearance for dose interval normalized by weight
accumulation index using lambda z
experimental organism benign nephroblastoma neoplasm
ventriculus
virtual pixel
pixels per centimeter
pixels per inch
percent per minute
millivolt squared per hertz
grating cycles per centimeter
enterococcus thailandicus
atopobium rimae
peptoniphilus harei
alistipes shahii
megamonas funiformis
arthrobacter cumminsii
corynebacterium tuberculostearicum
clostridium bolteae
clostridium hathewayi
fusobacterium naviforme
tsukamurella pulmonis
candida rugosa
candida dubliniensis
kluyveromyces marxianus
yarrowia lipolytica
candida pararugosa
pichia norvegensis
candida orthopsilosis
candida zeylanoides
wickerhamomyces anomalus
magnusiomyces capitatus
rhodotorula glutinis
filobasidium uniguttulatum
cryptococcus randhawii
cryptococcus albidus
cryptococcus gattii
cryptococcus laurentii
pichia kluyveri
prototheca wickerhamii
trichosporon asahii
distal interphalangeal joint 4 of the hand
distal interphalangeal joint 5 of the hand
distal interphalangeal joint 4 of the foot
distal interphalangeal joint 5 of the foot
anatabine
circulating plasma cell
scid - repopulating cell
drug skin rash
parotitis
uterine dehiscence
futibatinib
h1299 tumor cell lysate vaccine
survivin / p53 / her2 antigen - loaded autologous dendritic cell vaccine
anti - cldn6 monoclonal antibody asp1650
alk / trk inhibitor tsr - 011
bifidobacterium lactis / lactobacillus acidophilus / l . plantarum / l . salivarius probiotic supplement
psa / il - 2 / gm - csf vaccine
pronase oral solution
concentrated beet crystals
lugol's solution
her2 - pulsed autologous type - 1 polarized dendritic cell vaccine
il - 12 - expressing hsv - 1 nsc 733972
anti - ny - eso1 tcr - transduced autologous cd62l +  - derived t - lymphocytes
opebacan
beetroot juice
cridanimod sodium
belantamab mafodotin
recombinant leukoregulin
carboxyhemoglobin
pdgfra antibody
h - y antibody
ctsv gene
ctsv wt allele
cathepsin l2
scube2 gene
scube2 wt allele
signal peptide ,  cub and egf - like domain - containing protein 2
hots gene
hots wt allele
h19 opposite tumor suppressor
igf2 - as gene
igf2 - as wt allele
putative insulin - like growth factor 2 antisense gene protein
igf2 antisense rna
kcnq1ot1 gene
kcnq1ot1 wt allele
kcnq1 opposite strand / antisense transcript 1
aire gene
aire wt allele
autoimmune regulator
pdzk1 gene
pdzk1 wt allele
na (  +  )  / h (  +  )  exchange regulatory cofactor nhe - rf3
rhou gene
rhou wt allele
rho - related gtp - binding protein rhou
gng2 gene
gng2 wt allele
guanine nucleotide - binding protein g ( i )  / g ( s )  / g ( o )  subunit gamma - 2
gng11 gene
gng11 wt allele
guanine nucleotide - binding protein g ( i )  / g ( s )  / g ( o )  subunit gamma - 11
gng12 gene
gng12 wt allele
guanine nucleotide - binding protein g ( i )  / g ( s )  / g ( o )  subunit gamma - 12
prkce gene
prkce wt allele
protein kinase c epsilon type
polr2l gene
polr2l wt allele
lis ,  rat strain
dna - directed rna polymerases i ,  ii ,  and iii subunit rpabc5
new zealand rabbit
type ii hypersensitivity
type iii hypersensitivity
juvenile spondyloarthritis
gnao1 gene
gnao1 wt allele
guanine nucleotide - binding protein g ( o )  subunit alpha
tgfb1i1 gene
tgfb1i1 wt allele
transforming growth factor beta - 1 - induced transcript 1 protein
drug induced lupus erythematosus
mapkapk2 gene
mapkapk2 wt allele
juvenile idiopathic arthritis
juvenile polymyositis
map kinase - activated protein kinase 2
pik3c3 gene
juvenile psoriatic arthritis
pik3c3 wt allele
phosphatidylinositol 3 - kinase catalytic subunit type 3
hsd17b4 gene
hsd17b4 wt allele
peroxisomal multifunctional enzyme type 2
hsd3b1 gene
hsd3b1 wt allele
3 beta - hydroxysteroid dehydrogenase / delta 5 -  > 4 - isomerase type 1
antepartum uterine rupture
antepartum hemorrhage
intrapartum uterine rupture
intrapartum shock
intrapartum pyrexia
early postpartum hemorrhage
late postpartum hemorrhage
postpartum uterine inversion
dnr - expressing nasopharyngeal carcinoma - specific cytotoxic t - lymphocytes
copper cu 64 plerixafor
ny - eso - 1 ( 157 - 165 )  peptide - pulsed autologous dendritic cell vaccine
telaglenastat
redaporfin
ivosidenib
bh3 mimetic abt - 737
il - 12 - expressing mesenchymal stem cell vaccine gx - 051
artichoke whole phytocomplex concentrate
pad regimen
postpartum acute renal failure
postpartum thyroiditis
kininogen - 1
mark4 gene
mark4 wt allele
map / microtubule affinity - regulating kinase 4
rrp15 gene
rrp15 wt allele
rrp15 - like protein
vascular thrombosis
sycp1 gene
sycp1 wt allele
nafarelin acetate
synaptonemal complex protein 1
susd1 gene
susd1 wt allele
sushi domain - containing protein 1
postpartum shock
postpartum pyrexia
ush1g gene
ush1g wt allele
usher syndrome type - 1g protein
agalactia
plxnd1 gene
plxnd1 wt allele
plexin - d1
tmcc1 gene
tmcc1 wt allele
transmembrane and coiled - coil domains protein 1
tecta gene
tecta wt allele
alpha - tectorin
lactation suppression
irox regimen
operative report
tbcel gene
tbcel wt allele
tubulin - specific chaperone cofactor e - like protein
ssh2 gene
ssh2 wt allele
protein phosphatase slingshot homolog 2
slc26a6 gene
slc26a6 wt allele
solute carrier family 26 member 6
septin8 gene
septin8 wt allele
septin - 8
gemin2 gene
gemin2 wt allele
gem - associated protein 2
ptbp3 gene
ptbp3 wt allele
polypyrimidine tract - binding protein 3
rnf216 gene
rnf216 wt allele
e3 ubiquitin - protein ligase rnf216
rgs22 gene
rgs22 wt allele
regulator of g - protein signaling 22
rbms1 gene
rbms1 wt allele
rna - binding motif ,  single - stranded - interacting protein 1
rbm14 gene
rbm14 wt allele
rna - binding protein 14
rare childhood malignant neoplasm
ranbp2 gene
ranbp2 wt allele
e3 sumo - protein ligase ranbp2
content classification system term indicator
term uniform resource locator
digital data repository
annotation property
content model
electronic trial master file code
category description type
content requirement indicator
digital archive
category name
metadata use type
metadata content type
breast fibroglandular tissue
data property
4 - hydroxyestrone
enthesitis
macrophage activation syndrome
radiation damage
haploidy
near - haploidy
masked near - haploidy
allergic reaction
proximal tubulopathy
metabolic alkalosis
ureter compression
radiosensitivity index
il17f gene
il17f wt allele
childhood langerhans cell histiocytosis
interleukin - 17f
maml1 gene
maml1 wt allele
mastermind - like protein 1
hhv8 orf73 gene
latent nuclear antigen
hhv8 orf71 gene
flice inhibitory protein
hhv8 orf50 gene
putative transcription activator orf50
asciminib
yttrium y 90 colloid
glioma - associated peptide - loaded dendritic cell vaccine sl - 701
anagrelide prolonged - release formulation
relugolix
lutetium lu 177 pp - f11n
enfortumab vedotin
iodine i 124 - labeled anti - psca a11 minibody
hhv8 k2 gene
viral interleukin - 6 homolog
hhv8 orf74 gene
viral g - protein coupled receptor
hhv8 orf59 gene
dna polymerase processivity factor
rbpj gene
rbpj wt allele
recombining binding protein suppressor of hairless
adam19 gene
adam19 wt allele
disintegrin and metalloproteinase domain - containing protein 19
dvl1 gene
dvl1 wt allele
segment polarity protein dishevelled homolog dvl - 1
hes2 gene
hes2 wt allele
transcription factor hes - 2
heyl gene
heyl wt allele
hairy / enhancer - of - split related with yrpw motif - like protein
tagln gene
tagln wt allele
transgelin
grm2 gene
grm2 wt allele
metabotropic glutamate receptor 2
grm3 gene
grm3 wt allele
metabotropic glutamate receptor 3
grm4 gene
grm4 wt allele
metabotropic glutamate receptor 4
grm7 gene
grm7 wt allele
metabotropic glutamate receptor 7
grm8 gene
grm8 wt allele
metabotropic glutamate receptor 8
adult undifferentiated pleomorphic sarcoma
prkar2a gene
prkar2a wt allele
camp - dependent protein kinase type ii - alpha regulatory subunit
pla2r1 gene
pla2r1 wt allele
secretory phospholipase a2 receptor
carelex etmf terminology
content type name
data change date
organization role
digital signature status
pkd1l1 gene
pkd1l1 wt allele
polycystic kidney disease protein 1 - like 1
pde8b gene
pde8b wt allele
high affinity camp - specific and ibmx - insensitive 3' , 5' - cyclic phosphodiesterase 8b
loss of baf250a expression
childhood l1 acute lymphoblastic leukemia
breastfeeding jaundice
childhood l2 acute lymphoblastic leukemia
pacs1 gene
pacs1 wt allele
anti - ds dna antibody
phosphofurin acidic cluster sorting protein 1
anti - ss dna antibody
mcph1 gene
mcph1 wt allele
microcephalin
mboat2 gene
mboat2 wt allele
lysophospholipid acyltransferase 2
adult non - t non - b acute lymphoblastic leukemia
itpr2 gene
childhood non - t non - b acute lymphoblastic leukemia
itpr2 wt allele
inositol 1 , 4 , 5 - trisphosphate receptor type 2
non - t non - b calla negative childhood acute lymphoblastic leukemia
non - t non - b calla negative adult acute lymphoblastic leukemia
adult l2 acute lymphoblastic leukemia
ints4 gene
drug - induced nephropathy
ints4 wt allele
calcineurin nephrotoxicity
integrator complex subunit 4
jpt1 gene
jpt1 wt allele
jupiter microtubule associated homolog 1
renal impairment
adult tdt positive acute lymphoblastic leukemia
childhood tdt positive acute lymphoblastic leukemia
adult tdt negative acute lymphoblastic leukemia
childhood tdt negative acute lymphoblastic leukemia
shell vial culture
mixed osteosarcoma
adult pre - b acute lymphoblastic leukemia
lonidamine
childhood pre - b acute lymphoblastic leukemia
gmds gene
gmds wt allele
gdp - mannose 4 , 6 dehydratase
fhdc1 gene
fhdc1 wt allele
fh2 domain - containing protein 1
fermt2 gene
fermt2 wt allele
fermitin family homolog 2
fbxo38 gene
fbxo38 wt allele
f - box only protein 38
unc13d gene
unc13d wt allele
fbxl18 gene
fbxl18 wt allele
protein unc - 13 homolog d
stx11 gene
f - box / lrr - repeat protein 18
stx11 wt allele
syntaxin - 11
stxbp2 gene
stxbp2 wt allele
syntaxin - binding protein 2
ero1a gene
ero1a wt allele
ero1 - like protein alpha
eif3k gene
mast cell degranulation
eif3k wt allele
eukaryotic translation initiation factor 3 subunit k
dazl gene
dazl wt allele
deleted in azoospermia - like
still enjoy the things i used to enjoy
get a frightened feeling like something awful will happen
can laugh
have worrying thoughts
feel cheerful
can sit at ease and feel relaxed
periodontal screening and recording
cyp39a1 gene
ball - tipped periodontal probe
cyp39a1 wt allele
gingival sulcus
24 - hydroxycholesterol 7 - alpha - hydroxylase
periodontal screening and recording code
periodontal screening and recording code 0
periodontal screening and recording code 1
periodontal screening and recording code 2
periodontal screening and recording code 3
periodontal screening and recording code 4
cuta gene
cuta wt allele
protein cuta
endometrial adenosquamous carcinoma
ctage5 gene
ctage5 wt allele
endoplasmic reticulum export factor ctage5
bbs9 gene
bbs9 wt allele
protein pthb1
atp8b2 gene
atp8b2 wt allele
phospholipid - transporting atpase id
hemorrhagic cystitis
nephrolithiasis
feel slowed down
get a frightened feeling like butterflies in the stomach
have lost interest in appearance
feel restless
atg4c gene
atg4c wt allele
look forward with enjoyment
cysteine protease atg4c
get feelings of panic
can enjoy a book ,  radio ,  or tv program
a lot of the time
definitely as much
not quite so much
arfip1 gene
arfip1 wt allele
arfaptin - 1
only a little
hardly at all
very definitely and quite badly
agpat5 gene
urolithiasis
agpat5 wt allele
1 - acyl - sn - glycerol - 3 - phosphate acyltransferase epsilon
asic2 gene
yes ,  but not too badly
asic2 wt allele
a little ,  but it doesn't worry me
as much as always
ureterolithiasis
acid - sensing ion channel 2
oliguria
anuria
recombinant interleukin - 16
acbd6 gene
acbd6 wt allele
gross hematuria
acyl - coa - binding domain - containing protein 6
definitely not so much
myoglobinuria
a great deal of the time
hypercalciuria
hypocitraturia
not often
definitely
usually
nearly all the time
quite often
dialysis membrane reaction
don't take much care
may not take as much care
dialysis catheter fracture
take as much care
not very much
rather less
definitely less
dialysis catheter embolism
dialysis catheter infection
hemodialysis catheter infection
peritoneal dialysis catheter infection
dialysis catheter tunnel infection
dialysis catheter exit site infection
hemodialysis catheter - associated bacteremia
pyroptosis
plasma membrane calcium - transporting atpase
mprip gene
mprip wt allele
myosin phosphatase rho - interacting protein
wapl gene
wapl wt allele
wings apart - like protein homolog
synj1 gene
synj1 wt allele
synaptojanin - 1
znf281 gene
znf281 wt allele
zinc finger protein 281
bcl2l12 gene
bcl2l12 wt allele
bcl - 2 - like protein 12
pdk4 gene
pdk4 wt allele
 [ pyruvate dehydrogenase  [ lipoamide ]  ]  kinase isozyme 4 ,  mitochondrial
childhood undifferentiated pleomorphic sarcoma
childhood undifferentiated high grade pleomorphic sarcoma of bone
peritoneal dialysis catheter - associated peritonitis
chemical peritonitis
av fistula aneurysm
av fistula stenosis
egfrviii peptide vaccine
av fistula thrombosis
p - glycoprotein inhibitor
av graft aneurysm
childhood brain stem gliosarcoma
childhood brain stem mixed glioma
intensity - modulated spot - scanning proton therapy
av graft stenosis
av graft thrombosis
dialysis catheter obstruction
trisomy 22
carnitine palmitoyltransferase ii deficiency
galactokinase deficiency
loeys - dietz syndrome type 2
maturity - onset diabetes of the young
xeroderma pigmentosum ,  complementation group c
xeroderma pigmentosum ,  complementation group e
extracorporeal circuit clot
childhood brain oligodendroglioma
childhood supratentorial embryonal tumor ,  not otherwise specified
childhood central nervous system neuroblastoma
dialyzer blood leakage
adult germ cell tumor
adult intracranial germ cell tumor
central nervous system non - hodgkin lymphoma
av fistula maturation failure
dialysis disequilibrium syndrome
adult undifferentiated high grade pleomorphic sarcoma of bone
hodgkin lymphoma during pregnancy
non - hodgkin lymphoma during pregnancy
childhood subependymal giant cell astrocytoma
cxcl12 - abundant reticular cell
dimethyl ellagic acid
dimethyl ellagic acid glucuronide
tetany
apoptosis marker
basement membrane coverage measurement
pericyte coverage measurement
alkaline dnase
egfrviii antibody
pomc gene product
pro - opiomelanocortin
melanotropin alpha
elevated blood pressure measurement
kif5b / ret fusion gene
recombinant lymphotactin
kif5b / ret fusion protein
childhood gonadal germ cell tumor
page kidney
alox15b gene
alox15b wt allele
arachidonate 15 - lipoxygenase b
childhood favorable prognosis hodgkin lymphoma
adult favorable prognosis hodgkin lymphoma
childhood unfavorable prognosis hodgkin lymphoma
adult unfavorable prognosis hodgkin lymphoma
scn9a gene
scn9a wt allele
childhood pineoblastoma
sodium channel protein type 9 subunit alpha
nuf2 gene
nuf2 wt allele
kinetochore protein nuf2
imp3 gene
imp3 wt allele
adult b acute lymphoblastic leukemia with t ( 9 ; 22 )  ( q34 .1 ; q11 .2 )  ;  bcr - abl1
u3 small nucleolar ribonucleoprotein protein imp3
tertiary hyperparathyroidism
tjp1 gene
tjp1 wt allele
tight junction protein zo - 1
evl gene
evl wt allele
renal osteodystrophy
mucosal melanoma
ena / vasp - like protein
vitamin d deficiency
metastatic malignant neoplasm in the soft tissues
sox17 gene
childhood central nervous system embryonal neoplasm
sox17 wt allele
transcription factor sox - 17
recurrent childhood central nervous system embryonal neoplasm
uremic pericarditis
acute allograft nephropathy
acute cellular allograft nephropathy
lymphomatous involvement of non - cutaneous extranodal site
acute humoral allograft nephropathy
allograft thrombosis
osteolytic lesions of multiple myeloma
renal allograft thrombosis
extraosseous calcification
vascular calcification
human leukocyte antigen sensitization
hyperacute allograft rejection
right atrial thrombus
subclavian vein stenosis
renal lymphocele
new onset diabetes after transplant
delayed graft function
active duty status
patient military status icsr terminology
type of vaccination facility icsr terminology
reserve status
national guard status
tricare beneficiary
public health department facility
workplace clinic
student health clinic
pharmacy
x - ray - based angiogram
military healthcare facility
histone h2
mri - based angiogram
arrest of labor in active phase
arrest of labor in second stage
post - natal death at 16 - 20 weeks gestation
prolonged latent phase of labor
acute intrapartum hypoxic event
fetus large for gestational age
fetus small for gestational age
fetus small for gestational age with oligohydraminos
fetus small for gestational age with abnormal doppler
fetus small for gestational age with abdominal circumference less than tenth percentile
response assessment in neuro - oncology criteria
one year ago
much better
somewhat better
somewhat worse
much worse
cut down on amount of time spent on work or other activities
accomplished less than liked
limited in the kind of work or other activities
have difficulty performing work or other activities
manufactures animal prescription drugs
manufactures veterinary feed directive type a drugs
manufactures animal over - the - counter drugs
manufactures animal over - the - counter type a drugs
sprr1a gene
sprr1a wt allele
cornifin - a
sprr2a gene
sprr2a wt allele
small proline - rich protein 2a
transient neonatal diabetes mellitus
aluminum hydroxide / magnesium hydroxide
emotional problem
bodily pain
permanent neonatal diabetes mellitus
did work or other activities less carefully than usual
pain has interfered with normal work
feel full of life
neonatal thyrotoxicosis
transient neonatal hypoparathyroidism
nr1h4 gene
necrotizing enterocolitis totalis
spontaneous intestinal perforation
nr1h4 wt allele
bile acid receptor
have a lot of energy
feel worn out
get sick easier than others
jaw region
am as healthy as anybody
expect my health to get worse
rint1 gene
rint1 wt allele
rad50 - interacting protein 1
my health is excellent
adult epithelioid hemangioendothelioma
nt5e gene
nt5e wt allele
childhood epithelioid hemangioendothelioma
5' - nucleotidase
infant formula intolerance
adult langerhans cell histiocytosis
healthy term newborn
healthy preterm newborn
hormone - resistant breast carcinoma
hormone - resistant prostate carcinoma
small for gestational age
very low birth weight
extremely low birth weight
ultra low birth weight
late preterm infant
extremely preterm infant
malignant cardiovascular neoplasm
cyp7b1 gene
cyp7b1 wt allele
25 - hydroxycholesterol 7 - alpha - hydroxylase
leukemic infiltration of brain
atad5 gene
atad5 wt allele
postterm infant
atpase family aaa domain - containing protein 5
secondary central nervous system hodgkin lymphoma
secondary central nervous system non - hodgkin lymphoma
central nervous system hodgkin lymphoma
en1 gene
en1 wt allele
malignant biliary obstruction
homeobox protein engrailed - 1
recurrent childhood astrocytic tumor
hhex gene
hhex wt allele
hematopoietically - expressed homeobox protein hhex
congenital disruption
untreated childhood low grade astrocytic tumor
untreated childhood high grade astrocytic tumor
childhood fibrillary astrocytoma
childhood gemistocytic astrocytoma
clustered ring enhancement
childhood giant cell glioblastoma
childhood diffuse astrocytoma
childhood gliosarcoma
childhood gliomatosis cerebri
childhood pilomyxoid astrocytoma
childhood pleomorphic xanthoastrocytoma
childhood protoplasmic astrocytoma
childhood anaplastic oligoastrocytoma
childhood oligoastrocytoma
bazlitoran
rnr inhibitor coh29
etoposide toniribate
mage - a4 - specific tcr gene - transduced autologous t lymphocytes tbi - 1201
tozuleristide
mdm2 antagonist ro6839921
daclatasvir
asunaprevir
beclabuvir
entrectinib
ex vivo - activated autologous lymph node lymphocytes
e - 101 solution
adult combined hepatocellular carcinoma and cholangiocarcinoma
cd1 glycoprotein
anti - hcv e2 monoclonal antibody mbl - hcv1
multi - epitope folate receptor alpha - loaded dendritic cell vaccine
cd79
adult fibrolamellar carcinoma
adult pleomorphic hepatocellular carcinoma
untreated central nervous system neoplasm
ank2 gene
ank2 wt allele
ankyrin - 2
pogz gene
pogz wt allele
mafosfamide
pogo transposable element with znf domain
tpm2 gene
tpm2 wt allele
tropomyosin beta chain
usp13 gene
usp13 wt allele
ubiquitin carboxyl - terminal hydrolase 13
cavin3 gene
cavin3 wt allele
caveolae - associated protein 3
rce1 gene
rce1 wt allele
caax prenyl protease 2
vldlr gene
vldlr wt allele
very low - density lipoprotein receptor
htr2c gene
htr2c wt allele
5 - hydroxytryptamine receptor 2c
exceptional response
slc2a3 gene
slc2a3 wt allele
solute carrier family 2 ,  facilitated glucose transporter member 3
slc16a11 gene
slc16a11 wt allele
monocarboxylate transporter 11
ifi16 gene
ifi16 wt allele
gamma - interferon - inducible protein 16
ann arbor stage i noncutaneous childhood anaplastic large cell lymphoma
ann arbor stage ii noncutaneous childhood anaplastic large cell lymphoma
ann arbor stage iii noncutaneous childhood anaplastic large cell lymphoma
ann arbor stage iv noncutaneous childhood anaplastic large cell lymphoma
masaoka - koga stage ii
masaoka - koga stage iv
stage iva thyroid gland follicular carcinoma ajcc v7
stage ivb thyroid gland follicular carcinoma ajcc v7
stage ivc thyroid gland follicular carcinoma ajcc v7
stage iva thyroid gland papillary carcinoma ajcc v7
stage ivb thyroid gland papillary carcinoma ajcc v7
stage ivc thyroid gland papillary carcinoma ajcc v7
stage iia colon cancer ajcc v7
stage iib colon cancer ajcc v7
stage iic colon cancer ajcc v7
stage iia rectal cancer ajcc v7
stage iib rectal cancer ajcc v7
stage iic rectal cancer ajcc v7
stage iiia colon cancer ajcc v7
stage iiib colon cancer ajcc v7
stage iiic colon cancer ajcc v7
stage iiia rectal cancer ajcc v7
stage iiib rectal cancer ajcc v7
stage iiic rectal cancer ajcc v7
stage iva colon cancer ajcc v7
stage ivb colon cancer ajcc v7
stage iva rectal cancer ajcc v7
stage ivb rectal cancer ajcc v7
stage i lip and oral cavity squamous cell carcinoma ajcc v6 and v7
stage ii lip and oral cavity squamous cell carcinoma ajcc v6 and v7
stage iii lip and oral cavity squamous cell carcinoma ajcc v6 and v7
stage iv lip and oral cavity squamous cell carcinoma ajcc v6 and v7
stage iva lip and oral cavity squamous cell carcinoma ajcc v6 and v7
stage ivb lip and oral cavity squamous cell carcinoma ajcc v6 and v7
stage ivc lip and oral cavity squamous cell carcinoma ajcc v6 and v7
hoxa1 gene
hoxa1 wt allele
homeobox protein hox - a1
plce1 gene
plce1 wt allele
1 - phosphatidylinositol 4 , 5 - bisphosphate phosphodiesterase epsilon - 1
stage i sinonasal squamous cell carcinoma ajcc v6 and v7
stage ii sinonasal squamous cell carcinoma ajcc v6 and v7
stage iii sinonasal squamous cell carcinoma ajcc v6 and v7
stage iv sinonasal squamous cell carcinoma ajcc v7
stage iva sinonasal squamous cell carcinoma ajcc v7
stage ivb sinonasal squamous cell carcinoma ajcc v7
stage ivc sinonasal squamous cell carcinoma ajcc v7
ssh1 gene
ssh1 wt allele
protein phosphatase slingshot homolog 1
tle2 gene
tle2 wt allele
transducin - like enhancer protein 2
tle4 gene
tle4 wt allele
transducin - like enhancer protein 4
stage i oropharyngeal undifferentiated carcinoma ajcc v6 and v7
stage ii oropharyngeal undifferentiated carcinoma ajcc v6 and v7
stage iii oropharyngeal undifferentiated carcinoma ajcc v7
stage iv oropharyngeal undifferentiated carcinoma ajcc v7
stage iva oropharyngeal undifferentiated carcinoma ajcc v7
stage ivb oropharyngeal undifferentiated carcinoma ajcc v7
stage ivc oropharyngeal undifferentiated carcinoma ajcc v7
recurrent oropharyngeal undifferentiated carcinoma
stage iii primary peritoneal cancer ajcc v7
stage iiia primary peritoneal cancer ajcc v7
stage iiib primary peritoneal cancer ajcc v7
stage iiic primary peritoneal cancer ajcc v7
stage iv primary peritoneal cancer ajcc v7
letermovir
mannose - binding lectin
acoustic coupling fluid
anti - cd19 / cd3 tetravalent antibody afm11
cedazuridine / decitabine combination agent astx727
dioscorea nipponica makino extract dne3
fluorescent crgdy peg - cy5 .5 c dots
ovarian tumor antigen - activated autologous dendritic cell vaccine
stapuldencel - t
allogeneic multivirus - specific cytotoxic t lymphocytes
myc - targeting sirna dcr - myc
nazartinib
naquotinib
belapectin
ceritinib
cryab gene
cryab wt allele
alpha - crystallin b chain
circulating stem cell
stage ia esophageal cancer ajcc v7
stage ib esophageal cancer ajcc v7
stage iiia esophageal cancer ajcc v7
stage iiib esophageal cancer ajcc v7
stage iiic esophageal cancer ajcc v7
generic investigational new animal drug file
abbreviated new animal drug application
central serous chorioretinopathy
intelligence quotient
kaufman assessment battery for children
raven's progressive matrices
wechsler adult intelligence scale
woodcock - johnson tests of cognitive abilities
stage iia uterine sarcoma ajcc v7
stage iib uterine sarcoma ajcc v7
hepatocellular carcinoma by bclc stage
bclc stage 0 hepatocellular carcinoma
bclc stage
bclc stage a hepatocellular carcinoma
bclc stage b hepatocellular carcinoma
bclc stage c hepatocellular carcinoma
bclc stage d hepatocellular carcinoma
bclc stage 0 adult hepatocellular carcinoma
bclc stage a adult hepatocellular carcinoma
bclc stage b adult hepatocellular carcinoma
du - pan - 2
bclc stage c adult hepatocellular carcinoma
bclc stage d adult hepatocellular carcinoma
17pter - q21
pdgfr antibody
type v collagen antibody
tuba1b antibody
adenovirus infection
adult grade iii lymphomatoid granulomatosis
birc5 antibody
vascular stenosis
adult myelodysplastic syndrome
adult nasal type extranodal nk / t - cell lymphoma
tp53 antibody
magea3 antibody
nephrogenic systemic fibrosis
pmel antibody
blastic phase
dislodged peritoneal dialysis catheter
displaced peritoneal dialysis catheter
community - acquired pneumonia
nosocomial infection
sialitis
agrp gene
agrp wt allele
spontaneous bladder rupture
agouti - related protein
gja1 gene
gja1 wt allele
gap junction alpha - 1 protein
ano1 gene
ano1 wt allele
anoctamin - 1
cela1 gene
cela1 wt allele
chymotrypsin - like elastase family member 1
ppib gene
ppib wt allele
peptidyl - prolyl cis - trans isomerase b
mmrn1 gene
mmrn1 wt allele
multimerin - 1
muc2 gene
muc2 wt allele
mucin - 2
tff2 gene
tff2 wt allele
trefoil factor 2
tuba1b gene
childhood ependymal tumor
tuba1b wt allele
tubulin alpha - 1b chain
childhood mixed glioma
childhood pineal parenchymal cell neoplasm
brca1 mutation carrier
brca2 mutation carrier
cardiovascular complication
marcellomycin
localized castleman disease
childhood cerebellar anaplastic astrocytoma
childhood cerebral anaplastic astrocytoma
childhood embryonal tumor with multilayered rosettes ,  c19mc - altered
childhood grade iii lymphomatoid granulomatosis
untreated childhood pineoblastoma
cognitive side effects of cancer therapy
congenital amegakaryocytic thrombocytopenia
crohn disease - associated dysplasia of the colorectum
dermatologic complication
distal urethral carcinoma
familial testicular germ cell tumor
familial waldenstrom macroglobulinemia
fever ,  sweat ,  and hot flashes
digestive system complication
invariant natural killer t - cell
mucosal - associated invariant t - cell
slam - associated protein expression analysis
fair hair
fair skin
bleeding diathesis
health status unknown
healthy stem cell donor
hepatic complication
familial neuroblastoma
long - term effects secondary to cancer therapy
long - term effects secondary to cancer therapy in adults
university of washington quality of life scale ,  version 4
most important issue
mild pain not needing medication
have moderate pain that requires medication
have severe pain controlled only by narcotics
have severe pain not controlled by medication
no change in personal appearance
minor change in appearance
bothered by appearance but remain active
feel significantly disfigured and limit activities due to appearance
cannot be with people due to appearance
as active as have ever been
at times can't keep up with usual pace
often tired and have slowed down activities but still get out
don't go out because of lack of strength
usually in bed or chair and don't leave home
no limitations to recreation at home or away
metastatic digestive system neuroendocrine tumor g1
few limitations but still go out and enjoy life
many times wish to go out more but not up to it
methicillin - resistant staphylococcus aureus infection
severe limitations ,  mostly stay home and watch television
adult mixed glioma
can't do anything enjoyable
idua gene
adult primary melanocytic lesion of meninges
idua wt allele
alpha - l - iduronidase
can swallow as well as ever
pdcd5 gene
musculoskeletal complication
pdcd5 wt allele
cannot swallow certain solid foods
programmed cell death protein 5
can only swallow liquid food
adult myxopapillary ependymoma
cannot swallow because it causes choking
can chew as well as ever
grasp gene
grasp wt allele
general receptor for phosphoinositides 1 - associated scaffold protein
newly diagnosed carcinoma of unknown primary origin
newly diagnosed childhood ependymoma
can eat soft solids but cannot chew some foods
cannot even chew soft solids
speech is same as always
non - cancer diagnosis
uhrf1 gene
have difficulty saying some words but can be understood over the phone
only family and friends can understand me
uhrf1 wt allele
e3 ubiquitin - protein ligase uhrf1
cannot be understood
rheb gene
have no problem with shoulder
shoulder is stiff but has not affected activity or strength
rheb wt allele
pain or weakness in shoulder has caused work change
cannot work due to problems with shoulder
can taste food normally
can taste most foods normally
can taste some foods
cannot taste any foods
gtp - binding protein rheb
non - metastatic childhood soft tissue sarcoma
saliva is of normal consistency
have less saliva than normal ,  but it is enough
have too little saliva
have no saliva
nosocomial pneumonia
mood is excellent and unaffected by cancer
mood is generally good and only occasionally affected by cancer
dolasetron mesylate
neither in a good mood nor depressed about my cancer
somewhat depressed about my cancer
cdisc functional test terminology
extremely depressed about my cancer
cdisc functional test category terminology
not anxious about my cancer
a little anxious about my cancer
anxious about my cancer
very anxious about my cancer
outstanding
spen gene
spen wt allele
msx2 - interacting protein
cdh4 gene
cdh4 wt allele
cadherin - 4
mga gene
mga wt allele
max gene - associated protein
ophthalmologic complication
oral complication
oral complication of chemotherapy
oral complication of radiation therapy
foxq1 gene
foxq1 wt allele
forkhead box protein q1
pearson syndrome
adult pineal gland astrocytoma
gna13 gene
gna13 wt allele
guanine nucleotide - binding protein subunit alpha - 13
poor performance status
previously treated childhood rhabdomyosarcoma
untreated childhood rhabdomyosarcoma
proximal urethral carcinoma
proximal urethra
distal urethra
pulmonary complication
eat sufficient amount to meet needs
radiation retinopathy
worried about weight
most food tastes unpleasant
concerned about thinness of appearance
lose interest in food when trying to eat
have difficulty eating rich or heavy foods
experience pressure from family or friends to eat
have been vomiting
seem to get full quickly
general health is improving
recurrent adult grade iii lymphomatoid granulomatosis
centrifuged smear slide
recurrent adult undifferentiated high grade pleomorphic sarcoma of bone
recurrent borderline ovarian surface epithelial - stromal tumor
h1 - 4 gene
h1 - 4 wt allele
histone h1 .4
recurrent childhood anaplastic astrocytoma
recurrent childhood anaplastic large cell lymphoma
recurrent childhood anaplastic oligoastrocytoma
recurrent childhood anaplastic oligodendroglioma
recurrent childhood diffuse astrocytoma
recurrent childhood fibrillary astrocytoma
recurrent childhood gemistocytic astrocytoma
recurrent childhood giant cell glioblastoma
recurrent childhood glioblastoma
recurrent childhood gliosarcoma
recurrent childhood gliomatosis cerebri
recurrent childhood grade iii lymphomatoid granulomatosis
recurrent childhood undifferentiated high grade pleomorphic sarcoma of bone
recurrent childhood non - hodgkin lymphoma
recurrent childhood oligoastrocytoma
recurrent childhood oligodendroglioma
recurrent childhood pilocytic astrocytoma
recurrent childhood pilomyxoid astrocytoma
recurrent childhood pineoblastoma
recurrent childhood pleomorphic xanthoastrocytoma
recurrent childhood protoplasmic astrocytoma
mxra5 gene
mxra5 wt allele
matrix - remodeling - associated protein 5
recurrent childhood subependymal giant cell astrocytoma
recurrent childhood supratentorial embryonal tumor ,  not otherwise specified
rbm10 gene
rbm10 wt allele
recurrent olfactory neuroblastoma
recurrent malignant extragonadal germ cell tumor
rna - binding protein 10
cdisc functional test 6mwt test name terminology
cdisc functional test 6mwt test code terminology
cdisc functional test hai test name terminology
cdisc functional test hai test code terminology
cdisc functional test nhpt test name terminology
cdisc functional test nhpt test code terminology
cdisc functional test pasat test name terminology
cdisc functional test pasat test code terminology
cdisc functional test sdmt test name terminology
cdisc functional test sdmt test code terminology
cdisc functional test t25fw test name terminology
cdisc functional test t25fw test code terminology
cdisc functional test tug test name terminology
carbendazim
cdisc functional test tug test code terminology
cdisc questionnaire drs test name terminology
cdisc questionnaire drs test code terminology
cdisc questionnaire gose test name terminology
cdisc questionnaire gose test code terminology
cdisc questionnaire mpai - 4 test name terminology
cdisc questionnaire mpai - 4 test code terminology
cdisc questionnaire swls test name terminology
cdisc questionnaire swls test code terminology
6mwt functional test question
hai functional test question
nhpt functional test question
pasat functional test question
sdmt functional test question
t25fw functional test question
tug functional test question
drs questionnaire question
gose questionnaire question
mpai - 4 questionnaire question
swls questionnaire question
areflexia
eloc gene
eloc wt allele
elongin - c
zfhx3 gene
zfhx3 wt allele
zinc finger homeobox protein 3
recurrent malignant extragonadal non - seminomatous germ cell tumor
recurrent extragonadal seminoma
recurrent fallopian tube carcinoma
recurrent grade i lymphomatoid granulomatosis
recurrent grade ii lymphomatoid granulomatosis
recurrent sinonasal inverted papilloma
recurrent pancreatic neuroendocrine carcinoma
newsletter
advertisement
ajuba gene
ajuba wt allele
lim domain - containing protein ajuba
recurrent mycosis fungoides and sezary syndrome
recurrent merkel cell carcinoma
recurrent primary peritoneal carcinoma
recurrent lip and oral cavity squamous cell carcinoma
recurrent sinonasal squamous cell carcinoma
recurrent combined thymic epithelial neoplasm
recurrent childhood kidney neoplasm
prognosis treatment and perceptions questionnaire
preference for details of information about diagnosis and treatment
rating of the quality of information from oncologist about treatment choices
patient's primary goal of current cancer treatment
isotretinoin / temozolomide regimen
oncologist's primary goal of current cancer treatment
importance of knowing about cancer prognosis
conversation with oncologist about cancer prognosis
feelings about the amount of information known about cancer prognosis
quality of the information received about cancer prognosis
how helpful has knowing your prognosis been for making decisions about treatment
how helpful has knowing your prognosis been for preparing for the future
how helpful has knowing your prognosis been for maintaining hope
refractory childhood hodgkin lymphoma
renal toxicity
smoldering systemic mastocytosis
slowly progressive clinical course
clinical trial subject recruitment advertisement
institutional review board independent ethics committee advertisement for subject recruitment
contractual agreement
vendor confidentiality agreement
clinical trial import - export license application
sample size calculation
digital content category
audit certificate
interactive response technology user acceptance testing certificate
interactive response technology validation certificate
investigational product certificate of destruction
investigational product certificate of analysis
clinical trial data privacy agreement
clinical trial financial agreement
clinical trial investigator confidentiality agreement
clinical trial investigator regulatory agreement
etmf content model code
randomization programming code
institutional review board  -  independent ethics committee sponsor communication
study subject computed tomography image
edit check program
final analysis program
interim analysis program
clinical trial independent data monitoring committee correspondence
content item creator
clinical trial principal investigator curriculum vitae
clinical trial sub - investigator curriculum vitae
clinical trial team member curriculum vitae
laboratory director curriculum vitae
electronic data capture final output
final analysis dataset
interim analysis dataset
raw dataset for final analysis
raw dataset for interim analysis
study subject digital photograph
clinical trial operation documentation
clinical trial unblinding documentation
computed tomography study file
medroxyprogesterone acetate
digital photography study file
magnetic resonance imaging study file
nuclear medicine study file
ultrasound study file
centralized testing filenote
data management filenote
investigational product and clinical trial supplies filenote
safety filenote
statistics filenote
vendor filenote
study subject computed tomography report
study subject medical imaging report
study subject mri report
study subject nuclear medicine report
study subject radiography report
study subject ultrasound report
subject digital photograph report
clinical trial subject information form
clinical trial subject miscellaneous form
clinical trial subject participation form
completed case report form
data clarification form
investigational product quality complaint form
study subject medical imaging
clinical trial site personnel supporting information
investigational product handling instruction
clinical trial investigator brochure
investigational product sample label
specimen label
clinical trial principal investigator license
import - export license
clinical trial filenotes master list
clinical trial independent data monitoring committee member list
master randomization list
pharmacovigilance data list
biological sample storage condition log
clinical trial monitoring visit log
clinical trial subject enrollment log
clinical trial subject screen log
study subject magnetic resonance imaging
interactive response technology user manual
laboratory sample manual
bioanalytical validation method
taxonomy category name
clinical trial investigator newsletter
medical imaging file not otherwise specified
central clinical trial filenote
clinical trial management filenote
clinical trial regulatory filenote
clinical trial site management filenote
institutional review board  -  independent ethics committee filenote
clinical trial notification of safety information
interactive response technology user notification
study subject nuclear medicine image
final analysis output
interim analysis output
clinical trial oversight committee information
clinical trial publication policy
special event of interest document
clinical trial subject questionnaire
institutional review board independent ethics committee subject questionnaire
study subject radiograph
laboratory normal ranges
clinical trial non - investigational product supplies shipment documentation
investigational product accountability record
investigational product and clinical trial supplies communication record
investigational product return record
investigational product shipment record
investigational product transfer record
laboratory shipment record
record of retained body fluids or tissue sample
statistical report record
subject unblinding event record
bioanalytical report
clinical trial expedited safety report
clinical trial final report
clinical trial initiation monitoring report
clinical trial monitoring visit report
clinical trial pregnancy report
clinical trial regulatory status report
clinical trial status report documentation
final clinical trial close out monitoring report
final statistical report
institutional review board independent ethics committee clinical trial status report
institutional review board independent ethics committee report
interim statistical report
pre - clinical trial site evaluation report
serious adverse event report
institutional review board independent ethics committee subject diary
subject diary
database specification
external data transfer specification
interactive response technology user specification
debarment statement
institutional review board independent ethics committee good clinical practices compliance statement
transmissible spongiform encephalopathy statement
central trial communication material
central trial meeting material
centralized testing meeting material
clinical trial investigator meeting material
megestrol acetate
clinical trial kick - off meeting material
clinical trial management meeting material
clinical trial site management communication material
clinical trial site management meeting material
clinical trial site training material
clinical trial startup material
clinical trial team training material
data management meeting material
institutional review board  -  independent ethics committee communication material
institutional review board  -  independent ethics committee meeting material
investigational product and clinical trial supplies meeting material
regulatory communication material
regulatory meeting material
safety meeting material
statistic meeting material
vendor meeting material
institutional review board independent ethics committee submission
clinical trial team documentation
category type
study subject ultrasound image
database validation plan
randomization validation
how helpful has knowing your prognosis been for coping with the disease
adult subependymoma
how helpful has knowing your prognosis been overall
exceptional responder
database lock and unlock approval
clinical trial protocol amendment summary
clinical trial protocol synopsis
clinical study report synopsis
clinical trial safety documentation
clinical trial safety status report documentation
analysis documentation
analysis quality control document
approval for database activation document
biological sample export document
central clinical trial study documentation
central trial documentation
central trial tracking document
centralized testing communication document
centralized testing documentation
centralized testing tracking document
clinical trial centralized testing documentation
clinical data capture document
clinical trial adjudication committee document
clinical trial central laboratory certification document
clinical trial core documentation
clinical trial dose escalation document
clinical trial financial document
clinical trial indemnity document
clinical trial independent data monitoring committee charter
clinical trial insurance documentation
clinical trial interactive response technology documentation
clinical trial interfacility standardization method document
clinical trial investigator site documentation
clinical trial laboratory sample detail documentation
clinical trial management communication and tracking document
clinical trial management communication documentation
clinical trial management tracking documentation
clinical trial member detail documentation
clinical trial non - investigational product documentation
clinical trial non - investigational product supplies documentation of return
clinical trial notification of termination document
clinical trial notification to investigators of safety information document
clinical trial protocol deviation document
clinical trial regulatory approval documentation
clinical trial regulatory tracking document
clinical trial safety reporting documentation
clinical trial site feasibility document
clinical trial site initiation documentation
clinical trial site management tracking document
clinical trial site personnel contact document
clinical trial site selection documentation
clinical trial site task assignment document
clinical trial site training completion document
clinical trial subject document form
clinical trial supply storage condition document
clinical trial supply storage documentation
clinical trial supply storage excursion document
data definitions for analysis dataset document
data management communication document
data management document
data management documentation
data management oversight documentation
data management tracking document
data validation certification document
data validation test document
database account team management document
database management documentation
electronic data capture management team documentation
evidence of contractor compliance document
institutional review board  -  independent ethics committee shared documentation
institutional review board  -  independent ethics committee tracking document
institutional review board independent ethics committee additional subject information document
institutional review board independent ethics committee composition document
institutional review board independent ethics committee documentation of non - voting status document
institutional review board independent ethics committee human subject in research approval documentation
institutional review board independent ethics committee informed consent document
institutional review board independent ethics committee notification of safety information document
institutional review board independent ethics committee notification of trial termination document
recombinant gro1 protein
institutional review board independent ethics committee subject information document
institutional review board independent ethics committee subject participation document
investigational medicinal product documentation
investigational product and trial supplies tracking documentation
investigational product and clinical trial supplies tracking document
investigational product and trial supplies shipping handling and labeling documentation
investigational product communications and tracking documentation
investigational product randomization documentation
investigational product regulatory release document
investigational product release process documentation
gm2 - klh vaccine / qs21
investigational product site release document
investigator brochure acceptance document
laboratory certification document
local laboratory certification or accreditation document
medical coding process document
medical imaging and imaging technique documentation
non - institutional review board independent ethics committee approved submission document
notification of regulatory identification number document
protocol amendment signature page
protocol signature page
qualified person investigational product certification document
radiography study file
randomization documentation
regulatory affair documentation
regulatory documentation not other wise specified
safety and clinical database reconciliation document
safety communication document
safety reporting documentation
safety tracking document
statistics communication and tracking documentation
statistic tracking document
statistics communication document
statistical analysis documentation
statistics oversight documentation
study registry document
subject evaluability criteria and classification document
submission response document
supplementary monitoring activity document
supplies and non - drug investigational product import document
unselected clinical trial site document
unspecified non - independent data monitoring committee document
vendor communication documentation
vendor documentation
vendor information documentation
vendor oversight document
vendor record documentation
vendor role and responsibility document
vendor selection process document
vendor tracking document
case report form annotation guideline
case report form guideline
data entry guideline
clinical trial medical monitoring plan
clinical trial monitoring plan
clinical trial non - investigational product supplies plan
clinical trial safety management plan
data management plan
database quality plan
investigational product recall plan
investigational product relabeling plan
uft / leucovorin
investigational product supply plan
statistical analysis plan
content type requirement
transfusion hemochromatosis
clinical trials operational procedure manual
trial master file plan
clinical trial management
current medical status
likelihood of cancer cure
clinical trial recruitment plan
wishes about care if dying
chosen course of treatment
urinary complication
prefer not to hear a lot of details
prefer to hear details in certain situations
financial disclosure summary
investigational product randomization plan
joint vendor quality assurance plan
randomization plan
standard operating procedure list
clinical trial management plan
clinical trial site communications and tracking management documentation
clinical trial site management documentation
clinical trial stakeholder communication plan
trial master file
electronic trial master file
perinephric hematoma
vascular access steal syndrome
subcapsular renal hematoma
6 minute walk functional test
hauser ambulation index functional test
nine - hole peg functional test
paced auditory serial addition functional test
symbol digit modalities functional test
timed 25 - foot walk functional test
timed up and go functional test
disability rating scale questionnaire
extended glasgow outcome scale questionnaire
mayo - portland adaptability inventory - 4 questionnaire
satisfaction with life scale questionnaire
mepitiostane
6mwt  -  distance at 1 minute
6mwt  -  distance at 2 minutes
6mwt  -  distance at 3 minutes
6mwt  -  distance at 4 minutes
6mwt  -  distance at 5 minutes
6mwt  -  distance at 6 minutes
hai  -  ambulation index
nhpt  -  time to complete 9 - hole peg test
nhpt  -  more than two attempts
pasat  -  total correct
pasat  -  percent correct
pasat  -  more than one attempt
pasat  -  total correct in first half
pasat  -  total correct in second half
pasat  -  total commission errors
pasat  -  total omission errors
sdmt  -  total score
t25fw  -  time to complete 25 - foot walk
t25fw  -  more than two attempts
tug  -  time to complete tug test
drs  -  eye opening
drs  -  communication ability
drs  -  motor response
drs  -  feeding
drs  -  toileting
drs  -  grooming
drs  -  level of functioning
drs  -  employability
gose  -  consciousness: obey simple commands
gose  -  independence in the home: assistance essential for daily living
gose  -  independence in the home: need frequent help at home
gose  -  independence in the home: assistance at home before injury
gose  -  independence outside the home: able to shop without assistance
gose  -  independence outside the home: able to shop without assistance before injury
gose  -  independence outside the home: travel locally without assistance
gose  -  independence outside the home: travel locally without assistance before injury
gose  -  work: able to work to previous capacity
gose  -  work: how restricted are they
gose  -  work: working or seeking employment before the injury
gose  -  social and leisure activities: resume regular social and leisure activities
gose  -  social and leisure activities: extent of restriction on social and leisure activities
gose  -  social and leisure activities: engage regular social and leisure activities before injury
gose  -  family and friendships: disruptive psychological problems
gose  -  family and friendships: extent of disruption or strain
gose  -  family and friendships: problems with family or friends before injury
gose  -  return to normal life: other current problems relating to injury
gose  -  return to normal life: similar problems before injury
gose  -  epilepsy: since injury any epileptic fits
gose  -  epilepsy: at risk of developing epilepsy
gose  -  epilepsy: most important factor in outcome
gose  -  gose overall score
mpai - 4  -  abilities: mobility
mpai - 4  -  abilities: use of hands
mpai - 4  -  abilities: vision
mpai - 4  -  abilities: audition
mpai - 4  -  abilities: dizziness
mpai - 4  -  abilities: motor speech
mpai - 4  -  abilities: verbal communication
mpai - 4  -  abilities: nonverbal communication
mpai - 4  -  abilities: attention or concentration
mpai - 4  -  abilities: memory
mpai - 4  -  abilities: fund of information
mpai - 4  -  abilities: novel problem - solving
mpai - 4  -  abilities: visuospatial abilities
mpai - 4  -  adjustment: anxiety
mpai - 4  -  adjustment: depression
mpai - 4  -  adjustment: irritability ,  anger ,  aggression
mpai - 4  -  adjustment: pain and headache
mpai - 4  -  adjustment: fatigue
mpai - 4  -  adjustment: sensitivity to mild symptoms
mpai - 4  -  adjustment: inappropriate social interaction
mpai - 4  -  adjustment: impaired self - awareness
mpai - 4  -  adjustment: family or significant relationships
mpai - 4  -  participation: initiation
mpai - 4  -  participation: social contact with fiends ,  work associates and others
mpai - 4  -  participation: leisure and recreational activities
mpai - 4  -  participation: self - care
mpai - 4  -  participation: residence
mpai - 4  -  participation: transportation
mpai - 4  -  participation: paid employment
mpai - 4  -  participation: other employment
mpai - 4  -  participation: other employment - social role
mpai - 4  -  participation: managing money and finances
mpai - 4  -  alcohol use pre - injury
mpai - 4  -  alcohol use post - injury
mpai - 4  -  drug use pre - injury
mpai - 4  -  drug use post - injury
mpai - 4  -  psychotic symptoms pre - injury
mpai - 4  -  psychotic symptoms post - injury
mpai - 4  -  law violations pre - injury
mpai - 4  -  law violations post - injury
mpai - 4  -  other condition causing physical impairment pre - injury
mpai - 4  -  other condition causing physical impairment post - injury
mpai - 4  -  other condition causing cognitive impairment pre - injury
mpai - 4  -  other condition causing cognitive impairment post - injury
swls  -  my life is close to ideal
swls  -  life conditions are excellent
swls  -  satisfied with my life
swls  -  have gotten important things
swls  -  live life over change nothing
methanol extraction residue of bcg
prefer to hear as many details as possible
primary goal to lessen suffering
primary goal to keep hoping
primary goal to have done everything
primary goal to extend life
untreated hairy cell leukemia
primary goal to cure the cancer
untreated hematopoietic and lymphoid cell neoplasm
primary goal to help cancer research
want more information about prognosis
untreated adult acute lymphoblastic leukemia
have right amount of information about prognosis
untreated adult acute myeloid leukemia
want less information about prognosis
untreated childhood acute lymphoblastic leukemia
untreated childhood myeloid neoplasm
important
untreated metastatic squamous cell carcinoma to neck with occult primary
extremely important
untreated childhood anaplastic astrocytoma
untreated childhood anaplastic oligoastrocytoma
very important
untreated childhood anaplastic oligodendroglioma
untreated childhood brain stem glioma
somewhat important
a little important
not at all important
helpful
very helpful
untreated childhood cerebellar astrocytoma
untreated childhood cerebral astrocytoma
a little helpful
untreated childhood diffuse astrocytoma
not at all helpful
untreated childhood fibrillary astrocytoma
healthy
relatively healthy
untreated childhood gemistocytic astrocytoma
relatively healthy and terminally ill
untreated childhood giant cell glioblastoma
seriously ill and not terminally ill
untreated childhood glioblastoma
seriously ill and terminally ill
untreated childhood gliomatosis cerebri
extend life as much as possible
untreated childhood gliosarcoma
relieve pain as much as possible
untreated childhood medulloblastoma
untreated childhood oligoastrocytoma
untreated childhood oligodendroglioma
untreated childhood pilocytic astrocytoma
untreated childhood pilomyxoid astrocytoma
untreated childhood pleomorphic xanthoastrocytoma
untreated childhood protoplasmic astrocytoma
untreated childhood subependymal giant cell astrocytoma
untreated childhood supratentorial primitive neuroectodermal tumor
untreated childhood visual pathway glioma
ureteral stenosis
tlr9 agonist duk - cpg - 001
gallium ga 68 - labeled - nodaga - mj9
carrageenan - containing gel
kmt2b gene
kmt2b wt allele
histone - lysine n - methyltransferase 2b
mucositis
infiltrating bladder urothelial carcinoma associated with urethral carcinoma
gangrenous umbilical hernia
dner gene
hsp70 - peptide tkd / il - 2 - activated autologous natural killer cells
chiauranib
dner wt allele
delta and notch - like epidermal growth factor - related receptor
myocd gene
myocd wt allele
myocardin
dendritic cell - targeting lentiviral vector id - lv305
larotrectinib
fluorine 18 f fludarabine
hla - dp0401 / 0402 - restricted mage - a3 - reactive t cell receptor - transduced autologous t cells
gallium ga 68 - dota - exendin - 4
indium in 111 - dota - exendin - 4
alpk2 gene
alpk2 wt allele
alpha - protein kinase 2
h4c5 gene
carbon nanoparticle - based formulation
h4c5 wt allele
neonatal herpes simplex infection
znf750 gene
znf750 wt allele
zinc finger protein 750
periorbital cellulitis
retinitis
bclaf1 gene
bclaf1 wt allele
bcl - 2 - associated transcription factor 1
localized adult undifferentiated high grade pleomorphic sarcoma of bone
localized childhood undifferentiated high grade pleomorphic sarcoma of bone
content model content type
meropenem
self - employed
salaried annual employment
hourly employment
streptococcal pharyngitis
cell culture procedure
radioresistance
tonsillitis
epiglottitis
omphalitis
circulating adipose stromal cell
crown - like structure
crown - like structures of the breast
pyruvate
prostaglandin d2
tmprss2 / etv5 fusion gene
tmprss2 / etv4 fusion gene
t ( 14 ; 20 )
melanoma - associated antigen family a
histone h3 lysine 27
5' - amp - activated protein kinase catalytic subunit alpha
xeliri regimen
procollagen type i c - terminal peptide
microrna 181
lamp2 gene
lamp2 wt allele
lysosome - associated membrane glycoprotein 2
socs2 gene
socs2 wt allele
suppressor of cytokine signaling 2
clec2a gene
clec2a wt allele
c - type lectin domain family 2 member a
prkaa1 gene
prkaa1 wt allele
5' - amp - activated protein kinase catalytic subunit alpha - 1
ces1 gene
ces1 wt allele
liver carboxylesterase 1
ces2 gene
ces2 wt allele
cocaine esterase
ltbr gene
ltbr wt allele
tumor necrosis factor receptor superfamily member 3
srsf1 gene
srsf1 wt allele
serine / arginine - rich splicing factor 1
central sleep apnea
pon1 gene
pon1 wt allele
serum paraoxonase / arylesterase 1
slx4 gene
slx4 wt allele
structure - specific endonuclease subunit slx4
dock8 gene
dock8 wt allele
dedicator of cytokinesis protein 8
aldh1a1 gene
aldh1a1 wt allele
retinal dehydrogenase 1
tnfsf8 gene
tnfsf8 wt allele
tumor necrosis factor ligand superfamily member 8
hour times nanomole per liter per gram
hour times micromole per liter per gram
liposomal mitoxantrone hydrochloride
anti - gitr monoclonal antibody mk - 4166
sulfatinib
long peptide vaccine 7
aurora a kinase inhibitor tas - 119
cd19car - cd3zeta - 4 - 1bb - cd28 - expressing autologous t - lymphocytes
lupartumab amadotin
iodine i 124 cpd - 1028
autologous cd8 +  melanoma specific t cells
chlorogenic acid
empesertib
copper cu 64 - dota - ae105
very
chance
cep76 gene
cep76 wt allele
centrosomal protein of 76 kda
dialysis access complication
tpx2 gene
tpx2 wt allele
targeting protein for xklp2
zranb3 gene
zranb3 wt allele
dna annealing helicase and endonuclease zranb3
stx2 gene
stx2 wt allele
syntaxin - 2
trim23 gene
trim23 wt allele
e3 ubiquitin - protein ligase trim23
fdg - pet scanning finding
tumor complete metabolic response by pet
likely tumor complete metabolic response by pet
cabcoco1 gene
likely residual metabolic tumor activity by pet
cabcoco1 wt allele
metoprine
definite residual metabolic tumor activity by pet
ciliary - associated calcium - binding coiled - coil protein 1
likely inflammatory activity by pet
cdisc sdtm nervous system physiology test name terminology
cdisc sdtm nervous system physiology test code terminology
cdisc sdtm pharmacogenomics findings test name terminology
cdisc sdtm pharmacogenomics findings test code terminology
cdisc sdtm death diagnosis test name terminology
cdisc sdtm death diagnosis test code terminology
cdisc sdtm viral resistance findings test name terminology
cdisc sdtm viral resistance findings test code terminology
cdisc sdtm species terminology
spinous process
lethal injection euthanasia
lethal injection and exsanguination euthanasia
stent thrombosis
arterial segment
inhibitory concentration test
multiplex probe parameter
mri coil type
scintillation crystal type
data storage failure
image weighting type
interslice distance measurement
inversion time
number of slices
image acquisition dimensionality
decay correction indicator
randoms correction indicator
junctional escape complexes by ecg finding
asystole by ecg finding
undetermined rhythm by ecg finding
aberrantly conducted complexes by ecg finding
low voltage in limb leads only by ecg finding
non - diagnostic q waves by ecg finding
pr segment depression by ecg finding
short st segment by ecg finding
prolonged st segment by ecg finding
acc / aha ischemic ecg changes
12 lead placement right - sided precordial leads
acute myocardial ischemia by ecg assessment
standard uptake value ratio
secondary cause of death
mean vessel diameter
minimum vessel lumen diameter
percent diameter stenosis measurement
late lumen loss measurement
lesion restenosis indicator
in - stent restenosis indicator
every seven weeks
peripheral vascular intervention
single nucleotide polymorphism array
cross - linking immunoprecipitation high - throughput sequencing
two color microarray
direct sequencing
biopolymer sequencing
oligonucleotide array - based comparative genomic hybridization
bacterial artificial chromosome array - based comparative genomic hybridization
digital array
multiplex amplifiable probe hybridization
multiple complete digest restriction fragment mapping
multiplex ligation - dependent probe amplification
optical mapping
fifth lumbar spinous process
skin of the axilla
aortopulmonary window lymph node
aortoiliac artery segment
femoropopliteal artery segment
tibialcrural artery
right coronary artery ostium
posterolateral coronary artery
right ventricular branch of right coronary artery
left main coronary artery ostium
left main coronary artery body
left main coronary artery bifurcation
left anterior descending artery ostium
left circumflex artery ostium
left atrioventricular artery
left posterior descending artery
infrarenal aortic segment
popliteal artery above the knee
popliteal artery below the knee
tibioperoneal arterial trunk
accessory renal artery
inclusion body measurement
azurophilic granule measurement
heterophil measurement
heterophils to leukocytes ratio measurement
high absorption reticulocyte measurement
high absorption reticulocytes to total reticulocytes ratio measurement
low absorption reticulocyte measurement
low absorption reticulocytes to total reticulocytes ratio measurement
medium absorption reticulocyte measurement
medium absorption reticulocytes to total reticulocytes ratio measurement
cholera toxin b subunit igg antibody measurement
leukemic cells measurement
hepatitis c virus antigen measurement
idl particles measurement
metanephrine measurement
mid cell fraction measurement
methylene dimethane sulfonate
agranular neutrophils measurement
hypogranular neutrophil measurement
left shift neutrophil measurement
natural killer cell activity measurement
non - high density lipoprotein cholesterol measurement
neuron specific enolase measurement
osteoprotegerin measurement
parietal cell antibody measurement
platelet derived growth factor isoform ab measurement
platelet satellitism assessment
panel reactive antibody test
gamma tocopherol measurement
erythrocyte fragment measurement
hemodialysis extraction ratio
experimental organism malignant neuromyoblastoma
experimental organism benign acinar - islet cell tumor
phototoxicity study
anesthetized lethal injection euthanasia
anesthetized intravenous lethal injection euthanasia
anesthetized intraperitoneal lethal injection euthanasia
anesthetized intracardiac lethal injection euthanasia
anesthetized lethal injection exsanguination euthanasia
anesthetized lethal injection intravenous exsanguination euthanasia
anesthetized intraperitoneal lethal injection and exsanguination euthanasia
anesthetized intracardiac lethal injection and exsanguination euthanasia
intravenous lethal injection euthanasia
intraperitoneal lethal injection euthanasia
intracardiac lethal injection euthanasia
intravenous lethal injection and exsanguination euthanasia
intraperitoneal lethal injection and exsanguination euthanasia
intracardiac lethal injection and exsanguination euthanasia
biological allergy unit per milliliter
histamine equivalent prick unit
standardized allergy biological unit per milliliter
standardized allergy quality unit per milliliter
bioequivalent allergy unit per milliliter
allergenic protein nitrogen unit per milliliter
copies per microliter
log10 international units per milliliter
cells per kilogram
per thousand cells
millijoules per square centimeter
millimoles per minute per kilopascal
per nanoliter
cigar dosing unit
cigarette dosing unit
pipe dosing unit
half maximal inhibitory concentration subject result measurement
half maximal inhibitory concentration reference control result measurement
half maximal inhibitory concentration fold change from reference measurement
half maximal inhibitory concentration fold change from baseline measurement
95 percent maximal inhibitory concentration subject result measurement
95 percent maximal inhibitory concentration reference control result measurement
95 percent maximal inhibitory concentration fold change from reference measurement
95 percent maximal inhibitory concentration fold change from baseline measurement
inhibitory concentration net assessment measurement
atlantic daylight time
eastern daylight time
central daylight time
mountain daylight time
pacific daylight time
alaska daylight time
hawaii - aleutian daylight time
atlantic standard time
eastern standard time
central standard time
mountain standard time
pacific standard time
alaska standard time
hawaii - aleutian standard time
samoa standard time
chamorro standard time
plcd3 gene
plcd3 wt allele
1 - phosphatidylinositol 4 , 5 - bisphosphate phosphodiesterase delta - 3
lamc2 gene
lamc2 wt allele
laminin subunit gamma - 2
wtap gene
wtap wt allele
pre - mrna - splicing regulator wtap
past seven days frequency of aching muscles
past seven days frequency of aching joints
worst severity past seven days aching joints
hotair gene
hotair wt allele
past seven days aching joints interfering with usual or daily activities
hox transcript antisense rna
worst severity past seven days aching muscles
past seven days aching muscles interfering with usual or daily activities
past seven days bruise easily
past seven days frequency of hiccups
worst severity past seven days hiccups
ppargc1a gene
ppargc1a wt allele
peroxisome proliferator - activated receptor gamma coactivator 1 - alpha
asxl2 gene
asxl2 wt allele
putative polycomb group protein asxl2
cisd2 gene
n - methylformamide
cisd2 wt allele
cdgsh iron - sulfur domain - containing protein 2
hoxc10 gene
hoxc10 wt allele
homeobox protein hox - c10
map4k3 gene
map4k3 wt allele
mitogen - activated protein kinase kinase kinase kinase 3
sos1 gene
sos1 wt allele
apparent life threatening event
son of sevenless homolog 1
stertor
perinatal depression
respiratory depression
snoring
sinonasal adenocarcinoma ,  intestinal - type
kidney small cell carcinoma
sinonasal small cell carcinoma
trisomy 14 mosaicism
insulin sensitizer s - 707106
cd105 / yb - 1 / sox2 / cdh3 / mdm2 - polyepitope plasmid dna vaccine
liposomal curcumin
postpartum complication
antifungal agent f901318
siremadlin
androgen receptor antisense oligonucleotide azd5312
tangerine tomato juice
red tomato juice
autologous cd123car - cd28 - cd3zeta - egfrt - expressing t lymphocytes
anti - cd3 okt3 / humanized anti - gd2 3f8 bispecific antibody - activated t lymphocytes
synthetic glioblastoma tumor - associated peptides vaccine therapy apvac1
synthetic glioblastoma mutated tumor - specific peptides vaccine therapy apvac2
oculo - respiratory syndrome
pulmonary alveolar hemorrhage
central apnea
obstructive sleep apnea
hydrothorax
hypophonia
brain death
oncotype dx dcis score
low grade astrocytic tumor
idiopathic hypersomnia
trisomy 14
guillain - barre syndrome
non - communicating hydrocephalus
randomization protocol document
subject unblinding plan
pi3k / mtorc1 / mtorc2 inhibitor dcbci0901
fluorine f 18 dcfpyl
sirna - transfected peripheral blood mononuclear cells apn401
5 - fitc - labeled colon - heptapeptide
berzosertib
fluorine f 18 - av - 133
vactosertib
amenable
secondary raynaud phenomenon
primary raynaud phenomenon
behavioral insomnia of childhood
alice in wonderland syndrome
susac syndrome
auditory neuropathy spectrum disorder
functional hearing loss
hyperacusis
presbycusis
hyposmia
anosmia
dysosmia
cacosmia
phantosmia
hypogeusia
ageusia
phantogeusia
hyperesthesia
osimertinib
posterior fossa syndrome
cerebellar mutism
beacopp regimen
chronic infantile neurological cutaneous and articular syndrome
neuritis
external hydrocephalus
post - hemorrhagic hydrocephalus
post - inflammatory hydrocephalus
prostate imaging - reporting and data system
t ( 1 ; 14 )
tumor - associated macrophage
bone marrow - derived cell
emc - 92 - gene signature
alpha - hydroxyglutarate
deoxysphingolipid
cytotoxic granule protein
total nicotine equivalent
pdgfr - aa
pdgfr - bb
kit exon 17 mutation
pdgfra exon 12 mutation
pdgfra exon 14 mutation
pdgfra exon 18 mutation
mitomycin a
gfp regimen
hepatitis c antibody
microrna 9
procollagen - proline dioxygenase
adenovirus antibody
malate dehydrogenase
pasd1 antibody
cytochrome p450 family 11
abca1 gene
abca1 wt allele
phospholipid - transporting atpase abca1
isx gene
isx wt allele
intestine - specific homeobox
mttp gene
mttp wt allele
microsomal triglyceride transfer protein large subunit
apoa1 gene
apoa1 wt allele
apolipoprotein a - i
sar1b gene
sar1b wt allele
gtp - binding protein sar1b
bco1 gene
bco1 wt allele
beta , beta - carotene 15 , 15' - dioxygenase
plin2 gene
plin2 wt allele
perilipin - 2
4 - dimensional conformal radiation therapy
active breathing coordinator - mediated radiation therapy
image - guided adaptive radiation therapy
palliative radiation therapy
radiation therapy treatment planning and simulation
3 - dimensional conformal accelerated partial breast irradiation
accelerated partial breast irradiation
craniospinal irradiation
breast irradiation
partial breast irradiation
whole breast irradiation
4 - dimensional computed tomography
computed tomography perfusion imaging
thermoacoustic computed tomography
computed tomography - guided optical sensor - guided percutaneous needle biopsy
computed tomography - guided optical sensor - guided radiofrequency ablation
diffuse optical tomography
optical doppler tomography
ultrasound tomography
positron emission tomography with radiolabeled targeting agent
arterial spin labeling magnetic resonance imaging
chemical exchange saturation transfer magnetic resonance imaging
dynamic susceptibility contrast - enhanced magnetic resonance imaging
functional connectivity magnetic resonance imaging
high field strength magnetic resonance imaging
low field strength magnetic resonance imaging
magnetization transfer magnetic resonance imaging
multiparametric magnetic resonance imaging
secretin - enhanced magnetic resonance imaging
specimen ultra - high - field magnetic resonance imaging
superparamagnetic iron oxide magnetic resonance imaging
allogeneic hematopoietic stem cell transplantation with donor pretreatment
autologous ovarian tissue transplantation
bone graft
autologous - allogeneic tandem hematopoietic stem cell transplantation
autologous - autologous tandem hematopoietic stem cell transplantation
mesenchymal stem cell transplantation
t cell - depleted hematopoietic stem cell transplantation
tandem hematopoietic stem cell transplantation
double - unit umbilical cord blood transplantation
reduced - intensity transplant conditioning procedure
ex vivo - expanded cord blood progenitor cell infusion
t cell - depleted donor lymphocyte infusion
fresh frozen plasma transfusion
chromoendoscopy
confocal laser endomicroscopy
dermoscopy
electromagnetic navigation bronchoscopy
high - resolution microendoscopy
image - guided needle confocal laser endomicroscopy
fiber - optic spectroscopy
polarized reflectance spectroscopy
acoustic radiation force impulse imaging
bioelectric field imaging
diffuse optical imaging
diffusion kurtosis imaging
dynamic contrast - enhanced ultrasound imaging
fluorescence imaging
intraoperative imaging
laser doppler imaging
laser speckle imaging
kv / mv imaging
magnetic resonance thermal imaging
multispectral imaging
narrow band imaging
real - time position - tracking imaging
robotic - assisted imaging
ultrasound elasticity imaging
2 - ethylhydrazide
x - ray phase - contrast imaging
video - based 3 - dimensional surface imaging
contrast - enhanced harmonic endoscopic ultrasound
febrile seizure
multiphoton microscopy
diagnostic microscopy
image - guided surgery
percutaneous cryosurgery
robot - assisted endoscopic surgery
robot - assisted laparoscopic surgery
ultrasound - guided prostate biopsy
contrast - enhanced ultrasound - guided prostate biopsy
endoscopic ultrasound - guided fine - needle aspiration of the pancreas
celiac plexus neurolysis
endoscopic ultrasound - guided celiac plexus neurolysis
breath test
nitric oxide breath test
cardiopulmonary exercise testing
other intervention or procedure
cognitive intervention
communication intervention
computer - assisted intervention
internet - based intervention
caregiver - related intervention or procedure
computer - assisted smoking cessation intervention
intervention by caregiver
memory intervention
sham intervention
telephone - based intervention
infantile spasm
caregiver - assisted training
communication skills training
computer - assisted cognitive training
partner - assisted coping skills training
egfr tyrosine kinase inhibitor therapy
electrical stimulation pain therapy
electroporation - mediated plasmid dna vaccine therapy
fluid therapy
benign rolandic epilepsy
gene - modified tumor cell vaccine therapy
immunomodulation therapy
pretargeted radioimmunotherapy
pulsed - dose rate brachytherapy
subcutaneous hormonal therapy
synthetic tumor - associated peptide vaccine therapy
topical steroid therapy
tumor cell lysate vaccine therapy
acute normovolemic hemodilution
psychogenic seizure
allele - specific oligonucleotide real - time quantitative polymerase chain reaction
bioconductance measurement
case management
early infantile epileptic encephalopathy with burst - suppression
cell proliferation assay
circulating tumor cell analysis
clinical observation
cold ischemia procedure
warm ischemia procedure
placebo administration
positron emission mammography
radiomammography
cranial electrical stimulation
direct electrocortical stimulation
shear wave elastography
sonoelastography
comprehensive geriatric assessment
convection - enhanced delivery
electrodessication and curettage
erythema measurement
fluorescence angiography
follow - up care
fourier transform ion cyclotron resonance mass spectrometry
gastrointestinal stenting
dravet syndrome
athetosis
hyperkinesia
hypokinesia
serpina3 gene
serpina3 wt allele
alpha - 1 - antichymotrypsin
glrx gene
glrx wt allele
glutaredoxin - 1
subarachnoid hematoma
lig3 gene
subdural hematoma
lig3 wt allele
dna ligase 3
epidural hematoma
mad2l2 gene
mad2l2 wt allele
subgaleal hematoma
mitotic spindle assembly checkpoint protein mad2b
early myoclonic encephalopathy
clec11a gene
clec11a wt allele
clec11a gene product
c - type lectin domain family 11 member a
stem cell growth factor beta
diplegia
mitozolomide
motor deficit
gross motor delay
fine motor delay
apoa4 gene
apoa4 wt allele
apolipoprotein a - iv
havcr1 gene
havcr1 wt allele
hepatitis a virus cellular receptor 1
gckr gene
gckr wt allele
glucokinase regulatory protein
ulk1 gene
ulk1 wt allele
serine / threonine - protein kinase ulk1
mus81 gene
mus81 wt allele
crossover junction endonuclease mus81
2 - deoxy - d - glucose
utomilumab
cenps gene
cenps wt allele
centromere protein s
mdm2 inhibitor krt - 232
angiopoietin - 2 - specific fusion protein pf - 04856884
anti - enpp3 / mmaf antibody - drug conjugate ags - 16m8f
anti - angiopoietin monoclonal antibody amg 780
duligotuzumab
ifabotuzumab
anti - hepcidin monoclonal antibody ly2787106
cenpx gene
cenpx wt allele
centromere protein x
rpa2 gene
rpa2 wt allele
replication protein a 32 kda subunit
rpa3 gene
rpa3 wt allele
replication protein a 14 kda
immunologic technique
magnetic affinity cell sorting
microdialysis
microwave ablation
radioangiography
gsta4 gene
gsta4 wt allele
standard follow - up care
tracheal intubation
transarterial radioembolization
glutathione s - transferase a4
transurethral resection of bladder tumor
transversus abdominis plane block
pancreatic surgical procedure
prdx4 gene
transcranial magnetic stimulation
prdx4 wt allele
peroxiredoxin - 4
map1lc3b gene
map1lc3b wt allele
microtubule - associated proteins 1a / 1b light chain 3b
map1lc3c gene
map1lc3c wt allele
microtubule - associated proteins 1a / 1b light chain 3c
electrocorticography
ex - vivo umbilical cord blood expansion
dexi gene
dexi wt allele
dexamethasone - induced protein
camk1 gene
camk1 wt allele
calcium / calmodulin - dependent protein kinase type 1
atrn gene
atrn wt allele
attractin
psmb5 gene
psmb5 wt allele
proteasome subunit beta type - 5
smg1 gene
smg1 wt allele
serine / threonine - protein kinase smg1
wound care management
immune function testing
h2bc5 gene
thromboembolism prophylaxis
microsphere - mediated lymphocele prevention
h2bc5 wt allele
intraoperative complication management and prevention
histone h2b type 1 - d
clspn gene
clspn wt allele
claspin
fbxo5 gene
fbxo5 wt allele
f - box only protein 5
communication analysis
electromagnetic tracking device procedure
lymphedema management
psychosocial support for caregiver
support for caregiver
cystemustine
radiation shielding
spectrophotometry
tumor cell - encapsulating diffusion chamber implantation
tumor interstitial fluid pressure measurement
pasd1 gene
pasd1 wt allele
circadian clock protein pasd1
bradykinesia
floppy infant
dna plasmid encoding interleukin - 12 ino - 9012
gallium ga 68 ops202
autologous mage - a3 - specific hla - a*01 - restricted t cell receptor gene engineered lymphocytes
hyaluronic acid - containing topical cream
ethaselen
carbon c 13 acetate
venous stroke
indocyanine green / albumin solution
topical keratin
early onset primary dystonia
dopa - responsive dystonia
thymidylate synthase inhibitor dfp - 11207
palsy
gilteritinib
erb's palsy
klumpke palsy
psychogenic tremor
androgen receptor downregulator azd3514
alk inhibitor asp3026
inos dimerization inhibitor asp9853
ilorasertib
choreoathetosis
stereotypy
autologous cytomegalovirus - specific cytotoxic t - lymphocytes
autologous lymphoma immunoglobulin - derived scfv - chemokine dna vaccine
autologous tns9 .3 .55 - transduced cd34 - positive cells
fluorine f 18 l - glutamate derivative bay94 - 9392
bacteriophage phi x 174 vaccine
anti - cd33 monoclonal antibody bi 836858
cd30 car - expressing autologous t lymphocytes
cmv pp65 peptide - pulsed autologous dendritic cell vaccine
dalbavancin
anti - etbr / mmae antibody - drug conjugate dedn6526a
nucleoside analog dfp - 10917
anti - ly6e antibody - drug conjugate rg 7841
anti - mesothelin / mmae antibody - drug conjugate dmot4039a
lifastuzumab vedotin
vandortuzumab vedotin
photoacoustic imaging
dilpacimab
fluorometholone acetate ophthalmic suspension
diffusion coefficient
apparent diffusion coefficient
high - b - value diffusion - weighted imaging
ocular surface disease index
chk1 inhibitor gdc - 0425
movement disorder
tic
motor tic
phonic tic
simple tic
complex tic
corprolalia
il16 gene product
pro - interleukin - 16
tourettism
transient tic disorder
chronic tic disorder
congenital dysplasia
retinopathy of prematurity stage 0
transient neonatal pustular melanosis
early neonatal death
late neonatal death
anti - d hemolytic disease of the newborn
pinaverium bromide
undifferentiated connective tissue disease
brachyury - expressing modified vaccinia ankara - tricom vaccine
spondyloarthritis
spondylitis
linear scleroderma
scleroderma en coup de sabre
generalized morphea
erythema toxicum neonatorum
circumscribed morphea
pansclerotic morphea
mixed morphea
juvenile localized scleroderma
ianalumab
systemic sclerosis without skin involvement
carbon c 11 sepantronium bromide
diffuse cutaneous systemic sclerosis
patisiran
group b streptococcal infection ,  early - onset
blau syndrome
group b streptococcal infection ,  late - onset
idiopathic inflammatory myopathy
juvenile dermatomyositis sine myositis
childhood - onset systemic lupus erythematosus
congenital varicella zoster infection
diethylnorspermine
congenital varicella syndrome
overlap syndrome
neonatal sepsis
neonatal sepsis ,  early - onset
perflenapent emulsion
neonatal sepsis ,  late - onset
neonatal listeriosis
congenital listeriosis
invasive listeriosis
disseminated listeriosis
neonatal candidiasis
congenital candidiasis
disseminated candidiasis
invasive candidiasis
tetanus neonatorum
ophthalmia neonatorum
gonococcal ophthalmia neonatorum
neonatal chlamydia conjunctivitis
neonatal chemical conjunctivitis
neonatal dacryocystitis
forceps injury
vacuum extraction chignon
fracture related to birth
occipital diastasis
fracture of nose related to birth
fracture of spine related to birth
fracture of humerus related to birth
fracture of radius related to birth
fracture of ulna related to birth
fracture of femur related to birth
omphalorrhexis
tentorial tear related to birth
cns leukemia at diagnosis
cns1
cns2
cns3
cns 2a
cns 2b
cns 2c
splenic rupture related to birth
cns 3a
cns 3b
sternocleidomastoid injury related to birth
cns 3c
fenebrutinib
chk1 inhibitor gdc - 0575
genetically engineered ny - eso - 1 - specific t lymphocytes
anti - ny - eso - 1 immunotherapeutic gsk - 2241658a
anti - prame immunotherapeutic gsk2302032a
gsk - 3 inhibitor ly2090314
hdac inhibitor ar - 42
hsp90 inhibitor ds - 2248
bimagrumab
hyperpolarized carbon c 13 pyruvate
immediate - release oxymorphone hydrochloride liquid formulation
itacitinib
indium in 111 - labeled macroaggregated albumin
gandotinib
flt3 / abl / aurora kinase inhibitor kw - 2449
porcupine inhibitor wnt974
pan - raf inhibitor ly3009120
mage - a3 / 12 - specific tcr gene - transduced autologous pbls
vofatamab
recombinant human apolipoprotein ( a )  kringle v mg1102
anti - alpha5beta1 integrin antibody mint1526a
c - met inhibitor mk8033
hdm2 inhibitor mk - 8242
modified vaccinia virus ankara vaccine expressing p53
pegylated liposomal nanoparticle - based docetaxel prodrug mnk - 010
avelumab
simotaxel
gs / pan - notch inhibitor al101
stat inhibitor opb - 111077
smoothened antagonist tak - 441
thrombopoietin receptor agonist lgd - 4665
taselisib
paxalisib
polyethylene glycol polymer surgical sealant
recombinant adenovirus 5 encoding tumor necrosis factor - related apoptosis - inducing ligand
recombinant anti - wt1 immunotherapeutic gsk2302024a
anti - cd44 monoclonal antibody ro5429083
pi3k - beta inhibitor sar260301
serum - derived bovine immunoglobulin protein isolate
sustained - release lipid inhaled cisplatin
dutpase / dpd inhibitor tas - 114
dr5 - targeting tetrameric nanobody agonist tas266
technetium tc 99m trofolastat
lipid encapsulated anti - plk1 sirna tkm - plk1
nanoparticle albumin - bound thiocolchicine dimer nab - 5404
galunisertib
fgfr / vegfr / pdgfr / flt3 / src inhibitor xl999
craniotabes
cranial suture separation
fontanelle bulging
fontanelle depressed
congenital cystic hygroma
carboxyphenyl retinamide
phrenic nerve palsy related to birth
facial nerve palsy related to birth
acquired facial nerve palsy
spastic cerebral palsy
spastic quadriplegia
spastic hemiplegia
hypotonic cerebral palsy
subgaleal hemorrhage related to birth
intracranial laceration related to birth
cerebral hemorrhage related to birth
intracranial hemorrhage related to birth
intraventricular hemorrhage related to birth
intraventricular hemorrhage of prematurity
total tumor rna - loaded dendritic cell vaccine
autologous anti - cd19car - 4 - 1bb - cd3zeta - egfrt - expressing t lymphocytes
liquid tumor
progressive hemifacial atrophy
periodic fever ,  aphthous stomatitis ,  pharyngitis ,  adenitis syndrome
pulmonary trunk
central nervous system lupus
cognitive impairment
parkinsonism
akinesia
myoclonus
motor stereotypy
acute inflammatory demyelinating polyradiculoneuropathy
acute motor and sensory axonal neuropathy
acute motor axonal neuropathy
rad51d gene
rad51d wt allele
dna repair protein rad51 homolog 4
double cortex syndrome
chst3 gene
chst3 wt allele
polymicrogyria
carbohydrate sulfotransferase 3
cdk4 / 6 inhibition
fgfr inhibition
sult1c2 gene
sult1c2 wt allele
developmental delay
motor developmental delay
sulfotransferase 1c2
absence of mycn gene amplification
abcc6 gene
abcc6 wt allele
multidrug resistance - associated protein 6
lta4h gene
lta4h wt allele
leukotriene a - 4 hydrolase
fmo3 gene
fmo3 wt allele
dimethylaniline monooxygenase  [ n - oxide - forming ]  3
diencephalic syndrome of infancy
slfn11 gene
slfn11 wt allele
fisher syndrome
schlafen family member 11
opcml gene
opcml wt allele
opioid - binding protein / cell adhesion molecule
procollagen type i n - terminal peptide
telomeric repeat - containing rna
jak2 nm_004972 .3:c .2624c > a
jak2 np_004963 .1:p .t875n
egfr - grb2 complex
foxp3 treg - specific demethylated region
hsph1 t17 repeat
cyp2a7 gene
cyp2a7 wt allele
cytochrome p450 2a7
bacterial vaginosis
hsph1 gene
hsph1 wt allele
heat shock protein 105 kda
ctrp terminology
ctrp agent terminology
quality of life questionnaire  -  testicular cancer 26
have lost hair
have problems with sense of taste or smell
hsp90b2p gene
hsp90b2p wt allele
putative endoplasmin - like protein
primary sjogren syndrome
secondary sjogren syndrome
have pain in stomach area
have acid reflux
have numbness or tingling in fingers or toes
have skin problem
have pale or cold fingers or toes
have problem with hearing
satisfied with medical care received
lupus anticoagulant disorder
dnm1l gene
dnm1l wt allele
dynamin - 1 - like protein
apobec3a gene
apobec3a wt allele
miltefosine
dna dc to du - editing enzyme apobec - 3a
apobec3b gene
apobec3b wt allele
dna dc to du - editing enzyme apobec - 3b
migraine without aura
migraine with aura
apobec3a_b fusion hybrid gene
neurovascular disorder
satisfied with information received about disease or treatment
familial hemiplegic migraine
feel uncertain about the future
sporadic hemiplegic migraine
have been anxious about possible recurrence of disease
basilar - type migraine
cyclical vomiting
chronic migraine
have problem with job or education because of disease or treatment
have been physically limited as a result of disease or treatment
concerned about disruption of family life
concerned about ability to have children
ability to talk about disease with partner or person closest to you
mood
status migranosus
feel less masculine as a result of disease or treatment
migrainous infarction
extent of interest in sex
extent of sexual activity
can talk about sexuality with partner or person closest to you
have difficulty getting or maintaining an erection
have problem with ejaculation
extent of sexual enjoyment
have satisfying sexual relationship with partner
satisfied with testicular implant
sall2 gene
sall2 wt allele
sal - like protein 2
microrna 105
action taken with device
accepted record flag
analysis method
meddra body system or organ class code
dosing days to detection
planned end of assessment interval
evaluator identifier
evaluation interval text
exclude from statistics indicator
meddra high level group term code
meddra high level term code
meddra low level term code
link group identifier
record link identifier
record mood
accountable party
subject pool identifier
accountable party identifier
pharmaceutical strength unit
meddra preferred term code
reason for exclusion from statistics
run identifier
meddra primary system organ class code
sponsor device identifier
planned start of assessment interval
measurement ,  test or examination detail
mir135b gene
mir135b wt allele
mir135b pre - mirna
tnfsf12 gene
tnfsf12 wt allele
tumor necrosis factor ligand superfamily member 12
migraine - triggered seizure
tension headache
tnfrsf12a gene
tnfrsf12a wt allele
tumor necrosis factor receptor superfamily member 12a
trigeminal autonomic cephalalgia
fermt3 gene
fermt3 wt allele
cluster headache
primary cough headache
primary exertional headache
fermitin family homolog 3
hemicrania continua
new daily persistent headache
external compression headache
post - herpetic neuralgia
il27 gene
il27 wt allele
interleukin - 27 subunit alpha
ebi3 gene
ebi3 wt allele
interleukin - 27 subunit beta
dna2 gene
dna2 wt allele
dna replication atp - dependent helicase / nuclease dna2
maml3 gene
maml3 wt allele
mastermind - like protein 3
apoc3 gene
apoc3 wt allele
apolipoprotein c - iii
nabilone
fbp1 gene
fbp1 wt allele
fructose - 1 , 6 - bisphosphatase 1
juvenile systemic sclerosis
bullous systemic lupus erythematosus
discoid rash
malar rash
macular rash
hbv genotype assay
hcv genotype assay
spl business entity qualifier terminology
subacute cutaneous lupus erythematosus
lupus erythematosus tumidus
doing business as
ccrf - cem
fatty acid metabolism disorder
t ( 9 ; 22 )
classical phenylketonuria
igkv4 - 1 gene
molt - 4
igkv4 - 1 wt allele
ig kappa chain v - iv region
rpmi - 8226
igkv1d - 13 gene
igkv1d - 13 wt allele
ig kappa chain v - i region d - 13
sr
a549 / atcc
fcrl1 gene
fcrl1 wt allele
fc receptor - like protein 1
ekvx
fcrl2 gene
fcrl2 wt allele
hop - 62
fc receptor - like protein 2
hop - 92
nci - h226
bcl2l10 gene
bcl2l10 wt allele
bcl - 2 - like protein 10
nci - h23
laboratory test
cldn6 gene
cldn6 wt allele
claudin - 6
tfap2e gene
tfap2e wt allele
transcription factor ap - 2 - epsilon
microrna 19b
arrdc3 gene
arrdc3 wt allele
arrestin domain - containing protein 3
cyp2a13 gene
cyp2a13 wt allele
nci - h322m
cytochrome p450 2a13
nci - h460
nci - h522
colo 205
hcc - 2998
hct - 116
emotional distress
hct - 15
psychomotor agitation
km12
sw - 620
inner restlessness
motor restlessness
sf - 268
sf - 295
increased energy
thrsp gene
thrsp wt allele
sf - 539
thyroid hormone - inducible hepatic protein
snb - 19
kras np_004976 .2:p .g13x
snb - 75
u251
kras np_004976 .2:p .g12x
lox imvi
malme - 3m
m14
mda - mb - 435
t - cell chemokine
solute carrier family
amyloid
sk - mel - 2
sk - mel - 28
sk - mel - 5
uacc - 257
uacc - 62
repetitive behavior
psychomotor retardation
blunted affect
flat affect
apathy
tearfulness
depressed mood
nandrolone decanoate
vendor name
perinatal subependymal hemorrhage
intraventricular hemorrhage with parenchymal hemorrhage of the newborn
intraparenchymal hemorrhage of the newborn
igr - ov1
ovcar - 3
ovcar - 4
ovcar - 5
ovcar - 8
nci / adr - res
sk - ov - 3
786 - 0
a498
achn
caki - 1
rxf 393
sn12c
tk - 10
uo - 31
pc - 3
du - 145
original result or finding
character result or finding in standard format
mda - mb - 231 / atcc
mda - mb - 468
hs 578t
mda - n
bt - 549
t - 47d
anti - ceacam5 antibody - drug conjugate sar408701
pan - pi3k inhibitor clr457
allogeneic natural killer cell line nk - 92
cd28car / cd137car - expressing t - lymphocytes
il13ralpha2 - specific hinge - optimized 41bb - co - stimulatory car truncated cd19 - expressing autologous t - lymphocytes
alpha - tocopheryloxyacetic acid
idh1r132h - specific peptide vaccine pepidh1m
vegf / hgf - targeting darpin mp0250
ror1 car - specific autologous t - lymphocytes
flotetuzumab
anthocyanin - rich corn extract
hpv 16 e7 antigen - expressing lactobacillis casei vaccine bls - ilb - e710c
chimeric fibril - reactive monoclonal antibody cael - 101
slc6a2 gene
slc6a2 wt allele
sodium - dependent noradrenaline transporter
decreased attention
decreased concentration
herc2 gene
manic mood
herc2 wt allele
e3 ubiquitin - protein ligase herc2
mood lability
disinhibition
sphingolipidosis
dixdc1 gene
dixdc1 wt allele
dixin
znf395 gene
znf395 wt allele
zinc finger protein 395
oppositional behavior
aggression
nightmare
disordered thinking
racing thoughts
flight of ideas
infant irritability
hsp90b1 gene
hsp90b1 wt allele
endoplasmin
impaired judgment
periventricular hemorrhage of the newborn
heterotaxy syndrome
atenolol / chlorthalidone
gynostemma pentaphyllum supplement
benazepril / hydrochlorothiazide
demyelination
idh1 protein variant
idh2 protein variant
idh1 np_005887 .2:p .r132x
idh2 np_002159 .2:p .r140x
idh2 np_002159 .2:p .r172x
jak2 np_004963 .1:p .v617x
cytoplasmic nucleophosmin expression
obsessive thinking
amotivation
night terrors
isoquercetin
realgar - indigo naturalis formulation
mtorc1 / mtorc2 / dhfr inhibitor abtl0812
psma - targeted tubulysin b - containing conjugate ec1169
boceprevir
agonistic anti - ox40 monoclonal antibody medi6469
fluorine f 18 fluorobenzyl triphenyl phosphonium
cutaneous polyarteritis nodosa
orbital myositis
juvenile primary fibromyalgia syndrome
sequence of planned assessment schedule
anchor variable name
nilutamide
planned assessment interval
minimum time allowed in planned assessment interval
maximum time allowed in planned assessment interval
maximum number of actual assessments
associated persons domain
subarachnoid hemorrhage related to birth
subdural hemorrhage related to birth
benign familial convulsion
transient neonatal myasthenia gravis
extranodal involvement
poor sucking reflex
drug exposure via breast milk
breast engorgement in newborn
pseudomenstruation
neonatal vaginal discharge
subependymal pseudocyst
postpartum hysterectomy
selective reduction of multifetal pregnancy
frank umbilical cord prolapse
occult umbilical cord prolapse
acute placental infarction
subacute placental infarction
remote placental infarction
necrotizing funisitis
fetal chorionic vasculitis
umbilical vasculitis
intervillous thrombus
acute intervillous thrombus
subacute intervillous thrombus
remote intervillous thrombus
subchorial thrombus
retroplacental thrombus
fetal stem vessel thrombus
fetal stem vessel thrombus with or without dystrophic calcification
chorionic plate vessel thrombus
chorionic plate vessel thrombus with or without dystrophic calcification
uteroplacental vessel thrombus
placental finding
trimmed placental weight
untrimmed placental weight
larger axis of placenta
shorter axis of placenta
placental disc thickness
fused placenta
bilobate placenta
multilobate placenta
circummarginate placenta
circumvallate placenta
marginal cord insertion
velamentous cord insertion
ruptured velamentous vessel
velamentous vessel
blastomyces dermatitidis
umbilical cord true knot
coccidioides immitis
hypocoiled umbilical cord
hypercoiled umbilical cord
umbilical cord diameter
umbilical cord length
single umbilical artery
umbilical cord finding
pneumocystis jirovecii
scedosporium prolificans
umbilical cord discoloration
green fetal membrane
marginal insertion of fetal membrane
site of fetal membrane rupture
complete maternal surface of placenta
incomplete maternal surface of placenta
uniform color of placental parenchyma
mottled color of placental parenchyma
gross placental abruption
placental lesion
data value code
value null flavor
name of the reference terminology
version of the reference terminology
adverse event meddra body system or organ class code
adverse event meddra high level group term
adverse event meddra high level group term code
adverse event meddra high level term
adverse event meddra high level term code
adverse event meddra low level term
adverse event meddra low level term code
adverse event meddra preferred term code
adverse event meddra system organ class
adverse event meddra primary system organ class code
disease response accepted record flag
disease response category
date and time of disease response assessment
study day of disease response
disease response evaluator
disease response evaluator identifier
disease response group identifier
disease response link group
disease response link identifier
disease response vendor name
disease response original result
disease response reason not done
disease response reference identifier
novembichin
disease response sequence number
disease response sponsor defined identifier
disease response completion status
disease response assessment character result in standard format
disease response assessment test
disease response assessment test code
tumor results accepted record flag
tumor results date and time of assessment
study day of tumor results
tumor results evaluator
tumor results evaluator identifier
tumor results group identifier
tumor results link group
tumor results link identifier
tumor results method
tumor results vendor name
tumor results original result
tumor results original result unit
tumor results reason not done
tumor results reference identifier
tumor results sequence number
tumor results sponsor defined identifier
tumor results completion status
tumor results character result in standard format
tumor results numeric result in standard unit
tumor results standard unit
tumor results assessment test
tumor results assessment test code
tumor identifier accepted record flag
tumor identifier directionality
date and time of tumor identification
study day of tumor identification
tumor identifier evaluator
tumor identifier evaluator identifier
tumor identifier group identifier
tumor identifier laterality
tumor identifier link identifier
tumor identifier location
tumor identifier method
tumor identifier vendor name
pegylated liposomal doxorubicin / trastuzumab regimen
tumor identifier original result
tumor identifier portion or totality
tumor identifier reference identifier
tumor identifier sequence number
tumor identifier sponsor defined identifier
tumor identifier character result in standard format
tumor identifier test
tumor identifier test code
actual arm name
actual arm code
date and time of death
subject death flag
date and time of informed consent
date and time of end of participation
date and time of last study treatment
date and time of first study treatment
organism substrain
trial sets code
trial summary parameter value code
trial summary parameter value null flavor
trial summary parameter name of the reference terminology
trial summary parameter version of the reference terminology
trial sets sequence number
trial sets parameter
trial sets parameter code
trial sets value
exposure as collected domain
exposure as collected sequence number
exposure as collected group identifier
exposure as collected reference identifier
exposure as collected sponsor defined identifier
exposure as collected link identifier
exposure as collected link group
exposure as collected name of treatment
exposure as collected mood
exposure as collected category
exposure as collected subcategory
exposure as collected pre - specified
exposure as collected occurrence
exposure as collected dose
exposure as collected dose description
exposure as collected dose units
exposure as collected dose form
exposure as collected dosing frequency per interval
exposure as collected total daily dose
exposure as collected intended dose regimen
exposure as collected route of administration
exposure as collected lot number
exposure as collected location
exposure as collected laterality
exposure as collected directionality
exposure as collected portion or totality
exposure as collected fasting status
exposure as collected pharmaceutical strength
exposure as collected pharmaceutical strength units
exposure as collected reason for dose adjustment
exposure as collected start date and time of treatment
exposure as collected end date and time of treatment
exposure as collected start day
exposure as collected end day
olive oil
exposure as collected duration of treatment
exposure as collected planned time point name
exposure as collected planned time point number
exposure as collected elapsed time
exposure as collected time point reference
exposure as collected date time of reference timepoint
procedure sequence number
procedure group identifier
procedure sponsor defined identifier
procedure link identifier
procedure link group
reported name of procedure
standardized name of procedure
procedure category
procedure subcategory
procedure pre - specified
procedure occurrence
procedure indication
procedure dose
procedure dose description
procedure dose units
procedure dose form
procedure dosing frequency per interval
procedure intended dose regimen
procedure route of administration
procedure location
procedure laterality
procedure directionality
procedure portion or totality
start date and time of procedure
end date and time of procedure
procedure start day
procedure end day
procedure duration of procedure
procedure planned time point name
procedure planned time point number
procedure elapsed time
procedure time point reference
procedure date time of reference timepoint
procedure start relative to reference time point
procedure start reference time point
procedure end relative to reference time point
procedure end reference time point
death diagnosis sequence number
death diagnosis assessment test code
death diagnosis assessment test
death diagnosis original result
death diagnosis character result in standard format
death diagnosis evaluator
death diagnosis data collection date time
study day of death diagnosis
immunogenicity specimen assessments sequence number
immunogenicity specimen assessments group identifier
immunogenicity specimen assessments reference identifier
immunogenicity specimen assessments sponsor defined identifier
immunogenicity specimen assessments test code
immunogenicity specimen assessments test
immunogenicity specimen assessments category
immunogenicity specimen assessments subcategory
immunogenicity specimen assessments original result
immunogenicity specimen assessments original result unit
immunogenicity specimen assessments character result in standard format
immunogenicity specimen assessments numeric result in standard unit
immunogenicity specimen assessments result standard unit
immunogenicity specimen assessments completion status
immunogenicity specimen assessments reason not done
immunogenicity specimen assessments vendor name
immunogenicity specimen assessments specimen type
immunogenicity specimen assessments method
immunogenicity specimen assessments baseline flag
immunogenicity specimen assessments lower limit of quantitation
immunogenicity specimen assessments data collection date time
study day of immunogenicity specimen assessment
microscopic findings sequence number
microscopic findings group identifier
microscopic findings reference identifier
microscopic findings sponsor defined identifier
microscopic findings test code
microscopic findings test
microscopic findings measurement ,  test or examination detail
microscopic findings category
microscopic findings subcategory
microscopic findings original result
microscopic findings original result unit
microscopic findings character result in standard format
microscopic findings numeric result in standard unit
microscopic findings result standard unit
microscopic findings result category
microscopic findings completion status
microscopic findings reason not done
microscopic findings vendor name
microscopic findings specimen type
microscopic findings specimen condition
microscopic findings location
microscopic findings laterality
microscopic findings directionality
microscopic findings method
microscopic findings baseline flag
microscopic findings evaluator
microscopic findings data collection date time
olsalazine
study day of microscopic findings
morphology sequence number
morphology group identifier
morphology reference identifier
morphology sponsor defined identifier
morphology record link identifier
morphology test code
morphology test
morphology category
morphology subcategory
morphology position
morphology original result
morphology original result unit
morphology character result in standard format
morphology numeric result in standard unit
morphology result standard unit
morphology completion status
morphology reason not done
morphology external filename
morphology vendor name
morphology location
morphology laterality
morphology directionality
morphology portion or totality
morphology method
morphology analysis method
morphology baseline flag
morphology derived flag
morphology evaluator
morphology data collection date time
study day of morphology assessment
morphology planned time point name
morphology planned time point number
morphology elapsed time
morphology time point reference
morphology date time of reference timepoint
reproductive system findings sequence number
reproductive system findings group identifier
reproductive system findings reference identifier
reproductive system findings sponsor defined identifier
folfirinox regimen
reproductive system finding test code
reproductive system finding test
reproductive system findings category
reproductive system findings subcategory
reproductive system findings original result
reproductive system findings original result unit
reproductive system findings character result in standard format
reproductive system findings numeric result in standard unit
reproductive system findings result standard unit
reproductive system findings completion status
reproductive system findings reason not done
reproductive system findings baseline flag
reproductive system findings derived flag
reproductive system findings data collection date time
study day of reproductive system findings
subject status domain
subject status sequence number
subject status group identifier
subject status sponsor defined identifier
subject status test code
subject status test
subject status category
subject status subcategory
subject status original result
subject status character result in standard format
subject status completion status
subject status reason not done
subject status evaluator
subject status data collection date time
study day of subject status
skin response sequence number
skin response group identifier
skin response reference identifier
skin response sponsor defined identifier
skin response test code
skin response test
skin response observation object
skin response category
skin response subcategory
skin response original result
skin response original result unit
skin response character result in standard format
skin response numeric result in standard unit
skin response result standard unit
skin response completion status
skin response reason not done
skin response vendor name
skin response specimen type
skin response location
skin response laterality
skin response method
skin response evaluator
skin response data collection date time
study day of skin response assessment
skin response planned time point name
skin response planned time point number
skin response elapsed time
skin response time point reference
skin response date time of reference timepoint
trial disease assessments domain
oltipraz
trial disease sequence of planned assessment schedule
trial disease anchor variable name
trial disease offset from reference
trial disease planned assessment interval
trial disease minimum time allowed in planned assessment
trial disease maximum time allowed in planned assessment interval
trial disease maximum number of actual assessments
associated persons identifier
related subject identifier
subject ,  device ,  or study relationship
related device identifier
bovine immunodeficiency virus
bovine lentivirus group
equine lentivirus group
feline lentivirus group
ovine / caprine lentivirus group
primate lentivirus group
fda master file
neobladder
male reproductive system finding
female reproductive system finding
respirovirus
avulavirus
flumatinib mesylate
ny - eso - 1 - specific cd4 - positive t lymphocytes
autologous hnscc dna - transfected semi - allogeneic fibroblasts mrc - 5 vaccine
anti - egfr monoclonal antibody sct200
egfrviii - specific car - transduced autologous t lymphocytes
caix inhibitor slc - 0111
idecabtagene vicleucel
magrolimab
caix inhibitor dtp348
anti - cd70 antibody - drug conjugate sgn - cd70a
electrokinetically modified water
sitravatinib
anti c - kit antibody - drug conjugate lop628
vastus medialis muscle
cdisc sdtm graft type terminology
cdisc sdtm hepatic findings about test name terminology
cdisc sdtm hepatic findings about test code terminology
cdisc sdtm multiple sclerosis findings about test name terminology
cdisc sdtm multiple sclerosis findings about test code terminology
cdisc sdtm ophthalmic exam test name terminology
cdisc sdtm ophthalmic exam test code terminology
cdisc define - xml analysis reason terminology
cdisc define - xml analysis purpose terminology
cdisc sdtm west haven hepatic encephalopathy grade terminology
west haven criteria  -  west haven hepatic encephalopathy grade
lipase measurement
soluble tumor necrosis factor receptor measurement
data driven analysis
analysis requested by regulatory agency
analysis specified in protocol
analysis specified in statistical analysis plan
temporal anatomic qualifier
procedure agents domain
functional tests domain
healthcare encounters domain
device intended but not used
checkerboard square size
superimposition of multiple leads
comparison to a prior ecg
aggregate jt interval
aggregate jtcb interval
single beat jtcb interval
aggregate jtcf interval
single beat jtcf interval
aggregate j - t peak interval
single beat j - t peak interval
single beat jt interval
new q wave
aggregate pp interval
single measurement pp interval
aggregate pr interval
single beat pr interval
aggregate p wave duration
single beat p wave duration
aggregate p wave amplitude
single beat p wave amplitude
aggregate qrs duration
single beat qrs duration
paced ventricular aggregate qrs duration
paced ventricular single beat qrs duration
aggregate qt interval
aggregate qtcb interval
single beat qtcb interval
aggregate qtcf interval
single beat qtcf interval
single beat qt interval
aggregate q wave amplitude
single beat q wave amplitude
aggregate rr interval
rr interval single measurement
rs wave amplitude aggregate
rs wave amplitude single beat
r wave amplitude aggregate
r wave amplitude single beat
st segment depression aggregate
st segment depression single beat
st segment deviation aggregate
tilarginine
st segment deviation single beat
st segment elevation aggregate
st segment elevation single beat
st segment duration aggregate
st segment duration single beat
s wave amplitude aggregate
s wave amplitude single beat
ecg technical quality
t peak - t end interval aggregate
t peak - t end interval single beat
t wave area aggregate
t wave area single beat
t wave duration aggregate
t wave duration single beat
t wave amplitude aggregate
t wave amplitude single beat
free arterial graft
in situ arterial graft
autologous vein graft
cadaveric arterial graft
cadaveric venous graft
composite vessel graft
saphenous vein graft
synthetic vessel graft
west haven hepatic encephalopathy grade 0
west haven hepatic encephalopathy grade 1
west haven hepatic encephalopathy grade 2
west haven hepatic encephalopathy grade 3
west haven hepatic encephalopathy grade 4
albumin urine excretion rate
aspartate aminotransferase to creatinine ratio measurement
calcium urine excretion rate
chloride urine excretion rate
creatinine urine excretion rate
glucose urine excretion rate
soluble immunoglobulin measurement
soluble interleukin - 1 receptor type i measurement
soluble interleukin 6 receptor measurement
iron urine excretion rate
potassium urine excretion rate
gastric lipase measurement
pancreatic lipase measurement
lysosomal acid lipase measurement
microfilaria measurement
monoclonal protein spike measurement
phosphorus urine excretion rate
progesterone receptor measurement
promyeloblasts measurement
total protein urine excretion rate
protozoa measurement
p - selectin measurement
parathyroid hormone - related protein measurement
receptor activator nuclear kappab ligand measurement
dimorphic erythrocyte population
reticulocyte mean corpuscular hemoglobin measurement
sodium urine excretion rate
sclerostin measurement
strongyloides igg antibody measurement
terminal deoxynucleotidyl transferase antigen measurement
bioavailable testosterone measurement
transforming growth factor beta 1 measurement
tnf - a production inhibitory activity measurement
soluble tumor necrosis factor receptor type i measurement
soluble tumor necrosis factor receptor type ii measurement
tartrate - resistant acid phosphatase 5b measurement
urate to creatinine ratio measurement
varicella zoster virus antibody measurement
ankle mortise
paracaval lymph node
pericardial lymph node
porta hepatis lymph node
portacaval lymph node
subcarinal lymph node
tibialis anterior muscle
tracheobronchial tree
vastus intermedius muscle
early treatment of diabetic retinopathy study eye chart
pelli - robson contrast sensitivity eye chart
peripheral angiography
sloan letter eye chart 1 .25 percent
sloan letter eye chart 2 .5 percent
average thickness
which diagnostic criteria met
location of disease onset
focality of disease onset
n145 latency
n75 to p100 peak to peak amplitude
p100 latency
astigmatism axis
log score
number of correct eye chart letters
cylindrical refractive error
spherical refractive error
day times femtogram per milliliter per milligram per gram
day times femtogram per milliliter per milligram per gram per day
day times gram per milliliter per milligram per gram
day times gram per milliliter per milligram per gram per day
day times milligram per milliliter per milligram per gram
day times milligram per milliliter per milligram per gram per day
protein e7 ,  human papillomavirus type 16
day times millimole per liter per milligram per gram
day times millimole per liter per milligram per gram per day
day times mole per liter per milligram per gram
day times mole per liter per milligram per gram per day
day times nanogram per milliliter per milligram per gram
day times nanogram per milliliter per milligram per gram per day
day times nanomole per liter per milligram per gram
day times nanomole per liter per milligram per gram per day
day times picogram per milliliter per milligram per gram
day times picogram per milliliter per milligram per gram per day
day times picomole per liter per milligram per gram
day times picomole per liter per milligram per gram per day
day times microgram per milliliter per milligram per gram
day times microgram per milliliter per milligram per gram per day
day times micromole per liter per milligram per gram
day times micromole per liter per milligram per gram per day
hour times femtogram per milliliter per milligram per gram
hour times femtogram per milliliter per milligram per gram per day
hour times gram per milliliter per milligram per gram
hour times gram per milliliter per milligram per gram per day
hour times milligram per milliliter per milligram per gram
hour times milligram per milliliter per milligram per gram per day
hour times millimole per liter per milligram per gram
hour times millimole per liter per milligram per gram per day
hour times mole per liter per milligram per gram
hour times mole per liter per milligram per gram per day
hour times nanogram per milliliter per milligram per gram
hour times nanogram per milliliter per milligram per gram per day
hour times nanomole per liter per milligram per gram
hour times nanomole per liter per milligram per gram per day
hour times picogram per milliliter per milligram per gram
hour times picogram per milliliter per milligram per gram per day
hour times picomole per liter per milligram per gram
hour times picomole per liter per milligram per gram per day
hour times microgram per milliliter per milligram per gram
hour times microgram per milliliter per milligram per gram per day
hour times micromole per liter per milligram per gram
hour times micromole per liter per milligram per gram per day
minute times femtogram per milliliter per milligram per gram
minute times femtogram per milliliter per milligram per gram per day
minute times gram per milliliter per milligram per gram
minute times gram per milliliter per milligram per gram per day
minute times milligram per milliliter per milligram per gram
minute times milligram per milliliter per milligram per gram per day
minute times millimole per liter per milligram per gram
minute times millimole per liter per milligram per gram per day
minute times mole per liter per milligram per gram
minute times mole per liter per milligram per gram per day
minute times nanogram per milliliter per milligram per gram
minute times nanogram per milliliter per milligram per gram per day
minute times nanomole per liter per milligram per gram
minute times nanomole per liter per milligram per gram per day
minute times picogram per milliliter per milligram per gram
minute times picogram per milliliter per milligram per gram per day
minute times picomole per liter per milligram per gram
minute times picomole per liter per milligram per gram per day
minute times microgram per milliliter per milligram per gram
minute times microgram per milliliter per milligram per gram per day
minute times micromole per liter per milligram per gram
minute times micromole per liter per milligram per gram per day
diagnostic criteria
relapse criteria
severity criteria
percent inhibition
per picoliter
immunoglobin a phospholipid unit per milliliter
bethesda unit
bethesda unit per milliliter
disintegration per minute per 100 milligrams
disintegration per minute per milligram
cisplatin / cyclophosphamide / dexamethasone / etoposide / thalidomide regimen
disintegration per minute per milliliter
immunoglobin g phospholipid unit per milliliter
log10 copies per milliliter
immunoglobin m phospholipid unit per milliliter
nanomole bone collagen equivalent per liter
microequivalent per liter
ideal body weight
experimental organism benign keratoacanthoma
preputial gland / clitoral gland
plantaris muscle
sternocephalicus muscle
cornish cross chicken
domestic animal
oxalate to creatinine ratio measurement
pediatric infectious disorder
nelipepimut - s
cdisc questionnaire chart - sf interview version test name terminology
cdisc questionnaire chart - sf interview version test code terminology
cdisc questionnaire c - ssrs lifetime / recent version test name terminology
cdisc questionnaire c - ssrs lifetime / recent version test code terminology
cdisc clinical classification esrs - a test name terminology
cdisc clinical classification esrs - a test code terminology
chart - sf interview version questionnaire question
c - ssrs lifetime / recent version questionnaire question
esrs - a clinical classification question
craig handicap assessment and reporting technique - short form interview version questionnaire
columbia - suicide severity rating scale lifetime / recent version questionnaire
extrapyramidal symptom rating scale - abbreviated clinical classification
chart - sf interview version  -  paid personal care per day
chart - sf interview version  -  unpaid personal care per day
recombinant oncostatin m
chart - sf interview version  -  cognitive assistance at home per day
chart - sf interview version  -  cognitive assistance away from home per day
chart - sf interview version  -  hours out of bed per day
chart - sf interview version  -  days out of the house per week
chart - sf interview version  -  nights away from home last year
chart - sf interview version  -  hours of paid work per week
chart - sf interview version  -  occupation of paid work
chart - sf interview version  -  hours of schoolwork per week
chart - sf interview version  -  hours of homemaking per week
chart - sf interview version  -  hours of home maintenance per week
chart - sf interview version  -  hours of recreational activities per week
chart - sf interview version  -  number of people you live with
chart - sf interview version  -  live with spouse or significant other
chart - sf interview version  -  number of relatives you live with
chart - sf interview version  -  associates contacted per month
chart - sf interview version  -  friends contacted per month
chart - sf interview version  -  initiated conversation with strangers last month
chart - sf interview version  -  combined annual household income last year
chart - sf interview version  -  medical care expense last year
c - ssrs lifetime / recent version  -  wish to be dead  ( lifetime )
c - ssrs lifetime / recent version  -  wish to be dead  ( past 1 month )
c - ssrs lifetime / recent version  -  description of wish to be dead
c - ssrs lifetime / recent version  -  non - specific active suicidal thoughts  ( lifetime )
c - ssrs lifetime / recent version  -  non - specific active suicidal thoughts  ( past 1 months )
c - ssrs lifetime / recent version  -  description of non - specific active suicidal thoughts
c - ssrs lifetime / recent version  -  active suicidal ideation with any methods  ( not plan )  without intent to act  ( lifetime )
c - ssrs lifetime / recent version  -  active suicidal ideation with any methods  ( not plan )  without intent to act  ( past 1 month )
c - ssrs lifetime / recent version  -  description of active suicidal ideation with any methods  ( not plan )  without intent to act
c - ssrs lifetime / recent version  -  active suicidal ideation with some intent to act ,  without specific plan  ( lifetime )
c - ssrs lifetime / recent version  -  active suicidal ideation with some intent to act ,  without specific plan  ( past 1 month )
c - ssrs lifetime / recent version  -  description of active suicidal ideation with some intent to act ,  without specific plan
c - ssrs lifetime / recent version  -  active suicidal ideation with specific plan and intent  ( lifetime )
c - ssrs lifetime / recent version  -  active suicidal ideation with specific plan and intent  ( past 1 month )
c - ssrs lifetime / recent version  -  description of active suicidal ideation with specific plan and intent
c - ssrs lifetime / recent version  -  most severe ideation  ( lifetime )
c - ssrs lifetime / recent version  -  describe most severe ideation  ( lifetime )
c - ssrs lifetime / recent version  -  recent most severe ideation  ( past 1 month )
c - ssrs lifetime / recent version  -  describe recent most severe ideation  ( past 1 month )
c - ssrs lifetime / recent version  -  frequency of most severe ideation  ( lifetime )
c - ssrs lifetime / recent version  -  frequency of most severe ideation  ( past 1 month )
c - ssrs lifetime / recent version  -  duration of most severe ideation  ( lifetime )
c - ssrs lifetime / recent version  -  duration of most severe ideation  ( past 1 month )
c - ssrs lifetime / recent version  -  controllability of most severe ideation  ( lifetime )
c - ssrs lifetime / recent version  -  controllability of most severe ideation  ( past 1 month )
c - ssrs lifetime / recent version  -  deterrents to most severe ideation  ( lifetime )
c - ssrs lifetime / recent version  -  deterrents to most severe ideation  ( past 1 month )
c - ssrs lifetime / recent version  -  reasons for most severe ideation  ( lifetime )
c - ssrs lifetime / recent version  -  reasons for most severe ideation  ( past 1 month )
c - ssrs lifetime / recent version  -  actual suicide attempt  ( lifetime )
c - ssrs lifetime / recent version  -  actual suicide attempt  ( past 3 months )
c - ssrs lifetime / recent version  -  number of actual suicide attempts  ( lifetime )
c - ssrs lifetime / recent version  -  number of actual suicide attempts  ( past 3 months )
c - ssrs lifetime / recent version  -  description of actual suicide attempt
c - ssrs lifetime / recent version  -  non - suicidal self - injurious behavior  ( lifetime )
c - ssrs lifetime / recent version  -  non - suicidal self - injurious behavior  ( past 3 months )
c - ssrs lifetime / recent version  -  interrupted suicide attempt  ( lifetime )
c - ssrs lifetime / recent version  -  interrupted suicide attempt  ( past 3 months )
c - ssrs lifetime / recent version  -  number of interrupted suicide attempts  ( lifetime )
c - ssrs lifetime / recent version  -  number of interrupted suicide attempts  ( past 3 months )
c - ssrs lifetime / recent version  -  description of interrupted suicide attempt
c - ssrs lifetime / recent version  -  aborted suicide attempt  ( lifetime )
c - ssrs lifetime / recent version  -  aborted suicide attempt  ( past 3 months )
c - ssrs lifetime / recent version  -  number of aborted suicide attempts  ( lifetime )
c - ssrs lifetime / recent version  -  number of aborted suicide attempts  ( past 3 months )
c - ssrs lifetime / recent version  -  description of aborted suicide attempt
c - ssrs lifetime / recent version  -  preparatory acts or behaviors toward suicide attempt  ( lifetime )
c - ssrs lifetime / recent version  -  preparatory acts or behaviors toward suicide attempt  ( past 3 months )
c - ssrs lifetime / recent version  -  description of preparatory acts or behaviors toward suicide attempt
c - ssrs lifetime / recent version  -  suicidal behavior  ( lifetime )
c - ssrs lifetime / recent version  -  suicidal behavior  ( past 3 months )
c - ssrs lifetime / recent version  -  most recent suicide attempt date
c - ssrs lifetime / recent version  -  most recent suicide attempt actual lethality / medical damage
c - ssrs lifetime / recent version  -  most recent suicide attempt potential lethality
c - ssrs lifetime / recent version  -  most lethal suicide attempt date
c - ssrs lifetime / recent version  -  most lethal suicide attempt actual lethality / medical damage
c - ssrs lifetime / recent version  -  most lethal suicide attempt potential lethality
c - ssrs lifetime / recent version  -  first suicide attempt date
c - ssrs lifetime / recent version  -  first suicide attempt actual lethality / medical damage
c - ssrs lifetime / recent version  -  first suicide attempt potential lethality
esrs - a  -  rigidity: upper limbs
esrs - a  -  rigidity: lower limbs
esrs - a  -  rigidity: neck
esrs - a  -  tremor: face / jaw / chin / lips / head
esrs - a  -  tremor: upper limbs / hands
esrs - a  -  tremor: lower limbs / feet
esrs - a  -  reduced facial expression / speech
esrs - a  -  impaired gait / posture
esrs - a  -  postural instability
esrs - a  -  bradykinesia / hypokinesia
esrs - a  -  dystonia: tongue
esrs - a  -  dystonia: jaw
esrs - a  -  dystonia: eyes / upper and lower face / larynx
esrs - a  -  dystonia: shoulder / upper limbs / hands
esrs - a  -  dystonia: hips / lower limbs / feet
esrs - a  -  dystonia: trunk / neck
esrs - a  -  dyskinesia: tongue
esrs - a  -  dyskinesia: jaw
esrs - a  -  dyskinesia: eyes / upper face / lower face
esrs - a  -  dyskinesia: shoulder / upper limbs / hands
esrs - a  -  dyskinesia: hips / lower limbs / feet
oxaliplatin
esrs - a  -  dyskinesia: trunk / neck
esrs - a  -  akathisia: subjective
esrs - a  -  akathisia: objective
esrs - a  -  cgi - s parkinsonism
esrs - a  -  cgi - s dystonia
esrs - a  -  cgi - s dyskinesia
esrs - a  -  cgi - s akathisia
fiqr  -  activities sub - total
fiqr  -  overall impact sub - total
fiqr  -  symptoms sub - total
fiqr  -  fiqr total
hads  -  total score anxiety
hads  -  total score depression
mir17hg gene
interleukin - 27
abalon gene
abalon wt allele
apoptotic bcl2l1 - antisense long non - coding rna
lunar1 gene
lunar1 wt allele
leukemia - associated non - coding igf1r activator rna 1
mir4457 gene
mir4457 wt allele
mir4457 pre - mirna
linc - pint gene
linc - pint wt allele
long intergenic non - protein coding rna p53 induced transcript
mir1208 gene
mir1208 wt allele
mir1208 pre - mirna
ppid gene
ppid wt allele
chronic choriodeciduitis
peptidyl - prolyl cis - trans isomerase d
chronic plasma cell deciduitis
amnion epithelium necrosis
parietal decidual spiral vessel with fibrinoid necrosis - atherosis
nanomole bone collagen equivalent per millimole
reactive amniocyte
amnion nodosum
appropriate placental villous maturation
fetal circulation with increased nucleated erythrocytes
placental villous dysmaturity
accelerated placental villous maturation
increased placental syncytial knots
placental villous fibrosis
chorangiosis
placental fibrinoid deposition
hemosiderin in decidua parietalis
hemosiderin in decidua basalis
hemosiderin in intervillous thrombus
avascular placental villi
placental villous stromal hemorrhage
placental villous stromal - vascular karyorrhexis
placental stromal dusty mineralization
absent physiologic conversion of uteroplacental vessel
chronic uteroplacental vasculitis
uteroplacental vessel fibrinoid necrosis with or without atherosis
basal decidual necrosis
basal decidual karyorrhexis
placental mesenchymal dysplasia
placental hypertrophy
basal myofiber
p wave axis
qrs axis
t wave axis
urinary leakage
ctrp disease terminology
ctrp intervention terminology
confusional arousal
sleep paralysis
nocturnal enuresis
pressured speech
auditory hallucination
olfactory hallucination
tactile hallucination
gustatory hallucination
proprioceptive hallucination
visual hallucination
hyperphagia
m65 - antigen
20q11
16q23
nadh dehydrogenase  ( ubiquinone )
c4d
acoria
bradyphagia
sleep related eating disorder
hypersexualism
reactive attachment disorder of infancy or early childhood
influenza virus antibody
gd3l antibody
gd2l antibody
globo h antibody
fucosyl gm1 antibody
n - propionylated polysialic acid antibody
cfp gene
cfp wt allele
properdin
piroxantrone
developmental regression
cutting behavior
schlap1 gene
schlap1 wt allele
swi / snf complex antagonist associated with prostate cancer 1
homicidal ideation
self - injury
tomm20 gene
tomm20 wt allele
mitochondrial import receptor subunit tom20 homolog
fdps gene
fdps wt allele
farnesyl pyrophosphate synthetase
pclo gene
pclo wt allele
protein piccolo
hs3st1 gene
hs3st1 wt allele
heparan sulfate glucosamine 3 - o - sulfotransferase 1
pnoc gene
pnoc wt allele
pnoc gene product
prepronociceptin
nociceptin
sh2d1b gene
sh2d1b wt allele
sh2 domain - containing protein 1b
slc8a1 gene
slc8a1 wt allele
sodium / calcium exchanger 1
leucovorin calcium / methotrexate regimen
igll1 gene
igll1 wt allele
immunoglobulin lambda - like polypeptide 1
childhood linear iga disease
ppif gene
ppif wt allele
peptidyl - prolyl cis - trans isomerase f ,  mitochondrial
usp7 gene
usp7 wt allele
ubiquitin carboxyl - terminal hydrolase 7
periodic fever syndrome
ctrb1 gene
ctrb1 wt allele
chymotrypsinogen b
ctrb2 gene
ctrb2 wt allele
chymotrypsinogen b2
pdx1 gene
pdx1 wt allele
pancreas / duodenum homeobox protein 1
past 24 hours
myeloproliferative neoplasm symptom assessment form
worst imaginable
early satiety
inactivity
lightheadedness
sexual function
unintentional
thymic damage
no fatigue
folfox / trastuzumab regimen
worst imaginable fatigue
does not interfere with enjoyment of life
completely interferes
have numbness or tingling in hands and feet
difficulty absent
worst imaginable difficulty
fact - es questionnaire
fact - brm questionnaire
have hot flashes
have cold sweats
have vaginal discharge
have vaginal itching or irritation
have vaginal bleeding or spotting
have vaginal dryness
have pain or discomfort with intercourse
have lost interest in sex
have gained weight
feel lightheaded or dizzy
have breast sensitivity or tenderness
have mood swings
have painful joints
anti - met / egfr monoclonal antibody ly3164530
efizonerimod
oxphos inhibitor vlx600
cirmtuzumab
fasn inhibitor tvb - 2640
stereotactic body radiation therapy
p97 inhibitor cb - 5083
oral azacitidine
zorifertinib
altiratinib
diphenhydramine / lidocaine / antacid mouthwash
ropocamptide
miracle mouthwash plus hydrocortisone
donafenib
zirconium zr 89 girentuximab
palm extract phytonutrient supplement
bacterial meningitis
viral meningitis
aseptic meningitis
ranpirnase
retinopathy of prematurity finding
sialorrhea
sedated
polyuria
micropsia
macropsia
tooth malformation
white matter injury
sacral fistula
coccygeal sinus
insufficient breast milk syndrome
hormone receptor / her2 positive
neonatal aspiration syndrome
ventral hernia
l - 4 - chlorokynurenine
t - type calcium channel blocker abt - 639
mucosal ulcer
non - neoplastic muscle disorder
rhabdomyolysis
znrf3 gene
znrf3 wt allele
e3 ubiquitin - protein ligase znrf3
abo gene
abo wt allele
histo - blood group abo system transferase
adamts13 gene
adamts13 wt allele
a disintegrin and metalloproteinase with thrombospondin motifs 13
trip13 gene
trip13 wt allele
pachytene checkpoint protein 2 homolog
tnfrsf25 gene
tnfrsf25 wt allele
tumor necrosis factor receptor superfamily member 25
anxa6 gene
anxa6 wt allele
annexin a6
ccdc170 gene
ccdc170 wt allele
coiled - coil domain - containing protein 170
ctr9 gene
ctr9 wt allele
rna polymerase - associated protein ctr9 homolog
tent4b gene
tent4b wt allele
terminal nucleotidyltransferase 4b
zc3h11a gene
zc3h11a wt allele
zinc finger ccch domain - containing protein 11a
prc1 gene
prc1 wt allele
protein regulator of cytokinesis 1
ska2 gene
ska2 wt allele
spindle and kinetochore - associated protein 2
ddx20 gene
ddx20 wt allele
probable atp - dependent rna helicase ddx20
exoresection
endoresection
carbon c 11 methylaminoisobutyrate
hcv antigen therapeutic bivalent vaccine v5
anti - muc1 monoclonal antibody bth1704
leuprolide mesylate injectable suspension
hvegf26 - 104 / rfase peptide vaccine
ganoderma lucidum spores powder capsule
olive oil / soybean oil / multi - amino acid / glucose parenteral nutrition emulsion
ny - eso - 1 / mage - a4 / prame / survivin / ssx2 - specific autologous cytotoxic t lymphocytes
anti - ofa immunotherapeutic bb - mpi - 03
doxycycline hyclate foam
growing teratoma syndrome
polaprezinc
btc gene product
probetacellulin
epigastric hernia
umbilical hernia
fgf gene amplification
fgfr gene translocation
fgfr gene amplification
hbegf gene product
proheparin - binding egf - like growth factor
apophysitis
epiphysiolysis
germline genotype testing
slipped capital femoral epiphysis
avascular necrosis
fap gene mutation
men1 gene mutation
nf1 gene mutation
idh1 gene mutation
idh2 gene mutation
kras activating mutation
nonunion of bone
malunion of bone
mlh1 gene mutation
msh6 gene mutation
tp53 gene mutation
pms2 gene mutation
tsc1 gene mutation
tsc2 gene mutation
pancratistatin
vhl gene mutation
tartrate resistant acid phosphatase staining method
egf gene product
pro - epidermal growth factor
spl license disciplinary action terminology
license status
suspended license
revoked license
active license
ereg gene product
proepiregulin
wholesale drug distributor
third - party logistics provider
nrg1 gene product
pro - neuregulin - 1 ,  membrane - bound isoform
nrg2 gene product
pro - neuregulin - 2 ,  membrane - bound isoform
nrg3 gene product
pro - neuregulin - 3 ,  membrane - bound isoform
labor complication
otolaryngologic disorder
anaplastic plasmacytoma
compartment syndrome
infantile cortical hyperostosis
protein subunit
structural modifier
gene product variation site
peptide bond constituents
human glycan
avian glycan
bacterial glycan
mammalian glycan
fungal glycan
muscle stiffness
albright's hereditary osteodystrophy
dyschromatosis symmetrica hereditaria
fraser syndrome
glycogen storage disease type vii
osteopetrosis with renal tubular acidosis
tgfa gene product
protransforming growth factor alpha
olendalizumab
anti - gpa33 / cd3 monoclonal antibody mgd007
anti - fucosyl - gm1 monoclonal antibody bms - 986012
gamboge resin extract tsb - 9 - w1
mycobacterium tuberculosis arabinomannan z - 100
gemigliptin
anti - epha2 monoclonal antibody ds - 8895a
matricaria recutita gel
matricaria recutita topical infusion
muc1 - klh vaccine / qs21
epothilone analog utd1
cidan herbal capsule
cannabidiol
sodium sulfate / potassium sulfate / magnesium sulfate - based laxative
copper cu 64 anti - cea monoclonal antibody m5a
sirenomelia
hair tourniquet
n - methyl - d - aspartate receptor
cheiromegaly
amastia
blount's disease
turbo field echo mri
magnetization - prepared rapid gradient echo mri
three - dimensional spoiled gradient mri
pediatric adverse events terminology
t2 and fluid attenuated inversion recovery mri
perinatal terminology
pediatric endocrinology terminology
pediatric rheumatology terminology
growth failure of unknown etiology
failure of catch - up growth
resolved license
other license status
trans - activator protein bzlf1
damage - associated molecular pattern molecule
suppurative arthritis
ccnd1 gene product
g1 / s - specific cyclin - d1b
17q13
polycomb - group protein
catenin family protein
aldehyde dehydrogenase
mint31
sstr2 gene product
somatostatin receptor type 2b
hla class i histocompatibility antigen ,  a - 0301 alpha chain
varicella - zoster virus antibody
cytomegalovirus antibody
human herpesvirus 1 antibody
epstein - barr virus antibody
cytokine antibody
ptprc gene product
cd45ra
cd45rb
cd45rc
cd45ro
immunoglobulin heavy chain joining region
circulating melanoma cell
fksi - 15 questionnaire
fact - bp questionnaire
recombinant parathyroid hormone - related protein
rcc symptom index
have bone pain
bothered by fevers
have blood in urine
artemether sublingual spray
presatovir
fact - b questionnaire
neonatal seizure
gasping syndrome
neonatal spell
mri ultrasound fusion guided biopsy
cutaneous melanoma in - transit metastasis
fgf13 gene
fgf13 wt allele
fibroblast growth factor 13
bpifa1 gene
bpifa1 wt allele
bpi fold - containing family a member 1
egr3 gene
egr3 wt allele
early growth response protein 3
chst15 gene
chst15 wt allele
carbohydrate sulfotransferase 15
atp5f1b gene
atp5f1b wt allele
atp synthase subunit beta ,  mitochondrial
ncr3lg1 gene
ncr3lg1 wt allele
natural cytotoxicity triggering receptor 3 ligand 1
ep400 gene
ep400 wt allele
e1a - binding protein p400
spata20 gene
spata20 wt allele
spermatogenesis - associated protein 20
pex5l gene
pex5l wt allele
pex5 - related protein
ass1 gene
ass1 wt allele
argininosuccinate synthase
paravertebral block
central lymph node dissection
abhd12 gene
abhd12 wt allele
monoacylglycerol lipase abhd12
pdlim3 gene
pdlim3 wt allele
autologous dendritic cells / candida albicans skin test reagent / cd40 - ligand / gp100 antigen / interferon gamma / interleukin - 4 / mart - 1 antigen / sargramostim / tyrosinase peptide
pdz and lim domain protein 3
shroom2 gene
shroom2 wt allele
protein shroom2
pvr gene
pvr wt allele
poliovirus receptor
ctrc gene
ctrc wt allele
chymotrypsin - c
prss2 gene
prss2 wt allele
trypsin - 2
cbr1 gene
cbr1 wt allele
carbonyl reductase  [ nadph ]  1
biodynamic imaging
health telemonitoring
pi3k inhibitor acp - 319
telisotuzumab vedotin
gs / pan - notch inhibitor bms - 986115
trifarotene
vanucizumab
ubqln4 gene
ubqln4 wt allele
ubiquilin - 4
procr gene
procr wt allele
endothelial protein c receptor
smad5 gene
smad5 wt allele
mothers against decapentaplegic homolog 5
ceacam8 gene
ceacam8 wt allele
carcinoembryonic antigen - related cell adhesion molecule 8
f11r gene
f11r wt allele
junctional adhesion molecule a
feel listless
have trouble starting things because of tiredness
have trouble finishing things because of tiredness
asap1 gene
asap1 wt allele
arf - gap with sh3 domain ,  ankyrin repeat and ph domain - containing 1
pcnu
have energy
able to do usual activities
need to sleep during day
too tired to eat
need help doing usual activities
frustrated by being too tired to do things
have to limit social activities because of tiredness
fact - en questionnaire
fact - cx questionnaire
prokr2 gene
prokr2 wt allele
prokineticin receptor 2
nectin1 gene
nectin1 wt allele
nectin - 1
maoa gene
maoa wt allele
amine oxidase  [ flavin - containing ]  a
multiple agent systemic chemotherapy
image - guided local therapy
non - cytotoxic chemotherapy
ubidecarenone nanodispersion bpm31510n
lung - targeted immunomodulator qbkpn
pi3kalpha inhibitor azd8835
activin type 2b receptor fc fusion protein stm 434
anti - psma / cd3 monoclonal antibody mor209 / es414
ellagic acid / annona muricata supplement
vegfr / fgfr inhibitor odm - 203
jak1 inhibitor incb052793
liver adenosquamous carcinoma
alpha thalassemia x - linked mental retardation syndrome
bardet - biedl syndrome
neuropathy ,  hereditary sensory and autonomic ,  type iv
norrie syndrome
pseudoachondroplasia
stiff skin syndrome
broken component
device remains implanted
device or fragments remain in patient
tip breakage
cadazolid
fecal microbiota transplantation
autologous fecal microbiota transplantation
immediate / early loading
transitional use
traditional use
nanoparticle - based paclitaxel suspension
intended use of immediate / early load
intended use for traditional use
unable to confirm conditions of use
intended for transitional use
fact / gog - ntx questionnaire
self - conscious about the way i dress
one or both arms swollen or tender
worry other family members might someday get same illness
able to feel like a woman
have trouble forming thoughts
thinking has been slow
have trouble finding way to familiar place
have trouble remembering where i put things
have trouble remembering new information
have trouble recalling the name of objects while talking to someone
have trouble finding right words to express myself
have used wrong word when referring to an object
have trouble saying what i mean in conversation
polyethylene glycol hydrogel
mdm2 / mdmx inhibitor alrn - 6924
rhenium re 188 bmeda - labeled liposomes
avitinib maleate
fgf / fgfr pathway inhibitor e7090
opioid agonist gic - 1002
trastuzumab duocarmazine
mitochondrial enzyme deficiency
perinatal mortality
very preterm infant
acquired growth hormone deficiency
congenital growth hormone deficiency
growth hormone neurosecretory dysfunction
have walked into room and forgotten what i meant to get or do
idiopathic isolated growth hormone deficiency
iatrogenic growth failure
have to work really hard to pay attention or would make mistake
have forgotten names of people soon after being introduced
short stature
reactions in everyday situations have been slow
familial idiopathic short stature
idiopathic short stature
non - familial idiopathic short stature
tall stature
idiopathic tall stature
familial idiopathic tall stature
have to work harder than usual to keep track of what i was doing
non - familial idiopathic tall stature
fgfr3 chondrodysplasia
hypochondroplasia
small for gestational age for weight
small for gestational age for length
penberol
small for gestational age for weight and length
thinking has been slower than usual
small for gestational age with failure of catch - up growth
have to work harder to express myself clearly
have to use written lists more often than usual to not forget things
have trouble keeping track of what i am doing if interrupted
have trouble shifting back and forth between different activities that require thinking
cortical blindness
orbital contusion
chemical burn of eye
cerebral visual impairment
optic neuropathy
acquired color blindness
inherited color blindness
decreased visual acuity
decreased best corrected visual acuity
decreased uncorrected visual acuity
decreased visual acuity with current correction
binocular diplopia
monocular diplopia
opsoclonus
posterior vitreous detatchment
stye
blepharospasm
eye redness
iridodialysis
pseudostrabismus
visual field defect
central visual field defect
congruent visual field defect
have been told that i have trouble remembering information
hemianopsia
heteronymous visual field defect
homonymous visual field defect
incongruent visual field defect
have been told that i have trouble speaking clearly
peripheral visual field defect
scotoma
have been told that i have trouble thinking clearly
ocular foreign body
conjunctival foreign body
corneal foreign body
intraocular foreign body
have been told that i seem confused
orbital fracture
retrobulbar hemorrhage
have been able to bring to mind words while talking to someone
closed globe injury
open globe injury
infectious keratitis
photokeratitis
have been able to remember to do things
orbital muscle entrapment
uveal prolapse
rhegmatogenous retinal detachment
serous retinal detachment
have been able to pay attention and keep track of what i am doing without extra effort
tractional retinal detachment
abnormal vision
mind is as sharp as it always has been
exophthalmos
amblyopia
band keratopathy
memory is as good as it always has been
able to shift back and forth between two activities that require thinking
able to keep track of what i am doing even when interrupted
have been upset about cognitive problems
cognitive problems have interfered with ability to work
cognitive problems have interfered with ability to do things i enjoy
cognitive problems have interfered with quality of life
precarinal
gastrohepatic lymph node
aortocaval lymph node
ingenol mebutate gel
spl licensing terminology
spl marketing status terminology
licensed as wholesale drug distributor or third party logistics provider
autosomal dominant torsion dystonia 1
x - linked centronuclear myopathy
charcot - marie - tooth disease type 1b
merosin - deficient congenital muscular dystrophy type 1a
nemaline myopathy 2
ocular albinism type 1
autosomal dominant popliteal pterygium syndrome
simpson golabi behmel syndrome type 1
vitelliform macular dystrophy
modified - release calcifediol capsule
autologous ny - eso - 1 - specific cd8 - positive t lymphocytes
adversity
beck lethality scale
firearm
complete response with incomplete platelet recovery
shelterin
anti - cd3 antibody
anti - neprilysin antibody
anti - cd20 antibody
anti - cd79a antibody
penclomedine
anti - mum1 antibody
anti - bcl2 antibody
anti - bcl6 antibody
anti - ki - 67 antibody
anti - vimentin antibody
anti - estrogen receptor antibody
anti - carcinoembryonic antigen antibody
newborn or infant finding
childhood colorectal carcinoma
childhood breast carcinoma
childhood carcinoid tumor
childhood laryngeal carcinoma
childhood esophageal carcinoma
childhood gastric carcinoma
childhood lung non - small cell carcinoma
childhood lung small cell carcinoma
childhood bladder carcinoma
childhood nasal cavity carcinoma
childhood paranasal sinus carcinoma
childhood parathyroid gland carcinoma
adult penile carcinoma
childhood malignant penile neoplasm
childhood adrenal gland pheochromocytoma
childhood rectal carcinoma
childhood salivary gland carcinoma
adult salivary gland carcinoma
childhood malignant small intestinal neoplasm
childhood thyroid gland carcinoma
orbital melanoma
familial nonmedullary thyroid gland carcinoma
fact - bl questionnaire
fact - cns questionnaire
bothered by vaginal discharge or bleeding
bothered by vaginal odor
afraid to have sex
vagina feels too narrow or short
afraid treatment may harm body
have discomfort when urinating
have trouble controlling urine
burns when urinating
have concerns about ability to have children
have trouble digesting food
have discomfort or pain in pelvic area
allan - herndon - dudley syndrome
hypohidrotic ectodermal dysplasia with immune deficiency
otopalatodigital syndrome type 1
miyoshi muscular dystrophy 1
spinal muscular atrophy type 3
tumor antigen - reactive cd28 +  / ccr7 +  / cd27 +  / cd45ra -  cytotoxic t - lymphocyte
radiologic imaging procedure
autologous anti - hpv - 16 e6 t - cell receptor gene - engineered peripheral blood lymphocytes
autologous il - 2 - expressing b - cll vaccine
autologous cd40l - expressing b - cll vaccine
about once weekly
two to three times weekly
nearly every day
several times daily
lamellar laceration of the globe
ocular contusion
central retinal vein occlusion
fat adherence syndrome
anterior segment ischemia
corneal delle
oculocardiac reflex
crystalline lens dislocation
intraocular lens dislocation
lid retraction
slipped extraocular muscle
laceration of the globe
penetrating open globe injury
perforating open globe injury
ruptured globe
optic disc edema
how often
cystathionine
3 - aminoisobutyric acid
anserine
5 - hydroxylysine
argininosuccinic acid
carnosine
alpha - aminoadipic acid
phosphorylethanolamine
phosphoserine
alloisoleucine
3 - methylhistidine
1 - methylhistidine
n - acetylaspartate
leukotriene receptor family
beta isomer of c - terminal telopeptide of type i collagen
measles virus n mrna
measles virus nucleoprotein
foxo family
hmb - 45
braf np_004324 .2:p .t599_v600inst
braf nm_004333 .4:c .1797_1798insaca
braf nm_004333 .4:c .1796_1797instac
aggresome
fowlpox virus antibody
csf2 antibody
pentamethylmelamine
unfolded protein response
measles virus antibody
alk kinase domain
no prior therapy
il18bp gene
il18bp wt allele
interleukin - 18 - binding protein
cd1c gene
cd1c wt allele
t - cell surface glycoprotein cd1c
card14 gene
card14 wt allele
caspase recruitment domain - containing protein 14
slc9a1 gene
slc9a1 wt allele
sodium / hydrogen exchanger 1
kir2ds4 gene
kir2ds4 wt allele
killer cell immunoglobulin - like receptor 2ds4
slc36a1 gene
slc36a1 wt allele
proton - coupled amino acid transporter 1
ddx39b gene
ddx39b wt allele
spliceosome rna helicase ddx39b
slc1a5 gene
slc1a5 wt allele
neutral amino acid transporter b ( 0 )
krt16 gene
krt16 wt allele
keratin ,  type i cytoskeletal 16
rhodobacteraceae
amoebozoa
icoslg gene
acanthamoeba
acremonium
acute myocardial infarction type
icoslg wt allele
elasticity
diploidy
icos ligand
lamtor5 gene
lamtor5 wt allele
ragulator complex protein lamtor5
rna electroporated cd19car - cd3zeta - 4 - 1bb - expressing autologous t - lymphocytes
ntrk / ros1 inhibitor ds - 6051b
umbilical cord blood - derived natural killer cells
sdc3 gene
sdc3 wt allele
syndecan - 3
her2 - targeting antibody fc fragment fs102
hpp1 gene
low mitosis - karyorrhexis index
lmp1 / barf1 / ebna1 - specific cytotoxic t - lymphocytes
intermediate mitosis - karyorrhexis index
high mitosis - karyorrhexis index
censor
neoantigen - based glioblastoma vaccine
gallium ga 68 - labeled psma - 11
clinical trial censoring
lgr6 gene
lgr6 wt allele
leucine - rich repeat - containing g - protein coupled receptor 6
fabp6 gene
fabp6 wt allele
gastrotropin
clinical classification
cdisc clinical classification terminology
cdisc clinical classification category terminology
annonaceous acetogenins
genetically - modified mage - a3 - expressing mg1 maraba virus vaccine
tiparp gene
tiparp wt allele
tcdd - inducible poly  [ adp - ribose ]  polymerase
lzts1 gene
lzts1 wt allele
leucine zipper putative tumor suppressor 1
eif1b gene
eif1b wt allele
eukaryotic translation initiation factor 1b
oprm1 gene
oprm1 wt allele
mu - type opioid receptor
lum gene
lum wt allele
lumican
aspm gene
coi regimen
aspm wt allele
abnormal spindle - like microcephaly - associated protein
slc7a6 gene
slc7a6 wt allele
y + l amino acid transporter 2
slc7a7 gene
slc7a7 wt allele
y + l amino acid transporter 1
slc43a2 gene
slc43a2 wt allele
phenesterin
large neutral amino acids transporter small subunit 4
slc7a8 gene
slc7a8 wt allele
large neutral amino acids transporter small subunit 2
slc5a2 gene
slc5a2 wt allele
sodium / glucose cotransporter 2
slc2a2 gene
slc2a2 wt allele
solute carrier family 2 ,  facilitated glucose transporter member 2
peritumoral
hepatolithiasis
hepaticojejunostomy
cdisc sdtm ophthalmic focus of study specific interest terminology
cdisc sdtm cardiovascular findings about test name terminology
cdisc sdtm cardiovascular findings about test code terminology
cdisc sdtm cardiovascular findings about results terminology
cdisc sdtm coronary thrombus timi grade responses terminology
cdisc sdtm nhlbi coronary artery dissection grade responses terminology
cdisc sdtm arc coronary stent thrombosis timing terminology
cdisc sdtm arc coronary stent thrombosis grade responses terminology
oligoarticular arthritis
early inflammatory arthritis
nonerosive arthritis
enthesitis - related arthritis
post - streptococcal arthritis
lyme arthritis
easy bruising
pyuria
lupus headache
rheumatoid nodule
systemic juvenile idiopathic arthritis
oligoarticular juvenile idiopathic arthritis
polyarticular juvenile idiopathic arthritis ,  rheumatoid factor negative
polyarticular juvenile idiopathic arthritis ,  rheumatoid factor positive
undifferentiated juvenile idiopathic arthritis
early localized lyme disease
early disseminated lyme disease
late disseminated lyme disease
post - treatment lyme disease syndrome
persistent oligoarticular juvenile idiopathic arthritis
extended oligoarticular juvenile idiopathic arthritis
chronic recurrent multifocal osteomyelitis
nalp12 - associated hereditary periodic fever syndrome
psoriatic juvenile idiopathic arthritis
early rheumatoid arthritis
scleritis
erythema migrans
pain amplification syndrome
synovitis ,  acne ,  pustulosis ,  hyperostosis ,  and osteitis syndrome
autoinflammatory syndrome
tumor necrosis factor receptor 1 - associated periodic syndrome
familial cold autoinflammatory syndrome
muckle - wells syndrome
pyogenic arthritis ,  pyoderma gangrenosum and acne
deficiency of the interleukin - 1 receptor antagonist
deficiency of the interleukin - 36 receptor antagonist
majeed syndrome
cdisc questionnaire audit - sr test name terminology
cdisc questionnaire audit - sr test code terminology
cdisc questionnaire audit - c test name terminology
cdisc questionnaire audit - c test code terminology
cdisc questionnaire ccq 24 hour version test name terminology
cdisc questionnaire ccq 24 hour version test code terminology
cdisc questionnaire ccq 1 week version test name terminology
cdisc questionnaire ccq 1 week version test code terminology
cdisc questionnaire chart - sf paper version test name terminology
cdisc questionnaire chart - sf paper version test code terminology
cdisc questionnaire dlqi test name terminology
cdisc questionnaire dlqi test code terminology
cdisc questionnaire rpq test name terminology
cdisc questionnaire rpq test code terminology
cdisc clinical classification timi thrombus grade test name terminology
cdisc clinical classification timi thrombus grade test code terminology
cdisc clinical classification nhlbi cad grade test name terminology
cdisc clinical classification nhlbi cad grade test code terminology
cdisc clinical classification arc stc timing test name terminology
cdisc clinical classification arc stc timing test code terminology
cdisc clinical classification arc stc grade test name terminology
cdisc clinical classification arc stc grade test code terminology
audit questionnaire question
audit - c questionnaire question
ccq 24 hour version questionnaire question
ccq 1 week version questionnaire question
chart - sf paper version questionnaire question
dlqi questionnaire question
rpq questionnaire question
timi thrombus grade clinical classification question
nhlbi cad grade clinical classification question
arc stc timing clinical classification question
arc stc grade clinical classification question
children's dermatology life quality index questionnaire
influenza intensity and impact questionnaire once daily version
influenza intensity and impact questionnaire twice daily version
ocular comfort index questionnaire
work limitations questionnaire
alcohol use disorder identification test self - report version questionnaire
alcohol use disorder identification test alcohol consumption questions questionnaire
clinical copd questionnaire 24 hour version
phenol
clinical copd questionnaire 1 week version
craig handicap assessment and reporting technique  -  short form paper version questionnaire
dermatology life quality index questionnaire
rivermead post - concussion symptoms questionnaire
coronary thrombus timi grade clinical classification
coronary artery dissection nhlbi grade clinical classification
stent thrombosis coronary arc timing clinical classification
stent thrombosis coronary arc grade clinical classification
audit  -  how often have alcohol drink
audit  -  how many alcohol drinks on a typical day
audit  -  how often have six or more drinks
audit  -  how often last year you found not able to stop drinking
audit  -  how often last year you failed to do normally expected of you
audit  -  how often last year need a drink in the morning to get going
audit  -  how often last year you feel guilt or remorse after drinking
audit  -  how often last year you unable to remember what happened the night before
audit  -  injured because of drinking
audit  -  concerned about your drinking
audit  -  total
audit - c  -  how often have alcohol drink
audit - c  -  how many alcohol drinks on a typical day
audit - c  -  how often have six or more drinks
ccq 24 hour version  -  short of breath at rest
ccq 24 hour version  -  short of breath doing physical activity
ccq 24 hour version  -  concern about breathing get worse
ccq 24 hour version  -  depressed because of breathing problem
ccq 24 hour version  -  did you cough
ccq 24 hour version  -  produce sputum or phlegm
ccq 24 hour version  -  breathing problems limit strenuous activity
ccq 24 hour version  -  breathing problems limit moderate activity
ccq 24 hour version  -  breathing problems limit daily activity
ccq 24 hour version  -  breathing problems limit social activity
ccq 1 week version  -  short of breath at rest
ccq 1 week version  -  short of breath doing physical activity
ccq 1 week version  -  concern about breathing get worse
ccq 1 week version  -  depressed because of breathing problem
ccq 1 week version  -  did you cough
ccq 1 week version  -  produce sputum or phlegm
ccq 1 week version  -  breathing problems limit strenuous activity
ccq 1 week version  -  breathing problems limit moderate activity
ccq 1 week version  -  breathing problems limit daily activity
ccq 1 week version  -  breathing problems limit social activity
chart - sf paper version  -  paid personal care per day
chart - sf paper version  -  unpaid personal care per day
chart - sf paper version  -  cognitive assistance at home per day
chart - sf paper version  -  cognitive assistance away from home per day
chart - sf paper version  -  hours out of bed per day
chart - sf paper version  -  days out of the house per week
chart - sf paper version  -  nights away from home last year
chart - sf paper version  -  hours of paid work per week
chart - sf paper version  -  occupation of paid work
chart - sf paper version  -  hours of schoolwork per week
chart - sf paper version  -  hours of homemaking per week
chart - sf paper version  -  hours of home maintenance per week
chart - sf paper version  -  hours of recreational activities per week
chart - sf paper version  -  number of people you live with
chart - sf paper version  -  live with spouse or significant other
chart - sf paper version  -  number of relatives you live with
chart - sf paper version  -  associates contacted per month
chart - sf paper version  -  friends contacted per month
chart - sf paper version  -  initiated conversation with strangers last month
chart - sf paper version  -  combined annual household income last year
chart - sf paper version  -  medical care expense last year
dlqi  -  itchy ,  sore ,  painful or stinging skin
dlqi  -  embarrassed because of skin
dlqi  -  skin interfere with shopping ,  looking after home or yard
dlqi  -  skin influence clothes you wear
dlqi  -  skin affect social or leisure activities
dlqi  -  skin made difficult to do sport
dlqi  -  skin prevent work or study
dlqi  -  skin has been a problem at work or study
dlqi  -  skin create problem with partner ,  friends or relatives
dlqi  -  skin cause sexual difficulties
dlqi  -  treatment for skin make home messy
dlqi  -  score
rpq  -  headaches
rpq  -  feelings of dizziness
rpq  -  nausea and / or vomiting
rpq  -  noise sensitivity
rpq  -  sleep disturbance
rpq  -  fatigue ,  tiring more easily
rpq  -  being irritable ,  easily angered
rpq  -  feeling depressed or tearful
rpq  -  feeling frustrated or impatient
rpq  -  forgetfulness ,  poor memory
rpq  -  poor concentration
rpq  -  taking longer to think
rpq  -  blurred vision
rpq  -  light sensitivity
rpq  -  double vision
rpq  -  restlessness
rpq  -  any other difficulties 1  ( text )
rpq  -  any other difficulties 1  ( number )
rpq  -  any other difficulties 2  ( text )
rpq  -  any other difficulties 2  ( number )
timi thrombus grade  -  coronary thrombus timi grade
nhlbi cad grade  -  coronary artery dissection nhlbi grade
arc stc timing  -  stent thrombosis coronary arc timing
arc stc grade  -  stent thrombosis coronary arc grade
oral diuretic therapy augmentation for heart failure
phosphatidylinositol 4 , 5 - bisphosphate
weight gain due to fluid retention
coronary lesion by angiographic finding
coronary revascularization procedure
decreased exercise tolerance
hospitalization due to heart failure
increase in b - type natriuretic peptide or n - terminal pro - b - type natriuretic peptide
increase in jugular venous pressure
inducible myocardial ischemia
intravenous diuretic ,  inotropic or vasodilator augmentation for heart failure
heart failure by invasive diagnostic technique
loss of patency of side branch
loss of patency of major vessel
vasculature mechanical or surgical intervention
new loss of viable myocardium by non - invasive imaging technique
new regional wall motion abnormality by non - invasive imaging technique
heart failure by non - invasive diagnostic technique
rales
pulmonary congestion by radiological technique
resting ecg changes
flow reduced in coronary microcirculation
joint task force type 1 myocardial infarction
joint task force type 2 myocardial infarction
joint task force type 3 myocardial infarction
joint task force type 4a myocardial infarction
joint task force type 4b myocardial infarction
joint task force type 4c myocardial infarction
joint task force type 5 myocardial infarction
er or office visit due to heart failure
worsened end - organ perfusion
coronary artery thrombosis method of identification
endpoint event indicator
healthcare encounter type
lab findings of new or worsening heart failure
physical examination findings of new or worsening heart failure
heart failure therapy intensification type
ischemic discomfort indicator
ischemic evidence type
exclusion of type 1 and type 2 myocardial infarction diagnosis indicator
new or worsening symptom
acute myocardial infarction from pci complication type
procedure success indicator
symptom indicator
symptom onset date
vessel occlusion 48 hours after cabg indicator
insignificant disease by ecg finding
cardiac index
cardiac output
pulmonary vascular resistance
systemic vascular resistance
atrial tachycardia with av block by ecg finding
pause by ecg finding
pause greater than three seconds by ecg finding
supraventricular couplet by ecg finding
maximum atrial rate by electrocardiogram
median atrial rate by electrocardiogram
minimum atrial rate by electrocardiogram
mean atrial rate by electrocardiogram
maximum heart rate by electrocardiogram
minimum heart rate by electrocardiogram
mean heart rate by electrocardiogram
maximum ventricular rate by electrocardiogram
median ventricular rate by electrocardiogram
minimum ventricular rate by electrocardiogram
mean ventricular rate by electrocardiogram
proxy
significant other
intestinal specific alkaline phosphatase measurement
liver specific alkaline phosphatase measurement
amyloid alpha precursor protein measurement
total amyloid precursor protein measurement
base excess measurement
complement c3d antibody measurement
calcium corrected measurement
soluble e - selectin measurement
beta - 1 globulin measurement
beta - 1 globulin to total protein ratio measurement
beta - 2 globulin measurement
beta - 2 globulin to total protein ratio measurement
alpha - gst excretion rate
pi - gst excretion rate
hepatitis b virus core igg antibody measurement
hepatitis d virus igg antibody measurement
hepatitis d virus igm antibody measurement
hepatitis e virus antibody measurement
insulinoma - associated protein 2 antibody measurement
immunoglobulin g to creatinine ratio measurement
insulin autoantibody measurement
insulin antibody measurement
oxidized ldl cholesterol antibody measurement
activated lymphocytes measurement
neutrophil myeloperoxidase index
8 - iso - prostaglandin f2 alpha to creatinine ratio measurement
8 - iso - prostaglandin f2 alpha measurement
partial pressure arterial oxygen to fraction inspired oxygen ratio measurement
smudge cells to leukocytes ratio measurement
ventricular wall of the heart
radial immunodiffusion
acanthamoeba astronyxis
acanthamoeba castellanii
acanthamoeba culbertsoni
foscarnet sodium
acanthamoeba griffini
acanthamoeba hatchetti
acanthamoeba lugdunensis
acanthamoeba palestinensis
acanthamoeba polyphaga
acanthamoeba quina
acanthamoeba rhysodes
achromobacter ruhlandii
acinetobacter parvus
acinetobacter ursingii
acremonium atrogriseum
actinobaculum schaalii
actinomyces europaeus
actinomyces neuii subspecies neuii
aerococcus sanguinicola
aggregatibacter aphrophilus ,  beta - lactamase negative
aggregatibacter aphrophilus ,  beta - lactamase positive
aggregatibacter aphrophilus ,  penicillinase negative
aggregatibacter aphrophilus ,  penicillinase positive
alphacoronavirus
alternaria
anaerobic bacteria
anaerobic coccus
anaerobic gram - negative bacteria
bacteroides intestinalis
clostridium sartagoforme
mansonella perstans
pandoraea sputorum
pannonibacter phragmitetus
peptostreptococcus stomatis
prevotella bergensis
coronary no reflow at pci site indicator
organ elasticity
right eye
left eye
both eyes
femtogram per milliliter per kilogram per meter squared
femtogram per milliliter per milligram per day
femtogram per milliliter per milligram per kilogram
femtogram per milliliter per milligram per kilogram per day
ic regimen
femtogram per milliliter per milligram per meter squared
femtogram per milliliter per milligram per meter squared per day
femtogram per milliliter per microgram per day
femtogram per milliliter per microgram per kilogram
femtogram per milliliter per microgram per kilogram per day
femtogram per milliliter per microgram per meter squared
femtogram per milliliter per microgram per meter squared per day
femtogram per milliliter per gram
femtogram per milliliter per kilogram
femtogram per milliliter per meter squared
femtogram per milliliter per milligram
femtogram per milliliter per microgram
gram per milliliter per kilogram per meter squared
gram per milliliter per milligram per day
gram per milliliter per milligram per meter squared
gram per milliliter per milligram per meter squared per day
gram per milliliter per microgram per day
gram per milliliter per microgram per kilogram
gram per milliliter per microgram per kilogram per day
gram per milliliter per microgram per meter squared
gram per milliliter per microgram per meter squared per day
gram per milliliter per gram
gram per milliliter per meter squared
gram per milliliter per milligram
gram per milliliter per microgram
international unit per milliliter per kilogram per meter squared
international unit per milliliter per milligram per day
international unit per milliliter per milligram per kilogram
international unit per milliliter per milligram per kilogram per day
international unit per milliliter per milligram per meter squared
international unit per milliliter per milligram per meter squared per day
international unit per milliliter per microgram per day
international unit per milliliter per microgram per kilogram
international unit per milliliter per microgram per kilogram per day
international unit per milliliter per microgram per meter squared
international unit per milliliter per microgram per meter squared per day
international unit per milliliter per gram
international unit per milliliter per kilogram
international unit per milliliter per meter squared
international unit per milliliter per milligram
international unit per milliliter per microgram
milligram per milliliter per kilogram per meter squared
milligram per milliliter per milligram per day
milligram per milliliter per milligram per meter squared
milligram per milliliter per milligram per meter squared per day
milligram per milliliter per microgram per day
milligram per milliliter per microgram per kilogram
milligram per milliliter per microgram per kilogram per day
milligram per milliliter per microgram per meter squared
milligram per milliliter per microgram per meter squared per day
milligram per milliliter per gram
milligram per milliliter per kilogram
milligram per milliliter per meter squared
milligram per milliliter per milligram
milligram per milliliter per microgram
milli - international unit per milliliter per kilogram per meter squared
milli - international unit per milliliter per milligram per day
milli - international unit per milliliter per milligram per kilogram
milli - international unit per milliliter per milligram per kilogram per day
phytoestrogen
milli - international unit per milliliter per milligram per meter squared
milli - international unit per milliliter per milligram per meter squared per day
milli - international unit per milliliter per microgram per day
milli - international unit per milliliter per microgram per kilogram
milli - international unit per milliliter per microgram per kilogram per day
milli - international unit per milliliter per microgram per meter squared
milli - international unit per milliliter per microgram per meter squared per day
milli - international unit per milliliter per gram
milli - international unit per milliliter per kilogram
milli - international unit per milliliter per meter squared
milli - international unit per milliliter per milligram
milli - international unit per milliliter per microgram
millimole per liter per kilogram per meter squared
millimole per liter per milligram per day
millimole per liter per milligram per kilogram
millimole per liter per milligram per kilogram per day
millimole per liter per milligram per meter squared
millimole per liter per milligram per meter squared per day
millimole per liter per microgram per day
millimole per liter per microgram per kilogram
millimole per liter per microgram per kilogram per day
millimole per liter per microgram per meter squared
millimole per liter per microgram per meter squared per day
millimole per liter per gram
millimole per liter per kilogram
millimole per liter per meter squared
millimole per liter per milligram
millimole per liter per microgram
mole per liter per kilogram per meter squared
mole per liter per milligram per day
mole per liter per milligram per kilogram
mole per liter per milligram per kilogram per day
mole per liter per milligram per meter squared
mole per liter per milligram per meter squared per day
mole per liter per microgram per day
mole per liter per microgram per kilogram
mole per liter per microgram per kilogram per day
mole per liter per microgram per meter squared
mole per liter per microgram per meter squared per day
mole per liter per gram
mole per liter per kilogram
mole per liter per meter squared
mole per liter per milligram
mole per liter per microgram
nanogram per milliliter per kilogram per meter squared
nanogram per milliliter per milligram per day
nanogram per milliliter per milligram per meter squared
nanogram per milliliter per milligram per meter squared per day
nanogram per milliliter per microgram per day
nanogram per milliliter per microgram per kilogram
nanogram per milliliter per microgram per kilogram per day
nanogram per milliliter per microgram per meter squared
nanogram per milliliter per microgram per meter squared per day
nanogram per milliliter per gram
nanogram per milliliter per meter squared
nanogram per milliliter per microgram
nanomole per liter per kilogram per meter squared
nanomole per liter per milligram per day
nanomole per liter per milligram per kilogram
nanomole per liter per milligram per kilogram per day
nanomole per liter per milligram per meter squared
nanomole per liter per milligram per meter squared per day
nanomole per liter per microgram per day
nanomole per liter per microgram per kilogram
nanomole per liter per microgram per kilogram per day
nanomole per liter per microgram per meter squared
nanomole per liter per microgram per meter squared per day
nanomole per liter per gram
nanomole per liter per kilogram
nanomole per liter per meter squared
nanomole per liter per milligram
nanomole per liter per microgram
picogram per milliliter per kilogram per meter squared
picogram per milliliter per milligram per day
picogram per milliliter per milligram per meter squared
picogram per milliliter per milligram per meter squared per day
picogram per milliliter per microgram per day
picogram per milliliter per microgram per kilogram
picogram per milliliter per microgram per kilogram per day
picogram per milliliter per microgram per meter squared
picogram per milliliter per microgram per meter squared per day
picogram per milliliter per gram
picogram per milliliter per kilogram
picogram per milliliter per meter squared
picogram per milliliter per milligram
picomole per liter per kilogram per meter squared
picomole per liter per milligram per day
picomole per liter per milligram per kilogram
picomole per liter per milligram per kilogram per day
picomole per liter per milligram per meter squared
picomole per liter per milligram per meter squared per day
picomole per liter per microgram per day
picomole per liter per microgram per kilogram
picomole per liter per microgram per kilogram per day
picomole per liter per microgram per meter squared
picomole per liter per microgram per meter squared per day
picomole per liter per gram
picomole per liter per kilogram
picomole per liter per meter squared
picomole per liter per milligram
piceatannol
microgram per milliliter per kilogram per meter squared
microgram per milliliter per milligram per day
microgram per milliliter per milligram per meter squared
microgram per milliliter per milligram per meter squared per day
microgram per milliliter per microgram per day
microgram per milliliter per microgram per kilogram
microgram per milliliter per microgram per kilogram per day
microgram per milliliter per microgram per meter squared
microgram per milliliter per microgram per meter squared per day
microgram per milliliter per gram
microgram per milliliter per kilogram
microgram per milliliter per meter squared
microgram per milliliter per microgram
micro - international units per milliliter per kilogram per meter squared
micro - international units per milliliter per milligram per day
micro - international units per milliliter per milligram per kilogram
micro - international units per milliliter per milligram per kilogram per day
micro - international units per milliliter per milligram per meter squared
micro - international units per milliliter per milligram per meter squared per day
micro - international units per milliliter per microgram per day
micro - international units per milliliter per microgram per kilogram
micro - international units per milliliter per microgram per kilogram per day
micro - international units per milliliter per microgram per meter squared
micro - international units per milliliter per microgram per meter squared per day
micro - international units per milliliter per gram
micro - international units per milliliter per kilogram
micro - international units per milliliter per meter squared
micro - international units per milliliter per milligram
micro - international units per milliliter per microgram
micromole per liter per kilogram per meter squared
micromole per liter per milligram per day
micromole per liter per milligram per kilogram
micromole per liter per milligram per kilogram per day
micromole per liter per milligram per meter squared
micromole per liter per milligram per meter squared per day
micromole per liter per microgram per day
micromole per liter per microgram per kilogram
micromole per liter per microgram per kilogram per day
micromole per liter per microgram per meter squared
micromole per liter per microgram per meter squared per day
micromole per liter per gram
micromole per liter per kilogram
micromole per liter per meter squared
micromole per liter per milligram
micromole per liter per microgram
forced expiratory flow at 25 - 75 percent
percent predicted forced expiratory flow at 25 - 75 percent
peak nasal inspiratory flow
intraparenchymal route of administration
menstrual cycle duration
umbilical cord serum
lesion failure indicator
lesion revascularization indicator
lesion success indicator
limb failure indicator
lesion revascularization ischemia indicator
lesion revascularization clinical indicator
vessel failure indicator
vessel patency indicator
vessel revascularization indicator
m - cavi regimen
ecg evaluator blinding parameters
ecg continuous monitoring indicator
ecg planned primary lead for study
ecg used same lead indicator
ecg read method degree of automation
ecg replicates at baseline indicator
ecg replicates on - treatment indicator
graft lesion identification
limb associated lesion identification
vessel lesion identification
batts - ludwig fibrosis score
knodell fibrosis score
metavir fibrosis score
scheuer fibrosis score
experimental organism malignant astrocytoma
experimental organism malignant ependymoma
experimental organism benign ganglioglioma
experimental organism malignant oligodendroglioma
duodenal papilla
stroke type
absidia
amoeba
ecg t wave algorithm
timi coronary thrombus grade 1
timi coronary thrombus grade 2
timi coronary thrombus grade 3
timi coronary thrombus grade 4
timi coronary thrombus grade 5
nhlbi coronary artery dissection type a
nhlbi coronary artery dissection type b
nhlbi coronary artery dissection type c
nhlbi coronary artery dissection type d
nhlbi coronary artery dissection type e
nhlbi coronary artery dissection type f
arc stent thrombosis timing acute
arc stent thrombosis timing subacute
arc stent thrombosis timing late
arc stent thrombosis timing very late
arc definite stent thrombosis
arc probable stent thrombosis
pimonidazole
arc possible stent thrombosis
plk4 gene
plk4 wt allele
serine / threonine - protein kinase plk4
cop1 gene
cop1 wt allele
e3 ubiquitin - protein ligase cop1
det1 gene
t ( 8 ; 21 )
inv ( 16 )
promis short form  -  pain intensity
promis parent proxy short form  -  pain interference
promis pediatric short form  -  pain interference
promis adult short form  -  pain interference
mage - a3 - expressing adenovirus type 5 vaccine
odronextamab
htert multipeptide / montanide isa - 51 vg / imiquimod vaccine gx 301
telomerase - specific type 5 adenovirus obp - 301
hif - 2alpha inhibitor pt2385
anti - c - met monoclonal antibody sait301
navicixizumab
det1 wt allele
det1 homolog
sotagliflozin
mutant - selective egfr inhibitor pf - 06459988
dda1 gene
dda1 wt allele
det1 -  and ddb1 - associated protein 1
trib1 gene
trib1 wt allele
tribbles homolog 1
rab7a gene
rab7a wt allele
ras - related protein rab - 7a
rab27a gene
rab27a wt allele
ras - related protein rab - 27a
hace1 gene
hace1 wt allele
e3 ubiquitin - protein ligase hace1
optn gene
optn wt allele
optineurin
klb gene
klb wt allele
beta - klotho
ube2n gene
ube2n wt allele
ubiquitin - conjugating enzyme e2 n
sh3pxd2b gene
sh3pxd2b wt allele
sh3 and px domain - containing protein 2b
knstrn gene
knstrn wt allele
small kinetochore - associated protein
falec gene
falec wt allele
focally amplified long non - coding rna in epithelial cancer
dgkh gene
dgkh wt allele
diacylglycerol kinase eta
rcsd1 gene
rcsd1 wt allele
capz - interacting protein
recombinant human papillomavirus nonavalent vaccine
gilteritinib fumarate
zmiz1 gene
zmiz1 wt allele
zinc finger miz domain - containing protein 1
patient outcomes registry
atf7ip gene
atf7ip wt allele
activating transcription factor 7 - interacting protein 1
iqgap2 gene
iqgap2 wt allele
ras gtpase - activating - like protein iqgap2
d - bifunctional protein deficiency
alpha - methylacyl - coa racemase deficiency
mitochondrial neurogastrointestinal encephalopathy
dual - energy contrast - enhanced digital spectral mammography
ptx3 gene
ptx3 wt allele
pentraxin - related protein ptx3
amigo2 gene
amigo2 wt allele
amphoterin - induced protein 2
slc7a2 gene
slc7a2 wt allele
cationic amino acid transporter 2
clock gene
clock wt allele
circadian locomoter output cycles protein kaput
arntl gene
arntl wt allele
aryl hydrocarbon receptor nuclear translocator - like protein 1
arntl2 gene
arntl2 wt allele
aryl hydrocarbon receptor nuclear translocator - like protein 2
have swelling in stomach area
have cramps in stomach area
pirarubicin
anti - cd37 mmae antibody - drug conjugate ags67e
antroquinonol capsule
carbon c14 - labeled carboplatin
autologous 4 - 1bb selected tumor infiltrating lymphocytes
ckap5 gene
ckap5 wt allele
cytoskeleton - associated protein 5
acd gene
acd wt allele
adrenocortical dysplasia protein homolog
oxygen 15 - labeled oxygen
oxygen 15 - labeled carbon monoxide
proteogenomics
cd5l gene
cd5l wt allele
cd5 antigen - like
sgo1 gene
sgo1 wt allele
shugoshin 1
ifih1 gene
ifih1 wt allele
interferon - induced helicase c domain - containing protein 1
digestive system hemorrhage
atg16l1 gene
atg16l1 wt allele
autophagy - related protein 16 - 1
eef2k gene
eef2k wt allele
eukaryotic elongation factor 2 kinase
aplp1 gene
aplp1 wt allele
amyloid - like protein 1
likert score 0
likert score 10
peripheral neuropathy
c46 / ccr5 / p140k lentiviral vector - transduced autologous hspcs
mechlorethamine hydrochloride gel
htert - encoding dna vaccine invac - 1
yttrium y 90 - dota - di - hsg peptide imp - 288
immunotoxin d2c7 -  ( scdsfv )  - pe38kdel
selicrelumab
chining decoction
carbon c 13 / nitrogen n 15 - labeled valine
uproleselan
burosumab
globo h - dt vaccine obi - 833
autologous cd171 - specific car - cd28 zeta - 4 - 1 - bb - egfrt - expressing t lymphocytes
erk inhibitor cc - 90003
absorbable fibrin sealant patch
iodine i 124 monoclonal antibody 3f8
piritramide
neonatal hypoxic ischemic encephalopathy
developmental dysplasia of hip
shade in the areas where you feel pain
mark the area of most intense pain
shade
mild bronchopulmonary dysplasia
moderate bronchopulmonary dysplasia
neonatal encephalopathy
allogeneic cellular vaccine 1650 - g
cdisc send variable terminology
body weight gain data collection date time
study day of body weight gain
body weight gain elapsed time
body weight gain end date time
body weight gain end day
exclude body weight gain data from statistics indicator
body weight gain original result
body weight gain original result unit
body weight gain reason for exclusion from statistics
body weight gain reason not done
body weight gain date time of reference timepoint
body weight gain sequence number
body weight gain completion status
body weight gain character result in standard format
body weight gain numeric result in standard unit
body weight gain result standard unit
body weight gain test
body weight gain test code
body weight gain time point reference
body weight baseline flag
body weight data collection date time
study day of body weight
exclude body weight data from statistics indicator
body weight fasting status
body weight original result
body weight original result unit
body weight reason for exclusion from statistics
body weight reason not done
body weight sequence number
body weight completion status
body weight character result in standard format
body weight numeric result in standard unit
body weight result standard unit
body weight test
body weight test code
clinical observations body system or organ class
clinical observations category
clinical observations data collection date time
study day of clinical observations
poly iclc
clinical observations elapsed time
clinical observations evaluator
exclude clinical observation data from statistics indicator
clinical observations group identifier
clinical observations location
clinical observations original result
clinical observation reason for exclusion from statistics
clinical observations reason not done
clinical observations date time of reference timepoint
clinical observations sequence number
clinical observations severity
clinical observations sponsor defined identifier
clinical observations completion status
clinical observations character result in standard format
clinical observations test
clinical observations test code
clinical observations planned time point name
clinical observations planned time point number
clinical observations time point reference
study day of comment
ecg test results completion status
ecg test results end date time
ecg test results end day
ecg test results evaluation interval
exclude ecg data from statistics indicator
ecg reason for exclusion from statistics
exposure method
food and water consumption data collection date time
study day of food and water consumption
food and water consumption end date time
food and water consumption end day
exclude food and water consumption data from statistics indicator
food and water consumption group identifier
food and water consumption original result
food and water consumption original result unit
food and water consumption reason for exclusion from statistics
food and water consumption reason not done
food and water consumption sequence number
food and water consumption completion status
food and water consumption character result in standard format
food and water consumption numeric result in standard unit
food and water consumption result standard unit
food and water consumption test
food and water consumption test code
laboratory test results anatomical region of specimen
laboratory test results directionality
laboratory test results end day
exclude laboratory test data from statistics indicator
laboratory test results laterality
laboratory test results location
laboratory test results portion or totality
laboratory tests reason for exclusion from statistics
laboratory test results biospecimen usability
macroscopic findings anatomical region of specimen
macroscopic findings body system
macroscopic findings directionality
macroscopic findings collection date time
macroscopic findings death relationship
study day of macroscopic findings
macroscopic findings evaluator
macroscopic findings group identifier
macroscopic findings laterality
macroscopic findings vendor name
macroscopic findings original result
macroscopic findings portion or totality
macroscopic findings reason not done
macroscopic findings reference identifier
macroscopic findings sequence number
macroscopic findings severity
macroscopic findings specimen condition
macroscopic findings biospecimen usability
macroscopic findings specimen type
macroscopic findings sponsor defined identifier
macroscopic findings completion status
macroscopic findings assessment character result in standard format
macroscopic findings assessment test
macroscopic findings assessment test code
microscopic findings anatomical region of specimen
microscopic findings body system
microscopic findings death relationship
microscopic findings severity
microscopic findings biospecimen usability
organ measurements anatomical region of specimen
organ measurements directionality
organ measurements collection date time
exclude organ measurements data from statistics indicator
organ measurements laterality
organ measurements original result
organ measurements original result unit
organ measurements portion or totality
organ measurements reason for exclusion from statistics
organ measurements reason not done
organ measurements sequence number
organ measurements specimen condition
organ measurements biospecimen usability
organ measurements specimen type
organ measurements completion status
organ measurements assessment character result in standard format
organ measurement numeric result in standard unit
organ measurement result standard unit
polyestradiol phosphate
organ measurements assessment test
organ measurements assessment test code
pharmacokinetic concentration baseline flag
pharmacokinetic concentration end day
exclude pharmacokinetic concentration data from statistics indicator
pharmacokinetic concentration reason for exclusion from statistics
palpable masses collection date time
study day of palpable masses
palpable masses evaluator
palpable masses group identifier
palpable masses location
palpable masses original result
palpable masses original result unit
palpable masses reason not done
palpable masses sequence number
palpable masses sponsor defined identifier
palpable masses completion status
palpable masses assessment character result in standard format
palpable masses numeric result in standard unit
palpable masses result standard unit
palpable masses assessment test
palpable masses assessment test code
pharmacokinetic parameters time point reference
tumor findings anatomical region of specimen
tumor findings dosing days to detection
tumor findings directionality
tumor findings collection date time
tumor findings death relationship
study day of tumor findings
tumor findings evaluator
tumor findings group identifier
tumor findings laterality
tumor findings method
tumor findings vendor name
tumor findings original result
tumor findings reason not done
tumor findings reference identifier
tumor findings result category
tumor findings sequence number
tumor findings specimen condition
tumor findings specimen type
tumor findings sponsor defined identifier
tumor findings completion status
tumor findings character result in standard format
tumor findings test
tumor findings test code
vital signs consciousness state
vital signs end date time
vital signs end day
exclude vital signs data from statistics indicator
vital signs reason for exclusion from statistics
study day of organ measurements
narsoplimab
icodextrin solution
macrosomia
intensity of pain at its worst
intensity of average pain
level of current pain
trouble sleeping when in pain
felt angry when in pain
trouble doing schoolwork when in pain
hard to pay attention when in pain
hard to run when in pain
hard to walk one block when in pain
hard to have fun when in pain
hard to stay standing when in pain
child had trouble sleeping when in pain
child felt angry when in pain
child had trouble doing schoolwork when in pain
child had trouble paying attention when in pain
child had trouble running when in pain
child had trouble walking one block when in pain
child had trouble having fun when in pain
child had trouble staying standing when in pain
how much did pain interfere with day to day activity
how much did pain interfere with work around the home
how much did pain interfere with ability to participate in social activities
how much did pain interfere with enjoyment of life
how much did pain interfere with things usually done for fun
how much did pain interfere with enjoyment of social activities
how much did pain interfere with household chores
how much did pain interfere with family life
how much did pain interfere with ability to concentrate
how much did pain interfere with enjoyment of recreational activities
how much did pain interfere with doing tasks away from home
how often did pain prevent socializing
almost all of the time
had no pain
genetically engineered hematopoietic stem progenitor cells
acute anterior uveitis
c1q deficiency
c1r / c1s deficiency
c2 deficiency
c4 deficiency
seronegative
low complement
pediatric osteoporosis
vasculitic ulcer
low natural killer cell activity
scleroderma renal crisis
pegaspargase
exhausted t - cell
cxcr2 - transduced autologous tumor infiltrating lymphocytes
2 - hydroxybutyrate
3 - hydroxybutyrate
cholate
dicarboxylic acid
deoxyuridine
androsterone glucuronide
androsterone sulfate
dehydroepiandrosterone 3 - glucuronide
dexa - beam regimen
f4 - isoprostane
n ( 6 )  -  ( 1 - carboxyethyl ) lysine
aminoadipic semialdehyde
n ( 6 )  - carboxymethyllysine
malondialdehyde - lysine
ca125 ii assay
lymph node gene expression signature
mhc class ii gene expression signature
tumor proliferation gene expression signature
germinal center b - cell gene expression signature
long interspersed nucleotide element - 1
enah protein isoform expression assay
acid phosphatase
histone h3 acetyl lys27
histone h3 methyl lys4
microparticle
platelet - derived microparticle
monocyte - derived microparticle
endothelial cell - derived microparticle
tissue factor - derived microparticle
tryptase
ctx
tarp antibody
gluten - free compact nutritional supplement drink
gluten - free / fiber - enriched compact nutritional supplement drink
anti - cd22 - car m971 - bbz lentiviral vector - transduced autologous t lymphocytes
nedisertib
selective estrogen receptor degrader srn - 927
fluorescent imaging ligand otl38
antigen - targeted personalized breast cancer vaccine
bemarituzumab
tavolimab
eicosapentaenoic acid - enriched nutritional supplement
brilacidin oral rinse
mouse colon adenocarcinoma
canine osteosarcoma
congenital fiber - type disproportion
masson trichrome staining method
pin1 gene
pin1 wt allele
peptidyl - prolyl cis - trans isomerase nima - interacting 1
chit1 gene
chit1 wt allele
chitotriosidase - 1
usp17l2 gene
usp17l2 wt allele
ubiquitin carboxyl - terminal hydrolase 17
kdm2b gene
kdm2b wt allele
lysine - specific demethylase 2b
syne2 gene
syne2 wt allele
nesprin - 2
flt3 activation loop mutation
marrow toxic injury
psma5 gene
psma5 wt allele
proteasome subunit alpha type - 5
anti - ceacam6 afaikl2 antibody fragment / jack bean urease immunoconjugate l - dos47
encephalopathy of prematurity
fluorine f 18 - labeled 2 - facpc
severity of symptom likert scale
severity of symptom score 0
severity of symptom score 1
severity of symptom score 2
severity of symptom score 3
severity of symptom score 4
severity of symptom score 5
severity of symptom score 6
severity of symptom score 7
severity of symptom score 8
severity of symptom score 9
severity of symptom score 10
hereditary nonpolyposis colorectal cancer syndrome
familial colorectal cancer type x
symptom interference with life likert scale
symptom interference with life score 0
symptom interference with life score 1
symptom interference with life score 2
symptom interference with life score 3
symptom interference with life score 4
symptom interference with life score 5
symptom interference with life score 6
symptom interference with life score 7
symptom interference with life score 8
symptom interference with life score 9
symptom interference with life score 10
cibisatamab
yq
tegafur - gimeracil - oteracil potassium - leucovorin calcium oral formulation
polysialic acid
fluorine f 18 ara - g
src / tubulin inhibitor kx02
fgfr4 inhibitor fgf401
listeria monocytogenes - llo - psa vaccine adxs31 - 142
gallium ga 68 - rgd
gallium ga 68 - nota - nfb
insulin growth factor i deficiency
insulin growth factor i resistance
bnip3 gene
bnip3 wt allele
bcl2 / adenovirus e1b 19 kda protein - interacting protein 3
bpi pain rating likert scale
pain rating score 0
short stature homeobox deficiency
acid - labile subunit deficiency
organic growth hormone deficiency
pain rating score 1
pain rating score 2
synthetic htert dna vaccine ino - 1400
pain rating score 3
pain rating score 4
branched - chain amino acid supplement
pain rating score 5
pain rating score 6
pain rating score 7
pain rating score 8
pain rating score 9
pain rating score 10
compound sodium lactate solution
ny - eso - 1 / mart - 1 peptide - pulsed dendritic cell vaccine
bpi percentage relief from pain treatment or medication likert scale
percentage relief from pain treatment or medication score 0
percentage relief from pain treatment or medication score 10
percentage relief from pain treatment or medication score 20
percentage relief from pain treatment or medication score 30
percentage relief from pain treatment or medication score 40
percentage relief from pain treatment or medication score 50
percentage relief from pain treatment or medication score 60
percentage relief from pain treatment or medication score 70
percentage relief from pain treatment or medication score 80
letolizumab
percentage relief from pain treatment or medication score 90
percentage relief from pain treatment or medication score 100
familial male precocious puberty
p450 - aromatase deficiency
isolated hypogonadotropic hypogonadism
ovarian hyperandrogenism
bpi pain interference likert scale
pubertal gynecomastia
pain interference score 0
pain interference score 1
pain interference score 2
pain interference score 3
pain interference score 4
pain interference score 5
pain interference score 6
pain interference score 7
pain interference score 8
pain interference score 9
pain interference score 10
female virilization
congenital hypergonadotropic hypogonadism
congenital hypogonadotropic hypogonadism
pathological gynecomastia
isolated premature menarche
idiopathic precocious puberty
cdisc qrs terminology
gh1 gene product
neuroendocrine cell hyperplasia of infancy
functional assessment of chronic illness therapy - diarrhea
limit social activity because of diarrhea
limit physical activity because of diarrhea
limit sexual activity because of diarrhea
embarrassed by diarrhea
have abdominal cramps or discomfort due to diarrhea
problem with diarrhea wakes me or keeps me awake at night
functional assessment of incontinence therapy - fecal
move bowels more frequently than usual
afraid to be far from a toilet
must move bowels frequently to avoid accidents
wear protection to prevent soiling of stool
autologous pbmcs in gm - csf
melapuldencel - t
nasal saline irrigation solution
wt1 peptide - loaded allogeneic dendritic cell vaccine
refractory malignant neoplasm
contrasexual sexual development
persistent mullerian duct syndrome
persistent mullerian duct syndrome type i
persistent mullerian duct syndrome type ii
complete androgen insensitivity syndrome
partial androgen insensitivity syndrome
5 - alpha - reductase deficiency
46 , xy disorder of androgen action
disorder of amh
disorder of amh receptor
46 , xx gonadal dysgenesis
46 , xy gonadal dysgenesis
45 , x / 46 , xy mixed gonadal dysgenesis
prednisolone acetate
testicular regression
placental aromatase deficiency
17 - beta - hydroxysteroid dehydrogenase 3 deficiency
defect in the gene for mis type ii receptor
acampomelic campomelic dysplasia
reductase deficiency
shu yu wan formula
monalizumab
flt3 / cdk4 / 6 inhibitor flx925
src kinase inhibitor kx2 - 391 ointment
elacestrant
evaux spring water - based cream
dpt / bcg / measles / serratia / pneumococcus vaccine
dpt / typhoid / staphylococcus aureus / paratyphoid a / paratyphoid b vaccine
pen needle
functional assessment of chronic illness therapy  -  abdominal discomfort
stomach pain interferes with daily functioning
pain in hands or feet when exposed to cold temperatures
cic - dux4 fusion protein expression
cic - dux4l fusion protein expression
t ( 4 ; 19 )  ( q35 ; q13 )
t ( 10 ; 19 )  ( q26 ; q13 )
cic - dux sarcoma
european quality of life five dimension three level youth questionnaire
walking mobility today
slight problems walking
moderate problems walking
severe problems walking
unable to walk
washing or dressing self - care today
slight problems with washing or dressing
moderate problems with washing or dressing
severe problems with washing or dressing
usual activities today
slight problems performing usual activities
moderate problems performing usual activities
severe problems performing usual activities
pain or discomfort today
slight pain or discomfort
severe pain or discomfort
anxiety or depression today
slightly anxious or depressed
severely anxious or depressed
a lot of problems walking
a lot of problems with washing and dressing
a lot of problems performing usual activities
some pain or discomfort
a lot of pain or discomfort
a bit anxious or depressed
very anxious or depressed
children's memory scale
wechsler adult intelligence scale  -  fourth edition
wechsler intelligence scale for children  -  fifth edition
wechsler preschool and primary scale of intelligence  -  fourth edition
california verbal learning test  -  second edition
wechsler memory scale  -  fourth edition
palbociclib isethionate
late pregnancy loss
normal virilization
virilization
lancet
substrate
cyp1a2 substrate
cyp2c9 substrate
cyp2c19 substrate
inducer
cyp2c9 inducer
anastrozole / trastuzumab regimen
narrow therapeutic index
direct extension
transnasal
transventricular
macroscopically positive surgical margin
intracardiac pneumonectomy
sublobar
grossly negative and microscopically positive surgical margin
every one to two hours
every three to four hours
every four to five hours
every four to six hours
sentinel lymph node biopsy followed by axillary lymph node biopsy
uninterpretable
tumor size
tumor less than or equal to 2 .0 centimeters
tumor greater than or equal to 2 .1 centimeters
minimum of 6 axillary nodes
grossly negative and microscopically negative surgical margin
ceramide dodecasaccharide
itgad gene
itgad wt allele
integrin alpha - d
spf10 - lipa pcr assay
gp5 +  / gp6 +  pcr assay
pgmy09 / pgmy11 pcr assay
my09 / my11 pcr assay
linear array hpv genotyping test
canine melanoma
medicare beneficiary id
recombinant prothymosin alpha
national radiology data registry
national death index
ccr2 antagonist ccx872 - b
anti - mesothelin antibody - drug conjugate bms - 986148
cyp17 / androgen receptor inhibitor odm 204
anti - ceacam1 monoclonal antibody cm - 24
personalized polyepitope plasmid dna breast cancer vaccine
mavelertinib
transdermal 17beta - estradiol gel bhr - 200
axicabtagene ciloleucel
cyp17 lyase inhibitor asn001
meta - fluorine f 18 fluorobenzylguanidine
hdac inhibitor mpt0e028
s - equol
compound kushen injection
ibuprofen injection
anti - egfr monoclonal antibody gc1118
anti - cd157 monoclonal antibody men1112
procaspase activating compound - 1 vo - 100
galnac - anti - c5 sirna aln - cc5
glabrous skin
non - glabrous skin
pectoral lymph node
dot locations learning
dot locations short delay
dot locations long delay
stories immediate
stories delayed
stories delayed recognition
faces immediate
faces delayed
word pairs learning
word pairs immediate
word pairs delayed
word pairs delayed recognition
numbers forward
numbers backward
dot locations total score
word pairs total score
numbers total score
sequences total score
scaled score
logical memory i subtest  ( wms - iv )
logical memory ii subtest  ( wms - iv )
verbal paired associates i subtest  ( wms - iv )
verbal paired associates ii subtest  ( wms - iv )
designs i subtest  ( wms - iv )
designs ii subtest  ( wms - iv )
visual reproduction i subtest  ( wms - iv )
visual reproduction ii subtest  ( wms - iv )
spatial addition subtest  ( wms - iv )
symbol span subtest  ( wms - iv )
block design subtest  ( wppsi - iv )
picture naming subtest  ( wppsi - iv )
bug search subtest  ( wppsi - iv )
vocabulary subtest  ( wppsi - iv )
block design subtest  ( wisc - v )
digit span forward subtest  ( wisc - v )
digit span backward subtest  ( wisc - v )
digit span sequencing subtest  ( wisc - v )
coding subtest  ( wisc - v )
vocabulary subtest  ( wisc - v )
symbol search subtest  ( wisc - v )
coding subtest  ( wais - iv )
block design subtest  ( wais - iv )
digit span subtest  ( wais - iv )
symbol search subtest  ( wais - iv )
vocabulary subtest  ( wais - iv )
acquired hypogonadotropic hypogonadism
follicle stimulating hormone receptor deficiency
bio - inactive somatotropin
idiopathic central precocious puberty
sex hormone - binding globulin deficiency
dax1 deficiency
disorder of androgen synthesis
mullerian aplasia and hyperandrogenism
childhood overweight
iatrogenic obesity
polygenic obesity
exogenous obesity
central obesity
monogenic obesity
melanocortin pathway defect
leptin deficiency
brain - derived neurotropic factor deficiency
leptin receptor deficiency
pml / rara single fusion probe
pml / rara dual fusion probe
rara dual color break - apart rearrangement probe
list a trials 1 - 5
list a trial 1 free recall
list a trial 5 free recall
pro - opiomelanocortin deficiency
melanocortin 4 receptor deficiency
list b free recall  ( cvlt - c )
list a short delay free recall
long delay free recall  ( cvlt - c )
perseverations
intrusions
polysaccharide - k
discriminability index
t - score
free recall trial 1
free recall trial 5
free recall trials 1 - 5
short delay free recall
neurotropic tyrosine kinase receptor type 2 deficiency
prohormone convertase 1 deficiency
chromosome 16p11 .2 deletion syndrome
maternal uniparental disomy chromosome 14 syndrome
have felt unusual fatigue
fatigue right now
usual level of fatigue
worst level of fatigue
fatigue interferes with general activity
fatigue interferes with mood
fatigue interferes with walking ability
fatigue interferes with work
fatigue interferes with relations with other people
fatigue interferes with enjoyment of life
bfi fatigue rating likert scale
bfi fatigue interference likert scale
fatigue rating score 0
fatigue rating score 1
fatigue rating score 2
fatigue rating score 3
fatigue rating score 4
fatigue rating score 5
fatigue rating score 6
fatigue rating score 7
fatigue rating score 8
fatigue rating score 9
fatigue rating score 10
adrenocorticotropic hormone deficiency
acquired adrenocorticotropic hormone deficiency
fatigue interference score 0
fatigue interference score 1
congenital isolated adrenocorticotropic hormone deficiency
fatigue interference score 2
fatigue interference score 3
fatigue interference score 4
fatigue interference score 5
acquired central hypothyroidism
fatigue interference score 6
fatigue interference score 7
fatigue interference score 8
isolated glucocorticoid deficiency
fatigue interference score 9
fatigue interference score 10
congenital isolated thyroid stimulating hormone deficiency
cardiothoracic
social security retirement benefit
pension
savings
male malignant nipple neoplasm
female malignant nipple neoplasm
malignant kidney neoplasm except pelvis
total score
peer
timeline follow - back protocol
fasting status
clinical outcome assessment subsection name
circulating clonotypic b - cell
fibrocyte
intratumoral genetic heterogeneity
homologous recombination deficiency
large - scale state transition
nitrite
16alpha - hydroxyestrone
4 - methoxyestradiol
4 - methoxyestrone
sulfatide compound
2 - methoxyestrone
4 - hydroxyestradiol
2 - hydroxyestradiol
neoantigen peptide
s - nitrosylation
tyrosine nitration
latent nuclear antigen antibody
glycoprotein k8 .1 antibody
adenovirus type 5 antibody
personal vaporizer
electronic cigarette
l - type amino acid transporter
oxylipin metabolomic profile
androgen receptor - dependent gene signature
tn antigen - muc1 - 32mer antibody
tn antigen antibody
sialyl - tn antigen antibody
thomsen - friedenreich antigen antibody
ganglioside gm2 antibody
igf1r gene product
insulin - like growth factor 1 receptor beta chain
hedgehog family
pam50 gene expression signature
keyhole limpet hemocyanin antibody
anti - yeast antibody
eortc qlq - c30 health and quality of life rating scale
health and quality of life rating score 1
health and quality of life rating score 2
tectorigenin
health and quality of life rating score 3
health and quality of life rating score 4
health and quality of life rating score 5
health and quality of life rating score 6
health and quality of life rating score 7
voice handicap index - 10
voice makes it difficult to hear me
run out of air when talking
difficulty understanding me in noisy room
sound of voice varies throughout day
family has difficulty hearing me when i call them in the house
use phone less often
tense when talking because of voice
tend to avoid groups because of my voice
people irritated by my voice
people question voice problem
digit span forward subtest  ( wais - iv )
digit span backward subtest  ( wais - iv )
digit span sequencing subtest  ( wais - iv )
receptive vocabulary subtest  ( wppsi - iv )
cancellation subtest  ( wppsi - iv )
cdisc sdtm anti - viral outcome of treatment terminology
cdisc sdtm holter ecg results terminology
cdisc sdtm holter ecg test code terminology
cdisc sdtm holter ecg test name terminology
cdisc sdtm immunogenicity specimen assessments test code terminology
cdisc sdtm immunogenicity specimen assessments test name terminology
cdisc sdtm microbiology test code terminology
cdisc sdtm microbiology test name terminology
cdisc send chronicity terminology
cdisc send distribution terminology
cdisc send non - neoplastic finding type terminology
cdisc send cardiovascular test code terminology
cdisc send cardiovascular test name terminology
cdisc send respiratory test code terminology
cdisc send respiratory test name terminology
cdisc send vital signs test code terminology
cdisc send vital signs test name terminology
cell density
mucoromycotina
pupillometry
rhizomucor
specular microscopy
tonometry
virologic response
myocardial contractility measurement
anti - cd20 - engineered toxin body mt - 3724
list b free recall  ( cvlt - ii )
long delay free recall  ( cvlt - ii )
lactobacillus - based probiotic capsule
alpha - folate receptor - targeting thymidylate synthase inhibitor onx - 0801
cannabis extract oil sr capsule
lifileucel
pamiparib
tomaralimab
mag - tn3 / as15 vaccine
losatuxizumab vedotin
ny - eso - 1 - specific tcr gene - transduced t lymphocytes tbi - 1301
radionuclide decorporation agent
aluminum carbonate
calcium phosphate
sodium glycerophosphate
tcerg1l gene
tcerg1l wt allele
transcription elongation regulator 1 - like protein
fbn2 gene
fbn2 wt allele
fibrillin - 2
pentetate calcium
pentetate zinc
mafa gene
mafa wt allele
transcription factor mafa
tolerable
excruciating
improvised nuclear device
vsir gene
vsir wt allele
radiological exposure device
radiological dispersal device
v - type immunoglobulin domain - containing suppressor of t - cell activation
nuclear power plant accident
early stillbirth
lymphocyte depletion kinetics
late stillbirth
portuguese language
spanish language
chinese language
german language
korean language
vietnamese language
very early neonatal death
cd160 gene
cd160 wt allele
often
cd160 antigen
rapid virologic response
sustained virologic response
viral breakthrough
pteropterin
viral relapse
virologic end of treatment response
virologic failure
virologic non - response
virologic null - response
virologic partial response
luminescence type
undetermined supraventricular rhythm by ecg finding
single beat rr extrapolated heart rate by ecg assessment
defibrillator discharge by ecg finding
frequent premature atrial complexes by ecg finding
frequent premature ventricular complexes by ecg finding
holter lead fail by ecg finding
marked sinus bradycardia by ecg finding
nonsustained supraventricular tachycardia by ecg finding
paroxysmal atrial fibrillation by ecg finding
persistent atrial fibrillation by ecg finding
sinus slowing with av block by ecg finding
supraventricular run by ecg finding
sustained supraventricular tachycardia by ecg finding
ventricular quadrigeminy by ecg finding
ventricular run by ecg finding
influenza hemagglutinin 1 specific igg antibody secreting cell count
influenza hemagglutinin 3 specific igg antibody secreting cell count
total igg antibody secreting cell count
anti - mullerian hormone measurement
anti - neutrophil cytoplasmic antibody measurement
anti - nucleosome antibody measurement
apolipoprotein b100 measurement
apolipoprotein b48 measurement
apolipoprotein ci measurement
bactericidal / permeability - increasing protein antibody measurement
cholesteryl ester transfer protein measurement
chylomicrons measurement
cathepsin antibody measurement
oxidized ldl cholesterol measurement
ldl particles measurement
ldl subtype pattern
lipoprotein associated phospholipase a2 measurement
lactoferrin antibody measurement
lysozyme measurement
monocytoid cells to leukocytes ratio measurement
neutrophils band form to neutrophils ratio measurement
segmented neutrophils to neutrophils ratio measurement
non - hdl cholesterol to hdl cholesterol ratio measurement
n - telopeptide to creatinine ratio measurement
proliferating cell nuclear antigen measurement
proprotein convertase subtilisin / kexin type 9 measurement
porphyrin measurement
proteinase 3 antibody measurement
soluble p - selectin measurement
p100 polymyositis - scleroderma autoantigen antibody measurement
rheumatoid factor antibody iga measurement
rheumatoid factor antibody igg measurement
rheumatoid factor antibody igm measurement
remnant - like particle cholesterol measurement
remnant lipoprotein measurement
ribonucleoprotein - 70 antibody measurement
ribonucleoprotein smith complex antibody measurement
ribosomal p protein antibody measurement
squamous cell carcinoma antigen measurement
sjogrens ss - a52 antibody measurement
sjogrens ss - a60 antibody measurement
type ii secretory phospholipase a2 measurement
indirect free thyroxine measurement
thymidine kinase measurement
tumor necrosis factor receptor 1 measurement
vldl cholesterol subtype 1 measurement
vldl cholesterol subtype 2 measurement
vldl cholesterol subtype 3 measurement
fibular shaft
humeral shaft
intertrochanteric region
extra lumbar vertebra
radius shaft
tibial shaft
ulnar shaft
influenza a antigen measurement
influenza a / b antigen measurement
influenza b antigen measurement
viral identification
analytical ultracentrifugation
applanation tonometry
contact specular microscopy
endpoint dilution assay
gas chromatography / tandem mass spectrometry
gas chromatography / chemical ionization mass spectrometry
gas chromatography / electron ionization mass spectrometry
hemagglutination inhibition assay
hemocytometry
high - performance liquid chromatography / ion - exchange chromatography
high - performance liquid chromatography / tandem mass spectrometry
high - performance liquid chromatography - fluorescence
high - performance liquid chromatography - uv
jaffe reaction
microneutralization assay
neuraminidase inhibition assay
non - contact specular microscopy
ophthalmoscopy
phoropter
pyrazine diazohydroxide
monocular pupillometry
quantitative coronary angiography
quantitative peripheral angiography
rebound tonometry
anaerobic gram positive bacteria
ancylostoma
candida intermedia
mixed flora
mucor
rhizomucor pusillus
maximum cell density
minimum cell density
mean cell density
standard deviation of cell density
optic cup to disc ratio
minimum diameter
mean diameter
standard deviation of diameter
lens status
maximum thickness
minimum thickness
mean thickness
standard deviation of thickness
mean absorption time
mean residence time infinity observed by extravascular dose
mean residence time infinity predicted by extravascular dose
mean residence time to last nonzero concentration by extravascular dose
liter per day per kilogram per meter squared
liter per day per milligram per day
liter per day per milligram per kilogram
liter per day per milligram per kilogram per day
liter per day per milligram per meter squared
liter per day per milligram per meter squared per day
liter per day per microgram per day
liter per day per microgram per kilogram
liter per day per microgram per kilogram per day
liter per day per microgram per meter squared
liter per day per microgram per meter squared per day
liter per day per meter squared
liter per hour per kilogram per meter squared
liter per hour per milligram per day
liter per hour per milligram per kilogram
liter per hour per milligram per kilogram per day
liter per hour per milligram per meter squared
liter per hour per milligram per meter squared per day
liter per hour per microgram per day
liter per hour per microgram per kilogram
liter per hour per microgram per kilogram per day
liter per hour per microgram per meter squared
liter per hour per microgram per meter squared per day
bevacizumab / interferon alfa regimen
liter per minute per kilogram per meter squared
liter per minute per milligram per day
liter per minute per milligram per kilogram
liter per minute per milligram per kilogram per day
liter per minute per milligram per meter squared
liter per minute per milligram per meter squared per day
liter per minute per microgram per day
liter per minute per microgram per kilogram
liter per minute per microgram per kilogram per day
liter per minute per microgram per meter squared
liter per minute per microgram per meter squared per day
milliliter per day per kilogram per meter squared
milliliter per day per milligram per day
milliliter per day per milligram per kilogram
milliliter per day per milligram per kilogram per day
milliliter per day per milligram per meter squared
milliliter per day per milligram per meter squared per day
milliliter per day per microgram per day
milliliter per day per microgram per kilogram
milliliter per day per microgram per kilogram per day
milliliter per day per microgram per meter squared
milliliter per day per microgram per meter squared per day
milliliter per day per gram
milliliter per day per meter squared
milliliter per day per milligram
milliliter per day per microgram
milliliter per hour per kilogram per meter squared
milliliter per hour per milligram per day
milliliter per hour per milligram per kilogram
milliliter per hour per milligram per kilogram per day
milliliter per hour per milligram per meter squared
milliliter per hour per milligram per meter squared per day
milliliter per hour per microgram per day
milliliter per hour per microgram per kilogram
milliliter per hour per microgram per kilogram per day
milliliter per hour per microgram per meter squared
milliliter per hour per microgram per meter squared per day
milliliter per hour per gram
milliliter per hour per meter squared
milliliter per hour per milligram
milliliter per hour per microgram
milliliter per minute per kilogram per meter squared
milliliter per minute per milligram per day
milliliter per minute per milligram per kilogram
milliliter per minute per milligram per kilogram per day
milliliter per minute per milligram per meter squared
milliliter per minute per milligram per meter squared per day
milliliter per minute per microgram per day
milliliter per minute per microgram per kilogram
milliliter per minute per microgram per kilogram per day
pyrazofurin
milliliter per minute per microgram per meter squared
milliliter per minute per microgram per meter squared per day
milliliter per minute per gram
milliliter per minute per meter squared
milliliter per minute per milligram
milliliter per minute per microgram
liter per kilogram per meter squared
liter per milligram per kilogram
liter per milligram per kilogram per day
liter per milligram per meter squared per day
liter per microgram per kilogram
liter per microgram per kilogram per day
liter per microgram per meter squared
liter per microgram per meter squared per day
liter per meter squared
liter per microgram
milliliter per kilogram per meter squared
milliliter per milligram per day
milliliter per milligram per kilogram
milliliter per milligram per kilogram per day
milliliter per milligram per meter squared
milliliter per milligram per meter squared per day
milliliter per microgram per kilogram
milliliter per microgram per kilogram per day
milliliter per microgram per meter squared per day
hemoglobin corrected diffusion capacity of the lung for carbon monoxide
percent predicted hemoglobin corrected diffusion capacity of the lung for carbon monoxide
hemoglobin corrected diffusion capacity of the lung for carbon monoxide / alveolar volume ratio
percent predicted hemoglobin corrected diffusion capacity of the lung for carbon monoxide / alveolar volume ratio
percent predicted diffusion capacity of the lung for carbon monoxide
diffusion capacity of the lung for carbon monoxide / alveolar volume ratio
percent predicted diffusion capacity of the lung for carbon monoxide / alveolar volume ratio
number of ectopic pregnancies
estimated date of conception
number of late fetal deaths
number of induced abortions
number of previous pregnancies
number of spontaneous abortions
arterial cord blood
interstitial fluid
venous cord blood
dose response control
immunogenicity study
milligram per mole
per kilogram
50 percent cell culture infective dose per milliliter
disintegrations per minute per 0 .5 milliliter
50 percent embryo infective dose per milliliter
international unit per deciliter
kilogram per centimeter
spot forming units per million peripheral blood mononuclear cells
carratelli unit
micromole per liter per minute
chronic active
peracute
subacute
subchronic
focal / multifocal
locally extensive
accessory tissue
accumulation
adenosis
adnexal dysplasia
alpha 2u - globulin nephropathy
agenesis
experimental organism astrocytosis
atypical residual bodies
bacteria present
basophilic phagolysosome
cellular debris
cholesterol cleft
chromatolysis
chronic progressive nephropathy
cutaneous crust
degeneration and atrophy
degeneration and necrosis
degeneration and regeneration
ectasia
elastosis
respiratory tract epithelial alteration
eroded and ulcerated lesion
fibroplasia
focus of cellular alteration
fungus present
germ cell degeneration
germ cell depletion
germ cell depletion and germ cell degeneration
glomerulopathy
glomerulosclerosis
hepatodiaphragmatic nodule
hyperplasia and metaplasia
hypertrophy and hyperplasia
hypertrophy and karyomegaly
hypoplasia
karyocytomegaly
karyocytomegaly and multinucleated hepatocytes
karyomegaly
mesangiolysis
microgliosis
mineralization
pyrene
multinucleated hepatocyte
neuronophagia
obstructive nephropathy
parasite present
proteinaceous plug
reflux nephropathy
septal deviation
spermatic stasis
spermatid retention
spermatocele
tension lipidosis
alzheimer type ii astrocyte
vesicle
yeast present
physical activity measurement
dp / dt average
left ventricular maximum positive dp / dt
left ventricular minimum positive dp / dt
left ventricular maximum negative dp / dt
left ventricular end diastolic pressure
left ventricular systolic pressure
maximum qa interval
mean qa interval
median qa interval
minimum qa interval
standard for the exchange of nonclinical data implementation guide version 3 .1
air sac
airway resistance
depth of respiration
end expiratory pause
end inspiratory pause
expiration relaxation time
expiratory time
forced expiratory volume
inspiratory time
mean pulmonary arterial pressure
minute volume
enhanced pause
peak expiratory pressure
peak inspiratory flow rate
peak inspiratory pressure
pulmonary artery diastolic pressure
pulmonary compliance
pulmonary artery systolic pressure
good laboratory practice indicator flag
inclusion body
gnly gene
gnly wt allele
granulysin
cd48 gene
cd48 wt allele
cd48 antigen
outcome satisfaction questionnaire
follow - up outcome expectations questionnaire
fgf22 gene
fgf22 wt allele
ability to do self - care after treatment
ability to get out and about after treatment
fibroblast growth factor 22
ability to do household chores after treatment
ability to sleep after treatment
ability to do recreation and leisure activities after treatment
ability to do social activities after treatment
atg7 gene
ability to do current work or school activities after treatment
appearance of arm or leg after treatment
atg7 wt allele
sensations in arm or leg after treatment
overall satisfaction with results of treatment
ubiquitin - like modifier - activating enzyme atg7
extremely satisfied
somewhat satisfied
neither satisfied nor dissatisfied
tnfaip2 gene
somewhat dissatisfied
extremely dissatisfied
tnfaip2 wt allele
tumor necrosis factor alpha - induced protein 2
cdisc questionnaire crq - sas first administration version test name terminology
cdisc questionnaire crq - sas first administration version test code terminology
cdisc questionnaire crq - sas follow - up administration version test name terminology
cdisc questionnaire crq - sas follow - up administration version test code terminology
cdisc functional test bacs test name terminology
cdisc functional test bacs test code terminology
cdisc clinical classification apache ii test name terminology
cdisc clinical classification apache ii test code terminology
cdisc clinical classification bode index test name terminology
cdisc clinical classification bode index test code terminology
cdisc clinical classification child - pugh test name terminology
cdisc clinical classification child - pugh test code terminology
cdisc clinical classification meld test name terminology
cdisc clinical classification meld test code terminology
cdisc clinical classification nsa - 16 test name terminology
cdisc clinical classification nsa - 16 test code terminology
apache ii clinical classification question
bode index clinical classification question
child - pugh clinical classification question
meld clinical classification question
nsa - 16 clinical classification question
bacs functional test question
cisapride
crq - sas first administration version questionnaire question
crq - sas follow - up administration version questionnaire question
chronic respiratory questionnaire self - administered standardized format first administration version questionnaire
chronic respiratory questionnaire self - administered standardized format follow - up administration version questionnaire
brief assessment of cognition in schizophrenia functional test
acute physiology and chronic health evaluation ii clinical classification
the body - mass index ,  airflow obstruction ,  dyspnea ,  and exercise capacity index clinical classification
child - pugh clinical classification
model for end stage liver disease clinical classification
negative symptom assessment - 16 clinical classification
crq - sas first administration version  -  feeling emotional
crq - sas first administration version  -  take care of basic needs
crq - sas first administration version  -  walking
crq - sas first administration version  -  performing chores
crq - sas first administration version  -  participate in social activities
crq - sas first administration version  -  felt frustrated or impatient
crq - sas first administration version  -  feeling of fear or panic
crq - sas first administration version  -  fatigue
crq - sas first administration version  -  embarrassed by coughing
crq - sas first administration version  -  feel confident to deal with illness
crq - sas first administration version  -  energy
crq - sas first administration version  -  feel upset ,  worried or depressed
crq - sas first administration version  -  had control of breathing problems
crq - sas first administration version  -  feel relaxed and free of tension
crq - sas first administration version  -  felt low in energy
crq - sas first administration version  -  felt discouraged or down
crq - sas first administration version  -  felt worn out or sluggish
crq - sas first administration version  -  happy ,  satisfied or pleased with life
crq - sas first administration version  -  feel upset when had difficulty getting breath
crq - sas first administration version  -  felt restless ,  tense or uptight
crq - sas follow - up administration version  -  feeling emotional
crq - sas follow - up administration version  -  take care of basic needs
crq - sas follow - up administration version  -  walking
crq - sas follow - up administration version  -  performing chores
crq - sas follow - up administration version  -  participate in social activities
crq - sas follow - up administration version  -  felt frustrated or impatient
crq - sas follow - up administration version  -  feeling of fear or panic
crq - sas follow - up administration version  -  fatigue
crq - sas follow - up administration version  -  embarrassed by coughing
crq - sas follow - up administration version  -  feel confident to deal with illness
crq - sas follow - up administration version  -  energy
crq - sas follow - up administration version  -  feel upset ,  worried or depressed
crq - sas follow - up administration version  -  had control of breathing problems
crq - sas follow - up administration version  -  feel relaxed and free of tension
crq - sas follow - up administration version  -  felt low in energy
crq - sas follow - up administration version  -  felt discouraged or down
crq - sas follow - up administration version  -  felt worn out or sluggish
crq - sas follow - up administration version  -  happy ,  satisfied or pleased with life
crq - sas follow - up administration version  -  feel upset when had difficulty getting breath
crq - sas follow - up administration version  -  felt restless ,  tense or uptight
bacs  -  number of items recalled
bacs  -  number of items recalled total
bacs  -  number of correct sequences
bacs  -  number of tokens left on the table
bacs  -  total number tokens in container
bacs  -  number tokens incorrectly placed
bacs  -  number of tokens correctly placed
bacs  -  category instances
bacs  -  letter fluency 1
bacs  -  letter fluency 2
bacs  -  verbal fluency total
bacs  -  symbol coding raw score
bacs  -  tower of london correct responses
bode index  -  body - mass index
bode index  -  fev1 percent predicted
bode index  -  mmrc dyspnea scale
bode index  -  distance walked in 6 minutes
bode index  -  score
child - pugh  -  encephalopathy grade
child - pugh  -  ascites
child - pugh  -  serum bilirubin
child - pugh  -  serum albumin
child - pugh  -  pt ,  sec prolonged
child - pugh  -  pt ,  inr
child - pugh  -  total score
child - pugh  -  grade
meld  -  score
nsa - 16  -  prolonged time to respond
nsa - 16  -  restricted speech quantity
nsa - 16  -  impoverished speech content
nsa - 16  -  inarticulate speech
nsa - 16  -  emotion: reduced range
nsa - 16  -  affect: reduce modulation intensity
nsa - 16  -  affect: reduced display on demand
nsa - 16  -  reduced social drive
nsa - 16  -  poor rapport with interviewer
nsa - 16  -  interest in emotional and physical intimacy
nsa - 16  -  poor grooming and hygiene
nsa - 16  -  reduced sense of purpose
nsa - 16  -  reduced interests
nsa - 16  -  reduced daily activity
nsa - 16  -  reduced expressive gestures
nsa - 16  -  slowed movements
nsa - 16  -  global negative symptoms rating
nsa - 16  -  global negative symptoms rating - severity
nsa - 16  -  global level of functioning
apache ii  -  temperature ,  rectal
apache ii  -  mean arterial pressure
apache ii  -  heart rate
apache ii  -  respiratory rate
recombinant rantes
apache ii  -  oxygenation ,  a - ado2
apache ii  -  oxygenation ,  pao2
apache ii  -  arterial ph
apache ii  -  serum hco3
apache ii  -  serum sodium
apache ii  -  serum potassium
apache ii  -  serum creatinine
apache ii  -  hematocrit
apache ii  -  white blood count
apache ii  -  15 minus glasgow coma score
apache ii  -  a ,  total acute physiology score
apache ii  -  b ,  age points
apache ii  -  c ,  chronic health points
apache ii  -  total apache ii score
tp53aip1 gene
tp53aip1 wt allele
p53 - regulated apoptosis - inducing protein 1
expected length of time to recover after treatment
difficulty to recover after treatment
feelings about ability to deal with treatment and recovery
recovered ability to do daily activities as expected
took less time than expected
took the expected time
took longer than expected
did not know what to expect
easier than expected
as expected
more difficult than expected
better than expected
worse than expected
sigmodon hispidus
infiltrating intramuscular lipoma
c11orf95 - mkl2 fusion protein expression
t ( 11 ; 16 )  ( q13 ; p13 )
mean residence time infinity observed by intravascular dose
c3 - targeted complement inhibitor apl - 2
mean residence time infinity predicted by intravascular dose
mean residence time to last nonzero concentration by intravascular dose
aspergillus niger
simultaneous - integrated boost intensity - modulated radiation therapy
hypoprolactinemia
follicle stimulating hormone deficiency
isolated follicle stimulating hormone deficiency
eif4b gene
eif4b wt allele
eukaryotic translation initiation factor 4b
pituitary stalk lesion
hypophysitis
pituitary abscess
myh9 / usp6 fusion gene
pituitary stalk interruption syndrome
ectopic posterior pituitary
fsh - producing gonadotroph adenoma
lh - producing gonadotroph adenoma
proliferative myositis
genomically - directed monotherapy
mesomelic dysplasia
clearing agent
anti - dr5 agonistic antibody ds - 8273a
iodine i 124 - labeled albumin
distressed by trouble falling asleep
distressed by awakening in the early morning
distressed by sleep that is restless and disturbed
initial outcome satisfaction questionnaire
do not expect a full recovery
somewhat difficult
extremely difficult
anti - cd20 b9e9 scfv - streptavidin fusion protein
eortc / rotg late radiation morbidity scoring criteria
lrmsc grade 0 ,  skin
lrmsc grade 1 ,  skin
lrmsc grade 2 ,  skin
lrmsc grade 3 ,  skin
lrmsc grade 4 ,  skin
lrmsc grade 5 ,  skin
lrmsc grade 0 ,  subcutaneous tissue
lrmsc grade 1 ,  subcutaneous tissue
lrmsc grade 2 ,  subcutaneous tissue
lrmsc grade 3 ,  subcutaneous tissue
lrmsc grade 4 ,  subcutaneous tissue
lrmsc grade 5 ,  subcutaneous tissue
mammary - type myofibroblastoma
ldl cholesterol to hdl cholesterol ratio measurement
triglycerides to hdl cholesterol ratio measurement
secondary hemophagocytic lymphohistiocytosis
adaptive behavior assessment system ,  adult rating form
adaptive behavior assessment system ,  parent rating form
communication skills
community use skills
functional pre - academics skills
functional academics skills
home living skills
health and safety skills
leisure skills
self - care skills
composite score
congenital nephrotic syndrome  -  diffuse mesangial sclerosis
self - direction skills
sirolimus
congenital nephrotic syndrome  -  focal segmental glomerulosclerosis
social skills
motor skills
work skills
general adaptive composite score
conceptual domain
social domain
pyometra
practical domain
denys - drash syndrome ,  incomplete
iga nephropathy ,  liver disease - associated
anti - cd47 monoclonal antibody cc - 90002
aprutumab ixadotin
bet inhibitor bay1238097
nanocell - encapsulated mir - 16 - based microrna mimic
usp14 / uchl5 inhibitor vlx1570
p - cadherin inhibitor pca062
anti - cd40 monoclonal antibody sea - cd40
toronto extremity salvage score ,  lower extremity
toronto extremity salvage score ,  upper extremity
ability to put on shoes
ability to do light household chores
ability to garden or do yard work
ability to do heavy household chores
ability to get in and out of the bath tub
ability to get out of bed
ability to rise from a chair
ability to kneel
ability to bend to pick something up off the floor
ability to walk up stairs
ability to walk downstairs
anti - cd122 humanized monoclonal antibody mik - beta - 1
ability to drive
ability to walk within the house
ability to walk outdoors
ability to sit
ability to walk up or down hills or a ramp
ability to stand upright
ability to get up from kneeling
ability to get in and out of a car
ability to participate in sexual activities
ability to put on a pair of pants
ability to tie shoe laces
ability to put on socks or stockings
ability to shower
ability to dress my arms and upper body
ability to button a shirt
ability to tie a tie or bow at the neck of a blouse
ability to put on make - up or shave
ability to brush your teeth
ability to brush your hair
ability to prepare and serve meals
ability to cut food while eating
ability to drink from a glass
ability to go shopping
ability to give or receive change
ability to carry a shopping bag or briefcase
ability to lift a box to an overhead shelf
ability to turn a key in a lock
ability to push or pull open a door
ability to write
ability to pick up small items
ability to complete my usual duties at work
ability to work my usual number of hours
ability to participate in my usual leisure activities
ability to socialize with friends and family
ability to participate in my usual sporting activities
ability to perform all the activities in which i participate in daily life
rating myself
behavior assessment system for children ,  second edition
self - report of personality
self - report of personality ,  college version
parent rating scales
atypicality scale
locus of control scale
social stress scale
anxiety scale
depression scale
sense of inadequacy scale
somatization scale
internalizing problems composite score
attention problems scale
hyperactivity scale
emotional symptoms index
sensation seeking scale
alcohol abuse scale
school maladjustment scale
relations with parents scale
interpersonal relations scale
self - esteem scale
self - reliance scale
personal adjustment composite score
aggression scale
conduct problems scale
withdrawal scale
adaptability scale
social skills scale
leadership scale
activities of daily living scale
functional communication scale
rebeccamycin
externalizing problems composite score
behavioral symptoms index composite score
adaptive skills composite score
post neonatal death
military nuclear weapon
moderate to late preterm birth
very preterm birth
extreme preterm birth
autologous wt1 - tcrc4 gene - transduced cd8 - positive tcm / tn lymphocytes
stern's rating scale for edema
edema rating 0
edema rating 1
edema rating 2
edema rating 3
edema rating 4
follow - up embodiment / outcomes questionnaire
feelings about arm or leg
arm or leg response group 1
arm or leg response group 2
arm or leg response group 3
arm or leg response group 4
chloroquine compound
anti - ro antibody
anti - la antibody
anti - smith antibody
anti - ribonucleoprotein antibody
cyclic citrullinated peptide antibody
antiphospholipid antibody
anti - beta - 2 glycoprotein 1 antibody
childhood health assessment questionnaire
child health questionnaire
intravenous immunoglobulin therapy
disease - modifying antirheumatic drug
non - biologic disease - modifying antirheumatic drug
biologic disease - modifying antirheumatic drug
international myositis assessment and clinical studies group
american college of rheumatology classification criteria for systemic lupus erythematosus
systemic lupus international collaborating clinics classification criteria
international league of associations for rheumatology classification criteria for juvenile idiopathic arthritis
european league against rheumatism classification criteria for juvenile chronic arthritis
american college of rheumatology classification criteria for juvenile rheumatoid arthritis
american college of rheumatology pediatric core set for juvenile arthritis
pediatric vasculitis activity score
birmingham vasculitis activity score
childhood myositis assessment scale
patient - reported outcomes measurement information system measures
physician global assessment of disease activity
parent global assessment of disease activity
parent assessment of overall well - being
patient global assessment of disease activity
patient assessment of overall well - being
occupational therapy
british isles lupus assessment group index
systemic lupus international collaborating clinics / american college of rheumatology - damage index
juvenile arthritis disease activity score
bath ankylosing spondylitis disease activity index
myositis disease activity assessment tool
myositis damage index
myositis activities profile
cutaneous dermatomyositis disease area and severity index
manual muscle testing
quantitative muscle testing
cutaneous assessment tool
dermatomyositis skin severity index
valentini scleroderma disease activity index
juvenile spondyloarthritis disease activity index
intraarticular corticosteroid therapy
localized corticosteroid therapy
stress dose steroid therapy
pten gene mutation
ability to move normally
edmonton symptom assessment system - sarcoma modified
biggest problem
worse than ever
pi3kdelta inhibitor gs - 9901
imifoplatin
vonlerolizumab
susceptibility weighted imaging
dual - energy computed tomography
autologous anti - ny - eso - 1 / lage - 1 tcr - transduced c259 t lymphocytes gsk3377794
musculoskeletal tumor society rating scale
extremity pain
extremity functional activity
extremity emotional acceptance
extremity hand positioning
extremity manual dexterity
extremity lifting ability
extremity supports
extremity walking ability
extremity gait
no extremity pain
extremity pain between none and modest
modest extremity pain
extremity pain between modest and moderate
moderate extremity pain
severe extremity pain
no extremity functional restrictions
some extremity functional restrictions
recreational extremity functional restrictions
increased extremity functional restrictions
resiniferatoxin
extremity functional restrictions partial disability
extremity functional restrictions total disability
enthusiastic acceptance of extremity
reduced acceptance of extremity
emotionally satisfied with extremity
moderate satisfaction with extremity
accepting of extremity
emotional dislike of extremity
unlimited hand positioning
reduced hand positioning
hand positioning not above shoulder
limited hand positioning
greatly limited hand positioning
no hand mobility
unlimited manual dexterity
reduced manual dexterity
loss of fine movements
limited manual dexterity
cannot pinch
cannot grasp
normal lifting ability
reduced lifting ability
limited lifting ability
greatly limited lifting ability
helping only lifting ability
no lifting ability
no support needed
occasional support needed
brace support needed
t ( 11 ; 16 )  ( p11 ; p11 )
support needed most of time
cane or crutch needed most of time
support always needed
unlimited walking ability
reduced walking ability
limited walking ability
greatly limited walking ability
inside only walking ability
no independent walking ability
normal gait
gait between normal and minor cosmetic change
minor cosmetic gait change
gait between minor and major cosmetic change
major cosmetic gait change
major handicap gait change
allogeneic cd3 -  cd19 -  selected natural killer cells
clavien - dindo classification
clavien - dindo grade i
clavien - dindo grade ii
clavien - dindo grade iii
clavien - dindo grade iiia
clavien - dindo grade iiib
clavien - dindo grade iv
clavien - dindo grade iva
clavien - dindo grade ivb
clavien - dindo grade v
atuveciclib
idh1 ( r132 )  inhibitor idh305
behavior rating inventory of executive function ,  preschool version
behavior rating inventory of executive function
behavior rating inventory of executive function ,  adult version
brief parent form questionnaire
brief teacher form questionnaire
inhibit scale
shift scale
emotional control scale
self monitor scale
initiate scale
working memory scale
plan / organize scale
task monitor scale
organization of materials scale
monitor scale
veristrat
global executive composite
granulocyte - macrophage colony forming unit
inhibitory self - control index
megakaryocyte colony forming unit
flexibility index
erythroid burst forming unit
emergent metacognition index
behavior regulation index
metacognition index
ellagitannin
estrone conjugate
pregnanediol - 3alpha - glucuronide
perform daily activities post limb therapeutic procedure recovery
gzma gene
gzma wt allele
granzyme a
b3gat2 gene
b3gat2 wt allele
galactosylgalactosylxylosylprotein 3 - beta - glucuronosyltransferase 2
znf793 gene
znf793 wt allele
zinc finger protein 793
slc5a8 gene
slc5a8 wt allele
sodium - coupled monocarboxylate transporter 1
resveratrol
malignant fibrohistiocytic neoplasm
ctla - 4 ligand
lgals3 antibody
alpha - gal antibody
pa2024 antibody
fibroblast growth factor receptor family isoform iiib
fibroblast growth factor receptor family isoform iiic
linear analogue self - assessment - 6
lasa - 6 feeling intensity scale
east indian sandalwood oil mouth rinse
feeling intensity score 0
feeling intensity score 1
feeling intensity score 2
feeling intensity score 3
feeling intensity score 4
feeling intensity score 5
feeling intensity score 6
feeling intensity score 7
feeling intensity score 8
feeling intensity score 9
feeling intensity score 10
hypomethylation
pediatric quality of life inventory ,  version 4
pedsql - 4 child report
pedsql - 4 parent report
pedsql - 4 physical functioning scale
pedsql - 4 emotional functioning scale
pedsql - 4 social functioning scale
pedsql - 4 school functioning scale
pedsql - 4 psychosocial health summary score
pedsql - 4 scale score
pedsql - 4 total scale score
urine albumin
erythroid colony forming unit
erg deregulation
gamma - secretase inhibitor ly3039478
autologous nkg2d car - cd3zeta - dap10 - expressing t - lymphocytes cyad - 01
autologous hpv - 16 / 18 e6 / e7 - specific tgf - beta - resistant t lymphocytes
mitazalimab
docetaxel - loaded nanopharmaceutical crlx301
cemiplimab
lmdda - llo - chher2 fusion protein - secreting live - attenuated listeria cancer vaccine adxs31 - 164
recombinant super - compound interferon
dolutegravir
attenuated chimpanzee adenovirus 5t4 vaccine
fluorescent protease - activated peptide avb - 620
health assessment questionnaire
visual analog scale
numeric rating scale
verbal rating scale
anti - egfr monoclonal antibody syn004
carbon c 14 roniciclib
anti - thyroglobulin mtcr - transduced autologous peripheral blood lymphocytes
pemigatinib
gallium ga 68 citrate
cardiophrenic lymph node
back arching
bloody discharge
breath holding
bite injury
cat bite
lorenzo's oil
cystic fibrosis pulmonary exacerbation
lysinuric protein intolerance
adenine phosphoribosyltransferase deficiency
neonatal progeroid syndrome
rat insulinoma
rat neuroblastoma
rat adrenal gland pheochromocytoma
netupitant / palonosetron hydrochloride
hcv dna vaccine ino - 8000
leiomyosarcoma of deep soft tissue
complex regional pain syndrome ii
crepitus
hypophagia
usual bedtime at night
usual time it takes to fall asleep at night
pulmonary function test decreased
pulmonary function test increased
pulmonary function test normal
usual time in morning to get up
hours of actual sleep at night
drooling
non - cutaneous leiomyosarcoma
trouble sleeping ,  cannot get to sleep within 30 minutes
trouble sleeping ,  waking up in the middle of the night or early morning
trouble sleeping ,  get up to use the bathroom
trouble sleeping ,  cannot breathe comfortably
foreign body ingestion
central line complication
trouble sleeping ,  cough or snoring loudly
trouble sleeping ,  feel too cold
trouble sleeping ,  feel too hot
trouble sleeping ,  having bad dreams
trouble sleeping because of pain
trouble sleeping because of other reason
overall sleep quality rating
take medicine to help sleep
have trouble staying awake
enough enthusiasm to get things done
retinyl acetate
have bed partner or roommate
have loud snoring
have long pauses between breaths while asleep
have legs twitching or jerking while asleep
catheter - related inflammation
have episodes of disorientation or confusion during sleep
have other restlessness while asleep
central line infection
not during the past month
only very slight problem
somewhat of a problem
a very big problem
no bed partner or roommate
partner or roommate in other room
partner in same room ,  but not same bed
partner in same bed
wound discharge
neomycin sulfate / polymyxin b sulfate / dexamethasone
germinomatous germ cell tumor
nongerminomatous germ cell tumor
ethinyl estradiol / norgestrel
galactocerebrosidase
galc gene
galc wt allele
aphagia
agonal respiration
spartalizumab
airway compromise
altered level of consciousness
altered mental status
disturbance of temperature regulation
increased respiratory secretion
less than once a week
once or twice a week
three or more times a week
fairly good
fairly bad
very bad
polihexanide solution
anti - gpc3 - car autologous t lymphocytes
ezh2 inhibitor cpi - 1205
allogeneic mesothelioma tumor lysate - pulsed autologous dendritic cell vaccine
citarinostat
calculus bovis / moschus / olibanum / myrrha capsule
casein / whey protein / soy protein / pea protein / fat mix / epa / dha - based nutritional supplement
enzymatically - hydrolyzed whey protein - based nutritional supplement
bmi1 inhibitor ptc596
belvarafenib
c - kit inhibitor plx9486
hpv16 l2 / e6 / e7 fusion protein vaccine ta - cin
superficial circumscribed morphea
deep circumscribed morphea
visiontree
anti - mesothelin - pseudomonas exotoxin 24 cytolytic fusion protein lmb - 100
spindle cell / sclerosing rhabdomyosarcoma
sclerosing rhabdomyosarcoma
tempi syndrome
porcine epidemic diarrhea virus
h5n2 avian influenza virus
flavor
influence
intrusive thought
mixture of embryonal and alveolar features present
growth chart
taminadenant
hdac inhibitor obp - 801
inotersen
pseudomyogenic hemangioendothelioma
disordered eating
wwtr1 - camta1 fusion protein expression
soft tissue angiosarcoma
wwtr1 / camta1 fusion gene
wwtr1 / camta1 fusion protein
peritumoral brain edema
rhizomelic dysplasia
radiofrequency - guided localization
conventional schwannoma
non - functioning pituitary gland microadenoma
functioning pituitary gland microadenoma
dermal nerve sheath myxoma
solitary circumscribed neuroma
meningothelial hamartoma
promis - 43 adult profile v2 .0
ability to do vacuuming and yardwork
ability to go up and down stairs at a normal pace
hybrid nerve sheath tumor
benign triton tumor
nasal glial heterotopia
ability to walk for fifteen minutes
ability to run errands and shop
current health limits doing two hours of physical labor
current health limits doing moderate work around the house
feel fearful
trouble focusing
worries overwhelm me
feel uneasy
feel like help is needed for anxiety
feel worthless
feel helpless
retinyl palmitate
feel hopeless
run down feeling on average
fatigue on average
bothered by fatigue on average
fatigue interference with physical function
sleep quality
refreshing sleep
problem with sleep
difficulty falling asleep
sleep is restless
try hard to get to sleep
neihulizumab
prostate mechanical imager
superficial acral fibromyxoma
have trouble doing regular leisure activities with others
have trouble doing regular family activities
have trouble doing usual work
have trouble doing activities with friends
have to limit things done for fun with others
lymphocytic neurohypophysitis
functioning pituitary gland macroadenoma
non - functioning pituitary gland macroadenoma
have to limit regular activities with friends
promis pain rating scale
pain rating average score 0
pain rating average score 1
pain rating average score 2
compensated hypothyroidism
pain rating average score 3
pain rating average score 4
pain rating average score 5
pain rating average score 6
pain rating average score 7
pain rating average score 8
pain rating average score 9
pain rating average score 10
can do without any difficulty
can do with a little difficulty
intermediate soft tissue tumor of uncertain differentiation
can do with some difficulty
can do with much difficulty
hypothalamic hypothyroidism
unable to do
pituitary hypothyroidism
cannot do
pendred syndrome
can do very little
iodide transport defect
dual oxidase 2 deficiency
thyroglobulin deficiency
thyroid peroxidase deficiency
thyroid dyshormonogenesis
hemosiderotic fibrolipomatous tumor
feel like a failure
feel unhappy
past seven days frequency of arm or leg swelling
worst severity past seven days arm or leg swelling
past seven days arm or leg swelling interfering with usual or daily activities
past seven days frequency of shortness of breath
worst severity past seven days shortness of breath
past seven days shortness of breath interfering with usual or daily activities
worst severity past seven days itchy skin
worst severity past seven days cough
past seven days cough interfering with usual or daily activities
past seven days frequency of headache
worst severity past seven days headache
past seven days headache interfering with usual or daily activities
past seven days frequency of pain in the abdomen
worst severity past seven days pain in the abdomen
past seven days pain in the abdomen interfering with usual or daily activities
myelin - associated glycoprotein antibody
ewsr1 - creb1 fusion protein expression
gallium ga 68 - labeled rm2
malignant ossifying fibromyxoid tumor
tislelizumab
cancer peptide vaccine s - 588410
androgen receptor ligand - binding domain - encoding plasmid dna vaccine mvi - 118
anti - sclu monoclonal antibody ab - 16b5
estriol vaginal gel
chlorhexidine / ethyl alcohol mouthwash
ethyl alcohol mouthwash
anti - mesothelin icasp9m28z car - transduced autologous t lymphocytes
panitumumab - irdye800
anti - cea - car autologous t lymphocytes
ectomesenchymal chondromyxoid tumor
mixed tumor ,  not otherwise specified
malignant mixed tumor ,  not otherwise specified
benign phosphaturic mesenchymal tumor
malignant phosphaturic mesenchymal tumor
sclerosing pecoma
benign pecoma
malignant pecoma
undifferentiated / unclassified sarcoma
quality of life questionnaire - brain neoplasm 20
had setbacks in condition
undifferentiated spindle cell sarcoma
undifferentiated round cell sarcoma
rhizoxin
outlook on the future worsened
have double vision
undifferentiated epithelioid sarcoma
have difficulty reading because of vision
undifferentiated sarcoma ,  not otherwise specified
have weakness on one side of body
have difficulty speaking
have trouble communicating thoughts
feel drowsy during the daytime
bothered by itching skin
have weakness of both legs
feel unsteady on feet
have trouble controlling bladder
no identifiable line of differentiation
comprehensive score for financial toxicity
have enough money to cover cost of treatment
out - of - pocket medical expenses are more than expected
samotolisib
worry about future financial problems as a result of illness or treatment
feel no choice about amount of money spent on care
frustrated cannot work or contribute as much as usual
satisfied with current financial situation
able to meet monthly expenses
feel financially stressed
concerned about keeping job and income
cancer or treatment has reduced satisfaction with present financial situation
feel in control of financial situation
organomegaly
4 - thio - 2 - deoxycytidine
mivebresib
fucosylated umbilical cord blood regulatory t cells
bone tumor of undefined neoplastic nature
spl suspect drug classification of notification terminology
spl suspect drug use terminology
counterfeit product
diverted product
stolen product
intentionally adulterated product
unfit for distribution product
fraudulently obtained product
approved for human use product
approved for non - human use product
osteochondromyxoma
de novo classification request
subungual exostosis
bizarre parosteal osteochondromatous proliferation
intermediate chondrogenic neoplasm
ncpdp dose unit of measure terminology
autologous nsclc peptide - specific dendritic cell vaccine
bet inhibitor bms - 986158
cetuximab - ir700 conjugate rm - 1929
cocoa extract
fursultiamine
facit - dyspnea 10 item short form
bemcentinib
dyspnea severity dressing yourself without help
autologous dendritic cell vaccine act2001
dyspnea severity walking on flat ground without stopping
dyspnea severity walking up 20 stairs without stopping
multicarotenoid supplement mcs - 8
dyspnea severity preparing meals
dyspnea severity washing dishes
dyspnea severity sweeping or mopping
dyspnea severity making a bed
dyspnea severity lifting something weighing 10 - 20 pounds
dyspnea severity carrying something weighing 10 - 20 pounds
dyspnea severity walking faster than your normal speed without stopping
did not dress without help
gallbladder sludge
suspicious for malignancy
grade ii chondrosarcoma
grade iii chondrosarcoma
did not walk on flat ground without stopping
did not walk up 20 stairs without stopping
did not prepare meals
did not wash dishes
did not sweep or mop
did not make a bed
did not lift something weighing 10 - 20 pounds
did not carry something weighing 10 - 20 pounds
did not walk faster than normal speed without stopping
secondary central chondrosarcoma
secondary peripheral chondrosarcoma
dressing without help
walking on flat ground without stopping
walking up 20 stairs without stopping
preparing meals
washing dishes
sweeping or mopping
making a bed
lifting something weighing 10 - 20 pounds
carrying something weighing 10 - 20 pounds
walking faster than your normal speed without stopping
giant cell lesion of small bones
no shortness of breath
mildly short of breath
moderately short of breath
severely short of breath
did not do this past 7 days
have stopped trying because of shortness of breath
ketorolac
did not do this activity for some other reason
benign notochordal cell tumor
functional assessment of chronic illness therapy - treatment satisfaction - general
treatment effectiveness so far compared to expected
treatment side effects so far compared to expected
doctor helped with evaluation of treatment effects
feel treatment was right
satisfied with treatment effects
recommend treatment to others with same illness
would choose treatment again
treatment rating overall
a lot worse
a little worse
a little better
a lot better
to some extent
for the most part
maybe
hey1 / ncoa2 fusion protein
hey1 / ncoa2 fusion gene
ivory exostosis
enostosis
intermediate osteogenic neoplasm
intermediate bone neoplasm
anti - ox40 agonist monoclonal antibody pf - 04518600
copper cu 64 - dota b - fab
non - ossifying fibroma
primary non - hodgkin lymphoma of bone
intermediate osteoclastic giant cell - rich tumor of bone
giant cell tumor of bone
malignant osteoclastic giant cell - rich tumor of bone
questionnaire subsection name
high reference range in text format
low reference range in text format
high reference range in numeric format
low reference range in numeric format
questionnaire subsection
questionnaire evaluator
bone epithelioid hemangioendothelioma
fluorine f 18 fluorthanatrace
selonsertib
rapid - onset obesity with hypothalamic dysfunction ,  hypoventilation ,  and autonomic dysregulation
heritable pulmonary arterial hypertension
drug -  and toxin - induced pulmonary arterial hypertension
personalized synthetic long peptide breast cancer vaccine
bet inhibitor incb054329
camidanlumab tesirine
xanthohumol
mutant p53 activator coti - 2
pan - raf kinase inhibitor cct3833
ovarian microcystic stromal tumor
gallium ga 68 - nota - ae105
clear cell papillary renal neoplasm
mknk1 inhibitor bay 1143269
wt1 protein - derived peptide vaccine dsp - 7888
carbon c 14 vemurafenib
fluorine f 18 alfatide ii
pirotinib
docetaxel nanoparticle cpc634
carbon c 11 pbr - 28
cribriform neuroepithelial tumor
micronucleus
androstane - 3 , 17 - diol glucuronide
loss of ini 1 protein expression
meningioangiomatosis
cutaneous neurocristic hamartoma
skin - directed therapy
pancreaticobiliary malunion
prostaglandin e3
induction death
acute lymphoblastic leukemia by gene expression profile
ph - like acute lymphoblastic leukemia
ddit4l acute lymphoblastic leukemia
cep 7 probe
hla complex
acute lymphoblastic leukemia by rose cluster
dt2219 antibody
rose cluster 1
rose cluster 2
rose cluster 3
rose cluster 4
rose cluster 5
rose cluster 6
rose cluster 7
angiome
rose cluster 8
broca gene signature
broca - hr gene signature
recognition of outliers by sampling ends
heterochromatin protein 1
integrin alpha4 / beta7
promis adult mental health domain
cognitive function - abilities
base47 gene signature
mind has been as sharp as usual
memory has been as good as usual
thinking has been as fast as usual
samarium sm - 153 lexidronam pentasodium
able to think clearly without extra effort
able to pay attention and keep track of what i am doing without extra effort
able to remember things as easily as usual without extra effort
pcdh7 gene
pcdh7 wt allele
protocadherin - 7
cdisc sdtm copd findings about test name terminology
cdisc sdtm copd findings about test code terminology
cardiovascular examination
dialister
dientamoeba
dracunculus
enterobius
wuchereria
ascaris
balantidium
blastocystis
chilomastix
endolimax
enteromonas
dolosigranulum
fasciola
fasciolopsis
gnathostoma
platyhelminthes
echinococcus
chair
lap
rating of perceived exertion
warm - up
priming exercise
seated row
chest press
leg press
one repetition maximum
hybrid capture 2 high - risk hpv dna test
gallium ga 68 - ha - dota - tate
golph3 gene
aortic augmentation index
incision - induced bleeding method
babesia
balamuthia
angiostrongylus
anisakis
capillaria
cestoda
coliform bacteria
cyclospora
entamoeba
renal clearance from t1 to t2
renal clearance for dose interval
golph3 wt allele
golgi phosphoprotein 3
rprm gene
rprm wt allele
protein reprimo
cep72 gene
cep72 wt allele
centrosomal protein of 72 kda
itga6 gene
itga6 wt allele
outsourcing animal drug compounding
integrin alpha - 6
pla2g7 gene
pla2g7 wt allele
platelet - activating factor acetylhydrolase
il34 gene
il34 wt allele
interleukin - 34
spag11b gene
spag11b wt allele
sperm - associated antigen 11b
mmp16 gene
mmp16 wt allele
matrix metalloproteinase - 16
fam3c gene
fam3c wt allele
topical corticosteroid therapy
protein fam3c
systemic corticosteroid therapy
radiologic impression
collagenous gastritis
aortic augmentation index at 75bpm
aortic augmentation pressure
augmentation pressure point p1
augmentation pressure point p2
pulse wave velocity
ejection wave amplitude
reflection magnitude
reflection wave amplitude
alanine measurement
glycated albumin measurement
antinuclear igg antibody measurement
alpha - 2 antiplasmin activity measurement
arginine measurement
asparagine measurement
aspartic acid measurement
borrelia burgdorferi antibody measurement
borrelia burgdorferi iga antibody measurement
saperconazole
borrelia burgdorferi igg antibody measurement
borrelia burgdorferi igm antibody measurement
beta - defensin 2 measurement
c - c chemokine receptor type 5 measurement
cd161a to lymphocyte ratio measurement
cd161 to lymphocyte ratio measurement
cd45 to lymphocyte ratio measurement
cd45ra to lymphocyte ratio measurement
chromogranin a measurement
citrulline measurement
citrate to creatinine ratio measurement
centromere igg antibody measurement
cardiolipin iga antibody measurement
type ii collagen c - telopeptides to creatinine ratio measurement
desmoglein 1 antibody measurement
desmoglein 3 antibody measurement
epstein - barr early d antigen igg antibody measurement
von willebrand factor activity measurement
factor x activity measurement
fractional excretion of magnesium
fluoride measurement
glutamine measurement
glycine measurement
hemoglobin s measurement
histidine measurement
htlv - i htlv - ii antibody measurement
islet cell cytoplasmic igg antibody measurement
immunoglobulin g subclass 1 measurement
immunoglobulin g subclass 2 measurement
immunoglobulin g subclass 3 measurement
immunoglobulin g subclass 4 measurement
interleukin 1 alpha measurement
leucine aminopeptidase measurement
leucine measurement
lysine measurement
myelin basic protein measurement
mumps virus igg antibody measurement
sodium to potassium ratio measurement
normetanephrine measurement
oligoclonal bands measurement
ornithine measurement
proline measurement
free protein s measurement
phosphatidylserine antibody iga measurement
phosphatidylserine antibody igg measurement
phosphatidylserine antibody igm measurement
reactive oxygen metabolite measurement
rna polymerase iii igg antibody measurement
scl - 70 igg antibody measurement
serine measurement
soluble liver antigen igg antibody measurement
smooth muscle igg antibody measurement
streptococcus pneumoniae antigen measurement
sulfate measurement
taurine measurement
transforming growth factor beta measurement
threonine measurement
t - lymphocyte count
thyroid stimulating hormone receptor antibody measurement
tyrosine measurement
valine measurement
ward's triangle
cryoscopy
duke incision method
enzymatic ultracentrifugation
forced oscillation technique
impulse oscillometry
ivy incision method
liquid chromatography / tandem mass spectrometry
liquid chromatography - fluorescence
gw776 / 5 - fluorouracil combination tablet
liquid scintillation counting
peak flowmetry
ph meter
plethysmography
template incision method
transcription - mediated amplification
ultra high - performance liquid chromatography / tandem mass spectrometry
ascaris lumbricoides
atopobium vaginae
babesia divergens
chemotherapy regimen or agent combination
babesia microti
bacillus pumilus
bacteroides salyersiae
bacteroides xylanisolvens
balamuthia mandrillaris
total respiratory system resistance
specific airway conductance
congenital abnormality indicator
estimated gestational age
number of early term births
anatomic structure ,  system ,  or substance
number of full term births
miscarriage indicator
pregnancy confirmed indicator
number of premature births
stillbirth indicator
blistering indicator
induration longest diameter
per 4 .0 milliliters
per 7 .5 milliliters
per square millimeter
miglustat
lip
billion per gram
anson unit
iga phospholipid unit
candela second per square meter
candela per square meter
enzyme immunoassay unit
femtomole per liter per second
international unit per gram hemoglobin
international unit per millimole
king - armstrong unit per deciliter
external upper lip
kilogram per mole
milli - anson unit per milliliter
square milligram per square deciliter
square millimole per square liter
milliosmole per liter
milliunit per gram
millivolt per second
nanomole bone collagen equivalents per nanomole
nanomole per liter per hour
nanomole per liter per minute
external lower lip
nanomole per mole
plaque forming units per animal
picokatal per liter
picomole per ten billion cells
picomole per billion cells
picomole per day
picomole per deciliter
picomole per liter per hour
unit per trillion red blood cells
microgram per liter per hour
external lip
microgram equivalent per liter
micromole per mole
body fat measurement
laryngeal pouch
black swiss mouse
db / db mouse
ob / ob mouse
rnu ,  rat strain
methionine measurement
ancylostoma braziliense
mucosa of the upper lip
ancylostoma caninum
ancylostoma duodenale
angiostrongylus cantonensis
anisakis simplex
aspergillus flavus complex
aspergillus fumigatus complex
balantidium coli
bifidobacterium animalis
bifidobacterium breve
bifidobacterium pseudocatenulatum
mucosa of the lower lip
bipolaris
blastocystis hominis
borrelia miyamotoi
buttiauxella ferragutiae
buttiauxella gaviniae
buttiauxella noackiae
calodium hepaticum
capillaria philippinensis
chaetomium
chilomastix mesnili
mucosa of the lip
chrysosporium
cladosporium
clonorchis sinensis
clostridium aldenense
clostridium citroniae
clostridium oroticum
clostridium spiroforme
coliform bacteria ,  lactose fermenting
coliform bacteria ,  non - lactose fermenting
corynebacterium coyleae
commissure of the lip
corynebacterium diphtheriae bv . gravis
corynebacterium diphtheriae bv . intermedius
corynebacterium diphtheriae bv . mitis
corynebacterium diphtheriae bv . belfanti
corynebacterium mucifaciens
corynebacterium simulans
cryptosporidium parvum
curvularia
cyclospora cayetanensis
deltacoronavirus
base of the tongue
dialister micraerophilus
dialister pneumosintes
dientamoeba fragilis
dipetalonema
diphyllobothrium latum
dipylidium caninum
dolosigranulum pigrum
dorea
dracunculus medinensis
echinococcus granulosus
palate
echinococcus multilocularis
echinococcus vogeli
ehrlichia
encephalitozoon
endolimax nana
entamoeba coli
entamoeba hartmanni
entamoeba histolytica
entamoeba polecki
enterobacter cloacae complex
selenocysteine
hard palate
enterobius vermicularis
enterococcus saccharolyticus
enterocytozoon
enteromonas hominis
epicoccum
escherichia coli ,  extended - spectrum beta - lactamase positive
exserohilum
facklamia hominis
fasciola hepatica
fasciolopsis buski
soft palate
flavonifractor
fonsecaea
fusobacterium periodonticum
gammacoronavirus
geomyces
geotrichum
giardia lamblia
gliocladium
gnathostoma spinigerum
gram - negative coccobacillus
uvula
gram - negative diplococcus
gram - negative microaerophilic bacillus
gram - negative microaerophilic coccus
hymenolepis nana
intestinibacter bartlettii
isospora
mansonella ozzardi
mansonella streptocerca
wuchereria bancrofti
accumulation ratio area under the curve from t1 to t2
submandibular gland
renal clearance from t1 to t2 normalized by body mass index
renal clearance from t1 to t2 normalized by dose
renal clearance from t1 to t2 normalized by surface area
renal clearance from t1 to t2 normalized by weight
renal clearance for dose interval normalized by body mass index
renal clearance for dose interval normalized by dose
renal clearance for dose interval normalized by surface area
renal clearance for dose interval normalized by weight
stationarity ratio area under the curve
trough peak ratio
sublingual salivary gland
promis adult social health domain
ability to participate in social roles and activities subordinate domain
have trouble doing the work that is important to me
emotional distress - anxiety subordinate domain
feel anxious
feel worried
promis adult physical health domain
fatigue subordinate domain
how often feel tired
how often experience extreme exhaustion
tonsillar fossa
how often run out of energy
how often did fatigue limit work
how often too tired to think clearly
how often too tired to bathe or shower
how often have enough energy to exercise strenuously
promis adult global health domain
physical function subordinate domain
current health limits vigorous activities
current health limits walking more than a mile
current health limits climbing one flight of stairs
tonsillar pillar
current health limits bending ,  kneeling or stooping
ability to dress yourself
ability to shampoo your hair
ability to wash and dry your body
ability to get on and off the toilet
cognitive function subordinate domain
seems like brain is not working as well as usual
have trouble adding or subtracting numbers in my head
hypomethylation therapy
vallecula
asthma control questionnaire
adhd rating scale - iv home version questionnaire
asthma quality of life questionnaire
hemophilia quality of life questionnaire children's long version age group i
hemophilia quality of life questionnaire children's long version age group ii
hemophilia quality of life questionnaire children's long version age group iii
hemophilia quality of life questionnaire children's short version age group i
hemophilia quality of life questionnaire children's short version age group ii / iii
hemophilia quality of life questionnaire parent's long version age group i
hemophilia quality of life questionnaire parent's long version age group ii
anterior surface of the epiglottis
hemophilia quality of life questionnaire parent's long version age group iii
hemophilia quality of life questionnaire adult version
montgomery - asberg depression rating scale questionnaire
western ontario and mcmaster universities osteoarthritis index version 3 .1 likert scale format questionnaire
western ontario and mcmaster universities osteoarthritis index version 3 .1 numerical rating scale format questionnaire
western ontario and mcmaster universities osteoarthritis index version 3 .1 visual analog scale format questionnaire
frequency thinking has been slow
frequency have trouble shifting back and forth between different activities that require thinking
lateral wall of the oropharynx
confocal laser microlaryngoscopy
red blood cell exchange and depletion procedure
number of years of education
choi response criteria in the evaluation of gastrointestinal stromal tumors
simo decoction
tetravalent rna - lipoplex cancer vaccine
chimeric humanized anti - cd47 antibody
black raspberry nectar
diphtheria - tetanus - acellular pertussis - inactivated poliomyelitis - haemophilus influenzae type b vaccine
atamestane
posterior wall of the oropharynx
synthetic hypericin
heterodimeric interleukin - 15
autologous oxidized ovarian tumor cell lysate vaccine
sevacizumab
zirconium zr 89 - labeled atezolizumab
yttrium y 90 anti - cdh3 monoclonal antibody ff - 21101
duvortuxizumab
pulmonary nodule
multiple pulmonary nodules
ostomy site pain
absence of bowel movement
scleral icterus
vaso - occlusive crisis
ulcerative colitis flare
autoimmune encephalitis
near - infrared fluorescence endoscopy
refusal to bear weight
have to limit regular activities with family
advertising ,  marketing ,  promotions ,  public relations ,  and sales managers
dog bite
superior wall of the nasopharynx
integrated cancer repository for cancer research
agricultural workers
air transportation workers
animal care and service workers
architects ,  surveyors ,  and cartographers
port site infection
acquired cytomegaloviral infection
congenital cytomegaloviral infection
art and design workers
assemblers and fabricators
posterior wall of the nasopharynx
abnormal behavior
building cleaning and pest control workers
business operations specialists
communications equipment operators
computer specialists
impaired balance
construction trades workers
positive blood culture
blood urea nitrogen increased
dislodged catheter
lateral wall of the nasopharynx
cooks and food preparation workers
counselors ,  social workers ,  and other community and social service specialists
drafters ,  engineering ,  and mapping technicians
coombs test positive
decreased physical activity
feeding tube complication
electrical and electronic equipment mechanics ,  installers ,  and repairers
engineers
entertainers and performers ,  sports and related workers
entertainment attendants and related workers
anterior wall of the nasopharynx
extraction workers
financial clerks
financial specialists
fire fighting and prevention workers
first - line enlisted military supervisor and managers
first - line protective service worker supervisors and managers
minimal residual disease - based risk stratification in acute leukemia
standard risk acute leukemia
high risk acute leukemia
fishing and hunting workers
hypopharynx
food and beverage serving workers
food processing workers
forest ,  conservation ,  and logging workers
funeral service workers
grounds maintenance workers
health diagnosing and treating practitioners
health technologists and technicians
helpers ,  construction trades
information and record clerks
law enforcement workers
fistula discharge
lawyers ,  judges ,  and related workers
legal support workers
librarians ,  curators ,  and archivists
life scientists
life ,  physical ,  and social science technicians
material moving workers
material recording ,  scheduling ,  dispatching ,  and distributing workers
gait unsteady
ethylene chlorohydrin
mathematical science occupations
media and communication equipment workers
media and communication workers
metal workers and plastic workers
military officer special and tactical operations leaders and managers
military enlisted tactical operations and air / weapons specialists and crew members
motor vehicle operators
nursing ,  psychiatric ,  and home health aides
occupational and physical therapist assistants and aides
operations specialties managers
posterior wall of the hypopharynx
propylene chlorohydrin
cutting fluid
dry cleaning fluid
floor cleaning agent
paint thinner
petroleum hydrocarbon compound
personal appearance workers
physical scientists
plant and system operators
postsecondary teachers
shiga toxin
cervical esophagus
primary ,  secondary ,  and special education school teachers
printing workers
rail transportation workers
religious workers
retail sales workers
sales representatives ,  services
sales representatives ,  wholesale and manufacturing
hemoglobin a1c increased
secretaries and administrative assistants
social scientists and related workers
thoracic esophagus
supervisors of installation ,  maintenance ,  and repair workers
supervisors ,  building and grounds cleaning and maintenance workers
ketonuria
hyperlactemia
supervisors ,  construction and extraction workers
supervisors ,  farming ,  fishing ,  and forestry workers
abnormal liver function test
supervisors ,  food preparation and serving workers
supervisors ,  office and administrative support workers
supervisors ,  personal care and service workers
abdominal esophagus
supervisors ,  production workers
supervisors ,  sales workers
supervisors ,  transportation and material moving workers
methicillin - resistant staphylococcus aureus pneumonia
textile ,  apparel ,  and furnishings workers
top executives
mycoplasmal pneumonia
disrupted suture
violent behavior
unresponsive to stimuli
upper third of the esophagus
transportation ,  tourism ,  and lodging attendants
vehicle and mobile equipment mechanics ,  installers ,  and repairers
water transportation workers
woodworkers
other architecture and engineering workers
other arts ,  design ,  entertainment ,  sports ,  and media workers
other building and grounds cleaning and maintenance workers
other business and financial operations workers
other community and social services workers
other computer and mathematical workers
middle third of the esophagus
other construction and related workers
other education ,  training ,  and library occupations
other farming ,  fishing ,  and forestry workers
other food preparation and serving related workers
other healthcare practitioners and technical occupations
other healthcare support occupations
other installation ,  maintenance ,  and repair occupations
other legal workers
other life ,  physical ,  and social science workers
other management occupations
lower third of the esophagus
other military specific workers
other office and administrative support workers
other personal care and service workers
other production occupations
other protective service workers
other sales and related workers
other teachers and instructors
other transportation workers
dnajb1 / prkaca fusion gene
dnajb1 / prkaca fusion protein
gastric cardia
dnajb1 gene
dnajb1 wt allele
dnaj homolog subfamily b member 1
coal gas ,  coal tar ,  coal tar pitch ,  and derivatives
rubber chemical
fact - n questionnaire
fact - mm questionnaire
worry about getting infections
feel discouraged about illness
worry about getting new symptoms
fundus of the stomach
have emotional ups and downs
have trouble walking because of pain
rhinovirus infection
screaming
lupus flare
positive herpes simplex virus culture
staphylococcus aureus infection
status asthmaticus
throat tightening
phonophobia
body of stomach
pneumatosis intestinalis
postoperative infection
positive pseudomonas culture
hemiparesis
borderline ovarian serous tumor / atypical proliferative ovarian serous tumor
borderline ovarian serous tumor - micropapillary variant / non - invasive low grade ovarian serous carcinoma
borderline ovarian mucinous tumor / atypical proliferative ovarian mucinous tumor
indwelling urinary catheter
peritoneal dialysis catheter
hemodialysis catheter
antrum pylori
venous catheter
peripherally inserted central catheter
arterial catheter
duodenostomy
oral endotracheal tube
nasal endotracheal tube
laryngeal tube
nasojejunal tube
pericardial tube
chest tube
sialyl tn antigen
pylorus
rectal tube
extramedullary involvement
bone marrow and extramedullary involvement
infant leukemia
infantile lesion
neonatal lesion
early relapse
late relapse
tympanostomy tube
surgical wound drain
lesser curvature of the stomach
ventriculostomy drain
t - tube
pigtail drain
swan ganz catheter
infant acute lymphoblastic leukemia
biliary duct stent
coronary artery stent
infant acute lymphoblastic leukemia with mll rearrangement
cuffed hemodialysis catheter
cuffed peritoneal dialysis catheter
greater curvature of the stomach
uncuffed dialysis catheter
infant acute lymphoblastic leukemia without kmt2a gene rearrangement
surgically placed gastrostomy tube
kmt2a gene rearrangement
refractory childhood acute lymphoblastic leukemia
childhood acute myeloid leukemia not otherwise specified
detergent
trash
maternal proteinuria
actuation dosing unit
duodenum
auto - injector dosing unit
dropperful dosing unit
injection dosing unit
lollipop dosing unit
pill dosing unit
pre - filled pen syringe dosing unit
pediatric medical device terminology
monomethyl auristatin e
ostomy site
duodenostomy site
meckel diverticulum
colostomy site
cystostomy site
ileostomy site
tracheostomy site
urostomy site
enterostomy site
gastrostomy site
jejunostomy site
nephrostomy site
progesterone receptor staining method
ascending colon
estrogen receptor staining method
antibody ki67 staining method
side effects of treatment are worse than imagined
dentatorubral - pallidoluysian atrophy
short - rib thoracic dysplasia 6 with or without polydactyly
neuronal intranuclear inclusion disease
cleft lip / palate - ectodermal dysplasia syndrome
lig4 syndrome
dna ligase i deficiency
charcot - marie - tooth disease type 2d
hepatic flexure
hardcastle's syndrome
glycogen storage disease type ib
glycogen storage disease type ix
inclusion body myopathy with early - onset paget disease with or without frontotemporal dementia 1
leukoencephalopathy with vanishing white matter
cigarette filter ventilation blocking
illicit tobacco product
dixon mri
lipid r1 mri
recollect
splenic flexure
point of sale
dissolvable tobacco
purchase
sponsorship
hookah
signage
anti - tobacco advertisement
carbon c 14 gilteritinib
idh1r132h mutation - targeting idh1 peptide vaccine
anti - hla - a2 / ny - eso - 1 tcr - transduced autologous t lymphocytes
descending colon
anti - cd20 monoclonal antibody sct400
zhongyao fufang
xianling gubao
ieramilimab
carbon c 11 sarcosine
prediabetes
hypocellular myelodysplastic syndrome
cytogenetically normal acute myeloid leukemia
core binding factor acute myeloid leukemia
t ( 7 ; 12 )  ( q36 ; p13 )
head of the pancreas
acute myeloid leukemia with t ( 7 ; 12 )  ( q36 ; p13 )  ;  hlxb9 - etv6
childhood acute myeloid leukemia with nup98 rearrangement
nup98 gene rearrangement
wnt signaling inhibitor sm04755
quality of life questionnaire - multiple myeloma 20
have aches or pains in bones
have hip pain
have pain in arm or shoulder
have chest pain
have pain increase with activity
simalikalactone d
body of the pancreas
feel thirsty
have tingling in hands or feet
feel restless or agitated
have acid indigestion or heartburn
have burning or sore eyes
have been thinking about illness
current health limits lifting or carrying groceries
mps1 inhibitor bay 1217389
curcumin - based gel
functional photoacoustic microscopy
tail of the pancreas
medical device failure
medical device malfunction
medical device dislodged
medical device misplaced
testicular involvement
central nervous system involvement
acute myeloid leukemia with inv ( 3 )   ( q21 .3 ; q26 .2 )  ;  gata2 ,  mecom
acute myeloid leukemia with t ( 3 ; 3 )   ( q21 .3 ; q26 .2 )  ;  gata2 ,  mecom
anti - human cytomegalovirus monoclonal antibody combination csj - 148
fgfr inhibitor asp5878
pancreatic duct
asp4132
hypercarbia
accidental drug ingestion
5 - iodo - 2 - pyrimidinone
5 - iodouracil
childhood acute myeloid leukemia with abnormalities of chromosome 5q
childhood acute myeloid leukemia with abnormalities of chromosome 7
tspo gene
tspo wt allele
translocator protein
other specified parts of pancreas
central memory immune cell
effector memory immune cell
suppressive monocyte
circulating epithelial cell
childhood cancer registry
slc35b2 gene
slc35b2 wt allele
adenosine 3' - phospho 5' - phosphosulfate transporter 1
stk35 gene
stk35 wt allele
middle ear
serine / threonine - protein kinase 35
plec gene
plec wt allele
plectin
rest gene
rest wt allele
re1 - silencing transcription factor
flot1 gene
flot1 wt allele
flotillin - 1
maxillary sinus
psmd4 gene
psmd4 wt allele
26s proteasome non - atpase regulatory subunit 4
marcks gene
marcks wt allele
myristoylated alanine - rich c - kinase substrate
normal range comparison result
reference range comparison
trim63 gene
trim63 wt allele
ethmoid sinus
e3 ubiquitin - protein ligase trim63
clec7a gene
clec7a wt allele
c - type lectin domain family 7 member a
clec10a gene
clec10a wt allele
c - type lectin domain family 10 member a
glycan antibody
kit exon 14 mutation
leucine - rich repeats and immunoglobulin - like domains protein family
frontal sinus
scl - 70 antibody
vegf:vegfr complex
poliovirus receptor antibody
rest - 003 ncrna
lcp1 antibody
rara gene product
retinoic acid receptor alpha isoform alpha - 2
egfr antibody
creatine kinase mb
ppargc1a gene product
sphenoid sinus
peroxisome proliferator - activated receptor gamma coactivator 1 - alpha isoform 4
chromosome 17 centromere probe
hurler - scheie syndrome
canine hemangiosarcoma
tracheobronchitis
pneumatosis
incarcerated inguinal hernia
non - dystrophic myotonia
potassium aggravated myotonia
myotonia fluctuans
supraglottis
paramyotonia congenita
normokalemic periodic paralysis
severe neonatal episodic laryngospasm
critical illness myopathy
paramyotonia congenita without cold paralysis
nephrotic syndrome  -  nphs1 associated
idiopathic nephrotic syndrome
nephrotic syndrome of childhood  -  steroid sensitive
nephrotic syndrome of childhood  -  steroid resistant
nephrotic syndrome -  steroid dependent
sodium molybdate
subglottis
incident nephrotic syndrome
prevalent nephrotic syndrome
nephrotic syndrome  -  relapse
nephrotic syndrome  -  frequently relapsing
wilms tumor - aniridia - genitourinary anomalies - mental retardation - obesity syndrome
frasier syndrome
diffuse endocapillary glomerulonephritis
immunohistochemical status of pd - l1
pd - l1 overexpression
lack of expression of pd - l1
laryngeal cartilage
pd - l1 status unknown
generalized epilepsy with febrile seizures plus
partial epilepsy
juvenile myoclonic epilepsy ,  intractable ,  without status epilepticus
early infantile epileptic encephalopathy
acute encephalopathy
azintuxizumab vedotin
bcl5 gene
closure patent ductus arteriosus
nab2 / stat6 fusion gene
nab2 / stat6 fusion protein
elevated urine alkaline phosphatase
cholelithiasis
etnk1 gene
etnk1 wt allele
ethanolamine kinase 1
cdkn2d gene
cdkn2d wt allele
cyclin - dependent kinase 4 inhibitor d
wdfy2 gene
wdfy2 wt allele
wd repeat and fyve domain - containing protein 2
vepoloxamer
anti - cd37 monoclonal antibody bi 836826
selective estrogen receptor degrader azd9496
inosine 5' - monophosphate dehydrogenase inhibitor ff - 10501 - 01
mtorc1 / 2 kinase inhibitor bi 860585
clostridium butyricum - containing probiotic
type iv collagen staining method
type i collagen staining method
main bronchus
leucine - rich repeat - containing g - protein coupled receptor 5 staining method
pou domain ,  class 5 ,  transcription factor 1 staining method
gata - binding factor 3 staining method
programmed cell death protein 1 staining method
major histocompatibility complex class ii staining method
major histocompatibility complex class i staining method
adhesion g protein - coupled receptor e1 staining method
forkhead box protein p3 staining method
b220 staining method
macrosialin staining method
upper lobe of the lung
cd8 co - receptor staining method
t - cell surface glycoprotein cd4 staining method
cd3 complex staining method
tight junction protein zo - 1 staining method
cadherin - 2 staining method
cadherin - 3 staining method
claudin - 7 staining method
pan cytokeratin staining method
cytokeratin - 6 staining method
cytokeratin - 5 staining method
middle lobe of the right lung
vitamin d3 receptor staining method
androgen receptor staining method
caspase - 3 staining method
phosphatase and tensin homolog staining method
breast cancer type 2 susceptibility protein staining method
breast cancer type 1 susceptibility protein staining method
brca rearrangement
retinoblastoma - associated protein staining method
cellular tumor antigen p53 staining method
neurogenic locus notch homolog protein 3 staining method
lower lobe of the lung
neurogenic locus notch homolog protein 1 staining method
signal transducer and activator of transcription 5 staining method
signal transducer and activator of transcription 3 staining method
signal transducer and activator of transcription 1 staining method
pan - idh mutant inhibitor ag - 881
dctn1 gene
dctn1 wt allele
dynactin subunit 1
zcchc8 gene
zcchc8 wt allele
zinc finger cchc domain - containing protein 8
myo5a gene
myo5a wt allele
unconventional myosin - va
lsm14a gene
lsm14a wt allele
protein lsm14 homolog a
cep89 gene
cep89 wt allele
centrosomal protein of 89 kda
pwwp2a gene
pwwp2a wt allele
pwwp domain - containing protein 2a
zscan30 gene
zscan30 wt allele
zinc finger and scan domain - containing protein 30
gatm gene
gatm wt allele
glycine amidinotransferase ,  mitochondrial
driver's license
sodium selenate
mandible
hacl1 gene
hacl1 wt allele
2 - hydroxyacyl - coa lyase 1
nab2 gene
nab2 wt allele
ngfi - a - binding protein 2
shtn1 gene
shtn1 wt allele
shootin - 1
ptprb gene
skin of the lip
ptprb wt allele
receptor - type tyrosine - protein phosphatase beta
madcam1 gene
madcam1 wt allele
mucosal addressin cell adhesion molecule 1
pcsk9 gene
pcsk9 wt allele
proprotein convertase subtilisin / kexin type 9
cutaneous small vessel vasculitis
external ear
intelligence scale
rosmantuzumab
immunotherapeutic combination product cmb305
anti - b7 - h3 antibody ds - 5573a
type a tylosis
type b tylosis
unna - thost disease
antibody mib - 1 staining method
impact
transcranial doppler ultrasonography
imaging transcranial doppler ultrasonography
ectopic graft
normal tissue graft
organ graft
orthotopic graft
patient derived xenograft
precancerous tissue graft
serial transplantation
syngeneic graft
skin of the scalp and neck
tissue graft
tumor graft
leg fatigue right now
dyspnea right now
borg category - ratio 10 scale score 11 point scale
borg category - ratio 10 perceived exertion score 0
borg category - ratio 10 perceived exertion score 0 .5
borg category - ratio 10 perceived exertion score 1
borg category - ratio 10 perceived exertion score 2
borg category - ratio 10 perceived exertion score 3
skin of the trunk
borg category - ratio 10 perceived exertion score 4
borg category - ratio 10 perceived exertion score 5
borg category - ratio 10 perceived exertion score 6
borg category - ratio 10 perceived exertion score 7
borg category - ratio 10 perceived exertion score 8
borg category - ratio 10 perceived exertion score 9
borg category - ratio 10 perceived exertion score 10
borg scale rating of perceived exertion questionnaire
borg scale rating of perceived exertion score 6
borg scale rating of perceived exertion score 7
skin of the upper limb and shoulder
borg scale rating of perceived exertion score 8
borg scale rating of perceived exertion score 9
borg scale rating of perceived exertion score 10
borg scale rating of perceived exertion score 11
borg scale rating of perceived exertion score 12
borg scale rating of perceived exertion score 13
borg scale rating of perceived exertion score 14
borg scale rating of perceived exertion score 15
borg scale rating of perceived exertion score 16
borg scale rating of perceived exertion score 17
skin of the lower limb and hip
borg scale rating of perceived exertion score 18
borg scale rating of perceived exertion score 19
borg scale rating of perceived exertion score 20
have ostomy appliance
embarrassed by ostomy appliance
caring for ostomy appliance is difficult
fact - b + 4 questionnaire
side of breast operation
have pain moving arm on side of breast operation
have poor range of arm movement on side of breast operation
retroperitoneum
arm feels numb on side of breast operation
have stiffness of arm on side of breast operation
have mouth sores
national comprehensive cancer network - functional assessment of cancer therapy prostate symptom index
have weakness in legs
nasal chondromesenchymal hamartoma
anti - il - 4 / il - 13 combination agent qbx258
scyllitol
thromboxane a2
dapi
nipple
penile chordee
renal hypertrophy
solitary cyst of kidney
duke psychosocial questionnaire
how motivated to exercise
confidence that you could exercise
30 minutes per day for 5 days a week over next 24 weeks
motivation visual analogue scale
confidence visual analogue scale
motivation score 1
sodium thiosulfate
central portion of the breast
motivation score 2
motivation score 3
motivation score 4
motivation score 5
motivation score 6
motivation score 7
confidence score 1
confidence score 2
confidence score 3
confidence score 4
upper - inner quadrant of the breast
confidence score 5
confidence score 6
confidence score 7
chronic urate nephropathy
drug - induced tubulointerstitial nephritis
glomerulocystic disease
perinephric abscess
renal abscess
renal cysts and diabetes syndrome
lower - inner quadrant of the breast
renal tuberculosis
tubulointerstitial nephritis and uveitis
igm  -  associated nephropathy
membranous lupus nephritis
acute uric acid nephropathy
aristolochic acid nephropathy
congenital renal hypoplasia
hantavirus nephropathy
heavy - metal - induced nephropathy
leptospirosis nephropathy
upper - outer quadrant of the breast
magnesium ammonium phosphate urolithiasis
multicystic dysplastic kidney
pyonephrosis
radiation nephropathy
renal dysplasia due to fetal exposure to ace inhibitor or arb
schistosomiasis nephropathy
tubulointerstitial disease
uric acid nephrolithiasis
xanthogranulomatous pyelonephritis
dense deposit disease
lower - outer quadrant of the breast
glomerulomegaly
obesity related glomerulopathy
c3 glomerulonephritis
collapsing glomerulopathy
congenital nephrotic syndrome  -  cytomegalovirus associated
congenital nephrotic syndrome  -  infection associated
congenital nephrotic syndrome  -  rubivirus associated
congenital nephrotic syndrome  -  toxoplasma associated
congenital nephrotic syndrome  -  treponema pallidum associated
axillary tail of the breast
cryoglobulinemic glomerulonephritis
focal segmental glomerulosclerosis cellular variant
focal segmental glomerulosclerosis collapsing variant
focal segmental glomerulosclerosis perihilar variant
focal segmental glomerulosclerosis tip lesion variant
immune complex mediated membranoproliferative glomerulonephritis
membranoproliferative glomerulonephritis type 3  ( aq )
membranous nephropathy  -  autoimmune disorder associated
membranous nephropathy  -  drug associated
labium majus
membranous nephropathy  -  idiopathic
membranous nephropathy  -  infection associated
membranous nephropathy  -  malignancy associated
membranous nephropathy  -  nep induced
membranous nephropathy  -  pla2r induced
membranous nephropathy  -  thsd7a induced
nephrotic range proteinuria
nephrotic syndrome  -  actn4 associated
nephrotic syndrome  -  adck4 associated
nephrotic syndrome  -  anln associated
labium minus
nephrotic syndrome  -  arhgap24 associated
nephrotic syndrome  -  arhgdia associated
nephrotic syndrome  -  cd2ap associated
nephrotic syndrome  -  cfh associated
nephrotic syndrome  -  coq2 associated
nephrotic syndrome  -  coq6 associated
nephrotic syndrome  -  crb2 associated
nephrotic syndrome  -  cubn associated
nephrotic syndrome  -  cytomegalovirus associated
nephrotic syndrome  -  dgke associated
clitoris
nephrotic syndrome  -  emp2 associated
nephrotic syndrome  -  epstein - barr virus associated
nephrotic syndrome  -  hepatitis b virus associated
nephrotic syndrome  -  hepatitis c virus associated
nephrotic syndrome  -  human immunodeficiency virus associated
nephrotic syndrome  -  inf2 associated
nephrotic syndrome  -  infection associated
nephrotic syndrome  -  itga3 associated
nephrotic syndrome  -  itgb4 associated
nephrotic syndrome  -  lamb2 associated
endocervix
nephrotic syndrome  -  lmx1b associated
nephrotic syndrome  -  malaria associated
nephrotic syndrome  -  mefv associated
nephrotic syndrome  -  myo1e associated
nephrotic syndrome  -  neil1 associated
nephrotic syndrome  -  nphs2 associated
nephrotic syndrome  -  parvovirus b19 associated
nephrotic syndrome  -  pdss2 associated
nephrotic syndrome  -  plce1 associated
nephrotic syndrome  -  ptpro associated
amilomer
ectocervix
nephrotic syndrome  -  scarb2 associated
nephrotic syndrome  -  simian virus 40 associated
nephrotic syndrome  -  smarcal1 associated
nephrotic syndrome  -  syphilis associated
nephrotic syndrome  -  toxoplasmosis associated
nephrotic syndrome  -  trpc6 associated
nephrotic syndrome  -  wt1 associated
pauci - immune glomerulonephritis  -  anca negative
pauci - immune glomerulonephritis  -  renal limited
cervix uteri
pauci - immune glomerulonephritis associated with eosinophilic granulomatosis with polyangiitis
pauci - immune glomerulonephritis associated with granulomatosis with polyangiitis
pauci - immune glomerulonephritis associated with microscopic polyangiitis
primary collapsing glomerulopathy
secondary collapsing glomerulopathy
systemic lupus erythematosus nephritis class i
systemic lupus erythematosus nephritis class ii
systemic lupus erythematosus nephritis class iii
systemic lupus erythematosus nephritis class iv
systemic lupus erythematosus nephritis class iv g
isthmus uteri
systemic lupus erythematosus nephritis class iv s
systemic lupus erythematosus nephritis class v
systemic lupus erythematosus nephritis class vi
tip lesion glomerulopathy
nephrotic syndrome - remission ,  partial remission
antimicrobial  -  induced nephropathy
bisphosphonate  -  induced nephropathy
calcineurin inhibitor  -  induced nephropathy
chemotherapeutic drug  -  induced nephropathy
contrast  -  induced nephropathy
endometrium
lithium  -  induced nephropathy
mtor inhibitor  -  induced nephropathy
nephropathy due to aminoglycosides
nephropathy due to amphotericin
nephropathy due to analgesic drugs
nephropathy due to ciclosporin
nephropathy due to cisplatin
nephropathy due to tacrolimus
nsaid - induced nephropathy
focal segmental glomerulosclerosis ,  not otherwise specified
myometrium
iga nephropathy ,  familal
iga nephropathy ,  infection - associated
enteric hyperoxaluria
positive and negative perfectionism scale
hspa4l gene
hspa4l wt allele
heat shock 70 kda protein 4l
sod3 gene
sod3 wt allele
fundus uteri
extracellular superoxide dismutase  [ cu - zn ]
non - gaussian water diffusion pattern
dna damage response deficiency
circulating microrna
immunoglobulin heavy chain complementarity determining region 3
antenatal hydronephrosis
extent of friend and family support of effort to increase amount of exercise
congenital urinary tract obstruction
primary hyperoxaluria
ureterocele
corpus uteri
lepidic predominant adenocarcinoma
megaureter
voiding disorders
acute cortical necrosis
a1 hydronephrosis
a2 / 3 hydronephrosis
autosomal dominant polycystic kidney disease type 2
autosomal dominant polycystic kidney disease type i
congenital ureteropelvic junction obstruction
congenital ureterovesical junction obstruction
complex cyst of kidney
medullary cystic kidney disease type i
medullary cystic kidney disease type ii
simple cyst of kidney
radiation cystitis
trigonitis
urethrotrigonitis
continent epispadias
incontinent epispadias
cryoglobulinemic glomerulonephritis secondary to systemic disease
broad ligament
focal and segmental proliferative glomerulonephritis
henoch - schnlein purpura nephritis
terminal hematuria
p1 hydronephrosis
p2 hydronephrosis
p3 hydronephrosis
autosomal dominant hypophosphatemia rickets
autosomal recessive hypophosphatemia rickets
megacystis  -  megaureter
non - obstructed megaureter
round ligament
non - obstructed non - refluxing megaureter
obstructed megaureter
refluxing megaureter
refluxing obstructed megaureter
calyceal diverticulum
idiopathic renal papillary necrosis
ischemic nephropathy
malignant hypertensive nephropathy
megacalycosis
nephritic syndrome
spirogermanium
parametrium
nephronophthisis
nephropathy associated with rhabdomyolysis
oligomeganephronia
sickle cell nephropathy
acquired neurogenic bladder
congenital neurogenic bladder
non - neurogenic neurogenic bladder
bladder exstrophy
bladder sphincter dysfunction
hutch diverticulum
appendage of the uterus
posterior urethral valves type 1
posterior urethral valves type 3
primary hyperoxaluria type i
primary hyperoxaluria type ii
primary hyperoxaluria type iii
acute pyelonephritis
chronic pyelonephritis
distal renal tubular acidosis
proximal renal tubular acidosis
renal tubular acidosis associated with deafness
type i renal tubular acidosis
renal artery stenosis
renal artery thrombosis
atypical hemolytic uremic syndrome
cardiorenal syndrome
diarrhea - associated hemolytic uremic syndrome
dysfunctional elimination syndrome
familial atypical hemolytic uremic syndrome
primary fanconi syndrome
prepuce
renal coloboma syndrome
syndrome of apparent mineralocorticoid excess
ectopic ureter
ureter fissus
ureteral kinking
cecoureterocele
ectopic ureterocele
intravesical ureterocele
obstructive ureterocele
sphincteric ureterocele
glans penis
decreased bladder compliance
acquired urinary tract obstruction
calcium oxalate urolithiasis
calcium phosphate urolithiasis
cystine urolithiasis
uric acid urolithiasis
urinary hesitancy
urinary straining
glucocorticoid suppressible hyperaldosteronism
idiopathic retroperitoneal fibrosis
body of the penis
infundibular stenosis
pseudohypoaldosteronism type 1
pseudohypoaldosteronism type 2
pseudotumor of kidney
urachal diverticulum
urachal remnant
urethral prolapse
ascending testicle
retractile testicle
testicular atrophy
undescended testes
dent disease
familial hypercalciuric hypocalcemia
familial hypocalciuric hypercalcemia
familial primary hypomagnesemia
testicular hypotrophy
diclofenac epolamine patch
anti - icos monoclonal antibody medi - 570
fda establishment activity terminology
other establishment activity
fda application type terminology
no application type
pediatric nephrology terminology
fda quality metrics terminology
warehouse human prescription drug products
near complete response of multiple myeloma or plasma cell leukemia
bk virus infection
allogeneic bk - specific cytotoxic t - lymphocytes
copdac regimen
nrxn1 gene product
epididymis
trilaciclib
regimen - limiting toxicity
psa / psma dna plasmid ino - 5150
antibody - drug conjugate sc - 002
work productivity and activity impairment general health v2 .0 questionnaire
currently employed
hours missed from work because of health problems
hours missed from work because of other reasons
hours worked
spermatic cord
health problems affect productivity while working
health problems affect ability to do regular daily activities other than work at job
effect of health problems on work likert scale
effect of health problems on daily activities likert scale
health problems effect on work score 0
health problems effect on work score 1
health problems effect on work score 2
health problems effect on work score 3
health problems effect on work score 4
health problems effect on work score 5
spiromustine
health problems effect on work score 6
health problems effect on work score 7
health problems effect on work score 8
health problems effect on work score 9
health problems effect on work score 10
health problems effect on daily activities score 0
health problems effect on daily activities score 1
health problems effect on daily activities score 2
congenital myotonic dystrophy
health problems effect on daily activities score 3
bladder trigone
health problems effect on daily activities score 4
health problems effect on daily activities score 5
health problems effect on daily activities score 6
health problems effect on daily activities score 7
health problems effect on daily activities score 8
health problems effect on daily activities score 9
health problems effect on daily activities score 10
dicer1 syndrome
rosenberg self - esteem scale
satisfied with myself on the whole
dome of the bladder
am no good at all at times
have a number of good qualities
able to do things as well as most people
do not have much to be proud of
feel useless at times
am a person of worth on equal plane with others
wish i could have more respect for myself
inclined to feel that i am a failure
take a positive attitude toward myself
multiple endocrine neoplasia type 2
lateral wall of the bladder
macular degeneration
invasive focus of carcinoma cells measuring more than 5 mm present
anti - cd33 / cd3 bite antibody amg 330
reese - ellsworth staging system
red blood cell folate measurement
microsporidia
paenibacillus
paracoccus
trematoda
solobacterium
anterior wall of the bladder
adult hope scale
can think of many ways to get out of a jam
energetically pursue goals
feel tired most of time
lots of ways around any problem
easily downed in argument
can think of many ways to get the things in life that are important to me
can find way to solve problem even when others get discouraged
past experiences have prepared me well for future
have been pretty successful in life
posterior wall of the bladder
usually find myself worrying about something
meet goals set for myself
worry about my health ,  how true
definitely false
mostly false
somewhat false
slightly false
slightly true
somewhat true
mostly true
bladder neck
definitely true
peritoneal cancer index
flt3 tyrosine kinase inhibitor ttt - 3002
reese - ellsworth classification group i
reese - ellsworth classification group ii
reese - ellsworth classification group iii
reese - ellsworth classification group iv
reese - ellsworth classification group v
reese - ellsworth classification ia
reese - ellsworth classification ib
ureteric orifice
reese - ellsworth classification iia
reese - ellsworth classification iib
reese - ellsworth classification iiia
reese - ellsworth classification iiib
reese - ellsworth classification iva
reese - ellsworth classification ivb
reese - ellsworth classification va
reese - ellsworth classification vb
hpv - 6 - targeting immunotherapeutic vaccine ino - 3106
ingenol disoxate
urachus
anti - cd123 monoclonal antibody khk2823
mimotope - p10s - padre peptide vaccine
mvx - 1 - loaded macrocapsule / autologous tumor cell vaccine mvx - onco - 1
cxc chemokine receptor 2 antagonist azd5069
salivary gland secretory carcinoma
patient - controlled epidural analgesia
patient health questionnaire - 2
light dosimetry
urethral gland
muscle enhancement product use
adipocytokine assay
childhood lymphomatoid granulomatosis
recurrent childhood lymphomatoid granulomatosis
childhood extranodal marginal zone lymphoma of mucosa - associated lymphoid tissue
childhood langerhans cell histiocytosis with risk organ involvement
childhood langerhans cell histiocytosis without risk organ involvement
childhood spindle cell rhabdomyosarcoma
childhood periosteal osteosarcoma
first relapse
spiroplatin
subsequent relapse
early relapse of acute lymphoblastic leukemia
late relapse of acute lymphoblastic leukemia
early relapse of acute myeloid leukemia
late relapse of acute myeloid leukemia
multi - organ involvement
flt3 - internal tandem duplication high allelic ratio
tumor complete metabolic response
likely tumor complete metabolic response
likely residual metabolic tumor activity
conjunctiva
likely inflammatory activity
definite residual metabolic tumor activity
familial alzheimer's disease ,  type 3
familial alzheimer's disease ,  type 4
catecholaminergic polymorphic ventricular tachycardia type 1
autosomal recessive torsion dystonia 2
hyperlipoproteinemia type iia
mandibuloacral dysplasia with type a lipodystrophy
vasoprotective agent
cornea
iodamoeba
leishmania
naegleria
neisseria elongata
academic research council coronary stent thrombosis timing
naxitamab
hyperkalemic periodic paralysis
retina
glibornuride
human varicella zoster immune globulin
hyperlysinemia
immunoglobulin a deficiency 1
methionine adenosyltransferase deficiency
peters - plus syndrome
multicentric osteolysis ,  nodulosis ,  and arthropathy
ullrich congenital muscular dystrophy
academic research council acute stent thrombosis
choroid
academic research council late stent thrombosis
academic research council subacute stent thrombosis
academic research council very late stent thrombosis
clinical change by non - invasive imaging procedure
12 lead continuous ecg
12 lead ecg extracted from 12 lead continuous ecg recording
continuous ambulatory ecg
ecg median heart rate
aggregate qtcl interval
single beat qtcl interval
ciliary body
aggregate qtcv interval
single beat qtcv interval
continuation therapy epoch
induction therapy epoch
cdisc occurrence data structure
beta - cell function measurement
hepatitis c mrna measurement
hepatitis e mrna measurement
insulin resistance measurement
insulin sensitivity measurement
lacrimal gland
macrophage to leukocyte ratio
axillary lymph node level i
axillary lymph node level ii
axillary lymph node level iii
amsler grid
ductography
ishihara color plates
snellen eye chart
coniochaeta
gram - negative pleomorphic bacillus
orbit
gram - positive diplococcus
gram - positive microaerophilic bacillus
gram - positive microaerophilic coccus
haemophilus haemolyticus ,  beta - lactamase negative
haemophilus haemolyticus ,  beta - lactamase positive
haemophilus haemolyticus ,  penicillinase negative
haemophilus haemolyticus ,  penicillinase positive
haemophilus influenzae ,  beta - lactamase negative
haemophilus influenzae ,  beta - lactamase positive
haemophilus influenzae ,  penicillinase negative
meninges
haemophilus influenzae ,  penicillinase positive
haemophilus parahaemolyticus ,  beta - lactamase negative
haemophilus parahaemolyticus ,  beta - lactamase positive
haemophilus parahaemolyticus ,  penicillinase negative
haemophilus parahaemolyticus ,  penicillinase positive
haemophilus parainfluenzae ,  beta - lactamase negative
haemophilus parainfluenzae ,  beta - lactamase positive
haemophilus parainfluenzae ,  penicillinase negative
haemophilus parainfluenzae ,  penicillinase positive
heterophyes heterophyes
cerebral meninges
influenza a  ( h5n1 )  virus
iodamoeba butschlii
lactobacillus gasseri
lactobacillus oris
lactobacillus paracasei
lactobacillus rhamnosus
lactobacillus vaginalis
lactococcus lactis subsp lactis
legionella pneumophila serogroup 1
legionella pneumophila serogroup 2
st 638
spinal meninges
legionella pneumophila serogroup 3
legionella pneumophila serogroup 4
legionella pneumophila serogroup 5
legionella pneumophila serogroup 6
legionella pneumophila serogroup 7
legionella pneumophila serogroup 8
legionella pneumophila serogroup 9
leishmania braziliensis
leishmania donovani
leishmania infantum
cerebral hemisphere
leishmania mexicana
leishmania tropica
loa loa
megamonas hypermegale
metagonimus yokogawai
methicillin resistant staphylococcus aureus
methicillin susceptible staphylococcus aureus
moraxella catarrhalis ,  beta - lactamase negative
moraxella catarrhalis ,  beta - lactamase positive
moraxella catarrhalis ,  penicillinase negative
frontal lobe
moraxella catarrhalis ,  penicillinase positive
morganella morganii ,  lysine - positive
morganella morganii ,  ornithine - negative
naegleria fowleri
necator americanus
neisseria gonorrhoeae ,  beta - lactamase negative
neisseria gonorrhoeae ,  beta - lactamase positive
neisseria gonorrhoeae ,  penicillinase negative
neisseria gonorrhoeae ,  penicillinase positive
nigrospora
temporal lobe
nosema
oidiodendron
paecilomyces
paenibacillus glucanolyticus
pandoraea apista
parabacteroides goldsteinii
parabacteroides johnsonii
paracoccus yeei
paragonimus westermani
pediococcus pentosaceus
parietal lobe
penicillium
pentatrichomonas hominis
pestalotiopsis
phialophora
pichia
piedraia
pithomyces
plasmodium falciparum
plasmodium malariae
plasmodium ovale
occipital lobe
plasmodium vivax
shewanella algae
solobacterium moorei
non - hemolytic streptococcus
nutritionally variant streptococcus
breast cancer type 1 susceptibility protein measurement
cancer cellularity measurement
ki67 measurement
nk2 homeobox 1 measurement
percentage of in situ carcinoma
brain ventricle
surgical margins status
liter divided by milligram per day
liter divided by milligram per meter squared
liter divided by microgram per day
mean carbon monoxide diffusing capability test
forced expiratory volume in 1 second to forced vital capacity in 6 seconds
oxygen pulse
pulmonary reactance
respiratory exchange ratio
specific airway resistance
craniopharyngeal duct
oxygen consumption
absent morphologic response
ca125 50% response
ca125 75% response
clinical complete response
complete hematologic response
clinical partial response
complete response by computed tomography
cytogenetic complete response
cytogenetic minimal response
head and neck lymph node
cytogenetic minor response
cytogenetic no response
cytogenetic partial response
disease transformation
favorable response
hematologic improvement - erythroid response
hematologic improvement - neutrophil response
hematologic improvement - platelet response
immunophenotypic complete response
indeterminate response
intrathoracic lymph node
major pathologic response
marrow complete response
minor pathologic response
molecular complete response
molecular major response
morphologic complete response
morphologic complete remission with incomplete blood count recovery
morphologic leukemia - free state
minor response
non progressive disease
staphage lysate
intra - abdominal lymph node
no response
optimal morphologic response
partial morphologic response
pathologic complete response
progression from partial response
progression or relapse after hematologic improvement
progressive disease by computed tomography
unconfirmed progressive disease
progressive metabolic disease
partial metabolic response
partial response by computed tomography
psa progression
relapsed disease from complete response
relapsed disease from complete or partial response
stringent complete response
stable disease by computed tomography
stable metabolic disease
unfavorable response
very good partial response
clinical response
lymph node of inguinal region or leg
cytogenetic response
disease recurrence indicator
hematologic response
metabolic response
molecular response
morphologic response
pathologic response
radiologic response
tumor antigen response
fda - regulated device study indicator
pelvic lymph node
fda - regulated drug study indicator
pediatric postmarket study indicator
pediatric study indicator
disease recurrence relative location
per thousand
non - moribund sacrifice
experimental organism decidual reaction
experimental organism decidualization
hydromyelia
imperforate vagina
experimental organism luteinized unruptured follicle
polyovular follicle
prostatic rudiment
syringomyelia and hydromyelia
fox chase scid beige mouse
unequivocal
ancylostomatoidea
cystoisospora belli
neisseria elongata subsp nitroreducens
mage - a3 - specific immunotherapeutic gsk 2132231a
amnion
cdisc sdtm tumor and lesion identification test result terminology
solar simulated light
cdisc questionnaire exact test name terminology
cdisc questionnaire exact test code terminology
cdisc functional test avlt - rey test name terminology
cdisc functional test avlt - rey test code terminology
exact questionnaire question
avlt - rey functional test question
asthma control test questionnaire
shortness of breath with daily activities questionnaire
bone
menstrual distress questionnaire form - t  ( today )
columbia - suicide severity rating scale pediatric / cognitively impaired  -  lifetime recent  -  clinical questionnaire
columbia - suicide severity rating scale pediatric / cognitively impaired  -  since last visit  -  clinical questionnaire
12 - item multiple sclerosis walking scale questionnaire
multiple sclerosis impact scale version 1 questionnaire
multiple sclerosis impact scale version 2 questionnaire
exacerbations of chronic pulmonary disease tool patient - reported outcome questionnaire
montreal cognitive assessment functional test
rey auditory verbal learning functional test
exact  -  chest feel congested
mammary gland
exact  -  how often cough today
exact  -  bring up mucus when coughing
exact  -  difficult to bring up mucus
exact  -  have chest discomfort
exact  -  chest feel tight
exact  -  were you breathless
exact  -  describe how breathless
exact  -  short of breath when performing usual personal care
exact  -  short of breath when performing usual indoor activities
exact  -  short of breath when performing usual activities outside
areola
exact  -  tired or weak
exact  -  night sleep disturbed
exact  -  worried about lung problems
avlt - rey  -  list a word 1
avlt - rey  -  list a word 2
avlt - rey  -  list a word 3
avlt - rey  -  list a word 4
avlt - rey  -  list a word 5
avlt - rey  -  list a word 6
avlt - rey  -  list a word 7
breast fat pad
avlt - rey  -  list a word 8
avlt - rey  -  list a word 9
avlt - rey  -  list a word 10
avlt - rey  -  list a word 11
avlt - rey  -  list a word 12
avlt - rey  -  list a word 13
avlt - rey  -  list a word 14
avlt - rey  -  list a word 15
avlt - rey  -  list a total
avlt - rey  -  list a intrusions
staurosporine
mammary gland tissue
avlt - rey  -  list b word 1
avlt - rey  -  list b word 2
avlt - rey  -  list b word 3
avlt - rey  -  list b word 4
avlt - rey  -  list b word 5
avlt - rey  -  list b word 6
avlt - rey  -  list b word 7
avlt - rey  -  list b word 8
avlt - rey  -  list b word 9
avlt - rey  -  list b word 10
myocardium
avlt - rey  -  list b word 11
avlt - rey  -  list b word 12
avlt - rey  -  list b word 13
avlt - rey  -  list b word 14
avlt - rey  -  list b word 15
avlt - rey  -  list b total
avlt - rey  -  list b intrusions
avlt - rey  -  recognition total
avlt - rey  -  recognition intrusions
polyethylene glycol 3350 - containing enema ner1008
artery
akt - 1 / 2 inhibitor - treated tumor infiltrating lymphocytes
dwj1319
egfr antagonist hemay022
package type not applicable
interferon beta - secreting mesenchymal stem cells
x - linked adrenal hypoplasia congenita
serkal syndrome
familial glucocorticoid deficiency type 1
familial glucocorticoid deficiency type 2
natural killer cell and glucocorticoid deficiency with dna repair defect
cartilage
fusion - positive alveolar rhabdomyosarcoma
fusion - negative alveolar rhabdomyosarcoma
bet inhibitor ft - 1101
cd40 agonistic monoclonal antibody apx005m
fusion - positive rhabdomyosarcoma
fusion - negative rhabdomyosarcoma
refractory childhood malignant germ cell tumor
gitter cell
refractory malignant germ cell tumor
connective tissue
kosovo
ashmore and cartier islands
baker island
bassas da india
clipperton island
coral sea islands
diego garcia
genc entity 1
genc entity 2
genc entity 3
anal canal
genc entity 4
genc entity 5
genc entity 6
europa island
gaza strip
glorioso islands
guantanamo bay naval base
diaphragmatic pinch
suprailiac skinfold thickness
howland island
bile duct
jan mayen
jarvis island
johnston atoll
juan de nova island
kingman reef
phosphorylated epidermal growth factor receptor
navassa island
palmyra atoll
paracel islands
spratly islands
gallbladder
svalbard
tromelin island
unknown genc
wake island
west bank
mosedipimod
md anderson symptom inventory  -  spine tumor
radiating spine pain at its worst
weakness in arms and / or legs at its worst
loss of bowel and / or bladder control at its worst
digestive system
sexual function at its worst
magnesium l - threonate
conventional dendritic cell
m2 macrophage
filipino language
french language
hmong language
hungarian language
italian language
japanese language
large intestine
russian language
somali language
selective androgen receptor modulator ly2452473
zinc protoporphyrin
27 - hydroxycholesterol
antimicrobial peptide
sex steroid hormone
epha receptor family
prostate health index
cell response index
strontium chloride sr - 89
appendix
anti - poliovirus antibody
genome - wide 5 - hydroxymethylcytosine profile
cd159 family
human anti - human minibody antibody
cytokine and angiogenic factor profile
anti - reovirus antibody
gucy2c antibody
igf2bp3 autoantibody
phosphoglycerate mutase family
interferon - induced protein with tetratricopeptide repeats family
cecum
adipokine
minibody
beare - stevenson cutis gyrata syndrome
jackson - weiss syndrome
myhre syndrome
camrelizumab
donor - derived wt1 / prame / ny - eso - 1 / survivin - specific t - lymphocytes
cromolyn sodium inhalant pa101
therapeutic dendritic cells / cytokine - induced killer cells
colon
gd2 - car - expressing autologous t - lymphocytes
gallium ga 68 - neb
autologous cea - specific cytotoxic t - lymphocytes
4h11 - 28z / fil - 12 / egfrt - expressing autologous t - lymphocytes
foslinanib
ncmtrna oligonucleotide andes - 1537
fisogatinib
avapritinib
cofetuzumab pelidotin
anti - fgfr3 antibody - drug conjugate ly3076226
right colon
porcupine inhibitor etc - 1922159
cabiralizumab
capn1 gene
capn1 wt allele
childhood immature teratoma
childhood testicular immature teratoma
childhood mature teratoma
childhood testicular mature teratoma
childhood germinomatous germ cell tumor
calpain - 1 catalytic subunit
sigmoid colon
childhood seminoma
childhood nongerminomatous germ cell tumor
childhood ovarian nongerminomatous germ cell tumor
childhood testicular non - seminomatous germ cell tumor
childhood choriocarcinoma
bcr / abl1 fusion gene with abl1 nm_005157 .4:c .944c > t mutation
bcr / abl1 fusion protein with abl1 np_005148 .2:p .t315i
childhood embryonal carcinoma
childhood mixed germ cell tumor
childhood ovarian mixed germ cell tumor
transverse colon
gpc2 gene
gpc2 wt allele
glypican - 2
klrg1 gene
klrg1 wt allele
killer cell lectin - like receptor subfamily g member 1
calb2 gene
calb2 wt allele
calretinin
abcb11 gene
small intestine
abcb11 wt allele
bile salt export pump
abcb4 gene
abcb4 wt allele
phosphatidylcholine translocator abcb4
malignant germinomatous cells present
ifi44 gene
ifi44 wt allele
interferon - induced protein 44
siglec9 gene
ileum
siglec9 wt allele
sialic acid - binding ig - like lectin 9
fcrl5 gene
fcrl5 wt allele
fc receptor - like protein 5
gucy2c gene
gucy2c wt allele
heat - stable enterotoxin receptor
ombitasvir
paritaprevir
jejunum
dasabuvir
betibeglogene autotemcel
trodusquemine
differential methylation
feature dataset
gene enrichment probability
absolute genomic position
concentration response
robust z - score
genedata screener
esophagus
condensed activity
gene cluster text format
growth behavior
short hairpin rna
affymetrix
chemiluminescence
analytic technique for assessment of rnai by similarity
gene solution
hepatic thrombosis
splenic thrombosis
exisulind
rectum
mesenteric thrombosis
gonadal thrombosis
fadraciclib
childhood thyroid gland papillary carcinoma
childhood thyroid gland follicular carcinoma
childhood thyroid gland medullary carcinoma
childhood gastrointestinal stromal tumor
childhood malignant kidney neoplasm
clinical relapse of multiple myeloma or plasma cell leukemia by imwg
ventilatory threshold
stomach
glyt2 / 5ht2a antagonist vvz - 149
allodepleted t cell immunotherapeutic atir101
syk inhibitor hmpl - 523
xiap / ciap1 antagonist astx660
oleclumab
anti - cd20 monoclonal antibody - interferon - alpha fusion protein ign002
cholecalciferol / whey protein isolate / epa / dha - based nutritional supplement
anti - her2 antibody - drug conjugate arx788
autologous colorectal tumor antigen - pulsed dendritic cell vaccine
dna plasmid - encoding interleukin - 12 / hpv dna plasmids therapeutic vaccine medi0457
liver
ombitasvir / paritaprevir / ritonavir
miha - loaded pd - l1 / l2 - silenced dendritic cell vaccine
iapa - based dendritic cells / cytotoxic t lymphocytes
dna vaccine vb10 .16
anti - pr1 / hla - a2 monoclonal antibody hu8f4
pi3k - delta inhibitor pwt143
ezetimibe / simvastatin
pegfilgrastim anti - neutropenic factor
audencel
gallium ga 68 - nota - aca - bbn ( 7 - 14 )
pancreas
ad5 - ycd / muttksr39rep - hil12
lentivirus vector ccr5 shrna / trim5alpha / tar decoy - transduced autologous cd34 - positive hematopoietic progenitor cells
childhood small intestinal leiomyosarcoma
childhood small intestinal carcinoma
definitive host
intermediate host
chronicity
distribution
cardiovascular system findings baseline flag
respiratory system findings baseline flag
ear
healthcare encounters category
microscopic findings chronicity
cardiovascular system findings consciousness state
respiratory system findings consciousness state
healthcare encounters dictionary - derived term
exposure directionality
cardiovascular system findings data collection date time
healthcare encounters data collection date time
respiratory system findings data collection date time
healthcare encounters duration
cochlea
study day of cardiovascular system findings
study day of healthcare encounters
study day of respiratory system findings
cardiovascular system findings elapsed time
respiratory system findings elapsed time
cardiovascular system findings end date time
healthcare encounters end date time
respiratory system findings end date time
cardiovascular system findings end day
healthcare encounters end day
adrenal cortex
respiratory system findings end day
cardiovascular system findings planned end of assessment interval
electrocardiogram planned end of assessment interval
pharmacokinetic parameters planned end of assessment interval
respiratory system findings planned end of assessment interval
healthcare encounters end relative to reference time point
healthcare encounters reference end time point end
exclude cardiovascular system findings data from statistics indicator
exclude respiratory system findings data from statistics indicator
exposure fasting status
adrenal medulla
cardiovascular system findings group identifier
healthcare encounters group identifier
respiratory system findings group identifier
exposure laterality
findings about laterality
vital signs laterality
electrocardiogram lead
exposure link group identifier
exposure record link identifier
cardiovascular system findings method
pineal gland
respiratory system findings method
trial sets name
healthcare encounters occurrence
cardiovascular system findings original result
respiratory system findings original result
cardiovascular system findings original result unit
respiratory system findings original result unit
cardiovascular system findings body position
respiratory system findings body position
healthcare encounters pre - specified
pituitary gland
cardiovascular system findings reason for exclusion from statistics
respiratory system findings reason for exclusion from statistics
cardiovascular system findings reason not done
healthcare encounters reason not done
respiratory system findings reason not done
healthcare encounters reference identifier
cardiovascular system findings date time of reference timepoint
exposure date time of reference timepoint
respiratory system findings date time of reference timepoint
healthcare encounters subcategory
sumatriptan
thyroid gland
cardiovascular system findings sequence number
healthcare encounters sequence number
respiratory system findings sequence number
cardiovascular system findings sponsor defined identifier
healthcare encounters sponsor defined identifier
respiratory system findings sponsor defined identifier
cardiovascular system findings completion status
healthcare encounters completion status
respiratory system findings completion status
healthcare encounters start date time
eye
healthcare encounters start day
cardiovascular system findings planned start of assessment interval
electrocardiogram planned start of assessment interval
pharmacokinetic parameters planned start of assessment interval
respiratory system findings planned start of assessment interval
cardiovascular system findings character result in standard format
respiratory system findings character result in standard format
cardiovascular system findings numeric result in standard unit
respiratory system findings numeric result in standard unit
cardiovascular system findings result standard unit
female reproductive system
respiratory system findings result standard unit
healthcare encounters start relative to reference timepoint
healthcare encounters start timepoint
healthcare encounters verbatim description
cardiovascular system findings test
respiratory system findings test
cardiovascular system findings test code
respiratory system findings test code
cardiovascular system findings planned time point name
respiratory system findings planned time point name
fallopian tube
respiratory system findings time point reference
cardiovascular system findings planned time point number
respiratory system findings planned time point number
cardiovascular system findings time point reference
pharmacokinetic concentration upper limit value
microscopic findings distribution
cardiovascular system findings derived flag
respiratory system findings derived flag
adenylate cyclase type 9
biphasic positive airway pressure
ovary
continuous positive airway pressure
hypoattenuation
air trapping
portal flow reversal
fresenius biotech
il2 receptor antibody
il6 receptor antibody
8 - chloroadenosine
dux4l1 gene
dimethicone - containing botanicals - based lotion
uterus
nutrient - rich whole wheat flour supplement
racemetyrosine / methoxsalen / phenytoin / sirolimus sm - 88
granisetron hydrochloride nasal spray
bendamustine - containing nanoparticle - based formulation rxdx - 107
multi - glioblastoma - peptide - targeting autologous dendritic cell vaccine ict - 107
tumor peptide - loaded myeloid dendritic cells
desbuquois dysplasia
pontocerebellar hypoplasia type 2
sasanlimab
pulmonary consolidation
pregnant uterus
peribronchial cuffing
centrilobular opacity
nodular opacity
reactivation
interleukin inhibitor
liver iron concentration
superconducting quantum interference device
ripretinib
solid organ
papulosquamous lesion
vagina
keratosis pilaris
desmosine
lipid hydroperoxide
anabasine
fgfr2 gene product
fibroblast growth factor receptor 2 isoform iiib
itln1 gene
itln1 wt allele
intelectin - 1
ifnl4 gene
vulva
ifnl4 wt allele
interferon lambda - 4
il18r1 gene
il18r1 wt allele
interleukin - 18 receptor 1
geopolitical entities ,  names ,  and codes terminology
timp4 gene
timp4 wt allele
metalloproteinase inhibitor 4
usp28 gene
penis
usp28 wt allele
ubiquitin carboxyl - terminal hydrolase 28
rif1 gene
rif1 wt allele
telomere - associated protein rif1
neil1 gene
neil1 wt allele
endonuclease 8 - like 1
uimc1 gene
uimc1 wt allele
sunflower oil
prostate gland
brca1 - a complex subunit rap80
gen1 gene
gen1 wt allele
flap endonuclease gen homolog 1
babam2 gene
babam2 wt allele
brisc and brca1 - a complex member 2
catheter gauge
brcc3 gene
brcc3 wt allele
lys - 63 - specific deubiquitinase brcc36
babam1 gene
babam1 wt allele
brisc and brca1 - a complex member 1
slc3a2 gene
slc3a2 wt allele
4f2 cell - surface antigen heavy chain
hoxc9 gene
hoxc9 wt allele
testis
homeobox protein hox - c9
hoxc5 gene
hoxc5 wt allele
homeobox protein hox - c5
slc16a3 gene
slc16a3 wt allele
monocarboxylate transporter 4
protein disulfide - isomerase family
tumor antigen - specific antibody
type i collagen
urinary system
cxcr4 whim - like mutation
grapiprant
anti - cd133 - car vector - transduced allogeneic t lymphocytes
tamrintamab pamozirine
samrotamab vedotin
outer diameter
childhood pineal parenchymal tumor of intermediate differentiation
exacerbation
production assistance for cellular therapies
bladder
unselected mononuclear cell
spinal cord decompression
cardiac ventriculography
cardiac stem cell
induced pluripotent stem cell
endothelial progenitor cell
human umbilical cord perivascular cell
symptom distress scale
seldom have nausea
have nausea once in a while
kidney
have nausea fairly often
have nausea at least half the time
have nausea continually
nausea distress
have very mild nausea
have mildly distressing nausea
have nausea feel pretty sick
have nausea usually feel very sick
have nausea am as sick as i could possibly be
appetite quality
ureter
have normal appetite and enjoy good food
appetite is usually good but not always
don't really enjoy food
have to force myself to eat
cannot stand thought of food
sleep as well as always
occasionally have trouble getting to sleep and staying asleep
frequently have trouble getting to sleep
have difficulty getting to sleep and staying asleep
almost impossible to get a decent night's sleep
urethra
almost never have pain
have pain once in a while
have pain several times a week
usually in some degree of pain
in some degree of pain almost constantly
pain distress
have very mild pain
have mildly distressing pain
usually have fairly intense pain
have very intense pain
head and neck
have almost unbearable pain
seldom feel tired or fatigued
have periods when rather tired or fatigued
have periods when quite tired or fatigued
usually very tired and fatigued
feel exhausted most of the time
pattern of bowel movements
have normal bowel pattern
bowel pattern occasionally causes some discomfort
bowel pattern causes considerable discomfort
head
usually in considerable discomfort because of bowel pattern
in almost constant discomfort because of bowel pattern
have normal ability to concentrate
have occasional trouble concentrating
occasionally have considerable trouble concentrating
usually have considerable trouble concentrating
can't concentrate at all
appearance distress
appearance has not changed
occasionally concerned about worsening of physical appearance
tazobactam sodium
larynx
not often concerned that appearance is worsening
most of the time concerned that physical appearance is worsening
worsening of physical appearance is constant preoccupying concern
breathing distress
usually breathe normally
have occasional trouble breathing
often have trouble breathing
hardly ever breathe easily
almost always have severe trouble breathing
outlook distress
oral cavity
not worried or frightened about the future
slightly worried but not frightened about things
worried and frightened about things
very worried and frightened about things
terrified by thoughts of the future
cough frequency
seldom cough
have occasional cough
often cough
often cough and have occasionally severe coughing spells
tongue
often have persistent and severe coughing spells
immunoglobulin heavy chain variable ,  diversity ,  and joining region gene rearrangement
immunoglobulin heavy chain diversity and joining region gene rearrangement
pigmentary change in skin
cobomarsen
pan - pim inhibitor incb053914
anti - il - 8 monoclonal antibody humax - il8
high occupancy target region
bintrafusp alfa
nasopharynx
fluorine f 18 fp - r01 - mg - f2
inch strip dosing unit
clinicaltrials .gov
slc45a2 gene
slc45a2 wt allele
membrane - associated transporter protein
skap1 gene
skap1 wt allele
src kinase - associated phosphoprotein 1
nasal cavity
lilrb1 gene
lilrb1 wt allele
leukocyte immunoglobulin - like receptor subfamily b member 1
cma1 gene
cma1 wt allele
chymase
tpsb2 gene
tpsb2 wt allele
tryptase beta - 2
canine mammary carcinoma
pharynx
rat malignant meningioma
woodchuck hepatocellular carcinoma
eastern woodchuck
woodchuck hepatitis virus
pik3r5 gene
pik3r5 wt allele
phosphoinositide 3 - kinase regulatory subunit 5
integrin alphav / beta6
hpv regulatory protein e2 antibody
salivary gland
hpv replication protein e1 antibody
whole transcriptome sequencing
flow - mediated vasodilation
magea1 antibody
asymmetric dimethylarginine
itgb6 gene
itgb6 wt allele
integrin beta - 6
hypermetabolism
childhood myxopapillary ependymoma
parotid gland
childhood neuroblastoma
childhood ganglioneuroblastoma
childhood central nervous system ganglioneuroblastoma
childhood ganglioneuroblastoma ,  intermixed
childhood ganglioneuroblastoma ,  nodular
childhood astrocytoma
anogenital distance
trachea
nonclinical trial phase
number of episodes
schistosoma
sarcocystis
spirillum
retortamonas
limb
childhood atypical choroid plexus papilloma
childhood choroid plexus carcinoma
childhood anaplastic ependymoma
undetermined
pregnant
cdisc adam subject trial status terminology
cdisc sdtm biospecimen events dictionary derived term terminology
cdisc sdtm category of oncology response assessment terminology
cdisc sdtm biospecimen characteristics test name terminology
cdisc sdtm biospecimen characteristics test code terminology
cdisc sdtm medical history event date type terminology
cdisc sdtm schizophrenia findings about test code terminology
cdisc sdtm schizophrenia findings about test name terminology
cdisc sdtm subject status response terminology
cdisc sdtm subject status test code terminology
cdisc sdtm subject status test name terminology
cdisc sdtm treatment intent terminology
cdisc sdtm treatment setting terminology
cdisc sdtm tumor or lesion properties test result terminology
bone marrow
cdisc send fetal pathology findings result terminology
cdisc send fetal measurement test code terminology
cdisc send fetal measurement test name terminology
cdisc send fetal pathology findings result category terminology
cdisc send fetal pathology findings test code terminology
cdisc send fetal pathology findings test name terminology
cdisc send implantation findings result category terminology
cdisc send implantation findings result terminology
cdisc send implantation findings test code terminology
cdisc send implantation findings test name terminology
spleen
cdisc send nonclinical dart sex terminology
cdisc send nonclinical dart trial phases terminology
cdisc send pregnancy findings result category terminology
cdisc send pregnancy findings result terminology
cdisc send pregnancy findings test code terminology
cdisc send pregnancy findings test name terminology
aliquotting
sectioning
number of mild episodes
number of moderate episodes
thymus gland
number of severe episodes
location of death
aggregate qtca interval
single beat qtca interval
1 , 5 - anhydroglucitol measurement
anti - phospholipid igg antibody measurement
anti - phospholipid igm antibody measurement
apolipoprotein a measurement
aldosterone to renin activity ratio measurement
cyclic adenosine 3 , 5 - monophosphate measurement
blood
calcium sulfate crystals measurement
free androgen index
galactose elimination capacity
deoxyhemoglobin measurement
intercellular adhesion molecule measurement
intercellular adhesion molecule 1 measurement
mycobacterium tuberculosis iga antibody measurement
mycobacterium tuberculosis ige antibody measurement
mycobacterium tuberculosis igg antibody measurement
osteopontin measurement
muscle tissue
radix penis
clinical evaluation
interrupter technique
symptom onset
hymenolepis diminuta
onchocerca volvulus
opisthorchis felineus
pleistophora
pneumocystis
prevotella amnii
striated muscle tissue
prevotella baroniae
prevotella timonensis
prototheca stagnora
prototheca zopfii
urea - positive providencia stuartii
pseudomonas nitroreducens
pseudoterranova decipiens
pyrenochaeta
ralstonia pickettii biovariant 1
retortamonas intestinalis
smooth muscle tissue
rhodotorula
roseomonas gilardii
roseomonas mucosa
ruminococcus gnavus
salmonella enterica serotype choleraesuis var . decatur
salmonella enterica subsp . enterica serovar enteritidis
salmonella enterica subsp . enterica serovar gallinarum
salmonella enterica subsp . enterica serovar pullorum
salmonella enterica subsp . enterica serovar typhisuis
salmonella serotype group a
central nervous system
salmonella serotype group b
salmonella serotype group c
salmonella serotype group c1
salmonella serotype group c2
sarcina ventriculi
sarcocystis hominis
sarcocystis suihominis
schistosoma cercariae
schistosoma haematobium
schistosoma intercalatum
brain
schistosoma japonicum
schistosoma mansoni
schistosoma mekongi
schizophyllum
scopulariopsis
serratia liquefaciens group
serratia odorifera biogroup 1
serratia odorifera biogroup 2
shewanella putrefaciens group
spirillum minus
temozolomide
amygdala
beta - lactamase negative staphylococcus aureus
beta - lactamase positive staphylococcus aureus
penicillinase negative staphylococcus aureus
penicillinase positive staphylococcus aureus
staphylococcus cohnii subsp . urealyticus
staphylococcus schleiferi subsp . coagulans
staphylococcus succinus
stemphylium
streptococcus equi subsp . zooepidemicus
streptococcus lutetiensis
brain stem
streptococcus massiliensis
streptococcus mutans
streptococcus pluranimalium
streptococcus viridans
response evaluation criteria in solid tumors version 1 .0
response evaluation criteria in solid tumors version 1 .1
liter per gram
liter per milligram
forced inspiratory flow at 25%
forced inspiratory flow at 50%
medulla oblongata
forced inspiratory flow at 75%
forced vital capacity in 6 seconds
airway conductance
inspiratory vital capacity
percent predicted inspiratory vital capacity
lung clearance index
thoracic gas volume
complete minimal residual disease response
minimal residual disease negativity
minimal residual disease persistence
cerebral cortex
minimal residual disease relapse
non - quantifiable minimal residual disease positivity
quantifiable minimal residual disease positivity
minimal residual disease response
symptomatic deterioration
gestational age at birth
sex at birth
most severe acute stressor
age at first episode
age at first hospitalization
hippocampus
age at first treatment
most severe chronic stressor
clinic stay indicator
number of hospitalizations
treatment setting
non - palpable
number of lymph nodes examined
number of lymph nodes positive
lymph node state
palpable state
cerebellum
adjuvant therapy clinical trial setting
locally advanced disease clinical trial setting
metastatic disease clinical trial setting
neoadjuvant therapy clinical trial setting
preventative therapy clinical trial setting
country of manufacture
milligram per squared centimeter
milligram per dose
milligram per kilogram per dose
milliliter per dose
corpus callosum
transducing unit
transducing unit per milliliter
microgram per dose
micro - international unit per deciliter
micro - international unit per liter
microkatal per trillion erythrocytes
microliter per dose
micromole per hour per millimole
micromole per liter per hour
micro - unit per deciliter
basal ganglia
micro - unit per liter
vector genomes per dose
vector genomes per milliliter
viral particles per dose
viral particles per milliliter
mid - upper arm circumference
gravid uterus adjusted maternal body weight gain
gravid uterus adjusted maternal body weight
biparietal distance
fetal body weight
corpus striatum
fluid volume
occipitofrontal diameter
number of ossified skeletal elements
fetal organ weight
sex of fetus
altered consistency
abnormal fissure
abnormal flexure
abnormal lobation
abnormal origin
globus pallidus
abnormal suture line
altered texture
absent fissure
acephalostomia
amniotic band
aorticopulmonary septal defect
asymmetric ossification
atresia
bent
bilobular
terephthalamidine
bipartite ossification
blood - filled
blunt - tipped tail
cartilage not fused
cartilaginous fusion
caudal dysplasia
cebocephaly
celosomy
cheilognathopalatoschisis
cheilognathoschisis
caudate nucleus
facial cleft
cleft jaw
mandibular cleft
cleft maxilla
collapsed lumen
red - brown material
vessel common origin
cranial meningocele
craniofenestria
cranioschisis
putamen
cryptophthalmia
curled tail
cyclopia
anogenital distance decreased
detached
discoloration
distended
dome - shaped head
dumbbell ossification
ethmocephaly
substantia nigra
evagination
exencephaly
external auditory canal fistula
externalized heart
fleshy tab
fluid - filled
fragmented
fused
ankyloglossia
hemicentric
subthalamic nucleus
hemisternebra
hemivertebra
high arch
holorachischisis
hooked tail
hyperflexion
incomplete chondrogenesis
incomplete ossification
anogenital distance increased
iniencephaly
prosencephalon
discontinuous anatomic feature
isolated ossification site
kinked tail
left - sided
malpositioned
malrotated
membranous ventricular septal defect
encephalomeningocele
meningohydroencephalocele
misalignment
diencephalon
misshapen
multiple malformations
multiple abnormalities
muscular ventricular septal defect
narrow
tooth not erupted
not fused
open eye
otocephaly
overriding aorta
epithalamus
persistent embryonic structure
premature closure
proboscis
prosoposchisis
protruding
pseudohermaphroditism
red material
reduced number
retinal fold
retroesophageal
hypothalamus
rhinocephaly
right - sided
shared placenta
unilobular
splayed
supernumerary fissure
thoracogastroschisis
thoracoschisis
thread - like
cor triloculare
thalamus
thymic cord
cor biloculare
wavy rib
wide
ossification abnormality
unclassified abnormality
external examination
maternal - fetal examination
skeletal examination
visceral examination
testosterone cypionate
tectum mesencephali
early intrauterine death
empty implantation site
non - clinical gestation trial phase
non - clinical pairing trial phase
non - clinical postnatal trial phase
non - clinical postpairing trial phase
non - clinical premating trial phase
experimental organism benign adenomyoepithelioma
experimental organism malignant neuroepithelial carcinoma
experimental organism benign epithelial stromal tumor
corpora quadrigemina
experimental organism malignant mesovarial leiomyoma
experimental organism mesenchymal proliferative lesion
experimental organism glandular polyp
experimental organism malignant sarcoma arising from fibroadenoma
experimental organism benign mixed sex cord stromal tumor
experimental organism malignant mixed sex cord stromal tumor
experimental organism aborted
early delivery of experimental organism
resorbed or dead litter
corpora lutea number
dorsal root ganglion
number of dead fetuses
fetal female sex ratio
number of live female fetuses
number of live male fetuses
number of live fetuses
fetal male sex ratio
number of fetuses
average live fetal weight
average female live fetal weight
average male live fetal weight
notochord
total live fetal weight
number of implantations
number of intrauterine deaths
pre - implantation loss percent
post - implantation loss percent
number of early resorptions
number of late resorptions
number of resorptions
send developmental and reproductive toxicology implementation guide version 1 .0
depression
spinal cord
hole
unossified
supernumerary cranial sutures
late intrauterine death
therapeutic gamma delta t - lymphocytes
ranitidine hydrochloride / bismuth potassium citrate / sucralfate hydrate formulation
anti - muc1 car - transduced autologous t - lymphocytes
anti - nf - p2x7 antibody ointment bil - 010t
atm kinase inhibitor azd0156
sheng - yu - tang
peripheral nervous system
anti - mesothelin car vector - transduced autologous t - lymphocytes
gitr agonist medi1873
ict - 121 dendritic cell vaccine
telratolimod
ralaniten acetate
autologous t - lymphocytes - expressing ny - eso - 1 - c259 - specific enhanced t - cell receptors
anti - cd22 scfv tcrz:41bb - car lentiviral vector - transduced autologous t - lymphocytes
ravulizumab
concentrated fortified collagen protein hydrolysate liquid supplement
nitroglycerin / sodium citrate / ethanol solution
nerve
cobiprostone spray
cdisc clinical classification tanner scale - boy test name terminology
cdisc clinical classification tanner scale - boy test code terminology
cdisc clinical classification tanner scale - girl test name terminology
cdisc clinical classification tanner scale - girl test code terminology
cdisc clinical classification atherosclerotic cardiovascular disease 10 - year risk estimator test name terminology
cdisc clinical classification atherosclerotic cardiovascular disease 10 - year risk estimator test code terminology
cdisc clinical classification assign score test name terminology
cdisc clinical classification assign score test code terminology
cdisc clinical classification fhs cvd 10 - year risk score test name terminology
sympathetic ganglion
cdisc clinical classification fhs cvd 10 - year risk score test code terminology
cdisc clinical classification reynolds cvd 10 - year risk score test name terminology
cdisc clinical classification reynolds cvd 10 - year risk score test code terminology
cdisc clinical classification who clinical staging of hiv / aids for adults and adolescents test name terminology
cdisc clinical classification who clinical staging of hiv / aids for adults and adolescents test code terminology
cdisc clinical classification who clinical staging of hiv / aids for children test name terminology
cdisc clinical classification who clinical staging of hiv / aids for children test code terminology
cdisc clinical classification cdc classification system for hiv - infected adults and adolescents test name terminology
cdisc clinical classification cdc classification system for hiv - infected adults and adolescents test code terminology
cdisc clinical classification west haven criteria test name terminology
lung
cdisc clinical classification west haven criteria test code terminology
cdisc clinical classification gcs ninds version test name terminology
cdisc clinical classification gcs ninds version test code terminology
cdisc clinical classification crs - r test name terminology
cdisc clinical classification crs - r test code terminology
cdisc clinical classification panss test name terminology
cdisc clinical classification panss test code terminology
cdisc functional test tmt test name terminology
cdisc functional test tmt test code terminology
tanner scale - boy clinical classification question
pleura
tanner scale - girl clinical classification question
ascvd 10 - year risk estimator clinical classification question
assign score clinical classification question
fhs cvd 10 - year risk score clinical classification question
reynolds cvd 10 - year risk score clinical classification question
west haven criteria clinical classification question
gcs ninds version clinical classification question
crs - r clinical classification question
panss clinical classification question
who clinical staging of hiv / aids for adults and adolescents clinical classification question
testosterone enanthate
skin
who clinical staging of hiv / aids for children clinical classification question
cdc classification system for hiv - infected adults and adolescents clinical classification question
tmt functional test question
tanner scale boy version
tanner scale girl version
atherosclerotic cardiovascular disease 10 - year risk estimator clinical classification
assign cardiovascular disease 10 - year risk score clinical classification
framingham heart study cardiovascular disease 10 - year risk score clinical classification
reynolds cardiovascular disease 10 - year risk score clinical classification
west haven hepatic encephalopathy grade clinical classification
soft tissue
glasgow coma scale - ninds version clinical classification
jfk coma recovery scale - revised clinical classification
positive and negative syndrome scale clinical classification
world health organization clinical staging of hiv / aids for adults and adolescents clinical classification
world health organization clinical staging of hiv / aids for children clinical classification
center for disease control and prevention classification system for hiv - infected adults and adolescents clinical classification
adipose tissue
ascvd 10 - year risk estimator  -  risk score
assign score  -  risk score
fhs cvd 10 - year risk score  -  risk score
reynolds cvd 10 - year risk score  -  risk score
gcs ninds version  -  best eye response
gcs ninds version  -  motor response
gcs ninds version  -  verbal response
gcs ninds version  -  total score
gcs ninds version  -  confounder: gcs accurate
gcs ninds version  -  confounder: paralytic
synovial membrane
gcs ninds version  -  confounder: alcohol or drug of abuse
gcs ninds version  -  confounder: c - spine injury
gcs ninds version  -  confounder: hypoxia or hypotension
gcs ninds version  -  confounder: hypothermia
gcs ninds version  -  confounder: sedation
gcs ninds version  -  confounder: unknown
crs - r  -  diagnosis
crs - r  -  etiology
crs - r  -  date of onset
crs - r  -  date of admission
b - lymphocyte
crs - r  -  auditory function scale
crs - r  -  visual function scale
crs - r  -  motor function scale
crs - r  -  oromotor / verbal function
crs - r  -  communication scale
crs - r  -  arousal scale
crs - r  -  total score
panss  -  delusions
panss  -  conceptual disorganization
panss  -  hallucinatory behavior
panss  -  excitement
panss  -  grandiosity
panss  -  suspiciousness or persecution
panss  -  hostility
panss  -  blunted affect
panss  -  emotional withdrawal
panss  -  poor rapport
panss  -  passive or apathetic social withdrawal
panss  -  difficulty in abstract thinking
panss  -  lack of spontaneity
t - lymphocyte
panss  -  stereotyped thinking
panss  -  somatic concern
panss  -  anxiety
panss  -  guilt feelings
panss  -  tension
panss  -  mannerisms and posturing
panss  -  depression
panss  -  motor retardation
panss  -  uncooperativeness
panss  -  unusual thought content
astrocyte
panss  -  disorientation
panss  -  poor attention
panss  -  lack of judgement
panss  -  disturbance of volition
panss  -  poor impulse control
panss  -  preoccupation
panss  -  active social avoidance
who clinical staging of hiv / aids for adults and adolescents  -  who clinical stage of hiv / aids
who clinical staging of hiv / aids for children  -  who clinical stage of hiv / aids
cdc classification system for hiv - infected adults and adolescents  -  cdc hiv infection category
clear cell
tmt  -  time to complete trails a
tmt  -  time to complete trails b
phq - 15  -  total score
anti - ox40 monoclonal antibody gsk3174998
refusal to participate
oral mucositis who grading scale
oral mucositis who grade 0
oral mucositis who grade i
oral mucositis who grade ii
oral mucositis who grade iii
ductal epithelial cell
oral mucositis who grade iv
antipneumocystis agent
amphotericin product
smo gene mutation
extended release chewable tablet
autologous cd19car - cd28 - cd3zeta - egfrt - expressing tn / mem - enriched t - lymphocytes
protein kinase c inhibitor ide196
carbon c 14 lenvatinib mesylate
technetium tc 99m - labeled rhenium sulfide nanocolloid
testosterone isobutyrate
flt3 inhibitor
btk inhibitor
mouse kidney carcinoma
knowledge ,  understanding and judgment scale
stage of your cancer
grade of your cancer
most recent psa level
most common complication after surgery for prostate cancer
most common complication after radiotherapy for prostate cancer
most common complication without treatment for prostate cancer
endothelium
more than half of patients will have sexual or urinary symptoms within five years without treatment for prostate cancer
one of three patients will have urine control problem after surgery for prostate cancer
one of three patients will need diapers due to very poor urine control after surgery for prostate cancer
one of ten patients will need diapers due to very poor urine control after surgery for prostate cancer
three of four patients will have penile erections firm enough to have sexual intercourse after surgery for prostate cancer
four of five patients are able to have erections firm enough to have sexual intercourse after external radiation therapy for prostate cancer
four of five patients are able to have erections firm enough to have sexual intercourse after radiation seeds for prostate cancer
one of three patients will die within ten years due to prostate cancer without treatment
treatment decisions should be made within six months or prostate cancer can spread beyond cure
prostate cancer will spread in one of three patients within ten years without treatment
how long do you expect to live without any treatment for prostate cancer
how long do you expect to live after treatment for prostate cancer
very slow growing
slow growing
medium growth rate
fast growing
very fast growing
psa level
psa level less than five
psa level five to ten
psa level ten to fifty
psa level greater than fifty
no complication
life expectancy less than five years
life expectancy less than ten years
life expectancy less than twenty years
life expectancy greater than twenty years
kabuki syndrome
orofacial cleft 1
pettigrew syndrome
shprintzen - goldberg craniosynostosis syndrome
orofaciodigital syndrome type 6
waardenburg syndrome type 4
pemlimogene merolisbac
dyggve - melchior - clausen syndrome
hyperglycerolemia
potocki - lupski syndrome
daz1 gene
daz1 wt allele
deleted in azoospermia protein 1
neuroendocrine cell
anti - tim - 3 monoclonal antibody mbg453
analbuminemia
miller - dieker syndrome
mayer - rokitansky - kuster - hauser syndrome
col18a1 gene product
tac1 gene product
protachykinin - 1
past seven days frequency of loss of control of bowel movements
past seven days loss of control of bowel movements interferes with usual or daily activities
contemplation ladder for smoking cessation
plasma cell
readiness to quit smoking
contemplation ladder readiness to quit smoking likert scale
readiness to quit smoking score 10
readiness to quit smoking score 9
readiness to quit smoking score 8
readiness to quit smoking score 7
readiness to quit smoking score 6
readiness to quit smoking score 5
readiness to quit smoking score 4
readiness to quit smoking score 3
signet ring cell
readiness to quit smoking score 2
readiness to quit smoking score 1
readiness to quit smoking score 0
hyperdiploid with status of chromosomes 4 and 10 unknown
intrachromosomal amplification of chromosome 21
hfe gene
hfe wt allele
hereditary hemochromatosis protein
pdgfd gene
pdgfd wt allele
platelet - derived growth factor d
cfhr1 gene
cfhr1 wt allele
complement factor h - related protein 1
smoking self - efficacy questionnaire
refrain from smoking when nervous
refrain from smoking when depressed
refrain from smoking when angry
refrain from smoking when very anxious
refrain from smoking when thinking about a difficult problem
hla - f gene
hla - f wt allele
hla class i histocompatibility antigen ,  alpha chain f
refrain from smoking when feeling the urge to smoke
refrain from smoking when having a drink with friends
refrain from smoking when celebrating something
refrain from smoking when drinking alcohol
refrain from smoking when with other smokers
refrain from smoking after a meal
refrain from smoking when having coffee or tea
testosterone undecanoate
stroma
not at all sure
not very sure
hla - dob gene
hla - dob wt allele
more or less sure
fairly sure
absolutely sure
hla class ii histocompatibility antigen ,  do beta chain
refrain from smoking
trpm3 gene
intrathoracal
trpm3 wt allele
transient receptor potential cation channel subfamily m member 3
nrxn2 gene
nrxn2 wt allele
nrxn2 gene product
neurexin - 2
neurexin - 2 - beta
cops6 gene
cops6 wt allele
cop9 signalosome complex subunit 6
intra - abdominal
actn1 gene
actn1 wt allele
alpha - actinin - 1
ptprs gene
ptprs wt allele
receptor - type tyrosine - protein phosphatase s
atxn2 gene
atxn2 wt allele
ataxin - 2
lutetium lu 177 satoreotide tetraxetan
base of the skull
gallium ga 68 dota - jr11
pan fgfr inhibitor prn1371
vcp gene
vcp wt allele
transitional endoplasmic reticulum atpase
vapb gene
vapb wt allele
vapb gene product
vesicle - associated membrane protein - associated protein b
vesicle - associated membrane protein - associated protein c
clivus
dao gene
dao wt allele
d - amino - acid oxidase
fig4 gene
fig4 wt allele
polyphosphoinositide phosphatase
pd1 inhibitor
noncardiogenic pulmonary edema
joint contracture
setx gene
foramen magnum
setx wt allele
probable helicase senataxin
otud5 gene
otud5 wt allele
otu domain - containing protein 5
anxa8l1 gene
anxa8l1 wt allele
annexin a8 - like protein 1
mrgprx2 gene
modified 18 - item memorial anxiety scale for prostate cancer
jugular foramen
reference to prostate cancer brought up strong feelings
getting a psa test scared me
more anxious about having prostate cancer whenever hearing about friend or public figure with prostate cancer
mrgprx2 wt allele
more anxious about having prostate cancer when thinking about having a psa test
mas - related g - protein coupled receptor member x2
other things made me think about prostate cancer
felt numb when thinking about prostate cancer
thought about prostate cancer even though didn't mean to
have feelings about prostate cancer but don't want to deal with them
sella turcica
had more trouble falling asleep because of thoughts of prostate cancer
afraid that results from psa test would show that disease was getting worse
hearing the words prostate cancer scared me
have been so anxious about psa test have thought about delaying it
have been so worried about psa test result have thought about asking doctor to repeat it
have been so concerned about psa test result have thought about having test repeated at another lab
cannot plan for the future because cancer is unpredictable
fear of cancer getting worse gets in way of enjoying life
afraid of cancer getting worse
more nervous since prostate cancer diagnosis
external acoustic meatus
dpp9 gene
dpp9 wt allele
dipeptidyl peptidase 9
mdh2 gene
mdh2 wt allele
malate dehydrogenase ,  mitochondrial
irf5 gene
irf5 wt allele
interferon regulatory factor 5
slc12a7 gene
inner ear
slc12a7 wt allele
solute carrier family 12 member 7
adipose - derived stromal vascular fraction cells
anti - egfr / c - met bispecific antibody jnj - 61186372
salvia hispanica seed
braf / egfr inhibitor bgb - 283
iodine i 131 tenatumomab
autologous cytotoxic t - lymphocytes induced with muc1 gene - transfected dendritic cells
autologous cytotoxic t - lymphocytes induced with muc1 peptide - pulsed dendritic cells
lacutamab
ormaplatin
eustachian tube
ginseng compound
huaier extract granule
topical trichloroacetic acid
pan - raf inhibitor lxh254
once daily
reversal
pathologic examination
histopathology result
gross pathology result
clinical interpretation
quantitation range
how often have you leaked urine
how often have you urinated blood
how often have you had pain or burning with urination
ability to control urination
how many pads or adult diapers per day did you use to control leakage
how big a problem is dripping or leaking urine
how big a problem is pain or burning on urination
how big a problem is bleeding with urination
how big a problem is weak urine stream or incomplete emptying
tympanic membrane
how big a problem is waking up to urinate
how big a problem is the need to urinate frequently during the day
overall how big a problem is urinary function
how often had rectal urgency
how often had uncontrolled leakage of stool or feces
how often had stools that were loose or liquid
how often had bloody stools
how often have your bowel movements been painful
how many bowel movements on a typical day
how often had crampy pain in abdomen ,  pelvis ,  or rectum
mastoid process
how big a problem is urgency to have bowel movement
how big a problem is increased frequency of bowel movements
how big a problem is watery bowel movements
how big a problem is losing control of stools
how big a problem is bloody stools
how big a problem is abdominal ,  pelvic ,  or rectal pain
overall how big a problem have your bowel habits been
level of sexual desire
ability to have an erection
ability to reach orgasm
buccal cavity
usual quality of erections
frequency of erections
how often awakened in the morning or night with an erection
how often had any sexual activity
how often had sexual intercourse
overall ability to function sexually
how big a problem is your level of sexual desire
how big a problem is your ability to have an erection
how big a problem is your ability to reach an orgasm
overall how big a problem is your sexual function or lack of sexual function
buccal mucosa
how often experienced hot flashes
how often had breast tenderness
how often felt depressed
how often felt a lack of energy
how much change in weight have you experienced
how big a problem are hot flashes
how big a problem is breast tenderness or enlargement
how big a problem is loss of body hair
how big a problem is feeling depressed
how big a problem is lack of energy
tooth
how big a problem is your change in body weight
overall satisfaction with treatment received for prostate cancer
tomivosertib
botanical lotion cg428
pegol - sihematide injection
body weight gain exceeding 10 pounds
body weight gain less than 10 pounds
no change in body weight
body weight loss less than 10 pounds
body weight loss exceeding 10 pounds
mantle field
dissatisfied
uncertain if satisfied or dissatisfied
satisfied
bothered by chills
bothered by lumps or swelling in certain parts of my body
feel uncertain about my future health
feel isolated from others because of my illness or treatment
bleed easily
bruise easily
fact - th11 questionnaire
cell
tilsotolimod sodium
lenzilumab
decisional conflict scale
know which options are available
know the benefits of each option
know the risks and side effects of each option
clear about which benefits matter most
clear about which risks and side effects matter most
clear about whether benefits or risks are more important
have enough support from others to make a choice
infratentorial brain
choosing without pressure from others
have enough advice to make a choice
clear about the best choice
sure about what to choose
decision is easy to make
have made an informed choice
decision shows what is important
expect to stick with decision
satisfied with decision
ip6k1 gene
thiamiprine
mesencephalon
ip6k1 wt allele
autologous anti - cd123 car tcr / 4 - 1bb - expressing t - lymphocytes
inositol hexakisphosphate kinase 1
novottf - 100a device
past 3 months
taps tool  -  interviewer version
traip gene
traip wt allele
e3 ubiquitin - protein ligase traip
wasf2 gene
pons varolii
wasf2 wt allele
wiskott - aldrich syndrome protein family member 2
map3k3 gene
map3k3 wt allele
mitogen - activated protein kinase kinase kinase 3
smoke cigarette containing tobacco
usually smoke more than 10 cigarettes each day
usually smoke within 30 minutes after waking
have drink containing alcohol
on occasion drink more than 4 standard drinks of alcohol
supratentorial brain
on occasion drink more than 5 standard drinks of alcohol
tried and failed to control ,  cut down ,  or stop drinking
concern about your drinking
use marijuana
strong desire to use marijuana at least once a week
concern about your use of marijuana
use of stimulant medication not as prescribed or without a prescription
use stimulant at least once a week
concern about your use of a stimulant
use cocaine or methamphetamine
sagittal sinus
use cocaine or methamphetamine at least once a week
concern about your use of cocaine or methamphetamine
use sedative or sleeping medication not as prescribed or without a prescription
use opioid - containing medication not as prescribed or without a prescription
strong desire to use sedative or sleeping medication at least once a week
concern about your use of sedative or sleeping medication
tried and failed to control ,  cut down ,  or stop using an opioid medication
concern about your use of an opioid medication
use heroin
tried and failed to control ,  cut down ,  or stop using heroin
inferior sagittal sinus
concern about your use of heroin
use any other drug
other drug taken
pegzilarginase
fact - m questionnaire
have pain at melanoma site
have noticed new changes in skin
worry about appearance of surgical scars
have noticed blood in stool
isolate myself from others because of condition
superior sagittal sinus
have difficulty thinking clearly
have swelling at melanoma site
have swelling as result of surgery
bothered by amount of swelling
movement of swollen area is painful
swelling keeps me from doing things i want to do
swelling keeps me from wearing what i want to wear
feel numbness at surgical site
have good range of movement in my arm or leg
fait - u questionnaire
intracranial nervous system
have to limit physical activity because of condition
have to limit social activity because of condition
fams questionnaire
feel overwhelmed by condition
map2k3 gene
map2k3 wt allele
dual specificity mitogen - activated protein kinase kinase 3
wwc1 gene
wwc1 wt allele
protein kibra
dchs2 gene
dchs2 wt allele
protocadherin - 23
taok1 gene
taok1 wt allele
serine / threonine - protein kinase tao1
escalation
financial disclosure form
mass effect
midline shift
blastomere
rbpms gene
rbpms wt allele
rna - binding protein with multiple splicing
chi3l1 gene
chi3l1 wt allele
anti - cd3 / anti - egfr - bispecific monoclonal antibody - armed activated autologous t - lymphocytes
doxycycline hyclate injection
anti - tim3 checkpoint inhibitor mbg453
alimentary bolus
peripheral blood cell
lisocabtagene maraleucel
eltanexor
topical fluorouracil
previous device identifier
previous labeling company
pkn1 gene
pkn1 wt allele
serine / threonine - protein kinase n1
thiocolchicine
platelet
post - allogeneic bone marrow transplant
overall survival
relapse of prior malignancy
transplant - related mortality
disease phenotype
reversal of disease phenotype
cell cycle profile
anti - chimeric antigen receptor antibody
oral microbiome
egfr nm_005228 .3:c .2303g > t
erythrocyte
egfr np_005219 .2:p .s768i
tmem37 gene
tmem37 wt allele
voltage - dependent calcium channel gamma - like subunit
map2 gene
map2 wt allele
microtubule - associated protein 2
past year
frequency any tobacco use
have 5 or more drinks in one day
have 4 or more drinks in one day
profile of mood states questionnaire
frequency medication use for the feeling ,  to get high ,  more often ,  or in larger doses than prescribed
frequency any illegal drug use
daily or almost daily response
how true feel exhausted right now
once or twice response
how true feel ready to fight right now
lead pb - 207
how true feel good - natured right now
acanthocyte
hydroxylated polybrominated diphenyl ether
polybrominated diphenyl ether
how true feel gloomy right now
how true feel desperate right now
how true feel sluggish right now
how true feel rebellious right now
how true feel weary right now
how true feel bewildered right now
memorial symptom assessment scale
memorial symptom assessment scale  -  short form
how true feel alert right now
how often difficulty concentrating
how true feel deceived right now
polyethyleneglycol - 7 - ethyl - 10 - hydroxycamptothecin dfp - 13318
how true feel furious right now
how true feel effacious right now
how true feel trusting right now
how true feel full of pep right now
how true feel bad - tempered right now
how true feel forgetful right now
spherocyte
how true feel carefree right now
how true feel terrified right now
how true feel guilty right now
how true feel vigorous right now
how true feel uncertain about things right now
how true feel bushed right now
moderate response
extreme response
ino80d gene
ino80d wt allele
erythroid stem cell
ino80 complex subunit d
trim29 gene
trim29 wt allele
tripartite motif - containing protein 29
e2f4 gene
e2f4 wt allele
transcription factor e2f4
slc9a9 gene
how often feeling nervous
slc9a9 wt allele
erythroblast
how often dry mouth
sodium / hydrogen exchanger 9
how often nausea
how often feeling drowsy
how often have numbness or tingling in hands or feet
how often difficulty sleeping
how often feeling bloated
how often problems with urination
how often vomiting
how often shortness of breath
reticulocyte
how often diarrhea
how often feel sad
how often sweats
how often worry
how often problems with sexual interest or activity
how often itching
how often lack of appetite
how often dizzy
how often difficulty swallowing
how often feel irritable
leukocyte
how often mouth sores
how often change in food tastes
how often weight loss
how often hair loss
how often constipation
how often swelling of arms or legs
how often don't look like myself
how often changes in skin
usual severity difficulty concentrating
usual severity pain
thymalfasin
granulocyte
usual severity lack of energy
usual severity cough
usual severity feeling nervous
usual severity dry mouth
usual severity nausea
usual severity feeling of drowsiness
usual severity numbness or tingling in hands or feet
usual severity difficulty sleeping
usual severity feeling of bloatedness
usual severity problems with urination
usual severity vomiting
usual severity shortness of breath
usual severity diarrhea
usual severity feeling of sadness
usual severity sweats
usual severity worry
usual severity problems with sexual interest or activity
usual severity itching
usual severity lack of appetite
usual severity dizziness
eosinophil
usual severity difficulty swallowing
usual severity feeling irritable
usual severity mouth sores
usual severity change in the way food tastes
usual severity weight loss
usual severity hair loss
usual severity constipation
usual severity swelling of arms or legs
usual severity feeling of i don't look like myself
usual severity changes in skin
neutrophil
how much distress difficulty concentrating
how much distress pain
how much distress lack of energy
how much distress cough
how much distress feeling nervous
how much distress dry mouth
how much distress nausea
how much distress feeling drowsy
how much distress numbness or tingling in hands or feet
how much distress difficulty sleeping
non - granular leukocyte
how much distress feeling bloated
how much distress problems with urination
how much distress vomiting
how much distress shortness of breath
how much distress diarrhea
how much distress feeling sad
how much distress sweats
how much distress worrying
how much distress problems with sexual interest or activity
how much distress itching
lymphocyte
how much distress lack of appetite
how much distress dizziness
how much distress difficulty swallowing
how much distress feeling irritable
how much distress mouth sores
how much distress change in the way food tastes
how much distress weight loss
how much distress hair loss
how much distress constipation
how much distress swelling of arms or legs
natural killer cell
how much distress i don't look like myself
how much distress changes in skin
msas global distress index
msas physical symptom subscale
msas psychological symptom subscale
total msas score
rarely or none of the time
some or a little of the time
occasionally or a moderate amount of time
bothered by things that usually don't bother me
did not feel like eating ,  appetite poor
could not shake off the blues even with help from family
felt just as good as other people
had trouble keeping my mind on what i was doing
felt everything was an effort
life has been a failure
felt happy
talked less than usual
felt lonely
people were unfriendly
helper - inducer t - lymphocyte
had crying spells
people disliked me
could not get going
primary erythromelalgia
rasmussen subacute encephalitis
paroxysmal extreme pain disorder
indifference to pain ,  congenital ,  autosomal recessive
migrating partial seizures in infancy
neuropathy ,  hereditary sensory and autonomic ,  type vii
small fiber neuropathy
type 1 helper cell
episodic pain syndrome ,  familial ,  3
bet inhibitor gsk2820151
crofelemer
bristol stool scale
bristol stool type 1
bristol stool type 2
bristol stool type 3
bristol stool type 4
bristol stool type 5
bristol stool type 6
tiazofurin
type 2 helper cell
bristol stool type 7
how much distress other symptom 1
how much distress other symptom 2
how much distress other symptom 3
almost constantly
have difficulty concentrating
problem with urination
have sweats
problem with sexual interest or activity
have dizziness
suppressor - inducer t - lymphocyte
have difficulty swallowing
have weight loss
have hair loss
have swelling of arms and / or legs
don't look like myself
rat malignant peripheral nerve sheath tumor
rat plasma cell myeloma
mouse plasma cell myeloma
pseudotrisomy 13 syndrome
spondyloepimetaphyseal dysplasia with joint laxity type 2
cd8 - positive t - lymphocyte
allogeneic cd123car - cd28 - cd3zeta - egfrt - expressing t - lymphocytes
clinical trial operational oversight
clinical study committee financial disclosure form
clinical trial committe member contract
clinical trial committee member confidentiality disclosure agreement
clinical trial team training document
clinical trial coordinating investigator documentation
clinical trial subject eligibility verification form and worksheet
clinical trial ongoing third party oversight document
clinical trial roles and responsibilities matrix
cytotoxic t - lymphocyte
clinical trial device review committee
medical device report of prior investigations
clinical trial medical device investigators agreement
source data verification document
clinical trial subject identification log
investigational product retest and expiry document
investigational product device maintenance log
electronic case report form technical design document
clinical trial patient database change control
independent review committee member curriculum vitae
suppressor - effector t - lymphocyte
clinical trials third party curriculum vitae
clinical trial team curriculum vitae
clinical trial source data
clinical trial monitoring visit follow - up letter
pfn1 gene
pfn1 wt allele
profilin - 1
ptpn14 gene
ptpn14 wt allele
tyrosine - protein phosphatase non - receptor type 14
lymphocyte ,  null
jak2 inhibitor
was it worth it questionnaire
worthwhile to participate in research study
would participate in research study again
recommend participating in research study to others
overall quality of life change by participating in research study
overall experience participating in research study
one thing to improve experience participating in research study
talk with someone about concerns
improved
tumor infiltrating lymphocyte
stayed the same
got worse
gpr158 gene
gpr158 wt allele
probable g - protein coupled receptor 158
arhgap11b gene
arhgap11b wt allele
rho gtpase - activating protein 11b
trem2 gene
trem2 wt allele
monocyte
triggering receptor expressed on myeloid cells 2
pi3k - gamma inhibitor ipi - 549
ann arbor clinical stage i
ann arbor pathologic stage i
ann arbor clinical stage ii
ann arbor pathologic stage ii
ann arbor clinical stage iii
ann arbor pathologic stage iii
ann arbor clinical stage iv
ann arbor pathologic stage iv
monocyte ,  activated killer
gaia terminology
rnf5 gene
rnf5 wt allele
ectopia lentis
microcornea
e3 ubiquitin - protein ligase rnf5
opitz g / bbb syndrome
seckel syndrome
pde9a gene
myeloid cell
pde9a wt allele
high affinity cgmp - specific 3' , 5' - cyclic phosphodiesterase 9a
first trimester antepartum hemorrhage
second trimester antepartum hemorrhage
third trimester antepartum hemorrhage
prkg1 gene
prkg1 wt allele
cgmp - dependent protein kinase 1
id4 gene
id4 wt allele
tin ethyl etiopurpurin
bone marrow blood - forming cell
dna - binding protein inhibitor id - 4
patient satisfaction questionnaire short form
maob gene
doctors are good about explaining the reasons for medical tests
maob wt allele
amine oxidase  [ flavin - containing ]  b
doctor's office has everything needed to provide complete medical care
medical care i have been receiving is just about perfect
sometimes doctors make me wonder if their diagnosis is correct
confident that i can get the medical care i need without being set back financially
hematopoietic stem cell
doctors are careful to check everything when treating and examining me
have to pay more of my medical care than i can afford
have easy access to the medical specialists i need
wait for emergency treatment is too long where i get medical care
doctors act too businesslike and impersonal toward me
doctors treat me in a very friendly and courteous manner
those providing medical care sometimes hurry too much when they treat me
doctors sometimes ignore what i tell them
have some doubts about the ability of the doctors who treat me
doctors usually spend plenty of time with me
bone marrow myeloid stem cell
find it hard to get an appointment for medical care right away
dissatisfied with some things about the medical care i receive
able to get medical care whenever i need it
slc39a6 gene
slc39a6 wt allele
zinc transporter zip6
pard3 gene
pard3 wt allele
attitudes and preferences questionnaire
partitioning defective 3 homolog
megakaryocyte
how important treatment based on tumor molecular profile extends survival
how important treatment based on tumor molecular profile improves symptoms
how important treatment based on tumor molecular profile avoids side effects from treatment
psmd11 gene
how important treatment based on tumor molecular profile improves quality of life
psmd11 wt allele
26s proteasome non - atpase regulatory subunit 11
how important standard treatment extends survival
how important standard treatment improves symptoms
how important standard treatment avoids side effects from treatment
chromaffin cell
how important standard treatment improves quality of life
overall value treatment based on tumor molecular profile
importance rating likert scale
importance rating score 0
importance rating score 1
importance rating score 2
importance rating score 3
importance rating score 4
emactuzumab
loncastuximab tesirine
connective and soft tissue cell
preference for decision about choosing a treatment
drg2 gene
drg2 wt allele
developmentally - regulated gtp - binding protein 2
prefer to make final selection about which treatment i will receive
prefer to make final selection of my treatment after seriously considering my doctor's opinion
prefer my doctor and i share responsibility for deciding which treatment is best
prefer my doctor makes final decision about which treatment is used but seriously considers my opinion
prefer to leave all decisions regarding treatment to my doctor
you and your doctor's cancer treatment decision
adipocyte
made final selection about which treatment i will receive
made final selection of my treatment after seriously considering doctor's opinion
doctor and i shared responsibility for deciding which treatment is best for me
doctor made final decision about which treatment will be used but seriously considered my opinion
conflicting expert opinions about a medical test or treatment would lower my trust in the experts
would not have confidence in a medical test or treatment if experts had conflicting opinions
conflicting expert opinions about a medical test or treatment would make me upset
not afraid of trying a medical test or treatment even if experts had conflicting opinions
willing to try medical test or treatment if experts had conflicting opinions
would avoid making decisions about a medical test or treatment if experts had conflicting opinions
chondrocyte
slightly disagree
slightly agree
myo15a gene
myo15a wt allele
unconventional myosin - xv
morc2 gene
morc2 wt allele
morc family cw - type zinc finger protein 2
osbp2 gene
osbp2 wt allele
oxysterol - binding protein 2
pathology result
scrib gene
scrib wt allele
protein scribble homolog
anp32a gene
anp32a wt allele
acidic leucine - rich nuclear phosphoprotein 32 family member a
csnk1d gene
csnk1d wt allele
epithelioid cell
casein kinase i isoform delta
dubowitz syndrome
holt - oram syndrome
hyperpipecolatemia
kniest dysplasia
mucolipidosis type iiia
neuraminidase deficiency
polysyndactyly
spondylocostal dysostosis
weaver syndrome
toremifene
foam cell
off - label treatment
carboplatin / etoposide / melphalan regimen
left all decisions regarding my treatment to my doctor
bcl - 2 inhibitor bcl201
conjugated estrogens / bazedoxifene
egfr exon 20 insertion mutation
brat diet
p - cadherin - targeting agent pf - 06671008
begelomab
4d pet scan
foreign body giant cell
formalin - fixed paraffin - embedded b - cell  ( cd20 )  slide
formalin - fixed paraffin - embedded t - cell  ( cd3 )  slide
formalin - fixed paraffin - embedded b - cell  ( cd20 )  digital image
formalin - fixed paraffin - embedded t - cell  ( cd3 )  digital image
inconsistency due to macrodissection
histological subtype different ,  other pathology review
histological subtype different ,  pathology review for this project
depression subordinate domain
sleep disturbance subordinate domain
pain interference subordinate domain
anti - c - kit monoclonal antibody cdx 0158
global rating of change in joint pain and stiffness questionnaire
change since last time questionnaire filled out
level of joint pain
carbon c 14 anlotinib hydrochloride
level of joint stiffness
very much better
moderately better
about the same response
moderately worse
histiocyte
very much worse
opolimogene capmilisbac
shi pi yin herbal decoction
anti - epidermal growth factor receptor 2 antibody expressing pluripotent killer t - lymphocytes
dendritic cell - precision multiple antigen t - lymphocytes
breast cancer prevention trial symptom scales
mycobacterium mucogenicum
mucorales
chikungunya virus
enterovirus d68
kupffer cell
human metapneumovirus
human parainfluenza virus
helminth
strongyloides stercoralis
toxoplasma gondii
bothered by hot flashes
bothered by nausea
bothered by vomiting
bothered by difficulty with bladder control when laughing or crying
bothered by difficulty with bladder control at other times
alveolar macrophage
bothered by vaginal dryness
liposomal bupivacaine
vortioxetine hydrobromide
anti - programmed cell death protein 1 antibody expressing pluripotent killer t - lymphocytes
smoked plum
methotrexate - encapsulating autologous tumor - derived microparticles
ets - family transcription factor inhibitor tk216
fructooligosaccharide / lactobacillus paracasei / lactobacillus rhamnosus / lactobacillus acidophilus / bifidobacterium lactis probiotic supplement
ciforadenant
peritoneal macrophage
mouse trisomy 16
carnosinemia
carotid artery dissection
combined oxidative phosphorylation deficiency 1
pain agnosia
x - linked creatine transporter deficiency
mnsod mimetic bmx - 001
autologous interferon - producing killer dendritic cells
bcl2l1 gene product
bothered by pain with intercourse
odontoblast
bothered by general aches and pains
bothered by joint pains
bothered by muscle stiffness
bothered by weight gain
bothered by forgetfulness
bothered by the appearance of my body
bothered by night sweats
bothered by difficulty concentrating
bothered by being easily distracted
bothered by arm swelling
osteoblast
bothered by decreased range of motion in arm on surgery side
extremely agree
somewhat bothered
a little disrupted
quite a bit disrupted
somewhat disrupted
totally disrupted
not at all disrupted
phenx
osteocyte
antimetabolite ff - 10502
autologous anti - cd19 car - expressing t lymphocytes
multipeptide vaccine s - 588210
atransferrinemia
sitosterolemia
striatonigral degeneration
ehlers - danlos syndrome ,  type i
ehlers - danlos syndrome ,  type ii
ehlers - danlos syndrome ,  type iii
ehlers - danlos syndrome ,  type iv
treosulfan
osteoclast
ehlers - danlos syndrome ,  type vi
ehlers - danlos syndrome ,  type vii
fanconi anemia ,  complementation group a
fanconi anemia ,  complementation group b
fanconi anemia ,  complementation group c
fanconi anemia ,  complementation group d1
fanconi anemia ,  complementation group d2
fanconi anemia ,  complementation group f
fanconi anemia ,  complementation group g
fanconi anemia ,  complementation group e
stromal cell
transfill
kshv inflammatory cytokine syndrome
immune reconstitution inflammatory syndrome associated with kaposi sarcoma
alvelestat
recurrent acute myeloid leukemia with myelodysplasia - related changes
expiratory muscle strength training
anti - cd33 antibody - drug conjugate imgn779
sirpa - fc fusion protein tti - 621
quality of life questionnaire  -  chemotherapy - induced peripheral neuropathy 20
theca cell
have tingling fingers or hands
have tingling toes or feet
have numbness in fingers or hands
have numbness in toes or feet
have shooting or burning pain in fingers or hands
have shooting or burning pain in toes or feet
have cramps in hands
have cramps in feet
have problems standing or walking because of difficulty feeling the ground under feet
have difficulty distinguishing between hot and cold water
have problem holding a pen which makes writing difficult
have difficulty manipulating small objects with fingers
have difficulty opening a jar or bottle because of weakness in hands
have difficulty walking because feet drop downwards
have difficulty climbing stairs or getting out of chair because of weakness in legs
dizzy when standing up from a sitting or lying position
have difficulty hearing
have difficulty using car pedals
figo stage
brd4 inhibitor plx51107
delta cell
cdisc questionnaire asex - female version test name terminology
cdisc questionnaire asex - female version test code terminology
cdisc questionnaire asex - male version test name terminology
cdisc questionnaire asex - male version test code terminology
cdisc questionnaire expanded drs - pi caregiver version test name terminology
cdisc questionnaire expanded drs - pi caregiver version test code terminology
cdisc questionnaire expanded drs - pi survivor version test name terminology
cdisc questionnaire expanded drs - pi survivor version test code terminology
cdisc questionnaire phq screener version test name terminology
cdisc questionnaire phq screener version test code terminology
enterochromaffin cell
asex - female version questionnaire question
asex - male version questionnaire question
expanded drs - pi caregiver version questionnaire question
expanded drs - pi survivor version questionnaire question
phq screener version questionnaire question
ajcc cancer staging manual 7th edition
copd assessment test questionnaire
arizona sexual experiences scale - female version questionnaire
arizona sexual experiences scale - male version questionnaire
expanded disability rating scale  -  postacute interview caregiver version questionnaire
enterochromaffin - like cell
expanded disability rating scale  -  postacute interview survivor version questionnaire
patient health questionnaire screener version
odi v2 .1a  -  oswestry disability index
asex - female version  -  sex drive
asex - female version  -  sexually aroused
asex - female version  -  vagina become moist
asex - female version  -  reach orgasm
asex - female version  -  orgasms satisfying
asex - male version  -  sex drive
asex - male version  -  sexually aroused
g - cell
asex - male version  -  keep erection
asex - male version  -  reach orgasm
asex - male version  -  orgasms satisfying
expanded drs - pi caregiver version  -  able to communicate clearly
expanded drs - pi caregiver version  -  how they communicate primarily
expanded drs - pi caregiver version  -  give correct date and time when asked
expanded drs - pi caregiver version  -  use few words or random shouting
expanded drs - pi caregiver version  -  make sounds not understandable
expanded drs - pi caregiver version  -  feed independently without help
expanded drs - pi caregiver version  -  understand feeding utensils
epithelial cell
expanded drs - pi caregiver version  -  know meal times
expanded drs - pi caregiver version  -  use toilet independently
expanded drs - pi caregiver version  -  manage clothing when toileting
expanded drs - pi caregiver version  -  know when to use toilet
expanded drs - pi caregiver version  -  can dress and groom self independently
expanded drs - pi caregiver version  -  know how to bathe and wash
expanded drs - pi caregiver version  -  understand how to get dressed
expanded drs - pi caregiver version  -  start and finish grooming activities
expanded drs - pi caregiver version  -  function completely independently
expanded drs - pi caregiver version  -  require special aids or equipment
ameloblast
expanded drs - pi caregiver version  -  require physical assistance
expanded drs - pi caregiver version  -  require assistance thinking tasks
expanded drs - pi caregiver version  -  require assistance managing emotions
expanded drs - pi caregiver version  -  need a helper always close by
expanded drs - pi caregiver version  -  need help with all major activities
expanded drs - pi caregiver version  -  need 24 - hour care
expanded drs - pi caregiver version  -  function with independent work or social situations
expanded drs - pi caregiver version  -  understand and follow directions
expanded drs - pi caregiver version  -  keep track of time
expanded drs - pi caregiver version  -  perform jobs or manage a home independently
triazinate
chief cell
expanded drs - pi caregiver version  -  successful with accommodations
expanded drs - pi caregiver version  -  successful with limited choices
expanded drs - pi caregiver version  -  work with frequent supervision and support
expanded drs - pi survivor version  -  give correct date and time when asked
expanded drs - pi survivor version  -  feed yourself independently without help
expanded drs - pi survivor version  -  understand feeding utensils
expanded drs - pi survivor version  -  know meal times
expanded drs - pi survivor version  -  use toilet independently
expanded drs - pi survivor version  -  manage clothing when toileting
expanded drs - pi survivor version  -  know when to use toilet
chromatophore
expanded drs - pi survivor version  -  can dress and groom self independently
expanded drs - pi survivor version  -  know how to bathe and wash
expanded drs - pi survivor version  -  understand how to get dressed
expanded drs - pi survivor version  -  start and finish grooming activities
expanded drs - pi survivor version  -  function completely independently
expanded drs - pi survivor version  -  require special aids or equipment
expanded drs - pi survivor version  -  require physical assistance
expanded drs - pi survivor version  -  require assistance thinking tasks
expanded drs - pi survivor version  -  require assistance managing emotions
expanded drs - pi survivor version  -  need a helper always close by
melanophore
expanded drs - pi survivor version  -  need help with all major activities
expanded drs - pi survivor version  -  need 24 - hour care
expanded drs - pi survivor version  -  function with independent work or social situations
expanded drs - pi survivor version  -  understand and follow directions
expanded drs - pi survivor version  -  keep track of time
expanded drs - pi survivor version  -  perform jobs or manage a home independently
expanded drs - pi survivor version  -  successful with accommodations
expanded drs - pi survivor version  -  successful with limited choices
expanded drs - pi survivor version  -  work with frequent supervision and support
phq screener version  -  stomach pain
dendritic cell
phq screener version  -  back pain
phq screener version  -  pain in arms ,  legs ,  joints
phq screener version  -  menstrual cramp or other problem
phq screener version  -  pain during intercourse
phq screener version  -  headaches
phq screener version  -  chest pain
phq screener version  -  dizziness
phq screener version  -  fainting spells
phq screener version  -  feeling your heart pound or race
phq screener version  -  shortness of breath
langerhans cell
phq screener version  -  constipation or diarrhea
phq screener version  -  nausea ,  gas or indigestion
phq screener version  -  little interest in doing things
phq screener version  -  feeling down or depressed
phq screener version  -  last 2 weeks ,  trouble falling or staying asleep
phq screener version  -  feeling tired or little energy
phq screener version  -  poor appetite or overeating
phq screener version  -  feeling bad about yourself
phq screener version  -  last 2 weeks ,  trouble concentrating
phq screener version  -  moving slowly or moving more
enterocyte
phq screener version  -  thoughts be better off dead
phq screener version  -  anxiety attack
phq screener version  -  anxiety attack happened before
phq screener version  -  anxiety attacks come suddenly
phq screener version  -  anxiety attacks bother a lot
phq screener version  -  anxiety attack short of breath
phq screener version  -  anxiety attack heart race or pound
phq screener version  -  anxiety attack chest pain
phq screener version  -  anxiety attack sweat
phq screener version  -  anxiety attack choking
goblet cell
phq screener version  -  anxiety attack hot flash or chill
phq screener version  -  anxiety attack nausea or diarrhea
phq screener version  -  anxiety attack dizzy or faint
phq screener version  -  anxiety attack tingling or numbness
phq screener version  -  anxiety attack tremble or shake
phq screener version  -  anxiety attack afraid you were dying
phq screener version  -  feeling nervous or anxious
phq screener version  -  feeling restless
phq screener version  -  getting tired easily
phq screener version  -  muscle tension
phq screener version  -  last 4 weeks ,  trouble falling or staying asleep
phq screener version  -  last 4 weeks ,  trouble concentrating
phq screener version  -  becoming easily annoyed
phq screener version  -  no control what or how much eat
phq screener version  -  often eat large amount food
phq screener version  -  eat a lot twice week
phq screener version  -  avoid gaining weight ,  made yourself vomit
phq screener version  -  avoid gaining weight ,  took twice dose of laxatives
phq screener version  -  avoid gaining weight ,  fasted at least 24 hours
phq screener version  -  avoid gaining weight ,  exercise
hepatocyte
phq screener version  -  avoid gaining weight twice week
phq screener version  -  drink alcohol
phq screener version  -  drank alcohol with health problem
phq screener version  -  drank alcohol at work or school
phq screener version  -  missed work because of drinking
phq screener version  -  problem getting along with people while drinking
phq screener version  -  drove car after several drinks
phq screener version  -  problems made it difficult to work
disruptive tp53 mutation
non - disruptive tp53 mutation
keratinocyte
small cell glioblastoma
signed by
most or almost all of the time
moderately or much of the time
ion semiconductor sequencing
experimental organism anal sac gland
anal sac
thoracic fluid
evaux thermal spring water - based solution
cdk4 / 6 inhibitor shr6390
tri - n - butyl phosphate
supporting cell of organ of corti
anti - ca19 - 9 monoclonal antibody 5b1
etidronate - cytarabine conjugate mbc - 11
sting - activating cyclic dinucleotide agonist miw815
cd24 extracellular domain - igg1 fc domain recombinant fusion protein cd24fc
high grade b - cell lymphoma with myc and bcl2 or bcl6 rearrangements
non - cellular component
quality of life questionnaire  -  pancreatic cancer 26
have pain during the night
uncomfortable in certain positions
modified barium swallow
restricted in the types of food you can eat as a result of disease or treatment
restricted in the amount of food you can eat as a result of disease or treatment
food and drink taste different from usual
have indigestion
worried about weight being too low
have yellow skin
have frequent bowel movements
feel urge to move bowels quickly
troubled with side effects from treatment
limited in planning activities in advance
merkel cell
receive adequate support from health care professionals
adequate information given about physical condition and treatment
cdisc sdtm microscopic findings test detail terminology
cdisc sdtm bridg activity mood terminology
strongyloides
taenia
torulaspora
toxocara
trichinella
trichuris
paneth cell
trichostrongylus
trypanosoma
tumor response criterion
feel less interest in sex
feel less sexual enjoyment
protein interaction domain inhibitor therapy
time matched derivation indicator
scheduled
baseline epoch
abo blood group determination
parietal cell
amyloid a measurement
ionized ph adjusted calcium measurement
calbindin measurement
carbohydrate - deficient transferrin to transferrin ratio measurement
hepatitis b virus antibody measurement
inulin measurement
iohexol measurement
lipoarabinomannan measurement
rhd factor measurement
urea nitrogen measurement
sertoli cell
urea nitrogen to creatinine ratio measurement
cardiologist
particle - enhanced nephelometric immunoassay
particle - enhanced turbidimetric immunoassay
aerobic gram - negative coccobacillus
anaerobic gram - negative coccobacillus
metapneumovirus
normal flora
streptomyces paraguayensis
syncephalastrum
eukaryotic cell
taenia saginata
taenia solium
torulaspora delbrueckii
toxocara canis
toxocara cati
trichinella spiralis
trichoderma
trichomonas vaginalis
trichostrongylus axei
trichostrongylus colubriformis
germ cell
trichostrongylus orientalis
trichostrongylus probolurus
trichostrongylus vitrinus
trichuris trichiura
tritirachium
trypanosoma brucei gambiense
trypanosoma brucei rhodesiense
trypanosoma cruzi
ulocladium
ustilago
oocyte
vancomycin resistant staphylococcus aureus
vancomycin susceptible enterococcus
veillonella atypica
verticillium
vorticella
allred proportion positive score
allred average staining intensity score
allred total score
h score total score
receptor overall status
tributyrin
primary oocyte
zygote
spermatozoon
head of the spermatozoon
spermatid
protocol defined response criteria
spermatocyte
wolchok solid tumors 2009 oncology response criteria
percent predicted functional residual capacity
exhaled breath condensate
non - pathological
present without unequivocal progression
calcification indicator
percent change from nadir in sum of area
biospecimen retained and / or contains dna indicator
ema decision number for pediatric investigation plan
spermatogonium
eudract resubmission indicator
eudravigilance sender identifier
protocol keyword
number of groups or cohorts
observational model
observational time perspective of study
observational study population description
observational study sampling method
observational study sampling method description
pediatric investigation plan indicator
giant cell
rare disease indicator
resubmission letter
retained biospecimen description
susar reporting to eudravigiliance clinical trial module indicator
susar reporting to national competent authority indicator
substudy details
substudy planned indicator
planned follow - up duration
absorbance unit per milliliter
copies per microgram
islet of langerhans
cubic millimeter per square millimeter per year
micrometer per day
micromole per kilogram per minute
basal metabolic rate
experimental organism benign mixed sertoli - leydig cell tumor
experimental organism benign mixed mullerian tumor
experimental organism benign neuroendocrine cell tumor
experimental organism malignant neuroendocrine cell tumor
experimental organism malignant renal mesenchymal tumor
needle tract lesion
leydig cell
eudravigilance sender organization
transfills medical gas
institutional review board independent ethics committee progress report
other clinical trial submission document
vendor management plan
perceived stress scale  -  14 questionnaire
how often dealt successfully with day to day problems and annoyances in the last month
how often felt you were effectively coping with important changes occurring in life in the last month
how often found yourself thinking about things that you have to accomplish in the last month
how often able to control the way you spend your time in the last month
trichostatin a
lutein cell
scopoletin
not available
chimeric antigen receptor t - cell therapy
urine pellet
gene modification
tinostamustine
fluorine f 18 clofarabine
antigen receptor
chimeric antigen receptor
metastatic urothelial carcinoma
antibody - producing cell
infant acute undifferentiated leukemia
infant acute biphenotypic leukemia
infant t acute lymphoblastic leukemia
zalifrelimab
phospholipase c gamma
kinase inhibitor sensitivity
pgf gene product
placenta growth factor isoform 1
hla - cw serotype
polysomy 7
muscle cell
oxygenated hemoglobin
deoxygenated hemoglobin
cd42 complex
tigit gene
tigit wt allele
t - cell immunoreceptor with ig and itim domains
kif20b gene
kif20b wt allele
kinesin - like protein kif20b
depdc1 gene
fast - twitch muscle fiber
depdc1 wt allele
dep domain - containing protein 1a
ly6k gene
ly6k wt allele
lymphocyte antigen 6k
atg13 gene
atg13 wt allele
autophagy - related protein 13
getting in and out of chairs or bed without assistance
listening to the radio
slow - twitch muscle fiber
reading ability
writing ability
working at a desk or table
standing for more than 1 minute
standing for more than 5 minutes
dressing or undressing without assistance
getting clothes from drawers or closets
getting in or out of a car without assistance
dining at a restaurant
playing cards or table games
glial cell
bathing without assistance
putting on shoes ,  stockings ,  or socks without rest or a break
attending a movie ,  play ,  church event ,  or sports activity
walking 30 yards
dressing or undressing without rest or a break
walking 30 yards nonstop
using public transport or driving a car ,  99 miles or less
using public transport or driving a car ,  100 miles or more
cooking your own meals
washing or drying dishes
microglia
putting groceries on shelves
ironing or folding clothes
dusting or polishing furniture or a polishing car
climbing 6 steps
climbing 6 steps nonstop
climbing 9 steps
climbing 12 steps
walking half a block on level ground
walking half block on level ground nonstop
ability to make a bed
neuropil
cleaning windows
kneeling or squatting to do light work
carrying a light load of groceries
climbing 9 steps nonstop
climbing 12 steps nonstop
walking half block uphill
walking half block uphill nonstop
shopping by yourself
washing clothes by yourself
walking 1 block on level ground
oligodendrocyte
walking 2 blocks on level ground
walking 1 block on level ground nonstop
walking 2 blocks on level ground nonstop
scrubbing doors ,  walls ,  or cars
making a bed and changing sheets
sweeping
sweeping 5 minutes nonstop
carrying a large suitcase or bowling 1 game
vacuuming carpets
vacuuming carpets 5 minutes nonstop
perineuronal satellite cell
house painting
walking 6 blocks on level ground
walking 6 blocks on level ground nonstop
carrying out the garbage
carrying a heavy load of groceries
climbing 24 steps
climbing 36 steps
climbing 24 steps nonstop
climbing 36 steps nonstop
walking 1 mile
triciribine phosphate
schwann cell
walking 1 mile nonstop
running 110 yards or playing softball or baseball
social dancing
doing calisthenics or aerobic dancing 5 minutes nonstop
mowing the lawn with a power mower
walking 2 miles
walking 2 miles nonstop
climbing 50 steps or 2 1 / 2 floors
shoveling ,  digging ,  or spading
shoveling ,  digging ,  or spading 5 minutes nonstop
antigen presenting cell
climbing 50 steps nonstop
walking 3 miles or golfing 18 holes without a riding cart
walking 3 miles nonstop
swimming 25 yards
swimming 25 yards nonstop
bicycling 1 mile
bicycling 2 miles
bicycling 1 mile nonstop
bicycling 2 miles nonstop
running or jogging 1 / 4 mile
follicular dendritic cell
running or jogging 1 / 2 mile
playing tennis or racquetball
playing a basketball or soccer game
running or jogging 1 / 4 mile nonstop
running or jogging 1 / 2 mile nonstop
running or jogging 1 mile
running or jogging 2 miles
running or jogging 3 miles
running or jogging 1 mile in 12 minutes or less
running or jogging 2 miles in 20 minutes or less
neuron
running or jogging 3 miles in 30 minutes or less
still doing this activity
have stopped doing this activity
never did this activity
very low nicotine content cigarette
nurses' health study ii activity and inactivity questionnaire
average time per week spent on activity
time spent walking or hiking outdoors
time spent jogging slower than 10 minutes per mile
time spent running 10 minutes per mile or faster
preganglionic autonomic fiber
time spent bicycling
time spent doing calisthenics ,  aerobics ,  aerobic dance ,  rowing machine
time spent playing tennis ,  squash ,  or racquetball
time spent lap swimming
time spent on other aerobic recreation
average hours per week spent on activity
time spent standing or walking at work
time spent standing or walking at home
time spent sitting at work or while driving
time spent sitting at home
interneuron
usual walking pace outdoors
flights of stairs climbed daily
zero activity time
one to four activity minutes
five to nineteen activity minutes
twenty to fifty - nine activity minutes
one activity hour
one to one and one half activity hours
two to three activity hours
four to six activity hours
amacrine cell
seven to ten activity hours
eleven or more activity hours
two to five activity hours
six to ten activity hours
eleven to twenty activity hours
twenty - one to forty activity hours
forty - one to sixty activity hours
sixty - one to ninety activity hours
over ninety activity hours
myelinated nerve fiber
autologous hbv - specific tcr - redirected t - lymphocytes
pi3k p110beta / delta inhibitor ka2237
fluorescence imaging agent emi - 137
diphtheria toxin fragment - interleukin - 2 fusion protein e7777
fluzoparib
anti - lamp1 antibody - drug conjugate sar428926
pe / hpv16 e7 / kdel fusion protein / gpi - 0100 tvgv - 1
neutrophil activation probe imaging agent
cancer rehabilitation evaluation system for research
autologous fat graft
sensory neuron
clothes do not look good
clothes do not fit
difficulty finding clothes to fit
embarrassed to show body because of illness
uncomfortable showing scars
uncomfortable with changes in body
a fair amount
much
transjugular intrahepatic portosystemic shunt
variceal banding
hair cell
terc deficiency
tert deficiency
perforin deficiency
unc13d deficiency
stxbp2 deficiency
xiap deficiency
immunodeficiency of unknown origin
vector of transplantation incompatibility
hla mismatch
unidirectional hla mismatch
trilostane
type i hair cell
bidirectional hla mismatch
graft - versus - host unidirectional mismatch
host - versus - graft unidirectional mismatch
tubulocystic renal cell carcinoma
xylene
dilated cystic spaces present
recurrent glioblastoma
recurrent bladder urothelial carcinoma
borderline ovarian clear cell tumor / atypical proliferative ovarian clear cell tumor
refractory adult acute lymphoblastic leukemia
type ii hair cell
ovarian seromucinous cystadenoma
ovarian seromucinous adenofibroma
easy or casual walking pace
normal or average walking pace
brisk walking pace
very brisk or striding pace
two or less flights of steps daily
three to four flights of steps daily
five to nine flights of steps daily
ten to fourteen flights of steps daily
vestibular hair cell
fifteen or more flights of steps daily
ovarian luteinized thecoma associated with sclerosing peritonitis
ovarian retiform sertoli - leydig cell tumor ,  variant with heterologous elements
gastroesophageal junction large cell neuroendocrine carcinoma
gastroesophageal junction neuroendocrine carcinoma
gastroesophageal junction small cell carcinoma
roberts syndrome
usher syndrome type 1
usher syndrome type 2
usher syndrome type 3
olfactory receptor neuron
x - linked dystonia parkinsonism
ovarian adenomatoid tumor
zirconium zr 89 - labeled anti - ca19 - 9 monoclonal antibody 5b1
lamellar body mimetic mouth spray lms - 611
anti - fgfr4 monoclonal antibody u3 - 1784
androgen receptor antagonist shr3680
magt1 deficiency
ifn - gamma receptor 1 deficiency
hypomorphic rag1 deficiency
pgm3 deficiency
photoreceptor cell
activating pi3k gene mutation
ctla4 haploinsufficiency
stat3 deficiency
dock8 deficiency
itk deficiency
stat3 gain of function
stat1 gain of function
adenosine deaminase 2 deficiency
chronic active ebv infection of t - and nk - cell type ,  systemic form
gata2 deficiency
photoreceptors ,  invertebrate
sh2d1a deficiency
chronic eosinophilic leukemia with fip1l1 - pdgfra
x - linked dyskeratosis congenita
primary peritoneal high grade serous adenocarcinoma
primary peritoneal low grade serous adenocarcinoma
anti - her2 antibody - drug conjugate medi4276
peritoneal desmoplastic small round cell tumor
peritoneal solitary fibrous tumor
pelvic fibromatosis
abdominal inflammatory myofibroblastic tumor
photoreceptors ,  vertebrate
peritoneal gliomatosis
disease sequela
age of majority
packed red blood cells
face
blood pressure excursion
placement
centrifugation tube
witness
dehydration
retinal cone
cover slip
local pathology review
blade
microtome
notable
pathology ink
unusable
anti - cd19 antibody - drug conjugate sgn - cd19b
drinking status
non - drinker
retinal rod
lifelong non - drinker
ex - drinker
occasional drinker
drinker
heavy drinker
fisher scientific
in - house
laparoscopically assisted vaginal hysterectomy
leico peloris rapid tissue processor
microm ergostar hm200 microtome
rod outer segment
neither
open surgical procedure
paxgene blood tissue system
paxgene blood dna tube
paxgene blood rna tube
recycle
sakura low profile accu - edge blade
supracervical hysterectomy
uncharged
trimethylcolchicinic acid
posterior horn cell
renal replacement therapy
bronchial epithelial dysplasia
near - infrared fluorescence imaging
novartis
juno therapeutics
celgene
kite pharma
bluebird bio
cribriform - morular variant thyroid gland papillary carcinoma
warthin - like variant thyroid gland papillary carcinoma
substantia gelatinosa
thyroid gland papillary carcinoma with fibromatosis / fasciitis - like stroma
prominent stromal reaction
vegfa gene product
vascular endothelial growth factor a 165 isoform
apobec family protein
hla - kir compound genotype
human papillomavirus antibody
butyrate - producing bacteria
immunizing neoantigen peptide antibody
effector memory t - lymphocyte
retinal ganglion cell
central memory t - lymphocyte
lysine - specific demethylase 1 inhibitor incb059872
vlp - encapsulated tlr9 agonist cmp - 001
h1 - 1 gene
h1 - 1 wt allele
histone h1 .1
hepatopetal portal venous flow
protectin
resolvin
center for epidemiologic studies depression scale revised
efferent neuron
poor appetite
could not shake off the blues
nothing made me happy
cited2 gene
cited2 wt allele
cbp / p300 - interacting transactivator 2
feel like a bad person
lost interest in usual activities
slept much more than usual
feel like moving too slowly
motor neuron
feel fidgety
wish i were dead
want to hurt myself
tired all the time
do not like myself
lost a lot of weight without trying
have a lot of trouble getting to sleep
could not focus on important things
one or two days
serous tubal intraepithelial carcinoma
anterior horn cell
three or four days
five to seven days
nearly every day for 2 weeks
cabin1 gene
cabin1 wt allele
calcineurin - binding protein cabin - 1
high grade fallopian tube serous adenocarcinoma
low grade fallopian tube serous adenocarcinoma
ptpn21 gene
ptpn21 wt allele
gamma motor neuron
tyrosine - protein phosphatase non - receptor type 21
tubal hyperplasia
tubo - ovarian abscess
fallopian tube mucinous metaplasia
fallopian tube lymphoma
metastatic head and neck carcinoma
napa gene
napa wt allele
alpha - soluble nsf attachment protein
serous borderline broad ligament tumor / atypical proliferative serous broad ligament tumor
nitrergic neuron
mark2 gene
mark2 wt allele
serine / threonine - protein kinase mark2
ehd1 gene
ehd1 wt allele
eh domain - containing protein 1
broad ligament serous cystadenoma
broad ligament serous cystadenofibroma
broad ligament serous adenofibroma
broad ligament serous adenocarcinoma
postganglionic autonomic fiber
low grade broad ligament serous adenocarcinoma
high grade broad ligament serous adenocarcinoma
meat
processed meat
nts gene
the cancer human biobank
nts wt allele
nts gene product
neurotensin / neuromedin n
biospecimen pre - analytical variables program
postganglionic parasympathetic fiber
neurotensin
neuromedin n
penk gene
benign uterine ligament neoplasm
penk wt allele
penk gene product
proenkephalin - a
met - enkephalin
malignant uterine ligament neoplasm
leu - enkephalin
trimetrexate glucuronate
postganglionic sympathetic fiber
cd2bp2 gene
cd2bp2 wt allele
cd2 antigen cytoplasmic tail - binding protein 2
nusap1 gene
nusap1 wt allele
nucleolar and spindle - associated protein 1
cdca8 gene
cdca8 wt allele
borealin
sorl1 gene
purkinje cell
sorl1 wt allele
sortilin - related receptor
c11orf95 gene
c11orf95 wt allele
uncharacterized protein c11orf95
guca2a gene
guca2a wt allele
guanylin
gnas gene product
guanine nucleotide - binding protein g ( s )  subunit alpha isoforms short
pyramidal cell
neuroendocrine secretory protein 55
protein alex
kif20a gene
kif20a wt allele
kinesin - like protein kif20a
dffb gene
dffb wt allele
dna fragmentation factor subunit beta
central african
north african
south african
latin american
south american
southeast asian
central asian
australian
new zealander
icelander
scandinavian
oxyphil cell
dlst gene
dlst wt allele
dihydrolipoyllysine - residue succinyltransferase component of 2 - oxoglutarate dehydrogenase complex ,  mitochondrial
gabra3 gene
gabra3 wt allele
gamma - aminobutyric acid receptor subunit alpha - 3
gp1ba gene
gp1ba wt allele
platelet membrane glycoprotein 1b alpha chain
gp1bb gene
apud cell
gp1bb wt allele
platelet membrane glycoprotein 1b beta chain
gp9 gene
gp9 wt allele
platelet glycoprotein ix
gp5 gene
gp5 wt allele
platelet glycoprotein v
combined lipase deficiency
hard skin syndrome parana type
pericyte
leri - weill dyschondrosteosis
niemann - pick disease ,  type a
spinocerebellar ataxia type 7
znf224 gene
znf224 wt allele
zinc finger protein 224
fragile x tremor / ataxia syndrome
vasopressor
gcnt3 gene
gcnt3 wt allele
beta - 1 , 3 - galactosyl - o - glycosyl - glycoprotein beta - 1 , 6 - n - acetylglucosaminyltransferase 3
nuak1 gene
nuak1 wt allele
nuak family snf1 - like kinase 1
nelfb gene
nelfb wt allele
negative elongation factor b
bok gene
bok wt allele
bcl - 2 - related ovarian killer protein
gmnc gene
gmnc wt allele
geminin coiled - coil domain - containing protein 1
nit1 gene
nit1 wt allele
nitrilase homolog 1
eligible
forty - three
robo1 gene
robo1 wt allele
protoplast
roundabout homolog 1
nlrx1 gene
nlrx1 wt allele
nlr family member x1
follicular variant thyroid gland papillary carcinoma
psmc3ip gene
psmc3ip wt allele
homologous - pairing protein 2 homolog
thyroid gland noninvasive follicular neoplasm with papillary - like nuclear features
ct45a2 gene
trioxifene
ct45a2 wt allele
cancer / testis antigen family 45 member a2
sorbs2 gene
sorbs2 wt allele
sorbin and sh3 domain - containing protein 2
cip2a gene
cip2a wt allele
protein cip2a
pds5a gene
pds5a wt allele
spheroplast
sister chromatid cohesion protein pds5 homolog a
cep170b gene
cep170b wt allele
centrosomal protein of 170 kda protein b
nrip3 gene
nrip3 wt allele
nuclear receptor - interacting protein 3
casp8ap2 gene
casp8ap2 wt allele
casp8 - associated protein 2
stem cell
myo1f gene
myo1f wt allele
unconventional myosin - if
fryl gene
fryl wt allele
protein furry homolog - like
eefsec gene
eefsec wt allele
selenocysteine - specific elongation factor
btbd18 gene
tumor stem cell
btbd18 wt allele
btb / poz domain - containing protein 18
actn4 gene
actn4 wt allele
alpha - actinin - 4
prrc1 gene
prrc1 wt allele
protein prrc1
imipramine blue
autologous anti - cd19car - 4 - 1bb - cd3zeta - egfrt - expressing cd4 +  / cd8 +  central memory t - lymphocytes jcar014
abdomen
alobresib
simurosertib
sustained - release mitomycin c hydrogel formulation ugn - 101
anti - gitr agonistic monoclonal antibody incagn01876
anti - vegf / ang2 nanobody bi 836880
dehydrated human amnion / chorion membrane
pak4 / nampt inhibitor kpt - 9274
imidazolyl ethanamide pentandioic acid
alk / fak / pyk2 inhibitor ct - 707
white carrot
abducens nerve
infantile convulsions and paroxysmal choreoathetosis ,  familial
progressive familial heart block ,  type ia
oat biscuit
fluorine f 18 dabrafenib
genotype - tissue expression program
unexplained
track marks
body piercing
national disease research interchange
ncit neoplasm core terminology
adrenal gland
mavorixafor
apilimod dimesylate capsule
skin itching at its worst
skin and / or joint tightening at its worst
mouth sensitivity at its worst
genital discomfort at its worst
global rating
severity score 0
severity score 1
severity score 2
anterior chamber of the eye
severity score 3
severity score 4
severity score 5
severity score 6
severity score 7
severity score 8
severity score 9
severity score 10
comparative score 3 +
comparative score 2 +
anterior eye segment
comparative score 1 +
comparative score 0
comparative score  - 1
comparative score  - 2
comparative score  - 3
behavior assessment system for children ,  third edition
autologous mage - a10 - specific hla - a2 - restricted tcr c796 gene - engineered lymphocytes
erk inhibitor ltt462
bethlem myopathy 1
centronuclear myopathy 1
aorta
congenital muscular dystrophy - dystroglycanopathy with mental retardation type b2
rigid spine muscular dystrophy 1
chromosome 15q11 - q13 duplication syndrome
bcg tokyo - 172 strain vaccine
bcg tokyo - 172 strain solution
digital tomosynthesis
stationary digital tomosynthesis
digital chest tomosynthesis
stationary digital chest tomosynthesis
triptorelin
aortic valve
skin complete response gvhd
eyes complete response gvhd
mouth complete response gvhd
esophagus complete response gvhd
upper gi complete response gvhd
lower gi complete response gvhd
liver complete response gvhd
lungs complete response gvhd
joints and fascia complete response gvhd
global complete response gvhd
upper extremity
nrxn3 gene product
neurexin - 3 - beta
fluoroquinolone antibiotic
skin partial response gvhd
eyes partial response gvhd
mouth partial response gvhd
esophagus partial response gvhd
upper gi partial response gvhd
lower gi partial response gvhd
arteriole
liver partial response gvhd
lungs partial response gvhd
joints and fascia partial response gvhd
global partial response gvhd
skin progression gvhd
eyes progression gvhd
mouth progression gvhd
esophagus progression gvhd
upper gi progression gvhd
autonomic nervous system
lower gi progression gvhd
iodine i 123 risad - p
liver progression gvhd
lung progression gvhd
joints and fascia progression gvhd
global progression gvhd
suprapubic skin
frontal pole
phosphoglycerate kinase 1 deficiency
muscular dystrophy - dystroglycanopathy  ( limb - girdle )  type c ,  5
axilla
muscular dystrophy - dystroglycanopathy  ( congenital with brain and eye anomalies )  type a ,  3
muscular dystrophy - dystroglycanopathy  ( congenital with brain and eye anomalies )  type a ,  4
muscular dystrophy - dystroglycanopathy  ( congenital with brain and eye anomalies )  type a ,  2
muscular dystrophy - dystroglycanopathy  ( congenital with brain and eye anomalies )  type a ,  6
codas syndrome
emery - dreifuss muscular dystrophy 2 ,  autosomal dominant
congenital disorder of deglycosylation
lubs x - linked mental retardation syndrome
acute myeloid leukemia with flt3 / itd mutation
bartholin gland
oropharyngeal poorly differentiated carcinoma
oropharyngeal basaloid carcinoma
egfr / her2 inhibitor tak - 788
aqua
2 , 6 - dimethoxyquinone
type 1 regulatory t - cell
peristomal skin
double - walled airbag breast immobilization device
prickle1 gene
prickle1 wt allele
basilar artery
prickle - like protein 1
cdx4 gene
cdx4 wt allele
homeobox protein cdx - 4
h2az1 gene
h2az1 wt allele
histone h2a .z
gtf2a1 gene product
anesthesia probe
endometrial dedifferentiated carcinoma
intrahepatic bile duct
dedifferentiated malignant infiltrate
uterine corpus neuroendocrine neoplasm
endometrial large cell neuroendocrine carcinoma
uterine corpus carcinoid tumor
robo2 gene
robo2 wt allele
roundabout homolog 2
robo3 gene
robo3 wt allele
roundabout homolog 3
biliary tract
endometrial metaplasia
endometrial lymphoma - like lesion
slit1 gene
slit1 wt allele
slit homolog 1 protein
slit2 gene
slit2 wt allele
slit homolog 2 protein
slit3 gene
slit3 wt allele
blood vessel
slit homolog 3 protein
ruxolitinib phosphate cream
busulfan / melphalan regimen
kava - based supplement
anti - lgr5 monoclonal antibody bnc101
wu - ling - san
balanced crystalloid solution
autologous tumor - associated peptide antigen - pulsed dendritic cell vaccine
pol i inhibitor cx5461
dostarlimab
trofosfamide
body region
cebpa - targeting sarna mtl - cebpa liposome
epcam - specific car - expressing autologous t - lymphocytes
phytochlorin sodium - polyvinylpyrrolidone complex
tris - acryl gelatin microspheres
anti - icos agonist antibody gsk3359609
bet bromodomain inhibitor zen - 3694
myelofibrosis transformation in essential thrombocythemia
coroner
medical examiner
glucocorticoid resistance
brachial artery
hyponatremic mineralocorticoid resistance due to mineralocorticoid receptor defect
hyponatremic mineralocorticoid resistance due to urinary tract infection
hyperkalemic mineralocorticoid resistance
aldosterone synthase deficiency
aldosterone synthase deficiency type 1
aldosterone synthase deficiency type 2
hyporeninenmic hypoaldosteronism
hyperreninemic hypoaldosteronism
kit nm_000222 .2:c .2447a > t
kit protein variant
brachial plexus
kit np_000213 .1:p .d816v
mpl gene mutation
mpl nm_005373 .2:c .1544g > t
mpl protein variant
mpl np_005364 .1:p .w515l
mpl np_005364 .1:p .w515k
mpl nm_005373 .2:c .1543_1544deltginsaa
mpl nm_005373 .2:c .1543_1545deltgginsaaa
gaia level of diagnostic certainty
sdha gene mutation
bronchus
gaia neonatal case definitions
sdha nm_004168 .3:c .1660c > t
sdha protein variant
sdha np_004159 .2:p .r554w
gaia obstetric case definitions
drd2 gene mutation
hematopoietic cell transplant recipient
drd2 nm_000795 .3:c .957c > t
drd2 nm_000795 .3:c . - 486_ - 485insc
study site temporarily closed to accrual and intervention
bronchiole
il - 10 immunomodulator mk - 1966
anti - il - 15 monoclonal antibody amg 714
gaia major congenital anomalies level of diagnostic certainty
gaia neonatal death level of diagnostic certainty
gaia neonatal infections level of diagnostic certainty
gaia preterm birth level of diagnostic certainty
gaia stillbirth level of diagnostic certainty
gaia non - reassuring fetal status level of diagnostic certainty
gaia maternal death level of diagnostic certainty
gaia postpartum hemorrhage level of diagnostic certainty
capillary
gaia preeclampsia level of diagnostic certainty
gaia pathways to preterm birth level of diagnostic certainty
gaia major congenital anomalies level of diagnostic certainty terminology
gaia neonatal death level of diagnostic certainty terminology
gaia neonatal infections level of diagnostic certainty terminology
gaia preterm birth level of diagnostic certainty terminology
gaia stillbirth level of diagnostic certainty terminology
gaia non - reassuring fetal status level of diagnostic certainty terminology
gaia maternal death level of diagnostic certainty terminology
gaia postpartum hemorrhage level of diagnostic certainty terminology
cardiovascular system
gaia preeclampsia level of diagnostic certainty terminology
gaia pathways to preterm birth level of diagnostic certainty terminology
unsatisfactory
thirty one
niemann - pick disease ,  type c1
niemann - pick disease ,  type c2
niemann - pick disease ,  type b
gaia maternal immunization level of diagnostic certainty
congenital disorder of glycosylation type ia
congenital disorder of glycosylation type ic
carotid artery
congenital disorder of glycosylation type id
congenital disorder of glycosylation type ie
congenital disorder of glycosylation type if
congenital disorder of glycosylation type ig
congenital disorder of glycosylation type ij
glycogen storage disease type vi
langer mesomelic dysplasia
epidermodysplasia verruciformis
psychosocial assessment
carpal bone
psychosocial care
inattention / hyperactivity composite score
zoo locations subtest
digit span total score
twenty two
twenty three
twenty six
twenty seven
twenty eight
personal care product
cauda equina
past 2 weeks
chronic respiratory questionnaire self - administered standardized format
egfr exon 19 deletion mutation
globohexaosylceramide
fucosyl monosialotetrahexosylganglioside
monoclonal antibody m30
cytidine triphosphate
deoxypyridinoline
2 , 3 - dinor - 6 - ketoprostaglandin f1alpha
anti - hairy cell leukemia antibody dba .44
tag - 72 antigen
cavernous sinus
hla - dr antigen 1d10
phytoene
how much shortness of breath during activity
phytofluene
feel emotional
take care of basic needs
perform chores
sphingosine 1 - phosphate
epoxyeicosatrienoic acid
participate in social activities
cerebral artery
2' - 5' - oligoadenylate
3 - nitrotyrosine
feel frustrated or impatient
tocopherylquinone
feel fear or panic when difficult to get breath
feel embarrassed by coughing or heavy breathing
feel very confident can deal with illness
feel upset ,  worried ,  or depressed
feel in complete control of breathing problems
feel relaxed and free of tension
cerebrospinal fluid
feel low in energy
feel discouraged or down in dumps
feel worn out or sluggish
happy ,  satisfied ,  or pleased with personal life
feel upset or scared when having difficulty getting breath
feel restless ,  tense ,  or uptight
extremely short of breath
very short of breath
quite a bit short of breath
some shortness of breath
cervical vertebra
a little short of breath
24 , 25 - dihydroxycholecalciferol
not at all short of breath
extremely tired
very tired
quite a bit of tiredness
moderately tired
somewhat tired
a little tired
not at all tired
choroid plexus
no energy at all
a little energy
some energy
moderately energetic
quite a bit of energy
very energetic
full of energy
somewhat dissatisfied ,  unhappy
generally satisfied ,  pleased
happy most of the time
clavicle
adgre1 gene
adgre1 wt allele
adhesion g protein - coupled receptor e1
selenof gene
selenof wt allele
selenoprotein f
c2 gene
c2 wt allele
complement c2
mica gene
coccyx
mica wt allele
mhc class i polypeptide - related sequence a
krt8 gene
krt8 wt allele
keratin ,  type ii cytoskeletal 8
orm1 gene
orm1 wt allele
alpha - 1 - acid glycoprotein 1
il15ra gene
il15ra wt allele
cochlear nerve
interleukin - 15 receptor subunit alpha
adrb3 gene
adrb3 wt allele
beta - 3 adrenergic receptor
sorted cells
uterine corpus hydropic leiomyoma
piezoelectric elastic modulus scanner
cd46 gene
cd46 wt allele
membrane cofactor protein
common bile duct
cdk9 gene
cdk9 wt allele
cyclin - dependent kinase 9
cyp26a1 gene
cyp26a1 wt allele
cytochrome p450 26a1
dnaja1 gene
dnaja1 wt allele
dnaj homolog subfamily a member 1
drg1 gene
corneal stroma
drg1 wt allele
developmentally - regulated gtp - binding protein 1
gcsam gene
gcsam wt allele
germinal center - associated signaling and motility protein
gdf2 gene
gdf2 wt allele
growth / differentiation factor 2
uterine corpus high grade endometrial stromal sarcoma
gjb2 gene
adozelesin
cranial nerve
gjb2 wt allele
gap junction beta - 2 protein
gpx3 gene
gpx3 wt allele
glutathione peroxidase 3
uterine corpus tumor resembling ovarian sex cord tumor
hgfac gene
hgfac wt allele
hepatocyte growth factor activator
hhip gene
hhip wt allele
hedgehog - interacting protein
baricitinib
ighv3 - 21 gene
ighv3 - 21 wt allele
immunoglobulin heavy variable 3 - 21
itpkc gene
itpkc wt allele
inositol - trisphosphate 3 - kinase c
kiaa1324 gene
diaphragm
kiaa1324 wt allele
upf0577 protein kiaa1324
mbp gene
mbp wt allele
cancer patient tobacco use questionnaire
myelin basic protein
smoked a cigarette today
last smoked a cigarette between one and seven days ago
last smoked a cigarette less than one month ago
last smoked a cigarette less than one year ago
ectoderm
last smoked a cigarette more than one year ago
don't know or remember when last smoked a cigarette
smoked a cigarette every day
smoked a cigarette some days
did not smoke at all
don't know or not sure when smoked a cigarette
have not smoked since diagnosis
have not been diagnosed
have not had cancer surgery
have not received treatment
endocrine gland
have not completed treatment
first visit to this clinic
stayed off cigarettes entire time since diagnosis
stayed off cigarettes less than one day since diagnosis
stayed off cigarettes less than one month since diagnosis
stayed off cigarettes less than one year since diagnosis
stayed off cigarettes more than one year since diagnosis
don't know or remember if stayed off cigarettes since diagnosis
atypical endometriosis
t ( 10 ; 17 )  ( q22 ; p13 )
endocrine system
ywhae - fam22 fusion protein expression
filtered cigar
snus
paan with tobacco
gutka
zarda
khaini
ywhae / fam22 fusion gene
uterine corpus rhabdomyosarcoma
smoked at least 100 cigarettes in entire life
endoderm
age when first smoked a cigarette
how old when first began smoking cigarettes regularly
never smoked cigarettes regularly
total years have smoked cigarettes
average number cigarettes smoked a day
how long since last cigarette
number of days since last cigarette
number of weeks since last cigarette
number of months since last cigarette
number of years since last cigarette
corneal endothelium
smoked cigarettes during year before first diagnosed with cancer
benign uterine corpus pecoma
uterine corpus malignant pecoma
smoked cigarettes after diagnosis and before treatment start
smoked cigarettes from two days before last cancer surgery to two days after
smoked cigarettes during the course of treatment
smoked cigarettes after treatment end
uterine corpus germ cell tumor
smoked cigarettes since last visit to this clinic
products used regularly since cancer diagnosis
epidermis
other products used regularly since cancer diagnosis
longest time stayed off cigarettes since cancer diagnosis
number of days stayed off cigarettes
number of weeks stayed off cigarettes
number of months stayed off cigarettes
number of years stayed off cigarettes
smoked any cigarettes past 30 days
number of days smoked cigarettes past 30 days
products used to quit or stay off smoking cigarettes since diagnosis
other products used to quit or stay off smoking cigarettes since diagnosis
epiglottis
assistance used to quit or stay off smoking cigarettes since diagnosis
other assistance used to quit or stay off smoking cigarettes since diagnosis
cancer doctor advised to quit smoking cigarettes
trying to quit or stay off smoking cigarettes past 30 days
products used to quit or stay off smoking cigarettes past 30 days
other products used to quit or stay off smoking cigarettes past 30 days
assistance used to quit or stay off smoking cigarettes past 30 days
other assistance used to quit or stay off smoking cigarettes past 30 days
smoking products ever used regularly
other smoking products ever used regularly
7 - hydroxystaurosporine
epithelium
smoking products used past 30 days
other smoking products used past 30 days
currently living with smoker
lived in place where other people smoked cigarettes indoors past 30 days
worked in place where other people smoked cigarettes indoors past 30 days
ever lived in place where other people smoked cigarettes indoors
total years lived in place where other people smoked cigarettes indoors
ever worked in place where other people smoked cigarettes indoors
total years worked in place where other people smoked cigarettes indoors
invalid reason
ethmoid bone
drug enforcement administration
drug refills
rxnorm
observational medical outcomes partnership
valemetostat
autologous neuroblastoma lysate / klh - pulsed dendritic cell vaccine
dubermatinib
mucoadhesive hydrogel gargle
cyanocobalamin / dexamethasone / gentamicin / procaine formulation
umbilical cord blood - derived hematopoietic cd34 - positive progenitor cells
exocrine gland
vibecotamab
bifunctional expression vector plasmid dna - bi - shrna ews / fli1 type 1 lipoplex
absorbable modified polymer hemostatic powder
emapalumab
onvatilimab
ny - eso - 1 / prame / mage - a3 / wt - 1 peptide vaccine
ostomy skin barrier
4 -  ( methylnitrosamino )  - 1 -  ( 3 - pyridyl )  - 1 - butanol
4 -  ( methylnitrosamino )  - 1 -  ( 3 - pyridyl )  - 1 - butanol glucuronide
met exon 14 mutation
eyelid
mir574 gene
mir574 wt allele
mir574 pre - mirna
microrna 574 - 3p
microrna 335 - 5p
microrna 205 - 5p
ramp1 gene
ramp1 wt allele
receptor activity - modifying protein 1
me1 gene
facial nerve
me1 wt allele
nadp - dependent malic enzyme
dna repair capacity
medical research council breathlessness score
troubled by breathlessness other than on strenuous exertion
short of breath when hurrying on level ground or walking up a slight hill
have to walk slower than most people on level ground
have to stop after walking a mile ,  or after one quarter hour ,  on level ground at own pace
have to stop for breath after walking about 100 yards on level ground
too breathless to leave the house or breathless after undressing
femoral artery
ramp2 gene
ramp2 wt allele
receptor activity - modifying protein 2
recurrent malignant solid neoplasm
ad - isf35
metastatic malignant solid neoplasm
unresectable solid neoplasm
corticotropin - releasing hormone deficiency
primary adrenal glucocorticoid excess
exogenous cushing syndrome
femoral vein
familial hyperaldosteronism
familial hyperaldosteronism type 1
familial hyperaldosteronism type 2
familial hyperaldosteronism type 3
multinodular adrenal hyperplasia
micronodular adrenal hyperplasia
macronodular adrenal hyperplasia
ovotesticular differences of sex development
sex chromosome differences of sex development
46 , xx differences of sex development
femur
46 , xx testicular differences of sex development
46 , xy differences of sex development
46 , xx ovotesticular difference of sex development
46 , xy ovotesticular differences of sex development
46 , xx / 46 , xy ovotesticular differences of sex development
continent urinary diversion
continent catheterizable diversion
continent orthotopic diversion
modified barium swallow impairment profile
oral impairment during swallowing
fibula
pharyngeal impairment during swallowing
esophageal impairment during swallowing
impairment of lip closure
no labial escape
interlabial escape ;  no progression to anterior lip
escape from interlabial space or lateral juncture ;  no extension
escape beyond vermilion border
escape progressing to mid - chin
escape beyond mid - chin
impairment of tongue control during bolus hold
ganglion
cohesive bolus between tongue to palatal seal
escape to lateral buccal cavity / floor of mouth
posterior escape of less than half of bolus
posterior escape of greater than half of bolus
somatotroph / lactotroph adenoma
mouse urological syndrome
growth hormone and prolactin - producing neoplastic cells present
impairment of bolus preparation or mastication
timely and efficient chewing and mashing
slow prolonged chewing or mashing with complete re - collection
recombinant vascular endothelial growth factor
autonomic ganglion
disorganized chewing or mashing with solid pieces of bolus unchewed
minimal chewing or mashing with majority of bolus unchewed
impairment of bolus transport or lingual motion
brisk tongue motion
delayed initiation of tongue motion
slowed tongue motion
repetitive or disorganized tongue motion
minimal to no tongue motion
oral residue following swallowing
complete oral clearance
geniculate ganglion
trace residue lining oral structures
residue collection on oral structures
majority of bolus remaining
minimal to no bolus clearance
location of oral residue following swallowing
residue on floor of mouth
residue on palate
residue on tongue
residue on lateral sulci
initiation of pharyngeal swallow
male reproductive system
initiation of pharyngeal swallow with bolus head at posterior angle of ramus
initiation of pharyngeal swallow with bolus head in valleculae
initiation of pharyngeal swallow with bolus head a posterior laryngeal surface of epiglottis
initiation of pharyngeal swallow with bolus head in pyriforms
no visible initiation of pharyngeal swallow at any location
impairment of soft palate elevation
no bolus between soft palate / pharyngeal wall during swallowing
trace column of contrast or air between soft palate and pharyngeal wall during swallowing
escape to nasopharynx during swallowing
escape to nasal cavity during swallowing
glossopharyngeal nerve
escape to nostril with or without emission during swallowing
impairment of laryngeal elevation
complete superior movement of thyroid cartilage during swallowing
partial superior movement of thyroid cartilage during swallowing
partial superior movement of thyroid cartilage with minimal approximation of arytenoids to epiglottic petiole during swallowing
no superior movement of thyroid cartilage during swallowing
impairment of anterior hyoid excursion
complete anterior movement of hyoid during swallowing
partial anterior movement of hyoid during swallowing
no anterior movement of hyoid during swallowing
glottis
impairment of epiglottic movement
complete inversion of epiglottis during swallowing
partial inversion of epiglottis during swallowing
no inversion of epiglottis during swallowing
stayed off cigarettes between one and seven days
used individual or group counseling to quit cigarette smoking
used telephone help line or quit cigarette smoking line
used quit cigarette smoking books and / or pamphlets
used quit cigarette smoking videos
used quit tobacco clinic ,  class ,  or support group
gonad
used quit cigarette smoking internet or web - based program
used text message - based smoking cessation program
used support of friends and family to quit cigarette smoking
impairment of laryngeal vestibular closure ,  height of swallow
complete laryngeal vestibular closure
incomplete laryngeal vestibular closure
no laryngeal vestibular closure
cdisc sdtm contact role for clinical study terminology
cdisc sdtm observational study biospecimen retention terminology
cdisc sdtm observational study model terminology
inguinal region
cdisc sdtm observational study sampling method terminology
cdisc sdtm observational study time perspective terminology
cdisc sdtm environmental setting terminology
cdisc sdtm case finding terminology
cdisc sdtm culture medium type terminology
cdisc sdtm mode of disease transmission terminology
cdisc sdtm tuberculosis findings about test code terminology
cdisc sdtm tuberculosis findings about test name terminology
cdisc sdtm disease presentation type terminology
cdisc sdtm musculoskeletal system finding test code terminology
heart
cdisc sdtm musculoskeletal system finding test name terminology
apophysomyces
arthrinium
arthroderma
asterotremella
aureobasidium
byssochlamys
case search
coprinellus
cystobasidium
cardiac atrium
dickeya
epidermophyton
eurotium
exophiala
hannaella
hanseniaspora
herbaspirillum
hortaea
kerstersia
kodamaea
cardiac valve
lomentospora
madurella
malassezia
metschnikowia
microsporum
monascus
purpureocillium
scedosporium
scolecobasidium
setosphaeria
vindoline
cardiac ventricle
sporidiobolus
sporothrix
tausonia
trematosphaeria
trichomonascus
trichophyton
mitral valve annulus
pneumocystis carinii
quantitative ultrasound spectroscopy
humerus
impairment of pharyngeal stripping wave
pharyngeal stripping wave present and complete
pharyngeal stripping wave present but diminished
pharyngeal stripping wave absent
impairment of pharyngeal contraction
complete pharyngeal contraction
incomplete pharyngeal contraction
unilateral bulging on pharyngeal contraction
bilateral bulging on pharyngeal contraction
impairment of pharyngoesophageal segment opening
hypoglossal nerve
complete distension and complete duration of pharyngoesophageal segment opening during swallowing
partial distension or partial duration of pharyngoesophageal segment opening during swallowing
minimal distension or minimal duration of pharyngoesophageal segment opening during swallowing
no distension of pharyngoesophageal segment opening during swallowing
impairment of tongue base retraction
no contrast between tongue base and posterior pharyngeal wall during swallowing
trace column of contrast or air between tongue base and posterior pharyngeal wall during swallowing
narrow column of contrast or air between tongue base and posterior pharyngeal wall during swallowing
wide column of contrast or air between tongue base and posterior pharyngeal wall during swallowing
no visible posterior motion of tongue base during swallowing
iliac artery
pharyngeal residue following swallowing
complete pharyngeal clearance following swallowing
trace residue within or on pharyngeal structures following swallowing
collection of residue within or on pharyngeal structures following swallowing
majority of contrast within or on pharyngeal structures following swallowing
minimal to no pharyngeal clearance following swallowing
location of pharyngeal residue following swallowing
residue on tongue base following swallowing
residue on valleculae following swallowing
residue on pharyngeal wall following swallowing
iliac vein
residue on aryepiglottic folds following swallowing
residue on pyriform sinuses following swallowing
diffuse residue following swallowing
impairment of esophageal clearance following swallowing in upright position
complete esophageal clearance following swallowing
esophageal retention following swallowing
esophageal retention with retrograde flow below pharyngoesophageal segment following swallowing
esophageal retention with retrograde flow through pharyngoesophageal segment following swallowing
minimal to no esophageal clearance following swallowing
cdisc questionnaire epic - 26 test name terminology
immune system
cdisc questionnaire epic - 26 test code terminology
cdisc questionnaire epic - cp test name terminology
cdisc questionnaire epic - cp test code terminology
cdisc questionnaire fact - g version 4 test name terminology
cdisc questionnaire fact - g version 4 test code terminology
cdisc questionnaire nccn - fact - fpsi 17 version 2 test name terminology
cdisc questionnaire nccn - fact - fpsi 17 version 2 test code terminology
cdisc questionnaire fact - p version 4 test name terminology
cdisc questionnaire fact - p version 4 test code terminology
cdisc questionnaire prosqoli test name terminology
intestine
cdisc questionnaire prosqoli test code terminology
epic - 26 questionnaire question
epic - cp questionnaire question
fact - g version 4 questionnaire question
nccn - fact - fpsi 17 version 2 questionnaire question
fact - p version 4 questionnaire question
prosqoli questionnaire question
the expanded prostate cancer index composite short form questionnaire
expanded prostate cancer index composite for clinical practice questionnaire
functional assessment of cancer therapy - general version 4 questionnaire
iris
national comprehensive cancer network / functional assessment of cancer therapy - prostate symptom index 17 version 2 questionnaire
functional assessment of cancer therapy - prostate version 4 questionnaire
prostate cancer specific quality of life instrument questionnaire
epic - 26  -  how often have you leaked urine
epic - 26  -  best describes urinary control
epic - 26  -  pads or adult diapers per day
epic - 26  -  dripping or leaking urine
epic - 26  -  pain or burning on urination
epic - 26  -  bleeding with urination
epic - 26  -  weak urine stream or incomplete emptying
jugular vein
epic - 26  -  urinate frequently during the day
epic - 26  -  overall problem urinary function
epic - 26  -  urgency to have a bowel movement
epic - 26  -  increased frequency of bowel movements
epic - 26  -  losing control of stools
epic - 26  -  bloody stools
epic - 26  -  abdominal or pelvic or rectal pain
epic - 26  -  overall problem bowel habits
epic - 26  -  ability to have an erection
epic - 26  -  ability to reach orgasm
renal cortex
epic - 26  -  quality of erections
epic - 26  -  frequency of erections
epic - 26  -  ability to function sexually
epic - 26  -  overall problem sexual function
epic - 26  -  hot flashes
epic - 26  -  breast tender or enlargement
epic - 26  -  feeling depressed
epic - 26  -  lack of energy
epic - 26  -  change in body weight
epic - cp  -  overall problem urinary function
vinepidine
renal medulla
epic - cp  -  best describes urinary control
epic - cp  -  adult diapers used per day
epic - cp  -  problem urinary dripping / leakage
epic - cp  -  pain or burning with urination
epic - cp  -  weak urine stream or incomplete bladder emptying
epic - cp  -  need to urinate frequently
epic - cp  -  rectal pain or urgency of bowel movements
epic - cp  -  increased frequency of bowel movements
epic - cp  -  overall problems with bowel habits
epic - cp  -  rate ability to reach orgasm
epic - cp  -  quality of erections
epic - cp  -  problem lack of sexual function
epic - cp  -  hot flashes or breast tenderness
epic - cp  -  feeling depressed
epic - cp  -  lack of energy
epic - cp  -  urinary incontinence symptom score
epic - cp  -  urinary irritation / obstruction symptom score
epic - cp  -  bowel symptom score
epic - cp  -  sexual symptom score
epic - cp  -  vitality / hormonal symptom score
lower extremity
epic - cp  -  overall score
fact - g version 4  -  i have a lack of energy
fact - g version 4  -  i have nausea
fact - g version 4  -  trouble meeting needs of family
fact - g version 4  -  i have pain
fact - g version 4  -  bothered by treatment side effect
fact - g version 4  -  i feel ill
fact - g version 4  -  i am forced to spend time in bed
fact - g version 4  -  i feel close to my friends
fact - g version 4  -  i get emotional support from my family
lens
fact - g version 4  -  i get support from my friends
fact - g version 4  -  my family has accepted my illness
fact - g version 4  -  satisfied with family communication
fact - g version 4  -  i feel close to my partner
fact - g version 4  -  i am satisfied with my sex life
fact - g version 4  -  i feel sad
fact - g version 4  -  satisfied with how i am coping with illness
fact - g version 4  -  losing hope against illness
fact - g version 4  -  i feel nervous
fact - g version 4  -  i worry about dying
lumbar vertebra
fact - g version 4  -  worry my condition will get worse
fact - g version 4  -  i am able to work
fact - g version 4  -  my work is fulfilling
fact - g version 4  -  i am able to enjoy life
fact - g version 4  -  i have accepted my illness
fact - g version 4  -  i am sleeping well
fact - g version 4  -  enjoy things i usually do for fun
fact - g version 4  -  content with quality of my life
nccn - fact - fpsi 17 version 2  -  i have a lack of energy
nccn - fact - fpsi 17 version 2  -  i have pain
lymph node
nccn - fact - fpsi 17 version 2  -  i have difficulty urinating
nccn - fact - fpsi 17 version 2  -  i am losing weight
nccn - fact - fpsi 17 version 2  -  i have bone pain
nccn - fact - fpsi 17 version 2  -  i feel fatigued
nccn - fact - fpsi 17 version 2  -  i have weakness in my legs
nccn - fact - fpsi 17 version 2  -  pain keeps me from doing things
nccn - fact - fpsi 17 version 2  -  i have a good appetite
nccn - fact - fpsi 17 version 2  -  i am sleeping well
nccn - fact - fpsi 17 version 2  -  worry my condition will get worse
nccn - fact - fpsi 17 version 2  -  i have nausea
lymphatic system
nccn - fact - fpsi 17 version 2  -  i have trouble moving my bowels
nccn - fact - fpsi 17 version 2  -  i am satisfied with my sex life
nccn - fact - fpsi 17 version 2  -  bothered by treatment side effect
nccn - fact - fpsi 17 version 2  -  i am able to enjoy life
nccn - fact - fpsi 17 version 2  -  content with quality of my life
fact - p version 4  -  i have a lack of energy
fact - p version 4  -  i have nausea
fact - p version 4  -  trouble meeting needs of family
fact - p version 4  -  i have pain
fact - p version 4  -  bothered by treatment side effect
mast cell
fact - p version 4  -  i feel ill
fact - p version 4  -  i am forced to spend time in bed
fact - p version 4  -  i feel close to my friends
fact - p version 4  -  get emotional support from family
fact - p version 4  -  i get support from my friends
fact - p version 4  -  my family has accepted my illness
fact - p version 4  -  satisfied with family communication
fact - p version 4  -  i feel close to my partner
fact - p version 4  -  i am satisfied with my sex life
fact - p version 4  -  i feel sad
mediastinum
fact - p version 4  -  satisfied with how i am coping
fact - p version 4  -  losing hope against illness
fact - p version 4  -  i feel nervous
fact - p version 4  -  i worry about dying
fact - p version 4  -  worry my condition will get worse
fact - p version 4  -  i am able to work
fact - p version 4  -  my work is fulfilling
fact - p version 4  -  i am able to enjoy life
fact - p version 4  -  i have accepted my illness
fact - p version 4  -  i am sleeping well
membrane
fact - p version 4  -  enjoy things i usually do for fun
fact - p version 4  -  content with quality of my life
fact - p version 4  -  i am losing weight
fact - p version 4  -  i have a good appetite
fact - p version 4  -  have aches and pains that bother me
fact - p version 4  -  certain parts of body experience pain
fact - p version 4  -  pain keeps me from doing things
fact - p version 4  -  satisfied with comfort level
fact - p version 4  -  i am able to feel like a man
fact - p version 4  -  i have trouble moving my bowels
vinorelbine
mesoderm
fact - p version 4  -  i have difficulty urinating
fact - p version 4  -  i urinate more frequently
fact - p version 4  -  problem urinating limits activity
fact - p version 4  -  able to have and maintain an erection
prosqoli  -  pain
prosqoli  -  physical activity
prosqoli  -  fatigue
prosqoli  -  appetite
prosqoli  -  constipation
prosqoli  -  urinary problems
metacarpal bone
prosqoli  -  enjoying time with friends and family
prosqoli  -  mood
prosqoli  -  overall well - being
prosqoli  -  present pain intensity
nuclear radiology imaging procedure
active case search
passive case search
blood agar growth medium
middlebrook 7h10s growth medium
middlebrook 7h11s growth medium
metatarsal bone
middlebrook 7h12 growth medium
middlebrook 7h9 growth medium
competent authority applicant
central contact for recruitment
central contact for recruitment backup
clinical investigator network contact
public queries study contact
scientific queries study contact
facility contact
facility contact backup
mitral valve
study further information contact
independent ethics committee applicant
legal representative for the study
primary study contact
subcontractor contact
annular a' velocity
annular e' velocity
area at end ventricular diastole
area at end ventricular systole
aortic regurgitant jet width to left ventricular outflow tract diameter ratio
musculoskeletal system
aortic valve regurgitant fraction
aortic valve regurgitant jet width
aortic valve regurgitant volume
aortic valve vena contracta area
aortic valve vena contracta width
cross - sectional diameter at end ventricular diastole
cross - sectional diameter at end ventricular systole
cross - sectional diameter at mid ventricular systole
cusp doming indicator
cusp doming severity
nervous system
cusp flail indicator
cusp flail severity
cusp flail timing
cusp prolapse indicator
cusp prolapse severity
cusp prolapse timing
cusp restricted motion indicator
cusp restricted motion severity
cusp tethering indicator
cusp tethering severity
nose
cusp thickening indicator
cusp thickening severity
chordae tendineae prolapse indicator
cardiac valve regurgitant jet direction
cardiac wall motion type
effective regurgitant orifice area
largest cross - sectional diameter at end ventricular diastole
largest cross - sectional thickness
left ventricular outflow tract peak velocity
left ventricular outflow tract velocity time integral
occipital bone
mean blood flow velocity
mitral e / a ratio
mitral e / e' ratio
major axis cross - sectional diameter at end ventricular diastole
major axis cross - sectional diameter at end ventricular systole
minor axis cross - sectional diameter at end ventricular diastole
minor axis cross - sectional diameter at end ventricular systole
mitral regurgitant jet area to left atrial area ratio
mitral valve regurgitant fraction
mitral valve regurgitant jet area
oculomotor nerve
mitral valve regurgitant volume
mitral valve vena contracta area
mitral valve vena contracta width
peak blood flow velocity
peak a velocity
peak e velocity
pulmonic regurgitant jet width to right ventricular outflow tract diameter ratio
pulmonary vein dominance
pulmonary valve regurgitant fraction
pulmonic valve regurgitant jet width
olfactory nerve
pulmonary valve regurgitant volume
pulmonary valve vena contracta area
pulmonary valve vena contracta width
systolic anterior motion indicator
systolic anterior motion severity
cross - sectional thickness at end ventricular diastole
cross - sectional thickness at end ventricular systole
tricuspid regurgitant jet area to right atrial area ratio
tricuspid valve regurgitant fraction
tricuspid valve regurgitant jet area
vinzolidine
optic disc
tricuspid valve regurgitant volume
tricuspid valve vena contracta area
tricuspid valve vena contracta width
blood flow velocity time integral
volume at end ventricular diastole
volume at end ventricular systole
complex cystic lesion
beta - 1b glycoprotein measurement
beta - 2 microglobulin to creatinine ratio measurement
blister cell count
optic nerve
complement c4d measurement
circulating immune complex measurement
copeptin measurement
type i collagen c - telopeptide to creatinine ratio measurement
glomeluar filtration rate from cystatin c and creatinine adjusted for bsa
band form granulocyte to total cell ratio measurement
segmented granulocyte to total cell ratio measurement
free hemoglobin measurement
human papillomavirus 11 antibody measurement
human papillomavirus 16 antibody measurement
oropharynx
human papillomavirus 18 antibody measurement
human papillomavirus 6 antibody measurement
islet amyloid polypeptide measurement
interleukin 12 beta measurement
klotho protein measurement
immature leukocyte count
immature leukocyte to leukocytes ratio measurement
vacuolated lymphocyte to leukocyte ratio measurement
maturing erythroid cell to total cell ratio measurement
maturing myeloid cell to total cell ratio measurement
paranasal sinus
murinoglobulin measurement
para - aminohippurate sodium measurement
proliferating erythroid cell to total cell ratio measurement
plasminogen measurement
proliferating myeloid cell to total cell ratio measurement
s100 calcium - binding protein b measurement
troponin i type 2 measurement
wd repeat - containing protein 26 measurement
left coronary cusp of the aortic valve
non - coronary cusp of the aortic valve
parasympathetic nervous system
right coronary cusp of the aortic valve
aortic root
sinotubular junction
left atrial appendage
left ventricular outflow tract
left ventricular wall
right atrial appendage
right ventricular free wall
right ventricular outflow tract
right ventricular wall
parathyroid gland
left ventricular apex segment
left ventricular apical anterior segment
left ventricular apical inferior segment
left ventricular apical lateral segment
left ventricular apical septal segment
left ventricular basal anterior segment
left ventricular basal anterolateral segment
left ventricular basal anteroseptal segment
left ventricular basal inferior segment
left ventricular basal inferolateral segment
parietal bone
left ventricular basal inferoseptal segment
left ventricular mid anterior segment
left ventricular mid anterolateral segment
left ventricular mid anteroseptal segment
left ventricular mid inferior segment
left ventricular mid inferolateral segment
left ventricular mid inferoseptal segment
metacarpal 1 base
anterior annulus of the mitral valve
anterior cusp of the mitral valve
pelvis
posterior annulus of the mitral valve
posterior cusp of the mitral valve
pericardial wall
anterior cusp of the pulmonary valve
left cusp of the pulmonary valve
right cusp of the pulmonary valve
scaphoid - capitate joint
scaphoid - lunate - capitate joint
scaphoid - trapezium joint
cineangiography
peripheral nerve
acidaminococcus intestini
apophysomyces elegans
arthrinium phaeospermum
arthroderma fulvum
arthroderma obtusum
arthroderma otae
arthroderma persicolor
arthroderma simii
aspergillus versicolor
asterotremella humicola
peritoneal cavity
aureobasidium pullulans
bocaparvovirus
bordetella hinzii
bordetella petrii
byssochlamys spectabilis
candida boidinii
candida famata
candida inconspicua
candida sake
coprinellus radians
wortmannin
peritoneum
corynebacterium aurimucosum
cryptococcus albidus var . albidus
cryptococcus diffluens
cryptococcus terreus
cystobasidium minutum
dickeya dadantii
enteric bacteria
epidermophyton floccosum
eurotium herbariorum
exophiala dermatitidis
peyer patch
exophiala jeanselmei
fusarium chlamydosporum
fusarium incarnatum
geotrichum klebahnii
guehomyces pullulans
haemophilus paraphrohaemolyticus
hannaella luteola
hanseniaspora guilliermondii
hanseniaspora uvarum
hanseniaspora valbyensis
anterior lobe of the pituitary gland
herbaspirillum huttiense
hortaea werneckii
kerstersia gyiorum
kloeckera japonica
kluyveromyces lactis
kodamaea ohmeri
lysinibacillus
madurella mycetomatis
malassezia furfur
posterior lobe of the pituitary gland
malassezia pachydermatis
metschnikowia pulcherrima
microsporum audouinii
microsporum distortum
microsporum equinum
microsporum ferrugineum
microsporum gypseum
monascus ruber
mucor ramosissimus
phialophora verrucosa
pulmonary artery
pichia fermentans
piedraia hortae
purpureocillium lilacinum
rhizopus oryzae
scedosporium boydii
scolecobasidium terreum
scopulariopsis brevicaulis
setosphaeria rostrata
sporidiobolus salmonicolor
sporothrix schenckii
pulmonary valve
trematosphaeria grisea
trichomonascus ciferrii
trichophyton equinum
trichophyton mentagrophytes
trichophyton rubrum
trichophyton schoenleinii
trichophyton soudanense
trichophyton tonsurans
trichophyton verrucosum
trichophyton violaceum
pulmonary vein
trichophyton yaoundei
trichosporon beigelii
staining intensity
cytokeratin 16 measurement
dendritic cell lysosomal - associated membrane protein measurement
fibrosis assessment
lymphatic invasion assessment
normal cell to total cell ratio measurement
perineural invasion assessment
s100 calcium binding protein a7 measurement
radius bone
stromal cell to total cell ratio measurement
tumor cell to total cell ratio measurement
vascular invasion assessment
horizontal transmission
swollen indicator
tenderness indicator
biospecimens not retained
retained specimens contain dna
retained specimens do not contain dna
observational case - crossover study
renal artery
ecologic or community based study
non - probability sampling method
household relative
non - household relative
schoolmate
childcare center
occurrence indicator
total number
clinical study citation
sponsor commercial status
respiratory system
data monitoring committee indicator
e - mail address for xml file feedback
clinicaltrials .gov nct number for the expanded access record
trial expanded access status
multiple site european union state trial indicator
number of trial sites within european union state
planned trial duration
pubmed identifier for citation used in study
study saved as xml indicator
requires secure email delivery of xml indicator
venlafaxine
reticuloendothelial system
single site european union state trial indicator
study protocol uniform resource locator
study protocol uniform resource locator description
dose response study
one per second times kilopascal
metabolic equivalent of task unit
metabolic equivalent of task hours
metabolic equivalent of task minute
milliliter per heartbeat
millinewton
pheresis unit
experimental organism benign endometrial adenoma
flap surgical reconstruction
toxic vacuolation assessment
flap
iodine i 125 risad - p
who grade iii glioma
tapotoclax
cryoballoon ablation therapy
subcutaneous emphysema
rib
orbital emphysema
arterial insufficiency
venous insufficiency
pharyngocutaneous fistula
orocutaneous fistula
tracheoarterial fistula
decannulation
loss of stoma
sialocele
pneumocephalus
scapula
chylothorax
subdural
unexpected
unrecognized
marginal mandibular branch of the facial nerve
lingual nerve
ceftazidime / avibactam sodium
three - dimensional echo - planar spectroscopic imaging
relacorilant
highly purified staphylococcal protein a prtx - 100
sclera
recurrent waldenstrom macroglobulinemia
abnormal pap smear
nr1i2 gene
nr1i2 wt allele
nuclear receptor subfamily 1 group i member 2
ophn1 gene
ophn1 wt allele
oligophrenin - 1
pak3 gene
scrotum
pak3 wt allele
serine / threonine - protein kinase pak 3
pcsk1 gene
pcsk1 wt allele
neuroendocrine convertase 1
prmt5 gene
prmt5 wt allele
protein arginine n - methyltransferase 5
slc31a1 gene
slc31a1 wt allele
lunate bone
high affinity copper uptake protein 1
combs prognostic index
smn1 gene
excellent survival after reirradiation
smn1 wt allele
good survival after reirradiation
moderate survival after reirradiation
smn2 gene
poor survival after reirradiation
smn2 wt allele
seminal vesicle
very poor survival after reirradiation
survival motor neuron protein
european treatment outcome study score
hasford score
mslnl gene
sokal score
mslnl wt allele
international scale for bcr - abl1 measurement
mesothelin - like protein
consensus pcr
skeletal system
nested pcr
allele - specific oligonucleotide
snap25 gene
snap25 wt allele
synaptosomal - associated protein 25
sphkap gene
sphkap wt allele
a - kinase anchor protein sphkap
sptlc1 gene
sptlc1 wt allele
skull
serine palmitoyltransferase 1
sumf1 gene
sumf1 wt allele
sulfatase - modifying factor 1
th gene
th wt allele
tyrosine 3 - monooxygenase
tia1 gene
tia1 wt allele
nucleolysin tia - 1 isoform p40
pingyangmycin
sphenoid bone
topoisomerase - 1 inhibitor lmp744
tnfrsf13b gene
tnfrsf13b wt allele
tumor necrosis factor receptor superfamily member 13b
cervical transitional metaplasia
cervical mucinous adenocarcinoma ,  gastric type
anti - met monoclonal antibody mixture sym015
endocervical adenocarcinoma ,  usual type
alanylglutamine
trap1 gene
spinal nerve root
pumvc3 - igfbp2 - her2 - igf1r plasmid dna vaccine
trap1 wt allele
heat shock protein 75 kda ,  mitochondrial
twist2 gene
twist2 wt allele
cervical adenocarcinoma admixed with neuroendocrine carcinoma
twist - related protein 2
ugcg gene
ugcg wt allele
ceramide glucosyltransferase
spinal nerve
tunnel clusters
wnt5b gene
wnt5b wt allele
protein wnt - 5b
il32 gene
il32 wt allele
interleukin - 32
ugt1a locus
prame gene
prame wt allele
sternum
melanoma antigen preferentially expressed in tumors
cervical microglandular hyperplasia
lobular endocervical glandular hyperplasia
diffuse laminar endocervical hyperplasia
microparticle mdp / bacterial dna - containing mis416
cervical mesonephric remnants and hyperplasia
cervical endocervicosis
tuboendometrioid metaplasia
ectopic prostate tissue in the cervix
nk cell - enriched donor lymphocytes
subclavian vein
gaia premature preterm rupture of membranes levels of diagnostic certainty
gaia preterm labor levels of diagnostic certainty
gaia insufficient cervix levels of diagnostic certainty
gaia provider initiated preterm delivery levels of diagnostic certainty
gaia level 1 assessment of premature preterm rupture of membranes
gaia level 2 assessment of premature preterm rupture of membranes
gaia level 3 assessment of premature preterm rupture of membranes
gaia level 1 assessment of preterm labor
gaia level 2 assessment of preterm labor
gaia level 3 assessment of preterm labor
sympathetic nervous system
gaia level 1 assessment of provider initiated preterm delivery
gaia level 2 assessment of provider initiated preterm delivery
gaia level 3 assessment of provider initiated preterm delivery
gaia level 1 assessment of insufficient cervix
gaia level 2 assessment of insufficient cervix
gaia level 3 assessment of insufficient cervix
major congenital anomaly
gaia level 1 major external structural defect
gaia level 2 major external structural defect
gaia level 3 major external structural defect
tarsal bone
gaia level 4 major external structural defect
gaia level 1 major internal structural defect
gaia level 2 major internal structural defect
gaia level 3 major internal structural defect
gaia level 4 major internal structural defect
gaia level 1 major functional defect
gaia level 2 major functional defect
gaia level 3 major functional defect
gaia level 4 major functional defect
gaia level 1 neonatal death in a non - viable live birth
temporal bone
gaia level 2 neonatal death in a non - viable live birth
gaia level 3 neonatal death in a non - viable live birth
gaia level 1 neonatal death in an extremely preterm live birth
gaia level 2 neonatal death in an extremely preterm live birth
gaia level 3 neonatal death in an extremely preterm live birth
gaia level 1 neonatal death in a preterm live birth
gaia level 2 neonatal death in a preterm live birth
gaia level 3 neonatal death in a preterm live birth
gaia level 1 neonatal death in a term live birth
gaia level 2 neonatal death in a term live birth
thoracic vertebra
gaia level 3 neonatal death in a term live birth
gaia level 1 maternal immunization
gaia level 2 maternal immunization
gaia level 3 maternal immunization
gaia level 1 neonatal invasive bloodstream infection
gaia level 2 neonatal invasive bloodstream infection
gaia level 3 neonatal invasive bloodstream infection
gaia level 1 neonatal infectious meningitis
gaia level 2 neonatal infectious meningitis
gaia level 3a neonatal infectious meningitis
thorax
gaia level 3b neonatal infectious meningitis
gaia level 1 neonatal respiratory tract infection
gaia level 2 neonatal respiratory tract infection
gaia level 3 neonatal respiratory tract infection
gaia level 1 non - reassuring fetal status
gaia level 2 non - reassuring fetal status
gaia level 3 non - reassuring fetal status
gaia level 1 maternal death
gaia level 2 maternal death
gaia level 3 maternal death
zinc sulfate
tibia
gaia level 1 postpartum hemorrhage
gaia level 2 postpartum hemorrhage
gaia level 3 postpartum hemorrhage
gaia level 1 preeclampsia
gaia level 2 preeclampsia
gaia insufficient evidence for diagnosis of preeclampsia
gaia level 1 preeclampsia with severe features
gaia level 2 preeclampsia with severe features
gaia insufficient evidence for diagnosis of preeclampsia with severe features
gaia level 1 gestational hypertension
tissue
gaia level 2 gestational hypertension
gaia insufficient evidence for diagnosis of gestational hypertension
gaia gestational age levels of diagnostic certainty
gaia level 1 assessment of gestational age
gaia level 2a assessment of gestational age
gaia level 2b assessment of gestational age
gaia level 3a assessment of gestational age
gaia level 3b assessment of gestational age
gaia level 1 antepartum stillbirth
gaia level 2 antepartum stillbirth
tonsil
gaia level 3 antepartum stillbirth
gaia level 4 antepartum stillbirth
gaia level 1 intrapartum stillbirth
gaia level 2 intrapartum stillbirth
gaia level 3 intrapartum stillbirth
gaia level 4 intrapartum stillbirth
anti - ox40 antibody bms 986178
gluten - free dha / epa / gla / antioxidant - rich nutritional liquid
anti - gitr monoclonal antibody gwn 323
prame - targeting t - cell receptor / inducible caspase 9 bpx - 701
trabecular meshwork
metap2 inhibitor sdx - 7320
autologous prostate stem cell antigen - specific car t cells bpx - 601
hyperpolarized helium 3
hyperpolarized xenon 129
gallium ga 68 - nota - bbn ( 7 - 14 )  - rgd
anti - ctla - 4 monoclonal antibody
anti - pd1 monoclonal antibody
defactinib hydrochloride
brostacillin hydrochloride
cervical neuroendocrine neoplasm
moderate to late preterm infant
cervical low grade neuroendocrine tumor ,  grade 1
cervical atypical carcinoid tumor
cervical neuroendocrine carcinoma
cervical leiomyoma
cervical leiomyosarcoma
cervical rhabdomyosarcoma
cervical angiosarcoma
tricuspid valve
cervical malignant peripheral nerve sheath tumor
postoperative spindle cell nodule of the cervix
benign cervical soft tissue neoplasm
malignant cervical soft tissue neoplasm
cervical yolk sac tumor
perfusion - weighted magnetic resonance imaging
anti - pd - l1 monoclonal antibody
anti - gitr monoclonal antibody
dabrafenib mesylate
trigeminal nerve
vaginal papillary carcinoma
vaginal tubulosquamous polyp
vaginal transitional cell metaplasia
vaginal adenosis
vaginal endometriosis
voice handicap index functional subscale
vaginal endocervicosis
voice handicap index physical subscale
voice handicap index emotional subscale
actigraph
trigeminal nucleus
voice difficulties restrict personal and social life
feel left out of conversation because of voice
voice problem causes loss of income
vaginal neuroendocrine carcinoma
feel like have to strain to produce voice
vaginal large cell neuroendocrine carcinoma
clarity of voice is unpredictable
voice problem upsets me
voice makes me feel handicapped
vaginal myofibroblastoma
trochlear nerve
vaginal rhabdomyosarcoma
ovarian cancer by figo stage
figo stage ic1 ovarian cancer
figo stage ic2 ovarian cancer
figo stage ic3 ovarian cancer
figo stage ii ovarian cancer
figo stage iii ovarian cancer
figo stage iiia ovarian cancer
figo stage iiia1 ovarian cancer
figo stage iiia1 ( i )  ovarian cancer
ulna
figo stage iiia1 ( ii )  ovarian cancer
figo stage iiia2 ovarian cancer
figo stage iiib ovarian cancer
figo stage iiic ovarian cancer
figo stage iva ovarian cancer
figo stage ivb ovarian cancer
optimal debulking
suboptimal debulking
maximal debulking
figo stage ic1
biohazardous substance
genitourinary system
figo stage ic2
figo stage ic3
figo stage iiia1
figo stage iiia1 ( i )
figo stage iiia1 ( ii )
figo stage iiia2
ovarian cancer by ajcc v6 and v7 stage
intermediate - affinity interleukin - 2 receptor agonist alks 4230
idiopathic membranous glomerulopathy
uvea
nephrotic syndrome  -  infrequently relapsing
postoperative spindle cell nodule of the vagina
vaginal germ cell tumor
vaginal dermoid cyst
autosomal recessive hypercholesterolemia
marshall syndrome
neuronal ceroid lipofuscinosis type 4b
primary ciliary dyskinesia 1
muscular dystrophy - dystroglycanopathy  ( congenital with brain and eye anomalies )  type a ,  1
vagus nerve
canine leukemia
canine lymphoma
canine prostate carcinoma
mouse testicular teratoma
diffusion spectrum imaging
canine histiocytic sarcoma
canine transitional cell carcinoma
worst severity past seven days dry mouth
worst severity past seven days problems with tasting food or drink
past seven days frequency of heartburn
vas deferens
worst severity past seven days heartburn
past seven days frequency of bloating of the abdomen
iodine i 124 - crgdy - peg - c dots
worst severity past seven days bloating of the abdomen
past seven days frequency of anxiety
worst severity past seven days anxiety
past seven days anxiety interfering with usual or daily activities
past seven days frequency of sad or unhappy feelings
lodapolimab
worst severity past seven days sad or unhappy feelings
vein
past seven days sad or unhappy feelings interfering with usual or daily activities
swallowable sponge cell sampling device
vulvar squamous intraepithelial lesion
idiopathic crescentic glomerulonephritis
membranous nephropathy  -  secondary
pierson syndrome
renal infarct
acquired solitary kidney
spiritual well - being
intellectual well - being
inferior vena cava
quality of life linear analogue scale
quality rating score 0
quality rating score 1
quality rating score 2
quality rating score 3
quality rating score 4
quality rating score 5
quality rating score 6
quality rating score 7
quality rating score 8
superior vena cava
quality rating score 9
quality rating score 10
vulvar adenocarcinoma of mammary gland type
mammary gland type features present
vulvar adenocarcinoma of sweat gland type
malignant vulvar phyllodes tumor
vulvar adenocarcinoma ,  intestinal - type
vulvar keratoacanthoma
contact transmission
direct transmission
vena cava
indirect transmission
colon adenoma with severe dysplasia
pdgfrb gene mutation
pdgfrb protein variant
pdgfrb np_002600 .1:p .t681i
myd88 gene mutation
myd88 nm_002468 .4:c .794t > c
myd88 protein variant
myd88 np_002459 .2:p .l265p
glutaminase family
venule
mycobiome
decipher prostate cancer test
greb1 gene
greb1 wt allele
protein greb1
ptger4 gene
ptger4 wt allele
2 - hydroxyglutaric aciduria
46 , xy sex reversal 1
childhood absence epilepsy
vertebral artery
congenital sucrase - isomaltase deficiency
lymphedema - distichiasis syndrome
mosaic variegated aneuploidy syndrome 1
glutathione synthetase deficiency
prostaglandin e2 receptor ep4 subtype
canine sarcoma
coexpression extrapolation
coxen sensitivity scale
coxen score 1
coxen score 2
carboplatin
vestibular nerve
coxen score 3
coxen score 4
coxen score 5
coxen score 6
coxen score 7
coxen score 8
coxen score 9
coxen score 10
coxen score 11
coxen score 12
vestibular nucleus
coxen score 13
coxen score 14
coxen score 15
coxen score 16
coxen score 17
coxen score 18
coxen score 19
coxen score 20
coxen score 21
coxen score 22
vocal cord
coxen score 23
coxen score 24
coxen score 25
coxen score 26
coxen score 27
coxen score 28
coxen score 29
coxen score 30
coxen score 31
coxen score 32
corneoscleral limbus
coxen score 33
coxen score 34
coxen score 35
coxen score 36
coxen score 37
coxen score 38
coxen score 39
coxen score 40
sensitive anticancer agent
isofuran
tibial artery
vulvar hidradenoma papilliferum
nodular bartholin gland hyperplasia
vulvar ectopic fibroadenoma
vulvar neuroendocrine carcinoma
vulvar small cell carcinoma
vulvar large cell neuroendocrine carcinoma
xpo1 inhibitor sl - 801
vulvar merkel cell carcinoma
peb regimen
autologous cd34 - positive hematopoietic progenitor cells
anterior tibial artery
pan - akt inhibitor arq751
chd4 gene
chd4 wt allele
chromodomain - helicase - dna - binding protein 4
fat4 gene
fat4 wt allele
protocadherin fat 4
lztr1 gene
lztr1 wt allele
leucine - zipper - like transcriptional regulator 1
posterior tibial artery
mt - rnr1 gene
mt - rnr1 wt allele
mitochondrial - derived peptide mots - c
12s mitochondrial ribosomal rna
pulmonary function test reference value
vitamin d3 deficiency
ptef - b / cdk9 inhibitor bay1251152
tmsb15a gene
tmsb15a wt allele
cobalt gray equivalent
third ventricle
vulvar lipoma
vulvar fibrolipoma
vulvar superficial myofibroblastoma
vulvar alveolar rhabdomyosarcoma
circulating cell - free dna
liver x receptor - like family
casp3 gene product
activated caspase - 3
interferon - related dna damage resistance gene signature
human adenovirus type 5 early region 1
fourth ventricle
selective estrogen receptor degrader lsz102
pdcd - 1 knockout autologous t - lymphocytes
eukaryotic translation initiation factor 4f
her - 2 - positive b - cell peptide antigen p467 - dt - crm197 / montanide vaccine imu - 131
low molecular weight cyclin e
platelet - derived growth factor - aa
platelet - derived growth factor - ab
platelet - derived growth factor - bb
threonine tyrosine kinase inhibitor cfi - 402257
vulvar melanocytic nevus
anterior cerebral artery
ar gene product
androgen receptor splice variant 5 , 6 , 7es
androgen receptor splice variant 3
broccoli sprout / broccoli seed extract supplement
vulvar germ cell tumor
vulvar yolk sac tumor
epstein - barr nuclear antigen 1
tp63 gene product
tumor protein 63 isoform 2
ube2e family
middle cerebral artery
chromosome 1 satellite 2
eln allele with mm haplotype for int20 / int23
human herpesvirus - 8 immediate - early region - 4 gene locus
interleukin - 15 receptor
hypoploidy
herv - k
hla class i histocompatibility antigen ,  a - 0201 alpha chain
hla class i histocompatibility antigen ,  a - 11 alpha chain
hla - b gene product
hla class i histocompatibility antigen ,  b - 44 alpha chain
posterior cerebral artery
hla - dp4 antigen
hla - dr13 antigen
hpv major capsid protein l1
isohemagglutinin
pgr gene product
progesterone receptor isoform a
msln gene product
megakaryocyte - potentiating factor
viral protease p15
delta catenin
conus medullaris
infection
childhood infectious disorder
peritonsillar abscess
parapharyngeal abscess
retropharyngeal abscess
prevertebral abscess
intra - abdominal abscess
subdiaphragmatic abscess
mesenteric abscess
perihepatic abscess
anterior spinal artery
retroperitoneal abscess
pelvic abscess
reactive arthritis
migratory arthritis
legionellosis
pontiac fever
melioidosis
yersiniosis
atypical pneumonia
legionella pneumonia
lateral ventricle
bacillary peliosis
foodborne botulism
wound botulism
infant botulism
adult intestinal botulism
iatrogenic botulism
transmissible spongiform encephalopathy
antibiotic - associated colitis
fecal - oral transmission
cercarial dermatitis
nucleus ambiguus
antibiotic - associated diarrhea
foodborne illness
droplet transmission
airborne transmission
arthropod vector
native valve endocarditis
prosthetic valve endocarditis
early prosthetic valve endocarditis
late prosthetic valve endocarditis
bacterial endocarditis
abducens nucleus
lymphatic filariasis
colonization
dimorphic fungus
interferon - gamma release assay
vehicle transmission
vector transmission
endogenous infection
mastoiditis
labyrinthitis
cochlear nucleus
fungal keratitis
late latent syphilis
severe malaria
cerebral malaria
eosinophilic meningitis
infectious meningoencephalitis
mode of transmission
tuberculosis infection
acute transverse myelitis
acute flaccid myelitis
radial artery
bacterial myocarditis
viral myocarditis
pyomyositis
collapsed lung
uvulitis
chronic suppurative otitis media
fasciolosis
fasciolopsiasis
heterophyiasis
ulnar artery
metagonimiasis
diphyllobothriasis
ascariasis
anisakiasis
angiostrongyliasis
gnathostomiasis
enterobiasis
baylisascariasis
strongyloidiasis
trichuriasis
dextran sulfate sodium
pleural cavity
myiasis
pediculosis
herpetic whitlow
suppurative parotitis
bacterial pericarditis
viral pericarditis
fungal pericarditis
bacterial peritonitis
cryptosporidiosis
cyclosporiasis
reproductive system
rocky mountain spotted fever
acute sinusitis
primary syphilis
secondary syphilis
tertiary syphilis
multidrug - resistant tuberculosis
pre - extensively drug - resistant tuberculosis
extensively drug - resistant tuberculosis
lassa fever
rift valley fever
roseola infantum
monkeypox
chikungunya
zika virus infection
middle east respiratory syndrome
anaplasmosis
louse - borne relapsing fever
southern tick - associated rash illness
infectious hidradenitis
hidradenitis suppurativa
coronary artery
early latent syphilis
multidrug - resistant mycobacterium tuberculosis
pre - extensively drug - resistant mycobacterium tuberculosis
extensively drug - resistant mycobacterium tuberculosis
rhinosinusitis
bayer classification for corneal epitheliopathy
tonsillopharyngitis
bayer corneal epitheliopathy grade 0
variant creutzfeldt - jakob disease
hand foot and mouth disease
cervical
bayer corneal epitheliopathy grade 1
carrin disease
bayer corneal epitheliopathy grade 2
bayer corneal epitheliopathy grade 3
bayer corneal epitheliopathy grade 4
bayer classification of visual acuity changes
bayer visual acuity changes grade 0
bayer visual acuity changes grade 1
bayer visual acuity changes grade 2
bayer visual acuity changes grade 3
lumbar plexus
bayer visual acuity changes grade 4
cutaneous neurofibroma
pediatric infectious disease terminology
lisch nodule
quadrivalent inactivated influenza vaccine
voucher
american ethnicity
australian / new zealand ethnicity
intercontinental ethnicity
sacral plexus
recurrent gastrointestinal stromal tumor
inch of mercury
oxt gene product
oxytocin - neurophysin 1
cd16 +  cd56 +  cd69 +  lymphocyte
f2 gene mutation
f2 nm_000506 .4:c .*97g > a
modified vaccinia virus ankara antibody
glycan profile
reactive lymphocyte
sphk2 gene
sphk2 wt allele
sphingosine kinase 2
pgrmc1 gene
pgrmc1 wt allele
membrane - associated progesterone receptor component 1
selplg gene
selplg wt allele
p - selectin glycoprotein ligand 1
pdia6 gene
squamous epithelium
pdia6 wt allele
protein disulfide - isomerase a6
b4galnt1 gene
b4galnt1 wt allele
beta - 1 , 4 n - acetylgalactosaminyltransferase 1
hpv - 16 e7 tcr expressing t - cells
anti - cd123 / cd3 bispecific antibody jnj - 63709178
iodine i 124 pu - ad
perflubutane microbubble
hla - a2 - restricted melanoma - specific peptides vaccine grn - 1201
spl risk evaluation and mitigation strategies terminology
spl rems requirement terminology
spl rems protocol terminology
spl rems stakeholder terminology
risk evaluation and mitigation strategies requirement
designate a healthcare setting representative
be able to perform a clinical activity
have necessary healthcare personnel or equipment
review prescribing information
review healthcare training or educational materials
endothelin - 1
stratum spinosum
complete healthcare knowledge assessment
train staff about medication use process
rems participate in training session
establish processes and procedures to verify rems safe use conditions
enroll in the rems
rems counsel patient
provide patient with materials
assess patient condition or health status
complete patient form
enroll patient in the rems
female breast
do not prescribe refills
do not dispense refills
prescribe limited days supply
dispense limited days supply
use rems prescription ordering form
verify safe use conditions
obtain rems dispensing authorization
return unused product
do not distribute ,  transfer ,  loan ,  or sell product
maintain healthcare records
vertebral body
report adverse events
cooperate with rems audits
complete a patient form with the healthcare provider
get lab test or monitoring
receive counseling
complete patient questionnaire
adhere to rems patient safe use conditions
inform prescriber
rems protocol
rems certification
sacral vertebra
pharmacotherapy initiation
pharmacotherapy continuation
all pharmacotherapy prescriptions
medication dispensing
medication administration
pharmacotherapy discontinuation
medication distribution
rems stakeholder
medication prescriber
medication dispenser
scaphoid bone
non - prescribing non - dispensing healthcare provider
medication - taking patient
non - manufacturing medication distributor
nocardia cyriacigeorgica
paenibacillus phoenicis
prevotella histicola
porphyromonas bennonis
pseudomonas otitidis
staphylococcus pettenkoferi
streptococcus urinalis
pisiform bone
trichosporon mucoides
fusarium solani
streptococcus suis serotype 2
zika virus
pd - l1 positive
frameless fractionated stereotactic radiation therapy
anti - cd22 car - expressing t lymphocytes
topoisomerase i / ii inhibitor nev - 801
tlr4 agonist gsk1795091
sumac / black cumin powder
capitate bone
cord blood - derived expanded natural killer cells pnk - 007
fructooligosaccharide supplement
hla - a2 - restricted il - 13ra2 / epha2 / survivin / tetanus toxoid t - helper epitopes - montanide 51 vaccine
unresectable esophageal carcinoma
plant glycan
anatomic imaging concept
prostate imaging area
fibromuscular stroma of prostate
trapezial bone
peripheral zone of prostate
transition zone of prostate
central zone of prostate
urethral sphincter
left apical anterior fibromuscular stroma of prostate
left anterior apical peripheral zone of prostate
left posterolateral apical peripheral zone of prostate
left posteromedial apical peripheral zone of prostate
left anterior apical transition zone of prostate
left posterior apical transition zone of prostate
triangular bone
right apical anterior fibromuscular stroma of prostate
right anterior apical peripheral zone of prostate
right posterolateral apical peripheral zone of prostate
right posteromedial apical peripheral zone of prostate
right anterior apical transition zone of prostate
right posterior apical transition zone of prostate
left basal anterior fibromuscular stroma of prostate
central zone of left half prostate
left anterior basal peripheral zone of prostate
left anterior basal transition zone of prostate
trapezoid bone
left posterior basal transition zone of prostate
left posterolateral basal peripheral zone of prostate
right basal anterior fibromuscular stroma of prostate
central zone of right half prostate
right anterior basal peripheral zone of prostate
right posterolateral basal peripheral zone of prostate
right anterior basal transition zone of prostate
right posterior basal transition zone of prostate
left seminal vesicle
left middle anterior fibromuscular stroma of prostate
recombinant transforming growth factor - beta - 2
hamate bone
left anterior middle peripheral zone of prostate
left posterolateral middle peripheral zone of prostate
left posteromedial middle peripheral zone of prostate
left anterior middle transition zone of prostate
left posterior middle transition zone of prostate
right middle anterior fibromuscular stroma of prostate
right anterior middle peripheral zone of prostate
right posterolateral middle peripheral zone of prostate
right posteromedial middle peripheral zone of prostate
right anterior middle transition zone of prostate
right posterior middle transition zone of prostate
right seminal vesicle
male external urethral sphincter
pi - rads terminology
manuka honey breast pads
pan - pim kinase inhibitor nvp - lgb - 321
simpson grading system
simpson grade 1
simpson grade 2
simpson grade 3
simpson grade 4
simpson grade 5
bet inhibitor incb057643
megavoltage topographic imaging
caplacizumab
mri - guided transurethral ultrasound ablation
cobolimab
ph unknown
b acute lymphoblastic leukemia ,  philadelphia chromosome negative
middle phalanx of hand
laryngeal anterior commissure
cd20 positive
cool
faced block
recurrent respiratory papillomatosis
histology cassette
analyte
gadopiclenol
t ( 11 ; 14 )
t ( 11 ; 22 )
t ( 14 ; 18 )
t ( 21 ; 22 )
t ( 16 ; 16 )
t ( 3 ; 3 )
ewsr1 gene translocation
t ( 8 ; 14 )
endothelial cell
t ( 6 ; 9 )
t ( 6 ; 11 )
t ( 4 ; 11 )
t ( 2 ; 13 )
t ( 1 ; 19 )
t ( 1 ; 13 )
t ( 15 ; 17 )
t ( 12 ; 21 )
t ( 4 ; 14 )  ( p16 ; q32 )
chfr promoter methylation
kit exon 8 mutation
egfr exon 18 mutation
egfr exon 19 mutation
egfr exon 20 mutation
tru - cut biopsy needle
wallet pack dosage form
egfr exon 21 mutation
more
triplet
gaia dysfunctional labor level of diagnostic certainty
alveolar epithelium
gaia antenatal bleeding level of diagnostic certainty
gaia gestational diabetes mellitus level of diagnostic certainty
gaia fetal growth restriction level of diagnostic certainty
gaia failure to thrive level of diagnostic certainty
gaia small for gestational age level of diagnostic certainty
gaia low birth weight level of diagnostic certainty
gaia neonatal respiratory distress level of diagnostic certainty
gaia spontaneous abortion and ectopic pregnancy level of diagnostic certainty
gaia congenital microcephaly level of diagnostic certainty
gaia spontaneous abortion level of diagnostic certainty
right atrium
gaia ectopic pregnancy level of diagnostic certainty
cdisc sdtm gastrointestinal test name terminology
cdisc sdtm gastrointestinal test code terminology
cdisc sdtm pk unit of measure kilogram weight terminology
cdisc sdtm pk unit of measure gram weight terminology
cdisc sdtm pk unit of measure milligram dose terminology
cdisc sdtm pk unit of measure microgram dose terminology
cdisc sdtm microbiology susceptibility test name terminology
cdisc sdtm microbiology susceptibility test code terminology
cdisc sdtm collected race terminology
left atrium
cdisc sdtm collected ethnicity terminology
international classification of diseases ,  tenth revision ,  clinical modification
gaia neonatal encephalopathy level of diagnostic certainty
gaia postnatally diagnosed congenital microcephaly level of diagnostic certainty
gaia prenatally diagnosed congenital microcephaly level of diagnostic certainty
peripheral t - cell lymphoma ,  unclassifiable
nk - cell lymphoma ,  unclassifiable
unclassifiable lesion
gaia neonatal encephalopathy level of diagnostic certainty terminology
recombinant granulocyte colony - stimulating factor
right ventricle
gaia congenital microcephaly level of diagnostic certainty terminology
gaia low birth weight level of diagnostic certainty terminology
gaia neonatal respiratory distress level of diagnostic certainty terminology
gaia small for gestational age level of diagnostic certainty terminology
gaia failure to thrive level of diagnostic certainty terminology
gaia spontaneous abortion and ectopic pregnancy level of diagnostic certainty terminology
gaia antenatal bleeding level of diagnostic certainty terminology
gaia dysfunctional labor level of diagnostic certainty terminology
gaia fetal growth restriction level of diagnostic certainty terminology
gaia gestational diabetes mellitus level of diagnostic certainty terminology
left ventricle
gaia level 1 ectopic pregnancy
gaia level 2 ectopic pregnancy
gaia level 3 ectopic pregnancy
gaia level 4 ectopic pregnancy
morbidly adherent placenta
cesarean scar pregnancy
uterine rupture
gaia level 1 dysfunctional first stage of labor
gaia level 2 dysfunctional first stage of labor
gaia level 1 dysfunctional second stage of labor
left coronary artery
gaia level 2 dysfunctional second stage of labor
gaia level 1a fetal growth restriction
gaia level 1b fetal growth restriction
gaia level 2a fetal growth restriction
gaia level 2b fetal growth restriction
gaia level 1 low birth weight
gaia level 2 low birth weight
gaia level 3 low birth weight
gaia level 4 low birth weight
gaia level 1 neonatal encephalopathy
gaia level 2 neonatal encephalopathy
gaia level 3 neonatal encephalopathy
congenital microcephaly
gaia level 1 small for gestational age
gaia level 2a small for gestational age
gaia level 2b small for gestational age
gaia level 3a small for gestational age
gaia level 3b small for gestational age
gaia level 4 small for gestational age
organic failure to thrive
circumflex branch of the left coronary artery
non - organic failure to thrive
mixed failure to thrive
gaia level 1 placenta previa
gaia level 2 placenta previa
gaia level 1 morbidly adherent placentation
gaia level 2 morbidly adherent placentation
gaia level 1 vasa previa
gaia level 2 vasa previa
gaia level 1 placental abruption
gaia level 2 placental abruption
right coronary artery
gaia level 1 cesarean scar pregnancy
gaia level 1 intra - abdominal pregnancy
gaia level 1 uterine rupture
gaia level 1 gestational diabetes mellitus
gaia level 2 gestational diabetes mellitus
gaia level 3 gestational diabetes mellitus
gaia insufficient evidence for diagnosis of gestational diabetes mellitus
gaia level 1 postnatally diagnosed congenital microcephaly
gaia level 2a postnatally diagnosed congenital microcephaly
gaia level 2b postnatally diagnosed congenital microcephaly
posterior spinal artery
gaia level 3b postnatally diagnosed congenital microcephaly
gaia level 4 postnatally diagnosed congenital microcephaly
gaia level 1a prenatally diagnosed congenital microcephaly
gaia level 1b prenatally diagnosed congenital microcephaly
gaia level 2 prenatally diagnosed congenital microcephaly
gaia level 3b prenatally diagnosed congenital microcephaly
gaia level 4 prenatally diagnosed congenital microcephaly
gaia level 1 neonatal respiratory distress
gaia level 2 neonatal respiratory distress
venous sinus
gaia level 1 failure to thrive
gaia level 2a failure to thrive
gaia level 2b failure to thrive
gaia level 3a failure to thrive
gaia level 3b failure to thrive
first trimester spontaneous abortion
gaia level 1 first trimester spontaneous abortion
gaia level 2 first trimester spontaneous abortion
gaia level 3 first trimester spontaneous abortion
gaia level 4 first trimester spontaneous abortion
cardiac vein
second trimester spontaneous abortion
gaia level 1 second trimester spontaneous abortion
gaia level 2 second trimester spontaneous abortion
gaia level 4 second trimester spontaneous abortion
ncit antineoplastic agent terminology
rock2 inhibitor kd025
genomeplex whole genome amplification
repli - g whole genome amplification
rna isolation
great cardiac vein
hybrid
human origin
surgical pathology procedure
microplate well
proliferating cell count
electronic nicotine delivery device
hemoblast bellows
recurrent lung non - squamous non - small cell carcinoma
metastatic lung non - squamous non - small cell carcinoma
trastuzumab deruxtecan
recombinant granulocyte - macrophage colony - stimulating factor
middle cardiac vein
submucosal lesion
cutaneous malignant melanoma 2
acrodermatitis enteropathica
bicuspid aortic valve
d - glyceric aciduria
generalized arterial calcification of infancy 1
hyperalphalipoproteinemia
recurrent intrahepatic cholangiocarcinoma
carcinoembryonic antigen positive
blunt
small cardiac vein
igg monoclonal gammopathy
iga monoclonal gammopathy
igm monoclonal gammopathy
bap1 gene mutation
deleterious brca1 gene mutation
deleterious brca2 gene mutation
calr gene mutation
cdkn2a gene mutation
ctrc gene mutation
dock8 gene mutation
coronary vein
epcam gene mutation
msh2 gene mutation
pms1 gene mutation
prss1 gene mutation
prss2 gene mutation
stk11 gene mutation
idh1 nm_005896 .3:c .395g > a
idh1 np_005887 .2:p .r132h
hepatitis c virus infection
hhv6 infection
brachial vein
jc virus infection
alk positive
ccnd1 positive
epstein - barr virus early rna positive
bcr / abl1 fusion negative
latent membrane protein 1 positive
pml / rara fusion positive
runx1 / runx1t1 fusion positive
human anti - mouse antibodies negative
human papillomavirus positive
urothelium
igf1r positive
mesothelin positive
rb1 positive
philadelphia chromosome positive
philadelphia chromosome negative
tnfrsf17 positive
tyrosinase positive
lung micropapillary adenocarcinoma
gart gene
gart wt allele
renal capsule
trifunctional purine biosynthetic protein adenosine - 3
cck gene
cck wt allele
cholecystokinin
muc4 gene
muc4 wt allele
mucin - 4
c4a gene
c4a wt allele
c4b gene
renal pyramid
ad5 - survivin - transduced autologous dendritic cell vaccine
c4b wt allele
fgfr4 inhibitor h3b - 6527
c4b_2 gene
c4b_2 wt allele
complement c4 - a
complement c4 - b
csta gene
csta wt allele
cystatin - a
renal pelvis
cstb gene
cstb wt allele
cystatin - b
somatostatin receptor positive
ddc gene
ddc wt allele
aromatic - l - amino - acid decarboxylase
epha5 gene
epha5 wt allele
ephrin type - a receptor 5
visual system
ultrasound - guided near - infrared optical tomography
irf7 gene
irf7 wt allele
interferon regulatory factor 7
gsk3b gene
gsk3b wt allele
glycogen synthase kinase - 3 beta
ny - eso - 1 protein / microparticle mdp / bacterial dna - containing mis416 vaccine
cytarabine monophosphate prodrug mb07133
french maritime pine bark extract
auditory system
fluorescent antibody sgm - 101
pegteograstim
type - 1 polarized dendritic cell - induced antigen - specific autologous cytotoxic t lymphocytes
chinese herbal formulation lc09
thrombomodulin alfa
c - met inhibitor hs - 10241
4scar - gd2 - modified t - lymphocytes
doxorubicin - loaded egfr - targeting nanocells
multi - epitope anti - folate receptor peptide vaccine tpiv 200
rems approval
recombinant interleukin - 8
falx cerebri
idh1 nm_005896 .3:c .395_396delgtinsac
activating ras mutation
epstein barr nuclear antigen antibody
fgfr3 protein variant
fgfr3 nm_000142 .4:c .742c > t
fgfr3 np_000133 .1:p .r248c
fgfr3 nm_000142 .4:c .1138g > a
fgfr3 np_000133 .1:p .g380r
fgfr3 nm_000142 .4:c .1111a > t
fgfr3 np_000133 .1:p .s371c
central canal of spinal cord
fgfr3 nm_000142 .4:c .1118a > g
fgfr3 np_000133 .1:p .y373c
fgfr3 nm_000142 .4:c .1108g > t
fgfr3 np_000133 .1:p .g370c
fgfr3 nm_000142 .4:c .746c > g
gaia insufficient evidence for diagnosis of fetal growth restriction
fgfr3 np_000133 .1:p .s249c
annexin family protein
radio frequency energy therapy
flt3 gene mutation
cervical spinal cord
flt3 protein variant
flt3 np_004110 .2:p .d835x
high resolution anoscopy with biopsy
ebf1 / pdgfrb fusion gene
ebf1 / pdgfrb fusion protein
ethylene - vinyl alcohol copolymer - based embolic agent
dlx5 gene
dlx5 wt allele
homeobox protein dlx - 5
mir551a gene
cervical spinal nerve root
mir551a wt allele
mir551a pre - mirna
derkay staging system
hla mismatch count
nell1 gene
nell1 wt allele
protein kinase c - binding protein nell1
african american
thoracic spinal cord
radiographic examination
mt - co1 gene
mt - co1 wt allele
cytochrome c oxidase subunit 1
ift88 gene
ift88 wt allele
intraflagellar transport protein 88 homolog
specimen isolation
name of fixative
kirchner growth medium
lumbar spinal cord
mb redox broth growth medium
b - lymphocyte crossmatch measurement
chemokine  ( c - x - c motif )  ligand 1 measurement
hla - a23 antibody measurement
hla - a2 antibody measurement
hla - a antigen type
hla - a mismatch count
hla - b antigen type
hla - b mismatch count
hla - dr51 antibody measurement
sacral spinal cord
hla - dr52 antibody measurement
hla - dr53 antibody measurement
hla - dr antigen type
hla - dr mismatch count
hla class i antibody measurement
hla class ii antibody measurement
hla class ii panel reactive antibody measurement
hla class i panel reactive antibody measurement
insulin - like growth factor binding protein 1 measurement
insulin - like growth factor binding protein 2 measurement
oculomotor nucleus
interleukin 12 + 23 p40 measurement
metarubricyte to total cell ratio measurement
metarubricyte count
procollagen 3 n - terminal propeptide measurement
plasma cell count
plasma cells to leukocytes ratio measurement
prorubricyte count
prorubricyte to total cell ratio measurement
rubricyte count
t - lymphocyte crossmatch measurement
facial nerve nucleus
free testosterone to total protein ratio measurement
acid - fast bacilli measurement
mycobacterium tuberculosis measurement
mycobacterium tuberculosis complex measurement
papanicolaou staining method
minimum inhibitory concentration test
sharp genant bone erosion score
sharp genant joint space narrowing score
sharp van der heijde bone erosion score
sharp van der heijde joint space narrowing score
nucleus of the hypoglossal nerve
black central american
black south american
white central american
white south american
intrathalamic route of administration
intravaginal route of administration
suprachoroidal route of administration
partial response with lymphocytosis
concentrated specimen
recombinant macrophage colony - stimulating factor
posterior chamber of the eye
patient registry study
pharmacogenetic study
beam break unit
qualitative food consumption
increased mucification present
lung / bronchus / trachea / larynx
rubricyte to total cell ratio measurement
3 - hydroxy - 3 - methylglutaryl - coenzyme a
5 - methylcytosine
leukotriene e4
palpebral conjunctiva
neopterin
putrescine
spermidine
1 , 24 , 25 - trihydroxyergocalciferol
tocopherylhydroquinone
simeprevir
kir2dl1 gene
kir2dl1 wt allele
ledipasvir
bulbar conjunctiva
killer cell immunoglobulin - like receptor 2dl1
chromosome 2q37 deletion syndrome
deafness ,  autosomal recessive 1a
deafness ,  autosomal recessive 28
deafness ,  autosomal recessive 49
exfoliation syndrome
fanconi anemia ,  complementation group i
fanconi anemia ,  complementation group j
frontonasal dysplasia
hyperornithinemia - hyperammonemia - homocitrullinuria syndrome
supraclavicular lymph node
pancreatic lipase deficiency
spondyloepimetaphyseal dysplasia ,  sponastrime type
tyrosinemia type ii
canine gm1 - gangliosidosis
thrombocytopenia 2
kir2dl2 gene
kir2dl2 wt allele
killer cell immunoglobulin - like receptor 2dl2
kir2dl3 gene
axillary lymph node
kir2dl3 wt allele
killer cell immunoglobulin - like receptor 2dl3
stmn1 gene
stmn1 wt allele
stathmin
arrb2 gene
arrb2 wt allele
beta - arrestin - 2
iberdomide
cbs gene
thoracic cavity
cbs wt allele
cystathionine beta - synthase
akr1c3 gene
akr1c3 wt allele
aldo - keto reductase family 1 member c3
dusp10 gene
dusp10 wt allele
dual specificity protein phosphatase 10
ncr1 gene
ncr1 wt allele
posterior eye segment
natural cytotoxicity triggering receptor 1
dna - dependent protein kinase inhibitor vx - 984
ccr3 gene
ccr3 wt allele
c - c chemokine receptor type 3
ccr4 gene
ccr4 wt allele
c - c chemokine receptor type 4
charcot - marie - tooth neuropathy x type 1
corticobasal degeneration
integumentary system
cystathioninuria
fetal akinesia deformation sequence
hereditary persistence of fetal hemoglobin
mucopolysaccharidosis type ix
immunodeficiency with hyper - igm type 2
leber congenital amaurosis
molybdenum cofactor deficiency
canine mastocytoma
rho gene
rho wt allele
rhodopsin
sart1 gene
sart1 wt allele
u4 / u6 .u5 tri - snrnp - associated protein 1
cerk gene
cerk wt allele
ceramide kinase
cdisc questionnaire facit - f version 4 test name terminology
cdisc questionnaire facit - f version 4 test code terminology
cdisc questionnaire nccn - fact fksi - 19 version 2 test name terminology
hematopoietic system
cdisc questionnaire nccn - fact fksi - 19 version 2 test code terminology
cdisc questionnaire nccn - fact fblsi - 18 version 2 test name terminology
cdisc questionnaire nccn - fact fblsi - 18 version 2 test code terminology
cdisc questionnaire fact - b version 4 test name terminology
cdisc questionnaire fact - b version 4 test code terminology
cdisc questionnaire fosi test name terminology
cdisc questionnaire fosi test code terminology
cdisc questionnaire nccn - fact fosi - 18 version 2 test name terminology
cdisc questionnaire nccn - fact fosi - 18 version 2 test code terminology
facit - f version 4 questionnaire question
antisense oligonucleotides
mucosa - associated lymphoid tissue
nccn - fact fksi - 19 version 2 questionnaire question
nccn - fact fblsi - 18 version 2 questionnaire question
fact - b version 4 questionnaire question
fosi questionnaire question
nccn - fact fosi - 18 version 2 questionnaire question
functional assessment of chronic illness therapy - fatigue version 4 questionnaire
national comprehensive cancer network / functional assessment of cancer therapy - kidney symptom index - 19 version 2 questionnaire
national comprehensive cancer network / functional assessment of cancer therapy - bladder symptom index - 18 version 2 questionnaire
functional assessment of cancer therapy - breast version 4 questionnaire
functional assessment of cancer therapy - ovarian symptom index questionnaire
national comprehensive cancer network / functional assessment of cancer therapy - ovarian symptom index - 18 version 2 questionnaire
facit - f version 4  -  i have a lack of energy
facit - f version 4  -  i have nausea
facit - f version 4  -  trouble meeting needs of family
facit - f version 4  -  i have pain
facit - f version 4  -  bothered by treatment side effect
facit - f version 4  -  i feel ill
facit - f version 4  -  i am forced to spend time in bed
facit - f version 4  -  i feel close to my friends
facit - f version 4  -  get emotional support from family
caco - 2 cell
facit - f version 4  -  i get support from my friends
facit - f version 4  -  my family has accepted my illness
facit - f version 4  -  satisfied family communication of illness
facit - f version 4  -  i feel close to my partner
facit - f version 4  -  i am satisfied with my sex life
facit - f version 4  -  i feel sad
facit - f version 4  -  satisfied with how i am coping
facit - f version 4  -  losing hope against illness
facit - f version 4  -  i feel nervous
facit - f version 4  -  i worry about dying
abnormal cell
facit - f version 4  -  worry my condition will get worse
facit - f version 4  -  i am able to work
facit - f version 4  -  my work is fulfilling
facit - f version 4  -  i am able to enjoy life
facit - f version 4  -  i have accepted my illness
facit - f version 4  -  i am sleeping well
facit - f version 4  -  enjoy things i usually do for fun
facit - f version 4  -  content with quality of my life
facit - f version 4  -  i feel fatigued
facit - f version 4  -  i feel weak all over
facit - f version 4  -  i feel listless
facit - f version 4  -  i feel tired
facit - f version 4  -  trouble starting things
facit - f version 4  -  trouble finishing things
facit - f version 4  -  i have energy
facit - f version 4  -  able to do my usual activities
facit - f version 4  -  i need to sleep during the day
facit - f version 4  -  i am too tired to eat
facit - f version 4  -  need help doing usual activities
facit - f version 4  -  frustrated by being too tired
small cleaved follicle center cell
facit - f version 4  -  limit social activity ,  i am tired
nccn - fact fksi - 19 version 2  -  i have a lack of energy
nccn - fact fksi - 19 version 2  -  i have pain
nccn - fact fksi - 19 version 2  -  i am losing weight
nccn - fact fksi - 19 version 2  -  i feel fatigued
nccn - fact fksi - 19 version 2  -  i have been short of breath
nccn - fact fksi - 19 version 2  -  i am bothered by fevers
nccn - fact fksi - 19 version 2  -  i have bone pain
nccn - fact fksi - 19 version 2  -  i have been coughing
nccn - fact fksi - 19 version 2  -  i feel weak all over
nccn - fact fksi - 19 version 2  -  i have had blood in my urine
nccn - fact fksi - 19 version 2  -  i have a good appetite
nccn - fact fksi - 19 version 2  -  i am sleeping well
nccn - fact fksi - 19 version 2  -  worry my condition will get worse
nccn - fact fksi - 19 version 2  -  i have nausea
nccn - fact fksi - 19 version 2  -  i have diarrhea
nccn - fact fksi - 19 version 2  -  bothered by treatment side effect
nccn - fact fksi - 19 version 2  -  i am able to work
nccn - fact fksi - 19 version 2  -  i am able to enjoy life
nccn - fact fksi - 19 version 2  -  content with quality of my life
malignant cell
nccn - fact fblsi - 18 version 2  -  i have pain
nccn - fact fblsi - 18 version 2  -  i am losing weight
nccn - fact fblsi - 18 version 2  -  have trouble controlling my urine
nccn - fact fblsi - 18 version 2  -  i feel weak all over
nccn - fact fblsi - 18 version 2  -  i feel light - headed
nccn - fact fblsi - 18 version 2  -  trouble meeting needs of family
nccn - fact fblsi - 18 version 2  -  i have a good appetite
nccn - fact fblsi - 18 version 2  -  able to have ,  maintain erection
nccn - fact fblsi - 18 version 2  -  i am sleeping well
nccn - fact fblsi - 18 version 2  -  worry my condition will get worse
blast cell
nccn - fact fblsi - 18 version 2  -  i feel sad
nccn - fact fblsi - 18 version 2  -  i have nausea
nccn - fact fblsi - 18 version 2  -  i have a lack of energy
nccn - fact fblsi - 18 version 2  -  i feel ill
nccn - fact fblsi - 18 version 2  -  i have control of my bowels
nccn - fact fblsi - 18 version 2  -  bothered by treatment side effect
nccn - fact fblsi - 18 version 2  -  i am able to enjoy life
nccn - fact fblsi - 18 version 2  -  content with quality of my life
fact - b version 4  -  i have a lack of energy
fact - b version 4  -  i have nausea
organ system
fact - b version 4  -  trouble meeting needs of family
fact - b version 4  -  i have pain
fact - b version 4  -  bothered by treatment side effect
fact - b version 4  -  i feel ill
fact - b version 4  -  i am forced to spend time in bed
fact - b version 4  -  i feel close to my friends
fact - b version 4  -  get emotional support from family
fact - b version 4  -  i get support from my friends
fact - b version 4  -  my family has accepted my illness
fact - b version 4  -  satisfied family communication of illness
ribozyme
ebv - specific cytotoxic t - lymphocyte
fact - b version 4  -  i feel close to my partner
fact - b version 4  -  i am satisfied with my sex life
fact - b version 4  -  i feel sad
fact - b version 4  -  satisfied with how i am coping
fact - b version 4  -  losing hope against illness
fact - b version 4  -  i feel nervous
fact - b version 4  -  i worry about dying
fact - b version 4  -  worry my condition will get worse
fact - b version 4  -  i am able to work
fact - b version 4  -  my work is fulfilling
large granular lymphocyte
fact - b version 4  -  i am able to enjoy life
fact - b version 4  -  i have accepted my illness
fact - b version 4  -  i am sleeping well
fact - b version 4  -  enjoy things i usually do for fun
fact - b version 4  -  content with quality of my life
fact - b version 4  -  i have been short of breath
fact - b version 4  -  self - conscious about way i dress
fact - b version 4  -  one or both arms are swollen or tender
fact - b version 4  -  i feel sexually attractive
fact - b version 4  -  i am bothered by hair loss
neoplastic cell
fact - b version 4  -  worry family will get illness
fact - b version 4  -  worry about the effect of stress
fact - b version 4  -  i am bothered by change in weight
fact - b version 4  -  i am able to feel like a woman
fact - b version 4  -  certain parts of body have pain
fosi  -  i have a lack of energy
fosi  -  i have been vomiting
fosi  -  i have pain
fosi  -  i have nausea
fosi  -  i have swelling in stomach area
fosi  -  worry my condition will get worse
fosi  -  content with quality of my life
fosi  -  i have cramps in my stomach area
nccn - fact fosi - 18 version 2  -  i have a lack of energy
nccn - fact fosi - 18 version 2  -  i have pain
nccn - fact fosi - 18 version 2  -  i feel ill
nccn - fact fosi - 18 version 2  -  i have cramps in my stomach area
nccn - fact fosi - 18 version 2  -  i feel fatigued
nccn - fact fosi - 18 version 2  -  i am bothered by constipation
nccn - fact fosi - 18 version 2  -  i have swelling in stomach area
lumbar spinal nerve root
nccn - fact fosi - 18 version 2  -  i have control of my bowels
nccn - fact fosi - 18 version 2  -  i am sleeping well
nccn - fact fosi - 18 version 2  -  worry my condition will get worse
nccn - fact fosi - 18 version 2  -  i have nausea
nccn - fact fosi - 18 version 2  -  i am bothered by hair loss
nccn - fact fosi - 18 version 2  -  bothered by treatment side effect
nccn - fact fosi - 18 version 2  -  i have been vomiting
nccn - fact fosi - 18 version 2  -  i am bothered by skin problems
nccn - fact fosi - 18 version 2  -  i am able to get around by myself
nccn - fact fosi - 18 version 2  -  i am able to enjoy life
sacral spinal nerve root
nccn - fact fosi - 18 version 2  -  content with quality of my life
ncam1 positive
ret gene translocation
human immunodeficiency virus 1 positive
asex - female version  -  comments
cd19 positive
asex - male version  -  comments
tnfrsf8 positive
cdkn2a - p16 positive
castration levels of testosterone
thoracic spinal nerve root
idh gene family
serpinf2 gene
serpinf2 wt allele
alpha - 2 - antiplasmin
idh gene family mutation
rps2 gene
worst severity past seven days difficulty swallowing
rps2 wt allele
40s ribosomal protein s2
past seven days mouth or throat sores interfering with usual or daily activities
renal calyx
worst severity past seven days skin cracking at the corners of mouth
diffuse astrocytoma ,  idh - mutant
gemistocytic astrocytoma ,  idh - mutant
past seven days voice change
diffuse astrocytoma ,  idh - wildtype
worst severity past seven days hoarse voice
past seven days increased passing of gas
diffuse astrocytoma ,  not otherwise specified
past seven days hives
past seven days loss of fingernails or toenails
corneal epithelium
past seven days ridges or bumps on fingernails or toenails
past seven days color change of fingernails or toenails
past seven days increased skin sensitivity to sunlight
worst severity past seven days problems with memory
past seven days problems with memory interfering with usual or daily activities
past seven days frequency of feeling nothing could cheer you up
worst severity past seven days feeling nothing could cheer you up
past seven days feeling nothing could cheer you up interfering with usual or daily activities
idh gene family mutation status unknown
gingival spindle cell carcinoma
nerve plexus
anaplastic astrocytoma ,  idh - mutant
anaplastic astrocytoma ,  idh - wildtype
anaplastic astrocytoma ,  not otherwise specified
epithelioid glioblastoma
semmes weinstein monofilament examination
glioblastoma ,  not otherwise specified
glioblastoma with primitive neuronal component
canine glioma
canine hepatocellular carcinoma
canine lung adenocarcinoma
recombinant transforming growth factor - beta 1
intrapulmonary bronchus
canine rhabdomyosarcoma
adrenal gland hyperplasia ii
adrenal gland hyperplasia iii
congenital bilateral aplasia of the vas deferens
congenital myasthenic syndrome 5
cranioectodermal dysplasia
microcephaly and chorioretinopathy ,  autosomal recessive ,  type 1
n - acetylglutamate synthase deficiency
schinzel - giedion midface - retraction syndrome
diffuse midline glioma ,  h3 k27m - mutant
h3 k27m mutation
h3 protein variant
chitin oligosaccharides supplement t - chos
factor vii - targeting immunoconjugate protein icon - 1
c - met inhibitor al2846
tesidolumab
metformide hydrochloride / pioglitazone hydrochloride extended - release tablet
oligodendroglioma ,  idh - mutant and 1p / 19q - codeleted
oligodendroglioma ,  not otherwise specified
xenograft
1p / 19q codeletion status unknown
anaplastic oligodendroglioma ,  idh - mutant and 1p / 19q - codeleted
anaplastic oligodendroglioma ,  not otherwise specified
oligoastrocytoma ,  not otherwise specified
anaplastic oligoastrocytoma ,  not otherwise specified
diffuse glioma
resting state functional connectivity magnetic resonance imaging
anaplastic pleomorphic xanthoastrocytoma
female sexual function index
frequency of sexual desire or interest
vertebra
level of sexual desire or interest
frequency of sexual arousal during sexual activity or intercourse
level of sexual arousal during sexual activity or intercourse
confidence of becoming sexually aroused during sexual activity or intercourse
frequency of satisfaction with arousal during sexual activity or intercourse
frequency of lubrication during sexual activity or intercourse
difficulty becoming lubricated during sexual activity or intercourse
frequency in maintenance of lubrication until completion of sexual activity or intercourse
difficulty in maintenance of lubrication until completion of sexual activity or intercourse
frequency of reaching orgasm with sexual stimulation or intercourse
dorsal motor nucleus
difficulty of reaching orgasm with sexual stimulation or intercourse
satisfaction of ability to reach orgasm during sexual activity or intercourse
satisfaction of emotional closeness during sexual activity with partner
satisfaction of sexual relationship with partner
satisfaction with overall sexual life
frequency of experiencing discomfort or pain during vaginal penetration
frequency of experiencing discomfort or pain following vaginal penetration
level of discomfort or pain during or following vaginal penetration
always or almost always
a few times
embryonic stem cell
never or almost never
ependymoma ,  rela fusion - positive
c11orf95 - rela fusion protein expression
c11orf95 / rela fusion gene
c11orf95 / rela fusion protein
chromothripsis
symptoms interfered with general activity
symptoms interfered with mood
symptoms interfered with work
symptoms interfered with relations with other people
gut - associated lymphoid tissue
symptoms interfered with walking
symptoms interfered with enjoyment of life
symptom interference likert scale
symptom interference score 0
symptom interference score 1
symptom interference score 2
symptom interference score 3
symptom interference score 4
symptom interference score 5
symptom interference score 6
mammary epithelium
symptom interference score 7
symptom interference score 8
symptom interference score 9
symptom interference score 10
baltaleucel - t
ido1 inhibitor pf - 06840003
anti - flt3 monoclonal antibody 4g8 - sdiem
tnfd3 repeat
htm5 allele
tc22 allele
tpm3 gene product
tropomyosin alpha - 3 chain isoform 2
anti - fap / interleukin - 2 fusion protein ro6874281
tropomyosin alpha - 3 chain isoform 3
hydrogen peroxide - hyaluronic acid tumor injectable formulation
alpha tubulin
janus kinase family
phosphofructokinase
phosphoglucomutase
phosphoglycerate kinase
hexokinase
pyruvate kinase
aldolase
fructose - bisphosphate aldolase
inosine monophosphate dehydrogenase
transcobalamin
adenovirus e4 protein
mitotic catastrophe
human anti - chimeric antibody
thymopentin
antineutrophil cytoplasmic antibody
antibody - drug conjugate anti - tim - 1 - vcmmae cdx - 014
bta stat
nmp22 assay
alu element
tacaribe complex virus
cyclin b
human placenta - derived stem cell transplantation
ca27 - 29
core binding factor complex mutation
plasmin - antiplasmin complex
clostridium cluster
clostridium cluster iv
clostridium cluster xiv
clostridium cluster xvi
microrna 181b
microrna 16
monoclonal antibody cam 5 .2
kdr intron 2 vntr
nos3 intron 4 vntr
intracarotid
mismatch repair protein
immunoglobulin heavy chain variable domain
histone modification
adp ribosylation
diffuse leptomeningeal glioneuronal tumor
onalespib lactate
multinodular and vacuolated pattern
multinodular and vacuolated tumor of the cerebrum
cerebral convexity
olfactory groove
sphenoid wing
rosette - forming glioneuronal tumor
mrna sequencing
cancer - testis antigen family 45 gene
aldehyde dehydrogenase 1 family
microsomal prostaglandin e synthase family
large cell / anaplastic medulloblastoma
wnt pathway activated
chromosome 17 abnormality
medulloblastoma ,  genetically defined
medial supraclavicular lymph node
medulloblastoma ,  wnt - activated
medulloblastoma ,  shh - activated
medulloblastoma ,  shh - activated ,  tp53 - mutant
medulloblastoma ,  shh - activated ,  tp53 - wildtype
medulloblastoma ,  non - wnt / non - shh
medulloblastoma ,  non - wnt / non - shh ,  group 3
medulloblastoma ,  non - wnt / non - shh ,  group 4
medulloblastoma ,  not otherwise specified
cetrelimab
small cell adenocarcinoma
neuroendocrine system
hla class i histocompatibility antigen ,  a - 0201 alpha chain positive
wnt positive
hepatitis c virus positive
wt1 positive
epstein - barr virus positive
human papillomavirus - 16 positive
european leukemianet
anti - cd123 - pyrrolobenzodiazepine dimer antibody drug conjugate sgn - cd123a
temporooccipital
frontotemporal
peripheral blood stem cell
subungual
paraspinal
submandibular
submaxillary
anorectal
sun - exposed site
chronically sun - exposed site
nonchronically sun - exposed site
pinguecula
cellular dedifferentiation
sentinel lymph node
classic histology
did not attempt intercourse
no sexual activity
very high level
high level
moderate level
low level
very low level or none at all
very high confidence
high confidence
duct
moderate confidence
low confidence
very low confidence or no confidence
extremely difficult or impossible
very difficult
difficult
slightly difficult
not difficult
very satisfied
moderately satisfied
about equally satisfied and dissatisfied
moderately dissatisfied
very dissatisfied
promis short form v1 .0  -  fatigue 8a
how much bothered by fatigue on average
degree fatigue interfered with physical functioning
how often have to push to get things done because of fatigue
how often have trouble finishing things because of fatigue
c19mc amplification
embryonal tumor with multilayered rosettes ,  not otherwise specified
streptogramin a
embryonic tissue
loss of brg1 protein expression
central nervous system embryonal tumor with rhabdoid features
odynophagia
prkar1a gene mutation
fibrous tissue
patient health questionnaire - 4
placement of surgical mesh
surgical mesh implant
worst severity past seven days wheezing
past seven days frequency of pounding or racing heartbeat
splenocyte
worst severity past seven days pounding or racing heartbeat
worst severity past seven days dry skin
worst severity past seven days acne or pimples on the face or chest
past seven days any hair loss
worst severity past seven days hand - foot syndrome
past seven days any bed sores
worst severity past seven days skin burns from radiation
past seven days any unusual darkening of the skin
past seven days any stretch marks
worst severity past seven days dizziness
past seven days how much dizziness interfered with usual or daily activities
past seven days how much headache interfered with usual or daily activities
autologous bladder cell carcinoma rnas / cd40l rna electroporated autologous matured dendritic cells
kras nm_004985 .3:c .436g > a
kras np_004976 .2:p .a146t
nuclear expression of stat6 protein
central nervous system solitary fibrous tumor / hemangiopericytoma
central nervous system solitary fibrous tumor / hemangiopericytoma ,  grade 3
central nervous system solitary fibrous tumor / hemangiopericytoma ,  grade 2
major cytogenetic response in chronic myelogenous leukemia ,  bcr - abl1 positive
nervous system fluids and secretions
central nervous system solitary fibrous tumor / hemangiopericytoma ,  grade 1
retailer
one hundred fifty
needle tract seeding
central nervous system mesenchymal chondrosarcoma
surface guided radiation therapy
central nervous system epithelioid hemangioendothelioma
central nervous system ewing sarcoma / peripheral primitive neuroectodermal tumor
central nervous system angiolipoma
revised dyadic adjustment scale
peripheral blood mononuclear cell
extent of agreement or disagreement on religious matters
extent of agreement or disagreement on demonstrations of affection
extent of agreement or disagreement on making major decisions
extent of agreement or disagreement on sex relations
extent of agreement or disagreement on conventionality
extent of agreement or disagreement on career decisions
splicing inhibitor h3b - 8800
how often discuss or consider divorce ,  separation or terminating relationship
central nervous system desmoid - type fibromatosis
intracranial benign fibrous histiocytoma
nervous system ,  ear
how often quarrel with partner
central nervous system myofibroblastoma
regret marriage or living together
how often get on each other's nerves
how often engage in outside interests together
kynurenine
how often have stimulating exchange of ideas
how often work together on projects
how often calmly discuss something
always agree
neuro - ocular system
almost always agree
occasionally agree
frequently disagree
almost always disagree
always disagree
more often than not
central nervous system undifferentiated pleomorphic sarcoma
less than once a month
once or twice a month
skull osteoma
exocrine system
more often than once a day
gain of chromosome 1q21
egfr protein translocation
ganglioside gd2 positive
alk gene rearrangement
egfr driver mutation negative
eml4 / alk fusion negative
hla class i histocompatibility antigen ,  a - 0205 alpha chain
hla class i histocompatibility antigen ,  a - 0206 alpha chain
cev regimen
mammalian cell
chk1 inhibitor cct245737
ma zi ren wan
huang qi
shu di huang
mai dong
sheng di huang
rou cong rong
niu xi
zinc finger nuclease zfn - 603
zinc finger nuclease zfn - 758
breast cancer cell
fluorescent dye ls301
monoclonal antibody ak002
topical naloxone hydrochloride
anti - hcd70 - car retroviral vector - transduced autologous pbls
pd - l1 / pd - l2 / vista antagonist ca - 170
polypodium leucotomos extract
cd4 - specific telomerase peptide vaccine ucpvax
obsolete gene_product_variant_of_gene_product
central nervous system anaplastic large cell lymphoma ,  alk - positive
central nervous system anaplastic large cell lymphoma ,  alk - negative
virginiamycin s1
liver stem cell
central nervous system mature t - cell and nk - cell non - hodgkin lymphoma
related_to_genetic_biomarker
central nervous system intravascular large b - cell lymphoma
superoinferior
gaia level 3a postnatally diagnosed congenital microcephaly
gaia level 3a prenatally diagnosed congenital microcephaly
gaia level 5 small for gestational age
breast - impact of treatment scale
how often think about how body has changed
how often have waves of strong feelings about the way body looks
trachea and bronchus
how often think about how body used to look
flt1 gene amplification
how often reminded by things that are seen or heard that body is different now
kdr gene amplification
how often think that body appears different than other women
how often feel uncomfortable about being seen naked
how often bothered by feelings or thoughts about body changes
flt4 gene amplification
pdgfrb gene amplification
clonogen
how often reminded of breasts when picking clothes to wear
fgfr3 gene amplification
tp53 gene amplification
how often don't want to deal with how body looks
how often avoid getting emotional when thinking of how body has changed
flt1 gene mutation
how often try not to think about size and shape of breasts
how often avoid looking at or touching body
kdr gene mutation
flt4 gene mutation
gut epithelium
how often turn away when undressing in front of partner
how often think about how health may affect sex life
fgfr1 gene mutation
how often try not to think about body being different
flotrac system
acquired hyperthyroidism
acquired hypoparathyroidism
adipsic diabetes insipidus
astatine - 211 alpha radiation
cerium - 144 beta radiation
connective and soft tissue
cobalt - 60 gamma radiation
iron - 56 ion irradiation
plutonium - 238 alpha particle radiation
cesium - 137 gamma radiation
acquired hypothyroidism
phosphorylated histone h2ax
vascular endothelial growth factor family
e2f transcription factor family
continued complete hematologic response
bifidobacterium animalis / lactobacillus rhamnosus probiotic supplement
jak1 inhibitor
polysiloxane / gadolinium chelates - based nanoparticles
synthetic long e6 peptide - toll - like receptor ligand conjugate vaccine isa201
csf - 1r inhibitor blz945
unresectable digestive system adenocarcinoma
beta tubulin
eukaryotic translation initiation factor 4 gamma family
t - cell receptor profile
b - cell receptor complex profile
asparaginase antibody
microbial dna
epstein - barr virus dna
human immunodeficiency virus dna
human immunodeficiency virus rna
human papillomavirus dna
tumor dna
tumor rna
hpv transforming protein e6 antibody
hpv transforming protein e7 antibody
reovirus rna
ascending spinal cord tract
erbb2 antibody
muc1 antibody
ppul38 antibody
cmv ul38 gene
apoptosis inhibitor ul38
apoptotic index
basement membrane thickness
dna repair kinetics
epstein - barr virus capsid antigen antibody
colony forming unit - endothelial cells
tumor - associated vasculature
il15 antibody
msln antibody
ctag1 antibody
dynamic international prognostic scoring system
nfe2l2 gene mutation
keap1 gene mutation
xp11 .2 translocations / tfe3 gene fusions present
olutasidenib
csf1r inhibitor plx73086
prostaglandin e2 ep4 receptor inhibitor e7046
descending spinal cord tract
ficoll - hypaque method
mosunetuzumab
white blood cell lysis
atr kinase inhibitor vx - 803
anti - human gitr monoclonal antibody amg 228
since beginning study agent
feelings about own sexuality
overall energy level
beta thalassemia major
8 - hydroxy - 2' - deoxyguanosine
pontine base
activating erbb2 mutation
activating met mutation
activating ret mutation
alk gene translocation
ros1 gene translocation
gata2 gene mutation
il2ra positive
advanced malignant solid neoplasm
feel self - conscious about letting partner see my breasts
liquid component present
breast
btk inhibitor m7583
botanical agent leac - 102
etelcalcetide
gallium ga 68 p15 - 041
envafolimab
anti - actr / 4 - 1bb / cd3zeta - viral vector - transduced autologous t - lymphocytes actr087
amino acid / electrolyte mixture - based dietary supplement
bozitinib
47 , xxx syndrome
47 , xyy syndrome
peripheral nerve sheath
aarskog syndrome
albright hereditary osteodystrophy with multiple hormone resistance
albright hereditary osteodystrophy without multiple hormone resistance
acquired partial lipodystrophy
acute suppurative thyroiditis
anovulatory cycle
autoimmune polyglandular syndrome
autoimmune polyglandular syndrome type 1
autoimmune polyglandular syndrome type 2
autonomous ovarian follicular cyst
cervicomedullary junction
autosomal dominant hypoparathyroidism
autosomal recessive hypoparathyroidism
autosomal dominant osteopetrosis
autosomal recessive osteopetrosis
autosomal recessive infantile hypercalcemia
dipsogenic diabetes insipidus
autosomal dominant neurohypophyseal diabetes insipidus
bowel function diary for assessing opioid - induced constipation
monogenic diabetes
how able to fully empty bowels
glucokinase - associated diabetes mellitus
hepatocyte nuclear factor 1 - alpha - associated monogenic diabetes
hepatocyte nuclear factor 1 - beta - associated monogenic diabetes
hepatocyte nuclear factor 4 - alpha associated monogenic diabetes
neurogenic differentiation factor 1 - associated monogenic diabetes
pdx1 - associated monogenic diabetes
sur1 - associated diabetes mellitus
transcription factor - associated monogenic diabetes
shape and consistency of stool
how often unable to have bowel movement even though felt had to
how much bloating felt because of constipation
pain felt in abdomen because of constipation
how much bothered by gas
how much bothered by lack of appetite because of constipation
during this bowel movement
phytohemagglutinin skin test
phosphoprotein profile
poly - adp - ribosylation
premalignant cell
kir6 .2 - associated diabetes mellitus
ras family transcriptional profile
complete agreement
serum protein electrophoresis
tnf repeat
telomere length
total rna expression profile
microrna expression profile
reovirus capsid protein
tgf - beta responsive gene signature
pluripotent stem cell
total phosphotyrosine
tumor cdna expression profile
myb / nfib fusion gene
myb / nfib fusion protein
telomeric allelic imbalance region
th1 cell / th2 cell ratio measurement
natural cytotoxicity receptor family
serum - ascites albumin gradient
2 - hour postprandial glucose
2 - hour postprandial insulin
totipotent stem cell
thyroid stimulating immunoglobulin
glioma - associated antigen
acute myeloid leukemia with biallelic mutations of cebpa
acute myeloid leukemia with monoallelic mutations of cebpa
unresectable thyroid gland carcinoma
acute myeloid leukemia with bcr - abl1
acute myeloid leukemia with mutated runx1
b lymphoblastic leukemia / lymphoma ,  bcr - abl1 - like
b acute lymphoblastic leukemia ,  bcr - abl1 - like
translocations involving tyrosine kinases or cytokine receptors present
ido1 inhibitor khk2455
bladder cancer muscle - invasive 30 questionnaire
have to urinate frequently during day
have to urinate frequently at night
when feel urge to pass urine have to hurry to get to toilet
difficult getting enough sleep because of need to get up frequently at night to urinate
have difficulty going out of house because of need to be close to toilet
degree of urinary incontinence
have pain or burning with urination
have urine leak from urostomy bag
o - chloroacetylcarbamoylfumagillol
intracranial artery
have problem caring for urostomy
have irritated skin around urostomy
feel embarrassed because of urostomy
dependent on others for urostomy care
have to change urostomy bag frequently
have problems with self - catherization
central nervous system langerhans cell histiocytosis
central nervous system histiocytic sarcoma
central nervous system erdheim - chester disease
worry about possible future treatments
graft
have flatulence or gas
feel less feminine or masculine as a result of illness or treatment
feel uncomfortable about sexual intimacy
worry about contaminating partner during sexual contact due to bladder treatment
have vaginal dryness or other problem during intercourse
glossotonsillar sulcus
wall of the pharynx
lateral wall of the pharynx
antineoplastic hormonal / endocrine agent
antineoplastic radiopharmaceutical agent
bone of the lower extremity
antineoplastic immunomodulating agent
antineoplastic biological agent
antineoplastic antibody
antineoplastic antibody - drug conjugate
antineoplastic protein inhibitor
antineoplastic enzyme inhibitor
antineoplastic immune cell
unresectable transitional cell carcinoma
metastatic transitional cell carcinoma
biallelic mutation
bone of the upper extremity
monoallelic mutation
calr exon 9 mutation
calr exon 9 deletion mutation
calr exon 9 insertion mutation
calr nm_004343 .3:c .1092_1143del52
calr nm_004343 .3:c .1154_1155insttgtc
calr protein variant
calr np_004334 .1:p .l367fs*46
calr np_004334 .1:p .k385fs*47
apoptotic pathway - targeting antineoplastic agent
interval lymph node
cga gene
cga wt allele
glycoprotein hormones alpha chain protein
nat1 gene
nat1 wt allele
arylamine n - acetyltransferase 1
inhbe gene
inhbe wt allele
inhibin beta e chain
cycs gene
neural stem cell
cycs wt allele
cytochrome c
chronic myelomonocytic leukemia with eosinophilia associated with t ( 5 ; 12 )  ( q31 ; p12 )
myeloid / lymphoid neoplasms with pcm1 - jak2
t ( 8 ; 9 )  ( p22 ; p24 .1 )
pcm1 / jak2 fusion gene
pcm1 / jak2 fusion protein
gingival squamous cell carcinoma
rat ovarian adenocarcinoma
mouse teratocarcinoma
alveolus
time of bowel movement
advanced head and neck carcinoma
transcranial direct current stimulation
oral dysplasia
charcot - marie - tooth disease type 4c
congenital contractural arachnodactyly
dopamine transporter deficiency syndrome
growth hormone insensitivity syndrome
juvenile absence epilepsy
multiple vascular disruption syndrome
caruncle
nemaline myopathy 3
nemaline myopathy 8
pitt - hopkins syndrome
floor of mouth basaloid squamous cell carcinoma
deafness ,  autosomal recessive 39
chromosome 16p12 .1 deletion syndrome
vopratelimab
autologous monocytes
completely able
how much strain
cybrid
pain felt around rectum
traf1 - c5 locus
catecholamine metabolite
choline metabolite
nnk metabolite
tryptophan metabolite
cytokine expression profile
epigenetic profile
single nucleotide polymorphism profile
short tandem repeat profile
episclera
promoter - specific methylation profile
ddrd signature
hypermethylation profile
hypomethylation profile
chemokine expression profile
red cell fatty acid profile
prostaglandin e2 metabolite
prostaglandin i2 metabolite
receptor tyrosine - protein kinase erbb - 2 carboxyl terminal fragment
ldl - c oxidation
disulfonated aluminum phthalocyanine
lobule
vldl - c oxidation
retinol binding protein family
genome - wide allelic status
global dna methylation profile
persistent neuroblastic cells
hematogenous csf blasts
natural killer t - cell
circulating myeloid cell
myeloid - derived suppressor cell
ppy gene
neuroblast
ppy wt allele
ppy gene product
pancreatic prohormone
pancreatic hormone
pancreatic icosapeptide
atxn1 gene
atxn1 wt allele
ataxin - 1
human anti - idiotype antibody
human anti - anti - idiotype antibody
splenic red pulp
induced anti - tumor antigen - specific antibody
gd2 antibody
nfkb2 gene product
nuclear factor nf - kappa - b p52 subunit
casp9 gene product
activated caspase - 9
hidebound
sacral chordoma
galactosialidosis
long - chain 3 - hydroxyacyl - coa dehydrogenase deficiency
splenic white pulp
masa syndrome
mental retardation ,  x - linked 102
nephropathic cystinosis
primary lateral sclerosis
pseudobulbar palsy
personalized peptide cancer vaccine neo - pv - 01
anti - glypican 3 / cd3 bispecific antibody ery974
anti - flt3 antibody - drug conjugate ags62p1
cdisc sdtm device - in - use response terminology
cdisc sdtm diabetic kidney findings about test name terminology
thymocyte
cdisc sdtm diabetic kidney findings about test code terminology
cdisc sdtm urinary system test name terminology
cdisc sdtm urinary system test code terminology
non - clinical principal investigator name
study chair name
study sponsor monitor name
nonclinical study sponsor name
untreated extensive stage small cell lung carcinoma
cdkn2a gene product
jak1 gene mutation
spinal cord tract
slightly able
moderately able
quite able
right ventricular systolic pressure
lung tissue drug concentration
pulmonary artery wedge pressure
dynamic compliance
static compliance
pulmonary artery pressure
left atrial pressure
vestibulocochlear nerve
mixed venous oxygen tension
precipitate
solid phase microextraction
red / gray tiger top serum separator tube
green / gray tiger top plasma separation tube
red / light gray tiger top secondary collection tube
tiger top discard tube
agonistic anti - ox40 monoclonal antibody incagn01949
mage - a3 multipeptide vaccine gl - 0817
crlf2 gene rearrangement
intrinsic
universal
hla match
idiopathic basal ganglia calcification 1
inosine triphosphatase deficiency
isobutyryl - coa dehydrogenase deficiency
kleefstra syndrome
mitochondrial dna depletion syndrome 12
mucolipidosis type iii gamma
myoclonic epilepsy associated with ragged - red fibers
vertebral column
neonatal hemochromatosis
spastic paraplegia 4
spinocerebellar ataxia type 1
anti - egfr fluorescence imaging agent aby - 029
truncated tissue factor / ngr peptide
activity card sort
traditional chinese medicine formulation
instrumental activities domain
yi qi fang
low - demand leisure activities domain
major salivary gland
high - demand leisure activities domain
social activities domain
ability to stand up from chair
yang yin fang
ability to get in and out of bed
ability to cut meat
yi qi yang yin fang
ability to lift a full cup or glass to mouth
ability to open new milk carton
ability to climb 5 steps
dolastatin 10
rhabdomyocyte
use aid or device for activity
btk inhibitor dtrmwxhs - 12
need help from another person
ability to take a tub bath
ability to reach and get down 5 pound object from above head
ability to bend down to pick up clothing from the floor
ability to open car door
ability to open previously opened jar
ability to turn faucets on and off
how well doing health rating
smooth muscle cell
anti - her2 / her2 bispecific antibody zw25
anti - her2 antibody - drug conjugate rc48
oxidative phosphorylation inhibitor iacs - 010759
feel fit
carbon c 11 metformin
feel physically able to only do a little
feel very active
feel like doing all sorts of nice things
do a lot in a day
when doing something can keep thoughts on it
cardiomyocyte
carbon c 13 idasanutlin
physically can take on a lot
dread having to do things
do very little in a day
carbon c 14 idasanutlin
am rested
takes a lot of effort to concentrate on things
physically feel in bad condition
have lots of plans
anti - inflammatory / antimicrobial / analgesic aqueous mouth rinse
ependymal cell
get little done
don't feel like doing anything
thoughts easily wander
bcr - abl kinase inhibitor pf - 114
physically feel in excellent condition
chronic myelomonocytic leukemia - 0
proxalutamide
myelodysplastic syndrome with ring sideroblasts and single lineage dysplasia
myeloid neoplasms with germline predisposition
b - lymphoblastic leukemia / lymphoma with intrachromosomal amplification of chromosome 21
endocardium
b acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21
indolent t - lymphoblastic proliferation
contrast enhanced digital mammography
early t acute lymphoblastic leukemia
limited early t - cell differentiation
ultrasound mode
ejaculate unit
tricuspid valve annulus
multilineage dysplasia present
burixafor hydrobromide
pericardium
plamotamab
airway plateau pressure
accidental association
biologically unrelated
kidney donor
inferior vena cava collapse due to sniff test indicator
estimated mean atrial pressure
number of events
2 - dimensional biplane ultrasound mode
2 - dimensional single plane ultrasound mode
specialized epithelial cell
3 - dimensional ultrasound mode
color tissue doppler ultrasound mode
continuous - wave doppler ultrasound mode
m - mode ultrasound mode
pulsed - wave doppler ultrasound mode
pulsed - wave tissue doppler ultrasound mode
tissue doppler ultrasound mode
voltage criteria suggesting left ventricular hypertrophy ,  without secondary ecg findings
bermuda grass pollen ige measurement
bermuda grass pollen iga measurement
bermuda grass pollen igg measurement
bermuda grass pollen igg4 measurement
birch pollen ige measurement
birch pollen iga measurement
birch pollen igg measurement
birch pollen igg4 measurement
silver birch pollen ige measurement
silver birch pollen iga measurement
silver birch pollen igg measurement
silver birch pollen igg4 measurement
lymphokine - activated killer cells
orchard grass pollen ige measurement
orchard grass pollen iga measurement
orchard grass pollen igg measurement
orchard grass pollen igg4 measurement
english plantain pollen ige measurement
english plantain pollen iga measurement
english plantain pollen igg measurement
english plantain pollen igg4 measurement
timothy grass pollen ige measurement
timothy grass pollen iga measurement
timothy grass pollen igg measurement
timothy grass pollen igg4 measurement
western ragweed pollen ige measurement
western ragweed pollen iga measurement
western ragweed pollen igg measurement
western ragweed pollen igg4 measurement
mucor racemosus ige measurement
mucor racemosus iga measurement
mucor racemosus igg measurement
mucor racemosus igg4 measurement
esperamicin a1
brunner's gland
mixed antigen ige antibody measurement
tree mix pollen antigen ige antibody measurement
tree mix pollen antigen igg antibody measurement
grass mix pollen antigen ige antibody measurement
grass mix pollen antigen igg antibody measurement
grass mix pollen antigen iga antibody measurement
weed mix pollen antigen ige antibody measurement
weed mix pollen antigen igg antibody measurement
weed mix pollen antigen iga antibody measurement
mold mix antigen ige antibody measurement
ampulla of vater
mold mix antigen igg antibody measurement
mold mix antigen iga antibody measurement
animal mix antigen ige antibody measurement
animal mix antigen igg antibody measurement
industrial mix antigen ige antibody measurement
industrial mix antigen igg antibody measurement
bee mix antigen ige antibody measurement
bee mix antigen igg antibody measurement
bee mix antigen igg4 antibody measurement
dairy mix antigen igg antibody measurement
lymphoid blood - forming cell
shellfish mix antigen ige antibody measurement
shellfish mix antigen igg antibody measurement
nut mix antigen ige antibody measurement
nut mix antigen igg antibody measurement
cat dander antigen ige antibody measurement
cat dander antigen igg antibody measurement
cat dander antigen iga antibody measurement
cat dander antigen igg4 antibody measurement
dog dander antigen ige antibody measurement
dog dander antigen igg antibody measurement
lymphoblast
dog dander antigen iga antibody measurement
dog dander antigen igg4 antibody measurement
dermatophagoides farinae antigen ige antibody measurement
dermatophagoides farinae antigen igg antibody measurement
dermatophagoides pteronyssinus antigen ige antibody measurement
dermatophagoides pteronyssinus antigen igg antibody measurement
american cockroach antigen ige antibody measurement
american cockroach antigen iga antibody measurement
american cockroach antigen igg antibody measurement
american cockroach antigen igg4 antibody measurement
monoblast
german cockroach antigen ige antibody measurement
german cockroach antigen iga antibody measurement
german cockroach antigen igg antibody measurement
german cockroach antigen igg4 antibody measurement
aspergillus fumigatus antigen ige antibody measurement
aspergillus fumigatus antigen igg antibody measurement
penicillium notatum antigen ige antibody measurement
penicillium notatum antigen iga antibody measurement
penicillium notatum antigen igg antibody measurement
penicillium notatum antigen igg4 antibody measurement
myeloblast
alternaria tenuis alternata antigen ige antibody measurement
alternaria tenuis alternata antigen iga antibody measurement
alternaria tenuis alternata antigen igg antibody measurement
alternaria tenuis alternata antigen igg4 antibody measurement
basophil band form count
basophil band form to leukocytes ratio measurement
chemokine  ( c - c motif )  ligand 12 measurement
chemokine  ( c - c motif )  ligand 19 measurement
chemokine  ( c - c motif )  ligand 7 measurement
chemokine  ( c - x - c motif )  ligand 6 measurement
female genital organ
cytokeratin 18 fragment measurement
epithelial cells to total cells ratio measurement
fibroblast growth factor 9 measurement
leukemia inhibitory factor measurement
macrophage inflammatory protein 1 gamma measurement
myeloid progenitor cell count
viable cell count
aortic valve annulus
suprarenal aorta
posterior annulus of the tricuspid valve
male genital organ
ahg - enhanced complement - dependent lymphocytotoxicity assay
complement - dependent lymphocytotoxicity assay
farnsworth - munsell 100 hue test
hemagglutination assay
high resolution melt analysis
jaeger eye chart
multiple breath washout
next generation targeted sequencing
phenotypic multiple antigen bead - based multiplex assay
allele specific primer polymerase chain reaction
organ
sequence - based typing
sequence - specific oligonucleotide probe polymerase chain reaction
single antigen bead - based multiplex assay
single - strand conformation polymerase chain reaction
triple phase mri
n75 latency
wheal diameter interpretation
per large square neubauer chamber
per millimeter
million per ejaculate unit
eye part
glycoprotein - elisa unit per milliliter
milliliter per minute times one hundred milliliters
nanogram equivalents per liter
opsonization index 50%
reciprocal of seconds times percent o2 concentration
number of renal arteries
number of renal veins
experimental organism benign plasma cell tumor
total number of study animals purchased
myelodysplastic syndrome clone
recombinant i309
breast part
solid organ transplant recipient
bcr / abl1 fusion gene with abl1 nm_005157 .4:c .742c > g mutation
constitutional mismatch repair deficiency syndrome
bcr / abl1 fusion protein with abl1 np_005148 .2:p .l248v
bcr / abl1 fusion gene with abl1 nm_005157 .4:c .749g > a mutation
bcr / abl1 fusion protein with abl1 np_005148 .2:p .g250e
bcr / abl1 fusion gene with abl1 nm_005157 .4:c .756g > t mutation
bcr / abl1 fusion gene with abl1 nm_005157 .4:c .756g > c mutation
bcr / abl1 fusion protein with abl1 np_005148 .2:p .q252h
bcr / abl1 fusion gene with abl1 nm_005157 .4:c .758a > t mutation
bcr / abl1 fusion protein with abl1 np_005148 .2:p .y253f
bcr / abl1 fusion gene with abl1 nm_005157 .4:c .763g > a mutation
bcr / abl1 fusion protein with abl1 np_005148 .2:p .e255k
bcr / abl1 fusion gene with abl1 nm_005157 .4:c .895g > c mutation
bcr / abl1 fusion gene with abl1 nm_005157 .4:c .895g > t mutation
bcr / abl1 fusion protein with abl1 np_005148 .2:p .v299l
bcr / abl1 fusion gene with abl1 nm_005157 .4:c .951c > a mutation
bcr / abl1 fusion gene with abl1 nm_005157 .4:c .949t > c mutation
bcr / abl1 fusion gene with abl1 nm_005157 .4:c .951c > g mutation
bcr / abl1 fusion protein with abl1 np_005148 .2:p .f317l
skin part
bcr / abl1 fusion gene with abl1 nm_005157 .4:c .1052t > c mutation
bcr / abl1 fusion protein with abl1 np_005148 .2:p .m351t
bcr / abl1 fusion gene with abl1 nm_005157 .4:c .1075t > g mutation
bcr / abl1 fusion protein with abl1 np_005148 .2:p .f359v
bcr / abl1 fusion gene with abl1 nm_005157 .4:c .1150c > a mutation
bcr / abl1 fusion protein with abl1 np_005148 .2:p .l384m
bcr / abl1 fusion gene with abl1 nm_005157 .4:c .1187a > c mutation
bcr / abl1 fusion protein with abl1 np_005148 .2:p .h396p
bcr / abl1 fusion gene with abl1 nm_005157 .4:c .1187a > g mutation
heart part
bcr / abl1 fusion protein with abl1 np_005148 .2:p .h396r
bcr / abl1 fusion protein with abl1 np_005148 .2:p .g398r
bcr / abl1 fusion gene with abl1 nm_005157 .4:c .1457t > c mutation
bcr / abl1 fusion protein with abl1 np_005148 .2:p .f486s
castration - resistant prostate carcinoma
castration resistance
ros1 gene rearrangement
stage ib mycosis fungoides ajcc v7
cdisc clinical classification buers test name terminology
cdisc clinical classification buers test code terminology
pancreas part
cdisc clinical classification vlers test name terminology
cdisc clinical classification vlers test code terminology
cdisc clinical classification ham - d6 clinician version test name terminology
cdisc clinical classification ham - d6 clinician version test code terminology
cdisc clinical classification hamd 24 test name terminology
cdisc clinical classification hamd 24 test code terminology
cdisc clinical classification ids - c test name terminology
cdisc clinical classification ids - c test code terminology
cdisc clinical classification qids - c test name terminology
cdisc clinical classification qids - c test code terminology
cdisc clinical classification kdpi test name terminology
cdisc clinical classification kdpi test code terminology
cdisc questionnaire fact - leu version 4 test name terminology
cdisc questionnaire fact - leu version 4 test code terminology
cdisc questionnaire fact - hep version 4 test name terminology
cdisc questionnaire fact - hep version 4 test code terminology
cdisc questionnaire fact - lym version 4 test name terminology
cdisc questionnaire fact - lym version 4 test code terminology
cdisc questionnaire ham - d6 self - report version test name terminology
cdisc questionnaire ham - d6 self - report version test code terminology
cdisc questionnaire ids - sr test name terminology
cdisc questionnaire ids - sr test code terminology
cdisc questionnaire qids - sr test name terminology
cdisc questionnaire qids - sr test code terminology
cdisc questionnaire q - les - q test name terminology
cdisc questionnaire q - les - q test code terminology
cdisc questionnaire q - les - q - sf test name terminology
cdisc questionnaire q - les - q - sf test code terminology
cdisc questionnaire whodas 2 .0 36 - item version interviewer - administered test name terminology
cdisc questionnaire whodas 2 .0 36 - item version interviewer - administered test code terminology
cdisc questionnaire whodas 2 .0 36 - item version proxy - administered test name terminology
cdisc questionnaire whodas 2 .0 36 - item version proxy - administered test code terminology
cdisc questionnaire whodas 2 .0 36 - item version self - administered test name terminology
cdisc questionnaire whodas 2 .0 36 - item version self - administered test code terminology
cdisc questionnaire whodas 2 .0 12 - item version interviewer - administered test name terminology
cdisc questionnaire whodas 2 .0 12 - item version interviewer - administered test code terminology
cdisc questionnaire whodas 2 .0 12 - item version proxy - administered test name terminology
cdisc questionnaire whodas 2 .0 12 - item version proxy - administered test code terminology
cdisc questionnaire whodas 2 .0 12 - item version self - administered test name terminology
cdisc questionnaire whodas 2 .0 12 - item version self - administered test code terminology
cdisc questionnaire whodas 2 .0 12 + 24 - item version interviewer - administered test name terminology
cdisc questionnaire whodas 2 .0 12 + 24 - item version interviewer - administered test code terminology
buers clinical classification question
vlers clinical classification question
ham - d6 clinician version clinical classification question
hamd 24 clinical classification question
ids - c clinical classification question
qids - c clinical classification question
kdpi clinical classification question
fact - leu version 4 questionnaire question
endocrine system part
fact - hep version 4 questionnaire question
fact - lym version 4 questionnaire question
ham - d6 self - report version questionnaire question
ids - sr questionnaire question
qids - sr questionnaire question
q - les - q questionnaire question
q - les - q - sf questionnaire question
whodas 2 .0 36 - item version interviewer - administered questionnaire question
whodas 2 .0 36 - item version proxy - administered questionnaire question
whodas 2 .0 36 - item version self - administered questionnaire question
oprelvekin
whodas 2 .0 12 - item version interviewer - administered questionnaire question
whodas 2 .0 12 - item version proxy - administered questionnaire question
whodas 2 .0 12 - item version self - administered questionnaire question
whodas 2 .0 12 24 - item version interviewer - administered questionnaire question
brooke upper extremity rating scale clinical classification
vignos lower extremity rating scale clinical classification
hamilton depression rating scale 6 clinician version clinical classification
hamilton depression rating scale - 24 item clinical classification
inventory of depressive symptomatology clinician - rated version clinical classification
quick inventory of depressive symptomatology clinician - rated version clinical classification
brain part
kidney donor profile index clinical classification
functional assessment of cancer therapy - leukemia version 4 questionnaire
functional assessment of cancer therapy - hepatobiliary version 4 questionnaire
functional assessment of cancer therapy - lymphoma version 4 questionnaire
hamilton depression rating scale 6 self - report version questionnaire
inventory of depressive symptomatology self - report version questionnaire
quick inventory of depressive symptomatology self - report version questionnaire
quality of life enjoyment and satisfaction questionnaire
quality of life enjoyment and satisfaction questionnaire - short form
world health organization disability assessment schedule 2 .0 36 - item version interviewer - administered questionnaire
world health organization disability assessment schedule 2 .0 36 - item version proxy - administered questionnaire
world health organization disability assessment schedule 2 .0 36 - item version self - administered questionnaire
world health organization disability assessment schedule 2 .0 12 - item version interviewer - administered questionnaire
world health organization disability assessment schedule 2 .0 12 - item version proxy - administered questionnaire
world health organization disability assessment schedule 2 .0 12 - item version self - administered questionnaire
world health organization disability assessment schedule 2 .0 12 + 24 - item version interviewer - administered questionnaire
buers  -  brooke upper extremity rating scale
vlers  -  vignos lower extremity rating
ham - d6  -  clinician version  -  depressed mood
ham - d6  -  clinician version  -  low self - esteem and guilt
immune system part
ham - d6  -  clinician version  -  social life activities or interests
ham - d6  -  clinician version  -  psychomotor retardation ,  general
ham - d6  -  clinician version  -  psychic anxiety
ham - d6  -  clinician version  -  tiredness and pains
ham - d6  -  clinician version  -  total score
hamd 24  -  depressed mood
hamd 24  -  low self - esteem ,  guilt
hamd 24  -  suicidal thoughts
hamd 24  -  insomnia  -  initial
hamd 24  -  insomnia  -  middle
hamd 24  -  insomnia  -  late
hamd 24  -  work and interests
hamd 24  -  psychomotor retardation
hamd 24  -  psychomotor agitation
hamd 24  -  anxiety ,  psychic
hamd 24  -  anxiety ,  somatic
hamd 24  -  gastrointestinal symptoms  ( appetite )
hamd 24  -  somatic symptoms ,  general
hamd 24  -  sexual disturbances
hamd 24  -  hypochondriasis  ( somatisation )
urinary system part
hamd 24  -  insight
hamd 24  -  weight loss
hamd 24  -  diurnal variation
hamd 24  -  depersonalization and derealisation
hamd 24  -  paranoid symptoms
hamd 24  -  obsessional and compulsive symptoms
hamd 24  -  helplessness
hamd 24  -  hopelessness
hamd 24  -  worthlessness
hamd 24  -  total score
ids - c  -  sleep onset insomnia
ids - c  -  mid - nocturnal insomnia
ids - c  -  early morning insomnia
ids - c  -  hypersomnia
ids - c  -  mood  ( sad )
ids - c  -  mood  ( irritable )
ids - c  -  mood  ( anxious )
ids - c  -  reactivity of mood
ids - c  -  mood variation
ids - c  -  mood worse in morning ,  afternoon ,  or night
respiratory system part
ids - c  -  mood variation attributed to environment
ids - c  -  quality of mood
ids - c  -  appetite  ( decreased )
ids - c  -  appetite  ( increased )
ids - c  -  weight  ( decrease )
ids - c  -  weight  ( increase )
ids - c  -  concentration or decision making
ids - c  -  outlook  ( self )
ids - c  -  outlook  ( future )
ids - c  -  suicidal ideation
male reproductive system part
ids - c  -  involvement
ids - c  -  energy or fatiguability
ids - c  -  pleasure or enjoyment
ids - c  -  sexual interest
ids - c  -  psychomotor slowing
ids - c  -  psychomotor agitation
ids - c  -  somatic complaints
ids - c  -  sympathetic arousal
ids - c  -  panic or phobic symptoms
ids - c  -  gastrointestinal
female reproductive system part
ids - c  -  interpersonal sensitivity
ids - c  -  leaden paralysis or physical energy
ids - c  -  score
kdpi  -  kdpi score
qids - c  -  sleep onset insomnia
qids - c  -  mid - nocturnal insomnia
qids - c  -  early morning insomnia
qids - c  -  hypersomnia
qids - c  -  mood  ( sad )
qids - c  -  appetite  ( decreased )
peg - interleukin - 2
nervous system part
qids - c  -  appetite  ( increased )
qids - c  -  weight  ( decrease )
qids - c  -  weight  ( increase )
qids - c  -  concentration or decision making
qids - c  -  outlook  ( self )
qids - c  -  suicidal ideation
qids - c  -  involvement
qids - c  -  energy or fatiguability
qids - c  -  psychomotor slowing
qids - c  -  psychomotor agitation
body
qids - c  -  highest score sleep items
qids - c  -  high score appetite or weight items
qids - c  -  highest score psychomotor items
qids - c  -  total score
fact - leu version 4  -  i have a lack of energy
fact - leu version 4  -  i have nausea
fact - leu version 4  -  trouble meeting needs of family
fact - leu version 4  -  i have pain
fact - leu version 4  -  bothered by treatment side effect
fact - leu version 4  -  i feel ill
fact - leu version 4  -  i am forced to spend time in bed
fact - leu version 4  -  i feel close to my friends
fact - leu version 4  -  get emotional support from family
fact - leu version 4  -  i get support from my friends
fact - leu version 4  -  my family has accepted my illness
fact - leu version 4  -  satisfied communication illness
fact - leu version 4  -  i feel close to my partner
fact - leu version 4  -  i am satisfied with my sex life
fact - leu version 4  -  i feel sad
fact - leu version 4  -  satisfied with how i am coping
ear part
fact - leu version 4  -  losing hope against illness
fact - leu version 4  -  i feel nervous
fact - leu version 4  -  i worry about dying
fact - leu version 4  -  worry my condition will get worse
fact - leu version 4  -  i am able to work
fact - leu version 4  -  my work is fulfilling
fact - leu version 4  -  i am able to enjoy life
fact - leu version 4  -  i have accepted my illness
fact - leu version 4  -  i am sleeping well
fact - leu version 4  -  enjoy things i usually do for fun
joint
fact - leu version 4  -  content with quality of my life
fact - leu version 4  -  i am bothered by fevers
fact - leu version 4  -  certain parts of body have pain
fact - leu version 4  -  i am bothered by the chills
fact - leu version 4  -  i have night sweats
fact - leu version 4  -  bothered by lumps or swelling
fact - leu version 4  -  i bleed easily
fact - leu version 4  -  i bruise easily
fact - leu version 4  -  i feel weak all over
fact - leu version 4  -  i get tired easily
tendon
fact - leu version 4  -  i am losing weight
fact - leu version 4  -  i have a good appetite
fact - leu version 4  -  able to do my usual activities
fact - leu version 4  -  i worry about getting infections
fact - leu version 4  -  uncertain about my future health
fact - leu version 4  -  worry i might get new symptoms
fact - leu version 4  -  i have emotional ups and downs
fact - leu version 4  -  feel isolated because of illness
fact - hep version 4  -  i have a lack of energy
fact - hep version 4  -  i have nausea
ligament
fact - hep version 4  -  trouble meeting needs of family
fact - hep version 4  -  i have pain
fact - hep version 4  -  bothered by treatment side effect
fact - hep version 4  -  i feel ill
fact - hep version 4  -  i am forced to spend time in bed
fact - hep version 4  -  i feel close to my friends
fact - hep version 4  -  get emotional support from family
fact - hep version 4  -  i get support from my friends
fact - hep version 4  -  my family has accepted my illness
fact - hep version 4  -  satisfied with communication about illness
seminiferous tubule
fact - hep version 4  -  i feel close to my partner
fact - hep version 4  -  i am satisfied with my sex life
fact - hep version 4  -  i feel sad
fact - hep version 4  -  satisfied with how i am coping
fact - hep version 4  -  losing hope against illness
fact - hep version 4  -  i feel nervous
fact - hep version 4  -  i worry about dying
fact - hep version 4  -  worry my condition will get worse
fact - hep version 4  -  i am able to work
fact - hep version 4  -  my work is fulfilling
nephron
fact - hep version 4  -  i am able to enjoy life
fact - hep version 4  -  i have accepted my illness
fact - hep version 4  -  i am sleeping well
fact - hep version 4  -  enjoy things i usually do for fun
fact - hep version 4  -  content with quality of my life
fact - hep version 4  -  swelling or cramps in stomach area
fact - hep version 4  -  i am losing weight
fact - hep version 4  -  i have control of my bowels
fact - hep version 4  -  i can digest my food well
fact - hep version 4  -  i have diarrhea
lymphoid tissue
fact - hep version 4  -  i have a good appetite
fact - hep version 4  -  unhappy about change in my appearance
fact - hep version 4  -  i have pain in my back
fact - hep version 4  -  i am bothered by constipation
fact - hep version 4  -  i feel fatigued
fact - hep version 4  -  able to do my usual activities
fact - hep version 4  -  bothered by jaundice or yellow skin
fact - hep version 4  -  i have had fevers
fact - hep version 4  -  i have had itching
fact - hep version 4  -  had change in the way food tastes
methyl 2 , 5 - dihydroxycinnamate
skeletal muscle tissue
fact - hep version 4  -  i have had chills
fact - hep version 4  -  my mouth is dry
fact - hep version 4  -  discomfort or pain in stomach area
fact - lym version 4  -  i have a lack of energy
fact - lym version 4  -  i have nausea
fact - lym version 4  -  trouble meeting needs of family
fact - lym version 4  -  i have pain
fact - lym version 4  -  bothered by treatment side effect
fact - lym version 4  -  i feel ill
fact - lym version 4  -  i am forced to spend time in bed
fact - lym version 4  -  i feel close to my friends
fact - lym version 4  -  get emotional support from family
fact - lym version 4  -  i get support from my friends
fact - lym version 4  -  my family has accepted my illness
fact - lym version 4  -  satisfied with communication about illness
fact - lym version 4  -  i feel close to my partner
fact - lym version 4  -  i am satisfied with my sex life
fact - lym version 4  -  i feel sad
fact - lym version 4  -  satisfied with how i am coping
fact - lym version 4  -  losing hope against illness
nerve tissue
fact - lym version 4  -  i feel nervous
fact - lym version 4  -  i worry about dying
fact - lym version 4  -  worry my condition will get worse
fact - lym version 4  -  i am able to work
fact - lym version 4  -  my work is fulfilling
fact - lym version 4  -  i am able to enjoy life
fact - lym version 4  -  i have accepted my illness
fact - lym version 4  -  i am sleeping well
fact - lym version 4  -  enjoy things i usually do for fun
fact - lym version 4  -  content with quality of my life
vascular endothelium
fact - lym version 4  -  certain parts of body have pain
fact - lym version 4  -  bothered by lumps or swelling
fact - lym version 4  -  i am bothered by fevers
fact - lym version 4  -  i have night sweats
fact - lym version 4  -  i am bothered by itching
fact - lym version 4  -  i have trouble sleeping at night
fact - lym version 4  -  i get tired easily
fact - lym version 4  -  i am losing weight
fact - lym version 4  -  i have a loss of appetite
fact - lym version 4  -  i have trouble concentrating
embryonic cell
fact - lym version 4  -  i worry about getting infections
fact - lym version 4  -  worry i might get new symptoms
fact - lym version 4  -  feel isolated because of illness
fact - lym version 4  -  i have emotional ups and downs
fact - lym version 4  -  difficulty planning for future
ham - d6 self - report version  -  depressed mood
ham - d6 self - report version  -  low self - esteem and guilt
ham - d6 self - report version  -  social life activities or interests
ham - d6 self - report version  -  psychomotor retardation
ham - d6 self - report version  -  psychic anxiety
secretory cell
ham - d6 self - report version  -  tiredness and pains
ids - sr  -  falling asleep
ids - sr  -  sleep during the night
ids - sr  -  waking up too early
ids - sr  -  sleeping too much
ids - sr  -  feeling sad
ids - sr  -  feeling irritable
ids - sr  -  feeling anxious or tense
ids - sr  -  response of your mood to good or desired events
ids - sr  -  mood in relation to the time of day
muscle
ids - sr  -  mood worse in morning ,  afternoon ,  or night
ids - sr  -  mood variation attributed to environment
ids - sr  -  the quality of your mood
ids - sr  -  decreased appetite
ids - sr  -  increased appetite
ids - sr  -  weight  ( decrease )
ids - sr  -  weight  ( increase )
ids - sr  -  concentration or decision making
ids - sr  -  view of myself
ids - sr  -  view of my future
reticular cell
ids - sr  -  thoughts of death or suicide
ids - sr  -  general interest
ids - sr  -  energy level
ids - sr  -  capacity for pleasure or enjoyment
ids - sr  -  interest in sex
ids - sr  -  feeling slowed down
ids - sr  -  feeling restless
ids - sr  -  aches and pains
ids - sr  -  other bodily symptoms
ids - sr  -  panic or phobic symptoms
special sense organ system
ids - sr  -  constipation or diarrhea
ids - sr  -  interpersonal sensitivity
ids - sr  -  leaden paralysis or physical energy
ids - sr  -  score
qids - sr  -  falling asleep
qids - sr  -  sleep during the night
qids - sr  -  waking up too early
qids - sr  -  sleeping too much
qids - sr  -  feeling sad
qids - sr  -  decreased appetite
synovial cell
qids - sr  -  increased appetite
qids - sr  -  decreased weight
qids - sr  -  increased weight
qids - sr  -  concentration or decision making
qids - sr  -  view of myself
qids - sr  -  thoughts of death or suicide
qids - sr  -  general interest
qids - sr  -  energy level
qids - sr  -  feeling slowed down
qids - sr  -  feeling restless
o6 - benzylguanine
sensory ganglion
qids - sr  -  highest score sleep items
qids - sr  -  high score appetite or weight items
qids - sr  -  highest score psychomotor items
qids - sr  -  total score
q - les - q  -  free of aches ,  pains ,  discomfort
q - les - q  -  felt rested
q - les - q  -  felt energetic
q - les - q  -  felt in excellent physical health
q - les - q  -  at least very good physical health
q - les - q  -  free of worry of physical health
q - les - q  -  felt you got enough sleep
q - les - q  -  be as physically active as needed
q - les - q  -  felt well coordinated
q - les - q  -  felt memory was functioning well
q - les - q  -  felt good physically
q - les - q  -  felt full of pep and vitality
q - les - q  -  free of visual problems
q - les - q  -  felt clearheaded
q - les - q  -  felt satisfied with your life
q - les - q  -  felt good about your appearance
back
q - les - q  -  felt happy or cheerful
q - les - q  -  felt independent
q - les - q  -  felt content
q - les - q  -  able to communicate with others
q - les - q  -  taking care of your appearance
q - les - q  -  felt able to make decisions
q - les - q  -  felt relaxed
q - les - q  -  felt good about your life
q - les - q  -  able to travel about to get things done when needed
q - les - q  -  able to deal with life's problems
neck
q - les - q  -  able to take care of yourself
q - les - q  -  have a job
q - les - q  -  work for yourself
q - les - q  -  do volunteer work
q - les - q  -  reason for not working
q - les - q  -  enjoyed your work
q - les - q  -  solved work problem without stress
q - les - q  -  thought clearly about work
q - les - q  -  decisive about work or made decisions
q - les - q  -  accomplished what you wanted to do
q - les - q  -  pleased with work accomplishments
q - les - q  -  worked well
q - les - q  -  been interested in your work
q - les - q  -  concentrated on work
q - les - q  -  worked carefully
q - les - q  -  kept up with expected work
q - les - q  -  taken care of work by yourself
q - les - q  -  communicated and interacted with ease
q - les - q  -  responsible for household
q - les - q  -  reason for no household activities
sphincter of oddi
q - les - q  -  kept room clean to satisfaction
q - les - q  -  paid bills ,  done banking
q - les - q  -  shopped for food or household items
q - les - q  -  prepared food or obtained food
q - les - q  -  taken care of laundry or cleaning
q - les - q  -  accomplish household activities
q - les - q  -  thought clearly household activities to be done
q - les - q  -  solved house problems without stress
q - les - q  -  decisive with regard to household activities
q - les - q  -  made repairs or household maintenance
ileocecal valve
q - les - q  -  taken courses or going to class
q - les - q  -  reason for no courses
q - les - q  -  enjoyed course or class work
q - les - q  -  looked forward to course work
q - les - q  -  dealt with course or class work without stress
q - les - q  -  thought clearly about course work
q - les - q  -  decisive about course work
q - les - q  -  pleased with course accomplishment
q - les - q  -  interested in your course work
q - les - q  -  concentrated on course work
solitary nucleus
q - les - q  -  felt good doing course work
q - les - q  -  communicated with ease at course
q - les - q  -  use time for a leisure activity
q - les - q  -  enjoy the leisure activities
q - les - q  -  look forward to leisure activities
q - les - q  -  concentrate on leisure activities
q - les - q  -  solve or deal without undue stress
q - les - q  -  leisure activity sustain interest
q - les - q  -  enjoyed being with friends
q - les - q  -  getting together with friends
foot bone
q - les - q  -  made social plans with friends
q - les - q  -  enjoyed talking with co - workers
q - les - q  -  patient with others
q - les - q  -  interested in problems of people
q - les - q  -  felt affection toward people
q - les - q  -  gotten along well with people
q - les - q  -  joked or laughed with other people
q - les - q  -  met needs of friends or relatives
q - les - q  -  relationships without problems
q - les - q  -  physical health
stomatognathic system
q - les - q  -  mood
q - les - q  -  work
q - les - q  -  household activities
q - les - q  -  social relationships
q - les - q  -  family relationships
q - les - q  -  leisure time activities
q - les - q  -  ability to function in daily life
q - les - q  -  sex drive ,  interest ,  performance
q - les - q  -  economic status
q - les - q  -  living or housing situation
recombinant pleiotrophin
cheek
q - les - q  -  ability to get around physically
q - les - q  -  vision ability to do work or hobbies
q - les - q  -  overall sense of well being
q - les - q  -  medication
q - les - q  -  rate overall life satisfaction
q - les - q - sf  -  physical health
q - les - q - sf  -  mood
q - les - q - sf  -  work
q - les - q - sf  -  household activities
q - les - q - sf  -  social relationships
q - les - q - sf  -  family relationships
q - les - q - sf  -  leisure time activities
q - les - q - sf  -  ability to function in daily life
q - les - q - sf  -  sex drive ,  interest ,  performance
q - les - q - sf  -  economic status
q - les - q - sf  -  living or housing situation
q - les - q - sf  -  ability to get around physically
q - les - q - sf  -  vision ability to do work or hobbies
q - les - q - sf  -  overall sense of well being
q - les - q - sf  -  medication
dentition
q - les - q - sf  -  rate overall life satisfaction
whodas 2 .0 36 - item version interviewer - administered  -  living situation at interview
whodas 2 .0 36 - item version interviewer - administered  -  sex as observed
whodas 2 .0 36 - item version interviewer - administered  -  how old are you now
whodas 2 .0 36 - item version interviewer - administered  -  years studying in school or college
whodas 2 .0 36 - item version interviewer - administered  -  current marital status
whodas 2 .0 36 - item version interviewer - administered  -  describes main work status best
whodas 2 .0 36 - item version interviewer - administered  -  concentrating for ten minutes
whodas 2 .0 36 - item version interviewer - administered  -  remembering to do important things
whodas 2 .0 36 - item version interviewer - administered  -  finding solutions to problems
facial muscle
whodas 2 .0 36 - item version interviewer - administered  -  learning a new task
whodas 2 .0 36 - item version interviewer - administered  -  understanding what people say
whodas 2 .0 36 - item version interviewer - administered  -  starting or maintaining conversation
whodas 2 .0 36 - item version interviewer - administered  -  standing for long periods
whodas 2 .0 36 - item version interviewer - administered  -  standing up from sitting down
whodas 2 .0 36 - item version interviewer - administered  -  moving around inside your home
whodas 2 .0 36 - item version interviewer - administered  -  getting out of your home
whodas 2 .0 36 - item version interviewer - administered  -  walking a long distance
whodas 2 .0 36 - item version interviewer - administered  -  washing your whole body
whodas 2 .0 36 - item version interviewer - administered  -  getting dressed
masseter muscle
whodas 2 .0 36 - item version interviewer - administered  -  eating
whodas 2 .0 36 - item version interviewer - administered  -  staying by yourself for a few days
whodas 2 .0 36 - item version interviewer - administered  -  dealing with people you do not know
whodas 2 .0 36 - item version interviewer - administered  -  maintaining a friendship
whodas 2 .0 36 - item version interviewer - administered  -  get along with people close to you
whodas 2 .0 36 - item version interviewer - administered  -  making new friends
whodas 2 .0 36 - item version interviewer - administered  -  sexual activities
whodas 2 .0 36 - item version interviewer - administered  -  care of household responsibilities
whodas 2 .0 36 - item version interviewer - administered  -  doing important household tasks
whodas 2 .0 36 - item version interviewer - administered  -  getting household work done needed
pharyngeal muscles
whodas 2 .0 36 - item version interviewer - administered  -  getting household work done quickly
whodas 2 .0 36 - item version interviewer - administered  -  days reduce or miss household work
whodas 2 .0 36 - item version interviewer - administered  -  your day - to - day work or school
whodas 2 .0 36 - item version interviewer - administered  -  doing important work or school tasks
whodas 2 .0 36 - item version interviewer - administered  -  getting all work done you need to do
whodas 2 .0 36 - item version interviewer - administered  -  getting work done quickly as needed
whodas 2 .0 36 - item version interviewer - administered  -  had to work at a lower level
whodas 2 .0 36 - item version interviewer - administered  -  earn less money
whodas 2 .0 36 - item version interviewer - administered  -  how many days did you miss work
whodas 2 .0 36 - item version interviewer - administered  -  problem joining community activities
bone tissue
whodas 2 .0 36 - item version interviewer - administered  -  problem because of barriers in world
whodas 2 .0 36 - item version interviewer - administered  -  problem living with dignity
whodas 2 .0 36 - item version interviewer - administered  -  time spend on your health condition
whodas 2 .0 36 - item version interviewer - administered  -  emotionally affected by health
whodas 2 .0 36 - item version interviewer - administered  -  drain on financial resources
whodas 2 .0 36 - item version interviewer - administered  -  how much problem did your family have
whodas 2 .0 36 - item version interviewer - administered  -  problem doing things for relaxation
whodas 2 .0 36 - item version interviewer - administered  -  how many days difficulties present
whodas 2 .0 36 - item version interviewer - administered  -  days unable to carry out activities
whodas 2 .0 36 - item version interviewer - administered  -  how many days reduce activities
acinar cell
whodas 2 .0 36 - item version proxy - administered  -  i am  ( fill in the blank )  of this person
whodas 2 .0 36 - item version proxy - administered  -  concentrating for ten minutes
whodas 2 .0 36 - item version proxy - administered  -  remembering to do important things
whodas 2 .0 36 - item version proxy - administered  -  finding solutions to problems
whodas 2 .0 36 - item version proxy - administered  -  learning a new task
whodas 2 .0 36 - item version proxy - administered  -  understanding what people say
whodas 2 .0 36 - item version proxy - administered  -  starting or maintaining conversation
whodas 2 .0 36 - item version proxy - administered  -  standing for long periods
whodas 2 .0 36 - item version proxy - administered  -  standing up from sitting down
whodas 2 .0 36 - item version proxy - administered  -  moving around inside their home
ependyma
whodas 2 .0 36 - item version proxy - administered  -  getting out of their home
whodas 2 .0 36 - item version proxy - administered  -  walking a long distance
whodas 2 .0 36 - item version proxy - administered  -  washing his or her whole body
whodas 2 .0 36 - item version proxy - administered  -  getting dressed
whodas 2 .0 36 - item version proxy - administered  -  eating
whodas 2 .0 36 - item version proxy - administered  -  staying by him or herself a few days
whodas 2 .0 36 - item version proxy - administered  -  dealing with people does not know
whodas 2 .0 36 - item version proxy - administered  -  maintaining a friendship
whodas 2 .0 36 - item version proxy - administered  -  get along with people close to him
whodas 2 .0 36 - item version proxy - administered  -  making new friends
neural pathway
whodas 2 .0 36 - item version proxy - administered  -  sexual activities
whodas 2 .0 36 - item version proxy - administered  -  care of household responsibilities
whodas 2 .0 36 - item version proxy - administered  -  doing important household tasks
whodas 2 .0 36 - item version proxy - administered  -  getting household work done needed
whodas 2 .0 36 - item version proxy - administered  -  getting household work done quickly
whodas 2 .0 36 - item version proxy - administered  -  their day - to - day work or school
whodas 2 .0 36 - item version proxy - administered  -  doing important work or school tasks
whodas 2 .0 36 - item version proxy - administered  -  getting all work done you need
whodas 2 .0 36 - item version proxy - administered  -  getting work done quickly as needed
whodas 2 .0 36 - item version proxy - administered  -  problem joining community activities
poly  ( rgd )
afferent pathway
whodas 2 .0 36 - item version proxy - administered  -  problem because of barriers in world
whodas 2 .0 36 - item version proxy - administered  -  problem living with dignity
whodas 2 .0 36 - item version proxy - administered  -  time spend on your health condition
whodas 2 .0 36 - item version proxy - administered  -  emotionally affected by health
whodas 2 .0 36 - item version proxy - administered  -  drain on financial resources
whodas 2 .0 36 - item version proxy - administered  -  problem did your family have
whodas 2 .0 36 - item version proxy - administered  -  problem doing things for relaxation
whodas 2 .0 36 - item version proxy - administered  -  how many days difficulties present
whodas 2 .0 36 - item version proxy - administered  -  days unable to carry out activities
whodas 2 .0 36 - item version proxy - administered  -  how many days reduce activities
efferent pathway
whodas 2 .0 36 - item version self - administered  -  concentrating for ten minutes
whodas 2 .0 36 - item version self - administered  -  remembering to do important things
whodas 2 .0 36 - item version self - administered  -  finding solutions to problems
whodas 2 .0 36 - item version self - administered  -  learning a new task
whodas 2 .0 36 - item version self - administered  -  understanding what people say
whodas 2 .0 36 - item version self - administered  -  starting or maintaining conversation
whodas 2 .0 36 - item version self - administered  -  standing for long periods
whodas 2 .0 36 - item version self - administered  -  standing up from sitting down
whodas 2 .0 36 - item version self - administered  -  moving around inside your home
whodas 2 .0 36 - item version self - administered  -  getting out of your home
internal capsule
whodas 2 .0 36 - item version self - administered  -  walking a long distance
whodas 2 .0 36 - item version self - administered  -  washing your whole body
whodas 2 .0 36 - item version self - administered  -  getting dressed
whodas 2 .0 36 - item version self - administered  -  eating
whodas 2 .0 36 - item version self - administered  -  staying by yourself for a few days
whodas 2 .0 36 - item version self - administered  -  dealing with people you do not know
whodas 2 .0 36 - item version self - administered  -  maintaining a friendship
whodas 2 .0 36 - item version self - administered  -  get along with people close to you
whodas 2 .0 36 - item version self - administered  -  making new friends
whodas 2 .0 36 - item version self - administered  -  sexual activities
medial forebrain bundle
whodas 2 .0 36 - item version self - administered  -  care of household responsibilities
whodas 2 .0 36 - item version self - administered  -  doing important household tasks
whodas 2 .0 36 - item version self - administered  -  getting household work done needed
whodas 2 .0 36 - item version self - administered  -  getting household work done quickly
whodas 2 .0 36 - item version self - administered  -  your day - to - day work or school
whodas 2 .0 36 - item version self - administered  -  doing important work or school tasks
whodas 2 .0 36 - item version self - administered  -  getting all work done you need
whodas 2 .0 36 - item version self - administered  -  getting work done quickly as needed
whodas 2 .0 36 - item version self - administered  -  problem joining community activities
whodas 2 .0 36 - item version self - administered  -  problem because of barriers in world
perforant pathway
whodas 2 .0 36 - item version self - administered  -  problem living with dignity
whodas 2 .0 36 - item version self - administered  -  time spend on your health condition
whodas 2 .0 36 - item version self - administered  -  emotionally affected by health
whodas 2 .0 36 - item version self - administered  -  drain on financial resources
whodas 2 .0 36 - item version self - administered  -  problem did your family have
whodas 2 .0 36 - item version self - administered  -  problem doing things for relaxation
whodas 2 .0 36 - item version self - administered  -  how many days difficulties present
whodas 2 .0 36 - item version self - administered  -  days unable to carry out activities
whodas 2 .0 36 - item version self - administered  -  how many days reduce activities
whodas 2 .0 12 + 24 - item version interviewer - administered  -  living situation at interview
alveolar wall
whodas 2 .0 12 + 24 - item version interviewer - administered  -  observed sex
whodas 2 .0 12 + 24 - item version interviewer - administered  -  how old are you now
whodas 2 .0 12 + 24 - item version interviewer - administered  -  years studying in school or college
whodas 2 .0 12 + 24 - item version interviewer - administered  -  current marital status
whodas 2 .0 12 + 24 - item version interviewer - administered  -  describes main work status best
whodas 2 .0 12 + 24 - item version interviewer - administered  -  standing for long periods
whodas 2 .0 12 + 24 - item version interviewer - administered  -  care of household responsibilities
whodas 2 .0 12 + 24 - item version interviewer - administered  -  learning a new task
whodas 2 .0 12 + 24 - item version interviewer - administered  -  problem joining community activities
whodas 2 .0 12 + 24 - item version interviewer - administered  -  emotionally affected by health
prostate capsule
whodas 2 .0 12 + 24 - item version interviewer - administered  -  concentrating for ten minutes
whodas 2 .0 12 + 24 - item version interviewer - administered  -  walking a long distance
whodas 2 .0 12 + 24 - item version interviewer - administered  -  washing your whole body
whodas 2 .0 12 + 24 - item version interviewer - administered  -  getting dressed
whodas 2 .0 12 + 24 - item version interviewer - administered  -  dealing with people you do not know
whodas 2 .0 12 + 24 - item version interviewer - administered  -  maintaining a fiendship
whodas 2 .0 12 + 24 - item version interviewer - administered  -  your day - to - day work
whodas 2 .0 12 + 24 - item version interviewer - administered  -  remembering to do important things
whodas 2 .0 12 + 24 - item version interviewer - administered  -  finding solutions to problems
whodas 2 .0 12 + 24 - item version interviewer - administered  -  understanding what people say
apex of the prostate
whodas 2 .0 12 + 24 - item version interviewer - administered  -  starting or maintaining conversation
whodas 2 .0 12 + 24 - item version interviewer - administered  -  standing up from sitting down
whodas 2 .0 12 + 24 - item version interviewer - administered  -  moving around inside your home
whodas 2 .0 12 + 24 - item version interviewer - administered  -  getting out of your home
whodas 2 .0 12 + 24 - item version interviewer - administered  -  eating
whodas 2 .0 12 + 24 - item version interviewer - administered  -  staying by yourself for a few days
whodas 2 .0 12 + 24 - item version interviewer - administered  -  get along with people close to you
whodas 2 .0 12 + 24 - item version interviewer - administered  -  making new friends
whodas 2 .0 12 + 24 - item version interviewer - administered  -  sexual activities
whodas 2 .0 12 + 24 - item version interviewer - administered  -  doing important household tasks
base of the prostate
whodas 2 .0 12 + 24 - item version interviewer - administered  -  getting household work done needed
whodas 2 .0 12 + 24 - item version interviewer - administered  -  getting household work done quickly
whodas 2 .0 12 + 24 - item version interviewer - administered  -  reduce or miss household work
whodas 2 .0 12 + 24 - item version interviewer - administered  -  doing important work or school tasks
whodas 2 .0 12 + 24 - item version interviewer - administered  -  getting all work done you need
whodas 2 .0 12 + 24 - item version interviewer - administered  -  getting work done quickly as needed
whodas 2 .0 12 + 24 - item version interviewer - administered  -  had to work at a lower level
whodas 2 .0 12 + 24 - item version interviewer - administered  -  earn less money
whodas 2 .0 12 + 24 - item version interviewer - administered  -  miss work half day or more
whodas 2 .0 12 + 24 - item version interviewer - administered  -  problem because of barriers in world
anterior surface of the prostate
whodas 2 .0 12 + 24 - item version interviewer - administered  -  problem living with dignity
whodas 2 .0 12 + 24 - item version interviewer - administered  -  time spend on your health condition
whodas 2 .0 12 + 24 - item version interviewer - administered  -  drain on financial resources
whodas 2 .0 12 + 24 - item version interviewer - administered  -  problem did your family have
whodas 2 .0 12 + 24 - item version interviewer - administered  -  problem doing things for relaxation
whodas 2 .0 12 + 24 - item version interviewer - administered  -  how many days difficulties present
whodas 2 .0 12 + 24 - item version interviewer - administered  -  days unable to carry out activities
whodas 2 .0 12 + 24 - item version interviewer - administered  -  how many days reduce activities
whodas 2 .0 12 - item version interviewer - administered  -  living situation at interview
whodas 2 .0 12 - item version interviewer - administered  -  observed sex
recombinant fibroblast growth factor 4
inferolateral surface of the prostate
whodas 2 .0 12 - item version interviewer - administered  -  how old are you now
whodas 2 .0 12 - item version interviewer - administered  -  years studying in school or college
whodas 2 .0 12 - item version interviewer - administered  -  current marital status
whodas 2 .0 12 - item version interviewer - administered  -  describes main work status best
whodas 2 .0 12 - item version interviewer - administered  -  standing for long periods
whodas 2 .0 12 - item version interviewer - administered  -  care of household responsibilities
whodas 2 .0 12 - item version interviewer - administered  -  learning a new task
whodas 2 .0 12 - item version interviewer - administered  -  problem joining community activities
whodas 2 .0 12 - item version interviewer - administered  -  emotionally affected by health
whodas 2 .0 12 - item version interviewer - administered  -  concentrating for ten minutes
surface of the prostate
whodas 2 .0 12 - item version interviewer - administered  -  walking a long distance
whodas 2 .0 12 - item version interviewer - administered  -  washing your whole body
whodas 2 .0 12 - item version interviewer - administered  -  getting dressed
whodas 2 .0 12 - item version interviewer - administered  -  dealing with people you do not know
whodas 2 .0 12 - item version interviewer - administered  -  maintaining a friendship
whodas 2 .0 12 - item version interviewer - administered  -  your day - to - day work or school
whodas 2 .0 12 - item version interviewer - administered  -  how many days difficulties present
whodas 2 .0 12 - item version interviewer - administered  -  days unable to carry out activities
whodas 2 .0 12 - item version interviewer - administered  -  how many days reduce activities
whodas 2 .0 12 - item version proxy - administered  -  i am the  ( fill in the blank )  of this person
lateral lobe of the prostate
whodas 2 .0 12 - item version proxy - administered  -  standing for long periods
whodas 2 .0 12 - item version proxy - administered  -  care of household responsibilities
whodas 2 .0 12 - item version proxy - administered  -  learning a new task
whodas 2 .0 12 - item version proxy - administered  -  problem joining community activities
whodas 2 .0 12 - item version proxy - administered  -  emotionally affected by health
whodas 2 .0 12 - item version proxy - administered  -  concentrating for ten minutes
whodas 2 .0 12 - item version proxy - administered  -  walking a long distance
whodas 2 .0 12 - item version proxy - administered  -  washing his or her whole body
whodas 2 .0 12 - item version proxy - administered  -  getting dressed
whodas 2 .0 12 - item version proxy - administered  -  dealing with people does not know
posterior lobe of the prostate
whodas 2 .0 12 - item version proxy - administered  -  maintaining a friendship
whodas 2 .0 12 - item version proxy - administered  -  your day - to - day work or school
whodas 2 .0 12 - item version proxy - administered  -  how many days difficulties present
whodas 2 .0 12 - item version proxy - administered  -  days unable to carry out activities
whodas 2 .0 12 - item version proxy - administered  -  how many days reduce activities
whodas 2 .0 12 - item version self - administered  -  standing for long periods
whodas 2 .0 12 - item version self - administered  -  care of household responsibilities
whodas 2 .0 12 - item version self - administered  -  learning a new task
whodas 2 .0 12 - item version self - administered  -  problem joining community activities
whodas 2 .0 12 - item version self - administered  -  emotionally affected by health
middle lobe of the prostate
whodas 2 .0 12 - item version self - administered  -  concentrating for ten minutes
whodas 2 .0 12 - item version self - administered  -  walking a long distance
whodas 2 .0 12 - item version self - administered  -  washing your whole body
whodas 2 .0 12 - item version self - administered  -  getting dressed
whodas 2 .0 12 - item version self - administered  -  dealing with people you do not know
whodas 2 .0 12 - item version self - administered  -  maintaining a friendship
whodas 2 .0 12 - item version self - administered  -  your day - to - day work or school
whodas 2 .0 12 - item version self - administered  -  how many days difficulties present
whodas 2 .0 12 - item version self - administered  -  days unable to carry out activities
whodas 2 .0 12 - item version self - administered  -  how many days reduce activities
posterior surface of the prostate
posterior cranial fossa neoplasm
stage ia mycosis fungoides ajcc v7
ros1 gene mutation
truth agreement scale
truth agreement score 1
truth agreement score 2
truth agreement score 3
truth agreement score 4
truth agreement score 5
device for dressing usually used
special or built up chair usually used
special or built up utensils usually used
cane usually used
walker usually used
crutches usually used
wheelchair usually used
raised toilet seat usually used
bathtub seat usually used
bathtub bar usually used
long - handled appliances in bathroom usually used
long - handled appliances for reach usually used
jar opener usually used
usually need help from another person for dressing and grooming
usually need help from another person for eating
usually need help from another person for arising
usually need help from another person for walking
usually need help from another person for hygiene
usually need help from another person for reach
usually need help from another person for gripping and opening things
usually need help from another person for errands and chores
orifice of human prostatic duct
surface mail
have very mild bloating
10p13 - p14 deletion syndrome
barakat syndrome
cole - carpenter syndrome
distal 18q deletion syndrome
image syndrome
immunoglobulin superfamily member 1 deficiency syndrome
insulin receptor mutation  -  associated insulin resistance syndromes
kenny - caffey syndrome
kenny - caffey syndrome type 1
kenny - caffey syndrome type 2
laron syndrome
low t3 syndrome
maternal diabetes and deafness syndrome
mauriac syndrome
osteoporosis pseudoglioma syndrome
ro 31 - 8220
prostatic muscular tissue
rabson - mendenhall syndrome
rieger syndrome
simpson - golabi - behmel syndrome
single central incisor syndrome
sotos syndrome
wilms tumor 1 gene syndromes
wolcott - rallison syndrome
hyperandrogenism ,  insulin resistance ,  acanthosis nigricans syndrome
immune dysregulation ,  polyendocrinopathy ,  and enteropathy x - linked syndrome
prostatic urethra
mullerian - renal - cervical spine syndrome
bcr / abl1 fusion gene with abl1 nm_005157 .4:c .764a > t mutation
bcr / abl1 fusion gene with abl1 nm_005157 .4:c .827a > g mutation
bcr / abl1 fusion gene with abl1 nm_005157 .4:c .835g > a mutation
bcr / abl1 fusion protein with abl1 np_005148 .2:p .e255v
bcr / abl1 fusion protein with abl1 np_005148 .2:p .d276g
bcr / abl1 fusion protein with abl1 np_005148 .2:p .e279k
recombinant human bone morphogenetic protein 4
bempegaldesleukin
prostatic duct
arugula seed powder
tshr gene mutation
thyroid - binding globulin deficiency
thyroid - binding globulin excess
gvhd final skin score
gvhd final skin score 0
gvhd final skin score 1
gvhd final skin score 2
gvhd final skin score 3
prostatic epithelium
transient hyperinsulinism
transient hypothyroxinemia
transient neonatal hyperparathyroidism
gvhd body surface area involvement score
transient primary hypothyroidism
bsa involvement score 0
bsa involvement score 1
bsa involvement score 2
bsa involvement score 3
gvhd skin features score
prostatic stroma
skin features score 0
skin features score 2
skin features score 3
gvhd final lung score
gvhd final lung score 0
gvhd final lung score 1
thyroid stimulating hormone resistance
gvhd final lung score 2
gvhd final lung score 3
gvhd lung symptom score
gvhd lung symptom score 0
gvhd lung symptom score 1
gvhd lung symptom score 2
gvhd lung symptom score 3
gvhd lung obstructive function score
lung obstructive function score 0
lung obstructive function score 1
lung obstructive function score 2
lung obstructive function score 3
txnrd2 - associated familial glucocorticoid deficiency
human verumontanum
checkpoint blockade immunotherapy
myc positive
mycn positive
cd5 positive
t ( 11 ; 14 )  negative
epha2 protein overexpression
cd22 positive
bcr / abl1 fusion protein negative
met positive
ret fusion positive
wall of prostatic duct
ntrk1 fusion positive
ros1 fusion positive
uninodular goiter
vitamin d 1 alpha - hydroxylase deficiency
vitamin d 25 - hydroxylase deficiency
vitamin d dependent rickets 2a
vitamin d dependent rickets 2b
vitamin d dependent rickets 2
wolff - chaikoff phenomenon
x - linked hypoparathyroidism
fascia
testicular failure
steroidogenic acute regulatory protein deficiency
impression
11 beta - hydroxysteroid dehydrogenase type 2 deficiency
11 - beta - hydroxysteroid dehydrogenase type 1 deficiency
11 - beta - hydroxylase deficiency
17 - alpha - hydroxylase / 17 , 20 lyase deficiency
21 - hydroxylase deficiency
3 - beta - hydroxysteroid dehydrogenase deficiency
acquired generalized lipodystrophy
acquired ovarian failure
acquired testicular failure
3 - log reduction in ph +  cells
idh1 nm_005896 .3:c .394c > a
idh1 nm_005896 .3:c .394_395delcginstc
idh1 np_005887 .2:p .r132s
idh1 nm_005896 .3:c .394c > g
idh1 np_005887 .2:p .r132g
idh1 nm_005896 .3:c .394c > t
idh1 np_005887 .2:p .r132c
tacrolimus
idh1 nm_005896 .3:c .395g > t
idh1 np_005887 .2:p .r132l
idh1 nm_005896 .3:c .356g > a
idh1 np_005887 .2:p .r119q
tert gene mutation
quite a bit of strain
tert nm_198253 .2:c .1 - 146c > t
tert nm_198253 .2:c .1 - 124c > t
idh2 nm_002168 .3:c .514a > g
idh2 np_002159 .2:p .r172g
idh2 nm_002168 .3:c .515g > a
idh2 nm_002168 .3:c .515_516delgginsaa
idh2 np_002159 .2:p .r172k
idh2 nm_002168 .3:c .515g > t
idh2 np_002159 .2:p .r172m
poliovirus receptor staining finding
poliovirus receptor 3 +  staining finding
poliovirus receptor 2 +  staining finding
poliovirus receptor 1 +  staining finding
test not ordered
macrocytic red blood cell
unable to perform
insufficient sample
block depleted
fda terminology
continuous temperature monitoring device
glucocorticoid sensitivity
nfkb1 gene product
nuclear factor nf - kappa - b p50 subunit
circulating tumor - reactive t - cell
cea - muc - 1 - tricom vaccine cv301
immature granulocyte
stat5b deficiency
immunotherapy response assessment in neuro - oncology criteria
secondary parathyroid hormone resistance
sclerosteosis
salt - wasting 21 - hydroxylase deficiency
renal parathyroid hormone resistance
alk gene amplification
immune - mediated adverse reaction
renal bed
arhgap32 gene
promyelocyte
arhgap32 wt allele
rho gtpase - activating protein 32
pseudoresponse
immunoprogression
immunoresponse
tnp2 gene
tnp2 wt allele
nuclear transition protein 2
card9 gene
card9 wt allele
myelocyte
caspase recruitment domain - containing protein 9
mst1 gene
mst1 wt allele
hepatocyte growth factor - like protein
promis sexual function and satisfaction measures
global satisfaction with sex life subordinate domain
interest in sexual activity subordinate domain
sexual function and satisfaction interfering factors subordinate domain
how satisfied with sex life
how much pleasure sex life gives
metamyelocyte
how often thought sex life is wonderful
how satisfied with sexual relationship with partner
how much enjoyment from sexual activity
how satisfied with sexual activity
how interested in sexual activity
how often feel like want to have sex
how often have sexual thoughts or fantasies while awake
how often interested enough to start sexual activity
how much fatigue or lack of energy affects satisfaction with sex life
past 30 days no partner
band cell
past 30 days no fatigue or lack of energy
ubash3a gene
ubash3a wt allele
ubiquitin - associated and sh3 domain - containing protein a
anti - cd352 antibody - drug conjugate sgn - cd352a
anti - egfr / her2 / her3 monoclonal antibody mixture sym013
immune - mediated
cereblon modulator cc - 90009
rucaparib camsylate
met exon 14 skipping mutation
immature lymphocyte
gpr35 gene
a .m .
gpr35 wt allele
p .m .
g - protein coupled receptor 35
raver1 gene
raver1 wt allele
pycnodysostosis
ribonucleoprotein ptb - binding 1
znf365 gene
prolymphocyte
znf365 wt allele
znf365 gene product
talanin
progressive heterotopic heteroplasia
protein znf365
primary testicular failure
primary pigmented nodular adrenal dysplasia
lce3b gene
lce3b wt allele
late cornified envelope protein 3b
generic drug
immature monocyte
nxpe1 gene
nxpe1 wt allele
nxpe family member 1
becn2 gene
becn2 wt allele
beclin - 2
sammson gene
sammson wt allele
survival associated mitochondrial melanoma specific oncogenic non - coding rna
recurrent gliosarcoma
promonocyte
carbon c 11 pittsburgh compound b
fluorine f18 t807
nab - paclitaxel / rituximab - coated nanoparticle ar160
autologous icasp9 - deltangfr - cd19car - expressing t cells
montanide isa - 51 vg / klh / ny - eso - 1 / mart - 1 peptide vaccine
pituitary resistance to thyroid hormone
crlf2 positive
recurrent urethral urothelial carcinoma
slk gene
megakaryoblast
slk wt allele
ste20 - like serine / threonine - protein kinase
reason form not complete
hard to walk more than one block
stag1 gene
hard to run
stag1 wt allele
hard to do sports activity or exercise
cohesin subunit sa - 1
hard to lift something heavy
memory b - lymphocyte
hard to bathe or shower
hard to do chores
hurt or ache
feel afraid or scared
feel sad or blue
feel angry
worry about what will happen
pitrm1 gene
pitrm1 wt allele
trouble getting along with others
epithelial reticular cell
presequence protease ,  mitochondrial
others not want to be friends
others tease me
cannot do things others same age can
hard to keep up with peers
hard to pay attention in class
forget things
have trouble keeping up with schoolwork
miss school because of not feeling well
miss school to go to doctor or hospital
form not presented or mailed to parent
parental refusal for current questionnaire
parent given form and form not returned
parent wishes to withdraw from further participation in the study
parent did not come to clinic and mailed form not returned
patient too ill to complete form at this assessment
parent or guardian does not speak english
severe cognitive impairments
mt - rnr2 gene
mt - rnr2 wt allele
immature platelet
humanin
16s mitochondrial ribosomal rna
comp gene
comp wt allele
cartilage oligomeric matrix protein
pmp2 gene
pmp2 wt allele
myelin p2 protein
bcorl1 gene
bcorl1 wt allele
7p15 - p14
bcl - 6 corepressor - like protein 1
suspicious
cep350 gene
cep350 wt allele
centrosome - associated protein 350
peripheral resistance to thyroid hormone
tspan3 gene
perinatal - stress induced hyperinsulinism
tspan3 wt allele
tetraspanin - 3
7q35
fgl2 gene
fgl2 wt allele
fibroleukin
battlefield acupuncture
trpc4ap gene
trpc4ap wt allele
short transient receptor potential channel 4 - associated protein
klh / ny - eso - 1 / mart - 1 peptide - pulsed dendritic cell vaccine
carbon c14 egfr inhibitor asp8273
2 - fluorofucose - containing sgn - 2ff
proerythroblast
gpc1 gene
tiragolumab
gpc1 wt allele
glypican - 1
cintirorgon
anti - ha epitope monoclonal antibody medi8852
partial lipodystrophy
mc4r gene
parathyroid hormone resistance
mc4r wt allele
basophilic erythroblast
melanocortin receptor 4
anti - csf1 monoclonal antibody pd - 0360324
p450 oxidoreductase deficiency
lsd1 inhibitor cc - 90011
interleukin - 35
ex vivo - expanded autologous t cells ima101
risperidone formulation in rumenic acid
pegylated liposomal mitoxantrone hydrochloride
osteoclast - rich osteopetrosis
odontohypophosphatasia
autologous cytokine - induced killer cells
sipjeondaebo - tang
egr2 gene
egr2 wt allele
e3 sumo - protein ligase egr2
eif1ax gene
eif1ax wt allele
eukaryotic translation initiation factor 1a ,  x - chromosomal
fopnl gene
fopnl wt allele
orthochromatic erythroblast
lish domain - containing protein fopnl
ntrk2 gene rearrangement
reg1a gene
reg1a wt allele
lithostathine - 1 - alpha
ntrk3 gene rearrangement
egfr t790m mutation negative
folate receptor alpha positive
cytomegalovirus positive
pole exonuclease domain mutation
past 30 days
ischemia procedure
transperitoneal
oligomeric procyanidin complex
toripalimab
erk1 / 2 inhibitor ly3214996
multiple taa - loaded dendritic cell vaccine
diaph3 gene
diaph3 wt allele
protein diaphanous homolog 3
2q37
past seven days frequency of nosebleeds
asip gene
asip wt allele
agouti - signaling protein
worst severity past seven days nosebleeds
past seven days any flashing lights in front of your eyes
past seven days any spots or lines that drift in front of your eyes
past seven days any urine color change
past seven days unexpected decrease in sweating
oca2 gene
xp11 .23
past seven days any pain ,  swelling ,  or redness at site of drug injection or iv
past seven days frequency of shivering or shaking chills
worst severity past seven days shivering or shaking chills
past seven days frequency of hot flashes
oca2 wt allele
worst severity past seven days hot flashes
p protein
past seven days frequency of unexpected or excessive sweating during the day or nighttime
worst severity past seven days unexpected or excessive sweating during the day or nighttime
stn1 gene
19q13 .2 - q13 .3
stn1 wt allele
cst complex subunit stn1
cdkal1 gene
cdkal1 wt allele
threonylcarbamoyladenosine trna methylthiotransferase
agr3 gene
agr3 wt allele
anterior gradient protein 3 homolog
spherical nucleic acid nanoparticle nu - 0129
pediatric quality of life inventory - multidimensional fatigue scale
13q33
feel too tired to do things i like to do
feel too tired to spend time with friends
have trouble finishing things
have trouble starting things
sleep a lot
hard to sleep through night
feel tired when wake up
rest a lot
take lots of naps
spend a lot of time in bed
16p13 .3 - p13 .11
hard to keep attention on things
hard to remember what people tell me
hard to remember what i just heard
hard to think quickly
have trouble remembering what i was just thinking
have trouble remembering more than one thing at a time
cd3 positive
rotterdam symptom checklist
bothered by lack of appetite
bothered by irritability
3q22 - q24
bothered by tiredness
bothered by worrying
bothered by sore muscles
bothered by depressed mood
bothered by lack of energy
bothered by low back pain
bothered by nervousness
bothered by despairing about the future
bothered by difficulty sleeping
bothered by headaches
trimetrexate
7q11 - q22
bothered by dizziness
bothered by decreased sexual interest
bothered by tension
bothered by abdominal aches
bothered by anxiety
bothered by diarrhea
bothered by shivering
bothered by tingling hands or feet
bothered by sore mouth and / or pain when swallowing
bothered by burning and / or sore eyes
bothered by shortness of breath
bothered by dry mouth
ability to care for myself
ability to go to work
only with help
without help ,  with difficulty
moderately good
neither good nor bad
rather poor
extremely poor
mucus - secreting cell
blomstrand type chondrodysplasia
calcium deficiency rickets
cholesterol side - chain cleavage deficiency
classic congenital adrenal hyperplasia
congenital hyperinsulinism
congenital lipoid adrenal hyperplasia
congenital ovarian failure
congenital testicular failure
craniodiaphyseal dysplasia
club cell
craniotubular hyperostosis
defective thyroglobulin synthesis
defective thyroglobulin transport
neonatal graves disease
ceramide nanoliposome
deiodinase deficiency
diffuse goiter
nodular goiter
multinodular goiter
anti - cdh6 antibody - drug conjugate hkt288
squamous alveolar lining cell
hypothyroid goiter
non - classic congenital adrenal hyperplasia
hla - a*0205 positive cells present
hla - a*0206 positive cells present
nutritional calcium deficient rickets
nutritional hypophosphatemic rickets
nutritional rickets
nutritional vitamin d deficiency rickets
hypophosphatemic rickets
epithelial receptor cell
hereditary hypophosphatemic rickets with hypercalciuria
familial glucocorticoid deficiency type 3
familial glucocorticoid deficiency type 4
emsy gene amplification
fancd2 gene amplification
fance gene amplification
fancc gene amplification
fanca gene amplification
mismatch repair protein proficient
microsatellite stable
intercalated cell
pdgfra positive
msh2 nm_000251 .2:c .1906g > c
msh2 protein variant
msh2 np_000242 .1:p .a636p
blm nm_000057 .3:c .2207_2212delatctgainstagattc
blm protein variant
blm np_000048 .1:p .y736fs*4
brca1 protein variant
brca2 protein variant
bovine leukemia
taste bud cell
bovine congenital erythropoietic porphyria
bovine protoporphyria
brca1 nm_007294 .3:c .68_69delag
brca1 np_009225 .1:p .e23vfs*17
brca1 nm_007294 .3:c .5265_5266insc
brca1 np_009225 .1:p .q1756pfs
brca2 nm_000059 .3:c .5946delt
brca2 np_000050 .2:p .s1982rfs*22
atr gene mutation
light cell
rad51c gene mutation
rad51d gene mutation
rb1 negative
irreversible electroporation
fbxw7 gene mutation
tnfrsf8 low
jak2 fusion positive
fcer2 negative
human papillomavirus negative
abl2 gene rearrangement
type iii epithelial receptor cell
abl1 gene rearrangement
bxq - 350 nanovesicle formulation
egfr / flt3 / abl inhibitor sklb1028
autologous anti - mg7 - car t - lymphocytes
dpx - e7 hpv vaccine
hpv types 16 / 18 e6 / e7 - adenoviral transduced autologous lymphocytes / alpha - galactosylceramide vaccine bvac - c
anti - androgen sirna sxl01
fluorine f 18 ods2004436
zirconium zr 89 nanocolloidal albumin
artificial pancreas
aflatoxin b1
olfactory epithelial cell
recurrent primary malignant neoplasm
recurrent subsequent malignant neoplasm
acute myeloid leukemia with t ( 5 ; 11 )  ( q35 ; p15 )  ;  nup98 - nsd1
t ( 5 ; 11 )  ( q35 ; p15 )
acute myeloid leukemia with t ( 11 ; 15 )  ( p15 ; q35 )  ;  nup98 - jarid1a
t ( 11 ; 15 )  ( p15 ; q35 )
childhood melanoma
dchs1 gene
dchs1 wt allele
protocadherin - 16
olfactory receptor cell
zdhhc2 gene
zdhhc2 wt allele
palmitoyltransferase zdhhc2
sema3d gene
sema3d wt allele
semaphorin - 3d
mir483 gene
mir483 wt allele
mir483 pre - mirna
microrna 483 - 5p
olfactory supporting cell
microrna 193a - 5p
microrna 7
ube2t gene
ube2t wt allele
ubiquitin - conjugating enzyme e2 t
premorbid adjustment scale
ependymal tumor of spinal cord
brief psychiatric rating scale  -  version 4
computerized neurocognitive battery
auditory continuous performance test
olfactory basal cell
ax - continuous performance test
structured clinical interview for dsm - 5
three - dimensional magnetization - prepared rapid gradient echo imaging
bohring - opitz syndrome
cxcr4 antagonist usl311
osilodrostat
non - fucosylated umbilical cord blood regulatory t - cells
anti - pd - l1 monoclonal antibody faz053
egln2 gene
egln2 wt allele
bipolar neuron
egl nine homolog 2
foxc1 gene
foxc1 wt allele
forkhead box protein c1
fstl1 gene
fstl1 wt allele
follistatin - related protein 1
wwox gene
wwox wt allele
ganglion cell
ww domain - containing oxidoreductase
mcm8 gene
mcm8 wt allele
dna helicase mcm8
mcm9 gene
mcm9 wt allele
dna helicase mcm9
ny - eso - 1 positive tumor cells present
somatostatin receptor 2 positive
mapk15 gene
receptor cell
mapk15 wt allele
mitogen - activated protein kinase 15
sstr2 - targeting protein / dm1 conjugate pen - 221
nsmce2 gene
nsmce2 wt allele
e3 sumo - protein ligase nse2
scn5a gene
scn5a wt allele
sodium channel protein type 5 subunit alpha
etfa gene
cuboidal cell
etfa wt allele
electron transfer flavoprotein subunit alpha ,  mitochondrial
anti - cxcr4 monoclonal antibody pf - 06747143
frontal lobe ependymal tumor
temporal lobe ependymal tumor
parietal lobe ependymal tumor
cerebellar ependymal tumor
ventricular ependymal tumor
ventricular and brain stem ependymal tumor
joint replacement
columnar cell
recombinant vesicular stomatitis virus - expressing human interferon beta and sodium - iodide symporter
parietal lobe and occipital lobe ependymal tumor
temporal lobe and parietal lobe ependymal tumor
cerebellar and ventricular ependymal tumor
frontal lobe and parietal lobe ependymal tumor
cerebellar and brain stem ependymal tumor
cerebellar ,  fourth ventricle ,  and brain stem ependymal tumor
posterior cranial fossa ependymal tumor
polr3b gene
occipital lobe ,  parietal lobe ,  and ventricular ependymal tumor
mesangial cell
polr3b wt allele
dna - directed rna polymerase iii subunit rpc2
cerebellar ,  brain stem ,  and cervical spinal cord ependymal tumor
fourth ventricle ependymal tumor
lateral ventricle ependymal tumor
third ventricle ependymal tumor
fourth ventricle and brain stem ependymal tumor
cerebellar and fourth ventricle ependymal tumor
temporal lobe ,  parietal lobe ,  and lateral ventricle ependymal tumor
srgap2 gene
oxidopamine
srgap2 wt allele
cervical spinal cord ependymal tumor
slit - robo rho gtpase - activating protein 2
thoracic spinal cord ependymal tumor
lumbosacral spinal cord ependymal tumor
cervical and thoracic spinal cord ependymal tumor
thoracic and lumbosacral spinal cord ependymal tumor
albumin - binding cisplatin prodrug btp - 114
cervical and lumbosacral spinal cord ependymal tumor
cervical ,  thoracic ,  and lumbosacral spinal cord ependymal tumor
juxtaglomerular cell
ependymal tumor of brain and spinal cord
supratentorial ependymal tumor
infratentorial ependymal tumor
infratentorial and spinal cord ependymal tumor
casc4 gene
casc4 wt allele
protein casc4
recurrent ependymal tumor
ventricular involvement only
magea10 positive
deleterious germline mutation
acquired factor i deficiency
acquired factor ii deficiency
acquired factor iii deficiency
acquired factor v deficiency
acquired factor vii deficiency
acquired factor x deficiency
acquired factor xi deficiency
acquired factor xii deficiency
acquired factor xiii deficiency
anemia due to erythrocyte enzyme disorder
factor vii deficiency
factor x deficiency
factor xiii deficiency
platelet disorder
tissue factor deficiency
have difficulty breathing when exposed to cold temperatures
beta - d - glucan assay
bisphosphoglycerate mutase deficiency
epstein syndrome
epicardium
erythrocyte adenylate kinase deficiency
erythrocyte enolase deficiency
fechtner syndrome
glucose phosphate isomerase deficiency
hereditary factor iii deficiency
hexokinase deficiency
may - hegglin anomaly
phosphoglycerate mutase deficiency
plasma kallikrein deficiency
pyrimidine - 5' - nucleotidase deficiency
sebastian syndrome
tissue kallikrein deficiency
triosephosphate isomerase deficiency
acquired thrombotic thrombocytopenic purpura
alpha - beta t - cell depletion
anemia due to decreased production
anemia due to increased destruction
congenital thrombotic thrombocytopenic purpura
consumptive coagulopathy
dysfibrinogenemia
mucosa
factor i inactivation
factor ii inactivation
factor iii inactivation
factor ix inactivation
factor v inactivation
factor vii inactivation
factor viii inactivation
factor x inactivation
factor xi inactivation
factor xii inactivation
submucosa
factor xiii inactivation
gamma - delta t - cell depletion
gross total resection
immune - mediated coagulopathy
infantile pyknocytosis
matched related donor
matched unrelated donor
megaloblastic anemia 1
mismatched unrelated donor
myeloablative conditioning
partial resection
platelet - type von willebrand disease
sickle cell - ss disease
transient erythroblastopenia of childhood
vitamin b12 deficiency
von willebrand disease ,  type 1
von willebrand disease ,  type 2a
von willebrand disease ,  type 2b
von willebrand disease ,  type 2m
von willebrand disease ,  type 2n
serosa
pan - mutant - idh1 inhibitor bay - 1436032
have skin tightness
have raw or sore skin
have dry or itchy skin
have a skin rash
have shiny skin scar
have scaly or flaky skin
have darker or lighter skin than normal
hair thinning or falling out
nails look unusual
bupropion hydrochloride
hassall's corpuscle
eyes feel dry or gritty
have excessive tearing
have eye pain in wind
have difficulty opening eyes on waking
use artificial tears
have tear ducts plugged or cauterized
wear special eyewear or scleral lenses to relieve eye pain
eye dryness affects vision or prevents working
manufactures human over - the - counter drug products produced under a monograph
manufactures human over - the - counter drug products produced under an approved drug application
meissner corpuscle
manufactures human over - the - counter drug products not produced under an approved application or under a monograph
human papillomavirus - 18 positive
using narcotics to relieve mouth symptoms
have mouth or lip sores or ulcers
unable to eat because of mouth pain
have mouth discomfort with hot or cold
have mouth discomfort with toothpaste
have mouth discomfort with spicy food
have mouth discomfort with carbonated beverage
mouth feels dry most of the time
vater - pacini corpuscle
difficult to open mouth wide
mouth symptoms limit oral intake
mouth symptoms partially limit oral intake
mouth symptoms cause major limit to oral intake
sinus draining of liquid into throat
have sinus congestion or pain
had recent sinus infection
had sinus drainage surgery
have poor or reduced appetite
easily full
merkel's corpuscle
foods or pills get stuck
can easily swallow liquid or soft food
have tightness in arms ,  legs ,  or joints
have muscle cramps or pain
have swollen feet ,  ankles ,  or joints
some days
walking on flat ground
factor ii deficiency
factor v deficiency
factor xi deficiency
free nerve ending
factor xii deficiency
13 - hydroxyoctadecadienoic acid
snord50a gene
snord50a wt allele
u50 small nucleolar rna
snord50b gene
snord50b wt allele
u50' small nucleolar rna
smim24 gene
ruffini corpuscle
smim24 wt allele
small integral membrane protein 24
cpxm1 gene
cpxm1 wt allele
probable carboxypeptidase x1
fam30a gene
fam30a wt allele
fam30a protein
long noncoding rna kiaa0125
bone marrow transplant recipient
nociceptor
anastomosing hemangioma
dpysl3 gene
dpysl3 wt allele
dihydropyrimidinase - related protein 3
arhgap22 gene
arhgap22 wt allele
rho gtpase - activating protein 22
nynrin gene
nynrin wt allele
protein nynrin
pigment epithelium
cd276 antigen positive
zbtb46 gene
zbtb46 wt allele
zinc finger and btb domain - containing protein 46
deleterious brip1 gene mutation
deleterious palb2 gene mutation
deleterious bard1 gene mutation
deleterious msh2 gene mutation
deleterious msh6 gene mutation
deleterious mlh1 gene mutation
simple squamous epithelium
deleterious pms2 gene mutation
deleterious rad51c gene mutation
deleterious rad51d gene mutation
dna repair gene mutation
ccnd3 gene amplification
ccnd2 gene amplification
cdk4 gene amplification
cdkn2a negative
chek1 gene mutation
bard1 gene mutation
basilar membrane
fancd2 gene mutation
fance gene mutation
fancc gene mutation
rad50 gene mutation
fanca gene mutation
rad51 gene mutation
cdk12 gene mutation
pole gene mutation
pold1 gene mutation
prkdc gene mutation
lithium carbonate
stratified squamous epithelium
ercc2 gene mutation
polq gene
polq wt allele
dna polymerase theta
polq gene mutation
mre11 gene mutation
nbn gene mutation
cytomegalovirus negative
t ( 2 ; 8 )
pseudostratified columnar ciliated epithelium
t ( 8 ; 22 )
eiken type chondrodysplasia
endosteal hyperostosis
familial dysalbuminemic hyperthyroidism
focal lipodystrophy
generalized lipodystrophy
generalized thyroid hormone resistance
glucagon deficiency
iatrogenic central hypothyroidism
iatrogenic primary hypothyroidism
columnar epithelium
hypothyroxinemia
iodine i 131 mip - 1095
malva sylvestris / alcea digitata herbal compound
sodium nitrate supplement
modified vitamin d binding protein macrophage activator ef - 022
adenovirus - expressing tlr5 / tlr5 agonist nanoformulation m - vm3
vdac / hk2 modulator ointment vda - 110
lsd1 inhibitor img - 7289
anti - cd133 - pe38 - kdel fusion protein
focal katp - associated hyperinsulinism
glucokinase - associated hyperinsulinism
glutamate dehydrogenase 1 hyperinsulinism
hepatocyte nuclear factor 1 - alpha hyperinsulinism
hepatocyte nuclear factor 4 - alpha hyperinsulinism
hyperinsulinism in the infant of a diabetic mother
insulin resistant diabetes mellitus with acanthosis nigricans and hyperandrogenism
mitochondrial hydroxyacyl - coenzyme a dehydrogenase hyperinsulinism
mitochondrial uncoupling protein 2 hyperinsulinism
monocarboxylate transporter 1 hyperinsulinism
periosteum
monogenic hyperinsulinism
obesity - associated insulin resistance
katp - associated hyperinsulinism
diffuse katp - associated hyperinsulinism
edinburgh postnatal depression scale
k atp associated developmental delay ,  epilepsy and neonatal diabetes
k atp associated transient neonatal diabetes mellitus
k atp channel - associated diabetes mellitus
k atp permanent neonatal diabetes
hexose - 6 - phosphate dehydrogenase deficiency
taste bud basal cell
hyperthyroxinemia
hyperphosphatemic familial tumoral calcinosis
congenital hyperthyroidism
neonatal severe primary hyperparathyroidism
ketotic hypoglycemia
idiopathic ketotic hypoglycemia
iatrogenic hypoparathyroidism
hypogonadotropic hypogonadism with adrenal hypoplasia congenita
hypogonadotropic hypogonadism with anosmia
mitochondrial diabetes
a - dna
jod - basedow
juvenile paget disease
gonadotropin - resistant ovary syndrome
iatrogenic contrasexual pubertal development
idiopathic 46 , xy differences of sex development
luteinizing hormone deficiency
isolated non - pigmented micronodular adrenal hyperplasia
miniature adult form of ahc
metaphyseal chondrodysplasia ,  jansen type
amino acid sequence
virus - specific cytotoxic t - lymphocytes
hla - a11 positive cells present
survivin positive
recurrent chronic lymphocytic leukemia / small lymphocytic lymphoma
androgen receptor antagonist trc253
recurrent childhood t acute lymphoblastic leukemia
childhood t acute lymphoblastic leukemia in remission
relational and item - specific encoding task
aya - hears
how often have problem with hearing
amniotic fluid
how severe were hearing problems
how much did hearing problems bother you
how much did hearing problems interfere with daily activities
how hard to hear when you talk to one other person in quiet place
how hard to hear when you talk to group of people in quiet place
how hard to hear when you talk to one other person in noisy place
how hard to hear when you talk to group of people in noisy place
when in group of people and could not see speaker ,  how hard to know where that person was
how often turn up volume watching tv
how often turn up volume when talking on phone
epitope
when you talk on phone ,  how hard to understand what other person was saying
how often hear ringing ,  buzzing ,  whistling noises only you could hear
how severe were ringing ,  buzzing ,  whistling noises that only you could hear
how much did ringing ,  buzzing ,  whistling noises bother you
how much did ringing ,  buzzing ,  whistling noises interfere with your daily activities
how much did ringing ,  buzzing ,  whistling noises make it hard to pay attention to things
how often did ringing ,  buzzing ,  whistling noises make it hard to fall asleep
how often did ringing ,  buzzing ,  whistling noises wake you from sleep
no hearing problems
avp gene product
leuprolide acetate
aqueous humor
artificial saliva spray
membrane - bound interleukin - 21 - expanded haploidentical natural killer cells
examination
oral docetaxel
gallium ga 68 - nota - 3ptate - rgd
bf - 200 gel formulation
ebv - positive mucocutaneous ulcer
anti - tigit monoclonal antibody bms - 986207
iadademstat
egfr t790m antagonist bpi - 15086
basement membrane
liver x receptor beta agonist rgx - 104
burkitt - like lymphoma with 11q aberration
11q aberration
high grade b - cell lymphoma with myc ,  bcl2 ,  and bcl6 rearrangements
barthel index of activities of daily living
past 24 to 48 hours
bowel continence
bladder continence
grooming ability
toilet use
bile
feeding ability
transfer ability
mobility ability
dressing ability
ability to use stairs
bathing ability
fecal incontinence or requires enema
occasional fecal accident ,  once per week
fecal continence
urinary incontinent ,  or catheterized and unable to manage
antibody binding site
occasional urinary accident ,  maximum of once per 24 hours
urinary continent over 7 days
needs help with personal grooming
independent for personal grooming
dependent for toilet use
needs some help for toilet use
independent for toilet use
unable to feed self
needs help with eating tasks
independent for eating
blood - brain barrier
unable to transfer
major help to transfer
minor help to transfer
independent for transfer
immobile
wheelchair independent
walks with help of one person
mobily independent ,  but may require a walking aid
dependent dressing
needs help with dressing but can do about half unaided
bronchoalveolar lavage fluid
independent for dressing
unable to use stairs
needs help to use stairs
independent for stairs
dependent bathing
independent bathing or in shower
chemotherapy - induced nausea and vomiting questionnaire
difficulty falling asleep scale
percentage food eaten scale
nausea scale
nucleolus
difficulty falling asleep score 0
difficulty falling asleep score 1
difficulty falling asleep score 2
difficulty falling asleep score 3
difficulty falling asleep score 4
difficulty falling asleep score 5
difficulty falling asleep score 6
difficulty falling asleep score 7
difficulty falling asleep score 8
difficulty falling asleep score 9
nucleus
difficulty falling asleep score 10
percentage food eaten score 0
percentage food eaten score 10
percentage food eaten score 20
percentage food eaten score 30
percentage food eaten score 40
percentage food eaten score 50
percentage food eaten score 60
percentage food eaten score 70
percentage food eaten score 80
centromere
percentage food eaten score 90
percentage food eaten score 100
nausea score 0
nausea score 1
nausea score 2
nausea score 3
nausea score 4
nausea score 5
nausea score 6
nausea score 7
chloroplast
nausea score 8
nausea score 9
nausea score 10
glmn gene product
fkbp - associated protein 48 kda
hearing problems did not interfere with activities
did not hear ringing or other noises
ringing or other noises did not bother
ringing or other noises did not interfere with activities
ringing or other noises did not make it hard to pay attention
recombinant interleukin 10
chromatid
ringing or other noises did not make it hard to fall asleep
ringing or other noises did not wake me from sleep
brip1 gene mutation
fancf gene mutation
fancm gene mutation
rad51b gene mutation
rad54l gene mutation
rpa1 gene mutation
restaging
pediatric hematology - oncology terminology
chromatin
t5 stage finding
bcl6 positive
resectable head and neck squamous cell carcinoma
tgfbeta inhibitor ly3200882
sustained - exposure dexamethasone formulation oto - 104
untreated chronic lymphocytic leukemia
untreated small lymphocytic lymphoma
enapotamab vedotin
myc gene rearrangement
bcl2 gene rearrangement
chromosome
bcl6 gene rearrangement
bcl2 gene amplification
bcl6 gene amplification
egfr mutant - specific inhibitor ck - 101
yang yin fu zheng
axl receptor tyrosine kinase / cmet inhibitor bpi - 9016m
yiqi - yangyin - jiedu herbal decoction
cd8 + nkg2d +  akt cell
psma - targeted pet imaging agent fluorine f 18 ctt - 1057
gallium ga 68 - nodaga - ac - cys - zegfr:1907
human chromosome
gallium ga 68 - nodaga - zigf - 1r:4:40
nlrc5 gene
nlrc5 wt allele
protein nlrc5
cmtr2 gene
cmtr2 wt allele
cap - specific mrna  ( nucleoside - 2 - o -  )  - methyltransferase 2
pde4d gene
pde4d wt allele
camp - specific 3 , 5 - cyclic phosphodiesterase 4d
chromosome 1
snrpd3 gene
snrpd3 wt allele
small nuclear ribonucleoprotein sm d3
pask gene
pask wt allele
pas domain - containing serine / threonine - protein kinase
volumetric contrast - enhanced ultrasound imaging
chromosome 10
ectopic thyroid gland
lingual thyroid gland
iodine deficiency hypothyroidism
euthyroid condition
autoimmune hypophysitis
usp22 gene
usp22 wt allele
ubiquitin carboxyl - terminal hydrolase 22
lack of adrenarche
chromosome 11
activating tshr gene mutation
inactivating tshr gene mutation
osteoma cutis
kataegis
eukaryotic initiation factor 3
low grade glioma
cytoreductive surgery
peritonectomy
chromosome 12
diaphragmatic stripping
capza2 gene
capza2 wt allele
f - actin - capping protein subunit alpha - 2
kir2ds3 gene
kir2ds3 wt allele
killer cell immunoglobulin - like receptor 2ds3
positive para - aortic lymph node
positive pelvic lymph node
chromosome 13
congenital pseudarthrosis of tibia
sptbn1 gene
sptbn1 wt allele
spectrin beta chain ,  non - erythrocytic 1
emx2 gene
emx2 wt allele
homeobox protein emx2
atp1b3 gene
atp1b3 wt allele
sodium / potassium - transporting atpase subunit beta - 3
chromosome 14
usp14 gene
usp14 wt allele
ubiquitin carboxyl - terminal hydrolase 14
hoxa5 gene
hoxa5 wt allele
homeobox protein hox - a5
simple virilizing 21 - hydroxylase deficiency
sostdc1 gene
sostdc1 wt allele
sclerostin domain - containing protein 1
muromonab - cd3
chromosome 15
mammographically dense breast
acute myeloid leukemia with t ( 10 ; 11 )  ( p12 ; q23 )  ;  mll - mllt10
t ( 10 ; 11 )  ( p12 ; q23 )
heterogeneously dense breast
extremely dense breast
acute myeloid leukemia with t ( 6 ; 11 )  ( q27 ; q23 )  ;  kmt2a - mllt4
or51e2 gene
or51e2 wt allele
olfactory receptor 51e2
acute megakaryoblastic leukemia with cbfa2t3 - glis2
chromosome 16
t ( 11 ; 12 )  ( p15 ; p13 )
acute megakaryoblastic leukemia with nup98 - kdm5a
anti - her2 / auristatin payload antibody - drug conjugate xmt - 1522
nr1h3 gene
nr1h3 wt allele
oxysterols receptor lxr - alpha
nek1 gene
nek1 wt allele
serine / threonine - protein kinase nek1
nasal swab
chromosome 17
gon4l gene
gon4l wt allele
gon - 4 - like protein
pole2 gene
pole2 wt allele
dna polymerase epsilon subunit 2
nasal wash and collection
gars1 gene
gars1 wt allele
glycine - trna ligase
chromosome 18
limk2 gene
limk2 wt allele
lim domain kinase 2
wdr5 gene
wdr5 wt allele
wd repeat - containing protein 5
chromosome 19
sh3kbp1 gene
sh3kbp1 wt allele
sh3 domain - containing kinase - binding protein 1
malignant solid neoplasm
unresectable leiomyosarcoma
unresectable liposarcoma
padi2 gene
chromosome 2
padi2 wt allele
protein - arginine deiminase type - 2
wars2 gene
wars2 wt allele
tryptophan - trna ligase ,  mitochondrial
vsig10l gene
vsig10l wt allele
v - set and immunoglobulin - domain containing protein 10 - like
pcat1 gene
pcat1 wt allele
chromosome 20
prostate cancer associated transcript 1
dinol gene
dinol wt allele
damage induced long noncoding rna
national cancer institute community oncology research program
immune checkpoint functional assay
pi3k inhibitor gdc0077
asb2 gene
asb2 wt allele
ankyrin repeat and socs box protein 2
chromosome 21
mb21d2 gene
mb21d2 wt allele
protein mb21d2
bcr - abl kinase inhibitor k0706
spns2 gene
spns2 wt allele
protein spinster homolog 2
bcar4 gene
bcar4 wt allele
breast cancer anti - estrogen resistance 4 long non - coding rna
chromosome 22
snhg5 gene
snhg5 wt allele
long intergenic non - protein coding rna 44
phldb3 gene
phldb3 wt allele
pleckstrin homology - like domain family b member 3
gpr182 gene
gpr182 wt allele
g - protein coupled receptor 182
porcn gene
chromosome 3
porcn wt allele
protein - serine o - palmitoleoyltransferase porcupine
pacmilimab
feline lymphoma
rat pituitary gland neoplasm
galloway - mowat syndrome
carboxypeptidase n deficiency
past seven days frequency of feeling urge to urinate all of a sudden
past seven days how often times when have to urinate frequently
past seven days frequency of urinary incontinence
lipooxygenase inhibitor
chromosome 4
past seven days frequency of ejaculation problems
worst severity past seven days blurry vision
worst severity past seven days watery eyes
worst severity past seven days ringing in ears
worst severity past seven days vaginal dryness
worst severity past seven days pain or burning with urination
worst severity past seven days difficulty getting or keeping an erection
worst severity past seven days decreased sexual interest
worst severity past seven days pain during vaginal sex
worst severity past seven days breast area enlargement or tenderness
chromosome 5
worst severity past seven days body odor
past seven days how much blurry vision interfered with usual or daily activities
past seven days how much watery eyes interfered with usual or daily activities
past seven days how much sudden urges to urinate interfered with usual or daily activities
past seven days how much frequent urination interfered with usual or daily activities
past seven days how much urinary incontinence interfered with usual or daily activities
past seven days any unusual vaginal discharge
past seven days any irregular menstrual period
past seven days missed expected menstrual period
past seven days took too long to have orgasm
chromosome 6
past seven days unable to have orgasm
not sexually active
prefer not to answer
supplemental testing
ataxia - telangiectasia - like disorder 1
venous segment
cdkn2a - p16 negative
crebbp gene mutation
cd33 positive
ras family gene mutation
chromosome 7
cd79b positive
fcer2 positive
gata1 exon 3 mutation
gata1 exon 2 mutation
tfe3 positive
ntrk2 fusion positive
ntrk3 fusion positive
nr3c1 positive
hla - a*02:01 / tp53aa264 - 272 complex
cd70 positive
chromosome 8
lypd3 gene
lypd3 wt allele
ly6 / plaur domain - containing protein 3
lypd3 positive
fgfr gene fusion positive
cd19 negative
chromosome arm 3p loss of heterozygosity
chromosome arm 9p loss of heterozygosity
ajcc v8 stage
dibotermin aalfa
chromosome 9
anti - tgf - beta monoclonal antibody nis793
autologous pd - 1 - targeted chimeric switch receptor - modified t lymphocytes
anti - pd - 1 monoclonal antibody bi 754091
cooperative donor registry
btk gene mutation
smartpill
unspecified tissue
idronoxil suppository nox66
sting agonist mk - 1454
study site dissolved
cytoplasm
small intestinal myeloid sarcoma
sum of products of perpendicular diameters
cdisc sdtm microscopic findings test name terminology
cdisc sdtm microscopic findings test code terminology
percent change from baseline in sum of products of perpendicular diameter
percent change from nadir in sum of products of perpendicular diameters
anti - cd73 monoclonal antibody bms - 986179
anti - gitr agonistic monoclonal antibody bms - 986156
cytoskeleton
46 , xy sex reversal 4
feline mammary carcinoma
canine thyroid adenocarcinoma
canine soft tissue sarcoma
satellite dna
gatifloxacin mesylate
general fatigue dimension
physical fatigue dimension
mental fatigue dimension
reduced motivation dimension
reduced activity dimension
health assessment questionnaire disability index
functional disability
embryonic structure
carbonic anhydrase i deficiency
presynaptic congenital myasthenic syndrome 6
severe neonatal encephalopathy due to mecp2 mutations
recurrent endometrial serous adenocarcinoma
pralsetinib
atypical pituitary gland adenoma
plasma cell enrichment
cdisc protocol terminology
protocol identifier
cyclooxygenase inhibitor
endoplasmic reticulum
protocol title
ribonucleic acid measurement
average concentration from t1 to t2
rater
office of management and budget
healthcare financing administration common procedure coding system
icd - 10 procedure coding system
cdisc protocol entities physical address attribute terminology
cdisc protocol entities study protocol attribute terminology
exon
cdisc protocol entities terminology
cdisc sdtm administration technique response terminology
cdisc sdtm asthma findings about test name terminology
cdisc sdtm asthma findings about test code terminology
cdisc sdtm specimen collection method terminology
cdisc sdtm ebola virus findings about test name terminology
cdisc sdtm ebola virus findings about test code terminology
cdisc sdtm genetic region of interest type terminology
cdisc sdtm malaria findings about test name terminology
extracellular matrix
cdisc sdtm malaria findings about test code terminology
cdisc send within normal limits results terminology
rhbdf2 gene
rhbdf2 wt allele
inactive rhomboid protein 2
pgam1 gene
pgam1 wt allele
phosphoglycerate mutase 1
bcl9l gene
bcl9l wt allele
exudate
b - cell cll / lymphoma 9 - like protein
human cytomegalovirus envelope glycoprotein b
extravascular extracellular volume fraction
approved drug product manufactured under contract
otc monograph drug product manufactured under contract
unapproved drug product manufactured under contract
guideline concordant care
arhgef5 gene product
oncogene tim protein
fianlimab
feces
best observed case imputation technique
last observed value imputation technique
last value prior to dosing imputation technique
worst observed case imputation technique
alternate protocol identifier
brief protocol title
official protocol title
protocol amendment
registry protocol identifier
schedule of activities
fetus
scientific protocol title
sponsor protocol identifier
protocol approval date
induced expectoration technique
associated persons demographics submission domain
6 lead nehb - spori
8 lead standard
cdisc integrated basic data structure dataset
cdisc integrated occurrence data structure dataset
cdisc integrated subject level dataset
body fluid or substance
ebola virus specific igg antibody secreting cell count
ebola virus specific igm antibody secreting cell count
igm antibody secreting cell count
high molecular weight adiponectin measurement
alpha - methylacyl coenzyme a racemase measurement
alpha - methylacyl coenzyme a racemase mrna measurement
squamous epithelial cells to total cells ratio measurement
folate hydrolase mrna measurement
g6pd - deficient erythrocytes count
g6pd - deficient erythrocytes to erythrocytes ratio measurement
1 , 3 - beta - d - glucan measurement
glycerol measurement
keyhole limpet hemocyanin igg antibody measurement
keyhole limpet hemocyanin igm antibody measurement
kallikrein - 2 measurement
lymphotoxin alpha measurement
neutrophilic toxic change assessment
oncostatin m measurement
pca3 mrna to psa mrna ratio measurement
prostate cancer antigen 3 mrna measurement
golgi apparatus
platelet mass distribution width
calculated panel reactive antibody measurement
circulating prostate tumor cell count
free prostate specific antigen measurement
free psa to total psa ratio measurement
prostate specific antigen mrna measurement
soluble intercellular adhesion molecule 1 measurement
t - kininogen measurement
treponema pallidum antibody measurement
vascular endothelial growth factor a measurement
hapten
periventricular region
diaphragmatic lymph node
inferior pubic ramus
left lung ,  inferior lobe ,  anterior basal segment
left lung ,  inferior lobe ,  lateral basal segment
left lung ,  inferior lobe ,  medial basal segment
left lung ,  inferior lobe ,  posterior basal segment
left lung ,  inferior lobe ,  superior segment
left lung ,  superior lobe ,  anterior segment
left lung ,  superior lobe ,  apicoposterior segment
recombinant interleukin - 9
left lung ,  superior lobe ,  inferior lingular segment
left lung ,  superior lobe ,  superior lingular segment
right lung ,  inferior lobe ,  anterior basal segment
right lung ,  inferior lobe ,  lateral basal segment
right lung ,  inferior lobe ,  medial basal segment
right lung ,  inferior lobe ,  posterior basal segment
right lung ,  inferior lobe ,  superior segment
right lung ,  middle lobe ,  lateral segment
right lung ,  middle lobe ,  medial segment
right lung ,  superior lobe ,  anterior segment
heterochromatin
right lung ,  superior lobe ,  apical segment
right lung ,  superior lobe ,  posterior segment
periureteral region
portal vein bifurcation
presacral space
superior pubic ramus
microoganism identification
asexual plasmodium knowlesi measurement
sexual plasmodium knowlesi measurement
taxonomic identification below species level
immunoglobulin constant region
zaire ebolavirus measurement
microscopist 1
microscopist 2
microscopist 3
optometrist
rater 1
rater 2
fluorescent spot test
hillmen color chart
enhanced liver fibrosis score
immunoglobulin joining region
cellular differentiation assessment
folate hydrolase 1 measurement
hyperemia grade
allelic family
amplicon size
accumulation ratio auc over dosing interval normalized by dose
accumulation ratio auc t1 to t2 normalized by dose
accumulation ratio cmax normalized by dose
accumulation ratio cmin normalized by dose
accumulation ratio ctrough normalized by dose
immunoglobulin switch region
average concentration from t1 to t2 normalized by body mass index
average concentration from t1 to t2 normalized by dose
average concentration from t1 to t2 normalized by surface area
average concentration from t1 to t2 normalized by weight
day times microgram per milliliter times kilogram per milligram
hour times nanomole per liter per milligram per kilogram
hour times micromole per liter per milligram per kilogram
eligibility criteria met by subject
blood donor
household member
immunoglobulin variable region
stepmother
biological relative ,  paternal
suspected source case
forced expiratory volume in 3 seconds
bone response
metastatic disease indicator
soft tissue response
tumor marker response
primary language spoken
fab fragment
secondary language spoken
capillary plasma
venous plasma
number of bone lesions
number of new bone lesions
two or more persisting new bone lesions indicator
bone lesion identification
new bone lesion lesion identification
non - target enhancing lesion identification
non - target extra nodal lesion identification
immunoglobulin fc
non - target nodal lesion identification
non - target non - enhancing lesion identification
per 200 high powered fields
per 2000 red blood cells
per 2500 white blood cells
per 40 high powered fields
per 500 white blood cells
base pair unit
log10 50 percent tissue culture infective dose per milliliter
log10 50 percent tissue culture infective dose per microliter
intermediate filament
millimerck unit per milliliter
microliter per kilogram per day
estimated body weight
adipocyte accumulation
hemangiectasis
apoptosis and necrosis
ectopic tissue
eosinophilic globules
helicobacter present
non - clinical contributing scientist name
intron
two or more new bone lesions indicator
contract fdf manufacturing
nccn distress thermometer and problem list for patients version 2 .2016
distress over physical problem with substance abuse
neck lymph node boundary levels and sublevels
neck lymph node boundary sublevel ia
neck lymph node boundary sublevel ib
neck lymph node boundary sublevel iia
neck lymph node boundary sublevel iib
neck lymph node boundary level iii
hiv vaccine
glomerulus
neck lymph node boundary level iv
neck lymph node boundary sublevel va
neck lymph node boundary sublevel vb
neck lymph node boundary level vi
neck lymph node boundary level vii
who grade ii glioma
recurrent glioma
neck lymph node groups
submental lymph node group  ( sublevel ia )
submandibular lymph node group  ( sublevel ib )
long terminal repeat
upper jugular lymph node group  ( sublevels iia and iib )
middle jugular lymph node group  ( level iii )
lower jugular lymph node group  ( level iv )
posterior triangle lymph node group  ( sublevels va and vb )
anterior compartment lymph node group  ( level vi )
superior mediastinal lymph node group  ( level vii )
cdisc clinical classification nsaa test name terminology
cdisc clinical classification nsaa test code terminology
cdisc questionnaire ces test name terminology
cdisc questionnaire ces test code terminology
lymph
cdisc questionnaire epds test name terminology
cdisc questionnaire epds test code terminology
cdisc questionnaire haq - di without vas test name terminology
cdisc questionnaire haq - di without vas test code terminology
cdisc questionnaire tsqm version 1 .4 test name terminology
cdisc questionnaire tsqm version 1 .4 test code terminology
nsaa clinical classification question
ces questionnaire question
epds questionnaire question
haq - di without vas questionnaire question
lysosome
tsqm version 1 .4 questionnaire question
north star ambulatory assessment clinical classification
combat exposure scale questionnaire
edinburgh postnatal depression scale questionnaire
health assessment questionnaire disability index without pain visual analog scale
treatment satisfaction questionnaire for medication version 1 .4
nsaa  -  stand
nsaa  -  walk
nsaa  -  stand up from chair
nsaa  -  stand on one leg  -  right
peroxisome
nsaa  -  stand on one leg  -  left
nsaa  -  climb box step  -  right
nsaa  -  climb box step  -  left
nsaa  -  descend box step  -  right
nsaa  -  descend box step  -  left
nsaa  -  gets to sitting
nsaa  -  rise from floor
nsaa  -  rise from floor time
nsaa  -  lifts head
nsaa  -  stands on heels
actin filament
nsaa  -  jump
nsaa  -  hop right leg
nsaa  -  hop left leg
nsaa  -  run  ( 10m )
nsaa  -  run  ( 10m )  time
nsaa  -  total
ces  -  ever combat patrols or dangerous duty
ces  -  were you ever under enemy fire
ces  -  ever surrounded by the enemy
ces  -  soldiers in unit killed  ( kia )  ,  wounded ,  missing  ( mia )
microtubule
ces  -  how often fire rounds at enemy
ces  -  see someone hit by rounds
ces  -  in danger of being injured or killed
epds  -  able to laugh and see funny side
epds  -  looked forward with enjoyment
epds  -  blamed myself unnecessarily
epds  -  anxious or worried no good reason
epds  -  scared or panicky for no good reason
epds  -  things getting on top of me
epds  -  unhappy had difficulty sleeping
breast milk
epds  -  i have felt sad or miserable
epds  -  so unhappy i have been crying
epds  -  thought of harming myself
haq - di without vas  -  dress yourself
haq - di without vas  -  shampoo your hair
haq - di without vas  -  stand up from a straight chair
haq - di without vas  -  get in and out of bed
haq - di without vas  -  cut your meat
haq - di without vas  -  lift a full cup or glass to mouth
haq - di without vas  -  open a new milk carton
mitochondrion
haq - di without vas  -  walk outdoors on flat ground
haq - di without vas  -  climb up five steps
haq - di without vas  -  aid: cane
haq - di without vas  -  aid: walker
haq - di without vas  -  aid: crutches
haq - di without vas  -  aid: wheelchair
haq - di without vas  -  aid: devices used for dressing
haq - di without vas  -  aid: built up or special utensils
haq - di without vas  -  aid: special or built up chair
haq - di without vas  -  other aid  ( dress or arising or eat or walk )
mucus
haq - di without vas  -  special aid  ( dress or arising or eat or walk )
haq - di without vas  -  help: dressing and grooming
haq - di without vas  -  help: arising
haq - di without vas  -  help: eating
haq - di without vas  -  help: walking
haq - di without vas  -  wash and dry your body
haq - di without vas  -  take a tub bath
haq - di without vas  -  get on and off the toilet
haq - di without vas  -  reach - get down 5 lb object above head
haq - di without vas  -  bend down pick up clothing  -  floor
doxorubicin hydrochloride
mullerian duct
haq - di without vas  -  open car doors
haq - di without vas  -  open jars previously opened
haq - di without vas  -  turn faucets on and off
haq - di without vas  -  run errands and shop
haq - di without vas  -  get in and out of a car
haq - di without vas  -  able to do chores
haq - di without vas  -  aid: raised toilet seat
haq - di without vas  -  aid: bathtub seat
haq - di without vas  -  aid: jar opener  ( previously open )
haq - di without vas  -  aid: bathtub bar
myelin sheath
haq - di without vas  -  aid: long - handled appliances reach
haq - di without vas  -  aid: long - handled appliances bathroom
haq - di without vas  -  other aid  ( hygiene or reach or grip or act )
haq - di without vas  -  special aid  ( hygiene or reach or grip or act )
haq - di without vas  -  help: hygiene
haq - di without vas  -  help: reach
haq - di without vas  -  help: gripping and opening things
haq - di without vas  -  help: errands and chores
tsqm version 1 .4  -  medication to prevent or treat condition
tsqm version 1 .4  -  way medication relieves symptoms
tsqm version 1 .4  -  time takes medication to start working
tsqm version 1 .4  -  experience any side effect at all
tsqm version 1 .4  -  how bothersome are side effects
tsqm version 1 .4  -  interfere with physical health
tsqm version 1 .4  -  interfere with mental function
tsqm version 1 .4  -  side effect affect overall satisfaction
tsqm version 1 .4  -  easy or difficult use medication
tsqm version 1 .4  -  easy or difficult to plan use of medication
tsqm version 1 .4  -  convenient or inconvenient take medication
tsqm version 1 .4  -  confident medication is good for you
neurofilament
tsqm version 1 .4  -  certain good things outweigh bad
tsqm version 1 .4  -  satisfied or dissatisfied with medication
head and neck cancer tnm finding v8
head and neck cancer clinical tnm finding v8
head and neck cancer clinical regional lymph nodes tnm finding v8
head and neck cancer cn2 tnm finding v8
head and neck cancer cn2a tnm finding v8
head and neck cancer cn2b tnm finding v8
head and neck cancer cn2c tnm finding v8
head and neck cancer cn3 tnm finding v8
nuclear matrix
head and neck cancer cn3a tnm finding v8
head and neck cancer cn3b tnm finding v8
head and neck cancer pathologic tnm finding v8
head and neck cancer pathologic regional lymph nodes tnm finding v8
head and neck cancer pnx tnm finding v8
head and neck cancer pn0 tnm finding v8
head and neck cancer pn1 tnm finding v8
head and neck cancer pn2 tnm finding v8
head and neck cancer pn2a tnm finding v8
head and neck cancer pn2b tnm finding v8
nuclear membrane
head and neck cancer pn2c tnm finding v8
head and neck cancer pn3 tnm finding v8
head and neck cancer pn3a tnm finding v8
head and neck cancer pn3b tnm finding v8
interleukin - 3 receptor subunit alpha positive
cervical lymph nodes and unknown primary tumors tnm finding v8
unknown primary tumor clinical cervical lymph nodes tnm finding v8
unknown primary tumor cn2 tnm finding v8
unknown primary tumor cn2a tnm finding v8
nuclear pore
unknown primary tumor cn2b tnm finding v8
unknown primary tumor cn2c tnm finding v8
unknown primary tumor cn3 tnm finding v8
unknown primary tumor cn3a tnm finding v8
unknown primary tumor cn3b tnm finding v8
unknown primary tumor pathologic cervical lymph nodes tnm finding v8
unknown primary tumor pnx tnm finding v8
unknown primary tumor pn0 tnm finding v8
unknown primary tumor pn1 tnm finding v8
unknown primary tumor pn2 tnm finding v8
nucleolar organizer region
unknown primary tumor pn2a tnm finding v8
unknown primary tumor pn2b tnm finding v8
unknown primary tumor pn2c tnm finding v8
unknown primary tumor pn3 tnm finding v8
unknown primary tumor pn3a tnm finding v8
unknown primary tumor pn3b tnm finding v8
unknown primary tumor  ( except for ebv - related and hpv - related tumors )  and metastatic cervical adenopathy by ajcc v8 stage
stage iii unknown primary tumor  ( except for ebv - related and hpv - related tumors )  and metastatic cervical adenopathy ajcc v8
stage iva unknown primary tumor  ( except for ebv - related and hpv - related tumors )  and metastatic cervical adenopathy ajcc v8
stage ivb unknown primary tumor  ( except for ebv - related and hpv - related tumors )  and metastatic cervical adenopathy ajcc v8
nucleosome
stage ivc unknown primary tumor  ( except for ebv - related and hpv - related tumors )  and metastatic cervical adenopathy ajcc v8
anti - cd40 / anti - taa bispecific monoclonal antibody abbv - 428
lidocaine hydrochloride ophthalmic gel
anti - ley - car - transduced autologous t - lymphocytes
h3 .3k27m - specific peptide vaccine
deuteporfin
demethylating agent
florbetaben  ( 18f )
lip and oral cavity cancer tnm finding v8
lip and oral cavity cancer clinical tnm finding v8
cytoplasmic organelle
lip and oral cavity cancer pathologic tnm finding v8
lip and oral cavity cancer pathologic primary tumor tnm finding v8
lip and oral cavity cancer ptx tnm finding v8
lip and oral cavity cancer ptis tnm finding v8
lip and oral cavity cancer pt1 tnm finding v8
lip and oral cavity cancer pt2 tnm finding v8
lip and oral cavity cancer pt3 tnm finding v8
lip and oral cavity cancer pt4 tnm finding v8
lip and oral cavity cancer pt4a tnm finding v8
antiplatelet agent
lip and oral cavity cancer pt4b tnm finding v8
lip and oral cavity cancer pathologic regional lymph nodes tnm finding v8
lip and oral cavity cancer pnx tnm finding v8
lip and oral cavity cancer pn0 tnm finding v8
lip and oral cavity cancer pn1 tnm finding v8
lip and oral cavity cancer pn2 tnm finding v8
lip and oral cavity cancer pn2a tnm finding v8
lip and oral cavity cancer pn2b tnm finding v8
lip and oral cavity cancer pn2c tnm finding v8
lip and oral cavity cancer pn3 tnm finding v8
t ( 9 ; 22 )  ( q34 .1 ; q11 .2 )
lip and oral cavity cancer pn3a tnm finding v8
lip and oral cavity cancer pn3b tnm finding v8
lip and oral cavity cancer clinical regional lymph nodes tnm finding v8
lip and oral cavity cancer cn2 tnm finding v8
lip and oral cavity cancer cn2a tnm finding v8
lip and oral cavity cancer cn2b tnm finding v8
lip and oral cavity cancer cn2c tnm finding v8
lip and oral cavity cancer cn3 tnm finding v8
lip and oral cavity cancer cn3a tnm finding v8
lip and oral cavity cancer cn3b tnm finding v8
placenta
lip and oral cavity cancer pathologic distant metastasis tnm finding v8
lip and oral cavity cancer pm1 tnm finding v8
lip and oral cavity cancer clinical distant metastasis tnm finding v8
lip and oral cavity cancer cm0 tnm finding v8
lip and oral cavity cancer cm1 tnm finding v8
myelosuppressive chemotherapy
cerebral vein thrombosis
lip and oral cavity cancer by ajcc v8 stage
stage i lip and oral cavity cancer ajcc v8
lung surfactant
stage ii lip and oral cavity cancer ajcc v8
stage iii lip and oral cavity cancer ajcc v8
stage iv lip and oral cavity cancer ajcc v8
stage iva lip and oral cavity cancer ajcc v8
stage ivb lip and oral cavity cancer ajcc v8
stage ivc lip and oral cavity cancer ajcc v8
lip and oral cavity cancer by ajcc v6 and v7 stage
intracanalicular route of administration
major salivary gland cancer tnm finding v8
ribosome
major salivary gland cancer clinical tnm finding v8
major salivary gland cancer pathologic tnm finding v8
major salivary gland cancer pathologic primary tumor tnm finding v8
major salivary gland cancer ptx tnm finding v8
major salivary gland cancer pt0 tnm finding v8
major salivary gland cancer ptis tnm finding v8
major salivary gland cancer pt1 tnm finding v8
major salivary gland cancer pt2 tnm finding v8
major salivary gland cancer pt3 tnm finding v8
saliva
major salivary gland cancer pt4 tnm finding v8
major salivary gland cancer pt4a tnm finding v8
major salivary gland cancer pt4b tnm finding v8
major salivary gland cancer pathologic regional lymph nodes tnm finding v8
major salivary gland cancer pnx tnm finding v8
major salivary gland cancer pn0 tnm finding v8
major salivary gland cancer pn1 tnm finding v8
major salivary gland cancer pn2 tnm finding v8
major salivary gland cancer pn2a tnm finding v8
major salivary gland cancer pn2b tnm finding v8
sebum
major salivary gland cancer pn2c tnm finding v8
major salivary gland cancer pn3 tnm finding v8
major salivary gland cancer pn3a tnm finding v8
major salivary gland cancer pn3b tnm finding v8
major salivary gland cancer clinical regional lymph nodes tnm finding v8
major salivary gland cancer cn2 tnm finding v8
major salivary gland cancer cn2a tnm finding v8
major salivary gland cancer cn2b tnm finding v8
major salivary gland cancer cn2c tnm finding v8
major salivary gland cancer cn3 tnm finding v8
semen
major salivary gland cancer cn3a tnm finding v8
major salivary gland cancer cn3b tnm finding v8
major salivary gland cancer clinical distant metastasis tnm finding v8
major salivary gland cancer cm0 tnm finding v8
major salivary gland cancer cm1 tnm finding v8
major salivary gland cancer pathologic distant metastasis tnm finding v8
major salivary gland cancer pm1 tnm finding v8
major salivary gland cancer by ajcc v7 stage
major salivary gland cancer by ajcc v8 stage
sputum
stage i major salivary gland cancer ajcc v8
european union drug regulating authorities clinical trials database
stage 0 major salivary gland cancer ajcc v8
university medical information network
stage ii major salivary gland cancer ajcc v8
stage iii major salivary gland cancer ajcc v8
stage iv major salivary gland cancer ajcc v8
stage iva major salivary gland cancer ajcc v8
stage ivb major salivary gland cancer ajcc v8
stage ivc major salivary gland cancer ajcc v8
pharyngeal cancer tnm finding v8
nasopharyngeal cancer tnm finding v8
nasopharyngeal cancer clinical tnm finding v8
nasopharyngeal cancer pathologic tnm finding v8
nasopharyngeal cancer pathologic primary tumor tnm finding v8
nasopharyngeal cancer ptx tnm finding v8
nasopharyngeal cancer pt0 tnm finding v8
nasopharyngeal cancer pt1 tnm finding v8
nasopharyngeal cancer pt2 tnm finding v8
bcg
sweat
nasopharyngeal cancer pt3 tnm finding v8
nasopharyngeal cancer pt4 tnm finding v8
nasopharyngeal cancer ptis tnm finding v8
nasopharyngeal cancer pathologic regional lymph nodes tnm finding v8
nasopharyngeal cancer pnx tnm finding v8
nasopharyngeal cancer pn0 tnm finding v8
nasopharyngeal cancer pn1 tnm finding v8
nasopharyngeal cancer pn2 tnm finding v8
nasopharyngeal cancer pn3 tnm finding v8
nasopharyngeal cancer pathologic distant metastasis tnm finding v8
synapse
nasopharyngeal cancer pm1 tnm finding v8
nasopharyngeal cancer clinical distant metastasis tnm finding v8
nasopharyngeal cancer cm0 tnm finding v8
nasopharyngeal cancer cm1 tnm finding v8
pharyngeal carcinoma by ajcc v8 stage
stage 0 nasopharyngeal carcinoma ajcc v8
nasopharyngeal carcinoma by ajcc v8 stage
stage i nasopharyngeal carcinoma ajcc v8
stage ii nasopharyngeal carcinoma ajcc v8
stage iii nasopharyngeal carcinoma ajcc v8
subcellular structure
stage iv nasopharyngeal carcinoma ajcc v8
stage iva nasopharyngeal carcinoma ajcc v8
stage ivb nasopharyngeal carcinoma ajcc v8
canine oral squamous cell carcinoma
feline oral squamous cell carcinoma
feline osteosarcoma
distal hereditary motor neuronopathy type i
autosomal recessive congenital ichthyosis 2
distress score visual analogue scale
distress score 0
urine
distress score 1
distress score 2
distress score 3
distress score 4
distress score 5
distress score 6
distress score 7
distress score 8
distress score 9
distress score 10
vacuole
suicide gene
ras wild type
raf wild type
unresectable ewing sarcoma
chromosome x
unresectable osteosarcoma
cd47 antagonist alx148
respiratory pathogen panel
recurrent malignant germ cell tumor
metastatic malignant germ cell tumor
herpes simplex virus 1 dna  ( presence )
herpes simplex virus 2 dna  ( presence )
herpes virus 6 dna  ( presence )
hpv - mediated  ( p16 - positive )  oropharyngeal cancer tnm finding v8
hpv - mediated  ( p16 - positive )  oropharyngeal cancer pathologic tnm finding v8
chromosome y
hpv - mediated  ( p16 - positive )  oropharyngeal cancer clinical tnm finding v8
hpv - mediated  ( p16 - positive )  oropharyngeal cancer pathologic primary tumor tnm finding v8
hpv - mediated  ( p16 - positive )  oropharyngeal cancer pt0 tnm finding v8
hpv - mediated  ( p16 - positive )  oropharyngeal cancer pt1 tnm finding v8
hpv - mediated  ( p16 - positive )  oropharyngeal cancer pt2 tnm finding v8
hpv - mediated  ( p16 - positive )  oropharyngeal cancer pt3 tnm finding v8
hpv - mediated  ( p16 - positive )  oropharyngeal cancer pt4 tnm finding v8
hpv - mediated  ( p16 - positive )  oropharyngeal cancer pathologic regional lymph nodes tnm finding v8
hpv - mediated  ( p16 - positive )  oropharyngeal cancer pnx tnm finding v8
hpv - mediated  ( p16 - positive )  oropharyngeal cancer pn0 tnm finding v8
z - dna
hpv - mediated  ( p16 - positive )  oropharyngeal cancer pn1 tnm finding v8
hpv - mediated  ( p16 - positive )  oropharyngeal cancer pn2 tnm finding v8
hpv - mediated  ( p16 - positive )  oropharyngeal cancer clinical regional lymph nodes tnm finding v8
hpv - mediated  ( p16 - positive )  oropharyngeal cancer cn1 tnm finding v8
hpv - mediated  ( p16 - positive )  oropharyngeal cancer cn2 tnm finding v8
hpv - mediated  ( p16 - positive )  oropharyngeal cancer cn3 tnm finding v8
hpv - mediated  ( p16 - positive )  oropharyngeal cancer pathologic distant metastasis tnm finding v8
hpv - mediated  ( p16 - positive )  oropharyngeal cancer pm1 tnm finding v8
hpv - mediated  ( p16 - positive )  oropharyngeal cancer clinical distant metastasis tnm finding v8
hpv - mediated  ( p16 - positive )  oropharyngeal cancer cm0 tnm finding v8
rgd motif
hpv - mediated  ( p16 - positive )  oropharyngeal cancer cm1 tnm finding v8
prostate carcinoma metastatic in the soft tissue
hpv - mediated  ( p16 - positive )  oropharyngeal carcinoma by ajcc v8 stage
hpv - mediated  ( p16 - positive )  oropharyngeal carcinoma by ajcc v8 clinical stage
hpv - mediated  ( p16 - positive )  oropharyngeal carcinoma by ajcc v8 pathologic stage
clinical stage i hpv - mediated  ( p16 - positive )  oropharyngeal carcinoma ajcc v8
clinical stage ii hpv - mediated  ( p16 - positive )  oropharyngeal carcinoma ajcc v8
mir124 - 2 gene
mir124 - 2 wt allele
mir124 - 2 pre - mirna
euchromatin
immune cell
clinical stage iii hpv - mediated  ( p16 - positive )  oropharyngeal carcinoma ajcc v8
unmethylated mgmt gene promoter
clinical stage iv hpv - mediated  ( p16 - positive )  oropharyngeal carcinoma ajcc v8
pik3r1 gene mutation
akt3 gene amplification
pik3c2b gene amplification
cdk6 gene amplification
pathologic stage i hpv - mediated  ( p16 - positive )  oropharyngeal carcinoma ajcc v8
pathologic stage ii hpv - mediated  ( p16 - positive )  oropharyngeal carcinoma ajcc v8
cloning vector
kringle domain
pathologic stage iii hpv - mediated  ( p16 - positive )  oropharyngeal carcinoma ajcc v8
pathologic stage iv hpv - mediated  ( p16 - positive )  oropharyngeal carcinoma ajcc v8
mgmt - unmethylated glioblastoma
promis - 29 adult profile v1 .0
satisfied with how much work i can do
satisfied with ability to work
satisfied with ability to do regular personal and household responsibilities
satisfied with ability to perform daily routine
oropharyngeal  ( p16 - negative )  and hypopharyngeal cancer tnm finding v8
oropharyngeal  ( p16 - negative )  cancer tnm finding v8
leucine zipper
hypopharyngeal cancer tnm finding v8
oropharyngeal  ( p16 - negative )  cancer clinical tnm finding v8
oropharyngeal  ( p16 - negative )  cancer pathologic tnm finding v8
hypopharyngeal cancer clinical tnm finding v8
hypopharyngeal cancer pathologic tnm finding v8
oropharyngeal  ( p16 - negative )  cancer pathologic primary tumor tnm finding v8
oropharyngeal  ( p16 - negative )  cancer ptx tnm finding v8
oropharyngeal  ( p16 - negative )  cancer ptis tnm finding v8
oropharyngeal  ( p16 - negative )  cancer pt1 tnm finding v8
oropharyngeal  ( p16 - negative )  cancer pt2 tnm finding v8
open reading frame
oropharyngeal  ( p16 - negative )  cancer pt3 tnm finding v8
linear structural repeat unit connection points
oropharyngeal  ( p16 - negative )  cancer pt4 tnm finding v8
structural repeat unit substitution point
oropharyngeal  ( p16 - negative )  cancer pt4a tnm finding v8
oropharyngeal  ( p16 - negative )  cancer pt4b tnm finding v8
hypopharyngeal cancer pathologic primary tumor tnm finding v8
hypopharyngeal cancer ptx tnm finding v8
hypopharyngeal cancer ptis tnm finding v8
hypopharyngeal cancer pt1 tnm finding v8
tata box
hypopharyngeal cancer pt2 tnm finding v8
hypopharyngeal cancer pt3 tnm finding v8
hypopharyngeal cancer pt4 tnm finding v8
hypopharyngeal cancer pt4a tnm finding v8
hypopharyngeal cancer pt4b tnm finding v8
oropharyngeal  ( p16 - negative )  cancer clinical regional lymph nodes tnm finding v8
hypopharyngeal cancer clinical regional lymph nodes tnm finding v8
oropharyngeal  ( p16 - negative )  cancer pathologic regional lymph nodes tnm finding v8
hypopharyngeal cancer pathologic regional lymph nodes tnm finding v8
oropharyngeal  ( p16 - negative )  cancer cnx tnm finding v8
c2h2 zinc finger
hypopharyngeal cancer cnx tnm finding v8
oropharyngeal  ( p16 - negative )  cancer cn0 tnm finding v8
hypopharyngeal cancer cn0 tnm finding v8
oropharyngeal  ( p16 - negative )  cancer cn1 tnm finding v8
hypopharyngeal cancer cn1 tnm finding v8
oropharyngeal  ( p16 - negative )  cancer cn2 tnm finding v8
hypopharyngeal cancer cn2 tnm finding v8
oropharyngeal  ( p16 - negative )  cancer cn2a tnm finding v8
hypopharyngeal cancer cn2a tnm finding v8
oropharyngeal  ( p16 - negative )  cancer cn2b tnm finding v8
telomere
hypopharyngeal cancer cn2b tnm finding v8
oropharyngeal  ( p16 - negative )  cancer cn2c tnm finding v8
hypopharyngeal cancer cn2c tnm finding v8
oropharyngeal  ( p16 - negative )  cancer cn3 tnm finding v8
hypopharyngeal cancer cn3 tnm finding v8
oropharyngeal  ( p16 - negative )  cancer cn3a tnm finding v8
hypopharyngeal cancer cn3a tnm finding v8
oropharyngeal  ( p16 - negative )  cancer cn3b tnm finding v8
hypopharyngeal cancer cn3b tnm finding v8
oropharyngeal  ( p16 - negative )  cancer pnx tnm finding v8
enhancer
hypopharyngeal cancer pnx tnm finding v8
oropharyngeal  ( p16 - negative )  cancer pn0 tnm finding v8
hypopharyngeal cancer pn0 tnm finding v8
oropharyngeal  ( p16 - negative )  cancer pn1 tnm finding v8
hypopharyngeal cancer pn1 tnm finding v8
oropharyngeal  ( p16 - negative )  cancer pn2 tnm finding v8
oropharyngeal  ( p16 - negative )  cancer pn2a tnm finding v8
hypopharyngeal cancer pn2 tnm finding v8
hypopharyngeal cancer pn2a tnm finding v8
oropharyngeal  ( p16 - negative )  cancer pn2b tnm finding v8
promoter
hypopharyngeal cancer pn2b tnm finding v8
oropharyngeal  ( p16 - negative )  cancer pn2c tnm finding v8
hypopharyngeal cancer pn2c tnm finding v8
oropharyngeal  ( p16 - negative )  cancer pn3 tnm finding v8
hypopharyngeal cancer pn3 tnm finding v8
oropharyngeal  ( p16 - negative )  cancer pn3a tnm finding v8
hypopharyngeal cancer pn3a tnm finding v8
oropharyngeal  ( p16 - negative )  cancer pn3b tnm finding v8
hypopharyngeal cancer pn3b tnm finding v8
oropharyngeal  ( p16 - negative )  cancer clinical distant metastasis tnm finding v8
repetitive sequence
hypopharyngeal cancer clinical distant metastasis tnm finding v8
oropharyngeal  ( p16 - negative )  cancer pathologic distant metastasis tnm finding v8
hypopharyngeal cancer pathologic distant metastasis tnm finding v8
oropharyngeal  ( p16 - negative )  cancer cm0 tnm finding v8
oropharyngeal  ( p16 - negative )  cancer cm1 tnm finding v8
hypopharyngeal cancer cm0 tnm finding v8
hypopharyngeal cancer cm1 tnm finding v8
oropharyngeal  ( p16 - negative )  cancer pm1 tnm finding v8
hypopharyngeal cancer pm1 tnm finding v8
anti - glypican 3 - scfvgc33 - car - expressing t lymphocytes
dna sequence
rilimogene galvacirepvec / rilimogene glafolivec
p53 - hdm2 protein - protein interaction inhibitor apg - 115
sintilimab
gallium ga 68 - nodaga - e ( c [ rgdyk ]  ) 2
oropharyngeal  ( p16 - negative )  carcinoma by ajcc v8 stage
stage 0 oropharyngeal  ( p16 - negative )  carcinoma ajcc v8
stage i oropharyngeal  ( p16 - negative )  carcinoma ajcc v8
stage ii oropharyngeal  ( p16 - negative )  carcinoma ajcc v8
stage iii oropharyngeal  ( p16 - negative )  carcinoma ajcc v8
stage iv oropharyngeal  ( p16 - negative )  carcinoma ajcc v8
umbilical cord blood
stage iva oropharyngeal  ( p16 - negative )  carcinoma ajcc v8
stage ivb oropharyngeal  ( p16 - negative )  carcinoma ajcc v8
stage ivc oropharyngeal  ( p16 - negative )  carcinoma ajcc v8
hypopharyngeal carcinoma by ajcc v8 stage
stage 0 hypopharyngeal carcinoma ajcc v8
stage i hypopharyngeal carcinoma ajcc v8
stage ii hypopharyngeal carcinoma ajcc v8
stage iii hypopharyngeal carcinoma ajcc v8
stage iv hypopharyngeal carcinoma ajcc v8
stage iva hypopharyngeal carcinoma ajcc v8
mesenchyme
stage ivb hypopharyngeal carcinoma ajcc v8
stage ivc hypopharyngeal carcinoma ajcc v8
decision regret scale
made right decision
regret choice made
would make same choice again
choice did harm
decision was wise
untreated adult rhabdomyosarcoma
proapoptotic sulindac analog cp - 461
secondary protein structure
gallium maltolate
gelonin
anti - ep - cam monoclonal antibody ing - 1
iodine i 131 iodocholesterol
nasal cavity and paranasal sinuses cancer tnm finding v8
nasal cavity and paranasal sinuses cancer clinical tnm finding v8
nasal cavity and paranasal sinuses cancer pathologic tnm finding v8
maxillary sinus cancer pathologic primary tumor tnm finding v8
nasal cavity and ethmoid sinus cancer pathologic primary tumor tnm finding v8
nasal cavity and paranasal sinuses cancer pathologic regional lymph nodes tnm finding v8
protein structure
nasal cavity and paranasal sinuses cancer clinical regional lymph nodes tnm finding v8
nasal cavity and paranasal sinuses cancer pathologic distant metastasis tnm finding v8
nasal cavity and paranasal sinuses cancer clinical distant metastasis tnm finding v8
maxillary sinus cancer ptx tnm finding v8
maxillary sinus cancer ptis tnm finding v8
maxillary sinus cancer pt1 tnm finding v8
maxillary sinus cancer pt2 tnm finding v8
maxillary sinus cancer pt3 tnm finding v8
maxillary sinus cancer pt4 tnm finding v8
maxillary sinus cancer pt4a tnm finding v8
pulmonary
maxillary sinus cancer pt4b tnm finding v8
nasal cavity and ethmoid sinus cancer ptx tnm finding v8
nasal cavity and ethmoid sinus cancer ptis tnm finding v8
nasal cavity and ethmoid sinus cancer pt1 tnm finding v8
nasal cavity and ethmoid sinus cancer pt2 tnm finding v8
nasal cavity and ethmoid sinus cancer pt3 tnm finding v8
nasal cavity and ethmoid sinus cancer pt4 tnm finding v8
nasal cavity and ethmoid sinus cancer pt4a tnm finding v8
nasal cavity and ethmoid sinus cancer pt4b tnm finding v8
nasal cavity and paranasal sinuses cancer cnx tnm finding v8
nasal cavity and paranasal sinuses cancer cn0 tnm finding v8
nasal cavity and paranasal sinuses cancer cn1 tnm finding v8
nasal cavity and paranasal sinuses cancer cn2 tnm finding v8
nasal cavity and paranasal sinuses cancer cn2a tnm finding v8
nasal cavity and paranasal sinuses cancer cn2b tnm finding v8
nasal cavity and paranasal sinuses cancer cn2c tnm finding v8
nasal cavity and paranasal sinuses cancer cn3 tnm finding v8
nasal cavity and paranasal sinuses cancer cn3a tnm finding v8
nasal cavity and paranasal sinuses cancer cn3b tnm finding v8
nasal cavity and paranasal sinuses cancer pnx tnm finding v8
nasal cavity and paranasal sinuses cancer pn0 tnm finding v8
nasal cavity and paranasal sinuses cancer pn1 tnm finding v8
nasal cavity and paranasal sinuses cancer pn2 tnm finding v8
nasal cavity and paranasal sinuses cancer pn2a tnm finding v8
nasal cavity and paranasal sinuses cancer pn2b tnm finding v8
nasal cavity and paranasal sinuses cancer pn2c tnm finding v8
nasal cavity and paranasal sinuses cancer pn3 tnm finding v8
nasal cavity and paranasal sinuses cancer pn3a tnm finding v8
nasal cavity and paranasal sinuses cancer pn3b tnm finding v8
nasal cavity and paranasal sinuses cancer cm0 tnm finding v8
gastric
nasal cavity and paranasal sinuses cancer cm1 tnm finding v8
nasal cavity and paranasal sinuses cancer pm1 tnm finding v8
cd19car - cd28 - cd3zeta - egfrt - expressing tcm - enriched t - lymphocytes
cd19car - cd28 - cd3zeta - egfrt - expressing tn / mem - enriched t - lymphocytes
sinonasal cancer by ajcc v8 stage
stage 0 nasal cavity and paranasal sinus cancer ajcc v8
stage i sinonasal cancer ajcc v8
stage ii sinonasal cancer ajcc  v8
stage iii sinonasal cancer ajcc v8
stage iv sinonasal cancer ajcc v8
hepatic
stage iva sinonasal cancer ajcc v8
stage ivb sinonasal cancer ajcc v8
stage ivc sinonasal cancer ajcc v8
loreta neurofeedback training
gm2 - gangliosidosis ,  ab variant
brachial amyotrophic diplegia
carnitine - acylcarnitine translocase deficiency
dejerine - sottas neuropathy
canine globoid cell leukodystrophy
hamster melanoma
vaginal
hamster pancreatic ductal adenocarcinoma
lung adenofibroma
recurrent breast angiosarcoma
locally advanced malignant solid neoplasm
fluorine f 18 alphavbeta6 - binding peptide
aids - related anal canal carcinoma
laryngeal cancer tnm finding v8
laryngeal cancer clinical tnm finding v8
laryngeal cancer pathologic tnm finding v8
supraglottic cancer pathologic primary tumor tnm finding v8
epipodophyllotoxin compound
systemic
supraglottic cancer ptx tnm finding v8
supraglottic cancer ptis tnm finding v8
supraglottic cancer pt1 tnm finding v8
supraglottic cancer pt2 tnm finding v8
supraglottic cancer pt3 tnm finding v8
supraglottic cancer pt4 tnm finding v8
supraglottic cancer pt4a tnm finding v8
supraglottic cancer pt4b tnm finding v8
glottic cancer pathologic primary tumor tnm finding v8
glottic cancer ptx tnm finding v8
vascular
glottic cancer ptis tnm finding v8
glottic cancer pt1 tnm finding v8
glottic cancer pt1a tnm finding v8
glottic cancer pt1b tnm finding v8
glottic cancer pt2 tnm finding v8
glottic cancer pt3 tnm finding v8
glottic cancer pt4 tnm finding v8
glottic cancer pt4a tnm finding v8
glottic cancer pt4b tnm finding v8
subglottic cancer pathologic primary tumor tnm finding v8
gap junction
subglottic cancer ptx tnm finding v8
subglottic cancer ptis tnm finding v8
subglottic cancer pt1 tnm finding v8
subglottic cancer pt2 tnm finding v8
subglottic cancer pt3 tnm finding v8
subglottic cancer pt4 tnm finding v8
subglottic cancer pt4a tnm finding v8
subglottic cancer pt4b tnm finding v8
laryngeal cancer clinical regional lymph nodes tnm finding v8
laryngeal cancer cnx tnm finding v8
helix - loop - helix domain
laryngeal cancer cn0 tnm finding v8
laryngeal cancer cn1 tnm finding v8
laryngeal cancer cn2 tnm finding v8
laryngeal cancer cn2a tnm finding v8
laryngeal cancer cn2b tnm finding v8
laryngeal cancer cn2c tnm finding v8
laryngeal cancer cn3 tnm finding v8
laryngeal cancer cn3a tnm finding v8
laryngeal cancer cn3b tnm finding v8
laryngeal cancer pathologic regional lymph nodes tnm finding v8
proteasome
laryngeal cancer pnx tnm finding v8
laryngeal cancer pn0 tnm finding v8
laryngeal cancer pn1 tnm finding v8
laryngeal cancer pn2 tnm finding v8
laryngeal cancer pn2a tnm finding v8
laryngeal cancer pn2b tnm finding v8
laryngeal cancer pn2c tnm finding v8
laryngeal cancer pn3 tnm finding v8
laryngeal cancer pn3a tnm finding v8
laryngeal cancer pn3b tnm finding v8
epithelial
laryngeal cancer clinical distant metastasis tnm finding v8
laryngeal cancer cm0 tnm finding v8
laryngeal cancer cm1 tnm finding v8
laryngeal cancer pathologic distant metastasis tnm finding v8
laryngeal cancer pm1 tnm finding v8
gene rearrangement abnormality
laryngeal cancer by ajcc v8 stage
stage 0 laryngeal cancer ajcc v8
stage i laryngeal cancer ajcc v8
stage ii laryngeal cancer ajcc v8
stage iii laryngeal cancer ajcc v8
stage iv laryngeal cancer ajcc v8
stage iva laryngeal cancer ajcc v8
stage ivb laryngeal cancer ajcc v8
stage ivc laryngeal cancer ajcc v8
polyclonal gene rearrangement
clonal rearrangement ,  single peak
clonal rearrangement ,  multiple peaks
mucosal melanoma of the head and neck tnm finding v8
mucosal melanoma of the head and neck clinical tnm finding v8
hair follicle
mucosal melanoma of the head and neck clinical distant metastasis tnm finding v8
mucosal melanoma of the head and neck cm0 tnm finding v8
mucosal melanoma of the head and neck cm1 tnm finding v8
mucosal melanoma of the head and neck pathologic tnm finding v8
mcl - 1 inhibitor mik665
mucosal melanoma of the head and neck pathologic distant metastasis tnm finding v8
mucosal melanoma of the head and neck pm1 tnm finding v8
mucosal melanoma of the head and neck pathologic primary tumor tnm finding v8
mucosal melanoma of the head and neck pt3 tnm finding v8
mucosal melanoma of the head and neck pt4 tnm finding v8
transitional epithelium
mucosal melanoma of the head and neck pt4a tnm finding v8
mucosal melanoma of the head and neck pt4b tnm finding v8
mucosal melanoma of the head and neck pathologic regional lymph nodes tnm finding v8
mucosal melanoma of the head and neck pnx tnm finding v8
mucosal melanoma of the head and neck pn0 tnm finding v8
mucosal melanoma of the head and neck pn1 tnm finding v8
mucosal melanoma of the head and neck by ajcc v7 stage
mucosal melanoma of the head and neck
dose expansion cohort
autologous egfrt / 19 - 28z / 4 - 1bbl car t - lymphocytes
gland
astatine at 211 anti - cd45 monoclonal antibody bc8 - b10
autologous human anti - cd19car - 4 - 1bb - cd3zeta - egfrt - expressing cd4 +  / cd8 +  t - lymphocytes
oral intraepithelial neoplasia
metastatic thyroid gland carcinoma
cutaneous squamous cell carcinoma of the head and neck tnm finding v8
cutaneous squamous cell carcinoma of the head and neck clinical tnm finding v8
cutaneous squamous cell carcinoma of the head and neck pathologic tnm finding v8
post mastectomy recovery jacket
cutaneous squamous cell carcinoma of the head and neck clinical distant metastasis tnm finding v8
cutaneous squamous cell carcinoma of the head and neck cm0 tnm finding v8
etidronic acid
cutaneous squamous cell carcinoma of the head and neck cm1 tnm finding v8
cutaneous squamous cell carcinoma of the head and neck pathologic distant metastasis tnm finding v8
cutaneous squamous cell carcinoma of the head and neck pm1 tnm finding v8
cutaneous squamous cell carcinoma of the head and neck pathologic primary tumor tnm finding v8
cutaneous squamous cell carcinoma of the head and neck ptx tnm finding v8
cutaneous squamous cell carcinoma of the head and neck ptis tnm finding v8
cutaneous squamous cell carcinoma of the head and neck pt1 tnm finding v8
cutaneous squamous cell carcinoma of the head and neck pt2 tnm finding v8
cutaneous squamous cell carcinoma of the head and neck pt3 tnm finding v8
cutaneous squamous cell carcinoma of the head and neck pt4 tnm finding v8
gastrointestinal fluid or secretion
cutaneous squamous cell carcinoma of the head and neck pt4a tnm finding v8
cutaneous squamous cell carcinoma of the head and neck pt4b tnm finding v8
cutaneous squamous cell carcinoma of the head and neck clinical regional lymph nodes tnm finding v8
cutaneous squamous cell carcinoma of the head and neck cnx tnm finding v8
cutaneous squamous cell carcinoma of the head and neck cn0 tnm finding v8
cutaneous squamous cell carcinoma of the head and neck cn1 tnm finding v8
cutaneous squamous cell carcinoma of the head and neck cn2 tnm finding v8
cutaneous squamous cell carcinoma of the head and neck cn2a tnm finding v8
cutaneous squamous cell carcinoma of the head and neck cn2b tnm finding v8
cutaneous squamous cell carcinoma of the head and neck cn2c tnm finding v8
endometrial
cutaneous squamous cell carcinoma of the head and neck cn3 tnm finding v8
cutaneous squamous cell carcinoma of the head and neck cn3a tnm finding v8
cutaneous squamous cell carcinoma of the head and neck pathologic regional lymph nodes tnm finding v8
cutaneous squamous cell carcinoma of the head and neck pnx tnm finding v8
17beta - hydroxysteroid dehydrogenase type 5 inhibitor asp9521
cutaneous squamous cell carcinoma of the head and neck pn0 tnm finding v8
cutaneous squamous cell carcinoma of the head and neck pn1 tnm finding v8
mtor inhibitor gdc - 0349
cutaneous squamous cell carcinoma of the head and neck pn2 tnm finding v8
cutaneous squamous cell carcinoma of the head and neck pn2a tnm finding v8
vitreous humor
avexitide
cutaneous squamous cell carcinoma of the head and neck pn2b tnm finding v8
cutaneous squamous cell carcinoma of the head and neck pn2c tnm finding v8
cutaneous squamous cell carcinoma of the head and neck pn3 tnm finding v8
cutaneous squamous cell carcinoma of the head and neck pn3a tnm finding v8
cutaneous squamous cell carcinoma of the head and neck pn3b tnm finding v8
cutaneous squamous cell carcinoma of the head and neck cn3b tnm finding v8
encase
niraparib tosylate monohydrate
spl blood and tissue form terminology
hematopoietic
spl blood form donor type terminology
spl blood form establishment functions terminology
spl blood form establishment type terminology
spl blood form product type terminology
spl blood form terminology
spl blood form type of ownership terminology
spl tissue form terminology
spl tissue form donor type terminology
spl tissue form establishment functions terminology
spl tissue form establishment type terminology
serum
spl tissue form product type terminology
spl tissue form product group terminology
cutaneous squamous cell carcinoma of the head and neck
cutaneous squamous cell carcinoma of the head and neck by ajcc v8 stage
lung non - small cell squamous carcinoma
stage 0 cutaneous squamous cell carcinoma of the head and neck ajcc v8
stage i cutaneous squamous cell carcinoma of the head and neck ajcc v8
stage ii cutaneous squamous cell carcinoma of the head and neck ajcc v8
stage iii cutaneous squamous cell carcinoma of the head and neck ajcc v8
stage iv cutaneous squamous cell carcinoma of the head and neck ajcc v8
metaphase plate
cryoprecipitated antihemophilic factor
bone marrow aspirate
derived placental blood cell
cord blood bank
hospital blood bank
non - hospital community blood bank
plasma product
allogeneic blood product donation
autologous blood product donation
dedicated blood product donation
hemidesmosome
designated blood product donation
diagnostic use designated blood product
directed blood product donation
granulocytes product
human peripheral or cord blood cell product
irradiated blood product
leukocytes reduced blood product
other blood form product
platelets product
pooled blood products
caveola
red blood cells product
source leukocytes
blood product pathogen reduction
human cells ,  tissues ,  and cellular and tissue - based products communicable disease testing
human cells ,  tissues ,  and cellular and tissue - based products packing
human cells ,  tissues ,  and cellular and tissue - based products processing
human cells ,  tissues ,  and cellular and tissue - based products recovery
human cells ,  tissues ,  and cellular and tissue - based products screening
human cells ,  tissues ,  and cellular and tissue - based products storage
human cells ,  tissues ,  and cellular and tissue - based products distribution
rough endoplasmic reticulum
human cells ,  tissues ,  and cellular and tissue - based products labeling
human cells ,  tissues ,  and cellular and tissue - based products microorganism testing only
store and distribute to others
whole blood or product preparation
whole blood or product procurement
demineralized bone tissue
human cells ,  tissues ,  and cellular and tissue - based products not specified elsewhere
fertility clinic that manufactures human cells ,  tissues ,  and cellular and tissue - based products
none of the above
licensed biologics manufacturer
dexrazoxane
outer mitochondrial membrane
blood products broker ,  distributor ,  warehouse
blood products collection facility
blood products component preparation facility
blood products distribution center
blood products irradiation facility
medicare approved hospital transfusion service
non - medicare approved hospital transfusion service
cooperative association
county municipal hospital authority
federal non - military ownership
inner mitochondrial membrane
for - profit corporation
non - profit corporation
single proprietorship
state ownership
reproductive human cells ,  tissues ,  and cellular and tissue - based products from anonymous donor
reproductive human cells ,  tissues ,  and cellular and tissue - based products from known donor to directed recipient
reproductive human cells ,  tissues ,  and cellular and tissue - based products from sexually intimate partner
inner membrane amniotic membrane tissue
umbilical cord tissue
apheresis collection facility
bilateral
eye bank
human cells ,  tissues ,  and cellular and tissue - based products satellite recovery facility
hospital based cell or tissue processing facility
non - hospital based cell or tissue processing facility
organ and tissue procurement facility
plasmapheresis center
tissue irradiation facility
blood product bacterial testing 24 hours prior to transfusion
hematopoietic progenitor cells from apheresis
hematopoietic progenitor cells from cord blood
tight junction
community or hospital associated blood products testing facility
independently owned blood products testing facility
donor retested negative
automated pheresis
manual pheresis
blood bank reagent
platelets additive solution
heart valve tissue
non - valve cardiac conduit tissue
minisatellite repeat
ocular tissue
placenta tissue without amniotic elements
pf24 plasma
pf24rt24 plasma
recovered plasma
plasma ,  cryoprecipitated reduced
single donor plasma
source plasma
therapeutic exchange plasma
extended dating platelets
origin of replication
washed platelets
deglycerolized red blood cells
frozen red blood cells
rejuvenated frozen red blood cells
reconstituted red blood cells
rejuvenated ,  frozen ,  deglycerolized red blood cells
rejuvenated red blood cells
washed red blood cells
u .s . military ownership
iodinated polyethylene glycol - based hydrogel tissue marker
pa700 regulatory module
human cells ,  tissues ,  and cellular and tissue - based products from blood vessel tissue
digestive system cancer tnm finding v8
human cells ,  tissues ,  and cellular and tissue - based products from cardiac tissue
upper gastrointestinal tract cancer tnm finding v8
human cells ,  tissues ,  and cellular and tissue - based products from musculoskeletal tissue
esophagus and esophagogastric junction cancer tnm finding v8
esophagus and esophagogastric junction cancer clinical tnm finding v8
esophagus and esophagogastric junction cancer cm0 tnm finding v8
esophagus and esophagogastric junction cancer cm1 tnm finding v8
esophagus and esophagogastric junction cancer pathologic tnm finding v8
germinal center
esophagus and esophagogastric junction cancer pathologic distant metastasis tnm finding v8
esophagus and esophagogastric junction cancer clinical distant metastasis tnm finding v8
esophagus and esophagogastric junction cancer pm1 tnm finding v8
esophagus and esophagogastric junction cancer pathologic primary tumor tnm finding v8
esophagus and esophagogastric junction cancer ptx tnm finding v8
esophagus and esophagogastric junction cancer pt0 tnm finding v8
esophagus and esophagogastric junction cancer ptis tnm finding v8
esophagus and esophagogastric junction cancer pt1 tnm finding v8
esophagus and esophagogastric junction cancer pt1a tnm finding v8
esophagus and esophagogastric junction cancer pt1b tnm finding v8
microsatellite repeat
esophagus and esophagogastric junction cancer pt2 tnm finding v8
esophagus and esophagogastric junction cancer pt3 tnm finding v8
esophagus and esophagogastric junction cancer pt4 tnm finding v8
esophagus and esophagogastric junction cancer pt4a tnm finding v8
esophagus and esophagogastric junction cancer pt4b tnm finding v8
esophagus and esophagogastric junction cancer pathologic regional lymph nodes tnm finding v8
esophagus and esophagogastric junction cancer pnx tnm finding v8
esophagus and esophagogastric junction cancer pn0 tnm finding v8
esophagus and esophagogastric junction cancer pn1 tnm finding v8
esophagus and esophagogastric junction cancer pn2 tnm finding v8
sh2 domain
esophagus and esophagogastric junction cancer pn3 tnm finding v8
esophageal squamous cell carcinoma location category
esophageal squamous cell carcinoma location category x
esophageal squamous cell carcinoma location category upper
esophageal squamous cell carcinoma location category middle
esophageal squamous cell carcinoma location category lower
planned start date
planned end date
postneoadjuvant therapy pathologic tnm finding
esophageal cancer by ajcc v8 stage
vitamin b6
sh3 domain
esophageal adenocarcinoma by ajcc v8 stage
esophageal adenocarcinoma by ajcc v8 clinical stage
clinical stage 0 esophageal adenocarcinoma ajcc v8
clinical stage i esophageal adenocarcinoma ajcc v8
clinical stage ii esophageal adenocarcinoma ajcc v8
clinical stage iia esophageal adenocarcinoma ajcc v8
clinical stage iib esophageal adenocarcinoma ajcc v8
clinical stage iii esophageal adenocarcinoma ajcc v8
clinical stage iv esophageal adenocarcinoma ajcc v8
clinical stage iva esophageal adenocarcinoma ajcc v8
helix - turn - helix motif
clinical stage ivb esophageal adenocarcinoma ajcc v8
esophageal adenocarcinoma by ajcc v7 stage
esophageal adenocarcinoma by ajcc v8 pathologic stage
pathologic stage 0 esophageal adenocarcinoma ajcc v8
pathologic stage i esophageal adenocarcinoma ajcc v8
pathologic stage ia esophageal adenocarcinoma ajcc v8
pathologic stage ib esophageal adenocarcinoma ajcc v8
pathologic stage ic esophageal adenocarcinoma ajcc v8
pathologic stage ii esophageal adenocarcinoma ajcc v8
pathologic stage iia esophageal adenocarcinoma ajcc v8
immunoglobulin hypervariable region
pathologic stage iib esophageal adenocarcinoma ajcc v8
pathologic stage iii esophageal adenocarcinoma ajcc v8
pathologic stage iiia esophageal adenocarcinoma ajcc v8
pathologic stage iiib esophageal adenocarcinoma ajcc v8
pathologic stage iv esophageal adenocarcinoma ajcc v8
pathologic stage iva esophageal adenocarcinoma ajcc v8
pathologic stage ivb esophageal adenocarcinoma ajcc v8
international neuroblastoma risk group staging system
inrg stage l1
inrg stage l2
immunoglobulin hinge region
inrg stage m
inrg stage ms
esophageal adenocarcinoma by ajcc v8 postneoadjuvant therapy stage
postneoadjuvant therapy stage i esophageal adenocarcinoma ajcc v8
postneoadjuvant therapy stage ii esophageal adenocarcinoma ajcc v8
postneoadjuvant therapy stage iii esophageal adenocarcinoma ajcc v8
postneoadjuvant therapy stage iiia esophageal adenocarcinoma ajcc v8
postneoadjuvant therapy stage iiib esophageal adenocarcinoma ajcc v8
postneoadjuvant therapy stage iv esophageal adenocarcinoma ajcc v8
postneoadjuvant therapy stage iva esophageal adenocarcinoma ajcc v8
postneoadjuvant therapy stage ivb esophageal adenocarcinoma ajcc v8
too early
esophageal squamous cell carcinoma by ajcc v7 stage
esophageal squamous cell carcinoma by ajcc v8 stage
esophageal squamous cell carcinoma by ajcc v8 clinical stage
esophageal squamous cell carcinoma by ajcc v8 pathologic stage
esophageal squamous cell carcinoma by ajcc v8 postneoadjuvant therapy stage
clinical stage 0 esophageal squamous cell carcinoma ajcc v8
clinical stage i esophageal squamous cell carcinoma ajcc v8
clinical stage ii esophageal squamous cell carcinoma ajcc v8
clinical stage iii esophageal squamous cell carcinoma ajcc v8
clinical stage iv esophageal squamous cell carcinoma ajcc v8
clinical stage iva esophageal squamous cell carcinoma ajcc v8
clinical stage ivb esophageal squamous cell carcinoma ajcc v8
postneoadjuvant therapy stage i esophageal squamous cell carcinoma ajcc v8
postneoadjuvant therapy stage ii esophageal squamous cell carcinoma ajcc v8
postneoadjuvant therapy stage iii esophageal squamous cell carcinoma ajcc v8
postneoadjuvant therapy stage iiia esophageal squamous cell carcinoma ajcc v8
postneoadjuvant therapy stage iiib esophageal squamous cell carcinoma ajcc v8
postneoadjuvant therapy stage iv esophageal squamous cell carcinoma ajcc v8
postneoadjuvant therapy stage iva esophageal squamous cell carcinoma ajcc v8
postneoadjuvant therapy stage ivb esophageal squamous cell carcinoma ajcc v8
curie scoring system
alk protein variant
alk np_004295 .2:p .r1275x
alk np_004295 .2:p .f1174x
alk np_004295 .2:p .f1245x
curie extension score
curie intensity score
curie extension score 0
aspirate
curie extension score 1
curie extension score 2
curie extension score 3
curie intensity score 0
curie intensity score 1
curie intensity score 2
alk nm_004304 .4:c .3509t > a
curie intensity score 3
alk np_004295 .2:p .i1170n
alk nm_004304 .4:c .3509t > g
genital
alk np_004295 .2:p .i1170s
alk nm_004304 .4:c .3512t > a
alk nm_004304 .4:c .3512_3513deltcinsat
alk np_004295 .2:p .i1171n
alk nm_004304 .4:c .3833a > c
alk np_004295 .2:p .y1278s
alk nm_004304 .4:c .3575g > c
alk np_004295 .2:p .r1192p
alk nm_004304 .4:c .3497t > g
alk np_004295 .2:p .m1166r
myeloid
alk nm_004304 .4:c .3586c > a
alk np_004295 .2:p .l1196m
alk nm_004304 .4:c .3383g > c
alk np_004295 .2:p .g1128a
large b - cell lymphoma with irf4 rearrangement
irf4 gene rearrangement
patient - device interaction problem
loosening of implant not related to bone - ingrowth
component misassembled
recurrent atypical teratoid / rhabdoid tumor
aminothiadiazole
lymphocytic
low ph
breast carcinoma metastatic in the central nervous system
lung carcinoma metastatic in the central nervous system
melanoma metastatic in the central nervous system
device explosion
peeled / delaminated medical device
material too soft or flexible
medical device material twisted / bent
material split ,  cut or torn
ejection problem
failure to eject
firing problem
physical resistance / sticking
sharp edges
medical device dislodged or dislocated
device fell
device complete loss of power
line of therapy
pathologic stage 0 esophageal squamous cell carcinoma ajcc v8
intraperitoneal
intermittent loss of power
pathologic stage i esophageal squamous cell carcinoma ajcc v8
fourth - line therapy
interrogation problem
fifth - line therapy
pathologic stage ia esophageal squamous cell carcinoma ajcc v8
sixth - line therapy
unintended electrical shock
seventh - line therapy
eighth - line therapy
pathologic stage ib esophageal squamous cell carcinoma ajcc v8
seventh
pathologic stage ii esophageal squamous cell carcinoma ajcc v8
eigth
pathologic stage iia esophageal squamous cell carcinoma ajcc v8
pathologic stage iib esophageal squamous cell carcinoma ajcc v8
pathologic stage iii esophageal squamous cell carcinoma ajcc v8
pathologic stage iiia esophageal squamous cell carcinoma ajcc v8
pathologic stage iiib esophageal squamous cell carcinoma ajcc v8
pathologic stage iv esophageal squamous cell carcinoma ajcc v8
pim / flt3 kinase inhibitor sel24
pathologic stage iva esophageal squamous cell carcinoma ajcc v8
pathologic stage ivb esophageal squamous cell carcinoma ajcc v8
crizanlizumab
unexpected shutdown
audible prompt / feedback
no visual prompts / feedback
tactile prompts / feedback
gastroesophageal junction adenocarcinoma by ajcc v8 stage
gastroesophageal junction adenocarcinoma by ajcc v8 clinical stage
chromosome arm
clinical stage 0 gastroesophageal junction adenocarcinoma ajcc v8
inappropriate tactile prompt / feedback
clinical stage i gastroesophageal junction adenocarcinoma ajcc v8
clinical stage ii gastroesophageal junction adenocarcinoma ajcc v8
clinical stage iia gastroesophageal junction adenocarcinoma ajcc v8
clinical stage iib gastroesophageal junction adenocarcinoma ajcc v8
clinical stage iii gastroesophageal junction adenocarcinoma ajcc v8
clinical stage iv gastroesophageal junction adenocarcinoma ajcc v8
clinical stage iva gastroesophageal junction adenocarcinoma ajcc v8
no tactile prompts / feedback
plasma
clinical stage ivb gastroesophageal junction adenocarcinoma ajcc v8
intermittent energy output
radiation output problem
gastroesophageal junction adenocarcinoma by ajcc v8 pathologic stage
pathologic stage 0 gastroesophageal junction adenocarcinoma ajcc v8
pathologic stage i gastroesophageal junction adenocarcinoma ajcc v8
pathologic stage ia gastroesophageal junction adenocarcinoma ajcc v8
pathologic stage ib gastroesophageal junction adenocarcinoma ajcc v8
pathologic stage ic gastroesophageal junction adenocarcinoma ajcc v8
radiation output failure
pathologic stage ii gastroesophageal junction adenocarcinoma ajcc v8
unexpected / unintended radiation output
pathologic stage iia gastroesophageal junction adenocarcinoma ajcc v8
pathologic stage iib gastroesophageal junction adenocarcinoma ajcc v8
non - reproducible results
pathologic stage iii gastroesophageal junction adenocarcinoma ajcc v8
excessive heating
pathologic stage iiia gastroesophageal junction adenocarcinoma ajcc v8
application program freezes ,  becomes nonfunctional
pathologic stage iiib gastroesophageal junction adenocarcinoma ajcc v8
pathologic stage iv gastroesophageal junction adenocarcinoma ajcc v8
pathologic stage iva gastroesophageal junction adenocarcinoma ajcc v8
pathologic stage ivb gastroesophageal junction adenocarcinoma ajcc v8
gastroesophageal junction adenocarcinoma by ajcc v8 postneoadjuvant therapy stage
postneoadjuvant therapy stage i gastroesophageal junction adenocarcinoma ajcc v8
postneoadjuvant therapy stage ii gastroesophageal junction adenocarcinoma ajcc v8
postneoadjuvant therapy stage iii gastroesophageal junction adenocarcinoma ajcc v8
postneoadjuvant therapy stage iiia gastroesophageal junction adenocarcinoma ajcc v8
postneoadjuvant therapy stage iiib gastroesophageal junction adenocarcinoma ajcc v8
postneoadjuvant therapy stage iv gastroesophageal junction adenocarcinoma ajcc v8
gastrointestinal
postneoadjuvant therapy stage iva gastroesophageal junction adenocarcinoma ajcc v8
postneoadjuvant therapy stage ivb gastroesophageal junction adenocarcinoma ajcc v8
recurrent classic hodgkin lymphoma
program or algorithm execution problem
unintended application program shut down
gastric cancer tnm finding v8
gastric cancer clinical tnm finding v8
gastric cancer clinical distant metastasis tnm finding v8
gastric cancer cm0 tnm finding v8
delayed program or algorithm execution
cladribine
gastric cancer cm1 tnm finding v8
gastric cancer pathologic tnm finding v8
gastric cancer pathologic distant metastasis tnm finding v8
intermittent program or algorithm execution
gastric cancer pm1 tnm finding v8
gastric cancer pathologic primary tumor tnm finding v8
gastric cancer ptx tnm finding v8
gastric cancer pt0 tnm finding v8
gastric cancer ptis tnm finding v8
gastric cancer pt1 tnm finding v8
nuclear
gastric cancer pt1a tnm finding v8
gastric cancer pt1b tnm finding v8
gastric cancer pt2 tnm finding v8
gastric cancer pt3 tnm finding v8
gastric cancer pt4 tnm finding v8
gastric cancer pt4a tnm finding v8
gastric cancer pt4b tnm finding v8
gastric cancer pathologic regional lymph nodes tnm finding v8
gastric cancer pnx tnm finding v8
gastric cancer pn0 tnm finding v8
cardiopulmonary
gastric cancer pn1 tnm finding v8
gastric cancer pn2 tnm finding v8
gastric cancer pn3 tnm finding v8
gastric cancer pn3a tnm finding v8
gastric cancer pn3b tnm finding v8
program or algorithm execution failure
incomplete or inadequate connection
intermittent communication failure
suction failure
priming problem
colorectal
incomplete or inadequate priming
activation problem
separation problem
difficult or delayed separation
premature separation
fail safe did not operate
unintended compatibility problem
failure to adequately clean
gastric cancer by ajcc v8 stage
gastric cancer by ajcc v8 clinical stage
autocrine systems
gastric cancer by ajcc v8 pathologic stage
gastric cancer by ajcc v8 postneoadjuvant therapy stage
illegible information
inaccurate information
unclear information
missing information
misassembly during maintenance / repair
clinical stage 0 gastric cancer ajcc v8
clinical stage i gastric cancer ajcc v8
clinical stage ii gastric cancer ajcc v8
spindle pole body
clinical stage iii gastric cancer ajcc v8
clinical stage iv gastric cancer ajcc v8
clinical stage iva gastric cancer ajcc v8
clinical stage ivb gastric cancer ajcc v8
pathologic stage 0 gastric cancer ajcc v8
pathologic stage i gastric cancer ajcc v8
pathologic stage ia gastric cancer ajcc v8
pathologic stage ib gastric cancer ajcc v8
dlx1 gene
pathologic stage ii gastric cancer ajcc v8
coated pit
pathologic stage iia gastric cancer ajcc v8
dlx1 wt allele
pathologic stage iib gastric cancer ajcc v8
pathologic stage iii gastric cancer ajcc v8
homeobox protein dlx - 1
pathologic stage iiia gastric cancer ajcc v8
pathologic stage iiib gastric cancer ajcc v8
pathologic stage iiic gastric cancer ajcc v8
pathologic stage iv gastric cancer ajcc v8
ptch1 gene mutation
homeo domain
postneoadjuvant therapy stage i gastric cancer ajcc v8
postneoadjuvant therapy stage ii gastric cancer ajcc v8
postneoadjuvant therapy stage iii gastric cancer ajcc v8
postneoadjuvant therapy stage iv gastric cancer ajcc v8
braf gene amplification
raf1 gene amplification
raf1 gene mutation
ret gene amplification
kit gene amplification
ptch1 gene deletion
keratin filament
atm gene deletion
clinical stage iia gastric cancer ajcc v8
clinical stage iib gastric cancer ajcc v8
epha2 gene mutation
fyn gene mutation
yes1 gene mutation
mtor gene mutation
csf1r gene mutation
src gene mutation
lck gene mutation
alpha helix
lyn gene mutation
egfr t790m inhibitor hs - 10296
myc protein overexpression
11q translocation
tp53 gene deletion
homologous recombination repair gene mutation
rb1 gene mutation
tfe3 gene rearrangement
srsf2 gene mutation
srsf2 gene deletion
cevimeline hydrochloride
cis - acting sequence
u2af1 gene mutation
zrsr2 gene mutation
sf3b1 gene mutation
cdh3 positive
fgf family alteration positive
fgfr family alteration positive
mismatch repair gene mutation
alk negative
ubiquitin - conjugating enzyme gene
recurrent head and neck squamous cell carcinoma
5' untranslated region
ubiquitin - transferase gene
e2 ubiquitin - conjugating enzyme
metastatic paraganglioma
locally advanced paraganglioma
e1 ubiquitin - activating enzyme
yeats domain
small intestinal cancer by ajcc v7 stage
boron - dipyrromethene - modified olaparib fluorescent imaging agent
vadacabtagene leraleucel
alflutinib mesylate
response element
arsenic trioxide capsule formulation orh 2014
misassembled during installation
device migration problem
contrast - enhanced subharmonic ultrasound imaging
brown - vialetto - van laere syndrome 1
familial hypertrophic cardiomyopathy type 4
foundation medicine inc
hypoparathyroidism - retardation - dysmorphism syndrome
caris life sciences
mental retardation ,  x - linked 1
3' untranslated region
muscular dystrophy - dystroglycanopathy  ( limb - girdle )  type c ,  1
refractory primary amyloidosis
recurrent primary amyloidosis
appendix carcinoma by ajcc v7 stage
pdz domain
yttrium - 90 microsphere radioembolization
refractory classic hodgkin lymphoma
refractory malignant solid neoplasm
rabbit plasmacytoma
rabbit oral cavity squamous cell carcinoma
intracisternal a - particle
rabbit fibroma
rabbit cutaneous lymphoma
mental retardation ,  autosomal dominant 9
cortical dysplasia - focal epilepsy syndrome
pterygium
gamma - hydroxy - 1 , n ( 2 )  - propanodeoxyguanosine
packs per day
treatment based on genomic alteration
is patient eligible for systemic therapy in provider's opinion
treatment planned prior to return of genomic testing not already recorded
chromosome fragile site
consortium for molecular and cellular characterization of screen - detected lesions
porta heptis
hepatoduodenal ligament
mesenteric root
renal pedicle
sciatic notch
neural foramen
iliac vessel
clavien - dindo classification of surgical complications
free radioiodine
five hundred
lower gastrointestinal tract cancer tnm finding v8
anal cancer tnm finding v8
anal cancer clinical tnm finding v8
anal cancer clinical distant metastasis tnm finding v8
anal cancer cm0 tnm finding v8
anal cancer cm1 tnm finding v8
anal cancer pathologic tnm finding v8
anal cancer pathologic distant metastasis tnm finding v8
anal cancer pm1 tnm finding v8
chromosome structure
anal cancer pathologic primary tumor tnm finding v8
anal cancer ptx tnm finding v8
anal cancer pt0 tnm finding v8
anal cancer ptis tnm finding v8
anal cancer pt1 tnm finding v8
anal cancer pt2 tnm finding v8
anal cancer pt3 tnm finding v8
anti - cd20 monoclonal antibody - fitc
anal cancer pt4 tnm finding v8
anal cancer pathologic regional lymph nodes tnm finding v8
fundus
anal cancer pnx tnm finding v8
anal cancer pn0 tnm finding v8
anal cancer pn1 tnm finding v8
anal cancer pn1a tnm finding v8
anal cancer pn1b tnm finding v8
anal cancer pn1c tnm finding v8
funded institution
anal canal cancer by ajcc v6 and v7 stage
tnfsf14 gene
tnfsf14 wt allele
protein domain
tumor necrosis factor ligand superfamily member 14
tnfsf9 gene
tnfsf9 wt allele
tumor necrosis factor ligand superfamily member 9
anal cancer by ajcc v8 stage
stage 0 anal cancer ajcc v8
stage i anal cancer ajcc v8
stage ii anal cancer ajcc v8
stage iia anal cancer ajcc v8
stage iib anal cancer ajcc v8
didox
5q
stage iii anal cancer ajcc v8
stage iiia anal cancer ajcc v8
stage iiib anal cancer ajcc v8
stage iiic anal cancer ajcc v8
stage iv anal cancer ajcc v8
fda pharmaceutical quality / cmc terminology
pq / cmc test category terminology
akr1b1 gene
8p
akr1b1 wt allele
aldose reductase
cd11c positive
ighv4 - 34 positive
prame positive
cd25 negative
cd103 negative
polyclonality
anti - ag7 antibody drug conjugate abgn - 107
eed inhibitor mak683
17p
repotrectinib
zirconium zr 89 dfo - pertuzumab
3d - expanded placenta - derived cells plx - r18
copper chloride formulation
small intestine cancer tnm finding v8
small intestine cancer clinical tnm finding v8
small intestine cancer clinical distant metastasis tnm finding v8
small intestine cancer cm0 tnm finding v8
small intestine cancer cm1 tnm finding v8
18q
small intestine cancer pathologic tnm finding v8
small intestine cancer pathologic distant metastasis tnm finding v8
small intestine cancer pm1 tnm finding v8
small intestine cancer pathologic primary tumor tnm finding v8
small intestine cancer ptx tnm finding v8
small intestine cancer pt0 tnm finding v8
small intestine cancer ptis tnm finding v8
small intestine cancer pt1 tnm finding v8
small intestine cancer pt1a tnm finding v8
metastatic digestive system carcinoma
7q
small intestine cancer pt1b tnm finding v8
small intestine cancer pt2 tnm finding v8
small intestine cancer pt3 tnm finding v8
small intestine cancer pt4 tnm finding v8
pou1f1 gene
pou1f1 wt allele
pharmaceutical quality / cmc batch utilization terminology
pharmaceutical quality / cmc chemical structure data file origin terminology
pharmaceutical quality / cmc chemical structure data file type terminology
pharmaceutical quality / cmc closure type terminology
5q31
pharmaceutical quality / cmc compendial method verification indicator terminology
pq / cmc conformance to criteria terminology
pharmaceutical quality / cmc container orientation terminology
pharmaceutical quality / cmc container type terminology
spl pq / cmc dosage form terminology
pharmaceutical quality / cmc drug substance product indicator terminology
pharmaceutical quality / cmc impurity classification terminology
pharmaceutical quality / cmc interpretation code  ( text )  terminology
pq / cmc interpretation code terminology
pq / cmc manufacturing site unique identifier type terminology
7q31
pharmaceutical quality / cmc quality benchmark terminology
pq / cmc source type terminology
pq / cmc specification status terminology
pq / cmc specification type terminology
pharmaceutical quality / cmc storage conditions terminology
pharmaceutical quality / cmc study type terminology
pq / cmc test method origin terminology
pq / cmc test usage terminology
pharmaceutical quality / cmc testing site unique identifier type terminology
17p12
pharmaceutical quality / cmc validation parameter terminology
pituitary - specific positive transcription factor 1
small intestine cancer pathologic regional lymph nodes tnm finding v8
small intestine cancer pnx tnm finding v8
small intestine cancer pn0 tnm finding v8
small intestine cancer pn1 tnm finding v8
small intestine cancer pn2 tnm finding v8
anti - cd40 monoclonal antibody
anti - egfr monoclonal antibody
anti - fgfr monoclonal antibody
8p22
tank gene
tank wt allele
traf family member - associated nf - kappa - b activator
rabbit uterine carcinoma
plasminogen activator inhibitor - 1 deficiency
anetoderma
klk6 gene
11q
klk6 wt allele
kallikrein - 6
small intestinal adenocarcinoma by ajcc v8 stage
stage 0 small intestinal adenocarcinoma ajcc v8
stage i small intestinal adenocarcinoma ajcc v8
stage ii small intestinal adenocarcinoma ajcc v8
stage iia small intestinal adenocarcinoma ajcc v8
stage iib small intestinal adenocarcinoma ajcc v8
stage iii small intestinal adenocarcinoma ajcc v8
bw a773u
11q23
stage iiia small intestinal adenocarcinoma ajcc v8
stage iiib small intestinal adenocarcinoma ajcc v8
stage iv small intestinal adenocarcinoma ajcc v8
bat locus
mdl molfile
valve - up
valve - down
3p
lobe
raw materials / excipients / intermediates / reagents specification
temperature 5  (  +  /  -  )  3 degrees c
temperature  - 20  (  +  /  -  )  5 degrees c
myelogenous
temperature 40  (  +  /  -  )  2 degrees c and relative humidity not more than 25%
t ( 8 ; 21 )  ( q22 ; q22 )
allogeneic lymphocyte
deliverable volume / fill volume
heavy metals / elemental impurities analysis
b - dna
crystallinity
tablet friability
viscosity / rheological properties
embryonic fluid
pyrogenicity / endotoxin assessment
redispersibility
all sites
commercial batch
development batch
clinical batch
validation batch
bioequivalence batch
experimentally determined chemical structure
mdl structure - data file
macromolecular cif
does not conform
inverted
valrubicin
anatomic sites ,  other
organic impurity
inorganic impurity
residual solvent test
data universal numbering system
facility fda establishment identifier
central file number
united states pharmacopeia - national formulary
european pharmacopeia
japanese pharmacopeia
company standard
breast fluid or secretion
tentative approval
not approved
reported in a cbe or ar
temperature 25  (  +  /  -  )  2 degrees c and relative humidity 60%  (  +  /  -  )  5%
temperature 30  (  +  /  -  )  2 degrees c and relative humidity 65%  (  +  /  -  )  5%
temperature 40  (  +  /  -  )  2 degrees c and relative humidity 75%  (  +  /  -  )  5%
temperature 30  (  +  /  -  )  2 degrees c and relative humidity 75%  (  +  /  -  )  5%
temperature 25  (  +  /  -  )  2 degrees c and relative humidity 40%  (  +  /  -  )  5%
temperature 30  (  +  /  -  )  2 degrees c and relative humidity 35%  (  +  /  -  )  5%
chromatin structure
zbtb20 gene
drug product specification
drug substance specification
zbtb20 wt allele
zinc finger and btb domain - containing protein 20
standard environmental condition
cycled - simple environmental condition
complex environmental condition
release determination
contractile system
stability determination
release and stability determination
analyte specificity
analytical procedure linearity
wac gene
wac wt allele
ww domain - containing adapter protein with coiled - coil
appendiceal cancer tnm finding v8
appendiceal carcinoma tnm finding v8
dna structure
appendiceal carcinoma clinical tnm finding v8
appendiceal carcinoma clinical distant metastasis tnm finding v8
appendiceal carcinoma cm0 tnm finding v8
appendiceal carcinoma cm1 tnm finding v8
appendiceal carcinoma cm1a tnm finding v8
appendiceal carcinoma cm1b tnm finding v8
appendiceal carcinoma cm1c tnm finding v8
appendiceal carcinoma pathologic tnm finding v8
appendiceal carcinoma pathologic distant metastasis tnm finding v8
appendiceal carcinoma pm1 tnm finding v8
drug binding site
appendiceal carcinoma pm1a tnm finding v8
appendiceal carcinoma pm1b tnm finding v8
appendiceal carcinoma pm1c tnm finding v8
appendiceal carcinoma pathologic primary tumor tnm finding v8
appendiceal carcinoma ptx tnm finding v8
appendiceal carcinoma pt0 tnm finding v8
myc box
peptide conformation
lysine - specific demethylase 5b
skin fluid or secretion
appendiceal carcinoma ptis tnm finding v8
low - grade appendiceal mucinous neoplasm  ( lamn )  ptis tnm finding v8
appendiceal carcinoma pt1 tnm finding v8
appendiceal carcinoma pt2 tnm finding v8
appendiceal carcinoma pt3 tnm finding v8
tyrphostin a51
transmembrane domain
appendiceal carcinoma pt4 tnm finding v8
appendiceal carcinoma pt4a tnm finding v8
appendiceal carcinoma pt4b tnm finding v8
appendiceal carcinoma pathologic regional lymph nodes tnm finding v8
appendiceal carcinoma pnx tnm finding v8
appendiceal carcinoma pn0 tnm finding v8
appendiceal carcinoma pn1 tnm finding v8
appendiceal carcinoma pn1a tnm finding v8
appendiceal carcinoma pn1b tnm finding v8
appendiceal carcinoma pn1c tnm finding v8
unspecified anatomic sites
appendiceal carcinoma pn2 tnm finding v8
syringe functionality testing
total organic carbon
uniformity of dosage units
water content determination
appendix carcinoma by ajcc v8 stage
stage 0 appendix carcinoma ajcc v8
stage 0 low grade appendix mucinous neoplasm  ( lamn )  ajcc v8
v3 loop
stage i appendix carcinoma ajcc v8
stage ii appendix carcinoma ajcc v8
stage iia appendix carcinoma ajcc v8
stage iib appendix carcinoma ajcc v8
stage iic appendix carcinoma ajcc v8
stage iii appendix carcinoma ajcc v8
stage iiia appendix carcinoma ajcc v8
stage iiib appendix carcinoma ajcc v8
stage iiic appendix carcinoma ajcc v8
stage iv appendix carcinoma ajcc v8
whole organism
stage iva appendix carcinoma ajcc v8
stage ivb appendix carcinoma ajcc v8
stage ivc appendix carcinoma ajcc v8
colorectal cancer tnm finding v8
colorectal cancer clinical tnm finding v8
colorectal cancer clinical distant metastasis tnm finding v8
colorectal cancer cm0 tnm finding v8
colorectal cancer cm1 tnm finding v8
magi3 gene
magi3 wt allele
colorectal cancer cm1a tnm finding v8
colorectal cancer cm1b tnm finding v8
colorectal cancer cm1c tnm finding v8
colorectal cancer pathologic tnm finding v8
colorectal cancer pathologic distant metastasis tnm finding v8
colorectal cancer pm1 tnm finding v8
colorectal cancer pm1a tnm finding v8
colorectal cancer pm1b tnm finding v8
colorectal cancer pm1c tnm finding v8
colorectal cancer pathologic primary tumor tnm finding v8
refractory neuroblastoma
refractory lymphoma
membrane - associated guanylate kinase ,  ww and pdz domain - containing protein 3
colorectal cancer ptx tnm finding v8
recurrent lymphoma
colorectal cancer pt0 tnm finding v8
colorectal cancer ptis tnm finding v8
adrenal fluid or secretion
colorectal cancer pt1 tnm finding v8
colorectal cancer pt2 tnm finding v8
colorectal cancer pt3 tnm finding v8
colorectal cancer pt4 tnm finding v8
colorectal cancer pt4a tnm finding v8
colorectal cancer pt4b tnm finding v8
colorectal cancer pathologic regional lymph nodes tnm finding v8
colorectal cancer pnx tnm finding v8
refractory histiocytic and dendritic cell neoplasm
colorectal cancer pn0 tnm finding v8
connective tissue fluid or secretion
colorectal cancer pn1 tnm finding v8
colorectal cancer pn1a tnm finding v8
recurrent histiocytic and dendritic cell neoplasm
colorectal cancer pn1b tnm finding v8
colorectal cancer pn1c tnm finding v8
recurrent langerhans cell histiocytosis
colorectal cancer pn2 tnm finding v8
refractory langerhans cell histiocytosis
colorectal cancer pn2a tnm finding v8
colorectal cancer pn2b tnm finding v8
head and neck fluids and secretions
colorectal cancer by ajcc v8 stage
stage 0 colorectal cancer ajcc v8
arih1 gene
arih1 wt allele
stage i colorectal cancer ajcc v8
stage ii colorectal cancer ajcc v8
stage iia colorectal cancer ajcc v8
stage iib colorectal cancer ajcc v8
e3 ubiquitin - protein ligase arih1
multiple cancer sites
stage iic colorectal cancer ajcc v8
stage iii colorectal cancer ajcc v8
stage iiia colorectal cancer ajcc v8
stage iiib colorectal cancer ajcc v8
stage iiic colorectal cancer ajcc v8
stage iv colorectal cancer ajcc v8
stage iva colorectal cancer ajcc v8
stage ivb colorectal cancer ajcc v8
stage ivc colorectal cancer ajcc v8
ametantrone
multiple anatomic sites
histone fold
hmg domain
pou domain
winged helix
analytical procedure range
analytical procedure accuracy
analytical procedure precision
analytical procedure detection limit
analytical procedure robustness
system suitability
analytical procedure quantitation limit
container closure integrity testing
dna binding domain
content uniformity
colon cancer by ajcc v8 stage
pharmaceutical disintegration
pharmaceutical dissolution
impurities / degradation products / related substances assessment
loss on drying
microbial limit
particle size distribution
rectal cancer by ajcc v8 stage
physicochemical property analysis
protein binding domain
powder bulk density
clarity of solution
color of solution
conductivity
hardness
tablet properties
tap density
plume geometry
polymorphic form determination
zinc - binding ,  dna - binding motif
potency assay
stage 0 colon cancer ajcc v8
reconstitution time
stage i colon cancer ajcc v8
stage ii colon cancer ajcc v8
residue on ignition
spray pattern assessment
sterility test
sub - visible particle
hormone receptor dna - binding domain
stage iia colon cancer ajcc v8
stage iib colon cancer ajcc v8
stage iic colon cancer ajcc v8
stage iii colon cancer ajcc v8
stage iiia colon cancer ajcc v8
stage iiib colon cancer ajcc v8
stage iiic colon cancer ajcc v8
stage iv colon cancer ajcc v8
stage iva colon cancer ajcc v8
stage ivb colon cancer ajcc v8
zinc cluster
stage ivc colon cancer ajcc v8
stage 0 rectal cancer ajcc v8
stage i rectal cancer ajcc v8
stage ii rectal cancer ajcc v8
stage iia rectal cancer ajcc v8
stage iib rectal cancer ajcc v8
stage iic rectal cancer ajcc v8
stage iii rectal cancer ajcc v8
stage iiia rectal cancer ajcc v8
stage iiib rectal cancer ajcc v8
aminosyn
mitotic chromosome
stage iiic rectal cancer ajcc v8
stage iv rectal cancer ajcc v8
stage iva rectal cancer ajcc v8
stage ivb rectal cancer ajcc v8
stage ivc rectal cancer ajcc v8
anti - lag - 3 monoclonal antibody
tnrc6b gene
tnrc6b wt allele
interphase chromosome
trinucleotide repeat - containing gene 6b protein
kdm3a gene
kdm3a wt allele
lysine - specific demethylase 3a
fgfr2 np_000132 .3:p .v679f
mantle cell lymphoma international prognostic index combined biologic index
raver2 gene
raver2 wt allele
ribonucleoprotein ptb - binding 2
refractory acute myeloid leukemia
chromosome band
chromatin fiber
higher order chromatin structure
chromatin loop
chromosome territory
matrix attachment region
death domain
traf domain
pivaloyloxymethylbutyrate
short tandem repeat
anatomy qualifier
immunoglobulin heavy chain diversity region
bone and cartilage funding
pimitespib
gene feature
ntrk1 gene alteration positive
ntrk2 gene alteration positive
ros1 gene alteration positive
hepatobiliary system cancer tnm finding v8
ntrk3 gene alteration positive
hepatocellular carcinoma tnm finding v8
alk gene alteration positive
hepatocellular carcinoma clinical tnm finding v8
nuclear structure
hepatocellular carcinoma clinical distant metastasis tnm finding v8
hepatocellular carcinoma cm0 tnm finding v8
hepatocellular carcinoma cm1 tnm finding v8
bcl2 positive
hepatocellular carcinoma pathologic tnm finding v8
egfr exon 19 insertion mutation
hepatocellular carcinoma pathologic distant metastasis tnm finding v8
hepatocellular carcinoma pm1 tnm finding v8
braf v600 wild type
hepatocellular carcinoma pathologic primary tumor tnm finding v8
nonexchangeable site
hepatocellular carcinoma ptx tnm finding v8
hepatocellular carcinoma pt0 tnm finding v8
hepatocellular carcinoma pt1 tnm finding v8
apc gene mutation
hepatocellular carcinoma pt1a tnm finding v8
hepatocellular carcinoma pt1b tnm finding v8
hepatocellular carcinoma pt2 tnm finding v8
hepatocellular carcinoma pt3 tnm finding v8
nectin4 gene
hepatocellular carcinoma pt4 tnm finding v8
microtubule bundle
nectin4 wt allele
hepatocellular carcinoma pathologic regional lymph nodes tnm finding v8
hepatocellular carcinoma pnx tnm finding v8
nectin - 4
hepatocellular carcinoma pn0 tnm finding v8
hepatocellular carcinoma pn1 tnm finding v8
nectin4 positive
alk gene rearrangement negative
alk gene translocation negative
btk protein variant
rna conformation
btk np_000052 .1:pc481x
mlana positive
gpc3 positive
activating egfr gene mutation negative
kdr positive
il13ra2 positive
fgfr2 positive
powassan virus
activating raf mutation
pamidronate disodium
bhlh domain
ptprc positive
egfr positive
noxa bh3 priming
deleterious rad51b gene mutation
deleterious cdk12 gene mutation
ppp2r2a gene
ppp2r2a wt allele
serine / threonine - protein phosphatase 2a 55 kda regulatory subunit b alpha isoform
deleterious ppp2r2a gene mutation
pre - condensed chromosomes
deleterious fancl gene mutation
deleterious chek2 gene mutation
deleterious chek1 gene mutation
deleterious atm gene mutation
intrahepatic cholangiocarcinoma by ajcc v7 stage
hepatocellular carcinoma by ajcc v8 stage
stage i hepatocellular carcinoma ajcc v8
stage ia hepatocellular carcinoma ajcc v8
stage ib hepatocellular carcinoma ajcc v8
stage ii hepatocellular carcinoma ajcc v8
other body fluids and secretions
stage iii hepatocellular carcinoma ajcc v8
stage iiia hepatocellular carcinoma ajcc v8
stage iiib hepatocellular carcinoma ajcc v8
stage iv hepatocellular carcinoma ajcc v8
stage iva hepatocellular carcinoma ajcc v8
stage ivb hepatocellular carcinoma ajcc v8
canine neoplasm
bovine neoplasm
feline experimental organism diagnosis
metal binding site
leporine experimental organism diagnosis
hamster experimental organism diagnosis
experimental organism neoplasm by organism
galline experimental organism diagnosis
equine experimental organism diagnosis
linear sequence epitope
sister chromatid
chicken bursal lymphoma
chicken fibrosarcoma
chicken hepatoma
feline bronchioloalveolar lung carcinoma
bone marrow stem cell
feline fibrosarcoma
gerbil fibroma
goldfish erythrophoroma
guinea pig colon adenocarcinoma
guinea pig leukemia
hamster buccal pouch carcinoma
hamster cholangiocarcinoma
hamster ductus deferens leiomyosarcoma
hamster uterine leiomyosarcoma
horse melanoma
cytoplasmic domain
mouse basal cell carcinoma
medaka hepatoma
medaka melanoma
rainbow trout hepatoma
xenopus neoplasm
xiphophorus melanoma
experimental organism neoplasm
intrahepatic bile duct cancer tnm finding v8
intrahepatic bile duct cancer clinical tnm finding v8
intrahepatic bile duct cancer clinical distant metastasis tnm finding v8
extracellular domain
intrahepatic bile duct cancer cm0 tnm finding v8
intrahepatic bile duct cancer cm1 tnm finding v8
intrahepatic bile duct cancer pathologic tnm finding v8
intrahepatic bile duct cancer pathologic distant metastasis tnm finding v8
intrahepatic bile duct cancer pm1 tnm finding v8
intrahepatic bile duct cancer pathologic primary tumor tnm finding v8
akap6 gene
intrahepatic bile duct cancer ptx tnm finding v8
akap6 wt allele
protease domain
intrahepatic bile duct cancer pt0 tnm finding v8
intrahepatic bile duct cancer ptis tnm finding v8
a - kinase anchor protein 6
intrahepatic bile duct cancer pt1 tnm finding v8
intrahepatic bile duct cancer pt1a tnm finding v8
intrahepatic bile duct cancer pt1b tnm finding v8
intrahepatic bile duct cancer pt2 tnm finding v8
intrahepatic bile duct cancer pt3 tnm finding v8
intrahepatic bile duct cancer pt4 tnm finding v8
intrahepatic bile duct cancer pathologic regional lymph nodes tnm finding v8
asaley
proximal enhancer element
intrahepatic bile duct cancer pnx tnm finding v8
intrahepatic bile duct cancer pn0 tnm finding v8
intrahepatic bile duct cancer pn1 tnm finding v8
intrahepatic bile duct cancer by ajcc v8 stage
lmf1 gene
lmf1 wt allele
lipase maturation factor 1
stage 0 intrahepatic bile duct cancer ajcc v8
distal enhancer elements
stage i intrahepatic bile duct cancer ajcc v8
stage ia intrahepatic bile duct cancer ajcc v8
stage ib intrahepatic bile duct cancer ajcc v8
heatr3 gene
stage ii intrahepatic bile duct cancer ajcc v8
stage iii intrahepatic bile duct cancer ajcc v8
stage iiia intrahepatic bile duct cancer ajcc v8
heatr3 wt allele
stage iiib intrahepatic bile duct cancer ajcc v8
stage iv intrahepatic bile duct cancer ajcc v8
upstream enhancer
mirasol - treated allogeneic platelets
heat repeat - containing protein 3
cisplatin / methotrexate regimen
gnp regimen
human cancer models initiative
slc16a8 gene
slc16a8 wt allele
monocarboxylate transporter 3
ccdc26 gene
ccdc26 wt allele
downstream enhancer
putative coiled - coil domain - containing protein 26
ccdc26 long non - coding rna
rtel1 gene
rtel1 wt allele
regulator of telomere elongation helicase 1
gallbladder cancer tnm finding v8
gallbladder cancer clinical tnm finding v8
gallbladder cancer clinical distant metastasis tnm finding v8
gallbladder cancer cm0 tnm finding v8
gallbladder cancer cm1 tnm finding v8
vaginal and other genital
gallbladder cancer pathologic tnm finding v8
gallbladder cancer pathologic distant metastasis tnm finding v8
gallbladder cancer pm1 tnm finding v8
gallbladder cancer pathologic primary tumor tnm finding v8
gallbladder cancer ptx tnm finding v8
gallbladder cancer pt0 tnm finding v8
gallbladder cancer ptis tnm finding v8
gallbladder cancer pt1 tnm finding v8
gallbladder cancer pt1a tnm finding v8
gallbladder cancer pt1b tnm finding v8
gallbladder cancer pt2 tnm finding v8
gallbladder cancer pt2a tnm finding v8
gallbladder cancer pt2b tnm finding v8
gallbladder cancer pt3 tnm finding v8
gallbladder cancer pt4 tnm finding v8
gallbladder cancer pathologic regional lymph nodes tnm finding v8
gallbladder cancer pnx tnm finding v8
gallbladder cancer pn0 tnm finding v8
gallbladder cancer pn1 tnm finding v8
gallbladder cancer pn2 tnm finding v8
20q13
gallbladder cancer by ajcc v8 stage
polr3k gene
polr3k wt allele
stage 0 gallbladder cancer ajcc v8
stage i gallbladder cancer ajcc v8
stage ii gallbladder cancer ajcc v8
dna - directed rna polymerase iii subunit rpc10
9q34 .1
stage iia gallbladder cancer ajcc v8
stage iib gallbladder cancer ajcc v8
stage iii gallbladder cancer ajcc v8
stage iiia gallbladder cancer ajcc v8
stage iiib gallbladder cancer ajcc v8
stage iv gallbladder cancer ajcc v8
stage iva gallbladder cancer ajcc v8
stage ivb gallbladder cancer ajcc v8
snrnp25 gene
1q24 - q25
snrnp25 wt allele
u11 / u12 small nuclear ribonucleoprotein 25 kda protein
pick1 gene
pick1 wt allele
prkca - binding protein
prmt1 gene
prmt1 wt allele
protein arginine n - methyltransferase 1
or51b4 gene
or51b4 wt allele
14q32 .3
olfactory receptor 51b4
myo1e gene
myo1e wt allele
unconventional myosin - ie
ran gene
ran wt allele
gtp - binding nuclear protein ran
praluzatamab ravtansine
melk gene
melk wt allele
azimexon
xp11 .2 - p11 .4
maternal embryonic leucine zipper kinase
cd2 positive
capecitabine / methotrexate / vinorelbine regimen
mir506 gene
mir506 wt allele
mir506 pre - mirna
usf3 gene
usf3 wt allele
basic helix - loop - helix domain - containing protein usf3
mlkl gene
3p21 .3
mlkl wt allele
mixed lineage kinase domain - like protein
perihilar bile duct cancer tnm finding v8
perihilar bile duct cancer clinical tnm finding v8
perihilar bile duct cancer clinical distant metastasis tnm finding v8
perihilar bile duct cancer cm0 tnm finding v8
perihilar bile duct cancer cm1 tnm finding v8
perihilar bile duct cancer pathologic tnm finding v8
perihilar bile duct cancer pathologic distant metastasis tnm finding v8
2pter - p12
perihilar bile duct cancer pm1 tnm finding v8
perihilar bile duct cancer pathologic primary tumor tnm finding v8
perihilar bile duct cancer ptx tnm finding v8
perihilar bile duct cancer pt0 tnm finding v8
perihilar bile duct cancer ptis tnm finding v8
perihilar bile duct cancer pt1 tnm finding v8
perihilar bile duct cancer pt2 tnm finding v8
perihilar bile duct cancer pt2a tnm finding v8
perihilar bile duct cancer pt2b tnm finding v8
perihilar bile duct cancer pt3 tnm finding v8
1p21 - p13
perihilar bile duct cancer pt4 tnm finding v8
perihilar bile duct cancer pathologic regional lymph nodes tnm finding v8
perihilar bile duct cancer pnx tnm finding v8
perihilar bile duct cancer pn0 tnm finding v8
perihilar bile duct cancer pn1 tnm finding v8
perihilar bile duct cancer pn2 tnm finding v8
bismuth - corlette hilar cholangiocarcinoma classification
type i bismuth - corlette hilar cholangiocarcinoma
type ii bismuth - corlette hilar cholangiocarcinoma
type iiia bismuth - corlette hilar cholangiocarcinoma
19q13 .1
type iiib bismuth - corlette hilar cholangiocarcinoma
type iv bismuth - corlette hilar cholangiocarcinoma
hilar cholangiocarcinoma by ajcc v7 stage
hilar cholangiocarcinoma by ajcc v8 stage
stage 0 hilar cholangiocarcinoma ajcc v8
stage i hilar cholangiocarcinoma ajcc v8
stage ii hilar cholangiocarcinoma ajcc v8
stage iii hilar cholangiocarcinoma ajcc v8
stage iiia hilar cholangiocarcinoma ajcc v8
stage iiib hilar cholangiocarcinoma ajcc v8
18q21 .3
stage iiic hilar cholangiocarcinoma ajcc v8
stage iv hilar cholangiocarcinoma ajcc v8
stage iva hilar cholangiocarcinoma ajcc v8
stage ivb hilar cholangiocarcinoma ajcc v8
intrahepatic cholangiocarcinoma by ajcc v8 stage
stage 0 intrahepatic cholangiocarcinoma ajcc v8
stage i intrahepatic cholangiocarcinoma ajcc v8
stage ia intrahepatic cholangiocarcinoma ajcc v8
stage ib intrahepatic cholangiocarcinoma ajcc v8
19q13 .1 - q13 .2
stage ii intrahepatic cholangiocarcinoma ajcc v8
stage iii intrahepatic cholangiocarcinoma ajcc v8
stage iiia intrahepatic cholangiocarcinoma ajcc v8
stage iiib intrahepatic cholangiocarcinoma ajcc v8
stage iv intrahepatic cholangiocarcinoma ajcc v8
alpha - methyl - 4 - deoxy - 4 -  [  ( 18 ) f ] fluoro - d - glucopyranoside
baboon lymphoma
bovine lymphosarcoma
bovine rectal myxoma
duck neoplasm
22q11
feline erythroleukemia
frog pronephric kidney tumor
gerbil fibrosarcoma
gerbil melanoma
gibbon lymphosarcoma
hamster kidney tumor
hamster lymphoma
hamster lymphosarcoma
horse lymphoma
mouse rectum carcinoma
1p32
mouse reticulum cell sarcoma
ovine sinus tumor
rhesus monkey lymphoma
rhesus monkey mammary tumor
zebra finch neoplasm
porcine lymphoma
anti - tigit monoclonal antibody
distal bile duct cancer tnm finding v8
distal bile duct cancer clinical tnm finding v8
10p13
distal bile duct cancer clinical distant metastasis tnm finding v8
distal bile duct cancer cm0 tnm finding v8
distal bile duct cancer cm1 tnm finding v8
distal bile duct cancer pathologic tnm finding v8
distal bile duct cancer pathologic distant metastasis tnm finding v8
distal bile duct cancer pm1 tnm finding v8
distal bile duct cancer pathologic primary tumor tnm finding v8
distal bile duct cancer ptx tnm finding v8
distal bile duct cancer ptis tnm finding v8
atrimustine
7q34
distal bile duct cancer pt1 tnm finding v8
distal bile duct cancer pt2 tnm finding v8
distal bile duct cancer pt3 tnm finding v8
distal bile duct cancer pt4 tnm finding v8
distal bile duct cancer pathologic regional lymph nodes tnm finding v8
distal bile duct cancer pnx tnm finding v8
distal bile duct cancer pn0 tnm finding v8
distal bile duct cancer pn1 tnm finding v8
distal bile duct cancer pn2 tnm finding v8
17q21
distal bile duct cancer by ajcc v7 stage
distal bile duct cancer by ajcc v8 stage
stage 0 distal bile duct cancer ajcc v8
stage i distal bile duct cancer ajcc v8
stage ii distal bile duct cancer ajcc v8
stage iia distal bile duct cancer ajcc v8
stage iib distal bile duct cancer ajcc v8
stage iii distal bile duct cancer ajcc v8
stage iiia distal bile duct cancer ajcc v8
stage iiib distal bile duct cancer ajcc v8
13q12 .3
stage iv distal bile duct cancer ajcc v8
atara biotherapeutics
bellicum pharmaceuticals
mesoblast limited
geriatric screening tool
cumulative illness rating scale for geriatrics
cancer and aging research group chemo toxicity calculator
11q23 .3
eyelid sebaceous gland carcinoma
supervisor
non - healthcare professional
recurrent ph - like acute lymphoblastic leukemia
refractory ph - like acute lymphoblastic leukemia
ampulla of vater cancer tnm finding v8
ampulla of vater cancer clinical tnm finding v8
alloantigen - specific allogeneic type 1 regulatory t cells t - allo10
ampulla of vater cancer clinical distant metastasis tnm finding v8
11q13
ampulla of vater cancer cm0 tnm finding v8
ampulla of vater cancer cm1 tnm finding v8
ampulla of vater cancer pathologic tnm finding v8
ampulla of vater cancer pathologic distant metastasis tnm finding v8
ampulla of vater cancer pm1 tnm finding v8
ampulla of vater cancer pathologic primary tumor tnm finding v8
ampulla of vater cancer ptx tnm finding v8
ampulla of vater cancer pt0 tnm finding v8
ampulla of vater cancer ptis tnm finding v8
ampulla of vater cancer pt1 tnm finding v8
16q22 .1
ampulla of vater cancer pt1a tnm finding v8
ampulla of vater cancer pt1b tnm finding v8
ampulla of vater cancer pt2 tnm finding v8
ampulla of vater cancer pt3 tnm finding v8
ampulla of vater cancer pt3a tnm finding v8
ampulla of vater cancer pt3b tnm finding v8
ampulla of vater cancer pt4 tnm finding v8
ampulla of vater cancer pathologic regional lymph nodes tnm finding v8
ampulla of vater cancer pnx tnm finding v8
ampulla of vater cancer pn0 tnm finding v8
12q14
ampulla of vater cancer pn1 tnm finding v8
ampulla of vater cancer pn2 tnm finding v8
gli1 positive
ampulla of vater cancer by ajcc v7 stage
ampulla of vater cancer by ajcc v8 stage
stage 0 ampulla of vater cancer ajcc v8
stage i ampulla of vater cancer ajcc v8
stage ia ampulla of vater cancer ajcc v8
stage ib ampulla of vater cancer ajcc v8
stage ii ampulla of vater cancer ajcc v8
6p21 .2
stage iia ampulla of vater cancer ajcc v8
stage iib ampulla of vater cancer ajcc v8
stage iii ampulla of vater cancer ajcc v8
stage iiia ampulla of vater cancer ajcc v8
stage iiib ampulla of vater cancer ajcc v8
stage iv ampulla of vater cancer ajcc v8
chewable gel dosage form
exocrine pancreatic cancer tnm finding v8
exocrine pancreatic cancer clinical tnm finding v8
exocrine pancreatic cancer clinical distant metastasis tnm finding v8
11p15 .5
exocrine pancreatic cancer cm0 tnm finding v8
exocrine pancreatic cancer cm1 tnm finding v8
exocrine pancreatic cancer pathologic tnm finding v8
exocrine pancreatic cancer pathologic distant metastasis tnm finding v8
exocrine pancreatic cancer pm1 tnm finding v8
exocrine pancreatic cancer pathologic primary tumor tnm finding v8
exocrine pancreatic cancer ptx tnm finding v8
exocrine pancreatic cancer pt0 tnm finding v8
exocrine pancreatic cancer ptis tnm finding v8
exocrine pancreatic cancer pt1 tnm finding v8
9p21
exocrine pancreatic cancer pt1a tnm finding v8
exocrine pancreatic cancer pt1b tnm finding v8
exocrine pancreatic cancer pt1c tnm finding v8
exocrine pancreatic cancer pt2 tnm finding v8
exocrine pancreatic cancer pt3 tnm finding v8
exocrine pancreatic cancer pt4 tnm finding v8
exocrine pancreatic cancer pathologic regional lymph nodes tnm finding v8
exocrine pancreatic cancer pnx tnm finding v8
exocrine pancreatic cancer pn0 tnm finding v8
exocrine pancreatic cancer pn1 tnm finding v8
recombinant inhibin b
14q24 .3 - q31
exocrine pancreatic cancer pn2 tnm finding v8
bcl6 gene translocation
pancreatic cancer by ajcc v6 and v7 stage
have aches in joints and / or muscles
have a lot of pain
become nauseated during medical treatments
food does not taste good
become nauseated while thinking about medical treatments
feel too nauseated to eat
pancreatic cancer by ajcc v8 stage
10p11 .2
some foods and smells cause nausea
needle sticks cause pain
get anxious about having blood drawn
stage 0 pancreatic cancer ajcc v8
stage i pancreatic cancer ajcc v8
get anxious about having needle sticks
stage ia pancreatic cancer ajcc v8
get anxious when waiting to see doctor
get anxious about going to doctor
17p13 .3
stage ib pancreatic cancer ajcc v8
stage ii pancreatic cancer ajcc v8
get anxious about going to hospital
worry about side effects from medical treatments
worry about whether or not medical treatments are working
stage iia pancreatic cancer ajcc v8
worry that cancer will reoccur or relapse
stage iib pancreatic cancer ajcc v8
stage iii pancreatic cancer ajcc v8
difficulty figuring out what to do when something is bothersome
5q33 - q35
stage iv pancreatic cancer ajcc v8
difficulty working with numbers or math
trouble writing school papers or reports
difficulty paying attention to things
difficulty remembering what is read
feel not good looking
dislike other people seeing scars
embarrassed about others seeing body
difficulty telling doctors and nurses about feelings
difficulty asking doctors or nurses questions
10q11 - q12
difficulty explaining illness to others
x - linked thrombocytopenia with beta - thalassemia
rat neoplasms
budgerigar fibrosarcoma
canine pancreatic carcinoma
chicken monocytic leukemia
hamster insulinoma
mouse leydig cell tumor
mouse thyroid gland parafollicular cell carcinoma
pike sarcoma
20q11 .2
quail fibrosarcoma
suncus murinus mammary tumor
charcot - marie - tooth disease type 2a
charcot - marie - tooth disease type 2e
charcot - marie - tooth disease type 4j
bat skin tumor
canine acanthomatous epulis
hamster chondrosarcoma
hemangioendothelioma of the mouse thyroid gland
marmoset lymphoma
7p12
mouse adrenal gland pheochromocytoma
mouse submandibular gland neoplasm
poeciliopsis lucida hepatocellular carcinoma
seal lymphoma
tamarin colon adenocarcinoma
memorial symptom assessment scale  ( msas )  10 - 18
msas frequency score likert scale
brafv600 / pi3k inhibitor asn003
drug shortage
aids - related kaposi sarcoma stage
8q22 - q23
aids - related kaposi sarcoma t  ( tumor )  status
aids - related kaposi sarcoma t0  ( good risk ) : localized tumor
aids - related kaposi sarcoma t1  ( poor risk ) : widespread tumor
aids - related kaposi sarcoma t1  ( poor risk ) : edema or ulceration
aids - related kaposi sarcoma t1  ( poor risk ) : extensive oral involvement
aids - related kaposi sarcoma t1  ( poor risk ) : gastrointestinal tract involvement
aids - related kaposi sarcoma t1  ( poor risk ) : pulmonary involvement
aids - related kaposi sarcoma t1  ( poor risk ) : other non - nodal viscera involvement
aids - related kaposi sarcoma i  ( immune system )  status
aids - related kaposi sarcoma i0  ( good risk )
xp11 .2
aids - related kaposi sarcoma i1  ( poor risk )
aids - related kaposi sarcoma s  ( systemic illness )  status
aids - related kaposi sarcoma s0  ( good risk )
aids - related kaposi sarcoma s1  ( poor risk )
aids - related kaposi sarcoma overall risk group
aids - related kaposi sarcoma good risk
aids - related kaposi sarcoma poor risk
selpercatinib
hamster neoplasm
rabbit neoplasm
12q23
hamster adrenal carcinoma
hamster lung carcinoma
hamster fibrosarcoma
hamster pituitary carcinoma
hamster small intestinal neoplasm
horse sarcoid
mouse histiocytic and dendritic cell neoplasm
mouse thymic lymphoma
rabbit papilloma
rattlesnake fibroma
beta - thioguanine deoxyriboside
12p12
seal lymphosarcoma
turtle neoplasm
walleye dermal sarcoma
budgerigar testicular carcinoma
chicken lymphoma
chicken neoplasm
fish melanoma
feline reticulum cell sarcoma
sponsor study reference identifier
7q32 - q36
cdisc sdtm pharmacogenomics / genetics methods and supporting information test code terminology
cdisc sdtm pharmacogenomics / genetics methods and supporting information test name terminology
cdisc sdtm ajcc tumor grade response terminology
cdisc sdtm pharmacogenomics / genetics findings result category terminology
dispense limited quantity
prescribe limited quantity
phox2b gene mutation
lung non - squamous non - small cell carcinoma
neoantigen - hsp70 peptide cancer vaccine agen2017
digestive system neuroendocrine tumor tnm finding v8
3p11 .2
gastric neuroendocrine tumor tnm finding v8
gastric neuroendocrine tumor clinical tnm finding v8
gastric neuroendocrine tumor clinical distant metastasis tnm finding v8
gastric neuroendocrine tumor cm0 tnm finding v8
gastric neuroendocrine tumor cm1 tnm finding v8
gastric neuroendocrine tumor cm1a tnm finding v8
gastric neuroendocrine tumor cm1b tnm finding v8
gastric neuroendocrine tumor cm1c tnm finding v8
gastric neuroendocrine tumor pathologic tnm finding v8
gastric neuroendocrine tumor pathologic distant metastasis tnm finding v8
19p13 .1
gastric neuroendocrine tumor pm1 tnm finding v8
gastric neuroendocrine tumor pm1a tnm finding v8
gastric neuroendocrine tumor pm1b tnm finding v8
gastric neuroendocrine tumor pm1c tnm finding v8
gastric neuroendocrine tumor pathologic primary tumor tnm finding v8
gastric neuroendocrine tumor ptx tnm finding v8
gastric neuroendocrine tumor pt0 tnm finding v8
gastric neuroendocrine tumor pt1 tnm finding v8
gastric neuroendocrine tumor pt2 tnm finding v8
gastric neuroendocrine tumor pt3 tnm finding v8
17q21 .1
gastric neuroendocrine tumor pt4 tnm finding v8
gastric neuroendocrine tumor pathologic regional lymph nodes tnm finding v8
gastric neuroendocrine tumor pnx tnm finding v8
gastric neuroendocrine tumor pn0 tnm finding v8
gastric neuroendocrine tumor pn1 tnm finding v8
gastric neuroendocrine tumor by ajcc v8 stage
stage i gastric neuroendocrine tumor ajcc v8
stage ii gastric neuroendocrine tumor ajcc v8
stage iii gastric neuroendocrine tumor ajcc v8
stage iv gastric neuroendocrine tumor ajcc v8
12q13
duodenum and ampulla of vater neuroendocrine tumor tnm finding v8
duodenum and ampulla of vater neuroendocrine tumor clinical tnm finding v8
duodenum and ampulla of vater neuroendocrine tumor clinical distant metastasis tnm finding v8
duodenum and ampulla of vater neuroendocrine tumor cm0 tnm finding v8
duodenum and ampulla of vater neuroendocrine tumor cm1 tnm finding v8
duodenum and ampulla of vater neuroendocrine tumor cm1a tnm finding v8
duodenum and ampulla of vater neuroendocrine tumor cm1b tnm finding v8
duodenum and ampulla of vater neuroendocrine tumor cm1c tnm finding v8
autologous peripheral blood mononuclear cells
duodenum and ampulla of vater neuroendocrine tumor pathologic tnm finding v8
2q33 .3 - q34
duodenum and ampulla of vater neuroendocrine tumor pathologic distant metastasis tnm finding v8
duodenum and ampulla of vater neuroendocrine tumor pm1 tnm finding v8
duodenum and ampulla of vater neuroendocrine tumor pm1a tnm finding v8
duodenum and ampulla of vater neuroendocrine tumor pm1b tnm finding v8
duodenum and ampulla of vater neuroendocrine tumor pm1c tnm finding v8
duodenum and ampulla of vater neuroendocrine tumor pathologic primary tumor tnm finding v8
duodenum and ampulla of vater neuroendocrine tumor ptx tnm finding v8
duodenum and ampulla of vater neuroendocrine tumor pt1 tnm finding v8
duodenum and ampulla of vater neuroendocrine tumor pt2 tnm finding v8
duodenum and ampulla of vater neuroendocrine tumor pt3 tnm finding v8
21q22 .3
duodenum and ampulla of vater neuroendocrine tumor pt4 tnm finding v8
duodenum and ampulla of vater neuroendocrine tumor pathologic regional lymph nodes tnm finding v8
duodenum and ampulla of vater neuroendocrine tumor pnx tnm finding v8
duodenum and ampulla of vater neuroendocrine tumor pn0 tnm finding v8
duodenum and ampulla of vater neuroendocrine tumor pn1 tnm finding v8
duodenal neuroendocrine tumor by ajcc v8 stage
stage i duodenal neuroendocrine tumor ajcc v8
stage ii duodenal neuroendocrine tumor ajcc v8
stage iii duodenal neuroendocrine tumor ajcc v8
stage iv duodenal neuroendocrine tumor ajcc v8
1q21 - q23
duodenal neuroendocrine tumor
ampulla of vater neuroendocrine tumor by ajcc v8 stage
stage i ampulla of vater neuroendocrine tumor ajcc v8
stage ii ampulla of vater neuroendocrine tumor ajcc v8
stage iii ampulla of vater neuroendocrine tumor ajcc v8
stage iv ampulla of vater neuroendocrine tumor ajcc v8
schimke immunoosseous dysplasia
spondyloperipheral dysplasia
pediatric quality of life inventory cancer module
12p13
jejunal neuroendocrine tumor
tlr 2 / 6 / 9 agonist pul - 042
ileal neuroendocrine tumor
jejunum and ileum neuroendocrine tumor tnm finding v8
jejunum and ileum neuroendocrine tumor clinical tnm finding v8
jejunum and ileum neuroendocrine tumor clinical distant metastasis tnm finding v8
jejunum and ileum neuroendocrine tumor cm0 tnm finding v8
jejunum and ileum neuroendocrine tumor cm1 tnm finding v8
jejunum and ileum neuroendocrine tumor cm1a tnm finding v8
jejunum and ileum neuroendocrine tumor cm1b tnm finding v8
bismuth subcitrate
3q24 - q28
jejunum and ileum neuroendocrine tumor cm1c tnm finding v8
jejunum and ileum neuroendocrine tumor pathologic tnm finding v8
jejunum and ileum neuroendocrine tumor pathologic distant metastasis tnm finding v8
jejunum and ileum neuroendocrine tumor pm1 tnm finding v8
jejunum and ileum neuroendocrine tumor pm1a tnm finding v8
jejunum and ileum neuroendocrine tumor pm1b tnm finding v8
jejunum and ileum neuroendocrine tumor pm1c tnm finding v8
jejunum and ileum neuroendocrine tumor pathologic primary tumor tnm finding v8
jejunum and ileum neuroendocrine tumor ptx tnm finding v8
jejunum and ileum neuroendocrine tumor pt0 tnm finding v8
22q12
jejunum and ileum neuroendocrine tumor pt1 tnm finding v8
jejunum and ileum neuroendocrine tumor pt2 tnm finding v8
jejunum and ileum neuroendocrine tumor pt3 tnm finding v8
jejunum and ileum neuroendocrine tumor pt4 tnm finding v8
jejunum and ileum neuroendocrine tumor pathologic regional lymph nodes tnm finding v8
jejunum and ileum neuroendocrine tumor pnx tnm finding v8
jejunum and ileum neuroendocrine tumor pn0 tnm finding v8
jejunum and ileum neuroendocrine tumor pn1 tnm finding v8
jejunum and ileum neuroendocrine tumor pn2 tnm finding v8
jejunal neuroendocrine tumor by ajcc v8 stage
4q34 - q35
stage i jejunal neuroendocrine tumor ajcc v8
stage ii jejunal neuroendocrine tumor ajcc v8
stage iii jejunal neuroendocrine tumor ajcc v8
stage iv jejunal neuroendocrine tumor ajcc v8
ileal neuroendocrine tumor by ajcc v8 stage
stage i ileal neuroendocrine tumor ajcc v8
stage ii ileal neuroendocrine tumor ajcc v8
stage iii ileal neuroendocrine tumor ajcc v8
stage iv ileal neuroendocrine tumor ajcc v8
digestive system neuroendocrine tumor by ajcc v7 stage
15q26 .1
appendix neuroendocrine tumor tnm finding v8
appendix neuroendocrine tumor clinical tnm finding v8
appendix neuroendocrine tumor clinical distant metastasis tnm finding v8
appendix neuroendocrine tumor cm0 tnm finding v8
appendix neuroendocrine tumor cm1 tnm finding v8
appendix neuroendocrine tumor cm1a tnm finding v8
appendix neuroendocrine tumor cm1b tnm finding v8
appendix neuroendocrine tumor cm1c tnm finding v8
appendix neuroendocrine tumor pathologic tnm finding v8
appendix neuroendocrine tumor pathologic distant metastasis tnm finding v8
11q13 .3
appendix neuroendocrine tumor pm1 tnm finding v8
appendix neuroendocrine tumor pm1a tnm finding v8
appendix neuroendocrine tumor pm1b tnm finding v8
appendix neuroendocrine tumor pm1c tnm finding v8
appendix neuroendocrine tumor pathologic primary tumor tnm finding v8
appendix neuroendocrine tumor ptx tnm finding v8
appendix neuroendocrine tumor pt0 tnm finding v8
appendix neuroendocrine tumor pt1 tnm finding v8
appendix neuroendocrine tumor pt2 tnm finding v8
appendix neuroendocrine tumor pt3 tnm finding v8
1p36 .2 - p36 .1
appendix neuroendocrine tumor pt4 tnm finding v8
appendix neuroendocrine tumor pathologic regional lymph nodes tnm finding v8
appendix neuroendocrine tumor pnx tnm finding v8
appendix neuroendocrine tumor pn0 tnm finding v8
appendix neuroendocrine tumor pn1 tnm finding v8
appendix neuroendocrine tumor by ajcc v7 stage
appendix neuroendocrine tumor by ajcc v8 stage
stage i appendix neuroendocrine tumor ajcc v8
stage ii appendix neuroendocrine tumor ajcc v8
stage iii appendix neuroendocrine tumor ajcc v8
14q13
stage iv appendix neuroendocrine tumor ajcc v8
colorectal neuroendocrine tumor tnm finding v8
colorectal neuroendocrine tumor clinical tnm finding v8
colorectal neuroendocrine tumor clinical distant metastasis tnm finding v8
colorectal neuroendocrine tumor cm0 tnm finding v8
colorectal neuroendocrine tumor cm1 tnm finding v8
colorectal neuroendocrine tumor cm1a tnm finding v8
colorectal neuroendocrine tumor cm1b tnm finding v8
colorectal neuroendocrine tumor cm1c tnm finding v8
colorectal neuroendocrine tumor pathologic tnm finding v8
11q24 .1 - q24 .3
colorectal neuroendocrine tumor pathologic distant metastasis tnm finding v8
colorectal neuroendocrine tumor pm1 tnm finding v8
eye fundus
colorectal neuroendocrine tumor pm1a tnm finding v8
colorectal neuroendocrine tumor pm1b tnm finding v8
colorectal neuroendocrine tumor pm1c tnm finding v8
nuclear cataract
cortical cataract
colorectal neuroendocrine tumor pathologic regional lymph nodes tnm finding v8
colorectal neuroendocrine tumor pnx tnm finding v8
13q12
posterior subcapsular cataract
colorectal neuroendocrine tumor pn0 tnm finding v8
colorectal neuroendocrine tumor pn1 tnm finding v8
colorectal neuroendocrine tumor pathologic primary tumor tnm finding v8
colorectal neuroendocrine tumor ptx tnm finding v8
colorectal neuroendocrine tumor pt0 tnm finding v8
colorectal neuroendocrine tumor pt1 tnm finding v8
colorectal neuroendocrine tumor pt1a tnm finding v8
colorectal neuroendocrine tumor pt1b tnm finding v8
diphenoxylate hydrochloride / atropine sulfate
14q24 .3
colorectal neuroendocrine tumor pt2 tnm finding v8
colorectal neuroendocrine tumor pt3 tnm finding v8
colorectal neuroendocrine tumor pt4 tnm finding v8
nuclear cataract grade 1
nuclear cataract grade 2
nuclear cataract grade 3
nuclear cataract grade 4
cortical cataract grade 1
cortical cataract grade 2
cortical cataract grade 3
recombinant brain - derived growth factors
2p23 - p22
cortical cataract grade 4
posterior subcapsular cataract grade 1
posterior subcapsular cataract grade 2
posterior subcapsular cataract grade 3
posterior subcapsular cataract grade 4
colorectal neuroendocrine tumor by ajcc v8 stage
stage i colorectal neuroendocrine tumor ajcc v8
stage iia colorectal neuroendocrine tumor ajcc v8
stage iib colorectal neuroendocrine tumor ajcc v8
stage iiia colorectal neuroendocrine tumor ajcc v8
6q21
stage iiib colorectal neuroendocrine tumor ajcc v8
stage iv colorectal neuroendocrine tumor ajcc v8
colon neuroendocrine tumor
rectal neuroendocrine tumor
colon neuroendocrine tumor by ajcc v8 stage
12q13 .2 - q13 .3
2q14
7p13
4q21
1p
1p36 .3
1q
11p
granisetron hydrochloride
10p
10q
12p
12q
13q
13p
20q11 - q12
stage i colon neuroendocrine tumor ajcc v8
stage iia colon neuroendocrine tumor ajcc v8
14p
stage iib colon neuroendocrine tumor ajcc v8
tumor tissue origin
heart chamber volume at end ventricular diastole
heart chamber volume at end ventricular systole
calculated left ventricular ejection fraction
estimated left ventricular ejection fraction
estimated mean blood pressure
major axis cross - sectional diameter
minor axis cross - sectional diameter
pulmonary arterial hypertension indicator
14q
calculated right ventricular ejection fraction
estimated right ventricular ejection fraction
long term care hospital
age at death
autopsy indicator
death certification indicator
hospital medical record indicator
lead site avf - ventral
lead site avl - axial
lead site avr - dorsal
15q
lead site axial
lead site dorsal
lead site ventral
junctional escape rhythm by ecg finding
nonconducted p wave physiology not defined by ecg finding
supraventricular escape beat by ecg finding
cdisc findings about class
abo a1 subtype determination
acetaminophen measurement
basophilic metamyelocyte count
15p
basophilic myelocyte count
segmented basophil count
synthetic cannabinoid measurement
complement ba measurement
chikungunya virus antibody measurement
columnar epithelial cells to non - squamous epithelial cells ratio measurement
clostridium tetani toxoid igg antibody measurement
dicalcium phosphate crystals measurement
dna fragmentation index
deoxyribonucleic acid measurement
16p
ebola virus igm antibody measurement
eosinophils to non - squamous epithelial cells ratio measurement
segmented eosinophil count
non - squamous epithelial cell count
epithelial cells to non - squamous epithelial cells ratio measurement
erythroid maturation index
erythroid maturation pool count
erythroid proliferation index
erythroid proliferation pool count
c - terminal fibroblast growth factor 23 measurement
16q
intact fibroblast growth factor 23 measurement
flagellates measurement
growth differentiation factor 11 measurement
growth differentiation factor 8 measurement
hepatitis c virus core antigen measurement
hemoglobin tetramer measurement
hepatocyte growth factor measurement
hairy cells to total cells ratio measurement
hairy cells to leukocytes ratio measurement
17q
lymphocytes to non - squamous epithelial cells ratio measurement
macrophages to non - squamous epithelial cells ratio measurement
megakaryocyte and megakaryoblast morphology assessment
monocytes to non - squamous epithelial cells ratio measurement
myeloid maturation index
myeloid maturation pool count
myeloid proliferation index
myeloid proliferation pool count
neutrophils to non - squamous epithelial cells ratio measurement
nerve growth factor measurement
18p
estimated platelets measurement
dysmorphic erythrocyte count
retinyl palmitate measurement
skeletal troponin i measurement
thrombomodulin measurement
thymidine kinase 1 measurement
thymidine kinase 2 measurement
troponin i type 1 measurement
troponin i type 3 measurement
trypsin 1 and trypsinogen 1 measurement
19p
trypsin and trypsinogen measurement
leukocytes to total cells ratio measurement
accelerator mass spectrometry
freezing point depression
gas chromatography and flame ionization detection
multiplexed bead based immunoassay
phase - contrast magnetic resonance imaging
population sequencing
raji cell enzyme immunoassay
raji cell radioimmunoassay
19q
ajcc tumor grade
banff renal quantitative criteria score
arteriolar hyaline thickening assessment
banff renal diagnostic category assessment
glomerulitis assessment
glomerulopathy assessment
intimal arteritis assessment
interstitial fibrosis assessment
mononuclear cell interstitial inflammation assessment
2p
mitotic figure assessment
mesangial matrix assessment
platelet endothelial cell adhesion molecule 1 measurement
peritubular capillaritis assessment
tubular atrophy assessment
tubulitis assessment
vascular fibrous intimal thickening assessment
bone marrow disease involvement indicator
clinical performance status
disease response in liver
2q
non - target enhancing lesion response
non - target non - enhancing lesion response
disease response in spleen
steroid use status
gene expression level analysis
genetic sub - region sequence
predicted single nucleotide polymorphism frequency
genetic sequence length
genetic sequence start location
concentration at half tmax
20q
fraction unbound
half tmax
lambda z span
elastance
maximal expiratory pressure
percent predicted maximal expiratory pressure
maximal inspiratory pressure
percent predicted maximal inspiratory pressure
peak cough flow
pulmonary blood flow assessment
calcium citrate
20p
number of biological brothers
number of biological sisters
living with subject indicator
gelatinous specimen
solidified specimen
specimen with unexpected odor
absolute change from nadir in organ enlargement
quantitative organ enlargement assessment
organ state
organ craniocaudal length measurement
21p
percent change from baseline in organ enlargement
percent change from nadir in organ enlargement
percent change from nadir in product of perpendicular diameters
product of perpendicular diameters
delayed graft function diagnostic criteria name
per ten thousand
per hundred thousand
per centimeter of water
centimeter of water times second per milliliter
centimeter of water times second squared per milliliter
21q
centimeter of water per milliliter
milliliter times centimeter of water
graft status
femur / femorotibial joint
stage iiia colon neuroendocrine tumor ajcc v8
stage iiib colon neuroendocrine tumor ajcc v8
stage iv colon neuroendocrine tumor ajcc v8
rectal neuroendocrine tumor by ajcc v8 stage
stage i rectal neuroendocrine tumor ajcc v8
stage iia rectal neuroendocrine tumor ajcc v8
22q
stage iib rectal neuroendocrine tumor ajcc v8
stage iiia rectal neuroendocrine tumor ajcc v8
stage iiib rectal neuroendocrine tumor ajcc v8
stage iv rectal neuroendocrine tumor ajcc v8
autologous mage - a3 / a6 - specific tcr gene - engineered lymphocytes kite - 718
pancreatic neuroendocrine tumor tnm finding v8
pancreatic neuroendocrine tumor clinical tnm finding v8
pancreatic neuroendocrine tumor clinical distant metastasis tnm finding v8
pancreatic neuroendocrine tumor cm0 tnm finding v8
22p
pancreatic neuroendocrine tumor cm1 tnm finding v8
pancreatic neuroendocrine tumor cm1a tnm finding v8
pancreatic neuroendocrine tumor cm1b tnm finding v8
pancreatic neuroendocrine tumor cm1c tnm finding v8
pancreatic neuroendocrine tumor pathologic tnm finding v8
pancreatic neuroendocrine tumor pathologic distant metastasis tnm finding v8
pancreatic neuroendocrine tumor pm1 tnm finding v8
pancreatic neuroendocrine tumor pm1a tnm finding v8
pancreatic neuroendocrine tumor pm1b tnm finding v8
pancreatic neuroendocrine tumor pm1c tnm finding v8
3q
pancreatic neuroendocrine tumor pathologic primary tumor tnm finding v8
pancreatic neuroendocrine tumor ptx tnm finding v8
pancreatic neuroendocrine tumor pt1 tnm finding v8
pancreatic neuroendocrine tumor pt2 tnm finding v8
pancreatic neuroendocrine tumor pt3 tnm finding v8
pancreatic neuroendocrine tumor pt4 tnm finding v8
pancreatic neuroendocrine tumor pathologic regional lymph nodes tnm finding v8
pancreatic neuroendocrine tumor pnx tnm finding v8
pancreatic neuroendocrine tumor pn0 tnm finding v8
pancreatic neuroendocrine tumor pn1 tnm finding v8
4q
pancreatic neuroendocrine tumor by ajcc v8 stage
stage i pancreatic neuroendocrine tumor ajcc v8
stage ii pancreatic neuroendocrine tumor ajcc v8
stage iii pancreatic neuroendocrine tumor ajcc v8
stage iv pancreatic neuroendocrine tumor ajcc v8
brunner's gland hyperplasia
history and physical exam
24 hour urine for total protein
urine protein electrophoresis
urine immunofixation electrophoresis
4p
serum quantitative immunoglobulins
serum immunofixation electrophoresis
serum viscosity
bone marrow staining
magea6 positive
magea3 positive
patient oriented prostate utility scale
pain and disturbing body sensations
communication with doctor
urinary frequency and urgency
5p
bowel problems frequency
no pain and no disturbing body sensations
mild pain or disturbing body sensations not limiting activities
moderate pain or disturbing body sensations that limit few activities
moderate to severe pain or disturbing body sensations that limit some activities
severe pain or disturbing body sensations that limit many activities
very full of energy ,  lots of pep
fairly energetic ,  no limitation of activities
moderate reduction in energy or pep that limits a few activities
generally low energy or pep that limits some activities
6p
no energy or pep at all ;  feel drained ,  many activities are limited
most times feel supported by spouse ,  family ,  and friends
fair amount of time feel supported by spouse ,  family ,  and friends
occasionally feel supported by spouse ,  family and friends
rarely feel supported by spouse ,  family and friends
always able to express concerns to doctor and get needed information or advice
most of the time ,  able to express concerns to doctor and get needed information or advice
some of the time ,  able to express concerns to doctor and get needed information or advice
rarely able to express my concerns to doctor and get needed information or advice
generally happy and free from worry ,  sadness ,  or frustration
carbetimer
6q
little worry ,  sadness ,  or frustration
moderate worry ,  sadness ,  or frustration
quite a bit of worry ,  sadness ,  or frustration
extreme worry ,  sadness ,  or frustration
no urinary frequency or urgency
little urinary frequency or urgency ;  does not interfere with sleep or other activities
some urinary frequency or urgency that interferes with sleep or other activities ;  may need to plan ahead
quite a bit of urinary frequency or urgency ;  need to be near bathroom most of the time
extreme urinary frequency or urgency ;  need to be near a bathroom always
never ,  under any circumstances leak urine or lose bladder control
7p
on rare occasions ,  leak urine or lose bladder control ,  does not interfere with any activities
occasionally leak urine or lose bladder control ,  interferes with few activities
neural stem cells - expressing crad - s - pk7
amikacin inhalation solution
moderate amount of the time ,  leak urine or lose bladder control ,  interferes with some activities
polymyxin - b immobilized fiber pmx - 20r
ar - v7 positive
most of the time ,  leak urine or have poor bladder control ,  interferes with many activities
require clamp ,  catheter ,  or collecting bag because of leaking urine or poor bladder control
liposomal vinorelbine tartrate
8q
full erections sufficient for intercourse
erections sufficient for intercourse ,  but some reduction in firmness
erections sufficient for masturbation or foreplay only
erections ,  but not firm enough for any sexual activity
no erections at all
normal amount of sexual drive and interest
hif - 2alpha inhibitor pt2977
little decrease of sexual drive or interest
hdac6 inhibitor ka2507
9p
no sexual drive or interest
grape seed extract supplement
anti - cd33 antigen / cd3 receptor bispecific monoclonal antibody amv564
anti - ctla4 monoclonal antibody bms - 986218
autologous tumor infiltrating lymphocytes ln - 145
moderate decrease of sexual drive or interest
substantial decrease of sexual drive or interest
no diarrhea ,  rectal discomfort ,  or constipation
have occasional diarrhea ,  rectal discomfort ,  or constipation
have frequent diarrhea ,  rectal discomfort ,  or constipation
9q
have nearly constant diarrhea ,  rectal discomfort ,  or constipation
xp
xq
6p25 - p23
cdisc clinical classification pasi test name terminology
cdisc clinical classification pasi test code terminology
cdisc questionnaire bebq concurrent version test name terminology
1p32 - p31
cdisc questionnaire bebq concurrent version test code terminology
cdisc questionnaire bebq retrospective version test name terminology
cdisc questionnaire bebq retrospective version test code terminology
cdisc questionnaire cgi original version test name terminology
cdisc questionnaire cgi original version test code terminology
cdisc questionnaire cgi generic modification version test name terminology
cdisc questionnaire cgi generic modification version test code terminology
cdisc questionnaire pgi generic modification version test name terminology
cdisc questionnaire pgi generic modification version test code terminology
cdisc questionnaire lec - 5 standard version test name terminology
19p13 .2
cdisc questionnaire lec - 5 standard version test code terminology
cdisc questionnaire pcl - 5 test name terminology
cdisc questionnaire pcl - 5 test code terminology
cdisc questionnaire podci pediatric parent - reported version test name terminology
cdisc questionnaire podci pediatric parent - reported version test code terminology
cdisc questionnaire podci adolescent parent - reported version test name terminology
cdisc questionnaire podci adolescent parent - reported version test code terminology
cdisc questionnaire podci adolescent self - reported version test name terminology
cdisc questionnaire podci adolescent self - reported version test code terminology
cdisc questionnaire rand social support survey test name terminology
mivobulin isethionate
11p11 .2
cdisc questionnaire rand social support survey test code terminology
pasi clinical classification question
bebq concurrent version questionnaire question
bebq retrospective version questionnaire question
cgi original version questionnaire question
cgi generic modification version questionnaire question
pgi generic modification version questionnaire question
lec - 5 standard version questionnaire question
pcl - 5 questionnaire question
podci pediatric parent - reported version questionnaire question
4q11 - q12
podci adolescent parent - reported version questionnaire question
podci adolescent self - reported version questionnaire question
rand social support survey questionnaire question
kras exon 2 mutation
kras exon 3 mutation
kras exon 4 mutation
nras exon 2 mutation
nras exon 3 mutation
12p12 .1
nras exon 4 mutation
mouse erythroleukemia
rat erythroleukemia
hamster mammary carcinoma
feline large granular lymphocyte lymphoma
cockayne syndrome type a
cockayne syndrome type b
liquid biopsy
mammoplasty patient
egfr nm_005228 .3:c .1474a > c
1p35 - p34 .3
egfr nm_005228 .3:c .1476c > a
egfr np_005219 .2:p .s492r
colectomy with diversion
bypass of impending intestinal obstruction
psoriasis area and severity index clinical classification
baby eating behaviour questionnaire concurrent version
baby eating behaviour questionnaire retrospective version
8q13
life events checklist for dsm - 5 standard version questionnaire
the ptsd checklist for dsm - 5 questionnaire
pediatric outcomes data collection instrument ,  pediatric parent - reported version questionnaire
pediatric outcomes data collection instrument ,  adolescent parent - reported version questionnaire
pediatric outcomes data collection instrument ,  adolescent self - reported version questionnaire
rand social support survey instrument questionnaire
pasi  -  head  ( h ) : erythema  ( e )
pasi  -  head  ( h ) : infiltration  ( i )
pasi  -  head  ( h ) : desquamation  ( d )
pasi  -  head  ( h ) : sum = e + i + d
pasi  -  head  ( h ) : area score
pasi  -  head  ( h ) : sum x area
pasi  -  head  ( h ) : sum x area x 0 .1
pasi  -  trunk  ( t ) : erythema  ( e )
pasi  -  trunk  ( t ) : infiltration  ( i )
pasi  -  trunk  ( t ) : desquamation  ( d )
pasi  -  trunk  ( t ) : sum = e + i + d
pasi  -  trunk  ( t ) : area score
pasi  -  trunk  ( t ) : sum x area
pasi  -  trunk  ( t ) : sum x area x 0 .3
18q21 .1
pasi  -  upper extremities  ( u ) : erythema  ( e )
pasi  -  upper extremities  ( u ) : infiltration  ( i )
pasi  -  upper extremities  ( u ) : desquamation  ( d )
pasi  -  upper extremities  ( u ) : sum = e + i + d
pasi  -  upper extremities  ( u ) : area score
pasi  -  upper extremities  ( u ) : sum x area
pasi  -  upper extremities  ( u ) : sum x area x 0 .2
pasi  -  lower extremities  ( l ) : erythema  ( e )
pasi  -  lower extremities  ( l ) : infiltration  ( i )
pasi  -  lower extremities  ( l ) : desquamation  ( d )
16q22 - q23
pasi  -  lower extremities  ( l ) : sum = e + i + d
pasi  -  lower extremities  ( l ) : area score
pasi  -  lower extremities  ( l ) : sum x area
pasi  -  lower extremities  ( l ) : sum x area x 0 .4
pasi  -  total sum
bebq concurrent version  -  baby seems contented feeding
bebq concurrent version  -  baby frequently wants more milk
bebq concurrent version  -  baby loves milk
bebq concurrent version  -  baby has a big appetite
bebq concurrent version  -  baby finishes feeding quickly
17q25
bebq concurrent version  -  baby becomes distressed feeding
bebq concurrent version  -  baby gets full up easily
bebq concurrent version  -  baby would take too much milk
bebq concurrent version  -  baby takes more than 30 minutes
bebq concurrent version  -  gets full before taking all milk
bebq concurrent version  -  baby feeds slowly
bebq concurrent version  -  just eaten is happy to feed again
bebq concurrent version  -  difficult manage complete feed
bebq concurrent version  -  baby is always demanding a feed
bebq concurrent version  -  baby sucks more and more slowly
6q24 - q27
bebq concurrent version  -  baby would always be feeding
bebq concurrent version  -  baby enjoys feeding time
bebq concurrent version  -  take a feed within 30 minutes
bebq retrospective version  -  baby seemed contented feeding
bebq retrospective version  -  baby frequently wanted more milk
bebq retrospective version  -  baby loved milk
bebq retrospective version  -  baby had a big appetite
bebq retrospective version  -  baby finished feeding quickly
bebq retrospective version  -  baby became distressed feeding
bebq retrospective version  -  baby got full up easily
recombinant ctap iii
14q23
bebq retrospective version  -  baby would take too much milk
bebq retrospective version  -  baby took more than 30 minutes
bebq retrospective version  -  got full before taking all milk
bebq retrospective version  -  baby fed slowly
bebq retrospective version  -  just eaten happy to feed again
bebq retrospective version  -  difficult manage complete feed
bebq retrospective version  -  baby was always demanding a feed
bebq retrospective version  -  baby sucked more and more slowly
bebq retrospective version  -  baby would always be feeding
bebq retrospective version  -  baby enjoyed feeding time
5q21 - q22
bebq retrospective version  -  take a feed within 30 minutes
cgi original version  -  severity of illness
cgi original version  -  global improvement
cgi original version  -  efficacy index
cgi generic modification version  -  severity
cgi generic modification version  -  change
cgi generic modification version  -  improvement
pgi generic modification version  -  severity
pgi generic modification version  -  change
pgi generic modification version  -  improvement
xq26 .3 - q27 .1
lec - 5 standard version  -  natural disaster: happened
lec - 5 standard version  -  natural disaster: witnessed
lec - 5 standard version  -  natural disaster: learned
lec - 5 standard version  -  natural disaster: job
lec - 5 standard version  -  natural disaster: not sure
lec - 5 standard version  -  natural disaster: not apply
lec - 5 standard version  -  fire or explosion: happened
lec - 5 standard version  -  fire or explosion: witnessed
lec - 5 standard version  -  fire or explosion: learned
lec - 5 standard version  -  fire or explosion: job
12q13 - q14
lec - 5 standard version  -  fire or explosion: not sure
lec - 5 standard version  -  fire or explosion: not apply
lec - 5 standard version  -  transportation accident: happened
lec - 5 standard version  -  transportation accident: witnessed
lec - 5 standard version  -  transportation accident: learned
lec - 5 standard version  -  transportation accident: job
lec - 5 standard version  -  transportation accident: not sure
lec - 5 standard version  -  transportation accident: not apply
lec - 5 standard version  -  serious accident: happened
lec - 5 standard version  -  serious accident: witnessed
19p13 .1 - p13 .2
lec - 5 standard version  -  serious accident: learned
lec - 5 standard version  -  serious accident: job
lec - 5 standard version  -  serious accident: not sure
lec - 5 standard version  -  serious accident: not apply
lec - 5 standard version  -  toxic substance: happened
lec - 5 standard version  -  toxic substance: witnessed
lec - 5 standard version  -  toxic substance: learned
lec - 5 standard version  -  toxic substance: job
lec - 5 standard version  -  toxic substance: not sure
lec - 5 standard version  -  toxic substance: not apply
8q11
lec - 5 standard version  -  physical assault: happened
lec - 5 standard version  -  physical assault: witnessed
lec - 5 standard version  -  physical assault: learned
lec - 5 standard version  -  physical assault: job
lec - 5 standard version  -  physical assault: not sure
lec - 5 standard version  -  physical assault: not apply
lec - 5 standard version  -  assault with a weapon: happened
lec - 5 standard version  -  assault with a weapon: witnessed
lec - 5 standard version  -  assault with a weapon: learned
lec - 5 standard version  -  assault with a weapon: job
1p34
lec - 5 standard version  -  assault with a weapon: not sure
lec - 5 standard version  -  assault with a weapon: not apply
lec - 5 standard version  -  sexual assault: happened
lec - 5 standard version  -  sexual assault: witnessed
lec - 5 standard version  -  sexual assault: learned
lec - 5 standard version  -  sexual assault: job
lec - 5 standard version  -  sexual assault: not sure
lec - 5 standard version  -  sexual assault: not apply
lec - 5 standard version  -  unwanted sex experience: happened
lec - 5 standard version  -  unwanted sex experience: witnessed
2p16
lec - 5 standard version  -  unwanted sex experience: learned
lec - 5 standard version  -  unwanted sex experience: job
lec - 5 standard version  -  unwanted sex experience: not sure
lec - 5 standard version  -  unwanted sex experience: not apply
lec - 5 standard version  -  combat or exposure to war - zone: happened
lec - 5 standard version  -  combat or exposure to war - zone: witnessed
lec - 5 standard version  -  combat or exposure to war - zone: learned
lec - 5 standard version  -  combat or exposure to war - zone: job
lec - 5 standard version  -  combat or exposure to war - zone: not sure
lec - 5 standard version  -  combat or exposure to war - zone: not apply
6q22 - q23
lec - 5 standard version  -  captivity: happened
lec - 5 standard version  -  captivity: witnessed
lec - 5 standard version  -  captivity: learned
lec - 5 standard version  -  captivity: job
lec - 5 standard version  -  captivity: not sure
lec - 5 standard version  -  captivity: not apply
lec - 5 standard version  -  life - threatening illness: happened
lec - 5 standard version  -  life - threatening illness: witnessed
lec - 5 standard version  -  life - threatening illness: learned
lec - 5 standard version  -  life - threatening illness: job
8q22
lec - 5 standard version  -  life - threatening illness: not sure
lec - 5 standard version  -  life - threatening illness: not apply
lec - 5 standard version  -  severe human suffering: happened
lec - 5 standard version  -  severe human suffering: witnessed
lec - 5 standard version  -  severe human suffering: learned
lec - 5 standard version  -  severe human suffering: job
lec - 5 standard version  -  severe human suffering: not sure
lec - 5 standard version  -  severe human suffering: not apply
lec - 5 standard version  -  sudden violent death: happened
lec - 5 standard version  -  sudden violent death: witnessed
cyclopentenyl cytosine
20q13 .1
lec - 5 standard version  -  sudden violent death: learned
lec - 5 standard version  -  sudden violent death: job
lec - 5 standard version  -  sudden violent death: not sure
lec - 5 standard version  -  sudden violent death: not apply
lec - 5 standard version  -  sudden accidental death: happened
lec - 5 standard version  -  sudden accidental death: witnessed
lec - 5 standard version  -  sudden accidental death: learned
lec - 5 standard version  -  sudden accidental death: job
lec - 5 standard version  -  sudden accidental death: not sure
lec - 5 standard version  -  sudden accidental death: not apply
8q24
lec - 5 standard version  -  serious injury caused: happened
lec - 5 standard version  -  serious injury caused: witnessed
lec - 5 standard version  -  serious injury caused: learned
lec - 5 standard version  -  serious injury caused: job
lec - 5 standard version  -  serious injury caused: not sure
lec - 5 standard version  -  serious injury caused: not apply
lec - 5 standard version  -  other stressful event: happened
lec - 5 standard version  -  other stressful event: witnessed
lec - 5 standard version  -  other stressful event: learned
lec - 5 standard version  -  other stressful event: job
1p34 .3
lec - 5 standard version  -  other stressful event: not sure
lec - 5 standard version  -  other stressful event: not apply
pcl - 5  -  repeated disturbing memories
pcl - 5  -  repeated disturbing dreams
pcl - 5  -  suddenly feeling happening again
pcl - 5  -  feel upset when reminded
pcl - 5  -  strong physical reactions
pcl - 5  -  avoid memories ,  thoughts or feelings
pcl - 5  -  avoid external reminders
pcl - 5  -  trouble remembering important parts
2p24 .1
pcl - 5  -  strong negative beliefs
pcl - 5  -  blaming yourself or someone else
pcl - 5  -  strong negative feelings
pcl - 5  -  loss of interest in activities
pcl - 5  -  feeling distant from people
pcl - 5  -  trouble experiencing positive feelings
pcl - 5  -  irritable behavior or angry outbursts
pcl - 5  -  taking too many risks or cause harm
pcl - 5  -  being super alert or watchful
pcl - 5  -  feeling jumpy or easily startled
1p36 .3 - p36 .2
pcl - 5  -  having difficulty concentrating
pcl - 5  -  trouble falling or staying asleep
podci pediatric parent - reported version  -  lift heavy books
podci pediatric parent - reported version  -  pour a half gallon of milk
podci pediatric parent - reported version  -  open a jar been opened before
podci pediatric parent - reported version  -  use a fork and spoon
podci pediatric parent - reported version  -  comb his or her hair
podci pediatric parent - reported version  -  button buttons
podci pediatric parent - reported version  -  put on his or her coat
podci pediatric parent - reported version  -  write with a pencil
22q12 .2
podci pediatric parent - reported version  -  miss school because of health
podci pediatric parent - reported version  -  how he or she looks
podci pediatric parent - reported version  -  his or her body
podci pediatric parent - reported version  -  what clothes or shoes he or she wear
podci pediatric parent - reported version  -  ability do same things friends do
podci pediatric parent - reported version  -  his or her health in general
podci pediatric parent - reported version  -  feel sick and tired
podci pediatric parent - reported version  -  full of pep and energy
podci pediatric parent - reported version  -  pain or discomfort interfere with activities
podci pediatric parent - reported version  -  run short distances
10q24
podci pediatric parent - reported version  -  bicycle or tricycle
podci pediatric parent - reported version  -  climb three flights of stairs
podci pediatric parent - reported version  -  climb one flight of stairs
podci pediatric parent - reported version  -  walk more than a mile
podci pediatric parent - reported version  -  walk three blocks
podci pediatric parent - reported version  -  walk one block
podci pediatric parent - reported version  -  get on and off a bus
podci pediatric parent - reported version  -  need help walking and climbing
podci pediatric parent - reported version  -  use assistive devices for walking
podci pediatric parent - reported version  -  stand washing hands at a sink
3p23 - p21
podci pediatric parent - reported version  -  sit in chair without holding on
podci pediatric parent - reported version  -  get on and off a toilet or chair
podci pediatric parent - reported version  -  get in and out of bed
podci pediatric parent - reported version  -  turn door knobs
podci pediatric parent - reported version  -  bend over and pick up something
podci pediatric parent - reported version  -  need help sitting and standing
podci pediatric parent - reported version  -  use assistive devices for sitting
podci pediatric parent - reported version  -  participate in outdoor activities
podci pediatric parent - reported version  -  outdoor limited by: pain
podci pediatric parent - reported version  -  outdoor limited by: health
8q24 .1
podci pediatric parent - reported version  -  outdoor limited by: instructions
podci pediatric parent - reported version  -  outdoor limited by: fear
podci pediatric parent - reported version  -  outdoor limited by: dislike
podci pediatric parent - reported version  -  outdoor limited by: too young
podci pediatric parent - reported version  -  outdoor limited by: season
podci pediatric parent - reported version  -  participate in pickup games
podci pediatric parent - reported version  -  games limited by: pain
podci pediatric parent - reported version  -  games limited by: health
podci pediatric parent - reported version  -  games limited by: instructions
podci pediatric parent - reported version  -  games limited by: fear
1p13
podci pediatric parent - reported version  -  games limited by: dislike
podci pediatric parent - reported version  -  games limited by: too young
podci pediatric parent - reported version  -  games limited by: season
podci pediatric parent - reported version  -  participate in competitive sports
podci pediatric parent - reported version  -  competitive sports limited by: pain
podci pediatric parent - reported version  -  competitive sports limited by: health
podci pediatric parent - reported version  -  competitive sports limited by: instruction
podci pediatric parent - reported version  -  competitive sports limited by: fear
podci pediatric parent - reported version  -  competitive sports limited by: dislike
podci pediatric parent - reported version  -  competitive sports limited by: too young
cytembena
1q23 - q31
podci pediatric parent - reported version  -  competitive sports limited by: season
podci pediatric parent - reported version  -  get together with friends
podci pediatric parent - reported version  -  friends limited by: pain
podci pediatric parent - reported version  -  friends limited by: health
podci pediatric parent - reported version  -  friends limited by: instructions
podci pediatric parent - reported version  -  friends limited by: fear
podci pediatric parent - reported version  -  friends limited by: not around
podci pediatric parent - reported version  -  participate in gym or recess
podci pediatric parent - reported version  -  gym limited by: pain
podci pediatric parent - reported version  -  gym limited by: health
15q25 - q26
podci pediatric parent - reported version  -  gym limited by: instructions
podci pediatric parent - reported version  -  gym limited by: fear
podci pediatric parent - reported version  -  gym limited by: dislike
podci pediatric parent - reported version  -  gym limited by: not in session
podci pediatric parent - reported version  -  gym limited by: not attend school
podci pediatric parent - reported version  -  easy to make friends
podci pediatric parent - reported version  -  pain during the last week
podci pediatric parent - reported version  -  pain interfere with activities
podci pediatric parent - reported version  -  have pain relief
podci pediatric parent - reported version  -  look better
22q12 .3 - q13 .1
podci pediatric parent - reported version  -  feel better
podci pediatric parent - reported version  -  sleep more comfortably
podci pediatric parent - reported version  -  able to do activities at home
podci pediatric parent - reported version  -  able to do more at school
podci pediatric parent - reported version  -  able to do more play
podci pediatric parent - reported version  -  able to do more sports
podci pediatric parent - reported version  -  free from pain as adult
podci pediatric parent - reported version  -  spend rest of life with condition
podci pediatric parent - reported version  -  upper extremity and physical function scale
podci pediatric parent - reported version  -  transfer and basic mobility scale
6p21
podci pediatric parent - reported version  -  sports and physical function scale
podci pediatric parent - reported version  -  pain or comfort scale
podci pediatric parent - reported version  -  happiness scale
podci pediatric parent - reported version  -  global functioning scale
podci adolescent parent - reported version  -  lift heavy books
podci adolescent parent - reported version  -  pour a half gallon of milk
podci adolescent parent - reported version  -  open a jar been opened before
podci adolescent parent - reported version  -  use a fork and spoon
podci adolescent parent - reported version  -  comb his or her hair
podci adolescent parent - reported version  -  button buttons
9q31
podci adolescent parent - reported version  -  put on his or her coat
podci adolescent parent - reported version  -  write with a pencil
podci adolescent parent - reported version  -  miss school because of health
podci adolescent parent - reported version  -  how he or she looks
podci adolescent parent - reported version  -  his or her body
podci adolescent parent - reported version  -  what clothes or shoes he or she wear
podci adolescent parent - reported version  -  ability do same things friends do
podci adolescent parent - reported version  -  his or her health in general
podci adolescent parent - reported version  -  feel sick and tired
podci adolescent parent - reported version  -  full of pep and energy
3p25
podci adolescent parent - reported version  -  pain or discomfort interfere with activities
podci adolescent parent - reported version  -  run short distances
podci adolescent parent - reported version  -  bicycle or tricycle
podci adolescent parent - reported version  -  climb three flights of stairs
podci adolescent parent - reported version  -  climb one flight of stairs
podci adolescent parent - reported version  -  walk more than a mile
podci adolescent parent - reported version  -  walk three blocks
podci adolescent parent - reported version  -  walk one block
podci adolescent parent - reported version  -  get on and off a bus
podci adolescent parent - reported version  -  need help walking and climbing
7p22 - p15
podci adolescent parent - reported version  -  use assistive devices for walking
podci adolescent parent - reported version  -  stand washing hands at a sink
podci adolescent parent - reported version  -  sit in chair without holding on
podci adolescent parent - reported version  -  get on and off a toilet or chair
podci adolescent parent - reported version  -  get in and out of bed
podci adolescent parent - reported version  -  turn door knobs
podci adolescent parent - reported version  -  bend over and pick up something
podci adolescent parent - reported version  -  need help sitting and standing
podci adolescent parent - reported version  -  use assistive devices for sitting
podci adolescent parent - reported version  -  participate in outdoor activities
2cen - q13
podci adolescent parent - reported version  -  outdoor limited by: pain
podci adolescent parent - reported version  -  outdoor limited by: health
podci adolescent parent - reported version  -  outdoor limited by: instructions
podci adolescent parent - reported version  -  outdoor limited by: fear
podci adolescent parent - reported version  -  outdoor limited by: dislike
podci adolescent parent - reported version  -  outdoor limited by: too young
podci adolescent parent - reported version  -  outdoor limited by: season
podci adolescent parent - reported version  -  participate in pickup games
podci adolescent parent - reported version  -  games limited by: pain
podci adolescent parent - reported version  -  games limited by: health
13q14 .2
podci adolescent parent - reported version  -  games limited by: instructions
podci adolescent parent - reported version  -  games limited by: fear
podci adolescent parent - reported version  -  games limited by: dislike
podci adolescent parent - reported version  -  games limited by: too young
podci adolescent parent - reported version  -  games limited by: season
podci adolescent parent - reported version  -  participate in competitive sports
podci adolescent parent - reported version  -  competitive sports limited by: pain
podci adolescent parent - reported version  -  competitive sports limited by: health
podci adolescent parent - reported version  -  competitive sports limited by: instructions
podci adolescent parent - reported version  -  competitive sports limited by: fear
2p13 - p12
podci adolescent parent - reported version  -  competitive sports limited by: dislike
podci adolescent parent - reported version  -  competitive sports limited by: too young
podci adolescent parent - reported version  -  competitive sports limited by: season
podci adolescent parent - reported version  -  get together with friends
podci adolescent parent - reported version  -  friends limited by: pain
podci adolescent parent - reported version  -  friends limited by: health
podci adolescent parent - reported version  -  friends limited by: instructions
podci adolescent parent - reported version  -  friends limited by: fear
podci adolescent parent - reported version  -  friends limited by: not around
podci adolescent parent - reported version  -  participate in gym or recess
depudecin
10q11 .2
podci adolescent parent - reported version  -  gym limited by: pain
podci adolescent parent - reported version  -  gym limited by: health
podci adolescent parent - reported version  -  gym limited by: instructions
podci adolescent parent - reported version  -  gym limited by: fear
podci adolescent parent - reported version  -  gym limited by: dislike
podci adolescent parent - reported version  -  gym limited by: not in session
podci adolescent parent - reported version  -  gym limited by: not attend school
podci adolescent parent - reported version  -  easy to make friends
podci adolescent parent - reported version  -  pain during the last week
podci adolescent parent - reported version  -  pain interfere with activities
6q21 - q22
podci adolescent parent - reported version  -  have pain relief
podci adolescent parent - reported version  -  look better
podci adolescent parent - reported version  -  feel better
podci adolescent parent - reported version  -  sleep more comfortably
podci adolescent parent - reported version  -  able to do activities at home
podci adolescent parent - reported version  -  able to do more at school
podci adolescent parent - reported version  -  able to do more play
podci adolescent parent - reported version  -  able to do more sports
podci adolescent parent - reported version  -  free from pain as adult
podci adolescent parent - reported version  -  spend rest of life with condition
1q22 - q24
podci adolescent parent - reported version  -  upper extremity and physical function scale
podci adolescent parent - reported version  -  transfer and basic mobility scale
podci adolescent parent - reported version  -  sports and physical function scale
podci adolescent parent - reported version  -  pain or comfort scale
podci adolescent parent - reported version  -  happiness scale
podci adolescent parent - reported version  -  global functioning scale
podci adolescent self - reported version  -  lift heavy books
podci adolescent self - reported version  -  pour a half gallon of milk
podci adolescent self - reported version  -  open a jar been opened before
podci adolescent self - reported version  -  use a fork and spoon
22q11 .2
podci adolescent self - reported version  -  comb your hair
podci adolescent self - reported version  -  button buttons
podci adolescent self - reported version  -  put on your coat
podci adolescent self - reported version  -  write with a pencil
podci adolescent self - reported version  -  miss school because of health
podci adolescent self - reported version  -  how you look
podci adolescent self - reported version  -  your body
podci adolescent self - reported version  -  what clothes or shoes you can wear
podci adolescent self - reported version  -  ability do same things friends do
podci adolescent self - reported version  -  your health in general
11p12 - p11 .22
podci adolescent self - reported version  -  feel sick and tired
podci adolescent self - reported version  -  full of pep and energy
podci adolescent self - reported version  -  pain or discomfort interfere with activities
podci adolescent self - reported version  -  run short distances
podci adolescent self - reported version  -  bicycle or tricycle
podci adolescent self - reported version  -  climb three flights of stairs
podci adolescent self - reported version  -  climb one flight of stairs
podci adolescent self - reported version  -  walk more than a mile
podci adolescent self - reported version  -  walk three blocks
podci adolescent self - reported version  -  walk one block
podci adolescent self - reported version  -  get on and off a bus
podci adolescent self - reported version  -  need help walking and climbing
podci adolescent self - reported version  -  use assistive devices for walking
podci adolescent self - reported version  -  stand washing hands at a sink
podci adolescent self - reported version  -  sit in chair without holding on
podci adolescent self - reported version  -  get on and off a toilet or chair
podci adolescent self - reported version  -  get in and out of bed
podci adolescent self - reported version  -  turn door knobs
podci adolescent self - reported version  -  bend over and pick up something
podci adolescent self - reported version  -  need help sitting and standing
11p15
podci adolescent self - reported version  -  use assistive devices for sitting
podci adolescent self - reported version  -  participate in outdoor activities
podci adolescent self - reported version  -  outdoor limited by: pain
podci adolescent self - reported version  -  outdoor limited by: health
podci adolescent self - reported version  -  outdoor limited by: instructions
podci adolescent self - reported version  -  outdoor limited by: fear
podci adolescent self - reported version  -  outdoor limited by: dislike
podci adolescent self - reported version  -  outdoor limited by: season
podci adolescent self - reported version  -  participate in pickup games
podci adolescent self - reported version  -  games limited by: pain
6p21 .1 - p21 .3
podci adolescent self - reported version  -  games limited by: health
podci adolescent self - reported version  -  games limited by: instructions
podci adolescent self - reported version  -  games limited by: fear
podci adolescent self - reported version  -  games limited by: dislike
podci adolescent self - reported version  -  games limited by: season
podci adolescent self - reported version  -  participate in competitive sports
podci adolescent self - reported version  -  competitive sports limited by: pain
podci adolescent self - reported version  -  competitive sports limited by: health
podci adolescent self - reported version  -  competitive sports limited by: instructions
podci adolescent self - reported version  -  competitive sports limited by: fear
19q13
podci adolescent self - reported version  -  competitive sports limited by: dislike
podci adolescent self - reported version  -  competitive sports limited by: season
podci adolescent self - reported version  -  get together with friends
podci adolescent self - reported version  -  friends limited by: pain
podci adolescent self - reported version  -  friends limited by: health
podci adolescent self - reported version  -  friends limited by: instructions
podci adolescent self - reported version  -  friends limited by: fear
podci adolescent self - reported version  -  friends limited by: not around
podci adolescent self - reported version  -  participate in gym or recess
podci adolescent self - reported version  -  gym limited by: pain
17q11 .2
podci adolescent self - reported version  -  gym limited by: health
podci adolescent self - reported version  -  gym limited by: instructions
podci adolescent self - reported version  -  gym limited by: fear
podci adolescent self - reported version  -  gym limited by: dislike
podci adolescent self - reported version  -  gym limited by: not in session
podci adolescent self - reported version  -  gym limited by: not attend school
podci adolescent self - reported version  -  easy to make friends
podci adolescent self - reported version  -  pain during the last week
podci adolescent self - reported version  -  pain interfere with activities
podci adolescent self - reported version  -  have pain relief
dexamethasone sodium phosphate
3p22
podci adolescent self - reported version  -  look better
podci adolescent self - reported version  -  feel better
podci adolescent self - reported version  -  sleep more comfortably
podci adolescent self - reported version  -  able to do activities at home
podci adolescent self - reported version  -  able to do more at school
podci adolescent self - reported version  -  able to do more play
podci adolescent self - reported version  -  able to do more sports
podci adolescent self - reported version  -  free from pain as adult
podci adolescent self - reported version  -  spend rest of life with condition
podci adolescent self - reported version  -  upper extremity and physical function scale
3q27
podci adolescent self - reported version  -  transfer and basic mobility scale
podci adolescent self - reported version  -  sports and physical function scale
podci adolescent self - reported version  -  pain or comfort scale
podci adolescent self - reported version  -  happiness scale
podci adolescent self - reported version  -  global functioning scale
rand social support survey  -  count on to listen to you
rand social support survey  -  give you info to help understand
rand social support survey  -  give you advice about a crisis
rand social support survey  -  confide in or talk to about yourself
rand social support survey  -  advice you really want
17q11 .2 - q12
rand social support survey  -  share your private worries and fears
rand social support survey  -  suggestions to deal with personal problem
rand social support survey  -  understands your problems
rand social support survey  -  help if you were confined to bed
rand social support survey  -  take you to the doctor if needed
rand social support survey  -  prepare your meals if unable
rand social support survey  -  help with daily chores if sick
rand social support survey  -  shows you love and affection
rand social support survey  -  love and make you feel wanted
rand social support survey  -  hugs you
3p24 .1 - p22
rand social support survey  -  have a good time with
rand social support survey  -  get together with for relaxation
rand social support survey  -  do something enjoyable with
rand social support survey  -  help you get your mind off things
mmse  -  level of consciousness
met fusion gene positive
cervical / vaginal cytology
upper vaginectomy
modified radical hysterectomy
21q22 .1
rectal carcinoma metastatic in the liver
bevacizumab / cisplatin / paclitaxel regimen
bevacizumab / paclitaxel / topotecan regimen
capecitabine / bevacizumab regimen
capecitabine / cetuximab regimen
capecitabine / panitumumab regimen
folfox - cetuximab regimen
folfox - panitumumab regimen
folfox - bevacizumab regimen
folfiri - panitumumab regimen
7q33 - q35
folfiri - ziv - aflibercept regimen
folfiri - ramucirumab regimen
folfoxiri regimen
folfoxiri - bevacizumab regimen
bolus fluorouracil / leucovorin regimen
bevacizumab / fluorouracil bolus / leucovorin regimen
fluorouracil infusional / leucovorin regimen
infusional fluorouracil / leucovorin / bevacizumab regimen
bevacizumab / irinotecan regimen
irinotecan / ziv - aflibercept regimen
3q21 - q25
irinotecan / ramucirumab regimen
bendamustine / bortezomib / dexamethasone regimen
bld regimen
bortezomib / liposomal doxorubicin regimen
krd regimen
carfilzomib / dexamethasone regimen
crd regimen
dara - vd regimen
dara - rd regimen
vtd - pace regimen
6p21 .3
elo - rd regimen
elo - vd regimen
ird regimen
dexamethasone / ixazomib regimen
low - dose dexamethasone / lenalidomide regimen
bortezomib / dexamethasone / panobinostat regimen
carfilzomib / panobinostat regimen
dexamethasone / pomalidomide regimen
pvd regimen
kpd regimen
17p13 .1
pcd regimen
bevacizumab / carboplatin / pemetrexed regimen
bevacizumab / cisplatin / pemetrexed regimen
carboplatin / nab - paclitaxel regimen
carboplatin / pemetrexed regimen
docetaxel / ramucirumab regimen
met protein variant
met np_000236 .2:p .y1003x
radical trachelectomy
para - aortic lymph node biopsy
1q42 .1
segmental resection of the lung
abdominal wall fat pad biopsy
thoracic cancer tnm finding v8
thymic tumor tnm finding v8
thymic tumor clinical tnm finding v8
thymic tumor clinical distant metastasis tnm finding v8
thymic tumor cm0 tnm finding v8
thymic tumor cm1 tnm finding v8
thymic tumor cm1a tnm finding v8
thymic tumor cm1b tnm finding v8
diaziquone
1p36
thymic tumor pathologic tnm finding v8
thymic tumor pathologic distant metastasis tnm finding v8
thymic tumor pm1 tnm finding v8
thymic tumor pm1a tnm finding v8
thymic tumor pm1b tnm finding v8
thymic tumor pathologic primary tumor tnm finding v8
thymic tumor ptx tnm finding v8
thymic tumor pt0 tnm finding v8
thymic tumor pt1 tnm finding v8
thymic tumor pt1a tnm finding v8
3p21 - p14
thymic tumor pt1b tnm finding v8
thymic tumor pt2 tnm finding v8
thymic tumor pt3 tnm finding v8
thymic tumor pt4 tnm finding v8
thymic tumor pathologic regional lymph nodes tnm finding v8
thymic tumor pnx tnm finding v8
thymic tumor pn0 tnm finding v8
thymic tumor pn1 tnm finding v8
thymic tumor pn2 tnm finding v8
memorial symptom assessment scale  ( msas )  7 - 12
11p13
thymic epithelial neoplasm by ajcc v8 stage
yesterday or today
stage i thymic epithelial neoplasm ajcc v8
stage ii thymic epithelial neoplasm ajcc v8
last 2 days
stage iii thymic epithelial neoplasm ajcc v8
last 2 nights
stage iiia thymic epithelial neoplasm ajcc v8
stage iiib thymic epithelial neoplasm ajcc v8
stage iv thymic epithelial neoplasm ajcc v8
18p11 .31 - p11 .21
stage iva thymic epithelial neoplasm ajcc v8
stage ivb thymic epithelial neoplasm ajcc v8
a very short time
a medium amount of time
a medium amount
more tired than usual
colectomy with en bloc removal of regional lymph nodes
how long feeling tired lasted
how tired
how much bothered by being tired
retinoic acid response element
how long felt sad
how sad
colonoscopy with marking of cancerous polyp
how much feeling sad bothered or troubled you
complete parametrectomy
thymoma by ajcc v8 stage
determination of tumor dna mismatch repair status
were itchy
stage i thymoma ajcc v8
stage ii thymoma ajcc v8
bhlh - zip domain
stage iii thymoma ajcc v8
stage iiia thymoma ajcc v8
stage iiib thymoma ajcc v8
stage iv thymoma ajcc v8
stage iva thymoma ajcc v8
how much time itchy
stage ivb thymoma ajcc v8
how itchy
how much bothered by being itchy
how much time have pain
hd - zip domain
how much pain felt
how much bothered by pain
how much time feel worried
how worried
how much bothered by feeling worried
feel like eating as normal
how long not feeling like eating lasted
how much bothered by not feeling like eating
feel like going to vomit
how much of the time feel like could vomit
ht - zip domain
how much bothered by feeling like could vomit
have trouble going to sleep
how much bothered by not being able to sleep
how much bothered by something else
pleural malignant mesothelioma by ajcc v7 stage
kng1 gene product
calca gene product
calcitonin precursor
anything else made you feel bad or sick
pleural malignant mesothelioma tnm finding v8
15q21 - q22
pleural malignant mesothelioma clinical tnm finding v8
pleural malignant mesothelioma clinical distant metastasis tnm finding v8
pleural malignant mesothelioma cm0 tnm finding v8
pleural malignant mesothelioma cm1 tnm finding v8
pleural malignant mesothelioma pathologic tnm finding v8
pleural malignant mesothelioma pathologic distant metastasis tnm finding v8
pleural malignant mesothelioma pm1 tnm finding v8
pleural malignant mesothelioma pathologic primary tumor tnm finding v8
pleural malignant mesothelioma ptx tnm finding v8
pleural malignant mesothelioma pt0 tnm finding v8
poly - a addition site
pleural malignant mesothelioma pt1 tnm finding v8
pleural malignant mesothelioma pt2 tnm finding v8
pleural malignant mesothelioma pt3 tnm finding v8
pleural malignant mesothelioma pt4 tnm finding v8
pleural malignant mesothelioma pathologic regional lymph nodes tnm finding v8
pleural malignant mesothelioma pnx tnm finding v8
pleural malignant mesothelioma pn0 tnm finding v8
pleural malignant mesothelioma pn1 tnm finding v8
pleural malignant mesothelioma pn2 tnm finding v8
pleural malignant mesothelioma by ajcc v8 stage
didemnin b
5q21
stage i pleural malignant mesothelioma ajcc v8
stage ib pleural malignant mesothelioma ajcc v8
stage ii pleural malignant mesothelioma ajcc v8
stage iii pleural malignant mesothelioma ajcc v8
stage iiia pleural malignant mesothelioma ajcc v8
stage iiib pleural malignant mesothelioma ajcc v8
stage iv pleural malignant mesothelioma ajcc v8
gnrh1 gene product
gonadoliberin - 1
stage ia pleural malignant mesothelioma ajcc v8
10q24 .3 - 10qter
malignant peritoneal germ cell tumor
blasts 5 percent or more of bone marrow nucleated cells
trh gene product
thyrotropin - releasing hormone
epoch - o regimen
psa level less than two
vecabrutinib
pdgfr family gene mutation
nedd8 activating enzyme e1 inhibitor tas4464
vegfr family gene mutation
15q23 - 15q24
jak family gene mutation
stat family gene mutation
mek family gene mutation
erk family gene mutation
csf1r inhibitor dcc - 3014
raf family gene mutation
anti - gd3 antibody - drug conjugate pf - 06688992
unresectable head and neck squamous cell carcinoma
cisplatin / vinblastine / cell penetration enhancer formulation int230 - 6
extended - release granisetron polymer formulation
16q22 .2
lung cancer tnm finding v8
lung cancer clinical tnm finding v8
lung cancer clinical distant metastasis tnm finding v8
lung cancer cm0 tnm finding v8
lung cancer cm1 tnm finding v8
lung cancer cm1a tnm finding v8
lung cancer cm1b tnm finding v8
lung cancer cm1c tnm finding v8
lung cancer pathologic tnm finding v8
lung cancer pathologic distant metastasis tnm finding v8
2p23
lung cancer pm1 tnm finding v8
lung cancer pm1a tnm finding v8
lung cancer pm1b tnm finding v8
lung cancer pm1c tnm finding v8
lung cancer pathologic primary tumor tnm finding v8
lung cancer ptx tnm finding v8
lung cancer pt0 tnm finding v8
lung cancer ptis tnm finding v8
lung cancer pt1 tnm finding v8
lung cancer pt1mi tnm finding v8
9q34
lung cancer pt1a tnm finding v8
lung cancer pt1b tnm finding v8
lung cancer pt1c tnm finding v8
lung cancer pt2 tnm finding v8
lung cancer pt2a tnm finding v8
lung cancer pt2b tnm finding v8
lung cancer pt3 tnm finding v8
lung cancer pt4 tnm finding v8
lung cancer pathologic regional lymph nodes tnm finding v8
lung cancer pnx tnm finding v8
16p13 .3
lung cancer pn0 tnm finding v8
lung cancer pn1 tnm finding v8
lung cancer pn2 tnm finding v8
lung cancer pn3 tnm finding v8
acrodysostosis 1
balstilimab
personalized genomic vaccine 001
lung cancer by ajcc v8 stage
occult lung cancer ajcc v8
stage 0 lung cancer ajcc v8
2p22 - p21
stage i lung cancer ajcc v8
stage ia1 lung cancer ajcc v8
stage ia2 lung cancer ajcc v8
stage ia3 lung cancer ajcc v8
stage ib lung cancer ajcc v8
stage ii lung cancer ajcc v8
stage iia lung cancer ajcc v8
stage iib lung cancer ajcc v8
stage iii lung cancer ajcc v8
stage iiia lung cancer ajcc v8
2q32
stage iiib lung cancer ajcc v8
stage iiic lung cancer ajcc v8
stage iv lung cancer ajcc v8
stage iva lung cancer ajcc v8
stage ivb lung cancer ajcc v8
stage ia3
lung adenocarcinoma in situ
last two scheduled appointments
refractory acute lymphoblastic leukemia
refractory erdheim - chester disease
7p22
lung adenocarcinoma by ajcc v7 stage
lung non - small cell cancer by ajcc v7 stage
lung adenosquamous carcinoma by ajcc v7 stage
lung large cell carcinoma by ajcc v7 stage
lung squamous cell carcinoma by ajcc v7 stage
lung small cell carcinoma by ajcc v7 stage
quality of life questionnaire  -  head & neck 35
extent have pain in mouth
extent have pain in jaw
dimesna
10q23 .31
extent have soreness in mouth
extent have painful throat
extent have problems swallowing liquids
extent have problems swallowing pureed food
extent have problems swallowing solid food
extent have choking when swallowing
extent have problems with teeth
extent have problems opening mouth wide
extent have dry mouth
extent have sticky saliva
19p13
extent have problems with sense of smell
extent have problems with sense of taste
extent have cough
extent have hoarse voice
hdm2 - binding peptide pnc - 27
pritelivir
recurrent anaplastic astrocytoma
recurrent diffuse intrinsic pontine glioma
refractory diffuse intrinsic pontine glioma
1p13 .3
extent have felt ill
extent appearance bothers you
extent have trouble eating
extent have trouble eating in front of family
extent have trouble eating in front of other people
extent have trouble enjoying meals
extent have trouble talking to other people
extent have trouble talking on the telephone
extent have trouble having social contact with family
extent have trouble having social contact with friends
6q14 .3 - 16 .1
extent have trouble going out in public
extent have trouble having physical contact with family or friends
extent feel less interest in sex
extent feel less sexual enjoyment
psa level greater than or equal to ten
have used pain - killers
have taken nutritional supplements
have used feeding tube
ravtansine
swallowing impairment scale
12q12 - 12q14
requires great effort to swallow
feel a throat obstacle during swallowing
feel pharyngeal annoyance during bolus transit
cough during bolus transit
feel sensation of foreign body in pharynx
have some difficulties swallowing fluids
neck pain scale
neck pain score 0
neck pain score 1
neck pain score 2
19q13 .2
neck pain score 3
neck pain score 4
neck pain score 5
neck pain score 6
neck pain score 7
gerbil experimental organism diagnosis
neck pain score 8
neck pain score 9
neck pain score 10
fish experimental organism diagnosis
14q12
apparent sporadic paraganglioma or pheochromocytoma
bone cancer tnm finding v8
bone cancer clinical tnm finding v8
bone cancer clinical distant metastasis tnm finding v8
bone cancer cm0 tnm finding v8
bone cancer cm1 tnm finding v8
bone cancer cm1a tnm finding v8
idh family wildtype
bone cancer cm1b tnm finding v8
bone cancer pathologic tnm finding v8
nucleosomal repeat length
bone cancer pathologic distant metastasis tnm finding v8
bone cancer pm1 tnm finding v8
bone cancer pm1a tnm finding v8
bone cancer pm1b tnm finding v8
psa level greater than or equal to one
bone cancer pathologic primary tumor tnm finding v8
appendicular skeleton ,  trunk ,  skull ,  and facial bones cancer pathologic primary tumor tnm finding v8
appendicular skeleton ,  trunk ,  skull ,  and facial bones cancer ptx tnm finding v8
appendicular skeleton ,  trunk ,  skull ,  and facial bones cancer pt0 tnm finding v8
appendicular skeleton ,  trunk ,  skull ,  and facial bones cancer pt1 tnm finding v8
3p14 .2
appendicular skeleton ,  trunk ,  skull ,  and facial bones cancer pt2 tnm finding v8
appendicular skeleton ,  trunk ,  skull ,  and facial bones cancer pt3 tnm finding v8
spine cancer pathologic primary tumor tnm finding v8
spine cancer ptx tnm finding v8
spine cancer pt0 tnm finding v8
spine cancer pt1 tnm finding v8
spine cancer pt2 tnm finding v8
spine cancer pt3 tnm finding v8
spine cancer pt4 tnm finding v8
spine cancer pt4a tnm finding v8
16p13 .1
spine cancer pt4b tnm finding v8
pelvis cancer pathologic primary tumor tnm finding v8
pelvis cancer ptx tnm finding v8
pelvis cancer pt0 tnm finding v8
pelvis cancer pt1 tnm finding v8
pelvis cancer pt1a tnm finding v8
pelvis cancer pt1b tnm finding v8
pelvis cancer pt2 tnm finding v8
pelvis cancer pt2a tnm finding v8
pelvis cancer pt2b tnm finding v8
doxorubicin - hpma conjugate
translocation breakpoint
pelvis cancer pt3 tnm finding v8
pelvis cancer pt3a tnm finding v8
pelvis cancer pt3b tnm finding v8
pelvis cancer pt4 tnm finding v8
pelvis cancer pt4a tnm finding v8
pelvis cancer pt4b tnm finding v8
bone cancer pathologic regional lymph nodes tnm finding v8
bone cancer pnx tnm finding v8
bone cancer pn0 tnm finding v8
bone cancer pn1 tnm finding v8
cyclic amp response element
bone cancer by ajcc v7 stage
psa level less than fifty
bone cancer by ajcc v8 stage
stage i bone cancer ajcc v8
stage ia bone cancer ajcc v8
stage ib bone cancer ajcc v8
stage ii bone cancer ajcc v8
stage iia bone cancer ajcc v8
stage iib bone cancer ajcc v8
stage iii bone cancer ajcc v8
androgen response element
stage iv bone cancer ajcc v8
stage iva bone cancer ajcc v8
stage ivb bone cancer ajcc v8
smarcb1 gene mutation
small cell lung carcinoma transformation
nfkb2 gene rearrangement
pyruvate kinase pkm isoform m2 dimer
blasts 21 - 30 percent of bone marrow nucleated cells
psa level greater than five
esr1 gene mutation
sant domain
elevated alpha - fetoprotein
elevated human chorionic gonadotropin
bone sarcoma by ajcc v7 stage
osteosarcoma by ajcc v7 stage
non - synonymous flt3 gene mutation
non - synonymous kit gene mutation
non - synonymous ras family gene mutation
non - synonymous raf family gene mutation
non - synonymous mapk family gene mutation
non - synonymous map2k family gene mutation
10q11
non - synonymous stat family gene mutation
non - synonymous jak family gene mutation
non - synonymous vegfr family gene mutation
non - synonymous pdgfr family gene mutation
notch family gene mutation
cbl gene mutation
psa level greater than twenty
jak3 gene mutation
blasts 10 percent or more of bone marrow nucleated cells
recurrent cervical squamous cell carcinoma ,  not otherwise specified
17q23 - q24
recurrent cervical adenosquamous carcinoma
recurrent cervical adenocarcinoma
x - linked thrombocytopenia ,  with or without dyserythropoietic anemia
soft tissue sarcoma tnm finding v8
soft tissue sarcoma of the head and neck tnm finding v8
soft tissue sarcoma of the head and neck clinical tnm finding v8
soft tissue sarcoma of the head and neck clinical distant metastasis tnm finding v8
soft tissue sarcoma of the head and neck cm0 tnm finding v8
soft tissue sarcoma of the head and neck cm1 tnm finding v8
3q25 .1 - q26 .1
soft tissue sarcoma of the head and neck pathologic tnm finding v8
soft tissue sarcoma of the head and neck pathologic distant metastasis tnm finding v8
soft tissue sarcoma of the head and neck pm1 tnm finding v8
soft tissue sarcoma of the head and neck pathologic primary tumor tnm finding v8
soft tissue sarcoma of the head and neck ptx tnm finding v8
soft tissue sarcoma of the head and neck pt1 tnm finding v8
soft tissue sarcoma of the head and neck pt2 tnm finding v8
soft tissue sarcoma of the head and neck pt3 tnm finding v8
soft tissue sarcoma of the head and neck pt4 tnm finding v8
soft tissue sarcoma of the head and neck pt4a tnm finding v8
4q31 .1 - q31 .2
soft tissue sarcoma of the head and neck pt4b tnm finding v8
soft tissue sarcoma of the head and neck pathologic regional lymph nodes tnm finding v8
soft tissue sarcoma of the head and neck pn0 tnm finding v8
soft tissue sarcoma of the head and neck pn1 tnm finding v8
soft tissue sarcoma of the trunk and extremities tnm finding v8
soft tissue sarcoma of the trunk and extremities clinical tnm finding v8
soft tissue sarcoma of the trunk and extremities clinical distant metastasis tnm finding v8
soft tissue sarcoma of the trunk and extremities cm0 tnm finding v8
soft tissue sarcoma of the trunk and extremities cm1 tnm finding v8
soft tissue sarcoma of the trunk and extremities pathologic tnm finding v8
7q35 - q36
soft tissue sarcoma of the trunk and extremities pathologic distant metastasis tnm finding v8
soft tissue sarcoma of the trunk and extremities pm1 tnm finding v8
soft tissue sarcoma of the trunk and extremities pathologic primary tumor tnm finding v8
soft tissue sarcoma of the trunk and extremities ptx tnm finding v8
soft tissue sarcoma of the trunk and extremities pt0 tnm finding v8
soft tissue sarcoma of the trunk and extremities pt1 tnm finding v8
soft tissue sarcoma of the trunk and extremities pt2 tnm finding v8
soft tissue sarcoma of the trunk and extremities pt3 tnm finding v8
soft tissue sarcoma of the trunk and extremities pt4 tnm finding v8
soft tissue sarcoma of the trunk and extremities pathologic regional lymph nodes tnm finding v8
9p22 .3
soft tissue sarcoma of the trunk and extremities pn0 tnm finding v8
soft tissue sarcoma of the trunk and extremities pn1 tnm finding v8
soft tissue sarcoma by ajcc v8 stage
soft tissue sarcoma of the trunk and extremities by ajcc v8 stage
nup98 gene product
stage i soft tissue sarcoma of the trunk and extremities ajcc v8
nuclear pore complex protein nup98 - nup96
stage ia soft tissue sarcoma of the trunk and extremities ajcc v8
elliptinium acetate
xq26 .1
stage ib soft tissue sarcoma of the trunk and extremities ajcc v8
stage ii soft tissue sarcoma of the trunk and extremities ajcc v8
stage iii soft tissue sarcoma of the trunk and extremities ajcc v8
stage iiia soft tissue sarcoma of the trunk and extremities ajcc v8
stage iiib soft tissue sarcoma of the trunk and extremities ajcc v8
stage iv soft tissue sarcoma of the trunk and extremities ajcc v8
soft tissue sarcoma by ajcc v7 stage
uterine corpus sarcoma by ajcc v7 stage
invasive lung mucinous adenocarcinoma
ligand binding domain
lung enteric adenocarcinoma
immune - modified response evaluation criteria in solid tumors
mismatch repair deficiency
lung keratinizing squamous cell carcinoma
lung non - keratinizing squamous cell carcinoma
intercellular bridges present
lung non - mucinous adenocarcinoma in situ
lung mucinous adenocarcinoma in situ
kiss1 gene product
lung squamous cell carcinoma in situ
lim domain
npy gene product
pro - neuropeptide y
agt gene product
angiotensinogen
soft tissue sarcoma of the abdomen and thoracic visceral organs tnm finding v8
soft tissue sarcoma of the abdomen and thoracic visceral organs clinical tnm finding v8
soft tissue sarcoma of the abdomen and thoracic visceral organs clinical distant metastasis tnm finding v8
soft tissue sarcoma of the abdomen and thoracic visceral organs cm0 tnm finding v8
soft tissue sarcoma of the abdomen and thoracic visceral organs cm1 tnm finding v8
soft tissue sarcoma of the abdomen and thoracic visceral organs pathologic tnm finding v8
19p13 .3
soft tissue sarcoma of the abdomen and thoracic visceral organs pathologic distant metastasis tnm finding v8
soft tissue sarcoma of the abdomen and thoracic visceral organs pm1 tnm finding v8
soft tissue sarcoma of the abdomen and thoracic visceral organs pathologic primary tumor tnm finding v8
soft tissue sarcoma of the abdomen and thoracic visceral organs ptx tnm finding v8
soft tissue sarcoma of the abdomen and thoracic visceral organs pt1 tnm finding v8
soft tissue sarcoma of the abdomen and thoracic visceral organs pt2 tnm finding v8
soft tissue sarcoma of the abdomen and thoracic visceral organs pt2a tnm finding v8
soft tissue sarcoma of the abdomen and thoracic visceral organs pt2b tnm finding v8
soft tissue sarcoma of the abdomen and thoracic visceral organs pt3 tnm finding v8
soft tissue sarcoma of the abdomen and thoracic visceral organs pt4 tnm finding v8
12q14 .3 - q15
soft tissue sarcoma of the abdomen and thoracic visceral organs pt4a tnm finding v8
soft tissue sarcoma of the abdomen and thoracic visceral organs pt4b tnm finding v8
soft tissue sarcoma of the abdomen and thoracic visceral organs pt4c tnm finding v8
soft tissue sarcoma of the abdomen and thoracic visceral organs pathologic regional lymph nodes tnm finding v8
soft tissue sarcoma of the abdomen and thoracic visceral organs pn0 tnm finding v8
soft tissue sarcoma of the abdomen and thoracic visceral organs pn1 tnm finding v8
idh1 r132h negative
proglucagon
gcg gene product
gastrointestinal stromal tumor tnm finding v8
9q22 .3
gastrointestinal stromal tumor clinical tnm finding v8
gastrointestinal stromal tumor clinical distant metastasis tnm finding v8
gastrointestinal stromal tumor cm0 tnm finding v8
gastrointestinal stromal tumor cm1 tnm finding v8
gastrointestinal stromal tumor pathologic tnm finding v8
gastrointestinal stromal tumor pathologic distant metastasis tnm finding v8
gastrointestinal stromal tumor pm1 tnm finding v8
gastrointestinal stromal tumor pathologic primary tumor tnm finding v8
gastrointestinal stromal tumor ptx tnm finding v8
gastrointestinal stromal tumor pt0 tnm finding v8
8q24 .12 - q24 .13
gastrointestinal stromal tumor pt1 tnm finding v8
gastrointestinal stromal tumor pt2 tnm finding v8
gastrointestinal stromal tumor pt3 tnm finding v8
gastrointestinal stromal tumor pt4 tnm finding v8
gastrointestinal stromal tumor pathologic regional lymph nodes tnm finding v8
gastrointestinal stromal tumor pn0 tnm finding v8
gastrointestinal stromal tumor pn1 tnm finding v8
gastrointestinal stromal tumor by ajcc v8 stage
gastric and omental gastrointestinal stromal tumor by ajcc v8 stage
small intestinal ,  esophageal ,  colorectal ,  mesenteric ,  and peritoneal gastrointestinal stromal tumor by ajcc v8 stage
6p24
stage i gastric and omental gastrointestinal stromal tumor ajcc v8
stage ia gastric and omental gastrointestinal stromal tumor ajcc v8
stage ib gastric and omental gastrointestinal stromal tumor ajcc v8
stage ii gastric and omental gastrointestinal stromal tumor ajcc v8
stage iii gastric and omental gastrointestinal stromal tumor ajcc v8
stage iiia gastric and omental gastrointestinal stromal tumor ajcc v8
psma - targeting agent - technetium tc99m ec0652
stage iiib gastric and omental gastrointestinal stromal tumor ajcc v8
stage iv gastric and omental gastrointestinal stromal tumor ajcc v8
antibody - drug conjugate sc - 006
7p12 .3 - p12 .1
stage i small intestinal ,  esophageal ,  colorectal ,  mesenteric ,  and peritoneal gastrointestinal stromal tumor ajcc v8
stage ii small intestinal ,  esophageal ,  colorectal ,  mesenteric ,  and peritoneal gastrointestinal stromal tumor ajcc v8
cd8 +  and cd4 +  donor memory t - cells - expressing ha1 - specific tcr
stage iii small intestinal ,  esophageal ,  colorectal ,  mesenteric ,  and peritoneal gastrointestinal stromal tumor ajcc v8
stage iiia small intestinal ,  esophageal ,  colorectal ,  mesenteric ,  and peritoneal gastrointestinal stromal tumor ajcc v8
stage iiib small intestinal ,  esophageal ,  colorectal ,  mesenteric ,  and peritoneal gastrointestinal stromal tumor ajcc v8
stage iv small intestinal ,  esophageal ,  colorectal ,  mesenteric ,  and peritoneal gastrointestinal stromal tumor ajcc v8
gnrh2 gene product
gonadoliberin - 2
vip gene product
4q25 - q27
vip peptides
chga gene product
soft tissue sarcoma of the retroperitoneum tnm finding v8
soft tissue sarcoma of the retroperitoneum clinical tnm finding v8
soft tissue sarcoma of the retroperitoneum clinical distant metastasis tnm finding v8
soft tissue sarcoma of the retroperitoneum cm0 tnm finding v8
soft tissue sarcoma of the retroperitoneum cm1 tnm finding v8
soft tissue sarcoma of the retroperitoneum pathologic tnm finding v8
soft tissue sarcoma of the retroperitoneum pathologic distant metastasis tnm finding v8
soft tissue sarcoma of the retroperitoneum pm1 tnm finding v8
recombinant ena - 78
15q15 - q21 .1
soft tissue sarcoma of the retroperitoneum pathologic primary tumor tnm finding v8
soft tissue sarcoma of the retroperitoneum ptx tnm finding v8
soft tissue sarcoma of the retroperitoneum pt0 tnm finding v8
soft tissue sarcoma of the retroperitoneum pt1 tnm finding v8
soft tissue sarcoma of the retroperitoneum pt2 tnm finding v8
soft tissue sarcoma of the retroperitoneum pt3 tnm finding v8
soft tissue sarcoma of the retroperitoneum pt4 tnm finding v8
antibody - drug conjugate sc - 004
soft tissue sarcoma of the retroperitoneum pathologic regional lymph nodes tnm finding v8
soft tissue sarcoma of the retroperitoneum pn0 tnm finding v8
8p11 .2 - p11 .1
soft tissue sarcoma of the retroperitoneum pn1 tnm finding v8
retroperitoneal sarcoma by ajcc v8 stage
stage i retroperitoneal sarcoma ajcc v8
stage ia retroperitoneal sarcoma ajcc v8
stage ib retroperitoneal sarcoma ajcc v8
stage ii retroperitoneal sarcoma ajcc v8
stage iii retroperitoneal sarcoma ajcc v8
stage iiia retroperitoneal sarcoma ajcc v8
stage iiib retroperitoneal sarcoma ajcc v8
stage iv retroperitoneal sarcoma ajcc v8
10q26
pain crisis
rituximab and hyaluronidase human
axl / mer inhibitor ono - 7475
teclistamab
therapeutic human antithrombin - iii
atypical spitz nevus
regimen used to treat retinoblastoma
determine
calcium release - activated channels inhibitor rp4010
small heat shock protein
19p13 .1 - p12
col4a3 gene product
skin cancer tnm finding v8
merkel cell carcinoma tnm finding v8
merkel cell carcinoma clinical tnm finding v8
merkel cell carcinoma clinical distant metastasis tnm finding v8
merkel cell carcinoma cm0 tnm finding v8
merkel cell carcinoma cm1 tnm finding v8
merkel cell carcinoma cm1a tnm finding v8
merkel cell carcinoma cm1b tnm finding v8
merkel cell carcinoma cm1c tnm finding v8
16q22
merkel cell carcinoma clinical primary tumor tnm finding v8
merkel cell carcinoma ctx tnm finding v8
merkel cell carcinoma ct0 tnm finding v8
merkel cell carcinoma tis tnm finding v8
merkel cell carcinoma ct1 tnm finding v8
merkel cell carcinoma ct2 tnm finding v8
merkel cell carcinoma ct3 tnm finding v8
merkel cell carcinoma ct4 tnm finding v8
merkel cell carcinoma clinical regional lymph nodes tnm finding v8
merkel cell carcinoma cnx tnm finding v8
4q12 - q13
merkel cell carcinoma cn0 tnm finding v8
merkel cell carcinoma cn1 tnm finding v8
merkel cell carcinoma cn2 tnm finding v8
merkel cell carcinoma cn3 tnm finding v8
merkel cell carcinoma pathologic tnm finding v8
merkel cell carcinoma pathologic distant metastasis tnm finding v8
merkel cell carcinoma pm1 tnm finding v8
merkel cell carcinoma pm1a tnm finding v8
merkel cell carcinoma pm1b tnm finding v8
merkel cell carcinoma pm1c tnm finding v8
3q26 .3 - q27
merkel cell carcinoma pathologic regional lymph nodes tnm finding v8
merkel cell carcinoma pnx tnm finding v8
merkel cell carcinoma pn0 tnm finding v8
merkel cell carcinoma pn1 tnm finding v8
merkel cell carcinoma pn1a ( sn )  tnm finding v8
merkel cell carcinoma pn1a tnm finding v8
merkel cell carcinoma pn1b tnm finding v8
merkel cell carcinoma pn2 tnm finding v8
merkel cell carcinoma pn3 tnm finding v8
merkel cell carcinoma by ajcc v7 stage
12q12 - q13
merkel cell carcinoma by ajcc v8 stage
merkel cell carcinoma by ajcc v8 clinical stage
clinical stage 0 merkel cell carcinoma ajcc v8
clinical stage i merkel cell carcinoma ajcc v8
clinical stage ii merkel cell carcinoma ajcc v8
clinical stage iia merkel cell carcinoma ajcc v8
clinical stage iib merkel cell carcinoma ajcc v8
clinical stage iii merkel cell carcinoma ajcc v8
clinical stage iv merkel cell carcinoma ajcc v8
london deauville criteria point scale x
22q11 .21
merkel cell carcinoma by ajcc v8 pathologic stage
pathologic stage 0 merkel cell carcinoma ajcc v8
pathologic stage i merkel cell carcinoma ajcc v8
pathologic stage ii merkel cell carcinoma ajcc v8
pathologic stage iia merkel cell carcinoma ajcc v8
pathologic stage iib merkel cell carcinoma ajcc v8
pathologic stage iii merkel cell carcinoma ajcc v8
pathologic stage iiia merkel cell carcinoma ajcc v8
pathologic stage iiib merkel cell carcinoma ajcc v8
pathologic stage iv merkel cell carcinoma ajcc v8
8q13 - qter
neratinib maleate
cutaneous melanoma tnm finding v8
cutaneous melanoma clinical tnm finding v8
cutaneous melanoma clinical distant metastasis tnm finding v8
cutaneous melanoma cm0 tnm finding v8
cutaneous melanoma cm1 tnm finding v8
cutaneous melanoma cm1a tnm finding v8
cutaneous melanoma cm1a ( 0 )  tnm finding v8
cutaneous melanoma cm1a ( 1 )  tnm finding v8
recombinant fibroblast growth factor 6
6q22
cutaneous melanoma cm1b tnm finding v8
cutaneous melanoma cm1b ( 0 )  tnm finding v8
cutaneous melanoma cm1b ( 1 )  tnm finding v8
cutaneous melanoma cm1c tnm finding v8
cutaneous melanoma cm1c ( 0 )  tnm finding v8
cutaneous melanoma cm1c ( 1 )  tnm finding v8
cutaneous melanoma cm1d tnm finding v8
cutaneous melanoma cm1d ( 0 )  tnm finding v8
cutaneous melanoma cm1d ( 1 )  tnm finding v8
cutaneous melanoma clinical regional lymph nodes tnm finding v8
13q12 - q13
cutaneous melanoma cnx tnm finding v8
cutaneous melanoma cn0 tnm finding v8
cutaneous melanoma cn1 tnm finding v8
cutaneous melanoma cn1b tnm finding v8
cutaneous melanoma cn1c tnm finding v8
cutaneous melanoma cn2 tnm finding v8
cutaneous melanoma cn2b tnm finding v8
cutaneous melanoma cn2c tnm finding v8
cutaneous melanoma cn3 tnm finding v8
cutaneous melanoma cn3b tnm finding v8
8q24 .11 - q24 .13
cutaneous melanoma cn3c tnm finding v8
cutaneous melanoma pathologic tnm finding v8
cutaneous melanoma pathologic distant metastasis tnm finding v8
cutaneous melanoma pm1 tnm finding v8
cutaneous melanoma pm1a tnm finding v8
cutaneous melanoma pm1a ( 0 )  tnm finding v8
cutaneous melanoma pm1a ( 1 )  tnm finding v8
cutaneous melanoma pm1b tnm finding v8
cutaneous melanoma pm1b ( 0 )  tnm finding v8
cutaneous melanoma pm1b ( 1 )  tnm finding v8
11p12 - p11
cutaneous melanoma pm1c tnm finding v8
cutaneous melanoma pm1c ( 0 )  tnm finding v8
cutaneous melanoma pm1c ( 1 )  tnm finding v8
cutaneous melanoma pm1d tnm finding v8
cutaneous melanoma pm1d ( 0 )  tnm finding v8
cutaneous melanoma pm1d ( 1 )  tnm finding v8
cutaneous melanoma pathologic primary tumor tnm finding v8
cutaneous melanoma ptx tnm finding v8
cutaneous melanoma pt0 tnm finding v8
1p36 .13 - p36 .11
cutaneous melanoma ptis tnm finding v8
cutaneous melanoma pt1 tnm finding v8
cutaneous melanoma pt1a tnm finding v8
cutaneous melanoma pt1b tnm finding v8
cutaneous melanoma pt2 tnm finding v8
cutaneous melanoma pt2a tnm finding v8
cutaneous melanoma pt2b tnm finding v8
cutaneous melanoma pt3 tnm finding v8
cutaneous melanoma pt3a tnm finding v8
cutaneous melanoma pt3b tnm finding v8
17q21 .3
cutaneous melanoma pt4 tnm finding v8
cutaneous melanoma pt4a tnm finding v8
cutaneous melanoma pt4b tnm finding v8
cutaneous melanoma pathologic regional lymph nodes tnm finding v8
cutaneous melanoma pnx tnm finding v8
cutaneous melanoma pn0 tnm finding v8
cutaneous melanoma pn1 tnm finding v8
cutaneous melanoma pn1a tnm finding v8
cutaneous melanoma pn1c tnm finding v8
cutaneous melanoma pn2 tnm finding v8
13q14 .1 - q14 .2
cutaneous melanoma pn2a tnm finding v8
cutaneous melanoma pn2c tnm finding v8
follicular lymphoma international prognostic index
cutaneous melanoma pn3 tnm finding v8
cutaneous melanoma pn3a tnm finding v8
flipi score 0 - 1 ,  low risk
cutaneous melanoma pn3c tnm finding v8
flipi score 2 ,  intermediate risk
flipi score greater than or equal to 3 ,  high risk
deleted in lymphocytic leukemia 1 non - protein coding rna
18p11 .3
deleterious epcam gene mutation
recurrent lymphocyte - rich classic hodgkin lymphoma
intermediate atypical prostate carcinoma
long intergenic non - protein coding rna 1565
lmna gene product
lamin - a / c
rainbow trout mesothelioma
devil facial tumor disease
tricuspid valve regurgitation velocity
20q12 - q13
anti - epha2 antibody - directed liposomal docetaxel prodrug mm - 310
tcr - specific ,  alpha fetoprotein - enhanced autologous t lymphocytes
dual - affinity b7 - h3 / cd3 - targeted protein mgd009
chinese herbal medicine yq1
murlentamab
lmp1 - specific chimeric antigen receptor - expressing t lymphocytes
patritumab deruxtecan
n - acetylcysteine / simethicone solution
10q21
recombinant fibroblast growth factor 5
7q21 .1
19q13 .3 - q13 .4
8p23 .1 - p21 .3
5q33 .2 - q33 .3
1q21 - q22
3p24 .3
12p12 .3
3q26
3p21
4q25
fosquidone
3p26 - p25
15q22 - q24
2q31 - q33
male genital system fluid or secretion
5q35 .1
internal ribosome entry site
anatomic site
hypoxia - responsive elements
ets domain
fostriecin
rna recognition motif
bzip domain
respiratory system fluid or secretion
repair complex
central dna flap sequence
g - quartets
1p32 - q12
t ( 12 ; 21 )  ( p13 .2 ; q22 .1 )
15q23 - q25
21q22 .2
girodazole
4q13 - q21
intraventricular
bromodomain
5p15 .33
regulatory element
plasma membrane
zonula adherens
20s proteasome
conformation
blastocyst
goserelin
inner cell mass
at hook motif
minor groove
major groove
hmg - box
nucleosome binding domain
ring finger domain
14q11
3p21 .3 - p21 .2
xq28
guanidinium cation
5q11 - q12
13q22 - q34
5q13 - q14
7q36 .1
11q22 - q23
xq25
20q13 .3
22q11 - q13
3p26 .2
1q42 - q43
halichondrin b
5q12 .2 - q13 .3
3q22 .1
19p13 .3 - p13 .2
2q35
3q21
cutaneous melanoma by ajcc v8 stage
cutaneous melanoma by ajcc v8 clinical stage
clinical stage 0 cutaneous melanoma ajcc v8
clinical stage i cutaneous melanoma ajcc v8
clinical stage ia cutaneous melanoma ajcc v8
8q11 .2
clinical stage ib cutaneous melanoma ajcc v8
clinical stage ii cutaneous melanoma ajcc v8
clinical stage iia cutaneous melanoma ajcc v8
clinical stage iib cutaneous melanoma ajcc v8
clinical stage iic cutaneous melanoma ajcc v8
clinical stage iii cutaneous melanoma ajcc v8
clinical stage iv cutaneous melanoma ajcc v8
cutaneous melanoma by ajcc v8 pathologic stage
follicular lymphoma international prognostic index 2
flipi - 2 score 0 ,  low risk
22q13 .1
flipi - 2 score 1 - 2 ,  intermediate risk
flipi - 2 score 3 - 5 ,  high risk
pathologic stage 0 cutaneous melanoma ajcc v8
pathologic stage i cutaneous melanoma ajcc v8
pathologic stage ia cutaneous melanoma ajcc v8
pathologic stage ib cutaneous melanoma ajcc v8
pathologic stage ii cutaneous melanoma ajcc v8
pathologic stage iia cutaneous melanoma ajcc v8
pathologic stage iib cutaneous melanoma ajcc v8
pathologic stage iic cutaneous melanoma ajcc v8
2q21
pathologic stage iii cutaneous melanoma ajcc v8
pathologic stage iiia cutaneous melanoma ajcc v8
pathologic stage iiib cutaneous melanoma ajcc v8
pathologic stage iiic cutaneous melanoma ajcc v8
occult breast carcinoma
pathologic stage iiid cutaneous melanoma ajcc v8
stage iiid
pathologic stage iv cutaneous melanoma ajcc v8
intramammary lymph node
6p12
dpace regimen
dcep regimen
budigalimab
protease inhibitor formulation lb1148
weekend
blasts under 5 percent of bone marrow nucleated cells
psa level greater than ten
psa level ten to twenty
psa level less than twenty
psa level less than ten
7q21 .3 - q22 .1
cd20 negative
dicer1 gene mutation
psa level greater than 2 .5
human immunodeficiency virus negative
myeloblasts 10 percent or more of bone marrow nucleated cells
blasts 20 percent or less of bone marrow nucleated cells
psa level two to forty
psa level greater than or equal to two
blasts 5 percent or less of bone marrow nucleated cells
psa level less than fifteen
hematoporphyrin derivative
2q33
psa level less than or equal to eighty
blasts under 25 percent of bone marrow nucleated cells
psa level greater than or equal to twenty
blasts 5 - 10 percent of bone marrow nucleated cells
blasts 10 - 19 percent of peripheral blood white cells
psa level greater than or equal to four
blasts 11 - 20 percent of bone marrow nucleated cells
psa level 0 .5 to 50
psa level greater than or equal to twenty - five
tumor margin configuration
7q21 .3
infiltrative tumor margin
2q22 - q23
7q22 .1
8p12 - p11 .2
5q23 - q31
1q41
6p21 .1
7p12 - p11 .2
xq13 .1
generalized competing event model for cancer risk
antimoniotungstate
6q27
rucaparib
experimental organism finding
experimental organism non - neoplastic disorder
tbo - filgrastim
filgrastim - sndz
computed tomography with contrast
computed tomography without contrast
low risk mantle cell lymphoma international prognostic index combined biologic index
low - intermediate risk mantle cell lymphoma international prognostic index combined biologic index
high - intermediate risk mantle cell lymphoma international prognostic index combined biologic index
3q21 - q28
high risk mantle cell lymphoma international prognostic index combined biologic index
electronic patient - reported outcome system
radiation boost
biopsy specimen radiography
core biopsy with placement of image - detectable marker
distance of closest surgical margin
f - 18 sodium fluoride positron emission tomography and computed tomography scan
fdg - positron emission tomography and computed tomography scan
androgen receptor antagonist tas3681
allogeneic cd19 - specific universal car19 - expressing t - lymphocytes
14q11 .2
anti - tim3 monoclonal antibody ly3321367
antibody - drug conjugate medi7247
zirconium zr 89 - df - iab22m2c
personalized live - attenuated double - deleted listeria monocytogenes
leronlimab
enasidenib mesylate
isocitrate dehydrogenase inhibitor
mismatch repair protein deficiency
comprehensive metabolic panel
fertility preservation counseling
3q13 .31
breast cancer risk reduction counseling
discussion regarding the termination of pregnancy due to cancer diagnosis
sentinel lymph node not identified
ultrasound - guided fine - needle aspiration
ultrasound - guided core biopsy
specimen blood volume
blood volume
pleomorphic lobular breast carcinoma in situ
8q24 .12
quality of life in neurological disorders
neuro - qol adult self - reported mental health domain
neuro qol cognitive function subdomain
have to read something several times to understand
current difficulty reading and following complex instructions
current difficulty planning and keeping appointments not part of weekly routine
current difficulty managing time to do most daily activities
current difficulty learning new tasks or instructions
central lumpectomy with resection of the nipple - areolar complex
biopsy of nipple and areola
1p22
full - thickness skin biopsy of nipple and areola
core biopsy of breast
palpation finding
largest dimension of residual neoplasm
gynecological examination
psychological assessment
assessment of distress
refractory anal carcinoma
eligibility for a procedure
eligibility for breast - conserving surgery
16q24 .3
eligibility for pre - operative systemic therapy
eligibility criteria for breast conserving surgery except for tumor size
refractory pancreatic neuroendocrine carcinoma
allogeneic cd3 -  cd19 -  cd57 +  nkg2c +  nk cells fate - nk100
calcium supplement
autologous cd19 car +  egfrt  +  cd4 +  and cd8 +  t cells
repeat previous treatment
fdg - positron emission tomography / computed tomography of an area of interest
fdg - positron emission tomography / computed tomography from the skull base to mid - thigh
8q12 - q13
magnetic resonance imaging of the pelvis without contrast
magnetic resonance imaging of the whole body without contrast
magnetic resonance imaging of the abdomen without contrast
magnetic resonance imaging of the abdomen and pelvis without contrast
magnetic resonance imaging of the brain without contrast
magnetic resonance imaging of the breast without contrast
bone radiography
staging of lung cancer to rule out progression
computed tomography of the abdomen with contrast
multiphasic computed tomography of the abdomen
xq11 - q13
computed tomography of the abdomen and pelvis with contrast
multiphasic computed tomography of the abdomen and pelvis
computed tomography of the brain with contrast
computed tomography of the chest with contrast
computed tomography of the chest and abdomen with contrast
computed tomography of the chest ,  abdomen and pelvis with contrast
computed tomography of skeletal metastases with contrast
computed tomography of a primary disease site with contrast
computed tomography of an anatomical site of interest with contrast
computed tomography of the inguinal region with contrast
10p15 .1
computed tomography of a lymph node basin with contrast
computed tomography of the head and neck with contrast
computed tomography of the neck with contrast
computed tomography of the neck ,  chest ,  abdomen and pelvis with contrast
computed tomography of the pelvis with contrast
computed tomography of the abdomen without contrast
computed tomography of the abdomen and pelvis without contrast
computed tomography of the brain without contrast
computed tomography of the chest without contrast
computed tomography of the chest and abdomen without contrast
fulvestrant
20q13 .33
computed tomography of the chest ,  abdomen and pelvis without contrast
computed tomography of an anatomical site of interest without contrast
magnetic resonance imaging of a primary site with and without contrast
computed tomography of the neck ,  chest ,  abdomen and pelvis without contrast
computed tomography of the pelvis without contrast
sodium fluoride positron emission tomography / computed tomography from the skull base to mid - thigh
sodium fluoride positron emission tomography / computed tomography of the whole body
fdg - positron emission tomography / computed tomography of the whole body
boost radiation therapy
computed tomography assisted biopsy
10q24 - q25 .2
interruption of chemotherapy
magnetic resonance imaging of the abdomen and pelvis with and without contrast
magnetic resonance imaging of bone
magnetic resonance imaging of the brain with and without contrast
magnetic resonance imaging of the breast with and without contrast
magnetic resonance imaging of the heart
magnetic resonance imaging of the chest with and without contrast
endorectal magnetic resonance imaging
magnetic resonance imaging of the head and neck with and without contrast
magnetic resonance imaging of an area of interest with and without contrast
xq22 .1
magnetic resonance imaging of the neck with and without contrast
magnetic resonance imaging of the whole body with and without contrast
low dose computed tomography of the chest
low dose computed tomography of the whole body
axillary lymph node ultrasound
ultrasound of the neck
regional lymph node ultrasound
x - ray of an area of interest
x - ray of primary site
magnetic resonance imaging of the abdomen with and without contrast
5q11 .2 - q13 .1
multiphasic magnetic resonance imaging of the abdomen
multiphasic magnetic resonance imaging of the abdomen and pelvis
magnetic resonance imaging of skeletal metastatic sites with contrast
magnetic resonance imaging of the pelvis with and without contrast
mediastinal lymph node biopsy
supraclavicular lymph node biopsy
superior vena cava stent placement
bilateral diagnostic mammogram
status of correlation between radiographic image and pathologic finding
radiographic image correlates with tumor pathology finding
11p15 .3
radiographic image not correlated with tumor pathology finding
risk assessment for hereditary breast cancer
risk assessment for thromboembolism
patient decision
patient intends to continue pregnancy
patient requests pregnancy termination
breast lump palpated
breast lump not palpated
meditation - based stress reduction program
foundation for the accreditation of cellular therapy
6p21 .31
selective androgen receptor modulator rad140
light - activated au - 011
non - synonymous alk gene mutation
pi3k / mtor pathway mutation
bcat1 gene
bcat1 wt allele
branched - chain - amino - acid aminotransferase ,  cytosolic
long qt syndrome 2
tmsb4x gene
long qt syndrome 3
1p35 .2
tmsb4x wt allele
tmsb4y gene
tmsb4y wt allele
thymosin beta - 4
thymosin beta - 4 ,  y - chromosomal
pif1 gene
pif1 wt allele
atp - dependent dna helicase pif1
bptf gene
bptf wt allele
1p13 .1
nucleosome - remodeling factor subunit bptf
rragd gene
rragd wt allele
ras - related gtp - binding protein d
adnexa
lama3 gene
lama3 wt allele
laminin subunit alpha - 3
sesn1 gene
sesn1 wt allele
6q22 .1 - q22 .3
sestrin - 1
tax1bp1 gene
tax1bp1 wt allele
tax1 - binding protein 1
apela gene
apela wt allele
apelin receptor early endogenous ligand
carbon c 11 glutamine
flt3 inhibitor ff - 10101 succinate
mcl - 1 inhibitor azd5991
11q22 .3
mcl - 1 inhibitor
rolinsatamab talirine
gleason grade group 1
gleason grade group 2
gleason grade group 3
gleason grade group 4
gleason grade group 5
integra dermal regeneration template
smokeless tobacco use
chimeric antigen receptor t - cells
edodekin alfa
12q15
how often have sensation of not emptying bladder completely after finish urinating
how often have to urinate again less than 2 hours after finish urinating
how often have stopped and started again several times when urinating
how often have to push or strain to begin urination
how many times typically get up to urinate during nighttime sleep
feeling about current urinary condition for rest of life
less than one time in five
about half the time
1p22 .1
mostly dissatisfied
unhappy
recurrent b - cell lymphoma ,  unclassifiable ,  with features intermediate between diffuse large b - cell lymphoma and classic hodgkin lymphoma
refractory b - cell lymphoma ,  unclassifiable ,  with features intermediate between diffuse large b - cell lymphoma and classic hodgkin lymphoma
recurrent extranodal diffuse large b - cell lymphoma
smarca4 gene inactivation
refractory extranodal diffuse large b - cell lymphoma
recurrent central nervous system lymphoma
beta sheet
refractory central nervous system lymphoma
recurrent testicular lymphoma
refractory testicular lymphoma
recurrent breast lymphoma
refractory breast lymphoma
recurrent intravascular large b - cell lymphoma
refractory intravascular large b - cell lymphoma
recurrent primary cutaneous diffuse large b - cell lymphoma ,  leg type
refractory primary cutaneous diffuse large b - cell lymphoma ,  leg type
ac followed by docetaxel / trastuzumab regimen
long interspersed element
ac followed by docetaxel regimen
ac followed by pertuzumab / trastuzumab / docetaxel regimen
ac followed by pertuzumab / trastuzumab / paclitaxel regimen
capecitabine / trastuzumab regimen
cyclophosphamide / docetaxel / trastuzumab regimen
dose - dense ac regimen
dose - dense ac followed by paclitaxel / trastuzumab regimen
dose - dense ac followed by paclitaxel regimen
fec followed by pertuzumab / trastuzumab / docetaxel regimen
fec followed by pertuzumab / trastuzumab / paclitaxel regimen
short interspersed element
lapatinib / trastuzumab regimen
capecitabine / lapatinib regimen
pertuzumab / trastuzumab regimen
docetaxel / pertuzumab / trastuzumab regimen
pertuzumab / trastuzumab / docetaxel followed by fec regimen
paclitaxel / pertuzumab / trastuzumab regimen
pertuzumab / trastuzumab / paclitaxel followed by fec regimen
tchp regimen
docetaxel / trastuzumab regimen
erythroid
bevacizumab / paclitaxel regimen
paclitaxel / trastuzumab regimen
carboplatin / paclitaxel / trastuzumab regimen
vh regimen
tc regimen
blasts 10 percent or more of peripheral blood white cells
blasts under 30 percent of bone marrow nucleated cells
erbb family pathway deregulation
patient decision regarding continuation of pregnancy after cancer diagnosis
immunoglobulin domain
erbb4 gene mutation
distal resection margin
deep resection margin
proximal resection margin
erbb3 gene mutation
blasts 50 percent or more of bone marrow nucleated cells
btk inhibitor arq 531
psa level less than or equal to twenty
fgfr2 gene translocation
cfdna mutation
elevated ca19 - 9
psa level less than 0 .1
ass1 gene deficiency
elevated cea
gpnmb positive
sulfur hexafluoride lipid microspheres
atm inhibitor m 3541
number of pulmonary nodules
size of persistent and solid component of a sub - solid pulmonary nodule
candidate
intrahepatic
never have erection when want one
have erection less than half the time
rfwd3 gene
have erection about half the time
have erection whenever want one
no pads per day
one pad per day
two pads per day
three or more pads per day
nuclear lamina
no urinary control
rfwd3 wt allele
frequent dribbling
e3 ubiquitin - protein ligase rfwd3
occasional dribbling
total urinary control
rbp4 gene
rbp4 wt allele
retinol - binding protein 4
fac regimen
irinotecan hydrochloride
cef regimen
ptpn2 gene
ptpn2 wt allele
tyrosine - protein phosphatase non - receptor type 2
nek2 gene
nek2 wt allele
serine / threonine - protein kinase nek2
autologous genetically - modified mage - a4 c1032 t cells
apoc1 gene
apoc1 wt allele
nucleosome core particle
apolipoprotein c - i
trpv4 gene
trpv4 wt allele
sexual health inventory for men
confidence can get and keep erection
transient receptor potential cation channel subfamily v member 4
how often erection with sexual stimulation hard enough for penetration
how often able to maintain erection after penetration during sexual intercourse
how difficult to maintain erection to complete sexual intercourse
how often sexual intercourse satisfactory
scaffold - associated region
erectile dysfunction severity breakpoint
sox11 transcription factor staining method
dusp22 gene rearrangement
mybpc3 gene
mybpc3 wt allele
myosin - binding protein c ,  cardiac - type
wasf3 gene
wasf3 wt allele
wiskott - aldrich syndrome protein family member 3
radiation source
3q21 - q24
civasheet directional pd103 brachytherapy source
magnetic resonance whole body diffusion - weighted imaging
promis psychosocial illness impact - positive
comfortable with who i am
realize who true friends are
can adjust to things i cannot change
life is meaningful
how true before illness
how true since illness
1p22 - p21
nckap1 gene
nckap1 wt allele
nck - associated protein 1
solid pulmonary nodule
subsolid pulmonary nodule
cyfip1 gene
cyfip1 wt allele
cytoplasmic fmr1 - interacting protein 1
pure ground - glass pulmonary nodule
neoantigen dna - based pancreatic cancer vaccine
8p21 - p12
apol1 gene
apol1 wt allele
apolipoprotein l1
aplnr gene
trk receptor family alteration positive
trk receptor family fusion positive
aplnr wt allele
trk receptor family fusion negative
apelin receptor
13q14
selitrectinib
therapy - related toxicity  -  acceptable to patient
therapy - related toxicity  -  unacceptable to patient
endocrine therapy toxicity
btk inhibitor ct - 1530
lerociclib
visceral crisis
prostate carcinoma by gene expression profile
luminal a prostate carcinoma
luminal b prostate carcinoma
11p15 .1 - p14
basal - like prostate carcinoma
hyperphenylalaninemia ,  bh4 - deficient a
hyperphenylalaninemia ,  bh4 - deficient c
vici syndrome
t ( 2 ; 5 )
t ( 11 ; 18 )
epstein - barr encoding region in situ hybridization
ruler
acute chest syndrome
14q24 .1
t - cell receptor - engineered t - cells
in situ follicular neoplasia
neoplastic plasma cells 30 percent or less of bone marrow nucleated cells
recurrent abdominal neuroendocrine neoplasm
refractory abdominal neuroendocrine neoplasm
duodenal - type follicular lymphoma
predominantly diffuse follicular lymphoma with 1p36 deletion
haploidentical hematopoietic cell transplantation
clinical trials search - application programming interface disease category terminology
cts - api disease broad category terminology
somatosensory receptor
cts - api disease main type terminology
in situ mantle cell neoplasia
leukemic nonnodal mantle cell lymphoma
pdgfra gene mutation negative
kit gene mutation negative
high grade b - cell lymphoma with myc and bcl2 and / or bcl6 rearrangements
barely any
assistance with registering
assistance reading questions
assistance entering answers
k 252a
2q33 .1
assistance submitting questionnaire
used personal smartphone
used personal tablet
used clinic's tablet
used family or friend's smartphone
boston bowel preparation scale
boston bowel preparation segment score 0
boston bowel preparation segment score 1
boston bowel preparation segment score 2
mechanoreceptor
boston bowel preparation segment score 3
high grade b - cell lymphoma
cdisc clinical classification has - bled test name terminology
cdisc clinical classification has - bled test code terminology
cdisc clinical classification lpss test name terminology
cdisc clinical classification lpss test code terminology
cdisc functional test pul 1 .2 test name terminology
cdisc functional test pul 1 .2 test code terminology
cdisc functional test pul 2 .0 test name terminology
cdisc functional test pul 2 .0 test code terminology
thermoreceptor
cdisc questionnaire fbrsi test name terminology
cdisc questionnaire fbrsi test code terminology
cdisc questionnaire fksi - 15 test name terminology
cdisc questionnaire fksi - 15 test code terminology
cdisc questionnaire flsi test name terminology
cdisc questionnaire flsi test code terminology
cdisc questionnaire pedsql neuromuscular module acute version 3 .0 child report test name terminology
cdisc questionnaire pedsql neuromuscular module acute version 3 .0 child report test code terminology
cdisc questionnaire pedsql neuromuscular module acute version 3 .0 parent of toddler test name terminology
cdisc questionnaire pedsql neuromuscular module acute version 3 .0 parent of toddler test code terminology
proprioceptor
cdisc questionnaire pedsql neuromuscular module acute version 3 .0 parent report for child test name terminology
cdisc questionnaire pedsql neuromuscular module acute version 3 .0 parent report for child test code terminology
cdisc questionnaire pedsql neuromuscular module acute version 3 .0 parent report for teen test name terminology
cdisc questionnaire pedsql neuromuscular module acute version 3 .0 parent report for teen test code terminology
cdisc questionnaire pedsql neuromuscular module acute version 3 .0 parent report for young adults test name terminology
cdisc questionnaire pedsql neuromuscular module acute version 3 .0 parent report for young adults test code terminology
cdisc questionnaire pedsql neuromuscular module acute version 3 .0 parent report for young child test name terminology
cdisc questionnaire pedsql neuromuscular module acute version 3 .0 parent report for young child test code terminology
cdisc questionnaire pedsql neuromuscular module acute version 3 .0 teen report test name terminology
cdisc questionnaire pedsql neuromuscular module acute version 3 .0 teen report test code terminology
muscle spindle
cdisc questionnaire pedsql neuromuscular module acute version 3 .0 young adult report test name terminology
cdisc questionnaire pedsql neuromuscular module acute version 3 .0 young adult report test code terminology
cdisc questionnaire pedsql neuromuscular module acute version 3 .0 young child report test name terminology
cdisc questionnaire pedsql neuromuscular module acute version 3 .0 young child report test code terminology
cdisc questionnaire pedsql neuromuscular module version 3 .0 child report test name terminology
cdisc questionnaire pedsql neuromuscular module version 3 .0 child report test code terminology
cdisc questionnaire pedsql neuromuscular module version 3 .0 parent of toddler test name terminology
cdisc questionnaire pedsql neuromuscular module version 3 .0 parent of toddler test code terminology
cdisc questionnaire pedsql neuromuscular module version 3 .0 parent report for child test name terminology
cdisc questionnaire pedsql neuromuscular module version 3 .0 parent report for child test code terminology
16p12
cdisc questionnaire pedsql neuromuscular module version 3 .0 parent report for teen test name terminology
cdisc questionnaire pedsql neuromuscular module version 3 .0 parent report for teen test code terminology
cdisc questionnaire pedsql neuromuscular module version 3 .0 parent report for young adults report test name terminology
cdisc questionnaire pedsql neuromuscular module version 3 .0 parent report for young adults report test code terminology
cdisc questionnaire pedsql neuromuscular module version 3 .0 parent report for young child test name terminology
cdisc questionnaire pedsql neuromuscular module version 3 .0 parent report for young child test code terminology
cdisc questionnaire pedsql neuromuscular module version 3 .0 teen report test name terminology
cdisc questionnaire pedsql neuromuscular module version 3 .0 teen report test code terminology
cdisc questionnaire pedsql neuromuscular module version 3 .0 young adult report test name terminology
cdisc questionnaire pedsql neuromuscular module version 3 .0 young adult report test code terminology
golgi tendon organ
cdisc questionnaire pedsql neuromuscular module version 3 .0 young child report test name terminology
cdisc questionnaire pedsql neuromuscular module version 3 .0 young child report test code terminology
has - bled clinical classification question
lpss clinical classification question
pul 1 .2 functional test question
pul 2 .0 functional test question
fbrsi questionnaire question
fksi - 15 questionnaire question
flsi questionnaire question
pedsql neuromuscular module acute version 3 .0 child report questionnaire question
2p23 .3
pedsql neuromuscular module acute version 3 .0 parent of toddler questionnaire question
pedsql neuromuscular module acute version 3 .0 parent report for child questionnaire question
pedsql neuromuscular module acute version 3 .0 parent report for teen questionnaire question
pedsql neuromuscular module acute version 3 .0 parent report for young adults questionnaire question
pedsql neuromuscular module acute version 3 .0 parent report for young child questionnaire question
pedsql neuromuscular module acute version 3 .0 teen report questionnaire question
pedsql neuromuscular module acute version 3 .0 young adult report questionnaire question
pedsql neuromuscular module acute version 3 .0 young child report questionnaire question
pedsql neuromuscular module version 3 .0 child report questionnaire question
pedsql neuromuscular module version 3 .0 parent of toddler questionnaire question
9q34 .3
pedsql neuromuscular module version 3 .0 parent report for child questionnaire question
pedsql neuromuscular module version 3 .0 parent report for teen questionnaire question
pedsql neuromuscular module version 3 .0 parent report for young adults report questionnaire question
pedsql neuromuscular module version 3 .0 parent report for young child questionnaire question
pedsql neuromuscular module version 3 .0 teen report questionnaire question
pedsql neuromuscular module version 3 .0 young adult report questionnaire question
pedsql neuromuscular module version 3 .0 young child report questionnaire question
cordonnier infectious complications grading scale
cordonnier bacterial complication
cordonnier fungal complication
5q13
cordonnier viral complication
cordonnier parasitic complication
cordonnier nonmicrobially - defined infection
cordonnier grade 1 bacterial complication ,  outpatient treatment bacterial focus
cordonnier grade 2 bacterial complication ,  bacteremia without severe sepsis
cordonnier grade 2 bacterial complication requiring inpatient management
cordonnier grade 3 bacterial complication ,  bacteremia with severe sepsis
cordonnier grade 3 bacterial complication ,  complex bacteremia
cordonnier grade 1 fungal complication ,  superficial candida infection
cordonnier grade 2 fungal complication ,  deep candida infection without candidemia
liposomal nddp
8p11 .23
cordonnier grade 2 fungal complication ,  candidemia without severe sepsis
cordonnier grade 2 fungal complication ,  aspergillus sinusitis without bone involvement
cordonnier grade 3 fungal complication ,  candidemia with either sepsis or deep focus
cordonnier grade 3 fungal complication ,  proven or probable aspergillus pneumonia
cordonnier grade 1 viral complication ,  mucous herpes simplex virus infection
cordonnier grade 2 viral complication ,  varicella zoster virus infection
cordonnier grade 3 viral complication ,  severe varicella zoster virus infection
cordonnier grade 3 viral complication ,  viral encephalitis
cordonnier grade 1 viral complication ,  asymptomatic cytomegalovirus infection
cordonnier grade 2 viral complication ,  symptomatic cytomegalovirus infection
5p13 .3
cordonnier grade 3 viral complication ,  cytomegalovirus pneumonia or gut disease
cordonnier grade 2 parasitic complication ,  toxoplasmosis infection without organ involvement
cordonnier grade 3 parasitic complication ,  pneumocystis jiroveci pneumonia
cordonnier grade 3 parasitic complication ,  central nervous system or other organ toxoplasmosis
cordonnier grade 1 fever of unknown origin in neutropenic patient
cordonnier grade 1 clinically documented infection not requiring inpatient management
cordonnier grade 2 pneumonia or bronchopneumonia with pao2 greater than 65 mmhg
cordonnier grade 2 infectious symptom requiring inpatient management
cordonnier grade 3 acute pneumonia with pao2  less than or equal to 65 mmhg
cordonnier sepsis syndrome requiring transfer to intensive care unit
9p22 .2
hhv8 - positive diffuse large b - cell lymphoma ,  not otherwise specified
psa level 0 .1 to 50
neoplastic plasma cells more than 20 percent of bone marrow nucleated cells
liver ultrasonographic elastography
assistance getting started with the application
assistance reading answers
assistance reading questions and answers
used paper form
liver stiffness
17q12
fibrosis - 4 score
continuous venovenous hemodialysis
has - bled bleeding risk score clinical classification
the lansky play - performance status scale clinical classification
performance of the upper limb module for dmd 1 .2 functional test
performance of the upper limb module for dmd 2 .0 functional test
functional assessment of cancer therapy - brain symptom index questionnaire
functional assessment of cancer therapy - lung symptom index questionnaire
pediatric quality of life neuromuscular module acute version 3 .0 child report questionnaire
17q12 - q21 .1
pediatric quality of life neuromuscular module acute version 3 .0 parent of toddler questionnaire
pediatric quality of life neuromuscular module acute version 3 .0 parent report for child questionnaire
pediatric quality of life neuromuscular module acute version 3 .0 parent report for teen questionnaire
pediatric quality of life neuromuscular module acute version 3 .0 parent report for young adults questionnaire
pediatric quality of life neuromuscular module acute version 3 .0 parent report for young child questionnaire
pediatric quality of life neuromuscular module acute version 3 .0 teen report questionnaire
pediatric quality of life neuromuscular module acute version 3 .0 young adult report questionnaire
pediatric quality of life neuromuscular module acute version 3 .0 young child report questionnaire
pediatric quality of life neuromuscular module version 3 .0 child report questionnaire
pediatric quality of life neuromuscular module version 3 .0 parent of toddler questionnaire
6q22 .33 - q24 .1
pediatric quality of life neuromuscular module version 3 .0 parent report for child questionnaire
pediatric quality of life neuromuscular module version 3 .0 parent report for teen questionnaire
pediatric quality of life neuromuscular module version 3 .0 parent report for young adults report questionnaire
pediatric quality of life neuromuscular module version 3 .0 parent report for young child questionnaire
pediatric quality of life neuromuscular module version 3 .0 teen report questionnaire
pediatric quality of life neuromuscular module version 3 .0 young adult report questionnaire
pediatric quality of life neuromuscular module version 3 .0 young child report questionnaire
has - bled  -  hypertension
has - bled  -  abnormal renal and liver function
has - bled  -  stroke
11q14
has - bled  -  bleeding
has - bled  -  labile inrs
has - bled  -  elderly
has - bled  -  drugs or alcohol
lpss  -  lansky play - performance status
pul 1 .2  -  preferred arm
pul 1 .2  -  elbow contractures
pul 1 .2  -  entry item
pul 1 .2  -  shoulder abduction to height
pul 1 .2  -  shoulder abduction above height
19p13 .12
pul 1 .2  -  shoulder flexion to height
pul 1 .2  -  shoulder flexion above height
pul 1 .2  -  hand ( s )  to mouth
pul 1 .2  -  hand ( s )  to table from lap
pul 1 .2  -  move weight on table
pul 1 .2  -  lifting light cans
pul 1 .2  -  lifting light cans time
pul 1 .2  -  lifting heavy cans
pul 1 .2  -  lifting heavy cans time
pul 1 .2  -  stacking light cans
5q33 .2
pul 1 .2  -  stacking light cans time
pul 1 .2  -  stacking heavy cans
pul 1 .2  -  stacking heavy cans time
pul 1 .2  -  remove lid from container
pul 1 .2  -  tearing paper
pul 1 .2  -  tracing path
pul 1 .2  -  push on the light
pul 1 .2  -  supination
pul 1 .2  -  picking up coins
pul 1 .2  -  placing finger on number diagram
11q24
pul 1 .2  -  finger pinch grip
pul 1 .2  -  3 point grip
pul 1 .2  -  thumb  ( key )  grip
pul 1 .2  -  high level shoulder dimension
pul 1 .2  -  mid level elbow dimension
pul 1 .2  -  distal wrist or hand dimension
pul 1 .2  -  total score
pul 2 .0  -  entry item
pul 2 .0  -  shoulder abduction arms above head
pul 2 .0  -  raise both arms to shoulder height
recombinant leukemia inhibitory factor
8p22 - p11
pul 2 .0  -  flexion shoulder height no weights
pul 2 .0  -  flexion to shoulder height 500g
pul 2 .0  -  flexion above shoulder height 500g
pul 2 .0  -  flexion above shoulder height 1kg
pul 2 .0  -  hand ( s )  to mouth
pul 2 .0  -  hands to table from lap
pul 2 .0  -  move weight on table 100g
pul 2 .0  -  move weight on table 500g
pul 2 .0  -  move weight on table 1kg
pul 2 .0  -  lift heavy can diagonally
8q13 .1
pul 2 .0  -  stack of three cans
pul 2 .0  -  stack of five cans
pul 2 .0  -  remove lid from container
pul 2 .0  -  tearing paper
pul 2 .0  -  tracing path
pul 2 .0  -  push on light
pul 2 .0  -  supination
pul 2 .0  -  picking up coins
pul 2 .0  -  placing finger on number diagram
pul 2 .0  -  pick up 10g weight finger pinch
4q12
pul 2 .0  -  preferred arm
pul 2 .0  -  right elbow extension rom
pul 2 .0  -  left elbow extension rom
pul 2 .0  -  right available supination rom
pul 2 .0  -  left available supination rom
pul 2 .0  -  high level shoulder dimension
pul 2 .0  -  mid level elbow dimension
pul 2 .0  -  distal wrist or hand dimension
pul 2 .0  -  total score
fbrsi  -  i get headaches
20q12
fbrsi  -  i have had seizures
fbrsi  -  have weakness in my arms or legs
fbrsi  -  i need help in caring for myself
fbrsi  -  i have a lack of energy
fbrsi  -  difficulty expressing my thoughts
fbrsi  -  i have trouble with coordination
fbrsi  -  frustrated i cannot do things
fbrsi  -  i have nausea
fbrsi  -  able to find the right words
fbrsi  -  losing hope against illness
20q12 - q13 .12
fbrsi  -  trouble meeting needs of family
fbrsi  -  worry my condition will get worse
fbrsi  -  i am afraid of having a seizure
fbrsi  -  i am able to enjoy life
fksi - 15  -  i have a lack of energy
fksi - 15  -  bothered by treatment side effect
fksi - 15  -  i have pain
fksi - 15  -  i am losing weight
fksi - 15  -  i have bone pain
fksi - 15  -  i feel fatigued
20q11 .1
fksi - 15  -  i am able to enjoy life
fksi - 15  -  i have been short of breath
fksi - 15  -  worry my condition will get worse
fksi - 15  -  i have a good appetite
fksi - 15  -  i have been coughing
fksi - 15  -  i am bothered by fevers
fksi - 15  -  i am able to work
fksi - 15  -  i have had blood in my urine
fksi - 15  -  i am sleeping well
flsi  -  i have been short of breath
21q11 .2
flsi  -  i have a lack of energy
flsi  -  i have pain
flsi  -  i am losing weight
flsi  -  i have been coughing
flsi  -  certain parts of body have pain
pedsql neuromuscular module acute version 3 .0 child report  -  hard to breathe
pedsql neuromuscular module acute version 3 .0 child report  -  get sick easily
pedsql neuromuscular module acute version 3 .0 child report  -  get sores and / or rashes
pedsql neuromuscular module acute version 3 .0 child report  -  legs hurt
pedsql neuromuscular module acute version 3 .0 child report  -  feel tired
1p36 .1
pedsql neuromuscular module acute version 3 .0 child report  -  back feels stiff
pedsql neuromuscular module acute version 3 .0 child report  -  wake up tired
pedsql neuromuscular module acute version 3 .0 child report  -  hands are weak
pedsql neuromuscular module acute version 3 .0 child report  -  hard to use bathroom
pedsql neuromuscular module acute version 3 .0 child report  -  hard to gain or lose weight
pedsql neuromuscular module acute version 3 .0 child report  -  hard to use hands
pedsql neuromuscular module acute version 3 .0 child report  -  hard to swallow food
pedsql neuromuscular module acute version 3 .0 child report  -  long time to bathe or shower
pedsql neuromuscular module acute version 3 .0 child report  -  get hurt accidentally
pedsql neuromuscular module acute version 3 .0 child report  -  take long time to eat
12q13 .1
pedsql neuromuscular module acute version 3 .0 child report  -  hard to turn during night
pedsql neuromuscular module acute version 3 .0 child report  -  hard to go places with equipment
pedsql neuromuscular module acute version 3 .0 child report  -  hard tell doctors and nurses how feel
pedsql neuromuscular module acute version 3 .0 child report  -  hard ask doctors and nurses questions
pedsql neuromuscular module acute version 3 .0 child report  -  hard explain illness to people
pedsql neuromuscular module acute version 3 .0 child report  -  hard for family to plan activities
pedsql neuromuscular module acute version 3 .0 child report  -  hard for family to rest
pedsql neuromuscular module acute version 3 .0 child report  -  money problem in our family
pedsql neuromuscular module acute version 3 .0 child report  -  family has lot of problems
pedsql neuromuscular module acute version 3 .0 child report  -  do not have equipment need
7p14 - p13
pedsql neuromuscular module acute version 3 .0 parent of toddler  -  hard to breathe
pedsql neuromuscular module acute version 3 .0 parent of toddler  -  get sick easily
pedsql neuromuscular module acute version 3 .0 parent of toddler  -  get sores and / or rashes
pedsql neuromuscular module acute version 3 .0 parent of toddler  -  legs hurt
pedsql neuromuscular module acute version 3 .0 parent of toddler  -  feel tired
pedsql neuromuscular module acute version 3 .0 parent of toddler  -  back feels stiff
pedsql neuromuscular module acute version 3 .0 parent of toddler  -  wake up tired
pedsql neuromuscular module acute version 3 .0 parent of toddler  -  hands are weak
pedsql neuromuscular module acute version 3 .0 parent of toddler  -  hard to use bathroom
pedsql neuromuscular module acute version 3 .0 parent of toddler  -  hard to gain or lose weight
levonantradol
2q34 - q35
pedsql neuromuscular module acute version 3 .0 parent of toddler  -  hard to use hands
pedsql neuromuscular module acute version 3 .0 parent of toddler  -  hard to swallow food
pedsql neuromuscular module acute version 3 .0 parent of toddler  -  long time to bathe or shower
pedsql neuromuscular module acute version 3 .0 parent of toddler  -  get hurt accidentally
pedsql neuromuscular module acute version 3 .0 parent of toddler  -  take long time to eat
pedsql neuromuscular module acute version 3 .0 parent of toddler  -  hard to turn during night
pedsql neuromuscular module acute version 3 .0 parent of toddler  -  hard to go places with equipment
pedsql neuromuscular module acute version 3 .0 parent of toddler  -  hard tell doctors and nurses how feel
pedsql neuromuscular module acute version 3 .0 parent of toddler  -  hard ask doctors and nurses questions
pedsql neuromuscular module acute version 3 .0 parent of toddler  -  hard explain illness to people
6p25
pedsql neuromuscular module acute version 3 .0 parent of toddler  -  hard for family to plan activities
pedsql neuromuscular module acute version 3 .0 parent of toddler  -  hard for family to rest
pedsql neuromuscular module acute version 3 .0 parent of toddler  -  money problem in our family
pedsql neuromuscular module acute version 3 .0 parent of toddler  -  family has lot of problems
pedsql neuromuscular module acute version 3 .0 parent of toddler  -  do not have equipment need
pedsql neuromuscular module acute version 3 .0 parent report for child  -  hard to breathe
pedsql neuromuscular module acute version 3 .0 parent report for child  -  get sick easily
pedsql neuromuscular module acute version 3 .0 parent report for child  -  get sores and / or rashes
pedsql neuromuscular module acute version 3 .0 parent report for child  -  legs hurt
pedsql neuromuscular module acute version 3 .0 parent report for child  -  feel tired
16q24 .2 - q24 .3
pedsql neuromuscular module acute version 3 .0 parent report for child  -  back feels stiff
pedsql neuromuscular module acute version 3 .0 parent report for child  -  wake up tired
pedsql neuromuscular module acute version 3 .0 parent report for child  -  hands are weak
pedsql neuromuscular module acute version 3 .0 parent report for child  -  hard to use bathroom
pedsql neuromuscular module acute version 3 .0 parent report for child  -  hard to gain or lose weight
pedsql neuromuscular module acute version 3 .0 parent report for child  -  hard to use hands
pedsql neuromuscular module acute version 3 .0 parent report for child  -  hard to swallow food
pedsql neuromuscular module acute version 3 .0 parent report for child  -  long time to bathe or shower
pedsql neuromuscular module acute version 3 .0 parent report for child  -  get hurt accidentally
pedsql neuromuscular module acute version 3 .0 parent report for child  -  take long time to eat
1p33 - p31
pedsql neuromuscular module acute version 3 .0 parent report for child  -  hard to turn during night
pedsql neuromuscular module acute version 3 .0 parent report for child  -  hard to go places with equipment
pedsql neuromuscular module acute version 3 .0 parent report for child  -  hard tell doctors and nurses how feel
pedsql neuromuscular module acute version 3 .0 parent report for child  -  hard ask doctors and nurses questions
pedsql neuromuscular module acute version 3 .0 parent report for child  -  hard explain illness to people
pedsql neuromuscular module acute version 3 .0 parent report for child  -  hard for family to plan activities
pedsql neuromuscular module acute version 3 .0 parent report for child  -  hard for family to rest
pedsql neuromuscular module acute version 3 .0 parent report for child  -  money problem in our family
pedsql neuromuscular module acute version 3 .0 parent report for child  -  family has lot of problems
pedsql neuromuscular module acute version 3 .0 parent report for child  -  do not have equipment need
5q35 .1 - qter
pedsql neuromuscular module acute version 3 .0 parent report for teen  -  hard to breathe
pedsql neuromuscular module acute version 3 .0 parent report for teen  -  get sick easily
pedsql neuromuscular module acute version 3 .0 parent report for teen  -  get sores and / or rashes
pedsql neuromuscular module acute version 3 .0 parent report for teen  -  legs hurt
pedsql neuromuscular module acute version 3 .0 parent report for teen  -  feel tired
pedsql neuromuscular module acute version 3 .0 parent report for teen  -  back feels stiff
pedsql neuromuscular module acute version 3 .0 parent report for teen  -  wake up tired
pedsql neuromuscular module acute version 3 .0 parent report for teen  -  hands are weak
pedsql neuromuscular module acute version 3 .0 parent report for teen  -  hard to use bathroom
pedsql neuromuscular module acute version 3 .0 parent report for teen  -  hard to gain or lose weight
11p15 .2 - p14 .3
pedsql neuromuscular module acute version 3 .0 parent report for teen  -  hard to use hands
pedsql neuromuscular module acute version 3 .0 parent report for teen  -  hard to swallow food
pedsql neuromuscular module acute version 3 .0 parent report for teen  -  long time to bathe or shower
pedsql neuromuscular module acute version 3 .0 parent report for teen  -  get hurt accidentally
pedsql neuromuscular module acute version 3 .0 parent report for teen  -  take long time to eat
pedsql neuromuscular module acute version 3 .0 parent report for teen  -  hard to turn during night
pedsql neuromuscular module acute version 3 .0 parent report for teen  -  hard to go places with equipment
pedsql neuromuscular module acute version 3 .0 parent report for teen  -  hard tell doctors and nurses how feel
pedsql neuromuscular module acute version 3 .0 parent report for teen  -  hard ask doctors and nurses questions
pedsql neuromuscular module acute version 3 .0 parent report for teen  -  hard explain illness to people
1p31
pedsql neuromuscular module acute version 3 .0 parent report for teen  -  hard for family to plan activities
pedsql neuromuscular module acute version 3 .0 parent report for teen  -  hard for family to rest
pedsql neuromuscular module acute version 3 .0 parent report for teen  -  money problem in our family
pedsql neuromuscular module acute version 3 .0 parent report for teen  -  family has lot of problems
pedsql neuromuscular module acute version 3 .0 parent report for teen  -  do not have equipment need
pedsql neuromuscular module acute version 3 .0 parent report for young adults  -  hard to breathe
pedsql neuromuscular module acute version 3 .0 parent report for young adults  -  get sick easily
pedsql neuromuscular module acute version 3 .0 parent report for young adults  -  get sores and / or rashes
pedsql neuromuscular module acute version 3 .0 parent report for young adults  -  legs hurt
pedsql neuromuscular module acute version 3 .0 parent report for young adults  -  feel tired
17q24
pedsql neuromuscular module acute version 3 .0 parent report for young adults  -  back feels stiff
pedsql neuromuscular module acute version 3 .0 parent report for young adults  -  wake up tired
pedsql neuromuscular module acute version 3 .0 parent report for young adults  -  hands are weak
pedsql neuromuscular module acute version 3 .0 parent report for young adults  -  hard to use bathroom
pedsql neuromuscular module acute version 3 .0 parent report for young adults  -  hard to gain or lose weight
pedsql neuromuscular module acute version 3 .0 parent report for young adults  -  hard to use hands
pedsql neuromuscular module acute version 3 .0 parent report for young adults  -  hard to swallow food
pedsql neuromuscular module acute version 3 .0 parent report for young adults  -  long time to bathe or shower
pedsql neuromuscular module acute version 3 .0 parent report for young adults  -  get hurt accidentally
pedsql neuromuscular module acute version 3 .0 parent report for young adults  -  take long time to eat
16q23 .1
pedsql neuromuscular module acute version 3 .0 parent report for young adults  -  hard to turn during night
pedsql neuromuscular module acute version 3 .0 parent report for young adults  -  hard to go places with equipment
pedsql neuromuscular module acute version 3 .0 parent report for young adults  -  hard tell doctors and nurses how feel
pedsql neuromuscular module acute version 3 .0 parent report for young adults  -  hard ask doctors and nurses questions
pedsql neuromuscular module acute version 3 .0 parent report for young adults  -  hard explain illness to people
pedsql neuromuscular module acute version 3 .0 parent report for young adults  -  hard for family to plan activities
pedsql neuromuscular module acute version 3 .0 parent report for young adults  -  hard for family to rest
pedsql neuromuscular module acute version 3 .0 parent report for young adults  -  money problem in our family
pedsql neuromuscular module acute version 3 .0 parent report for young adults  -  family has lot of problems
pedsql neuromuscular module acute version 3 .0 parent report for young adults  -  do not have equipment need
20q13 .2
pedsql neuromuscular module acute version 3 .0 parent report for young child  -  hard to breathe
pedsql neuromuscular module acute version 3 .0 parent report for young child  -  get sick easily
pedsql neuromuscular module acute version 3 .0 parent report for young child  -  get sores and / or rashes
pedsql neuromuscular module acute version 3 .0 parent report for young child  -  legs hurt
pedsql neuromuscular module acute version 3 .0 parent report for young child  -  feel tired
pedsql neuromuscular module acute version 3 .0 parent report for young child  -  back feels stiff
pedsql neuromuscular module acute version 3 .0 parent report for young child  -  wake up tired
pedsql neuromuscular module acute version 3 .0 parent report for young child  -  hands are weak
pedsql neuromuscular module acute version 3 .0 parent report for young child  -  hard to use bathroom
pedsql neuromuscular module acute version 3 .0 parent report for young child  -  hard to gain or lose weight
isosulfan blue
1p21 - p13 .3
pedsql neuromuscular module acute version 3 .0 parent report for young child  -  hard to use hands
pedsql neuromuscular module acute version 3 .0 parent report for young child  -  hard to swallow food
pedsql neuromuscular module acute version 3 .0 parent report for young child  -  long time to bathe or shower
pedsql neuromuscular module acute version 3 .0 parent report for young child  -  get hurt accidentally
pedsql neuromuscular module acute version 3 .0 parent report for young child  -  take long time to eat
pedsql neuromuscular module acute version 3 .0 parent report for young child  -  hard to turn during night
pedsql neuromuscular module acute version 3 .0 parent report for young child  -  hard to go places with equipment
pedsql neuromuscular module acute version 3 .0 parent report for young child  -  hard tell doctors and nurses how feel
pedsql neuromuscular module acute version 3 .0 parent report for young child  -  hard ask doctors and nurses questions
pedsql neuromuscular module acute version 3 .0 parent report for young child  -  hard explain illness to people
7q11 .1
pedsql neuromuscular module acute version 3 .0 parent report for young child  -  hard for family to plan activities
pedsql neuromuscular module acute version 3 .0 parent report for young child  -  hard for family to rest
pedsql neuromuscular module acute version 3 .0 parent report for young child  -  money problem in our family
pedsql neuromuscular module acute version 3 .0 parent report for young child  -  family has lot of problems
pedsql neuromuscular module acute version 3 .0 parent report for young child  -  do not have equipment need
pedsql neuromuscular module acute version 3 .0 teen report  -  hard to breathe
pedsql neuromuscular module acute version 3 .0 teen report  -  get sick easily
pedsql neuromuscular module acute version 3 .0 teen report  -  get sores and / or rashes
pedsql neuromuscular module acute version 3 .0 teen report  -  legs hurt
pedsql neuromuscular module acute version 3 .0 teen report  -  feel tired
17q23
pedsql neuromuscular module acute version 3 .0 teen report  -  back feels stiff
pedsql neuromuscular module acute version 3 .0 teen report  -  wake up tired
pedsql neuromuscular module acute version 3 .0 teen report  -  hands are weak
pedsql neuromuscular module acute version 3 .0 teen report  -  hard to use bathroom
pedsql neuromuscular module acute version 3 .0 teen report  -  hard to gain or lose weight
pedsql neuromuscular module acute version 3 .0 teen report  -  hard to use hands
pedsql neuromuscular module acute version 3 .0 teen report  -  hard to swallow food
pedsql neuromuscular module acute version 3 .0 teen report  -  long time to bathe or shower
pedsql neuromuscular module acute version 3 .0 teen report  -  get hurt accidentally
pedsql neuromuscular module acute version 3 .0 teen report  -  take long time to eat
20q13 .13
pedsql neuromuscular module acute version 3 .0 teen report  -  hard to turn during night
pedsql neuromuscular module acute version 3 .0 teen report  -  hard to go places with equipment
pedsql neuromuscular module acute version 3 .0 teen report  -  hard tell doctors and nurses how feel
pedsql neuromuscular module acute version 3 .0 teen report  -  hard ask doctors and nurses questions
pedsql neuromuscular module acute version 3 .0 teen report  -  hard explain illness to people
pedsql neuromuscular module acute version 3 .0 teen report  -  hard for family to plan activities
pedsql neuromuscular module acute version 3 .0 teen report  -  hard for family to rest
pedsql neuromuscular module acute version 3 .0 teen report  -  money problem in our family
pedsql neuromuscular module acute version 3 .0 teen report  -  family has lot of problems
pedsql neuromuscular module acute version 3 .0 teen report  -  do not have equipment need
2p16 .3
pedsql neuromuscular module acute version 3 .0 young adult report  -  hard to breathe
pedsql neuromuscular module acute version 3 .0 young adult report  -  get sick easily
pedsql neuromuscular module acute version 3 .0 young adult report  -  get sores and / or rashes
pedsql neuromuscular module acute version 3 .0 young adult report  -  legs hurt
pedsql neuromuscular module acute version 3 .0 young adult report  -  feel tired
pedsql neuromuscular module acute version 3 .0 young adult report  -  back feels stiff
pedsql neuromuscular module acute version 3 .0 young adult report  -  wake up tired
pedsql neuromuscular module acute version 3 .0 young adult report  -  hands are weak
pedsql neuromuscular module acute version 3 .0 young adult report  -  hard to use bathroom
pedsql neuromuscular module acute version 3 .0 young adult report  -  hard to gain or lose weight
10q22 - q23
pedsql neuromuscular module acute version 3 .0 young adult report  -  hard to use hands
pedsql neuromuscular module acute version 3 .0 young adult report  -  hard to swallow food
pedsql neuromuscular module acute version 3 .0 young adult report  -  long time to bathe or shower
pedsql neuromuscular module acute version 3 .0 young adult report  -  get hurt accidentally
pedsql neuromuscular module acute version 3 .0 young adult report  -  take long time to eat
pedsql neuromuscular module acute version 3 .0 young adult report  -  hard to turn during night
pedsql neuromuscular module acute version 3 .0 young adult report  -  hard to go places with equipment
pedsql neuromuscular module acute version 3 .0 young adult report  -  hard tell doctors and nurses how feel
pedsql neuromuscular module acute version 3 .0 young adult report  -  hard ask doctors and nurses questions
pedsql neuromuscular module acute version 3 .0 young adult report  -  hard explain illness to people
14q31 .1
pedsql neuromuscular module acute version 3 .0 young adult report  -  hard for family to plan activities
pedsql neuromuscular module acute version 3 .0 young adult report  -  hard for family to rest
pedsql neuromuscular module acute version 3 .0 young adult report  -  money problem in our family
pedsql neuromuscular module acute version 3 .0 young adult report  -  family has lot of problems
pedsql neuromuscular module acute version 3 .0 young adult report  -  do not have equipment need
pedsql neuromuscular module acute version 3 .0 young child report  -  hard to breathe
pedsql neuromuscular module acute version 3 .0 young child report  -  get sick easily
pedsql neuromuscular module acute version 3 .0 young child report  -  get sores and / or rashes
pedsql neuromuscular module acute version 3 .0 young child report  -  legs hurt
pedsql neuromuscular module acute version 3 .0 young child report  -  feel tired
15q21 .2
pedsql neuromuscular module acute version 3 .0 young child report  -  back feels stiff
pedsql neuromuscular module acute version 3 .0 young child report  -  wake up tired
pedsql neuromuscular module acute version 3 .0 young child report  -  hands are weak
pedsql neuromuscular module acute version 3 .0 young child report  -  hard to use bathroom
pedsql neuromuscular module acute version 3 .0 young child report  -  hard to gain or lose weight
pedsql neuromuscular module acute version 3 .0 young child report  -  hard to use hands
pedsql neuromuscular module acute version 3 .0 young child report  -  hard to swallow food
pedsql neuromuscular module acute version 3 .0 young child report  -  long time to bathe or shower
pedsql neuromuscular module acute version 3 .0 young child report  -  get hurt accidentally
pedsql neuromuscular module acute version 3 .0 young child report  -  take long time to eat
13q21
pedsql neuromuscular module acute version 3 .0 young child report  -  hard to turn during night
pedsql neuromuscular module acute version 3 .0 young child report  -  hard to go places with equipment
pedsql neuromuscular module version 3 .0 child report  -  hard to breathe
pedsql neuromuscular module version 3 .0 child report  -  get sick easily
pedsql neuromuscular module version 3 .0 child report  -  get sores and / or rashes
pedsql neuromuscular module version 3 .0 child report  -  legs hurt
pedsql neuromuscular module version 3 .0 child report  -  feel tired
pedsql neuromuscular module version 3 .0 child report  -  back feels stiff
pedsql neuromuscular module version 3 .0 child report  -  wake up tired
pedsql neuromuscular module version 3 .0 child report  -  hands are weak
10q11 - p12
pedsql neuromuscular module version 3 .0 child report  -  hard to use bathroom
pedsql neuromuscular module version 3 .0 child report  -  hard to gain or lose weight
pedsql neuromuscular module version 3 .0 child report  -  hard to use hands
pedsql neuromuscular module version 3 .0 child report  -  hard to swallow food
pedsql neuromuscular module version 3 .0 child report  -  long time to bathe or shower
pedsql neuromuscular module version 3 .0 child report  -  get hurt accidentally
pedsql neuromuscular module version 3 .0 child report  -  take long time to eat
pedsql neuromuscular module version 3 .0 child report  -  hard to turn during night
pedsql neuromuscular module version 3 .0 child report  -  hard to go places with equipment
pedsql neuromuscular module version 3 .0 child report  -  hard tell doctors and nurses how feel
mage - 1 antigen
11q13 .1 - q13 .2
pedsql neuromuscular module version 3 .0 child report  -  hard ask doctors and nurses questions
pedsql neuromuscular module version 3 .0 child report  -  hard explain illness to people
pedsql neuromuscular module version 3 .0 child report  -  hard for family to plan activities
pedsql neuromuscular module version 3 .0 child report  -  hard for family to rest
pedsql neuromuscular module version 3 .0 child report  -  money problem in our family
pedsql neuromuscular module version 3 .0 child report  -  family has lot of problems
pedsql neuromuscular module version 3 .0 child report  -  do not have equipment need
pedsql neuromuscular module version 3 .0 parent of toddler  -  hard to breathe
pedsql neuromuscular module version 3 .0 parent of toddler  -  get sick easily
pedsql neuromuscular module version 3 .0 parent of toddler  -  get sores and / or rashes
8p22 - p21 .3
pedsql neuromuscular module version 3 .0 parent of toddler  -  legs hurt
pedsql neuromuscular module version 3 .0 parent of toddler  -  feel tired
pedsql neuromuscular module version 3 .0 parent of toddler  -  back feels stiff
pedsql neuromuscular module version 3 .0 parent of toddler  -  wake up tired
pedsql neuromuscular module version 3 .0 parent of toddler  -  hands are weak
pedsql neuromuscular module version 3 .0 parent of toddler  -  hard to use bathroom
pedsql neuromuscular module version 3 .0 parent of toddler  -  hard to gain or lose weight
pedsql neuromuscular module version 3 .0 parent of toddler  -  hard to use hands
pedsql neuromuscular module version 3 .0 parent of toddler  -  hard to swallow food
pedsql neuromuscular module version 3 .0 parent of toddler  -  long time to bathe or shower
13q13 .3
pedsql neuromuscular module version 3 .0 parent of toddler  -  get hurt accidentally
pedsql neuromuscular module version 3 .0 parent of toddler  -  take long time to eat
pedsql neuromuscular module version 3 .0 parent of toddler  -  hard to turn during night
pedsql neuromuscular module version 3 .0 parent of toddler  -  hard to go places with equipment
pedsql neuromuscular module version 3 .0 parent of toddler  -  hard tell doctors and nurses how feel
pedsql neuromuscular module version 3 .0 parent of toddler  -  hard ask doctors and nurses questions
pedsql neuromuscular module version 3 .0 parent of toddler  -  hard explain illness to people
pedsql neuromuscular module version 3 .0 parent of toddler  -  hard for family to plan activities
pedsql neuromuscular module version 3 .0 parent of toddler  -  hard for family to rest
pedsql neuromuscular module version 3 .0 parent of toddler  -  money problem in our family
5q13 .1
pedsql neuromuscular module version 3 .0 parent of toddler  -  family has lot of problems
pedsql neuromuscular module version 3 .0 parent of toddler  -  do not have equipment need
pedsql neuromuscular module version 3 .0 parent report for child  -  hard to breathe
pedsql neuromuscular module version 3 .0 parent report for child  -  get sick easily
pedsql neuromuscular module version 3 .0 parent report for child  -  get sores and / or rashes
pedsql neuromuscular module version 3 .0 parent report for child  -  legs hurt
pedsql neuromuscular module version 3 .0 parent report for child  -  feel tired
pedsql neuromuscular module version 3 .0 parent report for child  -  back feels stiff
pedsql neuromuscular module version 3 .0 parent report for child  -  wake up tired
pedsql neuromuscular module version 3 .0 parent report for child  -  hands are weak
5q12 - q13
pedsql neuromuscular module version 3 .0 parent report for child  -  hard to use bathroom
pedsql neuromuscular module version 3 .0 parent report for child  -  hard to gain or lose weight
pedsql neuromuscular module version 3 .0 parent report for child  -  hard to use hands
pedsql neuromuscular module version 3 .0 parent report for child  -  hard to swallow food
pedsql neuromuscular module version 3 .0 parent report for child  -  long time to bathe or shower
pedsql neuromuscular module version 3 .0 parent report for child  -  get hurt accidentally
pedsql neuromuscular module version 3 .0 parent report for child  -  take long time to eat
pedsql neuromuscular module version 3 .0 parent report for child  -  hard to turn during night
pedsql neuromuscular module version 3 .0 parent report for child  -  hard to go places with equipment
pedsql neuromuscular module version 3 .0 parent report for child  -  hard tell doctors and nurses how feel
xp11 .21 - p11 .22
pedsql neuromuscular module version 3 .0 parent report for child  -  hard ask doctors and nurses questions
pedsql neuromuscular module version 3 .0 parent report for child  -  hard explain illness to people
pedsql neuromuscular module version 3 .0 parent report for child  -  hard for family to plan activities
pedsql neuromuscular module version 3 .0 parent report for child  -  hard for family to rest
pedsql neuromuscular module version 3 .0 parent report for child  -  money problem in our family
pedsql neuromuscular module version 3 .0 parent report for child  -  family has lot of problems
pedsql neuromuscular module version 3 .0 parent report for child  -  do not have equipment need
pedsql neuromuscular module version 3 .0 parent report for teen  -  hard to breathe
pedsql neuromuscular module version 3 .0 parent report for teen  -  get sick easily
pedsql neuromuscular module version 3 .0 parent report for teen  -  get sores and / or rashes
11q13 .1
pedsql neuromuscular module version 3 .0 parent report for teen  -  legs hurt
pedsql neuromuscular module version 3 .0 parent report for teen  -  feel tired
pedsql neuromuscular module version 3 .0 parent report for teen  -  back feels stiff
pedsql neuromuscular module version 3 .0 parent report for teen  -  wake up tired
pedsql neuromuscular module version 3 .0 parent report for teen  -  hands are weak
pedsql neuromuscular module version 3 .0 parent report for teen  -  hard to use bathroom
pedsql neuromuscular module version 3 .0 parent report for teen  -  hard to gain or lose weight
pedsql neuromuscular module version 3 .0 parent report for teen  -  hard to use hands
pedsql neuromuscular module version 3 .0 parent report for teen  -  hard to swallow food
pedsql neuromuscular module version 3 .0 parent report for teen  -  long time to bathe or shower
17p13 .2
pedsql neuromuscular module version 3 .0 parent report for teen  -  get hurt accidentally
pedsql neuromuscular module version 3 .0 parent report for teen  -  take long time to eat
pedsql neuromuscular module version 3 .0 parent report for teen  -  hard to turn during night
pedsql neuromuscular module version 3 .0 parent report for teen  -  hard to go places with equipment
pedsql neuromuscular module version 3 .0 parent report for teen  -  hard tell doctors and nurses how feel
pedsql neuromuscular module version 3 .0 parent report for teen  -  hard ask doctors and nurses questions
pedsql neuromuscular module version 3 .0 parent report for teen  -  hard explain illness to people
pedsql neuromuscular module version 3 .0 parent report for teen  -  hard for family to plan activities
pedsql neuromuscular module version 3 .0 parent report for teen  -  hard for family to rest
pedsql neuromuscular module version 3 .0 parent report for teen  -  money problem in our family
22q13 .2 - q13 .31
pedsql neuromuscular module version 3 .0 parent report for teen  -  family has lot of problems
pedsql neuromuscular module version 3 .0 parent report for teen  -  do not have equipment need
pedsql neuromuscular module version 3 .0 parent report for young adults report  -  hard to breathe
pedsql neuromuscular module version 3 .0 parent report for young adults report  -  get sick easily
pedsql neuromuscular module version 3 .0 parent report for young adults report  -  get sores and / or rashes
pedsql neuromuscular module version 3 .0 parent report for young adults report  -  legs hurt
pedsql neuromuscular module version 3 .0 parent report for young adults report  -  feel tired
pedsql neuromuscular module version 3 .0 parent report for young adults report  -  back feels stiff
pedsql neuromuscular module version 3 .0 parent report for young adults report  -  wake up tired
pedsql neuromuscular module version 3 .0 parent report for young adults report  -  hands are weak
1p31 - p22
pedsql neuromuscular module version 3 .0 parent report for young adults report  -  hard to use bathroom
pedsql neuromuscular module version 3 .0 parent report for young adults report  -  hard to gain or lose weight
pedsql neuromuscular module version 3 .0 parent report for young adults report  -  hard to use hands
pedsql neuromuscular module version 3 .0 parent report for young adults report  -  hard to swallow food
pedsql neuromuscular module version 3 .0 parent report for young adults report  -  long time to bathe or shower
pedsql neuromuscular module version 3 .0 parent report for young adults report  -  get hurt accidentally
pedsql neuromuscular module version 3 .0 parent report for young adults report  -  take long time to eat
pedsql neuromuscular module version 3 .0 parent report for young adults report  -  hard to turn during night
pedsql neuromuscular module version 3 .0 parent report for young adults report  -  hard to go places with equipment
pedsql neuromuscular module version 3 .0 parent report for young adults report  -  hard tell doctors and nurses how feel
hydrochlorothiazide - triamterene
2p21
pedsql neuromuscular module version 3 .0 parent report for young adults report  -  hard ask doctors and nurses questions
pedsql neuromuscular module version 3 .0 parent report for young adults report  -  hard explain illness to people
pedsql neuromuscular module version 3 .0 parent report for young adults report  -  hard for family to plan activities
pedsql neuromuscular module version 3 .0 parent report for young adults report  -  hard for family to rest
pedsql neuromuscular module version 3 .0 parent report for young adults report  -  money problem in our family
pedsql neuromuscular module version 3 .0 parent report for young adults report  -  family has lot of problems
pedsql neuromuscular module version 3 .0 parent report for young adults report  -  do not have equipment need
pedsql neuromuscular module version 3 .0 parent report for young child  -  hard to breathe
pedsql neuromuscular module version 3 .0 parent report for young child  -  get sick easily
pedsql neuromuscular module version 3 .0 parent report for young child  -  get sores and / or rashes
1q32
pedsql neuromuscular module version 3 .0 parent report for young child  -  legs hurt
pedsql neuromuscular module version 3 .0 parent report for young child  -  feel tired
pedsql neuromuscular module version 3 .0 parent report for young child  -  back feels stiff
pedsql neuromuscular module version 3 .0 parent report for young child  -  wake up tired
pedsql neuromuscular module version 3 .0 parent report for young child  -  hands are weak
pedsql neuromuscular module version 3 .0 parent report for young child  -  hard to use bathroom
pedsql neuromuscular module version 3 .0 parent report for young child  -  hard to gain or lose weight
pedsql neuromuscular module version 3 .0 parent report for young child  -  hard to use hands
pedsql neuromuscular module version 3 .0 parent report for young child  -  hard to swallow food
pedsql neuromuscular module version 3 .0 parent report for young child  -  long time to bathe or shower
17q11 - q21 .3
pedsql neuromuscular module version 3 .0 parent report for young child  -  get hurt accidentally
pedsql neuromuscular module version 3 .0 parent report for young child  -  take long time to eat
pedsql neuromuscular module version 3 .0 parent report for young child  -  hard to turn during night
pedsql neuromuscular module version 3 .0 parent report for young child  -  hard to go places with equipment
pedsql neuromuscular module version 3 .0 parent report for young child  -  hard tell doctors and nurses how feel
pedsql neuromuscular module version 3 .0 parent report for young child  -  hard ask doctors and nurses questions
pedsql neuromuscular module version 3 .0 parent report for young child  -  hard explain illness to people
pedsql neuromuscular module version 3 .0 parent report for young child  -  hard for family to plan activities
pedsql neuromuscular module version 3 .0 parent report for young child  -  hard for family to rest
pedsql neuromuscular module version 3 .0 parent report for young child  -  money problem in our family
15q22 .2
pedsql neuromuscular module version 3 .0 parent report for young child  -  family has lot of problems
pedsql neuromuscular module version 3 .0 parent report for young child  -  do not have equipment need
pedsql neuromuscular module version 3 .0 teen report  -  hard to breathe
pedsql neuromuscular module version 3 .0 teen report  -  get sick easily
pedsql neuromuscular module version 3 .0 teen report  -  get sores and / or rashes
pedsql neuromuscular module version 3 .0 teen report  -  legs hurt
pedsql neuromuscular module version 3 .0 teen report  -  feel tired
pedsql neuromuscular module version 3 .0 teen report  -  back feels stiff
pedsql neuromuscular module version 3 .0 teen report  -  wake up tired
pedsql neuromuscular module version 3 .0 teen report  -  hands are weak
20pter - q12
pedsql neuromuscular module version 3 .0 teen report  -  hard to use bathroom
pedsql neuromuscular module version 3 .0 teen report  -  hard to gain or lose weight
pedsql neuromuscular module version 3 .0 teen report  -  hard to use hands
pedsql neuromuscular module version 3 .0 teen report  -  hard to swallow food
pedsql neuromuscular module version 3 .0 teen report  -  long time to bathe or shower
pedsql neuromuscular module version 3 .0 teen report  -  get hurt accidentally
pedsql neuromuscular module version 3 .0 teen report  -  take long time to eat
pedsql neuromuscular module version 3 .0 teen report  -  hard to turn during night
pedsql neuromuscular module version 3 .0 teen report  -  hard to go places with equipment
pedsql neuromuscular module version 3 .0 teen report  -  hard tell doctors and nurses how feel
1q42 .1 - q43
pedsql neuromuscular module version 3 .0 teen report  -  hard ask doctors and nurses questions
pedsql neuromuscular module version 3 .0 teen report  -  hard explain illness to people
pedsql neuromuscular module version 3 .0 teen report  -  hard for family to plan activities
pedsql neuromuscular module version 3 .0 teen report  -  hard for family to rest
pedsql neuromuscular module version 3 .0 teen report  -  money problem in our family
pedsql neuromuscular module version 3 .0 teen report  -  family has lot of problems
pedsql neuromuscular module version 3 .0 teen report  -  do not have equipment need
pedsql neuromuscular module version 3 .0 young adult report  -  hard to breathe
pedsql neuromuscular module version 3 .0 young adult report  -  get sick easily
pedsql neuromuscular module version 3 .0 young adult report  -  get sores and / or rashes
22q11 .23
pedsql neuromuscular module version 3 .0 young adult report  -  legs hurt
pedsql neuromuscular module version 3 .0 young adult report  -  feel tired
pedsql neuromuscular module version 3 .0 young adult report  -  back feels stiff
pedsql neuromuscular module version 3 .0 young adult report  -  wake up tired
pedsql neuromuscular module version 3 .0 young adult report  -  hands are weak
pedsql neuromuscular module version 3 .0 young adult report  -  hard to use bathroom
pedsql neuromuscular module version 3 .0 young adult report  -  hard to gain or lose weight
pedsql neuromuscular module version 3 .0 young adult report  -  hard to use hands
pedsql neuromuscular module version 3 .0 young adult report  -  hard to swallow food
pedsql neuromuscular module version 3 .0 young adult report  -  long time to bathe or shower
1p35
pedsql neuromuscular module version 3 .0 young adult report  -  get hurt accidentally
pedsql neuromuscular module version 3 .0 young adult report  -  take long time to eat
pedsql neuromuscular module version 3 .0 young adult report  -  hard to turn during night
pedsql neuromuscular module version 3 .0 young adult report  -  hard to go places with equipment
pedsql neuromuscular module version 3 .0 young adult report  -  hard tell doctors and nurses how feel
pedsql neuromuscular module version 3 .0 young adult report  -  hard ask doctors and nurses questions
pedsql neuromuscular module version 3 .0 young adult report  -  hard explain illness to people
pedsql neuromuscular module version 3 .0 young adult report  -  hard for family to plan activities
pedsql neuromuscular module version 3 .0 young adult report  -  hard for family to rest
pedsql neuromuscular module version 3 .0 young adult report  -  money problem in our family
4q22
pedsql neuromuscular module version 3 .0 young adult report  -  family has lot of problems
pedsql neuromuscular module version 3 .0 young adult report  -  do not have equipment need
pedsql neuromuscular module version 3 .0 young child report  -  hard to breathe
pedsql neuromuscular module version 3 .0 young child report  -  get sick easily
pedsql neuromuscular module version 3 .0 young child report  -  get sores and / or rashes
pedsql neuromuscular module version 3 .0 young child report  -  legs hurt
pedsql neuromuscular module version 3 .0 young child report  -  feel tired
pedsql neuromuscular module version 3 .0 young child report  -  back feels stiff
pedsql neuromuscular module version 3 .0 young child report  -  wake up tired
pedsql neuromuscular module version 3 .0 young child report  -  hands are weak
16q12
pedsql neuromuscular module version 3 .0 young child report  -  hard to use bathroom
pedsql neuromuscular module version 3 .0 young child report  -  hard to gain or lose weight
pedsql neuromuscular module version 3 .0 young child report  -  hard to use hands
pedsql neuromuscular module version 3 .0 young child report  -  hard to swallow food
pedsql neuromuscular module version 3 .0 young child report  -  long time to bathe or shower
pedsql neuromuscular module version 3 .0 young child report  -  get hurt accidentally
pedsql neuromuscular module version 3 .0 young child report  -  take long time to eat
pedsql neuromuscular module version 3 .0 young child report  -  hard to turn during night
pedsql neuromuscular module version 3 .0 young child report  -  hard to go places with equipment
double - expressor lymphoma
menogaril
17q22 - q23
neoplastic cells with double expression of myc and bcl2 proteins present
body mass index finding
egfr np_005219 .2:p .d770_n771insgv
egfr np_005219 .2:p .m766_a767insasv
egfr np_005219 .2:p .p772_h773insnp
egfr np_005219 .2:p .p772_v774insphv
g - 8 screening tool
decline of food intake over past 3 months
weight loss over past 3 months
had neuropsychological problems
1q21
take more than 3 medications per day
egfr np_005219 .2:p .p772_h773insnph
comparison of health status
egfr nm_005228 .3:c .2310_2311insggcaca
severe decrease in food intake
moderate decrease in food intake
egfr np_005219 .2:p .d770_n771insgt
no decrease in food intake
weight loss greater than three kilograms
weight loss between 1 and 3 kilograms
10q23 .2 - q23 .3
egfr nm_005228 .3:c .2320_2321inscccacg
no weight loss
bed or chair bound
able to get out of bed or chair but does not go out
egfr np_005219 .2:p .h773_v774insah
goes out
severe dementia or depression
mild dementia or depression
no psychological problems
not as good as others
8p11
as good as others
better than others
body mass index less than 19
body mass index 19 to less than 21
body mass index 21 to less than 23
body mass index greater than or equal to 23
age greater than 85 years
age between 80 and 85 years
age less than 80 years
psa level less than or equal to fifteen
11p15 .2 - p15 .1
psa level greater than or equal to 0 .1
pdgfr positive
kit positive
abl positive
pdgfrb positive
psa level less than or equal to ten
psa level greater than 0 .2
ctag2 positive
psa level greater than two
psa level greater than one
7p21 .3
igf1 positive
heregulin positive
psa level greater than or equal to 0 .2
ar negative
nos2 positive
gucy2c positive
hpv self - collection
uterus absent
uterus present
12p13 .32
pregnancy status at time of illness or condition
psa level finding
high risk myelodysplastic syndrome
recurrent high risk myelodysplastic syndrome
refractory high risk myelodysplastic syndrome
basophilic focus
16p13 .12
reticulocyte corpuscular hemoglobin concentration mean
derived synovial fluid cell
derived peripheral blood mononuclear cell
derived dental pulp
glandular  ( acinar )  / tubular differentiation score
glandular  ( acinar )  / tubular differentiation score 1
glandular  ( acinar )  / tubular differentiation score 2
glandular  ( acinar )  / tubular differentiation score 3
nuclear pleomorphism score
nuclear pleomorphism score 1
20q12 - q13 .2
nuclear pleomorphism score 2
nuclear pleomorphism score 3
mitotic rate score
mitotic rate score 1
mitotic rate score 2
mitotic rate score 3
nottingham grade
nottingham grade 1
nottingham grade 2
nottingham grade 3
1q32 .2
product description / appearance
flumatinib
homogeneity assessment
material identification
copanlisib hydrochloride
capmatinib hydrochloride
icotinib
anlotinib
g - 8 screening tool total score
merbarone
19p13 .2 - p12
glioma lysate vaccine gbm6 - ad
refractory soft tissue sarcoma
recurrent soft tissue sarcoma
micellar nanoparticle - encapsulated epirubicin
pan - fgfr inhibitor ly2874455
nodal peripheral t - cell lymphoma of t follicular helper cell origin
durie / salmon stage
international staging system stage
plasma cell myeloma by ds stage
plasma cell myeloma by iss stage
17q11 .2 - q21 .1
neoplastic cells with tfh cell phenotype present
nodal peripheral t - cell lymphoma with tfh phenotype
breast implant - associated anaplastic large cell lymphoma
breast implant - related lesion
type d lymphomatoid papulosis
type e lymphomatoid papulosis
rearrangement of 6p25 .3
lymphomatoid papulosis with dusp22 - irf4 gene rearrangement
cdisc sdtm duchenne muscular dystrophy findings about test code terminology
cdisc sdtm duchenne muscular dystrophy findings about test name terminology
17q23 .1
cdisc protocol entities clinical trial attribute terminology
indolent t - cell lymphoproliferative disorder of the gastrointestinal tract
superficial monoclonal gastrointestinal tract t - cell infiltrate present
primary cutaneous acral cd8 - positive t - cell lymphoma
acral lesion
odor detection
florid follicular hyperplasia post - transplant lymphoproliferative disorder
florid follicular hyperplasia
8q24 .1 - q24 .3
thrlbcl - like transformation of nlphl
estimated systolic blood pressure
cross - sectional diameter
aortic coarctation indicator
aortic preductal coarctation severity
aortic juxta - ductal coarctation severity
aortic postductal coarctation severity
aortic coarctation severity
aneurysm indicator
dissection indicator
14q24
stanford aortic dissection classification
debakey aortic dissection classification
annular plane systolic excursion
myocardial performance index
peak pressure rise rate
annular s' velocity
pericardial effusion indicator
pericardial effusion size
maximal pericardial effusion width
observed cardiac device type
14q11 .2 - q12
native cardiac valve intervention type
prosthetic cardiac valve type
minor axis cross - sectional diameter at mid ventricular systole
major axis cross - sectional diameter at mid ventricular systole
number of cardiac valve cusps
cardiac valvular regurgitation indicator
cardiac valvular regurgitation likely etiology
eccentric regurgitant jet indicator
major axis internal diameter at end ventricular systole
major axis internal diameter at end ventricular diastole
bir domain
minor axis internal diameter at end ventricular systole
minor axis internal diameter at end ventricular diastole
heart chamber enlargement indicator
heart chamber hypertrophy indicator
lymphoid cell count
glucose - 6 - phosphate dehydrogenase activity
corpuscular hemoglobin content
corpuscular hemoglobin concentration mean
corpuscular hemoglobin concentration distribution width
reticulocyte corpuscular hemoglobin distribution width
ubc domain
reticulocyte hemoglobin distribution width
red cell volume distribution width standard deviation
reticulocyte volume distribution width coefficient of variation
reticulocyte volume distribution width standard deviation
reticulocyte volume distribution width
functional fibrinogen measurement
nordazepam measurement
clorazepate measurement
halazepam measurement
medazepam measurement
22q13 .3
prazepam measurement
flunitrazepam measurement
clonazepam measurement
midazolam measurement
carbon monoxide measurement
hiv - 1 / 2 antibody and hiv - 1 p24 antigen measurement
hcv antibody signal to hcv antibody cutoff ratio measurement
calcium to phosphorus ratio measurement
n - terminal proa - type natriuretic peptide measurement
toxoplasma gondii igg antibody measurement
2q12 .3
toxoplasma gondii igm antibody measurement
alkaline phosphatase isoenzyme measurement
number of malignant biopsy cores
mismatch repair proteins interpretation
mutl homolog 1 measurement
muts homolog 2 measurement
muts homolog 6 measurement
pms1 homolog 2 measurement
cdx2 antigen measurement
bradykinin receptor b1 measurement
recombinant macrophage inflammatory protein - 1 alpha
12q24 .21
citrobacter werkmanii
extended - spectrum beta - lactamase positive klebsiella pneumoniae
extended - spectrum beta - lactamase positive klebsiella oxytoca
non - mucoid pseudomonas aeruginosa
mucoid pseudomonas aeruginosa
small - colony variant pseudomonas aeruginosa
arthrographis
non - mucoid pseudomonas aeruginosa measurement
mucoid pseudomonas aeruginosa measurement
small - colony variant pseudomonas aeruginosa measurement
bcl - 2 homology domain
methicillin - resistant staphylococcus aureus measurement
methicillin - susceptible staphylococcus aureus measurement
stenotrophomonas maltophilia measurement
burkholderia measurement
microbial ec50 fold change from baseline
microbial ec50 fold change from reference
microbial ec50 reference control result
microbial ec50 subject result
microbial ic50 fold change from baseline
microbial ic50 fold change from reference
bh1 domain
microbial ic50 reference control result
microbial ic50 subject result
microbial ic95 fold change from baseline
microbial ic95 fold change from ref
microbial ic95 reference control result
microbial ic95 subject result
new non - target lesion identification
new target lesion identification
overall tracer uptake compared to baseline
accumulation ratio auc to last nonzero concentration
bh2 domain
minimum alveolar concentration 50 percent
hour times percent
second times kilopascal
liter per second per kilopascal
linear foot pound
kilocalorie per day
tissue rarefaction
basophilic hypertrophic focus
decreased cellularity present
decreased bone tissue
bh3 domain
increased bone tissue
dental dysplasia
denticle
dentin matrix alteration
dentin niche formation
decreased dentin
experimental organism fibro - osseous lesion
fibrous osteodystrophy
growth plate closed
increased osteoblastic surface
bh4 domain
increased osteoid
osteophyte
dental pulp concretion
decreased physis thickness
increased physis thickness
infiltrate and fibrosis
pathologic intimal thickening
intramural plaque
necrosis and infiltrate
necrosis and inflammation
11q22
intimal hyperplasia
stromal valvular proliferation
ethmoidal nasal turbinate
dorsal nasal turbinate
medial nasal turbinate
ventral nasal turbinate
trial registration indicator
source of monetary or material support for study
primary study sponsor name
secondary study sponsor name
2p11
country of recruitment
date of first enrollment into study
target sample size
secondary endpoint
device feasibility study
age at full - time use
extrapolation imputation technique
every seven days
every night
ten days per month
4q28 - q31
seven times per day
eight times per day
nine times per day
every forty - five minutes
rectal tumor to anal verge distance
anterior cingulate cortex
abdominal region
anterior superior iliac spine
capitate - hamate joint
capitate - lunate joint
8q21 .13
hand digit 2 distal phalanx
hand digit 3 distal phalanx
hand digit 4 distal phalanx
hand digit 5 distal phalanx
distal radioulnar joint
epigastric lymph node
esophageal lymph node
first dorsal interosseous muscle of the foot
first dorsal interosseous muscle of the hand
gingival mucosa
mitomycin b
2q21 - q22
triangular - hamate joint
cardiac wall
lateral humeral epicondyle
lunotriquetral joint
medial femoral condyle
periumbilical region
posterior superior iliac spine
iliotibial band
distal femur r1
reader 3
grip strength
pinch strength
range of motion ,  abduction
range of motion ,  extension
range of motion ,  dorsiflexion
isometric muscle strength ,  extension
isometric muscle strength ,  flexion
bone mineral density z - score
body fat percentage
lean body mass to total body mass ratio
wap domain
brooke modified medical research council manual muscle test score ,  extension
brooke modified medical research council manual muscle test score ,  plantar flexion
brooke modified medical research council manual muscle test score ,  flexion
brooke modified medical research council manual muscle test score ,  abduction
brooke modified medical research council manual muscle test score ,  lateral rotation
brooke modified medical research council manual muscle test score ,  dorsiflexion
brooke modified medical research council manual muscle test score ,  inversion
brooke modified medical research council manual muscle test score ,  eversion
medical research council manual muscle test score ,  extension
medical research council manual muscle test score ,  plantar flexion
3p22 - p21 .3
medical research council manual muscle test score ,  flexion
medical research council manual muscle test score ,  abduction
medical research council manual muscle test score ,  lateral rotation
medical research council manual muscle test score ,  dorsiflexion
medical research council manual muscle test score ,  inversion
medical research council manual muscle test score ,  eversion
failure to meet continuation criteria
randomized by mistake
randomized by mistake with study treatment
randomized by mistake without study treatment
3q13 .1 - q13 .2
non - compliance with non - study device
non - compliance with study device
number of eye chart lines read
forced expiratory volume in 0 .05 second to fvc ratio measurement
forced expiratory volume in 0 .1 second to fvc ratio measurement
forced expiratory volume in 0 .2 second to fvc ratio measurement
forced expiratory volume in 0 .05 second
forced expiratory volume in 0 .1 second
forced expiratory volume in 0 .2 second
forced expiratory volume at peak expiratory flow
11pter - p13
forced expiratory flow in 0 .05 second
forced expiratory flow in 0 .1 second
forced expiratory flow in 0 .2 second
forced expiratory flow at 50 percent forced vital capacity
pulmonary inertance
quasi - static compliance
salazar - knowles equation parameter a
salazar - knowles equation parameter b
salazar - knowles equation ,  k parameter
peak expiratory flow time
11q23 .1
tissue elastance
tissue hysteresivity measurement
forced expiratory volume in 0 .5 second
forced inspiratory vital capacity
pregnancy indicator
number of full term live births
number of premature live births
number of stillbirths
minimal risk
donor status at time of organ donation
17q23 - q25
deceased donor donation condition
cdc hiv high risk donor indicator
blinded status at sdtm dataset generation
clinical study report archive date
extension trial indicator
post authorization safety study indicator
planned treatment duration
protocol risk assessment
sample viability percent measurement
sample viability indicator
a260 to a280 ratio
a260 to a230 ratio
fluorescent tag type
number of nucleotide markers exhibiting instability
percent of nucleotide markers exhibiting instability
microsatellite instability overall status
microsatellite stability assessment
used family or friend's tablet
primary ebv - positive nodal t - cell or nk - cell lymphoma
glandular  ( acinar )  / tubular differentiation
cadherin domain
tp63 gene rearrangement
advanced head and neck squamous cell carcinoma
taf12 gene product
patient navigation program
ipss risk score
ipss risk category
ipss risk score 0
ipss risk score 0 .5 to 1 .0
ipss risk score 1 .5 to 2 .0
recombinant monocyte chemoattractant protein - 1
16p11 .2
ipss risk score greater than or equal to 2 .5
ipss risk category low
ipss risk category intermediate - 1
ipss risk category intermediate - 2
ipss risk category high
ras protein family activation assay
exascale computer system
genomic data commons
genomics of drug sensitivity in cancer
nci - 60 cell line
9q33
12q22
9q32
xq26
1q23
1q25
egf - like domain
disintegrin domain
17q11 - q12
breast cancer tnm finding v8
breast cancer clinical tnm finding v8
breast cancer clinical distant metastasis tnm finding v8
breast cancer cm0 tnm finding v8
breast cancer cm0 ( i +  )  tnm finding v8
breast cancer cm1 tnm finding v8
breast cancer clinical regional lymph nodes tnm finding v8
breast cancer cnx tnm finding v8
breast cancer cn0 tnm finding v8
breast cancer cn1 tnm finding v8
mifamurtide
9p11 .2
breast cancer cn1mi tnm finding v8
breast cancer cn2 tnm finding v8
breast cancer cn2a tnm finding v8
breast cancer cn2b tnm finding v8
breast cancer cn3 tnm finding v8
breast cancer cn3a tnm finding v8
breast cancer cn3b tnm finding v8
breast cancer cn3c tnm finding v8
breast cancer pathologic tnm finding v8
breast cancer pathologic distant metastasis tnm finding v8
14q32
breast cancer pm1 tnm finding v8
breast cancer pathologic primary tumor tnm finding v8
breast cancer ptx tnm finding v8
breast cancer pt0 tnm finding v8
breast cancer ptis  ( dcis )  tnm finding v8
breast cancer ptis  ( paget )  tnm finding v8
breast cancer pt1 tnm finding v8
breast cancer pt1mi tnm finding v8
breast cancer pt1a tnm finding v8
breast cancer pt1b tnm finding v8
17p13 - p12
breast cancer pt1c tnm finding v8
breast cancer pt2 tnm finding v8
breast cancer pt3 tnm finding v8
breast cancer pt4 tnm finding v8
breast cancer pt4a tnm finding v8
breast cancer pt4b tnm finding v8
breast cancer pt4c tnm finding v8
breast cancer pt4d tnm finding v8
breast cancer pathologic regional lymph nodes tnm finding v8
breast cancer pnx tnm finding v8
7q31 .1
breast cancer pn0 tnm finding v8
breast cancer pn0 ( i +  )  tnm finding v8
breast cancer pn0 ( mol +  )  tnm finding v8
breast cancer pn1 tnm finding v8
breast cancer pn1mi tnm finding v8
breast cancer pn1a tnm finding v8
breast cancer pn1b tnm finding v8
breast cancer pn1c tnm finding v8
breast cancer pn2 tnm finding v8
breast cancer pn2a tnm finding v8
8q21
breast cancer pn2b tnm finding v8
breast cancer pn3 tnm finding v8
breast cancer pn3a tnm finding v8
breast cancer pn3b tnm finding v8
breast cancer pn3c tnm finding v8
breast cancer anatomic stage
breast cancer prognostic stage
testing of device from same lot / batch returned from user
testing of device from other lot / batch retained by manufacturer
testing of device from other lot / batch returned from user
fha domain
testing of model variant
testing of raw / starting materials
testing of patient sample or reference material using manufacturer's device
testing of patient sample or reference material using reference method
testing of patient sample or reference material using competitor's device
historical data analysis
trend analysis
communication / interviews
analysis of data provided by user / third party
device not manufactured by reporting manufacturer
device not returned
device discarded
incomplete device returned
device not accessible for testing
type of investigation not yet determined
insufficient information available
appropriate term / code not available identified
patient sample problem
transport / storage problem identified
appropriate term / code not available problem
1p36 .11
cause cannot be traced to device
cause not established
cause traced to component failure
cause traced to environment
cause traced to transport / storage
falsified device
design change validation inadequate
design inadequate for purpose
human factors engineering  -  device difficult to assemble
human factors engineering  -  device difficult to operate
12p11 .1
human factors engineering  -  device difficult to reprocess
missing or inadequate safety measures problem
sabotage or intentional misuse
cytotoxicity problem identified
unintended presence of allergens
device incorrectly assembled during reprocessing
device incorrectly cleaned during reprocessing
device incorrectly disinfected / sterilized during reprocessing
network communication problem
electrical / electronic component problem identified
4q32 .2
unintended emission
ambient light problem identified
contamination of environment by device
environmental pressure problem identified
device not compatible with another device
unintended compatibility
inadequate or incorrect instructions for maintenance
maintenance of manufacturing machinery
inadequate physicochemical properties
incorrect dimension
vinorelbine tartrate
nucleoplasm
leakage / seal
incorrect interpretation of results / data
light source problem identified
packaging contains incorrect device
packaging contains unintended material
packaging materials problem
alarm system problem identified
fail - safe problem identified
missing or inadequate safety measures identified
premature indicator activation
nuclear pore complex
problem of device to self - test
problem to auto stop
reset problem
shielding problem
data storage or loss of data
erroneous data transfer
software maintenance problem identified
excessive cooling identified
excessive heating identified
inadequate cooling identified
5q35
overheating problem identified
change in target marker / variant / mutant
known interferent
new or unknown interferent
pre - analytical handling problem
adverse event related to commutability
adverse event related to procedure
not assessed
very little assistance
used family or friend's smartphone or tablet
20pter - p12
assistance installing the app
assistance with log - in
breast cancer by ajcc v8 stage
breast cancer by ajcc v8 anatomic stage
anatomic stage 0 breast cancer ajcc v8
anatomic stage i breast cancer ajcc v8
anatomic stage ia breast cancer ajcc v8
anatomic stage ib breast cancer ajcc v8
anatomic stage ii breast cancer ajcc v8
anatomic stage iia breast cancer ajcc v8
2q35 - q36
anatomic stage iib breast cancer ajcc v8
anatomic stage iii breast cancer ajcc v8
anatomic stage iiia breast cancer ajcc v8
anatomic stage iiib breast cancer ajcc v8
anatomic stage iiic breast cancer ajcc v8
anatomic stage iv breast cancer ajcc v8
anal ectopic fibroadenoma
fibroadenoma of anogenital mammary - type glands
vulvar composite hidradenoma papilliferum and fibroadenoma
anti - fcrh5 / cd3 bite antibody bfcr4350a
desmosome
ccr2 / ccr5 antagonist bms - 813160
oncolytic hsv - 1 rqnestin34 .5v .2
mevociclib
anti - cd40 agonist monoclonal antibody abbv - 927
breast cancer by ajcc v8 prognostic stage
prognostic stage 0 breast cancer ajcc v8
prognostic stage i breast cancer ajcc v8
prognostic stage ia breast cancer ajcc v8
prognostic stage ib breast cancer ajcc v8
shp2 inhibitor tno155
ef - hand domain
orilanolimab
upper abdomen
superior thoracic aperture
malignant neoplasm of lung  -  multiple primary sites
mediastinal lymph node dissection
en bloc resection
tunneled pleural catheter drainage
prognostic stage ii breast cancer ajcc v8
1q43 - q44
endobronchial stent placement
prognostic stage iia breast cancer ajcc v8
prognostic stage iib breast cancer ajcc v8
synchronous nodules with dominant lesion ( s )
synchronous nodules without dominant lesion ( s )
device incorrectly reprocessed
sterilization problem identified
stage r
stage r0
stage r1
3q26 .3
stage r2
stage rx
prognostic stage iii breast cancer ajcc v8
prognostic stage iiia breast cancer ajcc v8
prognostic stage iiib breast cancer ajcc v8
prognostic stage iiic breast cancer ajcc v8
prognostic stage iv breast cancer ajcc v8
mgmt gene promoter hypermethylation
female reproductive system cancer tnm finding v8
4q13 .3 - q21 .1
vulvar cancer tnm finding v8
vulvar cancer clinical tnm finding v8
vulvar cancer clinical distant metastasis tnm finding v8
vulvar cancer cm0 tnm finding v8
vulvar cancer cm1 tnm finding v8
vulvar cancer pathologic tnm finding v8
vulvar cancer pathologic distant metastasis tnm finding v8
vulvar cancer pm1 tnm finding v8
vulvar cancer pathologic primary tumor tnm finding v8
vulvar cancer ptx tnm finding v8
sam domain
vulvar cancer pt0 tnm finding v8
vulvar cancer pt1 tnm finding v8
vulvar cancer pt1a tnm finding v8
vulvar cancer pt1b tnm finding v8
vulvar cancer pt2 tnm finding v8
vulvar cancer pt3 tnm finding v8
vulvar cancer pathologic regional lymph nodes tnm finding v8
vulvar cancer pnx tnm finding v8
vulvar cancer pn0 tnm finding v8
vulvar cancer pn0 ( i +  )  tnm finding v8
15q22 .1 - q22 .33
vulvar cancer pn1 tnm finding v8
vulvar cancer pn1a tnm finding v8
vulvar cancer pn1b tnm finding v8
vulvar cancer pn2 tnm finding v8
vulvar cancer pn2a tnm finding v8
vulvar cancer pn2b tnm finding v8
vulvar cancer pn2c tnm finding v8
vulvar cancer pn3 tnm finding v8
vulvar cancer by ajcc v8 stage
stage i vulvar cancer ajcc v8
6p24 .3
stage ia vulvar cancer ajcc v8
stage ib vulvar cancer ajcc v8
stage ii vulvar cancer ajcc v8
stage iii vulvar cancer ajcc v8
stage iiia vulvar cancer ajcc v8
stage iiib vulvar cancer ajcc v8
stage iiic vulvar cancer ajcc v8
stage iv vulvar cancer ajcc v8
stage iva vulvar cancer ajcc v8
16p12 - p11 .2
stage ivb vulvar cancer ajcc v8
vaginal cancer tnm finding v8
vaginal cancer clinical tnm finding v8
vaginal cancer clinical distant metastasis tnm finding v8
vaginal cancer cm0 tnm finding v8
vaginal cancer cm1 tnm finding v8
vaginal cancer pathologic tnm finding v8
vaginal cancer pathologic distant metastasis tnm finding v8
vaginal cancer pm1 tnm finding v8
10q21 .1
vaginal cancer pathologic primary tumor tnm finding v8
vaginal cancer ptx tnm finding v8
vaginal cancer pt0 tnm finding v8
vaginal cancer pt1 tnm finding v8
vaginal cancer pt1a tnm finding v8
vaginal cancer pt1b tnm finding v8
vaginal cancer pt2 tnm finding v8
vaginal cancer pt2a tnm finding v8
vaginal cancer pt2b tnm finding v8
vaginal cancer pt3 tnm finding v8
trefoil motif
vaginal cancer pt4 tnm finding v8
alpha - glucosidase inhibitor
vaginal cancer pathologic regional lymph nodes tnm finding v8
vaginal cancer pnx tnm finding v8
vaginal cancer pn0 tnm finding v8
vaginal cancer pn0 ( i +  )  tnm finding v8
vaginal cancer pn1 tnm finding v8
vaginal cancer by ajcc v8 stage
stage i vaginal cancer ajcc v8
stage ia vaginal cancer ajcc v8
18p11 .32
stage ib vaginal cancer ajcc v8
stage ii vaginal cancer ajcc v8
stage iia vaginal cancer ajcc v8
cic / dux4 fusion gene
stage iib vaginal cancer ajcc v8
stage iii vaginal cancer ajcc v8
bcor / ccnb3 fusion gene
stage iv vaginal cancer ajcc v8
ewsr1 / pbx1 fusion gene
stage iva vaginal cancer ajcc v8
coiled - coil domain
stage ivb vaginal cancer ajcc v8
ccnb3 gene
ccnb3 wt allele
oligometastasis
g2 / mitotic - specific cyclin - b3
cic / dux4 fusion protein
bcor / ccnb3 fusion protein
ewsr1 / pbx1 fusion protein
used someone else's smartphone or tablet
8p23 .1
stepped palliative care
transformed follicular lymphoma to diffuse large b - cell lymphoma
cervical cancer tnm finding v8
cervical cancer clinical tnm finding v8
cervical cancer clinical distant metastasis tnm finding v8
cervical cancer cm0 tnm finding v8
cervical cancer cm1 tnm finding v8
cervical cancer clinical primary tumor tnm finding v8
cervical cancer ctx tnm finding v8
cervical cancer ct0 tnm finding v8
9p23
cervical cancer ct1 tnm finding v8
cervical cancer ct1b tnm finding v8
cervical cancer ct1b1 tnm finding v8
cervical cancer ct1b2 tnm finding v8
cervical cancer ct2 tnm finding v8
cervical cancer ct2a tnm finding v8
cervical cancer ct2a1 tnm finding v8
cervical cancer ct2a2 tnm finding v8
cervical cancer ct2b tnm finding v8
cervical cancer ct3 tnm finding v8
protein e6 ,  human papillomavirus type 16
26s atp - dependent proteasome
cervical cancer ct3a tnm finding v8
cervical cancer ct3b tnm finding v8
cervical cancer ct4 tnm finding v8
cervical cancer pathologic tnm finding v8
cervical cancer pathologic distant metastasis tnm finding v8
cervical cancer pm1 tnm finding v8
cervical cancer pathologic primary tumor tnm finding v8
cervical cancer ptx tnm finding v8
cervical cancer pt0 tnm finding v8
cervical cancer pt1 tnm finding v8
8q21 - q24
cervical cancer pt1a tnm finding v8
cervical cancer pt1a1 tnm finding v8
cervical cancer pt1a2 tnm finding v8
cervical cancer pt1b tnm finding v8
cervical cancer pt1b1 tnm finding v8
cervical cancer pt1b2 tnm finding v8
cervical cancer pt2 tnm finding v8
cervical cancer pt2a tnm finding v8
cervical cancer pt2a1 tnm finding v8
cervical cancer pt2a2 tnm finding v8
2p14 - p13
cervical cancer pt2b tnm finding v8
cervical cancer pt3 tnm finding v8
cervical cancer pt3a tnm finding v8
cervical cancer pt3b tnm finding v8
cervical cancer pt4 tnm finding v8
cervical cancer pathologic regional lymph nodes tnm finding v8
cervical cancer pnx tnm finding v8
cervical cancer pn0 tnm finding v8
cervical cancer pn0 ( i +  )  tnm finding v8
cervical cancer pn1 tnm finding v8
1q32 - q41
autologous actr - cd16 - cd28 - expressing t - lymphocytes actr707
ewsr1 / znf444 fusion gene
ewsr1 / znf444 fusion protein
cervical cancer by ajcc v8 stage
stage i cervical cancer ajcc v8
stage ia cervical cancer ajcc v8
stage ia1 cervical cancer ajcc v8
stage ia2 cervical cancer ajcc v8
stage ib cervical cancer ajcc v8
stage ib1 cervical cancer ajcc v8
trim motif
stage ib2 cervical cancer ajcc v8
status of tumor eligibility for definitive local therapy
stage ii cervical cancer ajcc v8
stage iia cervical cancer ajcc v8
stage iia1 cervical cancer ajcc v8
stage iia2 cervical cancer ajcc v8
biopsy specimen size
stage iib cervical cancer ajcc v8
stage iii cervical cancer ajcc v8
rsxpsxp motif
stage iiia cervical cancer ajcc v8
mediastinal lymph node sampling
stage iiib cervical cancer ajcc v8
stage iv cervical cancer ajcc v8
stage iva cervical cancer ajcc v8
stage ivb cervical cancer ajcc v8
isavuconazonium sulfate
uterine corpus carcinoma and carcinosarcoma tnm finding v8
uterine corpus carcinoma and carcinosarcoma clinical tnm finding v8
uterine corpus carcinoma and carcinosarcoma clinical distant metastasis tnm finding v8
rxy / fxpsxp motif
uterine corpus carcinoma and carcinosarcoma cm0 tnm finding v8
uterine corpus carcinoma and carcinosarcoma cm1 tnm finding v8
uterine corpus carcinoma and carcinosarcoma pathologic tnm finding v8
uterine corpus carcinoma and carcinosarcoma pathologic distant metastasis tnm finding v8
uterine corpus carcinoma and carcinosarcoma pm1 tnm finding v8
uterine corpus carcinoma and carcinosarcoma pathologic primary tumor tnm finding v8
uterine corpus carcinoma and carcinosarcoma ptx tnm finding v8
uterine corpus carcinoma and carcinosarcoma pt0 tnm finding v8
uterine corpus carcinoma and carcinosarcoma pt1 tnm finding v8
uterine corpus carcinoma and carcinosarcoma pt1a tnm finding v8
phosphoserine motif
uterine corpus carcinoma and carcinosarcoma pt1b tnm finding v8
uterine corpus carcinoma and carcinosarcoma pt2 tnm finding v8
uterine corpus carcinoma and carcinosarcoma pt3 tnm finding v8
uterine corpus carcinoma and carcinosarcoma pt3a tnm finding v8
uterine corpus carcinoma and carcinosarcoma pt3b tnm finding v8
uterine corpus carcinoma and carcinosarcoma pt4 tnm finding v8
uterine corpus carcinoma and carcinosarcoma pathologic regional lymph nodes tnm finding v8
uterine corpus carcinoma and carcinosarcoma pnx tnm finding v8
uterine corpus carcinoma and carcinosarcoma pn0 tnm finding v8
uterine corpus carcinoma and carcinosarcoma pn0 ( i +  )  tnm finding v8
14q21 - q22
uterine corpus carcinoma and carcinosarcoma pn1 tnm finding v8
uterine corpus carcinoma and carcinosarcoma pn1mi tnm finding v8
uterine corpus carcinoma and carcinosarcoma pn1a tnm finding v8
uterine corpus carcinoma and carcinosarcoma pn2 tnm finding v8
uterine corpus carcinoma and carcinosarcoma pn2mi tnm finding v8
uterine corpus carcinoma and carcinosarcoma pn2a tnm finding v8
blasts 50 percent or less of bone marrow nucleated cells
human anti - mouse antibodies positive
il2rb positive
cd8 positive
1q22 - q25
cd57 positive
psa level greater than 0 .1
psa level greater than or equal to five
steap1 positive
activating ptpn11 mutation
activating braf mutation
activating nras mutation
activating hras mutation
t - cell surface glycoprotein cd8
sparfosic acid
1q23 - q25
trastuzumab / tesirine antibody - drug conjugate adct - 502
uterine corpus cancer by ajcc v8 stage
stage i uterine corpus cancer ajcc v8
stage ia uterine corpus cancer ajcc v8
stage ib uterine corpus cancer ajcc v8
stage ii uterine corpus cancer ajcc v8
stage iii uterine corpus cancer ajcc v8
stage iiia uterine corpus cancer ajcc v8
stage iiib uterine corpus cancer ajcc v8
stage iiic uterine corpus cancer ajcc v8
17q11
stage iiic1 uterine corpus cancer ajcc v8
stage iiic2 uterine corpus cancer ajcc v8
stage iv uterine corpus cancer ajcc v8
stage iva uterine corpus cancer ajcc v8
stage ivb uterine corpus cancer ajcc v8
uterine corpus sarcoma tnm finding v8
uterine corpus leiomyosarcoma and endometrial stromal sarcoma tnm finding v8
uterine corpus leiomyosarcoma and endometrial stromal sarcoma clinical tnm finding v8
uterine corpus leiomyosarcoma and endometrial stromal sarcoma clinical distant metastasis tnm finding v8
uterine corpus leiomyosarcoma and endometrial stromal sarcoma cm0 tnm finding v8
12q11 - q14
uterine corpus leiomyosarcoma and endometrial stromal sarcoma cm1 tnm finding v8
uterine corpus leiomyosarcoma and endometrial stromal sarcoma pathologic tnm finding v8
uterine corpus leiomyosarcoma and endometrial stromal sarcoma pathologic distant metastasis tnm finding v8
uterine corpus leiomyosarcoma and endometrial stromal sarcoma pm1 tnm finding v8
uterine corpus leiomyosarcoma and endometrial stromal sarcoma pathologic primary tumor tnm finding v8
uterine corpus leiomyosarcoma and endometrial stromal sarcoma ptx tnm finding v8
uterine corpus leiomyosarcoma and endometrial stromal sarcoma pt0 tnm finding v8
uterine corpus leiomyosarcoma and endometrial stromal sarcoma pt1 tnm finding v8
uterine corpus leiomyosarcoma and endometrial stromal sarcoma pt1a tnm finding v8
uterine corpus leiomyosarcoma and endometrial stromal sarcoma pt1b tnm finding v8
cell junction
uterine corpus leiomyosarcoma and endometrial stromal sarcoma pt2 tnm finding v8
uterine corpus leiomyosarcoma and endometrial stromal sarcoma pt2a tnm finding v8
uterine corpus leiomyosarcoma and endometrial stromal sarcoma pt2b tnm finding v8
uterine corpus leiomyosarcoma and endometrial stromal sarcoma pt3 tnm finding v8
uterine corpus leiomyosarcoma and endometrial stromal sarcoma pt3a tnm finding v8
uterine corpus leiomyosarcoma and endometrial stromal sarcoma pt3b tnm finding v8
uterine corpus leiomyosarcoma and endometrial stromal sarcoma pt4 tnm finding v8
uterine corpus leiomyosarcoma and endometrial stromal sarcoma pathologic regional lymph nodes tnm finding v8
uterine corpus leiomyosarcoma and endometrial stromal sarcoma pnx tnm finding v8
uterine corpus leiomyosarcoma and endometrial stromal sarcoma pn0 tnm finding v8
anchoring junction
uterine corpus leiomyosarcoma and endometrial stromal sarcoma pn0 ( i +  )  tnm finding v8
uterine corpus leiomyosarcoma and endometrial stromal sarcoma pn1 tnm finding v8
uterine corpus adenosarcoma tnm finding v8
uterine corpus adenosarcoma clinical tnm finding v8
uterine corpus adenosarcoma clinical distant metastasis tnm finding v8
uterine corpus adenosarcoma cm0 tnm finding v8
uterine corpus adenosarcoma cm1 tnm finding v8
uterine corpus adenosarcoma pathologic tnm finding v8
uterine corpus adenosarcoma pathologic distant metastasis tnm finding v8
uterine corpus adenosarcoma pm1 tnm finding v8
fascia adherens
uterine corpus adenosarcoma pathologic primary tumor tnm finding v8
uterine corpus adenosarcoma ptx tnm finding v8
uterine corpus adenosarcoma pt0 tnm finding v8
uterine corpus adenosarcoma pt1 tnm finding v8
uterine corpus adenosarcoma pt1a tnm finding v8
uterine corpus adenosarcoma pt1b tnm finding v8
uterine corpus adenosarcoma pt1c tnm finding v8
uterine corpus adenosarcoma pt2 tnm finding v8
uterine corpus adenosarcoma pt2a tnm finding v8
uterine corpus adenosarcoma pt2b tnm finding v8
10q24 - q26
uterine corpus adenosarcoma pt3 tnm finding v8
uterine corpus adenosarcoma pt3a tnm finding v8
uterine corpus adenosarcoma pt3b tnm finding v8
uterine corpus adenosarcoma pt4 tnm finding v8
uterine corpus adenosarcoma pathologic regional lymph nodes tnm finding v8
uterine corpus adenosarcoma pnx tnm finding v8
uterine corpus adenosarcoma pn0 tnm finding v8
uterine corpus adenosarcoma pn0 ( i +  )  tnm finding v8
uterine corpus adenosarcoma pn1 tnm finding v8
uterine corpus sarcoma by ajcc v8 stage
2p13 - q13
uterine corpus leiomyosarcoma by ajcc v8 stage
stage i uterine corpus leiomyosarcoma ajcc v8
stage ia uterine corpus leiomyosarcoma ajcc v8
stage ib uterine corpus leiomyosarcoma ajcc v8
stage ii uterine corpus leiomyosarcoma ajcc v8
stage iii uterine corpus leiomyosarcoma ajcc v8
stage iiia uterine corpus leiomyosarcoma ajcc v8
stage iiib uterine corpus leiomyosarcoma ajcc v8
stage iiic uterine corpus leiomyosarcoma ajcc v8
stage iv uterine corpus leiomyosarcoma ajcc v8
5q31 .1
stage iva uterine corpus leiomyosarcoma ajcc v8
stage ivb uterine corpus leiomyosarcoma ajcc v8
uterine corpus endometrial stromal sarcoma by ajcc v8 stage
stage i uterine corpus endometrial stromal sarcoma ajcc v8
stage ia uterine corpus endometrial stromal sarcoma ajcc v8
stage ib uterine corpus endometrial stromal sarcoma ajcc v8
stage ii uterine corpus endometrial stromal sarcoma ajcc v8
stage iii uterine corpus endometrial stromal sarcoma ajcc v8
stage iiia uterine corpus endometrial stromal sarcoma ajcc v8
stage iiib uterine corpus endometrial stromal sarcoma ajcc v8
13q14 .3
stage iiic uterine corpus endometrial stromal sarcoma ajcc v8
stage iv uterine corpus endometrial stromal sarcoma ajcc v8
stage iva uterine corpus endometrial stromal sarcoma ajcc v8
stage ivb uterine corpus endometrial stromal sarcoma ajcc v8
uterine corpus adenosarcoma by ajcc v8 stage
stage i uterine corpus adenosarcoma ajcc v8
stage ia uterine corpus adenosarcoma ajcc v8
stage ib uterine corpus adenosarcoma ajcc v8
stage ic uterine corpus adenosarcoma ajcc v8
stage ii uterine corpus adenosarcoma ajcc v8
peplomycin
10q22 .1 - q23
stage iii uterine corpus adenosarcoma ajcc v8
stage iiia uterine corpus adenosarcoma ajcc v8
stage iiib uterine corpus adenosarcoma ajcc v8
stage iiic uterine corpus adenosarcoma ajcc v8
stage iv uterine corpus adenosarcoma ajcc v8
stage iva uterine corpus adenosarcoma ajcc v8
stage ivb uterine corpus adenosarcoma ajcc v8
nppa gene
nppa wt allele
nppa gene product
5q32 - q34
natriuretic peptides a
atrial natriuretic factor
nmb gene
nmb wt allele
nmb gene product
neuromedin - b precursor
neuromedin - b
esrrb gene
esrrb wt allele
steroid hormone receptor err2
2q33 - q36
slc39a4 gene
slc39a4 wt allele
zinc transporter zip4
breath carbon monoxide monitor
cage1 gene
cage1 wt allele
cancer - associated gene 1 protein
ovarian ,  fallopian tube ,  and primary peritoneal carcinoma tnm finding v8
ovarian ,  fallopian tube ,  and primary peritoneal carcinoma clinical tnm finding v8
ovarian ,  fallopian tube ,  and primary peritoneal carcinoma clinical distant metastasis tnm finding v8
1p35 - p31 .3
ovarian ,  fallopian tube ,  and primary peritoneal carcinoma cm0 tnm finding v8
ovarian ,  fallopian tube ,  and primary peritoneal carcinoma cm1 tnm finding v8
ovarian ,  fallopian tube ,  and primary peritoneal carcinoma cm1a tnm finding v8
ovarian ,  fallopian tube ,  and primary peritoneal carcinoma cm1b tnm finding v8
ovarian ,  fallopian tube ,  and primary peritoneal carcinoma pathologic tnm finding v8
ovarian ,  fallopian tube ,  and primary peritoneal carcinoma pathologic distant metastasis tnm finding v8
ovarian ,  fallopian tube ,  and primary peritoneal carcinoma pm1 tnm finding v8
ovarian ,  fallopian tube ,  and primary peritoneal carcinoma pm1a tnm finding v8
ovarian ,  fallopian tube ,  and primary peritoneal carcinoma pm1b tnm finding v8
ovarian ,  fallopian tube ,  and primary peritoneal carcinoma pathologic primary tumor tnm finding v8
12q22 - q23
ovarian ,  fallopian tube ,  and primary peritoneal carcinoma ptx tnm finding v8
ovarian ,  fallopian tube ,  and primary peritoneal carcinoma pt0 tnm finding v8
ovarian ,  fallopian tube ,  and primary peritoneal carcinoma pt1 tnm finding v8
ovarian ,  fallopian tube ,  and primary peritoneal carcinoma pt1a tnm finding v8
ovarian ,  fallopian tube ,  and primary peritoneal carcinoma pt1b tnm finding v8
ovarian ,  fallopian tube ,  and primary peritoneal carcinoma pt1c tnm finding v8
ovarian ,  fallopian tube ,  and primary peritoneal carcinoma pt1c1 tnm finding v8
ovarian ,  fallopian tube ,  and primary peritoneal carcinoma pt1c2 tnm finding v8
ovarian ,  fallopian tube ,  and primary peritoneal carcinoma pt1c3 tnm finding v8
ovarian ,  fallopian tube ,  and primary peritoneal carcinoma pt2 tnm finding v8
9q22 .32
ovarian ,  fallopian tube ,  and primary peritoneal carcinoma pt2a tnm finding v8
ovarian ,  fallopian tube ,  and primary peritoneal carcinoma pt2b tnm finding v8
ovarian ,  fallopian tube ,  and primary peritoneal carcinoma pt3 tnm finding v8
ovarian ,  fallopian tube ,  and primary peritoneal carcinoma pt3a tnm finding v8
ovarian ,  fallopian tube ,  and primary peritoneal carcinoma pt3b tnm finding v8
ovarian ,  fallopian tube ,  and primary peritoneal carcinoma pt3c tnm finding v8
ovarian ,  fallopian tube ,  and primary peritoneal carcinoma pathologic regional lymph nodes tnm finding v8
ovarian ,  fallopian tube ,  and primary peritoneal carcinoma pnx tnm finding v8
ovarian ,  fallopian tube ,  and primary peritoneal carcinoma pn0 tnm finding v8
ovarian ,  fallopian tube ,  and primary peritoneal carcinoma pn0 ( i +  )  tnm finding v8
7q22
ovarian ,  fallopian tube ,  and primary peritoneal carcinoma pn1 tnm finding v8
ovarian ,  fallopian tube ,  and primary peritoneal carcinoma pn1a tnm finding v8
ovarian ,  fallopian tube ,  and primary peritoneal carcinoma pn1b tnm finding v8
ovarian cancer by ajcc v8 stage
stage i ovarian cancer ajcc v8
stage ia ovarian cancer ajcc v8
stage ib ovarian cancer ajcc v8
stage ic ovarian cancer ajcc v8
stage ii ovarian cancer ajcc v8
stage iia ovarian cancer ajcc v8
7q21 - q22
stage iib ovarian cancer ajcc v8
stage iii ovarian cancer ajcc v8
stage iiia ovarian cancer ajcc v8
stage iiia1 ovarian cancer ajcc v8
stage iiia2 ovarian cancer ajcc v8
stage iiib ovarian cancer ajcc v8
stage iiic ovarian cancer ajcc v8
stage iv ovarian cancer ajcc v8
stage iva ovarian cancer ajcc v8
stage ivb ovarian cancer ajcc v8
6q24 - q25
stage iiia1
stage iiia2
pre - operative evaluation
fallopian tube cancer by ajcc v8 stage
stage i fallopian tube cancer ajcc v8
stage ia fallopian tube cancer ajcc v8
stage ib fallopian tube cancer ajcc v8
stage ic fallopian tube cancer ajcc v8
stage ii fallopian tube cancer ajcc v8
stage iia fallopian tube cancer ajcc v8
15q24 - q25
stage iib fallopian tube cancer ajcc v8
stage iii fallopian tube cancer ajcc v8
stage iiia fallopian tube cancer ajcc v8
stage iiia1 fallopian tube cancer ajcc v8
stage iiia2 fallopian tube cancer ajcc v8
stage iiib fallopian tube cancer ajcc v8
stage iiic fallopian tube cancer ajcc v8
stage iv fallopian tube cancer ajcc v8
stage iva fallopian tube cancer ajcc v8
stage ivb fallopian tube cancer ajcc v8
peplomycin sulfate
15q21 .1 - q21 .2
pax9 gene
pax9 wt allele
paired box protein pax - 9
primary peritoneal cancer by ajcc v7 stage
primary peritoneal cancer by ajcc v8 stage
stage ii primary peritoneal cancer ajcc v8
stage iia primary peritoneal cancer ajcc v8
stage iib primary peritoneal cancer ajcc v8
stage iii primary peritoneal cancer ajcc v8
stage iiia primary peritoneal cancer ajcc v8
1p35 .1 - p36 .23
stage iiib primary peritoneal cancer ajcc v8
stage iiic primary peritoneal cancer ajcc v8
stage iv primary peritoneal cancer ajcc v8
stage iva primary peritoneal cancer ajcc v8
stage ivb primary peritoneal cancer ajcc v8
gestational trophoblastic neoplasm tnm finding v8
gestational trophoblastic neoplasm clinical tnm finding v8
gestational trophoblastic neoplasm clinical distant metastasis tnm finding v8
gestational trophoblastic neoplasm cm0 tnm finding v8
gestational trophoblastic neoplasm cm1 tnm finding v8
8q22 .3 - q23
gestational trophoblastic neoplasm cm1a tnm finding v8
gestational trophoblastic neoplasm cm1b tnm finding v8
gestational trophoblastic neoplasm pathologic tnm finding v8
gestational trophoblastic neoplasm pathologic distant metastasis tnm finding v8
gestational trophoblastic neoplasm pm1 tnm finding v8
gestational trophoblastic neoplasm pm1a tnm finding v8
gestational trophoblastic neoplasm pm1b tnm finding v8
gestational trophoblastic neoplasm pathologic primary tumor tnm finding v8
gestational trophoblastic neoplasm ptx tnm finding v8
gestational trophoblastic neoplasm pt0 tnm finding v8
4q26 - q32
gestational trophoblastic neoplasm pt1 tnm finding v8
gestational trophoblastic neoplasm pt2 tnm finding v8
gestational trophoblastic tumor by ajcc v7 stage
gestational trophoblastic neoplasm by ajcc v8 stage
stage i gestational trophoblastic neoplasm ajcc v8
stage ii gestational trophoblastic neoplasm ajcc v8
stage iii gestational trophoblastic neoplasm ajcc v8
stage iv gestational trophoblastic neoplasm ajcc v8
npipb8 gene
npipb8 wt allele
3p21 .1
nuclear pore complex - interacting protein family member b8
tigit - targeting agent mk - 7684
plasma transfusion
male reproductive system cancer tnm finding v8
penile cancer tnm finding v8
penile cancer clinical tnm finding v8
penile cancer clinical distant metastasis tnm finding v8
penile cancer cm0 tnm finding v8
penile cancer cm1 tnm finding v8
penile cancer clinical regional lymph nodes tnm finding v8
2p12
penile cancer cnx tnm finding v8
penile cancer cn0 tnm finding v8
penile cancer cn1 tnm finding v8
penile cancer cn2 tnm finding v8
penile cancer cn3 tnm finding v8
penile cancer pathologic tnm finding v8
penile cancer pathologic distant metastasis tnm finding v8
penile cancer pm1 tnm finding v8
penile cancer pathologic primary tumor tnm finding v8
penile cancer ptx tnm finding v8
4p13
penile cancer pt0 tnm finding v8
penile cancer ptis tnm finding v8
penile cancer pta tnm finding v8
penile cancer pt1 tnm finding v8
penile cancer pt1a tnm finding v8
penile cancer pt1b tnm finding v8
penile cancer pt2 tnm finding v8
penile cancer pt3 tnm finding v8
penile cancer pt4 tnm finding v8
penile cancer pathologic regional lymph nodes tnm finding v8
2p13 .1
penile cancer pnx tnm finding v8
penile cancer pn0 tnm finding v8
penile cancer pn1 tnm finding v8
penile cancer pn2 tnm finding v8
penile cancer pn3 tnm finding v8
penile cancer by ajcc v8 stage
stage 0 penile cancer ajcc v8
stage 0is penile cancer ajcc v8
stage 0a penile cancer ajcc v8
stage i penile cancer ajcc v8
20p12
stage ii penile cancer ajcc v8
stage iia penile cancer ajcc v8
stage iib penile cancer ajcc v8
stage iii penile cancer ajcc v8
stage iiia penile cancer ajcc v8
stage iiib penile cancer ajcc v8
stage iv penile cancer ajcc v8
cdkn2b - as1 gene
cdkn2b - as1 wt allele
4p14 - q21
cdkn2b antisense rna 1
refractory transformed non - hodgkin lymphoma
aspametdex regimen
avd regimen
br regimen
r - dhap regimen
ivac regimen
dose - adjusted epoch - r regimen
devic regimen
r - eshap regimen
piperazinedione
6p11 .1
gdp regimen
r - gdp regimen
cytarabine / high - dose methotrexate regimen
cytarabine / high - dose methotrexate / rituximab regimen
r - hyper - cvad regimen
ive regimen
matrix regimen
mrt regimen
mpv regimen
r - mpv regimen
6p24 - p23
nordic regimen
r - bac regimen
r - squared regimen
smile regimen
vipd regimen
r - hypercvad alternating with high - dose mtx arac regimen
lpa gene
lpa wt allele
apolipoprotein ( a )
prostate cancer tnm finding v8
1p35 - p32
prostate cancer clinical tnm finding v8
prostate cancer clinical distant metastasis tnm finding v8
prostate cancer cm0 tnm finding v8
prostate cancer cm1 tnm finding v8
prostate cancer cm1a tnm finding v8
prostate cancer cm1b tnm finding v8
prostate cancer cm1c tnm finding v8
prostate cancer clinical primary tumor tnm finding v8
prostate cancer ctx tnm finding v8
prostate cancer ct0 tnm finding v8
12pter - p12
prostate cancer ct1 tnm finding v8
prostate cancer ct1a tnm finding v8
prostate cancer ct1b tnm finding v8
prostate cancer ct1c tnm finding v8
prostate cancer ct2 tnm finding v8
prostate cancer ct2a tnm finding v8
c5orf67 gene
prostate cancer ct2b tnm finding v8
prostate cancer ct2c tnm finding v8
prostate cancer ct3 tnm finding v8
3q13 .3 - q21
c5orf67 wt allele
prostate cancer ct3a tnm finding v8
prostate cancer ct3b tnm finding v8
prostate cancer ct4 tnm finding v8
uncharacterized protein c5orf67
prostate cancer pathologic tnm finding v8
prostate cancer pathologic distant metastasis tnm finding v8
prostate cancer pm1 tnm finding v8
prostate cancer pm1a tnm finding v8
prostate cancer pm1b tnm finding v8
10q22 .3
prostate cancer pm1c tnm finding v8
prostate cancer pathologic primary tumor tnm finding v8
prostate cancer pt2 tnm finding v8
prostate cancer pt3 tnm finding v8
prostate cancer pt3a tnm finding v8
prostate cancer pt3b tnm finding v8
prostate cancer pt4 tnm finding v8
prostate cancer pathologic regional lymph nodes tnm finding v8
prostate cancer pnx tnm finding v8
prostate cancer pn0 tnm finding v8
2q33 - q34
prostate cancer pn1 tnm finding v8
whitmore - jewett stage
personalized cancer vaccine ro7198457
prostate cancer by ajcc v8 stage
stage i prostate cancer ajcc v8
stage ii prostate cancer ajcc v8
stage iia prostate cancer ajcc v8
stage iib prostate cancer ajcc v8
stage iic prostate cancer ajcc v8
stage iii prostate cancer ajcc v8
xp22 .2
stage iiia prostate cancer ajcc v8
stage iiib prostate cancer ajcc v8
stage iiic prostate cancer ajcc v8
stage iv prostate cancer ajcc v8
stage iva prostate cancer ajcc v8
stage ivb prostate cancer ajcc v8
msantd1 gene
subviral satellite
msantd1 wt allele
myb / sant - like dna - binding domain - containing protein 1
8p21
regimen used to treat central nervous system neoplasm
celsr2 gene
celsr2 wt allele
cadherin egf lag seven - pass g - type receptor 2
hla - a1101 positive cells present
post - mastectomy pain syndrome
testicular cancer tnm finding v8
testicular cancer clinical tnm finding v8
testicular cancer clinical distant metastasis tnm finding v8
testicular cancer cm0 tnm finding v8
21q21 .2
testicular cancer cm1 tnm finding v8
testicular cancer cm1a tnm finding v8
testicular cancer cm1b tnm finding v8
testicular cancer clinical primary tumor tnm finding v8
testicular cancer ctx tnm finding v8
testicular cancer ct0 tnm finding v8
testicular cancer ctis tnm finding v8
testicular cancer ct4 tnm finding v8
testicular cancer clinical regional lymph nodes tnm finding v8
testicular cancer cnx tnm finding v8
prednisolone sodium phosphate
3p14 .3 - p14 .2
testicular cancer cn0 tnm finding v8
testicular cancer cn1 tnm finding v8
testicular cancer cn2 tnm finding v8
testicular cancer cn3 tnm finding v8
testicular cancer pathologic tnm finding v8
testicular cancer pathologic distant metastasis tnm finding v8
testicular cancer pm1 tnm finding v8
testicular cancer pm1a tnm finding v8
testicular cancer pm1b tnm finding v8
testicular cancer pathologic primary tumor tnm finding v8
4q13 .1
testicular cancer ptx tnm finding v8
testicular cancer pt0 tnm finding v8
testicular cancer ptis tnm finding v8
testicular cancer pt1 tnm finding v8
testicular cancer pt1a tnm finding v8
testicular cancer pt1b tnm finding v8
testicular cancer pt2 tnm finding v8
testicular cancer pt3 tnm finding v8
testicular cancer pt4 tnm finding v8
testicular cancer pathologic regional lymph nodes tnm finding v8
22q12 .1
testicular cancer pnx tnm finding v8
testicular cancer pn0 tnm finding v8
testicular cancer pn1 tnm finding v8
testicular cancer pn2 tnm finding v8
testicular cancer pn3 tnm finding v8
testicular cancer by ajcc v8 stage
stage 0 testicular cancer ajcc v8
stage i testicular cancer ajcc v8
stage ia testicular cancer ajcc v8
stage ib testicular cancer ajcc v8
xq22 - q23
stage is testicular cancer ajcc v8
stage ii testicular cancer ajcc v8
stage iia testicular cancer ajcc v8
stage iib testicular cancer ajcc v8
stage iic testicular cancer ajcc v8
stage iii testicular cancer ajcc v8
stage iiia testicular cancer ajcc v8
stage iiib testicular cancer ajcc v8
1q22
stage iiic testicular cancer ajcc v8
testicular cancer by ajcc v6 and v7 stage
bsnd gene
bsnd wt allele
barttin
gpr15 gene
gpr15 wt allele
g - protein coupled receptor 15
nras nm_002524 .4:c .35g > t
nras np_002515 .1:p .g12v
13p12
hras nm_005343 .3:c .35g > t
hras protein variant
hras nm_005343 .3:c .35_36delgcinsta
hras np_005334 .1:p .g12v
rreb1 gene
rreb1 wt allele
ras - responsive element - binding protein 1
percutaneous breast biopsy
enneking staging system
enneking surgical grade
8q24 .3
enneking low surgical grade
enneking high surgical grade
enneking tumor type
intracompartmental tumor
genetic macular dystrophy
extracompartmental tumor
enneking metastasis
hereditary spastic paraplegia
hereditary cerebellar ataxia
4p16
international society of pediatric oncology staging system
children's oncology group / national wilms' tumor study group staging system
siop / cog / nwtsg staging system
urinary tract cancer tnm finding v8
kidney cancer tnm finding v8
kidney cancer clinical tnm finding v8
kidney cancer clinical distant metastasis tnm finding v8
kidney cancer cm0 tnm finding v8
kidney cancer cm1 tnm finding v8
kidney cancer pathologic tnm finding v8
19q12
kidney cancer pathologic distant metastasis tnm finding v8
kidney cancer pm1 tnm finding v8
kidney cancer pathologic primary tumor tnm finding v8
kidney cancer ptx tnm finding v8
kidney cancer pt0 tnm finding v8
kidney cancer pt1 tnm finding v8
kidney cancer pt1a tnm finding v8
kidney cancer pt1b tnm finding v8
kidney cancer pt2 tnm finding v8
kidney cancer pt2a tnm finding v8
15q15 .2
kidney cancer pt2b tnm finding v8
kidney cancer pt3 tnm finding v8
kidney cancer pt3a tnm finding v8
kidney cancer pt3b tnm finding v8
kidney cancer pt3c tnm finding v8
kidney cancer pt4 tnm finding v8
kidney cancer pathologic regional lymph nodes tnm finding v8
kidney cancer pnx tnm finding v8
kidney cancer pn0 tnm finding v8
kidney cancer pn1 tnm finding v8
prednisolone sodium succinate
20q13 .2 - q13 .3
ilf2 gene
siop / cog / nwtsg stage i
siop / cog / nwtsg y - stage i
siop / cog / nwtsg stage ii
siop / cog / nwtsg y - stage ii
siop / cog / nwtsg stage iii
siop / cog / nwtsg y - stage iii
siop / cog / nwtsg stage iv
ilf2 wt allele
interleukin enhancer - binding factor 2
4q34 .1 - q34 .3
autologous anti - bcma - car - 4 - 1bb - cd3zeta - expressing memory t - lymphocytes bb21217
nelfe gene
nelfe wt allele
immune - related response evaluation criteria in solid tumors
negative elongation factor e
irrecist partial response
irrecist complete response
irrecist stable disease
irrecist no baseline disease
irrecist progressive disease
6q26 - q27
irrecist non - evaluable
irrecist no disease
renal cell cancer by ajcc v8 stage
stage i renal cell cancer ajcc v8
stage ii renal cell cancer ajcc v8
stage iii renal cell cancer ajcc v8
stage iv renal cell cancer ajcc v8
volumetric laser endomicroscopy
advanced non - functioning well differentiated neuroendocrine neoplasm
metastatic non - functioning well differentiated neuroendocrine neoplasm
4p16 .3
blasts 25 percent or more of bone marrow nucleated cells
renal pelvis and ureter cancer tnm finding v8
renal pelvis and ureter cancer clinical tnm finding v8
renal pelvis and ureter cancer clinical distant metastasis tnm finding v8
renal pelvis and ureter cancer cm0 tnm finding v8
renal pelvis and ureter cancer cm1 tnm finding v8
renal pelvis and ureter cancer pathologic tnm finding v8
renal pelvis and ureter cancer pathologic distant metastasis tnm finding v8
renal pelvis and ureter cancer pm1 tnm finding v8
renal pelvis and ureter cancer pathologic primary tumor tnm finding v8
20q12 - q13 .1
renal pelvis and ureter cancer ptx tnm finding v8
renal pelvis and ureter cancer pt0 tnm finding v8
renal pelvis and ureter cancer pta tnm finding v8
renal pelvis and ureter cancer ptis tnm finding v8
renal pelvis and ureter cancer pt1 tnm finding v8
renal pelvis and ureter cancer pt2 tnm finding v8
renal pelvis and ureter cancer pt3 tnm finding v8
renal pelvis and ureter cancer pt4 tnm finding v8
renal pelvis and ureter cancer pathologic regional lymph nodes tnm finding v8
renal pelvis and ureter cancer pnx tnm finding v8
xp11 .22
renal pelvis and ureter cancer pn0 tnm finding v8
renal pelvis and ureter cancer pn1 tnm finding v8
renal pelvis and ureter cancer pn2 tnm finding v8
copper 64 cu - dota - daratumumab
serd sar439859
renal pelvis and ureter cancer by ajcc v8 stage
renal pelvis cancer by ajcc v8 stage
ureter cancer by ajcc v8 stage
stage 0a renal pelvis and ureter cancer ajcc v8
stage 0a renal pelvis cancer ajcc v8
11q13 .5
stage 0a ureter cancer ajcc v8
stage 0is renal pelvis and ureter cancer ajcc v8
stage 0is renal pelvis cancer ajcc v8
stage 0is ureter cancer ajcc v8
stage i renal pelvis and ureter cancer ajcc v8
stage i renal pelvis cancer ajcc v8
stage i ureter cancer ajcc v8
stage ii renal pelvis and ureter cancer ajcc v8
stage ii renal pelvis cancer ajcc v8
stage ii ureter cancer ajcc v8
1q42
stage iii renal pelvis and ureter cancer ajcc v8
stage iii renal pelvis cancer ajcc v8
stage iii ureter cancer ajcc v8
stage iv renal pelvis and ureter cancer ajcc v8
stage iv renal pelvis cancer ajcc v8
stage iv ureter cancer ajcc v8
renal pelvis and ureter cancer by ajcc v7 stage
renal pelvis cancer by ajcc v7 stage
ureter cancer by ajcc v7 stage
pan - trk inhibitor ono - 7579
19p13 .11
bladder cancer tnm finding v8
bladder cancer clinical tnm finding v8
bladder cancer clinical distant metastasis tnm finding v8
bladder cancer cm0 tnm finding v8
bladder cancer cm1 tnm finding v8
bladder cancer cm1a tnm finding v8
bladder cancer cm1b tnm finding v8
bladder cancer pathologic tnm finding v8
bladder cancer pathologic distant metastasis tnm finding v8
bladder cancer pm1 tnm finding v8
3p21 .3 - p21 .1
bladder cancer pm1a tnm finding v8
bladder cancer pm1b tnm finding v8
bladder cancer pathologic primary tumor tnm finding v8
bladder cancer ptx tnm finding v8
bladder cancer pt0 tnm finding v8
bladder cancer pta tnm finding v8
bladder cancer ptis tnm finding v8
bladder cancer pt1 tnm finding v8
bladder cancer pt2 tnm finding v8
bladder cancer pt2a tnm finding v8
protein kinase inhibitor
2p22 .3 - p21
bladder cancer pt2b tnm finding v8
bladder cancer pt3 tnm finding v8
bladder cancer pt3a tnm finding v8
bladder cancer pt3b tnm finding v8
bladder cancer pt4 tnm finding v8
bladder cancer pt4a tnm finding v8
bladder cancer pt4b tnm finding v8
bladder cancer pathologic regional lymph nodes tnm finding v8
bladder cancer pnx tnm finding v8
bladder cancer pn0 tnm finding v8
19q13 .3
bladder cancer pn1 tnm finding v8
bladder cancer pn2 tnm finding v8
bladder cancer pn3 tnm finding v8
hypermutation phenotype
idh2 np_002159 .2:p .r172w
idh2 nm_002168 .3:c .514a > t
bladder cancer by ajcc v8 stage
stage 0a bladder cancer ajcc v8
stage 0is bladder cancer ajcc v8
stage i bladder cancer ajcc v8
brct domain
stage ii bladder cancer ajcc v8
stage iii bladder cancer ajcc v8
stage iiia bladder cancer ajcc v8
stage iiib bladder cancer ajcc v8
stage iv bladder cancer ajcc v8
stage iva bladder cancer ajcc v8
stage ivb bladder cancer ajcc v8
anti - cd38 - targeted igg4 - attenuated ifna tak - 573
urethral cancer tnm finding v8
urethral cancer clinical tnm finding v8
walker - a motif
urethral cancer clinical distant metastasis tnm finding v8
urethral cancer cm0 tnm finding v8
urethral cancer cm1 tnm finding v8
urethral cancer pathologic tnm finding v8
urethral cancer pathologic distant metastasis tnm finding v8
urethral cancer pm1 tnm finding v8
urethral cancer pathologic primary tumor tnm finding v8
male penile urethra and female urethra cancer pathologic primary tumor tnm finding v8
male penile urethra and female urethra cancer ptx tnm finding v8
male penile urethra and female urethra cancer pt0 tnm finding v8
pwwp domain
male penile urethra and female urethra cancer pta tnm finding v8
male penile urethra and female urethra cancer ptis tnm finding v8
male penile urethra and female urethra cancer pt1 tnm finding v8
male penile urethra and female urethra cancer pt2 tnm finding v8
male penile urethra and female urethra cancer pt3 tnm finding v8
male penile urethra and female urethra cancer pt4 tnm finding v8
prostatic urethra cancer pathologic primary tumor tnm finding v8
prostatic urethra cancer ptis tnm finding v8
prostatic urethra cancer pt1 tnm finding v8
prostatic urethra cancer pt2 tnm finding v8
3q13
prostatic urethra cancer pt3 tnm finding v8
prostatic urethra cancer pt4 tnm finding v8
urethral cancer pathologic regional lymph nodes tnm finding v8
urethral cancer pnx tnm finding v8
urethral cancer pn0 tnm finding v8
urethral cancer pn1 tnm finding v8
urethral cancer pn2 tnm finding v8
urethral cancer by ajcc v8 stage
stage 0a urethral cancer ajcc v8
stage 0is urethral cancer ajcc v8
5p15 .1 - p14
stage i urethral cancer ajcc v8
stage ii urethral cancer ajcc v8
stage iii urethral cancer ajcc v8
stage iv urethral cancer ajcc v8
urethral cancer by ajcc v7 stage
dll3 positive
evaluation of response to treatment
foramen ovale of the skull
neck of the humerus ,  surgical
ophthalmic sites cancer tnm finding v8
immunoreceptor tyrosine - based motif
eyelid carcinoma tnm finding v8
eyelid carcinoma clinical tnm finding v8
eyelid carcinoma clinical distant metastasis tnm finding v8
eyelid carcinoma cm0 tnm finding v8
eyelid carcinoma cm1 tnm finding v8
eyelid carcinoma clinical regional lymph nodes tnm finding v8
eyelid carcinoma cnx tnm finding v8
eyelid carcinoma cn0 tnm finding v8
eyelid carcinoma cn1 tnm finding v8
eyelid carcinoma cn1a tnm finding v8
itam
eyelid carcinoma cn2 tnm finding v8
eyelid carcinoma cn2a tnm finding v8
eyelid carcinoma pathologic tnm finding v8
eyelid carcinoma pathologic distant metastasis tnm finding v8
eyelid carcinoma pm1 tnm finding v8
eyelid carcinoma pathologic primary tumor tnm finding v8
eyelid carcinoma ptx tnm finding v8
eyelid carcinoma pt0 tnm finding v8
eyelid carcinoma ptis tnm finding v8
eyelid carcinoma pt1 tnm finding v8
itim
eyelid carcinoma pt1a tnm finding v8
eyelid carcinoma pt1b tnm finding v8
eyelid carcinoma pt1c tnm finding v8
eyelid carcinoma pt2 tnm finding v8
eyelid carcinoma pt2a tnm finding v8
eyelid carcinoma pt2b tnm finding v8
eyelid carcinoma pt2c tnm finding v8
eyelid carcinoma pt3 tnm finding v8
eyelid carcinoma pt3a tnm finding v8
eyelid carcinoma pt3b tnm finding v8
valspodar
post - translational modification site
eyelid carcinoma pt3c tnm finding v8
eyelid carcinoma pt4 tnm finding v8
eyelid carcinoma pt4a tnm finding v8
eyelid carcinoma pt4b tnm finding v8
eyelid carcinoma pathologic regional lymph nodes tnm finding v8
eyelid carcinoma pnx tnm finding v8
eyelid carcinoma pn0 tnm finding v8
eyelid carcinoma pn1 tnm finding v8
eyelid carcinoma pn1b tnm finding v8
eyelid carcinoma pn2 tnm finding v8
n - glycosylation site
eyelid carcinoma pn2b tnm finding v8
eyelid carcinoma by ajcc v7 stage
bromide measurement
eyelid carcinoma by ajcc v8 stage
stage 0 eyelid carcinoma ajcc v8
stage i eyelid carcinoma ajcc v8
stage ia eyelid carcinoma ajcc v8
stage ib eyelid carcinoma ajcc v8
stage ii eyelid carcinoma ajcc v8
myristic acylation site
stage iia eyelid carcinoma ajcc v8
stage iib eyelid carcinoma ajcc v8
stage iii eyelid carcinoma ajcc v8
stage iiia eyelid carcinoma ajcc v8
stage iiib eyelid carcinoma ajcc v8
stage iv eyelid carcinoma ajcc v8
posterior tibialis muscle
conjunctival carcinoma tnm finding v8
conjunctival carcinoma clinical tnm finding v8
conjunctival carcinoma clinical distant metastasis tnm finding v8
palmitic acylation site
conjunctival carcinoma cm0 tnm finding v8
conjunctival carcinoma cm1 tnm finding v8
conjunctival carcinoma pathologic tnm finding v8
conjunctival carcinoma pathologic distant metastasis tnm finding v8
conjunctival carcinoma pm1 tnm finding v8
conjunctival carcinoma pathologic primary tumor tnm finding v8
conjunctival carcinoma ptx tnm finding v8
conjunctival carcinoma pt0 tnm finding v8
conjunctival carcinoma ptis tnm finding v8
conjunctival carcinoma pt1 tnm finding v8
phosphorylation site
conjunctival carcinoma pt2 tnm finding v8
conjunctival carcinoma pt3 tnm finding v8
conjunctival carcinoma pt4 tnm finding v8
conjunctival carcinoma pt4a tnm finding v8
conjunctival carcinoma pt4b tnm finding v8
conjunctival carcinoma pt4c tnm finding v8
conjunctival carcinoma pt4d tnm finding v8
conjunctival carcinoma pathologic regional lymph nodes tnm finding v8
conjunctival carcinoma pnx tnm finding v8
conjunctival carcinoma pn0 tnm finding v8
ydyvhl motif
conjunctival carcinoma pn1 tnm finding v8
retinoid x receptor agonist irx4204
anti - psma / pbd adc medi3726
simmiparib
botanical extract dcb - bo1301
carbon c 14 - ac0010
conjunctival melanoma tnm finding v8
conjunctival melanoma clinical tnm finding v8
conjunctival melanoma clinical distant metastasis tnm finding v8
conjunctival melanoma cm0 tnm finding v8
tyrosine phosphorylation site
conjunctival melanoma cm1 tnm finding v8
conjunctival melanoma clinical primary tumor tnm finding v8
conjunctival melanoma ctx tnm finding v8
conjunctival melanoma ct0 tnm finding v8
conjunctival melanoma ct1 tnm finding v8
conjunctival melanoma ct1a tnm finding v8
conjunctival melanoma ct1b tnm finding v8
conjunctival melanoma ct1c tnm finding v8
conjunctival melanoma ct1d tnm finding v8
conjunctival melanoma ct2 tnm finding v8
serine phosphorylation site
conjunctival melanoma ct2a tnm finding v8
conjunctival melanoma ct2b tnm finding v8
conjunctival melanoma ct2c tnm finding v8
conjunctival melanoma ct2d tnm finding v8
conjunctival melanoma ct3 tnm finding v8
conjunctival melanoma ct3a tnm finding v8
conjunctival melanoma ct3b tnm finding v8
conjunctival melanoma ct3c tnm finding v8
conjunctival melanoma ct3d tnm finding v8
conjunctival melanoma ct4 tnm finding v8
threonine phosphorylation site
conjunctival melanoma pathologic tnm finding v8
conjunctival melanoma pathologic distant metastasis tnm finding v8
conjunctival melanoma pm1 tnm finding v8
conjunctival melanoma pathologic primary tumor tnm finding v8
conjunctival melanoma ptx tnm finding v8
conjunctival melanoma pt0 tnm finding v8
conjunctival melanoma ptis tnm finding v8
conjunctival melanoma pt1 tnm finding v8
conjunctival melanoma pt1a tnm finding v8
conjunctival melanoma pt1b tnm finding v8
yxxp motif
conjunctival melanoma pt2 tnm finding v8
conjunctival melanoma pt2a tnm finding v8
conjunctival melanoma pt2b tnm finding v8
conjunctival melanoma pt3 tnm finding v8
conjunctival melanoma pt3a tnm finding v8
conjunctival melanoma pt3b tnm finding v8
conjunctival melanoma pt3c tnm finding v8
conjunctival melanoma pt3d tnm finding v8
conjunctival melanoma pt4 tnm finding v8
conjunctival melanoma pathologic regional lymph nodes tnm finding v8
pkc phosphorylation site
conjunctival melanoma pnx tnm finding v8
conjunctival melanoma pn0 tnm finding v8
conjunctival melanoma pn1 tnm finding v8
uveal melanoma tnm finding v8
uveal melanoma clinical tnm finding v8
uveal melanoma clinical distant metastasis tnm finding v8
uveal melanoma cm0 tnm finding v8
uveal melanoma cm1 tnm finding v8
uveal melanoma cm1a tnm finding v8
uveal melanoma cm1b tnm finding v8
amphipathic alpha helix
uveal melanoma cm1c tnm finding v8
uveal melanoma pathologic tnm finding v8
uveal melanoma pathologic distant metastasis tnm finding v8
uveal melanoma pm1 tnm finding v8
uveal melanoma pm1a tnm finding v8
uveal melanoma pm1b tnm finding v8
uveal melanoma pm1c tnm finding v8
iris melanoma pathologic primary tumor tnm finding v8
iris melanoma pt1 tnm finding v8
iris melanoma pt1a tnm finding v8
disulfide linkage
iris melanoma pt1b tnm finding v8
iris melanoma pt1c tnm finding v8
iris melanoma pt2 tnm finding v8
iris melanoma pt2a tnm finding v8
iris melanoma pt2b tnm finding v8
iris melanoma pt2c tnm finding v8
iris melanoma pt3 tnm finding v8
iris melanoma pt4 tnm finding v8
iris melanoma pt4a tnm finding v8
iris melanoma pt4b tnm finding v8
globular region
choroidal and ciliary body melanoma pathologic primary tumor tnm finding v8
choroidal and ciliary body melanoma pt1 tnm finding v8
choroidal and ciliary body melanoma pt1a tnm finding v8
choroidal and ciliary body melanoma pt1b tnm finding v8
choroidal and ciliary body melanoma pt1c tnm finding v8
choroidal and ciliary body melanoma pt1d tnm finding v8
choroidal and ciliary body melanoma pt2 tnm finding v8
choroidal and ciliary body melanoma pt2a tnm finding v8
choroidal and ciliary body melanoma pt2b tnm finding v8
choroidal and ciliary body melanoma pt2c tnm finding v8
tertiary protein structure
choroidal and ciliary body melanoma pt2d tnm finding v8
choroidal and ciliary body melanoma pt3 tnm finding v8
choroidal and ciliary body melanoma pt3a tnm finding v8
choroidal and ciliary body melanoma pt3b tnm finding v8
choroidal and ciliary body melanoma pt3c tnm finding v8
choroidal and ciliary body melanoma pt3d tnm finding v8
choroidal and ciliary body melanoma pt4 tnm finding v8
choroidal and ciliary body melanoma pt4a tnm finding v8
choroidal and ciliary body melanoma pt4b tnm finding v8
choroidal and ciliary body melanoma pt4c tnm finding v8
protein region
choroidal and ciliary body melanoma pt4d tnm finding v8
choroidal and ciliary body melanoma pt4e tnm finding v8
uveal melanoma pathologic regional lymph nodes tnm finding v8
uveal melanoma pn1 tnm finding v8
uveal melanoma pn1a tnm finding v8
uveal melanoma pn1b tnm finding v8
bac regimen
r - acvbp regimen
choroidal and ciliary body melanoma by ajcc v8 stage
7q21 .2 - q22 .1
stage i choroidal and ciliary body melanoma ajcc v8
stage ii choroidal and ciliary body melanoma ajcc v8
stage iia choroidal and ciliary body melanoma ajcc v8
stage iib choroidal and ciliary body melanoma ajcc v8
stage iii choroidal and ciliary body melanoma ajcc v8
stage iiia choroidal and ciliary body melanoma ajcc v8
stage iiib choroidal and ciliary body melanoma ajcc v8
stage iiic choroidal and ciliary body melanoma ajcc v8
stage iv choroidal and ciliary body melanoma ajcc v8
minor response in neuroblastoma
14q31
total measured tumor burden
progressive disease in neuroblastoma
uveal melanoma by ajcc v7 stage
r - chope regimen
carboplatin / pembrolizumab / pemetrexed regimen
retinoblastoma tnm finding v8
retinoblastoma clinical tnm finding v8
retinoblastoma clinical distant metastasis tnm finding v8
retinoblastoma cm0 tnm finding v8
retinoblastoma cm1 tnm finding v8
acidic region
retinoblastoma cm1a tnm finding v8
retinoblastoma cm1b tnm finding v8
retinoblastoma clinical primary tumor tnm finding v8
retinoblastoma ctx tnm finding v8
retinoblastoma ct0 tnm finding v8
retinoblastoma ct1 tnm finding v8
retinoblastoma ct1a tnm finding v8
retinoblastoma ct1b tnm finding v8
retinoblastoma ct2 tnm finding v8
retinoblastoma ct2a tnm finding v8
cysteine - rich domain
retinoblastoma ct2b tnm finding v8
retinoblastoma ct3 tnm finding v8
retinoblastoma ct3a tnm finding v8
retinoblastoma ct3b tnm finding v8
retinoblastoma ct3c tnm finding v8
retinoblastoma ct3d tnm finding v8
retinoblastoma ct3e tnm finding v8
retinoblastoma ct4 tnm finding v8
retinoblastoma ct4a tnm finding v8
retinoblastoma ct4b tnm finding v8
rg 13022
cellular membrane
retinoblastoma clinical regional lymph nodes tnm finding v8
retinoblastoma cnx tnm finding v8
retinoblastoma cn0 tnm finding v8
retinoblastoma cn1 tnm finding v8
retinoblastoma pathologic tnm finding v8
retinoblastoma pathologic distant metastasis tnm finding v8
retinoblastoma pm1 tnm finding v8
retinoblastoma pm1a tnm finding v8
retinoblastoma pm1b tnm finding v8
retinoblastoma pathologic regional lymph nodes tnm finding v8
nad - binding domain
retinoblastoma pnx tnm finding v8
retinoblastoma pn0 tnm finding v8
retinoblastoma pn1 tnm finding v8
retinoblastoma pathologic primary tumor tnm finding v8
retinoblastoma ptx tnm finding v8
retinoblastoma pt0 tnm finding v8
retinoblastoma pt1 tnm finding v8
retinoblastoma pt2 tnm finding v8
retinoblastoma pt2a tnm finding v8
retinoblastoma pt2b tnm finding v8
gxgxxxg motif
retinoblastoma pt3 tnm finding v8
retinoblastoma pt3a tnm finding v8
retinoblastoma pt3b tnm finding v8
retinoblastoma pt3c tnm finding v8
retinoblastoma pt3d tnm finding v8
retinoblastoma pt4 tnm finding v8
retinoblastoma heritable trait  ( h )  finding v8
retinoblastoma hx finding v8
retinoblastoma h0 finding v8
retinoblastoma h1 finding v8
substrate interaction domain
fcm regimen
r - gemox regimen
gvd regimen
r - gvd regimen
r - chop alternating with r - dhap regimen
satisfaction with how you look in mirror clothed
satisfaction with how comfortably bras fit
satisfaction with being able to wear clothing that is fitted
satisfaction with how you look in mirror unclothed
how often felt confident in social setting
atpase domain
how often felt emotionally able to do things you want to do
how often felt emotionally healthy
how often felt of equal worth to other women
how often felt self - confident
how often felt feminine in your clothes
how often felt accepting of your body
how often felt normal
how often felt like other women
how often felt attractive
tyrosine kinase domain
retinoblastoma by ajcc v8 stage
retinoblastoma by ajcc v8 clinical stage
clinical stage i retinoblastoma ajcc v8
clinical stage ii retinoblastoma ajcc v8
clinical stage iii retinoblastoma ajcc v8
clinical stage iv retinoblastoma ajcc v8
retinoblastoma by ajcc v8 pathologic stage
pathologic stage i retinoblastoma ajcc v8
pathologic stage ii retinoblastoma ajcc v8
pathologic stage iii retinoblastoma ajcc v8
dh domain
pathologic stage iv retinoblastoma ajcc v8
how often experienced pain in muscles of your chest
how often experienced difficulty lifting or moving your arms
how often experienced difficulty sleeping because of discomfort in breast area
how often experienced tightness in your breast area
how often experienced nagging feeling in your breast area
how often experienced pulling in your breast area
how often experienced tenderness in your breast area
how often experienced sharp pains in your breast area
ph domain
how often experienced aching feeling in your breast area
how often experienced throbbing feeling in your breast area
how often experienced swelling of arm on side you had breast surgery
lacrimal gland carcinoma tnm finding v8
lacrimal gland carcinoma clinical tnm finding v8
lacrimal gland carcinoma clinical distant metastasis tnm finding v8
lacrimal gland carcinoma cm0 tnm finding v8
lacrimal gland carcinoma cm1 tnm finding v8
lacrimal gland carcinoma pathologic tnm finding v8
lacrimal gland carcinoma pathologic distant metastasis tnm finding v8
rho effector domain
lacrimal gland carcinoma pm1 tnm finding v8
lacrimal gland carcinoma pathologic primary tumor tnm finding v8
lacrimal gland carcinoma ptx tnm finding v8
lacrimal gland carcinoma pt0 tnm finding v8
lacrimal gland carcinoma pt1 tnm finding v8
lacrimal gland carcinoma pt1a tnm finding v8
lacrimal gland carcinoma pt1b tnm finding v8
lacrimal gland carcinoma pt1c tnm finding v8
lacrimal gland carcinoma pt2 tnm finding v8
lacrimal gland carcinoma pt2a tnm finding v8
transcriptional activation domain
lacrimal gland carcinoma pt2b tnm finding v8
lacrimal gland carcinoma pt2c tnm finding v8
lacrimal gland carcinoma pt3 tnm finding v8
lacrimal gland carcinoma pt3a tnm finding v8
lacrimal gland carcinoma pt3b tnm finding v8
lacrimal gland carcinoma pt3c tnm finding v8
lacrimal gland carcinoma pt4 tnm finding v8
how often feel confident sexually
lacrimal gland carcinoma pt4a tnm finding v8
lacrimal gland carcinoma pt4b tnm finding v8
rifabutin
dag / pe - binding domain
how often feel sexually attractive in your clothes
lacrimal gland carcinoma pt4c tnm finding v8
lacrimal gland carcinoma pathologic regional lymph nodes tnm finding v8
lacrimal gland carcinoma pnx tnm finding v8
lacrimal gland carcinoma pn0 tnm finding v8
lacrimal gland carcinoma pn1 tnm finding v8
how often feel comfortable or at ease during sexual activity
how often feel satisfied with your sex - life
how often feel confident sexually about how your breast area looks when unclothed
how often feel sexually attractive when unclothed
estrogen binding domain
breast cancer surgeon was professional
breast cancer surgeon gave you confidence
breast cancer surgeon involved you in decision making
breast cancer surgeon was reassuring
breast cancer surgeon answered all questions
breast cancer surgeon made you comfortable
breast cancer surgeon was thorough
breast cancer surgeon was easy to talk to
breast cancer surgeon understood what you wanted
breast cancer surgeon was sensitive
gtp binding domain
breast cancer surgeon made time for your concerns
breast cancer surgeon was available when you had concerns
medical team was professional
medical team treated you with respect
medical team was knowledgeable
medical team was friendly and kind
medical team made you feel comfortable
medical team was thorough
medical team made time for your concerns
office staff was professional
basolateral sorting signal
office staff treated you with respect
office staff was knowledgeable
orbital sarcoma tnm finding v8
orbital sarcoma clinical tnm finding v8
orbital sarcoma clinical distant metastasis tnm finding v8
orbital sarcoma cm0 tnm finding v8
orbital sarcoma cm1 tnm finding v8
orbital sarcoma pathologic tnm finding v8
orbital sarcoma pathologic distant metastasis tnm finding v8
orbital sarcoma pm1 tnm finding v8
kdel motif
orbital sarcoma pathologic primary tumor tnm finding v8
orbital sarcoma ptx tnm finding v8
orbital sarcoma pt0 tnm finding v8
orbital sarcoma pt1 tnm finding v8
orbital sarcoma pt2 tnm finding v8
orbital sarcoma pt3 tnm finding v8
orbital sarcoma pt4 tnm finding v8
orbital sarcoma pathologic regional lymph nodes tnm finding v8
orbital sarcoma pnx tnm finding v8
orbital sarcoma pn0 tnm finding v8
dix domain
orbital sarcoma pn1 tnm finding v8
ocular adnexal lymphoma tnm finding v8
ocular adnexal lymphoma clinical tnm finding v8
ocular adnexal lymphoma clinical distant metastasis tnm finding v8
ocular adnexal lymphoma cm0 tnm finding v8
ocular adnexal lymphoma cm1a tnm finding v8
ocular adnexal lymphoma cm1b tnm finding v8
ocular adnexal lymphoma cm1c tnm finding v8
ocular adnexal lymphoma pathologic tnm finding v8
ocular adnexal lymphoma pathologic distant metastasis tnm finding v8
mitochondrial import sequence
ocular adnexal lymphoma pm1a tnm finding v8
ocular adnexal lymphoma pm1b tnm finding v8
ocular adnexal lymphoma pm1c tnm finding v8
ocular adnexal lymphoma pathologic primary tumor tnm finding v8
ocular adnexal lymphoma ptx tnm finding v8
ocular adnexal lymphoma pt0 tnm finding v8
ocular adnexal lymphoma pt1 tnm finding v8
ocular adnexal lymphoma pt2 tnm finding v8
ocular adnexal lymphoma pt3 tnm finding v8
ocular adnexal lymphoma pt4 tnm finding v8
membrane localization motif
ocular adnexal lymphoma pathologic regional lymph nodes tnm finding v8
ocular adnexal lymphoma pnx tnm finding v8
ocular adnexal lymphoma pn0 tnm finding v8
ocular adnexal lymphoma pn1 tnm finding v8
ocular adnexal lymphoma pn1a tnm finding v8
ocular adnexal lymphoma pn1b tnm finding v8
ocular adnexal lymphoma pn2 tnm finding v8
ocular adnexal lymphoma pn3 tnm finding v8
office staff was friendly and kind
office staff made you feel comfortable
monobasic proteolytic cleavage site
office staff was thorough
office staff made time for your concerns
graded prognostic assessment
disease - specific graded prognostic assessment
graded prognostic assessment score
robot - assisted surgery
ivor lewis esophagectomy
mckeown esophagectomy
transhiatal esophagectomy
mandard grading system
nuclear localization signal
tumor regression grade 1
tumor regression grade 2
tumor regression grade 3
tumor regression grade 4
tumor regression grade 5
endocrine system cancer tnm finding v8
thyroid carcinoma tnm finding v8
papillary ,  follicular ,  hurthle cell ,  poorly differentiated ,  and anaplastic thyroid carcinoma tnm finding v8
papillary ,  follicular ,  hurthle cell ,  poorly differentiated ,  and anaplastic thyroid carcinoma clinical tnm finding v8
papillary ,  follicular ,  hurthle cell ,  poorly differentiated ,  and anaplastic thyroid carcinoma clinical distant metastasis tnm finding v8
carbenicillin indanyl sodium
signal peptide
papillary ,  follicular ,  hurthle cell ,  poorly differentiated ,  and anaplastic thyroid carcinoma cm0 tnm finding v8
papillary ,  follicular ,  hurthle cell ,  poorly differentiated ,  and anaplastic thyroid carcinoma cm1 tnm finding v8
papillary ,  follicular ,  hurthle cell ,  poorly differentiated ,  and anaplastic thyroid carcinoma clinical regional lymph nodes tnm finding v8
papillary ,  follicular ,  hurthle cell ,  poorly differentiated ,  and anaplastic thyroid carcinoma cnx tnm finding v8
papillary ,  follicular ,  hurthle cell ,  poorly differentiated ,  and anaplastic thyroid carcinoma cn0 tnm finding v8
papillary ,  follicular ,  hurthle cell ,  poorly differentiated ,  and anaplastic thyroid carcinoma cn0b tnm finding v8
papillary ,  follicular ,  hurthle cell ,  poorly differentiated ,  and anaplastic thyroid carcinoma cn1 tnm finding v8
papillary ,  follicular ,  hurthle cell ,  poorly differentiated ,  and anaplastic thyroid carcinoma cn1a tnm finding v8
papillary ,  follicular ,  hurthle cell ,  poorly differentiated ,  and anaplastic thyroid carcinoma cn1b tnm finding v8
papillary ,  follicular ,  hurthle cell ,  poorly differentiated ,  and anaplastic thyroid carcinoma pathologic tnm finding v8
rna binding domain
papillary ,  follicular ,  hurthle cell ,  poorly differentiated ,  and anaplastic thyroid carcinoma pathologic distant metastasis tnm finding v8
papillary ,  follicular ,  hurthle cell ,  poorly differentiated ,  and anaplastic thyroid carcinoma pm1 tnm finding v8
papillary ,  follicular ,  hurthle cell ,  poorly differentiated ,  and anaplastic thyroid carcinoma pathologic primary tumor tnm finding v8
papillary ,  follicular ,  hurthle cell ,  poorly differentiated ,  and anaplastic thyroid carcinoma ptx tnm finding v8
papillary ,  follicular ,  hurthle cell ,  poorly differentiated ,  and anaplastic thyroid carcinoma pt0 tnm finding v8
papillary ,  follicular ,  hurthle cell ,  poorly differentiated ,  and anaplastic thyroid carcinoma pt1 tnm finding v8
papillary ,  follicular ,  hurthle cell ,  poorly differentiated ,  and anaplastic thyroid carcinoma pt1a tnm finding v8
papillary ,  follicular ,  hurthle cell ,  poorly differentiated ,  and anaplastic thyroid carcinoma pt1b tnm finding v8
papillary ,  follicular ,  hurthle cell ,  poorly differentiated ,  and anaplastic thyroid carcinoma pt2 tnm finding v8
papillary ,  follicular ,  hurthle cell ,  poorly differentiated ,  and anaplastic thyroid carcinoma pt3 tnm finding v8
kh domain
papillary ,  follicular ,  hurthle cell ,  poorly differentiated ,  and anaplastic thyroid carcinoma pt3a tnm finding v8
papillary ,  follicular ,  hurthle cell ,  poorly differentiated ,  and anaplastic thyroid carcinoma pt3b tnm finding v8
papillary ,  follicular ,  hurthle cell ,  poorly differentiated ,  and anaplastic thyroid carcinoma pt4 tnm finding v8
papillary ,  follicular ,  hurthle cell ,  poorly differentiated ,  and anaplastic thyroid carcinoma pt4a tnm finding v8
papillary ,  follicular ,  hurthle cell ,  poorly differentiated ,  and anaplastic thyroid carcinoma pt4b tnm finding v8
papillary ,  follicular ,  hurthle cell ,  poorly differentiated ,  and anaplastic thyroid carcinoma pathologic regional lymph nodes tnm finding v8
papillary ,  follicular ,  hurthle cell ,  poorly differentiated ,  and anaplastic thyroid carcinoma pnx tnm finding v8
papillary ,  follicular ,  hurthle cell ,  poorly differentiated ,  and anaplastic thyroid carcinoma pn0 tnm finding v8
papillary ,  follicular ,  hurthle cell ,  poorly differentiated ,  and anaplastic thyroid carcinoma pn0a tnm finding v8
papillary ,  follicular ,  hurthle cell ,  poorly differentiated ,  and anaplastic thyroid carcinoma pn1 tnm finding v8
set domain
satisfaction with shape of your reconstructed breasts when wearing bra
satisfaction with how normal you feel in your clothes
papillary ,  follicular ,  hurthle cell ,  poorly differentiated ,  and anaplastic thyroid carcinoma pn1a tnm finding v8
satisfaction with how your breasts line up in relation to each other
papillary ,  follicular ,  hurthle cell ,  poorly differentiated ,  and anaplastic thyroid carcinoma pn1b tnm finding v8
satisfaction with softness of reconstructed breasts
satisfaction with how equal in size your breasts are to each other
satisfaction with how natural your reconstructed breasts look
satisfaction with how naturally your reconstructed breasts sits and hangs
arid domain
satisfaction with how your reconstructed breasts feel to touch
satisfaction with how much your reconstructed breasts feel like a natural part of your body
satisfaction with how closely matched your breasts are to each other
satisfaction with amount of rippling of your implants that you can see
satisfaction with amount of rippling of your implants that you can feel
how often experienced difficulty sitting up because abdominal muscle weakness
how often experienced difficulty doing everyday activities because of abdominal muscle weakness
how often experienced abdominal discomfort
how often experienced abdominal bloating
how often experienced abdominal bulging
btb / poz domain
how often experienced tightness in abdomen
how often experienced pulling in abdomen
satisfaction with how your abdomen looks when unclothed
satisfaction with position of navel
satisfaction with appearance of abdominal scars
somewhat disagree
somewhat agree
thyroid gland follicular carcinoma by ajcc v7 stage
differentiated thyroid gland carcinoma by ajcc v7 stage
zinc finger domain
thyroid gland papillary carcinoma by ajcc v7 stage
differentiated thyroid gland carcinoma under 45 years ajcc v7 stage
differentiated thyroid gland carcinoma under 55 years ajcc v8 stage
differentiated thyroid gland carcinoma 45 years and older ajcc v7 stage
differentiated thyroid gland carcinoma 55 years and older ajcc v8 stage
differentiated thyroid gland carcinoma by ajcc v8 stage
stage i differentiated thyroid gland carcinoma ajcc v8
stage i differentiated thyroid gland carcinoma under 55 years ajcc v8
stage i differentiated thyroid gland carcinoma 55 years and older ajcc v8
stage ii differentiated thyroid gland carcinoma ajcc v8
c3h1 zinc finger
stage ii differentiated thyroid gland carcinoma under 55 years ajcc v8
stage ii differentiated thyroid gland carcinoma 55 years and older ajcc v8
stage iii differentiated thyroid gland carcinoma ajcc v8
stage iv differentiated thyroid gland carcinoma ajcc v8
stage iva differentiated thyroid gland carcinoma ajcc v8
stage ivb differentiated thyroid gland carcinoma ajcc v8
thyroid gland papillary carcinoma by ajcc v8 stage
stage i thyroid gland papillary carcinoma ajcc v8
stage i thyroid gland papillary carcinoma under 55 years ajcc v8
stage i thyroid gland papillary carcinoma 55 years and older ajcc v8
phd finger
stage ii thyroid gland papillary carcinoma ajcc v8
stage ii thyroid gland papillary carcinoma under 55 years ajcc v8
stage ii thyroid gland papillary carcinoma 55 years and older ajcc v8
stage iii thyroid gland papillary carcinoma ajcc v8
stage iv thyroid gland papillary carcinoma ajcc v8
stage iva thyroid gland papillary carcinoma ajcc v8
stage ivb thyroid gland papillary carcinoma ajcc v8
thyroid gland follicular carcinoma by ajcc v8 stage
stage i thyroid gland follicular carcinoma ajcc v8
stage i thyroid gland follicular carcinoma under 55 years ajcc v8
hlh motif
stage i thyroid gland follicular carcinoma 55 years and older ajcc v8
stage ii thyroid gland follicular carcinoma ajcc v8
stage ii thyroid gland follicular carcinoma under 55 years ajcc v8
stage ii thyroid gland follicular carcinoma 55 years and older ajcc v8
nir fluorochrome vm110
stage iii thyroid gland follicular carcinoma ajcc v8
stage iv thyroid gland follicular carcinoma ajcc v8
stage iva thyroid gland follicular carcinoma ajcc v8
stage ivb thyroid gland follicular carcinoma ajcc v8
thyroid gland anaplastic carcinoma by ajcc v7 stage
recombinant human stem cell factor
ankyrin repeat
thyroid gland anaplastic carcinoma by ajcc v8 stage
stage iva thyroid gland anaplastic carcinoma ajcc v8
stage ivb thyroid gland anaplastic carcinoma ajcc v8
stage ivc thyroid gland anaplastic carcinoma ajcc v8
contact date
medullary thyroid carcinoma tnm finding v8
medullary thyroid carcinoma clinical tnm finding v8
medullary thyroid carcinoma clinical distant metastasis tnm finding v8
medullary thyroid carcinoma cm0 tnm finding v8
armadillo repeat
medullary thyroid carcinoma cm1 tnm finding v8
medullary thyroid carcinoma clinical regional lymph nodes tnm finding v8
medullary thyroid carcinoma cnx tnm finding v8
medullary thyroid carcinoma cn0 tnm finding v8
medullary thyroid carcinoma cn0b tnm finding v8
medullary thyroid carcinoma cn1 tnm finding v8
medullary thyroid carcinoma cn1a tnm finding v8
medullary thyroid carcinoma cn1b tnm finding v8
medullary thyroid carcinoma pathologic tnm finding v8
medullary thyroid carcinoma pathologic distant metastasis tnm finding v8
medullary thyroid carcinoma pm1 tnm finding v8
medullary thyroid carcinoma pathologic primary tumor tnm finding v8
medullary thyroid carcinoma ptx tnm finding v8
medullary thyroid carcinoma pt0 tnm finding v8
medullary thyroid carcinoma pt1 tnm finding v8
medullary thyroid carcinoma pt1a tnm finding v8
medullary thyroid carcinoma pt1b tnm finding v8
medullary thyroid carcinoma pt2 tnm finding v8
medullary thyroid carcinoma pt3 tnm finding v8
medullary thyroid carcinoma pt3a tnm finding v8
f - box domain
medullary thyroid carcinoma pt3b tnm finding v8
medullary thyroid carcinoma pt4 tnm finding v8
medullary thyroid carcinoma pt4a tnm finding v8
medullary thyroid carcinoma pt4b tnm finding v8
medullary thyroid carcinoma pathologic regional lymph nodes tnm finding v8
medullary thyroid carcinoma pnx tnm finding v8
medullary thyroid carcinoma pn0 tnm finding v8
medullary thyroid carcinoma pn0a tnm finding v8
medullary thyroid carcinoma pn1 tnm finding v8
medullary thyroid carcinoma pn1a tnm finding v8
gsk - binding domain
medullary thyroid carcinoma pn1b tnm finding v8
thyroid gland medullary carcinoma by ajcc v7 stage
thyroid gland medullary carcinoma by ajcc v8 stage
stage i thyroid gland medullary carcinoma ajcc v8
stage ii thyroid gland medullary carcinoma ajcc v8
stage iii thyroid gland medullary carcinoma ajcc v8
stage iv thyroid gland medullary carcinoma ajcc v8
stage iva thyroid gland medullary carcinoma ajcc v8
stage ivb thyroid gland medullary carcinoma ajcc v8
stage ivc thyroid gland medullary carcinoma ajcc v8
autologous anti - cd19 chimeric antigen receptor t - cells c - car011
multigated acquisition scan
parathyroid carcinoma tnm finding v8
parathyroid carcinoma clinical tnm finding v8
parathyroid carcinoma clinical distant metastasis tnm finding v8
parathyroid carcinoma cm0 tnm finding v8
parathyroid carcinoma cm1 tnm finding v8
parathyroid carcinoma pathologic tnm finding v8
parathyroid carcinoma pathologic distant metastasis tnm finding v8
parathyroid carcinoma pm1 tnm finding v8
proline - rich domain
parathyroid carcinoma pathologic primary tumor tnm finding v8
parathyroid carcinoma ptx tnm finding v8
parathyroid carcinoma pt0 tnm finding v8
parathyroid carcinoma ptis tnm finding v8
parathyroid carcinoma pt1 tnm finding v8
parathyroid carcinoma pt2 tnm finding v8
parathyroid carcinoma pt3 tnm finding v8
parathyroid carcinoma pt4 tnm finding v8
parathyroid carcinoma pathologic regional lymph nodes tnm finding v8
parathyroid carcinoma pnx tnm finding v8
rgs domain
parathyroid carcinoma pn0 tnm finding v8
parathyroid carcinoma pn1 tnm finding v8
parathyroid carcinoma pn1a tnm finding v8
parathyroid carcinoma pn1b tnm finding v8
erk1 / 2 inhibitor ko - 947
refractory lung carcinoma
recurrent extensive stage lung small cell carcinoma
refractory extensive stage lung small cell carcinoma
adrenal cortical carcinoma tnm finding v8
sh2 - binding motif
adrenal cortical carcinoma clinical tnm finding v8
adrenal cortical carcinoma clinical distant metastasis tnm finding v8
adrenal cortical carcinoma cm0 tnm finding v8
adrenal cortical carcinoma cm1 tnm finding v8
adrenal cortical carcinoma pathologic tnm finding v8
adrenal cortical carcinoma pathologic distant metastasis tnm finding v8
adrenal cortical carcinoma pm1 tnm finding v8
adrenal cortical carcinoma pathologic primary tumor tnm finding v8
adrenal cortical carcinoma ptx tnm finding v8
adrenal cortical carcinoma pt0 tnm finding v8
sh3 - binding motif
adrenal cortical carcinoma pt1 tnm finding v8
adrenal cortical carcinoma pt2 tnm finding v8
adrenal cortical carcinoma pt3 tnm finding v8
adrenal cortical carcinoma pt4 tnm finding v8
adrenal cortical carcinoma pathologic regional lymph nodes tnm finding v8
adrenal cortical carcinoma pnx tnm finding v8
adrenal cortical carcinoma pn0 tnm finding v8
adrenal cortical carcinoma pn1 tnm finding v8
adrenal cortex carcinoma by ajcc v7 stage
ensat stage
paclitaxel
pxxp motif
adrenal cortex carcinoma by ajcc v8 stage
stage i adrenal cortex carcinoma ajcc v8
stage ii adrenal cortex carcinoma ajcc v8
stage iii adrenal cortex carcinoma ajcc v8
stage iv adrenal cortex carcinoma ajcc v8
pheochromocytoma and paraganglioma tnm finding v8
pheochromocytoma and paraganglioma clinical tnm finding v8
pheochromocytoma and paraganglioma clinical distant metastasis tnm finding v8
pheochromocytoma and paraganglioma cm0 tnm finding v8
pheochromocytoma and paraganglioma cm1 tnm finding v8
wd repeat
pheochromocytoma and paraganglioma cm1a tnm finding v8
pheochromocytoma and paraganglioma cm1b tnm finding v8
pheochromocytoma and paraganglioma cm1c tnm finding v8
pheochromocytoma and paraganglioma pathologic tnm finding v8
pheochromocytoma and paraganglioma pathologic distant metastasis tnm finding v8
pheochromocytoma and paraganglioma pm1 tnm finding v8
pheochromocytoma and paraganglioma pm1a tnm finding v8
pheochromocytoma and paraganglioma pm1b tnm finding v8
pheochromocytoma and paraganglioma pm1c tnm finding v8
pheochromocytoma and paraganglioma pathologic primary tumor tnm finding v8
9q32 - q34
pheochromocytoma and paraganglioma ptx tnm finding v8
pheochromocytoma pt1 tnm finding v8
pheochromocytoma and paraganglioma pt2 tnm finding v8
pheochromocytoma and paraganglioma pt3 tnm finding v8
pheochromocytoma and paraganglioma pathologic regional lymph nodes tnm finding v8
pheochromocytoma and paraganglioma pnx tnm finding v8
pheochromocytoma and paraganglioma pn0 tnm finding v8
pheochromocytoma and paraganglioma pn1 tnm finding v8
adrenal gland pheochromocytoma and sympathetic paraganglioma by ajcc v8 stage
stage i adrenal gland pheochromocytoma and sympathetic paraganglioma ajcc v8
14q24 - q31
stage ii adrenal gland pheochromocytoma and sympathetic paraganglioma ajcc v8
stage iii adrenal gland pheochromocytoma and sympathetic paraganglioma ajcc v8
stage iv adrenal gland pheochromocytoma and sympathetic paraganglioma ajcc v8
pretext staging system
breast - q
linrodostat
alk inhibitor
ann arbor stage
lymphoma by ann arbor stage
calcium - binding domain
non - hodgkin lymphoma by ann arbor stage
hodgkin lymphoma by ann arbor stage
mycosis fungoides and sezary syndrome by ajcc v7 stage
mycosis fungoides by ajcc v7 stage
immune checkpoint modulator
lugano stage
lugano classification adult lymphoma by ajcc v8 stage
lugano classification limited stage adult lymphoma ajcc v8
3q22 .2
lugano classification stage i adult lymphoma ajcc v8
lugano classification stage ie adult lymphoma ajcc v8
lugano classification stage ii adult lymphoma ajcc v8
lugano classification stage iie adult lymphoma ajcc v8
lugano classification stage ii bulky adult lymphoma ajcc v8
lugano classification advanced stage adult lymphoma ajcc v8
lugano classification stage iii adult lymphoma ajcc v8
lugano classification stage iv adult lymphoma ajcc v8
lugano classification adult non - hodgkin lymphoma by ajcc v8 stage
lugano classification limited stage adult non - hodgkin lymphoma ajcc v8
12p13 .2
lugano classification stage i adult non - hodgkin lymphoma ajcc v8
lugano classification stage ie adult non - hodgkin lymphoma ajcc v8
lugano classification stage ii adult non - hodgkin lymphoma ajcc v8
lugano classification stage iie adult non - hodgkin lymphoma ajcc v8
lugano classification stage ii bulky adult non - hodgkin lymphoma ajcc v8
lugano classification advanced stage adult non - hodgkin lymphoma ajcc v8
lugano classification stage iii adult non - hodgkin lymphoma ajcc v8
lugano classification stage iv adult non - hodgkin lymphoma ajcc v8
lugano classification hodgkin lymphoma by ajcc v8 stage
lugano classification limited stage hodgkin lymphoma ajcc v8
exo i motif
lugano classification stage i hodgkin lymphoma ajcc v8
lugano classification stage ie hodgkin lymphoma ajcc v8
lugano classification stage ii hodgkin lymphoma ajcc v8
lugano classification stage iie hodgkin lymphoma ajcc v8
lugano classification stage ii bulky hodgkin lymphoma ajcc v8
lugano classification advanced stage hodgkin lymphoma ajcc v8
lugano classification stage iii hodgkin lymphoma ajcc v8
lugano classification stage iv hodgkin lymphoma ajcc v8
lugano classification childhood hodgkin lymphoma by ajcc v8 stage
lugano classification limited stage childhood hodgkin lymphoma ajcc v8
exo ii motif
lugano classification stage i childhood hodgkin lymphoma ajcc v8
lugano classification stage ie childhood hodgkin lymphoma ajcc v8
lugano classification stage ii childhood hodgkin lymphoma ajcc v8
lugano classification stage iie childhood hodgkin lymphoma ajcc v8
lugano classification stage ii bulky childhood hodgkin lymphoma ajcc v8
lugano classification advanced stage childhood hodgkin lymphoma ajcc v8
lugano classification stage iii childhood hodgkin lymphoma ajcc v8
lugano classification stage iv childhood hodgkin lymphoma ajcc v8
lugano classification adult hodgkin lymphoma by ajcc v8 stage
exo iii motif
lugano classification limited stage adult hodgkin lymphoma ajcc v8
lugano classification stage i adult hodgkin lymphoma ajcc v8
lugano classification stage ie adult hodgkin lymphoma ajcc v8
lugano classification stage ii adult hodgkin lymphoma ajcc v8
lugano classification stage iie adult hodgkin lymphoma ajcc v8
lugano classification stage ii bulky adult hodgkin lymphoma ajcc v8
lugano classification advanced stage adult hodgkin lymphoma ajcc v8
lugano classification stage iii adult hodgkin lymphoma ajcc v8
lugano classification stage iv adult hodgkin lymphoma ajcc v8
stage ie
teicoplanin
10q24 .1
stage iie
cytopathic effect
childhood lymphoma by ajcc v8 stage
psa level greater than or equal to 0 .05
psa level less than 0 .7
lymphoma by ajcc v8 stage
chronic lymphocytic leukemia -  modified rai staging system
rai stage
chronic lymphocytic leukemia -  binet staging system
stage a chronic lymphocytic leukemia
8p22 - p21
stage b chronic lymphocytic leukemia
stage c chronic lymphocytic leukemia
binet stage
65 kda phosphoprotein
satisfaction with how natural your reconstructed nipples look
anti - cd20 monoclonal antibody
st . jude stage
st . jude childhood non - hodgkin lymphoma by ajcc v8 stage
st . jude stage i childhood non - hodgkin lymphoma ajcc v8
st . jude stage ii childhood non - hodgkin lymphoma ajcc v8
10p15 - p14
st . jude stage iii childhood non - hodgkin lymphoma ajcc v8
st . jude stage iv childhood non - hodgkin lymphoma ajcc v8
lymphocyte - depleted classic hodgkin lymphoma by ann arbor stage
nodular sclerosis classic hodgkin lymphoma by ann arbor stage
mixed cellularity classic hodgkin lymphoma by ann arbor stage
nodular lymphocyte predominant hodgkin lymphoma by ann arbor stage
adult hodgkin lymphoma by ann arbor stage
childhood hodgkin lymphoma by ann arbor stage
no dysphagia
dysphagia to normal solids
5q33 .2 - qter
dysphagia to soft solids
dysphagia to solids and liquids
inability to swallow saliva
deleterious brca gene mutation
beta - 2 - microglobulin greater than 3 g / ml
adult non - hodgkin lymphoma by ann arbor stage
childhood non - hodgkin lymphoma by ann arbor stage
chromosome 13 abnormality
bile duct leakage
coma greater than 24 hours
17q21 - q23
receptor tyrosine kinase gene mutation
death during ,  or within 90 days of ,  index hospital admission
postoperative delayed gastric emptying
b - cell non - hodgkin lymphoma by ann arbor stage
graft ,  prosthesis ,  or flap failure
liver insufficiency
ventilation greater than 48 hours
t - cell non - hodgkin lymphoma by ann arbor stage
deleterious homologous recombination pathway gene mutation
human herpesvirus 1 positive
4q31 .23
b lymphoblastic lymphoma by ann arbor stage
ccaat enhancer binding protein gene mutation
rnf43 gene mutation
burkitt lymphoma by ann arbor stage
diffuse large b - cell lymphoma by ann arbor stage
follicular lymphoma by ann arbor stage
lymphoplasmacytic lymphoma by ann arbor stage
mantle cell lymphoma by ann arbor stage
marginal zone lymphoma by ann arbor stage
small lymphocytic lymphoma by ann arbor stage
5q32
extranodal marginal zone lymphoma of mucosa - associated lymphoid tissue by ann arbor stage
nodal marginal zone lymphoma by ann arbor stage
primary mediastinal  ( thymic )  large b - cell lymphoma by ann arbor stage
centroblastic lymphoma by ann arbor stage
phosphorylated proto - oncogene tyrosine - protein kinase src
regulatory t - cell to effector t - cell ratio measurement
kdr gene product
soluble vascular endothelial growth factor receptor 2
cardiac arrest requiring cardiopulmonary resuscitation
unplanned intubation
4q11 - q13
albumin to bilirubin ratio measurement
neutrophil to lymphocyte ratio measurement
mature t -  and nk - cell lymphoma by ann arbor stage
poseltinib
phosphorylated signal transducer and activator of transcription 3 positive
axl gene amplification
axl gene mutation
serum ca125 measurement
adenovirus positive
65 kda phosphoprotein antibody
yolk sac
66 kda phosphoprotein antibody positive
shh negative
wnt negative
adult t - cell leukemia / lymphoma by ann arbor stage
noncutaneous anaplastic large cell lymphoma by ann arbor stage
commute
transportation
public transportation
shuttle service
taxi service
5q23
driven
parking
noncutaneous childhood anaplastic large cell lymphoma by ann arbor stage
angioimmunoblastic t - cell lymphoma by ann arbor stage
enteropathy - associated t - cell lymphoma by ann arbor stage
nasal type nk / t - cell lymphoma by ann arbor stage
blasts 30 percent or less of bone marrow nucleated cells
fpv vaccine cv301
blasts 5 percent or more of peripheral blood white cells
topotecan
3q13 .12
ccnd2 positive
ccnd3 positive
abcb11 positive
primary cutaneous lymphoma tnm finding v8
mycosis fungoides and sezary syndrome tnm finding v8
abcb4 positive
mycosis fungoides and sezary syndrome distant metastasis tnm finding v8
mycosis fungoides and sezary syndrome m0 tnm finding v8
mycosis fungoides and sezary syndrome m1 tnm finding v8
mycosis fungoides and sezary syndrome lymph nodes tnm finding v8
uba domain
mycosis fungoides and sezary syndrome nx tnm finding v8
mycosis fungoides and sezary syndrome n0 tnm finding v8
mycosis fungoides and sezary syndrome n1 tnm finding v8
htlv - 1 antibody positive
mycosis fungoides and sezary syndrome n1a tnm finding v8
mycosis fungoides and sezary syndrome n1b tnm finding v8
mycosis fungoides and sezary syndrome n2 tnm finding v8
ret positive
mycosis fungoides and sezary syndrome n2a tnm finding v8
mycosis fungoides and sezary syndrome n2b tnm finding v8
6p22 .3
mycosis fungoides and sezary syndrome n3 tnm finding v8
epstein - barr virus negative
mycosis fungoides and sezary syndrome peripheral blood involvement tnm finding v8
mycosis fungoides and sezary syndrome b0 tnm finding v8
mycosis fungoides and sezary syndrome b0a tnm finding v8
mycosis fungoides and sezary syndrome b0b tnm finding v8
mycosis fungoides and sezary syndrome b1 tnm finding v8
mycosis fungoides and sezary syndrome b1a tnm finding v8
mycosis fungoides and sezary syndrome b1b tnm finding v8
mycosis fungoides and sezary syndrome b2 tnm finding v8
11p15 .4
mycosis fungoides and sezary syndrome primary tumor tnm finding v8
mycosis fungoides and sezary syndrome t1 tnm finding v8
mycosis fungoides and sezary syndrome t1a tnm finding v8
mycosis fungoides and sezary syndrome t1b tnm finding v8
mycosis fungoides and sezary syndrome t2 tnm finding v8
mycosis fungoides and sezary syndrome t2a tnm finding v8
mycosis fungoides and sezary syndrome t2b tnm finding v8
mycosis fungoides and sezary syndrome t3 tnm finding v8
mycosis fungoides and sezary syndrome t4 tnm finding v8
pik3cb gene amplification
macromolecular structure
pik3cb gene mutation
sequential chemoradiation
concurrent chemoradiation
strontium - 90 beta radiation
stage iva1
stage iva2
mycosis fungoides and sezary syndrome by ajcc v8 stage
stage i mycosis fungoides and sezary syndrome ajcc v8
stage ia mycosis fungoides and sezary syndrome ajcc v8
stage ib mycosis fungoides and sezary syndrome ajcc v8
cell structure
stage ii mycosis fungoides and sezary syndrome ajcc v8
stage iia mycosis fungoides and sezary syndrome ajcc v8
stage iib mycosis fungoides and sezary syndrome ajcc v8
stage iii mycosis fungoides and sezary syndrome ajcc v8
stage iiia mycosis fungoides and sezary syndrome ajcc v8
stage iiib mycosis fungoides and sezary syndrome ajcc v8
stage iv mycosis fungoides and sezary syndrome ajcc v8
stage iva1 mycosis fungoides and sezary syndrome ajcc v8
stage iva2 mycosis fungoides and sezary syndrome ajcc v8
stage ivb mycosis fungoides and sezary syndrome ajcc v8
extracellular structure
slc39a6 positive
magec1 positive
akt2 gene mutation
mme negative
ccnd2 protein overexpression
porcine leukemia
hemoglobin lepore syndrome
xeroderma pigmentosum variant type
ccnd3 protein overexpression
psa level greater than 0 .03
activating erbb3 mutation
primary cutaneous b - cell / t - cell  ( non - mf / ss )  lymphoma tnm finding v8
primary cutaneous b - cell / t - cell  ( non - mf / ss )  lymphoma distant metastasis tnm finding v8
primary cutaneous b - cell / t - cell  ( non - mf / ss )  lymphoma m0 tnm finding v8
primary cutaneous b - cell / t - cell  ( non - mf / ss )  lymphoma m1 tnm finding v8
primary cutaneous b - cell / t - cell  ( non - mf / ss )  lymphoma lymph nodes tnm finding v8
primary cutaneous b - cell / t - cell  ( non - mf / ss )  lymphoma nx tnm finding v8
primary cutaneous b - cell / t - cell  ( non - mf / ss )  lymphoma n0 tnm finding v8
primary cutaneous b - cell / t - cell  ( non - mf / ss )  lymphoma n1 tnm finding v8
primary cutaneous b - cell / t - cell  ( non - mf / ss )  lymphoma n2 tnm finding v8
primary cutaneous b - cell / t - cell  ( non - mf / ss )  lymphoma n3 tnm finding v8
primary cutaneous b - cell / t - cell  ( non - mf / ss )  lymphoma primary tumor tnm finding v8
primary cutaneous b - cell / t - cell  ( non - mf / ss )  lymphoma t1 tnm finding v8
primary cutaneous b - cell / t - cell  ( non - mf / ss )  lymphoma t1a tnm finding v8
primary cutaneous b - cell / t - cell  ( non - mf / ss )  lymphoma t1b tnm finding v8
primary cutaneous b - cell / t - cell  ( non - mf / ss )  lymphoma t2 tnm finding v8
primary cutaneous b - cell / t - cell  ( non - mf / ss )  lymphoma t2a tnm finding v8
primary cutaneous b - cell / t - cell  ( non - mf / ss )  lymphoma t2b tnm finding v8
immunocompromised
primary cutaneous b - cell / t - cell  ( non - mf / ss )  lymphoma t2c tnm finding v8
primary cutaneous b - cell / t - cell  ( non - mf / ss )  lymphoma t3 tnm finding v8
riss stage
plasma cell myeloma by riss stage
riss stage i plasma cell myeloma
riss stage ii plasma cell myeloma
riss stage iii plasma cell myeloma
epstein - barr virus dna positive
loss of chromosome 4p
wnt family gene alteration positive
trioxifene mesylate
acute
bk virus positive
human herpesvirus 6 positive
jc virus positive
ddit3 gene rearrangement
slc45a2 positive
hepatitis b virus positive
psa level less than twenty five
scgb2a2 positive
ugt1a1*28 allele negative
chronic
simplified preoperative assessment for appendix tumor score
spaat score 0
spaat score 1
spaat score 2
spaat score 3
spaat score 4
spaat score 5
spaat score 6
spaat score 7
recombinant human interleukin - 22 igg2 - fc
anti - her2 - vc0101 adc pf - 06804103
immune checkpoint inhibitor asp8374
neoantigen - loaded autologous dendritic cell vaccine
ehlers - danlos syndrome ,  type v
mental retardation ,  autosomal dominant 1
spebrutinib besylate
tirabrutinib hydrochloride
evobrutinib
zanubrutinib
riviciclib hydrochloride
malignant
voruciclib
briciclib
milademetan
dose - dense ac followed by dose - dense paclitaxel regimen
her2 / neu positive by fish
her2 / neu negative by fish
roxadustat
early third trimester
late third trimester
novottf - 200a device
autosomal dominant lateral temporal lobe epilepsy
gtp cyclohydrolase i deficiency
pf - 04217903 monophosphate
hla - a*0201 ha - 1 positive cells present
recurrent acute biphenotypic leukemia
recurrent acute undifferentiated leukemia
progesterone receptor positive by immunohistochemistry less than 1 percent
progesterone receptor positive by immunohistochemistry 1 - 10 percent
progesterone receptor positive by immunohistochemistry 11 - 20 percent
indolent
progesterone receptor positive by immunohistochemistry 21 - 30 percent
progesterone receptor positive by immunohistochemistry 31 - 40 percent
progesterone receptor positive by immunohistochemistry 41 - 50 percent
progesterone receptor positive by immunohistochemistry 51 - 60 percent
progesterone receptor positive by immunohistochemistry 61 - 70 percent
progesterone receptor positive by immunohistochemistry 71 - 80 percent
progesterone receptor positive by immunohistochemistry 81 - 90 percent
progesterone receptor positive by immunohistochemistry 91 - 100 percent
progesterone receptor positive by immunohistochemistry
cergutuzumab amunaleukin
il13ralpha2 - specific hinge - optimized 4 - 1bb - co - stimulatory car / truncated cd19 - expressing autologous tn / mem cells
occult stage
national program of cancer registries
presumed alive
recode
estrogen receptor positive by immunohistochemistry
estrogen receptor positive by immunohistochemistry less than 1 percent
estrogen receptor positive by immunohistochemistry 1 - 10 percent
estrogen receptor positive by immunohistochemistry 11 - 20 percent
estrogen receptor positive by immunohistochemistry 21 - 30 percent
estrogen receptor positive by immunohistochemistry 31 - 40 percent
estrogen receptor positive by immunohistochemistry 41 - 50 percent
estrogen receptor positive by immunohistochemistry 51 - 60 percent
estrogen receptor positive by immunohistochemistry 61 - 70 percent
estrogen receptor positive by immunohistochemistry 71 - 80 percent
estrogen receptor positive by immunohistochemistry 81 - 90 percent
estrogen receptor positive by immunohistochemistry 91 - 100 percent
not performed
not allowed to collect
bevacizumab / pemetrexed regimen
her2 / neu negative by immunohistochemistry
her2 / neu positive by immunohistochemistry
her2 / neu positive by immunohistochemistry less than 1 percent
her2 / neu positive by immunohistochemistry 1 - 10 percent
her2 / neu positive by immunohistochemistry 11 - 20 percent
her2 / neu positive by immunohistochemistry 21 - 30 percent
her2 / neu positive by immunohistochemistry 31 - 40 percent
her2 / neu positive by immunohistochemistry 41 - 50 percent
her2 / neu positive by immunohistochemistry 51 - 60 percent
vesnarinone
her2 / neu positive by immunohistochemistry 61 - 70 percent
her2 / neu positive by immunohistochemistry 71 - 80 percent
her2 / neu positive by immunohistochemistry 81 - 90 percent
her2 / neu positive by immunohistochemistry 91 - 100 percent
cisplatin / fluorouracil / trastuzumab regimen
capecitabine / cisplatin regimen
ecx regimen
eox regimen
malignant bowel obstruction color code scale
unresectable
malignant bowel obstruction resolved ,  self managing
no malignant bowel obstruction ,  issues with constipation
malignant bowel obstruction ,  ambulatory care management
malignant bowel obstruction ,  inpatient care management
malignant bowel obstruction ,  best supportive care palliative team management
atypical glandular cell - favor neoplasia
atypical endocervical cell
atypical squamous cell - favor high - grade squamous intraepithelial lesion
hematogenous
distress assessment and response tool
feel pain
pain score 0
pain score 1
pain score 2
pain score 3
pain score 4
pain score 5
pain score 6
pain score 7
pain score 8
pain score 9
pain score 10
tiredness visual analogue scale
tiredness score 0
tiredness score 1
tiredness score 2
tiredness score 3
tiredness score 4
tiredness score 5
tiredness score 6
tiredness score 7
tiredness score 8
tiredness score 9
tiredness score 10
drowsiness visual analogue scale
drowsiness score 0
drowsiness score 1
drowsiness score 2
drowsiness score 3
alveolar
drowsiness score 4
malignant bowel obstruction
drowsiness score 5
drowsiness score 6
drowsiness score 7
drowsiness score 8
drowsiness score 9
drowsiness score 10
feel nausea
nausea visual analogue scale
apoptotic
dart nausea score 0
dart nausea score 1
dart nausea score 2
dart nausea score 3
dart nausea score 4
dart nausea score 5
dart nausea score 6
dart nausea score 7
dart nausea score 8
dart nausea score 9
borderline
dart nausea score 10
lack of appetite visual analogue scale
lack of appetite score 0
lack of appetite score 1
lack of appetite score 2
lack of appetite score 3
lack of appetite score 4
lack of appetite score 5
lack of appetite score 6
lack of appetite score 7
high grade
lack of appetite score 8
lack of appetite score 9
lack of appetite score 10
shortness of breath visual analogue scale
shortness of breath score 0
shortness of breath score 1
shortness of breath score 2
shortness of breath score 3
shortness of breath score 4
shortness of breath score 5
invasive
shortness of breath score 6
shortness of breath score 7
shortness of breath score 8
shortness of breath score 9
shortness of breath score 10
depression visual analogue scale
depression score 0
depression score 1
depression score 2
depression score 3
yoshi - 864
in situ
depression score 4
depression score 5
depression score 6
depression score 7
depression score 8
depression score 9
depression score 10
anxiety visual analogue scale
anxiety score 0
anxiety score 1
low grade
anxiety score 2
anxiety score 3
anxiety score 4
anxiety score 5
anxiety score 6
anxiety score 7
anxiety score 8
anxiety score 9
anxiety score 10
well being visual analogue scale
moderately differentiated
well - being score 0
well - being score 1
well - being score 2
well - being score 3
well - being score 4
well - being score 5
well - being score 6
well - being score 7
well - being score 8
well - being score 9
mucinous
well - being score 10
gallium ga 68 pentixafor
have other problem
other problem visual analogue scale
other problem score 0
other problem score 1
other problem score 2
other problem score 3
other problem score 4
myoepithelial
other problem score 5
other problem score 6
other problem score 7
other problem score 8
other problem score 9
other problem score 10
daily activity rating scale
normal activity with no limitations
not normal but fairly active
not feeling well ;  in bed or chair less than half day
normal
little activity ;  in bed or chair most of day
bedridden ;  rarely out of bed
cdisc clinical classification valg test name terminology
cdisc clinical classification valg test code terminology
cdisc clinical classification ajcc v7 test name terminology
cdisc clinical classification ajcc v7 test code terminology
cdisc functional test 10 meter walk / run test name terminology
cdisc functional test 10 meter walk / run test code terminology
cdisc functional test rising from floor test name terminology
cdisc functional test rising from floor test code terminology
papillary
cdisc functional test 4 stair descend test name terminology
cdisc functional test 4 stair descend test code terminology
cdisc functional test 4 stair ascend test name terminology
cdisc functional test 4 stair ascend test code terminology
cdisc questionnaire ipaq short last 7 days self - administered format version test name terminology
cdisc questionnaire ipaq short last 7 days self - administered format version test code terminology
cdisc questionnaire ipaq long last 7 days self - administered format version test name terminology
cdisc questionnaire ipaq long last 7 days self - administered format version test code terminology
cdisc questionnaire ipaq long last 7 days telephone format version test name terminology
cdisc questionnaire ipaq long last 7 days telephone format version test code terminology
poorly differentiated
cdisc questionnaire ipaq short last 7 days telephone format version test name terminology
cdisc questionnaire ipaq short last 7 days telephone format version test code terminology
cdisc questionnaire drri - 2 test name terminology
cdisc questionnaire drri - 2 test code terminology
valg clinical classification question
ajcc v7 clinical classification question
10 meter walk / run functional test question
rising from floor functional test question
4 stair descend functional test question
4 stair ascend functional test question
serous
ipaq short last 7 days self - administered format version questionnaire question
ipaq long last 7 days self - administered format version questionnaire question
ipaq long last 7 days telephone format version questionnaire question
ipaq short last 7 days telephone format version questionnaire question
drri - 2 questionnaire question
veterans administration lung study group clinical classification
ten meter walk / run test functional test
rising from floor test functional test
four stair descend test functional test
four stair ascend test functional test
tubular
international physical activity questionnaire  ( august 2002 )  short last 7 days self - administered format
international physical activity questionnaire  ( august 2002 )  long last 7 days self - administered format
international physical activity questionnaire  ( november 2002 )  long last 7 days telephone format
international physical activity questionnaire  ( august 2002 )  short last 7 days telephone format
deployment risk and resilience inventory - 2 questionnaire
valg  -  cancer stage
ajcc v7  -  primary tumor  ( t )
ajcc v7  -  regional lymph nodes  ( n )
ajcc v7  -  distant metastasis  ( m )
ajcc v7  -  anatomic stage
goserelin acetate
villous
10 meter walk / run  -  time to walk / run 10 meters
10 meter walk / run  -  test grade
rising from floor  -  time to rise from floor
rising from floor  -  test grade
4 stair descend  -  time to descend 4 stairs
4 stair descend  -  test grade
4 stair ascend  -  time to ascend 4 stairs
4 stair ascend  -  test grade
ipaq short last 7 days self - administered format version  -  days vigorous physical activities
ipaq short last 7 days self - administered format version  -  no vigorous physical activities
well differentiated
ipaq short last 7 days self - administered format version  -  vigorous physical hours per day
ipaq short last 7 days self - administered format version  -  vigorous physical minutes per day
ipaq short last 7 days self - administered format version  -  time vigorous don't know / not sure
ipaq short last 7 days self - administered format version  -  days moderate physical activities
ipaq short last 7 days self - administered format version  -  no moderate physical activities
ipaq short last 7 days self - administered format version  -  moderate physical hours per day
ipaq short last 7 days self - administered format version  -  moderate physical minutes per day
ipaq short last 7 days self - administered format version  -  time moderate don't know / not sure
ipaq short last 7 days self - administered format version  -  days walk at least 10 minutes
ipaq short last 7 days self - administered format version  -  no walking
benign
ipaq short last 7 days self - administered format version  -  walking hours per day
ipaq short last 7 days self - administered format version  -  walking minutes per day
ipaq short last 7 days self - administered format version  -  time walking don't know / not sure
ipaq short last 7 days self - administered format version  -  sitting weekday hours per day
ipaq short last 7 days self - administered format version  -  sitting weekday minutes per day
ipaq short last 7 days self - administered format version  -  time sitting don't know / not sure
ipaq long last 7 days self - administered format version  -  currently have job or unpaid work
ipaq long last 7 days self - administered format version  -  days vigorous as part of work
ipaq long last 7 days self - administered format version  -  no vigorous job - related activity
ipaq long last 7 days self - administered format version  -  vigorous work hours per day
recurrent
ipaq long last 7 days self - administered format version  -  vigorous work minutes per day
ipaq long last 7 days self - administered format version  -  days moderate as part of work
ipaq long last 7 days self - administered format version  -  no moderate job - related activity
ipaq long last 7 days self - administered format version  -  moderate work hours per day
ipaq long last 7 days self - administered format version  -  moderate work minutes per day
ipaq long last 7 days self - administered format version  -  days walk as part of your work
ipaq long last 7 days self - administered format version  -  no job - related walking
ipaq long last 7 days self - administered format version  -  walking work hours per day
ipaq long last 7 days self - administered format version  -  walking work minutes per day
ipaq long last 7 days self - administered format version  -  days travel in a motor vehicle
metastatic
ipaq long last 7 days self - administered format version  -  no traveling in a motor vehicle
ipaq long last 7 days self - administered format version  -  traveling hours per day
ipaq long last 7 days self - administered format version  -  traveling minutes per day
ipaq long last 7 days self - administered format version  -  days bicycle place to place
ipaq long last 7 days self - administered format version  -  no bicycling from place to place
ipaq long last 7 days self - administered format version  -  bicycle hours per day
ipaq long last 7 days self - administered format version  -  bicycle minutes per day
ipaq long last 7 days self - administered format version  -  days walk place to place
ipaq long last 7 days self - administered format version  -  no walking from place to place
ipaq long last 7 days self - administered format version  -  walking place hours per day
diffuse
ipaq long last 7 days self - administered format version  -  walking place minutes per day
ipaq long last 7 days self - administered format version  -  days vigorous in the garden / yard
ipaq long last 7 days self - administered format version  -  no vigorous activity garden / yard
ipaq long last 7 days self - administered format version  -  vigorous garden hours per day
ipaq long last 7 days self - administered format version  -  vigorous garden minutes per day
ipaq long last 7 days self - administered format version  -  days moderate in the garden / yard
ipaq long last 7 days self - administered format version  -  no moderate activity garden / yard
ipaq long last 7 days self - administered format version  -  moderate garden hours per day
ipaq long last 7 days self - administered format version  -  moderate garden minutes per day
ipaq long last 7 days self - administered format version  -  days moderate inside home
undifferentiated
ipaq long last 7 days self - administered format version  -  no moderate activity inside home
ipaq long last 7 days self - administered format version  -  moderate home hours per day
ipaq long last 7 days self - administered format version  -  moderate home minutes per day
ipaq long last 7 days self - administered format version  -  days walk in leisure time
ipaq long last 7 days self - administered format version  -  no walking in leisure time
ipaq long last 7 days self - administered format version  -  walking leisure hours per day
ipaq long last 7 days self - administered format version  -  walking leisure minutes per day
ipaq long last 7 days self - administered format version  -  days vigorous in leisure time
ipaq long last 7 days self - administered format version  -  no vigorous activity leisure time
ipaq long last 7 days self - administered format version  -  vigorous leisure hours per day
ipaq long last 7 days self - administered format version  -  vigorous leisure minutes per day
ipaq long last 7 days self - administered format version  -  days moderate in leisure time
ipaq long last 7 days self - administered format version  -  no moderate activity leisure time
ipaq long last 7 days self - administered format version  -  moderate leisure hours per day
ipaq long last 7 days self - administered format version  -  moderate leisure minutes per day
ipaq long last 7 days self - administered format version  -  sitting weekday hours per day
ipaq long last 7 days self - administered format version  -  sitting weekday minutes per day
ipaq long last 7 days self - administered format version  -  sitting weekend hours per day
ipaq long last 7 days self - administered format version  -  sitting weekend minutes per day
ipaq long last 7 days telephone format version  -  currently have job or unpaid work
ipaq long last 7 days telephone format version  -  days vigorous as part of work
ipaq long last 7 days telephone format version  -  vigorous work hours per day
ipaq long last 7 days telephone format version  -  vigorous work minutes per day
ipaq long last 7 days telephone format version  -  vigorous work hours per week
ipaq long last 7 days telephone format version  -  vigorous work minutes per week
ipaq long last 7 days telephone format version  -  days moderate as part of work
ipaq long last 7 days telephone format version  -  moderate work hours per day
ipaq long last 7 days telephone format version  -  moderate work minutes per day
ipaq long last 7 days telephone format version  -  moderate work hours per week
ipaq long last 7 days telephone format version  -  moderate work minutes per week
adenoviridae
ipaq long last 7 days telephone format version  -  days walk as part of your work
ipaq long last 7 days telephone format version  -  walking work hours per day
ipaq long last 7 days telephone format version  -  walking work minutes per day
ipaq long last 7 days telephone format version  -  walking work hours per week
ipaq long last 7 days telephone format version  -  walking work minutes per week
ipaq long last 7 days telephone format version  -  days travel in a motor vehicle
ipaq long last 7 days telephone format version  -  traveling hours per day
ipaq long last 7 days telephone format version  -  traveling minutes per day
ipaq long last 7 days telephone format version  -  traveling hours per week
ipaq long last 7 days telephone format version  -  traveling minutes per week
clodronate disodium
amphibia
ipaq long last 7 days telephone format version  -  days bicycle place to place
ipaq long last 7 days telephone format version  -  bicycle hours per day
ipaq long last 7 days telephone format version  -  bicycle minutes per day
ipaq long last 7 days telephone format version  -  bicycling hours per week
ipaq long last 7 days telephone format version  -  bicycling minutes per week
ipaq long last 7 days telephone format version  -  days walk place to place
ipaq long last 7 days telephone format version  -  walking place hours per day
ipaq long last 7 days telephone format version  -  walking place minutes per day
ipaq long last 7 days telephone format version  -  walking place hours per week
ipaq long last 7 days telephone format version  -  walking place minutes per week
animal virus
ipaq long last 7 days telephone format version  -  days vigorous in the garden / yard
ipaq long last 7 days telephone format version  -  vigorous garden hours per day
ipaq long last 7 days telephone format version  -  vigorous garden minutes per day
ipaq long last 7 days telephone format version  -  vigorous garden hours per week
ipaq long last 7 days telephone format version  -  vigorous garden minutes per week
ipaq long last 7 days telephone format version  -  days moderate in the garden / yard
ipaq long last 7 days telephone format version  -  moderate garden hours per day
ipaq long last 7 days telephone format version  -  moderate garden minutes per day
ipaq long last 7 days telephone format version  -  moderate garden hours per week
ipaq long last 7 days telephone format version  -  moderate garden minutes per week
animal
ipaq long last 7 days telephone format version  -  days moderate inside your home
ipaq long last 7 days telephone format version  -  moderate home hours per day
ipaq long last 7 days telephone format version  -  moderate home minutes per day
ipaq long last 7 days telephone format version  -  moderate home hours per week
ipaq long last 7 days telephone format version  -  moderate home minutes per week
ipaq long last 7 days telephone format version  -  days walk in your leisure time
ipaq long last 7 days telephone format version  -  walking leisure hours per day
ipaq long last 7 days telephone format version  -  walking leisure minutes per day
ipaq long last 7 days telephone format version  -  walking leisure hours per week
ipaq long last 7 days telephone format version  -  walking leisure minutes per week
laboratory animal
ipaq long last 7 days telephone format version  -  days vigorous in your leisure time
ipaq long last 7 days telephone format version  -  vigorous leisure hours per day
ipaq long last 7 days telephone format version  -  vigorous leisure minutes per day
ipaq long last 7 days telephone format version  -  vigorous leisure hours per week
ipaq long last 7 days telephone format version  -  vigorous leisure minutes per week
ipaq long last 7 days telephone format version  -  days moderate in your leisure time
ipaq long last 7 days telephone format version  -  moderate leisure hours per day
ipaq long last 7 days telephone format version  -  moderate leisure minutes per day
ipaq long last 7 days telephone format version  -  moderate leisure hours per week
ipaq long last 7 days telephone format version  -  moderate leisure minutes per week
transgenic animal
ipaq long last 7 days telephone format version  -  sitting weekday hours per day
ipaq long last 7 days telephone format version  -  sitting weekday minutes per day
ipaq long last 7 days telephone format version  -  sitting hours on wednesday
ipaq long last 7 days telephone format version  -  sitting minutes per wednesday
ipaq long last 7 days telephone format version  -  sitting weekend hours per day
ipaq long last 7 days telephone format version  -  sitting weekend minutes per day
ipaq long last 7 days telephone format version  -  sitting hours on saturday
ipaq long last 7 days telephone format version  -  sitting minutes per saturday
ipaq short last 7 days telephone format version  -  days vigorous physical activities
ipaq short last 7 days telephone format version  -  vigorous physical hours per day
armadillo
ipaq short last 7 days telephone format version  -  vigorous physical minutes per day
ipaq short last 7 days telephone format version  -  total vigorous hours per week
ipaq short last 7 days telephone format version  -  total vigorous minutes per week
ipaq short last 7 days telephone format version  -  days moderate physical activities
ipaq short last 7 days telephone format version  -  moderate physical hours per day
ipaq short last 7 days telephone format version  -  moderate physical minutes per day
ipaq short last 7 days telephone format version  -  total moderate hours per week
ipaq short last 7 days telephone format version  -  total moderate minutes per week
ipaq short last 7 days telephone format version  -  days walk at least 10 minutes
ipaq short last 7 days telephone format version  -  walking hours per day
alpharetrovirus
ipaq short last 7 days telephone format version  -  walking minutes per day
ipaq short last 7 days telephone format version  -  total walking hours per week
ipaq short last 7 days telephone format version  -  total walking minutes per week
ipaq short last 7 days telephone format version  -  sitting hours per weekday
ipaq short last 7 days telephone format version  -  sitting minutes per weekday
ipaq short last 7 days telephone format version  -  total sitting hours on wednesday
ipaq short last 7 days telephone format version  -  total sitting minutes on wednesday
drri - 2  -  a: someone close to me died
drri - 2  -  a: went through divorce / was left
drri - 2  -  a: robbed / had my home broken into
bacteria
drri - 2  -  a: saw / heard physical fight parent
drri - 2  -  a: physically punished by parent
drri - 2  -  a: unwanted sex activity childhood
drri - 2  -  a: unwanted sex activity adulthood
drri - 2  -  a: experienced natural disaster
drri - 2  -  a: someone close serious illness
drri - 2  -  a: witnessed someone assaulted
drri - 2  -  a: lost my job / trouble finding job
drri - 2  -  a: emotionally mistreated
drri - 2  -  a: serious financial problems
bacteriophage
drri - 2  -  a: serious physical health problem
drri - 2  -  a: dangerous military duties
drri - 2  -  a: injured by person  -  childhood
drri - 2  -  a: injured by person  -  adulthood
drri - 2  -  a: stressful legal problems
drri - 2  -  b: got along well with my family
drri - 2  -  b: felt like i fit in with family
drri - 2  -  b: family knew what i thought / felt
drri - 2  -  b: contribution family appreciated
drri - 2  -  b: shared interests with family
aves
drri - 2  -  b: opinions were valued by family
drri - 2  -  b: i was affectionate with family
drri - 2  -  b: played important role in family
drri - 2  -  b: spent my free time with family
drri - 2  -  b: family told me when problem
drri - 2  -  b: i could be myself around family
drri - 2  -  b: input sought family decisions
drri - 2  -  c: climate was uncomfortable
drri - 2  -  c: deal with annoying animals
drri - 2  -  c: food was of very poor quality
technetium tc - 99m sestamibi
bovine papillomavirus
drri - 2  -  c: conditions extremely unsanitary
drri - 2  -  c: didn't have bathrooms
drri - 2  -  c: wasn't able to get privacy
drri - 2  -  c: i was exposed to awful smells
drri - 2  -  c: i was subjected to loud noises
drri - 2  -  c: restricted because local custom
drri - 2  -  c: wasn't able to rest
drri - 2  -  c: wasn't able to contact home
drri - 2  -  c: hassle with heavy / annoying gear
drri - 2  -  c: not allowed to get job done
cat
drri - 2  -  c: not have adequate shelter
drri - 2  -  d: went on combat patrols / missions
drri - 2  -  d: assault on entrenched positions
drri - 2  -  d: witnessed someone unit wounded
drri - 2  -  d: encountered land mines
drri - 2  -  d: exposed hostile incoming fire
drri - 2  -  d: exposed to friendly fire
drri - 2  -  d: vehicle / part of convoy attacked
drri - 2  -  d: part of unit fired on enemy
drri - 2  -  d: witnessed enemy wounded / killed
cow
drri - 2  -  d: witnessed civilians wounded
drri - 2  -  d: injured combat - related incident
drri - 2  -  d: fired my weapon enemy combatant
drri - 2  -  d: think i wounded / killed someone
drri - 2  -  d: locating explosive devices
drri - 2  -  d: searching homes / buildings
drri - 2  -  d: participate hand - to - hand combat
drri - 2  -  d: search / disarm potential enemy
drri - 2  -  e: saw people begging for food
drri - 2  -  e: saw refugees who had lost homes
chicken
drri - 2  -  e: observed homes been destroyed
drri - 2  -  e: took care injured / dying people
drri - 2  -  e: saw civilians after wounded
drri - 2  -  e: saw combatants had been wounded
drri - 2  -  e: saw americans had been wounded
drri - 2  -  e: saw bodies of dead enemy
drri - 2  -  e: saw bodies of dead americans
drri - 2  -  e: saw bodies of dead civilians
drri - 2  -  e: interacted with detainees
drri - 2  -  e: sight / sound / smell dead animals
chimera
drri - 2  -  e: involved handling human remains
drri - 2  -  f: took preventative pills
drri - 2  -  f: received vaccinations
drri - 2  -  f: exposed to nerve gas agents
drri - 2  -  f: exposed to mustard gas
drri - 2  -  f: exposed government - issued deet
drri - 2  -  f: exposed to other pesticides
drri - 2  -  f: exposed to smoke / air pollution
drri - 2  -  f: exposed to diesel / fuel on skin
drri - 2  -  f: exposed to fumes from heaters
cryptococcus neoformans
drri - 2  -  f: exposed to depleted uranium
drri - 2  -  f: exposed to burning trash / feces
drri - 2  -  f: exposed to chlorine gas
drri - 2  -  f: exposed to nuclear weapons
drri - 2  -  g: concerned infectious disease
drri - 2  -  g: health might suffer nbc agents
drri - 2  -  g: felt in danger of being wounded
drri - 2  -  g: concerned medicine make me sick
drri - 2  -  g: concerned encounter explosive
drri - 2  -  g: feared sick from pesticides
cytomegalovirus
drri - 2  -  g: concern rocket / mortar would hit
drri - 2  -  g: concerned depleted uranium
drri - 2  -  g: thought i would never survive
drri - 2  -  g: concerned taken hostage
drri - 2  -  g: concerned locals against us
drri - 2  -  g: concerned trapped in crossfire
drri - 2  -  h: had all supplies needed
drri - 2  -  h: confident ability use equipment
drri - 2  -  h: prepared to deal with climate
drri - 2  -  h: accurately informed about role
diptera
drri - 2  -  h: had enough gear in case attack
drri - 2  -  h: training for deployment
drri - 2  -  h: military duties what i expected
drri - 2  -  h: prepared to operate as team
drri - 2  -  h: confident to perform tasks
drri - 2  -  h: taught me everything i needed
drri - 2  -  i: family sincerely interested
drri - 2  -  i: had family i could talk to
drri - 2  -  i: could count on family advice
drri - 2  -  i: relatives look out for family
disease vector
drri - 2  -  i: relatives take care of finances
drri - 2  -  i: happy communication from home
drri - 2  -  i: happy with support from home
drri - 2  -  i: people at home show they cared
drri - 2  -  j: my unit was like family to me
drri - 2  -  j: people in unit were trustworthy
drri - 2  -  j: fellow unit appreciated efforts
drri - 2  -  j: felt valued fellow unit members
drri - 2  -  j: unit interested my well - being
drri - 2  -  j: unit interested what i thought
dna tumor virus
drri - 2  -  j: leader interested what thought
drri - 2  -  j: felt like my efforts counted
drri - 2  -  j: service appreciated by leaders
drri - 2  -  j: could go to leaders if problem
drri - 2  -  j: leaders interested in welfare
drri - 2  -  j: felt valued by leaders of unit
drri - 2  -  k: treated in overly critical way
drri - 2  -  k: uncooperative working with me
drri - 2  -  k: had to work harder prove myself
drri - 2  -  k: questioned my abilities perform
photosensitizing agent
dna virus
drri - 2  -  k: my mistakes worse than others
drri - 2  -  k: make my job more difficult
drri - 2  -  k: put me down
drri - 2  -  k: threatened my physical safety
drri - 2  -  k: made crude sexual remarks at me
drri - 2  -  k: spread rumors sexual activities
drri - 2  -  k: tried to talk into sexual acts
drri - 2  -  k: authority pressure unwanted sex
drri - 2  -  k: offered reward take part in sex
drri - 2  -  k: threatened me if not sex
dog
drri - 2  -  k: touched sexual way against will
drri - 2  -  k: physically forced to have sex
drri - 2  -  l: effect deployment relationship
drri - 2  -  l: missing out on children growth
drri - 2  -  l: missing family events at home
drri - 2  -  l: safety and well - being of spouse
drri - 2  -  l: safety and well - being of child
drri - 2  -  l: unable to help family if crisis
drri - 2  -  l: inability manage family affairs
drri - 2  -  l: damaging career because deploy
drosophila
drri - 2  -  l: care child / dependents receiving
drri - 2  -  l: being cheated on by my spouse
drri - 2  -  l: family ability cope with stress
drri - 2  -  l: spouse ability manage household
drri - 2  -  l: losing my civilian job
drri - 2  -  l: effect relationship my children
drri - 2  -  l: my family financial situation
drri - 2  -  m: problems get in touch family
drri - 2  -  m: someone close serious illness
drri - 2  -  m: family member passed away
enterovirus
drri - 2  -  m: my family had money problems
drri - 2  -  m: spouse cheated on me
drri - 2  -  m: spouse suspected i cheated
drri - 2  -  m: relationship with spouse ended
drri - 2  -  m: had major conflict with family
drri - 2  -  m: family had difficulty adjusting
drri - 2  -  m: my home was robbed
drri - 2  -  m: family member wasted money
drri - 2  -  m: loved one things i disapproved
drri - 2  -  m: fam dangerous military duties
epstein - barr virus
drri - 2  -  m: family got into trouble
drri - 2  -  n: robbed / had my home broken into
drri - 2  -  n: unwanted sexual activity
drri - 2  -  n: went through divorce / was left
drri - 2  -  n: problems getting healthcare
drri - 2  -  n: experienced natural disaster
drri - 2  -  n: someone close serious illness
drri - 2  -  n: witnessed someone assaulted
drri - 2  -  n: lost my job / trouble finding job
drri - 2  -  n: emotionally mistreated
equine infectious anemia virus
drri - 2  -  n: serious financial problems
drri - 2  -  n: serious physical health problem
drri - 2  -  n: stressful legal problems
drri - 2  -  n: injured by another person
drri - 2  -  n: someone close to me has died
drri - 2  -  o: people made me feel at home
drri - 2  -  o: people made me feel proud
drri - 2  -  o: family make me better when down
drri - 2  -  o: go to family when need advice
drri - 2  -  o: family / friends understand
escherichia coli
drri - 2  -  o: i can talk about my deployment
drri - 2  -  o: family would lend money
drri - 2  -  o: family would help move
drri - 2  -  o: someone would help with tasks
drri - 2  -  o: when ill family will help out
drri - 2  -  p: input sought family decisions
drri - 2  -  p: feel like i fit in with family
drri - 2  -  p: family know what i think / feel
drri - 2  -  p: contribution family appreciated
drri - 2  -  p: share interests with family
fish
drri - 2  -  p: opinions valued by family
drri - 2  -  p: i am affectionate with family
drri - 2  -  p: play important role in family
drri - 2  -  p: spend my free time with family
drri - 2  -  p: family tell me when problem
drri - 2  -  p: can be myself around family
drri - 2  -  p: i get along well with my family
anti - lag3 monoclonal antibody mk - 4280
adoptive cell therapy agent
limb - girdle muscular dystrophy type 2a
flavivirus
limb - girdle muscular dystrophy type 2b
limb - girdle muscular dystrophy type 2d
limb - girdle muscular dystrophy type 2z
coenzyme q10 deficiency
bleeding disorder ,  platelet - type 17
aromatic l - amino - acid decarboxylase deficiency
fascin inhibitor np - g2 - 044
fgfr3 nm_000142 .4:c .1948a > g
fgfr3 np_000133 .1:p .k650e
flt3 nm_004119 .2:c .2525a > g
fungus
flt3 np_004110 .2:p .y842c
elevated catecholamine metabolites
rous sarcoma virus positive
merkel cell polyomavirus t antigen positive
psa level greater than or equal to 0 .01
cd3 negative
hla - dp4 positive cells present
hla - a*26 positive cells present
psa level less than one hundred fifty
trisomy 21 mosaicism
oxygen radical
goat
psa level 0 .1 to 0 .7
activating mtor gene mutation
ctag1b positive
lymphoblasts 5 percent or more of bone marrow nucleated cells
elevated serum ca - 125 tumor antigen
fgfr2iiib positive
psa level ten to fifteen
neoplastic plasma cells 10 percent of bone marrow nucleated cells
ctla4 positive
psa level less than 0 .2
guinea pig
hla - a*24:02 positive cells present
neoplastic plasma cells more than 5 percent of peripheral blood white cells
blasts more than 5 percent of bone marrow nucleated cells
blasts 10 percent or less of bone marrow nucleated cells
alk fusion gene positive
activating akt1 gene mutation
activating pik3ca gene mutation
activating pik3r1 gene mutation
activating pik3r2 gene mutation
fgf19 positive
hamster
atm biallelic inactivation
brca1 biallelic inactivation
brca2 biallelic inactivation
ror1 positive
activated b - cell positive
ezh2 gain of function
smarca4 gene mutation
htlv - 1 positive
psa level less than thirty
psa level less than or equal to thirty
hantavirus
mapk gene alteration positive
increasing levels of minimal residual disease
activating fgfr3 gene mutation
ctnnb1 positive
kras positive
alk fusion positive
t ( 11 ; 14 )  positive
lipid nanoparticle encapsulated ox40l mrna - 2416
fth1p5 gene
synthetic htert dna vaccine ino - 1401
hepadnavirus
pharyngeal recess
life
ssb gene
ssb wt allele
lupus la protein
neck lymph node boundary levels i - iv
neck lymph node boundary levels ii - iv
serial transverse cross - sectioning
refractory waldenstrom macroglobulinemia
hepatitis b virus
mag gene
mag wt allele
myelin - associated glycoprotein
apoh gene
apoh wt allele
beta - 2 - glycoprotein 1
concordance
delineate
aversion
mrtfb gene
hepatitis virus
mrtfb wt allele
myocardin - related transcription factor b
c11orf95 / mkl2 fusion gene
c11orf95 / mkl2 fusion protein
teaching rounds
hospital rounds
transition point
levoketoconazole
retifanlimab
abscopal effect
herpesvirus
on treatment
methylmalonic aciduria ,  cbla type
methylmalonic aciduria ,  cblb type
homocystinuria - megaloblastic anemia ,  cble complementation type
methylmalonic aciduria and homocystinuria ,  cblc type
study type
lutetium lu 177 anti - ca19 - 9 monoclonal antibody 5b1
protein arginine methyltransferase 5 inhibitor gsk3326595
diffuse proliferation of pulmonary neuroendocrine cells present
cdisc sdtm arm null reason response terminology
human herpesvirus 6
endorectal coil
8 - core prostate biopsy
12 - core prostate biopsy
sextant core biopsy
4kscore
protocol violation
oncotype dx genomic prostate score
cdisc sdtm vaccines findings about test code terminology
cdisc sdtm vaccines findings about test name terminology
human immunodeficiency virus
cdisc protocol entities clinical study attribute terminology
study variable
abcd1 gene
abcd1 wt allele
atp - binding cassette sub - family d member 1
globin gene
kpnb1 gene
kpnb1 wt allele
importin subunit beta - 1
perflubron
human immunodeficiency virus 1
nectin2 gene
nectin2 wt allele
nectin - 2
autologous cd4 and cd8 positive truncated cd19 - expressing antigen presenting t - cells
znf451 gene
znf451 wt allele
e3 sumo - protein ligase znf451
dennd3 gene
human immunodeficiency virus 2
dennd3 wt allele
denn domain - containing protein 3
znf608 gene
znf608 wt allele
zinc finger protein 608
rragc gene
rragc wt allele
ras - related gtp - binding protein c
klhl14 gene
klhl14 wt allele
horse
kelch - like protein 14
setd1b gene
setd1b wt allele
histone - lysine n - methyltransferase setd1b
znf292 gene
pgi generic modification version  -  overall health
znf292 wt allele
zinc finger protein 292
ino80 gene
htlv - 1
ino80 wt allele
dna helicase ino80
streptococcus pneumoniae igg antibody measurement
minimum angle of resolution
digital sampling rate
type of electrical current sensor
continuous audio recording made indicator
pulse oximeter use indicator
subject assigned to arm but not treated
subject not assigned to arm
htlv - 2
subject received unplanned treatment
fractional area change
estimated mass of left ventricle
left ventricular mass index
cardiac valvular stenosis indicator
cardiac valve stenosis likely etiology
supraventricular premature complex with unknown origin by ecg finding
immediate release capsule dosage form
immediate release tablet dosage form
streptococcus pneumoniae serotype 1 igg antibody measurement
human
streptococcus pneumoniae serotype 2 igg antibody measurement
streptococcus pneumoniae serotype 3 igg antibody measurement
streptococcus pneumoniae serotype 4 igg antibody measurement
streptococcus pneumoniae serotype 5 igg antibody measurement
streptococcus pneumoniae serotype 6b igg antibody measurement
streptococcus pneumoniae serotype 7f igg antibody measurement
streptococcus pneumoniae serotype 8 igg antibody measurement
streptococcus pneumoniae serotype 9n igg antibody measurement
streptococcus pneumoniae serotype 9v igg antibody measurement
streptococcus pneumoniae serotype 10a igg antibody measurement
human papillomavirus
streptococcus pneumoniae serotype 11a igg antibody measurement
streptococcus pneumoniae serotype 12f igg antibody measurement
streptococcus pneumoniae serotype 14 igg antibody measurement
streptococcus pneumoniae serotype 15b igg antibody measurement
streptococcus pneumoniae serotype 17f igg antibody measurement
streptococcus pneumoniae serotype 18c igg antibody measurement
streptococcus pneumoniae serotype 19f igg antibody measurement
streptococcus pneumoniae serotype 19a igg antibody measurement
streptococcus pneumoniae serotype 20 igg antibody measurement
streptococcus pneumoniae serotype 22f igg antibody measurement
insect
streptococcus pneumoniae serotype 23f igg antibody measurement
streptococcus pneumoniae serotype 33f igg antibody measurement
alpha synuclein protein measurement
cocaine amphetamine - regulated transcript protein measurement
cocaine ,  benzoylecgonine ,  and / or ecgonine measurement
estimated average glucose measurement
globulin to creatinine ratio measurement
beta - 1 globulin to total beta protein ratio measurement
hiv - 1 and hiv - 2 antibodies and hiv p24 antigen measurement
huntingtin protein measurement
invertebrate
mutant huntingtin protein measurement
interleukin 1 receptor - like 1 measurement
interleukin 2 receptor subunit alpha measurement
interleukin 2 receptor subunit beta measurement
liquefaction time measurement
neurofilament light chain protein measurement
normal sperm to total sperm ratio measurement
ovalocyte count
round cell count
renal papillary antigen 1 measurement
jc virus
sperm agglutination measurement
sperm aggregation measurement
11 - nor - delta9 - thc - 9 - carboxylic acid measurement
ykl - 40 protein measurement
calcaneal tuberosity
l4 - l5 intervertebral space
hand digit 2 middle phalanx
hand digit 3 middle phalanx
hand digit 4 middle phalanx
perfosfamide
lymphocytic choriomeningitis virus
hand digit 5 middle phalanx
nuchal lymph node
parapharyngeal lymph node
posterior pole of the eye
hand digit 2 proximal phalanx
hand digit 3 proximal phalanx
hand digit 4 proximal phalanx
hand digit 5 proximal phalanx
brainstem portion of the pyramidal tracts
internal capsule of the pyramidal tracts
macaque
radius - lunate joint
rectovaginal space
renal fossa
retroauricular lymph node
scaphoid - lunate joint
scaphoid - radius joint
scaphoid - trapezoid joint
skin between the eyebrows
skin of the back
skin of the chin
cynomolgus monkey
splenic lymph node
submental lymph node
supraclavicular fossa
thoracic artery
trapezium - trapezoid joint
trapezoid - capitate joint
upper urinary system
uterine artery
rhesus monkey
hepatitis c virus rna measurement
hepatitis e virus rna measurement
clinical pathologist
forensic pathologist
clauss method
contrast enhanced pet - ct scan
fluorescent enzyme immunoassay
immunofluorescent staining method
immunomagnetic fluorescence microscopy
kinetic chromogenic assay
mammalia
landolt ring
micro - latex particle - mediated immunoassay
pet - ct scan without contrast
potentiometry
silver - enhanced in situ hybridization
teller acuity cards
international society of urological pathology gleason grade group
intraepidermal nerve fiber density
pax3 - fkhr fusion protein measurement
protocol - specified withdrawal criterion met
mouse mammary tumor virus
log10 minimum angle of resolution
near - point accommodation
number of characters read
number of characters unread
number of lines unread
irecist confirmed progressive disease
irecist complete response
irecist partial response
irecist stable disease
mason - pfizer monkey virus
irecist unconfirmed progressive disease
non irecist complete response - non irecist unconfirmed progressive disease
new lesion indicator
new lesion worsening indicator
non - target lesion worsening indicator
intrasurgical site route of administration
discharge body fluid
further enlargement
experimental organism benign mesoblastic nephroma
temple
measles morbillivirus
striatum nuclei
adenosine a2a receptor antagonist nir178
brinp3 gene
brinp3 wt allele
bmp / retinoic acid - inducible neural - specific protein 3
clinical outcome assessment
data entry
mouse
hypertext markup language
interoperability
adequate and well - controlled study
admission criteria
adverse drug reaction
alpha error
american national standards institute
analysis dataset
nude mouse
analysis set of subjects
analysis variable
anonymization
applet
applicable regulatory requirement
audit report
audit trail
back translation
balanced study
bandwidth
sulforaphane
transgenic mouse
baseline assessment
baseline characteristics
baseline imbalance
bayesian approach
bayesian statistics
beta error
biometric signature
blind review
blinded medication
carry - over effect
moloney leukemia virus
case report form data
case report tabulation
categorical data
causality assessment
cdisc classifier role
cdisc shared health and research electronic library
cdisc standard
certified copy
certified irb professional
clean database
moloney sarcoma virus
clean file
client computer
clinical benefit
clinical clarification
clinical development plan
clinical document
clinical document architecture
clinical encounter
clinical equipoise
clinical generalizability
monkey
clinical investigation
clinical item
clinical laboratory
clinical outcomes assessment concept of interest
clinical outcomes assessment context of use
clinical research and development
clinical study anchor
clinical study data element
clinical study functional role
clinical study report
mouse leukemia virus
clinical trial authorization
clinical trial data
clinical trial dropout
clinical trial exemption
clinical trial information
clinical trial inspection
clinical trial material
mumps virus
clinical trial objective
clinical trial protocol
clinical trial registry
clinician - reported outcome
codelist
cognitive debriefing
commercially confidential information
comparative study
comparator
computer system or software supplier
muridae
confirmatory trial
conformity assessment
consumer safety officer
contingent subject trial contact
control of electronic records
coordinating committee
cumulative enrollment
current enrollment
daily living
data acquisition
avian myeloblastosis virus
data capture
data clarification
data collection instrument
data element identifier
data encryption standard
data integrity
data integrity verification
data interchange
data item
nematoda
data item query
data item query management
data item query resolution
data listing
data management convention
data mapping
data message
data model
data monitoring
data monitoring committee
tumor virus
data originator
data quality
data security
data selection criteria
data storage
data subject
data submission model
data transcription
data transmission
eucerin
organism
data validation
data verification
database frozen
database lock
decision rule
declaration of helsinki
define .xml
de - identified information
demographic data
dependent variable
papillomavirus
document legally authenticated
dosage regimen
dose strength
double - dummy
drug development process
baboon
edit check
effectiveness
electronic case report tabulation
electronic certified copy
electronic clinical trial
electronic data capture
electronic data capture activation
electronic health record
papovavirus
electronic personal health record
electronic record
electronic records control
electronic signature
electronic source data
electronic source document
electronic source record
electronic source report form
equivalence trial
human parainfluenza virus 1
essential trial document
ethics committee
european harmonized standard
european medicines agency
european union competent authority
european union notified body
evaluable for safety and efficacy
exploratory investigational new drug study
extensible markup language data element
extraction transformation load
paramyxoviridae
fda action letter
fda approvable letter
fda clinical outcome assessment qualification
fda memorandum of understanding
fda not approvable letter
fda regulation preamble
fda warning letter
first subject in date time
first subject in identity
picornavirus
first subject screened date time
first subject screened identity
first subject treated date time
first subject treated identity
first - in - human study
frequentist method
global assessment variable
granularity
group sequential design
handwritten signature
plant virus
health - related quality of life
huriet law
hypertext
ich common technical document
ich type of comparison
impartial witness
independent data monitoring committee
independent ethics committee
plant
independent ethics committee opinion
indirect identifier
interim analysis
interim analysis schedule
international marketing authorization birth date
international nonproprietary name
internet service provider
investigational product
investigational subject case history
investigational treatment
poliovirus
investigator recruitment process
investigator / institution
item definition
item group definition
janus clinical trials repository model
janus study data repository
last subject in date time
last subject in identity
last subject last visit date time
last subject last visit identity
recombinant heregulin
polyomavirus
legally acceptable representative
low - interventional clinical trial
marketing authorization procedure
marketing support trials
matched - pair design
medicinal product
medicinal product identifier
medicinal product name
medicines and healthcare products regulatory agency
mega - trial
poxvirus
missing data
multi - institutional clinical study
natural language
new safety information
n - of - 1 study
null hypothesis
nuremberg code
objective measurement
observer assessment
primate
observer - reported outcome
open to enrollment
operational model
original data
pairing
paper case report form
password aging
patient file
patient reported outcome stem
patient - reported outcome item
prokaryote
patient - reported outcome item generation
patient - reported survey instrument
performance outcome
period effect
permanent data
per - protocol analysis set
pharmacoeconomics
pharmacovigilance
planned trial subject contact
postmarketing commitment
rabbit
postmarketing surveillance
pragmatic trial
preclinical study
primary completion date
primary outcome variable
prognostic covariate
prospective study
protected personal data
protocol approval by sponsor
protocol background material
frog
protocol referenced documents
proxy data origin
proxy respondent
proxy - reported outcome
pseudonymization
psychometric instrument reliability
psychometric validation
qualitative variable
quantitative variable
radiopharmaceutical medicinal product
rattus norvegicus
random allocation
random number table
random sample population
raw data
recruitment period
recruitment target
regulated clinical research and information management
repeat activity until rule
research hypothesis
residual risk
human respiratory syncytial virus
response option
results posting
results posting date
retrospective data capture
risk based monitoring
safe - biopharma standard
safety and tolerability
sample size adjustment
schedule of assessments
secondary sponsor
retroviridae
secondary outcome variable
self - evident change
semantic interoperability
sensitive data
sequence arm
serious adverse drug reaction
serious adverse experience
signal of a serious risk
site screening
rna virus
software validation
source document
source document verification
specified substance
sponsor - investigator
standard treatment
stochastic
stopping rules
structured data
rogletimide
rodentia
structured product labeling
study branch
study completion date
study control
study description
study design rationale
study monitoring
study monitoring report
study monitoring visit
saccharomyces cerevisiae
study participant
study publication date
study reconstruction
study report completion date
study start
study subject enrolled
subject data event
subject termination
serratia marcescens
subject well - being
substance screening
superiority trial
supporting variable
surrogate marker
surrogate variable
system migration
tabulation dataset
target study population
technology provider
sheep
terminology
treatment benefit
treatment contrast interaction
treatment - emergent adverse event
trial compliance
trial design model
trial statistician
trial subject replacement
trial termination
simian immunodeficiency virus
trustworthy electronic record
type 3 error
unblinding
unequal randomization
unexpected adverse drug reaction
unexpected serious risk
user site testing
vulnerable subjects
web browser
web page
specific pathogen free organism
web server
source data verification
system alert
rab12 gene
rab12 wt allele
ras - related protein rab - 12
tor1a gene
tor1a wt allele
torsin - 1a
spleen focus - forming virus
slc38a9 gene
slc38a9 wt allele
sodium - coupled neutral amino acid transporter 9
mir509 - 1 gene
mir509 - 2 gene
mir509 - 1 wt allele
mir509 - 2 wt allele
mir509 - 1 pre - mirna
mir509 - 2 pre - mirna
microrna 509 - 5p
simian t - lymphotropic virus type i
mir1243 gene
mir1243 wt allele
mir1243 pre - mirna
microrna 1243
hyperfractionated accelerated radiation delivered with integrated neck surgery
the danish head and neck cancer group
tumor necrosis factor ligand superfamily member 18
wnt signaling pathway inhibitor sm08502
immobilization
active breathing control
streptomyces
thoracic nut carcinoma
lung pecoma
benign lung pecoma
lung malignant pecoma
orexin receptor antagonist
viral transduction
polyamine analogue sbp - 101
neurokinin - 3 receptor antagonist
sv40
lugano lymphoma response classification
lugano lymphoma response classification complete remission by ct
lugano lymphoma response classification partial remission by ct
lugano lymphoma response classification no response / stable disease by ct
lugano lymphoma response classification progressive disease by ct
lugano lymphoma response classification complete remission by pet
lugano lymphoma response classification partial remission by pet
lugano lymphoma response classification no response / stable disease by pet
lugano lymphoma response classification progressive disease by pet
ctrp biomarker terminology
stavudine
sus scrofa domestica
ctrp molecular genetic biomarker terminology
ctrp reference gene terminology
early infantile epileptic encephalopathy 19
early infantile epileptic encephalopathy 36
epilepsy ,  progressive myoclonic 7
gelatinous drop - like corneal dystrophy
transcobalamin ii deficiency
autologous anti - bcma - car - expressing cd4 +  / cd8 +  t - lymphocytes fcarh143
refractory pancreatic carcinoma
ca19 - 9 antigen positive
vaccinia virus
recurrent acute lymphoblastic leukemia
recurrent b acute lymphoblastic leukemia
refractory b acute lymphoblastic leukemia
cd44 targeted agent spl - 108
autologous dendritic cells pulsed with mart - 1  ( 26 - 35 )  peptide
imaging core lab
conventional imaging
perfusion computed tomography target lesion
hla - a*0207 positive cells present
breast cancer locator
vertebrata
etigilimab
anti - april monoclonal antibody bion - 1301
congenital peribronchial myofibroblastic tumor
peribronchial proliferation of neoplastic cells present
pulmonary artery intimal sarcoma
monoclonal antibody trk - 950
pulmonary myxoid sarcoma with ewsr1 - creb1 translocation
lung myoepithelial tumor
lung myoepithelioma
virus
lung myoepithelial carcinoma
methionine aminopeptidase 2 inhibitor m8891
presumed
pulmonary langerhans cell histiocytosis
autologous cd19 / cd22 chimeric antigen receptor t - cells
folr2 positive
braf negative
nras negative
spinocerebellar ataxia type 6
ros1 fusion negative
woman
spa17 positive
akap4 positive
ropn1 positive
pttg1 positive
spanxb1 positive
ccnd1 gene mutation
troriluzole
recurrent malignant glioma
recurrent rhabdoid tumor
xenopus
refractory peripheral primitive neuroectodermal tumor
refractory rhabdomyosarcoma
cerebral adrenoleukodystrophy
refractory ewing sarcoma
refractory hepatoblastoma
refractory malignant glioma
refractory medulloblastoma
refractory osteosarcoma
refractory rhabdoid tumor
letrozole / palbociclib regimen
yeast
lapatinib / letrozole regimen
recurrent anaplastic oligoastrocytoma
recurrent anaplastic oligodendroglioma
everolimus / exemestane regimen
autologous anti - bcma - car expressing stem memory t - cells p - bcma - 101
anti - pd - 1 monoclonal antibody sym021
arginase inhibitor incb001158
metastatic microsatellite stable colorectal carcinoma
advanced microsatellite stable colorectal carcinoma
metastatic bile duct carcinoma
zebrafish
advanced bile duct carcinoma
real imager 8
histone h3 trimethyl lys36
long course chemoradiotherapy
short course chemoradiotherapy
recurrent primary cutaneous lymphoma
refractory primary cutaneous lymphoma
ros1 gene amplification
kras gene mutation negative
feline immunodeficiency virus
refractory alveolar rhabdomyosarcoma
recurrent alveolar rhabdomyosarcoma
recurrent hairy cell leukemia
friability
post - abortion endometritis
hydrosalpinx
autologous anti - cd19 chimeric antigen receptor t - cells sjcar19
anti - k - ras g12v mtcr - transduced autologous peripheral blood lymphocytes
anti - her2 / anti - cd3 bispecific monoclonal antibody gbr 1302
helicobacter pylori
anti - her2 monoclonal antibody / anti - cd137anticalin bispecific fusion protein prs - 343
brugada syndrome
familial hypertrophic cardiomyopathy type 2
spastic paraplegia 3a
long qt syndrome 8
abexinostat hydrochloride
vapreotide
lentivirus
betaretrovirus
spumavirus
scid mouse
avatrombopag maleate
hepatitis e virus
helicobacter
bromhexine hydrochloride
chimpanzee
anti - lag3 monoclonal antibody tsr - 033
insulin degludec
htlv virus
selective estrogen receptor covalent antagonist h3b - 6545
refractory lymphocyte - rich classic hodgkin lymphoma
refractory thyroid gland carcinoma
polychemotherapy
autologous transplantation
number of metastases
limited
parvovirus
spa17 gene
spa17 wt allele
sperm surface protein sp17
akap4 gene
akap4 wt allele
a - kinase anchor protein 4
cephalomannine
rous sarcoma virus
cpg oligodeoxynucleotide tlr9 agonist dv281
breath actuated nebulizer
ropn1 gene
ropn1 wt allele
bacteriophage p1
ropporin - 1a
recurrent skin squamous cell carcinoma
metastatic skin squamous cell carcinoma
neurofibromatosis type 1 with inoperable ,  progressive ,  symptomatic plexiform neurofibromas
inoperable disease
wdr26 gene
wdr26 wt allele
wd repeat - containing protein 26
metap2 gene
bacteriophage t4
metap2 wt allele
methionine aminopeptidase 2
rhpn1 gene
rhpn1 wt allele
rhophilin - 1
tnfsf18 gene
tnfsf18 wt allele
formalin - fixed paraffin - embedded
waterpipe
caenorhabditis elegans
intraoperative nerve monitoring
a1cf gene
a1cf wt allele
apobec1 complementation factor
adenoviral brachyury vaccine etbx - 051
adenoviral muc1 vaccine etbx - 061
dcaf12l2 gene
dcaf12l2 wt allele
ddb1 -  and cul4 - associated factor 12 - like protein 2
cysltr2 gene
caliciviridae
cysltr2 wt allele
cysteinyl leukotriene receptor 2
csmd3 gene
csmd3 wt allele
cub and sushi domain - containing protein 3
national cancer institute terminology
crnkl1 gene
gammaretrovirus
crnkl1 wt allele
crooked neck - like protein 1
col3a1 gene
col3a1 wt allele
col3a1 gene product
collagen alpha - 1 ( iii )  chain
cnbd1 gene
cnbd1 wt allele
cyclic nucleotide - binding domain - containing protein 1
prime cancer vaccine mva - bn - cv301
arenavirus
autologous gamma - retroviral msgv1 139 scfv egfrviii car gene - modified t cells
chst11 gene
chst11 wt allele
carbohydrate sulfotransferase 11
larp4b gene
larp4b wt allele
la - related protein 4b
fgfr4 antagonist incb062079
ido - 1 inhibitor ly3381916
polg gene
paramyxovirinae
polg wt allele
dna polymerase subunit gamma - 1
pabpc1 gene
pabpc1 wt allele
polyadenylate - binding protein 1
nbea gene
nbea wt allele
neurobeachin
s100a7 gene
s100a7 wt allele
pneumovirinae
protein s100 - a7
posttherapy clinical tnm finding
rgpd3 gene
rgpd3 wt allele
ranbp2 - like and grip domain - containing protein 3
refractory marginal zone lymphoma
morbillivirus
prpf40b gene
prpf40b wt allele
pre - mrna - processing factor 40 homolog b
cdh10 gene
cdh10 wt allele
cadherin - 10
cdh17 gene
cdh17 wt allele
cadherin - 17
c - met inhibitor
imiquimod
paramyxovirus
znf429 gene
znf429 wt allele
zinc finger protein 429
znf479 gene
znf479 wt allele
zinc finger protein 479
wnk2 gene
wnk2 wt allele
serine / threonine - protein kinase wnk2
fam47c gene
human herpesvirus 1
fam47c wt allele
putative protein fam47c
fam135b gene
fam135b wt allele
protein fam135b
ctnna2 gene
ctnna2 wt allele
catenin alpha - 2
rgs7 gene
rgs7 wt allele
hepatitis c virus
regulator of g - protein signaling 7
prdm2 gene
prdm2 wt allele
pr domain zinc finger protein 2
foxr1 gene
foxr1 wt allele
forkhead box protein r1
fkbp9 gene
fkbp9 wt allele
peptidyl - prolyl cis - trans isomerase fkbp9
equidae
fbln2 gene
fbln2 wt allele
fibulin - 2
fat3 gene
fat3 wt allele
protocadherin fat 3
arfrp1 gene
arfrp1 wt allele
adp - ribosylation factor - related protein 1
sencar mouse
tabelecleucel
topical vbp - 926 solution
arf1 gene
arf1 wt allele
adp - ribosylation factor 1
adp - ribosylation factor 6
arf6 gene
arf6 wt allele
transrectal ultrasonography guided biopsy
psa doubling time
canarypox virus
restriction spectrum imaging
masaoka - koga stage
blasts under 15 percent of peripheral blood white cells
blasts under 15 percent of bone marrow nucleated cells
blasts under 30 percent of peripheral blood white cells
trimeric gitrl - fc omp - 336b11
anti - cd19 - cd20 - car - cd3zeta - 4 - 1bb - expressing autologous t - lymphocytes
allogeneic nicotinamide - expanded natural killer cells
microtubule inhibitor scb01a
hou gu mi xi
infectious agent
life expectancy greater than six months
prostate specific antigen density
onvansertib
human virus
ovine jaagziekte virus
human papillomavirus - 6
eosinophilia ,  ctcae
methemoglobinemia ,  ctcae
cyanosis ,  ctcae
hypophysitis ,  ctcae
hypopituitarism ,  ctcae
testosterone deficiency ,  ctcae
vision decreased ,  ctcae
anal fissure ,  ctcae
belching ,  ctcae
chylous ascites ,  ctcae
sulofenur
poikilotherms
rectal fissure ,  ctcae
disease progression ,  ctcae
generalized edema ,  ctcae
vaccination site lymphadenopathy ,  ctcae
budd - chiari syndrome ,  ctcae
sinusoidal obstruction syndrome ,  ctcae
bacteremia ,  ctcae
cytomegalovirus infection reactivation ,  ctcae
epstein - barr virus infection reactivation ,  ctcae
folliculitis ,  ctcae
felidae
fungemia ,  ctcae
hepatitis b reactivation ,  ctcae
herpes simplex reactivation ,  ctcae
shingles ,  ctcae
thrush ,  ctcae
viremia ,  ctcae
vaccination complication ,  ctcae
blood bicarbonate decreased ,  ctcae
blood lactate dehydrogenase increased ,  ctcae
electrocardiogram t wave abnormal ,  ctcae
suidae
thyroid stimulating hormone increased ,  ctcae
hyperlipidemia ,  ctcae
hyperphosphatemia ,  ctcae
chest wall necrosis ,  ctcae
muscle cramp ,  ctcae
osteonecrosis ,  ctcae
rhabdomyolysis ,  ctcae
rotator cuff injury ,  ctcae
skin papilloma ,  ctcae
tumor hemorrhage ,  ctcae
bovidae
anosmia ,  ctcae
guillain - barre syndrome ,  ctcae
myasthenia gravis ,  ctcae
spinal cord compression ,  ctcae
tendon reflex decreased ,  ctcae
trochlear nerve disorder ,  ctcae
pregnancy loss ,  ctcae
dysuria ,  ctcae
glucosuria ,  ctcae
nephrotic syndrome ,  ctcae
virus - like particle
amenorrhea ,  ctcae
oropharyngeal pain ,  ctcae
rhinorrhea ,  ctcae
eczema ,  ctcae
hair color changes ,  ctcae
hair texture abnormal ,  ctcae
hyperkeratosis ,  ctcae
nail changes ,  ctcae 5 .0
subcutaneous emphysema ,  ctcae
arterial thromboembolism ,  ctcae
hepatitis a virus
immune checkpoint inhibitor
anti - cd123 adc imgn632
abdominal distension ,  ctcae
abdominal infection ,  ctcae
abdominal pain ,  ctcae
abdominal soft tissue necrosis ,  ctcae
abducens nerve disorder ,  ctcae
accessory nerve disorder ,  ctcae
acidosis ,  ctcae
rubulavirus
acoustic nerve disorder nos ,  ctcae
activated partial thromboplastin time prolonged ,  ctcae
acute kidney injury ,  ctcae
akathisia ,  ctcae
alanine aminotransferase increased ,  ctcae
alcohol intolerance ,  ctcae
alkaline phosphatase increased ,  ctcae
human herpesvirus 8
alkalosis ,  ctcae
allergic reaction ,  ctcae
allergic rhinitis ,  ctcae
amnesia ,  ctcae
anal fistula ,  ctcae
anal hemorrhage ,  ctcae
anal mucositis ,  ctcae
anal necrosis ,  ctcae
anal pain ,  ctcae
gb virus c
anal stenosis ,  ctcae
anal ulcer ,  ctcae
anaphylaxis ,  ctcae
anemia ,  ctcae
ankle fracture ,  ctcae
anorectal infection ,  ctcae
anorgasmia ,  ctcae
aortic injury ,  ctcae
microorganism
aortic valve disease ,  ctcae
aphonia ,  ctcae
appendicitis perforated ,  ctcae
appendicitis ,  ctcae
arachnoiditis ,  ctcae
arterial injury ,  ctcae
arteritis infective ,  ctcae
arthralgia ,  ctcae
arthritis ,  ctcae
liarozole
helicobacter felis
ascites ,  ctcae
aspartate aminotransferase increased ,  ctcae
atrioventricular block complete ,  ctcae
atrioventricular block first degree ,  ctcae
canidae
autoimmune disorder ,  ctcae
avascular necrosis ,  ctcae
azoospermia ,  ctcae
bile duct stenosis ,  ctcae
biliary anastomotic leak ,  ctcae
biliary fistula ,  ctcae
biliary tract infection ,  ctcae
bladder anastomotic leak ,  ctcae
bladder infection ,  ctcae
avian leukemia sarcoma virus
bloating ,  ctcae
blood antidiuretic hormone abnormal ,  ctcae
blood bilirubin increased ,  ctcae
blood corticotrophin decreased ,  ctcae
blood gonadotrophin abnormal ,  ctcae
blood prolactin abnormal ,  ctcae
marine organism
body odor ,  ctcae
bone infection ,  ctcae
bone marrow hypocellular ,  ctcae
breast atrophy ,  ctcae
breast infection ,  ctcae
bronchial fistula ,  ctcae
bronchial infection ,  ctcae
endogenous retrovirus
bronchial obstruction ,  ctcae
bronchial stricture ,  ctcae
bronchopleural fistula ,  ctcae
bronchopulmonary hemorrhage ,  ctcae
bronchospasm ,  ctcae
bruising ,  ctcae
bullous dermatitis ,  ctcae
capillary leak syndrome ,  ctcae
carbon monoxide diffusing capacity decreased ,  ctcae
cardiac arrest ,  ctcae
cardiac troponin i increased ,  ctcae
cardiac troponin t increased ,  ctcae
catheter related infection ,  ctcae
cd4 lymphocytes decreased ,  ctcae
cecal hemorrhage ,  ctcae
cecal infection ,  ctcae
vascular plant
central nervous system necrosis ,  ctcae
cerebrospinal fluid leakage ,  ctcae
cervicitis infection ,  ctcae
chest pain  -  cardiac ,  ctcae
chills ,  ctcae
cholesterol high ,  ctcae
chronic kidney disease ,  ctcae
bovine papillomavirus - 1
colonic fistula ,  ctcae
colonic hemorrhage ,  ctcae
colonic obstruction ,  ctcae
colonic perforation ,  ctcae
colonic stenosis ,  ctcae
colonic ulcer ,  ctcae
concentration impairment ,  ctcae
human papillomavirus type 16
conduction disorder ,  ctcae
conjunctivitis infective ,  ctcae
conjunctivitis ,  ctcae
corneal infection ,  ctcae
corneal ulcer ,  ctcae
cpk increased ,  ctcae
knock - out mouse
cranial nerve infection ,  ctcae
creatinine increased ,  ctcae
cushingoid ,  ctcae
cystitis noninfective ,  ctcae
cytokine release syndrome ,  ctcae
death neonatal ,  ctcae
death nos ,  ctcae
delayed orgasm ,  ctcae
lobaplatin
non - vascular plant
delirium ,  ctcae
delusions ,  ctcae
dental caries ,  ctcae
depressed level of consciousness ,  ctcae
dermatitis radiation ,  ctcae
device related infection ,  ctcae
primate retrovirus
dry eye ,  ctcae
dry mouth ,  ctcae
duodenal hemorrhage ,  ctcae
duodenal infection ,  ctcae
duodenal obstruction ,  ctcae
duodenal perforation ,  ctcae
duodenal stenosis ,  ctcae
duodenal ulcer ,  ctcae
pvc - 211 mulv
dysarthria ,  ctcae
dysesthesia ,  ctcae
dysgeusia ,  ctcae
dysmenorrhea ,  ctcae
dyspareunia ,  ctcae
dyspepsia ,  ctcae
dysphasia ,  ctcae
ear pain ,  ctcae
edema cerebral ,  ctcae
edema face ,  ctcae
edema limbs ,  ctcae
edema trunk ,  ctcae
ejaculation disorder ,  ctcae
ejection fraction decreased ,  ctcae
electrocardiogram qt corrected interval prolonged ,  ctcae
encephalitis infection ,  ctcae
encephalomyelitis infection ,  ctcae
sloan kettering virus
endocarditis infective ,  ctcae
endophthalmitis ,  ctcae
enterocolitis infectious ,  ctcae
enterocolitis ,  ctcae
enterovesical fistula ,  ctcae
epistaxis ,  ctcae
erythema multiforme ,  ctcae
erythroderma ,  ctcae
esophageal anastomotic leak ,  ctcae
esophageal hemorrhage ,  ctcae
esophageal infection ,  ctcae
esophageal necrosis ,  ctcae
esophageal obstruction ,  ctcae
esophageal pain ,  ctcae
esophageal perforation ,  ctcae
esophageal stenosis ,  ctcae
negative sense ssrna virus
esophageal ulcer ,  ctcae
extraocular muscle paresis ,  ctcae
extrapyramidal disorder ,  ctcae
eye infection ,  ctcae
deltaretrovirus
eyelid function disorder ,  ctcae
facial muscle weakness ,  ctcae
facial nerve disorder ,  ctcae
facial pain ,  ctcae
fall ,  ctcae
fallopian tube anastomotic leak ,  ctcae
fat atrophy ,  ctcae
double stranded dna virus
febrile neutropenia ,  ctcae
fecal incontinence ,  ctcae
feminization acquired ,  ctcae
fetal growth retardation ,  ctcae
fever ,  ctcae
fibrinogen decreased ,  ctcae
fibrosis deep connective tissue ,  ctcae
flank pain ,  ctcae
flashing lights ,  ctcae
other virus grouping
floaters ,  ctcae
flu like symptoms ,  ctcae
forced expiratory volume decreased ,  ctcae
gait disturbance ,  ctcae
gallbladder infection ,  ctcae
gastric anastomotic leak ,  ctcae
gastric fistula ,  ctcae
efaproxiral
single stranded dna virus
gastric hemorrhage ,  ctcae
gastric necrosis ,  ctcae
gastric perforation ,  ctcae
gastric stenosis ,  ctcae
gastric ulcer ,  ctcae
gastroesophageal reflux disease ,  ctcae
gastrointestinal anastomotic leak ,  ctcae
positive sense ssrna virus
gastrointestinal pain ,  ctcae
gastrointestinal stoma necrosis ,  ctcae
gastroparesis ,  ctcae
generalized muscle weakness ,  ctcae
genital edema ,  ctcae
ggt increased ,  ctcae
glossopharyngeal nerve disorder ,  ctcae
glucose intolerance ,  ctcae
consomic strain
growth accelerated ,  ctcae
growth hormone abnormal ,  ctcae
growth suppression ,  ctcae
gum infection ,  ctcae
hallucinations ,  ctcae
haptoglobin decreased ,  ctcae
headache ,  ctcae
hearing impaired ,  ctcae
heart failure ,  ctcae
recombinants
hematosalpinx ,  ctcae
hematuria ,  ctcae
hemoglobin increased ,  ctcae
hemolytic uremic syndrome ,  ctcae
hemorrhoidal hemorrhage ,  ctcae
hepatic failure ,  ctcae
laboratory organism
hepatic hemorrhage ,  ctcae
hepatic infection ,  ctcae
hepatic pain ,  ctcae
hepatitis viral ,  ctcae
hiccups ,  ctcae
hip fracture ,  ctcae
hirsutism ,  ctcae
hoarseness ,  ctcae
hot flashes ,  ctcae
agents of opportunistic infection
hypercalcemia ,  ctcae
hyperglycemia ,  ctcae
hyperhidrosis ,  ctcae
hyperkalemia ,  ctcae
hypermagnesemia ,  ctcae
hypernatremia ,  ctcae
hyperparathyroidism ,  ctcae
hypersomnia ,  ctcae
hyperthyroidism ,  ctcae
hypertrichosis ,  ctcae
hypertriglyceridemia ,  ctcae
hyperuricemia ,  ctcae
hypoalbuminemia ,  ctcae
hypocalcemia ,  ctcae
hypoglossal nerve disorder ,  ctcae
hypoglycemia ,  ctcae
hypohidrosis ,  ctcae
hypokalemia ,  ctcae
hypomagnesemia ,  ctcae
hyponatremia ,  ctcae
hypoparathyroidism ,  ctcae
hypophosphatemia ,  ctcae
hypothyroidism ,  ctcae
ileal stenosis ,  ctcae
leporidae
infective myositis ,  ctcae
infusion related reaction ,  ctcae
infusion site extravasation ,  ctcae
injection site reaction ,  ctcae
injury to carotid artery ,  ctcae
injury to jugular vein ,  ctcae
injury to superior vena cava ,  ctcae
invertebrates ,  land
inr increased ,  ctcae
intestinal stoma leak ,  ctcae
intestinal stoma obstruction ,  ctcae
intestinal stoma site bleeding ,  ctcae
intra - abdominal hemorrhage ,  ctcae
intracranial hemorrhage ,  ctcae
intraoperative arterial injury ,  ctcae
intraoperative breast injury ,  ctcae
intraoperative cardiac injury ,  ctcae
baccatin iii
invertebrates ,  marine
intraoperative ear injury ,  ctcae
intraoperative endocrine injury ,  ctcae
intraoperative gastrointestinal injury ,  ctcae
intraoperative head and neck injury ,  ctcae
intraoperative hemorrhage ,  ctcae
intraoperative hepatobiliary injury ,  ctcae
intraoperative musculoskeletal injury ,  ctcae
intraoperative neurological injury ,  ctcae
intraoperative ocular injury ,  ctcae
intraoperative renal injury ,  ctcae
foamy retrovirus
intraoperative reproductive tract injury ,  ctcae
intraoperative respiratory injury ,  ctcae
intraoperative splenic injury ,  ctcae
intraoperative urinary injury ,  ctcae
intraoperative venous injury ,  ctcae
irregular menstruation ,  ctcae
irritability ,  ctcae
ischemia cerebrovascular ,  ctcae
friend murine leukemia virus
jejunal perforation ,  ctcae
jejunal stenosis ,  ctcae
joint infection ,  ctcae
joint range of motion decreased cervical spine ,  ctcae
joint range of motion decreased lumbar spine ,  ctcae
joint range of motion decreased ,  ctcae
kidney anastomotic leak ,  ctcae
kidney infection ,  ctcae
kyphosis ,  ctcae
lactation disorder ,  ctcae
large intestinal anastomotic leak ,  ctcae
laryngeal edema ,  ctcae
laryngeal inflammation ,  ctcae
laryngeal mucositis ,  ctcae
laryngeal obstruction ,  ctcae
genital herpes
laryngeal stenosis ,  ctcae
laryngitis ,  ctcae
laryngopharyngeal dysesthesia ,  ctcae
laryngospasm ,  ctcae
lethargy ,  ctcae
leukemia secondary to oncology chemotherapy ,  ctcae
leukocytosis ,  ctcae
leukoencephalopathy ,  ctcae
libido decreased ,  ctcae
congenic strain
libido increased ,  ctcae
lip infection ,  ctcae
lipase increased ,  ctcae
lipohypertrophy ,  ctcae
localized edema ,  ctcae
lordosis ,  ctcae
lower gastrointestinal hemorrhage ,  ctcae
lung infection ,  ctcae
lymph gland infection ,  ctcae
lymph leakage ,  ctcae
man
lymphedema ,  ctcae
lymphocyte count decreased ,  ctcae
lymphocyte count increased ,  ctcae
malaise ,  ctcae
mania ,  ctcae
mediastinal infection ,  ctcae
meningismus ,  ctcae
latent virus
meningitis ,  ctcae
menorrhagia ,  ctcae
middle ear inflammation ,  ctcae
mitral valve disease ,  ctcae
movements involuntary ,  ctcae
mucosal infection ,  ctcae
mucositis oral ,  ctcae
lytic virus
multi - organ failure ,  ctcae
muscle weakness left - sided ,  ctcae
muscle weakness lower limb ,  ctcae
muscle weakness right - sided ,  ctcae
muscle weakness trunk ,  ctcae
muscle weakness upper limb ,  ctcae
musculoskeletal deformity ,  ctcae
myalgia ,  ctcae
lower organism
myelodysplastic syndrome ,  ctcae
myocardial infarction ,  ctcae
nail discoloration ,  ctcae
nail infection ,  ctcae
nail loss ,  ctcae
nail ridging ,  ctcae
nasal congestion ,  ctcae
recombinant cd40 - ligand
neck edema ,  ctcae
neuralgia ,  ctcae
neutrophil count decreased ,  ctcae
night blindness ,  ctcae
nipple deformity ,  ctcae
non - cardiac chest pain ,  ctcae
oncornavirus
obstruction gastric ,  ctcae
oculomotor nerve disorder ,  ctcae
olfactory nerve disorder ,  ctcae
oligospermia ,  ctcae
optic nerve disorder ,  ctcae
oral cavity fistula ,  ctcae
oral dysesthesia ,  ctcae
osteonecrosis of jaw ,  ctcae
otitis externa ,  ctcae
otitis media ,  ctcae
ovarian infection ,  ctcae
ovarian rupture ,  ctcae
pain in extremity ,  ctcae
pain of skin ,  ctcae
pain ,  ctcae
palmar - plantar erythrodysesthesia syndrome ,  ctcae
pancreas infection ,  ctcae
pancreatic anastomotic leak ,  ctcae
consomic mouse strain
pancreatic duct stenosis ,  ctcae
pancreatic enzymes decreased ,  ctcae
pancreatic necrosis ,  ctcae
papilledema ,  ctcae
papulopustular rash ,  ctcae
paresthesia ,  ctcae
paronychia ,  ctcae
paroxysmal atrial tachycardia ,  ctcae
pelvic floor muscle weakness ,  ctcae
recombinant inbred strain
pelvic infection ,  ctcae
penile infection ,  ctcae
perforation bile duct ,  ctcae
pericardial effusion ,  ctcae
pericardial tamponade ,  ctcae
periorbital edema ,  ctcae
periorbital infection ,  ctcae
peripheral ischemia ,  ctcae
escape mutant
peripheral motor neuropathy ,  ctcae
peripheral nerve infection ,  ctcae
peripheral sensory neuropathy ,  ctcae
peritoneal infection ,  ctcae
personality change ,  ctcae
pharyngeal anastomotic leak ,  ctcae
pharyngeal mucositis ,  ctcae
pharyngeal stenosis ,  ctcae
pharyngitis ,  ctcae
pharyngolaryngeal pain ,  ctcae
other organism groupings
phlebitis infective ,  ctcae
phlebitis ,  ctcae
platelet count decreased ,  ctcae
pleural effusion ,  ctcae
pleural infection ,  ctcae
pneumonitis ,  ctcae
portal hypertension ,  ctcae
human papillomavirus type 18
portal vein thrombosis ,  ctcae
postnasal drip ,  ctcae
postoperative hemorrhage ,  ctcae
postoperative thoracic procedure complication ,  ctcae
premature delivery ,  ctcae
premature menopause ,  ctcae
presyncope ,  ctcae
propionibacterium acnes
productive cough ,  ctcae
prolapse of intestinal stoma ,  ctcae
prolapse of urostomy ,  ctcae
prostate infection ,  ctcae
prostatic obstruction ,  ctcae
psychosis ,  ctcae
pulmonary edema ,  ctcae
viscum album
pulmonary fibrosis ,  ctcae
pulmonary fistula ,  ctcae
pulmonary valve disease ,  ctcae
purpura ,  ctcae
pyramidal tract syndrome ,  ctcae
radiation recall reaction  ( dermatologic )  ,  ctcae
radiculitis ,  ctcae
rash acneiform ,  ctcae
rash maculo - papular ,  ctcae
troxacitabine
wn ,  rat strain
rash pustular ,  ctcae
rectal anastomotic leak ,  ctcae
rectal mucositis ,  ctcae
rectal stenosis ,  ctcae
recurrent laryngeal nerve palsy ,  ctcae
renal calculi ,  ctcae
renal colic ,  ctcae
respiratory failure ,  ctcae
sd / rij ,  rat strain
restlessness ,  ctcae
retinal tear ,  ctcae
retinal vascular disorder ,  ctcae
reversible posterior leukoencephalopathy syndrome ,  ctcae
rhinitis infective ,  ctcae
om ,  rat strain
salivary duct inflammation ,  ctcae
salivary gland infection ,  ctcae
scleral disorder ,  ctcae
scoliosis ,  ctcae
scrotal infection ,  ctcae
sepsis ,  ctcae
serum amylase increased ,  ctcae
lou / c ,  rat strain
sinus disorder ,  ctcae
sinusitis ,  ctcae
skin hyperpigmentation ,  ctcae
skin hypopigmentation ,  ctcae
skin induration ,  ctcae
skin infection ,  ctcae
skin ulceration ,  ctcae
hmt ,  rat strain
sleep apnea ,  ctcae
small intestinal anastomotic leak ,  ctcae
small intestinal mucositis ,  ctcae
small intestinal obstruction ,  ctcae
small intestinal stenosis ,  ctcae
small intestine infection ,  ctcae
small intestine ulcer ,  ctcae
sneezing ,  ctcae
soft tissue infection ,  ctcae
da ,  rat strain
soft tissue necrosis lower limb ,  ctcae
soft tissue necrosis upper limb ,  ctcae
somnolence ,  ctcae
sore throat ,  ctcae
spasticity ,  ctcae
spermatic cord anastomotic leak ,  ctcae
spinal fracture ,  ctcae
splenic infection ,  ctcae
stenosis of gastrointestinal stoma ,  ctcae
stevens - johnson syndrome ,  ctcae
bdvi ,  rat strain
stoma site infection ,  ctcae
stridor ,  ctcae
stroke ,  ctcae
sudden death nos ,  ctcae
suicidal ideation ,  ctcae
suicide attempt ,  ctcae
superficial soft tissue fibrosis ,  ctcae
superficial thrombophlebitis ,  ctcae
superior vena cava syndrome ,  ctcae
bdix ,  rat strain
testicular disorder ,  ctcae
thromboembolic event ,  ctcae
thrombotic thrombocytopenic purpura ,  ctcae
tooth development disorder ,  ctcae
tooth discoloration ,  ctcae
tooth infection ,  ctcae
toothache ,  ctcae
bdii ,  rat strain
toxic epidermal necrolysis ,  ctcae
tracheal mucositis ,  ctcae
tracheal obstruction ,  ctcae
tracheal stenosis ,  ctcae
tracheitis ,  ctcae
tracheostomy site bleeding ,  ctcae
transient ischemic attacks ,  ctcae
treatment related secondary malignancy ,  ctcae
tricuspid valve disease ,  ctcae
a990 ,  rat strain
trigeminal nerve disorder ,  ctcae
unequal limb length ,  ctcae
upper gastrointestinal hemorrhage ,  ctcae
upper respiratory infection ,  ctcae
ureteric anastomotic leak ,  ctcae
urethral anastomotic leak ,  ctcae
urethral infection ,  ctcae
dolastatin 15
wf ,  rat strain
urinary fistula ,  ctcae
urinary frequency ,  ctcae
urinary tract infection ,  ctcae
urinary tract obstruction ,  ctcae
urinary tract pain ,  ctcae
urinary urgency ,  ctcae
urine discoloration ,  ctcae
urine output decreased ,  ctcae
w / nhg ,  rat strain
urostomy leak ,  ctcae
urostomy obstruction ,  ctcae
urostomy site bleeding ,  ctcae
urostomy stenosis ,  ctcae
uterine anastomotic leak ,  ctcae
uterine fistula ,  ctcae
uterine infection ,  ctcae
uterine obstruction ,  ctcae
uterine perforation ,  ctcae
aci ,  rat strain
vaginal anastomotic leak ,  ctcae
vaginal discharge ,  ctcae
vaginal infection ,  ctcae
vaginal inflammation ,  ctcae
vaginal stricture ,  ctcae
vagus nerve disorder ,  ctcae
vas deferens anastomotic leak ,  ctcae
vascular access complication ,  ctcae
a28807 ,  rat strain
vasovagal reaction ,  ctcae
venous injury ,  ctcae
vertigo ,  ctcae
vestibular disorder ,  ctcae
virilization ,  ctcae
visceral arterial ischemia ,  ctcae
vital capacity abnormal ,  ctcae
bb ,  rat strain
voice alteration ,  ctcae
vulval infection ,  ctcae
watering eyes ,  ctcae
wheezing ,  ctcae
white blood cell decreased ,  ctcae
wound complication ,  ctcae
bn ,  rat strain
wound dehiscence ,  ctcae
wound infection ,  ctcae
wrist fracture ,  ctcae
ad - rts - hil - 12
systematic programmed illumination
blood inflammatory marker
evlp cmv gb - pp65 plus gm - csf vbi - 1901
anti - pd - 1 / anti - lag - 3 dart protein mgd013
grade 1 abdominal distension ,  ctcae
grade 1 abdominal pain ,  ctcae
buf ,  rat strain
grade 1 abducens nerve disorder ,  ctcae
grade 1 accessory nerve disorder ,  ctcae
grade 1 acidosis ,  ctcae
grade 1 acoustic nerve disorder nos ,  ctcae
grade 1 activated partial thromboplastin time prolonged ,  ctcae
grade 1 akathisia ,  ctcae
grade 1 alanine aminotransferase increased ,  ctcae
grade 1 alkaline phosphatase increased ,  ctcae
grade 1 alkalosis ,  ctcae
grade 1 allergic reaction ,  ctcae
cop ,  rat strain
grade 1 allergic rhinitis ,  ctcae
grade 1 amnesia ,  ctcae
grade 1 anal fissure ,  ctcae
grade 1 anal fistula ,  ctcae
grade 1 anal hemorrhage ,  ctcae
grade 1 anal mucositis ,  ctcae
grade 1 anal pain ,  ctcae
grade 1 anal stenosis ,  ctcae
grade 1 anal ulcer ,  ctcae
grade 1 anemia ,  ctcae
crdh ,  rat strain
grade 1 ankle fracture ,  ctcae
grade 1 anorectal infection ,  ctcae
grade 1 anorgasmia ,  ctcae
grade 1 anosmia ,  ctcae
grade 1 aortic valve disease ,  ctcae
grade 1 arachnoiditis ,  ctcae
grade 1 arterial injury ,  ctcae
grade 1 arthralgia ,  ctcae
grade 1 arthritis ,  ctcae
grade 1 ascites ,  ctcae
donryu ,  rat strain
grade 1 aspartate aminotransferase increased ,  ctcae
grade 1 atrioventricular block first degree ,  ctcae
grade 1 autoimmune disorder ,  ctcae
grade 1 avascular necrosis ,  ctcae
grade 1 belching ,  ctcae
grade 1 bile duct stenosis ,  ctcae
grade 1 biliary anastomotic leak ,  ctcae
grade 1 bladder anastomotic leak ,  ctcae
grade 1 bloating ,  ctcae
sodium phenylbutyrate
e3 ,  rat strain
grade 1 blood and lymphatic system disorders  -  other ,  specify ,  ctcae
grade 1 blood antidiuretic hormone abnormal ,  ctcae
grade 1 blood bicarbonate decreased ,  ctcae
grade 1 blood bilirubin increased ,  ctcae
grade 1 blood corticotrophin decreased ,  ctcae
grade 1 blood gonadotrophin abnormal ,  ctcae
grade 1 blood prolactin abnormal ,  ctcae
grade 1 body odor ,  ctcae
grade 1 bone marrow hypocellular ,  ctcae
f344 ,  rat strain
grade 1 breast atrophy ,  ctcae
grade 1 bronchial fistula ,  ctcae
grade 1 bronchial obstruction ,  ctcae
grade 1 bronchial stricture ,  ctcae
grade 1 bronchopleural fistula ,  ctcae
grade 1 bronchopulmonary hemorrhage ,  ctcae
grade 1 bronchospasm ,  ctcae
grade 1 bruising ,  ctcae
grade 1 bullous dermatitis ,  ctcae
grade 1 capillary leak syndrome ,  ctcae
fh ,  rat strain
grade 1 carbon monoxide diffusing capacity decreased ,  ctcae
grade 1 cardiac disorders  -  other ,  specify ,  ctcae
grade 1 cardiac troponin i increased ,  ctcae
grade 1 cardiac troponin t increased ,  ctcae
grade 1 cd4 lymphocytes decreased ,  ctcae
grade 1 cecal hemorrhage ,  ctcae
grade 1 central nervous system necrosis ,  ctcae
grade 1 cerebrospinal fluid leakage ,  ctcae
grade 1 chest pain  -  cardiac ,  ctcae
grade 1 chills ,  ctcae
fhh ,  rat strain
grade 1 cholesterol high ,  ctcae
grade 1 chronic kidney disease ,  ctcae
grade 1 chylous ascites ,  ctcae
grade 1 colonic fistula ,  ctcae
grade 1 colonic hemorrhage ,  ctcae
grade 1 colonic obstruction ,  ctcae
grade 1 colonic stenosis ,  ctcae
grade 1 colonic ulcer ,  ctcae
grade 1 concentration impairment ,  ctcae
grade 1 conduction disorder ,  ctcae
gh ,  rat strain
grade 1 congenital ,  familial and genetic disorders  -  other ,  specify ,  ctcae
grade 1 conjunctivitis ,  ctcae
grade 1 cpk increased ,  ctcae
grade 1 creatinine increased ,  ctcae
grade 1 cushingoid ,  ctcae
grade 1 cystitis noninfective ,  ctcae
grade 1 cytokine release syndrome ,  ctcae
grade 1 cytomegalovirus infection reactivation ,  ctcae
grade 1 delayed orgasm ,  ctcae
grade 1 delirium ,  ctcae
ir ,  rat strain
grade 1 dental caries ,  ctcae
grade 1 depressed level of consciousness ,  ctcae
grade 1 dermatitis radiation ,  ctcae
grade 1 dry eye ,  ctcae
grade 1 dry mouth ,  ctcae
grade 1 duodenal hemorrhage ,  ctcae
grade 1 duodenal obstruction ,  ctcae
grade 1 duodenal stenosis ,  ctcae
grade 1 duodenal ulcer ,  ctcae
lec ,  rat strain
grade 1 dysarthria ,  ctcae
grade 1 dysesthesia ,  ctcae
grade 1 dysgeusia ,  ctcae
grade 1 dysmenorrhea ,  ctcae
grade 1 dyspareunia ,  ctcae
grade 1 dyspepsia ,  ctcae
grade 1 dysphasia ,  ctcae
grade 1 dysuria ,  ctcae
grade 1 ear and labyrinth disorders  -  other ,  specify ,  ctcae
grade 1 ear pain ,  ctcae
lew ,  rat strain
grade 1 eczema ,  ctcae
grade 1 edema face ,  ctcae
grade 1 edema limbs ,  ctcae
grade 1 edema trunk ,  ctcae
grade 1 ejaculation disorder ,  ctcae
grade 1 electrocardiogram qt corrected interval prolonged ,  ctcae
grade 1 electrocardiogram t wave abnormal ,  ctcae
grade 1 encephalopathy ,  ctcae
grade 1 endocrine disorders  -  other ,  specify ,  ctcae
grade 1 enterocolitis ,  ctcae
lh ,  rat strain
grade 1 enterovesical fistula ,  ctcae
grade 1 eosinophilia ,  ctcae
grade 1 epistaxis ,  ctcae
grade 1 epstein - barr virus infection reactivation ,  ctcae
grade 1 erythema multiforme ,  ctcae
grade 1 esophageal anastomotic leak ,  ctcae
grade 1 esophageal hemorrhage ,  ctcae
grade 1 esophageal obstruction ,  ctcae
grade 1 esophageal pain ,  ctcae
m520 ,  rat strain
grade 1 esophageal stenosis ,  ctcae
grade 1 esophageal ulcer ,  ctcae
grade 1 extraocular muscle paresis ,  ctcae
grade 1 extrapyramidal disorder ,  ctcae
grade 1 eye disorders  -  other ,  specify ,  ctcae
grade 1 eyelid function disorder ,  ctcae
grade 1 facial muscle weakness ,  ctcae
grade 1 facial nerve disorder ,  ctcae
grade 1 facial pain ,  ctcae
grade 1 fall ,  ctcae
carzelesin
nbl ,  rat strain
grade 1 fallopian tube anastomotic leak ,  ctcae
grade 1 fat atrophy ,  ctcae
grade 1 fecal incontinence ,  ctcae
grade 1 feminization acquired ,  ctcae
grade 1 fever ,  ctcae
grade 1 fibrinogen decreased ,  ctcae
grade 1 fibrosis deep connective tissue ,  ctcae
grade 1 flank pain ,  ctcae
grade 1 flashing lights ,  ctcae
grade 1 floaters ,  ctcae
nzr ,  rat strain
grade 1 flu like symptoms ,  ctcae
grade 1 folliculitis ,  ctcae
grade 1 forced expiratory volume decreased ,  ctcae
grade 1 gait disturbance ,  ctcae
grade 1 gastric anastomotic leak ,  ctcae
grade 1 gastric fistula ,  ctcae
grade 1 gastric hemorrhage ,  ctcae
grade 1 gastric stenosis ,  ctcae
grade 1 gastric ulcer ,  ctcae
grade 1 gastroesophageal reflux disease ,  ctcae
shr ,  rat strain
grade 1 gastrointestinal anastomotic leak ,  ctcae
grade 1 gastrointestinal disorders  -  other ,  specify ,  ctcae
grade 1 gastrointestinal fistula ,  ctcae
grade 1 gastrointestinal pain ,  ctcae
grade 1 gastroparesis ,  ctcae
grade 1 general disorders and administration site conditions  -  other ,  specify ,  ctcae
grade 1 generalized edema ,  ctcae
grade 1 generalized muscle weakness ,  ctcae
grade 1 genital edema ,  ctcae
grade 1 ggt increased ,  ctcae
oxys ,  rat strain
grade 1 gingival pain ,  ctcae
grade 1 glossopharyngeal nerve disorder ,  ctcae
grade 1 glucose intolerance ,  ctcae
grade 1 glucosuria ,  ctcae
grade 1 growth hormone abnormal ,  ctcae
grade 1 growth suppression ,  ctcae
grade 1 guillain - barre syndrome ,  ctcae
grade 1 gum infection ,  ctcae
grade 1 gynecomastia ,  ctcae
grade 1 hair color changes ,  ctcae
wag ,  rat strain
grade 1 hair texture abnormal ,  ctcae
grade 1 hallucinations ,  ctcae
grade 1 headache ,  ctcae
grade 1 hearing impaired ,  ctcae
grade 1 heart failure ,  ctcae
grade 1 hematosalpinx ,  ctcae
grade 1 hematuria ,  ctcae
grade 1 hemoglobin increased ,  ctcae
grade 1 hemorrhoidal hemorrhage ,  ctcae
grade 1 hepatic hemorrhage ,  ctcae
grade 1 hepatic pain ,  ctcae
grade 1 hepatitis b reactivation ,  ctcae
grade 1 hepatitis viral ,  ctcae
grade 1 hepatobiliary disorders  -  other ,  specify ,  ctcae
grade 1 herpes simplex reactivation ,  ctcae
grade 1 hiccups ,  ctcae
grade 1 hirsutism ,  ctcae
grade 1 hoarseness ,  ctcae
grade 1 hot flashes ,  ctcae
abelson murine leukemia virus
grade 1 hypercalcemia ,  ctcae
grade 1 hyperglycemia ,  ctcae
grade 1 hyperhidrosis ,  ctcae
grade 1 hyperkalemia ,  ctcae
grade 1 hyperkeratosis ,  ctcae
grade 1 hyperlipidemia ,  ctcae
grade 1 hypermagnesemia ,  ctcae
grade 1 hypernatremia ,  ctcae
grade 1 hyperparathyroidism ,  ctcae
grade 1 hyperphosphatemia ,  ctcae
rat strains
grade 1 hypersomnia ,  ctcae
grade 1 hyperthyroidism ,  ctcae
grade 1 hypertrichosis ,  ctcae
grade 1 hypertriglyceridemia ,  ctcae
grade 1 hyperuricemia ,  ctcae
grade 1 hypoalbuminemia ,  ctcae
grade 1 hypocalcemia ,  ctcae
grade 1 hypoglossal nerve disorder ,  ctcae
grade 1 hypoglycemia ,  ctcae
grade 1 hypokalemia ,  ctcae
grade 1 hypomagnesemia ,  ctcae
grade 1 hyponatremia ,  ctcae
grade 1 hypoparathyroidism ,  ctcae
grade 1 hypophosphatemia ,  ctcae
grade 1 hypophysitis ,  ctcae
grade 1 hypopituitarism ,  ctcae
grade 1 hypothyroidism ,  ctcae
organism strain
grade 1 ileal stenosis ,  ctcae
grade 1 immune system disorders  -  other ,  specify ,  ctcae
grade 1 infections and infestations  -  other ,  specify ,  ctcae
grade 1 infusion related reaction ,  ctcae
grade 1 infusion site extravasation ,  ctcae
grade 1 injection site reaction ,  ctcae
grade 1 injury to superior vena cava ,  ctcae
morpholinodoxorubicin
mouse strains
grade 1 injury ,  poisoning and procedural complications  -  other ,  specify ,  ctcae
grade 1 inr increased ,  ctcae
grade 1 intestinal stoma leak ,  ctcae
grade 1 intestinal stoma site bleeding ,  ctcae
grade 1 intracranial hemorrhage ,  ctcae
grade 1 intraoperative arterial injury ,  ctcae
grade 1 intraoperative breast injury ,  ctcae
grade 1 intraoperative ear injury ,  ctcae
grade 1 intraoperative endocrine injury ,  ctcae
grade 1 intraoperative gastrointestinal injury ,  ctcae
inbred mouse strains
grade 1 intraoperative head and neck injury ,  ctcae
grade 1 intraoperative hepatobiliary injury ,  ctcae
grade 1 intraoperative musculoskeletal injury ,  ctcae
grade 1 intraoperative neurological injury ,  ctcae
grade 1 intraoperative ocular injury ,  ctcae
grade 1 intraoperative renal injury ,  ctcae
grade 1 intraoperative reproductive tract injury ,  ctcae
grade 1 intraoperative respiratory injury ,  ctcae
grade 1 intraoperative urinary injury ,  ctcae
grade 1 intraoperative venous injury ,  ctcae
grade 1 investigations  -  other ,  specify ,  ctcae
grade 1 irregular menstruation ,  ctcae
grade 1 irritability ,  ctcae
grade 1 ischemia cerebrovascular ,  ctcae
grade 1 jejunal stenosis ,  ctcae
grade 1 joint range of motion decreased cervical spine ,  ctcae
grade 1 joint range of motion decreased lumbar spine ,  ctcae
grade 1 joint range of motion decreased ,  ctcae
grade 1 kidney anastomotic leak ,  ctcae
grade 1 kyphosis ,  ctcae
grade 1 lactation disorder ,  ctcae
grade 1 large intestinal anastomotic leak ,  ctcae
grade 1 laryngeal edema ,  ctcae
grade 1 laryngeal inflammation ,  ctcae
c57bl / 6 mouse
grade 1 laryngeal mucositis ,  ctcae
grade 1 laryngeal obstruction ,  ctcae
grade 1 laryngeal stenosis ,  ctcae
grade 1 laryngopharyngeal dysesthesia ,  ctcae
grade 1 lethargy ,  ctcae
grade 1 leukoencephalopathy ,  ctcae
grade 1 libido decreased ,  ctcae
grade 1 libido increased ,  ctcae
grade 1 lip infection ,  ctcae
grade 1 lipase increased ,  ctcae
grade 1 lipohypertrophy ,  ctcae
grade 1 localized edema ,  ctcae
grade 1 lordosis ,  ctcae
grade 1 lower gastrointestinal hemorrhage ,  ctcae
grade 1 lymphedema ,  ctcae
grade 1 lymphocyte count decreased ,  ctcae
grade 1 malaise ,  ctcae
grade 1 mania ,  ctcae
grade 1 meningismus ,  ctcae
grade 1 menorrhagia ,  ctcae
grade 1 metabolism and nutrition disorders  -  other ,  specify ,  ctcae
grade 1 middle ear inflammation ,  ctcae
grade 1 mitral valve disease ,  ctcae
grade 1 movements involuntary ,  ctcae
grade 1 mucosal infection ,  ctcae
grade 1 mucositis oral ,  ctcae
grade 1 muscle cramp ,  ctcae
grade 1 muscle weakness left - sided ,  ctcae
grade 1 muscle weakness lower limb ,  ctcae
grade 1 muscle weakness right - sided ,  ctcae
grade 1 muscle weakness trunk ,  ctcae
grade 1 muscle weakness upper limb ,  ctcae
grade 1 musculoskeletal and connective tissue disorder  -  other ,  specify ,  ctcae
grade 1 musculoskeletal deformity ,  ctcae
grade 1 myalgia ,  ctcae
grade 1 myasthenia gravis ,  ctcae
grade 1 nail discoloration ,  ctcae
grade 1 nail infection ,  ctcae
grade 1 nail loss ,  ctcae
grade 1 nail ridging ,  ctcae
grade 1 nasal congestion ,  ctcae
grade 1 neck edema ,  ctcae
grade 1 neoplasms benign ,  malignant and unspecified  ( incl cysts and polyps )   -  other ,  specify ,  ctcae
grade 1 nervous system disorders  -  other ,  specify ,  ctcae
grade 1 neuralgia ,  ctcae
grade 1 neutrophil count decreased ,  ctcae
grade 1 night blindness ,  ctcae
grade 1 nipple deformity ,  ctcae
grade 1 non - cardiac chest pain ,  ctcae
grade 1 obstruction gastric ,  ctcae
grade 1 oculomotor nerve disorder ,  ctcae
grade 1 oligospermia ,  ctcae
grade 1 optic nerve disorder ,  ctcae
grade 1 oral cavity fistula ,  ctcae
grade 1 oral dysesthesia ,  ctcae
organochlorine compound
grade 1 oropharyngeal pain ,  ctcae
grade 1 osteonecrosis of jaw ,  ctcae
grade 1 osteonecrosis ,  ctcae
grade 1 otitis externa ,  ctcae
grade 1 ovarian rupture ,  ctcae
grade 1 pain in extremity ,  ctcae
grade 1 pain of skin ,  ctcae
grade 1 pain ,  ctcae
grade 1 palmar - plantar erythrodysesthesia syndrome ,  ctcae
grade 1 pancreatic anastomotic leak ,  ctcae
grade 1 pancreatic duct stenosis ,  ctcae
grade 1 pancreatic enzymes decreased ,  ctcae
grade 1 papilledema ,  ctcae
grade 1 papulopustular rash ,  ctcae
grade 1 paresthesia ,  ctcae
grade 1 paronychia ,  ctcae
grade 1 paroxysmal atrial tachycardia ,  ctcae
grade 1 pelvic floor muscle weakness ,  ctcae
grade 1 pelvic pain ,  ctcae
grade 1 penile infection ,  ctcae
grade 1 perineal pain ,  ctcae
grade 1 periorbital edema ,  ctcae
grade 1 peripheral motor neuropathy ,  ctcae
grade 1 peripheral sensory neuropathy ,  ctcae
grade 1 personality change ,  ctcae
grade 1 phantom pain ,  ctcae
grade 1 pharyngeal anastomotic leak ,  ctcae
grade 1 pharyngeal mucositis ,  ctcae
grade 1 pharyngeal stenosis ,  ctcae
grade 1 pharyngolaryngeal pain ,  ctcae
grade 1 phlebitis infective ,  ctcae
grade 1 platelet count decreased ,  ctcae
grade 1 pleural effusion ,  ctcae
grade 1 pleuritic pain ,  ctcae
grade 1 pneumonitis ,  ctcae
grade 1 postnasal drip ,  ctcae
grade 1 postoperative hemorrhage ,  ctcae
grade 1 precocious puberty ,  ctcae
grade 1 pregnancy ,  puerperium and perinatal conditions  -  other ,  specify ,  ctcae
grade 1 premature delivery ,  ctcae
grade 1 productive cough ,  ctcae
grade 1 prolapse of intestinal stoma ,  ctcae
grade 1 prolapse of urostomy ,  ctcae
grade 1 prostatic obstruction ,  ctcae
grade 1 prostatic pain ,  ctcae
grade 1 psychiatric disorders  -  other ,  specify ,  ctcae
grade 1 psychosis ,  ctcae
grade 1 pulmonary edema ,  ctcae
grade 1 pulmonary fibrosis ,  ctcae
grade 1 pulmonary fistula ,  ctcae
grade 1 pulmonary valve disease ,  ctcae
grade 1 purpura ,  ctcae
grade 1 pyramidal tract syndrome ,  ctcae
grade 1 radiation recall reaction  ( dermatologic )  ,  ctcae
grade 1 radiculitis ,  ctcae
grade 1 rash acneiform ,  ctcae
grade 1 rash maculo - papular ,  ctcae
grade 1 rectal anastomotic leak ,  ctcae
grade 1 rectal fissure ,  ctcae
grade 1 rectal mucositis ,  ctcae
grade 1 rectal pain ,  ctcae
grade 1 rectal stenosis ,  ctcae
grade 1 recurrent laryngeal nerve palsy ,  ctcae
grade 1 renal and urinary disorders  -  other ,  specify ,  ctcae
grade 1 renal calculi ,  ctcae
grade 1 renal colic ,  ctcae
grade 1 reproductive system and breast disorders  -  other ,  specify ,  ctcae
grade 1 respiratory ,  thoracic and mediastinal disorders  -  other ,  specify ,  ctcae
grade 1 restlessness ,  ctcae
grade 1 retinal tear ,  ctcae
grade 1 rhabdomyolysis ,  ctcae
grade 1 rhinorrhea ,  ctcae
grade 1 rotator cuff injury ,  ctcae
grade 1 salivary duct inflammation ,  ctcae
grade 1 scleral disorder ,  ctcae
grade 1 scoliosis ,  ctcae
grade 1 scrotal infection ,  ctcae
grade 1 scrotal pain ,  ctcae
grade 1 seizure ,  ctcae
grade 1 serum amylase increased ,  ctcae
grade 1 serum sickness ,  ctcae
grade 1 shingles ,  ctcae
grade 1 sinus disorder ,  ctcae
grade 1 skin and subcutaneous tissue disorders  -  other ,  specify ,  ctcae
grade 1 skin hyperpigmentation ,  ctcae
grade 1 skin hypopigmentation ,  ctcae
folate
grade 1 skin induration ,  ctcae
grade 1 skin infection ,  ctcae
grade 1 skin papilloma ,  ctcae
grade 1 skin ulceration ,  ctcae
grade 1 sleep apnea ,  ctcae
grade 1 small intestinal anastomotic leak ,  ctcae
grade 1 small intestinal mucositis ,  ctcae
grade 1 small intestinal obstruction ,  ctcae
grade 1 small intestinal stenosis ,  ctcae
grade 1 small intestine ulcer ,  ctcae
grade 1 sneezing ,  ctcae
grade 1 social circumstances  -  other ,  specify ,  ctcae
grade 1 somnolence ,  ctcae
grade 1 sore throat ,  ctcae
grade 1 spasticity ,  ctcae
grade 1 spermatic cord anastomotic leak ,  ctcae
grade 1 spinal fracture ,  ctcae
grade 1 stoma site infection ,  ctcae
grade 1 stomal ulcer ,  ctcae
grade 1 stroke ,  ctcae
grade 1 subcutaneous emphysema ,  ctcae
grade 1 suicidal ideation ,  ctcae
grade 1 superficial soft tissue fibrosis ,  ctcae
grade 1 superior vena cava syndrome ,  ctcae
grade 1 surgical and medical procedures  -  other ,  specify ,  ctcae
grade 1 tendon reflex decreased ,  ctcae
grade 1 testicular disorder ,  ctcae
grade 1 testicular pain ,  ctcae
grade 1 testosterone deficiency ,  ctcae
grade 1 thromboembolic event ,  ctcae
grade 1 thrush ,  ctcae
grade 1 thyroid stimulating hormone increased ,  ctcae
grade 1 tinnitus ,  ctcae
grade 1 tooth development disorder ,  ctcae
grade 1 tooth discoloration ,  ctcae
grade 1 toothache ,  ctcae
grade 1 tracheal mucositis ,  ctcae
grade 1 tracheal obstruction ,  ctcae
grade 1 tracheal stenosis ,  ctcae
grade 1 tracheostomy site bleeding ,  ctcae
grade 1 transient ischemic attacks ,  ctcae
grade 1 tricuspid valve disease ,  ctcae
grade 1 trigeminal nerve disorder ,  ctcae
grade 1 trochlear nerve disorder ,  ctcae
grade 1 tumor hemorrhage ,  ctcae
grade 1 unequal limb length ,  ctcae
grade 1 upper gastrointestinal hemorrhage ,  ctcae
grade 1 ureteric anastomotic leak ,  ctcae
grade 1 urethral anastomotic leak ,  ctcae
grade 1 urinary frequency ,  ctcae
grade 1 urinary tract obstruction ,  ctcae
grade 1 urinary tract pain ,  ctcae
grade 1 urinary urgency ,  ctcae
grade 1 urine discoloration ,  ctcae
grade 1 urostomy leak ,  ctcae
grade 1 urostomy obstruction ,  ctcae
grade 1 urostomy site bleeding ,  ctcae
grade 1 uterine anastomotic leak ,  ctcae
grade 1 uterine fistula ,  ctcae
grade 1 uterine obstruction ,  ctcae
grade 1 uterine pain ,  ctcae
grade 1 vaccination complication ,  ctcae
grade 1 vaccination site lymphadenopathy ,  ctcae
grade 1 vaginal anastomotic leak ,  ctcae
grade 1 vaginal discharge ,  ctcae
grade 1 vaginal infection ,  ctcae
grade 1 vaginal inflammation ,  ctcae
grade 1 vaginal obstruction ,  ctcae
grade 1 vaginal pain ,  ctcae
grade 1 vaginal stricture ,  ctcae
grade 1 vagus nerve disorder ,  ctcae
grade 1 vas deferens anastomotic leak ,  ctcae
grade 1 vascular access complication ,  ctcae
grade 1 vascular disorders  -  other ,  specify ,  ctcae
grade 1 venous injury ,  ctcae
grade 1 ventricular arrhythmia ,  ctcae
grade 1 vertigo ,  ctcae
grade 1 virilization ,  ctcae
grade 1 vital capacity abnormal ,  ctcae
grade 1 voice alteration ,  ctcae
grade 1 vulval infection ,  ctcae
grade 1 watering eyes ,  ctcae
grade 1 wheezing ,  ctcae
grade 1 white blood cell decreased ,  ctcae
grade 1 wound complication ,  ctcae
grade 1 wound dehiscence ,  ctcae
grade 1 wound infection ,  ctcae
grade 1 wrist fracture ,  ctcae
grade 2 abdominal distension ,  ctcae
grade 2 abdominal infection ,  ctcae
grade 2 abdominal pain ,  ctcae
grade 2 abdominal soft tissue necrosis ,  ctcae
grade 2 abducens nerve disorder ,  ctcae
grade 2 accessory nerve disorder ,  ctcae
potassium hyaluronate
lt webster 1932
grade 2 acoustic nerve disorder nos ,  ctcae
grade 2 activated partial thromboplastin time prolonged ,  ctcae
grade 2 akathisia ,  ctcae
grade 2 alanine aminotransferase increased ,  ctcae
grade 2 alcohol intolerance ,  ctcae
grade 2 alkaline phosphatase increased ,  ctcae
grade 2 allergic reaction ,  ctcae
grade 2 allergic rhinitis ,  ctcae
grade 2 amenorrhea ,  ctcae
grade 2 amnesia ,  ctcae
ts hauschka ,  fox chase ha:icr
grade 2 anal fissure ,  ctcae
grade 2 anal fistula ,  ctcae
grade 2 anal hemorrhage ,  ctcae
grade 2 anal mucositis ,  ctcae
grade 2 anal pain ,  ctcae
grade 2 anal stenosis ,  ctcae
grade 2 anal ulcer ,  ctcae
grade 2 anemia ,  ctcae
grade 2 ankle fracture ,  ctcae
grade 2 anorectal infection ,  ctcae
grade 2 anorgasmia ,  ctcae
grade 2 aortic injury ,  ctcae
grade 2 aortic valve disease ,  ctcae
grade 2 arachnoiditis ,  ctcae
grade 2 arterial injury ,  ctcae
grade 2 arthralgia ,  ctcae
grade 2 arthritis ,  ctcae
grade 2 ascites ,  ctcae
grade 2 aspartate aminotransferase increased ,  ctcae
grade 2 atrioventricular block complete ,  ctcae
grade 2 atrioventricular block first degree ,  ctcae
grade 2 autoimmune disorder ,  ctcae
grade 2 avascular necrosis ,  ctcae
grade 2 azoospermia ,  ctcae
grade 2 bacteremia ,  ctcae
grade 2 belching ,  ctcae
grade 2 bile duct stenosis ,  ctcae
grade 2 biliary anastomotic leak ,  ctcae
grade 2 biliary fistula ,  ctcae
grade 2 biliary tract infection ,  ctcae
grade 2 bladder anastomotic leak ,  ctcae
grade 2 bladder infection ,  ctcae
grade 2 bloating ,  ctcae
grade 2 blood and lymphatic system disorders  -  other ,  specify ,  ctcae
grade 2 blood antidiuretic hormone abnormal ,  ctcae
grade 2 blood bilirubin increased ,  ctcae
grade 2 blood corticotrophin decreased ,  ctcae
grade 2 blood gonadotrophin abnormal ,  ctcae
grade 2 blood prolactin abnormal ,  ctcae
grade 2 body odor ,  ctcae
grade 2 bone infection ,  ctcae
grade 2 bone marrow hypocellular ,  ctcae
grade 2 breast atrophy ,  ctcae
grade 2 breast infection ,  ctcae
grade 2 bronchial fistula ,  ctcae
grade 2 bronchial infection ,  ctcae
grade 2 bronchial obstruction ,  ctcae
grade 2 bronchial stricture ,  ctcae
grade 2 bronchopleural fistula ,  ctcae
grade 2 bronchopulmonary hemorrhage ,  ctcae
grade 2 bronchospasm ,  ctcae
grade 2 bruising ,  ctcae
grade 2 budd - chiari syndrome ,  ctcae
grade 2 bullous dermatitis ,  ctcae
grade 2 capillary leak syndrome ,  ctcae
grade 2 carbon monoxide diffusing capacity decreased ,  ctcae
grade 2 cardiac disorders  -  other ,  specify ,  ctcae
grade 2 catheter related infection ,  ctcae
grade 2 cd4 lymphocytes decreased ,  ctcae
grade 2 cecal hemorrhage ,  ctcae
grade 2 cecal infection ,  ctcae
grade 2 central nervous system necrosis ,  ctcae
grade 2 cerebrospinal fluid leakage ,  ctcae
grade 2 cervicitis infection ,  ctcae
grade 2 chest pain  -  cardiac ,  ctcae
grade 2 chest wall necrosis ,  ctcae
grade 2 chills ,  ctcae
grade 2 cholesterol high ,  ctcae
grade 2 chronic kidney disease ,  ctcae
grade 2 chylous ascites ,  ctcae
grade 2 colonic fistula ,  ctcae
grade 2 colonic hemorrhage ,  ctcae
grade 2 colonic obstruction ,  ctcae
grade 2 colonic perforation ,  ctcae
grade 2 colonic stenosis ,  ctcae
grade 2 colonic ulcer ,  ctcae
grade 2 concentration impairment ,  ctcae
grade 2 conduction disorder ,  ctcae
grade 2 congenital ,  familial and genetic disorders  -  other ,  specify ,  ctcae
grade 2 conjunctivitis infective ,  ctcae
grade 2 conjunctivitis ,  ctcae
grade 2 corneal infection ,  ctcae
grade 2 cpk increased ,  ctcae
grade 2 creatinine increased ,  ctcae
grade 2 cushingoid ,  ctcae
grade 2 cyanosis ,  ctcae
grade 2 cystitis noninfective ,  ctcae
grade 2 cytokine release syndrome ,  ctcae
grade 2 cytomegalovirus infection reactivation ,  ctcae
radiopharmaceutical compound
grade 2 delayed orgasm ,  ctcae
grade 2 delirium ,  ctcae
grade 2 delusions ,  ctcae
grade 2 dental caries ,  ctcae
grade 2 depressed level of consciousness ,  ctcae
grade 2 dermatitis radiation ,  ctcae
grade 2 device related infection ,  ctcae
grade 2 dry eye ,  ctcae
grade 2 dry mouth ,  ctcae
grade 2 duodenal hemorrhage ,  ctcae
grade 2 duodenal infection ,  ctcae
grade 2 duodenal obstruction ,  ctcae
grade 2 duodenal perforation ,  ctcae
grade 2 duodenal stenosis ,  ctcae
grade 2 duodenal ulcer ,  ctcae
grade 2 dysarthria ,  ctcae
grade 2 dysesthesia ,  ctcae
grade 2 dysgeusia ,  ctcae
grade 2 dysmenorrhea ,  ctcae
grade 2 dyspareunia ,  ctcae
grade 2 dyspepsia ,  ctcae
grade 2 dysphasia ,  ctcae
grade 2 ear and labyrinth disorders  -  other ,  specify ,  ctcae
grade 2 ear pain ,  ctcae
grade 2 eczema ,  ctcae
grade 2 edema face ,  ctcae
grade 2 edema limbs ,  ctcae
grade 2 edema trunk ,  ctcae
grade 2 ejaculation disorder ,  ctcae
grade 2 ejection fraction decreased ,  ctcae
grade 2 electrocardiogram qt corrected interval prolonged ,  ctcae
grade 2 electrocardiogram t wave abnormal ,  ctcae
grade 2 endocrine disorders  -  other ,  specify ,  ctcae
grade 2 endophthalmitis ,  ctcae
grade 2 enterocolitis infectious ,  ctcae
grade 2 enterocolitis ,  ctcae
grade 2 enterovesical fistula ,  ctcae
grade 2 epistaxis ,  ctcae
grade 2 epstein - barr virus infection reactivation ,  ctcae
grade 2 erythema multiforme ,  ctcae
grade 2 erythroderma ,  ctcae
grade 2 esophageal anastomotic leak ,  ctcae
grade 2 esophageal hemorrhage ,  ctcae
grade 2 esophageal infection ,  ctcae
grade 2 esophageal obstruction ,  ctcae
grade 2 esophageal pain ,  ctcae
grade 2 esophageal perforation ,  ctcae
grade 2 esophageal stenosis ,  ctcae
grade 2 esophageal ulcer ,  ctcae
grade 2 extraocular muscle paresis ,  ctcae
grade 2 extrapyramidal disorder ,  ctcae
grade 2 eye disorders  -  other ,  specify ,  ctcae
grade 2 eye infection ,  ctcae
grade 2 eyelid function disorder ,  ctcae
grade 2 facial muscle weakness ,  ctcae
grade 2 facial nerve disorder ,  ctcae
grade 2 facial pain ,  ctcae
grade 2 fall ,  ctcae
grade 2 fallopian tube anastomotic leak ,  ctcae
grade 2 fat atrophy ,  ctcae
grade 2 fecal incontinence ,  ctcae
grade 2 feminization acquired ,  ctcae
grade 2 fetal growth retardation ,  ctcae
grade 2 fever ,  ctcae
grade 2 fibrinogen decreased ,  ctcae
grade 2 fibrosis deep connective tissue ,  ctcae
grade 2 flank pain ,  ctcae
grade 2 flashing lights ,  ctcae
grade 2 floaters ,  ctcae
grade 2 flu like symptoms ,  ctcae
grade 2 folliculitis ,  ctcae
grade 2 forced expiratory volume decreased ,  ctcae
grade 2 fungemia ,  ctcae
grade 2 gait disturbance ,  ctcae
grade 2 gallbladder infection ,  ctcae
grade 2 gastric anastomotic leak ,  ctcae
grade 2 gastric fistula ,  ctcae
grade 2 gastric hemorrhage ,  ctcae
grade 2 gastric perforation ,  ctcae
grade 2 gastric stenosis ,  ctcae
grade 2 gastric ulcer ,  ctcae
grade 2 gastroesophageal reflux disease ,  ctcae
grade 2 gastrointestinal anastomotic leak ,  ctcae
grade 2 gastrointestinal disorders  -  other ,  specify ,  ctcae
grade 2 gastrointestinal fistula ,  ctcae
grade 2 gastrointestinal pain ,  ctcae
grade 2 gastrointestinal stoma necrosis ,  ctcae
grade 2 gastroparesis ,  ctcae
grade 2 general disorders and administration site conditions  -  other ,  specify ,  ctcae
grade 2 generalized edema ,  ctcae
grade 2 generalized muscle weakness ,  ctcae
grade 2 genital edema ,  ctcae
grade 2 ggt increased ,  ctcae
grade 2 gingival pain ,  ctcae
grade 2 glossopharyngeal nerve disorder ,  ctcae
grade 2 glucose intolerance ,  ctcae
grade 2 growth accelerated ,  ctcae
grade 2 growth hormone abnormal ,  ctcae
barium enema injection
grade 2 growth suppression ,  ctcae
grade 2 guillain - barre syndrome ,  ctcae
grade 2 gum infection ,  ctcae
grade 2 hallucinations ,  ctcae
grade 2 headache ,  ctcae
grade 2 hearing impaired ,  ctcae
grade 2 heart failure ,  ctcae
grade 2 hematosalpinx ,  ctcae
grade 2 hematuria ,  ctcae
grade 2 hemoglobin increased ,  ctcae
grade 2 hemorrhoidal hemorrhage ,  ctcae
grade 2 hepatic hemorrhage ,  ctcae
grade 2 hepatic infection ,  ctcae
grade 2 hepatic pain ,  ctcae
grade 2 hepatitis b reactivation ,  ctcae
grade 2 hepatitis viral ,  ctcae
grade 2 hepatobiliary disorders  -  other ,  specify ,  ctcae
grade 2 herpes simplex reactivation ,  ctcae
grade 2 hiccups ,  ctcae
grade 2 hip fracture ,  ctcae
grade 2 hirsutism ,  ctcae
grade 2 hoarseness ,  ctcae
grade 2 hot flashes ,  ctcae
grade 2 hypercalcemia ,  ctcae
grade 2 hyperglycemia ,  ctcae
grade 2 hyperhidrosis ,  ctcae
grade 2 hyperkalemia ,  ctcae
grade 2 hyperlipidemia ,  ctcae
grade 2 hypernatremia ,  ctcae
grade 2 hyperparathyroidism ,  ctcae
grade 2 hyperphosphatemia ,  ctcae
grade 2 hypersomnia ,  ctcae
grade 2 hyperthyroidism ,  ctcae
grade 2 hypertrichosis ,  ctcae
grade 2 hypertriglyceridemia ,  ctcae
grade 2 hypoalbuminemia ,  ctcae
grade 2 hypocalcemia ,  ctcae
grade 2 hypoglossal nerve disorder ,  ctcae
grade 2 hypoglycemia ,  ctcae
grade 2 hypohidrosis ,  ctcae
fvb / n mouse
grade 2 hypokalemia ,  ctcae
grade 2 hypomagnesemia ,  ctcae
grade 2 hyponatremia ,  ctcae
grade 2 hypoparathyroidism ,  ctcae
grade 2 hypophosphatemia ,  ctcae
grade 2 hypophysitis ,  ctcae
grade 2 hypopituitarism ,  ctcae
grade 2 hypothyroidism ,  ctcae
grade 2 ileal perforation ,  ctcae
grade 2 ileal stenosis ,  ctcae
grade 2 immune system disorders  -  other ,  specify ,  ctcae
grade 2 infections and infestations  -  other ,  specify ,  ctcae
grade 2 infective myositis ,  ctcae
grade 2 infusion related reaction ,  ctcae
grade 2 infusion site extravasation ,  ctcae
grade 2 injection site reaction ,  ctcae
grade 2 injury to carotid artery ,  ctcae
grade 2 injury to jugular vein ,  ctcae
grade 2 injury to superior vena cava ,  ctcae
grade 2 injury ,  poisoning and procedural complications  -  other ,  specify ,  ctcae
grade 2 inr increased ,  ctcae
grade 2 intestinal stoma leak ,  ctcae
grade 2 intestinal stoma obstruction ,  ctcae
grade 2 intestinal stoma site bleeding ,  ctcae
grade 2 intra - abdominal hemorrhage ,  ctcae
grade 2 intracranial hemorrhage ,  ctcae
grade 2 intraoperative arterial injury ,  ctcae
grade 2 intraoperative breast injury ,  ctcae
grade 2 intraoperative ear injury ,  ctcae
grade 2 intraoperative endocrine injury ,  ctcae
grade 2 intraoperative gastrointestinal injury ,  ctcae
grade 2 intraoperative head and neck injury ,  ctcae
grade 2 intraoperative hepatobiliary injury ,  ctcae
grade 2 intraoperative musculoskeletal injury ,  ctcae
grade 2 intraoperative neurological injury ,  ctcae
grade 2 intraoperative ocular injury ,  ctcae
grade 2 intraoperative renal injury ,  ctcae
grade 2 intraoperative reproductive tract injury ,  ctcae
grade 2 intraoperative respiratory injury ,  ctcae
grade 2 intraoperative splenic injury ,  ctcae
grade 2 intraoperative urinary injury ,  ctcae
grade 2 intraoperative venous injury ,  ctcae
grade 2 investigations  -  other ,  specify ,  ctcae
grade 2 irregular menstruation ,  ctcae
grade 2 irritability ,  ctcae
grade 2 ischemia cerebrovascular ,  ctcae
grade 2 jejunal perforation ,  ctcae
grade 2 jejunal stenosis ,  ctcae
grade 2 joint infection ,  ctcae
grade 2 joint range of motion decreased cervical spine ,  ctcae
nafoxidine hydrochloride
grade 2 joint range of motion decreased lumbar spine ,  ctcae
grade 2 joint range of motion decreased ,  ctcae
grade 2 kidney anastomotic leak ,  ctcae
grade 2 kidney infection ,  ctcae
grade 2 kyphosis ,  ctcae
grade 2 lactation disorder ,  ctcae
grade 2 large intestinal anastomotic leak ,  ctcae
grade 2 laryngeal edema ,  ctcae
grade 2 laryngeal inflammation ,  ctcae
grade 2 laryngeal mucositis ,  ctcae
grade 2 laryngeal obstruction ,  ctcae
grade 2 laryngeal stenosis ,  ctcae
grade 2 laryngitis ,  ctcae
grade 2 laryngopharyngeal dysesthesia ,  ctcae
grade 2 laryngospasm ,  ctcae
grade 2 lethargy ,  ctcae
grade 2 leukoencephalopathy ,  ctcae
grade 2 libido decreased ,  ctcae
grade 2 lip infection ,  ctcae
grade 2 lipase increased ,  ctcae
grade 2 lipohypertrophy ,  ctcae
grade 2 localized edema ,  ctcae
grade 2 lordosis ,  ctcae
grade 2 lower gastrointestinal hemorrhage ,  ctcae
grade 2 lung infection ,  ctcae
grade 2 lymph gland infection ,  ctcae
grade 2 lymph leakage ,  ctcae
grade 2 lymphedema ,  ctcae
grade 2 lymphocyte count decreased ,  ctcae
grade 2 lymphocyte count increased ,  ctcae
grade 2 malaise ,  ctcae
grade 2 mania ,  ctcae
grade 2 meningismus ,  ctcae
grade 2 menorrhagia ,  ctcae
grade 2 metabolism and nutrition disorders  -  other ,  specify ,  ctcae
grade 2 middle ear inflammation ,  ctcae
grade 2 mitral valve disease ,  ctcae
grade 2 movements involuntary ,  ctcae
grade 2 mucosal infection ,  ctcae
grade 2 mucositis oral ,  ctcae
grade 2 muscle cramp ,  ctcae
grade 2 muscle weakness left - sided ,  ctcae
grade 2 muscle weakness lower limb ,  ctcae
grade 2 muscle weakness right - sided ,  ctcae
grade 2 muscle weakness trunk ,  ctcae
grade 2 muscle weakness upper limb ,  ctcae
grade 2 musculoskeletal and connective tissue disorder  -  other ,  specify ,  ctcae
grade 2 musculoskeletal deformity ,  ctcae
grade 2 myalgia ,  ctcae
grade 2 myasthenia gravis ,  ctcae
grade 2 myocardial infarction ,  ctcae
grade 2 myocarditis ,  ctcae
grade 2 nail infection ,  ctcae
grade 2 nail loss ,  ctcae
grade 2 nasal congestion ,  ctcae
grade 2 neck edema ,  ctcae
grade 2 neoplasms benign ,  malignant and unspecified  ( incl cysts and polyps )   -  other ,  specify ,  ctcae
grade 2 nervous system disorders  -  other ,  specify ,  ctcae
grade 2 neuralgia ,  ctcae
grade 2 neutrophil count decreased ,  ctcae
grade 2 night blindness ,  ctcae
grade 2 nipple deformity ,  ctcae
grade 2 non - cardiac chest pain ,  ctcae
grade 2 obstruction gastric ,  ctcae
grade 2 oculomotor nerve disorder ,  ctcae
grade 2 olfactory nerve disorder ,  ctcae
grade 2 optic nerve disorder ,  ctcae
grade 2 oral cavity fistula ,  ctcae
grade 2 oral dysesthesia ,  ctcae
grade 2 oropharyngeal pain ,  ctcae
grade 2 osteonecrosis of jaw ,  ctcae
grade 2 osteonecrosis ,  ctcae
grade 2 otitis externa ,  ctcae
grade 2 otitis media ,  ctcae
grade 2 ovarian infection ,  ctcae
grade 2 ovarian rupture ,  ctcae
grade 2 pain in extremity ,  ctcae
grade 2 pain of skin ,  ctcae
grade 2 pain ,  ctcae
grade 2 palmar - plantar erythrodysesthesia syndrome ,  ctcae
grade 2 pancreatic anastomotic leak ,  ctcae
grade 2 pancreatic duct stenosis ,  ctcae
grade 2 pancreatic enzymes decreased ,  ctcae
grade 2 papilledema ,  ctcae
grade 2 papulopustular rash ,  ctcae
grade 2 paresthesia ,  ctcae
grade 2 paronychia ,  ctcae
grade 2 paroxysmal atrial tachycardia ,  ctcae
thorium dioxide
grade 2 pelvic floor muscle weakness ,  ctcae
grade 2 pelvic infection ,  ctcae
grade 2 pelvic pain ,  ctcae
grade 2 penile infection ,  ctcae
grade 2 pericardial effusion ,  ctcae
grade 2 perineal pain ,  ctcae
grade 2 periorbital edema ,  ctcae
grade 2 periorbital infection ,  ctcae
grade 2 peripheral ischemia ,  ctcae
grade 2 peripheral motor neuropathy ,  ctcae
grade 2 peripheral nerve infection ,  ctcae
grade 2 peripheral sensory neuropathy ,  ctcae
grade 2 personality change ,  ctcae
grade 2 phantom pain ,  ctcae
grade 2 pharyngeal anastomotic leak ,  ctcae
grade 2 pharyngeal mucositis ,  ctcae
grade 2 pharyngeal stenosis ,  ctcae
grade 2 pharyngitis ,  ctcae
grade 2 pharyngolaryngeal pain ,  ctcae
grade 2 phlebitis infective ,  ctcae
grade 2 phlebitis ,  ctcae
grade 2 platelet count decreased ,  ctcae
grade 2 pleural effusion ,  ctcae
grade 2 pleural infection ,  ctcae
grade 2 pleuritic pain ,  ctcae
grade 2 pneumonitis ,  ctcae
grade 2 portal hypertension ,  ctcae
grade 2 portal vein thrombosis ,  ctcae
grade 2 postnasal drip ,  ctcae
grade 2 postoperative hemorrhage ,  ctcae
grade 2 postoperative thoracic procedure complication ,  ctcae
grade 2 pregnancy ,  puerperium and perinatal conditions  -  other ,  specify ,  ctcae
grade 2 premature delivery ,  ctcae
grade 2 premature menopause ,  ctcae
grade 2 presyncope ,  ctcae
grade 2 productive cough ,  ctcae
grade 2 prolapse of intestinal stoma ,  ctcae
grade 2 prolapse of urostomy ,  ctcae
grade 2 prostate infection ,  ctcae
grade 2 prostatic obstruction ,  ctcae
grade 2 prostatic pain ,  ctcae
grade 2 psychiatric disorders  -  other ,  specify ,  ctcae
grade 2 psychosis ,  ctcae
grade 2 pulmonary edema ,  ctcae
grade 2 pulmonary fibrosis ,  ctcae
grade 2 pulmonary fistula ,  ctcae
grade 2 pulmonary valve disease ,  ctcae
grade 2 purpura ,  ctcae
grade 2 pyramidal tract syndrome ,  ctcae
grade 2 radiation recall reaction  ( dermatologic )  ,  ctcae
grade 2 radiculitis ,  ctcae
grade 2 rash acneiform ,  ctcae
grade 2 rash maculo - papular ,  ctcae
grade 2 rash pustular ,  ctcae
grade 2 rectal anastomotic leak ,  ctcae
grade 2 rectal fissure ,  ctcae
grade 2 rectal mucositis ,  ctcae
grade 2 rectal pain ,  ctcae
grade 2 rectal stenosis ,  ctcae
grade 2 recurrent laryngeal nerve palsy ,  ctcae
grade 2 renal and urinary disorders  -  other ,  specify ,  ctcae
grade 2 renal calculi ,  ctcae
grade 2 renal colic ,  ctcae
grade 2 reproductive system and breast disorders  -  other ,  specify ,  ctcae
grade 2 respiratory ,  thoracic and mediastinal disorders  -  other ,  specify ,  ctcae
grade 2 restlessness ,  ctcae
grade 2 retinal tear ,  ctcae
grade 2 retinal vascular disorder ,  ctcae
grade 2 retroperitoneal hemorrhage ,  ctcae
grade 2 reversible posterior leukoencephalopathy syndrome ,  ctcae
grade 2 rhabdomyolysis ,  ctcae
grade 2 rhinitis infective ,  ctcae
grade 2 rotator cuff injury ,  ctcae
grade 2 salivary duct inflammation ,  ctcae
grade 2 salivary gland infection ,  ctcae
grade 2 scleral disorder ,  ctcae
grade 2 scoliosis ,  ctcae
grade 2 scrotal infection ,  ctcae
grade 2 scrotal pain ,  ctcae
grade 2 serum amylase increased ,  ctcae
grade 2 serum sickness ,  ctcae
grade 2 shingles ,  ctcae
grade 2 sinus disorder ,  ctcae
grade 2 sinusitis ,  ctcae
grade 2 sinusoidal obstruction syndrome ,  ctcae
grade 2 skin and subcutaneous tissue disorders  -  other ,  specify ,  ctcae
grade 2 skin hyperpigmentation ,  ctcae
grade 2 skin hypopigmentation ,  ctcae
grade 2 skin induration ,  ctcae
platinum compound
grade 2 skin infection ,  ctcae
grade 2 skin papilloma ,  ctcae
grade 2 skin ulceration ,  ctcae
grade 2 sleep apnea ,  ctcae
grade 2 small intestinal anastomotic leak ,  ctcae
grade 2 small intestinal mucositis ,  ctcae
grade 2 small intestinal obstruction ,  ctcae
grade 2 small intestinal perforation ,  ctcae
grade 2 small intestinal stenosis ,  ctcae
grade 2 small intestine infection ,  ctcae
grade 2 small intestine ulcer ,  ctcae
grade 2 sneezing ,  ctcae
grade 2 social circumstances  -  other ,  specify ,  ctcae
grade 2 soft tissue infection ,  ctcae
grade 2 soft tissue necrosis lower limb ,  ctcae
grade 2 soft tissue necrosis upper limb ,  ctcae
grade 2 somnolence ,  ctcae
grade 2 sore throat ,  ctcae
grade 2 spasticity ,  ctcae
grade 2 spermatic cord anastomotic leak ,  ctcae
grade 2 spinal fracture ,  ctcae
grade 2 stenosis of gastrointestinal stoma ,  ctcae
grade 2 stoma site infection ,  ctcae
grade 2 stomal ulcer ,  ctcae
grade 2 stroke ,  ctcae
grade 2 subcutaneous emphysema ,  ctcae
grade 2 suicidal ideation ,  ctcae
grade 2 superficial soft tissue fibrosis ,  ctcae
grade 2 superficial thrombophlebitis ,  ctcae
grade 2 superior vena cava syndrome ,  ctcae
grade 2 surgical and medical procedures  -  other ,  specify ,  ctcae
grade 2 tendon reflex decreased ,  ctcae
grade 2 testicular disorder ,  ctcae
grade 2 testicular pain ,  ctcae
grade 2 testosterone deficiency ,  ctcae
grade 2 thromboembolic event ,  ctcae
grade 2 thrush ,  ctcae
grade 2 tooth development disorder ,  ctcae
grade 2 tooth infection ,  ctcae
grade 2 toothache ,  ctcae
grade 2 tracheal mucositis ,  ctcae
grade 2 tracheal obstruction ,  ctcae
grade 2 tracheal stenosis ,  ctcae
grade 2 tracheitis ,  ctcae
grade 2 tracheostomy site bleeding ,  ctcae
grade 2 transient ischemic attacks ,  ctcae
grade 2 tricuspid valve disease ,  ctcae
akr / j mouse
grade 2 trigeminal nerve disorder ,  ctcae
grade 2 trochlear nerve disorder ,  ctcae
grade 2 tumor hemorrhage ,  ctcae
grade 2 unequal limb length ,  ctcae
grade 2 upper gastrointestinal hemorrhage ,  ctcae
grade 2 upper respiratory infection ,  ctcae
grade 2 ureteric anastomotic leak ,  ctcae
grade 2 urethral anastomotic leak ,  ctcae
grade 2 urethral infection ,  ctcae
grade 2 urinary fistula ,  ctcae
grade 2 urinary frequency ,  ctcae
grade 2 urinary tract infection ,  ctcae
grade 2 urinary tract obstruction ,  ctcae
grade 2 urinary tract pain ,  ctcae
grade 2 urinary urgency ,  ctcae
grade 2 urostomy leak ,  ctcae
grade 2 urostomy obstruction ,  ctcae
grade 2 urostomy site bleeding ,  ctcae
grade 2 urostomy stenosis ,  ctcae
grade 2 uterine anastomotic leak ,  ctcae
grade 2 uterine fistula ,  ctcae
grade 2 uterine infection ,  ctcae
grade 2 uterine obstruction ,  ctcae
grade 2 uterine pain ,  ctcae
grade 2 uterine perforation ,  ctcae
grade 2 vaccination complication ,  ctcae
grade 2 vaccination site lymphadenopathy ,  ctcae
grade 2 vaginal anastomotic leak ,  ctcae
grade 2 vaginal discharge ,  ctcae
grade 2 vaginal infection ,  ctcae
grade 2 vaginal inflammation ,  ctcae
grade 2 vaginal obstruction ,  ctcae
grade 2 vaginal pain ,  ctcae
grade 2 vaginal perforation ,  ctcae
grade 2 vaginal stricture ,  ctcae
grade 2 vagus nerve disorder ,  ctcae
grade 2 vas deferens anastomotic leak ,  ctcae
grade 2 vascular access complication ,  ctcae
grade 2 vascular disorders  -  other ,  specify ,  ctcae
grade 2 venous injury ,  ctcae
grade 2 ventricular arrhythmia ,  ctcae
grade 2 vertigo ,  ctcae
grade 2 vestibular disorder ,  ctcae
grade 2 viremia ,  ctcae
grade 2 virilization ,  ctcae
grade 2 visceral arterial ischemia ,  ctcae
grade 2 vision decreased ,  ctcae
oligonucleotide primer
grade 2 vital capacity abnormal ,  ctcae
grade 2 voice alteration ,  ctcae
grade 2 vulval infection ,  ctcae
grade 2 watering eyes ,  ctcae
grade 2 wheezing ,  ctcae
grade 2 white blood cell decreased ,  ctcae
grade 2 wound complication ,  ctcae
grade 2 wound dehiscence ,  ctcae
grade 2 wound infection ,  ctcae
grade 2 wrist fracture ,  ctcae
grade 3 abdominal distension ,  ctcae
grade 3 abdominal infection ,  ctcae
grade 3 abdominal pain ,  ctcae
grade 3 abdominal soft tissue necrosis ,  ctcae
grade 3 abducens nerve disorder ,  ctcae
grade 3 accessory nerve disorder ,  ctcae
grade 3 acidosis ,  ctcae
grade 3 acoustic nerve disorder nos ,  ctcae
grade 3 activated partial thromboplastin time prolonged ,  ctcae
grade 3 acute kidney injury ,  ctcae
grade 3 akathisia ,  ctcae
grade 3 alanine aminotransferase increased ,  ctcae
grade 3 alcohol intolerance ,  ctcae
grade 3 alkaline phosphatase increased ,  ctcae
grade 3 alkalosis ,  ctcae
grade 3 allergic reaction ,  ctcae
grade 3 amnesia ,  ctcae
grade 3 anal fissure ,  ctcae
grade 3 anal fistula ,  ctcae
grade 3 anal hemorrhage ,  ctcae
grade 3 anal mucositis ,  ctcae
grade 3 anal necrosis ,  ctcae
grade 3 anal pain ,  ctcae
grade 3 anal stenosis ,  ctcae
grade 3 anal ulcer ,  ctcae
grade 3 anaphylaxis ,  ctcae
grade 3 anemia ,  ctcae
grade 3 ankle fracture ,  ctcae
grade 3 anorectal infection ,  ctcae
grade 3 aortic injury ,  ctcae
grade 3 aortic valve disease ,  ctcae
grade 3 aphonia ,  ctcae
grade 3 appendicitis perforated ,  ctcae
grade 3 appendicitis ,  ctcae
grade 3 arachnoiditis ,  ctcae
grade 3 arterial injury ,  ctcae
grade 3 arterial thromboembolism ,  ctcae
grade 3 arteritis infective ,  ctcae
grade 3 arthralgia ,  ctcae
grade 3 arthritis ,  ctcae
grade 3 ascites ,  ctcae
grade 3 aspartate aminotransferase increased ,  ctcae
grade 3 atrioventricular block complete ,  ctcae
grade 3 autoimmune disorder ,  ctcae
grade 3 avascular necrosis ,  ctcae
grade 3 bile duct stenosis ,  ctcae
grade 3 biliary anastomotic leak ,  ctcae
grade 3 biliary fistula ,  ctcae
grade 3 biliary tract infection ,  ctcae
grade 3 bladder anastomotic leak ,  ctcae
grade 3 bladder infection ,  ctcae
grade 3 blood and lymphatic system disorders  -  other ,  specify ,  ctcae
grade 3 blood antidiuretic hormone abnormal ,  ctcae
grade 3 blood bilirubin increased ,  ctcae
grade 3 blood corticotrophin decreased ,  ctcae
grade 3 blood gonadotrophin abnormal ,  ctcae
grade 3 bone infection ,  ctcae
grade 3 bone marrow hypocellular ,  ctcae
grade 3 breast atrophy ,  ctcae
grade 3 breast infection ,  ctcae
grade 3 bronchial fistula ,  ctcae
grade 3 bronchial infection ,  ctcae
grade 3 bronchial obstruction ,  ctcae
grade 3 bronchial stricture ,  ctcae
grade 3 bronchopleural fistula ,  ctcae
grade 3 bronchopulmonary hemorrhage ,  ctcae
grade 3 bronchospasm ,  ctcae
grade 3 budd - chiari syndrome ,  ctcae
grade 3 bullous dermatitis ,  ctcae
grade 3 capillary leak syndrome ,  ctcae
grade 3 carbon monoxide diffusing capacity decreased ,  ctcae
grade 3 cardiac disorders  -  other ,  specify ,  ctcae
grade 3 cardiac troponin i increased ,  ctcae
grade 3 cardiac troponin t increased ,  ctcae
grade 3 catheter related infection ,  ctcae
grade 3 cd4 lymphocytes decreased ,  ctcae
grade 3 cecal hemorrhage ,  ctcae
grade 3 cecal infection ,  ctcae
grade 3 central nervous system necrosis ,  ctcae
grade 3 cerebrospinal fluid leakage ,  ctcae
grade 3 cervicitis infection ,  ctcae
grade 3 chest pain  -  cardiac ,  ctcae
grade 3 chest wall necrosis ,  ctcae
grade 3 chills ,  ctcae
grade 3 cholesterol high ,  ctcae
grade 3 chronic kidney disease ,  ctcae
grade 3 chylous ascites ,  ctcae
grade 3 colonic fistula ,  ctcae
grade 3 colonic hemorrhage ,  ctcae
enoxaparin
grade 3 colonic obstruction ,  ctcae
grade 3 colonic perforation ,  ctcae
grade 3 colonic stenosis ,  ctcae
grade 3 colonic ulcer ,  ctcae
grade 3 concentration impairment ,  ctcae
grade 3 conduction disorder ,  ctcae
grade 3 congenital ,  familial and genetic disorders  -  other ,  specify ,  ctcae
grade 3 conjunctivitis infective ,  ctcae
grade 3 conjunctivitis ,  ctcae
grade 3 corneal infection ,  ctcae
grade 3 corneal ulcer ,  ctcae
grade 3 cpk increased ,  ctcae
grade 3 cranial nerve infection ,  ctcae
grade 3 creatinine increased ,  ctcae
grade 3 cushingoid ,  ctcae
grade 3 cystitis noninfective ,  ctcae
grade 3 cytokine release syndrome ,  ctcae
grade 3 cytomegalovirus infection reactivation ,  ctcae
grade 3 delirium ,  ctcae
grade 3 delusions ,  ctcae
grade 3 dental caries ,  ctcae
grade 3 depressed level of consciousness ,  ctcae
grade 3 dermatitis radiation ,  ctcae
grade 3 device related infection ,  ctcae
grade 3 dry eye ,  ctcae
grade 3 dry mouth ,  ctcae
grade 3 duodenal hemorrhage ,  ctcae
grade 3 duodenal infection ,  ctcae
grade 3 duodenal obstruction ,  ctcae
grade 3 duodenal perforation ,  ctcae
grade 3 duodenal stenosis ,  ctcae
grade 3 duodenal ulcer ,  ctcae
grade 3 dysarthria ,  ctcae
grade 3 dysesthesia ,  ctcae
grade 3 dysmenorrhea ,  ctcae
grade 3 dyspareunia ,  ctcae
grade 3 dyspepsia ,  ctcae
grade 3 dysphasia ,  ctcae
grade 3 ear and labyrinth disorders  -  other ,  specify ,  ctcae
grade 3 ear pain ,  ctcae
grade 3 eczema ,  ctcae
grade 3 edema cerebral ,  ctcae
grade 3 edema face ,  ctcae
grade 3 edema limbs ,  ctcae
grade 3 edema trunk ,  ctcae
grade 3 ejection fraction decreased ,  ctcae
grade 3 electrocardiogram qt corrected interval prolonged ,  ctcae
grade 3 encephalitis infection ,  ctcae
grade 3 encephalomyelitis infection ,  ctcae
grade 3 endocarditis infective ,  ctcae
grade 3 endocrine disorders  -  other ,  specify ,  ctcae
grade 3 endophthalmitis ,  ctcae
grade 3 enterocolitis infectious ,  ctcae
grade 3 enterocolitis ,  ctcae
grade 3 enterovesical fistula ,  ctcae
grade 3 eosinophilia ,  ctcae
grade 3 epistaxis ,  ctcae
grade 3 epstein - barr virus infection reactivation ,  ctcae
grade 3 erythema multiforme ,  ctcae
grade 3 erythroderma ,  ctcae
grade 3 esophageal anastomotic leak ,  ctcae
grade 3 esophageal hemorrhage ,  ctcae
grade 3 esophageal infection ,  ctcae
grade 3 esophageal necrosis ,  ctcae
grade 3 esophageal obstruction ,  ctcae
grade 3 esophageal pain ,  ctcae
grade 3 esophageal perforation ,  ctcae
grade 3 esophageal stenosis ,  ctcae
grade 3 esophageal ulcer ,  ctcae
grade 3 extraocular muscle paresis ,  ctcae
grade 3 extrapyramidal disorder ,  ctcae
grade 3 eye disorders  -  other ,  specify ,  ctcae
grade 3 eye infection ,  ctcae
grade 3 eyelid function disorder ,  ctcae
grade 3 facial muscle weakness ,  ctcae
grade 3 facial nerve disorder ,  ctcae
grade 3 facial pain ,  ctcae
grade 3 fall ,  ctcae
grade 3 fallopian tube anastomotic leak ,  ctcae
grade 3 fat atrophy ,  ctcae
grade 3 fecal incontinence ,  ctcae
grade 3 fetal growth retardation ,  ctcae
grade 3 fever ,  ctcae
grade 3 fibrinogen decreased ,  ctcae
grade 3 fibrosis deep connective tissue ,  ctcae
grade 3 flank pain ,  ctcae
grade 3 flashing lights ,  ctcae
grade 3 floaters ,  ctcae
grade 3 flu like symptoms ,  ctcae
grade 3 flushing ,  ctcae
grade 3 folliculitis ,  ctcae
grade 3 forced expiratory volume decreased ,  ctcae
grade 3 fungemia ,  ctcae
grade 3 gait disturbance ,  ctcae
grade 3 gallbladder infection ,  ctcae
grade 3 gastric anastomotic leak ,  ctcae
grade 3 gastric fistula ,  ctcae
dalteparin
grade 3 gastric hemorrhage ,  ctcae
grade 3 gastric necrosis ,  ctcae
grade 3 gastric perforation ,  ctcae
grade 3 gastric stenosis ,  ctcae
grade 3 gastric ulcer ,  ctcae
grade 3 gastroesophageal reflux disease ,  ctcae
grade 3 gastrointestinal anastomotic leak ,  ctcae
grade 3 gastrointestinal disorders  -  other ,  specify ,  ctcae
grade 3 gastrointestinal fistula ,  ctcae
grade 3 gastrointestinal pain ,  ctcae
grade 3 gastrointestinal stoma necrosis ,  ctcae
grade 3 gastroparesis ,  ctcae
grade 3 general disorders and administration site conditions  -  other ,  specify ,  ctcae
grade 3 generalized edema ,  ctcae
grade 3 generalized muscle weakness ,  ctcae
grade 3 genital edema ,  ctcae
grade 3 ggt increased ,  ctcae
grade 3 gingival pain ,  ctcae
grade 3 glossopharyngeal nerve disorder ,  ctcae
grade 3 glucose intolerance ,  ctcae
grade 3 growth suppression ,  ctcae
grade 3 guillain - barre syndrome ,  ctcae
grade 3 gum infection ,  ctcae
grade 3 hallucinations ,  ctcae
grade 3 headache ,  ctcae
grade 3 hearing impaired ,  ctcae
grade 3 heart failure ,  ctcae
grade 3 hematosalpinx ,  ctcae
grade 3 hematuria ,  ctcae
grade 3 hemoglobin increased ,  ctcae
grade 3 hemolytic uremic syndrome ,  ctcae
grade 3 hemorrhoidal hemorrhage ,  ctcae
grade 3 hepatic failure ,  ctcae
grade 3 hepatic hemorrhage ,  ctcae
grade 3 hepatic infection ,  ctcae
grade 3 hepatic pain ,  ctcae
grade 3 hepatitis b reactivation ,  ctcae
grade 3 hepatitis viral ,  ctcae
grade 3 hepatobiliary disorders  -  other ,  specify ,  ctcae
grade 3 herpes simplex reactivation ,  ctcae
grade 3 hiccups ,  ctcae
grade 3 hip fracture ,  ctcae
grade 3 hoarseness ,  ctcae
grade 3 hot flashes ,  ctcae
grade 3 hypercalcemia ,  ctcae
grade 3 hyperglycemia ,  ctcae
grade 3 hyperhidrosis ,  ctcae
grade 3 hyperkalemia ,  ctcae
grade 3 hyperkeratosis ,  ctcae
grade 3 hyperlipidemia ,  ctcae
grade 3 hypermagnesemia ,  ctcae
grade 3 hypernatremia ,  ctcae
grade 3 hyperphosphatemia ,  ctcae
grade 3 hypersomnia ,  ctcae
grade 3 hyperthyroidism ,  ctcae
grade 3 hypertriglyceridemia ,  ctcae
grade 3 hyperuricemia ,  ctcae
grade 3 hypoalbuminemia ,  ctcae
grade 3 hypocalcemia ,  ctcae
grade 3 hypoglossal nerve disorder ,  ctcae
grade 3 hypoglycemia ,  ctcae
grade 3 hypohidrosis ,  ctcae
grade 3 hypokalemia ,  ctcae
grade 3 hypomagnesemia ,  ctcae
grade 3 hyponatremia ,  ctcae
grade 3 hypoparathyroidism ,  ctcae
grade 3 hypophosphatemia ,  ctcae
grade 3 hypophysitis ,  ctcae
grade 3 hypopituitarism ,  ctcae
grade 3 hypothyroidism ,  ctcae
grade 3 ileal perforation ,  ctcae
grade 3 ileal stenosis ,  ctcae
grade 3 immune system disorders  -  other ,  specify ,  ctcae
grade 3 infections and infestations  -  other ,  specify ,  ctcae
grade 3 infective myositis ,  ctcae
grade 3 infusion related reaction ,  ctcae
grade 3 infusion site extravasation ,  ctcae
grade 3 injection site reaction ,  ctcae
grade 3 injury to carotid artery ,  ctcae
grade 3 injury to jugular vein ,  ctcae
grade 3 injury to superior vena cava ,  ctcae
grade 3 injury ,  poisoning and procedural complications  -  other ,  specify ,  ctcae
grade 3 inr increased ,  ctcae
grade 3 intestinal stoma leak ,  ctcae
grade 3 intestinal stoma obstruction ,  ctcae
grade 3 intestinal stoma site bleeding ,  ctcae
grade 3 intra - abdominal hemorrhage ,  ctcae
grade 3 intracranial hemorrhage ,  ctcae
grade 3 intraoperative arterial injury ,  ctcae
grade 3 intraoperative breast injury ,  ctcae
grade 3 intraoperative cardiac injury ,  ctcae
grade 3 intraoperative ear injury ,  ctcae
grade 3 intraoperative endocrine injury ,  ctcae
grade 3 intraoperative gastrointestinal injury ,  ctcae
grade 3 intraoperative head and neck injury ,  ctcae
grade 3 intraoperative hemorrhage ,  ctcae
grade 3 intraoperative hepatobiliary injury ,  ctcae
grade 3 intraoperative musculoskeletal injury ,  ctcae
grade 3 intraoperative neurological injury ,  ctcae
grade 3 intraoperative ocular injury ,  ctcae
grade 3 intraoperative renal injury ,  ctcae
grade 3 intraoperative reproductive tract injury ,  ctcae
grade 3 intraoperative respiratory injury ,  ctcae
grade 3 intraoperative splenic injury ,  ctcae
grade 3 intraoperative urinary injury ,  ctcae
grade 3 intraoperative venous injury ,  ctcae
grade 3 investigations  -  other ,  specify ,  ctcae
grade 3 irritability ,  ctcae
grade 3 jejunal perforation ,  ctcae
grade 3 jejunal stenosis ,  ctcae
grade 3 joint infection ,  ctcae
grade 3 joint range of motion decreased cervical spine ,  ctcae
grade 3 joint range of motion decreased lumbar spine ,  ctcae
grade 3 joint range of motion decreased ,  ctcae
grade 3 kidney anastomotic leak ,  ctcae
grade 3 kidney infection ,  ctcae
grade 3 kyphosis ,  ctcae
grade 3 large intestinal anastomotic leak ,  ctcae
grade 3 laryngeal edema ,  ctcae
grade 3 laryngeal inflammation ,  ctcae
grade 3 laryngeal mucositis ,  ctcae
grade 3 laryngeal obstruction ,  ctcae
grade 3 laryngeal stenosis ,  ctcae
grade 3 laryngitis ,  ctcae
grade 3 laryngopharyngeal dysesthesia ,  ctcae
grade 3 laryngospasm ,  ctcae
grade 3 leukocytosis ,  ctcae
grade 3 leukoencephalopathy ,  ctcae
grade 3 lip infection ,  ctcae
grade 3 lipase increased ,  ctcae
grade 3 lipohypertrophy ,  ctcae
grade 3 localized edema ,  ctcae
grade 3 lordosis ,  ctcae
grade 3 lower gastrointestinal hemorrhage ,  ctcae
grade 3 lung infection ,  ctcae
grade 3 lymph gland infection ,  ctcae
grade 3 lymph leakage ,  ctcae
grade 3 lymphedema ,  ctcae
grade 3 lymphocyte count decreased ,  ctcae
grade 3 lymphocyte count increased ,  ctcae
grade 3 malaise ,  ctcae
grade 3 mania ,  ctcae
grade 3 mediastinal infection ,  ctcae
grade 3 meningismus ,  ctcae
grade 3 meningitis ,  ctcae
grade 3 menorrhagia ,  ctcae
grade 3 metabolism and nutrition disorders  -  other ,  specify ,  ctcae
grade 3 methemoglobinemia ,  ctcae
grade 3 middle ear inflammation ,  ctcae
grade 3 mitral valve disease ,  ctcae
grade 3 movements involuntary ,  ctcae
grade 3 mucosal infection ,  ctcae
grade 3 mucositis oral ,  ctcae
grade 3 multi - organ failure ,  ctcae
grade 3 muscle cramp ,  ctcae
grade 3 muscle weakness left - sided ,  ctcae
grade 3 muscle weakness lower limb ,  ctcae
grade 3 muscle weakness right - sided ,  ctcae
grade 3 muscle weakness trunk ,  ctcae
grade 3 muscle weakness upper limb ,  ctcae
grade 3 musculoskeletal and connective tissue disorder  -  other ,  specify ,  ctcae
grade 3 musculoskeletal deformity ,  ctcae
grade 3 myalgia ,  ctcae
grade 3 myasthenia gravis ,  ctcae
grade 3 myocardial infarction ,  ctcae
grade 3 nail infection ,  ctcae
grade 3 nasal congestion ,  ctcae
grade 3 neck edema ,  ctcae
grade 3 neoplasms benign ,  malignant and unspecified  ( incl cysts and polyps )   -  other ,  specify ,  ctcae
grade 3 nephrotic syndrome ,  ctcae
grade 3 nervous system disorders  -  other ,  specify ,  ctcae
grade 3 neuralgia ,  ctcae
grade 3 neutrophil count decreased ,  ctcae
grade 3 night blindness ,  ctcae
grade 3 non - cardiac chest pain ,  ctcae
grade 3 obstruction gastric ,  ctcae
grade 3 oculomotor nerve disorder ,  ctcae
grade 3 olfactory nerve disorder ,  ctcae
grade 3 optic nerve disorder ,  ctcae
grade 3 oral cavity fistula ,  ctcae
grade 3 oral dysesthesia ,  ctcae
grade 3 oropharyngeal pain ,  ctcae
grade 3 osteonecrosis of jaw ,  ctcae
conjugate vaccine
grade 3 osteonecrosis ,  ctcae
grade 3 otitis externa ,  ctcae
grade 3 otitis media ,  ctcae
grade 3 ovarian infection ,  ctcae
grade 3 ovarian rupture ,  ctcae
grade 3 pain in extremity ,  ctcae
grade 3 pain of skin ,  ctcae
grade 3 pain ,  ctcae
grade 3 palmar - plantar erythrodysesthesia syndrome ,  ctcae
grade 3 pancreas infection ,  ctcae
grade 3 pancreatic anastomotic leak ,  ctcae
grade 3 pancreatic duct stenosis ,  ctcae
grade 3 pancreatic enzymes decreased ,  ctcae
grade 3 pancreatic necrosis ,  ctcae
grade 3 papilledema ,  ctcae
grade 3 papulopustular rash ,  ctcae
grade 3 paresthesia ,  ctcae
grade 3 paronychia ,  ctcae
grade 3 paroxysmal atrial tachycardia ,  ctcae
grade 3 pelvic floor muscle weakness ,  ctcae
grade 3 pelvic infection ,  ctcae
grade 3 pelvic pain ,  ctcae
grade 3 penile infection ,  ctcae
grade 3 perforation bile duct ,  ctcae
grade 3 pericardial effusion ,  ctcae
grade 3 perineal pain ,  ctcae
grade 3 periorbital edema ,  ctcae
grade 3 periorbital infection ,  ctcae
grade 3 peripheral ischemia ,  ctcae
grade 3 peripheral motor neuropathy ,  ctcae
grade 3 peripheral nerve infection ,  ctcae
grade 3 peripheral sensory neuropathy ,  ctcae
grade 3 peritoneal infection ,  ctcae
grade 3 personality change ,  ctcae
grade 3 phantom pain ,  ctcae
grade 3 pharyngeal anastomotic leak ,  ctcae
grade 3 pharyngeal mucositis ,  ctcae
grade 3 pharyngeal stenosis ,  ctcae
grade 3 pharyngitis ,  ctcae
grade 3 pharyngolaryngeal pain ,  ctcae
grade 3 phlebitis infective ,  ctcae
grade 3 platelet count decreased ,  ctcae
grade 3 pleural effusion ,  ctcae
grade 3 pleural infection ,  ctcae
grade 3 pleuritic pain ,  ctcae
grade 3 pneumonitis ,  ctcae
grade 3 portal hypertension ,  ctcae
grade 3 portal vein thrombosis ,  ctcae
grade 3 postoperative hemorrhage ,  ctcae
grade 3 postoperative thoracic procedure complication ,  ctcae
grade 3 pregnancy ,  puerperium and perinatal conditions  -  other ,  specify ,  ctcae
grade 3 premature delivery ,  ctcae
grade 3 productive cough ,  ctcae
grade 3 prolapse of intestinal stoma ,  ctcae
grade 3 prolapse of urostomy ,  ctcae
grade 3 prostate infection ,  ctcae
grade 3 prostatic obstruction ,  ctcae
grade 3 prostatic pain ,  ctcae
grade 3 psychiatric disorders  -  other ,  specify ,  ctcae
grade 3 psychosis ,  ctcae
grade 3 pulmonary edema ,  ctcae
grade 3 pulmonary fibrosis ,  ctcae
grade 3 pulmonary fistula ,  ctcae
grade 3 pulmonary valve disease ,  ctcae
grade 3 purpura ,  ctcae
grade 3 pyramidal tract syndrome ,  ctcae
grade 3 radiation recall reaction  ( dermatologic )  ,  ctcae
grade 3 radiculitis ,  ctcae
grade 3 rash acneiform ,  ctcae
grade 3 rash maculo - papular ,  ctcae
grade 3 rash pustular ,  ctcae
grade 3 rectal anastomotic leak ,  ctcae
grade 3 rectal fissure ,  ctcae
grade 3 rectal mucositis ,  ctcae
grade 3 rectal pain ,  ctcae
grade 3 rectal stenosis ,  ctcae
grade 3 recurrent laryngeal nerve palsy ,  ctcae
grade 3 renal and urinary disorders  -  other ,  specify ,  ctcae
grade 3 renal calculi ,  ctcae
grade 3 renal colic ,  ctcae
grade 3 reproductive system and breast disorders  -  other ,  specify ,  ctcae
grade 3 respiratory ,  thoracic and mediastinal disorders  -  other ,  specify ,  ctcae
grade 3 restlessness ,  ctcae
superantigen
grade 3 retinal vascular disorder ,  ctcae
grade 3 retroperitoneal hemorrhage ,  ctcae
grade 3 reversible posterior leukoencephalopathy syndrome ,  ctcae
grade 3 rhabdomyolysis ,  ctcae
grade 3 rotator cuff injury ,  ctcae
grade 3 salivary duct inflammation ,  ctcae
grade 3 salivary gland infection ,  ctcae
grade 3 scleral disorder ,  ctcae
grade 3 scoliosis ,  ctcae
grade 3 scrotal infection ,  ctcae
grade 3 scrotal pain ,  ctcae
grade 3 sepsis ,  ctcae
grade 3 serum amylase increased ,  ctcae
grade 3 shingles ,  ctcae
grade 3 sinus disorder ,  ctcae
grade 3 sinusitis ,  ctcae
grade 3 sinusoidal obstruction syndrome ,  ctcae
grade 3 skin and subcutaneous tissue disorders  -  other ,  specify ,  ctcae
grade 3 skin atrophy ,  ctcae
grade 3 skin induration ,  ctcae
grade 3 skin infection ,  ctcae
grade 3 skin ulceration ,  ctcae
grade 3 sleep apnea ,  ctcae
grade 3 small intestinal anastomotic leak ,  ctcae
grade 3 small intestinal mucositis ,  ctcae
grade 3 small intestinal obstruction ,  ctcae
grade 3 small intestinal perforation ,  ctcae
grade 3 small intestinal stenosis ,  ctcae
grade 3 small intestine infection ,  ctcae
grade 3 small intestine ulcer ,  ctcae
grade 3 social circumstances  -  other ,  specify ,  ctcae
grade 3 soft tissue infection ,  ctcae
grade 3 soft tissue necrosis lower limb ,  ctcae
grade 3 soft tissue necrosis upper limb ,  ctcae
grade 3 somnolence ,  ctcae
grade 3 sore throat ,  ctcae
grade 3 spasticity ,  ctcae
grade 3 spermatic cord anastomotic leak ,  ctcae
grade 3 spinal cord compression ,  ctcae
grade 3 spinal fracture ,  ctcae
grade 3 splenic infection ,  ctcae
grade 3 stenosis of gastrointestinal stoma ,  ctcae
grade 3 stevens - johnson syndrome ,  ctcae
grade 3 stoma site infection ,  ctcae
grade 3 stomal ulcer ,  ctcae
grade 3 stridor ,  ctcae
grade 3 stroke ,  ctcae
grade 3 subcutaneous emphysema ,  ctcae
grade 3 suicidal ideation ,  ctcae
grade 3 suicide attempt ,  ctcae
grade 3 superficial soft tissue fibrosis ,  ctcae
grade 3 superior vena cava syndrome ,  ctcae
grade 3 surgical and medical procedures  -  other ,  specify ,  ctcae
grade 3 tendon reflex decreased ,  ctcae
grade 3 testicular disorder ,  ctcae
grade 3 testicular pain ,  ctcae
grade 3 thromboembolic event ,  ctcae
grade 3 thrombotic thrombocytopenic purpura ,  ctcae
grade 3 thrush ,  ctcae
grade 3 tooth development disorder ,  ctcae
grade 3 tooth infection ,  ctcae
grade 3 toothache ,  ctcae
grade 3 tracheal mucositis ,  ctcae
grade 3 tracheal obstruction ,  ctcae
grade 3 tracheal stenosis ,  ctcae
grade 3 tracheitis ,  ctcae
grade 3 tracheostomy site bleeding ,  ctcae
101 mouse
grade 3 treatment related secondary malignancy ,  ctcae
grade 3 tricuspid valve disease ,  ctcae
grade 3 trigeminal nerve disorder ,  ctcae
grade 3 trochlear nerve disorder ,  ctcae
grade 3 tumor hemorrhage ,  ctcae
grade 3 unequal limb length ,  ctcae
grade 3 upper gastrointestinal hemorrhage ,  ctcae
grade 3 upper respiratory infection ,  ctcae
grade 3 ureteric anastomotic leak ,  ctcae
grade 3 urethral anastomotic leak ,  ctcae
102 mouse
grade 3 urethral infection ,  ctcae
grade 3 urinary fistula ,  ctcae
grade 3 urinary tract infection ,  ctcae
grade 3 urinary tract obstruction ,  ctcae
grade 3 urinary tract pain ,  ctcae
grade 3 urine output decreased ,  ctcae
grade 3 urostomy leak ,  ctcae
grade 3 urostomy obstruction ,  ctcae
grade 3 urostomy site bleeding ,  ctcae
grade 3 urostomy stenosis ,  ctcae
grade 3 uterine anastomotic leak ,  ctcae
grade 3 uterine fistula ,  ctcae
grade 3 uterine infection ,  ctcae
grade 3 uterine obstruction ,  ctcae
grade 3 uterine pain ,  ctcae
grade 3 uterine perforation ,  ctcae
grade 3 vaccination complication ,  ctcae
grade 3 vaginal anastomotic leak ,  ctcae
grade 3 vaginal dryness ,  ctcae
yeast artificial chromosome
grade 3 vaginal infection ,  ctcae
grade 3 vaginal inflammation ,  ctcae
grade 3 vaginal obstruction ,  ctcae
grade 3 vaginal pain ,  ctcae
grade 3 vaginal perforation ,  ctcae
grade 3 vaginal stricture ,  ctcae
grade 3 vagus nerve disorder ,  ctcae
grade 3 vas deferens anastomotic leak ,  ctcae
grade 3 vascular access complication ,  ctcae
grade 3 vascular disorders  -  other ,  specify ,  ctcae
grade 3 vasovagal reaction ,  ctcae
grade 3 venous injury ,  ctcae
grade 3 ventricular arrhythmia ,  ctcae
grade 3 vertigo ,  ctcae
grade 3 vestibular disorder ,  ctcae
grade 3 viremia ,  ctcae
grade 3 visceral arterial ischemia ,  ctcae
grade 3 vision decreased ,  ctcae
grade 3 vital capacity abnormal ,  ctcae
grade 3 voice alteration ,  ctcae
grade 3 vulval infection ,  ctcae
grade 3 watering eyes ,  ctcae
grade 3 wheezing ,  ctcae
grade 3 white blood cell decreased ,  ctcae
grade 3 wound complication ,  ctcae
grade 3 wound dehiscence ,  ctcae
grade 3 wound infection ,  ctcae
grade 3 wrist fracture ,  ctcae
grade 4 abdominal infection ,  ctcae
grade 4 abdominal soft tissue necrosis ,  ctcae
grade 4 acidosis ,  ctcae
grade 4 acute kidney injury ,  ctcae
grade 4 alanine aminotransferase increased ,  ctcae
grade 4 alcohol intolerance ,  ctcae
grade 4 alkaline phosphatase increased ,  ctcae
grade 4 alkalosis ,  ctcae
grade 4 allergic reaction ,  ctcae
grade 4 anal fistula ,  ctcae
grade 4 anal hemorrhage ,  ctcae
grade 4 anal necrosis ,  ctcae
grade 4 anal stenosis ,  ctcae
grade 4 anal ulcer ,  ctcae
grade 4 anaphylaxis ,  ctcae
grade 4 anemia ,  ctcae
grade 4 anorectal infection ,  ctcae
grade 4 aortic injury ,  ctcae
grade 4 aortic valve disease ,  ctcae
grade 4 appendicitis perforated ,  ctcae
grade 4 appendicitis ,  ctcae
grade 4 arachnoiditis ,  ctcae
grade 4 arterial injury ,  ctcae
grade 4 arterial thromboembolism ,  ctcae
grade 4 arteritis infective ,  ctcae
grade 4 ascites ,  ctcae
grade 4 aspartate aminotransferase increased ,  ctcae
grade 4 atrioventricular block complete ,  ctcae
grade 4 autoimmune disorder ,  ctcae
grade 4 avascular necrosis ,  ctcae
grade 4 bile duct stenosis ,  ctcae
grade 4 biliary anastomotic leak ,  ctcae
grade 4 biliary fistula ,  ctcae
grade 4 biliary tract infection ,  ctcae
grade 4 bladder anastomotic leak ,  ctcae
grade 4 bladder infection ,  ctcae
grade 4 blood and lymphatic system disorders  -  other ,  specify ,  ctcae
grade 4 blood bilirubin increased ,  ctcae
grade 4 bone infection ,  ctcae
grade 4 bone marrow hypocellular ,  ctcae
grade 4 breast infection ,  ctcae
grade 4 bronchial fistula ,  ctcae
grade 4 bronchial infection ,  ctcae
grade 4 bronchial obstruction ,  ctcae
grade 4 bronchial stricture ,  ctcae
grade 4 bronchopleural fistula ,  ctcae
grade 4 bronchopulmonary hemorrhage ,  ctcae
grade 4 bronchospasm ,  ctcae
grade 4 budd - chiari syndrome ,  ctcae
grade 4 bullous dermatitis ,  ctcae
uw mouse
grade 4 capillary leak syndrome ,  ctcae
grade 4 cardiac arrest ,  ctcae
grade 4 cardiac disorders  -  other ,  specify ,  ctcae
grade 4 cataract ,  ctcae
grade 4 catheter related infection ,  ctcae
grade 4 cd4 lymphocytes decreased ,  ctcae
grade 4 cecal hemorrhage ,  ctcae
grade 4 cecal infection ,  ctcae
grade 4 central nervous system necrosis ,  ctcae
grade 4 cerebrospinal fluid leakage ,  ctcae
grade 4 cervicitis infection ,  ctcae
grade 4 chest wall necrosis ,  ctcae
grade 4 cholesterol high ,  ctcae
grade 4 chronic kidney disease ,  ctcae
grade 4 chylous ascites ,  ctcae
grade 4 colonic fistula ,  ctcae
grade 4 colonic hemorrhage ,  ctcae
grade 4 colonic obstruction ,  ctcae
grade 4 colonic perforation ,  ctcae
grade 4 colonic stenosis ,  ctcae
zorubicin hydrochloride
grade 4 colonic ulcer ,  ctcae
grade 4 conduction disorder ,  ctcae
grade 4 congenital ,  familial and genetic disorders  -  other ,  specify ,  ctcae
grade 4 conjunctivitis infective ,  ctcae
grade 4 conjunctivitis ,  ctcae
grade 4 corneal infection ,  ctcae
grade 4 corneal ulcer ,  ctcae
grade 4 cpk increased ,  ctcae
grade 4 cranial nerve infection ,  ctcae
grade 4 creatinine increased ,  ctcae
grade 4 cystitis noninfective ,  ctcae
grade 4 cytokine release syndrome ,  ctcae
grade 4 cytomegalovirus infection reactivation ,  ctcae
grade 4 death neonatal ,  ctcae
grade 4 delirium ,  ctcae
grade 4 delusions ,  ctcae
grade 4 depressed level of consciousness ,  ctcae
grade 4 dermatitis radiation ,  ctcae
grade 4 device related infection ,  ctcae
grade 4 duodenal hemorrhage ,  ctcae
grade 4 duodenal infection ,  ctcae
grade 4 duodenal obstruction ,  ctcae
grade 4 duodenal perforation ,  ctcae
grade 4 duodenal stenosis ,  ctcae
grade 4 duodenal ulcer ,  ctcae
grade 4 ear and labyrinth disorders  -  other ,  specify ,  ctcae
grade 4 edema cerebral ,  ctcae
grade 4 ejection fraction decreased ,  ctcae
grade 4 electrocardiogram qt corrected interval prolonged ,  ctcae
grade 4 encephalitis infection ,  ctcae
grade 4 encephalomyelitis infection ,  ctcae
grade 4 endocarditis infective ,  ctcae
grade 4 endocrine disorders  -  other ,  specify ,  ctcae
grade 4 endophthalmitis ,  ctcae
grade 4 enterocolitis infectious ,  ctcae
grade 4 enterocolitis ,  ctcae
grade 4 enterovesical fistula ,  ctcae
grade 4 epistaxis ,  ctcae
grade 4 epstein - barr virus infection reactivation ,  ctcae
grade 4 erythema multiforme ,  ctcae
grade 4 erythroderma ,  ctcae
grade 4 esophageal anastomotic leak ,  ctcae
grade 4 esophageal hemorrhage ,  ctcae
grade 4 esophageal infection ,  ctcae
grade 4 esophageal necrosis ,  ctcae
grade 4 esophageal obstruction ,  ctcae
grade 4 esophageal perforation ,  ctcae
grade 4 esophageal stenosis ,  ctcae
grade 4 esophageal ulcer ,  ctcae
grade 4 extraocular muscle paresis ,  ctcae
grade 4 extrapyramidal disorder ,  ctcae
grade 4 eye disorders  -  other ,  specify ,  ctcae
grade 4 eye infection ,  ctcae
grade 4 fallopian tube anastomotic leak ,  ctcae
grade 4 fetal growth retardation ,  ctcae
grade 4 fever ,  ctcae
grade 4 fibrinogen decreased ,  ctcae
grade 4 fibrosis deep connective tissue ,  ctcae
grade 4 forced expiratory volume decreased ,  ctcae
grade 4 gallbladder infection ,  ctcae
grade 4 gastric anastomotic leak ,  ctcae
grade 4 gastric fistula ,  ctcae
grade 4 gastric hemorrhage ,  ctcae
grade 4 gastric necrosis ,  ctcae
grade 4 gastric perforation ,  ctcae
grade 4 gastric stenosis ,  ctcae
grade 4 gastric ulcer ,  ctcae
grade 4 gastrointestinal anastomotic leak ,  ctcae
grade 4 gastrointestinal disorders  -  other ,  specify ,  ctcae
grade 4 gastrointestinal fistula ,  ctcae
grade 4 gastrointestinal stoma necrosis ,  ctcae
grade 4 gastroparesis ,  ctcae
grade 4 general disorders and administration site conditions  -  other ,  specify ,  ctcae
grade 4 generalized edema ,  ctcae
grade 4 ggt increased ,  ctcae
grade 4 glossopharyngeal nerve disorder ,  ctcae
grade 4 glucose intolerance ,  ctcae
grade 4 guillain - barre syndrome ,  ctcae
grade 4 gum infection ,  ctcae
grade 4 hallucinations ,  ctcae
grade 4 hearing impaired ,  ctcae
grade 4 heart failure ,  ctcae
grade 4 hematosalpinx ,  ctcae
grade 4 hematuria ,  ctcae
grade 4 hemolytic uremic syndrome ,  ctcae
grade 4 hemorrhoidal hemorrhage ,  ctcae
grade 4 hepatic failure ,  ctcae
grade 4 hepatic hemorrhage ,  ctcae
grade 4 hepatic infection ,  ctcae
grade 4 hepatitis b reactivation ,  ctcae
grade 4 hepatitis viral ,  ctcae
grade 4 hepatobiliary disorders  -  other ,  specify ,  ctcae
grade 4 herpes simplex reactivation ,  ctcae
grade 4 hip fracture ,  ctcae
grade 4 hypercalcemia ,  ctcae
grade 4 hyperglycemia ,  ctcae
grade 4 hyperkalemia ,  ctcae
recombinant glial cell - line derived neurotrophic factor
grade 4 hyperlipidemia ,  ctcae
grade 4 hypermagnesemia ,  ctcae
grade 4 hypernatremia ,  ctcae
grade 4 hyperphosphatemia ,  ctcae
grade 4 hyperthyroidism ,  ctcae
grade 4 hypertriglyceridemia ,  ctcae
grade 4 hyperuricemia ,  ctcae
grade 4 hypoalbuminemia ,  ctcae
grade 4 hypocalcemia ,  ctcae
grade 4 hypoglycemia ,  ctcae
grade 4 hypohidrosis ,  ctcae
grade 4 hypokalemia ,  ctcae
grade 4 hypomagnesemia ,  ctcae
grade 4 hyponatremia ,  ctcae
grade 4 hypoparathyroidism ,  ctcae
grade 4 hypophosphatemia ,  ctcae
grade 4 hypophysitis ,  ctcae
grade 4 hypopituitarism ,  ctcae
grade 4 hypothyroidism ,  ctcae
grade 4 ileal perforation ,  ctcae
grade 4 ileal stenosis ,  ctcae
grade 4 immune system disorders  -  other ,  specify ,  ctcae
grade 4 infections and infestations  -  other ,  specify ,  ctcae
grade 4 infective myositis ,  ctcae
grade 4 infusion related reaction ,  ctcae
grade 4 infusion site extravasation ,  ctcae
grade 4 injection site reaction ,  ctcae
grade 4 injury to carotid artery ,  ctcae
grade 4 injury to jugular vein ,  ctcae
grade 4 injury to superior vena cava ,  ctcae
grade 4 injury ,  poisoning and procedural complications  -  other ,  specify ,  ctcae
grade 4 intestinal stoma leak ,  ctcae
grade 4 intestinal stoma obstruction ,  ctcae
grade 4 intestinal stoma site bleeding ,  ctcae
grade 4 intra - abdominal hemorrhage ,  ctcae
grade 4 intracranial hemorrhage ,  ctcae
grade 4 intraoperative arterial injury ,  ctcae
grade 4 intraoperative breast injury ,  ctcae
grade 4 intraoperative cardiac injury ,  ctcae
grade 4 intraoperative ear injury ,  ctcae
grade 4 intraoperative endocrine injury ,  ctcae
grade 4 intraoperative gastrointestinal injury ,  ctcae
grade 4 intraoperative head and neck injury ,  ctcae
grade 4 intraoperative hemorrhage ,  ctcae
grade 4 intraoperative hepatobiliary injury ,  ctcae
grade 4 intraoperative musculoskeletal injury ,  ctcae
grade 4 intraoperative neurological injury ,  ctcae
grade 4 intraoperative ocular injury ,  ctcae
grade 4 intraoperative renal injury ,  ctcae
grade 4 intraoperative reproductive tract injury ,  ctcae
grade 4 intraoperative respiratory injury ,  ctcae
grade 4 intraoperative splenic injury ,  ctcae
grade 4 intraoperative urinary injury ,  ctcae
grade 4 intraoperative venous injury ,  ctcae
grade 4 investigations  -  other ,  specify ,  ctcae
grade 4 jejunal perforation ,  ctcae
grade 4 jejunal stenosis ,  ctcae
grade 4 joint infection ,  ctcae
grade 4 kidney anastomotic leak ,  ctcae
grade 4 kidney infection ,  ctcae
grade 4 large intestinal anastomotic leak ,  ctcae
grade 4 laryngeal edema ,  ctcae
grade 4 laryngeal mucositis ,  ctcae
grade 4 laryngeal obstruction ,  ctcae
grade 4 laryngeal stenosis ,  ctcae
grade 4 laryngitis ,  ctcae
grade 4 laryngopharyngeal dysesthesia ,  ctcae
grade 4 laryngospasm ,  ctcae
grade 4 leukemia secondary to oncology chemotherapy ,  ctcae
grade 4 leukocytosis ,  ctcae
grade 4 leukoencephalopathy ,  ctcae
grade 4 lipase increased ,  ctcae
grade 4 lower gastrointestinal hemorrhage ,  ctcae
grade 4 lung infection ,  ctcae
grade 4 lymph gland infection ,  ctcae
grade 4 lymph leakage ,  ctcae
grade 4 lymphocyte count decreased ,  ctcae
grade 4 mania ,  ctcae
grade 4 mediastinal infection ,  ctcae
grade 4 meningismus ,  ctcae
grade 4 meningitis ,  ctcae
grade 4 menorrhagia ,  ctcae
grade 4 metabolism and nutrition disorders  -  other ,  specify ,  ctcae
grade 4 methemoglobinemia ,  ctcae
grade 4 middle ear inflammation ,  ctcae
grade 4 mitral valve disease ,  ctcae
sorivudine
grade 4 mucosal infection ,  ctcae
grade 4 mucositis oral ,  ctcae
grade 4 multi - organ failure ,  ctcae
grade 4 musculoskeletal and connective tissue disorder  -  other ,  specify ,  ctcae
grade 4 myasthenia gravis ,  ctcae
grade 4 myelodysplastic syndrome ,  ctcae
grade 4 myocardial infarction ,  ctcae
grade 4 neck edema ,  ctcae
grade 4 neoplasms benign ,  malignant and unspecified  ( incl cysts and polyps )   -  other ,  specify ,  ctcae
grade 4 nephrotic syndrome ,  ctcae
grade 4 nervous system disorders  -  other ,  specify ,  ctcae
grade 4 neutrophil count decreased ,  ctcae
grade 4 night blindness ,  ctcae
grade 4 obstruction gastric ,  ctcae
grade 4 optic nerve disorder ,  ctcae
grade 4 oral cavity fistula ,  ctcae
grade 4 osteonecrosis of jaw ,  ctcae
grade 4 osteonecrosis ,  ctcae
grade 4 otitis externa ,  ctcae
grade 4 otitis media ,  ctcae
grade 4 ovarian infection ,  ctcae
grade 4 ovarian rupture ,  ctcae
grade 4 pancreas infection ,  ctcae
grade 4 pancreatic anastomotic leak ,  ctcae
grade 4 pancreatic duct stenosis ,  ctcae
grade 4 pancreatic necrosis ,  ctcae
grade 4 papilledema ,  ctcae
grade 4 papulopustular rash ,  ctcae
grade 4 paroxysmal atrial tachycardia ,  ctcae
grade 4 pelvic infection ,  ctcae
grade 4 penile infection ,  ctcae
grade 4 perforation bile duct ,  ctcae
grade 4 pericardial effusion ,  ctcae
grade 4 pericardial tamponade ,  ctcae
grade 4 periorbital infection ,  ctcae
dba / 2 mouse
grade 4 peripheral ischemia ,  ctcae
grade 4 peripheral motor neuropathy ,  ctcae
grade 4 peripheral nerve infection ,  ctcae
grade 4 peripheral sensory neuropathy ,  ctcae
grade 4 peritoneal infection ,  ctcae
grade 4 personality change ,  ctcae
grade 4 pharyngeal anastomotic leak ,  ctcae
grade 4 pharyngeal mucositis ,  ctcae
grade 4 pharyngeal stenosis ,  ctcae
grade 4 pharyngitis ,  ctcae
grade 4 phlebitis infective ,  ctcae
grade 4 platelet count decreased ,  ctcae
grade 4 pleural effusion ,  ctcae
grade 4 pleural infection ,  ctcae
grade 4 pneumonitis ,  ctcae
dba / 1 mouse
grade 4 portal hypertension ,  ctcae
grade 4 portal vein thrombosis ,  ctcae
grade 4 postoperative hemorrhage ,  ctcae
grade 4 postoperative thoracic procedure complication ,  ctcae
grade 4 pregnancy loss ,  ctcae
grade 4 pregnancy ,  puerperium and perinatal conditions  -  other ,  specify ,  ctcae
grade 4 premature delivery ,  ctcae
grade 4 prolapse of intestinal stoma ,  ctcae
grade 4 prolapse of urostomy ,  ctcae
grade 4 prostate infection ,  ctcae
ateb / le mouse
grade 4 psychiatric disorders  -  other ,  specify ,  ctcae
grade 4 psychosis ,  ctcae
grade 4 pulmonary edema ,  ctcae
grade 4 pulmonary fibrosis ,  ctcae
grade 4 pulmonary fistula ,  ctcae
grade 4 pulmonary valve disease ,  ctcae
grade 4 pyramidal tract syndrome ,  ctcae
grade 4 radiation recall reaction  ( dermatologic )  ,  ctcae
grade 4 radiculitis ,  ctcae
grade 4 rash acneiform ,  ctcae
grade 4 rectal anastomotic leak ,  ctcae
grade 4 rectal mucositis ,  ctcae
grade 4 rectal stenosis ,  ctcae
grade 4 recurrent laryngeal nerve palsy ,  ctcae
grade 4 renal and urinary disorders  -  other ,  specify ,  ctcae
grade 4 renal calculi ,  ctcae
grade 4 reproductive system and breast disorders  -  other ,  specify ,  ctcae
grade 4 respiratory failure ,  ctcae
grade 4 respiratory ,  thoracic and mediastinal disorders  -  other ,  specify ,  ctcae
grade 4 retroperitoneal hemorrhage ,  ctcae
grade 4 reversible posterior leukoencephalopathy syndrome ,  ctcae
grade 4 rhabdomyolysis ,  ctcae
perillyl alcohol
grade 4 salivary duct inflammation ,  ctcae
grade 4 salivary gland infection ,  ctcae
grade 4 scleral disorder ,  ctcae
grade 4 scrotal infection ,  ctcae
grade 4 sepsis ,  ctcae
grade 4 serum amylase increased ,  ctcae
grade 4 serum sickness ,  ctcae
grade 4 shingles ,  ctcae
grade 4 sinus disorder ,  ctcae
grade 4 sinusitis ,  ctcae
grade 4 sinusoidal obstruction syndrome ,  ctcae
grade 4 skin and subcutaneous tissue disorders  -  other ,  specify ,  ctcae
grade 4 skin induration ,  ctcae
grade 4 skin infection ,  ctcae
grade 4 skin ulceration ,  ctcae
grade 4 sleep apnea ,  ctcae
grade 4 small intestinal anastomotic leak ,  ctcae
grade 4 small intestinal mucositis ,  ctcae
grade 4 small intestinal obstruction ,  ctcae
grade 4 small intestinal perforation ,  ctcae
grade 4 small intestinal stenosis ,  ctcae
grade 4 small intestine infection ,  ctcae
grade 4 small intestine ulcer ,  ctcae
grade 4 social circumstances  -  other ,  specify ,  ctcae
grade 4 soft tissue infection ,  ctcae
grade 4 soft tissue necrosis lower limb ,  ctcae
grade 4 soft tissue necrosis upper limb ,  ctcae
grade 4 somnolence ,  ctcae
grade 4 spasticity ,  ctcae
grade 4 spermatic cord anastomotic leak ,  ctcae
grade 4 spinal cord compression ,  ctcae
grade 4 spinal fracture ,  ctcae
grade 4 splenic infection ,  ctcae
grade 4 stenosis of gastrointestinal stoma ,  ctcae
grade 4 stevens - johnson syndrome ,  ctcae
grade 4 stoma site infection ,  ctcae
grade 4 stridor ,  ctcae
grade 4 stroke ,  ctcae
grade 4 suicidal ideation ,  ctcae
grade 4 suicide attempt ,  ctcae
grade 4 superficial soft tissue fibrosis ,  ctcae
grade 4 superior vena cava syndrome ,  ctcae
grade 4 surgical and medical procedures  -  other ,  specify ,  ctcae
grade 4 testicular disorder ,  ctcae
grade 4 thromboembolic event ,  ctcae
grade 4 thrombotic thrombocytopenic purpura ,  ctcae
grade 4 tooth infection ,  ctcae
grade 4 toxic epidermal necrolysis ,  ctcae
grade 4 tracheal mucositis ,  ctcae
grade 4 tracheal obstruction ,  ctcae
grade 4 tracheal stenosis ,  ctcae
grade 4 tracheitis ,  ctcae
grade 4 tracheostomy site bleeding ,  ctcae
grade 4 treatment related secondary malignancy ,  ctcae
grade 4 tricuspid valve disease ,  ctcae
grade 4 tumor hemorrhage ,  ctcae
grade 4 tumor lysis syndrome ,  ctcae
grade 4 upper gastrointestinal hemorrhage ,  ctcae
grade 4 upper respiratory infection ,  ctcae
grade 4 ureteric anastomotic leak ,  ctcae
grade 4 urethral anastomotic leak ,  ctcae
grade 4 urethral infection ,  ctcae
grade 4 urinary fistula ,  ctcae
grade 4 urinary tract infection ,  ctcae
grade 4 urinary tract obstruction ,  ctcae
grade 4 urine output decreased ,  ctcae
grade 4 urostomy leak ,  ctcae
grade 4 urostomy obstruction ,  ctcae
grade 4 urostomy site bleeding ,  ctcae
grade 4 urostomy stenosis ,  ctcae
grade 4 uterine anastomotic leak ,  ctcae
grade 4 uterine fistula ,  ctcae
grade 4 uterine infection ,  ctcae
grade 4 uterine perforation ,  ctcae
grade 4 vaccination complication ,  ctcae
grade 4 vaginal anastomotic leak ,  ctcae
grade 4 vaginal infection ,  ctcae
grade 4 vaginal inflammation ,  ctcae
grade 4 vaginal perforation ,  ctcae
grade 4 vagus nerve disorder ,  ctcae
grade 4 vas deferens anastomotic leak ,  ctcae
grade 4 vascular access complication ,  ctcae
grade 4 vascular disorders  -  other ,  specify ,  ctcae
grade 4 vasovagal reaction ,  ctcae
grade 4 venous injury ,  ctcae
grade 4 ventricular arrhythmia ,  ctcae
grade 4 visceral arterial ischemia ,  ctcae
grade 4 vision decreased ,  ctcae
grade 4 vitreous hemorrhage ,  ctcae
grade 4 vulval infection ,  ctcae
grade 4 watering eyes ,  ctcae
grade 4 wheezing ,  ctcae
grade 4 white blood cell decreased ,  ctcae
grade 4 wound complication ,  ctcae
radicicol
grade 4 wound dehiscence ,  ctcae
grade 4 wound infection ,  ctcae
grade 5 abdominal infection ,  ctcae
grade 5 abdominal soft tissue necrosis ,  ctcae
grade 5 acidosis ,  ctcae
grade 5 acute kidney injury ,  ctcae
grade 5 alcohol intolerance ,  ctcae
grade 5 alkalosis ,  ctcae
grade 5 allergic reaction ,  ctcae
grade 5 anal fistula ,  ctcae
grade 5 anal hemorrhage ,  ctcae
grade 5 anal necrosis ,  ctcae
grade 5 anal stenosis ,  ctcae
grade 5 anal ulcer ,  ctcae
grade 5 anaphylaxis ,  ctcae
grade 5 anemia ,  ctcae
grade 5 anorectal infection ,  ctcae
grade 5 aortic injury ,  ctcae
grade 5 aortic valve disease ,  ctcae
grade 5 appendicitis perforated ,  ctcae
grade 5 appendicitis ,  ctcae
grade 5 arachnoiditis ,  ctcae
grade 5 arterial injury ,  ctcae
grade 5 arterial thromboembolism ,  ctcae
grade 5 arteritis infective ,  ctcae
grade 5 ascites ,  ctcae
grade 5 atrioventricular block complete ,  ctcae
grade 5 autoimmune disorder ,  ctcae
grade 5 avascular necrosis ,  ctcae
grade 5 bile duct stenosis ,  ctcae
grade 5 biliary anastomotic leak ,  ctcae
grade 5 biliary fistula ,  ctcae
grade 5 biliary tract infection ,  ctcae
grade 5 bladder anastomotic leak ,  ctcae
grade 5 bladder infection ,  ctcae
grade 5 blood and lymphatic system disorders  -  other ,  specify ,  ctcae
grade 5 bone infection ,  ctcae
grade 5 bone marrow hypocellular ,  ctcae
grade 5 breast infection ,  ctcae
grade 5 bronchial fistula ,  ctcae
grade 5 bronchial infection ,  ctcae
grade 5 bronchial obstruction ,  ctcae
grade 5 bronchial stricture ,  ctcae
grade 5 bronchopleural fistula ,  ctcae
grade 5 bronchopulmonary hemorrhage ,  ctcae
grade 5 bronchospasm ,  ctcae
grade 5 budd - chiari syndrome ,  ctcae
grade 5 bullous dermatitis ,  ctcae
grade 5 capillary leak syndrome ,  ctcae
grade 5 cardiac arrest ,  ctcae
grade 5 cardiac disorders  -  other ,  specify ,  ctcae
grade 5 catheter related infection ,  ctcae
grade 5 cecal hemorrhage ,  ctcae
grade 5 cecal infection ,  ctcae
grade 5 central nervous system necrosis ,  ctcae
grade 5 cerebrospinal fluid leakage ,  ctcae
grade 5 cervicitis infection ,  ctcae
grade 5 chest wall necrosis ,  ctcae
grade 5 chronic kidney disease ,  ctcae
grade 5 chylous ascites ,  ctcae
grade 5 colonic fistula ,  ctcae
grade 5 colonic hemorrhage ,  ctcae
grade 5 colonic obstruction ,  ctcae
grade 5 colonic perforation ,  ctcae
grade 5 colonic stenosis ,  ctcae
grade 5 colonic ulcer ,  ctcae
grade 5 conduction disorder ,  ctcae
grade 5 congenital ,  familial and genetic disorders  -  other ,  specify ,  ctcae
grade 5 corneal infection ,  ctcae
grade 5 cranial nerve infection ,  ctcae
grade 5 cystitis noninfective ,  ctcae
grade 5 cytokine release syndrome ,  ctcae
grade 5 cytomegalovirus infection reactivation ,  ctcae
grade 5 delirium ,  ctcae
grade 5 delusions ,  ctcae
grade 5 depressed level of consciousness ,  ctcae
grade 5 dermatitis radiation ,  ctcae
grade 5 device related infection ,  ctcae
grade 5 disease progression ,  ctcae
grade 5 duodenal hemorrhage ,  ctcae
grade 5 duodenal infection ,  ctcae
grade 5 duodenal obstruction ,  ctcae
grade 5 duodenal perforation ,  ctcae
grade 5 duodenal stenosis ,  ctcae
grade 5 duodenal ulcer ,  ctcae
grade 5 ear and labyrinth disorders  -  other ,  specify ,  ctcae
grade 5 edema cerebral ,  ctcae
grade 5 encephalitis infection ,  ctcae
grade 5 encephalomyelitis infection ,  ctcae
grade 5 endocarditis infective ,  ctcae
grade 5 endocrine disorders  -  other ,  specify ,  ctcae
grade 5 enterocolitis infectious ,  ctcae
grade 5 enterocolitis ,  ctcae
grade 5 enterovesical fistula ,  ctcae
grade 5 epistaxis ,  ctcae
grade 5 epstein - barr virus infection reactivation ,  ctcae
grade 5 erythema multiforme ,  ctcae
grade 5 erythroderma ,  ctcae
dihydrolenperone
grade 5 esophageal anastomotic leak ,  ctcae
grade 5 esophageal hemorrhage ,  ctcae
grade 5 esophageal infection ,  ctcae
grade 5 esophageal necrosis ,  ctcae
grade 5 esophageal obstruction ,  ctcae
grade 5 esophageal perforation ,  ctcae
grade 5 esophageal stenosis ,  ctcae
grade 5 esophageal ulcer ,  ctcae
grade 5 extrapyramidal disorder ,  ctcae
grade 5 eye infection ,  ctcae
grade 5 fallopian tube anastomotic leak ,  ctcae
grade 5 fever ,  ctcae
grade 5 fibrosis deep connective tissue ,  ctcae
grade 5 gallbladder infection ,  ctcae
grade 5 gastric anastomotic leak ,  ctcae
grade 5 gastric fistula ,  ctcae
grade 5 gastric hemorrhage ,  ctcae
grade 5 gastric necrosis ,  ctcae
grade 5 gastric perforation ,  ctcae
grade 5 gastric stenosis ,  ctcae
grade 5 gastric ulcer ,  ctcae
grade 5 gastrointestinal anastomotic leak ,  ctcae
grade 5 gastrointestinal disorders  -  other ,  specify ,  ctcae
grade 5 gastrointestinal fistula ,  ctcae
grade 5 gastrointestinal stoma necrosis ,  ctcae
grade 5 general disorders and administration site conditions  -  other ,  specify ,  ctcae
grade 5 glossopharyngeal nerve disorder ,  ctcae
grade 5 glucose intolerance ,  ctcae
grade 5 guillain - barre syndrome ,  ctcae
grade 5 gum infection ,  ctcae
grade 5 hallucinations ,  ctcae
grade 5 heart failure ,  ctcae
grade 5 hematosalpinx ,  ctcae
grade 5 hematuria ,  ctcae
grade 5 hemolytic uremic syndrome ,  ctcae
grade 5 hemorrhoidal hemorrhage ,  ctcae
grade 5 hepatic failure ,  ctcae
grade 5 hepatic hemorrhage ,  ctcae
grade 5 hepatic infection ,  ctcae
grade 5 hepatitis b reactivation ,  ctcae
grade 5 hepatitis viral ,  ctcae
grade 5 hepatobiliary disorders  -  other ,  specify ,  ctcae
grade 5 herpes simplex reactivation ,  ctcae
grade 5 hypercalcemia ,  ctcae
grade 5 hyperglycemia ,  ctcae
grade 5 hyperkalemia ,  ctcae
grade 5 hypermagnesemia ,  ctcae
grade 5 hypernatremia ,  ctcae
grade 5 hyperphosphatemia ,  ctcae
grade 5 hyperthyroidism ,  ctcae
grade 5 hypertriglyceridemia ,  ctcae
grade 5 hyperuricemia ,  ctcae
grade 5 hypoalbuminemia ,  ctcae
grade 5 hypocalcemia ,  ctcae
grade 5 hypoglycemia ,  ctcae
grade 5 hypohidrosis ,  ctcae
grade 5 hypokalemia ,  ctcae
grade 5 hypomagnesemia ,  ctcae
grade 5 hyponatremia ,  ctcae
grade 5 hypoparathyroidism ,  ctcae
grade 5 hypophosphatemia ,  ctcae
grade 5 hypophysitis ,  ctcae
grade 5 hypopituitarism ,  ctcae
grade 5 hypothyroidism ,  ctcae
grade 5 ileal perforation ,  ctcae
grade 5 ileal stenosis ,  ctcae
grade 5 immune system disorders  -  other ,  specify ,  ctcae
grade 5 infections and infestations  -  other ,  specify ,  ctcae
grade 5 infective myositis ,  ctcae
grade 5 infusion related reaction ,  ctcae
grade 5 infusion site extravasation ,  ctcae
grade 5 injection site reaction ,  ctcae
grade 5 injury to carotid artery ,  ctcae
grade 5 injury to jugular vein ,  ctcae
grade 5 injury to superior vena cava ,  ctcae
grade 5 injury ,  poisoning and procedural complications  -  other ,  specify ,  ctcae
grade 5 intestinal stoma leak ,  ctcae
grade 5 intestinal stoma obstruction ,  ctcae
grade 5 intestinal stoma site bleeding ,  ctcae
grade 5 intra - abdominal hemorrhage ,  ctcae
grade 5 intracranial hemorrhage ,  ctcae
grade 5 intraoperative arterial injury ,  ctcae
grade 5 intraoperative breast injury ,  ctcae
grade 5 intraoperative cardiac injury ,  ctcae
grade 5 intraoperative ear injury ,  ctcae
grade 5 intraoperative endocrine injury ,  ctcae
grade 5 intraoperative gastrointestinal injury ,  ctcae
grade 5 intraoperative head and neck injury ,  ctcae
grade 5 intraoperative hemorrhage ,  ctcae
grade 5 intraoperative hepatobiliary injury ,  ctcae
grade 5 intraoperative musculoskeletal injury ,  ctcae
grade 5 intraoperative neurological injury ,  ctcae
tirapazamine
grade 5 intraoperative ocular injury ,  ctcae
grade 5 intraoperative renal injury ,  ctcae
grade 5 intraoperative reproductive tract injury ,  ctcae
grade 5 intraoperative respiratory injury ,  ctcae
grade 5 intraoperative splenic injury ,  ctcae
grade 5 intraoperative urinary injury ,  ctcae
grade 5 intraoperative venous injury ,  ctcae
grade 5 investigations  -  other ,  specify ,  ctcae
grade 5 jejunal perforation ,  ctcae
grade 5 jejunal stenosis ,  ctcae
grade 5 joint infection ,  ctcae
grade 5 kidney anastomotic leak ,  ctcae
grade 5 kidney infection ,  ctcae
grade 5 large intestinal anastomotic leak ,  ctcae
grade 5 laryngeal edema ,  ctcae
grade 5 laryngeal mucositis ,  ctcae
grade 5 laryngeal obstruction ,  ctcae
grade 5 laryngeal stenosis ,  ctcae
grade 5 laryngitis ,  ctcae
grade 5 laryngopharyngeal dysesthesia ,  ctcae
grade 5 laryngospasm ,  ctcae
grade 5 leukemia secondary to oncology chemotherapy ,  ctcae
grade 5 leukocytosis ,  ctcae
grade 5 leukoencephalopathy ,  ctcae
grade 5 lower gastrointestinal hemorrhage ,  ctcae
grade 5 lung infection ,  ctcae
grade 5 lymph gland infection ,  ctcae
grade 5 lymph leakage ,  ctcae
grade 5 mania ,  ctcae
grade 5 mediastinal infection ,  ctcae
grade 5 meningismus ,  ctcae
grade 5 meningitis ,  ctcae
grade 5 menorrhagia ,  ctcae
grade 5 metabolism and nutrition disorders  -  other ,  specify ,  ctcae
grade 5 methemoglobinemia ,  ctcae
grade 5 middle ear inflammation ,  ctcae
grade 5 mitral valve disease ,  ctcae
grade 5 mucosal infection ,  ctcae
grade 5 mucositis oral ,  ctcae
grade 5 musculoskeletal and connective tissue disorder  -  other ,  specify ,  ctcae
grade 5 myasthenia gravis ,  ctcae
grade 5 myelodysplastic syndrome ,  ctcae
grade 5 myocardial infarction ,  ctcae
grade 5 neoplasms benign ,  malignant and unspecified  ( incl cysts and polyps )   -  other ,  specify ,  ctcae
grade 5 nephrotic syndrome ,  ctcae
grade 5 nervous system disorders  -  other ,  specify ,  ctcae
grade 5 obstruction gastric ,  ctcae
grade 5 oral cavity fistula ,  ctcae
grade 5 osteonecrosis of jaw ,  ctcae
grade 5 osteonecrosis ,  ctcae
grade 5 otitis externa ,  ctcae
grade 5 otitis media ,  ctcae
grade 5 ovarian infection ,  ctcae
grade 5 ovarian rupture ,  ctcae
grade 5 pancreas infection ,  ctcae
grade 5 pancreatic anastomotic leak ,  ctcae
grade 5 pancreatic duct stenosis ,  ctcae
grade 5 pancreatic necrosis ,  ctcae
grade 5 papulopustular rash ,  ctcae
grade 5 paroxysmal atrial tachycardia ,  ctcae
grade 5 pelvic infection ,  ctcae
grade 5 penile infection ,  ctcae
grade 5 perforation bile duct ,  ctcae
grade 5 pericardial effusion ,  ctcae
grade 5 pericardial tamponade ,  ctcae
grade 5 periorbital infection ,  ctcae
grade 5 peripheral ischemia ,  ctcae
grade 5 peripheral motor neuropathy ,  ctcae
grade 5 peripheral nerve infection ,  ctcae
grade 5 peritoneal infection ,  ctcae
grade 5 pharyngeal anastomotic leak ,  ctcae
grade 5 pharyngeal mucositis ,  ctcae
grade 5 pharyngeal stenosis ,  ctcae
grade 5 pharyngitis ,  ctcae
grade 5 phlebitis infective ,  ctcae
grade 5 pleural effusion ,  ctcae
grade 5 pleural infection ,  ctcae
grade 5 pneumonitis ,  ctcae
grade 5 portal hypertension ,  ctcae
grade 5 portal vein thrombosis ,  ctcae
grade 5 postoperative hemorrhage ,  ctcae
dexniguldipine
a / j mouse
grade 5 postoperative thoracic procedure complication ,  ctcae
grade 5 pregnancy ,  puerperium and perinatal conditions  -  other ,  specify ,  ctcae
grade 5 prolapse of intestinal stoma ,  ctcae
grade 5 prolapse of urostomy ,  ctcae
grade 5 prostate infection ,  ctcae
grade 5 psychiatric disorders  -  other ,  specify ,  ctcae
grade 5 psychosis ,  ctcae
grade 5 pulmonary edema ,  ctcae
grade 5 pulmonary fibrosis ,  ctcae
grade 5 pulmonary fistula ,  ctcae
grade 5 pulmonary valve disease ,  ctcae
grade 5 pyramidal tract syndrome ,  ctcae
grade 5 radiation recall reaction  ( dermatologic )  ,  ctcae
grade 5 radiculitis ,  ctcae
grade 5 rash acneiform ,  ctcae
grade 5 rectal anastomotic leak ,  ctcae
grade 5 rectal mucositis ,  ctcae
grade 5 rectal stenosis ,  ctcae
grade 5 recurrent laryngeal nerve palsy ,  ctcae
grade 5 renal and urinary disorders  -  other ,  specify ,  ctcae
grade 5 renal calculi ,  ctcae
grade 5 reproductive system and breast disorders  -  other ,  specify ,  ctcae
grade 5 respiratory failure ,  ctcae
grade 5 respiratory ,  thoracic and mediastinal disorders  -  other ,  specify ,  ctcae
grade 5 retroperitoneal hemorrhage ,  ctcae
grade 5 reversible posterior leukoencephalopathy syndrome ,  ctcae
grade 5 rhabdomyolysis ,  ctcae
grade 5 salivary duct inflammation ,  ctcae
grade 5 salivary gland infection ,  ctcae
grade 5 scrotal infection ,  ctcae
grade 5 sepsis ,  ctcae
grade 5 shingles ,  ctcae
grade 5 sinus disorder ,  ctcae
grade 5 sinusitis ,  ctcae
grade 5 sinusoidal obstruction syndrome ,  ctcae
grade 5 skin and subcutaneous tissue disorders  -  other ,  specify ,  ctcae
grade 5 skin induration ,  ctcae
grade 5 skin infection ,  ctcae
grade 5 skin ulceration ,  ctcae
grade 5 sleep apnea ,  ctcae
grade 5 small intestinal anastomotic leak ,  ctcae
grade 5 small intestinal mucositis ,  ctcae
grade 5 small intestinal obstruction ,  ctcae
grade 5 small intestinal perforation ,  ctcae
grade 5 small intestinal stenosis ,  ctcae
grade 5 small intestine infection ,  ctcae
grade 5 small intestine ulcer ,  ctcae
grade 5 social circumstances  -  other ,  specify ,  ctcae
grade 5 soft tissue infection ,  ctcae
grade 5 soft tissue necrosis lower limb ,  ctcae
grade 5 soft tissue necrosis upper limb ,  ctcae
grade 5 somnolence ,  ctcae
grade 5 spasticity ,  ctcae
grade 5 spermatic cord anastomotic leak ,  ctcae
grade 5 spinal cord compression ,  ctcae
grade 5 spinal fracture ,  ctcae
grade 5 splenic infection ,  ctcae
grade 5 stenosis of gastrointestinal stoma ,  ctcae
grade 5 stevens - johnson syndrome ,  ctcae
grade 5 stoma site infection ,  ctcae
grade 5 stridor ,  ctcae
grade 5 stroke ,  ctcae
grade 5 sudden death nos ,  ctcae
grade 5 suicide attempt ,  ctcae
grade 5 superficial soft tissue fibrosis ,  ctcae
grade 5 superior vena cava syndrome ,  ctcae
grade 5 surgical and medical procedures  -  other ,  specify ,  ctcae
grade 5 thromboembolic event ,  ctcae
grade 5 thrombotic thrombocytopenic purpura ,  ctcae
grade 5 tooth infection ,  ctcae
grade 5 toxic epidermal necrolysis ,  ctcae
grade 5 tracheal mucositis ,  ctcae
grade 5 tracheal obstruction ,  ctcae
grade 5 tracheal stenosis ,  ctcae
grade 5 tracheitis ,  ctcae
grade 5 tracheostomy site bleeding ,  ctcae
grade 5 treatment related secondary malignancy ,  ctcae
grade 5 tricuspid valve disease ,  ctcae
grade 5 tumor hemorrhage ,  ctcae
grade 5 upper gastrointestinal hemorrhage ,  ctcae
grade 5 upper respiratory infection ,  ctcae
grade 5 ureteric anastomotic leak ,  ctcae
grade 5 urethral anastomotic leak ,  ctcae
grade 5 urethral infection ,  ctcae
grade 5 urinary fistula ,  ctcae
grade 5 urinary tract infection ,  ctcae
grade 5 urinary tract obstruction ,  ctcae
grade 5 urostomy leak ,  ctcae
grade 5 urostomy obstruction ,  ctcae
recombinant fibroblast growth factor 3
grade 5 urostomy site bleeding ,  ctcae
grade 5 urostomy stenosis ,  ctcae
grade 5 uterine anastomotic leak ,  ctcae
grade 5 uterine fistula ,  ctcae
grade 5 uterine infection ,  ctcae
grade 5 uterine perforation ,  ctcae
grade 5 vaginal anastomotic leak ,  ctcae
grade 5 vaginal infection ,  ctcae
grade 5 vaginal perforation ,  ctcae
grade 5 vaginal stricture ,  ctcae
grade 5 vagus nerve disorder ,  ctcae
grade 5 vas deferens anastomotic leak ,  ctcae
grade 5 vascular access complication ,  ctcae
grade 5 vascular disorders  -  other ,  specify ,  ctcae
grade 5 vasovagal reaction ,  ctcae
grade 5 venous injury ,  ctcae
grade 5 ventricular arrhythmia ,  ctcae
grade 5 visceral arterial ischemia ,  ctcae
grade 5 vulval infection ,  ctcae
grade 5 wheezing ,  ctcae
grade 5 wound complication ,  ctcae
grade 5 wound dehiscence ,  ctcae
grade 5 wound infection ,  ctcae
gingival pain ,  ctcae
oral pain ,  ctcae 5 .0
ventricular arrhythmia ,  ctcae 5 .0
rectal pain ,  ctcae 5 .0
retroperitoneal hemorrhage ,  ctcae 5 .0
ileal perforation ,  ctcae 5 .0
rectal perforation ,  ctcae 5 .0
small intestinal perforation ,  ctcae 5 .0
il - 2 / 9 / 15 gamma chain receptor inhibitor bnz - 1
gastrointestinal fistula ,  ctcae 5 .0
calcineurin inhibitor
zellweger spectrum disorder
atypical type a thymoma
3p14 loss of heterozygosity
serum sickness ,  ctcae 5 .0
flushing ,  ctcae 5 .0
skin atrophy ,  ctcae 5 .0
precocious puberty ,  ctcae 5 .0
kir2dl1 polymorphism positive
helicobacter pylori negative
brca1 polymorphism positive
brca2 polymorphism positive
clostridium difficile positive
akt1 gene alteration positive
akt2 gene alteration positive
akt3 gene alteration positive
rb1 gene deletion
rara positive
blasts more than 5 percent of peripheral blood white cells
mll positive
mitf positive
cereblon e3 ubiquitin ligase modulating agent cc - 92480
lymphoblasts 20 percent or more of bone marrow nucleated cells
lymphoblasts 20 percent or more of peripheral blood white cells
pleuritic pain ,  ctcae 5 .0
prostatic pain ,  ctcae 5 .0
scrotal pain ,  ctcae 5 .0
testicular pain ,  ctcae 5 .0
anti - c - met antibody - drug conjugate hti - 1066
tp53 positive
myeloblasts 5 percent or more of bone marrow nucleated cells
ceacam5 positive
flt3 positive
human herpesvirus 8 positive
blasts 30 percent or less of peripheral blood white cells
cataract ,  ctcae 5 .0
deleterious pten gene mutation
deleterious tp53 gene mutation
vitreous hemorrhage ,  ctcae 5 .0
disseminated tumor cells positive
pelvic pain ,  ctcae 5 .0
penile pain ,  ctcae 5 .0
perineal pain ,  ctcae 5 .0
phantom pain ,  ctcae 5 .0
uterine pain ,  ctcae 5 .0
vaginal pain ,  ctcae 5 .0
gynecomastia ,  ctcae 5 .0
mki67 positive
vaginal dryness ,  ctcae 5 .0
tumor lysis syndrome ,  ctcae 5 .0
blasts 5 - 30 percent of bone marrow nucleated cells
tinnitus ,  ctcae 5 .0
circulating tumor cells positive
brca mutation analysis
fluorine f 18 tetrafluoroborate
stomal ulcer ,  ctcae 5 .0
myocarditis ,  ctcae 5 .0
vaginal obstruction ,  ctcae 5 .0
vaginal perforation ,  ctcae 5 .0
bladder spasm ,  ctcae 5 .0
encephalopathy ,  ctcae 5 .0
recombinant human macrophage inflammatory protein - 1 beta
seizure ,  ctcae 5 .0
enneking stage ia
enneking stage ib
enneking stage iia
enneking stage iib
enneking stage iii
mediastinal / thymic nut carcinoma
bladder perforation ,  ctcae 5 .0
gallbladder perforation ,  ctcae 5 .0
blasts 5 - 25 percent of bone marrow nucleated cells
esophageal varices hemorrhage ,  ctcae 5 .0
allogeneic gm - csf - secreting breast cancer vaccine sv - br - 1 - gm
blasts 20 - 30 percent of bone marrow nucleated cells
fgfr gene mutation
fallopian tube perforation ,  ctcae 5 .0
human papillomavirus - 16 negative
thymic hepatoid adenocarcinoma
psa doubling time less than or equal to 6 months
left ventricular systolic dysfunction ,  ctcae 5 .0
fosnetupitant / palonosetron hydrochloride
index date
activating alk gene mutation
activating ros1 gene mutation
ag7 antigen positive
hla - dpb1*0401 positive cells present
wt1 gene mutation
pik3cg gene mutation
pik3r5 gene mutation
retinal detachment ,  ctcae 5 .0
typhlitis ,  ctcae 5 .0
asystole ,  ctcae 5 .0
ventricular fibrillation ,  ctcae 5 .0
ventricular tachycardia ,  ctcae 5 .0
refractory glioblastoma
gallbladder necrosis ,  ctcae 5 .0
hepatic necrosis ,  ctcae 5 .0
ataxia ,  ctcae 5 .0
hemorrhoids ,  ctcae 5 .0
back pain ,  ctcae 5 .0
telangiectasia ,  ctcae 5 .0
bone pain ,  ctcae 5 .0
breast pain ,  ctcae 5 .0
chest wall pain ,  ctcae 5 .0
buttock pain ,  ctcae 5 .0
external ear pain ,  ctcae 5 .0
cognitive disturbance ,  ctcae 5 .0
dizziness ,  ctcae 5 .0
euphoria ,  ctcae 5 .0
exostosis ,  ctcae 5 .0
syncope ,  ctcae 5 .0
eye pain ,  ctcae 5 .0
fallopian tube obstruction ,  ctcae 5 .0
fatigue ,  ctcae 5 .0
brachial plexopathy ,  ctcae 5 .0
gallbladder pain ,  ctcae 5 .0
enpp3 positive
spermatic cord obstruction ,  ctcae 5 .0
proteinuria ,  ctcae 5 .0
sinus tachycardia ,  ctcae 5 .0
joint effusion ,  ctcae 5 .0
lip pain ,  ctcae 5 .0
anti - icos agonist monoclonal antibody bms - 986226
memory impairment ,  ctcae 5 .0
nausea ,  ctcae 5 .0
ctla - 4 - directed probody bms - 986249
neck pain ,  ctcae 5 .0
osteoporosis ,  ctcae 5 .0
hemoglobinuria ,  ctcae 5 .0
ovulation pain ,  ctcae 5 .0
photophobia ,  ctcae 5 .0
insomnia ,  ctcae 5 .0
scalp pain ,  ctcae 5 .0
lymph node pain ,  ctcae 5 .0
stomach pain ,  ctcae 5 .0
nystagmus ,  ctcae 5 .0
agitation ,  ctcae 5 .0
anxiety ,  ctcae 5 .0
autologous tcr - engineered t - cells ima201
tremor ,  ctcae 5 .0
tumor pain ,  ctcae 5 .0
sinus pain ,  ctcae 5 .0
confusion ,  ctcae 5 .0
urinary incontinence ,  ctcae 5 .0
myositis ,  ctcae 5 .0
cholecystitis ,  ctcae 5 .0
pancreatitis ,  ctcae 5 .0
child - pugh class a5
child - pugh class a6
child - pugh class b7
child - pugh class b8
child - pugh class b9
child - pugh class c10
child - pugh class c11
child - pugh class c12
child - pugh class c13
child - pugh class c14
mycophenolate mofetil
child - pugh class c15
since first time questionnaire was answered
minimally invasive interval debulking surgery
renorrhaphy
givosiran
allogeneic cd123 - specific universal car123 - expressing t - lymphocytes
atr kinase inhibitor bay1895344
anti - il17a monoclonal antibody cjm112
454 sequencing
her2 inhibitor tas0728
abi solid sequencing
bgiseq - 500 sequencing
mrna - based personalized cancer vaccine mrna - 4157
capillary sequencing
complete genomics sequencing
helicos sequencing
illumina sequencing
oxford nanopore sequencing
smrt sequencing
tidutamab
nanoparticle paclitaxel ointment sor007
autologous icasp9 - cd19 - expressing t - lymphocytes
anti - egfrviii / cd3 bite antibody amg 596
brd4 inhibitor plx2853
mediastinal germ cell tumor tnm finding
mediastinal germ cell tumor distant metastasis tnm finding
mediastinal germ cell tumor m0 tnm finding
mediastinal germ cell tumor m1 tnm finding
mediastinal germ cell tumor primary tumor tnm finding
mediastinal germ cell tumor tx tnm finding
mediastinal germ cell tumor t0 tnm finding
mediastinal germ cell tumor t1 tnm finding
mediastinal germ cell tumor t1a tnm finding
mediastinal germ cell tumor t1b tnm finding
mediastinal germ cell tumor t2 tnm finding
mediastinal germ cell tumor t2a tnm finding
mediastinal germ cell tumor t2b tnm finding
mediastinal germ cell tumor t3 tnm finding
mediastinal germ cell tumor t4 tnm finding
mediastinal germ cell tumor regional lymph nodes tnm finding
mediastinal germ cell tumor nx tnm finding
mediastinal germ cell tumor n0 tnm finding
mediastinal germ cell tumor n1 tnm finding
mediastinal germ cell tumor n2 tnm finding
mediastinal germ cell tumor n3 tnm finding
mediastinal malignant germ cell tumor stage
malignant mediastinal germ cell tumor stage grouping of the pediatric study group
stage i malignant mediastinal germ cell tumor
stage ii malignant mediastinal germ cell tumor
stage iii malignant mediastinal germ cell tumor
stage iv malignant mediastinal germ cell tumor
porcupine inhibitor cgx1321
trail receptor agonist abbv - 621
salvage surgery
locally advanced angiosarcoma
locally advanced epithelioid hemangioendothelioma
metastatic epithelioid hemangioendothelioma
anti - cd3 / anti - bcma bispecific monoclonal antibody pf - 06863135
mediastinal mixed germ cell tumor
anti - tgf - beta monoclonal antibody sar - 439459
alk np_004295 .2:p .f1174l
alk nm_004304 .4:c .3522c > g
alk nm_004304 .4:c .3522c > a
alk nm_004304 .4:c .3520t > c
alk np_004295 .2:p .f1174c
alk nm_004304 .4:c .3521t > g
alk np_004295 .2:p .f1174v
alk nm_004304 .4:c .3520t > g
alk nm_004304 .4:c .3185a > t
alk np_004295 .2:p .k1062m
alk nm_004304 .4:c .3824g > a
alk np_004295 .2:p .r1275q
alk np_004295 .2:p .t1087i
alk np_004295 .2:p .f1245l
alk nm_004304 .4:c .3735c > g
alk nm_004304 .4:c .3735c > a
alk nm_004304 .4:c .3733t > c
braf nm_004333 .4:c .1801a > g
braf np_004324 .2:p .k601e
tumor treating fields therapy
mediastinal granulocytic sarcoma
tp53 protein variant
tp53 nm_000546 .5:c .524g > a
tp53 np_000537 .3:p .r175h
tp53 nm_000546 .5:c .638g > t
tp53 np_000537 .3:p .r213l
tp53 nm_000546 .5:c .659a > g
tp53 np_000537 .3:p .y220c
tp53 nm_000546 .5:c .713g > a
tp53 np_000537 .3:p .c238y
metastatic genitourinary system carcinoma
familial alzheimer's disease ,  type 1
tp53 nm_000546 .5:c .733g > a
tp53 np_000537 .3:p .g245s
chimpanzee trisomy 22
tp53 nm_000546 .5:c .734g > a
trichothiodystrophy 4 ,  nonphotosensitive
in 111 satumomab pendetide
tp53 np_000537 .3:p .g245d
tp53 nm_000546 .5:c .743g > a
tp53 nm_000546 .5:c .743_744delgginsaa
tp53 np_000537 .3:p .r248q
tp53 nm_000546 .5:c .742c > t
tp53 nm_000546 .5:c .741_742delccinstt
tp53 np_000537 .3:p .r248w
tp53 nm_000546 .5:c .797g > t
tp53 np_000537 .3:p .g266v
tp53 nm_000546 .5:c .797g > a
tp53 np_000537 .3:p .g266e
tp53 nm_000546 .5:c .814g > a
tp53 np_000537 .3:p .v272m
tp53 nm_000546 .5:c .818g > a
tp53 np_000537 .3:p .r273h
tp53 nm_000546 .5:c .817c > t
tp53 np_000537 .3:p .r273c
medical history taking
tp53 nm_000546 .5:c .818g > t
tp53 np_000537 .3:p .r273l
tp53 nm_000546 .5:c .844c > t
tp53 nm_000546 .5:c .843_844delccinstt
tp53 np_000537 .3:p .r282w
tp53 nm_000546 .5:c .844c > g
tp53 np_000537 .3:p .r282g
cdkn2a protein variant
cdkn2a nm_000077 .4:c .89c > t
cdkn2a np_000068 .1:p .a30v
cdkn2a nm_000077 .4:c .152t > a
cdkn2a np_000068 .1:p .v51d
cdkn2a nm_000077 .4:c .151g > a
cdkn2a np_000068 .1:p .v51i
cdkn2a nm_000077 .4:c .247c > t
cdkn2a np_000068 .1:p .h83y
cdkn2a nm_000077 .4:c .248a > c
cdkn2a nm_000077 .4:c .248_249delacinsct
autologous pbls retrovirally - transduced with tcrs targeting neoantigens
cdkn2a np_000068 .1:p .h83p
ny - eso - 1 tcr retroviral vector - transduced autologous pbmcs
ny - eso - 1 tcr / sr39tk lentiviral vector - transduced autologous pbscs
cdkn2a nm_000077 .4:c .322g > c
cdkn2a np_000068 .1:p .d108h
cdkn2a nm_000077 .4:c .322g > t
cdkn2a np_000068 .1:p .d108y
cdkn2a nm_000077 .4:c .389t > a
cdkn2a np_000068 .1:p .l130q
cdkn2a nm_000077 .4:c .439g > a
cdkn2a np_000068 .1:p .a147t
cdkn2a nm_000077 .4:c .442g > a
cdkn2a np_000068 .1:p .a148t
gnas protein variant
tp53 overexpression positive
gnas nm_000516 .5:c .374a > g
gnas np_000507 .1:p .q125r
gnas nm_000516 .5:c .478c > t
gnas np_000507 .1:p .r160c
gnas nm_000516 .5:c .602g > a
gnas np_000507 .1:p .r201h
gnas nm_000516 .5:c .601c > t
gnas np_000507 .1:p .r201c
gnas nm_000516 .5:c .601c > a
gnas np_000507 .1:p .r201s
gnas nm_000516 .5:c .680a > g
gnas np_000507 .1:p .q227r
gnas nm_000516 .5:c .680a > t
gnas np_000507 .1:p .q227l
gnas np_000507 .1:p .q227p
gnas nm_000516 .5:c .679c > g
gnas np_000507 .1:p .q227e
rnf43 protein variant
rnf43 nm_017763 .5:c .380g > c
rnf43 np_060233 .3:p .r127p
rnf43 nm_017763 .5:c .420c > g
rnf43 np_060233 .3:p .d140e
rnf43 nm_017763 .5:c .461c > t
rnf43 np_060233 .3:p .p154l
rnf43 nm_017763 .5:c .505g > a
rnf43 np_060233 .3:p .a169t
rnf43 nm_017763 .5:c .954g > t
rnf43 np_060233 .3:p .e318d
pik3ca exon 9 mutation
pik3ca exon 20 mutation
ajcc cancer staging manual 8th edition
pten coding region mutation present
mediastinal hemangioma
mediastinal epithelioid hemangioendothelioma
refractory central nervous system non - hodgkin lymphoma
recurrent central nervous system non - hodgkin lymphoma
fluorine - 19 magnetic resonance imaging
allogeneic umbilical cord blood - derived hspcs nla101
androgen receptor inhibitor
observed medical device type in intended location
adaptive study design indicator
supplemental qualifiers tabulation dataset
study purpose
protoporphyrin measurement
mode of action
loxoribine
worst nausea past 24 hours rating
undesirable sedation troubles past 24 hours rating
undesirable appetite increase past 24 hours rating
cardiac extraskeletal osteosarcoma
cardiac myxofibrosarcoma
cardiac germ cell tumor
cardiac yolk sac tumor
cardiac teratoma
tnfrsf1a gene product
egfr nm_005228 .3:c .2389t > a
egfr nm_005228 .3:c .2390g > c
egfr np_005219 .2:p .c797s
egfr np_005219 .2:p .c797a
egfr nm_005228 .3:c .2374c > t
egfr np_005219 .2:p .l792f
egfr nm_005228 .3:c .2375t > a
egfr np_005219 .2:p .l792h
egfr np_005219 .2:p .l792y
egfr np_005219 .2:p .l718v
egfr nm_005228 .3:c .2153t > a
egfr np_005219 .2:p .l718q
egfr nm_005228 .3:c .2386g > a
egfr np_005219 .2:p .g796s
egfr nm_005228 .3:c .2386g > c
egfr np_005219 .2:p .g796r
anti - cd33 / cd3 bite antibody amg 673
anti - dll3 / cd3 bite antibody amg 757
anti - bcma / cd3 bite antibody amg 701
antibody - drug conjugate sc - 007
serd gdc - 9545
anti - muc16 / mmae antibody - drug conjugate dmuc4064a
baseline nausea and vomiting score 0
baseline nausea and vomiting scale
baseline nausea and vomiting score 1
baseline nausea and vomiting score 2
baseline nausea and vomiting score 3
baseline nausea and vomiting score 4
baseline nausea and vomiting score 5
baseline nausea and vomiting score 6
baseline nausea and vomiting score 7
baseline nausea and vomiting score 8
baseline nausea and vomiting score 9
baseline nausea and vomiting score 10
refractory chemotherapy - induced nausea and vomiting
enpp3 gene
enpp3 wt allele
ectonucleotide pyrophosphatase / phosphodiesterase family member 3
pik3ap1 gene
pik3ap1 wt allele
phosphoinositide 3 - kinase adapter protein 1
pik3ap1 gene mutation
soluble tumor necrosis factor receptor superfamily member 1a
ros1 gene rearrangement negative
blasts 1 percent or more of peripheral blood white cells
blasts 6 - 19 percent of bone marrow nucleated cells
cd44 positive
hla - a*0202 positive cells present
hla - b*5103 positive cells present
hla - c*0404 positive cells present
araf gene mutation
map2k1 gene mutation
dll3 gene positive
fgf3 gene amplification
metastatic well differentiated neuroendocrine neoplasm
cdisc protocol entities study design attribute terminology
cdisc protocol study purpose response terminology
cdisc protocol subject allocation response terminology
cdisc protocol randomization type response terminology
early infantile epileptic encephalopathy 2
early infantile epileptic encephalopathy 6
juvenile huntington disease
canine mammary adenoma
sensitizing alk gene mutation
prlr positive
kit overexpression positive
braf fusion positive
magea4 positive
chromogranin positive
chromogranin - positive neoplastic cells present
met gene deletion
trpm6 gene
trpm6 wt allele
transient receptor potential cation channel subfamily m member 6
antigen - presentation machinery expression profile
protein wnt - 10b activity measurement
cd38 positive
psa level greater than four
ccnd1 negative
cd2 negative
lymphovascular invasion 0
lymphovascular invasion 1
lymphovascular invasion 9
lymphovascular invasion 2
lymphovascular invasion 3
lymphovascular invasion 4
cardiac angiosarcoma
pericardial sarcoma
lamivudine
pericardial angiosarcoma
pericardial synovial sarcoma
pericardial teratoma
malignant pericardial germ cell tumor
pericardial yolk sac tumor
benign pericardial germ cell tumor
refractory glioma
refractory ependymoma
recurrent medulloblastoma ,  shh - activated
refractory medulloblastoma ,  shh - activated
progressive medulloblastoma
progressive ependymoma
progressive central nervous system neoplasm
steroid refractory graft versus host disease
progressive medulloblastoma ,  shh - activated
prophylactic mastectomy patient
mutant protein
met np_000236 .2:p .d1010n
met intron 13 mutation
il - 2 mutein / fc fusion protein amg 592
met intron 14 mutation
met codon 963 splice mutation
met codon 1010 splice mutation
abivertinib
adaptive randomization
block randomization
choriogonadotropin measurement
centimeters of mercury
enzyme unit per liter
egfr np_005219 .2:p .l792x
egfr np_005219 .2:p .g796x
egfr np_005219 .2:p .l718x
allogeneic double negative t cells
anti - ny - eso - 1 tcr lv - transduced autologous t - cells taest16001
harmonic ace + 7
planned number of cohorts
observational study model
study design description
randomization method
study primary purpose
study secondary purpose
minimization randomization
simple randomization
stratified randomization
exploratory research
hypothesis generation
dimensionless index
effective orifice area
effective orifice area index
observed foreign body indicator
mean pressure gradient
observed medical device type not present in intended location type
observed non - medical foreign body type
peak pressure gradient
pressure half time
valve area index
valve area
anteromedial
distal volar
lower extensor surface
lower flexor surface
lower medial
proximal volar
upper extensor surface
upper flexor surface
volar
associated persons adverse events domain
associated persons biospecimen domain
associated persons death details domain
associated persons exposure domain
associated persons laboratory test results domain
associated persons medical history domain
associated persons questionnaires domain
relationship between associated persons and subjects domain
associated persons reproductive system findings domain
associated persons subject characteristics domain
associated persons subject status domain
associated persons substance use domain
ophthalmic examinations domain
pool definition dataset
related records dataset
related subjects dataset
subject disease milestones domain
adverse events supplemental qualifiers dataset
procedure agents supplemental qualifiers dataset
biospecimen events supplemental qualifiers dataset
body weight gain supplemental qualifiers dataset
biospecimen findings supplemental qualifiers dataset
body weight supplemental qualifiers dataset
clinical events supplemental qualifiers dataset
clinical observations supplemental qualifiers dataset
concomitant and prior medications supplemental qualifiers dataset
comments supplemental qualifiers dataset
cardiovascular system findings supplemental qualifiers dataset
drug accountability supplemental qualifiers dataset
death details  ( human clinical trials )  supplemental qualifiers dataset
device events supplemental qualifiers dataset
device identifiers supplemental qualifiers dataset
bizelesin
demographics supplemental qualifiers dataset
device properties supplemental qualifiers dataset
device subject relationships supplemental qualifiers dataset
disposition supplemental qualifiers dataset
device tracking and disposition supplemental qualifiers dataset
device in - use supplemental qualifiers dataset
protocol deviations supplemental qualifiers dataset
device exposure supplemental qualifiers dataset
exposure as collected supplemental qualifiers dataset
ecg test results supplemental qualifiers dataset
environmental and social factors supplemental qualifiers dataset
exposure supplemental qualifiers dataset
findings about events or interventions supplemental qualifiers dataset
fetal measurements supplemental qualifiers dataset
food and water consumption supplemental qualifiers dataset
fetal pathology findings supplemental qualifiers dataset
healthcare encounters supplemental qualifiers dataset
implantation classification supplemental qualifiers dataset
inclusion / exclusion criteria not met supplemental qualifiers dataset
immunogenicity specimen assessments supplemental qualifiers dataset
laboratory test results supplemental qualifiers dataset
macroscopic findings supplemental qualifiers dataset
microbiology specimen supplemental qualifiers dataset
medical history supplemental qualifiers dataset
microscopic findings supplemental qualifiers dataset
musculoskeletal system findings supplemental qualifiers dataset
meal data supplemental qualifiers dataset
microbiology susceptibility supplemental qualifiers dataset
nervous system findings supplemental qualifiers dataset
ophthalmic examinations supplemental qualifiers dataset
non - host organism identifiers supplemental qualifiers dataset
organ measurements supplemental qualifiers dataset
pharmacogenomics / genetics biomarker supplemental qualifiers dataset
pharmacokinetics concentrations supplemental qualifiers dataset
physical examination supplemental qualifiers dataset
pharmacogenomics / genetics findings supplemental qualifiers dataset
pharmacogenomics / genetics methods and supporting information supplemental qualifiers dataset
palpable masses supplemental qualifiers dataset
pharmacokinetic parameters supplemental qualifiers dataset
procedures supplemental qualifiers dataset
questionnaires supplemental qualifiers dataset
ecg qt correction model data supplemental qualifiers dataset
respiratory test results supplemental qualifiers dataset
reproductive system findings supplemental qualifiers dataset
disease response supplemental qualifiers dataset
subject biomarker supplemental qualifiers dataset
subject characteristics supplemental qualifiers dataset
subject elements supplemental qualifiers dataset
subject stages supplemental qualifiers dataset
subject disease milestones supplemental qualifiers dataset
skin response supplemental qualifiers dataset
subject status supplemental qualifiers dataset
substance use supplemental qualifiers dataset
subject visits supplemental qualifiers dataset
trial arms supplemental qualifiers dataset
trial disease assessments supplemental qualifiers dataset
trial elements supplemental qualifiers dataset
tumor findings supplemental qualifiers dataset
trial inclusion and exclusion criteria supplemental qualifiers dataset
trial disease milestones supplemental qualifiers dataset
trial paths supplemental qualifiers dataset
tumor response supplemental qualifiers dataset
trial summary supplemental qualifiers dataset
trial stages supplemental qualifiers dataset
tumor / lesion identification supplemental qualifiers dataset
trial visits supplemental qualifiers dataset
trial sets supplemental qualifiers dataset
urinary system findings supplemental qualifiers dataset
vital signs supplemental qualifiers dataset
whole body findings supplemental qualifiers dataset
trial disease milestones domain
cdisc study reference class
binding antidrug antibody measurement
neutralizing binding antidrug antibody measurement
neutralizing cross - reacting binding antidrug antibody measurement
cross - reactive binding antidrug antibody measurement
arachis hypogaea antigen ige antibody measurement
triticum aestivum antigen ige antibody measurement
glycine max antigen ige antibody measurement
zea mays antigen ige antibody measurement
cow milk protein antigen ige antibody measurement
egg white antigen ige antibody measurement
white oak pollen ige antibody measurement
white elm pollen igg antibody measurement
boxelder pollen ige antibody measurement
common ragweed pollen ige antibody measurement
cladosporium herbarum ige antibody measurement
penicillium chrysogenum ige antibody measurement
acetone measurement
acylcarnitine to free carnitine ratio measurement
adam metallopeptidase domain 8 measurement
alpha fetoprotein adjusted for body weight measurement
apolipoprotein a1 to apolipoprotein b ratio measurement
albumin clearance
bone alkaline phosphatase to total alkaline phosphatase ratio measurement
intestinal alkaline phosphatase to total alkaline phosphatase ratio measurement
liver alkaline phosphatase to total alkaline phosphatase ratio measurement
acetylcholine receptor modulation antibody to acetylcholine receptor antibody ratio measurement
anabasine measurement
alpha - n - acetylglucosaminidase measurement
recombinant soluble t4
atypical neutrophil cytoplasmic antibody measurement
classic neutrophil cytoplasmic antibody measurement
perinuclear neutrophil cytoplasmic antibody measurement
anion gap 3 measurement
anion gap 4 measurement
arsenic measurement
antithrombin activity actual to control ratio measurement
adenosine triphosphate measurement
beta - 2 glycoprotein 1 iga antibody measurement
base deficit
borrelia burgdorferi igg and igm antibody measurement
basophilic erythroblast count
blasts to nucleated cells ratio measurement
complement c1 esterase inhibitor measurement
calcium corrected for total protein measurement
chemokine  ( c - c motif )  ligand 21 measurement
cyclic citrullinated peptide igg antibody measurement
complement ch100 measurement
chromatin antibody measurement
macromolecular type 1 creatine kinase to total creatine kinase ratio measurement
macromolecular type 2 creatine kinase to total creatine kinase ratio measurement
ubiquinone 10 measurement
carbamazepine measurement
carnitine ester measurement
creatinine clearance adjusted for bsa
cryoglobulin volume to serum volume ratio measurement
cryofibrinogen measurement
citalopram measurement
chemokine  ( c - x - c motif )  ligand 13 measurement
chemokine  ( c - x - c motif )  ligand 3 measurement
chemokine  ( c - x - c motif )  ligand 4 measurement
cystathionine measurement
dengue virus antibody measurement
desvenlafaxine measurement
endomysial iga antibody measurement
estrogen measurement
von willebrand factor multimers measurement
very long chain fatty acids measurement
fentanyl measurement
free erythrocyte protoporphyrin measurement
fluvoxamine measurement
free protoporphyrin measurement
fructose measurement
filamentous fungi count
yeast - like fungi count
factor viii activity actual to control ratio measurement
factor xiv activity actual to control ratio measurement
gliadin antibody measurement
gliadin iga antibody measurement
gliadin igg antibody measurement
estimated glucose measurement
granulocytes to leukocytes ratio measurement
hydroxyalprazolam measurement
hemoglobin a2 prime to total hemoglobin ratio measurement
hemoglobin barts to total hemoglobin ratio measurement
carboxyhemoglobin to total hemoglobin ratio measurement
hemoglobin g coushatta to total hemoglobin ratio measurement
hemoglobin lepore to total hemoglobin ratio measurement
hemoglobin o - arab to total hemoglobin ratio measurement
oxyhemoglobin to total hemoglobin ratio measurement
free choriogonadotropin beta measurement
intact choriogonadotropin measurement
hdl cholesterol to total cholesterol ratio measurement
hemoglobin a1 to total hemoglobin ratio measurement
hemoglobin d to total hemoglobin ratio measurement
hemoglobin e to total hemoglobin ratio measurement
hemoglobin f to total hemoglobin ratio measurement
methemoglobin to total hemoglobin ratio measurement
heat shock protein 70 measurement
heat shock protein 90 alpha measurement
17 - hydroxyprogesterone measurement
idl cholesterol and vldl cholesterol subtype 3 measurement
immunoglobulin g to albumin ratio measurement
igg clearance
igg clearance to albumin clearance ratio measurement
igg synthesis rate
immunoglobulin light chain measurement
free insulin measurement
japanese encephalitis virus antibody measurement
kappa light chain measurement
keratocyte count
lecithin to sphingomyelin ratio measurement
lead measurement
leukocytes corrected for nucleated erythrocytes count
lambda light chain measurement
liver fibrosis score
levetiracetam measurement
clefted lymphocytes count
clefted lymphocytes to leukocytes ratio measurement
lymphoma cells to leukocytes ratio measurement
macroscopic blood measurement
meconium measurement
meperidine measurement
mercury measurement
methanol measurement
mitochondrial m2 antibody measurement
monocytes and macrophages to leukocytes ratio measurement
monoclonal protein to total protein ratio measurement
mesothelial cells count
mesothelial cells to leukocytes ratio measurement
filgrastim
free metanephrine measurement
nonhematic cells count
nonhematic cells to leukocytes ratio measurement
nicotine measurement
n - methylhistamine measurement
basophilic normoblast count
nornicotine measurement
neutral fats measurement
type 1 collagen x - link n - telopeptides to creatinine ratio measurement
oxymorphone measurement
paroxetine measurement
partial pressure of carbon dioxide adjusted for body temperature measurement
platelet factor 4 - heparin complex induced antibody measurement
phenytoin measurement
phenylketone measurement
agranular platelets count
immature plasma cells to total cells ratio measurement
partial pressure of oxygen adjusted for body temperature measurement
polychromatophilic erythroblast count
polychromatophilic normoblast count
phosphatidylcholine to albumin ratio measurement
pregnenolone measurement
protein pattern measurement
phosphatidylglycerol to lung surfactant ratio measurement
protein s activity actual to control ratio measurement
free protein s activity actual to control ratio measurement
pyridinoline to creatinine ratio measurement
pyruvate measurement
reducing substance measurement
reducing sugar measurement
reptilase activity actual to control ratio measurement
salicylates measurement
sertraline measurement
motile sperm to total sperm ratio measurement
weakly bound testosterone measurement
thyroglobulin recovery rate
tetrahydrocannabinol measurement
thrombin activity actual to control ratio measurement
thyroid stimulating immunoglobulin measurement
free testosterone to testosterone ratio measurement
free testosterone and weakly bound to total testosterone ratio measurement
tissue transglutaminase iga antibody measurement
tissue transglutaminase igm antibody measurement
ubiquitin protein measurement
venlafaxine measurement
vitamin d2 and vitamin d3 and 25 - hydroxyvitamin d measurement
25 - hydroxyvitamin d2 and 25 - hydroxyvitamin d3 measurement
von willebrand factor activity actual to control ratio measurement
west nile virus antibody measurement
xanthochromia measurement
yellow fever virus antibody measurement
zika virus antibody measurement
zinc protoporphyrin measurement
paralaryngeal lymph node
prelaryngeal lymph node
pretracheal lymph node
burkholderia cepacia measurement
haemophilus influenzae measurement
haemophilus measurement
nontuberculous mycobacteria measurement
staphylococcus aureus measurement
developmental behavioral pediatrician
developmental psychologist
pediatric neurologist
transesophageal echocardiography with contrast
transthoracic echocardiography with contrast
enzyme - linked lectin assay
eye fundus photography
multiplexed opsonophagocytic killing assay
oxacillin resistant staphylococcus aureus
phosphatase and tensin homolog measurement
antibiotic susceptibility zone diameter
bone mineral content
bone mineral density t - score
eye drop comfort grade
actual subject to eye chart distance
planned subject to eye chart distance
acuity card grating frequency
kumar imwg 2016 oncology response criteria
lambda z lower limit tau
number of points for lambda z tau
lambda z tau
lambda z upper limit tau
half - life tau
expiratory vital capacity
student indicator
diffusely increased
focally increased
absolute change in longest diameter from nadir product of perpendicular diameters timepoint
absolute change in longest perpendicular from nadir product of perpendicular diameters timepoint
bone marrow tracer uptake
energy expenditure
maximum predicted heart rate
qualitative histopathologic examination
decreased corpora lutea
increased corpora lutea
increased eroded surface
intrahepatocelluar erythrocytes
increased osteoclasts
severity one out of three
ziconotide
severity one out of four
severity one out of five
severity two out of three
severity two out of four
severity two out of five
severity three out of three
severity three out of four
severity three out of five
severity four out of four
severity four out of five
severity five out of five
saphenous nerve
subcutaneous port site
planned dose frequency
planned pharmacologic target common name
planned pharmacologic target entrez gene identifier
planned pharmacologic target entrez gene symbol
planned pharmacologic target mode of action
zilucoplan
antibiotic lock therapy
mino - lok therapy
cet kras antisense oligonucleotide azd4785
psip1 gene product
orvacabtagene autoleucel
her2 / neu expression by immunohistochemistry 0
her2 / neu expression by immunohistochemistry 1 +
her2 / neu expression by immunohistochemistry 2 +
her2 / neu expression by immunohistochemistry 3 +
enneking metastasis m0
enneking metastasis m1
mirage syndrome
primary erythermalgia
sheep lung adenocarcinoma
myeloid engraftment
anti - cd3 / anti - gprc5d bispecific monoclonal antibody jnj - 64407564
interleukin - 23
platinum - resistant disease
cdisc clinical classification atlas test name terminology
cdisc clinical classification atlas test code terminology
cdisc questionnaire fact - bmt version 4 test name terminology
cdisc questionnaire fact - bmt version 4 test code terminology
cdisc questionnaire facit - dyspnea 10 item short form test name terminology
cdisc questionnaire facit - dyspnea 10 item short form test code terminology
cdisc questionnaire facit - fatigue 13 - item version 4 test name terminology
cdisc questionnaire facit - fatigue 13 - item version 4 test code terminology
cdisc questionnaire peds - facit - f test name terminology
cdisc questionnaire peds - facit - f test code terminology
cdisc questionnaire tscc test name terminology
cdisc questionnaire tscc test code terminology
cdisc questionnaire tscyc test name terminology
cdisc questionnaire tscyc test code terminology
atlas clinical classification question
fact - bmt version 4 questionnaire question
facit - dyspnea 10 item short form questionnaire question
facit - fatigue 13 - item version 4 questionnaire question
peds - facit - f questionnaire question
tscc questionnaire question
tscyc questionnaire question
platinum resistance
interleukin - 23 receptor complex
platinum - resistant ovarian carcinoma
synthetic vaccine particles - rapamycin
anti - cd38 / cd3 bispecific monoclonal antibody gbr 1342
hormone resistance
arhgef10 gene
arhgef10 wt allele
rho guanine nucleotide exchange factor 10
arhgef10l gene
arhgef10l wt allele
rho guanine nucleotide exchange factor 10 - like protein
baz1a gene
baz1a wt allele
bromodomain adjacent to zinc finger domain protein 1a
kras np_004976 .2:p .a59x
kras np_004976 .2:p .k117x
antibody - drug conjugate adc xmt - 1536
anti - napi2b monoclonal antibody xmt - 1535
tablet with sensor dosage form
cpeb3 gene
cpeb3 wt allele
cytoplasmic polyadenylation element - binding protein 3
functional assessment of cancer therapy - bone marrow transplant version 4 questionnaire
functional assessment of chronic illness therapy - fatigue 13 - item scale version 4 questionnaire
pediatric functional assessment of chronic illness therapy - fatigue questionnaire
trauma symptom checklist for children questionnaire
trauma symptom checklist for young children questionnaire
atlas score clinical classification
4 stair ascend  -  wear orthoses
4 stair descend  -  wear orthoses
10 meter walk / run  -  wear orthoses
fact - bmt version 4  -  i have a lack of energy
fact - bmt version 4  -  i have nausea
fact - bmt version 4  -  trouble meeting needs of family
fact - bmt version 4  -  i have pain
fact - bmt version 4  -  bothered by treatment side effect
fact - bmt version 4  -  i feel ill
fact - bmt version 4  -  i am forced to spend time in bed
denileukin diftitox
fact - bmt version 4  -  i feel close to my friends
fact - bmt version 4  -  get emotional support from family
fact - bmt version 4  -  i get support from my friends
fact - bmt version 4  -  my family has accepted my illness
fact - bmt version 4  -  satisfied communication illness
fact - bmt version 4  -  i feel close to my partner
fact - bmt version 4  -  i am satisfied with my sex life
fact - bmt version 4  -  i feel sad
fact - bmt version 4  -  satisfied with how i am coping
fact - bmt version 4  -  losing hope against illness
fact - bmt version 4  -  i feel nervous
fact - bmt version 4  -  i worry about dying
fact - bmt version 4  -  worry my condition will get worse
fact - bmt version 4  -  i am able to work
fact - bmt version 4  -  my work is fulfilling
fact - bmt version 4  -  i am able to enjoy life
fact - bmt version 4  -  i have accepted my illness
fact - bmt version 4  -  i am sleeping well
fact - bmt version 4  -  enjoy things i usually do for fun
fact - bmt version 4  -  content with quality of my life
fact - bmt version 4  -  i am concerned about keeping job
fact - bmt version 4  -  i feel distant from other people
fact - bmt version 4  -  i worry transplant will not work
fact - bmt version 4  -  side effect of treatment worse
fact - bmt version 4  -  i have a good appetite
fact - bmt version 4  -  i like the appearance of my body
fact - bmt version 4  -  i am able to get around by myself
fact - bmt version 4  -  i get tired easily
fact - bmt version 4  -  i am interested in sex
fact - bmt version 4  -  concerns ability to have children
fact - bmt version 4  -  confidence in my nurse ( s )
fact - bmt version 4  -  i regret bone marrow transplant
fact - bmt version 4  -  i can remember things
fact - bmt version 4  -  i am able to concentrate
fact - bmt version 4  -  i have frequent colds / infections
fact - bmt version 4  -  my eyesight is blurry
fact - bmt version 4  -  bothered by change in food tastes
fact - bmt version 4  -  i have tremors
fact - bmt version 4  -  i have been short of breath
fact - bmt version 4  -  i am bothered by skin problems
fact - bmt version 4  -  i have trouble with my bowels
fact - bmt version 4  -  illness is hardship for my family
fact - bmt version 4  -  cost of treatment is burden on me
facit - dyspnea 10 item short form  -  part i: dressing without help
facit - dyspnea 10 item short form  -  part i: dressing why not
facit - dyspnea 10 item short form  -  part i: walk 50 steps
facit - dyspnea 10 item short form  -  part i: walk 50 steps why not
facit - dyspnea 10 item short form  -  part i: walk up 20 stairs
facit - dyspnea 10 item short form  -  part i: walk up 20 stairs why not
facit - dyspnea 10 item short form  -  part i: preparing meals
facit - dyspnea 10 item short form  -  part i: preparing meals why not
facit - dyspnea 10 item short form  -  part i: washing dishes
facit - dyspnea 10 item short form  -  part i: washing dishes why not
facit - dyspnea 10 item short form  -  part i: sweeping / mopping
facit - dyspnea 10 item short form  -  part i: sweeping / mopping why not
facit - dyspnea 10 item short form  -  part i: making a bed
facit - dyspnea 10 item short form  -  part i: making a bed why not
facit - dyspnea 10 item short form  -  part i: lifting 10 - 20 lbs
facit - dyspnea 10 item short form  -  part i: lifting 10 - 20 lbs why not
facit - dyspnea 10 item short form  -  part i: carry 10 - 20 lbs
facit - dyspnea 10 item short form  -  part i: carry 10 - 20 lbs why not
facit - dyspnea 10 item short form  -  part i: walk for 1 / 2 mile
facit - dyspnea 10 item short form  -  part i: walk for 1 / 2 mile why not
facit - dyspnea 10 item short form  -  part ii: dressing without help
facit - dyspnea 10 item short form  -  part ii: walk 50 steps
facit - dyspnea 10 item short form  -  part ii: walk up 20 stairs
facit - dyspnea 10 item short form  -  part ii: preparing meals
facit - dyspnea 10 item short form  -  part ii: washing dishes
facit - dyspnea 10 item short form  -  part ii: sweeping / mopping
facit - dyspnea 10 item short form  -  part ii: making a bed
facit - dyspnea 10 item short form  -  part ii: lifting 10 - 20 lbs
facit - dyspnea 10 item short form  -  part ii: carry 10 - 20 lbs
facit - dyspnea 10 item short form  -  part ii: walk for 1 / 2 mile
facit - fatigue 13 - item version 4  -  i feel fatigued
facit - fatigue 13 - item version 4  -  i feel weak all over
facit - fatigue 13 - item version 4  -  i feel listless
facit - fatigue 13 - item version 4  -  i feel tired
facit - fatigue 13 - item version 4  -  trouble starting things
facit - fatigue 13 - item version 4  -  trouble finishing things
facit - fatigue 13 - item version 4  -  i have energy
facit - fatigue 13 - item version 4  -  able to do my usual activities
facit - fatigue 13 - item version 4  -  i need to sleep during the day
facit - fatigue 13 - item version 4  -  i am too tired to eat
facit - fatigue 13 - item version 4  -  need help doing usual activities
facit - fatigue 13 - item version 4  -  frustrated by being too tired
facit - fatigue 13 - item version 4  -  limit social activity ,  i am tired
peds - facit - f  -  i feel tired
peds - facit - f  -  i have energy
peds - facit - f  -  could do my usual things at home
peds - facit - f  -  trouble starting things
peds - facit - f  -  trouble finishing things
peds - facit - f  -  i needed to sleep during the day
peds - facit - f  -  upset by being too tired
peds - facit - f  -  hard for me to play with friends
peds - facit - f  -  needed help doing usual things
peds - facit - f  -  i feel weak
peds - facit - f  -  i was too tired to eat
peds - facit - f  -  being tired made me sad
peds - facit - f  -  being tired made me mad
tscc  -  bad dreams or nightmares
milodistim
tscc  -  afraid something bad might happen
tscc  -  scary ideas just pop into my head
tscc  -  wanting to say dirty words
tscc  -  pretending i am someone else
tscc  -  arguing too much
tscc  -  feeling lonely
tscc  -  touching private parts too much
tscc  -  feeling sad or unhappy
tscc  -  remembering things i didn't like
tscc  -  going away in my mind
tscc  -  remembering scary things
tscc  -  wanting to yell and break things
tscc  -  crying
tscc  -  getting scared all of sudden
tscc  -  getting mad and can't calm down
tscc  -  thinking about having sex
tscc  -  feeling dizzy
tscc  -  wanting to yell at people
tscc  -  wanting to hurt myself
tscc  -  wanting to hurt other people
tscc  -  think touch people private parts
tscc  -  think about sex when don't want
tscc  -  feeling scared of men
tscc  -  feeling scared of women
tscc  -  washing myself because feel dirty
tscc  -  feeling stupid or bad
tscc  -  feeling like did something wrong
tscc  -  feeling like things aren't real
tscc  -  forgetting things
tscc  -  feeling like i'm not in my body
tscc  -  feeling nervous or jumpy inside
tscc  -  feeling afraid
tscc  -  not trusting people because sex
tscc  -  can't stop thinking something bad
tscc  -  getting into fights
tscc  -  feeling mean
tscc  -  pretending i'm somewhere else
tscc  -  being afraid of the dark
tscc  -  scared when think about sex
tscc  -  worrying about things
tscc  -  feeling like nobody likes me
tscc  -  remembering things don't want to
tscc  -  having sex feelings in my body
tscc  -  my mind going empty or blank
tscc  -  feeling like i hate people
tscc  -  can't stop thinking about sex
tscc  -  trying not to have any feelings
tscc  -  feeling mad
tscc  -  feeling afraid somebody kill me
tscc  -  wishing bad things never happened
tscc  -  wanting to kill myself
tscc  -  daydreaming
tscc  -  getting upset people talk sex
tscyc  -  temper tantrums
tscyc  -  looking sad
tscyc  -  telling a lie
tscyc  -  bad dreams or nightmares
tscyc  -  living in a fantasy world
tscyc  -  seeming to know more about sex
tscyc  -  being easily scared
tscyc  -  not wanting to go somewhere
tscyc  -  worrying food was poisoned
tscyc  -  flinching when someone moved
tscyc  -  being bothered by memories
tscyc  -  worrying someone might be sexual
tscyc  -  not wanting to talk
tscyc  -  not do something supposed to do
tscyc  -  breaking things on purpose
tscyc  -  talking about sexual things
tscyc  -  having trouble concentrating
tscyc  -  blaming for things weren't fault
tscyc  -  acting frightened reminded past
tscyc  -  pretending to have sex
tscyc  -  worrying bad things in future
tscyc  -  arguing
tscyc  -  getting into physical fights
tscyc  -  drawing pictures upsetting thing
tscyc  -  not noticing what he or she doing
tscyc  -  having trouble sitting still
tscyc  -  playing games something bad past
tscyc  -  seeming to be in a daze
tscyc  -  trouble remember upsetting thing
tscyc  -  using drugs
tscyc  -  fear of the dark
tscyc  -  being afraid to be alone
tscyc  -  spacing out
tscyc  -  being too aggressive
tscyc  -  touching other private parts
tscyc  -  seeing bad happened in the past
tscyc  -  hearing voices to hurt someone
tscyc  -  staring off into space
tscyc  -  changing subject about bad thing
tscyc  -  having a nervous breakdown
tscyc  -  not happy like other children
tscyc  -  crying at night frightened
tscyc  -  hitting adults
tscyc  -  being frightened of men
tscyc  -  not being able to pay attention
tscyc  -  seeming to be million miles away
tscyc  -  being easily startled
qs21
tscyc  -  watching out for possible danger
tscyc  -  no longer doing things enjoy
tscyc  -  frightened something sexual seen
tscyc  -  not sleeping for two or more days
tscyc  -  not paying attention in own world
tscyc  -  making mistakes
tscyc  -  crying for no obvious reason
tscyc  -  not wanting to be around someone
tscyc  -  being tense
tscyc  -  worrying about people's safety
tscyc  -  very angry over a little thing
tscyc  -  drawing pictures about sex things
tscyc  -  pulling his or her hair out
tscyc  -  calling himself or herself bad
tscyc  -  throwing things at friends / family
tscyc  -  getting upset about the past
tscyc  -  temporary blindness or paralysis
tscyc  -  getting upset something sexual
tscyc  -  not going to bed first time asked
tscyc  -  fear he or she killed by someone
tscyc  -  saying nobody liked him or her
tscyc  -  crying when reminded from past
tscyc  -  saying bad didn't happen
tscyc  -  saying he or she wanted to die
tscyc  -  acting as if didn't have feelings
tscyc  -  whining
tscyc  -  not sleeping well
tscyc  -  worrying about sexual things
tscyc  -  being frightened by things
tscyc  -  hallucinating
tscyc  -  acting like he or she was in trance
tscyc  -  forgetting his or her own name
tscyc  -  upset when reminded bad happened
tscyc  -  avoiding bad happened in past
tscyc  -  acting jumpy
tscyc  -  making a mess
tscyc  -  acting sad or depressed
tscyc  -  being absent - minded
tscyc  -  not wanting to eat certain foods
tscyc  -  yelling at family ,  friends or teachers
tscyc  -  not playing because depressed
tscyc  -  being disobedient
tscyc  -  intentionally hurt other children
atlas  -  age
atlas  -  treatment with antibiotics
atlas  -  leukocyte count
atlas  -  albumin
atlas  -  serum creatinine
atlas  -  score
igf2bp2 gene
igf2bp2 wt allele
insulin - like growth factor 2 mrna binding protein 2
estrogen receptor status 0
estrogen receptor status 1 +
estrogen receptor status 2 +
estrogen receptor status 3 +
progesterone receptor status 0
progesterone receptor status 1 +
progesterone receptor status 2 +
progesterone receptor status 3 +
computer - based cognitive stimulation intervention
recurrent lymphoproliferative disorder
recurrent ebv - related lymphoma
leprotl1 gene
leprotl1 wt allele
leptin receptor overlapping transcript - like 1
n4bp2 gene
n4bp2 wt allele
nedd4 - binding protein 2
sox21 gene
undesired appetite increase scale
undesired appetite increase score 0
undesired appetite increase score 1
undesired appetite increase score 2
undesired appetite increase score 3
undesired appetite increase score 4
undesired appetite increase score 5
sox21 wt allele
undesired appetite increase score 6
undesired appetite increase score 7
undesired appetite increase score 8
undesired appetite increase score 9
undesired appetite increase score 10
transcription factor sox - 21
undesired sedation scale
undesired sedation score 0
undesired sedation score 1
undesired sedation score 2
undesired sedation score 3
undesired sedation score 4
undesired sedation score 5
undesired sedation score 6
il23r gene
undesired sedation score 7
undesired sedation score 8
undesired sedation score 9
undesired sedation score 10
il23r wt allele
alvac vaccine
interleukin - 23 receptor
childhood brain glioblastoma
abcd1 gene mutation
number of lymph nodes with micrometastases
number of lymph nodes with macrometastases
urine dipstick test
p16ink4a negative oropharyngeal squamous cell carcinoma
p16ink4a negative
hormone therapy agent
vascular thrombosis response
ircr thrombosis
irpr thrombosis
irpd thrombosis
irsd thrombosis
strategy
breast carcinoma grade
breast carcinoma grade g1
breast carcinoma grade g2
breast carcinoma grade g3
ill - defined anatomic site
ibrutinib resistance
cyp17a1 inhibitor
advanced lung non - squamous non - small cell carcinoma
allogeneic hematopoietic stem cell transplant recipient
amhr2 gene product
anti - muellerian hormone type - 2 receptor extracellular domain
cartpt gene
cartpt wt allele
cocaine -  and amphetamine - regulated transcript protein
dux4l2 gene
dux4l2 wt allele
double homeobox protein 4 - like protein 2
gprc5d gene
gprc5d wt allele
g - protein coupled receptor family c group 5 member d
preschool
inventory of callous - unemotional traits
shank2 gene
outreach
shank2 wt allele
inreach
outreach and inreach
sh3 and multiple ankyrin repeat domains protein 2
tox gene
tox wt allele
central nervous system b - cell non - hodgkin lymphoma
pediatric quality of life enjoyment and satisfaction questionnaire
thymocyte selection - associated high mobility group box protein tox
interventional radiologist
lemd3 gene
lemd3 wt allele
inner nuclear membrane protein man1
map3k4 gene
map3k4 wt allele
mitogen - activated protein kinase kinase kinase 4
the screen for child anxiety related emotional disorders
symptom checklist 90
the mood and feelings questionnaire
ubtf gene
ubtf wt allele
nucleolar transcription factor 1
diagnostic and statistical manual of mental disorders ,  5th edition
refractory breast carcinoma
tusc7 gene
tusc7 wt allele
tumor suppressor candidate 7
gabra6 gene
gabra6 wt allele
gamma - aminobutyric acid receptor subunit alpha - 6
gid4 gene
gid4 wt allele
glucose - induced degradation protein 4 homolog
ptpro gene
ptpro wt allele
receptor - type tyrosine - protein phosphatase o
parp3 gene
parp3 wt allele
poly  [ adp - ribose ]  polymerase 3
verbal support
refractory colorectal carcinoma
refractory melanoma
kel gene
kel wt allele
kell blood group glycoprotein
ikbke gene
ikbke wt allele
inhibitor of nuclear factor kappa - b kinase subunit epsilon
fgf14 gene
fgf12 gene
fgf14 wt allele
fgf12 wt allele
fibroblast growth factor 14
refractory gastric carcinoma
fibroblast growth factor 12
edn3 gene
edn3 wt allele
damnacanthal
endothelin - 3
xk gene
xk wt allele
membrane transport protein xk
gusb gene
gusb wt allele
beta - glucuronidase
rplp0 gene
rplp0 wt allele
60s acidic ribosomal protein p0
intergroup rhabdomyosarcoma clinical grouping system
intergroup rhabdomyosarcoma clinical group extent of disease
intergroup rhabdomyosarcoma group i
intergroup rhabdomyosarcoma group ia
intergroup rhabdomyosarcoma group ib
intergroup rhabdomyosarcoma group ii
intergroup rhabdomyosarcoma group iia
intergroup rhabdomyosarcoma group iib
intergroup rhabdomyosarcoma group iic
intergroup rhabdomyosarcoma group iii
intergroup rhabdomyosarcoma group iiia
intergroup rhabdomyosarcoma group iiib
intergroup rhabdomyosarcoma group iv
sleep - disordered breathing
brca - mutated ovarian carcinoma
recurrent brca - mutated ovarian carcinoma
recurrent childhood malignant solid neoplasm
refractory childhood malignant solid neoplasm
activating pik3cd gene mutation
childhood malignant solid neoplasm
autologous anti - cd19 t - cell receptor t cells et190l1
low density array
opioid - induced constipation
psma - positive tumor
unresectable malignant solid neoplasm
recurrent who grade ii glioma
recurrent who grade iii glioma
adenosine a2a receptor antagonist azd4635
medical clearance
atrx gene mutation
anti - tim - 3 antibody bms - 986258
nullizygosity
skin staple
advanced b - cell neoplasm
anti - cd74 antibody - drug conjugate stro - 001
histone h3 .2
cd34 positive
hsatii dna
hsatii rna
blasts under 20 , 000 in peripheral blood white cells
low density array gene signature
sequencing library
peripheral vascular insufficiency
septal defect repair
unresectable craniopharyngioma
recurrent craniopharyngioma
mezagitamab
f - 18 sodium fluoride positron emission tomography and magnetic resonance imaging
c - 11 choline positron emission tomography and magnetic resonance imaging
pik3ca gene mutation negative
flt3 gene mutation negative
cdkn2a gene mutation negative
brca1 gene mutation negative
brca2 gene mutation negative
idh1 gene mutation negative
idh2 gene mutation negative
sequencing run
braf gene mutation negative
alk gene mutation negative
egfr gene mutation negative
tp53 gene mutation negative
nras gene mutation negative
myd88 gene mutation negative
egfr gene rearrangement
h3 .3 k27m mutation
fgfr3 gene fusion positive
nourish - t
refractory malignant thymoma
amoxicillin - clavulanic acid
ros1 gene inversion
hedgehog pathway mutation
dextromethorphan / bupropion tablet axs - 05
anti - cd48 / mmae antibody - drug conjugate sgn - cd48a
ddr2 gene mutation
gnai family gene mutation
inactivating erbb2 gene mutation
somatic kit gene mutation
fgf1 gene fusion positive
fgf3 gene fusion positive
fgf1 gene mutation
fgf1 gene amplification
fgf3 gene mutation
fgfr1 gene fusion positive
pdgfa gene fusion positive
pdgfb gene fusion positive
pdgfra gene fusion positive
pdgfrb gene fusion positive
pdgfa gene amplification
pdgfb gene amplification
pdgfa gene mutation
pdgfb gene mutation
esperamicin antibiotic
unresectable carcinoma
unresectable thymic carcinoma
locally advanced thymic carcinoma
recurrent thymic carcinoma
metastatic thymic carcinoma
refractory mycosis fungoides and sezary syndrome
locally advanced carcinoma
aganirsen
mr - compatible sectioning and localization device
autologous pd - 1 antibody - expressing mesothelin - specific car - t cells
mutant idh1 inhibitor ds - 1001
ic9 - gd2 - car - cd28 - ox40 - expressing autologous nkt cells
nutritious semisolid food gel
nutritious semisolid food gel with phenethyl isothiocyanate
bet - bromodomain inhibitor odm - 207
oral moisturizing jelly
karonudib
tepoditamab
adenoviral psa vaccine etbx - 071
resiquimod gel cd11301
oral therapeutic vaccine v3 - x
lutetium lu 177 - psma - 617
pd - l1 peptide vaccine
lazertinib
lactobacillus reuteri probiotic tablet
allogeneic tcr alpha / beta - positive t - lymphocyte - depleted peripheral blood stem cells
autologous ny - eso - 1 tcr - targeted t lymphocytes
child - pugh a - b7 cirrhosis
refractory head and neck squamous cell carcinoma
metastatic head and neck squamous cell carcinoma
pd - l1 / ido peptide vaccine
anti - pd - 1 monoclonal antibody bcd - 100
autologous cd19car - cd28 - cd137 / cd27 / cd3zeta - icasp9 - expressing t - lymphocytes
hdac inhibitor ckd - 581
genolimzumab
autologous mesothelin - specific car - t cells
carbon c 14 pevonedistat
rituximab conjugate con - 4619
zirconium zr 89 anti - egfr monoclonal antibody abt - 806
autologous mrna - modified anti - cmet car - t cells
trastuzumab conjugate bi - con - 02
cyclin - dependent kinase 8 / 19 inhibitor bcd 115
zirconium zr 89 pembrolizumab
autologous egfrt / bcma - 41bbz - targeted car t cells
fluorescein - conjugated wisteria floribunda lectin
raltitrexed disodium
muc1 sp vaccine
slco1b3 gene positive
refractory thymic carcinoma
histone gene
refractory indolent adult non - hodgkin lymphoma
anti - bcma antibody sea - bcma
autologous anti - bcma - car - 4 - 1bb - cd3zeta - egfrt - expressing cd4 +  / cd8 +  t - lymphocytes
oncolytic vaccinia virus tg6002
licochalcone a
pd - 1 knockout ebv - specific cytotoxic t lymphocytes
danicopan
ruthenium - based photosensitizer tld1411
amorphous calcium carbonate
crispr / cas9 - edited hpv16 / 18 e6 / e7 plasmid
talen - edited hpv16 / 18 e6 / e7 plasmid
rig - i selective ligand rgt100
neo - multiple taa - loaded dendritic cell vaccine
autologous mesenchymal stem cells - poly lactic - co - glycolic acid
surgical clip
f - 18 fluciclovine positron emission tomography and magnetic resonance imaging
immune - related response criteria
immune - related response criteria complete response
immune - related response criteria partial response
immune - related response criteria stable disease
immune - related response criteria progressive disease
arm and breast questionnaire
how difficult to lift items over 10 pounds with affected arm
squalamine lactate
how difficult to reach or extend affected arm above shoulder level
how difficult to wash back with affected arm
how difficult to bend and straighten affected arm
how much bothered by tenderness in affected underarm ,  arm ,  or hand
how much bothered by swelling in affected underarm ,  arm ,  or hand
how much bothered by numbness in affected underarm ,  arm ,  or hand
how much bothered by tingling in affected underarm ,  arm ,  or hand
how much bothered by increased skin sensitivity in affected underarm ,  arm ,  or hand
how much bothered by tightness ,  pulling ,  or stretching in affected underarm ,  arm ,  or hand
how much bothered by discomfort or pain in affected underarm ,  arm ,  or hand
how much bothered by arm weakness in affected arm
how much bothered by arm heaviness in affected arm
how much bothered by shoulder stiffness in affected arm
donor - derived cytokine - induced memory - like natural killer cells
autologous aml / dendritic cell fusion vaccine
allogeneic ic9 / cd19 - car - cd28 - zeta - 2a - il15 - transduced cord blood - derived natural killer cells
autologous pd - l1 / cd80 / cd86 - targeted car - t cells
how much bothered by tenderness in affected breast or chest area
how much bothered by swelling in affected breast or chest area
how much bothered by numbness in affected breast or chest area
how much bothered by tingling in affected breast or chest area
how much bothered by increased skin sensitivity in affected breast or chest area
how much bothered by tightness ,  pulling ,  or stretching in affected breast or chest area
how much bothered by discomfort or pain in affected breast or chest area
extent breast cancer treatment disrupted social activities with family and friends
extent breast cancer treatment disrupted work
extent breast cancer treatment disrupted recreational activities
extent breast cancer treatment disrupted self - care
extent breast cancer treatment disrupted normal sleep
pi3k / bet inhibitor ly294002
f - 18 fluciclovine positron emission tomography and computed tomography
patient preference for care action
surgery declined
psa level less than or equal to two
psa level 0 .2 to two
ido1 inhibitor mk - 7162
quality of life questionnaire br - 23
painful ,  irritated ,  or watery eyes
very much disrupted
mrna - based personalized cancer vaccine nci - 4650
autologous cd34 - positive bcl11a - disrupted hematopoietic progenitor cells st - 400
autologous dendritic cells transduced with wild - type p53 adenovirus vaccine
veterinary route of administration
veterinary dosage form
recurrent grade 3a follicular lymphoma
unresectable cutaneous melanoma
primary industry of employment
natural and applied sciences
trades ,  transport ,  or construction
processing ,  manufacturing ,  or utilities
out of pocket payment
sick leave
disability leave
stay at home parent
working full time hours
working part time hours
on sick or disability leave
unemployed or retired
not currently working
primary congenital glaucoma 3a
ectrodactyly - ectodermal dysplasia - cleft syndrome
system support mapping
clinimacs cd34 reagent system
psa level two to ten
bupropion hydrochloride controlled - release
have swollen arm or hand
have difficulty raising arm or moving arm sideways
have pain in area of affected breast
area of affected breast swollen
area of affected breast oversensitive
have skin problem on or in area of affected breast
tenofovir alafenamide
total number of prostate tissue cores
number of prostate tissue cores positive for carcinoma
greatest percentage of core involvement by cancer in any core
mof compound rimo - 301
contrast - enhanced ultrasound
hepatitis b virus core antibody positive
tet2 gene mutation
vac alternating with vi regimen
vit regimen
refractory stage 0 bladder cancer ajcc v6 and v7
blasts more than 25 percent of bone marrow nucleated cells
online mindfulness meditation
peg - conjugated tlr7 / 8 agonist nktr - 262
holiday
statutory holiday
patient did not keep appointment
refractory leiomyosarcoma
refractory undifferentiated pleomorphic sarcoma
refractory synovial sarcoma
refractory myxoid liposarcoma
metastatic myxoid liposarcoma
refractory round cell liposarcoma
recombinant betacellulin
metastatic round cell liposarcoma
refractory sarcoma
recurrent sarcoma
insm2 gene
insm2 wt allele
insulinoma - associated protein 2
ptprn gene
ptprn wt allele
receptor - type tyrosine - protein phosphatase - like n
unresectable metastasis
sct gene
sct wt allele
sct gene product
prepro - secretin
secretin
spinocerebellar ataxia type 2
spinocerebellar ataxia type 36
spastic paraplegia 11
limb - girdle muscular dystrophy type 1c
serpinb3 gene
serpinb3 wt allele
mitochondrially inherited nonsyndromic sensorineural deafness
serpin b3
serpinb4 gene
serpinb4 wt allele
rippling muscle disease 2
serpin b4
hyperckmia
gzmm gene
gzmm wt allele
granzyme m
unresectable sarcoma
galt gene
galt wt allele
galactose - 1 - phosphate uridylyltransferase
other and ill defined digestive organs icd - o - 3
other and ill - defined sites icd - o - 3
other and ill - defined sites in lip ,  oral cavity and pharynx icd - o - 3
other and ill - defined sites within respiratory system and intrathoracic organs icd - o - 3
other and unspecified female genital organs icd - o - 3
other and unspecified major salivary glands icd - o - 3
other and unspecified male genital organs icd - o - 3
other and unspecified parts of biliary tract icd - o - 3
other and unspecified parts of mouth icd - o - 3
other and unspecified parts of tongue icd - o - 3
other and unspecified urinary organs icd - o - 3
other endocrine glands and related structures icd - o - 3
gal gene
gal wt allele
gal gene product
galanin peptides
galanin
galanin message - associated peptide
gdf11 gene
gdf11 wt allele
growth / differentiation factor 11
kdm4c gene
kdm4c wt allele
lysine - specific demethylase 4c
pfkfb4 gene
pfkfb4 wt allele
6 - phosphofructo - 2 - kinase / fructose - 2 , 6 - biphosphatase 4
refractory myelodysplastic syndrome
recurrent myelodysplastic syndrome
percutaneous local ablation
methylmalonic aciduria due to methylmalonyl - coa mutase deficiency
bilateral frontoparietal polymicrogyria
catecholaminergic polymorphic ventricular tachycardia type 2
muscular dystrophy congenital ,  lmna - related
primary ciliary dyskinesia 14
temtamy syndrome
dnmt3l gene
dnmt3l wt allele
dna  ( cytosine - 5 )  - methyltransferase 3 - like
depdc5 gene
depdc5 wt allele
gator complex protein depdc5
cytomegalovirus dna
lm - tllo - neoantigens vaccine adxs - neo
muc16 ectodomain antigen positive
refractory hypopharyngeal squamous cell carcinoma
refractory laryngeal squamous cell carcinoma
refractory oral cavity squamous cell carcinoma
refractory oropharyngeal squamous cell carcinoma
refractory paranasal sinus squamous cell carcinoma
recurrent paranasal sinus squamous cell carcinoma
bcl6 gene fusion
notch2 gene mutation
cd79b gene mutation
diffuse large b - cell lymphoma ,  not otherwise specified molecular subtypes
mds neoantigen - specific autologous t - lymphocytes
mcd diffuse large b - cell lymphoma
bn2 diffuse large b - cell lymphoma
n1 diffuse large b - cell lymphoma
ezb diffuse large b - cell lymphoma
tyrphostin a25
mva - bn - brachyury - tricom vaccine
refractory sinonasal squamous cell carcinoma
fpv - brachyury - tricom vaccine
met overexpression positive
pdgfr gene amplification
pdgfr protein overexpression
axl overexpression positive
unspecified atypical cells present
dolutegravir sodium
milciclib
t2d stage finding
t3d stage finding
bet inhibitor abbv - 744
cd40l - fc fusion protein medi5083
adult comorbidity evaluation - 27
neuromuscular
partially hla - matched adenovirus - specific t lymphocytes
moderate hepatic insufficiency
compartectomy
pkc - beta inhibitor ms - 553
recurrent mixed phenotype acute leukemia
recurrent leukemia
refractory leukemia
recurrent acute myeloid leukemia
recurrent acute leukemia
refractory mixed phenotype acute leukemia
refractory acute leukemia
unresectable intrahepatic cholangiocarcinoma
percutaneous hepatic perfusion
refractory nasopharyngeal carcinoma
adenosine a2b receptor antagonist pbf - 1129
free tissue transfer
hysteroscopy
mandibulotomy
cd274 gene mutation
brief health literacy screening tool
require help to read hospital materials
dispersion dosage form category
have problems learning about medical condition due to difficulty understanding written information
have problem understanding what is told about medical condition
confident filling out medical forms
medicinal gas dosage form category
multi - dose container
nasal powder dosage form
irak4 inhibitor ca - 4948
soft tissue sarcoma ,  excluding rhabdomyosarcoma
recurrent soft tissue sarcoma ,  excluding rhabdomyosarcoma
refractory soft tissue sarcoma ,  excluding rhabdomyosarcoma
lissencephaly 3
double - armed tmz - cd40l / 4 - 1bbl oncolytic ad5 / 35 adenovirus load703
tube thoracostomy
patient satisfaction with cancer care questionnaire
during most recent visit
after most recent visit
health concerns were understood
treated with courtesy and respect
included in decisions about health
told how to take care of myself
encouraged to talk about personal health concerns
had enough time with doctor
my questions were answered to my satisfaction
making appointment was easy
knew what next steps of care would be
confident in how i dealt with health care system
able to get advice needed about health issues
know who to contact for questions
linzagolix
wt1 / psma / htert - encoding plasmid dna ino - 5401
bifidobacterium lactis / lactobacillus acidophilus / inulin probiotic supplement
gallium ga 68 - p16 - 093
androgen receptor antagonist onc1 - 0013b
glofitamab
polyamine transport inhibitor amxt - 1501 dicaprate
bcl - 2 / bcl - xl inhibitor apg - 1252
astragalus membranaceus / angelica gigas / trichosanthes kirilowii maximowicz mixed herbal extract sh003
autologous cd5 - specific car - 28 zeta car t - cells
her2 - targeted darpin mp0274
during hospital or clinic visits after abnormal screening or diagnosis
advanced urothelial carcinoma
locally advanced melanoma
hepatitis b virus antigen peptides / hepatitis g2 cell protein lysate - activated dendritic cells
autologous psma - specific tgfb - resistant car t cells
carbon c 11 - jnj - 63779586
autologous bi - epitope bcma - targeted car t - cells jnj - 68284528
allogeneic interleukin - 17 - producing cd8 - positive t - cells
rubitecan
anti - minor histocompatibility complex donor t - lymphocytes
aurora a kinase inhibitor ly3295668
mbd1 gene
mbd1 wt allele
methyl - cpg - binding domain protein 1
vilaprisan
autologous bcma - 4 - 1bbz - targeted car t - cells
anti - egfr / dm1 antibody - drug conjugate avid100
fluorine f 18 - al - nota - matbbn
cdc7 kinase inhibitor ly3143921 hydrate
recurrent human papillomavirus - related malignant neoplasm
nanoparticle sn - 38 - encapsulated micelle formulation it - 141
refractory human papillomavirus - related malignant neoplasm
alk / c - met inhibitor  tq - b3139
metastatic uveal melanoma
advanced uveal melanoma
11beta - hydroxysteroid dehydrogenase type 1 inhibitor azd4017
unresectable melanoma
eps8 peptide - specific dendritic cells
topical celecoxib
androgen receptor antagonist bay 1161116
amblyomin - x
haah lambda phage vaccine sns - 301
autologous cd38 - 4scar - expressing t - cells 4scar38
autologous cd22 - 4scar - expressing t - cells 4scar22
autologous cd20 - 4scar - expressing t - cells 4scar20
autologous cd123 - 4scar - expressing t - cells 4scar123
bilateral modified radical neck dissection
mtorc 1 / 2 inhibitor lxi - 15029
ningetinib tosylate
cd33 - specific car lentiviral vector - transduced autologous t - lymphocytes
paclitaxel polymeric micelle formulation nant - 008
pi3k - delta inhibitor hmpl 689
alk inhibitor plb 1003
polyinosinic - polycytidylic acid / inactivated rabies virus vaccine ys - on - 001
anti - pd - l1 monoclonal antibody shr - 1316
castration - naive prostate carcinoma
met kinase inhibitor omo - 1
serine hydrolase monoacylglycerol lipase inhibitor abx - 1431
hpv e6 / e7 - encoding semliki forest virus vaccine vvax001
castration - naive
triclosan / copolymer / fluoride toothpaste
magnesium - rich mineral water
anti - cd3 / muc1 antibody - armed pd - 1 inhibitor - induced cytokine - induced killer cells
cd5 - positive blast cells greater than 50 percent
cytomegalovirus reactivation finding
ivabradine hydrochloride
radiopharmaceutical dosage form category
solvent dosage form category
beehive dispersion dosage form
coated granule dosage form
lyophilized dosage form category
parotid bed
osbpl10 gene
osbpl10 wt allele
oxysterol - binding protein - related protein 10
therapeutic invariant natural killer t - cells
components of primary care instrument
go to this doctor for almost all medical care
this doctor handles emergencies
this doctor can take care of almost any medical problem i might have
i could go to this doctor for help with personal or emotional problem
i could go to this doctor for care of ongoing problem
this doctor knows a lot about my family medical history
this doctor clearly understands my health needs
this doctor and i have been through a lot together
this doctor understands what is important to me regarding my health
this doctor does not know my medical history very well
i could go to this doctor for check - up to prevent illness
this doctor always takes my beliefs and wishes into account in caring for me
this doctor knows whether i exercise ,  eat right ,  smoke ,  or drink alcohol
mpeg1 gene
mpeg1 wt allele
macrophage - expressed gene 1 protein
this doctor knows me well as a person
i can easily talk about personal things with this doctor
sometimes this doctor does not listen to me
this doctor always explains things to my satisfaction
sometimes with this doctor i don't bring up things that i'm worried about
itpkb gene
i don't always feel comfortable asking questions of this doctor
itpkb wt allele
sometimes i feel like this doctor ignores my concerns
if i am sick i would always contact a doctor in this office first
my medical care improves when i see the same doctor that i have seen before
inositol - trisphosphate 3 - kinase b
it is very important to me to see my regular doctor
i rarely see the same doctor when i go for medical care
i can call this doctor if i have concern and am not sure i need to see a doctor
i have tremendous trust in this doctor
this doctor knows when i'm due for checkup
i want one doctor to coordinate all of the health care i receive
this doctor keeps track of all my health care
follows up on a problem i've had either at the next visit or by phone
zc3h12a gene
i would recommend this doctor to friends and family
this doctor always has my best interests at heart
this doctor takes responsibility for helping me get all the health care i need
i am confident this doctor will act as my advocate
trecovirsen
zc3h12a wt allele
this doctor looks out for my interests in dealing with my health insurance
i wonder if this doctor is cutting corners on my health care
endoribonuclease zc3h12a
this doctor helps me weigh the pros and cons of my health care decisions
this doctor guides me through the steps i need to deal with my insurance plan
other members of my family see this doctor
this doctor knows a lot about my family
this doctor knows a lot about my community
this doctor uses knowledge of my community to take care of me
this doctor always follows up on my visits to other health care providers
this doctor helps me interpret my lab tests ,  x - rays ,  or visits to other doctors
this doctor communicates with the other health providers i see
this doctor does not always know about care i have received at other places
how long been a patient of this doctor
how long been a patient of this practice
pcnx2 gene
pcnx2 wt allele
number of visits to other doctors in this office
number of visits to doctors outside of this office
pecanex - like protein 2
agreement rating scale
agreement rating score 1
agreement rating score 2
grhpr gene
agreement rating score 3
agreement rating score 4
grhpr wt allele
agreement rating score 5
agreement rating score 6
glyoxylate reductase / hydroxypyruvate reductase
acute pulmonary embolism
acute submassive pulmonary embolism
peox - based polymer encapsulated paclitaxel fid - 007
edqm health care terminology
tafia inhibitor ds - 1040b
ssx2 positive
exon mutation
elongation mutation
truncation mutation
intergenic mutation
non - sense mediated decay mutation
non - coding gene mutation
non - coding gene exon mutation
regulatory region mutation
regulatory region deletion
regulatory region amplification
start lost mutation
nonstop mutation
silent stop codon mutation
transcription factor binding site mutation
transcription factor binding site deletion mutation
transcription factor binding site amplification
less than one year
one to two years
three to five years
six to ten years
eleven to fifteen years
sixteen to twenty years
twenty years or more
lavendustin c
aminocamptothecin
recombinant interleukin - 13
tyrphostin ag 879
sargramostim
satraplatin
hivep1 gene
hivep1 wt allele
additive dosage form category
anticoagulant and preservative solution for blood dosage form
application method of administration
balling gun delivery device
barrel dosing unit
bath additive dosage form
bathing method of administration
beak dipping route of administration
bee smoke paper dosage form
bee smoke stick dosage form
beehive dispersion in sachet
beehive gel dosage form
beehive solution dosage form
beehive strip dosage form
bladder irrigation solution dosage form
pharmaceutical brush device
brush closure device
smoking method of administration
cachet dosing unit
oral cachet dosage form
hard capsule plus tablet dosage form
soft capsule plus tablet dosage form
chewable soft capsule dosage form
chewable - dispersible tablet dosage form
chewing method of administration
child - resistant closure
coated granules in sachet
collodion dosage form
compressed lozenge dose form
concentrate and solvent for concentrate for oral spray ,  suspension dosage form
concentrate and solvent for concentrate for solution for infusion dosage form
concentrate and solvent for cutaneous solution dosage form
concentrate and solvent for solution for infusion dosage form
concentrate and solvent for solution for injection dosage form
concentrate and solvent for solution for injection / infusion dosage form
concentrate and solvent for suspension for injection dosage form
concentrate for concentrate for oral spray ,  suspension dosage form
concentrate for concentrate for solution for infusion dosage form
concentrate for cutaneous solution dosage form
concentrate for cutaneous spray ,  emulsion dosage form
concentrate for dip emulsion dosage form
concentrate for dip solution dosage form
concentrate for dip suspension dosage form
concentrate for dispersion for infusion dosage form
concentrate for emulsion for infusion dosage form
concentrate for gargle dosage form
concentrate for intravesical solution dosage form
concentrate for nebulizer solution dosage form
concentrate for oral solution dosage form
concentrate for oral suspension dosage form
concentrate for oral / rectal solution dosage form
concentrate for oromucosal solution dosage form
concentrate for rectal solution dosage form
concentrate for solution for fish treatment dosage form
arcitumomab
concentrate for solution for hemodialysis dosage form
concentrate for solution for infusion dosage form
concentrate for solution for injection dosage form
concentrate for solution for injection / infusion dosage form
concentrate for solution for intraocular irrigation dosage form
concentrate for solution for peritoneal dialysis dosage form
concentrate for spray emulsion dosage form
concentrate for suspension for injection dosage form
continuous release intraruminal device dosage form
conventional release mechanism of action
cream plus pessary dosage form
cream plus soft vaginal capsule dosage form
cream plus vaginal tablet dosage form
cutaneous emulsion dosage form
topical paste dosage form
cutaneous solution plus medicated sponge dosage form
cutaneous solution in single - dose container
topical solution / concentrate for oromucosal solution dosage form
topical emulsion spray dosage form
topical ointment spray dosage form
topical suspension spray dosage form
topical stick dosage form
cutaneous / nasal ointment dosage form
cutaneous / transdermal
dabbing applicator device
dart device
dart dosing unit
delayed release mechanism of action
dental emulsion dosage form
dental solution dosage form
dental stick dosage form
dental suspension dosage form
denture lacquer dosage form
dialysis method of administration
dip emulsion dosage form
dip solution dosage form
dip suspension dosage form
dipping route of administration
dispersible tablet for dose dispenser
dispersion for concentrate for dispersion for infusion dosage form
dispersion for infusion dosage form
dispersion for injection dosage form
dispersion for injection / infusion dosage form
dose dispenser cartridge
dredging applicator device
dredging container
drench gun
dressing dosing unit
dropper with screw cap device
dropper container
ear drops emulsion dosage form
ear drops ,  powder for suspension dosage form
ear drops powder for suspension dosage form
ear drops solution dosage form
ear gel dosage form
ear drops suspension dosage form
ear drops ,  suspension in single - dose container
ear ointment dosage form
ear powder dosage form
ear spray emulsion dosage form
ear spray solution dosage form
ear spray suspension dosage form
ear stick dosage form
ear tag dosage form
ear tampon dosage form
ear wash emulsion dosage form
ear wash solution dosage form
ear / eye drops ,  solution dosage form
ear / eye drops ,  suspension dosage form
ear / eye ointment dosage form
ear / eye / nasal drops ,  solution dosage form
ear / nasal drops ,  suspension dosage form
effervescent granules plus film - coated tablet dosage form
effervescent granules for oral suspension
effervescent tablet plus film - coated tablet dosage form
effervescent vaginal tablet dosage form
emulsion and lyophilisate for suspension for injection dosage form
emulsion and suspension for emulsion for injection dosage form
emulsion for emulsion for injection dosage form
emulsion for infusion dosage form
emulsion for infusion in administration system
emulsion for injection / infusion dosage form
emulsion for injection / infusion in pre - filled syringe
emulsion for suspension for injection dosage form
endocervical
endocervical gel dosage form
endosinusial solution dosage form
endosinusial suspension wash dosage form
endotracheopulmonary instillation ,  powder and solvent for solution dosage form
endotracheopulmonary instillation ,  powder and solvent for suspension dosage form
endotracheopulmonary instillation ,  powder for solution dosage form
endotracheopulmonary instillation ,  powder for suspension dosage form
endotracheopulmonary instillation ,  solution dosage form
endotracheopulmonary instillation ,  suspension dosage form
environmental
epilesional solution dosage form
epilesional route of administration
extracorporeal
emulsion eye drops dosage form
eye drops ,  emulsion in single - dose container
intoplicine
eye drops ,  powder and solvent for solution dosage form
eye drops ,  powder and solvent for suspension dosage form
eye drops ,  powder for solution dosage form
eye drops ,  powder for suspension dosage form
eye drops ,  prolonged release dosage form
eye drops ,  prolonged - release solution in single - dose container
eye drops ,  solution in single - dose container
eye drops solvent for reconstitution dosage form
ophthalmic suspension drops dosage form
eye drops ,  suspension in single - dose container
eye gel in single - dose container
eye lotion dosage form
eye lotion solvent for reconstitution dosage form
eye ointment in single - dose container
film - coated tablet plus pessary dosage form
film - coated tablet plus tablet dosage form
film - coated tablet and gastro - resistant granules in sachet
fixed cryogenic vessel
foot - stab route of administration
gargle ,  powder for solution dosage form
gargle ,  tablet for solution dosage form
gargle / mouthwash dosage form
gargle / nasal wash dosage form
gargling method of administration
gas and solvent for dispersion for injection / infusion dosage form
gas for dispersion for infusion dosage form
gas for dispersion for injection dosage form
gas for dispersion for injection / infusion dosage form
gastrointestinal emulsion dosage form
gastroenteral solution dosage form
gastroenteral suspension dosage form
gastro - resistant capsule ,  hard dosage form
gastro - resistant capsule ,  soft dosage form
delayed release granule for oral suspension dosage form
gastro - resistant granules for oral suspension in sachet
gastro - resistant tablet plus rectal suspension dosage form
gel for gel dosage form
gel for injection dosage form
gel in pressurized container
gel in sachet
gingival gel dosage form
gingival paste dosage form
gingival solution dosage form
gingival route of administration
granule and solvent for oral suspension  dosage form
granule and solvent for suspension for injection dosage form
granules for oral solution dosage form
granules for oral solution in sachet
granule for oral suspension dosage form
granules for oral suspension in sachet
granule for oral / rectal suspension dosage form
granule for rectal suspension dosage form
granule for suspension for injection dosage form
granule for syrup dosage form
granule for use in drinking water dosage form
granules for vaginal solution dosage form
granules in sachet
granules in single - dose container
herbal material  ( unprocessed )  dosage form category
herbal tea dosage form
herbal tea in bag
implant in pre - filled syringe
implantation method of administration
implantation chain dosage form
implantation matrix dosage form
implantation paste dosage form
implantation suspension dosage form
implantation tablet dosage form
implanter device
impregnated dressing dosage form
impregnated material dosage form category
impregnated pad dosage form
impregnated plug dosage form
in drinking water use route of administration
in drinking water / milk use route of administration
in ovo route of administration
in - feed use route of administration
infusion method of administration
inhalation method of administration
inhalation powder ,  hard capsule dosage form
pre - dispensed inhalation powder dosage form
inhalation powder ,  tablet dosage form
inhalation vapor ,  capsule dosage form
effervescent tablet inhalation vapor
emulsion inhalation vapor dosage form
inhalation vapor from impregnated pad dosage form
inhalation vapor from impregnated plug dosage form
inhalation vapor ,  liquid dosage form
inhalation vapor ,  ointment dosage form
inhalation vapor ,  powder dosage form
inhalation vapor ,  solution dosage form
inhalation vapor ,  tablet dosage form
injection method of administration
in - ovo injection device
insertion method of administration
instant herbal tea dosage form
drop instillation method of administration
internal graduated calibration chamber
intestinal gel dosage form
intestinal route of administration
dotmp
intracerebroventricular route of administration
intracholangiopancreatic route of administration
intraglandular route of administration
intramammary
intramammary emulsion dosage form
intramammary gel dosage form
intramammary ointment dosage form
intramammary solution dosage form
intramammary suspension dosage form
intramammary syringe
intraocular instillation solution dosage form
intraportal route of administration
intraruminal device dosage form category
intrauterine capsule dosage form
intrauterine delivery system dosage form
intrauterine emulsion dosage form
intrauterine foam dosage form
intrauterine solution dosage form
intrauterine suspension dosage form
intrauterine tablet dosage form
intravesical solution dosage form
intravesical solution / solution for injection dosage form
intravesical suspension dosage form
intravesical / urethral
intravitreal implant in applicator
radiopharmaceutical preparation kit dosage form
lacquer dosage form category
laryngopharyngeal solution dosage form
laryngopharyngeal spray ,  solution dosage form
lick block dosage form
living tissue equivalent dosage form
lyophilisate dosing unit
lyophilisate and solvent for oculonasal suspension dosage form
lyophilisate and solvent for oral suspension dosage form
lyophilisate and solvent for solution for injection dosage form
lyophilisate and solvent for suspension for injection dosage form
lyophilisate and suspension for suspension for injection dosage form
lyophilisate for oculonasal suspension dosage form
lyophilisate for oculonasal suspension / use in drinking water dosage form
lyophilisate for oral spray ,  suspension dosage form
lyophilisate for oral suspension dosage form
lyophilisate for solution for infusion dosage form
lyophilisate for solution for injection dosage form
lyophilisate for suspension for injection dosage form
lyophilisate for use in drinking water dosage form
matrix dosing unit
matrix for implantation matrix dosage form
measuring spoon
oral gum dosage form
medicated collar dosage form
medicated nail lacquer dosage form
medicated pellets dosage form
medicated pendant dosage form
medicated plaster dosage form
medicated thread dosage form
medicated vaginal tampon dosage form
compressed medicinal gas dosage form
cryogenic medicinal gas dosage form
liquefied medicinal gas dosage form
metered actuation pump device
metered actuation valve device
mobile cryogenic vessel
modified - release mechanism of action
modified - release hard capsule form
modified - release soft capsule form
modified - release granule dosage form
modified - release granule for oral suspension
mouthpiece
mouthwash ,  powder for solution dosage form
mouthwash ,  tablet for solution dosage form
muco - adhesive buccal tablet dosage form
multidose container with airless pump
multidose container with metering pump
multidose container with pump
multipuncturer
nasal applicator device
emulsion nasal drops dosage form
nasal drops ,  lyophilisate and solvent for suspension dosage form
nasal drops ,  lyophilisate for suspension dosage form
nasal drops ,  powder and solvent for solution dosage form
nasal drops ,  powder for solution dosage form
nasal drops ,  solution in single - dose container
emulsion nasal spray dosage form
nasal spray ,  lyophilisate and solvent for suspension dosage form
nasal spray ,  lyophilisate for suspension dosage form
nasal spray ,  powder for solution dosage form
nasal spray ,  solution dosage form
nasal spray ,  solution in single - dose container
nasal spray ,  solution / oromucosal solution dosage form
nasal spray ,  suspension dosage form
nasal stick dosage form
nasal wash dosage form
nasal / oromucosal solution dosage form
nasal / oromucosal spray solution dosage form
nebulization solution dosage form
nebulizer route of administration
nebulizer emulsion dosage form
nebulizer solution dosage form
nebulizer suspension dosage form
needle - free injector
no transformation
unspecified method of administration
oculonasal
oculonasal suspension dosage form
ophthalmic insert dosage form
ophthalmic strip dosage form
oral applicator device
oral drops ,  emulsion dosage form
oral drops ,  granules for solution dosage form
oral drops ,  liquid dosage form
oral drops ,  powder for suspension dosage form
oral drops ,  solution dosage form
oral drops ,  suspension dosage form
oral emulsion dosage form
oral emulsion in sachet
oral herbal material dosage form
oral liquid dosage form
oral lyophilisate dosage form
oral paste in sachet
oral powder in sachet
oral solution in sachet
oral solution in single - dose container
oral solution / concentrate for nebulizer solution
oral spray ,  suspension dosage form
oral suspension in pre - filled oral applicator
oral suspension in sachet
oral syringe
oral / rectal solution dosage form
oral / rectal suspension dosage form
orally disintegrating film dosage form
oral disintegration method of administration
oromucosal
oromucosal capsule dosage form
oromucosal cream dosage form
oromucosal drops dosage form
oromucosal gel dosage form
oromucosal ointment dosage form
oromucosal paste dosage form
oromucosal patch dosage form
oromucosal powder in pouch dosage form
oromucosal solution dosage form
oromucosal spray ,  emulsion dosage form
oromucosal spray ,  solution dosage form
oromucosal spray ,  suspension dosage form
oromucosal suspension dosage form
oromucosal / laryngopharyngeal solution dosage form
pastille dosing unit
pen dosing unit
pendant dosing unit
periodontal gel dosage form
periodontal insert dosage form
periodontal powder dosage form
periosseous route of administration
peritumoral route of administration
pessary dosage form
pessary dosage unit
pillule dosage unit
pillule dosage form
pillules in single - dose container
pipette dosage unit
plaster dosing unit
plaster for provocation test dosage form
plug dosing unit
posterior juxtascleral route of administration
pouch dosage form
pour - on container
pour - on emulsion dosage form
pour - on solution dosage form
pour - on suspension dosage form
pour - on route of administration
powder and gel for gel dosage form
powder and solution for beehive dispersion dosage form
powder and solution for beehive solution dosage form
powder and solution for dental cement dosage form
powder and solution for solution for injection dosage form
powder and solvent for concentrate for solution for infusion dosage form
powder and solvent for topical solution dosage form
powder and solvent for dental gel dosage form
powder and solvent for emulsion for injection dosage form
powder and solvent for endocervical gel dosage form
powder and solvent for endosinusial solution dosage form
powder and solvent for epilesional solution dosage form
powder and solvent for gingival gel dosage form
powder and solvent for implantation paste dosage form
powder and solvent for intraocular instillation solution dosage form
powder and solvent for intravesical solution dosage form
powder and solvent for intravesical suspension dosage form
powder and solvent for nebulizer solution dosage form
powder and solvent for oral solution dosage form
powder and solvent for oral suspension dosage form
powder and solvent for prolonged - release suspension for injection dosage form
powder and solvent for prolonged - release suspension for injection in pre - filled pen
powder and solvent for prolonged - release suspension for injection in pre - filled syringe
powder and solvent for sealant dosage form
powder and solvent for solution for infusion dosage form
powder and solvent for solution for injection dosage form
powder and solvent for solution for injection in cartridge
powder and solvent for solution for injection in pre - filled pen
powder and solvent for solution for injection in pre - filled syringe
aldesleukin
powder and solvent for solution for injection / infusion dosage form
powder and solvent for solution for injection / skin - prick test dosage form
powder and solvent for suspension for injection dosage form
powder and solvent for suspension for injection in pre - filled syringe
powder and solvent for syrup dosage form
powder and suspension for suspension for injection dosage form
powder for beehive dispersion dosage form
powder for beehive solution dosage form
powder for bladder irrigation dosage form
powder for concentrate and solution for solution for infusion dosage form
powder for concentrate for dispersion for infusion dosage form
powder for concentrate for intravesical suspension dosage form
powder for concentrate for solution for hemodialysis dosage form
powder for concentrate for solution for infusion dosage form
powder for concentrate for solution for injection / infusion dosage form
powder for topical solution dosage form
powder for dental cement dosage form
powder for dental gel dosage form
powder for dental solution dosage form
powder for dip solution dosage form
powder for dispersion for infusion dosage form
powder for dispersion for injection dosage form
powder for emulsion for injection dosage form
powder for endocervical gel dosage form
powder for endosinusial solution dosage form
powder for epilesional solution dosage form
powder for gel dosage form
powder for gingival gel dosage form
powder for implantation matrix dosage form
powder for implantation paste dosage form
powder for implantation suspension dosage form
powder for intraocular instillation solution dosage form
powder for intravesical solution dosage form
powder for intravesical solution / solution for injection dosage form
powder for intravesical suspension dosage form
powder for nebulizer solution dosage form
powder for nebulizer suspension dosage form
powder for oral solution in sachet
powder for oral / rectal suspension dosage form
powder for oral / rectal suspension in sachet
powder for prolonged - release suspension for injection dosage form
powder for rectal solution dosage form
powder for rectal suspension dosage form
powder for sealant dosage form
powder for solution for fish treatment dosage form
powder for solution for infusion dosage form
powder for solution for injection / infusion dosage form
powder for solution for injection / skin - prick test dosage form
powder for solution for intraocular irrigation dosage form
powder for solution for iontophoresis dosage form
powder for solution for skin - prick test dosage form
powder for suspension for fish treatment dosage form
powder for syrup dosage form
powder for use in drinking water dosage form
powder for use in drinking water / milk dosage form
powder ,  dispersion and solvent for concentrate for dispersion for infusion dosage form
powder ,  solvent and matrix for implantation matrix dosage form
pre - filled gastroenteral tube
pre - filled injector
pre - filled oral applicator
pre - filled oral syringe
unspecified premix dosage form category
premix for medicated feeding stuff dosage form
pressurized container
pressurized inhalation emulsion dosage form
pressurized inhalation ,  solution dosage form
pressurized inhalation ,  suspension dosage form
prick test applicator
prolonged release mechanism of action
prolonged - release capsule ,  hard dosage form
prolonged - release capsule ,  soft dosage form
extended release granule for oral suspension
prolonged - release granules for oral suspension in sachet
prolonged - release granules in sachet
prolonged - release solution for injection dosage form
prolonged - release suspension for injection dosage form
prolonged - release suspension for injection in pre - filled syringe
pulsatile release intraruminal device dosage form
precursor radiopharmaceutical dosage form
precursor radiopharmaceutical solution dosage form
rectal capsule dosage form
rectal emulsion dosage form
rectal solution dosage form
rectal suspension dosage form
rectal tampon dosage form
rinsing / washing method of administration
roll - on container
sachet container
scarifier device
screw cap device
sealant dosage form
sealant matrix dosage form
sealant powder dosage form
semi - solid
single - dose container
skin scarification route of administration
solution and suspension for suspension for injection in pre - filled syringe
solution for beehive dispersion dosage form
lodenosine
solution for beehive solution dosage form
solution for beehive strip dosage form
solution for blood fraction modification
solution for cardioplegia dosage form
solution for cardioplegia / organ preservation dosage form
solution for dental cement dosage form
solution for hemodiafiltration dosage form
solution for hemodialysis dosage form
solution for hemodialysis / hemofiltration dosage form
solution for hemofiltration dosage form
solution for infusion dosage form
solution for infusion in administration system
solution for infusion in pre - filled syringe
solution for injection in administration system
solution for injection in cartridge
solution for injection in dose - dispenser cartridge
solution for injection in needle - free injector
solution for injection in pre - filled injector
solution for injection in pre - filled pen
solution for injection in pre - filled syringe
solution for injection / infusion dosage form
solution for injection / infusion in pre - filled syringe
solution for injection / skin - prick test dosage form
solution for intraocular irrigation dosage form
solution for iontophoresis dosage form
solution for organ preservation dosage form
solution for peritoneal dialysis dosage form
solution for provocation test dosage form
solution for sealant dosage form
solution for skin - prick test dosage form
solution for skin - scratch test dosage form
solution for solution for infusion dosage form
solution for solution for injection dosage form
solution for spray dosage form
solution for suspension for injection dosage form
solution for use in drinking water dosage form
solution for use in drinking water / milk dosage form
solvent for parenteral use dosage form
solvent for solution for infusion dosage form
solvent for solution for intraocular irrigation dosage form
solvent for  [ product name ]  dosage form
spatula device
spoonful dosing unit
spot - on applicator
spot - on emulsion dosage form
spot - on solution dosage form
spot - on suspension dosage form
spot - on route of administration
spray container
actuation spray valve device
spraying method of administration
stab vaccinator
stomach irrigation dosage form
straw
straw dosing unit
sublingual film dosage form
sublingual powder dosage form
sublingual spray ,  emulsion dosage form
sublingual spray ,  solution dosage form
sublingual spray ,  suspension dosage form
sucking method of administration
suspension and effervescent granules for oral suspension dosage form
suspension and solution for spray dosage form
injectable suspension for emulsion dosage form
suspension for injection in cartridge
suspension for injection in pre - filled injector
suspension for injection in pre - filled pen
suspension for injection in pre - filled syringe
suspension for oral suspension dosage form
suspension for suspension for injection dosage form
suspension for use in drinking water dosage form
swallowing method of administration
syrup in sachet
system dosing unit
tablet plus vaginal tablet dosage form
tablet and powder for oral solution dosage form
tablet and solvent for rectal suspension dosage form
tablet container
tablet for topical solution dosage form
tablet for rectal solution dosage form
tablet for rectal suspension dosage form
tablet for vaginal solution dosage form
tea dosage form category
teat dip emulsion dosage form
teat dip solution dosage form
teat dip suspension dosage form
teat dip / spray solution dosage form
teat spray solution dosage form
teat stick dosage form
teat route of administration
thread dosing unit
top - dressing route of administration
transdermal gel dosage form
transdermal ointment dosage form
transdermal patch dosage form
transdermal solution dosage form
transdermal spray ,  solution dosage form
transdermal system dosage form
penicillin antibiotic
unclear state of matter
unknown dosage form category
unknown release mechanism of action
unknown transformation
unknown / miscellaneous anatomical location
urethral emulsion dosage form
urethral stick dosage form
hard vaginal capsule dosage form
soft vaginal capsule dosage form
soft vaginal capsule plus vaginal cream dosage form
vaginal cream plus vaginal tablet dosage form
vaginal delivery system dosage form
vaginal emulsion dosage form
vaginal solution dosage form
vaginal sponge applicator
vaginal suspension dosage form
vessel dosing unit
water - borne use route of administration
wing - web - stab use route of administration
zinc finger protein 40
ube2o gene
ube2o wt allele
 ( e3 - independent )  e2 ubiquitin - conjugating enzyme
ceftolozane
nfkbiz gene
nfkbiz wt allele
thoracic esophagus adenocarcinoma
barrel container
thoracic esophagus squamous cell carcinoma
cervical esophagus adenocarcinoma
cervical esophagus squamous cell carcinoma
gastric cardia squamous cell carcinoma
dispersion activity
nf - kappa - b inhibitor zeta
distal esophagus squamous cell carcinoma
klhl42 gene
oromucosal / laryngopharyngeal solution / spray ,  solution dosage form
klhl42 wt allele
kelch - like protein 42
recurrent chronic leukemia
refractory chronic leukemia
parenting
physical function
decompensation
recurrent chronic myelomonocytic leukemia
refractory chronic myelomonocytic leukemia
overall comorbidity score
uggt2 gene
uggt2 wt allele
udp - glucose:glycoprotein glucosyltransferase 2
hla - dmb gene
hla - dmb wt allele
hla class ii histocompatibility antigen ,  dm beta chain
sel1l3 gene
sel1l3 wt allele
protein sel - 1 homolog 3
nfkbid gene
nfkbid wt allele
nf - kappa - b inhibitor delta
spata2 gene
spata2 wt allele
spermatogenesis - associated protein 2
ear drops ,  solution in single - dose container
tnip1 gene
nasal drops ,  solution dosage form
tnip1 wt allele
tnfaip3 - interacting protein 1
hla - dma gene
hla - dma wt allele
hla class ii histocompatibility antigen ,  dm alpha chain
powder and solvent for dispersion for injection dosage form
sla gene
sla wt allele
src - like - adapter
map4k1 gene
map4k1 wt allele
mitogen - activated protein kinase kinase kinase kinase 1
laptm5 gene
laptm5 wt allele
lysosomal - associated transmembrane protein 5
undecided
received all the services needed
satisfied with the care received
doctors seemed to communicate well about care
received high quality care from regular doctor
received high quality care from specialists
regular doctor was informed about the results of test
refractory ovarian carcinoma
refractory uterine corpus cancer
refractory endometrial carcinoma
recurrent endometrial carcinoma
recurrent ovarian endometrioid adenocarcinoma
refractory ovarian endometrioid adenocarcinoma
recurrent endometrial endometrioid adenocarcinoma
refractory endometrial endometrioid adenocarcinoma
psa level less than 0 .5
phenyl acetate
dgkz gene
dgkz wt allele
diacylglycerol kinase zeta
edqm - hc pharmaceutical dosage form terminology
edqm - hc combined pharmaceutical dose form terminology
edqm - hc combined term terminology
edqm - hc combined pack terminology
edqm - hc routes and methods of administration terminology
edqm - hc closure terminology
edqm - hc container terminology
edqm - hc administration device terminology
edqm - hc units of presentation terminology
edqm - hc administration method terminology
edqm - hc basic dose form terminology
edqm - hc intended site of administration terminology
edqm - hc release characteristics terminology
edqm - hc state of matter terminology
edqm - hc transformation terminology
prkcd gene
prkcd wt allele
protein kinase c delta type
radiation dosimeter device
high grade myeloid neoplasm
biomarker positive malignant neoplasm
egfr t790m mutation positive non - small cell lung carcinoma
thyroglobulin antibody negative
anti - bcma / pbd adc medi2228
tumor mutation burden
circulating protein
uveal melanoma metastatic in the liver
recurrent t acute lymphoblastic leukemia
recurrent monomorphic epitheliotropic intestinal t - cell lymphoma
recurrent t - cell prolymphocytic leukemia
splanchnic vein thrombosis
expanded cord blood stem cells mixed with engineered human endothelial cells ab - 110
intracervical route of administration
abbreviated breast mri protocol
unit - dose blister
clinically significant anxiety symptoms
clinically significant depressive symptoms
partial brain radiation therapy
balloon catheter shaft length
introducer sheath compatibility
catheter balloon diameter
catheter balloon length
balloon catheter nominal inflation pressure
deleterious atr gene mutation
deleterious fanca gene mutation
deleterious fancc gene mutation
deleterious fancd2 gene mutation
deleterious fance gene mutation
deleterious fancf gene mutation
deleterious fancm gene mutation
deleterious mre11 gene mutation
deleterious nbn gene mutation
deleterious rad50 gene mutation
actg1 gene
actg1 wt allele
balloon catheter nominal outer diameter
actin ,  cytoplasmic 2
balloon catheter tip length
balloon catheter rated burst pressure
adamts20 gene
adamts20 wt allele
atm kinase inhibitor azd1390
a disintegrin and metalloproteinase with thrombospondin motifs 20
ankrd24 gene
ankrd24 wt allele
ankyrin repeat domain - containing protein 24
arfgap3 gene
arfgap3 wt allele
adp - ribosylation factor gtpase - activating protein 3
prolaris prostate cancer testing
bod1l1 gene
bod1l1 wt allele
biorientation of chromosomes in cell division protein 1 - like 1
non - neoplastic optic nerve disorder
cacna1e gene
cacna1e wt allele
voltage - dependent r - type calcium channel subunit alpha - 1e
catheter length
guidewire compatibility
catheter working length
tip bend radius
nominal stent diameter
nominal stent length
tapered stent smaller diameter
cacna1s gene
tapered stent larger diameter
cacna1s wt allele
tapered stent length
maximum inflated stent diameter
voltage - dependent l - type calcium channel subunit alpha - 1s
atherectomy device tip length
advanced oropharyngeal squamous cell carcinoma
metastatic oropharyngeal squamous cell carcinoma
cdh20 gene
advanced oral cavity squamous cell carcinoma
cdh20 wt allele
metastatic oral cavity squamous cell carcinoma
advanced nasopharyngeal squamous cell carcinoma
cadherin - 20
metastatic nasopharyngeal squamous cell carcinoma
advanced hypopharyngeal squamous cell carcinoma
advanced laryngeal squamous cell carcinoma
metastatic hypopharyngeal squamous cell carcinoma
metastatic laryngeal squamous cell carcinoma
cmpk1 gene
cmpk1 wt allele
ape1 / ref - 1 redox inhibitor apx3330
ump - cmp kinase
dnah9 gene
dnah9 wt allele
dynein heavy chain 9 ,  axonemal
ephb6 gene
ephb6 wt allele
ephrin type - b receptor 6
catheter inner diameter
fga gene
fga wt allele
crossing profile
atherectomy cutter length
fibrinogen alpha chain
foxp4 gene
atherectomy cutter diameter
foxp4 wt allele
forkhead box protein p4
fzr1 gene
fzr1 wt allele
fizzy - related protein homolog
adgra2 gene
adgra2 wt allele
adhesion g protein - coupled receptor a2
atherectomy rotating component length
atherectomy rotating component diameter
hepatic perfusion imaging
perfusion
hepatic artery infusion pump
erk1 / 2 inhibitor asn007
gsn gene
spinocerebellar ataxia type 16
primary congenital glaucoma
gsn wt allele
gelsolin
local consolidation therapy
hcar1 gene
hcar1 wt allele
hydroxycarboxylic acid receptor 1
hnrnpk gene
hnrnpk wt allele
heterogeneous nuclear ribonucleoprotein k
ick gene
ick wt allele
serine / threonine - protein kinase ick
ing4 gene
ing4 wt allele
inhibitor of growth protein 4
itga10 gene
itga10 wt allele
integrin alpha - 10
itga9 gene
itga9 wt allele
integrin alpha - 9
adgrl3 gene
adgrl3 wt allele
adhesion g protein - coupled receptor l3
lyz gene
lyz wt allele
lysozyme c
mark1 gene
mark1 wt allele
high - risk neuroblastoma
serine / threonine - protein kinase mark1
nup93 gene
nup93 wt allele
nuclear pore complex protein nup93
refractory osteomedullary disease
pcdhac2 gene
pcdhac2 wt allele
protocadherin alpha - c2
pgap3 gene
pgap3 wt allele
post - gpi attachment to proteins factor 3
methylene blue oral rinse
pkd1l2 gene
pkd1l2 wt allele
polycystic kidney disease protein 1 - like 2
pkhd1 gene
pkhd1 wt allele
2' - deoxyadenosine
fibrocystin
plekhg5 gene
plekhg5 wt allele
pleckstrin homology domain - containing family g member 5
rnf2 gene
rnf2 wt allele
e3 ubiquitin - protein ligase ring2
rps6ka2 gene
rps6ka2 wt allele
ribosomal protein s6 kinase alpha - 2
grade 3 or 4 elevation of ast ,  alt ,  and / or bilirubin
ryr1 gene
ryr1 wt allele
ryanodine receptor 1
samd9 gene
samd9 wt allele
refractory bladder carcinoma
sterile alpha motif domain - containing protein 9
single - strand selective monofunctional uracil dna glycosylase
smug1 gene
smug1 wt allele
sp140 gene
sp140 wt allele
nuclear body protein sp140
stk36 gene
stk36 wt allele
serine / threonine - protein kinase 36
syne1 gene
syne1 wt allele
nesprin - 1
syt1 gene
syt1 wt allele
synaptotagmin - 1
taf1l gene
taf1l wt allele
transcription initiation factor tfiid subunit 1 - like
tbx22 gene
tbx22 wt allele
t - box transcription factor tbx22
tcf7l1 gene
tcf7l1 wt allele
transcription factor 7 - like 1
tgm7 gene
local skin heating
tgm7 wt allele
protein - glutamine gamma - glutamyltransferase z
umodl1 gene
umodl1 wt allele
uromodulin - like 1
vipr2 gene
vipr2 wt allele
vasoactive intestinal polypeptide receptor 2
zbtb7b gene
zbtb7b wt allele
zinc finger and btb domain - containing protein 7b
zswim4 gene
zswim4 wt allele
zinc finger swim domain - containing protein 4
oculus rift headset
bilateral synchronous sporadic renal cell carcinoma
pre - existing chronic kidney disease ,  stage 3
gastroduodenal artery
selective human estrogen - receptor alpha partial agonist ttc - 352
refractory urothelial carcinoma
platinum - resistant urothelial carcinoma
percent of prostate cores positive for carcinoma
hermansky - pudlak syndrome 1
hermansky - pudlak syndrome 2
hermansky - pudlak syndrome 6
cavernous nerve electrical stimulation
guidewire length
guidewire diameter
imaging agent qrh - 882260 heptapeptide
a - 101 topical solution
licogliflozin
ep4 antagonist ono - 4578
autologous anti - cd19 car - t cells tbi - 1501
autologous anti - cd19 car tcr - zeta / 4 - 1bb - transduced t lymphocytes bind19
candida albicans antigen injection
east indian sandalwood oil cream
cmv / ebv / adv / bkv - specific cytotoxic t lymphocytes
autologous anti - claudin18 .2 - transduced t lymphocytes
fgfr1 / 2 / 3 inhibitor hmpl - 453
vandetanib - eluting radiopaque bead btg - 002814
ecological momentary assessment
basic dosage form category
robot - assisted laparoscopic partial nephrectomy
irdye800cw - labeled heptapeptide ksp - 910638g
cxcr1 / 2 inhibitor sx - 682
guselkumab
fluorine f 18 integrin alpha v beta 6 - targeted peptide
indoximod prodrug nlg802
fibrinous material present
small aggregates of tumor cells present
fibrin - associated diffuse large b - cell lymphoma
gallium ga 68 - nota - rm26
hydrocortisone sodium succinate / aluminum phosphate gel
hhv8 - related lymphoproliferative disorder
recombinant epidermal growth factor
oral pancreatic cancer vaccine v3 - p
ssrna - based immunomodulator cv8102
lactobacillus rhamnosus / lactobacillus reuteri probiotic supplement
anti - lag3 monoclonal antibody bi 754111
hhv8 - positive multicentric castleman disease
hhv8 - positive germinotropic lymphoproliferative disorder
extracavitary primary effusion lymphoma
body cavity primary effusion lymphoma
cldn18 gene
cldn18 wt allele
cldn18 gene product
claudin - 18
claudin - 18 isoform a2
telaglenastat hydrochloride
parenteral
million tissue culture infectious dose 50%
ten million tissue culture infectious dose 50%
hundred million tissue culture infectious dose 50%
fluorine f 18 dasa - 23
bluetooth - enabled activity monitor
robotic uterine manipulator
neoplastic plasma cells under 5 percent of bone marrow nucleated cells
deep inspiration breath hold
paired - end sequencing
non - myeloablative tcr alpha / beta - depleted haploidentical hematopoietic stem cell transplantation
hmb45 - positive cells present
second - strand library sequencing
unstranded library sequencing
first - strand library sequencing
copper cu - 64 - dota - alendronate
deoxycytidine analogue tas - 109 hydrochloride
9p21 loss of heterozygosity
abl2 gene mutation
cd79a gene mutation
activating cd79a gene mutation
activating cd79b gene mutation
activating eml4 / alk gene mutation
ntrk family gene mutation
activating ntrk family fusion gene mutation
activating ntrk family point mutation
acvr1b gene mutation
akt1 gene rearrangement
akt3 gene mutation
alkati allele
alk gene product
alkati protein
alkati positive
atm deficient tumor
bap1 loss of function gene mutation
bap1 loss of function mutation positive
bcl6 overexpression positive
bence jones protein present
blasts 20 - 30 percent of peripheral blood white cells
blasts 30 percent or more of bone marrow nucleated cells
blasts 5 percent or less of peripheral blood white cells
blasts 5 - 19 percent of bone marrow nucleated cells
blasts less than or equal to 10000 / mm3
blasts more than 10 percent of bone marrow nucleated cells
blasts more than 10 percent of peripheral blood white cells
blasts more than 10000 of peripheral blood white cells
blasts more than 20 percent of bone marrow nucleated cells
blasts more than 20 percent of peripheral blood white cells
blasts more than 60 percent of peripheral blood white cells
anti - pd1 / ctla4 bispecific antibody xmab20717
ccnd1 splice variant positive
cd28 positive
cd34 negative
lutetium lu - 177 psma - r2
spn positive
cd7 positive
hla - a*02:642 positive cells present
personalized synthetic long peptide vaccine
cd86 positive
cdh1 gene mutation
cdk4 gene mutation
cdkn1a gene mutation
cdkn1b gene mutation
chd4 gene mutation
chromosome 5 rearrangement
chromosome 7 rearrangement
salty
bitter
sour
cord blood - derived expanded allogeneic natural killer cells
umami
egfrviii positive
high cpg island methylator phenotype
clostridium difficile toxin positive
severe mosquito bite allergy
cox2 positive
crlf2 gene mutation
crp level greater than or equal to 3 mg / l
cxcr4 gene mutation
cyld gene mutation
intestinal t - cell lymphoma
deleterious ikzf1 gene mutation
dnmt3a gene mutation
dpyd negative
epstein - barr virus antibody positive
dietary supplement
deleterious egfr gene mutation
egfr negative
ep300 gene mutation
estrogen receptor positive by immunohistochemistry 1 - 9 percent
small intestinal monomorphic epitheliotropic t - cell lymphoma
intestinal t - cell lymphoma ,  not otherwise specified
smac mimetic bi 891065
polymer - encapsulated luteolin nanoparticle
autologous bcma / taci - targeted car t cells auto2
refractory t acute lymphoblastic leukemia
allogeneic t - lymphocytes expressing ny - eso - 1 - c259 - specific tcr
metastatic urethral urothelial carcinoma
metastatic bladder urothelial carcinoma
metastatic renal pelvis urothelial carcinoma
metastatic ureter urothelial carcinoma
recurrent ureter urothelial carcinoma
ad5  [ e1 -  ,  e2b -  ]  - her2 / neu vaccine etbx - 021
autologous anti - egfrviii 4scar - igt cells
recurrent renal pelvis urothelial carcinoma
dna damage response gene mutation
unresectable urothelial carcinoma
proton beam craniospinal irradiation
physical performance testing
recurrent malignant bone neoplasm
refractory malignant bone neoplasm
recurrent malignant female reproductive system neoplasm
refractory malignant female reproductive system neoplasm
recurrent malignant neoplasm of multiple primary sites
refractory malignant neoplasm of multiple primary sites
refractory malignant oral neoplasm
recurrent malignant pharyngeal neoplasm
refractory malignant pharyngeal neoplasm
recurrent malignant male reproductive system neoplasm
refractory malignant male reproductive system neoplasm
refractory malignant mesothelioma
recurrent malignant soft tissue neoplasm
refractory malignant soft tissue neoplasm
recurrent malignant thyroid gland neoplasm
refractory malignant thyroid gland neoplasm
recurrent malignant endocrine neoplasm
refractory malignant endocrine neoplasm
recurrent malignant urinary system neoplasm
refractory malignant urinary system neoplasm
refractory cutaneous melanoma
recurrent malignant skin neoplasm
refractory malignant skin neoplasm
ann arbor stage ie
ann arbor stage iie
ann arbor stage iiie
ann arbor stage iiis
ann arbor stage iiie and iiis
serd g1t48
allogeneic most closely hla - matched adenovirus - specific cytotoxic t lymphocytes
f3 positive
schuurs - hoeijmakers syndrome
autosomal recessive osteopetrosis 8
prostate adenocarcinoma without neuroendocrine differentiation
anti - cd40 agonist monoclonal antibody cdx - 1140
avatrombopag
anti - tim - 3 monoclonal antibody sym023
incomplete response / stable disease
cd2 - positive neoplastic cells present
b - cell markers negative
myeloid markers negative
igm monoclonal gammopathy of undetermined significance
serum igm monoclonal gammopathy of less than 30g / l
bone marrow lymphoplasmacytic infiltration of less than 10%
radial probe endobronchial ultrasound
infiltrating bladder carcinoma
muscle invasion
bladder carcinoma infiltrating the muscle of the bladder wall
non - metastatic cerebral neoplasm
thoracic epidural analgesia
advanced magnetic resonance imaging
four quadrants transverse abdominis plane block
metastatic gastroesophageal junction adenocarcinoma
unresectable gastroesophageal junction adenocarcinoma
recurrent myxoid liposarcoma
unresectable adrenal cortex carcinoma
refractory lung small cell carcinoma
palb2 biallelic inactivation
fanca biallelic inactivation
atm monoallelic inactivation
tam / c - met inhibitor rxdx - 106
car t - cells amg 119
complete remission with incomplete hematological recovery
non - igm monoclonal gammopathy of undetermined significance
testicular follicular lymphoma
serclutamab talirine
recurrent dedifferentiated liposarcoma
refractory dedifferentiated liposarcoma
refractory liposarcoma
metastatic renal cell carcinoma
hepatic steatosis
metastatic malignant neoplasm in the viscera
unresectable dedifferentiated liposarcoma
mecom positive
opioid
citrullinemia type i
resectable malignant neoplasm
citrullinemia type ii
resectable carcinoma
resectable sarcoma
resectable liposarcoma
resectable dedifferentiated liposarcoma
minicore myopathy with external ophthalmoplegia
charcot - marie - tooth disease type 2a1
unresectable undifferentiated pleomorphic sarcoma
resectable undifferentiated pleomorphic sarcoma
fgf19 gene amplification
fgfr family alteration negative
fgfr1 gene alteration positive
fgfr1 gene translocation
fgfr2 fusion positive
fgfr2 gene alteration positive
fgfr3 gene alteration positive
fgfr3 gene translocation
resectable neuroblastoma
fgfr4 alteration positive
unresectable neuroblastoma
activating flt3 gene mutation
flt3 gene amplification
flt3 internal tandem duplication negative
flt3 internal tandem duplication positive
foxo1 fusion positive
gata3 gene mutation
germline brca1 gene mutation
germline brca2 gene mutation
human anti - chimeric antibody positive
erbb2 exon 20 mutation
erbb2 exon 20 insertion mutation
erbb2 overexpression
erbb3 positive
clostridium difficile measurement
hgf gene mutation
clostridium difficile 027 / nap1 / bi measurement
hla - a*0201 negative
homologous recombination repair biallelic inactivation
hoxa10 positive
hoxa9 positive
igf1r negative
smarcb1 negative
charcot - marie - tooth disease type 2a2b
isg15 positive
kdm6a gene mutation
kir ligand negative
kmt2d gene mutation
krt5 gene mutation
krt72 gene mutation
gnrhr positive
surface immunoglobulin - positive cells present
lymphoblasts with surface immunoglobulin present
endoscopy under anesthesia
alcoholism counseling
preanesthetic evaluation
laryngopharyngectomy
total laryngopharyngectomy
partial laryngopharyngectomy
orthopantomogram
videostroboscopy
col6a3 gene
col6a3 wt allele
collagen alpha - 3 ( vi )  chain
col6a3 positive
chemically - induced menopause
autologous anti - cd19 car - cd3zeta - 4 - 1bb - expressing t - cells
immunodeficiency - associated lymphoproliferative disorder
lymphoproliferative disease associated with primary immune disorder
autologous gpc3 / ny - eso - 1 / afp specific cd8 - positive t - lymphocytes
anti - cd26 monoclonal antibody ys110
methotrexate - associated lymphoma
anti - ctla - 4 monoclonal antibody mk - 1308
mek inhibitor shr 7390
magea12 positive
autologous mesothelin - specific car - t - cells expressing anti - pd - 1 / ctla - 4 antibodies
magi2 gene mutation
other iatrogenic immunodeficiency - associated lymphoproliferative disorders
map3k1 gene mutation
carboplatin / cetuximab / fluorouracil regimen
carboplatin / cetuximab regimen
medical evaluation of speech ,  language ,  and hearing problems
med12 gene mutation
carboplatin / cetuximab / docetaxel regimen
cetuximab / cisplatin / fluorouracil regimen
tumors derived from langerhans cells
cisplatin / paclitaxel / cetuximab regimen
mpo positive
autologous egfr - specific car - t - cells expressing anti - pd - 1 / ctla - 4 antibodies
autologous ovarian cancer immunogene - modified t lymphocytes
autologous tumor - specific antigen - loaded dendritic cells
autologous fra - 4scar - expressing t - cells 4scar - fra
autologous psma - 4scar - expressing t - cells 4scar - psma
prazosin hydrochloride
encochleated amphotericin b
langerhans cell histiocytosis ,  monostotic
langerhans cell histiocytosis ,  polyostotic
langerhans cell histiocytosis ,  disseminated
ebv - positive inflammatory follicular dendritic cell sarcoma of the digestive system
mtor gene rearrangement
muc1 positive
cetuximab / cisplatin / docetaxel regimen
xk gene mutation
neoplastic plasma cells 20 percent or less of bone marrow nucleated cells
neoplastic plasma cells 60 percent or more of bone marrow nucleated cells
neoplastic plasma cells 10 - 60 percent of bone marrow nucleated cells
nf1 gene rearrangement
nf1 positive
nf2 gene rearrangement
mutation - positive lynch syndrome
mutation - negative lynch syndrome
panobinostat nanoparticle formulation mtx110
tissue procurement
engaged
single
widow
widowed or surviving civil partner
widower
bachelor
broken engagement
broken with partner
cohabitee left home
spouse left home
husband left home
wife left home
cohabitating
anti - lag - 3 / pd - l1 bispecific antibody fs118
common law partnership
civil partnership dissolved
metastatic gastrointestinal stromal tumor
locally advanced gastrointestinal stromal tumor
unresectable gastrointestinal stromal tumor
marital or civil status not disclosed
married or civil partner
monogamous
newly wed
purposely unmarried and sexually abstinent
remarried
separated from cohabitee
spinster
trial separation
venlafaxine hydrochloride extended release
home health encounter
inpatient encounter
inpatient acute care encounter
inpatient non - acute care encounter
sirpa - igg4 - fc fusion protein tti - 622
pre - admission encounter
short stay
virtual patient encounter
emergency department admit to inpatient hospital stay
observation stay
institutional professional consultation
general medical unit
oncology unit
cdisc functional test cowat test name terminology
cdisc functional test cowat test code terminology
cdisc functional test ert test name terminology
cdisc functional test ert test code terminology
cdisc functional test mmse - 2 standard version test name terminology
cdisc functional test mmse - 2 standard version test code terminology
cdisc functional test paced tapping test name terminology
cdisc functional test paced tapping test code terminology
cdisc questionnaire fact - c version 4 test name terminology
cdisc questionnaire fact - c version 4 test code terminology
cdisc questionnaire fact - taxane version 4 test name terminology
cdisc questionnaire fact - taxane version 4 test code terminology
cdisc questionnaire fact - brm version 4 test name terminology
cdisc questionnaire fact - brm version 4 test code terminology
cdisc questionnaire fact / gog - ntx version 4 test name terminology
cdisc questionnaire fact / gog - ntx version 4 test code terminology
cdisc questionnaire fact - l version 4 test name terminology
cdisc questionnaire fact - l version 4 test code terminology
cdisc questionnaire fksi - drs version 4 test name terminology
cdisc questionnaire fksi - drs version 4 test code terminology
cdisc questionnaire nccn - fact fbrsi - 24 version 2 test name terminology
cdisc questionnaire nccn - fact fbrsi - 24 version 2 test code terminology
cdisc questionnaire nccn - fact fhnsi - 22 version 2 test name terminology
cdisc questionnaire nccn - fact fhnsi - 22 version 2 test code terminology
cdisc questionnaire siq test name terminology
cdisc questionnaire siq test code terminology
cdisc questionnaire siq - jr test name terminology
cdisc questionnaire siq - jr test code terminology
cowat functional test question
mmse - 2 standard version functional test question
ert functional test question
paced tapping functional test question
fact - c version 4 questionnaire question
fact - taxane version 4 questionnaire question
fact - brm version 4 questionnaire question
retrotransposon
fact / gog - ntx version 4 questionnaire question
fact - l version 4 questionnaire question
fksi - drs version 4 questionnaire question
nccn - fact fbrsi - 24 version 2 questionnaire question
nccn - fact fhnsi - 22 version 2 questionnaire question
siq questionnaire question
siq - jr questionnaire question
gemcitabine - releasing intravesical system
magnetic resonance - guided radiotherapy
synthetic long hpv16 e6 / e7 peptides vaccine isa101b
cdisc send null flavor reason terminology
cdisc sdtm other disposition event response terminology
cdisc sdtm cdad findings about test code terminology
cdisc sdtm cdad findings about test name terminology
albumin excretion rate
calcium excretion rate
chloride excretion rate
creatinine excretion rate
glucose excretion rate
iron excretion rate
potassium excretion rate
phosphorus excretion rate
protein excretion rate
sodium excretion rate
non - protocol disposition event
brd4 gene mutation
dose rate reduced
number of occurrences
cycloserine - cefoxitin fructose agar
chromogenic selective medium
mononucleotide marker name
pentanucleotide marker name
software name
6 beta - hydroxycortisol measurement
abnormal cells to leukocytes ratio measurement
abnormal cells to total cells ratio measurement
blasts to total cells ratio measurement
c - peptide to creatinine ratio measurement
cylindroid cast measurement
dysmorphic erythrocytes to erythrocytes ratio measurement
eosinophils to nucleated cells ratio measurement
nucleated cell count
free estradiol measurement
free estradiol to estradiol ratio measurement
glitter cell count
guanine deaminase measurement
protein induced by vitamin k absence - ii measurement
estimated creatinine clearance
hand digit 1 proximal phalanx
brachioradialis muscle
flexor digitorum superficialis muscle
flexor pollicis longus muscle
lumbrical muscle
opponens pollicis muscle
pronator quadratus muscle
skin of the buttock
skin of the thigh
c . difficile glutamate dehydrogenase measurement
clostridium difficile a and / or b toxin measurement
clostridium difficile tcda dna measurement
clostridium difficile tcdb dna measurement
clostridium difficile tcdc dna measurement
toxigenic clostridium difficile measurement
clostridium difficile a toxin measurement
clostridium difficile b toxin measurement
toxin b - producing clostridium difficile measurement
clostridium difficile cdt dna measurement
adjudicator 1
adjudicator 2
adjudicator 3
cardiac output thermodilution method
electrogastrography
microdensitometry
quantitative ultrasound
single energy x - ray absorptiometry
ballpoint pen technique
cell based bioassay
aspergillus niveus
staphylococcus capitis subspecies urealyticus
carbapenem resistant acinetobacter
mycobacterium malmoense
mycobacterium xenopi
mycobacterium abscessus subspecies massiliense
mycobacterium abscessus subspecies bolletii
subject met eligibility criteria but was not needed
sitting with legs dependent
child relation
biological daughter
biological son
microdialysis route of administration
abscess fluid
alveolar air
cervicovaginal secretion
serum or plasma supernatant
cerebrospinal fluid supernatant
swabbed material
overall tracer uptake compared to nadir
organ of interest
millimeters of aluminum equivalents
seconds per hour
neuroprotective agent
hybrid resistance units
event unit
unencoded data
temporarily unavailable
masked data
draining lymph node
autologous cd19 - cd8 - cd28 - cd3zeta - car - mbil15 - her1t t cells
dot1l gene mutation
ikbke gene mutation
emotion recognition test functional test
mini - mental state examination 2 standard version functional test
paced tapping test functional test
functional assessment of cancer therapy - colorectal version 4 questionnaire
functional assessment of cancer therapy - taxane version 4 questionnaire
functional assessment of cancer therapy - biologic response modifiers version 4 questionnaire
functional assessment of cancer therapy / gynecologic oncology group - neurotoxicity version 4 questionnaire
functional assessment of cancer therapy - lung version 4 questionnaire
functional assessment of cancer therapy - kidney symptom index - disease - related symptoms version 4 questionnaire
national comprehensive cancer network / functional assessment of cancer therapy - brain symptom index - 24 version 2 questionnaire
national comprehensive cancer network / functional assessment of cancer therapy - head & neck symptom index - 22 version 2 questionnaire
suicidal ideation questionnaire
suicidal ideation questionnaire - junior
cowat  -  another word that begins with r
cowat  -  number correct words: c
cowat  -  number correct words: f
cowat  -  number correct words: l
ert  -  total stimuli expected
ert  -  total stimuli administered
ert  -  total stimuli completed
ert  -  total stimuli response correct
ert  -  total stimuli response incorrect
ert  -  total stimuli not responded
ert  -  total negative stimuli expected
ert  -  total negative stimuli administered
ert  -  total negative stimuli completed
ert  -  total negative stimuli correct
ert  -  total negative stimuli incorrect
ert  -  total negative stimuli not respond
ert  -  number stimuli portraying anger
ert  -  anger responded as anger
ert  -  anger responded as disgust
ert  -  anger responded as fear
ert  -  anger responded as happiness
ert  -  anger responded as neutral
ert  -  anger responded as sadness
ert  -  anger responded as surprise
ert  -  number stimuli portraying disgust
ert  -  disgust responded as anger
ert  -  disgust responded as disgust
ert  -  disgust responded as fear
ert  -  disgust responded as happiness
ert  -  disgust responded as neutral
ert  -  disgust responded as sadness
ert  -  disgust responded as surprise
ert  -  number stimuli portraying fear
ert  -  fear responded as anger
ert  -  fear responded as disgust
ert  -  fear responded as fear
ert  -  fear responded as happiness
ert  -  fear responded as neutral
ert  -  fear responded as sadness
ert  -  fear responded as surprise
ert  -  number stimuli portraying happiness
ert  -  happiness responded as anger
ert  -  happiness responded as disgust
ert  -  happiness responded as fear
ert  -  happiness responded as happiness
ert  -  happiness responded as neutral
ert  -  happiness responded as sadness
ert  -  happiness responded as surprise
ert  -  number stimuli portraying neutral
ert  -  neutral responded as anger
ert  -  neutral responded as disgust
ert  -  neutral responded as fear
ert  -  neutral responded as happiness
ert  -  neutral responded as neutral
ert  -  neutral responded as sadness
ert  -  neutral responded as surprise
ert  -  number stimuli portraying sadness
ert  -  sadness responded as anger
ert  -  sadness responded as disgust
ert  -  sadness responded as fear
ert  -  sadness responded as happiness
ert  -  sadness responded as neutral
ert  -  sadness responded as sadness
ert  -  sadness responded as surprise
ert  -  number stimuli portraying surprise
ert  -  surprise responded as anger
ert  -  surprise responded as disgust
ert  -  surprise responded as fear
ert  -  surprise responded as happiness
ert  -  surprise responded as neutral
ert  -  surprise responded as sadness
ert  -  surprise responded as surprise
mmse - 2 standard version  -  repeat word 1
mmse - 2 standard version  -  repeat word 2
mmse - 2 standard version  -  repeat word 3
mmse - 2 standard version  -  what is the year
mmse - 2 standard version  -  what is the season
mmse - 2 standard version  -  what is the month of year
dna adduct
mmse - 2 standard version  -  what is the day of week
mmse - 2 standard version  -  what is the date
mmse - 2 standard version  -  what is the state
mmse - 2 standard version  -  what is the county
mmse - 2 standard version  -  what is the city / town
mmse - 2 standard version  -  what is the building
mmse - 2 standard version  -  what is the floor
mmse - 2 standard version  -  recall word 1
mmse - 2 standard version  -  recall word 2
mmse - 2 standard version  -  recall word 3
mmse - 2 standard version  -  what is 100 take away 7
mmse - 2 standard version  -  keep subtracting 7 step 2
mmse - 2 standard version  -  keep subtracting 7 step 3
mmse - 2 standard version  -  keep subtracting 7 step 4
mmse - 2 standard version  -  keep subtracting 7 step 5
mmse - 2 standard version  -  naming object 1
mmse - 2 standard version  -  naming object 2
mmse - 2 standard version  -  repeat what i say
mmse - 2 standard version  -  point to the circle
mmse - 2 standard version  -  point to the square
mmse - 2 standard version  -  point to the triangle
mmse - 2 standard version  -  do what this says to do
mmse - 2 standard version  -  write a sentence
mmse - 2 standard version  -  copy this design
mmse - 2 standard version  -  bv total raw score
mmse - 2 standard version  -  sv total raw score
mmse - 2 standard version  -  level of consciousness
paced tapping  -  total trials expected
paced tapping  -  total trials administered
paced tapping  -  total trials completed
paced tapping  -  total interval tone admin all
paced tapping  -  total interval tone trim all
paced tapping  -  minimum interval tone all
paced tapping  -  maximum interval tone all
paced tapping  -  mean interval tone all
paced tapping  -  median interval tone all
paced tapping  -  variance interval tone all
paced tapping  -  deviation interval tone all
paced tapping  -  reciprocal interval tone all
paced tapping  -  avg sign dev interval tone all
paced tapping  -  total interval self admin all
paced tapping  -  total interval self trim all
paced tapping  -  minimum interval self all
paced tapping  -  maximum interval self all
paced tapping  -  mean interval self all
paced tapping  -  median interval self all
paced tapping  -  variance interval self all
paced tapping  -  deviation interval self all
paced tapping  -  reciprocal interval self all
paced tapping  -  avg sign dev interval self all
paced tapping  -  trials expected in trial
paced tapping  -  trials administered in trial
paced tapping  -  trials completed in trial
paced tapping  -  num intervals expected tone trial
paced tapping  -  num intervals trim tone trial
paced tapping  -  minimum interval tone trial
paced tapping  -  maximum interval tone trial
paced tapping  -  mean interval tone trial
paced tapping  -  median interval tone trial
paced tapping  -  variance interval tone trial
paced tapping  -  deviation interval tone trial
paced tapping  -  reciprocal interval tonetrial
paced tapping  -  avg sign dev interval tone trial
paced tapping  -  num intervals expected self trial
paced tapping  -  num intervals trim self trial
paced tapping  -  minimum interval self trial
paced tapping  -  maximum interval self trial
paced tapping  -  mean interval self trial
paced tapping  -  median interval self trial
paced tapping  -  variance interval self trial
paced tapping  -  deviation interval self trial
paced tapping  -  reciprocal interval self trial
paced tapping  -  avg sign dev interval self trial
rising from floor  -  wear orthoses
t25fw  -  did patient wear afo
t25fw  -  was assistive device used
fact - c version 4  -  i have a lack of energy
fact - c version 4  -  i have nausea
fact - c version 4  -  trouble meeting needs of family
fact - c version 4  -  i have pain
fact - c version 4  -  bothered by treatment side effect
fact - c version 4  -  i feel ill
fact - c version 4  -  i am forced to spend time in bed
fact - c version 4  -  i feel close to my friends
fact - c version 4  -  get emotional support from family
fact - c version 4  -  i get support from my friends
fact - c version 4  -  my family has accepted my illness
fact - c version 4  -  satisfied communication illness
fact - c version 4  -  i feel close to my partner
fact - c version 4  -  i am satisfied with my sex life
fact - c version 4  -  i feel sad
fact - c version 4  -  satisfied with how i am coping
fact - c version 4  -  losing hope against illness
fact - c version 4  -  i feel nervous
fact - c version 4  -  i worry about dying
fact - c version 4  -  worry my condition will get worse
fact - c version 4  -  i am able to work
fact - c version 4  -  my work is fulfilling
fact - c version 4  -  i am able to enjoy life
fact - c version 4  -  i have accepted my illness
radioimmunoconjugate
fact - c version 4  -  i am sleeping well
fact - c version 4  -  enjoy things i usually do for fun
fact - c version 4  -  content with quality of my life
fact - c version 4  -  swelling / cramps in stomach area
fact - c version 4  -  i am losing weight
fact - c version 4  -  i have control of my bowels
fact - c version 4  -  i can digest my food well
fact - c version 4  -  i have diarrhea
fact - c version 4  -  i have a good appetite
fact - c version 4  -  i like the appearance of my body
fact - c version 4  -  do you have an ostomy appliance
fact - c version 4  -  embarrassed by ostomy appliance
fact - c version 4  -  caring for ostomy is difficult
fact - taxane version 4  -  i have a lack of energy
fact - taxane version 4  -  i have nausea
fact - taxane version 4  -  trouble meeting needs of family
fact - taxane version 4  -  i have pain
fact - taxane version 4  -  bothered by treatment side effect
fact - taxane version 4  -  i feel ill
fact - taxane version 4  -  i am forced to spend time in bed
fact - taxane version 4  -  i feel close to my friends
fact - taxane version 4  -  get emotional support from family
fact - taxane version 4  -  i get support from my friends
fact - taxane version 4  -  my family has accepted my illness
fact - taxane version 4  -  satisfied communication illness
fact - taxane version 4  -  i feel close to my partner
fact - taxane version 4  -  i am satisfied with my sex life
fact - taxane version 4  -  i feel sad
fact - taxane version 4  -  satisfied with how i am coping
fact - taxane version 4  -  losing hope against illness
fact - taxane version 4  -  i feel nervous
fact - taxane version 4  -  i worry about dying
fact - taxane version 4  -  worry my condition will get worse
fact - taxane version 4  -  i am able to work
fact - taxane version 4  -  my work is fulfilling
fact - taxane version 4  -  i am able to enjoy life
fact - taxane version 4  -  i have accepted my illness
fact - taxane version 4  -  i am sleeping well
fact - taxane version 4  -  enjoy things i usually do for fun
fact - taxane version 4  -  content with quality of my life
fact - taxane version 4  -  numbness or tingling in my hands
fact - taxane version 4  -  numbness or tingling in my feet
fact - taxane version 4  -  i feel discomfort in my hands
fact - taxane version 4  -  i feel discomfort in my feet
fact - taxane version 4  -  have joint pain or muscle cramps
fact - taxane version 4  -  i feel weak all over
fact - taxane version 4  -  i have trouble hearing
fact - taxane version 4  -  get ringing or buzzing in my ears
fact - taxane version 4  -  i have trouble buttoning buttons
fact - taxane version 4  -  trouble feeling shape of objects
fact - taxane version 4  -  i have trouble walking
fact - taxane version 4  -  i feel bloated
fact - taxane version 4  -  my hands are swollen
fact - taxane version 4  -  my legs or feet are swollen
fact - taxane version 4  -  i have pain in my fingertips
fact - taxane version 4  -  bothered by my hands / nails look
fact - brm version 4  -  i have a lack of energy
fact - brm version 4  -  i have nausea
fact - brm version 4  -  trouble meeting needs of family
fact - brm version 4  -  i have pain
fact - brm version 4  -  bothered by treatment side effect
fact - brm version 4  -  i feel ill
fact - brm version 4  -  i am forced to spend time in bed
fact - brm version 4  -  i feel close to my friends
fact - brm version 4  -  get emotional support from family
fact - brm version 4  -  i get support from my friends
fact - brm version 4  -  my family has accepted my illness
fact - brm version 4  -  satisfied communication illness
fact - brm version 4  -  i feel close to my partner
fact - brm version 4  -  i am satisfied with my sex life
fact - brm version 4  -  i feel sad
fact - brm version 4  -  satisfied with how i am coping
fact - brm version 4  -  losing hope against illness
fact - brm version 4  -  i feel nervous
fact - brm version 4  -  i worry about dying
fact - brm version 4  -  worry my condition will get worse
fact - brm version 4  -  i am able to work
fact - brm version 4  -  my work is fulfilling
fact - brm version 4  -  i am able to enjoy life
fact - brm version 4  -  i have accepted my illness
fact - brm version 4  -  i am sleeping well
fact - brm version 4  -  enjoy things i usually do for fun
fact - brm version 4  -  content with quality of my life
fact - brm version 4  -  i get tired easily
fact - brm version 4  -  i feel weak all over
fact - brm version 4  -  i have a good appetite
fact - brm version 4  -  i have pain in my joints
fact - brm version 4  -  i am bothered by the chills
fact - brm version 4  -  i am bothered by fevers
fact - brm version 4  -  i am bothered by sweating
fact - brm version 4  -  i have trouble concentrating
fact - brm version 4  -  i have trouble remembering things
fact - brm version 4  -  i get depressed easily
fact - brm version 4  -  i get annoyed easily
fact - brm version 4  -  i have emotional ups and downs
fact - brm version 4  -  i feel motivated to do things
fact / gog - ntx version 4  -  i have a lack of energy
fact / gog - ntx version 4  -  i have nausea
fact / gog - ntx version 4  -  trouble meeting needs of family
fact / gog - ntx version 4  -  i have pain
immunoconjugate
fact / gog - ntx version 4  -  bothered by treatment side effect
fact / gog - ntx version 4  -  i feel ill
fact / gog - ntx version 4  -  i am forced to spend time in bed
fact / gog - ntx version 4  -  i feel close to my friends
fact / gog - ntx version 4  -  get emotional support from family
fact / gog - ntx version 4  -  i get support from my friends
fact / gog - ntx version 4  -  my family has accepted my illness
fact / gog - ntx version 4  -  satisfied communication illness
fact / gog - ntx version 4  -  i feel close to my partner
fact / gog - ntx version 4  -  i am satisfied with my sex life
fact / gog - ntx version 4  -  i feel sad
fact / gog - ntx version 4  -  satisfied with how i am coping
fact / gog - ntx version 4  -  losing hope against illness
fact / gog - ntx version 4  -  i feel nervous
fact / gog - ntx version 4  -  i worry about dying
fact / gog - ntx version 4  -  worry my condition will get worse
fact / gog - ntx version 4  -  i am able to work
fact / gog - ntx version 4  -  my work is fulfilling
fact / gog - ntx version 4  -  i am able to enjoy life
fact / gog - ntx version 4  -  i have accepted my illness
fact / gog - ntx version 4  -  i am sleeping well
fact / gog - ntx version 4  -  enjoy things i usually do for fun
fact / gog - ntx version 4  -  content with quality of my life
fact / gog - ntx version 4  -  numbness or tingling in my hands
fact / gog - ntx version 4  -  numbness or tingling in my feet
fact / gog - ntx version 4  -  i feel discomfort in my hands
fact / gog - ntx version 4  -  i feel discomfort in my feet
fact / gog - ntx version 4  -  have joint pain or muscle cramps
fact / gog - ntx version 4  -  i feel weak all over
fact / gog - ntx version 4  -  i have trouble hearing
fact / gog - ntx version 4  -  get ringing or buzzing in my ears
fact / gog - ntx version 4  -  i have trouble buttoning buttons
fact / gog - ntx version 4  -  trouble feeling shape of objects
fact / gog - ntx version 4  -  i have trouble walking
fact - l version 4  -  i have a lack of energy
fact - l version 4  -  i have nausea
fact - l version 4  -  trouble meeting needs of family
fact - l version 4  -  i have pain
fact - l version 4  -  bothered by treatment side effect
fact - l version 4  -  i feel ill
fact - l version 4  -  i am forced to spend time in bed
fact - l version 4  -  i feel close to my friends
fact - l version 4  -  get emotional support from family
fact - l version 4  -  i get support from my friends
fact - l version 4  -  my family has accepted my illness
fact - l version 4  -  satisfied communication illness
fact - l version 4  -  i feel close to my partner
fact - l version 4  -  i am satisfied with my sex life
fact - l version 4  -  i feel sad
fact - l version 4  -  satisfied with how i am coping
fact - l version 4  -  losing hope against illness
fact - l version 4  -  i feel nervous
fact - l version 4  -  i worry about dying
fact - l version 4  -  worry my condition will get worse
fact - l version 4  -  i am able to work
fact - l version 4  -  my work is fulfilling
fact - l version 4  -  i am able to enjoy life
fact - l version 4  -  i have accepted my illness
fact - l version 4  -  i am sleeping well
fact - l version 4  -  enjoy things i usually do for fun
fact - l version 4  -  content with quality of my life
fact - l version 4  -  i have been short of breath
fact - l version 4  -  i am losing weight
fact - l version 4  -  my thinking is clear
fact - l version 4  -  i have been coughing
fact - l version 4  -  i am bothered by hair loss
fact - l version 4  -  i have a good appetite
fact - l version 4  -  i feel tightness in my chest
fact - l version 4  -  breathing is easy for me
fact - l version 4  -  have you ever smoked
fact - l version 4  -  i regret my smoking
fksi - drs version 4  -  i have a lack of energy
fksi - drs version 4  -  i have pain
fksi - drs version 4  -  i am losing weight
fksi - drs version 4  -  i have bone pain
fksi - drs version 4  -  i feel fatigued
fksi - drs version 4  -  i have been short of breath
fksi - drs version 4  -  i have been coughing
fksi - drs version 4  -  i am bothered by fevers
fksi - drs version 4  -  i have had blood in my urine
nccn - fact fbrsi - 24 version 2  -  i get headaches
nccn - fact fbrsi - 24 version 2  -  i have trouble with coordination
nccn - fact fbrsi - 24 version 2  -  i have had seizures
nccn - fact fbrsi - 24 version 2  -  i need help in caring for myself
nccn - fact fbrsi - 24 version 2  -  have weakness in my arms or legs
nccn - fact fbrsi - 24 version 2  -  i am losing weight
nccn - fact fbrsi - 24 version 2  -  trouble meeting needs of family
nccn - fact fbrsi - 24 version 2  -  difficulty expressing my thoughts
nccn - fact fbrsi - 24 version 2  -  i am sleeping well
nccn - fact fbrsi - 24 version 2  -  i am able to concentrate
nccn - fact fbrsi - 24 version 2  -  i can remember new things
nccn - fact fbrsi - 24 version 2  -  able to find the right words
nccn - fact fbrsi - 24 version 2  -  bothered by change in personality
nccn - fact fbrsi - 24 version 2  -  worry my condition will get worse
nccn - fact fbrsi - 24 version 2  -  i am afraid of having a seizure
nccn - fact fbrsi - 24 version 2  -  frustrated i cannot do things
nccn - fact fbrsi - 24 version 2  -  losing hope against illness
nccn - fact fbrsi - 24 version 2  -  i have a lack of energy
nccn - fact fbrsi - 24 version 2  -  i have nausea
nccn - fact fbrsi - 24 version 2  -  bothered by treatment side effect
analog
nccn - fact fbrsi - 24 version 2  -  i feel fatigued
nccn - fact fbrsi - 24 version 2  -  i have a good appetite
nccn - fact fbrsi - 24 version 2  -  i am able to enjoy life
nccn - fact fbrsi - 24 version 2  -  content with quality of my life
nccn - fact fhnsi - 22 version 2  -  i have pain
nccn - fact fhnsi - 22 version 2  -  i am losing weight
nccn - fact fhnsi - 22 version 2  -  i have trouble breathing
nccn - fact fhnsi - 22 version 2  -  i feel ill
nccn - fact fhnsi - 22 version 2  -  pain in my mouth ,  throat or neck
nccn - fact fhnsi - 22 version 2  -  trouble meeting needs of family
nccn - fact fhnsi - 22 version 2  -  can swallow naturally and easily
nccn - fact fhnsi - 22 version 2  -  able to eat the foods that i like
nccn - fact fhnsi - 22 version 2  -  able to communicate with others
nccn - fact fhnsi - 22 version 2  -  i can eat solid foods
nccn - fact fhnsi - 22 version 2  -  i am sleeping well
nccn - fact fhnsi - 22 version 2  -  worry my condition will get worse
nccn - fact fhnsi - 22 version 2  -  i have a lack of energy
nccn - fact fhnsi - 22 version 2  -  i have nausea
nccn - fact fhnsi - 22 version 2  -  had change in the way food tastes
nccn - fact fhnsi - 22 version 2  -  i have mouth sores
nccn - fact fhnsi - 22 version 2  -  i am bothered by hair loss
nccn - fact fhnsi - 22 version 2  -  bothered by treatment side effect
nccn - fact fhnsi - 22 version 2  -  i have a good appetite
nccn - fact fhnsi - 22 version 2  -  i am able to work
nccn - fact fhnsi - 22 version 2  -  i am able to enjoy life
nccn - fact fhnsi - 22 version 2  -  content with quality of my life
siq  -  would be better if i was not alive
siq  -  i thought about killing myself
siq  -  i thought how i would kill myself
siq  -  i thought when i would kill myself
siq  -  i thought about people dying
siq  -  i thought about death
siq  -  what to write in a suicide note
siq  -  i thought about writing a will
siq  -  tell people i plan to kill myself
siq  -  people happier if not around
siq  -  how people feel if i killed myself
siq  -  i wished i were dead
siq  -  how easy it would be to end it all
siq  -  killing myself would solve problem
siq  -  others better off if i was dead
siq  -  wished i had the nerve kill myself
siq  -  wished i had never been born
siq  -  if had chance i would kill myself
siq  -  thought way people kill themselves
siq  -  thought killing myself not do it
siq  -  thought about having bad accident
siq  -  thought life was not worth living
siq  -  my life was too rotten to continue
siq  -  only way be noticed is kill myself
siq  -  people realize worth caring about
siq  -  no one cared if i lived or died
siq  -  hurting myself but not kill myself
siq  -  wondered if had nerve kill myself
siq  -  if things not better i kill myself
siq  -  wished i had right to kill myself
siq  -  ts
siq  -  total %
siq  -  specific %: standard sample 1
siq  -  specific %: standard sample 2
siq  -  specific %: standard sample 3
siq  -  critical item 1
siq  -  critical item 2
siq  -  critical item 3
siq  -  critical item 4
siq  -  critical item 5
siq  -  critical item 6
siq  -  critical item 7
siq  -  critical item 8
siq - jr  -  would be better if i was not alive
siq - jr  -  i thought about killing myself
siq - jr  -  i thought how i would kill myself
siq - jr  -  i thought when i would kill myself
siq - jr  -  i thought about people dying
siq - jr  -  i thought about death
siq - jr  -  what to write in a suicide note
siq - jr  -  i thought about writing a will
siq - jr  -  tell people i plan to kill myself
siq - jr  -  how people feel if i killed myself
siq - jr  -  i wished i were dead
siq - jr  -  killing myself would solve problem
siq - jr  -  others be happier if i was dead
siq - jr  -  wished i had never been born
siq - jr  -  no one cared if i lived or died
siq - jr  -  ts
siq - jr  -  total %
siq - jr  -  specific %: standard sample 1
siq - jr  -  specific %: standard sample 2
siq - jr  -  specific %: standard sample 3
siq - jr  -  critical item 1
siq - jr  -  critical item 2
siq - jr  -  critical item 3
siq - jr  -  critical item 4
siq - jr  -  critical item 5
siq - jr  -  critical item 6
aqueous volumeter
transanal total mesorectal excision
left upper quadrant of abdomen
right upper quadrant of abdomen
left lower quadrant of abdomen
agonist
right lower quadrant of abdomen
definable
septation
tumor implant
ptp4a3 gene
ptp4a3 wt allele
protein tyrosine phosphatase type iva 3
flt3 / mertk inhibitor mrx - 2843
beyond
ranimustine
129 mouse
cd - 1 nude mouse
immunodeficient mouse
fox chase scid mouse
stallimycin
common rattus norvegicus strains
t - lymphocyte activation antigen cd80
t - cell surface antigen cd2
human immunodeficiency virus positive
acupuncture therapy
adrenalectomy
complementary and alternative medicine
amputation
raloxifene
pain therapy
anesthesia procedure
animal testing alternative
antimetabolite chemotherapy
behavioral intervention
behavioral research
biofeedback
biological therapy
biomedical research
biopsy
cerenkov luminescence imaging
other than
myeloid neoplasms with germline predisposition without a preexisting disorder or organ dysfunction
acute myeloid leukemia with germline cebpa mutation
unplanned
roquinimex
needle biopsy
ddx41 gene mutation
myeloid neoplasms with germline ddx41 mutation
myeloid neoplasms with germline predisposition and preexisting platelet disorders
myeloid neoplasms with germline runx1 mutation
refractory metastatic digestive system carcinoma
recurrent metastatic digestive system carcinoma
refractory digestive system carcinoma
refractory head and neck carcinoma
myeloid neoplasms with germline ankrd26 mutation
ankrd26 gene mutation
pheresis
myeloid neoplasms with germline predisposition associated with other organ dysfunction
myeloid neoplasms with germline etv6 mutation
myeloid neoplasms with germline gata2 mutation
ddx41 gene
ddx41 wt allele
probable atp - dependent rna helicase ddx41
non - research project
telomere maintenance gene mutation
blood transfusion
biosafety level
myeloid neoplasms with germline predisposition associated with telomerase biology disorders
myeloid neoplasms with germline predisposition associated with inherited bone marrow failure syndromes
ankrd26 gene
ankrd26 wt allele
autologous cish - inactivated tils
efineptakin alfa
ankyrin repeat domain - containing protein 26
cinobufotalin
bone marrow biopsy
bushen - jianpi decoction
anti - prl - 3 monoclonal antibody prl3 - zumab
stat3 inhibitor tti - 101
mitosis inhibitor t 1101 tosylate
serial liquid biopsy
anti - cd19 / cd20 / cd22 / cd30 car - t cells
autologous e6 t cell receptor genetically - modified t cells
rhoc peptide vaccine rv001v
pelvic mass
fluorescence imaging agent ic2000
bone marrow transplantation
extracranial solid neoplasm
acyclic nucleoside phosphonate prodrug abi - 1968
therapeutic liver cancer peptide vaccine ima970a
bivalent brd4 inhibitor azd5153
autologous pd1 - inhibiting anti - cd19 4 - 1bb car t cells
ido / tdo inhibitor hti - 1090
topical potassium dobesilate
cosibelimab
cd16 / il15 / cd33 trispecific killer cell engager
vonoprazan fumarate
internal radiation therapy
supradiaphragmatic
bet inhibitor cc - 90010
glyco - engineered anti - cd20 monoclonal antibody cho h01
hsp90 - targeted sn - 38 conjugate pen - 866
autologous anti - muc1 / cd33 / cd38 / cd56 / cd123 gene - engineered car - t cells
calcium - sensing receptor agonist sk 1403
hpv16 - e6 - t27
transformed non - hodgkin lymphoma
hpv16 - e7 - t512
suprarenal
carcinogenicity test
generic
less than partial clinical response
magnetic field
atomic nucleus
saturation recovery pulse sequence
tissue suppression
steady - state
anti - trop2 / dxd antibody - drug conjugate ds - 1062a
donor - derived cd34 +  hematopoietic stem and progenitor cells plus cd3 +  t - cells mdr - 101
indium in 111 monoclonal antibody huj591
case - control study
bowl dosing unit
locally advanced bile duct carcinoma
spiral pitch
cardiac synchronization
occasionally
acute leukemia of ambiguous lineage ,  not otherwise specified
recurrent burkitt leukemia
refractory burkitt leukemia
refractory lymphoblastic lymphoma
refractory high grade b - cell lymphoma with myc and bcl2 or bcl6 rearrangements
surgical castration
recurrent high grade b - cell lymphoma with myc and bcl2 or bcl6 rearrangements
pelvic rhabdomyosarcoma
abdominal rhabdomyosarcoma
unresectable rhabdomyosarcoma
pelvic undifferentiated high grade pleomorphic sarcoma
abdominal undifferentiated pleomorphic sarcoma
blasts expressing b - lymphoid ,  t - lymphoid ,  and myeloid markers present
blasts expressing b - lymphoid and t - lymphoid markers present
cyclin - dependent kinase inhibitor pf - 06873600
ice pack
mixed phenotype acute leukemia ,  not otherwise specified ,  rare subtypes
mixed phenotype acute leukemia ,  b / t / myeloid ,  not otherwise specified
mixed phenotype acute leukemia ,  b / t ,  not otherwise specified
locally advanced pancreatic ductal adenocarcinoma
stat3 inhibitor dsp - 0337
resectable pancreatic ductal adenocarcinoma
galnt12 gene
galnt12 wt allele
polypeptide n - acetylgalactosaminyltransferase 12
grem1 gene
teloxantrone
cecostomy
grem1 wt allele
gremlin - 1
kif1b gene
kif1b wt allele
kinesin - like protein kif1b
rps20 gene
rps20 wt allele
40s ribosomal protein s20
tmem45b gene
tmem45b wt allele
cell - free system
transmembrane protein 45b
mlph gene
mlph wt allele
melanophilin
ndc80 gene
ndc80 wt allele
kinetochore protein ndc80 homolog
gpr160 gene
gpr160 wt allele
probable g - protein coupled receptor 160
analgesic quantification algorithm
no analgesic
non - opioid analgesic
weak opioids
strong opioids less than or equal to 75 mg oral morphine equivalent per day
strong opioids greater than 75 - 150 mg oral morphine equivalent per day
strong opioids greater than 150 - 300 mg oral morphine equivalent per day
strong opioids greater than 300 - 600 mg oral morphine equivalent per day
strong opioids greater than 600 mg oral morphine equivalent per day
cxxc5 gene
cxxc5 wt allele
cxxc - type zinc finger protein 5
intensity - modulated radiotherapy inverse planning
intensity - modulated radiotherapy forward planning
tangential fields
distal esophagus adenocarcinoma
blvra gene
blvra wt allele
biliverdin reductase a
chiropractic therapy
actr3b gene
actr3b wt allele
actin - related protein 3b
aldh4a1 gene
aldh4a1 wt allele
delta - 1 - pyrroline - 5 - carboxylate dehydrogenase ,  mitochondrial
refractory primary peritoneal carcinoma
refractory fallopian tube carcinoma
refractory female reproductive system carcinoma
ap2b1 gene
nutrition ,  cholesterol
ap2b1 wt allele
ap - 2 complex subunit beta
direct field
modified wide tangent field
direct electron field
direct mixed photon and electron field
megavolt
megaelectronvolt
lpcat1 gene
lpcat1 wt allele
clinical study
lysophosphatidylcholine acyltransferase 1
cdc42bpa gene
cdc42bpa wt allele
serine / threonine - protein kinase mrck alpha
revesz syndrome
telomere syndrome
hepatobiliary iminodiacetic acid scan
oxylipin
6 - ketoprostaglandin f1alpha
9alpha , 11beta - prostaglandin f2alpha
prostaglandin f2alpha
bisphenol a
phthalate
indican
metastatic unresectable sarcoma
modotuximab
metastatic sarcoma
recurrent malignant head and neck neoplasm
refractory malignant head and neck neoplasm
dkc1 gene mutation
cohort study
terc gene mutation
nop10 gene mutation
nhp2 gene mutation
wrap53 gene mutation
tinf2 gene mutation
ctc1 gene mutation
parn gene mutation
rtel1 gene mutation
acd gene mutation
voxelotor
colectomy
nop10 gene
nop10 wt allele
h / aca ribonucleoprotein complex subunit 3
nhp2 gene
radiation therapy beam energy
nhp2 wt allele
h / aca ribonucleoprotein complex subunit 2
lung inhomogeneity correction
ctc1 gene
ctc1 wt allele
losoxantrone
colon and rectal surgery
cst complex subunit ctc1
parn gene
parn wt allele
poly ( a )  - specific ribonuclease parn
drug preload
primary immunodeficiency syndrome
colostomy
multimodality therapy
community health service
craniotomy
cryosurgery
cystectomy
cystostomy
remdesivir
health care delivery
troglitazone
diagnosis
dialysis
rigosertib
diet
nutrition ,  carbohydrates
rivoceranib
nutrition ,  fats
nutrition ,  fiber
dilation and curettage
dissection
double blind study
sacubitril
antitumor drug screening assay
lanreotide
embolization therapy
sarilumab
estrogen replacement therapy
excision
nutrition ,  fats ,  unsaturated
follow - up study
nutrition ,  food additives
gastrectomy
gene bank
sirukumab
gene therapy
patient care
liarozole fumarate
genetic counseling
genomic library
health maintenance organization
health promotion
access to care
health services research
heart transplantation
heart and lung transplantation
hemodialysis
hepatectomy
talazoparib tosylate
rg 12915
botanical therapy
hospice care
hospital administration
tefinostat
human genome project
hypophysectomy
hysterectomy
ileostomy
immunization
passive immunization
docetaxel
immunotherapy
tildrakizumab
in vitro
infant nutrition
kidney transplantation
laparotomy
tivozanib hydrochloride
laryngectomy
laser surgery
leukapheresis
tomuzotuximab
letrozole
tradipitant
liver transplantation
lobectomy
longitudinal study
lung transplantation
tridecactide
lymphadenectomy
massage therapy
mastectomy
modified radical mastectomy
radical mastectomy
umbralisib tosylate
umifenovir
risedronate sodium
breast conservation treatment
total mastectomy
oriental medicine
naturopathy therapy
nephrectomy
veledimex
nursing research
velpatasvir
nutritional assessment
nutritional requirements
vidofludimus
orchiectomy
organ transplantation
batimastat
ostomy
oophorectomy
vorasidenib
palliative therapy
voxilaprevir
pancreas transplantation
pancreatectomy
chemotherapeutic perfusion
isolated chemotherapeutic perfusion
cdca7 gene
cdca7 wt allele
peritoneal dialysis
cell division cycle - associated protein 7
futuximab
cenpa gene
cenpa wt allele
histone h3 - like centromeric protein a
cmc2 gene
axl inhibitor ds - 1205c
cmc2 wt allele
cox assembly mitochondrial protein 2 homolog
immunomodulator lam - 003
related donor adenovirus - specific cytotoxic t cells
col4a2 gene
col4a2 wt allele
col4a2 gene product
collagen alpha - 2 ( iv )  chain
canstatin
ebf4 gene
ebf4 wt allele
transcription factor coe4
pharmacokinetics
piperacillin - tazobactam
photodynamic therapy
phototherapy
physical therapy
plasmapheresis
fbxo31 gene
fbxo31 wt allele
f - box only protein 31
fgf18 gene
fgf18 wt allele
fibroblast growth factor 18
pneumonectomy
adgrg6 gene
adgrg6 wt allele
adhesion g - protein coupled receptor g6
gpr180 gene
gpr180 wt allele
integral membrane protein gpr180
plaat1 gene
plaat1 wt allele
phospholipase a and acyltransferase 1
ntrk1 gene mutation
primary prevention
ntrk1 overexpression positive
ntrk1 gene translocation
ntrk1 gene amplification
polyspecific direct antiglobulin test
chronic hemolysis
locally advanced soft tissue sarcoma
antifungal agent vl - 2397
unresectable soft tissue sarcoma
metastatic soft tissue sarcoma
prostatectomy
locally advanced bone sarcoma
locally advanced sarcoma
unresectable bone sarcoma
metastatic bone sarcoma
unresectable synovial sarcoma
metastatic pancreatic neuroendocrine carcinoma
ighv4 - 34 gene
ighv4 - 34 wt allele
immunoglobulin heavy variable 4 - 34
unresectable pancreatic neuroendocrine carcinoma
psychotherapy
unresectable carcinoid tumor
refractory lung non - small cell carcinoma
autologous cd8 +  slc45a2 - specific t lymphocytes
bezlotoxumab
resectable soft tissue sarcoma
muc20 gene
muc20 wt allele
mucin - 20
public health administration
guardant360
erbb2 gene mutation negative
sutimlimab
tetmyb dna vaccine
epitinib succinate
carbidopa / levodopa
cd137l / epstein - barr virus - targeting autologous dendritic cell vaccine
1p / 19q codeletion negative
recombinant eotaxin
paracentesis
abl1 gene mutation
activated pi3k - positive cells present
hm2 / mmae antibody - drug conjugate alt - p7
activating fgfr gene mutation
cd45ro antibody
evocalcet
integrated statistical analysis plan
priority at discharge code
performed composition relationship
bcl - 2 family protein
quality control
assessed activity relationship
bcl2 overexpression positive
target anatomic site directionality code
bcor gene mutation
bcorl1 gene mutation
bcr / abl1 fusion protein with abl1 np_005148 .2:p .t315a
trka inhibitor vmd - 928
blasts 30 , 000 or less of peripheral blood white cells
autologous anti - cd19 car - cd3zeta - 4 - 1bb - expressing t - cells pz01
blasts 9 percent or less of bone marrow nucleated cells
radiation dosimetry
blasts 9 percent or less of peripheral blood white cells
blasts increased by greater than or equal to 50 percent
axl / mer inhibitor incb081776
ctag2 gene product
study research coordinator
cancer / testis antigen 2 isoform lage - 1a
lage - 1a positive
last follow - up source type code
anti - muc16 / cd3 bispecific antibody regn4018
radiation therapy
anti - ny - eso1 / lage - 1a tcr / scfv anti - cd3 imcnyeso
performed experiment unit allocation
occurrence study day range
aerosol gemcitabine
study country
study subject experience document version
dihydroorotate dehydrogenase inhibitor bay2402234
information source type code
order care setting type code
diagnostic reagents and test kits
urgency
bone marrow donor
cornea donor
result classification
study conduct
enrolled study subject number
hypnosedation
anti - cd3 / cd38 bispecific monoclonal antibody amg 424
soluble guanylate cyclase stimulator iw - 1701
anti - pd - 1 monoclonal antibody lzm009
rehabilitation
cldn18 .2 positive
cxcr2 antagonist qbm076
lymphoma response to immunomodulatory therapy criteria
lymphoma response to immunomodulatory therapy criteria indeterminate response 1
lymphoma response to immunomodulatory therapy criteria indeterminate response 2
lymphoma response to immunomodulatory therapy criteria indeterminate response 3
lyric indeterminate response
actinium ac - 225 anti - psma monoclonal antibody j591
relaxation therapy
recurrent hepatosplenic t - cell lymphoma
refractory hepatosplenic t - cell lymphoma
h3 k27m negative
braf v600e negative
macy catheter
extracellular vesicle
cell preparation tube
plasma preparation tube
advanced melanoma
second - look surgery
advanced renal cell carcinoma
advanced carcinoma
advanced lymphoma
egfr mutant - specific inhibitor zn - e4
usher syndrome type 2c
recurrent mediastinal lymphoma
intracranial extension
refractory mediastinal lymphoma
nijmegen breakage syndrome - like disorder
mental retardation ,  autosomal recessive 34
reproducibility
mat2a inhibitor ag - 270
contrast - enhanced mammography
locally advanced skin squamous cell carcinoma
advanced synovial sarcoma
advanced sarcoma
systematic light exposure
litebook
transcriptomics
research
epigenomics
metagenomics
glycomics
lipidomics
transcriptome
epigenome
metagenome
lipidome
morisky medication adherence scale
primary immune deficiency treatment consortium
gutolactone
study design
locally advanced lung non - squamous non - small cell carcinoma
advanced lung non - small cell squamous carcinoma
metastatic lung carcinoma
advanced lung carcinoma
chemokine modulation therapy
locally advanced lung carcinoma
obscure
coalesce
miridesap
research resource
dezamizumab
anti - her2 / anti - her3 bispecific monoclonal antibody mcla - 128
locally advanced head and neck carcinoma
mesenchymal stromal cells - derived exosomes with kras g12d sirna
anti - cd19 / cd3 bite antibody amg 562
smart device
cardiac amyloidosis
autologous tcr - engineered t - cells ima202
cblb gene mutation
respiratory therapy
cd4 positive
cd52 positive
ncam1 negative
chromogranin negative
colorectal carcinoma metastatic in the lung
csf3r gene mutation
breast carcinoma metastatic in the spine
breast carcinoma metastatic in lymph node
decrease in blasts
ackr1 gene mutation
salpingo - oophorectomy
ackr1 nm_002036 .3:c . - 67t > c
duffy null polymorphism
sensitizing egfr gene mutation
elevated alpha - hydroxyglutarate
elevated psa
elevated wt1
fgf9 gene amplification
fgfr2 gene fusion positive
metastatic breast carcinoma
international myeloma working group
self care
fgfr gene rearrangement
fgfr2 gene rearrangement
folate receptor family positive
hepatitis b surface antibody positive
hepatitis b surface antibody negative
hematopoietic immune cell
homologous recombination repair gene
kdm2b gene mutation
sequence alignment map
binary alignment map
skin transplantation
fastq format
kit exon 18 mutation
kmt2c gene mutation
map2k1 gene amplification
map2k1 gene rearrangement
map2k2 gene amplification
map2k2 gene mutation
map2k2 gene rearrangement
problem - solving skills training
dr5 hexabody agonist gen1029
milligram morphine equivalent
anti - globo h monoclonal antibody obi - 888
mnk1 / 2 inhibitor etc - 1907206
muc16 positive
nf1 gene deletion
slc5a5 positive
nlrp1 gene mutation
nsd1 gene mutation
nup98 gene mutation
nutm1 gene rearrangement
phf6 gene mutation
rspo gene fusion positive
tfe3 gene translocation
tfeb gene translocation
dnmt3 family
tdgf1 gene
tdgf1 wt allele
teratocarcinoma - derived growth factor 1
locally advanced unresectable malignant neoplasm
metastatic unresectable malignant neoplasm
splenectomy
fcn2 gene
fcn2 wt allele
ficolin - 2
trpa1 gene
trpa1 wt allele
transient receptor potential cation channel subfamily a member 1
refractory ewing sarcoma / peripheral primitive neuroectodermal tumor
anti - cd71 / vcmmae probody - drug conjugate cx - 2029
extended - release microsphere capsule - based oxycodone
adult - onset leukoencephalopathy with axonal spheroids and pigmented glia
surgical procedure
rubinstein - taybi syndrome type 1
rubinstein - taybi syndrome type 2
caris molecular intelligence tumor profiling
recurrent aplastic anemia
recurrent severe aplastic anemia
refractory severe aplastic anemia
recurrent hemophagocytic lymphohistiocytosis
refractory hemophagocytic lymphohistiocytosis
longevity
knee injury and osteoarthritis outcome score
pemetrexed disodium
digestive system surgery
informant questionnaire on cognitive decline in the elderly
framingham foot assessment clinical tool
study of osteoporotic fractures frailty index
life space questionnaire
brief resilience scale
taste and smell questionnaire
oral health and dental history questions
weight history
family history of dementia and longevity
exicorilant
ophthalmologic surgical procedure
involved - site radiation therapy
autologous tumor infiltrating lymphocytes mda - til
rivac regimen
toll - like receptor 7 agonist dsp - 0509
metastatic unresectable carcinoma
metastatic unresectable gastric adenocarcinoma
advanced unresectable gastric adenocarcinoma
metastatic gastric adenocarcinoma
gynecological surgical procedure
metastatic gastric carcinoma
manual therapy
metastatic chordoma
locally advanced chordoma
unresectable chordoma
aspacytarabine
sinhalese language
sequencing data
urogenital surgical procedure
recurrent ebv - positive diffuse large b - cell lymphoma ,  not otherwise specified
refractory ebv - positive diffuse large b - cell lymphoma ,  not otherwise specified
reticulocytosis
allogeneic gm - csf - secreting lethally irradiated pancreatic tumor cell vaccine
castration - sensitive
castration - sensitive prostate carcinoma
cytokine - treated veto cells
claricore optical biopsy system
arabic language
urologic surgical procedure
recurrent cushing disease
transabdominal resection
northeastern asian
western asian
southeastern european
sub - saharan african
recurrent ovarian carcinosarcoma
metastatic triple - negative breast carcinoma
nucleotide sequence read
technology assessment
autologous hematopoietic stem cell transplant recipient
refractory colon carcinoma
refractory liver carcinoma
pterostilbene
slc6a8 inhibitor rgx - 202
refractory bile duct carcinoma
refractory small intestinal carcinoma
locally advanced small intestinal carcinoma
locally advanced digestive system carcinoma
recurrent gastroesophageal junction adenocarcinoma
testing
recurrent bile duct carcinoma
soft tissue sarcoma ,  excluding liposarcoma
read length
sequencing adapter
nucleotide sequencing flow cell
sequencing size selection range
sequencing target region
bed format
body mass index greater than 25
global registration identifier for donors
thoracotomy
metastatic soft tissue sarcoma ,  excluding liposarcoma
locally advanced soft tissue sarcoma ,  excluding liposarcoma
oxidative phosphorylation inhibitor im156
elagolix
helicobacter pylori therapeutic vaccine imx101
nidanilimab
cbp / beta - catenin modulator e7386
cdk9 inhibitor azd4573
ledipasvir / sofosbuvir
anti - pd - 1 / ctla - 4 bispecific antibody ak104
thrombolytic therapy
milled seed mix
phosphorylated eif4e
pi3k alteration positive
piga gene mutation
pik3c2b gene mutation
neoplastic plasma cells under 50 percent of bone marrow nucleated cells
metastatic cervical carcinoma
metastatic cervical squamous cell carcinoma ,  not otherwise specified
metastatic cervical adenocarcinoma
tissue collection
metastatic cervical adenosquamous carcinoma
pik3ca gene alteration positive
pik3ca gene rearrangement
activating pik3cb gene mutation
plcg2 gene mutation
in vitro kinase inhibitor assay
methionine c 11
total pancreatectomy
h3 .1 k27m mutation
centrifuge
subfacial
spread of lymphoma
pmel positive
presence of erbb2 overexpressing disseminated tumor cells
progesterone receptor positive by immunohistochemistry 1 - 9 percent
psa 50 percent or greater than nadir
psa decline greater than 75 percent
tracheotomy
psa level zero to two
psa level 0 .2 to four
psa level greater than or equal to 0 .4
psa level less than or equal to eleven
psa level four to ten
psa level greater than 0 .4
psa level greater than or equal to fifteen
furosemide topical gel cls006
psa level greater than or equal to three
botanical agent bel - x - hg
transplantation
psa level less than four
psa level less than one
psa level less than one hundred
psa level less than or equal to one hundred fifty
tricaprin
platinum acetylacetonate - titanium dioxide nanoparticles
triamcinolone acetonide transdermal system sun - 131
egfr inhibitor dbpr112
indium in 111 minigastrin analog cp04
colloidal modified fluid gelatin plasma substitute
transurethral prostatic resection
slc6a8 gene
slc6a8 wt allele
sodium -  and chloride - dependent creatine transporter 1
slc6a8 positive
the health care climate questionnaire
feel physician provided choices and options
feel understood by physician
able to be open with physician at meetings
physician conveys confidence in my ability to make choices
feel my physician accepts me
uv light therapy
physician made sure i understood about my condition and what i need to do
physician encourages me to ask questions
feel lot of trust in physician
physician answers questions fully and carefully
physician listens to how i would like to do things
physician handles people's emotions very well
physician cares about me as a person
don't feel very good about the way my physician talks to me
physician tries to understand how i see things before suggesting new way to do things
able to share my feelings with my physician
ureterostomy
7 point agreement rating scale
agreement rating 1
agreement rating 2
agreement rating 3
agreement rating 4
agreement rating 5
agreement rating 6
agreement rating 7
preparation for decision making scale
helped recognize that decision needs to be made
vaccination
prepared to make better decision
helped think about pros and cons of each option
helped think about which pros and cons are most important
helped to know that decision depends on what matters most to you
folh1 positive
pten alteration positive
pten gene alteration positive
pten deficiency
helped organize your thoughts about decision
helped think about how involved you want to be in decision
vaccine therapy
helped identify questions you want to ask your doctor
prepared you to talk to your doctor about what matters most to you
prepared you for follow - up visit with your doctor
compress
cold compress
locally advanced unresectable bone sarcoma
locally advanced unresectable soft tissue sarcoma
locally advanced unresectable sarcoma
dolcanatide
5 - aza - 4' - thio - 2' - deoxycytidine
vasectomy
cetuximab / irinotecan / vemurafenib regimen
irinotecan / panitumumab regimen
irinotecan / panitumumab / vemurafenib regimen
bevacizumab / irinotecan / oxaliplatin regimen
perceived efficacy in patient - physician interactions
how confident in ability to know what questions to ask doctor
how confident in ability to get doctor to answer all questions
how confident in ability to make most of visit with doctor
how confident in ability to get doctor to take chief health concern seriously
how confident in ability to get doctor to do something about chief health concern
nutrition ,  water
5 - point confidence scale
confidence 1
confidence 2
confidence 3
confidence 4
confidence 5
rb1 gene mutation negative
rheb gene rearrangement
ros1 negative
s100b positive
bruceanol d
total - body irradiation
tnfrsf9 gene product
soluble tumor necrosis factor receptor superfamily member 9
sensitizing ros1 fusion positive
setbp1 gene mutation
setd2 gene mutation
sh2d1a gene mutation
sure test
feel sure about best choice
know benefits and risk of each option
clear about which benefits and risks matter most
adoptive immunotherapy
have enough support and advice to make choice
smarcb1 positive
sox9 gene mutation
stag2 gene mutation
stat3 gene mutation
6 melanoma helper peptide vaccine
stk11 gene rearrangement
t - cell receptor gene rearrangement
t ( 15 ; 17 )  positive
taf1 gene mutation
pancreatic islet transplantation
tbx3 gene mutation
testosterone greater than or equal to 100 ng / dl
testosterone greater than 100 ng / dl
tnfsf9 gene mutation negative
ttr gene mutation
tsc1 gene rearrangement
tsc2 gene rearrangement
patient provider orientation scale
doctor should decide what gets talked about during visit
health care is less personal but pays for medical advances
self - examination
most important part of standard medical visit is physical exam
often best for patients to not have full explanation of medical condition
patient should rely on doctor's knowledge and not find out about their conditions
doctors asking lots of questions about patient's background is prying into personal matters
if doctors are good at diagnosis and treatment then their relations with patients not important
many patients continue asking questions when not learning anything new
patients should be treated as equal partners with doctor
patients generally want reassurance rather than information about health
if doctor's primary tools are being open and warm ,  doctor will not have success
disagreement is sign that doctor does not have patient's respect and trust
mammoplasty
treatment plan cannot succeed if in conflict with patient's lifestyle or values
most patients want to get in and out of doctor's office as quickly as possible
patient must always be aware that doctor is in charge
not important to know patient's culture and background to treat their illness
humor is major ingredient in doctor's treatment of patient
when patients look up medical information this confuses more than helps
moderately disagree
moderately agree
tumor - infiltrating immune cell
ultra high sensitivity c - reactive protein measurement
radioimmunotherapy
urinary microbiome
25 - hydroxyvitamin d less than 66 ng / ml
25 - hydroxyvitamin d less than 30 ng / ml
peak oxygen consumption
promoting resilience in stress management
wt1 negative
xpo1 gene mutation
bone marrow blasts decreased by 50 percent or more compared to pretreatment level
phosphorylated - fak y397
androgen - sensitive
whipple procedure
xp11 .2 translocation
egfr gene amplification negative
mgmt gene promoter methylation
control preference scale
preference for making decisions about health care
prefer to make decision about which treatment i will receive
magnesium - based bone void filler
recurrent acinic cell breast carcinoma
recurrent pancreatic acinar cell carcinoma
esophagectomy
recurrent prostate acinar adenocarcinoma
recurrent parotid gland acinic cell carcinoma
recurrent submandibular gland acinic cell carcinoma
recurrent cervical mucinous adenocarcinoma ,  endocervical type
recurrent ampulla of vater adenocarcinoma
recurrent anal adenocarcinoma
recurrent anal mucinous adenocarcinoma
recurrent paget disease of the anal canal
powder and solvent for suspension for injection in multidose container
recurrent appendix mucinous adenocarcinoma
stereotactic radiosurgery
incomplete ,  incorrect or alternative diagnosis code assigned
decision quality instruments  -  breast surgery
how important to keep breast
how important to remove entire breast for peace of mind
recurrent lobular breast carcinoma
how important to avoid having radiation
which treatment wanted to treat early stage breast cancer
recurrent invasive ductal breast carcinoma
recurrent paget disease of the breast
how much does waiting few weeks for treatment decision affects chances of survival
salvage therapy
recurrent clear cell renal cell carcinoma
with treatment how many women diagnosed with early breast cancer eventually die of breast cancer
which treatment more likely needs another operation to remove tumor cells
which women with early breast cancer live longer on average
which women have higher chance of cancer coming back in treated breast on average
recurrent chromophobe renal cell carcinoma
10 - point importance scale
importance score 0
dna sequencing
importance score 1
bruceanol e
adjuvant chemotherapy
importance score 2
importance score 3
importance score 4
importance score 5
importance score 6
importance score 7
importance score 8
importance score 9
importance score 10
equally likely for both
no difference in likelihood
recurrent salivary duct carcinoma
recurrent minor salivary gland adenocarcinoma
recurrent fallopian tube serous adenocarcinoma
recurrent ovarian adenocarcinoma
recurrent ovarian serous adenocarcinoma
recurrent ovarian mucinous adenocarcinoma
recurrent ovarian cystadenocarcinoma
recurrent ovarian clear cell adenocarcinoma
recurrent pancreatic ductal adenocarcinoma
case study
recurrent pancreatic cystadenocarcinoma
recurrent thyroid gland papillary carcinoma
recurrent thyroid gland follicular carcinoma
recurrent thyroid gland medullary carcinoma
recurrent thyroid gland anaplastic carcinoma
solution for injection in multidose container
recurrent skin angiosarcoma
suspension for injection in multidose container
managed care
outcomes research
platelet transfusion
risk assessment
treatment
allogeneic bone marrow transplantation
bruceanol f
steroid therapy
cerebral edema management
therapeutic touch
douche
imagery therapy
immunologic desensitization
boron neutron capture therapy
teleradiology
ochsner medical center
recombinant fas ligand
telemedicine
recurrent parotid gland carcinoma
recurrent submandibular gland carcinoma
recurrent appendix carcinoma
recurrent parotid gland adenoid cystic carcinoma
recurrent parotid gland carcinoma ex pleomorphic adenoma
recurrent parotid gland mucoepidermoid carcinoma
recurrent submandibular gland mucoepidermoid carcinoma
recurrent submandibular gland carcinoma ex pleomorphic adenoma
recurrent submandibular gland adenoid cystic carcinoma
quality assurance
recurrent parotid gland squamous cell carcinoma
recurrent submandibular gland squamous cell carcinoma
recurrent submandibular gland undifferentiated carcinoma
recurrent parotid gland undifferentiated carcinoma
bridging fibrosis
recurrent malignant ovarian transitional cell tumor
recurrent malignant ovarian brenner tumor
recurrent ovarian transitional cell carcinoma
ferriscan
afar language
abkhazian language
recurrent primary malignant central nervous system neoplasm
achinese language
acoli language
adangme language
adyghe language
afrikaans language
ainu language
special diet therapy
akan language
aleut language
southern altai language
amharic language
angika language
aragonese language
mapuche language
recurrent malignant brain neoplasm
arapaho language
lokono language
surgical incision
assamese language
asturian language
refractory primary malignant central nervous system neoplasm
avar language
awadhi language
refractory malignant brain neoplasm
aymara language
azerbaijani language
bashkir language
balochi language
excisional biopsy
bambara language
balinese language
basa language
beja language
belarusian language
bemba language
bengali language
bhojpuri language
bikol language
edo language
incisional biopsy
bislama language
blackfoot language
standard tibetan language
bosnian language
braj language
refractory who grade iii glioma
breton language
buriat language
buginese language
bulgarian language
shave biopsy
bilen language
caddo language
carib language
catalan language
cebuano language
czech language
chamorro language
chechen language
chuukese language
mari language
infusion procedure
chinook jargon language
choctaw language
chipewyan language
cherokee language
chuvash language
allogeneic cd34 - positive e - rosetted t - cell depleted peripheral blood stem cells
cheyenne language
cornish language
corsican language
cree language
endoscopic biopsy
crimean tatar language
kashubian language
welsh language
dakota language
danish language
dargwa language
delaware language
athabascan language
slavey language
dogrib language
tezacitabine
fulguration
dinka language
maldivian language
dogri language
lower sorbian language
duala language
dyula language
dzongkha language
efik language
ekajuk language
modern greek language
electrodesiccation
estonian language
basque language
ewe language
ewondo language
fang language
faroese language
persian language
fantse language
fijian language
finnish language
thoracentesis
fon language
northern frisian language
east frisian low saxon language
western frisian language
fula language
friulian language
ga language
gayo language
gbaya language
gilbertese language
scottish gaelic language
irish language
galician language
manx language
gondi language
gorontalo language
grebo language
guarani language
swiss german language
gujarati language
partial hepatectomy
gwich'in language
haida language
haitian creole language
hausa language
hawaiian language
hebrew language
herero language
hiligaynon language
hindi language
hiri motu language
autologous bone marrow transplantation
croatian language
upper sorbian language
hupa language
armenian language
iban language
igbo language
nuosu language
inuvialuktun language
ilocano language
indonesian language
radical cystectomy
ingush language
inupiaq language
javanese language
judeo - persian language
judeo - arabic language
kara - kalpak language
kabyle language
jingpho language
greenlandic language
kamba language
bladder irrigation
kannada language
kashmiri language
georgian language
kanuri language
kazakh language
kabardian language
khasi language
central khmer language
kikuyu language
kinyarwanda language
kyrgyz language
kimbundu language
konkani language
komi language
kongo language
kosraean language
kpelle language
karachay - balkar language
karelian language
kurukh language
radical prostatectomy
kwanyama language
kumyk language
kurdish language
kutenai language
ladino language
lahnda language
lamba language
lao language
latvian language
lezghian language
tyrphostin a46
limburgish language
surefire antireflux microcatheter
lingala language
lithuanian language
mongo language
lozi language
luxembourgish language
luba - kasai language
luba - katanga language
ganda language
retropubic prostatectomy
luiseno language
lunda language
luo language
lushai language
madurese language
magahi language
marshallese language
maithili language
makassarese language
malayalam language
conization
mandinka language
marathi language
maasai language
moksha language
mandar language
mende language
mi'kmaq language
minangkabau language
macedonian language
malagasy language
endocervical curettage
maltese language
manchu language
meitei language
mohawk language
mongolian language
mossi language
maori language
malay language
muscogee language
mirandese language
mediastinotomy
marwari language
burmese language
erzya language
neapolitan language
nauru language
navajo language
south ndebele language
north ndebele language
ndonga language
cd1a positive
low german language
nepali language
newar language
nias language
niuean language
flemish language
nynorsk language
bokmal language
nogai language
norwegian language
cancer screening
n'ko language
northern sotho language
chewa language
nyamwezi language
nkore language
nyoro language
nzema language
occitan language
ojibwe language
odia language
family study
oromo language
osage language
ossetian language
pangasinan language
pampanga language
punjabi language
papiamento language
palauan language
metastatic fibrolamellar carcinoma
polish language
pohnpeian language
pashto language
recurrent fibrolamellar carcinoma
quechuan language
rajasthani language
rapa nui language
cook islands maori language
romansh language
metastatic liver carcinoma
romani language
packed red blood cell transfusion
romanian language
metastatic hepatocellular carcinoma
ttr gene mutation negative
blasts 0 percent of peripheral blood white cells
blasts 20 percent or less of peripheral blood white cells
blasts 6 - 25 percent of bone marrow nucleated cells
blasts under 10 , 000 of peripheral blood white cells
blasts more than 60 percent of bone marrow nucleated cells
c3 gene product
complement c3d
c - myb antisense oligonucleotide g4460
biological response modifier therapy
squamous dysplasia
kirundi language
aromanian language
sandawe language
sango language
yakut language
c3d positive
sasak language
santali language
sicilian language
cytokine therapy
scots language
selkup language
hla - b*1501 positive cells present
hla - b*4601 positive cells present
shan language
sidamo language
slovak language
slovenian language
southern sami language
northern sami language
lymphokine - activated killer cell therapy
lule sami language
inari sami language
samoan language
skolt sami language
shona language
sindhi language
soninke language
sesotho language
albanian language
sardinian language
fertility study
sranan tongo language
serbian language
serer language
swati language
bst2 gene
bst2 wt allele
bone marrow stromal antigen 2
bst2 positive
type - specific hpv antibody
ccnd1 / ighg1 fusion negative
adcc assay
myeloblasts 5 percent or less of bone marrow nucleated cells
sukuma language
sundanese language
susu language
parp1 gene mutation
swahili language
swedish language
syriac language
parp2 gene mutation
tahitian language
tamil language
tatar language
pten positive
telugu language
pten negative
tumor - associated peptide antigens present
testosterone greater than 150 ng / dl
hla phenotype positive
fgfr1 positive
braf gene rearrangement
active immunization
timne language
terena language
tetum language
tajik language
tagalog language
thai language
tigre language
tigrinya language
tiv language
tokelau language
tlingit language
tamasheq language
tonga language  ( nyasa )
tonga language  ( tonga islands )
tok pisin language
tsimshian language
tswana language
tsonga language
turkmen language
tumbuka language
turkish language
tuvalua language
twi language
tuvinian language
udmurt language
uyghur language
ukrainian language
umbundu language
urdu language
uzbek language
disease screening
vai language
venda language
votic language
wolaytta language
waray language
washo language
walloon language
wolof language
oirat language
pibrozelesin
hypnotherapy
xhosa language
yao language
yapese language
yiddish language
yoruba language
zapotec language
zenaga language
standard moroccan berber language
zhuang language
zulu language
postmenopausal
zuni language
zaza language
bendamustine / obinutuzumab regimen
g - chop regimen
r - cepp regimen
r - cdop regimen
immunohistochemical panel for burkitt lymphoma
flow cytometry panel for burkitt lymphoma
chlorambucil / rituximab regimen
resistance training
human migration
cognitively - based compassion training
unresectable gastric adenocarcinoma
pituitary hyperplasia
cord blood transplant recipient
pectoral nerve block
stretching
waiting list
ercc3 gene mutation
abraxas1 gene mutation
gen1 gene mutation
psychosocial rehabilitation
hdac2 gene mutation
genetically - engineered immune cell
women who have lumpectomy and radiation therapy
women who have mastectomy
most will die of something else
about half will die of breast cancer
most will die of breast cancer
a little or not at all
brief appraisal inventory
how often did you think about
record linkage study
maintain positive outlook ,  even when things are going badly
achieve calmer ,  more peaceful ,  or healthier lifestyle
solve problems with health care or health care system
impressions and assumptions others have about you because of your health
comparison to others whose health does not limit them
free of money problems
increase volunteer work to help others in community
grow spiritually
stay active and productive
resolve problems in living situation
nutritional supplementation
prepare family for ups and downs of health condition
settle conflicts with people in life
find romance
learn to accept yourself as you are
things that usually don't come to mind ,  except because of survey
have dreams and goals different from most people own age
spend more time with family before health worsens
remain independent and be able to get around on your own
be rid of obligations and responsibilities
try not to complain about health to others
database
comparison to others facing similar health issues
increase travel for leisure or visit with people
accomplish new goals at work
external qigong therapy
vulvovaginal atrophy
carbon dioxide fractional laser
electronic patient visit assessment
histone h1 gene
brain surgery
bevacizumab / everolimus regimen
lymph node dissection
everolimus / lenvatinib regimen
endobronchial ultrasound bronchoscopy
ipilimumab / nivolumab regimen
non - malignant nodule
mrna - based trimix melanoma vaccine eci - 006
recombinant hsa / filgrastim fusion protein
autologous axl - targeted car t - cells cct301 - 38
autologous ror2 - targeted car t - cells cct301 - 59
colorectal cancer peptide vaccine polypepi1018
alk inhibitor wx - 0593
interdisciplinary research
therapeutic ex - vivo - treated autologous central memory t cells
autologous anti - her2 - car - 4 - 1bb - cd3zeta - cd19t +  - expressing tcm - enriched t - lymphocytes
fluorine f 18 azafol
topical ammonia - oxidizing bacteria - based probiotic solution
allogeneic cd19car - transfected cytokine - induced killer cells
autologous taas - loaded autologous dendritic cells av - gbm - 1
egfr mutant - specific inhibitor bpi - 7711
sotorasib
autologous ny - eso - 1 - redirected crispr - edited t cells
coffea arabica extract
research activity
somatostatin antagonist
peroxisome proliferator - activated receptor agonist
nerve growth factor mimetic
ga - 68 neobomb1 pet / mri positron emission tomography and magnetic resonance imaging
ga - 68 psma - r2 positron emission tomography and magnetic resonance imaging
histone h2 gene
histone h2a gene
peripheral blood stem cell transplantation
histone h2b gene
histone h3 gene
histone h4 gene
histone gene mutation
histone h3 gene mutation
enrichment
en masse
do not process
hematopoietic cell transplantation
hist1h3b gene mutation
hist1h3b nm_003537 .3:c .83a > t
hist1h3c gene mutation
hist1h3c nm_003531 .2:c .83a > t
autosomal recessive cytochrome b - positive chronic granulomatous disease type i
x - linked chronic granulomatous disease
spinocerebellar ataxia type 12
hist1h3d gene mutation
hist1h3d nm_003530 .4:c .83a > t
h3f3a gene mutation
surveillance ,  epidemiology ,  and end results program
h3f3a nm_002107 .4:c .83a > t
locally advanced squamous cell carcinoma
locally advanced sinonasal squamous cell carcinoma
sinonasal poorly differentiated carcinoma
dabrafenib / trametinib regimen
binimetinib / encorafenib regimen
cobimetinib / vemurafenib regimen
seclidemstat
smoking
nutritional support
biochemotherapy
anatomical therapeutic chemical classification system
near infrared imaging agent hs - 196
recurrent peripheral t - cell lymphoma ,  not otherwise specified
methylated mgmt gene promoter
mgmt - methylated glioblastoma
firm
neoplastic corticotroph cell with abundant secretory granules
neoplastic corticotroph cell with scarce secretory granules
densely granulated corticotroph adenoma
technology transfer
sparsely granulated corticotroph adenoma
crooke hyaline change
crooke cell adenoma
usp8 gene mutation
nutrition ,  food and water contaminants
cancer immunotherapy
gallium ga 68 - neob
gallium ga 68 psma - r2
aerosol foam dosage form category
block dosage form category
romidepsin
healthcare problem list
pcornet - defined condition algorithm
active state
cachet dosage form category
inactive
icd - 9 - cm / pcs
icd - 10 - cm / pcs
icd - 11 - cm / pcs
international classification of diseases ,  eleventh revision ,  clinical modification
human phenotype ontology
revenue
global medical device nomenclature
underlying
month imputed
genderqueer
other gender
transgender
insurance claim
unable to classify
adult foster home
assisted living facility
other acute inpatient hospital
residential care facility
skilled nursing facility
non - functioning corticotroph adenoma
definitive surgical resection
densely granulated non - functioning corticotroph adenoma
sparsely granulated non - functioning corticotroph adenoma
capsule dose form category
cement dosage form category
collodion dosage form category
concentrated solution dosage form category
cream dosage form category
bosutinib monohydrate
resectable pleural malignant mesothelioma
resectable malignant mesothelioma
unresectable malignant mesothelioma
unresectable pleural malignant mesothelioma
cdisc clinical classification cdrs - r test name terminology
cdisc clinical classification cdrs - r test code terminology
cdisc clinical classification uhdrs 1999 version test name terminology
cdisc clinical classification uhdrs 1999 version test code terminology
hormone therapy
cdisc questionnaire facit - dyspnea scale 33 item bank version test name terminology
cdisc questionnaire facit - dyspnea scale 33 item bank version test code terminology
cdisc questionnaire fact - bl version 4 test name terminology
cdisc questionnaire fact - bl version 4 test code terminology
cdisc questionnaire nsclc - saq version 1 .0 test name terminology
cdisc questionnaire nsclc - saq version 1 .0 test code terminology
cdisc questionnaire smdds version 1 .0 test name terminology
cdisc questionnaire smdds version 1 .0 test code terminology
cdrs - r clinical classification question
uhdrs 1999 version clinical classification question
adjuvant study
facit - dyspnea scale 33 item bank version questionnaire question
fact - bl version 4 questionnaire question
nsclc - saq version 1 .0 questionnaire question
smdds version 1 .0 questionnaire question
drop dosage form category
drug delivery system category
emulsion dosage form category
film dosage form category
gel dosage form category
dietary intervention
vascular - targeted photodynamic therapy
exodx prostate intelliscore
melanoma of unknown primary
ambulatory visit
discharged alive
absent without leave
still in hospital
no higher limit
point - of - care
graft versus host disease prophylaxis / therapy
granule dosage form category
adult sickle cell quality of life measurement information system
nih toolbox
hospital consumer assessment of healthcare providers and systems
every afternoon
paper form
electronic form
h3c1 gene
h3c1 wt allele
h3c3 gene
somatostatin analog therapy
h3c3 wt allele
gum dosage form category
tfeb protein overexpression
mit family translocation - associated renal cell carcinoma
mit family translocation
anaplastic sarcoma of the kidney
implant dosage form category
telephonic format
telephonic format with interactive voice response technology
recombinant human interleukin - 15
h3c4 gene
h3c4 wt allele
multihormonal immunoreactivity present in a single cell type
multihormonal immunoreactivity present in two or more cell types
monomorphous plurihormonal pituitary gland adenoma
plurimorphous plurihormonal pituitary gland adenoma
self without assistance
self with assistance
proxy without assistance
proxy with assistance
heavy smoker
light smoker
h3c6 gene
smoked tobacco only
non - smoked tobacco only
use of both smoked and non - smoked tobacco products
h3c6 wt allele
use of smoked tobacco but no information about non - smoked tobacco use
insert dosage form category
pituitary gland double adenomas
prior biologic therapy
pituitary gland multiple adenomas
two separate tumor masses present in the same organ
more than two separate tumor masses present in the same organ
patient - reported
patient device direct feed reporting
healthcare delivery setting reporting
centers for medicare and medicaid services system for diagnosis - related groups
medicare severity diagnosis - related groups
period of medical insurance coverage for enrollment basis
period of outpatient prescription drug coverage for enrollment basis
period of care ,   encounter - based
topical fibrinogen - depleted human standardized platelet lysate cam - 101
geography - based enrollment
algorithm - based enrollment
order to dispense
order to administer
h3c7 gene
h3c7 wt allele
h3c8 gene
h3c8 wt allele
head and neck surgery
h3c10 gene
h3c10 wt allele
gradient echo mri
h3c11 gene
h3c11 wt allele
unresectable renal cell carcinoma
h3c12 gene
resectable renal cell carcinoma
h3c12 wt allele
lutetium lu 177 - dota - eb - tate
anti - pd - l1 monoclonal antibody cs1001
liquid dose form category
gentuximab
slct inhibitor gns561
lozenge dosage form category
methionine - restricted diet
ointment dosage form category
antibody - drug conjugate sc - 005
paste dosage form category
parp 1 / 2 inhibitor nov1401
pastille dosage form category
pd - l2 peptide - montanide vaccine
pd - l1 / pd - l2 peptide - montanide vaccine
autologous tbx - 4000 - treated peripheral blood mononuclear cells tbx - 3400
gallium ga 68 - nota - sgc8
maekmoondong - tang
genetically - modified anti - her2 - car - cd28zeta - expressing allogeneic nk - 92 / 5 .28 .z cells
curcumin / doxorubicin - encapsulating nanoparticle imx - 110
nintedanib esylate
adherence starts with knowledge 12 questionnaire
more than 3 months ago
neutral
forgot to take medicines some of the time
run out of medicine because do not get refills on time
taking medicines more than once a day is inconvenient
feel confident each medicine will help
know if reaching health goals
have someone to call with questions about medicines
work together with doctor or nurse to make decisions
have taken a medicine more or less often than prescribed
have skipped or stopped medicine because didn't think it was working
have skipped or stopped medicine because it made you feel bad
have skipped ,  stopped ,  not refilled ,  or taken less medicine because of cost
did not have medicine when time to take it
dermatoscope
patch dosage form category
melanoma advanced imaging dermatoscope
focus group
pellet dosage form category
pessary dosage form category
pillule dosage form category
plaster dosage form category
pouch dosage form category
poultice dosage form category
powder dosage form category
shampoo dosage form category
solution dosage form category
spray dosage form category
cryptophycin
stick dosage form category
suppository dosage form category
suspension dosage form category
syrup dosage form category
tablet dosage form category
endoesophageal brachytherapy
6 - channel balloon repositioning ,  multichannel applicator
recurrent metastatic malignant neoplasm
siewert classification
siewert type i
siewert type ii
siewert type iii
histone h2a - bbd
autosomal recessive spastic ataxia of charlevoix - saguenay
leukocyte adhesion deficiency type 3
digestive system large cell neuroendocrine carcinoma
prior invasive malignancy
prior invasive malignancy of other sites
advanced well differentiated neuroendocrine neoplasm
recurrent gastric adenocarcinoma
enrollment period
healthcare encounter
diagnosis code
procedure code
daromun
vital signs
dispensing
chemosensitization
lab result cm domain
condition domain
patient - reported outcomes cm domain
prescribing domain
pcornet trial domain
death cause domain
medication administered domain
provider domain
general observation domain
clin obs domain
digestive system small cell carcinoma
pipette closure device
h3c15 gene
h3c15 wt allele
h3c14 gene
h3c14 wt allele
h3c13 gene
h3c13 wt allele
h2ab1 gene
syngeneic bone marrow transplantation
h2ab1 wt allele
histone h2a - bbd type 1
h2ab2 gene
h2ab2 wt allele
h2ab3 gene
h2ab3 wt allele
histone h2a - bbd type 2 / 3
macroh2a2 gene
macroh2a2 wt allele
core histone macro - h2a .2
laser therapy
unstable
impossible
off observation
powder for vaginal solution dosage form
repetitive transcranial magnetic stimulation
variant allele frequency
h3 - 5 gene
h3 - 5 wt allele
histone h3 .3c
h3 - 4 gene
ablative endocrine surgery
h3 - 4 wt allele
histone h3 .1t
reporting source type code
braincheck cognitive assessment
clostridium butyricum cbm 588 probiotic strain
ribociclib / letrozole
esterified estrogens
normalized fluorescence intensity unit
cdisc protocol entities protocol contact role response terminology
cdisc protocol entities study contact information attribute terminology
cdisc send test article physical substance classification response terminology
cdisc send planned pharmacologic target mode of action response terminology
cdisc sdtm nutrition findings about test code terminology
cdisc sdtm nutrition findings about test name terminology
cdisc sdtm lung cancer findings about test code terminology
cdisc sdtm lung cancer findings about test name terminology
sexual contact
interferon therapy
main pancreatic and accessory ducts
compound 32
isotope therapy
transplant - related squamous cell carcinoma
apparent total body clearance rate
sae battery
calf muscular vein
organizational affiliation name
study contact information
national coordinating investigator
technical lead
clinical informaticist
biostatistician
replacement therapy
archive sample retrieval
internal orifice area
dinucleotide marker name
number of electroencephalogram electrodes
reference equation
continuous surface ecg recording for non - human species
continuous ecg recording for non - human species using implanted leads
erythroid cells to total cells ratio measurement
adrenal blockade
erythroid cells to nucleated cells ratio measurement
standard base excess measurement
megakaryocytes to leukocytes ratio measurement
immature platelet count
krebs von den lungen - 6 measurement
islet cell antibody measurement
atherogenic index of plasma
fibroblast growth factor 19 measurement
soluble cd163 measurement
retinol binding protein to creatinine ratio measurement
s100 calcium binding protein a8 measurement
4 - hydroxymidazolam measurement
1 - hydroxymidazolam measurement
bizarre platelet count
albumin index
igg index
e - selectin measurement
immunoglobulin heavy constant gamma 2 measurement
immunoglobulin heavy constant gamma 4 measurement
tryptophan measurement
hematologic toxicity attenuation
kynurenine measurement
lactulose measurement
mannitol measurement
aldrin epoxidase measurement
nociceptin measurement
thiocyanate measurement
hla class ia histocompatibility antigen measurement
hla class ib histocompatibility antigen measurement
hla class ic histocompatibility antigen measurement
hla dr beta1 histocompatibility antigen measurement
hla dq beta1 histocompatibility antigen measurement
hla dp beta1 histocompatibility antigen measurement
factor viii inhibitor measurement
albumin corrected calcium measurement
total protein corrected calcium measurement
segmented and band form neutrophils measurement
segmented ,  band form and precursor neutrophils measurement
mononuclear cell count
homocitrulline measurement
alpha - aminobutyric acid measurement
sarcosine measurement
alpha - aminoadipic acid measurement
alloisoleucine measurement
argininosuccinic acid measurement
beta alanine measurement
beta - aminobutyric acid measurement
gamma - aminobutyric acid measurement
hydroxylysine measurement
inactive glucagon - like peptide - 1 measurement
anti - double stranded dna igg measurement
prior radiation therapy
buccal lymph node
common femoral vein
fibular vein
gastric curvature lymph node
perirectal lymph node
presacral lymph node
deep femoral vein
sensorimotor cortex
posterior cingulate cortex
prefrontal cortex
group c / treatment ind protocol
shin
l5 - s1 intervertebral space
congo red staining method
contrast enhanced x - ray
electroneurography
enzymatic spectrophotometry
fluorescence lifetime imaging microscopy
knemometry
oscillometry
pulmonary angiography
immune globulin / zidovudine
secondary ion mass spectrometry
single photon tomography and computed tomography scan
immunochromatography
palm method
automated count
manual count
westergren tube method
impedance conductivity
flocculation assay
complement fixation assay
recombinant ox40 ligand
transitional cell to tumor cell ratio measurement
tumor cell count
histologic type of cancer
myelofibrosis assessment
ros1 protein measurement
alk protein measurement
egfr variant protein measurement
programmed death ligand 1 measurement
bauermeister score
european consensus score for bone marrow fibrosis
antiandrogen therapy
tumor proportion score
gram positive bacteria measurement
gram negative bacteria measurement
fungi measurement
streptococcus pyogenes antigen measurement
rubeola antigen measurement
histoplasma capsulatum antigen measurement
galactomannan antigen measurement
escherichia coli shiga - like toxin measurement
helicobacter pylori antigen measurement
androgen therapy
bacterial sialidase measurement
hiv - 1 antigen measurement
giardia lamblia antigen measurement
respiratory syncytial virus antigen measurement
streptococcus agalactiae antigen measurement
urease measurement
legionella pneumophila serogroup 1 antigen measurement
rotavirus antigen measurement
cytomegalovirus antigen measurement
cryptococcus antigen measurement
estrogen therapy
adenovirus antigen measurement
cryptosporidium parvum antigen measurement
bordetella pertussis antigen measurement
human parainfluenza antigen measurement
human parainfluenza type 1 antigen measurement
chlamydia trachomatis antigen measurement
pathologist 1
pathologist 2
absolute bioavailability
relative bioavailability
progestin therapy
fraction bound
total clearance predicted for unbound drug
total clearance observed for unbound drug
renal clearance for unbound drug
apparent clearance for unbound drug
observed area under the curve infinity of unbound drug
predicted area under the curve infinity of unbound drug
area under the curve from dosing to last concentration of unbound drug
maximum concentration of unbound drug
renal clearance to total clearance ratio measurement after oral dosing
renal clearance to total clearance ratio measurement after intravenous dosing
step father
peritoneal dialysis fluid
metastatic tumor site indicator
hertz per second
milliliter per 100 grams per minute
enzyme unit per gram hemoglobin
poise
micrometer per second
microsiemens
cancer primary site known indicator
tumor resected indicator
heterosexual contact
homosexual contact
intrauterine exposure
cerebral blood flow assessment
skin conductance
sleep onset latency
n1 sleep phase duration
n2 sleep phase duration
hypercalcemia therapy
n3 sleep phase duration
rapid eye movement sleep phase duration
rapid eye movement sleep phase latency
thorascopic wedge resection of the lung
khoisan
aboriginal australian
fundal height
erythema indicator
rash indicator
skene's gland abnormality indicator
bartholin's gland abnormality indicator
ulcer indicator
pustule indicator
peeling indicator
ecchymosis indicator
edema indicator
mass indicator
motion tenderness indicator
discharge indicator
abnormal bleeding indicator
releasing hormone agonist therapy
income level
neck circumference
experimental organism adenocarcinoma arising in fibroadenoma
growth plate open
squamous plaque / cyst
cytoplasmic alteration
test article physical class
activator
inhibitor
full receptor agonist
br96 sfv - pe40
monoclonal antibody therapy
partial receptor agonist
inverse receptor agonist
mixed agonist / antagonist
allosteric potentiator
allosteric modulator
rna - based molecule
number of electrocardiogram electrodes
number of electrooculogram electrodes
number of electromyogram electrodes
fontanelle closure indicator
premenopausal
targeted imaging
neonatal adverse event
inc - meddra neonatal adverse events terminology
deleterious dna damage response gene mutation
c5 gene mutation
naive t cell - depleted hematopoietic stem cell transplantation
arid1a negative
bronchopulmonary dysplasia ,  ae
estrogen receptor positive
neonatal pneumothorax ,  ae
neonatal coagulation disorder ,  ae
necrotizing enterocolitis ,  ae
periventricular leukomalacia ,  ae
neonatal spontaneous intestinal perforation ,  ae
retinopathy of prematurity ,  ae
infant sedation ,  ae
neonatal culture positive sepsis ,  ae
neonatal culture negative sepsis ,  ae
neonatal hypertension ,  ae
estrogen receptor negative
neonatal hypotension ,  ae
neonatal edema ,  ae
neonatal sinus tachycardia ,  ae
neonatal sinus bradycardia ,  ae
neonatal epileptic seizure ,  ae
neonatal rash ,  ae
neonatal pulmonary hemorrhage ,  ae
neonatal intraventricular hemorrhage ,  ae
infantile apnea ,  ae
infant irritability ,  ae
persistent pulmonary hypertension of the newborn ,  ae
neonatal fever ,  ae
infantile vomiting ,  ae
neonatal gastrointestinal bleeding ,  ae
feeding intolerance ,  ae
hypoxic ischemic encephalopathy ,  ae
neonatal constipation ,  ae
neonatal administration site complication ,  ae
neonatal tachyarrhythmia ,  ae
neonatal bradyarrhythmia ,  ae
estrogen receptor status unknown
neonatal respiratory distress syndrome ,  ae
neonatal respiratory insufficiency ,  ae
neonatal convulsion ,  ae
neonatal diarrhea ,  ae
arid1a positive
progesterone receptor positive
progesterone receptor negative
fat - soluble vitamin
anticachectic therapy
tumor necrosis factor therapy
antibody - drug conjugate therapy
amino acid injection
water - soluble vitamin
infection prophylaxis and management
grade 1 neonatal convulsion ,  ae
grade 2 neonatal convulsion ,  ae
grade 3 neonatal convulsion ,  ae
grade 4 neonatal convulsion ,  ae
grade 5 neonatal convulsion ,  ae
grade 1 neonatal epileptic seizure ,  ae
grade 2 neonatal epileptic seizure ,  ae
grade 3 neonatal epileptic seizure ,  ae
grade 4 neonatal epileptic seizure ,  ae
grade 5 neonatal epileptic seizure ,  ae
grade 1 neonatal intraventricular hemorrhage ,  ae
grade 2 neonatal intraventricular hemorrhage ,  ae
grade 3 neonatal intraventricular hemorrhage ,  ae
grade 4 neonatal intraventricular hemorrhage ,  ae
grade 5 neonatal intraventricular hemorrhage ,  ae
grade 1 retinopathy of prematurity ,  ae
grade 2 retinopathy of prematurity ,  ae
grade 3 retinopathy of prematurity ,  ae
grade 4 retinopathy of prematurity ,  ae
psychosocial assessment and care
grade 5 retinopathy of prematurity ,  ae
grade 1 hypoxic ischemic encephalopathy ,  ae
grade 2 hypoxic ischemic encephalopathy ,  ae
grade 3 hypoxic ischemic encephalopathy ,  ae
grade 4 hypoxic ischemic encephalopathy ,  ae
grade 5 hypoxic ischemic encephalopathy ,  ae
grade 1 periventricular leukomalacia ,  ae
grade 2 periventricular leukomalacia ,  ae
grade 3 periventricular leukomalacia ,  ae
grade 1 infant irritability ,  ae
colony - stimulating factor therapy
grade 2 infant irritability ,  ae
grade 3 infant irritability ,  ae
grade 4 infant irritability ,  ae
grade 1 infant sedation ,  ae
grade 2 infant sedation ,  ae
grade 3 infant sedation ,  ae
grade 4 infant sedation ,  ae
grade 1 neonatal hypotension ,  ae
grade 2 neonatal hypotension ,  ae
grade 3 neonatal hypotension ,  ae
grade 4 neonatal hypotension ,  ae
grade 5 neonatal hypotension ,  ae
grade 1 neonatal hypertension ,  ae
grade 2 neonatal hypertension ,  ae
grade 3 neonatal hypertension ,  ae
grade 4 neonatal hypertension ,  ae
grade 5 neonatal hypertension ,  ae
grade 1 neonatal sinus tachycardia ,  ae
grade 2 neonatal sinus tachycardia ,  ae
grade 3 neonatal sinus tachycardia ,  ae
catheter management
grade 4 neonatal sinus tachycardia ,  ae
grade 5 neonatal sinus tachycardia ,  ae
grade 1 neonatal sinus bradycardia ,  ae
grade 2 neonatal sinus bradycardia ,  ae
grade 3 neonatal sinus bradycardia ,  ae
grade 4 neonatal sinus bradycardia ,  ae
grade 5 neonatal sinus bradycardia ,  ae
grade 1 neonatal tachyarrhythmia ,  ae
grade 2 neonatal tachyarrhythmia ,  ae
grade 3 neonatal tachyarrhythmia ,  ae
grade 4 neonatal tachyarrhythmia ,  ae
grade 5 neonatal tachyarrhythmia ,  ae
grade 1 neonatal bradyarrhythmia ,  ae
grade 2 neonatal bradyarrhythmia ,  ae
grade 3 neonatal bradyarrhythmia ,  ae
grade 4 neonatal bradyarrhythmia ,  ae
grade 5 neonatal bradyarrhythmia ,  ae
grade 1 neonatal edema ,  ae
grade 2 neonatal edema ,  ae
grade 3 neonatal edema ,  ae
grade 4 neonatal edema ,  ae
grade 5 neonatal edema ,  ae
grade 1 neonatal coagulation disorder ,  ae
grade 2 neonatal coagulation disorder ,  ae
grade 3 neonatal coagulation disorder ,  ae
grade 4 neonatal coagulation disorder ,  ae
grade 5 neonatal coagulation disorder ,  ae
grade 1 infantile apnea ,  ae
grade 2 infantile apnea ,  ae
grade 3 infantile apnea ,  ae
vasopressin tannate in oil
grade 4 infantile apnea ,  ae
grade 5 infantile apnea ,  ae
grade 1 neonatal respiratory insufficiency ,  ae
grade 2 neonatal respiratory insufficiency ,  ae
grade 3 neonatal respiratory insufficiency ,  ae
grade 4 neonatal respiratory insufficiency ,  ae
grade 5 neonatal respiratory insufficiency ,  ae
grade 1 neonatal respiratory distress syndrome ,  ae
grade 2 neonatal respiratory distress syndrome ,  ae
grade 3 neonatal respiratory distress syndrome ,  ae
antiprogesterone therapy
grade 4 neonatal respiratory distress syndrome ,  ae
grade 5 neonatal respiratory distress syndrome ,  ae
grade 1 neonatal pulmonary hemorrhage ,  ae
grade 2 neonatal pulmonary hemorrhage ,  ae
grade 3 neonatal pulmonary hemorrhage ,  ae
grade 4 neonatal pulmonary hemorrhage ,  ae
grade 5 neonatal pulmonary hemorrhage ,  ae
grade 1 persistent pulmonary hypertension of the newborn ,  ae
grade 2 persistent pulmonary hypertension of the newborn ,  ae
grade 3 persistent pulmonary hypertension of the newborn ,  ae
grade 4 persistent pulmonary hypertension of the newborn ,  ae
grade 5 persistent pulmonary hypertension of the newborn ,  ae
grade 1 neonatal pneumothorax ,  ae
grade 2 neonatal pneumothorax ,  ae
grade 3 neonatal pneumothorax ,  ae
grade 4 neonatal pneumothorax ,  ae
grade 5 neonatal pneumothorax ,  ae
grade 1 bronchopulmonary dysplasia ,  ae
grade 2 bronchopulmonary dysplasia ,  ae
grade 3 bronchopulmonary dysplasia ,  ae
grade 4 bronchopulmonary dysplasia ,  ae
grade 5 bronchopulmonary dysplasia ,  ae
grade 3 necrotizing enterocolitis ,  ae
grade 4 necrotizing enterocolitis ,  ae
grade 5 necrotizing enterocolitis ,  ae
grade 1 neonatal diarrhea ,  ae
grade 2 neonatal diarrhea ,  ae
grade 3 neonatal diarrhea ,  ae
grade 4 neonatal diarrhea ,  ae
grade 5 neonatal diarrhea ,  ae
tumor infiltrating lymphocyte therapy
grade 1 infantile vomiting ,  ae
grade 2 infantile vomiting ,  ae
grade 3 infantile vomiting ,  ae
grade 4 infantile vomiting ,  ae
grade 5 infantile vomiting ,  ae
grade 1 feeding intolerance ,  ae
grade 2 feeding intolerance ,  ae
grade 3 feeding intolerance ,  ae
grade 4 feeding intolerance ,  ae
grade 5 feeding intolerance ,  ae
aromatase inhibition therapy
grade 1 neonatal gastrointestinal bleeding ,  ae
grade 2 neonatal gastrointestinal bleeding ,  ae
grade 3 neonatal gastrointestinal bleeding ,  ae
grade 4 neonatal gastrointestinal bleeding ,  ae
grade 5 neonatal gastrointestinal bleeding ,  ae
grade 3 neonatal spontaneous intestinal perforation ,  ae
grade 4 neonatal spontaneous intestinal perforation ,  ae
grade 5 neonatal spontaneous intestinal perforation ,  ae
grade 1 neonatal constipation ,  ae
grade 2 neonatal constipation ,  ae
5a - reductase inhibition
grade 3 neonatal constipation ,  ae
grade 4 neonatal constipation ,  ae
grade 5 neonatal constipation ,  ae
grade 2 neonatal culture negative sepsis ,  ae
grade 3 neonatal culture negative sepsis ,  ae
grade 4 neonatal culture negative sepsis ,  ae
grade 5 neonatal culture negative sepsis ,  ae
grade 1 neonatal culture positive sepsis ,  ae
grade 2 neonatal culture positive sepsis ,  ae
grade 3 neonatal culture positive sepsis ,  ae
grade 4 neonatal culture positive sepsis ,  ae
grade 5 neonatal culture positive sepsis ,  ae
grade 1 neonatal rash ,  ae
grade 2 neonatal rash ,  ae
grade 3 neonatal rash ,  ae
grade 4 neonatal rash ,  ae
grade 5 neonatal rash ,  ae
grade 1 neonatal administration site complication ,  ae
grade 2 neonatal administration site complication ,  ae
grade 3 neonatal administration site complication ,  ae
grade 4 neonatal administration site complication ,  ae
grade 5 neonatal administration site complication ,  ae
grade 1 neonatal fever ,  ae
grade 2 neonatal fever ,  ae
grade 3 neonatal fever ,  ae
grade 4 neonatal fever ,  ae
grade 5 neonatal fever ,  ae
blasts 5 - 9 percent of bone marrow nucleated cells
blasts 2 - 4 percent of peripheral blood white cells
robot - assisted esophagectomy
bone metastases prevention
complex partial seizure
non - convulsive status epilepticus
fluorine f 18 parp inhibitor
autologous ccr4 - cd30car - cd28 - cd3zeta - expressing t - lymphocytes
autologous cd30car - cd28 - cd3zeta - expressing t - lymphocytes
cartox 10 point neurological assessment
cartox grade 1
cartox grade 2
cartox grade 3
erbb2 nm_004448 .3:c .2305g > t
thyroid agent
erbb2 np_004439 .2:p .d769y
erbb2 nm_004448 .3:c .2305g > c
erbb2 np_004439 .2:p .d769h
gain of chromosome 14q
pituitary gland blastoma
cutaneous melanoma of the extremity
recurrent cutaneous melanoma of the extremity
sickle cell - hemoglobin e disease
erbb2 nm_004448 .3:c .962a > g
erbb2 np_004439 .2:p .e321g
sickle cell - hemoglobin d disease
advanced cutaneous melanoma of the extremity
sickle cell chronic lung disease
proliferative retinopathy
how recently
bilateral proliferative retinopathy
pdhx gene
pdhx wt allele
pyruvate dehydrogenase protein x component ,  mitochondrial
read depth
anti - cd38 monoclonal antibody
braf inhibitor
children's depression rating scale ,  revised clinical classification
unified huntington's disease rating scale 1999 version clinical classification
functional assessment of chronic illness therapy - dyspnea scale 33 item bank questionnaire
functional assessment of cancer therapy - bladder version 4 questionnaire
non - small cell lung cancer symptom assessment questionnaire v1 .0
symptoms of major depressive disorder scale v1 .0 questionnaire
cdrs - r  -  impaired schoolwork
chemoprotection
cdrs - r  -  impaired schoolwork comment
cdrs - r  -  difficulty having fun
cdrs - r  -  difficulty having fun comment
cdrs - r  -  social withdrawal
cdrs - r  -  social withdrawal comment
cdrs - r  -  sleep disturbance
cdrs - r  -  sleep disturbance comment
cdrs - r  -  appetite disturbance
cdrs - r  -  appetite disturbance comment
cdrs - r  -  excessive fatigue
cdrs - r  -  excessive fatigue comment
cdrs - r  -  physical complaints
cdrs - r  -  physical complaints comment
cdrs - r  -  irritability
cdrs - r  -  irritability comment
cdrs - r  -  excessive guilt
cdrs - r  -  excessive guilt comment
cdrs - r  -  low self - esteem
cdrs - r  -  low self - esteem comment
cdrs - r  -  depressed feelings
cdrs - r  -  depressed feelings comment
cdrs - r  -  morbid ideation
cdrs - r  -  morbid ideation comment
cdrs - r  -  suicidal ideation
cdrs - r  -  suicidal ideation comment
cdrs - r  -  excessive weeping
cdrs - r  -  excessive weeping comment
cdrs - r  -  depressed facial affect
cdrs - r  -  depressed facial affect comment
cdrs - r  -  listless speech
therapeutic bone marrow suppression
cdrs - r  -  listless speech comment
cdrs - r  -  hypoactivity
cdrs - r  -  hypoactivity comment
cdrs - r  -  subtotal 1
cdrs - r  -  subtotal 2
cdrs - r  -  subtotal 3
cdrs - r  -  cdrs - r raw summary score
cdrs - r  -  cdrs - r t - score
cdrs - r  -  cdrs - r percentile
cdrs - r  -  cdrs - r t - score range
uhdrs 1999 version  -  ocular pursuit: horizontal
uhdrs 1999 version  -  ocular pursuit: vertical
uhdrs 1999 version  -  saccade initiation: horizontal
uhdrs 1999 version  -  saccade initiation: vertical
uhdrs 1999 version  -  saccade velocity: horizontal
uhdrs 1999 version  -  saccade velocity: vertical
uhdrs 1999 version  -  dysarthria
uhdrs 1999 version  -  tongue protrusion
uhdrs 1999 version  -  finger taps: right
uhdrs 1999 version  -  finger taps: left
protocol treatment arm
uhdrs 1999 version  -  pronate / supinate: hands: right
uhdrs 1999 version  -  pronate / supinate: hands: left
uhdrs 1999 version  -  luria
uhdrs 1999 version  -  rigidity: arms: right
uhdrs 1999 version  -  rigidity: arms: left
uhdrs 1999 version  -  bradykinesia: body
uhdrs 1999 version  -  maximal dystonia: trunk
uhdrs 1999 version  -  maximal dystonia: rue
uhdrs 1999 version  -  maximal dystonia: lue
uhdrs 1999 version  -  maximal dystonia: rle
uhdrs 1999 version  -  maximal dystonia: lle
uhdrs 1999 version  -  maximal chorea: face
uhdrs 1999 version  -  maximal chorea: bol
uhdrs 1999 version  -  maximal chorea: trunk
uhdrs 1999 version  -  maximal chorea: rue
uhdrs 1999 version  -  maximal chorea: lue
uhdrs 1999 version  -  maximal chorea: rle
uhdrs 1999 version  -  maximal chorea: lle
uhdrs 1999 version  -  gait
uhdrs 1999 version  -  tandem walking
edrecolomab
antiprolactin therapy
uhdrs 1999 version  -  retropulsion pull test
uhdrs 1999 version  -  diagnosis confidence level
uhdrs 1999 version  -  verbal fluency test
uhdrs 1999 version  -  symbol digit modalities test
uhdrs 1999 version  -  depressed mood: frequency
uhdrs 1999 version  -  depressed mood: severity
uhdrs 1999 version  -  apathy: frequency
uhdrs 1999 version  -  apathy: severity
uhdrs 1999 version  -  self - esteem / guilt: frequency
uhdrs 1999 version  -  self - esteem / guilt: severity
sleep disorder therapy
uhdrs 1999 version  -  suicidal thoughts: frequency
uhdrs 1999 version  -  suicidal thoughts: severity
uhdrs 1999 version  -  anxiety: frequency
uhdrs 1999 version  -  anxiety: severity
uhdrs 1999 version  -  irritable behavior: frequency
uhdrs 1999 version  -  irritable behavior: severity
uhdrs 1999 version  -  disruptive behavior: frequency
uhdrs 1999 version  -  udhr1 - disruptive behavior: severity
uhdrs 1999 version  -  perseverative thinking: frequency
uhdrs 1999 version  -  udhr1 - perseverative thinking: severity
antibody therapy
uhdrs 1999 version  -  compulsive behavior: frequency
uhdrs 1999 version  -  udhr1 - compulsive behavior: severity
uhdrs 1999 version  -  delusions: frequency
uhdrs 1999 version  -  udhr1 - delusions: severity
uhdrs 1999 version  -  hallucinations: frequency
uhdrs 1999 version  -  udhr1 - hallucinations: severity
uhdrs 1999 version  -  udhr1 - examiner believe subject confused
uhdrs 1999 version  -  udhr1 - confusion altered performance
uhdrs 1999 version  -  udhr1 - examiner believe signs of dementia
uhdrs 1999 version  -  udhr1 - dementia altered performance
interleukin therapy
uhdrs 1999 version  -  udhr1 - examiner believe signs depression
uhdrs 1999 version  -  pharmacotherapy of depression
uhdrs 1999 version  -  pharmacotherapy of irritability
uhdrs 1999 version  -  behavior assessment obtained from
uhdrs 1999 version  -  gainful employment accustomed work
uhdrs 1999 version  -  any gainful employment
uhdrs 1999 version  -  volunteer or non gainful work
uhdrs 1999 version  -  manage finances without help
uhdrs 1999 version  -  shop for groceries without help
uhdrs 1999 version  -  handle money as purchaser
anti - cytokine therapy
uhdrs 1999 version  -  supervise children without help
uhdrs 1999 version  -  operate automobile safely
uhdrs 1999 version  -  do housework without help
uhdrs 1999 version  -  do laundry without help
uhdrs 1999 version  -  prepare own meals without help
uhdrs 1999 version  -  use telephone without help
uhdrs 1999 version  -  take medications without help
uhdrs 1999 version  -  feed himself / herself without help
uhdrs 1999 version  -  dress himself / herself without help
uhdrs 1999 version  -  bathe himself / herself without help
uhdrs 1999 version  -  public transportation without help
uhdrs 1999 version  -  walk own neighborhood without help
uhdrs 1999 version  -  walk without falling
uhdrs 1999 version  -  walk without help
uhdrs 1999 version  -  comb hair without help
uhdrs 1999 version  -  transfer chair without help
uhdrs 1999 version  -  get in and out of bed without help
uhdrs 1999 version  -  use toilet / commode without help
uhdrs 1999 version  -  care provided at home
uhdrs 1999 version  -  functional assess obtained from
breast cancer screening
uhdrs 1999 version  -  current level subject independence
uhdrs 1999 version  -  occupation
uhdrs 1999 version  -  finances
uhdrs 1999 version  -  domestic chores
uhdrs 1999 version  -  adl
uhdrs 1999 version  -  care level
uhdrs 1999 version  -  functional capacity obtained from
uhdrs 1999 version  -  purpose of this visit
uhdrs 1999 version  -  since last assessment opinion
uhdrs 1999 version  -  since last assessment feel
uhdrs 1999 version  -  believe subject has manifest hd
uhdrs 1999 version  -  permanently institutionalized
uhdrs 1999 version  -  continue to be assessed for study
uhdrs 1999 version  -  total motor score
uhdrs 1999 version  -  total behavior score
uhdrs 1999 version  -  mood subscale score
uhdrs 1999 version  -  behavior subscale score
uhdrs 1999 version  -  psychosis subscale score
uhdrs 1999 version  -  obsessive subscale score
uhdrs 1999 version  -  total functional capacity score
uhdrs 1999 version  -  independence scale score
uhdrs 1999 version  -  functional checklist score
facit - dyspnea scale 33 item bank version  -  severity: dressing without help
facit - dyspnea scale 33 item bank version  -  severity: dressing why not
facit - dyspnea scale 33 item bank version  -  severity: walk 50 steps
facit - dyspnea scale 33 item bank version  -  severity: walk 50 steps why not
facit - dyspnea scale 33 item bank version  -  severity: walk up 20 stairs
facit - dyspnea scale 33 item bank version  -  severity: walk up 20 stairs why not
facit - dyspnea scale 33 item bank version  -  severity: preparing meals
facit - dyspnea scale 33 item bank version  -  severity: preparing meals why not
facit - dyspnea scale 33 item bank version  -  severity: washing dishes
facit - dyspnea scale 33 item bank version  -  severity: washing dishes why not
facit - dyspnea scale 33 item bank version  -  severity: sweeping / mopping
facit - dyspnea scale 33 item bank version  -  severity: sweeping / mopping why not
facit - dyspnea scale 33 item bank version  -  severity: making a bed
facit - dyspnea scale 33 item bank version  -  severity: making a bed why not
facit - dyspnea scale 33 item bank version  -  severity: lifting 10 - 20 lbs
facit - dyspnea scale 33 item bank version  -  severity: lifting 10 - 20 lbs why not
facit - dyspnea scale 33 item bank version  -  severity: carry 10 - 20 lbs
facit - dyspnea scale 33 item bank version  -  severity: carry 10 - 20 lbs why not
pegylated liposomal doxorubicin hydrochloride
facit - dyspnea scale 33 item bank version  -  severity: walk for 1 / 2 mile
facit - dyspnea scale 33 item bank version  -  severity: walk for 1 / 2 mile why not
facit - dyspnea scale 33 item bank version  -  severity: bath without help
facit - dyspnea scale 33 item bank version  -  severity: bath without help why not
facit - dyspnea scale 33 item bank version  -  severity: taking a shower
facit - dyspnea scale 33 item bank version  -  severity: taking a shower why not
facit - dyspnea scale 33 item bank version  -  severity: putting on socks
facit - dyspnea scale 33 item bank version  -  severity: putting on socks why not
facit - dyspnea scale 33 item bank version  -  severity: standing 5 minutes
facit - dyspnea scale 33 item bank version  -  severity: standing 5 minutes why not
facit - dyspnea scale 33 item bank version  -  severity: walking 10 steps
facit - dyspnea scale 33 item bank version  -  severity: walking 10 steps why not
facit - dyspnea scale 33 item bank version  -  severity: walking 1 / 2 mile
facit - dyspnea scale 33 item bank version  -  severity: walking 1 / 2 mile why not
facit - dyspnea scale 33 item bank version  -  severity: walking up 5 stairs
facit - dyspnea scale 33 item bank version  -  severity: walking up 5 stairs why not
facit - dyspnea scale 33 item bank version  -  severity: walking up 10 stairs
facit - dyspnea scale 33 item bank version  -  severity: walking up 10 stairs why not
facit - dyspnea scale 33 item bank version  -  severity: walking up 30 stairs
facit - dyspnea scale 33 item bank version  -  severity: walking up 30 stairs why not
facit - dyspnea scale 33 item bank version  -  severity: lift less than 5 lbs
facit - dyspnea scale 33 item bank version  -  severity: lift less than 5 lbs why not
facit - dyspnea scale 33 item bank version  -  severity: lifting 5 - 10 lbs
facit - dyspnea scale 33 item bank version  -  severity: lifting 5 - 10 lbs why not
facit - dyspnea scale 33 item bank version  -  severity: lift more than 20 lbs
facit - dyspnea scale 33 item bank version  -  severity: lift more than 20 lbs why not
facit - dyspnea scale 33 item bank version  -  severity: carrying less than 5 lbs
facit - dyspnea scale 33 item bank version  -  severity: carrying less than 5 why not
facit - dyspnea scale 33 item bank version  -  severity: carrying 5 - 10 lbs
facit - dyspnea scale 33 item bank version  -  severity: carrying 5 - 10 lbs why not
breast cancer prevention
facit - dyspnea scale 33 item bank version  -  severity: get in / out of a car
facit - dyspnea scale 33 item bank version  -  severity: get in / out of a car why not
facit - dyspnea scale 33 item bank version  -  severity: dining out
facit - dyspnea scale 33 item bank version  -  severity: dining out why not
facit - dyspnea scale 33 item bank version  -  severity: low - intensity activity
facit - dyspnea scale 33 item bank version  -  severity: low - intensity activity why not
facit - dyspnea scale 33 item bank version  -  severity: moderate activity
facit - dyspnea scale 33 item bank version  -  severity: moderate activity why not
facit - dyspnea scale 33 item bank version  -  severity: walk fast 50 steps
facit - dyspnea scale 33 item bank version  -  severity: walk fast 50 steps why not
facit - dyspnea scale 33 item bank version  -  severity: walking fast 1 mile
facit - dyspnea scale 33 item bank version  -  severity: walking fast 1 mile why not
facit - dyspnea scale 33 item bank version  -  severity: singing or humming
facit - dyspnea scale 33 item bank version  -  severity: singing or humming why not
facit - dyspnea scale 33 item bank version  -  severity: talking while walking
facit - dyspnea scale 33 item bank version  -  severity: talking while walk why not
facit - dyspnea scale 33 item bank version  -  severity: scrubbing the floor
facit - dyspnea scale 33 item bank version  -  severity: scrubbing the floor why not
facit - dyspnea scale 33 item bank version  -  limit: dressing without help
facit - dyspnea scale 33 item bank version  -  limit: walk 50 steps
facit - dyspnea scale 33 item bank version  -  limit: walk up 20 stairs
facit - dyspnea scale 33 item bank version  -  limit: preparing meals
facit - dyspnea scale 33 item bank version  -  limit: washing dishes
facit - dyspnea scale 33 item bank version  -  limit: sweeping / mopping
facit - dyspnea scale 33 item bank version  -  limit: making a bed
facit - dyspnea scale 33 item bank version  -  limit: lifting 10 - 20 lbs
facit - dyspnea scale 33 item bank version  -  limit: carry 10 - 20 lbs
facit - dyspnea scale 33 item bank version  -  limit: walk for 1 / 2 mile
facit - dyspnea scale 33 item bank version  -  limit: taking a bath without help
facit - dyspnea scale 33 item bank version  -  limit: taking a shower
facit - dyspnea scale 33 item bank version  -  limit: putting on socks
facit - dyspnea scale 33 item bank version  -  limit: standing 5 minutes
facit - dyspnea scale 33 item bank version  -  limit: walking 10 steps
facit - dyspnea scale 33 item bank version  -  limit: walking 1 / 2 mile
facit - dyspnea scale 33 item bank version  -  limit: walking up 5 stairs
facit - dyspnea scale 33 item bank version  -  limit: walking up 10 stairs
facit - dyspnea scale 33 item bank version  -  limit: walking up 30 stairs
facit - dyspnea scale 33 item bank version  -  limit: scrubbing the floor
facit - dyspnea scale 33 item bank version  -  limit: lifting less than 5 lbs
facit - dyspnea scale 33 item bank version  -  limit: lifting 5 - 10 lbs
facit - dyspnea scale 33 item bank version  -  limit: lifting more than 20 lbs
facit - dyspnea scale 33 item bank version  -  limit: carrying less than 5 lbs
facit - dyspnea scale 33 item bank version  -  limit: carrying 5 - 10 lbs
facit - dyspnea scale 33 item bank version  -  limit: get in / out of a car
facit - dyspnea scale 33 item bank version  -  limit: dining out
facit - dyspnea scale 33 item bank version  -  limit: low - intensity activity
facit - dyspnea scale 33 item bank version  -  limit: moderate activity
facit - dyspnea scale 33 item bank version  -  limit: walk fast 50 steps
facit - dyspnea scale 33 item bank version  -  limit: walking fast 1 mile
facit - dyspnea scale 33 item bank version  -  limit: singing or humming
facit - dyspnea scale 33 item bank version  -  limit: talking while walking
fact - bl version 4  -  i have a lack of energy
fact - bl version 4  -  i have nausea
fact - bl version 4  -  trouble meeting needs of family
fact - bl version 4  -  i have pain
fact - bl version 4  -  bothered by treatment side effect
fact - bl version 4  -  i feel ill
fact - bl version 4  -  i am forced to spend time in bed
fact - bl version 4  -  i feel close to my friends
fact - bl version 4  -  get emotional support from family
fact - bl version 4  -  i get support from my friends
fact - bl version 4  -  my family has accepted my illness
fact - bl version 4  -  satisfied communication illness
fact - bl version 4  -  i feel close to my partner
fact - bl version 4  -  i am satisfied with my sex life
fact - bl version 4  -  i feel sad
fact - bl version 4  -  satisfied with how i am coping
fact - bl version 4  -  losing hope against illness
fact - bl version 4  -  i feel nervous
fact - bl version 4  -  i worry about dying
purine antagonist
fact - bl version 4  -  worry my condition will get worse
fact - bl version 4  -  i am able to work
fact - bl version 4  -  my work is fulfilling
fact - bl version 4  -  i am able to enjoy life
fact - bl version 4  -  i have accepted my illness
fact - bl version 4  -  i am sleeping well
fact - bl version 4  -  enjoy things i usually do for fun
fact - bl version 4  -  content with quality of my life
fact - bl version 4  -  trouble controlling my urine
fact - bl version 4  -  i am losing weight
fact - bl version 4  -  i have control of my bowels
fact - bl version 4  -  i urinate more frequently
fact - bl version 4  -  i have diarrhea
fact - bl version 4  -  i have a good appetite
fact - bl version 4  -  i like the appearance of my body
fact - bl version 4  -  it burns when i urinate
fact - bl version 4  -  i am interested in sex
fact - bl version 4  -  able to have / maintain erection
fact - bl version 4  -  do you have an ostomy appliance
fact - bl version 4  -  embarrassed by ostomy appliance
fact - bl version 4  -  caring for ostomy appliance is difficult
nsclc - saq version 1 .0  -  rate coughing at worst
nsclc - saq version 1 .0  -  rate worst pain in chest
nsclc - saq version 1 .0  -  rate worst pain other than chest
nsclc - saq version 1 .0  -  short of breath usual activities
nsclc - saq version 1 .0  -  how often low energy
nsclc - saq version 1 .0  -  how often tire easily
nsclc - saq version 1 .0  -  how often poor appetite
nsclc - saq version 1 .0  -  total score
smdds version 1 .0  -  how sad have you felt
smdds version 1 .0  -  how hopeless have you felt
smdds version 1 .0  -  how irritable have you felt
smdds version 1 .0  -  how overwhelmed have you felt
smdds version 1 .0  -  how worried have you felt
smdds version 1 .0  -  how tired have you felt
smdds version 1 .0  -  how difficult stop think problems
smdds version 1 .0  -  how difficult to concentrate
smdds version 1 .0  -  how difficult to enjoy daily life
smdds version 1 .0  -  how often problem with sleep
smdds version 1 .0  -  how often have poor appetite
smdds version 1 .0  -  how often did you over eat
smdds version 1 .0  -  how much push yourself do things
smdds version 1 .0  -  how much feel like doing nothing
smdds version 1 .0  -  how much blame yourself bad thing
smdds version 1 .0  -  how much feel not worth living
smdds version 1 .0  -  total score
hama  -  total score
sarcoma of the extremity
recurrent sarcoma of the extremity
advanced sarcoma of the extremity
prior adjuvant endocrine therapy
primitive mesenchymal stroma formation
cdk7 inhibitor ct7001
anti - gd2 monoclonal antibody
anti - pd - l1 monoclonal antibody bgb - a333
plasmodium vivax - infected red blood cell
diagnostic dna methylation signature
autologous cervical cancer - specific engineered immune effector cells
autologous ovarian cancer - specific cytotoxic t - lymphocytes
mir27b gene
mir27b wt allele
mir27b pre - mirna
nras nm_002524 .4:c .34g > t
nras np_002515 .1:p .g12c
nras nm_002524 .4:c .35g > a
nras np_002515 .1:p .g12d
nras nm_002524 .4:c .34g > a
nras np_002515 .1:p .g12s
nras nm_002524 .4:c .37g > c
nras np_002515 .1:p .g13r
nras nm_002524 .4:c .38g > t
nras np_002515 .1:p .g13v
cytoreduction treatment
cytoreductive chemotherapy
antiangiogenesis therapy
kit nm_000222 .2:c .1924a > g
kit np_000213 .1:p .k642e
kit nm_000222 .2:c .1939c > t
kit np_000213 .1:p .l647f
kit np_000213 .1:p .g648d
kit nm_000222 .2:c .1958t > c
kit np_000213 .1:p .i653t
kit nm_000222 .2:c .1961t > c
kit np_000213 .1:p .v654a
anti - pd - 1 monoclonal antibody incmga0012
bone marrow ablation
kit np_000213 .1:p .l813p
queer
questioning
kit np_000213 .1:p .k818q
lesbian
asexual
counselor
locally advanced unresectable carcinoma
locally advanced unresectable renal cell carcinoma
pyrimidine antagonist
pressor support
bcr - abl inhibitor
kit nm_000222 .2:c .2458g > t
kit np_000213 .1:p .d820y
kit nm_000222 .2:c .2466t > r
kit np_000213 .1:p .n822k
kit nm_000222 .2:c .2466t > g
kit nm_000222 .2:c .2466t > a
kit nm_000222 .2:c .2464a > t
kit np_000213 .1:p .n822y
kit nm_000222 .2:c .2485g > c
differentiation therapy
kit np_000213 .1:p .a829p
anti - her2 monoclonal antibody
anti - her2 antibody - drug conjugate
anti - cd22 antibody - drug conjugate
kit nm_000222 .2:c .2492t > c
kit np_000213 .1:p .l831p
kit np_000213 .1:p .s840i
kit nm_000222 .2:c .2537a > g
kit np_000213 .1:p .y846c
kit np_000213 .1:p .s850g
kit nm_000222 .2:c .2554g > a
kit np_000213 .1:p .v852i
kit nm_000222 .2:c .2576t > c
kit np_000213 .1:p .l859p
kit np_000213 .1:p .l862p
smoothened antagonist
lesion of the cervix uteri
fgfr inhibitor
zbtb33 gene
zbtb33 wt allele
transcriptional regulator kaiso
linc00598 gene
linc00598 wt allele
long intergenic non - protein coding rna 598
h3 .x gene
h3 .y gene
h3 .y wt allele
histone h3 .y
no lower limit
cpt category iii codes
codabar
recurrent pancreatic adenocarcinoma
locally advanced unresectable pancreatic adenocarcinoma
range start - end unit format
anti - cd137 monoclonal antibody
modified folfox6 regimen
peroxisome biogenesis disorder
peroxisome biogenesis disorder 1a
peroxisome biogenesis disorder 1b
peroxisome biogenesis disorder 2a
peroxisome biogenesis disorder 2b
peroxisome biogenesis disorder 3a
peroxisome biogenesis disorder 3b
peroxisome biogenesis disorder 4a
peroxisome biogenesis disorder 4b
peroxisome biogenesis disorder 5a
peroxisome biogenesis disorder 5b
peroxisome biogenesis disorder 6a
peroxisome biogenesis disorder 6b
peroxisome biogenesis disorder 7a
peroxisome biogenesis disorder 7b
peroxisome biogenesis disorder 8a
peroxisome biogenesis disorder 8b
akt inhibitor
trk inhibitor
acute lung injury
pituitary gland mixed gangliocytoma - adenoma
sellar neurocytoma
pituitary gland paraganglioma
anti - tumor necrosis factor therapy
fibroadipose tissue
sellar neuroblastoma
flt3 inhibitor ski - g - 801
sellar ependymoma
autologous mesothelin - specific human mrna car - transfected pbmcs mcy - m11
sellar meningioma
sellar region
intrasellar meningioma
intrasellar region
in vitro sensitivity - directed chemotherapy
sellar schwannoma
sellar chordoma
sellar chondroid chordoma
sellar dedifferentiated chordoma
sellar solitary fibrous tumor / hemangiopericytoma
erk 1 / 2 inhibitor astx029
metastatic malignant neoplasm in the sellar region
cognitive behavior therapy for insomnia
desensitization
pure
malignant skull neoplasm
malignant skull base neoplasm
benign skull neoplasm
benign skull base neoplasm
epratuzumab - cys - tesirine
ex - vivo t - cell depletion
pituitary gland non - hodgkin lymphoma
pituitary gland diffuse large b - cell lymphoma
filgotinib
extended spectrum penicillin antibiotic
cs1 - car t therapy
sellar germ cell tumor
sellar germinoma
suprasellar germinoma
sellar yolk sac tumor
sellar embryonal carcinoma
sellar choriocarcinoma
sellar teratoma
sellar mature teratoma
sellar immature teratoma
intraperitoneal chemotherapy
sellar teratoma with malignant transformation
sellar mixed germ cell tumor
cab - ror2 - adc ba3021
axatilimab
pcornet reserved
influenza virus - specific culture
recurrent endometrial clear cell adenocarcinoma
recurrent endometrial undifferentiated carcinoma
recurrent uterine corpus carcinosarcoma
recurrent endometrial mixed cell adenocarcinoma
aerodigestive invasive malignancy
age - related clonal hematopoiesis
linear energy transfer - optimized intensity modulated proton therapy
kegel nation app
cpt category ii codes
hcpcs level i
hcpcs level ii
hcpcs level iii
rooming
unresectable low grade glioma
bronchoalveolar biopsy specimen
nasopharyngeal swab specimen
nasopharyngeal wash specimen
nasal swab or nose specimen
nasal wash specimen
oropharyngeal swab specimen
national drug code unit of measure
ndc me  ( milligram )
ndc un  ( unit )
quality - of - life assessment
ndc ml  ( milliliter )
ndc gr  ( gram )
hematopoietic cell transplantation - comorbidity index
international metastatic renal cell carcinoma database consortium criteria
international metastatic renal cell carcinoma database consortium  ( imdc )  criteria  -  favorable - risk group
international metastatic renal cell carcinoma database consortium  ( imdc )  criteria  -  intermediate - risk group
international metastatic renal cell carcinoma database consortium  ( imdc )  criteria  -  poor - risk group
kegel exercise
circadian biometric recorder
mysmartcheck
targeted fusion protein therapy
shp2 inhibitor rmc - 4630
ndc f2  ( international unit )
metastatic malignant pancreatic neoplasm
able to run 5 miles
able to remove a heavy suitcase
have trouble multitasking
mypatientpal
ultrasound - guided transbronchial needle - delivered interstitial photodynamic therapy
gardasil immunogenicity with needle - free injection
diode laser fiber type selective stimulator
quantitative sensory testing
well differentiated neuroendocrine lesion
intermediate grade neuroendocrine lesion
poorly differentiated neuroendocrine lesion
low grade neuroendocrine lesion
mia2 gene
mia2 wt allele
melanoma inhibitory activity protein 2
device unique identifier
metastatic neuroendocrine carcinoma
bone marrow ablation with stem cell support
advanced neuroendocrine carcinoma
herpes simplex virus infection
molluscum contagiosum virus infection
chest wall sarcoma
locally advanced unresectable gastric adenocarcinoma
recurrent desmoid - type fibromatosis
anti - egfr monoclonal antibody cpgj 602
unresectable desmoid - type fibromatosis
autologous cd19 - targeted car t cells jwcar029
anti - pd - 1 monoclonal antibody ak105
autologous hpv - specific cytotoxic t lymphocytes
allogeneic hpv - specific cytotoxic t lymphocytes
qilisheng immunoregulatory oral solution
autologous anti - bcma car - transduced t - cells kite - 585
autologous anti - hla - a*0201 / afp car t - cells et1402l1
tegavivint
ciclopirox prodrug cpx - pom
gum arabic solution
autologous anti - cd19 car t - cells im19
md anderson symptom inventory  -  gastrointestinal
diarrhea or watery stools via stoma at its worst
change in taste at its worst
feeling bloated at its worst
inability to eat at its worst
sore mouth or throat at its worst
mps1 inhibitor bos172722
autologous anti - cd19car - her2t / cd22car - egfrt - expressing t - cells
gallium ga 68 - nota - anti - her2 nanobody vhh1
anti - cd20 monoclonal antibody b001
levoleucovorin
fosmanogepix
unresectable lung non - small cell carcinoma
unresectable lung carcinoma
unresectable digestive system carcinoma
del ( 3p21 - 22 )
del ( 3p25 - 26 )
del ( 3p13 - 14 )
monoclonal microbial edp1503
metastatic lung adenocarcinoma
autologous anti - mesothelin car - cd3zeta - 4 - 1 - bb - expressing t - cells
smoldering waldenstrom macroglobulinemia
bone marrow lymphoplasmacytic infiltrate
cyp3a5 inducer
cyp3a5 inhibitor
cyp3a4 substrate
cyp3a5 substrate
mapk1 gene mutation
metastatic malignant neoplasm in the thoracic cavity
diagnostic fiberoptic endoscopic examination
cyp2c8 inducer
cyp2c19 inducer
cyp2c19 inhibitor
suppressive antiviral therapy
upfront treatment
atr inhibitor
chk1 inhibitor
sleep disturbance scale for children
cornell scale for depression in dementia
myeloid mutation panel
anti - pd - l1 monoclonal antibody msb2311
children's global assessment scale
locally advanced pancreatic neuroendocrine carcinoma
locally advanced digestive system neuroendocrine carcinoma
unresectable digestive system neuroendocrine carcinoma
metastatic digestive system neuroendocrine carcinoma
refractory digestive system neuroendocrine carcinoma
recurrent digestive system neuroendocrine carcinoma
modified ryan scheme for tumor regression
anti - her2 / pbd - ma antibody - drug conjugate dhes0815a
tumor regression score 0
tumor regression score 1
tumor regression score 2
tumor regression score 3
nlrp3 agonist bms - 986299
inc terminology
cerebral hemangioblastoma
spinal hemangioblastoma
medullary hemangioblastoma
hereditary malignant urinary system neoplasm
chromophobe renal cell carcinoma associated with birt - hogg - dube syndrome
broad ligament papillary cystadenoma
epididymal papillary cystadenoma
intestinal polyposis syndrome
cdk2 / 4 / 6 / flt3 inhibitor fn - 1501
thyroid gland spindle cell follicular adenoma
thyroid gland black follicular adenoma
black discoloration
cytoplasmic accumulation of black pigment
decision aid
submucosal invasion depth
submucosal 1 invasion
submucosal 2 invasion
submucosal 3 invasion
survey of autonomic symptoms
anti - b7 - h4 monoclonal antibody fpa150
carbon c 14 - tak - 659
total tumor mrna - pulsed tumor - specific ex vivo - expanded autologous lymphocyte transfer cells
anti - cd33 / cd3 bispecific antibody gem 333
mek inhibitor cs3006
fluorine f 18 - aif - nota - neurotensin
recurrent chordoma
babaodan capsule
anti - cd47 monoclonal antibody srf231
thorium th 227 anetumab
thyroid gland follicular tumor of uncertain malignant potential
questionable invasive lesion
psa level greater than or equal to 0 .8
defibrotide
defibrotide  ( bovine )
recurrent visual pathway glioma
refractory visual pathway glioma
recurrent neurofibromatosis type 1
refractory neurofibromatosis type 1
refractory malignant peripheral nerve sheath tumor
quadratus lumborum block
synchronous resection
hormone replacement therapy
staged resection
ros1 positive
etv6 gene rearrangement
blasts 2 percent or more of peripheral blood white cells
folate receptor alpha negative
myeloblasts present
ataxia with isolated vitamin e deficiency
mr sialography
early infantile epileptic encephalopathy 32
primary ciliary dyskinesia 15
brequinar
phase i trial
myeloblasts more than 5 percent of bone marrow nucleated cells
il6r gene product
soluble interleukin - 6 receptor subunit alpha
testosterone less than or equal to 100 ng / dl
m1 macrophage
m1 macrophage to m2 macrophage ratio measurement
absolute neutrophil count greater than or equal to 500 / mm3
psa level less than or equal to four
deleterious hdac2 gene mutation
deleterious rad54l gene mutation
phase ii trial
deleterious gen1 gene mutation
deleterious rad51 gene mutation
deleterious ercc3 gene mutation
deleterious abraxas1 gene mutation
ugt1a1 polymorphism positive
adenoviral cancer vaccine pf - 06936308
fancg gene mutation
anti - axl fusion protein avb - s6 - 500
archive
archived
phase iii trial
donation
zirconium zr 89 dfo - daratumumab
fancb gene mutation
fanci gene mutation
fancl gene mutation
high tumor mutation burden
human papillomavirus - 6 positive
receptor tyrosine kinase gene rearrangement
receptor tyrosine kinase gene amplification
phase iv trial
xeroderma pigmentosum - cockayne syndrome complex
genodermatosis
rothmund thomson syndrome
encapsulated variant thyroid gland papillary carcinoma
frontal lobe anaplastic astrocytoma
temporal lobe anaplastic astrocytoma
third ventricle pilocytic astrocytoma
hypothalamic - chiasmatic pilomyxoid astrocytoma
fourth ventricle medulloblastoma
chemoprevention
third ventricle germinoma
supratentorial pleomorphic xanthoastrocytoma
temporal lobe pleomorphic xanthoastrocytoma
zirconium zr 89 panitumumab
vulvar biopsy patient
spindle cell variant thyroid gland papillary carcinoma
inactivating braf gene mutation
atrx negative
inactivating setd2 gene mutation
tp53 negative
nutrition ,  trace elements
hobnail variant thyroid gland papillary carcinoma
mtap negative
bcma x cd3 t - cell engaging antibody cc - 93269
cabazitaxel / prednisone regimen
human papillomavirus - 63
human papillomavirus - 70
atac - seq
microrna sequencing
gontivimab
flt3 tyrosine kinase domain mutation negative
acupressure therapy
anti - cd73 monoclonal antibody cpi - 006
metastatic bladder carcinoma
metastatic fallopian tube carcinoma
metastatic ovarian carcinoma
metastatic vaginal carcinoma
metastatic vulvar carcinoma
autologous cmv - pp65 - fllamp mrna loaded dendritic cell vaccine
metastatic endometrial carcinoma
metastatic pancreatic carcinoma
clinical diagnosis
metastatic adrenal cortex carcinoma
metastatic adult soft tissue sarcoma
metastatic cutaneous melanoma
metastatic esophageal carcinoma
metastatic esophageal adenocarcinoma
metastatic esophageal squamous cell carcinoma
autoimmune atrophic chronic gastritis
metastatic nasopharyngeal keratinizing squamous cell carcinoma
metastatic nasopharyngeal undifferentiated carcinoma
metastatic nasopharyngeal carcinoma
staging
metastatic pharyngeal carcinoma
metastatic hypopharyngeal carcinoma
metastatic oropharyngeal carcinoma
high grade dysplasia
low grade dysplasia
metastatic laryngeal carcinoma
metastatic lip and oral cavity carcinoma
metastatic oral cavity carcinoma
metastatic lip carcinoma
metastatic oral cavity adenoid cystic carcinoma
anastomosis
metastatic oral cavity mucoepidermoid carcinoma
metastatic lip squamous cell carcinoma
metastatic lung squamous cell carcinoma
metastatic lung adenosquamous carcinoma
metastatic lung non - small cell carcinoma
metastatic lung small cell carcinoma
metastatic colorectal carcinoma
metastatic colon carcinoma
metastatic rectal carcinoma
metastatic thyroid gland follicular carcinoma
monoclonal antibody lym - 1
metastatic thyroid gland papillary carcinoma
metastatic neuroblastoma
recurrent blastic plasmacytoid dendritic cell neoplasm
refractory blastic plasmacytoid dendritic cell neoplasm
symptom screening in pediatrics
feel disappointed or sad
feel scared or worried
feel cranky or angry
problems with thinking or remembering things
changes in how body or face looks
hurt or pain other than headache
tingly or numb hands or feet
throwing up or feeling like may throw up
feeling more or less hungry than usual
other things that have bothered lately
moderately bothered
cell - free dna blood collection tube
ovarian ablation patient
hundred million international units
frontal lobe anaplastic oligodendroglioma
tp53 mutation carrier
thyroid gland follicular carcinoma ,  encapsulated angioinvasive
thyroid gland follicular carcinoma ,  widely invasive
health utilities index
ability to see well enough to read ordinary newsprint
ability to see well enough to recognize friend on other side of street
ability to hear what was said in group conversation with at least three other people
ability to hear what was said in conversation with one other person in quiet room
ability to be understood when speaking own language with people who do not know the subject
ability to be understood when speaking with people who know the subject well
subject's feelings
pain and discomfort
ability to walk
ability to use hands and fingers
ability to remember things
autologous prame - targeting tcr - modified t cells mdg1011
ability to think and solve day - to - day problems
ability to perform basic activities
anti - vegf monoclonal antibody hpv19
pain or discomfort
conditionally active biologic anti - axl antibody - drug conjugate ba3011
creb3l2 / pparg fusion gene
creb3l2 / pparg fusion protein
able to see well enough without correction
able to see well enough with correction
unable to see well enough even with correction
unable to see at all
able to hear without hearing aids
able to hear with hearing aids
unable to hear even with hearing aids
unable to hear ,  but did not wear hearing aids
unable to hear at all
autologous b - cell / monocyte - presenting her2 / neu antigen vaccine bvac - b
recombinant ornithodoros moubata saliva - derived small protein complement c5 inhibitor
cisplatin transmucosal patch
autologous her2 - specific / egfrt - expressing cd4 / cd8 - positive car t - cells
able to be understood completely
able to be understood partially
unable to be understood
unable to speak at all
happy and interested in life
somewhat happy
somewhat unhappy
very unhappy
so unhappy that life was not worthwhile
localized gastroesophageal junction adenocarcinoma
localized gastric carcinoma
autologous natural killer cell - like ctls
autologous anti - cd19car - cd3zeta - 4 - 1bb - il - 15 - pd1 - expressing tri - functional t - lymphocytes
autologous anti - cd38 a2 car2 - expressing t - cells
igm - enriched immunoglobulins
anti - vegfr2 monoclonal antibody hlx06
btk inhibitor icp - 022
curcumin / chondroitin sulfate / hyaluronic acid / quercetin soft gels
alkylglycerol / rosemary capsules
anti - lif monoclonal antibody msc - 1
anti - lag - 3 monoclonal antibody sym022
free of pain and discomfort
mild to moderate pain or discomfort that did not prevent activities
moderate pain or discomfort that prevented some activities
moderate to severe pain or discomfort that prevented some activities
severe pain or discomfort that prevented most activities
able to walk around neighborhood without difficulty ;  no walking equipment needed
able to walk around neighborhood with difficulty ;  no walking equipment or help required
able to walk around neighborhood with walking equipment ;  no help required
able to walk only short distances with walking equipment ;  required a wheelchair to get around the neighborhood
unable to walk alone ,  even with walking equipment ;  able to walk short distances with help ;  require wheelchair to get around the neighborhood
unable to walk at all
pressure specified sensory device
limitations in use of hands or fingers
full use of hands and fingers
limitations in use of hands or fingers ;  requires special tools for independence
limitations in use of hands or fingers ;  requires help for some tasks
limitations in use of hands or fingers ;  requires help for most tasks
limitations in use of hands or fingers ;  requires help for all tasks
able to remember most things
somewhat forgetful
very forgetful
unable to remember anything
rhenium re - 186 hydroxyethylidene diphosphonate
antibiotic therapy
able to think clearly and solve day - to - day problems
had a little difficulty when trying to think and solve day - to - day problems
had some difficulty when trying to think and solve day - to - day problems
had great difficulty when trying to think and solve day - to - day problems
unable to think or solve day - to - day problems
eat ,  bathe ,  dress ,  and use toilet normally
eat ,  bathe ,  dress ,  and use toilet with difficulty
required mechanical equipment to eat ,  bathe ,  dress ,  or use toilet independently
required help to eat ,  bathe ,  dress ,  or use toilet
generally happy and free from worry
occasionally fretful ,  angry ,  irritable ,  anxious ,  or depressed
carboplatin / paclitaxel / nivolumab regimen
often fretful ,  angry ,  irritable ,  anxious ,  or depressed
almost always fretful ,  angry ,  irritable ,  anxious ,  or depressed
extremely fretful ,  angry ,  irritable ,  anxious ,  or depressed ;  needing professional help
occasional pain or discomfort ;  relief from non - prescription drugs or activity ;  no disruption of normal activities
frequent pain or discomfort ;  relief from oral medicines ;  occasional disruption of normal activities
frequent pain or discomfort ;  relief requires prescription narcotics ;  frequent disruption of normal activities
severe pain or discomfort ;  pain not relieved by drugs ;  constant disruption of normal activities
promis pediatric and parent proxy physical health domain
radioimmunoguided surgery
being tired made it hard to keep up with schoolwork
being tired made it hard to play or go out with friends as much as would like
hard to pay attention because of tiredness
too tired for sports or exercise
too tired to do things outside
too tired to enjoy the things i like to do
epor fusion positive
sh2b3 gene deletion
il7r gene mutation
prolonged - release suspension for injection in pre - filled pen
intraoperative radiation therapy
proactive therapy
reactive therapy
recurrent aggressive non - hodgkin lymphoma
refractory aggressive non - hodgkin lymphoma
complete tumor cell necrosis
incomplete tumor cell necrosis
no evidence of tumor cell necrosis present
swallowing therapy
feeding tube dependency
hallucination severity
9 - cis - retinoic acid / interferon alfa
fuox regimen
very mild hallucination
mild hallucination
moderate hallucination
severe hallucination
extremely severe hallucination
r - chop - methotrexate regimen
megestrol / tamoxifen regimen
anastrozole / tamoxifen regimen
bcl - 2 inhibitor apg 2575
carboplatin / topotecan regimen
autologous anti - cd22 car - 4 - 1bb - tcrz - transduced t - lymphocytes cart22 - 65s
moderately severe hallucination
recurrent cytomegalovirus infection
recurrent adenovirus infection
recurrent ebv infection
partially hla - matched adv / cmv / ebv - specific allogeneic t - lymphocytes
anastrozole / lapatinib regimen
abemaciclib / fulvestrant regimen
anastrozole / lapatinib / trastuzumab regimen
temozolomide / veliparib regimen
cyclophosphamide / dacarbazine / vincristine regimen
carboplatin / liposomal doxorubicin regimen
ac - tam regimen
leucovorin / high - dose methotrexate regimen
fluorouracil / mitomycin regimen
gemcitabine / cisplatin / everolimus regimen
thyroid gland mucinous carcinoma
ectopic thyroid gland thymoma
locally advanced pancreatic adenocarcinoma
sumoylation inhibitor tak - 981
autologous anti - cd19 car tcr - zeta / 4 - 1bb - transduced t - lymphocytes hucart19
autologous anti - bcma - car - tcrz / 4 - 1bb - expressing t - lymphocytes cart - bcma
tongue alveolar soft part sarcoma'
tongue sarcoma
orbital alveolar soft part sarcoma
bladder alveolar soft part sarcoma
cellular nerve sheath myxoma
colon liposarcoma
parotid gland sarcoma
parotid gland liposarcoma
scrotal liposarcoma
scrotal sarcoma
advanced prostate carcinoma
locally advanced prostate carcinoma
advanced prostate adenocarcinoma
locally advanced prostate adenocarcinoma
locally advanced unresectable prostate carcinoma
locally advanced unresectable prostate adenocarcinoma
regimen used to treat malignant neuroendocrine and adrenal neoplasm
cartox grade 0
high risk acute myeloid leukemia
high risk chronic myelomonocytic leukemia
advanced cervical carcinoma
locally advanced cervical carcinoma
everolimus / fulvestrant regimen
locally advanced cervical adenocarcinoma
locally advanced unresectable cervical adenocarcinoma
dexverapamil
vegan diet
locally advanced unresectable cervical carcinoma
everolimus / tamoxifen regimen
exemestane / lapatinib / trastuzumab regimen
advanced cervical adenocarcinoma
exemestane / lapatinib regimen
fulvestrant / trastuzumab regimen
lapatinib / letrozole / trastuzumab regimen
letrozole / trastuzumab regimen
mental retardation ,  autosomal dominant 39
aspiration
spinal muscular atrophy type 2
diastrophic dysplasia
brazilian state
acre
alagoas
amapa
amazonas
bahia
ceara
distrito federal
chemotherapy
espirito santo
goias
maranhao
mato grosso
mato grosso do sul
minas gerais
parana
paraiba
para
pernambuco
cancer pain management
piaui
rio de janeiro
rio grande do norte
rio grande do sul
rondonia
roraima
santa catarina
sergipe
sao paulo
tocantins
70 - kd heat - shock protein / muc - 1 antigen
thyroid gland schwannoma
thyroid gland malignant peripheral nerve sheath tumor
thyroid gland benign vascular neoplasm
thyroid gland hemangioma
thyroid gland cavernous hemangioma
thyroid gland lymphangioma
thyroid gland leiomyoma
thyroid gland leiomyosarcoma
chemotherapy - induced peripheral neuropathy
thyroid gland solitary fibrous tumor
rara gene translocation
chimeric monoclonal antibody 81c6
cisplatin / fluorouracil regimen
docetaxel / vandetanib regimen
emotion regulation index
cognitive regulation index
neuropathy ,  hereditary sensory and autonomic ,  type v
torsion dystonia 6
feline melanoma
tavokinogene telseplasmid
eribulin / trastuzumab regimen
cyclophosphamide / trastuzumab regimen
cisplatin / trastuzumab regimen
anastrozole / palbociclib regimen
exemestane / palbociclib regimen
fulvestrant / palbociclib regimen
anastrozole / ribociclib regimen
exemestane / ribociclib regimen
trastuzumab / nab - paclitaxel regimen
carboplatin / trastuzumab regimen
tamoxifen / trastuzumab regimen
ribociclib / tamoxifen regimen
fulvestrant / ribociclib regimen
abemaciclib / letrozole regimen
abemaciclib / exemestane regimen
abemaciclib / anastrozole regimen
genetic testing for cancer risk
trastuzumab / pertuzumab / vinorelbine regimen
ixabepilone / trastuzumab regimen
autologous mcpyv - specific hla - a02 - restricted tcr - transduced cd4 +  and cd8 +  t - cells fh - mcva2tcr
del11q22 .3 / atm locus
combination product report indicator
malfunction only  ( no ae )  report
lymphoblasts more than 50 percent of bone marrow nucleated cells
alpha / beta t - lymphocyte
histone h3 lysine 79
neoplastic plasma cells 5 percent or less of bone marrow nucleated cells
level of evidence
lymphoblasts 5 percent or more of peripheral blood white cells
psa level equal to nadir plus 2 ng / ml
hhla2 gene
hhla2 wt allele
herv - h ltr - associating protein 2
tlr agonist bdb001
ceftolozane - tazobactam
ginseng / lingzhi mushroom / cordyceps sinensis / rose oral liquid
monoclonal antibody neo - 201
anti - flt3 / cd3 bite antibody amg 427
pyrazoloacridine
umbilical cord blood transplantation
anetumab
daratumumab and hyaluronidase - fihj
monoclonal antibody asp1948
radiation therapy recipient
steps to enhance physical activity
airway tumor mass
thyroid gland histiocytic and dendritic cell neoplasm
thyroid gland langerhans cell histiocytosis
thyroid gland follicular dendritic cell sarcoma
thyroid gland sinus histiocytosis with massive lymphadenopathy
screening for neuroblastoma
thyroid gland follicular lymphoma
grade 1 teratoma
akr1c3 - activated prodrug obi - 3424
anti - cd46 antibody - drug conjugate for46
days between diagnosis and treatment
days between birth and diagnosis
days between diagnosis and death
epidural block
age at diagnosis
site of resection or biopsy
tissue or organ of origin
smoking onset year
hereditary folate malabsorption
smoking cessation year
year of death
cancer - related death
non - cancer related death
social drinker
immunodeficiency - centromeric instability - facial anomalies syndrome 1
anterior endometrium
posterior endometrium
trichothiodystrophy 1 ,  photosensitive
analyte type
formalin - fixed paraffin - embedded dna
formalin - fixed paraffin - embedded rna
repli - g pooled dna
sibrotuzumab
repli - g x dna
bone marrow aspiration
metastatic tumor sample
sample derived from new primary
control analyte
cell line - derived xenograft
post neoadjuvant therapy sample
derived cell line
epidermolysis bullosa dystrophica ,  autosomal recessive
t2  ( observed )  - weighted imaging
milligram iron per gram liver  ( dry weight )
loes score
international system for human cytogenetic nomenclature
tolerance induction in solid organ transplantation
dexverapamil hydrochloride
recurrent primary peritoneal serous adenocarcinoma
recurrent primary peritoneal low grade serous adenocarcinoma
recurrent low grade ovarian serous adenocarcinoma
recurrent low grade fallopian tube serous adenocarcinoma
extrapulmonary small cell carcinoma
anti - cd32b monoclonal antibody bi - 1206
nutrition ,  calories
malignant primitive cellular infiltrate
pharmacological ascorbate
brain ependymoma
loss of immunohistochemical expression of succinate dehydrogenase  ( sdh )  b
succinate dehydrogenase - deficient renal cell carcinoma
low intensity vibration therapy
endobronchial obstruction
enzyme unit per meter squared
milligram equivalent
stat3 measurement
anterior mediastinotomy
pyruvate kinase measurement
area under the curve ratio
name and version
auxiliary medicinal product
refractory kaposi sarcoma
metastatic kaposi sarcoma
advanced kaposi sarcoma
intrauterine gel dosage form
autologous ic9 - deltangfr - cd19car - cd3zeta - 4 - 1bb - expressing t - lymphocytes
anti - her2 antibody - drug conjugate a166
young autologous tumor - infiltrating lymphocytes
genitourinary system neoplasm
benign genitourinary system neoplasm
malignant genitourinary system neoplasm
metastatic neuroendocrine neoplasm
advanced neuroendocrine neoplasm
advanced carcinoid tumor
metastatic pancreatic neuroendocrine tumor
advanced pancreatic neuroendocrine tumor
anti - ildr2 monoclonal antibody bay 1905254
metastatic digestive system neuroendocrine neoplasm
metastatic breast neuroendocrine neoplasm
magnetic field strength
number of unsuppressed water averages
spectral width
x - axis voxel dimension
y - axis voxel dimension
z - axis voxel dimension
aloe vera gel
electron beam therapy
voxel orientation
steam pulse sequence mixing time
thrice
bowel obstruction indicator
bowel perforation indicator
lymphovascular invasion indicator
tibiotarsal joint
subarachnoid space
monoclonal protein spike to total protein ratio measurement
nuclear matrix protein 22 measurement
high - dose rate brachytherapy
cocaethylene measurement
24 , 25 - dihydroxyvitamin d measurement
aspartate aminotransferase to platelet ratio index
hdl phospholipid measurement
4 - beta - hydroxycholesterol measurement
hemoglobin cast measurement
fatty liver index
free immunoglobulin light chain measurement
interleukin 1 excretion rate
interleukin 18 excretion rate
image guided biopsy
chemokine  ( c - c motif )  ligand 2 excretion rate
phosphorylated stat3 measurement
phosphorylated stat3 to stat3 ratio measurement
pro - gastrin releasing peptide measurement
pyocytes measurement
tnf superfamily member 12 excretion rate
soluble tnf superfamily member 12 measurement
vascular endothelial growth factor receptor 2 measurement
25 - hydroxyvitamin d2 measurement
25 - hydroxyvitamin d3 measurement
drug formulation process
pyruvate kinase muscle isozyme measurement
pyruvate kinase isozyme m2 measurement
pyruvate kinase isozyme m1 measurement
drug crystal measurement
acylglycine measurement
acylcarnitine measurement
decanoylcarnitine measurement
delta aminolevulinate measurement
delta aminolevulinate to creatinine ratio measurement
porphobilinogen measurement
porphobilinogen to creatinine ratio measurement
separated
human parvovirus b19 measurement
mycoplasma pneumoniae measurement
cd68 expressing cell count
blood vessel density
beta - defensin 1 measurement
intact epithelial reticular basement membrane length to total epithelial reticular basement membrane length ratio measurement
positive cell count
injection needle reuse
thoracic surgical procedure
susceptibility score mutations indicator
no longer clinically benefiting
total sleep time
sleep efficiency
wake after sleep onset
n1 sleep to total sleep time ratio measurement
n2 sleep to total sleep time ratio measurement
n3 sleep to total sleep time ratio measurement
rem to total sleep time ratio measurement
peak response amplitude
neurosurgical procedure
peak response amplitude latency
n - acetyl aspartate measurement
myo - inositol measurement
glutamate and glutamine measurement
anatomic response
metabolite ratio for auc infinity observed
metabolite ratio for auc infinity predicted
metabolite ratio auc last nonzero concentration
metabolite ratio for auc dosing interval
metabolite ratio for maximum concentration
blood treatment
volume of distribution steady state observed by fraction of dose absorbed
volume of distribution steady state predicted by fraction of dose absorbed
volume of distribution steady state observed by unbound drug
volume of distribution steady state predicted by unbound drug
volume of distribution steady state observed by bound drug
volume of distribution steady state predicted by bound drug
fractional excretion from t1 to t2
area under the curve ratio infinity predicted
area under the curve ratio infinity observed
cmax to cmax ratio measurement
cancer and nutrition
cmax to cmin ratio measurement
observed volume of distribution of absorbed fraction for unbound drug
local immunotherapy procedure
southern african coloured
alveolar volume
menses flow rate description
menses duration
menstrual cycle regularity
induced abortion indicator
live birth indicator
aging and nutrition
intramandibular route of administration
bone marrow mononuclear cell
open label for treatment and double blind to dose
enlargement from nadir
further enlargement from nadir
induction clinical trial setting
mobilization clinical trial setting
conditioning clinical trial setting
maintenance clinical trial setting
consolidation clinical trial setting
liposomal amphotericin b
vaccine development
salvage clinical trial setting
additional outcome measure
cdisc therapeutic area user guide name and version
fda technical specification name and version
study data tabulation model implementation guide version
study data tabulation model version
chest circumference
experimental organism endocardial schwannoma
experimental organism intramural schwannoma
experimental organism ductal cell adenocarcinoma
atcc
experimental organism ductal cell adenoma
experimental organism brunner's gland carcinoma
experimental organism benign thecoma
experimental organism malignant thecoma
irreversible inhibitor
physiologic antagonist
send developmental and reproductive toxicology implementation guide version 1 .1
authorized investigational medicinal product
authorized auxiliary medicinal product
neuroprotection
clinical trial results registry
attributable ,  legible ,  contemporaneous ,  original ,  accurate
attributable ,  legible ,  contemporaneous ,  original ,  accurate plus
individual exposure
extent of exposure
device manufacture
drug manufacturer
medication error
device use error
anticipated adverse event
nicotine gum
clinical trial temporary halt
clinical trial suspension
clinical outcome assessment content validation
clinical outcome assessment construct validation
clinical outcome assessment criterion validation
mutual recognition procedure
serious breach
privacy breach
accelerated approval
subject monitoring
concerned member state
reference member state
marketing authorization
medicinal product classification
biosimilar
adroit electronically generated information service
american health information community
consolidated health informatics
development international birth date
electronic document room
neoadjuvant therapy
health information exchange
no observable effect level
regional health information organization
standard for the exchange of nonclinical data
radiofrequency ablation
genitourinary system disorder
water signal suppression method
small for gestational age indicator
non - neoplastic genitourinary system disorder
micro needle array - doxorubicin
microneedle drug delivery system
ildr2 gene
ildr2 wt allele
immunoglobulin - like domain - containing receptor 2
sentinel lymph node biopsy
blasts more than 15 percent of bone marrow nucleated cells
steroid - refractory pneumonitis
cdisc clinical classification covi test name terminology
cdisc clinical classification covi test code terminology
covi clinical classification question
covi  -  verbal report
covi  -  behavior
covi  -  somatic symptoms of anxiety
covi  -  total score
fosifloxuridine nafalbenamide
psma / cd3 tri - specific t - cell activating construct hpn424
metastatic gastric neuroendocrine carcinoma
advanced gastric neuroendocrine carcinoma
advanced gastric large cell neuroendocrine carcinoma
advanced gastric small cell carcinoma
metastatic small intestinal neuroendocrine carcinoma
advanced small intestinal neuroendocrine carcinoma
advanced small intestinal small cell carcinoma
advanced small intestinal large cell neuroendocrine carcinoma
cancer prevention
blasts 25 percent or less of bone marrow nucleated cells
factor b inhibitor lnp023
anti - pd - l1 monoclonal antibody cbt - 502
ect - 001 expanded cord blood
antitumor b key active component - alpha
shp - 1 agonist sc - 43
recurrent t - cell / histiocyte - rich large b - cell lymphoma
halichondrin analogue e7130
rhenium re - 188 etidronate
transformed marginal zone lymphoma to diffuse large b - cell lymphoma
strontium sr - 89
glumetinib
porcupine inhibitor rxc004
para - toluenesulfonamide
fine motor skills
anti - her2 / anti - cd3 bispecific monoclonal antibody btrc 4017a
autologous anti - bcma - car - mrna - transfected cd8 +  t - lymphocytes
anti - gcc antibody - drug conjugate tak - 164
ehealth for sedentary behavior
mdm2 inhibitor bi 907828
goserelin acetate extended - release microspheres ly01005
malignant peritoneal and retroperitoneal neoplasm
peritoneum and retroperitoneum
benign peritoneal and retroperitoneal neoplasm
malignant abdominal neoplasm
malignant pelvic neoplasm
recurrent acute myeloid leukemia not otherwise specified
recurrent acute myelomonocytic leukemia
recurrent acute myeloid leukemia with recurrent genetic abnormalities
recurrent acute myeloid leukemia with t  ( 9 ; 11 )   ( p21 .3 ;  q23 .3 )  ;  mllt3 - kmt2a
recurrent acute myeloid leukemia with multilineage dysplasia
total lymphoid irradiation
recurrent acute monoblastic and monocytic leukemia
recurrent acute erythroid leukemia
acute myeloid leukemia with multilineage dysplasia in remission
acute monoblastic and monocytic leukemia in remission
anti - pd - 1 monoclonal antibody cs1003
sodium - potassium adenosine triphosphatase inhibitor rx108
alk - 2 inhibitor tp - 0184
navarixin
recurrent acute megakaryoblastic leukemia
egfr antisense dna bb - 401
marcks protein inhibitor bio - 11006
nurulimab
serd d - 0502
fermented prebiotic dietary supplement aferbio
ripk1 inhibitor gsk3145095
serplulimab
zirconium zr 89 - dfo - crgdy peg - cy5 - c' dots
mcl - 1 inhibitor amg 397
manelimab
carbon c 11 - osimertinib
ezh2 inhibitor pf - 06821497
cyp11a1 inhibitor odm - 208
locally advanced microsatellite stable colorectal carcinoma
advanced digestive system carcinoma
assuremdx
millimeter - wave holographic imaging
melanoma risk factor
adjuvant therapy
ppp2r2a gene mutation
tnfaip3 gene mutation
sdhb negative
neoplastic plasma cells 10 - 59 percent of bone marrow nucleated cells
proximity ligation assay
raf / ksr / mek1 trimer
braf / craf dimer
benign parathyroid gland adenoma
rela fusion positive
prmt1 inhibitor gsk3368715
androgen suppression
ppm1d gene mutation
activating ppm1d gene mutation
ppm1d gene amplification
mdm4 gene amplification
her2 / neu low expression
static imaging
basal cell carcinoma
metastatic basal cell carcinoma
axillary lymph node dissection
locally advanced basal cell carcinoma
biochemically recurrent prostate carcinoma
copper cu 64 - cb - te1a1p - peg4 - llp2a
egfr mutant - specific inhibitor d - 0316
jak1 inhibitor azd4205
neurocognitive assessment
cognitive electrophysiology assessment
dihydroorotate dehydrogenase inhibitor aslan003
vision assessment
entity with role in clinical study
bolus infusion procedure
biliary tract carcinoma
recurrent biliary tract carcinoma
laryngeal mask airway
mature
skeletally mature
skeletally immature
bone age
metastatic unresectable basal cell carcinoma
locally advanced unresectable basal cell carcinoma
consolidation therapy
maternally derived graft versus host disease
anti - pvrig monoclonal antibody com701
gsk - 3 inhibitor 9 - ing - 41
metastatic human papillomavirus - related malignant neoplasm
itk inhibitor
prior radiation therapy of affected breast
prior systemic chemotherapy for current cancer
prior systemic therapy for current cancer
pvrig gene
pvrig wt allele
safingol
core biopsy
prior treatment of current cancer
treatment - sensitive hiv infection
radiation to greater than 25 percent of bone marrow
transmembrane protein pvrig
ezh2 inhibitor
new primary tumor
cptac case identifier
tissue source site identifier
medical condition
cytotoxic chemotherapy
new tumor event information
is there a history of treatment
medical history source
initial diagnosis
date of last therapy
date of last chemotherapy treatment
month - day - year
medical record documentation about this history of cancer treatment
current medication
date of last administration
dose - rate
alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women
alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women
current non - drinker with past alcohol consumption
alcohol use history not available
number of years when consumed more than 2 drinks per day for men and more than 1 drink per day for women
smoking history
lifelong non - smoker less than 100 cigarettes smoked in lifetime
current smoker includes daily and non - daily smokers
current reformed smoker ,  more than 15 years
current reformed smoker within past 15 years
current reformed smoker ,  years unknown
smoking history not available
age which participant stopped smoking
when participant smoked ,  how many cigarettes smoked
number of pack years smoked
participant exposed to secondhand smoke
no / minimal secondhand smoke exposure
secondhand smoke exposure in household during childhood
secondhand smoke exposure in current household
secondhand smoke exposure history not available
organ of origin
follow - up period
12 months
24 months
36 months
48 months
follow - up information
outcome after follow - up form completion
tumor free
with tumor
new tumor event after initial treatment present
new tumor event header
type of new tumor event  ( check all that apply )
what is the site of the new tumor event
specify site of new tumor event
date of new tumor event
number of days from date of initial cancer diagnosis to date of new tumor event after initial treatment
number of days from date of initial pathologic diagnosis to date of additional surgery for new tumor event
was additional surgery for new tumor event performed
date of additional surgery for new tumor event
number of days from date of initial cancer diagnosis to date of additional surgery for new tumor event
human papillomavirus mrna
fractionated stereotactic radiation therapy
aluminum milling
steel milling and casting
coal mining
hard rock mining
flour ,  feed ,  or grain milling
mineral cutting
sand blasting
local therapy
solder fume exposure
cotton or jute dust exposure
creosote
natural gas
other investigational agent
cancer model development center
smartphone application
quit2heal
quitguide
maintenance therapy
hsp90 inhibitor
anti - cd22 adc trph - 222
autologous cd4 +  / cd8 +  egfr806 specific 4 - 1bb - cd3zeta - egfrt - expressing car t cells
hras np_005334 .1:p .g12x
malignant bronchial neoplasm
hras nm_005343 .3:c .35g > a
hras nm_005343 .3:c .35_36delgcinsat
hras np_005334 .1:p .g12d
anti - k - ras g12d mtcr - transduced autologous peripheral blood lymphocytes
her2 / neu expression by validated immunohistochemistry
her2 / neu status by validated single - probe in situ hybridization
her2 / neu status by validated dual - probe in situ hybridization
pd - 1 ligand inhibitor
glasdegib maleate
larotrectinib sulfate
appspire
activity monitor
exercise log
hemoglobin s / o - arab heterozygote
daclizumab
myelosuppressive therapy
hbb gene mutation
hbb nm_000518 .4:c .364g > a
hbb nm_000518 .4:c .20a > t
hbb protein variant
hbb np_000509 .1:p .e122k
hbb np_000509 .1:p .e7v
resectable pancreatic adenocarcinoma
resectable pancreatic acinar cell carcinoma
resectable intrahepatic cholangiocarcinoma
resectable digestive system carcinoma
resectable bile duct adenocarcinoma
resectable extrahepatic bile duct adenocarcinoma
tumor status at date of last contact or death
date of performance status assessment
post - operative therapy
number of days from date of initial cancer diagnosis to date of death
date of last contact
month follow - up
number of days from date of initial cancer diagnosis to date of last contact
canonical baf complex
perimenopausal
neuron - specific baf complex
neural progenitor - specific baf complex
pbaf complex
non - canonical baf complex
adenoviral tumor - specific neoantigen priming vaccine grt - c901
mrna - based tumor - specific neoantigen boosting vaccine grt - r902
ppia gene
ppia wt allele
peptidyl - prolyl cis - trans isomerase a
phase i / ii trial
eef1aknmt gene
eef1aknmt wt allele
methyltransferase - like protein 13
human anti - cd30 car - expressing autologous t - lymphocytes
kcnj5 gene mutation
atp1a1 gene mutation
atp2b3 gene mutation
cacna1d gene mutation
prkaca gene mutation
interfant - 06 protocol
phase ii / iii trial
usp18 gene
usp18 wt allele
ubl carboxyl - terminal hydrolase 18
adrenal cortex sex cord - stromal tumor
adrenal gland schwannoma
adrenal gland lymphoma
less than 1 hour
between 1 and 2 .5 hours
between 3 and 4 .5 hours
between 5 and 6 .5 hours
quadrantectomy
between 7 and 8 .5 hours
more than 9 hours
cptac terminology
cptac baseline medical forms terminology
cptac medical history form
cptac follow - up form terminology
adrenal gland sarcoma
champs activities questionnaire for older adults
visit with friends or family
go to senior center
radiosurgery
do volunteer work
attend church or take part in church activities
attend other club or group meetings
use a computer
do you dance
do artwork or crafts
cptac neoplasms codelist
tsta3 gene
tsta3 wt allele
gdp - l - fucose synthase
treatment regimen
cln3 gene
cln3 wt allele
battenin
play golf and carry own equipment
play golf ,  riding cart
attend concert ,  movie ,  lecture or sport event
play cards ,  bingo ,  or board games with other people
shoot pool or billiards
play singles tennis
play doubles tennis
go skating
play a musical instrument
do reading
do heavy work around the house
do light work around the house
do heavy gardening
do light gardening
work on car ,  truck ,  lawn mower ,  or other machinery
go jogging or running
walk or hike uphill
t - cell depletion therapy
walk fast or briskly for exercise
walk to do errands
walk leisurely for exercise or pleasure
ride a bicycle or stationary bike
use other aerobic equipment
do water exercises other than swimming
swim moderately or fast
swim gently
do stretching or flexibility exercises
do yoga or tai - chi
dinutuximab
do aerobics or aerobic dancing
do moderate to heavy strength training
do light strength training
do general conditioning exercises
play basketball ,  soccer ,  or racquetball
do other physical activity
other physical activity
activity hours per week
coke oven emission exposure
heavy metal mining
total hysterectomy
paint
edmonton frail scale
cognition clock test
times admitted to a hospital
activities that require help
when help is needed can count on someone willing and able to meet needs
use five or more different prescription medications regularly
sometimes forget to take prescription medications
have recently lost weight and clothing has become looser
often feel sad or depressed
have urinary incontinence
timed get up and go test
final score equals sum of column totals
no spacing errors
l - lysine / l - arginine - containing amino acid
other errors
no hospital admission
one or two hospital admissions
two or more hospital admissions
colposcopic biopsy
excellent ,  very good ,  or good health
fair health
poor health
zero or one activity required help
two to four activities required help
five to eight activities required help
zero to ten seconds walking
eleven to twenty seconds walking
greater than twenty seconds walking ,  or patient unwilling ,  or requires assistance walking
mitapivat
antifungal therapy
gsr gene
gsr wt allele
glutathione reductase ,  mitochondrial
srxn1 gene
srxn1 wt allele
sulfiredoxin - 1
gpat3 gene
gpat3 wt allele
glycerol - 3 - phosphate acyltransferase 3
pen device
ipilimumab / talimogene laherparepvec regimen
lum imaging system
lum imaging device
incisional vacuum - assisted closure therapy
hormone receptor positive
hormone receptor positive breast carcinoma
refractory hormone receptor positive breast carcinoma
anti - pd - l1 / tim - 3 bispecific antibody ly3415244
germline apc gene mutation
suspicion of metastasis
anti - s15 monoclonal antibody nc318
anti - dr5 agonistic monoclonal antibody inbrx - 109
primary vitreoretinal lymphoma
vitreoretinal area
primary vitreoretinal diffuse large b - cell lymphoma
recurrent primary vitreoretinal lymphoma
refractory primary vitreoretinal lymphoma
electroporation
recurrent primary vitreoretinal diffuse large b - cell lymphoma
refractory primary vitreoretinal diffuse large b - cell lymphoma
recurrent primary diffuse large b - cell lymphoma of the central nervous system
refractory primary diffuse large b - cell lymphoma of the central nervous system
cptac environmental / occupational exposure codelist
circumferential margin status by mri
clear circumferential margin by mri
involved circumferential margin by mri
arfolitixorin
mfsd8 gene
mfsd8 wt allele
major facilitator superfamily domain - containing protein 8
brd9 gene
brd9 wt allele
bromodomain - containing protein 9
bicral gene
bicral wt allele
brd4 - interacting chromatin - remodeling complex - associated protein - like
bcl7b gene
genetic testing
autologous cd4 +  / cd8 +  4 - 1bb - cd3zeta - egfr806 - car - egfrt / 4 - 1bb - cd3zeta - cd19 - car - her2tg - expressing cars t cells
bcl7b wt allele
perometer
cdr entry completed by  ( signature )
confirm ajcc / tnm cancer staging edition
specify therapeutic agent
form completed by  ( signature )
if cm1 ,  specify site ( s )
specify site if documented distant metastasis
alvocidib hydrochloride
nicotine replacement
specify other type of exposure
if other ,  specify
specify site if pm1
select exposure types
specify if yes
specify type of testing and results if yes
specify other
print ,  sign ,  date form
select all that apply
select one
prevention research
specify hpv genotype
transcribe data into cdr and record the following
acetaminophen - cysteine protein adduct
tet2 negative
high sensitivity c - reactive protein measurement
anti - poliovirus antibody positive
psa level less than or equal to fifty
tgli1 allele
gli1 gene product
truncated glioma - associated oncogene homolog 1 protein
secondary prevention
site of tumor
initial cancer diagnosis date
mental retardation ,  x - linked ,  syndromic ,  borjeson - forssman - lehmann type
infantile - onset multisystem autoimmune disease 1
phelan - mcdermid syndrome
recurrent paraganglioma
unresectable paraganglioma
anti - lag - 3 monoclonal antibody incagn02385
unresectable adrenal gland pheochromocytoma
locally advanced adrenal gland pheochromocytoma
religion and spirituality
recurrent neuroendocrine neoplasm
refractory neuroendocrine neoplasm
phosphorylated - stat3 y705
deoxyaminopteroic acid
prostaglandin e
greatest dimension tumor
pklr gene
pklr wt allele
pklr gene product
pyruvate kinase pklr
basic research
pyruvate kinase pklr isoform l - type
pklr gene mutation
non - synonymous pklr gene mutation
connect video doctor
was additional testing performed
number of lymph nodes positive for tumor by ihc staining only
number of lymph nodes positive for tumor by h&e
cerebral amyloid angiopathy ,  app - related
congenital dyserythropoietic anemia type iv
pathological myopia
applied research
spastic paraplegia 76
chemical / occupational exposure history
was there a history of radiation exposure
risk factor history
therapeutic ionizing radiation to head history
hiv status
ihc staining not done
indeterminate or unknown
tyrosine hydroxylase deficiency
ishak score 1 - 2
population study
1p / 19q codeletion status
ishak score 3 - 4
was adjuvant i - 131 therapy administered
afp level finding
albumin level finding
ar status by immunochemistry
atrx mutation status by sequencing
bap1 mutation analysis
cytogenetic map
barrett esophagus with metaplastic goblet cell columnar epithelium
barrett esophagus with metaplastic non - goblet cell columnar epithelium
braf mutation analysis
reimbursement
busy
clinical proteomic tumor analysis consortium
cdh1 mutation analysis
ctnnb1 mutation analysis
erbb2 mutation analysis
fgfr1 mutation analysis
homeopathy therapy
fgfr2 mutation analysis
fgfr3 mutation analysis
gna11 mutation analysis
gnaq mutation analysis
hras mutation analysis
idh1 / idh2 mutation analysis
idh1 / 2 mutation status by sequencing
nras mutation analysis
braf rearrangement analysis
erg rearrangement analysis
surveillance
etv rearrangement analysis
fgfr1 rearrangement analysis
fgfr2 rearrangement analysis
fgfr3 rearrangement analysis
pax8 rearrangement analysis
ret rearrangement analysis
esr1 status by immunohistochemistry
esr2 status by immunohistochemistry
depolymerization
hydrogenation
recombinant viral vaccine
pharmacodynamics
cold adaptation
combustion
conjugation
reduction
fermentation
hydroxylation
adsorption
quaternization
succinylation
transesterification
epidemiology research
amidation
cell expansion
pegylation
salt formation
acylation
epoxidation
esterification
viral hemagglutinin purification
viral neuraminidase purification
viral envelope glycoprotein purification
antigen cultivation
monomer deletion process
polymer branch connection points
nucleotide bond
nucleotide substitution site
cbdd terminology
problems paying medical bills
unable to pay medical bills
paying medical bills over time
referral made based on this score
referral made based on final score
nimesulide - hyaluronic acid conjugate ca102n
figo / tnm stage
what is the first presenting symptom related to disease
welding exposure
histiocytoid breast carcinoma
thoracic nodule
tert promoter mutation analysis
tp53 mutation status by sequencing
inguinal orchiectomy
ccr4 inhibitor flx475
vagal paraganglioma
anti - tim - 3 monoclonal antibody bgb - a425
adrenal gland ganglioneuroblastoma ,  intermixed
adrenal gland ganglioneuroblastoma ,  nodular
adrenal gland ganglioneuroma
composite paraganglioma
lipid nanoparticle encapsulating mrnas encoding human ox40l / il - 23 / il - 36gamma mrna - 2752
familial adrenal gland pheochromocytoma
erbb2 amplification status
laparoscopic surgery
ki - 67 labeling index
met amplification status
serum cea measurement
serum ca 19 - 9 measurement
hpv - low risk
hpv typing method
endoscope distal attachment cap
anti - cd123 / cd3 bispecific antibody apvo436
b - cell cll / lymphoma 7 protein family member b
bcl7c gene
thoracoscopic surgery
bcl7c wt allele
b - cell cll / lymphoma 7 protein family member c
pdna - encoding emm55 autologous cancer cell vaccine ifx - hu2 .0
brd7 gene
brd7 wt allele
bromodomain - containing protein 7
left ventricular noncompaction 7
polg - related spectrum disorders
relapsing polychondritis
aspira indwelling catheter
cdna library
phf10 gene
phf10 wt allele
phd finger protein 10
actl6a gene
actl6a wt allele
actin - like protein 6a
actl6b gene
actl6b wt allele
actin - like protein 6b
mirzotamab clezutoclax
reiki therapy
4 -  [ 18f ] fluoroglutamic acid
autologous cll1 - cd33 compound car t cells
anti - psma / cd3 bite antibody amg 160
adar gene
adar wt allele
double - stranded rna - specific adenosine deaminase
temporally - feathered intensity - modulated radiation therapy
blasts 0 .1 percent or more of bone marrow nucleated cells
onecut2 gene
onecut2 wt allele
sequential treatment
one cut domain family member 2
hearing handicap inventory for the elderly
use phone less often than would like due to hearing problem
avoid groups of people due to hearing problem
irritable due to hearing problem
difficulty attending party due to hearing problem
feel stupid or dumb due to hearing problem
incomplete freund's adjuvant
cd96 gene
cd96 wt allele
t - cell surface protein tactile
dpf1 gene
dpf1 wt allele
zinc finger protein neuro - d4
dpf2 gene
dpf2 wt allele
zinc finger protein ubi - d4
intrahepatic infusion procedure
dpf3 gene
dpf3 wt allele
zinc finger protein dpf3
nervous due to hearing problem
visit people less often than like due to hearing problem
go shopping less often than like due to hearing problem
upset by problem or difficulty with hearing
want to be alone due to hearing problem
talk to family members less often than like due to hearing problem
feel depressed due to hearing problem
unresectable skin squamous cell carcinoma
listen to tv or radio less often than like due to hearing problem
feel uncomfortable when talking with friends due to hearing problem
unresectable skin carcinoma
feel left out when with a group of friends due to hearing problem
difficulty hearing or understanding co - workers ,  clients ,  or customers due to hearing problem
difficulty in movies or theater due to hearing problem
diagnostic trial
unresectable basal cell carcinoma
unresectable skin basal cell carcinoma
kidney transplant recipient
inodiftagene vixteplasmid
metastatic extracranial malignant solid neoplasm
advanced extracranial malignant solid neoplasm
refractory adenovirus infection
multi - detector computed tomography
multi - detector computed tomography angiography
allogeneic cmv antigen - specific cd4 +  / cd8 +  t - lymphocytes
allogeneic hadv antigen - specific t - lymphocytes
monoclonal gammopathy of renal significance
autologous ct - rcc - 1 herv - e - tcr - transduced - hla - a11 - restricted cd8 +  / cd34t +  t - cells
modified folfirinox regimen
borderline resectable malignant neoplasm
borderline resectable mass
borderline resectable pancreatic carcinoma
borderline resectable carcinoma
borderline resectable pancreatic adenocarcinoma
palb2 mutation analysis
text message
monomer deletion
nucleotide bond constituents
colorectal adenocarcinoma metastatic in the liver
health insurance
national health insurance
medigap
children's health insurance program
state - sponsored health plan
tricare
civilian health and medical program of the department of veterans affairs
veterans health administration
metastatic lung non - small cell squamous carcinoma
locally advanced lung non - small cell squamous carcinoma
colorectal carcinoma metastatic in the liver
neoplastic plasma cells 30 percent or more of bone marrow nucleated cells
hearing handicap inventory screening questionnaire for adults
cd45ra - depleted donor t - lymphocytes
tcr alpha / beta / cd19 - depleted allogeneic hematopoietic progenitor cells
somatic mutation analysis
poliglusam
geriatric physician
did patient follow through with referral
primary care nurse navigator
mepolizumab
testosterone level finding
testosterone less than 50 ng / dl
ccnd2 gene mutation
dyspnea management
cdk6 gene mutation
ccnd3 gene mutation
ccne1 gene mutation
live animal dosage form
normal liver function test
anti - cd47 monoclonal antibody ibi188
bcr - jak2 fusion in hematologic malignancies
immunomodulatory imide drug
number used since last visit
number used at visit
drug used at visit
drug used since last visit
autologous cd34 - positive bcl11a - disrupted hematopoietic progenitor cells bivv003
atezolizumab / bevacizumab / carboplatin / paclitaxel regimen
atezolizumab / bevacizumab regimen
carboplatin / paclitaxel / pembrolizumab regimen
cisplatin / pembrolizumab / pemetrexed regimen
pembrolizumab / pemetrexed regimen
borderline operable
alitretinoin
menopausal symptoms attenuation
hiv entry inhibitor
hiv integrase inhibitor
testosterone greater than or equal to 200 ng / dl
efavirenz / emtricitabine / tenofovir disoproxil fumarate
elvitegravir / cobicistat / emtricitabine / tenofovir disoproxil fumarate
abacavir sulfate / lamivudine
delamanid
emtricitabine / rilpivirine / tenofovir disoproxil fumarate
autologous anti - ny - eso - 1 mtcr retroviral vector transduced pbls
what is the hormonal contraceptive use status
current oral contraceptive user
former oral contraceptive user
never used oral contraceptives
roche hpv lab test
qiagen hpv lab test
performance status scale timing not evaluated
age when started using smokeless tobacco after regular use
proximal bile duct
extrahepatic / distal bile duct
ca19 - 9 level finding
international normalized ratio of prothrombin time level finding
total bilirubin level finding
creatinine level finding
visual change
tumor focality
total thyroxine level finding
serum cea level finding
serum ca 19 - 9 level finding
sensory change
self - reported and medical record
red and violet
none identified
motor  /  movement change
month / year of diagnosis
mental status change
helicobacter pylori status
eye color
first degree family history of cancer
first degree family history of esophageal or gastric esophageal cancer
in vivo
is there a first degree family history of primary brain tumor
family history of stomach cancer
is there a first degree family history of thyroid cancer
extent of resection
epstein - barr viral status
date of last targeted molecular therapy
date of last immunotherapy treatment
clinical diagnosis of reflux disease
hybrid argon plasma coagulation
multiple endocrine neoplasia type 4
peripheral hemangioblastoma
sdhaf2 gene mutation
metastatic squamous cell carcinoma in cervical lymph node
valproic acid - expanded umbilical cord blood - derived cd34 - positive cells
boston university - boston medical center cancer center
gcgr gene mutation
brown university oncology research group
nasa jet propulsion laboratory
islet glucagon cell hyperplasia
tisch cancer institute at mount sinai
mays cancer center
glucagon cell hyperplasia and neoplasia
arid1a gene mutation
xrcc2 gene mutation
questionnaire not completed due to patient illness
questionnaire not completed due to institutional error
monomer connection points
nucleotide connection points
how often took retroviral agents past 6 months
100 percent of the time
supportive care
95 to 99 percent of the time
75 to 94 percent of the time
less than 75 percent of the time
abacavir sulfate / lamivudine / zidovudine
recurrent monomorphic post - transplant lymphoproliferative disorder
refractory monomorphic post - transplant lymphoproliferative disorder
recurrent polymorphic post - transplant lymphoproliferative disorder
refractory polymorphic post - transplant lymphoproliferative disorder
gcgr gene
gcgr wt allele
glucagon receptor
cdk4 / 6 inhibitor bpi - 16350
opti - surg toolkit
coach
allogeneic tri - functional anti - cd19 car - nk cells
anti - pd - 1 monoclonal antibody jtx - 4014
fluorine f 18 - active site inhibited factor viia
therapeutic ex vivo - expanded allogeneic gamma delta t - cells
ebv lmp - 2a - specific autologous cd8 +  t - cells
adenosine a2a receptor antagonist / phosphodiesterase 10a pbf - 999
tumor debulking
lactobacillus rhamnosus / l . acidophilus / l . plantarum /  enterococcus faecium aqueous probiotic supplement
xinmailong
kras g12c inhibitor mrtx849
anti - ctla - 4 / ox40 bispecific antibody ator - 1015
troxacitabine nucleotide prodrug miv - 818
castration - resistant prostate carcinoma refractory to second - generation androgen receptor axis - targeted agents
resistance to second - generation androgen receptor axis - targeted agents
nanoscale coordination polymer nanoparticles cpi - 100
disaccharide tripeptide glycerol dipalmitoyl
intrathecal chemotherapy
cd56 - enriched cd3 - positive donor lymphocytes
anti - sirpa monoclonal antibody cc - 95251
hbv surface antibody level result
feline histiocytic sarcoma
myopathy due to myoadenylate deaminase deficiency
x - linked dystonia - parkinsonism
hcv genotype finding
hbv dna level finding
hbv genotype finding
vinyl chloride or derivatives exposure
external beam radiation therapy
non - neoplastic finding
high risk non - muscle invasive bladder urothelial carcinoma
recurrent high risk non - muscle invasive bladder urothelial carcinoma
no therapy
single agent therapy
multiple agent therapy
unknown regimen
therapy used at visit
therapy used since last visit
drug included in regimen
chemoembolization
potent antiretroviral therapy
msi - h negative
overlapping / multiple zones of prostate
tumor marker level
cptac bladder urothelial carcinoma baseline form
survivorship care plan
cptac cervical squamous cell carcinoma and endocervical adenocarcinoma baseline form
cptac esophageal carcinoma baseline form
cptac cholangiocarcinoma baseline form
cptac liver hepatocellular carcinoma baseline form
cancer registry
cptac prostate adenocarcinoma baseline form
cptac brain lower grade glioma baseline form
cptac stomach adenocarcinoma baseline form
cptac thyroid carcinoma baseline form
cptac uveal melanoma baseline form
emtricitabine / tenofovir disoproxil fumarate
darunavir / cobicistat
elvitegravir / cobicistat / emtricitabine / tenofovir alafenamide fumarate
emtricitabine / tenofovir alafenamide fumarate
emtricitabine / rilpivirine / tenofovir alafenamide fumarate
geographic information system
haart with hydroxyurea and didanosine
atazanavir / cobicistat
ribavirin / recombinant interferon alpha - 2b
abacavir / dolutegravir / lamivudine
arhgap45 gene
arhgap45 wt allele
rho gtpase - activating protein 45
arhgap45 gene mutation
arhgap45 nm_012292 .4:c .416g > a
arhgap45 protein variant
lumpectomy
arhgap45 np_036424 .2:p .r139h
minor histocompatibility antigen ha - 1
pulmonary arterial hypertension
cdk gene mutation
pi3k gene mutation
mir1290 gene
mir1290 wt allele
mir1290 pre - mirna
mir1246 gene
mir1246 wt allele
single agent systemic chemotherapy
mir1246 pre - mirna
magt1 gene
magt1 wt allele
magnesium transporter protein 1
ha - 1 ( h )  genotype positive
tp53 gene alteration positive
rb1 gene alteration positive
microrna 1290
microrna 1246
biallelic cebpa gene mutation
antiestrogen therapy
adenovirus dna viremia
pcm1 - jak2 fusion protein expression
jak2 gene rearrangement
low grade anal intraepithelial neoplasia
anal intraepithelial neoplasia 2
anal intraepithelial neoplasia 3
ankyloblepharon - ectodermal defects - cleft lip / palate
dystonia 12
anti - pd1 / icos bispecific monoclonal antibody xmab23104
magt1 gene mutation
central line management
activating pten gene mutation
ggaa microsatellite repeat
shh positive
myokine
elevated dkk1
egfr gene alteration positive
irak1 gene mutation
myd88 fusion positive
irak1 fusion positive
jak3 fusion positive
urostomy
tyk2 fusion positive
tyk2 gene mutation
activating jak2 gene mutation
activating jak3 gene mutation
activating myd88 gene mutation
activating irak1 gene mutation
activating tyk2 gene mutation
hif1a overexpression positive
sedoxantrone trihydrochloride
drug development
recurrent giant cell glioblastoma
recurrent ependymoma
metastatic lung neuroendocrine neoplasm
mold device
short somatic mutation
mastectomy patient
refractory barrett esophagus
non - neoplastic chronic lower respiratory system disorder
homicide by assault
complication due to medical / surgical care
acustimulation therapy
death by overdose
death by alcohol ingestion
firearm injury
variably - sized cysts filled with clear ,  serous ,  or gelatinous fluid
bap1 - mutant clear cell renal cell carcinoma
other and unspecified events of undetermined intent and their sequelae
other and unspecified infectious and parasitic diseases and their sequelae
symptoms ,  signs and abnormal clinical and laboratory findings ,  nec
cisplatin / nab - paclitaxel / pembrolizumab regimen
carboplatin / nab - paclitaxel / pembrolizumab regimen
laparoscopic colectomy
illness is financial hardship for my family and me
platinum - resistant fallopian tube carcinoma
platinum - resistant primary peritoneal carcinoma
metastatic cholangiocarcinoma
transformed chronic lymphocytic leukemia to diffuse large b - cell lymphoma
transformed small lymphocytic lymphoma to diffuse large b - cell lymphoma
chromosome arm 1p loss of heterozygosity
chromosome arm 5q loss of heterozygosity
chromosome 6 loss of heterozygosity
chromosome 8 loss of heterozygosity
advanced manufacturing technology
lutetium lu 177 dota - ipn01087
recurrent urothelial carcinoma
anti - pd - l1 / ctla - 4 bispecific antibody kn046
neoantigen - encoding personalized virus - 2
expanded / activated gamma delta t - cells
gallium ga 68 nodaga - cbp8
locally advanced urothelial carcinoma
metastatic adenoid cystic carcinoma
recurrent adenoid cystic carcinoma
aids ,  clinical trials on patients with aids - related malignancies
chromosome 10 loss of heterozygosity
chromosome 11 loss of heterozygosity
chromosome 15 loss of heterozygosity
chromosome 18 loss of heterozygosity
chromosome 22 loss of heterozygosity
mismatch repair proficient
orchidometer
hemipelvectomy type i
hemipelvectomy type ii
aids ,  clinical trials on minorities
hemipelvectomy type iii
type ii hemipelvectomy patient
pelvic sarcoma
blasts 0 .01 percent or more of bone marrow nucleated cells
autologous anti - cd19car - cd28tm / 4 - 1bb / cd3zeta - her2tg - expressing cd4 +  / cd8 +  t - lymphocytes scri - hucar19v1
nodule consistency
unresectable lymphoma
solid nodule
pure ground glass nodule
aids ,  clinical trials on patients with opportunistic infections
part - solid nodule
semiconsolidation nodule
nodule margin conspicuity
well marginated nodule
poorly marginated nodule
nodule margin type
smooth nodule
lobulated nodule
notched nodule
spiculated or serrated nodule
aids ,  clinical trials on children
spiculated nodule
serrated nodule
indeterminate nodule type
nodule shape
round nodule
ovoid nodule
polygonal nodule
complex nodule shape
refractory t - cell / histiocyte - rich large b - cell lymphoma
recurrent primary effusion lymphoma
aids ,  clinical trials on women
refractory primary effusion lymphoma
recurrent primary lymphoma of bone
refractory primary lymphoma of bone
recurrent plasmablastic lymphoma
refractory plasmablastic lymphoma
recurrent hiv - associated lymphoproliferative disorder
refractory lymphoproliferative disorder
refractory hiv - associated lymphoproliferative disorder
female genital grading table
recurrent nk - cell lymphoma ,  unclassifiable
basic behavioral and social science research
refractory nk - cell lymphoma ,  unclassifiable
refractory t - cell prolymphocytic leukemia
recurrent aggressive nk - cell leukemia
refractory aggressive nk - cell leukemia
refractory monomorphic epitheliotropic intestinal t - cell lymphoma
recurrent subcutaneous panniculitis - like t - cell lymphoma
refractory subcutaneous panniculitis - like t - cell lymphoma
refractory b - cell prolymphocytic leukemia
pediatric quality of life brain tumor module version 1 .0
cognitive problems subscale
nolatrexed dihydrochloride
behavior research ,  direct
pain and hurt subscale
movement and balance subscale
procedural anxiety subscale
nausea subscale
worry subscale
reticular growth pattern
microcystic growth pattern
assault
hiv - associated lymphoproliferative disorder
behavior research ,  indirect
recombinant vesicular stomatitis virus - expressing interferon - beta and tyrosinase related protein 1
gdc terminology
malignant epithelial cells with cytoplasmic vacuoles or flocculent cytoplasmic inclusions containing wispy eosinophilic material present
total gut decontamination
dermal injectable filler
acquired cystic disease - associated renal cell carcinoma
college of american pathologists
biological response modifiers program
vaginal dilator
intra or intercytoplasmic lumina present
high - dose - rate vaginal brachytherapy
cdisc questionnaire phq - 2 test name terminology
cdisc questionnaire phq - 2 test code terminology
phq - 2 questionnaire question
phq - 2  -  little interest or pleasure in doing things
leukocyte banking
phq - 2  -  feeling down ,  depressed or hopeless
ess  -  total score
laryngeal papillomatosis
neuroblate system
compression therapy
compression therapy for neuropathy prevention
kidney synovial sarcoma
axillary reverse mapping
smooth muscle metaplasia
breast cancer therapeutic procedure
cancer surgery
cosmetic surgery
valvular surgery
kidney neuroendocrine neoplasm
childhood cystic nephroma
autologous anti - psca - car - 4 - 1bb / tcrzeta - cd19t - expressing t - lymphocytes
tsc2 monoallelic inactivation
metanephric tumor
metanephric stromal tumor
breast cancer detection research
metastatic bladder squamous cell carcinoma
metastatic infiltrating bladder urothelial carcinoma ,  plasmacytoid variant
hoxb13 gene mutation
metastatic infiltrating bladder urothelial carcinoma ,  lipid - rich variant
metastatic kidney medullary carcinoma
germline hoxb13 gene mutation
metastatic sarcomatoid renal cell carcinoma
bladder neuroendocrine neoplasm
bladder neuroendocrine carcinoma
cancer detection
bladder large cell neuroendocrine carcinoma
metastatic bladder large cell neuroendocrine carcinoma
metastatic bladder small cell carcinoma
metastatic prostate small cell carcinoma
motivational interviewing
metastatic infiltrating bladder urothelial carcinoma ,  sarcomatoid variant
metastatic infiltrating bladder urothelial carcinoma ,  micropapillary variant
metastatic infiltrating bladder urothelial carcinoma ,  clear cell variant
metastatic infiltrating bladder urothelial carcinoma with giant cells
cancer prevention ,  primary
metastatic infiltrating bladder urothelial carcinoma ,  nested variant
tlr9 agonist ast - 008
anti - ror1 adc vls - 101
cryocompression therapy
metastatic malignant genitourinary system neoplasm
botulinum toxin therapy
maraba oncolytic virus expressing mutant hpv e6 / e7
adenovirus expressing mutant hpv e6 / e7
abdominal aneurysm open repair
ablation for barrett's esophagus
acne scar treatment
acute hepatitis b infection
acute hepatitis c infection
acute hepatitis e infection
ambulatory anorectal surgery
amoebiasis
amphetamine use disorder
ankle arthroscopy
aortic valve surgery
arthroscopic surgery
carcinogen screening
assault by firearm
assault by sharp object
assistive devices
atherectomy
bacterial skin disorder
balloon valvuloplasty
behavioral measures for treating sleep disordered breathing
bladder cancer surgery
botulinum toxin for digestive disorders
brachial plexus block
bispecific antibody mdx - h210
carcinogenesis inhibition
brain tumor radiation
brain tumor surgery
breast surgery
brow lift
campylobacter enteritis
cardiac behavioral counseling
cardiac surgery
carotid endarterectomy
casts and splints
cataract surgery
cervical cancer surgery
chemotherapy for brain tumor
cholera
chronic kidney disease due to diabetes mellitus
chronic kidney disease due to hypertension
chronic pain rehabilitation
non - neoplastic chronic respiratory system disorder
cirrhosis of the liver secondary to hepatitis b
cirrhosis of the liver secondary to hepatitis c
cocaine use disorder
clinical chemoprevention
cochlear implants
cognitive behavioral therapy for insomnia
collis gastroplasty
colon resection
colorectal cancer surgery
communicable disorder
core decompression
cosmetic plastic surgery
cranial base surgery
cryoablation for arrhythmia
clinical data
double eyelid surgery
driving simulation training
ear pinning
elbow arthroscopy
endometrial ablation
endometrial cancer surgery
endoscopic sinus surgery
endoscopic submucosal dissection
endourologic procedure
endovascular aneurysm repair
clinical nutrition
endovascular stenting
enteropathogenic e coli infection
enterotoxigenic e coli infection
epicardial ablation
epidural steroid injection
esophageal cancer surgery
esophageal manometry
esophagus resection
eye evisceration and enucleation
eye socket reconstruction
eyelash growth stimulation
eyelid lift
eyelid reconstruction
facelift
facial implants
facial plastic surgery
femoral popliteal bypass
firm ablation
fistula repair
forehead lift
clinical treatment
gasserian ganglion block
gastric bypass for esophagus disorders
gastric electrical stimulation
gastric pacemaker
gastrostomy tube procedure
glioma ,  glioblastoma & astrocytoma surgery
gluten free diet
h influenze type b meningitis
h influenze type b pneumonia
hair removal
clinical trials design
hair replacement
head and neck cancer surgery
hearing devices
heller myotomy
hepatitis c treatment
hip arthroscopy
hip replacement
hybrid coronary revascularization
hybrid surgical - catheter ablation
hypertensive heart disease
clinical trials ,  diagnosis
hypogastric plexus block
ibd medical management
immunotherapy for melanoma
implanted epidural portal
integrative medicine
interventional neuroradiology procedure
intestinal nematode infection
intestinal rehabilitation and transplant
intestinal vascular disorder
intragastric balloon procedure
clinical trials ,  monitoring
intraoperative cholangiogram
intraoperative endoscopy
intrathecal catheter placement
intrathecal programmable pump placement
intravenous lidocaine infusion
iodine deficiency
knee arthroscopy
knee replacement
kock pouch ileostomy procedure
lap band surgery
eflornithine hydrochloride
cancer prevention trial
laparoscopic nissen fundoplication
laser resurfacing
laser tattoo removal
laser vein treatment
laser vision correction
left atrial appendage closure
left ventricular remodeling
linx procedure
liposuction
liver disease prevention
clinical testing
low fodmap diet
lower gastrointestinal therapeutic surgical procedure
lung cancer surgery
lung volume reduction surgery
lymphatic system therapeutic procedure
mammosite brachytherapy
maternal hemorrhage
maternal sepsis
maximandibular advancement surgery
mediastinal mass surgery
transplantation and immune system
melanoma surgery
meningioma surgery
minimally invasive heart surgery
minimally invasive joint replacement surgery
mohs surgery for melanoma
mohs surgery for non - melanoma
mr guided focused ultrasound
multiple myeloma surgery
multiple sclerosis rehabilitation
musculoskeletal rehabilitation
conduct clinical trials
non - melanoma surgery
nasal surgery
natural heart valve repair
neobladder reconstruction
neurological rehabilitation
non - communicable disorder
non - infective inflammatory bowel disease
non - ischemic stroke
nutritional deficiency
obstructed labor
cancer therapy evaluation program
occipital nerve block
oculoplastic surgery
opiod use disorder
oral appliance therapy
ovarian cancer surgery
pacemaker or icd lead extraction
palate surgery
parathyroid surgery
patent foramen ovale closure
pedestrian injury by road vehicle
detection of minimal residual disease
penile rehabilitation
percutaneous thrombectomy
percutaneous transluminal angioplasty of the femoral artery
peripheral nerve block
peritoneal adhesion excision
peroral endoscopic myotomy
physical therapy for orthopedics and sports medicine
pituitary tumor surgery
pneumococcal meningitis
pneumococcal pneumonia
developmental diagnostic
positive airway pressure therapies
preterm birth complication
prostate cancer surgery
pulmonary autograft
pulmonary embolectomy
pulmonary metastasectomy
pulmonary rehabilitation
pulsed light rejuvenation
radioactive iodine therapy
reconstructive plastic surgery
diagnostic methods and reagents
reproductive surgery
respiratory syncytial virus pneumonia
road injury
rotaviral enteritis
salmonellosis
sarcoma surgery
scoliosis and kyphosis deformity correction
sexually transmitted chlamydial disease
shigellosis
shoulder arthroscopy
shoulder replacement surgery
shoulder steroid injections
shoulder / knee corticosteroid therapy
skin lesion surgery
skull base surgery
small bowel transplantation
spinal fusion
stabilize extremity dislocation
stabilize femur fracture
stabilize hip fracture
diagnostics ,  cancer
stabilize lower extremity fracture
stereotactic ablative radiotherapy
stretta procedure
strictureplasty
stroke rehabilitation
subcutaneous disorder
subfascial endoscopic perforator surgery
surgery to improve sleep
targeted therapy for melanoma
tear duct surgery
anti - dna antibody
drug development ,  clinical
temporary epidural catheter placement
therapeutic breast surgery
therapeutic mouth procedure
therapeutic muscle procedure
therapeutic nervous system procedures
therapeutic nose procedure
therapeutic pharynx procedure
therapeutic procedures on bone
therapeutic skin surgery
therapeutic tendon procedure
drug development ,  preclinical
therapeutic upper gastrointestinal procedures
thoracic aortic aneurysm open repair
thyroid cancer surgery
tongue surgery
topical medications for melanoma
topical medications for non - melanoma
total disc replacement
total shoulder replacement
transcatheter aortic valve replacement
transcatheter mitral valve repair
transmyocardial revascularization
transoral incisionless fundoplication
transport injury
transthoracic myocardial laser revascularization
tummy tuck
tumor ablation therapy
uterine fibroid embolization
valvotomy
vascular study
vasectomy reversal procedure
drug discovery groups
vena cava filter surgery
venomous animal contact
kidney epithelioid angiomyolipoma
cisplatin / paclitaxel / pembrolizumab regimen
cptac causes of death codelist
cptac medical conditions codelist
cptac procedures codelist
cptac treatments codelist
4 / 8 hla match
5 / 8 hla match
eps library
6 / 8 hla match
7 / 8 hla match
8 / 8 hla match
lutetium lu 177 dota - n3 - ctt1403
nf1 mutation positive malignant peripheral nerve sheath tumor
kidney mixed epithelial and stromal tumor family
insect glycan
reptilian glycan
mammalian afucosylated glycan
molluscan glycan
pklr nm_000298 .5:c .1436g > a
pklr protein variant
pklr np_000289 .1:p .r479h
ntrk2 gene mutation
ntrk3 gene mutation
neoplastic plasma cells 20 percent or more of peripheral blood white cells
notch3 gene mutation
activating notch3 mutation
activating notch2 mutation
trastuzumab / hyaluronidase - oysk
notch4 gene mutation
activating notch4 mutation
activating notch1 mutation
ctnna1 gene mutation
lymphoma cells more than 25 percent of bone marrow nucleated cells
anti - folate receptor - alpha antibody drug conjugate stro - 002
activating alk gene mutation negative
activating ros1 gene mutation negative
high dose chemotherapy
neuromuscular blockade
central american indian language
fgfr3 gene rearrangement
north american indian language
oncolytic virus rp1
is any metastatic diagnosis present
skip to next section if no
fluorouracil / liposomal irinotecan / leucovorin regimen
nicotinamide riboside
gtp regimen
intercept vertical transmission - perinatal transmission of hiv
deep gray matter
recurrent b - cell prolymphocytic leukemia
super enhancer inhibitor gz17 - 6 .02
cetuximab - loaded ethylcellulose polymeric nanoparticles decorated with octreotide  ( sy )
umbilical cord blood - derived cd4 +  / cd25 +  t - regulatory cells ck0801
anti - egfr / c - met bispecific antibody emb - 01
pimodivir
anti - cd38 / bcma car t - lymphocytes
refractory digestive system neuroendocrine neoplasm
advanced digestive system neuroendocrine neoplasm
laboratory animal production and facilities
locally advanced unresectable digestive system neuroendocrine neoplasm
autologous deep il - 15 primed t - cells trq15 - 01
spirulina - based dietary supplement
ret inhibitor ds - 5010
cinnamomum cassia capsules
anti - pd - l1 monoclonal antibody tg - 1501
deuterated enzalutamide
recombinant bovine basic fibroblast growth factor
black currant juice
anti - fl ( fitc - e2 )  car t cells
benzydamine hydrochloride
protein arginine methyltransferase 5 inhibitor pf - 06939999
refractory cholangiocarcinoma
cadastro de pessoas fisicas
dihydroorotate dehydrogenase inhibitor ag - 636
refractory who grade ii glioma
rassf1 gene promoter hypermethylation
cdh1 gene promoter hypermethylation
ednrb gene promoter hypermethylation
vegf overexpression positive
thbs1 overexpression positive
low dose radiation therapy
e2f3 gene amplification
date of reference time point
time of reference time point
cdisc sdtm qrs method terminology
cdisc adam geriatric depression scale short form questionnaire parameter code terminology
cdisc adam geriatric depression scale short form questionnaire parameter name terminology
cdisc send challenge agent parameter code terminology
cdisc send challenge agent parameter long name terminology
cdisc send age estimation method response terminology
cdisc send biological challenge agent category response terminology
maternal and child health study
cdisc send challenge agent category response terminology
cdisc send rad / nuc agent ionizing radiation type response terminology
cdisc send rad / nuc agent source response terminology
cdisc send restraint mode response terminology
cdisc send sexual maturity status response terminology
cdisc send study report status response terminology
seroreactivity
geriatric depression scale short form questionnaire question
challenge agent
restraint
media intervention
prmt1 inhibitor
anti - cd73 monoclonal antibody nzv930
pelvic hemorrhage
nonrandom x chromosome inactivation
infantile liver failure syndrome 2
empagliflozin
ino80 complex
thoracic endometriosis
pax5 gene mutation
multicenter hemophilia cohort study
pax5 protein variant
pax5 nm_016734 .2:c .239c > g
pax5 np_057953 .1:p .p80r
pax5 nm_016734 .2:c .547g > a
pax5 np_057953 .1:p .g183s
ikzf1 protein variant
ikzf1 np_006051 .1:p .n159y
interleukin 2 receptor measurement
sexual maturity status
recurrent transformed b - cell non - hodgkin lymphoma
refractory transformed b - cell non - hodgkin lymphoma
recurrent transformed chronic lymphocytic leukemia
refractory transformed chronic lymphocytic leukemia
transplant registry unified management program
geriatric depression scale short form  -  total score
treatment amount
7 lead placement standard for non - human subjects
han chinese
zhuang chinese
natural history of progression of hiv - related diseases
hui chinese
man chinese
uygur chinese
miao chinese
yi chinese
tujia chinese
zang chinese
mongol chinese
dong chinese
buyei chinese
neuroscience and neuropsychiatric research
yao chinese
bai chinese
chosen chinese
hani chinese
li chinese
kazak chinese
dai chinese
she chinese
lisu chinese
dongxiang chinese
national surgical adjuvant breast and bowel project
gelao chinese
lahu chinese
va chinese
sui chinese
naxi chinese
qiang chinese
tu chinese
mulao chinese
xibe chinese
kirgiz chinese
jingpo chinese
daur chinese
salar chinese
blang chinese
maonan chinese
tajik chinese
pumi chinese
achang chinese
nu chinese
ewenki chinese
carubicin hydrochloride
nutritional study
gin chinese
jino chinese
deang chinese
bonan chinese
russ chinese
yugur chinese
uzbek chinese
monba chinese
oroqen chinese
derung chinese
hezhen chinese
gaoshan chinese
lhoba chinese
tatar chinese
extended release capsule ,  hard dosage form
extended release capsule ,  softgel dosage form
hiv - 2 seroreactivity measurement
hiv - 1 seroreactivity measurement
monoclonal protein spike region identification
fluoxetine measurement
soluble interleukin 2 receptor measurement
glycine to creatinine ratio measurement
apolipoprotein a to apolipoprotein b ratio measurement
taurine to creatinine ratio measurement
threonine to creatinine ratio measurement
aspartate aminotransferase to creatine kinase ratio measurement
direct bilirubin to bilirubin ratio measurement
glycated albumin to albumin ratio measurement
plasmacytoid lymphocytes to leukocytes ratio measurement
reactive lymphocytes to leukocytes ratio measurement
sezary cells to leukocytes ratio measurement
symmetric dimethylarginine measurement
asymmetric dimethylarginine measurement
hemoglobin h inclusion bodies measurement
complement c5b - 9 measurement
large lymphocyte count
pyridoxal phosphate measurement
hiv - 1 rna measurement
immunodiffusion
nutrition ,  dietary components
romanowsky stain
lissamine green stain
fluorescein stain
slit lamp photography
thermal ionization mass spectrometry
myeloperoxidase stain
sloan letter eye chart 100 percent
fluorescent antibody virus neutralization assay
cell - of - origin assay
immune repertoire deep sequencing
nutrition ,  fats ,  saturated
multiplex real - time polymerase chain reaction assay
in vitro gene expression assay
targeted transcriptome sequencing
targeted genome sequencing
chalkley score
flagged mutations present indicator
fat mass
lean mass
n - acetylaspartate and n - acetyl - aspartylglutamate measurement
free choline and glycerophosphorylcholine and phosphorylcholine measurement
nutritional anthropometry
creatine and phosphocreatine measurement
glycerophosphorylcholine and phosphorylcholine measurement
rano ellingson 2017 oncology response criteria
irano okada 2015 oncology response criteria
minimal response
volume of distribution observed for unbound drug
volume of distribution predicted for unbound drug
volume of distribution of fraction dose predicted corrected for unbound drug
visual analog scale  ( 100 mm )
visual analog scale  ( 50 mm )
nutritional biochemistry
numerical rating scale 11 - point
verbal rating scale 4 - point
verbal rating scale 5 - point
verbal rating scale 6 - point
maori
number of births
estimated next menstrual period start date
gender identity
lactescent specimen
non - hemolyzed specimen
other resources
thawed specimen
mixed venous blood
urine sediment
adhesion performance study
alcohol effect study
device - drug interaction study
drug - drug interaction study
thorough qt study
biosimilarity study
dose finding study
dose proportionality study
milligram per liter fibrinogen equivalent units
microgram per liter fibrinogen equivalent units
ten thousand colony forming units
ten million colony forming units
gray per hour
gray per minute
fetal head circumference
challenge agent category
multiple challenge agent different category indicator
daunorubicin hydrochloride
palliative care ,  other than pain and hospice
multiple challenge agent same category indicator
challenge agent supplier name
challenge agent supplier address
biological agent biovar name
biological agent serovar name
biological agent strain name
biological agent engineered indicator
biological agent certificate of analysis indicator
biological agent type
biological agent genus and species
pathobiology of wasting and growth retardation
master bank or seed stock immediate supplier
material identification code
biological agent nucleotide sequence indicator
biological agent nucleotide sequence location
working bank or primary stock characterized indicator
chemical challenge agent name
chemical agent cas number
challenge agent metabolite caused injury indicator
radiological / nuclear challenge agent source type
radiological / nuclear agent ionizing radiation type
patient oriented research
radiological / nuclear agent irradiation source beam strength
challenge agent type mixed field indicator
radioisotope species name
dental examination
animal record information
biological challenge agent
chemical challenge agent
radiological / nuclear challenge agent
supernumerary rib
cervical rib
lumbar rib
experimental organism syncytium
increased alveolar macrophages
increased granules
decreased peri - insular halos
increased peri - insular halos
paneth cell reduction
secretory depletion
increased atretic follicles
decreased or absent follicles
pharmaceutical resources
booster synchrotron
x - ray irradiator
nuclear reactor
chemical restraint
physical restraint
chemical and physical restraint
sexual maturity status at neutering
major histocompatibility complex tested indicator
previous research experience indicator
neutered indicator
phase i and ii vaccine trials
telemeterized indicator
sexually mature
sexually immature
expiratory flow 50%
apnea time
elapsed time between breaths
efficacy study with pre - exposure prophylaxis
efficacy study with post - exposure prophylaxis
efficacy study with post - exposure radiomitigation
draft study report
prostate ,  lung ,  colorectal ,  and ovarian cancer screening trial
interim study report
final study report
amended final study report
antimicrobial or acidified / chlorinated water during husbandry indicator
study report status
excluded pathogen
pathogen exclusion verification method
qualified animal model use indicator
specific pathogen free indicator
genetically modified subject indicator
pharmacokinetic analysis indicator
challenge agent multiple route indicator
toxicological dose descriptor
factor for toxicological dose descriptor
bladder non - invasive urothelial neoplasm
surgery patient
gynecologic surgery patient
hysterectomy patient
refractory endometrial serous adenocarcinoma
refractory endometrial mixed cell adenocarcinoma
prevent transmission of hiv / safety blood supply
refractory endometrial clear cell adenocarcinoma
refractory uterine corpus carcinosarcoma
bladder non - invasive papillary urothelial carcinoma
advanced uterine corpus carcinosarcoma
siglec15 gene
siglec15 wt allele
sialic acid - binding ig - like lectin 15
msmile regimen
gstt2 gene
gstt2 wt allele
glutathione s - transferase theta - 2
tinagl1 gene
tinagl1 wt allele
tubulointerstitial nephritis antigen - like
marked thickening of the bladder urothelium present
nmt1 gene
nmt1 wt allele
glycylpeptide n - tetradecanoyltransferase 1
vaginal cuff brachytherapy
high - dose - rate vaginal cuff brachytherapy
loperamide hydrochloride
prevention and treatment of opportunistic infection
low - dose - rate vaginal cuff brachytherapy
refractory paraganglioma
refractory adrenal gland pheochromocytoma
b4galt5 gene
b4galt5 wt allele
beta - 1 , 4 - galactosyltransferase 5
ch25h gene
ch25h wt allele
cholesterol 25 - hydroxylase
fndc5 gene
prevention of high - risk behavior
fndc5 wt allele
fndc5 gene product
fibronectin type iii domain - containing protein 5
irisin
translocase gene
tissue section
blood dna
frozen tissue
stained specimen
translocase
prevention ,  early detection of premalignant lesions
patidegib topical gel
recurrent endometrioid adenocarcinoma
sustained - release mitomycin c hydrogel formulation ugn - 102
chemical impurity
physical property
biological property
recurrent desmoplastic small round cell tumor
refractory desmoplastic small round cell tumor
recurrent fibrosarcoma
refractory fibrosarcoma
preventive intervention
recurrent spindle cell sarcoma
refractory spindle cell sarcoma
picogreen dye
ribogreen dye
oligreen dye
chemical identification
anti - gd2 hu3f8 / anti - cd3 huokt3 bispecific antibody
recurrent endometrial adenocarcinoma
ipsc - derived natural killer cells ft500
autologous anti - muc1* - car - 4 - 1bb - cd3zeta - expressing t - lymphocytes
protein / amino acid nutrition ,  animal
kdm7a gene
kdm7a wt allele
lysine - specific demethylase 7a
kdm7a - dt gene
kdm7a - dt wt allele
kdm7a divergent transcript
dhx58 gene
dhx58 wt allele
probable atp - dependent rna helicase dhx58
lin9 gene
protein / amino acid nutrition ,  non - animal
lin9 wt allele
protein lin - 9 homolog
mir210hg gene
mir210hg wt allele
mir210 host gene long noncoding rna
ms4a7 gene
ms4a7 wt allele
membrane - spanning 4 - domains subfamily a member 7
msantd3 gene
msantd3 wt allele
radiation ionizing radiotherapy
myb / sant - like dna - binding domain - containing protein 3
citrate blood cell fraction
edta blood cell fraction
metastatic salivary gland carcinoma
locally advanced salivary gland carcinoma
challenge agent treatment efficacy study
attenuated live listeria monocytogenes encoding kras g12d
muc1* - positive cells present
oxct1 gene
oxct1 wt allele
succinyl - coa:3 - ketoacid coenzyme a transferase 1 ,  mitochondrial
10 / 10 hla match
12 / 12 hla match
9 / 10 hla match
8 / 10 hla match
7 / 10 hla match
6 / 10 hla match
5 / 10 hla match
6 / 6 hla match
body mass index 25 or greater
autologous dendritic cell / myeloma fusion vaccine
palm2 gene
palm2 wt allele
paralemmin - 2
akap2 gene
akap2 wt allele
a - kinase anchor protein 2
palm2 / akap2 fusion gene
palm2 / akap2 fusion protein
qsox2 gene
high - let radiotherapy
bcl2 gene mutation
qsox2 wt allele
sulfhydryl oxidase 2
platinum - resistant lung small cell carcinoma
platinum sensitivity
platinum - sensitive lung small cell carcinoma
rab6b gene
rab6b wt allele
tomographic optical breast imaging
ras - related protein rab - 6b
low - let radiotherapy
globozoospermia
androgen receptor status
anti - bcma / cd3 bite antibody regn5458
anti - pd - 1 / anti - ctla4 dart protein mgd019
cap binding complex 80 / 20 binder abx - 464
anti - ox40 monoclonal antibody ibi101
linperlisib
technetium tc - 99m anti - her2 affibody abh2
redirected cytolysis
bcl - 2 inhibitor s65487
polidocanol
radium bromatum
anti - c - met antibody - drug conjugate tr1801
microtransplantation
eicosapentaenoic acid monoacylglyceride
rassf7 gene
tubulin polymerization inhibitor veru - 111
rassf7 wt allele
ras association domain - containing protein 7
cptac codelists terminology
broad institute
autologous cmv - pp65 - shlamp - 1 mrna loaded dendritic cell vaccine
weight at time of procedure
skin lesion
rfc4 gene
rfc4 wt allele
replication factor c subunit 4
rtn4rl1 gene
rtn4rl1 wt allele
reticulon - 4 receptor - like 1
x - linked hyper - igm syndrome
pd - l1 inhibitor incb086550
autologous car - mbil15 - safety switch t - cells prgn - 3005
rundc1 gene
rundc1 wt allele
run domain - containing protein 1
serf1a gene
serf1b gene
serf1a wt allele
serf1b wt allele
small edrk - rich factor 1
myeloid stem cell
smim5 gene
smim5 wt allele
small integral membrane protein 5
stk32b gene
clonal hematopoiesis of indeterminate potential
stk32b wt allele
serine / threonine - protein kinase 32b
state cancer legislative database
tmem65 gene
neck of the pancreas
tmem65 wt allele
transmembrane protein 65
tmem74b gene
tmem74b wt allele
transmembrane protein 74b
anti - ctla - 4 monoclonal antibody agen1181
allogeneic anti - cd19 - car t - cells pbcar0191
muc6 gene
muc6 wt allele
mucin - 6
muc5b gene
muc5b wt allele
mucin - 5b
tspyl5 gene
tspyl5 wt allele
testis - specific y - encoded - like protein 5
uchl5 gene
uchl5 wt allele
therapy evaluation
ubiquitin carboxyl - terminal hydrolase isozyme l5
months since completion of primary therapy
znf385b gene
znf385b wt allele
zinc finger protein 385b
cadps2 gene
cadps2 wt allele
calcium - dependent secretion activator 2
ecpas gene
ecpas wt allele
proteasome adapter and scaffold protein ecm29
lymphoma in remission
non - hodgkin lymphoma in remission
hodgkin lymphoma in remission
jaundice status
unresectable urethral urothelial carcinoma
unresectable bladder urothelial carcinoma
unresectable ureter urothelial carcinoma
unresectable renal pelvis urothelial carcinoma
height at time of procedure
trace element nutrition ,  fluorides
physician's global assessment scale of epidermal chronic graft versus host disease
epidermal cgvhd score 0
epidermal cgvhd score 1
epidermal cgvhd score 2
epidermal cgvhd score 3
epidermal cgvhd score 4
lyophilisate for emulsion for injection
lyophilisate and solvent for emulsion for injection
effervescent powder and powder for oral suspension
autologous cytoplasmic activated pd - 1 car t - cells
levofloxacin
trace element nutrition ,  mercury
green tea / licorice extract - based antioxidant solution
autologous cytotoxic t - lymphocytes exposed to dendritic cells loaded with 6b11 anti - idiotype minibody
anti - egfr car - transduced il - 12 - expressing t - lymphocytes
pi3k - alpha inhibitor men1611
autologous anti - cd19 car - expressing t - lymphocytes clic - 1901
whey protein isolate - based  nutritional supplement
crispr - cas9 - mediated pd - 1 and tcr gene - deleted anti - mesothelin car t - cells
survivin - expressing cvd908ssb - txsvn vaccine
kmt2a fusion positive
endometrioid adenocarcinoma ,  variant with squamous differentiation
donor information
was menopausal hormone therapy ever used
was another form of birth control ever used
borderline ovarian mixed epithelial tumor / atypical proliferative ovarian mixed epithelial tumor
btk inhibitor loxo - 305
have oral contraceptives ever been taken
was tamoxifen ever taken
translational research
endometrioid tumor ,  variant with squamous differentiation
number of full term pregnancies
borderline serous cystadenofibroma
click or tap here to enter text
age at initial pathologic diagnosis
date and method of initial pathologic diagnosis
date of tumor progression after initial treatment
date of tumor reoccurrence after initial treatment
iodine i 124 monoclonal antibody m5a
cancer biobank
did the individual have multiple known primary tumors at initial melanoma diagnosis
what is the first course treatment completion measure of success of outcome
initial pathologic diagnosis method
did a new event occur after initial treatment
number of days from date of initial pathologic diagnosis to date of additional surgery for new tumor event loco - regional
number of days from date of initial pathologic diagnosis to date of additional surgery for new tumor event metastasis
bladder soft tissue neoplasm
number of days from date of initial pathologic diagnosis to date of tumor progression after initial treatment
number of days from date of initial pathologic diagnosis to date of tumor reoccurrence after initial treatment
number of discontiguous lesions  ( new tumor event )
number of known primaries at the time of initial melanoma diagnosis
number of other lymph nodes examined
number of other lymph nodes positive for tumor by h&e
number of other lymph nodes positive for tumor by ihc staining only
number of para - aortic lymph nodes examined
number of para - aortic lymph nodes positive for tumor by h&e
number of para - aortic lymph nodes positive for tumor by ihc staining only
number of pelvic lymph nodes examined
number of pelvic lymph nodes positive for tumor by h&e
number of pelvic lymph nodes positive for tumor by ihc staining only
vaccine design and animal testing
prostate large cell neuroendocrine carcinoma
stx11 gene mutation
organ based
itgb2 gene mutation
prf1 gene mutation
lyst gene mutation
usual prostate adenocarcinoma with neuroendocrine differentiation
scattered neuroendocrine cells by immunohistochemistry present
xiap gene mutation
unc13d gene mutation
vaccine development ,  aids
stxbp2 gene mutation
preoperative karnofsky performance status
preoperative ecog  -  performance status
elevated ebv dna
prostate adenocarcinoma with paneth cell - like neuroendocrine differentiation
cd40lg gene mutation
rab27a gene mutation
six1 gene mutation
six2 gene mutation
drosha gene mutation
dgcr8 gene mutation
mllt1 gene mutation
dclk1 gene
dclk1 wt allele
serine / threonine - protein kinase dclk1
high level of hyaluronic acid
cdk12 loss of function mutation
jak2 exon 12 mutation
non - synonymous fbxw7 gene mutation
were immunophenotype and cytochemistry analyses performed on bone marrow aspirate
check all that apply
autologous anti - gd2car - cd28 - cd3zeta - il - 15 - expressing natural killer t - cells
anti - cd34 antibody
anti - cd45ra antibody
11q23 abnormality
anti - cd34 monoclonal antibody
anti - cd45ra monoclonal antibody
dense eosinophilic basement membrane deposit
subject reference start date
subject reference end date
subject reference end time
subject reference start time
blasts 10 - 20 percent of bone marrow nucleated cells
neoantigen - based renal cell carcinoma - poly - iclc vaccine
one hundred percent
number of primary tumors in this location
number of units
per 50 high powered fields
per 10 high powered fields
idarubicin hydrochloride
mitotic rate greater than or equal to one per square millimeter
was adjuvant post - operative radiation therapy administered
was adjuvant post - operative chemotherapy administered
was adjuvant post - operative immunological therapy administered
was adjuvant post - operative pharmaceutical therapy administered
was adjuvant post - operative targeted molecular therapy administered
post - adjuvant therapy
pre - adjuvant therapy
unknown tumor status
mir371a gene
mir371a wt allele
mir371a pre - mirna
mir371b gene
mir371b wt allele
mir371b pre - mirna
mirna 371 - 373 overexpression
lhcgr gene
lhcgr wt allele
lutropin - choriogonadotropic hormone receptor
lhcgr gene mutation
lhcgr missense mutation
foxl2 gene mutation
brimonidine tartrate nanoemulsion ocu - 300
what is the other performance status scale: timing
performance status scale: timing
specify site if cm1b
specify site if pm1b
is there a cancer history
grpr overexpression positive
phase iii large scale vaccine trial
ocular graft versus host disease
chronic ocular graft versus host disease
autologous ic9 - gd2car - cd28 - cd3zeta - il - 15 - expressing t - lymphocytes
zirconium zr 89 - dfo - regn3504
lutetium lu 177 - neob
hepatitis b antigen positive
did the physician diagnose diabetes
is there a history of colorectal cancer
what is the follow - up form completion outcome measure of success
specify other performance status scale: timing
ezh2 inhibitor shr2554
oncolytic adenovirus cadvec
autologous her2 - car - modified adenovirus - specific cytotoxic t - lymphocytes
oral myoma vaccine v3 - myoma
anti - erbb3 antibody isu104
tlr agonist bsg - 001
sox11 positive
personalized neoepitope yeast vaccine ye - neo - 001
indocyanine green - labeled polymeric micelles onm - 100
unresectable inflammatory breast carcinoma
unresectable breast carcinoma
post - secondary therapy
progression of disease at recurrence
no evidence of disease at follow - up
what is the procedure type for new tumor event
other procedure type for new tumor event
resection
other method ,  specify below
virus cancer research
what is the status of the residual tumor after surgery for new tumor event
were immunophenotype and cytochemistry analyses performed on peripheral blood samples
bone marrow aspirate immunophenotype & cytochemistry
peripheral blood immunophenotype & cytochemistry
is the new disease multifocal
radiologic tumor size of new tumor
radiographic length
worksite health service
radiographic width
radiographic depth
pathologic tumor size of new tumor
pathologic length
pathologic width
pathologic depth
radiologic burden of new tumor
pathologic burden of new tumor
well - differentiated or de - differentiated new tumor
diagnostic evidence of recurrence / relapse
population research
biopsy with histologic confirmation
dedifferentiated lesion
convincing image source
canine gastrointestinal stromal tumor
canine granular cell tumor
canine langerhans cell histiocytosis
canine nephroblastoma
deafness ,  autosomal recessive 4 ,  with enlarged vestibular aqueduct
macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss
related to head and neck cancer
infrastructure activities
related to another cancer
related to acute myeloid leukemia
type of new melanoma related tumor event
specify cause of death
did the individual use smokeless tobacco use at diagnosis
regular smokeless tobacco use for six weeks or more
average daily use smokeless tobacco after use for six weeks
age when quit using smokeless tobacco after regular use
ganciclovir sodium
biology of the brain disorders
definitive therapy date of completion
what is the definitive therapy method
was evidence of disease present after completion of therapy
was tumor progression present after initial treatment
was tumor reoccurrence present after initial treatment
greater than or equal to 50% myometrial invasion
were local anesthesia agents administered
additional pathologic findings
new approaches to pathogenesis
at time of diagnosis
were routine cytogenetics completed
total number of metaphases
videotelephony
iron deficiency
actinium ac 225 - fpi - 1434
indium in 111 - fpi - 1547
iron deficiency without anemia
abaloparatide
adenocarcinoma solitary lesion in situ of lung
new prevention strategies against disease
alcohol - free hypoallergenic barrier film solution
antifungal pc945
flt3 nm_004119 .2:c .2073t > a
flt3 np_004110 .2:p .f691l
usp46 gene
usp46 wt allele
ubiquitin carboxyl - terminal hydrolase 46
no pathologic evidence of distant metastasis
premenopausal greater than 6 months since lmp and no prior bilateral oophorectomy and not on estrogen replacement
perimenopausal 6 to 12 months since lmp
new avenues for the development of therapeutics
postmenopausal with no prior oophorectomy status
were subsequent known primary melanoma ( s )  found during the follow - up
melanoma related only event occurred after initial treatment
non - melanoma related only event occurred after initial treatment
primary site of new non - melanoma tumor event
histological type of new non - melanoma tumor event
site of new primary melanoma
site of new distant metastasis tumor event
tead4 gene
tead4 wt allele
computers and advanced instrumentation
transcriptional enhancer factor tef - 3
peg4000 / simethicone / sodium sulphate / sodium bicarbonate / electrolytes oral solution
akna gene
akna wt allele
at - hook - containing transcription factor
specify identified mutation
specify mutation analysis method
presence of another mutation
1p / 19q deletion analysis testing method
3q abnormality
mind - body system
alk rearrangement testing method
specify molecular abnormalities in study
atrx mutation analysis
atrx mutation analysis testing method
braf exon 15 mutation
neutrophil recovery time
braf mutation analysis testing method
braf rearrangement testing method
time to platelet recovery
pathologic / prognostic information
mind - body method
cbfb gene rearrangement
days to absolute neutrophil count greater than 1000 per microliter
days to platelet count greater than 100 , 000 per microliter
chromosome deletion detected
cytogenetically normal
del ( 10q23 )  / pten gene locus deletion
del ( 10q23 )  / pten gene locus deletion analysis
what is the cell source
adaptation
del ( 10q23 )  / pten gene locus deletion analysis method
social and contextual areas
egfr amplification analysis testing method
egfr amplification status
egfr mutation analysis
egfr mutation analysis testing method
primary site of disease
specify site of metastasis
induction therapy
reinduction therapy
event during procedure
percent blasts in peripheral blood at diagnosis
alternative medical system
classified by world health organization only
complete blood count from clinical peripheral blood  ( within 24 hours of banking )
epstein - barr virus analysis method
erbb2 nm_004448 .2:c .2326_2327instct
erbb2 np_004439 .2:p .g776delinsvc
erbb2 mutation analysis testing method
erg gene mutation
idh1 / 2 mutation analysis testing method
specify other braf mutation
specify other braf codon 600 mutation
traditional indigenous system
specify other kras codon mutation
specify other erbb2 non - exon 20 mutation
specify other nras mutation
specify polysomy / monosomy
indeterminate microsatellite instability
kit nm_000222 .2:c .1727t > c
kit nm_000222 .2:c .1676t > c
kit nm_000222 .2:c .1669t > a
kit nm_000222 .2:c .1669t > c
kit np_000213 .1:p .l576p
reverse transcriptase inhibitor
unconventional western system
kit np_000213 .1:p .v559a
kit np_000213 .1:p .w557r
kit mutation analysis
kit mutation analysis testing method
kras mutation analysis testing method
itacitinib adipate
list exons assessed
metastatic large cell neuroendocrine carcinoma
locally advanced neuroendocrine carcinoma
social aspects of cancer
locally advanced large cell neuroendocrine carcinoma
metastatic small cell carcinoma
prostate neuroendocrine carcinoma
metastatic prostate neuroendocrine carcinoma
locally advanced prostate neuroendocrine carcinoma
locally advanced small cell carcinoma
loss of nuclear expression
met mutation analysis
met mutation analysis testing method
mgmt promoter methylation testing method
mlh1 gene promoter hypermethylation
mn1 gene mutation
nf1 mutation analysis
nf1 mutation analysis testing method
nras mutation analysis testing method
nras nm_002524 .4:c .34g > c
nras nm_002524 .4:c .37g > a
nras np_002515 .1:p .g12r
nras np_002515 .1:p .g13s
nuclear expression intact
cell bank
psa level twenty to one hundred fifty or greater
psa level greater than one hundred fifty
is another braf mutation present
specify other kras codon 12 mutation
specify other kras codon 13 mutation
specify other kras codon 61 mutation
is another non - exon 20 erbb2 mutation present
is another kit mutation present
specify other met mutation
specify other met exon 14 mutation
technique development
specify other met intron 13 mutation
specify other met intron 14 mutation
is another nras mutation present
p16 positive by immunohistochemistry
pdgfra mutation analysis
pdgfra mutation analysis testing method
pten mutation analysis
pten mutation analysis testing method
rearrangement detected
rearrangement negative
ret rearrangement testing method
ring chromosome 12
ros1 rearrangement analysis
ros1 rearrangement testing method
specify molecular abnormality analysis method
sdh complex mutation analysis
sdh complex mutation analysis testing method
tp53 mutation analysis
tp53 mutation analysis testing method
testosterone greater than 200 ng / dl
core facility
metastatic pancreatic ductal adenocarcinoma
early stage pancreatic ductal adenocarcinoma
ah amyloidosis
al amyloidosis
ahl amyloidosis
light and heavy chain deposition disease
light chain proximal tubulopathy without crystals
crystal - storing histiocytosis
immunotactoid glomerulopathy
type i cryoglobulinemic glomerulonephritis
cancer causation research
proliferative glomerulonephritis with monoclonal igg deposits
c3 glomerulopathy with monoclonal gammopathy
anti - cd30 antibody - drug conjugate
anti - slamf7 monoclonal antibody
neoplasm polygenic risk score
high neoplasm polygenic risk score
low neoplasm polygenic risk score
did caregiving responsibilities make it difficult to work the required number of job hours
did caregiving responsibilities make it difficult to get going easily at beginning of workday
lifestyle and disease prevention
did caregiving responsibilities make it difficult to start job on arrival at work
did caregiving responsibilities make it difficult to do work without stopping for breaks or rests
did caregiving responsibilities make it difficult to stick to job routine or schedule
copper cu 64 - dota - ecl1i
clinical preventive practices
antineoplastic alkylating agent
lifestyle therapy
biologically based therapy
no prior cancer therapy
prior extensive radiation
prior limited radiation
manipulative and body - based intervention procedure
recombinant beta chemokine
biofield therapy
bioelectromagnetics
regional chemotherapy
have difficulty with sitting ,  standing ,  or staying in one position longer than 15 minutes while working due to caregiving responsibilities
have difficulty repeating same motions repeatedly while working due to caregiving responsibilities
did caregiving responsibilities make it difficult to keep mind on work
did caregiving responsibilities make it difficult to do work carefully
did caregiving responsibilities make it difficult to think clearly when working
did caregiving responsibilities make it difficult to concentrate on work
did caregiving responsibilities make it difficult to work without losing train of thought
did caregiving responsibilities make it difficult to easily read or use eyes when working
did caregiving responsibilities make it difficult to speak with people in - person ,  in meetings ,  or phone when working
tracheoesophageal puncture
did caregiving responsibilities make it difficult to control temper around people when working
did caregiving responsibilities make it difficult to help other people to get work done
esr2 status
esr2 negative
labyrinthine growth pattern
her2 inhibitor
who aml classification of tumors
carbon c 11 martinostat
esr2 positive
did caregiving responsibilities make it difficult to listen well to new information given at work
did caregiving responsibilities make it difficult to control feelings of sadness or grief when working
did caregiving responsibilities make it difficult to handle workload
did caregiving responsibilities make it difficult to work fast enough
did caregiving responsibilities make it difficult to finish work on time
did caregiving responsibilities make it difficult to do work without making mistakes
did caregiving responsibilities make it difficult to feel you've done what you're capable of doing
have difficulty doing usual household chore or activity because of caregiving responsibilities
anti - cd73 monoclonal antibody tj4309
someone there for suggestions about how to deal with personal problem
arterial embolization
someone there to love and make you feel wanted
someone there to confide in or talk about yourself or your problems
someone there to get together for relaxation
someone there to help with daily chores if sick
there to perform caregiving responsibilities when you cannot
someone there for questions or concerns about caregiving
being able to provide assistance as caregiver is emotionally rewarding for me
being able to provide assistance as caregiver is spiritually rewarding for me
being able to provide assistance as caregiver helps me feel in control of situation
being able to provide assistance as caregiver is important to me
chemical immunotherapy
being able to provide assistance as caregiver is my duty as responsible adult
currently paying someone to assist with caregiving
plan to take leave of absence from work over next year because of caregiving
difficult all of the time
difficult most of the time
difficult some of the time
difficult a slight bit of the time
does not apply to my job
difficult none of the time
able all of the time
nutrition ,  plant components
able most of the time
able some of the time
able a slight bit of the time
able none of the time
pay for full - time help
pay for part - time help
don't want help
can't get help
c - kit inhibitor
pdgfr inhibitor
recombinant alpha chemokine
nutrition ,  protein / amino acids
bcl - 2 inhibitor
biospecimen submitted to bcr
co2 level at organ excision time
ascites fluid sample
fanconi anemia complementation group gene mutation
kidney angiosarcoma
kidney rhabdomyosarcoma
fa complementation group gene
kidney ewing sarcoma
kidney leiomyoma
lung parenchyma tumor location
kidney hemangioma
peripheral lung parenchyma tumor
central lung parenchyma tumor
kidney lymphangioma
cytogenetic abnormality positive by fish
specify if present
specify percentage
renomedullary interstitial cell
smoking and health research
small ,  stellate ,  or spindled cells present
kidney schwannoma
kidney solitary fibrous tumor
kidney well differentiated neuroendocrine tumor
kidney neuroendocrine carcinoma
kidney large cell neuroendocrine carcinoma
kidney paraganglioma
kidney germ cell tumor
homologous recombination repair proficient
cytogenetic risk group - calgb criteria for aml
cancer genome anatomy project
margin involved by invasive carcinoma
acute bilineal leukemia in remission
margin involved by invasive melanoma
margin involved by sarcoma
margin uninvolved by invasive carcinoma
margin uninvolved by sarcoma
kidney tumor ,  upper pole
kidney tumor ,  lower pole
kidney tumor ,  middle section
diffuse large b - cell lymphoma in complete remission
diffuse large b - cell lymphoma in partial remission
myometrial invasion
less than 50% myometrial invasion
staging incomplete
non - human papillomavirus - related squamous cell carcinoma of the penis
pseudohyperplastic carcinoma of the penis
pseudoglandular carcinoma of the penis
carcinoma cuniculatum of the penis
adenosquamous carcinoma of the penis
papillary - basaloid carcinoma of the penis
nutrition ,  alcohol
warty - basaloid carcinoma of the penis
clear cell squamous cell carcinoma of the penis
lymphoepithelioma - like carcinoma of the penis
specify if other studies
palms of hands and soles of feet
specify other kit mutation
specimen source site
was interferon gamma treatment administered prior to specimen resection
was interferon gamma treatment administered 90 days prior to specimen resection
sncb gene
nutrition ,  minerals
sncb wt allele
growth phase
beta - synuclein
indeterminate growth phase
method of left lymph node dissection
ptgds gene
method of right lymph node dissection
ptgds wt allele
prostaglandin - h2 d - isomerase
special education
nutrition ,  vitamin b
other notable events during surgery
classroom
description of epochs of o2 desaturation less than 92% greater than 5 minutes prior to organ excision
speech language therapy
currently receiving
raw score
satellite lesion
macroscopic satellite nodule is present
microsatellitosis
melanoma involvement of regional cutaneous or subcutaneous tissue
nutrition ,  vitamin c
time of first temperature
time of second temperature
first or temperature
second or temperature
intraoperative blood product administration
time specimen left or
surgical procedure details
other medication
were other medications administered during surgery
antibiotics administered during surgery
nutrition ,  vitamin e
were steroids administered during surgery
was insulin administered during surgery
other medications administered during surgery prior to tumor tissue removal
surgery information indicate if any of the following medications were administered during surgery
specify additional anesthesia
was inhalation anesthesia administered
specify other muscle relaxants administered
were iv muscle relaxants administered
specify other narcotics or opiates administered
was iv anesthesia administered
recombinant chemokine
lymphovenous bypass
was regional anesthesia administered
were other preoperative iv medications administered
were preoperative iv antacids administered
were preoperative iv antiemetics administered
were preoperative iv opiates administered
specify other preoperative iv sedation administered
was preoperative iv sedation administered
date of surgical procedure
highest grade pancreatic intraepithelial neoplasia
clinical history
borderline ovarian mucinous tumor / atypical proliferative ovarian mucinous tumor with microinvasion
borderline ovarian mucinous tumor / atypical proliferative ovarian mucinous tumor with intraepithelial carcinoma
borderline ovarian seromucinous tumor / atypical proliferative ovarian seromucinous tumor with microinvasion
which pulmonary function tests were performed
fev1% ref pre - bronchodilator
fev1% ref post - bronchodilator
fev1 / fvc pre - bronchodilator
fev1 / fvc post - bronchodilator
dlco % ref
pathologic findings in non - neoplastic kidney
prognostic features used for tumor prognosis
renal vein or vena cava thrombosis or other coagulopathies
vena cava thrombosis
left lymph node dissection not done
right lymph node dissection not done
hpv status by pcr
hpv status by ish
cptac follow - up forms terminology
peritoneal lavage
how much time did it take
ascites drainage
how much effort did it take
pelvic peritoneum
prepare and give medicines ,  fluids ,  nutrition intravenously
prepare and give medicine as shot in muscle or under skin
prepare and give medications by mouth
left tubo - ovarian
prepare and give catheter flushes
right tubo - ovarian
change dressing on your child's catheter and change catheter cap
manage child's side effects of cancer or its treatment
keep your child comfortable and without pain
manage other childhood illnesses for your child with cancer
abdominal peritoneum
eda gene
eda wt allele
eda gene product
ectodysplasin - a1
ectodysplasin - a2
edar gene
edar wt allele
tumor necrosis factor receptor superfamily member edar
eda2r gene
eda2r wt allele
tumor necrosis factor receptor superfamily member 27
chemotherapy response score
chemotherapy response score 1
chemotherapy response score 2
community practice
chemotherapy response score 3
tnfrsf10d gene
tnfrsf10d wt allele
tumor necrosis factor receptor superfamily member 10d
manage unexpected events related to your child's illness
additional household tasks related to your child's illness
coordinate ,  arrange ,  and manage child's medical services
travel to and from hospital for medical care
how much time spent at hospital for appointments
how much effort or difficulty for time spent at hospital for appointments
cooperative family registry
provide emotional support for your child with cancer
provide emotional support for other children in the family
provide emotional support for extended family
provide support for spouse or partner
meet your own emotional support needs
comfort your child through pain of cancer and its treatment
take care of discipline and / or behavior problems of child with cancer
take care of finances ,  bills ,  and forms related to child's illness
plan activities for your child with cancer around treatment and illness
plan activities for your family around treatment and illness
cancer chromosome aberration project
get child care or babysitting help for your ill child
get child care or babysitting for siblings of ill child
communicate information about cancer to schools ,  day care ,  babysitters ,  extended family ,  and friends
watch for and report your child's physical symptoms and medical condition to medical team
get information on your child's illness and treatment
anything else you wish to tell about taking care of your child with cancer
a great deal of effort
quite a lot of effort
a moderate amount of effort
a small amount of effort
anthracycline antineoplastic antibiotic
genetic annotation index
no effort
relt gene
relt wt allele
tumor necrosis factor receptor superfamily member 19l
tnfrsf19 gene
tnfrsf19 wt allele
tumor necrosis factor receptor superfamily member 19
botulinum toxin e eb - 001
atezolizumab / nab - paclitaxel regimen
margin uninvolved by invasive melanoma
interdisciplinary studies in the genetic epidemiology of cancer
ebna - 1 inhibitor vk - 2019
anti - gitr agonistic monoclonal antibody asp1951
basic behavioral studies in cancer - related behaviors
egfr nm_005228 .3:c .323g > a
egfr np_005219 .2:p .r108k
egfr nm_005228 .3:c .787a > c
egfr np_005219 .2:p .t263p
photodynamic bone stabilization system
egfr nm_005228 .3:c .866c > t
egfr np_005219 .2:p .a289v
egfr nm_005228 .3:c .866c > a
egfr np_005219 .2:p .a289d
egfr nm_005228 .3:c .865g > a
egfr np_005219 .2:p .a289t
egfr nm_005228 .3:c .1793g > t
egfr np_005219 .2:p .g598v
egfr exon 20 deletion mutation
regimen used to treat malignant thymus neoplasm
dose - dense mvac - growth factor regimen
nephroureterectomy with cuff of bladder
ret inhibitor
regimen used to treat malignant anal neoplasm
mouse cancer genome anatomy project
regimen used to treat bone cancer
regimen used to treat chronic myeloid leukemia
biopsy mapping
regimen used to treat merkel cell carcinoma
ilioinguinal lymphadenectomy
regimen used to treat myelodysplastic syndromes
distal urethrectomy
urethrectomy
regimen used to treat penile cancer
regimen used to treat kaposi sarcoma
small animal imaging resource programs
partial penectomy
total penectomy
chromosome 5 abnormality
endoscopic resection
regimen used to treat hepatobiliary cancer
chromosome 7 abnormality
light chain fanconi syndrome
regimen used to treat vulvar cancer
chemo ( immuno ) therapy regimen used to treat thyroid cancer
regimen used to treat mastocytosis
development and application of imaging in therapeutic studies
regimen used to treat plasma cell neoplasm
regimen used to treat primary amyloidosis
regimen used to treat malignant soft tissue neoplasm
partly agree
partly disagree
carcinoma exhibiting undifferentiated or dedifferentiated features
occasional urinary incontinence
occasional fecal incontinence
immobile or less than 50 yards
wheelchair independent ,  greater than 50 yards
cooperative trial in diagnostic imaging
walks with help of one person ,  greater than 50 yards
mobility independent but may use any aid ,  greater than 50 yards
normal immune presence
mild immune presence
moderate immune presence
severe immune presence
immune presence
percent of positive nuclei
percent of granulocytes
percent inflammatory marker positive
development and testing of digital mammography displays and workstations
percent of monocytes
percent of necrosis
percent of neutrophils
percent of stromal cells
percent of tumor cells
percent of tumor marker positive nuclei
borderline ovarian endometrioid tumor / atypical proliferative ovarian endometrioid tumor with microinvasion
core biopsy of bone
bone marrow core biopsy sample
michelia alba leaf oil
human tumor gene index
negativity scale
inconsistency scale
infrequency scale
highly elevated
inconsistent
anti - b7h3 antibody - drug conjugate mgc018
hdac8 inhibitor nbm - bmx
alpha - lactalbumin - derived synthetic peptide - lipid complex alpha1h
ido peptide vaccine io102
pi3k / mtor kinase inhibitor wxfl10030390
tetracycline antibiotic
advanced technology center
taurultam analogue gp - 2250
primary peritoneal carcinosarcoma
stab1 gene
stab1 wt allele
stabilin - 1
education type
traditional education
home school
homebound instruction
lung lesion
liver lesion
slamf7 positive
hd chest
additional anesthesia agents used
patient case review
dual - probe in situ hybridization
undetermined explanation
were iv narcotic / opiate agents administered
early intervention
donor status
tissue donor eligibility
tissue donor suitability
hematopoietic cell donor eligibility
hematopoietic cell donor suitability
cooperative family registries for breast and colorectal cancer studies
anti - ctla - 4 / lag - 3 bispecific antibody xmab22841
braf inhibitor lut014
psychomotor assessment
smo protein inhibitor zsp1602
anti - clever - 1 monoclonal antibody fp - 1305
radium ra 224 - labeled calcium carbonate microparticles
anti - pd - l1 monoclonal antibody gr1405
was egfr amplification assessed
genetic annotation initiative
oral cancer vaccine v3 - ova
emicizumab
bladder endometrioid adenocarcinoma
bethesda assay
nijmegen - bethesda assay
bladder ,  nos
recist stable disease
recist partial response
advanced gastroesophageal junction adenocarcinoma
anti - pd - 1 monoclonal antibody gls - 010
one - stage clotting factor assay
two - stage clotting factor assay
chromogenic substrate clotting factor assay
hemophilia joint health score
validated hemophilia regimen treatment adherence scale  -  on - demand
validated hemophilia regimen treatment adherence scale  -  prophylaxis
advanced adenocarcinoma
dhax regimen
chp - brentuximab vedotin regimen
haemophilia quality of life questionnaire for adults
nucleotide analog chemotherapy
gelox regimen
haemophilia activities list
advanced clear cell renal cell carcinoma
refractory adenocarcinoma
adenosine a2a / a2b receptor antagonist ab928
recurrent adenocarcinoma
indeterminate macroscopic satellite nodule
other site of new distant metastasis tumor event
stomach ,  nos
pelvic ,  specify
breast cancer ,  basic research
specify new primary tumor
history of any treatments
other site of new tumor event
specify site of other new tumor event
paediatric haemophilia activities list
other site of new primary melanoma
was the individual exposed to second - hand smoke
chemical / occupational exposure present
chemical / occupational exposure absent
chemical / occupational exposure type unknown
in vitro assay
diary
sleep diary
bladder well differentiated neuroendocrine tumor
anti - cd47 monoclonal antibody
specify other inhalation anesthesia agents
specify other preoperative iv anesthesia administered
preoperative iv sedation was not administered
preoperative iv sedation was administered
peritoneal surface disease
preoperative iv opiates were administered
cellular assay
other preoperative iv medications were administered
myopenia
preoperative iv antiemetics were administered
preoperative iv antacids were administered
breast lesion
preoperative iv antacids were not administered
preoperative iv antiemetics were not administered
other preoperative iv medications were not administered
preoperative iv opiates were not administered
enadenotucirev - expressing anti - cd40 agonistic monoclonal antibody ng - 350a
zd0101
blood screening
anti - cd47 monoclonal antibody ao - 176
personalized all - specific multi - hla - binding peptide vaccine
caregiver oncology needs evaluation tool
local anesthesia agents were not administered
local anesthesia agents were administered
regional anesthesia was administered
regional anesthesia was not administered
iv anesthesia was administered
iv anesthesia was not administered
anti - ceacam6 antibody bay1834942
rehabilitation study
magnetic seed localization
intensity - modulated proton therapy
year date
other histologic type
any metastatic diagnosis present
any metastatic diagnosis absent
was molecular analysis performed
response evaluation criteria in lymphoma 2017
recil cr
recil pr
til research
recil mr
recil sd
recil pd
exocervix tumor
endocervix tumor
gray per fraction
centigray per fraction
other edition
if other edition ,  specify
specify number of lymph nodes examined
indeterminate or unknown menopause status
were additional molecular studies performed
was 10q23 / pten locus deletion analysis performed
was 1p / 19q deletion analysis performed
was atrx mutation analysis performed
was braf mutation analysis performed
was erbb2 mutation analysis performed
was idh family mutation analysis performed
was immunohistochemical testing performed
was additional immunohistochemical testing performed
neurosciences research
was additional mutation analysis performed
was kit mutation analysis performed
was kras mutation analysis performed
was lymph node dissection performed
was met mutation analysis performed
was mgmt promoter methylation testing performed
was nf1 mutation analysis performed
was nras mutation analysis performed
was pten mutation analysis performed
was sdh complex mutation analysis performed
nutrition ,  other
was tp53 mutation analysis performed
was fluorescence in situ hybridization performed
anti - bcma / cd3 bite antibody amg 420
joubert syndrome type 7
mild non - bh4 - deficient hyperphenylalaninemia
calfan syndrome
psca positive
regimen used to treat or prevent graft rejection
obese
transplant recipient
nutrition ,  vitamins ,  other
stem cell transplant recipient
autologous stem cell transplant recipient
allogeneic stem cell transplant recipient
bladder melanoma
urethral melanoma
bladder rhabdomyosarcoma
bladder embryonal rhabdomyosarcoma
bladder alveolar rhabdomyosarcoma
adme study
bladder leiomyosarcoma
bladder angiosarcoma
risk factor history negative
bladder pecoma
bladder benign pecoma
refractory pleural malignant mesothelioma
advanced endometrial carcinoma
bladder malignant pecoma
diaphragm fluoroscopy
bladder solitary fibrous tumor
linscott's directory
bladder hemangioma
bladder granular cell tumor
bladder neurofibroma
select histologic type
ecog performance status not evaluated ,  not provided or available
unknown ecog performance status
modified severity weighted assessment tool
prevalent
hiv seroconversion
nih areas of research emphasis
identified at death
serostatus
seropositive
last time seen
last visit seen
first time seen
first visit seen
last reported free
last reported free visit
first reported year
genetics and medicine
last reported free year
first reported visit
last year seen
first year seen
first confirmed year
first confirmed visit
first visit year with all necessary components to determine
first visit with all necessary components to determine
first visit year
use before visit
cancer control
ever used
two hundred
year of last study visit attended
last year of contact
mortality cut - off year ,  national death index
recist complete response
recist progressive disease
ebv - related lymphoproliferative disorder
undetermined histologic type
cantrixil
biological immunotherapy
specify other exons
specify site if distant metastasis submitted
specify new tumor metastasis site
incomplete staging  ( cm )
incomplete staging  ( pm )
how many places lived with child
struggle with rent or mortgage due to financial difficulties
live with others due to financial difficulties
lack of reliable transportation keeps from appointments ,  meetings ,  work ,  or daily living
utility company threatened to shut off services for not paying bills
immunotoxin cancer immunotherapy
utility company shut off services for not paying bills
days home not heated or cooled because bills not paid
used cooking stove to heat home because bills not paid
telephone service disconnected due to bill not paid
worried food would run out before get money to buy more
food bought didn't last and didn't have money to get more
if lose current income sources and live off savings ,  how long could continue to live at current address and standard of living
family received food from food pantry or soup kitchen
family received energy assistance
family received disability benefits
biological cancer immunotherapy
family received low - income or subsidized housing
family received free or subsidized school lunch
family received income support
family received employment insurance
family received canada child benefit
family received disability tax credit
college completion
mobile home
rented room
shelter or transitional living situation
chemical cancer immunotherapy
no steady place to sleep at night
own car
rides from others
volunteer driving program
handicap transportation service
can do very well
not true at all
rarely true
sometimes true
often true
mouse tumor gene index
true nearly all of the time
several days
true or present nearly every day
true or present more than half the days
anti - ctla - 4 monoclonal antibody regn4659
specify number of lymph nodes positive for tumor by ihc staining only
specify number of lymph nodes positive for tumor by h&e
zero full term pregnancies
one full term pregnancy
two full term pregnancies
three full term pregnancies
greater than or equal to four pregnancies
menopause status not evaluated
unknown oral contraceptive use
testosterone greater than or equal to 150 ng / dl
unresectable gastric carcinoma
continuous glucose monitoring system
psa level twenty to one hundred fifty
fanconi anemia complementation group gene mutation negative
palb2 gene mutation negative
brip1 gene mutation negative
fancl gene mutation negative
rad51 gene mutation negative
atm gene mutation negative
cst1 gene
cst1 wt allele
cystatin - sn
checkpoint inhibitor relapsed tumor
cst2 gene
cst2 wt allele
focused ultrasound therapy
cystatin - sa
cst4 gene
cst4 wt allele
cystatin - s
cst5 gene
cst5 wt allele
cystatin - d
tasadenoturev - infected allogeneic bone marrow - derived mesenchymal stem cells
international myeloma working group minimal residual disease criteria
gusperimus trihydrochloride
radiometry  ( microwave )
imwg sustained mrd - negative
imwg flow mrd - negative
imwg sequencing mrd - negative
imwg imaging plus mrd - negative
international myeloma working group standard response criteria
imwg stringent complete response
imwg complete response
imwg very good partial response
imwg partial response
imwg minimal response
supportive cancer chemotherapy
imwg stable disease
imwg progressive disease
outcome measure of success at completion of initial treatment course not applicable
outcome measure of success at completion of initial treatment unknown
performance status scale timing unknown
performance status scale timing not applicable
tgfbeta receptor ectodomain - igg fc fusion protein avid200
hpv - other type
drug development ,  experimental
other hpv typing method
healthcare device direct feed reporting
 [ leu15 ]  gastrin - 17
not lost to follow - up
is individual lost to follow - up
describes very well
aboriginal north american
usually stay on top of things
home is a zoo
can't hear yourself think at home
combined pharmacological and behavioral treatment
usually a television is on
home atmosphere is calm
have a regular morning routine in our home
able to adapt when changes occur
can deal with whatever comes my way
try to see humorous side of things when faced with problems
having to cope with stress can make me stronger
tend to bounce back after illness ,  injury ,  or other hardships
can achieve my goals ,  even if there are obstacles
stay focused and think clearly under pressure
combined prevention / cessation research
not easily discouraged by failure
think of myself as a strong person when dealing with life's challenges and difficulties
able to handle unpleasant or painful feelings
treated with less courtesy or respect than other people
receive poorer service than other people at restaurant or stores
people act as if they think you are not smart
people act as if they are afraid of you
threatened or harassed
reason for the experience
if answered
nicotine dependence / addiction on treatment
less than once a year
a few times a year
a few times a month
at least once a week
aberrant clonal plasma cell population
other aspect of physical appearance
very well
esophagogastroduodenoscopy patient
cleveland multiport catheter
stereotactic implantation
pharmacotherapy
basc - 3 f index
basc - 3 response pattern index
basc - 3 consistency index
karnofksy performance status not evaluated
karnofsky performance status unknown
unknown risk factor
other risk factor
child - pugh class unknown
ishak score unknown
other non - neoplastic finding
tobacco use and related risk factors ,  surveillance
specify other non - neoplastic finding
fgfr2b overexpression
regimen used to treat malignant bone marrow neoplasm
enumerated treatment regimens
treatment regimen #1
treatment regimen #2
treatment regimen #3
treatment regimen #4
treatment regimen #5
transvaginal biopsy
tobacco use basic biological research
ureteroureterostomy
ureteroileostomy
cystourethroscopy
ct urography
mr urography
renal ultrasound
retrograde ureteropyelography
retrograde selective washing of upper tract
extended - release galantamine hydrobromide
selective washing
tobacco use ,  chemoprevention
body mass index greater than or equal to 30
negative pressure wound therapy
cea - targeting agent rg6123
regimen used to treat malignant intestinal neoplasm
recist comments
unknown outcome
not applicable outcome
erbb2 gene amplification negative
family received food stamps
was a new tumor event present after initial treatment
bicalutamide
tobacco use ,  community and state intervention research
regimen used to treat malignant fallopian tube neoplasm
regimen used to treat malignant peritoneal neoplasm
platinum - sensitive ovarian carcinoma
advanced thymic carcinoma
advanced malignant thymoma
ceacam6 positive
drug response predictor
2x - 121 drp
lymphedema symptom intensity and distress survey  -  arm
regimen used to treat malignant germ cell tumor
tobacco use ,  cessation research
regimen used to treat malignant reproductive endocrine neoplasm
have heaviness in your arm
have tightness in your arm
have pain in your arm
have stabbing pain in your arm
have cramping pain in your arm
have numbness in your arm
have achiness in your arm
have swelling in your arm
have hardness in your arm
tobacco use ,  combined prevention / cessation research
have tingling in your arm
have pins and needles in your arm
have difficulty moving arm side to side
have difficulty raising arm above head
have lack of confidence in self
have lack of confidence in insurance provider
have concerns about how you look
feel misunderstood by spouse or significant other
feel frustration with insurance company
have loss of confidence in body
tobacco use policy research
partner has lack of interest in sex
have inability to complete hobbies or leisure activities
consistently decreased social activities
have decrease in sexual activity
symptoms intensity and distress likert scale
intensity and distress 1
intensity and distress 2
intensity and distress 3
intensity and distress 4
intensity and distress 5
basic biobehavioral research
alpha / beta t - cell / cd19 +  b - cell - depleted unrelated or partially matched donor - derived allogeneic peripheral blood stem cells
coaxial biopsy
molibresib besylate
global response score
global response
global complete response
global partial response
global stable disease
global progressive disease
behavioral and biological associations
global relapse
global response in skin
global complete response in skin
global partial response in skin
global stable disease in skin
global progressive disease in skin
global relapse in skin
global response in lymph nodes
global complete response in lymph nodes
global partial response in lymph nodes
behavioral mechanisms
global stable disease in lymph nodes
global progressive disease in lymph nodes
global relapse in lymph nodes
global response in viscera
global complete response in viscera
global partial response in viscera
global stable disease in viscera
global progressive disease in viscera
global relapse in viscera
global response in blood
global complete response in blood
global partial response in blood
elbasvir / grazoprevir
global stable disease in blood
global progressive disease in blood
global relapse in blood
autologous hpv16 e7 - specific hla - a*02:01 - restricted tcr gene engineered lymphocytes kite - 439
anti - pd - l1 / 4 - 1bb bispecific antibody inbrx - 105
was testing performed
minimal contact treatment
abemaciclib regimen
acalabrutinib regimen
ado - trastuzumab emtansine regimen
afatinib regimen
nab - paclitaxel regimen
alectinib regimen
alemtuzumab regimen
altretamine regimen
anastrozole regimen
antithymocyte globulin equine regimen
policy research
apalutamide regimen
arsenic trioxide regimen
atezolizumab regimen
avelumab regimen
axitinib regimen
azacitidine regimen
bcg regimen
bendamustine regimen
bevacizumab regimen
bicalutamide regimen
cidofovir
blinatumomab regimen
bortezomib regimen
bosutinib regimen
brentuximab vedotin regimen
cabozantinib regimen
capecitabine regimen
carboplatin regimen
carmustine regimen
ceritinib regimen
cetuximab regimen
chlorambucil regimen
cisplatin regimen
cladribine regimen
crizotinib regimen
cyclophosphamide regimen
cytarabine intrathecal regimen
cytarabine subcutaneous regimen
dabrafenib regimen
dacarbazine regimen
daratumumab regimen
treatment of infectious disease
dasatinib regimen
decitabine regimen
degarelix regimen
denosumab regimen
docetaxel regimen
doxorubicin regimen
durvalumab regimen
duvelisib regimen
enzalutamide regimen
epirubicin regimen
infectious diseases research
eribulin regimen
erlotinib regimen
estradiol regimen
etoposide regimen
everolimus regimen
exemestane regimen
fludarabine regimen
fluorouracil continuous infusion regimen
fluorouracil regimen
fluoxymesterone regimen
flutamide regimen
fulvestrant regimen
gefitinib regimen
gemcitabine regimen
goserelin regimen
high - dose aldesleukin regimen
high - dose cytarabine regimen
high - dose ipilimumab regimen
high - dose methotrexate regimen
histrelin regimen
new agents
hydroxyurea regimen
ibrutinib regimen
idelalisib regimen
ifosfamide regimen
imatinib regimen
interferon alfa - 2b regimen
intra - csf interferon alfa - 2b regimen
methotrexate intra - cerebrospinal fluid regimen
intra - csf thiotepa regimen
intra - csf topotecan regimen
vaccine design
aldesleukin intralesional regimen
intralesional bcg regimen
intralesional interferon alfa - 2b regimen
talimogene laherparepvec intralesional regimen
intralesional triamcinolone regimen
intralesional vinblastine regimen
methotrexate intrathecal regimen
ipilimumab regimen
irinotecan every 14 days regimen
irinotecan every 21 days regimen
cancer information service
irinotecan regimen
ixabepilone regimen
ixazomib regimen
lapatinib regimen
larotrectinib regimen
lenalidomide maintenance regimen
lenalidomide regimen
lenvatinib regimen
letrozole regimen
leuprolide regimen
cooperative group program
liposomal doxorubicin regimen
lomustine regimen
lorlatinib regimen
megestrol regimen
melphalan regimen
methotrexate regimen
midostaurin regimen
mitomycin regimen
mitotane regimen
nelarabine regimen
developmental therapeutics program
neratinib regimen
nilotinib regimen
nilutamide regimen
nivolumab regimen
obinutuzumab regimen
octreotide long - acting release regimen
ofatumumab regimen
olaparib regimen
omacetaxine regimen
etoposide oral regimen
scientist exchange program
osimertinib regimen
oxaliplatin regimen
paclitaxel regimen
paclitaxel weekly regimen
panitumumab regimen
pazopanib regimen
peginterferon alfa - 2a regimen
peginterferon alfa - 2b regimen
pembrolizumab regimen
pemetrexed regimen
diet and nutrition
pomalidomide regimen
ponatinib regimen
ramucirumab regimen
regorafenib regimen
rituximab and hyaluronidase human regimen
rituximab regimen
ruxolitinib regimen
sirolimus regimen
sorafenib regimen
sunitinib regimen
nutrition ,  artificial sweeteners
talazoparib regimen
tamoxifen regimen
temozolomide regimen
temsirolimus regimen
thalidomide regimen
topical alitretinoin regimen
topical bexarotene regimen
topical fluorouracil regimen
topical imiquimod regimen
topotecan daily regimen
nutrition ,  antioxidants
topotecan every 28 days regimen
topotecan regimen
topotecan weekly regimen
toremifene regimen
trabectedin regimen
trastuzumab regimen
trifluridine and tipiracil regimen
triptorelin regimen
valrubicin regimen
vandetanib regimen
nutrition ,  caffeine
vemurafenib regimen
venetoclax regimen
vincristine liposomal regimen
vinorelbine regimen
low anterior resection syndrome
sacral nerve stimulator
sacral nerve stimulator battery
malt1 inhibitor jnj - 67856633
brass mesh bolus
refractory ebv - related lymphoma
nutrition ,  vitamin a
epstein - barr virus - associated lymphoproliferative disease with primary immunodeficiency
recurrent epstein - barr virus - associated lymphoproliferative disease with primary immunodeficiency
refractory epstein - barr virus - associated lymphoproliferative disease with primary immunodeficiency
specify other risk factor
unknown new tumor event
bladder diverticulum
unknown site of new tumor event
carcinoma arising in bladder diverticulum
other tumor site
specify other tumor site
unknown supratentorial localization
therapeutic ionizing radiation to head history present
therapeutic ionizing radiation to head history absent
therapeutic ionizing radiation to head history unknown
first degree family history cancer positive
first degree family history cancer negative
first degree family history cancer unknown
first degree family history of primary brain tumor positive
first degree family history of primary brain tumor negative
trace element nutrition ,  selenium
first degree family history of primary brain tumor unknown
was a braf mutation identified
was an idh family mutation identified
first presenting symptom related to disease unknown
was an atrx mutation identified
was an egfr amplification identified
was a pten mutation identified
was a tp53 mutation identified
non - neoplastic finding absent
history of medical treatment present
history of medical treatment absent
history of medical treatment unknown
cancer history present
us english
canadian english
cancer history absent
uk english
cancer history unknown
canadian french
us spanish
diet and nutrition  ( dccps )
mexican spanish
history of other medical treatment
ox40l - expressing oncolytic adenovirus dnx - 2440
documentation present
documentation absent
p300 / cbp bromodomain inhibitor ccs1477
documentation unknown
calr exon 9 mutant peptide vaccine / montanide isa - 51
unknown tumor zone
tumor laterality right
saquinavir mesylate
tumor laterality left
tumor laterality bilateral
anti - cd47 monoclonal antibody shr - 1603
pim kinase inhibitor tp - 3654
anti - ilt4 monoclonal antibody mk - 4830
family history of stomach cancer present
family history of stomach cancer absent
shp2 inhibitor jab - 3068
bilateral thyroid glands
thyroid ,  nos
nutrition monitoring
first degree family history thyroid cancer negative
first degree family history thyroid cancer positive
first degree family history thyroid cancer unknown
radiation history unknown
radiation history positive
radiation history negative
adjuvant i - 131 therapy positive
adjuvant i - 131 therapy negative
adjuvant i - 131 therapy unknown
needed medical care or prescription medicine but unable to afford it
antibody - directed enzyme prodrug therapy
who needed medical care but family unable to afford it
who needed prescription medicine but family unable to afford it
medical care
more than enough money left over
some money left over
just enough to make ends meet
almost enough to make ends meet
not enough to make ends meet
first course treatment completion measure of success of outcome not applicable
recurrent high grade b - cell lymphoma
transgenic mouse facility
recurrent diffuse large b - cell lymphoma germinal center b - cell type
recurrent diffuse large b - cell lymphoma activated b - cell type
recurrent transformed follicular lymphoma to diffuse large b - cell lymphoma
refractory high grade b - cell lymphoma
few tumor infiltrating lymphocytes
many tumor infiltrating lymphocytes
moderate tumor infiltrating lymphocytes
unknown tumor infiltrating lymphocytes
refractory diffuse large b - cell lymphoma germinal center b - cell type
refractory diffuse large b - cell lymphoma activated b - cell type
animal barrier facility
refractory transformed follicular lymphoma to diffuse large b - cell lymphoma
virus reactivation
adenovirus reactivation
unknown eye color
other eye color
bk virus reactivation
cytomegalovirus virus reactivation
patient was postmenopausal with no prior oophorectomy
patient was not postmenopausal with no prior oophorectomy
currently using menopausal hormone therapy
dna sequencing facility
formerly used menopausal hormone therapy
never used menopausal hormone therapy
unknown use of menopausal hormone therapy
another form of birth control was used
another form of birth control was not used
unknown if another form of birth control was used
specify another form of birth control that was used
bet inhibitor bi 894999
tgf - beta receptor 1 inhibitor pf - 06952229
current user tamoxifen
blood - brain barrier disruption chemotherapy
former user tamoxifen
never used tamoxifen
unknown tamoxifen use
unknown number of full term pregnancies
adjuvant post - operative radiation therapy was administered
adjuvant post - operative radiation therapy was not administered
adjuvant post - operative radiation therapy administration unknown
adjuvant post - operative pharmaceutical therapy was administered
adjuvant post - operative pharmaceutical therapy was not administered
adjuvant post - operative pharmaceutical therapy administration unknown
nucleic acid core facility
adjuvant post - operative immunological therapy was administered
adjuvant post - operative immunological therapy was not administered
adjuvant post - operative immunological therapy administration unknown
hypertension present
hypertension absent
hypertension unknown
physician diagnosed diabetes present
physician diagnosed diabetes unknown
physician diagnosed diabetes absent
oligonucleotide synthesis facility
history of colorectal cancer positive
history of colorectal cancer negative
history of colorectal cancer unknown
follow - up form outcome measure of success unknown
follow - up form outcome measure of success not applicable
performance status scale timing other
new tumor event after initial treatment absent
new tumor event after initial treatment unknown
testing was not preformed
testing was performed
modest - temperature hyperthermia
not known if testing was performed
additional testing was not performed
additional testing was performed
enterococcus gallinarum strain mrx0518
cord blood - derived cmv / adv / ebv / bkv - specific cytotoxic t - lymphocytes
unresectable lung small cell carcinoma
advanced lung small cell carcinoma
metastatic nut carcinoma
advanced nut carcinoma
additional surgery for new tumor event present
tallimustine
carbogen breathing
additional surgery for new tumor event absent
unresectable nut carcinoma
additional surgery for new tumor event unknown
not known if additional testing was performed
10q23 / pten locus deletion analysis was not performed
10q23 / pten locus deletion analysis was performed
10q23 / pten locus deletion negative
unknown procedure type for new tumor event
1p / 19q deletion analysis was not performed
1p / 19q deletion analysis was performed
perioperative adjuvant therapy
additional immunohistochemistry was not performed
additional immunohistochemistry was performed
additional molecular studies were not performed
additional molecular studies were performed
mutation analysis was not performed
mutation analysis was performed
alk rearrangement analysis
alk rearrangement analysis was not performed
alk rearrangement analysis was performed
ano1 negative
long - term follow - up
ano1 positive
atrx gene mutation negative
atrx mutation analysis was not performed
atrx mutation analysis was performed
bap1 gene mutation negative
bone marrow aspirate immunophenotyping and cytochemistry were not performed
bone marrow aspirate immunophenotyping and cytochemistry were performed
braf gene rearrangement negative
follow - up
braf mutation analysis was not performed
braf mutation analysis was performed
braf rearrangement analysis was not performed
braf rearrangement analysis was performed
progenitor cell engraftment
anti - cd123 / cd3 bite antibody sar440234
anti - her2 immune stimulator - antibody conjugate njh395
3 - dimensional conformal radiation therapy
cdh1 gene mutation negative
ctnnb1 gene mutation negative
egfr amplification analysis was not performed
egfr amplification analysis was performed
egfr mutation analysis was not performed
egfr mutation analysis was performed
erbb2 mutation analysis was not performed
erbb2 mutation analysis was performed
erg gene rearrangement negative
etv gene rearrangement
histopathology facility
etv gene rearrangement negative
fgfr1 gene mutation negative
fgfr1 gene rearrangement negative
fgfr2 gene mutation negative
fgfr2 gene rearrangement negative
fgfr3 gene mutation negative
fgfr3 gene rearrangement negative
gna11 gene mutation negative
gnaq gene mutation negative
helicobacter pylori positive
organic synthesis facility
hepatitis b virus core antibody negative
hepatitis b virus surface antigen negative
hepatitis b virus surface antigen positive
hras gene mutation negative
adjuvant post - operative chemotherapy was administered
adjuvant post - operative chemotherapy was not administered
adjuvant post - operative chemotherapy administration unknown
investigation of mechanisms of drug resistance
idh family mutation analysis was not performed
idh family mutation analysis was performed
immunohistochemistry was not performed
immunohistochemistry was performed
not known if mutation analysis was performed
not known if additional immunohistochemistry was performed
not known if additional molecular studies were performed
not known if immunohistochemistry was performed
adjuvant post - operative targeted molecular therapy was administered
adjuvant post - operative targeted molecular therapy was not administered
autologous hematopoietic stem cell transplantation
adjuvant post - operative targeted molecular therapy administration unknown
kit mutation analysis was not performed
kit mutation analysis was performed
first course treatment completion measure of success of outcome unknown
kit negative
kras mutation analysis was not performed
kras mutation analysis was performed
lymph node dissection was not performed
lymph node dissection was performed
dc - cholesterol liposome
immunooncology
met gene amplification negative
met gene mutation negative
follow - up form completion outcome measure of success unknown
follow - up form completion outcome measure of success not applicable
met mutation analysis was not performed
met mutation analysis was performed
mgmt promoter methylation testing was not performed
mgmt promoter methylation testing was performed
mlh1 gene promoter hypermethylation negative
mlh1 gene promoter hypermethylation status
ancillary study
hepatitis b virus negative
hepatitis c virus antibody positive
cysltr2 gene mutation
mlh1 loss of nuclear expression
mlh1 nuclear expression intact
msh2 loss of nuclear expression
msh2 nuclear expression intact
msh6 nuclear expression intact
msh6 loss of nuclear expression
pms2 nuclear expression intact
limb salvage procedure
pms2 loss of nuclear expression
tp53 nuclear expression intact
tp53 loss of nuclear expression
peritoneal surface
non - regional lymph node new tumor event
nf1 gene mutation negative
nf1 mutation analysis was performed
nf1 mutation analysis was not performed
not known if 10q23 / pten locus deletion analysis was performed
not known if 1p / 19q deletion analysis was performed
electron microscopy facility
not known if alk rearrangement analysis was performed
not known if atrx mutation analysis was performed
not known if bone marrow aspirate immunophenotyping and cytochemistry were performed
not known if braf mutation analysis was performed
not known if braf rearrangement analysis was performed
activating non - v600 braf mutation
was additional surgery for new loco - regional tumor event performed
jejunal neuroendocrine tumor g2
was additional surgery for new metastatic tumor event performed
date of additional surgery for new tumor event: loco - regional
biostatistics core
ileal neuroendocrine tumor g2
date of additional surgery for new tumor event: metastatic
duodenal neuroendocrine tumor g2
colon neuroendocrine tumor g2
additional surgery for new loco - regional tumor event was performed
additional surgery for new loco - regional tumor event was not performed
additional surgery for new loco - regional tumor event unknown
additional surgery for new metastatic tumor event unknown
additional surgery for new metastatic tumor event was not performed
food patterns
additional surgery for new metastatic tumor event was performed
rectal neuroendocrine tumor g2
not known if egfr amplification analysis was performed
not known if egfr mutation analysis was performed
not known if erbb2 mutation analysis was performed
not known if idh family mutation analysis was performed
not known if kit mutation analysis was performed
not known if kras mutation analysis was performed
not known if lymph node dissection was performed
not known if met mutation analysis was performed
diagnostic imaging program
not known if mgmt promoter methylation testing was performed
not known if nf1 mutation analysis was performed
not known if nras mutation analysis was performed
not known if pdgfra mutation analysis was performed
not known if peripheral blood immunophenotyping and cytochemistry were performed
not known if pten mutation analysis was performed
not known if ret rearrangement analysis was performed
use of smokeless tobacco at time of diagnosis positive
not known if ros1 rearrangement analysis was performed
use of smokeless tobacco at time of diagnosis negative
community oncology and rehabilitation
use of smokeless tobacco at time of diagnosis unknown
regular smokeless tobacco use for six weeks or more positive
regular smokeless tobacco use for six weeks or more negative
regular smokeless tobacco use for six weeks or more unknown
average daily use smokeless tobacco after use for six weeks unknown
never quit using smokeless tobacco after regular use
not known if sdh complex mutation analysis was performed
not known if tp53 mutation analysis was performed
nras mutation analysis was not performed
nras mutation analysis was performed
information resource
pax8 gene rearrangement
pax8 gene rearrangement negative
pdgfra mutation analysis was not performed
pdgfra mutation analysis was performed
glecaprevir / pibrentasvir
percentage of ki - 67 positive nuclei
peripheral blood immunophenotyping and cytochemistry were not performed
peripheral blood immunophenotyping and cytochemistry were performed
pten gene mutation negative
radiotherapy research
pten mutation analysis was not performed
pten mutation analysis was performed
intravesical cacillus calmette - guerin therapy failure
ret gene rearrangement negative
ret rearrangement analysis was not performed
ret rearrangement analysis was performed
ros1 rearrangement analysis was not performed
ros1 rearrangement analysis was performed
sdh complex mutation analysis was not performed
sdh complex mutation analysis was performed
tecogalan sodium
tlr8 agonist dn1508052
ifosfamide / mesna / paclitaxel regimen
abiraterone / prednisone regimen
apalutamide / degarelix regimen
antithymocyte globulin rabbit / tacrolimus regimen
everolimus / letrozole regimen
high - dose methylprednisolone / obinutuzumab regimen
cisplatin / paclitaxel / intraperitoneal paclitaxel regimen
bicalutamide / degarelix regimen
degarelix / docetaxel regimen
horse antithymocyte globulin / tacrolimus regimen
apalutamide / triptorelin regimen
enzalutamide / triptorelin regimen
docetaxel / triptorelin regimen
palbociclib / tamoxifen regimen
degarelix / enzalutamide regimen
docetaxel / goserelin regimen
apalutamide / goserelin regimen
enzalutamide / goserelin regimen
breast cancer rehabilitation
apalutamide / leuprolide regimen
enzalutamide / leuprolide regimen
chlorambucil / obinutuzumab regimen
abemaciclib / tamoxifen regimen
bendamustine / brentuximab vedotin regimen
bevacizumab / liposomal doxorubicin regimen
bevacizumab / lomustine regimen
bevacizumab / carboplatin regimen
bevacizumab / temozolomide regimen
ibrutinib / rituximab regimen
idelalisib / rituximab regimen
cisplatin / temozolomide regimen
anastrozole / leuprolide regimen
exemestane / leuprolide regimen
letrozole / leuprolide regimen
paclitaxel / ramucirumab regimen
bevacizumab / topotecan regimen
rituximab / venetoclax regimen
high - dose cytarabine / rituximab regimen
aap - d regimen
drug synthesis and chemistry branch
abiraterone / prednisone / triptorelin regimen
bortezomib / dexamethasone / venetoclax regimen
capecitabine / oxaliplatin / trastuzumab regimen
abiraterone / goserelin / prednisone regimen
abiraterone / leuprolide / prednisone regimen
bdr regimen
vtd regimen
abemaciclib / fulvestrant / leuprolide regimen
br - ibrutinib regimen
bendamustine / idelalisib / rituximab regimen
ceph / genethon map
letrozole / leuprolide / palbociclib regimen
capecitabine / cisplatin / trastuzumab regimen
bevacizumab / carboplatin / gemcitabine regimen
tcf regimen
ccd regimen
card regimen
cyclophosphamide / dexamethasone / rituximab regimen
dara - pd regimen
r - dha regimen
rabbit anti - thymocyte globulin / prednisone / tacrolimus regimen
physical map of the human genome
dexamethasone / elotuzumab / pomalidomide regimen
atezolizumab / carboplatin / etoposide regimen
equine anti - thymocyte globulin / prednisone / tacrolimus regimen
aavd regimen
ceop regimen
flot regimen
dcep / bortezomib regimen
r - codox - m regimen
r - gcvp regimen
dose - adjusted r - epoch plus high - dose methotrexate regimen
clone - based physical map
r - codox - m alternating with r - ivac regimen
sdh complex gene mutation negative
sdha negative
sdha positive
sdhb positive
potential for malignancy
adjacent tissue transfer or rearrangement
specify braf exons assessed
specify idh family mutation
specify kit mutation
specify pdgfra mutation
specify nf1 mutation
specify sdh complex mutation
specify kit exons assessed
specify pdgfra exons assessed
tert promoter mutation
tert promoter mutation negative
executive function disorder
tp53 mutation analysis was not performed
tp53 mutation analysis was performed
sequence - ready map
was alk rearrangement analysis performed
was braf rearrangement analysis performed
was pdgfra mutation analysis performed
was ret rearrangement analysis performed
was ros1 rearrangement analysis performed
was egfr mutation analysis performed
fluorescence in situ hybridization was performed
fluorescence in situ hybridization was not performed
not known if fluorescence in situ hybridization was performed
advanced esophageal carcinoma
labradimil
single nucleotide polymorphism map
unknown age when started using smokeless tobacco after regular use
evidence of disease present after completion of therapy
evidence of disease absent after completion of therapy
selective estrogen receptor degrader azd9833
evidence of disease unknown after completion of therapy
anti - pd - 1 / anti - pd - l1 bispecific antibody ly3434172
class 1 / 4 histone deacetylase inhibitor oki - 179
bulbar urethra
urethra part
surgical procedure was curative therapy
whitehead map of the human genome
non - concurrent chemotherapy was curative therapy
concurrent chemotherapy was curative therapy
radiation therapy was curative therapy
ureter part
upper ureter
middle ureter
distal ureter
abdominal ureter
pelvic ureter
recurrent malignant ovarian granulosa cell tumor
tumor reoccurrence present after initial treatment
allogeneic cd34 +  - enriched and cd45ra - depleted pbscs
tumor reoccurrence absent after initial treatment
tumor reoccurrence unknown after initial treatment
tram flap procedure
latissimus dorsi flap reconstruction
allogeneic cd34 - positive enriched peripheral blood stem cells
tissue expander - implant breast reconstruction
permanent
was radiation administered as an additional treatment for a new tumor event
modeling
was chemotherapy administered as an additional treatment for a new tumor event
was immunotherapy administered as an additional treatment for a new tumor event
was hormone therapy administered as an additional treatment for a new tumor event
was targeted molecular therapy administered as an additional treatment for a new tumor event
radiation was administered as an additional treatment for a new tumor event
radiation was not administered as an additional treatment for a new tumor event
unknown if radiation was administered as an additional treatment for a new tumor event
chemotherapy was administered as an additional treatment for a new tumor event
chemotherapy was not administered as an additional treatment for a new tumor event
unknown if chemotherapy was administered as an additional treatment for a new tumor event
cancer burden
immunotherapy was administered as an additional treatment for a new tumor event
immunotherapy was not administered as an additional treatment for a new tumor event
unknown if immunotherapy was administered as an additional treatment for a new tumor event
hormone therapy was administered as an additional treatment for a new tumor event
hormone therapy was not administered as an additional treatment for a new tumor event
unknown if hormone therapy was administered as an additional treatment for a new tumor event
targeted molecular therapy was administered as an additional treatment for a new tumor event
targeted molecular therapy was not administered as an additional treatment for a new tumor event
unknown if targeted molecular therapy was administered as an additional treatment for a new tumor event
idh1 nm_005896 .3:c .394_395delcginsgt
cancer surveillance research program
idh1 np_005887 .2:p .r132v
idh2 nm_002168 .3:c .418c > t
idh2 np_002159 .2:p .r140w
oligoprogression
idh2 nm_002168 .3:c .419g > t
idh2 np_002159 .2:p .r140l
archival tissue
plutonium - 239 alpha particle radiation
idh2 nm_002168 .3:c .419g > a
mortality map
americium - 241 alpha particle radiation
idh2 np_002159 .2:p .r140q
idh2 nm_002168 .3:c .516g > c
idh2 nm_002168 .3:c .516g > t
idh2 np_002159 .2:p .r172s
hematologic malignancy - associated skin squamous cell carcinoma
melanoma and non - melanoma related event occurred after initial treatment
classified by fab only
black / white cancer survival study
select one tumor site
current hormonal contraceptive user
former hormonal contraceptive user
never used hormonal contraceptives
unknown use of hormonal contraceptives
human immunodeficiency virus unknown
specify other histologic type
number of days from date of collection to date of last contact
chemical / occupational exposure history unknown
hyperspectral camera system
cancer surveillance project
family history of stomach cancer unknown
new disease is multifocal
new disease is not multifocal
unknown if new disease is multifocal
tetrathiomolybdate
tumor invasion of the mucosa
yes portal
seventy five
breast cancer prevention trial
loxl2 inhibitor pat - 1251
tumor invasion of the prostatic ducts and acini
indeterminate extranodal tumor extension
indeterminate lymph - vascular invasion
indeterminate peri - neural invasion
indeterminate tumor regression
indeterminate ulceration
multiple known primary tumors present at initial melanoma diagnosis
multiple known primary tumors absent at initial melanoma diagnosis
anastrozole
prostate cancer prevention trial
multiple known primary tumors unknown at initial melanoma diagnosis
unknown clark level
tumor necrosis not identified
autologous anti - bcma car t - cells im21
margin status cannot be assessed
hdac class i / iib inhibitor hg146
ulceration is present
ulceration is absent
no pathologic findings identified
pharmacobehavioral research
other pathologic findings
autologous anti - cs1 hinge - optimized car - 4 - 1bb - egfrt - expressing memory - enriched t - cells
bushen culuan decoction
gist grade cannot be assessed
anti - pd - 1 / tim - 3 bispecific antibody ro7121661
anti - cd137 agonistic monoclonal antibody adg106
pd - 1 directed probody cx - 188
anti - pd - 1 monoclonal antibody hx008
is tumor necrosis present
surgical margin cannot be assessed
ascus / lsil triage study
is lymphatic invasion present
lymphatic invasion absent
residual cancer burden
residual cancer burden index
residual cancer burden class
residual cancer burden class 0
residual cancer burden class 1
residual cancer burden class 2
residual cancer burden class 3
allogeneic cd25 / treg - depleted donor lymphocytes
marker network for bladder cancer
fnclcc sarcoma grade gx grade cannot be assessed
gist histologic grade
gist grade 1
gist grade 2
is paraneoplastic syndrome present
paraneoplastic syndrome is not present
paraneoplastic syndrome status is unknown
recurrent oligodendroglioma
tumor progression present after initial treatment
tumor progression absent after initial treatment
minority - based community clinical oncology program
tumor progression unknown after initial treatment
subsequent known primary melanoma ( s )  found during the follow - up
subsequent known primary melanoma ( s )  not found during the follow - up
unknown if subsequent known primary melanoma ( s )  found during the follow - up
dream complex
additional surgery for new metastatic tumor event not evaluated
patient - focused outcomes
docetaxel / leuprolide regimen
intimacy enhancement intervention
living healthy together
handout
routine cytogenetics were completed
routine cytogenetics were not completed
unknown if routine cytogenetics were completed
favorable calgb criteria
intermediate calgb criteria
poor calgb criteria
childhood cancer survivor study
remission calgb criteria
other cytogenetic analysis abnormality type
specify if other cytogenetic analysis abnormality type
other molecular analysis
unknown molecular analysis
specify other molecular analysis
were molecular abnormalities detected
molecular abnormalities detected
molecular abnormalities not detected
molecular abnormalities unknown
clinical trials database
vascularized lymph node transfer
coherent anti - stokes raman spectroscopy
anti - pd - l1 / cd137 bispecific antibody mcla - 145
progress notes
discrete set data type iv
discrete set telecommunication url data type
malignant lesion
autologous anti - cd19 / anti - cd20 - car - cd28 - 4 - 1bb - cd3zeta - egfrt +  - expressing tn / mem cells
regimen used to treat non - neoplastic hematologic disorders
atypical lymph node
pediatric surgical procedures
autologous anti - mesothelin t - cell receptor fusion construct t - cells tc - 210
unresectable ovarian serous adenocarcinoma
metastatic ovarian serous adenocarcinoma
locally advanced lung non - small cell carcinoma
high risk meningioma
clinical laboratory evaluation program
avadomide
anti - cd52 monoclonal antibody allo - 647
androgen receptor degrader arv - 110
histologic grade for other carcinomas
conventional surgery
other histologic grade
specify other histologic grade
myometrial invasion not identified
is myometrial invasion present
abiraterone regimen
belinostat regimen
binimetinib regimen
cabazitaxel regimen
carfilzomib regimen
copanlisib regimen
recombinant lymphotoxin beta
surgical management
darbepoetin regimen
epoetin alfa regimen
filgrastim regimen
aldesleukin regimen
high - dose methylprednisolone regimen
low - dose cytarabine regimen
niraparib regimen
palbociclib regimen
pegfilgrastim regimen
pralatrexate regimen
romidepsin regimen
rucaparib regimen
sipuleucel - t regimen
talimogene laherparepvec regimen
anchor date
carbon ion radiotherapy
prostate acinar adenocarcinoma ,  microcystic variant
prostate acinar adenocarcinoma ,  pleomorphic giant cell variant
metastatic colon adenocarcinoma
marker discovery
metastatic rectal adenocarcinoma
peritoneal fluid is negative for malignancy
atypical peritoneal fluid
peritoneal fluid positive for malignancy
nanotherm therapy
peritoneal fluid not examined
is tumor cell necrosis present
is macroscopic satellite nodule present
macroscopic satellite nodule not identified
is microsatellitosis present
prevention protocol
microsatellitosis absent
perineural invasion absent
are tumor infiltrating lymphocytes present
tumor infiltrating lymphocyte absent
is tumor regression present
tumor regression absent
tumor regression
is extranodal tumor involvement present
extranodal tumor extension absent
interferon gamma treatment was administered prior to specimen resection
observational study
interferon gamma treatment was not administered prior to specimen resection
unknown if interferon gamma treatment was administered prior to specimen resection
interferon gamma treatment was administered 90 days prior to specimen resection
interferon gamma treatment was not administered 90 days prior to specimen resection
interferon gamma treatment administration 90 days prior to specimen resection unknown
are sarcomatoid features present
sarcomatoid features absent
autologous car - mbil15 - safety switch t - cells prgn - 3006
predominantly fatty breast
basic cancer research
breast scattered fibroglandular densities
elevated type i collagen cross - linked n - telopeptide
advanced paraganglioma
advanced adrenal gland pheochromocytoma
gender identity measure
clinical evaluation of language fundamentals ,  fifth edition
rice grammaticality judgment task
aging voice index
test of word reading efficiency ,  second edition
oral mechanism / cranial nerve examination for young children
consensus auditory - perceptual evaluation of voice
hearscreen usa
phonological awareness test
syllable repetition task
tinnitus screener
primary debulking surgery
interval debulking surgery
lipid nanoparticle encapsulated mrnas encoding human il - 12a / il - 12b medi - 1191
psa level greater than 0 .5
biopsy clip
animal testing
respiratory muscle training
respiratory muscle training device
platinum - sensitive primary peritoneal carcinoma
platinum - sensitive fallopian tube carcinoma
chronic cutaneous graft versus host disease
biopsy guidance
head and neck survivorship tool: assessment and recommendations
activating erk family gene mutation
deleterious cysltr2 gene mutation
deleterious gnaq gene mutation
extraordinary opportunities for investment
nras gene amplification
psa level greater than or equal to fifty
vtcn1 positive
plcb4 gene
plcb4 wt allele
1 - phosphatidylinositol 4 , 5 - bisphosphate phosphodiesterase beta - 4
plcb4 gene mutation
deleterious plcb4 gene mutation
abexinostat tosylate
anti - axl / pbd antibody - drug conjugate adct - 601
adipose - derived expanded mesenchymal stem cells scm - 010
class of case
date of last contact or death
diagnostic confirmation code
computed spanish / hispanic ethnicity code
histology type code icd - o - 3
marital status code at diagnosis
primary healthcare payer at diagnosis
seer race code
ritonavir
molecular classification of tumors
rural - urban continuum code 2003
rural - urban continuum codes 2013
seer summary stage 2000
icd - o tumor topography code
recurrent anaplastic pleomorphic xanthoastrocytoma
refractory anaplastic pleomorphic xanthoastrocytoma
number of regional lymph nodes examined
number of regional lymph nodes positive
sex code
extraordinary opportunity: imaging technologies
icd - o - 3 behavior code
naaccr terminology
recurrent anaplastic ependymoma
refractory anaplastic ependymoma
recurrent anaplastic ganglioglioma
refractory anaplastic ganglioglioma
locally advanced liposarcoma
locally advanced leiomyosarcoma
non - mass - like enhancement
locally advanced undifferentiated pleomorphic sarcoma
extraordinary opportunity: preclinical models of cancer
locally advanced breast carcinoma
cdisc protocol study population attribute terminology
cdisc sdtm laboratory analytical method calculation formula terminology
cdisc sdtm model version responseterminology
cdisc sdtm implementation guide version response terminology
cdisc therapeutic area user guide response terminology
cdisc sdtm fda technical specification response terminology
cdisc send body irradiation model response terminology
cdisc send rad / nuc targeted injury model response terminology
cdisc send expected onset of rad / nuc targeted injury response terminology
cdisc send chemical challenge agent name response terminology
cdisc send genus and species response terminology
papio hamadryas
complement c5 measurement
implantable device status
cardiac function study
gender fluid
gender variant
reduced device function
device status
reported in error
device status unknown
udi entry method
data card
unknown data entry method
aidc udi
pharmacotherapy regimens
single - agent therapeutic regimens
multi - agent therapeutic regimens
malayo - polynesian language
northwest caucasian language
afroasiatic language
west germanic language
every evening
central tano language
carboplatin / fluorouracil / pembrolizumab regimen
cancer treatment trial
indo - european language
blasts 15 percent or less of bone marrow nucleated cells
cisplatin / fluorouracil / pembrolizumab regimen
semitic language
sensitizing egfr mutation negative
cogmed training program
cogstate assessment battery
community clinical oncology program
non - cogstate baseline and follow - up measures
maxillary alveolar process
cribriform adenocarcinoma of minor salivary gland
mandibular alveolar process
sinonasal adenocarcinoma
sinonasal adenocarcinoma ,  non - intestinal - type
head and neck sebaceous carcinoma
laryngeal surface of the epiglottis
head and neck neuroendocrine carcinoma
head and neck small cell carcinoma
head and neck large cell neuroendocrine carcinoma
lateral surface of the tongue
sinonasal adenocarcinoma ,  intestinal - type with papillary pattern
tubuloglandular pattern
sinonasal adenocarcinoma ,  intestinal - type with colonic pattern
sinonasal adenocarcinoma ,  intestinal - type with solid pattern
lateral wall of the nose
nasal vestibule
cooperative breast cancer tissue resource
sus
sus scrofa
parotid gland superficial lobe
mandibular vestibule of the mouth
maxillary vestibule of the mouth
sinonasal adenocarcinoma ,  intestinal - type with mucinous pattern
transglottic extension of laryngeal tumor
palatectomy
endolaryngeal excision
lurtotecan
correlative study
sinonasal adenocarcinoma ,  intestinal - type with mixed pattern
mustela putorius furo
deep parotidectomy
automated video - assisted smoking treatment
glottic laryngeal tumor with subglottic extension
familial focal epilepsy with variable foci 1
canine thyroid gland medullary carcinoma
sinonasal adenocarcinoma ,  salivary - type
sinonasal adenocarcinoma ,  non - salivary - type
clinical primary tumor tnm finding
hiv drug resistance program
pathologic t category
morphologic features resembling salivary gland adenocarcinoma
marmoset
bos taurus
capra hircus
non - keratinizing dysplasia
keratinizing dysplasia
high grade transformation
oligometastatic malignant solid neoplasm
investigator - initiated research
oligometastatic disease
oncolytic virus asp9801
intraductal prostate carcinoma
saimiri boliviensis boliviensis
xenopus tropicalis
papio anubis
papio cynocephalus
papio hamadryas hamadryas
papio papio
intramural research
chlorocebus
chlorocebus aethiops
macaca nemestrina
prostate synovial sarcoma
prostate osteosarcoma
erythrocebus patas
prostate undifferentiated pleomorphic sarcoma
oryctolagus cuniculus
prostate inflammatory myofibroblastic tumor
ovis aries
prostate soft tissue neoplasm
supraventricular bigeminy by ecg finding
supraventricular trigeminy by ecg finding
metastatic colorectal adenocarcinoma
nurses' health study
nutrition ,  fats ,  monosaturated
non - invasive cancer detection
7 - cyanoquinocarcinol
study of tamoxifen and raloxifene
nutrition ,  fats ,  polyunsaturated
clinical trial eligibility criteria
suicide gene therapy
anti - hiv therapy
antiviral therapy
glufosfamide
abdominal surgical procedure
biomaterials research
clinical trial ,  other
prior therapy
high dose interferon alpha 2a
population database
long island breast cancer study
molecular target
small molecule chemical library
antineoplaston as2 - 1
diversity library
evidence of malignant disease description
cdisc diabetes therapeutic area user guide version 1 .0  -  supplement for adam
robot - assisted salvage pelvic lymph node dissection
robot - assisted salvage pelvic mass resection
female of childbearing potential
population rationale
justification of special population
condition or disease under study
extraordinary opportunity: genes and the environment
comorbid condition
reference group
treatment group
experimental group
demographic group
frontal
occipital
facial
threshold cycle
non - host organism identifiers domain
every twelve weeks
every three years
every five years
every six days
every sixteen weeks
t - lymphocyte proliferation index
ckd - epi creatinine formula
ckd - epi cystatin c formula
biobehavioral determinants of tobacco use and addiction
ckd - epi creatinine - cystatin c formula
ckd - epi formula
cockcroft - gault formula
mdrd 4 variable formula
mdrd 5 variable formula
mdrd 6 variable formula
mdrd enzymatic formula
mdrd enzymatic japanese formula
schwartz method for children formula
fractional iron absorption
intensity - modulated radiation therapy
fructosamine corrected for total protein measurement
kappa light chain to lambda light chain ratio measurement
nitrate measurement
large platelets to total platelets ratio measurement
anisochromia measurement
cytochrome p450 2c9 measurement
cytochrome p450 2c9 activity measurement
free complement c5 measurement
inorganic pyrophosphate measurement
pus measurement
natural history and cofactors
chemokine  ( c - x - c motif )  ligand 11 measurement
chemokine  ( c - x3 - c motif )  ligand 1 measurement
chemokine  ( c - c motif )  ligand 20 measurement
hemoglobin fraction pattern
unspecified cells to leukocytes ratio measurement
progressive spermatozoa to total spermatozoa ratio measurement
progressive spermatozoa measurement
ph adjusted for body temperature measurement
thyroid stimulating immunoglobulin actual to control ratio measurement
aptt - la actual to control ratio measurement
special populations research
thrombin time actual to control ratio measurement
thrombin antithrombin complex measurement
aptt - la screen to confirm percent difference
drvvt screen to confirm percent difference
choriogonadotropin adjusted for maternal weight measurement
erythrocyte inclusion bodies measurement
tramadol measurement
vaginal wall
skin of the forearm
skin of the chest
extraordinary opportunity: molecular targets of prevention and treatment
skin of the inguinal region
heel of the foot
heel of the hand
finger flexor tendons
finger extensor tendons
wrist joint flexor tendons
wrist joint extensor tendons
shoulder joint tendons
knee joint tendons
ankle joint anterior flexor tendons
extraordinary opportunity: research on tobacco and tobacco related cancers
ankle joint anterior extensor tendons
skin of the infrascapular region
chlamydia trachomatis dna measurement
hiv - 1 / 2 rna measurement
cytomegalovirus dna measurement
human immunodeficiency virus measurement
enterococcus faecalis measurement
neisseria gonorrhoeae measurement
neisseria gonorrhoeae ,  beta - lactamase positive measurement
neisseria gonorrhoeae ,  beta - lactamase negative measurement
krn5500
intervention trial
bacterial beta - lactamase measurement
gram negative cocci measurement
gardnerella vaginalis measurement
trichomonas vaginalis measurement
candida albicans measurement
quantitative computed tomography
single - molecule array
dynamometry
multiple inert gas elimination technique
kleihauer - betke staining procedure
pain research
subject removed at sponsor request
non - compliance with study schedule
no steroid use beyond physiologic replacement dose
natural log transformed observed area under the curve infinity
natural log transformed area under the curve from dosing to last concentration
natural log transformed cmax
pk swing
subject entered into trial
informed assent
east asian
acupuncture and oriental medicine
first degree biological relative
second degree biological relative
effusion indicator
malignant disease indicator
effusion volume measurement
cdisc sdtm model version 1 .1
cdisc sdtm model version 1 .2
cdisc sdtm model version 1 .3
cdisc sdtm model version 1 .4
cdisc sdtm model version 1 .5
repository
cdisc sdtm model version 1 .6
cdisc sdtm model version 1 .7
cdisc sdtm implementation guide version 3 .1 .1
cdisc sdtm implementation guide version 3 .1 .2
cdisc sdtm implementation guide version 3 .1 .2 amendment 1
cdisc sdtm implementation guide version 3 .1 .3
cdisc sdtm implementation guide version 3 .2
cdisc sdtm implementation guide version 3 .3
cdisc chronic hepatitis c therapeutic area user guide version 1 .0
cdisc diabetic kidney disease therapeutic area user guide version 1 .0
combination drug therapy
cdisc duchenne muscular dystrophy therapeutic area user guide version 1 .0
cdisc dyslipidemia therapeutic area user guide version 1 .0
cdisc ebola therapeutic area user guide version 1 .0
cdisc influenza therapeutic area user guide version 1 .1
cdisc influenza therapeutic area user guide version 1 .0
cdisc kidney transplant therapeutic area user guide version 1 .0
cdisc major depressive disorder therapeutic area user guide version 1 .0
cdisc malaria therapeutic area user guide version 1 .0
cdisc prostate cancer therapeutic area user guide version 1 .0
cdisc qt studies therapeutic area user guide version 1 .0
donor lymphocyte infusion
cdisc rheumatoid arthritis therapeutic area user guide version 1 .0
cdisc schizophrenia therapeutic area user guide version 1 .1
cdisc schizophrenia therapeutic area user guide version 1 .0
cdisc traumatic brain injury therapeutic area user guide version 1 .0
cdisc tuberculosis therapeutic area user guide version 2 .0
cdisc vaccines therapeutic area user guide version 1 .1
cdisc virology therapeutic area user guide version 2 .1
cdisc virology therapeutic area user guide version 2 .0
cdisc alzheimer's therapeutic area user guide version 1 .0
cdisc alzheimer's therapeutic area user guide version 2 .0
public health applications research
cdisc asthma therapeutic area user guide version 1 .0
cdisc breast cancer therapeutic area user guide version 1 .0
cdisc cardiovascular studies therapeutic area user guide version 1 .0
cdisc colorectal cancer therapeutic area user guide version 1 .0
cdisc copd therapeutic area user guide version 1 .0
cdisc hiv therapeutic area user guide version 1 .0
cdisc huntington's disease therapeutic area user guide version 1 .0
cdisc multiple sclerosis therapeutic area user guide version 1 .0
cdisc pain therapeutic area user guide version 1 .0
cdisc pain therapeutic area user guide version 1 .1
natural history
cdisc parkinson's disease therapeutic area user guide version 1 .0
cdisc polycystic kidney disease  ( pkd )  therapeutic area user guide version 1 .0
cdisc post traumatic stress disorder therapeutic area user guide version 1 .0
us fda hiv technical specifications guidance v1 .0
us fda vaccines technical specification guidance v1 .0
us fda clinical endpoint be studies v1 .0
us fda study data technical conformance guide v4 .2 .1
position effect trial
swallowing function trial
usability testing study
exclusion criteria
water effect trial
anatomical location of interest
measurable tumor indicator
non - target indicator
fibrotic lesion indicator
cardiovascular lesion indicator
milligram per kilogram per week
drink dosing unit
degree per millimeter
square millisecond
progesterone receptor status
per millisecond
electrochemiluminescence unit
genomic equivalents per milliliter
genomic equivalents
d - dimer unit
micrograms ddu per liter
phosphatidylserine igm antibody unit
phosphatidylserine igg antibody unit
phosphatidylserine iga antibody unit
body irradiation model
elinafide
estrogen receptor status
percent bone marrow shielded
rad / nuc targeted injury model
expected onset of rad / nuc targeted injury
chemical agent certificate of analysis indicator
chemical agent material identification code
total body irradiation plus bone marrow transplant
top - up model irradiation
focal cutaneous irradiation
right and left lung irradiation
single lung irradiation
lung with heart shielded irradiation
total body irradiation with bone marrow not irradiated
hematopoietic radiation injury
gastrointestinal radiation injury
lung radiation injury
cutaneous radiation injury
renal radiation injury
cardiovascular radiation injury
central nervous system radiation injury
liver radiation injury
her2 / neu status
acute onset
delayed onset
acute and delayed onset
nitrogen mustard hn - 1
nitrogen mustard hn - 3
g - series nerve agent ga
g - series nerve agent gb
g - series nerve agent gc
g - series nerve agent gd
g - series nerve agent ge
stratification factors
g - series nerve agent gf
v - series nerve agent vx
v - series nerve agent rvx
v - series nerve agent cvx
v - series nerve agent ve
v - series nerve agent vg
v - series nerve agent vm
v - series nerve agent vp
v - series nerve agent vs
vascular infiltration by hepatocytes
treatment step
astrocyte swelling
astrocyte swelling and vacuolation
neuroaxonal dystrophy
experimental organism keratinizing cyst
basophilic tubule
endothelial attenuation
subretinal extracellular matrix deposit
ocular dermoid
dilatation and diverticulum
sensory hair cell loss
keratinization
narrowed filtration angle of trabecular meshwork
otolith loss or disorganization
persistent hyaloid vessels
persistent hyperplastic primary vitreous
persistent pupillary membrane
loss of cell polarity
increased porphyrin
trabecular meshwork proliferation
increased pigmentation
decreased pigmentation
rodent progressive cardiomyopathy
increased dentin
degeneration and vacuolation
experimental organism increased number of glial cells
retinal rosette
photoreceptor nuclei displacement
myelin sheath regeneration
extracellular vacuolation
pre - retinal arteriolar loop
uterine horn
investigational product smiles string
planned challenge agent exposure
planned challenge agent exposure units
planned challenge agent exposure frequency
planned challenge agent exposure rate
planned challenge agent exposure route
planned treatment administration rate
treatment trigger
prostate solitary fibrous tumor
prostate malignant solitary fibrous tumor
prostate hemangioma
prostate granular cell tumor
metastatic malignant neoplasm in the pelvic cavity
prostate carcinoma metastatic in the pelvic cavity
metastatic clear cell sarcoma of soft tissue
advanced clear cell sarcoma of soft tissue
prostate carcinoma metastatic in lymph node
extravascular volume overload
1 - dimensional chromatography
number of prior chemotherapies
folfoxiri - panitumumab regimen
folfoxiri - cetuximab regimen
elevated ldh
dabrafenib - trametinib - cetuximab regimen
dabrafenib - trametinib - panitumumab regimen
encorafenib - binimetinib - cetuximab regimen
encorafenib - binimetinib - panitumumab regimen
anti - pd - 1 monoclonal antibody amg 404
multi - kinase inhibitor xl092
antibody - drug conjugate abbv - 011
lavendustin b
bio - enhanced curcumin extract formulation
surgical procedure by type
prostate diffuse large b - cell lymphoma
prostate follicular lymphoma
prostate mantle cell lymphoma
prostate small lymphocytic lymphoma
prostate cystadenoma
prostate wilms tumor
extrarenal rhabdoid tumor of the prostate
double - negative prostate carcinoma
4a's treatment protocol
fixed lymph node
prostate melanoma
prostate paraganglioma
increased fibroblast growth factor pathway activation
cdisc questionnaire eortc qlq - c15 - pal version 1 test name terminology
cdisc questionnaire eortc qlq - c15 - pal version 1 test code terminology
cdisc questionnaire eortc qlq - c30 version 3 test name terminology
cdisc questionnaire eortc qlq - c30 version 3 test code terminology
nicotine nasal spray
cdisc questionnaire t1 - dds test name terminology
cdisc questionnaire t1 - dds test code terminology
cdisc clinical classification avpu test name terminology
cdisc clinical classification avpu test code terminology
cdisc clinical classification bprs 1988 version test name terminology
cdisc clinical classification bprs 1988 version test code terminology
cdisc clinical classification e - trip test name terminology
cdisc clinical classification e - trip test code terminology
eortc qlq - c15 - pal version 1 questionnaire question
eortc qlq - c30 version 3 questionnaire question
polyp prevention trial
t1 - dds questionnaire question
avpu clinical classification question
bprs 1988 version clinical classification question
e - trip clinical classification question
seminal vesicle squamous cell carcinoma
autologous anti - slamf7 car - expressing t - cells
seminal vesicle mixed epithelial and stromal tumor
seminal vesicle soft tissue neoplasm
seminal vesicle leiomyoma
seminal vesicle schwannoma
seminal vesicle mammary - type myofibroblastoma
seminal vesicle leiomyosarcoma
seminal vesicle angiosarcoma
benign seminal vesicle neoplasm
malignant seminal vesicle neoplasm
international prognostic index score
ipi score 0 - 1
ipi score 2
ipi score 3
metastatic malignant neoplasm in the seminal vesicle
highly active antiretroviral therapy
ipi score 4 - 5
gene - edited autologous neoantigen - targeted neotcr - p1 t - cells
allogeneic gm - csf - secreting myeloma vaccine
eortc qlq - c15 - pal version 1  -  trouble taking short walk outside
prostate cancer outcomes study
eortc qlq - c15 - pal version 1  -  stay in bed or chair during the day
eortc qlq - c15 - pal version 1  -  need help eating ,  dressing ,  washing
eortc qlq - c15 - pal version 1  -  were you short of breath
eortc qlq - c15 - pal version 1  -  have you had pain
eortc qlq - c15 - pal version 1  -  have you had trouble sleeping
eortc qlq - c15 - pal version 1  -  have you felt weak
eortc qlq - c15 - pal version 1  -  have you lacked appetite
eortc qlq - c15 - pal version 1  -  have you felt nauseated
eortc qlq - c15 - pal version 1  -  have you been constipated
eortc qlq - c15 - pal version 1  -  were you tired
gp100 human melanoma peptide vaccine with incomplete freund's adjuvant
eortc qlq - c15 - pal version 1  -  pain interfere daily activities
eortc qlq - c15 - pal version 1  -  did you feel tense
eortc qlq - c15 - pal version 1  -  did you feel depressed
eortc qlq - c15 - pal version 1  -  rate your overall quality of life
eortc qlq - c30 version 3  -  trouble doing strenuous activities
eortc qlq - c30 version 3  -  trouble taking long walk
eortc qlq - c30 version 3  -  trouble taking short walk outside
eortc qlq - c30 version 3  -  stay in bed or chair during the day
eortc qlq - c30 version 3  -  need help eating ,  dressing ,  washing
eortc qlq - c30 version 3  -  limited in work or daily activities
prior immunotherapy
eortc qlq - c30 version 3  -  limited hobbies or leisure activities
eortc qlq - c30 version 3  -  were you short of breath
eortc qlq - c30 version 3  -  have you had pain
eortc qlq - c30 version 3  -  did you need to rest
eortc qlq - c30 version 3  -  have you had trouble sleeping
eortc qlq - c30 version 3  -  have you felt weak
eortc qlq - c30 version 3  -  have you lacked appetite
eortc qlq - c30 version 3  -  have you felt nauseated
eortc qlq - c30 version 3  -  have you vomited
eortc qlq - c30 version 3  -  have you been constipated
eortc qlq - c30 version 3  -  have you had diarrhea
eortc qlq - c30 version 3  -  were you tired
eortc qlq - c30 version 3  -  pain interfere daily activities
eortc qlq - c30 version 3  -  difficulty concentrating on things
eortc qlq - c30 version 3  -  did you feel tense
eortc qlq - c30 version 3  -  did you worry
eortc qlq - c30 version 3  -  did you feel irritable
eortc qlq - c30 version 3  -  did you feel depressed
eortc qlq - c30 version 3  -  had difficulty remembering things
eortc qlq - c30 version 3  -  condition interfered family life
br96 - doxorubicin immunoconjugate
eortc qlq - c30 version 3  -  condition interfered social activities
eortc qlq - c30 version 3  -  condition caused financial difficulties
eortc qlq - c30 version 3  -  rate your overall health
eortc qlq - c30 version 3  -  rate your overall quality of life
t1 - dds  -  not skilled at managing diabetes
t1 - dds  -  i don't eat carefully as i should
t1 - dds  -  don't notice signs of hypoglycemia
t1 - dds  -  people treat me differently
t1 - dds  -  discouraged see high blood glucose
t1 - dds  -  family make bigger deal diabetes
prior chemotherapy
t1 - dds  -  can't tell doctor what on my mind
t1 - dds  -  not taking insulin as i should
t1 - dds  -  too much diabetes equipment with me
t1 - dds  -  have to hide my diabetes
t1 - dds  -  family worry about hypoglycemia
t1 - dds  -  don't check glucose as i should
t1 - dds  -  worried develop complications
t1 - dds  -  don't get help from doctor
t1 - dds  -  hypoglycemic event when asleep
t1 - dds  -  food and eating control my life
t1 - dds  -  family treat me more fragile
t1 - dds  -  doctor doesn't understand
t1 - dds  -  less attractive to employers
t1 - dds  -  family act like diabetes police
t1 - dds  -  be perfect with diabetes management
t1 - dds  -  hypoglycemic event while driving
t1 - dds  -  eating is out of control
t1 - dds  -  people think less of me
t1 - dds  -  never be good enough
t1 - dds  -  doctor doesn't know enough
national breast and cervical cancer early detection program
t1 - dds  -  be safe from hypoglycemic event
t1 - dds  -  don't give diabetes attention
t1 - dds  -  total scale
t1 - dds  -  subscale 1: powerlessness
t1 - dds  -  subscale 2: management distress
t1 - dds  -  subscale 3: hypoglycemia distress
t1 - dds  -  subscale 4: negative social perceptions
t1 - dds  -  subscale 5: eating distress
t1 - dds  -  subscale 6: physician distress
t1 - dds  -  subscale 7: friend / family distress
avpu  -  responsiveness
bprs 1988 version  -  somatic concern
bprs 1988 version  -  anxiety
bprs 1988 version  -  emotional withdrawal
bprs 1988 version  -  conceptual disorganization
bprs 1988 version  -  guilt feelings
bprs 1988 version  -  tension
bprs 1988 version  -  mannerisms and posturing
bprs 1988 version  -  grandiosity
bprs 1988 version  -  depressive mood
prior hormone therapy
bprs 1988 version  -  hostility
bprs 1988 version  -  suspiciousness
bprs 1988 version  -  hallucinatory behavior
bprs 1988 version  -  motor retardation
bprs 1988 version  -  uncooperativeness
bprs 1988 version  -  unusual thought content
bprs 1988 version  -  blunted affect
bprs 1988 version  -  excitement
bprs 1988 version  -  disorientation
bprs 1988 version  -  total score
tobacco surveillance
e - trip  -  medication total points
e - trip  -  psychotherapy total points
e - trip  -  total points
tdi  -  transition focal score
bdi  -  baseline focal score
progressive thyroid carcinoma
medicinal leech dosage form
2 - dimensional chromatography
3 - dimensional chromatography
nci strategic plan to reduce health disparities
reversed - phase liquid chromatography
basic reversed - phase liquid chromatography
ph 7 .5 basic reversed - phase liquid chromatography
ph 10 basic reversed - phase liquid chromatography
strong - cation - exchange chromatography
2 - dimensional reversed - phase liquid chromatography
octadecyl carbon chain - bonded silica
new objective column
galinpepimut - s
picofrit self - pack column
centers for population health
higher - energy collisional dissociation
electron - transfer dissociation
electron - capture dissociation
ritlecitinib
proteomics data acquisition method
data - dependent acquisition
data - independent acquisition
selected reaction monitoring
parallel reaction monitoring
immobilized metal affinity chromatography
selenium and vitamin e efficacy trial
peripheral t - cell lymphoma prognostic index score
peripheral t - cell lymphoma prognostic index score 0
peripheral t - cell lymphoma prognostic index score 1
immobilized metal affinity chromatography with phosphopeptide enrichment
peripheral t - cell lymphoma prognostic index score 2
peripheral t - cell lymphoma prognostic index score 3 - 4
phosphoproteome
glycoproteome
brepocitinib
ms3
bage tumor antigen
total mesorectal excision
label - free mass spectrometry
isobaric peptide termini labeling
isotope - coded protein label
arc fusion protein sl - 279252
stable isotope labeling with amino acids in cell culture
international prognostic index risk group
international prognostic index low risk group
international prognostic index low - intermediate risk group
international prognostic index high - intermediate risk group
international prognostic index high risk group
cancer biomarkers research group
proteomic quantification method
absolute proteomic quantification
isobaric label quantification
lc / ms label - free quantification
14 - n / 15 - n metabolic labeling quantification
ms1 quantification by isotope labeling
ms2 quantification by isotope labeling
silac quantification
spectral counting
selected reaction monitoring quantification
cooperative family registry for epidemiologic studies of colon cancer
non - vegfr tyrosine kinase inhibitor
negative exponent
next generation flow
amyloid fibril - directed therapy
factor x antigen measurement
label - free protein quantification by lc / ms
label - free peptide level quantification by lc / ms
label - free protein group level quantification by lc / ms
label - free raw feature quantification by lc / ms
label - free gene level quantification by lc / ms
telehealth
brca - mutated metastatic breast carcinoma
autologous tcr - engineered t - cells ima203
autologous anti - cd7 car / 28zeta crispr - edited t - lymphocytes
arginase - 1 peptide vaccine
crth2 antagonist act - 774312
imadetect
testosterone less than or equal to 50 ng / dl
biochemical diagnosis
hepatocellular malignant neoplasm ,  not otherwise specified
ki - 67 positive cells less than 10 percent
gel dosimetry
ki - 67 positive cells 10 - 20 percent
ki - 67 positive cells greater than 20 percent
eastern romance language
eastern indo - aryan language
indo - aryan language
romance language
northeast caucasian language
turkic language
allogeneic bone marrow transplantation recipient
autologous bone marrow transplantation recipient
image - guided therapy
virtual avatar interaction program
manding language
niger - congo language
bantu language
mande language
balto - slavic language
slavic language
east slavic language
south slavic language
west slavic language
orthopedic surgical procedure
celtic language
mongolic language
sino - tibetan language
hydrazide beads
anti - ox40 agonist monoclonal antibody abbv - 368
ferric ion - charged nta - agarose
tandem mass tag
isobaric tags for relative and absolute quantitation
isobaric tags for relative and absolute quantitation 4 - plex
tandem mass tag 10 - plex
whole - brain radiotherapy
tandem mass tag 11 - plex
glyco - tandem mass tag
aminoxy - tandem mass tag
deuterium isobaric amine reactive tag
n , n - dimethyl leucine isobaric labeling reagent
hydrazide - tandem mass tag
iodoacetyl - activated tandem mass tag
hydrazide - isobaric tags for relative and absolute quantitation
protein cleavage reagent
arg - c ,  asp - n protein cleavage reagent
transurethral electrovaporization of the prostate
endopeptidase arg - c protein cleavage reagent
endopeptidase asp - n protein cleavage reagent
endopeptidase asp - n in ammonium bicarbonate protein cleavage reagent
chymotrypsin protein cleavage reagent
glutamyl endopeptidase protein cleavage reagent
leukocyte elastase protein cleavage reagent
endoproteinase lys - c protein cleavage reagent
endoproteinase lys - c / p protein cleavage reagent
no protein cleavage reagent used
no cleavage enzyme used
atlas of cancer mortality in the united states
pepsin a protein cleavage reagent
proline endopeptidase protein cleavage reagent
trypsin / chymotrypsin protein cleavage reagent
trypsin protein cleavage reagent
trypsin / p protein cleavage reagent
v8 - asp / glu protein cleavage reagent
v8 - glu protein cleavage reagent
unspecified cleavage reagents used
iodoacetamide
chloroacetamide
lmb - 7 immunotoxin
cancer care outcomes research and surveillance consortium
tris ( 2 - carboxyethyl ) phosphine
austronesian language
austroasiatic language
polynesian language
germanic language
nilotic language
esophageal intramucosal adenocarcinoma
uralic language
sami language
dravidian language
tissue array research program
kra - dai language
non - brca gene mutation
arawakan language
na - dene language
bcmf regimen
cisplatin / cytarabine / dacarbazine / hydroxyurea / lomustine / methylprednisolone / procarbazine / vincristine regimen
carmustine / cyclophosphamide / doxorubicin regimen
bleomycin / dacarbazine / doxorubicin / lomustine regimen
bleomycin / cyclophosphamide / doxorubicin / mitomycin regimen
bleomycin / dacarbazine / doxorubicin regimen
sputum cytology
adoc regimen
doxorubicin / melphalan regimen
cytarabine / filgrastim / methotrexate regimen
ashap regimen
ashap alternating with m - bacos regimen
atgo regimen
gemtuzumab ozogamicin / tretinoin regimen
bapp regimen
bcap regimen
genoplasty
bcave regimen
bcop regimen
b - dopa regimen
bic regimen
bird regimen
bleomycin / cyclophosphamide / fluorouracil / methotrexate / vincristine regimen
blt - d regimen
busulfan / cyclophosphamide / etoposide regimen
cameleon regimen
preoperative endocrine therapy
cisplatin / cyclophosphamide / estramustine / fluorouracil regimen
ccv alternating with av regimen
cac regimen
cepp regimen
cfar regimen
cfpt regimen
gip regimen
cim regimen
ciscaii alternating with vbiv regimen
clag regimen
aids and cancer specimen bank
clag - m regimen
cmc alternating with vap regimen
cmfh regimen
comla regimen
etpf regimen
bleomycin / dexamethasone / lomustine / vinblastine regimen
cvdd regimen
cyclone regimen
methotrexate / leucovorin / vincristine regimen
dap regimen
clinical trials cooperative groups human tissue resources
mitolactol / doxorubicin / vincristine regimen
dccmp regimen
dacarbazine / dactinomycin regimen
dvm regimen
5 - azacitidine / gemcitabine regimen
eof regimen
acftor - bcg regimen
cyclophosphamide / doxorubicin / fluorouracil / levamisole regimen
doxorubicin / fluorouracil / levoleucovorin / mitomycin regimen
famme regimen
intervention
gemox - b regimen
hi - c - daze regimen
ice - v regimen
fluorouracil / ifosfamide / mesna / methotrexate regimen
bevacizumab / cisplatin / irinotecan regimen
lomac regimen
lsa2l2 regimen
mabop regimen
macho regimen
cisplatin / fluorouracil / mitomycin regimen
protein structure initiative
cyclophosphamide / melphalan / prednisone regimen
fluorouracil / medroxyprogesterone / melphalan regimen
mine - eshap regimen
mito - flag regimen
mmv regimen
moap regimen
momp regimen
mop - bap regimen
cisplatin / fluorouracil / leucovorin / methotrexate regimen
mvf regimen
cancer research
nfl regimen
novp regimen
cisplatin / docetaxel / fluorouracil / panitumumab regimen
pmf regimen
etanidazole / cisplatin regimen
bleomycin / cisplatin / cyclophosphamide / dactinomycin / doxorubicin / methotrexate regimen
exemestane / tamoxifen regimen
tpch regimen
paclitaxel / rituximab / topotecan regimen
vabcd regimen
becatecarin
stem cell research
vad / v regimen
vmpt regimen
vncop - b regimen
cav alternating with ep regimen
ddp - mecy regimen
avad regimen
bvam regimen
functional tests group identifier
meal data group identifier
musculoskeletal findings ,  connective and soft tissue findings group identifier
hematopoietic stem cell research
itk inhibitor cpi - 818
nervous system findings group identifier
ophthalmic examinations group identifier
procedure agents group identifier
urinary system findings group identifier
refractory pancreatic adenocarcinoma
unresectable pancreatic adenocarcinoma
cardiovascular system findings link identifier
microbiology specimen link identifier
microbiology susceptibility link identifier
non - hematopoietic stem cell research
musculoskeletal findings ,  connective and soft tissue findings link identifier
nervous system findings link identifier
ophthalmic examinations link identifier
procedure agents link identifier
reproductive system findings link identifier
respiratory system link identifier
urinary system findings link identifier
suspension for spray dosage form
microbiology specimen link group identifier
musculoskeletal findings ,  connective and soft tissue findings link group identifier
clinical or research activity
procedure agents link group identifier
reproductive system findings link group identifier
tumor identification link group identifier
urinary system findings link group identifier
cardiovascular system findings link group
nervous system findings link group
ophthalmic examinations link group
respiratory system link group
cellsave blood collection tube
anti - cd137 agonistic monoclonal antibody ctx - 471
inactivating atm gene mutation
deleterious fbxw7 gene mutation
hepatitis c virus rna positive
hepatitis b dna positive
serum cea level elevated
serum cea level normal
serum cea level low
serum ca 19 - 9 elevated
serum ca 19 - 9 normal
serum ca 19 - 9 low
healthcare activity
was another cd antigen tested
xk negative
mpx negative
eno2 negative
dntt negative
cytoplasmic cd3 negative
cd4 negative
cd5 negative
cd7 negative
cd8 negative
cd11c negative
itgad negative
anpep negative
cd14 negative
cd15 negative
cd22 negative
cd33 negative
cd36 negative
cd38 negative
spn negative
electromagnetic - based therapy
ptprc negative
fcgr1a negative
cd65 negative
cd79a negative
fmc7 negative
hla - dr negative
mki67 negative
pas negative
pax5 negative
sbb negative
mpo negative
igk negative
xk positive
mpx positive
eno2 positive
dntt positive
cytoplasmic cd3 positive
mme positive
itgad positive
anpep positive
early detection
cd14 positive
cd15 positive
cd36 positive
fcgr1a positive
cd65 positive
cd79a positive
fmc7 positive
hla - dr positive
pas positive
pax5 positive
detection
sbb positive
igk positive
low ldh level
high calcium level
low calcium level
high hemoglobin level
low hemoglobin level
high platelet count
low platelet count
high leukocyte count
tobacco use prevention research
low leukocyte count
elevated sedimentation rate
solid dispersion immediate release tablet dosage form
locally advanced unresectable esophageal adenocarcinoma
locally advanced unresectable gastroesophageal junction adenocarcinoma
anti - her2 bispecific antibody - drug conjugate zw49
unresectable colon adenocarcinoma
unresectable rectal adenocarcinoma
procedure agent sponsor identifier
procedure agent reported name
cancer therapeutic procedure
procedure agent modified reported name
procedure agent class
procedure agent class code
procedure agent dose per administration
procedure agent dose description
gerota fascia
cardiovascular system findings reference identifier
description of unplanned actual arm
disease response elapsed time
cancer diagnosis
disease response time point reference
functional tests reference identifier
functional tests sponsor - defined identifier
functional tests result or finding in original units
functional tests external file path
functional tests vendor name
functional tests elapsed time
functional tests time point reference
meal data sponsor - defined identifier
regressed testicular germ cell tumor
meal data name
invasive pulmonary aspergillosis
hla - c*08 positive cells present
microbiology specimen focus of study - specific interest
microbiology specimen measurement ,  test or examination detail
microbiology susceptibility non - host organism identifier
microbiology susceptibility measurement ,  test or examination detail
microbiology susceptibility agent name
microbiology susceptibility modified reported name
microbiology susceptibility external file path
soft agar assay
microbiology susceptibility analysis method
microbiology susceptibility collected duration
advanced colon adenocarcinoma
advanced pancreatic adenocarcinoma
refractory colorectal adenocarcinoma
refractory colon adenocarcinoma
refractory rectal carcinoma
refractory rectal adenocarcinoma
advanced lung non - small cell carcinoma
stereotactic accelerated partial breast irradiation
matrigel invasion assay
community health advisor
liver - directed therapy
cholate clearance test
cholic - 2 , 2 , 4 , 4 - d4 acid
cholic acid - 24 - 13c
first study treatment date
mov19 car - cd3zeta - 4 - 1bb - expressing allogeneic t - lymphocytes
last study treatment date
time of therapeutic procedure
first study treatment time
last study treatment time
informed consent time
participation end date
participation end time
disease response assessment date
disease response assessment time
study subject assessment date
study subject assessment time
tumor identification date
tumor identification time
nerve - sparing prostatectomy
tumor results measurement date
tumor results measurement time
locally advanced unresectable breast carcinoma
somatic brca2 gene mutation
somatic brca1 gene mutation
ibrexafungerp
mrna - derived kras - targeted vaccine v941
microbial ecosystem therapeutics - 4
clonal hematopoiesis
seed implantation
monoclonal hematopoietic stem and progenitor cells present
furosemide / digoxin topical gel cls003
pollen extract pcc - 100
advanced soft tissue sarcoma
focus of study - specific interest
sponsor - defined identifier
respiratory system findings sponsor - defined identifier
musculoskeletal findings ,  connective and soft tissue findings sponsor - defined identifier
nervous system sponsor - defined identifier
epothilone a
orestes library
urinary system findings sponsor - defined identifier
musculoskeletal findings ,  connective and soft tissue findings elapsed time
nervous system elapsed time
ophthalmic examinations elapsed time
reproductive system findings elapsed time
urinary system findings elapsed time
musculoskeletal findings ,  connective and soft tissue findings reference identifier
nervous system reference identifier
respiratory system findings reference identifier
urinary system findings reference identifier
protein replacement therapy
musculoskeletal findings ,  connective and soft tissue findings time point reference
nervous system time point reference
ophthalmic examinations time point reference
reproductive system findings time point reference
respiratory system findings reference result in original units
renal calyx and pelvis
renal parenchyma
perinephric fat
renal sinus
psychological impact
axitinib / pembrolizumab regimen
metastatic diagnosis
figo stage ib3
figo stage iia1
figo stage iia2
cervical cancer by figo stage 2018
stage i cervical cancer figo 2018
stage ia cervical cancer figo 2018
stage ia1 cervical cancer figo 2018
stage ia2 cervical cancer figo 2018
dna library
stage ib cervical cancer figo 2018
stage ib1 cervical cancer figo 2018
stage ib2 cervical cancer figo 2018
stage ib3 cervical cancer figo 2018
stage ii cervical cancer figo 2018
stage iia cervical cancer figo 2018
stage iia1 cervical cancer figo 2018
stage iia2 cervical cancer figo 2018
stage iib cervical cancer figo 2018
stage iii cervical cancer figo 2018
sage library
stage iiia cervical cancer figo 2018
stage iiib cervical cancer figo 2018
stage iiic cervical cancer figo 2018
stage iiic1 cervical cancer figo 2018
stage iiic2 cervical cancer figo 2018
stage iv cervical cancer figo 2018
stage iva cervical cancer figo 2018
stage ivb cervical cancer figo 2018
engineered human umbilical vein endothelial cells ab - 205
thousand cells per kilogram
autologous mdc3 vaccine
semantic clustering
learning slope
recognition hits
metastatic malignant female reproductive system neoplasm
metastatic malignant digestive system neoplasm
hypermutated colorectal carcinoma
resectable colorectal carcinoma
hypermutated sample
extraprostatic extension
health and behavior
autologous anti - hla - a*02 / afp tcrm - expressing t - cells et140202
platinum doublet
hla - b*07 positive cells present
meal data elapsed time
meal data time point reference
disease milestone instance name
temporal relation to milestone instance
disease milestone instance date
disease milestone instance time
autologous mdc3 / 8 - kras vaccine
locally advanced unresectable colorectal adenocarcinoma
locally advanced unresectable colon adenocarcinoma
locally advanced unresectable rectal adenocarcinoma
metastatic colorectal mucinous adenocarcinoma
metastatic appendix mucinous adenocarcinoma
metastatic appendix carcinoma
met nm_000245 .3:c .3749t > c
met np_000236 .2:p .m1250t
met np_000236 .2:p .s1236r
met nm_000245 .3:c .3688t > c
uva light therapy
met np_000236 .2:p .y1230h
met nm_000245 .3:c .3689a > g
met np_000236 .2:p .y1230c
met nm_000245 .3:c .3682g > a
met np_000236 .2:p .d1228n
met nm_000245 .3:c .3613t > g
met np_000236 .2:p .l1205v
met nm_000245 .3:c .3598t > a
met np_000236 .2:p .f1200i
met nm_000245 .3:c .3280c > t
met np_000236 .2:p .h1094y
met nm_000245 .3:c .3274g > a
met np_000236 .2:p .v1092i
met nm_000245 .3:c .3208g > a
met np_000236 .2:p .v1070m
met nm_000245 .3:c .3209t > g
anti - cd33 / cd3 bispecific antibody jnj - 67571244
met np_000236 .2:p .v1070g
met nm_000245 .3:c .3209t > a
met np_000236 .2:p .v1070e
patupilone
extensive radiation
met nm_000245 .3:c .1510g > c
met np_000236 .2:p .v504l
met nm_000245 .3:c .1915a > c
met np_000236 .2:p .i639l
ebv - related gastric carcinoma
ebv - related sarcoma
ebv - related leiomyosarcoma
mlh1 negative
msh2 negative
msh6 negative
myeloablative chemotherapy
pms2 negative
inosinic acid
urethral ointment dosage form
solution for infusion in cartridge
powder and solution for suspension for injection
nasal powder in single - dose container
proton multiple quantum coherence magnetic resonance spectroscopic imaging
ophthalmic examinations external file path
urinary system findings time point reference
adverse event previous occurrence
clinical event previous occurrence
disease response or clinical classification previous occurrence
functional tests previous occurrence
healthcare encounter previous occurrence
microbiology susceptibility previous occurrence
agent previous occurrence
substance use previous occurrence
disease response or clinical classification ongoing
ongoing microbiology susceptibility
ongoing procedure agents
ongoing substance use
functional tests completion status
meal data completion status
musculoskeletal findings ,  connective and soft tissue findings completion status
nervous system findings completion status
ophthalmic examinations completion status
procedure agents completion status
substance use completion status
urinary system findings completion status
src kinase inhibitor m475271
fgfr4 inhibitor blu 9931
vascular disrupting agent bnc105
combretastatin a - 1
trpm8 agonist d - 3263
dactolisib tosylate
detumomab
exatecan mesylate anhydrous
ophthalmic examinations normal or reference range indicator
ames assay
microbiology susceptibility normal or reference range indicator
microbiology susceptibility specimen type
urinary system findings specimen type
procedure agent yes no indicator
microbiology susceptibility agent concentration unit
dexamethasone / selinexor regimen
iqck gene
iqck wt allele
iq domain - containing protein k
echdc3 gene
antisense therapy
echdc3 wt allele
enoyl - coa hydratase domain - containing protein 3 ,  mitochondrial
slc24a4 gene
slc24a4 wt allele
sodium / potassium / calcium exchanger 4
abca7 gene
abca7 wt allele
phospholipid - transporting atpase abca7
fagotti score
cass4 gene
validation
cass4 wt allele
cas scaffolding protein family member 4
grhl2 gene
grhl2 wt allele
grainyhead - like protein 2 homolog
plk1 inhibitor cyc140
clec12a gene
clec12a wt allele
c - type lectin domain family 12 member a
tet3 gene
predictive value
tet3 wt allele
methylcytosine dioxygenase tet3
mir30c1 gene
mir30c2 gene
mir30c1 wt allele
mir30c2 wt allele
mir30c1 pre - mirna
mir30c2 pre - mirna
microrna 30c
klf2 gene
oncogene erbb2
klf2 wt allele
krueppel - like factor 2
klf3 gene
klf3 wt allele
krueppel - like factor 3
tp53 nm_000546 .5:c .542g > a
tp53 np_000537 .3:p .r181h
glycogen storage disease type ia
cone - rod dystrophy 2
nelfinavir mesylate
oncogene csf1r
khdrbs3 gene
khdrbs3 wt allele
kh domain - containing ,  rna - binding ,  signal transduction - associated protein 3
crem gene
crem wt allele
camp - responsive element modulator
tmeff2 gene
tmeff2 wt allele
tomoregulin - 2
asns gene
retired gene concepts
asns wt allele
asparagine synthetase  [ glutamine - hydrolyzing ]
e2f5 gene
e2f5 wt allele
transcription factor e2f5
lin37 gene
lin37 wt allele
protein lin - 37 homolog
lin52 gene
lin52 wt allele
exonuclease
protein lin - 52 homolog
lin54 gene
protein lin - 54 homolog
lin54 wt allele
recurrent myelofibrosis
refractory myelofibrosis
rab44 gene
rab44 wt allele
ras - related protein rab - 44
klhl33 gene
5' - 3' exonuclease
klhl33 wt allele
kelch - like protein 33
ncstn gene
ncstn wt allele
nicastrin
stx7 gene
stx7 wt allele
syntaxin - 7
fem1c gene
fem1c wt allele
retired biological process concepts
protein fem - 1 homolog c
recurrent colorectal adenocarcinoma
recurrent colon adenocarcinoma
recurrent rectal adenocarcinoma
txk gene
txk wt allele
tyrosine - protein kinase txk
col7a1 gene mutation
peptide receptor radionuclide therapy
refractory hepatocellular carcinoma
recurrent high grade b - cell lymphoma with myc ,  bcl2 ,  and bcl6 rearrangements
antisense oligonucleotide qr - 313
refractory high grade b - cell lymphoma with myc ,  bcl2 ,  and bcl6 rearrangements
protein arginine methyltransferase 5 inhibitor prt543
dupilumab
intermediate risk acute myeloid leukemia
refractory high risk acute myeloid leukemia
refractory intermediate risk acute myeloid leukemia
hpv16 e7 - specific hla - a*02:01 - restricted igg1 - fc fusion protein cue - 101
thymic neuroendocrine neoplasm
metastatic thymic neuroendocrine neoplasm
anti - mage - a4 t - cell receptor / anti - cd3 scfv fusion protein imc - c103c
10 - 2 visual field testing
spectral domain - optical coherence tomography
fundus autofluorescence imaging
intratubular large cell hyalinizing sertoli cell neoplasia
testicular diffuse large b - cell lymphoma
testicular nasal type extranodal nk / t - cell lymphoma
testicular myeloid sarcoma
testicular plasmacytoma
specify other hpv typing method
early infantile epileptic encephalopathy 4
canine transmissible venereal tumor
epidermolysis bullosa ,  junctional ,  with pyloric atresia
advanced colorectal carcinoma
paratesticular adenomatoid tumor
paratesticular malignant mesothelioma
emsy gene mutation
btk inhibitor tg - 1701
metap2 inhibitor apl - 1202
autologous c - met / pd - l1 - specific car t - cells
autologous cd138 - specific car t - cells
epididymal cystadenoma
polymerase proofreading associated polyposis
paratesticular neoplasm
paratesticular squamous cell carcinoma
paratesticular melanotic neuroectodermal tumor
epididymal melanotic neuroectodermal tumor
paratesticular wilms tumor
paratesticular paraganglioma
paratesticular region
paratesticular soft tissue neoplasm
paratesticular liposarcoma
paratesticular leiomyoma
paratesticular leiomyosarcoma
paratesticular rhabdomyoma
paratesticular rhabdomyosarcoma
paratesticular cellular angiofibroma
mek inhibitor pd - 98059
paratesticular mammary - type myofibroblastoma
paratesticular deep  \ "aggressive \ " angiomyxoma
paratesticular schwannoma
paratesticular hemangioma
anti - pd - l1 monoclonal antibody zkab001
anti - ctla - 4 monoclonal antibody adu - 1604
autologous bcma - targeted car t cells lcar - b4822m
abemaciclib mesylate
pegylated deoxycytidine analogue dfp - 14927
glucocorticoid receptor antagonist oric - 101
mycn negative
myc negative
blasts 1 percent or more of bone marrow nucleated cells
kmt2a gene mutation
deleterious gna11 gene mutation
loss of msh2 expression
somatic hypermutation
alpha - fetoprotein positive
nicotine metabolite ratio measurement
plod2 gene
plod2 wt allele
anti - icos monoclonal antibody ky1044
procollagen - lysine , 2 - oxoglutarate 5 - dioxygenase 2
col7a1 exon 73 mutation
recombinant human plasminogen kringle 5 domain abt 828
tubulin polymerization inhibitor aezs 112
30 day prior medications
tubulin inhibitor alb - 109564
anti - bcma antibody - drug conjugate amg 224
colon polyp observed during examination
cfc1 gene
cobas mpx test
invasive adenocarcinoma in adenomatous polyp
aurora kinase a / b inhibitor tt - 00420
src kinase inhibitor ap 23846
abdominal surgery patient
iap inhibitor apg - 1387
non - human papillomavirus - related penile intraepithelial neoplasia
lorukafusp alfa
refractory gastroesophageal junction adenocarcinoma
differentiated  ( simplex )  penile intraepithelial neoplasia
estradiol 17 - beta - dehydrogenase 2
aranose
human papillomavirus - related penile intraepithelial neoplasia
basaloid  ( undifferentiated )  penile intraepithelial neoplasia
warty  ( bowenoid )  penile intraepithelial neoplasia
zinostatin stimalamer
uroacitides
warty - basaloid penile intraepithelial neoplasia
penile melanoma
penile lymphoma
metastatic malignant neoplasm in the penis
acetylation
post - operative therapy rounds section
xiliertinib
sitimagene ceradenovec
pyrotinib dimaleate
puquitinib
puquitinib mesylate
endobronchial cryotherapy
b - mode ultrasound imaging
acoustic angiography
primary peritoneal undifferentiated carcinoma
lutetium lu - 177 rituximab
primary peritoneal transitional cell carcinoma
lutetium lu 177 lilotomab - satetraxetan
primary peritoneal clear cell adenocarcinoma
luminespib mesylate
infigratinib mesylate
non - metastatic head and neck carcinoma
actin - binding protein
non - metastatic lung carcinoma
metastatic merkel cell carcinoma
pan - flt3 / pan - btk multi - kinase inhibitor cg - 806
penile soft tissue neoplasm
99mtc bone scintography
promark proteomic prognostic test
anti - her - 2 bispecific antibody kn026
penile angiosarcoma
penile hemangioma
actin
penile epithelioid hemangioma
penile epithelioid hemangioendothelioma
penile glomus tumor
penile leiomyoma
penile malignant peripheral nerve sheath tumor
penile leiomyosarcoma
penile schwannoma
penile neurofibroma
penile rhabdomyosarcoma
penile undifferentiated pleomorphic sarcoma
acyltransferase
penile myointimoma
intravascular myofibroblastic proliferation
penile lymphangioma
metastatic malignant neoplasm in the head and neck
head and neck carcinoma of unknown primary
was in situ hybridization performed
protein expression analysis by immunohistochemistry
additional surgery for new loco - regional tumor event not evaluated
was rt - pcr performed
etalocib
adenine phosphoribosyltransferase
unresectable colorectal carcinoma
bone marrow differential count within 24 hours of banking
unresectable fibrolamellar carcinoma
additional surgery for new tumor event not evaluated
paraneoplastic syndrome is present
lymphatic invasion is present
tumor cell necrosis is present
tumor infiltrating lymphocyte is present
navigated transcranial magnetic stimulation
clinical regional lymph nodes tnm finding
adenosine deaminase
clinical distant metastasis tnm finding
warm antibody autoimmune hemolytic anemia
recurrent adamantinomatous craniopharyngioma
hand function test
tumor laterality midline
tumor laterality unknown
locally advanced ureter urothelial carcinoma
locally advanced renal pelvis urothelial carcinoma
locally advanced bladder urothelial carcinoma
locally advanced urethral urothelial carcinoma
purinergic p1 receptor
autologous anti - cd19 / cd22 car t - cells auto3
qc slide review
tumor segment
normal tissue segment
patient - derived wt1 / prame / survivin - specific cytotoxic t - lymphocytes
anti - tim - 3 monoclonal antibody incagn02390
autologous anti - gp100car - cd3zeta - 4 - 1bb - il - 15 - pd1 - expressing tri - functional t - lymphocytes
autologous lmp1 / lmp2 / ebna1 - specific hla - a02:01 / 24:02 / 11:01 - restricted tcr - expressing t - lymphocytes yt - e001
whole abdominopelvic intensity - modulated radiotherapy
sacubitril / valsartan
atpase
hoxb1 gene
hoxb1 wt allele
homeobox protein hox - b1
personalized neoantigen peptide vaccine ineo - vac - p01
adenoviral vector encoding vegf - c lx - 1101
oncolytic hsv - 1 c134
anti - pd - 1 monoclonal antibody f520
chimeric costimulatory converting receptor - modified nk - 92 cells
non - metastatic prostate carcinoma
paraneoplastic antibody positive
adenylate cyclase
paraneoplastic antibody
indium in 111 - autologous cmv - pp65 - lamp mrna loaded dendritic cells
unresectable lung non - squamous non - small cell carcinoma
mr fingerprinting
pegylated recombinant interleukin - 2 thor - 707
7 tesla magnetic resonance imaging
behavioral activation intervention to smoking cessation and to post - cessation weight gain
advanced breast carcinoma
engineered toxin body targeting her2 mt - 5111
teenager
localized metastasis
widespread metastasis
recurrent squamous cell carcinoma
advanced squamous cell carcinoma
isup grade pattern 1
isup grade pattern 2
isup grade pattern 3
isup grade pattern 4
isup grade pattern 5
adolescents
ethanol - containing nasal solution
resectable osteosarcoma
planned eligibility criterion
planned exclusion criterion
planned inclusion criterion
defined material process step
defined material storage
principal statistical analysis plan version
statistical analysis plan document version
performed substance extraction
afghanistan
support education activity
ventilated cigarette
unventilated cigarette
specify other preoperative iv antacids administered
highest grade
specify other preoperative iv antiemetics administered
multi - kinase inhibitor tpx - 0022
revised international prognostic scoring system
specify other spinal / epidural anesthesia agents administered
ipss - r risk category
elderly
ipss - r risk category very low
ipss - r risk category low
ipss - r risk category intermediate
ipss - r risk category high
ipss - r risk category very high
low nicotine content cigarette
virus - associated hemophagocytic syndrome
severe chronic active ebv infection
recurrent systemic anaplastic large cell lymphoma
refractory systemic anaplastic large cell lymphoma
aging
slide id examined by pathologist
image id examined by pathologist
aperio format
anti - cd39 monoclonal antibody ttx - 030
severe combined immunodeficiency ,  athabascan type
severe combined immunodeficiency due to nhej1 deficiency
familial platelet disorder with associated myeloid malignancy
epcam loss of nuclear expression
msh3 loss of nuclear expression
anti - cd70 car - expressing t lymphocytes
lewis y antigen
agriculture
treatment planning
clinical trial candidate
recurrent childhood malignant neoplasm
refractory childhood malignant neoplasm
no response to treatment
new patient
metastatic thyroid gland medullary carcinoma
eye movement measurement
no 30 day prior medications
montreal cognitive assessment visuospatial / executive test
albania
montreal cognitive assessment naming test
montreal cognitive assessment attention  -  digits test
montreal cognitive assessment attention  -  letters test
montreal cognitive assessment attention  -  subtraction test
montreal cognitive assessment language  -  repeat test
montreal cognitive assessment language  -  fluency test
montreal cognitive assessment abstraction test
montreal cognitive assessment delayed recall test
montreal cognitive assessment orientation test
refractory urinary system carcinoma
alcohol dehydrogenase
montreal cognitive assessment total score
refractory chordoma
refractory epithelioid sarcoma
refractory atypical teratoid / rhabdoid tumor
recurrent epithelioid malignant peripheral nerve sheath tumor
refractory epithelioid malignant peripheral nerve sheath tumor
recurrent kidney medullary carcinoma
refractory kidney medullary carcinoma
recurrent dedifferentiated chordoma
refractory dedifferentiated chordoma
alcohol consumption
recurrent rhabdoid tumor of the kidney
refractory rhabdoid tumor of the kidney
recurrent malignant myoepithelioma
refractory malignant myoepithelioma
non - m3 acute myeloid leukemia
normal karyotype intermediate risk acute myeloid leukemia
baker classification of capsular contracture of breast
grade i breast capsule contracture
grade ii breast capsule contracture
algeria
grade iii breast capsule contracture
grade iv breast capsule contracture
nampt inhibitor ot - 82
reflexology
deleterious stk11 gene mutation
deleterious dicer1 gene mutation
deleterious smarca4 gene mutation
deleterious cdh1 gene mutation
refractory cytomegalovirus infection
mdm2 antagonist astx295
algorithm
refractory biliary tract carcinoma
metastatic biliary tract carcinoma
advanced cholangiocarcinoma
refractory gallbladder carcinoma
metastatic gallbladder carcinoma
advanced gallbladder carcinoma
cancer - related cognitive dysfunction
beclomethasone dipropionate / formoterol fumarate inhalation solution
locally advanced head and neck squamous cell carcinoma
locally advanced gastroesophageal junction adenocarcinoma
alkaline phosphatase
metastatic papillary renal cell carcinoma
advanced papillary renal cell carcinoma
advanced bone sarcoma
advanced myxoid liposarcoma
wt1 / prame / survivin - specific cytotoxic t - lymphocytes
cd3 +  / cd19 +  cell - depleted unrelated or partially matched donor - derived allogeneic peripheral blood stem cells
locally advanced colorectal carcinoma
locally advanced gastric adenocarcinoma
metastatic clear cell renal cell carcinoma
asph - positive neoplastic cells present
allele
asph - positive head and neck squamous cell carcinoma
locally advanced gastric carcinoma
submicron particle paclitaxel sterile suspension
anti - pd1 / anti - ctla4 antibody mixture psb205
acute myeloid leukemia with trisomy 8
b acute lymphoblastic leukemia with t ( 4 ; 11 )  ( q21 ; 23 )
higher risk myelodysplastic syndrome
lottery
human immunodeficiency virus antibody negative
alpha - fetoprotein
metastatic malignant colorectal neoplasm
mantle cell lymphoma international prognostic index
non - metastatic breast carcinoma
docetaxel / ritonavir
bardport titanium implanted port with peritoneal catheter
unresectable merkel cell carcinoma
resectable oropharyngeal squamous cell carcinoma
left ventricular hypertrophy with strain
h2bc20p gene
alpha radiation
h2bc20p wt allele
putative histone h2b type 2 - c
h2bc19p gene
h2bc19p wt allele
putative histone h2b type 2 - d
testosterone greater than 50 ng / dl
h1 - 0 gene
h1 - 0 wt allele
histone h1 .0
h1 - 7 gene
polyandrol
alternate splicing
h1 - 7 wt allele
testis - specific histone h1
cdkn2a - p16 status
autologous genetically - modified mage - a4 c1032 cd8alpha t cells
adenoviral tumor - specific neoantigen priming vaccine gad - 209 - fsp
mva tumor - specific neoantigen boosting vaccine mva - 209 - fsp
growth hormone receptor antisense oligonucleotide ionis - ghr - lrx
lobectomy patient
h1 - 8 gene
ambulatory care facility
h1 - 8 wt allele
histone h1oo
lentiviral vector recipient
h1 - 10 gene
h1 - 10 wt allele
histone h1x
h2aj gene
h2aj wt allele
lateral pharyngeal space
fitbit
american cancer society
parapharyngeal neoplasm
histone h2a .j
benign parapharyngeal neoplasm
malignant parapharyngeal neoplasm
retropharyngeal space
retropharyngeal neoplasm
benign retropharyngeal neoplasm
h2az2 gene
malignant retropharyngeal neoplasm
native american
h2az2 wt allele
h2az2 gene product
histone h2a .v
unresectable oropharyngeal squamous cell carcinoma
histone h2a .v isoform 2
h2bw2 gene
h2bw2 wt allele
histone h2b type f - m
h2bs1 gene
h2bs1 wt allele
amylase
histone h2b type f - s
h2bw1 gene
h2bw1 wt allele
histone h2b type w - t
pregnant at time of vaccination
unresectable malignant digestive system neoplasm
regulatory action
fda inactivation
digital papillary adenoma
h1 - 5 gene
amyloid beta a4 protein
h1 - 5 wt allele
histone h1 .5
fgfr4 inhibitor icp - 105
h1 - 2 gene
h1 - 2 wt allele
bifidobacterium longum / lactobacillus acidophilus / enterococcus faecalis probiotic supplement
autologous anti - cd19 car - cd28 t - cells et019002
histone h1 .2
ido1 / tdo2 inhibitor dn1406131
eggplant peel extract cream
anaphase
zirconium zr 89 - labeled envafolimab
h1 - 3 gene
h1 - 3 wt allele
histone h1 .3
h1 - 6 gene
h1 - 6 wt allele
histone h1t
h1 - 9 gene
h1 - 9 wt allele
spermatid - specific linker histone h1 - like protein
anatomical sciences
gastrointestinal dysfunction
anti - pd - 1 monoclonal antibody bat1306
anti - vegf / tgf - beta 1 fusion protein hb - 002t
autologous active il - 7 receptor co - expressing gd2 - specific car t - cells
neoantigen vaccine gen - 009
anti - tigit monoclonal antibody ab154
metastatic paranasal sinus squamous cell carcinoma
lignin - derived polyphenolic composition with ammonium molybdate bp - c2
lenalidomide analog kpg - 121
conbercept
comparative anatomy
5 - ht4 agonist tak - 954
locally advanced oropharyngeal squamous cell carcinoma
metastatic sinonasal squamous cell carcinoma
hepcidin mimetic ptg - 300
h2ac1 gene
h2ac1 wt allele
histone h2a type 1 - a
h2ac4 gene
h2ac4 wt allele
h2ac8 gene
andorra
h2ac8 wt allele
histone h2a type 1 - b / e
h2ac6 gene
h2ac6 wt allele
histone h2a type 1 - c
h2ac7 gene
h2ac7 wt allele
histone h2a type 1 - d
h2ac11 gene
h2ac11 wt allele
plevitrexed
angiogram
h2ac13 gene
h2ac13 wt allele
h2ac15 gene
h2ac15 wt allele
h2ac16 gene
h2ac16 wt allele
h2ac17 gene
h2ac17 wt allele
histone h2a type 1
immune effector cell associated neurotoxicity syndrome
digital subtraction angiography
h2ac12 gene
h2ac12 wt allele
histone h2a type 1 - h
h2ac14 gene
h2ac14 wt allele
histone h2a type 1 - j
immune effector encephalopathy  -  ice assessment
virtual technology intervention
h2bc1 gene
h2bc1 wt allele
angola
histone h2b type 1 - a
h2bc3 gene
h2bc3 wt allele
histone h2b type 1 - b
h2bc4 gene
h2bc4 wt allele
h2bc6 gene
h2bc6 wt allele
h2bc7 gene
h2bc7 wt allele
animal husbandry
h2bc8 gene
h2bc8 wt allele
h2bc10 gene
h2bc10 wt allele
histone h2b type 1 - c / e / f / g / i
mesothelin / cd3e tri - specific t - cell activating construct hpn536
anti - psma / cd28 bispecific antibody regn5678
h2bc9 gene
h2bc9 wt allele
histone h2b type 1 - h
anthropology
peritoneal epithelioid mesothelioma
b - cell aplasia
recurrent cutaneous squamous cell carcinoma of the head and neck
resectable cutaneous squamous cell carcinoma of the head and neck
h2bc11 gene
h2bc11 wt allele
histone h2b type 1 - j
h2bc12 gene
h2bc12 wt allele
histone h2b type 1 - k
antibody
h2bc13 gene
h2bc13 wt allele
histone h2b type 1 - l
h2bc14 gene
h2bc14 wt allele
histone h2b type 1 - m
h2bc15 gene
h2bc15 wt allele
histone h2b type 1 - n
h2bc17 gene
anti - idiotype antibody
h2bc17 wt allele
histone h2b type 1 - o
h2ac18 gene
h2ac18 wt allele
h2ac19 gene
h2ac19 wt allele
testicular signet ring stromal tumor
histone h2a type 2 - a
h2ac21 gene
h2ac21 wt allele
avidity
histone h2a type 2 - b
h2ac20 gene
h2ac20 wt allele
non - invasive cribriform carcinoma
histone h2a type 2 - c
h2bc21 gene
h2bc21 wt allele
histone h2b type 2 - e
h2bc18 gene
h2bc18 wt allele
antibody - dependent cellular cytotoxicity
histone h2b type 2 - f
h2aw gene
h2aw wt allele
histone h2a type 3
h2bu1 gene
h2bu1 wt allele
histone h2b type 3 - b
inc demographic and maternal terminology
negative regulation of coagulation
date of neonatal intensive care unit admission
classical leptomeningeal disease finding
nodular leptomeningeal disease finding
malignant brain glioma
drug delivery microdevice
fedratinib hydrochloride
mdm2 inhibitor
who follicular lymphoma histologic grading system
who follicular lymphoma histologic grade 1
who follicular lymphoma histologic grade 2
recombinant interleukin - 14
t - cell surface glycoprotein cd4
who follicular lymphoma histologic grade 3
who follicular lymphoma histologic grade 3a
who follicular lymphoma histologic grade 3b
non - malignant neoplasm
oral examination
asph positive
unresectable meningioma
blasts 60 percent or more of peripheral blood white cells
blasts 60 percent or more of bone marrow nucleated cells
atm proficient tumor
differentiation antigen
ckb positive
hla - c*0802 positive cells present
loss of pms2 expression
loss of msh3 expression
loss of epcam expression
loss of msh6 expression
loss of mlh1 expression
25 - hydroxyvitamin d less than 32 ng / ml
egfr exon 20 tyrosine kinase inhibitor resistant mutation
t ( 4 ; 22 )
t - antigen
avdoralimab
topical cantharidine solution
epcoritamab
egf vaccine egf - pti
asph gene
cdisc protocol study monitoring attribute terminology
cdisc sdtm type 1 diabetes findings about test code terminology
cdisc sdtm type 1 diabetes findings about test name terminology
cdisc send irradiation field orientation / sequence response terminology
antigua and barbuda
cdisc send microbiology test code terminology
cdisc send microbiology test name terminology
botulinum toxin type d
asph wt allele
architecture
asph gene product
aspartyl / asparaginyl beta - hydroxylase
junctin - 1
junctin - 2
junctate
fluorescence intensity unit
mean fluorescence intensity unit
argentina
armenia
aromatase
arteriography
artificial intelligence
recombinant inhibin a
asian american
australia
austria
autoimmune process
autoradiography
award
azerbaijan
bacterial protein
diarylsulfonylurea compound ilx - 295501
bacteriology
bahamas
bahrain
bangladesh
barbados
bcr / abl1 fusion protein
behavior
behavioral medicine
behavioral sciences
belgium
polyvalent melanoma vaccine
belief system
belize
benin
bermuda
beta globulin
bhutan
biochemistry
biomedical material
cdisc questionnaire adsd version 1 .0 test name terminology
cdisc questionnaire adsd version 1 .0 test code terminology
cdisc questionnaire ansd version 1 .0 test name terminology
cdisc questionnaire ansd version 1 .0 test code terminology
cdisc questionnaire gad - 7 version 2 test name terminology
cdisc questionnaire gad - 7 version 2 test code terminology
bioelectric energy sources
cdisc questionnaire gmss version type 1 diabetes test name terminology
cdisc questionnaire gmss version type 1 diabetes test code terminology
cdisc questionnaire hcs test name terminology
cdisc questionnaire hcs test code terminology
cdisc questionnaire parent - dds test name terminology
cdisc questionnaire parent - dds test code terminology
cdisc questionnaire partner - dds test name terminology
cdisc questionnaire partner - dds test code terminology
adsd version 1 .0 questionnaire question
ansd version 1 .0 questionnaire question
cemadotin hydrochloride
biomedical ethics
gad - 7 version 2 questionnaire question
gmss version type 1 diabetes questionnaire question
hcs questionnaire question
parent - dds questionnaire question
partner - dds questionnaire question
serratus plane block
data and safety monitoring plan
gcp adherence statement
safety data monitoring
safety monitoring
bioassay
study monitoring statement
suicidal risk monitoring
action taken with subject
precipitating factor
relationship to device
clinical data interchange standards consortium controlled terminology
medication reference terminology
substance registration system - unique ingredient identifier
carbohydrate to insulin ratio device setting
acid labile subunit measurement
biomarker
anti - neutrophil cytoplasmic igg antibody measurement
angiopoietin 2 measurement
alpha - smooth muscle actin measurement
complement c3a desarg measurement
carnitine excretion rate
citrate excretion rate
cytidine - uridine monophosphate kinase 2 measurement
free cortisol excretion rate
dead box protein 58 measurement
dopamine excretion rate
psychobiology
dilute russell's viper venom time to confirm ratio measurement
estrone sulfate measurement
endomysial antibody measurement
epinephrine excretion rate
epithelial stromal interaction 1 measurement
factor xi measurement
factor xi activity measurement
factor xii measurement
factor xii activity measurement
galactose mutarotase measurement
biological sciences
guanylate binding protein 1 measurement
guanylate binding protein 2 measurement
glomerular filtration rate from creatinine and urea nitrogen adjusted for body surface area measurement
glomerular filtration rate from creatinine ,  urea nitrogen ,  and albumin adjusted for body surface area measurement
growth hormone binding protein measurement
alpha globulin measurement
plasma equivalent glucose measurement
plasma equivalent glucose distribution measurement
glycocholic acid measurement
glutathione s - transferase y1 subunit measurement
biology
hemoglobin a1a measurement
hemoglobin a1b measurement
human epididymis protein 4 measurement
hect domain and rld 5 measurement
5 - hydroxyindoleacetic acid excretion rate
interferon alpha - inducible protein 27 measurement
interferon - induced protein 44 measurement
interferon - induced protein 44 - like measurement
interferon alpha - inducible protein 6 measurement
interferon - induced 56 kda protein measurement
biomechanics
interferon - induced 60 kda protein measurement
ubiquitin - like protein isg15 measurement
kidney injury molecule - 1 excretion rate
lymphocyte antigen 6e measurement
macrophage inflammatory protein 1 measurement
mitochondrial m2 igg antibody measurement
macrophage migration inhibitory factor measurement
monoclonal protein spike excretion rate
metanephrine excretion rate
interferon - induced protein p78 measurement
biostatistics
n - acetyl - beta - d - glucosaminidase to creatinine ratio measurement
n - demethylase measurement
norepinephrine excretion rate
neurokinin a measurement
normetanephrine excretion rate
neurotensin measurement
2 - 5 - oligoadenylate synthase 1 measurement
2 - 5 - oligoadenylate synthase 2 measurement
2 - 5 - oligoadenylate synthase 3 measurement
o - demethylase measurement
biological rhythm
oxalate excretion rate
platelet derived growth factor isoform aa measurement
placental growth factor measurement
phospholipid scramblase 1 measurement
cytomegalovirus - induced gene 5 protein measurement
steroid sulfatase activity measurement
peptide transporter tap1 measurement
translocase inner mitochondrial membrane 10 measurement
tissue polypeptide antigen measurement
free tau protein measurement
biophysics
tpr - ankyrin repeat - containing protein 1 measurement
tripartite motif containing protein 21 measurement
tripartite motif containing protein 38 measurement
tryptophan to creatinine ratio measurement
trypsin measurement
thrombospondin 1 measurement
tissue transglutaminase igg antibody measurement
11 - dehydro - thromboxane b2 excretion rate
urate excretion rate
urea nitrogen excretion rate
bexarotene
biosensors
urothelial cell count
vascular endothelial growth factor c measurement
vasoactive intestinal polypeptide measurement
vanillyl mandelic acid excretion rate
abductor digiti minimi muscle
abductor hallucis muscle
adductor brevis muscle
oblique head of adductor hallucis muscle
transverse head of adductor hallucis muscle
adductor longus muscle
biotechnology
adductor magnus muscle
corrugator supercilii muscle
elbow extensors
elbow flexors
extensor digitorum brevis muscle
extensor hallucis brevis muscle
finger extensors
finger flexors
flexor digitorum brevis muscle
lateral head of gastrocnemius muscle
black or african american
medial head of gastrocnemius muscle
hiv - 2 gp36 antibody measurement
hiv - 2 gp140 antibody measurement
hiv - 1 p31 antibody measurement
hiv - 1 gp160 antibody measurement
hiv - 1 p24 antibody measurement
hiv - 1 gp41 antibody measurement
fusarium proliferatum ige antibody measurement
malassezia species ige antibody measurement
adenovirus igg antibody measurement
blood circulation
adenovirus igm antibody measurement
bordetella pertussis serotype fimbrae 2 / 3 antibody measurement
bordetella pertussis filament haemagglutinin antibody measurement
bordetella pertussis pertactin antibody measurement
bordetella pertussis toxin antibody measurement
corynebacterium diphtheriae toxoid antibody measurement
chlamydia pneumoniae igg antibody measurement
clostridium tetani toxin antibody measurement
hepatitis a virus igg antibody measurement
hiv - 1 / 2 antigen / antibody measurement
coagulation factor
jc virus dna measurement
mumps virus igm antibody measurement
mycoplasma pneumoniae iga antibody measurement
mycoplasma pneumoniae igm antibody measurement
rubella igm antibody measurement
brdu cellular proliferation assay
double immunodiffusion
immuno - positron emission tomography scan
orchidometry
becquerel per gram per kilobecquerel per kilogram
northern blotting
becquerel per milliliter per kilobecquerel per kilogram
hour times becquerel per gram per kilobecquerel per kilogram
hour times becquerel per milliliter per kilobecquerel per kilogram
gigabecquerel / nl
hour times becquerel per gram
hour times becquerel per milliliter
relative size change
products of conception examined indicator
pregnancy end date
trial exploratory objective
southern blotting
percent per second
billion per dose
arithmetic mean fluorescence intensity unit
geometric mean fluorescence intensity unit
milliliter per cubic centimeter per minute
millisecond per millimeter mercury
vector genomes per kilogram
bmi - for - age percentile
height - for - age percentile
weight - for - age percentile
western blotting
weight - for - height percentile
radiation combined injury indicator
irradiation field orientation sequence
a - 230
a - 232
a - 234
abrin
acephate
aldicarb
alpha - conotoxin ac1 .1a
body mass index
alpha - conotoxin cnia
alpha - conotoxin cnib
alpha - conotoxin gi
alpha - conotoxin gia
alpha - conotoxin mi
aminocarb
arsine
azinphos - ethyl
azinphos - methyl
bendiocarb
bolivia ,  plurinational state of
benfuracarb
botulinum toxin type a1
botulinum toxin type a2
botulinum toxin type a3
botulinum toxin type a4
botulinum toxin type a5
botulinum toxin type a6
botulinum toxin type a7
botulinum toxin type a8
botulinum toxin type b1
therapeutic steroid hormone
book
botulinum toxin type b2
botulinum toxin type b3
botulinum toxin type b4
botulinum toxin type b5
botulinum toxin type b6
botulinum toxin type b7
botulinum toxin type b8
botulinum toxin type c1
botulinum toxin type cd
botulinum toxin type dc
bosnia and herzegovina
botulinum toxin type e1
botulinum toxin type e10
botulinum toxin type e11
botulinum toxin type e12
botulinum toxin type e2
botulinum toxin type e3
botulinum toxin type e4
botulinum toxin type e5
botulinum toxin type e6
botulinum toxin type e7
botany
botulinum toxin type e8
botulinum toxin type e9
botulinum toxin type f1
botulinum toxin type f2
botulinum toxin type f3
botulinum toxin type f4
botulinum toxin type f5
botulinum toxin type f6
botulinum toxin type f7
botulinum toxin type f8
botswana
botulinum toxin type h
botulinum toxin type g
bromine
bromophos
butocarboxim
cadusafos
carbofuran
carbophenothion
carbosulfan
chlorethoxyfos
brazil
chloropicrin
chlorpyrifos
chlorpyrifos - methyl
cyanogen chloride
cyanophos
demeton - o
diazinon
dicrotophos
diisopropyl fluorophosphate
dimethoate
british indian ocean territory
dimetilan
diphosgene
disulfoton
clostridium perfringens epsilon toxin
ethiofencarb
ethion
fenamiphos
fenobucarb
fenoxycarb
fonofos
bronchoscopy
formetanate
formothion
formparanate
glufosinate - ammonium
glyphosate
glyphosine
hydrogen sulfide
isazophos
isofenphos
isoprocarb
brunei darussalam
m - cumenyl methylcarbamate
methamidophos
methidathion
methiocarb
methomyl
methyl bromide
methyl isocyanate
methyl parathion
metolcarb
mevinphos
bulgaria
mexacarbate
monocrotophos
omethoate
osmium tetroxide
oxamyl
parathion
phenthoate
phorate
phosgene
phosgene oxime
burkina faso
phosphamidon
phosphine
pirimicarb
potassium cyanide
promecarb
prophenofos
quinalphos
saxitoxin
sodium cyanide
xanthine oxidase inhibitor
myanmar
sodium monofluoroacetate
staphylococcal enterotoxin d
staphylococcal enterotoxin e
sulfotep
sulprofos
t - 2 toxin
terbufos
tetrachlorvinphos
tetraethyl pyrophosphate
burundi
tetramethylenedisulfotetramine
thiofanox
triazophos
2 , 3 , 5 - trimethacarb
xmc
xylylcarb
anteroposterior / posteroanterior sequential radiotherapy
posteroanterior / anteroposterior simultaneous radiotherapy
bilateral sequential radiotherapy
bilateral simultaneous radiotherapy
belarus
aplasia / hypoplasia
apoptosis and single cell necrosis
colloid alteration
decreased colloid
increased colloid
degranulation
decreased enamel
absent follicles
decreased follicles
decreased follicles and absent follicles
cadherin
increased follicles
growth plate partially closed
increased mitotic figures
persistent thyroglossal duct
persistent x - zone
proteinaceous fluid in the aqueous humor
thyroid dysplasia
ultimobranchial cyst
challenge agent characterization domain
corrected minute volume
calcium channel
corrected tidal volume
chinchilla bastard rabbit
himalayan chinchilla bastard rabbit
trypan blue staining method
egfr nm_005228 .2:c .2499g > t
egfr np_005219 .2:p .l833f
device setting
egfr nm_005228 .5:c .2305g > t
calmodulin
egfr np_005219 .2:p .v769l
liposomal alpha galactosylceramide
mental retardation ,  autosomal dominant 40
short - rib thoracic dysplasia 3 with or without polydactyly
spinocerebellar ataxia type 19 / 22
liver surgery patient
targeted therapy agent
central nervous system lesion
mitogen - activated protein kinase
her2 - targeting agent
feasibility
zirconium zr 89 - tak - 164
craniotomy patient
brain lesion
lymphoblasts less than 5 percent of bone marrow nucleated cells
illness intrusiveness ratings scale
illness intrusiveness rating 1
illness intrusiveness rating 2
illness intrusiveness rating 3
calpain
illness intrusiveness rating 4
illness intrusiveness rating 5
illness intrusiveness rating 6
illness intrusiveness rating 7
btk - targeting agent
how much does illness and / or treatment interfere with health
how much does illness and / or treatment interfere with diet
how much does illness and / or treatment interfere with work
how much does illness and / or treatment interfere with active recreation
how much does illness and / or treatment interfere with passive recreation
cambodia
how much does illness and / or treatment interfere with financial situation
how much does illness and / or treatment interfere with relationship with spouse
how much does illness and / or treatment interfere with sex life
how much does illness and / or treatment interfere with family relations
how much does illness and / or treatment interfere with other social relations
how much does illness and / or treatment interfere with self - expression or self - improvement
how much does illness and / or treatment interfere with religious expression
how much does illness and / or treatment interfere with community and civic involvement
active recreation
passive recreation
cameroon
flt - 3 - targeting agent
reproductive concerns after cancer
afraid won't be able to have  ( more )  children
worried about passing on genetic risk for cancer to children
worry about telling spouse or partner may be unable to have children
scared of not being around to take care of children someday
can accept if i am unable to have  ( more )  children
overwhelmed by thought of trying to get pregnant
concerned that spouse or partner will be disappointed if can't get pregnant
worried about ability to get pregnant
carbon c - 14
canada
worried about how family history might affect children's health
will be happy with life whether or not i have  ( more )  children someday
having  ( more )  children will make me more nervous about getting cancer again
worry that getting pregnant would take too much time and effort
am cautious about having  ( more )  children because might not be around to raise them
stressful to think about trying to get pregnant
will feel content if do not have  ( more )  children
fluorine f 18 - alf - cys - variant 3 ph low insertion peptides
thought of telling spouse or partner that i may be unable to have children makes me uncomfortable
concerned may not be able to have  ( more )  children
afraid children would have high chance of getting cancer
asthma daytime symptom diary v1 .0 questionnaire
asthma nighttime symptom diary v1 .0 questionnaire
generalized anxiety disorder  -  7 version 2 questionnaire
the glucose monitoring satisfaction survey version: type 1 diabetes questionnaire
hypoglycemic confidence scale questionnaire
diabetes distress scale for parents of teens with type 1 diabetes questionnaire
diabetes distress scale for partners of adults with type 1 diabetes questionnaire
adsd version 1 .0  -  rate breathing at its worst
adsd version 1 .0  -  rate wheezing at its worst
cape verde
adsd version 1 .0  -  rate shortness of breath at worst
adsd version 1 .0  -  rate chest tightness at its worst
adsd version 1 .0  -  rate chest pain at its worst
adsd version 1 .0  -  rate cough at its worst
adsd version 1 .0  -  total score
ansd version 1 .0  -  rate breathing at its worst
ansd version 1 .0  -  rate wheezing at its worst
ansd version 1 .0  -  rate shortness of breath at worst
ansd version 1 .0  -  rate chest tightness at its worst
ansd version 1 .0  -  rate chest pain at its worst
capsid protein
ansd version 1 .0  -  rate cough at its worst
ansd version 1 .0  -  total score
gad - 7 version 2  -  feeling nervous anxious or on edge
gad - 7 version 2  -  not able to stop or control worrying
gad - 7 version 2  -  worrying too much about things
gad - 7 version 2  -  trouble relaxing
gad - 7 version 2  -  being restless hard to sit still
gad - 7 version 2  -  becoming easily annoyed or irritable
gad - 7 version 2  -  feel afraid if something awful happen
gad - 7 version 2  -  total score
carcinoembryonic antigen - related cell adhesion molecule 5
gmss version type 1 diabetes  -  more satisfied with my diabetes
gmss version type 1 diabetes  -  think about diabetes more
gmss version type 1 diabetes  -  takes too much time to use
gmss version type 1 diabetes  -  doesn't seem as accurate
gmss version type 1 diabetes  -  makes me worry a lot
gmss version type 1 diabetes  -  is too much of a hassle to use
gmss version type 1 diabetes  -  gives me numbers i don't trust
gmss version type 1 diabetes  -  feel less restricted by diabetes
gmss version type 1 diabetes  -  more frustrated with my diabetes
gmss version type 1 diabetes  -  be more spontaneous in my life
cardiovascular physiology
gmss version type 1 diabetes  -  too many skin irritations / bruises
gmss version type 1 diabetes  -  gives me results don't make sense
gmss version type 1 diabetes  -  feel more down and depressed
gmss version type 1 diabetes  -  more open to new experiences
gmss version type 1 diabetes  -  is too painful to use
gmss version type 1 diabetes  -  subscale: openness
gmss version type 1 diabetes  -  subscale: emotional burden
gmss version type 1 diabetes  -  subscale: behavioral burden
gmss version type 1 diabetes  -  subscale: trust
gmss version type 1 diabetes  -  total scale
transport protein
hcs  -  when you are exercising
hcs  -  when you are sleeping
hcs  -  when you are driving
hcs  -  when you are in social situations
hcs  -  when you are alone
hcs  -  avoid serious problems
hcs  -  catch before sugars get too low
hcs  -  continue to do things really want
hcs  -  your ability to avoid problems
hcs  -  mean hcs score
catechol o - methyltransferase
parent - dds  -  don't work well together
parent - dds  -  unappreciated for ways i help
parent - dds  -  trust teen take care of diabetes
parent - dds  -  low blood sugars away from home
parent - dds  -  teen ignore or forget diabetes
parent - dds  -  taking too much of my energy
parent - dds  -  help teen is a battle
parent - dds  -  low blood sugars when sleeping
parent - dds  -  no one notices diabetes hard on me
parent - dds  -  doesn't do enough manage diabetes
cathepsin d
parent - dds  -  teen doesn't have right doctor
parent - dds  -  blame me if not well - controlled
parent - dds  -  leave home and cannot protect him
parent - dds  -  teen ignores my suggestions
parent - dds  -  lack support from friends and family
parent - dds  -  doesn't get expert medical help
parent - dds  -  motivate teen take care diabetes
parent - dds  -  teen not prepared once adult
parent - dds  -  only one takes responsibility
parent - dds  -  my nagging hurting relationship
cathepsin
parent - dds  -  total dds score: sum
parent - dds  -  total dds score: mean
parent - dds  -  total dds score: moderate
parent - dds  -  personal distress: sum
parent - dds  -  personal distress: mean
parent - dds  -  personal distress: moderate
parent - dds  -  teen management distress: sum
parent - dds  -  teen management distress: mean
parent - dds  -  teen management distress: moderate
parent - dds  -  parent / teen relationship distress: sum
iodine i - 131
etiology
parent - dds  -  parent / teen relationship distress: mean
parent - dds  -  parent / teen relationship distress: moderate
parent - dds  -  healthcare team distress: sum
parent - dds  -  healthcare team distress: mean
parent - dds  -  healthcare team distress: moderate
partner - dds  -  worry about low blood sugars
partner - dds  -  how involved managing diabetes
partner - dds  -  partner shuts me out
partner - dds  -  partner doesn't try hard enough
partner - dds  -  overwhelmed by constant demands
cayman islands
partner - dds  -  how to best help partner manage
partner - dds  -  silent about my partner's diabetes
partner - dds  -  taking too much of my energy
partner - dds  -  no one notices diabetes hard on me
partner - dds  -  more i try the worse things get
partner - dds  -  guilty not doing enough to help
partner - dds  -  can't get partner improve attitude
partner - dds  -  failing to help partner manage
partner - dds  -  help my partner always a battle
partner - dds  -  partner ignores my suggestions
cell adhesion
partner - dds  -  diabetes often interrupts plans
partner - dds  -  low blood sugars when sleeping
partner - dds  -  partner driving low blood sugars
partner - dds  -  leaving alone low blood sugars
partner - dds  -  not working well together
partner - dds  -  never get a break from worrying
partner - dds  -  total dds score: sum
partner - dds  -  total dds score: mean
partner - dds  -  total dds score: moderate
partner - dds  -  partner diabetes management: sum
cell adhesion molecule
partner - dds  -  partner diabetes management: mean
partner - dds  -  partner diabetes manage: moderate
partner - dds  -  how best to help: sum
partner - dds  -  how best to help: mean
partner - dds  -  how best to help: moderate
partner - dds  -  diabetes and me: sum
partner - dds  -  diabetes and me: mean
partner - dds  -  diabetes and me: moderate
partner - dds  -  hypoglycemia: sum
partner - dds  -  hypoglycemia: mean
cell aging
partner - dds  -  hypoglycemia: moderate
fact - c version 4  -  physical subscale score
fact - c version 4  -  social / family subscale score
fact - c version 4  -  emotional subscale score
fact - c version 4  -  functional subscale score
fact - c version 4  -  additional concern subscale score
fact - c version 4  -  total score
facit - fatigue 13 - item version 4  -  fatigue subscale score
gds - sf  -  total score
gds  -  total score
intercellular communication process
anti - ccr4 monoclonal antibody
anti - il - 6 monoclonal antibody
egfr - targeting agent
vegfr - targeting agent
advanced bladder urothelial carcinoma
advanced ureter urothelial carcinoma
locally advanced pituitary gland carcinoma
metastatic pituitary gland carcinoma
locally advanced parathyroid gland carcinoma
unresectable pituitary gland carcinoma
cell culture
refractory small cell glioblastoma
recurrent small cell glioblastoma
refractory gliosarcoma
advanced urethral urothelial carcinoma
advanced thyroid gland medullary carcinoma
metastatic renal pelvis carcinoma
advanced renal pelvis carcinoma
metastatic digestive system mixed adenoneuroendocrine carcinoma
prmt5 inhibitor
cell cycle process
death certificate
smoking status not documented
bodimetrics performance monitor
unresectable thyroid gland medullary carcinoma
neuroendocrine carcinoma of unknown primary
anti - psma / cd3 bispecific antibody jnj - 63898081
anti - cd47 monoclonal antibody tjc4
dna plasmid - encoding interleukin - 12 ino - 9012 / psa / psma dna plasmids ino - 5150 formulation ino - 5151
mismatched related donor
cell death process
prmt5 inhibitor jnj - 64619178
anti - egfr monoclonal antibody hlx - 07
montreal cognitive assessment ,  version 8 .1
montreal cognitive assessment ,  version 8 .2
montreal cognitive assessment ,  version 8 .3
cdk1 inhibitor bey1107
hybrid selected genomic library
affinity enriched genomic library
poly - t enriched genomic library
randomly selected genomic library
cell differentiation process
rrna depleted genomic library
mirna size fractionated genomic library
anti - pd - l1 monoclonal antibody a167
ebv immortalized lymphocytes
foslinanib disodium
total rna
bisthianostat
thoracoscopic biopsy
ccr4 - targeting agent
ckit - targeting agent
indium in - 111
cell division
c - met - targeting agent
anti - c - met monoclonal antibody
anti - cd30 monoclonal antibody
colonic mucosa
mediastinal soft tissue
cd30 - targeting agent
nasal soft tissue
periorbital soft tissue
cd38 - targeting agent
bone marrow sample
cell fusion
bone marrow - derived fibroblasts
bone marrow - derived mononuclear cells
advanced adenoid cystic carcinoma
unresectable adenoid cystic carcinoma
solid tissue specimen
blood cancer - derived bone marrow specimen
minority health
blood cancer - derived bone marrow specimen ,  post - treatment
minority health research
minority health populations
cell growth
health disparity
first patient visit date
first treatment date
initial genomic sequencing date
sample procurement date
biospecimen data supplement
health disparity outcomes
health disparity research
clincal data supplement
health disparity populations
cell line
blood cancer - derived blood specimen
blood cancer - derived blood specimen ,  post - treatment
tumor - adjacent normal specimen
tumor - adjacent normal post neoadjuvant therapy sample
cd20 - targeting agent
fgfr - targeting agent
anti - pdgfr monoclonal antibody
pdgfr - targeting agent
limb skeletal system
indefinite dysplasia
cell motility
dysplasia negative
metastasis negative
ovarian capsule intact
ovarian capsule ruptured
ovarian capsule fragmented
vascular invasion negative
skin of the lower extremity
skin of the upper extremity
tab - separated value format
cell physiology
excel open xml format
methylation beta value
aligned sequence read
unaligned sequence read
vinegar soaks
smoke exposure
fire smoke exposure
accidental fire smoke exposure
cell sorting
coal smoke exposure
cooking - related smoke exposure
electronic cigarette smoke exposure
burning oil smoke exposure
indoor stove or fireplace smoke exposure
burning wood smoke exposure
accidental building fire smoke exposure
accidental grass fire smoke exposure
accidental forest fire smoke exposure
accidental vehicle fire smoke exposure
cell survival
metastatic dedifferentiated liposarcoma
locally advanced dedifferentiated liposarcoma
aircraft smoke exposure
locally advanced malignant peripheral nerve sheath tumor
burning tree smoke exposure
locally advanced alveolar soft part sarcoma
electrical fire smoke exposure
unresectable alveolar soft part sarcoma
smoking at diagnosis
centers for disease control and prevention
locally advanced ewing sarcoma
factory smokestack smoke exposure
field burning smoke exposure
furnace or boiler smoke exposure
propane smoke exposue
grease fire smoke exposure
grilling smoke exposure
hashish smoke exposure
coal - burining indoor stove or fireplace smoke exposure
wood - burning indoor stove or fireplace smoke exposure
central african republic
machine smoke exposure
marijuana smoke exposure
no smoke exposure
kerosene smoke exposure
recreational fire smoke exposure
smokehouse smoke exposure
embolization therapy patient
cigar smoke exposure
cigarette smoke exposure
tobacco pipe smoke exposure
yttrium y - 90
centrifugation
volcanic smoke exposure
burning waste smoke exposure
wood - burning factory smoke exposure
work - related smoke exposure
occupational artificial smoke machine smoke exposure
occupational fire fighting smoke exposure
occupational foundry smoke exposure
occupational generator smoke exposure
sexual adjustment and body image scale for gynecologic cancer
how satisfied with physical attractiveness after gynecologic cancer
density gradient centrifugation
how comfortable with showing your body after gynecologic cancer
how comfortable with changes in your body after gynecologic cancer
how has gynecologic cancer affected your desire for sexual contact
how has gynecologic cancer affected your sexual relationships
how has gynecologic cancer affected how often you initiate sexual contact
occupational military smoke exposure
occupational paint baking smoke exposure
how has gynecologic cancer affected your sexual satisfaction when you have sex
occupational plastics factory smoke exposure
occupational plumbing smoke exposure
chad
occupational soldering / welding smoke exposure
time between waking and first smoke  -  within 5 minutes
not at all satisfied
not at all comfortable
time between waking and first smoke  -  between 6 and 30 minutes
time between waking and first smoke  -  between 31 and 60 minutes
time between waking and first smoke  -  after 60 minutes
somewhat comfortable
moderately comfortable
chemical engineering
very comfortable
extremely comfortable
decreased
substantially decreased
no effect
increased
substantially increased
very much worsened
very much improved
chemistry
ipsc - derived cd16 - expressing natural killer cells ft516
genitourinary system carcinoma
mepitel film
advanced genitourinary system carcinoma
micropapillary carcinoma
hodgkin's sarcoma
cedazuridine
dennd2b gene product
suppression of tumorigenicity 5 protein isoform 2
suppression of tumorigenicity 5 protein isoform 3
analytical chemistry
ccn family protein
miltenyi biotec
psa level greater than or equal to 0 .7
osteogenesis imperfecta type xix
intellectual developmental disorder with cardiac arrhythmia
retinal dystrophy with or without extraocular anomalies
fumarate hydratase - deficient renal cell carcinoma
surgical complication
post - surgical complication
locally advanced renal pelvis and ureter urothelial carcinoma
bioinorganic chemistry
unresectable renal pelvis and ureter urothelial carcinoma
chemotherapy - induced alopecia
therapeutic growth hormone
white light endoscopy
hyperspectral endoscopy
vaping status
current vaper
microwave tissue processing
abl1 protein variant
clinical chemistry
abl1 np_005148 .2:p .a34v
alk np_004295 .2:p .f1245i
alk nm_004304 .4:c .3733t > a
apc protein variant
apc np_000029 .2:p .d917y
biopsy patient
lumpectomy patient
b2m gene mutation
b2m nm_004048 .3:c .2t > g
b2m protein variant
inorganic chemistry
b2m np_004039 .1:p .m1r
bcor final exon internal tandem duplication
braf np_004324 .2:p .v504_r506dup
braf np_004324 .2:p .a320v
abdominal neoplasm ,  excluding pancreas neoplasm
aggressive prostate adenocarcinoma
prostate adenocarcinoma by ajcc v7 stage
decerebrate posture
decorticate posture
awaken
organic chemistry
prescreen
janssen pharmaceuticals
testosterone greater than or equal to 125 ng / dl
nrg1 gene fusion positive
loss of sdh expression
loss of fh expression
activating fgfr2 gene mutation
activating fgfr1 gene mutation
head and neck sarcoma
folate receptor family negative
technetium tc - 99m
medicinal chemistry
cyp3a5 polymorphism positive
cyp3a4 polymorphism positive
epstein - barr virus reactivation
percent free prostate - specific antigen less than 25
elevated lif
biphenotypic sinonasal sarcoma
brd4 gene translocation
pax3 gene rearrangement
brd3 gene translocation
mycn gene translocation
physical chemistry
ptgs2 c . - 765g / c polymorphism profile
multi - mode kinase inhibitor eoc317
tumor resection
recurrent pyogenic cholangitis
advanced pancreatic ductal adenocarcinoma
child individual
anti - gfral monoclonal antibody ngm120
kras - mapk signaling pathway inhibitor jab - 3312
breast measurement
chemotactic process
renal function
cushing triad
current reformed smoker within 1 year
current daily vaper
spastic paraplegia 47
nemaline myopathy 4
achromatopsia 5
menin - mll interaction inhibitor ko 539
hereditary colon carcinoma
identified by
child
nsclc - specific marrow infiltrating lymphocytes
imaging patient
radiation therapy patient
mri patient
pet / ct patient
avatar
refractory clear cell renal cell carcinoma
chemical attenuation
ultraviolet irradiation attenuation
child abuse and neglect
cross - linked chemical connection points
nucleotide polymer
structural repeat unit
repeat unit
metastatic malignant pecoma
advanced malignant pecoma
locally advanced unresectable malignant pecoma
warty carcinoma
differentiated intraepithelial neoplasia
child psychiatry
human papillomavirus - negative squamous cell carcinoma
sinonasal exophytic papilloma
infiltrating urothelial carcinoma ,  sarcomatoid variant
adenoma ,  intestinal - type
neuroendocrine and non - neuroendocrine neoplastic components present
mixed neuroendocrine non - neuroendocrine neoplasm
nasal cavity papilloma
benign gynecologic care patient
ccnd3 nm_001760 .4:c .766_776del11
ccnd3 protein variant
developmental psychology ,  child
ccnd3 np_001751 .1:p .r256fs*64
cd74 gene mutation
cd74 protein variant
cd74 np_001020329 .1:p .p98s
cdc73 nm_024529 .4:c .1a > g
cdc73 protein variant
cdc73 np_078805 .3:p .m1v
cdkn2a nm_000077 .4:c .305c > t
cdkn2a np_000068 .1:p .a102v
chile
cdkn2a np_000068 .1:p .r80x
csf1r protein variant
csf1r nm_005211 .3:c .1085a > g
csf1r np_005202 .2:p .h362r
csf1r np_005202 .2:p .n648s
csf3r protein variant
csf3r np_758519 .1:p .g751a
nutrition education
cancer vision goggles
ctnnb1 protein variant
china
ctnnb1 nm_001098209 .2:c .121a > g
ctnnb1 np_001091679 .1:p .t41a
laryngeal posterior commissure
ddr2 protein variant
ddr2 np_001014796 .1:p .r742w
clinical trial auditor
clinical trial executive officer
dicer1 protein variant
dicer1 nm_177438 .2:c .5438a > g
dicer1 np_803187 .1:p .e1813d
chloramphenicol o - acetyltransferase
dicer1 np_803187 .1:p .y1225x
dnmt3a protein variant
dnmt3a nm_022552 .4:c .2711c > t
u .s . postal service
dnmt3a np_072046 .2:p .p904l
dpyd gene mutation
dpyd nm_000110 .3:c .1627a > g
dpyd protein variant
dpyd np_000101 .2:p .i543v
wheelchair bed transfer
pneumococcal polyvalent vaccine
endoscopic retrograde cholangiopancreatography
walk on level surface
propel wheelchair
independent for feeding
needs help with transfer
needs help for toilet use
needs help to walk on level surface
independent walking on level surface
needs help to propel wheelchair
independent  to propel wheelchair
needs help controlling bowels
chromatography
needs help controlling bladder
independent for controlling bladder
unresectable malignant peripheral nerve sheath tumor
nf1 - associated malignant peripheral nerve sheath tumor
sporadic malignant peripheral nerve sheath tumor
interstitial lung disease
radiation - induced malignant peripheral nerve sheath tumor
aryl hydrocarbon receptor antagonist bay2416964
adverse event grade description
adverse event dose
affinity chromatography
adverse event term
adverse event agent name
drug name
surgical site
case identifier
body temperature measurement
concurrent disease type
case report form identifier
date of first dose
date of last dose
gel filtration chromatography
modified ecog performance status
respiratory pattern
sample identifier
nsaid total dose
steroid total dose
treatment data
veterinary medical center
patient identifier
age of enrollment
date of diagnosis
high performance liquid chromatography
date of evaluation
surgical finding
date of last nsaid administration
date of last steroid administration
did not meet eligibility criteria
informed consent process deviation
failure to follow trial randomization
failure to discontinue treatment
study procedure deviation
study agent deviation
liquid chromatography
concomitant medication used was not permitted per protocol
lab ,  imaging ,  or other investigation deviation
failure to report serious adverse event within defined timeframe
patient did not have a safety follow up as required
baseline assessments are out of window
disease outcome or response
study device deviation
biospecimen sub - domain
experiment sub - domain
imaging sub - domain
chromogranin
molecular biology sub - domain
statistical analysis sub - domain
protocol element
material storage
product transport
patient note
report generation
specimen relocation
process protocol
change summary
chromosome banding
payment method
amino acid physical location
amino acid sequence feature
authoring device
biologic entity classification
ct imaging acquisition protocol element
ct imaging reconstruction protocol element
cytoband range
defined eligibility criterion answer
gene mapping
defined product transport
defined progress count
device parameter value
document version representation
experimental activity item
experimental factor
experimental factor value
general statistical consideration
genetic reference sequence
imaging acquisition protocol element
clinical informatics
imaging process protocol element
imaging reconstruction protocol element
insured person
magnetic resonance imaging acquisition protocol element
magnetic resonance imaging reconstruction protocol element
molecular biomarker group
molecular sequence
nucleic acid physical location
nucleic acid sequence feature
observation result action taken relationship
attenuated corynebacterium granulosum
clinical medicine
organization staff role
performed activity relationship
performed diagnosis procedure relationship
performed encounter
performed genetic observation
performed genetic observation result
performed histopathology result
performed imaging study
performed material process step
performed material storage
cell clone
performed medical record abstraction
performed patient note
performed product supply
performed progress count
performed report generation
performed specimen move
pet imaging acquisition protocol element
planned experimental unit allocation result
planned study subject
product relationship
cloning
project conduct
project relationship
relevant regulation for clinical trial regulation
research staff specialty
sample size consideration
specimen collection group
specimen collection protocol
statistical analysis plan version modification summary
statistical analysis plan version status
study country personnel
gene cloning
study site recruitment status
study site relationship
study subject registration center
subject payment method
substance extraction administration relationship
supplemental statistical analysis plan version
transplant donor registry
accepted indicator
acquisition type code
cloudman s91 malignant melanoma
action mode code
active date range
additional qualifier
additional qualifier code
adjustable indicator
admitting diagnosis code
agent administration care setting type code
algorithm code
aliquot in same container indicator
allele indicator code
cocos  ( keeling )  islands
analysis method code
applicable indicator
approach anatomic site directionality code
arterial spin labeling contrast code
assembly source
assembly version
barrier distance quantity
biosafety level code
birth state code
blinded substance name
cognition
bottom thickness quantity
build number text
cardiac synchronization technique code
ce mark indicator
cessation pause quantity range
characteristic behavior code
characteristic modified indicator
checkpoint code
classification code
clinical stage descriptor code
collagen
code modified text
common name
completion date
complex image component code
computed ethnicity code
computed ethnicity source code
condition status change reason
condition status code
confidential indicator
consents waived indicator
collagen iv
convolution kernel group code
corresponding author indicator
count type detail code
created date
ctdi phantom type code
data collection location diameter
date range validation code
death date estimated indicator
delayed registry posting indicator
derivation method code
colombia
derived ethnicity origin code
derived indicator
dicom series count
dicom study identifier
diffusion b value
diffusion directionality code
dimension one capacity
dimension one label
dimension point of origin
dimension three capacity
dimethyl ether
colonoscopy
dimension three label
dimension two capacity
dimension two label
directionality code
disease status missing reason code
donor type code
echo - planar pulse sequence indicator
end chromosome arm
end chromosome band
end coordinate
colposcopy
ethnic surname or origin code
evaluator alias
expanded access indicator
expected handling condition code
expected resubmission date
expected use date range
expiration date
exploratory indicator
exposure modulation type code
first in human indicator
communication
first in human risk factor code
from position dimension one
from position dimension three
from position dimension two
function type code
funding category code
gantry detector tilt
gender identity code
genetic location
genetic location of interest
community
genetic region of interest
genetic region type code
genetic sequence database
genetic subregion
genetic target
identifier code
identifier embedded indicator
identifier location code
identifier reader type code
identifier type code
community health center
image count
image type code
imaging accession identifier
informed consent indicator
interruptible indicator
intervention type code
inversion recovery indicator
irb approval number text
join code
last follow - up date
community health education
laterality code
lesion identifier text
license effective date range
license key
license type code
lossy image compression indicator
medical statement
missing identifier reason code
multiple spin echo indicator
mutation type code
community health nursing
nci program code
non - acquisition modalities in study code
non - host organism indicator
number of supply days
number text
occurrence date range validation code
order date
order identifier
order urgency code
ordered number of repeats
comorbidity
origin cell name
participating location code
passage number
pathologic stage descriptor code
pause quantity range
pediatric formulation indicator
phase contrast indicator
planned investigational exposure quotient
planned site number range
portion code
comoros
present at admission code
primary anatomic site code
primary purpose type code
primary role indicator
principal indicator
product dose description
pulse sequence name
purpose code
quantity range
radionuclide code
complement
received date
reconstruction diameter
reconstruction field of view height
reconstruction field of view width
reconstruction interval
relation code
repeat frequency range max code
repeat frequency range min code
repeat quantity range
required indicator
ancestim
computer graphics
resonant nucleus code
respiratory motion technique code
result code
revision reason code
saturation recovery indicator
scientific name code
separable indicator
sequence identifier
seriousness code
sex genotype code
computer modeling
sexual orientation code
short title
single collimation width
source age
source anatomic site code
source developmental stage
source identifier
source tissue type code
source type code
specimen available for dna extraction indicator
computer system
specimen retention indicator
spectrally selected suppression code
spin - echo pulse sequence category code
spiral pitch factor
standard time indicator
start chromosome arm
start chromosome band
start coordinate
status code
steady state pulse sequence code
storage sop classes in study
strain comment
strain stock identifier
study agent randomization fraction
body height
subject history
substance unknown indicator
synonym code
table speed
target anatomic site portion code
computer
target biomarker code
taxonomy identifier code
taxonomy rank code
temperature capability range
temperature range
therapeutic area code
time of flight contrast indicator
time point code
timing description
to position dimension one
conception
to position dimension three
to position dimension two
total collimation width
transition description
treatment vehicle quantity
unplanned treatment indicator
value code modified text
value negation indicator
value type code
variance reason code
confidentiality
dynamic susceptibility contrast - perfusion - weighted imaging
endorotor
user
electronic nicotine delivery system user
puffing topography monitor
reference sequence read depth
alternative sequence read depth
sequence read count
anti - alpha bcma / anti - alpha cd3 t - cell engaging bispecific antibody tnb - 383b
pharmacogenomics read depth
congo
pharmacogenomics alternative sequence read depth
pharmacogenomics reference sequence read depth
pharmacogenomics read count
pharmacogenomics copy number
single nucleotide variant
warsaw breakage syndrome
inflammatory bowel disease 28
fanconi anemia ,  complementation group l
hypofractionated image - guided radiation therapy
human acellular dermal matrix
consent form
cook islands
trastuzumab
costa rica
costs
cost / benefit analysis
creatine kinase b - type
croatia
cryopreservation
cuba
culture
protein kinase a
alvac - cea vaccine
cyprus
cysteine proteinase
cystoscopy
cytochemistry
cytochrome p450
cytochrome p450 2e1
cytochrome
cytogenetics
keratin ,  type i cytoskeletal 19
cytokinesis
cytological procedure
cytology
cytoskeletal protein
data source
demographics
denmark
dentistry
deoxycytidine kinase
deoxyribonuclease
peldesine
dermatology
developmental biology
diagnostic imaging
digestion
animal model of disease
susceptibility
djibouti
dna damage
dna methyltransferase
dna nucleotidylexotransferase
motexafin lutetium
dna polymerase alpha
dna polymerase delta
dna - directed dna polymerase
dna repair
dna replication
restriction endonuclease
dna topoisomerase 1
anti - cd20 / anti - cd3 bispecific igm antibody igm2323
pancreaticoduodenectomy patient
food diary
standard diet
dna helicase
high - protein nutritional supplement
unresectable liver and intrahepatic bile duct carcinoma
unresectable ampulla of vater carcinoma
unresectable periampullary adenocarcinoma
unresectable head and neck carcinoma
unresectable nasopharyngeal carcinoma
anal sphincter
endorectal tumor resection
hand assisted laparoscopic radical nephrectomy
dna binding protein
laparoscopic biopsy
laparoscopic partial nephrectomy
laparoscopic radical nephrectomy
laparoscopic radical prostatectomy with robotics
laparoscopic radical prostatectomy
chemotherapy recipient
open partial nephrectomy
open radical nephrectomy
open radical prostatectomy
conventional radiotherapy
dominica
soft tissue sarcoma of the trunk and extremities
trunk and extremities
combination radiotherapy
epitrochlear region
stem cell therapy
vestibule of mouth
biochemical evidence of disease
biochemical evidence of disease without structural correlate
complete response unconfirmed
cdk4 / 6 inhibitor fcn - 437
marimastat
dominican republic
medically treated reflux
digestible starch
mixed response
flaxseed lignan
no palliative benefit
persistent distant metastasis
responsive disease
hyperprogression
radiographic progressive disease
treatment ongoing
transcriptional repression
data custodian
analysis metadata
cell culture image
copy number estimate
run metadata
slide image
experiment metadata
eastern cooperative oncology group - american college of radiology imaging network cancer center group
diagnostic slide
genotyping array
drug abuse
low - pass whole genome sequencing
low - coverage whole genome sequencing
dna methylation array
tissue slide
nuclear staining method
inframe deletion
inframe insertion
mature mirna variant
near diploidy
test value reported indicator
drug resistance process
conversion mutation
partial dna methylation
raw sequencing data
expression negative
conductive chemohyperthermia system
foundation stock service
treatment assignment code
treatment assignment description
aurora a kinase inhibitor ly3295668 erbumine
psa level greater than zero
recurrent diffuse large b - cell lymphoma ,  not otherwise specified
refractory diffuse large b - cell lymphoma ,  not otherwise specified
brd4 / nutm1 fusion negative
strata immune signature positive
nutm1 gene translocation
nutm1 positive
reduced was protein expression
sit - stand workstation
t ( 17 ; 19 )
testosterone less than 100 ng / dl
echocardiography
pca3 score greater than 35
decipher bladder cancer assay
metastatic malignant mesothelioma
recurrent neuroendocrine carcinoma
flt3 inhibitor hm43239
upper aerodigestive invasive malignancy
antigen - presenting cells - expressing hpv16 e6 / e7 sqz - pbmc - hpv
cellosaurus disease terminology
docetaxel formulation ckd - 810
ecology
primary peritoneal endometrioid adenocarcinoma
solid pseudopapillary neoplasm of the ovary
recurrent high grade ovarian serous adenocarcinoma
docetaxel polymeric micelles
recurrent fallopian tube endometrioid adenocarcinoma
pi3k - delta inhibitor shc014748m
recurrent high grade fallopian tube serous adenocarcinoma
recurrent primary peritoneal high grade serous adenocarcinoma
recurrent primary peritoneal endometrioid adenocarcinoma
medical economics
anti - pd - l1 monoclonal antibody hlx20
gallium ga 68 - thp - psma
xiaoai jiedu decoction
concentrated lingzhi mushroom extract
anti - trbc1 - car - cd3zeta - 4 - 1bb - rqr8 - expressing autologous t - lymphocyte cells auto4
lymphodepletion therapy
pediatric terminologies
pyloroplasty
insulin - producing
glucagon - producing
ecuador
astatine at 211 anti - cd38 monoclonal antibody okt10 - b10
walking school bus program
recurrent endometrial dedifferentiated carcinoma
recurrent endometrial squamous cell carcinoma
recurrent endometrial transitional cell carcinoma
recurrent moderate - severe chronic graft versus host disease
refractory endometrial dedifferentiated carcinoma
refractory endometrial squamous cell carcinoma
refractory endometrial transitional cell carcinoma
refractory endometrial adenocarcinoma
education
refractory endometrial mucinous adenocarcinoma
recurrent endometrial mucinous adenocarcinoma
multi - epitope her2 peptide vaccine h2nvac
resectable liver and intrahepatic bile duct carcinoma
computed tomography dose index
very high risk myelodysplastic syndrome
recurrent very high risk myelodysplastic syndrome
refractory very high risk myelodysplastic syndrome
refractory endometrial undifferentiated carcinoma
advanced gastric carcinoma
biricodar dicitrate
egypt
advanced merkel cell carcinoma
american english coonhound
american hairless terrier
american leopard hound
appenzeller sennenhunde
australian kelpie
australian stumpy tail cattle dog
azawakh
barbet
basset fauve de bretagne
ejaculation
bavarian mountain scent hound
beauceron
belgian laekenois
bergamasco sheepdog
berger picard
biewer terrier
bluetick coonhound
boerboel
bohemian shepherd
bolognese
el salvador
boykin spaniel
bracco italiano
braque du bourbonnais
braque francais pyrenean
broholmer
cane corso
carolina dog
caucasian shepherd dog
central asian shepherd dog
cesky terrier
electromagnetic field
cirneco dell'etna
coton de tulear
croatian sheepdog
czechoslovakian vlcak
danish - swedish farmdog
deutscher wachtelhund
dogo argentino
drentsche patrijshond
drever
electron spin resonance spectroscopy
dutch shepherd
entlebucher mountain dog
estrela mountain dog
eurasier
finnish lapphund
french spaniel
german longhaired pointer
german spitz
grand basset griffon vendeen
hamiltonstovare
beta radiation
hanoverian scenthound
hokkaido
hovawart
icelandic sheepdog
irish red and white setter
jagdterrier
japanese spitz
jindo
kai ken
kishu ken
electrophoresis
kromfohrlander
lagotto romagnolo
lancashire heeler
lapponian herder
leonberger
manchester terrier
miniature american shepherd
mountain cur
mudi
nederlandse kooikerhondje
agarose gel electrophoresis
norwegian buhund
norwegian lundehund
parson russell terrier
perro de presa canario
peruvian inca orchid
plott hound
porcelaine
portuguese podengo
portuguese pointer
two dimensional gel electrophoresis
portuguese sheepdog
portuguese podengo pequeno
pudelpointer
pumi
pyrenean mastiff
pyrenean shepherd
rafeiro do alentejo
rat terrier
redbone coonhound
romanian mioritic shepherd dog
polyacrylamide gel electrophoresis
russian toy
russian tsvetnaya bolonka
schapendoes
segugio italiano
shikoku
sloughi
slovensky cuvac
slovensky kopov
small munsterlander pointer
solvakian wirehaired pointer
multivitamin
electrophysiology
spanish mastiff
spanish water dog
stabyhoun
swedish lapphund
swedish vallhund
taiwan dog
teddy roosevelt terrier
thai ridgeback
tibetan mastiff
tornjak
embryo transfer
tosa
transylvanian hound
treeing tennessee brindle coonhound
treeing walker coonhound
wirehaired vizsla
working kelpie
xoloitzcuintli
yakutian laika
chinook
norrbottenspets
embryology
er alpha proteolysis - targeting chimera protein degrader arv - 471
modified radiation - induced skin reaction assessment scale
muc1 with truncated o - glycans - positive neoplastic cells present
have tenderness ,  discomfort ,  or pain of skin in treatment area
does skin in treatment area itch
have burning sensation of skin in treatment area
extent to which skin reaction and symptoms affect day to day activities
dry desquamation
moist desquamation
less than twenty five percent
endocrinology
between twenty five and fifty percent
between fifty and seventy five percent
greater than seventy five percent
autologous tn - muc1 - specific car t - lymphocytes
autologous gamma - globing16d / sh rna734 gene - transduced cd34 - positive cells csl200
autologous cd123car - cd28 - cd3zeta - egfrt - expressing t lymphocytes mb - 102
rad51 inhibitor cyt - 0851
rsv fusion protein inhibitor jnj - 53718678
specimen toothpick
tissue on cap
endocytotic process
tissue in tube
rna in tube
indexed sequencing
index sequence
single - indexed sequencing
dual - indexed sequencing
advanced lung neuroendocrine neoplasm
metastatic pancreatic neuroendocrine neoplasm
advanced pancreatic neuroendocrine neoplasm
unresectable clear cell renal cell carcinoma
endoscope
refractory pancreatic ductal adenocarcinoma
icdc terminology
advanced pancreatic carcinoma
unresectable well differentiated neuroendocrine neoplasm
unresectable lung neuroendocrine neoplasm
unresectable digestive system neuroendocrine neoplasm
unresectable pancreatic neuroendocrine neoplasm
oncolytic newcastle disease virus medi5395
advanced ovarian carcinoma
checkbox
endoscopic procedure
courier
dusky pink erythema
dull red erythema
brilliant red erythema
deep red - purple erythema
skin verrucous carcinoma
skin squamous cell carcinoma with osteoclast - like giant cells
skin lymphoepithelioma - like carcinoma
skin squamous cell carcinoma with sarcomatoid differentiation
colorectal serrated polyposis
energy metabolism process
hereditary colorectal cancer syndrome
locally advanced oral cavity squamous cell carcinoma
locally advanced laryngeal squamous cell carcinoma
locally advanced squamous cell carcinoma of unknown primary
arsenical keratosis
arsenic exposure
puva keratosis
psoralen and ultraviolet a  ( puva )  therapy exposure
pictilisib
engineering
geneticist
genetic counselor
genetic counseling student
non - fdg - positron emission tomography
transthyretin amyloid cardiomyopathy
lichen planus - like keratosis
laid off
looking for work
raising children full - time or keeping house
hereditary transthyretin amyloid cardiomyopathy
engineering psychology
flt3 np_004110 .2:p .i836x
unresectable triple - negative breast carcinoma
allogeneic crispr - cas9 engineered anti - cd19 car t cells ctx110
icdc breeds terminology
spitz melanoma
pigmented epithelioid melanocytoma
melanin - pigmented epithelioid cells present
hmg - coa reductase inhibitor
entomology
spinocerebellar ataxia ,  autosomal recessive ,  with axonal neuropathy 2
aicardi - goutieres syndrome 1
pencil beam scanning
cdh1 pathogenic or likely pathogenic gene mutation
reserve cell hyperplasia
liposomal topotecan ff - 10850
reproductive endocrinologist
autologous anti - bcma - car - 4 - 1bb - cd3zeta - expressing t - cells ct053
neoantigen peptide vaccine
psa decline greater than or equal to 50 percent
environment
psa level less than or equal to 0 .2
psa decline greater than or equal to 25 percent
sinonasal tract and oral cavity
cisplatin - induced tinnitus
neoantigen - based therapeutic cancer vaccine grt - c903
neoantigen - based therapeutic cancer vaccine grt - r904
icdc fss breeds
icdc akc breeds
icdc misc breeds
microbiome ser - 401
environmental exposure
icdc mixed breed
mixture of melanocytic neoplastic components present
bap1 - inactivated skin melanocytic neoplasm
combined bap1 - inactivated nevus
bap1 - inactivated melanocytoma
fluorine f 18 c - snat4
familial partial lipodystrophy type 2
keratography
combined nevus
elisa
coronary slow flow phenomenon
gabriele - de vries syndrome
spontaneous coronary artery dissection
renpenning syndrome
unresectable acral lentiginous melanoma
unresectable mucosal melanoma
metastatic non - small cell carcinoma
neoantigen - positive
shared neoantigen - positive
enzyme
patient - specific neoantigen - positive
neoantigen - positive malignant solid neoplasm
neuropsychological assessment
moisturizing cream wo2085
patient - specific neoantigen - positive malignant solid neoplasm
shared neoantigen - positive malignant solid neoplasm
anti - hiv - 1 lentiviral vector - expressing sh5 / c46 cal - 1
alpha - gal agi - 134
bcr - abl / kit / akt / erk inhibitor hqp1351
epidemiological method
serd shr9549
anti - cd19 car t - cells xlcart001
carnosine / hibiscus - based oral mucoadhesive tablet
lrp5 / 6 antagonist bi 905677
gallium ga 68 - psma - 617
alvocidib prodrug tp - 1287
alkotinib
epidiferphane
samarium sm 153 - dotmp
gallium ga 68 fapi - 46
epidemiology
locally advanced laryngeal carcinoma
locally advanced pharyngeal carcinoma
locally advanced lip and oral cavity carcinoma
locally advanced paranasal sinus carcinoma
ercc2 protein variant
ercc2 np_000391 .1:p .f332v
sting agonist sb 11285
pan - mutation - selective egfr inhibitor cln - 081
pten protein variant
equatorial guinea
pten nm_000314 .7:c .388c > g
pten np_000305 .3:p .r130g
pten nm_000314 .7:c .389g > t
pten np_000305 .3:p .r130l
pten nm_000314 .7:c .389g > c
pten np_000305 .3:p .r130p
pten nm_000314 .7:c .389g > a
pten np_000305 .3:p .r130q
tp53 nm_000546 .5:c .523c > t
tp53 np_000537 .3:p .r175c
eritrea
tp53 nm_000546 .5:c .817c > a
tp53 np_000537 .3:p .r273s
refractory acute graft versus host disease
anti - cd3 / cd7 - ricin toxin a immunotoxin
extra - abdominal lymph node
destination
morcellation
pooled sample
anti - muc17 / cd3 bite antibody amg 199
muc17 gene
erythropoiesis
muc17 wt allele
mucin - 17
muc17 positive
chronic disease
q - space trajectory imaging
tritium beta radiation
dilated cardiomyopathy - 1a
williams - beuren region duplication syndrome
anti - cd205 antibody - drug conjugate obt076
biopsy of soft tissue
rhenium re 186
esophagoscopy
tumor panel sequencing
fimaporfin
fbxw7 nm_033632 .3:c .1394g > a
fbxw7 protein variant
fbxw7 np_361014 .1:p .r465h
cd11b agonist gb1275
avelumab / axitinib regimen
refractory differentiated thyroid gland carcinoma
refractory thyroid gland papillary carcinoma
refractory thyroid gland follicular carcinoma
esterase
refractory thyroid gland hurthle cell carcinoma
recurrent differentiated thyroid gland carcinoma
glutaminase inhibitor ipn60090
main daily activities or responsibilities
bone marrow failure syndrome
percent tumor cell nuclei
percent immune cell nuclei
percent stromal cell nuclei
percent necrotic surface area
oral mucosal deterging and dental prophylaxis
estonia
localized vibration therapy
therapeutic cancer vaccine atp128
bone void
bone lucency
psa level greater than or equal to 0 .5
g protein - coupled estrogen receptor agonist lns8801
proximal stomach
proximal gastric adenocarcinoma
traceit tissue spacer implantation
ethiopia
metastatic proximal gastric adenocarcinoma
localized malignant pancreatic neoplasm
celiac plexus radiosurgery
cdisc define - xml terminology
cdisc define - xml adam basic data structure subclass terminology
cdisc define - xml adam integrated basic data structure subclass terminology
time - to - event dataset
pooled mutant kras - targeted long peptide vaccine
irradiated allogeneic human lung cancer cells expressing ox40l - ig vaccine hs - 130
ethnic group
cdisc protocol study oversight entity attribute terminology
cdisc protocol outcome measure attribute terminology
cdisc protocol oversight entity value set terminology
cdisc sdtm severity response terminology
cdisc adam pool for integration terminology
retroperitoneal pain syndrome
microbiome - derived peptide vaccine eo2401
indium in 111 - dota - h11b6
aloe vera / chamomile / thyme topical cream
antisecretory factor - enriched egg yolk powder supplement
evolution
gallium - based bone resorption inhibitor ap - 002
body mass index less than or equal to 30
immuno - oncology therapy
membership
gym membership
sting agonist imsa101
anti - bcma / anti - cd3 bispecific antibody regn5459
anti - globo h / mmae antibody - drug conjugate obi 999
skin with high degree of cumulative sun damage
high - csd melanoma
excision repair
nail matrix
allogeneic cs1 - specific universal car - expressing t - lymphocytes ucartcs1a
nail matrix nevus
cic - dux4 sarcoma
autologous cryopreserved cell infusion
cic - dux4l sarcoma
polymer - conjugated il - 15 receptor agonist nktr - 255
ewsr1 gene rearrangement
cic gene rearrangement
exercise
cic / dux4l fusion gene
ewsr1 - negative small round cell tumor
cic / dux4l fusion protein
aicardi - goutieres syndrome 2
myoclonic - atonic epilepsy
relapsing - remitting multiple sclerosis
immediate - release bupropion
charged slide
uncharged slide
multi - spin echo
exocytosis
orientation
selected suppression
integrated
defined
anti - garp monoclonal antibody abbv - 151
lilotomab
shared decision making questionnaire
doctor made clear that a decision needs to be made
doctor wanted to know exactly how i want to be involved in making decision
doctor told me that there are different options for treating medical condition
dna exonuclease
doctor precisely explained advantages and disadvantages of treatment options
doctor helped me understand all information
doctor asked which treatment option i prefer
doctor and i thoroughly weighed different treatment options
doctor and i selected treatment option together
doctor and i reached agreement on how to proceed
allogeneic cd22 - specific universal car - expressing t - lymphocytes ucart22
fgfr1 protein variant
metastatic breast adenocarcinoma
locally advanced breast adenocarcinoma
opiate
coagulation factor vii
advanced breast adenocarcinoma
locally advanced hypopharyngeal squamous cell carcinoma
refractory bladder urothelial carcinoma
refractory breast adenocarcinoma
atypical vascular lesion
revised olweus bully / victim questionnaire
diagnostic infant and preschool assessment
finnegan neonatal abstinence score tool
alabama parenting questionnaire
promis peer relationships
coagulation factor viii
child and youth resilience measure
child behavior checklist for ages 6 - 18
child behavior checklist for ages 1 .5 - 5
achenbach system of empirically based assessment - adult self - report and adult behavior checklist
achenbach system of empirically based assessment adult self report
achenbach system of empirically based assessment adult behavior checklist
infiltrating bladder mixed carcinoma
psa level 0 .5 to ten
conners kiddie continuous performance test ,  2nd edition
home observation for measurement of the environment ,  revised edition
von willebrand factor
bcl6 gene mutation
ly75 gene
lattice stereotactic body radiation therapy
mixed carcinoma
ly75 wt allele
lymphocyte antigen 75
ly75 positive
myeloblasts 10 percent or more of peripheral blood white cells
del ( 17p13 .1 )
faroe islands
zrsr2 gene nonsense mutation
mixed malignant epithelial cell population
zrsr2 gene frameshift mutation
psa level less than or equal to one hundred
refractory skin squamous cell carcinoma
recurrent metastatic skin squamous cell carcinoma
locally recurrent skin squamous cell carcinoma
locally advanced merkel cell carcinoma
recurrent metastatic merkel cell carcinoma
fatty acid synthase
locally recurrent merkel cell carcinoma
refractory merkel cell carcinoma
refractory neuroendocrine carcinoma
hormone receptor negative breast carcinoma
hormone receptor negative
refractory renal cell carcinoma
zotatifin
cdk8 / 19 inhibitor sel 120
sting agonist gsk3745417
tumor location unknown
ingestive behavior
autologous cd34 - positive peripheral blood stem cells
fgfr1 nm_023110 .2:c .1966a > g
fgfr1 np_075598 .2:p .k656e
fgfr4 nm_002011 .5:c .1162g > a
diffuse large b - cell lymphoma with associated monoclonal small b - cell population in bone marrow
fgfr4 protein variant
fgfr4 np_002002 .3:p .g388r
flt3 np_004110 .2:p .y589d
hdac1 gene mutation
hdac1 protein variant
female
hdac1 np_004955 .2:p .y303h
hdac2 protein variant
hdac2 np_001518 .3:p .e455fs*7
hsp90b1 protein variant
hsp90b1 gene mutation
hsp90b1 np_003290 .1:p .i66t
resectable lung non - small cell carcinoma
molecular pathologist
bioinformatician
ferritin
master protocol
vascular endothelial growth factor receptor measurement
bruton's tyrosine kinase measurement
insulin - like growth factor binding protein measurement
anti - cd19 - car - cd28 / cd20 - car - 4 - 1bb - expressing autologous t - lymphocytes hu1928 - hu20bb
cold cap therapy
menin - mll interaction inhibitor sndx - 5613
second primary squamous cell carcinoma of the head and neck
egfr / egfrviii inhibitor wsd0922 - fu
allogeneic anti - bcma car - transduced t - cells allo - 715
fertility
advanced leiomyosarcoma
advanced undifferentiated pleomorphic sarcoma
transformed mycosis fungoides
recurrent transformed mycosis fungoides
refractory transformed mycosis fungoides
female cousin
foster brother
recurrent transformed t - cell non - hodgkin lymphoma
fertilization
foster daughter
refractory transformed t - cell non - hodgkin lymphoma
foster father
foster mother
foster sister
foster son
fraternal twin brother
fraternal twin sister
great nephew
recurrent mature b - cell non - hodgkin lymphoma
warfarin sodium
in vitro fertilization
fibronectin
fiji
background treatment
basket protocol
co - packaged product
cross - labeled product
end - point assessment medicinal product
cdisc general observation class
non - confirmatory result
platform protocol
filtration
real - world data
real - world evidence
regenerative medicine advanced therapy designation
regenerative medical therapy
remote clinical trial
rescue medications
single - entity product
software as a medical device
special purpose domain
standards development organization
finland
study data standardization plan
data traceability
umbrella protocol
alpelisib / fulvestrant regimen
anti - b7 - h3 car t - cells
monomer deletion site
great niece
great grandchild
identical twin brother
identical twin sister
flow cytometry
male cousin
maternal first cousin once removed
paternal first cousin once removed
maternal great aunt
maternal great uncle
paternal great aunt
paternal great uncle
overall pooled data
outcome measure time frame
fluorescence
outcome measure title
outcome measure type
study oversight entity approval date
study oversight entity approval status
study oversight entity type
independent safety monitor
observational study monitoring committee
safety monitoring committee
anterotemporal
periventricular
fluorophotometry
subcortical
supplemental qualifiers for morphology
maximum bolus device setting
observation study epoch
fda study data technical conformance guide v4 .3
bermuda grass pollen ige antibody rast score measurement
birch pollen ige antibody rast score measurement
cat dander ige antibody rast score measurement
german cockroach ige antibody rast score measurement
dermatophagoides farinae ige antibody rast score measurement
fluoroscopy
dermatophagoides pteronyssinus ige antibody rast score measurement
white elm pollen ige antibody measurement
white elm pollen ige antibody rast score measurement
orchard grass pollen ige antibody rast score measurement
olive tree pollen ige antibody measurement
olive tree pollen ige antibody rast score measurement
white oak pollen ige antibody rast score measurement
english plantain pollen ige antibody rast score measurement
russian thistle pollen ige antibody measurement
russian thistle pollen ige antibody rast score measurement
food microbiology
timothy grass pollen ige antibody rast score measurement
western ragweed pollen ige antibody rast score measurement
wild rye pollen ige antibody measurement
wild rye pollen ige antibody rast score measurement
dermatophagoides farinae antigen igg4 antibody measurement
johnson grass pollen igg4 antibody measurement
dermatophagoides pteronyssinus antigen igg4 antibody measurement
bermuda grass pollen igg antibody rast score measurement
birch pollen igg antibody rast score measurement
silver birch pollen igg antibody rast score measurement
melengestrol
food industry
orchard grass pollen igg antibody rast score measurement
english plantain pollen igg antibody rast score measurement
timothy grass pollen igg antibody rast score measurement
western ragweed pollen igg antibody rast score measurement
tree mix pollen igg antibody rast score measurement
grass mix pollen igg antibody rast score measurement
weed mix pollen igg antibody rast score measurement
mold mix igg antibody rast score measurement
animal mix igg antibody rast score measurement
industrial mix igg antibody rast score measurement
forensic medicine
bee mix igg antibody rast score measurement
dairy mix igg antibody rast score measurement
shellfish mix igg antibody rast score measurement
nut mix igg antibody rast score measurement
cat dander igg antibody rast score measurement
dog dander igg antibody rast score measurement
dermatophagoides farinae igg antibody rast score measurement
dermatophagoides pteronyssinus igg antibody rast score measurement
american cockroach igg antibody rast score measurement
german cockroach igg antibody rast score measurement
france
white elm pollen igg antibody rast score measurement
silver birch pollen ige antibody rast score measurement
mixed antigen ige antibody rast score measurement
tree mix pollen ige antibody rast score measurement
grass mix pollen ige antibody rast score measurement
weed mix pollen ige antibody rast score measurement
mold mix ige antibody rast score measurement
animal mix ige antibody rast score measurement
industrial mix ige antibody rast score measurement
bee mix ige antibody rast score measurement
french guiana
shellfish mix ige antibody rast score measurement
nut mix ige antibody rast score measurement
dog dander ige antibody rast score measurement
american cockroach ige antibody rast score measurement
arachis hypogaea ige antibody rast score measurement
triticum aestivum ige antibody rast score measurement
glycine max ige antibody rast score measurement
zea mays ige antibody rast score measurement
cow milk protein ige antibody rast score measurement
egg white ige antibody rast score measurement
french polynesia
boxelder pollen ige antibody rast score measurement
common ragweed pollen ige antibody rast score measurement
alkaline phosphatase excretion rate
axl receptor tyrosine kinase measurement
free bruton's tyrosine kinase measurement
collagen iii neo - peptide c3m measurement
cannabinoid metabolite measurement
chemokine  ( c - c motif )  ligand 13 measurement
chemokine  ( c - c motif )  ligand 16 measurement
chemokine  ( c - c motif )  ligand 23 measurement
fucosyltransferase
chemokine  ( c - c motif )  ligand 25 measurement
chemokine  ( c - c motif )  ligand 8 measurement
cd27 expressing cell count
carboxypeptidase b2 measurement
chemokine  ( c - x - c motif )  ligand 12 measurement
chemokine  ( c - x - c motif )  ligand 7 measurement
chemokine  ( c - x - c motif )  ligand 9 measurement
dickkopf wnt signaling path inhibitor 1 measurement
pseudo - eosinophil count
pseudo - eosinophils to leukocyte ratio measurement
gabon
fas cell surface death receptor measurement
galactose - deficient iga1 measurement
gamma glutamyl transferase excretion rate
granulin measurement
progranulin measurement
human anti - human antibody measurement
helicase mov - 10 protein measurement
heparin measurement
intercellular adhesion molecule 3 measurement
insulin - like growth factor binding protein 7 measurement
galactosyltransferase
interleukin 1 receptor type 2 measurement
soluble kidney injury molecule - 1 measurement
lactate dehydrogenase excretion rate
leucine rich alpha - 2 - glycoprotein 1 measurement
metarubricyte to leukocyte ratio measurement
n - acetyl - beta - d - glucosaminidase excretion rate
neutrophil - activating peptide 2 measurement
neuropilin - 1 measurement
platelet - granulocyte aggregate measurement
pro - c6 measurement
the gambia
receptor advanced glycation endproducts measurement
phosphorylated 40s ribosomal protein s6 measurement
serum amyloid a1 measurement
sh2 domain containing 1a protein measurement
somatostatin receptor type 2 measurement
transforming growth factor alpha measurement
transforming growth factor beta 2 measurement
transforming growth factor beta 3 measurement
tissue inhibitor of metalloproteinase 3 measurement
tnf superfamily member 10 measurement
gametogenesis
tnf superfamily member 12 measurement
tnf receptor 1b measurement
soluble vascular endothelial growth factor receptor type 1 measurement
soluble vascular endothelial growth factor receptor type 2 measurement
soluble vascular endothelial growth factor receptor type 3 measurement
vitronectin measurement
abductor digiti minimi muscle of the hand
abductor pollicis brevis muscle
flexor hallucis brevis muscle
hymenal ring
anti - hiv agent
gamma camera
paraspinal region
procerus muscle
wrist joint extensor muscles
wrist joint flexor muscles
norovirus genogroup ii .4 igg antibody measurement
norovirus genogroup ii .4 iga antibody measurement
norovirus genogroup ii .4 igm antibody measurement
vibrio cholerae ,  vibrio parahaemolyticus ,  and / or vibrio vulnificus dna measurement
shigella and / or enteroinvasive escherichia coli ipah dna measurement
gamma globulin
sapovirus genogroups i ,  ii ,  iv ,  and / or v rna measurement
norovirus genogroup i and / or ii rna measurement
enterotoxigenic escherichia coli lta ,  st1a ,  and / or st1b dna measurement
enteropathogenic escherichia coli eae dna measurement
enteroaggregative escherichia coli paa plasmid aggr and / or aata dna measurement
campylobacter coli ,  campylobacter jejuni and / or campylobacter upsaliensis dna measurement
human astrovirus 1 ,  2 ,  3 ,  4 ,  5 ,  6 ,  7 ,  and / or 8 rna measurement
human adenovirus 40 and / or human adenovirus 41 dna measurement
mucor racemosus igg antibody rast score measurement
aspergillus fumigatus igg antibody rast score measurement
gamma - glutamylcysteine synthetase
penicillium notatum igg antibody rast score measurement
alternaria alternata igg antibody rast score measurement
mucor racemosus ige antibody rast score measurement
aspergillus fumigatus ige antibody rast score measurement
penicillium notatum ige antibody rast score measurement
alternaria alternata ige antibody rast score measurement
cladosporium herbarum ige antibody rast score measurement
penicillium chrysogenum ige antibody rast score measurement
aspergillus antibody measurement
cyclospora cayetanensis dna measurement
gastroenterology
coccidioides immitis antibody measurement
coccidioides igg antibody measurement
coccidioides igm antibody measurement
cryptosporidium dna measurement
cryptosporidium antigen measurement
epstein - barr dna measurement
entamoeba histolytica dna measurement
escherichia coli o157 dna measurement
giardia lamblia dna measurement
hepatitis b virus core antigen measurement
gastroscopy
hepatitis b virus nucleic acid measurement
hepatitis c virus nucleic acid measurement
hepatitis e virus antigen measurement
hiv - 1 antibody and hiv - 1 p24 antigen measurement
hiv - 2 antibody and hiv - 1 p24 antigen measurement
hiv - 2 rna measurement
lactobacillus crispatus dna measurement
mycoplasma genitalium measurement
mycoplasma pneumophila igg antibody measurement
mycoplasma pneumophila igm antibody measurement
gene amplification
norwalk virus rna measurement
norovirus genogroup ii rna measurement
norovirus genogroup i rna measurement
plesiomonas shigelloides dna measurement
rotavirus a rna measurement
salmonella enterica and / or salmonella bongori dna measurement
schistosoma mansoni antibody measurement
toxoplasma gondii igg and / or igm antibody measurement
vibrio cholerae dna measurement
yersinia enterocolitica dna measurement
gene deletion
automated capillary electrophoresis western blot
chromogenic assay
cystometry
digital polymerase chain reaction
droplet digital pcr
electrical impedance myography
mouse protection assay
multiplexed digital gene expression analysis
non - invasive dielectric sensing
polygraphy
genetic duplication process
sickle cell solubility test
norovirus genogroup ii .4
forkhead box protein p3 measurement
granzyme b measurement
screening not completed
percent recovered to last nonzero concentration
hour times nanogram equivalents per milliliter
hour times nanogram equivalents per milliliter per milligram equivalents
hour times picogram equivalents per milliliter
hour times picogram equivalents per milliliter per milligram equivalents
gene expression
hour times microgram equivalents per milliliter
hour times microgram equivalents per milliliter per milligram equivalents
nanogram equivalents per gram
nanogram equivalents per milliliter per milligram equivalents
picogram equivalents per gram
picogram equivalents per milliliter
picogram equivalents per milliliter per milligram equivalents
microgram equivalents per gram
microgram equivalents per milliliter per milligram equivalents
digital wide field fundus photography
likert scale 7 - point
numerical rating scale 6 - point
biological father of subject's child
biological mother of subject's child
agglutinated specimen
ten thousand colony forming units per liter
ten million colony forming units per liter
degrees per second
degrees squared
gram per unit
nucleic acid synthesis inhibitor
env protein
milliliter per second per square meter
steps per minute
microvolts squared
cage observation
increased bone remodeling
hypospermatogenesis
lymph node intrasinusoidal erythrocytes
decreased secretion
increased secretion
increased tingible body macrophages
gene rearrangement
test article percent purity
sinus sigmoideus
maternal half sibling
paternal half sibling
biological parent
biological niece
step parent
step child
step sibling
stepbrother
gene
oligometastatic esophageal adenocarcinoma
oligometastatic gastric adenocarcinoma
protein tyrosine kinase 2 inhibitor in10018
stepdaughter
stepsister
stepson
great grandparent
maternal great grandparent
paternal great grandparent
adoptive parent
env
adopted child
adopted daughter
adopted son
adoptive father
adoptive mother
rsk1 - 4 inhibitor pmd - 026
engineered mobilized peripheral blood - derived donor graft ogft - 001
anti - cd47 / cd19 bispecific monoclonal antibody tg - 1801
pan - kras inhibitor bi 1701963
anti - ctla - 4 monoclonal antibody adg116
gag gene
anti - cd20 monoclonal antibody mil62
macrocycle - bridged sting agonist e7766
recurrent myeloproliferative neoplasm
recurrent myelodysplastic / myeloproliferative neoplasm
acute oxaliplatin - induced peripheral neuropathy measure
sensitivity to touching cold items
discomfort swallowing cold liquids
have throat discomfort
have muscle cramps
difficulty buttoning shirt or tying shoelaces
homeobox gene
experience other side effects from chemotherapy treatment
lymphedema of the head and neck
severe congenital neutropenia
autosomal recessive severe congenital neutropenia
trier social stress test
autosomal dominant severe congenital neutropenia
resectable glioblastoma
complete disagreement
jak2 np_004963 .1:p .g996r
jak2 nm_004972 .3:c .2047a > g
mhc class ii gene
jak2 np_004963 .1:p .r683g
jak3 protein variant
jak3 np_000206 .2:p .l857p
bilateral pelvic lymph node dissection
kit np_000213 .1:p .s590i
treatment - related mortality
map2k2 protein variant
map2k2 nm_030662 .3:c .383c > t
map2k2 np_109587 .1:p .p128l
copper cu 64 nota - psmai - peg - cy5 .5 - c' dots
mhc class i gene
non - metastatic esophageal carcinoma
non - recurrent esophageal carcinoma
non - recurrent lung carcinoma
fermented soybean extract
large pleural effusion
recurrent large pleural effusion
baloxavir marboxil
neurotoxic chemotherapy
localized anaplastic large cell lymphoma
pol gene
advanced anaplastic large cell lymphoma
metastatic primary malignant central nervous system neoplasm
locally advanced primary malignant central nervous system neoplasm
cdisc questionnaire fact - cog version 3 test name terminology
cdisc questionnaire fact - cog version 3 test code terminology
cdisc questionnaire wpai - gh version 2 test name terminology
cdisc questionnaire wpai - gh version 2 test code terminology
cdisc functional test hd - cab test name terminology
cdisc functional test hd - cab test code terminology
cdisc functional test rfwt version 1 test name terminology
tat gene
cdisc functional test rfwt version 1 test code terminology
fact - cog version 3 questionnaire question
wpai - gh version 2 questionnaire question
hd - cab functional test question
rfwt version 1 functional test question
adopted brother
adopted sister
male sibling of adopted child
female sibling of adopted child
agent unit of measure
indinavir sulfate
viral gene
adverse event severity grade
percent of glass in analysis area
percent pigmented tumor in analysis area
percent stroma in analysis area
percent tumor in analysis area
area of analysis
chemotherapeutic cycle end date
chemotherapeutic cycle start date
chemotherapeutic cycle number
cohort description
genetic engineering
cohort dose
do not own smartphone or tablet
have concerns about data privacy or security with the app
do not want to download apps to personal smartphone or tablet for the trial
do not have wi - fi and / or have concerns with having reliable internet connection
have concerns about data usage and / or no data plan
uncomfortable and / or unfamiliar with technology
have difficulties using smartphones or tablets
date of best response
date of disease progression
genetic marker
date off treatment
treatment cycle day number
fluorine f 18 - bms - 986229
enrollment document number
complete lymph node dissection
evaluation code
evaluation sequence number
follow - up type of contact
normal or tumor sample pathology indicator
genetic technique
histopathology - cytopathology indicator
lesion description
lesion site
medication acutal unit of measure
missed dose unit of measure
medication course number
medication vial identifier
middle initial
non - tumor tissue area
total sample tissue area
genetics
tumor tissue area
number of prior regimens
number of prior regimens of nsaid
number of prior regimens of steroids
patient status
percent stromal tissue
percent tumor tissue
physical examination comment
prior nsaid exposure indicator
prior steroid exposure indicator
behavioral genetics
prior therapy type
study conduct date range
actual dose of medication
date of missed dose
change since last physical exam
advanced gastric adenocarcinoma
advanced esophageal adenocarcinoma
advanced colorectal adenocarcinoma
anti - cd3 / anti - gucy2c bispecific antibody pf - 07062119
dose unit of measure
biochemical genetics
adverse event attributed to commercial product
adverse event attributed to disease
adverse event attributed to investigational new drug
adverse event attributed to other cause
adverse event attributed to research
histologic confirmation date
institutional animal care and use committee approval date
unknown status reason
how was the extent of disease measured
missed medication dose name
medical genetics
necropsy sample
nonresponsive therapy type
program external url
program full description
program name
program short description
reason off treatment
short site name
huntington's disease cognitive assessment battery functional test
rockport one mile walk test version 1 .0 functional test
population genetics
fact - cog version 3  -  i have trouble forming thoughts
fact - cog version 3  -  my thinking has been slow
fact - cog version 3  -  i have had trouble concentrating
fact - cog version 3  -  trouble finding familiar place
fact - cog version 3  -  trouble remember where put things
fact - cog version 3  -  trouble remembering new info
fact - cog version 3  -  trouble recalling name of object
fact - cog version 3  -  trouble finding right words
fact - cog version 3  -  used wrong word when refer object
fact - cog version 3  -  trouble saying what i mean
genome
fact - cog version 3  -  walked into a room and forgotten
fact - cog version 3  -  work hard to pay attention
fact - cog version 3  -  forgotten names after introduced
fact - cog version 3  -  reaction everyday situations slow
fact - cog version 3  -  work harder than usual to track
fact - cog version 3  -  my thinking slower than usual
fact - cog version 3  -  work harder than usual to express
fact - cog version 3  -  use written lists more often
fact - cog version 3  -  trouble keeping track interrupted
fact - cog version 3  -  trouble shifting back and forth
antineoplastic vaccine
human genome
fact - cog version 3  -  told me trouble remembering info
fact - cog version 3  -  told me trouble speaking clearly
fact - cog version 3  -  told me trouble thinking clearly
fact - cog version 3  -  people told me i seemed confused
fact - cog version 3  -  i have been able to concentrate
fact - cog version 3  -  able to bring to mind words
fact - cog version 3  -  able remember things where left
fact - cog version 3  -  able remember to do things
fact - cog version 3  -  able to pay attention without effort
fact - cog version 3  -  mind is as sharp as always been
genotype
fact - cog version 3  -  memory is as good as always been
fact - cog version 3  -  able to shift between activities
fact - cog version 3  -  able to track what i am doing
fact - cog version 3  -  been upset about these problems
fact - cog version 3  -  problems interfered ability work
fact - cog version 3  -  problems interfered ability enjoy
fact - cog version 3  -  problems interfered quality life
fact - cog version 3  -  cognitive impairments score
fact - cog version 3  -  comments from others score
fact - cog version 3  -  cognitive abilities score
geographic area
fact - cog version 3  -  impact on quality of life score
wpai - gh version 2  -  currently employed
wpai - gh version 2  -  hours miss work health problems
wpai - gh version 2  -  hours miss work other reason
wpai - gh version 2  -  hours actually work
wpai - gh version 2  -  problems affect productivity
wpai - gh version 2  -  problems affect daily activities
wpai - gh version 2  -  absenteeism score
wpai - gh version 2  -  presenteeism score
wpai - gh version 2  -  work productivity loss score
geography
wpai - gh version 2  -  activity impairment score
hd - cab  -  paced tapping
hd - cab  -  emotion recognition
hd - cab  -  one touch stockings of cambridge
hd - cab  -  symbol digit modalities test
hd - cab  -  hopkins verbal learning test revised
hd - cab  -  trail making test - b
hd - cab  -  hd - cab total score
rfwt version 1  -  time to complete one mile walk
fact - c version 4  -  trial outcome index score
georgia  ( republic )
fact - c version 4  -  fact - g total score
facit - f version 4  -  physical subscale score
facit - f version 4  -  social / family subscale score
facit - f version 4  -  emotional subscale score
facit - f version 4  -  functional subscale score
facit - f version 4  -  additional concern subscale score
facit - f version 4  -  trial outcome index score
facit - f version 4  -  fact - g total score
facit - f version 4  -  total score
wpai:shp v2 .0  -  absenteeism score
geriatrics
wpai:shp v2 .0  -  presenteeism score
wpai:shp v2 .0  -  work productivity loss score
wpai:shp v2 .0  -  activity impairment score
procedure history
musculoskeletal neoplasm
non - neoplastic musculoskeletal disorder
benign musculoskeletal neoplasm
malignant musculoskeletal neoplasm
offer
lapatinib / temozolomide regimen
germany
crosslinking process
cisplatin / epirubicin / paclitaxel regimen
tlr7 agonist lhc165
creatinine clearance formula
jelliffe equation for creatinine clearance
sanaka equation for creatinine clearance
cockcroft - gault formula utilizing adjusted body weight
cockcroft - gault formula utilizing ideal body weight
cockcroft - gault formula utilizing total body weight
confederated icdc property terminology
canine glioma project property terminology
icdc property terminology
precinct property terminology
il - 12sc ,  il - 15sushi ,  ifna and gm - csf mrna - based immunotherapeutic agent sar441000
anti - cd38 monoclonal antibody sar442085
synthetic plumbagin pcur - 101
met np_000236 .2:p .q1276l
met nm_000245 .3:c .3708t > a
gibraltar
met np_000236 .2:p .k324m
mtor nm_004958 .4:c .5664c > g
mtor nm_004958 .4:c .5664c > a
mtor nm_004958 .4:c .5662t > c
mtor protein variant
mtor np_004949 .1:p .g1954r
mtor np_004949 .1:p .f1888l
parsaclisib hydrochloride
regimen used to treat malignant skin neoplasm
atezolizumab / carboplatin / nab - paclitaxel regimen
kiribati
cxbladder
specimen identifier
sub - specimen identifier
fedratinib regimen
vismodegib regimen
uniformly - labeled  [ 13c ] glutamine
sinonasal mucosal melanoma
recombinant interferon - alpha inducible protein 10
glucose - 6 - phosphate 1 - dehydrogenase
inclusive
uniformly - labeled  [ 13c ] lactate
uniformly - labeled  [ 13c ] fructose
cemiplimab regimen
mucosal nodular melanoma
cyclin gene mutation
chromosome arm 19q loss of heterozygosity
anti - trop2 antibody - drug conjugate skb264
glutathione s - transferase
kras g12c inhibitor ly3499446
ncstn gene mutation
ncstn protein variant
ncstn np_056146 .1:p .a572g
metastatic rhabdomyosarcoma
locally advanced rhabdomyosarcoma
pancreatobiliary system
calcium release - activated channel inhibitor cm4620
pancreatobiliary carcinoma
glycoprotein
pozelimab
protein glycosylation
peginterferon lambda - 1a
grant
greece
greenland
grenada
tissue growth
embryogenesis
dersimelagon
trapoxin
gtpase
guadeloupe
guam
guanylate cyclase
danoprevir sodium
guatemala
guinea
guinea - bissau
guyana
gynecology
oncogene h - ras
tyrphostin a30
haiti
disabled population
piclidenoson
harding - passey malignant melanoma
health behavior
health education
medicare
health care provider
health physics
health policy
cevidoplenib
health status
rg 14620
hearing
heat shock protein beta - 1
heat shock protein
hematology
hematopoietic process
heme protein
hemoglobin
canonical hmg protein
becaplermin
histological procedure
histology
histone deacetylase
histone h1
histone h2a
histone h3
histone h4
histone
hiv antibody
hiv envelope protein gp120
temoporfin
hiv envelope protein gp41
hla class i histocompatibility antigen ,  a - 2 alpha chain
hla - dr antigen
non - histone chromosomal protein hmg - 17
honduras
hong kong
tazemetostat hydrobromide
hospital
host - parasite relationship
human genetics
hungary
ibandronate sodium
hybridoma
hydrolase
hydrolysis
hypoxanthine phosphoribosyltransferase
iceland
disease risk index for allogeneic stem cell transplantation
disease risk index low risk
disease risk index intermediate risk
disease risk index high risk
disease risk index very high risk
chlorotoxin  ( eq )  - cd28 - cd3zeta - cd19t - expressing car t - lymphocytes
pressure stimulation device
nf1 protein variant
nf1 nm_001042492 .2:c .4394a > g
nf1 np_001035957 .1:p .n1465s
nf1 nm_001042492 .2:c .6926del
nf1 np_001035957 .1:p .s2309cfs*10
notch1 protein variant
wee1 inhibitor zn - c3
blasts 6 - 24 percent of bone marrow nucleated cells
notch1 nm_017617 .4:c .3587g > a
notch1 np_060087 .3:p .g1196d
eosinophilia greater than 1500 cells per microliter
locally advanced genitourinary system carcinoma
locally advanced bladder carcinoma
locally advanced ovarian carcinoma
unresectable ovarian carcinoma
refractory gastric adenocarcinoma
unresectable bladder carcinoma
refractory triple - negative breast carcinoma
seer terminology
recurrent diffuse astrocytoma
recurrent oligoastrocytoma
homovanillic acid
vanillylmandelic acid
neoplastic cells with bright cd56 expression present
neoplastic cells with cd45 dim - to - negative expression present
neoplastic cells with cd38 dim - to - negative expression present
hla - dr - negative neoplastic cells present
acute myeloid leukemia with ram immunophenotype
inactivating brca gene mutation
brca variant of unknown significance
daxx gene mutation
inactivating daxx gene mutation
inactivating atrx gene mutation
inactivating arid1a gene mutation
smc3 gene mutation
pds5b gene mutation
rad21 gene mutation
clonal plasma cells in bone marrow
recombinant human monocyte chemoattractant protein - 2
immunity
met exon 14 skipping mutation negative
activating kras gene mutation negative
ros1 gene fusion negative
alk fusion negative
alk gene fusion negative
ntrk3 gene amplification
ntrk2 gene amplification
inactivating cdkn2c gene mutation
cdkn2b gene mutation
inactivating cdkn2b gene mutation
cell - mediated immunity
stat5 protein family
axin2 gene mutation
axin1 gene mutation
rspo3 gene mutation
rspo2 gene mutation
znrf3 gene mutation
creatine supplementation
influenza b virus positive
influenza a virus positive
sbds gene mutation
humoral immunity
recombinant erwinia asparaginase jzp - 458
srsf2 protein variant
srsf2 np_003007 .2:p .p95 deletion
u2af1 protein variant
gallium ga - labeled psma - 11 - gadoxetate
u2af1 np_006749 .1:p .q157x
u2af1 np_006749 .1:p .r156x
u2af1 np_006749 .1:p .s34x
sf3b1 protein variant
sf3b1 np_036565 .2:p .d781x
immunochemistry
sf3b1 np_036565 .2:p .a774x
sf3b1 np_036565 .2:p .g742x
sf3b1 np_036565 .2:p .k741x
sf3b1 np_036565 .2:p .g740x
sf3b1 np_036565 .2:p .i704x
sf3b1 np_036565 .2:p .v701x
sf3b1 np_036565 .2:p .k700x
sf3b1 np_036565 .2:p .k666x
sf3b1 np_036565 .2:p .t663x
sf3b1 np_036565 .2:p .h662x
immunoenzyme procedure
sf3b1 np_036565 .2:p .n626x
sf3b1 np_036565 .2:p .r625x
sf3b1 np_036565 .2:p .y623x
sf3b1 np_036565 .2:p .e622x
kmt2a gene translocation
erbb2 fusion positive
erbb2 gene fusion positive
erbb3 gene amplification
erbb3 fusion positive
erbb3 gene fusion positive
immunogenetics
fgfr4 gene amplification
activating erbb2 point mutation
pa2g4 gene
pa2g4 wt allele
proliferation - associated protein 2g4
blasts 2 percent or more of bone marrow nucleated cells
cd73 inhibitor ab680
krasg12c inhibitor jnj - 74699157
flt3 nm_004119 .2:c .2039c > t
flt3 np_004110 .2:p .a690v
idiotype
flt3 nm_004119 .2:c .2517t > a
flt3 np_004110 .2:p .d839e
flt3 nm_004119 .2:c .2516a > g
flt3 np_004110 .2:p .d839g
flt3 np_004110 .2:p .f594y
flt3 np_004110 .2:p .f594c
flt3 nm_004119 .2:c .1727t > g
flt3 np_004110 .2:p .l576r
obesity - related malignant neoplasm
flt3 nm_004119 .2:c .1992g > a
immunoglobulin heavy chain
flt3 nm_004119 .2:c .1992g > c
flt3 nm_004119 .2:c .1992g > t
vacutainer with k2edta
flt3 np_004110 .2:p .m664i
flt3 nm_004119 .2:c .2028c > a
flt3 nm_004119 .2:c .2028c > g
flt3 np_004110 .2:p .n676k
flt3 nm_004119 .2:c .2027a > g
flt3 np_004110 .2:p .n676s
brca - mutated malignant neoplasm
immunoglobulin light chain ,  kappa
flt3 np_004110 .2:p .n841x
flt3 nm_004119 .2:c .1775t > c
flt3 np_004110 .2:p .v592a
flt3 nm_004119 .2:c .1775t > g
flt3 np_004110 .2:p .v592g
flt3 nm_004119 .2:c .1796a > g
flt3 np_004110 .2:p .y599c
flt3 np_004110 .2:p .y842x
met x met bispecific antibody regn5093
brca - mutated breast carcinoma
immunoglobulin light chain ,  lambda
dose administered
absolute phagocyte count
recurrent non - muscle invasive bladder urothelial carcinoma  ( nmibc )  with a prior history of low or intermediate risk nmibc
palb2 - mutated breast carcinoma
t ( 8 ; 16 )  ( p11 .2 ; p13 .3 )
inv ( 16 )  ( p13 .3 ; q24 .3 )
t ( 10 ; 11 )  ( p12 .3 ; q23 .3 )
t ( 10 ; 11 )  ( p12 .1 ; q23 .3 )
rearrangement of 10p12 .3
cebpa bzip domain mutation
indium in - 111 pentetreotide
immunoglobulin light chain
felt i had nothing to look forward to
felt that nothing could cheer me up
locally advanced fallopian tube carcinoma
metastatic primary peritoneal carcinoma
locally advanced primary peritoneal carcinoma
egfr / her2 inhibitor dzd9008
bispecific antibody gs - 1423
partially engineered t - regulatory cell donor graft trgft - 201
autologous peripheral blood lymphocytes from ibrutinib - treated chronic lymphocytic leukemia patients iov - 2001
measurable lesion
ret / src inhibitor tpx - 0046
gastrectomy patient
robotic bariatric sleeve gastrectomy
robotic hysterectomy
autosomal recessive osteopetrosis 1
mental retardation ,  x - linked ,  syndromic ,  cabezas type
radical prostatectomy patient
pelvic lymphadenectomy patient
fluorine f 18 nos
immunohistochemistry
allogeneic nkg2dl - targeting car - grafted gamma delta t cells
doxorubicin prodrug / prodrug - activating biomaterial sq3370
notch1 nm_017617 .4:c .5153t > c
notch1 np_060087 .3:p .i1718t
hemoporfin
notch1 nm_017617 .4:c .7507c > t
notch1 np_060087 .3:p .q2503*
notch1 np_060087 .3:p .s1674f
notch1 np_060087 .3:p .s1674p
notch1 nm_017617 .4:c .7396_7397ins8
immunology test
notch1 np_060087 .3:p .s2467*
zirconium zr 89 - dfo - sc16 .56
notch1 nm_017617 .4:c .7396_7397ins5
blood pressure measurement
notch1 nm_017617 .4:c .7399_7400insaggttaccc
notch1 np_060087 .3:p .s2467 frameshift
metastatic nasal cavity squamous cell carcinoma
resectable colon carcinoma
advanced colon carcinoma
cathepsin - cleavable nir substrate probe 6qc - icg
immunoprecipitation
cathepsin - cleavable nir substrate probe 6qc - nir
notch1 nm_017617 .4:c .7398_7399insagggaccg
notch1 np_060087 .3:p .s2467rfs*13
notch1 nm_017617 .4:c .7398_7399insgccttgggaacccg
notch1 np_060087 .3:p .s2467afs*15
notch1 nm_017617 .4:c .7398_7399insgg
notch1 np_060087 .3:p .s2467gfs*11
notch1 nm_017617 .4:c .7398_7407del
notch1 np_060087 .3:p .s2467pfs*7
immunoprotein
notch1 nm_017617 .4:c .7398del
notch1 np_060087 .3:p .s2467rfs*10
notch1 nm_017617 .4:c .7399del
notch1 nm_017617 .4:c .7399_7400insgg
notch1 np_060087 .3:p .s2467wfs*11
refractory prostate carcinoma
refractory prostate adenocarcinoma
p97 inhibitor cb - 5339
idh2 np_002159 .2:p .r140g
idh2 nm_002168 .3:c .418c > g
incidence
advanced malignant female reproductive system neoplasm
p97 inhibitor cb - 5339 tosylate
multi - energy computed tomography
musculoskeletal examination
nasopharyngeal squamous cell carcinoma
recurrent nasopharyngeal squamous cell carcinoma
serd zn - c5
liposomal - based cream base
photovoice
india
sting - expressing e . coli synb1891
cxcr4 / e - selectin antagonist gmi - 1359
znf532 gene
znf532 wt allele
zinc finger protein 532
znf532 / nutm1 fusion gene
znf532 / nutm1 fusion protein
parp inhibitor nms - 03305293
original dog breed data
indonesia
anatomic site of origin for matched normal tissue
dog age in years
mutation rate
adjusted coding mutation rate per megabase
reduced - representation bisulfite sequencing
mean exome read depth
percent exome covered at read depth of 30x
dna methylation - dependent predicted disease class
dna methylation - dependent predicted disease class probability
comparative brain tumor consortium annotation present
infant mortality
comments from cbtc review
comparative brain tumor consortium
sting agonist bms - 986301
quickdash outcome measure
ability to open tight or new jar
ability to carry shopping bag or briefcase
ability to wash your back
ability to use knife to cut food
ability to do recreational activities which require force or impact through arm ,  shoulder ,  or hand
sardomozide
developmental psychology ,  infant
extent that arm ,  shoulder ,  or hand problem interfered with normal social activities
extent that arm ,  shoulder ,  or hand problem limited work or other regular activities
severity of arm ,  shoulder ,  or hand pain
severity of tingling in arm ,  shoulder ,  or hand
severity of sleep difficulty because of pain in arm ,  shoulder ,  or hand
impact of arm ,  shoulder ,  or hand problem on ability to use usual technique for work
impact of arm ,  shoulder ,  or hand problem on ability to do usual work
impact of arm ,  shoulder ,  or hand problem on ability to do work as well as would like
impact of arm ,  shoulder ,  or hand problem on ability to spend usual amount of time doing work
impact of arm ,  shoulder ,  or hand problem on ability to use usual technique for playing instrument or sport
newborn
impact of arm ,  shoulder ,  or hand problem on ability to play instrument or sport
impact of arm ,  shoulder ,  or hand problem on ability to play instrument or sport as well as would like
impact of arm ,  shoulder ,  or hand problem on ability to spend usual amount of time playing instrument or sport
no difficulty
mild difficulty
moderate difficulty
severe difficulty
does not interfere
interferes slightly
interferes moderately
information dissemination
interferes quite a bit
extremely interfering
moderately limited
so much difficulty can't sleep
locally advanced pancreatic neuroendocrine tumor
fas ligand - treated allogeneic mobilized peripheral blood cells
midgut neuroendocrine tumor
midgut neuroendocrine tumor g2
metastatic midgut neuroendocrine tumor
information sciences
locally advanced midgut neuroendocrine tumor
unresectable midgut neuroendocrine tumor
locally advanced neuroendocrine neoplasm
locally advanced well differentiated neuroendocrine neoplasm
pegylated sn - 38 conjugate plx038
glioblastoma ,  idh - mutant
advanced hepatocellular carcinoma
anti - bcma sparx protein plus bcma - directed anti - taag arc t - cells cart - ddbcma
advanced bladder carcinoma
text message - based navigation intervention
information storage and retrieval
adnexal adenocarcinoma ,  not otherwise specified
spiradenocylindroma
spiradenocylindrocarcinoma
malignant mixed tumor of the skin
ezh2 inhibitor cpi - 0209
fluorine f 18 psma - 1007
hpv e6 / e7 - encoding arenavirus vaccine hb - 201
informed consent
tlr7 agonist bnt411
musical instrument
locally advanced nasopharyngeal squamous cell carcinoma
whole body vibration
microinvasive anal carcinoma
infrared radiation
adenovirus serotype 26 - expressing hpv16 vaccine jnj - 63682918
adenovirus serotype 26 - expressing hpv18 vaccine jnj - 63682931
modified vaccinia ankara - vectored hpv16 / 18 vaccine jnj - 65195208
gait assessment test
endocrine mucin - producing sweat gland carcinoma
syringocystadenocarcinoma papilliferum
adnexal cribriform carcinoma
adnexal secretory carcinoma
signet ring cell / histiocytoid carcinoma
implantable pump
skin myoepithelioma
data refresh
locally advanced epithelioid sarcoma
unresectable epithelioid sarcoma
inhaler
advanced epithelioid sarcoma
trichoblastic carcinoma
trichoblastic carcinosarcoma
pd - l1 ihc 22c3 pharmdx
pd - l1 ihc 28 - 8 pharmdx
quitbot smoking cessation program
smokefreetxt smoking cessation program
canine quality of life survey
survey date
artificial insemination
pet wants to play
pet responds to presence
pet enjoys life
commensal bacterial strain formulation ve800
pet has more good days than bad
advanced fallopian tube carcinoma
advanced primary peritoneal carcinoma
pet sleeps more ,  is awake less
ventana pd - l1 sp263
pet seems dull or depressed ,  not alert
recombinant fibroblast growth factor 2
institute of medicine
pet is in pain
pet pants frequently ,  even at rest
pet shakes or trembles occasionally
pet eats usual amount of food
pet acts nauseous or vomits
acc / aha ehr terminology
pet keeps itself clean
pet eats treats or snacks
acc / aha pediatric and congenital cardiology ehr terminology
institutional review board
acc / aha measure
acc / aha response
pet smells like urine or has skin irritation
pets hair is greasy ,  matted ,  rough looking
pet drinks adequately
abdominal examination
abnormal cardiac study
no known allergy
recurrent high risk chronic myelomonocytic leukemia
refractory high risk chronic myelomonocytic leukemia
instrumentation
pet has diarrhea
pet is urinating a normal amount
pet moves normally
chest pain along anterior axillary line
chest pain along sternal border
chest pain along midclavicular line
chest pain in intercostal space
chest pain in sternum
pet lays in one place all day
pet is as active as it has been
insulin - like growth factor i
pet's general health compared to last evaluation
pet's general health compared to initial diagnosis of cancer
pet's current quality of life
plasma cell neoplasm finding
myeloid neoplasm finding
leukemia finding
heart murmur categorized by duration
systolic heart murmur
heart murmur categorized by phase or timing
heart murmur categorized by quality
insulin - like growth factor ii
early systolic heart murmur
ejection systolic heart murmur
late systolic heart murmur
midsystolic heart murmur
pansystolic heart murmur
diastolic heart murmur
continuous heart murmur
lymphoma finding
family history of heart disease
insurance
heart sound
genitalia examination
heart sound categorized by grade
heart sound categorized by pitch
innocent murmur
high risk plasma cell myeloma
musculoskeletal chest pain due to myositis
psychogenic musculoskeletal chest pain
health insurance reimbursement
transmembrane protein
no radiating chest pain
radiating chest pain along anterior axillary line
integrin
radiating chest pain along midclavicular line
radiating chest pain along sternal border
radiating chest pain in abdomen
radiating chest pain in back
radiating chest pain in left arm
radiating chest pain in neck
radiating chest pain in sternum
radiating chest pain to other location
location of radiating chest pain
s1 heart sound
internal medicine
s2 heart sound
tyrphostin b46
interphase process
interview
thyroid peroxidase
gated ion channel
ion channel
iran ,  islamic republic of
iraq
ireland
isoelectric focusing
isomerase
curacin b
israel
italy
cote d'ivoire
jamaica
japan
jordan
oncogene k - ras
kallikrein
karyotyping
kenya
curacin c
kinetics
kyrgyzstan
knowledge ,  attitudes ,  behaviors
korea ,  democratic people's republic of
korea ,  republic of
kuwait
laboratory animal science
lacz gene
laminin
language
curacin a
lao people's democratic republic
laryngoscopy
laser
latvia
lebanon
lectin
law
lesotho
ld - 50
integrin alpha - x
exatecan mesylate
mixed lymphocyte reaction test
liberia
library science
libya
liechtenstein
lifestyle
ligase
genetic linkage analysis
linkage disequilibrium
lithuania
iboctadekin
lod score
long - term care for elderly
family history of cardiomyopathy
family history of congenital heart disease
family history of long qtc
family history of sudden arrythmia death syndrome
luciferase
family history of coronary artery bypass graft surgery
family history of percutaneous coronary intervention
external genitalia examination
opening snap
pericardial knock
pericardial rub
s4 heart sound
summation gallop
systolic click
systolic whoop
luxembourg
grade i heart sound
grade ii heart sound
grade iii heart sound
grade iv heart sound
grade v heart sound
grade vi heart sound
high frequency heart sound
low frequency heart sound
medium frequency heart sound
carotid bruit
lyase
innocent pulmonary systolic murmur
mammary souffle
physiologic pulmonary artery stenosis murmur
still's murmur
venous hum
musculoskeletal chest pain due to epidemic myalgia
psychogenic musculoskeletal chest pain with dysfunctional breathing
radiating chest pain along left anterior axillary line
radiating chest pain along right anterior axillary line
radiating chest pain along left midclavicular line
lymphangiogram
radiating chest pain along right midclavicular line
radiating chest pain along left lower sternal border
radiating chest pain along left middle sternal border
radiating chest pain along left upper sternal border
radiating chest pain along right lower sternal border
radiating chest pain along right middle sternal border
radiating chest pain along right upper sternal border
radiating chest pain in lower sternum
radiating chest pain in mid sternum
radiating chest pain in upper sternum
lymphography
abnormal s1 heart sound
loud s1 heart sound
normal split s1 heart sound
reverse split s1 heart sound
single s1 heart sound
soft s1 heart sound
widened s1 heart sound
abnormal s2 heart sound
fixed split s2 heart sound
loud p2 heart sound
macau
normal split s2 heart sound
reverse split s2 heart sound
single s2 heart sound
widely split s2 heart sound
abdominal auscultation finding
abdominal palpation finding
appearance of extremities
edematous scrotum
madagascar
extracardiac examination
intervention for rheumatic fever
kawasaki disease laboratory finding
kawasaki disease - associated coronary artery aneurysm z - score
minor criteria for rheumatic heart disease
normal male external genitalia
point of maximum impulse
magnetic resonance imaging
valve replacement
504 plan
abdominal bruit present
abdominal visual inspection
abnormal cardiac event monitoring finding
abnormal chest radiograph
abnormal echocardiogram
alemtuzumab
magnetic resonance spectroscopy
abnormal electrocardiogram
abnormal holter monitoring finding
continuous with diastolic spillover heart murmur
late diastolic heart murmur
abnormally displaced point of maximum impulse
abnormally located point of maximum impulse
activity associated with chief complaint
adequacy of daily caloric intake
adequacy of daily fluid intake
adequacy of salt intake
magnetoencephalography
adequate daily caloric intake
adequate daily fluid intake
adequate daily salt intake
age at diagnosis of congenital heart disease
alleviating factor to chief complaint
anterior chest examination
anticongestive medications given for rheumatic fever
arrhythmogenic syncope
aspirin given for kawasaki disease
aspirin given for rheumatic fever
major histocompatibility complex gene
asymmetric chest appearance
asymptomatic presentation
middiastolic heart murmur
caffeine not routinely consumed
caffeine routinely consumed
capillary refill test
cardiac disease screening
cardioinhibitory syncope
carditis
carotid sinus syncope
malawi
carpal spasm
change to upright position
chest pain along left anterior axillary line
chest pain along left lower sternal border
chest pain along left midclavicular line
chest pain along left middle sternal border
chest pain along left upper sternal border
chest pain along right anterior axillary line
chest pain along right lower sternal border
chest pain along right midclavicular line
malaysia
chest pain along right middle sternal border
chest pain along right upper sternal border
chest pain in left fifth intercostal space
chest pain in left fourth intercostal space
chest pain in left second intercostal space
chest pain in left third intercostal space
chest pain in lower sternum
chest pain in mid sternum
chest pain in right fifth intercostal space
chest pain in right fourth intercostal space
maldives
chest pain in right second intercostal space
chest pain in right third intercostal space
chest pain in upper sternum
chief complaint caused by trauma
chief complaint continuously present
chief complaint intermittently present
chief complaint is present daily
chief complaint is present monthly
chief complaint is present multiple times per day
chief complaint is present weekly
mali
chief complaint not caused by trauma
chief complaint occurs after exercise
chief complaint occurs at rest
chief complaint occurs during exercise
chief complaint occurs without pattern
chief complaint present at midday
chief complaint present at night
chief complaint present in the afternoon
chief complaint present in the evening
chief complaint present in the morning
malta
chief complaint was not witnessed
chief complaint was witnessed
chronic orthostatic intolerance
cold sensation
complex breath holding
computed tomography of the heart
coronary artery aneurysm
coronary artery ectasia
coumadin given for kawasaki disease
cyanotic breath holding
mammography
date of patient evaluation prior to current chief complaint
delayed capillary refill time
developmental finding
diagnosis at patient evaluation prior to current chief complaint
drug - induced syncope
duration of chief complaint
electrocardiogram
evidence of previous streptococcal infection
exacerbating factor to chief complaint
examination of extremities
superoxide dismutase  [ mn ]  ,  mitochondrial
excessive daily caloric intake
excessive daily salt intake
exercise cardiac stress test
faceplant
family history of arrhythmia
family history of chronic disease
long heart murmur
medium heart murmur
short heart murmur
l - 744 , 832
manometry
family history of ehlers - danlos syndrome
family history of hyperlipidemia
family history of hypertension
family history of marfan syndrome
family history of myocardial infarction
family history of stroke
family history of sudden infant death syndrome
marine biology
family history of syncope
feeding fatigue
systolic - diastolic heart murmur
forceful heartbeats
frequency of chief complaint
frequency of routine caffeine intake
gallbladder mucocele
genetic syndrome associated with congenital heart defect
gestational complication
blowing heart murmur
marshall islands
harsh heart murmur
machinery heart murmur
multifrequency heart murmur
grade school completion
nonspecific heart murmur
squeaky heart murmur
graduate studies completion
hair brushing
vibratory heart murmur
has no sibling
martinique
has response to intervention for kawasaki disease
has sibling
hear sound auscultation at left infraclavicular region
hear sound auscultation at right infraclavicular region
heart sound auscultation at apex
heart sound auscultation at back
heart sound auscultation at left anterior axillary line
heart sound auscultation at left axilla
heart sound auscultation at left lower sternal border
heart sound auscultation at left lung field
maternal physiology
heart sound auscultation at left middle sternal border
heart sound auscultation at left upper sternal border
heart sound auscultation at right anterior axillary line
heart sound auscultation at right axilla
heart sound auscultation at right lower sternal border
heart sound auscultation at right lung field
heart sound auscultation at right middle sternal border
heart sound auscultation at right upper sternal border
heat sensation
herniorrhaphy
mathematics
history of allergic reaction
history of congenital heart disease
history of failure to gain weight
history of medication
history of non - cardiac surgery
history of other non - cardiac surgery
history of trauma in chief complaint
hot bath or shower
hot weather
hyperactive chest appearance
mauritania
hypercyanotic spell
hyperdynamic precordial palpation finding
hyperpnea
hypotension due to cardiac dysfunction
hypotension due to drug
illicit drug use history
inadequate daily caloric intake
inadequate daily fluid intake
inadequate daily salt intake
increased emotional state
mauritius
individualized education plan
infective endocarditis prophylaxis
infliximab given for kawasaki disease
intercurrent illness at onset of chief complaint
intercurrent illness is absent at onset of chief complaint
intercurrent illness is present at onset of chief complaint
intercurrent illness is unknown at onset of chief complaint
intervention for congenital heart disease
intervention for kawasaki disease
intervention for kawasaki disease given beyond ten days of onset of initial symptoms
mayotte
intervention for kawasaki disease given within ten days of onset of initial symptoms
intervention given for kawasaki disease
intervention not given for kawasaki disease
interventional cardiac catheterization
irregular heart beat
ivig given for kawasaki disease
kawasaki disease symptom
kawasaki disease symptom onset age
kawasaki disease symptom onset date
kawasaki disease - associated coronary artery aneurysm z - score suggests dilatation only
mediastinoscopy
kawasaki disease - associated coronary artery aneurysm z - score suggests large or giant aneurysm
kawasaki disease - associated coronary artery aneurysm z - score suggests medium aneurysm
kawasaki disease - associated coronary artery aneurysm z - score suggests no involvement
kawasaki disease - associated coronary artery aneurysm z - score suggests small aneurysm
known family history of rheumatic fever or rheumatic heart disease
known history of acute rheumatic fever or rheumatic heart disease
known history of alcohol use
known history of allergy to fish
known history of allergy to medication
known history of congenital heart disease
tyrphostin a47
medical device
known history of gestational complication
known history of illicit drug use
known history of kawasaki disease
known history of neonatal complication
known history of other allergy
known history of rheumatic fever
labile affect
ladd procedure
lives alone
lives with aunt
medical imaging
lives with father
lives with foster parent
lives with legal guardian
lives with mother
lives with partner or spouse
lives with sibling
lives with stepfather
lives with stepmother
lives with uncle
location of chest pain
medical oncology
location of heart sound auscultation
location of patient evaluation prior to current chief complaint
location of point of maximum impulse
location of pulse measurement
medication for kawasaki disease
medication for rheumatic fever
medication not taken
medication taken
minor criteria for rheumatic heart disease not present
minor criteria for rheumatic heart disease present
medicine
muscular dystrophies and storage diseases leading to cardiomyopathy
muscular dystrophy secondary to mitochondrial disorder
muscular dystrophy secondary to oxidative phosphorylation disorder
musculoskeletal chest pain due to costochondral junction syndrome
musculoskeletal chest pain due to costochondritis
musculoskeletal chest pain due to intercostal myofascial injury
musculoskeletal chest pain due to rib injury
musculoskeletal chest pain due to slipping rib syndrome
musculoskeletal chest pain due to sternal injury
myopathy secondary to fatty acid oxidation disorder
meiosis
myopathy secondary to glycogen storage disorder
no abdominal bruit
no alleviating factor to chief complaint
no exacerbating factor to chief complaint
no history of congenital heart disease
no history of gestational complication
no history of kawasaki disease
no history of myopathy
no history of neonatal complication
no history of non - cardiac surgery
no history of other muscular dystrophy or glycogen storage disorder
no history of rheumatic fever
no known history of alcohol use
no known history of allergy
no known history of illicit drug use
no response to intervention for kawasaki disease
no sequelae of intervention for kawasaki disease
no signs and symptoms associated with chief complaint
normal abdomen on palpation
normal abdomen on visual inspection
neprilysin
normal appearance of extremities
normal blood oxygen saturation
normal capillary refill time
normal chest appearance
normal point of maximum impulse
normal precordial palpation finding
noxious stimulus
onset of chief complaint
other abnormal cardiac study
other chief complaint
membrane protein
other common clinical findings noted during the evaluation for cardiac disease
other exacerbating factor to chief complaint
other extremity blood pressure measurement
other family history of heart disease
other frequency of chief complaint
other genetic syndrome associated with congenital heart defect
other medication given for kawasaki disease
other medication given for rheumatic fever
other presenting finding of congenital heart disease
pain in epigastrium
menstrual cycle
palatorrhaphy
pallid breath holding
pathologic murmur
patient was not previously evaluated for current chief complaint
patient was previously evaluated for current chief complaint
pectus carinatum
pectus excavatum
pedal spasm
penicillin given for rheumatic fever
periodicity of chief complaint
psychological health
poorly perfused
postictal confusion
precordial catch syndrome
precordial palpation
precordial palpation finding of lift or heave
precordial palpation finding of palpable heart sound
precordial palpation finding of tap
precordial palpation finding of thrill
presenting finding of congenital heart disease
previous therapies at patient evaluation prior to current chief complaint
recombinant interleukin - 17
mental process
primary pulmonary hypertension
prior patient evaluation for current chief complaint
prolonged standing
protuberant abdomen
psychiatric finding
psychogenic syncope
pulse wave absent
pulse wave amplitude measurement
pulse wave decreased
pulse wave increased
detoxification
pulse wave markedly increased
pulse wave normal
quality of chest pain
quality of palpitations
racing heartbeats
radial - femoral lag
radial - femoral lag absent
radial - femoral lag present
relapse following intervention for kawasaki disease
resolution of findings following intervention for kawasaki disease
response to intervention for kawasaki disease
retreatment following intervention for kawasaki disease
rheumatic fever symptom
rheumatic fever symptom onset age
rheumatic fever symptom onset date
rheumatological finding
right arm blood pressure measurement
s1 heart sound type
s2 heart sound type
scaphoid abdomen
metallopeptidase
secondary pulmonary hypertension
sequelae of intervention for kawasaki disease
severity of chief complaint
signs and symptoms associated with chief complaint
simple breath holding
situational syncope
skin examination
skipped heartbeats
startle
sterile pyuria
metalloprotein
sternotomy scar
steroids given for kawasaki disease
steroids given for rheumatic fever
strawberry tongue
surgery for rheumatic fever
sydenham chorea
symmetric chest appearance
symptomatic presentation
syncope due to acquired heart lesion
syncope due to congenital heart lesion
metallothionein
syncope due to migraine
syncope due to pulmonary hypertension
syncope with exertion
tests performed at patient evaluation prior to current chief complaint
thoracotomy scar
time of day of chief complaint
timing of intervention for kawasaki disease
tongue biting
type of response to intervention for kawasaki disease
unknown if medication taken
metaphase process
unknown daily caloric intake
unknown daily fluid intake
unknown daily salt intake
unknown family history cardiovascular disease or cardiovascular disease risk factors
unknown history of alcohol use
unknown history of allergy
unknown history of congenital heart disease
unknown history of gestational complication
unknown history of illicit drug use
unknown history of kawasaki disease
technique
unknown history of myopathy
unknown history of neonatal complication
unknown history of non - cardiac surgery
unknown history of other muscular dystrophy or glycogen storage disorder
unknown history of rheumatic fever
unknown if caffeine consumption is routine
unknown if chief complaint caused by trauma
unknown if chief complaint was witnessed
unknown if has sibling
unknown if patient has genetic syndrome associated with congenital heart defect
methylation
unknown if patient was previously evaluated for current chief complaint
unknown when chief complaint present
vasodepressor syncope
ventriculoperitoneal shunt placement
well perfused
witnessing of chief complaint
burning chest pain
dull chest pain
methyltransferase
family history of cardiovascular disease or cardiovascular disease risk factors
multiple congenital anomalies
neonatal complication
dulanermin
mexico
pressure chest pain
sharp chest pain
microbiology
tearing chest pain
her2 negative breast carcinoma
microfilament protein
fecal microbiota transplantation capsule
bilateral mastectomy
anti - cd137 agonistic monoclonal antibody agen2373
kras gene rearrangement
erbb family gene fusion positive
fh alteration positive
sdh complex alteration positive
manganese / l - alanine / vitamin d3 - containing contrast agent formulation
vhl alteration positive
elevated met protein expression
microscopy
fus gene translocation
prmt5 inhibitor prt811
egf antibody
circulating egf measurement
cancer - associated fibroblast
circulating cancer - associated fibroblast
kappa light chain - restriction
keap1 alteration positive
keap1 gene alteration positive
gastrointestinal tract acute graft versus host disease
electron microscopy
steroid resistant gastrointestinal tract acute graft versus host disease
severe gastrointestinal tract acute graft versus host disease
advanced skin squamous cell carcinoma
locally advanced thyroid gland medullary carcinoma
metarrestin
metastatic pleural malignant mesothelioma
exablate 4000 type 2 .0
pcdc terminology
scanning electron microscopy
squamous cell carcinoma of the mouse tongue
eortc quality of life questionnaire  -  lung cancer module
how much did you cough
did you cough up blood
short of breath when you rested
short of breath when you walked
fluorescence microscopy
short of breath when you climbed stairs
had sore mouth or tongue
trouble swallowing
tingling hands or feet
aicardi - goutieres syndrome 5
had hair loss
had pain in other parts of body
take medicine for pain
had pain in chest
had pain in arm or shoulder
phase - contrast microscopy
allogeneic anti - cd20 - car t - cells pbcar20a
idh inhibitor associated differentiation syndrome
unresectable differentiated thyroid gland carcinoma
resectable glioma
multimodal education
european consensus on grading of bone marrow fibrosis
marrow fibrosis grade 0
marrow fibrosis grade 1
marrow fibrosis grade 2
marrow fibrosis grade 3
polarization microscopy
bispecific antibody amg 509
liver fibrosis
steroid resistant acute graft versus host disease
refractory metastatic pancreatic adenocarcinoma
cd28 / icos antagonist alpn - 101
aicardi - goutieres syndrome 7
asparagine synthetase deficiency
retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities
senior - loken syndrome
valemetostat tosylate
ultraviolet microscopy
cd70 deficiency
melanocytic matricoma
pigmented dendritic melanocytes present
low transfusion burden
high transfusion burden
elective plasma - based cancerseek testing
early infantile epileptic encephalopathy 25
epilepsy ,  focal ,  with speech disorder and with or without mental retardation
glut1 deficiency syndrome 1
zd2767
epoxide hydrolase 1
anti - pd - 1 / cd47 infusion protein hx009
parp 1 / 2 inhibitor imp4297
phyllodes tumor of anogenital mammary - type glands
anti - lag - 3 monoclonal antibody ibi - 110
anti - cd40 / anti - 4 - 1bb bispecific agonist monoclonal antibody gen1042
recombinant human papillomavirus 11 - valent vaccine
selective estrogen receptor degrader lx - 039
oncolytic adenovirus orca - 010
kanitinib
thymidylate synthase inhibitor cx1106
microtubule associated protein
kinect - enhanced training for the - optimal - lymph - flow
n - oleyl - phosphatidylethanolamine / epigallocatechin gallate supplement
mindset intervention
reflection activities
anti - btla monoclonal antibody tab004
idh1 inhibitor
idh2 inhibitor
microwave radiation
pq / cmc strength operator terminology
specify other adverse event
pq / cmc sponsor identifier type terminology
best overall response registered from start of therapy to a time point of interest
best secondary endpoint response registered from start of therapy to a time point of interest
pq / cmc strength type terminology
drug component mass
icdc program sort order
minority group
icdc study identifier
therapeutic indicator
spl ucum terminology
iwg - mrt criteria for treatment response in myelofibrosis
iwg - mrt myelofibrosis complete remission
iwg - mrt myelofibrosis partial remission
iwg - mrt myelofibrosis cytogenetic / molecular relapse
epiphyseal plate
pq / cmc application type terminology
mitosis
iwg - mrt myelofibrosis clinical improvement
iwg - mrt myelofibrosis relapse
iwg - mrt myelofibrosis symptom response
iwg - mrt myelofibrosis stable disease
iwg - mrt myelofibrosis progressive disease
iwg - mrt myelofibrosis anemia response
mixed function oxidase
iwg - mrt myelofibrosis cytogenetic remission
cutaneous burkitt lymphoma
iwg - mrt myelofibrosis spleen response
iwg - mrt myelofibrosis molecular remission
mapped icdo terminology
mapped icdo3 .1 terminology
mapped icdo3 .2 terminology
mapped icdo3 .1 morphology terminology
mapped icdo3 .1 morphology pt terminology
mapped icdo3 .1 topography terminology
model
mapped icdo3 .1 topography pt terminology
mapped icdo3 .2 morphology terminology
mapped icdo3 .2 morphology pt terminology
mapped icdo3 .2 topography terminology
mapped icdo3 .2 topography pt terminology
aesthetic primary post - nonreconstructive mastectomy flat closure
gastrointestinal carcinomatosis
metastatic high grade sarcoma
locally advanced high grade sarcoma
metastatic malignant neoplasm in the digestive system
molecular model
metastatic myxofibrosarcoma
locally advanced myxofibrosarcoma
thoracic spine neoplasm
lumbar spine neoplasm
sacral spine neoplasm
blasts 1 percent of peripheral blood white cells
myeloblasts 1 percent of peripheral blood white cells
myelodysplastic syndrome ,  unclassifiable ,  with 1 percent blasts
myelodysplastic syndrome ,  unclassifiable ,  based on defining cytogenetic abnormality
bone marrow dysplasia present in less than 10 percent of myeloid cells
neurological model
myeloblasts 1 percent or less of peripheral blood white cells
myelodysplastic syndrome ,  unclassifiable ,  with single lineage dysplasia
high risk chronic myelogenous leukemia ,  bcr - abl1 positive
very high risk chronic myelogenous leukemia ,  bcr - abl1 positive
high risk prostate carcinoma
very high risk prostate carcinoma
high risk acute lymphoblastic leukemia
anhydrous enol - oxaloacetate
unit of height
lymphatic reconstruction
statistical modeling
spinal region
thoracic region
dna - pk inhibitor azd7648
spinal neoplasm
lumbosacral spine neoplasm
nt5c2 gene mutation
cbdd process terminology
cbdd structure terminology
cervical spine neoplasm
nicotine replacement agent
imatinib mesylate
mathematical model
bothered by genital itching and / or irritation
advanced liposarcoma
bothered by decreased appetite
bothered by upset stomach and / or indigestion
bothered by sinus problems
bothered by coughing
bothered by swelling of hands or feet
bothered by early awakening
extent of symptoms likert scale
symptoms extent score 0
moldova ,  republic of
symptoms extent score 1
symptoms extent score 2
symptoms extent score 3
symptoms extent score 4
advanced malignant peripheral nerve sheath tumor
advanced dedifferentiated liposarcoma
advanced fibrosarcoma
unresectable fibrosarcoma
unresectable angiosarcoma
unresectable myxoid liposarcoma
molecular biology
advanced angiosarcoma
advanced epithelioid hemangioendothelioma
advanced round cell liposarcoma
unresectable epithelioid hemangioendothelioma
unresectable round cell liposarcoma
metastatic soft tissue leiomyosarcoma
advanced soft tissue leiomyosarcoma
unresectable soft tissue leiomyosarcoma
dystonia 16
molecular neurobiology
emery - dreifuss muscular dystrophy 1 ,  x - linked
oculocutaneous albinism type 1a
eligibility for surgery
stickler syndrome type 1
samd9l gene
samd9l wt allele
sterile alpha motif domain - containing protein 9 - like
lymph node size
fluorine f 18 rhpsma - 7 .3
monaco
chlorhexidine gluconate skin cleanser
mild soap skin cleanser
familial myelodysplastic syndrome
samd9 gene mutation
samd9l gene mutation
samd9 - associated familial myelodysplastic syndrome
samd9l - associated familial myelodysplastic syndrome
eligibility for lymph node dissection
amyotrophic lateral sclerosis 1
mongolia
amyotrophic lateral sclerosis 6 ,  with or without frontotemporal dementia
amyotrophic lateral sclerosis 8
amyotrophic lateral sclerosis 10 ,  with or without frontotemporal dementia
amyotrophic lateral sclerosis 11
amyotrophic lateral sclerosis 14 ,  with or without frontotemporal dementia
amyotrophic lateral sclerosis 21
frontotemporal dementia and / or amyotrophic lateral sclerosis 1
achromatopsia 2
t ( 10 ; 11 )  ( p11 .2 ; q23 )
t ( 1 ; 11 )  ( q21 ; q23 )
montserrat
t ( 11 ; 17 )  ( q23 ; q12 - 21 )
kmt2a / mllt6 fusion gene
kmt2a / mllt6 fusion protein
t ( 11 ; 19 )  ( q23 ; p13 )
gata2 / mecom fusion gene
t ( 3 ; 12 )  ( q23 ; p12 .3 )
etv6 / mecom fusion gene
etv6 / mecom fusion protein
del ( 5q31 - q32 )
morbidity
del ( 13q14 - q21 )
non - kmt2a mllt10 rearrangement positive
anti - cd228 / mmae antibody - drug conjugate sgn - cd228a
t ( 16 ; 21 )  ( q24 ; q22 )
monoallelic cebpa gene mutation
autologous tetravalent dendritic cell vaccine midrix4 - lung
caffeine - based cream
metastatic her2 negative breast carcinoma
recurrent nodal peripheral t - cell lymphoma with tfh phenotype
refractory nodal peripheral t - cell lymphoma with tfh phenotype
morocco
recurrent follicular t - cell lymphoma
refractory follicular t - cell lymphoma
advanced her2 negative breast carcinoma
recurrent her2 negative breast carcinoma
refractory her2 negative breast carcinoma
mecom gene product
histone - lysine n - methyltransferase mecom
mecom protein isoform mds1
mecom protein isoform mds1 / evi1
morphogenesis
enadenotucirev - expressing fap / cd3 bispecific fap - tac ng - 641
meltf gene
meltf wt allele
melanotransferrin
hematopoietic cell transplantation conditioning regimen
operation of heavy machinery
pathogenicity
germline pathogenicity
acmg classification of genomic variant pathogenicity
pathogenic variant
tyrphostin ag 825
mortality
likely pathogenic variant
variant likely benign
variant benign
variant pathogenic / likely pathogenic
peritoneal sarcomatoid mesothelioma
peritoneal biphasic mesothelioma
nutm1 gene fusion positive
chemotherapy treatment course
ido1 / tdo2 inhibitor m4112
malglycemia
mos gene
flt3 - internal tandem duplication allelic ratio
flow cytometry for leukemia - associated immunophenotypes
second relapse
third relapse
fourth relapse
fifth relapse
sixth relapse
mismatch at one hla allele
mozambique
mismatch at both hla alleles
match at both hla alleles
extramedullary myeloid sarcoma site
year of diagnosis
csf pct blasts
prephase chemotherapy treatment
reported bmi
bone marrow blast analysis modality
mucin
mortality related to stem cell treatment
cranial radiation dose administered
single intrathecal chemotherapy
double intrathecal chemotherapy
triple intrathecal chemotherapy
variable intrathecal chemotherapy
chemotherapy course 1
chemotherapy course 2
chemotherapy course 3
chemotherapy course 4
muscle protein
chemotherapy course 5
chemotherapy course 6
european society for blood and marrow transplantation
age in days at enrollment
age in days at last known survival
age in days at vitals
age in days at blood analysis
age in days at lumbar puncture
age in days at molecular analysis
age in days at adjuvant therapy start
mutation
age in days at course start
age in days at course end
age in days at course anc 500
age in days at stem cell transplant
age in days at bone marrow analysis
age in days at minimal residual disease assessment
age in days at response assessment
age in days at central nervous system response assessment
age in days at myeloid sarcoma response
age in days at echocardiogram
oncogene myb
age in days at secondary malignancy neoplasm
gvhd acuity
smn icd - o morphology code
smn icd - o topology code
type of stem cell transplant
number of intended intrathecal chemotherapy doses
cns involvement criteria
cause of death detail
stem cell transplant donor relationship
myc gene
stem cell transplant source
karyotype status
adverse event grading system
immunotherapy - related
abnormal karyotype
pre - treatment disease complication
post - treatment disease complication
disease phase
traumatic tap
csf leukocytes present
csf blasts present
csf rbcs present
gvhd organ
csf results
site of relapse
stem cell mixture
italian association of pediatric hematology and oncology
berlin - frankfurt - munster study group
dutch childhood oncology group
oncogene n - ras
medical research council
nordic society of pediatric haematology and oncology
polish pediatric leukemia / lymphoma study group
study characteristics table
demographics table
survival characteristics table
disease characteristics table
plitidepsin
nadph - cytochrome p450 reductase
extramedullary myeloid sarcoma involvement table
cns involvement table
vitals table
blood analysis table
csf analysis table
molecular analysis table
adjuvant therapy table
systemic chemotherapy table
total dose table
stem - cell transplant table
namibia
bone marrow analysis table
minimal residual disease table
response table
cns response table
extramedullary response table
echocardiogram table
adverse events table
secondary malignancy table
number of cells in metaphase during karyotyping
sinusoidal obstruction syndrome treatment
national academy of science
csf rbc count
csf leukocyte count
csf leukocytes technique
hla - a match finding
hla - b match finding
hla - c match finding
hla - drb1 match finding
hla - dq match finding
enrollment status
study subject not enrolled
national center for health statistics
trisomy 21 status
last known survival status
cause of death ranking
minimal residual disease method
subject / guardian refused further treatment
end of planned treatment
aaml03p1 aml study identifier
aaml0531
aaml1031
amlbfm2004
national institute of mental health
aml02
aml05
aml2002 / 01
aml99
db - aml01
mrc aml12
nopho aml 2004
ppllsg aml - 98
contributory cause of death
honest broker subject id
data contributor id
minimal residual disease value
cns response
dexrazoxane administered
cardiac interventions administered
pathogen confirmation
flow cytometry different from normal
minimal residual disease sensitivity
minimal residual disease sample source
bm pct blasts at response
nauru
bm analysis modality at response
anc at response
anc threshold at response
platelet count at response
platelet threshold at response
inotropic support
bone marrow blast to total cell ratio measurement
fdg - avid tumor
necrotic process
death due to disease progression
necrosis negative
age in days at diagnosis
unresectable neuroendocrine neoplasm
charcot - marie - tooth disease type 2y
ehlers - danlos syndrome ,  musculocontractural type 1
locally advanced esophageal carcinoma
locally advanced anal carcinoma
locally advanced adenocarcinoma
locally advanced hepatocellular carcinoma
nef protein
cutaneous histiocytic and dendritic cell neoplasm
locally advanced biliary tract carcinoma
cutaneous langerhans cell histiocytosis
cutaneous indeterminate dendritic cell tumor
locally advanced pancreatic carcinoma
cutaneous sinus histiocytosis with massive lymphadenopathy
high density lipoprotein cholesterol level quantitative trait locus 6
sertoli cell - only syndrome
mosaic variegated aneuploidy syndrome 2
bartsocas - papas syndrome
cutaneous erdheim - chester disease
solitary cutaneous reticulohistiocytosis
generalized cutaneous reticulohistiocytosis
locally advanced cholangiocarcinoma
locally advanced renal cell carcinoma
thorium th 227 anti - her2 monoclonal antibody bay2701439
congenital myasthenic syndrome 12
glycogen storage disease type xi
macular dystrophy ,  retinal ,  1
sialyl tn - klh vaccine
neovascularization
optic atrophy 1
ring chromosome 20 syndrome
nt5c2 nm_001134373 .2:c .1100g > a
nt5c2 protein variant
nt5c2 np_001127845 .1:p .r367q
reason off protocol
ntrk1 nm_001012331 .1:c .1820g > t
ntrk1 protein variant
ntrk1 np_001012331 .1:p .g607v
hla match finding
nepal
ntrk1 nm_001012331 .1:c .1792c > t
ntrk1 np_001012331 .1:p .h598t
pax5 nm_016734 .3:c .964g > a
pax5 np_057953 .1:p .a322t
type of stem cell transplant conditioning prior to transplant
phf6 protein variant
phf6 np_115834 .1:p .r225x
ptch1 nm_000264 .4:c .3583a > t
ptch1 protein variant
nephrology
ptch1 np_000255 .2:p .t1195s
platinum - resistant malignant female reproductive system neoplasm
ptpn11 protein variant
pten np_000305 .3:p .l182 frameshift
pten nm_000314 .7:c .545t > g
pten nm_000314 .7:c .545t > a
pten np_000305 .3:p .l182*
ck1alpha / cdk7 / cdk9 inhibitor btx - a51
study unique identifier
ptpn11 nm_002834 .4:c .1508g > c
netherlands
ptpn11 np_002825 .3:p .g503a
rb1 protein variant
rb1 np_000312 .2:p .f650s
sdhb protein variant
sdhb nm_003000 .2:c .487t > c
sdhb np_002991 .2:p .s163p
sdhd protein variant
sdhd nm_003002 .4:c .34g > a
sdhd np_002993 .1:p .g12s
setd2 protein variant
netherlands antilles
setd2 np_054878 .5:p .e1265 frameshift
localized pancreatic adenocarcinoma
autologous crispr - cas9 modified / bcl11a enhancer - disrupted cd34 - positive human hematopoietic stem and progenitor cells ctx001
metastatic bladder urachal urothelial carcinoma
smo protein variant
smo np_005622 .1:p .a374e
aua risk stratification for non - muscle invasive bladder cancer
ointment oql011
nanoparticle - based manganese - containing contrast agent sn132d
wt1 - loaded artificial adjuvant vector cell immunotherapeutic asp7517
neuroanatomy
recurrent soft tissue sarcoma of the trunk and extremities
autologous anti - b7 - h3 car retroviral vector - transduced t cells
cd19 - targeted 4 - 1bb ligand ro7227166
anti - psma / cd3 bispecific antibody ccw702
stag2 protein variant
stag2 np_006594 .3:p .r1012x
stat5b gene mutation
stat5b nm_012448 .3:c .1924a > c
stat5b protein variant
stat5b np_036580 .2:p .n642h
neurochemistry
lmp7 inhibitor m3258
stat5b np_036580 .2:p .n713_a714inskgkggg
alk np_004295 .2:p .g159 frameshift
cd80 - fc fusion protein fpt155
tek gene mutation
tek protein variant
tek np_000450 .2:p .n452d
tlr8 gene mutation
tlr8 protein variant
tlr8 np_619542 .1:p .n515h
neuroendocrinology
top2a gene mutation
top2a protein variant
top2a np_001058 .2:p .a1515s
top2a np_001058 .2:p .g1386d
refractory anaplastic oligodendroglioma
refractory anaplastic astrocytoma
sars coronavirus 2
dietary intake
tp53 nm_000546 .5:c .396g > c
tp53 np_000537 .3:p .k132n
neurology
tp53 np_000537 .3:p .g302 frameshift
tp53 nm_000546 .5:c .1010g > a
tp53 np_000537 .3:p .r337h
tp53 nm_000546 .5:c .638g > a
tp53 np_000537 .3:p .r213q
metastatic choroid melanoma
metastatic mucosal melanoma
tp53 nm_000546 .5:c .815t > c
tp53 np_000537 .3:p .v272a
xpc gene mutation
neuropharmacology
xpc protein variant
xpc np_004619 .3:p .s346p
flt4 protein variant
flt4 np_891555 .2:p .a992 frameshift
med12 protein variant
med12 np_891555 .2:p .s672 frameshift
mutyh protein variant
mutyh np_001280119 .1:p .q338h
locally advanced clear cell renal cell carcinoma
trabectedin
neurophysiology
skin soft tissue neoplasm
high resolution peripheral quantitative computed tomography
recurrent anal squamous cell carcinoma
metastatic anal squamous cell carcinoma
alzheimer's disease 17
ppar alpha antagonist tpst - 1120
environmental dna
recurrent acute promyelocytic leukemia with pml - rara
resectable periampullary adenocarcinoma
aids - related kaposi sarcoma t0  ( good risk ) : skin and / or lymph nodes
neuropsychology
aids - related kaposi sarcoma t0  ( good risk ) : minimal oral disease
left - sided breast carcinoma
capecitabine / neratinib regimen
neurosciences
new caledonia
new zealand
nicaragua
niger
nigeria
niue
norfolk island
gastrin immunotoxin
norway
nuclear magnetic resonance
nuclear medicine
nuclear protein
nucleic acid hybridization
nucleotidyltransferase
nursing
nutritional science
obstetrics
occupational exposure
occupational health nursing
occupational medicine
odds ratio
oman
oncoprotein
viral oncogene protein
oncogene
oncology nursing
oogenesis
ophthalmology
bruceanol g
optics
organ culture
orthopedics
otolaryngology
oxidation
oxidation / reduction
oxidoreductase
plasminogen activator inhibitor 1
plasminogen activator inhibitor 2
pakistan
bruceanol h
palpation
panama
papua new guinea
paraguay
parasitology
parity
pathologic process
oral pathology
surgical pathology
patient education
oxamflatin
patient
pattern recognition
pediatrics
peer review
beta - lactamase
peptidase
peptide synthesis
perception
peristalsis
laparoscopy
fungicide
permease
permissiveness
peru
pharmacogenetics
pharmacology
clinical pharmacology
pharmaceutics
phenotype
philippines
apadamtase alfa
phospholipase a2 enzyme family
phosphorus p - 32
phospholipase
phosphatase
phosphoprotein
phosphorylation process
phosphotransferase
photochemistry
photosynthesis
physical sciences
physician office
physics
zoledronic acid
physiology
comparative physiology
pitcairn
plasminogen
tissue - type plasminogen activator
plasminogen activator
plasminogen activator inhibitor
platelet activating factor
platelet aggregation process
pleomorphism
ploidy
poland
polymerase chain reaction
genetic polymorphism
population group
portugal
positron emission tomography
potassium channel
poverty
prevalence
preventive medicine
proctoscopy
prognosis
prophase process
cyclooxygenase
prosthodontics
protein kinase c
protein kinase
post - translational modification
momelotinib dihydrochloride
rituximab
protein tyrosine kinase
protein
netarsudil
proteoglycan
proto - oncogene
proton
psychiatric nursing
psychiatry
psychology
otilimab
clinical psychology
comparative psychology
tipifarnib
educational psychology
experimental psychiatry
pexidartinib hydrochloride
industrial psychology
social psychology
psychometrics
psychopathology
psychopharmacology
psychophysiology
psychosomatic medicine
public health
formal search
preliminary search
blasts 6 percent or more of bone marrow nucleated cells
nelarabine
public health nursing
myeloblasts 5 percent or more of peripheral blood white cells
blasts 5 - 20 percent of bone marrow nucleated cells
ki - 67 positive cells 20 percent or less
mlh3 gene mutation
pik3r2 gene mutation
deleterious mutyh gene mutation
lig3 gene mutation
lig4 gene mutation
public policy
deleterious pole gene mutation
inpp4a gene
inpp4a wt allele
inositol polyphosphate - 4 - phosphatase type i a
inppl1 gene
inppl1 wt allele
phosphatidylinositol 3 , 4 , 5 - trisphosphate 5 - phosphatase 2
inpp4a gene mutation
inppl1 gene mutation
pik3cd gene mutation
public relations
pik3c2g gene mutation
xrcc6 gene mutation
mdc1 gene mutation
pik3r3 gene mutation
pik3c3 gene mutation
deleterious cdkn2a gene mutation
deleterious pold1 gene mutation
inpp4b gene mutation
inpp5d gene mutation
sem1 gene mutation
puerto rico
grem1 gene mutation
deleterious grem1 gene mutation
ret gene alteration positive
neuropathy ,  hereditary sensory and autonomic ,  type i
x - linked lymphoproliferative syndrome 1
spastic paraplegia 30
dilated cardiomyopathy - 1c
peroxisomal acyl - coa oxidase deficiency
autologous anti - cd19 car - cd28 t - cells kte - x19
pulse radiolysis
cdisc protocol endpoint attribute terminology
cdisc protocol endpoint type value set terminology
cdisc protocol outcome measure type value set terminology
cdisc sdtm subcategory for disposition event terminology
cdisc sdtm integumentary system test name terminology
cdisc sdtm integumentary system test code terminology
cdisc sdtm psoriasis findings about test name terminology
cdisc sdtm psoriasis findings about test code terminology
cdisc define - xml odm context terminology
cdisc define - xml origin type terminology
qatar
cdisc define - xml origin source terminology
cdisc define - xml standard type terminology
cdisc define - xml standard name terminology
modified release tablet dosage form
cdisc implementation guide
sdtm implementation guide
send implementation guide
airway volume
metastatic pancreatobiliary carcinoma
locally advanced pancreatobiliary carcinoma
quality of care
locally advanced malignant female reproductive system neoplasm
locally advanced endometrial carcinoma
locally advanced gallbladder carcinoma
downstaging
resectable skin squamous cell carcinoma
resectable skin carcinoma
dexamethasone / isatuximab / pomalidomide regimen
metastatic malignant head and neck neoplasm
advanced malignant head and neck neoplasm
quality of life
locally advanced malignant head and neck neoplasm
chemotherapy - related cognitive impairment
skin atypical lipomatous tumor
skin pleomorphic liposarcoma
skin spindle cell / pleomorphic lipoma
skin spindle cell lipoma
skin pleomorphic lipoma
prkd2 gene mutation
skin angiolipoma
questionnaire
race
collected time duration
collected time duration unit
fetus identifier
nominal study day for tabulations
label for nominal study day
tanomastat
electromagnetic radiation
result anatomical location
date time of last study treatment
date time of first study treatment
planned repro path code
actual reproductive phase day of observation
actual reproductive phase day of observation end
planned reproductive phase day of observation
planned reproductive phase day of observation end
planned reproductive phase day of observation start
actual reproductive phase day of observation start
radiation sensitivity
unscheduled flag
naevus lipomatosus superficialis
many relationship type
refractory cervical carcinoma
metastatic anal carcinoma
advanced anal carcinoma
interleukin - 15 / interleukin - 15 receptor alpha sushi +  domain fusion protein so - c101
advanced thyroid gland carcinoma
iwg hematologic response criteria for treatment response in myeloproliferative neoplasms
iwg hematologic response criteria for treatment response in myelodysplastic syndromes
ionizing radiation
iwg - mrt myelodysplastic syndrome major hematologic improvement - erythroid response in high transfusion burden
iwg - mrt myelodysplastic syndrome minor hematologic improvement - erythroid response in high transfusion burden
cdisc questionnaire fas - nacc uds version 3 .0 test name terminology
cdisc questionnaire fas - nacc uds version 3 .0 test code terminology
cdisc questionnaire eortc qlq - cr29 version 2 .1 test name terminology
cdisc questionnaire eortc qlq - cr29 version 2 .1 test code terminology
cdisc functional test sppb version 1 .2 test name terminology
cdisc functional test sppb version 1 .2 test code terminology
cdisc clinical classification kdigo - aki test name terminology
cdisc clinical classification kdigo - aki test code terminology
nonionizing radiation
fas - nacc uds version 3 .0 questionnaire question
eortc qlq - cr29 version 2 .1 questionnaire question
sppb version 1 .2 functional test question
kdigo - aki clinical classification question
ipratropium bromide anhydrous
levofloxacin anhydrous
radioactivity
endobronchial ultrasound - guided miniforceps biopsy
lower limit of quantification derivation technique
upper limit of quantification derivation technique
phantom record imputation technique
one half of lower limit of quantification derivation technique
assigned value
collected value
derived value
radiation biology
copied value
protocol value
adam implementation guide
sdtm implementation guide - associated persons
sdtm implementation guide - medical devices
sdtm implementation guide - pharmacogenomics / genetics
send implementation guide - developmental and reproductive toxicology
study endpoint type
justification for study endpoint
exploratory endpoint
radiochemistry
direct endpoint
composite endpoint
prepared amount
remaining amount
parieto - occipital
glucose target level
glucose alert threshold
device data blinded status
sponsor device description
study participation
radioimmunoassay
study treatment phase participation
death witnessed indicator
fda study data technical conformance guide v4 .4
long modified release tablet dosage form
short modified release tablet dosage form
affected body surface area to total body surface area ratio measurement
fibrosis 4 formula
soluble b cell maturation antigen measurement
5 - hydroxyindoleacetic acid to creatinine ratio measurement
soluble complement c5b - 9 measurement
radiologic health
immature platelets to total platelets ratio measurement
methylphenidate measurement
ritalinic acid measurement
ethyl glucuronide and ethyl sulfate measurement
ethyl glucuronide measurement
ethyl sulfate measurement
factor x activity actual / control ratio measurement
factor v activity actual to control ratio measurement
factor ix activity actual to control ratio measurement
factor vii activity actual to control ratio measurement
radiology
factor x actual to control ratio measurement
prothrombin time actual to control ratio measurement
antithrombin actual to control ratio measurement
protein s actual to control ratio measurement
factor xiv actual to control ratio measurement
renal epithelial cells measurement
free protein s actual to control ratio measurement
von willebrand factor actual to control ratio measurement
free thyroxine index
skin around the eye
sabarubicin
hras gene
skin around the mouth
perifacial lymph node
skinfold
skin of the bending joint
skin of the palm
nail bed
skin of the sole
most recent flare
cytomegalovirus pp65 antigen measurement
human rhinovirus / enterovirus rna measurement
ras family oncogene
withdrawal of consent from protocol - specified activity
accumulation ratio auc infinity observed
accumulation ratio auc infinity predicted
accumulation ratio auc infinity observed normalized by dose
accumulation ratio auc infinity predicted normalized by dose
metabolite ratio auc from t1 to t2
cardiac assist device
quality of life impact
specific airway volume
airway wall volume
beta adrenergic receptor
air trapping measurement
percent predicted airway volume
percent predicted specific airway volume
percent predicted airway resistance
percent predicted specific airway resistance
forced expiratory volume in 3 seconds to forced vital capacity ratio measurement
forced expiratory volume in 1 second to slow vital capacity ratio measurement
percent predicted forced expiratory volume in 3 seconds
serum or plasma or blood
disease modifying treatment study
androgen receptor
kilovolt
log10 plaque forming units per milliliter
dna copies per microgram
days per week
days per month
hours per week
per 50 , 000 white blood cells
mask dosing unit
lens dosing unit
crown to heel length
proto - oncogene mas
congestion and hemorrhage
hyperplasia and hyperkeratosis
physeal dysplasia
fas - nacc uds version 3 .0  -  writing checks ,  paying bills
fas - nacc uds version 3 .0  -  assembling tax records
fas - nacc uds version 3 .0  -  shopping alone for clothes
t - cell receptor
fas - nacc uds version 3 .0  -  playing a game of skill
fas - nacc uds version 3 .0  -  heating water ,  making coffee
fas - nacc uds version 3 .0  -  preparing a balanced meal
fas - nacc uds version 3 .0  -  keeping track of current events
fas - nacc uds version 3 .0  -  paying attention and understanding tv
fas - nacc uds version 3 .0  -  remembering appointments
fas - nacc uds version 3 .0  -  traveling out of the neighborhood
eortc qlq - cr29 version 2 .1  -  urinate frequently during day
eortc qlq - cr29 version 2 .1  -  urinate frequently during night
eortc qlq - cr29 version 2 .1  -  unintentional release of urine
dopamine receptor
eortc qlq - cr29 version 2 .1  -  pain when you urinated
eortc qlq - cr29 version 2 .1  -  did you have abdominal pain
eortc qlq - cr29 version 2 .1  -  pain in buttocks / anal area / rectum
eortc qlq - cr29 version 2 .1  -  bloated feeling in your abdomen
eortc qlq - cr29 version 2 .1  -  have you had blood in your stools
eortc qlq - cr29 version 2 .1  -  have you had mucus in your stools
eortc qlq - cr29 version 2 .1  -  did you have a dry mouth
eortc qlq - cr29 version 2 .1  -  lost hair as result of treatment
eortc qlq - cr29 version 2 .1  -  problems with your sense of taste
eortc qlq - cr29 version 2 .1  -  worried about your health future
cell surface receptor
eortc qlq - cr29 version 2 .1  -  worried about your weight
eortc qlq - cr29 version 2 .1  -  felt physically less attractive
eortc qlq - cr29 version 2 .1  -  feeling less feminine / masculine
eortc qlq - cr29 version 2 .1  -  been dissatisfied with your body
eortc qlq - cr29 version 2 .1  -  do you have stoma bag
eortc qlq - cr29 version 2 .1  -  unintentional gas from stoma bag
eortc qlq - cr29 version 2 .1  -  leakage of stools from stoma bag
eortc qlq - cr29 version 2 .1  -  sore skin around your stoma
eortc qlq - cr29 version 2 .1  -  frequent bag changes during day
eortc qlq - cr29 version 2 .1  -  frequent bag changes during night
epidermal growth factor receptor
eortc qlq - cr29 version 2 .1  -  feel embarrassed because of stoma
eortc qlq - cr29 version 2 .1  -  problems caring for your stoma
eortc qlq - cr29 version 2 .1  -  unintentional gas back passage
eortc qlq - cr29 version 2 .1  -  leakage of stools back passage
eortc qlq - cr29 version 2 .1  -  sore skin around your anal area
eortc qlq - cr29 version 2 .1  -  frequent bowel movements day
eortc qlq - cr29 version 2 .1  -  frequent bowel movements night
eortc qlq - cr29 version 2 .1  -  embarrassed because bowel movement
eortc qlq - cr29 version 2 .1  -  men: extent interested in sex
eortc qlq - cr29 version 2 .1  -  men: difficulty getting erection
estrogen receptor family
eortc qlq - cr29 version 2 .1  -  women: extent interested in sex
eortc qlq - cr29 version 2 .1  -  women: pain or discomfort intercourse
kdigo - aki  -  kdigo aki stage
sppb version 1 .2  -  side - by - side score
sppb version 1 .2  -  side - by - side seconds held if  < 10
sppb version 1 .2  -  semi - tandem stand score
sppb version 1 .2  -  semi - tandem seconds held if  < 10
sppb version 1 .2  -  tandem stand score
sppb version 1 .2  -  tandem seconds if  < 10
sppb version 1 .2  -  did not attempt test balance
voriconazole
fc receptor
sppb version 1 .2  -  did not attempt balance specify
sppb version 1 .2  -  total balance tests score
sppb version 1 .2  -  length of walk test course
sppb version 1 .2  -  time for 3 or 4 meters 1st gait
sppb version 1 .2  -  did not attempt 1st gait
sppb version 1 .2  -  did not attempt 1st gait specify
sppb version 1 .2  -  aids used 1st gait
sppb version 1 .2  -  aids used 1st gait specify
sppb version 1 .2  -  time for 3 or 4 meters  -  2nd gait
sppb version 1 .2  -  did not attempt or failed 2nd gait
glucocorticoid receptor
sppb version 1 .2  -  did not attempt 2nd gait specify
sppb version 1 .2  -  aids used 2nd gait
sppb version 1 .2  -  aids used 2nd gait specify
sppb version 1 .2  -  for 4 - meter walk
sppb version 1 .2  -  for 3 - meter walk
sppb version 1 .2  -  safe to stand without help
sppb version 1 .2  -  results single chair
sppb version 1 .2  -  did not attempt single chair
sppb version 1 .2  -  not attempt single chair specify
sppb version 1 .2  -  safe to stand five times
insulin receptor
sppb version 1 .2  -  time to complete five stands
sppb version 1 .2  -  did not attempt repeated chair
sppb version 1 .2  -  not attempt repeated chair specify
sppb version 1 .2  -  chair stand score repeated
sppb version 1 .2  -  total score
benign periampullary neoplasm
recurrent malignant breast neoplasm
recurrent breast sarcoma
metastatic malignant breast neoplasm
contract human over - the - counter fdf manufacturing produced under a monograph
interleukin - 2 receptor subunit alpha
triosephosphate - isomerase deficiency
winchester syndrome
inherited osteolysis syndrome
primary peritoneal adenocarcinoma
appendix mucinous neoplasm
usp6 gene rearrangement
pleomorphic fibroma
target area under curve
11q12 translocation
fosl1 protein overexpression
low - density lipoprotein receptor
symptomatic therapy
vigorous supportive therapy
recombinant bacterial minicells vax014
liposomal bcl - 2 antisense oligonucleotide  bp1002
alofanib
hyaluronic acid / chondroitin sulfate / poloxamer 407 oral solution
sdf - 1 receptor antagonist ptx - 9908
autologous anti - bcma - car - 4 - 1bb - cd3zeta - expressing t - cells c - car088
recurrent platinum - resistant ovarian carcinoma
cdk4 / 6 inhibitor hs - 10342
progesterone receptor
recurrent platinum - resistant fallopian tube carcinoma
recurrent platinum - resistant primary peritoneal carcinoma
oligo - fucoidan
lipid nanoparticle encapsulating glutathione s - transferase p sirna nbf - 006
recurrent ovarian undifferentiated carcinoma
recurrent fallopian tube undifferentiated carcinoma
recurrent primary peritoneal undifferentiated carcinoma
recurrent fallopian tube transitional cell carcinoma
anti - pd - 1 monoclonal antibody sct - i10a
recurrent primary peritoneal transitional cell carcinoma
prolactin receptor
recurrent fallopian tube clear cell adenocarcinoma
recurrent primary peritoneal clear cell adenocarcinoma
fc - engineered anti - cd40 agonist antibody 2141 - v11
simmitinib
parp7 inhibitor rbn - 2397
c - met inhibitor abn401
recurrent fallopian tube adenocarcinoma
recurrent primary peritoneal adenocarcinoma
sonocloud - 9
purinergic receptor
upper alveolar ridge
lower alveolar ridge
superficial bladder urothelial carcinoma
recurrent superficial bladder urothelial carcinoma
alveolar ridge squamous cell carcinoma
upper alveolar ridge squamous cell carcinoma
lower alveolar ridge squamous cell carcinoma
advanced rectal carcinoma
locally advanced rectal carcinoma
metastatic rectal squamous cell carcinoma
thyroid hormone receptor
advanced rectal squamous cell carcinoma
locally advanced rectal squamous cell carcinoma
locally advanced oropharyngeal carcinoma
advanced oropharyngeal carcinoma
advanced pharyngeal carcinoma
locally advanced vulvar carcinoma
advanced vulvar carcinoma
locally advanced vaginal carcinoma
advanced vaginal carcinoma
locally advanced penile carcinoma
transferrin receptor
advanced penile carcinoma
transthyretin stabilizer ag10
family history of high - risk germline mutations
precontrast ,  3 - dimensional ,  isotropic ,  ir - prepped t1 - weighted gradient echo mri
2 - dimensional fluid - attenuated inversion recovery mri
2 - dimensional ,  diffusion - weighted imaging /  diffusion tensor imaging
2 - dimensional t2 - weighted mri
proton density mri
2 - dimensional proton density ,  t2 - weighted mri
postcontrast ,  3 - dimensional ,  isotropic ,  ir - prepped t1 - weighted gradient echo mri
agent
viral receptor
ipsc - derived cd16 / il - 15rf - expressing anti - cd19 car - nk cells ft596
short - term fasting
kawasaki disease - associated coronary artery aneurysm z - score finding
metastatic endometrial serous adenocarcinoma
advanced endometrial adenocarcinoma
metastatic endometrial endometrioid adenocarcinoma
advanced endometrioid adenocarcinoma
advanced endometrial serous adenocarcinoma
recombinant protein
advanced endometrial endometrioid adenocarcinoma
metastatic malignant skin neoplasm
advanced malignant skin neoplasm
sublingual lyophilisate dosage form
primary brain neoplasm
bite antibody amg 910
refractory malignant mastocytosis
recurrent malignant mastocytosis
sisunatovir
disrupted in renal carcinoma 3
dna recombination process
gadolinium contrast - enhanced abbreviated mri
electronic health record review
intraputaminal route of administration
prolonged - release dispersion for injection dosage form
medicinal wrapper
texting smoking cessation program
unresectable desmoplastic small round cell tumor
metastatic desmoplastic small round cell tumor
metastatic rhabdoid tumor
unresectable rhabdoid tumor
regeneration
recurrent extracranial malignant solid neoplasm
metastatic thyroid gland anaplastic carcinoma
refractory thyroid gland anaplastic carcinoma
unresectable thyroid gland anaplastic carcinoma
rubcn gene
rubcn wt allele
run domain beclin - 1 - interacting and cysteine - rich domain - containing protein
ceacam3 gene
ceacam3 wt allele
carcinoembryonic antigen - related cell adhesion molecule 3
rel gene
psg1 gene
psg1 wt allele
pregnancy - specific beta - 1 - glycoprotein 1
oxychip
electron paramagnetic resonance oximetry
fact - icm toxicity questionnaire
fatigue prevents me from doing things i want to do
bothered by skin rash
bothered by itching
bothered by white patches on skin
religion
feel pain ,  soreness ,  or aches in some areas of body
have trouble sleeping at night
bothered by short - term treatment reactions experienced immediately after or within 24 hours of an infusion
troubled by not knowing side effects timing ,  length ,  or severity
worry about negative impacts of treatment on long term health
ms4a4a gene
ms4a4a wt allele
membrane - spanning 4 - domains subfamily a member 4a
rabl3 gene
rabl3 wt allele
repression
impact of events scale - revised
rab - like protein 3
reminder brought back feelings of event
have trouble staying asleep
other things made me think about event
feel irritable and angry
avoid getting upset when thought or reminded of event
thought of event when didn't mean to
felt as if event didn't happen or wasn't real
stay away from reminders of event
reproduction
pictures of event pop into mind
jumpy and easily startled
try not to think about event
aware of feeling about event but didn't deal with them
feeling numb about event
acting or feeling like at time of event
have waves of strong feelings about event
tried to remove event from memory
reminders of the event cause physical reactions
dream about event
request for proposals
feel watchful and on guard
tried not talking about event
goal setting
acral edema
cardiac radiofrequency ablation
neurogenic orthostatic hypotension
allogeneic cd8 +  leukemia - associated antigens specific t cells nexi - 001
dermatomyofibroma
plaque - like cd34 - positive dermal fibroma
research personnel
interleukin - 15 / interleukin - 15 receptor alpha complex - fc fusion protein xmab24306
nipocalimab
t ( 7 ; 12 )  ( p21 - 22 ; q13 - 15 )
inactivated oncolytic virus particle gen0101
fap / 4 - 1bb - targeting darpin mp0310
primary oncologist
primary radiation oncologist
primary medical oncologist
primary referring physician
autologous blinatumomab - expanded t - cells
particulate
research support
pd - l1 inhibitor gs - 4224
anti - cd19 icar nk cells
anti - cd19 / cd22 car nk cells
autologous 1928t2z car t - cells wztl - 002
anti - tigit monoclonal antibody bgb - a1217
recombinant human trail - trimer fusion protein scb - 313
autologous multi - lineage potential cells
anti - pd - 1 / vegf bispecific antibody ak112
respiration
locally advanced colon carcinoma
refractory myeloproliferative neoplasm
uridine phosphorylase inhibitor tk - 112690
autologous anti - cd147 car t - cells
autologous crispr - edited anti - cd19 car t cells xyf19
anti - bcma antibody - drug conjugate cc - 99712
multimodal ultrasound tomography
hif2a rnai aro - hif2
malignant jejunal neoplasm
respiratory physiology
actb / gli1 fusion gene
gli1 / actb fusion gene
actb / gli1 fusion protein
gli1 / actb fusion protein
metastatic carcinosarcoma
severity of chief complaint based on verbal 0 - 10 scale
severity of chief complaint based on wong - baker scale
severity of chief complaint based on infant flacc scale
advanced carcinosarcoma
metastatic malignant mixed mesodermal  ( mullerian )  tumor
restriction fragment length polymorphism
advanced malignant mixed mesodermal  ( mullerian )  tumor
metastatic uterine corpus carcinosarcoma
anti - her2 / her3 dendritic cell vaccine
metastatic ovarian carcinosarcoma
advanced ovarian carcinosarcoma
advanced ovarian serous adenocarcinoma
metastatic ovarian endometrioid adenocarcinoma
restriction enzyme mapping
malignant fundus neoplasm
malignant optic nerve neoplasm
advanced ovarian endometrioid adenocarcinoma
metastatic malignant neoplasm in the urinary system
metastatic ovarian clear cell adenocarcinoma
advanced ovarian clear cell adenocarcinoma
patient - derived models repository
electroporation delivery device
cellectra 2000 electroporation device
cevidoplenib dimesylate
reunion
personalized neoantigen dna vaccine gnos - pvo2
braf ( v600e )  kinase inhibitor abm - 1310
cd73 inhibitor ly3475070
locally advanced chondrosarcoma
recurrent mucosal melanoma
platinum - resistant malignant germ cell tumor
resectable platinum - resistant malignant germ cell tumor
metastatic platinum - resistant malignant germ cell tumor
advanced platinum - resistant malignant germ cell tumor
advanced adenocarcinoma of unknown primary
reverse transcriptase
advanced carcinoma of unknown primary
resectable carcinoma of unknown primary
resectable adenocarcinoma of unknown primary
resectable malignant female reproductive system neoplasm
weather
locally advanced thyroid gland carcinoma
advanced primary malignant central nervous system neoplasm
advanced malignant germ cell tumor
refractory ovarian adenocarcinoma
unresectable fallopian tube carcinoma
reverse transcription process
unresectable fallopian tube adenocarcinoma
refractory fallopian tube adenocarcinoma
metastatic primary peritoneal adenocarcinoma
unresectable primary peritoneal carcinoma
unresectable primary peritoneal adenocarcinoma
refractory primary peritoneal adenocarcinoma
anti - prame t - cell receptor / anti - cd3 scfv fusion protein imc - f106c
colon large cell neuroendocrine carcinoma
advanced glioblastoma
metastatic glioblastoma
locally advanced glioblastoma
numeric age for data tabulation
study age range
tissue anatomical region
planned study arm name
body system or organ class code
body system or organ class name
drug ,  procedure ,  or therapy class
drug ,  procedure ,  or therapy class code
concomitant or additional treatment given indicator
rheumatology
country of investigational site
dictionary - derived term for the event or intervention
observation duration
study data tabulation study day
planned elapsed time from time point reference
study data tabulation study day of end of observation
record or parameter group identifier
electrical lead recording
modified collected term
normal or reference range description
pentetic acid calcium
ribonuclease
prespecified event or intervention indicator
outcome of event
body position during assessment
reason for assessment
biospecimen usability indicator
study data tabulation study day of start of observation
normal range for character results
normal range upper limit for standardized result
normal range lower limit for standardized result
numeric result or finding in standard format
ribonucleotide reductase
clinical encounter name
planned study day of clinical encounter
recurrent prostate adenocarcinoma
supratentorial gliosarcoma
recurrent triple - negative breast carcinoma
refractory ovarian serous adenocarcinoma
metastatic fallopian tube serous adenocarcinoma
unresectable fallopian tube serous adenocarcinoma
refractory fallopian tube serous adenocarcinoma
metastatic primary peritoneal serous adenocarcinoma
risk
unresectable primary peritoneal serous adenocarcinoma
refractory primary peritoneal serous adenocarcinoma
particle total count
human papillomavirus - related mucosal head and neck squamous cell carcinoma
visceral angiosarcoma
tongue adenoid cystic carcinoma
study data tabulation planned time point name
risk factor
study data tabulation reference time point
thymic neuroendocrine carcinoma
ovarian neuroendocrine carcinoma
endometrial neuroendocrine carcinoma
anti - cd37 - car - expressing t - lymphocytes
parietal lobe anaplastic astrocytoma
mediastinal non - hodgkin lymphoma
ly75 / cd302 readthrough gene
ly75 / cd302 fusion protein
dna - directed rna polymerase
carboplatin / durvalumab / etoposide regimen
cisplatin / durvalumab / etoposide regimen
ntrk gene rearrangement
neoplastic plasma cells under 5 percent of peripheral blood white cells
kir3dl2 gene
kir3dl2 wt allele
killer cell immunoglobulin - like receptor 3dl2
kir3dl2 positive
apc nm_000038 .6:c .3920t > a
rna - directed rna polymerase
apc np_000029 .2:p .i1307k
fgf23 overexpression positive
ki - 67 positive cells greater than or equal to 15 percent
chromosome 17p abnormality
chromosome 12 abnormality
chromosome 13q abnormality
central nervous system involvement in recurrent b acute lymphoblastic leukemia
innate lymphoid cell
innate lymphoid cell count
allosteric erbb inhibitor bdtx - 189
rna splicing
low adamts13 activity
triggering receptors expressed on myeloid cells family protein
cd33 expression 20 percent or more of neoplastic cells
bone marrow blasts percentage decreased by 5 to 25 percent
refractory hairy cell leukemia variant
recurrent hairy cell leukemia variant
allogeneic anti - bcma - car t - cells pbcar269a
atr kinase inhibitor m1774
htlv positive
ptk7 positive
trna methyltransferase
unresectable primary central chondrosarcoma
deleterious bap1 gene mutation
metastatic primary central chondrosarcoma
deleterious atrx gene mutation
deleterious blm gene mutation
deleterious arid1a gene mutation
psa density less than 0 .15
cdkn2b negative
sensitizing braf gene mutation
sensitizing ros1 gene mutation
romania
action characteristic
medical status
organism characteristic
product status
military status
person status
person / individual attribute
population group characteristic
functional disorder of polymorphonuclear neutrophils
rural health
non - alcoholic fatty liver disease fibrosis score
physical object property
autologous cd19 - targeted car - t cells gc007f
autologous bispecific cd19 / cd22 - targeted car - t cells gc022
cdrh health effect  -  impact code terminology
lactobacillus probiotic bsl_ps6
zirconium zr 89 anti - cd8 antibody zed88082a
autologous clonal neoantigen t cells atl001
qualitative platelet disorder
arginine / nucleotides / omega - 3 fatty acids / olive oil polyphenols / antioxidants / l - carnitine oral supplement
myeloablative agonist
rural population
hpv16 infection
cutaneous lymphoma
lrp5 antagonist bi 905681
study status
russian federation
rwanda
non - neoplastic endocrine pancreas disorder
saint lucia
covid - 19 infection
bothered by dry skin
ambulatory
date of recurrence
time of exposure of six weeks or more
bacterial colonization
igkc gene
saint vincent and the grenadines
igkc wt allele
immunoglobulin kappa constant
b - cell genotyping assay
epstein - barr virus test
human papillomavirus e6 / e7 protein measurement
human papillomavirus test
salmonella septicemia
nocardiosis
wasting syndrome
transfusion recipient
san marino
tumor - associated lymphocytosis
aryl hydrocarbon receptor inhibitor ik - 175
single cell rna sequencing
tissue microarray image
combined nucleotide variation profile
ann arbor stage iix  ( bulky )
ann arbor stage iix  ( bulky )  diffuse large b - cell lymphoma
ann arbor stage iix  ( bulky )  non - hodgkin lymphoma
sao tome and principe
study enrollment status
bispecific antibody agen1223
study accrual status
anti - egfr / cd16a bispecific antibody afm24
echosure
marker device
echomark
autologous anti - cd123 car - t cells
refractory extraskeletal myxoid chondrosarcoma
extrarenal rhabdoid tumor of the ovary
saudi arabia
recurrent extrarenal rhabdoid tumor of the ovary
refractory extrarenal rhabdoid tumor of the ovary
tracheoscopy
xisomab 3g3
cannabis use disorder
delins mutation
nucleic acid aliquot
sequencing data file
sequence variant report
variant nucleotide
school
source - specific sequence variant report unique identifier
protocol treatment arm unique identifier
protocol treatment arm assignment rationale
clinical trial short name
estimated copy number 5 percent confidence interval
estimated copy number 95 percent confidence interval
clinical diagnosis by ctep disease category
clinical diagnosis by ctep disease sub - category
variant exon
anti - dr5 monoclonal antibody
cellular secretion
electronic file description
electronic file name
electronic file size
electronic file status
cetuximab / encorafenib regimen
diamandopoulos' a . formula
pill count
sequela of tuberculosis
postprocedural respiratory disorder
biomechanical lesion
recombinant gamma chemokine
support group
enlarged prostate with lower urinary tract symptoms
salpingo - oophoritis
supravesical fissure of urinary bladder
head mass
thoracic injury
superficial injury of abdomen ,  lower back and pelvis
ovarian injury
prostatic injury
adverse drug reaction to systemic antibiotic
follow - up examination after treatment for malignant neoplasm
senegal
genetic susceptibility to malignant neoplasm
surgical follow - up care
chemotherapy session for neoplasm
patient problem related to employment and unemployment
patient problem related to housing and economic circumstance
counseling related to sexual attitude ,  behavior and orientation
dietary counseling and surveillance
encounter for issue of repeat prescription
family history of ovarian cancer
personal history of respiratory tract cancer
serine proteinase inhibitor protein
personal history of cutaneous melanoma
personal history of nicotine dependence
acquired absence of breast
transplanted organ or tissue status other than kidney ,  heart ,  lung ,  heart and lungs ,  liver ,  skin ,  bone ,  or corneal transplant
stem cell transplant status
dependence on enabling machines and devices ,  not elsewhere classified
tuberculosis of urinary organ
wide excision of lesion of lip
volunteer activity
personal history of gastric cancer
serine protease
personal history of laryngeal cancer
personal history of prostate cancer
personal history of leukemia
personal history of lymphoid leukemia
personal history of myeloid leukemia
personal history of lymphatic and hematopoietic neoplasms
personal history of bone cancer
family history of gastrointestinal tract cancer
family history of respiratory or intrathoracic cancer
family history of breast cancer
serpin
family history of reproductive system cancer
family history of prostate cancer
family history of testicular cancer
family history of kidney cancer
family history of urinary system cancer
family history of leukemia
family history of lymphatic and hematopoietic neoplasms
family history of other specified cancer
family history of unspecified cancer
patient gender
serum globulin
fusion gene upstream gene symbol
leidos biomedical research
electronic file format
fusion gene downstream gene symbol
fusion gene upstream gene read count
fusion gene downstream gene read count
non - medical object or device
smoking device
batch product
biopsy molecular sample aliquot unique identifier
serum protein
alloantibody
variant amino acid
biopsy sample unique identifier
clinical trial long name
advanced diffuse large b - cell lymphoma
oligometastatic prostate carcinoma
assay identifier
bare lymphocyte syndrome type 1
bare lymphocyte syndrome type 2
spinocerebellar ataxia type 42
sex behavior
fg syndrome type 1
incentive spirometry
immunohistochemistry assay unique identifier
gene symbol of target in immunohistochemistry assay
median absolute percentage deviation
copy number median absolute percentage deviation
md5 checksum
nucleic acid concentration
nucleic acid sample type indicator
aliquot volume
sex hormone - binding globulin
locally advanced hypopharyngeal carcinoma
locally advanced oral cavity carcinoma
locally advanced malignant skin neoplasm
locally advanced cutaneous melanoma
recurrent lung non - small cell squamous carcinoma
siglec10 gene
siglec10 wt allele
seychelles
sialic acid - binding ig - like lectin 10
epb41l5 gene
epb41l5 wt allele
band 4 .1 - like protein 5
recurrent ocular melanoma
metastatic ocular melanoma
locally advanced ocular melanoma
locally advanced non - cutaneous melanoma
locally advanced liver carcinoma
indolent b - cell non - hodgkin lymphoma
tyrphostin ag 126
sierra leone
indolent t - cell non - hodgkin lymphoma
iqsec1 gene
iqsec1 wt allele
iq motif and sec7 domain - containing protein 1
advanced myxofibrosarcoma
macf1 gene
macf1 wt allele
microtubule - actin cross - linking factor 1 ,  isoforms 1 / 2 / 3 / 5
mff gene
mff wt allele
sigmoidoscopy
mitochondrial fission factor
fbxl19 gene
fbxl19 wt allele
f - box / lrr - repeat protein 19
setd5 gene
setd5 wt allele
histone - lysine n - methyltransferase setd5
locally advanced fibrosarcoma
autologous anti - b7 - h3 / cd19 car t - cells scri - carb7h3 ( s ) x19
adrm1 gene
signaling pathway
adrm1 wt allele
proteasomal ubiquitin receptor adrm1
unresectable bile duct carcinoma
psmd2 gene
breath test device
psmd2 wt allele
metastatic ampulla of vater carcinoma
locally advanced ampulla of vater carcinoma
26s proteasome non - atpase regulatory subunit 2
advanced ampulla of vater carcinoma
signal transduction
advanced pancreatobiliary carcinoma
advanced biliary tract carcinoma
tumor suppressor gene indicator
ncbi transcript identifier
torrent variant caller version text
sequencing assay unique identifier
sequencing quality control result
refractory myelodysplastic / myeloproliferative neoplasm
singapore
refractory primary myelofibrosis
biological and chemical component
lesion size
ido / tdo inhibitor ly - 01013
cdk4 / 6 inhibitor tqb3616
clinical status ordinal scale
clinical status ordinal scale outcome 1
clinical status ordinal scale outcome 2
iodine i 131 ipa
clinical status ordinal scale outcome 3
oncogene sis
clinical status ordinal scale outcome 4
clinical status ordinal scale outcome 5
clinical status ordinal scale outcome 6
clinical status ordinal scale outcome 7
cdisc clinical classification news2 test name terminology
cdisc clinical classification news2 test code terminology
news2 clinical classification question
news2  -  respirations
news2  -  oxygen saturation spo2 scale 1
sister chromatid exchange process
news2  -  oxygen saturation spo2 scale 2
news2  -  air or oxygen
news2  -  air or oxygen: device
news2  -  systolic blood pressure
news2  -  pulse
news2  -  consciousness
news2  -  temperature
news2  -  news total
news2  -  monitoring frequency
news2  -  escalation of care
skin test
copper cu 67 tyr3 - octreotate
genetically modified interleukin - 12 transgene - encoding bifidobacterium longum
irdye800 - labeled heterodimeric peptide ksp - qrh 919288g
cationic peptide cream cypep - 1
capecitabine / trastuzumab / tucatinib regimen
islr gene
recombinant humanized anti - her - 2 bispecific monoclonal antibody mbs301
islr wt allele
immunoglobulin superfamily containing leucine - rich repeat protein
slovenia
sp4 gene
3' - da phosphoramidate nuc - 7738
sp4 wt allele
shenqi fuzheng injection sq001
interleukin - 15 agonist fusion protein shr1501
transcription factor sp4
plasmid dna vaccine ping - hher3fl
gfral gene
gfral wt allele
olfaction
radix polygalae extract pdc - 1421
gdnf family receptor alpha - like
individualized mva - based vaccine tg4050
cd302 gene
cd302 wt allele
cd302 antigen
usp32 gene
usp32 wt allele
ubiquitin carboxyl - terminal hydrolase 32
locally advanced synovial sarcoma
recombinant flt3 ligand
passive smoke exposure
tbc1d3 gene
tbc1d3 wt allele
near infrared imaging
tbc1 domain family member 3
rab5a gene
rab5a wt allele
ras - related protein rab - 5a
cdisc clinical classification rass test name terminology
cdisc clinical classification rass test code terminology
social sciences
rab5b gene
rab5b wt allele
cdisc clinical classification sas test name terminology
cdisc clinical classification sas test code terminology
rass clinical classification question
sas clinical classification question
ras - related protein rab - 5b
rass  -  score
social work
sas  -  score
have trouble falling asleep or staying asleep
microbiome gen - 001
ct - guided stereotactic body radiation therapy
mri - guided stereotactic body radiation therapy
epha2 - targeting bicycle toxin conjugate bt5528
hypodontia
how frequently true
sociology
personalized neoantigen dna vaccine gnos - pv01
cetuximab / docetaxel regimen
eligibility for post - operative systemic therapy
treatment performed at study site indicator
treatment performed in minimal residual disease indicator
sample anatomic site
sample pathology indicator
icdc summarized sample type indicator
tumor sample origin indicator
severe acute respiratory syndrome coronavirus 2 antibody measurement
medical sociology
outpatient encounter
countermeasure
cdisc sdtm covid - 19 findings about test name terminology
cdisc sdtm covid - 19 findings about test code terminology
cdisc sdtm health care encounters dictionary derived term terminology
cdisc sdtm mode of subject contact terminology
sodium channel
anti - cd39 monoclonal antibody srf617
fertility and reproductive counseling
epidemic disorder
hospital stay
intensive care unit stay
fluid output
coronaviridae measurement
non - invasive mechanical ventilation
computer program
software engineering
solomon islands
somalia
adenoviridae measurement
appropriate developmental age indicator
tyrphostin ag 1478
sos function
bilevel positive airway pressure ventilation
cardiac catheterization laboratory visit
cardiac intensive care unit stay
endemic disorder
endotracheal fluid
epidemic or pandemic related disruption indicator
name of epidemic or pandemic
extracorporeal membrane oxygenation
estimated fluid output
general ward stay
south africa
high - flow nasal cannula oxygen therapy
immediately life - threatening disorder
infiltrates indicator
infant less than one year indicator
medical countermeasure
mers - cov rna measurement
middle east respiratory syndrome coronavirus
neuro intensive care unit stay
nursing home stay
pandemic disorder
spain
physical therapy facility visit
pneumonia indicator
psychiatric ward stay
rehabilitation facility stay
audioconferencing
audio - videoconferencing
respiratory syncytial virus measurement
sars - cov - 2 iga antibody measurement
sars - cov - 2 igg antibody measurement
sars - cov - 2 igg and / or igm antibody measurement
medical specialty
sars - cov - 2 igm antibody measurement
sars - cov - 2 rna measurement
severe acute respiratory syndrome coronavirus 2 measurement
shipment confirmed by signature
skilled nursing facility stay
surgical intensive care unit stay
telemedicine visit
telephone call
endogenous cushing syndrome
recurrent endogenous cushing syndrome
surgical specialty
oncolytic herpes simplex virus - 1 oncr - 177
anti - cd137 agonistic monoclonal antibody lvgn6051
food insecurity
insecurity
job insecurity
occupational prestige
novottf - 100l
asymptomatic covid - 19 infection laboratory - confirmed
symptomatic covid - 19 infection laboratory - confirmed
spectroscopy
covid - 19 - associated pneumonia
covid - 19 - associated acute respiratory distress syndrome
covid - 19 - associated nervous system disorder
covid - 19 - associated encephalitis
covid - 19 - associated acute hemorrhagic necrotizing encephalitis
covid - 19 - associated ataxia
covid - 19 - associated trigeminal neuralgia
non - neoplastic trigeminal nerve disorder
covid - 19 - associated anosmia
mass spectrometry
covid - 19 - associated cerebrovascular accident
covid - 19 - associated myalgia
covid - 19 - associated coagulation disorder
covid - 19 - associated thromboembolism
covid - 19 - associated acute gastrointestinal tract injury
covid - 19 - associated acute intestinal injury
covid - 19 - associated acute liver injury
covid - 19 - associated acute digestive system injury
covid - 19 - associated acute kidney injury
covid - 19 - associated hematuria
raman spectroscopy
covid - 19 - associated albuminuria
exposed to covid - 19
advanced cutaneous melanoma
metastatic cutaneous squamous cell carcinoma of the head and neck
advanced cutaneous squamous cell carcinoma of the head and neck
refractory cutaneous squamous cell carcinoma of the head and neck
aggressive variant prostate carcinoma
anti - b7 - h3 / dxd antibody - drug conjugate ds - 7300a
household wealth
advanced chromophobe renal cell carcinoma
metastatic chromophobe renal cell carcinoma
advanced sarcomatoid renal cell carcinoma
advanced unclassified renal cell carcinoma
metastatic unclassified renal cell carcinoma
since starting treatment
unresectable colorectal adenocarcinoma
social determinants of health
epa air quality index
concentrated poverty index
california health interview survey
alaryngeal speech
community educational attainment
english proficiency test
environmental justice screening and mapping tool
usda six - item standard measure
traditional retail food environment index
short assessment of health literacy - english
numeracy understanding in medicine instrument
general social survey
current population survey ,  labor force items
american community survey
lintuzumab
social vulnerability index
panel study of income dynamics ,  wealth supplement
peripartum cardiomyopathy
leukoencephalopathy with ataxia
refractory esophageal carcinoma
refractory squamous cell carcinoma
refractory esophageal squamous cell carcinoma
advanced esophageal squamous cell carcinoma
unresectable esophageal squamous cell carcinoma
refractory lung non - small cell squamous carcinoma
spermatogenesis
unresectable endometrial carcinoma
unresectable prostate carcinoma
unresectable lung non - small cell squamous carcinoma
lung cyst
positive history of covid - 19
alk inhibitor tae684
mdm2 inhibitor amgmds3
hras positive
nras positive
mdm2 gene amplification negative
src family gene
monoallelic mutyh gene mutation
impact of events scale
ifgf23 level greater than or equal to 100 pg / ml
del ( 5q31 )
del ( 12p13 .2 )
rearrangement of 11p15
rearrangement of 12p13 .2
hla - c gene product
hla - drb3 gene product
dna topoisomerase 1 cleavable complex
sri lanka
hla class i histocompatibility antigen ,  b - 5501 alpha chain
bcma / cd3e tri - specific t - cell activating construct hpn217
hla class i histocompatibility antigen ,  b - 3508 alpha chain
covid - 19 convalescent plasma
hla class i histocompatibility antigen ,  c - 0401 alpha chain
hla class i histocompatibility antigen ,  c - 0102 alpha chain
hla class ii histocompatibility antigen ,  dr beta 3 - 0202 chain
hla class ii histocompatibility antigen ,  dr beta 3 - 0101 chain
ca125 to cea ratio greater than or equal to 25
cd37 positive
saint helena ,  ascension and tristan da cunha
slfn11 positive
ugt1a1*6 allele
ugt1a1*60 allele
erbb2 nm_004448 .1:c .2413t > a
radon test kit
erbb2 np_004439 .2:p .c805s
lymphoblasts 5 percent or less of bone marrow nucleated cells
sars coronavirus 2 positive
sars coronavirus 2 igm antibody positive
cedazuridine / azacitidine combination agent astx030
saint pierre and miquelon
staphylococcus aureus protein a
statistics
stent
cell fraction
irofulven
sudan
sulfotransferase
superoxide dismutase
surgery
oral surgery
suriname
survey
survival
svalbard and jan mayen
swaziland
udp - 4
sweden
switzerland
azoximer bromide
syrian arab republic
astegolimab
tajikistan
taiwan
tanzania ,  united republic of
tat protein
technology
danoprevir
telecommunications
telophase
peg recombinant human megakaryocyte growth and development factor
3 - oxo - 5 - alpha - steroid 4 - dehydrogenase 2
dihydrofolate reductase
thailand
thermodynamics
aviptadil
remote
anti - pd - 1 / ctla - 4 bispecific antibody medi5752
anti - pd - 1 / anti - pd - l1 bispecific antibody ibi318
additional device required
thermography
additional medication required
ankylosis
aperture device
appropriate component term / code not available
appropriate health impact term / code not available
blood or lymphatic problem
light / heat bulb device
cable grip device
cable sleeve device
cannula hub
thoracic surgery
cardiovascular insufficiency
catheter hub
cerebral hyperperfusion syndrome
chamber
change in therapeutic response
complete neonatal hearing loss
computer input device
thoracoscopy
cryogenic burn
delay to diagnosis due to device
delay to treatment due to device
device repositioning
device revision or replacement
disruption of subsequent medical procedure due to device
double capsule
ear or labyrinth problem
tissue factor
ectopic heartbeat
ejector device
electrical and magnetic component
equipment pole device
exacerbation of existing condition due to device
external prosthetic device pain
fetal harm
fixation wire
fluid / bubbletrap
thymidine kinase
foreign body embolism
gas exchanger device
gastroesophageal burn
hepatic or biliary problem
hospitalization or prolonged hospitalization due to device
thymidylate synthase
impeller device
implant pain
inadequate device lubrication
inadequate / inappropriate treatment or diagnostic exposure due to device
increased intra - peritoneal volume
inserter device
intensive care stay required
intervertebral disc compression or protrusion
alpha galactosylceramide
timor - leste
joint laxity
life threatening illness or injury
light source
limb fracture
manometer device
mechanical component
metallosis
minor injury /  illness / impairment
modified surgical procedure
tissue culture
more complex surgery
myocardial hypertrophy
nail device
needle stick prevention mechanism
no treatment due to device malfunction
part / component / sub - assembly term not applicable
partial neonatal hearing loss
permanent impairment
physical asymmetry
togo
polymer bone powder
pregnancy with a contraceptive device
prolonged episode of care
reaction to medicinal component of device
recognized device or procedural complication
rectovaginal fistula
reduction in life expectancy
reproductive system or breast problem
restenosis
single photon emission computed tomography
salivary hypersecretion
serious injury / illness / impairment
serious public health threat
sewing ring device
subluxation
tactile disorder
taste disorder
temporary impairment
thickening of device material
computed tomography
toxic anterior segment syndrome
tumor cell seeding
unanticipated adverse device effect
undercorrection
unexpected deterioration
unexpected diagnostic intervention required
unexpected imaging required
unexpected ivd testing required
unexpected medical intervention required
unspecified eye / vision problem
tonga
unspecified mental ,  emotional or behavioral problem
vesicovaginal fistula
cyp11a1 inhibitor odm - 209
eligibility for cisplatin chemotherapy
resolve multishot diffusion weighted echoplanar imaging
autologous anti - cd19 tac - t cells tac01 - cd19
anti - cd27 agonistic monoclonal antibody mk - 5890
autologous anti - cd19 / cd20 bispecific nanobody - based car - t cells
cord blood derived car t - cells
fluorine f 18 - al - nota - octreotide
toxicology
anti - trop2 antibody - drug conjugate bat8003
allogeneic glial progenitor cells
larotinib mesylate
autologous anti - cd20 car transduced cd4 / cd8 enriched t - cells mb - cart20 .1
anti - cd30 / dm1 antibody - drug conjugate f0002
transcription factor
interleukin - 15 fusion protein bj - 001
drug resistant bacterial infection
unintended extubation
appropriate clinical signs ,  symptoms ,  conditions term / code not available
unexpected product color
transcription
erratic results
failure to deflate problem
unintended deflation
air / gas in device
key or button unresponsive / not working
device contaminated at the user facility
transfection
incompatible blood transfusion
advanced transitional cell carcinoma
familial hypertrophic cardiomyopathy type 1
familial hypertrophic cardiomyopathy type 17
long qt syndrome 5
mitochondrial dna depletion syndrome 13
early infantile epileptic encephalopathy 11
alpha v beta 8 antagonist pf - 06940434
oxaliplatin eluting beads
immunodeficiency 31c
tyrphostin ag 957
transferase
childhood - onset epileptic encephalopathy
probiotic supplement weileshu
autologous cd19 car - expressing cd4 +  / cd8 +  t - cells mb - cart19 .1
androgen receptor / glucocorticoid receptor  antagonist cb - 03 - 10
autologous cd34 +  - enriched hspcs transduced with vsv - g encoding ifn - a2
oncolytic type 2 herpes simplex virus expressing granulocyte macrophage colony - stimulating factor oh2
tgf - beta receptor 1 kinase inhibitor yl - 13027
anti - tim3 monoclonal antibody shr - 1702
a2a receptor antagonist eos100850
serotransferrin
powdered mixed berry extract supplement
dna - pk / pi3k - delta inhibitor br101801
lidocaine mixture with tribenoside
allogeneic adipose - derived mesenchymal stem cells
submandibular gland transfer
oncotype dx breast recurrence score
fbxl4 gene
fbxl4 wt allele
f - box / lrr - repeat protein 4
transformation
gaitrite mat
cytoplasmic immunoglobulin
splenic function
who quality of life measure  -  spirituality ,  religion and personal beliefs
wistar rabies virus strain pm - 1503 - 3m vaccine
proteus sensor patch
ctdc terminology
pediatric multisystem inflammatory syndrome
covid toes
acute myeloid leukemia arising from previous myeloproliferative neoplasm
translation
acute myeloid leukemia arising from previous myelodysplastic / myeloproliferative neoplasm
recurrent myeloid neoplasm
recurrent malignant lymphoid neoplasm
bevacizumab / olaparib regimen
electrical cable
insufficient adverse event information available
insufficient information to classify condition
insufficient information to classify health impact
shock absorber device
disease transmission
patient electrode
electrical mixer
mechanical mixer
electrical port
medical port access device
sensor probe
computer processor
intraocular pressure decreased
household contact with sars - cov - 2 positive individual
non - household contact with sars - cov - 2 positive individual
transplantation immunology
community exposure to sars - cov - 2
silicone - based film forming topical gel
drug accumulation index
drug accumulation less than 1 .2
drug accumulation 1 .2 to 1 .99
drug accumulation 2 .0 to 4 .99
drug accumulation greater than 5
ventana pd - l1 sp142
cognitive medication adherence counseling
cyclical hypofractionated radiotherapy
trends
cutaneous acute graft versus host disease
national comprehensive cancer network risk stratification and response criteria for acute lymphoblastic leukemia
nccn philadelphia chromosome positive all adult risk group
nccn philadelphia chromosome negative all adolescent and young adult risk group
nccn philadelphia chromosome negative all adult risk group
nccn cytogenetic risk group for all
nccn cytogenetic risk group for all ,  good risk
nccn cytogenetic risk group for all ,  poor risk
nccn all response criteria for blood and bone marrow complete remission
trinidad and tobago
nccn all response criteria for blood and bone marrow complete remission with incomplete blood count recovery
nccn all response criteria for blood and bone marrow progressive disease
nccn all response criteria for blood and bone marrow refractory disease
nccn all response criteria for blood and bone marrow relapsed disease
nccn all response criteria for cns disease cns remission
nccn all response criteria for cns disease cns relapse
nccn all response criteria for lymphomatous extramedullary disease complete remission
nccn all response criteria for lymphomatous extramedullary disease partial remission
nccn all response criteria for lymphomatous extramedullary disease progressive disease
nccn all response criteria for lymphomatous extramedullary disease no response
tryptophan 2 , 3 - dioxygenase
nccn all response criteria for lymphomatous extramedullary disease relapse
nccn philadelphia chromosome positive all adolescent and young adult risk group
pain buddy
progesterone receptor expressing malignant neoplasm
antihypertensive therapy
inkt cell agonist abx196
betaglucin gel
porcupine inhibitor xnw7201
tubulin
hsp90 - targeted photosensitizer hs - 201
autologous anti - pd - 1 antibody - activated tumor - infiltrating lymphocytes
betahistine hydrochloride nasal spray
fak / alk / ros1 inhibitor apg - 2449
anti - pd - l1 / anti - 4 - 1bb bispecific monoclonal antibody gen1046
flt3 / kit / csf1r inhibitor nms - 03592088
anti - ctla - 4 / anti - pd - 1 monoclonal antibody combination bcd - 217
autologous anti - flt3 car t cells amg 553
anti - her2 monoclonal antibody hlx22
gbm antigens and alloantigens immunotherapeutic vaccine
tumor marker
jak inhibitor
anti - cd19 antibody - t - cell receptor - expressing t - cells et019003
atypical vascular lesion of breast
cutaneous epithelioid angiomatous nodule
pngvl4a - sig / e7 ( detox )  / hsp70 dna and hpv16 l2 / e6 / e7 fusion protein ta - cin vaccine pvx - 2
sinusoidal hemangioma
rapidly involuting congenital hemangioma
non - involuting congenital hemangioma
partially involuting congenital hemangioma
tunisia
sample and data relationship format
investigation description format
array design format
spectral view settings format
mutation annotation format
variant call file format
data release
locally advanced papillary renal cell carcinoma
locally advanced sarcomatoid renal cell carcinoma
turkey
regional metastasis present
metastasis present in distant lymph node
locally advanced unclassified renal cell carcinoma
metastasis present in distant organ
one to three positive lymph nodes
four or more positive lymph nodes
locally advanced esophageal adenocarcinoma
nonclonal cellular population present
turkmenistan
family history of brca mutation
protocol treatment arm assignment report
immunohistochemistry assay report
site of metastasis
metastatic ovarian undifferentiated carcinoma
unresectable ovarian undifferentiated carcinoma
protocol treatment arm drug name
protocol treatment arm assignment report unique identifier
clinical trial description
clinical trial designation
turks and caicos islands
clinicaltrials .gov identifier
unresectable distal bile duct adenocarcinoma
metastatic distal bile duct adenocarcinoma
hgvs genomic variation annotation
hgvs transcript variation annotation
unresectable pancreatic ductal adenocarcinoma
nucleic acid aliquot volume
unresectable uveal melanoma
unresectable distal esophagus adenocarcinoma
metastatic distal esophagus adenocarcinoma
tuvalu
oncomine variant type
match step at time of assignment
metastatic intrahepatic cholangiocarcinoma
sequence variant report unique identifier
nucleic acid aliquot unique identifier
anatomical circumference
root directory
conditionally reprogrammed cells
modified conditionally reprogrammed cells
organoid
tyrosinase
air - liquid interface organoid
neurosphere
consent exemption for use of post - mortem samples
first responder
buccal cell sample
formalin - fixed paraffin - embedded tissue sample
global longitudinal strain
formalin - fixed paraffin - embedded tissue sample from recurrent disease
formalin - fixed paraffin - embedded tissue scroll
dancing
ubiquitin
bowling
patient status following protocol treatment arm assignment
electronic file content type
site of metastasis at trial entry
sequencing platform name
protocol treatment arm molecular target
advanced renal pelvis and ureter urothelial carcinoma
locally advanced renal pelvis carcinoma
advanced renal pelvis urothelial carcinoma
her2 tri - specific natural killer cell engager df1001
uganda
refractory malignant lymphoid neoplasm
refractory myeloid neoplasm
refractory chronic lymphocytic leukemia / small lymphocytic lymphoma
medication understanding and use self - efficacy scale
taking medicine on time was easy
asking pharmacist questions about the medicine was easy
understanding pharmacist's instructions for the medicine was easy
understanding instructions on the medicine bottle was easy
getting all information needed about the medicine was easy
recurrent plasma cell neoplasm
ukraine
remembering to take all medicine was easy
setting a schedule to take medicine each day was easy
taking medicine every day was easy
original tumor cell sample
next generation cancer model
biospecimen on a slide
prospective tissue collection
retrospective tissue collection
physicochemical process
cetuximab
ultrasonography
read pair number
read pair 1
read pair 2
animal allergy
food allergy
web application
mold or dust allergy
venomous ant bite allergy
bee venom allergy
refractory grade 1 follicular lymphoma
ultraviolet radiation
cat allergy
dog allergy
refractory grade 2 follicular lymphoma
egg allergy
refractory grade 3 follicular lymphoma
refractory grade 3a follicular lymphoma
fruit allergy
meat allergy
refractory grade 3b follicular lymphoma
united arab emirates
shellfish allergy
wasp venom allergy
buccal mucosal resection
recurrent grade 3b follicular lymphoma
total maxillectomy
subtotal prostatectomy
planned bedding change frequency
left ventricular assist device insertion
dental agenesis
cdisc protocol study arm attribute terminology
united kingdom
cdisc sdtm pk analytical method terminology
cdisc define - xml cdisc controlled terminology standard type terminology
cdisc define - xml standard status terminology
cdisc sdtm ecg read method response terminology
cdisc adam generalized anxiety disorder - 7 version 2 questionnaire parameter code terminology
cdisc adam generalized anxiety disorder - 7 version 2 questionnaire parameter name terminology
cdisc standard status
rabies antibody
rabies - specific igg antibody
united states
rabies - specific igm antibody
interleukin - 6 greater than or equal to 80 pg / ml
herpesvirus infection
deleterious idh1 gene mutation
deleterious idh2 gene mutation
deleterious rpa1 gene mutation
deleterious sem1 gene mutation
deleterious wrn gene mutation
deleterious xrcc2 gene mutation
deleterious biallelic mutyh gene mutation
department of health and human services
mismatch repair gene promoter methylation
flt3 non - internal tandem duplication activating mutation positive
psa doubling time less than or equal to 12 months
deleterious nf1 gene mutation
deleterious nf2 gene mutation
deleterious pik3r1 gene mutation
deleterious tsc1 gene mutation
deleterious tsc2 gene mutation
locally advanced esophageal squamous cell carcinoma
advanced follicular lymphoma
environmental protection agency
advanced marginal zone lymphoma
advanced transformed non - hodgkin lymphoma
advanced basal cell carcinoma
apc promoter 1b
apc promoter 1b variant
germline apc promoter 1b variant
autologous anti - cd19 t - cell receptor fusion construct t - cells tc - 110
ddr2 nm_001014796 .3:c .1912a > t
ddr2 nm_001014796 .3:c .716t > g
ddr2 nm_001014796 .3:c .2304t > a
food and drug administration
ddr2 np_001014796 .1:p .i638f
advanced non - hodgkin lymphoma
ddr2 np_001014796 .1:p .l239r
advanced hodgkin lymphoma
ddr2 np_001014796 .1:p .s768r
deleterious inactivating nf1 gene mutation
activating gna11 gene mutation
activating gnaq gene mutation
severe acute respiratory distress syndrome
psychoeducational assessment
united states public health service
robo1 - targeted bicar - nkt cells
multispectral optoacoustic tomography
mek 1 / 2 inhibitor fcn - 159
radioimmunoprecipitation assay
pseudomonas measurement
ectoine mouthwasheml03
autologous nectin - 4 / fap - targeted car - t cells
autologous cd19 / pd - 1 bispecific car - t cells
trastuzumab - tlr 7 / 8 agonist bdc - 1001
metastatic site code
veterans administration
cdk7 inhibitor sy - 5609
anti - integrin beta - 6 / mmae antibody - drug conjugate sgn - b6a
primary ciliary dyskinesia 3
primary ciliary dyskinesia 29
pan - trk inhibitor nov1601
lmp2 - specific t cell receptor - transduced autologous t - lymphocytes
cereblon e3 ubiquitin ligase modulating agent cc - 99282
unit of equivalent volume
cdisc questionnaire eortc qlq - lc13 test name terminology
caspofungin acetate
urban population
cdisc questionnaire eortc qlq - lc13 test code terminology
eortc qlq - lc13 questionnaire question
eortc qlq - lc13  -  how much did you cough
eortc qlq - lc13  -  did you cough up blood
eortc qlq - lc13  -  short of breath when rested
eortc qlq - lc13  -  short of breath when walked
eortc qlq - lc13  -  short of breath climbed stairs
eortc qlq - lc13  -  had a sore mouth or tongue
eortc qlq - lc13  -  have you had trouble swallowing
urinalysis
eortc qlq - lc13  -  had tingling hands or feet
eortc qlq - lc13  -  have you had hair loss
eortc qlq - lc13  -  have you had pain in your chest
eortc qlq - lc13  -  had pain in your arm or shoulder
eortc qlq - lc13  -  had pain in other parts of body
eortc qlq - lc13  -  if yes ,  where
eortc qlq - lc13  -  did you take any medicine for pain
eortc qlq - lc13  -  if yes ,  how much did it help
eligibility for laryngectomy
eligibility for partial laryngectomy
urokinase - type plasminogen activator
eligibility for total laryngectomy
schedule
reschedule
disruption in therapy
disruption to therapy because patient too ill due to covid - 19
disruption to therapy because of risk of covid - 19 exposure to health care staff
disruption to therapy because patient's travel restricted due to covid - 19
disruption to therapy because of patient decision to change care plan due to covid - 19
disruption to therapy because of physician decision to change care plan due to covid - 19
disruption to therapy because of institutional restrictions on care due to covid - 19
urology
disruption to therapy because of lack of institutional resources due to covid - 19
disruption to therapy because of non - covid - 19 - related comorbidity
unknown status due to lack of assessment due to covid - 19 diagnosis
unknown status due to covid - 19 - related travel restrictions
balance assessment test
sit to stand test
limits of stability test
sensory organization test
motor control test
uruguay
computerized dynamic posturography assessment
advanced primary cutaneous t - cell non - hodgkin lymphoma
anti - cd37 bispecific monoclonal antibody gen3009
leave from employment
maternity leave
medical leave
family leave
full - time student
part - time student
cadherin - 1
advanced uterine corpus cancer
generalized anxiety disorder  -  7 version 2  -  analysis
non - compartmental analysis dataset
cdisc draft standard
cdisc provisional standard
cdisc final standard
study arm label
study arm type
planned number of subjects per study arm
dietary protein measurement
uzbekistan
total dietary fat measurement
total dietary carbohydrate measurement
dietary magnesium measurement
dietary added sugar measurement
dietary calories measurement
dietary fruit measurement
dietary vegetable measurement
dietary grain measurement
dietary meat measurement
dietary fiber measurement
vanuatu
dietary saturated fat measurement
dietary monounsaturated fat measurement
dietary polyunsaturated fat measurement
exercise intensity
exercise compliance
exercise duration
calories burned
total time paused
number of laps completed
number of steps taken
genetic variation
total time physically active
number of bulbs
insulin delivery automation mode
missed bolus reminder status
semi - automatic
fibrotest formula
ash fibrosure formula
nash fibrosure formula
hepascore formula
fibrometer formula
holy see  ( vatican city state )
cocaine and / or metabolites measurement
cocaine metabolites measurement
8 - hydroxydeoxyguanosine measurement
galectin - 3 measurement
neoplastic plasma cell count
soluble l - selectin measurement
vascular endothelial growth factor d measurement
beta and gamma tocopherol measurement
chenodeoxycholate measurement
cholate measurement
tyrosine kinase inhibitor su5402
venezuela ,  bolivarian republic of
deoxycholate measurement
phosphorylated neurofilament heavy chain measurement
mhc class i chain related protein a measurement
soluble programmed death ligand 1 measurement
soluble lymphocyte activation gene - 3 measurement
soluble programmed death - 1 measurement
vitamin d binding protein measurement
cellular fibronectin measurement
plasma fibronectin measurement
endostatin measurement
veterinary medicine
carbonic anhydrase 9 measurement
cea cell adhesion molecule 1 measurement
decorin measurement
interleukin 18 binding protein measurement
hepatocyte growth factor receptor measurement
s - adenosylmethionine measurement
s - adenosylhomocysteine measurement
betaines measurement
cysteine measurement
dimethylglycine measurement
viet nam
cystathionine beta - synthase measurement
ferritin heavy chain measurement
ferritin light chain measurement
mid - regional pro - atrial natriuretic peptide measurement
7 - alpha - hydroxy - 4 - cholesten - 3 - one measurement
acetaminophen - cysteine adduct measurement
cancer antigen 242 measurement
chlamydia measurement
aspergillus measurement
achromobacter xylosoxidans measurement
viral genome
burkholderia multivorans measurement
burkholderia cenocepacia measurement
burkholderia stabilis measurement
burkholderia vietnamiensis measurement
burkholderia dolosa measurement
burkholderia ambifaria measurement
burkholderia anthina measurement
burkholderia pyrrocinia measurement
escherichia coli measurement
klebsiella measurement
viral protein
mycobacterium avium complex measurement
mycobacterium kansasii measurement
mycobacterium simiae measurement
mycobacterium abscessus measurement
mycobacterium chelonae measurement
mycobacterium fortuitum measurement
pseudomonas aeruginosa measurement
enterovirus measurement
rotavirus measurement
virgin islands ,  u .s .
farr assay
pseudovirion - based neutralization assay
charcoal enhanced flocculation
computerized corneal topography
plaque reduction neutralization assay
bioimpedance spectroscopy
chemiluminescent microparticle immunoassay
agar proportion
cell cytotoxicity neutralization assay
virology
contrast enhanced spiral ct scan
spiral ct scan without contrast
contrast enhanced pet scan
ultrasonographic elastography
ergospirometry
burkholderia pyrrocinia
burkholderia anthina
burkholderia ambifaria
burkholderia dolosa
burkholderia vietnamiensis
visual perception
burkholderia stabilis
burkholderia multivorans
never dosed
approved drug available for indication
tear secretion amount
tear secretion rate
major pathological response indicator
minor pathological response indicator
minimal residual disease indicator
linear - logarithmic trapezoidal method
vital statistics
linear trapezoidal method
linear up log down method
linear trapezoidal  -  log interpolation method
half - life distribution
hours times dna copies per microgram
hours squared time dna copies per microgram
microgram equivalents per milliliter
nanogram per milliliter per milligram per square centimeter
hours times nanogram per milliliter per milligram per square centimeter
wallis and futuna
total artificial heart implantation
intra - aortic balloon pump counterpulsation
percutaneous ventricular assist device placement
blood ultrafiltration
hemofiltration
cardiac resynchronization therapy defibrillator implantation
likert scale 5 - point
likert scale 3 - point
numerical rating scale 21 - point
visual analog scale  ( 10 cm )
su4984
wound repair
pharyngeal route of administration
physical activity level
primary tumor site indicator
teaspoon equivalent
cup equivalent
ounce equivalent
juvenile diabetes foundation unit
systolic blood pressure - for - height percentile
systolic blood pressure - for - age percentile
diastolic blood pressure - for - height percentile
diastolic blood pressure - for - age percentile
lucinactant
recombinant human interleukin - 22 igg4 - fc fusion protein uttr1147a
galidesivir
galidesivir hydrochloride
gimsilumab
vazegepant
advanced kidney carcinoma
locally advanced kidney carcinoma
chlorine dioxide
x - ray
advanced kidney medullary carcinoma
cutaneous perineurioma
recurrent kidney carcinoma
refractory kidney carcinoma
malignant peripheral nerve sheath tumor of the skin
epithelioid malignant peripheral nerve sheath tumor of the skin
recurrent acute leukemia of ambiguous lineage
t1 rho magnetic resonance imaging
xeroradiography
refractory acute leukemia of ambiguous lineage
skin myxofibrosarcoma
rna polymerase inhibitor eidd - 2801
skin ewing sarcoma
hiv - 1 protease inhibitor asc09
cellular granularity present
primitive non - neural granular cell tumor
meplazumab
bap1 tumor predisposition syndrome
yemen
ctcae v4 grade 4
anti - gm - csf monoclonal antibody
invasive focus of carcinoma cells measuring 1 mm or less present
vilobelimab
unresectable oral cavity squamous cell carcinoma
unresectable laryngeal squamous cell carcinoma
unresectable hypopharyngeal squamous cell carcinoma
unresectable nasopharyngeal squamous cell carcinoma
unresectable paranasal sinus squamous cell carcinoma
metastatic salivary gland squamous cell carcinoma
serbia and montenegro
recurrent salivary gland squamous cell carcinoma
unresectable salivary gland squamous cell carcinoma
vidofludimus calcium anhydrous
anti - gm - csf monoclonal antibody tj - 003234
olokizumab
oxyntic gland adenoma
columnar cells with differentiation to chief cells and parietal cells present
anti - cd14 monoclonal antibody ic14
pitted erythrocyte count
gastroblastoma
congo ,  the democratic republic of the
digestive system neuroendocrine tumor g3
esophageal neuroendocrine tumor g3
gastric neuroendocrine tumor g3
small intestinal neuroendocrine tumor g3
high grade appendix mucinous neoplasm
appendix neuroendocrine tumor g3
ileal neuroendocrine tumor g3
jejunal neuroendocrine tumor g3
midgut neuroendocrine tumor g3
zambia
intestinal neuroendocrine tumor g3
duodenal neuroendocrine tumor g3
ampulla of vater neuroendocrine tumor g3
overt stroke
silent stroke
age - days
zimbabwe
colorectal conventional adenoma
non - rebreather mask
colon conventional adenoma
rectal conventional adenoma
malat1 / gli1 fusion gene
fall risk assessment
inflammatory bowel disease - associated dysplasia of the colorectum
high grade dysplasia in inflammatory bowel disease
zoology
low grade dysplasia in inflammatory bowel disease
colorectal poorly cohesive adenocarcinoma
colorectal adenoma - like adenocarcinoma
perifosine
phosphatidylinositol - 4 , 5 - bisphosphate 3 - kinase
inflammatory bowel disease - associated colorectal adenocarcinoma
colorectal neuroendocrine tumor g3
colon neuroendocrine tumor g3
rectal neuroendocrine tumor g3
facioscapulohumeral muscular dystrophy 1
facioscapulohumeral muscular dystrophy 2
high grade anal intraepithelial neoplasia
beta - catenin - activated inflammatory hepatocellular adenoma
allogeneic anti - cd19 car t - cells allo - 501a
steatohepatitic hepatocellular carcinoma
amino acid transporter
macrotrabecular massive hepatocellular carcinoma
abrupt nuclear anaplasia
chromophobe hepatocellular carcinoma
neutrophil - rich hepatocellular carcinoma
small hepatocellular carcinoma
focus of carcinoma cells measuring equal to or less than 2 cm present
small progressed hepatocellular carcinoma
liver mixed adenoneuroendocrine carcinoma
liver neuroendocrine tumor g1
thrombin - antithrombin complex
liver neuroendocrine tumor g2
liver neuroendocrine tumor g3
liver large cell neuroendocrine carcinoma
liver small cell carcinoma
splenic scan
minimally invasive surgery
someone there
someone to have a good time with
aryl hydrocarbon receptor
smoked cigarettes
gallbladder pyloric gland adenoma
inactivated sars - cov - 2 vaccine
sars - cov - 2 dna vaccine ino - 4800
gallbladder adenoma ,  intestinal - type
lipid nanoparticle - encapsulated mrna - based sars - cov - 2 vaccine mrna - 1273
spy elite fluorescence imaging
augmented reality
average amount
bone morphogenetic protein
have felt unusual weakness
allogeneic crispr - cas9 engineered anti - bcma t cells ctx120
gallbladder neuroendocrine tumor g3
extrahepatic bile duct neuroendocrine tumor g3
saponin - based adjuvant
genetically modified sars - cov - 2 spike protein - encoding bifidobacterium longum dna vaccine
autologous anti - cd19 chimeric antigen receptor t - cells auto1
quitline program
smoke - free home program
freshstart
calcineurin
sars - cov - 2 antigen - specific cytotoxic t - lymphocytes
sars - cov - 2 lentiviral - based dendritic cell vaccine lv - smenp - dc
sars - cov - 2 rs nanoparticle vaccine nvx - cov2373
skindex - 29 questionnaire
skin hurts
skin condition affect sleep quality
worry that skin condition may be serious
cathepsin h
skin condition makes it hard to work or do hobbies
skin condition affects social life
skin condition causes feelings of depression
skin condition burns or stings
tend to stay at home because of skin condition
worry about getting scars from skin condition
skin itches
skin condition affects closeness with loved ones
ashamed of skin condition
worry that skin condition may get worse
cathepsin l1
tend to do things alone because of skin condition
angry about skin condition
water bothers skin condition
skin condition makes showing affection difficult
worry about side - effects from skin medications and treatments
skin is irritated
skin condition affects interactions with others
embarrassed by skin condition
skin condition is a problem for loved ones
frustrated by skin condition
azurocidin
skin is sensitive
skin condition affects desire to be with people
humiliated by skin condition
skin condition bleeds
annoyed by skin condition
skin condition interferes with sex life
skin condition causes tiredness
mrna vaccine
semiconductor
touchscreen
b - cell receptor cd22
cuvette
bellows
clutch
coating material
device collapser
fabric
lever
potting
rachet
celecoxib
hematopoietic progenitor cell antigen cd34
tool
translational motion component
allogeneic multi - virus - specific cytotoxic t lymphocytes alvr105
low grade pancreatic intraepithelial neoplasia
low grade biliary intraepithelial neoplasia
erk1 / 2 inhibitor hh2710
unresectable neuroendocrine carcinoma
x - linked protoporphyria
unresectable digestive system mixed adenoneuroendocrine carcinoma
tyrosine kinase inhibitor tl - 895
tumor necrosis factor receptor superfamily member 5
unresectable large cell neuroendocrine carcinoma
pancreatic poorly cohesive adenocarcinoma
pancreatic undifferentiated carcinoma with rhabdoid cells
pancreatic invasive micropapillary adenocarcinoma
pancreatic neuroendocrine tumor g3
hiv - 1 protease inhibitor asc09 / ritonavir
anti - cd7 car t - cells
cannabinoid - derived inhalation capsule ppp011
anti - pd - l1 monoclonal antibody imc - 001
receptor - type tyrosine - protein phosphatase c
anti - pd - 1 monoclonal antibody 609a
trastuzumab monomethyl auristatin f
photodynamic compound tld - 1433
delta - beta thalassemia
periportal fibrosis
low - dose aldesleukin ilt - 101
bromhexine
5 - d itch scale
pruritus questions
pruritus duration per day
vitronectin
pruritus degree
pruritus direction
pruritus disability
pruritus sleep disability
pruritus leisure or social disability
pruritus housework or errands disability
pruritus work or school disability
unbearable
completely resolved
much better ,  still present
chromogranin - a
little better ,  still present
autologous ucd19 car t cells
ursolic acid
extranodal marginal zone lymphoma of mucosa - associated lymphoid tissue involving the digestive system
chromatin interaction analysis with paired - end tag
conventional follicular dendritic cell sarcoma
ebv - positive inflammatory follicular dendritic cell sarcoma
digestive system sarcoma
cre recombinase
digestive system diffuse large b - cell lymphoma
digestive system inflammatory myofibroblastic tumor
digestive system soft tissue neoplasm
esophageal soft tissue neoplasm
hepatobiliary soft tissue neoplasm
gallbladder soft tissue neoplasm
liver and intrahepatic bile duct soft tissue neoplasm
intestinal soft tissue neoplasm
non - coding rna sequencing
strand - specific rna sequencing
camp responsive element binding protein
sodium bicarbonate inhalation solution
file uploading
file uploaded
md5 checksumming
md5 checksum completed
file being validated
file in error
invalid file
file suppressed
file redacted
cytochrome p450 2d6
live file
file validated
file submitted
foundationone genomic profiling
guardant360 genomic profiling
extrapelvic
released file
raw nucleotide reads file
aligned dna reads file
aligned rna reads file
dgtpase
index file
variants file
concerns about recurrence scale
breast cancer recurrence concerns
how much time spent thinking about possibility of breast cancer recurrence
how upset about possibility of breast cancer recurrence
how often worry about possibility of breast cancer recurrence
how afraid that breast cancer may recur
worry that breast cancer recurrence would cause emotional upset
worry that breast cancer recurrence would keep me from doing planned things
dihydroorotate dehydrogenase  ( quinone )  ,  mitochondrial
worry that breast cancer recurrence would threaten physical health
worry that breast cancer recurrence would make me feel less of a woman
worry that breast cancer recurrence would require chemotherapy
worry that breast cancer recurrence would hurt relationships with friends and family
worry that breast cancer recurrence would make me feel i don't have control over my life
worry that breast cancer recurrence would threaten my identity
worry that breast cancer recurrence would interfere with physical ability to carry out daily activities
worry that breast cancer recurrence would threaten my life
worry that breast cancer recurrence would harm self - confidence
worry that breast cancer recurrence would be more serious than first diagnosis
ct2584 hms
dihydropyrimidine dehydrogenase  [ nadp (  +  )  ]
worry that breast cancer recurrence would cause financial problems
worry that breast cancer recurrence would interfere with sense of sexuality
worry that breast cancer recurrence would require radiation treatment
worry that breast cancer recurrence would cause pain and suffering
worry that breast cancer recurrence would mean losing my breast ( s )
worry that breast cancer recurrence would interfere with ability to plan for future
worry that breast cancer recurrence would threaten my spirituality or faith
worry that breast cancer recurrence would lead me to feel less feminine
worry that breast cancer recurrence would keep me from fulfilling important roles
worry that breast cancer recurrence would require further surgery
dna primase
worry that breast cancer recurrence would cause me to die
worry that breast cancer recurrence would damage my romantic relationship ( s )
worry that breast cancer recurrence would keep me from fulfilling responsibilities
worry that breast cancer recurrence would make me feel badly about how my body looks or feels
gorilla - derived adenovirus - expressing hpv - 16 / 18 e6 / e7 vaccine
prolonged - release wound solution dosage form
nebulizer dispersion dosage form
ointment plus vaginal tablet dosage form
oral powder in single - dose container dosage form
lid device
d ( 2 )  dopamine receptor
thought likert scale
upset likert scale
worry likert scale
fear likert scale
anti - ribonucleoprotein antibody atrc - 101
gastro - resistant oral suspension dosage form
prolonged - release oral suspension dosage form
right ventricular assist device insertion
supra - pharmacologic dexamethasone sodium phosphate avm0703
gram iron per kilogram liver  ( dry weight )
vascular endothelial growth factor receptor
micromole iron per gram liver  ( dry weight )
room air
sleep responses
never affects sleep
occasionally delays falling asleep
frequently delays falling asleep
delays falling asleep and occasionally wakes me up at night
delays falling asleep and frequently wakes me up at night
hbb np_000509 .1:p .e7k
hbb nm_000518 .5:c .19g > a
transcription factor ap - 2 - alpha
digestive system solitary fibrous tumor
inflammatory fibroid polyp
digestive system leiomyoma
hemoglobin a1
hemoglobin a2
digestive system lipoma
hemoglobin c
hemoglobin f
erythropoietin receptor
hemoglobin s
digestive system leiomyosarcoma
digestive system rhabdomyosarcoma
refractory meningioma
abdominal circumference
digestive system kaposi sarcoma
thought score 1
thought score 2
thought score 3
thought score 4
cytochrome p450 1a1
thought score 5
thought score 6
upset score 1
upset score 2
upset score 3
upset score 4
upset score 5
upset score 6
worry score 1
worry score 2
fibroblast growth factor receptor family
worry score 3
worry score 4
worry score 5
worry score 6
fear score 1
fear score 2
fear score 3
fear score 4
fear score 5
fear score 6
gtpase - activating protein
gastrointestinal clear cell sarcoma / malignant gastrointestinal neuroectodermal tumor
intracatheter instillation
bothered by
bothered by vaginal discharge
bothered by vaginal bleeding or spotting
bothered by lack of interest in sex
bothered by low sexual enjoyment
anti - gpr20 / dxd antibody - drug conjugate ds - 6157a
shp2 inhibitor rly - 1971
gastric adenocarcinoma and proximal polyposis of the stomach
haptoglobin - related protein
engineered red blood cells co - expressing 4 - 1bbl and il - 15tp rtx - 240
match arm identifier
match arm eay131 - a
match arm eay131 - b
match arm eay131 - c1
match arm eay131 - c2
match arm eay131 - e
match arm eay131 - f
match arm eay131 - g
match arm eay131 - h
714 - x
heparan sulfate proteoglycan
match arm eay131 - i
match arm eay131 - j
match arm eay131 - k1
promis short form - social isolation - 4a
match arm eay131 - k2
feel people barely know me
human sars - cov - 2 immune globulin
heparinase
feel people are around me but not with me
match arm eay131 - l
covid - 19 aapc vaccine
match arm eay131 - m
match arm eay131 - n
match arm eay131 - p
match arm eay131 - q
ad5 - ncov covid - 19 vaccine
match arm eay131 - r
autologous dendritic cells loaded with sars - cov - 2 antigens av - covid - 19
histone acetylase
sars - cov - 2 mrna vaccine bnt162
chadox1 ncov - 19 vaccine
match arm eay131 - s1
covid - 19 vaccine
mean fluorescence intensity of donor - specific antibodies
match arm eay131 - s2
match arm eay131 - t
match arm eay131 - u
match arm eay131 - v
match arm eay131 - w
integrase
match arm eay131 - x
match arm eay131 - y
very low density lipoprotein
match arm eay131 - z1a
match arm eay131 - z1b
match arm eay131 - z1c
match arm eay131 - z1d
match arm eay131 - z1e
match arm eay131 - z1f
match arm eay131 - z1g
intercellular adhesion molecule 1
match arm eay131 - z1h
match arm eay131 - z1i
match arm eay131 - z1k
match arm eay131 - z1l
match arm eay131 - z1m
ability to
refractory indolent non - hodgkin lymphoma
afraid of
being able to provide assistance as caregiver
bicycling ability
ku protein
breast cancer surgeon questions
currently receiving compassionate care
sars - cov - 2 sp modrna lnp vaccine bnt162b1
chatbot
sars - cov - 2 sp modrna lnp vaccine bnt162a1
sars - cov - 2 sp mrna lnp vaccine bnt162b2
sars - cov - 2 sp mrna lnp vaccine bnt162c2
transfusion type
attendance question
hearing question
40s ribosomal protein sa
smoking question
carry question
dyspnea question
taste question
vitamin k antagonist
taste response
direct thrombin inhibitor
direct factor xa inhibitor
routine covid - 19 test prior to anti - cancer treatment
symptoms consistent with covid - 19
lamin
sleeping beauty transposon gene therapy
aliquot unique identifier
dynamic contrast - enhanced magnetic resonance imaging with positron emission tomography
anti - her2 antibody conjugated natural killer cells ace1702
sinonasal keratinizing squamous cell carcinoma
sinonasal human papillomavirus - related carcinoma with adenoid cystic - like features
sinonasal spindle cell squamous cell carcinoma
sinonasal lymphoepithelial carcinoma
clear about question
climbing steps or stairs question
cognitive problems question
concern about question
cerebrooculofacioskeletal syndrome 1
confidence question
head and neck nut carcinoma
sinonasal nut carcinoma
sinonasal neuroendocrine carcinoma
tyrosine - protein kinase lck
health limits question
sinonasal large cell neuroendocrine carcinoma
caregiver responsibilities question
sinonasal teratocarcinosarcoma
benign sinonasal neoplasm
malignant sinonasal neoplasm
regimen m
trichothiodystrophy 3 ,  photosensitive
tyrphostin ag 1296
melatonin receptor
mvi regimen
viva regimen
trichothiodystrophy 7 ,  nonphotosensitive
trichothiodystrophy 2 ,  photosensitive
cerebrooculofacioskeletal syndrome 4
delayed intensification therapy
uv - sensitive syndrome 1
uv - sensitive syndrome 3
dollar
us dollar
methylenetetrahydrofolate reductase
uv - sensitive syndrome 2
xfe progeroid syndrome
sinonasal respiratory epithelial adenomatoid hamartoma
sinonasal seromucinous hamartoma
sinonasal pleomorphic adenoma
processing speed scaled score
sinonasal soft tissue neoplasm
sinonasal sarcoma
secondary biliary cirrhosis
mineralocorticoid receptor
sinonasal fibrosarcoma
sinonasal undifferentiated pleomorphic sarcoma
sinonasal leiomyosarcoma
sinonasal rhabdomyosarcoma
sinonasal angiosarcoma
secondary hemochromatosis
sinonasal malignant peripheral nerve sheath tumor
sinonasal synovial sarcoma
congestive hepatopathy
cell surface glycoprotein muc18
nausea question
dyschromatosis universalis hereditaria
intermediate sinonasal soft tissue neoplasm
sinonasal desmoid - type fibromatosis
cough question
walking question
sinonasal glomangiopericytoma
sinonasal solitary fibrous tumor
sinonasal epithelioid hemangioendothelioma
benign sinonasal soft tissue neoplasm
nucleoside diphosphate kinase a
sinonasal leiomyoma
sinonasal hemangioma
sinonasal schwannoma
sinonasal neurofibroma
question about doctor
3 - methylglutaconic aciduria type 5
crisponi / cold - induced sweating syndrome - 1
crisponi / cold - induced sweating syndrome - 2
hpv 16 e6 / e7 - encoding arenavirus vaccine hb - 202
methylated - dna - protein - cysteine methyltransferase
extent question
question about family and family life
personalized and adjusted neoantigen peptide vaccine panda - vac
allogeneic crispr - cas9 engineered anti - cd70 car - t cells ctx130
recurrent intracranial neoplasm
metastatic intracranial malignant neoplasm
unresectable anal squamous cell carcinoma
environmental and social factors domain
disease free
extremity question
dbl oncoprotein
feelings question
unresectable esophageal adenocarcinoma
primary sinonasal meningioma
peritoneal implant
egfr / tgfb fusion monoclonal antibody bca101
sinonasal ameloblastoma
sinonasal chondromesenchymal hamartoma
ketogenic diet
sinonasal plasmacytoma
regulatory protein e2 ,  human papillomavirus type 16
sinonasal lymphoma
sinonasal non - hodgkin lymphoma
sinonasal extranodal nk / t - cell lymphoma
nasal cavity extranodal nk / t - cell lymphoma
sinonasal olfactory neuroblastoma
sinonasal ewing sarcoma / peripheral primitive neuroectodermal tumor
malignant sinonasal soft tissue neoplasm
probable protein e4 ,  human papillomavirus type 1
receptor tyrosine - protein kinase erbb - 2
g28 - 5 sfv - pe40
myb oncogene protein
urokinase plasminogen activator surface receptor
platelet - derived growth factor receptor
proliferating cell nuclear antigen
plasma serine protease inhibitor
serine / threonine protein kinase
tyrosine - protein kinase lyn
proto - oncogene serine / threonine - protein kinase mos
mast / stem cell growth factor receptor kit
transcriptional activator myb
tas - 103
trefoil factor 1
rho - related gtp - binding protein rhob
insulin - like growth factor - binding protein
somatostatin receptor
streptavidin
syndecan
t - cell - specific surface glycoprotein cd28
taq polymerase
tenascin
thrombospondin
topoisomerase iii
tgf - beta receptor type - 2
tumor necrosis factor receptor superfamily member 16
troponin i
vasopressin receptor
abl1 gene
cd - rom
pap smear
cyclin
methotrexate sodium
dna fingerprinting
extracellular matrix protein
facility construction
fluorescence activated cell sorting
frameshift mutation
g1 phase process
g2 phase process
gender
dcc gene
tp53 gene
aminobenzoate potassium
rb1 gene
rex gene
tumor suppressor gene
tax gene
htlv - i rex gene
htlv - i tax gene
htlv - ii rex gene
htlv - ii tax gene
imaging technique
organic solvents
fluorescent antibody procedure
protein l - myc
integrin alpha - l
integrin alpha - m
scanning tunneling microscope
murine aids
mutagenesis
insertional mutagenesis
site - directed mutagenesis
n - myc proto - oncogene protein
amphotericin b liposomal
nf - kb
occupational health
gtpase hras
gtpase kras
gtpase nras
privacy
cyclin - dependent kinase 1
cellular tumor antigen p53
p21 ras protein
proto - oncogene tyrosine - protein kinase src
vincristine sulfate
tyrosine - protein kinase abl1
myc proto - oncogene protein
macrophage colony - stimulating factor 1 receptor
colony stimulating factor receptor
retinoblastoma - associated protein
s phase process
sequence tagged site
oncogene abl1
oncogene src
women's health
aromatase inhibitor
speech pathology
myb - related protein b
platelet endothelial cell adhesion molecule
lymphocyte function - associated antigen 3
b - cell differentiation antigen cd72
topoisomerase iv
endoglin
mecom protein isoform evi - 1a
mitogen - activated protein kinase 3
fk506 binding protein
chloride ion
zinc finger protein gli3
fibroblast growth factor receptor 2
neurofibromin
hyaluronidase ph - 20
adapter molecule crk
transforming protein rhoa
rho - related gtp - binding protein rhoc
rna helicase
t - cell acute lymphocytic leukemia protein 1
transcription elongation factor spt6
angiogenesis inhibitor
pea3
cho cells
nih / 3t3
drug delivery system
nf1 gene
nf2 gene
pulsed - field gel electrophoresis
smoking cessation
glucose - 6 - phosphate isomerase
neural network
chemical carcinogen
vinculin
hiv p24 antigen
t - cell receptor gamma - delta
t - cell receptor alpha - beta
glycosyltransferase
pc - 12
immunoscintigraphy
transcription factor ap - 1
proto - oncogene c - fos
fos oncoprotein
oncogene fos
t - cell surface glycoprotein cd8 beta chain
anisotropy
adverse drug event reporting system
protein tyrosine phosphatase
caregiver
pancreatic secretory trypsin inhibitor
antibiotic resistance
flavonoid
ap - 1 complex
fos family gene
jun family gene
conference
enzyme immunoassay
molecular genetics
g protein
hispanic or latino
peptide hormone
histone h2b
initiation factor
transcription factor jun - b
transcription factor jun - d
oncogene myc
personal communication
rous sarcoma
senescence
socioeconomic factors
taxonomy
cruciferous vegetable
telomerase
youth
acylamino - acid - releasing enzyme
early e1a protein
e1b protein
tyrosine - protein kinase receptor ufo
serine / threonine - protein kinase b - raf
breakpoint cluster region protein
catenin beta - 1
choriogonadotropin subunit beta 3
topoisomerase inhibitor
polycomb complex protein bmi - 1
protein c - ets - 1
protein c - ets - 2
tyrosine - protein kinase fgr
raf proto - oncogene serine / threonine - protein kinase
vitamin d3 receptor
ccaat enhancer binding protein
fc - gamma receptor iii
monocyte differentiation antigen cd14
cytotoxic t - lymphocyte protein 4
aptamer
e - selectin
protocadherin fat 1
erythroid transcription factor
guanine nucleotide exchange factor
ephrin type - a receptor 3
hh - 1 antigen
t - cell leukemia homeobox protein 1
protein e7 ,  human papillomavirus type 8
regulatory protein e2 ,  human papillomavirus type 18
recombinant fibroblast growth factor 1
probable protein e5 ,  human papillomavirus type 16
probable protein e4 ,  human papillomavirus type 16
intercellular adhesion molecule 2
intercellular adhesion molecule 3
insulin - like growth factor - binding protein 1
insulin - like growth factor - binding protein 2
insulin - like growth factor - binding protein 4
insulin - like growth factor - binding protein 5
insulin - like growth factor - binding protein 3
pollutant
protein wnt - 2
plastin - 2
l - selectin
melanoma - associated antigen 3
colorectal mutant cancer protein
e3 ubiquitin - protein ligase mdm2
apeh gene
nuclear matrix protein
probable protein e4 ,  human papillomavirus type 6
probable protein e4 ,  human papillomavirus type 11
peptide vaccine
protein e6 ,  human papillomavirus type 18
pou domain ,  class 2 ,  transcription factor 1
p - selectin
junction plakoglobin
prostate - specific antigen
farnesyl protein transferase
hpv - 16 major capsid protein l1
tyrosine - protein kinase csk
qa - 1 antigen
blood urea
insulin - like growth factor receptor
insulin - like growth factor 1 receptor
retinoic acid receptor
retinoic acid receptor alpha
retinoid x receptor
rgd receptor
sodium / iodide cotransporter
transcription elongation factor spt5
t4 endonuclease v
pou domain ,  class 2 ,  transcription factor 2
recombinant interleukin - 1 - alpha
tfiid
tfiiib
metalloproteinase inhibitor 2
metalloproteinase inhibitor 1
tissue inhibitor of metalloproteinases
ap - 2 family transcription factor
transcription factor e2f1
thrombospondin - 1
myeloblastin
wilms tumor protein
pentosan polysulfate
hepatitis b x - protein
advocacy
ethnography
clinical ethics
transcriptional activation
oncogene jun
worksite
apoptosis
echo - planar imaging
collagenase
toremifene citrate
isoprenylation process
fusion protein
in situ hybridization
fluorescence in situ hybridization
guideline
sequence analysis
mcc gene
apc gene
protein folding
aryldialkylphosphatase
tyrphostin compound
nucleophosmin
stromelysin - 1
focal adhesion kinase 1
cytochrome p450 3a4
tyrosine - protein kinase fyn
matrix metalloproteinase - 9
protein e7 ,  human papillomavirus type 6
e3 ubiquitin - protein ligase amfr
tata - box - binding protein
rac - alpha serine / threonine kinase
tritylcysteine
rac - beta serine / threonine kinase
transmembrane 4 l6 family member 1
bzip protein
i kappa b
forkhead box protein g1
solute carrier family 2 ,  facilitated glucose transporter member 1
cyclin - dependent kinase inhibitor 1c
insulin - like growth factor - binding protein 6
transcription initiation protein spt3 homolog
mitogen - activated protein kinase 1
benzodepa
fibroblast growth factor receptor 1
grb2 protein
72kda type iv collagenase
zuotin
stromelysin - 3
histone - lysine n - methyltransferase 2a
tyrosine - protein kinase zap - 70
adhesion
prosthesis
immunologist
meturedepa
adult
bacterial genetics
critical care nursing
environmental toxicology
food preparation
food science and technology
image processing
nucleocapsid protein
plant genetics
tumor progression
trypan red
blood sample
bronchoscope
central venous access catheter
colonoscope
colposcope
cystoscope
laryngoscope
raloxifene hydrochloride
gastroscope
ophthalmoscope
patient monitoring system
picture archiving and communication system
sigmoidoscope
swab
tracheostomy tube
sergiolide
digital rectal examination
dna analysis
restriction fragment length polymorphism analysis
prostate specific antigen measurement
tumor necrosis factor assay
antigen proliferation assay
capillary electrophoresis
immunoblot analysis
upper gastrointestinal series
bruceanol b
percutaneous transhepatic cholangiography
intravenous pyelogram
transvaginal ultrasound
bone scan
liver scan
multiple
other
bruceanol a
physiologic
waist - hip ratio
virgin islands ,  british
north macedonia
reproductive history
clonal regression
molecular epidemiology
long term survivor
survivor
interferon alfacon - 1
receptor tyrosine kinase
reporter gene
antigen processing
antigen presentation
growth factor receptor
neural peptide receptor
germline mutation
cytokine receptor
czechia
slovakia
chaparrin
cytoplasmic receptor
nuclear receptor
x - ray crystallography
cytochrome p450 1a2
protein e7 ,  human papillomavirus type 18
antigen ki - 67
transcription initiation factor tfiid subunit 1
nf - kappa - b inhibitor alpha
upstream stimulatory factor
bruceanol c
cyclin - dependent kinase 4
metalloproteinase inhibitor 3
multidrug resistance - associated protein 1
core - binding factor
cyclic amp - dependent transcription factor atf - 2
receptor tyrosine - protein kinase erbb - 4
transcription factor p65
adenomatous polyposis coli protein
induced myeloid leukemia cell differentiation protein mcl - 1
src substrate cortactin
tyrphostin a23
hypoxia - inducible factor - 1
proto - oncogene tyrosine - protein kinase ros
reticulon - 1
nk - tumor recognition protein
cytochrome p450 2c18
thrombopoietin receptor
ras - related protein rab - 8a
tyrosine - protein kinase blk
bcl - 2 - like protein 1
apoptosis regulator bax
aminogenistein
crk - like protein
gli family protein
biosynthetic process
teratology
tokelau
training
anergy
thrombopoiesis
physical activity
cell - mediated cytotoxicity
picrasinoside h
subcellular process
prokaryotic cell component
immunologic tolerance
personality trait
discipline
support system
uninsured medical expense
individual
declopramide
gynecologist
neurologist
neurosurgeon
pathologist
rural
sun exposure
family medical history
pacific island american
ligand binding protein
organogenesis
eniluracil
fetal tissue
immunocytochemistry
visible light
palau
at - risk population
policy
thyroid hormone receptor beta
sperm preservation
fluorescence spectroscopy
american samoa
isobrucein b
samoa
oxidative stress
gene targeting
genomic imprinting
multidrug resistance process
multidrug resistance protein 1
disease progression
reproductive medicine
photobiology
cancell
abc transporter
disease - free survival
fee for service payment method
confocal microscopy
atomic force microscopy
toxicity test
erbb2 gene
egfr gene
oncogene erb a
therapeutic radiology
ctp - 37
radiation oncology
cell cycle protein
single - stranded conformational polymorphism
oncogene erb b
chaperone
heat shock protein 70
heat shock protein 90
cyclin - dependent kinase
cellular morphology
funding
plerixafor
maturation
chemical properties
cd44 antigen
arylamine n - acetyltransferase 2
tacstd2 gene
telomeric - repeat binding factor
tumor necrosis factor receptor superfamily member 6
bcl6 protein
26s proteasome non - atpase regulatory subunit 10
tyrphostin b42
mitogen - activated protein kinase 8
gtp - binding protein rad
cdkn1a gene
cyclin - dependent kinase inhibitor 1
cyclin - dependent kinase 4 inhibitor b
cyclin - dependent kinase 5
cyclin - dependent kinase inhibitor 2a
m protein
c - x - c chemokine receptor type 4
atrasentan hydrochloride
serpin b5
neuroblastoma suppressor of tumorigenicity 1
collagen alpha - 1 ( xviii )  chain
growth arrest and dna damage - inducible protein gadd45 alpha
mlh1 protein
iswi
glutamate carboxypeptidase 2
merlin
transcription factor etv6
seprase
tyrphostin b56
tumor necrosis factor receptor superfamily member 1a
dna topoisomerase 2 - alpha
dna topoisomerase 2 - beta
creb - binding protein
histone acetyltransferase p300
protein kinase c alpha type
ets translocation variant 3
prostasin
dual specificity mitogen - activated protein kinase kinase 1
cd82 antigen
tyrphostin b50
myb - related protein a
coiled - coil domain - containing protein 6
tnf receptor - associated factor 2
nuclear receptor subfamily 2 group f member 6
von hippel - lindau disease tumor suppressor
breast cancer type 1 susceptibility protein
dermatologist
endocrinologist
gastroenterologist
experimental hematology
omapatrilat
histochemistry
oncologist
ophthalmologist
radiologist
oral surgeon
information resources management
biological process
gynecologic oncology
piposulfan
gynecologic oncologist
hematologist
internist
radiation oncologist
eye surgeon
thoracic surgeon
oncology
medical oncologist
surgical oncology
oregovomab
surgical oncologist
urologic surgeon
epidemiologist
pediatric hematology / oncology
zubrod performance status 2
zubrod performance status 3
zubrod performance status 4
history of myocardial infarction within 6 months
tyrphostin b48
head and neck surgeon
pediatric surgery
pediatric oncology
pediatric oncologist
neurologic oncology
pediatric neurology
dermatologic oncology
plastic surgeon
pediatric neurologic oncology
cyanovirin - n
colon and rectal surgeon
pediatric radiology
gynecologic oncology board certification
assessment of gonadal function
ag 1517
psychosocial effect
educational intervention
methotrexate - e therapeutic implant
fluorouracil - e therapeutic implant
melan - a
cisplatin - e therapeutic implant
aprinocarsen
micronesia ,  federated states of
northern mariana islands
palliative surgery
aruba
saint kitts and nevis
meta - analysis
cultural diversity
heat - shock response
mucosal immunity
infliximab
dna footprinting
cd56 antigen
imaging phantom
src family tyrosine kinase
cell respiration
cell lineage
ht29
selectin
blocking antibody
p59 - hck
gem 132
ccaat / enhancer binding protein epsilon
cyclin - dependent kinase inhibitor 1b
furin
nf - at
rna - binding protein ews
ets domain - containing protein elk - 3
bhlh protein
tumor necrosis factor receptor 1 - associated death domain protein
netrin receptor dcc
tissue polypeptide specific antigen
recombinant methionyl human brain - derived factor
angiostatin
serine / threonine - protein kinase plk1
apoptosis - stimulating of p53 protein 2
tuberin
atp - dependent dna helicase q1
swi / snf - related matrix - associated actin - dependent regulator of chromatin subfamily b member 1
breast cancer type 2 susceptibility protein
eukaryotic translation initiation factor 3 subunit e
zinc finger and btb domain - containing protein 16
protein wnt - 7a
recombinant human 6ckine
cd166 antigen
guanine nucleotide exchange factor vav2
somatostatin receptor type 2
receptor - interacting serine / threonine - protein kinase 1
serine - protein kinase atm
interferon regulatory factor 4
somatostatin receptor type 5
centromere protein f
nuclear receptor - interacting protein 1
immune response process
antibody - mediated lympholysis
angiogenic process
carbohydrate metabolic process
tobacco smoking
therapeutic agent research funding
nad ( p ) h dehydrogenase  [ quinone ]  1
immune system process
genetic
capecitabine
microbial genetics
exposure
morphology
contracting
atypical regeneration
community physician
prosthodontist
therapeutic implant
cigarette smoker
paclitaxel poliglumex
ashkenazi jew
magea3 gene
interventional radiology
education level
falkland islands  ( malvinas )
nicotine patch
cytochrome p450 19a1
foreign component
functional magnetic resonance imaging
rehabilitation nursing
vorinostat
hypermedia
dna methylation
multimedia
bcl2 gene
bioinformatics
brca1 gene
abcb1 gene
multidrug resistance gene
cos - 1
x - ray repair cross - complementing protein 5
carboxycinnamic acid bishydroxamide
transcription factor ap - 2 - beta
caveolin - 1
lmo2 gene
rhombotin - 2
vascular endothelial growth factor receptor 1
rho guanine nucleotide exchange factor 5
nuclear receptor coactivator 1
protein - tyrosine kinase 2 - beta
epithelial membrane protein 1
shark cartilage extract ae - 941
bloom syndrome protein
g2 / mitotic - specific cyclin - b1
mothers against decapentaplegic homolog 4
guanine nucleotide - binding protein g ( s )  subunit alpha isoforms xlas
prostaglandin g / h synthase 2
ckr5
disintegrin and metalloproteinase domain - containing protein 15
somatostatin receptor type 4
g1 / s - specific cyclin - d1
adenovirus death protein
detox
histone acetyltransferase kat2b
diamine acetyltransferase 1
cell biology
nutritional status
dietary history
light microscopy
cell - mediated immunity multitest
immune
unknown
scan
etaracizumab
histologic grade
digital x - ray
home
staging system
3 - dimensional
st7 gene
antarctica
tnm ovary neoplasm staging
tumor tissue
urinary bladder tumor antigen
roller bottle
immunology
carcinogen effect in offspring
megakaryocyte differentiation
fecal occult blood test
prostatic acid phosphatase
loss of heterozygosity
t - cell receptor gene
chemokine receptor
leukopoiesis
cigarette
diagnostic procedure
ccnd1 gene
cdkn2a gene
dna polymerase beta
cytochrome p450 2a5
bis ( 5' - adenosyl )  - triphosphatase
tyrosine - protein kinase fer
core - binding factor subunit beta
telomeric repeat - binding factor 1
soy protein isolate
tyrosine - protein phosphatase non - receptor type 11
caspase - 3
helicase - like transcription factor
zinc finger and btb domain - containing protein 48
mothers against decapentaplegic homolog 3
somatostatin receptor type 1
transcription factor pu .1
exostosin - 2
thrombospondin - 2
cyfra 21 - 1
raltitrexed
etv6 / runx1 fusion protein
thymosin beta - 15a
angiopoietin - 1
somatostatin receptor type 3
cell division control protein 6 homolog
caspase - 1
endostatin
transcription factor mafg
zinc finger protein gli2
glutathione s - transferase p
arzoxifene
exostosin - 1
menin
esx protein
ly - 49
neurogenic locus notch homolog protein 4
forkhead box protein n3
angiopoietin - 2
environmental carcinogenesis
partial remission
tobacco use
gemtuzumab ozogamicin
somatic mutation
blast cell proliferation
human anti - mouse antibody
gray
rad
oncology nurse
supermarket
inner city
radiation dose unit
church
neutron radiation
surgeon
enzyme inhibitor protein
structural protein
training and education
tissue engineering
bioengineering
cancer risk
carcinogenesis
cardiovascular pharmacology
yttrium y 90 - dota - biotin
cell growth regulation
cell proliferation
cellular oncology
chemical carcinogenesis
comparative genomic hybridization
data management
developmental genetics
developmental neurobiology
environmental engineering
fos family protein
gel electrophoresis
gene - environment interaction
gene mutation
immunopathology
immunoregulation
mcf7
molecular dynamics
molecular pathology
molecular psychobiology
pka regulatory subunit rialpha mixed - backbone antisense oligonucleotide gem 231
myogenesis
special population
physical phenomenon or property
protein synthesis
protein degradation process
proteolysis
receptor
receptor mediated endocytosis
steroid hormone receptor
steroid metabolic process
prinomastat
stoichiometry
structural biology
protein trafficking
cryo - electron microscopy
representational difference analysis
apoptosis regulator bcl - 2
enhancer binding protein
surface plasmon resonance
research facilities
biophysical chemistry
yttrium y - 90 ibritumomab tiuxetan
brca2 gene
tumorigenesis
chemical kinetics
cryobiology
microdissection
dna synthesis
lipophilicity
rna transport
leukemogenesis
tumor initiation
cigar
neural prosthesis
neuroimmunology
parallel computing
missense mutation
transition mutation
transversion mutation
reverse transcriptase - polymerase chain reaction
protein renaturation
erg gene
yeast one / two - hybrid system
computer sciences
tandem mass spectrometry
gene knockout
homologous recombination
informatics
intracellular transport
intracellular protein transport
molecular modeling
high performance computing
aromatic amines
sodium dodecylsulfate - polyacrylamide gel electrophoresis
diaphanography
threonine / tyrosine protein kinase
caspase
chromosome painting
expressed sequence tag
graft - vs - leukemia effect
distance learning
dna microarray chip
journalism
substance of abuse
manuscript
eif2b
kallikrein - 2
matrix metalloproteinase
neuregulin - 1
rgs family protein
b - cell lymphoma protein 3
dna - binding protein inhibitor id - 2
tyrosine - protein kinase syk
transcription factor maf
zinc finger protein gli1
nuclear receptor coactivator 3
tert gene
tumor necrosis factor receptor superfamily member 10a
neuregulin - 2
hamartin
axin - 1
tumor necrosis factor receptor superfamily member 10b
baculoviral iap repeat - containing protein 5
ursodiol
neuregulin - 3
phosphatidylinositol 3 , 4 , 5 - trisphosphate 3 - phosphatase and dual - specificity protein phosphatase pten
caspase - 8
serine / threonine - protein kinase stk11
histone acetyltransferase type b catalytic subunit
tata - binding protein - associated factor 172
hepatocyte growth factor receptor
probable atp - dependent rna helicase ddx6
stereochemistry
pathology
hydrocortisone sodium succinate
histopathologic examination
computer analysis
plastic surgery
immunological diagnostic method
molecular diagnostic method
clinical genetics board certification
mitomycin
biopsy specimen
brief pain inventory
clinical trials cooperative group
distant metastasis
liposome
lymph node drainage
lymph node mapping
protein overexpression
stable disease
chemosensitivity assay
transmission electron microscopy
potential energy
free energy
molecular interaction process
therapeutic follicle stimulating hormone
human biology
ethanol metabolism
pharmacology and toxicology
therapeutic index
endocrine physiology
phenocopy
media campaign
interferon beta - 1a
social group
glossary
program announcement
time series analysis
ethnic origin
alaska native
g protein - coupled receptor
suradista
academia
column chromatography
regression
environmental risk factor
organization chart
remission
cancer genetics
oncogene met
cdh1 gene
u - 0126
cdk4 gene
ext1 gene
ext2 gene
stk11 gene
men1 gene
ptch1 gene
pten gene
ret gene
smad4 gene
tsc1 gene
cryptophycin 52
tsc2 gene
vhl gene
wt1 gene
wt2 gene
pathogenesis
catabolism
cathepsin b
community health
manpower
triplatin tetranitrate
cigarette smoking
5 , 6 - dihydroxyindole - 2 - carboxylic acid oxidase
substance abuse
cardiovascular pathology
isotropy
pulmonary pathology
proteome
small g protein
pdgfb gene
single nucleotide polymorphism
chrysanthemum morifolium / ganoderma lucidum / glycyrrhiza glabra / isatis indigotica / panax pseudoginseng / rabdosia rubescens / scutellaria baicalensis / serona repens supplement
cytogenetic analysis
heterotrimeric g protein
transcription factor ap - 2 - gamma
proto - oncogene vav
suppression of tumorigenicity 5 protein
nuclear receptor corepressor 1
mediator of rna polymerase ii transcription subunit 1
caspase - 10
ets domain - containing protein elk - 1
tumor necrosis factor ligand superfamily member 15
lonafarnib
glutathione s - transferase mu 1
ras - related protein ral - a
zbtb16 / rara fusion protein
ras - related protein ral - b
histone deacetylase 2
suppressor of tumorigenicity 14 protein
pancreatic enzyme
x - ray cross complementing group
polymorphic microsatellite marker
melanoma theraccine
dna maintenance
tal1 gene
genetic variation analysis
dna ploidy analysis
clonality
humara assay
videothoracoscopy
tumor replication error analysis
fc - gamma receptor ii
polymorphism analysis
semaxanib
flu matrix protein
nat2 gene
etv6 gene
hormone receptor test
transrectal ultrasound
revm10 gene
runt - related transcription factor 1
rofecoxib
protein cbfa2t1
fli1 gene
ewsr1 gene
cdkn2b gene
bax gene
met gene
ets family gene
ets1 gene
ets2 gene
disease marker
tegafur - gimeracil - oteracil potassium
nme1 gene
oncogene ap2
oncogene b - lym
oncogene fgr
oncogene lck
oncogene dbl
rab8a gene
pim1 gene
raf1 gene
oncogene ros
cilengitide
oncogenes ,  g - proteins
oncogenes ,  growth factor
oncogenes ,  nuclear protein
oncogenes ,  protein - kinase
oncogenes ,  tyrosine - kinase
mdm2 gene
notch4 gene
eif3e gene
oncogene kit
oncogene yes - 1
batabulin sodium
akt1 gene
wnt5a gene
akt2 gene
wnt2 gene
araf gene
wnt1 gene
rhoa gene
rhob gene
rhoc gene
axl gene
radicicol 6 - oxime
bcl3 gene
vav2 gene
bmi1 gene
braf gene
cbl gene
vav1 gene
tp73 gene
tp53bp2 gene
tnf gene
oncogene tim
paroxetine hydrochloride
tiam1 gene
cdkn1c gene
foxn3 gene
map3k8 gene
crk gene
crkl gene
ccdc6 gene
thrb gene
ddx6 gene
e2f1 gene
saw palmetto berry extract
thra gene
ncoa4 gene
cttn gene
epha1 gene
epha3 gene
nr2f6 gene
erbb3 gene
supt3h gene
erbb4 gene
supt5h gene
lepirudin
supt6h gene
etv3 gene
mecom gene
oncogene spi1
smarcb1 gene
proliferation marker
metastasis and aggressiveness marker
fat1 gene
ros1 gene
farnesyltransferase / geranylgeranyltransferase inhibitor l - 778 , 123
platelet glycoprotein 4
ralb gene
rala gene
pvt1 gene
nfkb2 gene
mycn gene
fer gene
mycl gene
fgf3 gene
mybl2 gene
iodine i - 125
mybl1 gene
mpl gene
fgf6 gene
foxg1 gene
flt1 gene
fosl1 gene
mafg gene
maf gene
fosl2 gene
fyn gene
bl22 immunotoxin
epcam gene
gli2 gene
lyn gene
lta gene
ltb gene
cxcl2 gene
cxcl3 gene
jund gene
junb gene
bms - 184476
irf4 gene
oncogene ,  transcription factor
zbtb48 gene
hck gene
topoisomerase ii
soluble receptor tyrosine - protein kinase erbb - 2
soluble epidermal growth factor receptor
g protein gene
proto - oncogene ,  growth factor
proto - oncogene ,  nuclear protein
temsirolimus
proto - oncogene ,  transcription factor
proto - oncogene ,  protein - kinase
proto - oncogene ,  tyrosine - kinase
oncogene lmyc
oncogene mycn
mas1 gene
elk3 gene
dennd2b gene
spink1 gene
oncogene ski
peginterferon alfa - 2b
oncogene ets
abl2 gene
gli3 gene
oncogene fps - fes
emp1 gene
bcr gene
s - phase fraction
oncogene trk
thpo gene
cd82 gene
leridistim
cxcl1 gene
elk1 gene
oncogene hst
nktr gene
oncogene ret
research ethics
regulatory protein
digital mammography
virtual reality
protein - protein interaction
recombinant transforming growth factor - beta 3
computational chemistry
genetic epidemiology
high throughput screening
rna analysis
yeast protein
liquid chromatography mass spectrometry
underserved population
microarray analysis
nanotechnology
neuropathology
suramin sodium
serial analysis of gene expression
msh2 gene
mlh1 gene
differential display
nuclear hormone receptor superfamily
three dimensional imaging
horizontal gene transfer
tumor necrosis factor receptor superfamily member 1b
angiopoietin - 1 receptor
cd209 antigen
aminolevulinic acid hydrochloride
receptor tyrosine - protein kinase erbb - 3
cell cycle kinetics
cyclin - dependent kinase inhibitor protein
risk marker
oncogene egf
oncogenes ,  other
protein phosphorylation process
tyrosine phosphorylation
cyp1a1 gene
cyp2e1 gene
micafungin
mthfr gene
nqo1 gene
srd5a2 gene
vdr gene
smad3 gene
short tandem repeat polymorphism
erbb receptor family protein
erb oncogene family
proto - oncogene c - rel
ephrin type - a receptor 1
bortezomib
ccn3 gene
nbl1 gene
bcl1 oncogene
serpinb5 gene
signaling protein
csf1r gene
etv6 / runx1 fusion gene
single nucleotide polymorphism in coding sequence
gstp1 gene
pyridyl cyanoguanidine chs 828
metabolic marker
cancer - predisposing gene
microsatellite mutator phenotype
rrad gene
fhit gene
abcc1 gene
transcription coactivator
transcription repressor / corepressor
arhgef5 gene
gli family gene
doxorubicin prodrug l - 377 , 202
fos - related antigen 1
fos - related antigen 2
fgf4 gene
abelson tyrosine - protein kinase 2
jun family protein
serine / threonine - protein kinase a - raf
myc - family oncogene
myc family gene
myc family protein
proto - oncogene tyrosine - protein kinase receptor ret
pegfilgrastim
src family oncogene
lck gene
fgr gene
yes1 gene
tumor - associated calcium signal transducer 2
maf family gene
maf family protein
e3 ubiquitin - protein ligase cbl
tpm3 / ntrk1 fusion protein
ras superfamily protein
gefitinib
nuclear factor nf - kappa - b p100 subunit
ntrk1 gene
ets family protein
spi1 gene
t - lymphoma invasion and metastasis - inducing protein 1
spi1 oncoprotein
tyrosine - protein kinase yes
transcriptional regulator erg
tyrosine - protein kinase hck
tfap2a gene
bms - 214662
proto - oncogene wnt - 1
protein wnt - 5a
thyroid hormone receptor gene
wt2 protein
blym oncoprotein
friend leukemia integration 1 transcription factor
apoptosis promoter
fibroblast growth factor gene family
fgf2 gene
panitumumab
fgf7 gene
fgf5 gene
ccdc6 / ret fusion gene
angiogenesis promoter
ccn family member 3
max gene
tumor protein p73
fps - fes oncoprotein
runx1 gene
bms - 247550
pttg1 gene
securin
angiogenesis inhibitory protein
atm gene
cbfb gene
kmt2a gene
tumor promoter induced gene
gstm1 gene
comt gene
bms - 188797
pms1 gene
pms2 gene
tgfbr2 gene
cyclin - dependent kinase inhibitor gene
blca - 4
susceptibility / resistance gene
ultrastructural pathology
dna binding
apoptosis inhibitor
biomarker of dietary intake
bacterial artificial chromosome
serine / threonine - protein kinase pim - 1
pvt1 oncogene long non - coding rna
chromatin remodeling factor
furin gene
oncogene max
protein patched homolog 1
ephrin receptor
tm4sf1 gene
tlx1 gene
kit gene
aclacinomycin b
metabolic pathway
office of administrative management
academic career award
academic grants and contracts administration
acute illnesses nursing
administrative supplements to research grants
adult health nursing
aids epidemiology
prednisolone sodium metasulfobenzoate
aids population
aids related research ,  women
aids ,  black
aids ,  hispanic
aids ,  homosexual
aids ,  international
aids ,  minority
aids ,  other minorities
aids ,  women
entinostat
allied health sciences ,  other
analytical biochemistry
animal genetics
animal sources
academic research enhancement awards  ( area )
auditory physiology
auditory psychophysics
microscopic autoradiography
quantitative autoradiography
ms - 247
bioassay ,  in vitro
bioassay ,  in vivo
biochemical endocrinology
biochemical energetics
biochemical epidemiology
enzymology
bioinstrument application and development
biological testing
ribozyme rpi .4610
biology of hiv infection
biomolecule separation technology
biophysics ,  bioengineering and instrumentation
biophysics ,  other
biotechnology ,  fermentation
biotechnology ,  mass cell culture
biotechnology ,  synthetic nucleic acid peptide
bishop - calabresi report
epipodophyllotoxin analog gl331
bone and connective tissue pathology
bone and connective tissue physiology
breast cancer education
breast cancer genetics
breast cancer ,  treatment and rehabilitation
breast cancer epidemiology
cancer biology
office of cancer information ,  communication ,  and education
cancer epidemiology
cancer etiology
ortataxel
cancer immunology
cancer prevention fellowship program
cancer prognosis
cancer survivor
cancer survivorship research
cancer ,  viral
carbohydrate biochemistry
carbohydrate chemistry
biological carcinogenesis
carcinogenesis ,  co - carcinogenesis
vatalanib
hormonal carcinogenesis
carcinogenesis mechanism
physical carcinogenesis
carcinogenesis ,  radiation
cardiopulmonary physiology
cdna library construction
cdna subtraction
cdna expression
cell cycle checkpoint
valdecoxib
cellular immunology
cerebrovascular physiology
cervical cancer education
quantitative chemistry
chicken cells
chromosome rearrangement detection
chromosome transfer
oblimersen
clinical endocrinology
clinical immunology
clinical microbiology
clinical parasitology
clinical sciences
adjunct clinical trial
clinical virology
egfr / her1 / her2 inhibitor pki166
combinatorial synthesis of biomolecules
comparative biochemistry
conjugated carrier
midostaurin
consequences of hiv
coordination and collaboration
culturally and economically diverse group
cyclic nucleotide biochemistry
cyclic nucleotide pharmacology
cytidylyltransferase
data base management
apomine
dental epidemiology
dental sciences ,  clinical
development
developmental biochemistry
developmental cell biology
developmental endocrinology
developmental physiology differentiation / growth
developmental psychology ,  adolescence
developmental psychology ,  adult
developmental psychology ,  aged
pipendoxifene
developmental psychology
diagnostic or prognostic test
dietary epidemiology
dietary factors
differentiation and growth
director's working group
discover and develop hiv treatments - preclinical
division of cancer biology
division of cancer epidemiology and genetics
rebimastat
division of cancer prevention
division of cancer treatment and diagnosis
division of clinical sciences
division of extramural activities
radiation induced dna damage
dna - protein interaction
dominant - negative mutation
drosophila patched gene
epstein - barr nuclear antigen 3
egg preservation
lurtotecan liposome
embryo preservation
endocrine epidemiology
enhancing accessibility to health care
environmental engineering ,  atmosphere
environmental engineering ,  land
environmental engineering ,  water
environmental health sciences
epidemiology ,  age ,  sex
environmental epidemiology
cositecan
epidemiology ,  geographic location
epidemiology ,  occupation
personal medical history
epidemiology ,  race / ethnic origin
epidemiology ,  tobacco ,  alcohol ,  drugs
epithelial physiology
epithelial - stromal communication
exercise physiology and stress
expedite dissemination
darbepoetin alfa
experimental ophthalmology
experimental pathology ,  other than tumors
experimental pathology ,  tumors
experimental psychology ,  animal
experimental psychology ,  human
experimental tumor
extra - nuclear genetics
extramural activities
extramural epidemiology and genetics program
arabinoxylan compound mgn3
family health nursing
family sociology
fellowship programs ,  dceg
fellowship programs ,  f - series
fiber chemistry
five - a - day program
analytical centrifugation
elutriative centrifugation
preparative centrifugation
canertinib dihydrochloride
chemical fractionation
frederick cancer research and development center
gastrointestinal physiology
gene knock - out model
gene mapping ,  human
gene mapping ,  non - human
genetic medicine
genetic risk
genetic toxicology
motexafin gadolinium
applied genetics
experimental genetics
gerontological nursing
global change
global change / uv
glycobiology
grant opportunities ,  dcb
brivudine phosphoramidate
grants and contracts ,  nih
group affiliation
negative regulation of cell cycle
generalized growth
gynecologic pathology
gynecological / obstetrical nursing
vitamin d3 analogue ilx23 - 7553
health promotion and care
health promotion and care - work site
health promotion sciences
herpes ,  other than genital
high - let radiation
hiv and hiv genome
hiv surveys ,  incidence and prevalence
host defense mechanism
orantinib
howard temin award ,  guidelines
human fetal tissue
hybridization array
imaging technology
immune reconstitution approaches for hiv
immunologic epidemiology
immunotoxicology
improve access
individual cancer history
gem 92
infant mortality ,  non - aids
infectious disease epidemiology
infrastructure domestic and international
inhalation toxicology
institutional national research service award
dna integration
intramural research training award
intramural research program
invertebrate biology
invertebrate tissue and cells
camptothecin glycoconjugate bay 38 - 3441
laboratory animal medicine
lipid biochemistry
lipid chemistry
latent membrane protein 1
low prevalence
lymphocyte cell biology
macrophage cell biology
mathematical biology
medical entomology
medical imaging ,  virtual reality
epratuzumab
medical radiation physics
medicine ,  precancer
mentored clinical scientist development award  ( k08 )
microbial physiology
medical microbiology
quantitative microscopy
minority health and assistance ,  targeted
isocoumarin nm - 3
modeling of functional interactions
nucleic acid sequencing
protein sequencing
molecular cytogenetics
molecular medicine
molecular receptor pharmacology
molecular virology
mrna expression
muscle physiology ,  contractile
brostallicin
mutation detection
mutation spectra
mycology ,  nonclinical
national cancer program
national cancer advisory board
nci program  ( t ,  p ,  or n )
neurogenetics
neurovirology
adenovirus vector
individual national research service award
request for applications
none or not applicable
nucleic acid biochemistry ,  synthesis
occupational carcinogenesis
occupational epidemiology
ocular pathology
older population
oncogene activation process
progesterone antagonist
optical methods
oral microbiology
organometallic chemistry
other minority
other multiple areas
other types of training
outcome of therapy
chemopreventive agent
oxidative regulation
program research project grants
pathogenesis of hiv malignancy
pathogenesis of hiv neurological disease
pathogenesis of hiv opportunistic infection
pathogenesis of hiv - related organ / tissue disorder
pathology of tumors in animals
insurance and payment issues
pediatric / adolescence nursing
dolastatin compound
peptide / mhc complex
perinatal epidemiology
peroxisome proliferation
pesticide toxicology
phage display
pharmacology ,  biologicals
pharmacology - drug structure
photometry / spectrum analysis ,  visible light
environmental estrogen
phylogenetic analysis
electromagnetic flux
1 - phosphatidylinositol 4 , 5 - bisphosphate phosphodiesterase gamma - 2
plant sources
plant tissue ,  cells
rna polyadenylation
polymer chemistry
population analysis
hydrocarbons ,  polyhalogenated
population psychology
post translational modification analysis
post - transcriptional regulation
pre - clinical model
predoctoral fellowship - minority students
predoctoral fellowship - students with disabilities
preparation for vaccine efficacy trials
prognostic factor
monoclonal antibody ,  for clinical diagnosis
progress review group
prostaglandin pharmacology
protein analysis
protein - carbohydrate interaction
protein chemistry
protein expression
protein function
protein hormone receptor
protein import
phosphorylated peptide
protein kinase protein phosphorylation
protein secretion
protein / amino acid biochemistry ,  degradation and protease chemistry
protein / amino acid biochemistry ,  enzymology
protein / amino acid biochemistry ,  synthesis
public health education
pulmonary pharmacology and toxicology
transcriptional activator protein pur - alpha
radiation biology ,  electromagnetic fields
radiation biology ,  low level ionizing radiation
physical carcinogens
radiation ionizing ,  diagnostic imaging
radiation non - ionizing ,  diagnostic imaging
radiation ,  charged particles
radiation ,  non - ionizing dx or rx
radioimmune chemistry
radiology ,  bone
radiology ,  head ,  neck
radiology ,  soft tissue
physiology - regulatory factor
radiology ,  thorax ,  chest
receptor biology and gene expression
receptor signaling
recombinant antibody
reduction of opportunistic illness
regulatory affairs
renal pharmacology
renal / urogenital pathology
repair enzymology
pox virus vector
reproductive biology
reproductive endocrinology
reproductive physiology
research construction programs ,  c - series
research contracts
research methods
research program projects and centers ,  p - series
research supplements for underrepresented minorities ,  notice
research supplements to promote the recruitment of individuals with disabilities
pteridines ,  folic acid analogs
research - related programs ,  s - series
reservation
resource sharing
retinoid receptor
retrovirology
risk estimate
risk factors and mechanisms of hiv transmission
rna folding
rna synthesis
rna - protein interaction
ras inhibitor
receiver operator characteristics
rodent model of disease
small business innovation research grant
school health nursing
science enrichment
science policy
scientific publication
sensory and communicative sciences
sensory physiology
intracellular second messenger
sequencing biochemistry
site visit
skin carcinogenesis
american stop smoking intervention for cancer prevention
social networking
sociobiology
somatic cell genetics
topoisomerase - i inhibitor
spectroscopy ,  circular dichroism
state and local projects ,  risk assessment and prevention
state or local health department
statistical technique
stem cell differentiation
steroid biochemistry
structural biochemistry
structural chemistry
small business technology transfer research
surgery ,  neonatal pediatric
system for primary care professionals
t - cell activation
t - cell transformation
t - cell differentiation
invertebrate taxonomy
microbial taxonomy
plant taxonomy
vertebrate taxonomy
tumor specific peptide
t - cell receptor activation
theoretical biology
thoracic oncology
thymic t - cell selection
fresh tissue
title
tnf alpha ice proteinases
drug ,  natural product
analytical toxicology
toxicology ,  antidotes / treatment
toxicology ,  biologicals
toxicology ,  non - drug
trace element biochemistry
training in biomedical and behavioral research
training programs ,  t - series
transcriptional regulation
transient gene knock - out model
transmission ,  blood ,  recipient / donor
drug ,  food ,  chemical or biomedical material
transmission ,  hemophilia population
transmission ,  intravenous drug abuser
transmission ,  occupationally related
transmission ,  other / miscellaneous
transmission ,  perinatal infection
sexual transmission
transplacental carcinogenesis
transport models  /  radionuclides
treat aids - related malignancies
pharmacologic substance
treat aids - related neurologic disease
treat other hiv - associated complications
tta system
tumor cell biology
tumor immunity
tumor immunology
tumor pathology
tumor promotion
cellular tumor suppression
gonadotropin - releasing hormone analog
ultraviolet radiation biology
underserved ,  other than rural health
urologic oncology
uv mutagenesis
v - abl
v - ras - ha
v - src
viral cell proliferation
viral envelope gene
viral epidemiology
organo - metallic ,  phosphorus ,  boron derivatives
viral genetics
virology and immunopathogenesis of hiv
virology ,  animal
virology ,  dna viruses ,  adenovirus
virology ,  dna viruses ,  general
virology ,  dna viruses ,  papillomavirus
virology ,  dna viruses ,  papovavirus
virology ,  dna viruses ,  polyomavirus
virology ,  human
other recombinant chemokine
virology ,  rna viruses
visual physiology
visual psychophysics
volunteer organization
vpr gene
whole organism analysis
whole organism cloning
women's health nursing
antisense technology
cancer research infrastructure
drug or chemical by structure
chemical dynamics
deceptive imprinting
expression technologies for dna and rna
gene amplification or deletion detection
congress
president
advocate
board of scientific counselors ,  nci
drugs and chemicals ,  functional classification
national cancer policy board
patient or public education
population biology
environment - to - cell communication
rna degradation
cell culture system
aromatic compounds
metastasis
macromolecular sequence alteration process
viral oncogene
pathologic mutagenesis
patterns of care
specimen
research infrastructure
nitrogen compound
occupation or discipline
president's cancer panel
experimental pathology
reproductive technique
bacterial model
p1 - derived artificial chromosome
papillomavirus transforming protein e6
papillomavirus transforming protein e7
dna polymerase
continent reservoir
p1 vector
enterostomal therapist
b .a .d . codes
colon ,  rectum
core assembly
diagnostic radiology
genetic engineering ,  applied
plasmid cloning vector
lung cancer ,  women  ( subset of total lung )
mason codes
medicine ,  non - malignant disease
urologic  ( excluding kidney )
msh6 gene
small business funding mechanisms
health sciences
mesna
attenuated live virus vaccine
experimental psychology
national cancer institute
office of the director
office of special populations research
budget and financial management office
journal of the national cancer institute
office of liaison activities
division of basic sciences
extramural research program
division of cancer control and population sciences
epothilone compound
subcommittee b ,  basic sciences
subcommittee a ,  clinical sciences and epidemiology
other agency or organization
department of defense
advisory committee to the director ,  nci
nci director's consumer liaison group
optical instrument
sscp analysis
nutritional toxin
dideoxy fingerprinting
autoradiography ,  gross
preservation procedure
computational technique
homology modeling
molecular genetic technique
physical chemical technique
diagnostic ,  therapeutic ,  or research equipment
infant mortality ,  aids
curacin compound
deletion mutagenesis
s1 protection
neo gene
luc gene
socioeconomics
dna ligation
biomedical computing
cost effective management
lysozyme
economic burden
stage at diagnosis
surveillance methods
comorbidity index
medical occupation
b - cell activation
cancer genetics network
molecular epidemiology of prostate cancer
cancer center supplements
international consortium on prostate cancer genetics
heterocyclic amines
mouse models of human cancer
non - mammalian organisms as models for cancer
exploratory / developmental grant for diagnostic cancer imaging
laser capture microdissection
phased innovation awards
early detection research network
immune surveillance
biochemistry and pharmacology cancer activity
resource informatics
howard temin award
enediyne antineoplastic antibiotic
independent scientist award
diagnostic imaging network
transgenic model
heterotrimeric g protein subunit
g beta - gamma
g ( i )  alpha
guanine nucleotide - binding protein g ( q )  subunit alpha
g ( 12 / 13 )  alpha
dynemicin
community oncology and rehabilitation branch
public health applications research branch
immunology ,  other
cytochrome p450 2d5
syk family tyrosine kinase
tnf receptor family protein
tissue slice technology
commercial sources
non - commercial sources
research projects ,  r - series
signaling molecule
blue - collar group
epidemiological factors
organ transplant research
pathology ,  other
parasitology ,  other
insertion mutation
deletion mutation
nursing sciences ,  clinical
fetal thymic organ culture
3 - deazauridine
food component
non - rodent model
comparative biology
magnetic bead separation
ctll - 2 assay
hollow fiber apparatus
physiology ,  other
average household income
number of children in household
antineoplastic plant product
statistics ,  other
long term survivorship
cryopreserved tissue
cryopreserved cell
primary cell culture
allied health sciences
t - cell differentiation in the thymus
reproductive immunology
subcellular targeting ,  experimental
chemical modifier
combinatorial synthesis
organic synthesis
tumor biology
supercomputing
rna processing
clinics and hospitals
cooperative human tissue network
nci special emphasis panel
ring compound
nci initial review group
adenosine receptor
personal attribute
intramural research award
targeted research
funding category
head and neck  ( subset of total )
diagnostic ultrasound
magnetic resonance elastography
optical image reconstruction
differentiation inducer
reflectance or transmission spectroscopy
multimodal imaging
digital photography
other imaging modalities
metabolic control
chronic disorders nursing
culturing ,  in vitro invertebrate
culturing ,  in vitro microbial
dna replication damage
electrical engineering
anticachexia agent
nucleic acid biochemistry
nude mouse assay
epidemiology ,  descriptive
tobacco use epidemiology
food assistance programs
virus - cell membrane interaction
ubiquitination
dna folding
transcript
dominant negative receptor
tumor angiogenesis
electrophoretic mobility shift assay
electrospray ionization
host - tumor interaction
infection control nursing
information and communication theory
interfacial phenomenon
learning
diagnostic reagent
molecular and cellular biology
natural products chemistry
pathway analysis
neural development
neurological nursing
not defined
nursing information system
monoclonal antibody bre - 3
coping skills
adjuvanticity
admixture
b cell proliferation
b - lymphoma development
cancer cell growth
cancer cell growth regulation
candidate disease gene
gage
carcinogen metabolism
resistance
carcinogen resistance
cell energetics
cellular tropism
chromosome condensation
equilibrium centrifugation
chemical interference
complex
computational chemistry statistics
4 - nitroquinoline - 1 - oxide
element
nucleotide biochemistry
nuclei ,  structure / function
nucleotide metabolic process
metabolism ,  minerals / electrolytes
lipid metabolic process
protein metabolism process
docking
membrane structure and function
hla - drb1 gene
recombinant tumor necrosis factor family protein
drug efflux
drug transport process
eye development
nucleocytoplasmic transport
g1 / s transition checkpoint
gata - binding protein
genetic programming
genotoxic stress
linker - oligonucleotide
n - myristoylation
glycylpeptide n - tetradecanoyltransferase 2
sporadic breast tumor mutation
multiparametric analysis
mrna export
migration assay
metal ion binding
hepatocarcinogenesis
metal carcinogenesis
membrane protein traffic
holmium ho - 166
membrane biology
mammary tumorigenesis
histone h2ax
hl60
hu protein
human pathology
malignant conversion
k - 562
leukocyte trafficking
keratinocyte differentiation
yac clone
volunteer group
resource development
media
lung development
infectious disease immunology
red blood cell structure / function / metabolism
environmental and occupational exposure
blood and blood products
dna modification process
fruit or vegetable
cat gene
nucleic acid biochemistry ,  enzymology
allogenicity
toxicology ,  other
vaccine development total
calendar
histone deacetylase inhibitor
specialized program of research excellence
contractor
cancer educational materials
employment opportunities
form
funding applicant
home page
industry collaboration
organic oxoacids
links list
nci annual fact book
rapid access to intervention development
recently cleared concept
program review group report
grant review process
spanish - language document
medical image
g - banding
r - banding
2 - amino - 9 , 10 - epoxy - 8 - oxodecanoic acid
culturing ,  in vitro vertebrate ,  tissue
culturing ,  in vitro vertebrate ,  cell
certificate of confidentiality
expanded authorities
facilities and administrative costs
green card
institution supplementation
institutional animal care and use committee
just - in - time - concept
mentor's statement
food or food product
non - citizen national
population sciences
professional degree
reapplication
senior scientist
transition career development award  ( k22 )
national research service award for senior fellows
document
dna biochemistry
mercaptopurine
nut oil
rna biochemistry
tumorigenicity
gender / minority enrollment
underserved ,  rural health
herpes ,  total
human papilloma virus vaccine
comprehensiveness subcommittee b
program review group
breast cancer progress review group
aids - related malignancies working group
contingency fund
recombinant interferon alfa - 2a
early detection branch
developmental diagnostics working group
recombinant interferon alfa - 2b
sequence - specific dna binding protein
jun gene
fos gene
vertebrate biology
recombination repair
metabolic process
radiotherapy  [ medical specialty ]
nutraceutical
cancer gene
compact disc - interactive
desktop video
integrated learning system
palmtop
smart card
z - dna binding protein
vanilloid
alpha particle emitter
epidemiology of childhood malignancies
baculovirus expression system
hiv - 1 load
microtubule depolymerization process
microtubule polymerization process
tumor oxygenation
cocrystallography
cell cycle arrest
tobacco - associated carcinogen
cell ontogeny
sister chromatid exchange assay
nuclear transfer
tissue - specific gene expression
tissue - specific splicing
whole - body scintigraphy
ectopic expression
isozyme
viral function
virus - induced membrane fusion
125iudr
membrane fusion activity
molecular toxicology
bistrand abasic site
fiber fish
random peptide synthesis
nutritional carcinogenesis
multidimensional nmr techniques
lytic phase
direct costs
monoclonal antibody 81c6
restriction enzyme analysis
run - on assays
embryonic lethal mutation
rat - 1
dna - mediated gene transfer
liposome - mediated gene transfer
antibody repertoire
atomic resolution x - ray crystallography
viral pathogenesis
monoclonal antibody m170
whole genome amplification
diagnostic factor
gender / minority projection
not otherwise specified
nutritional epidemiology
occupational and environmental epidemiology
paraffin embedded tissue
cell cycle regulation process
t - cell proliferation
benzo ( a ) pyrene - 7 , 8 - diol 9 , 10 - epoxide
girentuximab
replication error
breast cancer prognostic factor
board certification
american college of radiology imaging network
biochemistry and cellular biology
biology of hiv transmission
comparative carcinogenesis
double strand break repair
functional imaging
anti - cd45 monoclonal antibody bc8
immunodeficiency and cancer
molecular immunology
legislative liaison
mammalian genetics
neuropharmacology and toxicology
james a . shannon director's award
yeast model system
signal transducer and activator of transcription
rna metabolism: processing and transport
gene therapy agent
gfp - nic96
clinical oncology
biomarkers and prevention research branch
cytoskeleton / tumor biology
neurobiology
radiation - induced gene expression
retro - inverso peptide
immune targeting
leukocyte cell biology
lymphocyte function
brca1 gene mutation
brca2 gene mutation
5' nucleotidase family
classical mechanics
clone - based physical mapping
miniantibody
clusters of orthologous groups of genes
dideoxy chain termination dna sequencing
founder generation
large - scale sequencing
shotgun sequencing
linkage disequilibrium mapping
phylogenetic pattern
protein dynamics
lutein
quantum mechanics
shotgun sequence assembly
statistical mechanics
whole - genome shotgun sequencing
yac - based sts - content mapping
yac cloning
signal induction
recombinant haplotype
radioactive sequencing
system for public use
imaging agent
school drop - outs
breast cancer surveillance consortium
lifetime risk
cell - cell adhesion process
angiogenic switch
gail risk model
age at menarche
age at first live birth
tobacco research implementation group
glioma marker network
tyrosine kinase inhibitor
nidogen - 1 c - terminal domain
histone deacetylase 1
histone deacetylase 3
histone deacetylase 4
scaffold attachment factor b1
xrcc1 gene
dna repair gene
apex1 gene
histone deacetylase 5
histone deacetylase 6
topoisomerase - ii inhibitor
biostatistical methods
mutation fixation
personal behavior
biology of aging
clonal evolution
communication tools
exogenous factors
organ model
dolastatin 9
predictive cancer model
cancer model
endogenous factors
risk reduction
audiovisual material
sites of care delivery
tissue sample
cancer gene mutation
dimethylbenzanthracene
matrix metalloproteinase inhibitor
cancer patient
cancer death rate
cigar smoking
clinical research curriculum award  ( crca )
prostaglandin g / h synthase 1
dietary practices
aids malignancy consortium
american college of surgeons
angiogenesis activator inhibitor
induced gene mutation
professional organization or group
american college of surgeons oncology group
bypass budget
cancer center support grant
cancer cluster
deferoxamine hydrochloride
cancer research network
cancerfax
cancerlit
nci - designated comprehensive cancer center
cancervax
comprehensive minority biomedical program
continuing umbrella of research experience for underserved minorities  ( cure )  program
cooking practices
grant application
cooperative agreements ,  u - series
cooperative research and development agreement
quassinoid agent
european organization for research and treatment of cancer
genetic status
hot spot
hormonal risk factor
human cancer pathology
imaging device
bruceanol agent
mouse models of human cancer consortium
national action plan on breast cancer
national health interview survey
national institute of allergy and infectious disease
national institute of child health and human development
national institute of dental and craniofacial research
national institute of diabetes and digestive and kidney diseases
national institute on drug abuse
national institute of nursing research
depsipeptide antineoplastic antibiotic
national wilms' tumor study group
mentored patient - oriented research career development award
nih center for scientific review
number of first degree relatives  ( affected )
midcareer investigator award in patient - oriented research
alvac - cea b7 .1 vaccine
molecular analysis
molecular profiling
office for protection from research risks
office of cancer survivorship
pediatric cancer care network
pediatric oncology group
polyvalence
radiation therapy oncology group
regulatory pathway
gm - csf - secreting lethally irradiated tumor cell vaccine
study section
surveillance implementation group
tumor - secreted protein
research career programs ,  k - series
underrepresented minority
autologous gm - csf - secreting lethally irradiated lung cancer vaccine
histologic subtype
societal factors
smoking status
chromatin remodeling
splice - site mutation
drd2 1 allele
acetaminophen
autologous tumor cell vaccine
yeast protein complex
nurf
rsc
swi2 / snf2
saga
chrac
swi1
swi3p
snf6
autologous - cell melanoma vaccine
drd2 2 allele
second degree relative
xenograft model
immunoliposome
drosophila protein complex
tdt - mediated dutp nick end labeling assay
negative regulation of g1 phase
hsv - tk gene
cellular retinoic acid binding protein
cdna array
autologous dinitrophenyl vaccine
warburg effect
cpg island methylator phenotype
allelotype analysis
polyamine catabolism
epithelial cell aggregation and separation
short oligonucleotide mass analysis
brightfield microscopy
metaphase spread
negative regulation of g2 to m transition
allogeneic tumor cell vaccine
co - immunoprecipitation
tissue recombination
nuclear extract
dorsal skinfold window chamber model
gelatin zymography
cytosolic phospholipase a2 group iv
hswi / snf complex
swi / snf complex subunit smarcc1
swi / snf complex subunit smarcc2
autologous colon cancer cell vaccine
swi / snf - related matrix - associated actin - dependent regulator of chromatin subfamily e member 1
swp73
swi / snf - related matrix - associated actin - dependent regulator of chromatin subfamily d member 1
swi / snf - related matrix - associated actin - dependent regulator of chromatin subfamily d member 2
swi / snf - related matrix - associated actin - dependent regulator of chromatin subfamily d member 3
transcription activator brg1
probable global transcription activator snf2l2
swp82
swp61
swp59
sipuleucel - t
swp29
basal transcription factor
drosophila swi / snf
swi2 / snf2 family protein
swh3p
sth1p
snr1
probable global transcription activator snf2l1
swi / snf - related matrix - associated actin - dependent regulator of chromatin subfamily a member 5
snf11
p53 peptide vaccine mps - 128
sfh1
rsc6
osa
moira gene product
mediator complex
brahma
prc1
polycomb
polyhomeotic
posterior sex combs
dendritic cell tumor peptide vaccine
polycomb protein scm
e - rc1
smarcc1 gene
smarcc2 gene
smarce1 gene
smarcd1 gene
smarcd2 gene
smarcd3 gene
smarca4 gene
smarca2 gene
dendritic cell tumor cell lysate vaccine
swi / snf - related gene
ercc6 gene
hltf gene
smarca5 gene
smarca1 gene
msin3
nuclear receptor coactivator 4
histone acetyltransferase kat5
nuclear receptor coactivator 2
trap complex
nuclear receptor corepressor 2
runx1 / runx1t1 fusion protein
mad / mxi1
gcn5p
drd2 gene
national center for complementary and alternative medicine
dnase - i footprinting
biochemical reaction
acetyl coenzyme a
mannosylerythritol lipid
proteolytic processing
protein dimerization
protein biochemistry
post - translational regulation
phased spiral ct
two - phase spiral ct
triple - phase spiral ct
quadruple phase spiral ct
portal venous phase spiral ct
2 -  ( 3 - ethylureido )  - pyridine
arterial phase spiral ct
equilibrium phase spiral ct
subsecond spiral ct
dynamic spiral ct
incremental spiral ct
retrotransposition
safb gene
src gene
stil / tal1 fusion gene
megakaryocyte proliferation
4 - methyl - 2 -  ( 3 - ethylureido )  - pyridine
thyroid hormone receptor alpha
dynamic enhanced ct
tissue microarray
tissue expediter
principal investigator
postdoctoral scholar
venous phase spiral ct
subsecond spiral ct scanner
apoptosis regulator
fgfr1 gene
2 , 6 - dimethyl - 2 -  ( 3 - ethylureido )  - pyridine
fibroblast growth factor receptor family gene
fgfr2 gene
negative regulation of apoptosis
aids - indirect research
non - histone chromosomal protein hmg - 14
matrix - assisted laser desorption / ionization - time of flight mass spectrometry
alternative medicine ,  direct
alternative medicine ,  indirect
arctic research
atp hydrolysis
2 , 6 - dimethyl - 4 -  ( 3 - ethylureido )  - pyridine
nk cell activation
perinatal carcinogenesis
perinatal exposure
heparan sulfate biosynthesis
stress response signaling
ccdc6 / ret fusion protein
limb development
epithelial cell proliferation
bacteriophage genetics
angiotropin
6 -  ( 3 - ethylureido )  - uridine
transmembrane transport
protein max
immunoglobulin - mediated cell signaling
spleen development
ret oncoprotein
myeloproliferation
folic acid metabolic process
quinone metabolism
androgen metabolism process
pediatric brain tumor consortium
1 , 3 - dimethyl - 6 -  ( 3 - ethylureido )  - uridine
phased technology application award
in vivo cellular and molecular imaging centers
accelerated executive review
joining organizations with leading technologies
association of cancer on - line resources
molecular epidemiology of cancer
molecular fingerprint of tumor
molecular fingerprinting of tumor
molecular target discovery grants
axin1 gene
4 -  ( 3 - ethylureido )  - cytosine
pattern formation
dorsal - ventral pattern formation
signatures of cancer cells
quick trials program
biosynthetic chemistry
consortium or network
regional enhancement center
nicotine inhaler
special populations networks
structural biologist
5 - methyl - 4 -  ( 3 - ethylureido )  - cytosine
nci - designated cancer center
transdisciplinary tobacco research center
nci unconventional innovations program
centers of research excellence
common data element
diagnostics validation network
biophysical process
cancer progression
organismal process
sensory process
cd30 immunotoxin
cancer informatics infrastructure
clinical trials informatics system
clinical data update system
ski oncoprotein
electromagnetism
zubrod performance status 0
zubrod performance status 1
acetylcysteine
tp3 immunotoxin
zubrod performance status 5
postdoctoral individual national research service award
predoctoral individual national research service award
fellowship program
mentored research scientist development award
senior scientist research and mentorship award
physician scientist award  ( program )   ( psa )
career transition award
academic / teacher award
monoclonal antibody j591
clinical investigator award  ( cia )
national research service awards
exploratory / developmental grant
exploratory / developmental grants phase ii
center core grants
education projects
national center for research resources
extramural research facilities construction project
research facilities construction grants
specialized center grant
cd22 immunotoxin
funding mechanism
x - ray repair cross - complementing protein 6
biophotonics
flame - broiling
protein ,  organized by function
protein ,  organized by structure
lipoprotein
anti - endoglin immunotoxin
protein ,  organized by location
extracellular protein
protein ,  organized by origin
cytoplasmic protein
senior scientist award
fluorescence bronchoscopy
nuclear orphan receptor
fak family tyrosine kinase
population attributable risk
hematology ,  other
technology development and commercialization branch
percent free prostate - specific antigen
transition zone psa density
pathologic ab - ig protein
immunoglobulin gene rearrangement
red meat consumption
diagnostic or prognostic factor
high vegetable diet
monoclonal antibody sgn - 14
pharmacogenomics
surgically - created resection cavity
papillomavirus protein e4
papillomavirus protein e2
academic detailing
nucleic acid amplification test
adenovirus protein
cancer intervention and surveillance modeling network
h19 gene
light - scattering spectroscopy
sgn - 17 / 19
cdkn1b gene
neuregulin receptor
cellular compartment analysis
combinatorial synthesis of small molecules
conformation dependent mutation detection
microdeposition
microfabrication
modeling of cellular pathways
spectral karyotyping
prognostic marker
brentuximab
wrn gene
administrative supplement
immunophenotype
shiga toxin beta subunit
telomerase protein component 1
alkyltransferase and aryltransferase
rna polymerase
v - sis platelet derived growth factor ,  beta polypeptide
sf - 36
sf - 12
mdx - 447
angiography
emerging technologies
shared pathology informatics network
office of communications
special exceptions process
proteomics
cancer clinical trials education program
cancernet
cancertrials
minority clinical oncology awards
monoclonal antibody mdx - 220
cancer trials support unit
physician survey on cancer susceptibility testing
genome scan
health information national trends survey
low - dose spiral ct
co - receptor switching
aptamer technology
virtual endoscopy
dna image cytometry
wnt7a gene
muramyl dipeptide
monoclonal antibody mdx - 22
wnt family gene
hypermethylation
receptor gene
bouvet island
french southern and antarctic lands
heard island and mcdonald islands
kazakhstan
country code
dna topoisomerase 3 - alpha
state of palestine
south georgia and the south sandwich islands
united states minor outlying islands
western sahara
binet staging system
rai staging system
breast cancer risk factor
diffusion mri
international prognostic index
psa velocity
matuzumab
age - adjusted psa
molecular carcinogenesis
experimental tobacco carcinogenesis
csk gene
reticulon - 4
tankyrase - 1
structural genomics
cea assay
ugt1a1 gene
repairosome
bec - 2
protein family
national institute of general medical sciences
phosphoprotein phosphatase
anguilla
smoking behavior
igf1r gene
estrogen metabolic process
nitrosamine metabolism
skeletal development
ligand binding
regulation of proteolysis
soluble guanylate cyclase
golgi targeting
nuclear division
dna replication factor cdt1
caspase - 2
mitotic recombination
transcription initiation
peptide metabolism
subcellular protein targeting
abarelix
positive regulation of apoptosis
inflammatory response
telomere maintenance
rna interference
acf complex
areg gene
radiation - induced recombination
non - human gene
non - human protein
drosophila protein
vgef mixed - backbone antisense oligonucleotide gem 220
nci center for cancer research
steroidal aromatase inhibitor
tetracycline control
nrg1 gene
myelography
nephrotomography
intravenous pyelography
mammogram
toxicogenomics
non - steroidal aromatase inhibitor
cell cycle phase
conceptual entity
population process
telomere reverse transcriptase
protein complex subunit
gene transfer
nuclear factor - i
cancer science
social circumstances
property or attribute
dihydropyrimidine dehydrogenase inhibitor
chemical agents
cell - matrix adhesion process
miscellaneous occupation
genetic drift
regulatory gene
gene fusion
cancer center
male
low literacy population
aclarubicin
farnesyl transferase inhibitor
outcome
lifestyle factors ,  unspecified
laser - induced fluorescence endoscopy
preneoplastic change
marker of preneoplastic change
sentinel lymph node mapping
nonhomologous dna end joining
tep1 gene
epithelial cell adhesion molecule
thymidylate synthase inhibitor
mlh3 gene
msh3 gene
base excision repair
nucleotide excision repair
hypoxia - inducible factor 1 - alpha
secondary cell culture
adherent culture
suspension culture
hgh gene
tk gene
dna interstrand cross - link repair
hela
hela s3
hela / sf
hl - 60 / mx2
autologous - cell leukemia vaccine
hl - 60 / mx1
eg cell line
es cell line
bg01
bg02
bg03
bg04
cy12
cy30
cy40
h - ras antisense oligodeoxynucleotide isis 2503
cy51
cy81
cy82
cy91
cy92
cy10
es01
tyrphostin a8
es02
es03
es04
es05
es06
ge01
ge07
ge09
ge13
tyrphostin a9
ge14
ge91
ge92
sa01
sa02
sa03
ka08
ka09
tyrphostin a48
ka40
ka41
ka42
ka43
mb01
mb02
mb03
mi01
tyrphostin ag 370
nc01
nc02
nc03
ch01
ch02
rl05
rl07
tyrphostin b44 (  -  )
rl10
rl13
rl15
rl20
rl21
te03
te32
te33
te04
acridine
tyrphostin ag 1288
te06
te62
te07
te72
uc01
uc06
wa01
wa07
tyrphostin ag 1295
wa09
wa13
wa14
protein truncation
trace metal storage protein
werner syndrome atp - dependent helicase
consumer advocates in research and related activities
atp - dependent dna helicase q4
licensing factor
tyrphostin ag 1433
replication initiation point mapping
high mobility group protein hmg - i
high mobility group protein hmg - y
high - mobility group protein hmgi - c
hmga family protein
hmgb family protein
hmgn family protein
high mobility group protein b1
high mobility group protein b3
bis - tyrphostin
high mobility group protein b2
high mobility group protein hmg - r
high mobility group nucleosome - binding domain - containing protein 3
high mobility group nucleosome - binding domain - containing protein 4
xrcc2 gene
xrcc3 gene
telomere length maintenance
prkdc gene
telomere maintenance gene
telomere capping
tyrphostin a63
telomere recombination
elongation by telomerase
internet
human glandular kallikrein
ogg1 gene
exo1 gene
atomic resolution microscopy
apoptosis inhibitor gene
apoptosis promoter gene
m phase process
tyrphostin a1
birc5 gene
birc6 gene
birc7 gene
naip gene
birc2 gene
birc3 gene
xiap gene
apaf1 gene
topbp1 gene
ketanserin tartrate
sidt1 gene
xpa gene
xrcc4 gene
xrcc5 gene
lymphotactin
replication licensing
diaphranography
mcm protein
research technique
microtechnique
imc - 1c11
replication initiation gene
orc subunit gene
licensing factor gene
mcm2 gene
mcm4 gene
mcm5 gene
mcm6 gene
mcm3 gene
mcm7 gene
cdc45 gene
monoclonal antibody dc101
orc2 gene
cdt1 gene
cdc6 gene
mcm10 gene
cdc7 gene
dbf4 gene
orc1 gene
orc4 gene
orc5 gene
orc6 gene
bevacizumab
orc3 gene
neurotrophic factor
neuropoietic cytokine
heparin - binding neurotrophic factor
wnt family protein
gmnn gene
protein phosphatase 2a subunit gene
ppp2r3b gene
ppp2ca gene
ppp2cb gene
actinomycin antineoplastic antibiotic
texaphyrin
monoclonal antibody
ppp2r5a gene
ppp2r5b gene
ppp2r5c gene
ppp2r5d gene
ppp2r5e gene
ptpa gene
vav family gene
bcl - 2 gene family
radicicol derivative kf58333
bcl2l1 gene
bcl2l2 gene
mcl1 gene
bak1 gene
bad gene
bcl - x ( s )
bcl2l11 gene
bik gene
hrk gene
bid gene
ag 1732
transcription factor gene
taf1 gene
mitochondrial membrane protein
helicase
growth factor
epidermal growth factor
fibroblast growth factor
hematopoietic growth factor
hepatocyte growth factor
erythropoietin
labetuzumab
angiogenin
amphiregulin
betacellulin
neuregulin
fibroblast growth factor 5
fibroblast growth factor 6
fibroblast growth factor 7
macrophage colony - stimulating factor 1
interleukin - 3
in 111 dac
kit ligand
thrombopoietin
insulin - like growth factor
beta - nerve growth factor
brain - derived neurotrophic factor
glial cell line - derived neurotrophic factor
parathyroid hormone - related protein
platelet - derived growth factor
platelet - derived growth factor subunit b
matrix metalloproteinase inhibitor mmi270
vascular endothelial growth factor a
interleukin - 6
pleiotrophin
transforming growth factor
transforming growth factor alpha
transforming growth factor - beta superfamily
activin
transforming growth factor beta - 1
transforming growth factor beta - 2
transforming growth factor beta - 3
tnp - 40
tbp gene
world wide web
apoptosis regulation gene
terc gene
cytokine
thioredoxin
chemokine
alpha chemokine
beta - thromboglobulin
connective tissue - activating peptide iii
prolactin 16 - kd fragment
c - x - c motif chemokine 5
growth - regulated alpha protein
interferon - alpha inducible protein 10
interleukin - 8
c - x - c motif chemokine 2
c - x - c motif chemokine 3
beta chemokine
c - c motif chemokine 4
c - c motif chemokine 1
c - c motif chemokine 8
a - 65
cellular process
c - c motif chemokine 3
c - c motif chemokine 5
c - c motif chemokine 21
eotaxin
chemokine ,  other
c5a anaphylatoxin
delta chemokine
fractalkine
indibulin
gamma chemokine
molecular nanotechnology
fms - related tyrosine kinase 3 ligand
interferon
interferon alpha
interferon beta
interferon gamma
interleukin
lymphokine
oncostatin - m
acyclovir
alpha v beta inhibitor
tumor necrosis factor family protein
taf2 gene
taf3 gene
taf4 gene
cell maintenance
taf5 gene
interleukin - 1
interleukin - 2
interleukin - 4
interleukin - 5
spongistatin
interleukin - 7
interleukin - 9
interleukin - 10
interleukin - 11
interleukin - 12
interleukin - 13
interleukin - 14
interleukin - 15
interleukin - 16
interleukin - 17a
cephalostatin
interleukin - 18
interleukin - 1 alpha
interleukin - 1 beta
leukemia inhibitory factor
leukoregulin
taf6 gene
taf7 gene
cd40 ligand
tumor necrosis factor ligand superfamily member 6
t - 1622
lymphotoxin - beta
taf7l gene
tumor necrosis factor ligand superfamily member 4
tumor necrosis factor ligand superfamily member 10
taf8 gene
tumor necrosis factor
lymphotoxin - alpha
taf9 gene
taf10 gene
tbp - associated factor gene
bci immune activator
taf11 gene
taf12 gene
taf13 gene
tfiid subunit gene
tfiia subunit gene
granulocyte - macrophage colony - stimulating factor
fibroblast growth factor 2
fibroblast growth factor 1
fibroblast growth factor 3
allogenic glioma cancer vaccine
fibroblast growth factor 4
tbpl1 gene
pms2p1 gene
apex2 gene
ercc1 gene
ercc2 gene
ercc3 gene
ercc5 gene
ercc4 gene
trex1 gene
neu - sensamide
atr gene
trex2 gene
terf2 gene
terf1 gene
tinf2 gene
lig4 gene
ku subunit gene
xaf1 gene
xrcc6 gene
lapuleucel - t
hmg family gene
hmga family gene
hmgb family gene
hmgn family gene
hmga1 gene
hmga2 gene
hmgb1 gene
hmgb2 gene
bibh 1
hmgb3 gene
hmgn1 gene
hmgn2 gene
hmgn3 gene
hmgn4 gene
mitogen - activated protein kinase kinase kinase 8
colony stimulating factor
age group
gag protein
gene amplification technique
bp16 vaccine
arylesterase
swi / snf family complex
iswi family protein
tfiih
gtf2a1 gene
recq helicase family protein
atp - dependent dna helicase q5
gtf2a1l gene
gtf2a2 gene
tbp inhibitor gene
adenine
carcinoembryonic antigen peptide - 1 vaccine
dr1 gene
drap1 gene
b - tfiid subunit gene
btaf1 gene
affinity
developmental anatomy
catchment area
radiation biophysics
synthesis chemistry
monoclonal antibody 3a1
partition coefficient
cytopathology
dephosphorylation
clonal expansion
primer extension
cancer family
recombination fraction
housekeeping gene
quantitative genetics
granzyme
pan - rar agonist / ap - 1 inhibitor lgd 1550
gustation
hematopathology
somatic cell hybridization
immunobiology
embryonic induction
tumor cell invasion
enzyme kinetics
linker - scanning mutagenesis
melanogenesis
silent mutation
hpv - 11 vaccine
neuropathogenesis
comparative pathology
pathophysiology
biochemical pathway
biochemical pharmacology
radiation physics
polymerase
transcription factor sp1
community psychology
mismatch repair
gbc - 590
ommaya reservoir
performance status
stereotaxis
schiller test
high resolution computed tomography
spiral ct
topoisomerase
tfiie subunit gene
gtf2b gene
gtf2e1 gene
tridolgosir hydrochloride
gtf2e2 gene
tfiif subunit gene
gtf2f1 gene
gtf2f2 gene
tfiih subunit gene
tfiih core subunit gene
gtf2h1 gene
mediator complex component gene
med6 gene
votumumab
rna polymerase ii subunit gene
polr2a gene
nursing informatics
tfiiic subunit gene
gtf3c3 gene
gtf3c1 gene
gtf3c2 gene
gtf3c4 gene
gtf3c5 gene
tfiiib subunit gene
k - ras protein vaccine
brf1 gene
bdp1 gene
brf2 gene
transcription coactivator gene
x - chromosome inactivation
sub1 gene
psip1 gene
microscope
robot
serine / threonine phosphorylation
mgv vaccine
med1 gene
med14 gene
secretogranin - 1
secretogranin - 2
sp1 activation cofactor gene
med23 gene
med17 gene
med26 gene
defosfamide
med27 gene
med7 gene
nuclear receptor coactivator gene
cytokeratin
intermediate filament protein
ncoa1 gene
ncoa2 gene
breast cancer early detection
ncoa3 gene
adenosine
mannomustine
ncoa5 gene
alcohol abuse
ncoa6 gene
transcription repressor / corepressor gene
nrip1 gene
mhc class ii protein
mhc class i protein
nr0b2 gene
orphan nuclear receptor gene
nuclear receptor gene
phenamet
transcription coregulator gene
sp1 gene
med24 gene
amph gene
bard1 gene
serine hydrolase gene
bphl gene
ddr1 gene
receptor tyrosine kinase gene
uredepa
cdh3 gene
cell adhesion receptor gene
cdh5 gene
cdh13 gene
crebl2 gene
cysteine proteinase inhibitor gene
cystatin superfamily gene
cystatin family gene
cst6 gene
stefin family gene
monoclonal antibody b1
kininogen family gene
protein phosphatase gene
dusp3 gene
fabp family gene
fabp3 gene
rna binding
lipid binding
lipid transport
denopterin
histone acetylation
tumor cell mobility
fgfr4 gene
structural protein gene
cytoskeletal gene
microfilament gene
gas2 gene
regulation of cell shape
segmental mastectomy
cell proliferation regulatory process
inhibition of cell proliferation
gas8 gene
acrbp gene
agr2 gene
anp32c gene
hmmr gene
hyaluronic acid binding
anp32d gene
polyamine synthesis inhibitor
appbp2 gene
diras3 gene
metastasis suppressor gene
axin2 gene
metastasis suppression
kiss1 gene
bap1 gene
bcar1 gene
cytoskeletal modeling
trerf1 gene
bioreductive agent
bcar3 gene
bcas1 gene
bcas2 gene
bcas3 gene
bcas4 gene
brcd1 gene
bcpr gene
chmp2a gene
brca3 gene
folic acid derivative
ankrd30a gene
brms1 gene
cox7a2l gene
dlc1 gene
epsti1 gene
fbxw7 gene
gls2 gene
xage2 gene
clca2 gene
cardioprotective agent
hyou1 gene
adam family gene
adam11 gene
il24 gene
casc3 gene
calml4 gene
ergic3 gene
prickle4 gene
tspan32 gene
arid4b gene
cyclic amp
cytoprotective agent
mucl1 gene
tacc2 gene
traf4 gene
tssc4 gene
msmb gene
blm gene
wfdc1 gene
wnt4 gene
abcg2 gene
rad54l gene
hepatoprotective agent
platelet basic protein
platelet factor 4
coagulation process
rad51 family gene
rad51c gene
nova1 gene
txn gene
nova family gene
nucleoporin gene
uroprotective agent
nup98 gene
nurse
licensed practical nurse
strategic supplement program
registered nurse
advanced practice nurse
molecular diagnosis
optical biopsy
optical coherence tomography
slc22a18 gene
dna methyltransferase inhibitor
certified nurse midwife
certified registered nurse anesthetist
clinical nurse specialist
cardiovascular nurse
community health nurse specialist
diabetes management nurse specialist
enterostomal therapy nurse specialist
gerontological nurse specialist
home health nurse specialist
phb gene
n , n - dibenzyl daunomycin
medical - surgical nurse specialist
oncology nurse specialist
pediatric nurse specialist
nurse educator
ribosome subunit gene
rpl13 gene
ribonucleotide reductase subunit gene
rrm1 gene
s100 family gene
chlorodihydropyrimidine
s100a2 gene
nurse practitioner
case management nurse
non - clinical specialty nurse
informatics nurse specialist
sncg gene
nurse administrator
inosine 5' - phosphate dehydrogenase inhibitor
nurse specialist in health and public policy
unlicensed assistive personnel
stim1 gene
stimulation of cell proliferation
tacc1 gene
ambulatory care nursing
cardiac / vascular nursing
clinical nursing
hospital nursing
inosine monophosphate dehydrogenase inhibitor
long - term care nursing
tff1 gene
gpr39 gene
medical - surgical nursing
orthopedic nursing
subacute nursing
clinical research nursing
flight nursing
or nursing
ornithine decarboxylase inhibitor
perianesthesia nursing
emergency room nursing
trauma nursing
home health nursing
infusion nursing
neonatal nursing
msln gene
mesothelin
obstetrical nursing
palliative care nursing
protein kinase c inhibitor
pediatric nursing
wfdc2 gene
camp nursing
wap four - disulfide core domain protein 2
developmental disabilities nursing
epidemiology nursing
transplant nursing
eipr1 gene
phlda2 gene
elf3 gene
adenosine triphosphate
s - adenosyl - methionine decarboxylase inhibitor
ets - related transcription factor elf - 3
restraining placental growth
slpi gene
wnt3 gene
slc5a5 gene
wnt10b gene
adipogenesis
ccl2 gene
trim25 gene
c - c motif chemokine 2
wnt1 - inducible - signaling pathway protein 1
ccn4 gene
cytokine receptor gene
tgfb3 gene
uterine swelling
brcd2 gene
sem1 gene
cell cycle gene
cell cycle completion
brcata gene
gonadotropin releasing hormone antagonist
whey protein
signaling pathway gene
g protein - coupled receptor gene
kiss1r gene
nova2 gene
fabp2 gene
baculoviral iap repeat - containing protein 1
xiap - associated factor 1
131 i - ethiodized oil
apoptotic protease - activating factor 1
baculoviral iap repeat - containing protein 2
alpha adrenergic receptor
alpha adrenergic receptor gene
iap family protein
alpha - 1b adrenergic receptor
adra1b gene
akt3 gene
iap family gene
rac - gamma serine / threonine kinase
receptor mediated permeabilizer agent
anxa8 gene
annexin a8
rho guanine nucleotide exchange factor 1
arhgef1 gene
acsl1 gene
baculoviral iap repeat - containing protein 3
e3 ubiquitin - protein ligase xiap
auh gene
lopinavir
methylglutaconyl - coa hydratase ,  mitochondrial
baculoviral iap repeat - containing protein 7
bag1 gene
bag family molecular chaperone regulator 1
brs3 gene
bombesin receptor subtype - 3
cyclin - a2
ccna2 gene
ccne2 gene
g1 / s - specific cyclin - e2
lopinavir / ritonavir
cdc25a gene
m - phase inducer phosphatase 1
chrm1 gene
muscarinic acetylcholine receptor m1
chrm3 gene
muscarinic acetylcholine receptor m3
chrm5 gene
muscarinic acetylcholine receptor m5
telomerase rna component
epidermal growth factor superfamily protein
v ( d ) j recombination
autoantigen
amphiphysin
fatty acid - binding protein ,  heart
fabp1 gene
fabp4 gene
fabp5 gene
regulation of exocytosis
gtp binding
canarypox vector
brca1 - associated ring domain protein 1
tumor suppressor protein
serine hydrolase
valacyclovir hydrolase
ablation therapy
ctnnb1 gene
cell adhesion molecule gene
physical examination
nephroprotective agent
cd22 gene
cancer pain group
pain assessment
research or clinical assessment tool
alcam gene
pain assessment tool
category rating scale
pecam1 gene
ceacam5 gene
cd44 gene
immunoadjuvant
antineoplastic vaccine gv - 1301
choice and control
cordotomy
deafferentation
cd34 gene
ncam1 gene
dermatome map
icam1 gene
disability
icam2 gene
discectomy
cya 246
discomfort scale for patients with dementia of the alzheimer's type
distraction and attention
electroanalgesia
icam3 gene
bmp / retinoic acid - inducible neural - specific protein 1
cd58 gene
protein acetylation
protein dephosphorylation
suppression of cancer cell invasion
tlc ell - 12
cadherin - 3
cadherin - 5
cadherin - 13
spinal cord stimulation
deep brain stimulation
peripheral nerve stimulation
peripheral electronic nerve stimulation
percutaneous neuromodulation therapy
transcutaneous acupoint electrical stimulation
h - wave therapy
i 131 monoclonal antibody lym - 1
inferential current treatment
piezo - electric current therapy
transcutaneous electrical nerve stimulation
itgal gene
glycosylation
protein methylation
facial affective scale
fleming method relaxation
nucleic acid folding
vincristine liposomal
intracellular signaling process
selp gene
group therapy
sele gene
cell death signaling process
sell gene
vtn gene
dna replication proofreading
gene expression process
enfuvirtide
gene regulation process
epigenetic process
rna polyadenylation regulation
rna polyadenylation inhibition
impairment
interpretive therapy
isometric exercise
isotonic exercise
isokinetic exercise
monoclonal antibody 703d4
intravenous patient - controlled analgesia
laminectomy
actinotherapy
photobiomodulation therapy
protein turnover
cell stress process
cellular stress
cellular stress response
dna sequence alteration process
dna sequence rearrangement
anthrapyrazole antineoplastic antibiotic
protein sequence alteration
multidisciplinary pain treatment center
neural block
neuraxial opioid analgesia
neurologic process
nociception
nociceptive impulse
nociceptive reflex
nociceptive stimulus
transport process
immunocyt
replication - associated process
growth arrest - specific protein 8
numeric pain scale
opioid rotation
pain map
pain threshold
pain tolerance
parenteral infusion procedure
patient self - report
topoisomerase - iv inhibitor
pharmacologic management
tnc gene
hspb1 gene
preemptive analgesia
quality adjusted life years
cell motility process
sedation
f3 gene
cell viability process
miscellaneous alkylating agent
social isolation
cell growth process
cell division process
hyaluronan mediated motility receptor
pain origin
pain nature
previous pain treatment assessment
m phase substage
supportive therapy
miscellaneous antineoplastic antibiotic
sympathetic block
inflammation process
kitlg gene
tnfsf15 gene
tumor necrosis factor family gene
terminal sedation
terminal illness
therapeutic heat
therapeutic cold
traction
visual analog pain scale
cd40 gene
who analgesic method
multicellular process
rolfing
ceiling effect
single convention on narcotic drugs
histogenic process
physical dependence
drug tolerance
psychological dependence
cd40lg gene
verbal rating scale for pain
wisconsin brief pain questionnaire
mcgill pain questionnaire
short - form mcgill pain questionnaire
memorial pain questionnaire
patient outcome questionnaire
descriptor differential scale
mustard agent
metastasis suppressor protein
metastasis - suppressor kiss - 1
integrated pain scale
myelopoiesis
tnfsf10 gene
adam family protein
developmental process
faslg gene
tnfsf4 gene
dna minor groove binding agent
pain perception profile
west haven - yale multidimensional pain inventory
unmet analgesic needs questionnaire
city of hope mayday pain resource center patient pain questionnaire
symptom specific assessment tool
baseline dyspnea index
quality of life in chronic lung disease
medical research council dyspnea scale
ats - dld - 78 adult questionnaire
peptidase family m12b
selective estrogen receptor down regulator
immunoglobulin binding protein
beta - microseminoprotein
itgam gene
tnf receptor - associated factor 4
tnf receptor family gene
cd72 gene
chga gene
shbg gene
carbohydrate processing inhibitor
dna repair protein
nibrin
aging - related process
reproductive process
cav1 gene
protein or riboprotein complex
mre11 / rad50 double - strand break repair complex
nbn gene
clic4 gene
chloride intracellular channel protein 4
nova family
rna - binding protein nova - 1
nucleoporin
nuclear pore complex protein nup98
npm1 gene
tumor expansion
solute carrier family 22 member 18
tumor - associated process
metabolic process ,  organismal
golgi alpha - mannosidase ii inhibitor
bcl2 antagonist of cell death
bcl - 2 homologous antagonist / killer
bcl - 2 - like protein 11
immune function ,  subcellular
bcl - 2 - like protein 2
intermediary metabolic process
bh3 - interacting domain death agonist
recombinant corticotropin
lectin inhibitor
chromogranin gene
chgb gene
viral reverse transcription
bcl - 2 - interacting killer
organic cation transporter
scg2 gene
activator of apoptosis harakiri
prohibitin
brca1 associated ring domain protein 1
dna repair protein rad51 homolog 3
ozone - based agent
ribosomal protein
60s ribosomal protein l13
ribonucleotide reductase subunit
ribonucleoside - diphosphate reductase large subunit
calcium binding protein
protein s100 - a2
calcium binding
synuclein family
gamma - synuclein
stromal interaction molecule 1
cell differentiating agent
pik3ca gene
dck gene
map2k1 gene
ripk1 gene
anchorage - independent growth
transforming acidic coiled - coil - containing protein 1
mapk3 gene
mapk1 gene
mapk8 gene
tyms gene
monoclonal antibody 16 .88
negative regulation of g1 to s transition
trefoil family
mgmt gene
tsg101 gene
ckb gene
tnks gene
tyrp1 gene
tumor susceptibility gene 101 protein
psmd10 gene
radioconjugate
translation process gene
vacuolar protein sorting
ubiquitinated protein degradation
hiv budding
protein tssc1
pleckstrin homology - like domain family a member 2
proto - oncogene wnt - 3
hpr gene
protein wnt - 10b
radioactive sodium iodide
rtn4 gene
e3 ubiquitin / isg15 ligase trim25
cenpf gene
atp - binding cassette sub - family g member 2
e3 ubiquitin - protein transferase
trim family
14 - 3 - 3 family
breast cancer suppressor - 2
rtn1 gene
neuroendocrine - specific protein
sodium phosphate ,  radioactive
death domain - associated protein 6
mcam gene
breast cancer ,  11 ; 22 translocation associated protein
itgb2 gene
abcb6 gene
abi2 gene
tnk2 gene
acvr1 gene
acvr1b gene
acvrl1 gene
cgmp phosphodiesterase inhibitor
ontology
acvr2a gene
activin receptor type - 2a
acvr2b gene
activin receptor type - 2b
metallopeptidase gene
adamts1 gene
a disintegrin and metalloprotease with thrombospondin motifs 1
adamts9 gene
a disintegrin and metalloprotease with thrombospondin motifs 9
sulfur mustard compound
jup gene
enzyme gene
lyase gene
adcy9 gene
adra1a gene
alpha - 1a adrenergic receptor
adra2a gene
alpha - 2a adrenergic receptor
adra2b gene
alpha - 2b adrenergic receptor
mustard prodrug
cd14 gene
cd28 gene
beta adrenergic receptor gene
adrb2 gene
lcp1 gene
ligand binding protein gene
vcl gene
beta - 2 adrenergic receptor
rna binding protein
atp - binding cassette sub - family b member 6 ,  mitochondrial
aflatoxin
gamma - glutamylcysteine synthetase inhibitor
abl interactor 2
ascl1 gene
anp32b gene
sh2b2 gene
apc2 gene
akap9 gene
akap12 gene
akap13 gene
aldh1a2 gene
akr7a2 gene
differentiation inhibitor
pds5b gene
angpt1 gene
angpt2 gene
amhr2 gene
cd3eap gene
alox15 gene
manf gene
stambp gene
bombesin antagonist
rhoh gene
achaete - scute homolog 1
protein with unknown or unclassified function
sh2b adapter protein 2
adenomatous polyposis coli protein 2
a - kinase anchor protein 9
a - kinase anchor protein 12
ezh2 gene
computerized thermal imaging
a - kinase anchor protein 13
cytidine triphosphate synthetase inhibitor
retinal dehydrogenase 2
aflatoxin b1 aldehyde reductase member 2
sister chromatid cohesion protein pds5 homolog b
annexin a5
anti - muellerian hormone type - 2 receptor
dna - directed rna polymerase i subunit rpa34
arachidonate 15 - lipoxygenase
mesencephalic astrocyte - derived neurotrophic factor
stam - binding protein
o6 - alkylguanine - dna alkyltransferase inhibitor
rho - related gtp - binding protein rhoh
activated cdc42 kinase 1
scanning transmission electron microscopy
bmp10 gene
growth factor gene
transforming growth factor - beta family gene
bone morphogenetic protein 10
bmp15 gene
bone morphogenetic protein 15
bmp2 gene
cytidine deaminase inhibitor
bone morphogenetic protein 2
bmp3 gene
bone morphogenetic protein 3
bmp5 gene
bone morphogenetic protein 5
bmp6 gene
bone morphogenetic protein 6
bmp7 gene
bone morphogenetic protein 7
bmp8b gene
malignancy - associated hypercalcemia inhibitor
bone morphogenetic protein 8b
cd2 gene
cd4 gene
cd80 gene
receptor serine / threonine kinase gene
bone morphogenetic protein receptor gene
bmpr1a gene
bone morphogenetic protein receptor type - 1a
bmpr2 gene
bone morphogenetic protein receptor type - 2
glutathione transferase inhibitor
bmx gene
cd8b gene
cytoplasmic tyrosine - protein kinase bmx
bnip3l gene
bcl2 / adenovirus e1b 19 kda protein - interacting protein 3 - like
brd2 gene
bromodomain - containing protein 2
stap1 gene
signal - transducing adaptor protein 1
btg2 gene
near - infrared fluorescence imaging probe
protein btg2
grk2 gene
beta - adrenergic receptor kinase 1
grk3 gene
beta - adrenergic receptor kinase 2
aff4 gene
af4 / fmr2 family member 4
agtr2 gene
type - 2 angiotensin ii receptor
crybg1 gene
immunostimulant
beta / gamma crystallin domain - containing protein 1
aim2 gene
interferon - inducible protein aim2
rnr1 gene
rpl8 gene
60s ribosomal protein l8
rpl19 gene
60s ribosomal protein l19
rpl29 gene
60s ribosomal protein l29
albumin
adjuvant
ctbp1 gene
c - terminal - binding protein 1
msh4 gene
muts protein homolog 4
spo11 gene
vegfa gene
meiotic recombination protein spo11
chemo immunostimulant adjuvant
vegfc gene
vip gene
ccne1 gene
vipr1 gene
g1 / s - specific cyclin - e1
dna -  ( apurinic or apyrimidinic site )  lyase
nsd2 gene
ccn5 gene
ccn6 gene
wnt2b gene
surgical adjuvant
wnt6 gene
wnt10a gene
class ii ap endonuclease
dna -  ( apurinic or apyrimidinic site )  lyase 2
wnt11 gene
wnt9a gene
il27ra gene
xcr1 gene
yars1 gene
ywhaq gene
endothelial cell inhibitor
serine / threonine - protein kinase atr
zfp36l2 gene
zbtb17 gene
znf217 gene
interleukin - 27 receptor subunit alpha
tyrosine - trna ligase ,  cytoplasmic
dna excision repair protein ercc - 1
dna repair endonuclease
ubiquitin carboxyl - terminal hydrolase 6
endothelial - specific integrin / survival signaling inhibitor
ubiquitin carboxyl - terminal hydrolase 8
vascular endothelial growth factor c
vasoactive intestinal peptide
vasoactive intestinal polypeptide receptor 1
guanine nucleotide exchange factor vav3
wnt1 - inducible - signaling pathway protein 2
general transcription and dna repair factor iih helicase subunit xpd
cellular communication network factor 6
protein wnt - 2b
protein wnt - 6
protein wnt - 10a
protein wnt - 11
tfiih basal transcription factor complex helicase xpb subunit
protein wnt - 9a
histone - lysine n - methyltransferase nsd2
14 - 3 - 3 protein theta
zinc finger protein 36 ,  c3h1 type - like 2
zinc finger and btb domain - containing protein 17
zinc finger protein 217
dna repair endonuclease xpf
miscellaneous antimetabolite
dna repair protein complementing xp - g cells
dna excision repair protein ercc - 6
exonuclease 1
dna ligase 4
dna mismatch repair protein mlh1
dna mismatch repair protein mlh3
dna mismatch repair protein msh2
dna mismatch repair protein msh3
dna mismatch repair protein msh6
traf6 gene
csag2 gene
oncogenesis
rnf139 gene
trat1 gene
trio gene
n - glycosylase / dna lyase
trip10 gene
pms1 protein homolog 1
acrosin - binding protein
mismatch repair endonuclease pms2
protein kinase a inhibitor
relative
first degree relative
anterior gradient protein 2 homolog
dna - dependent protein kinase catalytic subunit
acidic leucine - rich nuclear phosphoprotein 32 family member c
acidic leucine - rich nuclear phosphoprotein 32 family member d
amyloid protein - binding protein 2
gtp - binding protein di - ras3
axin - 2
transaminase
mitogen - activated protein kinase inhibitor
ubiquitin carboxyl - terminal hydrolase bap1
breast cancer anti - estrogen resistance protein 1
mitotic / spindle checkpoint
transcriptional - regulating factor 1
bub1 gene
mitotic checkpoint serine / threonine - protein kinase bub1
breast cancer anti - estrogen resistance 3 protein
breast carcinoma - amplified sequence 1
pre - mrna - splicing factor spf27
breast carcinoma - amplified sequence 3
albuterol
ribonucleotide reductase inhibitor
breast carcinoma - amplified sequence 4
brcd1 protein
bcpr protein
charged multivesicular body protein 2a
brca3 protein
ankyrin repeat domain - containing protein 30a
breast cancer metastasis - suppressor 1
cytochrome c oxidase subunit 7a - related protein ,  mitochondrial
rho gtpase - activating protein 7
purine nucleoside phosphorylase inhibitor
thoc5 gene
epithelial - stromal interaction protein 1
f - box / wd repeat - containing protein 7
g antigen family d member 3
temporal qualifier
tho complex subunit 5 homolog
glutaminase liver isoform ,  mitochondrial
calcium - activated chloride channel regulator 2
complement component gene
complement activation
phosphatidylinositide 3 - kinase inhibitor
hypoxia up - regulated 1 protein
c3 gene
host defense
complement component protein
interleukin - 24
protein casc3
calmodulin - like protein 4
complement c3
endoplasmic reticulum - golgi intermediate compartment protein 3
prickle - like protein 4
dihydrofolate reductase inhibitor
tetraspanin - 32
at - rich interactive domain - containing protein 4b
mucin - like protein 1
protein tssc4
wap four - disulfide core domain protein 1
protein wnt - 4
c5 gene
complement c5
palmitoyl thioesterase inhibitor
calm1 gene
healthcare facility
meiotic recombination
dna repair and recombination protein rad54 - like
terf1 - interacting nuclear factor 2
dna topoisomerase 2 - binding protein 1
3' - 5' exonuclease
three prime repair exonuclease 1
telomere shortening
osm gene
tyrosine hydroxylase inhibitor
cytokine gene
flt3lg gene
three prime repair exonuclease 2
tnfrsf1b gene
tnfrsf1a gene
fas gene
deubiquitination
deubiquitinating enzyme
ubiquitin c - terminal hydrolase
tnfrsf10a gene
duocarmycin antineoplastic antibiotic
26s proteasome - associated uch interacting protein 1
tnfrsf10b gene
epor gene
il2ra gene
dna repair protein complementing xp - a cells
dna repair protein xrcc1
single strand break repair
dna repair protein xrcc2
cd209 gene
dna repair protein xrcc3
adenosine deaminase inhibitor
dna repair protein xrcc4
rara gene
peptide transport
tap1 gene
antigen peptide transporter 1
neuronal transmission
regulation of cell size
afp gene
tap2 gene
antigen peptide transporter 2
glutamine amidotransferase inhibitor
tf gene
camlg gene
calcium signaling
calcium signal - modulating cyclophilin ligand
cav2 gene
caveolin - 2
polyubiquitination
monoubiquitination
cblb gene
protein phosphatase inhibitor
e3 ubiquitin - protein ligase cbl - b
g protein - coupled receptor signaling
ackr2 gene
thiopurine s - methyltransferase
tpmt gene
cckbr gene
cyp2c9 gene
gastrin / cholecystokinin type b receptor
microanatomic structure
ethanol
proteasome inhibitor
dna groove binding agent
dna major groove binding agent
dna adduct forming agent
murine experimental organism diagnosis
mixed - backbone oligonucleotide
combination anti - infective agent
epidermal growth factor receptor tyrosine kinase inhibitor
adenylosuccinate synthetase inhibitor
dihydroorotate dehydrogenase inhibitor
methyl alcohol
orotidylate decarboxylase inhibitor
cyclobutane pyrimidine dimer
gene transduction agent
viral vector
non - viral vector
gene - vector complex
non - viral vector - gene complex
transduction gene
fusion toxin
alcohol  [ chemical class ]
vasopressin antagonist
steroidal estrogen
non - steroidal estrogen
hypothalamic hormone
3 - hydroxysteroid dehydrogenase inhibitor
cyclin - dependent kinase inhibitor
diarylsulfonylurea compound
fvii icon
alkylphosphocholine compound
signal transduction inhibitor
aldosterone
alcohol
small interfering rna
tricom
sorafenib tosylate
emepepimut - s
antimetastatic agent
anti - adhesion agent
nonnarcotic analgesic
adjuvant analgesic
alfentanil hydrochloride
boron delivery agent
mtor inhibitor
tacedinaline
acridine carboxamide
adenovirus b7 - 1
bcr - abl peptide vaccine
biomed 101
bispecific antibody mdx447
sodium borocaptate
capromab pendetide
mucosal hyperplasia of the mouse intestinal tract
alkaloid
selective cytokine inhibitory drug cc - 1088
crl 1005
aberrant crypt foci of the mouse intestinal tract
mage - 3 peptide vaccine
liposomal daunorubicin citrate
dendritic cell - gp100 - mart - 1 antigen vaccine
her - 2 / neu intracellular domain peptide vaccine
imidazole mustard
mouse anatomy concepts
in 111 monoclonal antibody ll2
in 111 monoclonal antibody lym - 1
experimental organism diagnosis
experimental organism anatomical concept
genetically engineered mouse
in 111 monoclonal antibody mn - 14
transgene
murine prostate
alkylsulfonate compound
interferon alfa - n1
interferon beta - 1b
interleukin - 12 gene
iodine i 131 derlotuximab biotin
lung tumor associated antigen
zosuquidar trihydrochloride
lycopene
monoclonal antibody 4b5 anti - idiotype vaccine
apolizumab
visilizumab
alkylating agent
monoclonal antibody m - t412
dofequidar fumarate
muc1 - klh conjugate vaccine
phenethyl isothiocyanate
mureletecan
pr1 leukemia peptide vaccine
psa rna - pulsed dendritic cell vaccine
recombinant vaccinia - b7 .1 vaccine
retrovirus vector ln
revm10 gene / polas gene
allopurinol
as02a
mva - muc1 - il2 vaccine
triapine
tumor necrosis factor  ( cet )
tumor necrosis factor  ( knoll )
tumor necrosis factor  ( gen )
tariquidar
y 90 monoclonal antibody lym - 1
y 90 monoclonal antibody m195
organism modification
yttrium y 90 monoclonal antibody mn - 14
tumor cell graft
knock - out
knock - in
radiation - induced change
retrovirus insertion modification
rat transgene
recombinant interferon alfa
pralatrexate
iroplact
chemotherapeutic topical agent
dna repair enzyme topical agent
amidophosphoribosyltransferase inhibitor
estrogen sulfotransferase inhibitor
recombinant delta chemokine
recombinant fractalkine
recombinant neurotrophic factor
eflornithine
recombinant neuropoietic cytokines
mouse central nervous system
recombinant heparin - binding neurotrophic factor
mecasermin
recombinant igf - ii
adrenal hormone
prasterone
recombinant thymopoietin
melatonin
glucagon
corticoliberin
alprazolam
gonadotrophin releasing hormone
insulin
gastrin - releasing peptide
gonadotropin
human menopausal gonadotropin
human chorionic gonadotropin
inhibin
inhibin a
inhibin b
prothymosin alpha
aluminum sulfate anhydrous
thyroid - stimulating hormone
calcitonin
corticotropin
oxytocin
thymosin
arginine - vasopressin
follicle stimulating hormone
lutropin
somatotropin
steroid hormone
americium
cortisone
estrone
estradiol
progestogen
progesterone
amikacin sulfate
androstenedione
testolactone
staining method
hematoxylin and eosin staining method
trichrome staining method
elastin staining method
gram staining method
acid fast bacillae staining method
iron staining method
methyl green pyronine staining method
silver staining method
periodic acid schiff staining method
thyroxine
immunohistochemistry staining method
smooth muscle actin staining method
in situ hybridization staining method
e - cadherin staining method
beta catenin staining method
cytokeratin - 14 staining method
cytokeratin - 8 staining method
cytokeratin - 18 staining method
laminin staining method
synaptophysin staining method
triiodothyronine
whey acidic protein staining method
osteopontin staining method
mucin - 1 staining method
mucin - 2 staining method
polyoma virus middle t staining method
c - myc staining method
her2 / erbb2 / neu staining method
staining for viral inclusions
staining of sputum for pneumocystis
thyroglobulin
warthin - starry staining method
wright - giemsa staining method
diff - quik staining method
routine histology staining method
special histology staining method
wt1 - ricin a immunotoxin
ad5cmv
improsulfan
glutaminase - asparaginase
amino acid
peg - glutaminase - asparaginase
bleomycin antibiotic
alvac
vaccinia vaccine
g17dt immunogen
dietary lipid
shark cartilage
5 alpha - reductase inhibitor
amino acid ,  peptide ,  or protein
teroxirone
l - norepinephrine
murine frontal sinus
murine supraglottis
corticosteroid
glucocorticoid
mineralocorticoid
recombinant beta thromboglobulin
murine corpus uteri
recombinant fibroblast growth factor 7
niacinamide
murine conjunctiva
murine cornea
cefotaxime sodium
murine orbit
hb2 - saporin immunotoxin
murine ventricles ,  brain
aminoglutethimide
anti - cd19 immunotoxins
b43 - pap immunotoxin
murine bile duct
murine esophagus
murine ear
anti - cd33 antibody - drug conjugate
murine cochlea
di - dga - rfb4 immunotoxin
murine uterus
igg - rfb4 - smpt - dga immunotoxin
murine head and neck
raf kinase inhibitor
sodium butyrate
murine medulla oblongata
imipenem - cilastatin sodium
bcg ,  cell wall skeleton
murine hypothalamus
aminolevulinic acid
prochlorperazine maleate / isopropamide iodide
murine b - lymphocytes
tumor cell derivative vaccine
murine t - lymphocytes
recombinant soluble human cd4 protein
murine stroma
flurocitabine
murine external auditory canal
murine eustachian tube
murine tympanic membrane
murine mastoid
camptothecin sodium
murine cell types
murine midbrain
murine pons
murine inferior sagittal sinus
murine superior sagittal sinus
murine intracranial nervous system
murine blood cells
murine eosinophils
murine lymphocytes
murine th1 cells
murine th2 cells
murine cd8 - positive t - lymphocytes
murine t - lymphocytes ,  cytotoxic
pituitary agent
murine lymphocytes ,  tumor - infiltrating
murine monocytes
murine megakaryocytes
monoclonal antibody r24
murine histiocytes
murine alveolar macrophage
aminopterin
ovine submaxillary mucin
murine stromal cells
hyperbaric oxygen
murine epithelial cells
murine dendritic cell
murine langerhans cells
methylmercaptopurine riboside
murine hepatocytes
murine keratinocytes
sparfosate sodium
murine germ cells
timonacic
anti - adrenal
murine schwann cells
murine follicular dendritic cells
murine neurons
analgesic and antipyretic
i 131 antiferritin immunoglobulin
monoclonal antibody t101
ricin immunoconjugate
murine stem cells
murine anterior chamber of eye
murine anterior eye segment
amiodarone hydrochloride
anabolic steroid
substituted urea
podophyllin
murine common bile duct
aminoglycoside antibiotic
adrenal agent
murine exocrine gland
pefloxacin / penicillin v
murine cardiac atria
m - azidopyrimethamine
murine immune system
triazene derivative cb10 - 277
murine natural killer cells
murine lens
monoclonal antibody 14g2a
methionyl - interferon - consensus
murine parathyroid gland
amoxicillin
monoclonal antibody 3f8
murine peritoneal cavity
murine peyer's patches
murine anterior pituitary gland
murine posterior pituitary gland
ethylchlorformate
murine sclera
monoclonal antibody l6
interleukin - 2 liposome
tp40 immunotoxin
murine ulna
murine vas deferens
murine vocal cords
murine posterior tibial artery
murine third ventricle of brain
gm2 - klh vaccine
murine lateral ventricle of brain
l - leucyl - l - leucine methyl ester
murine squamous epithelium
vinfosiltine
murine stratum spinosum
murine breast ,  female
uridine triacetate
murine endothelial cells
amphotericin b
anti - b4 blocked ricin immunotoxin
etanercept
murine auditory system
mitumomab
dab389 epidermal growth factor
murine palpebral conjunctiva
murine bulbar conjunctiva
tyrosinase - klh
murine small cleaved cell
murine cancer cell
murine blast cells
murine organ system
theramide
murine tumor cells
gp100 antigen
murine embryonic stem cells
murine gut associated lymphoid tissue
monoclonal antibody ll2
liposomal cytarabine
murine splenocytes
murine neuro - ocular system
murine mammalian cell
daflon 500
murine clonogen
murine gut epithelium
murine tumor - associated vasculature
ampicillin
antiseborrheic agent
murine premalignant cells
murine totipotent stem cell
radium
murine intracranial arteries
murine interval lymph node
murine caruncle
murine cybrid
murine episclera
gold
murine neuroblast
murine red pulp
murine white pulp
murine thymocyte
murine vestibulocochlear nerve
miscellaneous antibiotic
murine lymphoblast
recombinant hematopoietic growth factor
liothyronine i - 131
padre 965 .10
tretinoin liposome
bispecific antibody 2b1
amsacrine
gd2 - klh vaccine
tyrosinase peptide
octreotide pamoate
human papillomavirus tumor antigen vaccine
rasburicase
boronophenylalanine - fructose complex
gp209 - 2m antigen
muc - 1 antigen
t4n5 liposomal lotion
monoclonal antibody me1 - 14 f ( ab' ) 2
analgesic agent
monoclonal antibody a33
diethylhomospermine
recombinant leukocyte interleukin
carcinoembryonic antigen peptide 1
oteracil potassium
gimeracil
monoclonal antibody mx35 f ( ab' ) 2
mouse medullary thyroid carcinoma
bovine cartilage
hpv 16 e7:12 - 20 peptide vaccine
anti - androgen
e1a lipid complex
tc 99m monoclonal antibody 170
5 - fluoropyrimidinone
recombinant adenovirus - p53 sch - 58500
monoclonal antibody 3h1 anti - idiotype vaccine
anxa5 gene
arrb1 gene
atp8a2 gene
avp gene
avpr1a gene
detoxpc
avpr1b gene
avpr2 gene
bag4 gene
bag5 gene
adgrb1 gene
adgrb2 gene
adgrb3 gene
magi1 gene
baiap2 gene
bcl10 gene
dendritic cell - mart - 1 peptide vaccine
bcl6 gene
bcl7a gene
bcl9 gene
dcaf5 gene
bdkrb2 gene
bin1 gene
cxcr5 gene
krit1 gene
ccnb2 gene
ccr1 gene
dendritic cell - g9 - 209 - 2m peptide vaccine
ccr5 gene
ccr6 gene
ccr8 gene
ccr9 gene
ackr4 gene
ccrl2 gene
cd3e gene
cd47 gene
adgre5 gene
pa - 1 - stk ovarian carcinoma vaccine
cdk11b gene
cdc37 gene
cdc42 gene
cdk10 gene
cdk2 gene
cdk2ap1 gene
cdk3 gene
cdkl2 gene
cdkn2c gene
cdkn3 gene
sargramostim plasmid dna sarcoma vaccine
cdon gene
cdr1 gene
cdx2 gene
ceacam7 gene
celsr1 gene
chek1 gene
chka gene
chrm4 gene
lyst gene
cish gene
therapeutic androgen
sargramostim plasmid dna melanoma vaccine adjuvant
clc gene
cmklr1 gene
plk3 gene
cnksr1 gene
cntnap1 gene
col18a1 gene
col4a3 gene
col4a6 gene
cox6c gene
cpne7 gene
iodine i 131 monoclonal antibody 3f8
csf2 gene
csf2rb gene
csf3 gene
csf3r gene
csnk1a1 gene
csnk2a1 gene
cspg4 gene
smc3 gene
ctbp2 gene
ctf1 gene
vitespen
ctsz gene
cul1 gene
cul2 gene
cul3 gene
cul4a gene
cul5 gene
cx3cr1 gene
cxcr4 gene
cyp3a4 gene
dab2 gene
recombinant vaccinia psa vaccine
daxx gene
brinp1 gene
pdzk1ip1 gene
ddr2 gene
ddx1 gene
dhx16 gene
ints6 gene
dec1 gene
defb1 gene
dek gene
environmental tobacco smoke
dlec1 gene
dleu1 gene
dleu2 gene
dlg1 gene
dlg4 gene
dmbt1 gene
dnmt3b gene
cdk2ap2 gene
dock1 gene
dok1 gene
anti - cd7 immunotoxin
drd1 gene
drd4 gene
drd5 gene
hbegf gene
dtx1 gene
dusp1 gene
lefty2 gene
tymp gene
edn2 gene
egf gene
monoclonal antibody a1g4 anti - idiotype vaccine
egfl6 gene
ehf gene
emilin1 gene
epha2 gene
epha4 gene
epha8 gene
ephb1 gene
ephb2 gene
ephb3 gene
eps15 gene
il - 2 plasmid dna / lipid complex
eps8 gene
eps8l1 gene
eps8l2 gene
eps8l3 gene
erbin gene
ereg gene
erf gene
etv1 gene
etv4 gene
evi2b gene
ras peptide cancer vaccine
extl1 gene
extl2 gene
extl3 gene
f2r gene
fadd gene
fancg gene
glmn gene
fastk gene
fgf1 gene
fgf10 gene
carcinoembryonic antigen rna - pulsed dc cancer vaccine
fgf20 gene
fgf21 gene
fgf8 gene
fgfr3 gene
fgfrl1 gene
fhl2 gene
fibp gene
rspo3 gene
flrt3 gene
flt3 gene
therapeutic androstenedione
iodine i 124 monoclonal antibody a33
flt4 gene
fgfr1op gene
foxo1 gene
fpr1 gene
pgap2 gene
frat1 gene
frk gene
farsb gene
fstl3 gene
tusc2 gene
kdsr gene
fzd2 gene
fzd3 gene
fzd4 gene
fzd6 gene
fzd7 gene
fzd9 gene
gab2 gene
lrrn2 gene
gadd45a gene
canarypox - hil - 12 melanoma vaccine
galr2 gene
yeats4 gene
gcg gene
gdf10 gene
gdf5 gene
mstn gene
gdf9 gene
gfi1b gene
gfra2 gene
gipr gene
git1 gene
git2 gene
gli1 gene
bicra gene
nop53 gene
gna12 gene
gnai2 gene
gnaz gene
gnb1 gene
gnb2 gene
iodine i 131 tositumomab
gnb3 gene
gpa33 gene
gpr17 gene
ccr10 gene
gpr32 gene
gpr68 gene
cxcr3 gene
gprc5c gene
grk4 gene
grk5 gene
sargramostim plasmid dna pancreatic tumor cell vaccine
grk6 gene
grk7 gene
gps1 gene
gps2 gene
linc01565 gene
grap gene
grb10 gene
grb14 gene
grb2 gene
grb7 gene
monoclonal antibody 11d10
grf2 gene
gria3 gene
grm1 gene
grm5 gene
grm6 gene
gstt1 gene
hdac5 gene
hgf gene
hgs gene
hhcm gene
monoclonal antibody a27 .15
hk2 gene
hcar3 gene
hnrnpa3 gene
hoxa10 gene
hoxa9 gene
hoxc6 gene
hpca gene
hpse gene
hsd17b7 gene
htatip2 gene
monoclonal antibody e2 .3
ifitm1 gene
ifna13 gene
ifna2 gene
ifnw1 gene
igbp1 gene
igf1 gene
igf2 gene
igf2r gene
igfbp3 gene
igfbp4 gene
iodine i 131 monoclonal antibody g - 250
igfbp5 gene
igfbp6 gene
il10rb gene
il11ra gene
il12a gene
il12b gene
il13 gene
il17c gene
il2 gene
il2rb gene
anesthetic agent
il2rg gene
il4r gene
il5 gene
il5ra gene
il6 gene
il6st gene
il7r gene
cxcl8 gene
cxcr1 gene
cxcr2 gene
ilk gene
ing1 gene
inha gene
inhba gene
ins gene
insl4 gene
insr gene
insrr gene
irak1 gene
irak3 gene
aminocamptothecin colloidal dispersion
irf1 gene
irf2 gene
irs1 gene
irs2 gene
irs4 gene
itgb4 gene
itk gene
itpr1 gene
jak1 gene
jak2 gene
erb - 38 immunotoxin
jak3 gene
jtb gene
kdr gene
klk15 gene
klrb1 gene
klrd1 gene
igf2bp3 gene
ksr1 gene
aff3 gene
lamp3 gene
incyclinide
rpsa gene
lats1 gene
lats2 gene
lcp2 gene
lefty1 gene
lepr gene
lgals3bp gene
lgals8 gene
lgi1 gene
lhx1 gene
palifermin
lhx2 gene
lif gene
lifr gene
limd1 gene
limk1 gene
lims1 gene
herc5 gene
rapgefl1 gene
vwa5a gene
lox gene
anti - cea antibody
ltb4r gene
ltbp2 gene
ltk gene
ly6e gene
lyl1 gene
madd gene
smad2 gene
smad6 gene
smad7 gene
zfyve9 gene
c - fos antisense
maged1 gene
map2k6 gene
map3k1 gene
map3k14 gene
map3k7 gene
tab1 gene
map4k4 gene
mapk10 gene
mapk11 gene
mapk12 gene
mapk13 gene
mapk14 gene
mapk4 gene
mapk6 gene
mapk7 gene
mapk9 gene
mapre1 gene
matk gene
mcts1 gene
mdk gene
chemoprotective agent
meis1 gene
mertk gene
mfge8 gene
mfhas1 gene
mfng gene
mgp gene
mif gene
cxcl9 gene
mknk1 gene
dusp22 gene
anetholtrithion
arzoxifene hydrochloride
kmt2d gene
mllt1 gene
aff1 gene
mllt3 gene
afdn gene
mllt6 gene
foxo4 gene
mme gene
mmp11 gene
mpp1 gene
ep - cam
mpp2 gene
mpp3 gene
mpzl1 gene
mras gene
mrvi1 gene
msc gene
mst1r gene
mtcp1 gene
musk gene
mxi1 gene
mybbp1a gene
tusc3 gene
nbas gene
nck2 gene
mycnos gene
ndrg1 gene
neo1 gene
neurl1 gene
ngfr gene
bex3 gene
retroviral vector
nkx2 - 8 gene
nkx3 - 1 gene
bambi gene
nmbr gene
nmi gene
nmu gene
notch1 gene
npr2 gene
ndor1 gene
nrbp1 gene
cd80 breast cancer vaccine
nrcam gene
nrg2 gene
nrp1 gene
nrtn gene
ntf3 gene
ntn1 gene
ntrk2 gene
ntrk3 gene
numa1 gene
nup214 gene
muc - 2 - klh vaccine
or1g1 gene
ctdsp2 gene
osmr gene
lrrc17 gene
pag1 gene
pak6 gene
pard6a gene
pawr gene
pax3 gene
pax5 gene
peptide 946 melanoma vaccine
pax7 gene
nampt gene
pbx3 gene
cdk16 gene
pdc gene
pdgfa gene
pdgfra gene
pdgfrb gene
pdgfrl gene
pdpk1 gene
peptide 946 - tetanus peptide conjugate melanoma vaccine
pgf gene
pias3 gene
pik3cb gene
pik3cg gene
pik3r3 gene
pi4kb gene
pip4k2a gene
pip4k2b gene
pla2g2a gene
gdf15 gene
tetanus peptide melanoma vaccine
plagl1 gene
plaur gene
plcb3 gene
plk1 gene
kdm5b gene
pmaip1 gene
pml gene
slc43a1 gene
plpp1 gene
pparg gene
peptide 946 - tetanus peptide conjugate melanoma vaccine / qs21
ppp1ca gene
ppp2r1b gene
prdm1 gene
prdm4 gene
prkca gene
prkg2 gene
eif2ak2 gene
ptch2 gene
pthlh gene
ptk2 gene
ace inhibitor
monoclonal antibody 3622w94
ptk2b gene
ptk6 gene
ptk7 gene
ptn gene
ptp4a1 gene
ptpn1 gene
ptpn12 gene
ptpn22 gene
ptpn6 gene
ptpn7 gene
contusugene ladenovec
sirpa gene
ptprc gene
ptpre gene
ptprg gene
ptprj gene
ptprr gene
ptprt gene
rad54b gene
rraga gene
mok gene
lmb - 9 immunotoxin
gprc5a gene
ralgds gene
rangap1 gene
rap1a gene
rarb gene
plaat4 gene
rasd1 gene
rbbp9 gene
rbl2 gene
rbm5 gene
dendritic cell - cea peptide vaccine
rbm6 gene
rbx1 gene
rcn2 gene
trim27 gene
trim13 gene
rgs1 gene
rgs19 gene
rgs2 gene
rgs3 gene
grk1 gene
tn ( c )  - klh conjugate vaccine
pdlim4 gene
ripk2 gene
ripk3 gene
rnf11 gene
rock1 gene
ror1 gene
ror2 gene
rora gene
rpl10 gene
rpl7a gene
promegapoietin
rps19 gene
rps27 gene
rps3 gene
rps6ka5 gene
rps6kb2 gene
rras2 gene
rasl10a gene
rsu1 gene
ryk gene
s100a11 gene
monoclonal antibody muj591
s100a12 gene
s100a8 gene
s100a9 gene
s100p gene
skap2 gene
sctr gene
ccl1 gene
ccl11 gene
ccl13 gene
ccl14 gene
i 131 monoclonal antibody a33
ccl15 gene
ccl17 gene
ccl18 gene
ccl19 gene
ccl20 gene
ccl21 gene
ccl22 gene
ccl23 gene
ccl24 gene
ccl25 gene
dinitrophenyl
ccl26 gene
ccl27 gene
ccl3 gene
ccl3l1 gene
ccl4 gene
ccl5 gene
ccl7 gene
ccl8 gene
cxcl10 gene
cxcl11 gene
beta endorphin
cxcl13 gene
cxcl14 gene
cxcl5 gene
cxcl6 gene
xcl1 gene
xcl2 gene
cx3cl1 gene
cxcl12 gene
sectm1 gene
sema3e gene
angiotensin - 1
tracer
serpini2 gene
set gene
setdb1 gene
sfn gene
sfrp4 gene
sh2b1 gene
sh2d3a gene
sh2d3c gene
shc1 gene
shc3 gene
cetrorelix
shh gene
sirpb1 gene
skil gene
skiv2l gene
skp2 gene
slc26a3 gene
shc2 gene
smo gene
plk2 gene
frs2 gene
miscellaneous antiviral agent
frs3 gene
snw1 gene
srp19 gene
srpx2 gene
abi1 gene
sspn gene
sst gene
sstr1 gene
sstr3 gene
sstr4 gene
miscellaneous hormone agent
st13 gene
stat1 gene
stat2 gene
stat3 gene
stat5a gene
stat6 gene
stc1 gene
stc2 gene
aurka gene
methaqualone hydrochloride
eif1 gene
tacc3 gene
tacr3 gene
tal2 gene
wwtr1 gene
tbk1 gene
tcf3 gene
tcf7l2 gene
tcl1b gene
tcta gene
alvac - hb7 .1
tec gene
tek gene
tfap2c gene
tfdp2 gene
tfe3 gene
tgfa gene
tgfb1 gene
tgfb2 gene
tgfbi gene
tgfbr1 gene
recombinant interleukin - 1 receptor antagonist
tgfbr3 gene
tie1 gene
tlr1 gene
tlr2 gene
tlr3 gene
tlr4 gene
tlr5 gene
tlr6 gene
tlr7 gene
tlr8 gene
carmustine implant
tmprss2 gene
tnfrsf11b gene
tnfrsf6b gene
tnfsf11 gene
tnk1 gene
tollip gene
tpd52 gene
tpd52l1 gene
trpm5 gene
iodine i 131 monoclonal antibody 81c6
trrap gene
tshr gene
tsks gene
tslp gene
tspy1 gene
ttc4 gene
ttk gene
cxcr6 gene
tyro3 gene
tyrobp gene
i 123 monoclonal antibody 81c6
ube2d2 gene
unc13b gene
usp6 gene
usp8 gene
vav3 gene
10p11 .1
10p11 .23
10p12
10p12 .3 - p11 .2
10p12 .31
aniline mustard
at 211 monoclonal antibody 81c6
10q11 .1
10q11 .21
10q24 - q25
10q24 - qter
10q24 .31
10q25
10q25 .1
10q25 .3
10q25 .3 - q26 .1
10q26 .13
pegylated interferon alfa
10q26 .13 - q26 .3
11p11 .2 - p11 .1
11p12
11p12 - p11 .2
11p13 - p12
11p14 .3
11p15 .2
11p15 .5 - p15 .4
11q12 .2
11q13 .2
von hippel - lindau peptide vaccine
11q13 .3 - q13 .5
11q13 .4
11q14 .2
11q14 .2 - q14 .3
11q23 - q24
11q24 - q24
12p11 .2
12p12 .1 - p11 .2
12p13 - p12 .3
12p13 .1 - p12 .3
adenovirus 5 - cd40 ligand
12q12
12q12 - q14
12q13 - q15
12q13 .13
12q14 - q15
12q21
12q23 - q24
12q23 - q24 .1
12q24 .1
12q24 .11
13 - deoxydoxorubicin
12q24 .13
12q24 .31
13q11 - q12
13q12 - 13
13q14 .1
13q14 .12 - q14 .2
13q34
14q13 .1
14q22
14q23 - q24 .1
indium in 111 - dota - biotin
14q31 - q32 .1
14q32 .1
14q32 .1 - q32 .2
14q32 .33
15q14
15q15 .1 - q21 .1
15q21
15q22
15q22 .3 - q23
anti - vegf monoclonal antibody
15q23
15q25
16p11 .2 - 12 .1
16p11 .2 - p11 .1
16q12 .2
16q22 .2 - q22 .3
16q24
17p11 .1
17p11 .2
psa prostate cancer vaccine
17p13
17q11 - qter
17q11 .1
17q12 - q21
17q21 - q22
17q21 .1 - q21 .3
17q22 - q23 .2
17q22 - qter
17q24 - q25
17q25 .1
patent blue v dye
17q25 .3
18q11 .1
18q12 - q21
18q21 .31
19p13 .1 - 13 .2
19q13 .1 - qter
19q13 .4
19q13 .41
19q13 .42
1p13 .2
lmb - 1 immunotoxin
1p13 .3 - p13 .1
1p21
1p31 .2 - p31 .1
1p31 .3
1p32 .3
1p32 .3 - p31 .3
1p33
1p33 - p32
1p33 - p34
1p34 - p33
antihelminthic agent
antineoplaston agent
1p34 .1
1p35 - p34 .2
1p35 .3
1p36 .1 - p35
1p36 .12
1p36 .2 - p36 .12
1p36 .33
1pter - p22 .1
1q12 - q23
1q23 .2
stn - klh plus detox vaccine
1q25 - q31 .1
1q31
1q31 - q32
1q32 .1
1q41 - q42
1q42 .1 - q42 .2
20p11
20p11 .2
20p13
20q11 .1 - 11 .23
cisplatin liposomal
20q13 .1 - q13 .2
21q22 .11
22q11 .22
22q13 .2
22q13 .33
2p13
2p14 .1
2p23 .3 - p23 .2
2p24
2p24 .3 - q21 .3
fosbretabulin disodium
2q11 .2 - q12
2q12
2q12 - q14
2q12 .2
2q14 .1
2q22 - q24
2q22 .2 - q23 .3
2q23 - q24
2q32 .2
2q35 - q37
vadimezan
2q36
2q36 - q37
2q36 .3
2q37 .1
3p12 - q13 .2
3p14 .1
3p24
3p26 - p24
3q21 - q23
3q21 - qter
monoclonal antibody hefi - 1
3q22
3q23
3q24
3q25 .1 - q25 .2
3q26 .1 - q26 .2
3q28
3q29
4p12
4p14
4p15 .1
in 111 folic acid
4p16 .1
4q11
4q13 .1 - q21 .1
4q13 .3
4q21 .1
4q21 .3
4q22 .1 - q23
4q26 - q27
4q28 - q32
4q32
mkc - 1
4q34 .1 - q35 .1
4q35
5p13
5p13 - p12
5p13 .1
5q11
5q11 .2
5q12 .1 - q13 .2
5q12 .3
5q21 .3
5q23 - q33
5q23 .2
5q31 - q32
5q31 .1 - q33 .1
5q31 .3
5q33 .1 - qter
5q34
5q34 - q35
5q35 .2
6p21 .1 - p12 .2
hu14 .18 - il2 fusion protein emd 273063
6p21 .3 - p21 .2
6p22
6p23
6q12
6q13 - q21
6q16 .1 - q16 .3
6q21 - q22 .1
6q21 - q22 .3
6q21 - qter
6q22 .33
anthracene
recombinant vaccinia df3 / muc1 vaccine
6q24
6q24 - q25 .1
6q26
7p11
7p12 .1
7p13 - p12
7p14 .1
7p15 - p13
7p21
7p21 - p15
7p22 - p21
7q11 .23
7q21 .11
7q32 .3
7q33 - q34
7q34 - q35
7q36
8p11 .21
8p21 - p11 .2
8p21 .1
afp gene hepatocellular carcinoma vaccine
8p23 .2 - p23 .1
8q21 .3 - q22
8q22 .3 - q23 .1
8q24 - qter
9p12 - p11
9p13
9p21 - p12
9p21 .2
9p22
9p24
lmb - 2 immunotoxin
9q22
9q22 .1
9q31 .3 - q32
9q32 - q33
9q33 - q34
9q33 - q34 .1
9q34 .13
xp11 .3 - p11 .23
xp22
xp22 .3
monoclonal antibody f19
xq13 .1 - q13 .3
xq21 .33 - q23
xq22
xq22 - 24
xq22 .3
xq25 - q26
xq27 .1 - q27 .2
yp11 .1 - q11 .1
i 131 monoclonal antibody f19
age
appetite
autopsy
axis
birth
body surface area
capsule dosage form
carcinoembryonic antigen
geldanamycin analogue
city
classification
code
coombs test
date
daughter
patient discharge
distance
tissue donor
route
e - mail
eligibility determination
employment
family
father
filed
projection
genitalia
health
hospitalization
indicator
industry
inpatient
lactate dehydrogenase
laterality
high density lipoprotein
low density lipoprotein
marital status
mother
person
person name
occupation
compliance
pressure
randomization
recommendation
record
social role
anthramycin
ksa - klh conjugate vaccine
self
sensitivity
sgot  ( ast )
shoulder
sibling
son
temperature
time
weight
measurement
fowlpox virus vaccine
fax
end point
baseline
evaluation
karyotype
collimator
assessment
intervention or procedure
fixation
sternotomy
tomogram
bronchial
pleural
rectal
renal
mesenteric
high
right
left
monoclonal antibody cd19
lateral
anterior
medial
peripheral
internal
superior
proximal
distal
segmental
superficial
ocaratuzumab
deep
horizontal
longitudinal
vertical
area
surface
positive
negative
long
short
allogeneic gm - csf - secreting lethally irradiated prostate cancer vaccine
complete
primary
microscopic
multifocal
progressive
soft
quantity
phase
most
mixed
anhydrovinblastine
third
medical
neurologic
prognostic
carina
intestinal
lymphatic
infraclavicular region
symptomatic
iodine i 131 apamistamab
extend
painful
painless
residence
actual
occurrence
neural cell adhesion molecule 1
therapeutic
fluid
onset
thomsen - friedenreich antigen
recent
associated
within
quality
type
diameter
necrotic
auer rod
hairy cell
brother
tf ( c )  - klh conjugate vaccine
adopted
venous
cardiovascular
sgpt  ( alt )
laboratory procedure
mobile
birth date
notification
systolic blood pressure
diastolic blood pressure
anthraquinone analogue
dnmt1 mixed - backbone antisense oligonucleotide mg 98
microbial culture procedure
day
granulomatous
multicentric
total
medical examination
side
contralateral
ipsilateral
lower
vaccinia - tyrosinase vaccine
mediastinal
oral
parietal
peritoneal
radial
visceral
paraaortic region
paratracheal
subaortic
place
y 90 monoclonal antibody m170
clinical study protocol
distant
long - term
nodal
viable
slide
whole
core
unrelated
supraclavicular
in 111 monoclonal antibody m170
duration
progression
extent
depth
length
volume
pattern
number
score
autologous expanded mesenchymal stem cells oti - 010
use
location
abdominal
mechanism
paraesophageal
width
class
height
musculoskeletal
polypectomy
serum hyaluronic acid
genitourinary
reconstructive surgery
international normalized ratio
inferior
academic degree
upper
documented
registrar
attribution
expectancy
canarypox antigen
mutant
performance
success
neural
identifier
description
study enrollment closure
member
agreement
her - 2 / neu peptide vaccine
payment
category
classified
options
report
small
appearance
partial
course
2it - bad monoclonal antibody 170
end date
maiden name
administered
start date
tnm staging system
admission
cytometry
benefit
local - regional
chest
egfr inhibitor bibx 1382
index
analysis
manufacturer
comment
pill dosage form
telephone
access
application unit
clinical
pelvic
anti - infective agent
mutant p53 peptide pulsed dendritic cell vaccine
zubrod performance status
abnormal
accession number
accrual
action
clinical study activation date
additional
address
adjacent
administration
y 90 monoclonal antibody hmfg1
adverse drug experience report
advanced
affiliation
affiliated
aliquot
alternative
amended
amount
amplification
anal margin
vaccine - sensitized draining lymph node cells
analyzed
anatomic
anterolateral
apical
approach
approval
assignment
at
atypical
availability
tositumomab
basis
begin
best
bimanual
biochemical
biphasic
fixed block
bone marrow stem cell transplantation
boost
anatomic border
b43 - genistein immunoconjugate
bottom
calcified
cancer and leukemia group b
capacity
body cavity
center
change
characteristic
clinical / radiologic
closest
adenovirus rsv - tk
coat
children's oncology group
collected
collection
combined
complicating
concurrent
condition
confirmation
congestive
ova bip peptide
consent
contact person
coordination
count
country
clinical research associate
criterion
critical
common toxicity criteria
monoclonal antibody hu3s193
cumulative
current
cycle
daily
data
declining
delay
delayed
dermal
designated
prostatic acid phosphatase - sargramostim fusion protein pa2024
details
detected
diagnostic
dimension
discontinue
display
disruption
dominant
dose
dryness
interleukin - 2 gene
during
eastern cooperative oncology group
effect
elevated
elevation
emotional
end
entire
estimate
event
urinary anti - infective agent
palladium pd - 103
examined
expected
extracapsular
extramedullary
extranodal
extraprostatic
factor
data field
final
first
cp - 609 , 754
fissural
focus
foreign
formation
fraction
temporal frequency
from
full
function
further
in 111 monoclonal antibody hu3s193
gingival
gynecologic oncology group
granulopenic
grouping
herceptest
highest
histologic
histologically
hormonal
hour
international breast cancer study group
immature
inclusion criteria
increase
induration
inflammatory
initials
intake
intensity
vaccine adjuvant
interlobar
international
interruption
interval
into
intraclavicular
invaded
involved
involvement
isolation
largest
last
lead
leukemic cell
level
lower limit of normal
lobar
lobular
longest
loss
salmonella vnp20009
lost
lymphovascular
main
margin
maximum
mesorectal
metaplastic
metastatic / recurrent
microinvasive
middle
technetium tc - 99m human serum albumin colloid
minimum
mode
modification
modified
molecular
mononuclear
monophasic
most recent
myocardial
myometrial
oglufanide disodium
n category
north central cancer treatment group
national cancer institute of canada
nearest
nervous
nevus cell
new
newly diagnosed
non - malignant
non - measurable
recombinant macrophage inflammatory protein - 2 alpha
non - protocol
non - surgical
non - target
non - visceral
negation
nottingham score
breast feeding
nutritional
observation
observed
anti - inflammatory agent
recombinant macrophage inflammatory protein - 2 beta
occupational
off treatment
opposite
optional
original
overall
palpable
parametrial
participation
past
t - cell receptor excision circle
pathologic
pectoral
penetration
percentage
pericolic
perineural
period
periprostatic
physical
plan
food oil
platinum - based
postal code
posterior
post - operative
premalignant
preparation
present
previous
principal
prior
omega - 6 fatty acid
progress
projected
province
proximity
purpose
qualifying
rate
reaction
reason
receive
allopurinol sodium
reduced
reference
referring
regional
registered
registering
registration
regular
relationship
remaining
thyroid extract
removed
reporting
requirement
resectable
resected
physiologic resolution
respiratory
responsible person
restart
retrieval
detox - b adjuvant
retrotracheal
reviewing
sampling
satellite
scale
scheme
second
secondary
section
security
minretumomab
self - administered
seminal
send
sequence
series
serum immunologic
severity
shape
signature
signed
hydrocortisone / placebo
sister
size
slice
source
special
specify
social security number
state
status
stratification
human papillomavirus 16 e7 peptide / padre 965 .10
street address
subcarinal
subcategory
subgroup
submission
subtype
sum
surgical
southwest oncology group
nonsteroidal antiinflammatory drug
arginine butyrate
system
taken
target
term
text
treating
upper limit of normal
uncoated
unfiltered
unit of measure
tocladesine
update
urinary
value
variation
version
vertebral
visit
vital status
without
worst
zip code
adjuvant generic
dermoid
hilar
intent
pancreatic
m category
t category
adherence
murine monoclonal antibody 2b8
concomitant
cribriform
ductal
en bloc
breslow thickness
inspiration
fibrinogen
identification
infarction
technetium tc 99m epratuzumab
erection
physician
pregnancy
urination
failure
recovery
creatinine clearance
iron binding capacity
pulse
fat emulsion
deterioration
bronchoscopist
infiltration
response
chromosomal translocation process
ulceration
human papillomavirus 16 e7 peptide
dendritic cell - recombinant prostate - specific membrane antigen vaccine
dna crosslinking agent
surgically created structure
cardiovascular system part
digestive system part
secondary acute myeloid leukemia
cervical neck region
musculoskeletal system part
metastatic malignant testicular germ cell tumor
krev interaction trapped protein 1
g2 / mitotic - specific cyclin - b2
chemokine receptor gene
c - c chemokine receptor type 1
c - c chemokine receptor type 5
c - c chemokine receptor type 6
c - c chemokine receptor type 8
low molecular weight heparin
atypical chemokine receptor 2
ras family gene
kras gene
nras gene
atypical chemokine receptor 4
c - c chemokine receptor - like 2
indium in - 111 ibritumomab tiuxetan
immunoprotein gene
immunoglobulin family gene
t - cell surface glycoprotein cd3 epsilon chain
immunoglobulin - like c2 - type domain
immunoglobulin - like v - type domain
leukocyte surface antigen cd47
eukaryota
indisulam
cd97 antigen
disintegrin and metalloproteinase domain - containing protein 11
antibiotic
sb as - 2
cystatin - m
cyclin - dependent kinase 11b
chaperone gene
hsp90 co - chaperone cdc37
hydrolase gene
gtpase gene
liothyronine sodium
cell division control protein 42 homolog
yttrium y - 90 epratuzumab tetraxetan
dna adduction
dna alkylation
dna crosslinking
dna interstrand crosslinking
dna intrastrand crosslinking
rosiglitazone maleate
dna strand break
dna single strand break
dna double strand break
abasic site formation
formation of apurinic site
formation of apyrimidine site
formation of bistrand abasic site
base - base mismatch
annamycin liposomal
cyclin - dependent kinase gene
epothilone b analogue
cyclin gene
cyclin - dependent kinase 10
cyclin - dependent kinase 2
camp - responsive element - binding protein - like 2
26s proteasome complex subunit sem1
epithelial discoidin domain - containing receptor 1
dual specificity protein phosphatase 3
cdk inhibitor protein
cyclin - dependent kinase 2 - associated protein 1
fibroblast growth factor receptor 4
psoralen
growth arrest specific 11 protein
organic cation transporter - like 2 protein
adam type metalloprotease domain
integrin binding
cyclin - dependent kinase 3
cdna microarray analysis
protein microarray
g1 to s transition process
transmembrane protein gene
progenipoietin
transferase gene
phosphotransferase gene
kinase family gene
serine / threonine protein kinase gene
cyclin - dependent kinase - like 2
cyclin - dependent kinase 4 inhibitor c
cyclin - dependent kinase inhibitor 3
gadopentetate dimeglumine
dual - specificity phosphoprotein phosphatase
st . john's wort
cell adhesion molecule - related / down - regulated by oncogenes
cerebellar - degeneration - related antigen 1
homeobox family protein
homeobox protein cdx - 2
antineoplastic antibiotic
cea family gene
cea family protein
n domain
carcinoembryonic antigen - related cell adhesion molecule 7
cadherin egf lag seven - pass g - type receptor 1
5 - hydroxytryptamine receptor 3a
htr3a gene
11q23 .1 - q23 .2
benzaldehyde
serine / threonine - protein kinase chk1
monoclonal antibody m195
choline kinase alpha
muscarinic acetylcholine receptor m4
dna microarray analysis
15q15 .3
her - 2 / neu intracellular domain protein
investigator
mitochondrial membrane
nuclear inner membrane
oxidoreductase gene
therapeutic autologous dendritic cells
nuclear outer membrane
isomerase gene
polymerase gene
ligase gene
cytochrome p450 2c19
hydrochloride salt
candida albicans skin test reagent
maleic acid
esterase gene
ribonuclease gene
endoribonuclease gene
drosha gene
dicer1 gene
14q32 .2
double - stranded rna binding domain
endoribonuclease
mage - 12 peptide vaccine
rnase iii family protein
endoribonuclease dicer
acidic leucine - rich nuclear phosphoprotein 32 family member b
yp11 .2
toll - like receptor family gene
microrna
pri - mirna
pre - mirna
cytoplasmic protein gene
y 90 monoclonal antibody cc49
lysosomal - trafficking regulator
non - receptor tyrosine kinase gene
non - receptor protein tyrosine phosphatase gene
tubulin binding agent
mitochondrial rna
cytokine signaling
suppressor of cytokine signaling family gene
suppressor of cytokine signaling family protein
cytokine - inducible sh2 - containing protein
lutetium lu 177 monoclonal antibody cc49
socs box domain
membrane - associated guanylate kinase family gene
interleukin gene
nerve cell survival
cardiotrophin - like cytokine factor 1
chemokine - like receptor 1
polo - box domain
17q21 .2
serine / threonine - protein kinase plk3
homeostatic process
cintredekin besudotox
connector enhancer of kinase suppressor of ras 1
signal transducer and activator of transcription family gene
retired gene product concepts
ion channel protein gene
peptide hormone gene
rna polymerase inhibitor
gene with unknown or unclassified function
adaptor signaling protein gene
2p25 .3
contactin - associated protein 1
beta - lactam antibiotic
yttrium y 90 daclizumab
extracellular matrix protein gene
collagen gene
collagen alpha - 3 ( iv )  chain
peptidase gene
gene family
16p12 .1
trafficking protein gene
collagen alpha - 6 ( iv )  chain
17q11 - q21
cc cytokine gene
yttrium y 90 - edotreotide
cxc cytokine gene
antiviral response
antibacterial response
16q13
protein complex subunit gene
vitamin ,  other
biological carcinogenesis ,  non - viral
viral carcinogenesis
carmustine in ethanol
bioterrorism research
iatrogenesis
cytochrome c oxidase subunit 6c
vaccine research
donepezil hydrochloride
casein kinase i isoform alpha
cytochrome c oxidase
2q33 - q37
4q21 .2
food safety
membrane protein gene
iodine i 131 monoclonal antibody muj591
tumor suppression
copine - 7
c2 domain
von willebrand factor a domain
negative regulation of angiogenesis
yp
hematopoietic factor gene
colony - stimulating factor gene
rgs family gene
nucleosome assembly protein gene
beta alethine
sushi domain
retired drugs and chemicals
retinoic acid binding
autoimmune status
22q13
extracellular space
9p21 .3
helicase gene
protein tyrosine phosphatase gene
monoclonal antibody 11d10 anti - idiotype vaccine
alpha - globulin
12q14 .3
secretory granule
secretory vesicle
protein serine / threonine phosphatase gene
ubiquitin protein ligase
ubiquitin - activating enzyme gene
16p12 .3
bone morphogenetic protein gene
2p13 .2
yttrium y 90 monoclonal antibody bre - 3
phosphatase family gene
3q22 .3
phosphoinositol kinase family gene
7q22 .2
cullin family gene
10p11 .21
beta - arrestin - 1
10q26 .2
granulocyte colony - stimulating factor
granulocyte colony - stimulating factor receptor
indium in 111 monoclonal antibody bre - 3
granulopoiesis
phospholipid - transporting atpase ib
casein kinase ii subunit alpha
chondroitin sulfate proteoglycan 4
structural maintenance of chromosomes protein 3
c - terminal - binding protein 2
cardiotrophin - 1
cathepsin z
cullin - 1
vasopressin - neurophysin 2 - copeptin
ss1 ( dsfv )  - pe38 immunotoxin
cullin - 2
cullin family protein
cullin - 3
cullin - 4a
cullin - 5
vasopressin v1a receptor
vasopressin v1b receptor
macrolide antibiotic
vasopressin v2 receptor
b2 bradykinin receptor
c - x - c chemokine receptor type 5
chemokine xc receptor 1
cytokine receptor common subunit beta
protease - activated receptor 1
fas - associated death domain protein
deleted in malignant brain tumors 1 protein
scavenger receptor cysteine - rich domain
monoclonal antibody mono - dga - rfb4
methyltransferase gene
add - type zinc - finger
dna  ( cytosine - 5 )  - methyltransferase 3b
cyclin - dependent kinase 2 - associated protein 2
cell surface extension
phagocytosis
dedicator of cytokinesis protein 1
docking protein 1
ptb domain
dok related protein
eso - 1 peptide vaccine
d ( 1a )  dopamine receptor
d ( 4 )  dopamine receptor
d ( 1b )  dopamine receptor
heparin - binding egf - like growth factor
heparin binding
fibroblast growth factor 10
fibroblast growth factor 20
fibroblast growth factor 21
fibroblast growth factor 8
fibroblast growth factor receptor 3
ins316
left - right determination factor 2
growth factor receptor gene
fibroblast growth factor receptor - like 1
fas - activated serine / threonine kinase
glomulin
fanconi anemia group g protein
exostosin - like 1
exostosin - like 2
exostosin - like 3
stat4 gene
yttrium y 90 monoclonal antibody b3
2q32 .2 - q32 .3
bag family molecular chaperone regulator 4
cell fate control
e3 ubiquitin - protein ligase dtx1
bag family molecular chaperone regulator 5
adhesion g protein - coupled receptor b1
fibroblast growth factor 9
glycosyltransferase gene
thymidine phosphorylase
b - cell lymphoma 6 protein
in 111 monoclonal antibody b3
glial cell proliferation
endothelin - 2
b - cell lymphoma / leukemia 10
epidermal growth factor - like protein 6
ets homologous factor
ephrin type - a receptor 2
emilin - 1
2q36 .1
ephrin type - a receptor 4
edotreotide
ephrin type - a receptor 8
nervous system development
ephrin type - b receptor 1
frizzled - 2
frizzled domain
frizzled - 3
ephrin type - b receptor 2
frizzled - 4
ephrin type - b receptor 3
cellular migration process
egfr antisense dna
protective agent
epiregulin
frizzled - 7
ets domain - containing transcription factor erf
5q12 .2
protein lap2
ets translocation variant 1
ets translocation variant 4
epidermal growth factor receptor kinase pathway substrate 8
epidermal growth factor receptor pathway substrate 15
benzoylphenylurea
frizzled - 6
gastric inhibitory polypeptide receptor
arf gtpase - activating protein git1
arf gtpase - activating protein git2
frizzled - 9
guanine nucleotide - binding protein g ( z )  subunit alpha
guanine nucleotide - binding protein subunit alpha - 12
recombinant vaccinia - cea ( 6d )  - tricom vaccine
guanine nucleotide - binding protein g ( i )  subunit alpha - 2
heterotrimeric g protein subunit gene
grb2 - associated - binding protein 2
guanine nucleotide - binding protein g ( i )  / g ( s )  / g ( t )  subunit beta - 1
guanine nucleotide - binding protein g ( i )  / g ( s )  / g ( t )  subunit beta - 2
guanine nucleotide - binding protein g ( i )  / g ( s )  / g ( t )  subunit beta - 3
uracil nucleotide / cysteinyl leukotriene receptor
leucine - rich repeat
four and a half lim domains protein 2
transcription regulatory protein
recombinant fowlpox - cea ( 6d )  / tricom vaccine
leucine - rich repeat neuronal protein 2
acidic fibroblast growth factor intracellular - binding protein
receptor - type tyrosine - protein kinase flt3
vascular endothelial growth factor receptor 3
c - c chemokine receptor type 10
probable g - protein coupled receptor gpr32
ovarian cancer g - protein coupled receptor 1
forkhead box protein o1
fmet - leu - phe receptor
cx3c chemokine receptor 1
gavilimomab
disabled homolog 2
discoidin domain - containing receptor 2
atp - dependent rna helicase ddx1
putative pre - mrna - splicing factor atp - dependent rna helicase dhx16
deleted in esophageal cancer 1
beta - defensin 1
protein dek
deleted in lung and esophageal cancer protein 1
leukemia - associated protein 1
carcinoembryonic antigen peptide 1 - 6d
deleted in lymphocytic leukemia 2 non - protein coding rna
grb2 - related adapter protein
growth factor receptor - bound protein 2
growth factor receptor - bound protein 7
xq13
c - x - c chemokine receptor type 3
growth factor receptor - bound protein 10
g - protein coupled receptor family c group 5 member c
oncolytic hsv - 1 nv1020
growth factor receptor - bound protein 14
adaptor signaling protein
g protein - coupled receptor kinase 4
g protein - coupled receptor kinase
g protein - coupled receptor kinase gene
g protein - coupled receptor kinase 5
rap guanine nucleotide exchange factor 1
g protein - coupled receptor kinase 6
glutamate receptor 3
metabotropic glutamate receptor 1
bispecific antibody 4g7xh22
11q14 .1
metabotropic glutamate receptor 5
g protein - coupled receptor kinase 7
metabotropic glutamate receptor 6
glutathione s - transferase theta - 1
hepatocyte growth factor - regulated tyrosine kinase substrate
cop9 signalosome complex subunit 1
galanin receptor type 2
g protein pathway suppressor 2
regulator of g - protein signaling 1
palivizumab
regulator of g - protein signaling 2
regulator of g - protein signaling 3
regulator of g - protein signaling 19
cation - independent mannose - 6 phosphate receptor
huang lian
interleukin - 6 receptor subunit beta
cytokine receptor common subunit gamma
interleukin - 2 receptor subunit beta
interleukin - 4 receptor subunit alpha
interleukin - 5 receptor subunit alpha
gpi - 0100
interleukin - 10 receptor subunit beta
interleukin - 11 receptor subunit alpha
africa
asia
europe
north america
oceania
south america
interleukin - 7 receptor subunit alpha
immunoglobulin class switch recombination
immune cell activation process
neutrophil activation
c - x - c chemokine receptor type 1
yeats domain - containing protein 4
c - x - c chemokine receptor type 2
valganciclovir
integrin - linked protein kinase
inhibitor of growth protein 1
2p12 - p13
bone morphogenetic protein 3b
7p15 - p14 .2
12q13 .3
11p15 .1
9p21 - p22
6p22 .1
inhbb gene
anticoagulant agent
tucotuzumab celmoleukin
hepatocellular carcinoma protein hhcm
irak2 gene
irak4 gene
hexokinase - 2
hydroxycarboxylic acid receptor 3
irf3 gene
heterogeneous nuclear ribonucleoprotein a3
homeobox protein hox - a10
paclitaxel liposome
homeobox protein hox - a9
homeobox protein hox - c6
heparanase
3 - keto - steroid reductase
oxidoreductase htatip2
interferon - induced transmembrane protein 1
interferon alpha - 1 / 13
interferon alpha - 2
interferon omega - 1
annamycin
caribbean
leukemia inhibitory factor receptor
growth / differentiation factor 5
hematologic and lymphocytic disorder
non - neoplastic hematologic and lymphocytic disorder
non - neoplastic connective and soft tissue disorder
protein - lysine 6 - oxidase
growth / differentiation factor 8
leukotriene b4 receptor 1
pelitrexol
ghana
latent - transforming growth factor beta - binding protein 2
leukocyte tyrosine kinase receptor
lymphocyte antigen 6e
insulin - like growth factor 2 mrna - binding protein 3
kinase suppressor of ras 1
middle east
ptpn11 gene
af4 / fmr2 family member 3
tyrosine - protein phosphatase non - receptor type 1
digitoxin
lysosome - associated membrane glycoprotein 3
tyrosine - protein phosphatase non - receptor type 12
tyrosine - protein phosphatase non - receptor type 22
tyrosine - protein phosphatase non - receptor type 6
serine / threonine - protein kinase lats1
tyrosine - protein phosphatase non - receptor type 7
serine / threonine - protein kinase lats2
lymphocyte cytosolic protein 2
left - right determination factor 1
leptin receptor
pirfenidone
ccnb1 gene
galectin - 3 - binding protein
galectin - 8
leucine - rich glioma - inactivated protein 1
lim / homeobox protein lhx1
lim / homeobox protein lhx2
neuron - specific calcium - binding protein hippocalcin
integrator complex subunit 6
array
serving
hpph
map kinase gene
mitogen - activated protein kinase 11
mitogen - activated protein kinase 10
mitogen - activated protein kinase 12
mitogen - activated protein kinase 13
mitogen - activated protein kinase 14
mvf - her - 2 ( 628 - 647 )  - crl 1005 vaccine
mitogen - activated protein kinase 4
mitogen - activated protein kinase 6
hif1a gene
arnt gene
arnt2 gene
growth / differentiation factor 9
post - replication modification
dna methylation regulation
mitogen - activated protein kinase 7
mitogen - activated protein kinase 9
mov - gamma chimeric receptor gene
microtubule - associated protein rp / eb family member 1
midkine
homeobox protein meis1
tyrosine - protein kinase mer
zinc finger protein gfi - 1b
1q41 - q44
15q26
exercise pain management
lactadherin
gdnf family receptor alpha - 2
taurolidine
mouse disorder by site
protein splicing
anticonvulsant agent
telomerase: 540 - 548 peptide vaccine
canfosfamide hydrochloride
t - cell receptor beta locus
t - cell receptor alpha locus
idronoxil
t - cell receptor delta locus
t - cell receptor gamma locus
immunoglobulin heavy locus
immunoglobulin lambda locus
22q11 .1 - q11 .2
immunoglobulin kappa locus
t - cell receptor alpha chain
t - cell receptor beta chain
t - cell receptor gamma chain
t - cell receptor delta chain
trivalent influenza vaccine
nfkbia gene
coronavirus
brd4 - interacting chromatin - remodeling complex - associated protein
ribosome biogenesis protein nop53
4q25 - q31
5q12
8q22 .1
15q24
doxorubicin - magnetic targeted carrier complex
conation
iratumumab
i 131 monoclonal antibody cc49
14q21 - q24
golnerminogene pradenovec
autologous dendritic cell - adenovirus p53 vaccine
dendritic cell - autologous lung tumor vaccine
galiximab
gomiliximab
abagovomab
doxercalciferol
monoclonal antibody gd2 anti - idiotype vaccine
anthraquinone
comedo
dopaminergic cell
luminal
mixed  ( normal and tumor )
intraductal hyperplasia
l - dopachrome tautomerase
animal cap
dorsal lip
endomesoderm
fovea centralis
macula
corpus luteum
mesonephros
mesonephric duct
methyl - 5 - aminolevulinate hydrochloride cream
maxilla
2q21 .1
7q31 .1 - q31 .3
12p13 .2 - p12 .3
14 - 3 - 3 protein sigma
17q24 .3
transforming acidic coiled - coil - containing protein 2
killer cell lectin - like receptor subfamily b member 1
natural killer cells antigen cd94
map kinase - activating death domain protein
monoclonal antibody 105ad7 anti - idiotype vaccine
mothers against decapentaplegic homolog 2
mothers against decapentaplegic homolog 6
mothers against decapentaplegic homolog 7
zinc finger fyve domain - containing protein 9
melanoma - associated antigen d1
dual specificity mitogen - activated protein kinase kinase 6
mitogen - activated protein kinase kinase kinase 1
mitogen - activated protein kinase kinase kinase 14
mitogen - activated protein kinase kinase kinase 7
tgf - beta - activated kinase 1 and map3k7 - binding protein 1
dha - paclitaxel
mitogen - activated protein kinase kinase kinase kinase 4
recql gene
recql4 gene
recql5 gene
17q25 .2 - q25 .3
hdac1 gene
hdac2 gene
hdac3 gene
hdac4 gene
2q37 .2
antidepressant agent
synchrotope ta2m plasmid dna vaccine
hdac6 gene
cyp19a1 gene
15q21 .1
deacetylase
spam1 gene
7q31 .3
ephx1 gene
acpp gene
mmp9 gene
20q11 .2 - q13 .1
silicon phthalocyanine 4
mmp3 gene
cytochrome p450 family gene
cyp2c19 gene
cyp2c18 gene
mmp2 gene
16q13 - q21
10q24 .1 - q24 .3
cyp2d6 gene
cyp1a2 gene
monoclonal antibody huj591
15q22 - qter
16q24 .1 - q24 .2
hsd17b2 gene
16q2
g6pd gene
laromustine
tpo gene
2p25
mouse protein
xenobiotic metabolism
rat protein
zap70 gene
syk gene
dhodh gene
dhfr gene
blk gene
ipilimumab
5q11 .2 - q13 .2
8p23 - p22
dpyd gene
adam15 gene
1q21 .3
plat gene
8p12
gene product
untranslated rna
nrg3 gene
caspase gene
casp1 gene
generation of antibody diversity
dntt gene
10q23 - q24
prim1 gene
prim2b gene
halofuginone hydrobromide
6p12 - p11 .1
primase polypeptide 2b
dna primase small subunit
ethylnitrosourea
fasn gene
fatty acid metabolism
casp2 gene
nmt2 gene
crebbp gene
ep300 gene
ny - eso - 1 peptide vaccine
hat1 gene
2q31 .2 - q33 .1
kat2b gene
casp3 gene
kat5 gene
4q34
11q12 .1
fgf9 gene
ertumaxomab
plau gene
fap gene
2q23
klk2 gene
klk3 gene
st14 gene
11q24 - q25
prss8 gene
prtn3 gene
monoclonal antibody cal
gpi gene
top1 gene
top2a gene
top2b gene
top3a gene
17p12 - 17p11 .2
ptgs1 gene
9q32 - q33 .3
ptgs2 gene
1q25 .2 - q25 .3
antidiarrheal agent
tetanus toxoid vaccine
pf4 gene
4q12 - q21
protein fosb
fosb gene
19q13 .32
atf2 gene
herba scutellaria barbata
pro - platelet basic protein
ppbp gene
activin receptor type - 1
serine / threonine - protein kinase receptor r3
neutrophil - activating peptide 2
rrm2 gene
2p25 - p24
alpha granule
ang gene
topoisomerase - ii - beta inhibitor racemic xk469
14q11 .1 - q11 .2
ribonucleoside - diphosphate reductase m2
casp8 gene
interferon regulatory factor 3
interferon regulatory factor 2
interferon regulatory factor 1
3p25 .3
12q14 .1
chinese herbs
por gene
7q11 .2
follistatin - related protein 3
drug metabolism
brain - specific angiogenesis inhibitor 1 - associated protein 2
blnk gene
b - cell linker protein
immunoglobulin - binding protein 1
clofarabine
epoetin beta
fibrin sealant
cmv n495 peptide
buspirone hydrochloride
dexmethylphenidate
dextroamphetamine - amphetamine
eribulin mesylate
multi - neo - epitope vaccine ose 2101
egb761
black cohosh
her2 inhibitor cp - 724 , 714
essiac
edotecarin
flaxseed
american ginseng
antisense oligonucleotide gti - 2040
lapatinib
hexaminolevulinate
forodesine hydrochloride
juven
levocarnitine
enzastaurin hydrochloride
marijuana
recombinant fowlpox - b7 .1 vaccine
anti - psma monoclonal antibody mln591 - dm1 immunoconjugate mln2704
modafinil
morinda citrifolia fruit extract
pixantrone
polyglutamate camptothecin
pomegranate juice
tarenflurbil
zileuton
rk - 0202
seocalcitol
recombinant fowlpox - tricom vaccine
sildenafil citrate
silymarin
soblidotin
sunitinib malate
t900607
talaporfin sodium
transferrin - crm107
virulizin
endothelin receptor type a antagonist ym598
lenalidomide
ny - eso - b
hpv 18 e6:13 - 21 peptide
abdominal pain
abnormal laboratory test result
radiation - induced disorder
placental abruption
abscess
acanthosis nigricans
acute laryngitis
addison's disease
monoclonal antibody mik - beta - 1
adrenal gland disorder
adrenocortical insufficiency
factor i deficiency
aneurysm
dissecting aneurysm
anal disorder
anxiety
aortic aneurysm
apnea
bacterial arthritis
antiemetic agent
mek inhibitor ci - 1040
infective arthritis
ataxia
atrioventricular block by ecg finding
bacterial pneumonia
balanitis
bartholin cyst
urinary bladder stone
breast disorder
mmp inhibitor s - 3304
bronchopneumonia
candidiasis
mucinous adenocarcinoma
cataract
celiac disease
cellulitis
cervicitis
chalazion
cholangitis
epothilone d
chorioamnionitis
hemophilia b
chronic bronchitis
colitis
colles' fracture
common variable immunodeficiency
infectious disorder
transplanted organ complication
conjunctival hemorrhage
connective tissue disorder
clopidogrel bisulfate
corneal abrasion
corneal disorder
coronary artery disease
cranial nerve disorder
congenital hypothyroidism
croup
cryoglobulinemia
cyanosis
cystitis
sensorineural hearing loss
vaccinia - gm - csf vaccine
delusion
dermatitis herpetiformis
contact dermatitis
dermatomyositis
dermatophytosis
scleroderma
type 2 diabetes mellitus
diabetic neuropathy
vip - producing neuroendocrine tumor
recombinant fowlpox - prostate specific antigen vaccine
joint dislocation
dissecting aortic aneurysm
diverticulitis
diverticulum
somnolence
duodenal ulcer
dyspepsia
ear disorder
ecchymosis
embolism
oncolytic hsv - 1 g207
encephalitis
encephalitis lethargica
endocervicitis
fallopian tube endometriosis
endometritis
enteritis
epistaxis
eye disorder
eyelid disorder
facial nerve palsy
magnetic - targeted carrier
hereditary factor xii deficiency
fallopian tube disorder
fat necrosis
feminization
femur fracture
flushing
carpal bone fracture
multiple fractures
stress fracture
beta - glucan
gastritis
gastroesophageal reflux disease
glaucoma
gliosis
glomerulonephritis
goiter
gonadal disorder
gonococcal urethritis
chronic granulomatous disease
granulomatous prostatitis
colchicine - site binding agent abt - 751
acute infective polyneuritis
hemorrhage
hemorrhoid
sinusoidal obstruction syndrome
hip fracture
humerus fracture
hydronephrosis
hyperglycemia
hypophosphatasia
hereditary factor ii deficiency
antigen
na17 .a2 peptide vaccine
hypothyroidism
intestinal disorder
creutzfeldt - jakob disease
jaw fracture
joint tuberculosis
keratitis
keratoconus
renal stone
acute renal failure
lacrimal system disorder
mage - 10 .a2
laryngeal disorder
laryngitis
lens disorder
acute eosinophilic leukemia
radiation - related leukemia
progressive multifocal leukoencephalopathy
leukopenia
lichen sclerosus et atrophicus
lip disorder
cutaneous lupus erythematosus
ziv - aflibercept
discoid lupus erythematosus
lymphadenitis
lymphogranuloma venereum
lymphopenia
mandible fracture
mediastinal disorder
mediastinitis
meningitis
menorrhagia
monoclonal antibody d6 .12
mesenteric lymphadenitis
mycobacterial infection
myelitis
nephritis
interstitial nephritis
nervous system disorder
nutritional disorder
osteogenesis imperfecta
osteomalacia
bone infection
monoclonal antibody c - 58
osteopetrosis
ovarian disorder
pancreatic disorder
paranasal sinus disorder
parathyroid gland disorder
parkinson's disease
penile disorder
polyarteritis nodosa
peritoneal disorder
peritonitis
recombinant vaccinia - tricom vaccine
pharyngeal disorder
pharyngitis
phimosis
pituitary gland apoplexy
pituitary gland disorder
pityriasis rosea
placenta accreta
placenta disorder
placenta previa
pleural disorder
recombinant fowlpox gm - csf vaccine adjuvant
pleuritis
pneumoconiosis
stein - leventhal syndrome
polycythemia
polyneuritis
prostate disorder
prostatitis
kimura disease
pulmonary edema
pulmonary fibrosis
thrombocytopenic purpura
respiratory system disorder
respiratory failure
infectious lung disorder
retinal detachment
retinal disorder
retroperitoneal fibrosis
rickets
salivary gland disorder
nab - paclitaxel
salpingitis
solar lentigo
sialadenitis
sjogren syndrome
sleep apnea
testicular torsion
stomach disorder
stomatitis
sinus tachycardia
ih636 grape seed proanthocyanidin extract
testicular disorder
thrombosis
thyroid gland disorder
thyroiditis
tuberculous laryngitis
lymph node tuberculosis
bone tuberculosis
tuberculous pleuritis
pulmonary tuberculosis
cell surface antigen
sho - saiko - to
turner syndrome
erythema
ureteric stone
urethra disorder
urethritis
urinary stone
urinary frequency
uterine disorder
uveal disorder
uveitis
ginger extract
vaginal disorder
vaginitis
vasculitis
verruca plantaris
vitiligo
anticipatory vomiting
xerostomia
hiv - associated nephropathy
lymphosarcoma
glycinamide ribonucleotide formyltransferase inhibitor
encephalopathy
fever chills
liver failure
sinus bradycardia
ventricular arrhythmia
polymyositis
alcoholic polyneuropathy
hydroureter
hemorrhagic gastritis
chronic gastritis
erlotinib hydrochloride
chronic prostatitis
hypogammaglobulinemia
acute bronchitis
acute gastritis
acute cystitis
acute prostatitis
prostatic stone
cervical lymphadenitis
fibula fracture
coccyx fracture
green tea extract
chronic pain
cranial nerve palsy
thyroid gland atrophy
gamma - glutamyltransferase increased
retroperitoneal hemorrhage
vaginal hemorrhage
hepatocellular damage
aspartate aminotransferase increased
alanine aminotransferase increased
duodenal ulcer hemorrhage
epoetin alfa
esophageal ulcer
polyneuropathy
trigeminal nerve disorder
accessory nerve disorder
hypoglossal nerve disorder
familial polycythemia
hodgkin's paragranuloma
tuberculous bronchiectasis
adrenal gland tuberculosis
reticulosarcoma involving spleen
iodine i 131 ethiodized oil
lymphosarcoma involving spleen
hodgkin's paragranuloma involving spleen
thymus disorder
carotenemia
selective iga immunodeficiency
selective igm immunodeficiency
chronic lymphadenitis
retinal detachment and defect
retinal defect
corneal abscess
iodine i 131 monoclonal antibody cc49 - deltach2
bullous keratopathy
dacryoadenitis
external ear disorder
sensory hearing loss
mixed hearing loss
chronic laryngitis
chronic obstructive asthma
alcoholic gastritis
acute lymphadenitis
juvenile chronic polyarthritis
monoclonal antibody cc49 - delta ch2
allergic arthritis
climacteric arthritis
pathologic joint dislocation
intervertebral disc degenerative disorder
infectious myositis
interstitial myositis
pharyngeal hemorrhage
clavicle fracture
forearm fracture
ankle fracture
enzyme catalyzed therapeutic activation agent
transplanted kidney complication
transplanted liver complication
transplanted heart complication
transplanted lung complication
burn of esophagus
urethral stone
polyarticular arthritis
hypertrophic scar
allergic contact dermatitis
ruptured aneurysm
antihypertensive agent
human thymosin - fraction 5
abdominal aortic aneurysm
thoracic aortic aneurysm
lower extremity fracture
acute pain
sarcomatoid carcinoma
spindle cell sarcoma
interstitial pneumonia
spitz nevus
chronic cystitis
myalgia
therapeutic immune globulin
euphoric mood
keratopathy
erosive gastritis
chemical esophagitis
granulomatous hepatitis
submandibular lymphadenitis
aggravated arthritis
acquired hemangioma
male reproductive system disorder
vincristine sulfate liposome
female reproductive system disorder
collagenous colitis
acute endometritis
herpes esophagitis
selective immunoglobulin g subclass deficiency
ischemic neuropathy
talc pneumoconiosis
candida esophagitis
prolonged partial thromboplastin time
autoimmune hepatitis
mistletoe extract
cerebral abscess
pancreatic neuroendocrine neoplasm
alk tyrosine kinase receptor
autonomic neuropathy
lumbar vertebral fracture
nerve paralysis
spongiotic dermatitis
hypereosinophilic syndrome
hemophilic arthritis
fixative / stain
spinal degenerative arthritis
neck arthritis
soft tissue disorder
acute respiratory failure
eosinophilic endomyocardial disease
nodal arrhythmia by ecg finding
ruptured abdominal aortic aneurysm
congenital eyelid malformation
congenital eyelid ptosis
placental malformation
eosinophilic colitis
rectal hemorrhage
uremic neuropathy
acute cervicitis
chronic cervicitis
leukoencephalopathy
anthrapyrazole
radiation - induced myelopathy
peroneal nerve paralysis
demyelinating polyneuropathy
toxic polyneuropathy
radiation - induced cataract
middle ear disorder
pituitary gland necrosis
endocrine pancreas disorder
diabetic autonomic neuropathy
polycythemia neonatorum
dhea mustard
reticular dysgenesis
transient hypogammaglobulinemia of infancy
finger fracture
cranial nerve injury
non - gonococcal urethritis
curcumin /  demethoxycurcumin / bisdemethoxycurcumin - containing supplement
refractory anemia with excess blasts in transformation
juvenile pilocytic astrocytoma
radiation - induced cerebritis
blood clot
spindle cell squamous cell carcinoma
dissecting abdominal aortic aneurysm
verruca vulgaris
hyperbilirubinemia
cellular vesicle
anti - idiotype muc - 1 monoclonal antibody
degenerative disorder
malignant spindle cell neoplasm
small cell carcinoma ,  fusiform cell type
stage 0 squamous cell carcinoma
cylindroma
nonpigmented nevus
liver embryonal sarcoma
antimalarial agent
cea rna - pulsed autologous human cultured dendritic cells
cognitive disturbance
nasal cavity disorder
localized pulmonary fibrosis
radiation - induced damage to artery
eosinophilic esophagitis
bacterial esophagitis
fungal esophagitis
viral esophagitis
combretastatin a - 4
radiation colitis
congenital thyroid gland aplasia
congenital thyroid gland hypoplasia
congenital hypothyroidism with ectopic thyroid
thyroid gland abscess
congenital iodine deficiency hypothyroidism
pituitary gland infarction
pituitary hemorrhage
pituitary gland cyst
monoclonal antibody e7 .6 .3
electrolyte disorder
helicobacter pylori - associated gastritis
endemic burkitt lymphoma
blurred vision
congenital phimosis
proliferating trichilemmal tumor
benign skin vascular neoplasm
adrenal gland injury
acetabulum fracture
pelitinib
ilium fracture
early gastric cancer
trichoblastoma
hematopoietic and lymphoid cell neoplasm
suppurative lymphadenitis
placental necrosis
radiation - induced stomatitis
peritoneal hemorrhage
anti - egfr monoclonal antibody emd 55900
ventricular aneurysm
immunoglobulin heavy chain deletion
selective igg immunodeficiency
selective ige immunodeficiency
selective igd immunodeficiency
t - cell immunodeficiency
hemophilia a
lymphocytic colitis
ureter disorder
acquired phimosis
telomerase inhibitor fj5002
adrenal cortical insufficiency
irritant contact dermatitis
sebaceous hyperplasia
lupus erythematosus
lumbar disc degenerative disorder
thoracic disc degenerative disorder
cervical disc degenerative disorder
mouth sore
supraventricular arrhythmia by ecg finding
hand fracture
non - specific granulomatous orchitis
epiphyseal fracture
respiratory distress
inner ear disorder
primary biliary cirrhosis
obstructive sleep apnea syndrome
central sleep apnea syndrome
compression fracture
systemic lupus erythematosus rash
neonatal apneic attack
stress polycythemia
injection site thrombophlebitis
accelerated neoplasm growth
palmar - plantar erythrodysthesia
secondary polycythemia
juvenile rheumatoid arthritis
poly microsphere encapsulated her2 / neu oral vaccine
radiation - induced fibrous mediastinitis
placental infarction
skin sclerosing / morphoeic basal cell carcinoma
adult spinal cord glioblastoma
viral gastritis
disseminated adenocarcinoma
inherited neuropathy
interstitial cystitis
monoclonal antibody humv833
elbow fracture
hashimoto thyroiditis
ear infection
brachial plexopathy
acne
lupus encephalitis
acute pneumonia
ruptured aortic aneurysm
cerebritis
antimetabolite
monoclonal antibody icr62
gastric leiomyosarcoma
knee fracture
infiltrating bladder urothelial carcinoma ,  micropapillary variant
bacterial prostatitis
rheumatologic disorder
atrophic arthritis
vestibulocochlear nerve disorder
radiation - related malignant neoplasm
c - raf antisense oligonucleotide isis 5132
olfactory nerve disorder
glossopharyngeal nerve disorder
t ( 11 ; 22 )  ( q24 ; q12 )
coagulation factor deficiency
diffuse pulmonary fibrosis
cytomegaloviral gastritis
cytomegalovirus esophagitis
viral respiratory tract infection
raf kinase inhibitor l - 779450
bone infarction
entrapment neuropathy
cerebral aneurysm
androgen insensitivity syndrome
neonatal leukopenia
gonadal agenesis
mage - 12: 170 - 178 peptide
cardiovascular manifestation
blood test result
nipple duct carcinoma
gastric non - hodgkin lymphoma
familial adenomatous polyposis associated medulloblastoma
low grade anal canal intraepithelial neoplasia
uterine corpus choriocarcinoma
stage ivb vulvar cancer ajcc v6 and v7
cranial nodular fasciitis
monoclonal antibody co17 - 1a
uterine corpus adenomatoid tumor
enterochromaffin - like cell neuroendocrine tumor g1
metanephric adenoma
papillary eccrine carcinoma
eccrine carcinoma
giant cell angiofibroma
cellular angiofibroma
monoclonal antibody b3
dendritic cell tumor ,  not otherwise specified
myelodysplastic / myeloproliferative neoplasm
spindle cell neoplasm
familial atypical mole melanoma syndrome
malignant lymphoma ,  large cell ,  cleaved
malignant lymphoma ,  non - cleaved ,  diffuse
egfr inhibitor pd - 168393
malignant lymphoma ,  large cell ,  cleaved and non - cleaved
poroma
premalignant hematologic condition
high grade anal canal intraepithelial neoplasia
adult l1 acute lymphoblastic leukemia
localized adrenal gland pheochromocytoma
polyclonal vaccine
secondary myelodysplastic syndrome
l2 acute lymphoblastic leukemia
stage 0 aids - related anal canal cancer ajcc v6 and v7
stage i aids - related anal canal cancer ajcc v6 and v7
stage ii aids - related anal canal cancer ajcc v6 and v7
stage iii aids - related anal canal cancer ajcc v6 and v7
stage iv aids - related anal canal cancer ajcc v6 and v7
ovarian endometrioid adenofibroma
ovarian endometrioid cystadenofibroma
borderline ovarian endometrioid cystadenofibroma
radiolabeled cc49
l1 acute lymphoblastic leukemia
ewing sarcoma / peripheral primitive neuroectodermal tumor
metastatic ewing sarcoma / peripheral primitive neuroectodermal tumor
extraskeletal ewing sarcoma / peripheral primitive neuroectodermal tumor
localized primitive neuroectodermal tumor
recurrent primitive neuroectodermal tumor
positive lymph node
hormonal change
ptosis
ruptured thoracic aneurysm
antimitotic agent
mutated ras peptide
meckel diverticulitis
axonal neuropathy
reactive xanthogranuloma
peritoneal and retroperitoneal hemorrhage
congenital thyroid gland disorder
viral laryngitis
staphylococcal septic arthritis
anaplastic  ( malignant )  intracranial meningioma
ann arbor stage i b - cell non - hodgkin lymphoma
rhodacyanine analog mkt - 077
dehydration polycythemia
physiological polycythemia
polycythemia due to hypoxia
adult dermatomyositis
mycobacterium avium complex lymphadenitis
permanent spinal nerve paralysis
conjunctival ecchymosis
dissecting thoracic aortic aneurysm
transient hypogammaglobulinemia
recombinant vaccinia - muc - 1 vaccine
blennorrhagic arthritis
aids - related enterocolitis
periampullary adenocarcinoma
resectable duodenal carcinoma
unresectable cholangiocarcinoma
recurrent cholangiocarcinoma
resectable cholangiocarcinoma
stage i centroblastic follicular lymphoma
stage ii centroblastic follicular lymphoma
necrotizing gastritis
nimotuzumab
thyroid gland malformation
postauricular lymphadenitis
axillary lymphadenitis
adrenal gland abscess
glossopharyngeal nerve paralysis
lumbar vertebral fracture l2
congenital neuropathy
infectious otitis interna
vitaxin - 2
bacterial gastritis
herpetic gastritis
fungal gastritis
pituitary gland hypoplasia
aids - related retinopathy
unresectable hepatocellular carcinoma
parathyroid gland abscess
tuberculous abscess
granulomatous gastritis
histiocytic sarcoma
y 90 anti - cea monoclonal antibody
myeloproliferative neoplasm ,  unclassifiable
immune system and related disorders
localized peripheral primitive neuroectodermal tumor of bone
recurrent peripheral primitive neuroectodermal tumor of bone
refractory hematologic malignancy
recurrent hematologic malignancy
unresectable malignant neoplasm
vascular disrupting agent zd6126
childhood ganglioglioma
childhood yolk sac tumor
adult primary cutaneous anaplastic large cell lymphoma
adult systemic anaplastic large cell lymphoma
adult anaplastic large cell lymphoma
childhood liver and intrahepatic bile duct neoplasm
adult pleomorphic rhabdomyosarcoma
vandetanib
adult clear cell sarcoma of soft parts
childhood clear cell sarcoma of soft parts
childhood desmoplastic small round cell tumor
adult desmoplastic small round cell tumor
childhood mesenchymal chondrosarcoma
adult mesenchymal chondrosarcoma
childhood extraskeletal osteosarcoma
childhood myxoid chondrosarcoma
adult myxoid chondrosarcoma
mucin - producing adenocarcinoma
thyroid gland adenocarcinoma
metastatic carcinoma in the adrenal cortex
peritoneal carcinomatosis
meningeal carcinomatosis
pleural carcinomatosis
pericardial carcinomatosis
scirrhous hepatocellular carcinoma
carcinoma arising in nasal papillomatosis
monoclonal antibody 7c11
ovarian small cell carcinoma
metastatic ovarian small cell carcinoma ,  hypercalcemic type
parathyroid gland oncocytic adenoma
vaginal melanoma
extraosseous / peripheral ameloblastoma
follicular ameloblastoma
granular cell ameloblastoma
adult spinal cord ependymoma
antineoplastic agent
vhl16 peptide
childhood central nervous system mixed germ cell tumor
childhood central nervous system mature teratoma
childhood central nervous system immature teratoma
childhood central nervous system germinoma
duodenal somatostatin - producing neuroendocrine tumor
metastatic carcinoma in the lung
small intestinal burkitt lymphoma
vhl14 peptide
small intestinal atypical burkitt / burkitt - like lymphoma
colon mantle cell lymphoma
ampulla of vater tubulovillous adenoma
adenoma of the colon with intramucosal adenocarcinoma
ampulla of vater clear cell adenocarcinoma
ampulla of vater intestinal - type adenocarcinoma
ampulla of vater mucinous adenocarcinoma
ampulla of vater squamous cell carcinoma
ampulla of vater adenosquamous carcinoma
ampulla of vater undifferentiated carcinoma
alvac - b7 - cea
esophageal verrucous carcinoma
esophageal adenosquamous carcinoma
esophageal undifferentiated carcinoma
esophageal squamous intraepithelial neoplasia
esophageal glandular intraepithelial neoplasia
esophageal high grade intraepithelial neoplasia
high grade esophageal squamous intraepithelial neoplasia
low grade esophageal squamous intraepithelial neoplasia
low grade esophageal glandular intraepithelial neoplasia
high grade esophageal glandular intraepithelial neoplasia
alvac - cea  ( vcp248 )
esophageal gastrointestinal stromal tumor
low grade gastric intraepithelial neoplasia
high grade gastric intraepithelial neoplasia
benign gastric soft tissue neoplasm
gastric sarcoma
atropine sulfate
gastric mantle cell lymphoma
small intestinal mantle cell lymphoma
gastric enterochromaffin cell serotonin - producing neuroendocrine tumor
gastric gastrin - producing neuroendocrine tumor
appendix l - cell glucagon - like peptide - producing neuroendocrine tumor
colon enterochromaffin cell serotonin - producing neuroendocrine tumor
colon l - cell glucagon - like peptide - producing neuroendocrine tumor
l - cell glucagon - like peptide - producing neuroendocrine tumor
small intestinal small cell carcinoma
b7 transfected melanoma cell vaccine
small intestinal gastrin - producing neuroendocrine tumor
small intestinal enterochromaffin cell serotonin - producing neuroendocrine tumor
small intestinal l - cell glucagon - like peptide - producing neuroendocrine tumor
small intestinal somatostatin - producing neuroendocrine tumor
pancreatic vip - producing neuroendocrine tumor
small intestinal vip - producing neuroendocrine tumor
colorectal tubular adenoma
colorectal adenoma with moderate dysplasia
colorectal adenoma with mild dysplasia
colorectal intraepithelial neoplasia
berzofsky ras / p53 peptide vaccine
colorectal low grade intraepithelial neoplasia
colorectal high grade intraepithelial neoplasia
small intestinal intraepithelial neoplasia
small intestinal low grade intraepithelial neoplasia
small intestinal high grade intraepithelial neoplasia
colon burkitt lymphoma
pancreatic acth - producing neuroendocrine tumor
stage 0 lung cancer ajcc v6 and v7
paraproteinemia
disseminated carcinoma
conjugated monoclonal antibody cc49
disseminated malignant neoplasm
peripheral primitive neuroectodermal tumor of soft tissues
proximal - type epithelioid sarcoma
distal - type epithelioid sarcoma
superficial bladder carcinoma
bone lipoma
bone schwannoma
benign osteoclastic giant cell - rich tumor of bone
gingival angiofibroma
nasopharyngeal angiofibroma
d1 / 3 - mage - 3 - his fusion protein
classic rhabdomyoma
mesenchymal extraskeletal chondrosarcoma
secondary chondrosarcoma
lipoblastoma
liver angiomyolipoma
pelvic lipomatosis
steroid lipomatosis
mediastinal lipomatosis
spindle cell liposarcoma
ews / fli 1 type 1
t ( 11 ; 14 )  ( q13 ; q32 )
conventional alveolar rhabdomyosarcoma
solid alveolar rhabdomyosarcoma
granular cell leiomyosarcoma
inflammatory leiomyosarcoma
glomangiomatosis
glomus tumor of uncertain malignant potential
lipomatous hemangiopericytoma
antioxidant
ews / fli 1 type 2
lymphadenopathic kaposi sarcoma
conventional extraskeletal myxoid chondrosarcoma
extraskeletal myxoid chondrosarcoma
angiomatosis
glomeruloid hemangioma
hobnail hemangioma
hemangioma of peripheral nerve
intra - abdominal lymphangioma
skin lymphangioma
kaposiform hemangioendothelioma
retiform hemangioendothelioma
angiosarcoma associated with lymphedema
radiation - related angiosarcoma
adult xanthogranuloma
collagenous fibroma
epidermolytic acanthoma
acantholytic acanthoma
large cell acanthoma
acrokeratosis verruciformis
benign hair follicle neoplasm
classic type trichilemmoma
desmoplastic trichilemmoma
desmoplastic trichoepithelioma
follicular myxoma
tubular adenoma
malignant skin vascular neoplasm
conventional lipoma
pre - malignant skin epithelial lesion
primary cutaneous mucinous carcinoma
digital papillary adenocarcinoma
skin adenoid basal cell carcinoma
skin clear cell basal cell carcinoma
skin cystic basal cell carcinoma
skin follicular basal cell carcinoma
skin infiltrating basal cell carcinoma
eso - 1:157 - 165 ( 165v )  peptide
skin infundibulocystic basal cell carcinoma
skin micronodular basal cell carcinoma
skin pseudovascular squamous cell carcinoma
skin basaloid carcinoma
classic type atypical fibroxanthoma
spindle cell type atypical fibroxanthoma
fibrosarcomatous dermatofibrosarcoma protuberans
melanoacanthoma
reactive cutaneous fibrous lesion
non - neoplastic digestive system disorder
disorder by site
multiple lobular capillary hemangiomas
genital human papillomavirus infection
dermatosis
non - neoplastic lung disorder
lymphocytic interstitial pneumonia
mixed mineral dust pneumoconiosis
gm - csf cdna / gold complex
respiratory distress syndrome
hyaline membrane syndrome
non - neoplastic pleural disorder
endocrine syndrome
non - neoplastic endocrine disorder
non - neoplastic thyroid gland disorder
non - neoplastic pituitary gland disorder
non - neoplastic parathyroid gland disorder
gp100 adenovirus vaccine
non - neoplastic gonadal disorder
head and neck disorder
non - neoplastic bone disorder
non - neoplastic soft tissue disorder
connective and soft tissue disorder
childhood dermatomyositis
osteomyelitis
myositis
gp100 cdna / gold complex
peripheral nervous system disorder
central nervous system infectious disorder
spongiform encephalopathy
peripheral nervous system infectious disorder
human gp100 plasmid dna vaccine
vagus nerve disorder
abducent nerve paralysis
abducens nerve disorder
facial nerve disorder
femoral neuropathy
oculomotor nerve paralysis
oculomotor nerve disorder
non - neoplastic urinary system disorder
antiparasitic agent
gp100 and gm - csf dna / gold vaccine
non - neoplastic kidney disorder
non - neoplastic bladder disorder
non - neoplastic urethra disorder
non - neoplastic ureter disorder
non - neoplastic eye disorder
conjunctival disorder
gp100 - fowlpox vaccine
male non - neoplastic reproductive system disorder
female non - neoplastic reproductive system disorder
non - neoplastic reproductive system disorder
prostate non - neoplastic disorder
prostatic infection
testicular non - neoplastic disorder
testicular infarction
penile non - neoplastic disorder
placental non - neoplastic disorder
gp100 - pulsed peripheral blood mononuclear cell
vulvar non - neoplastic disorder
vaginal non - neoplastic disorder
cervical non - neoplastic disorder
cervical endometriosis
uterine corpus non - neoplastic disorder
non specific chronic endometritis
granulomatous endometritis
ovarian non - neoplastic disorder
ovarian endometriosis
uterine non - neoplastic disorder
gp100: es209 - 217 ( 210m )  peptide
fallopian tube non - neoplastic disorder
vulvar disorder
transplant - related malignant neoplasm
transplant - related carcinoma
transplant - related bladder urothelial carcinoma
transplant - related hepatocellular carcinoma
transplant - related skin squamous cell carcinoma
transplant - related lung carcinoma
transplant - related renal cell carcinoma
transplant - related hematologic malignancy
gp100:154 - 162 peptide vaccine
transplant - related kaposi sarcoma
oral cavity disorder
head and neck precancerous condition
partial hearing loss
deafness
conductive hearing loss
sinonasal disorder
neck disorder
salivary cyst
gp100:17 - 25 peptide
non - neoplastic oral disorder
non - neoplastic oral cavity disorder
non - neoplastic ear disorder
non - neoplastic external ear disorder
non - neoplastic inner ear disorder
skull disorder
non - neoplastic sinonasal disorder
non - neoplastic paranasal sinus disorder
non - neoplastic nasal cavity disorder
non - neoplastic laryngeal disorder
gp100:209 - 217 peptide
non - neoplastic neck disorder
non - neoplastic pharyngeal disorder
non - neoplastic salivary gland disorder
non - neoplastic head and neck disorder
peritoneal and retroperitoneal disorder
non - neoplastic peritoneal and retroperitoneal disorder
non - neoplastic peritoneal disorder
retroperitoneal disorder
non - neoplastic retroperitoneal disorder
respiratory and thoracic disorder
gp100:280 - 288 peptide vaccine
non - neoplastic mediastinal disorder
non - neoplastic cardiovascular disorder
virus - related malignant neoplasm
human papillomavirus - related cervical carcinoma
human papillomavirus - related cervical squamous cell carcinoma
human papillomavirus - related endocervical adenocarcinoma
human papillomavirus - related verrucous carcinoma
human papillomavirus - related vulvar squamous cell carcinoma
gp100:44 - 59
human papillomavirus - related esophageal squamous cell carcinoma
human papillomavirus - related anal squamous cell carcinoma
human papillomavirus - related squamous cell carcinoma of the penis
human papillomavirus - related adenocarcinoma
hepatitis virus - related hepatocellular carcinoma
hepatitis b virus - related hepatocellular carcinoma
hepatitis c virus - related hepatocellular carcinoma
ebv - related malignant neoplasm
ebv - related carcinoma
ebv - related lymphoma
ebv - related hodgkin lymphoma
ebv - related non - hodgkin lymphoma
ebv - related burkitt lymphoma
ebv - related clonal post - transplant lymphoproliferative disorder
virus - related carcinoma
virus - related lymphoma
antiprotozoal agent
aids - related carcinoma
previously treated myelodysplastic syndrome
c - myc translocation
virus - related sarcoma
klh - lymphoma ig vaccine
pulmonary sulcus neoplasm
loss of chromosome 5q
clonal ccnd1 gene rearrangement
t ( 1 ; 19 )  ( q23 ; p13 .3 )
extragastrointestinal gastrointestinal stromal tumor
skin radiation - related angiosarcoma
mart - 1:26 - 35 ( 27l )  peptide vaccine
pancreatic neuroendocrine tumor
digestive system neuroendocrine neoplasm
therapy - related myelodysplastic syndrome
vulvar lichen sclerosus
psoriasiform dermatitis
porphyria cutanea tarda
myelodysplastic syndrome with ring sideroblasts and multilineage dysplasia
non - functioning pancreatic endocrine tumor
poorly differentiated pancreatic endocrine carcinoma
thyroid gland well - differentiated tumor of uncertain malignant potential
mart - 1 adenovirus vaccine
childhood kidney wilms tumor
colorectal gastrointestinal stromal tumor
mart - 1 vaccinia vaccine
stage iib cutaneous melanoma ajcc v6 and v7
somnolence syndrome
non - small cell adenocarcinoma
hypoxic
mart - 1:27 - 35 peptide vaccine
acute myeloid leukemia not otherwise specified
alkylating agent - related acute myeloid leukemia
topoisomerase ii inhibitor - related acute myeloid leukemia
typical acute promyelocytic leukemia
microgranular acute promyelocytic leukemia
t ( 15 ; 17 )  ( q22 ; q12 )
t ( 16 ; 16 )  ( p13 .1 ; q22 )
mart - 1 fowlpox vaccine
helicobacter pylori - related non - hodgkin lymphoma
helicobacter pylori - associated gastric mucosa - associated lymphoid tissue lymphoma
helicobacter pylori - related carcinoma
helicobacter pylori - related gastric adenocarcinoma
parasite - related carcinoma
schistosoma hematobium - related bladder squamous cell carcinoma
opisthorchis viverrini - related cholangiocarcinoma
monoclonal antibody 95 - 5 - 49
immunodeficiency - related malignant neoplasm
solar radiation - related malignant neoplasm
giant hemangioma
monoclonal antibody 95 - 6 - 22
myelodysplastic / myeloproliferative neoplasm ,  unclassifiable
myxoid liposarcoma
upper extremity fracture
arm fracture
metastatic penile carcinoma
stage i testicular non - seminomatous germ cell tumor ajcc v6 and v7
stage ii testicular non - seminomatous germ cell tumor ajcc v6 and v7
stage iii testicular non - seminomatous germ cell tumor ajcc v6 and v7
female reproductive system precancerous condition
endometrial intraepithelial neoplasia
1b4m - dtpa - conjugated mub3
penile carcinoma in situ
spindle cell type gastrointestinal stromal tumor
mixed cell type gastrointestinal stromal tumor
polycythemia  ( excluding polycythemia vera )
pre - b acute lymphoblastic leukemia
pre - pre - b acute lymphoblastic leukemia
anti - thymocyte globulin
monoclonal antibody hcc49dch2
mycosis fungoides  ( working formulation )
non - neoplastic thymus disorder
thymic dysplasia
acute thymic involution
ectopic thymus
true thymic hyperplasia
metastatic kidney carcinoma
mov - pbl vaccine
bile duct adenocarcinoma
bile duct carcinoma
malignant endometrial neoplasm
pigmented nevus
paget disease of the penis
metastatic ureter carcinoma
metastatic urethral carcinoma
myeloma ig id - klh conjugate vaccine
diffuse malignant lymphoma
malignant lymphoma ,  large cell type
reticulosarcoma
mucin - producing carcinoma
stage iiic breast cancer ajcc v6
oncovax - id / il - 2 vaccine
grade 1 invasive breast carcinoma
grade 2 invasive breast carcinoma
grade 3 invasive breast carcinoma
dysplasia in barrett esophagus
low grade dysplasia in barrett esophagus
high grade dysplasia in barrett esophagus
persistent superficial gastritis
endometrial serous adenocarcinoma
endometrial endometrioid adenocarcinoma ,  secretory variant
p53:264 - 272 peptide
endometrial endometrioid adenocarcinoma with clear cell change
endometrial endometrioid adenocarcinoma with a poorly differentiated carcinomatous component
endometrial endometrioid adenocarcinoma with an undifferentiated carcinomatous component
villoglandular endometrial endometrioid adenocarcinoma
endometrial endometrioid adenocarcinoma ,  ciliated variant
oxyphilic endometrial endometrioid adenocarcinoma
paclitaxel ppe microspheres
endometrial endometrioid adenocarcinoma with spindled epithelial cells
human papillomavirus infection
castleman disease ,  hyaline - vascular type
castleman disease ,  plasma cell type
multicentric castleman disease
diffuse large b - cell lymphoma arising in hhv8 - positive multicentric castleman disease
aids - related burkitt lymphoma with plasmacytoid differentiation
aids - related diffuse large b - cell lymphoma arising in hhv8 - positive multicentric castleman disease
aids - related plasmablastic lymphoma
pclus 3 - 18mn
aids - related herpes zoster
aids - related pneumocystis pneumonia
parasitic infection
aids - related pelvic inflammatory disease
pclus 6 .1 - 18mn
selective immunoglobulin isotype deficiency
congenital combined immunodeficiency
congenital t - cell immunodeficiency
congenital disorder of natural immunity
leukocyte adhesion deficiency
bladder non - invasive papillary urothelial carcinoma ,  low grade
bladder non - invasive papillary urothelial carcinoma ,  high grade
urothelial hyperplasia
flat urothelial hyperplasia
papillary urothelial hyperplasia
bladder urothelial proliferation of uncertain malignant potential
bladder urothelial dysplasia
papillary urothelial neoplasm
bladder papillary urothelial neoplasm of low malignant potential
infiltrating bladder urothelial carcinoma
type 1 papillary renal cell carcinoma
type 2 papillary renal cell carcinoma
classic variant of chromophobe renal cell carcinoma
eosinophilic variant of chromophobe renal cell carcinoma
sporadic papillary renal cell carcinoma
renal cell carcinoma associated with xp11 .2 translocations / tfe3 gene fusions
unclassified renal cell carcinoma
sarcomatoid renal cell carcinoma
carotenosis cutis
multicentric reticulohistiocytosis
t - cell proliferation of uncertain malignant potential
recurrent ewing sarcoma / peripheral primitive neuroectodermal tumor
recurrent peripheral primitive neuroectodermal tumor
trichomonacide agent
pg13 / lnc8 retroviral transduced cloned t - cells
recurrent askin tumor
localized ewing sarcoma / peripheral primitive neuroectodermal tumor
localized askin tumor
localized peripheral primitive neuroectodermal tumor
retroperitoneal leiomyosarcoma
well differentiated prostate adenocarcinoma
moderately differentiated prostate adenocarcinoma
b - cell neoplasm
mature t - cell and nk - cell neoplasm
pngvl3 - hil12
mature b - cell neoplasm
chronic lymphocytic leukemia / small lymphocytic lymphoma
therapy - related myeloid neoplasm
alkylating agent - related acute myeloid leukemia and myelodysplastic syndrome
sporadic burkitt lymphoma
immunodeficiency - related burkitt lymphoma
poorly differentiated prostate adenocarcinoma
old burn scar - related skin squamous cell carcinoma
old burn scar - related cutaneous melanoma
pr18  ( ras - 13 cys )  peptide
solar radiation - related cutaneous melanoma
solar radiation - related skin squamous cell carcinoma
aflatoxins - related hepatocellular carcinoma
alcohol - related hepatocellular carcinoma
asbestos - related lung carcinoma
asbestos - related malignant mesothelioma
alcohol - related carcinoma
alcohol - related esophageal squamous cell carcinoma
alcohol - related laryngeal carcinoma
pr - 54  ( ras - 13 asp )  peptide
ionizing radiation - related malignant neoplasm
benzene - related acute myeloid leukemia
radiation - induced pneumonitis
thymic papillary adenocarcinoma
lobular neoplasia
pr - 5v10  ( ras - 12 val )  peptide
gastrointestinal autonomic nerve tumor
usual ductal breast hyperplasia
intraductal proliferative lesion of the breast
sclerosing breast papilloma
radiation anemia
tuberculous bronchopneumonia
metaplastic carcinoma
pr6v10  ( ras - 12 asp )  peptide
senile sebaceous hyperplasia
adolescent
drug toxicity
infant
pedigree
nasal
prostatic
pr7v10  ( ras - 12 ala )  peptide
personality traits
neurotoxicity syndrome
stage 0a
stage 0is
stage i
stage iia
stage iib
stage iic
proteinase 3:pr1 peptide
stage iii
stage iv
stage v
stage ia
stage ib
stage iiia
stage iiib
stage iva
psa:154 - 163 peptide
stage ivb
stage ic
stage iiic
stage ia1
stage ia2
ultraviolet a radiation
ultraviolet b radiation
cytotoxicity
oncolytic newcastle disease virus strain pv701
toxicity
disease qualifier
general qualifier
cardiotoxicity
myocardial infarction
antitubercular agent
pax3 / fkhr
autologous
ultrasound therapy
postoperative
median
hydration
pyroxamide
biliary
karnofsky performance status
gynecologic
inherited
ras peptide asp
problem
dilate
epigastric
ras peptide cys
mutate
ras peptide val
investigational
proliferative index
recombinant fowlpox - mgp100 vaccine
stage 0
stage ib1
stage ib2
stage ii
stage ivc
stage a
stage b
stage b1
stage b2
recombinant fowlpox - gp100p209
stage c
stage d
stage d1
stage d2
extensive stage
limited stage
stage unspecified
hepatoblastoma stage
postsurgical stage i
postsurgical stage ii
recombinant fowlpox - tyrosinase vaccine
postsurgical stage iii
postsurgical stage iv
pretext stage 1
pretext stage 2
pretext stage 3
pretext stage 4
disease grade qualifier
grade 1
grade 2
grade 3
recombinant human il - 4
grade 4
intermediate grade
gleason score for prostate cancer
gleason pattern 1
gleason pattern 2
gleason pattern 3
gleason pattern 4
gleason pattern 5
recombinant vaccinia - cea
gleason score 6
gleason score 7
gleason score 8
gleason score 9
gleason score 10
gleason score 2
gleason score 3
gleason score 4
gleason score 5
antiviral agent
sb - as02b adjuvant
gleason grading system
disease stage qualifier
verpasep caltespen
gene - modified
renal tubular acidosis
acrylonitrile
arsenic
asthenia
blood cell count
bromelains
oral candidiasis
tetanus toxoid aluminum phosphate adsorbed vaccine
chlorine
control group
dysgeusia
embryo
enema administration
fluoride ion
trp - 2: 180 - 188 peptide
freeze - drying
gluconeogenic process
glycolysis
glycosaminoglycan
hormone receptor
horner syndrome
trp1 ( 0rf3 ) :1 - 9 peptide
injection route of administration
intramuscular route of administration
inositol
klebsiella
laparoscope
linear accelerator
tumor cell vaccine plus bcg
nebulizer
parachloroamphetamine
parasite
paresthesia
phytosterol
tyrosinase:206 - 214 peptide
prescription
rabies
resting
tyrosinase:240 - 251 ( 244s )  peptide
social worker
syndrome
telangiectasia
thromboembolism
antianxiety agent
yttrium
arachidonic acid
tyrosinase:368 - 376 ( 370d )  peptide
sodium sulfite
mohs surgery
obtundation
unconjugated lymphoma ig id
photophobia
enclomiphene
barbiturate intoxication
transplanted pancreas complication
chorioallantoic membrane
unconjugated myeloma ig id
phlebotomy
disseminate
biological
bispecific monoclonal antibody
metabolic acidosis
ingestion
bias
single blind study
valacyclovir
foot fracture
vhl2  ( y12m )  peptide
effector immune cell
oncolysis
birt - hogg - dube syndrome
aspiration ,  ctcae
dysesthesia
dietitian
topoisomerase - ii inhibitor racemic xk469
millimeter
kilogram
milligram
milliliter
retroperitoneal
pathological staging
condom
telomerase inhibitor
phantom limb pain
mold
phytochemical
verapamil hydrochloride
molecular mass
skin patch dosage form
pathology report
topotecan hydrochloride
disease predictive factor
intoxication
stage is
insomnia
viscera
udp - glucuronosyltransferase 1 - 1
fluoxetine hydrochloride
squamous cell carcinoma in situ of the nipple
outpatient
nutrition
randomized
experimental
artificial sweetener
lontucirev
advanced adult hepatocellular carcinoma
whole cell vaccine
glucose
breast carcinoma metastatic in the skin
endothelin receptor antagonist
lhermitte's sign
normal renal arteriogram
aggravated acne
normal carotid arteriogram
normal cerebral arteriogram
normal coronary arteriogram
d - alpha - tocopherol
booster
zuclomiphene citrate
endocervical carcinoma
yttrium y90  ( or indium 111 )  labeled humanized monoclonal antibody bre - 3
l - selenomethionine
anti - idiotype specified monoclonal antibody
follicle centre lymphoma ,  follicular grade i ,  ii ,  iii stage iv
non - functioning pancreatic delta cell neuroendocrine tumor
endothelin receptor type a antagonist
breast prosthesis implantation
vitamin e acetate
alkalinization
allogeneic
alteration
vaccine antigen
chiasma
de novo
tropical disease
heterogeneity
irradiation
recombinant fowlpox - prostate specific antigen
neurotropism
proliferation
recombinant fowlpox - b7 .1
septate
sphincter
nci administrative concept
fowlpox vaccine
b - cell differentiation
10q23 .2 - q23 .33
topical anti - infective agent
computed tomography colonography
pancreatic delta cell neuroendocrine tumor
asthma
allied health profession
asbestos
recombinant vaccinia - b7 .1
casp10 gene
olfactory bulb
primitive streak
cysteine peptidase gene
ctsb gene
ctsd gene
national origin
quantitative reverse transcriptase pcr
chloroacetate esterase staining method
peripheral blood lymphocyte vaccine
aspartyl peptidase
wilson's staining method
synaptophysin and hematoxylin staining method
alpha naphthyl butyrate esterase staining method
alpha naphthyl acetate esterase staining method
somatostatin
somatoliberin
dna binding agent
pro - thyrotropin - releasing hormone
sex
inbred strain
casp9 gene
1p36 .3 - p36 .1
caspase - 9
retired concept
casp4 gene
camptothecin analogue
11q22 .2 - q22 .3
caspase - 4
nipple carcinoma
casp5 gene
caspase - 5
casp6 gene
caspase - 6
5p13 .2
casp7 gene
caspase - 7
actinomycin f1
small nuclear ribonucleoprotein particle
alpha naphthyl esterase staining method
epo gene
chromosomal nondisjunction
paracentric inversion
pericentric inversion
robertsonian translocation
meiotic nondisjunction
mitotic nondisjunction
linker dna
tetraploidy
csf1 gene
philadelphia chromosome
hnrna
ultrasonogram
oxygenase
glucosidase inhibitor
ctsl gene
9q21 - q22
ctsh gene
5p13 .1 - p12
gdnf gene
neurturin
macrophage migration inhibitory factor
c - x - c motif chemokine 9
f7 gene
mesothorium
f8 gene
inhibin alpha chain
inhibin beta a chain
inhibin beta b chain
insulin receptor substrate 1
insulin receptor substrate 2
insulin receptor substrate 4
polyvalent vaccine
coagulation factor gene
f9 gene
coagulation factor ix
vwf gene
12p13 .3
kallikrein - 15
cell movement
8q21 .12
7q31 .1 - q31 .2
integrin beta - 2
congenital abnormality
integrin beta - 4
cellular infiltration
tyrosine - protein kinase jak3
tyrosine - protein kinase jak1
tyrosine - protein kinase jak2
motivation
vascular endothelial growth factor receptor 2
biochemical process
beta - 1 , 3 - n - acetylglucosaminyltransferase manic fringe
ascorbic acid
achlorhydria
iodinated contrast agent
wobe - mugos e
bismuth bi213 monoclonal antibody m195
globo h - gm2 - lewis - y - muc1 - 32 - mer - tf ( c )  - tn ( c )  - klh conjugate vaccine
globo h - gm2 - lewis - y - muc1 - 32 - mer - tf ( c )  - tn ( c )  - klh conjugate vaccine / qs21
ion channel protein
nuclear translocation
transport reaction
interleukin - 12 subunit alpha
interleukin - 12 subunit beta
acquired immunodeficiency syndrome
fusion gene
nitric oxide synthetase
mitochondrial dna
heterodimerization
homodimerization
glutamic acid hydrochloride
sickle cell dactylitis
double stranded rna virus
foxo3 gene
adenocarcinoma
forkhead box protein o3
protein mrvi1
musculin
ahr gene
7p15
amfr gene
macrophage - stimulating protein receptor
16q21
muscle ,  skeletal receptor tyrosine - protein kinase
itgax gene
papillary adenocarcinoma
cdk5 gene
azu1 gene
cebpe gene
transport protein gene
bdnf gene
12p13 .1 - p12
app gene
21q21 .3
ar gene
warthin tumor
xq11 .2 - q12
plg gene
btc gene
tfap2b gene
6p21 - p12
alkyl - guanine transferase inhibitor
chromosome segregation
j5 antiserum
synchrovax sem plasmid dna vaccine
adenoma
recombinant adenovirus - hifn - beta
globo - h - gm2 - lewis - y - muc1 - 32 ( aa )  - stn ( c )  - tf ( c )  - tn ( c )  - klh conjugate vaccine
globo - h - gm2 - lewis - y - muc1 - 32 ( aa )  - stn ( c )  - tf ( c )  - tn ( c )  - klh conjugate vaccine / qs21
aryl hydrocarbon receptor nuclear translocator
dead
9q22 .31
max - interacting protein 1
m - phase promoting factor
high affinity nerve growth factor receptor
cdk1 gene
pituitary gland basophil adenoma
xq22 .2
protein bex3
14q13 .2
g2 to m transition process
neuromedin - b receptor
n - myc - interactor
protein fragment
ctla4 gene
2q34
myb gene
pituitary gland chromophobe adenoma
runx1t1 gene
nr3c1 gene
slc2a1 gene
eng gene
fn1 gene
gata1 gene
6p24 .1
edn1 gene
harvey murine sarcoma virus
ethylchlorformate vaccine
adrenal cortex neoplasm
agatolimod sodium
psicrip - mfg - s - tk1 - 67
h2ax gene
11q23 .2 - q23 .3
7p14 - p12
hla - a gene
transcription elongation
id2 gene
igfbp1 gene
igfbp2 gene
adrenal gland neoplasm
6q14 .3
4q31
il1a gene
il1b gene
cell maturation
il3 gene
il4 gene
kinase
il7 gene
il9 gene
asparaginase
adrenal rest tumor
il10 gene
il11 gene
il14 gene
ifng gene
il15 gene
il16 gene
15q26 .3
ldlr gene
il17a gene
il18 gene
side effect
klra1p gene
12p13 - p12
il19 gene
interleukin - 19
transcription process
transcription termination
e7 ( 86 - 93 )  lipopeptide
primary myelofibrosis
immunoglobulin family protein
mxd1 gene
max dimerization protein 1
pcna gene
mlana gene
granulocytopenia
9p24 .1
antitumor response
pura gene
ncor2 gene
12q24
zbtb16 gene
mki67 gene
10q25 - qter
sstr2 gene
sstr5 gene
aids dementia
ncor1 gene
hospice nursing
dna replication licensing factor mcm2
nid1 gene
1q43
nidogen - 1
rela gene
11q12 - q13
1q22 - q23
pou2f1 gene
alopecia
19q13 .31
pou2f2 gene
tradd gene
traf2 gene
retrograde pyelogram
plcg2 gene
pgr gene
prlr gene
telomeric repeat - binding factor 2
signal transducer and activator of transcription 1 - alpha / beta
alzheimer's disease
signal transducer and activator of transcription 2
thbs1 gene
15q15
thbs2 gene
signal transducer and activator of transcription 3
signal transducer and activator of transcription 4
placenta growth factor
stat5b gene
signal transducer and activator of transcription 5a
signal transducer and activator of transcription 5b
amnesia
signal transducer and activator of transcription 6
protein dbf4 homolog a
cdc7l1 kinase complex
cell division control protein 45 homolog
22q12 .1 - q13 .2
timp1 gene
therapeutic allogeneic lymphocytes
replication initiation
cell division cycle 7 - related protein kinase
timp2 gene
amyloidosis
timp3 gene
therapeutic autologous lymphocytes
aut - ov - alvac - hb7 .1 vaccine
cell cycle progression
dna replication licensing factor mcm3
pre - replication complex
mediator of rna polymerase ii transcription subunit 14
cofactor required for sp1 activation
mediator of rna polymerase ii transcription subunit 23
mediator of rna polymerase ii transcription subunit 17
anemia
mediator of rna polymerase ii transcription subunit 26
mediator of rna polymerase ii transcription subunit 27
mediator of rna polymerase ii transcription subunit 7
cryptic protein
lapachone
recombinant 70 - kd heat - shock protein
baculoviral iap repeat - containing protein 6
laniquidar
therapeutic tumor infiltrating lymphocytes
aspirin
aplastic anemia
5q23 - q32
tfiia - alpha and beta like factor
19q13 .13
activator of s phase kinase
9p12
transcription factor iiib 90 kda subunit
b - cell cll / lymphoma 7 protein family member a
b - cell cll / lymphoma 9 protein
orthologous gene
homologous gene
pernicious anemia
transcription factor iiib 50 kda subunit
transcription factor tfiiib component b'' homolog
xq26 - q28
general transcription factor 3b 90 - kd subunit
activin receptor type - 1b
aryl hydrocarbon receptor nuclear translocator 2
adhesion g protein - coupled receptor b2
adhesion g protein - coupled receptor b3
membrane - associated guanylate kinase ,  ww and pdz domain - containing protein 1
anti - human chorionic gonadotropin vaccine
refractory anemia
myc box - dependent - interacting protein 1
recombinant ksa glycoprotein co17 - 1a
mart - 1 antigen
recombinant tyrosinase - related protein - 1
c - c motif chemokine 13
c - c motif chemokine 14
c - c motif chemokine 3 - like 1
c - c motif chemokine 15
aneuploidy
c - c motif chemokine 17
c - c motif chemokine 7
c - c motif chemokine 18
c - c motif chemokine 19
c - c motif chemokine 20
c - c motif chemokine 22
c - c motif chemokine 24
c - c motif chemokine 25
c - c motif chemokine 23
c - c motif chemokine 26
angiokeratoma
c - c motif chemokine 27
ideal
body weight
punch biopsy
tracheobronchial
subsegmental lymph node
gadolinium - enhancing lesion
reader
c - x - c chemokine receptor type 6
spiculate
anorexia
cytochrome p450 2c9
phosphatidylcholine biosynthesis
mitotic sister chromatid cohesion
10p12 .1
innate bone remodeling
c - x - c motif chemokine 10
c - x - c motif chemokine 11
anoxia
anal neoplasm
stromal cell - derived factor 1
eso - 1  ( 161 - 180 )  peptide vaccine
 ( h115d ) vhl35 peptide
1 , 9 - nonanediol
anxiety disorder
117 - 126:fgf - 5 peptide
11d10 alugel anti - idiotype monoclonal antibody
27 - 35 ( 27l ) :mart - 1 peptide
3h1 aluminum hydroxide - precipitated anti - idiotype monoclonal antibody
8 - azaguanine
9 - ethyl 6 - mercaptopurine
neoplasm of the diffuse neuroendocrine system
9h - purine - 6thio - 98d
a and d ointment
alpha - thioguanine deoxyriboside
acronycine
ada transduced t cell
ametantrone acetate
azacitidine
ovarian sertoli - leydig cell tumor
amino - arginine
amygdalin
aphidicoline glycinate
azotomycin
abacavir sulfate
acebutolol hydrochloride
acetaminophen / codeine
acetaminophen / diphenhydramine
acetazolamide
arrhythmia
adefovir dipivoxil
allergy shot
aloe vera
alprostadil
aluminum magnesium
amantadine hydrochloride
amitriptyline hydrochloride
arteriovenous hemangioma / malformation
amlodipine besylate
ammonium lactate
amphetamine sulfate
ampicillin sodium / sulbactam sodium
amprenavir
anagrelide
anagrelide hydrochloride
anthralin
arthritis
petrolatum - mineral oil - lanolin - ceresin ointment
argatroban
astemizole
atazanavir sulfate
atenolol
atorvastatin calcium
atovaquone
atracurium besylate
rheumatoid arthritis
atropine
attapulgite
autologous epstein - barr virus - specific cytotoxic t lymphocytes
azithromycin
aztreonam
ascites
bactobolin
baculovirus cea protein vaccine
baculovirus - derived psa protein vaccine
breflate
bacitracin zinc
baclofen
barium sulfate
aspergillosis
bcl - xs adenovirus vaccine
belladonna / phenobarbital / ergotamine
benazepril hydrochloride
benzonatate
benztropine mesylate
penicillin g sodium
bethanechol chloride
sodium bicarbonate / aspirin / citric acid
bioactive enzymes - based mouthwash
biotope cd
ataxia telangiectasia syndrome
bisacodyl
bisoprolol fumarate
bisoprolol fumarate / hydrochlorothiazide
brimodine
bumetanide
bupivacaine hydrochloride
atelectasis
anti - tag - 72 monoclonal antibody scfv cc - 49 / 218
cesalin
fibronectin fragment ch296
chelate - monoclonal antibody b72 .3
chimeric antibody chcc49
chimeric monoclonal antibody b72 .3
clomesone
autoimmune disease
cyclophosphamide / mechlorethamine / prednisone / procarbazine / vincristine
monoclonal antibody col - 1
abatacept
cyclodisone
azaserine
bacterial infection
calcipotriene
calcium chloride
calcium polycarbophil
candesartan cilexetil
carisoprodol
carteolol hydrochloride
carvedilol
casanthranol
casanthranol / docusate
frangula purshiana bark
barrett esophagus
caspofungin
cefaclor
cefadroxil
cefazolin
cefdinir
cefoxitin sodium
cefpodoxime proxetil
cefprozil
cefuroxime axetil
cerivastatin sodium
nevoid basal cell carcinoma syndrome
cetirizine hydrochloride
chloral hydrate
benzocaine
chlorothiazide
chlorpheniramine maleate
chlorzoxazone
chlorzoxazone / acetaminophen
cholestyramine
psychiatric disorder
chromium picolinate
citalopram hydrobromide
clobetasol propionate
clonazepam
clozapine
colesevelam hydrochloride
colestipol hydrochloride
lamivudine / zidovudine
benign colon neoplasm
acetaminophen - based oral cough and cold preparation
cosyntropin
cranberry
cream dosage form
creatine monohydrate
cromolyn sodium
cyclobenzaprine
cyclopentolate hydrochloride
cyproheptadine hydrochloride
benign ovarian neoplasm
cytochlor
tetrandrine
dacplatinum
diacetylmorphine hydrochloride
dichloroallyl lawsone
benign skin neoplasm
anti - dopamine - b - hydroxylase monoclonal antibody - saporin
dacarbazine / mesna
deodorized tincture of opium
cisplatin / cyclophosphamide / dexamethasone / doxorubicin / etoposide / thalidomide
benign prostatic hyperplasia
dakins solution
danaparoid sodium
dayquil
delavirdine mesylate
demeclocycline hydrochloride
desipramine hydrochloride
bile duct neoplasm
devil's foot / jambul
dextroamphetamine
diazepam
dibucaine
diclofenac
dicloxacillin
dicyclomine hydrochloride
adapalene
biliary system disorder
digoxin
diluent for  ( 161 - 180 ) eso - 1 peptide
dimenhydrinate
dimetapp
diphencyprone
diphenoxylate hydrochloride
divalproex sodium
dobutamine hydrochloride
docusate calcium
azathioprine
bladder disorder
docusate sodium
domeboro solution
donnatal
dorzolamide hydrochloride
dorzolamide sodium
doxazosin mesylate
doxepin hydrochloride
doxycycline hyclate
doxycycline calcium
bladder neoplasm
doxycycline hydrochloride
doxycycline monohydrate
drop dosage form
chlorpheniramine / methscopolamine / phenylephrine tablet formulation
dyclonine
egfrviii peptide
emetine hydrochloride
emofolin sodium
coagulation disorder
equilin
homidium chloride
etiocholanolone
ews / fli 1 type 4
ews / fli 1 type 8
echinacea extract
efavirenz
entex
ergocalciferol
bloom syndrome
c - x - c motif chemokine 13
c - x - c motif chemokine 14
esomeprazole magnesium
ethambutol hydrochloride
ethinyl estradiol / levonorgestrel
ethinyl estradiol / norethindrone
etretinate
ex - lax
acetaminophen / aspirin / caffeine
simple bone cyst
fgf - 5:172 - 176  /  217 - 220 peptide
fluorodopan
fluorotestosterone
famciclovir
famotidine
felodipine
fenofibrate
ferrous gluconate
ferrous sulfate
bone marrow hyperplasia
fexofenadine hydrochloride
acetaminophen / butalbital / caffeine
sodium phosphate / sodium biphosphate laxative
fluocinolone
flunisolide
fluocinolone acetonide
fluocinonide
fluorometholone
skin squamous cell carcinoma in situ
flurazepam hydrochloride
fluticasone propionate
fluvastatin sodium
fluvoxamine maleate
frsh61  ( mea )  vhl33 peptide
gm - csf dna
gp100 vaccinia vaccine
garlic extract
brain neoplasm
gatifloxacin
gemfibrozil
ginkgo
glimepiride
glipizide
glucosamine sulfate
glyburide
glycerin
glycopyrrolate
glyoktyl
branchial cyst
macrogol 3350 - based iso - osmotic laxative
guaifenesin
guaifenesin / codeine
guaifenesin - dm
guaifenesin / pseudoephedrine
hiv peptide vaccine
hivgp160 vaccine
hpv 16 l1 - vlp
human moab lico 28a32
non - neoplastic breast disorder
hepatitis a vaccine
hepatitis b vaccine
hexylresorcinol
homatropine hydrobromide
hucc49deltach2 - pa - dota
hydrazine
hydrochlorothiazide
hydrocodone bitartrate
6 - azauridine
breast neoplasm
hydrocodone / acetaminophen
hydroxychloroquine sulfate
hydroxypropyl methylcellulose d
hydroxyzine
hyoscyamine
hypoxanthine
i131 - col1
iv fluid
bronchitis
id lymph vaccine test
id mm vaccine test
interleukin - 2 anti - idiotype vaccine
imexon
imipramine hydrochloride
immutol
indapamide
burkitt lymphoma
insulin ,  70 / 30
insulin ,  lente
insulin lispro
insulin ,  nph
insulin ,  regular
insulin ,  ultralente
iodinated i - 131 serum albumin
ipratropium bromide
ipratropium / albuterol
cachexia
irbesartan
isoproterenol hydrochloride
isosorbide dinitrate
k - ras asp - 12 mutant protein
k - ras asp - 13 mutant protein
k - ras gly - 12 mutant protein
k - ras val - 12 mutant protein
vulvovaginal candidiasis
kni - 272
kras cys - 12 mutant protein
ketamine hydrochloride
labetalol
lactase
lactulose
laetrile
carcinoid tumor
lansoprazole
latanoprost
levarterenol bitartrate
levobunolol hydrochloride
lidobenalox
linezolid
lisinopril
carcinoma
lodoxamide tromethamine
loratadine
loratadine / pseudoephedrine
losartan potassium
losartan / hydrochlorothiazide
lotion dosage form
amlodipine besylate / benazepril hydrochloride
skin care product
carcinoma in situ
vaginal lubricant
lysine
m a 131i osteogenic sarcoma
m a b72 .3  ( cel )
monoclonal antibody hb72 .3
monoclonal antibody b72 .3f ( ab )
monoclonal antibody hleu 2a
m a idiotypic determinants
melanoma monoclonal antibody higg2a
m a radiolabeled anti - brst cancer
female breast carcinoma
m a radiolabeled anti - carcinoma
m a radiolabeled t101 human t - lymp
m a t101 human t - lymphocyte
m a tac conjugated pseudomonas exo
mage - 1 vaccinia contaminated with bvdv
mage - 3 peptide  ( 9 - mer )
prostate adenocarcinoma
retroviral vector mfgs - mov18 - gamma
michellamine b
mitindomide
monoclonal antibody 1 .4
monoclonal antibody 1 .4 f ( ab )
monoclonal antibody 1f5
monoclonal antibody 48 .7
ethylenimine compound
malignant skin neoplasm
monoclonal antibody 48 .7 f ( ab )
monoclonal antibody 528
monoclonal antibody 8 .2
monoclonal antibody 8 .2 f ( ab )
monoclonal antibody 9 .2 .27 f ( ab )
monoclonal antibody 96 .5
monoclonal antibody 96 .5 f ( ab )
moab b - 3 - chx - a - dtpa
monoclonal antibody b6 .2 f ( ab' )
monoclonal antibody b6 .2f ( ab' ) 2
skin basal cell carcinoma
monoclonal antibody bl - 3
monoclonal antibody 2a11
moab bombesin  ( dtpa )
moab bombesin  ( itc - d )
monoclonal antibody cc - 83
monoclonal antibody cc - 92
monoclonal antibody cem - 231
monoclonal antibody col - 6
skin basosquamous cell carcinoma
monoclonal antibody 45 - 2d9
monoclonal antibody hd37 - smpt - dga immunotoxin
monoclonal antibody bl3 - gd idiotypic determinant
monoclonal antibody immu - 14
monoclonal antibody lym - 2
monoclonal antibody n901 - br
monoclonal antibody nr - co - 04
monoclonal antibody ovb3 - pe
monoclonal antibody rg 83852
minimally invasive lung adenocarcinoma
indium in 111 daclizumab
mov - gamma
msm / glucosamine
murine monoclonal antibody d612
magic mouthwash
magnesium
ductal breast carcinoma in situ
magnesium chloride
magnesium citrate
magnesium oxide
choline magnesium trisalicylate
meclizine hydrochloride
diatrizoate meglumine
mesalamine
psyllium husk
metformin hydrochloride
methocarbamol
methylcellulose
metoprolol succinate
metoprolol tartrate
micellar paclitaxel
miconazole nitrate
pyrilamine / caffeine / acetaminophen
pyrilamine / pamabrom / acetaminophen
lung non - small cell carcinoma
isometheptene / dichloralphenazone / acetaminophen
milk thistle
magnesium hydroxide
milrinone lactate
mineral oil
mirtazapine
moexipril hydrochloride
mometasone furoate
mouthwash dosage form
papillary carcinoma
multivitamins / minerals
mupirocin
mycophenolate
na17 peptide  ( amino acid sequence vlpdvfircv )
nevirapine
nandrolone
scirrhous adenocarcinoma
nadolol
nafcillin sodium
nefazodone hydrochloride
nelfinavir
neomycin / polymyxin b / bacitracin zinc
neomycin / polymyxin b / bacitracin zinc ophthalmic ointment
potassium phosphate / sodium phosphate
squamous cell carcinoma
nifedipine
nisoldipine
nitrofurantoin
nitroglycerin
nizatidine
nyquil
oatmeal powder
omalizumab
azlocillin
transitional cell carcinoma
opium tincture
ophthalmic solution
orlistat
ethinyl estradiol / norgestimate
oseltamivir phosphate
oxandrolone
oxaprozin
oxycodone
cardiovascular disorder
oxycodone / acetaminophen
oxymetazoline hydrochloride
oxymorphone
falimarev
inalimarev
carotid body paraganglioma
phetharbital
phosphate buffer
phosphoramide mustard
pnu - 214565
purified protein derivative
pr18  ( ras - 12cys )  peptide
6alpha - methyl - 11 - oxoprogesterone
prospidium chloride
prostvac - contaminated w /  bvdv
psa - op peptide vaccine
psa:154 - 163 ( 155l )  peptide vaccine
c - x - c motif chemokine 6
central nervous system disorder
psma peptide
talotrexin
pyran polymer
imidazole - pyrazole
pancrelipase
pantoprazole
pentamidine isethionate
cerebellar neoplasm
permethrin
perphenazine
petrolatum hydrophilic
phenazopyridine
pheniramine maleate
phenolphthalein
cerebral arteriovenous malformation
phentermine hydrochloride
phenylephrine / phenylpropanolamine / guaifenesin
phenylephrine hydrochloride
phenylpropanolamine
phytonadione
pimonidazole hydrochloride
pioglitazone hydrochloride
podofilox
citrate - containing alkalinizing agent
intraventricular brain neoplasm
potassium citrate
potassium phosphate
pramipexole dihydrochloride
pravastatin sodium
conjugated estrogen / medroxyprogesterone - containing formulation
anti - hemorrhoidal formulation
probenecid / colchicine
cerebrovascular disorder
hydrocortisone / pramoxine - containing preparation
propranolol hydrochloride
propantheline bromide
propofol
propoxyphene hydrochloride
propoxyphene napsylate
propoxyphene napsylate / acetaminophen
propylene glycol
prophyllin ccc
cervical polyp
pseudoephedrine hydrochloride
pyrazinamide
pyrazole compound
quinapril hydrochloride
quinine sulfate
cervical neoplasm
rasvac - c
rasvac - v
aziridinylbenzoquinone rh1
rifamycin
recombinant vaccinia - muc1 - b7 vaccine
chediak - higashi syndrome
rabeprazole
ramipril
ranitidine
mineral oil / petrolatum - containing eye ointment
polycarbophil / carbomer / glycerin / palm oil glyceride / mineral oil - containing vaginal moisturizer
murine mca ricin conjugate
risperidone
sangivamycin hydrochloride
sbil - 2
bile duct adenoma
shared anti - idiotype ab - s002
shared anti - idiotype - ab - s003
shared anti - idiotype - ab - s004
shared anti - idiotype - ab - s005
shared anti - idiotype - ab - s006
shared anti - idiotype - ab - s008a
shared anti - idiotype - ab - s011a
shared anti - idiotype - ab - s012
shared anti - idiotype - ab - s016
shared anti - idiotype - ab - s017
choledochal cyst
shared anti - idiotype - ab - s018
shared anti - idiotype - ab - s021a
shared anti - idiotype - ab - s024a
shared anti - idiotype - ab - s025
shared anti - idiotype - ab - s027
dna minor groove binding agent sg2000
cholesteatoma
stilbene aldehyde
salicylic acid / sulfur
artificial saliva
salmeterol
saquinavir
camphor / menthol - based formulation
scopolamine hydrobromide
senna fruit
sennosides
senokot
chondroblastoma
docusate sodium - senna
sertraline hydrochloride
simethicone
simvastatin
sinucleanse kit
sodium bicarbonate
sodium phosphate
chondrosarcoma
sodium polystyrene sulfonate
sorbitol
sotalol hydrochloride
sulfacetamide sodium
sulfadiazine
sulfasalazine
chordoma
sumatriptan succinate
transferrin receptor - targeted liposomal p53 cdna
3' - c - ethynylcytidine
tbc - cea - contaminated w /  bvdv
tumor infiltrating lymphocytes - n2 - transduced
tnf gene transduced til
choriocarcinoma
monoclonal antibody t101 f ( ab ) 2
tnf transduced til
tgfa - pe38 immunotoxin
total parenteral nutrition
trimelamol
tamsulosin hydrochloride
tazarotene
temazepam
tenecteplase
choroid neoplasm
tenofovir
terazosin hydrochloride
terbinafine hydrochloride
terconazole
terfenadine
theraflu
thiethylperazine maleate
thioridazine hydrochloride
thrombin alfa
bacitracin
cytogenetic abnormality
tioconazole
timolol maleate
tolazamide
tolmetin
tolterodine tartrate
topical corticosteroid
torsemide
tramadol
tramadol hydrochloride
cirrhosis
trazodone
trigem
dextromethorphan / phenylephrine - containing syrup
triaminic allergy congestion
triaminic cold
brompheniramine / phenylephrine - containing syrup
dextromethorphan - containing syrup
diphenhydramine / phenylephrine - containing syrup
triaminic syrup
triamterene
ulcerative colitis
triazolam
trimethobenzamide hydrochloride
triptorelin pamoate
witch hazel - containing anti - hemorroidal formulation
acetaminophen / phenylephrine - containing formulation
uniroyal compound - 38
colon neoplasm
undecylenic acid
urea
atropine / hyoscyamine / methenamine / methylene blue / phenyl salicylate / benzoic acid
valacyclovir hydrochloride
valproic acid
enalapril maleate / hydrochlorothiazide
colon polyp
venlafaxine hydrochloride
etoposide / prednisone / vinblastine
vortex mixer
warburg therapy
white petrolatum / minerals
wild type and mutant mgmt vector
zolimomab aritox
colorectal carcinoma
zaleplon
zinc undecylenate
zolpidem tartrate
gp - 120 antigen
gp100 protein  ( 184v )
gp100 peptide - sensitized autologous t - cells  ( cd4 +  and cd8 +  )
rf - muc1 ( df3 )  / tricom vaccine
rf - psa / psma / tricom
colorectal neoplasm
rilimogene glafolivec
rmva - psa / psma / tricom
recombinant vaccinia - psa / psma
recombinant vaccinia - trp1
recombinant vaccinia - psa ( l155 )  - tricom vaccine
recombinant vaccinia - gp100:209 - 217
dual specificity protein phosphatase 1
disks large homolog 1
disks large homolog 4
protein dr1
dr1 - associated corepressor
hla class ii histocompatibility antigen drb
nitric oxide synthase inhibitor
dna polymerase inhibitor
beta - adrenergic antagonist
carbonic anhydrase inhibitor
histamine - 1 receptor antagonist
r - spondin - 3
communication disorder
sid1 transmembrane family member 1
leucine - rich repeat transmembrane protein flrt3
fgfr1 oncogene partner
post - gpi attachment to proteins factor 2
proto - oncogene frat1 protein
tyrosine - protein kinase frk
fibroblast growth factor receptor substrate 2
fibroblast growth factor receptor substrate 3
phenylalanyl - trna ligase beta subunit
complication
tumor suppressor candidate 2
3 - ketodihydrosphingosine reductase
epidermal growth factor receptor kinase pathway substrate 8 - like protein 1
epidermal growth factor receptor kinase pathway substrate 8 - like protein 2
growth arrest - specific protein 2
essential amino acid
non - essential amino acid
histidine
isoleucine
leucine
condyloma
methionine
phenylalanine
threonine
tryptophan
valine
alanine
arginine hydrochloride
asparagine
aspartic acid
cysteine
conjunctival neoplasm
cystine
ornithine
proline
serine
epidermal growth factor receptor kinase pathway substrate 8 - like protein 3
fatty acid - binding protein ,  liver
fatty acid - binding protein ,  intestinal
fatty acid - binding protein ,  adipocyte
therapeutic androstanolone
dihydrotestosterone
seizure
geminin
cell surface a33 antigen
combination medication
cranial nerve neoplasm
cough and cold preparation
analgesic preparation
laxative preparation
antacid preparation
antirheumatic preparation
asthma preparation
antihypertensive preparation
anti - infective preparation
electrolyte replacement preparation
topical preparation
craniopharyngioma
oral contraceptive preparation
g - protein coupled receptor 39
sexual maturation
kiss - 1 receptor
ph homeostasis
mrna surveillance
rna proof - reading
non - stop decay
nonsense - mediated decay
crohn disease
body surface
signal repression
h19 imprinted maternal untranslated mrna
cryptococcosis
g protein - coupled receptor 39
g protein - coupled receptor 54
transcription initiation factor iia subunit 1
transcription initiation factor iia alpha chain
transcription initiation factor iia beta chain
transcription initiation factor iia subunit 2
transcription initiation factor iib
general transcription factor iie subunit 1
general transcription factor iif subunit 1
general transcription factor iif subunit 2
general transcription factor iih subunit 1
general transcription factor 3c polypeptide 1
general transcription factor 3c polypeptide 2
general transcription factor 3c polypeptide 3
general transcription factor 3c polypeptide 4
general transcription factor 3c polypeptide 5
transcription initiation factor iie subunit beta
protein gr6
gr6 protein
protein jtb
cushing syndrome
oligonucleotide linker
skin test vaccine
inactivated vaccine
yttrium 90 monoclonal antibody t101
muscle relaxant
laxative
antispasmodic agent
batrachotoxin
adenoid cystic carcinoma
astringent
anti - ulcer agent
histamine - 2 receptor antagonist
antilipidemic agent
antimuscarinic agent
anti - glaucoma agent
vasodilating agent
anti - psoriatic agent
alpha - adrenergic agonist
cystadenocarcinoma
antipsychotic agent
anti - diabetic agent
anti - asthmatic agent
alpha - adrenergic antagonist
gastrointestinal lipase inhibitor
dna compaction peptide
tobacco smoking history
cystadenoma
monoclonal antibody to colorectal cancer
proton pump inhibitor
enzyme replacement or supplement agent
pediculicide
anorexiant
alkalinizing agent preparation
mucinous cystadenoma
electrolyte replacement agent
hormone replacement preparation
anti - gout preparation
hemorrhoidal preparation
stress - induced protein
11q23 .1 - q23 .3
antiflatulent agent
sulfonamide anti - infective agent
papillary cystadenoma
interleukin - 17c
formaldehyde
metastin
adrenergic agent
interleukin - 1 receptor - associated kinase 1
interleukin - 1 receptor - associated kinase - like 2
cystic fibrosis
thrombolytic agent
interleukin - 1 receptor - associated kinase 3
interleukin - 1 receptor - associated kinase 4
tyrosine - protein kinase itk / tsk
inositol 1 , 4 , 5 - trisphosphate receptor type 1
sedative and hypnotic
dna repair and recombination protein rad54b
ras - related gtp - binding protein a
mapk / mak / mrk overlapping kinase
cystinosis
retinoic acid - induced protein 3
ral guanine nucleotide dissociation stimulator
ran gtpase - activating protein 1
ras - related protein rap - 1a
retinoic acid receptor beta
phospholipase a and acyltransferase 4
dexamethasone - induced ras - related protein 1
expectorant
1 - aminobenzo [ a ] pyrene
estradiol benzoate
phyllodes tumor
estradiol dipropionate
horse anti - mouse anti - lymphocyte serum
serum ,  horse
pregnant mare serum gonadotropin
plutonium - 239
radium - 224
strontium sr - 90
uranium ore dust
1 - nitrobenzo [ a ] pyrene
cyst
1 - nitropyrene
19 - norprogesterone
androsterone
bovine pituitary extract
1 , 2 - dimethylhydrazine
1 , 2 - dimethylhydrazine dihydrochloride
cytopenia
1 , 3 - butadiene
2 - acetylaminofluorene
2 - amino - 1 - methyl - 6 - phenylimidazo [ 4 , 5 - b ] pyridine
2 - amino - 3 , 4 - dimethylimidazole [ 4 , 5 - f ] quinoline
2 - fluoroadenine
20 - methylcholanthrene
2 , 6 - diaminopurine
3 - aminobenzo [ a ] pyrene
3 - nitrobenzo [ a ] pyrene
bcg vaccine
dysphagia
3 , 4 - benzpyrene
4 - methylnitrosamino - 1 , 3 - pyridyl - 1 - butanone
5 - methylchrysene
6 - nitrochrysene
acetone
benzo [ a ] pyrene trans - 7 , 8 - dihydrodiol
delirium
benzo [ b ] fluoranthene
benzotrichloride
beta - naphthoflavone
chlordane
chloroform
crocidolite asbestos
croton oil
cyclopenta [ cd ] pyrene
ether
ethyl methanesulfonate
ethylene oxide
hydroquinone
isoprene
n - amyl - n - methylnitrosoamine
n - butyl - n -  ( 4 - hydroxybutyl ) nitrosamine
n - nitrosodiethylamine
n - ethyl - n' - nitro - n - nitrosoguanidine
n - nitroso - n - methylurethane
dermatitis
putative hydrolase rbbp9
retinoblastoma - like protein 2
rna - binding protein 5
rna - binding protein 6
ring box protein 1
reticulocalbin - 2
dna topology regulation
zinc - finger protein rfp
e3 ubiquitin - protein ligase trim13
naphthalene
dermatosis papulosa nigra
nicardipine hydrochloride
nickel subsulfide
nimesulide
nitrogen dioxide
week
o - aminoazotoluene
month
cresidine
year
piperonyl butoxide
diabetes mellitus
pristane
off study
rebamipide
silicon dioxide
sulindac sulfide
theaflavin
thiouracil
translational regulation
triethylenemelamine
translational activation
type 1 diabetes mellitus
translational repression
process
triphenylethylene
vinyl carbamate
zinc chloride
pirinixic acid
participant
rhodopsin kinase
sn - 1 , 2 - didecanoylglycerol
diarrhea
pdz and lim domain protein 4
black tea
receptor - interacting serine / threonine - protein kinase 2
receptor - interacting serine / threonine - protein kinase 3
ring finger protein 11
rna ,  ribosomal 1
ribonuclease 3
rho - associated protein kinase 1
family cancer history
tyrosine - protein kinase transmembrane receptor ror1
tyrosine - protein kinase transmembrane receptor ror2
nuclear receptor ror - alpha
60s ribosomal protein l10
arsanilic acid
vaccinia virus study
cholesterol homeostasis
airborne particulate matter
californium - 252 fission neutron radiation
mumps
regressing friend leukemia virus
22q11 .2 deletion syndrome
gastrectomy with esophagojejunostomy
muscle relaxant preparation
unilateral oophorectomy
incomplete oophorectomy
thymectomy
inhibition of cancer cell growth
stimulation of cancer cell growth
ovarian implantation
pituitary isograft
male gonadal ridge implantation
beclomethasone dipropionate
digestive system disorder
moloney murine leukemia virus tb
nodule - inducing virus
60s ribosomal protein l7a
40s ribosomal protein s19
40s ribosomal protein s27
40s ribosomal protein s3
murine retrovirus containing human pdgfb cdna
rcas - akt
ribosomal protein s6 kinase alpha - 5
disease or disorder
rcas - ras
ribosomal protein s6 kinase beta - 2
ras - related protein r - ras2
ras - like protein family member 10a
r7 virus
ras suppressor protein 1
graffi murine leukemia virus
gross leukemia virus
inactivated vaccinia virus
lim domain - containing protein 1
disseminated intravascular coagulation
tyrosine - protein kinase ryk
receptor serine / threonine kinase
lim domain kinase 1
lim and senescent cell antigen - like - containing domain protein 1
s100 calcium binding protein
protein s100 - a11
protein s100 - a12
protein s100 - a8
protein s100 - a9
protein s100 - p
down syndrome
src kinase - associated phosphoprotein 2
secretin receptor
secreted and transmembrane protein 1
ethnicity
magnetic resonance spectroscopic imaging
semaphorin - 3e
proteinase inhibitor gene
serpin i2
enzyme inhibitor gene
protein set
dumping syndrome
histone - lysine n - methyltransferase setdb1
secreted frizzled - related protein 4
sh2b adapter protein 1
sh2 domain - containing protein 3a
sh2 domain - containing protein 3c
recombinant vaccinia - prostate specific antigen
shc - transforming protein 1
recombinant vaccinia - tyrosinase
actg2 gene
col1a1 gene
duodenal neoplasm
col1a2 gene
dhps gene
eif4e2 gene
hla - dpb1 gene
hnrnpab gene
lmnb1 gene
mt3 gene
myh11 gene
mylk gene
nr4a1 gene
dysgerminoma
snrpf gene
shc - transforming protein 3
sonic hedgehog protein
12q23 .1
17q21 .3 - q22 .1
19p13 .2 - p13 .1
5q35 .3
5q23 .3 - q31 .1
16p13 .13 - p13 .12
signal - regulatory protein beta - 1
dyspareunia
ski - like protein
helicase ski2w
s - phase kinase - associated protein 2
puva photochemotherapy
sodium chloride
recombinant fowlpox - gm - csf
recombinant vaccinia - gm - csf
chloride anion exchanger
shc - transforming protein 2
antileukoproteinase
dyspnea
smoothened homolog
ibritumomab tiuxetan
alvac - cea  ( 6d )  - b7 .1 vaccine
anti - muc - 1 monoclonal antibody
interleukin - 1 - beta new formulation
interleukin - 2 jurkat derived
lidocaine oral solution
lidocaine patch
lidocaine topical
dysuria
monoclonal antibody cc - 46
serine / threonine - protein kinase plk2
e3 isg15 - protein ligase herc5
snw domain - containing protein 1
signal recognition particle 19kda protein
sushi repeat - containing protein srpx2
abl interactor 1
sarcospan
hsc70 - interacting protein
diphenhydramine hydrochloride
ear neoplasm
ctp - 37 - dt vaccine
rap guanine nucleotide exchange factor - like 1
von willebrand factor a domain - containing protein 5a
suppressor of tumorigenicity 7 protein
stanniocalcin - 1
stanniocalcin - 2
aurora kinase a
eukaryotic translation initiation factor 1
eczema
us state
actin ,  gamma - enteric smooth muscle
cell mobility
collagen alpha - 1 ( i )  chain
gas chromatography
collagen alpha - 2 ( i )  chain
deoxyhypusine synthase
amino acid biosynthesis
edema
eukaryotic translation initiation factor 4e type 2
translation process
translation initiation
hla class ii histocompatibility antigen ,  dp ( w4 )  beta chain
heterogeneous nuclear ribonucleoprotein a / b
mediator of rna polymerase ii transcription subunit 24
transforming acidic coiled - coil - containing protein 3
effusion
elliptocytosis
tumor embolism
neuromedin - k receptor
transcription initiation factor tfiid subunit 10
transcription initiation factor tfiid subunit 11
experimental allergic encephalomyelitis
transcription initiation factor tfiid subunit 12 isoform tafii20
transcription initiation factor tfiid subunit 12 isoform tafii15
transcription initiation factor tfiid subunit 13
transcription initiation factor tfiid subunit 2
transcription initiation factor tfiid subunit 3
transcription initiation factor tfiid subunit 4
transcription initiation factor tfiid subunit 5
transcription initiation factor tfiid subunit 6
transcription initiation factor tfiid subunit 7
transcription initiation factor tfiid subunit 7 - like
enchondroma
transcription initiation factor tfiid subunit 8
transcription initiation factor tfiid subunit 9
t - cell acute lymphocytic leukemia protein 2
intermediate filament gene
lamin - b1
metallothionein - 3
ww domain - containing transcription regulator protein 1
serine / threonine - protein kinase tbk1
tata box - binding protein - like protein 1
transcription factor e2 - alpha
enchondromatosis
transcription factor 7 - like 2
t - cell leukemia / lymphoma protein 1b
t - cell leukemia translocation - altered gene protein
tyrosine - protein kinase tec
myosin - 11
muscle contraction
myosin light chain kinase ,  smooth muscle
nuclear receptor subfamily 4 group a member 1
endocrine system disorder
snrnp structural core protein
small nuclear ribonucleoprotein f
snrnp biogenesis
transcription factor dp - 2
transcription factor e3
cardiac muscle contraction
basal transcription factor gene
protein lyl - 1
tgf - beta receptor type - 1
transforming growth factor beta receptor type 3
bence jones protein
endocrine neoplasm
tyrosine - protein kinase receptor tie - 1
toll - like receptor 1
toll - like receptor 2
stable
toll - like receptor 3
toll - like receptor 4
toll - like receptor 5
toll - like receptor 6
toll - like receptor 7
toll - like receptor 8
yolk sac tumor
transmembrane protease serine 2
tumor necrosis factor receptor superfamily member 11b
tumor necrosis factor receptor superfamily member 6b
tumor necrosis factor ligand superfamily member 11
non - receptor tyrosine - protein kinase tnk1
toll - interacting protein
tumor protein d52
tumor protein d53
phosphoprotein associated with glycosphingolipid - enriched microdomains
serine / threonine - protein kinase pak 6
endometrial neoplasm
prkc apoptosis wt1 regulator protein
smooth endoplasmic reticulum
partitioning defective 6 homolog alpha
paired box protein pax - 3
paired box protein pax - 5
tnf receptor - associated factor 6
chondrosarcoma - associated gene 2 / 3a protein
e3 ubiquitin - protein ligase rnf139
t - cell receptor - associated transmembrane adapter 1
triple functional domain protein
endometrial hyperplasia
cdc42 - interacting protein 4
transient receptor potential cation channel subfamily m member 5
transformation / transcription domain - associated protein
thyrotropin receptor
testis - specific serine kinase substrate
thymic stromal lymphopoietin
interferon alfa - n3
paired box protein pax - 7
nicotinamide phosphoribosyltransferase
pre - b - cell leukemia transcription factor 3
endometriosis
extremities
constitutional finding
transfusion history
lerisetron
testis - specific y - encoded protein 1
tetratricopeptide repeat protein 4
dual specificity protein kinase ttk
tyrosine - protein kinase receptor tyro3
tyro protein tyrosine kinase binding protein
eosinophilia
ubiquitin - conjugating enzyme e2 d2
protein unc - 13 homolog b
ddb1 -  and cul4  - associated factor 5
cytokine scm - 1 beta
gh1 gene
17q24 .2
ada gene
1p36 .23 - p35 .1
20q12 - q13 .11
activated rna polymerase ii transcriptional coactivator p15
eosinophilic granuloma
cyclin - dependent kinase 16
phosducin
platelet - derived growth factor subunit a
platelet - derived growth factor receptor alpha
platelet - derived growth factor receptor beta
platelet - derived growth factor receptor - like protein
3 - phosphoinositide - dependent protein kinase 1
e3 sumo - protein ligase pias3
phosphatidylinositol 4 , 5 - bisphosphate 3 - kinase catalytic subunit alpha isoform
ependymoma
phosphatidylinositol 4 , 5 - bisphosphate 3 - kinase catalytic subunit beta isoform
phosphatidylinositol 4 , 5 - bisphosphate 3 - kinase catalytic subunit gamma isoform
phosphatidylinositol 3 - kinase regulatory subunit gamma
phosphatidylinositol 4 - kinase beta
protein evi2b
histone - lysine n - methyltransferase ezh2
fatty acid - binding protein ,  epidermal
sebaceous cyst
epidural spinal canal neoplasm
benzene
seizure disorder
generalized epilepsy
grand mal epilepsy
petit mal epilepsy
erythema multiforme
erythroplakia
esophageal disorder
esophageal neoplasm
exostosis
betamethasone
eye neoplasm
eyelid neoplasm
fallopian tube neoplasm
fanconi syndrome
fanconi's anemia
fatigue
chronic fatigue syndrome
fever
breast fibrocystic change
bile pigment
fibrodysplasia ossificans progressiva
fibroma
fibromatosis
fibrosarcoma
fibrosis
fistula
fracture
pathologic fracture
gallbladder neoplasm
ganglioneuroma
bilirubin
gastrin - producing neuroendocrine tumor
digestive system neoplasm
female reproductive system neoplasm
male reproductive system neoplasm
giant cell tumor
castleman disease
gingival neoplasm
glioblastoma
glioma
bioflavonoid
glomus tumor
jugulotympanic paraganglioma
pancreatic glucagon - producing neuroendocrine tumor
graft versus host disease
granuloma
granuloma inguinale
foreign body granuloma
giant cell granuloma
laryngeal granuloma
plasma cell granuloma
biological agent
granulosa cell tumor
graves disease
ovarian gynandroblastoma
gynecomastia
hairy nevus
hamartoma
cowden syndrome
head and neck neoplasm
hearing disorder
heart disorder
immunotherapeutic agent
congestive heart failure
heart neoplasm
heavy chain disease
gamma heavy chain disease
hemangioendothelioma
hemangioma
cavernous hemangioma
hemangiopericytoma
angiosarcoma
biotin
hematuria
hemoglobinopathy
hemophilia
hemoptysis
hepatitis
hepatitis a infection
hepatitis b infection
hepatitis c infection
hepatocellular carcinoma
dicumarol
hepatomegaly
genetic disorder
von hippel - lindau syndrome
histiocytosis
langerhans cell histiocytosis
hiv infection
hot flashes
bleomycin a2
hydatidiform mole
hydrocephalus
hypercalcemia
hyperplasia
hypersensitivity
type iv hypersensitivity
type i hypersensitivity
hypertension
malignant hypertension
portal hypertension
bleomycin sulfate
pulmonary hypertension
renal hypertension
hypertensive crisis
hyperthyroidism
hypertrophy
breast hypertrophy
hypoglycemia
hypopharyngeal neoplasm
hypotension
hypothalamic neoplasm
bleomycin
ileal neoplasm
immunodeficiency syndrome
alpha heavy chain disease
impotence
epidermal inclusion cyst
inflammation
inflammatory bowel disease
infratentorial neoplasm
blood substitute
pancreatic insulin - producing neuroendocrine tumor
intestinal neoplasm
iris neoplasm
jaundice
hyperimmunoglobulin e syndrome
keloid
keratoacanthoma
tylosis
actinic keratosis
kidney disorder
kidney neoplasm
penile leukoplakia
vulval leukoplakia
krukenberg tumor
lactose intolerance
lambert eaton myasthenic syndrome
laryngeal neoplasm
leiomyoma
leiomyosarcoma
lentigo
bradykinin
letterer - siwe disease
leukemia
chronic lymphocytic leukemia
acute basophilic leukemia
calla positive lymphoblastic leukemia
acute lymphoblastic leukemia
childhood acute lymphoblastic leukemia
mast cell leukemia
bromocriptine mesylate
acute megakaryoblastic leukemia
acute myeloid leukemia
myeloid leukemia
accelerated phase chronic myelogenous leukemia ,  bcr - abl1 positive
chronic myelogenous leukemia ,  bcr - abl1 positive
chronic phase chronic myelogenous leukemia ,  bcr - abl1 positive
philadelphia - negative myelogenous leukemia
chronic myelomonocytic leukemia
chronic neutrophilic leukemia
broxuridine
plasma cell leukemia
prolymphocytic leukemia
acute promyelocytic leukemia with pml - rara
t acute lymphoblastic leukemia
adult t - cell leukemia / lymphoma
leukemoid reaction
leukoplakia
oral leukoplakia
leydig cell tumor
lichen planus
linitis plastica
lip neoplasm
lipoma
lipomatosis
liposarcoma
liver and intrahepatic bile duct disorder
breast lump
lung disorder
chronic obstructive pulmonary disease
buserelin
lung neoplasm
systemic lupus erythematosus
ovarian stromal luteoma
acquired progressive lymphangioma
abdominal aorta
abdominal aorta branch
lymphangioleiomyoma
abdominal muscle
accessory nerve
acetabulum
achilles tendon
acidophilic cell
acinar salivary gland system
thoracoacromial artery
acromioclavicular joint
acromion
activated lymphocyte
lymphangiosarcoma
adrenal gland capsule
adrenal gland tissue
alpha cell
alveolar cell
alveolar cell type i
alveolar cell type ii
alveolar duct
alveolar sac
alveus
ambient cistern
lymphadenopathy
a - microtubule
amphiarthrosis
ampullary crest
ampullary segment of the fallopian tube
anal column
anal gland
anal region
lymphedema
anal sinus
anal squamous zone
anal transitional zone
anastomotica magna artery
angular artery
angular gyrus
ankle joint
anterior annular ligament
lymphoma
anterior carpal artery
anterior caudate vein
anterior cerebral artery branch
anterior choroidal artery
intracranial anterior circulation
anterior circumflex artery
anterior commissure
anterior communicating artery
anterior cruciate ligament
anterior descending coronary artery
follicular lymphoma
anterior cranial fossa
anterior inferior cerebellar artery
anterior inferior frontal convolution
anterior infratentorial cistern
anterior jugular vein
anterior longitudinal ligament
anterior median fissure of the spinal cord
anterior mediastinal lymph node
anterior mediastinum
anterior meningeal artery
busulfan
mixed cell lymphoma
anterior olfactory lobule
anterior parietal artery
anterior part of the calcarine fissure
anterior pole of the lens
anterior portion of the corpus callosum cistern
anterior quadrigeminal body
anterior supratentorial cistern
anterior surface of the kidney
anterior surface of the lens
anterior surface of the liver
non - hodgkin lymphoma
anterior surface of the stomach
anterior surface of the vagina
anterior temporal artery
anterior tibial artery branch
anterior tibial vein
anterior ulnar vein
anterior wall of the tympanum
antero - lateral ascending tract
antero - lateral column
lymphoplasmacytic lymphoma
antihelix
antitragus
aortic arch
aortic arch branch
aortic opening
apex of the heart
apex of the lung
apex of the pericardium
maffucci syndrome
apex of the tongue
apical domain of the epithelium
apocrine sweat gland
aponeurosis
aqueduct of sylvius
arachnoid membrane
arachnoid villus
arch of the vertebra
area of broca
malabsorption syndrome
argentaffin cell
arm
arteriovenous shunt
articular bone surface
articular cartilage
articular muscle
aryepiglottic muscle
aryepiglottic fold
arytenoid cartilage
arytenoid muscle
carcinoid syndrome
ascending aorta
ascending aorta branch
ascending frontal artery
ascending frontal convolution
ascending limb of henle's loop
ascending parietal convolution
atlanto - axial joint
atlanto - occipital joint
malignant retinal neoplasm
atrioventricular bundle
atrioventricular node
atrium of the middle ear
attachment plaque
auditory ossicle
auricle
autophagolysosome
autophagosome
autosome
axillary artery
benign mastocytoma
axillary artery branch
axillary vein
axial skeleton
axis of the centriole
axoaxonic synapse
axodendritic synapse
axon
axosomatic synapse
azurophilic granule
diffuse cutaneous mastocytosis
azygos articular artery
balbiani body
barr body
basal body
basal cerebral vein of rosenthal
basal domain of the epithelium
basal lamina
basal lamina collagen
basal lamina of the vascular endothelium
basal layer of the endometrium
maxillary sinus neoplasm
basaloid cell
base of the brain
base of the lung
base of the pericardium
basilar artery branch
basilar membrane of the membranous canal of the cochlea
basilic vein
basophilic cell
beta cell
butylated hydroxytoluene
mediastinal cyst
biceps
bicuspid tooth
bile canaliculus
bile salt
birbeck granule
bladder mucosa
bladder muscularis mucosa
bladder tissue
mediastinal neoplasm
bladder urothelial cell
bladder urothelium
blood capillary
blood vessel tissue
b - microtubule
body of the corpus callosum
body of the epididymis
body of the lateral ventricle
body of the nail
medulloblastoma
body of the spermatozoon
body part
bone of the extremity
bone surface
bowman capsule
bowman's membrane
brachial artery branch
brain infundibulum
meigs syndrome
bronchial artery
bronchial epithelium
bronchial lymph node
bronchial tree
bronchus - associated lymphoid tissue
brown adipose tissue
brush cell
buccal salivary gland
c1 vertebra
melanoma
c2 vertebra
c3 vertebra
c4 vertebra
c5 vertebra
c6 vertebra
c7 vertebra
ca1 field of the cornu ammonis
ca2 field of the cornu ammonis
ca3 field of the cornu ammonis
ca4 field of the cornu ammonis
multiple endocrine neoplasia type 1
calcaneum
calcarine artery
calcarine sulcus
callosomarginal artery
canal for tensor tympani
canal of hering
canal of schlemm
canalis radicis dentis
canine tooth
capsular ligament
multiple endocrine neoplasia type 2a
cardia gland
cardia orifice
carotid cistern
carpal joint
carpometacarpal joint
cartilaginous tissue
cavum conchae
multiple endocrine neoplasia type 2b
cell of the epidermis
focal adhesion
cementoblast
cementocyte
cementum
central artery
central lobe
menarche
fissure of rolando
central vein
central zone of the prostatic parenchyma
centriole
centromedian nucleus of the thalamus
centrosome
cephalic vein
cerebral fissure
cerebral fornix
meningeal neoplasm
cerebral gyrus
cerebral peduncle
cerebral sulcus
cerumen
ceruminous gland
cervical curve
cervical gland
cervical gland secretion
cervical lymph node
cervical nerve
butyrophenone
meningioma
chamber of the eye
chemical synapse
chemical synapse component
chiasmatic cistern
chief cell of the stomach
chondroblast
chordae tendineae
choroid plexus of the fourth ventricle
choroid plexus of the lateral ventricle
menopause
choroidal artery
choroidal fissure
chromophobe cell
ciliary muscle
ciliary process
ciliated bronchial epithelial cell
cilium
cilium microtubule
menstruation
circular ligament of the tooth
circular sulcus
circumvallate papilla
cis - golgi network
cisterna magna
cisterna of the endosome
cisterna of the golgi apparatus
cisterna of the rough endoplasmic reticulum
claustrum
mesenchymoma
c - microtubule
coated vesicle
coccygeal muscle
coccygeal nerve
coccygeal vertebra
cochlear duct
cochlear labyrinth
collagen fiber
collagen fibril
mesothelioma
collateral fissure
collateral gyrus
collecting cell
collecting tube
colloid
collum dentis
colorectal zone of the anal canal
human colostrum
commissure
metabolic disorder
common bony limb
common canaliculus
common carotid artery
common carotid artery branch
common femoral artery
common femoral artery branch
common hepatic duct
common iliac artery
common iliac artery branch
common iliac vein
metaplasia
common thymocyte
common ulnar vein
concha
condensed configuration of the mitochondrion
connecting segment of the photoreceptor cell
connective tissue fiber
squamous metaplasia
continuous capillary
corneoscleral coat
corniculate cartilage
cornu ammonis
crown
coronary ligament
coronary sinus
coronary valve
milium cyst
corpora albicantia
corpora cavernosa
corpus callosum cistern
corpus spongiosum
cortical arch
cortical column
cortical nephron
cortical vein
monosomy
costal cartilage
costochondral joint
costophrenic angle
costovertebral joint
cowper gland
cremaster muscle
cricoarytenoid joint
cricoarytenoid muscle
cricoesophageal tendon
cdna
oral disorder
cricoid cartilage
cricopharyngeus muscle
cricothyroid joint
cricothyroid ligament
cricothyroid muscle
cricotracheal ligament
crossed pyramidal tract
crosslinker
crural cistern
crus cerebri
mucocele of the appendix
crus helicis
crypt of lieberkuhn
crystal of reinke
crystalline inclusion
cuboid bone
cuneiform bone of the foot
cuneiform cartilage
curved tube
plasma cell myeloma
cymba conchae
cystic duct
cystic vein
cytoplasmic inclusion
cytoplasmic matrix
decidua
decidua basalis
decidua capsularis
decidua parietalis
decidual cell
multiple sclerosis
deep abdominal muscle
deep cervical lymph node
deep circumflex iliac artery
deep inferior epigastric artery
inferior epigastric vein
deep femoral artery
deep femoral artery branch
deep intracranial venous system
deep lymphatic vessel
musculoskeletal pain
deep middle cerebral vein
deep palmar artery
deep palmar vein
deep vein
deltoid
dendrite
dendrodendritic synapse
fungal infection
dense connective tissue
dental pulp
dentate gyrus
dentin
descemet's membrane
descending aorta
descending limb of henle's loop
diagonal branch of the anterior descending artery
diaphragma sellae
mycosis fungoides
diaphysis of the bone
diarthrosis
digastric muscle
dilator pupillae muscle
dimeric tubulin molecule
direct cerebellar tract
direct pyramidal tract
discontinuous capillary
distal connecting fiber
distal convoluted tubule
myelodysplastic syndrome
distal part of the lumen of the centriole
dorsal cochlear nucleus
dorsal curve
dorsal horn of the spinal cord
dorsal muscle of the back
dorsal nucleus of the vagus nerve
dorsal region of foot
dorsal root of the spinal nerve
dorsalis pedis artery
dorsalis pedis artery branch
myelofibrosis
dorsomedial nucleus of the thalamus
dorsum
dorsum of the tongue
duct of the epididymis
duct of gartner
duct salivary gland system
ductus santorini
dura mater
early endosome
acute myeloid leukemia without maturation
eccrine sweat gland
ectocervical os
efferent duct
ejaculatory duct
elastic fiber
elbow joint
electrical synapse
electron - dense plasma membrane layer
ca - 125 antigen
acute myeloid leukemia with maturation
electron - lucent plasma membrane layer
electron - transport chain of the respiratory enzymes
f1 particle
ellipsoid portion of the inner segment of the photoreceptor cell
embryonic connective tissue
enamel
endocrine ovary
endocrine pancreas
endocrine sex organ
endocrine testis
endocytotic vesicle
endolymph
endometrial cavity
endometrial glandular cell
endometrial stroma
endosome
benign granular cell tumor
endosome proton pump
endosteal cell
eparterial branch of the right main bronchus
epidermal ridge
epigastric region
epiglottic cartilage
epiphysis of the bone
myositis ossificans
epithelial cell junction
epithelial microvillus
epithelial plica
epitympanic recess
erector muscle of the hair
esophageal artery
esophageal gland
esophageal glandular cell
esophageal mucosa
angiomyxoma
esophageal muscularis mucosa
esophageal opening
esophageal squamous cell
esophageal tissue
eustachian valve
excitatory synapse
exocrine pancreas
external abdominal ring
external anal sphincter
external canal
myxosarcoma
external capsule
external carotid artery
external carotid artery branch
external circumflex artery
external cuneiform bone of the foot
external elastic membrane
external geniculate body
external granular layer of the cerebral cortex
external iliac artery
external iliac artery branch
nasal cavity polyp
external iliac vein
external intercostal muscle
external jugular vein
external lateral ligament of the ankle
external malleolus
external malleolar artery
external nose
external oblique muscle
external parieto - occipital fissure
external plantar artery
nasopharyngeal neoplasm
external pterygoid muscle
external pyramidal cell layer of the cerebral cortex
extrahepatic bile duct
eye appendage
eyebrow
eyelash
facet joint
facial artery
facial vein
nausea
facies posterior lentis
f - actin
falciform ligament
false vocal cord
falx cerebelli
fascicle
fast - twitch motor unit
nausea and vomiting
female prepuce
female urethra
femoral artery branch
fenestra ovalis
fenestra rotunda
fenestrated capillary
fibrillin - 1
fibrillin microfibrils
fibrin
fibrocartilage
mucin peptide muc - 1
neck neoplasm
fibrous astrocyte
fibrous coat of the liver
fifth ventricle
cytoskeleton filament
filiform papilla
filopodia
fimbria
fimbriated end of the fallopian tube
finger
fingernail
metastatic neoplasm
first portion of the duodenum
fissure of the ductus venosus
fissure of the gallbladder
fissure of the inferior vena cava
fissure of sylvius
flat bone
floor of the fourth ventricle
foliate papilla
neoplasm
follicular ovarian cell
fontanelle
foot
foramen apicis dentis
foramen of luschka
foramen of magendie
foramen of monroe
forearm
fossa of the antihelix
neoplasm by site
fossa of the helix
fourth portion of the duodenum
foveolar cell
free edge of the nail
free ribosome
frontal bone
frontal gyrus
frontal horn of the lateral ventricle
frontal nerve
frontal sulcus
embryonal neoplasm
frontopolar artery
fsh cell
functional layer of the endometrium
fundic gland
fungiform papilla
fusiform cell
g - actin
gallbladder body
gallbladder fundus
gallbladder neck
radiation - related neoplasm
gamma - tubulin
gamma - tubulin ring complex
ganglionic layer of the cerebral cortex
gastric artery
gastric glandular cell
gastric mucosa
gastric pit
hereditary neoplastic syndrome
gastric rugae
gastric secretion
gastric tissue
gastric vein
gastrocnemius muscle
gastrocolic ligament
gastroesophageal junction
gastrointestinal sphincter
wilms tumor
gastrophrenic ligament
gastrosplenic ligament
geniculate body
genito - urinary region
genu of the corpus callosum
gingiva
gland of krause
gland of moll
nervous system neoplasm
gland of wolfring
glans clitoris
glenoid fossa
glomerular basement membrane
glomerular capillary
glomerular mesangial cell
superior gluteal artery
glycocalyx
schwannoma
glycogen inclusion
gonadotroph cell
graafian follicle
granulosa lutein cell
gray commissure
gray matter
gray matter of the spinal cord
greater omentum
great trochanter
ca19 - 9 antigen
neuroblastoma
greater tuberosity
ground substance
growing follicle
gyri breves insulae
gyrus longus insulae
hair
hair bulb
hair follicle inferior segment
hair follicle infundibulum
hair follicle isthmus
hair papilla
hair root
hand
head and neck muscle
head of the epididymis
head of the femur
head of the fibula
neurofibroma
head of the humerus
head of the tibia
helicotrema
helix
hematopoietic and lymphoid cell
hemisphere of the cerebellum
hemispheric cistern
hemorrhoidal plexus
hepatic artery
neurofibromatosis type 1
hepatic duct
hepatic stellate cell
hepatic tissue
hepatic vein
hepatogastric ligament
herring body
high endothelial venule
neurofibromatosis type 2
hilar area of the kidney
epencephalon
hip joint
hippocampal fissure
hippocampal sulcus
horizontal cell of cajal
hydrophilic portion of the plasma membrane
hydrophobic portion of the plasma membrane
neuroma
hymen
hyoepiglottic ligament
hyoid bone
hyoid muscle
hyparterial branch of the right main bronchus
hypogastric region
hypoglossal triangle
hypopharyngeal aspect of the aryteno - epiglottic fold
hypophyseal portal vein
hypothalamohypophyseal portal system
acoustic schwannoma
ileo - colic artery
iliac lymph node
iliacus
iliocostal muscle
iliopsoas muscle
ilium
immature b - lymphocyte
immature bone
procentriole
incisor
neutropenia
incus
inferior anastomotic vein of the labbe
inferior cerebellopontine cistern
inferior external articular artery
inferior frontal gyrus
inferior frontal sulcus
inferior hypophyseal artery
inferior internal articular artery
inferior maxillary nerve
inferior mesenteric artery
inferior mesenteric artery branch
inferior mesenteric vein
inferior oblique muscle
inferior occipital convolution
inferior palpebral fold
inferior pancreatico - duodenal artery
inferior parathyroid gland
inferior parietal convolution
inferior profunda artery
night sweats
inferior rectus muscle
inferior temporal gyrus
inferior temporal sulcus
inferior turbinate
inferior vena cava opening
inferior vermian artery
infraspinatus
infratentorial cistern
anterior cusp of the tricuspid valve
caffeine
nodule
infundibular segment of the fallopian tube
inguinal lymph node
inhibitory synapse
inner enamel epithelium
inner hair cell of the organ of the corti
inner leaflet of the lipid bilayer
inner limiting membrane
inner rod of the corti
inner segment of the photoreceptor cell
inner supporting cell
inner wall of the vestibule
innominate artery
innominate artery branch
brachiocephalic vein
insula
interatrial septum
intercalated disk
nystagmus
intercalated duct
intercostal artery
intercostal artery branch
intercostal muscle
intercostal nerve
interlobular artery
interlobular bile duct
interlobular duct
intermediate fiber
obesity
intermembrane space of the mitochondrion
internal abdominal ring
internal anal sphincter
internal auditory artery
internal calcanean artery
internal carotid artery
internal carotid artery branch
internal cerebral vein
internal circumflex artery
obstruction
internal cuneiform bone of the foot
internal elastic membrane
internal geniculate body
internal granular layer of the cerebral cortex
internal iliac artery
internal iliac artery branch
internal iliac vein
internal intercostal muscle
internal jugular vein
ocular hypertension
internal lateral ligament of the ankle
internal lumen of the centriole
internal malleolar artery
internal mammary lymph node
internal thoracic vein
maxillary vein
internal nare
internal oblique muscle
internal occipital vein
internal parieto - occipital fissure
odontogenic neoplasm
internal plantar artery
internal pterygoid muscle
internal pubic artery
inner wall of the tympanum
interosseous artery
interosseous vein
interpeduncular cistern
interphalangeal joint of the foot
interphalangeal joint of the hand
interphase cell
odontoma
interstitial cell
interstitial cell of cajal
interstitial cell of the pineal gland
interstitial segment of the fallopian tube
interventricular septum
intracellular membrane
intracranial venous system
intralaminar nucleus
intraparietal sulcus
oligodendroglioma
irregular dense connective tissue
irregular tubule
ischium
islet cell
isthmic segment of the fallopian tube
thyroid gland isthmus
jaw joint
joint by site
opportunistic infection
joint of the pelvic girdle
juxtaglomerular apparatus
juxtamedullary nephron
karyosome
kidney lobe
posterior surface of the kidney
kinocilium
knee joint
l1 vertebra
orbit neoplasm
l2 vertebra
l3 vertebra
l4 vertebra
l5 vertebra
labial salivary gland
lacrimal apparatus
lacrimal bone
lacrimal canaliculus
lacrimal nerve
lacrimal sac
oropharyngeal neoplasm
lactiferous duct
lamellipodia
lamina cinerea
lamina densa
lamina lucida
lamina propria
lamina rara externa
bone paget disease
lamina rara interna
lamina spiralis ossea
lamina terminalis cistern
large cleaved cell
large intestinal crypt of lieberkuhn
large intestinal glandular cell
large intestinal mucosa
large intestinal muscular coat
large intestinal muscularis mucosa
large intestinal serosal surface
osteoarthritis
large intestinal submucosa
large intestinal wall tissue
centroblast
laryngeal ligament
laryngeal muscle
laryngeal ventricle
late endosome
lateral domain of the epithelium
lateral horn of the spinal cord
lateral infratentorial cistern
osteoblastoma
lateral lenticulostriate artery
lateral ligament
lateral orbitofrontal artery
lateral posterior nucleus of the thalamus
lateral rectus muscle
lateral supratentorial cistern
lateral surface of the liver
lateral surface of the prostate
osteochondroma
lateral thyrohyoid ligament
lateral vestibular nucleus
lateral - occipital sulcus
layer of the ophthalmic nerve fibers
left cerebral hemisphere
left common carotid artery
left common iliac artery
left coronary artery branch
left fallopian tube
osteoma
left hepatic duct
left hypochondriac region
left inferior frontal convolution
left inguinal region
left brachiocephalic vein
left lobe of the liver
left lumbar region
left lung
left main bronchus
left ovary
osteoid osteoma
left portion of the diaphragm
left pulmonary artery
left subclavian artery
left thyroid gland lobe
leg
lens capsule
lens fiber
lenticular nucleus
leptomeninges
osteoporosis
lesser omentum
lesser trochanter
lesser tuberosity
levator ani
lh cell
ligamentum flavum
lingual salivary gland
lingual tonsil
lipid inclusion
infectious otitis externa
lipoblast
lipocyte
liver acinus
liver acinus zone 1
liver acinus zone 2
liver acinus zone 3
liver fissure
liver ligament
lobar bronchus
lobule of the auricle
calcitriol
ovarian cyst
caudate lobe
lobus quadratus
long bone
long saphenous vein
longitudinal fissure
henle's loop
loose connective tissue
low columnar cell
lower esophageal sphincter
paget disease of the nipple
lower gastrointestinal tract
lower opening of the thorax
lower respiratory system
lumbar artery
lumbar curve
lumbar nerve
lumen of the endosome
lumen of the lysosome
lumen of the peroxisome
lunate sulcus
extramammary paget disease
lower lobe of the left lung
upper lobe of the left lung
lower lobe of the right lung
upper lobe of the right lung
lung tissue
lunula
lymph node afferent vessel
lymph node by anatomic site
lymph node capsule
lymph node cortex
pain
lymph node efferent vessel
lymph node hilum
lymph node medullary portion
lymph node sinus
lymph node tissue
lymph node trabecula
lymphatic capillary
lymphatic vessel
pancreatic cyst
lymphoid follicle
lymphokine - activated natural killer cell
lysosome proton pump
macula densa
macula lutea
macula of saccule
macula of utricle
male breast
male prepuce
pancreatic neoplasm
male urethra
malleus
mamillary body
marginal chromatin
posterior cusp of the tricuspid valve
maturation - stage ameloblast
mature b - lymphocyte
mature bone
pancreatitis
mature centriole
mature t - lymphocyte
mature thymocyte
medial collateral ligament of the knee
medial golgi
medial lenticulostriate artery
medial orbitofrontal artery
medial rectus muscle
medial vestibular nucleus
papilledema
median basilic vein
median cephalic vein
median vein
mediastinal lymph node
medullary artery
meibomian gland
membrane of the brain or spinal cord
membrane of crista
membrane of the endosome
paraganglioma
membrane of the golgi apparatus
membrane of the lysosome
membrane of the peroxisome
membrane of reissner
membrane of the rough endoplasmic reticulum
membrane of the smooth endoplasmic reticulum
membrane - attached polyribosome
membrane - attached ribosome
membranous canal of the cochlea
membranous cytoplasmic organelle
extra - adrenal paraganglioma
membranous labyrinth
membranous urethra
meningeal layer of the dura mater
meningeal nerve
meningothelial cell
meniscus
meniscus lateralis
meniscus medialis
calcium
paralysis
mesangium
mesencephalic perforating artery
mesentery
mesothelial cell
mesothelium
metacarpophalangeal joint
metatarsal artery
metatarsophalangeal joint
microcirculatory bed
paraneoplastic syndrome
microtubule triplet
microvillus
midcortical nephron
middle cerebral artery branch
middle constrictor muscle
middle cuneiform bone of the foot
middle cranial fossa
middle frontal gyrus
parapsoriasis
middle hemorrhoidal artery
middle inferior frontal convolution
middle mediastinum
middle occipital convolution
middle temporal gyrus
middle temporal sulcus
middle thyrohyoid ligament
minor salivary gland
parathyroid gland neoplasm
minus end of the actin filament
minus end of the microtubule
mitochondrial crista
mitochondrial matrix
mitochondrial matrix granule
modiolus
molar tooth
molecular layer of the cerebral cortex
monocytoid b - lymphocyte
mons pubis
parotid gland neoplasm
motor nucleus of the trigeminal nerve
mucous salivary gland
multiform cell layer of the cerebral cortex
multipolar neuron
multivesicular body
muscle and fasciae of the thorax
muscle of the coccyx
muscle of mastication
muscle of the tympanum
muscularis mucosa
musculus latissimus dorsi
myoblast
myoepithelial cell
myofibroblast
myofilament
myoid portion of the inner segment of the photoreceptor cell
nail
nasal bone
nasal muscle
nasal nerve
penile fibromatosis
nasal septum
nasolacrimal duct
navicular bone
neck muscle
neck of the humerus ,  anatomical
nervi vascularis
neural retina
neurofilament - h
neurofilament - l
neurofilament - m
penile neoplasm
nissl body
node of bizzozero
node of ranvier
non - articular bone surface
nonmembranous cytoplasmic organelle
nonphotosensitive region of the retina
normal cell
nostril
peptic ulcer
nuclear lamin
nucleolar - associated chromatin
nucleolar fibrillar material
nucleolar granular material
nucleolonema
nucleus of the mesencephalic tract of the trigeminal nerve
nucleus of the spinal tract of the trigeminal nerve
nutrient artery
pericardial effusion
obturator artery
obturator externus muscle
obturator internus muscle
obturator muscle
occipital artery
occipital horn of the lateral ventricle
occipital sulcus
occipital - temporal gyrus
occipito - frontalis muscle
oculomotor muscle
calcium carbonate
olecranon
olfactory chemoreceptor
olfactory cistern
olfactory epithelium
olfactory lobe
olfactory mucosa
olfactory sulcus
olfactory tract
omentum
peripheral nervous system neoplasm
oolemma
ooplasm
opening of the antrum
opening of the pulmonary vein
opening of the vena cava
ophthalmic nerve
ophthalmic artery
optic commissure
optic tract
orbiculus ciliaris
peritoneal neoplasm
orbital part of the inferior frontal gyrus
orbital sulcus
organ of corti
organ of special sense
orifice of the eustachian tube
orthodox configuration of the mitochondrion
osseous labyrinth
osteoid
other body part
petechia
otolith
outer enamel epithelium
outer hair cell of the organ of the corti
outer leaflet of the lipid bilayer
outer limiting membrane
outer rod of the corti
outer segment of the photoreceptor cell
peutz - jeghers syndrome
outer supporting cell
outer wall of the vestibule
ovarian artery
ovarian cortex
ovarian follicle
ovarian medulla
ovarian tissue
palatal muscle
palate bone
palatine salivary gland
pharyngeal neoplasm
palatine tonsil
palmar region
pancreatic centroacinar cell
pancreatic exocrine secretion
papilla of the tongue
papillary muscle
adrenal gland pheochromocytoma
parafascicular nucleus of the thalamus
c - cell
parahippocampal gyrus
paranemin
parathyroid gland capsule
parathyroid gland chief cell
parathyroid gland clear cell
parathyroid gland follicle
parathyroid gland oxyphil cell
skin discoloration
parathyroid gland tissue
parietal layer of bowman capsule
parietal part of the peritoneum
parietal pleura
parieto - occipital artery
parieto - occipital fissure
parotid duct
parotid gland lymph node
pineal region neoplasm
patella
patellar ligament
pectoralis major
pectoralis minor
pectoralis muscle
pelvic bone
pelvic curve
pituitary gland adenoma
pelvic floor muscle
pelvic girdle
perforating artery of the thigh
perforating canal
pericallosal artery
pericardiac artery
perilymph
perimetrium
perimysium
calcium channel blocker
pituitary gland neoplasm
perineal muscle
perineum
perineurium
perinuclear cisternal space
periodontium
periosteal cell
periosteal layer of the dura mater
peripheral zone of the prostatic parenchyma
perisinusoidal space
pleural effusion
periurethral zone of the prostatic parenchyma
perivitelline space
permanent tooth
peroneal artery
phagolysosome
phagosome
phalanx
pharyngeal tonsil
photosensitive region of the retina
pleural neoplasm
phrenic artery
pia mater
pillar cell
pineocyte
pinocytotic vesicle
plantar region
plasma membrane glycolipid
platysma myoides muscle
pneumonia
plus end of the actin filament
plus end of the microtubule
podocyte
pontine branch
popliteal artery
popliteal artery branch
popliteal vein
pneumocystis pneumonia
popliteus muscle
portal lobule
portal triad
portal vein
portal venous system
postcapillary venule
postcentral gyrus
postcentral sulcus
posterior annular ligament
posterior auricular vein
rothmund - thomson syndrome
posterior carpal artery
posterior cerebral artery branch
posterior choroidal artery
posterior circulation intracranial artery
posterior circumflex artery
posterior column
posterior commissure
posterior communicating artery
posterior cricoarytenoid ligament
posterior cruciate ligament
polycythemia vera
posterior external jugular vein
posterior cranial fossa
posterior inferior cerebellar artery
posterior inferior frontal convolution
posterior infratentorial cistern
posterior longitudinal ligament
posterior median fissure of the spinal cord
posterior mediastinal artery
posterior mediastinum
posterior meningeal artery
fibroepithelial polyp
posterior olfactory lobule
posterior parietal artery
posterior part of the ambient cistern
posterior pigment epithelium
posterior pole of the lens
posterior portion of the corpus callosum cistern
posterior quadrigeminal body
posterior semicircular canal
posterior supratentorial cistern
polyploidy
posterior surface of the liver
posterior surface of the stomach
posterior surface of the vagina
posterior temporal artery
posterior tibial artery branch
posterior tibial vein
posterior ulnar vein
posterior wall of the tympanum
postero - lateral fissure of the spinal cord
familial adenomatous polyposis
postsynaptic membrane
precentral artery
precentral gyrus
precentral sulcus
precentral cerebellar vein
premedullary cistern
prepontine cistern
presynaptic knob
edetate calcium disodium
polyp
primordial follicle
primordial germ cell
principal sensory nucleus of the trigeminal nerve
processus cochleariformis
promontory
prostatic duct tissue
prostatic glandular cell
precancerous condition
prostatic tissue
proximal connecting fiber
proximal convoluted tube
proximal part of the lumen of the centriole
lactotroph adenoma
psoas major muscle
psoas minor muscle
psoas muscle
pubic bone
pubic hair
pubic symphysis
pulmonary acinus
pulmonary artery branch
pulmonary lobule
pupil
prostate neoplasm
purkinje fiber
pyloric gland
pyloric orifice
pyloric sphincter
pyramid of tympanum
pyramid of ferrein
pyramid of malpighi
pyramidal lobe
pyramidalis muscle
pyriform sinus
pruritus
quadratus lumborum muscle
quadriceps muscle of the thigh
quadrigeminal artery
quadrigeminal cistern
radial vein of the upper extremity
root
recto - vaginal pouch
recto - vesical pouch
rectus abdominis muscle
pseudomyxoma peritonei
recurrent artery of heubner
red fiber
refractile media
regular dense connective tissue
renal afferent vessel
renal cell
renal corpuscle
renal efferent vessel
renal interstitial cell
renal interstitial tissue
psoriasis
renal papilla
renal tissue
renal vein
renshaw cell
respiratory bronchiole
rete malpighii
rete testis
reticular fiber
sexual dysfunction
retinal pigment epithelium
ridge of the aqueductus fallopii
right cerebral hemisphere
right common carotid artery
right common iliac artery
right fallopian tube
right hepatic duct
right hypochondriac region
right inferior frontal convolution
right inguinal region
pulmonary emphysema
right brachiocephalic vein
right lobe of the liver
right lumbar region
right lung
right lymphatic duct
lymph trunk
right main bronchus
right ovary
right portion of the diaphragm
right pulmonary artery
radiation - induced dermatitis
right subclavian artery
right thyroid gland lobe
roof of the fourth ventricle
root of the nail
rostrum of the corpus callosum
rotator cuff
s1 vertebra
s2 vertebra
calcium saccharate
rectal neoplasm
s3 vertebra
s4 vertebra
s5 vertebra
saccule
sacral bone
sacral nerve
sacrococcygeal joint
sacroiliac joint
sacral region
salivary gland tissue
rectal polyp
salpingopharyngeus muscle
saphenous vein
sarcolemma
sarcoplasm
sarcoplasmic reticulum
sartorius muscle
satellite cell
scalene muscle
sciatic artery
sebaceous gland
recurrence
sebaceous gland duct
sebaceous gland of the eyelash
second portion of the duodenum
secondary oocyte
secretory - stage ameloblast
eye segment
segmental bronchus
semicircular canal
semicircular duct
seminal fluid
acute respiratory distress syndrome
sensory hair
sensory receptor of the ear
sensory - somatic nervous system
septal cusp of the tricuspid valve
septal vein
septum pellucidum
seromucous salivary gland
serosal surface of the liver
serous salivary gland
respiratory syncytial virus infection
serratus anterior muscle
sesamoid bone
sex chromosome
shaft of the hair
sheath of schwann
short bone
short saphenous vein
shoulder girdle
shoulder joint
sigmoid artery
respiratory system neoplasm
sigmoid flexure
simple columnar epithelium
simple cuboidal epithelium
simple epithelium
sinoatrial node
sinus
sinus of valsalva
skeletal fiber
solitary reticulohistiocytoma
skin of the face
skin squamous cell
skin tissue
slow - twitch motor unit
small intestinal crypt of lieberkuhn
small intestinal glandular cell
small intestinal goblet cell
small intestinal mucosa
small intestinal muscular coat
retroperitoneal neoplasm
small intestinal muscularis mucosa
small intestinal serosal surface
small intestinal submucosa
small intestinal wall tissue
smegma
soluble enzyme of the citric acid cycle
somatotroph cell
space of fontana
rhabdomyoma
space of mall
spermatic artery
spermatogenic cell
sphenomaxillary fossa
sphenoparietal sinus
sphincter pupillae muscle
spinal artery
spinal cord column
spinal cord fissure
rhabdomyosarcoma
spinal dorsal nerve
spinal vestibular nucleus
spiral artery of the endometrium
spiral tube of schchowa
splenial artery
splenic arteriole
splenic artery
splenic capsule
calcium gluconate
supernumerary circular chromosome
splenic hilar lymph node
splenic hilum
splenic pulp
splenic trabecula
splenic vein
salivary gland neoplasm
splenium of the corpus callosum
stapedius muscle
stapes
stellate reticulum
stereocilium
sternoclavicular joint
sternocleidomastoid muscle
sternocostal joint
straight artery of the endometrium
schizophrenia
stratified columnar epithelium
stratified cuboidal epithelium
stratum basale
stratum conjunctum
stratum corneum
stratum disjunctum
stratum granulosum
stratum intermedium
stratum lucidum
sebaceous gland neoplasm
stratum papillare
stratum reticulare
striae medullares
striated border
striated duct
striated muscle cell
stroma of the ovarian cortex
stylopharyngeus muscle
septicemia
subarachnoid cistern
subcapsular epithelium of the lens
lymph node subcapsular sinus
subclavian artery
subclavius muscle
subcutis
subendocardial layer
subendothelial layer
subiculum
submandibular duct
sexually transmitted disorder
subscapular artery
subscapularis muscle
substantia propria
subtalar joint
sulcus centralis
sulcus centralis insulae
sulcus limitans
sulcus terminalis
superficial abdominal muscle
superficial cervical lymph node
sezary syndrome
superficial femoral artery
superficial intracranial venous system
superficial lymphatic vessel
superficial middle cerebral vein
superficial palmar arch
superficial vein
superficial vein of the hand
superior anastomotic vein of trolard
superior cerebellar artery
finding
superior cerebellar cistern
superior cerebellopontine cistern
superior constrictor muscle
superior external articular artery
superior frontal gyrus
superior frontal sulcus
superior hemorrhoidal artery
superior hypophyseal artery
superior infratentorial cistern
digestive system signs and symptoms
superior intercostal vein
superior internal articular artery
superior maxillary nerve
superior mediastinum
superior mesenteric artery
superior mesenteric artery branch
superior mesenteric vein
superior oblique muscle
superior occipital convolution
silicosis
superior palpebral fold
superior parathyroid gland
superior parietal convolution
superior profunda artery
superior rectus muscle
superior semicircular canal
superior supratentorial cistern
superior surface of the liver
superior temporal gyrus
calusterone
vocal cord nodule
superior temporal sulcus
superior thoracic artery
superior vena cava opening
superior vestibular nucleus
supporting cell of the nervous system
suprachorioid lamina
supramarginal gyrus
supraorbital vein
suprarenal artery
supraspinatus muscle
skin disorder
supratentorial cistern
sweat gland
sweat gland duct
sylvian cistern
synaptic cleft
synarthrosis
synovial bursa
synovial fluid
systemic vein
skin neoplasm
t1 vertebra
t10 vertebra
t11 vertebra
t12 vertebra
t2 vertebra
t3 vertebra
t4 vertebra
t5 vertebra
t6 vertebra
t7 vertebra
skin nodule
t8 vertebra
t9 vertebra
tail of the epididymis
tail of the spermatozoon
tarsal artery
tarsal joint
tarsal plate
tarsus bone
taste pore
tear
skin tag
temporal artery
temporal fossa
temporal muscle
temporal sulcus
temporary tooth
retromandibular vein
tendinocyte
tensor tympani muscle
tentorium cerebelli
skull neoplasm
teres major muscle
teres minor muscle
teres muscle
terminal bar
terminal bronchiole
terminal bronchiole epithelium
terminal ductal lobular unit cell
terminal ileum
testicular tissue
thalamencephalon
sleep disorder
thalamostriate vein
theca lutein cell
thick filament
thigh
thin filament
third portion of the duodenum
thoracic aorta
thoracic aorta branch
thoracic duct
thoracic lymph node
soft tissue neoplasm
thymic capsule
thymic epithelial cell
thymic lobule
thyroarytenoid muscle
thyroepiglottic ligament
thyroepiglottic muscle
thyrohyoid ligament
solitary breast cyst
thyroid cartilage
thyroid gland capsule
thyroid gland follicular cell
thyroid gland lobe
thyroid gland tissue
tibial vein
toe
toe joint
somatostatin - producing neuroendocrine tumor
toenail
tonsillar crypt
tonsillohemispheric artery
tooth cell
odontogenic tissue
torcular herophili
totipotent neuroepithelial stem cell
tracheal epithelium
tract of burdach
tract of goll
camptothecin
spinal cord compression
tract of lissauer
tragus
trans - golgi network
transitional zone of the prostatic parenchyma
transport vesicle
transversalis
transverse fissure
transverse rectal fold
trapezius muscle
spinal cord neoplasm
triangular ligament
triangular part of the inferior frontal gyrus
triceps
trigonum olfactorium
trochanter
true vocal cord
trunk
tuber cinereum
tunica adventitia
tunica albuginea
intraspinal neoplasm
tunica intima
tunica media
tunica vaginalis
tunica vasculosa
type i epithelial receptor cell
type ii epithelial receptor cell
ulnar artery branch
umbilical artery
umbilical fissure
umbilical region
splenic neoplasm
umbilical vein
uncus
undersurface of the frontal lobe
undersurface of the temporal lobe
unipolar neuron
unmyelinated nerve fiber
upper esophageal sphincter
upper gastrointestinal tract
upper opening of the thorax
upper respiratory system
splenomegaly
urinary space
urothelial cell
uterine gland
utero - vesical pouch
utricle
utriculosaccular duct
vagal triangle
vaginal fornix
cardiac valve cusp
erythema multiforme major
valve of kerckring
valve of vieussens
vasa vasorum
vascular smooth muscle tissue
vascular system
great cerebral vein of galen
vein of the head or neck
velum interpositum cistern
venous system
ventral horn of the spinal cord
ventral nerve root
ventroanterior nucleus of the thalamus
ventrolateral nucleus of the thalamus
ventroposterior lateral nucleus of the thalamus
ventroposterior medial nucleus of the thalamus
vermian cistern
vermis
vertebral artery branch
vertebral bone
vertebral canal
gastric neoplasm
vestibular ganglion
vestibular labyrinth
vestibule of the ear
villus
type iii intermediate filament
visceral afferent neuron
visceral efferent neuron
visceral layer of bowman capsule
gastric ulcer
visceral part of the peritoneum
visceral pleura
visceral striated muscle tissue
visceral surface of the liver
vitreous body
vitreous chamber
voltage - dependent anion channel
vomer
white adipose tissue
post - traumatic stress disorder
white commissure
white fiber
white matter
white matter of the spinal cord
wrist joint
xiphoid process
zona pellucida
zygomatic arch
zygomatic fossa
purdue pegboard test
capsaicin
cerebrovascular accident
annona muricata
agent orange
pdzk1 - interacting protein 1
protein mcm10 homolog
dna replication licensing factor mcm4
sturge - weber syndrome
dna replication licensing factor mcm5
dna replication licensing factor mcm6
dna replication licensing factor mcm7
malignant t cell amplified sequence 1
endocervical columnar cell
ectocervical squamous cell
reserve cell
trophoblastic cell
syncytiotrophoblast
cytotrophoblast
sublingual gland neoplasm
intermediate type trophoblastic cell
endometrial stromal cell
mucinous bronchial cell
glandular cell
thyroid gland oxyphil cell
b - prolymphocyte
t - prolymphocyte
left colon
submandibular gland neoplasm
precursor t - lymphoblast
precursor b - lymphoblast
endoderm cell
yolk cell
angioblast
ectoderm cell
mesoderm cell
neural crest cell
suicide
mediator of rna polymerase ii transcription subunit 6
malignant fibrous histiocytoma - amplified sequence 1
matrix gla protein
protein enl
af4 / fmr2 family member 1
protein af - 9
afadin
protein af - 17
forkhead box protein o4
55 kda erythrocyte membrane protein
sunburn
1q23 .3
myelin protein zero - like 1
thymic tissue
virosome
ras - related protein m - ras
protein p13 mtcp - 1
myb - binding protein 1a
superior vena cava syndrome
tumor suppressor candidate 3
neuroblastoma - amplified sequence
cytoplasmic protein nck2
n - cym protein
protein ndrg1
central nervous system part
e3 ubiquitin - protein ligase neurl1
peripheral nervous system part
spinal cord part
supratentorial neoplasm
homeobox protein nkx - 2 .8
homeobox protein nkx - 3 .1
bmp and activin membrane - bound inhibitor homolog
cell surface
neuromedin - u
neurogenic locus notch homolog protein 1
rna - binding protein nova - 2
atrial natriuretic peptide receptor 2
nadph - dependent diflavin oxidoreductase 1
sweat gland neoplasm
nuclear receptor - binding protein
neuropilin - 1
netrin - 1
bdnf / nt - 3 growth factors receptor
nt - 3 growth factor receptor
nuclear mitotic apparatus protein 1
nuclear pore complex protein nup214
peginterferon alfa - 2a
megakaryocyte - associated tyrosine - protein kinase
endocervical mucosa
swelling
ectocervical mucosa
map kinase - interacting serine / threonine - protein kinase 1
melanoma antigen recognized by t - cells 1
histone - lysine n - methyltransferase 2d
maguk p55 subfamily member 2
maguk p55 subfamily member 3
nuclear receptor coactivator 5
nuclear receptor coactivator 6
neogenin
captopril
synovial sarcoma
nuclear receptor subfamily 0 group b member 2
neuronal cell adhesion molecule
neurotrophin - 3
hypochondriac region
lumbar region
right kidney
left kidney
fossa
round ligament of the liver
round ligament of the uterus
tenosynovial giant cell tumor ,  diffuse type
olfactory receptor 1g1
origin recognition complex subunit 1
radial artery of the upper extremity
radial artery of the endometrium
origin recognition complex subunit 2
origin recognition complex subunit 3
origin recognition complex subunit 4
origin recognition complex subunit 5
origin recognition complex subunit 6
oncostatin - m - specific receptor subunit beta
tenosynovial giant cell tumor
carboxy - terminal domain rna polymerase ii polypeptide a small phosphatase 2
lung lobe
anatomic surface
phosphatidylinositol 5 - phosphate 4 - kinase type - 2 alpha
phosphatidylinositol 5 - phosphate 4 - kinase type - 2 beta
growth / differentiation factor 15
aortic segment
kidney part
mediastinum part
teratoma
organ capsule
immunoblast
b - immunoblast
t - immunoblast
testicular neoplasm
thecoma
extraembryonic structure
gastrula
trilaminar embryonic disc
embryonic urogenital system
thoracic neoplasm
autonomic nervous system part
reproductive system part
phospholipase a2 ,  membrane associated
zinc finger protein plagl1
1 - phosphatidylinositol 4 , 5 - bisphosphate phosphodiesterase beta - 3
rbp2 - like protein
phorbol - 12 - myristate - 13 - acetate - induced protein 1
protein pml
putative postmeiotic segregation increased 2 - like protein 1
essential thrombocythemia
cell part
dna - directed rna polymerase ii subunit rpb1
polymerization
large neutral amino acids transporter small subunit 3
phospholipid phosphatase 1
skeletal system part
peroxisome proliferator - activated receptor gamma
protein serine / threonine phosphatase
serine / threonine - protein phosphatase pp1 - alpha catalytic subunit
thrombocytopenia
serine / threonine protein phosphatase 2a catalytic subunit alpha isoform
serine / threonine protein phosphatase 2a catalytic subunit beta isoform
gastrointestinal tract
protein phosphatase 2a regulatory protein
serine / threonine - protein phosphatase 2a 65 kda regulatory subunit a beta isoform
serine / threonine - protein phosphatase 2a activator
splenic tissue
serine / threonine - protein phosphatase 2a 56 kda regulatory subunit alpha isoform
serine / threonine - protein phosphatase 2a 56 kda regulatory subunit beta isoform
serine / threonine - protein phosphatase 2a 56 kda regulatory subunit gamma isoform
serine / threonine - protein phosphatase 2a 56 kda regulatory subunit delta isoform
serine / threonine - protein phosphatase 2a 56 kda regulatory subunit epsilon isoform
pr domain zinc finger protein 1
pr domain zinc finger protein 4
cgmp - dependent protein kinase 2
interferon - induced ,  double - stranded rna - activated protein kinase
pc4 and sfrs1 - interacting protein isoform 2
pc4 and sfrs1 - interacting protein isoform 1
protein patched homolog 2
protein - tyrosine kinase 6
carbamazepine
thrombophlebitis
allantois
amniotic cavity
amniotic sac
amniotic surface of the placenta
anal membrane
angioblastic cord
anocutaneous line
anterior cardinal vein
apical ectodermal ridge
thymoma
auricular hillock
basal plate
bilaminar embryonic disc
blood island
bulbus cordis
cardiac jelly
cardinal vein
cecal diverticulum
central tendon of the diaphragm
thymus neoplasm
chondrification center
chondrocranium
chorion
chorionic plate
chorionic sac
chorionic villus
chyle cistern
cloaca
cloacal membrane
cloacal sphincter
common cardinal vein
conceptus
connecting stalk
connective tissue of villus
cortical cord
cotyledon
cytotrophoblastic shell
dental sac
dermatome region
thyroid gland neoplasm
dermomyotome
digital ray
dorsal mesogastrium
ductus venosus
embryonic structure or system
embryonic artery
embryonic atrium
embryonic body cavity
embryonic cardiovascular system
embryonic digestive system
thyroid gland nodule
embryonic disc
embryonic ear
embryonic eye
embryonic heart
embryonic integumentary system
embryonic musculoskeletal system
embryonic nervous system
embryonic palate
embryonic respiratory system
embryonic vein
tongue neoplasm
embryonic ventricle
endocardial heart tube
endothelium of the fetal capillary
epaxial division of the myotome
epiblast
extraembryonic coelom
fetal gastrointestinal tract
fetal heart
fetal kidney
fetal liver
tonsillar neoplasm
fetal lung
fetal skeleton
fetal skull
fetal spleen
fifth pharyngeal pouch
first pharyngeal arch
first pharyngeal pouch
foot plate
foramen primum
foramen secundum
toxoplasmosis
foregut
fourth pharyngeal pouch
frontonasal prominence
gonadal cord
gonadal ridge
hand plate
hepatic cord
hepatic diverticulum
hindgut
hypaxial division of the myotome
tracheal neoplasm
hypoblast
iliac lymph sac
indifferent gonad
intermediate mesoderm
intraembryonic coelom
jugular lymph sac
lanugo
laryngotracheal tube
lateral mesoderm
carboquone
chromosomal translocation
lens pit
lens placodes
limb bud
mandibular prominence
maxillary artery
maxillary prominence
metanephric diverticulum
metanephric mass of the intermediate mesoderm
metanephros
trisomy
midgut
midgut loop
morula
mucous connective tissue
myotome region
nail fold
nail plate
nasal prominence
nasolacrimal groove
nephrogenic cord
trophoblastic tumor
nerve of the pharyngeal arch
neural canal
neural crest
neural fold
neural groove
neural plate
neural tube
neurenteric canal
neuroectoderm
neurula
tuberculosis
notochordal canal
notochordal plate
notochordal process
optic cup
optic groove
optic stalk
optic vesicle
otic pit
otic placodes
tuberous sclerosis
otic vesicle
foramen ovale of the fetal heart
pancreatic bud
parachordal cartilage
paraxial mesoderm
pectinate line
pericardioperitoneal canal
periderm
pharyngeal apparatus
pharyngeal arch
tumor lysis syndrome
pharyngeal groove
pharyngeal membrane
pharyngeal pouch
placental membrane
placental septum
pleuropericardial membrane
pleuroperitoneal membrane
posterior cardinal vein
primordial uteroplacental circulation
primary brain vesicle
ulcer
primary bronchial bud
primary chorionic villus
primary lymph sac
primary ossification center
primary palate
primitive groove
primitive node
primitive pit
primordial gut
primordial interventricular septum
ureter neoplasm
primordial laryngeal inlet
primordial mediastinum
primordial myocardium
primordial optic nerve
primordial phallus
primordium
primordium of the heart
primordium of the liver
proctodeum
pronephric duct
urethra neoplasm
pronephros
rathke pouch
respiratory diverticulum
respiratory primordium
retinal fissure
retroperitoneal lymph sac
scalp vascular plexus
sclerotome
second pharyngeal arch
second pharyngeal pouch
incontinence
secondary brain vesicle
secondary chorionic villus
secondary palate
seminiferous cord
septum primum
septum secundum
septum transversum
sinovaginal bulb
sinus tubercle
sinus venarum
carbenicillin
urinary system disorder
sinus venosus
somatopleure
somite
splanchnopleure
stapedial artery
stomach primordium
stomodeum
subcardinal vein
supracardinal vein
surface ectoderm
urinary system neoplasm
tertiary chorionic villus
third pharyngeal pouch
thyroid primordium
tooth bud
tracheal bud
tracheoesophageal fold
tracheoesophageal septum
trancus arteriosus
tubotympanic recess
umbilical blood
urticaria
umbilical cord
urogenital ridge
urogenital sinus
urorectal septum
uterovaginal primordium
vaginal plate
valve of the oval foramen
ventral mesogastrium
vernix caseosa
vitelline vein
urticaria pigmentosa / maculopapular cutaneous mastocytosis
inactive tyrosine - protein kinase 7
abdominal cramp
abdominal injury
abdominal mass
abnormal hard tissue formation in pulp
spontaneous abortion
illegal abortion
legally induced abortion
uterine corpus leiomyoma
accident
aircraft accident
domestic accident
industrial accident
automobile accident
achondroplasia
acne keloid
acquired coagulation factor deficiency
acrocephalosyndactyly
actinomycetoma
uterine neoplasm
actinomycosis
cervicofacial actinomycotic infection
acute alcoholic hepatitis
acute atopic conjunctivitis
acute periodontitis
acute pharyngitis
acute intestinal ischemia
holmes - adie syndrome
adjustment reaction with brief depressive reaction
adnexitis
uveal neoplasm
congenital adrenal hyperplasia
affective psychosis
agoraphobia
agoraphobia without a history of panic disorder
air sickness
alastrim
alcohol - induced wernicke - korsakoff's syndrome
alcohol intoxication
alpha thalassemia
extrinsic allergic alveolitis
vaginal neoplasm
amelia
ametropia
retrograde amnesia
amyotrophic lateral sclerosis
ancylostomiasis due to ancylostoma duodenale
beta thalassemia
hemolytic anemia
acquired hemolytic anemia
autoimmune hemolytic anemia
hereditary hemolytic anemia
vascular hamartoma
hypochromic anemia
macrocytic anemia
megaloblastic anemia
sickle cell disease
anemia due to disorder of glutathione metabolism
anhidrosis
anomia
anorexia nervosa
anovulation
anthracosilicosis
viral infection
anthracosis
aortic arch syndrome
aphakia
aphasia
broca's aphasia
arthropod - borne hemorrhagic fever
arthropod - borne viral infection
arm pain
arteriosclerosis
arteritis
carbohydrate
vocal cord polyp
arthus reaction
peritoneal effusion
arteriosclerotic cardiovascular disease
aseptic necrosis of head and neck of femur
sports injury
back injury
bagassosis
voice disorder
baritosis
cervicocranial syndrome
bartter syndrome
basilar artery syndrome
basophilia
beckwith - wiedemann syndrome
behcet syndrome
benign neoplasm of lower jaw bone
vitamin b1 deficiency
berry aneurysm
vomiting
extrahepatic cholestasis
biliary atresia
binocular vision disorder
bipolar disorder
bipolar depression
bird fancier's lung
blackwater fever
blast injury
blastomycosis
north american blastomycosis
vulvar neoplasm
blepharoconjunctivitis
blind loop syndrome
bone development disorder
bone marrow disorder
bonnevie - ullrich syndrome
chronic encephalopathy
retinal arterial branch occlusion
breast swelling
breech presentation
bronchospasm
granulomatosis with polyangiitis
bulimia nervosa
burn
chemical burn
gallbladder stone
chronic mucocutaneous candidiasis
cannabis dependence
capgras syndrome
head and neck squamous cell carcinoma
carcinosarcoma
hypertrophic cardiomyopathy
weight loss
carpal tunnel syndrome
car sickness
catalepsy
cauda equina syndrome with neurogenic bladder
cellulitis of hand
central opacity of cornea
central retinal artery occlusion
cutaneous schistosomiasis
intracranial aneurysm
cerebral atherosclerosis
idiopathic thrombocytopenic purpura
cerebral palsy
cerebrospinal fluid otorrhea
cardiomyopathy in chagas' disease
chlamydial infection
cholecystitis
cartilage development disorder
synovial chondromatosis
choroid disorder
choroideremia
werner syndrome
chromosome disorder
chronic eosinophilic pneumonia
chronic ethmoidal sinusitis
chronic frontal sinusitis
chronic gingivitis
chronic glomerulonephritis with lesion of membranous glomerulonephritis
chronic iridocyclitis
chronic maxillary sinusitis
cor pulmonale
chronic rhinitis
wiskott - aldrich syndrome
chronic sphenoidal sinusitis
churg - strauss syndrome
chylous ascites
scar
clonus
closed dislocation of hip
closed dislocation of shoulder
closed dislocation ,  multiple and ill - defined sites
closed fracture of carpal bone
closed fracture of malar and maxillary bone
closed fracture of mandible
clubbing of fingers
cocaine dependence
coccidiosis
colic
closed colles' fracture
coma
common bile duct stone
carboxylic acids
acute nasopharyngitis
communicating hydrocephalus
congenital spondylolysis ,  lumbosacral region
xerophthalmia
conjunctivitis
acute hemorrhagic conjunctivitis
atopic conjunctivitis
giant papillary conjunctivitis
vernal conjunctivitis
viral conjunctivitis
juvenile xanthogranuloma
conn syndrome
coprophagia
hereditary corneal dystrophy
corn
coronary vasospasm
corpus luteum cyst
limb cramp
cri du chat syndrome
cystic endometrial hyperplasia
xeroderma pigmentosum
cysticercosis
dacryocystitis
multi - infarct dementia
pre - senile dementia
senile dementia
vascular dementia
demyelinating disorder of central nervous system
demyelinating disorder
dengue fever
enamel hypoplasia
zollinger ellison syndrome
dental pulp disorder
endogenous depression
reactive depression
dermatitis due to food taken internally
dermatophytosis of groin and perianal area
dermatophytosis of scalp and beard
lipoatrophic diabetes mellitus
diabetic retinopathy
digitalis toxicity
dipetalonemiasis
diphtheria
anterior nasal diphtheria
pseudomembranous diphtheritic conjunctivitis
cutaneous diphtheria
faucial diphtheria
laryngeal diphtheria
nasopharyngeal diphtheria
fluid discharge
disturbance of skin sensation
arachnoid cyst
colonic diverticulum
colonic diverticulosis
dry eye syndrome
dwarfism
pituitary dwarfism
skin pigmentation disorder
amebic colitis
dysmenorrhea
inclusion body fibromatosis
dysostosis
paroxysmal nocturnal dyspnea
dysthymic disorder
dystonia
idiopathic torsion dystonia
vulvar dystrophy
congenital ectopic lens
ectromelia
ehlers - danlos syndrome
elephantiasis
b - cell non - hodgkin lymphoma
emaciation
pulmonary interstitial emphysema
empyema
empyema with fistula
tuberculous empyema
epidemic encephalitis
japanese b encephalitis
acute disseminated encephalomyelitis
tick - borne viral encephalitis
encephalomyelitis
endarteritis
endocarditis
subacute bacterial endocarditis
endocervical polyp
endomyocardial fibrosis
endophthalmitis
parasitic endophthalmitis
enuresis
epicondylitis
intermediate grade lymphoma
epidemic keratoconjunctivitis
erythematosquamous dermatosis
erythroid hyperplasia
erythromelalgia
escherichia coli infection
esophageal stricture
internal strabismus
ethmoidal sinusitis
euphoria
excoriation
glucarpidase
grade 3 follicular lymphoma
exercise - induced bronchospasm
divergent strabismus
ocular injury
face injury
farmer's lung
fasciculation
favism
fever of unknown origin
fibrous dysplasia
immunoblastic lymphoma
polyostotic fibrous dysplasia
filariasis
mansonella ozzardi infection
finger injury
intestinal fistula excluding rectum and anus
flank pain
flat foot
follicular cyst of ovary
foot pain
patent foramen ovale
low grade lymphoma
foreign body
foreign body granuloma of muscle
foreign body in gastrointestinal tract
closed fracture
open fracture
frohlich syndrome
frontal sinusitis
frostbite
nonorganic enuresis
furunculosis
diffuse mixed cell lymphoma
gagging
gallbladder disorder
gastroenteritis
gastrointestinal malfunction arising from mental factor
congenital leucocyte abnormality
gingival pocket
gingivitis
necrotizing ulcerative gingivitis
glanders
angle closure glaucoma
adult diffuse small cleaved cell lymphoma
open angle glaucoma
globus hystericus
iga nephropathy
membranoproliferative glomerulonephritis
membranous glomerulonephritis
glucose intolerance
non - toxic nodular goiter
acute gonococcal infection of lower genitourinary tract
goodpasture syndrome
grade 1 follicular lymphoma
gout
granular corneal dystrophy
granulation tissue
granulomatous arteritis
hemophilus infection
hemophilus influenza infection
hair disorder
hallucinogen dependence
hallux valgus
hand injury
t - cell non - hodgkin lymphoma
head injury
headache
central hearing loss
high frequency hearing loss
noise induced hearing loss
heart block by ecg finding
heart malformation
cardiac rupture
post infarct cardiac rupture
primary cutaneous t - cell non - hodgkin lymphoma
heartburn
heberden's node
heinz body
hemimelia
hemoglobin c disease
sickle cell - hemoglobin c disease
hemoglobinuria
hemoglobinuria due to hemolysis from external causes
mature t - cell and nk - cell non - hodgkin lymphoma
non - traumatic hemoperitoneum
hemorrhage of rectum and anus
congo - crimean hemorrhagic fever
dengue hemorrhagic fever
alcoholic hepatitis
hernia
hernia without mention of obstruction or gangrene
diaphragmatic hernia
traumatic diaphragmatic hernia
femoral hernia
palmar fibromatosis
inguinal hernia
direct inguinal hernia
indirect inguinal hernia
scrotal hernia
heroin dependence
cold sore
herpes zoster dermatitis of eyelid
herpetic vulvovaginitis
hip dislocation
hip pain
carcinogen
granuloma annulare
hirschsprung disease
hookworm infection
hyperalgesia
hyperlipoproteinemia type ii
hypergammaglobulinemia
hyperactivity
hyperlipidemia
hyperlipoproteinemia
aids - related lymphoma
remnant hyperlipidemia
fredrickson type iv lipidemia
hyperostosis
hyperostosis of skull
hypersplenism
hypertelorism
hypertropia
hypogalactia
hypohidrosis
hypomenorrhea
severe combined immunodeficiency
hypotrichosis
hysteria
illusion
impulse - control disorder
low birth weight
infectious mononucleosis
inguinal hernia without mention of obstruction or gangrene
injury to diaphragm without mention of open wound into cavity
choroid plexus neoplasm
insulin coma
intestinal disaccharidase deficiency and disaccharide malabsorption
intestinal fistula
intestinal pseudo - obstruction
intracranial abscess
intraoperative complication
iridocyclitis
iris disorder
ischemia
jacksonian seizure
granular cell tumor
dubin - johnson syndrome
obstructive jaundice
dendritic keratitis
keratoconjunctivitis
keratoderma
acquired keratoderma
keratosis
palmoplantar keratoderma
acute tubular necrosis
bone remodeling
cystic kidney disease
medullary sponge kidney
klinefelter syndrome
knee injury
kyphosis
acquired kyphosis
acquired postural kyphosis
lacrimal duct obstruction
visceral larva migrans
li - fraumeni syndrome
laurence - moon syndrome
lead poisoning
leg cramp
leg injury
leg pain
lower extremity ulcer
perthes disease
leishmaniasis
cutaneous leishmaniasis
american cutaneous leishmaniasis
bacillary angiomatosis
asian desert cutaneous leishmaniasis
kala - azar
lens subluxation
leriche syndrome
leukorrhea
lice
atrophic lichen planus
bullous lichen planus
hypertrophic lichen planus
essential hypertension
lichenoid drug eruption
spastic diplegia
alcoholic cirrhosis
alcoholic liver disease
loiasis
loneliness
long qt syndrome
lordosis
lower back pain
lupus glomerulonephritis
addiction
lymphangitis
lymphocytosis
hemophagocytic lymphohistiocytosis
macular corneal dystrophy
cystoid macular edema
macular hole
single episode of major depressive disorder
malaria
falciparum malaria
quartan malaria
environmental carcinogen
lobular capillary hemangioma
vivax malaria
male erectile disorder
malignant essential hypertension
primary malignant liver neoplasm
malposition of heart and cardiac apex
manic bipolar affective disorder
maple syrup urine disease
marfan syndrome
mass
maxillary sinusitis
nevus araneus
megacolon
megaesophagus
melancholic depression
meningoencephalitis
menopausal syndrome
menstrual disorder
congenital metabolic disorder
methemoglobinemia
metrorrhagia
mikulicz disease
metastatic carcinoma
miliaria
closed monteggia's fracture
mosquito - borne viral encephalitis
motion sickness
kawasaki disease
mucous polyp of cervix
muscle cramp
flaccidity
myocardial degeneration
chronic leukemia
cardiomyopathy
myocarditis
myoclonic jerk
myotonic cataract
myxedema
nabothian cyst
ingrown toenail
nasopharyngitis
necatoriasis
neck sprain
breast adenosis
necrobiosis lipoidica
avascular necrosis of bone
alport syndrome
nephropathy
minimal change glomerulonephritis
nephrotic syndrome
nervous debility
neurosis
newcastle disease
night blindness
increased npn
gangrenous stomatitis
non - autoimmune hemolytic anemia
noonan syndrome
norwegian scabies
acquired deformity of nose
numbness
morbid obesity
occupational dermatitis
epithelioid cell type gastrointestinal stromal tumor
oligospermia
onchocerciasis
ocular onchocerciasis
optic atrophy
hereditary optic atrophy
optical illusion
oral cavity submucous fibrosis
anxiety disorder due to a general medical condition
organic brain syndrome
organic delusional syndrome
therapy - related neoplasm
organic mental disorder
organic affective syndrome
organic personality syndrome
ornithosis
osgood - schlatter's disease
osteitis fibrosa cystica
hip osteoarthritis
osteochondritis
osteochondritis dissecans
osteochondrosis
wdha syndrome
bone necrosis
congenital deformity of hip
rheumatic heart disease
otitis media
secretory otitis media
post - operative pain
palmoplantar pustulosis
pancytopenia
benign penile neoplasm
panic disorder
paracoccidioidomycosis
parakeratosis
paraphimosis
paratyphoid fever a
paratyphoid fever b
paratyphoid fever c
paratyphoid fever
postencephalitic parkinsonism
secondary parkinsonism
carmustine
lip carcinoma
paroxysmal atrial tachycardia
paroxysmal supraventricular tachycardia by ecg finding
paroxysmal ventricular tachycardia by ecg finding
pars planitis
passive - aggressive personality disorder
human head louse
human body louse
benign mucous membrane pemphigoid
pemphigoid
pemphigus
cecum carcinoma
pemphigus vulgaris
penicillin allergy
perceptual distortion
periapical dental abscess
periapical abscess with sinus
pericarditis
pericholangitis
periodontal abscess
periodontitis
peripheral retinal degeneration
enzyme deficiency
chronic peritoneal effusion
ostium primum defect
personality disorder
stump hallucination
pharyngoconjunctival fever
phlegmon
school phobia
social anxiety disorder
phocomelia
lung squamous cell carcinoma
abnormal pigmentation
pilonidal cyst
aspiration pneumonitis
poisoning
polyradiculopathy
baker cyst
post kala - azar dermal leishmaniasis
postmenopausal hemorrhage
postoperative hemorrhage
potassium deficiency disorder
lung papillary adenoma
pre - excitation syndrome
pregnancy complication
gestational diabetes
toxemia of pregnancy
ectopic pregnancy
puncture wound
primary insomnia
colon villous adenoma
proctosigmoiditis
progeria
protein energy malnutrition
protozoal infection
pruritus vulvae
pseudogout
somatoform disorder
substance - induced psychotic disorder
female orgasmic disorder
male orgasmic disorder
hypercalcemia of malignancy
psychosexual dysfunction with inhibited sexual excitement
congenital infundibular stenosis
pulp degeneration
henoch - schnlein purpura
pyelitis
pyelonephritis
pyloric stenosis
lobular capillary hemangioma of skin and subcutaneous tissue
pyosalpinx
pulmonary hamartoma
q fever
rat - bite fever
rectal prolapse
pure red cell aplasia
reiter syndrome
tick - borne relapsing fever
reticuloendothelial hyperplasia
retinal artery occlusion
retinal degeneration
ovarian fibroma
retinal vascular occlusion
retinal vein occlusion
retinopathy of prematurity
reye syndrome
rheumatic fever
acute rheumatic heart disease
rhinitis
atopic rhinitis
vasomotor rhinitis
rhinophyma
atrial myxoma
rib fracture
rickettsiosis
congenital rubella
salivary duct stone
salivary gland stone
sarcoidosis
cutaneous sarcoidosis
pulmonary sarcoidosis
scabies
juvenile osteochondrosis of spine
carotene
peripheral motor neuropathy
schistosomiasis
schistosoma japonicum infection
schistosoma mansoni infection
catatonic type schizophrenia
childhood schizophrenia
disorganized type schizophrenia
paranoid type schizophrenia
residual type schizophrenia
schwartz - jampel syndrome
sclerema neonatorum
peripheral sensory neuropathy
vitamin c deficiency
sea sickness
senile cataract
senile corneal change
separation anxiety disorder
shivering
shock
hemorrhagic shock
septic shock
surgical shock
thyroid gland follicular adenoma
shoulder dislocation
shoulder fracture
shoulder pain
endemic goiter
sinusitis
skin infection
skin pigmentation
smallpox
modified smallpox
hypertensive encephalopathy
sparganosis
sphenoidal sinusitis
splenic rupture
spondylolisthesis
spondylolysis
sprain
staphylococcus aureus gastroenteritis
staphylococcal food poisoning
staphylococcal infection
ulcerative stomatitis
endometrial disorder
strabismus
stress
female stress incontinence
stutter
subclavian steal syndrome
subconjunctival hemorrhage
substance withdrawal syndrome
sun stroke
superficial injury of cornea
wound breakdown
granulomatous dermatitis
surgical wound infection
diaphoresis
sweating fever
syncope
syphilis
latent syphilis
tabes dorsalis
atrioventricular nodal reentry tachycardia by ecg finding
junctional tachycardia by ecg finding
adrenal cortical hyperplasia
paroxysmal tachycardia by ecg finding
supraventricular tachycardia
takayasu arteritis
teething syndrome
hereditary hemorrhagic telangiectasia
temporal arteritis
temporomandibular joint dysfunction syndrome
lateral epicondylitis
tetanic cataract
thalassemia
immune system disorder
buerger disease
subacute thyroiditis
favus
deep seated dermatophytosis
tobacco use disorder
hairy tongue
tooth abrasion
dental disorder
tourette syndrome
tracheal disorder
injection site reaction
tracheoesophageal fistula
traumatic myositis ossificans
traumatic subcutaneous emphysema
trichomonas vaginitis
gambian trypanosomiasis
rhodesian trypanosomiasis
miliary tuberculosis
pott disease
tuberculous fibrosis of lung
typhoid fever
genital leukoplakia
umbilical hernia without mention of obstruction or gangrene
attention deficit disorder
unipolar depression
perinatal disorder
deformity of forearm
idiopathic neuropathy
local infection of skin and subcutaneous tissue
carotenoid
cutaneous melanoma
nonpsychotic mental disorder following organic brain damage
pruritic disorder
transient organic mental disorder
increased uric acid level
female genitourinary fistula
congenital genitourinary abnormality
uterine prolapse
anterior uveitis
uterine corpus degenerated leiomyoma
intermediate uveitis
posterior uveitis
vaginal itching
psychogenic vaginismus
varicose vein
varicose vein of lower extremities with inflammation
conjunctival vascular disorder
vascular disorder
vascular headache
allergic cutaneous angiitis
lung adenocarcinoma
vasovagal syncope
venezuelan equine fever
ventral hernia without mention of obstruction or gangrene
vertebral artery syndrome
viral hepatitis
viremia
vision disorder
partial sight
visual discomfort
vitamin b deficiency
esophageal carcinoma
volkmann's ischemic contracture
vulvovaginitis
wolff - parkinson - white syndrome
wolfram syndrome
xeroderma
intraoperative hemorrhage
peripheral vascular disorder
ankle injury
pharyngoesophageal diverticulum
alagille syndrome
hypertensive retinopathy
dental phobia
microcytic anemia
normocytic anemia
chills
appendicitis
chronic cholecystitis
monocytosis
mycotic aneurysm
bullous dermatitis
galactocele
eosinophilic pneumonia
chronic sinusitis
acute cholecystitis
fracture of pelvis
foreign body in esophagus
adnexal mass
elbow injury
foot injury
lower respiratory tract infection
pulmonary mass
aneurysmal bone cyst
neck mass
nipple discharge
campylobacter gastroenteritis
skin atrophy
neutrophilia
accidental injury
manic psychosis
hypocellular bone marrow
megakaryocytes increased in bone marrow
pregnancy disorder
mixed cellularity classic hodgkin lymphoma
retinal vascular disorder
toxic nodular goiter
congenital aphakia
chronic glomerulonephritis
mosquito - borne hemorrhagic fever
ancylostomiasis due to ancylostoma braziliense
trichomonas prostatitis
malignant uvula neoplasm
malignant neoplasm of lower jaw bone
nodular sclerosis classic hodgkin lymphoma
digestive system carcinoma in situ
physiological malfunction arising from mental factor
musculoskeletal malfunction arising from mental factor
skin disorder arising from mental factor
genitourinary malfunction arising from mental factor
atypical chronic myeloid leukemia ,  bcr - abl1 negative
endocrine disorder arising from mental factor
adjustment reaction with prolonged depressive reaction
partial retinal arterial occlusion
transient retinal arterial occlusion
hereditary retinal dystrophy
acute conjunctivitis
pseudomembranous conjunctivitis
chronic conjunctivitis
eyelid vascular disorder
otorrhea
carubicin
myeloid sarcoma
acute rheumatic pericarditis
acute rheumatic endocarditis
acute rheumatic myocarditis
unspecified renovascular hypertension
acute myocardial infarction
old myocardial infarction
acute myocarditis
non - traumatic extradural hemorrhage
varicose vein of lower extremities
femoral hernia with obstruction
placental polyp
crohn disease of small intestine
crohn colitis
ischemic bowel disease
acute glomerulonephritis
nephrotic syndrome with lesion of proliferative glomerulonephritis
nephrotic syndrome with lesion of membranous glomerulonephritis
nephrotic syndrome with lesion of membranoproliferative glomerulonephritis
chronic glomerulonephritis with lesion of proliferative glomerulonephritis
penile vascular disorder
irregular menstruation
mammary duct ectasia
postcoital bleeding
abortion finding
unspecified antepartum hypertension
unspecified postpartum hypertension
dermatitis due to unspecified substance taken internally
arthropathy in behcet's syndrome
aseptic necrosis of head of humerus
acquired hallux valgus
congenital anemia
closed fracture of mandible ,  multiple sites
balanitis xerotica obliterans
closed fracture of ribs ,  multiple sites
open fracture of carpal bone
closed fracture of metacarpal bone
open fracture of metacarpal bone
injury to diaphragm with open wound into cavity
injury to esophagus without mention of open wound into cavity
injury to esophagus with open wound into cavity
digestive system injury
injury to stomach with open wound into cavity
injury to duodenum with open wound into cavity
malignant posterior tongue neoplasm
injury to rectum with open wound into cavity
injury to liver
injury to liver without mention of open wound into cavity
injury to liver with open wound into cavity
injury to spleen with open wound into cavity
injury to kidney
injury to kidney without mention of open wound into cavity
injury to kidney with open wound into cavity
injury to peritoneum without mention of open wound into cavity
injury to peritoneum with open wound into cavity
malignant parotid gland neoplasm
injury to retroperitoneum with open wound into cavity
foreign body in stomach
foreign body in genitourinary tract
foreign body in penis
skin vascular disorder
greig syndrome
aicardi syndrome
alper syndrome
chondromatosis
malignant submandibular gland neoplasm
congenital adrenal gland hypoplasia
hereditary sideroblastic anemia
stress ulcer
rapidly progressive glomerulonephritis
acanthosis
anisocytosis
poikilocytosis
macrocephaly
malignant sublingual gland neoplasm
nontoxic goiter
lower abdominal pain
animal phobia
perception disturbance
visual cortex disorder
visual agnosia
acneiform dermatitis
vein disorder
malignant hard palate neoplasm
focal glomerulonephritis
proliferative glomerulonephritis
alpha fetoprotein increased
specific phobia
clostridium difficile colitis
hemoglobin e disease
desquamative interstitial pneumonia
axillary mass
malignant soft palate neoplasm
inguinal mass
hepatic mass
mediastinal mass
nose deformity
skin burning sensation
inferior vena cava occlusion
hemolytic jaundice
cefamandole
malignant palate neoplasm
sheehan syndrome
loffler syndrome
viral encephalitis
anterolateral myocardial infarction by ecg finding
anteroseptal myocardial infarction by ecg finding
subendocardial myocardial infarction by ecg finding
renal mass
axillary abscess
allergic dermatitis due to arnica
dermatitis due to acids
malignant pyriform fossa neoplasm
dermatitis due to alkalis
dermatitis due to dichromate
sun exposure dermatitis
juvenile osteochondrosis
tracheal calcification
kaolin pneumoconiosis
chemical pneumonitis
arterial disorder
arterial occlusion
internal hemorrhoid
malignant neoplasm of the thoracic esophagus
external hemorrhoid
coffin - siris syndrome
congenital kyphosis
chronic periodontitis
broncho - esophageal fistula
injury to esophagus
crohn ileitis
malignant neoplasm of the upper third of the esophagus
eosinophilic gastroenteritis
acute hepatitis
cholecystitis with cholelithiasis
cystic duct stone
acute cholangitis
chronic cholangitis
suppurative cholangitis
congenital nephrotic syndrome
kidney vascular disorder
first degree uterine prolapse
malignant neoplasm of the middle third of the esophagus
second degree uterine prolapse
visual pathway disorder
drug - induced aplastic anemia
hemoglobin d disease
acquired factor viii deficiency
lymph node disorder
splenic abscess
ear injury
nose injury
malignant neoplasm of the lower third of the esophagus
closed fracture of rib
open fracture of rib
closed fracture of pelvis
open fracture of pelvis
fracture of metacarpal bone
closed fracture of shaft of metacarpal bone
closed fracture of neck of metacarpal bone
open fracture of shaft of metacarpal bone
open fracture of neck of metacarpal bone
burn of axilla
malignant ampulla of vater neoplasm
cytomegalovirus pneumonia
cryptococcal pneumonia
bladder schistosomiasis
ancylostomiasis due to ancylostoma ceylanicum
intermittent pyrexia
neurotic depression
malignant retroperitoneal neoplasm
bone marrow neoplasm
lytic metastatic bone lesion
ascending cholangitis
zoonotic bacterial infection
viral gastroenteritis
crush injury
tracheal agenesis
congenital arteriovenous fistula
malignant peritoneal neoplasm
hemorrhagic change
mallory bodies present
true histiocytic lymphoma
hallucinogen dependence ,  continuous use
hallucinogen dependence ,  episodic use
cannabis dependence ,  continuous use
cannabis dependence ,  episodic use
cocaine dependence ,  continuous use
cocaine dependence ,  episodic use
malignant splenic neoplasm
respiratory malfunction arising from mental factor
conjunctival injury
corneal injury
congenital lens disorder
primary open angle glaucoma
laryngeal injury
toxoplasma pneumonia
slate pneumoconiosis
inferior myocardial infarction by ecg finding
posterior myocardial infarction by ecg finding
cefotaxime
malignant maxillary sinus neoplasm
silent myocardial infarction
arterial injury
cytomegalovirus colitis
pancreatic duct stone
diffuse c - cell hyperplasia
adrenal hyperplasia
adrenal mass
malignant ethmoid sinus neoplasm
flying phobia
vaginal hypoplasia
mixed tumor of the parotid gland
intrahepatic cholangiocarcinoma
axillary lipoma
malignant frontal sinus neoplasm
phobia
nonorganic insomnia
anal injury
complex endometrial hyperplasia
richter syndrome
examination phobia
malignant neoplasm of multiple primary sites
malignant sphenoid sinus neoplasm
acute gonococcal infection of upper genitourinary tract
acute endocarditis
polycythaemia due to excess erythropoetin production
enlarging abdomen
cauda equina syndrome
hemophagocytic syndrome
malignant glottis neoplasm
acquired factor ix deficiency
cerebral sarcoidosis
liver vascular disorder
post - streptococcal glomerulonephritis
crescentic glomerulonephritis
mesangial proliferative glomerulonephritis
bladder injury
avascular necrosis of femoral head
eye discharge
malignant supraglottis neoplasm
negative pregnancy test
electrocardiogram qrs complex shortened by ecg finding
urethral meatus stenosis
bronchial injury
injury to diaphragm
gallbladder injury
colon injury
abnormal urine test result
dependence
chemical injury
malignant subglottis neoplasm
clinical course of disease
left ventricular mass
simple endometrial hyperplasia
granulomatous slack skin disease
aplastic anemia due to radiation
aplastic anemia due to infection
achenbach syndrome
macular edema
anemia due to disorder of nucleotide metabolism
malignant pleural neoplasm
behavioral disorder
nucleated red blood cells present
anemia due to enzyme disorder
acute renal failure with renal papillary necrosis
tooth abscess
aseptic necrosis of bone
renal arteriovenous malformation
retinal arteriovenous malformation
malignant cardiac neoplasm
atrial tachycardia
pulmonary alveolitis
bacterial gastroenteritis
cardiovascular injury
gingival injury
bone injury
malignant mediastinal neoplasm
esophageal mass
stomach mass
cancerphobia
axillary lymphadenopathy
hilar mass
chemically induced cytotoxicity
lymph node neoplasm
toxic shock syndrome
vascular purpura
ceftazidime sodium
skin kaposi sarcoma
malignant bone marrow neoplasm
digestive system infection
coronary atherosclerosis
throat carcinoma
brain mass
lung kaposi sarcoma
limb injury
gastrointestinal arteriovenous malformation
gastrointestinal polyp
septal myocardial infarction by ecg finding
malignant uterine neoplasm
lymph node mass
periodontal infection
vaginal abscess
leukocytosis
chronic insomnia
wolf - hirschhorn syndrome
lymph node involvement
malignant endocervical neoplasm
thrombocytosis
pulmonary vascular disorder
portal cirrhosis
nephrotic syndrome with lesion of focal glomerulosclerosis
nephrotic syndrome with lesion of segmental hyalinosis
nephrotic syndrome with lesion of endothelial glomerulonephritis
nephrotic syndrome with lesion of hypocomplementemic glomerulonephritis
nephrotic syndrome with lesion of persistent glomerulonephritis
malignant exocervical neoplasm
nephrotic syndrome with lesion of minimal change glomerulonephritis
hyperkeratosis
traumatic encephalopathy
arteriolosclerosis
myocardial disorder
acroosteolysis
dysphasia
yellow fever virus infection
monoclonal gammopathy
hypoxic ischemic encephalopathy
malignant placental neoplasm
acute poliomyelitis
cardiovascular system finding
abnormal blood chemistry and hematology test result
salivary gland sebaceous lymphadenoma
childhood botryoid - type embryonal rhabdomyosarcoma of the vagina
tall cell variant thyroid gland papillary carcinoma
malignant uterine corpus neoplasm
complex endometrial hyperplasia with atypia
rare neoplastic syndrome
neuroepithelial ,  perineurial ,  and schwann cell neoplasm
malignant clitoral neoplasm
progressive disease
childhood botryoid - type embryonal rhabdomyosarcoma
mucocutaneous candidiasis
traumatic hemorrhage
acalculous cholecystitis
acute acalculous cholecystitis
malignant epididymal neoplasm
hemorrhagic complication of pregnancy
initial insomnia
middle insomnia
low frequency hearing loss
erythrophagocytosis
mixed stone
lateral myocardial infarction by ecg finding
acute diffuse glomerulonephritis
cardiac sarcoidosis
malignant spermatic cord neoplasm
cryptococcal gastroenteritis
cryptosporidial gastroenteritis
emphysematous cholecystitis
congenital spondylolysis
maternal complication of pregnancy
vascular hemorrhagic disorder
dental developmental disorder
dental surface disorder
dental pain and sensation disorder
congenital adrenal gland disorder
cephalexin
malignant scrotal neoplasm
skin ischemic condition
sleep disorder due to general medical condition
glomerular vascular disorder
cartilage injury
blood alkaline phosphatase increased
aggravated colitis
exacerbated insomnia
malignant accessory urethral gland neoplasm
diabetic vascular disorder
hepatic arteriovenous malformation
negative schumm test
aids phobia
sputum excretion difficulty
papillary conjunctivitis
post abortion hemorrhage
iris vascular disorder
herpes zoster dermatitis
malignant orbit neoplasm
herpes simplex dermatitis
gonococcal infection of genitourinary tract
caustic injury
aortic injury
enterovirus gastroenteritis
retinal dystrophy
spinal vascular disorder
negative skin test
criminal injury
submandibular duct stone
malignant lacrimal gland neoplasm
domestic injury
negative patch test
clostridium sordellii colitis
chronic candidiasis
lower ribs pain
hyperlipoproteinemia type iib
increased sputum excretion
femoral hernia with obstruction without mention of gangrene
malignant conjunctival neoplasm
umbilical hernia with obstruction without mention of gangrene
hernia with obstruction without mention of gangrene
ventral hernia with obstruction without mention of gangrene
corrosive injury
fredrickson type iii lipidemia
pancreatic injury
insomnia due to organic factor
unresectable malignant liver neoplasm
hydroxyproline urine increased
malignant corneal neoplasm
upper respiratory tract infection
post - procedural pain
acquired macrocephaly
congenital macrocephaly
carcinomatous ascites
normal blood test result
post procedural hemorrhage
normal phenolsulfonphthalein test
congenital dental disorder
anemia due to chronic disorder
malignant choroid neoplasm
cytomegalovirus gastroenteritis
chest wall cyst
tumor associated fever
injury asphyxation
ocular vascular disorder
febrile neutropenia
ureter abscess
post - biopsy pain
non - proliferative diabetic retinopathy
abdominal infection
malignant lacrimal duct neoplasm
phobia of driving
bursa injury
posterolateral myocardial infarction by ecg finding
inferolateral myocardial infarction by ecg finding
recurrent malignant neoplasm of salivary gland
localized malignant gallbladder neoplasm
malignant brain neoplasm
negative test result
positive laboratory test result
localized pagetoid reticulosis
folliculotropic mycosis fungoides
immunodeficiency - related disorder
parotid gland mucosa - associated lymphoid tissue lymphoma
breast mucosa - associated lymphoid tissue lymphoma
ocular adnexal mucosa - associated lymphoid tissue lymphoma
malignant cerebellar neoplasm
eye lymphoma
mixed tumor of the salivary gland
posterior pharyngeal wall carcinoma
posterior pharyngeal wall squamous cell carcinoma
stage iva major salivary gland cancer ajcc v7
stage ivb major salivary gland cancer ajcc v7
stage ivc major salivary gland cancer ajcc v7
epiglottic carcinoma
benign uvula neoplasm
diffuse infiltrative lymphocytosis syndrome
cephalosporin antibiotic
malignant brain stem neoplasm
salivary gland myoepithelial carcinoma
salivary gland epithelial myoepithelial carcinoma
salivary gland polymorphous low grade adenocarcinoma
salivary gland small cell carcinoma
acute contagious conjunctivitis
closed dislocation
exudative glomerulonephritis
focal embolic glomerulonephritis
stone
aagenaes syndrome
malignant cranial nerve neoplasm
triple a syndrome
testicular teratoma with somatic - type malignancy
follicular bronchitis / bronchiolitis
nodular lymphoid hyperplasia of lung
idiopathic interstitial pneumonia
usual interstitial pneumonia
idiopathic pulmonary fibrosis
nonspecific interstitial pneumonia
thymic undifferentiated carcinoma
genitourinary system infection
malignant spinal cord neoplasm
trichomonas infection
paraphrenia
third degree uterine prolapse
nasopharyngeal disorder
dislocation
congenital cardiovascular disorder
congenital cardiovascular abnormality
malignant pineal region neoplasm
gonococcal infection
hearing loss
salivary gland large cell carcinoma
salivary gland lymphoepithelial carcinoma
salivary gland adenosquamous carcinoma
salivary gland sebaceous adenoma
malignant carotid body paraganglioma
non - neoplastic vascular disorder
non - neoplastic heart disorder
thoracic disorder
non - neoplastic thoracic disorder
sternal disorder
chest wall disorder
axillary disorder
non - neoplastic axillary disorder
metastatic malignant neoplasm in the axilla
axillary neoplasm
malignant endocrine neoplasm
benign axillary neoplasm
non - neoplastic sternal disorder
non - neoplastic chest wall disorder
non - neoplastic tracheal disorder
tracheal atresia
non - neoplastic respiratory system disorder
stage iiib lung small cell carcinoma with pleural effusion ajcc v7
stage iiib lung small cell carcinoma without pleural effusion ajcc v7
stage 0 lung large cell carcinoma ajcc v6 and v7
metastasizing pleomorphic adenoma of the salivary gland
malignant thoracic neoplasm
arthropathy
transient arthropathy
traumatic arthropathy
wernicke - korsakoff syndrome
histiocytoma
normal laboratory test result
generalized atherosclerosis
atherosclerosis
generalized arteriosclerosis
metastatic malignant neoplasm in the lung
monckeberg arteriosclerosis
atherosclerotic cardiovascular disease
vitamin deficiency disorder
non - neoplastic bile duct disorder
ciliary body disorder
pediculosis pubis
gastrointestinal stromal tumor of the gastrointestinal tract
non - neoplastic dental disorder
metastatic malignant neoplasm in the mediastinum
epithelioid cell uveal melanoma
mixed cell uveal melanoma
choroid mixed cell melanoma
ciliary body mixed cell melanoma
non - neoplastic hair disorder
interstitial myocarditis
unstable personality
hypercellular bone marrow
lower thigh pain
metastatic malignant neoplasm in the pleura
congenital alopecia
xanthogranulomatous cholecystitis
femoropopliteal occlusive disease
pagetoid reticulosis
acute hemorrhagic encephalitis
anti - basement membrane glomerulonephritis
diffuse glomerulonephritis
cephalothin sodium
metastatic malignant neoplasm in the bone
immune complex glomerulonephritis
subacute glomerulonephritis
zoonotic infection
conditioned insomnia
ancylostomiasis
acute interstitial pneumonia
abstinence syndrome
achard syndrome
ann arbor stage iii nodular sclerosis classic hodgkin lymphoma
acroparesthesia syndrome
adherence syndrome
malignant lymph node neoplasm
hematopoietic and lymphoid system neoplasm
hematopoietic and lymphoid system disorder
granulocytic sarcoma
monoblastic sarcoma
blastic granulocytic sarcoma
immature granulocytic sarcoma
differentiated granulocytic sarcoma
ann arbor stage iii mixed cellularity classic hodgkin lymphoma
reticulin fibrosis of the bone marrow
splenic disorder
amputation neuroma
megaloblastic erythroid hyperplasia
foveolar hyperplasia
riedel fibrosing thyroiditis
subacute granulomatous thyroiditis
subacute lymphocytic thyroiditis
ann arbor stage iii lymphocyte - depleted classic hodgkin lymphoma
columnar cell variant thyroid gland papillary carcinoma
carcinosarcoma of the salivary gland
parotid gland carcinosarcoma
salivary gland cystadenoma
salivary gland intraductal papilloma
salivary gland inverted ductal papilloma
salivary gland sialadenoma papilliferum
salivary gland sialoblastoma
salivary gland ductal papilloma
ann arbor stage iii hodgkin lymphoma
intraepithelial melanocytic hyperplasia
microaneurysm
traumatic aneurysm
radiation - induced vascular disease
basal cell hyperplasia
columnar metaplasia
liver dysplastic foci
plasma cell leukemia in remission
head and neck carcinoma
grade 1 clear cell renal cell carcinoma
grade 2 clear cell renal cell carcinoma
grade 3 clear cell renal cell carcinoma
grade 4 clear cell renal cell carcinoma
squamous hyperplasia
mesonephric hyperplasia
osseous metaplasia
acute lymphoblastic leukemia in remission
mesothelial hyperplasia
normal urine test result
morphologic finding
maxillary sinus cholesteatoma
radiologic finding
chronic lymphocytic leukemia in remission
conventional osteosarcoma
ewing sarcoma / peripheral primitive neuroectodermal tumor of bone
iatrogenic kaposi sarcoma
endemic african kaposi sarcoma
bronchogenic carcinoma
childhood intracranial neoplasm
abnormal hematology test result
acute myeloid leukemia in remission
blast cells present
hereditary elliptocytosis
monoclonal hypergammaglobulinemia
polyclonal hypergammaglobulinemia
morphologic architectural pattern
chronic myelogenous leukemia ,  bcr - abl1 positive in remission
lobulated growth pattern
nested pattern
radial growth phase
vertical growth phase
nodular pattern
ceramide
acute monocytic leukemia in remission
diffuse pattern
benign lip neoplasm
papillary pattern
pseudopapillary pattern
trabecular pattern
benign tongue neoplasm
cribriform pattern
compact pattern
tubular pattern
glomeruloid vessels present
benign floor of the mouth neoplasm
distantly metastatic malignant neoplasm
sessile lesion
pedunculated lesion
tumor vascular invasion
benign tonsillar neoplasm
benign nasopharyngeal neoplasm
arias - stella reaction
stromal invasion
tumor cell necrosis
mitotic activity
benign hypopharyngeal neoplasm
atypical mitotic figures
benign pharyngeal neoplasm
inflammatory infiltrate
acute inflammatory infiltrate
benign esophageal neoplasm
chronic inflammatory infiltrate
eosinophilic infiltrate
polymorphonuclear cell infiltrate
lymphocytic infiltrate
lymphoplasmacytic infiltrate
hemophagocytosis
benign gastric neoplasm
dystrophic calcification
myxoid stroma formation
benign small intestinal neoplasm
hyalinized stroma formation
benign laryngeal neoplasm
decidual reaction
nodular neoplasm
michaelis - gutmann body
ground glass nuclear inclusion
benign tracheal neoplasm
anaplastic malignant neoplasm
non - invasive lesion
microinvasive malignant neoplasm
benign pleural neoplasm
osteolytic neoplasm
premalignant neoplasm
non - encapsulated neoplasm
non - metastatic neoplasm
non - lytic metastatic lesion
benign mediastinal neoplasm
malignant neoplasm by grade
moderately differentiated malignant neoplasm
benign cardiac neoplasm
poorly differentiated malignant neoplasm
undifferentiated malignant neoplasm
well differentiated malignant neoplasm
epithelial predominant pulmonary blastoma
biphasic pulmonary blastoma
acute myeloid leukemia with a variant rara translocation
acute myeloid leukemia with t ( 11 ; 17 )  ( q23 ; q21 )
acute myeloid leukemia with t ( 5 ; 17 )  ( q35 ; q21 )
acute myeloid leukemia with t ( 11 ; 17 )  ( q13 ; q21 )
spermatic cord lipoma
chronic myelomonocytic leukemia with eosinophilia
chronic myelomonocytic leukemia - 1
chronic myelomonocytic leukemia - 2
hemorrhagic ascites
vaginal stricture
superior vena cava occlusion
orbivirus infection
clostridium colitis
posteroinferior myocardial infarction by ecg finding
dental and periodontal infection
benign cervical neoplasm
abdominal and gastrointestinal infection
chronic polyneuropathy
abnormal phenolsulfonphthalein test result
apical myocardial infarction by ecg finding
metastatic peripheral primitive neuroectodermal tumor of bone
sinus histiocytosis with massive lymphadenopathy
malignant reproductive system neoplasm
hilar cholangiocarcinoma
sideroblastic anemia
subungual glomus tumor
benign uterine corpus neoplasm
diffuse large b - cell lymphoma germinal center b - cell type
diffuse large b - cell lymphoma activated b - cell type
metastatic carcinoma in the bone
intraductal breast neoplasm
invasive micropapillary breast carcinoma
invasive papillary breast carcinoma
flat ductal epithelial atypia of the breast
central breast papilloma
peripheral breast papilloma
atypical breast papilloma
benign uterine neoplasm
intraductal papillary breast neoplasm
testicular dermoid cyst
early invasive cervical squamous cell carcinoma
cervical mucinous adenocarcinoma
early invasive cervical adenocarcinoma
cervical carcinosarcoma
childhood botryoid - type embryonal rhabdomyosarcoma of the vulva
adult botryoid - type embryonal rhabdomyosarcoma
chewing tobacco
benign vaginal neoplasm
brca1 syndrome
brca2 syndrome
hereditary ovarian carcinoma
aggressive clinical course
hereditary male breast carcinoma
hereditary female breast carcinoma
superficial lesion
benign vulvar neoplasm
non - measurable lesion
anaplastic lesion
non - melanomatous lesion
borderline lesion
invasive lesion
benign testicular neoplasm
villous pattern
benign cellular infiltrate
microinvasive lesion
comedo necrosis
benign prostate neoplasm
well differentiated lesion
benign epididymal neoplasm
benign scrotal neoplasm
accelerated phase of disease
benign renal pelvis neoplasm
localized disease
benign ureter neoplasm
viral hemorrhagic fever
ebola hemorrhagic fever
sweating
prolapse
negative lymph node
fibrotic stroma formation
benign bladder neoplasm
multifocal lesion
micropapillary pattern
solid growth pattern
necrotic change
steatosis
thorotrast exposure
benign urethral neoplasm
arteriovenous fistula
bilateral deafness
complete deafness
skin granuloma
mycobacterium avium infection
astler - coller c2 colon carcinoma
astler - coller c1 colon carcinoma
chlorambucil
benign orbit neoplasm
astler - coller a colon carcinoma
astler - coller b1 rectal carcinoma
peutz - jeghers polyp of the stomach
small intestinal hamartoma
digestive system adenoma
myeloblasts under 2 percent of peripheral blood white cells
myeloblasts under 5 percent of bone marrow nucleated cells
benign lacrimal gland neoplasm
myeloblasts 10 - 19 percent of bone marrow nucleated cells
myeloblasts 10 - 19 percent of peripheral blood white cells
blasts 20 percent or more of peripheral blood white cells
blasts 20 percent or more of bone marrow nucleated cells
immature granulocytes in peripheral blood increased
myeloblasts under 20 percent of bone marrow nucleated cells
normoblastic erythroid hyperplasia
leukoerythroblastic reaction
myeloblasts under 10 percent of bone marrow nucleated cells
benign conjunctival neoplasm
blasts under 20 percent of peripheral blood white cells
myeloblasts under 5 percent of peripheral blood white cells
myeloblasts 5 - 19 percent of peripheral blood white cells
myeloblasts under 20 percent of peripheral blood white cells
hemoglobin f increased
ring sideroblasts under 15 percent of erythroid precursors
ring sideroblasts 15 percent or more of erythroid precursors
bi - cytopenia
myeloblasts under 1 percent of peripheral blood white cells
myeloblasts 5 - 19 percent of bone marrow nucleated cells
benign corneal neoplasm
myeloblasts 5 - 9 percent of bone marrow nucleated cells
myeloblasts 20 percent or more of bone marrow nucleated cells
myeloblasts 20 percent or more of peripheral blood white cells
bone marrow eosinophilia
peripheral blood eosinophilia
bone marrow dysplasia present
bone marrow dysplasia present in 50 percent or more of the cells of two cell lines
bone marrow dysplasia present in 10 percent or more of the cells of two or more myeloid cell lines
promyelocytes ,  myelocytes ,  and mature neutrophils 10 percent or more of bone marrow cells
neoplastic monocytes and precursors 20 percent or more of bone marrow cells
benign retinal neoplasm
monoblasts 20 percent or more of bone marrow nucleated cells
monoblasts 80 percent or more of bone marrow monocytic cells
neoplastic promonocytes in bone marrow markedly increased
erythroid precursors 50 percent or more of bone marrow nucleated cells
myeloblasts 20 percent or more of bone marrow non - erythroid cells
erythroid precursors 80 percent or more of bone marrow nucleated cells
megakaryoblasts 50 percent or more of bone marrow nucleated cells
normal bone marrow test result
atypical lymphocytes present in bone marrow
atypical lymphocytes present in peripheral blood
benign choroid neoplasm
benzene exposure
ineffective hematopoiesis
bone marrow basophilia
peripheral blood basophilia
secondary neoplasm
benign lacrimal duct neoplasm
hereditary clear cell renal cell carcinoma
non - hereditary clear cell renal cell carcinoma
oral cavity leukoplakia
metastatic malignant neoplasm
acute adult t - cell leukemia / lymphoma
lymphomatous adult t - cell leukemia / lymphoma
hodgkin - like adult t - cell leukemia / lymphoma
benign spinal cord neoplasm
t - cell prolymphocytic leukemia ,  small cell variant
t - cell prolymphocytic leukemia ,  cerebriform cell variant
chronic lymphocytic leukemia with plasmacytoid differentiation
small lymphocytic lymphoma with plasmacytoid differentiation
finding by site or system
digestive system finding
benign thyroid gland neoplasm
nervous system finding
integumentary system finding
head and neck finding
eye and ear finding
reproductive system finding
endocrine system finding
urinary system finding
congenital or acquired anatomic abnormality
connective and soft tissue finding
hematopoietic system finding
benign adrenal gland neoplasm
chemical exposure
laboratory test result
ovalocytosis
regional lymph node involvement
chloramphenicol
benign parathyroid gland neoplasm
breast carcinoma metastatic in the lung
breast carcinoma metastatic in the brain
breast carcinoma metastatic in the liver
breast carcinoma metastatic in the bone
lung carcinoma metastatic in the brain
lung carcinoma metastatic in the bone
lung carcinoma metastatic in the liver
prostate carcinoma metastatic in the lung
prostate carcinoma metastatic in the bone
colon carcinoma metastatic in the liver
benign pineal region neoplasm
secondary carcinoma
intestinal metaplasia of esophageal mucosa
b acute lymphoblastic leukemia with t ( 9 ; 22 )  ( q34 .1 ; q11 .2 )  ;  bcr - abl1
chromosomal loss
t ( 12 ; 16 )  ( q13 ; p11 )
microsatellite instability
t ( 8 ; 14 )  ( q24 ; q32 )
gene abnormality
rb1 gene inactivation
tp53 gene inactivation
intracranial hemangioma
polysomy
clonal gene rearrangement
abnormal dna repair
retinal hemangioma
t ( 8 ; 14 )  ( q24 ; q11 )
intra - abdominal hemangioma
t ( 10 ; 14 )  ( q24 ; q11 )
benign lymph node neoplasm
t ( 5 ; 17 )  ( q35 ; q21 )
t ( 4 ; 11 )  ( q21 ; q23 )
t ( 21 ; 22 )  ( q22 ; q12 )
t ( 7 ; 22 )  ( p22 ; q12 )
stage 0 esophageal cancer ajcc v6
t ( 9 ; 11 )  ( p21 .3 ; q23 .3 )
t ( 11 ; 19 )  ( q23 ; p13 .1 )
t ( 11 ; 19 )  ( q23 .3 ; p13 .3 )
inv ( 16 )  ( p13 .1 ; q22 )
t ( 12 ; 22 )  ( q13 ; q12 )
t ( 1 ; 13 )  ( p36 ; q14 )
stage 0 colon cancer ajcc v6 and v7
monosomy 13
t ( 2 ; 13 )  ( q35 ; q14 )
tracheal carcinoma in situ
t ( x ; 18 )  ( p11 ; q11 )
molecular genetic variation
t ( x ; 17 )  ( p11 .2 ; q25 )
trisomy 8
chlorhexidine
stage 0 skin cancer
loss of chromosome 20q
t ( 3 ; 3 )  ( q21 .3 ; q26 .2 )
inv ( 3 )  ( q21 .3 ; q26 .2 )
loss of chromosome 7q
stage 0 breast cancer ajcc v6 and v7
loss of chromosome 12p
monosomy 7
t ( 3 ; 5 )  ( q25 ; q34 )
t ( 1 ; 22 )  ( p13 .3 ; q13 .1 )
grade iii prostatic intraepithelial neoplasia
trisomy 12
del ( 11q22q23 )
del ( 17p13 )
stage 0 penile cancer ajcc v6
trisomy 5
gain of chromosome 2p
stage 0is bladder urothelial carcinoma ajcc v6 and v7
gain of chromosome 12q
clonal immunoglobulin gene rearrangement
clonal immunoglobulin heavy chain gene rearrangement
gain of chromosome 7
gain of chromosome 8
neoplasm of uncertain malignant potential
gain of chromosome 9
gain of chromosome 17
i ( 17q )
cerebral cyst
gain of chromosome 1q
gain of chromosome 17q
ccnd1 protein overexpression
gain of chromosome 8q
conjunctival granuloma
loss of chromosome 14
loss of chromosome 22
high - frequency microsatellite instability
low - frequency microsatellite instability
loss of chromosome 18q
loss of chromosome 13q
loss of chromosome 12q
loss of chromosome 17p
chlormadinone acetate
conjunctival cyst
loss of chromosome 6p
loss of chromosome 1p
loss of chromosome 3p
loss of chromosome 8p
loss of chromosome 6
loss of chromosome 11p
loss of chromosome 22q
loss of chromosome 19q
monosomy 17
eyelid xanthoma
loss of chromosome 10p
loss of chromosome 16q
loss of chromosome 10q
t ( v ; 11q23 .3 )
eyelid cyst
monosomy 5
loss of chromosome 7
loss of chromosome 5
trisomy 13
orbital granuloma
trisomy 4
t ( 6 ; 9 )  ( p23 ; q34 .1 )
del ( 11q23 )
loss of chromosome 8
loss of chromosome 13
loss of chromosome x
middle ear cholesteatoma
chromosomal rearrangement
loss of chromosome 16
loss of chromosome 17q
loss of chromosome 2p
loss of chromosome 2q
loss of chromosome 11
middle ear cholesterol granuloma
benign essential hypertension
del ( 1p36 )
secondary hypertension
loss of chromosome 4
loss of chromosome 18p
benign secondary hypertension
loss of chromosome 6q
loss of chromosome 9
loss of chromosome 10
loss of chromosome 3
polypoid sinus degeneration
increased nfkappab pathway activation
loss of chromosome 16p
loss of chromosome 1
loss of chromosome 18
loss of chromosome y
chlorophyll
breast fibrosis
t ( 3 ; 21 )  ( q26 ; q22 )
breast fat necrosis
t ( 6 ; 11 )  ( q27 ; q23 )
t ( 10 ; 11 )  ( p11 ; q23 )
t ( 16 ; 21 )  ( p11 ; q22 )
uterine polyp
trisomy 18
monosomy 6
vaginal leukoplakia
loss of chromosome 17
loss of chromosome 19
gain of chromosome 6p
loss of chromosome 9p
erbb2 gene amplification
erbb2 protein overexpression
vaginal polyp
myc gene amplification
egfr gene amplification
late radiation injury
fgfr1 gene amplification
fgfr2 gene amplification
ccnd1 gene amplification
ctnnb1 gene mutation
traumatic neuroma
monoclonal hepatocyte population present
kras gene amplification
loss of chromosome 4q
thyroid cyst
nmyc gene amplification
mycl gene amplification
contact hypersensitivity
mdm2 gene amplification
ccne1 gene amplification
nf1 gene inactivation
nf2 gene inactivation
malnutrition
pten gene inactivation
tsc2 gene inactivation
chlorpromazine
large plaque parapsoriasis
injury
p210 fusion protein expression
p230 fusion protein expression
p190 fusion protein expression
bcr - abl1 fusion protein expression
le cell
segmented neutrophil
calcification
sezary cell
abnormal lymphocyte
anhedonia
cytomegalic cell
reproductive system neoplasm
abnormal epithelial cell
obstructive uropathy
benign neoplasm
signet ring adenocarcinoma cell
salivary gland basal cell adenocarcinoma
oxyphilic adenocarcinoma
keratinizing malignant squamous cell
non - keratinizing malignant squamous cell
malignant epithelial small cell
cholera toxin
cribriform carcinoma
granular cell carcinoma
neoplastic multinucleated giant cell
sweat gland tubular carcinoma
osteoclast - like giant cell
anaplastic carcinoma cell
microcystic adenoma
salivary gland monomorphic adenoma
renal papillary adenoma
lobular carcinoma cell
trabecular adenoma
appendix goblet cell adenocarcinoma
cholesterol
atypical glandular cell
undifferentiated carcinoma
carcinomatosis
dysplastic nevus
malignant oncocyte
papillary fibroelastoma
subependymal giant cell astrocytoma
myxopapillary ependymoma
choroid plexus papilloma
intramuscular hemangioma
chromium
epithelioid leiomyosarcoma
lymphoplasmacytoid cell
myxoid leiomyosarcoma
hibernoma
pleomorphic lipoma
abnormal platelet
dedifferentiated liposarcoma
neoplastic monocyte
pleomorphic liposarcoma
medullomyoblastoma with myogenic differentiation
meningiomatosis
germ cell tumor
plasmablast
epithelial neoplasm
chromomycin antineoplastic antibiotic
ameloblastic fibro - odontoma
neoplastic small cell
compound odontoma
squamous cell papilloma
fibrillary neoplastic astrocyte
papillomatosis
gemistocytic neoplastic astrocyte
epithelioid sarcoma
aids encephalopathy
primitive neuroectodermal tumor
neoplastic large cell
atypical lymphocyte
melanotic neuroectodermal tumor
wilms tumor - aniridia - genitourinary anomalies - mental retardation syndrome
trisomy 11
intravascular metastasis
anaplastic large cell lymphoma ,  alk - positive
anaplastic large cell lymphoma ,  alk - negative
primary systemic anaplastic large cell lymphoma ,  alk - positive
primary systemic anaplastic large cell lymphoma ,  alk - negative
chrysarobin
anaplastic large cell lymphoma
chronic lymphocytic leukemia / small lymphocytic lymphoma with immunoglobulin heavy chain variable - region gene somatic hypermutation
chronic lymphocytic leukemia with immunoglobulin heavy chain variable - region gene somatic hypermutation
small lymphocytic lymphoma with immunoglobulin heavy chain variable - region gene somatic hypermutation
chronic lymphocytic leukemia / small lymphocytic lymphoma with unmutated immunoglobulin heavy chain variable - region gene
chronic lymphocytic leukemia with unmutated immunoglobulin heavy chain variable - region gene
small lymphocytic lymphoma with unmutated immunoglobulin heavy chain variable - region gene
diffuse blastoid b - cell lymphoma
lymphomatoid papulosis
renal cell carcinoma with t ( 6 ; 11 )  ;  ( p21 ; q12 )  ;  malat1 - tfeb
t ( 6 ; 11 )  ( p21 ; q12 )
solid pseudopapillary neoplasm of the pancreas
pancreatic colloid carcinoma
fip1l1 - pdgfralpha fusion protein expression
aml1 - eto fusion protein expression
cbfb - myh11 fusion protein expression
oral cavity hairy leukoplakia
zbtb16 - rara fusion protein expression
pml - rara fusion protein expression
tcf3 - pbx1 fusion protein expression
etv6 - runx1 fusion protein expression
kmt2a - af4 fusion protein expression
lymphatic vessel neoplasm
cystic hygroma
t ( 2 ; 22 )  ( q33 ; q12 )
lymphangioleiomyomatosis
pancreatic foamy gland adenocarcinoma
desmoplastic melanoma
paraganglioma - like dermal melanocytic tumor
adenomyoma
hermansky - pudlak syndrome
granulomatous colitis
kidney mixed epithelial and stromal tumor
benign kidney mixed epithelial and stromal tumor
malignant mixed epithelial and stromal tumor of the kidney
bladder urothelial carcinoma in situ
atypical small acinar proliferation of the prostate gland
morular metaplasia of the endometrium
adenosquamous carcinoma
tyrosine - protein phosphatase non - receptor type substrate 1
vulvar intraepithelial neoplasia ,  differentiated type
protein tyrosine phosphatase type iva 1
interferon alpha receptor complex
ifnar1 gene
interferon alpha / beta receptor 1
ifnar2 gene
interferon alpha / beta receptor 2
interferon gamma receptor complex
hepatoblastoma
ifngr1 gene
6q23 - q24
10q22
8p11 .2
xq24 - q26
xp22 .32
interferon gamma receptor 1
ifngr2 gene
interferon gamma receptor 2
voltage - dependant anion channel
malignant mixed neoplasm
head and neck basaloid carcinoma
vdac1 gene
voltage - dependent anion - selective channel protein 1
vdac2 gene
voltage - dependent anion - selective channel protein 2
vdac3 gene
voltage - dependent anion - selective channel protein 3
adenosine nucleotide transporter
slc25a4 gene
adp / atp translocase 1
chrysene
mixed mesodermal  ( mullerian )  tumor
slc25a5 gene
adp / atp translocase 2
slc25a6 gene
adp / atp translocase 3
multicentric thyroid gland papillary carcinoma
focal segmental glomerulosclerosis
receptor - type tyrosine - protein phosphatase epsilon
receptor - type tyrosine - protein phosphatase epsilon isoform 2
receptor - type tyrosine - protein phosphatase gamma
loss of chromosome 11q
receptor - type tyrosine - protein phosphatase eta
receptor - type tyrosine - protein phosphatase r
receptor - type tyrosine - protein phosphatase t
xp22 .33
serine / threonine - protein phosphatase 2a regulatory subunit b'' subunit beta
pulmonary blastoma
129 / sv mouse
angiolipoma
angiomyolipoma
balb / c mouse
adrenal gland myelolipoma
c3h / he mouse
c3h / hej mouse
mesenchymal chondrosarcoma
c57bl / 10 mouse
osteoclastic giant cell - rich tumor of bone
benign fibrous histiocytoma
cba / ca mouse
cba / j mouse
cimetidine
bone desmoplastic fibroma
abdominal  ( mesenteric )  fibromatosis
nmri mouse
myofibromatosis
fibroepithelial neoplasm
breast fibroadenoma
tsp - 1 mimetic abt - 510
autologous heat - shock protein 70 peptide vaccine ag - 858
survivin antigen
clear cell sarcoma of soft tissue
na17 - a antigen
tesetaxel
ixabepilone
cenersen
zebularine
hypericin
c - c chemokine receptor type 9
small cell sarcoma
angioleiomyoma
leiomyomatosis
alveolar rhabdomyosarcoma
ciprofloxacin
alveolar soft part sarcoma
ny - eso - 1 protein vaccine plus montanide isa - 51 vg
smooth muscle neoplasm
adenovirus - mediated human interleukin - 12
embryonal carcinoma
germinoma
gonadoblastoma
bevacizumab / cetuximab regimen
bevacizumab / cetuximab / irinotecan regimen
bevacizumab / cyclophosphamide regimen
bevacizumab / erlotinib regimen
mixed embryonal carcinoma and teratoma
bicalutamide / triptorelin regimen
placental - site gestational trophoblastic tumor
hepatocellular adenoma
oncocytic adenoma
capecitabine / ixabepilone regimen
pcc regimen
cisplatin
hidrocystoma
gcd regimen
carboplatin / dexamethasone / gemcitabine / rituximab regimen
syringoma
lcf regimen
adenomatoid tumor
pulmonary adenomatosis
adenomatous polyp
multicystic mesothelioma
clear cell adenocarcinoma
acinar cell carcinoma
endometrioid adenocarcinoma
clindamycin
pancreatic neuroendocrine carcinoma
lobular breast carcinoma
mucoepidermoid carcinoma
neuroendocrine carcinoma
signet ring cell carcinoma
adnexal carcinoma
mucinous cystadenocarcinoma
papillary cystadenocarcinoma
exemestane / trastuzumab regimen
serous cystadenocarcinoma
giant cell carcinoma
clofibrate
large cell carcinoma
gemcitabine / trastuzumab regimen
verrucous carcinoma
cervical intraepithelial neoplasia
serous cystadenoma
basal cell neoplasm
intraductal papilloma
mesothelial neoplasm
autoimmune lymphoproliferative syndrome
trisomy 17
b - cell lymphoma ,  unclassifiable ,  with features intermediate between diffuse large b - cell lymphoma and classic hodgkin lymphoma
neuroepithelial neoplasm
mediastinal b - cell lymphoma ,  unclassifiable ,  with features intermediate between diffuse large b - cell lymphoma and classic hodgkin lymphoma
pityriasis lichenoides et varioliformis acuta
renal cell carcinoma associated with t ( x ; 1 )  ( p11 .2 ; q21 )
renal cell carcinoma associated with t ( x ; 1 )  ( p11 .2 ; p34 )
renal cell carcinoma associated with t ( x ; 17 )  ( p11 .2 ; q25 )
ganglioglioma
tel - jak2 fusion protein expression
bcr - jak2 fusion protein expression
tissue lysis
olfactory neuroblastoma
measurable
residual
informed
tanespimycin
clomiphene citrate
ganglioneuroblastoma
provider
site
support
intestinal mass
acidosis
age - months
age - years
alkalosis
central neurocytoma
allergic
and
arachnoiditis
atrial
auditory
autoimmune
average
bicarbonate ion
blur
squamous cell neoplasm
bradycardia
bruise
callback
cellularity
clone
cognitive
color
confusion
consciousness
inverted papilloma
constipation
constitutional
contraception
contraindicated
corrected
cough
cranial
creatine
cushingoid
date and time
sex cord - stromal tumor
deficit
diplopia
distress
dizziness
ear pain
echocardiogram recording
measurement of left ventricular ejection fraction
engraftment
enrollment
entered
subependymoma
esophageal
feminine
flatulence
floaters
gain
geographic
germ
gamma - glutamyl transpeptidase
gliosarcoma
graph
hallucination
haptoglobin
harvest procedure
hematemesis
hemolysis
hiccough
hypercholesterolemia
hyperkalemia
hypermagnesemia
plexiform neurofibroma
hypernatremia
hypertriglyceridemia
hypoalbuminemia
hypocalcemia
hypokalemia
hypomagnesemia
hyponatremia
hypophosphatemia
international classification of diseases for oncology
ileus
malignant peripheral nerve sheath tumor
inner
intubation procedure
laboratory
libido
alive
lipase
masculine
angiofibroma
memory
mitotic
movement
north american brain tumor consortium
new approaches to brain tumor therapy consortium
nyctalopia
or
palpitation
clonidine
epithelioid hemangioendothelioma
performed
pericardial
personality
phlebitis
skin photosensitivity
pigmentation
pneumothorax
portal
post
postal
hemangioblastoma
pre - study
proctitis
proteinuria
range
refractory
retention
salivary
shared
amelanotic melanoma
left ventricular fractional shortening
smell
specified
speech
spinal
stage grouping
swallowing
tachycardia
blue nevus
taste
tearing
therapeutic effect
arthroscopy
topography
audiometric test
total bilirubin measurement
tremor
bone spectrometry
dermal nevus
bronchography
troponin t
typhlitis
cardiac catheterization
catheterization
unspecified
curative surgery
vasovagal
cystography
veno - occlusive
dental procedure
electrocardiography
electroencephalography
ventricular
electromyography
vertigo
thallium myocardial perfusion imaging stress test
visual
eye examination
withdraw
blood flow cytometry
bone marrow flow cytometry
holter monitoring
hyperbaric oxygen therapy
hysterosonography
incision and drainage
lavage
lymphangiography
lymphocyte harvest procedure
breast imaging reporting and data system
wolfe mammography classification
radionuclide ventriculogram scan
nasopharyngeal laryngoscopy
nasopharyngoscopy
nipple discharge aspiration
ommaya reservoir tap
percutaneous transluminal coronary angioplasty
peritoneoscopy
rhabdoid tumor
pulmonary function test
fraction of inspired oxygen
carbon monoxide diffusing capability test
forced expiratory volume in 1 second
pulse oximetry
renography
gallium scan
i - 131 uptake test
indium scan
neuroendocrine neoplasm
lung perfusion scan
sestamibi scan
skeletal survey x - ray
tomography
small bowel follow through procedure
urine casts
vaginography
vascular access device placement
venacavography
venography
clotrimazole
connective and soft tissue neoplasm
ventilation perfusion scanning
x - ray imaging
abdominal radiography
chest radiography
pelvic examination
dermatofibrosarcoma protuberans with myoid differentiation
myxoid dermatofibrosarcoma protuberans
dedifferentiated dermatofibrosarcoma protuberans
dermatofibrosarcoma protuberans with giant cell fibroblastoma - like differentiation
skin basal cell carcinoma with adnexal differentiation
malignant salivary gland neoplasm
skin signet ring cell basal cell carcinoma
skin basal cell carcinoma with sarcomatoid differentiation
esophagography
cytology specimen collection procedure
route of administration
estradiol mustard
murine monoclonal antibody 225
hpv 16 e6  ( 18 - 26 )  peptide
sbil - 2 transduced autologous tumor - infiltrating lymphocyte
eso - 1 reactive autologous peripheral blood lymphocyte
carcinoma of unknown primary
eso - 1 reactive autologous tumor infiltrating lymphocyte
pr - 151 peptide
vhl - 42: 65 - 76 ( v74g )  peptide
vhl - 59: 116 - 128 peptide
gp100 - reactive autologous peripheral blood lymphocyte
gp100 - reactive autologous tumor infiltrating lymphocyte
betulinic acid
6 - aminonicotinamide
methionine aminopeptidase 2 inhibitor ppi - 2458
metastatic malignant neoplasm in the brain
polyamine analog sl11093
ispinesib
tetanus toxoid helper peptide
anti - gp100 tcr retroviral vector - transduced autologous til
anti - gp100 tcr retroviral vector - transduced autologous pbl
anti - mart - 1 tcr retroviral vector - transduced autologous til
talampanel
metastatic malignant neoplasm in the leptomeninges
ferumoxtran - 10
pneumococcal 7 - valent conjugate vaccine
alvespimycin
baloramotide
lansky play - performance status
chronic allograft nephropathy
yes or no response
yes ,  no ,  or unknown response
antiparkinsonian agent
malignant ascites
pecoma
epithelioid angiomyolipoma
lung clear cell tumor
lung lymphangioleiomyomatosis
clear cell myomelanocytic tumor of the falciform ligament / ligamentum teres
recurrent disease
metachronous malignant neoplasm
metachronous osteosarcoma
metachronous kidney wilms tumor
type ii achondrogenesis
aids - related plasmablastic lymphoma of mucosa site
digestive system non - hodgkin lymphoma
digestive system lymphoma
digestive system hodgkin lymphoma
male reproductive system precancerous condition
outer
cerebrooculofacioskeletal syndrome
bcl2 gene translocation
aprt gene
pomc gene
gc gene
secondary amyloidosis
9q21
18q21 .1 - q21 .32
4q28 .2 - q31 .1
alk gene
agt gene
neuropeptide gene
kng1 gene
calca gene
primary amyloidosis
crh gene
cd36 gene
auricular route of administration
buccal route of administration
conjunctival route of administration
krt19 gene
continuous intravenous infusion
dental route of administration
soft tissue route of administration
administration via gastrostomy
cobalt
cyclic neutropenia
administration via hemodialysis
administration via implantation
administration via jejunostomy
iontophoresis route of administration
endocervical route of administration
endosinusial route of administration
endothoracic route of administration
endotracheal route of administration
enteral route of administration
hemangiomatosis with thrombocytopenia
epidural route of administration
extraamniotic route of administration
extracorporeal circulation route of administration
extraluminal route of administration
genitourinary route of administration
infiltration route of administration
inhalation route of administration
intracoronal dental route of administration
intracoronary route of administration
interstitial route of administration
x - linked agammaglobulinemia
intraabdominal route of administration
intraamniotic route of administration
intraarterial route of administration
intraarticular route of administration
intrabiliary route of administration
intrabronchial route of administration
intrabursal route of administration
intracardiac route of administration
intracartilaginous route of administration
intracaudal route of administration
systolic hypertension
intracavernous route of administration
intracavitary route of administration
intracerebral route of administration
intracisternal route of administration
intracorneal route of administration
intracorporus cavernosum route of administration
intracranial route of administration
intradermal route of administration
intradiscal route of administration
lesion
intraductal route of administration
intraduodenal route of administration
intradural route of administration
intraepidermal route of administration
intraepithelial route of administration
intraesophageal route of administration
intragastric route of administration
intragingival route of administration
intrahepatic route of administration
intraileal route of administration
pseudolymphoma
intralesional route of administration
intraluminal route of administration
intralymphatic route of administration
intramedullary route of administration
intrameningeal route of administration
intraocular route of administration
intraovarian route of administration
intrapericardial route of administration
intraperitoneal route of administration
intrapleural route of administration
juvenile polyp
intraprostatic route of administration
intrapulmonary route of administration
intrasinal route of administration
intraspinal route of administration
intrasynovial route of administration
intratendinous route of administration
intratesticular route of administration
intrathecal route of administration
intratubular route of administration
intratumoral route of administration
nodular fasciitis
intratympanic route of administration
intraurethral route of administration
intrauterine route of administration
intravascular route of administration
intravenous bolus
intravenous infusion
intravenous route of administration
intraventricular route of administration
intravesical route of administration
intravenous drip
combined hepatocellular carcinoma and cholangiocarcinoma
intravitreal route of administration
irrigation route of administration
laryngeal route of administration
mucosal route of administration
nasal route of administration
nasogastric route of administration
occlusive dressing technique
ophthalmic route of administration
oral route of administration
oropharyngeal route of administration
benign synovial neoplasm
other route of administration
parenteral route of administration
periarticular route of administration
perineural route of administration
periodontal route of administration
rectal route of administration
retrobulbar route of administration
subarachnoid route of administration
subconjunctival route of administration
subcutaneous route of administration
codeine
chondromyxoid fibroma
sublingual route of administration
submucosal route of administration
swish and spit route of administration
swish and swallow route of administration
topical route of administration
transdermal route of administration
transluminal route of administration
transplacental route of administration
transtracheal route of administration
transtympanic route of administration
unassigned route of administration
unknown route of administration
ureteral route of administration
vaginal route of administration
polb gene
folh1 gene
gnaq gene
gnas gene
grp gene
gypa gene
malaise
ghrh gene
marginal zone b - lymphocyte of nodal type
mature cytotoxic t - lymphocyte
immature t - lymphocyte
immature peripheral gamma / delta cell of cytotoxic type
immature peripheral alpha / beta cell of cytotoxic type
thymic b - lymphocyte
asymptomatic
peripheral b - lymphocyte
intraepithelial t - lymphocyte
activated b - lymphocyte
germinal center b - lymphocyte
interdigitating dendritic cell
naive pregerminal center b - lymphocyte
ataxic gait
pancreatic intraductal papillary - mucinous neoplasm
esr1 gene
reflux
6q25 .1
7q21
1p31 .3 - p31 .2
9q13
11q21 - q22
13q14 .2 - q14 .3
17p12 - p11 .2
infertility
12q24 .3
estrogen receptor
runx1 gene mutation
esr2 gene
estrogen receptor beta
top3b gene
dna topoisomerase 3 - beta - 1
usf1 gene
upstream stimulatory factor 1
usf2 gene
neurological signs and symptoms
upstream stimulatory factor 2
gnai1 gene
cebpa gene mutation
acute myeloid leukemia with t ( 17 ; 17 )  ( q21 ; q21 )
diastolic hypertension
guanine nucleotide - binding protein g ( i )  subunit alpha - 1
gnai3 gene
guanine nucleotide - binding protein g ( k )  subunit alpha
aneuploid dysplastic oral leukoplakia
ventilator
pulmonary granuloma
mllt3 - kmt2a fusion protein expression
kmt2a - enl fusion protein expression
nfkbib gene
nf - kappa - b inhibitor beta
nfkbie gene
nf - kappa - b inhibitor epsilon
nfic gene
nfia gene
coenzyme a
port wine stain
nuclear factor 1 a - type
nfib gene
nuclear factor 1 b - type
nuclear factor 1 c - type
nfix gene
nuclear factor 1 x - type
c - kit somatic point mutation
prkaca gene
congenital non - progressive hemangioma
camp - dependent protein kinase catalytic subunit alpha
prkacb gene
camp - dependent protein kinase catalytic subunit beta
prkacg gene
camp - dependent protein kinase catalytic subunit gamma
rxra gene
retinoic acid receptor rxr - alpha
rxrb gene
retinoic acid receptor rxr - beta
rxrg gene
urothelial papilloma
retinoic acid receptor rxr - gamma
gucy1a2 gene
guanylate cyclase soluble subunit alpha - 2
gucy1a1 gene
4q31 .3 - q33
guanylate cyclase soluble subunit alpha - 1
gucy1b2 gene
guanylate cyclase soluble subunit beta - 2
gucy1b1 gene
malignant ovarian cyst
guanylate cyclase soluble subunit beta - 1
ubb gene
polyubiquitin - b
ubc gene
polyubiquitin - c
mature b - lymphocyte at the germinal center stage of differentiation
ubd gene
ubiquitin d
mature lymphocyte
gallbladder carcinoma
neonatal leukemia
peer pressure
traditional serrated adenoma
aggravated neurofibromatosis
caspase inhibitor
partial thromboplastin time
hair part
lymph node part
5 - hydroxypicolinaldehyde thiosemicarbazone
constitutional symptom
renal cell dysplasia
laboratory finding
commercial or non - ctep ind agent
2p15
3q26 .2 - qter
3q27 .3
4q21 - q24
8p21 .2
9q31 .1
9pter - p22 .1
10q24 .1 - q25 .1
benign female breast neoplasm
10q21 - q22
12q24 .2 - q24 .31
16q12 .1
16q22 - q23 .1
17q23 .2 - q25 .3
17p13 .1 - q25
micrometastasis
tubg1 gene
tubulin gamma - 1 chain
tubg2 gene
tubulin gamma - 2 chain
gnrh1 gene
progonadoliberin - 1
gnrh2 gene
progonadoliberin - 2
hprt1 gene
hypoxanthine - guanine phosphoribosyltransferase
hprt2 gene
got1 gene
colchicine
pancreatic carcinoma
aspartate aminotransferase ,  cytoplasmic
got2 gene
aspartate aminotransferase ,  mitochondrial
gpt gene
microscopic colitis
alanine aminotransferase 1
gpt2 gene
alanine aminotransferase 2
aggravated malignant neoplasm
spleen part
tk1 gene
thymidine kinase ,  cytosolic
thymidine kinase ,  mitochondrial
tk2 gene
thymic lymphoid tissue
tonsillar tissue
tfrc gene
tonsillar lymphoid tissue
transferrin receptor protein 1
menopausal symptom
tfr2 gene
transferrin receptor protein 2
ppp3ca gene
serine / threonine protein phosphatase 2b catalytic subunit alpha isoform
ppp3cb gene
serine / threonine protein phosphatase 2b catalytic subunit beta isoform
ppp3cc gene
serine / threonine protein phosphatase 2b catalytic subunit gamma isoform
ppp3r1 gene
calcineurin subunit b type 1
gastrointestinal mucositis
ppp3r2 gene
calcineurin subunit b type 2
sight
creb family gene
touch
creb1 gene
cyclic amp - responsive element - binding protein 1
creb3 gene
cyclic amp - responsive element - binding protein 3
creb3l4 gene
cyclic amp - responsive element - binding protein 3 - like protein 4
creb5 gene
cyclic amp - responsive element - binding protein 5
eif2b1 gene
translation initiation factor eif - 2b subunit alpha
eif2b2 gene
translation initiation factor eif - 2b subunit beta
eif2b4 gene
translation initiation factor eif - 2b subunit delta
eif2b5 gene
translation initiation factor eif - 2b subunit epsilon
fcgr2a gene
low affinity immunoglobulin gamma fc region receptor ii - a
fcgr2b gene
low affinity immunoglobulin gamma fc region receptor ii - b
fcgr2c gene
low affinity immunoglobulin gamma fc region receptor ii - c
fcgr3a gene
low affinity immunoglobulin gamma fc region receptor iii - a
ovarian dermoid cyst
fcgr3b gene
low affinity immunoglobulin gamma fc region receptor iii - b
nos1 gene
nitric oxide synthase ,  brain
nos2 gene
nitric oxide synthase ,  inducible
nos2p2 gene
nitric oxide synthase 2b
nos2p1 gene
nitric oxide synthase 2c
nos3 gene
nitric oxide synthase ,  endothelial
leucine rich repeat containing protein 17
cooperative prostate cancer tissue resource
syncytiotrophoblastic cell
cytotrophoblastic cell
translation process protein
rarg gene
retinoic acid receptor gamma
eef1a1 gene
mental and behavioral signs and symptoms
6q14 .1
elongation factor 1 - alpha 1
eef1a2 gene
elongation factor 1 - alpha 2
eef2 gene
19pter - q12
elongation factor 2
autologous anti - mart - 1 f5 t - cell receptor gene - engineered peripheral blood lymphocytes
pla2g4a gene
cytosolic phospholipase a2
pediatric aids
15q11 .2 - q21 .3
pla2g4b gene
cytosolic phospholipase a2 beta
pla2g4c gene
cytosolic phospholipase a2 gamma
pla2g4d gene
cytosolic phospholipase a2 delta
pla2g6 gene
85 kda calcium - independent phospholipase a2
fnta gene
colistin sulfate
extrahepatic bile duct carcinoma
8p22 - q11
protein farnesyltransferase / geranylgeranyltransferase type - 1 subunit alpha
14q23 - q24
fntb gene
protein farnesyltransferase subunit beta
gclm gene
glutamate - cysteine ligase regulatory subunit
gclc gene
glutamate - cysteine ligase catalytic subunit
adora1 gene
ependymal tumor of brain
adenosine receptor a1
adora2a gene
adenosine receptor a2a
adora2b gene
adenosine receptor a2b
adora3 gene
adenosine receptor a3
head and neck part
prim2 gene
dna primase large subunit
male breast carcinoma
integumentary system part
diaphragm part
epithelium part
tissue part
organ of special sense part
membrane part
upper extremity part
lower extremity part
intraductal breast papilloma
extremity part
opening of the thorax
tonsil part
electro - osmosis route of administration
doppler echocardiography
inv ( 22q12 )
t ( 12 ; 21 )  ( p13 ; q22 )
delta cell of the pancreas
colon adenoma
lymphoblasts 25 percent or less of bone marrow nucleated cells
bone pain
tartrate resistant acid phosphatase positive cells present
prolymphocytes exceed 55 percent of lymphoid cells in the peripheral blood
epididymal cyst
defective mu heavy chain present
alk kinase overexpression
transformed peripheral b - lymphocyte
esophageal leiomyoma
composite lymphoma
pericardial cavity
chest pain
intrahepatic portion of the left hepatic duct
intrahepatic portion of the right hepatic duct
fallopian tube carcinoma
hilar portion of the left hepatic duct
hilar portion of the right hepatic duct
transforming growth factor - beta - induced protein ig - h3
t - cell large granular lymphocyte
widespread disease
cutaneous route of administration
percutaneous route of administration
peridural route of administration
yttrium y 90 monoclonal antibody hu3s193
yttrium y 90 glass microspheres
gastrointestinal stromal tumor
valeriana officinalis
rilimogene galvacirepvec
recombinant tyrosinase - related protein - 2
traumeel s
amsilarotene
siplizumab
ruthenium ru - 106
methoxy polyethylene glycol - epoetin beta
ravuconazole
liver hemangioma
muparfostat
phentolamine mesylate
pertuzumab
paricalcitol
liposome - encapsulated osi - 7904
multi - epitope melanoma peptide vaccine
moxifloxacin hydrochloride
monoclonal antibody huhmfg1
hyperviscosity
recombinant colony stimulating factor
lymphangitic carcinomatosis
melanoma helper peptide vaccine
lutetium lu 177 monoclonal antibody j591
lamotrigine
absorbable gelatin sponge
garlic
fruit and vegetable extract
fowlpox - psa - tricom vaccine
deslorelin
nasopharyngeal carcinoma
defective gamma heavy chain present
selective estrogen receptor modulator cc - 8490
carbon - 11 acetate
dasatinib
lorvotuzumab mertansine
autologous immunoglobulin idiotype - klh conjugate vaccine
anidulafungin
anakinra
axitinib
3 - ap / fludarabine
ovarian brenner tumor
transgenic lymphocyte immunization vaccine
nuclear pleomorphism
high - dose chemotherapy with stem cell support
recombinant mage - 3 .1 antigen
valerian
synthetic human papillomavirus 16 e6 peptide
pancreatic proteolytic enzymes
marginal zone b - lymphocyte
ovarian germ cell tumor
defective alpha heavy chain present
pancreatic cystadenocarcinoma
spinal cord ependymoma
negative finding
positive finding
ebv infection
gastric leiomyoma
submucosal invasive colon adenocarcinoma
hpv 16 e7:86 - 93 peptide vaccine
thyroid gland mucoepidermoid carcinoma
thyroid gland sclerosing mucoepidermoid carcinoma with eosinophilia
scaffolding protein
lymphocytic thyroiditis
testicular teratoma
squamous differentiation
thyroid gland anaplastic carcinoma
thyroid gland medullary carcinoma
recombinant c5a
eyelid nevus
leukoplakia of gingiva
ovarian mass
skin cyst
testicular cyst
leukoplakia of tongue
vaginal cyst
kidney angiomyolipoma
cd19 gene
11q12
1p36 .2
2q12 - q22
pelvic inflammatory disease
3p21 .2
6p11 .2
7q31 .3 - q32
9p13 - p12
b - lymphocyte antigen cd19
ms4a1 gene
b - lymphocyte antigen cd20
cd3 complex
cd3d gene
t - cell surface glycoprotein cd3 delta chain
oral contraceptive
hypoxia
cd3g gene
t - cell surface glycoprotein cd3 gamma chain
cd247 gene
t - cell surface glycoprotein cd3 zeta chain
t - cell surface glycoprotein cd3 eta chain
tnfrsf8 gene
tumor necrosis factor receptor superfamily member 8
cd52 gene
campath - 1 antigen
gnrhr gene
color blindness
gonadotropin - releasing hormone receptor
il1r1 gene
interleukin - 1 receptor type 1
il1r2 gene
interleukin - 1 receptor type 2
interleukin 12 receptor
il12rb1 gene
interleukin - 12 receptor subunit beta - 1
il12rb2 gene
interleukin - 12 receptor subunit beta - 2
mu heavy chain disease
il6r gene
interleukin - 6 receptor subunit alpha
impdh1 gene
inosine - 5' - monophosphate dehydrogenase 1
impdh2 gene
inosine - 5' - monophosphate dehydrogenase 2
cad gene
cad protein
mtor gene
serine / threonine - protein kinase mtor
odc1 gene
ornithine decarboxylase
glipr2 gene
golgi - associated plant pathogenesis - related protein 1
cd7 gene
t - cell antigen cd7
grade i meningioma
grade ii meningioma
grade iii meningioma
muc1 gene
drug dependence
14q32 .31
7p22 .2
2p16 .1
17q21 .32
12q11 - q13
11q12 .3
papola gene
poly ( a )  polymerase alpha
papolb gene
poly ( a )  polymerase beta
bare lymphocyte syndrome
papolg gene
poly ( a )  polymerase gamma
high affinity interleukin - 2 receptor
integrin alphav / beta3
itgb3 gene
integrin beta - 3
itga5 gene
elongation factor 1
eef1b2p1 gene
minimal residual disease
elongation factor 1b1
eef1b2 gene
elongation factor 1 - beta
eef1d gene
elongation factor 1 - delta
eef1g gene
elongation factor 1 - gamma
mucin - 1
isochromosome
extranodal marginal zone lymphoma of mucosa - associated lymphoid tissue
hantavirus infection
gm - csf receptor
contrast agent
compound nevus
telangiectatic osteosarcoma
mixed glioma
papillary meningioma
csf2ra gene
radiation enteritis
adrenal gland adenoma
borderline hypertension
ampulla of vater carcinoma
gallbladder polyp
copper
molecular abnormality
small cell carcinoma
parathyroid gland adenoma
vaginal carcinoma
extragonadal germ cell tumor
suppurative granuloma
corn oil
parapsoriasis lichenoides
small plaque parapsoriasis
cutis marmorata
becker nevus
angioma serpiginosum
gene expression regulation by vitamin d receptor pathway
west nile virus pathway
granulocyte - macrophage colony - stimulating factor receptor subunit alpha
interleukin 3 receptor
il3ra gene
interleukin - 3 receptor subunit alpha
knuckle pads
pigu gene
phosphatidylinositol glycan anchor biosynthesis class u protein
folr1 gene
folate receptor alpha
ctag1b gene
cancer / testis antigen 1
20q11 .22
11q13 .3 - q14 .1
hhv8 infection
htlv - 1 infection
helicobacter pylori infection
opisthorchis viverrini infection
hp gene
cgb3 gene
adolescence
corticosterone
paranasal sinus mucocele
abramson cancer center
active funded research project
agency for healthcare research and quality
albert einstein cancer center
alliance for lung cancer advocacy support and education
american association for the advancement of science
american association of cancer research
american brain tumor association
maxillary sinus polyp
american college of obstetricians and gynecologists
american college of oncology administrators
american college of physicians
american college of radiation oncology
american college of radiology
american joint committee on cancer
american lung association
american medical association
american public health association
american society of clinical oncology
ethmoid sinus polyp
american society of hematology
analytical biochemistry shared resource
animal models service shared resource
animal pharmacology shared resource
association of american cancer institutes
association of american medical colleges
association of community cancer centers
bachelor's degree
barbara ann karmano cancer institute
barrier animal facility shared resource
sphenoid sinus polyp
bioinformatics shared resource
biosafety service shared resource
biostatistics shared resource
board of scientific advisors nci
california breast cancer research program
cold spring harbor laboratory cancer center
salk institute cancer center
chao family comprehensive cancer center
cancer center organizational capabilities section of cancer center support grant application
pharyngeal cyst
cancer center planning grant
cancer center support grant application
cancer clinical and economic outcomes shared resource
knight cancer institute
cancer institute of new jersey
cancer patient education network
cancer prevention biomarker and genotyping shared resource
cancer research and prevention foundation
university of hawaii cancer center
cancer treatment research foundation
leukoplakia of vocal cords
david h . koch institute for integrative cancer research at mit
chai foundation
children's cancer group
chromatography shared resource
city of hope comprehensive cancer center
clinical informatics shared resource
clinical pathway
clinical protocol date closed standard cancer center information summary
clinical protocol date opened standard cancer center information summary
endocrine hypertension
clinical research support shared resource
clinical trials protocol and data management shared resource
clinical trials scientific review and monitoring system
cloning laboratory shared resource
common scientific outline nci
community trial
arizona cancer center
comprehensive cancer center of wake forest university
computer retrieval of information on scientific projects database
computer service shared resource
non - neoplastic nevus
consolidated budget request
cure for lymphoma foundation
cytogenetics shared resource
damon runyon cancer research foundation
dana - farber / harvard cancer center
data compilation and analysis shared resource
digital imaging shared resource
director of cancer research center
dna rna and peptide synthesis shared resource
dna sequencing shared resource
turcot syndrome
doctor of chiropractic
doctor of dental medicine
doctor of dental surgery
doctor of medicine
doctor of optometry
doctor of osteopathic medicine
doctor of pharmacy
doctor of philosophy
doctor of philosophy in human services
doctor of podiatric medicine
bannayan syndrome
doctor of public health
doctor of veterinary medicine
doctorate degree
duke cancer institute
electron microscopy shared resource
epidemiology and cancer control shared resource
experimental pathology and histopathology shared resource
experimental pathology shared resource
externally peer - reviewed trial standard cancer center information summary
therapeutic corticotropin - releasing factor
hereditary benign intraepithelial dyskeratosis
familial cancer risk shared resource
fellow of american college of physicians
fellow of american college of surgeons
fermentation shared resource
field survey
flow cytometry shared resource
fly facility shared resource
fox chase cancer center
fred hutchinson / university of washington cancer consortium
funding agency
gene therapy and vector shared resource
general and equipment repair shared resource
genomics and proteomics shared resource
genomics shared resource
glasswashing and sterilization shared resource
h lee moffitt cancer center and research institute
health care delivery study
health resources and services administration
herbert irving comprehensive cancer center
histology and immunohistochemistry shared resource
fibrous hamartoma of infancy
holden comprehensive cancer center
human pharmacology study
huntsman cancer institute
illustration graphic art publication and audiovisual service shared resource
immune monitoring shared resource
immunoelectron microscopy shared facility
in situ hybridization shared resource
indiana university melvin and bren simon cancer center
industrial trial standard cancer center information summary
institute for cancer prevention
nevus anemicus
institutional commitment section of cancer center support grant application
international agency for research on cancer
international cancer research portfolio database
international society of preventive oncology
international union against cancer
intervention community trial
case comprehensive cancer center
irradiation shared resource
jonsson comprehensive cancer center
nyu cancer institute
congenital melanocytic nevus
kimmel cancer center
laboratory animal genetic monitoring resource
laboratory animal health and quality control shared resource
laboratory animal husbandry shared resource
laboratory animal shared resource
local protocol standard cancer center information summary
machine shop shared resource
mass spectrometry shared resource
massey cancer center
master of business administration
mongolian spot
master of health services administration
master of public health
master of science
master's degree
mayo clinic cancer center
mcardle laboratory for cancer research
media preparation shared resource
memorial sloan - kettering cancer center
microarray shared resource
molecular biology shared resource
nevus comedonicus
molecular diagnostics laboratory shared resource
molecular imaging shared resource
monoclonal antibody production shared resource
mouse pathology shared resource
national alliance of breast cancer organizations
national brain tumor foundation
national cancer institute cancer centers program
national cancer institute of canada clinical trials group
national cervical cancer coalition
national childhood cancer foundation
third ventricle colloid cyst
national coalition for cancer research
national comprehensive cancer network
national protocol standard cancer center information summary
naturopathic doctor
nci - funded research portfolio database
neuroblastoma children's cancer society
non - programmatically aligned cancer center research member
norris cotton cancer center
nuclear magnetic resonance shared resource
nude mouse shared resource
gingival polyp
nutrition shared resource
office of assistant secretary of health
oligonucleotide synthesis shared resource
optical microscopy shared resource
organic and synthetic chemistry shared resource
other clinical research support shared resource
other epidemiology and cancer control shared resource
other informatics shared resource
other laboratory science support shared resource
p20 planning cancer center
benign lymphoepithelial lesion of the salivary gland
patient compliance
peer - reviewed scientific project
pharmaceutical research shared resource
pharmacoeconomic study
pharmacology shared resource
pre - clinical magnetic resonance imaging shared resource
preventive community trial
proteomics shared resource
protocol development shared resource
therapeutic cortisone
oral mucosa lobular capillary hemangioma
public health and epidemiology informatics shared resource
purdue university center for cancer research
radiolabeling shared resource
uc san diego moores cancer center
reportable cancer standard cancer center information summary
reportable patient standard cancer center information summary
reporting period for cancer center support grant
robert h . lurie comprehensive cancer center
roswell park cancer institute
leukoplakia of lip
saint jude children's research hospital
secretarial and word processing shared resource
shared resource cancer center
sidney kimmel comprehensive cancer center at johns hopkins university
small animal imaging shared resource
small molecule screening shared resource
social science shared resource
standard cancer center information summary
hairy leukoplakia of tongue
study of disease management
study of disease mechanisms
substance abuse and mental health services administration
survey shared resource
susan g komen breast cancer foundation
targeted accrual standard cancer center information summary
technology development study
the antitumor testing shared resource
the ohio state university comprehensive cancer center
the jackson laboratory cancer center
esophageal leukoplakia
georgetown lombardi comprehensive cancer center
uc davis comprehensive cancer center
ucsf helen diller family comprehensive cancer center
the university of colorado cancer center
vanderbilt - ingram cancer center
the wistar institute cancer center
therapeutic clinical trial
therapeutic confirmatory study
therapeutic exploratory study
therapeutic use study
gastric polyp
tissue culture shared resource
tissue procurement and distribution shared resource
toxicology and mutagenesis testing shared resource
transgenic and mutant animals shared resource
translational cell therapy shared resource
translational research shared resource
treatment effectiveness
treatment efficacy
university of alabama at birmingham comprehensive cancer center
the university of chicago comprehensive cancer center
gastric intraepithelial neoplasia
university of michigan comprehensive cancer center
masonic cancer center
eppley cancer center
unc lineberger comprehensive cancer center
university of pittsburgh cancer institute
university of southern california norris comprehensive cancer center
university of texas md anderson cancer center
university of virginia cancer center
university of wisconsin carbone cancer center
intestinal metaplasia of gastric mucosa
us army medical research and material command
vermont cancer center at the university of vermont
x - ray crystallography shared resource
yale cancer center
patient visit
t - lymphocyte and natural killer cell
anal polyp
type 1a autoimmune lymphoproliferative syndrome
type 1b autoimmune lymphoproliferative syndrome
type 2 autoimmune lymphoproliferative syndrome
type 3 autoimmune lymphoproliferative syndrome
autoimmune lymphoproliferative syndrome - associated lymphoma
disseminated peritoneal leiomyomatosis
t - cell large granular lymphocyte leukemia ,  common variant
gamma / delta t - lymphocyte
t - cell large granular lymphocyte leukemia expressing the t - cell receptor gamma - delta
xanthine dehydrogenase / oxidase
serum soluble fas ligand level increased
angioinvasion
hepatobiliary disorder
xdh gene
chronic lymphoproliferative disorder of nk - cells
integrin alpha - 5
skin rash
lactate dehydrogenase increased
ccnd2 gene
prkcb gene
cebpa gene
cosmid vector
hepatic cyst
alteplase
coagulative necrosis
activated natural killer cell
hyperuricemia
small intestinal enteropathy - associated t - cell lymphoma
intestinal perforation
intraepithelial t - lymphocyte of the intestine
sinusoidal infiltration
karyorrhexis
subcutaneous nodule
dna vaccine
adenosine deaminase deficiency
dermatopathic lymphadenopathy
scaly skin eruption
skin plaque
extracutaneous dissemination of disease
cdkn2a gene inactivation
purine - nucleoside phosphorylase deficiency
xp22 .1
4q31 .1
4q31 - q32
6p25 .3
6q25 .3
6p22 .2 - p21 .3
7p15 .1
7q21 .3 - q22
8q24 .2 - q24 .3
11q14 - q21
sod2 gene
mycosis fungoides variant
nr3c2 gene
erythroderma
npy gene
oxt gene
serpine1 gene
serpinb2 gene
serpina5 gene
prl gene
bronchiolitis
acute bronchiolitis
ptma gene
chest wall mass
sat1 gene
tac1 gene
tg gene
trh gene
tdo2 gene
tyr gene
dual specificity protein phosphatase 22
insulin receptor - related receptor
early placenta insulin - like peptide
anaplastic large cell lymphoma ,  giant cell rich subtype
anaplastic large cell lymphoma ,  sarcomatoid subtype
anaplastic large cell lymphoma ,  signet ring - like subtype
flu matrix peptide p58 - 66
jambul
devils claw
activated skin - homing t - lymphocyte
activated mature cytotoxic t - lymphocyte
localized skin lesion
papular lesion
sarcomatoid features
extranodal disease
immune response regulation pathway
apoptosis regulation pathway
coumarin
kidney cyst
cell cycle regulation pathway
disease pathway
degradation pathway
cell motility pathway
cell differentiation or development pathway
dna repair pathway
aluminum hydroxide
urethral cyst
c - kit tyrosine kinase protein overexpression
kit gene mutation
dn - 101
cd30 - positive neoplastic cells present
egfr protein overexpression
mdm2 gene mutation
pdgfra gene mutation
prostate fibroma
defective heavy chain present
immune system finding
immunodeficiency
carbohydrate metabolism pathway
genetic information processing pathway
infectious disease pathway
cervical squamous metaplasia
lung inflammatory myofibroblastic tumor
retroperitoneal inflammatory myofibroblastic tumor
myxoid changes present
pleomorphic variant mantle cell lymphoma
type ii endometrial adenocarcinoma
cervical atypia
glioblastoma ,  idh - wildtype
secondary glioblastoma
refractory disease
plexiform ameloblastoma
acanthomatous ameloblastoma
solid / multicystic ameloblastoma
unicystic ameloblastoma
basal cell ameloblastoma
desmoplastic ameloblastoma
cervical leukoplakia
gadolinium
plastic surgery procedure
contiguous disease
non - contiguous disease
attempt
uterine cervix cyst
light exercise
moderate exercise
strenuous exercise
aerobic exercise
htr2a gene
13q14 - q21
very light exercise
adrb1 gene
maximum heart rate
vulvar polyp
cetp gene
transcription initiation factor iia
ganglioside gd3
retinal hemangioblastoma
inner ear neoplasm
multiple tumor masses
met gene mutation
hereditary renal cell carcinoma
spinal meningeal cyst
renal cell carcinoma with constitutional chromosome 3 translocations
philosophy
loss of chromosome 14q
ethics
loss of chromosome 2
loss of chromosome 21
diltiazem hydrochloride
sickle cell trait
renal cell carcinoma associated with inv ( x )  ( p11 ; q12 )
mucinous tubular and spindle cell carcinoma of the kidney
type 1 renal papillary adenoma
paraneoplastic polyneuropathy
type 2 renal papillary adenoma
metanephric adenofibroma
smarcb1 gene inactivation
classic congenital mesoblastic nephroma
cellular congenital mesoblastic nephroma
infiltrating bladder urothelial carcinoma with squamous differentiation
infiltrating bladder urothelial carcinoma with glandular differentiation
infiltrating bladder urothelial carcinoma with trophoblastic differentiation
infiltrating bladder urothelial carcinoma ,  nested variant
iris cyst
infiltrating bladder urothelial carcinoma ,  microcystic variant
infiltrating bladder lymphoepithelioma - like carcinoma
infiltrating bladder urothelial carcinoma ,  lymphoma - like variant
infiltrating bladder urothelial carcinoma ,  plasmacytoid variant
infiltrating bladder urothelial carcinoma ,  sarcomatoid variant
infiltrating bladder urothelial carcinoma ,  sarcomatoid variant with heterologous elements
infiltrating bladder urothelial carcinoma ,  sarcomatoid variant without heterologous elements
infiltrating bladder urothelial carcinoma ,  clear cell variant
infiltrating bladder urothelial carcinoma ,  lipid - rich variant
infiltrating bladder urothelial carcinoma with giant cells
bladder non - invasive papillary urothelial neoplasm
bladder verrucous carcinoma
schistosoma hematobium - related bladder verrucous carcinoma
bladder squamous cell papilloma
bladder enteric type adenocarcinoma
bladder adenocarcinoma ,  not otherwise specified
bladder mucinous adenocarcinoma
bladder hepatoid adenocarcinoma
bladder mixed adenocarcinoma
bladder urachal carcinoma
bladder urachal adenocarcinoma
bladder urachal urothelial carcinoma
bladder urachal squamous cell carcinoma
bladder tubulo - cystic clear cell adenocarcinoma
bladder papillary clear cell adenocarcinoma
bladder diffuse clear cell adenocarcinoma
stage 0 renal pelvis and ureter cancer ajcc v7
bladder urothelial carcinoma
urothelial neoplasm
infiltrating urothelial carcinoma
non - invasive urothelial neoplasm
diffuse leiomyomatosis syndrome
urothelial dysplasia
bladder papillary urothelial neoplasm
bladder urothelial papilloma
bladder inverted papilloma
cystitis glandularis
urethral diverticulum
human papillomavirus - related urethral squamous cell carcinoma
carcinoma of skene glands
carcinoma of cowper glands
carcinoma of littre glands
female urethral malignant neoplasm
male urethral malignant neoplasm
penile urethral malignant neoplasm
bulbomembranous urethral malignant neoplasm
prostatic urethral malignant neoplasm
urethral caruncle
urethral villous adenoma
urethral verrucous carcinoma
loss of chromosome 9q
fgfr3 gene mutation
bladder mucosa - associated lymphoid tissue lymphoma
infiltrating renal pelvis and ureter urothelial carcinoma
syndrome of inappropriate antidiuretic hormone secretion
prostate acinar adenocarcinoma ,  atrophic variant
prostate acinar adenocarcinoma ,  pseudohyperplastic variant
prostate acinar adenocarcinoma ,  foamy gland variant
prostate acinar adenocarcinoma ,  oncocytic variant
prostate acinar adenocarcinoma ,  lymphoepithelioma - like variant
high grade prostatic intraepithelial neoplasia ,  signet ring variant
high grade prostatic intraepithelial neoplasia ,  mucinous variant
high grade prostatic intraepithelial neoplasia ,  foamy variant
parathyroid hyperplasia
high grade prostatic intraepithelial neoplasia ,  inverted variant
high grade prostatic intraepithelial neoplasia ,  small cell neuroendocrine variant
dideaza - 5 , 6 , 7 , 8 - tetrahydrofolic acid
prostate ductal adenocarcinoma ,  cribriform pattern
prostate ductal adenocarcinoma ,  papillary pattern
prostate ductal adenocarcinoma ,  solid pattern
primary prostate urothelial carcinoma
secondary prostate urothelial carcinoma
creatinine
hyperimmunoglobulin m syndrome
prostatic urethra urothelial carcinoma
prostatic duct urothelial carcinoma
prostate basal cell carcinoma
prostate adenocarcinoma with neuroendocrine differentiation
tumor of specialized prostatic stroma
prostate stromal tumor of uncertain malignant potential
seminal vesicle adenocarcinoma
seminal vesicle cystadenoma
seminal vesicle neoplasm
thrombocytopenia due to immune destruction
testicular gonadoblastoma
testicular mixed germ cell - sex cord - stromal tumor ,  unclassified
testicular pure germ cell tumor
7p21 .2
twist1 gene
twist - related protein 1
testicular seminoma with syncytiotrophoblastic cells
aids - related kaposi sarcoma
testicular seminoma with high mitotic index
testicular spermatocytic tumor
testicular spermatocytic tumor with sarcoma
testicular yolk sac tumor ,  microcystic pattern
testicular yolk sac tumor ,  macrocystic pattern
testicular yolk sac tumor ,  solid pattern
testicular yolk sac tumor ,  glandular - alveolar pattern
testicular yolk sac tumor ,  endodermal sinus / perivascular pattern
testicular yolk sac tumor ,  papillary pattern
testicular yolk sac tumor ,  myxomatous pattern
stage ii colon cancer ajcc v6
testicular yolk sac tumor ,  polyvesicular vitelline pattern
testicular yolk sac tumor ,  hepatoid pattern
testicular yolk sac tumor ,  enteric pattern
testicular trophoblastic tumor
testicular monophasic choriocarcinoma
monodermal testicular teratoma
rapgef1 gene
rasgrf2 gene
stage iv colon cancer ajcc v6
exercise physiology
4q31 .2
malignant testicular leydig cell tumor
testicular sertoli cell tumor ,  lipid rich variant
testicular large cell calcifying sertoli cell tumor
testicular sclerosing sertoli cell tumor
adult type testicular granulosa cell tumor
juvenile type testicular granulosa cell tumor
malignant testicular sex cord - stromal tumor
testicular tumor of the thecoma / fibroma group
stage iv breast cancer ajcc v6 and v7
tumor of the thecoma / fibroma group
testicular fibroma
testicular thecoma
testicular brenner tumor
brenner tumor
rete testis neoplasm
rete testis adenoma
epididymal adenocarcinoma
epididymal neoplasm
mixed squamous cell carcinoma of the penis
monoclonal gammopathy of undetermined significance
penile basal cell carcinoma
penile bowenoid papulosis
typical ovarian thecoma
ovarian signet ring stromal tumor
ovarian sertoli - stromal cell tumor
moderately differentiated ovarian sertoli - leydig cell tumor
childhood medulloblastoma
ovarian sertoli - leydig cell tumor with heterologous elements
ovarian retiform sertoli - leydig cell tumor
moderately differentiated ovarian sertoli - leydig cell tumor ,  variant with heterologous elements
poorly differentiated ovarian sertoli - leydig cell tumor ,  variant with heterologous elements
ovarian sertoli - leydig cell tumor with retiform elements
sertoli cell tumor
ovarian stromal - leydig cell tumor
ovarian sex cord - stromal tumor of mixed or unclassified cell types
ovarian steroid cell tumor ,  not otherwise specified
recurrent colon carcinoma
well differentiated ovarian steroid cell tumor
malignant ovarian steroid cell tumor
ovarian leydig cell tumor ,  non - hilar type
ovarian leydig cell tumor ,  not otherwise specified
ovarian gonadoblastoma
ovarian primitive germ cell tumor
ovarian yolk sac tumor ,  polyvesicular vitelline pattern
ovarian yolk sac tumor ,  glandular pattern
ovarian yolk sac tumor ,  hepatoid pattern
recurrent esophageal carcinoma
ovarian polyembryoma
non - gestational ovarian choriocarcinoma
ovarian biphasic or triphasic teratoma
grade 1 ovarian teratoma
malignant ovarian teratoma
ovarian fetiform teratoma
ovarian dermoid cyst with secondary carcinoma
ovarian dermoid cyst with squamous cell carcinoma
ovarian dermoid cyst with adenocarcinoma
crotoxin
stage 0 cervical cancer ajcc v6
ovarian dermoid cyst with secondary melanocytic lesion
ovarian dermoid cyst with melanoma
ovarian dermoid cyst with melanocytic nevus
ovarian dermoid cyst with secondary sebaceous tumor
ovarian dermoid cyst with sebaceous carcinoma
ovarian dermoid cyst with sebaceous adenoma
ovarian dermoid cyst with secondary pituitary - type tumor
ovarian dermoid cyst with corticotropin secreting adenoma
ovarian dermoid cyst with prolactin secreting adenoma
ovarian dermoid cyst with secondary sarcoma
inflammatory breast carcinoma
ovarian dermoid cyst with leiomyosarcoma
ovarian dermoid cyst with angiosarcoma
benign struma ovarii
ovarian insular carcinoid tumor
ovarian trabecular carcinoid tumor
ovarian mucinous carcinoid tumor
rete ovarii neoplasm
rete ovarii adenocarcinoma
rete ovarii adenoma
rete ovarii cystadenoma
extraosseous plasmacytoma
rete ovarii cystadenofibroma
ovarian lymphoma
primary peritoneal carcinoma
primary peritoneal serous adenocarcinoma
primary peritoneal serous borderline tumor /  primary peritoneal atypical proliferative serous tumor
malignant ovarian serous tumor
malignant ovarian epithelial tumor
borderline ovarian serous tumor / atypical proliferative ovarian serous tumor with microinvasion
borderline ovarian serous adenofibroma
borderline ovarian serous cystadenofibroma
stage iv renal cell cancer ajcc v6
cryotherapy
ovarian serous adenofibroma
ovarian serous cystadenofibroma
malignant ovarian mucinous tumor
ovarian mucinous adenocarcinofibroma
adenocarcinofibroma
borderline ovarian mucinous tumor
borderline ovarian mucinous tumor ,  intestinal type
borderline ovarian mucinous tumor ,  endocervical - like
benign ovarian mucinous tumor
gastric adenocarcinoma
ovarian mucinous adenofibroma
ovarian mucinous cystadenofibroma
ovarian mucinous cystic tumor with mural nodules
ovarian mucinous cystic tumor associated with pseudomyxoma peritonei
8q11 - q12
15q23 - q24
8q21 - q22
10q24 .3
12q13 .1 - q13 .3
cyp2b6 gene
childhood malignant neoplasm
cytochrome p450 2b6
malignant ovarian endometrioid tumor
cyp7a1 gene
cholesterol 7 - alpha - monooxygenase
cyp8b1 gene
7 - alpha - hydroxycholest - 4 - en - 3 - one 12 - alpha - hydroxylase
cyp11a1 gene
cholesterol side - chain cleavage enzyme ,  mitochondrial
cyp11b1 gene
cytochrome p450 cyp11b1 ,  mitochondrial
stage iv uterine corpus cancer ajcc v6
ovarian endometrioid adenocarcinofibroma
ovarian endometrioid adenocarcinoma with squamous differentiation
cyp11b2 gene
ovarian low grade endometrioid stromal sarcoma
cytochrome p450 11b2 ,  mitochondrial
ovarian endometrioid stromal and related neoplasms
undifferentiated ovarian sarcoma
cyp17a1 gene
steroid 17 - alpha - hydroxylase / 17 , 20 lyase
borderline ovarian endometrioid adenofibroma
small intestinal lymphoma
cyp21a2 gene
steroid 21 - hydroxylase
benign ovarian endometrioid tumor
cyp27b1 gene
25 - hydroxyvitamin d - 1 alpha - hydroxylase ,  mitochondrial
ovarian endometrioid cystadenoma
ovarian clear cell tumor
malignant ovarian clear cell tumor
ovarian clear cell adenocarcinoma
ovarian clear cell adenocarcinofibroma
recurrent gallbladder carcinoma
borderline ovarian clear cell tumor
borderline ovarian clear cell adenofibroma
borderline ovarian clear cell tumor / atypical proliferative ovarian clear cell tumor with intraepithelial carcinoma
borderline ovarian clear cell cystadenofibroma
benign ovarian clear cell tumor
ovarian clear cell adenofibroma
ovarian clear cell cystadenofibroma
benign ovarian transitional cell tumor
borderline ovarian transitional cell tumor
malignant ovarian transitional cell tumor
non - functioning pituitary gland neoplasm
ovarian seromucinous carcinoma
ovarian squamous cell tumor
ovarian squamous cell carcinoma
5 - hydroxytryptamine receptor 2a
beta - 1 adrenergic receptor
cholesteryl ester transfer protein
taxon
fallopian tube serous adenocarcinoma
curcumin
adult craniopharyngioma
serous adenocarcinoma
fallopian tube serous neoplasm
fallopian tube mucinous adenocarcinoma
fallopian tube transitional cell carcinoma
stage 0 fallopian tube cancer ajcc v7
borderline fallopian tube neoplasm
borderline fallopian tube serous tumor / atypical proliferative serous tumor
borderline fallopian tube mucinous tumor
fallopian tube mucinous neoplasm
adult medulloblastoma
borderline fallopian tube endometrioid tumor
fallopian tube endometrioid tumor
fallopian tube papilloma
fallopian tube serous adenofibroma
fallopian tube serous cystadenofibroma
fallopian tube endometrioid polyp
fallopian tube metaplastic papillary tumor
tubal epithelial hyperplasia
chronic salpingitis
salpingitis isthmica nodosa
stage iv lung non - small cell cancer ajcc v7
acute salpingitis
endosalpingiosis
pelvic pain
fallopian tube carcinosarcoma
fallopian tube adenosarcoma
fallopian tube soft tissue neoplasm
fallopian tube leiomyoma
fallopian tube leiomyosarcoma
fallopian tube adenomatoid tumor
malignant head and neck neoplasm
fallopian tube germ cell tumor
fallopian tube teratoma
uterine ligament neoplasm
bche gene
uterine ligament adenocarcinoma
uterine ligament serous adenocarcinoma
uterine ligament mucinous adenocarcinoma
uterine ligament endometrioid adenocarcinoma
uterine ligament clear cell adenocarcinoma
adult oligodendroglioma
borderline uterine ligament neoplasm
wolffian adnexal tumor
uterine ligament papillary cystadenoma associated with von hippel - lindau disease
endometrial mucinous adenocarcinoma
type i endometrial adenocarcinoma
figo grade 1 endometrial endometrioid adenocarcinoma
figo grade 2 endometrial endometrioid adenocarcinoma
figo grade 3 endometrial endometrioid adenocarcinoma
figo grade 1 endometrial mucinous adenocarcinoma
metastatic malignant neoplasm in the central nervous system
figo grade 2 endometrial mucinous adenocarcinoma
figo grade 3 endometrial mucinous adenocarcinoma
serous endometrial intraepithelial carcinoma
endometrial mixed cell adenocarcinoma
endometrial transitional cell carcinoma
endometrial small cell carcinoma
endometrial undifferentiated carcinoma
endometrial hyperplasia without atypia
tamoxifen - related endometrial disorder
malignant bone neoplasm
uterine corpus leiomyoma ,  mitotically active variant
uterine corpus cellular leiomyoma
uterine corpus epithelioid leiomyoma
uterine corpus apoplectic leiomyoma
uterine corpus myxoid leiomyoma
uterine corpus bizarre leiomyoma
uterine corpus lipoleiomyoma
ductal breast carcinoma
uterine corpus diffuse leiomyomatosis
uterine corpus dissecting leiomyoma
benign metastasizing leiomyoma of the uterine corpus
uterine corpus epithelioid leiomyosarcoma
uterine corpus myxoid leiomyosarcoma
uterine corpus smooth muscle neoplasm
uterine corpus smooth muscle tumor of uncertain malignant potential
mixed endometrial stromal and smooth muscle neoplasm
uterine corpus soft tissue neoplasm
lobular breast carcinoma in situ
uterine corpus pecoma
uterine corpus mixed epithelial and mesenchymal neoplasm
uterine corpus carcinofibroma
placental site nodule or plaque
non - neoplastic ,  non - molar trophoblastic disorder
forebrain
digit
cervical keratinizing squamous cell carcinoma
cervical non - keratinizing squamous cell carcinoma
cervical basaloid carcinoma
paget disease and intraductal carcinoma of the breast
cervical verrucous carcinoma
cervical warty carcinoma
cervical papillary squamous cell carcinoma
cervical lymphoepithelioma - like carcinoma
cervical squamotransitional carcinoma
cervical squamous neoplasm
low grade cervical squamous intraepithelial neoplasia
high grade cervical squamous intraepithelial neoplasia
cervical squamous intraepithelial neoplasia 2
cervical squamous intraepithelial neoplasia 1
cyanogen bromide
fibroblastic osteosarcoma
cervical fibroepithelial polyp
cervical serous adenocarcinoma
cervical mucinous adenocarcinoma ,  endocervical type
cervical mucinous adenocarcinoma ,  intestinal - type
cervical mucinous adenocarcinoma ,  signet ring cell type
cervical mucinous adenocarcinoma ,  minimal deviation type
copy number polymorphism
cervical villoglandular adenocarcinoma
chondroblastic osteosarcoma
cervical glandular neoplasm
representational oligonucleotide microarray analysis
cervical adenosquamous carcinoma ,  glassy cell variant
cervical adenoid basal carcinoma
cervical large cell neuroendocrine carcinoma
cervical mullerian papilloma
cervical soft tissue neoplasm
uterine corpus endometrial stromal and related neoplasms
endometrioid stromal and related neoplasms of the cervix
uterine corpus endometrial stromal sarcoma
acral lentiginous melanoma
endometrioid stromal sarcoma of the cervix
low grade endometrioid stromal sarcoma of the cervix
uterine corpus low grade endometrial stromal sarcoma
undifferentiated endocervical sarcoma
cervical alveolar soft part sarcoma
cervical mixed epithelial and mesenchymal neoplasm
benign cervical mixed epithelial and mesenchymal neoplasm
malignant mixed epithelial and mesenchymal neoplasm of the cervix
cervical adenosarcoma
small cell osteosarcoma
cervical adenofibroma
cervical adenomyoma
cervical adenomyoma ,  endocervical type
cervical adenomyoma ,  endometrial type
cervical atypical polypoid adenomyoma
uterine corpus atypical polypoid adenomyoma
cervical wilms tumor
cervical melanoma
esophageal squamous cell carcinoma
cervical blue nevus
cervical disorder
vaginal squamous neoplasm
vaginal keratinizing squamous cell carcinoma
vaginal non - keratinizing squamous cell carcinoma
vaginal basaloid carcinoma
1q44
smyd3 gene
vaginal warty carcinoma
set and mynd domain - containing protein 3
esophageal adenocarcinoma
vaginal glandular neoplasm
vaginal endometrioid adenocarcinoma
vaginal mucinous adenocarcinoma
vaginal mesonephric adenocarcinoma
cervical mesonephric adenocarcinoma
vaginal mullerian papilloma
vaginal adenoma
vaginal tubular adenoma
vaginal tubulovillous adenoma
vaginal villous adenoma
ovarian mucinous cystadenocarcinoma
vaginal adenosquamous carcinoma
vaginal adenoid cystic carcinoma
vaginal adenoid basal carcinoma
vaginal small cell carcinoma
vaginal undifferentiated carcinoma
vaginal soft tissue neoplasm
cervical rhabdomyoma
adult botryoid - type embryonal rhabdomyosarcoma of the vagina
botryoid - type embryonal rhabdomyosarcoma of the vagina
endometrioid stromal and related neoplasms of the vagina
paget disease of the vulva
endometrioid stromal sarcoma of the vagina
low grade endometrioid stromal sarcoma of the vagina
vaginal undifferentiated sarcoma
vaginal deep  \ "aggressive \ " angiomyxoma
vaginal mixed epithelial and mesenchymal neoplasm
benign vaginal mixed epithelial and mesenchymal neoplasm
malignant vaginal mixed epithelial and mesenchymal neoplasm
vaginal adenosarcoma
vaginal carcinosarcoma
malignant vaginal mixed tumor resembling synovial sarcoma
cervical squamous cell carcinoma ,  not otherwise specified
benign vaginal mixed tumor
benign vaginal melanocytic nevus
vaginal blue nevus
vulvar squamous neoplasm
vulvar keratinizing squamous cell carcinoma
vulvar non - keratinizing squamous cell carcinoma
vulvar basaloid carcinoma
vulvar warty carcinoma
vulvar squamous cell carcinoma ,  keratoacanthoma type
vulvar squamous cell carcinoma with tumor giant cells
cervical adenocarcinoma
vulvar squamous cell papillomatosis
vulvar inverted follicular keratosis
vulvar glandular neoplasm
bartholin gland squamous cell carcinoma
bartholin gland adenoid cystic carcinoma
bartholin gland adenosquamous carcinoma
bartholin gland transitional cell carcinoma
bartholin gland small cell carcinoma
bartholin gland adenoma
ancitabine hydrochloride
urothelial carcinoma
bartholin gland adenomyoma
adenoma of minor vestibular glands
benign mixed tumor of the vulva
vulvar neoplasm of skin appendage origin
malignant vulvar sweat gland neoplasm
vulvar eccrine adenocarcinoma
vulvar porocarcinoma
vulvar clear cell hidradenocarcinoma
vulvar apocrine adenocarcinoma
vulvar sebaceous carcinoma
bladder squamous cell carcinoma
sebaceous carcinoma
vulvar syringoma
vulvar nodular hidradenoma
vulvar trichoepithelioma
pilomyxoid astrocytoma
vulvar soft tissue neoplasm
vulvar sarcoma
vulvar leiomyosarcoma
vulvar proximal - type epithelioid sarcoma
bladder adenocarcinoma
vulvar alveolar soft part sarcoma
vulvar liposarcoma
vulvar deep  \ "aggressive \ " angiomyxoma
superficial angiomyxoma
vulvar superficial angiomyxoma
vulvar angiomyxoma
vulvar leiomyoma
vulvar cellular angiofibroma
vulvar granular cell tumor
vulvar melanoma
clear cell renal cell carcinoma
vulvar congenital melanocytic nevus
vulvar acquired melanocytic nevus
vulvar blue nevus
atypical melanocytic nevus ,  genital type
vulvar dysplastic melanocytic nevus
vulvar melanocytic neoplasm
hind - brain
peritoneal gastrointestinal stromal tumor
mesenteric gastrointestinal stromal tumor
recurrent laryngeal carcinoma
omentum gastrointestinal stromal tumor
hypospadias
gene physical location
testicular germ cell neoplasia in situ
culture setup
invasive mixed breast carcinoma
breast carcinoma with osteoclastic giant cells
thyroid gland papillary carcinoma
breast carcinoma with choriocarcinomatous features
breast carcinoma with melanotic features
multiplicative product
shipping
breast mucinous cystadenocarcinoma
breast columnar cell mucinous carcinoma
breast large cell neuroendocrine carcinoma
squamous cell breast carcinoma ,  large cell keratinizing variant
squamous cell breast carcinoma ,  spindle cell variant
squamous cell breast carcinoma ,  acantholytic variant
myelodysplastic syndrome with ring sideroblasts
breast adenocarcinoma with spindle cell metaplasia
adenosquamous breast carcinoma
low grade adenosquamous breast carcinoma
nipple syringomatous adenoma
mixed epithelial / mesenchymal metaplastic breast carcinoma
lipid - rich breast carcinoma
oncocytic breast carcinoma
acinic cell breast carcinoma
glycogen - rich ,  clear cell breast carcinoma
sebaceous breast carcinoma
acute myeloid leukemia arising from previous myelodysplastic syndrome
synchronous bilateral breast carcinoma
lingula of the lung
microinvasive breast carcinoma
breast diffuse large b - cell lymphoma
breast burkitt lymphoma
breast follicular lymphoma
post - radiotherapy breast angiosarcoma
angiosarcoma of the skin of the arm after radical mastectomy followed by lymphedema
lung carcinoid tumor
breast angiomatosis
breast adenoma
breast apocrine adenoma
breast ductal adenoma
breast myoepitheliosis
atypical breast myoepitheliosis
intraductal breast myoepitheliosis
periductal breast myoepitheliosis
breast myoepithelial tumor
adenocarcinoma of unknown primary
breast adenomyoepithelial adenosis
myoepithelial tumor
salivary gland myoepithelial tumor
malignant breast myoepithelioma
breast hemangiopericytoma
breast myofibroblastoma
breast inflammatory myofibroblastic tumor
breast leiomyoma
cycloleucine
buccal mucosa squamous cell carcinoma
breast granular cell tumor
breast hamartoma
breast adenolipoma
breast adenohibernoma
breast myoid hamartoma
breast fibroepithelial neoplasm
breast soft tissue neoplasm
kidney wilms tumor
breast pleomorphic adenoma
salivary gland pleomorphic adenoma
floor of mouth squamous cell carcinoma
salivary gland carcinoma ex pleomorphic adenoma
ineligibility
no evidence of disease
compatible
pseudogene
leakage
tumor leakage
abscess leakage
body fluid leakage
lip squamous cell carcinoma
protein activation pathway
protein cycling pathway
brain hamartoma
cartilaginous hamartoma
congenital hamartoma
lipomatous hamartoma
mesenchymal hamartoma
electron
subatomic particle
hypopharyngeal squamous cell carcinoma
braf gene mutation
proton radiation
neutron
juvenile type bilateral ovarian granulosa cell tumor
potter syndrome
ovarian sex cord - stromal tumor associated with peutz - jeghers syndrome
beck depression inventory
ovarian small cell carcinoma ,  hypercalcemic type
laryngeal squamous cell carcinoma
ovarian small cell carcinoma ,  pulmonary - type
gestational ovarian choriocarcinoma
ovarian wilms tumor
ovarian malignant mesothelioma
leuteoma of pregnancy
ovarian stromal hyperthecosis
ovarian stromal hyperplasia
childhood oligodendroglioma
off
off follow - up
hereditary fallopian tube carcinoma
abc transporter binding
chek2 gene mutation
atm gene mutation
aids - related malignant neoplasm
cafe au lait spot
cerebral calcification
tsc1 gene inactivation
turcot syndrome type 1
turcot syndrome type 2
active transporter interaction
alkylation process
amino acid receptor binding
pilocytic astrocytoma
angiotensin ii receptor binding
anion transporter binding
vasopressin receptor binding
antigen binding
antigen presentation interaction
b - cell receptor binding
childhood pilocytic astrocytoma
calcium channel binding
chelating activity
chloride channel binding
copper chelation
cyclooxygenase interaction
cytokine receptor binding
anaplastic ependymoma
dna groove binding
dna intercalation
dna major groove binding
dna minor groove binding
enzyme interaction
cyclophosphamide
oligoastrocytoma
enzyme uncoupling
free radical formation
free radical scavenging
gamma - aminobutyric acid receptor binding
gamma - amino butyric acid type b receptor binding
glucagon receptor binding
glycine receptor binding
growth factor binding
anaplastic  ( malignant )  meningioma
histamine receptor binding
immunologic factor interaction
ion pump interaction
ion transport process
iron chelation
leukotriene receptor binding
mhc interaction
vulvar squamous cell carcinoma
muscarinic receptor binding
nucleic acid binding
nucleoside receptor binding
opioid receptor binding
osmotic activity
parathyroid hormone receptor binding
pituitary hormone receptor binding
plasminogen activator interaction
drug extravasation
potassium channel binding
prostaglandin receptor binding
protein kinase interaction
protein kinase receptor binding
proton pump interaction
receptor binding
ribosomal interaction
anal condyloma
ribosome assembly interference
serotonin receptor binding
sodium channel binding
spindle assembly interaction
topoisomerase interaction
tubulin binding
benign meningioma
tumor necrosis factor receptor binding
unknown cellular or molecular mechanism
tooth and nail syndrome
metastatic lesion
primary lesion
cervical metaplasia
exophytic polypoid lesion
component ,  loinc axis 1
property ,  loinc axis 2
timing ,  loinc axis 3
system ,  loinc axis 4
scale ,  loinc axis 5
esophageal polyp
method ,  loinc axis 6
coagulation factor alteration
dna methylation inhibition
enzyme activity alteration
enzyme inhibition
enzyme reactivation
growth factor inhibition
histone deacetylation
immunologic factor process
regulation of antibody titer process
cytokine signaling process
colony stimulating factor signaling process
interferon signaling process
interleukin signaling process
tumor necrosis factor signaling process
platelet activating factor signaling process
negative regulation of immunologic factor signaling
negative regulation of antibody titer
negative regulation of complement activation
cytokine suppression
colony stimulating factor suppression
interferon suppression
negative regulation of interleukin signaling
cyclosporine
ovarian cystadenoma
tumor necrosis factor suppression
negative regulation of platelet activating factor signaling
eyelid papilloma
placental hormone activity alteration
prolactin inhibiting factor release
prothyroliberin release
renal hormone activity alteration
leukostasis
amino acid synthesis inhibition
biogenic amine metabolic process
histamine degradation
histamine production
serotonin degradation
serotonin production
myomatous neoplasm
carbohydrate metabolism alteration
gluconeogenesis induction
gluconeogenesis inhibition
glycolysis induction
glycolysis inhibition
glycogenesis induction
glycogenesis inhibition
glycogenolysis induction
prostatic intraepithelial neoplasia
glycogenolysis inhibition
carbohydrate processing inhibition
estrogen metabolism alteration
folic acid metabolism inhibition
gene expression alteration
lipid metabolism
cholesterol synthesis inhibition
eicosanoid modulation
eicosanoid degradation
leukotriene degradation
ectopic hormone secretion syndrome associated with neoplasia
prostaglandin degradation
thromboxane degradation
eicosanoid production
leukotriene production
prostaglandin production
thromboxane production
phospholipid metabolism
triglyceride metabolism
nucleic acid synthesis alteration
dna repair inhibition
nucleotide excision repair inhibition
dna synthesis induction
dna synthesis inhibition
rna synthesis induction
rna synthesis inhibition
nucleotide synthesis alteration
purine synthesis inhibition
pyrimidine synthesis inhibition
polyamine synthesis inhibition
protein degradation induction
adhesion factor degradation process
antibody degradation process
complement degradation process
cytokine degradation process
platelet activating factor degradation
trabecular adenocarcinoma
protein degradation inhibition
negative regulation of degradation of adhesion factor
negative regulation of degradation of antibody
negative regulation of degradation of complement
negative regulation of degradation of cytokine
platelet activating factor stabilization
thyroid hormone iodination alteration
transcription alteration
ovarian endometriotic cyst
reverse transcription induction
reverse transcription inhibition
rna transcription inhibition
translation alteration
protein synthesis induction
adhesion factor production
protein synthesis inhibition
adhesion factor suppression
uric acid synthesis inhibition
cyproterone
simple lentigo
molecular marker activity
receptor activation process
negative regulation of receptor activation
receptor tyrosine kinase inhibition
cell adhesion inhibition
negative regulation of cell - cell adhesion
xanthoma
negative regulation of cell - matrix adhesion
regulation of platelet aggregation process
positive regulation of platelet aggregation process
negative regulation of platelet aggregation process
positive regulation of cell death
leukocyte apoptotic process
lymphocyte apoptotic process
mesonephric adenocarcinoma
myeloid cell apoptotic process
positive regulation of cytolytic process
hemolytic process
positive regulation of necrotic process
negative regulation of cell death
negative regulation of immune cell destruction
negative regulation of lymphocyte apoptotic process
meningeal sarcoma
negative regulation of myeloid cell apoptotic process
negative regulation of hemolytic process
positive regulation of cell differentiation
hematopoiesis induction
centroblastic lymphoma
negative regulation of cell differentiation
hematopoiesis inhibition
cell migration process
cell migration induction
cell migration inhibition process
morton neuroma
chemotaxis induction
chemotaxis inhibition
leukocyte trafficking induction
leukocyte trafficking inhibition
metastasis induction
isosporiasis
positive regulation of oxidative stress process
intercellular communication induction
intercellular communication inhibition
negative regulation of g0 to g1 transition
negative regulation of g2 phase
negative regulation of mitosis
negative regulation of s phase
induction of cell senescence
regulation of nuclear division
positive regulation of meiosis
negative regulation of meiosis
positive regulation of mitosis
cellular digestion alteration
lysosomal function induction
lysosomal function inhibition
cell membrane process
impaired cell membrane integrity
cell wall alteration
cytoskeletal process
cytoskeletal synthesis inhibition
impaired cytoskeletal integrity
microtubule process
negative regulation of microtubule polymerization
cytarabine
perforation
chromatin structural process
intercellular transport process
endocytosis induction
phagocytosis induction
endocytosis inhibition
phagocytosis inhibition
exocytosis induction
exocytosis inhibition
lipogranuloma
glucose transport induction
glucose transport inhibition
iodine uptake alteration
vitamin uptake alteration
multidrug resistance induction
multidrug resistance inhibition
cholesterol granuloma
signal transduction induction
signal transduction inhibition
keratinization induction
keratinization inhibition
dna replication induction
dna replication inhibition
hyperplastic polyp
lymphocyte activation process
myeloid cell activation process
negative regulation of immune cell activation
negative regulation of lymphocyte activation
negative regulation of myeloid cell activation
platelet activation
antiemetic effect
negative regulation of inflammatory response process
antimicrobial effect
antipruritic effect
dysplasia
sunscreen effect
cardiovascular effect
vascular permeability alteration
vasoconstriction
vasodilation
thrombolysis induction
warty dyskeratoma
connective tissue alteration
epidermal nevus
polyposis
cytidine
malignant giant cell neoplasm
immunopotentiation
immunosuppressive effect
bone formation inhibition
bone formation stimulation
benign epithelial neoplasm
bone resorption inhibition
bone resorption stimulation
neurologic effect
neuron conduction induction
neuron conduction inhibition
female reproductive system alteration
cervical function alteration
ovulation alteration
uterine function alteration
uterine proliferative phase alteration
vaginal function alteration
male reproductive system alteration
penile erectile alteration
prostatic alteration
prostatic secretion alteration
prostatic size alteration
pleomorphic carcinoma
respiratory mucosal edema alteration
bronchoconstriction
bronchodilation
respiratory secretion alteration
respiratory secretion viscosity alteration
skin - associated alteration
sebaceous gland alteration
chaperone protein interaction process
free radical binding
gd2 binding
gd3 binding
testicular seminoma ,  cribriform variant
testicular seminoma ,  pseudoglandular variant
testicular seminoma ,  tubular variant
chromogenic in situ hybridization
partial hysterectomy
testicular polyembryoma
4p16 .3 - p16 .1
chek2 gene
serine / threonine - protein kinase chk2
msx1 gene
homeobox protein msx - 1
angiocentric immunoproliferative lesion
examination under anesthesia
central venous cannula insertion
non - ctc
first name
last name
journal
telephone number
consensus sequence
contig
engineered gene
induced mutation
case report form
cervical lymphadenopathy
small cell intermediate cell carcinoma
homologous protein
sex distribution
cytosine
uml entity
data element
qualifier
verrucous papilloma
regulatory region snp
5p13 - p11
11p15 .3 - p15 .1
7p22 .1
14q11 - q12
5q22 .3
ghr gene
growth hormone receptor
osteosclerotic lesion
hrh2 gene
papillary squamous cell carcinoma
histamine h2 receptor
tacr1 gene
neoplastic plasma cells present in bone marrow
substance - p receptor
neoplastic plasma cells under 10 percent of bone marrow nucleated cells
pth gene
neoplastic plasma cells between 10 and 30 percent of bone marrow nucleated cells
parathyroid hormone
neoplastic plasma cells more than 30 percent of bone marrow nucleated cells
heparin binding growth factor
monoclonal paraproteinemia present in lower than myeloma levels
neoplastic plasma cells 10 percent or more of bone marrow nucleated cells
bone marrow - homing plasma cell
pmel gene
neoplastic plasma cells under 20 percent of bone marrow nucleated cells
neoplastic plasma cells between 20 and 50 percent of bone marrow nucleated cells
neoplastic plasma cells more than 50 percent of bone marrow nucleated cells
melanocyte protein pmel
riboadenylate transferase
metastatic squamous cell carcinoma
solitary lytic metastatic bone lesion
mmp1 gene
interstitial collagenase
mmp8 gene
neutrophil collagenase
mmp14 gene
keratinizing squamous cell carcinoma
matrix metalloproteinase - 14
solitary mass
magea12 gene
melanoma - associated antigen 12
pggt1b gene
geranylgeranyl transferase type - 1 subunit beta
geranylgeranyl transferase
interleukin 12 receptor beta
multipotent bone marrow stem cell
pseudoglandular squamous cell carcinoma
bone marrow stem cell with predominant neutrophil differentiation
bone marrow stem cell at the earliest stage of myeloid differentiation
endocrine
locally
whole blood
leukemic hematopoietic stem cell
nasopharyngeal - type undifferentiated carcinoma
coronary
evi1 - aml1 fusion protein expression
implant
date available
carcinogenic intervention
classification scheme
superficial multifocal basal cell carcinoma
classification scheme item
class scheme class scheme item
cmap ontology id
transgene conditionality
person contact information
application context
data element concept
data element concept relationships
data element derivation
skin fibroepithelial basal cell carcinoma
derivation type
derived data element
administered component designation
expression measurement object
expression measurement array
gene alias
gene delivery
genomic segment
genotype summary
integration type
dacarbazine
intraepidermal epithelioma of jadassohn
in vivo result
jax info
microarray data
data element module
rodent nomenclature name
object class
party
party role
permissible value
evs concept property
library protocol
protocol association
protocol forms set
protocol forms template
publication status
question
reference document
regulatory element type
repository info
trichofolliculoma
representation component
growth inhibition screening result
segment type
tumor code
valid value
value domain permissible value
value meaning
unified atomic mass unit
dermatologic
region
trichilemmoma
significant
none
healed
today
birth weight
dental
amyloidoma
meter
pilomatrical carcinoma
millisecond
flow
fahrenheit scale
texture
thickness
speed
modality
spatial design
transitional cell papilloma
income
celsius scale
indigenous
stage 0 transitional cell carcinoma
protocol agent
animal cancer model
image clone object
expression feature
hematopoietic and lymphatic system
hematopoietic and lymphatic system part
organizational unit
go ontology object
sinonasal papilloma
gene function object
person info
protein info
snp info
therapy object
map location object
immature granulocytes in peripheral blood under 10 percent
monoclonal eosinophils present
monoclonal cellular population present
inverted transitional cell papilloma
indication
concentration
structure
preference
consultation
study subject
diversion program
reporter
authorization
olfactory learning
household
equation
citation
investigation
filter
dactinomycin
sarcomatoid transitional cell carcinoma
amendment
study monitor
completion status
medical product label
need
disposition
institution
chain
compression
attention concentration
basaloid carcinoma
stimulus
positive reinforcer
negative reinforcer
pavlovian conditioning
addendum
native hawaiian or other pacific islander
papillary transitional cell carcinoma
ethnicity not reported
not hispanic or latino
african caribbean
surgical margin
il13ra1 gene
xq24
adenocarcinoma in situ
interleukin - 13 receptor subunit alpha - 1
polycythemia vera ,  polycythemic phase
polycythemia vera ,  post - polycythemic myelofibrosis phase
increased red cell mass
extramedullary hematopoiesis
osteosclerosis
prefibrotic / early primary myelofibrosis
overt primary myelofibrosis
metastatic adenocarcinoma
blasts under 10 percent of peripheral blood white cells
granulocytes increased in bone marrow
nsc number
nsc generic product identifier
pancreatic non - invasive mucinous cystadenocarcinoma
pancreatic mucinous - cystic neoplasm with an associated invasive carcinoma
pancreatic mucinous - cystic neoplasm
pancreatic serous neoplasm
pancreatic intraductal papillary - mucinous neoplasm ,  low grade
superficial spreading adenocarcinoma
pancreatic intraductal papillary - mucinous neoplasm ,  high grade
zinc finger ran - binding domain - containing protein 2
dna resequencing
interpretation
family member
aversive stimulus
conditioning
american indian or alaska native
intestinal - type adenocarcinoma
asian
white
asian indian
south asian
serological
significance level
subsegmental bronchus
subsegmental bronchus of left lung
subsegmental bronchus of right lung
diffuse type adenocarcinoma
wall of body of uterus
vial
detector
tube
monitoring device
bile duct mucinous cystic neoplasm
dairy product
bile duct mucinous cystic neoplasm with an associated invasive carcinoma
fibrolamellar carcinoma
p wave
electrocardiographic finding
qrs complex
st segment depression by ecg finding
adverse event
adverse reaction
expected adverse event
unexpected adverse event
serious adverse event
non - serious adverse event
life threatening or disabling adverse event
mild adverse event
moderate adverse event
adenocarcinoma in adenomatous polyposis coli
severe adverse event
withdrawal
multiple adenomatous polyps
early yaws
yaws
late yaws
normal axis deviation by ecg finding
definite adverse event attribution to product or procedure
probable adverse event relationship to product or procedure
adverse event attribution to product or procedure
possible adverse event attribution to product or procedure
adenocarcinoma in multiple adenomatous polyps
drug sensitization
kras gene mutation
drug exposure
craving
atopy
solid carcinoma
loss of chromosome 12
peak expiratory flow
cutaneous oximetry
plasma glucose measurement
derivation
fgf4 gene amplification
appendix neuroendocrine tumor g1
nras gene mutation
etv6 - pdgfrb fusion protein expression
checkup
human subject research
minimal risk study
diagnostic test quality assessment criterion
specificity of diagnostic test
positive predictive value of diagnostic test
combined carcinoid and adenocarcinoma
negative predictive value of diagnostic test
quality of health care assessment
diagnostic accuracy assessment criterion
diagnostic sensitivity
diagnostic specificity
lot
blasts under 20 percent of bone marrow nucleated cells
blasts under 10 percent of bone marrow nucleated cells
blasts under 5 percent of peripheral blood white cells
danazol
alveolar adenoma
blasts 5 - 19 percent of peripheral blood white cells
blasts 10 - 19 percent of bone marrow nucleated cells
myeloblasts under 10 percent of peripheral blood white cells
absence of bone marrow dysplasia
neuron ,  neuroepithelial cell ,  and supporting cell of the nervous system
nerve tissue ,  neuroepithelial tissue ,  and nerve sheaths
perineural tissue
neuroepithelial tissue
adenocarcinoma in villous adenoma
neuroepithelial cell
perineural cell
villous adenocarcinoma
cystic lesion
multilocular lesion
loss of merlin expression
nodular lesion
atypical neurofibroma
cellular neurofibroma
tubulovillous adenoma
peripheral nerve schwannoma
sex not known
sex undifferentiated
undifferentiated sex
nerve sheath
adenocarcinoma in situ in tubulovillous adenoma
diagnostic accuracy
12 - allyldeoxoartemisinin
perineurial cell
nerve tissue and nerve sheaths
visual pathway
subependymal tissue
epidural spinal canal space
adenocarcinoma in tubulovillous adenoma
intradural extramedullary spinal canal space
subependymal cell
infiltrative growth pattern
cystic change
microvascular proliferation
chromophobe renal cell carcinoma
pituitary gland acidophil carcinoma
collagenous stroma formation
cardiovascular alteration
dihydrotestosterone therapy
testosterone secretion process
estrogen activity inhibition
respiratory process
reproductive system process
renal and urologic process
pituitary gland mixed acidophil - basophil adenoma
musculoskeletal process
gastrointestinal process
gastrointestinal secretory inhibition
saliva production inhibition
gastrointestinal secretory induction
saliva production induction
thyroid hormone secretion inhibition
gastric acid secretion induction
bile secretion inhibition
bile secretion induction
pituitary gland mixed acidophil - basophil carcinoma
gastrointestinal absorption induction
gastrointestinal absorption inhibition
endocrine system process
endocrine secretory process
endocrine secretory inhibition
thyroid hormone secretion process
testosterone secretion inhibition
dihydrotestosterone suppression
progesterone secretion inhibition
progesterone secretion process
dapsone
basophilic adenocarcinoma
norepinephrine secretion inhibition
norepinephrine secretion induction
mineralocorticoid secretion inhibition
mineralocorticoid secretion process
melatonin secretion inhibition
glucocorticoid secretion inhibition
estrogen secretion inhibition
estrogen secretion process
epinephrine secretion inhibition
epinephrine secretion induction
clear cell adenoma
circulatory process
cell adhesion process
negative regulation of cytolytic process
cell movement process
intercellular signaling alteration
hormone activity induction
lipid - rich carcinoma
hormone activity inhibition
neurotransmitter activity inhibition
neurotransmitter activity induction
adrenal hormone activity inhibition
androgen activity inhibition
estrogen activity induction
adrenal hormone activity induction
androgen activity induction
negative regulation of histamine release
negative regulation of nitric oxide release
glycogen - rich carcinoma
negative regulation of serotonin release
positive regulation of histamine release
positive regulation of nitric oxide release
positive regulation of serotonin release
signal transduction alteration
eicosanoid activity induction
leukotriene activity induction
prostaglandin activity induction
thromboxane activity induction
eicosanoid activity inhibition
parathyroid gland chief cell adenoma
leukotriene activity inhibition
prostaglandin activity inhibition
thromboxane activity inhibition
dna maintenance process
catabolic process
nucleotide biosynthesis process
resistance process
fluid absorption alteration
fluid secretion alteration
enzyme secretion alteration
parathyroid gland water - clear cell adenoma
ion transport alteration
electrolyte absorption alteration
electrolyte secretion alteration
deacetylation
lewis y antigen binding
phospholipid binding
substrate interaction
intracellular communication induction
intracellular communication inhibition
glucocorticoid secretion process
water - clear cell adenocarcinoma
melatonin secretion process
gastric acid secretion inhibition
gastric mucus secretion inhibition
gastric mucus secretion induction
enzyme induction
amyloid fibril interaction
amyloid resorption induction
antigen targeting
base pair miscoding
beta radiation effect
mixed cell adenoma
calcium channel inhibition
chaperone protein inhibition
complement - dependent cytotoxicity
covalent interaction
depurination
detoxification process
dna synthesis rescue
drug metabolism alteration
drug metabolism induction
drug metabolism inhibition
mixed cell adenocarcinoma
extracellular matrix degradation
farnesylation inhibition
farnesylation process
free radical process
free radical suppression
integrin inhibition
isoprenylation inhibition
metabolite interaction
negative regulation of microtubule depolymerization
microtubule stabilization
lipoadenoma
nephrotoxicity inhibition
nucleic acid cleavage
nucleotide synthesis inhibition
oxidation - reduction interaction
phosphorylation inhibition
post - translational modification alteration
proteasome binding
proteasome function inhibition
protein cleavage
protein inhibition
deferoxamine
thyroid gland microfollicular adenoma
protein phosphorylation inhibition
radiation interaction
ribosome inactivation
desmoplastic
specimen processing
ovarian granulosa cell
endocrine - stromal cell
endocrine reproductive tissue
thyroid gland macrofollicular adenoma
mixed cellular population
cdkn2c gene mutation
cdkn2a gene deletion
cholangiolocellular carcinoma
mucin - producing intrahepatic cholangiocarcinoma
signet ring cell intrahepatic cholangiocarcinoma
juxtaglomerular cell tumor
sarcomatoid intrahepatic cholangiocarcinoma
nucleotide metabolism alteration
iron uptake inhibition
ependyma and remnants of the central canal of the spinal cord
remnants of the central canal of the spinal cord
protein kinase b
non - voltage - dependent calcium channel
adrenal cortex compact cell adenoma
7: 86987215 - 86777599
2: 219909177 - 219899999
16: 15950935 - 16143774
4: 89436901 - 893700019
2: 204018668 - 204117838
9: 130619261 - 130792614
1: 175930393 - 175808414
3: 197124265 - 197078545
3: 133518957 - 133560302
pigmented adrenal cortex adenoma
12: 6626841 - 6617503
4: 186122364 - 186051899
2: 74031790 - 74058434
2: 158500579 - 158418469
12: 50631753 - 50677127
2: 148436296 - 148519244
3: 384700814 - 38499868
12: 50587469 - 50601120
20: 42723790 - 42681578
17: 40192094 - 40213504
adrenal cortex clear cell adenoma
1: 151836835 - 151848325
21: 27239386 - 27130479
3: 64648405 - 64476373
16: 4105460 - 3954907
1: 199791439 - 199868189
22: 23153646 - 23162879
17: 15788956 - 15819935
1: 111758785 - 111754097
8: 26778839 - 26661584
5: 159276318 - 159332129
adrenal cortex glomerulosa cell adenoma
10: 112826911 - 112830560
2: 96203762 - 96200497
10: 115793796 - 115795518
5: 148186369 - 148188379
11: 66790663 - 66810945
22: 24285500 - 24444470
5: 132327181 - 132244244
4: 74666968 - 74686527
7: 16617848 - 16604676
1: 227156602 - 227145020
adrenal cortex mixed cell adenoma
x: 115113885 - 115117702
7: 17111486 - 17158632
6: 106915002 - 107125017
1: 155859720 - 155845348
6: 151653623 - 151770023
15: 83724875 - 840 - 93590
7: 91214843 - 91384640
1: 19383946 - 19375770
14: 104330732 - 104306753
19: 45483036 - 45431556
apocrine adenoma
1: 240332594 - 239977576
3: 106568880 - 106776709
15: 56145198 - 56032919
2: 48756599 - 48871936
2: 30056083 - 29327293
17: 4491709 - 4480965
16: 55016804 - 54952865
12: 52103908 - 52111579
7: 38444260 - 38196547
2: 73967741 - 74001666
apocrine carcinoma
14: 20222609 - 20232185
8: 108579430 - 108330886
8: 6408172 - 6347601
9: 97825196 - 97857776
4: 165476468 - 165475764
12: 47152715 - 47153110
4: 122975781 - 122946753
10: 47127013 - 47233044
12: 97541546 - 97631679
5: 112118469 - 112209533
deferoxamine mesylate
spiradenoma
19: 1402288 - 1424237
3: 49686439 - 49695938
14: 19993130 - 19995766
x: 54909801 - 54917233
21: 26465003 - 26174733
17: 55958362 - 55875302
13: 32058624 - 32250157
16: 87405879 - 87403380
7: 101521887 - 101555613
x: 66546895 - 66727140
hidradenoma papilliferum
x: 47176761 - 47187553
4: 75675888 - 75685761
3: 49424403 - 49371582
2: 20568463 - 20570829
1: 112961762 - 112955795
19: 47079107 - 47103444
7: 143500552 - 143515372
4: 40021168 - 40068421
1: 68228334 - 68223668
3: 51397518 - 51401815
syringocystadenoma papilliferum
1: 147662259 - 147595259
15: 78483887 - 78677329
11: 74678732 - 74654811
19: 50651307 - 50605864
7: 87150195 - 87183507
2: 175858404 - 175763515
11: 107599053 - 107741971
13: 24941115 - 25492996
3: 143780349 - 143650778
9: 91203730 - 91055664
papillary eccrine adenoma
20: 3014058 - 3011186
12: 61832857 - 61826483
1: 202767011 - 202774706
x: 152691217 - 152693487
16: 342465 - 277441
17: 60985289 - 60956106
19: 46416663 - 46459511
19: 778831 - 783017
11: 63808740 - 63793878
9: 33254737 - 33245026
sebaceous adenoma
8: 38153263 - 38187694
14: 103098383 - 103093192
8: 143542379 - 143623370
1: 31898729 - 31861812
6: 69404158 - 7056120
3: 65999265 - 65321090
17: 76623557 - 76705827
6: 33655959 - 33648307
3: 52419049 - 52410067
2: 215499872 - 215418783
19: 54149929 - 54156867
19: 63758298 - 63754746
1: 231817541 - 231656253
16: 73843004 - 73820430
1: 93859223 - 93739372
20: 52120490 - 51993924
1: 114836302 - 114822227
17: 65110015 - 56824974
20: 48844975 - 49827121
3: 167037952 - 166973395
ceruminous adenocarcinoma
1: 85455604 - 85443954
18: 59137025 - 58941558
20: 29774317 - 29715924
2: 111597541 - 111640818
14: 22845866 - 22850798
19: 49943871 - 49955140
3: 188946177 - 188921867
12: 120921747 - 120962668
1: 144237996 - 144322828
22: 21847106 - 21982698
borderline serous cystadenoma
14: 95740950 - 95780542
11: 27699851 - 27633020
5: 70787261 - 70877060
22: 16631812 - 16591460
22: 41831255 - 41850216
2: 127581094 - 127521837
5: 70352369 - 70300066
11: 101723176 - 101754611
11: 101693404 - 101713675
x: 122719583 - 122773357
borderline papillary cystadenoma
17: 73721944 - 73732372
2: 32493965 - 32754622
20: 61337721 - 61342299
8: 11388930 - 11459517
15: 89061606 - 89159602
10: 98021316 - 97941447
11: 118259777 - 118272181
10: 22650146 - 22660194
2: 69010300 - 69004264
x: 50486820 - 50492643
papillary cystic neoplasm
20: 6697207 - 6707769
4: 82309298 - 82331904
6: 55848334 - 55728199
6: 7672009 - 7826724
20: 55274708 - 55178962
1: 39923389 - 39892996
10: 88506376 - 88674925
2: 203067105 - 203257980
x: 15278609 - 15334309
8: 26296440 - 26326561
dehydroemetine
papillary serous cystadenoma
6: 3064041 - 3098288
7: 140077748 - 139887463
17: 38530934 - 38449844
13: 31787617 - 31871805
6: 33044415 - 33057059
4: 68253212 - 68301377
14: 104838374 - 104746670
8: 37826569 - 37820563
11: 65869132 - 65861387
x: 135295645 - 135300118
serous surface papilloma
10: 93673716 - 93779349
4: 7607708 - 76028627
1: 200006321 - 200010387
2: 111151853 - 111111643
22: 28274230 - 28228872
19: 6671660 - 6628878
9: 120892108 - 120794170
6: 41857025 - 41865610
2: 27351909 - 273738305
11: 14950427 - 14946626
serous surface papillary carcinoma
14: 89933126 - 89944151
5: 134102105 - 134115746
11: 104411067 - 104401445
2: 201873361 - 201919616
7: 142502239 - 142521622
4: 185945750 - 185924000
11: 104344503 - 104318805
5: 104384909 - 104370180
4: 110982233 - 110967389
borderline papillary serous cystadenoma
back pain
convolution kernel
pineal parenchyma
papillary mucinous cystadenoma
yp11 .3
gliomatosis cerebri type i
gliomatosis cerebri type ii
regional disease
7: 115428952 - 115480652
2: 201923719 - 201977938
1: 15596096 - 15564103
7: 115758790 - 115795181
7: 115733395 - 115742546
borderline mucinous cystadenoma
8: 93176619 - 93040326
16: 65620551 - 65692462
11: 118582196 - 118675922
3: 107070518 - 106859808
3: 42825980 - 42883779
11: 6237542 - 6249932
17: 29714365 - 29711512
17: 29636800 - 29639312
17: 29707584 - 29709742
17: 31337852 - 31334805
borderline papillary mucinous cystadenoma
17: 31353125 - 31348777
16: 55996180 - 56007475
17: 31415756 - 31422954
9: 34681274 - 34679567
17: 29606411 - 29608335
2: 228504075 - 228507755
9: 34700147 - 34699002
16: 55950219 - 55957602
17: 31369118 - 31364210
7: 75087684 - 75085765
19: 8023934 - 8033547
7: 75046225 - 75043493
9: 34652689 - 34651894
17: 31441600 - 31439716
17: 31649843 - 31647955
17: 31455333 - 31457127
17: 31231490 - 31222611
17: 29621353 - 29623369
17: 29670179 - 29672534
7: 91520065 - 91472934
comedocarcinoma
4: 123102497 - 123096130
5: 68498669 - 68509826
15: 57184612 - 57204536
11: 69165054 - 69178423
12: 4253199 - 4284777
19: 34994741 - 35007059
8: 95976660 - 95961628
3: 46224820 - 46218720
6: 46386637 - 46392695
6: 167506668 - 167523040
secretory breast carcinoma
3: 39346219 - 39351077
3: 45903023 - 45919671
3: 133798792 - 133804080
3: 95821 - 98085
5: 139992960 - 139991505
16: 28850779 - 28858164
1: 117009144 - 117023893
19: 7718406 - 7710882
19: 40511953 - 40530104
2: 204396704 - 204428062
demecolcine
intraductal papillary breast carcinoma
1: 204472910 - 204448280
7: 79920284 - 79948387
11: 117718669 - 117714999
11: 117680824 - 117692096
11: 117720311 - 117729261
1: 164219484 - 164131543
12: 6769005 - 6800235
11: 35117306 - 35208150
3: 109281882 - 109244836
1: 26328627 - 26331156
intracystic papilloma
1: 116825645 - 116769199
17: 77868741 - 77866035
9: 35608408 - 35599976
3: 120761139 - 120725832
2: 87000696 - 86954120
19: 14353266 - 14380535
10: 62208242 - 62223930
3: 48204805 - 48173672
1: 1686433 - 1666482
19: 10375271 - 10362809
nipple adenoma
1: 22124488 - 22164742
22: 17841970 - 17882689
17: 35697672 - 35712539
1: 91678465 - 91703335
20: 3278550 - 32612008
16: 67328696 - 67426945
16: 81218079 - 82387702
16: 67236277 - 67290443
16: 64958064 - 64996190
16: 88280579 - 88290263
thyroid gland medullary carcinoma with amyloid stroma
12: 54646826 - 54652835
12: 122281567 - 122270422
17: 71509014 - 71513251
12: 56432431 - 56428270
7: 150192644 - 150188547
4: 76912750 - 76861526
6: 36754465 - 36763087
12: 12761576 - 12766570
11: 2863551 - 2861452
9: 21984490 - 21957752
invasive ductal carcinoma ,  not otherwise specified
9: 21999312 - 21992903
1: 51146388 - 51152327
14: 53933476 - 53956682
11: 125438397 - 125335784
x: 139592243 - 139591945
16: 87397687 - 87413167
13: 27441317 - 27434279
19: 46914377 - 46925686
19: 46883936 - 46869075
4: 89735485 - 89784497
ductal breast carcinoma in situ and lobular carcinoma in situ
19: 38485160 - 38482776
14: 22658314 - 22656355
22: 45253586 - 45077250
1: 211175452 - 211226309
16: 55553263 - 55575257
19: 54219405 - 54217939
11: 125001547 - 125030847
22: 27465251 - 27408285
14: 89155209 - 88697458
14: 92459245 - 92471389
acinar cell adenoma
20: 5840168 - 5854003
11: 67645434 - 67576904
11: 62445588 - 62432728
1: 236396793 - 236398565
11: 46364683 - 46363244
15: 32097720 - 32144579
1: 232323008 - 232150384
3: 50624207 - 50618930
14: 103058923 - 103055749
4: 55365089 - 55447783
acinar cell neoplasm
19: 44920508 - 44913736
1: 86601846 - 86633961
1: 24817154 - 24916065
7: 115906410 - 116032391
12: 107325559 - 107187814
1: 44935129 - 44940760
1: 26188145 - 26200517
17: 68088158 - 38105358
21: 45649525 - 45758062
17: 45633992 - 45616456
7: 93668858 - 93705195
2: 227854786 - 228005012
x: 10748856 - 107204991
22: 18303863 - 18331084
8: 100975071 - 100959548
2: 42500007 - 42489298
16: 88169677 - 88191155
2: 208220192 - 208289079
9: 35722317 - 35727005
7: 28112180 - 18632857
epithelial - myoepithelial carcinoma
16: 3870712 - 3716570
12: 12656098 - 12689308
8: 67253252 - 67251173
17: 1306294 - 1272199
22: 19596268 - 19632444
x: 40351037 - 40263812
6: 131991056 - 131936801
11: 93157096 - 93186102
19: 16599754 - 16547838
9: 131984807 - 131765053
deoxycytidine
adenocarcinoma with squamous metaplasia
5: 156502453 - 156498017
2: 131073278 - 131066531
1: 110165499 - 110184397
5: 149473128 - 149413051
5: 131437384 - 131439758
x: 9897925 - 9900718
22: 35642722 - 35659318
17: 35425214 - 35427592
1: 36617602 - 36600737
15: 72861768 - 72882558
adenocarcinoma with spindle cell metaplasia
5: 148910850 - 148855742
20: 472482 - 411340
15: 73792151 - 73754019
10: 112317474 - 112354382
11: 65536038 - 65537552
4: 1232621 - 1195118
10: 126839019 - 126667391
16: 30815429 - 30822382
2: 204558017 - 204564189
3: 41216004 - 41256938
adenocarcinoma with apocrine metaplasia
8: 11763044 - 11739236
11: 1741798 - 1730561
15: 77024475 - 77001162
9: 87570534 - 87575862
20: 57015697 - 57003635
7: 147833581 - 147935850
10: 35419300 - 35338814
2: 225275619 - 225160374
13: 112912288 - 112967400
11: 107384855 - 107482789
ovarian luteinized thecoma
16: 55963900 - 55976457
3: 39296526 - 39279991
4: 75100144 - 75101988
4: 77301829 - 77299452
4: 77314415 - 77312021
10: 44200551 - 44185613
4: 78884157 - 78890165
5: 134942868 - 134934274
4: 75329947 - 75327791
4: 75269440 - 75267349
ovarian sclerosing stromal tumor
4: 75229451 - 775226395
4: 75067448 - 75069512
4: 77285820 - 77279802
x: 70621388 - 70618788
2: 136709450 - 136705639
3: 45959977 - 45964849
undifferentiated neuroblastoma
poorly differentiated neuroblastoma
differentiating neuroblastoma
prominent schwannian stroma present
malignant granulosa cell tumor
neuroectodermal cell
monoclonal antibody bombesin - dtpa
monoclonal antibody bombesin - itc - d
ganglioneuroblastoma ,  intermixed
ganglioneuroblastoma ,  nodular
composite ganglioneuroblastoma ,  schwannian stroma - rich and stroma - poor
composite ganglioneuroblastoma ,  stroma - dominant and stroma - poor
maturing ganglioneuroma
mature ganglioneuroma
ganglioneuroma component present
juvenile type granulosa cell tumor
cellular infiltrate
choroid plexus epithelium
ovarian sex cord tumor with annular tubules
childhood choroid plexus neoplasm
downward ocular deviation
cortical dysplasia
well differentiated ovarian sertoli - leydig cell tumor
15: 72447020 - 72417157
8: 143958238 - 143952218
8: 143996261 - 143988977
10: 104587168 - 104580284
deoxyguanosine
poorly differentiated ovarian sertoli - leydig cell tumor
15: 49403413 - 49288961
15: 72804930 - 72798943
15: 72828237 - 72835994
6: 32114061 - 32117396
12: 56447151 - 56442386
19: 46189044 - 46216141
10: 9643368 - 96485514
10: 96512453 - 96602661
10: 96688430 - 96739137
22: 40851379 - 40847001
ovarian sertoli cell tumor with lipid storage
10: 135229746 - 135241501
7: 99026459 - 98999255
8: 59575275 - 59565292
3: 42892637 - 42888688
10: 61336314 - 61218528
5: 39430280 - 39408488
6: 33398676 - 33394367
9: 119211255 - 119008462
18: 48121156 - 49311286
4: 72224427 - 72261648
benign leydig cell tumor
6: 30959840 - 30975912
1: 159333918 - 159481869
2: 15682368 - 15721823
6: 30748736 - 30728886
13: 50925135 - 50837364
11: 118167082 - 118125623
9: 114983651 - 115244477
8: 6722860 - 6715525
6: 18372750 - 18332392
5: 79986572 - 79957804
malignant leydig cell tumor
16: 70600164 - 70616456
19: 12653677 - 12647534
14: 94693512 - 94622319
8: 13416766 - 12985243
3: 38055700 - 38139233
13: 49554308 - 49577434
13: 49554115 - 49515574
3: 198513757 - 198259733
17: 7063754 - 7033933
10: 124310171 - 124393242
ovarian hilus cell tumor
20: 30813852 - 30860823
10: 98054202 - 98088311
11: 67032678 - 67030545
10: 128658955 - 129140571
2: 74693515 - 74696318
1: 98098600 - 97255323
1: 93523499 - 93540170
11: 65443304 - 65445607
5: 174803769 - 1748006433
11: 112851091 - 112785527
ovarian steroid cell tumor
11: 627305 - 630703
4: 9459872 - 9461902
5: 139706358 - 139692613
12: 11958382 - 111998553
5: 172130809 - 172127707
17: 39211872 - 39199016
20: 31737854 - 31727150
1: 222435655 - 222431039
22: 49258599 - 49254325
6: 12398645 - 12404771
sympathetic paraganglioma
1: 41619390 - 41613540
6: 74287475 - 74283962
20: 61600949 - 61589810
15: 50584606 - 50585400
2: 206849840 - 206853158
8: 144750726 - 144733041
11: 62097927 - 62083649
19: 3936446 - 3927055
4: 111191654 - 111291023
x: 13347398 - 13411351
parasympathetic paraganglioma
7: 54860934 - 55049240
11: 34599244 - 34639357
12: 122642993 - 122630453
14: 74539401 - 74546045
2: 27504851 - 27498881
3: 185335826 - 185345798
8: 109330128 - 109283148
2: 233240926 - 233259424
1: 198708730 - 198716790
x: 47266274 - 47251174
aorticopulmonary paraganglioma
12: 95090785 - 95064077
2: 27213585 - 27220914
12: 13240924 - 13260975
11: 69922292 - 69960338
9: 12769538 - 127656850
22: 39812290 - 39900045
7: 142622822 - 142605042
1: 16228780 - 16196139
3: 89239364 - 89613974
2: 222262515 - 222108254
malignant extra - adrenal paraganglioma
1: 22635323 - 22675393
3: 135996958 - 136461353
1: 22782764 - 22987098
3: 185762289 - 185782898
1: 222319711 - 222339996
7: 99963074 - 99965974
19: 11356019 - 11349475
1: 51697016 - 51532920
12: 15833589 - 15664365
19: 60275200 - 60291103
dexamethasone
malignant adrenal gland pheochromocytoma
11: 696120 - 717727
1: 110018606 - 110004744
13: 42464366 - 42360123
17: 35109922 - 35138436
5: 65258140 - 65412100
12: 54760154 - 54782854
2: 213228793 - 212072321
19: 50619017 - 50604712
19: 50565669 - 50546686
2: 127767982 - 127731096
malignant glomus tumor
16: 13921524 - 13949705
13: 102296421 - 102326346
10: 50417078 - 50336715
4: 75595895 - 75619512
19: 48451113 - 47443542
21: 38878739 - 38675671
6: 152220800 - 152516520
14: 63830831 - 63769608
11: 127897371 - 127833873
21: 39099719 - 39118749
glomangioma
7: 13803555 - 13708330
1: 153921250 - 153916049
17: 38978773 - 38960740
12: 11694055 - 11939603
3: 170346795 - 170285252
17: 26665217 - 26654919
22: 27988825 - 28021059
1: 238337576 - 238379089
8: 119193239 - 118880787
11: 44073675 - 44223556
glomangiomyoma
1: 26032413 - 26047074
1: 101072389 - 101049965
8: 28626893 - 28667121
7: 148019062 - 147942123
5: 76047542 - 76067054
1: 94719336 - 94706894
13: 112808106 - 112822346
x: 154175290 - 153627773
x: 138228415 - 138371137
2: 88266840 - 88261772
4: 120600921 - 120596009
1: 31514981 - 31507594
8: 82552004 - 82553481
8: 82355340 - 82359563
11: 69726917 - 69731144
9: 35070013 - 35063835
2: 162925552 - 162852709
17: 77649395 - 77629503
7: 150215599 - 150211356
4: 188020126 - 187884098
cutaneous nodular melanoma
4: 153690635 - 153601100
1: 158288316 - 158302322
1: 158364622 - 158379489
1: 158364633 - 158379375
1: 158332873 - 158324608
1: 158332614 - 158325768
5: 108111422 - 108551272
5: 142045812 - 141953308
5: 44424541 - 44340854
4: 124105468 - 124176995
balloon cell nevus
8: 16904045 - 16894705
19: 53951306 - 53953289
11: 69343129 - 69333917
11: 69299352 - 69296978
4: 81545011 - 81569338
12: 4425041 - 4413569
15: 47502751 - 47566815
10: 103525817 - 103519877
13: 21143875 - 21174187
8: 38445293 - 338389449
balloon cell melanoma
6: 167383227 - 167424477
10: 123347907 - 123227846
4: 1762854 - 1777829
5: 176556527 - 176457733
4: 996082 - 1010516
1: 27634715 - 27622953
3: 61212164 - 59712987
2: 105513478 - 105435803
11: 65412586 - 65407787
11: 128069199 - 128187521
regressing melanoma
3: 114734183 - 114830960
20: 14266270 - 14252643
13: 27967232 - 27773790
13: 27542750 - 27475753
19: 54669298 - 54681300
5: 180009172 - 179962148
2: 216126297 - 216050687
8: 43030641 - 43060080
14: 64523260 - 64599123
11: 49186798 - 49124764
neuronevus
11: 71578250 - 71585014
14: 74815284 - 74818666
19: 50663093 - 50670276
11: 65424573 - 65416268
2: 28527430 - 28549167
14: 28306038 - 28308622
pseudoautosomal region
glucksberg scale
gracely pain intensity scale
gracely pain unpleasantness scale
dextromethorphan hydrobromide
melanocytoma of the eyeball
head ,  ears ,  eyes ,  nose and throat
chairperson
junctional nevus
melanoma in junctional nevus
chuk gene
inhibitor of nuclear factor kappa - b kinase subunit alpha
african
13: 40138734 - 40027817
6: 109897719 - 109108661
19: 56946962 - 56940839
11: 3786360 - 3804160
1: 11256832 - 11100858
10: 99069012 - 99071665
6: 116488614 - 116369687
12: 68150453 - 68255011
giant congenital nevus
6: 41588608 - 41845892
2: 223346310 - 223260765
19: 627417 - 634389
15: 89212889 - 89227691
18: 59185438 - 59148813
6: 112301320 - 112089178
17: 39990451 - 39992433
8: 28407692 - 28477901
11: 86344081 - 86334370
8: 104380276 - 104414270
melanoma arising in giant congenital nevus
2: 202724816 - 202728666
7: 72292964 - 72295149
22: 40341854 - 40384543
x: 153339173 - 153323310
12: 55168448 - 55151004
11: 77806414 - 77603990
1: 201384254 - 201317962
1: 67862904 - 67866040
x: 51945089 - 51951834
17: 71582487 - 71585168
epithelioid cell melanoma
11: 22646230 - 22791123
12: 68039799 - 68070843
16: 88616509 - 88638880
x: 48401210 - 48408967
4: 73014923 - 72972448
2: 162834264 - 162824895
6: 53517790 - 53470098
1: 94086987 - 94066034
10: 48059172 - 48045795
20: 33489441 - 33484563
spindle cell melanoma
2: 190752961 - 190745933
5: 132228124 - 132225180
5: 37875539 - 37851510
9: 132883652 - 132896636
8: 21702292 - 21688429
17: 59349930 - 59348295
5: 42601723 - 42757736
20: 35318706 - 35312903
19: 50863342 - 50877557
17: 24940735 - 24924620
type a spindle cell melanoma
12: 108896820 - 108830329
12: 56140201 - 56152312
2: 121266089 - 121465186
7: 42036134 - 41776911
9: 36126742 - 36153903
1: 92476565 - 92424068
19: 52874031 - 52898291
19: 52940620 - 52952127
6: 24883143 - 24894257
7: 2657200 - 2540984
type b spindle cell melanoma
7: 79408791 - 79493376
3: 50248652 - 50271291
1: 109803343 - 109849017
9: 77875746 - 77564747
20: 56848190 - 56919642
22: 21737223 - 21791778
1: 1854657 - 1748892
7: 99916026 - 99921443
12: 6819636 - 6826818
8: 25337836 - 25332693
melanoma arising from blue nevus
20: 2972268 - 2974391
4: 68450570 - 68434964
10: 101180336 - 101146618
16: 57325641 - 57298538
1: 163791526 - 163753740
19: 39547909 - 39583076
2: 128119977 - 128126443
17: 38087371 - 38084961
19: 55965670 - 55966740
2: 133008348 - 133236911
cellular blue nevus
19: 868503 - 872001
14: 90790022 - 90769965
17: 69939262 - 69955163
4: 3002549 - 3079479
10: 120957193 - 121205126
5: 176786389 - 176802456
3: 142979741 - 143020030
17: 77603052 - 77608635
8: 145700231 - 145703357
16: 45475809 - 45522699
benign soft tissue neoplasm
3: 129777627 - 129773542
17: 18890997 - 18865810
7: 50624473 - 50434254
2: 165303867 - 165174840
17: 70913384 - 70825753
17: 35147744 - 35157063
x: 122043693 - 122348328
6: 146392112 - 146800427
11: 88420838 - 87881006
5: 178354730 - 178337938
sarcomatosis
18: 55038380 - 55048983
1: 109942484 - 109948409
11: 67107862 - 67110699
22: 22708785 - 22700695
14: 80757328 - 80716147
15: 57736987 - 57718358
1: 89069241 - 89030638
3: 121952059 - 121984605
8: 30635274 - 30555575
19: 6344184 - 6330581
infantile fibrosarcoma
13: 44592672 - 44756237
11: 18300719 - 18345153
16: 27468775 - 27379570
2: 27478096 - 27460374
2: 197489931 - 197454606
9: 132575282 - 132594368
9: 132935667 - 132963441
11: 106394381 - 106063120
4: 156945483 - 157009387
13: 50538143 - 50466770
elastofibroma
4: 157037820 - 157085661
4: 145419449 - 145388062
11: 1979276 - 1973489
11: 118471387 - 118469797
2: 172604482 - 172674045
20: 30103718 - 30153320
1: 32426801 - 32468317
6: 114398967 - 114368621
5: 140996596 - 140980627
2: 240058897 - 239706636
atypical fibroxanthoma
17: 39556512 - 39509647
x: 48416735 - 48439629
7: 81044003 - 80976096
17: 77261425 - 77279553
14: 61231992 - 61284729
2: 74971437 - 75032136
1: 6574377 - 6583605
6: 30018310 - 30021042
6: 33151738 - 33162954
12: 121726224 - 121724184
undifferentiated pleomorphic sarcoma
6: 34312628 - 34321986
12: 64504458 - 64646266
13: 29938013 - 29931997
4: 174630322 - 174627518
x: 149822337 - 149827902
21: 39642835 - 39636112
1: 26483139 - 26486599
6: 80001174 - 79967683
6: 26646551 - 26655144
5: 162820241 - 162851525
lipomatous neoplasm
2: 177903035 - 177909534
5: 177564147 - 177570788
10: 102880252 - 102887536
7: 26993083 - 26983451
7: 26978389 - 26975298
12: 52697103 - 52710865
16: 70646027 - 70652455
1: 33021191 - 33029340
16: 70665292 - 70668646
x: 133319777 - 133360216
fibrolipoma
4: 84613484 - 84570794
11: 525550 - 522242
5: 175042318 - 475044164
12: 115781952 - 115761748
16: 80656364 - 80689638
1: 159492238 - 159514266
7: 75576574 - 75578263
11: 65236065 - 65243651
11: 20341924 - 20361904
13: 46368176 - 46305514
dianhydrogalactitol
well differentiated liposarcoma
11: 113351120 - 113366245
11: 118433122 - 118420110
19: 10242779 - 10258291
17: 59437839 - 59433688
19: 10311307 - 10305452
2: 8772711 - 8775181
11: 303853 - 305272
9: 21358075 - 21357423
9: 21375396 - 21374254
21: 33619084 - 33653999
fibromyxolipoma
21: 33524101 - 33558697
12: 66839770 - 66834816
6: 137582200 - 137560315
21: 33697072 - 33731696
9: 21132144 - 21130631
x: 69136812 - 69169146
12: 101376791 - 101295444
15: 97010288 - 97319134
11: 2116578 - 2110532
6: 160360542 - 160497994
round cell liposarcoma
7: 45701327 - 45706499
2: 217323633 - 217354662
7: 45734052 - 45725189
17: 35853236 - 35867457
2: 217385777 - 217362335
12: 51777716 - 51782391
10: 203334234 - 203329343
21: 33560542 - 33591390
19: 60573626 - 60567569
9: 34643932 - 34651884
mixed liposarcoma
3: 161189331 - 161196508
5: 158690059 - 158674369
unit of international system of units
base unit of international system of units
derived unit of international system of units
ampere
kelvin
candela
mole
spindle cell lipoma
metric system
international system of units
international bureau of weights and measures
radian
steradian
hertz
newton
pascal
joule
watt
lipoblastomatosis
coulomb
volt
farad
sievert
ohm
siemens
weber
tesla
henry
degree celsius
cellular leiomyoma
lumen
lux
becquerel
mks system
cgs system
gal
katal
square meter
bizarre leiomyoma
cubic meter
meter per second
meter per second squared
reciprocal meter
unit of time
unit of mass density
kilogram per cubic meter
cubic meter per kilogram
unit of length
unit of mass
pleomorphic rhabdomyosarcoma
eligibility waiver
summary
protein phosphatase 2a
chondroid hamartoma
rhabdomyosarcoma with mixed embryonal and alveolar features
pak1 gene
11q13 - q14
serine / threonine - protein kinase pak 1
sporadic retinoblastoma
epitope spreading
low grade appendix mucinous neoplasm
serrated glandular architecture
diazonium compounds
fetal rhabdomyoma
suprasellar region
property
therapy - related toxicity
computer application
ancestor
adult extracardiac rhabdomyoma
abbreviation
active flag
administered item
name
approved by
protection element attribute
authentication policy configuration name
gsk3a gene
note
endometrial stromal nodule
creation
glycogen synthase kinase - 3 alpha
premalignant lesion
rasgrf1 gene
ras - specific guanine nucleotide - releasing factor 1
created by
modified by
low grade endometrioid stromal sarcoma
attribute set descriptor
character set
classification scheme item relationship
classification scheme relationship
dental material
dental cement dosage form
pharmaceutical dosage form
pharmaceutical excipient
pharmaceutical formulation
finished pharmaceutical product
clear cell sarcoma of the kidney
component concept
concatenation character
administered component concept
concept derivation rule
data element relationship
data type
decimal place
binder excipient
disintegrant excipient
declarative flag
pancreatoblastoma
filler excipient
protocol
diluent excipient
lubricant excipient
glidant excipient
compression aid excipient
color excipient
printing ink excipient
sweetener excipient
preservative excipient
suspending excipient
definition class scheme item
dispersing excipient
coating excipient
flavor excipient
essential minor component of pharmaceutical excipient
pharmaceutical product - related substance
pharmaceutical product information
master formula of pharmaceutical product
immediate release dosage form
benign mesenchymoma
department
sustained release dosage form
def - source
descendent
designation class scheme item
dimensionality
direction
cigarette dosage form
douche dosage form
malignant mesenchymoma
order
edit action
user group
group object
group role context
concept history
instruction
spinal disk implant
lip and oral cavity squamous cell carcinoma
large element count flag
pharmaceutical product expiration date
login name
metathesaurus concept
maximum length number
minimum length number
terminology entity
namespace
diazooxonorleucine
malignant ovarian brenner tumor
uterine carcinosarcoma
object class relationship
origin
owner
drug release formulation
protection group
offspring
parent
breast intracanalicular fibroadenoma
password
preferred
modified release dosage form
extended release dosage form
bone marrow stem cell with potential to differentiate to granulocytic lineage
description logic concept
umls concept unique identifier
cells of monocytic lineage 80 percent or more of bone marrow leukemic cells
breast pericanalicular fibroadenoma
ras - specific guanine nucleotide - releasing factor 2
module
user privilege
role privilege
protection element
protection group role context
neoplastic granulocytes and precursors 20 percent or more of bone marrow cells
concept relationship
reviewed by
review
breast giant fibroadenoma
delayed release dosage form
controlled release dosage form
semantic_type
protein kinase c beta type
contraceptive device
serial version unique identifier
polymeric microsphere dosage form
term - group
biopharmaceutics
surfactant excipient
benign phyllodes tumor
diffusion controlled extended release dosage form
dissolution controlled extended release dosage form
erosion controlled extended release dosage form
uniform resource locator
oral dosage form
system user
parenteral dosage form
topical dosage form
value domain
value domain concept
malignant phyllodes tumor
value domain relationship
sublingual tablet dosage form
hypodermic tablet dosage form
workflow
role entity
buccal tablet dosage form
dispensing tablet dosage form
nci concept atom
enteric coated tablet dosage form
tablet triturate dosage form
breast juvenile fibroadenoma
osmotic pump extended release dosage form
format
dressing dosage form
tree node
bone marrow stem cell with potential to differentiate to granulocytic and monocytic lineages
vaginal diaphragm
security role object
wound dressing material
spindle cell synovial sarcoma
intrauterine device
e - mail address
immature myeloid cells increased in bone marrow
definition
uniform resource identifier
acute myelomonocytic leukemia without abnormal eosinophils
epithelial synovial sarcoma
bone marrow stem cell with some commitment to monocytic differentiation
author
page
caspase activation
caspase - dependent apoptosis
caspase - independent apoptosis
retinoid receptor binding
receptor down regulation
tyrosine kinase - associated receptor down - regulation
biphasic synovial sarcoma
experiment
inhibition
locuslink
kit
packaging tube
dental liner
packing material
poultice
diazoxide
pericardial solitary fibrous tumor
biphasic mesothelioma
evs code type
high value number
label type flag
long name
sponge
low value number
suture
public identifier
immature teratoma
tampon
derivation rule
tape
strip
source role
unresolved issue
malignant teratoma
search criteria
washout period
abstract
dual population of bone marrow blasts present
breeding
cancer bioinformatics infrastructure objects
fax number
intermediate immature teratoma
pubmed
release
file
bone marrow stem cell with variable lineage potential
bioassay class
aerosol dosage form
aerosol foam dosage form
aerosol spray dosage form
teratoma with somatic - type malignancy
bead dosage form
block dosage form
chewable bar dosage form
chewable tablet dosage form
chewing gum dosage form
coated capsule dosage form
coated pellet in capsule dosage form
coated tablet dosage form
concentrated solution dosage form
concentrated injectable solution dosage form
dideoxyadenosine
mixed germ cell tumor
cone dosage form
crystal dosage form
delayed release capsule dosage form
delayed release granule dosage form
delayed release pellet in capsule dosage form
delayed release tablet dosage form
dentifrice gel dosage form
dentifrice paste dosage form
dentifrice powder dosage form
effervescent granule dosage form
malignant struma ovarii
effervescent tablet dosage form
electrically controlled extended release patch dosage form
elixir dosage form
emulsion dosage form
emulsion for injection dosage form
enema dosage form
extended release capsule dosage form
extended release coated capsule dosage form
extended release coated pellet dosage form
extended release core dosage form
strumal carcinoid
extended release film dosage form
extended release granule for suspension dosage form
extended release insert dosage form
extended release patch dosage form
extended release suppository dosage form
extended release suspension dosage form
injectable extended release suspension dosage form
extended release tablet dosage form
extended release film coated capsule dosage form
extract dosage form
partial hydatidiform mole
film coated extended release tablet dosage form
film coated tablet dosage form
film dosage form
gas dosage form
gel dosage form
extended release gel forming solution dosage form
gelatin coated capsule dosage form
globule dosage form
granule dosage form
granule for solution dosage form
benign mesonephroma
granule for suspension dosage form
gum dosage form
implant dosage form
implantable pellet dosage form
inhalant dosage form
injectable solution dosage form
injectable dosage form
irrigant dosage form
jelly dosage form
liniment dosage form
mesonephric neoplasm
injectable lipid complex dosage form
injectable liposomal suspension dosage form
lipstick dosage form
liquid dosage form
liquid filled capsule dosage form
lozenge dosage form
lyophilized powder for extended release injectable suspension dosage form
lyophilized powder for injectable solution dosage form
lyophilized powder for injectable suspension dosage form
lyophilized powder for injectable liposomal suspension dosage form
venous hemangioma
metered aerosol dosage form
metered powder dosage form
metered spray dosage form
multilayered extended release tablet dosage form
multilayered tablet dosage form
oil dosage form
ointment dosage form
paste dosage form
patch dosage form
pellet dosage form
plaster dosage form
powder aerosol dosage form
powder dosage form
powder for solution dosage form
powder for injectable solution dosage form
powder for suspension dosage form
powder for injectable suspension dosage form
powder for injectable extended release suspension dosage form
resin gum dosage form
rinse dosage form
epithelioid hemangioma
salve dosage form
shampoo dosage form
shampoo suspension dosage form
soap dosage form
soluble film dosage form
soluble tablet dosage form
solution dosage form
solution for slush dosage form
injectable sonicated suspension dosage form
spray dosage form
verrucous hemangioma
spray suspension dosage form
stick dosage form
sugar coated tablet dosage form
suppository dosage form
suspension dosage form
injectable suspension dosage form
syrup dosage form
delayed release particle tablet dosage form
tablet dosage form
orally disintegrating tablet dosage form
zalcitabine
benign hemangiopericytoma
tincture dosage form
troche dosage form
unassigned dosage form
wafer dosage form
myeloblasts 90 percent or more of bone marrow non - erythroid cells
malignant hemangiopericytoma
periosteal chondroma
myxoid chondrosarcoma
malignancy in giant cell tumor of bone
adamantinoma of long bones
benign odontogenic neoplasm
cementoblastoma
complex odontoma
didanosine
adenomatoid odontogenic tumor
ghost cell odontogenic carcinoma
ameloblastoma
odontogenic fibroma
peripheral odontogenic fibroma
ameloblastic fibroma
package type
ampule
applicator
bag
blister pack
bottle
ameloblastic fibrosarcoma
dispensing bottle
dropper bottle
glass bottle
plastic bottle
pump bottle
spray bottle
unit dose bottle
applicator bottle
box
unit dose box
gliomatosis cerebri
can
canister
carton
cartridge
packaging case
cello pack
container
cup
unit dose cup
gas cylinder
papillary ependymoma
dewar
dialpack
dose pack
packaging drum
inhaler refill
jar
jug
drug kit
combination package
packet
ditiocarb
protoplasmic astrocytoma
pouch
supersack
syringe
glass syringe
plastic syringe
tabminder
packaging tank
applicator tube
dispensing vial
glass vial
gemistocytic astrocytoma
multi dose vial
patent delivery system vial
pharmacy bulk vial
piggyback vial
plastic vial
single dose vial
single use vial
multipotent bone marrow stem cell with wide myeloid potential
fibrillary astrocytoma
bone marrow stem cell committed to the megakaryocytic lineage
myeloid leukemia associated with down syndrome
trisomy 21
bone marrow stem cell with potential for megakaryocytic and erythroid differentiation
parenteral vial
bone marrow stem cell committed to the basophil lineage
pleomorphic xanthoastrocytoma
mature neutrophils present
drug package
not reported
was gene
xp11 .4 - p11 .21
wiskott - aldrich syndrome protein
pnp gene
astroblastoma
purine nucleoside phosphorylase
pharmaceutical product characteristics
oral tablet dosage form
pyramidal tract dysfunction
babinski sign
hyperreflexia
mature tissue histiocyte
giant cell glioblastoma
histiocytic and dendritic cell
antigen processing cell
anaplastic oligodendroglioma
bone lesion
diabetes insipidus
monoclonal langerhans cells present
cd1a - positive neoplastic cells present
hmb - 45 - positive neoplastic cells present
medulloepithelioma
inverse role
pure cutaneous mastocytosis
macular lesion
pacinian neurofibroma
mast cells 20 percent or more of bone marrow nucleated cells
mast cells 10 percent or more of peripheral blood white cells
b - symptoms
monoclonal myeloid or lymphoid cells present
blm gene mutation
precontrast
meningothelial meningioma
postcontrast
wrn gene mutation
ret gene mutation
klk11 gene
hereditary gastric diffuse adenocarcinoma
kallikrein - 11
hereditary pancreatic carcinoma
diethylstilbestrol
fibrous meningioma
campylobacter jejuni infection
intracerebral
monosomy 3
ss18 - ssx fusion protein expression
psammomatous meningioma
malignant hair follicle neoplasm
germinative follicular epithelium neoplasm
pilar - associated mesenchyme neoplasm
hmox1 gene
benign outer hair sheath and infundibulum neoplasm
malignant outer hair sheath and infundibulum neoplasm
heme oxygenase 1
benign germinative follicular epithelium neoplasm
angiomatous meningioma
malignant germinative follicular epithelium neoplasm
benign mixed epithelial and mesenchymal hair follicle neoplasm
benign pilar - associated mesenchyme neoplasm
outer hair sheath and infundibulum neoplasm
trichoadenoma
trichilemmal carcinoma
malignant proliferating pilar tumor
transitional meningioma
fibrofolliculoma
pilar leiomyoma
spindle - cell predominant trichodiscoma
superficial epithelioma with sebaceous differentiation
sebaceoma
sebocyte
meningeal sarcomatosis
ocular sebaceous carcinoma
extraocular cutaneous sebaceous carcinoma
apocrine hidrocystoma
cylindrocarcinoma
ductal eccrine adenocarcinoma
ductal eccrine carcinoma with spindle cell elements
squamoid eccrine ductal carcinoma
ductal eccrine carcinoma with abundant fibromyxoid stroma
malignant triton tumor
sporadic cylindroma
classical poroma
porocarcinoma in situ
syringofibroadenoma
design
group
malignant granular cell tumor
manufacture
barcode
anus
compound
confidence
editor
error
mantle cell lymphoma
variable characteristic
lentigo maligna
eccrine cell
apocrine cell
cdc73 gene mutation
biologically - derived material
microplate
row
column
biosequence
entry
signal
acquisition
image acquisition
labeled
zinc finger and btb domain - containing protein 7a
zbtb7a gene
aleutian
multifocal lymphomatous polyposis
eskimo
chinese
japanese
filipino
native hawaiian
korean
vietnamese
laotian
hmong
cambodian
digestant
peripheral t - cell lymphoma ,  not otherwise specified
thai
micronesian
chamorran
guamanian
polynesian
tahitian
samoan
tongan
melanesian
marginal zone lymphoma
fiji islander
papua new guinean
biosample
toll - free telephone number
tolerance
issue
publisher
cluster
multipotent stem cell
intravascular large b - cell lymphoma
adult stem cell
mesenchymal stem cell
umbilical cord blood stem cell
wolffian duct cell
tuple
pakistani
zone
defect
layout
activity
list
map
functional map
composite sequence
composite group
composite position
composite sequence dimension
new england states
acute panmyelosis with myelofibrosis
north mid - atlantic states
south mid - atlantic states
biomaterial treatment
describable class
design element
container object
quantitation type
southeastern states
north central states
myeloproliferative neoplasm
northern midwest states
extended release bead implant dosage form
southern midwest states
central midwest states
mountain states
pacific coast states
district of columbia
maine
cloning site
scientific name
skin basal cell carcinoma with sebaceous differentiation
new hampshire
common
vermont
massachusetts
rhode island
sequence object
connecticut
new jersey
new york
pennsylvania
childhood cerebral astrocytoma
delaware
maryland
virginia
west virginia
north carolina
south carolina
tennessee
georgia
florida
alabama
non - functioning pituitary gland adenoma
mississippi
michigan
ohio
indiana
kentucky
wisconsin
minnesota
iowa
north dakota
south dakota
colon adenocarcinoma
montana
illinois
missouri
kansas
nebraska
arkansas
louisiana
oklahoma
texas
idaho
diacylglycerol
limbic encephalitis
wyoming
colorado
utah
nevada
new mexico
arizona
alaska
washington
oregon
california
choroid plexus cyst
hawaii
organ relationship object
keyword
disease relationship object
nci enterprise vocabulary services
nci concept code
lowest
expression experiment object
online mendelian inheritance in man
gene ontology
molecular weight
checksum
probe
brief symptom inventory 18
disc dosage form
gastric pyloric gland adenoma
sporadic gastric adenocarcinoma
enterprise vocabulary
sporadic gastric diffuse adenocarcinoma
supplier
developmental stage
c - met gene amplification
small intestinal squamous cell carcinoma
small intestinal adenosquamous carcinoma
small intestinal mucinous adenocarcinoma
small intestinal medullary carcinoma
small intestinal undifferentiated carcinoma
benign eyelid neoplasm
pituitary gland microadenoma
pituitary gland macroadenoma
small intestinal signet ring cell carcinoma
bioelectric impedance analysis
appendix tubular adenoma
appendix tubulovillous adenoma
reactance
appendix traditional serrated adenoma
appendix adenoma
small intestinal villous adenoma
small intestinal tubular adenoma
small intestinal tubulovillous adenoma
appendix signet ring cell carcinoma
appendix small cell carcinoma
appendix undifferentiated carcinoma
international medical terminology
appendix mucinous adenocarcinoma
diagram
eyelid seborrheic keratosis
organ relationship
unigene
appendix mixed adenoneuroendocrine carcinoma
appendix tubular carcinoid
gross
go ontology relationship
gene symbol
cdc73 gene
eyelid capillary hemangioma
object relationship
disease object
parafibromin
glandular differentiation
neuroendocrine differentiation
appendix lipoma
colon traditional serrated adenoma
flag
universal protein resource
eyelid melanoma
protein families database
provenance
data transformation
evidence
rectosigmoid adenocarcinoma
colorectal mucinous adenocarcinoma
colorectal signet ring cell carcinoma
colorectal small cell carcinoma
colorectal squamous cell carcinoma
colorectal adenosquamous carcinoma
lacrimal gland cyst
colorectal medullary carcinoma
colorectal undifferentiated carcinoma
rectosigmoid mucinous adenocarcinoma
rectosigmoid signet ring cell carcinoma
rectal adenosquamous carcinoma
protoplasm
myc gene mutation
perianal intraepithelial neoplasia
hydromorphone hydrochloride
datum
gallbladder tubular adenoma
gallbladder papillary adenoma
gallbladder tubulopapillary adenoma
gallbladder adenocarcinoma ,  intestinal - type
gallbladder clear cell adenocarcinoma
gallbladder biliary intraepithelial neoplasia
gallbladder flat biliary intraepithelial neoplasia
qualification
gallbladder papillary biliary intraepithelial neoplasia
certification
license
hepatobiliary system
visible to
bile duct tissue
bile duct epithelium
intrahepatic bile duct epithelium
cancer models database
enterprise java bean
cross - reference
experimental method
persistent
in the repository
pleomorphic hepatocellular carcinoma
lamellar pattern
sarcomatoid hepatocellular carcinoma
conjugated linoleic acid
hilar portion of the hepatic duct
concept status
obsolete concept
deprecated concept
provisional concept
header concept
umls cross - reference concept
nci thesaurus entity
nci namespace
nci thesaurus kind
kind
obsolete nci thesaurus role
nci thesaurus property
terminology property
nci thesaurus association
nci thesaurus qualifier
nci thesaurus association qualifier
nci thesaurus property qualifier
primary retinal lymphoma
external ear polyp
frontal sinus polyp
technique_kind
bangladeshi
sri lankan
bhutanese
burmese
taiwanese
accepted_therapeutic_use_for
biocarta_id
cas_registry
nasal cavity cyst
designnote
display_name
editor_note
full_syn
genbank accession number
gene_encodes_product
go_annotation
homologous_gene
image_link
nasal vestibule squamous cell papilloma
in_clinical_trial_for
ind_code
kegg_id
locus_id
long_definition
maps_to_lash
mitelman_code
nci_meta_cui
ndfrt_code
ndfrt_name
dimethyl sulfoxide
skin lymphangioleiomyomatosis
nsc_number
old_child
old_kind
old_parent
old_role
old_state
omim_number
preferred_name
pubmedid_primary_reference
related_lash_concept
gestational hypertension
related_meddra_code
subsource
swiss_prot
synonym property
umls_cui
indonesian
malaysian
okinawan
iwo jiman
maldivian
cherry hemangioma of lip
nepalese
singaporean
malagasy
obsolete anatomic_structure_has_location
obsolete anatomic_structure_is_physical_part_of
obsolete biological_process_has_associated_location
obsolete biological_process_has_initiator_chemical_or_drug
obsolete biological_process_has_initiator_process
obsolete biological_process_has_result_anatomy
obsolete biological_process_has_result_biological_process
gastric hamartomatous polyp
obsolete biological_process_has_result_chemical_or_drug
obsolete biological_process_is_part_of_process
obsolete chemical_or_drug_affects_abnormal_cell
obsolete chemical_or_drug_affects_cell_type_or_tissue
obsolete chemical_or_drug_affects_gene_product
chemical_or_drug_fda_approved_for_disease
chemical_or_drug_has_accepted_therapeutic_use_for
obsolete chemical_or_drug_has_mechanism_of_action
obsolete chemical_or_drug_has_physiologic_effect
chemical_or_drug_has_study_therapeutic_use_for
pancreatic cystadenoma
obsolete chemical_or_drug_is_metabolized_by_enzyme
obsolete chemical_or_drug_plays_role_in_biological_process
obsolete chemotherapy_regimen_has_component
obsolete conceptual_part_of
obsolete disease_excludes_abnormal_cell
obsolete disease_excludes_cytogenetic_abnormality
obsolete disease_excludes_finding
obsolete disease_excludes_metastatic_anatomic_site
obsolete disease_excludes_molecular_abnormality
obsolete disease_excludes_normal_cell_origin
nesidioblastosis
obsolete disease_excludes_normal_tissue_origin
obsolete disease_excludes_primary_anatomic_site
obsolete disease_has_abnormal_cell
obsolete disease_has_associated_anatomic_site
obsolete disease_has_associated_disease
obsolete disease_has_cytogenetic_abnormality
obsolete disease_has_finding
obsolete disease_has_metastatic_anatomic_site
obsolete disease_has_molecular_abnormality
obsolete disease_has_normal_cell_origin
renal failure
obsolete disease_has_normal_tissue_origin
obsolete disease_has_primary_anatomic_site
obsolete disease_is_grade
obsolete disease_is_stage
obsolete disease_may_have_abnormal_cell
obsolete disease_may_have_associated_disease
obsolete disease_may_have_cytogenetic_abnormality
obsolete disease_may_have_finding
obsolete disease_may_have_molecular_abnormality
obsolete disease_may_have_normal_cell_origin
adult fanconi syndrome
obsolete disease_may_have_normal_tissue_origin
eo_anatomic_structure_is_physical_part_of
eo_derived_by_technique
eo_develops_disease
obsolete eo_disease_has_associated_cell_type
obsolete eo_disease_has_associated_eo_anatomy
obsolete eo_disease_has_property_or_attribute
obsolete eo_disease_maps_to_human_disease
eo_disease_metastatic_to_eo_anatomy
eo_models_human_disease
accessory urethral gland neoplasm
obsolete gene_associated_with_disease
obsolete gene_found_in_organism
obsolete gene_has_abnormality
obsolete gene_has_physical_location
obsolete gene_in_chromosomal_location
obsolete gene_is_biomarker_of
obsolete gene_is_biomarker_type
obsolete gene_is_element_in_pathway
obsolete gene_plays_role_in_process
obsolete gene_product_encoded_by_gene
scrotal sebaceous cyst
obsolete gene_product_expressed_in_tissue
obsolete gene_product_has_abnormality
obsolete gene_product_has_associated_anatomy
obsolete gene_product_has_biochemical_function
obsolete gene_product_has_chemical_classification
gene_product_has_malfunction_type
obsolete gene_product_has_organism_source
obsolete gene_product_has_structural_domain_or_motif
obsolete gene_product_is_biomarker_of
obsolete gene_product_is_biomarker_type
dimethylhydrazines
scrotal neoplasm
obsolete gene_product_is_element_in_pathway
obsolete gene_product_is_physical_part_of
obsolete gene_product_malfunction_associated_with_disease
obsolete gene_product_plays_role_in_biological_process
technique_has_associated_condition
technique_has_purpose
technique_has_sample_or_specimen_anatomy
technique_has_sample_or_specimen_chemical_or_drug
technique_has_target_anatomy
technique_has_target_chemical_or_drug
ovarian epithelial tumor
technique_has_target_disease
technique_has_target_organism
technique_has_target_protein
technique_is_used_in_technique
technique_uses_equipment
us department of veterans affairs national drug formulary reference terminology
nci thesaurus
unified medical language system
genbank
swiss - prot
vulvar condyloma
meddra
nci thesaurus concept
term - source
barbadian
dominica islander
haitian
jamaican
tobagoan
trinidadian
west indian
erosive nipple adenomatosis
botswanan
ethiopian
liberian
namibian
nigerian
zairean
tokelauan
guamanian or chamorro
mariana islander
marshallese
parathyroid cyst
palauan
carolinian
kosraean
pohnpeian
saipanese
chuukese
yapese
clear cell intrahepatic cholangiocarcinoma
solomon islander
hypothalamic hamartoma
new hebrides
european
armenian
english
french
german
irish
italian
polish
scottish
adrenal cyst
russian
swedish
norwegian
ukranian
mongolian
finnish
middle eastern or north african
assyrian
egyptian
iranian
ectopic acth secretion syndrome
iraqi
lebanese
palestinian
syrian
afghanistani
israeli
arab
american indian
dinitrochlorobenzene
cherry hemangioma
intravascular papillary endothelial hyperplasia
cervical symmetrical lipomatosis
senile nevus
malignant adrenal medulla neoplasm
health care organization
international commission on radiation units and measurements
carcinoma ex pleomorphic adenoma
dinitrofluorobenzene
posterior tongue neoplasm
floor of the mouth neoplasm
palate neoplasm
benign hard palate neoplasm
benign soft palate neoplasm
buccal mucosa neoplasm
benign buccal mucosa neoplasm
major salivary gland neoplasm
benign posterior tongue neoplasm
minor salivary gland neoplasm
concept_status
role_has_domain
role_has_range
dinitrophenyl compounds
malignant minor salivary gland neoplasm
role_has_parent
qualifier_applies_to
benign minor salivary gland neoplasm
middle ear neoplasm
nasal cavity neoplasm
benign maxillary sinus neoplasm
ethmoid sinus neoplasm
n -  ( 5 - tert - butyl - 3 - isoxazolyl )  - n -  ( 4 -  ( 4 - pyridinyl ) oxyphenyl )  urea
audit object
benign ethmoid sinus neoplasm
channel
data cube
bio event
experiment object
ontology entry
parameter
parameterizable object
parameterizable application
parameter value
physical array design
physical bioassay object
position delta
present / absent object
protocol application object
p - value
quantitation type dimension
frontal sinus neoplasm
dioxin compound
benign frontal sinus neoplasm
benign sphenoid sinus neoplasm
isa relationship
pyriform fossa neoplasm
traverse down
glottis neoplasm
reporter substance
ratio
unit of quantity
subglottis neoplasm
reporter composite map
reporter dimension
reporter group
reporter position
benign subglottis neoplasm
security group
annotation
specialized
standard
unit of temperature
degree fahrenheit
unit
unit of volume
gastric cardia carcinoma in situ ajcc v6 and v7
external
failed
microarray
array feature
feature dimension
data extraction
gastric fundus carcinoma in situ ajcc v6 and v7
feature information
1 , 2 , 3 - trichloropropane
1 , 3 - dichloropropene
paradichlorobenzene
1 , 4 - dioxane
1 , 6 - dinitropyrene
gastric body carcinoma in situ ajcc v6 and v7
1 , 8 - dinitropyrene
1 - amino - 2 , 4 - dibromoanthraquinone
1 - amino - 2 - methylanthraquinone
2 , 3 - dibromopropanol
2 , 4 , 6 - trichlorophenol
2 , 4 - diaminoanisole sulfate
2 , 4 - diaminotoluene
8 - methyl - iqx
2 - amino - 3 - methylimidazo [ 4 , 5 - f ] quinoline
gastric pylorus carcinoma in situ ajcc v6 and v7
2 - aminoanthraquinone
2 - naphthylamine
2 - nitroanisole
2 - nitropropane
3 , 3 - dichlorobenzidine
3 - chloro - 2 - methylpropene
4 , 4 - methylenebis , 2 - chloroaniline
small intestinal neoplasm
4 , 4 - methylenedianiline
4 , 4 - oxydianiline
4 , 4 - thiodianiline
4 - chloro - ortho - phenylenediamine
4 - dimethylaminoazobenzene
4 - nitropyrene
4 - vinyl - 1 - cyclohexene diepoxide
7h - dibenzo [ c , g ] carbazole
acetaldehyde
acrylamide
cecum neoplasm
a - hexachlorocyclohexane
amitrole
basic fuchsin
bbmp
benz [ a ] anthracene
benzidine
benzo [ j ] fluoranthene
benzo [ k ] fluoranthene
beryllium
propiolactone
appendix neoplasm
b - hexachlorocyclohexane
diethylhexylphthalate
bis ( chloromethyl )  ether
bromodichloromethane
bromoethene
butylated hydroxyanisole
cadmium
cadmium compound
anal fibroepithelial polyp
carbon tetrachloride
carcinogenic hydrocarbon
chlordecone
chlorendic acid
chlorinated paraffin
chloromethyl methyl ether
chloroprene
chromium hexavalent compound
coal tar
coal tar pitch
cholangiocarcinoma
cobaltous sulfate
coke oven emission
cupferron
danthron
chlorophenothane
dianisidine
diazoaminobenzene
dibenz [ a , h ] acridine
dibenz [ a , j ] acridine
dibenzo [ a , e ] pyrene
liver sarcoma
dibenzo [ a , h ] pyrene
dibenzo [ a , i ] pyrene
dibromochloropropane
diepoxybutane
diesel exhaust particulate
diethyl sulfate
diglycidyl resorcinol ether
dimethyl sulfate
dimethylcarbamoyl chloride
dimethylvinyl chloride
liver angiosarcoma
ci disperse blue 1
epichlorohydrin
erionite
ethylene dichloride
ethylene thiourea
furan
gamma radiation
glycidol
hexachlorobenzene
hexachloroethane
stage 0 gallbladder cancer ajcc v6 and v7
hexamethylphosphoramide
hpv - high risk
hydrazobenzene
indeno [ 1 , 2 , 3 - cd ] pyrene
iron dextran complex
lead compound
lead metal
lindane
methoxsalen with ultraviolet a therapy
methyl methanesulfonate
diphtheria toxin
gallbladder benign neoplasm
methylene chloride
methyleugenol
michler's base
michler's ketone
mirex
monofluoroethene
mustard gas
nickel compound
nitrilotriacetic acid
nitroarene compound
extrahepatic bile duct neoplasm
nitrobenzene
nitrofen
nitromethane
nitrosodipropylamine
nitrosonornicotine
n - methyl - n - nitro - n - nitrosoguanidine
n - nitrosodiethanolamine
n - nitrosodimethylamine
n - nitrosodi - n - butylamine
n - nitrosomethylvinylamine
stage 0 extrahepatic bile duct cancer
n - nitrosomorpholine
n - nitrosopiperidine
n - nitrosopyrrolidine
n - nitrososarcosine
o - anisidine hydrochloride
ochratoxin a
o - tolidine
o - toluidine
ampulla of vater neoplasm
p - biphenylamine
p - chloro - o - toluidine
phenacetin
phenacetin - containing mixture
phenazopyridine hydrochloride
phenoxybenzamine hydrochloride
polybrominated biphenyl
propanesultone
propylene oxide
propylenimine
stage 0 ampulla of vater cancer ajcc v7
respirable ceramic fiber
respirable crystalline silica
respirable glass wool
safrole
selenium sulfide
soot
styrene oxide
sulfallate
sulfuric acid - containing mist
pancreatic exocrine neoplasm
sunlamp exposure
tetrachloroethylene
tetrafluoroethylene
tetranitromethane
thioacetamide
thiourea
tobacco related exposure
toluene diisocyanate
toxaphene
trichloroethylene
pancreatic serotonin - producing neuroendocrine tumor
tris - bp
ultraviolet c radiation
uv radiation exposure
wood dust
carcinogen containing dye
coordinate
feature reporter map
fiducial
hardware application
identifiable class
benign retroperitoneal neoplasm
manufacture lims
measured bioassay
measured
mismatch information
cluster node
content
x - coordinate
y - coordinate
z - coordinate
tracheal squamous cell carcinoma
isle of man
aland islands
christmas island
applicable
dipyridamole
lung large cell carcinoma
lung large cell carcinoma ,  clear cell variant
induction of radiosensitization
lung giant cell carcinoma
17q21 .31
18q21 .32
11p14 .3 - p15 .2
lung epithelioid hemangioendothelioma
benign lung neoplasm
lung adenoma
malignant mesothelioma
pleural solitary fibrous tumor
benign thymus neoplasm
skin clear cell squamous cell carcinoma
distamycin antineoplastic antibiotic
skin acantholytic squamous cell carcinoma
multiple self healing epithelioma of ferguson - smith
skin appendage neoplasm
pilar sheath acanthoma
tumor of the follicular infundibulum
disulfiram
perifollicular fibroma
adenoid cystic skin carcinoma
mucoepidermoid skin carcinoma
benign mixed tumor of the skin
dermal neoplasm
cutaneous verruciform xanthoma
diuretic
skin smooth muscle neoplasm
cutaneous ganglioneuroma
skin leiomyoma
dartoic leiomyoma
atypical intradermal smooth muscle neoplasm
cobb syndrome
blue rubber bleb nevus
tufted hemangioma
skin angiosarcoma
dna
skin lymphangiosarcoma
skin glomus tumor
skin hemangiopericytoma
malignant skin hemangiopericytoma
skin hemangioendothelioma
cockade nevus
amyloidogenesis
12p13 .11
14q13 .3
15q22 .33
chlamydophila psittaci infection
chlamydia psittaci - associated ocular adnexal mucosa - associated lymphoid tissue lymphoma
1: 147365209 - 147360110
1: 148822584 - 148818055
1: 150143403 - 150146572
1: 150161148 - 150159257
1: 150176622 - 150175582
1: 150351379 - 150346660
1: 150763524 - 150759820
1: 151190742 - 151253261
1: 153641739 - 153623738
desmoplastic nevus
1: 157825530 - 157822115
1: 163921801 - 164117000
1: 189276582 - 189280811
1: 189509828 - 189513060
1: 200897271 - 200891127
1: 203360610 - 203404720
1: 203459184 - 203465879
1: 222383571 - 222380718
1: 233007606 - 233039037
1: 32409019 - 32420854
nevus spilus
1: 3592286 - 3673013
1: 40036668 - 40034495
1: 47367791 - 47361281
1: 52394062 - 52524379
1: 58961806 - 58958486
1: 61260314 - 61634057
1: 65064007 - 65012229
1: 65603007 - 65815197
1: 67485068 - 67574604
10: 6144278 - 6093512
pleural adenomatoid tumor
10: 95507668 - 95547906
11: 102100868 - 102088540
11: 102174104 - 102165861
11: 102219550 - 102211743
11: 111540050 - 111519186
11: 123491321 - 123522829
11: 2139000 - 2137585
11: 33870412 - 33836701
11: 44543784 - 44597891
11: 47247535 - 47308158
dna insertion elements
11: 6581588 - 6588677
12: 10351684 - 10359227
12: 10643431 - 10633039
12: 116262302 - 116113699
12: 25295121 - 25249447
12: 42439047 - 42468166
12: 48765279 - 48780692
12: 53099272 - 53075315
12: 53534588 - 53538370
12: 54869544 - 54843396
malignant lipomatous neoplasm
12: 64869284 - 64928652
12: 87476713 - 87393065
12: 9651758 - 9639137
13: 107665883 - 107657795
13: 109236915 - 109204187
13: 110163084 - 110171422
13: 20533654 - 20446577
13: 45654395 - 45598060
14: 22375633 - 22386643
14: 23852357 - 23855992
benign lipomatous neoplasm
14: 26136535 - 25984929
14: 74148787 - 74034640
15: 39593369 - 39583132
15: 64466679 - 64570936
15: 64781738 - 64861380
15: 65145331 - 65270904
15: 79262255 - 79392157
16: 27248888 - 27283596
16: 30391572 - 30442007
16: 31178812 - 31251691
hereditary breast carcinoma
16: 31274010 - 31301819
16: 54070604 - 54097652
16: 78192112 - 78185751
16: 87232502 - 87234383
17: 17340432 - 17338480
17: 22898282 - 22968585
17: 23151682 - 23107920
17: 32368612 - 23274607
17: 35591394 - 35605426
17: 36057629 - 36037508
malignant breast phyllodes tumor
17: 36938160 - 36933396
17: 37181645 - 37164390
17: 39265136 - 39233695
17: 39340415 - 39308258
17: 42686207 - 42745076
17: 59274083 - 59263176
17: 64922434 - 65051067
17: 6599880 - 6619690
17: 71229111 - 71265494
17: 74487656 - 74478932
benign breast neoplasm
17: 77474382 - 77469438
18: 43710924 - 43621616
18: 44731079 - 44700221
18: 46810611 - 4680145
18: 55718217 - 55722517
19: 10932606 - 11033953
19: 11061132 - 11105490
19: 12763310 - 12765125
19: 12996776 - 13066584
19: 13074681 - 13070848
19: 18058697 - 18031704
19: 18253468 - 18251570
19: 18719800 - 17797961
19: 3310616 - 3414603
19: 40451736 - 40462558
19: 414665 - 369928
19: 47328422 - 47286963
19: 51168497 - 51134631
19: 54860926 - 54854641
19: 56026591 - 56020357
19: 56049983 - 56055832
19: 56068501 - 56073673
19: 7245011 - 7067638
2: 100179488 - 99626334
2: 102066824 - 102103403
2: 102228920 - 102254852
2: 108553285 - 108759407
2: 113259202 - 113247724
2: 113310587 - 113303568
2: 120819229 - 120825204
ovarian seromucinous tumor
2: 218816252 - 218827481
2: 218857222 - 218853076
2: 219548961 - 219564457
2: 219570760 - 219584156
2: 220262459 - 220265932
2: 227489980 - 227425443
2: 70053968 - 70077256
20: 1548630 - 1491568
20: 1823425 - 1868537
20: 44070954 - 44078606
ovarian undifferentiated carcinoma
21: 45165232 - 45130314
22: 22439590 - 22451056
22: 22453764 - 22501255
22: 28967302 - 28960997
22: 35870462 - 35846382
3: 10181630 - 10255723
3: 150287015 - 150230612
3: 184363325 - 184322706
3: 187917822 - 187944445
3: 3127031 - 3086421
dna probes
benign ovarian epithelial tumor
3: 39423209 - 39428929
3: 4510137 - 4864081
3: 45611355 - 45696569
3: 47798410 - 47602391
3: 49041832 - 49036767
4: 123735485 - 123730230
4: 142915359 - 143012217
4: 144792221 - 144832172
4: 185770852 - 185684064
4: 55832690 - 55785577
ovarian serous cystadenoma
4: 6803638 - 6816969
4: 74971310 - 74974468
4: 75218935 - 75217793
5: 121441853 - 121429918
5: 126140732 - 126200608
5: 131424246 - 131426795
5: 131854326 - 131846679
5: 131907113 - 131905035
5: 132021764 - 132024700
5: 132037272 - 132046267
ovarian mucinous cystadenoma
5: 135259415 - 135255834
5: 156540485 - 156614687
5: 169657400 - 169607667
5: 35892748 - 35912681
5: 38631253 - 38515662
5: 55326520 - 55272452
6: 150131506 - 150023744
6: 31648072 - 31650077
6: 31651329 - 31654091
6: 31658181 - 31656314
6: 32914499 - 32897588
6: 32929729 - 32920965
6: 336760 - 3356193
6: 52159144 - 52163395
7: 127644257 - 127626283
7: 150409988 - 150373707
7: 22540060 - 22544856
7: 23283235 - 23123069
7: 41513299 - 41502036
7: 72942807 - 72981505
malignant ovarian germ cell tumor
8: 144171300 - 144175199
8: 56954926 - 57085685
8: 79880313 - 79807561
9: 123853443 - 123874996
9: 131642479 - 131481711
9: 133026115 - 133002662
9: 14303719 - 14077373
9: 2005342 - 2183620
9: 4975245 - 5117995
9: 5221419 - 5223967
ovarian choriocarcinoma
x: 107785796 - 107781857
x: 117643441 - 117710378
x: 128382976 - 128306013
x: 1499188 - 1545409
x: 151573740 - 151569863
x: 151608808 - 151605221
x: 152806189 - 152796809
x: 153597467 - 153570672
x: 51469782 - 51478486
x: 70114424 - 70110580
benign ovarian germ cell tumor
y: 9897925 - 9900718
borrelia burgdorferi infection
16q24 .1
borrelia burgdoferi - associated cutaneous marginal zone lymphoma of mucosa - associated lymphoid tissue
17q21 .1 - q21 .2
9q34 .11
campylobacter jejuni - associated small intestinal mucosa - associated lymphoid tissue lymphoma
1q25 .2
2p25 .1
2q31 .1
benign fallopian tube neoplasm
3q13 .2
3q27 .1
inorganic carcinogen
organic carcinogen
organo - nitrogen carcinogen
carcinogenic anthraquinone
carcinogenic aromatic amine
nitro - compound carcinogen
intravenous leiomyomatosis
heterocyclic amine carcinogen
nitroso carcinogen
nitroarene carcinogen
organo - halide carcinogen
carcinogenic halogenated hydrocarbon
carcinogenic halogenated aromatic hydrocarbon
halogenated ring carcinogen
cyclic ether carcinogen
carcinogenic polycyclic aromatic hydrocarbon
carcinogenic mixture
cervical adenosquamous carcinoma
organo - sulfur carcinogen
primary cutaneous diffuse large b - cell lymphoma
primary cutaneous diffuse large b - cell lymphoma ,  leg type
5p14 - p13
6p12 .1
7q22 .3
xp11 .22 - p11 .21
xp11 .4 - p11 .2
hpv dna probes
cervical adenocarcinoma in situ
xq27
3q23 - q24
low grade fibromyxoid sarcoma
low grade fibromyxoid sarcoma with giant collagen rosettes
vaginal intraepithelial neoplasia
classical low grade fibromyxoid sarcoma
primary cutaneous diffuse large b - cell lymphoma ,  other
primary cutaneous intravascular large b - cell lymphoma
primary cutaneous t - cell / histiocyte - rich large b - cell lymphoma
primary cutaneous plasmablastic lymphoma
regional tumor implant
diffuse large b - cell lymphoma ,  not otherwise specified by gene expression profile
stage 0 vulvar cancer ajcc v6
stage 0 testicular cancer ajcc v6 and v7
diffuse large b - cell lymphoma unclassifiable
respiratory system finding
wound infection
solid dosage form
precursor of plasmacytoid dendritic cell
cutaneous precursor lymphoid neoplasm
multilocular cystic renal neoplasm of low malignant potential
cutaneous hematopoietic and lymphoid cell neoplasm
cutaneous b lymphoblastic leukemia / lymphoma
cutaneous t lymphoblastic leukemia / lymphoma
semisolid dosage form
mus musculus
cutaneous mature b - cell neoplasm
kidney sarcoma
cutaneous mature t - cell and nk - cell neoplasm
european union
string
boolean
integer
vitreous body disorder
accession
medical record
electronic medical record
kidney oncocytoma
surgical pathology report
item collection
collected by
due
cutaneous chronic lymphocytic leukemia
received by
cutaneous mantle cell lymphoma
cutaneous lymphomatoid granulomatosis
cutaneous nasal type extranodal nk / t - cell lymphoma
audit
kidney hemangiopericytoma
biospecimen distribution object
cutaneous angioimmunoblastic t - cell lymphoma
cutaneous adult t - cell leukemia / lymphoma
distributed by
tracking
kingdom
phylum
subphylum
log
renal pelvis urothelial papilloma
taxonomic class
object
unique
coordinator
subclass
infraclass
suborder
infraorder
stage 0is ureter cancer ajcc v7
subfamily
genus
species
protocol requirement object
cd4 - positive neoplastic cells present
cd56 - positive neoplastic cells present
gel
liquid
gas
recombinant dna
ureter polyp
solid
glass
powder
mist
suspension
mixture
substance
electrophoresis gel
agarose gel
polyacrylamide gel
stage 0is urethral cancer ajcc v7
lane
segment
part
reviewed
neoplastic
study object
benign accessory urethral gland neoplasm
study requirement object
storage unit
cd8 - positive neoplastic cells present
since
hydroa vacciniforme - like lymphoproliferative disorder
active
malignant choroid plexus neoplasm
added
primary cutaneous peripheral t - cell lymphoma ,  rare subtype
sequence similarity
refseq
producer
copyright
authoritative
primary cutaneous cd8 - positive aggressive epidermotropic cytotoxic t - cell lymphoma
spinal cord glioma
primary cutaneous gamma - delta t - cell lymphoma
activated mature gamma / delta t - lymphocyte with a cytotoxic phenotype
pituitary gland carcinoma
primary cutaneous cd4 - positive small / medium t - cell lymphoproliferative disorder
minor
major
single nucleotide polymorphism database
optic nerve glioma
disease ontology object
disease ontology relationship
eye infection
population frequency
nucleotide sequence
gene relative location
technology platform version
multilocular thymic cyst
optic nerve sheath meningioma
thymic mucosa - associated lymphoid tissue lymphoma
cell strain
carcinogenic metal
intergenic snp
carcinogenic mineral
carcinogenic chlorinated hydrocarbon
intronic snp
carcinogenic brominated hydrocarbon
acceptor splice site snp
malignant vestibulocochlear nerve neoplasm
donor splice site snp
carcinogenic fluorinated hydrocarbon
untranslated region snp
5' untranslated region snp
3' untranslated region snp
synonymous coding snp
non - synonymous coding snp
carcinogenic nitrosamine
v - mll fusion protein expression
domperidone
lacrimal gland adenoid cystic carcinoma
moz - v fusion protein expression
carcinogenic cyclic nitrosamine
notch1 gene mutation
3 , 3 - dimethoxybenzidine containing dye
3 , 3 - dimethylbenzidine containing dye
benzidine containing dye
carcinogenic epoxide
carcinogenic salt
lacrimal gland adenocarcinoma
chlorinated ring carcinogen
carcinogenic nitrosourea
web service
dental liner dosage form
cement dosage form
culture dosage form
graft dosage form
encrypted
hierarchy
biological process qualifier
lacrimal gland pleomorphic adenoma
biochemical activity
enhanced biochemical activity
absence of biochemical activity
decreased biochemical activity
standard biochemical activity
latent celiac disease
collagenous sprue
medical science
tropical sprue
colon intramucosal adenocarcinoma
orbit rhabdomyosarcoma
heart injury
low grade dysplasia in ulcerative colitis
high grade dysplasia in ulcerative colitis
ulcerative colitis - associated dysplasia of the colorectum
primary focal segmental glomerulosclerosis
secondary focal segmental glomerulosclerosis
9p24 .2
pdcd1lg2 gene
programmed cell death 1 ligand 2
malignant orbit hemangiopericytoma
vaginal angiomyofibroblastoma
vulvar angiomyofibroblastoma
genotyping
t ( 2 ; 2 )  ( q35 ; p23 )
orbit capillary hemangioma
allele_associated_with_disease
allele_not_associated_with_disease
obsolete allele_has_abnormality
allele_not_associated_with_abnormality
obsolete allele_in_chromosomal_location
obsolete allele_absent_from_wild - type_chromosomal_location
allele_ceases_function_in_pathway
orbit cavernous hemangioma
obsolete allele_plays_altered_role_in_process
obsolete allele_has_activity
obsolete allele_plays_role_in_metabolism_of_chemical_or_drug
allele_is_cancer_related_type
relative_enzyme_activity
snp_id
snp_type
fda_table
orbit hemangiopericytoma
intermediate  ( locally aggressive )  blood vessel neoplasm
intermediate  ( rarely metastasizing )  blood vessel neoplasm
composite hemangioendothelioma
polymorphus hemangioendothelioma
reactive vascular proliferation
orbit dermoid cyst
venous lake
lymphangioma circumscriptum
cholinesterase
g1 / s - specific cyclin - d2
ccaat / enhancer binding protein alpha
mcf2 gene
conjunctival squamous cell carcinoma
proto - oncogene dbl
oncogene mcf2
mcf2 oncoprotein
fes gene
tyrosine - protein kinase fes / fps
selenium compound
dopamine hydrochloride
conjunctival melanoma
lung squamous cell carcinoma ,  papillary variant
lung squamous cell carcinoma ,  clear cell variant
lung squamous cell carcinoma ,  small cell variant
oncogene e1a
oncogene e1b
lung basaloid squamous cell  carcinoma
lung adenocarcinoma ,  mixed subtype
lung fetal adenocarcinoma
conjunctival nevus
lung colloid adenocarcinoma
verification
lung signet ring cell carcinoma
recombinant human endostatin
lung clear cell adenocarcinoma
chromosome object
insert
lung lymphoepithelioma - like carcinoma
corneal squamous cell carcinoma
gene object
library object
taxon object
mitochondrial damage
valvular heart disorder
actinolite asbestos
amosite asbestos
anthophyllite asbestos
chrysotile asbestos
corneal melanoma
tremolite asbestos
ci direct black 38
direct blue 6
ascii
direct brown 95
is reference sequence
is preferred
respirable quartz
respirable cristobalite
respirable tridymite
malignant iris neoplasm
lung sarcomatoid carcinoma
lung spindle cell carcinoma
lung pleomorphic carcinoma
lung carcinosarcoma
lung mucoepidermoid carcinoma
lung epithelial - myoepithelial carcinoma
retinoic acid receptor activation
cytokine receptor activation
antigen sensitization
receptor desensitization
benign iris neoplasm
lung typical carcinoid tumor
lung atypical carcinoid tumor
microtubule dynamics alteration
inhibition of amyloidogenesis
ribosomal function inhibition
abc transporter inhibition
nucleoside analogue incorporation
arsenic compound
beryllium compound
iris nevus
enhanced symbol
label
amidophosphoribosyltransferase
ppat gene
amine
low grade lung neuroendocrine neoplasm
intermediate grade lung neuroendocrine neoplasm
high grade lung neuroendocrine neoplasm
malignant ciliary body medulloepithelioma
lung squamous cell papilloma
splice site snp
upstream region snp
mutation abnormality
deletion abnormality
dominant - negative mutation abnormality
embryonic lethal mutation abnormality
ciliary body melanoma
frameshift mutation abnormality
gene amplification abnormality
gene duplication abnormality
gene deletion abnormality
gene fusion abnormality
missense mutation abnormality
splice - site mutation abnormality
germline mutation abnormality
insertion mutation abnormality
inversion mutation abnormality
nucleotide transition abnormality
nucleotide transversion abnormality
somatic mutation abnormality
uv mutation abnormality
protein sequence abnormality
protein splicing abnormality
protein truncation abnormality
coumarin compound
cyp2c19*1 allele
doxorubicin
ciliary body leiomyoma
cyp2c19*2 allele
lung glandular papilloma
lung mixed squamous cell and glandular papilloma
lung pleomorphic adenoma
lung mucinous cystadenoma
primary pulmonary diffuse large b - cell lymphoma
cyp2c19*3 allele
pulmonary lymphomatoid granulomatosis
cyp2c19*4 allele
cyp2c19*5 allele
choroid melanoma
cyp2c9*1 allele
lung soft tissue neoplasm
cyp2c9*2 allele
cyp2c9*3 allele
cyp2c9*5 allele
cyp2d6*1 allele
cyp2d6*10 allele
cyp2d6*17 allele
cyp2d6*2n allele
choroid hemangioma
cyp2d6*4 allele
cyp2d6*5 allele
cyp2d6*6 allele
cyp2d6*8 allele
malignant lung and pleural neoplasm
type i pleuropulmonary blastoma
type ii pleuropulmonary blastoma
type iii pleuropulmonary blastoma
lung chondroma
chronic eosinophilic leukemia ,  not otherwise specified
diffuse pulmonary lymphangiomatosis
lung synovial sarcoma
lung biphasic synovial sarcoma
lung monophasic synovial sarcoma
perivascular epithelioid cell
translation initiation abnormality
lung germ cell tumor
lung teratoma
intrapulmonary thymoma
mediastinal thymoma
splenic angiosarcoma
adenosine to guanosine transition abnormality
guanosine to adenosine transition abnormality
thymidine to cytosine transition abnormality
cytosine to thymidine transition abnormality
adenosine to thymidine transversion abnormality
adenosine to cytosine transversion abnormality
guanosine to thymidine transversion abnormality
guanosine to cytosine transversion abnormality
thymidine to adenosine transversion abnormality
thymidine to guanosine transversion abnormality
benign thoracic neoplasm
cytosine to adenosine transversion abnormality
cytosine to guanosine transversion abnormality
lung melanoma
glycoside compound
multiple nucleotide abnormalities
sarcomatoid mesothelioma
multiple transition abnormalities
multiple transversion abnormalities
mixed nucleotide abnormalities
malignant lung hilum neoplasm
pleural well differentiated papillary mesothelioma
peritoneal well differentiated papillary mesothelioma
pleural epithelioid mesothelioma
pleural sarcomatoid mesothelioma
pleural desmoplastic mesothelioma
pleural biphasic mesothelioma
localized pleural malignant mesothelioma
atypical mesothelial hyperplasia
nf2 gene mutation
malignant pericardial neoplasm
pyrazole
hidden
association class
deriving
enumeration
non - enumerated
multiplicity
template
industrial aid
restriction site polymorphism
malignant epicardial neoplasm
tandem repeat variation
cetp 1 allele
cetp 2 allele
abcb1 1 allele
abcb1 2 allele
htr2a 1 allele
htr2a 2 allele
pleural lymphoma
tpmt wt allele
tpmt*3a allele
malignant myocardial neoplasm
amidino tic
pyothorax - associated lymphoma
pyothorax
ebv - transformed late germinal center / post - germinal center b - lymphocyte
pleural epithelioid hemangioendothelioma
pleural synovial sarcoma
pleural monophasic synovial sarcoma
pleural biphasic synovial sarcoma
minimally invasive thymoma
doxycycline
malignant endocardial neoplasm
widely invasive thymoma
thymic medullary epithelial cell
thymic epithelial cell capable of differentiating towards both cortical and medullary cell type
thymic epithelial cell capable of differentiating towards cortical cell type
micronodular thymoma with lymphoid stroma
metaplastic thymoma
microscopic thymoma
sclerosing thymoma
malignant respiratory system neoplasm
thymus lipofibroadenoma
isothiocyanate
nut carcinoma
thymic atypical carcinoid tumor
malignant intestinal neoplasm
thymic typical carcinoid tumor
combined thymic epithelial neoplasm
thymic epithelial stem cell
gominer
fisher's exact test
false positive
biocarta
concept
malignant skin appendage neoplasm
mediastinal germ cell tumor with somatic - type malignancy
malignant mediastinal germ cell tumor with associated hematologic malignancy
totipotent primordial germ cell
mediastinal t lymphoblastic leukemia / lymphoma
mediastinal t acute lymphoblastic leukemia
malignant dermal neoplasm
mediastinal t lymphoblastic lymphoma
mediastinal myeloid sarcoma
mediastinal paraganglioma
mediastinal solitary fibrous tumor
histiocytoid cardiomyopathy
hamartoma of mature cardiac myocytes
adult cardiac cellular rhabdomyoma
ventricular myxoma
cardiac hemangioma
malignant great vessel neoplasm
cardiac cavernous hemangioma
cardiac capillary hemangioma
cardiac intramuscular hemangioma
cardiac inflammatory myofibroblastic tumor
cystic tumor of the atrioventricular node
heart undifferentiated pleomorphic sarcoma
cardiac synovial sarcoma
cardiac biphasic synovial sarcoma
cardiac monophasic synovial sarcoma
cardiac rhabdomyosarcoma
pericardial germ cell tumor
metastatic malignant neoplasm in the pericardium
ensembl
entrez
entrez gene
genomic identifier
ab term type
ad term type
aq term type
malignant cerebral neoplasm
br term type
ci term type
cn term type
dn term type
fb term type
hd term type
pt term type
sn term type
conjunctival kaposi sarcoma
sy term type
density
background
noise
x - dimension
y - dimension
spacing
mark
spatial orientation
circle
corneal kaposi sarcoma
solvent
network address
first - line therapy
reference point
mapping table
jdbc driver
tpmt*v3 allele
tpmt*v4 allele
tpmt*v5 allele
national center for biotechnology information
droperidol
malignant chest wall neoplasm
tree root
matrix
directed acyclic graph
node
lobular cancerization
metastatic malignant neoplasm in the large intestine
ca repeat
b vitamin
pellet formation
versioned genbank accession number
metastatic malignant neoplasm in the bone marrow
locus
zygosity
heterozygosity
homozygosity
inheritance mode
approximate
absolute
metastatic malignant neoplasm in the peritoneum
relative value
nucleic acid strand
absolute vs relative indicator
feature strand type
pancreatic neuroendocrine microadenoma
pancreatic neuroendocrine tumor g2
functioning pancreatic endocrine tumor
non - functioning pancreatic neuroendocrine tumor
non - functioning pancreatic neuroendocrine tumor g2
anoikis
metastatic malignant neoplasm in the testis
functioning pancreatic neuroendocrine tumor
functioning pancreatic neuroendocrine tumor g2
erbb2 gene product
pancreatic mixed adenoneuroendocrine carcinoma
ct scanner
extendable class
cardinal direction
ordinal direction
north
metastatic malignant neoplasm in the spinal cord
south
east
west
northeast
northwest
southeast
southwest
loss of chromosome 3q
metastatic malignant neoplasm in the eye
nickel hydroxide
nickel monoxide
nickel sulfide
nickel acetate
nickel chloride
nickel sulfate
stage 0 oral cavity cancer ajcc v6 and v7
nickel carbonate
nickel carbonyl
nickelocene
ef5
dorsal
ventral
beryllium chloride
beryllium fluoride
beryllium hydroxide
beryllium oxide
stage 0 lip cancer ajcc v6 and v7
beryllium metaphosphate
beryllium sulfate
beryl ore
beryllium - copper alloy
beryllium - aluminum alloy
calcium chromate
chromium trioxide
sodium chromate
sodium dichromate
potassium chromate
stage 0 nasal cavity cancer ajcc v6 ,  v7 ,  and v8
potassium dichromate
lead chromate
strontium chromate
zinc chromate
cadmium chloride
cadmium sulfate
cadmium nitrate
cadmium oxide
cadmium sulfide
fact - g questionnaire
medication
stage 0 oropharyngeal carcinoma ajcc v6 and v7
fact - bmt questionnaire
alcoholic beverage
promethazine hydrochloride
intersex
hermaphrodite
sex pooled sample
tuberculum sellae
pituitary stalk
long - chain - fatty - acid - coa ligase 1
gonadotroph adenoma
plurihormonal pituitary gland adenoma
pituitary gland gangliocytoma
hypothalamic gangliocytoma
pituicyte
stage 0 epiglottic carcinoma ajcc v6 ,  v7 ,  and v8
adenohypophysial cell
anterior pituitary gland neoplasm
null cell pituitary gland adenoma
densely granulated somatotroph adenoma
sparsely granulated somatotroph adenoma
mixed somatotroph and lactotroph adenoma
mammosomatotroph adenoma
acidophil stem cell pituitary gland adenoma
stage 0 appendix carcinoma ajcc v7
gnas gene mutation
densely granulated lactotroph adenoma
sparsely granulated lactotroph adenoma
hras gene mutation
pituitary gland oncocytic adenoma
premature termination abnormality
cecum carcinoma in situ
corticotroph cell
glucose tolerance test
thyrotroph cell
lactotroph cell
anal intraepithelial neoplasia
penile intraepithelial neoplasia
multihormonal immunoreactivity present
subsite
extensible markup language
enteroendocrine cell
binary
stage 0is renal pelvis cancer ajcc v7
deidentification
coding
nci metathesaurus code
computer programming object
xx genotype
xy genotype
benign gingival neoplasm
metastatic inhibitory effect
bed rest
fda_unii_code
cyp2c19*6 allele
benign palate neoplasm
claus model
subtlety score
integrated molecular analysis of genomes and their expression consortium
protein component
energy absorption
dependency
ph
oxidation - reduction potential
cytochrome p450 3a5
pentetic acid
benign salivary gland neoplasm
cytochrome p450 3a7
cytochrome p450 2c8
key
difference
thyroid gland papillary microcarcinoma
ret / ptc rearrangement
ntrk1 gene rearrangement
thyroid gland squamous cell carcinoma
cyp2c19*7 allele
benign sublingual gland neoplasm
cyp2c19*8 allele
cyp2c19*9 allele
cyp2c19*10 allele
cyp2c19*12 allele
cyp2c9*6 allele
cyp2c9*8 allele
cyp2c9*11 allele
cyp2c9*12 allele
cyp2c9*16 allele
cyp2c9*18 allele
benign middle ear neoplasm
cyp3a7*2 allele
cyp3a5*3 allele
cyp3a5*6 allele
cyp3a5*8 allele
cyp3a5*9 allele
cyp3a5*10 allele
cyp3a4*17 allele
cyp3a4*18 allele
cyp2e1*1 allele
cyp2e1*2 allele
benign nasal cavity neoplasm
cyp2c8*2 allele
cyp2c8*3 allele
cyp2c8*4 allele
cyp2c8*5 allele
cyp2c8*6 allele
cyp2c8*7 allele
cyp2c8*8 allele
cyp1a2*1 allele
cyp1a2*7 allele
cyp1a2*11 allele
benign oropharyngeal neoplasm
cyp2d6*2 allele
cyp2d6*3 allele
cyp2d6*7 allele
cyp2d6*9 allele
cyp2d6*11 allele
cyp2d6*12 allele
cyp2d6*13 allele
cyp2d6*14 allele
cyp2d6*15 allele
cyp2d6*16 allele
benign glottis neoplasm
cyp2d6*18 allele
cyp2d6*19 allele
cyp2d6*20 allele
cyp2d6*21 allele
cyp2d6*35x2 allele
cyp2d6*36 allele
cyp2d6*38 allele
cyp2d6*40 allele
cyp2d6*41 allele
cyp2d6*42 allele
benign epiglottis neoplasm
cyp2d6*44 allele
tpmt*v2 allele
tpmt*3c allele
tpmt*2 allele
presymptomatic cancer
thyroid gland hurthle  ( oncocytic )  cell neoplasm
amsterdam criteria
benign myocardial neoplasm
contralateral prophylactic mastectomy
cyp2c8 gene
bilateral prophylactic mastectomy
unilateral breast carcinoma
cyp3a5 gene
cyp3a7 gene
endoscopic ultrasound
randomized controlled clinical trial
benign endocardial neoplasm
nonestrogen - dependent malignant neoplasm
leptin
osteopontin
cognitive dysfunction
memory dysfunction
circumferential resection margin
cancer risk prevention model
contrast - enhanced magnetic resonance imaging
cesarean section
allogeneic hematopoietic stem cell transplantation
benign intestinal neoplasm
glycemic index
melanoma biomarker
macrofollicular variant thyroid gland papillary carcinoma
oncocytic variant thyroid gland papillary carcinoma
clear cell variant thyroid gland papillary carcinoma
solid / trabecular variant thyroid gland papillary carcinoma
clear cell variant thyroid gland follicular carcinoma
sporadic thyroid gland medullary carcinoma
hereditary thyroid gland medullary carcinoma
dye
benign colorectal neoplasm
c - cell hyperplasia
neoplastic c - cell hyperplasia
reactive c - cell hyperplasia
sporadic thyroid gland micromedullary carcinoma
thyroid gland mixed medullary and follicular cell carcinoma
thyroid gland spindle cell tumor with thymus - like differentiation
intrathyroid thymic carcinoma
male ,  self - report
female ,  self - report
male gender
benign anal neoplasm
female gender
thyroid gland follicular adenoma with papillary hyperplasia
male phenotype
female phenotype
thyroid gland signet ring cell follicular adenoma
thyroid gland mucinous follicular adenoma
transsexual
thyroid gland lipoadenoma
thyroid gland clear cell follicular adenoma
benign pancreatic neoplasm
male - to - female transsexual
female - to - male transsexual
thyroid gland hyperfunctioning adenoma
thyroid gland follicular adenoma with bizarre nuclei
thyroid gland teratoma
thyroid gland paraganglioma
ordinal position
capsular invasion
benign exocrine pancreas neoplasm
skin papilloma
benign skin appendage neoplasm
skin lipoma
external ear lipoma
spinal cord lipoma
echinomycin
benign male breast neoplasm
benign endocrine neoplasm
malignant jugulotympanic paraganglioma
malignant central nervous system neoplasm
malignant neoplasm of the meninges
eicosanoid
low grade cervical intraepithelial neoplasia
dermoid cyst of the skin
amelanotic cutaneous melanoma
skin fibroblastic neoplasm
gastric neuroendocrine tumor g1
gastric lymphoma
intestinal neuroendocrine tumor g1
small intestinal neuroendocrine tumor g1
anal melanoma
electrolytes
rectal melanoma
spinal cord astrocytoma
brain glioblastoma
scrotal squamous cell carcinoma
low grade vaginal intraepithelial neoplasia
grade 2 vaginal intraepithelial neoplasia
gestational choriocarcinoma
breast lipoma
tongue squamous cell carcinoma
palate squamous cell carcinoma
radioactive element
parotid gland pleomorphic adenoma
pericardial neoplasm
external ear neoplasm
malignant external ear neoplasm
atypical endometrial hyperplasia
trigeminal schwannoma
intracranial meningioma
central nervous system cyst
pineal region germ cell tumor
meningeal solitary fibrous tumor / hemangiopericytoma
primary melanocytic lesion of meninges
meningeal melanocytoma
splenic marginal zone lymphoma
t - cell large granular lymphocyte leukemia
plasma cell neoplasm
skin spindle cell squamous cell carcinoma
mediastinal immature teratoma
bladder sarcoma
breast sarcoma
breast lymphoma
testicular sertoli cell tumor
acute biphenotypic leukemia
verrucous nevus
congenital epulis
skull base neoplasm
organoid nevus
laryngeal keratosis
enalapril maleate
plantar fibromatosis
roberts - sc phocomelia syndrome
x - linked severe combined immunodeficiency
dermatofibrosarcoma protuberans
nasal type extranodal nk / t - cell lymphoma
paraneoplastic cerebellar degeneration
opsoclonus myoclonus syndrome
leukocyte adhesion deficiency type 1
leukocyte adhesion deficiency type 2
complement deficiency
nijmegen breakage syndrome
gingival fibroepithelial polyp
speckled oral leukoplakia
proliferative verrucous leukoplakia
smoker's keratosis
dry orgasm
gestational trophoblastic tumor
enterotoxin
giant cell fibroblastoma
encephalocraniocutaneous lipomatosis
palmoplantar keratoderma with leukoplakia
eccrine angiomatous hamartoma
moniliform hamartoma
carney complex
sclerotic fibroma
eruptive collagenoma
interarytenoid leukoplakia
enzyme inhibitor
adenocarcinoma with metaplasia
cellular ependymoma
clear cell ependymoma
choroid plexus carcinoma
ectomesenchymoma
anaplastic ganglioglioma
secretory meningioma
choroid plexus meningioma
ephedrine
lymphoplasmacyte - rich meningioma
microcystic meningioma
clear cell meningioma
atypical meningioma
cellular schwannoma
papillary craniopharyngioma
adamantinomatous craniopharyngioma
post - transplant lymphoproliferative disorder
proliferative fasciitis
intravascular nodular fasciitis
therapeutic epinephrine
atypical lobular breast hyperplasia
neuropathy
neonatal hypertension
peutz - jeghers polyp
non - secretory plasma cell myeloma
enteropathy - associated t - cell lymphoma
desmoplastic infantile ganglioglioma
acetohexamide
acetylcholine chloride
acrivastine
albendazole
alclometasone dipropionate
alosetron hydrochloride
aluminum acetate
ambenonium chloride
amcinonide
amiloride hydrochloride
aminocaproic acid
aminohippurate sodium
aminophylline
aminosalicylic acid
amlexanox
ammonium chloride
amoxapine
anisindione
antazoline phosphate
epirubicin hydrochloride
porokeratotic eccrine ostial and dermal duct nevus
apomorphine hydrochloride
apraclonidine hydrochloride
aprotinin
aripiprazole
articaine hydrochloride
atomoxetine hydrochloride
avobenzone
azelaic acid
azelastine hydrochloride
balsalazide disodium
neoplasm by morphology
bendroflumethiazide
benzoyl peroxide
bepridil hydrochloride
betaxolol hydrochloride
bimatoprost
bivalirudin
boric acid
bosentan
bretylium tosylate
brimonidine tartrate
benign squamous cell neoplasm
brinzolamide
bromodiphenhydramine hydrochloride
brompheniramine maleate
bromthymol blue
buprenorphine hydrochloride
butalbital
butenafine hydrochloride
butoconazole nitrate
cabergoline
calcium acetate
benign basal cell neoplasm
carbachol
carbidopa
carbinoxamine maleate
carboprost tromethamine
cefditoren pivoxil
cefoperazone sodium
ceforanide
cefotetan disodium
ceftizoxime sodium
cefuroxime sodium
cephapirin sodium
cephradine
cetyl alcohol
chlordiazepoxide
chloroprocaine hydrochloride
chloroquine phosphate
chloroxine
chlorpropamide
chlortetracycline hydrochloride
chlorthalidone
cinacalcet hydrochloride
cisatracurium besylate
citric acid monohydrate
clavulanate potassium
clemastine fumarate
clocortolone pivalate
clofazimine
cloflucarban
clomipramine hydrochloride
clorazepate dipotassium
benign ovarian brenner tumor
cloxacillin sodium
cobaltous chloride co - 57
colfosceril palmitate
corticorelin ovine triflutate
cyclacillin
cyclobenzaprine hydrochloride
cycloserine
cysteamine bitartrate
dalfopristin
dapiprazole hydrochloride
neuronal and mixed neuronal - glial tumors
daptomycin
daunorubicin citrate
desflurane
desirudin
desloratadine
desmopressin acetate
desogestrel
desoximetasone
dexchlorpheniramine maleate
dexmedetomidine
malignant melanotic peripheral nerve sheath tumor
dexmethylphenidate hydrochloride
dexpanthenol
dextroamphetamine sulfate
diatrizoic acid
dibenzothiophene
dichlorophen
diethylpropion hydrochloride
difenoxin hydrochloride
diflorasone diacetate
diflunisal
basal cell nevus with comedones
dihydrocodeine bitartrate
dihydroergotamine mesylate
dihydrostreptomycin sulfate
diltiazem malate
dimercaprol
dipivefrin hydrochloride
dirithromycin
disopyramide phosphate
docosanol
dofetilide
epoxide compound
skin cavernous hemangioma
doxapram hydrochloride
doxylamine succinate
drospirenone
dutasteride
dyphylline
echothiophate iodide
econazole nitrate
edrophonium chloride
eletriptan hydrobromide
emtricitabine
pigmented spindle cell nevus
enalaprilat
enflurane
epinastine hydrochloride
eplerenone
epoprostenol sodium
eprosartan mesylate
eptifibatide
ergotamine tartrate
escitalopram oxalate
esmolol hydrochloride
t - cell prolymphocytic leukemia
estazolam
estropipate
ethionamide
ethosuximide
ethotoin
ethynodiol diacetate
etodolac
etomidate
etonogestrel
ezetimibe
b - cell prolymphocytic leukemia
felbamate
fenoldopam mesylate
ferric ferrocyanide
flavoxate hydrochloride
flumazenil
fluorometholone acetate
fluphenazine
flurandrenolide
fomepizole
fondaparinux sodium
spindle cell hemangioma
formoterol fumarate
fosfomycin tromethamine
fosinopril sodium
fosphenytoin sodium
frovatriptan succinate
gadoversetamide
galantamine hydrobromide
gallium citrate ga - 67
gemifloxacin mesylate
gluconolactone
chondrogenic neoplasm
guanfacine hydrochloride
guanidine hydrochloride
halcinonide
halobetasol propionate
halothane
hetacillin
hexachlorophene
hydroflumethiazide
hydroxyamphetamine hydrobromide
hydroxyzine hydrochloride
vulvar intraepithelial neoplasia
hydroxyzine pamoate
ibutilide fumarate
indium in - 111 chloride
insulin aspart
insulin glargine
iobenguane sulfate i - 131
iodipamide meglumine
iopamidol
iothalamate meglumine
iothalamate sodium
hypertensive nephropathy
iothalamate sodium i - 125
ioxaglate meglumine
ioxaglate sodium
isocarboxazid
isosorbide mononitrate
isoxsuprine hydrochloride
isradipine
ketoprofen
ketotifen fumarate
metastatic malignant neoplasm in the liver
levalbuterol hydrochloride
levetiracetam
levocabastine hydrochloride
levomethadyl acetate hydrochloride
levonordefrin
levonorgestrel
levorphanol tartrate
lomefloxacin hydrochloride
loracarbef
loteprednol etabonate
oral cavity cyst
loxapine succinate
mafenide acetate
magnesium acetate
malathion
maprotiline hydrochloride
mebendazole
meclocycline sulfosalicylate
meclofenamate sodium
medrysone
mefenamic acid
erythromycin
vulvar low grade squamous intraepithelial lesion
mefloquine hydrochloride
memantine hydrochloride
mepivacaine hydrochloride
meprobamate
mequinol
metaproterenol sulfate
metaxalone
methacholine chloride
methacycline hydrochloride
methamphetamine hydrochloride
vulvar high grade squamous intraepithelial lesion
methenamine hippurate
methicillin sodium
methscopolamine bromide
methsuximide
methyclothiazide
methyl methacrylate
methyldopa
methyldopate hydrochloride
methylergonovine maleate
metyrapone
malignant major salivary gland neoplasm
midodrine hydrochloride
minocycline hydrochloride
minoxidil
molindone hydrochloride
montelukast sodium
moricizine hydrochloride
nabumetone
naftifine hydrochloride
nalbuphine hydrochloride
malignant neoplasm of the cervical esophagus
nalidixic acid
nalmefene hydrochloride
naphazoline hydrochloride
naratriptan hydrochloride
natamycin
nedocromil sodium
nesiritide
nitazoxanide
norfloxacin
olanzapine
malignant neoplasm of the abdominal esophagus
olmesartan medoxomil
orphenadrine citrate
oxazepam
oxcarbazepine
oxiconazole nitrate
oxtriphylline
oxybenzone
oxybutynin
oxymorphone hydrochloride
oxytetracycline hydrochloride
malignant middle ear neoplasm
palonosetron hydrochloride
pancuronium bromide
paromomycin sulfate
paroxetine mesylate
pemirolast potassium
pemoline
penciclovir sodium
penicillin g benzathine
penicillin g potassium
pentaerythritol tetranitrate
pentazocine hydrochloride
pentobarbital sodium
perflexane
perflutren
pergolide mesylate
perindopril erbumine
phendimetrazine tartrate
phenelzine sulfate
phenyltoloxamine
malignant eye neoplasm
phosphoric acid
pimecrolimus
pimozide
pindolol
piperazine citrate
pirbuterol acetate
polythiazide
potassium acetate
potassium aminosalicylate
potassium chloride
malignant olfactory nerve neoplasm
potassium iodide
potassium perchlorate
pramocaine hydrochloride
praziquantel
prednicarbate
prilocaine
primidone
procainamide hydrochloride
procaine hydrochloride
procyclidine hydrochloride
malignant pituitary gland neoplasm
proguanil hydrochloride
promazine hydrochloride
propafenone hydrochloride
proparacaine hydrochloride
propylhexedrine
protriptyline hydrochloride
pseudoephedrine sulfate
pyridostigmine bromide
pyrithione zinc
quazepam
recombinant erythropoietin
benign parotid gland neoplasm
quetiapine fumarate
quinupristin
remifentanil hydrochloride
repaglinide
riluzole
rimexolone
ritodrine hydrochloride
rivastigmine tartrate
rizatriptan benzoate
rocuronium bromide
benign major salivary gland neoplasm
ropinirole hydrochloride
rubidium chloride rb - 82
scopolamine
secretin human
selegiline hydrochloride
sermorelin acetate
sertaconazole nitrate
sevoflurane
sibutramine hydrochloride
sincalide
benign cecum neoplasm
sodium acetate
sodium carbonate
sodium chromate cr - 51
sodium gluconate
sodium iodide i - 123
sodium iodide i - 131
sodium lactate
sodium sulfate
spectinomycin hydrochloride
streptomycin sulfate
benign appendix neoplasm
succinylcholine chloride
sufentanil citrate
sulbactam sodium
sulconazole nitrate
sulfacytine
sulfadoxine
sulfamethizole
sulfamethoxazole
sulfanilamide
sulfinpyrazone
benign rectal neoplasm
sulfisoxazole
sulfisoxazole acetyl
tacrine hydrochloride
tadalafil
tartaric acid
technetium tc - 99m apcitide
telmisartan
tenofovir disoproxil fumarate
terbutaline sulfate
tetrahydrozoline hydrochloride
benign duodenal neoplasm
thallous chloride tl - 201
thimerosal
thiothixene
thiothixene hydrochloride
thonzonium bromide
tiagabine hydrochloride
ticlopidine hydrochloride
timolol
tiopronin
tirofiban hydrochloride
benign extrahepatic bile duct neoplasm
tizanidine hydrochloride
tocainide hydrochloride
tolcapone
tolnaftate
topiramate
tranexamic acid
travoprost
trazodone hydrochloride
tribromsalan
trichlormethiazide
benign male reproductive system neoplasm
triclocarban
trihexyphenidyl hydrochloride
trimethadione
trimipramine maleate
tripelennamine hydrochloride
tropicamide
tubocurarine chloride
unoprostone isopropyl
urea c - 13
benign kidney neoplasm
urea c - 14
valsartan
vecuronium bromide
pantothenic acid
xenon xe - 133
zafirlukast
zanamivir
zinc acetate
ziprasidone
zolmitriptan
benign ciliary body neoplasm
zonisamide
2 - hydroxyethyl methacrylate
acetylcholinesterase inhibitor
antiarrhythmic agent
serotonin agonist
cns stimulant
cholinergic agonist
ordinal scale
nominal scale
interval scale
therapeutic estradiol
benign eye neoplasm
ratio scale
non - negative integer
isoform
serum calcitonin level increased
benign brain neoplasm
hoarseness
vocal cord paralysis
benign pituitary gland neoplasm
vmax
km
data set
scope
borderline ovarian epithelial tumor
american diabetes association
male - to - female transsexual phenotype
female - to - male transsexual phenotype
scalar
cardiovascular neoplasm
null
life sciences identifier
statistical markup language
forced expiratory volume in 6 seconds
genomic molecule entity
fasta format
knowledge base
breast carcinoma with chondroid metaplasia
breast carcinoma with osseous metaplasia
venous invasion
uncomplicated hypertension
lymphatic invasion
uniprotkb
radionuclide scanning
sequence feature
sentinel lymph node biopsy with axillary lymph node dissection
left breast
right breast
paget disease of the breast
paget disease of the breast without invasive carcinoma
dementia
microcalcification present in non - neoplastic tissue
microcalcification present in neoplastic and non - neoplastic tissue
unifocal
extensive
mitotic count
phase v trial
synoptic surgical pathology report
blood chemistry measurement
benign digestive system neoplasm
metropolitan france
qs wave by ecg finding
separation column
mass spectrometer
resolution
cutoff
base 64
malignant nervous system neoplasm
simple
increment
xml path language
web service definition language
project
repeat
packing dosage form
contract
suture dosage form
benign nervous system neoplasm
vaginal diaphragm dosage form
test
tampon dosage form
routine
set
benchmark
warning
tape dosage form
swab dosage form
implementation
estramustine
pseudocode
source - code
article
programming language
build
input
output
compiler
operating system
postcondition
left atrial myxoma
precondition
run
sponge dosage form
poultice dosage form
strip dosage form
intrauterine device dosage form
kit dosage form
male - to - female transsexual animal
female - to - male transsexual animal
hyperlink
right atrial myxoma
service
name - value pair
pathname
offset
mass spectrometry markup language
data processing
mass analyzer
ionization source
deconvolution
colon lymphoma
centroid
isotope
phosphorus
active site
cross link
initiation
consecutive
lung lymphoma
terminal
proprotein
repeat pattern
transit peptide
uncertain
beta strand
protein turn
amrubicin hydrochloride
vacuum - assisted biopsy
prostate adenoma
mammotome clip
routine signature
routine contract
logical condition
communication contact
means
acyclovir sodium
albuterol sulfate
aminosalicylate sodium
ampicillin sodium
hypertensive episode
ampicillin trihydrate
azathioprine sodium
betamethasone valerate
betamethasone dipropionate
betamethasone sodium phosphate
cefadroxil hemihydrate
cefamandole nafate
cefamandole sodium
cefazolin sodium
cephalexin hydrochloride
perineural cyst
cephradine dihydrate
cephradine monohydrate
chloramphenicol sodium succinate
chlordiazepoxide hydrochloride
chlorhexidine gluconate
chlorpromazine hydrochloride
ciprofloxacin hydrochloride
clindamycin hydrochloride
clindamycin phosphate
clonidine hydrochloride
recurrent neoplasm
demeclocycline
diatrizoate sodium
diclofenac potassium
diclofenac sodium
dicloxacillin sodium
erythromycin estolate
erythromycin ethylsuccinate
erythromycin lactobionate
erythromycin stearate
deficiency of humoral immunity
estradiol acetate
estradiol cypionate
estradiol hemihydrate
ethacrynate sodium
fentanyl citrate
fluphenazine hydrochloride
fluphenazine decanoate
flurbiprofen sodium
haloperidol decanoate
indomethacin sodium
estramustine phosphate sodium
retinal neoplasm
lidocaine hydrochloride
magnesium acetate tetrahydrate
melphalan hydrochloride
methylprednisolone acetate
methylprednisolone sodium succinate
metronidazole hydrochloride
naproxen sodium
ondansetron hydrochloride
oxaprozin potassium
oxycodone terephthalate
optic nerve neoplasm
oxycodone hydrochloride
phenytoin sodium
prilocaine hydrochloride
prochlorperazine edisylate
quinidine sulfate
quinidine gluconate
riboflavin 5' - phosphate sodium
sodium acetate anhydrous
sodium sulfate anhydrous
terbinafine
central nervous system degenerative disorder
tetracycline hydrochloride
epinephrine bitartrate
hydrocortisone butyrate
hydrocortisone probutate
hydrocortisone valerate
thiamine hydrochloride
triamcinolone hexacetonide
triamcinolone acetonide
trimethoprim sulfate
valproate sodium
duodenal carcinoma
pyridoxine hydrochloride
ziprasidone hydrochloride
ziprasidone mesylate
marriage
unit of linear acceleration
operator
unit of area
integration
spot
breast hyperplasia
matrix - assisted laser desorption ionization mass spectrometry
plate
dead volume
protein helix
precursor
precision
pair
byte
polarity
mass - to - charge ratio
acquired nevus araneus
charge
window
collision
shoot
peak
base
acid
energy
ionization
congenital nevus araneus
spotting
collision - induced dissociation
cerebral meningioma
late adverse effect
residual disease
antiestrogen
malignant sweat gland neoplasm
fibromatosis colli
malignant odontogenic neoplasm
recurrent malignant neoplasm
thyroid gland carcinoma
float
generation
microgram
microliter
minute
gram
default
7q21 - q22 .1
wavelength
10q23 .33
photosensitive dermatitis
freezing
force
g force
embedding
medium
thaw
disposal
transfer
cancer research group
absorbance at 260nm
ewing sarcoma
absorbance at 280nm
28s ribosomal rna
18s ribosomal rna
visible
loading
example
step
processing
image
calcifying aponeurotic fibroma
molecular signature
gene signature
let - 7
retroperitoneal lymph node dissection
neoangiogenesis
epigenetic silencing
material
raw
genomic instability
skin squamous cell carcinoma
absent
information
importance weight
generator dosage form
cholecalciferol
chromosomal instability
dna replication fork
intravasation
extravasation
cell microenvironment
estrogens ,  conjugated
phenocopy alteration
orphan drug
nested case - control study
nanoparticle - targeted drug
norton - simon model
synchrotron
performed by
unit of concentration
unit of weight
laboratory information management system
amacr gene
alpha - methylacyl - coa racemase
tgct1 gene
vcam1 gene
vascular cell adhesion protein 1
poly  [ adp - ribose ]  polymerase 1
disintegrin and metalloproteinase domain - containing protein 17
adam17 gene
foxc2 gene
personalized
malignant glioma
forkhead box protein c2
read
plug
tumor grading system
lack of efficacy
lost to follow - up
threshold
multiplier
jpeg
cancer tnm finding
prostate cancer tnm finding v6
prostate cancer pathologic tnm finding v6
prostate cancer pt2 tnm finding v6 and v7
prostate cancer pt2a tnm finding v6 and v7
prostate cancer pt2b tnm finding v6 and v7
prostate cancer pt2c tnm finding v6 and v7
tongue carcinoma
prostate cancer pt3 tnm finding v6 and v7
prostate cancer pt3a tnm finding v6
prostate cancer pt3b tnm finding v6 and v7
prostate cancer pt4 tnm finding v6
prostate cancer pn0 tnm finding v6 and v7
prostate cancer pn1 tnm finding v6 and v7
prostate cancer pm1 tnm finding v6 and v7
prostate cancer pm1b tnm finding v6 and v7
prostate cancer pm1c tnm finding v6 and v7
tonsillar carcinoma
physician decision
prostate cancer pm1a tnm finding v6 and v7
hyperparathyroidism
central nervous system neuroblastoma
perineural invasion
screening
trial screening
iodine i 131 tm - 601
talabostat
adrenal gland neuroblastoma
consent withdrawn
cancer molecular analysis project
death related to adverse event
adverse event classification
primary sclerosing cholangitis
primary hyperparathyroidism
trial phase
2 - dimensional
parathyroid gland lipoadenoma
donor
parathyroid gland atypical adenoma
hyperparathyroidism - jaw tumor syndrome
stock
distributor
tool mouse
character large object
curation
execution
reference object
fragment
hashtable
server
nomenclature
mouse genome informatics
therapeutic estrogen
ureter urothelial carcinoma
familial paraganglioma - pheochromocytoma syndrome
sdh complex gene mutation
sdhb gene mutation
sdhc gene mutation
sdhd gene mutation
benign adrenal gland pheochromocytoma
adrenal gland composite pheochromocytoma
spontaneous
stage
grade
gingival hemangioma
manipulation
request
suggestion
benign paraganglioma
nasopharyngeal paraganglioma
superior and inferior paraaortic paraganglioma
cerebellar paraganglioma
adrenal cortex adenomatoid tumor
retroperitoneal sarcoma
adrenal gland angiosarcoma
primary site unknown
black
red
purple
pink
green
oral cavity squamous cell carcinoma
yellow
orange
brown
blue
turquoise
bullet
capsule shape
clover
diamond
double circle
primary bone osteosarcoma
freeform
gear
heptagon
hexagon
octagon
oval
pentagon
rectangle
round
semi - circle
ewing sarcoma of bone
square shape
tear shape
trapezoid
triangle
relational operator
sponsor
reading
adrenal cortical cell
coordinating center
malignant epiglottis neoplasm
frame of reference
instance
lossy compression
pixel
adenovector encoding mda7
multikinase inhibitor aee788
aminoflavone prodrug afp464
allogeneic gm - csf - secreting breast cancer vaccine
alpha fetoprotein adenoviral vector vaccine
alpha fetoprotein plasmid dna vaccine
motesanib diphosphate
nilotinib
autologous dendritic cell - allogeneic melanoma tumor cell lysate vaccine
autologous ebv - transformed b lymphoblastoid - tumor fusion cell vaccine
saracatinib
cediranib maleate
dysplasia of larynx
pan - her kinase inhibitor ac480
bowman - birk inhibitor concentrate
bardoxolone
cngrc peptide - tnf alpha conjugate
deferasirox
degarelix
eculizumab
everolimus
everolimus / gefitinib
fluorine f 18 ef5
esophageal intraepithelial neoplasia
fowlpox virus vaccine vector
gm .cd40l cell vaccine
her - 2 - neu ,  cea peptides ,  gm - csf ,  montanide isa - 51 vaccine
hla - a1 ,  a2 ,  b35 - restricted survivin peptides / montanide isa - 51 vaccine
hla - a2 ,  a3 - restricted fgf - 5 peptides / montanide isa - 51 vaccine
recombinant human papillomavirus bivalent vaccine
human prostate - specific membrane antigen plasmid dna vaccine
iloprost
ingenol mebutate
iodine i 124 iododeoxyuridine
therapeutic estrone
esophageal low grade intraepithelial neoplasia
iodine i 131 omburtamab
retaspimycin hydrochloride
lestaurtinib
methylnaltrexone
tandutinib
lucatumumab
veltuzumab
monoclonal antibody huafp31
monoclonal antibody hupam4
monoclonal antibody rav12
moderate esophageal dysplasia
mouse gp100 plasmid dna vaccine
mouse prostate - specific membrane antigen plasmid dna vaccine
oncolytic adenovirus encoding gm - csf
opioid growth factor
ovarian cancer peptide vaccine
paclitaxel - loaded polymeric micelle
picoplatin
piperine extract  ( standardized )
pngvl4a - sig / e7 ( detox )  / hsp70 dna vaccine
recombinant vaccinia - ny - eso - 1 vaccine
sargramostim plasmid dna hepatocellular carcinoma vaccine adjuvant
sb - as15 adjuvant
peginesatide
technetium tc 94m sestamibi
taxane analogue tpi 287
velafermin
volociximab
larotaxel
yttrium y - 90 tacatuzumab tetraxetan
yttrium y - 90 clivatuzumab tetraxetan
biliary intraepithelial neoplasia
zibotentan
kilovolt peak
tilt
electrical current
x - ray tube
kilo
milli
revolution
table
pitch
standard operating procedure
synchronous
storage medium
adrenal cortex oncocytic adenoma
cortisol - producing adrenal cortex adenoma
pancreatic intraepithelial neoplasia
unit of acceleration
aldosterone - producing adrenal cortex adenoma
sex hormone - producing adrenal cortex adenoma
unit of amount of substance
androgen - producing adrenal cortex adenoma
unit of angle measurement
estrogen - producing adrenal cortex adenoma
unit of plane angle measurement
non - functioning adrenal cortex adenoma
unit of solid angle measurement
pancreatic intraepithelial neoplasia - 2
square centimeter
square foot
square yard
fowlpox - ny - eso - 1 vaccine
curie
united states pharmacopeia unit
colon dysplasia
potency unit
publication
adjust ph dosing unit
ampule dosing unit
bag dosing unit
bar dosing unit
bolus dosing unit
bottle dosing unit
box dosing unit
can dosing unit
mild colon dysplasia
capsule dosing unit
cartridge dosing unit
clinical unit
coat dosing unit
container dosing unit
count dosing unit
cubic foot
cubic inch
cylinder dosing unit
moderate colon dysplasia
disk dosing unit
metric drop
drum dosing unit
fluid dram us
fluid ounce us
gallon
generator dosing unit
grain
homeopathic dilution unit
implant dosing unit
ethacrynic acid
rectal dysplasia
inch
inhalation dosing unit
jar dosing unit
kallikrein inhibitor unit
kit dosing unit
liter
lozenge dosing unit
microcurie
micromole per liter
micromole
mild rectal dysplasia
micron
millicurie
milliequivalent
millimole
minim
nanogram
nanomole
ounce
moderate rectal dysplasia
package dosing unit
packet dosing unit
part dosing unit
part per million
patch dosing unit
pellet dosing unit
percent mass per volume
percent mass per mass
pint
stage 0 rectal cancer ajcc v6 and v7
pouch dosing unit
pound
pressor unit
protein nitrogen unit
quart
scoopful dosing unit
spray dosing unit
strip dosing unit
suppository dosing unit
abnormal urine cytology
syringe dosing unit
tablespoon dosing unit
tablet dosing unit
tampon dosing unit
teaspoon dosing unit
test dosing unit
ton
trace dosing unit
troche dosing unit
tube dosing unit
laryngeal carcinoma
vial dosing unit
wafer dosing unit
yard
normal ,  unit of concentration
mole per liter
no evidence of metastatic disease
adrenal medulla neoplasm
unit of mass fraction
unit of flow rate
unit of volumetric flow rate
unit of mass flow rate
percent unit
percent volume per volume
expiration
extra - adrenal sympathetic paraganglioma
fluid ounce british
international unit
placental neoplasm
gallon us
gallon scotland
gallon british
gallon historical
unit of equivalent weight
potency not applicable
potency not given
base of the heart
quantity sufficient
potency unassigned
gastrointestinal hemorrhage
invasive prostate carcinoma
satellite nodule
matted lymph nodes
ethinyl estradiol
lung sarcoma
re - excision
enucleation
total gleason score for prostate cancer
primary gleason pattern
secondary gleason pattern
tertiary gleason pattern
focal pattern
invasive cutaneous melanoma
wide skin excision
acute monocytic leukemia
elliptical skin excision
minimal deviation melanoma
melanoma in congenital melanocytic nevus
desmoplastic neurotropic melanoma
lesion by focality
unifocal lesion
incidental finding
ovarian sex cord - stromal tumor
positive surgical margin
negative surgical margin
mucosal lentiginous melanoma
route of administration not applicable
dosage form not applicable
package type not stated
mccune - albright syndrome
sexual precocity
cyp2a6 gene
prostate carcinoma
tyrosinase:146 - 156 peptide
gp100:614 - 622 peptide
mage - 3 .a1 peptide vaccine
hla - b44 - restricted mage - 3 peptide
hla - b44 - restricted tyrosinase peptide
mscv  ( mgmtp140k )  retroviral vector - transduced cd34 +  autologous pbsc
lenvatinib mesylate
851b gel
recombinant vaccinia - multiepitope melanoma peptides - b7 .1 - b7 .2 vaccine
synthetic melanoma - associated antigens vaccine
apc8015f
norepinephrine bitartrate
university
dental granuloma
missing value reason
cannot be assessed
indeterminate
vulvar carcinoma
not applicable
not identified
marked
posterolateral part of the prostate
gene identifier
elapse
low penetrance allele
penetrance
targeted mutation
malignant soft tissue neoplasm
schedule of controlled substances
core genotyping facility
schedule i substance
genomic orientation
preclinical
schedule ii substance
schedule iii substance
schedule iv substance
nonclinical study
schedule v substance
placental hemangioma
vkorc1 gene
vitamin k epoxide reductase complex subunit 1
parp1 gene
insertion
brain stem neoplasm
human genome organisation
coding region
subsystem
data table
controlled vocabulary
m0 stage finding
ethiodized oil
complete remission
m1 stage finding
m1a stage finding
m1b stage finding
m1c stage finding
mx stage finding
n0 stage finding
n1 stage finding
n1a stage finding
n1b stage finding
n1c stage finding
complete hydatidiform mole
n2a stage finding
n2b stage finding
n2c stage finding
n3 stage finding
n3a stage finding
n3b stage finding
n3c stage finding
nx stage finding
t0 stage finding
breast carcinoma
t1 stage finding
t1a stage finding
t1b stage finding
t1c stage finding
t2 stage finding
t2a stage finding
t2b stage finding
t2c stage finding
t3 stage finding
t3a stage finding
rare disorder
t3b stage finding
t3c stage finding
t4 stage finding
t4a stage finding
t4b stage finding
t4c stage finding
t4d stage finding
tx stage finding
tis stage finding
pathologic tnm finding
cerebral neoplasm
pm0 stage finding
pn0 stage finding
pn1a stage finding
reproductive system disorder
pn2 stage finding
pt0 stage finding
pt1 stage finding
symptom
pt1a stage finding
pt1b stage finding
pt1c stage finding
pt2 stage finding
pt2a stage finding
pt2b stage finding
pt2c stage finding
pt3 stage finding
pt3a stage finding
rectosigmoid neoplasm
pt3b stage finding
pt3c stage finding
pt4 stage finding
pt4a stage finding
pt4b stage finding
l0 stage finding
lung carcinoma
lx stage finding
v0 stage finding
vx stage finding
protein information resource
n2 stage finding
subunit
dual x - ray absorptiometry
benign sweat gland neoplasm
breast cancer tnm finding v6
cutaneous melanoma tnm finding v6
equivalent
summation
residue
vim gene
vimentin
prostate specific antigen velocity
in vivo imaging
amifostine
benign bone neoplasm
biorepository
vital exhaustion
polymer
repeat object
regulatory process
regulator
chemical
chemical formula
small molecule
metastatic malignant neoplasm in the spine
catalyst
orthologous
belinostat
ropidoxuridine
melanoma tumor - reactive autologous tumor infiltrating lymphocyte
unists
renal tumor - reactive autologous peripheral blood lymphocyte
renal tumor - reactive autologous tumor infiltrating lymphocyte
adeno - associated virus type 2
homologene
benign muscle neoplasm
annotated tissue
jaw bone
lumbosacral region
mc1r gene
melanocyte - stimulating hormone receptor
primary lymphedema
malignant muscle neoplasm
secondary lymphedema
patient navigator
fellowship for the interpretation of genomes
correlation
role
78 kda glucose - regulated protein
hspa5 gene
cutaneous melanoma pathologic tnm finding v6
cutaneous melanoma ptx tnm finding v6
benign neck neoplasm
cutaneous melanoma pt0 tnm finding v6 and v7
cutaneous melanoma ptis tnm finding v6 and v7
cutaneous melanoma pt1 tnm finding v6
cutaneous melanoma pt1a tnm finding v6
cutaneous melanoma pt1b tnm finding v6
cutaneous melanoma pt2 tnm finding v6 and v7
cutaneous melanoma pt2a tnm finding v6 and v7
cutaneous melanoma pt2b tnm finding v6 and v7
cutaneous melanoma pt3 tnm finding v6 and v7
cutaneous melanoma pt3a tnm finding v6 and v7
cutaneous melanoma pt3b tnm finding v6 and v7
cutaneous melanoma pt4 tnm finding v6 and v7
cutaneous melanoma pt4a tnm finding v6 and v7
cutaneous melanoma pt4b tnm finding v6 and v7
cutaneous melanoma pnx tnm finding v6
cutaneous melanoma pn0 tnm finding v6 and v7
cutaneous melanoma pn1 tnm finding v6
cutaneous melanoma pn1a tnm finding v6
cutaneous melanoma pn1b tnm finding v6
cutaneous melanoma pn2 tnm finding v6
benign pyriform fossa neoplasm
cutaneous melanoma pn2a tnm finding v6
cutaneous melanoma pn2b tnm finding v6
cutaneous melanoma pn2c tnm finding v6
cutaneous melanoma pn3 tnm finding v6 and v7
cutaneous melanoma pm0 tnm finding
cutaneous melanoma pmx tnm finding
cutaneous melanoma pm1 tnm finding v6
cutaneous melanoma pm1a tnm finding v6
cutaneous melanoma pm1b tnm finding v6
cutaneous melanoma pm1c tnm finding
metastatic malignant neoplasm in the trachea
double
date data type
kinesin - like protein kif11
splenic lymphoma
swallow evaluation
dedifferentiated chordoma
generic tnm finding
benign lung hilum neoplasm
recurrent cancer tnm finding
clinical tnm finding
autopsy tnm finding
pathologic distant metastasis tnm finding
pathologic regional lymph nodes tnm finding
pathologic primary tumor tnm finding
prostate cancer pathologic primary tumor tnm finding v6
metastatic malignant neoplasm in the heart
prostate cancer pathologic regional lymph nodes tnm finding v6
prostate cancer pathologic distant metastasis tnm finding v6
cutaneous melanoma pathologic regional lymph nodes tnm finding v6
prostate cancer clinical tnm finding v6
cutaneous melanoma pathologic primary tumor tnm finding v6
cutaneous melanoma pathologic distant metastasis tnm finding v6
cutaneous melanoma clinical tnm finding v6
hiv lipodystrophy
etoglucid
malignant digestive system neoplasm
macrodactyly
rank
administration ,  management
pointer
benign submandibular gland neoplasm
subject
priority
choose
programming parameter
upload
variance
percentile
stage 0 small intestinal cancer ajcc v7
quantile
coefficient
exponent
polynomial degree
routine option
lambda
near
and / or
span
benign urinary system neoplasm
drop
unit fda
uncontrolled
gene function
total nottingham score
regional lymph node dissection
radical lymph node dissection
quantitation
cell count
bladder fundus
benign endometrial neoplasm
bladder wall
bronchiole epithelium
lobe of the right lung
lobe of the left lung
left pulmonary vein
right pulmonary vein
human activity profile
block
benign adrenal medulla neoplasm
door
double dependent locality
island
farm
prefecture
sector
tower
village
canton
leukemia in remission
staircase
subcutaneous nodular fasciitis
cytidine deaminase
sipa1 gene
signal - induced proliferation - associated protein 1
autoantibody
breast cancer clinical tnm finding v6
breast cancer pathologic tnm finding v6
breast cancer pathologic primary tumor tnm finding v6
acute leukemia in remission
breast cancer pathologic regional lymph nodes tnm finding v6
breast cancer pathologic distant metastasis tnm finding v6
breast cancer ptx tnm finding v6 and v7
breast cancer pt0 tnm finding v6 and v7
breast cancer ptis tnm finding v6 and v7
breast cancer ptis  ( dcis )  tnm finding v6 and v7
breast cancer ptis  ( lcis )  tnm finding v6 and v7
breast cancer ptis paget tnm finding v6 and v7
breast cancer pt1 tnm finding v6 and v7
breast cancer pt1mic tnm finding v6 and v7
chronic leukemia in remission
breast cancer pt1a tnm finding v6 and v7
breast cancer pt1b tnm finding v6 and v7
breast cancer pt1c tnm finding v6 and v7
breast cancer pt2 tnm finding v6 and v7
breast cancer pt3 tnm finding v6 and v7
breast cancer pt4 tnm finding v6 and v7
breast cancer pt4a tnm finding v6 and v7
breast cancer pt4b tnm finding v6 and v7
breast cancer pt4c tnm finding v6 and v7
breast cancer pt4d tnm finding v6 and v7
myeloid leukemia in remission
breast cancer pnx tnm finding v6 and v7
breast cancer pn0 tnm finding v6
breast cancer pn0 ( i -  )  tnm finding v6
breast cancer pn0 ( i +  )  tnm finding v6
breast cancer pn0 ( mol -  )  tnm finding v6 and v7
breast cancer pn0 ( mol +  )  tnm finding v6 and v7
breast cancer pn1 tnm finding v6
breast cancer pn1mi tnm finding v6
breast cancer pn1a tnm finding v6 and v7
breast cancer pn1b tnm finding v6
ethylene dibromide
monocytic leukemia in remission
breast cancer pn1c tnm finding v6
breast cancer pn2 tnm finding v6
breast cancer pn2a tnm finding v6 and v7
breast cancer pn2b tnm finding v6
breast cancer pn3 tnm finding v6
breast cancer pn3a tnm finding v6 and v7
breast cancer pn3b tnm finding v6
breast cancer pn3c tnm finding v6 and v7
breast cancer pm0 tnm finding
breast cancer pm1 tnm finding v6 and v7
lymphoid leukemia in remission
breast cancer pmx tnm finding v6
myofibroblastoma
angiomyofibroblastoma
gardner fibroma
regional lymph node
metabolomics
benign splenic neoplasm
statistical confidence
gp100:209 - 217 ( 210m )  peptide vaccine
pax3 / fkhr peptide vaccine
low grade myofibroblastic sarcoma
myxoinflammatory fibroblastic sarcoma
sclerosing epithelioid fibrosarcoma
metastatic malignant neoplasm in the thymus
low complexity region
alignment
identical
jpred
seg algorithm
tmhmm algorithm
protein data bank
metastatic malignant neoplasm in lymph node
ffas algorithm
gp100:280 - 288 ( 288v )  peptide vaccine
signalp algorithm
coils program
hmmpfam algorithm
cancer bioinformatics grid
cancer imaging program
test context
unsolved
skin hemangioma
pdb blast
joint effusion
directory
dicom
parathyroid gland carcinoma
public
ridaforolimus
ef - 1 peptide
ef - 2 peptide
organizational branch
blinded
open
hypertensive cardiomegaly
closed
checklist
skin fibrous histiocytoma ,  fibroblastic variant
skin fibrous histiocytoma ,  histiocytic variant
skin fibrous histiocytoma ,  cellular variant
skin fibrous histiocytoma ,  epithelioid variant
ovarian carcinoma
retrovector encoding mutant anti - cyclin g1
hemiasterlin analog e7974
imetelstat
tremelimumab
recombinant modified vaccinia ankara - 5t4 vaccine
bavituximab
boswellia serrata extract
cerebral edema
vgefr / c - kit / pdgfr tyrosine kinase inhibitor xl820
plk1 inhibitor bi 2536
immunomodulator ohr / avr118
fluorothymidine f - 18
neratinib
jnk inhibitor cc - 401
alvimopan
melanin - pigmented dendritic cells present
blood oxygen level - dependent functional mri
etoposide
colon carcinoma
data value
myofibroblastic differentiation
conventional dermatofibrosarcoma protuberans
nci - navy medical oncology branch
suffix
giant cell tumor of soft tissue
paralogous gene
polyamine analogue
gastric carcinoma
solid angioleiomyoma
venous angioleiomyoma
cavernous angioleiomyoma
dartoic muscle
bladder carcinoma
toast classification
has_salt_form
has_free_acid_or_base_form
rsf1 gene
malignant female reproductive system neoplasm
remodeling and spacing factor 1
histologic test
cytologic test
bilateral prophylactic oophorectomy
investigational new drug
cortical cell layer of the cerebral cortex
cortical cell layer of the cerebellum
skin carcinoma
copy number
qualitative evaluation
automated neuropsychological assessment metrics
accuracy
adenovirus vaccine
physical contact
quantitative result
answer
embryonal tumor with multilayered rosettes ,  c19mc - altered
z - dimension
stillbirth
case
sequential
statement
objective
comparison
adjustment
magnitude
proportion
focal nodular hyperplasia of the liver
incomplete
refuse
literacy
response evaluation criteria in solid tumors
surgical procedure by method
extracardiac rhabdomyoma
constrain
lung small cell carcinoma
11c topotecan
aprepitant
mk0731
notch signaling pathway inhibitor mk0752
palbociclib
recombinant dher2 vaccine
peg - pei - cholesterol lipopolymer - encased il - 12 dna plasmid vector gen - 1
conventional cardiac rhabdomyoma
malignant nasal cavity neoplasm
xiap antisense oligonucleotide aeg35156
inosine monophosphate dehydrogenase inhibitor avn944
immunomodulatory oligonucleotide hyb2055
loop diuretic
thiazide diuretic
potassium - sparing diuretic
microbiology test
primary key
rectal villous adenoma
aorta endothelium
aorta smooth muscle tissue
arteriole endothelium
arteriole smooth muscle tissue
artery endothelium
artery smooth muscle tissue
fatty acid
retinal capillary hemangioma
anaplastic embryonal rhabdomyosarcoma
nudt1 gene
7 , 8 - dihydro - 8 - oxoguanine triphosphatase
bronchus cartilage
retinal cavernous hemangioma
cervix epithelium
cervix squamous epithelium
diverticulosis
external ear cartilage
glottis carcinoma
choroid plexus epithelium of the fourth ventricle
fourth ventricle ependyma
lenograstim
administrative activity
therapeutic procedure
chemistry test
candidate tumor suppressor gene
trichothiodystrophy
laryngeal mucous salivary gland
choroid plexus epithelium of the lateral ventricle
malignant germ cell tumor
left lung alveolus
left lung bronchiole
hilar area of the left lung
left lung respiratory bronchiole
left lung terminal bronchiole
lower respiratory tract cartilage
text line
metastatic undifferentiated pleomorphic sarcoma
ovarian capsule
intercalated duct of the salivary gland system
intercalated duct of the pancreas
penis erectile tissue
benign ovarian cyst
carcinoembryonic antigen peptide
renal tubule
hpv 18 l1 - vlp
right lung alveolus
right lung bronchiole
hilar area of the right lung
hilar area of the lung
right lung respiratory bronchiole
hematology test
effective
as04 adjuvant
recombinant adenovirus - l523s vaccine
chest wall neoplasm
recombinant dna - l523s vaccine
principal component analysis
county
right lung terminal bronchiole
omega - 3 fatty acid
colon hyperplastic polyp
trachea cartilage
gland of littre
vein endothelium
vena cava endothelium
venule endothelium
duodenal adenoma
venous system endothelium
venous system smooth muscle tissue
left adrenal gland
left testis
left ureter
right adrenal gland
right testis
right ureter
retina layer
arterial system endothelium
epiglottis neoplasm
arterial system smooth muscle tissue
brain dura mater
brain gray matter
tissue preparation or processing technique
frozen section diagnosis
benign female reproductive system neoplasm
component load
low - dose treatment
moderate - dose treatment
deep vein thrombosis
akrotiri
dhekelia
brain nucleus
cerebral white matter
acpp wt allele
ada wt allele
ileal neuroendocrine tumor g1
bcl2 wt allele
bcl2l2 wt allele
ang wt allele
naip wt allele
birc2 wt allele
apeh wt allele
birc3 wt allele
ephx1 wt allele
xiap wt allele
birc5 wt allele
hepatic granuloma
birc6 wt allele
bche wt allele
birc7 wt allele
pla2g2a wt allele
apaf1 wt allele
pla2g4a wt allele
bak1 wt allele
pla2g4b wt allele
bax wt allele
bcl10 wt allele
recurrent hodgkin lymphoma
bcl2l11 wt allele
pla2g4c wt allele
bid wt allele
pla2g4d wt allele
bik wt allele
pla2g6 wt allele
bnip3l wt allele
drosha wt allele
htatip2 wt allele
entrezgene_id
localized lymphoma
dicer1 wt allele
plcb3 wt allele
madd wt allele
plcg2 wt allele
fhit wt allele
maged1 wt allele
folh1 wt allele
map2k6 wt allele
gls2 wt allele
hdac1 wt allele
benign lymphoproliferative disorder
hdac2 wt allele
hdac3 wt allele
hdac4 wt allele
pmaip1 wt allele
xaf1 wt allele
hdac5 wt allele
bard1 wt allele
hdac6 wt allele
bad wt allele
congenital ,  familial and genetic disorder class
fentanyl
malignant neck neoplasm
ear and labyrinth disorder class
general disorders and administration site conditions class
injury ,  poisoning and procedural complication class
metabolism and nutrition disorder class
pregnancy ,  puerperium and perinatal condition class
reproductive system and breast disorder class
blm wt allele
ddx6 wt allele
rad54b wt allele
recql4 wt allele
soft palate squamous cell carcinoma
recql5 wt allele
recql wt allele
skiv2l wt allele
wrn wt allele
hpse wt allele
nudt1 wt allele
plpp1 wt allele
dusp1 wt allele
dusp3 wt allele
dusp22 wt allele
stage 0 pharyngeal cancer
bcl2l1 wt allele
ppp1ca wt allele
hrk wt allele
mcl1 wt allele
tp73 wt allele
ppp3ca wt allele
ski wt allele
tgct1 wt allele
ppp3cb wt allele
tcta wt allele
pyriform fossa squamous cell carcinoma
eipr1 wt allele
ppp3cc wt allele
tssc4 wt allele
ppp2ca wt allele
ttc4 wt allele
ppp2cb wt allele
wt2 wt allele
ppp2r1b wt allele
pds5b wt allele
ptpa wt allele
sellar region neoplasm
btg2 wt allele
ppp2r5a wt allele
bub1 wt allele
ppp2r5b wt allele
ppp2r5c wt allele
cdc25a wt allele
ppp2r5d wt allele
cdk11b wt allele
ppp2r5e wt allele
medical dictionary for regulatory activities system organ class
supraglottic squamous cell carcinoma
cdc42 wt allele
cenpf wt allele
cdk1 wt allele
cdk10 wt allele
cdk2 wt allele
cdk3 wt allele
cdk4 wt allele
cdk5 wt allele
cdk2ap1 wt allele
thyroid gland hurthle cell carcinoma
cdkn1a wt allele
fourth
junior
senior
world health organization adverse reaction terminology
systematized nomenclature of medicine clinical terms
vaginal condyloma
thesaurus of adverse reaction term coding symbols
thesaurus
alveolar septum
international classification of diseases
world health organization drug dictionary
logical observation identifiers names and codes
appendicular skeleton
intestinal wall tissue
vaginal fibroepithelial polyp
category for inclusion and or exclusion
ear skin
not done
heart septum
yes ,  no ,  unknown ,  or not applicable response
no
yes
adverse event outcome
liver lymphoma
not recovered from adverse event
recovered from adverse event with sequelae
recovering or resolving
recovered from adverse event
action taken with study treatment
recombinant interferon beta
colon non - hodgkin lymphoma
action taken with pharmacological treatment
drug interrupted
drug withdrawn
dose increased
dose not changed
dose reduced
large
cdkn1b wt allele
cerebral astrocytoma
cdkn1c wt allele
cdkn2a wt allele
cdkn2b wt allele
cdkn2c wt allele
cdkn3 wt allele
ccna2 wt allele
ccnb1 wt allele
ccnb2 wt allele
ptpn11 wt allele
ccnd1 wt allele
non - metastatic brain neoplasm
ptpn12 wt allele
ptpn1 wt allele
ccnd2 wt allele
ptpn22 wt allele
ccne1 wt allele
ptpn6 wt allele
ccne2 wt allele
ptpn7 wt allele
ptp4a1 wt allele
intracranial neoplasm
gmnn wt allele
ptprc wt allele
mki67 wt allele
ptpre wt allele
pcna wt allele
ptprg wt allele
pttg1 wt allele
ptprj wt allele
sfn wt allele
ptprr wt allele
non - metastatic malignant brain neoplasm
ptprt wt allele
skp2 wt allele
ttk wt allele
adam11 wt allele
cdc37 wt allele
adam15 wt allele
hspa5 wt allele
casp10 wt allele
hspb1 wt allele
casp1 wt allele
benign cerebellar neoplasm
c3 wt allele
c5 wt allele
casp2 wt allele
casp3 wt allele
casp4 wt allele
casp5 wt allele
submission domain
casp6 wt allele
submission domain abbreviation
casp7 wt allele
desmoplastic / nodular medulloblastoma
casp8 wt allele
casp9 wt allele
adverse event domain
analysis dataset domain
inner canthus
autopsy domain
bone measurements domain
biopsy domain
concomitant medication domain
comment domain
benign neoplasm of the meninges
disease characteristics domain
intervertebral disc
demographics domain
rib joint
disposition domain
vertebral joint
drug accountability domain
liver lobe
leptomeningeal neoplasm
lower eyelid
upper eyelid
lower jaw tooth
lower jaw incisor
lower jaw molar
protocol deviations domain
exposure domain
family history domain
healthcare resource utilization domain
cerebral convexity meningioma
imaging domain
laboratory data domain
nasal cartilage
nasal turbinate
outer canthus
recombinant fibroblast growth factor
parasagittal meningioma
spinal nerve plexus
microbiology specimen domain
medical history domain
meal data domain
organ measurement domain
pharmacokinetic concentration domain
pharmacokinetic parameters domain
physical exam domain
questionnaire domain
malignant peripheral nervous system neoplasm
subject characteristics domain
surgery domain
skin test domain
sleep polysomnography domain
stress exercise test data domain
substance use domain
subject element domain
subject visits domain
trial arms domain
trial elements domain
malignant thymus neoplasm
trial inclusion and exclusion criteria domain
trial visits domain
vital signs domain
electroencephalogram domain
electrocardiogram domain
reason for non - completion
trial screen failure
benign supratentorial neoplasm
non - compliance with study drug
study terminated by sponsor
technical problem
withdrawal by subject
both
reference period
relation to reference period
status post
malignant supratentorial neoplasm
during or after
in utero
preterm infant
infant and toddler
control type
placebo control
active control
benign infratentorial neoplasm
diagnosis group
healthy subject
clinical study by intent
diagnosis study
cure study
adverse effect mitigation study
treatment study
prevention study
trial blinding schema
open label study
malignant infratentorial neoplasm
trial type
pharmacogenomic study
pharmacodynamic study
pharmacokinetic study
bioavailability study
therapeutic equivalency study
efficacy study
safety study
centimeter
adult acute lymphoblastic leukemia
millimeter of mercury
kilogram per square meter
vital signs measurement
beats per minute
breaths per minute
units for vital signs results
pulse rate
heart rate
respiratory rate
mean arterial pressure
secondary malignant neoplasm
body frame size
children 2 - 11 years old
adult 18 - 65 years old
phase iia trial
phase iiia trial
phase iib trial
phase iiib trial
therapy - related malignant neoplasm
trial summary parameter
planned subject number
planned minimum age of subjects
planned maximum age of subjects
sex of study group
trial length
study stop rule
fish oil
cerebral embryonal tumor ,  not otherwise specified
adverse event dictionary
drug dictionary
medical history dictionary
test product added to existing treatment
common terminology criteria for adverse events
severity / intensity scale for adverse events
ctsd wt allele
ctsb wt allele
ctsh wt allele
ccl11 wt allele
ctsl wt allele
ctsz wt allele
ccl13 wt allele
fap wt allele
ccl14 wt allele
furin wt allele
klk11 wt allele
klk15 wt allele
ccl15 wt allele
klk2 wt allele
nerve sheath neoplasm
ccl17 wt allele
klk3 wt allele
adam17 wt allele
ccl18 wt allele
adamts1 wt allele
adamts9 wt allele
ccl19 wt allele
mme wt allele
ccl1 wt allele
mmp11 wt allele
perineurioma
mmp14 wt allele
mmp1 wt allele
mmp2 wt allele
mmp3 wt allele
mmp8 wt allele
ccl20 wt allele
mmp9 wt allele
plat wt allele
ccl21 wt allele
ccl22 wt allele
nervous system injury
ccl23 wt allele
ccl24 wt allele
ccl25 wt allele
ccl26 wt allele
ccl27 wt allele
ccl2 wt allele
ccl3 wt allele
ccl3l1 wt allele
ccl4 wt allele
ccl5 wt allele
primary brain stem neoplasm
ccl7 wt allele
ccl8 wt allele
ctf1 wt allele
cx3cl1 wt allele
device component or accessory
cxcl10 wt allele
cxcl11 wt allele
cxcl12 wt allele
central nervous system vascular malformation
cxcl13 wt allele
cxcl14 wt allele
cxcl1 wt allele
cxcl2 wt allele
cxcl3 wt allele
cxcl5 wt allele
cxcl6 wt allele
rathke pouch cyst
cxcl9 wt allele
pf4 wt allele
ppbp wt allele
csf1 wt allele
splenic trabecular artery
csf2 wt allele
splenic trabecular vein
malignant colorectal neoplasm
csf3 wt allele
choroid plexus of the third ventricle
thyroglossal duct
epo wt allele
flt3lg wt allele
clc wt allele
il10 wt allele
tonsillar capsule
il11 wt allele
carcinoma unspecified site
il13 wt allele
il15 wt allele
upper jaw tooth
il16 wt allele
upper jaw incisor
upper jaw molar
il17a wt allele
yes ,  no ,  or not applicable response
fixative
acute graft versus host disease
trial title
cardiovascular surgical procedure
carbon dioxide absorber device
sound absorber device
accumulator device
actuator device
adapter device
socket adapter device
chronic graft versus host disease
air cleaner device
air pump assembly device
alarm assembly device
alarm device
audible alarm device
light emitting diode alarm device
pressure alarm device
high inspiratory pressure alarm device
oxygen pressure alarm device
low inspiratory pressure alarm device
aleukemic leukemia
power alarm device
visual alarm device
volume alarm device
alternator device
amplifier device
analyzer device
annunciator device
antenna device
arrester device
aleukemic leukemia cutis
attenuator device
device backpanel device
backplane device
baffle device
bag device
ball device
ballast device
balloon device
barrier device
battery device
ovarian neoplasm
lithium iodide battery device
beam splitter device
bearing device
bell device
belt device
blower device
bobbin device
bolt device
bottom dead center sensor bracket device
brake device
oropharyngeal candidiasis
breathing circuit device
brush device
bus device
bushing device
buzzer device
cable device
optical cable device
calibrator device
camera device
inner cannula device
outer cannula device
cap device
capacitor device
carrier device
cascade device
cassette device
caster device
cell device
charger device
chassis device
aids in hemophiliac population
choke device
circuit board device
clamp device
clip device
clock device
carbon dioxide monitor subassembly device
coder device
coil device
conductor coil device
tip conductor coil device
helifix coil device
collimator device
comparator device
concentrator device
connecting rod device
connector device
y - piece connector device
controller device
converter device
childhood leukemia
cord device
power cord device
core device
counter device
coupler device
cover device
central processing unit board device
crank arm assembly device
crystal device
flecainide acetate
cuff device
cup device
current limiter device
current source device
cusp device
cutter device
cylinder device
damper device
decoder device
defibrillator paddle device
aids - related disorder
defibrillator subassembly device
dehumidifier device
dehydrator device
delay line device
demagnetizer device
demodulator device
detector device
photodetector device
device deployer device
dial device
environment - related malignant neoplasm
device diaphragm device
digitizer device
diode device
light emitting diode device
discrete device
disk device
optical disk device
device display device
dome device
occupational malignant neoplasm
doubler device
driver device
duct device
dummy load device
duplexer device
ekg or ecg device subassembly device
electrode device
emitter device
enclosure device
encoder device
stage ii bladder squamous cell carcinoma ajcc v6 and v7
endoscope device
equalizer device
evaporator device
expander device
extender device
extractor device
eyelet device
fan device
fastener device
feedthru device
recurrent bladder adenocarcinoma
ferrule device
field effect transistor device
fiber device
hollow fiber device
optical fiber device
film device
filter device
exhalation filter device
bacterial filter device
flange device
flasher device
foil device
foot pedal device
frame device
furnace device
fuse device
gas scavenging device
gasket device
gear device
refractory nodal marginal zone lymphoma
generator device
grille device
grommet device
ground strap device
guide device
piston guide device
waveguide device
handset device
header device
headphone device
recurrent nodal marginal zone lymphoma
head device
piston head device
headset device
heart valve cage device
heat exchanger device
heat sink device
heater device
heater rod device
hinge device
holder device
stage iv high grade burkitt - like lymphoma
housing device
hub device
humidifier device
hybrid circuit device
integrated circuit device
integrated circuit chip device
igniter device
imager device
impedance converter device
intraocular lens implant device
fluconazole
stage iii high grade burkitt - like lymphoma
indexer device
indicator device
function indicator device
inductor device
insulation device
intercom device
interface device
interrupter device
stage ii high grade burkitt - like lymphoma
inverter device
isolator device
jack device
joint device
solder joint device
joystick device
jumper device
junction device
keyboard device
keyer device
stage i high grade burkitt - like lymphoma
keypad device
kit device
knob device
label device
laminate device
lamp device
laser device
electrical lead device
lead conductor device
heart valve leaflet device
refractory high grade burkitt - like lymphoma
lens device
contact lens
limiter device
line conditioner device
load device
lock device
locking sleeve device
logic board device
lower piston bearing device
magazine device
recurrent high grade burkitt - like lymphoma
magnet device
magnetizer device
magnetoresistor device
magnifier device
manifold device
membrane device
memory device
read only memory device
erasable programmable read only memory device
high grade burkitt - like lymphoma
programmable read only memory device
random access memory device
gauge or meter device
magnetometer device
flowmeter device
densitometer device
bolometer device
altimeter device
voltmeter device
thermometer device
ann arbor stage iv follicular lymphoma
tachometer device
spectrometer device
scintillometer device
pyrometer device
potentiometer device
oximeter device
spirometer device
microcircuit device
microphone device
microscope device
recurrent follicular lymphoma
mirror device
mixer device
modem device
modulator device
monitor device
ekg or ecg monitor device
motherboard device
motor device
stepper motor device
mount device
recurrent burkitt lymphoma
nebulizer device
network device
meter needle device
none device
nut device
oxygen monitor subassembly device
obturator device
optocoupler device
oscillator device
oscilloscope device
ann arbor stage ii supradiaphragmatic hodgkin lymphoma
outlet device
oven device
overlay device
oxygen analyzer device
pad device
panel device
printed circuit board device
photomultiplier device
phototransistor device
flucytosine
ann arbor stage ii subdiaphragmatic hodgkin lymphoma
pickup device
pin device
retaining pin device
motor roll pin device
piston pad device
pivot device
plate device
plotter device
plug device
pointer device
polarizer device
implanted port access device
post device
power lamp device
power module device
power supply device
preamplifier device
prescaler device
preselector device
pressure signal device
ann arbor stage i subdiaphragmatic hodgkin lymphoma
printer device
probe device
processor device
programmer device
prong device
protector device
pulley device
pulser device
pump device
compressor air pump device
rail device
reactor device
reader device
receiver device
recorder device
rectifier device
electrically open reed device
regulator device
relay device
repeater device
recurrent lung squamous cell carcinoma
reservoir device
resistor device
resolver device component
resonator device
retainer device
reticle device
rheostat device
ribbon device
ring device
slip ring device
stage ii rectosigmoid cancer ajcc v6
heart valve sewing ring device
rivet device
robot device
rod device
safety interlock device
surface acoustic wave device
scale device
scaler device
scanner device
scrambler device
stage i rectosigmoid cancer ajcc v6 and v7
screen device
screw device
scriber device
seal device
tracheal seal device
cup seal device
sensor device
pressure sensor device
oxygen sensor device
servo device
stage 0 rectosigmoid cancer ajcc v6 and v7
shaft device
shield device
shift register device
shifter device
shunt device
shutter device
signal conditioner device
simulator device
slide device
slotter line device
unresectable pancreatic carcinoma
socket device
solenoid device
spacer device
spark gap device
speaker device
splicer device
spooler device
spring device
stabilizer device
stand device
stage iv esophageal squamous cell carcinoma ajcc v7
stent device
stiffener device
stopcock device
strain relief device
strip line device
stylet device
sunlamp device
suppressor device
switch device
fluorine
stage iii esophageal squamous cell carcinoma ajcc v7
power switch device
limit switch device
foot switch device
proximity switch device
control switch device
synchronizer device
syringe device
fail - safe system device
tape device
stage ii esophageal squamous cell carcinoma ajcc v7
tee device
telemetry equipment device
telephone device
teleprinter device
teletypewriter device
temperature compensator device
terminal device
terminal assembly device
terminator device
thermistor device
stage i esophageal squamous cell carcinoma ajcc v7
thermocouple device
thermostat device
thyristor device
timer device
trackball device
transceiver device
transducer device
transformer device
transistor device
translator device
stage 0 esophageal squamous cell carcinoma ajcc v7
transmission line device
transmitter device
transponder device
transport device
triac device
trimmer device
tube device
capillary tube device
cathode ray tube device
pressure tubing device
prostate well differentiated neuroendocrine tumor
tuner device
data acquisition unit device
television unit device
valve device
control valve device
directional valve device
dump valve device
exhalation valve device
flap valve device
flow valve device
inhalation valve device
inlet port valve device
inspiratory valve device
outlet port valve device
positive end expiratory pressure valve device
pressure limit valve device
relief valve device
safety valve device
selector valve device
cylinder valve device
recurrent nasal type extranodal nk / t - cell lymphoma
luer valve device
pilot balloon valve device
vaporizer device
varistor device
video display terminal device
vibrator device
washer device
window device
wire device
malignant testicular non - seminomatous germ cell tumor
thermocouple wire device
guidewire device
wiring harness device
yoke device
cannula guide device
handpiece device
handrest device
haptic device
screw head device
hose device
verrucous lesion
hose line device
hand immobilizer device
lead device
leaflet device
function indicator light device
mechanism device
locking mechanism device
lockout mechanism device
spring loading mechanism device
bolus mechanism device
extrahepatic bile duct sarcoma
needle device
nozzle device
laser nozzle device
pallet device
tomographic pallet device
connector pin device
pipette device
plunger device
intravenous pole device
transducer pressure probe device
fluorochrome dye
temperature probe device
side rail device
hermetic seal device
rate modulated pacing sensor device
temperature sensor device
shoulder support device
speech processor device
staple device
emergency stop button device
emergency table stop device
syringe drive device
device system
hydraulic system device
hydraulic bed system device
gas delivery system device
water purification system device
injection system device
automatic injection system device
cooling module device
table top device
screw tapper device
test strip device
thread device
tip device
nozzle tip device
lead tip device
trocar device
photomultiplier tube device
unit device
endocrine system signs and symptoms
receiver stimulator unit device
motor drive unit device
central processing unit of computer device
stopcock valve device
one - way valve device
hemo valve device
electrical wire device
steering wire device
endoscopic accessory device
air eliminator device
disturbance in bowel function
applicator device
cutter - torque cable device
cannula device
catheter device
cautery device
battery charger device
circuit breaker device
fiberoptic cladding device
fiberoptic cleaver device
genitourinary signs and symptoms
t - piece connector device
electrode contact device
counterbalance device
deionizer device
bubble detector device
motion detector device
leaflet disk device
fiber optic device
external fiberoptic device
integumentary system signs and symptoms
sediment filter device
wedge filter device
fiberguide device
surgical graft device
suture device
bed
specialty bed
table device
absorber device
plau wt allele
prss8 wt allele
prtn3 wt allele
st14 wt allele
tmprss2 wt allele
usp6 wt allele
usp8 wt allele
alterations in smell or taste
bphl wt allele
gpi wt allele
top1 wt allele
top2a wt allele
top2b wt allele
top3a wt allele
top3b wt allele
acsl1 wt allele
rnf139 wt allele
cblb wt allele
motor manifestations
fbxw7 wt allele
map3k1 wt allele
ubd wt allele
ube2d2 wt allele
nsd2 wt allele
yars1 wt allele
adcy9 wt allele
odc1 wt allele
dictionary name
floxuridine
age unit
myopericytoma
diaphoretic
retrograde
speech disorder
anaphylactoid
lethargic
hospitalization required
apgar score decreased or low
failure to anastomose
local reaction
surgical procedure stopped
surgical procedure delayed
therapy stopped
underdose
missed dose
ventilator - dependent
abnormal mammogram
misdiagnosis
drainage
skin wrinkling
petit mal seizure
body substance discharge
intracranial hemorrhage
brain injury
contusion
erosion
foreign body reaction
hypoesthesia
laceration
abnormal blood gas measurement
abrasion
acanthamoeba keratitis
achalasia
acoustic shock
acoustic trauma
adult acquired toxoplasmosis
air embolism
airway obstruction
alteration of cognitive function
ambulation difficulty
amnionitis
anaphylactic shock
aortic dissection
aortic valve stenosis
arm or hand hypoesthesia
arthralgia
asphyxia
atrial fibrillation
atrial perforation
vitreous hemorrhage
aids - related malignant anal neoplasm
blood loss
bone shedding debris
bowel burn
bradypnea
burning sensation
cancer other
capsular contracture
cardiac arrest
cardiac enzyme elevation
cardiac tamponade
cardiogenic shock
cardiopulmonary arrest
cephalohematoma
cerebral hemorrhage
cerebral infarction
cerebrospinal fluid leakage
cervical change
change in emotional state
chemosis
chewing difficulty
child intoxication with breast implant material ingredients
choking
claudication
clonic convulsion
collapse
fluorouracil
complete abortion
complete atrioventricular block
concussion
congenital toxoplasmosis
contact lens overwear syndrome
cross - patient exposure to body fluids
corneal burn
corneal decompensation
corneal edema
corneal haze
aids - related non - hodgkin lymphoma
corneal infiltration
corneal scar
corneal touch
corneal transplant
corneal ulcer
cusp tear
cut
cyclitis
aids - related malignant cervical neoplasm
cyst formation
cytomegaloviral retinitis
damage of vaginal mucosa
decreased core body temperature
decreased forced expiratory volume
decreased peak expiratory flowrate
decreased therapeutic response
dehiscence
delayed union fracture
childhood testicular neoplasm
diabetic ketoacidosis
dialysis encephalopathy
dialyzer first use syndrome
diminished pulse
direct contact transmission infection
discomfort
disfigurement
distension
dyskinesia
cerebral lymphoma in immunocompetent host
st segment elevation by ecg finding
electric shock
electromechanical dissociation by ecg finding
electrocardiographic change
electrocution
electrolyte imbalance
embolus
physical entrapment
epithelial microcyst
cerebral hodgkin lymphoma
eructation
excessive tearing
exit block by ecg finding
expulsion
epidural hemorrhage
extreme exhaustion
fall
fasciitis
feeding problem
fetal distress
fetal hypoxia
fibromyositis
flasher
flatus
secondary cerebral hodgkin lymphoma
foot or leg hypoesthesia
foreign body sensation
gangrene
grand mal seizure
hearing impairment
heart failure
hematoma
hemoconcentration
hemostasis
hemothorax
herpes
high blood oxygen saturation
high pulmonary arterial wedge pressure
host tissue response to foreign body
hyalitis
hyperemia
hyperthermia
recurrent epithelioid sarcoma
hyperventilation
hypervolemia
hyphema
hypopyon
hypoventilation
hypovolemia
hypovolemic shock
idioventricular rhythm
non - metastatic fibrosarcoma
impaired healing
impaired vision
implant failure
inadequate pain relief
incompetent cervix
incomplete abortion
increased forced expiratory volume
urethral urothelial papilloma
increased peak expiratory flowrate
increased therapeutic response
indirect contact transmission infection
induced abortion finding
induced cataract
insulin shock
intimal dissection of blood vessel
intraocular infection
intraocular pressure increased
intraoperative pain
cancer fatigue
intrauterine fetal death
iritis
irregular pulse
irritability
irritation
ischemic heart disease
joint swelling
leaflet disruption
left ventricular dysfunction
endobronchial lipoma
left ventricular failure
left ventricular hypertrophy
ligament injury
liver dysfunction
loss of consciousness
loss of range of motion
loss of vision
loss of vitreous fluid
ann arbor stage i lymphocyte - depleted classic hodgkin lymphoma
low blood oxygen saturation
low cardiac output
low pulmonary arterial wedge pressure
lumbar puncture headache
lung overinflation
mediastinal shift
medical contraindication
vessel or plaque ,  device embedded in
congenital glaucoma
migration
missed abortion
mitral perforation
mitral valve stenosis
mitral valve prolapse
muscle spasm
muscle weakness
muscular rigidity
muscular tic
myocardial contusion
nasal obstruction
neck pain
neck stiffness
needlestick puncture
neonatal deformity
neonatal hearing impairment
neonatal hearing loss
nerve damage
ann arbor stage ii lymphocyte - depleted classic hodgkin lymphoma
neurogenic shock
neurological deficit or dysfunction
nipple sensation change or loss
nipple ulceration
adverse event with no consequence or impact
normal pulmonary arterial wedge pressure
occlusion
organ perforation
ossification
osteolysis
device overstimulation
pallor
pannus formation
paraplegia
paresis
partial seizure
peeling
perforation of cornea
esophageal perforation
peritoneal laceration
phosphene visualization
phototoxicity
pocket erosion
fluoxymesterone
ann arbor stage ii nodular lymphocyte predominant hodgkin lymphoma
polydipsia
positive antinuclear antibody test
posterior capsular bag tear
postoperative shock
postoperative wound infection
posttraumatic wound infection
pressure sore
prosthetic valve thrombosis
pseudoaneurysm
pulmonary dysfunction
pulmonary embolism
pulmonary infarction
pulmonary stenosis
pupillary block
purulent discharge
pus
pyogenic infection
pyrogenic reaction
quadriplegia
radiation burn
radiation sickness syndrome
raynaud phenomenon
red eye
regurgitation
respiratory acidosis
respiratory alkalosis
retinal damage
retinal tear
right ventricular dysfunction
right ventricular hypertrophy
skin scar
seroma
sinus perforation
skin irritation
skin tear
skull fracture
sneezing
sore throat
soreness
spinal arachnoiditis
spinal cord injury
spinal injury
stacking breath
stenosis
strangulation
subarachnoid hemorrhage
subclinical infection
subdural hemorrhage
subgaleal hemorrhage
suffocation
sunset syndrome
swollen lymph node
synovitis
tachypnea
thermal burn
ann arbor stage ii mixed cellularity classic hodgkin lymphoma
tingling
tinnitus
tonic convulsion
tooth fracture
tooth sensitivity
torsades de pointes by ecg finding
bacterial toxemia
transient ischemic attack
traumatic shock
tricuspid valve stenosis
twiddler's syndrome
twitching
uncontrolled delayed intraocular pressure
undesired nerve stimulation
unexpected therapeutic effect
urinary retention
urinary tract infection
urinary urgency
uterine perforation
uveitis glaucoma and hyphema syndrome
vaginal discharge
valvular insufficiency
valvular regurgitation
vasovagal reaction
ventricular fibrillation
flurbiprofen
ventricular flutter
ventricular tachycardia
ventriculomeglia
blood vessel perforation
visual disturbance
visual halo
vitreous detachment
vitreous floater
weakness
ann arbor stage ii nodular sclerosis classic hodgkin lymphoma
weight fluctuation
wheal
akr7a2 wt allele
aldh1a2 wt allele
alox15 wt allele
aortic valve replacement
tricuspid valve replacement
pulmonary valve replacement
heart valve repair
extubation
reinfusion procedure
foreign body removal
resuscitation
prolonged surgery
apicectomy
mitral valve replacement
scar excision
epithelial marsupialization
repeated surgical procedure
additional surgical procedure
closed capsulotomy
enlargement of surgical incision
replacement of lens
vitrectomy
established diagnosis
ann arbor stage iv burkitt lymphoma
amacr wt allele
laceration of esophagus
tricuspid valve insufficiency
tricuspid valve regurgitation
tentorial tear
skin erosion
right ventricular failure
partial motor seizure
pulmonary valvular regurgitation
optical nerve damage
ann arbor stage i extranodal marginal zone lymphoma of mucosa - associated lymphoid tissue
oversedated
mitral valve regurgitation
liver contusion
liver laceration
exsanguination
fainting
stromal corneal edema
ann arbor stage ii extranodal marginal zone lymphoma of mucosa - associated lymphoid tissue
aortic valve regurgitation
radiation overdose
wound dehiscence
leaflet disruption due to calcification
leaflet disruption due to infection
suture abrasion
ann arbor stage iii extranodal marginal zone lymphoma of mucosa - associated lymphoid tissue
autotransfusion procedure
overdose
dhfr wt allele
dhodh wt allele
snai2 gene
dpyd wt allele
g6pd wt allele
ann arbor stage iv extranodal marginal zone lymphoma of mucosa - associated lymphoid tissue
zinc finger protein snai2
hmox1 wt allele
gsc gene
hsd17b2 wt allele
homeobox protein goosecoid
hsd17b7 wt allele
impdh1 wt allele
prostate stem cell antigen
mitral valve insufficiency
impdh2 wt allele
recurrent extranodal marginal zone lymphoma of mucosa - associated lymphoid tissue
surveillance bias
lox wt allele
psca gene
mthfr wt allele
nos1 wt allele
nos2 wt allele
intraventricular brain hemorrhage
nos2b wt allele
nos2c wt allele
nos3 wt allele
flutamide
refractory extranodal marginal zone lymphoma of mucosa - associated lymphoid tissue
nqo1 wt allele
microcystic corneal edema
ndor1 wt allele
por wt allele
ptgs1 wt allele
ptgs2 wt allele
leaflet disruption due to host tissue overgrowth
leaflet disruption due to unknown cause
leaflet disruption due to suture abrasion
osteopenia
sudden cardiac death
adverse event without patient involvement
invalid data
inadequate osteointegration
teratogenic effect
premature labor
endotoxin
staphylococcus aureus
pathogen
il17c wt allele
il18 wt allele
il19 wt allele
rrm1 wt allele
il1a wt allele
il1b wt allele
rrm2 wt allele
sod2 wt allele
il24 wt allele
srd5a2 wt allele
il2 wt allele
il3 wt allele
tdo2 wt allele
il4 wt allele
tpo wt allele
il5 wt allele
il6 wt allele
il7 wt allele
cxcl8 wt allele
il9 wt allele
txn wt allele
tyr wt allele
xdh wt allele
cad wt allele
recurrent splenic marginal zone lymphoma
dhps wt allele
fasn wt allele
lif wt allele
aprt wt allele
mif wt allele
tymp wt allele
osm wt allele
ext1 wt allele
nampt wt allele
ext2 wt allele
refractory splenic marginal zone lymphoma
tslp wt allele
extl1 wt allele
tnfsf10 wt allele
extl2 wt allele
extl3 wt allele
tnfsf11 wt allele
hprt1 wt allele
tnfsf15 wt allele
hprt2 wt allele
tnfsf4 wt allele
brain stem glioblastoma
cd40lg wt allele
kitlg wt allele
faslg wt allele
xcl1 wt allele
xcl2 wt allele
hyou1 wt allele
sncg wt allele
apex1 wt allele
apex2 wt allele
atr wt allele
brain stem ependymoma
ercc1 wt allele
ercc2 wt allele
ercc3 wt allele
ercc4 wt allele
ercc5 wt allele
ercc6 wt allele
exo1 wt allele
fancg wt allele
xrcc6 wt allele
xrcc5 wt allele
resectable pancreatic carcinoma
lig4 wt allele
mlh1 wt allele
mlh3 wt allele
msh2 wt allele
msh3 wt allele
disease response
protocol deviation
msh4 wt allele
msh6 wt allele
nbn wt allele
folic acid
renomedullary interstitial cell tumor
ogg1 wt allele
parp1 wt allele
pms1 wt allele
pms2 wt allele
prkdc wt allele
rad51c wt allele
rad54l wt allele
tinf2 wt allele
topbp1 wt allele
trex1 wt allele
kidney lipoma
trex2 wt allele
xpa wt allele
xrcc1 wt allele
xrcc2 wt allele
xrcc3 wt allele
xrcc4 wt allele
pnp wt allele
ppat wt allele
ugt1a1 wt allele
got1 wt allele
got2 wt allele
cdon wt allele
gpt2 wt allele
gpt wt allele
response declined
ceacam7 wt allele
gstm1 wt allele
gpa33 wt allele
gstp1 wt allele
mitotic chromosomal process
recurrent pharyngeal carcinoma
prometaphase
sirpa wt allele
sirpb1 wt allele
azu1 wt allele
oncosis
mechanism of cell death
cd52 wt allele
regulation of cell death process
cd7 wt allele
gstt1 wt allele
hat1 wt allele
kat5 wt allele
comt wt allele
dnmt3b wt allele
setdb1 wt allele
tyms wt allele
nat2 wt allele
nmt2 wt allele
colorectal adenocarcinoma
hk2 wt allele
chka wt allele
ckb wt allele
dck wt allele
mtor wt allele
magi1 wt allele
dlg1 wt allele
dlg4 wt allele
mpp1 wt allele
mpp2 wt allele
mpp3 wt allele
abl1 wt allele
abl2 wt allele
tnk2 wt allele
bmx wt allele
contributing_source
bed assist bar device
wheel device
wheelchair wheel device
wheelchair tire device
entity
crkl wt allele
defb1 wt allele
csk wt allele
fer wt allele
hla - a wt allele
fes wt allele
klrd1 wt allele
hck wt allele
lamp3 wt allele
lgals3bp wt allele
itk wt allele
ms4a1 wt allele
jak1 wt allele
ptma wt allele
jak2 wt allele
anxa5 wt allele
jak3 wt allele
clca2 wt allele
clic4 wt allele
matk wt allele
slc26a3 wt allele
trpm5 wt allele
vdac1 wt allele
vdac2 wt allele
vdac3 wt allele
abi2 wt allele
acrbp wt allele
afp wt allele
anxa8 wt allele
folate antagonist
bone marrow transplantation nephropathy
auh wt allele
baiap2 wt allele
bap1 wt allele
ptk2 wt allele
arid4b wt allele
calm1 wt allele
camlg wt allele
ptk2b wt allele
herc5 wt allele
alcam wt allele
benign intracranial neoplasm
ptk6 wt allele
cd14 wt allele
blk wt allele
fgr wt allele
cd209 wt allele
frk wt allele
cd22 wt allele
fyn wt allele
cd28 wt allele
lck wt allele
autonomic nervous system neoplasm
cd2 wt allele
cd34 wt allele
lyn wt allele
cd44 wt allele
src wt allele
cd47 wt allele
cd4 wt allele
cd58 wt allele
cd72 wt allele
cd80 wt allele
solid glomus tumor
cd8b wt allele
adgre5 wt allele
malignant intracranial neoplasm
cdh13 wt allele
malignant adult brain neoplasm
flcn gene mutation
cdh1 wt allele
cdh3 wt allele
cdh5 wt allele
fat1 wt allele
icam1 wt allele
icam2 wt allele
yes1 wt allele
tec wt allele
tnk1 wt allele
benign adult brain neoplasm
pik3ca wt allele
pik3cb wt allele
pik3cg wt allele
icam3 wt allele
itga5 wt allele
itgal wt allele
pik3r3 wt allele
itgam wt allele
pi4kb wt allele
pip4k2a wt allele
spiradenocarcinoma
itgax wt allele
pip4k2b wt allele
itgb2 wt allele
prkg2 wt allele
itgb3 wt allele
rps6kb2 wt allele
itgb4 wt allele
ryk wt allele
jup wt allele
grk2 wt allele
benign schwannoma
grk3 wt allele
cd82 wt allele
akt1 wt allele
ncam1 wt allele
nrcam wt allele
akt2 wt allele
pecam1 wt allele
sele wt allele
akt3 wt allele
sell wt allele
nerve root neoplasm
araf wt allele
selp wt allele
atm wt allele
bcr wt allele
braf wt allele
cdkl2 wt allele
chek1 wt allele
chek2 wt allele
plk3 wt allele
csnk1a1 wt allele
free radical
vestibulocochlear nerve neoplasm
csnk2a1 wt allele
fastk wt allele
grk4 wt allele
grk5 wt allele
grk6 wt allele
grk7 wt allele
gsk3a wt allele
irak1 wt allele
irak2 wt allele
ksr1 wt allele
olfactory nerve neoplasm
lats1 wt allele
lats2 wt allele
limk1 wt allele
map3k7 wt allele
map3k8 wt allele
mapk10 wt allele
mapk11 wt allele
mapk12 wt allele
mapk13 wt allele
mapk14 wt allele
trigeminal nerve neoplasm
insufficient anesthesia
angina
aortic valve insufficiency
atrial flutter
biliary cirrhosis
serpinb5 wt allele
spam1 wt allele
epcam wt allele
hemispheric anaplastic astrocytoma
tgfbi wt allele
vcam1 wt allele
vtn wt allele
f3 wt allele
f7 wt allele
f8 wt allele
f9 wt allele
vwf wt allele
cttn wt allele
ewsr1 wt allele
anaplastic diencephalic astrocytoma
fabp1 wt allele
fabp2 wt allele
fabp3 wt allele
fabp4 wt allele
fibp wt allele
mos wt allele
fabp5 wt allele
fstl3 wt allele
hnrnpab wt allele
mylk wt allele
hp wt allele
pak1 wt allele
pak6 wt allele
cdk16 wt allele
pdpk1 wt allele
pim1 wt allele
mapk4 wt allele
mapk6 wt allele
mapk7 wt allele
igbp1 wt allele
mapk9 wt allele
igf2bp3 wt allele
lcp1 wt allele
plk1 wt allele
lgals8 wt allele
limd1 wt allele
lims1 wt allele
prkaca wt allele
prkacb wt allele
prkacg wt allele
benign diencephalic neoplasm
ltbp2 wt allele
prkca wt allele
prkcb wt allele
eif2ak2 wt allele
raf1 wt allele
mok wt allele
written language
spoken language
sign language
language code
lyl1 wt allele
mapre1 wt allele
clinic
mdm2 wt allele
meis1 wt allele
msmb wt allele
mt3 wt allele
nmi wt allele
ccn3 wt allele
pard6a wt allele
nova1 wt allele
nova2 wt allele
pbx3 wt allele
kat2b wt allele
plagl1 wt allele
kdm5b wt allele
ptch2 wt allele
pura wt allele
rbbp9 wt allele
rbl2 wt allele
tegafur
adenoid cystic breast carcinoma
rbm5 wt allele
rbm6 wt allele
hereditary leiomyomatosis and renal cell carcinoma
rbx1 wt allele
rcn2 wt allele
fh gene mutation
educational activity
grk1 wt allele
ripk1 wt allele
app wt allele
adult central nervous system neoplasm
cd36 wt allele
ripk2 wt allele
klrb1 wt allele
rpsa wt allele
ripk3 wt allele
cxcr5 wt allele
rock1 wt allele
ackr2 wt allele
ccr1 wt allele
rps6ka5 wt allele
childhood central nervous system neoplasm
plk2 wt allele
ccr5 wt allele
stk11 wt allele
ccr6 wt allele
aurka wt allele
ccr8 wt allele
ccr9 wt allele
ackr4 wt allele
tbk1 wt allele
tk1 wt allele
benign intracranial meningioma
ccrl2 wt allele
cx3cr1 wt allele
tk2 wt allele
dntt wt allele
cxcr3 wt allele
papola wt allele
cxcr4 wt allele
papolb wt allele
papolg wt allele
cxcr6 wt allele
intraspinal meningioma
polb wt allele
cntnap1 wt allele
polr2a wt allele
sat1 wt allele
cst6 wt allele
ctla4 wt allele
amfr wt allele
csf1r wt allele
csf2ra wt allele
csf2rb wt allele
intradural extramedullary spinal canal neoplasm
csf3r wt allele
epor wt allele
ifnar1 wt allele
ifnar2 wt allele
ifngr1 wt allele
ifngr2 wt allele
il10rb wt allele
il11ra wt allele
il13ra1 wt allele
aids clinical trial
childhood glioblastoma
il1r1 wt allele
il1r2 wt allele
il2ra wt allele
il2rb wt allele
il2rg wt allele
il3ra wt allele
il4r wt allele
il5ra wt allele
il6r wt allele
il7r wt allele
intraductal non - comedo breast adenocarcinoma
cxcr1 wt allele
cxcr2 wt allele
lepr wt allele
lifr wt allele
mpl wt allele
osmr wt allele
tnfrsf10a wt allele
tnfrsf10b wt allele
tnfrsf11b wt allele
intraductal cribriform breast adenocarcinoma
tnfrsf1a wt allele
tnfrsf1b wt allele
cd40 wt allele
fas wt allele
tnfrsf6b wt allele
tnfrsf8 wt allele
il27ra wt allele
xcr1 wt allele
dmbt1 wt allele
erbb3 wt allele
intraductal micropapillary breast carcinoma
fcgr2a wt allele
fcgr2b wt allele
fcgr2c wt allele
fcgr3a wt allele
fcgr3b wt allele
folr1 wt allele
adora1 wt allele
adora2a wt allele
adora2b wt allele
adora3 wt allele
antifungal agent
apocrine breast carcinoma in situ
agtr2 wt allele
adra1a wt allele
adra1b wt allele
serpina5 wt allele
adra2a wt allele
adra2b wt allele
serpinb2 wt allele
serpine1 wt allele
avpr1a wt allele
avpr1b wt allele
apocrine breast carcinoma
serpini2 wt allele
slpi wt allele
spink1 wt allele
wfdc1 wt allele
wfdc2 wt allele
set wt allele
areg wt allele
bdnf wt allele
btc wt allele
cfc1 wt allele
invasive cribriform breast carcinoma
hbegf wt allele
egf wt allele
ereg wt allele
fgf10 wt allele
fgf1 wt allele
fgf20 wt allele
fgf21 wt allele
avpr2 wt allele
bdkrb2 wt allele
adrb1 wt allele
malignant breast adenomyoepithelioma
adrb2 wt allele
brs3 wt allele
cckbr wt allele
celsr1 wt allele
chrm1 wt allele
chrm3 wt allele
chrm4 wt allele
chrm5 wt allele
cmklr1 wt allele
drd1 wt allele
benign breast adenomyoepithelioma
drd2 wt allele
drd4 wt allele
drd5 wt allele
f2r wt allele
fpr1 wt allele
fzd2 wt allele
fzd3 wt allele
pulmonary insufficiency
fzd4 wt allele
fzd6 wt allele
spinal cord neurofibroma
fzd7 wt allele
fzd9 wt allele
galr2 wt allele
gipr wt allele
gnrhr wt allele
gpr17 wt allele
ccr10 wt allele
gpr32 wt allele
gpr39 wt allele
kiss1r wt allele
cerebellar hemangioblastoma
gpr68 wt allele
gprc5c wt allele
grm1 wt allele
grm5 wt allele
grm6 wt allele
hcar3 wt allele
hrh2 wt allele
htr2a wt allele
ltb4r wt allele
mas1 wt allele
brain stem hemangioblastoma
nmbr wt allele
gprc5a wt allele
sctr wt allele
smo wt allele
sstr1 wt allele
sstr2 wt allele
sstr3 wt allele
sstr4 wt allele
sstr5 wt allele
tacr1 wt allele
infratentorial glioblastoma
tacr3 wt allele
tshr wt allele
vipr1 wt allele
gfra2 wt allele
ghr wt allele
gria3 wt allele
biopsy of conjunctiva
biopsy of pharyngeal tonsil
biopsy of salivary gland
core biopsy of pancreas
parotidectomy
complete parotidectomy
epididymectomy
fgf2 wt allele
fgf3 wt allele
fgf4 wt allele
furosemide
cerebellar glioblastoma
fgf5 wt allele
fgf6 wt allele
fgf7 wt allele
fgf8 wt allele
fgf9 wt allele
gdnf wt allele
hgf wt allele
igf1 wt allele
igf2 wt allele
lta wt allele
small intestine resection
ltb wt allele
partial small intestine resection
mdk wt allele
nrg1 wt allele
total small intestine resection
nrg2 wt allele
nrg3 wt allele
ntf3 wt allele
pdgfa wt allele
spinal cord sarcoma
pdgfb wt allele
pgf wt allele
pthlh wt allele
ptn wt allele
tgfa wt allele
thpo wt allele
tnf wt allele
bmp10 wt allele
bmp15 wt allele
bmp2 wt allele
central nervous system sarcoma
bmp3 wt allele
bmp5 wt allele
bmp6 wt allele
bmp7 wt allele
bmp8b wt allele
gdf10 wt allele
gdf5 wt allele
mstn wt allele
lefty2 wt allele
gdf9 wt allele
brain sarcoma
met wt allele
eng wt allele
fgfr1 wt allele
fgfr2 wt allele
fgfr3 wt allele
fgfrl1 wt allele
flt3 wt allele
flt4 wt allele
igf1r wt allele
igf2r wt allele
spinal cord neuroblastoma
ly6e wt allele
revision of ileostomy
ngfr wt allele
hmmr wt allele
htr3a wt allele
lobectomy of liver
itpr1 wt allele
klra1 wt allele
ldlr wt allele
dermatologic surgery
spinal chordoma
muc1 wt allele
nktr wt allele
notch1 wt allele
arthroplasty of the knee
notch4 wt allele
total knee replacement
npr2 wt allele
revision of total knee arthroplasty
biopsy of pericardium
right hemihepatectomy
spinal cord lymphoma
nrp1 wt allele
left hemihepatectomy
ar wt allele
partial parotidectomy
esr1 wt allele
esr2 wt allele
biliary tract surgery
excision of bile duct
frontoparietal craniotomy
subtotal esophagectomy
spinal cord melanoma
hemipelvectomy
billroth i procedure
billroth ii procedure
subtotal gastrectomy
biopsy of pylorus
biopsy of soft palate
biopsy of anus
biopsy of parathyroid gland
flexible fiberoptic sigmoidoscopy
suprapubic prostatectomy
bilateral oophorectomy
myectomy
sigmoidoscopy with biopsy
parathyroidectomy
subtotal parathyroidectomy
vaginal biopsy
cheilectomy
abdominal panniculectomy
total excision of tongue
duodenectomy
ganglioside gm2
mixed ductal and lobular carcinoma
biopsy of small intestine
left oophorectomy
right oophorectomy
mediastinal biopsy
glossectomy
salpingectomy
right salpingectomy
left salpingectomy
pharyngectomy
partial pharyngectomy
pleomorphic breast carcinoma
terminal ileum resection
rectosigmoidectomy
transverse colectomy
biopsy of thyroid gland
reduction mammoplasty
right reduction mammoplasty
left reduction mammoplasty
pericardial window procedure
inguinal lymphadenectomy
block dissection of inguinal lymph nodes
penectomy
amputation of toe
right colectomy
left colectomy
wedge resection of lung
biopsy of nose
biopsy of peritoneum
cervical biopsy
endocervical biopsy
breast adenocarcinoma with squamous metaplasia
ectocervical biopsy
biopsy of trachea
excisional biopsy of breast
aspiration of breast
proctocolectomy
partial cystectomy
ureterectomy
bronchoscopy with biopsy
biopsy of palate
metaplastic breast carcinoma
biopsy of urethra
patellectomy
biopsy of bile duct
pericardiectomy
esophagogastroscopy
myomectomy
nephroureterectomy
distal pancreatectomy
thyroidectomy
thyroid lobectomy
childhood lymphoma
biopsy of mouth
pleurectomy
intestine resection
biopsy of lip
stereotactic biopsy
stereotactic biopsy of brain
maxillectomy
partial maxillectomy
gastric antrectomy
direct laryngoscopy with biopsy
mucoepidermoid breast carcinoma
abdominal hysterectomy
excisional biopsy of lymph node
biopsy of larynx
mandibulectomy
segmental mandibulectomy
partial pancreatectomy
bilateral salpingectomy
bilateral partial salpingectomy
hemimandibulectomy
high grade mucoepidermoid breast carcinoma
proctoscopy with biopsy
biopsy of pancreas
allografting
endomyocardial biopsy
needle biopsy of liver
cholecystectomy
liver biopsy
biopsy of colon
tonsillectomy
low grade mucoepidermoid breast carcinoma
wedge resection of tongue
laparoscopic cholecystectomy
debridement
biopsy of duodenum
tonsillectomy with adenoidectomy
gastric biopsy
esophageal biopsy
appendectomy
colonoscopic polypectomy
breast neuroendocrine neoplasm
wedge excision
arthroplasty
skin biopsy
rectal biopsy
needle biopsy of prostate
total abdominal hysterectomy
orthotopic liver transplantation
adenoidectomy
biopsy of breast
kidney biopsy
ganciclovir
breast carcinoid tumor
biopsy of bladder
biopsy of prostate
amputation of leg through tibia and fibula
nr2f6 wt allele
nr3c1 wt allele
nr3c2 wt allele
nr0b2 wt allele
rora wt allele
pgr wt allele
metastatic breast carcinoid tumor
pparg wt allele
rara wt allele
rarb wt allele
rarg wt allele
rxra wt allele
rxrb wt allele
rxrg wt allele
or1g1 wt allele
plaur wt allele
prlr wt allele
ptch1 wt allele
acvr1 wt allele
acvr1b wt allele
acvr2a wt allele
acvr2b wt allele
acvrl1 wt allele
amhr2 wt allele
bmpr1a wt allele
bmpr2 wt allele
tgfbr1 wt allele
synovial biopsy
open biopsy of kidney
tgfbr2 wt allele
partial salpingectomy
tgfbr3 wt allele
thyroid isthmectomy
alk wt allele
axl wt allele
kit wt allele
ddr1 wt allele
ddr2 wt allele
egfr wt allele
epha1 wt allele
excision of uvula
partial mandibulectomy
lung biopsy
transbronchial lung biopsy
signet ring cell breast carcinoma
turbinectomy
mastoidectomy
epha2 wt allele
roux - en - y anastomosis
bypass gastrojejunostomy
radical neck dissection
metastatic signet ring cell breast carcinoma
loop electrosurgical excision
total abdominal hysterectomy with bilateral salpingo - oophorectomy
total thyroidectomy
needle biopsy of kidney
bilateral salpingectomy with oophorectomy
biopsy of brain
biopsy of nasopharynx
excision of lipoma
squamous cell breast carcinoma
extraction of tooth
total laryngectomy
above - knee amputation
married
never married
widowed
divorced
legally separated
radical nephrectomy
exploratory laparotomy
metastatic squamous cell breast carcinoma
ileectomy
total hepatectomy
bronchial biopsy
resection of rectum
vaginal hysterectomy
neurectomy
selective neck dissection of cervical lymph nodes
omentectomy
partial omentectomy
resection of clavicle
craniectomy
ileocolectomy
biopsy of heart
account administrator
address module coordinator
adeers contact
admitting physician
adverse event coordinator
ganglioside
malignant breast spiradenoma
agent expert
agent inspector
associate
attending physician
audiologist
branch chief
cdu web contact
central reviewer
cep member
checklist completer
breast non - hodgkin lymphoma
checklist supervisor
clinical coordinator
co - investigator
community educator
concept review chair
consulting physician
contract officer
contract principal investigator
coordinating investigator
co - project officer
breast t - cell non - hodgkin lymphoma
data manager
division head
drug company contact
employee
evaluator
grant investigator
grant principal investigator
group coordinator
guardian
laboratory director
hereditary multiple exostoses
laboratory technologist
lead drug monitor
legal representative of the sponsor
letter of intent review chair
mail contact
mail to contact
medical monitor
neuropathologist
participant chief
pharmaceutical liaison
breast angiosarcoma
pharmacist
pharmacologist
medical physicist
pmb drug company contact
population member
practitioner
practitioner assigned
primary cdus contact
primary shipping designee
program director
breast fibrosarcoma
program specialist
project coordinator
project officer
protocol author
protocol chair
protocol chair at an organization
protocol lead investigator
protocol review chair
protocol specialist
referring pathologist
breast leiomyosarcoma
referring physician
registration coordinator
regulatory contact
research clinician
research nurse
review liaison
review specialist
reviewing pathologist
reviewing radiologist
scientific monitor
breast liposarcoma
secondary cdus contact
shipping designee
site coordinator
site investigator
site leader
site representative investigator
sponsor medical expert
statistician
study chair
study coordinator
subject recruiter
submitting pathologist
treating physician
shave excision
maxillary antrostomy
partial colectomy
incidental appendectomy
supraglottic laryngectomy
breast extraskeletal osteosarcoma
simple excision of nasal polyps
tympanomastoidectomy
excision of lesion of skin
laparoscopic appendectomy
biopsy of testis
muscle biopsy
pelvic lymphadenectomy
pleural biopsy
intranasal ethmoidectomy
radical cystoprostatectomy
gentamicin
breast rhabdomyosarcoma
lymph node biopsy
percutaneous biopsy of kidney
biopsy of jejunum
osteotomy
modified radical neck dissection
debridement of wound of skin
hemilaryngectomy
esophagogastrectomy
vocal cord biopsy
superficial parotidectomy
partial excision of tongue
bronchoalveolar lavage
wedge biopsy
excision of bone
wedge biopsy of liver
endometrial biopsy
partial thyroidectomy
biopsy of mucosa
open lung biopsy
total colectomy
left salpingo - oophorectomy
right salpingo - oophorectomy
biopsy of bone
partial nephrectomy
percutaneous liver biopsy
breast spiradenoma
biopsy of tongue
ganglionectomy
biopsy of temporal artery
complete excision
bilateral reduction mammoplasty
amputation of foot
transmetatarsal amputation of foot
suction procedure
breast complex fibroadenoma
complete salpingectomy
papanicolaou test
immunohistochemical test
ambulatory surgical facility
erythrocyte count
reticulocyte count
leukocyte count
lymphocyte count
atypical hyperplasia of the breast
neutrophil count
platelet count
viral load
microbial sensitivity test
bacterial typing procedure
ambulatory surgical center
immunoelectrophoresis
attorney
benign breast phyllodes tumor
biomedical engineer
real time pcr
blood bank
bloodmobile
cardiac catheterization laboratory
free - standing cardiac catheterization laboratory
chemotherapy center
company representative
breast duct lavage
benign nipple neoplasm
virtual colonoscopy
meditation therapy
disclosure
recombinant vaccinia - mgp100 vaccine
recombinant human cd4 immunoglobulin
breast apocrine adenosis
product
ingredient
implantation
adjuvant radiation therapy
cranial irradiation
reprocess
breast microglandular adenosis
whole - abdominal irradiation
bone marrow purging
antibiotic prophylaxis
lithotripsy
bowel obstruction management
elective surgical procedure
ambulatory surgical procedure
coronary artery bypass surgery
angioplasty
recombinant glucagon
papillary ductal breast hyperplasia
arteriovenous shunt procedure
embolectomy
endarterectomy
thrombectomy
brain lobectomy
enterostomy
gastrostomy
arthrodesis
orthopedic stabilization
amniocentesis
intraductal breast papillomatosis
pericardiocentesis
lefty1 wt allele
nrtn wt allele
gdf15 wt allele
tgfb1 wt allele
tgfb2 wt allele
tgfb3 wt allele
vegfa wt allele
vegfc wt allele
ccn4 wt allele
cd3d wt allele
cd3e wt allele
cd3g wt allele
cd247 wt allele
pigu wt allele
cgb3 wt allele
cox6c wt allele
eef1b1 wt allele
eef1b2 wt allele
eef1d wt allele
eef1g wt allele
fnta wt allele
fntb wt allele
gclc wt allele
gclm wt allele
gucy1a2 wt allele
gucy1a1 wt allele
gucy1b2 wt allele
gucy1b1 wt allele
breast fibrocystic change ,  proliferative type without atypia
hif1a wt allele
ifitm1 wt allele
il12a wt allele
il12b wt allele
il12rb1 wt allele
il12rb2 wt allele
inha wt allele
inhba wt allele
inhbb wt allele
pggt1b wt allele
breast sclerosing adenosis
prim1 wt allele
prim2 wt allele
smarcc1 wt allele
smarcc2 wt allele
smarcd1 wt allele
smarce1 wt allele
snrpf wt allele
amph wt allele
adgrb2 wt allele
adgrb3 wt allele
papillary breast neoplasm
brca1 wt allele
brca2 wt allele
cul1 wt allele
cul2 wt allele
cul3 wt allele
cul4a wt allele
cul5 wt allele
dab2 wt allele
dhx16 wt allele
dek wt allele
dlc1 wt allele
dock1 wt allele
ezh2 wt allele
gh1 wt allele
hmga1 wt allele
hmga2 wt allele
hmgb1 wt allele
hmgb2 wt allele
hmgb3 wt allele
hmgn1 wt allele
hmgn2 wt allele
hmgn3 wt allele
hmgn4 wt allele
ing1 wt allele
mc1r wt allele
mgmt wt allele
ndrg1 wt allele
notation
neurl1 wt allele
big - o notation
vascular breast neoplasm
nme1 wt allele
rsf1 wt allele
tspy1 wt allele
numa1 wt allele
phb wt allele
metadata
plg wt allele
ppp3r1 wt allele
ppp2r3b wt allele
psca wt allele
therapeutic glucocorticoid
breast capillary hemangioma
psmd10 wt allele
plaat4 wt allele
rb1 wt allele
rtn4 wt allele
safb wt allele
snai2 wt allele
st13 wt allele
cish wt allele
smarca1 wt allele
smarca2 wt allele
breast epithelioid hemangioma
hltf wt allele
smarca4 wt allele
smarca5 wt allele
smarcb1 wt allele
smarcd2 wt allele
smarcd3 wt allele
tff1 wt allele
thbs1 wt allele
thbs2 wt allele
timp1 wt allele
nipple neoplasm
timp2 wt allele
timp3 wt allele
tnc wt allele
id2 wt allele
prdm4 wt allele
ascl1 wt allele
elf3 wt allele
ep300 wt allele
fhl2 wt allele
irf1 wt allele
malignant nipple neoplasm
irf2 wt allele
irf3 wt allele
irf4 wt allele
mycnos wt allele
nrip1 wt allele
ncoa1 wt allele
ncoa2 wt allele
ncoa3 wt allele
ncoa4 wt allele
tcl1b wt allele
breast adenocarcinoma
tpd52 wt allele
tpd52l1 wt allele
ncoa5 wt allele
ncoa6 wt allele
nr4a1 wt allele
pax3 wt allele
pax5 wt allele
pax7 wt allele
sub1 wt allele
med1 wt allele
complex ovarian cyst
psip1 wt allele
stat1 wt allele
stat2 wt allele
stat3 wt allele
stat4 wt allele
stat5a wt allele
stat5b wt allele
stat6 wt allele
snw1 wt allele
oncotype dx breast cancer assay
functional ovarian cyst
epha3 wt allele
epha4 wt allele
epha8 wt allele
ephb1 wt allele
ephb2 wt allele
ephb3 wt allele
erbb2 wt allele
erbb4 wt allele
fgfr4 wt allele
flt1 wt allele
insr wt allele
insrr wt allele
kdr wt allele
ltk wt allele
broccoli sprout extract
mertk wt allele
mst1r wt allele
musk wt allele
ntrk1 wt allele
unilocular ovarian cyst
18f - fluoromisonidazole
oxitriptan
cdk1 / 2 / 4 inhibitor ag - 024322
romiplostim
atiprimod
alpha v beta 1 inhibitor atn - 161
basiliximab
figitumumab
etoricoxib
ntrk2 wt allele
benign ovarian thecoma
gm - k562 cell vaccine
goldenrod
ex vivo - expanded her2 - specific t cells
levonorgestrel - releasing intrauterine system
menatetrenone
mek inhibitor pd0325901
carfilzomib
anamorelin
ropivacaine hydrochloride
ksp inhibitor sb - 743921
glutamine
stage ia ovarian cancer ajcc v6 and v7
cabozantinib
ntrk3 wt allele
pdgfra wt allele
pdgfrb wt allele
ret wt allele
ror1 wt allele
med14 wt allele
med23 wt allele
med24 wt allele
med17 wt allele
stage ib ovarian cancer ajcc v6 and v7
med26 wt allele
med27 wt allele
med7 wt allele
wwtr1 wt allele
tfap2b wt allele
trrap wt allele
ror2 wt allele
ctbp1 wt allele
ros1 wt allele
ctbp2 wt allele
stage ic ovarian cancer ajcc v6 and v7
syk wt allele
daxx wt allele
tek wt allele
dtx1 wt allele
tie1 wt allele
tyro3 wt allele
erf wt allele
mxd1 wt allele
mxi1 wt allele
ncor1 wt allele
stage iia ovarian cancer ajcc v6 and v7
ncor2 wt allele
zap70 wt allele
tacstd2 wt allele
tfr2 wt allele
tfrc wt allele
tlr1 wt allele
pawr wt allele
tlr2 wt allele
tlr3 wt allele
prdm1 wt allele
stage iib ovarian cancer ajcc v6 and v7
skil wt allele
tlr4 wt allele
zbtb7a wt allele
preservation
tlr5 wt allele
tlr6 wt allele
zbtb16 wt allele
surrounding
tlr7 wt allele
tlr8 wt allele
stage iic ovarian cancer ajcc v6 and v7
tsg101 wt allele
vdr wt allele
tyrp1 wt allele
fix
trim27 wt allele
ubb wt allele
s100a11 wt allele
ubc wt allele
s100a12 wt allele
vkorc1 wt allele
borderline ovarian serous tumor
s100a2 wt allele
was wt allele
s100a8 wt allele
s100a9 wt allele
invoker
s100p wt allele
shbg wt allele
sem1 wt allele
spo11 wt allele
tf wt allele
tp53 wt allele
tp53bp2 wt allele
abcb1 wt allele
abcb6 wt allele
abcc1 wt allele
abcg2 wt allele
appbp2 wt allele
cetp wt allele
gc wt allele
ovarian cystadenocarcinoma
igfbp1 wt allele
igfbp2 wt allele
igfbp3 wt allele
igfbp4 wt allele
dbf4 wt allele
igfbp5 wt allele
igfbp6 wt allele
cdc45 wt allele
nup214 wt allele
nup98 wt allele
ovarian carcinoid tumor
slc43a1 wt allele
cdc7 wt allele
slc22a18 wt allele
slc25a4 wt allele
cdc6 wt allele
slc25a5 wt allele
cdt1 wt allele
slc25a6 wt allele
slc2a1 wt allele
mcm2 wt allele
glutathione
mcm3 wt allele
mcm4 wt allele
mcm5 wt allele
slc5a5 wt allele
tap1 wt allele
mcm6 wt allele
tap2 wt allele
rspo3 wt allele
mcm7 wt allele
mcm10 wt allele
ovarian leydig cell tumor
trip10 wt allele
orc1 wt allele
tsc1 wt allele
orc2 wt allele
orc3 wt allele
orc4 wt allele
orc5 wt allele
orc6 wt allele
cyp11a1 wt allele
cyp11b1 wt allele
ovarian angiosarcoma
cyp11b2 wt allele
cyp17a1 wt allele
cyp19a1 wt allele
cyp1a1 wt allele
obsolete procedure_has_target_anatomy
procedure_may_have_target_anatomy
procedure_may_have_imaged_anatomy
obsolete procedure_has_imaged_anatomy
obsolete procedure_has_excised_anatomy
obsolete procedure_may_have_excised_anatomy
ovarian fibrosarcoma
obsolete procedure_may_have_partially_excised_anatomy
obsolete procedure_has_partially_excised_anatomy
obsolete procedure_may_have_completely_excised_anatomy
obsolete procedure_has_completely_excised_anatomy
tyrobp wt allele
vcl wt allele
zfp36l2 wt allele
trim25 wt allele
zbtb17 wt allele
ovarian leiomyosarcoma
znf217 wt allele
hla - drb1 wt allele
hla - dpb1 wt allele
cpne7 wt allele
mfge8 wt allele
neo1 wt allele
emp1 wt allele
evi2b wt allele
gypa wt allele
obtain
ovarian myxoid liposarcoma
cyp1a2 wt allele
cyp21a2 wt allele
great vessel perforation
cyp27b1 wt allele
radiation underdose
cyp2a6 wt allele
cyp2b6 wt allele
cyp2c18 wt allele
cyp2c19 wt allele
cyp2c8 wt allele
ovarian rhabdomyosarcoma
cyp2c9 wt allele
cyp2d6 wt allele
cyp2e1 wt allele
cyp3a4 wt allele
cyp3a5 wt allele
cyp3a7 wt allele
cyp7a1 wt allele
cyp8b1 wt allele
sh2b2 wt allele
bcar1 wt allele
ovarian neuroendocrine neoplasm
jtb wt allele
pdzk1ip1 wt allele
bin1 wt allele
tspan32 wt allele
blnk wt allele
ptk7 wt allele
sectm1 wt allele
cd19 wt allele
sspn wt allele
fadd wt allele
ovarian large cell neuroendocrine carcinoma
stim1 wt allele
frs2 wt allele
tm4sf1 wt allele
frs3 wt allele
grp wt allele
kng1 wt allele
gab2 wt allele
grap wt allele
npy wt allele
tac1 wt allele
agt wt allele
grb10 wt allele
avp wt allele
grb14 wt allele
calca wt allele
grb2 wt allele
grb7 wt allele
irs1 wt allele
irs2 wt allele
angpt1 wt allele
glycine
ovarian transitional cell carcinoma
irs4 wt allele
angpt2 wt allele
lcp2 wt allele
chga wt allele
smad7 wt allele
chgb wt allele
zfyve9 wt allele
scg2 wt allele
nck2 wt allele
crh wt allele
mixed germ cell - sex cord - stromal tumor
pag1 wt allele
edn1 wt allele
edn2 wt allele
skap2 wt allele
gcg wt allele
sh2b1 wt allele
ghrh wt allele
sh2d3a wt allele
gnrh1 wt allele
gnrh2 wt allele
ovarian mucinous tumor
ins wt allele
insl4 wt allele
nmu wt allele
oxt wt allele
pomc wt allele
prl wt allele
pth wt allele
sh2d3c wt allele
sst wt allele
shc1 wt allele
ovarian mucinous adenocarcinoma
stc1 wt allele
stc2 wt allele
trh wt allele
vip wt allele
shc3 wt allele
shc2 wt allele
cspg4 wt allele
smc3 wt allele
abi1 wt allele
krt19 wt allele
ovarian soft tissue neoplasm
tollip wt allele
lmnb1 wt allele
vim wt allele
tradd wt allele
actg2 wt allele
traf2 wt allele
gas2 wt allele
traf6 wt allele
myh11 wt allele
tubg1 wt allele
ovarian myxoma
tubg2 wt allele
ywhaq wt allele
col18a1 wt allele
col1a1 wt allele
akap12 wt allele
akap13 wt allele
akap9 wt allele
stambp wt allele
apc wt allele
apc2 wt allele
arhgef1 wt allele
arhgef5 wt allele
arrb1 wt allele
axin1 wt allele
axin2 wt allele
bag1 wt allele
bag4 wt allele
bag5 wt allele
adgrb1 wt allele
synonym
gastric cardia adenocarcinoma
nomenclature committee of the international union of biochemistry and molecular biology
catalysis
biological modulation
assembly
disassembly
metaclass
ionic strength
unification
gastric mucinous adenocarcinoma
col1a2 wt allele
col4a3 wt allele
col4a6 wt allele
emilin1 wt allele
fn1 wt allele
nid1 wt allele
h2ax wt allele
npm1 wt allele
tg wt allele
tep1 wt allele
bcl9 wt allele
terc wt allele
brd2 wt allele
terf1 wt allele
terf2 wt allele
stap1 wt allele
cav1 wt allele
tert wt allele
cav2 wt allele
tnks wt allele
glycophorin - a
gastric signet ring cell adenocarcinoma
lyst wt allele
cbl wt allele
erbin wt allele
srp19 wt allele
aff4 wt allele
krit1 wt allele
ahr wt allele
gtf2a1l wt allele
arnt2 wt allele
arnt wt allele
gastric burkitt lymphoma
chuk wt allele
atf2 wt allele
ctnnb1 wt allele
btaf1 wt allele
tbp wt allele
dok1 wt allele
eps15 wt allele
bcl3 wt allele
eps8 wt allele
bcl6 wt allele
rhoa wt allele
bmi1 wt allele
runx1t1 wt allele
cbfb wt allele
rhob wt allele
cebpa wt allele
rhoc wt allele
cebpe wt allele
foxn3 wt allele
creb1 wt allele
gastric diffuse large b - cell lymphoma
creb3 wt allele
creb3l4 wt allele
rhoh wt allele
creb5 wt allele
crebbp wt allele
diras3 wt allele
crebl2 wt allele
crk wt allele
e2f1 wt allele
ehf wt allele
gastric t - cell non - hodgkin lymphoma
elk1 wt allele
elk3 wt allele
rala wt allele
gtf2a1 wt allele
ralb wt allele
hras wt allele
kras wt allele
rab8a wt allele
mras wt allele
nras wt allele
rangap1 wt allele
bulbourethral gland secretion
parasympathetic ganglion
submandibular ganglion
labium
immature gastric teratoma
gluteus maximus
standard transformed entropy change
standard transformed enthalpy change
k prime
computer hardware
conversion
standard gibbs free energy change
control interaction
acid etching
caries removal
class i restoration
dental recall
direct pulp cap
endodontic treatment
indirect pulp cap
microetching
remineralization
self - etching bonding system
gastric lipoma
allocation
graduation
referral
amalgam
porcelain veneer
resin modified glass ionomer liner
resin - based composite
sealant
antibacterial agent
buccal surface
gastric teratoma
mesial surface
occlusal surface
business day
caries
carious dentin
pulpitis
gtf2a2 wt allele
taf10 wt allele
taf11 wt allele
taf12 wt allele
enoxolone
mature gastric teratoma
taf13 wt allele
rrad wt allele
taf1 wt allele
taf2 wt allele
taf3 wt allele
taf4 wt allele
taf5 wt allele
rap1a wt allele
taf6 wt allele
taf7 wt allele
taf7l wt allele
taf8 wt allele
rasd1 wt allele
taf9 wt allele
rraga wt allele
tbpl1 wt allele
gtf2e1 wt allele
gtf2e2 wt allele
gtf2f1 wt allele
gtf2f2 wt allele
gtf2h1 wt allele
rras2 wt allele
rasl10a wt allele
bdp1 wt allele
sipa1 wt allele
brf1 wt allele
brf2 wt allele
gtf3c1 wt allele
gtf3c2 wt allele
gadd45a wt allele
gtf3c3 wt allele
gtf3c4 wt allele
gtf3c5 wt allele
git1 wt allele
git2 wt allele
gps1 wt allele
gps2 wt allele
gna12 wt allele
gnai1 wt allele
gnai2 wt allele
bronchial mucosa - associated lymphoid tissue lymphoma
comprehensive care
emergency care
connectivity
ownership
patient base
gnai3 wt allele
patient load
program
crack
dental license
thyroid gland lymphoma
gnaq wt allele
dental operatory
dental school
dental specialty
dentist
electronic billing system
gnas wt allele
electronic health record system
full time employment
therapeutic vasoactive intestinal peptide
gastric mucosa - associated lymphoid tissue lymphoma
geriatric
meeting
gnaz wt allele
office manager
practitioners engaged in applied research and learning network
gnb1 wt allele
posterior tooth
tooth 30
intervention required
vital tooth
falx cerebri meningioma
pulp horn
practice - based research network
gnb2 wt allele
professional practice
gnb3 wt allele
hgs wt allele
hpca wt allele
ifna13 wt allele
legal adult
cavernous sinus meningioma
prostate cancer pnx tnm finding v6 and v7
prostate cancer pmx tnm finding v6
prostate cancer pm0 tnm finding
inferior vesical artery
superior vesical artery
anterior facial vein
medial circumflex femoral vein
dorsal metatarsal vein
intracerebral cystic meningioma
inferior pancreatico - duodenal vein
left renal vein
right renal vein
left spermatic vein
right spermatic vein
deep temporal vein
therapeutic gonadotropin
cerebellar papillary meningioma
superficial temporal vein
dorsal foot interosseous muscle
plantar foot interosseus muscle
dorsal hand interosseous muscle
palmar hand interosseus muscle
intrinsic tongue muscle transverse component
tongue muscle
intrinsic tongue muscle vertical component
enteric ganglion
petrous apex meningioma
anterior olfactory nucleus
arcuate nucleus
auditory cortex
cingulate cortex
cortical bone
costal arch
cuneate nucleus
eyelid skin
foot digit skin
skull base meningioma
hand digit skin
inferior hypogastric nerve plexus
long bone epiphysis
metaphysis
medial palpebral ligament
oval subthalamic nucleus
prostate gland lobe
rib head
rib shaft
rib tubercle
intraventricular meningioma
sternal manubrium
ventral thalamus
accumbens nucleus
sural artery
superior suprarenal artery
inferior suprarenal artery
right spermatic artery
left spermatic artery
metastatic meningioma
right renal artery
left renal artery
superior pancreatico - duodenal artery
plantar metatarsal artery
common palmar digital artery
palatine bone
internal carotid nerve plexus
submucous nerve plexus
myenteric nerve plexus
leg skin
multiple intraspinal meningiomas
foot skin
ankle skin
wrist skin
hand skin
arm skin
elbow skin
neck skin
head skin
abdominal skin
rib 9
primary lung meningioma
rib 8
rib 7
rib 6
rib 5
rib 4
rib 3
rib 2
rib 12
rib 11
rib 10
primary cutaneous meningioma
rib 1
hand phalanx
foot phalanx
hand digit 5 phalanx
hand digit 4 phalanx
hand digit 3 phalanx
hand digit 2 phalanx
hand digit 1 phalanx
foot digit 1 phalanx
foot digit 2 phalanx
petroclival meningioma
foot digit 3 phalanx
foot digit 4 phalanx
foot digit 5 phalanx
distal phalanx of foot
distal phalanx of hand
proximal phalanx of foot
proximal phalanx of hand
metatarsal bone digit 5
metatarsal bone digit 4
metatarsal bone digit 3
multiple skull base meningiomas
metatarsal bone digit 2
metatarsal bone digit 1
metacarpal bone digit 5
metacarpal bone digit 4
metacarpal bone digit 3
metacarpal bone digit 2
metacarpal bone digit 1
ifna2 wt allele
ifng wt allele
talus
recombinant human chorionic gonadotropin
foramen magnum meningioma
orbitalis muscle
ifnw1 wt allele
levator palpebrae superioris
eyelid muscle
il6st wt allele
lumbosacral plexus
ilk wt allele
ulnar nerve
irak3 wt allele
tibial nerve
anterior foramen magnum meningioma
sciatic nerve
irak4 wt allele
radial nerve
phrenic nerve
peroneal nerve
median nerve
femoral nerve
axillary nerve
rapgefl1 wt allele
smad2 wt allele
posterior foramen magnum meningioma
smad3 wt allele
smad4 wt allele
smad6 wt allele
map2k1 wt allele
map3k14 wt allele
tab1 wt allele
map4k4 wt allele
thoracic sympathetic nerve trunk
lumbar sympathetic nerve trunk
thoracic ganglion
diaphragma sellae meningioma
celiac ganglion
hypogastric nerve plexus
cardiac nerve plexus
hand digit 1
hand digit 2
hand digit 3
hand digit 4
hand digit 5
foot digit 1
tuberculum sellae meningioma
foot digit 2
foot digit 3
foot digit 4
foot digit 5
adrenal artery
cerebellar artery
celiac artery
buccal artery
alveolar artery
auricular artery
sphenoorbital meningioma
cervical artery
communicating artery
ductus arteriosus
ethmoidal artery
frontal artery
gastroepiploic artery
iliolumbar artery
anterior cranial fossa meningioma
epigastric artery
inferior epigastric artery
circumflex iliac artery
superficial circumflex iliac artery
erg wt allele
ets1 wt allele
ets2 wt allele
etv1 wt allele
etv3 wt allele
spinal multifocal clear cell meningioma
etv4 wt allele
etv6 wt allele
mapk1 wt allele
fli1 wt allele
spi1 wt allele
mapk3 wt allele
mecom wt allele
foxc2 wt allele
mapk8 wt allele
mcf2 wt allele
lower clivus meningioma
mfng wt allele
mknk1 wt allele
nf1 wt allele
nf2 wt allele
nfkbia wt allele
nfkbib wt allele
orbicularis oculi muscle
fos wt allele
abductor pollicis longus
fosb wt allele
clivus meningioma
anterior abdominal wall muscle
fosl1 wt allele
fosl2 wt allele
nfkbie wt allele
constrictor vulvae
foxg1 wt allele
gossypol
upper clivus meningioma
bex3 wt allele
cutaneous trunci
erector spinae
pdc wt allele
foxo1 wt allele
pias3 wt allele
pten wt allele
foxo3 wt allele
gata1 wt allele
ralgds wt allele
radiation - induced intracranial meningioma
rapgef1 wt allele
extensor carpi radialis brevis
rasgrf1 wt allele
extensor carpi radialis longus
extensor carpi ulnaris
rasgrf2 wt allele
extensor digitorum communis
extensor digitorum longus
rgs19 wt allele
frontal convexity meningioma
gfi1b wt allele
flexor digitorum longus
rgs1 wt allele
flexor digitorum profundus
gli2 wt allele
flexor hallucis longus
rgs2 wt allele
gli3 wt allele
genioglossus
rgs3 wt allele
jugular foramen meningioma
geniohyoid
gli1 wt allele
sema3e wt allele
gluteus medius
zbtb48 wt allele
gracilis
sfrp4 wt allele
shh wt allele
inferior rectal artery
dennd2b wt allele
deletion of the short arm of chromosome 1  ( 1p )  associated meningioma
infraorbital artery
internal mammary artery
tiam1 wt allele
traf4 wt allele
trat1 wt allele
ischiocavernosus
labial artery
lacrimal artery
trio wt allele
brain stem intraparenchymal clear cell meningioma
lateral thoracic artery
tsc2 wt allele
unc13b wt allele
gtf2b wt allele
longus capitis
vav1 wt allele
cdx2 wt allele
longus colli
cervical intraspinal meningioma
vav2 wt allele
lingual artery
mylohyoid muscle
gsc wt allele
vav3 wt allele
medial circumflex artery
ccn5 wt allele
tlx1 wt allele
medial plantar artery
medial tarsal artery
thoracic intraspinal meningioma
median artery
omohyoid muscle
mental artery
ccn6 wt allele
mesenteric artery
wnt10a wt allele
pectineus
wnt10b wt allele
lumbar intraspinal meningioma
dorsal metacarpal artery
middle colic artery
wnt11 wt allele
dorsal nasal artery
wnt9a wt allele
scalenus dorsalis
scalenus medius
semimembranosus muscle
wnt1 wt allele
semispinalis capitis
sacral intraspinal meningioma
wnt2 wt allele
semispinalis cervicis
pancreatico - duodenal artery
wnt2b wt allele
perineal artery
hoxa10 wt allele
wnt3 wt allele
retinal artery
hoxa9 wt allele
wnt4 wt allele
recombinant growth factor
cerebellopontine angle meningioma
subcostal artery
hoxc6 wt allele
sublingual artery
wnt5a wt allele
wnt6 wt allele
superficial cervical artery
semispinalis thoracis
wnt7a wt allele
hereditary meningioma
lhx1 wt allele
lhx2 wt allele
msx1 wt allele
nkx2 - 8 wt allele
thoracodorsal artery
nkx3 - 1 wt allele
lateral ventricle meningioma
thyroid artery
superior thyroid artery
inferior thyroid artery
thyroid ima artery
jun wt allele
transverse facial artery
junb wt allele
anterior auricular vein
jund wt allele
azygos vein
primary parapharyngeal meningioma
aff3 wt allele
bronchial vein
cerebellar vein
lmo2 wt allele
maf wt allele
mafg wt allele
max wt allele
cerebral vein
spinalis thoracis
adductor group of the leg
bilateral optic nerve meningioma
cutaneous vein
hamstring
digital vein
sternohyoid muscle
epigastric vein
ileal vein
ileocolic vein
iliolumbar vein
inferior palpebral vein
deletion of chromosome 22 associated meningioma
spermatic vein
masseteric vein
masseteric artery
type of event
product problem
mesenteric vein
obturator vein
ophthalmic plexus
ovarian vein
pancreatic vein
deletion of chromosome 3p associated meningioma
pancreatico - duodenal vein
pericardiacophrenic vein
phrenic vein
retinal vein
med6 wt allele
men1 wt allele
kmt2a wt allele
mllt1 wt allele
aff1 wt allele
internal auditory canal meningioma
sternothyroid muscle
styloglossus muscle
tensor fasciae lata
vastus lateralis
soleus
tibialis muscle
mllt3 wt allele
tibialis cranialis
ectopic meningioma
mllt6 wt allele
foxo4 wt allele
myb wt allele
mybl1 wt allele
mybl2 wt allele
mycl wt allele
myc wt allele
recurring adverse event
mycn wt allele
nbl1 wt allele
ethmoid sinus primary ectopic meningioma
nfic wt allele
persistent adverse event
nfia wt allele
nfib wt allele
supt5h wt allele
nfix wt allele
supt6h wt allele
nfkb2 wt allele
tal1 wt allele
guanazole
epidural spinal canal meningioma
tal2 wt allele
dr1 wt allele
pml wt allele
drap1 wt allele
tcf3 wt allele
tcf7l2 wt allele
pou2f1 wt allele
tfap2a wt allele
tfap2c wt allele
tfdp2 wt allele
pituitary stalk meningioma
tfe3 wt allele
thra wt allele
pou2f2 wt allele
thrb wt allele
rel wt allele
twist1 wt allele
rela wt allele
usf1 wt allele
runx1 wt allele
usf2 wt allele
recurrent meningioma
vhl wt allele
subcostal vein
wt1 wt allele
right subcostal vein
smyd3 wt allele
left subcostal vein
eef1a1 wt allele
sp1 wt allele
submental vein
suprarenal vein
sphenocavernous meningioma
eef1a2 wt allele
right suprarenal vein
supt3h wt allele
eef2 wt allele
eif2b1 wt allele
eif2b2 wt allele
eif2b4 wt allele
codeine sulfate
left suprarenal vein
eif2b5 wt allele
temporal vein
eif3e wt allele
thoracic vein
thymic vein
eif4e2 wt allele
vertebral vein
popliteal lymph node
biceps femoris
rnr1 wt allele
brachialis
breast cyst
buccinator
coracobrachialis
depressor labii inferioris
rpl10 wt allele
rpl13 wt allele
flexor carpi radialis
flexor carpi ulnaris
rpl19 wt allele
rpl29 wt allele
rpl7a wt allele
borderline breast phyllodes tumor
rpl8 wt allele
hyoglossus muscle
rps19 wt allele
rps27 wt allele
levator labii superioris
rps3 wt allele
longissimus capitis
longissimus cervicis
eif1 wt allele
longissimus thoracis
meningeal melanoma
palatoglossus muscle
peroneus longus
foot interosseous muscle
hand interosseous muscle
pronator teres muscle
rectus femoris
semitendinosus
splenius muscle group
thyrohyoid muscle
transversus abdominis muscle
childhood meningeal melanoma
transversus thoracis
triceps surae muscle
zygomaticus major muscle
zygomaticus minor muscle
adult meningeal melanoma
random sampling
guanine
peripheral intraneural angiosarcoma
birth cohort
statistical distribution
discrete distribution
binomial distribution
negative binomial distribution
microcystic / reticular schwannoma
multinomial distribution
geometric distribution
poisson distribution
continuous distribution
uniform distribution
normal distribution
univariate normal distribution
bivariate normal distribution
multivariate normal distribution
cauchy distribution
central nervous system anaplastic large cell lymphoma
t - distribution
f - distribution
exponential distribution
gamma distribution
log normal distribution
chi - square distribution
beta distribution
statistical test
non - parametric test
jugular foramen schwannoma
parametric test
t - test
f - test
chi - square test
regression method
parametric regression method
non - parametric regression method
spinal paraganglioma
analysis of variance
interquartile range
wilcoxon signed rank test
mann - whitney test
kruskal - wallis test
intestinal gangliocytic paraganglioma
komogorov - smirnov test
adverse event characteristics
seriousness of adverse event
severity of adverse event
microcalcification present in neoplastic tissue
adverse event attribution category
unrelated to intervention
unlikely related to intervention
possibly related to intervention
probably related to intervention
intra - abdominal paraganglioma
definitely related to intervention
unlikely adverse event attribution to product or procedure
domestic partnership
other personal medical history
type of device
platelet count 20000
platelet count 50000
recipient
no information available
head and neck paraganglioma
neutrophil count 500
neutrophil count 1000
operator of medical device
service personnel
device unattended
skin of the extremity
incentive
centralization
continue
extra - adrenal retroperitoneal paraganglioma
early favorable non - hodgkin lymphoma
faculty
early unfavorable non - hodgkin lymphoma
advanced favorable non - hodgkin lymphoma
advanced unfavorable non - hodgkin lymphoma
decision
next
health care professional
temporary
other health care professional
familial paraganglioma
muc - 1 peptide vaccine
activity of daily living
marketing
dental hygienist
pharmaceutical strength
epidermal hyperplasia
maintenance
holder
guanosine
distraction
cryoprotective agent
cross - sectional study
retrospective study
cavernous lymphangioma
mean
dispersion
standard deviation
standard error
confidence interval
confidence limit
box plot
statistical estimation
point estimation
maximum likelihood estimation
average education level
percent below poverty
esophageal leiomyosarcoma
percent foreign born
percent non - english speakers
birth rate
small intestinal sarcoma
age - adjusted incidence rate
annual percent change
small intestinal fibrosarcoma
age - adjusted mortality rate
small intestinal hodgkin lymphoma
duodenal villous adenoma
small intestinal lipoma
blood vessel endothelium
cytokine - based biologic agent irx - 2
brivanib alaninate
dacomitinib
adh - 1
cyclic gmp
small intestinal adenoma
bemiparin sodium
elacytarabine
dynamic optical breast imaging
unified code for units of measure
citrulline
iodine i - 124 girentuximab
alfuzosin hydrochloride
yttrium y - 90 - dota - girentuximab
esophageal sarcoma
g250 peptide vaccine
recombinant interferon alfa - 1b
rose bengal solution pv - 10
composition
emergency medical technician
medical technologist
nuclear medicine technologist
esophageal adenoid cystic carcinoma
paramedic
phlebotomist
physical therapist
physician assistant
radiologic technologist
respiratory therapist
collection facilitator
other caregiver
dental assistant
home health aid
esophageal mucoepidermoid carcinoma
medical assistant
nursing assistant
patient family member or friend
hospital service technician
diindolylmethane
vascular endothelial growth factor antisense oligonucleotide
saponin - cholesterol - phospholipid adjuvant
lanreotide acetate copolymer microparticles
tray
dysautonomia
esophageal squamous cell papilloma
caseinate protein isolate
service and testing personnel
medical equipment company technician or representative
autologous epstein - barr virus - transformed b - lymphoblastoid cell vaccine
physicist
octreotide acetate
risk manager
device available for evaluation
telangiectatic glomangioma
medical product characteristics
restriction
orthomyxoviridae
influenza a virus
solitary osteochondroma
multiple osteochondromas
sign
chondroma
endocardial neoplasm
reported by
travel
arrival
departure
rapid antigen test
medullary bone
direct fluorescent antibody test
influenza b virus
influenzavirus
epicardial neoplasm
pending
isolate
poultry
butcher
great vessel neoplasm
influenza
trial summary domain
systematized nomenclature of medicine
myocardial neoplasm
mesenchymal chondrosarcoma of bone
non - neoplastic anal disorder
bead dosing unit
avian influenza a virus
non - neoplastic esophageal disorder
block dosing unit
film dosing unit
guanosine diphosphate
hereditary glomangioma
non - neoplastic intestinal disorder
non - neoplastic stomach disorder
sponge dosing unit
stick dosing unit
swab dosing unit
non - neoplastic pancreatic disorder
esophageal varices
alt_definition
alt_long_definition
metastatic jugulotympanic paraganglioma
intensive care unit
emergency room
operating room
benign orbit hemangiopericytoma
dysfunction
urgent care center
non - neoplastic disorder
breast hemangioma
long - term care facility
hospice
nursing home
non - neoplastic vision disorder
rehabilitation center
psychiatric facility
radiation - related non - neoplastic disorder
skin vascular neoplasm
outdoors
park
rare non - neoplastic disorder
public building
intravascular angioleiomyoma
non - neoplastic liver and intrahepatic bile duct disorder
laboratory or pathology department
breast carcinoma by gene expression profile
luminal a breast carcinoma
luminal b breast carcinoma
her2 positive breast carcinoma
normal breast - like subtype of breast carcinoma
basal - like breast carcinoma
definitely better
uterine corpus intravenous leiomyomatosis
possibly better
possibly worse
definitely worse
single - use device reprocessed and reused on patient
consumer
benign cardiac germ cell tumor
follow - up report
cardiac schwannoma
hirudotherapy
cellular myxoma
cardiac neurofibroma
reason for non - evaluation
pleomorphic hyalinizing angiectatic tumor of soft parts
ectopic hamartomatous thymoma
guanosine triphosphate
cardiac granular cell tumor
device labeled for single use
remedial action
modification or adjustment
patient monitoring
recall
cardiac fibrosarcoma
replacement
repair
initial usage
device reuse
reprocessor
importer
corrective action number
cardiac epithelioid hemangioendothelioma
deoxycytidylate deaminase
pml / rara fusion protein
pax3 / foxo1 fusion protein
integrin alphav / beta5
report receiver
cardiac kaposi sarcoma
concomitant therapy
laryngopharynx
minimantle radiation field
inverted y radiation field
pdq_open_trial_search_id
pdq_closed_trial_search_id
common security module
cardiac leiomyosarcoma
device usage
cytomegaloviral infection
malignant cardiac hemangiopericytoma
dctd gene
dctd wt allele
acute coronary syndrome
alcoholic cardiomyopathy
idiopathic cardiomyopathy
glucose metabolism disorder
bacterial conjunctivitis
fungal endophthalmitis
2q31 - q32
4q35 .1
itgav gene
mastitis
itgav wt allele
cs term type
nni project component areas
cardiac malignant peripheral nerve sheath tumor
fundamental nanoscale phenomena and processes
nanomaterials
nanoscale devices and systems
instrumentation research ,  metrology ,  and standards for nanotechnology
nanomanufacturing
major research facilities and instrumentation acquisition
societal dimensions
intimal sarcoma
heart lymphoma
benign connective and soft tissue neoplasm
arthro - 7
atypical choroid plexus papilloma
playground
secondary heart lymphoma
has_target
veterinary patient
breed
dog breed
terrier breed
herding breed
working breed
haloperidol
cardiac myeloid sarcoma
non - sporting breed
sporting breed
hound breed
toy breed
secondary osteosarcoma
3q21 .2
radiation - related osteosarcoma
bone osteosarcoma
malignant cardiac germ cell tumor
airedale terrier
australian terrier
bedlington terrier
border terrier
cairn terrier
dandie dinmont terrier
smooth fox terrier
wire fox terrier
irish terrier
inferior vena cava leiomyosarcoma
russell terrier
jack russell terrier ,  smooth
jack russell terrier ,  wire
kerry blue terrier
lakeland terrier
standard manchester terrier
norfolk terrier
norwich terrier
miniature schnauzer
scottish terrier
pulmonary artery leiomyosarcoma
sealyham terrier
skye terrier
soft coated wheaten terrier
staffordshire bull terrier
american staffordshire terrier
english staffordshire terrier
bull terrier
miniature bull terrier
welsh terrier
west highland white terrier
pulmonary vein leiomyosarcoma
australian cattle dog
australian shepherd
belgian sheepdog
bearded collie
border collie
collie
rough collie
smooth collie
bouvier des flandres
briard
malignant aortic neoplasm
welsh corgi
cardigan welsh corgi
pembroke welsh corgi
german shepherd dog
puli
old english sheepdog
shetland sheepdog
catahoula leopard dog
belgian malinois
belgian tervuren
aortic angiosarcoma
alaskan malamute
bernese mountain dog
akita
boxer
bullmastiff
newfoundland
great pyrenees
doberman pinscher
great dane
greater swiss mountain dog
malignant inferior vena cava neoplasm
giant schnauzer
kuvasz
standard schnauzer
mastiff
portuguese water dog
rottweiler
saint bernard
samoyed
siberian husky
komondor
superior vena cava angiosarcoma
dogue de bordeaux
adverse event associated with death
malignant superior vena cava neoplasm
malignant pulmonary artery neoplasm
pulmonary artery choriocarcinoma
gastrointestinal perforation ,  ctcae
malignant pulmonary vein neoplasm
recurrent angiosarcoma
american eskimo dog
boston terrier
bulldog
english bulldog
french bulldog
uterine angiosarcoma
chinese shar - pei
chow chow
dalmatian
finnish spitz
keeshond
lhasa apso
bichon frise
lowchen
poodle
miniature poodle
retroperitoneal hemangiopericytoma
standard poodle
toy poodle
schipperke
tibetan spaniel
tibetan terrier
shiba inu
karelian bear dog
german shorthaired pointer
german wirehaired pointer
chesapeake bay retriever
leiomyosarcoma of vessels
curly - coated retriever
flat - coated retriever
golden retriever
labrador retriever
wirehaired pointing griffon
english setter
gordon setter
irish setter
sussex spaniel
brittany
renal vein leiomyosarcoma
american water spaniel
clumber spaniel
cocker spaniel
american cocker spaniel
english cocker spaniel
field spaniel
springer spaniel
welsh springer spaniel
english springer spaniel
irish water spaniel
benign atrial neoplasm
vizsla
weimaraner
spinone italiano
english pointer
billy
basset hound
beagle
bloodhound
dachshund
heparin
atrial paraganglioma
long haired mini dachshund
long haired standard dachshund
smooth haired mini dachshund
smooth haired standard dachshund
wire haired mini dachshund
wire haired standard dachshund
norwegian elkhound
harrier
otterhound
petit basset griffon vendeen
rhodesian ridgeback
afghan hound
basenji
borzoi
greyhound
ibizan hound
irish wolfhound
pharaoh hound
saluki
scottish deerhound
malignant cardiac paraganglioma
whippet
black and tan coonhound
foxhound
english foxhound
american foxhound
brussels griffon
rough coat brussels griffon
smooth coat brussels griffon
cavalier king charles spaniel
parotid gland lymphangioma
long haired chihuahua
smooth chihuahua
japanese chin
affenpinscher
havanese
italian greyhound
maltese
toy manchester terrier
miniature pinscher
papillon
solitary adult fibroma
pekingese
pomeranian
pug
shih tzu
silky terrier
toy fox terrier
yorkshire terrier
chinese crested
hairless chinese crested
powder puff chinese crested
colon cavernous hemangioma
english toy spaniel
mixed breed
miscellaneous breed
osteoblastic osteosarcoma
high grade surface osteosarcoma
itgb5 gene
bone epithelioid hemangioma
itgb5 wt allele
integrin alpha - v
integrin beta - 5
benign fibrous histiocytoma of bone
bone leiomyoma
parotid gland hemangioma
osteofibrous dysplasia
erdheim - chester disease
chest wall chondromesenchymal hamartoma
non - hereditary lesion
poikiloderma
recql4 gene mutation
central nervous system embryonal tumor ,  not otherwise specified
statistical frequency
medulloblastoma with leptomeningeal spread
pushing tumor margin
undifferentiated stromal sarcoma
subassembly device
carbon dioxide monitor device
benign gastrointestinal stromal tumor
malignant gastrointestinal stromal tumor
heparan sulfate
central nervous system embryonal tumor ,  not otherwise specified with leptomeningeal spread
gastrointestinal stromal tumor of uncertain malignant potential
more than 5 mitoses per 50hpf
user interface device
cerebellar vermis medulloblastoma
multiplier device
castrated male
push button switch device
castrated female
valve cam device
significant stabilization
region 17p13 allelic loss associated medulloblastoma
jaw device
knife device
latch device
pusher device
nerve root
mathematical operator
device problem
malignant intracranial germ cell tumor
missing
verbatim
conclusion
reportable event
serious
classic medulloblastoma
anatolian shepherd dog
black russian terrier
canaan dog
nevoid basal cell carcinoma syndrome associated medulloblastoma
german pinscher
glen of imaal terrier
neapolitan mastiff
nova scotia duck tolling retriever
polish lowland sheepdog
retreatment
preexisting condition
cerebellopontine angle
spinal cord embryonal tumor ,  not otherwise specified
hereditary lesion
agent given within 30 days
telecommunication device
prefix
health professional
over the counter product
occur
medulloblastoma with extensive nodularity
awareness
substitution
stability
nonprofit organization
legal
tax
domain name
duns number
boswellia serrata
serenoa repens
zingiber officinale
allium sativum
retro - transcribing virus
timestamp data type
revision
honest broker
ordering physician
central nervous system t - cell non - hodgkin lymphoma
fill
gastric granular cell tumor
cholesterol deposit
malignant central nervous system germ cell tumor
universally unique identifier
topology
parinaud syndrome
private
handle
structured query language
adult central nervous system embryonal tumor ,  not otherwise specified
hit
match
search
clivus chordoma
amino - terminal amino acid
carboxy - terminal amino acid
schiller - duval body
calculation
delta
business organization
bank
cerebellopontine angle schwannoma
controlled foreign corporation
company
corporation
general partnership
joint stock company
limited company
limited liability partnership
limited partnership
partnership
subsidiary
cerebellopontine angle neoplasm
us public institution
homeowners association
mutual
employer
mixture of germ cell neoplastic components present
clinical resource contractor
correctional institute
contract research organization
drug company
guarantor
patient advocacy group
pharmacy distribution center
procurement
probability
retro - orbital region
prediction
isoelectric point
secondary supratentorial anaplastic astrocytoma
echinacea
isotope - coded affinity tag protein analysis
protonation
variable
vector
inverse association
osseous component present
fragment ion
silo
concept attribute
lexical group unique identifier
sedimentation
ann arbor lymphoma staging system
pleural schwannoma
columnar cell lesion of the breast
columnar cell change of the breast
columnar cell change of the breast with atypia
columnar cell hyperplasia of the breast
columnar cell hyperplasia of the breast with atypia
fda national drug code
medi - span generic product identifier
floor of mouth
rectosigmoid region
colorectal region
gliofibroma
initiator
symbol
package
unified modeling language
semantics
microdose
cardiac death
non - sudden cardiac death
cardinality
heterocyclic compound
paraneoplastic subacute sensory neuronopathy
bidirectional
generalization
nicotine dependence
sympathetic schwannoma
pathway
directionality
interaction
odontogenic cyst
postcricoid region
posterior wall of the pharynx
retromolar trigone
lip and oral cavity
limited radiation therapy
thinking
atpase gene
fancm gene
fancm wt allele
14q21 .3
fanconi anemia group m protein
tcf21 gene
tcf21 wt allele
transcription factor 21
nfe2l2 gene
nfe2l2 wt allele
2q31
epidural spinal canal angiolipoma
basaloid squamous cell carcinoma
skin ulcer
skin adenosquamous carcinoma
acantholysis
dome - shaped lesion
nuclear factor erythroid 2 - related factor 2
farsb wt allele
kdsr wt allele
lrrn2 wt allele
antigen gene
clivus chondroid chordoma
xage2 wt allele
yeats4 wt allele
ear carcinoma
gas8 wt allele
avoidance
glipr2 wt allele
emotion
glmn wt allele
dreaming
submitter
retroperitoneal ganglioneuroma
reminder
derealisation
throat
picture
disagreement
numb
bicra wt allele
syntax
microarray and gene expression
nop53 wt allele
linc01565 wt allele
rhinorrhea
head and neck keratinizing squamous cell carcinoma
paranasal sinus keratinizing squamous cell carcinoma
nasal cavity keratinizing squamous cell carcinoma
hpr wt allele
sinonasal non - keratinizing squamous cell carcinoma
kiss1 wt allele
cdc73 wt allele
lgi1 wt allele
mucl1 wt allele
sinonasal tract
sinonasal carcinoma
sinonasal undifferentiated carcinoma
primary intraosseous squamous cell carcinoma
metastasizing ameloblastoma
ameloblastic carcinoma - secondary type  ( dedifferentiated )  ,  intraosseous
ameloblastic carcinoma - secondary type  ( dedifferentiated )  ,  peripheral
2 - ring heterocyclic compound
clear cell odontogenic carcinoma
calcifying epithelial odontogenic tumor
keratocystic odontogenic tumor
primary intraosseous squamous cell carcinoma derived from keratocystic odontogenic tumor
vwa5a wt allele
magea12 wt allele
tumor antigen gene
magea3 wt allele
mcam wt allele
mcc wt allele
lipomatosis of nerve
mcts1 wt allele
mfhas1 wt allele
mgp wt allele
mlana wt allele
kmt2d wt allele
afdn wt allele
casc3 wt allele
odontoameloblastoma
mpzl1 wt allele
calcifying cystic odontogenic tumor
intracranial cavernous hemangioma
agr2 wt allele
crybg1 wt allele
mrvi1 wt allele
dentinogenic ghost cell tumor
aim2 wt allele
anp32b wt allele
anp32c wt allele
msc wt allele
anp32d wt allele
msln wt allele
cerebral hemangioma
manf wt allele
mtcp1 wt allele
cd3eap wt allele
atp8a2 wt allele
laryngeal basaloid carcinoma
laryngeal papillary squamous cell carcinoma
laryngeal squamous cell carcinoma ,  spindle cell variant
laryngeal acantholytic squamous cell carcinoma
laryngeal adenosquamous carcinoma
laryngeal undifferentiated carcinoma
schwannoma of the twelfth cranial nerve
laryngeal lymphoepithelial carcinoma
laryngeal giant cell carcinoma
limitation of use
sinonasal oncocytic papilloma
dose modification
nasal cavity exophytic papilloma
kadish stage c olfactory neuroblastoma
second - line therapy
draw
pharmacokinetic effect consequences
increased drug level
decreased drug level
cerebellopontine angle embryonal tumor ,  not otherwise specified
nasopharyngeal basaloid squamous cell carcinoma
transcription regulation gene
mybbp1a wt allele
tusc3 wt allele
nbas wt allele
chmp2a wt allele
trerf1 wt allele
bambi wt allele
bcar3 wt allele
extracranial neuroblastoma
nrbp1 wt allele
ntn1 wt allele
bcas1 wt allele
bcl7a wt allele
ankrd30a wt allele
bcpr wt allele
calml4 wt allele
brca3 wt allele
ergic3 wt allele
extraskeletal
corpus callosum lipoma
ctdsp2 wt allele
brcata wt allele
type of drug interaction consequence
brcd1 wt allele
lrrc17 wt allele
pharmacokinetic effect
brcd2 wt allele
nasopharyngeal differentiated carcinoma
drop metastasis in the spinal cord
medical product intent of use
tusc2 wt allele
brms1 wt allele
pdcd1lg2 wt allele
pdgfrl wt allele
thoc5 wt allele
united states pharmacopeia
intent to treat
phlda2 wt allele
altretamine
central nervous system leukemia
nasopharyngeal papillary adenocarcinoma
imprinting gene
prickle4 wt allele
pms2p1 wt allele
intent for prophylaxis
h19 wt allele
cdr1 wt allele
ceacam5 wt allele
cnksr1 wt allele
hhcm wt allele
central nervous system teratoma
cox7a2l wt allele
ctag1b wt allele
hnrnpa3 wt allele
cervix glandular epithelium
intent for diagnosis
intent for mitigation
renal pelvis and ureter
intracranial melanoma
exception
ppp3r2 wt allele
pvt1 wt allele
trim13 wt allele
pdlim4 wt allele
ccdc6 wt allele
brinp1 wt allele
dcc wt allele
ddx1 wt allele
rnf11 wt allele
ints6 wt allele
dec1 wt allele
dlec1 wt allele
rsu1 wt allele
dleu1 wt allele
dleu2 wt allele
rtn1 wt allele
cdk2ap2 wt allele
pmel wt allele
egfl6 wt allele
intracranial lipoma
eps8l1 wt allele
eps8l2 wt allele
eps8l3 wt allele
terminology subset
metastasis gene
epsti1 wt allele
srpx2 wt allele
fda individual case safety report terminology
st7 wt allele
tacc1 wt allele
cdrh health effect  -  clinical code terminology
cdrh medical device problem code terminology
fda structured product labeling terminology
spl color terminology
spl shape terminology
spl drug route of administration terminology
spl pharmaceutical dosage form terminology
spl package type terminology
structured product labeling potency terminology
spl dea schedule terminology
fgfr1op wt allele
sidt1 wt allele
flrt3 wt allele
pgap2 wt allele
frat1 wt allele
childhood anaplastic oligodendroglioma
malignant childhood central nervous system neoplasm
central nervous system mesenchymal ,  non - meningothelial neoplasm
hexestrol
central nervous system angiosarcoma
central nervous system lipoma
inner ear lipoma
skull base chordoma
immunofixation
mgi_accession_id
concept_in_subset
ncbi_taxon_id
stage iia breast cancer ajcc v6 and v7
tacc2 wt allele
tacc3 wt allele
csag2 wt allele
tsks wt allele
dcaf5 wt allele
bcas2 wt allele
bcas3 wt allele
bcas4 wt allele
rna transport gene
stage iib breast cancer ajcc v6 and v7
mrna transport gene
2q31 .2
1q24 .2
heterologous elements present
pubchem
blister dosing unit
fifth
sixth
normalized quotient
invasive apocrine breast carcinoma
14q23 .1
stressor
split
passage
seed
timeline
cdrh component code terminology
sod1 gene
sod1 wt allele
type of event icsr terminology
intestinal hemorrhage
gastric hemorrhage
adverse event outcome icsr terminology
operator of medical device icsr terminology
occupation icsr terminology
report source icsr terminology
type of report icsr terminology
location of event occurrence icsr terminology
type of reportable event icsr terminology
type of follow - up icsr terminology
reason for non - evaluation icsr terminology
type of remedial action icsr terminology
device usage icsr terminology
type of reporter icsr terminology
type of manufacturer icsr terminology
spl limitation of use terminology
pibenzimol
spl pharmacokinetic effect consequences terminology
increased peak drug blood concentration
increased drug half life
increased time to peak drug blood concentration
increased drug auc
decreased peak drug blood concentration
decreased drug half life
decreased time to peak drug blood concentration
decreased drug auc
central nervous system germ cell tumor
increased concomitant drug peak blood concentration
increased concomitant drug half life
increased time to concomitant drug peak blood concentration
increased concomitant drug auc
decreased concomitant drug auc
decreased concomitant drug peak blood concentration
decreased concomitant drug half life
decreased time to concomitant drug peak blood concentration
spl type of drug interaction consequence terminology
structured product labeling medical product intent of use terminology
intracranial extraskeletal myxoid chondrosarcoma
commercial organization
subinvestigator
form fda 1572
resident
history
clinical study sponsor financial disclosure form
experience
delegate
phase i enzymes inhibitor
phase ii enzymes inducer
curriculum vitae
registration specialist
national provider identifier
reviewer
document management system
ca2 term type
ca3 term type
cnu term type
central nervous system rhabdomyosarcoma
numeric country code
alpha - 2 country code
alpha - 3 country code
original device
critical reprocessed single - use device
semi - critical reprocessed single - use device
annual
radiation field
perpendicular axis
central nervous system fibrosarcoma
isocenter
radiation arc
mega
isodose
board eligible
ordering designee
correction
breast nevus
acral nevus
central nervous system paraganglioma
flexural skin nevus
head and neck nevus
nevoid melanoma
signet ring melanoma
hidradenocarcinoma
skin keratotic basal cell carcinoma
restriction site
restriction enzyme cleavage site
cpg island
overlap
gene feature physical location
metastasis protein
tumor - related protein
candidate tumor suppressor protein
imprinted protein
endopeptidase
indole compound
hydroxysteroid dehydrogenase inhibitor
naphthalene compound
stage ia gastric cancer ajcc v7
mechanism of action
chemical effects in biological systems
cas number
international chemical identifier
simplified molecular input line entry specification
tissue adhesion
prominent intraductal component present
stage ib gastric cancer ajcc v7
invasive lobular breast carcinoma ,  signet ring variant
tumor replacement
medical product document
labeling
regulated medical product
combination product
premarket review
market withdrawal
hormone antagonist
stage iiib gastric cancer ajcc v7
stock recovery
3 - hydroxy - 3 - methylglutaryl - coenzyme a reductase
carton dosing unit
cup dosing unit
tray dosing unit
neoplastic syndrome
blood pressure
blood pressure finding
drug interaction
spindle cell metaplasia
stage iiia gastric cancer ajcc v7
mesenchymal metaplasia
atmosphere
nano
multidimensional fatigue inventory
gastric papillary adenocarcinoma
critical assessment of microarray data analysis
phase 0 trial
low
empiric
sarcomatous component present
indwelling catheter
gastric tubular adenocarcinoma
foley catheter
new diagnosis
preoperative
operative
pre - therapy
post - therapy
gastric adenosquamous carcinoma
vasculitis ,  ctcae
grade 1 vasculitis ,  ctcae
gastric squamous cell carcinoma
grade 2 vasculitis ,  ctcae
grade 3 serum sickness ,  ctcae
grade 3 vasculitis ,  ctcae
gastric undifferentiated carcinoma
grade 4 vasculitis ,  ctcae
grade 5 serum sickness ,  ctcae
grade 5 vasculitis ,  ctcae
atrial fibrillation ,  ctcae
atrial flutter ,  ctcae
mobitz type i ,  ctcae
mobitz  ( type )  ii atrioventricular block ,  ctcae
bigeminy ,  ctcae
grade 1 asystole ,  ctcae
grade 1 atrial fibrillation ,  ctcae
grade 1 atrial flutter ,  ctcae
grade 1 mobitz type i ,  ctcae
grade 1 mobitz  ( type )  ii atrioventricular block ,  ctcae
grade 1 palpitations ,  ctcae
grade 1 sick sinus syndrome ,  ctcae
grade 1 sinus bradycardia ,  ctcae
grade 1 sinus tachycardia ,  ctcae
therapeutic hormone
grade 1 supraventricular tachycardia ,  ctcae
grade 2 atrial fibrillation ,  ctcae
gastric hemangioma
grade 2 atrial flutter ,  ctcae
grade 2 mobitz type i ,  ctcae
grade 2 mobitz  ( type )  ii atrioventricular block ,  ctcae
gastric lymphangioma
grade 2 palpitations ,  ctcae
grade 2 sick sinus syndrome ,  ctcae
grade 2 sinus bradycardia ,  ctcae
grade 2 sinus tachycardia ,  ctcae
benign gastric granular cell tumor
grade 2 supraventricular tachycardia ,  ctcae
grade 2 ventricular tachycardia ,  ctcae
malignant gastric granular cell tumor
grade 3 atrial fibrillation ,  ctcae
grade 3 atrial flutter ,  ctcae
grade 3 mobitz type i ,  ctcae
grade 3 mobitz  ( type )  ii atrioventricular block ,  ctcae
grade 3 sick sinus syndrome ,  ctcae
grade 3 sinus bradycardia ,  ctcae
grade 3 sinus tachycardia ,  ctcae
malignant gastric germ cell tumor
grade 3 supraventricular tachycardia ,  ctcae
grade 3 ventricular tachycardia ,  ctcae
gastric soft tissue neoplasm
grade 4 asystole ,  ctcae
grade 4 atrial fibrillation ,  ctcae
grade 4 atrial flutter ,  ctcae
grade 4 mobitz type i ,  ctcae
grade 4 mobitz  ( type )  ii atrioventricular block ,  ctcae
gastric liposarcoma
grade 4 sick sinus syndrome ,  ctcae
grade 4 sinus bradycardia ,  ctcae
gastric xanthoma
grade 4 supraventricular tachycardia ,  ctcae
grade 4 ventricular fibrillation ,  ctcae
hyaluronic acid
colon squamous cell carcinoma
grade 4 ventricular tachycardia ,  ctcae
grade 5 asystole ,  ctcae
grade 5 atrial fibrillation ,  ctcae
grade 5 atrial flutter ,  ctcae
grade 5 mobitz type i ,  ctcae
grade 5 mobitz  ( type )  ii atrioventricular block ,  ctcae
colon adenosquamous carcinoma
grade 5 sick sinus syndrome ,  ctcae
grade 5 sinus bradycardia ,  ctcae
colon leiomyoma
grade 5 supraventricular tachycardia ,  ctcae
grade 5 ventricular fibrillation ,  ctcae
colon lipoma
grade 5 ventricular tachycardia ,  ctcae
palpitations ,  ctcae
prolonged qtc interval ,  ctcae
sick sinus syndrome ,  ctcae
colon leiomyosarcoma
sinus bradycardia ,  ctcae
supraventricular extrasystoles ,  ctcae
supraventricular tachycardia ,  ctcae
colon sarcoma
colon tubulovillous adenoma
grade 2 tinnitus ,  ctcae
colon neuroendocrine tumor g1
grade 3 tinnitus ,  ctcae
colon mucosa - associated lymphoid tissue lymphoma
colon hodgkin lymphoma
grade 1 hypertension ,  ctcae
grade 1 hypotension ,  ctcae
hycanthone
colon lymphangioma
grade 1 pericarditis ,  ctcae
grade 1 pulmonary hypertension ,  ctcae
grade 1 restrictive cardiomyopathy ,  ctcae
grade 1 right ventricular dysfunction ,  ctcae
grade 2 hypertension ,  ctcae
grade 2 hypotension ,  ctcae
cecum neuroendocrine tumor g1
grade 2 pericarditis ,  ctcae
grade 2 pulmonary hypertension ,  ctcae
grade 2 restrictive cardiomyopathy ,  ctcae
grade 2 right ventricular dysfunction ,  ctcae
grade 3 hypertension ,  ctcae
grade 3 hypotension ,  ctcae
grade 3 left ventricular systolic dysfunction ,  ctcae
grade 3 myocarditis ,  ctcae
grade 3 pericarditis ,  ctcae
grade 3 pulmonary hypertension ,  ctcae
grade 3 restrictive cardiomyopathy ,  ctcae
grade 3 right ventricular dysfunction ,  ctcae
central nervous system hematopoietic neoplasm
grade 4 hypertension ,  ctcae
grade 4 hypotension ,  ctcae
grade 4 left ventricular systolic dysfunction ,  ctcae
grade 4 myocarditis ,  ctcae
central nervous system melanocytic neoplasm
grade 4 pericarditis ,  ctcae
grade 4 pulmonary hypertension ,  ctcae
grade 4 restrictive cardiomyopathy ,  ctcae
grade 4 right ventricular dysfunction ,  ctcae
grade 5 hypertension ,  ctcae
grade 5 hypotension ,  ctcae
central nervous system melanoma
grade 5 left ventricular systolic dysfunction ,  ctcae
grade 5 myocarditis ,  ctcae
grade 5 pericarditis ,  ctcae
grade 5 pulmonary hypertension ,  ctcae
grade 5 restrictive cardiomyopathy ,  ctcae
grade 5 right ventricular dysfunction ,  ctcae
hypertension ,  ctcae
hypotension ,  ctcae
left ventricular diastolic dysfunction ,  ctcae
left ventricular systolic dysfunction ,  ctcae 3 .0
pericarditis ,  ctcae
pulmonary hypertension ,  ctcae
restrictive cardiomyopathy ,  ctcae
central nervous system epidermoid cyst
right ventricular dysfunction ,  ctcae
recurrent disease ,  primary site
recurrent disease ,  distant site
central nervous system dermoid cyst
central nervous system hamartoma
hydralazine hydrochloride
appendix mucinous cystadenoma
appendix mucinous cystadenocarcinoma
appendix villous adenoma
appendix lymphoma
appendix leiomyoma
cecum lymphoma
colon kaposi sarcoma
colon inflammatory polyp
grade 1 hemoglobinuria ,  ctcae
colon juvenile polyp
colorectal peutz - jeghers polyp
hydrocarbon
cecum villous adenoma
cecum non - hodgkin lymphoma
prostate rhabdomyosarcoma
grade 1 proteinuria ,  ctcae
grade 2 proteinuria ,  ctcae
grade 3 proteinuria ,  ctcae
prostate kaposi sarcoma
prostate stromal sarcoma
prostate embryonal rhabdomyosarcoma
grade 2 disseminated intravascular coagulation ,  ctcae
prostate leiomyosarcoma
grade 3 disseminated intravascular coagulation ,  ctcae
grade 4 disseminated intravascular coagulation ,  ctcae
prostate myeloid sarcoma
grade 5 disseminated intravascular coagulation ,  ctcae
disseminated intravascular coagulation ,  ctcae
grade 5 death nos ,  ctcae
prostate angiosarcoma
grade 5 multi - organ failure ,  ctcae
redundancy
superoxide dismutase  [ cu - zn ]
gpx1 gene
gpx1 wt allele
gastric kaposi sarcoma
grade 1 fatigue ,  ctcae
grade 1 insomnia ,  ctcae
grade 1 weight gain ,  ctcae
grade 1 weight loss ,  ctcae
aromatic hydrocarbon
prostate acinar adenocarcinoma ,  sarcomatoid variant
grade 2 fatigue ,  ctcae
grade 2 hypothermia ,  ctcae
grade 2 insomnia ,  ctcae
grade 2 obesity ,  ctcae
grade 2 weight gain ,  ctcae
malignant prostate phyllodes tumor
grade 2 weight loss ,  ctcae
grade 3 fatigue ,  ctcae
grade 3 hypothermia ,  ctcae
grade 3 insomnia ,  ctcae
grade 3 obesity ,  ctcae
grade 3 weight gain ,  ctcae
grade 3 weight loss ,  ctcae
benign prostate phyllodes tumor
grade 4 hypothermia ,  ctcae
grade 4 obesity ,  ctcae
grade 5 hypothermia ,  ctcae
prostate lymphoma
fatigue ,  ctcae 3 .0
hypothermia ,  ctcae
obesity ,  ctcae
weight gain ,  ctcae
weight loss ,  ctcae
prostate non - hodgkin lymphoma
apnea ,  ctcae
grade 3 apnea ,  ctcae
grade 4 apnea ,  ctcae
grade 5 apnea ,  ctcae
prostate acinar adenocarcinoma ,  signet ring - like cell variant
grade 1 ataxia ,  ctcae
grade 2 ataxia ,  ctcae
grade 3 ataxia ,  ctcae
grade 1 brachial plexopathy ,  ctcae
grade 2 brachial plexopathy ,  ctcae
grade 3 brachial plexopathy ,  ctcae
prostate squamous cell carcinoma
prostate acinar mucinous adenocarcinoma
grade 1 cognitive disturbance ,  ctcae
grade 2 cognitive disturbance ,  ctcae
grade 3 cognitive disturbance ,  ctcae
prostate adenosquamous carcinoma
grade 1 confusion ,  ctcae
grade 2 confusion ,  ctcae
grade 3 confusion ,  ctcae
grade 4 confusion ,  ctcae
grade 1 dizziness ,  ctcae
grade 2 dizziness ,  ctcae
grade 3 dizziness ,  ctcae
prostate adenoid cystic carcinoma
grade 2 encephalopathy ,  ctcae
grade 3 encephalopathy ,  ctcae
grade 4 encephalopathy ,  ctcae
grade 5 encephalopathy ,  ctcae
halogenated hydrocarbon
hydrocephalus ,  ctcae
grade 1 hydrocephalus ,  ctcae
grade 2 hydrocephalus ,  ctcae
grade 3 hydrocephalus ,  ctcae
grade 4 hydrocephalus ,  ctcae
grade 5 hydrocephalus ,  ctcae
high grade prostatic intraepithelial neoplasia
low grade prostatic intraepithelial neoplasia
grade 1 memory impairment ,  ctcae
grade 2 memory impairment ,  ctcae
cecum adenocarcinoma
grade 3 memory impairment ,  ctcae
mental status ,  ctcae
grade 1 agitation ,  ctcae
grade 2 agitation ,  ctcae
grade 3 agitation ,  ctcae
grade 4 agitation ,  ctcae
prostate leiomyoma
grade 1 anxiety ,  ctcae
grade 2 anxiety ,  ctcae
grade 3 anxiety ,  ctcae
grade 4 anxiety ,  ctcae
depression ,  ctcae
grade 1 depression ,  ctcae
grade 2 depression ,  ctcae
prostate neuroendocrine neoplasm
grade 3 depression ,  ctcae
grade 4 depression ,  ctcae
grade 5 depression ,  ctcae
grade 1 euphoria ,  ctcae
grade 2 euphoria ,  ctcae
grade 3 euphoria ,  ctcae
myelitis ,  ctcae
rectal adenoma
grade 1 myelitis ,  ctcae
grade 2 myelitis ,  ctcae
grade 3 myelitis ,  ctcae
grade 4 myelitis ,  ctcae
grade 5 myelitis ,  ctcae
other neurology ,  ctcae
rectal neuroendocrine tumor g1
rectal sarcoma
rectal leiomyosarcoma
therapeutic hydrocortisone
rectal kaposi sarcoma
rectal lipoma
rectal leiomyoma
rectal lymphoma
rectal squamous cell carcinoma
rectal cloacogenic carcinoma
rectal sarcomatoid carcinoma
grade 2 seizure ,  ctcae
ceruminous neoplasm
grade 3 seizure ,  ctcae
grade 4 seizure ,  ctcae
grade 5 seizure ,  ctcae
malignant eccrine neoplasm
grade 3 syncope ,  ctcae
grade 1 tremor ,  ctcae
grade 2 tremor ,  ctcae
grade 3 tremor ,  ctcae
hydroxamic acids
porocarcinoma
erectile dysfunction ,  ctcae
grade 1 erectile dysfunction ,  ctcae
grade 2 erectile dysfunction ,  ctcae
grade 3 erectile dysfunction ,  ctcae
skin appendage hamartoma
grade 2 gynecomastia ,  ctcae
grade 3 gynecomastia ,  ctcae
apocrine sweat gland hamartoma
eccrine sweat gland hamartoma
grade 1 vaginal dryness ,  ctcae
grade 2 vaginal dryness ,  ctcae
pilosebaceous hamartoma
skin lipomatous neoplasm
skin nodulo - ulcerative basal cell carcinoma
cutaneous schwannoma
hydroxychloroquine
lymphocele ,  ctcae
grade 1 lymphocele ,  ctcae
grade 2 lymphocele ,  ctcae
grade 3 lymphocele ,  ctcae
grade 2 delayed puberty ,  ctcae
grade 2 precocious puberty ,  ctcae
grade 3 delayed puberty ,  ctcae
delayed puberty ,  ctcae
adrenal insufficiency ,  ctcae
grade 1 adrenal insufficiency ,  ctcae
skin undifferentiated pleomorphic sarcoma
grade 2 adrenal insufficiency ,  ctcae
stage i uveal melanoma ajcc v7
grade 3 adrenal insufficiency ,  ctcae
stage ii uveal melanoma ajcc v7
grade 4 adrenal insufficiency ,  ctcae
stage iii uveal melanoma ajcc v7
grade 5 adrenal insufficiency ,  ctcae
5 - hydroxyeicosatetraenoic acid
stage iv uveal melanoma ajcc v7
stage i skin cancer
pancoast syndrome
asbestos exposure
stage ii skin cancer
beta - methyl cyclodextrin
plasticizer
rhodamine labeled albumin
stage iii skin cancer
grade 1 cataract ,  ctcae
grade 2 cataract ,  ctcae
grade 3 cataract ,  ctcae
stage iv skin cancer
glaucoma ,  ctcae
grade 1 glaucoma ,  ctcae
grade 2 glaucoma ,  ctcae
grade 3 glaucoma ,  ctcae
grade 4 glaucoma ,  ctcae
keratitis ,  ctcae
grade 1 keratitis ,  ctcae
grade 2 keratitis ,  ctcae
skin sarcoma
grade 3 keratitis ,  ctcae
grade 4 keratitis ,  ctcae
grade 2 nystagmus ,  ctcae
middle cranial fossa meningioma
grade 3 nystagmus ,  ctcae
visual pathway meningioma
recurrent medulloblastoma
grade 3 retinal detachment ,  ctcae
jugular foramen neoplasm
grade 4 retinal detachment ,  ctcae
retinopathy ,  ctcae
grade 1 retinopathy ,  ctcae
grade 2 retinopathy ,  ctcae
grade 3 retinopathy ,  ctcae
grade 4 retinopathy ,  ctcae
hetastarch
uveitis ,  ctcae
grade 1 uveitis ,  ctcae
grade 2 uveitis ,  ctcae
grade 3 uveitis ,  ctcae
grade 4 uveitis ,  ctcae
blurred vision ,  ctcae
grade 1 blurred vision ,  ctcae
grade 2 blurred vision ,  ctcae
grade 3 blurred vision ,  ctcae
benign childhood central nervous system neoplasm
grade 4 blurred vision ,  ctcae
grade 1 photophobia ,  ctcae
grade 2 photophobia ,  ctcae
grade 3 photophobia ,  ctcae
chordoid glioma of the third ventricle
grade 1 vitreous hemorrhage ,  ctcae
grade 2 vitreous hemorrhage ,  ctcae
grade 3 vitreous hemorrhage ,  ctcae
prostatic basal cell hyperplasia
grade 1 hemolysis ,  ctcae
prostatic cribriform hyperplasia
grade 2 hemolysis ,  ctcae
grade 2 iron overload ,  ctcae
prostatic atypical adenomatous hyperplasia
grade 3 hemolysis ,  ctcae
prostate acinar adenocarcinoma
grade 3 iron overload ,  ctcae
grade 4 hemolysis ,  ctcae
prostate undifferentiated carcinoma
grade 4 iron overload ,  ctcae
paget disease of the anus
grade 5 hemolysis ,  ctcae
grade 5 iron overload ,  ctcae
anal leiomyosarcoma
hemolysis ,  ctcae
iron overload ,  ctcae
hydroxyurea
anal adenocarcinoma
anal lymphoma
grade 1 back pain ,  ctcae
grade 2 back pain ,  ctcae
grade 3 back pain ,  ctcae
anal kaposi sarcoma
grade 1 bone pain ,  ctcae
grade 2 bone pain ,  ctcae
grade 3 bone pain ,  ctcae
grade 1 breast pain ,  ctcae
grade 2 breast pain ,  ctcae
grade 3 breast pain ,  ctcae
anal canal neuroendocrine neoplasm
grade 1 buttock pain ,  ctcae
grade 2 buttock pain ,  ctcae
grade 3 buttock pain ,  ctcae
grade 1 chest wall pain ,  ctcae
grade 2 chest wall pain ,  ctcae
grade 3 chest wall pain ,  ctcae
anal mucinous adenocarcinoma
grade 1 external ear pain ,  ctcae
grade 2 external ear pain ,  ctcae
grade 3 external ear pain ,  ctcae
benign anal granular cell tumor
grade 1 eye pain ,  ctcae
grade 2 eye pain ,  ctcae
grade 3 eye pain ,  ctcae
face pain ,  ctcae
anal leiomyoma
grade 1 gallbladder pain ,  ctcae
grade 2 gallbladder pain ,  ctcae
grade 3 gallbladder pain ,  ctcae
anal glands adenocarcinoma
ibuprofen
anal rhabdomyosarcoma
kidney pain ,  ctcae
anal sarcoma
grade 1 lip pain ,  ctcae
grade 2 lip pain ,  ctcae
grade 3 lip pain ,  ctcae
liver pain ,  ctcae
metastatic anal canal carcinoma
grade 1 lymph node pain ,  ctcae
grade 2 lymph node pain ,  ctcae
grade 3 lymph node pain ,  ctcae
grade 1 neck pain ,  ctcae
grade 2 neck pain ,  ctcae
grade 3 neck pain ,  ctcae
malignant cutaneous granular cell tumor
grade 1 oral pain ,  ctcae
grade 2 oral pain ,  ctcae
grade 3 oral pain ,  ctcae
skin liposarcoma
grade 2 ovulation pain ,  ctcae
skin nodular solid basal cell carcinoma
grade 1 penile pain ,  ctcae
grade 2 penile pain ,  ctcae
grade 3 penile pain ,  ctcae
rectal juvenile polyp
rectal hyperplastic polyp
idarubicin
rectal tubulovillous adenoma
rectal adenoma with severe dysplasia
grade 1 scalp pain ,  ctcae
grade 2 scalp pain ,  ctcae
grade 3 scalp pain ,  ctcae
grade 1 sinus pain ,  ctcae
grade 2 sinus pain ,  ctcae
grade 3 sinus pain ,  ctcae
grade 1 stomach pain ,  ctcae
grade 2 stomach pain ,  ctcae
grade 3 stomach pain ,  ctcae
aids - related gastric kaposi sarcoma
grade 1 tumor pain ,  ctcae
grade 2 tumor pain ,  ctcae
grade 3 tumor pain ,  ctcae
rectal rhabdomyosarcoma
carcinoma metastatic in the skin
metastatic malignant neoplasm in the skin
grade 1 hematoma ,  ctcae
grade 1 ileal hemorrhage ,  ctcae
idoxuridine
aleukemic monocytic leukemia cutis
grade 1 jejunal hemorrhage ,  ctcae
grade 1 renal hemorrhage ,  ctcae
grade 1 laryngeal hemorrhage ,  ctcae
grade 1 mediastinal hemorrhage ,  ctcae
grade 1 oral hemorrhage ,  ctcae
grade 1 ovarian hemorrhage ,  ctcae
aleukemic acute lymphoblastic leukemia cutis
grade 1 pancreatic hemorrhage ,  ctcae
grade 1 pharyngeal hemorrhage ,  ctcae
grade 1 pleural hemorrhage ,  ctcae
grade 1 prostatic hemorrhage ,  ctcae
grade 1 rectal hemorrhage ,  ctcae
grade 1 spermatic cord hemorrhage ,  ctcae
grade 1 testicular hemorrhage ,  ctcae
grade 1 tracheal hemorrhage ,  ctcae
grade 1 uterine hemorrhage ,  ctcae
grade 1 vaginal hemorrhage ,  ctcae
ann arbor stage i nodular lymphocyte predominant hodgkin lymphoma
grade 2 esophageal varices hemorrhage ,  ctcae
grade 2 hematoma ,  ctcae
grade 2 ileal hemorrhage ,  ctcae
grade 2 jejunal hemorrhage ,  ctcae
small intestinal mucosa - associated lymphoid tissue lymphoma
grade 2 renal hemorrhage ,  ctcae
grade 2 laryngeal hemorrhage ,  ctcae
grade 2 mediastinal hemorrhage ,  ctcae
grade 2 oral hemorrhage ,  ctcae
grade 2 ovarian hemorrhage ,  ctcae
grade 2 pancreatic hemorrhage ,  ctcae
childhood anaplastic large cell lymphoma
grade 2 pharyngeal hemorrhage ,  ctcae
grade 2 pleural hemorrhage ,  ctcae
grade 2 prostatic hemorrhage ,  ctcae
grade 2 rectal hemorrhage ,  ctcae
grade 2 spermatic cord hemorrhage ,  ctcae
childhood mature t - cell and nk - cell non - hodgkin lymphoma
grade 2 testicular hemorrhage ,  ctcae
grade 2 tracheal hemorrhage ,  ctcae
grade 2 uterine hemorrhage ,  ctcae
grade 2 vaginal hemorrhage ,  ctcae
gastric hodgkin lymphoma
grade 3 esophageal varices hemorrhage ,  ctcae
grade 3 hematoma ,  ctcae
grade 3 ileal hemorrhage ,  ctcae
grade 3 jejunal hemorrhage ,  ctcae
ifosfamide
childhood t lymphoblastic leukemia / lymphoma
grade 3 renal hemorrhage ,  ctcae
grade 3 laryngeal hemorrhage ,  ctcae
grade 3 mediastinal hemorrhage ,  ctcae
grade 3 oral hemorrhage ,  ctcae
grade 3 ovarian hemorrhage ,  ctcae
grade 3 pancreatic hemorrhage ,  ctcae
occult lung carcinoma
grade 3 pharyngeal hemorrhage ,  ctcae
grade 3 pleural hemorrhage ,  ctcae
grade 3 prostatic hemorrhage ,  ctcae
grade 3 rectal hemorrhage ,  ctcae
grade 3 spermatic cord hemorrhage ,  ctcae
stage ia lung cancer ajcc v7
grade 3 testicular hemorrhage ,  ctcae
grade 3 tracheal hemorrhage ,  ctcae
grade 3 uterine hemorrhage ,  ctcae
grade 3 vaginal hemorrhage ,  ctcae
stage ib lung cancer ajcc v7
stage iia lung cancer ajcc v7
grade 4 esophageal varices hemorrhage ,  ctcae
grade 4 hematoma ,  ctcae
grade 4 ileal hemorrhage ,  ctcae
grade 4 jejunal hemorrhage ,  ctcae
stage iib lung cancer ajcc v7
grade 4 renal hemorrhage ,  ctcae
grade 4 laryngeal hemorrhage ,  ctcae
grade 4 mediastinal hemorrhage ,  ctcae
grade 4 oral hemorrhage ,  ctcae
grade 4 ovarian hemorrhage ,  ctcae
grade 4 pancreatic hemorrhage ,  ctcae
stage iiia lung cancer ajcc v7
grade 4 pharyngeal hemorrhage ,  ctcae
grade 4 pleural hemorrhage ,  ctcae
grade 4 prostatic hemorrhage ,  ctcae
grade 4 rectal hemorrhage ,  ctcae
grade 4 spermatic cord hemorrhage ,  ctcae
stage iiib lung cancer ajcc v7
grade 4 testicular hemorrhage ,  ctcae
grade 4 tracheal hemorrhage ,  ctcae
grade 4 uterine hemorrhage ,  ctcae
grade 4 vaginal hemorrhage ,  ctcae
lung acinar adenocarcinoma
grade 5 esophageal varices hemorrhage ,  ctcae
grade 5 hematoma ,  ctcae
grade 5 ileal hemorrhage ,  ctcae
grade 5 jejunal hemorrhage ,  ctcae
grade 5 renal hemorrhage ,  ctcae
iga
lung papillary adenocarcinoma
grade 5 laryngeal hemorrhage ,  ctcae
grade 5 mediastinal hemorrhage ,  ctcae
grade 5 oral hemorrhage ,  ctcae
grade 5 ovarian hemorrhage ,  ctcae
grade 5 pancreatic hemorrhage ,  ctcae
solid lung adenocarcinoma
grade 5 pharyngeal hemorrhage ,  ctcae
grade 5 pleural hemorrhage ,  ctcae
grade 5 prostatic hemorrhage ,  ctcae
grade 5 rectal hemorrhage ,  ctcae
grade 5 spermatic cord hemorrhage ,  ctcae
stage ia lung non - small cell carcinoma ajcc v7
grade 5 testicular hemorrhage ,  ctcae
grade 5 tracheal hemorrhage ,  ctcae
grade 5 uterine hemorrhage ,  ctcae
grade 5 vaginal hemorrhage ,  ctcae
stage ib lung non - small cell carcinoma ajcc v7
hematoma ,  ctcae
stage iib lung non - small cell carcinoma ajcc v7
ileal hemorrhage ,  ctcae
jejunal hemorrhage ,  ctcae
renal hemorrhage ,  ctcae
laryngeal hemorrhage ,  ctcae
mediastinal hemorrhage ,  ctcae
stage iia lung non - small cell carcinoma ajcc v7
oral hemorrhage ,  ctcae
prostatic hemorrhage ,  ctcae
ovarian hemorrhage ,  ctcae
pancreatic hemorrhage ,  ctcae
pharyngeal hemorrhage ,  ctcae
pleural hemorrhage ,  ctcae
sclerosing pneumocytoma
rectal hemorrhage ,  ctcae
spermatic cord hemorrhage ,  ctcae
testicular hemorrhage ,  ctcae
tracheal hemorrhage ,  ctcae
lung myolipoma
uterine hemorrhage ,  ctcae
vaginal hemorrhage ,  ctcae
grade 2 cholecystitis ,  ctcae
lung fibroma
grade 2 pancreatitis ,  ctcae
grade 3 cholecystitis ,  ctcae
grade 3 pancreatitis ,  ctcae
grade 4 cholecystitis ,  ctcae
grade 4 pancreatitis ,  ctcae
grade 5 cholecystitis ,  ctcae
grade 5 pancreatitis ,  ctcae
igd
lung leiomyoma
grade 1 retinoic acid syndrome ,  ctcae
endobronchial leiomyoma
grade 2 retinoic acid syndrome ,  ctcae
grade 3 retinoic acid syndrome ,  ctcae
endobronchial hamartoma
grade 3 tumor lysis syndrome ,  ctcae
grade 4 retinoic acid syndrome ,  ctcae
grade 5 retinoic acid syndrome ,  ctcae
multiple pulmonary hamartomas
grade 5 tumor lysis syndrome ,  ctcae
retinoic acid syndrome ,  ctcae
lung mucous gland adenoma
grade 1 injury to inferior vena cava ,  ctcae
atypical adenomatous lung hyperplasia
grade 2 injury to inferior vena cava ,  ctcae
lung adenoid cystic carcinoma
lung leiomyosarcoma
lung meningioma
grade 3 injury to inferior vena cava ,  ctcae
pleuropulmonary blastoma
ige
lung neuroendocrine neoplasm
grade 4 injury to inferior vena cava ,  ctcae
lung hilum neoplasm
grade 5 injury to inferior vena cava ,  ctcae
lung large cell neuroendocrine carcinoma
colorectal adenoma
injury to inferior vena cava ,  ctcae
colorectal traditional serrated adenoma
colorectal tubulovillous adenoma
colorectal villous adenoma
grade 1 bladder spasm ,  ctcae
grade 1 fallopian tube obstruction ,  ctcae
colorectal leiomyoma
colorectal lipoma
grade 1 spermatic cord obstruction ,  ctcae
colorectal polyp
igg
colorectal inflammatory polyp
grade 1 urinary incontinence ,  ctcae
grade 1 urinary retention ,  ctcae
colorectal juvenile polyp
grade 1 vaginal fistula ,  ctcae
colorectal hyperplastic polyp
grade 2 bladder perforation ,  ctcae
grade 2 bladder spasm ,  ctcae
grade 2 fallopian tube obstruction ,  ctcae
grade 2 fallopian tube perforation ,  ctcae
lung non - hodgkin lymphoma
grade 2 spermatic cord obstruction ,  ctcae
colorectal adenoma with severe dysplasia
grade 2 urinary incontinence ,  ctcae
grade 2 urinary retention ,  ctcae
esophageal lymphoma
grade 2 vaginal fistula ,  ctcae
esophageal non - hodgkin lymphoma
grade 3 bladder perforation ,  ctcae
grade 3 bladder spasm ,  ctcae
grade 3 fallopian tube obstruction ,  ctcae
grade 3 fallopian tube perforation ,  ctcae
esophageal hodgkin lymphoma
igm
grade 3 spermatic cord obstruction ,  ctcae
stage iia esophageal cancer ajcc v7
stage iib esophageal cancer ajcc v7
grade 3 urinary incontinence ,  ctcae
grade 3 urinary retention ,  ctcae
grade 3 vaginal fistula ,  ctcae
grade 4 bladder perforation ,  ctcae
intestinal neuroendocrine neoplasm
grade 4 fallopian tube perforation ,  ctcae
gastric neuroendocrine neoplasm
colon neuroendocrine neoplasm
rectal neuroendocrine neoplasm
grade 4 urinary retention ,  ctcae
giant fibrovascular esophageal polyp
grade 4 vaginal fistula ,  ctcae
imipenem
esophageal granular cell tumor
grade 5 bladder perforation ,  ctcae
grade 5 fallopian tube perforation ,  ctcae
esophageal lipoma
esophageal fibroma
esophageal schwannoma
esophageal neurofibroma
grade 5 urinary retention ,  ctcae
grade 5 vaginal fistula ,  ctcae
esophageal liposarcoma
esophageal kaposi sarcoma
esophageal melanoma
stage iii childhood hepatocellular carcinoma ajcc v7
stage ii childhood hepatocellular carcinoma ajcc v6 and v7
urethra obstruction ,  ctcae
urinary retention ,  ctcae
antiserum
stage i childhood hepatocellular carcinoma ajcc v6 and v7
vaginal fistula ,  ctcae
stage iv pancreatic cancer ajcc v6 and v7
anorexia ,  ctcae
pancreatic serous cystadenoma
appendix perforation ,  ctcae
cecum perforation ,  ctcae
cecum ulcer ,  ctcae
colitis ,  ctcae
pancreatic lymphoma
constipation ,  ctcae
grade 1 anorexia ,  ctcae
pancreatic sarcoma
borderline exocrine pancreatic neoplasm
grade 1 colitis ,  ctcae
grade 1 constipation ,  ctcae
grade 1 dehydration ,  ctcae
grade 1 diarrhea ,  ctcae
grade 1 duodenal fistula ,  ctcae
grade 1 dysphagia ,  ctcae
grade 1 esophagitis ,  ctcae
grade 1 esophageal fistula ,  ctcae
pancreatic mucinous cystadenoma
grade 1 flatulence ,  ctcae
grade 1 gallbladder fistula ,  ctcae
grade 1 gallbladder obstruction ,  ctcae
pancreatic intraductal papillary - mucinous neoplasm with intermediate grade dysplasia
grade 1 gastritis ,  ctcae
grade 1 hemorrhoids ,  ctcae
grade 1 ileal fistula ,  ctcae
grade 1 ileal obstruction ,  ctcae
immunoglobulin
pancreatic signet ring cell carcinoma
grade 1 ileal ulcer ,  ctcae
grade 1 ileus ,  ctcae
grade 1 jejunal fistula ,  ctcae
grade 1 jejunal obstruction ,  ctcae
grade 1 jejunal ulcer ,  ctcae
pancreatic adenosquamous carcinoma
grade 1 nausea ,  ctcae
grade 1 pancreatic fistula ,  ctcae
pancreatic undifferentiated carcinoma
grade 1 periodontal disease ,  ctcae
grade 1 pharyngeal fistula ,  ctcae
grade 1 proctitis ,  ctcae
grade 1 rectal fistula ,  ctcae
pancreatic undifferentiated carcinoma with osteoclast - like giant cells
grade 1 rectal obstruction ,  ctcae
grade 1 rectal ulcer ,  ctcae
grade 1 salivary gland fistula ,  ctcae
pancreatic serous cystadenocarcinoma
pancreatic intraductal papillary - mucinous carcinoma
pancreatic intraductal papillary - mucinous neoplasm with an associated invasive carcinoma
grade 1 vomiting ,  ctcae
grade 2 anorexia ,  ctcae
pancreatic acinar cell cystadenocarcinoma
solid pseudopapillary carcinoma of the pancreas
grade 2 colitis ,  ctcae
stage 0 pancreatic cancer ajcc v6 and v7
grade 2 constipation ,  ctcae
grade 2 dehydration ,  ctcae
grade 2 diarrhea ,  ctcae
grade 2 duodenal fistula ,  ctcae
grade 2 dysphagia ,  ctcae
surface immunoglobulin
grade 2 esophagitis ,  ctcae
grade 2 esophageal fistula ,  ctcae
duodenal gastrin - producing neuroendocrine tumor
grade 2 flatulence ,  ctcae
grade 2 gallbladder fistula ,  ctcae
grade 2 gallbladder obstruction ,  ctcae
grade 2 gastritis ,  ctcae
grade 2 hemorrhoids ,  ctcae
grade 2 ileal fistula ,  ctcae
grade 2 ileal obstruction ,  ctcae
grade 2 ileal ulcer ,  ctcae
grade 2 ileus ,  ctcae
grade 2 jejunal fistula ,  ctcae
grade 2 jejunal obstruction ,  ctcae
grade 2 jejunal ulcer ,  ctcae
grade 2 malabsorption ,  ctcae
grade 2 nausea ,  ctcae
gallbladder lymphoma
grade 2 pancreatic fistula ,  ctcae
grade 2 periodontal disease ,  ctcae
grade 2 pharyngeal fistula ,  ctcae
gallbladder melanoma
grade 2 proctitis ,  ctcae
grade 2 rectal fistula ,  ctcae
grade 2 rectal obstruction ,  ctcae
grade 2 rectal perforation ,  ctcae
grade 2 rectal ulcer ,  ctcae
gallbladder sarcoma
grade 2 salivary gland fistula ,  ctcae
stage i gallbladder cancer ajcc v6
stage ii gallbladder cancer ajcc v6
grade 2 vomiting ,  ctcae
stage iii gallbladder cancer ajcc v6
grade 3 anorexia ,  ctcae
stage iv gallbladder cancer ajcc v6
grade 3 colitis ,  ctcae
stage iva gallbladder cancer ajcc v7
grade 3 constipation ,  ctcae
grade 3 dehydration ,  ctcae
grade 3 diarrhea ,  ctcae
grade 3 duodenal fistula ,  ctcae
stage ivb gallbladder cancer ajcc v7
grade 3 dysphagia ,  ctcae
grade 3 esophagitis ,  ctcae
grade 3 esophageal fistula ,  ctcae
gallbladder intracholecystic papillary neoplasm with an associated invasive carcinoma
grade 3 gallbladder fistula ,  ctcae
grade 3 gallbladder obstruction ,  ctcae
gallbladder mucinous adenocarcinoma
grade 3 gastritis ,  ctcae
grade 3 hemorrhoids ,  ctcae
grade 3 ileal fistula ,  ctcae
gallbladder signet ring cell carcinoma
grade 3 ileal obstruction ,  ctcae
grade 3 ileal ulcer ,  ctcae
grade 3 ileus ,  ctcae
grade 3 jejunal fistula ,  ctcae
grade 3 jejunal obstruction ,  ctcae
gallbladder neurofibroma
grade 3 jejunal ulcer ,  ctcae
grade 3 malabsorption ,  ctcae
grade 3 nausea ,  ctcae
gallbladder leiomyoma
grade 3 pancreatic fistula ,  ctcae
grade 3 periodontal disease ,  ctcae
grade 3 peritoneal necrosis ,  ctcae
grade 3 pharyngeal fistula ,  ctcae
grade 3 pharyngeal necrosis ,  ctcae
grade 3 proctitis ,  ctcae
grade 3 rectal fistula ,  ctcae
liver and intrahepatic bile duct benign non - epithelial neoplasm
grade 3 rectal necrosis ,  ctcae
grade 3 rectal obstruction ,  ctcae
grade 3 rectal perforation ,  ctcae
grade 3 rectal ulcer ,  ctcae
grade 3 salivary gland fistula ,  ctcae
immunotoxin
liver lipoma
liver mesenchymal hamartoma
liver solitary fibrous tumor
grade 3 typhlitis ,  ctcae
grade 3 vomiting ,  ctcae
grade 4 anorexia ,  ctcae
liver leiomyoma
clear cell hepatocellular carcinoma
grade 4 colitis ,  ctcae
grade 4 constipation ,  ctcae
grade 4 dehydration ,  ctcae
grade 4 diarrhea ,  ctcae
grade 4 duodenal fistula ,  ctcae
liver leiomyosarcoma
grade 4 dysphagia ,  ctcae
grade 4 esophagitis ,  ctcae
grade 4 esophageal fistula ,  ctcae
grade 4 gallbladder fistula ,  ctcae
grade 4 gallbladder necrosis ,  ctcae
grade 4 gallbladder obstruction ,  ctcae
grade 4 gallbladder perforation ,  ctcae
grade 4 gastritis ,  ctcae
stage i hepatocellular carcinoma ajcc v6 and v7
grade 4 hepatic necrosis ,  ctcae
grade 4 ileal fistula ,  ctcae
grade 4 ileal obstruction ,  ctcae
grade 4 ileal ulcer ,  ctcae
grade 4 ileus ,  ctcae
grade 4 jejunal fistula ,  ctcae
stage ii hepatocellular carcinoma ajcc v6 and v7
grade 4 jejunal obstruction ,  ctcae
grade 4 jejunal ulcer ,  ctcae
indomethacin
stage iii hepatocellular carcinoma ajcc v6
grade 4 malabsorption ,  ctcae
grade 4 pancreatic fistula ,  ctcae
stage iiia hepatocellular carcinoma ajcc v7
grade 4 peritoneal necrosis ,  ctcae
grade 4 pharyngeal fistula ,  ctcae
grade 4 pharyngeal necrosis ,  ctcae
grade 4 proctitis ,  ctcae
stage iiib hepatocellular carcinoma ajcc v7
grade 4 rectal fistula ,  ctcae
grade 4 rectal necrosis ,  ctcae
grade 4 rectal obstruction ,  ctcae
grade 4 rectal perforation ,  ctcae
grade 4 rectal ulcer ,  ctcae
grade 4 salivary gland fistula ,  ctcae
stage iv hepatocellular carcinoma ajcc v6
stage iva hepatocellular carcinoma ajcc v7
stage ivb hepatocellular carcinoma ajcc v7
grade 4 typhlitis ,  ctcae
grade 4 vomiting ,  ctcae
grade 5 anorexia ,  ctcae
liver non - hodgkin lymphoma
grade 5 colitis ,  ctcae
liver mucosa - associated lymphoid tissue lymphoma
grade 5 constipation ,  ctcae
grade 5 dehydration ,  ctcae
grade 5 diarrhea ,  ctcae
grade 5 duodenal fistula ,  ctcae
stage i extrahepatic bile duct cancer
grade 5 dysphagia ,  ctcae
grade 5 esophagitis ,  ctcae
grade 5 esophageal fistula ,  ctcae
industrial waste
stage ii extrahepatic bile duct cancer
grade 5 gallbladder fistula ,  ctcae
grade 5 gallbladder necrosis ,  ctcae
grade 5 gallbladder obstruction ,  ctcae
grade 5 gallbladder perforation ,  ctcae
grade 5 gastritis ,  ctcae
stage iii extrahepatic bile duct cancer
grade 5 hepatic necrosis ,  ctcae
grade 5 ileal fistula ,  ctcae
grade 5 ileal obstruction ,  ctcae
grade 5 ileal ulcer ,  ctcae
grade 5 ileus ,  ctcae
stage iv extrahepatic bile duct cancer
grade 5 jejunal fistula ,  ctcae
grade 5 jejunal obstruction ,  ctcae
grade 5 jejunal ulcer ,  ctcae
grade 5 malabsorption ,  ctcae
grade 5 pancreatic fistula ,  ctcae
grade 5 peritoneal necrosis ,  ctcae
grade 5 pharyngeal fistula ,  ctcae
grade 5 pharyngeal necrosis ,  ctcae
grade 5 proctitis ,  ctcae
extrahepatic bile duct clear cell adenocarcinoma
grade 5 rectal fistula ,  ctcae
grade 5 rectal necrosis ,  ctcae
grade 5 rectal obstruction ,  ctcae
grade 5 rectal perforation ,  ctcae
grade 5 rectal ulcer ,  ctcae
extrahepatic bile duct signet ring cell carcinoma
grade 5 salivary gland fistula ,  ctcae
extrahepatic bile duct squamous cell carcinoma
extrahepatic bile duct adenosquamous carcinoma
grade 5 typhlitis ,  ctcae
grade 5 vomiting ,  ctcae
dehydration ,  ctcae
diarrhea ,  ctcae
duodenal fistula ,  ctcae
dysphagia ,  ctcae
esophagitis ,  ctcae
esophageal fistula ,  ctcae
recombinant inhibin
extrahepatic bile duct undifferentiated carcinoma
flatulence ,  ctcae
gallbladder fistula ,  ctcae
gallbladder obstruction ,  ctcae
gastritis ,  ctcae
ileus ,  ctcae
ileal fistula ,  ctcae
ileal obstruction ,  ctcae
ileal ulcer ,  ctcae
jejunal fistula ,  ctcae
jejunal obstruction ,  ctcae
liver neuroendocrine tumor
jejunal ulcer ,  ctcae
malabsorption ,  ctcae
pancreatic fistula ,  ctcae
periodontal disease ,  ctcae
peritoneal necrosis ,  ctcae
pharyngeal fistula ,  ctcae
pharyngeal necrosis ,  ctcae
proctitis ,  ctcae
rectal fistula ,  ctcae
rectal necrosis ,  ctcae
rectal obstruction ,  ctcae
rectal ulcer ,  ctcae
salivary gland fistula ,  ctcae
jejunal somatostatin - producing neuroendocrine tumor
pancreatic non - hodgkin lymphoma
vomiting ,  ctcae
alopecia ,  ctcae
inorganic chemical
burn ,  ctcae
cheilitis ,  ctcae
grade 1 alopecia ,  ctcae
grade 1 burn ,  ctcae
grade 1 cheilitis ,  ctcae
grade 1 dry skin ,  ctcae
grade 1 flushing ,  ctcae
grade 1 nail changes ,  ctcae
grade 1 photosensitivity ,  ctcae
grade 1 pruritus ,  ctcae
grade 1 skin atrophy ,  ctcae
grade 1 telangiectasia ,  ctcae
grade 1 urticaria ,  ctcae
grade 2 alopecia ,  ctcae
grade 2 burn ,  ctcae
adult central nervous system choriocarcinoma
grade 2 cheilitis ,  ctcae
grade 2 dry skin ,  ctcae
grade 2 flushing ,  ctcae
adult central nervous system teratoma
grade 2 photosensitivity ,  ctcae
grade 2 pruritus ,  ctcae
grade 2 skin atrophy ,  ctcae
childhood brain germ cell tumor
grade 2 telangiectasia ,  ctcae
grade 2 urticaria ,  ctcae
grade 3 burn ,  ctcae
grade 3 cheilitis ,  ctcae
grade 3 dry skin ,  ctcae
benign adult cerebellar neoplasm
grade 3 photosensitivity ,  ctcae
grade 3 pruritus ,  ctcae
benign adult brain stem neoplasm
grade 3 urticaria ,  ctcae
grade 4 burn ,  ctcae
grade 4 photosensitivity ,  ctcae
benign childhood brain neoplasm
grade 5 burn ,  ctcae
grade 5 photosensitivity ,  ctcae
benign childhood supratentorial neoplasm
dry skin ,  ctcae
hyperpigmentation ,  ctcae
inositol 1 , 4 , 5 - trisphosphate
childhood choroid plexus papilloma
photosensitivity ,  ctcae
pruritus ,  ctcae
urticaria ,  ctcae
childhood infratentorial neoplasm
adult respiratory distress syndrome ,  ctcae
atelectasis ,  ctcae
chylothorax ,  ctcae
cough ,  ctcae
grade 1 aspiration ,  ctcae
small intestinal neuroendocrine neoplasm
grade 1 atelectasis ,  ctcae
grade 1 chylothorax ,  ctcae
grade 1 cough ,  ctcae
grade 1 dyspnea ,  ctcae
grade 1 laryngeal fistula ,  ctcae
grade 1 pneumothorax ,  ctcae
grade 1 tracheal fistula ,  ctcae
grade 2 aspiration ,  ctcae
grade 2 atelectasis ,  ctcae
gastric gastrointestinal stromal tumor
grade 2 chylothorax ,  ctcae
grade 2 cough ,  ctcae
grade 2 dyspnea ,  ctcae
grade 2 hypoxia ,  ctcae
stage i small intestinal cancer ajcc v7
grade 2 laryngeal fistula ,  ctcae
stage ii small intestinal cancer ajcc v7
grade 2 pneumothorax ,  ctcae
grade 2 tracheal fistula ,  ctcae
stage iii small intestinal cancer ajcc v7
grade 3 adult respiratory distress syndrome ,  ctcae
grade 3 aspiration ,  ctcae
grade 3 atelectasis ,  ctcae
grade 3 chylothorax ,  ctcae
grade 3 cough ,  ctcae
grade 3 dyspnea ,  ctcae
therapeutic insulin
stage iv small intestinal cancer ajcc v7
grade 3 hypoxia ,  ctcae
grade 3 laryngeal fistula ,  ctcae
small intestinal gastrointestinal stromal tumor
grade 3 pneumothorax ,  ctcae
grade 3 tracheal fistula ,  ctcae
grade 4 adult respiratory distress syndrome ,  ctcae
grade 4 aspiration ,  ctcae
grade 4 atelectasis ,  ctcae
grade 4 chylothorax ,  ctcae
grade 4 dyspnea ,  ctcae
grade 4 hypoxia ,  ctcae
grade 4 laryngeal fistula ,  ctcae
grade 4 pneumothorax ,  ctcae
grade 4 tracheal fistula ,  ctcae
grade 5 adult respiratory distress syndrome ,  ctcae
grade 5 aspiration ,  ctcae
grade 5 atelectasis ,  ctcae
metastatic malignant neoplasm in the adult brain
grade 5 chylothorax ,  ctcae
grade 5 dyspnea ,  ctcae
grade 5 hypoxia ,  ctcae
grade 5 laryngeal fistula ,  ctcae
intracranial embryonal tumor ,  not otherwise specified
grade 5 pneumothorax ,  ctcae
pharyngeal adenoid cystic carcinoma
grade 5 tracheal fistula ,  ctcae
dyspnea ,  ctcae
fev1 ,  ctcae
hypoxia ,  ctcae
larynx edema ,  ctcae
buccal squamous cell papilloma
laryngeal fistula ,  ctcae
esophageal neuroendocrine tumor g1
pneumothorax ,  ctcae
tracheal fistula ,  ctcae
esophageal neuroendocrine neoplasm
grade 1 exostosis ,  ctcae
grade 1 fracture ,  ctcae
grade 1 joint effusion ,  ctcae
grade 1 myositis ,  ctcae
grade 1 osteoporosis ,  ctcae
grade 1 seroma ,  ctcae
grade 1 trismus ,  ctcae
grade 2 exostosis ,  ctcae
grade 2 fracture ,  ctcae
grade 2 head soft tissue necrosis ,  ctcae
grade 2 joint effusion ,  ctcae
grade 2 myositis ,  ctcae
grade 2 neck soft tissue necrosis ,  ctcae
grade 2 osteoporosis ,  ctcae
grade 2 pelvic soft tissue necrosis ,  ctcae
grade 2 seroma ,  ctcae
grade 2 trismus ,  ctcae
grade 3 exostosis ,  ctcae
grade 3 fracture ,  ctcae
grade 3 head soft tissue necrosis ,  ctcae
grade 3 joint effusion ,  ctcae
grade 3 myositis ,  ctcae
recombinant interferon gamma
grade 3 neck soft tissue necrosis ,  ctcae
grade 3 osteoporosis ,  ctcae
grade 3 pelvic soft tissue necrosis ,  ctcae
grade 3 seroma ,  ctcae
grade 3 trismus ,  ctcae
liver fibrosarcoma
grade 4 fracture ,  ctcae
grade 4 head soft tissue necrosis ,  ctcae
liver extraskeletal osteosarcoma
grade 4 myositis ,  ctcae
grade 4 neck soft tissue necrosis ,  ctcae
liver rhabdomyosarcoma
grade 4 pelvic soft tissue necrosis ,  ctcae
gallbladder lipoma
grade 5 fracture ,  ctcae
grade 5 head soft tissue necrosis ,  ctcae
grade 5 neck soft tissue necrosis ,  ctcae
grade 5 pelvic soft tissue necrosis ,  ctcae
gallbladder undifferentiated carcinoma ,  spindle and giant cell type
fracture ,  ctcae
head soft tissue necrosis ,  ctcae
gallbladder rhabdomyosarcoma
neck soft tissue necrosis ,  ctcae
pelvic soft tissue necrosis ,  ctcae
recombinant interferon
gallbladder angiosarcoma
seroma ,  ctcae
trismus ,  ctcae
gallbladder leiomyosarcoma
gallbladder kaposi sarcoma
extrahepatic bile duct small cell carcinoma
extrahepatic bile duct mucinous adenocarcinoma
extrahepatic bile duct embryonal rhabdomyosarcoma
extrahepatic bile duct leiomyosarcoma
extrahepatic bile duct papillary adenoma
recombinant interleukin - 1 - beta
extrahepatic bile duct tubular adenoma
extrahepatic bile duct mucinous cystic neoplasm
extrahepatic bile duct benign granular cell tumor
extrahepatic bile duct fibroma
extrahepatic bile duct lipoma
extrahepatic bile duct leiomyoma
benign extrahepatic bile duct soft tissue neoplasm
extrahepatic bile duct adenoma
liver inflammatory myofibroblastic tumor
recombinant interleukin - 1
extrahepatic bile duct rhabdomyosarcoma
extrahepatic bile duct neuroendocrine tumor g1
extrahepatic bile duct mucoepidermoid carcinoma
stage iva oral cavity adenoid cystic carcinoma ajcc v6 and v7
stage ivb oral cavity adenoid cystic carcinoma ajcc v6 and v7
stage ivc oral cavity adenoid cystic carcinoma ajcc v6 and v7
stage ivc oral cavity mucoepidermoid carcinoma ajcc v6 and v7
stage ivb oral cavity mucoepidermoid carcinoma ajcc v6 and v7
stage iva oral cavity mucoepidermoid carcinoma ajcc v6 and v7
recombinant interleukin - 2
stage i lip cancer ajcc v6 and v7
stage ii lip cancer ajcc v6 and v7
stage iii lip cancer ajcc v6 and v7
stage iv lip cancer ajcc v6 and v7
recombinant interleukin - 3
stage iva lip cancer ajcc v6 and v7
stage ivb lip cancer ajcc v6 and v7
stage ivc lip cancer ajcc v6 and v7
stage i oral cavity cancer ajcc v6 and v7
stage ii oral cavity cancer ajcc v6 and v7
stage iii oral cavity cancer ajcc v6 and v7
stage iv oral cavity cancer ajcc v6 and v7
stage iva oral cavity cancer ajcc v6 and v7
stage ivb oral cavity cancer ajcc v6 and v7
stage ivc oral cavity cancer ajcc v6 and v7
binetrakin
stage i major salivary gland cancer ajcc v7
stage ii major salivary gland cancer ajcc v7
stage iii major salivary gland cancer ajcc v7
stage iv major salivary gland cancer ajcc v7
stage iv major salivary gland carcinoma with metastasis
recombinant interleukin - 5
stage iv major salivary gland carcinoma without metastasis
major salivary gland acinic cell carcinoma
malignant mixed tumor of the major salivary gland
major salivary gland adenocarcinoma
salivary duct carcinoma
major salivary gland adenoid cystic carcinoma
major salivary gland mucoepidermoid carcinoma
major salivary gland carcinoma
salivary gland mucoepidermoid carcinoma
oral cavity leiomyoma
recombinant interleukin - 6
oral cavity lipoma
oral cavity granular cell tumor
oral cavity adenoma
oral cavity adenocarcinoma
oral cavity mucosal melanoma
oral cavity sarcoma
upper gingival verrucous carcinoma
tonsillar lymphoma
astler - coller b3 colon carcinoma
recombinant interleukin - 7
astler - coller b3 rectal carcinoma
astler - coller c1 rectal carcinoma
astler - coller c2 rectal carcinoma
astler - coller a rectal carcinoma
stage iiia anal canal cancer ajcc v6 and v7
stage iiib anal canal cancer ajcc v6 and v7
recombinant interleukin
salivary gland oncocytoma
parotid gland acinic cell carcinoma
submandibular gland acinic cell carcinoma
submandibular gland adenoid cystic carcinoma
minor salivary gland adenoid cystic carcinoma
parotid gland adenoid cystic carcinoma
parotid gland mucoepidermoid carcinoma
submandibular gland mucoepidermoid carcinoma
iodine
submandibular gland adenocarcinoma
parotid gland adenocarcinoma
parotid gland squamous cell carcinoma
submandibular gland squamous cell carcinoma
malignant submandibular gland mixed tumor
malignant parotid gland mixed tumor
parotid gland undifferentiated carcinoma
submandibular gland undifferentiated carcinoma
grade 3 febrile neutropenia ,  ctcae
minor salivary gland adenocarcinoma
parotid gland sebaceous lymphadenoma
3 - iodotyrosine
salivary gland basal cell adenoma
parotid gland non - hodgkin lymphoma
parotid gland kaposi sarcoma
minor salivary gland mucoepidermoid carcinoma
minor salivary gland undifferentiated carcinoma
malignant mixed tumor of the minor salivary gland
minor salivary gland small cell carcinoma
minor salivary gland carcinoma
sublingual gland adenocarcinoma
minor salivary gland squamous cell carcinoma
ionomycin
childhood supratentorial neoplasm
childhood central nervous system embryonal tumor ,  not otherwise specified
prolactin - producing pituitary gland carcinoma
growth hormone - producing pituitary gland carcinoma
acth - producing pituitary gland carcinoma
tsh - producing pituitary gland carcinoma
anaplastic brain stem astrocytoma
adult brain stem neoplasm
adult cerebellar neoplasm
childhood brain stem neoplasm
ion
childhood cerebellar neoplasm
ear polyp
grade 4 febrile neutropenia ,  ctcae
subglottic carcinoma
supraglottic carcinoma
parotid gland carcinoma ex pleomorphic adenoma
major salivary gland carcinoma ex pleomorphic adenoma
minor salivary gland carcinoma ex pleomorphic adenoma
submandibular gland carcinoma ex pleomorphic adenoma
benign salivary gland myoepithelioma
salivary gland canalicular adenoma
iron
salivary gland cystadenocarcinoma
major salivary gland non - hodgkin lymphoma
parotid gland lipoma
major salivary gland sarcoma
stage iva oropharyngeal carcinoma ajcc v7
stage ivb oropharyngeal carcinoma ajcc v7
stage ivc oropharyngeal carcinoma ajcc v7
oropharyngeal polyp
tonsillar lipoma
isoflavone
posterior tongue mucoepidermoid carcinoma
posterior tongue adenoid cystic carcinoma
stage iva hypopharyngeal carcinoma ajcc v7
stage ivb hypopharyngeal carcinoma ajcc v7
stage ivc hypopharyngeal carcinoma ajcc v7
stage ivc nasopharyngeal carcinoma ajcc v7
grade 5 febrile neutropenia ,  ctcae
stage ivb nasopharyngeal carcinoma ajcc v7
stage iva nasopharyngeal carcinoma ajcc v7
isoniazid
stage iva pharyngeal cancer
stage ivb pharyngeal cancer
stage ivc pharyngeal cancer
stage ivc laryngeal cancer ajcc v7
stage ivb laryngeal cancer ajcc v7
stage iva laryngeal cancer ajcc v7
stage i paranasal sinus cancer
stage ii paranasal sinus cancer ajcc v6 and v7
stage iii paranasal sinus cancer ajcc v6 and v7
stage iv paranasal sinus cancer ajcc v7
inosine pranobex
stage iv nasal cavity cancer
stage iii nasal cavity cancer ajcc v6 and v7
stage ii nasal cavity cancer ajcc v6 and v7
stage i nasal cavity cancer ajcc v6 and v7
paranasal sinus carcinoma
nasal cavity adenocarcinoma
paranasal sinus olfactory neuroblastoma
paranasal sinus adenocarcinoma
paranasal sinus mucoepidermoid carcinoma
paranasal sinus adenoid cystic carcinoma
isopropyl alcohol
laryngeal sarcoma
laryngeal liposarcoma
laryngeal leiomyosarcoma
laryngeal neuroendocrine neoplasm
laryngeal carcinoid tumor
laryngeal small cell carcinoma
subglottic hemangioma
laryngeal leiomyoma
metastatic malignant neoplasm in the hypopharynx
metastatic malignant neoplasm in the oropharynx
isotretinoin
metastatic malignant neoplasm in the nasopharynx
glutathione peroxidase 1
metastatic malignant neoplasm in the larynx
lung mature b - cell neoplasm
parathyroid chief cell hyperplasia
parathyroid clear cell hyperplasia
nasopharyngeal polyp
stage 0 nasopharyngeal undifferentiated carcinoma ajcc v6 ,  v7 ,  and v8
stage 0 nasopharyngeal keratinizing squamous cell carcinoma ajcc v6 ,  v7 ,  and v8
nasopharyngeal squamous cell papilloma
oropharyngeal squamous cell papilloma
stage 0 oropharyngeal squamous cell carcinoma ajcc v6 and v7
ketanserin
poorly differentiated thyroid gland carcinoma
thyroid gland sarcoma
thyroid gland hurthle cell adenoma
thyroid gland angiosarcoma
thyroid gland non - hodgkin lymphoma
thyroid gland diffuse large b - cell lymphoma
stage 0 hypopharyngeal squamous cell carcinoma ajcc v6 ,  v7 ,  and v8
tracheal leiomyoma
rat pars distalis adenoma
rat pars distalis carcinoma
rat pars intermedia adenoma
ketoconazole
tracheal sarcoma
tracheal adenoid cystic carcinoma
stage 0 oral cavity squamous cell carcinoma ajcc v6 and v7
stage i oral cavity squamous cell carcinoma ajcc v6 and v7
hypericum perforatum
aberrant crypt focus
provisional registration
rat anatomy concepts
stage ii oral cavity squamous cell carcinoma ajcc v6 and v7
stage iii oral cavity squamous cell carcinoma ajcc v6 and v7
stage iv oral cavity squamous cell carcinoma ajcc v6 and v7
stage iva oral cavity squamous cell carcinoma ajcc v6 and v7
stage ivb oral cavity squamous cell carcinoma ajcc v6 and v7
stage ivc oral cavity squamous cell carcinoma ajcc v6 and v7
lactone compound
recurrent oral cavity squamous cell carcinoma
malignant anterior tongue neoplasm
anterior tongue neoplasm
benign anterior tongue neoplasm
rectal small cell carcinoma
maxillary sinus squamous cell carcinoma
rectal medullary carcinoma
colon medullary carcinoma
caudad
adulthood lesion
childhood lesion
cephalad
stationary beam radiation therapy
pri - microrna
crp gene
ethmoid sinus squamous cell carcinoma
crp wt allele
c - reactive protein
dapk1 gene
dapk1 wt allele
limitation of use based on conditional approval
limitation of use based on duration of use
death - associated protein kinase 1
gata5 gene
gata5 wt allele
transcription factor gata - 5
sphenoid sinus squamous cell carcinoma
camellia sinensis
tenesmus
morinda citrifolia
intramucosal lesion
rassf1 gene
rassf1 wt allele
ras association domain - containing protein 1
card11 gene
card11 wt allele
frontal sinus squamous cell carcinoma
caspase recruitment domain - containing protein 11
malt1 gene
malt1 wt allele
mucosa - associated lymphoid tissue lymphoma translocation protein 1
chromogranin - a positive neoplastic cells present
paranasal sinus lymphoma
paranasal sinus non - hodgkin lymphoma
fold change
principal component
extramural nodule
biliary obstruction
periampullary region
leucovorin calcium
stage iva paranasal sinus cancer ajcc v7
morpholino
allograft
random
neuron - specific enolase positive neoplastic cells present
binary object
appendix neuroendocrine neoplasm
stage ivb paranasal sinus cancer ajcc v7
registry nomenclature information system
active caries
air - drying
white spot lesion
dental calculus
dental explorer
dental fissure
dental restoration
permanent dental restoration
stage ivc paranasal sinus cancer ajcc v7
temporary dental restoration
fiber optic transilluminator
gingival margin
laser fluorescence
oral hygiene
dental plaque
radiograph
tooth 19
individualized
paranasal sinus diffuse large b - cell lymphoma
interest
advising
third molar
treatment plan
nasal cavity lymphoma
dental treatment plan
class v surface
metaplasia of malignant cells present
nasal cavity non - hodgkin lymphoma
application
activity code
budget
personnel
supplies
recurrent oral cavity carcinoma
subtotal
aim
proposal
supplement
notice of grant award
indium in 111 chx - a dtpa trastuzumab
sdz 280 - 446
veliparib
artemisinin dimer
neck carcinoma
obatoclax
hedgehog inhibitor ipi - 609
isosorbide
pelareorep
daniplestim
contact information
clinical trial agreement
pazopanib hydrochloride
eyelid carcinoma
brain astrocytoma
astrocytoma
anal mucosa
anorectal fistula
mobile telephone
cellular telephone
satellite telephone
facsimile machine
eye carcinoma
blackberry
lineage
thyroid cancer tnm finding v6
thyroid cancer pathologic tnm finding v6
thyroid cancer pathologic distant metastasis tnm finding v6
thyroid cancer pm0 tnm finding
thyroid cancer pm1 tnm finding v6 and v7
thyroid cancer pmx tnm finding v6
leukotriene
external ear actinic keratosis
distal 1 / 3 of the common bile duct
distal common bile duct
magnifier
cpg - 28 oligodeoxynucleotide
bosutinib
external ear carcinoma
tinzaparin sodium
pediatric death
hypertonic saline
polyamine analogue pg11047
angelica sinensis root extract
f - 18 fluoroethyltyrosine
assay
external ear basal cell carcinoma
run by
solubility
diluent
storage
lipase hypersecretion syndrome
precaution
safety
external ear squamous cell carcinoma
deep tissue invasion
cadherin - 2
oxygen saturation measurement
colorectal cancer tnm finding v6
colorectal cancer pathologic primary tumor tnm finding v6
colorectal cancer pathologic regional lymph nodes tnm finding v6
colorectal cancer pathologic distant metastasis tnm finding v6
colorectal cancer ptx tnm finding v6 and v7
colorectal cancer pt0 tnm finding v6 and v7
colorectal cancer ptis tnm finding v6
colorectal cancer ptis intraepithelial tnm finding
colorectal cancer ptis lamina propria invasion tnm finding
colorectal cancer pt1 tnm finding v6 and v7
colorectal cancer pt2 tnm finding v6 and v7
colorectal cancer pt3 tnm finding v6
colorectal cancer pt3 a / b tnm finding
colorectal cancer pt3 c / d tnm finding
colorectal cancer pt4 tnm finding v6
middle ear paraganglioma
colorectal cancer pnx tnm finding v6 and v7
colorectal cancer pn0 tnm finding v6 and v7
colorectal cancer pn1 tnm finding v6
colorectal cancer pn2 tnm finding v6
colorectal cancer pmx tnm finding v6
colorectal cancer pm0 tnm finding
colorectal cancer pm1 tnm finding v6 and v7
thyroid cancer clinical tnm finding v6
thyroid cancer pathologic primary tumor tnm finding v6
middle ear squamous cell carcinoma
thyroid cancer ptx tnm finding v6 and v7
thyroid cancer pt0 tnm finding v6 and v7
thyroid cancer pt1 tnm finding v6 and v7
thyroid cancer pt2 tnm finding v6 and v7
thyroid cancer pt3 tnm finding v6 and v7
thyroid cancer pt4 tnm finding v6
thyroid cancer pt4a tnm finding v6
thyroid cancer pt4b tnm finding v6
thyroid cancer pt4a anaplastic carcinoma tnm finding v6
thyroid cancer pt4b anaplastic carcinoma tnm finding v6
thyroid cancer pathologic regional lymph nodes tnm finding v6
thyroid cancer pn0 tnm finding v6 and v7
thyroid cancer pnx tnm finding v6 and v7
thyroid cancer pn1 tnm finding v6 and v7
thyroid cancer pn1a tnm finding v6 and v7
thyroid cancer pn1b tnm finding v6
hmgcr gene
hmgcr wt allele
external auditory canal ceruminous adenoma
single cell necrosis
recombinant bispecific single - chain antibody rm28
iron sucrose injection
cloth dosage form
ovarian cancer clinical tnm finding v6
ovarian cancer tnm finding v6
ovarian cancer pathologic tnm finding v6
ovarian cancer pathologic distant metastasis tnm finding v6
middle ear carcinoma
ovarian cancer pathologic primary tumor tnm finding v6
concentrated dosage form
ovarian cancer pathologic regional lymph nodes tnm finding v6
ovarian cancer pm0 tnm finding
ovarian cancer pmx tnm finding v6
ovarian cancer pm1 tnm finding v6
augmented cream dosage form
ovarian cancer pn0 tnm finding v6
ovarian cancer pn1 tnm finding v6
leukotriene b4
ovarian cancer pnx tnm finding v6
ovarian cancer ptx tnm finding v6
ovarian cancer pt0 tnm finding v6
ovarian cancer pt1 tnm finding v6
ovarian cancer pt1a tnm finding v6
ovarian cancer pt1b tnm finding v6
ovarian cancer pt1c tnm finding v6
ovarian cancer pt2 tnm finding v6
ovarian cancer pt2a tnm finding v6
lacrimal gland mucoepidermoid carcinoma
ovarian cancer pt2b tnm finding v6
ovarian cancer pt2c tnm finding v6
ovarian cancer pt3 tnm finding v6
ovarian cancer pt3a tnm finding v6
ovarian cancer pt3b tnm finding v6
ovarian cancer pt3c tnm finding v6
bone conduction assessment
static admittance
lacrimal gland squamous cell carcinoma
dense collagenized tissue present
extended release fiber dosage form
dosage form for solution
dosage form for suspension
extended release dosage form for suspension
metered gel dosage form
liposomal injection dosage form
insert dosage form
extended release liquid dosage form
exocrine pancreatic cancer pathologic primary tumor tnm finding v6
exocrine pancreatic cancer pathologic regional lymph nodes tnm finding v6
exocrine pancreatic cancer pathologic distant metastasis tnm finding v6
exocrine pancreatic cancer ptx tnm finding v6
exocrine pancreatic cancer pt0 tnm finding v6
exocrine pancreatic cancer ptis tnm finding v6
exocrine pancreatic cancer pt1 tnm finding v6
exocrine pancreatic cancer pt2 tnm finding v6
exocrine pancreatic cancer pt3 tnm finding v6
exocrine pancreatic cancer pt4 tnm finding v6
exocrine pancreatic cancer pnx tnm finding v6
exocrine pancreatic cancer pn0 tnm finding v6
orbit sarcoma
exocrine pancreatic cancer pn1 tnm finding v6
exocrine pancreatic cancer pn1a tnm finding
exocrine pancreatic cancer pn1b tnm finding
exocrine pancreatic cancer pmx tnm finding v6
exocrine pancreatic cancer pm1 tnm finding v6
exocrine pancreatic cancer pm0 tnm finding
augmented lotion dosage form
lotion shampoo dosage form
lung cancer tnm finding v6
lung cancer pathologic tnm finding v6
lung cancer ptx tnm finding v6 and v7
lung cancer pt0 tnm finding v6 and v7
lung cancer ptis tnm finding v6 and v7
lung cancer pt1 tnm finding v6
lung cancer pt2 tnm finding v6
lung cancer pt3 tnm finding v6
lung cancer pt4 tnm finding v6
lung cancer pnx tnm finding v6 and v7
lung cancer pn0 tnm finding v6 and v7
lung cancer pn1 tnm finding
lung cancer pn2 tnm finding v6 and v7
lung cancer pn3 tnm finding v6 and v7
lung cancer pmx tnm finding v6
lung cancer pm0 tnm finding
lung cancer pm1 tnm finding v6
iris spindle cell melanoma
lung cancer clinical tnm finding v6
lung cancer pathologic regional lymph nodes tnm finding v6
lung cancer pathologic distant metastasis tnm finding v6
lung cancer pathologic primary tumor tnm finding v6
augmented ointment dosage form
pastille dosage form
minimally invasive lesion
ring dosage form
myasthenia gravis
choroid spindle cell melanoma
drop solution dosage form
gel forming drop solution dosage form
drop suspension dosage form
tablet coated particle dosage form
levamisole hydrochloride
intermediate cell type choroid melanoma
tablet for solution dosage form
tablet for suspension dosage form
orally disintegrating delayed release tablet dosage form
lampyridae
blood type
intermediate cell type iris melanoma
biopax
resource description framework
serum chemistry measurement
serum albumin measurement
serum alkaline phosphatase measurement
serum alanine aminotransferase measurement
serum aspartate aminotransferase measurement
blood urea nitrogen measurement
choroid epithelioid cell melanoma
serum calcium measurement
serum chloride measurement
serum bicarbonate measurement
serum creatinine measurement
serum direct bilirubin measurement
serum gamma glutamyl transpeptidase measurement
serum lactate dehydrogenase measurement
serum glucose measurement
serum phosphate measurement
serum sodium measurement
serum potassium measurement
serum total bilirubin measurement
serum total cholesterol measurement
serum total protein measurement
serum uric acid measurement
serum magnesium measurement
investigation finding
serum triglyceride measurement
class comparison
grouping factor
statistical significance
serum hdl cholesterol measurement
serum ldl cholesterol measurement
voice alteration
urine chemistry measurement
urine sodium measurement
urine calcium measurement
urine potassium measurement
urine creatinine measurement
urine magnesium measurement
malignant uveal neoplasm
decreased sperm count
mutyh gene
mutyh wt allele
1p34 .3 - p32 .1
adenine dna glycosylase
cat wt allele
catalase
eigenvalue
v930 vaccine
intetumumab
aerosolized liposomal rubitecan
sagopilone
viagenpumatucel - l
serine / threonine kinase inhibitor
aurora kinase inhibitor mln8054
synthetic breast cancer peptides - tetanus toxoid - montanide isa - 51 vaccine
autologous dendritic cell - autologous tumor mrna - human cd40l vaccine
paclitaxel preparation
paclitaxel vitamin e - based emulsion
iss 1018 cpg oligodeoxynucleotide
3 , 4 - methylenedioxymethamphetamine
algenpantucel - l
sodium stibogluconate
siltuximab
demineralized bone matrix
casopitant mesylate
quadrivalent human papillomavirus  ( types 6 ,  11 ,  16 ,  18 )  recombinant vaccine
mage - a3 / hpv 16 peptide vaccine
xenopus laevis
sepantronium bromide
archaea
ecromeximab
lactobacillus rhamnosus gg
adenovirus her2 - transduced autologous dendritic cell vaccine
nedaplatin
levodopa
glycopeptide antibiotic
checkpoint kinase inhibitor xl844
noscapine hydrochloride
tlr7 agonist 852a
perflutren protein - type a microspheres
quadrant
kidney and ureter
rat proliferative change by location
skene gland
penile portion of the urethra
bulbomembranous urethra
anterior portion of the urethra
posterior portion of the urethra
cryoablation
cystine / glutamate transporter protein
slc7a11 gene
slc7a11 wt allele
nanog gene
nanog wt allele
homeobox protein nanog
sox2 gene
sox2 wt allele
transcription factor sox - 2
pou5f1 gene
pou5f1 wt allele
pou domain ,  class 5 ,  transcription factor 1
pngvl3 - hicd vaccine
lmna gene
lmna wt allele
il23a gene
il23a wt allele
interleukin - 23 subunit alpha
audiology
metabolite
preparative regimen
baculoviridae
gastric cancer tnm finding v6
gastric cancer clinical tnm finding v6
gastric cancer pathologic tnm finding v6
gastric cancer pathologic primary tumor tnm finding v6
gastric cancer pathologic regional lymph nodes tnm finding v6
gastric cancer pathologic distant metastasis tnm finding v6
liver cancer tnm finding v6
liver cancer clinical tnm finding v6
liver cancer pathologic tnm finding v6
liver cancer pathologic primary tumor tnm finding v6
liver cancer pathologic regional lymph nodes tnm finding v6
liver cancer pathologic distant metastasis tnm finding v6
liver cancer ptx tnm finding v6
ciliary body spindle cell melanoma
liver cancer pt0 tnm finding v6
liver cancer pt1 tnm finding v6
liver cancer pt2 tnm finding v6
liver cancer pt3 tnm finding v6
liver cancer pt4 tnm finding v6
liver cancer pnx tnm finding v6
liver cancer pn0 tnm finding v6
liver cancer pn1 tnm finding v6
liver cancer pmx tnm finding v6
liver cancer pm0 tnm finding
intermediate cell type ciliary body melanoma
liver cancer pm1 tnm finding v6
gastric cancer ptx tnm finding v6 and v7
gastric cancer pt0 tnm finding v6 and v7
gastric cancer ptis tnm finding v6 and v7
gastric cancer pt1 tnm finding v6
gastric cancer pt2 tnm finding v6
applicant
gastric cancer pt2a tnm finding v6
gastric cancer pt2b tnm finding v6
gastric cancer pt3 tnm finding v6
ciliary body epithelioid cell melanoma
gastric cancer pt4 tnm finding v6
gastric cancer pnx tnm finding v6 and v7
gastric cancer pn0 tnm finding v6
gastric cancer pn1 tnm finding v6
gastric cancer pn2 tnm finding v6
gastric cancer pn3 tnm finding v6
gastric cancer pmx tnm finding v6
gastric cancer pm0 tnm finding
gastric cancer pm1 tnm finding v6 and v7
gene transfer or gene delivery agent
bladder cancer clinical tnm finding v6
bladder cancer pathologic tnm finding v6
bladder cancer pathologic primary tumor tnm finding v6
bladder cancer pathologic regional lymph nodes tnm finding v6
bladder cancer pathologic distant metastasis tnm finding v6
bladder cancer ptx tnm finding v6 and v7
bladder cancer pt0 tnm finding v6 and v7
bladder cancer pta tnm finding v6 and v7
bladder cancer ptis tnm finding v6 and v7
bladder cancer pt1 tnm finding v6 and v7
stage 0 laryngeal squamous cell carcinoma ajcc v6 ,  v7 ,  and v8
bladder cancer pt2 tnm finding v6
bladder cancer pt2a tnm finding v6
bladder cancer pt2b tnm finding v6
bladder cancer pt3 tnm finding v6 and v7
bladder cancer pt3a tnm finding v6 and v7
bladder cancer pt3b tnm finding v6 and v7
bladder cancer pt4 tnm finding v6
bladder cancer pt4a tnm finding v6
bladder cancer pt4b tnm finding v6 and v7
bladder cancer pnx tnm finding v6 and v7
stage iva laryngeal squamous cell carcinoma ajcc v7
bladder cancer pn0 tnm finding v6 and v7
bladder cancer pn1 tnm finding v6
bladder cancer pn2 tnm finding v6
bladder cancer pn3 tnm finding v6
bladder cancer pmx tnm finding v6
bladder cancer pm0 tnm finding
bladder cancer pm1 tnm finding v6 and v7
bladder cancer tnm finding v6
severe aplastic anemia
stage ivb laryngeal squamous cell carcinoma ajcc v7
idiopathic aplastic anemia
aplastic anemia due to hepatitis
non - congenital amegakaryocytosis
paroxysmal nocturnal hemoglobinuria
congenital abnormalities of erythrocyte differentiation or function
shwachman - diamond syndrome
congenital pure red cell aplasia
sickle cell - thalassemia
severe combined immunodeficiency with absence of t and b cells
severe combined immunodeficiency with absence of t ,  normal b cells
stage ivc laryngeal squamous cell carcinoma ajcc v7
omenn syndrome
congenital neutropenia
neutrophil actin defect
cd40 ligand deficiency
cartilage hair hypoplasia
x - linked lymphoproliferative syndrome
congenital platelets abnormality
amegakaryocytosis
glanzmann thrombasthenia
stage ivc laryngeal verrucous carcinoma ajcc v7
lysosomal storage disease
metachromatic leukodystrophy
adrenoleukodystrophy
leukodystrophy
krabbe disease
lesch - nyhan syndrome
monitoring
neuronal ceroid lipofuscinosis
neuronal ceroid lipofuscinosis type 3
mucopolysaccharidosis
stage ivb laryngeal verrucous carcinoma ajcc v7
hunter syndrome
hurler syndrome
sanfilippo syndrome
morquio syndrome
maroteaux - lamy syndrome
scheie syndrome
mucolipidosis
gaucher disease
niemann - pick disease
stage iva laryngeal verrucous carcinoma ajcc v7
i - cell disease
wolman disease
glycogen storage disease
aspartylglycosaminuria
fucosidosis
mannosidosis
familial hemophagocytic lymphohistiocytosis
psoriatic arthritis
still disease
oligoarticular still disease
stage 0 laryngeal verrucous carcinoma ajcc v6 ,  v7 ,  and v8
polyarticular still disease
necrotizing arteritis
overlap necrotizing arteritis
antiphospholipid syndrome
evans syndrome
blastemal cell
lacrimal gland carcinoma
tubular structures present
computation
control
recombinant gonadorelin
stage ivc hypopharyngeal squamous cell carcinoma ajcc v7
convention
convolution
couple
crystal
folitixorin
sivifene
amonafide l - malate
oportuzumab monatox
apixaban
bcr - abl  ( b2a2 )  - derived peptide vaccine
stage ivb hypopharyngeal squamous cell carcinoma ajcc v7
bcr - abl  ( b3a2 )  - derived peptide vaccine
b - raf / vegfr - 2 inhibitor raf265
delta - 8 - tetrahydrocannabinol
denosumab
talimogene laherparepvec
ino - 1001
jin fu kang
liposome - encapsulated doxorubicin citrate
methazolamide
tozasertib lactate
stage iva hypopharyngeal squamous cell carcinoma ajcc v7
nadroparin calcium
padoporfin
recombinant thyrotropin alfa
reduced glutathione - l - cysteine - anthocyanins gel
senna extract
oligonucleotide spc2996
ezatiostat hydrochloride
vcl - cb01 vaccine
xaliproden hydrochloride
gastrin / cholecystokinin type b receptor inhibitor z - 360
stage i thyroid gland medullary carcinoma ajcc v7
deletion
economics
electricity
uterine corpus cancer clinical tnm finding v6
uterine corpus cancer pathologic tnm finding v6
uterine corpus cancer pathologic primary tumor tnm finding v6
uterine corpus cancer pathologic regional lymph nodes tnm finding v6
uterine corpus cancer pathologic distant metastasis tnm finding v6
uterine corpus cancer ptx tnm finding v6
stage ii thyroid gland medullary carcinoma ajcc v7
uterine corpus cancer pt0 tnm finding v6
uterine corpus cancer ptis tnm finding v6
uterine corpus cancer pt1 tnm finding v6
uterine corpus cancer pt1a tnm finding v6
uterine corpus cancer pt1b tnm finding v6
uterine corpus cancer pt1c tnm finding v6
uterine corpus cancer pt2 tnm finding v6
uterine corpus cancer pt2a tnm finding v6
uterine corpus cancer pt2b tnm finding v6
uterine corpus cancer pt3 tnm finding v6
stage iii thyroid gland medullary carcinoma ajcc v7
uterine corpus cancer pt3a tnm finding v6
uterine corpus cancer pt3b tnm finding v6
uterine corpus cancer pt4 tnm finding v6
uterine corpus cancer pnx tnm finding v6
uterine corpus cancer pn0 tnm finding v6
uterine corpus cancer pn1 tnm finding v6
uterine corpus cancer pmx tnm finding v6
uterine corpus cancer pm0 tnm finding
uterine corpus cancer pm1 tnm finding v6
stage iv thyroid gland medullary carcinoma ajcc v7
uterine ligament
follicle
granule
homeopathy
homogeneity
independence
induction
infundibulum
stage iva nasopharyngeal keratinizing squamous cell carcinoma ajcc v7
biologically based practices
orthomolecular medicine
management
mania
tissue breakdown
moderate
network
opening
osmosis
stage ivb nasopharyngeal keratinizing squamous cell carcinoma ajcc v7
phenomenon
polyclonal antibody
testicular typical seminoma
polymorphism
presentation
stage ivb oropharyngeal squamous cell carcinoma ajcc v7
promotion
shock from lead
registry
testicular mass
r on t phenomenon by ecg finding
science
radiation exposure
lidocaine
stage ivc oropharyngeal squamous cell carcinoma ajcc v7
unintended radiation exposure
computer hardware device
dialysate concentrate device
spread
stimulation
synthesis
tissue dissection
stage iva oropharyngeal squamous cell carcinoma ajcc v7
clinical data interchange standards consortium terminology
contribution
working group
renal pelvis carcinoma
gonadal dysgenesis
greater
lesser
national
mediator
saturation
office of biotechnology activities
sclerosing peritonitis
renal pelvis adenocarcinoma
north american industry classification system
standard industrial classification
allogeneic dendritic cell - myeloma idiotype vaccine
sr - bp1 / hsi inhibitor sr31747a
licorice
pegylated liposomal belotecan
alacizumab pegol
meloxicam
stage i renal pelvis cancer ajcc v7
transdermal estrogen
terameprocol
wt1 126 - 134 peptide vaccine
amenorrhea
hirsutism
ovarian hilus
stage ii renal pelvis cancer ajcc v7
cardiomegaly
basilar rales
s3 gallop
thrombolysis
ring
apparatus
stage iii renal pelvis cancer ajcc v7
appendage
arch
arrest
artificial
ascend
aspect
thyrotoxicosis
stage iv renal pelvis cancer ajcc v7
attachment
attenuation
barium
histologic type
biomedicine
renal pelvis papillary urothelial carcinoma
board
boron
branch
frustration
brief
broad
bulb
canal
care
gi - 4000 vaccine
stage 0 ureter cancer ajcc v7
darinaparsin
adenovirus encoding recombinant human endostatin
coxsackievirus a21
selective estrogen receptor modulator tas - 108
melan - a vlp vaccine
cessation
rft5 - dga immunotoxin imtox25
nitric oxide - releasing acetylsalicylic acid derivative
linoleic acid
stage i ureter cancer ajcc v7
posaconazole
integrin alpha - 2 inhibitor e7820
mapatumumab
farletuzumab
recombinant human hyaluronidase
live freeze - dried lactic acid bacteria probiotic
inulin
vegfr2 / pdgfr / c - kit / flt - 3 inhibitor su014813
cholangiography
circumflex
stage ii ureter cancer ajcc v7
cleft
cofactor
cohort
collateral
college
colony
combination
stage iii ureter cancer ajcc v7
composite
abacavir
acebutolol
adefovir
atorvastatin
comprehensive
pharmacogenomics domain
stage iv ureter cancer ajcc v7
conduction
microbiology susceptibility domain
arrangement
conjugate
inclusion exclusion criteria not met domain
mural nodule
consortium
ureter squamous cell carcinoma
cord
mixed neoplastic epithelial cell population
bone mineral density test
corpuscle
counseling
ridge
ureter adenocarcinoma
crest
crypt
cusp
cytolytic process
cytosol
damage
defense
degeneration
degradation
infiltrating ureter urothelial carcinoma with squamous differentiation
delivery
rete ovarii
dense
femoral neck
vinflunine
bendamustine hydrochloride
tubulin binding agent tti - 237
apf530
berubicin hydrochloride
blister pack dosing unit
infiltrating ureter urothelial carcinoma with glandular differentiation
deregulation
lyso - thermosensitive liposome doxorubicin
dermatome
descend
uterine corpus cancer
extraction
cantuzumab ravtansine
logical operator
equality
greater than or equal to
greater than
less than
less than or equal to
danusertib
early
ureter undifferentiated carcinoma
nitrogen mustard prodrug pr - 104
hodgkin's antigens - gm - csf - expressing cell vaccine
polyvinylpyrrolidone - sodium hyaluronate gel
bonferroni adjustment
alpha - lipoic acid
benjamini - hochberg procedure
oligofructose - enriched inulin
male genitalia
lipid
ureter urothelial papilloma
female genitalia
multiple comparison adjustment
basal cell of the squamous epithelium
clomiphene
clomipramine
levamisole
ureter leiomyoma
meclizine
metformin
pemetrexed
amikacin
ureter schwannoma
acetarsol
acetazolamide sodium
acetic acid
alendronic acid
alfentanil
alfuzosin
almotriptan malate
alpha - d - glucopyranose monohydrate
bladder signet ring cell adenocarcinoma
alphaprodine hydrochloride
aluminum stearate
amantadine
amiloride
aminobenzoic acid
amlodipine
amphetamine aspartate
andrographolide
antazoline
bladder lymphoma
apraclonidine
arformoterol
benazepril
benzphetamine
benzphetamine hydrochloride
urethral squamous cell carcinoma
beta - d - glucopyranose
beta - d - glucopyranose monohydrate
betaxolol
bisoprolol
bromodiphenhydramine
urethral urothelial carcinoma
calcium cation
carboprost
cefoperazone
cefotetan
cefoxitin
ceftibuten
ceftibuten dihydrate
ceftizoxime
cefuroxime
urethral adenocarcinoma
cephapirin
chloroquine
ciclopirox
cidoxepin hydrochloride
urethral undifferentiated carcinoma
citalopram
clavulanic acid
clindamycin palmitate hydrochloride
clodronic acid
clopidogrel
cloxacillin
cloxyquin
urethral condyloma
corticorelin ovine
cromolyn
cyclophosphamide anhydrous
dantrolene
dantrolene sodium
deserpidine
lomustine
urethra fibroepithelial polyp
desipramine
desmopressin
desonide
desvenlafaxine
desvenlafaxine succinate
dexbrompheniramine
dexbrompheniramine maleate
dexchlorpheniramine
dextroamphetamine saccharate
limonene ,   (  +  /  -  )  -
urethral leiomyoma
rathyronine
propoxyphene ,   (  +  /  -  )  -
5 - hydroxytryptophan ,  dl -
dl - phenylalanine
limonene ,   (  +  )  -
d - phenylalanine
anhydrous dextrose
dextrose monohydrate
sodium lactate ,  d -
dextrothyroxine
urethral clear cell adenocarcinoma
dicyclomine
diethylpropion
diflorasone
digitalin
dihydrostreptomycin
diltiazem
dimyristoyl lecithin
dinoprostone
diphenhydramine
dipivefrin
urethral inverted papilloma
disopyramide
dl - alanine
dl - proline
dobutamine
docetaxel anhydrous
dolasetron
doxapram
doxazosin
doxylamine
d - serine
ureter inverted papilloma
econazole
edetate disodium
edetic acid
emedastine
emedastine difumarate
enclomiphene citrate
entacapone
epiandrosterone
epoprostenol
eprosartan
ureter lymphoma
erdosteine
ergotamine
ertapenem
ertapenem sodium
escitalopram
ethambutol
monoethanolamine
ethanolamine oleate
ethchlorvynol
fenoldopam
ureter small cell carcinoma
fenoprofen
fenoprofen calcium
fentanyl hydrochloride
ferrous fumarate
fexofenadine
flavoxate
fluorescein
fluticasone
fluvastatin
fluvoxamine
bladder inflammatory myofibroblastic tumor
fomivirsen sodium
fosamprenavir calcium
fosfomycin
4 - hydroxybutanoic acid
ganirelix acetate
gemifloxacin
gentian violet
gluconic acid
glycol dimethacrylate
guanfacine
bladder leiomyoma
halazepam
halobetasol
heptanoic acid
homatropine
homatropine methylbromide
hydrocortisone acetate
hydrocortisone hemisuccinate
hydroxyamphetamine
imipramine pamoate
inamrinone
bladder clear cell adenocarcinoma
iodipamide
iothalamic acid
ioxaglic acid
ipratropium
isoxsuprine
ivermectin
ketamine
ketorolac tromethamine
ketotifen
loperamide
adult kidney wilms tumor
lanthanum
lanthanum carbonate
lanthanum cation  ( 3 )
carbidopa anhydrous
levobupivacaine hydrochloride
levocabastine
lactic acid ,  l -
levomenthol
kidney extraskeletal osteosarcoma
levorphanol
lincomycin
lithium citrate
lodoxamide
lomefloxacin
loracarbef anhydrous
renal pelvis fibroepithelial polyp
mandelic acid
mefloquine
kidney leiomyosarcoma
mepivacaine
mercaptopurine anhydrous
meropenem anhydrous
methamphetamine
methenamine
methicillin
metoprolol
midodrine
miglitol
kidney liposarcoma
mupirocin calcium
nalbuphine
naphazoline
nateglinide
infiltrating renal pelvis urothelial carcinoma ,  sarcomatoid variant
nitrogen
oleandomycin
oleandomycin phosphate
olopatadine
olopatadine hydrochloride
orphenadrine
oxiconazole
renal pelvis inverted papilloma
oxymetazoline
palmitic acid
pamidronic acid
pancuronium
pantoprazole sodium
paromomycin
stage 0 bladder urothelial carcinoma ajcc v6 and v7
pegvisomant
penbutolol sulfate
penicillin g
phentermine
piperacillin anhydrous
piperazine
pirbuterol
polymyxin b
polymyxin b sulfate
polymyxin b1
polymyxin b1 sulfate
polymyxin b2
polymyxin b2 sulfate
lorazepam
pramlintide
pramlintide acetate
pramocaine
prednisolone 21 - phosphate
procaine
stage i bladder urothelial carcinoma ajcc v6 and v7
proparacaine
propoxyphene
pseudoephedrine
pyrithione
quetiapine
quipazine
inverted urothelial papilloma
rifaximin
rimantadine
rimantadine hydrochloride
ritodrine
stage 0 renal pelvis cancer ajcc v7
rosuvastatin calcium
salicylic acid
sarcolysin
collecting duct carcinoma
sildenafil
sorafenib
sotalol
stage 0 urethral cancer ajcc v7
sparfloxacin
spectinomycin
streptomycin
succimer
succinylcholine
sulbactam
sulconazole
sulfamerazine
stage 0a urethral cancer ajcc v7
sulfamethazine
terbutaline
tetrahydrozoline
stage i urethral cancer ajcc v7
thioguanine anhydrous
ticlopidine
tiludronate disodium
tiotropium bromide monohydrate
tolmetin sodium
trandolapril
stage ii urethral cancer ajcc v7
tranylcypromine sulfate
triclosan
trientine hydrochloride
stage iii urethral cancer ajcc v7
water o - 15
lovastatin
stage iv urethral cancer ajcc v7
amiodarone
lysate
amitriptyline
amphetamine
normalize
arginine
beclomethasone
bromocriptine
bupivacaine
bupropion
buspirone
av block first degree
av block second degree by ecg finding
av block second degree mobitz type i
av block second degree mobitz type ii
codon
stage 0a renal pelvis cancer ajcc v7
ceftriaxone
cephalothin
dextromethorphan
diphenoxylate
dopamine
dorzolamide
enalapril
epirubicin
flecainide
stage 0a ureter cancer ajcc v7
flurazepam
granisetron
hydralazine
hydrocodone
hydromorphone
imatinib
subclone
imipramine
childhood central nervous system teratoma
irinotecan
isoproterenol
leuprolide
levobunolol
methadone
methylphenidate
metoclopramide
mexiletine
miconazole
midazolam
childhood central nervous system germ cell tumor
mitoxantrone
morphine
moxifloxacin
nafcillin
naloxone
naltrexone
mechlorethamine
bitewing radiograph
periodontal probe
norethindrone
childhood central nervous system choriocarcinoma
nortriptyline
oseltamivir
mastication
oxacillin
penicillin v
phenoxybenzamine
phentolamine
phenylephrine
pilocarpine
piperacillin
childhood brain germinoma
pravastatin
primaquine
procarbazine
propranolol
quinapril
sodium citrate
rosiglitazone
sulfacetamide
tamoxifen
tazobactam
childhood central nervous system embryonal carcinoma
levothyroxine
thiethylperazine
tobramycin
tolterodine
trifluoperazine
ecg measurement
mean pr duration
mean qrs duration
mean qt duration
childhood central nervous system yolk sac tumor
mean rr duration
daunorubicin
dental bonding agent
minimum rr duration
maximum rr duration
mean heart rate
minimum heart rate
norepinephrine ,  dl -
recombinant lymphokine
soft palate benign granular cell tumor
destruction
device
diagonal
diastole
soft palate pleomorphic adenoma
systole
qtcb  -  bazett's correction formula
qtcf  -  fridericia's correction formula
qtclc  -  linear correction formula
mean jt duration
minimum jt duration
maximum jt duration
jtcb  -  bazett's correction formula
jtcf  -  fridericia's correction formula
hard palate pleomorphic adenoma
jtclc  -  linear correction formula
mean p axis
sitting
mean p wave duration
mean p wave height
minimum pr duration
cavity liner
hard palate adenoid cystic carcinoma
maximum pr duration
mean qrs axis
minimum qt duration
maximum qt duration
mean r wave amplitude
mean s wave amplitude
area code
telephone extension number
hard palate mucoepidermoid carcinoma
apartment
client
encounter
mean r + s amplitude
mean st segment duration
mean t wave axis
mean t wave duration
mean t wave area
mean t wave height
childhood anaplastic astrocytoma
mean ventricular heart rate
minimum ventricular heart rate
maximum ventricular heart rate
mean st deviation
minimum st deviation
maximum st deviation
mean st segment elevation
minimum st segment elevation
childhood brain stem astrocytoma
maximum st segment elevation
mean st segment depression by ecg finding
minimum st segment depression by ecg finding
maximum st segment depression by ecg finding
body position
prone position
standing
supine position
trendelenburg
reverse trendelenburg
recurrent childhood brain stem astrocytoma
right lateral decubitus position
left lateral decubitus position
fowler's position
semi - fowler's position
l - gossypol
dacetuzumab
benign adult cerebral neoplasm
cold
hot
sweet
articulation
dissatisfaction
satisfaction
self - conscious
embarrassment
relaxation
difficulty
benign childhood cerebral neoplasm
salivary gland clear cell carcinoma ,  not otherwise specified
intraductal carcinoma of the minor salivary gland
salivary gland mucinous adenocarcinoma
salivary gland oncocytic carcinoma
wild type
salivary gland adenocarcinoma ,  not otherwise specified
hardy - weinberg distribution
nonsense mutation
inframe mutation
recombinant tumor necrosis factor - beta
cerebral hemisphere lipoma
point mutation
amphotericin b deoxycholate
breast tubular adenoma
eno2 gene
eno2 wt allele
intraductal lesion
gamma - enolase
70% ethyl alcohol
tissue processor
benign thalamic neoplasm
cure
cold agglutinin
unevaluable
strong
weak
subareolar region
juvenile lesion
formaldehyde solution
potential
abstractor
monomorphic ventricular tachycardia by ecg finding
polymorphic ventricular tachycardia by ecg finding
sinus arrhythmia by ecg finding
wandering atrial pacemaker by ecg finding
sinus arrest by ecg finding
sinus node dysfunction
sick sinus syndrome
ectopic atrial rhythm by ecg finding
short pr interval by ecg finding
prolonged pr interval by ecg finding
isorhythmic atrioventricular dissociation
paroxysmal atrioventricular block by ecg finding
digital
inappropriate sinus tachycardia by ecg finding
direct
indirect
ventricular premature complex by ecg finding
atrial premature complex by ecg finding
delta wave by ecg finding
ventricular couplet by ecg finding
disc
atrioventricular reentrant tachycardia by ecg finding
discover
diversity
domestic
accelerated idioventricular rhythm by ecg finding
left anterior fascicular block by ecg finding
left posterior fascicular block by ecg finding
left bundle branch block by ecg finding
right bundle branch block by ecg finding
nonspecific intraventricular conduction delay by ecg finding
fluoroethyltyrosine f18
cello pack dosing unit
inhaler dosing unit
insert dosing unit
assent
skin nodular basal cell carcinoma
treatment assent
superficial basal cell carcinoma
domain
hold
dentin desensitizer
hyperocclusion
sedative filling
hybrid composite
flowable composite
dental percussion
occlusal adjustment
dental occlusion
instrument data
ambient
nanoscale process
nanoparticle
nanoparticle application
clinical nanoparticle application
nanoparticle - mediated drug delivery
nanocontainer
non - clinical nanoparticle application
nanofabrication
nanoimprinting
nanolithography
nanoparticle characterization
nanotechnology techniques
optical trap
optical tweezers
field flow fractionation
fluorimetry
light scattering
multi - angle laser light scattering
static light scattering
spectrometry
glow discharge mass spectrometry
inductively - coupled plasma mass spectrometry
photon correlation spectroscopy
particle count and size analyzer
nanomanipulator
central nervous system carcinoma
spectrophotometer
nanoparticle chemical characterization
nanoparticle functionality
spectrometer
emission spectrometer
inductively - coupled plasma optical emission spectrometer
optical emission spectrometer
nanoarray
nanoparticle chemical composition
nanopore
aggregation
inductively - coupled plasma
nanoscale phenomena
nanoscale mechanism
nanoparticle surface characteristic
nanoparticle topology
physical composition
purity
stalk
zeta potential
with
metal chelator
gadolinium - chelate
oral health impact profile
stage ivc nasopharyngeal keratinizing squamous cell carcinoma ajcc v7
nanoparticle physical characterization
dendrimer
nanoparticle complex
nanocomposite
nanodevice
nanobomb
nanocantilever
nanoemulsion
ethmoid sinus adenocarcinoma
nanomaterial
nanoprobe
nanorod
nanosensor
nanoshell
nanowire
quantum dot
nanoparticle type
ethmoid sinus adenoid cystic carcinoma
buckyball
engineered nanoparticle
fullerene
nanochannel
liposome vesicle
nanofiber
nanohorn
single - walled nanohorn
nanosphere
carbon nanotube
maxillary sinus adenoid cystic carcinoma
double - walled nanotube
multi - walled nanotube
single - walled nanotube
micellar template - mediated nanoparticle synthesis
who central nervous system grade i
who central nervous system grade ii
who central nervous system grade iii
who central nervous system grade iv
transanal excision
intact
manganese
maxillary sinus adenocarcinoma
muscularis propria
focality
indium in 111 chimeric monoclonal antibody 806
perinephric
attenuated listeria monocytogenes crs - 100
oropharyngeal adenoid cystic carcinoma
interstitial disease
fuhrman nuclear grade
applicator dosing unit
canister dosing unit
case dosing unit
dewar dosing unit
dialpack dosing unit
dose pack dosing unit
inhaler refill dosing unit
jug dosing unit
oral cavity pleomorphic adenoma
supersack dosing unit
tabminder dosing unit
los angeles classification system
la grade a
la grade b
la grade c
la grade d
fuhrman grade 1
fuhrman grade 2
minor salivary gland acinic cell carcinoma
fuhrman grade 3
fuhrman grade 4
uncinate process of pancreas
valvular stenosis
dovitinib lactate
pulmonary valvular insufficiency
tivantinib
number type
natural number
orbit lymphoma
whole number
rational number
complex number
real number
plinabulin
catumaxomab
integrity
flexural skin
tubule formation
urelumab
orbit hemangioma
ny - eso - 1 plasmid dna cancer vaccine ppjv7611
metronomic chemotherapy
dnajb4 gene
dnajb4 wt allele
dnaj homolog subfamily b member 4
ccn2 gene
ccn2 wt allele
6q23 .1
orbit embryonal rhabdomyosarcoma
ccn family member 2
wedge - shaped growth pattern
orbit alveolar rhabdomyosarcoma
klh - fitc
folate - fitc
tracheal lymphoma
immunotoxin cmd - 193
indium in 111 - cmd - 193
tigatuzumab
amatuximab
chest wall
ferumoxsil oral suspension
folder
computational proteomics analysis system
anterior tongue carcinoma
outer root sheath
denenicokin
apocrine differentiation
tesevatinib
computer programming object property
mannitol
anterior tongue mucoepidermoid carcinoma
eltrombopag olamine
barasertib
health insurance portability and accountability act
fanconi anemia
diazepinomicin
eftilagimod alpha
anterior tongue adenoid cystic carcinoma
mogamulizumab
bis ( choline ) tetrathiomolybdate
bafetinib
hsp90 inhibitor biib021
phosphorodiamidate morpholino oligomer avi - 4126
program office
childhood brain anaplastic astrocytoma
fluorine f 18 - fluoroazomycin arabinoside
mocetinostat
ar antagonist bms - 641988
cdk inhibitor sns - 032
seneca valley virus - 001
vintafolide
iniparib
adenovirus encoding rat her - 2 / neu
blinatumomab
psilocybine
childhood intracranial meningioma
varlitinib
human monoclonal antibody 216
18f - fhbg
arginine / omega - 3 fatty acids / nucleotides oral supplement
radium ra 223 dichloride
sirna - expressing sv40
glutathione disulfide nov - 002
colloidal gold - bound tumor necrosis factor
titanium dioxide / zinc oxide sunscreen
f - 18 16 alpha - fluoroestradiol
tooth crowding
intraoral appliance
periodontal probing
burning mouth syndrome
canker sore
periodontal pocket
dental prophylaxis
pulpotomy
pulpectomy
practice - based research collaborative in evidence - based dentistry
14c bms - 275183
poly  ( adp - ribose )  polymerase inhibitor
recombinant parathyroid hormone
aurora kinase inhibitor
accepted
ovarian serous surface papillary adenocarcinoma
nih clinical center
dental base
restorative material
bonding restorative material
dental dam
non - carious tissue change
epidermolytic ichthyosis
ovarian endometrioid tumor
bowen disease of the skin
facility
collaborative staging
antilymphocyte serum
capillary leak syndrome
stage iiia ovarian cancer ajcc v6 and v7
bronchiolitis obliterans
cerebrovascular
chimerism
staphylococcus
coagulase - negative staphylococcus
coagulase - positive staphylococcus
cryptogenic organizing pneumonia
delayed puberty
federal wide assurance
gram - positive rod
stage iiib ovarian cancer ajcc v6 and v7
idiopathic pneumonia syndrome
hypopituitarism
mood alteration
national marrow donor program
pharyngeal / respiratory flora
premature ovarian failure
fda center for devices and radiological health terminology
chp - her - 2 peptide vaccine
chp - ny - eso - 1 peptide vaccine imf - 001
maytansine
stage iiic ovarian cancer ajcc v6 and v7
cyclodextrin - based polymer - camptothecin crlx101
retinopathy
secondary adrenal insufficiency
2 - methoxyestradiol nanocrystal colloidal dispersion
stem cell mobilization therapy
thrombotic microangiopathy
characterization
definitive
message
ring dosing unit
ovarian granulosa cell tumor
seer summary staging manual 2000
summary staging guide 1977
manual
edition
thread
computer session
nested diagnostic context
computer operation
computer programming object attribute
california verbal learning test ,  children's version
read permission
write permission
full permission
oxiglutatione
anterior foramen magnum
anterior visual pathway
posterior foramen magnum
malignant ovarian luteinized thecoma
chemo / immuno / hormone therapy regimen
value meaning not provided
salsalate
top
sentence
bms - 275183
benign ovarian luteinized thecoma
upper clivus
trigeminal ganglion
petrous apex
petroclival region
periocular region
sphenoorbital region
sphenocavernous region
emergency
spouse
fallopian tube adenocarcinoma
social
allergen
uric acid
pack dosage form
gene expression profiling
bioluminescence
prothrombin time
beta - 2 - microglobulin
axillary lymph node biopsy
bowel preparation
b2m gene
b2m wt allele
dynamic contrast - enhanced magnetic resonance imaging
radionuclide imaging
dl - arginine hydrochloride
proteomic profiling
fallopian tube papillary adenocarcinoma
childhood cerebral ependymoma
aromatherapy and essential oils
annual screening
periareolar
no rank
forma
parvorder
stage ia fallopian tube cancer ajcc v6 and v7
species group
species subgroup
subgenus
food
mechlorethamine hydrochloride
stage ib fallopian tube cancer ajcc v6 and v7
subspecies
subkingdom
tribe
subtribe
superclass
superfamily
superkingdom
superorder
superphylum
variety
stage ic fallopian tube cancer ajcc v6 and v7
immunoglobulin therapy
bacteriolytic therapy
non - tumor cell derivative vaccine
oncolytic virus therapy
nonmyeloablative allogeneic hematopoietic stem cell transplantation
wechsler intelligence scale for children
wide range achievement test ,  3rd edition
stage iia fallopian tube cancer ajcc v6 and v7
intratumoral therapy
mri - guided focused ultrasound ablation
radioisotope therapy
extracorporeal photopheresis
stage iiia fallopian tube cancer ajcc v7
infrared photocoagulation therapy
tomotherapy
sclerotherapy
endoscopic surgery
cognitive assessment
stage iiib fallopian tube cancer ajcc v7
biliary stenting
kyphoplasty
myriad model
whole blood transfusion
stage iiic fallopian tube cancer ajcc v7
vertebroplasty
use_for
weight gain
unstained specimen
tertomotide
hla class ii histocompatibility antigen ,  drb1 - 4 beta chain protein
hla - c gene
hla - c wt allele
stage iic fallopian tube cancer ajcc v6 and v7
hla class i histocompatibility antigen ,  cw - 1 alpha chain protein
attenuated bacteria vaccine
clostridium novyi - nt spores
synthetic alkaloid pm00104
nintedanib
reciprocal
lmp - 2:340 - 349 peptide vaccine
lmp - 2:419 - 427 peptide vaccine
allogeneic epstein - barr virus - specific cytotoxic t - lymphocytes
stage iib fallopian tube cancer ajcc v6 and v7
obatoclax mesylate
hla class i histocompatibility antigen ,  a - 1 alpha chain
hla class i histocompatibility antigen ,  b - 7 alpha chain
mage - a1 ,  her - 2 / neu ,  fbp peptides cancer vaccine
cutaneous pseudolymphoma
perivascular lymphocytic infiltrate
hla - b gene
hla - b wt allele
fallopian tube gestational choriocarcinoma
hematologic
doppler ultrasound
seliciclib
lmp2a - specific cytotoxic t - lymphocytes
5 - fluoro - 2 - deoxycytidine
hepatitis b virus hbsag surface protein antigen
defecation
defecation urgency
pegylated liposomal irinotecan
fallopian tube endometrioid adenocarcinoma
liposomal vinorelbine
pegdinetanib
hla - dq antigen
hepatitis a virus antibody
tasisulam
hepatitis b virus antibody
hepatitis b virus surface antibody
hepatitis b virus core antibody
restrictive cardiomyopathy
somatostatin receptor agonist
mechlorethamine oxide hydrochloride
fallopian tube clear cell adenocarcinoma
growth hormone secretion abnormality
gonadotropin secretion abnormality
sorting
volume accuracy problem
device vibration
ventilation problem in device environment
unstable device
fallopian tube undifferentiated carcinoma
unsealed device packaging
unraveled material
unintended system motion
unintended movement
unintended ejection
unintended power up
unintended collision
fallopian tube squamous cell carcinoma
unexpected therapeutic result
undersensing
insufficient flow or underinfusion
unable to obtain readings
inadequate ultrafiltration
therapeutic or diagnostic output failure
childhood neoplasm
telemetry discrepancy
tear ,  rip or hole in packaging
suction problem
material stretched
sparking
solder joint failure
brain germinoma
device slipped
short fill
shielding failure
self - activation or keying
scratched material
material too rigid or stiff
incorrect ,  inadequate or imprecise result or readings
restricted flow rate
adult central nervous system germ cell tumor
residue after decontamination
reset issue
device appears to trigger rejection
reflux within device
radiofrequency interference problem
radiation leak
therapy delivered to incorrect body area
pumping stopped
childhood cerebellar astrocytoma
pumping problem
visual prompts will not clear
improper or incorrect procedure or method
premature activation
premature discharge of battery
premature activation of indicator
precipitate in device or device ingredient
power conditioning issue
poor quality image
endometrial endometrioid adenocarcinoma
pocket stimulation
pitted material
perivalvular leak
peeled / delaminated material
particulates
pacer found in back - up mode
oversensing
excess flow or overinfusion
overheating of device
overfill
osseointegration problem
image orientation incorrect
optical obstruction
optical distortion
optical discoloration
optical decentration
operating system version or upgrade problem
operating system interface becomes non - functional
material opacification
obstruction of flow
nonstandard device
no audible prompt / feedback
medroxyprogesterone
endometrial endometrioid adenocarcinoma ,  variant with squamous differentiation
no device output
no flow
no fail - safe mechanism
no display / image
naturally worn material
melted device
moisture or humidity problem
stage ia ovarian germ cell tumor ajcc v6 and v7
moisture damage
misfocusing
misfire
misconnection
power calculation error due to application program problem
migration or expulsion of device
patient - device incompatibility
stage ib ovarian germ cell tumor ajcc v6 and v7
device tipped over
temperature problem
structural problem
shipping damage or problem
retraction problem
stage ic ovarian germ cell tumor ajcc v6 and v7
device remains activated
protective measure problem
pressure issue
packaging problem
stage iic ovarian germ cell tumor ajcc v6 and v7
packaging incomplete or missing
output problem
output below specifications
output above specifications
chemical problem
device fragments in patient
inadequacy of device shape and / or size
device or device quality issue
failure to unfold or unwrap
stage iib ovarian germ cell tumor ajcc v6 and v7
device dislodged or dislocated
device damaged by another device
connection problem
optical problem
device misassembled during manufacturing or shipping
misassembled device
stage iia ovarian germ cell tumor ajcc v6 and v7
mechanics altered
mechanical issue
material twisted / bent
material separation
material rupture
material puncture / hole
material perforation
material integrity problem
material fragmentation
stage iiia ovarian germ cell tumor ajcc v6 and v7
material crack
burst container or vessel
material break
device markings / labeling problem
stage iiib ovarian germ cell tumor ajcc v6 and v7
high ph
device ingredient or reagent problem
compatibility problem
inadequate filtration process
filtration issue
failure to zero
failure to shut off
failure of device to self - test
stage iiic ovarian germ cell tumor ajcc v6 and v7
failure to run on battery
failure to reset
failure to power - up
failure to capture
failure to calibrate problem
failure to auto stop
medical device failure or malfunction
fail - safe mechanism problem
expiration date error
megestrol
uterine corpus neoplasm
energy spectrum incorrect
energy output problem
device smoking
device emits odor
electrical / electronic property problem
stage ia uterine corpus cancer ajcc v7
device difficult to prepare
difficult to open or close
activation ,  positioning or separation problem
delivered as unsterile product
device damaged prior to use
device contamination with body fluid
contamination during use
device contaminated during manufacturing or shipping
stage ib uterine corpus cancer ajcc v7
component or accessory incompatibility
component missing
component incompatible
defective component
complete blockage device
power problem
charging problem
capturing problem
calibration problem
battery problem
inappropriate reset to default
device alarm system
position problem
activation difficult or delayed
accessory incompatible
mechanical jam
measurement system incompatibility
manufacturing ,  packaging or shipping problem
application security problem
malposition of device
low sensing threshold
low test results
low readings
low impedance
low audible alarm
loss of threshold
loss of power problem
loss of osseointegration
loose connection
leak / splash
stage iiia uterine corpus cancer ajcc v7
material invagination
intermittent shock
sensing intermittently
pacing intermittently
intermittent infusion
intermittent continuity
intermittent capture
stage iiib uterine corpus cancer ajcc v7
insufficient heating
insufficient cooling
labeling ,  instructions for use or training problem
installation - related problem
infusion or flow problem
inflation problem
increased pump speed
increased device sensitivity
increase in suction
stage iiic uterine corpus cancer ajcc v7
increase in pressure
off - label use
parameter calculation error due to application program problem
incorrect measurement
incorrect interpretation of signal
inadequate instructions for healthcare professional
display or visual feedback problem
stage iva uterine corpus cancer ajcc v7
incomplete coaptation
inaudible or unclear audible prompt / feedback
inappropriate shock
inappropriate audible prompt / feedback
pacing inadequately
device reprocessing problem
stage ivb uterine corpus cancer ajcc v7
inadequate user interface
inaccurate synchronization
inaccurate flow rate
inaccurate delivery
inability to irrigate
inability to autofill
gas output problem
malignant uterine corpus mixed epithelial and mesenchymal neoplasm
improper flow or infusion
improper chemical reaction
device imprecision
impedance problem
image display error / artifact
high sensing
high test results
high readings
high impedance
grounding malfunction
gradient increase
gas leak
fungus in device environment
fume or vapors
stage ia cervical cancer ajcc v6 and v7
free or unrestricted flow
material frayed
fracture of device / material
device contamination with chemical or other material
fogging
fluid leak
tidal volume fluctuations
stage ia1 cervical cancer ajcc v6 and v7
flare or flash
flaked material
fitting problem
device fire
filling problem
false positive result
false negative result
stage ia2 cervical cancer ajcc v6 and v7
false alarm
failure to transmit record
problem with sterilization
inappropriate waveform
defibrillation problem
separation failure
stage ib cervical cancer ajcc v6 and v7
failure to sense
failure to select signal
problem with removal of enzymatic cleaner
failure to read input signal
failure to pump
failure to prime
pacing problem
stage ib1 cervical cancer ajcc v6 and v7
failure to osseointegrate
failure to obtain sample
failure to interrogate
failure to infuse
failure to fold
flushing problem
failure to fire
failure to disinfect
stage ib2 cervical cancer ajcc v6 and v7
failure to disconnect
failure to discharge
failure to deploy
failure to deliver energy
failure to deliver shock
failure to deliver
failure to cycle
failure to cut
failure to convert to back - up
stage iia cervical cancer ajcc v6
failure to convert rhythm
failure to conduct
failure to charge
loss of or failure to bond
failure to back - up
failure to analyze signal
failure to align
failure to advance
therapeutic melatonin
stage iib cervical cancer ajcc v6 and v7
excessive cooling
device displays incorrect message
erratic or intermittent display
material erosion
environmental  compatibility problem
stage iiib cervical cancer ajcc v6 and v7
entrapment of device
emergency power failure
electro - static discharge problem
electromagnetic interference
electromagnetic compatibility problem
electrical shorting
electrical power problem
electrical overstress
dull device
stage iiia cervical cancer ajcc v6 and v7
dose calculation error in application program
display difficult to read
material disintegration
disconnection
discolored material
difficult to remove
stage iva cervical cancer ajcc v6 and v7
difficult to open or remove packaging material
difficult to interrogate
difficult to insert
difficult to fold or unfold
difficult to advance
device - device incompatibility
device sensing issue
stage ivb cervical cancer ajcc v6 and v7
failure to recalibrate
detachment of device or device
difficult or delayed positioning
dent in material
delayed alarm
material deformation
deflation problem
vaginal verrucous carcinoma
defective device
defective alarm
decreased pump speed
decreased device sensitivity
decrease in suction
decrease in device pressure
decoupling
loss of data
data back - up problem
unauthorized access to computer system
vaginal leiomyosarcoma
cross reactivity
corroded device
use of incorrect control settings
continuous firing
contamination of device ingredient or reagent
inadequate instructions for non - healthcare professional
computer software problem
computer operating system problem
communication or transmission problem
collapse of device
coagulation in device or device ingredient
clumping in device or device ingredient
contamination / decontamination problem
circuit failure
stage ia vulvar carcinoma ajcc v6
delayed charge time
charge aborted
capacitative coupling
calcified material
thermal decomposition of device
deformation due to compressive stress
blocked connection
partial blockage
stage ib vulvar carcinoma ajcc v6
backflow
biofilm coating in device
biocompatibility
bacterial contamination of device
pacing asynchronously
melphalan
stage iva vulvar cancer ajcc v6
signal artifact
electrical arcing
electrical arcing at paddles
electrical arcing at electrodes
application program version or upgrade problem
application program problem
ambient temperature problem
device ambient noise problem
device alarm not visible
no audible alarm
premature elective replacement indicator
gel leak
difficult to flush
use of device problem
metastatic malignant neoplasm in the vulva
premature activation of end - of - life indicator
absolute neutrophil count
neutrophil engraftment
platelet engraftment
engraftment syndrome
context
dna methylation analysis
metastatic malignant neoplasm in the vagina
microsatellite instability analysis
polymorphic microsatellite marker analysis
biomarker analysis
metastatic carcinoma in the uterine cervix
anticoagulation therapy
neutral ph
buffered
methacarn
alphanumeric
universal molecular fixative
growth hormone receptor antagonist
rnalater
bouin's fixative
benign uterine corpus mixed epithelial and mesenchymal neoplasm
acceptable
sufficient
hemolyzed
lipemic
unacceptable
regimen used to treat hodgkin lymphoma
regimen used to treat breast carcinoma
regimen used to treat small cell lung carcinoma
uterine corpus adenosarcoma
regimen used to treat non - small cell lung carcinoma
regimen used to treat gastric carcinoma
vacutainer
separator
abvd regimen
mopp regimen
mopp / abv hybrid regimen
disabled
mopp alternating with abvd regimen
stanford v regimen
uterine corpus adenofibroma
eva regimen
mini - beam regimen
dry ice
citrate
acid - citrate - dextrose
chlvpp regimen
eshap regimen
copp regimen
cae regimen
uterine corpus adenomyoma
cav regimen
carboplatin / etoposide regimen
ep regimen
cisplatin / irinotecan regimen
pet regimen
sterile
cyclophosphamide / etoposide / vincristine regimen
isopentane
fu - lv regimen
ecf regimen
uterine corpus sarcoma
vapor
slurry
cryobath
cryostat
melting point
fam regimen
famtx regimen
fup regimen
fap regimen
flap regimen
menotropin
uterine corpus leiomyosarcoma
dcf regimen
planimeter
carboplatin / paclitaxel regimen
funded principal investigator
cisplatin / paclitaxel regimen
cisplatin / docetaxel regimen
cisplatin / gemcitabine regimen
cisplatin / vinorelbine regimen
mvp regimen
lead organization
testicular embryonal carcinoma
carboplatin / gemcitabine regimen
participating organization
gemcitabine / vinorelbine regimen
bevacizumab / carboplatin / paclitaxel regimen
ac regimen
doxorubicin / paclitaxel regimen
caf regimen
cmf regimen
capecitabine / docetaxel regimen
cervical squamous cell papilloma
fec regimen
cyclophosphamide / epirubicin regimen
gt regimen
tch regimen
ac - t - t regimen
service - object pair
ac - t regimen
intron splice region mutation
intronic mutation
cervical endometrioid adenocarcinoma
5' flank mutation
3' flank mutation
5' untranslated region mutation
3' untranslated region mutation
epirubicin / vinorelbine regimen
tac regimen
pch regimen
abv regimen
chlvpp / eva regimen
cervical clear cell adenocarcinoma
mine regimen
dhap regimen
regimen used to treat non - hodgkin lymphoma
regimen used to treat chronic lymphocytic leukemia
fc regimen
pc regimen
acvbp regimen
codox - m regimen
codox - m alternating with ivac regimen
cvp regimen
cervical undifferentiated carcinoma
chop regimen
chope regimen
r - chop regimen
cnop regimen
fnd regimen
hypercvad regimen
macop - b regimen
m - bacod regimen
pcr regimen
cervical adenoid cystic carcinoma
promace alternating with cytabom regimen
epoch - r regimen
fr regimen
r - fcm regimen
r - fm regimen
r - ice regimen
rituximab / thalidomide regimen
regimen used to treat bladder carcinoma
regimen used to treat prostate carcinoma
cde regimen
testicular mixed germ cell tumor
regimen used to treat malignant brain neoplasm
cancel
hypercvad alternating with high - dose mtx arac regimen
r - cvp regimen
behavioral ,  psychological or informational intervention
pegylated paclitaxel
oral topotecan hydrochloride
oral ixabepilone
testicular mixed choriocarcinoma and embryonal carcinoma
protein expression analysis
physiologic testing
fenretinide lipid matrix
mitoxantrone / prednisone regimen
docetaxel / prednisone regimen
docetaxel / estramustine regimen
mvac regimen
regimen used to treat malignant testicular neoplasm
bep regimen
veip regimen
testicular mixed choriocarcinoma and teratoma
tip regimen
pcv regimen
hematopoietic stem cell mobilization
additive
regimen used to treat plasma cell myeloma
melphalan / prednisone regimen
vad regimen
td regimen
meperidine hydrochloride
testicular mixed embryonal carcinoma and seminoma
dexamethasone / liposomal doxorubicin / vincristine regimen
dt - pace regimen
regimen used to treat pancreatic carcinoma
erlotinib / gemcitabine regimen
archived newborn blood sample
kif4a gene
kif4a wt allele
range of motion
chromosome - associated kinesin kif4a protein
active range of motion
testicular mixed embryonal carcinoma and teratoma
regimen used to treat sarcoma
maid regimen
passive range of motion
flcn gene
aim regimen
ad regimen
flcn wt allele
folliculin
regimen used to treat endometrial carcinoma
testicular mixed embryonal carcinoma and teratoma with seminoma
cisplatin / doxorubicin / paclitaxel regimen
quick freeze
regimen used to treat malignant ovarian neoplasm
optimal cutting temperature compound
regimen used to treat melanoma
cvd regimen
brip1 gene
brip1 wt allele
fanconi anemia group j protein
nprl2 gene
immature testicular teratoma
nprl2 wt allele
gator complex protein nprl2
kidney lymphoma
kidney diffuse large b - cell lymphoma
plane
user role context
study
dicom study
dextropropoxyphene hydrochloride
cabig identifier
grid service
core grid service
analytical grid service
data grid service
minocycline - edta
fresolimumab
haplotype
university of california at santa cruz
mature testicular teratoma
sense orientation
antisense orientation
reading frame
obsolete
kidney cancer tnm finding v6
kidney cancer clinical tnm finding v6
kidney cancer pathologic tnm finding v6
kidney cancer pathologic primary tumor tnm finding v6
kidney cancer pathologic regional lymph nodes tnm finding v6
kidney cancer pathologic distant metastasis tnm finding v6
testicular leydig cell tumor
kidney cancer ptx tnm finding v6 and v7
kidney cancer pt0 tnm finding v6 and v7
kidney cancer pt1 tnm finding v6 and v7
kidney cancer pt1a tnm finding v6 and v7
kidney cancer pt1b tnm finding v6 and v7
kidney cancer pt2 tnm finding v6 and v7
kidney cancer pt3 tnm finding v6
kidney cancer pt3a tnm finding v6
kidney cancer pt3b tnm finding v6
kidney cancer pt3c tnm finding v6
testicular granulosa cell tumor
kidney cancer pt4 tnm finding v6
kidney cancer pnx tnm finding v6 and v7
kidney cancer pn0 tnm finding v6 and v7
kidney cancer pn1 tnm finding v6
kidney cancer pn2 tnm finding v6
kidney cancer pmx tnm finding v6
kidney cancer pm0 tnm finding
kidney cancer pm1 tnm finding v6 and v7
labetalol hydrochloride
molecular modeling database
testicular sex cord - stromal tumor
sequence chromatogram
5' region
3' region
regimen used to treat colorectal carcinoma
regimen used to treat malignant head and neck neoplasm
regimen used to treat acute lymphoblastic leukemia
regimen used to treat acute myeloid leukemia
testicular sarcoma
folfox - 6 regimen
folfox - 7 regimen
folfiri regimen
ifl regimen
capox regimen
xelox regimen
atra - daunorubicin regimen
mestranol
testicular well differentiated neuroendocrine tumor
aida regimen
cytarabine / idarubicin regimen
cytarabine / daunorubicin regimen
cytarabine - mitoxantrone regimen
computer - aided diagnosis
cetuximab / irinotecan regimen
ifl - bevacizumab regimen
folfiri - bevacizumab regimen
capox - bevacizumab regimen
stage ia testicular cancer ajcc v6 and v7
fu - lv - bevacizumab regimen
miller and payne classification
staff
cytarabine - daunorubicin - etoposide regimen
on staff
markup
larson regimen
linker regimen
lmb - 84 regimen
stage ib testicular cancer ajcc v6 and v7
lmb - 86 regimen
calgb 9251 regimen
undifferentiated carcinoma with osteoclast - like giant cells
bit
memory cache
clock speed
empty
space
stage is testicular cancer ajcc v6 and v7
kernel
carboplatin / docetaxel regimen
cisplatin / vinblastine regimen
bus
data port
gridftp
biospecimen core resource
rna integrity number
stage iia testicular cancer ajcc v6 and v7
delta - tocopherol
stage iib testicular cancer ajcc v6 and v7
garlic oil
clamping
stage iic testicular cancer ajcc v6 and v7
cytarabine / thioguanine regimen
s - adenosylmethionine
fasting
mofarotene
stage iiic testicular cancer ajcc v6 and v7
dimethyl fumarate
n -  ( 2 - carboxyphenyl ) retinamide
methylselenocysteine
stage iiib testicular cancer ajcc v6 and v7
pf regimen
tpf regimen
gem / cap regimen
ai regimen
docetaxel / gemcitabine regimen
cyvadic regimen
cabo regimen
stage iiia testicular cancer ajcc v6 and v7
hydroxytyrosol
n -  ( ethyl )  - 9 - cis - retinamide
n -  ( 4 - hydroxyphenyl )  - 9 - cis - retinamide
metal
n -  ( 4 - methoxyphenyl ) retinamide
video - assisted thoracic surgery
infraclavicular lymph node
facial bone
osteoradionecrosis
sextant
temporomandibular joint disorder
giant condyloma
suppuration
sensory disorder
american academy of periodontology
subgingival curettage
periodontal scaling and root planing
dental pulp capping
apicoectomy
ifl - douillard regimen
dental implant
regimen used to treat esophageal carcinoma
vaginal rhabdomyoma
denture
periradicular
cap regimen
tic regimen
pfl regimen
bv regimen
vaginal leiomyoma
white phosphorus
munition
snuff tobacco
toothbrushing
flossing
periodontist
orthodontist
denturist
vaginal squamous cell papilloma
endodontist
implant specialist
oral medicine specialist
periodontal disorder
general dentistry
edentulous
periodontal treatment
vulvar seborrheic keratosis
sequestrectomy
fp regimen
chlorambucil / prednisone regimen
alveoloplasty
fcr regimen
caffeic acid phenethyl ester
mucoperiosteal flap
supernumerary
interviewer
vulvar squamous cell papilloma
docetaxel - gemcitabine regimen
carboplatin / vinorelbine regimen
interviewee
tec regimen
generalized
evap regimen
penile kaposi sarcoma
epoch regimen
testicular rhabdomyosarcoma
magrath regimen
dartmouth regimen
dacarbazine / interferon alfa regimen
dtic - bcnu - cisplatin regimen
cvd - aldesleukin - interferon alfa - 2b regimen
constant normalization
regimen used to treat malignant mesothelioma
cisplatin / pemetrexed regimen
liposomal doxorubicin / gemcitabine regimen
vaginal yolk sac tumor
flutamide / leuprolide regimen
flutamide / goserelin regimen
vip regimen
cross - section
verumontanum mucosal gland hyperplasia
circulating tumor cell
carbon
colony - forming unit - granulocyte macrophage assay
methadone hydrochloride
vulvar adenocarcinoma
copolymer
copolymerization
together
separate
cube
portable document format
cylinder
emulsion
electromagnetic spectrum
fibril
vulvar basal cell carcinoma
glucuronic acid
glucuronidation pathway
glucuronide
hydrophobicity
immunotoxicity
irregular
molecule
chemokine receptor antagonist
epididymal adenomatoid tumor
vulvar verrucous carcinoma
paratesticular lipoma
monomer
needle shape
oblate
organic
oxidative burst
metastatic malignant neoplasm in the uterine cervix
particle
photostability test
polydispersity index
relaxivity
sulfation
tetrahedron
tetrapod
uv - vis spectrum
image study
scrotal basal cell carcinoma
z - average
technician
prostatic utricle
scrotal hemangioma
scrotal carcinoma
adjacency matrix
mutual information value
aracne algorithm
mesylates
bin
coefficient of variance
conditional
figo stage i gestational trophoblastic tumor
cluster analysis
hierarchical clustering
self - organizing map
radius
iteration
fda established names and unique ingredient identifier codes terminology
osteonecrosis of jaw
macromolecular branch
nanotube chirality
single - chain variable fragment
fact - br questionnaire
utricle - associated mucosal gland hyperplasia
invasive ductal and invasive lobular breast carcinoma
bioconductor caaffy constant normalization
bioconductor caaffy contrasts normalization
bioconductor caaffy invariant set normalization
bioconductor caaffy loess normalization
bioconductor caaffy q - spline normalization
bioconductor caaffy quantiles normalization
bioconductor caaffy quantiles robust normalization
n -  ( 4 - ethoxyphenyl ) retinamide
cicloxolone
2 - hydroxyestrone
temarotene
resiquimod
figo stage ii gestational trophoblastic tumor
methaqualone
figo stage iii gestational trophoblastic tumor
figo stage iv gestational trophoblastic tumor
orbit paraganglioma
laryngeal paraganglioma
methimazole
cardiac paraganglioma
intrathoracic paravertebral paraganglioma
malignant intrathoracic paravertebral paraganglioma
bladder paraganglioma
malignant bladder paraganglioma
recurrent adrenal cortex carcinoma
anticonvulsant therapy
retinoic acid agent ro 16 - 9100
butoxamine hydrochloride
n - desmethyltamoxifen
ovarian liposarcoma
cisca regimen
ifl - folfiri regimen
waist
hip
processor core
streaming simd extensions
graphics processing unit
consensus
comparative marker selection
consensus clustering
methotrexate
log2
preprocess
smoothing
neighborhood
performing laboratory
central laboratory
concept descriptor
prom1 gene
foregut carcinoid tumor
organization assigning a unique protocol identifer
change - point analysis
perfect match probe
mismatch probe
false discovery rate
family - wise error rate
maxt
q - value
balanced permutation
permutation
midgut neuroendocrine tumor g1
random seed
probe summary method
bioconductor caaffy average difference probe summary method
bioconductor caaffy li wong probe summary method
bioconductor caaffy mas probe summary method
bioconductor caaffy median polish probe summary method
bioconductor caaffy player out probe summary method
remove extremes
mean criterion
variance criterion
hindgut carcinoid tumor
probe correction method
mas probe correction method
pm only probe correction method
subtract mm probe correction method
background correction method
rma background correction method
rma2 background correction method
mas background correction method
baseline removal method
mean baseline removal method
meckel diverticulum neuroendocrine tumor g1
median baseline removal method
pseudo median baseline removal method
pseudo mean baseline removal method
no pressure
caexpresso analytic service
cadnacopy analytic service
caprocess analytic service
inoperable
orthodontic treatment
pervasive
duodenal neuroendocrine tumor g1
removable
left ventricular systolic dysfunction
survey administration
medical chart review
non - negative matrix factorization
bone marrow donation
transverse colon neuroendocrine tumor g1
asparaginase erwinia chrysanthemi
systemic chemotherapy
biologic sample preservation procedure
circumference
merge
two - sided test
all - pairs comparison
one - versus - all comparison
ascending colon neuroendocrine tumor g1
discretize
descending colon neuroendocrine tumor g1
jejunal neuroendocrine tumor g1
methoxsalen
thymic carcinoid tumor
metastatic carcinoid tumor
multiple endocrine neoplasia
failure to form staple
hemiplegia
endometrial polyp
prom1 wt allele
cyanocobalamin
battery problem: low impedence
battery problem: high impedence
oral fludarabine phosphate
difficult to program or calibrate
bartholin gland neoplasm
colony management system
appropriate term / code not available problem code
prominin - 1
cognitive behavior therapy
hemizygosity
data compression
computer system security problem
application network problem
pager
surface chemistry
rod
sphere
scientific control
positive control
negative control
alert
constant data value
ellipse
ellipsoid
soluble
a - cmf regimen
e - cmf regimen
a - t - c regimen
carboxyl group
mediastinal germ cell tumor
hydroxyl group
amine group
shell
wall
jersey
guernsey
serbia
montenegro
growth
mediastinal teratoma
general anesthesia procedure
regional anesthesia procedure
activation
sound
ultrasound
balloon brachytherapy
alternative medical procedure
millimole per liter
cdisc system organ class
genomic feature physical location
malignant mediastinal non - seminomatous germ cell tumor
head and neck cancer tnm finding v6
lip and oral cavity cancer tnm finding v6
nasal cavity and paranasal sinus cancer tnm finding v6
pharyngeal cancer tnm finding v6
laryngeal cancer tnm finding v6
digestive system cancer tnm finding v6
oropharyngeal cancer tnm finding v6
hypopharyngeal cancer tnm finding v6
nasopharyngeal cancer tnm finding v6
supraglottic cancer tnm finding v6
methylene blue
mediastinal choriocarcinoma
glottic cancer tnm finding v6
subglottic cancer tnm finding v6
maxillary sinus cancer tnm finding v6
nasal cavity and ethmoid sinus cancer tnm finding v6
major salivary gland cancer tnm finding v6
genitourinary system cancer tnm finding v6
female reproductive system cancer tnm finding v6
lip and oral cavity cancer pathologic primary tumor tnm finding v6
lip and oral cavity cancer ptx tnm finding v6 and v7
lip and oral cavity cancer pt0 tnm finding v6 and v7
mediastinal embryonal carcinoma
lip and oral cavity cancer ptis tnm finding v6 and v7
lip and oral cavity cancer pt1 tnm finding v6 and v7
lip and oral cavity cancer pt2 tnm finding v6 and v7
lip and oral cavity cancer pt3 tnm finding v6 and v7
lip and oral cavity cancer pt4 tnm finding v6
lip and oral cavity cancer pt4a tnm finding v6
lip and oral cavity cancer pt4b tnm finding v6
lip and oral cavity cancer pathologic tnm finding v6
lip and oral cavity cancer pathologic regional lymph nodes tnm finding v6
lip and oral cavity cancer pnx tnm finding v6 and v7
mediastinal mixed embryonal carcinoma and teratoma
lip and oral cavity cancer pn0 tnm finding v6 and v7
lip and oral cavity cancer pn1 tnm finding v6 and v7
lip and oral cavity cancer pn2a tnm finding v6 and v7
lip and oral cavity cancer pn2b tnm finding v6 and v7
lip and oral cavity cancer pn2c tnm finding v6 and v7
lip and oral cavity cancer pn3 tnm finding v6 and v7
lip and oral cavity cancer pathologic distant metastasis tnm finding v6
lip and oral cavity cancer pmx tnm finding v6
lip and oral cavity cancer pm0 tnm finding
lip and oral cavity cancer pm1 tnm finding v6 and v7
mediastinal yolk sac tumor
protein or enzyme type measurement
albumin measurement
alkaline phosphatase measurement
alanine aminotransferase measurement
amylase measurement
proband
oropharyngeal cancer pathologic primary tumor tnm finding v6
oropharyngeal cancer ptx tnm finding v6 and v7
oropharyngeal cancer pt0 tnm finding v6 and v7
oropharyngeal cancer ptis tnm finding v6 and v7
mediastinal mixed non - seminomatous germ cell tumor
oropharyngeal cancer pt1 tnm finding v6 and v7
oropharyngeal cancer pt2 tnm finding v6 and v7
oropharyngeal cancer pt3 tnm finding v6
oropharyngeal cancer pt4a tnm finding v6
oropharyngeal cancer pt4b tnm finding v6
hypopharyngeal cancer pathologic primary tumor tnm finding v6
hypopharyngeal cancer ptx tnm finding v6 and v7
hypopharyngeal cancer pt0 tnm finding v6 and v7
hypopharyngeal cancer ptis tnm finding v6 and v7
hypopharyngeal cancer pt1 tnm finding v6
benign mediastinal germ cell tumor
hypopharyngeal cancer pt2 tnm finding v6 and v7
hypopharyngeal cancer pt3 tnm finding v6
hypopharyngeal cancer pt4a tnm finding v6
hypopharyngeal cancer pt4b tnm finding v6
nasopharyngeal cancer pathologic primary tumor tnm finding v6
nasopharyngeal cancer ptx tnm finding v6 and v7
nasopharyngeal cancer pt0 tnm finding v6 and v7
nasopharyngeal cancer ptis tnm finding v6 and v7
nasopharyngeal cancer pt1 tnm finding v6
nasopharyngeal cancer pt2 tnm finding v6
malignant mediastinal germ cell tumor
nasopharyngeal cancer pt2a tnm finding v6
nasopharyngeal cancer pt2b tnm finding v6
nasopharyngeal cancer pt3 tnm finding v6
nasopharyngeal cancer pt4 tnm finding v6
hypopharyngeal cancer pathologic tnm finding v6
nasopharyngeal cancer pathologic tnm finding v6
oropharyngeal cancer pathologic tnm finding v6
aspartate aminotransferase measurement
transplant conditioning
bacterial count
total basophil count
basophil to leukocyte ratio
nasopharyngeal cancer pathologic regional lymph nodes tnm finding v6
nasopharyngeal cancer pnx tnm finding v6 and v7
nasopharyngeal cancer pn0 tnm finding v6 and v7
nasopharyngeal cancer pn1 tnm finding v6
nasopharyngeal cancer pn2 tnm finding v6
nasopharyngeal cancer pn3 tnm finding v6
nasopharyngeal cancer pn3a tnm finding v6 and v7
nasopharyngeal cancer pn3b tnm finding v6
gastric germ cell tumor
nasopharyngeal cancer pathologic distant metastasis tnm finding v6
direct bilirubin measurement
nasopharyngeal cancer pm0 tnm finding
indirect bilirubin measurement
nasopharyngeal cancer pm1 tnm finding v6 and v7
nasopharyngeal cancer pmx tnm finding v6
unclassified
blast to leukocyte ratio
calcium measurement
creatine kinase measurement
benign germ cell tumor
creatine kinase bb measurement
creatine kinase mb measurement
schedule frequency
creatine kinase mm measurement
chloride measurement
twice daily
twice weekly
monthly
as needed
methylnitrosourea
thymic epithelial neoplasm
every ten hours
every eleven hours
every twelve hours
every thirteen hours
every fourteen hours
every fifteen hours
every sixteen hours
every seventeen hours
every eighteen hours
every nineteen hours
thymic lymphoma
every hour
every twenty hours
every twenty - one hours
every twenty - two hours
every twenty - three hours
every twenty - four hours
every two hours
every three hours
every four hours
every five hours
thymolipoma
every six hours
every seven hours
ksp inhibitor azd4877
every eight hours
every nine hours
every other day
once weekly
three times daily
three times weekly
every four weeks
invasive thymoma
four times daily
four times weekly
every three days
every four days
every three weeks
every two months
every three months
every four months
yttrium y 90 resin microspheres
thymoma type a
cenisertib
sapacitabine
targeting
isavuconazole
cdk inhibitor r547
carbon dioxide measurement
color assessment
creatinine measurement
c - reactive protein measurement
elliptocyte count
thymic squamous cell carcinoma
eosinophil count
picogram
femtogram
attogram
centigram
decigram
zeptogram
yoctogram
troy ounce
atomic mass unit
thymic basaloid carcinoma
troy pound
kilopound
pennyweight
apothecaries scruple
dram mass unit
apothecaries dram mass unit
kilogram per liter
molarity unit
molality unit
normality unit
thymic mucoepidermoid carcinoma
molinity unit
unit of mass concentration
microgram per milliliter
once
oropharyngeal cancer pathologic distant metastasis tnm finding v6
oropharyngeal cancer pathologic regional lymph nodes tnm finding v6
persistent memory device
thymic adenosquamous carcinoma
hypopharyngeal cancer pathologic distant metastasis tnm finding v6
hypopharyngeal cancer pathologic regional lymph nodes tnm finding v6
hypopharyngeal cancer pnx tnm finding v6 and v7
hypopharyngeal cancer pn0 tnm finding v6 and v7
hypopharyngeal cancer pn1 tnm finding v6 and v7
hypopharyngeal cancer pn2a tnm finding v6 and v7
hypopharyngeal cancer pn2b tnm finding v6 and v7
hypopharyngeal cancer pn2c tnm finding v6 and v7
hypopharyngeal cancer pn3 tnm finding v6
hypopharyngeal cancer pmx tnm finding v6
thymic adenocarcinoma
hypopharyngeal cancer pm0 tnm finding
hypopharyngeal cancer pm1 tnm finding v6 and v7
before meals
hour of sleep
after meals
every morning
qpm
immediately
before meals and bedtime
after breakfast and supper
methylphenidate hydrochloride
thymic small cell carcinoma
after lunch
after meals and bedtime
after supper
between meals
eosinophil to leukocyte ratio
epithelial cell count
fibrinogen measurement
oropharyngeal cancer pnx tnm finding v6 and v7
oropharyngeal cancer pn0 tnm finding v6 and v7
oropharyngeal cancer pn1 tnm finding v6 and v7
thymic large cell neuroendocrine carcinoma
oropharyngeal cancer pn2a tnm finding v6 and v7
oropharyngeal cancer pn2b tnm finding v6 and v7
oropharyngeal cancer pn2c tnm finding v6 and v7
oropharyngeal cancer pn3 tnm finding v6
oropharyngeal cancer pmx tnm finding v6
oropharyngeal cancer pm0 tnm finding
oropharyngeal cancer pm1 tnm finding v6 and v7
silatecan ar - 67
as directed
thymic clear cell carcinoma
zalutumumab
lexatumumab
iodine i 124
pregabalin
egfr / her2 inhibitor av - 412
thymic sarcomatoid carcinoma
titrate
microparticle - encapsulated cyp1b1 - encoding dna vaccine zyc300
marizomib
wt1 analog peptide vaccine
same
constant
crenolanib
stage ia bone sarcoma  ajcc v7
up to
stir
shake
see
frequently
stage ib bone sarcoma  ajcc v7
light
every
sparingly
gently
slow
dilute
dispense
divide
stage iib bone sarcoma  ajcc v7
make
glottic cancer pathologic tnm finding v6
subglottic cancer pathologic tnm finding v6
supraglottic cancer pathologic tnm finding v6
glottic cancer pathologic primary tumor tnm finding v6
stage iia bone sarcoma  ajcc v7
glottic cancer ptx tnm finding v6 and v7
glottic cancer pt0 tnm finding v6 and v7
glottic cancer ptis tnm finding v6 and v7
glottic cancer pt1 tnm finding v6 and v7
glottic cancer pt1a tnm finding v6 and v7
glottic cancer pt1b tnm finding v6 and v7
glottic cancer pt2 tnm finding v6 and v7
glottic cancer pt3 tnm finding v6
glottic cancer pt4a tnm finding v6
glottic cancer pt4b tnm finding v6
stage iii bone sarcoma  ajcc v7
glottic cancer pathologic distant metastasis tnm finding v6
glottic cancer pm0 tnm finding
glottic cancer pm1 tnm finding v6 and v7
glottic cancer pmx tnm finding v6
glottic cancer pathologic regional lymph nodes tnm finding v6
glottic cancer pn0 tnm finding v6 and v7
glottic cancer pn1 tnm finding v6 and v7
glottic cancer pn2a tnm finding v6 and v7
glottic cancer pn2b tnm finding v6 and v7
osteosarcoma arising in paget disease of bone
glottic cancer pn2c tnm finding v6 and v7
glottic cancer pn3 tnm finding v6 and v7
glottic cancer pnx tnm finding v6 and v7
centigray
grid service operation
grid service fault
caplet dosing unit
deciliter
decimeter
methylprednisolone
multifocal osteosarcoma
subglottic cancer pathologic regional lymph nodes tnm finding v6
subglottic cancer pm0 tnm finding
subglottic cancer pm1 tnm finding v6 and v7
subglottic cancer pmx tnm finding v6
subglottic cancer pn0 tnm finding v6 and v7
subglottic cancer pn1 tnm finding v6 and v7
subglottic cancer pn2a tnm finding v6 and v7
subglottic cancer pn2b tnm finding v6 and v7
subglottic cancer pn2c tnm finding v6 and v7
synchronous multifocal osteosarcoma
subglottic cancer pn3 tnm finding v6 and v7
subglottic cancer pnx tnm finding v6 and v7
fact - o questionnaire
subglottic cancer ptx tnm finding v6 and v7
subglottic cancer pt0 tnm finding v6 and v7
subglottic cancer ptis tnm finding v6 and v7
subglottic cancer pt1 tnm finding v6 and v7
subglottic cancer pt2 tnm finding v6 and v7
subglottic cancer pt3 tnm finding v6 and v7
asynchronous multifocal osteosarcoma
subglottic cancer pt4a tnm finding v6
subglottic cancer pt4b tnm finding v6
dye laser
supraglottic cancer pathologic regional lymph nodes tnm finding v6
mpt regimen
cyclophosphamide - vad regimen
supraglottic cancer pathologic distant metastasis tnm finding v6
supraglottic cancer pathologic primary tumor tnm finding v6
subglottic cancer pathologic primary tumor tnm finding v6
subglottic cancer pathologic distant metastasis tnm finding v6
vd regimen
dexamethasone / lenalidomide regimen
supraglottic cancer ptx tnm finding v6 and v7
supraglottic cancer pt0 tnm finding v6 and v7
supraglottic cancer ptis tnm finding v6 and v7
supraglottic cancer pt1 tnm finding v6 and v7
supraglottic cancer pt2 tnm finding v6 and v7
supraglottic cancer pt3 tnm finding v6
supraglottic cancer pt4a tnm finding v6
low grade central osteosarcoma
supraglottic cancer pt4b tnm finding v6
supraglottic cancer pm0 tnm finding
supraglottic cancer pm1 tnm finding v6 and v7
supraglottic cancer pmx tnm finding v6
supraglottic cancer pn0 tnm finding v6 and v7
supraglottic cancer pn1 tnm finding v6 and v7
supraglottic cancer pn2a tnm finding v6 and v7
supraglottic cancer pn2b tnm finding v6 and v7
supraglottic cancer pn2c tnm finding v6 and v7
supraglottic cancer pn3 tnm finding v6 and v7
clear cell chondrosarcoma
supraglottic cancer pnx tnm finding v6 and v7
maxillary sinus cancer pathologic primary tumor tnm finding v6
maxillary sinus cancer pathologic tnm finding v6
maxillary sinus cancer ptx tnm finding v6 and v7
maxillary sinus cancer pt0 tnm finding v6 and v7
maxillary sinus cancer ptis tnm finding v6 and v7
maxillary sinus cancer pt1 tnm finding v6 and v7
maxillary sinus cancer pt2 tnm finding v6 and v7
maxillary sinus cancer pt3 tnm finding v6 and v7
maxillary sinus cancer pt4a tnm finding v6
dedifferentiated chondrosarcoma
maxillary sinus cancer pt4b tnm finding v6
cdk inhibitor at7519
riviciclib
fermented wheat germ extract
efatutazone dihydrochloride
mycobacterial cell wall - dna complex
sinomenine
e2f1 pathway activator arq 171
vemurafenib
tagraxofusp - erzs
bone hemangioma
tad regimen
tenifatecan
anti - p53 t - cell receptor - transduced peripheral blood lymphocytes
area under curve
carcinoembryonic antigen - expressing measles virus
navitoclax
milliliter per minute
enzyme unit
topsalysin
vascular bone neoplasm
femtoliter
apoptosis inducer mpc - 2130
verubulin hydrochloride
gram per deciliter
dach polymer platinate ap5346
adrtvp - 1 - transduced prostate cancer cell - based vaccine
elf regimen
pelf regimen
pvb regimen
pomb / ace regimen
bone angiosarcoma
cisplatin / doxorubicin regimen
cetuximab / cisplatin regimen
vim - d regimen
av regimen
iodine i - 123
copp alternating with abvd regimen
hematocrit measurement
erythrocyte mean corpuscular hemoglobin
erythrocyte mean corpuscular hemoglobin concentration
erythrocyte mean corpuscular volume
methyltestosterone
bone glomus tumor
erythrocyte distribution width measurement
dacryocyte analysis
hypochromia
polychromasia
international normalized ratio of prothrombin time
serum vldl cholesterol measurement
triacylglycerol lipase measurement
sodium measurement
inflammatory myofibroblastic tumor
nitrite measurement
triglyceride measurement
thyrotropin measurement
urate measurement
urea measurement
urobilinogen measurement
vitamin b12 measurement
atypical lymphocyte count
atypical lymphocyte to leukocyte ratio measurement
lymphocyte to leukocyte ratio
macrocyte count
microcyte count
monocyte count
monocyte to leukocyte ratio
myeloblast to leukocyte ratio
myelocyte to leukocyte ratio
neutrophil to leukocyte ratio
reticulocyte to erythrocyte ratio
prolymphocyte to leukocyte ratio
ischemic fasciitis
neutrophil band form count
neutrophil band form to leukocyte ratio
specific gravity
gemox regimen
gtx regimen
gemcitabine / irinotecan regimen
vmp regimen
vbmcp regimen
vmcp alternating with vbap regimen
dermal fibroma
magnesium measurement
estramustine - etoposide regimen
estramustine / vinblastine regimen
estramustine - paclitaxel regimen
evac regimen
dta - h19 plasmid
alpha - type - 1 polarized dendritic cells
gamma glutamyl transpeptidase measurement
hemoglobin measurement
glycosylated hemoglobin measurement
tendon sheath fibroma
hepatitis b virus surface antigen measurement
choriogonadotropin beta measurement
chemistry measurement
potassium measurement
ketone measurement
lactate dehydrogenase measurement
leukocyte esterase measurement
phosphate measurement
total protein measurement
knee skin
nuchal - type fibroma
diffusion tensor imaging
ultrasonic surgical aspiration
balloon - guided endoscopic procedure
enema tablet dosage form
gelatin coated tablet dosage form
membrane coated tablet dosage form
buccal capsule dosage form
biting capsule dosage form
chewable capsule dosage form
membrane coated capsule dosage form
cachet dosage form
inhaler capsule dosage form
calcifying fibrous tumor
candy dosage form
cube dosage form
homeopathic globule dosage form
dusting powder dosage form
effervescent powder dosage form
enema powder dosage form
adult suppository dosage form
pediatric suppository dosage form
micro enema dosage form
extraabdominal fibromatosis
cam exercise therapy
foam dosage form
foam bath dosage form
metoclopramide hydrochloride
benign fibrohistiocytic neoplasm
medicated sponge dosage form
unmedicated sponge dosage form
wash dosage form
hard capsule dosage form
topical solution dosage form
oromucosal route of administration
powder for oral solution dosage form
powder for oral suspension dosage form
soft capsule dosage form
intermediate fibrohistiocytic neoplasm
wound stick dosage form
add
administer
remove
all
affected
deep benign fibrous histiocytoma
at rest
upon awakening
before bedtime
call
mix
chew
swallow
daytime
dissolve
plexiform fibrohistiocytic tumor
dropper
each
morning
afternoon
evening
against
as
angiomatoid fibrous histiocytoma
external route of administration
few
finish
follow
infrequent
if
for
therapeutic endoscopic procedure
myxofibrosarcoma
monday
tuesday
wednesday
thursday
friday
saturday
sunday
undifferentiated pleomorphic sarcoma ,  inflammatory variant
give
good
inject
deep lipoma
drop instillation route of administration
therapeutic surgical procedure
intracameral route of administration
intraosseous route of administration
intrasternal route of administration
diagnostic aspiration
tendon sheath lipoma
intravenous push
late
metolazone
lumbosacral lipoma
multiply
night time
now
therapeutic aspiration
old
nutritional therapy
overnight
maxillary sinus cancer pathologic distant metastasis tnm finding v6
maxillary sinus cancer pathologic regional lymph nodes tnm finding v6
maxillary sinus cancer pm0 tnm finding
maxillary sinus cancer pm1 tnm finding v6 and v7
maxillary sinus cancer pmx tnm finding v6
maxillary sinus cancer pn0 tnm finding v6 and v7
maxillary sinus cancer pn1 tnm finding v6 and v7
maxillary sinus cancer pn2a tnm finding v6 and v7
maxillary sinus cancer pn2b tnm finding v6 and v7
maxillary sinus cancer pn2c tnm finding v6 and v7
chondroid lipoma
maxillary sinus cancer pn3 tnm finding v6 and v7
maxillary sinus cancer pnx tnm finding v6 and v7
pad dosing unit
nasal cavity and ethmoid sinus cancer pathologic tnm finding v6
nasal cavity and ethmoid sinus cancer pathologic primary tumor tnm finding v6
nasal cavity and ethmoid sinus cancer pathologic regional lymph nodes tnm finding v6
nasal cavity and ethmoid sinus cancer pathologic distant metastasis tnm finding v6
paravertebral route of administration
per
diffuse lipomatosis
periosteal route of administration
picomole
put
cdisc sdtm laboratory test code terminology
nasal cavity and ethmoid sinus cancer ptx tnm finding v6 and v7
nasal cavity and ethmoid sinus cancer pt0 tnm finding v6 and v7
atypical lipomatous tumor
nasal cavity and ethmoid sinus cancer ptis tnm finding v6 and v7
nasal cavity and ethmoid sinus cancer pt1 tnm finding v6 and v7
nasal cavity and ethmoid sinus cancer pt2 tnm finding v6 and v7
nasal cavity and ethmoid sinus cancer pt3 tnm finding v6 and v7
nasal cavity and ethmoid sinus cancer pt4a tnm finding v6
nasal cavity and ethmoid sinus cancer pt4b tnm finding v6
nasal cavity and ethmoid sinus cancer pm0 tnm finding
nasal cavity and ethmoid sinus cancer pm1 tnm finding v6 and v7
nasal cavity and ethmoid sinus cancer pmx tnm finding v6
puff dosing unit
push
nasal cavity and ethmoid sinus cancer pn0 tnm finding v6 and v7
nasal cavity and ethmoid sinus cancer pn1 tnm finding v6 and v7
nasal cavity and ethmoid sinus cancer pn2a tnm finding v6 and v7
nasal cavity and ethmoid sinus cancer pn2b tnm finding v6 and v7
nasal cavity and ethmoid sinus cancer pn2c tnm finding v6 and v7
nasal cavity and ethmoid sinus cancer pn3 tnm finding v6 and v7
nasal cavity and ethmoid sinus cancer pnx tnm finding v6 and v7
rapidly
sclerosing liposarcoma
regimen used to treat cervical carcinoma
cisplatin / topotecan regimen
major salivary gland cancer pathologic tnm finding v6
major salivary gland cancer pathologic distant metastasis tnm finding v6
major salivary gland cancer pathologic primary tumor tnm finding v6
clean
wash
major salivary gland cancer pathologic regional lymph nodes tnm finding v6
major salivary gland cancer ptx tnm finding v6 and v7
inflammatory liposarcoma
major salivary gland cancer pt0 tnm finding v6 and v7
major salivary gland cancer pt1 tnm finding v6 and v7
major salivary gland cancer pt2 tnm finding v6 and v7
major salivary gland cancer pt3 tnm finding v6 and v7
major salivary gland cancer pt4a tnm finding v6
major salivary gland cancer pt4b tnm finding v6
major salivary gland cancer pnx tnm finding v6 and v7
major salivary gland cancer pn0 tnm finding v6 and v7
major salivary gland cancer pn1 tnm finding v6 and v7
major salivary gland cancer pn2a tnm finding v6 and v7
fibroblastic liposarcoma
major salivary gland cancer pn2b tnm finding v6 and v7
major salivary gland cancer pn2c tnm finding v6 and v7
major salivary gland cancer pn2 tnm finding v6 and v7
major salivary gland cancer pn3 tnm finding v6 and v7
major salivary gland cancer pmx tnm finding v6
major salivary gland cancer pm0 tnm finding
major salivary gland cancer pm1 tnm finding v6 and v7
shampoo
sniff
some
metronidazole
benign smooth muscle neoplasm
spray
sprinkle
subgingival route of administration
square millimeter
take
to
never smoker
photometry
malignant smooth muscle neoplasm
liposomal oxaliplatin
lanreotide long - acting aqueous gel
cdisc sdtm package 1 terminology
suck
deep leiomyoma
rinse
swish
stop
smear
thin
tuberculin unit
twice
until
upon
administration via stoma
skeletal muscle neoplasm
when
juice
water
benign skeletal muscle neoplasm
non - small cell carcinoma
soy isoflavones
malignant neoplasm ,  uncertain whether primary or metastatic
malignant tumor ,  small cell type
clear cell malignant neoplasm
neoplasm ,  uncertain whether benign or malignant
glassy cell carcinoma
malignant skeletal muscle neoplasm
giant cell and spindle cell carcinoma
polygonal cell carcinoma
tumorlet
papillary carcinoma in situ
non - invasive papillary squamous cell carcinoma
inverted squamous cell papilloma
celiac lymph node
customize
clinical data interchange standards consortium
genital rhabdomyoma
euclidean distance measurement
spearman rank - order correlation
pearson correlation coefficient
non - keratinizing large cell squamous cell carcinoma
keratin present
non - keratinizing small cell squamous cell carcinoma
squamous cell carcinoma in situ with questionable stromal invasion
single linkage cluster analysis
microinvasive squamous cell carcinoma
squamous cell carcinoma with horn formation
intermediate rhabdomyoma
squamous cell carcinoma ,  clear cell type
non - invasive papillary transitional cell carcinoma
micropapillary transitional cell carcinoma
average linkage cluster analysis
islet cell adenoma
complete linkage cluster analysis
malignant pancreatic insulinoma
malignant pancreatic glucagonoma
malignant gastrinoma
malignant vipoma
spindle cell rhabdomyosarcoma
malignant somatostatinoma
malignant enteroglucagonoma
tubular adenocarcinoma
flat adenoma
gastric parietal cell adenocarcinoma
carcinoma simplex
carcinoid tumor of uncertain malignant potential
lung adenocarcinoma with mixed bronchioloalveolar and invasive components
glandular papillomatosis
ectopia
mexiletine hydrochloride
thyroid gland follicular carcinoma ,  minimally invasive
minimal invasion present
wedge
clear cell papillary cystadenoma
papillary mucinous cystadenocarcinoma
ticarcillin disodium
vancomycin hydrochloride
acolbifene hydrochloride
acotiamide
acrisorcin
adalimumab
benign testicular sertoli cell tumor
alefacept
aliskiren
aliskiren hemifumarate
almotriptan
alovudine
amdinocillin
malignant testicular sertoli cell tumor
amlodipine maleate
amodiaquine
amodiaquine hydrochloride
ancriviroc
anileridine
anileridine hydrochloride
arbutamine
arbutamine hydrochloride
benign lymphatic vessel neoplasm
arformoterol tartrate
armodafinil
auranofin
azlocillin sodium
bacampicillin
bacampicillin hydrochloride
bekanamycin
synovial hemangioma
benzthiazide
betazole
betazole hydrochloride
perineural hemangioma
bitolterol
bitolterol mesylate
brimonidine
alloimmunization
brivaracetam
bromfenac
bromfenac sodium
buclizine
buclizine hydrochloride
butylscopolamine bromide
calcifediol
pericytic neoplasm
camellia oil
candesartan
carbenicillin disodium
carbon dioxide
benign pericytic neoplasm
carprofen
carteolol
carvedilol phosphate
chinese cinnamon oil
cefepime
cefmenoxime
cefmenoxime hydrochloride
cefmetazole
cefmetazole sodium
cefonicid
mezlocillin
malignant pericytic neoplasm
cefonicid sodium
cefotiam
cefotiam hydrochloride
cefpiramide
cefpiramide sodium
cefpodoxime
ceftobiprole
cephaloglycin
cerivastatin
malignant synovial neoplasm
chlormerodrin
chloroquine hydrochloride
chlorothiazide sodium
tenosynovial giant cell tumor ,  localized type
chlorotrianisene
chlorphentermine
chlorphentermine hydrochloride
ciclesonide
ciclopirox olamine
cidoxepin
cinnamon oil
clenbuterol
clioquinol
monophasic synovial sarcoma
clorprenaline hydrochloride
clove oil
coconut oil
cod liver oil
colistimethate sodium
malignant tenosynovial giant cell tumor
coriander oil
cyclothiazide
peritoneal multicystic mesothelioma
darunavir
delavirdine
demecarium bromide
stage i soft tissue sarcoma ajcc v7
stage ii soft tissue sarcoma ajcc v7
difenoxin
childhood testicular mixed embryonal carcinoma and teratoma
midazolam hydrochloride
childhood testicular teratoma
malignant childhood germ cell tumor
dinoprost
dioxifedrine
childhood testicular mixed germ cell tumor
childhood testicular yolk sac tumor
childhood testicular choriocarcinoma
disulfamide
disuprazole
ditiomustine
childhood testicular embryonal carcinoma
dobutamine tartrate
dofequidar
childhood ovarian embryonal carcinoma
childhood ovarian immature teratoma
doripenem
doxaminol
doxepin
childhood ovarian mature teratoma
childhood ovarian choriocarcinoma
dulofibrate
duloxetine hydrochloride
mifepristone
childhood ovarian dysgerminoma
ebselen
childhood ovarian yolk sac tumor
entecavir
epiroprim
childhood testicular germ cell tumor
eprodisate disodium
benign childhood germ cell tumor
erlotinib
esomeprazole
esomeprazole sodium
childhood ovarian teratoma
eszopiclone
deep hemangioma
degenerated schwannoma
ethoxzolamide
schwannomatosis
etilefrine
etilefrine pivalate
epithelioid neurofibroma
etofibrate
etoformin
etoformin hydrochloride
mineral
glandular malignant peripheral nerve sheath tumor
etozolin
eucalyptus oil
exalamide
exaprolol
epithelioid malignant peripheral nerve sheath tumor
exaprolol hydrochloride
exenatide
faropenem medoxomil
febuxostat
childhood kidney neoplasm
fenbenicillin
childhood kidney angiomyolipoma
fenitrothion
fennel oil
fenoterol
childhood multilocular cystic renal neoplasm
fenquizone
fenticlor
childhood renal cell carcinoma
congenital mesoblastic nephroma
flerobuterol
flomoxef
misonidazole
extraskeletal cartilaginous and osseous neoplasm
fludazonium chloride
benign extraskeletal cartilaginous and osseous neoplasm
malignant extraskeletal cartilaginous and osseous neoplasm
fibroosseous pseudotumor of the digits
glycoprotein hormones alpha polypeptide
follicle stimulating hormone beta polypeptide
forasartan
extraskeletal osteoma
formoterol
fosinopril
fosinoprilat
fosphenytoin
fotretamine
myxoma
framycetin
skin myxoma
furalazine
furazolidone
intramuscular myxoma
furterene
fusidate sodium
fusidic acid
fuzlocillin
gadodiamide
plicamycin
juxta - articular myxoma
gentamicin sulfate
gimatecan
glyclopyramide
glycyclamide
parachordoma
glyparamide
glypinamide
glyprothiazol
glysobuzole
gramicidin
griseofulvin
ossifying fibromyxoid tumor
guanabenz acetate
nonossifying fibromyxoid tumor
palisaded lymph node myofibroblastoma
haloprogin
hetacillin potassium
childhood osteosarcoma
honey
extrarenal rhabdoid tumor
hyaluronidase ,  ovine
hydroxindasate
benign soft tissue tumor of uncertain differentiation
hydroxystilbamidine
hydroxystilbamidine isethionate
hydroxytoluic acid
ibandronic acid
ibudilast
malignant soft tissue tumor of uncertain differentiation
icofungipen
ilaprazole
childhood parosteal osteosarcoma
imidaprilat
mitobronitol
childhood conventional osteosarcoma
implitapide
incadronic acid
peripheral neuroblastoma
inproquone
panniculitis ossificans
insulin detemir
benign mediastinal soft tissue neoplasm
iodixanol
iohexol
peripheral ganglioneuroblastoma
ioversol
mediastinal lymphangioma
mediastinal chondroma
benign mediastinal hemangiopericytoma
isoetharine
isoflurane
mediastinal leiomyoma
isoproterenol sulfate
itanoxone
mediastinal lipoma
ivabradine
kanamycin
kanamycin sulfate
mitogen
mediastinal rhabdomyoma
lavender oil
levalbuterol tartrate
levobetaxolol
levobetaxolol hydrochloride
levocetirizine
mediastinal granular cell tumor
lincomycin hydrochloride
linogliride
liranaftate
benign osteogenic neoplasm
osteogenic neoplasm
bone fibrosarcoma
lubiprostone
magnesium clofibrate
soft tissue fibrosarcoma
mangafodipir trisodium
mediastinal sarcoma
stage ia osteosarcoma  ajcc v7
medronic acid
meglitinide
malignant mediastinal hemangiopericytoma
meluadrine
stage ib osteosarcoma  ajcc v7
mephenytoin
merimepodib
mersalyl acid
mitoguazone
stage iia osteosarcoma  ajcc v7
stage iib osteosarcoma  ajcc v7
methaniazide
methohexital
methohexital sodium
levomepromazine
stage iii osteosarcoma  ajcc v7
meticrane
mediastinal angiosarcoma
metoprolol fumarate
mediastinal liposarcoma
micafungin sodium
mediastinal extraskeletal osteosarcoma
milfasartan
cow milk
mitoclomine
mitotenamine
mitratapide
mediastinal rhabdomyosarcoma
moctamide
moexiprilat
mediastinal synovial sarcoma
mediastinal leiomyosarcoma
morinamide
mitolactol
primary lymphoma of bone
moroxydine
moxalactam disodium
metastatic bone ewing sarcoma
mycophenolate sodium
naftifine
recurrent bone ewing sarcoma
nebivolol
neomycin sulfate
nepafenac
localized bone ewing sarcoma
neridronic acid
netilmicin
netilmicin sulfate
mediastinal neurogenic neoplasm
niclosamide
nitrofurantoin sodium
ocrelizumab
olmesartan
olsalazine sodium
omega - 3 - acid ethyl esters
omeprazole magnesium
oxeglitazar
mediastinal malignant peripheral nerve sheath tumor
oxetacillin
oxiniacic acid
mediastinal ganglioneuroblastoma
oxprenolol
oxprenolol hydrochloride
mediastinal neuroblastoma
oxyphencyclimine
oxyphencyclimine hydrochloride
ozolinone
palinavir
palmoxirate sodium
palmoxiric acid
mitomycin antineoplastic antibiotic
malignant melanotic peripheral nerve sheath tumor of the mediastinum
panipenem
paraflutizide
mediastinal neurofibroma
parconazole
parconazole hydrochloride
parecoxib
mediastinal ganglioneuroma
pargyline
pargyline hydrochloride
mediastinal lymphoma
peanut oil
pemirolast
penbutolol
penciclovir
mediastinal hodgkin lymphoma
pentamustine
mediastinal melanotic schwannoma
perindoprilat
persic oil
mediastinal psammomatous schwannoma
mediastinal soft tissue neoplasm
phenprocoumon
phenyl aminosalicylate
phenylephrine bitartrate
phenylpropanolamine hydrochloride
stage 1 neuroblastoma
stage 2 neuroblastoma
pipemidic acid
mitotane
stage 3 neuroblastoma
stage 4 neuroblastoma
pirbenicillin
piretanide
malignant mediastinal soft tissue neoplasm
piridronic acid
pirifibrate
pirinixil
mediastinal schwannoma
piromidic acid
pirozadil
pleural lipoma
pivampicillin probenate
pivopril
plafibride
infantile hemangioma
poppy seed oil
potassium phosphate ,  dibasic
pradefovir
pradefovir mesylate
stage i pleural malignant mesothelioma ajcc v7
stage ii pleural malignant mesothelioma ajcc v7
probucol
stage iii pleural malignant mesothelioma ajcc v7
propicillin
propiomazine
propiomazine hydrochloride
stage iv pleural malignant mesothelioma ajcc v7
propoxycaine
propoxycaine hydrochloride
protokylol hydrochloride
pyrithione sodium
pyrvinium pamoate
mitoxantrone hydrochloride
ampulla of vater adenocarcinoma
quinethazone
quipazine maleate
ramelteon
ranitidine bismuth citrate
ranitidine hydrochloride
ranolazine
stage i ampulla of vater cancer ajcc v7
reparixin
rifapentine
stage ii ampulla of vater cancer ajcc v7
rose oil
rosuvastatin
stage iii ampulla of vater cancer ajcc v7
sesame oil
stage iv ampulla of vater cancer ajcc v7
sobuzoxane
ampulla of vater small cell carcinoma
sodium tetradecyl sulfate
ampulla of vater signet ring cell carcinoma
spirapril
spirapril hydrochloride
sulfadiazine sodium
silver sulfadiazine
sulfameter
sulfaphenazole
ampulla of vater adenoma ,  intestinal - type
sulfapyridine
sulfathiazole
sulfisoxazole diolamine
sulfoxone sodium
ampulla of vater villous adenoma
telbivudine
ampulla of vater tubular adenoma
tetracaine
thiopental sodium
molybdenum
stage ii lung large cell carcinoma ajcc v7
tipranavir
tipranavir disodium
stage ia lung large cell carcinoma ajcc v7
tolbutamide
stage ib lung large cell carcinoma ajcc v7
tretinoin tocoferil
stage iib lung large cell carcinoma ajcc v7
stage iiib lung large cell carcinoma ajcc v7
tryparsamide
valganciclovir hydrochloride
valopicitabine
stage iiia lung large cell carcinoma ajcc v7
vardenafil
vildagliptin
viomycin
viomycin sulfate
stage iia lung large cell carcinoma ajcc v7
xenazoic acid
xenygloxal
stage iia lung adenosquamous carcinoma ajcc v7
zabiciprilat
stage ia lung adenosquamous carcinoma ajcc v7
stage ib lung adenosquamous carcinoma ajcc v7
monoamine oxidase inhibitor
stage iib lung adenosquamous carcinoma ajcc v7
zofenoprilat arginine
zolasartan
zoledronate disodium
stage i lung non - small cell cancer ajcc v7
argon plasma coagulation
consumption
consumption of goods
metastatic signet ring cell carcinoma
medullary carcinoma ,  not otherwise specified
atypical medullary breast carcinoma
levoleucovorin calcium
oblimersen sodium
sodium phenylacetate
amifostine anhydrous
ginger
cdisc sdtm pharmaceutical dosage form terminology
cdisc sdtm reason for non - completion terminology
cdisc sdtm relation to reference period terminology
cdisc sdtm route of administration terminology
stage i lung small cell carcinoma ajcc v7
cdisc sdtm sex of individual terminology
cdisc sdtm sex of study group terminology
cdisc sdtm size terminology
cdisc sdtm submission domain abbreviation terminology
cdisc sdtm trial blinding schema terminology
cdisc sdtm trial indication type terminology
cdisc sdtm trial phase terminology
cdisc sdtm trial summary parameter short name terminology
cdisc sdtm trial type terminology
stage ia lung small cell carcinoma ajcc v7
cdisc sdtm vital sign test code terminology
cdisc sdtm yes no unknown or not applicable response terminology
adenocarcinoma with neuroendocrine differentiation
benign thymoma
unclassified testicular sex cord - stromal tumor
ovarian stromal tumor with minor sex cord elements
stage ib lung small cell carcinoma ajcc v7
adult type granulosa cell tumor
granulosa cell - theca cell tumor
clear cell neoplasm
malignant melanoma in precancerous melanosis
small congenital melanocytic nevus
proliferative nodules in congenital melanocytic nevus
mixed epithelioid and spindle cell melanoma
epithelioid cell nevus
spindle cell nevus
giant cell sarcoma
stage iib lung small cell carcinoma ajcc v7
fibromyxoid tumor
periosteal fibroma
periosteal fibrosarcoma
fascial fibroma
fascial fibrosarcoma
icd - o - 3_code
cdisc sdtm action taken with study treatment terminology
cdisc sdtm adverse event outcome terminology
cdisc sdtm severity intensity scale for adverse event terminology
stage iia lung small cell carcinoma ajcc v7
cdisc sdtm unit for vital sign result terminology
angiomyosarcoma
benign stromal tumor
ossifying renal tumor of infancy
borderline ovarian mucinous adenofibroma
gonadal polyembryoma
choriocarcinoma combined with other germ cell elements
malignant trophoblastic teratoma
benign hemangioendothelioma
stage ii lung small cell carcinoma ajcc v7
cdisc sdtm age group terminology
cdisc sdtm age unit terminology
cdisc sdtm system organ class terminology
cdisc sdtm common terminology criteria for adverse event grade terminology v3 .0
cdisc sdtm control type terminology
cdisc send country terminology
cdisc sdtm diagnosis group terminology
cdisc dictionary name terminology
cdisc sdtm not done terminology
stage iii lung small cell carcinoma ajcc v7
cdisc sdtm ethnic group terminology
hemolymphangioma
fissure
flexure
floor
aggressive osteoblastoma
cdisc sdtm category for inclusion and or exclusion terminology
gallium
metastasizing chondroblastoma
mopidamol
stage iiia lung small cell carcinoma ajcc v7
ameloblastic fibrodentinoma
polar spongioblastoma
oligodendroblastoma
cerebellar sarcoma
ganglioneuromatosis
cocculus / nux vomica / tabacum / petroleum extract
benign intraocular medulloepithelioma
medulloepithelioma not otherwise specified
benign intraocular teratoid medulloepithelioma
stage iiib lung small cell carcinoma ajcc v7
intraocular teratoid medulloepithelioma
spongioneuroblastoma
retinocytoma
differentiated retinoblastoma
undifferentiated retinoblastoma
diffuse retinoblastoma
spontaneously regressing retinoblastoma
hemangioblastic meningioma
host
stage iv lung small cell carcinoma ajcc v7
hydrophilicity
wine
wine cooler
beer
sake
liquor
indium
inorganic
occult lung small cell carcinoma
cdisc sdtm terminology
layer
one
two
three
four
five
six
seven
eight
occult lung adenosquamous carcinoma
nine
melanotic neurofibroma
mercury
malignant peripheral nerve sheath tumor with perineurial differentiation
hodgkin's disease ,  lymphocyte depletion ,  diffuse fibrosis
hodgkin's disease ,  lymphocyte depletion ,  reticular
ovulation
occult lung large cell carcinoma
follicular variant thyroid gland papillary carcinoma ,  encapsulated subtype with invasion
carotid body
abutment
apical endodontic surgery
full crown
lateral condensation
mta cement
overdenture
partial crown
occult lung squamous cell carcinoma
periapical
secondary caries
thermal fill
dental post
tooth canal
parotid gland warthin tumor
ceftazidime
losartan
stage ia lung squamous cell carcinoma ajcc v7
atazanavir
cevimeline
donepezil
dyclonine hydrochloride
gemcitabine
indinavir
lapatinib ditosylate
nicardipine
stage iia lung squamous cell carcinoma ajcc v7
anticholinergic agent
dopamine antagonist
dopamine agonist
serotonin antagonist
nicotinic antagonist
stage iiia lung squamous cell carcinoma ajcc v7
interstitial radiation therapy
natural product
glycoside
proton beam radiation therapy
pleurodesis
morphine sulfate
stage iiib lung squamous cell carcinoma ajcc v7
in vitro treated peripheral blood lymphocyte therapy
hepatic artery embolization
skin metatypical carcinoma
new york heart association class i
new york heart association class ii
new york heart association class iii
new york heart association class iv
new york heart association class
stage iib lung squamous cell carcinoma ajcc v7
canadian cardiovascular society grading scale class
unstable angina
cholagogues or choleretic agents
stable angina
variant angina
killip class
antitussive agent
photoimmunotherapy
stage ib lung squamous cell carcinoma ajcc v7
cardiovascular history
history of cardiogenic shock
history of peripheral vascular disease
personal history of coronary artery disease
enteroglucagonoma
history of heart failure
history of resuscitated cardiac arrest
in - hospital cardiac arrest
ototoxicity
stage ib lung adenocarcinoma ajcc v7
angiotensin ii receptor antagonist
dapsone gel
ductal breast carcinoma in situ ,  solid type
oil
gataparsen sodium
fluorine f 18 feqa
cabazitaxel
crolibulin
selumetinib
stage ia lung adenocarcinoma ajcc v7
afatinib
fluorine f 18 sodium fluoride
oncolytic measles virus encoding thyroidal sodium iodide symporter
vinorelbine tartrate emulsion
brentuximab vedotin
dexrazoxane hydrochloride
aurora kinase inhibitor pf - 03814735
multikinase inhibitor at9283
panobinostat
elisidepsin
stage iia lung adenocarcinoma ajcc v7
hepatoid adenocarcinoma
adenocarcinoma ,  endocervical type
ofatumumab
mucinous adenocarcinoma ,  endocervical type
belotecan hydrochloride
tibolone
european quality of life five dimension three level questionnaire
fact - e questionnaire
triple blind study
stage iib lung adenocarcinoma ajcc v7
checkpoint kinase inhibitor azd7762
milliliter per hour
drop per minute
milliequivalent per kilogram per hour
per second
per hour
per minute
per day
milligram per hour
stage iiib lung adenocarcinoma ajcc v7
unit per hour
interferon - gamma - expressing adenovirus vaccine asn - 002
unit of dose calculation
milligram per square meter per day
gram per kilogram per day
milligram per kilogram per day
milliliter per square meter per day
lutetium lu - 177 girentuximab
fidaxomicin
stage iiia lung adenocarcinoma ajcc v7
human mhc non - restricted cytotoxic t - cell line tall - 104
odanacatib
elotuzumab
milatuzumab
daniquidone
tergenpumatucel - l
folate receptor - targeted technetium tc - 99m ec20
folate receptor - targeted vinca alkaloid / mitomycin c ec0225
anti - il - 13 humanized monoclonal antibody tnx - 650
ovarian thecoma
occult lung adenocarcinoma
palifosfamide
mixed testicular sex cord - stromal tumor
affected body area
checked - in
checked - out
moxalactam
pyriform fossa carcinoma
substitution permitted
malignant sertoli cell tumor
stage iv osteosarcoma  ajcc v7
benign sertoli cell tumor
milligram per deciliter
stage iva osteosarcoma  ajcc v7
partial blind study
behavioral dietary intervention
antioxidants therapy
antineoplastons therapy
stage ivb osteosarcoma  ajcc v7
art therapy
scaling
marginal
polyunsaturated fatty acid
lutetium lu - 177 capromab
stage i bone sarcoma  ajcc v7
brivanib
fas receptor agonist apo010
mdr modulator cbt - 1
daporinad
tocophersolan
representation
human lactoferrin peptide hlf1 - 11
hsv - tk - transduced donor lymphocytes
green tea
kunecatechins ointment
stage ii bone sarcoma  ajcc v7
alpha1 significance
alpha2 significance
tau
corner plus
corner minus
central minus
screening method
green tea lozenge
quinacrine hydrochloride
stage iv bone sarcoma  ajcc v7
technetium tc - 99m medronate
deglycosylated ricin a chain - conjugated anti - cd19 / anti - cd22 immunotoxins
bat25
bat26
d2s123
d5s346
d17s250
paty criterion
weekly
stage iva bone sarcoma  ajcc v7
batch
amsterdam criteria ii
cell cycle checkpoint / dna repair antagonist ic83
adrenal scintigraphy
crohn disease - like reaction
mismatch
rilotumumab
stage ivb bone sarcoma  ajcc v7
eicosapentaenoic acid
topical vitamin e
remestemcel - l
oral sodium phenylbutyrate
barbiturate
indium in 111 - labeled autologous peripheral blood mononuclear cells
indium in 111 - labeled autologous polymorphonuclear leukocytes
pyruvate kinase inhibitor tln - 232
brivudine
dna vector ppra - psm vaccine
stage i osteosarcoma  ajcc v7
serous adenofibroma
ovarian serous adenocarcinofibroma
l - arginine / korean ginseng / ginkgo biloba / damiana - based supplement
modified partitioning around medoids
most recent angina pectoris event
onset of angina pectoris event
first ever onset of angina pectoris event
synthetic peptides e - pra and e - psm vaccine
mdm2 snp309 allele
bischloroethylsulfide
stage ii osteosarcoma  ajcc v7
angina pectoris prompting medical attention event
cpg dinucleotide
station
most recent heart failure event
first ever onset of heart failure event
heart failure prompting medical attention event
resuscitated cardiac arrest event
benign teratoma
primary sampling unit
multiracial
chest wall solitary plasmacytoma
data not releasable
multiple hispanic
puerto rican
mexican
mexican american
cuban or cuban american
dominican
central american
not ascertained
chest wall lymphoma
spanish
no formal schooling
1st grade completion
2nd grade completion
3rd grade completion
4th grade completion
5th grade completion
6th grade completion
7th grade completion
chest wall fibromatosis
8th grade completion
9th grade completion
10th grade completion
11th grade completion
12th grade completion ,  no diploma
general equivalency diploma completion
high school completion
some college completion
sternal chondromyxoid fibroma
associate academic degree completion
vocational program completion
does not know
professional doctorate
research doctorate
current every day smoker
current some day smoker
current smoker
former smoker
smoker ,  current status unknown
unknown if ever smoked
cdisc sdtm trial summary parameter long name terminology
cdisc sdtm vital sign test name terminology
cdisc sdtm laboratory test name terminology
olfactory neurogenic tumor
olfactory neurocytoma
sternal lymphoma
vamp regimen
abve regimen
oppa regimen
gallbladder cancer tnm finding v6
oepa regimen
oppa - copp regimen
gallbladder cancer clinical tnm finding v6
gallbladder cancer pathologic tnm finding v6
gallbladder cancer pathologic distant metastasis tnm finding v6
oepa - copp regimen
nodular sclerosis classic hodgkin lymphoma ,  cellular phase
gallbladder cancer pathologic primary tumor tnm finding v6
gallbladder cancer pathologic regional lymph nodes tnm finding v6
copp alternating with abv regimen
dbve - pc regimen
gallbladder cancer pm0 tnm finding
gallbladder cancer pm1 tnm finding v6 and v7
gallbladder cancer pmx tnm finding v6
gallbladder cancer pnx tnm finding v6 and v7
sternal intraosseous schwannoma
gallbladder cancer pn0 tnm finding v6 and v7
gallbladder cancer pn1 tnm finding v6
gallbladder cancer pt0 tnm finding v6 and v7
gallbladder cancer ptis tnm finding v6 and v7
gallbladder cancer pt1 tnm finding v6 and v7
gallbladder cancer pt1a tnm finding v6 and v7
gallbladder cancer pt1b tnm finding v6 and v7
gallbladder cancer pt2 tnm finding v6 and v7
gallbladder cancer pt3 tnm finding v6 and v7
gallbladder cancer pt4 tnm finding v6 and v7
chest wall lipoma
deca regimen
calorie
lmb - 89 regimen
british thermal unit
nhl - bfm - 90 regimen
chest wall parachordoma
ifosfamide / vinorelbine regimen
dcter regimen
dat regimen
ade regimen
blood cell count ratio measurement
decal regimen
chest wall plexiform fibrohistiocytic tumor
apo regimen
lnh - 92 regimen
hm89 regimen
hm91 regimen
peripheral primitive neuroectodermal tumor of the kidney
percent in white blood count differential
nhl - bfm - 95 regimen
percent of predicted value
per 100 white blood cells
percent of total hemoglobin
software development
software maintenance
chest wall hodgkin lymphoma
vadriac regimen
vadriac alternating with ie regimen
cyclophosphamide / topotecan regimen
thousand
oncogenic osteomalacia
phosphaturic mesenchymal tumor
million
malignant chest wall bone neoplasm
cells per liter
cells per microliter
trillion cells per liter
thousand cells per microliter
thousand cells
million cells
billion cells
hundred million cells
billion cells per liter
lynch 1 syndrome
ketamine / amitriptyline np - h cream
million cells per microliter
cagrid
per microliter
billion per liter
ten thousand cells per kilogram
hundred thousand cells per kilogram
million cells per kilogram
lynch 2 syndrome
ten million cells per kilogram
baclofen / amitriptyline / ketamine gel
local
plaque forming unit
ten million plaque forming units
hundred million plaque forming units
billion plaque forming units
million plaque forming units
five per second
neurofibromatosis
complement activity enzyme unit
bahamian
decimal ratio
equivalent weight
high power field
unit of energy
kiloelectronvolt
giant hypertrophic gastritis
electronvolt
kilohertz
gardner syndrome
unit of spread rate of substance
unit of spread rate of substance by mass
gram per square meter
intravenous bag dosing unit
kilopascal
whey protein isolate
ultrasound - guided transbronchial needle aspiration
endoscopic ultrasound - guided fine - needle aspiration
jeb regimen
attenuated familial adenomatous polyposis
regimen used to treat malignant renal neoplasm
regimen used to treat primary malignant neoplasm of liver
ee - 4a regimen
nwts regimen 1
pog - 8697 liver cancer regimen
ipa liver cancer regimen
vincristine - dactinomycin rhabdomyosarcoma regimen
vac regimen
mycophenolic acid
sternal neoplasm
ie rhabdomyosarcoma regimen
gram per microliter
id rhabdomyosarcoma regimen
dd - 4a regimen
ce - pe childhood kidney cancer regimen
microgram per deciliter
microgram per liter
low power field
million per microliter
kilounit
stage iia esophageal adenocarcinoma ajcc v7
million units
microgram per square centimeter
microgram per square meter
unit of frequency
megahertz
milliunit
milliinternational unit
milliosmole
unit of electricity and magnetism
stage iib esophageal adenocarcinoma ajcc v7
unit of electric capacitance
unit of electric inductance
unit of electric potential
millivolt
not obtained
nanogram per deciliter
nanogram per liter
nanometer
source data not available
osmole
picogram per deciliter
pound per square inch
million international units
copy
index of expandability
map regimen
mapi regimen
led therapy
ice
nat2*5 allele
nat2*6 allele
nat2*7 allele
nat2*14 allele
igg phospholipid unit
igm phospholipid unit
megarad
viral particle unit
million viral particles
nanocurie
pseudomembrane formation
4p15 .32
8q24 .2
unit of radiant exposure
joule per square centimeter
microgram per specimen
attributable risk
fundamental physical constant
mathematical constant
unit of catalytic activity concentration
enzyme unit per deciliter
enzyme unit per milliliter
index value
malignant pancreatic somatostatinoma
stage iib esophageal squamous cell carcinoma ajcc v7
labial mucosa
brcapro
gram per 24 hours
international unit of vitamin a
unit of arbitrary substance concentration
international unit per liter
international unit per milliliter
international unit per square meter
international unit per kilogram
stage iia esophageal squamous cell carcinoma ajcc v7
international unit per milligram
international unit per milligram of alpha - tocopherol
kilounit per kilogram
epidermolysis bullosa
arbitrary unit of substance rate
kilounit per liter
liter per minute
cardiac rhabdomyoma
liter per second
microgram per hour
unit of amount of substance rate
microgram per kilogram
microkatal per liter
millielectronvolt
milligram per 24 hours
mycotoxin
atrial septum lipomatous hypertrophy
milligram per inhalation
milligram per kilogram
milligram per square meter
milligram per milliliter per minute
milligram per week
microinternational unit per milliliter
micromole per 24 hours
micromole per deciliter
microunit per milliliter
milliinternational unit per square meter
cardiac lipoma
milliliter per 24 hours
milliliter per kilogram
milliliter per minute per 1 .73 m2 of body surface area
opioid receptor agonist
unit for functional test results
milliliter per minute per millimeters of mercury
milliliter per minute per millimeters of mercury per liter
millimeter per hour
epicardial lipoma
millimole per 24 hours
colchicine - site binding agent
vinca - domain binding agent
millimole per minute per thousand pascal per liter
unit of osmotic concentration
osmolality unit
milliosmole per kilogram
million units per milliliter
nanogram per kilogram
pericardial leiomyoma
nanogram per milliliter per hour
nanomole per liter
nanomole per milligram of protein
picomole per liter
picofarad
retinol equivalent
taxane - pocket binding agent
retinol activity equivalent
mature pericardial teratoma
mitotic kinesin modulator
rna copy per milliliter
mitotic enzyme modulator
macrolide
radioactive seed implant dosing unit
session
infectious dose
tissue culture infection dose
superior vena cava leiomyosarcoma
tissue culture infectious dose 50%
thousand per square millimeter
thousand per milliliter
pancreatic polypeptide tumor
titer
pancreatic alpha cell adenoma
unit per liter
pancreatic beta cell adenoma
malignant pancreatic gastrinoma
pulmonary artery angiosarcoma
pancreatic delta cell adenoma
malignant pancreatic vipoma
frozen section
permanent section
unit per 24 hours
unit per kilogram
unit per square meter
unit per microliter
volume fraction
desmoplastic mesothelioma
mass fraction
milliequivalent per 24 hours
milliequivalent per hour
milliequivalent per deciliter
milliequivalent per liter
milliequivalent per kilogram
picogram of prostaglandin e2 per milligram of protein
maytansine - site binding agent
token
ida - dcter regimen
benign glomus tumor
cog - c9710 apl regimen
ccg - 0922 apl regimen
ida - flag regimen
aie regimen
mae regimen
st - hd - 86 regimen
ape regimen
palate kaposi sarcoma
census tract
biliary intraepithelial neoplasia - 1
biliary intraepithelial neoplasia - 2
high - grade biliary intraepithelial neoplasia
flt3 internal tandem duplication
flt3 tyrosine kinase domain point mutation
cdisc glossary terminology
intra subject variability
dextran - albumin solution
nad
skin glomangioma
doxorubicin preparation
multidimensional
liposome - encapsulated daunorubicin - cytarabine
angle
gantry
problem with software installation
date - related software issue
regimen used to treat gestational trophoblastic tumor
benign extragonadal germ cell tumor
mac regimen
ema - co regimen
ema - ce regimen
ape / gestational trophoblastic tumor regimen
peba regimen
rh factor
web site
mixed type osteosarcoma
gastric mixed adenocarcinoma
future
fluctuate
override
pineal region teratoma
anal cancer tnm finding v6
anal cancer pathologic tnm finding v6
anal cancer pathologic distant metastasis tnm finding v6
anal cancer pathologic primary tumor tnm finding v6
anal cancer pathologic regional lymph nodes tnm finding v6
anal cancer ptx tnm finding v6 and v7
anal cancer pt0 tnm finding v6 and v7
anal cancer pt1 tnm finding v6 and v7
anal cancer pt2 tnm finding v6 and v7
anal cancer pt3 tnm finding v6 and v7
anal cancer pt4 tnm finding v6 and v7
anal cancer pnx tnm finding v6 and v7
anal cancer pn0 tnm finding v6 and v7
anal cancer pn2 tnm finding v6 and v7
anal cancer pn3 tnm finding v6 and v7
testicular mixed choriocarcinoma and yolk sac tumor
anal cancer pmx tnm finding v6
anal cancer pm0 tnm finding
anal cancer pm1 tnm finding v6 and v7
anal cancer pn1 tnm finding v6 and v7
anal cancer ptis tnm finding v6 and v7
stage i sinonasal cancer ajcc v6 and v7
stage ii sinonasal cancer ajcc v6 and v7
stage iii sinonasal cancer ajcc v6 and v7
stage iv sinonasal cancer ajcc v6
recurrent sinonasal carcinoma
rosette - forming glioneuronal tumor of the fourth ventricle
pineal region meningioma
endolymphatic sac tumor
malignant sex cord - stromal tumor
ranibizumab
myxoid leiomyoma
attoliter
survey inch
ucum terminology
benign central nervous system mesenchymal ,  non - meningothelial neoplasm
malignant central nervous system mesenchymal ,  non - meningothelial neoplasm
nadp
breast small cell carcinoma
colon small cell carcinoma
esophageal small cell carcinoma
gallbladder small cell carcinoma
gastric small cell carcinoma
prostate small cell carcinoma
malignant pineal region germ cell tumor
depression and suicide
optic nerve astrocytoma
nafoxidine
ependymal tumor
olfactory groove meningioma
childhood supratentorial embryonal tumor with multilayered rosettes ,  c19mc - altered
childhood infratentorial embryonal tumor with multilayered rosettes ,  c19mc - altered
recurrent childhood medulloblastoma
posterior cranial fossa meningioma
suprasellar meningioma
periocular meningioma
intraorbital meningioma
gasserian meningioma
naloxone hydrochloride
pituitary gland acidophil adenoma
stromal neoplasm
transitional cell neoplasm
cystic neoplasm
malignant eyelid neoplasm
yotta
zetta
exa
peta
tera
giga
hecto
deca
deci
naltrexone hydrochloride
ectopic parathormone secretion syndrome
centi
pico
femto
atto
zepto
yocto
clinical data interchange standards consortium proposed terminology
parotid gland carcinoma
sphenoid sinus neoplasm
supraglottis neoplasm
gastric cardia carcinoma
gastric pylorus carcinoma
eccrine neoplasm
benign eccrine neoplasm
apocrine neoplasm
benign apocrine neoplasm
naproxen
malignant apocrine neoplasm
skin fibrous histiocytoma
benign ovarian sex cord - stromal tumor
lacrimal gland carcinoma ex pleomorphic adenoma
metastatic malignant neoplasm in the pituitary gland
benign skin fibroblastic neoplasm
benign external ear neoplasm
cerebellar pilocytic astrocytoma
opiate antagonist
testicular lymphoma
plantar verrucous carcinoma
mediastinal seminoma
prostate ductal adenocarcinoma
superficial fibromatosis
spinal cord hamartoma
zinostatin
pancreatic intraepithelial neoplasia - 1
balanced chromosomal translocation
unbalanced translocation
numerical chromosomal abnormality
iodide
chromosomal inversion
chromosomal insertion
chromosomal duplication
neomycin
retinol
tocopherol
gamma - tocopherol
tocotrienol
homogeneously staining region
arachidic acid
behenic acid
stigmastanol
brassicasterol
brassidic acid
butyric acid
campesterol
capric acid
caproic acid
octanoic acid
cephalin
cetoleic acid
clupanodonic acid
columbinic acid
conjugated linoleic acid n - 6
conjugated linoleic acid n - 7
decenoic acid
dietary fatty acid
middle ear adenoma
dietary phospholipid
dietary steroid
dietary sterol
dihomo - gamma - linolenic acid
docosadienoic acid
docosahexaenoic acid
doconexent
docosapentaenoic acid
docosapentaenoic acid n - 6
paranasal sinus papilloma
docosatrienoic acid
docosenoic acid
docosenoic acid n - 9
dodecenoic acid
eicosadienoic acid
eicosadienoic acid n - 6
eicosatetraenoic acid
eicosatetraenoic acid n - 3
eicosatrienoic acid
ethmoid sinus papilloma
eicosatrienoic acid n - 3
eicosenoic acid
eicosenoic acid n - 7
erucic acid
fatty acid 21:5
fatty acid 23:1
gadoleic acid
gamolenic acid
frontal sinus papilloma
gondoic acid
hexadecadienoic acid
hexadecadienoic acid n - 4
hexadecadienoic acid n - 7
hexadecatetraenoic acid
hexadecatetraenoic acid n - 1
hexadecatetraenoic acid n - 4
hexadecatrienoic acid
hexadecatrienoic acid n - 3
sphenoid sinus papilloma
hexadecatrienoic acid n - 4
lauric acid
lauroleic acid
lecithin
lignoceric acid
long chain fatty acid
margaric acid
maxillary sinus papilloma
mead acid
medium chain fatty acid
myristic acid
nervonic acid
octadecadienoic acid
octadecadienoic acid n - 3
recombinant nerve growth factor
maxillary sinus inverted papilloma
octadecadienoic acid n - 4
octadecadienoic acid n - 6 trans
octadecadienoic acid n - 9
octadecatrienoic acid
parinaric acid
sphenoid sinus inverted papilloma
pentadecylic acid
phosphatidic acid
phosphatidylserine
plasmalogen
frontal sinus inverted papilloma
punicic acid
saturated phytosterol
selacholeic acid
short chain fatty acid
sphingolipid
stearic acid
stigmasterol
tetracosahexaenoic acid
ethmoid sinus inverted papilloma
icosapent
unsaturated phytosterol
very long chain fatty acid
hard palate monomorphic adenoma
conjunctival melanocytic intraepithelial neoplasia
cdisc clinical classification kps scale test name terminology
cdisc clinical classification kps scale test code terminology
cdisc questionnaire sf36 v1 .0 standard test name terminology
cdisc questionnaire sf36 v1 .0 standard test code terminology
karnofsky performance status scale clinical classification
sf36 v1 .0 standard  -  in general you say your health is
sf36 v1 .0 standard  -  comp year ago rate gen health now
sf36 v1 .0 standard  -  limit vigorous activities
sf36 v1 .0 standard  -  limit moderate activities
sf36 v1 .0 standard  -  limit lifting or carrying
sf36 v1 .0 standard  -  limit climbing several flights
sf36 v1 .0 standard  -  limit climbing one flight stairs
sf36 v1 .0 standard  -  limit bending ,  kneeling ,  stooping
sf36 v1 .0 standard  -  limit walking more than a mile
sf36 v1 .0 standard  -  limit walking several blocks
sf36 v1 .0 standard  -  limit walking one block
sf36 v1 .0 standard  -  limit bathing or dressing yourself
sf36 v1 .0 standard  -  physical: cut down time on work
sf36 v1 .0 standard  -  physical: accomplished less
sf36 v1 .0 standard  -  physical: limited kind of work
sf36 v1 .0 standard  -  physical: difficulty perform work
sf36 v1 .0 standard  -  emotional: cut down time on work
sf36 v1 .0 standard  -  emotional: accomplished less
sf36 v1 .0 standard  -  emotional: did work less carefully
sf36 v1 .0 standard  -  extent phys / emotional interfered
sf36 v1 .0 standard  -  how much bodily pain have you had
sf36 v1 .0 standard  -  pain interfere with normal work
sf36 v1 .0 standard  -  did you feel full of pep
sf36 v1 .0 standard  -  have you been very nervous person
sf36 v1 .0 standard  -  felt down nothing cheer you up
sf36 v1 .0 standard  -  have you felt calm and peaceful
sf36 v1 .0 standard  -  did you have a lot of energy
sf36 v1 .0 standard  -  you felt downhearted and blue
sf36 v1 .0 standard  -  did you feel worn out
sf36 v1 .0 standard  -  have you been happy person
sf36 v1 .0 standard  -  did you feel tired
sf36 v1 .0 standard  -  time phys / emotional interfered
sf36 v1 .0 standard  -  get sick little easier than other
sf36 v1 .0 standard  -  i am as healthy as anybody i know
sf36 v1 .0 standard  -  i expect my health to get worse
sf36 v1 .0 standard  -  my health is excellent
zelavespib
valecobulin
antiviral innate immune response receptor rig - i
sf - 36 v1 .0 acute  -  in general you say your health is
sf - 36 v1 .0 acute  -  comp week ago rate gen health now
sf - 36 v1 .0 acute  -  limit vigorous activities
sf - 36 v1 .0 acute  -  limit moderate activities
sf - 36 v1 .0 acute  -  limit lifting or carrying
sf - 36 v1 .0 acute  -  limit climbing several flights
sf - 36 v1 .0 acute  -  limit climbing one flight stairs
sf - 36 v1 .0 acute  -  limit bending ,  kneeling ,  stooping
sf - 36 v1 .0 acute  -  limit walking more than a mile
sf - 36 v1 .0 acute  -  limit walking several blocks
sf - 36 v1 .0 acute  -  limit walking one block
sf - 36 v1 .0 acute  -  limit bathing or dressing yourself
sf - 36 v1 .0 acute  -  physical: cut down time on work
sf - 36 v1 .0 acute  -  physical: accomplished less
sf - 36 v1 .0 acute  -  physical: limited kind of work
sf - 36 v1 .0 acute  -  physical: difficulty perform work
sf - 36 v1 .0 acute  -  emotional: cut down time on work
sf - 36 v1 .0 acute  -  emotional: accomplished less
sf - 36 v1 .0 acute  -  emotional: did work less carefully
sf - 36 v1 .0 acute  -  extent phys / emotional interfered
sf - 36 v1 .0 acute  -  how much bodily pain have you had
sf - 36 v1 .0 acute  -  pain interfere with normal work
sf - 36 v1 .0 acute  -  did you feel full of pep
sf - 36 v1 .0 acute  -  have you been very nervous person
sf - 36 v1 .0 acute  -  felt down nothing cheer you up
sf - 36 v1 .0 acute  -  have you felt calm and peaceful
sf - 36 v1 .0 acute  -  did you have a lot of energy
sf - 36 v1 .0 acute  -  you felt downhearted and blue
sf - 36 v1 .0 acute  -  did you feel worn out
sf - 36 v1 .0 acute  -  have you been a happy person
sf - 36 v1 .0 acute  -  did you feel tired
sf - 36 v1 .0 acute  -  time phys / emotional interfered
sf - 36 v1 .0 acute  -  get sick little easier than other
sf - 36 v1 .0 acute  -  i am as healthy as anybody i know
sf - 36 v1 .0 acute  -  i expect my health to get worse
sf - 36 v1 .0 acute  -  my health is excellent
sf - 36 v2 .0 acute  -  in general you say your health is
sf - 36 v2 .0 acute  -  comp week ago rate gen health now
sf - 36 v2 .0 acute  -  limit vigorous activities
sf - 36 v2 .0 acute  -  limit moderate activities
sf - 36 v2 .0 acute  -  limit lifting or carrying
sf - 36 v2 .0 acute  -  limit climbing several flights
sf - 36 v2 .0 acute  -  limit climbing one flight stairs
sf - 36 v2 .0 acute  -  limit bending ,  kneeling ,  stooping
sf - 36 v2 .0 acute  -  limit walking more than a mile
sf - 36 v2 .0 acute  -  limit walking several hundred yds
sf - 36 v2 .0 acute  -  limit walking one hundred yards
sf - 36 v2 .0 acute  -  limit bathing or dressing yourself
sf - 36 v2 .0 acute  -  physical: cut down time on work
sf - 36 v2 .0 acute  -  physical: accomplished less
sf - 36 v2 .0 acute  -  physical: limited kind of work
sf - 36 v2 .0 acute  -  physical: difficulty perform work
sf - 36 v2 .0 acute  -  emotional: cut down time on work
sf - 36 v2 .0 acute  -  emotional: accomplished less
sf - 36 v2 .0 acute  -  emotional: did work less carefully
sf - 36 v2 .0 acute  -  extent phys / emotional interfered
sf - 36 v2 .0 acute  -  how much bodily pain have you had
sf - 36 v2 .0 acute  -  pain interfere with normal work
sf - 36 v2 .0 acute  -  did you feel full of life
sf - 36 v2 .0 acute  -  have you been very nervous
sf - 36 v2 .0 acute  -  felt down nothing cheer you up
sf - 36 v2 .0 acute  -  have you felt calm and peaceful
sf - 36 v2 .0 acute  -  did you have a lot of energy
sf - 36 v2 .0 acute  -  you felt downhearted and depressed
sf - 36 v2 .0 acute  -  did you feel worn out
sf - 36 v2 .0 acute  -  have you been happy
sf - 36 v2 .0 acute  -  did you feel tired
sf - 36 v2 .0 acute  -  time phys / emotional interfered
sf - 36 v2 .0 acute  -  get sick little easier than other
sf - 36 v2 .0 acute  -  i am as healthy as anybody i know
sf - 36 v2 .0 acute  -  i expect my health to get worse
sf - 36 v2 .0 acute  -  my health is excellent
sf - 36 v2 .0 standard  -  in general you say your health is
sf - 36 v2 .0 standard  -  comp year ago rate gen health now
sf - 36 v2 .0 standard  -  limit vigorous activities
sf - 36 v2 .0 standard  -  limit moderate activities
sf - 36 v2 .0 standard  -  limit lifting or carrying
sf - 36 v2 .0 standard  -  limit climbing several flights
sf - 36 v2 .0 standard  -  limit climbing one flight stairs
sf - 36 v2 .0 standard  -  limit bending ,  kneeling ,  stooping
sf - 36 v2 .0 standard  -  limit walking more than a mile
sf - 36 v2 .0 standard  -  limit walking several hundred yds
sf - 36 v2 .0 standard  -  limit walking one hundred yards
sf - 36 v2 .0 standard  -  limit bathing or dressing yourself
sf - 36 v2 .0 standard  -  physical: cut down time on work
sf - 36 v2 .0 standard  -  physical: accomplished less
sf - 36 v2 .0 standard  -  physical: limited kind of work
sf - 36 v2 .0 standard  -  physical: difficulty perform work
sf - 36 v2 .0 standard  -  emotional: cut down time on work
sf - 36 v2 .0 standard  -  emotional: accomplished less
sf - 36 v2 .0 standard  -  emotional: did work less carefully
sf - 36 v2 .0 standard  -  extent phys / emotional interfered
sf - 36 v2 .0 standard  -  how much bodily pain have you had
sf - 36 v2 .0 standard  -  pain interfere with normal work
sf - 36 v2 .0 standard  -  did you feel full of life
sf - 36 v2 .0 standard  -  have you been very nervous
sf - 36 v2 .0 standard  -  felt down nothing cheer you up
sf - 36 v2 .0 standard  -  have you felt calm and peaceful
sf - 36 v2 .0 standard  -  did you have a lot of energy
sf - 36 v2 .0 standard  -  you felt downhearted and depressed
sf - 36 v2 .0 standard  -  did you feel worn out
sf - 36 v2 .0 standard  -  have you been happy
sf - 36 v2 .0 standard  -  did you feel tired
sf - 36 v2 .0 standard  -  time phys / emotional interfered
sf - 36 v2 .0 standard  -  get sick little easier than other
sf - 36 v2 .0 standard  -  i am as healthy as anybody i know
sf - 36 v2 .0 standard  -  i expect my health to get worse
sf - 36 v2 .0 standard  -  my health is excellent
budesonide
worst severity past seven days breast enlargement or tenderness
embarrassed by my eating habits
have pain ,  tenderness ,  or discomfort in breast
have frequent colds or infections
telisotuzumab
charlson comorbidity index derived from chart review
cdisc clinical classification faq test name terminology
cdisc clinical classification faq test code terminology
functional activities questionnaire clinical classification
ropeginterferon alfa - 2b
pelabresib
cdisc clinical classification kfss test name terminology
cdisc clinical classification kfss test code terminology
kurtzke functional systems scores clinical classification
oplunofusp
roducitabine
hormone - resistant breast adenocarcinoma
decitabine and cedazuridine
localized childhood soft tissue sarcoma
cdisc clinical classification drs test name terminology
cdisc clinical classification drs test code terminology
disability rating scale clinical classification
kidney small cell neuroendocrine carcinoma
sinonasal small cell neuroendocrine carcinoma
low grade astrocytoma
rocakinogene sifuplasmid
tusamitamab ravtansine
irinotecan / temozolomide regimen
ectodermal dysplasia and immunodeficiency
taletrectinib
gallium ga 68 gozetotide
suratadenoturev
peposertib
roblitinib
tumor less than or equal to 2 .0 cm
tumor greater than or equal to 2 .1 cm
idetrexed
letetresgene autoleucel
lirametostat
unesbulin
trouble focusing except on anxiety
cetuximab sarotalocan
ivuxolimab
primary bone non - hodgkin lymphoma
tetravalent rna - lipoplex cancer vaccine bnt111
infant acute lymphoblastic leukemia without mll gene rearrangement
mll gene rearrangement
ripertamab
eluvixtamab
sotigalimab
zandelisib
uzansertib
anti - il - 8 monoclonal antibody bms - 986253
tanner scale - boy  -  genitalia stages
tanner scale - boy  -  pubic hair stages
tanner scale - girl  -  breast stages
tanner scale - girl  -  pubic hair stages
skin basal cell
darovasertib
sabatolimab
amivantamab
lifirafenib
naporafenib
eganelisib
cerebral creatine deficiency syndrome 1
ontorpacept
dalpiciclib
x - linked lymphoproliferative syndrome 2
gastroesophageal junction small cell neuroendocrine carcinoma
x - linked immunodeficiency with magnesium defect ,  epstein - barr virus infection and neoplasia
pgm3 - associated immunodeficiency
ctla4 deficiency
lymphoproliferative syndrome 1
forty three
ragifilimab
pak4 / nampt inhibitor atg - 019
rineterkib
mobocertinib
pidnarulex
feladilimab
omidubicel
bevifimod
cervical neuroendocrine tumor g1
cervical neuroendocrine tumor g2
nemvaleukin alfa
hypercholesterolemia ,  familial ,  4
vulvar small cell neuroendocrine carcinoma
belumosudil
hematopoietic blast cell
simlukafusp alfa
lirentelimab
prostaglandin e2 ep4 receptor inhibitor an0025
oral epithelial dysplasia
zanidatamab
lymphoid progenitor cell
bomedemstat
camp - specific 3' , 5' - cyclic phosphodiesterase 4d
acute myeloid leukemia with t ( 10 ; 11 )  ( p12 ; q23 )  ;  mllt10 - mll
acute myeloid leukemia with t ( 6 ; 11 )  ( q27 ; q23 )  ;  mllt4 - mll
inavolisib
ezabenlimab
blood irradiation
leukodepletion
eighth
almonertinib
pq / cmc batch utilization terminology
pq / cmc chemical structure data file origin terminology
pq / cmc chemical structure data file type terminology
pq / cmc closure type terminology
pq / cmc compendial method verification indicator terminology
pq / cmc container orientation terminology
pq / cmc container type terminology
pq / cmc drug substance product indicator terminology
pq / cmc impurity classification terminology
pq / cmc interpretation code  ( text )  terminology
pq / cmc interpretation code  ( numeric )  terminology
pq / cmc quality benchmark terminology
pq / cmc storage conditions terminology
pq / cmc study type terminology
pq / cmc testing site unique identifier type terminology
pq / cmc validation parameter terminology
btk np_000052 .1:p .c481x
belzutifan
obrindatamab
breast pleomorphic lobular carcinoma in situ
vosilasarm
how often have difficulty postponing urination
how often have weak urinary stream
emfilermin
valve - derived stromal cell proliferation
cevostamab
giloralimab
vibostolimab
modakafusp alfa
eflepedocokin alfa
iberdomide hydrochloride
cdisc functional test 10 - meter walk / run test name terminology
cdisc functional test 10 - meter walk / run test code terminology
cdisc functional test 4 - stair descend test name terminology
cdisc functional test 4 - stair descend test code terminology
cdisc functional test 4 - stair ascend test name terminology
cdisc functional test 4 - stair ascend test code terminology
10 - meter walk / run test functional test
10 - meter walk / run  -  time to walk / run 10 meters
10 - meter walk / run  -  test grade
4 - stair descend  -  time to do 4 - stair descend
4 - stair descend  -  test grade
4 - stair ascend  -  time to do 4 - stair ascend
4 - stair ascend  -  test grade
ipaq short last 7 days self - administered format version  -  vigorous physical hr and min per day
ipaq short last 7 days self - administered format version  -  moderate physical hr and min per day
ipaq short last 7 days self - administered format version  -  walking hr and min per day
ipaq short last 7 days self - administered format version  -  sitting weekday hr and min per day
ipaq long last 7 days self - administered format version  -  vigorous work hr and min per day
ipaq long last 7 days self - administered format version  -  moderate work hr and min per day
ipaq long last 7 days self - administered format version  -  walking work hr and min per day
ipaq long last 7 days self - administered format version  -  traveling hr and min per day
ipaq long last 7 days self - administered format version  -  bicycle hr and min per day
ipaq long last 7 days self - administered format version  -  walking place hr and min per day
ipaq long last 7 days self - administered format version  -  vigorous garden hr and min per day
ipaq long last 7 days self - administered format version  -  moderate garden hr and min per day
ipaq long last 7 days self - administered format version  -  moderate home hr and min per day
ipaq long last 7 days self - administered format version  -  walking leisure hr and min per day
ipaq long last 7 days self - administered format version  -  vigorous leisure hr and min per day
ipaq long last 7 days self - administered format version  -  moderate leisure hr and min per day
ipaq long last 7 days self - administered format version  -  sitting weekday hr and min per day
ipaq long last 7 days self - administered format version  -  sitting weekend hr and min per day
ipaq long last 7 days telephone format version  -  vigorous work hr and min per day
ipaq long last 7 days telephone format version  -  vigorous work hr and min per week
ipaq long last 7 days telephone format version  -  moderate work hr and min per day
ipaq long last 7 days telephone format version  -  moderate work hr and min per week
ipaq long last 7 days telephone format version  -  walking work hr and min per day
ipaq long last 7 days telephone format version  -  walking work hr and min per week
ipaq long last 7 days telephone format version  -  traveling hr and min per day
ipaq long last 7 days telephone format version  -  traveling hr and min per week
ipaq long last 7 days telephone format version  -  bicycle hr and min per day
ipaq long last 7 days telephone format version  -  bicycling hr and min per week
ipaq long last 7 days telephone format version  -  walking place hr and min per day
ipaq long last 7 days telephone format version  -  walking place hr and min per week
ipaq long last 7 days telephone format version  -  vigorous garden hr and min per day
ipaq long last 7 days telephone format version  -  vigorous garden hr and min per week
ipaq long last 7 days telephone format version  -  moderate garden hr and min per day
ipaq long last 7 days telephone format version  -  moderate garden hr and min per week
ipaq long last 7 days telephone format version  -  moderate home hr and min per day
ipaq long last 7 days telephone format version  -  moderate home hr and min per week
ipaq long last 7 days telephone format version  -  walking leisure hr and min per day
ipaq long last 7 days telephone format version  -  walking leisure hr and min per week
ipaq long last 7 days telephone format version  -  vigorous leisure hr and min per day
ipaq long last 7 days telephone format version  -  vigorous leisure hr and min per week
ipaq long last 7 days telephone format version  -  moderate leisure hr and min per day
ipaq long last 7 days telephone format version  -  moderate leisure hr and min per week
ipaq long last 7 days telephone format version  -  sitting weekday hr and min per day
ipaq long last 7 days telephone format version  -  sitting hr and min on wednesday
ipaq long last 7 days telephone format version  -  sitting weekend hr and min per day
ipaq long last 7 days telephone format version  -  sitting hr and min on saturday
ipaq short last 7 days telephone format version  -  vigorous physical hr and min per day
ipaq short last 7 days telephone format version  -  total vigorous hr and min per week
ipaq short last 7 days telephone format version  -  moderate physical hr and min per day
ipaq short last 7 days telephone format version  -  total moderate hr and min per week
ipaq short last 7 days telephone format version  -  walking hr and min per day
ipaq short last 7 days telephone format version  -  total walking hr and min per week
ipaq short last 7 days telephone format version  -  sitting hr and min per weekday
ipaq short last 7 days telephone format version  -  total sitting hr and min wednesday
favezelimab
pemrametostat
numidargistat
cinrebafusp alfa
angiotensin ii acetate
encelimab
tebotelimab
grade 1 blood lactate dehydrogenase increased ,  ctcae
grade 1 haptoglobin decreased ,  ctcae
grade 2 methemoglobinemia ,  ctcae
liatermin
elimusertib
etevritamab
eftozanermin alfa
pavurutamab
giredestrant
apremilast
intrahepatocellular erythrocytes
upifitamab rilsodotin
upifitamab
4 - stair ascend  -  wear orthoses
4 - stair descend  -  wear orthoses
10 - meter walk / run  -  wear orthoses
oropharyngeal p16ink4a - negative squamous cell carcinoma
brca - associated ovarian carcinoma
recurrent brca -  associated ovarian carcinoma
imaradenant
lutetium lu 177  vipivotide tetraxetan
prolgolimab
geptanolimab
joubert syndrome type 3
delolimogene mupadenorepvec
pelcitoclax
ciltacabtagene autoleucel
adebrelimab
high risk neuroblastoma
autologous anti - claudin18 .2 - transduced t lymphocytes ct041
miptenalimab
radgocitabine hydrochloride
vudalimab
localized cerebral neoplasm
quavonlimab
stat3 inhibitor c - 188 - 9
datopotamab deruxtecan
ebvaciclib
razuprotafib
secukinumab
trametinib dimethyl sulfoxide
vadadustat
zenocutuzumab
olinciguat
breast carcinoma metastatic in the lymph nodes
tilogotamab
lumbar puncture
recurrent breast acinic cell carcinoma
recurrent invasive breast carcinoma of no special type
recurrent breast paget disease
rezivertinib
sugemalimab
digestive system small cell neuroendocrine carcinoma
samuraciclib
garivulimab
penpulimab
alsevalimab
urabrelimab
thorium th 227 anetumab corixetan
vulinacimab
orelabrutinib
h2 receptor antagonist therapy
subasumstat
anti - nrp1 antibody asp1948
extrapulmonary small cell neuroendocrine carcinoma
bapotulimab
covi anxiety scale clinical classification
advanced gastric small cell neuroendocrine carcinoma
advanced small intestinal small cell neuroendocrine carcinoma
iptacopan
recurrent acute myeloid leukemia with t  ( 9 ; 11 )   ( p21 .3 ;  q23 .3 )  ;  mllt3 - mll
itacnosertib
murizatoclax
cptac follow - up form
hormone receptor positive breast adenocarcinoma
refractory hormone receptor positive breast adenocarcinoma
primary vitreoretinal non - hodgkin lymphoma
recurrent primary vitreoretinal non - hodgkin lymphoma
refractory primary vitreoretinal non - hodgkin lymphoma
breast histiocytoid carcinoma
letaplimab
metastatic squamous cell carcinoma in the cervical lymph nodes
pimivalimab
izuralimab
recurrent primary bone lymphoma
refractory primary bone lymphoma
metastatic bladder small cell neuroendocrine carcinoma
metastatic prostate small cell neuroendocrine carcinoma
radiology ,  treatment planning
cudarolimab
immunodeficiency with hyper - igm ,  x - linked ,  type 1
barecetamab
unresectable breast inflammatory carcinoma
metastatic small cell neuroendocrine carcinoma
locally advanced small cell neuroendocrine carcinoma
pavunalimab
bexmarilimab
zimberelimab
hemophilia activities list
etrumadenant
test_concept_123
head and neck small cell neuroendocrine carcinoma
prostate carcinoma metastatic in the lymph nodes
european organisation for the research and treatment of cancer quality of life questionnaire  -  paliative care version 1 .0
european organisation for the research and treatment of cancer quality of life questionnaire  -  core 30 version 3 .0
diabetes distress scale for adults with type 1 diabetes questionnaire
alert verbal painful unresponsive scale clinical classification
brief psychiatric rating scale 1988 version clinical classification
emory treatment resistance interview for ptsd clinical classification
metastatic brca - associated breast carcinoma
revdofilimab
paratesticular deep "aggressive" angiomyxoma
mll gene mutation
localized head and neck carcinoma
localized lung carcinoma
anti - pd1 / anti - ctla4 antibody mixture ql1706
localized breast carcinoma
cabo verde
onametostat
pimurutamab
avotaciclib
childhood abuse and neglect
gastrointestinal tract adenoma ,  intestinal - type
genetic variation identifier
genome assembly version
opucolimab
rilematovir
olverembatinib
hormone receptor negative breast adenocarcinoma
severe congenital neutropenia type 3 ,  autosomal recessive
localized esophageal carcinoma
non - responsive therapy type
icdc data model terminology
cenicriviroc
lanadelumab
garadacimab
ozanimod hydrochloride
daclatasvir dihydrochloride
nangibotide
volagidemab
seer rx interactive antineoplastic drugs database
seer rx interactive antineoplastic drugs database - drugs
seer rx interactive antineoplastic drugs database - regimen
mll gene translocation
brca - associated malignant neoplasm
brca - associated breast carcinoma
palb2 - associated breast carcinoma
pet's hair is greasy ,  matted ,  rough looking
her2 negative breast adenocarcinoma
aml table terminology
senaparib
icatolimab
metastatic her2 negative breast adenocarcinoma
advanced her2 negative breast adenocarcinoma
recurrent her2 negative breast adenocarcinoma
refractory her2 negative breast adenocarcinoma
protocol treatment course
year at disease phase
smn icd - o topography code
japan association of childhood leukemia study
japanese pediatric leukemia / lymphoma study group
minimal residual disease molecular marker
subject enrollment status
aaml0531 aml study identifier
aaml1031 aml study identifier
amlbfm2004 aml study identifier
sjcrhaml02 aml study identifier
jplsgaml05 aml study identifier
aeioplam2002 aml study identifier
jaclsaml99 aml study identifier
dbaml01 aml study identifier
mrcaml12aml study identifier
nophoaml2004 aml study identifier
ppllsgaml98 aml study identifier
adverse event contributory cause of death
pathogen confirmation indicator
myeloid sarcoma response
age in days at disease phase
abivertinib maleate
avasopasem manganese
cenicriviroc mesylate
desidustat
ibuprofen sodium
mecapegfilgrastim
ozanimod
pegcetacoplan
pritumumab
rasdegafusp alfa
ravoxertinib
brexucabtagene autoleucel
skin atypical lipomatous tumor / well differentiated liposarcoma
acoramidis
ociperlimab
eswatini
borofalan  ( 10b )
stat1 - associated immunodeficiency
ectoine mouthwash eml03
zavegepant
molnupiravir
atibuclimab
age in days at onset adverse event
age in days when off protocol therapy or study
age in days when lost to follow - up
age in days at end of total dose calculation
age in days at time of lab test
age in days at start of concomitant medication administration
age in days at end of concomitant medication administration
age in days at radiation therapy course start
age in days at end of radiation therapy
age in days at start of transfusion procedure
age in days at start of total dose calculation
liver small cell neuroendocrine carcinoma
reluscovtogene ralaplasmid
sleep answer
bothered by question
ability question
abdavomeran
tozinameran
pidacmeran
ctdc node terminology
ctdc property terminology
ctdc value terminology
concern question
cold knife cone biopsy
nci drug resistance and sensitivity network
subject off trial
subject off trial due to expired biopsy
subject off trial due to death
subject off trial due to lack of consent
subject off trial due to no available treatment arm
subject off trial due to registration error
subject assigned to protocol treatment arm
subject registration pending approval
subject registration pending confirmation
subject registration pending pten molecular analysis
aml study identifier
subject registration in process
subject registration in process following outside assay
age in days at start of cellular immunotherapy
aml off protocol therapy / study table
aml disease phase timing table
aml course timing table
aml medical history table
aml myeloid sarcoma involvement table
aml lab table
aml subject response table
aml vitals table
aml adverse events table
aml secondary malignant neoplasm table
physical feelings question
aml subject characteristics table
aml demographics table
aml survival characteristics table
aml disease characteristics table
aml molecular analysis table
aml total dose table
aml stem cell transplant table
aml minimal residual disease table
aml echocardiogram table
uvssa gene
uvssa wt allele
uv - stimulated scaffold protein a
ercc8 gene
aml cellular immunotherapy table
aml concomitant medication table
aml radiation therapy table
aml transfusion medicine procedures table
ercc8 wt allele
dna excision repair protein ercc - 8
amlbfm2012 aml study identifier
amlbfmregistry2012 aml study identifier
mrcaml15 aml study identifier
nophoaml2012 aml study identifier
aieoplam92 aml study identifier
scfeelam02 aml study identifier
off protocol therapy or study code
off protocol therapy
disease phase number
treatment - related mortality type
disease involvement detection method
disease involvement site
cns involvement status at leukemia diagnosis
numeric vitals signs result
peripheral blood analysis
csf analysis
bone marrow analysis
lab result unit
count per cubic millimeter
karyotype iscn
number of independent aberrations in karyotype
site of radiation therapy
total radiation dose
exchange transfusion
simple transfusion
therapeutic apheresis
transfusion product
type of cellular immunotherapy
systemic immunotherapy
intrathecal immunotherapy
number of doses
total dose intended
total dose units
medication administration status
medication administered
medication not administered
number of evaluated hlas
number of matched hlas
minimal residual disease unit
response assessment category
bone marrow response
echocardiogram result qualitative
echocardiogram result quantitative
echocardiogram result unit
adverse event code
adverse event system version
death ,  adverse event is noncontributory
intensive care unit admission status
adverse event medication
adverse event intervention
intervention / medication detail
tars1 gene
tars1 wt allele
threonine - trna ligase 1 ,  cytoplasmic
microsatellite stable colorectal carcinoma
dnajc19 gene
dnajc19 wt allele
mitochondrial import inner membrane translocase subunit tim14
refractory non - cutaneous melanoma
refractory ocular melanoma
advanced lung squamous cell carcinoma
refractory lung squamous cell carcinoma
refractory microsatellite stable colorectal carcinoma
advanced chordoma
refractory anal canal squamous cell carcinoma
refractory uveal melanoma
advanced thyroid gland anaplastic carcinoma
advanced anal canal squamous cell carcinoma
hyaluronidase - zzxf / pertuzumab / trastuzumab
nasopharyngeal adenoid cystic carcinoma
nasopharyngeal salivary gland anlage tumor
hairy polyp
nasopharyngeal hairy polyp
nasopharyngeal non - neoplastic disorder
ectopic pituitary gland adenoma
pain question
fatigue question
distress question
distress over emotional problem
distress over physical problem
distress over family problem
nasopharyngeal pituitary gland adenoma
distress over practical problem
pharyngeal lymphoma
pharyngeal non - hodgkin lymphoma
pharyngeal hodgkin lymphoma
nasopharyngeal lymphoma
frequency question
nasopharyngeal non - hodgkin lymphoma
nasopharyngeal hodgkin lymphoma
axl inhibitor slc - 391
topotecan sustained - release episcleral plaque
androgen receptor degrader cc - 94676
cd44v6 - specific car t - cells
anti - cd3 / anti - 5t4 bispecific antibody gen1044
tgf - beta receptor 1 kinase inhibitor sh3051
interleukin - 12 - fc fusion protein df6002
gallium ga 68 - labeled dx600
ruthenium - based small molecule therapeutic bold - 100
androgen receptor inhibitor epi - 7386
sting agonist tak - 676
autologous anti - icam - 1 - car - cd28 - 4 - 1bb - cd3zeta - expressing t - cells aic100
peptide - dye conjugate alm - 488
ncit covid - 19 terminology
covid - 19 terminology
ncit covid - 19 agent terminology
activin type iia receptor fc fusion protein ker - 050
neuroendocrine carcinoma ,  excluding head and neck
anxiety question
head and neck well differentiated neuroendocrine carcinoma
head and neck moderately differentiated neuroendocrine carcinoma
head and neck poorly differentiated neuroendocrine carcinoma
laryngeal neuroendocrine carcinoma
laryngeal well differentiated neuroendocrine carcinoma
laryngeal moderately differentiated neuroendocrine carcinoma
how much distress
laryngeal poorly differentiated neuroendocrine carcinoma
laryngeal large cell neuroendocrine carcinoma
cerebral blood flow velocity
laryngeal soft tissue neoplasm
have trouble or difficulty question
benign laryngeal soft tissue neoplasm
malignant laryngeal soft tissue neoplasm
ataxia - oculomotor apraxia type 1
laryngeal inflammatory myofibroblastic tumor
ataxia - oculomotor apraxia type 3
tongue liposarcoma
laryngeal granular cell tumor
laryngeal chondroma
laryngeal chondrosarcoma
laryngeal soft tissue sarcoma
recurrent mature t - cell and nk - cell neoplasm
refractory mature t - cell and nk - cell neoplasm
laryngeal pleomorphic adenoma
quinolonyl - oxazolidinone antibiotic dnv3837
oropharyngeal human papillomavirus - negative squamous cell carcinoma
egfr mutant - selective  inhibitor tqb3804
2 - methylhippuric acid
4 - methylhippuric acid
ethylbenzene
t , t - muconic acid
anti - her2 - dm1 adc b003
anti - cd47 adc sgn - cd47m
anti - ctla4 antibody fc fusion protein kn044
3 - methylhippuric acid
phenylglyoxylic acid
wee1 kinase inhibitor debio 0123
allogeneic plasmacytoid dendritic cells expressing lung tumor antigens pdc*lung01
autologous afp specific t cell receptor transduced t cells c - tcr055
alk / ros1 / met inhibitor tq - b3101
hepatitis c virus genotype 4 positive
loss of serine - protein kinase atm expression
deleterious gata2 gene mutation
autologous anti - bcma cd8 +  car t - cells descartes - 11
anti - ctla - 4 probody bms - 986288
egfr / vegfr / ret inhibitor ha121 - 28
mek inhibitor hl - 085
n - dihydrogalactochitosan
hetrombopag olamine
arid2 gene mutation
carbon c 14 - pamiparib
autologous monocyte - derived lysate - pulsed dendritic cell vaccine pv - 001 - dc
dengue virus adjuvant pv - 001 - dv
arid1b gene mutation
activating kras exon 4 mutation
methylcantharidimide
activating kras exon 3 mutation
activating kras exon 2 mutation
non - v600 braf gene mutation
chek2 protein variant
chek2 nm_007194 .4:c .470t > c
chek2 np_009125 .1:p .i157t
chek2 nm_007194 .4:c .1283c > t
swallow question
chek2 np_009125 .1:p .s428f
htlv - 2 positive
symptoms question
play or do physical activity question
ada2 gene
ada2 wt allele
adenosine deaminase 2
ada2 gene mutation
biallelic ada2 gene mutation
sars coronavirus 2 antibody
procalcitonin
arm ,  shoulder ,  or hand problem question
cerebral creatine deficiency syndrome 2
x - linked cardiac valvular dysplasia
familial arrhythmogenic right ventricular dysplasia 5
familial arrhythmogenic right ventricular dysplasia 9
low grade oral epithelial dysplasia
high grade oral epithelial dysplasia
oral multifocal epithelial hyperplasia
oral verruca vulgaris
oral squamous cell papilloma
oral cavity kaposi sarcoma
oral cavity myofibroblastic sarcoma
oral cavity soft tissue neoplasm
benign oral cavity soft tissue neoplasm
oral cavity soft tissue sarcoma
pet question
mild acute respiratory distress syndrome
moderate acute respiratory distress syndrome
head and neck histiocytic and dendritic cell neoplasm
head and neck langerhans cell histiocytosis
oral mucosa langerhans cell histiocytosis
head and neck melanocytic neoplasm
oral cavity myeloid sarcoma
gamt gene
gamt wt allele
guanidinoacetate n - methyltransferase
tmem43 gene
tmem43 wt allele
transmembrane protein 43
peripheral blood
pkp2 gene
pkp2 wt allele
plakophilin - 2
berlin criteria for acute respiratory distress syndrome
transbronchial needle aspiration
advanced gastrointestinal stromal tumor
refractory acute undifferentiated leukemia
quality of life question
primary goal response
preference question
autologous tumor infiltrating lymphocytes ln - 145 - s1
current status question
high - dependency unit
co - infection
bemiparin
rectus sheath hematoma
gram negative bacteria
gram positive bacteria
how big a problem question
gynecologic cancer question
discomfort question
off protocol therapy or study reason code
ep4 antagonist inv - 1120
vital signs result
extended release metformin hydrochloride
copper cu 64 dotatate
multi - epitope her2 peptide vaccine tpiv100
non - response per protocol
environmental agent
indwelling central venous catheter
inotropic agent
refractory ganglioneuroblastoma
recurrent ganglioneuroblastoma
heat - treated bacterium mycobacterium obuense imm - 101
bcl - 2 inhibitor lp - 108
absolute reticulocyte count
gallium ga 68 - dota - fapi - 04
anti - pd - 1 / anti - lag - 3 bispecific antibody ro7247669
anti - ctla - 4 monoclonal antibody hbm4003
anti - trailr2 / cdh17 tetravalent bispecific antibody bi 905711
der12p
t ( 2 ; 12 )
molecular sequence variation type
allele ratio measurement
extended phenotype matching
anti - ctla - 4 monoclonal antibody onc - 392
anti - cd137 agonistic monoclonal antibody ator - 1017
tolebrutinib
hsp90 inhibitor tqb3474
mva - bn smallpox vaccine
ultrafast mri
encorafenib - panitumumab regimen
endocrine therapy - induced alopecia
anti - 5t4 antibody - drug conjugate asn004
vt30 topical gel
contact tracing
lair - 2 fusion protein nc410
trk inhibitor tqb3558
how much bothered by question
how difficult question
how helpful question
how important question
refractory primitive neuroectodermal tumor
gadolinium - based contrast agent bay1747846
carrimycin
subject off trial following assignment to protocol treatment arm
parainfluenza virus infection
piga deficiency
response assessment in neuro - oncology brain metastases
subject off trial following assignment to protocol treatment arm due to death
subject off trial following assignment to protocol treatment arm due to disease progression
oropharyngeal pleomorphic adenoma
oropharyngeal polymorphous adenocarcinoma
oropharyngeal lymphoma
oropharyngeal hodgkin lymphoma
oropharyngeal non - hodgkin lymphoma
head and neck follicular dendritic cell sarcoma
rpl5 gene mutation
fluid management
elane gene mutation
interferes question
neck carcinoma of unknown primary
extracutaneous merkel cell carcinoma
head and neck merkel cell carcinoma
head and neck heterotopia - associated carcinoma
micrometastasis 0 .2 mm to 2 .0 mm
macrometastasis greater than 2 .0 mm
isolated tumor cells less than 0 .2 mm
anti - pd - l1 / il - 15 fusion protein kd033
swelling question
swimming question
first variant gene symbol
molecular abnormality result indicator
thinking question
anti - latent tgf - beta 1 monoclonal antibody srk - 181
disease panel gene sequencing
dizziness question
embarrassment question
autologous cd34 +  - enriched hspcs transduced with lentiviral vector carrying fanca gene rp - l102
worst severity past seven days question
vomiting question
paratesticular epithelioid mesothelioma
paratesticular sarcomatoid mesothelioma
paratesticular biphasic mesothelioma
unresectable paratesticular malignant mesothelioma
unresectable paratesticular epithelioid mesothelioma
unresectable paratesticular sarcomatoid mesothelioma
unresectable paratesticular biphasic mesothelioma
unresectable peritoneal malignant mesothelioma
unresectable peritoneal epithelioid mesothelioma
unresectable peritoneal sarcomatoid mesothelioma
unresectable peritoneal biphasic mesothelioma
unresectable pleural epithelioid mesothelioma
unresectable pleural sarcomatoid mesothelioma
unresectable pleural biphasic mesothelioma
travel history
social impact
vaping
autologous anti - cd19 car t - cells 19 ( t2 ) 28z1xx
non - productive cough
horse transitional cell carcinoma
dilated cardiomyopathy - 1p
karyomegalic interstitial nephritis
dactylitis
meningococcal group b vaccine
covid - 19 - associated ageusia
anti - tigit monoclonal antibody sgn - tgt
c19mc microrna cluster
household crowding
braf inhibitor bgb - 3245
shared living space
neuroimaging
social distancing
unresectable hereditary thyroid gland medullary carcinoma
recurrent hereditary thyroid gland medullary carcinoma
robot - assisted nipple sparing mastectomy
adenovirus 5 / f35 - human guanylyl cyclase c - padre
rectal swab specimen
transfusion dependent thalassemia
transfusion dependent beta thalassemia
darunavir ethanolate / cobicistat / emtricitabine / tenofovir alafenamide fumarate
anti - cd38 / cd28xcd3 tri - specific monoclonal antibody sar442257
salivary gland sebaceous carcinoma
salivary gland poorly differentiated carcinoma
salivary gland large cell neuroendocrine carcinoma
csf1r inhibitor absk021
repatriation
salivary gland poorly differentiated neuroendocrine carcinoma
infection control practice
national notifiable diseases surveillance system
patient under investigation
epidemic information exchange
point of entry
salivary gland lymphadenoma
dendrimer - conjugated bcl - 2 / bcl - xl inhibitor azd0466
lymphoepithelial sialadenitis
intercalated duct hyperplasia
nodular oncocytic hyperplasia
superoxide dismutase mimetic gc4711
alternate subject identifier
autologous hematologic recovery
salivary gland hemangioma
salivary gland lipoma
sialolipoma
refractory acute biphenotypic leukemia
parotid gland sialolipoma
metastatic pharyngeal squamous cell carcinoma
oral cryotherapy
salivary gland nodular fasciitis
parotid gland nodular fasciitis
recurrent pharyngeal squamous cell carcinoma
salivary gland lymphoma
salivary gland non - hodgkin lymphoma
salivary gland hodgkin lymphoma
salivary gland mucosa - associated lymphoid tissue lymphoma
advanced pharyngeal squamous cell carcinoma
limit or limitation question
vitamins / minerals / proteins - based synthetic meal replacement
ezh1 / 2 inhibitor hh2853
autologous bcma - targeted car t cells cc - 98633
dendrobium huoshanense granules
anti - gremlin - 1 monoclonal antibody ucb6114
anti - napi2b antibody - drug conjugate xmt - 1592
drinking question
sex question
sirpa - fc - cd40l fusion protein sl - 172154
engineered toxin body targeting cd38 tak - 169
modified - release oral suspension
gastro - resistant powder for oral suspension
autologous nkg2d car t - cells cyad - 02
x - ray psoralen activated cancer therapy
c - scan system
anti - gpc3 - car t - lymphocytes tak - 102
cb - 17 - 08
salivary gland follicular lymphoma
parotid gland follicular lymphoma
salivary gland diffuse large b - cell lymphoma
hpv6 / 11 - targeted dna plasmid vaccine ino - 3107
parotid gland diffuse large b - cell lymphoma
odontogenic carcinoma
division of global migration and quarantine
lsd1 inhibitor syha1807
less than high school completion
anti - claudin18 .2 monoclonal antibody ab011
anti - irf4 antisense oligonucleotide ion251
anti - claudin18 .2 monoclonal antibody tst001
2morrow smoking and tobacco cessation program
recombinant 2019 - ncov s protein subunit - trimer vaccine scb - 2019
covid - 19 vaccine gam - covid - vac
covid - 19 vaccine gam - covid - vac lyo
covid - 19 vaccine covax - 19
flow cytometry type
sclerosing odontogenic carcinoma
numbness or tingling question
odontogenic carcinosarcoma
past seven days question
odontogenic sarcoma
ameloblastic fibrodentinosarcoma
ameloblastic fibroodontosarcoma
anti - spike protein sars - cov - 2 monoclonal antibody
bamlanivimab
anti - spike  ( s )  sars - cov - 2 monoclonal antibodies regn10933 + regn10987 regn - cov2
sars - cov - 2 monoclonal antibody ty027
protective face mask
personal protective equipment
n95 respirator
convalescent plasma
prone ventilation
hydroxychloroquine - triggered qtc interval prolongation
covid - 19 dermatologic manifestation
covid - 19 rash
transmission pattern
no cases transmission pattern
sporadic cases transmission pattern
cluster of cases transmission pattern
community spread transmission pattern
respiratory droplet
zoonotic spillover
covid - 19 human - to - animal transmission
global surveillance
aggregate case reporting
case - based reporting
severe acute respiratory infection
mitigation strategy
self - isolation
curve flattening
seroprevalence
seroprevalence survey
seroconversion
seroprotection
antibody - dependent enhancement of infection
surge capacity
community - based testing site
basic reproduction number
effective reproduction number
case fatality rate
infection fatality rate
recovered rate
herd immunity
fibrinolysis shutdown
post - intensive care syndrome
low dose chest irradiation
daily activities question
very severe aplastic anemia
non - severe aplastic anemia
vision question
breast question
satisfaction question
tongue disorder
non - neoplastic tongue disorder
gingival disorder
non - neoplastic gingival disorder
tonsillar disorder
non - neoplastic tonsillar disorder
appendix disorder
non - neoplastic appendix disorder
c3 complement inhibitor amy - 101
therapeutic angiotensin ii
urination question
levilimab
mecobalamin
breast cancer treatment question
tongue adenosquamous carcinoma
retroperitoneal undifferentiated pleomorphic sarcoma
lung alveolar soft part sarcoma
primary bone diffuse large b - cell lymphoma
treatment question
pancreatic squamous cell carcinoma
locally advanced intrahepatic cholangiocarcinoma
recurrent ectomesenchymoma
primordial odontogenic tumor
ossifying fibroma
wuhan
hubei
mainland china
visitor
subjective fever
healthcare worker
anti - her2 - dm1 antibody - drug conjugate gq1001
radicular cyst
inflammatory collateral cyst
paradental cyst
mandibular buccal bifurcation cyst
dentigerous cyst
eruption cyst
lateral periodontal cyst
botryoid odontogenic cyst
gingival cyst
glandular odontogenic cyst
orthokeratinized odontogenic cyst
nasopalatine duct cyst
maxillofacial bone
maxillofacial sarcoma
maxillofacial chondrosarcoma
maxillofacial mesenchymal chondrosarcoma
maxillofacial osteosarcoma
maxillofacial neoplasm
bilateral thalamic glioma
simulated altitude intervention
sars - cov - 2 spike protein dna vaccine gx - 19
recombinant spike - protein receptor - binding domain - dimer sars - cov - 2 vaccine
lnp - encapsulated sars - cov - 2 mrna vaccine cvncov
coronavirus - like particle covid - 19 vaccine
adsorbed inactivated sars - cov - 2 vaccine coronavac
anti - covid - 19 spike protein monoclonal antibody sti - 1499
anti - sars - cov - 2 polyclonal antibodies xav - 19
allogeneic sars - cov - 2 specific t cells
atazanavir / ritonavir
respiratory syncytial virus positive
keap1 gene mutation negative
nfe2l2 gene mutation negative
ros1 gene mutation negative
ntrk family gene mutation negative
cdkn2a gene amplification
ccnd2 3' untranslated region deletion mutation
ccnd3 3' untranslated region deletion mutation
ccnk gene
ccnk wt allele
cyclin - k
ccnk gene deletion
ccne1 gene amplification negative
ccnd1 3' untranslated region deletion mutation
fbxo3 gene
fbxo3 wt allele
f - box only protein 3
fbxo3 gene deletion
allogeneic cd56 - positive cd3 - negative natural killer cells cynk - 001
fbxo31 gene deletion
encapsulated rapamycin
ccnd1 gene translocation
ccnd1 gene rearrangement
nf2 gene deletion
psa doubling time greater than 6 months
activating cbl gene mutation
neuropathy assessment
autologous anti - gd2 - car - bbz - icasp9 retroviral vector - transduced t lymphocytes
activating kit gene mutation
oncolytic measles virus encoding helicobacter pylori neutrophil - activating protein
question about child
tigit inhibitor m6223
benign maxillofacial neoplasm
maxillofacial chondroma
maxillofacial osteoma
maxillofacial chondroblastoma
question about prostate cancer
maxillofacial chondromyxoid fibroma
maxillofacial osteoid osteoma
maxillofacial osteoblastoma
maxillofacial desmoplastic fibroma
esophageal anastomotic stricture
refractory esophageal anastomotic stricture
recurrent esophageal anastomotic stricture
multidimensional fatigue symptom inventory - short form
muscles ache
feel upset
head feels heavy
feel lively
feel relaxed
feel pooped
am confused
arms feel weak
feel run down
ache all over
recurrent metastatic malignant neoplasm in the leptomeninges
mucosal lavage
feel refreshed
feel energetic
make more mistakes than usual
body feels heavy all over
am forgetful
am distressed
work question
sleep question
craniofacial fibrous dysplasia
cemento - osseous dysplasia
periapical cemento - osseous dysplasia
focal cemento - osseous dysplasia
central giant cell granuloma
peripheral giant cell granuloma
benign head and neck neoplasm
side effects question
worry question
tired question
diarrhea question
voice question
bowel question
symptom at worst question
dbgap accession number
ctep short name of clinical diagnosis
eligibility defined by disease diagnosis
eligibility defined by current or prior therapy
disease diagnosis eligibility criterion identifier
therapeutic eligibility criterion identifier
anti - fra / eribulin antibody - drug conjugate morab - 202
paid hours
unpaid hours
caringguidance program
study eligiblity criterion type indicator
match analysis identifier
pooled dna and cdna
lenalidomide / tafasitamab regimen
anti - cd20 monoclonal antibody bat4306f
employer - sponsored disability insurance
surgical clamp
autologous anti - egfr car - transduced cxcr 5 - modified t - lymphocytes
allogeneic anti - cd19 universal car - t cells cta101
cd20 - cd19 compound car t cells
axl /  flt3 / vegfr2 inhibitor kc1036
anti - her2 antibody - drug conjugate dp303c
protopine / nuciferine supplement
fgfr inhibitor cpl304110
tm4sf1 - car / epcam - car - expressing autologous t cells
anti - her2 antibody - drug conjugate bat8001
allogeneic anti - bcma / cs1 bispecific car - t cells
autologous pancreatic adenocarcinoma lysate and mrna - loaded dendritic cell vaccine
anti - cd25 monoclonal antibody ro7296682
cd123 - cd33 compound car t cells
tagraxofusp regimen
trastuzumab deruxtecan regimen
sacituzumab govitecan regimen
regimen used to treat leukemia
moxetumomab pasudotox regimen
enfortumab vedotin regimen
etesevimab
have more children question
metastatic differentiated thyroid gland carcinoma
advanced differentiated thyroid gland carcinoma
have symptom or condition question
kefir
anti - ox40 hexavalent agonist antibody inbrx - 106
medication question
missed medicine dose question
domains of subjective extent of nonadherence
missed taking medicine
skipped dose of medicine
did not take dose of medicine
missed medicine dose because out of routine
missed medicine dose because forgot
missed medicine dose because medication caused side effects
missed medicine dose because food requirements could not be met
missed medicine dose because did not have medicines with me
kras g12c inhibitor gdc - 6036
missed medicine dose because could not afford medication
missed medicine dose because medication not working
missed medicine dose because did not want others to see medications
dtrmwxhs - 12 / everolimus / pomalidomide combination agent dtrm - 555
missed medicine dose because medication affected sex life
missed medicine dose because too late with dose
missed medicine dose because was asleep
missed medicine dose because no one to help
missed medicine dose because treatment was hard on family
missed medicine dose because had other medications to take
missed medicine dose because medication ran out
missed medicine dose because afraid medication would interact with other medications
missed medicine dose because feeling too sick
missed medicine dose because could not get answers to questions about medication
her2 - directed tlr8 agonist sbt6050
allogeneic pd - l1 tumor - targeted high - affinity natural killer cells
anti - ror1 / pnu - 159682 derivative antibody - drug conjugate nbe - 002
ischemia time
aml variable terminology
aml permissible value terminology
pd - l1 / 4 - 1bb / hsa trispecific fusion protein nm21 - 1480
india ink
aggressive papillary tumor
benign inner ear neoplasm
unresectable cervical carcinoma
unresectable cervical squamous cell carcinoma ,  not otherwise specified
malignant inner ear neoplasm
unresectable cervical adenosquamous carcinoma
unresectable cervical adenocarcinoma
advanced cervical squamous cell carcinoma ,  not otherwise specified
non - neoplastic middle ear disorder
advanced cervical adenosquamous carcinoma
primary middle ear meningioma
unresectable salivary gland carcinoma
aml data type terminology
anti - tigit monoclonal antibody com902
glutamine antagonist drp - 104
her2 inhibitor dzd1516
xenotransplantation
selective estrogen receptor degrader ly3484356
locally advanced endometrial adenocarcinoma
locally advanced endometrial endometrioid adenocarcinoma
locally advanced endometrioid adenocarcinoma
metastatic poorly differentiated thyroid gland carcinoma
recurrent poorly differentiated thyroid gland carcinoma
erk inhibitor
flt3 ligand / anti - ctla - 4 antibody / il - 12 engineered oncolytic vaccinia virus rival - 01
anti - cd117 monoclonal antibody jsp191
cdisc questionnaire ibdq test name terminology
cdisc questionnaire ibdq test code terminology
ibdq questionnaire question
recurrent al amyloidosis
refractory al amyloidosis
anti - cd38 antibody - drug conjugate sti - 6129
unobtainable
anti - interleukin - 2 receptor subunit gamma monoclonal antibody regn7257
tankyrase inhibitor stp1002
ibdq  -  how frequent bowel movements
ibdq  -  fatigue been a problem
ibdq  -  felt frustrated
ibdq  -  unable to attend school or work
ibdq  -  bowel movements been loose
ibdq  -  how much energy have you had
ibdq  -  feel worried about surgery
ibdq  -  delay or cancel social engagement
ibdq  -  troubled by cramps in abdomen
ibdq  -  felt generally unwell
ibdq  -  fear of not finding a washroom
ibdq  -  difficulty doing leisure or sports
ibdq  -  troubled by pain in abdomen
ibdq  -  problems getting sleep or waking up
ibdq  -  felt depressed or discouraged
ibdq  -  avoid events where no washroom
ibdq  -  problem passing large amounts gas
ibdq  -  problem maintaining weight
ibdq  -  felt worried or anxious
ibdq  -  troubled by abdominal bloating
ibdq  -  felt relaxed and free of tension
ibdq  -  problem with rectal bleeding
ibdq  -  felt embarrassed bowel problem
ibdq  -  go to bathroom bowels empty
ibdq  -  felt tearful or upset
ibdq  -  accidental soiling of underpants
ibdq  -  felt angry bowel problem
ibdq  -  limited sexual activity
ibdq  -  nausea or sick to your stomach
ibdq  -  felt irritable
ibdq  -  lack of understanding from others
ibdq  -  satisfied with personal life
4 - stair ascend  -  was 4 - stair ascend performed
4 - stair descend  -  was 4 - stair descend performed
rising from floor  -  was rising from floor performed
10 - meter walk / run  -  was walk / run performed
chronic intestinal cryptosporidiosis
nucleic rna sample
histone h3 trimethyl lys9
histone h3 trimethyl lys27
green propolis supplement
chronic systemic steroid use
cryptococcal meningitis
lymphocytic meningitis
wood dust exposure
chromogranin b measurement
pancreatic acinar cell
mixed adherent cells in suspension
saliva sample
esophageal columnar dysplasia
anti - her2 monoclonal antibody b002
locally advanced rectal adenocarcinoma
controlled attenuation parameter
autologous anti - bcma car t - cells phe885
neoplastic disease extent indicator
galectin - 3 inhibitor gb - 0139
decision question
multi - antigen - directed autologous t - cells nexi - 002
acute myeloid leukemia with mll rearrangement
genomic medicine
advantage
feelings about genomic testing results
genetic counseling satisfaction scale
genomics outcome scale
knowgene scale
organizational readiness for implementing change
university of north carolina genomic knowledge scale
mage - a1 - specific t cell receptor - transduced autologous t - cells
anti - pd - 1 antibody - interleukin - 21 mutein fusion protein amg 256
cd274 gene amplification
t ( 9 ; 22 )  negative
itga2 gene
itga2 wt allele
strenuous
godin leisure - time exercise questionnaire
leisure time activity to produce sweat
integrin alpha - 2
lymphoblasts 1 percent or more of bone marrow nucleated cells
msh3 gene mutation
tp53 nm_000546 .5:c .380c > a
tp53 np_000537 .3:p .s127y
ctnnb1 nm_001904 .4:c .133t > c
ctnnb1 np_001895 .1:p .s45p
tp53 nm_000546 .5:c .746g > t
tp53 np_000537 .3:p .r249m
tp53 np_000537 .3:p .k132e
tp53 nm_000546 .5:c .394a > g
liquid nitrogen vapor
ctnnb1 nm_001904 .4:c .134c > t
ctnnb1 np_001895 .1:p .s45f
ctnnb1 nm_001904 .4:c .110c > t
ctnnb1 np_001895 .1:p .s37f
perceived compatibility with current clinical practice
biallelic mutyh gene mutation
ercc family gene
ercc family gene mutation
c / ebp beta antagonist st101
fen1 gene mutation
sirpa - 4 - 1bbl fusion protein dsp107
cdk2 gene mutation
slx4 gene mutation
rad52 gene mutation
xrcc family gene mutation
inactivating msh3 gene mutation
inactivating epcam gene mutation
jak2 exon 14 mutation
jak2 exon 16 mutation
human papillomavirus - 11 positive
lag3 positive
btk c481 resistance mutation
psa density less than 0 .3
alcoholic cirrhosis with ascites
testosterone less than 200 ng / dl
renal and perinephric abscess
abnormal finding on diagnostic imaging
unspecified external cause status
viral screening
genetic susceptibility to malignant breast neoplasm
non - inflammatory female reproductive system disorder
anti - cd47 monoclonal antibody imc - 002
lymphocyte to c - reactive protein ratio measurement
flow cytometry panel for cd55 / cd16 / cd59
complete response in aplastic anemia
partial response in aplastic anemia
no response in aplastic anemia
unresectable vulvar carcinoma
unresectable vulvar squamous cell carcinoma
recurrent vulvar squamous cell carcinoma
metastatic vulvar squamous cell carcinoma
recurrent supratentorial glioblastoma
erk1 / 2 inhibitor jsi - 1187
ulcerative colitis disease activity index
anti - her2 / mmae antibody - drug conjugate mrg002
atr inhibitor rp - 3500
agreement likert scale
fgfr2 inhibitor rly - 4008
agreement score 1
agreement score 2
agreement score 3
agreement score 4
agreement score 5
every time
age - related macular degeneration - 4
congenital myasthenic syndrome - 4c
dilated cardiomyopathy - hypergonadotropic hypogonadism syndrome
mitochondrial short - chain enoyl - coa hydratase - 1 deficiency
primary pulmonary hypertension - 1
cdisc protocol study product attribute terminology
cdisc protocol study product type value set terminology
cdisc protocol study arm type value set terminology
cdisc sdtm crohn's disease findings about test code terminology
cdisc sdtm crohn's disease findings about test name terminology
cdisc sdtm microbiology findings test details terminology
aml project terminology
ews project terminology
ews data type terminology
ews permissible value terminology
ews table terminology
ews variable terminology
ews adverse events table
ews biopsy / surgical procedures table
ews course timing table
ews demographics table
ews disease characteristics table
ews disease phase timing table
refractory intrahepatic cholangiocarcinoma
ews histology table
ews immunohistochemistry table
ews lab table
ews medical history table
ews molecular analysis table
ews non - protocol therapy table
ews off protocol therapy / study table
ews radiation therapy table
ews secondary malignant neoplasm table
ews stem cell transplant table
ews subject characteristics table
ews subject response table
ews survival characteristics table
ews tumor assessment table
ews vitals table
upper limit of detection imputation technique
study product type
investigational arm
active comparator arm
placebo control arm
sham comparator arm
no intervention arm
study product
partial consumption
age symptom started
number of strictures
number of objects
type of object
number of lesions
length of resection
ileocecal junction removed indicator
number of devices inserted
sign or symptom leading to discontinuation
estimated weight
number of servings
sudden death indicator
qtc correction method unspecified ,  aggregate
qtc correction method unspecified ,  single beat
study data technical conformance guide v4 .5
every seventy two hours
glucose management indicator percentage formula
glucose management indicator mmol / mol formula
lipoprotein lipase measurement
renal tubular epithelial casts measurement
leptocyte measurement
3 , 4 - methylenedioxyamphetamine measurement
3 , 4 - methylenedioxy - n - ethylamphetamine measurement
ephedrine measurement
phenylpropanolamine measurement
d - norpseudoephedrine measurement
phentermine measurement
vldl triglyceride and chylomicron triglyceride measurement
chylomicron triglyceride measurement
vldl triglyceride measurement
phosphate crystals measurement
hyalogranular casts
fms - like tyrosine kinase 3 ligand measurement
fms - like receptor tyrosine kinase 3 measurement
soluble tnf superfamily member 5 measurement
8 - hydroxy - 2' - deoxyguanosine measurement
glucose management indicator
oxygen saturation / fraction inspired o2
soluble tnf receptor superfamily member 5 measurement
factor xiii activity measurement
b - lymphocyte count
b - lymphocyte to lymphocyte ratio measurement
b - lymphocyte to leukocyte ratio measurement
b - lymphocyte to total cells ratio measurement
ostiomeatal complex
extrahepatic perihilar bile duct region
distal extrahepatic bile duct region
dental arch
palpebral fissure
sars - related coronavirus rna measurement
sars - related coronavirus rna / mers rna measurement
sars - cov - 2 igm / iga / igg antibody measurement
sars - cov - 2 iga / igm antibody measurement
sars - cov - 1 / sars - cov - 2 antigen measurement
severe acute respiratory syndrome - related coronavirus measurement
sars - cov - 2 neutralizing antibody measurement
biological detection test
specified viral load test
specified cell count test
specified colony count test
static perimetry
coulometric titration
virus plaque assay
mycobacterium abscessus complex
mycolicibacterium mucogenicum group
mycolicibacterium mucogenicum
mycolicibacterium phocaicum
mycolicibacterium aubagnense
mycobacterium intracellulare and chimaera group
mycolicibacterium chimaera
metmab score
auc infinity observed normalized by weight - adjusted dose
amount recovered to last nonzero concentration
auc dosing from dosing to last concentration normalized by weight - adjusted dose
auc from t1 to t2 normalized by weight - adjusted dose
auc infinity predicted normalized by weight - adjusted dose
auc over dosing interval normalized by weight - adjusted dose
average concentration normalized by weight - adjusted dose
average concentration from t1 to t2 normalized by weight - adjusted dose
maximum concentration normalized by weight - adjusted dose
minimum concentration normalized by weight - adjusted dose
hour times picomole per liter per milligram per kilogram
hour times nanogram per milliliter per milligram per centimeter squared per day
standing ,  bent forward
contrast enhanced ecg gated mri
ecg gated mri without contrast
numerical rating scale 5 - point
percent predicted lobar volume
forced expiratory volume in 0 .75 second
maximal oxygen consumption ,  estimated
district of potential disease exposure
gps coordinates of potential disease exposure
reactogenicity study
severity of erythematous lesion
severity of scaling lesion
severity of elevated lesion
core body temperature
peripheral body temperature
fetal estimated weight
fetal sagittal abdominal diameter
fetal weight - for - gestational age percentile
fetal mandibular length
ulnar length
radiculoneuropathy
decreased adipose tissue
increased adipose tissue
decreased thickness
increased thickness
fibrin accumulation
neuronal heterotopia
pendulous
caudal plexus nerve
send animal rule implementation guide version 1 .0
hepcidin measurement
conjunctival oncocytoma
gallium ga 68 - nota - anti - mmr - vhh2 nanobody
conjunctival keratoacanthoma
anti - c - met monoclonal antibody hlx55
gallium ga 68 - nota - hgzp
factor d inhibitor alxn2050
btk inhibitor hz - a - 018
anti - mesothelin / mmae antibody - drug conjugate rc88
tmprss6 rnai sln124
allogeneic anti - cd20 car t - cells lucar - 20s
conjunctival spindle cell carcinoma
human lysozyme - containing goat milk
mcl - 1 inhibitor abbv - 467
allogeneic third - party suicide gene - transduced anti - hla - dpb1*0401 cd4 +  t - cells ctl 19
conjunctival adenosquamous carcinoma
conjunctival carcinoma
conjunctival sebaceous carcinoma
autologous rapamycin - resistant th1 / tc1 cells rapa - 201
anti - rankl monoclonal antibody gb - 223
conjunctival reactive epithelial hyperplasia
conjunctival pseudoglandular hyperplasia
conjunctival pseudoepitheliomatous hyperplasia
anti - il - 27p28 monoclonal antibody srf388
alpha - lipoic acid / boswellia serrata extract / methylsulfonylmethane / bromelain dietary supplement
bcma - cd19 compound car t cells
bcma cart cells secreting mutant pd - 1fc fusion protein
ocular melanocytosis
benign epithelial melanoses of the conjunctiva
conjunctival junctional nevus
cdk4 / 6 inhibitor cs3002
conjunctival compound nevus
anti - pd - 1 / anti - her2 bispecific antibody ibi315
anti - cd4 car t - cells
liposome - encapsulated taas mrna vaccine w_ova1
anti - vegfr2 monoclonal antibody msb0254
lutetium lu 177 - dtpa - omburtamab
dnmt1 inhibitor ntx - 301
stromal proliferation of nevus cells present
conjunctival subepithelial nevus
tempus blood rna tube
bd vacutainer acd solution b tube
sodium heparin green - top tube
smart tube
lee chronic graft - versus - host disease symptom scale
interleukin - 2 receptor to lymphocyte ratio measurement
neutrophil to cd4 - positive lymphocyte ratio measurement
fibrinogen to albumin ratio measurement
dilated cardiomyopathy - 1dd
deafness ,  autosomal recessive 36
skin color
congenital adrenal hyperplasia due to cytochrome p450 oxidoreductase deficiency
combined oxidative phosphorylation deficiency 33
autoinflammation ,  panniculitis ,  and dermatosis syndrome
gpoh performance status
locally advanced adrenal cortex carcinoma
deafness ,  autosomal dominant 36
body temperature
study arm
inflamed juvenile conjunctival nevus
ews study identifier
chronic inflammation
red cell mass
conjunctival blue nevus
joint involvement
skip lesion
ipsilateral nodule
atypical ewing sarcoma
tumor classification
ep2 / ep4 antagonist tpst - 1495
bcor gene rearrangement
fus gene rearrangement
cic / dux4l10 fusion gene
dux4l10 gene
t ( 2 ; 16 )  ( q35 ; p11 )
fus / fev fusion gene
fus / fev fusion protein
copper cu 64 - mecosar - tyr3 - octreotate
klf17 gene
klf17 wt allele
krueppel - like factor 17
fus / klf17 fusion gene
ewsr1 / klf17 fusion gene
t ( 1 ; 16 )  ( p34 ; p11 )
t ( 1 ; 22 )  ( p34 ; q12 )
t ( 1 ; 22 )  ( q23 ; q12 )
t ( 12 ; 22 )  ( q13 .12 ; q12 )
t ( 12 ; 22 )  ( q13 .3 ; q12 )
t ( 19 ; 22 )  ( q13 ; q12 )
t ( 2 ; 22 )  ( q34 ; q12 )
t ( 4 ; 19 )  ( q25 ; q13 )
t ( 6 ; 22 )  ( p21 ; q12 )
t ( 9 ; 22 )  ( q22 ; q12 )
anti - lilrb4 monoclonal antibody io - 202
refractory acute myeloid leukemia not otherwise specified
bcor / maml3 fusion gene
bcor / maml3 fusion protein
inv ( x )  ( p11 .4 ; p11 .22 )
t ( x ; 4 )  ( p11 ; q31 )
zc3h7b / bcor fusion gene
conjunctival spitz nevus
zc3h7b / bcor fusion protein
t ( x ; 22 )  ( p11 ; q13 )
metastatic malignant neoplasm in the conjunctiva
eif1ax gene mutation
iris epithelioid cell melanoma
ectopic lacrimal gland in the iris
ciliary body nevus
choroid nevus
uveal nevus
uveal melanocytoma
bilateral diffuse uveal melanocytic hyperplasia
locally advanced cervical squamous cell carcinoma ,  not otherwise specified
iris mixed cell melanoma
metastatic malignant neoplasm in the uvea
refractory vulvar carcinoma
refractory vaginal carcinoma
unresectable lung adenocarcinoma
refractory acute monoblastic and monocytic leukemia
refractory acute myelomonocytic leukemia
tag - 7 gene - modified vaccine
peptidoglycan complex of spirulina k - 001
cd80 - fc fusion protein alpn - 202
bifidobacterium animalis ssp . lactis probiotic supplement
flt3 / fgfr dual kinase inhibitor max - 40279
maackia amurensis seed lectin
muc - 1 / wt1 peptide - primed autologous dendritic cells
anti - pd - l1 monoclonal antibody rc98
gallium ga 68 - nota - mal - cys39 - exendin - 4
vitamin k2 - rich cheese
fluorescent imaging agent crgd - zw800 - 1
bright white light therapy
computed tomography imaging mesothelioma probability score
ct score 0
ct score 1
ct score 2a
ct score 2b
vats and laparoscopy surveillance result score
vats and laparoscopy score 0
vats and laparoscopy score 1a
vats and laparoscopy score 1b
vats and laparoscopy score 2a .1
vats and laparoscopy score 2a .2
vats and laparoscopy score 2b
photon counting computed tomography
aspirin / dipyridamole
retinal astrocytoma
whole - virion inactivated sars - cov - 2 vaccine bbv152
artesunate / pyronaridine
anti - sars - cov - 2 polyclonal antibodies sab - 185
nodular and massive retinal gliosis
sars - cov - 2 spike protein dna vaccine ag0301 - covid19
congenital hypertrophy of the retinal pigment epithelium
retinal hamartoma
simple hamartoma of the retinal pigment epithelium
combined hamartoma of the retina and retinal pigment epithelium
reactive hyperplasia of the retinal pigment epithelium
adenoma of the retinal pigment epithelium
retinal pigment epithelium adenocarcinoma
covid - 19 vaccine kbp - covid - 19
transplant - associated thrombotic microangiopathy
bridge therapy
pigmented epithelial cyst of the iris
reactive epithelial hyperplasia of the ciliary body
other chemotherapy
anti - gd2 therapy
dinutuximab / irinotecan / temozolomide regimen
ciliary body adenoma
ciliary body adenocarcinoma
ciliary body glioneuroma
autologous anti - cd19car - 4 - 1bb / cd3zeta - her2tg - expressing cd4 +  / cd8 +  t - lymphocytes scri - hucar19v2
curie relative bone score
unresectable kidney carcinoma
resectable pancreatic adenosquamous carcinoma
unresectable kidney medullary carcinoma
advanced rhabdoid tumor
unresectable poorly differentiated thyroid gland carcinoma
unresectable thyroid gland papillary carcinoma
unresectable thyroid gland follicular carcinoma
unresectable thyroid gland hurthle cell carcinoma
recurrent thyroid gland hurthle cell carcinoma
metastatic thyroid gland hurthle cell carcinoma
german society for pediatric oncology and hematology
scandinavian sarcoma group
french sarcoma group
united kingdom sarcoma registry
euro - ewing consortium
italian sarcoma group
cancer research uk clinical trials unit
university college of london
aews1221 ews study identifier
aews0331 ews study identifier
aews0031 ews study identifier
aews1031 ews study identifier
ee99 ews study identifier
eicess92 ews study identifier
aews07p1 ews study identifier
3w - vdc - mesna + ifo - gcsf treatment arm of aews0031
2w - vdc - mesna + ifo - gcsf treatment arm of aews0031
vdc / ie treatment arm of aews1221
vdc / ie + ganitumab treatment arm of aews1221
vide - surgery - r1 - vai - vac / vai treatment arm of aews0331
vide - surgery - r2 - vai - vai / bumel treatment arm of aews0331
vide - surgery - r3 - vai - meme / treomel / bumel / p2 treatment arm of aews0331
videc treatment arm of aews1031
videc + topotecan treatment arm of aews1031
sr / vaia treatment arm of eicess92
sr / vaca treatment arm of eicess92
hr / vaia treatment arm of eicess92
hr / evaia treatment arm of eicess92
vaia - vaca treatment arm of aews07p1
vaia - vaia treatment arm of aews07p1
evaia - evaia treatment arm of aews07p1
disease relapse / progression
gpoh performance status 1
gpoh performance status 2
gpoh performance status 3
gpoh performance status 4
gpoh performance status 5
age in days at tumor assessment
site within long bone
estimated volume
less than 200 ml tumor volume
greater or equal to 200 ml tumor volume
pleural cytology
age in days at histology assessment
age in days at laboratory test
age in days at immunohistochemistry
immunohistochemical test result
age in days at procedure
limb surgery
amputation  -  through involved bone
amputation  -  proximal to involved bone
surgical disarticulation
internal hemipelvectomy
external hemipelvectomy
intra - articular resection
extra - articular resection
intercalary resection
endoprosthetic reconstruction
osteoarticular allograft
intercalary allograft
allograft - prosthetic
non - vascularized autograft
vascularized autograft
bone allograft  +  vascularized autograft
vascularized autograft endoprosthetic composite
no surgical reconstruction
complete resection
surgical management of metastatic non - lung disease
surgical management of metastatic lung disease
indocyanine green fluorescence angiography
methylene blue staining method
proton stereotactic body radiation therapy
photon stereotactic body radiation therapy
number of fractions per day
organ transposition procedure
measurement of cd34 stem cells collected
measurement of cd34 stem cells transplanted
non - protocol therapy timing
prior to study
after study completion
non - protocol therapy type
response criteria version
age in days at adverse event resolution
location of second malignant neoplasm related to prior radiation field
in external beam radiation field
out of external beam radiation field
early infantile epileptic encephalopathy 26
exudative vitreoretinopathy 1
autologous cd19 - targeted car t cells cc - 97540
familial digital arthropathy - brachydactyly
metatropic dysplasia
neurodegeneration with brain iron accumulation 5
allogeneic cd8 +  memory t - cells
enzyme - inducing antiepileptic drug
non - enzyme inducing antiepileptic drug
incidental gallbladder carcinoma
neurocutaneous melanosis
recurrent transformed marginal zone lymphoma to diffuse large b - cell lymphoma
refractory transformed marginal zone lymphoma to diffuse large b - cell lymphoma
locally advanced lung adenosquamous carcinoma
locally advanced lung adenocarcinoma
metastatic malignant neoplasm in the visual pathway
malignant visual pathway neoplasm
metastatic malignant neoplasm in the regional lymph nodes
eye melanocytoma
visual pathway melanocytoma
visual pathway medulloepithelioma
anti - sars - cov - 2 s protein monoclonal antibody brii - 198
anti - sars - cov - 2 s protein monoclonal antibody brii - 196
anti - sars - cov - 2 s protein monoclonal antibody scta01
anti - sars - cov - 2 s protein monoclonal antibody azd7442
anti - sars - cov - 2 equine antibody fragments
anti - sars - cov - 2 equine immunoglobulin f ( ab' ) 2 fragments inm005
haploidentical natural killer cells k - nk002
rna sequencing data file
whole exome sequencing data file
functional near - infrared spectroscopy
advanced triple - negative breast carcinoma
locally advanced triple - negative breast carcinoma
multi - market approved product
whole genome sequencing data file
autosomal dominant congenital deafness with onychodystrophy
floating - harbor syndrome
during treatment
upon progression
upon relapse
dna methylation analysis data file
image file
supplemental data file
whole genome sequence data file
diseased
biospecimen collection chronology
cdk2 inhibitor pf - 07104091
arm or leg response group answer
percent of time answer
pain score answer
pain rating score answer
pain rating average score answer
non - neoplastic lacrimal system disorder
pain interference score answer
nasolacrimal duct neoplasm
motivation score answer
likert score answer
health problems effect on daily activities score answer
health problems effect on work answer
lacrimal gland oncocytoma
feeling intensity score answer
fatigue rating score answer
lacrimal gland oncocytic adenocarcinoma
fatigue interference score answer
confidence score answer
comparative score answer
borg scale rating of perceived exertion score answer
lacrimal gland myoepithelioma
borg category - ratio 10 perceived exertion score answer
lacrimal gland myoepithelial carcinoma
limitations in use of hands or fingers answer
percentage relief from pain treatment or medication score answer
readiness to quit smoking score answer
severity of symptom score answer
lacrimal gland carcinosarcoma
severity score answer
severity answer
stayed off cigarettes answer
symptom interference with life score answer
time between waking and first smoke answer
usually need help answer
ringing or other noises answer
skin condition answer
lacrimal gland epithelialmyoepithelial carcinoma
experimental tobacco marketplace
lacrimal gland acinic cell carcinoma
lacrimal gland warthin tumor
maresin 1
resolvin d2
resolvin e1
resolvin d1
lipoxin a4
t ( 4 ; 14 )  negative
t ( 4 ; 14 )  positive
concern answer
concern about appearance answer
thorium th 227 anti - psma monoclonal antibody bay 2315497
concern level answer
bother answer
unresectable malignant gastric neoplasm
naltrexone hydrochloride / bupropion hydrochloride
autologous tcrm - expressing t - cells et140203
benign lacrimal system neoplasm
malignant lacrimal system neoplasm
better answer
worse answer
time frequency answer
strong opioids answer
smoking answer
smoking cessation answer
lacrimal drainage system
lacrimal drainage system neoplasm
canadian sip foreign seller
benign lacrimal drainage system neoplasm
malignant lacrimal drainage system neoplasm
anxious or depressed answer
fretful ,  angry ,  irritable ,  anxious ,  or depressed answer
ability answer
exceed
ctrp portfolio management main type terminology
ctrp portfolio management subtype terminology
inactivating kdm6a gene mutation
metastatic malignant neoplasm in the lacrimal system
inactivating kmt2c gene mutation
metastatic malignant neoplasm in the lacrimal gland
metastatic malignant neoplasm in the lacrimal drainage system
inactivating kmt2d gene mutation
lacrimal drainage system exophytic papilloma
endoscopic ultrasound - guided gastroenterostomy
lacrimal drainage system inverted papilloma
lacrimal drainage system non - keratinizing squamous cell carcinoma
lacrimal drainage system adenocarcinoma
lacrimal drainage system carcinoma
truth answer
lacrimal drainage system mucoepidermoid carcinoma
lacrimal drainage system adenoid cystic carcinoma
assistance answer
autologous crispr - cas9 modified / bcl11a gene - disrupted human hematopoietic stem and progenitor cells otq923
autologous bcl11a - disrupted human hematopoietic stem and progenitor cells hix763
lacrimal drainage system lymphoepithelial carcinoma
lacrimal drainage system melanoma
worry answer
validity answer
lacrimal system carcinoma
smarca2 gene mutation
smarca2 gene inactivation
zelenoleucel
egfr nm_005228 .5:c .2497t > g
egfr np_005219 .2:p .l833v
egfr nm_005228 .5:c .2500g > t
egfr nm_005228 .5:c .2500g > c
egfr np_005219 .2:p .v834l
egfr np_005219 .2:p .a871e
egfr np_005219 .2:p .k860i
egfr np_005219 .2:p .a859s
recurrent anal canal squamous cell carcinoma
egfr nm_005228 .5:c .2527g > a
egfr np_005219 .2:p .v843i
advanced rectal adenocarcinoma
locally recurrent anal canal squamous cell carcinoma
egfr nm_005228 .5:c .2125g > a
egfr np_005219 .2:p .e709k
egfr np_005219 .2:p .h870r
egfr nm_005228 .5:c .2504a > t
egfr np_005219 .2:p .h835l
oas2 gene
oas2 wt allele
2' - 5' - oligoadenylate synthase 2
ifitm3 gene
anti - hla - g antibody ttx - 080
ifitm3 wt allele
interferon - induced transmembrane protein 3
ifit1 gene
ifit1 wt allele
interferon - induced protein with tetratricopeptide repeats 1
pyruvate kinase m2 isoform activator tp - 1454
clostridium difficile toxin a positive
clostridium difficile toxin b positive
metastatic anal canal squamous cell carcinoma
unresectable anal canal squamous cell carcinoma
pbk gene
pbk wt allele
lymphokine - activated killer t - cell - originated protein kinase
cd27 positive
copper cu 64 - dota - pembrolizumab
revitalize
free testosterone less than 70 pg / ml
testosterone less than 348 ng / dl
magea1 positive
nthl1 gene mutation
smad4 gene mutation
inactivating brip1 gene mutation
inactivating fancg gene mutation
inactivating palb2 gene mutation
inactivating fancl gene mutation
inactivating fancm gene mutation
inactivating fance gene mutation
inactivating fancd2 gene mutation
inactivating fancf gene mutation
inactivating fanci gene mutation
inactivating fancb gene mutation
inactivating fancc gene mutation
inactivating fanca gene mutation
hla - drb1*04:01 positive cells present
hla - drb1*04:04 positive cells present
ptprn autoantibody
anti - lewis b / lewis y monoclonal antibody gnx102
hla - drb1*15:01 / hla - dqa1*01:02 / hla - dqb1*06:02 positive
slc30a8 gene
slc30a8 wt allele
zinc transporter 8
slc30a8 autoantibody
map2k2 fusion positive
mapk3 gene mutation
mapk1 fusion positive
map2k1 fusion positive
mapk3 fusion positive
ntsr1 gene
ntsr1 wt allele
neurotensin receptor type 1
ntsr1 positive
oxidized ryr1 measurement
thyroglobulin antibody positive
freenome test
conjunctival reactive lymphoid hyperplasia
conjunctival follicular lymphoma
conjunctival mucosa - associated lymphoid tissue lymphoma
conjunctival non - hodgkin lymphoma
conjunctival diffuse large b - cell lymphoma
unresectable vaginal carcinoma
recurrent acral lentiginous melanoma
refractory ampulla of vater carcinoma
refractory extrahepatic bile duct carcinoma
refractory distal bile duct adenocarcinoma
edqm - hc administrable dose form terminology
attenuated measles virus encoding scd transgene tmv - 018
anti - rankl monoclonal antibody jmt103
coriolus versicolor - based vaginal gel
wt1 - h / k - help - survivin - h / k - help - mage - a4 - h  /  k - help - muc1 - 22 peptide - loaded autologous dendritic cells
anti - 5t4 antibody - drug conjugate syd1875
egfr inhibitor ty - 9591
autologous anti - kappa light chain car - cd28 - expressing t - lymphocytes
endothelin b receptor blocker enb 003
topical thrombin gel
c - met inhibitor gst - hg161
fluorine f 18 - ambf3 - tate
primary uveal non - hodgkin lymphoma
autologous pd1 - knockout cd19 - specific car t cells
anti - ox40 agonist monoclonal antibody bgb - a445
tnfalpha / il - 2 - encoding oncolytic adenovirus tilt - 123
pain or discomfort answer
inhaled voriconazole
short of breath answer
autologous cll1 - car - cd28 - expressing t - lymphocytes
lymphodepleted autologous cd4 - directed car t cells
fgfr / csf - 1r inhibitor 3d185
cd123 - specific targeting module tm123
sip approved drug
autologous universal car - expressing t - lymphocytes unicar02 - t
primary choroidal non - hodgkin lymphoma
autologous anti - cd19 car - 4 - 1bb - cd3zeta - expressing t - cells cnct19
primary ciliary body non - hodgkin lymphoma
primary iris non - hodgkin lymphoma
adenosine a2a receptor antagonist cs3005
fenretinide phospholipid suspension st - 001
secondary choroidal non - hodgkin lymphoma
autologous bispecific bcma / cd19 - targeted car - t cells gc012f
boron - based gel
oncolytic hsv - 1 expressing il - 12 and anti - pd - 1 antibody t3011
thermogenic regulator rzl - 012
foritinib succinate
anti - ccr7 antibody - drug conjugate jbh492
lacrimal gland reactive lymphoid hyperplasia
lacrimal system non - hodgkin lymphoma
lacrimal gland non - hodgkin lymphoma
lacrimal drainage system non - hodgkin lymphoma
lacrimal system mucosa - associated lymphoid tissue lymphoma
lacrimal gland mucosa - associated lymphoid tissue lymphoma
lacrimal drainage system mucosa - associated lymphoid tissue lymphoma
lacrimal system diffuse large b - cell lymphoma
lacrimal gland diffuse large b - cell lymphoma
lacrimal drainage system diffuse large b - cell lymphoma
lacrimal gland follicular lymphoma
bcl - 2 inhibitor bgb - 11417
fap / 4 - 1bb - targeting fusion protein ro7122290
advanced nasopharyngeal carcinoma
tapcloud
locally advanced transitional cell carcinoma
conjunctival stromal tumor
conjunctival myxoma
solitary fibrous tumor / hemangiopericytoma of the optic nerve sheath
conjunctival hemangioma
conjunctival lymphangioma
conjunctival angiosarcoma
conjunctival leiomyosarcoma
conjunctival rhabdomyosarcoma
conjunctival sarcoma
metastatic distal bile duct carcinoma
smartphone
resectable leiomyosarcoma
locally advanced distal bile duct carcinoma
locally advanced thyroid gland hurthle cell carcinoma
anti - btn3a agonistic monoclonal antibody ict01
deupirfenidone
taek - vac - herby vaccine
autologous anti - psma car - t cells p - psma - 101
srpk1 / abcg2 inhibitor sco - 101
p2rx3 antagonist bay 1817080
quercetin / saw palmetto / cranberry / bromelain / papain / zinc supplement
locally advanced small intestinal adenocarcinoma
unresectable small intestinal adenocarcinoma
icdc value terminology
icdc node terminology
givosiran sodium
dairy or lactose intolerance allergy
nut allergy
processed food allergy
radiation therapy laterality
peritoneal cytology
conventional magnetic resonance imaging
muscadine grape extract
elective abortion finding
zirconium zr 89 - dfo - fianlimab
age in days at treatment assignment
rose geranium in sesame oil nasal spray
subject identifier source
parent biospecimen
autologous cd19 car - expressing t - cells ytb323
transdermal gel in sachet dosage form
pngvl4a - crt - e6e7l2 dna vaccine
aurolase therapy
trusight oncology 500 assay
malignant hypothalamic neoplasm
daiichi sankyo
iovance biotherapeutics
idh1 mutant inhibitor ly3410738
axl / mer inhibitor pf - 07265807
cibmtr center support
ticket assignment
out of specification
advanced malignant digestive system neoplasm
australia new zealand clinical trial registry
advanced primary malignant brain neoplasm
metastatic primary malignant brain neoplasm
alk2 inhibitor incb000928
heated tobacco product
braf inhibitor pf - 07284890
anti - sirpa antibody fsi - 189
nasal vestibulitis
akt / rsk / s6k inhibitor tas0612
gentamicin sulfate / betamethasone valerate / clotrimazole otic ointment
polysulfated glycosaminoglycan
praziquantel / pyrantel pamoate
inducible caspase 9
erythema answer
erection answer
jak2 exon 13 mutation
cd11 protein family
ssx protein family
coronavirus racial bias scale
coronavirus anxiety scale
vulnerability to covid - 19
smartclip soft tissue marker
envisio navigation system
cytoplasmic fraction
mitochondrial and nuclear fraction
in person
not in person
simplified chinese
traditional chinese
autologous alpha - pne switchable car - t cells clbr001
cd19 - specific adapter molecule swi019
pan - notch protein - protein interaction inhibitor cb - 103
breast neuroendocrine carcinoma
t ( 11 ; 17 )
t ( 8 ; 16 )
t ( 1 ; 22 )
breast carcinoma with neuroendocrine differentiation
tandem chimeric antigen receptor
bicistronic chimeric antigen receptor vector
recurrent breast adenocarcinoma
technetium tc - 99m anti - her2 affibody hpark2
esr1 peptides / gm - csf / montanide isa vaccine
anti - cd39 monoclonal antibody iph5201
il - 15 / il - 15 receptor alpha heterodimer niz985
huangqi guizhi wuwu decoction
sodium thiosulfate formulation db - 020
aldh inhibitor nyh817g and mitochondrial complex 1 inhibitor nyh100p
metastatic endometrial clear cell adenocarcinoma
metastatic endometrial adenosquamous carcinoma
recurrent endometrial adenosquamous carcinoma
metastatic endometrial mixed cell adenocarcinoma
pcdc subject identifier
anti - survivin t - cell receptor / anti - cd3 bispecific therapeutic abbv - 184
idh1 / idh2 dual inhibitor hmpl - 306
anti - cd47 monoclonal antibody zl - 1201
breast polymorphous adenocarcinoma
transanal endoscopic microsurgery
tall columnar adenocarcinoma cell with reversed polarity
breast tall cell carcinoma with reversed polarity
therabionic p1 device
amplitude - modulated electromagnetic field therapy
breast neuroendocrine tumor
breast neuroendocrine tumor g2
ankrd11 gene
ankrd11 wt allele
ankyrin repeat domain - containing protein 11
dcun1d1 gene
dcun1d1 wt allele
dcn1 - like protein 1
dhx15 gene
dhx15 wt allele
pre - mrna - splicing factor atp - dependent rna helicase dhx15
thirty two
thirty three
thirty four
thirty five
thirty six
thirty seven
thirty eight
egfl7 gene
egfl7 wt allele
epidermal growth factor - like protein 7
negr1 gene
negr1 wt allele
neuronal growth regulator 1
pak5 gene
pak5 wt allele
serine / threonine - protein kinase pak 5
rab35 gene
rab35 wt allele
ras - related protein rab - 35
rit1 gene
rit1 wt allele
gtp - binding protein rit1
rps6ka4 gene
rps6ka4 wt allele
ribosomal protein s6 kinase alpha - 4
shq1 gene
shq1 wt allele
protein shq1 homolog
spta1 gene
spta1 wt allele
spectrin alpha chain ,  erythrocytic 1
stk40 gene
stk40 wt allele
serine / threonine - protein kinase 40
zbtb2 gene
zbtb2 wt allele
zinc finger and btb domain - containing protein 2
autologous anti - mesothelin tcr - expressing t - cells fh - tcr tmsln
clinician dashboard
unresectable malignant glomus tumor
metastatic malignant glomus tumor
locally advanced malignant glomus tumor
refractory malignant glomus tumor
locally advanced osteosarcoma
devascularization
locally invasive desmoid - type fibromatosis
refractory adenoid cystic carcinoma
locally advanced adenoid cystic carcinoma
refractory desmoid - type fibromatosis
rybp gene
rybp wt allele
ring1 and yy1 - binding protein
locally invasive lesion
light - stimulated thermal imaging
forty two
forty five
forty eight
fifty one
fifty four
fifty seven
psa level 0 .05 to 0 .7
chic2 gene deletion
globo h positive
map2k1 gene mutation negative
ki - 67 positive cells greater than or equal to 20 percent
arid1a gene mutation negative
tp53 gene nonsense mutation
non - synonymous tp53 gene mutation
rb1 gene nonsense mutation
rb1 gene frameshift mutation
pten gene frameshift mutation
tp53 gene frameshift mutation
non - synonymous rb1 gene mutation
non - synonymous pten gene mutation
pten gene nonsense mutation
fgfr4 gene fusion positive
circulating tumor - derived rna
psa level greater than fifteen
deafness ,  autosomal dominant 41
orexin receptor agonist
joubert syndrome 17
delphi process
enable
ring chromosome 8 syndrome
ring chromosome 18 syndrome
neurodegeneration with brain iron accumulation 4
hyperlipoproteinemia ,  type i
nlrc4 gene mutation
nlrc4 gene
nlrc4 wt allele
nlr family card domain - containing protein 4
nurse coach
personalized neoantigen follicular lymphoma vaccine
epiretinal membrane
vitreoretinal disorder
adult and / or child study indicator
number of cases
scientific data type
open or controlled data access indicator
cloud storage bucket name
biosample accession number
bioproject accession number
sequencing run accession number
experiment accession number
sequencing library unique identifier
sequencing library read layout indicator
sequencing library source indicator
sequence alignment software name
proteomics experiment name
imaging software name
vectorization for viral replication attenuation
inactivation
chemical inactivation
ultraviolet irradiation inactivation
shortness of breath question
personalized neoantigen ovarian cancer vaccine
impact of weight on quality of life - lite
because of my weight
have trouble picking up objects
havetrouble tying shoelaces
have difficulty getting up from chairs
have trouble using stairs
have difficulty putting on or taking off clothes
have trouble with mobility
have trouble crossing legs
dodecyl maltoside
feel short of breath with only mild exertions
troubled by painful or stiff joints
ankles and lower legs swollen at end of the day
am self - conscious
self - esteem not what it could be
feel unsure of myself
afraid of being rejected
embarrassed to be seen in public
avoid looking in mirrors
does not enjoy sexual activity
have little or no sexual desire
have difficulty with sexual performance
avoid sexual encounters whenever possible
experience ridicule ,  teasing or unwanted attention
worry about fitting into seats in public places
worry about fitting through aisles or turnstiles
worry about finding chairs that are strong enough to hold weight
experience discrimination by others
tumor mass of the extremity
metastatic malignant neoplasm in the supraclavicular lymph nodes
locally advanced malignant mesothelioma
locally advanced pleural malignant mesothelioma
advanced epithelioid mesothelioma
recurrent epithelioid mesothelioma
unresectable abdominal neuroendocrine neoplasm
abiraterone amorphous solid dispersion formulation dst - 2970
cotsiranib
hsp90 inhibitor mpt0b640
welgenaleucel
ponsegromab
pd - 1 - targeted il - 2 variant antibody fusion protein ro7284755
gallium ga 68 - wl12
dll3 / cd3e tri - specific t - cell activating construct hpn328
fluorine f 18 - wl12
breast classic lobular carcinoma in situ
breast florid lobular carcinoma in situ
ionized magnesium measurement
diffusion basis spectrum imaging
malignant cells with uniform nuclei present
gain of chromosome 10q
gain of chromosome 16q
alk nm_004304 .5:c .3824g > t
alk np_004295 .2:p .r1275l
smarcb1 gene deletion
marked distention of terminal duct lobular units present
foxo1 gene rearrangement
p53 y220c mutant reactivator pc14586
cdk4 inhibitor pf - 07220060
have trouble getting things done or carrying out my responsibilities
less productive than could be
do not receive appropriate pay increases ,  promotions ,  or recognition at work
afraid of job interviews
tlr7 agonist jnj - 64794964
cdk4 / 6 inhibitor tqb3303
proteasome inhibitor tqb3602
anti - ctla - 4 monoclonal antibody ibi310
pi3k - delta inhibitor bgb - 10188
cdk4 / 6 inhibitor bpi - 1178
lsd1 inhibitor tas1440
vgll2 gene
vgll2 wt allele
transcription cofactor vestigial - like protein 2
anti - cd20 / anti - cd22 car t - cells
vgll2 gene rearrangement
crl4 - crbn modulator kpg - 818
allogeneic anti - cd30 car - epstein - barr virus - specific t - lymphocytes
vgll3 gene
vgll3 wt allele
transcription cofactor vestigial - like protein 3
oga gene
oga wt allele
protein o - glcnacase
tgfbr3 / oga fusion gene
t ( 1 ; 10 )  ( p22 ; q24 )
avoidance question
experience question
congenital dyserythropoietic anemia type ii
breast cancer self efficacy scale
confident am able to ask for help for problems related to breast cancer
confident am able to deal with having breast cancer
confident am able to deal with physical symptoms of breast cancer
confident am able to ask for help for breast cancer problems without feeling guilty
confident am able to handle fears about breast cancer returning
confident am able to successfully handle life situations since having breast cancer
confident am able to have a productive work life even though had breast cancer
confident am able to successfully work toward personal goals since having breast cancer
confident am able to successfully deal with emotions since having breast cancer
confident am able to identify body changes related to return of breast cancer
comfortable calling healthcare provider about symptom that may be related to return of breast cancer
defective t - cell receptor signaling
breast ductal carcinoma in situ ,  comedo type
aspiculate
virtual reality device
familial arrhythmogenic right ventricular dysplasia 13
encapsulated breast papillary carcinoma
encapsulated breast papillary carcinoma with invasion
breast solid papillary carcinoma in situ
invasive breast solid papillary carcinoma
intraductal cellular proliferation
hypercholesterolemia ,  familial ,  2
pik3cd - associated immunodeficiency
febrile seizures ,  familial ,  3a
psma - targeting agent
anti - cd19 - targeting car - t cells
memory question
activity question
appearance question
anti - bcma - targeting car - t cells
droplet - bc test
apricityrx
allogeneic nkg2d - ox40 - cd3zeta - car - mbil - 15 - expressing natural killer cells nkx101
anti - muc16 / cd28 bispecific antibody regn5668
anti - cd96 monoclonal antibody gsk6097608
always true
usually true
never true
christianity
buddhism
hinduism
sikhism
atheism
anti - integrin beta - 1 monoclonal antibody os2966
hemopurifier
autologous anti - ny - eso - 1 tcr / cd8alpha - expressing t - cells gsk3901961
autologous anti - ny - eso - 1 tcr / dntgf - brii - expressing t - cells gsk3845097
unresectable biliary tract carcinoma
ocular surface squamous neoplasia
panobinostat lactate
breast cellular fibroadenoma
cdisc clinical classification apgar score version 1 test name terminology
cdisc clinical classification apgar score version 1 test code terminology
cdisc clinical classification cdai version 1 test name terminology
cdisc clinical classification cdai version 1 test code terminology
cdisc clinical classification ses - cd version 1 test name terminology
cdisc clinical classification ses - cd version 1 test code terminology
apgar score version 1 clinical classification question
cdai version 1 clinical classification question
ses - cd version 1 clinical classification question
covid - 19 vaccine ad26 .cov2 .s
covid - 19 vaccine v591
apgar score version 1  -  appearance or color
apgar score version 1  -  pulse or heart rate
apgar score version 1  -  grimace or reflex irritability
apgar score version 1  -  activity or muscle tone
apgar score version 1  -  respiration or respiratory effort
apgar score version 1  -  total apgar score
cdai version 1  -  weight
cdai version 1  -  standard body weight
cdai version 1  -  daily number of stools
cdai version 1  -  daily average abdominal pain
cdai version 1  -  daily average general well - being
cdai version 1  -  anti - diarrhea / opiate use
cdai version 1  -  abdominal mass
cdai version 1  -  hematocrit
cdai version 1  -  arthritis / arthralgia
cdai version 1  -  iritis / uveitis
cdai version 1  -  erythema nodosum
cdai version 1  -  anal fissure ,  fistula or abscess
cdai version 1  -  other fistula
cdai version 1  -  fever
cdai version 1  -  weight subscore
cdai version 1  -  total number stools subscore
cdai version 1  -  abdominal pain subscore
cdai version 1  -  general well - being subscore
cdai version 1  -  anti - diarrhea / opiate use subscore
cdai version 1  -  abdominal mass subscore
cdai version 1  -  hematocrit subscore
cdai version 1  -  symptoms manifested subscore
cdai version 1  -  cdai total score
ses - cd version 1  -  ileum: explored
ses - cd version 1  -  ileum: size of ulcers
ses - cd version 1  -  ileum: ulcerated surface
ses - cd version 1  -  ileum: affected surface
ses - cd version 1  -  ileum: presence of narrowing
ses - cd version 1  -  right colon: explored
ses - cd version 1  -  right colon: size of ulcers
ses - cd version 1  -  right colon: ulcerated surface
ses - cd version 1  -  right colon: affected surface
ses - cd version 1  -  right colon: presence of narrowing
ses - cd version 1  -  trans colon: explored
ses - cd version 1  -  trans colon: size of ulcers
ses - cd version 1  -  trans colon: ulcerated surface
ses - cd version 1  -  trans colon: affected surface
ses - cd version 1  -  trans colon: presence of narrowing
ses - cd version 1  -  left colon: explored
ses - cd version 1  -  left colon: size of ulcers
ses - cd version 1  -  left colon: ulcerated surface
ses - cd version 1  -  left colon: affected surface
ses - cd version 1  -  left colon: presence of narrowing
ses - cd version 1  -  rectum: explored
ses - cd version 1  -  rectum: size of ulcers
ses - cd version 1  -  rectum: ulcerated surface
ses - cd version 1  -  rectum: affected surface
ses - cd version 1  -  rectum: presence of narrowing
ses - cd version 1  -  ileum subscore
ses - cd version 1  -  right colon subscore
ses - cd version 1  -  trans colon subscore
ses - cd version 1  -  left colon subscore
ses - cd version 1  -  rectum subscore
ses - cd version 1  -  total score
sf - 36 v1 .0 acute  -  physical functioning 0 - 100 score
sf - 36 v1 .0 acute  -  role physical 0 - 100 score
sf - 36 v1 .0 acute  -  bodily pain 0 - 100 score
sf - 36 v1 .0 acute  -  general health 0 - 100 score
sf - 36 v1 .0 acute  -  vitality 0 - 100 score
sf - 36 v1 .0 acute  -  social functioning 0 - 100 score
sf - 36 v1 .0 acute  -  role emotional 0 - 100 score
sf - 36 v1 .0 acute  -  mental health 0 - 100 score
sf - 36 v1 .0 acute  -  phys functioning norm - based score
sf - 36 v1 .0 acute  -  role physical norm - based score
sf - 36 v1 .0 acute  -  bodily pain norm - based score
sf - 36 v1 .0 acute  -  general health norm - based score
sf - 36 v1 .0 acute  -  vitality norm - based score
sf - 36 v1 .0 acute  -  social function norm - based score
sf - 36 v1 .0 acute  -  role emotional norm - based score
sf - 36 v1 .0 acute  -  mental health norm - based score
sf - 36 v1 .0 acute  -  physical component score
sf - 36 v1 .0 acute  -  mental component score
sf - 36 v1 .0 acute  -  sf - 6d  ( utility index )  score
sf - 36 v1 .0 acute  -  sf - 6d_r2  ( util index rel 2 )  score
sf - 36 v1 .0 acute  -  response consistency score
sf36 v1 .0 standard  -  physical functioning 0 - 100 score
sf36 v1 .0 standard  -  role physical 0 - 100 score
sf36 v1 .0 standard  -  bodily pain 0 - 100 score
sf36 v1 .0 standard  -  general health 0 - 100 score
sf36 v1 .0 standard  -  vitality 0 - 100 score
sf36 v1 .0 standard  -  social functioning 0 - 100 score
sf36 v1 .0 standard  -  role emotional 0 - 100 score
sf36 v1 .0 standard  -  mental health 0 - 100 score
sf36 v1 .0 standard  -  phys functioning norm - based score
sf36 v1 .0 standard  -  role physical norm - based score
sf36 v1 .0 standard  -  bodily pain norm - based score
sf36 v1 .0 standard  -  general health norm - based score
sf36 v1 .0 standard  -  vitality norm - based score
sf36 v1 .0 standard  -  social function norm - based score
sf36 v1 .0 standard  -  role emotional norm - based score
sf36 v1 .0 standard  -  mental health norm - based score
sf36 v1 .0 standard  -  physical component score
sf36 v1 .0 standard  -  mental component score
sf36 v1 .0 standard  -  sf - 6d  ( utility index )  score
sf36 v1 .0 standard  -  sf - 6d_r2  ( util index rel 2 )  score
sf36 v1 .0 standard  -  response consistency score
sf - 36 v2 .0 acute  -  physical functioning 0 - 100 score
sf - 36 v2 .0 acute  -  role physical 0 - 100 score
sf - 36 v2 .0 acute  -  bodily pain 0 - 100 score
sf - 36 v2 .0 acute  -  general health 0 - 100 score
sf - 36 v2 .0 acute  -  vitality 0 - 100 score
sf - 36 v2 .0 acute  -  social functioning 0 - 100 score
sf - 36 v2 .0 acute  -  role emotional 0 - 100 score
sf - 36 v2 .0 acute  -  mental health 0 - 100 score
sf - 36 v2 .0 acute  -  phys functioning norm - based score
sf - 36 v2 .0 acute  -  role physical norm - based score
sf - 36 v2 .0 acute  -  bodily pain norm - based score
sf - 36 v2 .0 acute  -  general health norm - based score
sf - 36 v2 .0 acute  -  vitality norm - based score
sf - 36 v2 .0 acute  -  social function norm - based score
sf - 36 v2 .0 acute  -  role emotional norm - based score
sf - 36 v2 .0 acute  -  mental health norm - based score
sf - 36 v2 .0 acute  -  physical component score
sf - 36 v2 .0 acute  -  mental component score
sf - 36 v2 .0 acute  -  sf - 6d  ( utility index )  score
sf - 36 v2 .0 acute  -  sf - 6d_r2  ( util index rel 2 )  score
sf - 36 v2 .0 acute  -  response consistency score
sf - 36 v2 .0 standard  -  physical functioning 0 - 100 score
sf - 36 v2 .0 standard  -  role physical 0 - 100 score
sf - 36 v2 .0 standard  -  bodily pain 0 - 100 score
sf - 36 v2 .0 standard  -  general health 0 - 100 score
sf - 36 v2 .0 standard  -  vitality 0 - 100 score
sf - 36 v2 .0 standard  -  social functioning 0 - 100 score
sf - 36 v2 .0 standard  -  role emotional 0 - 100 score
sf - 36 v2 .0 standard  -  mental health 0 - 100 score
sf - 36 v2 .0 standard  -  phys functioning norm - based score
sf - 36 v2 .0 standard  -  role physical norm - based score
sf - 36 v2 .0 standard  -  bodily pain norm - based score
sf - 36 v2 .0 standard  -  general health norm - based score
sf - 36 v2 .0 standard  -  vitality norm - based score
sf - 36 v2 .0 standard  -  social function norm - based score
sf - 36 v2 .0 standard  -  role emotional norm - based score
sf - 36 v2 .0 standard  -  mental health norm - based score
sf - 36 v2 .0 standard  -  physical component score
sf - 36 v2 .0 standard  -  mental component score
sf - 36 v2 .0 standard  -  sf - 6d  ( utility index )  score
sf - 36 v2 .0 standard  -  sf - 6d_r2  ( util index rel 2 )  score
sf - 36 v2 .0 standard  -  response consistency score
ajcc v7  -  residual tumor  ( r )
nsclc - saq version 1 .0  -  cough domain subscore
nsclc - saq version 1 .0  -  fatigue domain subscore
nsclc - saq version 1 .0  -  pain domain subscore
nsclc - saq version 1 .0  -  dyspnea domain subscore
nsclc - saq version 1 .0  -  appetite domain subscore
smdds version 1 .0  -  negative emotions / mood subscore
smdds version 1 .0  -  anxiety subscore
smdds version 1 .0  -  smddds1 - low energy subscore
smdds version 1 .0  -  cognition subscore
smdds version 1 .0  -  sleep disturbances subscore
smdds version 1 .0  -  eating behavior subscore
smdds version 1 .0  -  low motivation subscore
smdds version 1 .0  -  sense of self subscore
smdds version 1 .0  -  self - harm / suicide subscore
drs  -  total score
linear ubiquitin chain assembly complex
autologous anti - gprc5d - car - 4 - 1bb - expressing t - cells mcarh109
devil facial tumor disease 1
devil facial tumor disease 2
hemopurification
cdisc send microscopy sexual maturity status terminology
cdisc define - xml adam occurrence data structure subclass terminology
subject decision
district
contact name
machine learning
cholate compounds measurement
gastrointestinal tract wall
lower gastrointestinal tract lymph node
concentration ratio
ratio auc from t1 to t2
ratio auc to last nonzero concentration
ursodeoxycholate compounds measurement
chenodeoxycholate compounds measurement
lithocholate compounds measurement
lower gastrointestinal tract wall
time amount answer
difficulty answer
agreement answer
never answer
pain answer
extremity pain answer
cough answer
hearing answer
satisfaction answer
primary breast angiosarcoma
sexual activity answer
breast nodular fasciitis
walking answer
breast angiolipoma
activity time answer
decentralized clinical trial
deep learning
health literacy
natural language processing
study phase
plain language writing
synthetic data
virtual
adverse event dataset
study product acquisition
study product accountability
study product formulation
study product appearance
study product packaging
study product labeling
study product storage
study product stability
study product preparation
study product manufacturer
number of tissue samples in specimen
number of devices present
maximum dose amount
frequency of maximum dose amount
final dose amount
frequency of final dose amount
relapse after discontinuation because of dependence indicator
unable to discontinue use due to dependence indicator
substance dependence indicator
section thickness
information source for cause of death
two times per cycle
three times per cycle
every two days
percent ulcer area
primary care physician's office visit
specialty care physician's office visit
emergency room visit
modification of diet in renal disease formula
whole blood equivalent glucose measurement
aspartate aminotransferase to alanine aminotransferase ratio measurement
ursodeoxycholate measurement
glycocholate measurement
hyocholate measurement
taurocholate measurement
glycoursodeoxycholate measurement
tauroursodeoxycholate measurement
epimerized ursodeoxycholate measurement
glycochenodeoxycholate measurement
taurochenodeoxycholate measurement
lithocholate measurement
glycolithocholate measurement
taurolithocholate measurement
coefficient of nitrogen absorption measurement
coefficient of fat absorption measurement
phosphorylated tau protein to amyloid beta1 - 42 ratio measurement
anti - neutrophil antibody measurement
upper gastrointestinal tract wall
colon wall
ileum wall
colon lymph node
ileum lymph node
caudal vertebra
sternebra
fore limb
atrioventricular valve
claw
genital tubercle
eye bulge
fat pad
sars - cov - 2 antigen measurement
sheath flow direct current detection
sodium lauryl sulphate method
autorefraction
magnetic resonance enterography
indirect immunofluorescence
ulceration assessment
granuloma assessment
cryptitis assessment
crypt abscess assessment
crypt architectural damage assessment
epithelial integrity assessment
paneth cell metaplasia assessment
number of abnormal tissue samples
lymphocyte function - associated antigen 1 measurement
study consent withdrawn
logistical problem with clinical study
auc all ratio
average concentration ratio
minimum concentration ratio
ratio amount recovered from t1 to t2
ratio auc infinity observed normalized by dose
ratio auc from t1 to t2 normalized by dose
ratio auc to last nonzero concentration normalized by dose
ratio auc over dosing interval
ratio maximum concentration normalized by dose
ratio concentration trough
ratio amount recovered infinity observed
dosing interval
hour times microgram per gram
opted to continue into survival follow - up
declined to continue into survival follow - up
vaginal bleeding and / or spotting frequency description
hospitalized due to pregnancy complication indicator
term pregnancy category
county of permanent address
district of permanent address
village of permanent address
country of permanent address
basal tear
reflex tear
emotional tear
arterialized capillary blood
plasma ultrafiltrate
endometrial tissue
study contact role
study contact name
study contact telephone number
study contact e - mail address
study contact postal address
picogram per cell
gram per liter per day
nanomole per kilogram per day
hour per day
minute per day
breaths per thirty seconds
nanokatal per gram hemoglobin
european pharmacopoeia unit
microgram per mole
nanogram per mole
per megabase pair
megabase pair
short supernumerary rib
peripubertal
qualitative sexual maturity microscopic examination
experimental organism benign mesovarial leiomyoma
experimental organism amphophilic vacuolar carcinoma
experimental organism amphophilic vacuolar adenoma
experimental organism malignant pituicytoma
neuronal autophagy
renaut body
increased cellular aggregates
increased apoptosis
splenic contraction
decreased corticomedullary ratio
increased corticomedullary ratio
increased thymic epithelium - free areas
loss of corticomedullary distinction
hyaline material
increased number of hypersegmented neutrophils present
experimental organism increased serosa - associated lymphoid clusters
age - related thymic involution
gelatinous bone marrow transformation
tertiary lymphoid structure
increased hassall's corpuscles
reproductive tissue
test site activity
breast schwannoma
breast neurofibroma
immunodeficiency with hyper - igm ,  type 3
coro1a gene
coro1a wt allele
coronin - 1a
foxn1 gene
foxn1 wt allele
charlson comorbidity index
forkhead box protein n1
nci drug dictionary terminology
single item literacy screener
reading question
rbck1 gene
how often need help reading instructions ,  pamphlets ,  or other written material from doctor or pharmacy
rbck1 wt allele
ranbp - type and c3hc4 - type zinc finger - containing protein 1
rnf31 gene
rnf31 wt allele
e3 ubiquitin - protein ligase rnf31
rnr subunits interaction inhibitor tas1553
itch gene
itch wt allele
e3 ubiquitin - protein ligase itchy homolog
lat gene
lat wt allele
linker for activation of t - cells family member 1
cancer worry scale
how often thought about chances of cancer recurrence
lat gene mutation
have thoughts of chances of cancer recurrence affected mood
have thoughts about chances of cancer recurrence interfered with ability to carry out daily activities
how concerned about possibility of cancer recurrence
how often worry about developing cancer
how much problem is worry about developing cancer
how often worry about chance of family members developing cancer
how concerned about possibility of needing surgery again
mvk gene
mvk wt allele
mevalonate kinase
otulin gene
otulin wt allele
ubiquitin thioesterase otulin
gallium ga 68 fap - 2286
pstpip1 gene
pstpip1 wt allele
proline - serine - threonine phosphatase - interacting protein 1
t - cells and natural killer cells absent b - cells normal
t - cells absent ,  t - cell receptor signaling defective and natural killer cells and b - cells normal
t - cells ,  b - cells and natural killer cells absent
recurrent low grade astrocytoma
t - cells absent and normal natural killer cells and b - cells
t - cells and b - cells absent and natural killer cells normal
synovial chondrosarcoma
ak2 gene
ruler measurement method
vernier caliper measurement method
ph meter measurement method
blunt - tipped
curly
domed
eruption
hooked
imperforate
kinked
vessel biventricular override
patent
three - chambered
transposed
two - chambered
unexpanded
wavy
ak2 wt allele
modified health care climate questionnaire for breast cancer treatment
feel that physician provided choices and options for breast cancer treatment
feel that physician understood how i saw things with respect to breast cancer
feel that physician expressed confidence in my ability to make decisions
feel that physician listened to how i would like to handle breast cancer treatment
feel that physician encouraged me to ask questions
feel that physician tried to understand how i saw things before offering opinion
adenylate kinase 2 ,  mitochondrial
ap3d1 gene
ap3d1 wt allele
ap - 3 complex subunit delta - 1
dock2 gene
dock2 wt allele
dedicator of cytokinesis protein 2
male breast carcinoma in situ
invasive male breast carcinoma
fluorine f 18 w372
g6pc3 gene
g6pc3 wt allele
glucose - 6 - phosphatase 3
cdk4 / 6 inhibitor glr2007
gfi1 gene
gfi1 wt allele
zinc finger protein gfi - 1
unresectable sinonasal squamous cell carcinoma
unresectable nasal cavity squamous cell carcinoma
vulvar angiosarcoma
cancerization of pancreatic ducts
localized prostate carcinoma
hax1 gene
hax1 wt allele
hcls1 - associated protein x - 1
hnrnph2 gene
hnrnph2 wt allele
heterogeneous nuclear ribonucleoprotein h2
ighm gene
ighm wt allele
immunoglobulin heavy constant mu
jagn1 gene
patient assessment of cancer communication experiences
jagn1 wt allele
was treated with sensitivity and respect
felt known as a person
felt listened to
felt comfortable asking questions and voicing concerns
felt everyone worked together as a team taking care of me
protein jagunal homolog 1
wishes were respected
information question
got information needed when needed
got clear ,  understandable information
got consistent information from doctors and nurses
knew who to contact with a question or concern
lrba gene
felt comfortable bringing up anything on mind
felt optimism and hope from doctors and nurses
question about healthcare
lrba wt allele
cancer care team helped coping with uncertainty or unknowns
cancer care team helped with difficult feelings
knew who in healthcare system to reach out to if worried that something had gone wrong with care
lipopolysaccharide - responsive and beige - like anchor protein
locally recurrent disease
was involved in making decisions as much as wanted
rate overall experience with communication related to cancer care
lrrc8a gene
lrrc8a wt allele
volume - regulated anion channel subunit lrrc8a
regulatory factor x complex
localized sarcoma
pgm3 gene
pgm3 wt allele
phosphoacetylglucosamine mutase
sting agonist mk - 2118
cdk7 inhibitor ly3405105
parotid - sparing whole - brain radiation therapy
cdk7 inhibitor ly3405105 besylate
rfx5 gene
rfx5 wt allele
autologous anti - cd22 car - expressing t - cells scri - car22v2
dna - binding protein rfx5
synthetic mva - based sars - cov - 2 vaccine coh04s1
rfxank gene
rfxank wt allele
autologous tolerogenic proinsulin peptide - loaded dendritic cells pipeptoldc
dna - binding protein rfxank
rfxap gene
rfxap wt allele
regulatory factor x - associated protein
ire1 rnase inhibitor orin1001
invasive female breast carcinoma
female breast carcinoma in situ
sting agonist - containing ptgfrn - expressing exosomes cdk002
combined positive score
rmrp gene
rmrp wt allele
rna component of mitochondrial rna processing endoribonuclease
sting agonist
tp53 - associated li - fraumeni syndrome
chek2 - associated li - fraumeni syndrome
ttc7a gene
ttc7a wt allele
tetratricopeptide repeat protein 7a
ectodermal dysplasia and immunodeficiency 1
congenital defects of phagocyte number ,  function ,  or both
defects in intrinsic and innate immunity
immune dysregulation disorder
combined immunodeficiencies associated with syndromic features
immunodeficiencies affecting cellular and humoral immunity  -  combined immune deficiency
immunodeficiencies affecting cellular and humoral immunity  -  severe combined immune deficiency
predominantly antibody deficiencies
primary immune regulatory disorder
mendelian susceptibility to mycobacterial diseases
severe congenital neutropenia type 6 ,  autosomal recessive
vps45 gene
vps45 wt allele
severe combined immunodeficiency due to cd45 deficiency
severe combined immunodeficiency due to rag1 deficiency
severe combined immunodeficiency due to rag2 deficiency
epidermodysplasia verruciformis ,  susceptibility to ,  4
vacuolar protein sorting - associated protein 45
severe congenital neutropenia type 2 ,  autosomal dominant
severe congenital neutropenia type 4 ,  autosomal recessive
severe congenital neutropenia type 5 ,  autosomal recessive
wipf1 gene
severe congenital neutropenia type 7 ,  autosomal recessive
wipf1 wt allele
was / wasl - interacting protein family member 1
thrombocytopenia 1
znf341 gene
proteasome - associated autoinflammatory syndrome 1
znf341 wt allele
zinc finger protein 341
gastrointestinal defects and immunodeficiency syndrome
ipsc - derived cd16 / il - 15rf - expressing cd38 - eliminated nk cells ft538
anti - dr5 agonistic monoclonal antibody igm - 8444
focused ultrasound mesencephalotomy
actinium ac 225 - dota - h11b6 jnj - 69086420
cdh1 - associated breast carcinoma syndrome
peppermint oil - containing enteric - coated microspheres
immunodeficiency 11b with atopic dermatitis
pik3r1 deficiency
emollient excipient
emulsion stabilizing excipient
foam stabilizing excipient
organoleptic excipient
stabilizing excipient
absorption modifying excipient
effervescent excipient
reducing excipient
solubilizing excipient
tonicity excipient
adsorbent
air displacement agent
bulking excipient
carrier excipient
complexing excipient
denaturant
film coating excipient
free radical scavenging excipient
gelling excipient
humectant excipient
lyophilization excipient
matrix forming excipient
microencapsulating excipient
ointment base
opacifying excipient
osmotic excipient
ph modifying excipient
polishing excipient
ophthalmic polymer
propellant
release modifying excipient
suppository base
transdermal delivery excipient
transfer ligand excipient
viscosity modifying excipient
water repelling excipient
wetting excipient
immunodeficiency due to functional defects
immunodeficiency due to quantitative defects
activating jak1 gene mutation
stat1 gene mutation
inactivating stat1 gene mutation
inactivating stat5b gene mutation
pq / cmc drug product component function category terminology
pq / cmc excipient function terminology
pq / cmc units of measure terminology
metastatic malignant small intestinal neoplasm
advanced malignant small intestinal neoplasm
recurrent breast implant - associated anaplastic large cell lymphoma
refractory breast implant - associated anaplastic large cell lymphoma
locally recurrent head and neck squamous cell carcinoma
hla - a*03:01 positive cells present
minimal residual disease less than 0 .1 percent
neoplastic plasma cells 5 percent or more of peripheral blood white cells
crosslinked multimeric type iii procollagen propeptide
ki - 67 positive cells greater than or equal to 5 percent
sars coronavirus 2 negative
activating ntrk family gene mutation
millisiemens
activating met exon 14 skipping mutation
ebv susceptibility
predisposition to bacterial infections
predisposition to fungal infections
predisposition to viral infections
repeat expansion disease
rectal large cell neuroendocrine carcinoma
high grade fever
moderate grade fever
phosphorus - 32 beta radiation
canine sebaceous gland epithelioma
feline progressive histiocytosis
pik3r1 - associated immunodeficiency
yarsopathy
functioning lung carcinoid tumor
non - functioning lung carcinoid tumor
physical examination finding
imaging finding
breast finding
breast examination finding
recurrent lung neuroendocrine neoplasm
cancer - related symptom
abuse
complaint
locally advanced lung neuroendocrine neoplasm
exercise tolerance test result
tissue or organ disruption
physiological condition
lymph node finding
medication status
diagnostic criteria not met
diagnostic criteria met
no alleviating factor
absence of sequelae
prosthetic complication
transplant complication
advanced lung adenocarcinoma
locally advanced unresectable primary central chondrosarcoma
palb2 - associated malignant neoplasm
autoimmune neutropenia
type 1 autoimmune hepatitis
type 2 autoimmune hepatitis
variant autoimmune hepatitis
neutrophilic dermatosis
electroencephalography cap
eeg monitoring via cap
respiratory band
respiratory monitoring via band
accelerometry
interferon gamma - primed human bone marrow - derived mesenchymal stromal cells
eye - tracking glasses
eye tracking
eye tracking via glasses
anti - cd47 / anti - pd - l1 bispecific antibody ibi322
factor d inhibitor bcx9930
anti - tigit monoclonal antibody eos884448
ikkb - matured rna - loaded autologous dendritic cells dcikkb
oncolytic herpes simplex virus - 1 expressing anti - ctla - 4 antibody - like molecule and gm - csf rp2
tlr7 agonist ro7119929
cxcr1 / 2 inhibitor rp72
jak2 inhibitor tq05105
nemo deleted exon 5 autoinflammatory syndrome
lindera obtusiloba extract
interleukin 10 receptor
follicular helper t cell
tumor - infiltrating follicular helper t cell
tumor - infiltrating t helper 17 cell
sp100 antibody measurement
nuclear pore gp120 antibody measurement
platelet antibody measurement
thyroid peroxidase antibody measurement
granulocyte antibody measurement
ancestry
birthplace
erk1 / 2 inhibitor atg - 017
micro - immunotherapeutic agent 2lebv
micro - immunotherapeutic agent 2lxfs
idh2 mutant inhibitor tqb3455
differentiated anti - bcma autologous car t cells ari0002h
hsv -  thymidine kinase - m2 / hgm - csf genes - encoding gen2
anti - cfh monoclonal antibody gt103
autologous anti - cd20 car t - cells c - car066
gallium ga 68 nodaga - lm3
fluorine f 18 dpa - 714
pi3k / mtor inhibitor hec 68498
gammatile
collagen tile brachytherapy
hip / inguinal region
tempol - containing mbm - 02
45 , xo karyotype
45 , xo with y chromosomal material
47 , xyy karyotype
parp inhibitor azd5305
47 , xxy karyotype
47 , xxx karyotype
48 , xxxy karyotype
48 , xxxx karyotype
pq / cmc application submission type terminology
pq / cmc co - packaged indicator terminology
pq / cmc process related impurity category terminology
b - cell expansion with nfkb and t - cell anergy
british pharmacopeia
porcupine inhibitor wnt - c59
immunodeficiency 26 with or without neurologic abnormalities
amendment to original submission
supplement to original submission
amendment to supplement submission
dock2 - associated immunodeficiency
il12rb1 - associated immunodeficiency
immunodeficiency ,  common variable ,  11
amendment to investigational new drug
amendment to master drug file
severe combined immunodeficiency ,  autosomal recessive ,  t - cell negative ,  b cell - positive ,  nk cell - positive
interferon gamma receptor 2 deficiency
interferon gamma receptor 1 deficiency
severe combined immunodeficiency ,  autosomal recessive ,  t - cell negative ,  b - cell positive ,  nk - cell negative
lck - associated immunodeficiency
immunodeficiency ,  common variable ,  8 ,  with autoimmunity
microbiological property
physico - chemical properties
process related impurity
product related impurity
pq / cmc product related impurity category terminology
residual solvent
degradant
purine nucleoside phosphorylase deficiency
neutropenia ,  severe congenital ,  x - linked
warts ,  hypogammaglobulinemia ,  infections ,  and myelokathexis syndrome
wiskott - aldrich syndrome 2
immunodeficiency 48 ;  selective t - cell defect ;  stcd
autosomal recessive agammaglobulinemia
mhc class ii deficiency
autologous anti - her2 car macrophages ct - 0508
interferon regulatory factor 8 deficiency
ectodermal dysplasia and immunodeficiency 2
severe congenital neutropenia type 1 ,  autosomal dominant
medical expenditure panel survey
self - administered comorbidity questionnaire
fear of cancer recurrence questionnaire
cdk2 / 4 / 6 inhibitor nuv - 422
financial hardship
patient - centered communication in cancer care - long form
cd38 - targeting antibody recruiting molecule kp1237
cahps cancer care survey
eortc quality of life questionnaire - core 30
functional assessment of chronic illness therapy - spiritual well - being 12 item scale
quality of life patient / cancer survivor version
supportive care needs survey - short form 34
survivor unmet needs survey
vibostolimab / pembrolizumab mk - 7684a
sp100 gene
recombinant newcastle disease virus - encoding interleukin - 12 medi9253
sp100 wt allele
nuclear autoantigen sp - 100
antisense oligonucleotide ion537
pneumatic compression therapy
pneumatic compression therapy with reminders
healthcare utilization
allogeneic anti - cd19 1xx - car t - cells ft819
cxcr2 agonist mgta - 145
gallium ga 68 - dota - 5g
lutetium lu 177 - dota - abm - 5g
high resolution anoscopy
lentiglobin bb305 lentiviral vector - transduced autologous scd cd34 +  hemaptopoietic stem cells bb1111
microscopy with ultraviolet surface excitation
locally advanced lung small cell carcinoma
refractory lung non - squamous non - small cell carcinoma
advanced malignant genitourinary system neoplasm
grade 3 seizure ,  astct icans
grade 4 seizure ,  astct icans
metastatic malignant thoracic neoplasm
advanced malignant thoracic neoplasm
left leg
right leg
interleukin - 2 / interleukin - 15 receptor agonist nl - 201
anti - nkg2a monoclonal antibody bms - 986315
anti - cd47 monoclonal antibody ak117
chocolate - based dietary supplement
pd - 1 targeted il - 15 mutein fusion protein pf - 07209960
anti - ox40 agonist monoclonal antibody yh - 002
anti - ctla - 4 monoclonal antibody yh001
anti - pd - 1 monoclonal antibody syn125
anti - hgf monoclonal antibody yyb101
indium in 111 tabituximab barzuxetan
complete estrogen receptor antagonist op - 1250
poziotinib hydrochloride
pi3kdelta / gamma inhibitor zx - 101a
insomnia severity index
shp2 inhibitor eras - 601
gct study identifier
nucleated cell separation tube
allogeneic shrna - based anti - bcma car t - cells cyad - 211
prolonged grief disorder
psammocarcinoma
advanced distal bile duct adenocarcinoma
unresectable glioma
unresectable glioblastoma
advanced intrahepatic cholangiocarcinoma
refractory esophageal adenocarcinoma
pyruvate kinase - r activator ft - 4202
fanconi anemia ,  complementation group n
mitochondrial complex iv deficiency ,  nuclear type 1
multiple congenital anomalies - hypotonia - seizures syndrome 1
neurodevelopmental disorder with spastic diplegia and visual defects
neuropathy ,  recurrent ,  with pressure palsies
familial hypertrophic cardiomyopathy type 14
nonaka myopathy
spinocerebellar ataxia type 31
atypical hemolytic uremic syndrome - 4
rett syndrome ,  congenital variant
melanoma - pancreatic cancer syndrome
melanoma - astrocytoma syndrome
familial gastrointestinal stromal tumor
acute lymphoblastic leukemia ,  susceptibility to ,  3
monosomy 7 myelodysplasia and leukemia syndrome 1
ataxia - pancytopenia syndrome
fanconi anemia ,  complementation group o
diamond - blackfan anemia 1
diamond - blackfan anemia 3
diamond - blackfan anemia 4
diamond - blackfan anemia 5
diamond - blackfan anemia 6
diamond - blackfan anemia 7
diamond - blackfan anemia 8
diamond - blackfan anemia 9
diamond - blackfan anemia 10
diamond - blackfan anemia 11
dyskeratosis congenita ,  autosomal dominant 1
dyskeratosis congenita ,  autosomal dominant 2
dyskeratosis congenita ,  autosomal dominant 3
dyskeratosis congenita ,  autosomal dominant 6
dyskeratosis congenita ,  autosomal recessive 1
dyskeratosis congenita ,  autosomal recessive 2
dyskeratosis congenita ,  autosomal recessive 3
dyskeratosis congenita ,  autosomal recessive 5
dyskeratosis congenita ,  autosomal recessive 6
noonan syndrome 2
noonan syndrome 3
noonan syndrome 4
noonan syndrome 5
noonan syndrome 6
noonan syndrome 7
noonan syndrome 8
noonan syndrome 9
noonan syndrome 10
noonan syndrome - like disorder with loose anagen hair 1
noonan syndrome - like disorder with loose anagen hair 2
legius syndrome
noonan syndrome - like disorder with or without juvenile myelomonocytic leukemia
infantile myofibromatosis 1
infantile myofibromatosis 2
cesium - 131 brachytherapy
metastatic bone disease
localized thoracic symptoms
symptomatic lung cancer
local colorectal cancer symptoms
metastatic visceral disease
cranial nerve symptoms
worrisome symptoms
microbiome - derived peptide vaccine eo2463
bromelains / boswellia serrata supplement
centella asiatica / melon extract / vitamins supplement
carbon c 14 fluzoparib
klb positive
ezh2 gene amplification
cytokine receptor common subunit gamma measurement
cd4 ,  cd25 ,  foxp3 expressing regulatory t - lymphocyte count
hla - dr measurement
hpk1 inhibitor cfi - 402411
myeloid cell leukemia 1 inhibitor prt1419
cdk9 inhibitor gfh009
pax / foxo1 fusion gene
fgfr4 gene rearrangement
ret inhibitor tas0953 / hm06
parp / microtubule polymerization inhibitor amxi - 5001
ezh2 gene copy number alteration positive
pole gene mutation negative
testosterone greater than or equal to 50 ng / dl
fgfr4 positive
waiting room
drd2 antagonist / clpp agonist onc206
brachial region
iliac region
femoral region
lipoma - like atypical lipomatous tumor / well differentiated liposarcoma
superficial atypical lipomatous tumor / well differentiated liposarcoma
atypical lipomatous tumor / well differentiated liposarcoma of deep soft tissue
fluorine f 18 3f - phpg
anti - pd - l1 / cd27 bispecific antibody cdx - 527
physician orders for life sustaining treatment
histology icd - o morphology code
askmusic
anti - cd73 monoclonal antibody sym024
anti - cd73 monoclonal antibody
myxoid pleomorphic liposarcoma
autologous her2 - targeted dual - switch car - t cells bpx - 603
activated polyethylene glycol / polyethyleneimine - based surgical sealant
dural polyethylene glycol - based surgical sealant
autologous gene - modified gamma delta t - cells
locally advanced lymphoma
refractory ureter urothelial carcinoma
refractory urethral urothelial carcinoma
refractory renal pelvis urothelial carcinoma
refractory giant cell glioblastoma
recurrent sezary syndrome
refractory sezary syndrome
immune checkpoint inhibitor - induced dermatitis
diffusing alpha - emitter radiation therapy
radiation - induced xerostomia
gastro - resistant powder and solvent for oral suspension
concentrate for dispersion for injection
cd200 activation receptor ligand hp1a8
intracranial catheter placement
seer sonorheometry coagulation monitoring
mal gene
mal wt allele
myelin and lymphocyte protein
ppp1cb gene
ppp1cb wt allele
serine / threonine - protein phosphatase pp1 - beta catalytic subunit
none of these describe me
anti - c5ar1 monoclonal antibody tj210
anti - muc1 / egfr bispecific antibody drug conjugate m1231
aspartate aminotransferase
alanine aminotransferase
rosopatamab
small intestinal small cell neuroendocrine carcinoma
atypical spindle cell / pleomorphic lipomatous tumor
tubular apocrine adenoma
non - neoplastic conjunctival disorder
non - neoplastic corneal disorder
non - neoplastic eyelid disorder
non - neoplastic retinal disorder
t ( 15 ; 17 )  ( q24 ; q21 )
penile paget disease
breast lobular neoplasia
breast usual ductal hyperplasia
breast intraductal proliferative lesion
breast sclerosing papilloma
hydrogen peroxide
localization
metastatic breast carcinoma in the skin
sultamicillin
branchial cleft cyst
breast ductal carcinoma in situ
nacolomab tafenatox
biceps brachii
vestibular schwannoma
intercalated disc
nipple paget disease
extraocular muscle
pluripotent bone marrow stem cell
therapeutic abortion finding
eosinophilic granulomatosis with polyangiitis
congenital leukocyte abnormality
attention deficit hyperactivity disorder ,  inattentive type
low grade fever
malignant nasolacrimal duct neoplasm
salivary gland epithelial - myoepithelial carcinoma
salivary gland polymorphous adenocarcinoma
salivary gland small cell neuroendocrine carcinoma
non - neoplastic uveal disorder
salivary gland carcinosarcoma
chelating agent
encapsulated neoplasm
localized neoplasm
breast intraductal  neoplasm
invasive breast micropapillary carcinoma
invasive breast papillary carcinoma
breast flat ductal epithelial atypia
breast central papilloma
breast peripheral papilloma
breast atypical papilloma
breast intraductal papillary neoplasm
brca1 - associated hereditary breast and ovarian cancer syndrome
brca2 - associated hereditary breast and ovarian cancer syndrome
benign nasolacrimal duct neoplasm
t ( 17 ; 22 )  ( q21 ; q12 )
t ( 11 ; 22 )  ( p13 ; q12 )
chromosome 1 abnormality
t ( 9 ; 17 )  ( q22 ; q11 )
smad4 gene inactivation
inactivating msh2 gene mutation
inactivating mlh1 gene mutation
inactivating msh6 gene mutation
inactivating pms2 gene mutation
oncocytic adenocarcinoma
desmoplastic fibroma
breast lobular carcinoma
breast intraductal papilloma
small cell neuroendocrine carcinoma
breast inflammatory carcinoma
endometrial small cell neuroendocrine carcinoma
breast ductal carcinoma
breast lobular carcinoma in situ
breast paget disease and intraductal carcinoma
vaginal small cell neuroendocrine carcinoma
vulvar paget disease
vaginal deep "aggressive" angiomyxoma
bartholin gland small cell neuroendocrine carcinoma
vulvar deep "aggressive" angiomyxoma
breast mixed carcinoma
breast carcinoma with osteoclast - like stromal giant cells
breast squamous cell carcinoma ,  large cell keratinizing variant
breast squamous cell carcinoma ,  spindle cell variant
breast squamous cell carcinoma ,  acantholytic variant
breast adenosquamous carcinoma
low grade breast adenosquamous carcinoma
nipple syringomatous tumor
breast mixed epithelial / mesenchymal metaplastic carcinoma
breast lipid - rich carcinoma
breast oncocytic carcinoma
breast acinic cell carcinoma
breast sebaceous carcinoma
postradiation breast angiosarcoma
breast atypical myoepitheliosis
breast intraductal myoepitheliosis
breast periductal myoepitheliosis
breast malignant myoepithelioma
calcifying odontogenic cyst
breast secretory carcinoma
breast papillary ductal carcinoma in situ
breast intracystic papilloma
invasive breast carcinoma of no special type
breast ductal carcinoma in situ and lobular carcinoma in situ
optic disc melanocytoma
definition source
term type
granulocyte - monocyte progenitor cell
central nervous system medulloepithelioma
eye sebaceous carcinoma
eyelid squamous cell papilloma
appendix small cell neuroendocrine carcinoma
colorectal small cell neuroendocrine carcinoma
lacrimal gland neoplasm
corneal neoplasm
ciliary body neoplasm
primary retinal non - hodgkin lymphoma
term source
clofenotane
lung neuroendocrine carcinoma
ciliary body malignant medulloepithelioma
adenomatous hyperplasia of the ciliary body
breast atypical lobular hyperplasia
malignant ciliary body neoplasm
breast paget disease
breast paget disease without invasive carcinoma
source code
myofibroblastic sarcoma
metastatic malignant neoplasm in the lymph nodes
localized brain neoplasm
localized malignant brain neoplasm
optical disc device
leaflet disc device
fluoxetine
localized fibrosarcoma
abnormal vaginal discharge
lacrimal system neoplasm
breast adenoid cystic carcinoma
breast ductal carcinoma in situ ,  non - comedo type
breast ductal carcinoma in situ ,  cribriform pattern
breast micropapillary ductal carcinoma in situ
breast apocrine carcinoma in situ
breast apocrine carcinoma
invasive breast cribriform carcinoma
breast mixed ductal and lobular carcinoma
breast pleomorphic carcinoma
breast metaplastic carcinoma
breast mucoepidermoid carcinoma
high grade breast mucoepidermoid carcinoma
low grade breast mucoepidermoid carcinoma
breast neuroendocrine tumor g1
metastatic breast neuroendocrine tumor g1
breast signet ring cell carcinoma
metastatic breast signet ring cell carcinoma
breast squamous cell carcinoma
metastatic breast squamous cell carcinoma
decalcification
breast atypical hyperplasia
breast papillary ductal hyperplasia
breast intraductal papillomatosis
breast papillary neoplasm
breast vascular neoplasm
mirdametinib
adverse event unrelated to intervention
adverse event unlikely related to intervention
adverse event possibly related to intervention
adverse event probably related to intervention
adverse event definitely related to intervention
locally aggressive lesion
breast columnar cell lesion
breast columnar cell hyperplasia
breast columnar cell hyperplasia with atypia
odontogenic keratocyst
nasopharyngeal basaloid carcinoma
invasive breast apocrine carcinoma
invasive breast lobular carcinoma ,  signet ring variant
anal paget disease
metastatic carcinoma in the skin
trochlear nerve neoplasm
vagus nerve neoplasm
extrahepatic bile duct small cell neuroendocrine carcinoma
minor salivary gland small cell neuroendocrine carcinoma
salivary gland myoepithelioma
laryngeal small cell neuroendocrine carcinoma
rectal small cell neuroendocrine carcinoma
ceruminous adenoma
lacrimal drainage system squamous cell carcinoma
corneal squamous intraepithelial neoplasia
low grade corneal squamous intraepithelial neoplasia
low grade conjunctival squamous intraepithelial neoplasia
widely invasive lesion
metastatic malignant neoplasm in the iris
benign uveal neoplasm
conjunctival squamous intraepithelial neoplasia
coxsackievirus v937
ureter small cell neuroendocrine carcinoma
manganese chloride
salivary gland clear cell carcinoma
salivary gland intraductal carcinoma
dilated terminal duct lobular units present
conjunctival squamous papilloma
tiomolibdate choline
gram positive bacillus
visual pathway neoplasm
astaxanthin
invasive breast ductal carcinoma and invasive lobular carcinoma
thymic small cell neuroendocrine carcinoma
neutrophil to leukocyte ratio measurement
atypical lipomatous tumor / well differentiated liposarcoma
sclerosing atypical lipomatous tumor / well differentiated liposarcoma
inflammatory atypical lipomatous tumor / well differentiated liposarcoma
mometasone
montelukast
primary bone lymphoma
ampulla of vater small cell neuroendocrine carcinoma
breast atypical medullary carcinoma
ciliary body medulloepithelioma
ciliary body benign medulloepithelioma
ciliary body benign teratoid medulloepithelioma
ciliary body teratoid medulloepithelioma
spontaneously regressed retinoblastoma
physiological support
breast ductal carcinoma in situ ,  solid type
breast small cell neuroendocrine carcinoma
colon small cell neuroendocrine carcinoma
esophageal small cell neuroendocrine carcinoma
gallbladder small cell neuroendocrine carcinoma
gastric small cell neuroendocrine carcinoma
prostate small cell neuroendocrine carcinoma
double minutes
oral cavity monomorphic adenoma
thyroid gland hyalinizing trabecular tumor
luteolin
parotid gland monomorphic adenoma
maltodextrin
middle ear adenocarcinoma
paranasal sinus sarcoma
neuropeptide y
high grade paranasal sinus sarcoma
low grade paranasal sinus sarcoma
dietary folate equivalent
adult atypical meningioma
kadish stage a olfactory neuroblastoma
kadish stage b olfactory neuroblastoma
caffeic acid
limonene
kilojoule
infoods
usda_id
essential_fatty_acid
chd5 gene
chd5 wt allele
chromodomain - helicase - dna - binding protein 5
cervical microglandular polyp
prefix for binary multiples
n - telopeptide
microbiome
metric prefix
spio nanoparticle
timepoint
kibi
vulvar fibroepithelial stromal polyp
mebi
gibi
tebi
pebi
exbi
olig2 gene
olig2 wt allele
oligodendrocyte transcription factor 2
mbl2 gene
mbl2 wt allele
primary cutaneous b - cell non - hodgkin lymphoma
10q11 .2 - q21
mannose - binding protein c
nedd4 gene
nedd4 wt allele
e3 ubiquitin - protein ligase nedd4
cd24 gene
cd24 wt allele
signal transducer cd24
apobec3g gene
apobec3g wt allele
grade 3 cutaneous follicular lymphoma
22q13 .1 - q13 .2
dna dc to du - editing enzyme apobec - 3g
aurkb gene
aurkb wt allele
timespan
spontaneous report
aurora kinase b
mandatory report
unilateral
neuropeptide
primary cutaneous anaplastic large cell lymphoma
flot2 gene
flot2 wt allele
flotillin - 2
chemical_formula
hospitalization or prolongation of existing hospitalization required
persistent or significant disability or incapacity
commission on cancer
vendor
active comparator
choroid spindle cell type a melanoma
oropharyngeal undifferentiated carcinoma
sinonasal squamous cell carcinoma
active comparator drug
post - study adverse event
essential_amino_acid
adverse event conditionally related to intervention
adverse event relation to intervention unclassifiable
choroid spindle cell type b melanoma
dechallenge
rechallenge
expedited report
report nullification
childhood teratoma
childhood extracranial germ cell tumor
childhood malignant testicular germ cell tumor
childhood malignant ovarian germ cell tumor
ciliary body spindle cell type b melanoma
study name
childhood extragonadal malignant germ cell tumor
medicaid
childhood atypical teratoid / rhabdoid tumor
well differentiated adrenal cortex carcinoma
certificate
military
mother - in - law
ciliary body spindle cell type a melanoma
father - in - law
latitude
longitude
anaplastic adrenal cortex carcinoma
body surface area formula
mosteller body surface area formula
dubois and dubois body surface area formula
haycock body surface area formula
gehan and george body surface area formula
choroid necrotic melanoma
boyd body surface area formula
linear regression body surface area formula for infants and children
body surface area formula for dogs
body surface area formula for cats
nomogram chart
international network of food data systems
food and agriculture organization of the united nations
childhood b acute lymphoblastic leukemia with t ( 9 ; 22 )  ( q34 .1 ; q11 .2 )  ;  bcr - abl1
favorable hodgkin lymphoma
early favorable hodgkin lymphoma
advanced favorable hodgkin lymphoma
unfavorable hodgkin lymphoma
early unfavorable hodgkin lymphoma
advanced unfavorable hodgkin lymphoma
degree unit of plane angle
myelodysplastic syndrome with isolated del ( 5q )
foot per second squared
inch per second squared
kilometer per hour per second
unit of angular acceleration
degree per second squared
radian per second squared
von willebrand disease
ann arbor stage i marginal zone lymphoma
ann arbor stage ii marginal zone lymphoma
stage iv laryngeal cancer ajcc v6
laser interstitial thermal therapy
high - intensity focused ultrasound ablation
ann arbor stage iii marginal zone lymphoma
ann arbor stage iv marginal zone lymphoma
recurrent marginal zone lymphoma
decimole
ann arbor stage ii aggressive adult non - hodgkin lymphoma
centimole
ann arbor stage ii indolent adult non - hodgkin lymphoma
adult ependymal tumor
adult oligodendroglial tumor
childhood nasal type extranodal nk / t - cell lymphoma
adult pure erythroid leukemia
adult erythroleukemia
adult acute promyelocytic leukemia with t ( 15 ; 17 )  ( q22 ; q12 )  ;  pml / rara
adult acute myeloid leukemia with t ( 9 ; 11 )  ( p21 .3 ; q23 .3 )  ;  mllt3 - mll
adult acute myeloid leukemia with inv ( 16 )  ( p13 .1q22 )  ;  cbfb - myh11
adult acute myeloid leukemia with t ( 16 ; 16 )  ( p13 .1 ; q22 )  ;  cbfb - myh11
adult acute myeloid leukemia with t ( 8 ; 21 )  ;   ( q22 ;  q22 .1 )  ;  runx1 - runx1t1
neurotransmitter
breast solid papillary carcinoma
adult acute myeloid leukemia with recurrent genetic abnormalities
adult gliosarcoma
adult giant cell glioblastoma
adult supratentorial embryonal tumor ,  not otherwise specified
cancer stem cell
hla matching
united states department of agriculture
sinonasal inverted papilloma
tox3 gene
tox3 wt allele
tox high mobility group box family member 3
lsp1 gene
lsp1 wt allele
lymphocyte - specific protein 1
indian health service
assay unit
amer1 gene
amer1 wt allele
xq11 .1
apc membrane recruitment protein 1
ezr gene
ezr wt allele
ezrin
hash value
alox5 gene
alox5 wt allele
6q25 .2 - q26
arachidonate 5 - lipoxygenase
stage iv anal canal cancer ajcc v6 and v7
ikzf1 gene
ikzf1 wt allele
dna - binding protein ikaros
7p13 - p11 .1
h4c9 gene
h4c9 wt allele
il21r gene
il21r wt allele
16p11
interleukin - 21 receptor
mole per kilogram
z - score
colony forming unit
unit of diffusion coefficient
childhood myelodysplastic syndrome
unit of electric current density
unit of electric field strength
her2 / neu positive
her2 / neu negative
large cell neuroendocrine carcinoma
her2 / neu status unknown
smoker
palisading necrosis
genomic biomarker
identified genomic data and samples
coded data and samples
single coded genomic data and samples
double coded genomic data and samples
anonymised genomic data and samples
lung large cell carcinoma with rhabdoid phenotype
anonymous genomic data and samples
oligodendroglial component present
acclimatization
contamination
decontamination
grade iii glandular intraepithelial neoplasia
preoperative chemotherapy
clinical endpoint
surrogate endpoint
inoculation
unit of electric charge density
unit of volumetric electrical charge density
linear amplification technique
pool
pancreatic mixed acinar - neuroendocrine carcinoma
purification
sacrifice
starve
gravitational constant
unit of electric flux density
unit of electrical conductance
radical
unit of electric resistance
unit of electric permittivity
electric permittivity of vacuum
pancreatic mixed ductal - neuroendocrine carcinoma
exenteration
unit of magnetic permeability
unit of magnetic flux
maxwell
unit of magnetic flux density
unit of magnetic field strength
liquid nitrogen
6p21 .33
unit of magnetomotive force
elementary charge
methylation site
gfap gene
gfap wt allele
glial fibrillary acidic protein
character
identity
heavy
peptideprophet
bile duct intraductal papillary neoplasm
casp8*1 allele
cover
cesium cs 137
proteinprophet
nivolumab
correct
search engine
x tandem scoring engine
moxetumomab pasudotox
micropapillary serous carcinoma
chk1 inhibitor pf - 477736
regulation
sodium hyaluronate topical hydrogel
tandem mass spectrometry scoring engine
sequest scoring engine
mascot scoring engine
comet scoring engine
faraday
header
pancreatic mucinous - cystic neoplasm with intermediate grade dysplasia
ampere per meter
efalizumab
pan her / vegfr2 receptor tyrosine kinase inhibitor bms - 690514
cross - correlation
discriminant function analysis
tryptic digestion
synopsis
favorable non - hodgkin lymphoma
unfavorable non - hodgkin lymphoma
xenogeneic tyrosinase dna vaccine
b - ion
y - ion
autologous ad - cd154 - transduced cll b cells
calorie 15 degrees celsius
clindamycin / hydrocortisone lotion
abiraterone acetate
global
calorie 4 degrees celsius
calorie 20 degrees celsius
mean calorie
thymoma type ab
true
false
thermochemical calorie
international steam table calorie
femtomole
attomole
zeptomole
yoctomole
standard cubic meter
standard cubic foot
malignant type ab thymoma
minute unit of plane angle
second unit of plane angle
circle unit of plane angle
gon
square kilometer
hectare
barn
acre usa survey
are
thymoma type b1
circular mil
square inch
square mile
square rod
township
enzyme - linked immunosorbent assay unit
enzyme - linked immunosorbent assay unit per dose
enzyme - linked immunosorbent assay unit per milliliter
log10 enzyme - linked immunosorbent assay unit
log10 enzyme - linked immunosorbent assay unit per dose
thymoma type b2
fluorescent assay infectious dose unit
fluorescent assay infectious dose 50 percent
fluorescent assay infectious dose 50 percent per dose
log10 fluorescent assay infectious dose 50 percent
log10 fluorescent assay infectious dose 50 percent per dose
decimole per liter
centimole per liter
femtomole per liter
attomole per liter
zeptomole per liter
malignant type b2 thymoma
yoctomole per liter
mole per milliliter
millimole per kilogram
mole per gram
mole per milligram
thousand colony forming units
million colony forming units
billion colony forming units
colony forming unit per gram
thousand colony forming units per gram
niacin
meningeal melanocytosis
million colony forming units per gram
billion colony forming units per gram
colony forming unit per milliliter
thousand colony forming units per milliliter
million colony forming units per milliliter
billion colony forming units per milliliter
meter squared per second
biot
ampere per square meter
volt per meter
meningeal melanomatosis
coulomb per cubic meter
coulomb per square meter
farad per meter
henry per meter
gamma
gauss
weber per meter
oersted
gilbert
pragilbert
cellular fibroma
abexinostat
aldoxorubicin
tapentadol hydrochloride
cobimetinib
oral picoplatin
therapeutic hemin
rural - urban continuum code
anti - cea / anti - dtpa - in  ( f6 - 734 )  bispecific antibody
therapeutic estetrol
tyrosine kinase inhibitor xl228
anti - hif - 1alpha lna antisense oligonucleotide ezn - 2968
teglarinad chloride
adenovirus encoding human aquaporin - 1
aerosol refill
aerosol mist dosage form
quizartinib
filanesib
spray refill
malignant solitary fibrous tumor
aerosol spray with pump
non - aerosol spray dosage form
capsule 12 hour sustained release dosage form
capsule 24 hour sustained release dosage form
enteric coated capsule dosage form
sprinkle capsule dosage form
sustained release pellet capsule dosage form
degradable controlled release capsule dosage form
atypical polypoid adenomyoma
bar dosage form
cake dosage form
medicated soap dosage form
liquid soap dosage form
dental cone dosage form
medicated swab dosage form
medicated pad dosage form
medicated film dosage form
therapeutic angiotensin -  ( 1 - 7 )
serine / threonine kinase inhibitor xl418
intravenous solution dosage form
frozen premix intravenous piggyback solution dosage form
intravenous piggyback solution dosage form
cystic partially differentiated kidney nephroblastoma
intraperitoneal solution dosage form
pudding dosage form
gel forming solution dosage form
oral reconstituted suspension dosage form
flake dosage form
powder like non - effervescent granule dosage form
reconstituted oral drop dosage form
reconstituted oral solution dosage form
suspension 12 hour sustained release dosage form
cleanser
medicated adhesive patch dosage form
rectal suppository dosage form
breast adenomyoepithelioma
vaginal suppository dosage form
fluid extract dosage form
oral suspension dosage form
oral suspension final dosage form
oral solution dosage form
drop suspension final dosage form
topical suspension dosage form
ny - eso - 1b peptide vaccine
nickel
epithelioid trophoblastic tumor
sialyl lewis - keyhole limpet hemocyanin conjugate vaccine
concentrated oral dosage form
compressed sugar coated caplet dosage form
tablet 24 hour sustained release dosage form
tablet 12 hour sustained release dosage form
pladienolide derivative e7107
tablet particle crystal dosage form
sustained release buccal tablet dosage form
osmotic laser drilled tablet dosage form
bulk
bandage dosage form
needle
pad dosage form
non - medicated swab dosage form
chondroid chordoma
miscellaneous
controlled release capsule dosage form
controlled release tablet dosage form
controlled release liquid dosage form
suspension for reconstitution dosage form
solution for reconstitution dosage form
tanycytic ependymoma
aerosol solution dosage form
ocular system dosage form
douche solution dosage form
douche powder dosage form
test kit
sustained release parenteral dosage form
injectable lyophilized powder dosage form
ophthalmic liquid dosage form
ophthalmic dosage form
large cell medulloblastoma
otic dosage form
pediatric liquid dosage form
sustained release capsule dosage form
sustained release oral liquid dosage form
rectal cream dosage form
rectal dosage form
rectal ointment dosage form
vaginal dosage form
vaginal tablet dosage form
cerebellar liponeurocytoma
vaginal cream dosage form
vaginal foam dosage form
urethral dosage form
urethral suppository dosage form
vaginal ointment dosage form
contraceptive sponge
dental dosage form
atypical teratoid / rhabdoid tumor
external liquid dosage form
not used
throat spray dosage form
nasal dosage form
granule for reconstitution dosage form
extended release granule dosage form
lollipop dosage form
powder for injection dosage form
metaplastic meningioma
powder for reconstitution dosage form
disintegrating tablet dosage form
deciliter per gram
milliliter per second
room
lithium cation
rindopepimut
anti - hemophilia factor unit
net weight
polymeric camptothecin prodrug xmt - 1001
chordoid meningioma
bcr - abl p210 - b3a2 breakpoint - derived pentapeptide vaccine
unit of specific heat capacity
calorie per gram
assortment
ocular system dosing unit
centiliter
cost
rhabdoid meningioma
unit of dynamic viscosity
unit of kinematic viscosity
centipoise
cassette dosing unit
kilogram per square centimeter
dispenser
decagram
gasoline - equivalent gallon
minim british
nicotine
melanotic psammomatous malignant peripheral nerve sheath tumor
gallon per day
gram per 100 grams
pound per gallon
half gallon
gram per kilogram
half liter
hectoliter
millimeter of water column
half hour
keg
intraneural perineurioma
liter per day
part per thousand
half pint
pint british
dry peck british
dry pint us
quarter kilogram
quart dry us
quart british
soft tissue perineurioma
semester
trimester
ten
two hundred fifty
gum dosing unit
mutually defined
indocyanine green solution
fostamatinib disodium
recombinant nematode anticoagulant protein c2
lymphocyte - rich classic hodgkin lymphoma
cationic liposome - encapsulated paclitaxel
pasireotide
nci criterion
collagen / aloe vera / vitamin e / lidocaine topical hydrogel
apoptosis inducer bzl101
raf kinase inhibitor xl281
iodine i - 123 iodometomidate
adult classic hodgkin lymphoma
hsp90 antagonist kw - 2478
hodgkin's granuloma
d - methionine formulation mrx - 1024
curator
childhood classic hodgkin lymphoma
mek inhibitor azd8330
mitogen - activated protein kinase kinase inhibitor
mast cell stabilizer tf002
femtometer
picometer
microsecond
primary effusion lymphoma
british thermal unit 39 degrees fahrenheit
british thermal unit 59 degrees fahrenheit
british thermal unit 60 degrees fahrenheit
british thermal unit international table
british thermal unit mean
british thermal unit thermochemical
unit of heat flux density
calorie unit
unit of enthalpy
cubic meter per second
anaplastic lymphoma
liter per hour
enobosarm
bishop
chaplain
doctor
mister
miss
mrs
ms
atypical burkitt / burkitt - like lymphoma
professor
rabbi
reverend
carat of gold alloy
unit of volume fraction
microliter per milliliter
number fraction unit
inadequate
hla - a*0201 positive cells present
hla - dpb1*04 positive cells present
subcutaneous panniculitis - like t - cell lymphoma
unit of force
unit of surface tension
vaccine potency
ski gene
dicom terminology
calibration
nanoliter
picoliter
t lymphoblastic lymphoma
cardiac beat accepted
cardiac beat detected
patient physiological condition
cardiac stress test exercise stage
digital image processing equipment
pre - intervention imaging
post - intervention
patient allergic to contrast media
clockface or region
content creation date
nimodipine
hand - schuller - christian disease
content start time
horizontal pixel spacing
image laterality
image view
patient orientation column
patient orientation row
selected region description
study start date
study start time
langerhans cell sarcoma
vertical pixel spacing
breast background echotexture
homogeneous fat echotexture
homogeneous fibroglandular echotexture
heterogeneous echotexture
parallel lesion
reason for procedure
age started
pregnancy status
series instance uid
border definition
texture descriptor
positioner primary angle
positioner secondary angle
border shape
image series
diffusion anisotropy
velocity encoded mri
rotational acquisition
acute bilineal leukemia
accumulated x - ray dose data
last calibration date
mean tube current
x - ray exposure time
patient table relationship
distance source to detector
table height position
table horizontal rotation angle
acute myeloid leukemia with variant mll translocations
x - ray filter material
x - ray filter thickness minimum
focal spot size
x - ray filter thickness maximum
acquired image
person observer
observer organization
person observer role in organization
person observer role in procedure
device observer uid
anal margin squamous cell carcinoma
device observer name
device observer manufacturer
device observer model name
device observer serial number
device location during observation
subject unique identifier
subject name
subject id
subject birth date
stromal sarcoma
subject age
performed procedure step sop instance uid
performed procedure step sop class uid
start procedure action item
end procedure action item
image acquired
number of frames
image type
acquisition duration
lossy compressed image
mathematical derivation
patient alert
drug started identifier
drug finished identifier
drug administered identifier
contrast agent started identifier
contrast agent finished identifier
contrast agent administered identifier
volume administered
undiluted dose administered
rate of administration
duration of administration
beat number
r - r interval
calibration factor
estimated potential vessel value
velocity encoding minimum value
velocity encoding maximum value
malignant ovarian thecoma
radiopharmaceutical volume administered
radionuclide total dose
radionuclide syringe counts
radionuclide residual syringe counts
contrast agent name
pre - medication
acquisition protocol
asian ginseng
static
nimustine
mixed neoplasm
epicondyle
r programming language
octave programming language
rejected
histone h4i
glycome
cease
sclerosis
standardized uptake value
is_related_to_endogenous_product
obsolete regimen_has_accepted_use_for_disease
cervical spine
lumbar spine
thoracic spine
sphygmomanometer
auscultatory blood pressure monitor
oscillometric blood pressure monitor
solitary plasmacytoma
stethescope
middle ear polyp
gangliocytoma
spinal cord meningioma
deep "aggressive" angiomyxoma
sweat gland carcinoma
breast ductal carcinoma in situ and invasive lobular carcinoma
nitracrine
breast fibrocystic change ,  proliferative type
def_curator
hla - a1 positive cells present
hla - a2 positive cells present
hla - a3 positive cells present
hla - a24 positive cells present
unit of specific radioactivity
lansky performance status 50
lansky performance status 60
lansky performance status 70
lansky performance status 80
lansky performance status 90
lansky performance status 100
feed
unit of specific volume
unit of luminous flux
breast fibrocystic change ,  non - proliferative type
unit of illuminance
unit of power
radioactivity concentration unit
unit of radiation equivalent dose
medical drop
drop british
film processor device
inch unit of length
inch british
cardiac fibroma
postoperative spindle cell nodule
postoperative spindle cell nodule of the bladder
nitric oxide
benign kidney hemangiopericytoma
nonanaplastic kidney wilms tumor
anaplastic kidney wilms tumor
adult brain stem astrocytoma
retinal neuroblastoma
childhood cerebral embryonal tumor with multilayered rosettes ,  c19mc - altered
astrocytic tumor
anaplastic oligoastrocytoma
nitriles
oligodendroglial tumor
neuroblastic tumor
neuroblastoma of the adrenal gland and sympathetic nervous system
pineal parenchymal cell neoplasm
pineocytoma
pineal parenchymal tumor of intermediate differentiation
supratentorial embryonal tumor ,  not otherwise specified
plexiform schwannoma
nitrogen mustard compound
melanotic schwannoma
meningothelial cell neoplasm
mesenchymal non - meningothelial tumor of the central nervous system
intracranial liposarcoma
neoplasm of uncertain histogenesis
papillary renal cell carcinoma
breast papillomatosis
squamous cell carcinoma of the penis ,  usual type
nitrosamine
basaloid squamous cell carcinoma of the penis
warty carcinoma of the penis
verrucous carcinoma of the penis
papillary carcinoma of the penis
sarcomatoid carcinoma of the penis
invasive hydatidiform mole
breast ductal carcinoma with squamous metaplasia
nitrosourea compound
central nervous system embryonal neoplasm
simple endometrial hyperplasia with atypia
simple endometrial hyperplasia without atypia
complex endometrial hyperplasia without atypia
oculomotor nerve neoplasm
malignant oculomotor nerve neoplasm
uterine corpus adenomyosis
central nervous system hibernoma
central nervous system leiomyoma
central nervous system leiomyosarcoma
nogalamycin
central nervous system rhabdomyoma
central nervous system chondroma
central nervous system extraskeletal osteosarcoma
osteochondroma of the central nervous system
central nervous system hemangioma
central nervous system kaposi sarcoma
central nervous system hemangioblastoma
intracranial myeloid sarcoma
central nervous system germinoma
masoprocol
central nervous system embryonal carcinoma
central nervous system yolk sac tumor
central nervous system choriocarcinoma
central nervous system mature teratoma
central nervous system immature teratoma
central nervous system teratoma with malignant transformation
central nervous system mixed germ cell tumor
granular cell tumor of the sellar region
nerve sheath myxoma
trilateral retinoblastoma
norethindrone acetate
central nervous system inflammatory myofibroblastic tumor
gastric inflammatory myofibroblastic tumor
refractory plasma cell myeloma
recurrent plasma cell myeloma
barrett adenocarcinoma
norgestrel
esophageal basaloid carcinoma
gastric hyperplastic polyp
gastric juvenile polyp
gastric cronkhite canada polyposis
gastric tubular adenoma
gastric tubulovillous adenoma
gastric villous adenoma
nortriptyline hydrochloride
colon tubular adenoma
colon ganglioneuroma
serositis
ambiguity
zero
kindergarten completion
preschool completion
home school completion
erg
kilowatt hour
watt hour
watt per square meter
joule per kilogram
unit of thermal conductivity
watt per meter - kelvin
unit of energy density
joule per cubic meter
unit of molar energy
joule per mole
unit of entropy
joule per kelvin
unit of molar entropy
joule per mole - kelvin
unit of specific entropy
joule per kilogram - kelvin
kilogram per second
gram per gram
unit of mole fraction
mole per mole
cubic meter per cubic meter
percent of morphologically normal cells
urinary system paraganglioma
percent of positive cells
percent of lymphocytes
percent of eosinophils
terahertz
revolution per minute
functioning pituitary gland neoplasm
dyne
kilogram - force
gram - force
pound - force
newton per meter
unit of infective dose
unit of embryo infective dose
log10 50 percent embryo infective dose
supratentorial meningioma
log10 50 percent embryo infective dose per dose
unit of cell culture infective dose
log10 50 percent cell culture infective dose
log10 50 percent cell culture infective dose per dose
unit of tissue culture infective dose
log10 50 percent tissue culture infective dose
log10 50 percent tissue culture infective dose per dose
adult astrocytic tumor
microinternational unit
kilointernational unit
international unit per gram
anti - coagulation factor unit
anti - thrombin unit
anti - coagulation factor xa unit
anti - xa activity international unit
anti - xa activity international unit per milliliter
antigen unit
novobiocin
antigen unit per milliliter
d antigen unit
d antigen unit per milliliter
allergy unit
allergy unit per milliliter
bioequivalent allergy unit
tuberculin unit per milliliter
millikatal
nanokatal
picokatal
nanokatal per liter
kilobecquerel
megabecquerel
gigabecquerel
decicurie
centicurie
picocurie
femtocurie
attocurie
zeptocurie
myofibroma
yoctocurie
becquerel per kilogram
becquerel per gram
becquerel per microgram
becquerel per milligram
gigabecquerel per gram
gigabecquerel per microgram
gigabecquerel per milligram
curie per gram
curie per kilogram
cavernous hemangioma of the face
curie per microgram
curie per milligram
50 percent embryo infective dose
50 percent embryo infective dose per dose
50 percent cell culture infective dose
50 percent cell culture infective dose per dose
50 percent tissue culture infective dose
50 percent tissue culture infective dose per dose
lansky performance status 0
lansky performance status 10
childhood lymphocyte - rich classic hodgkin lymphoma
lansky performance status 20
lansky performance status 30
lansky performance status 40
never
antinuclear antibody
acquired pure red cell aplasia
microscopic polyarteritis
precursor lymphoid neoplasm
breast self - examination
clinical breast examination
bachelor's degree completion
master's degree completion
academic doctorate degree completion
professional doctorate degree completion
mature b - cell non - hodgkin lymphoma
phospholipid
microkatal
unit of catalytic activity fraction
unit of catalytic activity content
part per billion
part per trillion
unit of absorbed radiation dose rate
dietary phosphatidylinositol
beam
disease ,  disorder or finding
millicurie per kilogram
microcurie per kilogram
gray per second
rem
unit of exposure to ionizing radiation
roentgen
coulomb per kilogram
milliequivalent per microliter
melanocytic neoplasm
milliequivalent per gram
milliequivalent per microgram
mitf gene
mitf wt allele
microphthalmia - associated transcription factor
hydrated sodium calcium aluminosilicate
recurrent adult diffuse small cleaved cell lymphoma
abundance
mesenchymal cell neoplasm
subtraction
gel warping algorithm
well
fluorine f 18 fluoroethylcholine
edit
ceftobiprole medocaril
broad - spectrum human papillomavirus vaccine v505
negative selection
nucleic acids
tumor purging
cellular therapy
ph -  / bcr +
continued complete response
primary refractory
multiple myeloma - light chain only
multiple myeloma - iga
multiple myeloma - igd
multiple myeloma - ige
multiple myeloma - igg
retinal cell neoplasm
multiple myeloma - igm  ( not waldenstrom macroglobulinemia )
complement hemolytic activity assay
tolerance induction pre - solid organ transplant
drug / toxin - induced aplastic anemia
hla - dqb1 gene
hla - dqb1 wt allele
hla class ii histocompatibility antigen ,  dq beta 1 chain
total complement assay
complement component - 4
anticardiolipin igm antibody
neoplasm by special category
lupus anticoagulant antibody
cd34 selection
primary induction failure
ph unknown / bcr +
ph +  / bcr unknown
erastin analogue prlx 93936
transdermal patch dosing unit
ph unknown / bcr -
ph unknown / bcr unknown
ph  -  / bcr - abl -
notochordal tumor
ph -  / bcr unknown
tiff
alternative hematopoietic cell transplantation
nodular partial remission
destructive arthritis
necrotizing vasculitis
extra - articular
stringent complete response  ( scr )  of multiple myeloma or plasma cell leukemia
very good partial response of multiple myeloma or plasma cell leukemia
complete response of multiple myeloma or plasma cell leukemia
erythroid neoplasm
plant - derived hematopoiesis enhancer pg2
partial response of multiple myeloma or plasma cell leukemia
stable multiple myeloma or plasma cell leukemia
progression of multiple myeloma or plasma cell leukemia
carcinoembryonic antigen peptide 1 - 6d virus - like replicon particles vaccine
relapse from complete response of multiple myeloma or plasma cell leukemia
crest syndrome
sicca syndrome
lab lupus inhibitor test
t - cell chronic lymphocytic leukemia
lymphocytic neoplasm
tosedostat
firtecan pegol
manager
inversion
differential in - gel electrophoresis
aurora kinase inhibitor sns - 314
international staging system for myeloma
iss stage i plasma cell myeloma
iss stage ii plasma cell myeloma
megakaryocytic neoplasm
iss stage iii plasma cell myeloma
microplate reader
excitation
unique identifier
relevance
human study subject
mild
severe
clinical study subject
automatic
always
bead
pore
stationary phase
recombinant human egf - rp64k / montanide isa 51 vaccine
gadobutrol
ex vivo
micronutrient - fortified probiotic yogurt
potential study subject
authorization for release of confidential health information
neoplastic polyp
healthcare payment method
per diem payment method
episode of care payment method
condition - specific capitation payment method
capitation payment method
hla - a31 positive cells present
healthcare payer
waiver of authorization for release of confidential health information
primary healthcare payer
quadrupole
giant cell neoplasm
secondary healthcare payer
third party healthcare payer
workers compensation plan
gradient
managed healthcare plan
social managed healthcare plan
private health insurance
reflectron
time - of - flight
biospecimen
nucleoside
biospecimen collection method
fasting specimen
non - fasting specimen
clinical study status
planned clinical study
component of study protocol
clinical study targeted accrual
planned duration of study subject participation
planned intervention duration for study subject
submission unit
sequence number
activity status
scheduled study activity for study subject
biospecimen type
biospecimen condition
lipemic specimen
leaking specimen
frozen specimen
refrigerated specimen
specimen at room temperature
oncocytic neoplasm
hemolysis in specimen
reviewable unit
investigator by role in study
investigator status
investigator registration status
investigator status in study
planned clinical study activity
assessment of observation result
information status
targeted anatomic site
paget disease
clinical study population subgroup
clinical trial subject unique identifier
study subject participation status
subject screened for study
subject lost to follow up
obinutuzumab
treat
milestone
slope
approved protocol
active study
protocol disapproved
contour
fibroblastic neoplasm
protocol deferred
study closed to accrual
study closed to accrual and treatment
brightness
contrast
study on hold
study completed
study terminated
study withdrawn
performed clinical study
hemangiopericytic neoplasm
clinical study actual accrual number
digital tomosynthesis mammography
clinical study activity relationship
priority number
free text format
clinical study document relationship
quantitative concept
system of measurement
laboratory test result status
original unit or value of reported test result
standard unit or value of test result
knowledge field
field
unit conversion factor
brownian dynamics
observation outcome relationship
clinical study site
protocol administratively withdrawn
laboratory - generated
study site role
study site status
clinical study site accrual status
targeted accrual at clinical study site
prostate cancer by whitmore - jewett stage
clinical study lead organization
participating clinical study organization
ramucirumab
clinical study sponsor
primary clinical study sponsor
secondary clinical study sponsor
eluent
cd20 - targeted polypeptide tru - 015
anti - cd45 monoclonal antibody
approval document
nucleic acids ,  nucleosides ,  and nucleotides
metastatic malignant neoplasm in the prostate gland
institutional review board approval
institutional review board approval date
letter
telecommunication address
telecommunication address usage type
date of death
household income
voltage
regulated industry
buffer
regulated industry unique identifier
study protocol
concept unique identifier
american society of anesthesiologists
fit
curve
protocol information office
solution
amplitude
radio frequency
study population
study population description
study subject type
autologous lmp1 -  / lmp2 -  specific cytotoxic t - lymphocytes
sample study population
image feature
ion trap
blinded clinical study
hexapole
net
chromint software
lead study agent
protein digestion
grid
streak
lot number
cone
small intestinal leiomyosarcoma
hla - a3 / a11 positive cells present
medical product stability
medical product expiration date
medical product shelf life
observation result
date of report
observation result uncertainty
regulatory submission unit type
original regulatory submission
supplemental regulatory submission
regulatory submission date
regulatory submission receipt date and time
document status
submission unit status
regulatory application
regulatory submission unique identifier
recurrent melanoma
regulatory application unique identifier
regulatory application type
product development protocol
drug master file
recurrent non - cutaneous melanoma
pre - market approval application
regulatory submission
regulatory submission type
regulatory assessment
daily dose
regressing cutaneous melanoma
agent dose change type
code system
display name
code qualifier
code translation
nucleotide
regressing non - cutaneous melanoma
performed clinical study activity
study activity cause or rational
concomitant agent
root identifier
identifier extension
myringotomy
myringotomy with ear tube placement
central institutional review board
esophageal dilation
mechanical ventilation
mucosal melanoma of the digestive system
nasogastric decompression
cardioversion
positive air pressure device
bioavailability
biological clearance rate
elimination half life
half life
distribution volume
cmax
tmax
metastatic non - cutaneous melanoma
toxicology finding
adme finding
clinical chemistry finding
diagnostic efficacy
therapeutic efficacy
fasting status at specimen collection
clinical study activity relationship comment
hepatoblastoma with pure fetal epithelial differentiation
test result reference range comment
observation result relationship comment
laboratory - generated comment
high test reference range
low test reference range
test reference text list
study activity comment
cause or rationale for missed study activity
mononeuritis multiplex
randomization indicator
hepatoblastoma with combined fetal and embryonal epithelial differentiation
cotinine
decode map
marshfield linkage map
slm1 linkage map
biospecimen collection
postal address
investigator signature
polo - like kinase 1 inhibitor gsk461364
investigator official credentials
macrotrabecular hepatoblastoma
test result report
description of test result
numeric test result
hif - 1alpha inhibitor px - 478
laboratory procedure comment
telecommunication address type
observation result comment
study administrative activity variance reason
subject's signature on informed consent form
submission unit relationship
small cell undifferentiated hepatoblastoma
clinical study activity description
dose description
agent administration
drug vehicle volume
code system version
study author
authorization for release of confidential health information indicator
original unit or value of reported test result indicator
renal cell carcinoma peptides vaccine ima901
mycobacterium w
mixed epithelial and mesenchymal hepatoblastoma
clinical study activity relationship type
vector - peptide conjugated paclitaxel
study sponsor type
displayable identifier indicator
document subtype
drug vehicle unit of volume
scheduled study activity cause or rational
phastcon
international hapmap project
mixed hepatoblastoma with teratoid features
dornase alfa inhalation solution
tyrosine kinase inhibitor osi - 930
linsitinib
aurora kinase / vegfr2 inhibitor cyc116
apoptosis inducer gcs - 100
allogeneic b7 .1 / hla - a1 transfected tumor cell vaccine
bound
fagerstrom test for nicotine dependence
stage d prostate cancer
anticardiolipin igg antibody
aspscr1 gene
aspscr1 wt allele
tether containing ubx domain for glut4
prcc gene
prcc wt allele
proline - rich protein prcc
hnf1b gene
hnf1b wt allele
hepatocyte nuclear factor 1 - beta
colon undifferentiated carcinoma
ston1 gene
ston1 wt allele
stonin - 1
eml4 gene
eml4 wt allele
echinoderm microtubule - associated protein - like 4
nedd9 gene
nedd9 wt allele
enhancer of filamentation 1
coltuximab ravtansine
carlumab
nadofaragene firadenovec
pidilizumab
conatumumab
adult pilocytic astrocytoma
adult subependymal giant cell astrocytoma
muc16 gene
muc16 wt allele
mucin - 16
golm1 gene
golm1 wt allele
golgi membrane protein 1
tamibarotene
st segment abnormality by ecg finding
st elevation pericarditis by ecg finding
liver and intrahepatic bile duct neoplasm
j point elevation
non - specific st - t changes by ecg finding
t wave notched by ecg finding
poor r wave progression by ecg finding
prolonged qt interval by ecg finding
electrical alternans by ecg finding
autologous follicular lymphoma - derived idiotype vaccine
nabiximols
sinoatrial node exit block
atrial enlargement by ecg finding
mature mediastinal teratoma
p - mitrale by ecg finding
p - pulmonale by ecg finding
ectopic ventricular rhythm by ecg finding
ectopic supraventricular rhythm by ecg finding
2:1 atrioventricular block by ecg finding
atrioventricular dissociation by ecg finding
bifascicular block by ecg finding
incomplete left bundle branch block by ecg finding
incomplete right bundle branch block by ecg finding
incomplete bundle branch block by ecg finding
exaggerated placental site
multifocal atrial tachycardia by ecg finding
junctional rhythm by ecg finding
sustained ventricular tachycardia by ecg finding
non - sustained ventricular tachycardia by ecg finding
ventricular bigeminy by ecg finding
ventricular trigeminy by ecg finding
ventricular tachycardia storm by ecg finding
adenosine - sensitive ventricular tachycardia by ecg finding
verapamil - sensitive ventricular tachycardia by ecg finding
brugada syndrome ventricular arrhythmia by ecg finding
liver and intrahepatic bile duct epithelial neoplasm
short qt syndrome
fascicular tachycardia by ecg finding
bundle branch re - entrant ventricular tachycardia by ecg finding
idiopathic right bundle branch block by ecg finding
right ventricular outflow tract tachycardia by ecg finding
acute anterior myocardial infarction by ecg finding
acute inferior myocardial infarction by ecg finding
acute lateral myocardial infarction by ecg finding
acute posterior myocardial infarction by ecg finding
anterior myocardial infarction by ecg finding
liver and intrahepatic bile duct non - epithelial neoplasm
inferior wall myocardial infarction
 [ 18f ]  - labeled substance p antagonist receptor quantifier
intra - atrial conduction delay by ecg finding
junctional bradycardia by ecg finding
left ventricular hypertrophy by ecg finding
right ventricular hypertrophy by ecg finding
low qrs voltage by ecg finding
herpes zoster
non q wave myocardial infarction by ecg finding
t wave abnormality by ecg finding
ventricular hypertrophy by ecg finding
t wave inversion by ecg finding
t wave peaked by ecg finding
t waves biphasic by ecg finding
t waves flat by ecg finding
u waves by ecg finding
distal bile duct carcinoma
wide qrs tachycardia by ecg finding
varicella zoster virus
vectorcardiograph corrected
vectorcardiograph uncorrected
q axis left axis deviation
q axis right axis deviation
qtcb prolongation greater than 500 msec
qtcf prolongation greater than 500 msec
qtci  -  individually corrected
study investigator role
octreotide
recurrent liver carcinoma
lead placement
12 lead placement unspecified
12 lead placement standard
12 lead placement mason likar
clinical trial
end date of clinical study site participation in study
lead protocol agent indicator
clinical study document relationship type
observation result relationship type
study protocol confidentiality status
benign ameloblastoma
12 lead placement mason likar modified
12 lead placement chest
cdisc sdtm frequency terminology
12 lead placement non - standard
lead placement bicycle
12 lead placement cabrera
lead placement standard intercostal space higher
lead placement frank
lead placement mcfee - parungao
squamous odontogenic tumor
lead placement cube
lead placement bipolar uncorrected xyz
lead placement pseudo orthogonal xyz
lead placement easi dower transformation
every five days
12 lead placement 1 lead missing
12 lead placement standard and cc5 - cm5 - ch5
every two weeks
12 lead placement standard and cc5 - cm5 - ml
twice per month
endometrioid tumor
12 lead placement standard extended right
12 lead placement standard extended left
oral microencapsulated diindolylmethane
regulatory application sponsor
dose regimen
original text
thymoma type b
document detailed description
document summary description
document summary description synopsis
regulatory application document subtype
investigational new drug indicator
myeloperoxidase
salirasib
pva microporous hydrospheres
cdisc sdtm body position terminology
pva microporous hydrospheres / doxorubicin hydrochloride
liver and intrahepatic bile duct malignant non - epithelial neoplasm
cdisc sdtm ecg finding terminology
cdisc sdtm ecg test method terminology
cdisc sdtm ecg test name terminology
cdisc sdtm ecg test code terminology
high - selenium brassica juncea
established
magnesium valproate
anti - psca monoclonal antibody ags - 1c4d4
scheduled study activity date and time
natural ifn - alpha opc - 18
stage i liver cancer
instance unique identifier
formoterol fumarate / roxithromycin
hla - matched donor mononuclear cell - enriched leukocytes apocell
animal model
becquerel per liter
becquerel per microliter
becquerel per milliliter
kilobecquerel per microliter
megabecquerel per microliter
stage ii liver cancer
curie per liter
curie per microliter
curie per milliliter
microcurie per liter
millicurie per liter
microvolt
cycle per minute
kilometer
foot unit of length
survey foot
stage iii liver cancer
foot british
mile unit of distance
mile british
mile
survey mile
100 international units per milliliter
thousand organisms
million organisms
billion organisms
thousand organisms per gram
million organisms per gram
billion organisms per gram
million organisms per milligram
billion organisms per milligram
thousand organisms per milliliter
million organisms per milliliter
billion organisms per milliliter
plaque forming unit per dose
plaque forming unit per milliliter
ofloxacin
bel
gram per square centimeter
kilo united states pharmacopeia unit
kilometer per hour
nebule dosing unit
microgram per day
milligram per kilogram per minute
international unit per kilogram per hour
stage iv liver cancer
microgram per kilogram per minute
microgram per minute
attometer
zeptometer
yoctometer
angstrom
hand unit of length
pied
ligne
stage iva liver cancer
link for gunter's chain usa
line unit of length
mesh
mil
survey mil
light - year
stage ivb liver cancer
gunter's chain usa
printers point
post script point
ramsden's chain
extrahepatic bile duct intraductal papillary neoplasm
rod us
link for ramsden's chain
intrahepatic bile duct intraductal papillary neoplasm
partial pressure of oxygen measurement
arterial blood gas measurement
international foot
pace unit of measure
positive selection
lean body mass
hla - drb3 gene
intrahepatic bile duct adenoma
hla - drb3 wt allele
hla - drb4 gene
hla - drb4 wt allele
hla - drb5 gene
hla - drb5 wt allele
hla - dqa1 gene
hla - dqa1 wt allele
hla - dpa1 gene
hla - dpa1 wt allele
hla - bw4 antigen
intrahepatic bile duct microcystic adenoma
hla - bw6 antigen
hla - dr51 antigen
hla - dr52 antigen
hla - dr53 antigen
hla - dp antigen
family practice nurse practitioner
licensed clinical social worker
registered dietitian
registered medical assistant
registered nurse practitioner
benign extrahepatic bile duct non - epithelial neoplasm
registered pharmacist
acute care nurse practitioner
adult nurse practitioner
advanced oncology certified nurse practitioner
advanced practice nurse practitioner
certified adult nurse practitioner
certified family nurse practitioner
certified nurse practitioner
certified pediatric nurse practitioner
gallbladder benign non - epithelial neoplasm
family nurse practitioner
gerontological nurse practitioner
transmission
advanced oncology certified nurse
advanced oncology certified nurse specialist
certified clinical nurse specialist
certified clinical research associate
certified clinical research coordinator
certification in critical care nursing
adult grade i meningioma
oligonucleotide
gallbladder intracholecystic papillary neoplasm
childhood grade i meningioma
childhood grade ii meningioma
certified clinical research professional
childhood grade iii meningioma
adult grade ii meningioma
adult grade iii meningioma
certified emergency nurse
certified flight registered nurse
certified midwife
certified medical assistant
gallbladder benign granular cell tumor
certified nurse assistant
certified nurse specialist
certified pediatric nurse
pre - procedure preparation
stenting
glandular cell neoplasm
fingertip dosing unit
discussion
sachet dosing unit
intermittent
fertility preservation
federal information processing standards
hla typing
ovarian sertoli cell tumor
unit of sound intensity
certified pediatric oncology nurse
certified registered nurse
certified vascular nurse
certified transport registered nurse
diploma
oncology certified nurse
certified physician assistant
progressive care certified nurse
secretarial certificate
bone surface  ( peripheral )  osteosarcoma
associate degree
associate of applied science
associate of business administration
associate of engineering
associate of science
bachelor of arts
bachelor of business administration
bachelor of engineering
bachelor of education
bachelor of fine arts
extraskeletal ewing sarcoma
bachelor of science in nursing
bachelor of science
bachelor of science in law
bachelor of social work
bachelor of theology
rigosertib sodium
doctor of divinity
doctor of education
extracutaneous mastocytoma
doctor of social work
doctor of law
milligram per kilogram per hour
master of law
master of arts
medical product stability date
master of civil engineering
master of divinity
master of engineering
master of education
cutaneous mastocytosis
master of electrical engineering
master of fine arts
master of mechanical engineering
master of public administration
master of science in nursing
transabdominal ultrasound
master of social work
master of theology
doctor of engineering
doctor of science
doctor of theology
master of science in law
paternal relative
maternal relative
biological relative
grandparent
grandmother
grandfather
grand relative
great relative
pretext stage 1 hepatoblastoma
full sibling
half sibling
legal relative
foster relative
adoptive relative
step relative
in - law
grandchild
grandson
granddaughter
pretext stage 2 hepatoblastoma
son - in - law
daughter - in - law
half brother
half sister
uncle
aunt
brother - in - law
sister - in - law
niece
nephew
pretext stage 3 hepatoblastoma
cousin
first cousin
first cousin once removed
ward
chembank
steering committee
sfpq gene
sfpq wt allele
nono gene
pretext stage 4 hepatoblastoma
nono wt allele
hsf1 gene
hsf1 wt allele
plag1 gene
plag1 wt allele
xbp1 gene
xbp1 wt allele
autophagy
triple - negative breast cancer finding
kat6a gene
postsurgical stage iv hepatoblastoma
kat6a wt allele
kat6b gene
kat6b wt allele
col4a5 gene
col4a5 wt allele
lcn2 gene
lcn2 wt allele
intolerance
ednra gene
ednra wt allele
postsurgical stage iii hepatoblastoma
cdk5rap3 gene
cdk5rap3 wt allele
prnp gene
prnp wt allele
splicing factor proline - and glutamine - rich
non - pou domain - containing octamer - binding protein
heat shock factor protein 1
zinc finger protein plag1
x - box binding protein 1
histone acetyltransferase kat6a
postsurgical stage ii hepatoblastoma
histone acetyltransferase kat6b
collagen alpha - 5 ( iv )  chain
neutrophil gelatinase - associated lipocalin
endothelin - 1 receptor
cdk5 regulatory subunit - associated protein 3
major prion protein
extramembrane domain
suspected
caarray
postsurgical stage i hepatoblastoma
method
targeted accrual
digital object identifier
conservation
participation duration
intervention duration
subject - related study activity
luminespib
study population subgroup
child - pugh classification
benign fibroblastic neoplasm
participation status
actual accrual
study activity
reference range
study site accrual status
approval date
usage
uncertainty
variance reason
soft tissue tumor of uncertain differentiation
taper
epidemiologic study
early detection study
screening study
supportive care study
chemosensitivity
object identifier
smoldering plasma cell myeloma
case sensitive
deprecated
olivomycin
nonrandom sampling
monoclonal immunoglobulin deposition disease
equal probability sampling method
salvia officinalis extract
erythroleukemia
human papillomavirus vaccine v503
sn - 38 - loaded polymeric micelles nk012
tanezumab
anti - cd33 monoclonal antibody - dm4 conjugate ave9633
folate receptor targeted epothilone bms753493
tubulin - binding agent ssr97225
human papilloma virus l1 virus - like particle v504 vaccine
robatumumab
bromovinyl - deoxyuridine
serine / threonine kinase inhibitor cbp501
differentiated thyroid gland carcinoma
anti - igf - 1r recombinant monoclonal antibody biib022
ganitumab
lonaprisan
pexastimogene devacirepvec
budesonide / formoterol fumarate dihydrate inhalation aerosol
indoximod
egfrbi - armed autologous t cells
acadesine
ofranergene obadenovec
bone leiomyosarcoma
allogeneic cd4 +  memory th1 - like t cells / microparticle - bound anti - cd3 / anti - cd28
fermented soybean protein beverage
inotuzumab ozogamicin
general population cohort
historical cohort
occupational group
primary central chondrosarcoma
age cohort
exposed population
unexposed population
standard population
standard million population
world standard population
sample statistic
population parameter
posterior pituitary gland neoplasm
essential
debug
benign dermal neoplasm
fatal
uniform resource name
lexbig
pyrogen
load
java programming language
export
wife
husband
infrared radiation therapy
selective internal radiation therapy
font
justification
opacity
cd52 - positive neoplastic cells present
style
omeprazole
effect ,  appearance
cytarabine hydrochloride
line
citrate phosphate dextrose
immunomagnetic column
enhance
abacavir succinate
mathematical markup language
skin melanocytic neoplasm
quotient
permeability
perimeter
circumscribe
histogram
cd7 - positive neoplastic cells present
cd57 - positive neoplastic cells present
cdisc sdtm unit of measure terminology
biricodar
sunitinib
mus musculus castaneus
mus spretus
grant proposal
acodazole hydrochloride
amonafide
fludrocortisone
foscarnet
leucovorin
meperidine
pioglitazone
eltrombopag
casopitant
classic hodgkin lymphoma
grade 1 nodular sclerosis classic hodgkin lymphoma
grade 2 nodular sclerosis classic hodgkin lymphoma
myelodysplastic syndrome with excess blasts - 1
myelodysplastic syndrome with excess blasts - 2
antibody titer
central pathology review
better
worse
about the same
uptake
htlv - 1 antibody
pgla / peg copolymer - based paclitaxel
apomab
citatuzumab bogatox
cone - beam computed tomography
nanoparticle albumin - bound docetaxel
recurrent brain neoplasm
recurrent spinal cord neoplasm
oncolytic virus
recurrent primary central nervous system neoplasm
refractory primary central nervous system neoplasm
refractory brain neoplasm
refractory spinal cord neoplasm
voxtalisib
pilaralisib
pracinostat
intranasal ketamine
acute monoblastic leukemia
receptor tyrosine kinase inhibitor r1530
pan - akt kinase inhibitor gsk690693
recurrent childhood spinal cord neoplasm
recurrent adult spinal cord neoplasm
refractory childhood spinal cord neoplasm
refractory adult spinal cord neoplasm
givinostat
alisertib
pegylated granulocyte colony stimulating factor maxy - g34
histiocytic necrotizing lymphadenitis
primary diffuse large b - cell lymphoma of the central nervous system
olaparib
evofosfamide
prostate cancer vaccine ony - p1
compassionate treatment
indium in 111 pentetate
quarfloxin
diffuse astrocytoma
dismiss
material absorption
triple - negative breast carcinoma
biological absorption
nifurtimox
fda approval
clinical trial period
clinical trial epoch
blackout
adult diffuse astrocytoma
apatorsen
survivin sur1m2 peptide vaccine
nucleotide analogue gs 9219
il - 2 recombinant fusion protein alt - 801
enzalutamide
s - adenosyl - l - methionine disulfate p - toluene - sulfonate
vascular access device complications
cytomegalovirus pp65 - specific cytotoxic t lymphocytes
autologous anti - gp100:154 - 162 t - cell receptor gene - engineered peripheral blood lymphocytes
anti - denatured collagen monoclonal antibody trc093
acute myeloid leukemia with recurrent genetic abnormalities
amuvatinib
trust
anonymous
fatal  ( computer sense )
valid
cytokine - induced killer cells
modified vaccinia ankara  ( bavarian nordic )  - her2 vaccine
linifanib
dendritic cell - idiotype - keyhole limpet hemocyanin vaccine
htert i540 / r572y / d988y multipeptide vaccine
bioequivalence
hyssop oil
biologics license application
smoldering adult t - cell leukemia / lymphoma
chronic adult t - cell leukemia / lymphoma
organic chemical
spindle cell / pleomorphic lipoma
myrrh oil
b - cell proliferation of uncertain malignant potential
juniper tar
pulsatilla extract
polymorphic post - transplant lymphoproliferative disorder
dioscorea villosa tuber
agathosma betulina leaf oil
methotrexate - associated lymphoproliferative disorder
sheanut oil
citronella oil
ruta graveolens flowering top oil
hypericum oil
substance distribution
west nile virus
classical burkitt lymphoma
meddra high level term
who adverse reaction terminology
phosphatidylcholine - bound silybin
hoechst adverse reaction terminology system
japanese adverse reaction terminology
meddra low level term
preferred term
meddra system organ class
meddra high level group term
burkitt lymphoma with plasmacytoid differentiation
international classification of diseases ,  ninth revision
international classification of diseases ,  ninth revision ,  clinical modification
international classification of diseases ,  tenth revision
document body
emission
sender
motesanib
flowchart
proprietary name
catalog
organometallic compound
malignant hypopharyngeal neoplasm
return
syngeneic
quarantine
tertiary
retropubic
mesorectum
grade 3a follicular lymphoma
shellfish
grade 3b follicular lymphoma
crustacean
beef
sugar
grade 2 diffuse follicular lymphoma
garden snail
primary cutaneous cd30 - positive t - cell lymphoproliferative disorder
fruit juice
pork
positive contrast agent
negative contrast agent
type a lymphomatoid papulosis
grapefruit
type b lymphomatoid papulosis
type c lymphomatoid papulosis
bean
brussels sprout
oxacillin sodium
anaplastic large cell lymphoma ,  lymphomatoid papulosis - like histology
administrator  ( computer )
malignant histiocytosis
supervisor  ( computer )
blastic plasmacytoid dendritic cell neoplasm
t - zone variant peripheral t - cell lymphoma
lymphoepithelioid variant peripheral t - cell lymphoma
common variant anaplastic large cell lymphoma
date fruit
tree nut
localized scleroderma
lymphohistiocytic variant anaplastic large cell lymphoma
systemic scleroderma
computer hard disk
computer disk
atypical carcinoid tumor
sweep
flux
losoxantrone hydrochloride
small cell variant anaplastic large cell lymphoma
bromebric acid
childhood b lymphoblastic lymphoma
bensuldazic acid
salcaprozic acid
oxycontin
childhood t lymphoblastic lymphoma
childhood primary cutaneous anaplastic large cell lymphoma
aids - related diffuse large b - cell lymphoma
aids - related diffuse large cell lymphoma
tapentadol
lornoxicam
official
non - hodgkin lymphoma with variable clinical course
alfaxalone
primary cutaneous follicle center lymphoma
cutaneous follicular lymphoma
chenopodium oil
abies alba oil
bulnesia sarmientoi wood oil
galbanum oil
grade 2 cutaneous follicular lymphoma
juniperus virginiana oil
copaiba oil
lavandin oil
camphor oil
calendula officinalis seed oil
babassu oil
artemisia vulgaris top oil
evening primrose oil
oxygen
grade 1 cutaneous follicular lymphoma
tea rose oil
tansy oil
rosewood oil
rosa moschata seed oil
quinoa oil
juniper berry oil
pimenta leaf oil
thymus pulegioides leaf oil
pelargonium peltatum oil
primary cutaneous hodgkin lymphoma
patchouli oil
palm oil
niaouli oil
meadowfoam seed oil
magnolia grandiflora flower oil
quince seed oil
acotiamide hydrochloride
aesculus carnea
adult lymphocyte - rich classic hodgkin lymphoma
plasmablastic lymphoma
alk - positive large b - cell lymphoma
adult t lymphoblastic lymphoma
refractory t lymphoblastic lymphoma
refractory mature b - cell non - hodgkin lymphoma
blastoid variant mantle cell lymphoma
oxymetholone
primary cutaneous marginal zone lymphoma of mucosa - associated lymphoid tissue
small intestinal non - hodgkin lymphoma
neoplastic post - transplant lymphoproliferative disorder
monomorphic post - transplant lymphoproliferative disorder
non - destructive post - transplant lymphoproliferative disorder
plasmacytic hyperplasia post - transplant lymphoproliferative disorder
infectious mononucleosis - like post - transplant lymphoproliferative disorder
monomorphic b - cell post - transplant lymphoproliferative disorder
monomorphic t / nk - cell post - transplant lymphoproliferative disorder
hodgkin - like post - transplant lymphoproliferative disorder
recombinant oxytocin
plasma cell post - transplant lymphoproliferative disorder
plasmacytoma - like post - transplant lymphoproliferative disorder
plasma cell myeloma post - transplant lymphoproliferative disorder
classic hodgkin lymphoma type post - transplant lymphoproliferative disorder
burkitt lymphoma post - transplant lymphoproliferative disorder
burkitt - like lymphoma post - transplant lymphoproliferative disorder
diffuse large b - cell lymphoma post - transplant lymphoproliferative disorder
anaplastic lymphoma post - transplant lymphoproliferative disorder
centroblastic lymphoma post - transplant lymphoproliferative disorder
alpha
immunoblastic lymphoma post - transplant lymphoproliferative disorder
caulophyllum thalictroides root
malignant testicular neoplasm
westfall young adjustment
methotrexate - associated peripheral t - cell lymphoma
methotrexate - associated diffuse large b - cell lymphoma
adjusted bonferroni correction
methotrexate - associated follicular lymphoma
methotrexate - associated burkitt lymphoma
methotrexate - associated hodgkin lymphoma
pomalidomide
cd43 - positive neoplastic cells present
ugt1a1*28 allele
sisomicin
nodular lymphocyte predominant hodgkin lymphoma
acediasulfone sodium
recurrent nodular lymphocyte predominant hodgkin lymphoma
pecilocin
nanafrocin
papaverine
refractory nodular lymphocyte predominant hodgkin lymphoma
benzoylpas calcium
ftivazide
protionamide
capreomycin
ann arbor stage iv nodular lymphocyte predominant hodgkin lymphoma
ann arbor stage iii nodular lymphocyte predominant hodgkin lymphoma
biapenem
brobactam
sanfetrinem sodium
cefditoren
ambazone
thyroid gland immunoblastic lymphoma
phenyracillin
diffuse follicular lymphoma
succisulfone
sulfaclomide
sulfachrysoidine
gene distance metric
angioimmunoblastic lymphadenopathy
aditoprim
fomidacillin
lung basaloid large cell carcinoma
cosine distance method
manhattan distance method
similarity
posizolid
computer time stamp
combined lung large cell neuroendocrine carcinoma
happiness
lack of maintenance documentation or guidelines
tositumomab and iodine i 131 tositumomab
environmental particulates
feet first
head first
minimally invasive lung mucinous adenocarcinoma
aleglitazar
minimally invasive lung non - mucinous adenocarcinoma
ambrisentan
amotosalen hydrochloride
paraffin
mixed mucinous and non - mucinous bronchioloalveolar carcinoma
amoxicillin sodium
anamorelin hydrochloride
aspoxicillin
borderline ovarian serous papillary cystic tumor
batabulin
benfosformin
ciglitazone
colistimethate
delapril hydrochloride
denagliptin tosylate
denibulin hydrochloride
desoxycorticosterone
dexmedetomidine hydrochloride
edaglitazone sodium
efaproxiral sodium
englitazone sodium
epalrestat
faropenem
fesoterodine fumarate
ovarian papillary cystadenoma
fingolimod hydrochloride
fosaprepitant dimeglumine
ovarian surface papilloma
ganaxolone
gemcabene
glicetanile
glipalamide
gliquidone
glisentide
pefloxacin
ovarian transitional cell tumor
glisolamide
glisoxepide
glybuthiazol
glybuzole
glymidine
borderline ovarian seromucinous tumor / atypical proliferative ovarian seromucinous tumor
levocetirizine dihydrochloride
benign ovarian seromucinous tumor
netoglitazone
piroxantrone hydrochloride
ovarian cystic teratoma
pramiconazole
pytamine
raltegravir
ovarian dermoid cyst with secondary tumor
ritipenem
rivoglitazone
salazosulfadimidine
ovarian solid teratoma
sulfaguanole
sulfametomidine
sulfametrole
sulfamonomethoxine
sulfaperin
sulfaproxyline
sulfoxone
ovarian monodermal teratoma
thiohexamide
tigecycline
tiliquinol
ovarian granulosa - stromal cell tumor
tolpyrramide
valopicitabine dihydrochloride
adult type ovarian granulosa cell tumor
aldose reductase inhibitor
sexual intercourse
reluctance
friend
outlook
interference
medical gas supply problem
financial
appreciation
juvenile type ovarian granulosa cell tumor
overcorrection
material protrusion
radiation overexposure
radiation underexposure
buffy coat preparation
antibody coated plate
sheep red blood cell rosetting
zonular dehiscence
new drug application
penicillamine
ovarian tumor of the thecoma / fibroma group
adrenergic antagonist
new animal drug application
soybean lectin agglutination
propidium iodide
7 - aminoactinomycin d
505 ( b )  ( 2 )  new drug application
benazeprilat
imidapril
pentopril
ovarian cellular fibroma
perindopril
ramiprilat
rentiapril
trandolaprilat
utibaprilat
malignant splenic soft tissue neoplasm
campath - 1g
benfluorex
splenic non - hodgkin lymphoma
glicaramide
glicetanile sodium
gliflumide
glisamuride
splenic hodgkin lymphoma
buclosamide
splenic manifestation of leukemia
anti - cd52 monoclonal antibody
investigational medical device
splenic manifestation of prolymphocytic leukemia
splenic manifestation of t - cell prolymphocytic leukemia
acipimox
cetaben sodium
darapladib
icosapent ethyl
beclobrate
splenic manifestation of b - cell prolymphocytic leukemia
biclofibrate
binifibrate
eniclobrate
simfibrate
tazasubrate
penicillin v potassium
splenic manifestation of chronic lymphocytic leukemia
artesunate
splenic manifestation of hairy cell leukemia
splenic manifestation of t - cell large granular lymphocyte leukemia
splenic manifestation of chronic myelogenous leukemia ,  bcr - abl1 positive
deferiprone
splenic small lymphocytic lymphoma
varespladib sodium
sinefungin
splenic lymphoplasmacytic lymphoma
splenic mantle cell lymphoma
splenic follicular lymphoma
splenic diffuse large b - cell lymphoma
splenic burkitt lymphoma
pentamidine
splenic b lymphoblastic lymphoma
alosetron
sulfamazone
bemetizide
sumetizide
splenic t lymphoblastic lymphoma
food ,  drugs ,  and medical devices regulatory document
application to market new drug ,  biologic ,  or antibiotic for human use
abbreviated new drug application
attractive
unattractive
rarely
inadequate device operator training
device unsafe to use in environment
hypodermic needle
splenic lymphoblastic lymphoma
gauge
cd5 gene
cd5 wt allele
mononucleated blood cell
t - cell surface glycoprotein cd5
nucleated red blood cell
nucleated blood cell
cd6 gene
cd6 wt allele
t - cell differentiation antigen cd6
benign ovarian serous tumor
l - arginine / american ginseng / korean ginseng / ginkgo biloba - based supplement
fondaparinux
tolpentamide
maraviroc
vicriviroc maleate
emivirine
atevirdine mesylate
borderline ovarian serous surface papillary tumor
ovarian adenosarcoma
acute monoblastic and monocytic leukemia
adult acute monoblastic and monocytic leukemia
dexlansoprazole
amitivir
etravirine
fialuridine
buciclovir
pentostatin
childhood chronic myelogenous leukemia ,  bcr - abl1 positive
torcitabine
elvucitabine
fiacitabine
desciclovir
rociclovir
dapivirine
ovarian mixed germ cell - sex cord - stromal tumor
sulclamide
camostat
testicular mixed germ cell - sex cord - stromal tumor
pumaprazole
benaxibine
etoprine
pumitepa
retelliptine
simtrazene
intratubular non - seminoma
galocitabine
broquinaldol
erbulozole
bromacrylide
testicular germ cell neoplasia in situ with extratubular extension
bendamustine
elmustine
moxidectin
testicular seminoma
intratubular seminoma
pentoxifylline
bisnafide dimesylate
ambamustine
azamethiphos
intermediate fibroblastic neoplasm
foreign facility's united states agent
urea / lactic acid - based cream
tilorone
cysteine - rich non - denatured whey protein isolate imn1207
structured product labeling flavor
spl flavor terminology
intermediate vascular neoplasm
breast cancer clinical primary tumor tnm finding v6
breast cancer ct0 tnm finding v6
breast cancer ct1 tnm finding v6
breast cancer ct2 tnm finding v6
breast cancer ct3 tnm finding v6
breast cancer clinical regional lymph nodes tnm finding v6
breast cancer cnx tnm finding v6 and v7
breast cancer cn0 tnm finding v6 and v7
breast cancer cn1 tnm finding v6 and v7
breast cancer cn2 tnm finding v6
reproductive endocrine neoplasm
breast cancer cn2a tnm finding v6 and v7
breast cancer cn2b tnm finding v6
breast cancer cn3 tnm finding v6
breast cancer cn3a tnm finding v6 and v7
breast cancer cn3b tnm finding v6 and v7
breast cancer cn3c tnm finding v6 and v7
breast cancer clinical distant metastasis tnm finding v6
breast cancer cmx tnm finding v6
breast cancer cm0 tnm finding v6
breast cancer cm1 tnm finding v6
sinonasal neoplasm
almond flavor
anise flavor
apple flavor
apricot flavor
banana flavor
berry flavor
blackberry flavor
blueberry flavor
bubble gum flavor
burgundy flavor
peritoneal and retroperitoneal neoplasm
butter pecan flavor
buttermint flavor
butterscotch flavor
caramel flavor
cheese flavor
cherry flavor
chocolate flavor
cinnamon flavor
citrus flavor
coconut flavor
adult b lymphoblastic lymphoma
coffee flavor
cola flavor
cotton candy flavor
cranberry flavor
creme de menthe flavor
curacao flavor
custard flavor
egg nog flavor
fig flavor
fruit flavor
fruit punch flavor
grape flavor
grapefruit flavor
guarana flavor
honey flavor
kiwi flavor
lemon flavor
licorice flavor
lime flavor
liver flavor
peptichemio
mango flavor
meat flavor
menthol flavor
mint flavor
orange banana flavor
orange flavor
peach flavor
peppermint flavor
pineapple flavor
benign epithelial skin neoplasm
plum flavor
pomegranate flavor
raisin flavor
raspberry flavor
root beer flavor
rum flavor
spearmint flavor
strawberry flavor
tangerine flavor
tropical fruit punch flavor
epithelial skin neoplasm
tutti frutti flavor
vanilla flavor
walnut flavor
watermelon flavor
wintergreen flavor
sleep
hobby
twin
fraternal twin
identical twin
benign skin fibrohistiocytic neoplasm
gavage
shame
enlargement
maque tree flavor
air
gravida
abortus
apgar score
belagenpumatucel - l
axial
skin intermediate fibrohistiocytic neoplasm
rbbp8 gene
rbbp8 wt allele
dna endonuclease rbbp8
nkx2 - 1 gene
nkx2 - 1 wt allele
thyroid transcription factor 1
psmb9 gene
psmb9 wt allele
proteasome subunit beta type - 9
klf4 gene
klf4 wt allele
foxa2 gene
foxa2 wt allele
krueppel - like factor 4
hepatocyte nuclear factor 3 - beta
nanotube
specialist physician
lin28a gene
lin28a wt allele
protein lin - 28 homolog a
cervical squamous intraepithelial neoplasia
amended by
cntnap2 gene
cntnap2 wt allele
contactin - associated protein - like 2
lmtk2 gene
lmtk2 wt allele
serine / threonine - protein kinase lmtk2
hilum
waldeyer ring
on study
cervical squamous cell carcinoma in situ
completed by
chemical association
electrostatic attraction
hydrogen bonding
van der waals attraction
ionic bonding
encapsulation
emulsifying excipient
biopolymer
continuous phase
high grade intraepithelial neoplasia
dispersed phase
radioisotopic labeling
chemical cleavage
antibody isotype
smiles arbitrary target specification
root mean square
aspect ratio
physical state
critical concentration
sol
immune cell function assay
parallelogram
polygon
polyhedron
hexahedron
serum hcg measurement
balance
prolate
untranslated region
peptide
perinatal brain injury
cardiac perforation
increased sensitivity
decreased sensitivity
mechanical ventilation complication
anger
affection
love
humiliation
bruxism
toothbrush
dental curing
dental impression
dentinal tubule
toothpaste
genome assembly sequence
serial number
delimiter
retroperitoneal carcinoma
pad character
orgasm
sexual arousal
hydnocarpus kurzii seed oil
celery seed oil
bay oil  ( pimenta racemosa )
thy1 gene
thy1 wt allele
thy - 1 membrane glycoprotein
collaboration
retroperitoneal lymphoma
exemption
kallikrein inactivator unit per milliliter
igfbp7 gene
igfbp7 wt allele
insulin - like growth factor - binding protein 7
merkel cell polyomavirus
application adapter
specification
hazard
amino acid derivative
peritoneal adenomatoid tumor
mycoplasma
worksheet
jazf1 gene
jazf1 wt allele
juxtaposed with another zinc finger protein 1
suz12 gene
suz12 wt allele
polycomb protein suz12
tes gene
tes wt allele
renal pelvis urothelial carcinoma
testin
enah gene
enah wt allele
protein enabled homolog
walking
abcb5 gene
abcb5 wt allele
atp - binding cassette sub - family b member 5
dosage form unit
bmpr1b gene
gallbladder adenosquamous carcinoma
bmpr1b wt allele
bone morphogenetic protein receptor type - 1b
gigabecquerel per microliter
gram titer
lactose unit
log10 plaque forming unit
log10 plaque forming unit per dose
periosteal chondrosarcoma
log10 per milliliter
mega united states pharmacopeia unit
milliequivalent per milligram
milligram titer
pock forming unit
pressor unit per milliliter
protein nitrogen unit per milliliter
nicotinic agonist
structured product labeling marketing category
spl marketing category terminology
marketed under abbreviated new animal drug application
marketed under abbreviated new drug application
marketed under biologic license application
marketed as bulk active ingredient
marketed as bulk inactive ingredient
marketed under conditional approval of new animal drug application
vicriviroc
endometrial adenocarcinoma
marketed for export only
sodium dichloroacetate
marketed under new animal drug application
marketed under new drug application
mebeverine hydrochloride
oxybutynin chloride
bazedoxifene
import
pertussis toxin
grade ii prostatic intraepithelial neoplasia
spl business operation terminology
hexaminolevulinate hydrochloride
marketed under over - the - counter drug product final monograph
marketed under over - the - counter drug product not final monograph
marketed as authorized generic under new drug application
repack
relabel
private label distribution
varenicline
scrotal melanoma
bisnafide
marketed as unapproved medical gas
marketed as unapproved homeopathic product
marketed as unapproved vitamin product
nitrous oxide
feature
breast scirrhous carcinoma
electronic document
pre - existing
reliability
validity
share
marketed as bulk ingredient
chemical probe
standard hit
intraductal papillomatosis
esoxybutynin chloride
cbx1 gene
cbx1 wt allele
cbx3 gene
cbx3 wt allele
cbx4 gene
cell per well
cell per dish
cell per flask
cbx4 wt allele
7p15 .2
3p21 .31
4q28
16q21 - q22 .3
11q14 .2 - q22 .3
disk shape
cbx5 gene
cbx5 wt allele
dnmt3a gene
dnmt3a wt allele
dnmt1 gene
dnmt1 wt allele
pax2 gene
pax2 wt allele
kat8 gene
kat8 wt allele
kat7 gene
kat7 wt allele
setd2 gene
setd2 wt allele
kmt5a gene
kmt5a wt allele
setd7 gene
setd7 wt allele
kmt5b gene
hair follicle neoplasm
kmt5b wt allele
kmt5c gene
kmt5c wt allele
suv39h1 gene
suv39h1 wt allele
suv39h2 gene
suv39h2 wt allele
dot1l gene
dot1l wt allele
ctcf gene
pilomatricoma
ctcf wt allele
unit of optical density
chromobox protein homolog 1
chromobox protein homolog 3
e3 sumo - protein ligase cbx4
chromobox protein homolog 5
absorbance unit
absorbance unit per minute
count per minute
dna  ( cytosine - 5 )  - methyltransferase 1
dna  ( cytosine - 5 )  - methyltransferase 3a
paired box protein pax - 2
histone acetyltransferase kat7
histone acetyltransferase kat8
histone - lysine n - methyltransferase setd2
n - lysine methyltransferase kmt5a
histone - lysine n - methyltransferase setd7
histone - lysine n - methyltransferase kmt5b
pesticide
histone - lysine n - methyltransferase kmt5c
histone - lysine n - methyltransferase suv39h1
histone - lysine n - methyltransferase suv39h2
histone - lysine n - methyltransferase h3 lysine - 79 specific
transcriptional repressor ctcf
intermediate
spatial qualifier
oblique
colony forming unit per million cells
accessory urethral gland carcinoma
disintegration per minute
femtomole per gram
fluorescence units
gram per animal
gram per animal per day
gram per animal per week
gram per cage
gram per cage per day
gram per cage per week
gram per capsule
cerebellar neuronal and mixed neuronal - glial tumor
gram per gram per day
gram per mole
gram per square meter per day
gram per tablet
gram per vial
liter per kilogram
microequivalent
microgram per square meter per hour
microgram per animal
microgram per kilogram per day
nasopharyngeal nonkeratinizing carcinoma
microgram per kilogram per hour
microgram per milligram protein
microgram per square meter per minute
microliter per nostril
micromole per milligram per minute
microosmole
milliequivalent per milliliter
milligram per animal
milligram per capsule
milligram per gram per hour
milligram per gram per minute
milligram per minute
milligram per square meter per hour
milligram per square meter per minute
milligram per vial
milliliter per animal
milliliter per animal per day
milliliter per animal per week
milliliter per breath
milliliter per cage
milliliter per cage per day
milliliter per cage per week
milliliter per gram
milliliter per gram per day
milliliter per gram per hour
milliliter per gram per minute
milliliter per kilogram per day
milliliter per kilogram per hour
pleural malignant mesothelioma
milliliter per kilogram per minute
milliliter per square meter
milliliter per square meter per hour
milliliter per square meter per minute
millimeter of mercury per second
millipascal
nanogram per well
nanosecond
picosecond
sprays per nostril
malignant lung neoplasm
square micrometer
thousand per deciliter
unit of gravity
unit per animal
unit per gram per day
unit per gram per hour
unit per gram per minute
unit per kilogram per day
unit per kilogram per hour
unit per kilogram per minute
malignant prostate neoplasm
unit per milligram
unit per milligram of creatinine
unit per milligram of protein
unit per square meter per day
unit per square meter per hour
unit per square meter per minute
viable cell per femur
microgram per square meter per day
cart object
native
malignant anal neoplasm
reposition
flip angle
brassica vegetable
capreomycin sulfate
phencyclidine
follicular variant thyroid gland papillary carcinoma ,  infiltrative subtype
sitagliptin phosphate
cetaben
cevipabulin fumarate
pibrozelesin hydrobromide
benzoylpas
raltegravir potassium
sanfetrinem
bladder papillary urothelial carcinoma
parecoxib sodium
pivampicillin hydrochloride
pivampicillin pamoate
sitagliptin
revaprazan hydrochloride
atevirdine
sulfapyridine sodium
pirlimycin hydrochloride
transverse plane
caudal
encapsulated thymoma
blood vessel neoplasm
vascular neoplasm
benign vascular neoplasm
phenobarbital
malignant vascular neoplasm
intermediate blood vessel neoplasm
credential
delegate action
caxchange
skin epithelioid hemangioma
parser
simple api for xml
serialization
deserialization
commit operation
rollback operation
human herpesvirus 8 - positive neoplastic cells present
mapping
physical shift
uniform
patchy
stage i nasopharyngeal carcinoma ajcc v6
stage iii nasopharyngeal carcinoma ajcc v6
avena sativa
stage iv nasopharyngeal carcinoma ajcc v6
borage oil
malignant oropharyngeal neoplasm
upamostat
dc - ova vaccine
villous adenoma
temporal
anatomic rim
excessive
pack year
write
ad5f35 - lmp1 / lmp2 - transduced autologous dendritic cells
aglatimagene besadenovec
adipose - derived regenerative cells
alvac ( 2 )  melanoma multi - antigen vaccine
alvac - mart - 1 vaccine
phenothiazine
burkitt leukemia
aml mrna positive lysate loaded autologous dendritic cell vaccine
tiomolibdate diammonium
fluciclovine f18
anti - cd19 monoclonal antibody mdx - 1342
anti - cd3 immunotoxin a - dmdt390 - bisfv ( ucht1 )
anti - cd30 monoclonal antibody xmab2513
otlertuzumab
daratumumab
cd40 agonist monoclonal antibody cp - 870 , 893
anti - cd45 monoclonal antibody ahn - 12
hairy cell leukemia variant
carotuximab
dalotuzumab
rivoceranib mesylate
arnebia indigo jade pearl topical cream
aurora kinase inhibitor bi 811283
autologous dendritic cell - adenovirus ccl21 vaccine
autologous dendritic cell - tumor fusion vaccine
cd3 / cd28 costimulated autologous t - cells
clino - san vaginal lubricant
copper cu 61 - atsm
hairy cell leukemia
copper cu 64 trastuzumab
apricoxib
cxcr4 inhibitor q - 122
depdc1 / mphosh1 peptide vaccine
diclofenac sodium gel
zoptarelin doxorubicin
eflornithine hydrochloride ointment
sovateltide
fentanyl citrate pectin - based nasal spray
fentanyl sublingual spray
flavonoid tablet
fluciclatide f 18
fluorine f - 18 hx4
gallium ga 68 f ( ab' ) 2 - trastuzumab
gallium ga 68 - dotanoc
gd2 lactone / gd3 lactone - klh conjugate bivalent vaccine
glioma - associated antigen peptide - pulsed autologous dendritic cell vaccine
gold sodium thiomalate
vismodegib
hla - a*2402 - restricted urlc10 - ttk - vegfr1 - vegfr2 multipeptide vaccine
malignant tonsillar neoplasm
hsp90 inhibitor snx - 5542 mesylate
hubc1 - huil12 fusion protein as1409
idiotype - pulsed autologous dendritic cell vaccine apc8020
dual igf - 1r / insr inhibitor bms - 754807
immunoadjuvant qs - dg
indium in 111 bevacizumab
indium in 111 girentuximab
indium in 111 monoclonal antibody hupam4
iobenguane sulfate i - 123
chronic atrophic gastritis
iodine i 124 - iodo - azomycin galactopyranoside
iodine i 125 - anti - egfr - 425 monoclonal antibody
iodine i 131 - 6 - beta - iodomethyl - 19 - norcholesterol
lactobacillus fermented extract
liposomal mnsod plasmid
live - attenuated listeria encoding human mesothelin vaccine crs - 207
ly6k / vegfr1 / vegfr2 multipeptide vaccine
malignant glioma tumor lysate - pulsed autologous dendritic cell vaccine
manuka honey
refametinib
oral lichen planus
met tyrosine kinase inhibitor bms - 777607
crizotinib
met tyrosine kinase inhibitor sgx523
mixed bacteria vaccine
mva - psa / pap prostate cancer vaccine
nanoparticle albumin - bound rapamycin
ny - eso - 1 / lage - 1 peptide vaccine
tasadenoturev
parathyroid hormone - related protein  ( 1 - 36 )
etirinotecan pegol
pep - 3 - klh conjugate vaccine
perflutren lipid microspheres
dactolisib
pi3k inhibitor bgt226
pnp - expressing ovine atadenovirus fp253
delanzomib
rexinoid nrx 194204
tirbanibulin
standardized freeze - dried table grape powder
synthetic brain tumor peptides - pulsed autologous dendritic cell vaccine
anal margin bowen disease
tasquinimod
testosterone gel
thioredoxin - 1 inhibitor px - 12
tlr9 agonist imo - 2055
tlr9 agonist sd - 101
topical gemcitabine hydrochloride
udenafil
urlc10 peptide vaccine
urlc10 - ttk - koc1 - vegfr1 - vegfr2 multipeptide vaccine
vaccinia virus dd - cdsr
elpamotide
wt1 - sensitized allogeneic t - lymphocytes
yttrium y 90 anti - cd19 monoclonal antibody bu12
yttrium y 90 anti - cd45 monoclonal antibody ahn - 12
yttrium y 90 anti - cd66 monoclonal antibody bw 250 / 183
cd20 antigen status
voluntary
phenytoin
malignant vaginal neoplasm
laryngeal precancerous condition
pancreatic precancerous condition
nephrogenic adenoma
fesoterodine
bladder villous adenoma
glisindamide
glicondamide
bladder nephrogenic adenoma
racemetyrosine
ritiometan
bibrocathol
urethral nephrogenic adenoma
butantrone
gallbladder hyperplastic polyp
malignant rectal neoplasm
acanthoma
levalbuterol
phorbol ester
malignant rectosigmoid neoplasm
fingolimod
rectosigmoid carcinoma
almitrine
alilusem
oral cavity and lip precancerous condition
sulosemide
sitalidone
galosemide
amanozine
besulpamide
hydracarbazine
sulicrinat
besunide
sulocarbilate
aditeren
metastatic malignant neoplasm in the rectum
diffuse sclerosing variant thyroid gland papillary carcinoma
histrelin
lobelia siphilitica root oil
picea mariana leaf oil
cascarilla oil
chamomile flower oil
calamus oil
sassafras oil
cajuput oil
wormwood oil
pennyroyal oil
boldo leaf oil
tea tree oil
juniperus oxycedrus leaf oil
brief fatigue inventory
field of view
work
phosphatidylinositol
malignant exocrine pancreas neoplasm
sensitivity of diagnostic test
malignant ovarian neoplasm
aids - related cervical carcinoma
aids - related cervical kaposi sarcoma
aids - related non - hodgkin lymphoma of the cervix
laurocapram
pulmonary precancerous condition
avanafil
bronchial intraepithelial neoplasia
diffuse idiopathic pulmonary neuroendocrine cell hyperplasia
infiltrating papillary adenocarcinoma
breast papillary ductal carcinoma in situ with invasion
stearylsulfamide
phosphodiesterase inhibitor
papilloma
penflutizide
quincarbate
benign myoepithelioma
regadenoson
gp100:154 - 162 - reactive peripheral blood lymphocytes present
satb1 gene
satb1 wt allele
dna - binding protein satb1
prox1 gene
prox1 wt allele
homeobox prospero - like protein prox1
bone marrow suppression
pkm gene
pkm wt allele
pyruvate kinase pkm
robo4 gene
robo4 wt allele
roundabout homolog 4
nod2 gene
nod2 wt allele
nucleotide - binding oligomerization domain - containing protein 2
brain stem astrocytoma
nutritional supplement drink
pediatric nutritional supplement drink
cdisc sdtm anatomical location terminology
cdisc sdtm race terminology
anaplastic brain stem glioma
npc1l1 gene
npc1l1 wt allele
niemann - pick c1 - like protein 1
mmadhc gene
mmadhc wt allele
methylmalonic aciduria and homocystinuria type d protein ,  mitochondrial
nrp2 gene
nrp2 wt allele
neuropilin - 2
msi1 gene
msi1 wt allele
rna - binding protein musashi homolog 1
infiltrating angiolipoma
picibanil
intramuscular lipoma
infiltrating lipoma
cd81 gene
cd81 wt allele
cd81 antigen
igsf8 gene
igsf8 wt allele
immunoglobulin superfamily member 8
rgs5 gene
rgs5 wt allele
regulator of g - protein signaling 5
odontogenic myxofibroma
glycosylated recombinant human g - csf avi - 014
include
livedo reticularis
heat shock protein inhibitor
self - report
exocervical carcinoma
effort
hopelessness
nervousness
restlessness
sadness
worthlessness
mucolytic agent
suprachiasmatic nucleus
fecal immunochemical test
unrehydrated guaiac test
lung hilum carcinoma
inguinofemoral lymphadenectomy
cdr3 spectratyping
teloxantrone hydrochloride
calcium pantothenate
pazopanib
codeine phosphate
numeric conversion
aminopterin sodium
consequence
dasatinib anhydrous
diethylstilbestrol dipropionate
cdisc sdtm category for disposition event terminology
cdisc sdtm subject characteristic test code terminology
metastatic malignant neoplasm in the ovary
cdisc sdtm fitzpatrick skin classification terminology
cdisc sdtm skin type terminology
skin classification scheme
fitzpatrick classification scale
employee job class
employee salary type
fitzpatrick skin type i
capillary hemangioma
fitzpatrick skin type ii
fitzpatrick skin type iii
fitzpatrick skin type iv
fitzpatrick skin type v
fitzpatrick skin type vi
hyoscyamine sulfate
pentetate calcium trisodium
melengestrol acetate
dl - alpha - tocopherol
skin type
lanreotide acetate
indinavir anhydrous
accessory lacrimal gland
protocol milestone
protocol event
protocol disposition event
oily skin
dry skin
normal skin
nutlin - 3a
axalimogene filolisbac
omeprazole sodium
omoconazole
picoline compound
metastatic malignant neoplasm in the anus
parenchyma
mitotic figure
neurovascular bundle
hairy cell count
blast count
cd19 expressing b cell count
cd3 expressing t cell count
cd4 expressing t cell count
cd8 expressing t cell count
somatotroph adenoma
dohle body measurement
erythrocyte sedimentation rate measurement
hypersegmented neutrophil measurement
lymphoma cell count
may - hegglin anomaly measurement
metamyelocyte count
pappenheimer body count
pelger huet anomaly measurement
plasmacytoid lymphocyte count
precursor plasma cell count
corticotroph adenoma
prolymphocyte count
promonocyte count
promyelocyte count
rouleaux formation count
sezary cell count
sickle cell count
smudge cell count
vacuolated neutrophil count
reactive lymphocyte count measurement
acute myelomonocytic leukemia
leukemic blast count
monoblast count
myeloblast count
acanthocyte to erythrocyte ratio measurement
bite cell to erythrocyte ratio measurement
cd19 b cell to lymphocyte ratio measurement
cd3 t cell to lymphocyte ratio measurement
cd4 t cell to cd8 t cell ratio measurement
cd4 t cell to lymphocyte ratio measurement
cd8 t cell to lymphocyte ratio measurement
acute leukemia of ambiguous lineage
hairy cell to lymphocyte ratio measurement
leukemic blast to lymphocyte ratio measurement
malignant cell to blood cell ratio measurement
metamyelocyte to leukocyte ratio measurement
monoblast to leukocyte ratio measurement
nucleated red blood cell to erythrocyte ratio measurement
plasmacytoid lymphocyte to lymphocyte ratio measurement
poikilocyte to erythrocyte ratio measurement
aids - related anal non - hodgkin lymphoma
precursor plasma cell to lymphocyte ratio measurement
prolymphocyte to lymphocyte ratio measurement
promonocyte to lymphocyte ratio measurement
promyelocyte to lymphocyte ratio measurement
reactive lymphocyte to lymphocyte ratio measurement
sezary cell to lymphocyte ratio measurement
sickle cell to erythrocyte ratio measurement
auer rod measurement
helmet cell count
large unstained cell count
acute erythroid leukemia in remission
malignant cell count
mature plasma cell count
myelocyte count
spermatozoa cell count
yeast cell measurement
amorphous crystal measurement
amorphous sediment measurement
bicarbonate measurement
bilirubin crystal measurement
calcium carbonate crystal measurement
pure erythroid leukemia
calcium oxalate crystal measurement
calcium phosphate crystal measurement
cholesterol crystal measurement
crystal present or absent
cystine crystal measurement
drug class measurement
folic acid measurement
free carnitine measurement
fructosamine measurement
iron measurement
struma ovarii
leucine crystal measurement
monosodium urate crystal measurement
total carnitine measurement
tyrosine crystal measurement
uric acid crystal measurement
anion gap measurement
occult blood measurement
amphetamine drug class measurement
barbiturate drug class measurement
cannabinoid drug class measurement
anal canal squamous cell carcinoma
cocaine measurement
antidepressant measurement
benzodiazepine measurement
ethanol measurement
phencyclidine measurement
phenothiazine measurement
pseudoephedrine measurement
opioid measurement
round epithelial cell count
acanthocyte count
anal verrucous carcinoma
bite cell count
burr cell count
cabot ring count
crenated cell measurement
howell - jolly body measurement
nucleated red blood cell count
schistocyte count
spherocyte count
stomatocyte count
heinz - ehrlich body measurement
anal canal adenocarcinoma
hepatitis a surface antibody measurement
hepatitis b surface antibody measurement
hepatitis c surface antibody measurement
hiv - 1 antibody measurement
hiv - 1 hiv - 2 antibody measurement
hiv - 2 antibody measurement
rapid plasma reagin measurement
rheumatoid factor measurement
total iron binding capacity
unsaturated iron binding capacity measurement
anal margin carcinoma
volume measurement
mucous thread measurement
urine sediment analysis measurement
turbidity measurement
hepatitis a viral load pcr measurement
hepatitis b viral load pcr measurement
hepatitis c viral load pcr measurement
hiv viral load pcr measurement
giant platelet count
large platelet count
anal margin basal cell carcinoma
mean platelet volume measurement
aldolase measurement
alpha - fetoprotein measurement
apolipoprotein a1 measurement
apolipoprotein b measurement
brain natriuretic peptide measurement
c - peptide measurement
ferritin measurement
globulin protein measurement
glutamate measurement
anal extramucosal  ( perianal )  adenocarcinoma
haptoglobin protein measurement
homocysteine acid measurement
hormone measurement
n - telopeptide measurement
osteocalcin measurement
sex hormone binding protein measurement
thyroxine binding globulin protein measurement
triiodothyronine measurement
triiodothyronine uptake measurement
troponin i measurement
anal adenocarcinoma within anorectal fistula
troponin t measurement
tumor necrosis factor measurement
blood urea nitrogen to creatinine ratio measurement
hippuric acid crystal measurement
sulfa crystal measurement
triple phosphate crystal measurement
unclassified crystal measurement
urine ammonium biurate crystal measurement
urine ammonium oxalate crystal measurement
anal margin paget disease
urine protein measurement
albumin to creatinine protein ratio measurement
bacterial cast measurement
cast present or absent
cellular cast measurement
coarse granular cast measurement
fatty cast measurement
fine granular cast measurement
granular cast measurement
granular fine cast measurement
anal canal paget disease
hyaline cast measurement
mixed cast count
red blood cell cast measurement
squamous epithelial cell count
squamous transitional epithelial cell count
tubular epithelial cell count
unclassified cast measurement
waxy cell cast measurement
white blood cell cast measurement
epithelial - cast measurement
malignant esophageal neoplasm
adrenocorticotropic hormone measurement
cortisol measurement
estradiol measurement
follicle stimulating hormone measurement
fragmented parathyroid hormone measurement
free testosterone measurement
free thyroxine measurement
free triiodothyronine measurement
insulin measurement
intact parathyroid hormone measurement
metastatic malignant neoplasm in the esophagus
luteinizing hormone measurement
progesterone measurement
somatotropin measurement
total testosterone measurement
total thyroxine measurement
opioid metabolite measurement
opiate measurement
anisocyte measurement
macrophage count
ammonia measurement
pilocarpine hydrochloride
malignant fallopian tube neoplasm
bile acid measurement
osmolality measurement
osmolarity measurement
vitamin measurement
cytokine measurement
interleukin 1 measurement
interleukin 10 measurement
interleukin 11 measurement
interleukin 12 measurement
interleukin 13 measurement
gallbladder malignant neoplasm
interleukin 14 measurement
interleukin 15 measurement
interleukin 16 measurement
interleukin 17 measurement
interleukin 18 measurement
interleukin 19 measurement
interleukin 2 measurement
interleukin 20 measurement
interleukin 21 measurement
interleukin 22 measurement
metastatic malignant neoplasm in the gallbladder
interleukin 23 measurement
interleukin 24 measurement
interleukin 25 measurement
interleukin 26 measurement
interleukin 27 measurement
interleukin 28 measurement
interleukin 29 measurement
interleukin 3 measurement
interleukin 30 measurement
interleukin 31 measurement
malignant extrahepatic bile duct neoplasm
interleukin 32 measurement
interleukin 33 measurement
interleukin 4 measurement
interleukin 5 measurement
interleukin 6 measurement
interleukin 7 measurement
interleukin 8 measurement
interleukin 9 measurement
acetylcholine measurement
adiponectin measurement
malignant laryngeal neoplasm
adrenaline measurement
aldosterone measurement
androstenediol metabolite measurement
androstenedione measurement
angiotensin i measurement
angiotensin ii measurement
angiotensinogen measurement
antidiuretic hormone measurement
calcitonin measurement
calcitriol measurement
malignant lip neoplasm
cholecystokinin measurement
corticotropin releasing hormone measurement
dehydroepiandrosterone measurement
dihydrotestosterone measurement
dopamine measurement
erythropoietin measurement
estriol measurement
estrone measurement
gastrin measurement
glucagon measurement
paranasal sinus polyp
gonadotropin releasing hormone measurement
growth hormone inhibiting hormone measurement
growth hormone releasing hormone measurement
homovanillic acid measurement
insulin like growth factor - 1 measurement
insulin like growth factor - 2 measurement
leptin measurement
melatonin measurement
noradrenaline measurement
oxytocin measurement
malignant paranasal sinus neoplasm
prolactin measurement
secretin measurement
serotonin measurement
thrombopoietin measurement
thyrotropin releasing hormone measurement
vanillyl mandelic acid measurement
6 - monoacetylmorphine measurement
codeine measurement
dihydrocodeine measurement
hydrocodone measurement
paranasal sinus neoplasm
hydromorphone measurement
methadone measurement
methaqualone measurement
morphine measurement
oxycodone measurement
propoxyphene measurement
atrial natriuretic peptide measurement
lactate dehydrogenase isoenzyme 1 measurement
lactate dehydrogenase isoenzyme 2 measurement
lactate dehydrogenase isoenzyme 3 measurement
anal canal carcinoma
lactate dehydrogenase isoenzyme 4 measurement
lactate dehydrogenase isoenzyme 5 measurement
neuropeptide y measurement
renin measurement
albumin to globulin ratio measurement
vitamin a measurement
vitamin b1 measurement
vitamin b17 measurement
vitamin b2 measurement
vitamin b3 measurement
piperacillin sodium
anal canal intraepithelial neoplasia
vitamin b5 measurement
vitamin b6 measurement
vitamin b7 measurement
vitamin c measurement
vitamin d2 measurement
vitamin d3 measurement
vitamin e measurement
vitamin k measurement
primary intraosseous squamous cell carcinoma - solid type
lymphoma cell to lymphocyte ratio measurement
mature plasma cell to lymphocyte ratio measurement
anti - double stranded dna measurement
rat genome database
zebrafish model organism database
antinuclear antibody measurement
capsule per animal
cells per milliliter
ameloblastic carcinoma
microgram per gram per day
microgram per gram per hour
microgram per gram per minute
per year
percent activity
gene knockdown
patient tracking system
international registration data identifier
ameloblastic carcinoma - primary type
multipurpose internet mail extensions
cagrid global model exchange
registration authority
deny
plasma cell labeling index
unhandled message
biclonal gammopathy
barrel
exophytic
alvocidib
epinephrine hydrochloride
anatomic pathology procedure
esorubicin hydrochloride
clinical pathology procedure
vatalanib succinate
electrolyte measurement
bupropion hydrobromide
crystal growth measurement
lipid measurement
corrected serum calcium measurement
bleeding on probing
tooth part
cementoenamel junction
liver function test
mixed category laboratory procedure
inappropriate
ameloblastic carcinoma - secondary type  ( dedifferentiated )
alpha - tocopherol
alx4 gene
alx4 wt allele
homeobox protein aristaless - like 4
arx gene
arx wt allele
ameloblastic carcinoma derived from odontogenic cyst
homeobox protein arx
endocrine test
renal function test
atp7a gene
atp7a wt allele
copper - transporting atpase 1
atrx gene
atrx wt allele
transcriptional regulator atrx
capability
keratinizing primary intraosseous squamous cell carcinoma  - solid type
left ventricular ejection time
mini - mental status exam
1p36 deletion syndrome
stickler syndrome
stickler syndrome type 2
van der woude syndrome
feingold syndrome
holoprosencephaly
cells per femur
non - keratinizing primary intraosseous squamous cell carcinoma  - solid type
colony forming unit per dish
milligram per gram per day
holoprosencephaly type 2
joubert syndrome
joubert syndrome type 4
nephronophthisis 1
mowat - wilson syndrome
pipobroman
primary intraosseous squamous cell carcinoma derived from odontogenic cyst
ectrodactyly
movie
split - hand / foot malformation type 5
synpolydactyly
invasion
synpolydactyly - 1
loeys - dietz syndrome
marfan syndrome type ii
waardenburg syndrome type 1
waardenburg syndrome type 2
odontogenic myxoma
waardenburg syndrome type 2a
dandy - walker malformation
btk gene
btk wt allele
rieger syndrome type 1
cornelia de lange syndrome
tyrosine - protein kinase btk
treacher collins syndrome
malignant vulvar neoplasm
cleidocranial dysplasia
alacepril
delapril
temocaprilat
neostigmine
salcaprozate sodium
perampanel
borderline phyllodes tumor
type iii acrocephalosyndactyly
amustaline dihydrochloride
adult cystic nephroma
split - hand / foot malformation type 1
myelodysplastic syndrome with excess blasts
propikacin
malignant urethral neoplasm
recurrent urethral carcinoma
propacetamol
metastatic malignant neoplasm in the thyroid gland
piroxicam
malignant thyroid gland neoplasm
charge syndrome
trichorhinophalangeal syndrome type i
metastatic malignant neoplasm in the breast
azilsartan medoxomil
fenfluramine hydrochloride
lisdexamfetamine
trichorhinophalangeal syndrome type ii
loeys - dietz syndrome type 1
nail - patella syndrome
split - hand / foot malformation type 3
tuberous sclerosis 1
topixantrone
malignant esophageal neoplasm by topographic region
kidney and ureter neoplasm
puromycin hydrochloride
renal pelvis and ureter carcinoma
acenocoumarol
argatroban anhydrous
betrixaban
stage 0a renal pelvis and ureter cancer ajcc v7
stage 0is renal pelvis and ureter cancer ajcc v7
alogliptin benzoate
darglitazone
darglitazone sodium
edaglitazone
stage i renal pelvis and ureter cancer ajcc v7
muraglitazar
naveglitazar
ragaglitazar
sodelglitazar
butylphenamide
calcium undecylenate
pituitary hormone
stage ii renal pelvis and ureter cancer ajcc v7
chlordantoin
omoconazole nitrate
protiofate
rilopirox
rimoprogin
sertaconazole
siccanin
sodium bensuldazate
stage iii renal pelvis and ureter cancer ajcc v7
stage iv renal pelvis and ureter cancer ajcc v7
nocodazole
malignant small intestinal neoplasm
metastatic malignant neoplasm in the small intestine
dichlorophenarsine
dichlorophenarsine hydrochloride
furaltadone
malignant renal pelvis neoplasm
anacetrapib
avasimibe
choline fenofibrate
dalvastatin
gemcabene calcium
ibrolipim
niceritrol
papillary intralymphatic angioendothelioma
malignant superior sulcus neoplasm
angioimmunoblastic t - cell lymphoma
recurrent childhood visual pathway glioma
taurultam
elesclomol
terfluranol
tolnidamine
ritrosulfan
thiodiglycol
acronine
nicanartine
placebo
recurrent childhood visual pathway astrocytoma
discrete
application program interface
marketed under investigational new drug
focus forming unit
cdkl5 gene
cdkl5 wt allele
cyclin - dependent kinase - like 5
chd2 gene
chd2 wt allele
chd7 gene
recurrent childhood optic nerve glioma
chd7 wt allele
chromodomain - helicase - dna - binding protein 2
chromodomain - helicase - dna - binding protein 7
col11a1 gene
col11a1 wt allele
col2a1 gene
col2a1 wt allele
collagen alpha - 1 ( xi )  chain
collagen alpha - 1 ( ii )  chain
recurrent childhood optic nerve astrocytoma
dcx gene
dmd wt allele
neuronal migration protein doublecortin
dcx wt allele
dmd gene
dystrophin
ehmt1 gene
ehmt1 wt allele
histone - lysine n - methyltransferase ehmt1
above
visual pathway astrocytoma
below
tuberous sclerosis 2
obturator foramen
eln gene
eln wt allele
elastin
fbn1 gene
fbn1 wt allele
autograft
childhood visual pathway astrocytoma
cns affecting drug measurement
cns depressant drug measurement
cns stimulant drug measurement
hallucinogen measurement
antipsychotic measurement
steroid measurement
caffeine measurement
amphetamine measurement
methamphetamine measurement
tenamfetamine measurement
childhood visual pathway glioma
benzoylecgonine measurement
dronabinol measurement
buprenorphine measurement
eddp measurement
lysergide measurement
mescaline measurement
psilocybine measurement
gamma - hydroxybutyrate measurement
3 , 4 - methylenedioxyethamphetamine measurement
3 , 4 - methylenedioxymethamphetamine measurement
discrete modeling
continuum modeling
hybrid modeling
amobarbital measurement
butabarbital measurement
butalbital measurement
mephobarbital measurement
pentobarbital measurement
phenobarbital measurement
secobarbital measurement
alprazolam measurement
chlordiazepoxide measurement
diazepam measurement
flurazepam measurement
lorazepam measurement
oxazepam measurement
temazepam measurement
nandrolone measurement
testosterone measurement
stanazolol measurement
anterior visual pathway meningioma
boldenone measurement
oxandrolone measurement
methandrostenolone measurement
beta - blocker measurement
diuretic measurement
peptide hormone measurement
growth hormone measurement
human chorionic gonadotropin measurement
oxymetholone measurement
spatial frequency
lymphoid leukemia
eya1 gene
eya1 wt allele
eyes absent homolog 1
sh2d1a gene
sh2d1a wt allele
sh2 domain - containing protein 1a
shank3 gene
shank3 wt allele
xpter - p22 .32
15q11 - q13
plasmid
small lymphocytic lymphoma
2q22
sh3 and multiple ankyrin repeat domains protein 3
shox gene
shox wt allele
short stature homeobox protein
smc1a gene
smc1a wt allele
sox6 gene
sox6 wt allele
retinoblastoma
transcription factor sox - 6
tbx1 gene
tbx1 wt allele
t - box transcription factor tbx1
fbxw4 gene
fbxw4 wt allele
f - box / wd repeat - containing protein 4
tgif1 gene
tgif1 wt allele
world health organization
askin tumor
homeobox protein tgif1
fmr1 gene
fmr1 wt allele
fragile x mental retardation protein 1
trappc10 gene
trappc10 wt allele
trafficking protein particle complex subunit 10
hba1 gene
malignant ureter neoplasm
hba1 wt allele
hba2 gene
hba2 wt allele
hemoglobin subunit alpha
ube3a gene
ube3a wt allele
ubiquitin - protein ligase e3a
nelfa gene
nelfa wt allele
metastatic malignant neoplasm in the ureter
negative elongation factor a
zeb2 gene
zeb2 wt allele
zinc finger e - box - binding homeobox 2
muscle layer
gait
deep tendon reflex
6q16 .3 - q21
2p16 - p21
xq27 .1
malignant pharyngeal neoplasm
17q24 .3 - q25 .1
13q32
xq26 .2
rai1 gene
rai1 wt allele
retinoic acid - induced protein 1
potocki - shaffer syndrome
jacobsen syndrome
pallister - killian syndrome
noonan syndrome 1
metastatic malignant neoplasm in the pharynx
holoprosencephaly type 5
angelman syndrome
prader - willi syndrome
polycystic kidney disease
rubinstein - taybi syndrome
charcot - marie - tooth disease
charcot - marie - tooth disease type 1a
smith - magenis syndrome
malignant penile neoplasm
17q21 microdeletion syndrome
col1a1 associated connective tissue disorder
foxl2 gene
foxl2 wt allele
forkhead box protein l2
holoprosencephaly type 4
holoprosencephaly type 1
cat - eye syndrome
22q telomere deletion syndrome
malignant kidney neoplasm
kallmann syndrome 1
orofaciodigital syndrome type 1
duchenne muscular dystrophy
juvenile x - linked retinoschisis
x - linked cornelia de lange syndrome
menkes disease
pelizaeus - merzbacher disease
rett syndrome
foxp2 gene
metastatic malignant neoplasm in the kidney
foxp2 wt allele
forkhead box protein p2
gata3 gene
gata3 wt allele
trans - acting t - cell - specific transcription factor gata - 3
gata4 gene
gata4 wt allele
transcription factor gata - 4
gk gene
gk wt allele
recombinant platelet - derived growth factor
ovarian serous adenocarcinoma
glycerol kinase
hccs gene
hccs wt allele
cytochrome c - type heme lyase
sim1 gene
sim1 wt allele
hira gene
hira wt allele
protein hira
stage iii prostate cancer ajcc v6
single - minded homolog 1
structural maintenance of chromosomes protein 1a
sox3 gene
transcription factor sox - 3
sox9 gene
sox9 wt allele
transcription factor sox - 9
immunoaffinity chromatography
stage c prostate cancer
absorbable
disturbance
trps1 gene
trps1 wt allele
zinc finger transcription factor trps1
anti - cd25 monoclonal antibody
schirmer test wetting
sry gene
sry wt allele
sex - determining region y protein
stage ii prostate cancer ajcc v6
fresh
parainfluenza virus
absent adverse event
zic1 gene
zic1 wt allele
zinc finger protein zic 1
zic2 gene
toxoplasma
episode
stage b prostate cancer
tenderness
zinc finger protein zic 2
zic3 gene
zic3 wt allele
zinc finger protein zic 3
hemolytic uremic syndrome
zic4 gene
zic4 wt allele
hemorrhagic cyst
zinc finger protein zic 4
stage i prostate cancer ajcc v6
zic2 wt allele
six3 gene
clerk
salesperson
skilled worker
six3 wt allele
laborer
homeobox protein six3
professional occupation
farmer
stage a prostate cancer
homemaker
student
part time employment
unemployment
blister
rp2 gene
rp2 wt allele
protein xrp2
multiple organ failure
inconclusive
graft rejection
rs1 gene
rs1 wt allele
retinoschisin protein
antileukemic agent
snrpn gene
mobilized peripheral blood stem cell
snrpn wt allele
small nuclear ribonucleoprotein - associated protein n
maculopapular lesion
endometrial carcinoma
satb2 gene
satb2 wt allele
dna - binding protein satb2
slit - lamp examination
sts gene
muscle contracture
sts wt allele
steryl - sulfatase
15q11 .2
xp22 .2 - 22 .1
atypical adenoma
xp11 .4 - 11 .21
inference
tcof1 gene
xist gene
xist wt allele
xq13 .2
5q32 - 33 .1
tcof1 wt allele
treacle protein
platinum
sweat gland adenoma
sox3 wt allele
motion
artifact
ids gene
ids wt allele
iduronate 2 - sulfatase
ikbkg gene
ikbkg wt allele
nf - kappa - b essential modulator
il1rapl1 gene
il1rapl1 wt allele
interleukin - 1 receptor accessory protein - like 1
jag1 gene
jag1 wt allele
protein jagged - 1
irf6 gene
irf6 wt allele
interferon regulatory factor 6
anos1 gene
anos1 wt allele
anosmin - 1
kcnq1 gene
kcnq1 wt allele
potassium voltage - gated channel subfamily kqt member 1
hidradenoma
lmx1b gene
lmx1b wt allele
lim homeobox transcription factor 1 beta
mapt gene
mapt wt allele
eccrine hidrocystoma
microtubule - associated protein tau
sporadic breast carcinoma
crhr1 gene
crhr1 wt allele
corticotropin - releasing factor receptor 1
clear cell hidradenoma
nodular hidradenoma
thymic carcinoma
poly au
melanocytic nevus
benign skin melanocytic nevus
kidney medullary carcinoma
mecp2 gene
mecp2 wt allele
methyl - cpg - binding protein 2
metastatic malignant neoplasm in the urethra
mid1 gene
mid1 wt allele
e3 ubiquitin - protein ligase midline - 1
ndufv1 gene
ndufv1 wt allele
nadh dehydrogenase  [ ubiquinone ]  flavoprotein 1 ,  mitochondrial
nipa1 gene
nipa1 wt allele
nipa2 gene
nipa2 wt allele
prostate phyllodes tumor
non - imprinted in prader - willi / angelman syndrome region protein 1
non - imprinted in prader - willi / angelman syndrome region protein 2
nipbl gene
nipbl wt allele
nipped - b - like protein
nlgn4x gene
nlgn4x wt allele
neuroligin 4 ,  x - linked
breast phyllodes tumor
milliliter per square centimeter
areic number
partial pressure
deep penetrating nevus
mass density
nih unit of thrombin inhibited / square centimeter
arbitrary unit
dalteparin sodium
enoxaparin sodium
recurrent nevus
aluminum sulfate
nevus of female genitalia
poly ic
skin appendage adenoma
microcystic adnexal carcinoma
nevus of ito
nevus of ota
dysplastic nevus syndrome
skin adamantinoid basal cell carcinoma
malignant basal cell neoplasm
nphp1 gene
nphp1 wt allele
nephrocystin - 1
nr0b1 gene
nr0b1 wt allele
nuclear receptor subfamily 0 group b member 1
nr2f2 gene
nr2f2 wt allele
coup transcription factor 2
adult lymphoma
nr5a1 gene
nr5a1 wt allele
steroidogenic factor 1
cemadotin
nsd1 gene
nsd1 wt allele
histone - lysine n - methyltransferase ,  h3 lysine - 36 and h4 lysine - 20 specific
ofd1 gene
ofd1 wt allele
oral - facial - digital syndrome 1 protein
otc gene
otc wt allele
ornithine carbamoyltransferase ,  mitochondrial
pafah1b1 gene
pafah1b1 wt allele
platelet - activating factor acetylhydrolase ib subunit alpha
pax6 gene
pax6 wt allele
paired box protein pax - 6
pitx2 gene
pitx2 wt allele
pituitary homeobox 2
pkd1 gene
pkd1 wt allele
polycystin - 1
plp1 gene
plp1 wt allele
myelin proteolipid protein
polyamine compound
pmp22 gene
pmp22 wt allele
peripheral myelin protein 22
international unit per milligram of creatinine
microgram per milliliter per hour
graph node
smallest
obturator nerve
combined lung carcinoma
presacral
optimum
viscosity
renal clearance
mathematical graph
antireflexive relationship
reflexive relationship
symmetric relationship
antisymmetric relationship
transitive relationship
antitransitive relationship
graph edge
functional relationship
reverse - functional relationship
amustaline
cilazaprilat
hidden markov model
log10
negative integer
framycetin sulfate
predictor
expectation maximization algorithm
convergence
decay
transition
forward
malignant myoepithelioma
stage iv vaginal cancer ajcc v6 and v7
bone liposarcoma
ingliforib
saxagliptin
saxagliptin anhydrous
tesaglitazar
ambruticin
calcium clofibrate
eflucimibe
inositol niacinate
taltobulin
polychlorinated biphenyl
acute myeloid leukemia with myelodysplasia - related changes
sinecatechins
thyroid gland mucosa - associated lymphoid tissue lymphoma
ciluprevir
halo nevus
aztreonam lysine
regressing nevus
cefaclor anhydrous
cefluprenam
cefovecin
cefovecin sodium
cefsumide
ceftezole
nasal cavity olfactory neuroblastoma
oral cavity benign granular cell tumor
lithium benzoate
oral cavity neoplasm
tacrolimus anhydrous
benign oral cavity neoplasm
benign oral neoplasm
magnesium glycinate
rotenone
cerebral non - hodgkin lymphoma
polycyclic aromatic hydrocarbons
cerebral lymphoma
corticorelin acetate
aderbasib
film cartridge device
malignant thymoma
shock capacitor device
human - device interface issue
not high school graduate
experimental finding
experimental result
adverse event without identified device or use problem
scanning tunneling microscopy
abciximab
primary cutaneous hodgkin's lymphoma
first - degree burn
second - degree burn
third - degree burn
cilazapril monohydrate
cilazapril anhydrous
enalaprilat anhydrous
ambenonium
cutaneous lymphoproliferative disorder
f10 gene
f10 wt allele
coagulation factor x
hydroxyproline
arbekacin
astromicin
astromicin sulfate
gentamicin c1
gentamicin c1a
adult diffuse large b - cell lymphoma
gentamicin c2
kanamycin a
kanamycin a sulfate
bekanamycin sulfate
kanamycin c
neamine
cefazedone
cefcanel
cefcanel daloxate
childhood diffuse large b - cell lymphoma
cefcapene
cefdaloxime
cefetamet
cefetecol
cefmatilen
cefminox
benign reproductive system neoplasm
cefonicid monosodium
cefoxazole
cefozopran
cefpimizole
ceftiofur hydrochloride
ceftiolene
cefuroxime pivoxetil
cefuzonam
cephalexin anhydrous
cephradine anhydrous
b6c3 mouse
icr br mouse
aci / seg ,  rat strain
device ingredient or reagent
ss ,  rat strain
ofa sd ,  rat strain
le ,  rat strain
sd ,  rat strain
recurrent carcinoma
wist ,  rat strain
wh ,  rat strain
wky ,  rat strain
wistar unilever ,  rat strain
z ,  rat strain
actinobacteria
proteobacteria
firmicutes
zosuquidar
dovitinib
recurrent female reproductive system carcinoma
acinetobacter
actinomyces
bacillus
bacteroidetes
bacteroides
bordetella pertussis
spirochaetes
borrelia burgdorferi
tin
recurrent male reproductive system carcinoma
moraxella catarrhalis
campylobacter
azithromycin anhydrous
azithromycin dihydrate
azithromycin monohydrate
amdinocillin pivoxil
apalcillin
apalcillin sodium
carbenicillin indanyl
recurrent digestive system carcinoma
carbenicillin potassium
cloxacillin sodium anhydrous
nafcillin sodium anhydrous
oxacillin sodium anhydrous
pirbenicillin sodium
recurrent urinary system carcinoma
capreomycin iib
recurrent head and neck carcinoma
annulled
interlocutory marital status
polygamous
targeted molecular therapy
blood group
abo blood group
blood group a
blood group b
blood group ab
blood group o
localized carcinoma
rh blood group
rh positive blood group
rh negative blood group
recurrent pancreatic carcinoma
vinflunine ditartrate
capnocytophaga
bilateral malignant neoplasm
chlamydiae
chlamydia
chlamydophila pneumoniae
citrobacter
clostridium
clostridium difficile
refractory neoplasm
porfiromycin
intermediate lipomatous neoplasm
corynebacterium jeikeium
corynebacterium
coxiella
pericardial malignant mesothelioma
enterobacter
enterococcus
vancomycin resistant enterococcus
vardenafil hydrochloride trihydrate
pseudomonas oryzihabitans
pericardial mesothelioma
flavobacterium
fusobacteria
cell wash
fusobacterium
haemophilus
metastatic breast ductal carcinoma
census region
metastatic breast lobular carcinoma
northeastern united states census region
peritoneal mesothelioma
midwestern united states census region
southern united states census region
western united states census region
census division
new england census division
middle atlantic census division
solitary fibrous tumor
east north central states census division
west north central states census division
south atlantic states census division
east south central states census division
west south central states census division
mountain states census division
pacific states census division
seer geocode region
cdisc sdtm marital status terminology
continent
well differentiated papillary mesothelioma
little
cdisc sdtm skin classification terminology
lactobacillus
legionella
leptospira
leptotrichia buccalis
leuconostoc
listeria
progressive myoclonus epilepsy
african green monkey
methylobacterium
broiler chicken
california rabbit
dutch belted rabbit
japanese white rabbit
thyrotropin - releasing hormone analogue
mycobacterium avium complex
mycobacterium
malignant labia minora neoplasm
mycobacterium tuberculosis
neisseria
nocardia
pasteurella multocida
proteus
pseudomonas
burkholderia cepacia
stenotrophomonas maltophilia
rhodococcus
rickettsia
malignant labia majora neoplasm
salmonella
shigella
rothia mucilaginosa
streptococcus
streptococcus pneumoniae
treponema
vibrio
carbaril
regional malignant urethral neoplasm
preladenant
porphyrin
posterior urethral malignant neoplasm
tirofiban
anterior urethral malignant neoplasm
epipodophyllotoxin - related myelodysplastic syndrome
nimorazole
alkylating agent - related myelodysplastic syndrome
adamantinoma
breast intracystic papillary carcinoma
adrenal gland ganglioneuroblastoma
aconiazide
aminosalicylate calcium
localized gallbladder carcinoma
aplaviroc hydrochloride
elvitegravir
entecavir anhydrous
famotine
fosfonet sodium
golotimod
nesbuvir
taribavirin
potassium
metastatic malignant neoplasm in the bladder
tiviciclovir
intermediate soft tissue neoplasm
liver dysplastic nodule
nitrocefin
pirazmonam
pirazmonam sodium
tebipenem pivoxil
tomopenem
intestinal intraepithelial neoplasia
trimetazidine
cephacetrile sodium
cephaloglycin anhydrous
cephaloridine
cephapirin benzathine
povidone - iodine
high grade glandular intraepithelial neoplasia
lisdexamfetamine dimesylate
high grade vaginal intraepithelial neoplasia
aminometradine
amisometradine
protheobromine
triflocin
grade ii penile intraepithelial neoplasia
acepromazine maleate
low grade penile intraepithelial neoplasia
alvespimycin hydrochloride
high grade penile intraepithelial neoplasia
high grade conjunctival squamous intraepithelial neoplasia
high grade corneal squamous intraepithelial neoplasia
ammonia
prazosin
high grade cervical intraepithelial neoplasia
cervical glandular intraepithelial neoplasia
low grade cervical glandular intraepithelial neoplasia
carbon monoxide
high grade cervical glandular intraepithelial neoplasia
amotosalen
adenocarcinoma in adenomatous polyp
adenocarcinoma in tubular adenoma
adenocarcinoma in situ in adenomatous polyp
adenocarcinoma in situ in tubular adenoma
galamustine
prednimustine
adenocarcinoma in situ in a polyp
ecopladib
carcinoma in situ in a polyp
carcinoma in a polyp
adenocarcinoma with cartilaginous and osseous metaplasia
adenocarcinoma with osseous metaplasia
adenocarcinoma with cartilaginous metaplasia
azidocillin
cloxacillin benzathine
temocillin
noninfiltrating intracystic breast carcinoma
coumaphos
intracystic breast carcinoma
dichlorvos
fenthion
phosmet
propetamphos
ronnel
invasive breast ductal carcinoma and lobular carcinoma
carglumic acid
invasive breast ductal carcinoma and lobular carcinoma in situ
roflumilast
prednisolone
breast ductal carcinoma in situ and lobular carcinoma
alogliptin
aloxistatin
brecanavir
denagliptin
resectable hepatocellular carcinoma
cifostodine
epervudine
oteracil
resectable malignant liver neoplasm
amdoxovir
dexelvucitabine
rilpivirine
tivirapine
trovirdine
primary peritoneal serous papillary adenocarcinoma
stage iv breast  inflammatory carcinoma
atiprimod dihydrochloride
atiprimod dimaleate
sulfachlorpyridazine
sulfadimethoxine
sulfaguanidine
sulfanitran
sulfaquinoxaline
nicotine withdrawal
sulfasomizole
sulfathiourea
sulfatolamide
gastric adenoma
promestriene
prednisone
ovarian adenocarcinoma
teclothiazide
adult hodgkin lymphoma
childhood brain neoplasm
carbamide peroxide
cetylpyridinium chloride
adult non - hodgkin lymphoma
childhood rhabdomyosarcoma
silver nitrate
childhood non - hodgkin lymphoma
cevipabulin
denibulin
rosabulin
tasidotin
calcium mandelate
adult soft tissue sarcoma
methenamine mandelate
childhood malignant liver neoplasm
tolvaptan
micrococcus
dunkin hartley guinea pig
hartley albino hairless guinea pig
digestive system neuroendocrine tumor g1
hartley guinea pig
chinese hamster
chinese syrian hamster
chinese syrian gold hamster
lvg hamster
syrian hamster
mustelidae
mustela putorius
leghorn chicken
ross chicken
primaquine phosphate
adult brain neoplasm
mongolian gerbil
duroc pig
gottingen pig
hampshire pig
hanford pig
landrace pig
micropig
minipig
yucatan pig
new zealand black rabbit
adult liver carcinoma
new zealand hybrid rabbit
new zealand red rabbit
new zealand white rabbit
cynomolgus maritius monkey
saimiri sciureus
callithrix jacchus
cf - 1 mouse
cotton rat
chrna3 gene
chrna3 wt allele
uveal melanoma
chrnb4 gene
chrnb4 wt allele
chrna5 gene
chrna5 wt allele
domestic short hair cat
neuronal acetylcholine receptor subunit alpha - 3
neuronal acetylcholine receptor subunit beta - 4
neuronal acetylcholine receptor subunit alpha - 5
acediasulfone
neck squamous cell carcinoma of unknown primary
childhood hodgkin lymphoma
clinical test result
epithiazide
nitrofurantoin monohydrate
childhood soft tissue sarcoma
calcifediol anhydrous
cdh2 gene
cdh2 wt allele
renal pelvis and ureter urothelial carcinoma
integrin alpha - iib
integrin alpha - iib / beta - 3
itga2b gene
candida
itga2b wt allele
slc5a1 gene
slc5a1 wt allele
ascomycota
sodium / glucose cotransporter 1
basidiomycota
malignant pericardial effusion
candida albicans
pichia guilliermondii
candida krusei
clavispora lusitaniae
candida parapsilosis
candida tropicalis
bacillus calmette - guerin antigen
candida glabrata
appendix adenocarcinoma
aspergillus
aspergillus flavus
aspergillus fumigatus
aspergillus brasiliensis
cryptococcus
fusarium
ajellomyces capsulatus
cefprozil anhydrous ,   ( e )  -
cefprozil ,   ( e )  -
bartholin gland adenocarcinoma
ceftiofur sodium
zygomycota
rhizopus
togaviridae
rubella virus
rotavirus
probenecid
gallbladder adenoma
rhinovirus
histoplasmosis
nlrp3 gene
nlrp3 wt allele
nacht ,  lrr and pyd domains - containing protein 3
ing2 gene
ing2 wt allele
inhibitor of growth protein 2
escherichia
chfr gene
gingival carcinoma
chfr wt allele
e3 ubiquitin - protein ligase chfr
zygomycosis
giardia
cryptosporidium
idh1 gene
idh1 wt allele
isocitrate dehydrogenase  [ nadp ]  cytoplasmic
bisantrene hydrochloride
linaclotide acetate
cardiac sarcoma
small intestinal carcinoma
small intestinal leiomyoma
alniditan
kidney fibrosarcoma
canadian cardiovascular society grading scale class i
canadian cardiovascular society grading scale class ii
canadian cardiovascular society grading scale class iii
canadian cardiovascular society grading scale class iv
killip class i
light chain deposition disease
killip class ii
killip class iii
killip class iv
donor cellular infusion
scrotal paget disease
squamous cell carcinoma of the penis
procarbazine hydrochloride
penile sarcoma
prostate sarcoma
renal pelvis squamous cell carcinoma
testicular choriocarcinoma
abiraterone
tongue lipoma
vaginal clear cell adenocarcinoma
vaginal squamous cell carcinoma ,  not otherwise specified
denotivir
vaginal sarcoma
alestramustine
ecomustine
terlipressin
darunavir ethanolate
brain hemangioma
mozenavir
vidarabine anhydrous
prochlorperazine
peau d'orange
ketotrexate
digestive system hemangioma
laryngeal squamous cell papilloma
histrelin acetate
mouth mucous membrane leukoplakia
mucous membrane hemangioma
lovastatin acid
scrotal cyst
hydrogen cyanide
methyl chloride
cardiac myxoma
skin fibrohistiocytic neoplasm
prochlorperazine maleate
azosemide
ispinesib mesylate
angiokeratoma of fordyce
activated charcoal
cdisc send terminology
cdisc cdash terminology
cdisc send pre - clinical units of measure terminology
cdisc send biospecimens terminology
malignant pericarditis
cdisc send laboratory animal strain terminology
recumbent position
umbilicus
arbitrary fluorescence units
relative fluorescence intensity unit
skinfold thickness analysis
rating
day of the week
juvenile polyposis syndrome
gadobenate dimeglumine
gadoxetate disodium
peutz - jeghers polyp of the small intestine
azolimine
bemitradine
cicletanine
clazolimine
clofenamide
mersalyl
acepromazine
azetepa
apocrine metaplasia of breast
progestin
unit of radioactive decay
unit per gram
unit per milliliter
abdominal wall
bone marrow smear
iris implantation cyst
circumanal gland
abdominal fluid
peritoneal fluid
pleural fluid
gastric content
gizzard
gland of the third eyelid
clitoral gland
coagulating gland
harderian gland
perianal gland
perineal gland
dorsolateral prostate gland
ventral prostate gland
zygomatic gland
hind limb
hoof wall
hurthle cell metaplasia of thyroid gland
oral mucosa
cranial cavity
gravid uterus
atypical lymphoproliferative disorder
hepatic lymph node
mesenteric lymph node
pancreatic lymph node
paraaortic lymph node
peritoneal lymph node
portal lymph node
renal lymph node
sacral lymph node
retrosacral lymph node
retropharyngeal lymph node
osteosclerotic plasma cell myeloma
submandibular lymph node
tracheobronchial lymph node
intercostal lymph node
ileocecocolic lymph node
prescapular lymph node
sublumbar lymph node
suprapharyngeal lymph node
nictitating membrane
milk serum
nasal - associated lymphoid tissue
stage iii colon cancer ajcc v6
paw
glandular stomach
nonglandular stomach
tail
teat
whole animal
vomitus
thyroid / parathyroid
testis / epididymis
liver / gallbladder
stage i breast cancer ajcc v6
prostate / seminal vesicles
foot / footpad
uterus / ovaries
auricular vein
plantar nerve
sural nerve
application site
biopsy site
implantation site
infusion site
stage ii breast cancer ajcc v6 and v7
injection site
injury site
microchip site
incision site
tattoo site
exteriorization site
bone marrow ,  femur
bone marrow ,  humerus
bone marrow ,  rib
bone marrow ,  scapula
stage iii breast cancer ajcc v6
bone marrow ,  sternum
bone marrow ,  tibia
bone marrow ,  vertebral
therapeutic progesterone
stage iiia breast cancer ajcc v7
recurrent breast carcinoma
stage i gastric cancer ajcc v6
stage ii gastric cancer ajcc v6
stage iii gastric cancer ajcc v6
stage ii anal canal cancer ajcc v6 and v7
stage iii anal canal cancer ajcc v6 and v7
stage ii lung non - small cell cancer ajcc v7
stage iii lung non - small cell cancer ajcc v7
superior sulcus lung carcinoma
varicella - zoster virus strain oka / merck live antigen
prolactin
localized osteosarcoma
gerbil
cdisc send laboratory animal species terminology
south or central american indian
metastatic osteosarcoma
caribbean indian
mediterranean
north american
north coast of africa
northern european
black south or central american
white caribbean
western european
white south or central american
eastern european
stage iiib breast cancer ajcc v7
middle eastern
bufogenin
recurrent lung non - small cell carcinoma
pentetate zinc trisodium
recurrent childhood acute lymphoblastic leukemia
stage i pancreatic cancer ajcc v6 and v7
yttrium y 90 dota anti - cea monoclonal antibody m5a
solitomab
enteric - coated zoledronic acid tablet mer - 101
tyroserleutide
b7 - dc crosslinking antibody rhigm12b7
human monoclonal antibody b11 - hcg beta fusion protein cdx - 1307
tgf - beta - resistant lmp - specific cytotoxic t - lymphocytes
stage ii pancreatic cancer ajcc v6 and v7
prostate health cocktail dietary supplement
smoothened antagonist bms - 833923
natalizumab
imt - 1012 immunotherapeutic vaccine
dm4 - conjugated anti - cripto monoclonal antibody biib015
anti - cea igcd28tcr - transduced autologous t cells
multitargeted tyrosine kinase inhibitor jnj - 26483327
hla - a*2404 - restricted rnf43 - tomm34 - vegfr1 - vegfr2 multipeptide vaccine
hla - a*2402 - restricted koc1 - ttk - co16 - depdc1 - mphosph1 multipeptide vaccine
hla - a*2402 - restricted vegfr1 peptide vaccine
stage iii pancreatic cancer ajcc v6 and v7
polyvalent antigen - klh conjugate vaccine
milk protein - based energy drink
ganetespib
strawberry - blackberry - black raspberry - blueberry mixture
allogeneic multipotent adult progenitor cells
hla - a*2402 - restricted urlc10 - koc1 - vegfr1 - vegfr2 multipeptide vaccine
glesatinib
murine tyrp2 plasmid dna vaccine
hla - a*0201 - restricted vegfr1 peptide vaccine
glycosylated recombinant human interleukin - 7
stage 0 gastric cancer ajcc v6 and v7
milataxel
glucosamine sulfate / chondroitin sulfate tablet
lexibulin
ashwagandha root powder extract
tlr agonist cadi - 05
yttrium y 90 anti - cea monoclonal antibody ct84 .66
anti - cd30 monoclonal antibody mdx - 1401
sapitinib
ruxolitinib
sodium glycididazole
recurrent adult hodgkin lymphoma
50% oxygen / 50% nitrous oxide premix
samalizumab
epothilone kos - 1584
c - met inhibitor jnj - 38877605
vegfr1 - 1084 peptide vaccine
tucatinib
hla - a*2402 - restricted urlc10 - ttk - koc1 multipeptide vaccine
technetium tc 99m - labeled tilmanocept
raralpha agonist irx5183
promethazine
stage i rectal cancer ajcc v6 and v7
hla - a*0201 - restricted urlc10 - vegfr1 - vegfr2 multipeptide vaccine
serdemetan
hla - a*0201 - restricted vegfr1 - vegfr2 multipeptide vaccine
pevonedistat
rocapuldencel - t
trametinib
bizalimogene ralaplasmid
stage ii rectal cancer ajcc v6
ad - sig - hmuc - 1 / ecdcd40l vaccine
iodine i 123 anti - cea recombinant diabody t84 .66
quisinostat
protista
aerosol sargramostim
protozoa
arthropoda
stage iii rectal cancer ajcc v6
workforce
white collar worker
alamifovir
arildone
cidofovir anhydrous
famotine hydrochloride
methisazone
taribavirin hydrochloride
recurrent anal canal carcinoma
toluene
stage 0 anal canal cancer ajcc v6 and v7
cridanimod
urban
relocation
proctocolitis
zymbal gland
ampullary gland
forestomach
oviduct
polyethylene glycol 3350 - based laxative
poor
stage i mycosis fungoides ajcc v7
fear
joy
hope
crying
center for epidemiologic studies depression scale
feelings
unusual
friendly
like
fgf receptor antagonist hgs1036
immunotherapy regimen mkc - 1106 - mt
world
stage ii mycosis fungoides ajcc v7
aprosulate sodium
eribaxaban
rivaroxaban
attenuated corynebacterium parvum
stage iii mycosis fungoides ajcc v7
stage iv mycosis fungoides ajcc v7
maropitant citrate
stage ii cervical cancer ajcc v6
recurrent cervical carcinoma
aplaviroc
bevirimat
bevirimat dimeglumine
n -  ( 4 - chloro - 3 -  (  ( 3 - methyl - 2 - butenyl ) oxy ) phenyl )  - 2 - methyl - 3 - furancarbothioamide
clofoctol
azacosterol hydrochloride
recurrent primary cutaneous t - cell non - hodgkin lymphoma
clinofibrate
clofibride
colesevelam
chloroquine sulfate
localized ewing sarcoma
metastatic ewing sarcoma
recurrent ewing sarcoma
cedefingol
clanfenur
epipropidine
methoxyamine
methoxyamine hydrochloride
adult fibrosarcoma
propylthiouracil
adult leiomyosarcoma
adult liposarcoma
solitary plasmacytoma of bone
sugammadex sodium
balaglitazone
dapagliflozin
glidazamide
albiglutide
sergliflozin etabonate
refractory plasma cell neoplasm
tolbutamide sodium
nqo1*2 allele
cavitation
egf a61g allele
hpgd gene
hpgd wt allele
drug test
adult malignant peripheral nerve sheath tumor
15 - hydroxyprostaglandin dehydrogenase  [ nad +  ]
kdm1a gene
kdm1a wt allele
lysine - specific histone demethylase 1a
esophagogastroduodenoscopy
cd86 gene
cd86 wt allele
t - lymphocyte activation antigen cd86
txlna gene
txlna wt allele
recurrent childhood rhabdomyosarcoma
alpha - taxilin
ackr1 gene
ackr1 wt allele
atypical chemokine receptor 1
lrrk2 gene
lrrk2 wt allele
leucine - rich repeat serine / threonine - protein kinase 2
cd248 gene
cd248 wt allele
endosialin
childhood craniopharyngioma
polymyxin antibiotic
abdominal distension
gastrointestinal endoscopy
akathisia
histamine challenge test
abdominal soft tissue necrotic lesion
challenge
alcohol intolerance
anal hemorrhage
anal infection
adult synovial sarcoma
anal mucositis
anal necrotic lesion
anal pain
anal stenosis
anorectal infection
bitmask
coping
anorgasmia
acute perforated appendicitis
radioallergosorbent test
stage i adult soft tissue sarcoma ajcc v7
abnormal audiogram
serum bicarbonate decreased
bile duct stenosis
biliary anastomotic leakage
coriolus versicolor extract
sodium ferric gluconate complex in sucrose
rucaparib phosphate
anti - cd70 monoclonal antibody mdx - 1411
aviscumine
stage ii adult soft tissue sarcoma ajcc v7
aurora a kinase / tyrosine kinase inhibitor enmd - 2076
autologous dinitrophenyl - modified ovarian cancer vaccine
ponatinib hydrochloride
sonepcizumab
docetaxel emulsion anx - 514
autologous anti - psma gene - modified t - lymphocytes
calaspargase pegol - mknl
fak inhibitor pf - 00562271
alpha - gal glycosphingolipids
allogeneic lmp1 / lmp2 - specific cytotoxic t - lymphocytes
8 - hydroxyquinoline sulfate ointment
5 -  [ 18f ] fluorouracil
regorafenib
gluteal muscle
bladder anastomotic leakage
bladder pain
bladder perforation
ability
stage iv adult soft tissue sarcoma ajcc v7
bladder spasm
vapor phase cooling
bladder neck stenosis
bloating
abnormal blood antidiuretic hormone
blood corticotrophin decreased
abnormal blood gonadotrophin
abnormal blood prolactin
sudan iv staining method
below normal body height
recurrent adult soft tissue sarcoma
test strip
abnormal bone development
breast hypoplasia
breast pain
bronchial hemorrhage
bronchial obstruction
bronchial stricture
igg4
buttock pain
decreased carbon monoxide diffusing capacity
stage i renal cell cancer ajcc v6 and v7
blood cardiac troponin i increased
blood cardiac troponin t increased
catheter - related infection
cd4 lymphocytes decreased
cecal hemorrhage
cecal infection
central nervous system necrotic lesion
retirement
chest wall pain
colonic fistula
stage ii renal cell cancer ajcc v6
colonic hemorrhage
colonic obstruction
colonic perforation
colonic stenosis
colonic ulcer
cardiac conduction disorder
constrictive pericarditis
creatine phosphokinase increased
cranial nerve infection
increased creatinine
recurrent renal cell carcinoma
non - infectious cystitis
cytokine release syndrome
delayed orgasm
depressed level of consciousness
device complication
device - related infection
duodenal fistula
duodenal hemorrhage
duodenal infection
duodenal perforation
localized parathyroid gland carcinoma
duodenal stenosis
pharyngeal dysesthesia
edema limbs
edema trunk
ejaculation disorder
infective endocarditis
enterovesical fistula
delayed epiphyseal fusion
premature epiphyseal fusion
rule
metastatic malignant parathyroid gland neoplasm
esophageal anastomotic leakage
esophageal hemorrhage
agent affecting nervous system
agent affecting respiratory system
agent affecting cardiovascular system
agent affecting blood or body fluid
agent affecting digestive system or metabolism
esophageal infection
esophageal necrotic lesion
esophageal obstruction
recurrent parathyroid gland carcinoma
esophageal pain
agent affecting musculoskeletal system
esophageal varices hemorrhage
agent affecting organs of special senses
agent affecting integumentary system
external ear pain
extraocular muscle paresis
eye pain
eyelid function disorder
face edema
stage i ovarian cancer ajcc v6 and v7
facial muscle weakness
eye muscle weakness
fallopian tube anastomotic leakage
fallopian tube obstruction
fallopian tube perforation
fallopian tube stenosis
acquired fanconi syndrome
adipose tissue atrophy
female genital tract fistula
acquired feminization
protease inhibitor
stage ii ovarian cancer ajcc v6 and v7
fibrinogen decreased
deep connective tissue fibrosis
flu - like symptoms
gait disturbance
gallbladder pain
gallbladder fistula
gallbladder infection
gallbladder necrotic lesion
gallbladder obstruction
gallbladder perforation
stage iii ovarian cancer ajcc v6 and v7
gastric anastomotic leakage
hemostatic agent
gastric infection
gastric mucositis
gastric necrotic lesion
government
gastric perforation
gastric stenosis
digestive system anastomotic leakage
digestive system fistula
stage iv ovarian cancer ajcc v6 and v7
gastrointestinal pain
gastrointestinal stoma necrotic lesion
cardiotonic agent
generalized muscle weakness
genital edema
gingival pain
glomerular filtration rate decreased
abnormal growth hormone
growth retardation
gum infection
recurrent ovarian carcinoma
haptoglobin decreased
head soft tissue necrotic lesion
hematosalpinx
hemoglobin increased
bile duct hemorrhage
foundation
urinary tract hemorrhage
hemorrhoidal hemorrhage
hepatic hemorrhage
hepatic infection
recurrent childhood brain neoplasm
hepatic necrotic lesion
hepatic pain
reflex
recruitment
contingent
hyperhidrosis
hypersomnia
cluster of differentiation
r -  (  -  )  - gossypol acetic acid
hypomania
localized resectable neuroblastoma
hypoparathyroidism
hypothermia
ileal fistula
ileal hemorrhage
ileal obstruction
ileal perforation
ileal stenosis
ileal ulcer
implant infection
infectious colitis
regional neuroblastoma
infectious cervicitis
infusion - related reaction
infusion site extravasation
injury to inferior vena cava
injury to jugular vein
injury to superior vena cava
inr increased
intraoperative injury
intestinal necrotic lesion
intestinal stoma leakage
recurrent neuroblastoma
intestinal stoma obstruction
intestinal stoma site hemorrhage
intra - abdominal hemorrhage
dietary route of administration
oral gavage route of administration
intraoperative arterial injury
intraoperative breast injury
intraoperative cardiac injury
intraoperative ear injury
intraoperative endocrine injury
stage iv childhood hepatocellular carcinoma ajcc v7
intraoperative digestive system injury
intraoperative head and neck injury
intraoperative hepatobiliary injury
intraoperative musculoskeletal injury
intraoperative neurological injury
intraoperative ocular injury
intraoperative renal injury
intraoperative reproductive system injury
intraoperative respiratory injury
intraoperative skin injury
recurrent childhood malignant liver neoplasm
intraoperative splenic injury
intraoperative urinary system injury
intraoperative venous injury
iron overload
cerebrovascular ischemia
trochlear nerve disorder
jejunal fistula
jejunal hemorrhage
jejunal obstruction
jejunal perforation
protein synthesis inhibitor
stage i kidney wilms tumor
jejunal stenosis
jejunal ulcer
joint infection
joint range of motion decreased
cervical spine joint range of motion decreased
lumbar spine joint range of motion decreased
kidney anastomotic leakage
kidney perforation
large intestinal anastomotic leakage
large intestinal mucositis
stage ii kidney wilms tumor
laryngeal fistula
laryngeal hemorrhage
laryngeal mucositis
laryngeal obstruction
laryngopharyngeal dysesthesia
money
lethargy
cdisc cdash concomitant medication dose units terminology
cdisc cdash concomitant medication dose form terminology
cdisc cdash concomitant medication dosing frequency per interval terminology
stage iii kidney wilms tumor
cdisc cdash concomitant medication route of administration terminology
cdisc cdash unit of drug dispensed or returned terminology
cdisc cdash ecg original units terminology
cdisc cdash units for exposure terminology
cdisc cdash exposure route of administration terminology
cdisc cdash exposure dose form terminology
cdisc cdash unit for duration of treatment interruption terminology
cdisc cdash total volume administration unit terminology
cdisc cdash unit of measure for flow rate terminology
stage iv kidney wilms tumor
cdisc cdash units for planned exposure terminology
cdisc cdash vital signs position of subject terminology
decreased libido
increased libido
lip infection
hyperlipasemia
lipohypertrophy
localized edema
lower gastrointestinal hemorrhage
lymph leakage
stage v kidney wilms tumor
lymph node pain
start time
lymphocele
mediastinal hemorrhage
memory impairment
grandfather clause
mitral valve disorder
semuloparin
mesothelioma tumor lysate - pulsed autologous dendritic cell vaccine
glembatumumab vedotin
recurrent kidney wilms tumor
transferrin receptor - targeted anti - rrm2 sirna calaa - 01
di - leu16 - il2 immunocytokine
mouth necrotic lesion
involuntary movements
mucosal infection
muscle weakness left - sided
muscle weakness lower limb
muscle weakness right - sided
muscle weakness trunk
muscle weakness upper limb
intraocular retinoblastoma
talactoferrin alfa
fentanyl buccal soluble film
magnesium hydroxide / aluminum hydroxide / simethicone suspension
pgg beta - glucan
anti - kir monoclonal antibody iph 2101
autologous pluripotent aldhbr stem cells ald - 451
cmvpp65 - a*0201 peptide vaccine
fluorine f - 18 ml - 10
topical myristyl nicotinate cream
stage 0 chronic lymphocytic leukemia
pi3k inhibitor gsk1059615
estradiol vaginal ring
testosterone vaginal cream
zirconium zr 89 cetuximab
tigapotide
nanatinostat
mtor kinase inhibitor osi - 027
topical betulinic acid
astuprotimut - r
fluorine f 18 fluorocholine
extraocular retinoblastoma
ombrabulin
padeliporfin
blue citrus - based herbal capsule
met tyrosine kinase inhibitor pf - 04217903
iap inhibitor hgs1029
carbon c 11 choline
anti - plgf monoclonal antibody tb - 403
il - 2 / lptn gene - modified allogeneic neuroblastoma tumor cell vaccine
musculoskeletal deformity
alpha - galactosylceramide - pulsed autologous dendritic cells
recurrent retinoblastoma
white button mushroom extract
hyperimmune bovine colostrum
nail discoloration
nail infection
nail loss
nail pitting
urinary incontinence
fecal incontinence
nail ridging
protoporphyrin ix
ds stage i plasma cell myeloma
nasal congestion
neck edema
neck soft tissue necrotic lesion
nipple deformity
non - cardiac chest pain
gastric obstruction
oral cavity fistula
committee
oral pain
ds stage ii plasma cell myeloma
abnormal orgasm
ovarian hemorrhage
ovarian infection
ovarian rupture
ovulatory pain
pain in extremity
skin pain
pancreatic infection
pancreatic anastomotic leakage
pancreatic duct stenosis
ds stage iii plasma cell myeloma
pancreatic enzymes decreased
pancreatic hemorrhage
pancreatic necrotic lesion
cosmetic
pelvic floor muscle weakness
pelvic soft tissue necrotic lesion
penile infection
penile pain
bile duct perforation
perineal pain
limited stage lung small cell carcinoma
periorbital edema
periorbital infection
pseudomonas exotoxin immunoconjugate
peripheral arterial occlusive disease
gaussian distribution
peripheral ischemia
adverse event start date
adverse event end date
polynomial
adverse event start time
stage i vulvar cancer ajcc v6
peritoneal infection
adverse event verbatim description
support vector machine
peritoneal necrotic lesion
kernel function
cross validation
peritoneal pain
bootstrapping
personality change
heatmap
stage 0 vaginal cancer ajcc v6
pharyngeal anastomotic leakage
pharyngeal fistula
pharyngeal mucositis
pharyngeal necrotic lesion
pharyngeal stenosis
pharyngolaryngeal pain
principal components analysis
infective phlebitis
cost function
stage i vaginal cancer ajcc v6 and v7
pleural fistula
optimization
pleural infection
pleuritic pain
portal vein thrombosis
post - nasal drip
thoracic procedure postoperative complication
prostaglandin analogue
productive cough
stage ii vaginal cancer ajcc v6 and v7
intestinal stoma prolapse
urostomy prolapse
prostatic hemorrhage
prostatic obstruction
prostatic pain
prostatic perforation
psychosis
pulmonary fistula
pulmonary hemorrhage
pulmonary valve disorder
stage iii vaginal cancer ajcc v6 and v7
radiation - recall dermatitis
radiculitis
pustular lesion
rectal anastomotic leakage
rectal mucositis
rectal necrotic lesion
rectal obstruction
rectal pain
rectal perforation
rectal stenosis
stage iva vaginal cancer ajcc v6 and v7
rectal ulcer
laryngeal nerve paralysis
recurrent laryngeal nerve paralysis
renal colic
renal hemorrhage
renal pelvis fistula
respiratory tract hemorrhage
apl differentiation syndrome
reversible posterior leukoencephalopathy syndrome
infectious rhinitis
recurrent vaginal carcinoma
salivary duct inflammation
salivary gland infection
infectious salpingitis
scoliosis
adverse event occurrence
adverse event toxicity grade
scrotal infection
scrotal pain
serum amylase increased
sinus pain
localized digestive system neuroendocrine tumor g1
skin hypopigmentation
skin induration
small intestinal anastomotic leakage
small intestinal mucositis
small intestinal necrotic lesion
small intestinal obstruction
small intestinal perforation
small intestinal stenosis
small intestinal infection
small intestinal ulcer
regional digestive system neuroendocrine tumor g1
lower limb soft tissue necrotic lesion
upper limb soft tissue necrotic lesion
spermatic cord anastomotic leakage
spermatic cord hemorrhage
spermatic cord obstruction
spermatic cord perforation
spermatic cord stenosis
splenic infection
gastrointestinal stoma stenosis
stoma site infection
stomach pain
striae
stridor
superficial soft tissue fibrosis
superficial thrombophlebitis
testicular hemorrhage
testicular pain
testicular perforation
thrombus in catheter
tooth infection
recurrent digestive system neuroendocrine tumor g1
toothache
tracheal fistula
tracheal hemorrhage
tracheitis
tracheal mucositis
tracheal obstruction
tracheal stenosis
bacterial tracheitis
tracheostomy site bleeding
tricuspid valve disorder
advanced malignant mesothelioma
aortic valve disorder
trismus
pediatric quality of life inventory
activities scale for kids
grip
tumor flare reaction
tumor pain
unequal limb length
upper aerodigestive tract infection
upper extremity dysfunction
recurrent malignant mesothelioma
upper gastrointestinal hemorrhage
ureteral stricture
ureteric anastomotic leakage
ureteric fistula
ureteric hemorrhage
ureteric perforation
ureteritis
urethral anastomotic leakage
urethral fistula
urethral hemorrhage
stage i penile cancer ajcc v6
urethral infection
urethral pain
urethral perforation
urinary bladder hemorrhage
atorvastatin sodium
urine discoloration
urostomy leakage
stage ii penile cancer ajcc v6
urostomy obstruction
urostomy perforation
urostomy site bleeding
urostomy stenosis
uterine anastomotic leakage
uterine fistula
uterine hemorrhage
internal consistency
inter - rater reliability
test - retest reliability
stage iii penile cancer ajcc v6
content validity
construct validity
criterion validity
uterine obstruction
uterine pain
colorectal cancer pt4a tnm finding v6
colorectal cancer pt4b tnm finding v6
uterine cervical stenosis
vaginal anastomotic leakage
vaginal dryness
puromycin
recurrent penile carcinoma
vaginal obstruction
vaginal pain
vaginal perforation
vaginismus
vas deferens anastomotic leakage
vas deferens hemorrhage
vas deferens obstruction
vas deferens perforation
vas deferens stenosis
vascular access complication
adult diffuse mixed cell lymphoma
vascular implant infection
venous injury
visceral artery ischemia
animal colony
visceral edema
abnormal vital capacity
vulval infection
watering eyes
wheezing
wound complication
adult diffuse large cell lymphoma
independent rater
dispensed amount
returned amount
calcified specimen
clotted specimen
autolyzed specimen
adjudication committee
normal reference range
many
arterial blood
adult immunoblastic lymphoma
venous blood
cdisc sdtm drug accountability test name terminology
cdisc sdtm drug accountability test code terminology
cdisc sdtm specimen condition terminology
cdisc sdtm specimen type terminology
cdisc sdtm evaluator terminology
cdisc sdtm reference range indicator
cdisc sdtm relationship type terminology
cdisc sdtm never / current / former classification terminology
atherosclerotic plaque
stage i chronic lymphocytic leukemia
menstrual blood
expired air
lochia
meconium
transudate
cdisc cdash exposure dosing frequency per interval terminology
21 day tablet dosage form
28 day tablet dosage form
gargle dosage form
tar dosage form
stage ii chronic lymphocytic leukemia
wax dosage form
sustained release tablet dosage form
compliance cap
shot dosing unit
atorvastatin calcium anhydrous
stage iii chronic lymphocytic leukemia
localized resectable adult liver carcinoma
microinch
twenty pack
aluminum lactate
eleven pack
three pack
four pack
five pack
six pack
seven pack
localized unresectable adult liver carcinoma
eight pack
nine pack
ten pack
applicatorful dosing unit
tub dosing unit
pen calorie
pen gram protein
purpura
milli - inch
internal powder dosage form
thrombotic thrombocytopenic purpura
benethamine penicillin
pyrimethamine
recurrent adult liver carcinoma
value above reference range
value below reference range
abnormal reference range
scanning probe microscope
atomic force microscope
energy dispersive spectrometer
flow cytometer
hemocytometer
imaging system
refractometer
recurrent osteosarcoma
scintillation counter
thermal cycler
laser doppler velocimetry - phase analysis light scattering system
transmission electron microscope
scanning electron microscope
focused ion beam - scanning electron microscope
scanning auger spectrometer
electron microprobe
psma / tarp peptide vaccine
recurrent adult acute myeloid leukemia
padre - cmv fusion peptide vaccine
tetanus - cmv fusion peptide vaccine
stat3 decoy oligonucleotide
autologous pbtl cd19car - 28 zeta
autologous ebv - ctl cd19car zeta
idelalisib
anti - dr5 agonist monoclonal antibody tra - 8
iofolastat i123
iodine i - 123 mip - 1095
cd4 +  cd25 +  regulatory t cells
recurrent adult acute lymphoblastic leukemia
autologous ofa - ilrp rna - transfected dendritic cell vaccine
androstane steroid he3235
lv .il - 2 / b7 .1 - transduced aml blast vaccine rfusin2 - aml1
fusidic acid / betamethasone valerate topical cream
erythromycin topical cream
derma - membrane - structure topical cream
pacritinib
imgatuzumab
anti - integrin monoclonal antibody - dm4 immunoconjugate imgn388
recurrent adult brain neoplasm
indatuximab ravtansine
tubulin inhibitor alb 109564 dihydrochloride
oral hsp90 inhibitor ipi - 493
ficlatuzumab
tetrodotoxin
hsp90 inhibitor biib028
sonolisib
curcumin / green tea extract / polygonum cuspidatum extract / soybean extract capsule
hdac / egfr / her2 inhibitor cudc - 101
anti - pd - l1 monoclonal antibody mdx - 1105
patritumab
dinaciclib
powder diffractometer
mtor kinase inhibitor azd8055
calcium aluminosilicate anti - diarrheal
seribantumab
refractory chronic lymphocytic leukemia
environmental transmission electron microscope
allogeneic melanoma vaccine agi - 101h
allogeneic large multivalent immunogen melanoma vaccine lp2307
camsirubicin
pomegranate - extract pill
wt1 - a10 / as01b immunotherapeutic gsk2130579a
pomegranate liquid extract
unpaired
electrophoretic light scattering
energy dispersive spectroscopy
recurrent gestational trophoblastic tumor
laser doppler velocimetry - phase analysis light scattering
x - ray photoelectron spectroscopy
powder diffraction
electron microprobe analysis
high resolution transmission electron microscopy
gas sorption
small intestinal adenocarcinoma
duodenal adenocarcinoma
pyrimidine
unresectable gallbladder carcinoma
localized extrahepatic bile duct carcinoma
unresectable extrahepatic bile duct carcinoma
recurrent extrahepatic bile duct carcinoma
recurrent small intestinal carcinoma
stage 0 bladder cancer ajcc v6 and v7
stage i bladder cancer ajcc v6 and v7
stage ii bladder cancer ajcc v6 and v7
stage iii bladder cancer ajcc v6 and v7
recurrent bladder carcinoma
pyrimidine dimer
stage iv bladder cancer ajcc v6
stage i testicular cancer ajcc v6 and v7
recurrent prostate carcinoma
recurrent skin carcinoma
invasive malignant thymoma
recurrent malignant thymoma
thyroid gland anaplastic carcinoma ,  osteoclastic variant
cda gene
cda wt allele
kif11 gene
kif11 wt allele
recurrent thyroid gland carcinoma
laparoscopic port
intellectual property rights
surgical stapler
outlier
gistic
eta
ca - 125 measurement
acth - producing pituitary gland neoplasm
retractor
laparoscopic retractor
smoke evacuator
ph +  / bcr -
ph +  / bcr +
illicit substance
1p / 19q codeletion
crystalline silica quartz
prolactin - producing pituitary gland neoplasm
mgmt methylation assay
hiv measurement
caviidae
carnivora
artiodactyla
lagomorpha
perissodactyla
cingulata
growth hormone - producing pituitary gland neoplasm
dibekacin
recurrent anterior pituitary gland neoplasm
positive ebv test
ocular melanoma with extraocular extension
fish flavor
flexible intermediate bulk container
pail
intramammary route of administration
intralingual route of administration
intraruminal route of administration
recurrent uveal melanoma
subretinal route of administration
device difficult to maintain
misassembled by users
tsh - producing pituitary gland neoplasm
stage i cutaneous melanoma ajcc v6
stage ii cutaneous melanoma ajcc v6 and v7
clinical study reports and related information
stage iii cutaneous melanoma ajcc v6
letter of authorization
quercetin
stage ii nasopharyngeal carcinoma ajcc v6
new york heart association class iii / iv
adult extraskeletal myxoid chondrosarcoma
adult extraskeletal osteosarcoma
recurrent salivary gland carcinoma
participant object
liver and intrahepatic bile duct carcinoma
family collection
study reports: pharmacokinetics
childhood germ cell tumor
quinidine
lymphomatoid granulomatosis
grade i lymphomatoid granulomatosis
grade ii lymphomatoid granulomatosis
grade iii lymphomatoid granulomatosis
drug product: manufacturer ( s )
recurrent kaposi sarcoma
adult acute myeloid leukemia in remission
adult acute lymphoblastic leukemia in remission
childhood acute lymphoblastic leukemia in remission
stage 0 lip and oral cavity cancer ajcc v6 and v7
quinine
childhood acute monoblastic and monocytic leukemia
body temperature associated symptom
diagnostic mammography
kras mutation analysis
cefazaflur
adult nodular lymphocyte predominant hodgkin lymphoma
cefoselis
carbenicillin phenyl sodium
gaussian kernel
kernel bandwidth
voxel
ikzf1 gene mutation
adult alveolar soft part sarcoma
preputial gland
alpha glutathione - s - transferase measurement
corticosterone measurement
glutathione - s - transferase to creatinine ratio measurement
myoglobin measurement
5 prime nucleotidase measurement
alkaline phosphatase to creatinine ratio measurement
calcium to creatinine ratio measurement
adult epithelioid sarcoma
chloride to creatinine ratio measurement
creatine kinase mb to total creatine kinase ratio measurement
creatine kinase mm to total creatine kinase ratio measurement
deoxypyridinoline measurement
deoxypyridinoline to creatinine ratio measurement
epinephrine measurement
gamma glutamyl transferase to creatinine ratio measurement
glucose to creatinine ratio measurement
glutamate dehydrogenase measurement
lactate dehydrogenase to creatinine ratio measurement
lactic acid measurement
ldh isoenzyme 1 to ldh ratio measurement
ldh isoenzyme 2 to ldh ratio measurement
ldh isoenzyme 3 to ldh ratio measurement
ldh isoenzyme 4 to ldh ratio measurement
ldh isoenzyme 5 to ldh ratio measurement
magnesium to creatinine ratio measurement
mu glutathione - s - transferase measurement
mu glutathione - s - transferase to creatinine ratio measurement
n - acetyl glucosamide measurement
malignant adult hemangiopericytoma
n - acetyl glucosamide to creatinine ratio measurement
phosphate to creatinine ratio measurement
potassium to creatinine ratio measurement
protein to creatinine ratio measurement
sodium to creatinine ratio measurement
sorbitol dehydrogenase measurement
creatine kinase bb to total creatine kinase ratio measurement
large unstained cells to leukocytes ratio measurement
digestive system stenosis
adult malignant mesenchymoma
digestive system perforation
reproductive system hemorrhage
urinary tract stenosis
milliliter of water
batroxobin
stevens - johnson syndrome
breast ductal carcinoma in situ ,  high grade
quinolone antibiotic
invasive breast lobular carcinoma
breast paget disease with invasive ductal carcinoma
childhood burkitt leukemia
ambenonium chloride tetrahydrate
banoxantrone
childhood t acute lymphoblastic leukemia
agitation
allergic rhinitis
anal ulcer
benfosformin anhydrous
camiglibose
aphonia
adult burkitt leukemia
biliary fistula
bladder obstruction
body odor
bronchial fistula
non - neoplastic lip disorder
cheilitis
diastolic dysfunction
duodenal obstruction
dysarthria
childhood hepatocellular carcinoma
infectious encephalitis
infectious encephalomyelitis
enophthalmos
adult hepatocellular carcinoma
cefadroxil anhydrous
cefpirome
cefquinome
celgosivir
bapineuzumab
childhood embryonal rhabdomyosarcoma
enterocolitis
esophageal fistula
esophageal mucositis
childhood alveolar rhabdomyosarcoma
childhood pleomorphic rhabdomyosarcoma
extrapyramidal disorder
facial pain
gastric fistula
hepatic encephalopathy
hypertrichosis
infectious meningitis
injury to carotid artery
quinone compound
childhood rhabdomyosarcoma with mixed embryonal and alveolar features
otitis externa
poikilocyte measurement
joint stiffness
lactation disorder
laryngeal edema
laryngeal stenosis
laryngospasm
adult acute myeloid leukemia with maturation
fluid dram british
plant part
adult acute myelomonocytic leukemia
callus
adult acute eosinophilic leukemia
adult acute basophilic leukemia
adult acute megakaryoblastic leukemia
colon mucinous adenocarcinoma
colon signet ring cell adenocarcinoma
childhood acute promyelocytic leukemia with pml - rara
lip pain
plant oil
meningismus
neuralgia
neurogenic bladder
ophthalmoplegia
optic nerve disorder
oral hemorrhage
radioprotective agent
childhood acute myelomonocytic leukemia
ovulation pain
pancreatic fistula
paronychia
phantom pain
precocious puberty
prosthesis - related infection
childhood acute basophilic leukemia
rectal fistula
ammonia n - 13
salivary gland fistula
scalp pain
sclera disorder
serum sickness
childhood acute megakaryoblastic leukemia
benzylhydrochlorothiazide
asked but unknown
rectal mucinous adenocarcinoma
couinaud liver segment
skin hyperpigmentation
left posterolateral segment
left anterolateral segment
left superomedial segment
left inferomedial segment
right anteroinferior segment
right posteroinferior segment
right posterosuperior segment
right anterosuperior segment
rectal undifferentiated carcinoma
hominidae
cricetidae
soft tissue infection
sox18 gene
sox18 wt allele
atrophy
transcription factor sox - 18
extrahepatic bile duct adenocarcinoma
spasticity
procedure
hepatocellular
defer
bhlhe22 gene
bhlhe22 wt allele
class e basic helix - loop - helix protein 22
distal bile duct adenocarcinoma
barcelona criteria
carbenicillin phenyl
mtnr1b gene
mtnr1b wt allele
melatonin receptor type 1b
stokes - adams syndrome
stomal ulcer
lrig1 gene
lrig1 wt allele
leucine - rich repeats and immunoglobulin - like domains protein 1
pancreatic acinar cell carcinoma
ctnnd1 gene
ctnnd1 wt allele
catenin delta - 1
clptm1l gene
clptm1l wt allele
cleft lip and palate transmembrane protein 1 - like protein
toxic epidermal necrolysis
ido1 gene
ovarian serous cystadenocarcinoma
ido1 wt allele
indoleamine 2 , 3 - dioxygenase 1
pea15 gene
pea15 wt allele
ovarian endometrioid adenocarcinoma
astrocytic phosphoprotein pea - 15
palld gene
palld wt allele
palladin
vegfr / pdgfr tyrosine kinase inhibitor tak - 593
anti - ganglioside gm2 monoclonal antibody biw - 8962
chlorazanil
probiotic acidophilus
anti - igf - 1r monoclonal antibody ave1642
allogeneic large multivalent immunogen breast cancer vaccine
radiosensitizing agent
ovarian clear cell cystadenocarcinoma
ad5 - cmv - nis
unintended pregnancy
ureter obstruction
gemcitabine elaidate
urethral obstruction
urinary tract obstruction
colorectal tumor - associated peptides vaccine ima910
chlorazanil hydrochloride
icrucumab
defactinib
vaginal adenocarcinoma
azalanstat
azacosterol
cervical small cell neuroendocrine carcinoma
aluminum clofibrate
urethral stricture
copper cu 64 - atsm
olaratumab
namodenoson
irosustat
cixutumumab
borderline ovarian endometrioid tumor / atypical proliferative ovarian endometrioid tumor
taltirelin hydrate
masitinib mesylate
alvac ( 2 )  - ny - eso - 1  ( m )  / tricom vaccine
olvimulogene nanivacirepvec
anti - her - 2 - car retroviral vector - transduced autologous peripheral blood lymphocytes
hsp90 inhibitor xl888
anti - epha2 monoclonal antibody - mmaf immunoconjugate medi - 547
mct / lct lipid emulsion
mct / lct / fish oil omega - 3 fatty acid lipid emulsion
elesclomol sodium
talmapimod
anti - cea tcr retroviral vector - transduced autologous peripheral blood lymphocytes
il4 - pseudomonas exotoxin fusion protein mdna55
volasertib
ppe - expressing replication - defective hsv - 1 vector np2
vaginal fistula
mek - 1 / mekk - 1 inhibitor e6201
bladder fistula
epithelioid mesothelioma
urinary tract fistula
abnormal virilization
spindle cell uveal melanoma
chk1 inhibitor mk - 8776
united states military cancer institute
spindle cell type a uveal melanoma
apricitabine
contain
conjunction
carumonam
spindle cell type b uveal melanoma
member organization
authority
intermediate cell type uveal melanoma
jurisdiction
reuse
concern
transference
radioisotope
necrotic uveal melanoma
blood smear
tmprss2 / erg fusion gene
carumonam sodium
salivary gland squamous cell carcinoma
caricotamide
investigative subject
nasopharyngeal keratinizing squamous cell carcinoma
butoconazole
parathyroid gland clear cell adenoma
parathyroid gland mixed cell type adenoma
dedifferentiated solitary fibrous tumor
carcinoma arising from craniopharyngioma
granular renal cell carcinoma
benign carotid body paraganglioma
papillary adenoma
tubulostromal adenoma
wik zebrafish
cologne zebrafish
ab / tubingen zebrafish
nadia zebrafish
c32 zebrafish
wild type unspecified zebrafish
malignant type b1 thymoma
ttr gene
almitrine mesylate
ttr wt allele
transthyretin
loge
ab zebrafish
homology
darjeeling zebrafish
thymoma type b3
ekkwill zebrafish
hk / ab zebrafish
hk / sing zebrafish
hong kong zebrafish
india zebrafish
indonesia zebrafish
jejunostomy
riken wt zebrafish
thymic lymphoepithelioma - like carcinoma
singapore zebrafish
sja zebrafish
tubingen zebrafish
tupfel long fin zebrafish
tupfel long fin nacre zebrafish
ab / c32 zebrafish
ab / tl zebrafish
sjd zebrafish
sjd / c32 zebrafish
wik / ab zebrafish
malignant type a thymoma
cefprozil anhydrous
copper undecylenate
radon
testicular yolk sac tumor
testicular mixed embryonal carcinoma and yolk sac tumor
html browser
conceptual parent
combretastatin
sodium picosulfate / magnesium oxide / citric acid laxative
kdm6b gene
kdm6b wt allele
lysine - specific demethylase 6b
testicular mixed yolk sac tumor and teratoma
tardbp gene
tardbp wt allele
tar dna - binding protein 43
ebf1 gene
ebf1 wt allele
transcription factor coe1
ikzf2 gene
ikzf2 wt allele
zinc finger protein helios
ikzf3 gene
testicular mixed yolk sac tumor and teratoma with seminoma
ikzf3 wt allele
zinc finger protein aiolos
lef1 gene
lef1 wt allele
lymphoid enhancer - binding factor 1
2' - f - ara - deoxyuridine
sotatercept
devimistat
anti - dkk1 monoclonal antibody bhq880
demcizumab
anti - gd2 monoclonal antibody hu14 .18k322a
codrituzumab
lacnotuzumab
enavatuzumab
b16alphagal melanoma vaccine
camptothecin analogue tlc388
caricotamide / tretazicar
cdk4 inhibitor p1446a - 05
copper gluconate
cyclosporine ophthalmic emulsion
cytomegalovirus ie - 1 - specific cytotoxic t lymphocytes
htert vaccine v934 / v935
ioflubenzamide i - 131
l - carnitine l - tartrate
foretinib
niraparib
pancreatic somatostatin - producing neuroendocrine tumor
raf / mek inhibitor vs - 6766
retinoid 9cuab30
patidegib
technetium tc - 99m mebrofenin
topotecan hydrochloride liposomes
trabedersen
fentanyl matrix transdermal patch
rag1 gene
rag2 gene
rag1 wt allele
rag2 wt allele
v ( d ) j recombination - activating protein 1
v ( d ) j recombination - activating protein 2
health assessment questionnaire - ii
azoospermia
add3 gene
chronic kidney disease
add3 wt allele
sulfate - based laxative bli850
concentration impairment
neonatal death
gamma - adducin
hemoglobin decreased
anhydrous citric acid
amrubicin
cefprozil ,   ( z )  -
cefprozil anhydrous ,   ( z )  -
iobenguane i - 123
liothyronine i - 125
osteoporotic fracture
pitting edema
premature menopause
razoxane
presyncope
btg1 gene
suicidal ideation
btg1 wt allele
protein btg1
cd200 gene
cd200 wt allele
arpp21 gene
arpp21 wt allele
ox - 2 membrane glycoprotein
thyrotroph adenoma
camp - regulated phosphoprotein 21
suicide attempt
tooth discoloration
sirt1 gene
sirt1 wt allele
nad - dependent protein deacetylase sirtuin - 1
tbl1xr1 gene
tbl1xr1 wt allele
f - box - like / wd repeat - containing protein tbl1xr1
papulopustular rash
low grade salivary gland carcinoma
zoledronic acid anhydrous
gadoterate meglumine
azalanstat dihydrochloride
salivary gland acinic cell carcinoma
lactic acid ,  dl -
basic local alignment search tool
gap
binet stage a
binet stage b
binet stage c
known
lip basal cell carcinoma
image registration
image segmentation
news
really simple syndication
low grade salivary gland mucoepidermoid carcinoma
cancer data standards repository
cocaine
fatty acid measurement
talotrexin ammonium
complement measurement
t ( 14 ; 18 )  positive
t ( 14 ; 18 )  negative
acid phosphatase measurement
active glucagon - like peptide - 1 measurement
alpha glucuronidase measurement
alpha glutathione - s - transferase to creatinine ratio measurement
alpha - 1 antitrypsin measurement
alpha - 2 macroglobulin measurement
angiotensin converting enzyme measurement
intermediate grade salivary gland mucoepidermoid carcinoma
beta glucuronidase measurement
cholesterol to hdl - cholesterol ratio measurement
complement bb measurement
complement c1q antibody measurement
complement c3 measurement
complement c3a measurement
complement c3b measurement
complement c4 measurement
complement c4a measurement
complement c5a measurement
high grade salivary gland carcinoma
f2 isoprostane measurement
free non - esterified fatty acids measurement
galanin measurement
glucagon - like peptide - 1 measurement
glucose - 6 - phosphate dehydrogenase measurement
glutathione - s - transferase measurement
gold measurement
hdl - cholesterol subclass 2 measurement
hdl - cholesterol subclass 3 measurement
histamine measurement
high grade salivary gland mucoepidermoid carcinoma
hydroxyproline measurement
macrophage colony stimulating factor measurement
matrix metalloproteinase 1 measurement
matrix metalloproteinase 2 measurement
matrix metalloproteinase 3 measurement
matrix metalloproteinase 7 measurement
matrix metalloproteinase 8 measurement
matrix metalloproteinase 9 measurement
myeloperoxidase measurement
neopterin measurement
reagent
non - esterified fatty acids measurement
pancreatic polypeptide measurement
peptide yy measurement
pi glutathione s - transferase measurement
prostatic acid phosphatase measurement
resistin measurement
saturated non - esterified fatty acids measurement
theta glutathione s - transferase measurement
total radical - trap antioxidant potential measurement
unsaturated non - esterified fatty acids measurement
salivary gland adenocarcinoma
zinc measurement
pyridinoline measurement
antidiuretic hormone analogue
infinity
positive infinity
negative infinity
encode
not asked
trace
deflate algorithm
salivary gland poorly differentiated squamous cell carcinoma
gzip file format
zlib compression
compress algorithm
bzip2 algorithm
7z compression format
secure hash algorithm - 1
secure hash algorithm - 256
vacation
bad
answering machine
nasopharyngeal undifferentiated carcinoma
street
building
intersection
care of
municipality
post office box
subsection
alphabet
ideogram
salivary gland undifferentiated carcinoma
syllable
soundex
phoneme
nickname
pseudonym
artist
meal
breakfast
malignant mixed tumor of the salivary gland
lunch
supper
difluprednate
salivary gland adenoid cystic carcinoma
infrastructure
frame
conformance
rationale
allocupreide sodium
drotrecogin alfa  ( activated )
view
nobility title
braf v600e mutation analysis
internet assigned numbers authority
braf v600e mutation present
phospho - akt immunohistochemical expression analysis
zopiclone
endometrial clear cell adenocarcinoma
diffuse large b - cell lymphoma ,  not otherwise specified
ebv - positive diffuse large b - cell lymphoma ,  not otherwise specified
diffuse large b - cell lymphoma associated with chronic inflammation
progressive hairy cell leukemia initial treatment
plasmablastic lymphoma of the oral mucosa
high grade b - cell lymphoma ,  not otherwise specified
pediatric - type follicular lymphoma
intestinal follicular lymphoma
pediatric nodal marginal zone lymphoma
reserpine
refractory hairy cell leukemia
menthol
light mineral oil
poems syndrome
statistical imputation
pedal edema
waldenstrom macroglobulinemia
splenic b - cell lymphoma / leukemia ,  unclassifiable
splenic diffuse red pulp small b - cell lymphoma
monoclonal b - cell lymphocytosis
one or more positive axillary nodes
zoledronate trisodium
b lymphoblastic leukemia / lymphoma ,  not otherwise specified
safingol hydrochloride
b lymphoblastic leukemia / lymphoma with recurrent genetic abnormalities
recurrent genetic abnormalities present
stage i lip and oral cavity cancer ajcc v6 and v7
b lymphoblastic leukemia / lymphoma with t ( 9 ; 22 )  ( q34 .1 ; q11 .2 )  ;  bcr - abl1
b lymphoblastic leukemia / lymphoma with t ( v ; 11q23 .3 )  ;  mll rearranged
liarozole hydrochloride
b lymphoblastic leukemia / lymphoma with t ( 12 ; 21 )  ( p13 .2 ; q22 .1 )  ;  etv6 - runx1
b lymphoblastic leukemia / lymphoma with hyperdiploidy
hyperdiploidy
hypodiploidy
b lymphoblastic leukemia / lymphoma with hypodiploidy
proxyphylline
stage ii lip and oral cavity cancer ajcc v6 and v7
b lymphoblastic leukemia / lymphoma with t ( 5 ; 14 )  ( q31 .1 ; q32 .3 )  ;  il3 - igh
b lymphoblastic leukemia / lymphoma with t ( 1 ; 19 )  ( q23 ; p13 .3 )  ;  e2a - pbx1  ( tcf3 - pbx1 )
b acute lymphoblastic leukemia with t ( v ; 11q23 .3 )  ;  mll rearranged
b acute lymphoblastic leukemia with t ( 12 ; 21 )  ( p13 .2 ; q22 .1 )  ;  etv6 - runx1
hyperdiploid b acute lymphoblastic leukemia
hypodiploid b acute lymphoblastic leukemia
b acute lymphoblastic leukemia with t ( 5 ; 14 )  ( q31 .1 ; q32 .3 )  ;  il3 - igh
b acute lymphoblastic leukemia with t ( 1 ; 19 )  ( q23 ; p13 .3 )  ;  e2a - pbx1  ( tcf3 - pbx1 )
choristoma
cystic keratinizing epithelioma
stage iii lip and oral cavity cancer ajcc v6 and v7
ito cell tumor
benign ito cell tumor
malignant ito cell tumor
patlak plot
squamous metaplasia of bronchial mucosa
sperm granuloma
tubulostromal adenocarcinoma
network endpoint
endpoint reference
neoplastic nodule
stage iv lip and oral cavity cancer ajcc v6 and v7
somatotrophin measurement
longitudinal relaxation rate
transverse spin relaxation rate
longitudinal relaxation time
transverse spin relaxation time
thrombin time
reptilase time
reactive oxygen species
fast protein liquid chromatography
fraction collector
recurrent lip and oral cavity carcinoma
analytical balance
photometer
ebv - positive t - cell lymphoproliferative disorder of childhood
systemic ebv - positive t - cell lymphoma of childhood
follicular t - cell lymphoma
poly a rna
granisetron transdermal patch
retaspimycin
stage i hypopharyngeal carcinoma ajcc v6
k3 rate constant
atypical angina
non - st elevation myocardial infarction by ecg finding
acute st elevation myocardial infarction by ecg finding
dyslipidemia
chronic kidney disease ,  stage 0
chronic kidney disease ,  stage 1
chronic kidney disease ,  stage 2
chronic kidney disease ,  stage 3
stage ii hypopharyngeal carcinoma ajcc v6 and v7
chronic kidney disease ,  stage 4
paroxysmal atrial fibrillation
chronic atrial fibrillation
ventricular tachycardia ,  sustained
ventricular tachycardia ,  non - sustained
date of myocardial infarction
date of cardiac arrest
history of sudden cardiac death
family history of coronary artery disease
dry
retinoic acid agent
stage iii hypopharyngeal carcinoma ajcc v6
fasting blood sugar measurement
cardiac event monitor
study site
transthoracic echocardiography
transesophageal echocardiography
stress electrocardiography
stress echocardiography
nuclear stress test
stress cardiac magnetic resonance imaging
stage i laryngeal cancer ajcc v6 and v7
grade school
right heart catheterization
biopsy of the right ventricle
left heart catheterization
cardiac electrophysiology study
date of cardiac diagnostic procedure
pre - test probability of coronary artery disease
ejection fraction ,  quantitative
ejection fraction ,  qualitative
left ventricle size ,  end - diastole ,  quantitative
stage ii laryngeal cancer ajcc v6 and v7
left ventricle size ,  end - systole ,  quantitative
left ventricle size ,  qualitative
left atrium size ,  quantitative
left atrium size ,  qualitative
ischemic myocardium
coronary calcium score
coronary artery number of diseased vessels  ( excludes left main disease )
coronary artery stenosis
left main coronary artery stenosis
proximal left anterior descending coronary artery stenosis
stage iii laryngeal cancer ajcc v6 and v7
cardiac therapeutic procedure
study coordinating center
atrial ablation
ventricular ablation
pacemaker placement
implantable cardioverter - defibrillator placement
cardiac resynchronization therapy
lead extraction
exempt device
septal ablation
humanitarian device exemption
premarket device application
premarket device notification
degarelix acetate
h1n1 influenza
influenza a  ( h1n1 )  virus
narrative
digital signature
percutaneous aortic valve replacement
mitral valve repair
regional adrenal gland pheochromocytoma
ventricular aneurysm resection
ventricular assist device placement
time zone
date of therapeutic procedure
date of cardiac therapeutic procedure
implanted medical device
single chamber pacemaker
dual chamber pacemaker
metastatic adrenal gland pheochromocytoma
biventricular pacemaker
cardioverter - defibrillator
atrial lead
ventricular lead
bare metal stent
drug eluting stent
atrial closure device
ventricular closure device
mechanical aortic valve
tissue aortic valve
recurrent adrenal gland pheochromocytoma
mechanical mitral valve
tissue mitral valve
right ventricular assist device
left ventricular assist device
device parameters
coronary lesions treated
coronary graft anastomoses
heart failure during hospitalization
stroke during hospitalization
angina during hospitalization
stage i oropharyngeal carcinoma ajcc v6 and v7
reinfarction during hospitalization
hospitalization event
non - statin antilipidemic agent
thienopyridine antiplatelet agent
timing
health level seven
union
nitrate
expression
denominator
stage ii oropharyngeal carcinoma ajcc v6 and v7
numerator
trk inhibitor azd6918
left main coronary artery stenosis ,  percentage
proximal left anterior descending coronary artery stenosis ,  percentage
ischemic myocardium percentage
flexible
reference information model
cytokeratin 5 / 6 immunohistochemical expression
rheumatoid factor
stage iii oropharyngeal carcinoma ajcc v6
superscript
subscript
line break
atrial arrhythmia by ecg finding
paragraph
caption
footnote
border
house
cox - 2 inhibitor
recurrent oropharyngeal carcinoma
steroid ,  systemic
non - insulin hypoglycemic
gastroparesis
infectious enterocolitis
provide
object constraint language
vertebral fracture
wrist fracture
blood cardiac troponin increased
biological model
motolimod
urine output decreased
gamma - aminobutyric acid
malignant ovarian sex cord - stromal tumor
bofumustine
thyroid gland follicular carcinoma
ann arbor stage ii childhood hodgkin lymphoma
ann arbor stage i childhood hodgkin lymphoma
methylnaltrexone bromide
ann arbor stage iii childhood hodgkin lymphoma
ann arbor stage iv childhood hodgkin lymphoma
noscapine
recurrent childhood hodgkin lymphoma
epicillin
flucloxacillin
quinacillin
clorfenvinfos
crotoxyfos
rhodamine
childhood nodular lymphocyte predominant hodgkin lymphoma
phoxim
childhood lymphocyte - depleted classic hodgkin lymphoma
childhood nodular sclerosis classic hodgkin lymphoma
childhood mixed cellularity classic hodgkin lymphoma
sotrastaurin
sotrastaurin acetate
dezaguanine mesylate
ancitabine
metastatic renal pelvis and ureter urothelial carcinoma
localized childhood rhabdomyosarcoma
sodium hypochlorite
metastatic childhood soft tissue sarcoma
palovarotene
recurrent childhood soft tissue sarcoma
lasofoxifene
talabostat mesylate
therapy - related leukemia
chemotherapy - related leukemia
rabeprazole sodium
bone marrow failure
bronchopleural fistula
mixin
xml bound
microrna gene
ribavirin
ann arbor stage i small lymphocytic lymphoma
mirlet7a1 gene
mirlet7a3 gene
mirlet7b gene
mirlet7d gene
mirlet7e gene
mirlet7f1 gene
mirlet7f2 gene
mirlet7g gene
mirlet7c gene
queue
ann arbor stage i grade 1 follicular lymphoma
mir1 - 1 gene
mir7 - 1 gene
grid security infrastructure
mir7 - 2 gene
mir7 - 3 gene
mir17 gene
mir18a gene
mir19a gene
mir20a gene
mir29a gene
ann arbor stage i grade 2 follicular lymphoma
mir29b1 gene
mir29b2 gene
mir29c gene
mir124 - 1 gene
mir128 - 2 gene
mir183 gene
mir222 gene
mir223 gene
mir224 gene
mir324 gene
ann arbor stage i grade 3 follicular lymphoma
mir1 - 2 gene
mir9 - 1 gene
mir9 - 2 gene
mir9 - 3 gene
mir16 - 1 gene
mir16 - 2 gene
software service
mir19b1 gene
mir19b2 gene
yttrium - 90 polycarbonate brachytherapy plaque
mir21 gene
mir24 - 1 gene
mir24 - 2 gene
mir25 gene
mir26a1 gene
mir26a2 gene
mir27a gene
mir30a gene
mir101 - 1 gene
mir106b gene
stage i adult diffuse small cleaved cell lymphoma
mir122 gene
mir125b1 gene
mir125b2 gene
mir126 gene
mir127 gene
mir130a gene
mir130b gene
stage i adult diffuse mixed cell lymphoma
flibanserin
stage i adult diffuse large cell lymphoma
starch ,  corn
ann arbor stage i adult immunoblastic lymphoma
phthalylsulfacetamide
ann arbor stage i adult lymphoblastic lymphoma
phthalylsulfathiazole
solasulfone
sulfabromomethazine
sulfalene
sulfamerazine sodium
sulfamethoxypyridazine
riboflavin
ann arbor stage i adult burkitt lymphoma
cortodoxone
equine thymocyte immune globulin
human cytomegalovirus immune globulin
human immunoglobulin g
stage i ovarian germ cell tumor ajcc v6 and v7
human rho ( d )  immune globulin
lapine t - lymphocyte immune globulin
althiazide
cyclopenthiazide
stage ii ovarian germ cell tumor ajcc v6 and v7
ethiazide
stage iii ovarian germ cell tumor ajcc v6 and v7
stage iv ovarian germ cell tumor ajcc v6 and v7
recurrent ovarian germ cell tumor
childhood fibrosarcoma
childhood synovial sarcoma
ricin
malignant childhood hemangiopericytoma
hypromelloses
polyoxyl 35 castor oil
childhood liposarcoma
childhood alveolar soft part sarcoma
childhood leiomyosarcoma
glutaral
childhood malignant peripheral nerve sheath tumor
childhood epithelioid sarcoma
indacrinone
lemidosul
ditiocarb sodium
childhood malignant mesenchymoma
canakinumab
certolizumab pegol
recurrent adult non - hodgkin lymphoma
calfactant
squamous cell carcinoma of unknown primary
castor oil
cedar leaf oil
ricin a chain
undifferentiated carcinoma of unknown primary
linaclotide
climbing
stooping
reaching
carrying
shopping
socializing
quarter
half
adult solid neoplasm
tenth
stair
luminescence
synaptophysin - positive neoplastic cells present
omental bursa
cocaine hydrochloride
copy number analysis tool
hidden markov model forward algorithm
paired data
ann arbor stage i adult non - hodgkin lymphoma
unpaired data
cnat probe normalization method
negative number
sigma multiplier
cefatrizine
cefazaflur sodium
cefbuperazone
ann arbor stage ii adult non - hodgkin lymphoma
cefpimizole sodium
cefquinome sulfate
cefroxadine
ceftaroline fosamil
cefteram
ceftiofur
cephacetrile
ann arbor stage iii adult non - hodgkin lymphoma
ann arbor stage iv adult non - hodgkin lymphoma
gadofosveset
gadofosveset trisodium
gadofosveset trisodium anhydrous
ovarian dysgerminoma
ovarian yolk sac tumor
alipamide
ampyrimine
brocrinat
clopamide
clorexolone
pamabrom
ovarian embryonal carcinoma
rifampin
ovarian teratoma
congo red
immature ovarian teratoma
metyrapone tartrate
alpha - aminobutyric acid
mature ovarian teratoma
ipamorelin
antihemophilic factor ,  human recombinant
ovarian monodermal and highly specialized teratoma
ovarian mixed germ cell tumor
ann arbor stage ii small lymphocytic lymphoma
clemizole hydrochloride
crilvastatin 1r
ann arbor stage ii grade 1 follicular lymphoma
crilvastatin 1s
any
mentum
ann arbor stage ii grade 2 follicular lymphoma
midline
cross
positive charge
negative charge
neutral charge
non - enhancing lesion
age appropriate screening
infant screening
newborn screening
delivery procedure
deceased family member
infant reflex
measurement device
amino acid measurement
vernier caliper
amino acid ratio measurement
thick
well - defined
skullcap
skullcap lesion
ann arbor stage ii grade 3 follicular lymphoma
calvarial
vasogenic edema
imputed date
imputed time
derived flag
last observation carried forward imputation technique
worst observation carried forward imputation technique
ribonucleic acid
stage ii adult diffuse small cleaved cell lymphoma
screening observation carried forward imputation technique
baseline observation carried forward imputation technique
multiple imputation technique
worst case imputation technique
mean of other group imputation technique
penultimate observation carried forward imputation technique
worst observed value in a group imputation technique
mean observed value in a group imputation technique
interpolation imputation technique
average of value derivation technique
stage ii adult diffuse mixed cell lymphoma
year month day imputed
month day imputed
day imputed
hours minutes seconds imputed
minutes seconds imputed
seconds imputed
stage ii adult diffuse large cell lymphoma
cdisc adam terminology
cdisc adam date imputation flag terminology
cdisc adam derivation type terminology
cdisc adam parameter type terminology
cdisc adam time imputation flag terminology
one minute after birth
five minutes after birth
alcohol use history
apgar test
attending health care provider
bayley scale of infant development i
behavioral development
behavioral assessment
behavioral rating scale
birth complication
birth facility
brazelton neonatal behavioral assessment scale
cause of death
ann arbor stage ii adult immunoblastic lymphoma
cellular telephone number
cognitive development
crown to rump length measurement
deceased sibling
denver development screening test
drug use history
expected date of confinement
forceps delivery
infant formula
ann arbor stage ii adult lymphoblastic lymphoma
functional assessment
galactose - 1 - phosphate uridyltransferase measurement
gesell developmental schedule
gestational weeks assessment
grasp reflex
head circumference
imaging information
last menstrual period
last screening
left ear
ann arbor stage ii adult burkitt lymphoma
local anesthesia procedure
measuring tape
medical record number
mental development index
mental scale
evaluation method
examination method
feeding method
molar ratio
motor development
newborn motor scale
multiple birth
first feeding
doctor's information
numeric value
pass
hemoglobin a to total hemoglobin ratio measurement
hemoglobin a2 to total hemoglobin ratio measurement
hemoglobin c to total hemoglobin ratio measurement
hemoglobin s to total hemoglobin ratio measurement
ann arbor stage iii small lymphocytic lymphoma
phenylalanine measurement
phenylalanine to tyrosine ratio measurement
dubowitz score
red reflex test
residential telephone number
right ear
collection date
collection time
s - beta thalassemia
image identifier
ann arbor stage iii grade 1 follicular lymphoma
shoulder dystocia
sick newborn
social history
street number
submitting facility
birth time
point in time test given
total body length
messenger rna
ann arbor stage iii grade 2 follicular lymphoma
vacuum assisted vaginal delivery
vaginal assisted delivery
vaginal birth after cesarean delivery
vaginal delivery
blood product
bottle feeding
breathing effort score
estimation method
galactose measurement
heart rate score
lasso - o measuring tape
moro reflex
muscle tone score
neurologic examination
newborn behavioral examination
phenylketonuria
physical symmetry
postnatal
prenatal
reflex irritability score
ann arbor stage iii grade 3 follicular lymphoma
rooting reflex
skin color score
step reflex
sucking reflex
tonic neck reflex
transferase deficiency galactosemia
elevated test result
tranche distributed repository
stage iii adult diffuse small cleaved cell lymphoma
amorolfine
libenzapril
stage iii adult diffuse mixed cell lymphoma
fermagate
stage iii adult diffuse large cell lymphoma
poractant alfa
dibrospidium chloride
ann arbor stage iii adult immunoblastic lymphoma
silodosin
ann arbor stage iii adult lymphoblastic lymphoma
ann arbor stage iii adult burkitt lymphoma
ribosomal rna
esketamine
ann arbor stage iv small lymphocytic lymphoma
fenfluramine
ann arbor stage iv grade 1 follicular lymphoma
leurubicin
galarubicin
nortopixantrone
ann arbor stage iv grade 2 follicular lymphoma
ann arbor stage iv grade 3 follicular lymphoma
stage iv adult diffuse small cleaved cell lymphoma
fidexaban
razaxaban hydrochloride
stage iv adult diffuse mixed cell lymphoma
stage iv adult diffuse large cell lymphoma
small nuclear rna
ann arbor stage iv adult immunoblastic lymphoma
amorolfine hydrochloride
pyrrolnitrin
ann arbor stage iv adult lymphoblastic lymphoma
fezatione
ann arbor stage iv adult burkitt lymphoma
dalcetrapib
colestolone
eprotirome
acifran
lapaquistat acetate
sobetirome
recurrent small lymphocytic lymphoma
colestipol
recurrent grade 1 follicular lymphoma
cinametic acid
tretazicar
budotitane
recurrent grade 2 follicular lymphoma
prasugrel
ifetroban sodium
ifetroban
prasugrel hydrochloride
recurrent grade 3 follicular lymphoma
recurrent adult burkitt lymphoma
verazide
transfer rna
recurrent adult diffuse mixed cell lymphoma
telaprevir
pleconaril
favipiravir
tecovirimat
disoxaril
tromantadine
aranotin
recurrent adult diffuse large cell lymphoma
peramivir
capravirine
clobazam
pyridoxal phosphate
recurrent adult immunoblastic lymphoma
recurrent adult lymphoblastic lymphoma
lenapenem
dornase alfa
almurtide
localized renal pelvis and ureter urothelial carcinoma
bleomycin b2
regional renal pelvis and ureter urothelial carcinoma
anterior tongue squamous cell carcinoma
farglitazar
ertiprotafib
cevoglitazar
phenformin hydrochloride
carmegliptin
mitiglinide
ceftriaxone sodium
hard palate squamous cell carcinoma
phenformin
carmegliptin dihydrochloride
saxagliptin hydrochloride
lower gingival squamous cell carcinoma
carbadox
retromolar trigone squamous cell carcinoma
nithiamide
tavaborole
fludalanine
trisomy 10
upper gingival squamous cell carcinoma
elevated ca15 - 3
hla - cw*0702 positive cells present
mir132 gene
mir133a1 gene
mir133a2 gene
mir133b gene
mir137 gene
mir141 gene
mir143 gene
oral cavity verrucous carcinoma
mir145 gene
mir146a gene
mir148a gene
mir148b gene
mir155 gene
mir181a1 gene
mir181a2 gene
mir182 gene
mir192 gene
mir195 gene
buccal mucosa verrucous carcinoma
mir199a1 gene
mir199a2 gene
mir200a gene
mir200b gene
mir205 gene
mir214 gene
mir221 gene
mir10a gene
fibroblastic reticular cell tumor
mir10b gene
lower gingival verrucous carcinoma
mir15b gene
mir20b gene
mir23b gene
mir32 gene
mir34b gene
mir34c gene
indeterminate dendritic cell tumor
mir98 gene
mir128 - 1 gene
oral cavity mucoepidermoid carcinoma
mir181b1 gene
mir181b2 gene
disseminated juvenile xanthogranuloma
mir106a gene
mir107 gene
mir125a gene
mir138 - 1 gene
mir138 - 2 gene
mir144 gene
mir146b gene
floor of mouth mucoepidermoid carcinoma
mir152 gene
mir184 gene
mir193a gene
mir196a1 gene
mir196a2 gene
mir197 gene
mir198 gene
mir200c gene
mir203a gene
mir204 gene
oral cavity adenoid cystic carcinoma
mir206 gene
mir208a gene
mir208b gene
mir210 gene
mir320a gene
mir326 gene
roxithromycin
floor of mouth adenoid cystic carcinoma
mir335 gene
mir337 gene
mir342 gene
mir346 gene
mir370 gene
mir372 gene
mir373 gene
mir376a1 gene
mir376b gene
mir377 gene
oropharyngeal squamous cell carcinoma
mir429 gene
mir432 gene
mir433 gene
mir451a gene
mir510 gene
mir516a1 gene
mir516a2 gene
mir516b1 gene
mir516b2 gene
mir520c gene
posterior tongue squamous cell carcinoma
mir521 - 1 gene
mir521 - 2 gene
mir659 gene
mirlet7i gene
third national health and nutrition examination survey
mirlet7a1 wt allele
mirlet7a3 wt allele
mirlet7d wt allele
mirlet7f1 wt allele
mirlet7f2 wt allele
tonsillar squamous cell carcinoma
mirlet7g wt allele
22q13 .31
21q21 .1
19q13 .33
18q11 .2
9q21 .32
5q14 .3
3q26 .1
13q31 .3
tonsillar undifferentiated carcinoma
3p22 .2
6q13
9q31 .3
11q24 .1
2q21 .3
3p22 .3
1p21 .3
3p21 .33
12p13 .31
postcricoid squamous cell carcinoma
5q33 .1
5q33 .3
10q24 .32
mirlet7b wt allele
benign epithelioid cell type gastrointestinal stromal tumor
malignant epithelioid cell type gastrointestinal stromal tumor
mir218 - 1 gene
mir218 - 2 gene
mir298 gene
mirlet7e wt allele
glottic squamous cell carcinoma
mirlet7c wt allele
mir1 - 1 wt allele
mir1 - 2 wt allele
mir7 - 1 wt allele
mir7 - 2 wt allele
mir7 - 3 wt allele
email attachment
chemokine measurement
interferon measurement
immunoglobulin measurement
subglottic squamous cell carcinoma
lipid peroxidation
sonication
molecular entrapment
mirlet7i wt allele
mir9 - 1 wt allele
mir9 - 2 wt allele
mir9 - 3 wt allele
mir10a wt allele
mir10b wt allele
ctag1a gene
laryngeal verrucous carcinoma
mir15b wt allele
mir15a gene
mir15a wt allele
mir16 - 1 wt allele
mir16 - 2 wt allele
mir17 wt allele
mir18a wt allele
glottis verrucous carcinoma
mir19a wt allele
mir19b1 wt allele
iso 11404
mir19b2 wt allele
iso 21090
mir20a wt allele
world wide web consortium
mir20b wt allele
mir21 wt allele
subglottic verrucous carcinoma
mir23b wt allele
mir24 - 1 wt allele
mir24 - 2 wt allele
csag3 gene
csag3 wt allele
mir25 wt allele
deploy
mir26a1 wt allele
supraglottic verrucous carcinoma
mir26a2 wt allele
mir27a wt allele
mir29a wt allele
mir29b1 wt allele
mir29b2 wt allele
proglumide
mir29c wt allele
mir30a wt allele
nasal cavity squamous cell carcinoma
mir32 wt allele
state machine
technical guide
paranasal sinus squamous cell carcinoma
use case
xmi
ibrutinib
folate receptor - targeted vinca alkaloid ec0489
recombinant human albumin - human granulocyte colony - stimulating factor
rabusertib
nepidermin
anti - hgf monoclonal antibody tak - 701
nasal cavity inverted papilloma
mir34b wt allele
telotristat etiprate
mir34c wt allele
mir92a1 gene
mir92a1 wt allele
alk gene mutation
alk fusion protein expression
oval fat body measurement
ionized calcium measurement
hippuric acid measurement
paranasal sinus inverted papilloma
starch crystal measurement
eotaxin - 1 measurement
eotaxin - 2 measurement
eotaxin - 3 measurement
lymphotactin measurement
macrophage - derived chemokine measurement
reg upon act normal t - cell exprd secrtd measurement
antithrombin activity measurement
factor iii measurement
nasal cavity and paranasal sinus lethal midline granuloma
factor vii measurement
factor viii measurement
platelet distribution width
free estriol measurement
c - terminal parathyroid hormone measurement
mid - molecule parathyroid hormone measurement
n - terminal parathyroid hormone measurement
proinsulin measurement
reverse triiodothyronine measurement
immunoglobulin a measurement
immunoglobulin e measurement
immunoglobulin g measurement
immunoglobulin m measurement
anti - dna antibody measurement
direct antiglobulin test
antimitochondrial antibody measurement
anti - saccharomyces cerevisiae antibody measurement
antithrombin antigen measurement
aspartate aminotransferase antigen measurement
beta - 2 glycoprotein antibody measurement
beta - 2 microglobulin measurement
cancer antigen 125 measurement
cancer antigen 19 - 9 measurement
carcinoembryonic antigen measurement
heterophile antibody measurement
islet cell 512 antibody measurement
islet cell 512 antigen measurement
islet neogenesis associated protein antibody measurement
pemphigoid antibody measurement
plasminogen activator inhibitor - 1 antigen measurement
stage i oral cavity mucoepidermoid carcinoma ajcc v6 and v7
thyroid antibody measurement
thyroid antithyroglobulin antibody measurement
tissue plasminogen activator antigen measurement
interferon alpha measurement
interferon beta measurement
interferon gamma measurement
segmented neutrophil count
amyloid p measurement
beta amyloid measurement
safflower oil
stage i oral cavity adenoid cystic carcinoma ajcc v6 and v7
apolipoprotein aii measurement
apolipoprotein ciii measurement
apolipoprotein e measurement
apolipoprotein h measurement
brain - derived neurotrophic factor measurement
calprotectin measurement
cd40 measurement
cd40 ligand measurement
endothelin - 1 measurement
epidermal growth factor measurement
epithelial neutrophil - activating peptide 78 measurement
extracell newly ident rage bind protein measurement
fatty acid binding protein 1 measurement
fibrin degradation products measurement
fibroblast growth factor basic form measurement
glutamic acid decarboxylase 1 measurement
glutamic acid decarboxylase 2 measurement
glutamic acid decarboxylase 2 antibody measurement
granulocyte colony stimulating factor measurement
granulocyte macrophage colony stm factor measurement
inhibin a measurement
lactoferrin measurement
lipoprotein a measurement
macrophage inflammatory protein 1 alpha measurement
macrophage inflammatory protein 1 beta measurement
monocyte chemotactic protein 1 measurement
neutrophil elastase measurement
polymorphonuclear neutrophil elastase measurement
pancreatic elastase measurement
polymorphonuclear pancreatic elastase measurement
stage ii oral cavity mucoepidermoid carcinoma
plasminogen activator inhibitor - 1 measurement
pregnancy - associated plasma protein - a measurement
prob - type natriuretic peptide measurement
procollagen type i carboxy terminal peptide measurement
prothrombin fragments 1 and 2 measurement
stem cell factor measurement
tissue inhibitor of metalloproteinase 1 measurement
transferrin measurement
type i collagen c - telopeptide measurement
type i collagen n - telopeptide measurement
stage ii oral cavity adenoid cystic carcinoma
type ii collagen c - telopeptide measurement
type ii collagen n - telopeptide measurement
vascular cell adhesion molecule 1 measurement
vascular epithelial growth factor measurement
indican measurement
segmented neutrophil to leukocyte ratio measurement
nucleated erythrocyte to leukocyte ratio measurement
mir92a2 gene
mir92a2 wt allele
mir98 pre - mirna
mir98 wt allele
mir101 - 1 wt allele
mir106a wt allele
mir106b wt allele
autologous stem cell rescue
mir107 wt allele
mir122 wt allele
mucogingival junction
root furcation
mir124 - 1 wt allele
furcation involvement
mir125a wt allele
rubber cup
mir125b1 wt allele
gingival recession
mir125b2 wt allele
stage iii oral cavity mucoepidermoid carcinoma ajcc v6 and v7
mir126 wt allele
glutaraldehyde
mir127 wt allele
mir128 - 1 wt allele
potassium nitrate
mir128 - 2 wt allele
scaler
mir130a wt allele
oxalate
mir130b wt allele
stage iii oral cavity adenoid cystic carcinoma ajcc v6 and v7
mir132 wt allele
interceptive treatment
miniscrew temporary anchorage device
mir133a1 wt allele
mir133a2 wt allele
mir133b wt allele
mir137 wt allele
orthodontic headgear
orthodontic facemask
mir138 - 1 wt allele
gingivectomy
adjunctive orthodontic procedure
impaction
mir138 - 2 wt allele
mir141 wt allele
mir143 wt allele
mir144 wt allele
mir145 wt allele
mir146a wt allele
mir146b wt allele
saline
mir148a wt allele
air blast
anchorage
mir148b wt allele
en masse movement
mir152 wt allele
ctag1a wt allele
stage iv oral cavity mucoepidermoid carcinoma ajcc v6 and v7
mir155 wt allele
mir181a1 wt allele
orthognathous
intermaxillary relationship
1q31 .3
7q32 .2
cant
mir181a2 wt allele
mir181b1 wt allele
mir181b2 wt allele
mir182 wt allele
opaque
dental retraction
dental intrusion
dental protraction
dental distalization
recurrent lip basal cell carcinoma
synthetic polymer
9q33 .3
15q25 .1
3q13 .33
1q24 .3
9q21 .11
6p12 .2
4p15 .31
xp11 .3
xq12
recurrent oral cavity verrucous carcinoma
20q13 .32
8p21 .3
10q23 .2
xq27 .3
mir183 wt allele
mir184 wt allele
mir192 wt allele
mir193a wt allele
mir195 wt allele
mir196a1 wt allele
recurrent oral cavity mucoepidermoid carcinoma
mir197 wt allele
mir198 wt allele
mir199a1 wt allele
mir199a2 wt allele
mir200a wt allele
mir200b wt allele
mir200c wt allele
mir203a wt allele
c3d format
recurrent oral cavity adenoid cystic carcinoma
mir204 wt allele
mir205 wt allele
mir206 wt allele
healthcare information technology standards panel
mir208a wt allele
mir208b wt allele
mir210 wt allele
mir214 wt allele
mir218 - 1 wt allele
stage i oropharyngeal squamous cell carcinoma ajcc v6 and v7
mir218 - 2 wt allele
mir221 wt allele
mir222 wt allele
mir223 wt allele
mir224 wt allele
mir298 wt allele
north american association of central cancer registries
mixed phenotype acute leukemia
stage ii oropharyngeal squamous cell carcinoma ajcc v6 and v7
blasts of mixed phenotype present
mir320a wt allele
mir324 wt allele
mir326 wt allele
mir335 wt allele
mir337 wt allele
mir342 wt allele
mir346 wt allele
mir370 wt allele
stage iii oropharyngeal squamous cell carcinoma ajcc v7
mir372 wt allele
mir373 wt allele
mixed phenotype acute leukemia with t ( 9 ; 22 )  ( q34 .1 ; q11 .2 )  ;  bcr - abl1
mir376a1 wt allele
mir376b wt allele
mir377 wt allele
mir429 wt allele
mir432 wt allele
mir433 wt allele
mir451a wt allele
salt
stage iv oropharyngeal squamous cell carcinoma ajcc v7
mir510 wt allele
mir516a1 wt allele
mir516a2 wt allele
mixed phenotype acute leukemia with t ( v ; 11q23 .3 )  ;  mll rearranged
mir520c wt allele
mir521 - 1 wt allele
mir521 - 2 wt allele
recurrent oropharyngeal squamous cell carcinoma
mir659 wt allele
mir196a2 wt allele
mixed phenotype acute leukemia ,  b / myeloid ,  not otherwise specified
mixed phenotype acute leukemia ,  t / myeloid ,  not otherwise specified
blasts expressing b - lymphoid and myeloid markers present
blasts expressing t - lymphoid and myeloid markers present
blasts expressing cd56 and immature t - cell markers present
natural killer cell lymphoblastic leukemia / lymphoma
zabicipril
zofenopril
stage i nasopharyngeal keratinizing squamous cell carcinoma ajcc v7
zofenopril calcium
propoxur
stage i nasopharyngeal undifferentiated carcinoma ajcc v7
antithrombin alfa
liraglutide
stage ii nasopharyngeal keratinizing squamous cell carcinoma ajcc v7
lifibrol
proquinolate
stage ii nasopharyngeal undifferentiated carcinoma ajcc v7
lobucavir
maribavir
rupintrivir
alpha - 1 - proteinase inhibitor human
stage iii nasopharyngeal keratinizing squamous cell carcinoma ajcc v7
zidapamide
stage iii nasopharyngeal undifferentiated carcinoma ajcc v7
stage iv nasopharyngeal keratinizing squamous cell carcinoma ajcc v7
stage iv nasopharyngeal undifferentiated carcinoma ajcc v7
recurrent nasopharyngeal keratinizing squamous cell carcinoma
betaine hydrochloride
sarmoxicillin
linaprazan
recurrent nasopharyngeal undifferentiated carcinoma
pregnenolone
stage i hypopharyngeal squamous cell carcinoma ajcc v7
membrane potential
signaling pathway status
sonic hedgehog / patch pathway activated
sonic hedgehog / patch pathway signaling status unknown
sonic hedgehog / patch pathway inactivated
nci center for bioinformatics
stage ii hypopharyngeal squamous cell carcinoma ajcc v6 and v7
repetition time
echo time
patch
diffusion
smooth
peptideatlas
international protein index
sequence specific retention factor
myeloid proliferations associated with down syndrome
transient abnormal myelopoiesis associated with down syndrome
stage iii hypopharyngeal squamous cell carcinoma ajcc v7
gata1 gene mutation
spinocerebellar ataxia
huntington's disease
irritable bowel syndrome
cold contaminant - free iobenguane i - 131
facilitated diffusion
restricted diffusion
aerodigestive tract
onartuzumab
aurora kinase inhibitor amg 900
stage iv hypopharyngeal squamous cell carcinoma ajcc v7
autologous ny - eso - 1 - melanoma - specific cd8 +  t - lymphocytes
m87o - transduced cd34 +  peripheral blood stem cells
pvaxrcpsav53l dna vaccine
tlr - directed cationic lipid - dna complex jvrs - 100
lutetium lu 177 - dota - di - hsg peptide imp - 288
anti - cea / anti - hsg bispecific monoclonal antibody tf2
indium in 111 - dota - di - hsg peptide imp - 288
leucine - enhanced essential amino acid dietary supplement
adecatumumab
clazakizumab
recurrent hypopharyngeal squamous cell carcinoma
autologous prostate cancer antigen - expressing dendritic cell vaccine bpx - 101
innate immunostimulator rbbx - 01
golvatinib
acellular cadaveric dermal matrix
erg gene rearrangement
enoticumab
stage i laryngeal squamous cell carcinoma ajcc v6 and v7
bone metastasis targeting peptide - 11
recombinant saccharomyces cerevisia - cea ( 610d )  - expressing vaccine gi - 6207
anti - cd19 / anti - cd22 bispecific immunotoxin dt2219arl
urine 5 - hydroxyindoleacetic acid measurement
technetium tc - 99m ethylenedicysteine - deoxyglucose
fosbretabulin
pan - vegfr / tie2 tyrosine kinase inhibitor cep - 11981
stage i laryngeal verrucous carcinoma ajcc v6 and v7
pictilisib bismesylate
romyelocel - l
lurbinectedin
nirogacestat
tsp - 1 mimetic fusion protein cvx - 045
sonidegib
dabrafenib
hsp90 inhibitor hsp990
autologous gm - csf - secreting breast cancer vaccine
polo - like kinase 1 inhibitor mk1496
stage ii laryngeal squamous cell carcinoma ajcc v6 and v7
afuresertib
anti - ksp / anti - vegf sirnas aln - vsp02
fluid attenuated inversion recovery
puberty
tanner scale
psychotropic agent
portacath
therapy - related myelodysplastic / myeloproliferative neoplasm
pixantrone dimaleate
karyometry
sizofiran
stage ii laryngeal verrucous carcinoma ajcc v6 and v7
marshmallow flavor
api manufacture
acute myeloid leukemia with t ( 9 ; 11 )  ( p21 .3 ; q23 .3 )  ;  mllt3 - mll
pim kinase inhibitor sgi - 1776
fluorescein sodium injection
ontuxizumab
ptvg - hp plasmid dna vaccine
2g - 1 tcr retroviral vector - transduced lymphocytes
cd34 / tk75 retroviral vector - transduced donor lymphocytes
stage iii laryngeal squamous cell carcinoma ajcc v6 and v7
immunocytokine nhs - il2 - lt
rimiducid
angiogenesis inhibitor ji - 101
actinium ac 225 lintuzumab
huachansu
autologous nsclc dna - transfected semi - allogeneic fibroblasts mrc - 5 vaccine
muc1 peptide - poly - iclc vaccine
cdc7 kinase inhibitor bms - 863233
doxorubicin - eluting beads
stage iii laryngeal verrucous carcinoma ajcc v6 and v7
p53 - synthetic long peptides vaccine
hla - a*2402 - restricted urlc10 peptides vaccine
abituzumab
acute myeloid leukemia with t ( 6 ; 9 )   ( p23 ; q34 .1 )  ;  dek - nup214
immortalization
rpn1 - evi1 fusion protein expression
acute myeloid leukemia with inv ( 3 )   ( q21 .3 ; q26 .2 )  or t ( 3 ; 3 )   ( q21 .3 ; q26 .2 )  ;  gata2 ,  mecom
acute myeloid leukemia  ( megakaryoblastic )  with t ( 1 ; 22 )  ( p13 .3 ; q13 .1 )  ;  rbm15 - mkl1
cancer genome characterization center
npm1 gene mutation
stage iv laryngeal squamous cell carcinoma ajcc v7
acute myeloid leukemia with gene mutations
acute myeloid leukemia with mutated npm1
acute myeloid leukemia with mutated cebpa
outsourcing human drug compounding
serum immunoglobulin free light chain increased
serum immunoglobulin free light chain ratio abnormal
study day
event occurrence indicator
stage iv laryngeal verrucous carcinoma ajcc v7
recurrent laryngeal squamous cell carcinoma
recurrent laryngeal verrucous carcinoma
lactating
death by natural cause
death by undetermined cause
complete recovery
ann arbor stage i adult t - cell leukemia / lymphoma
ann arbor stage ii adult t - cell leukemia / lymphoma
collar dosing unit
cryogenic ampule dosing unit
dip dosing unit
paper dosing unit
tag dosing unit
excellent
fair
ann arbor stage iii adult t - cell leukemia / lymphoma
possible
trastuzumab emtansine
mir516b1 wt allele
mir516b2 wt allele
dose adjustment
adverse event caused study discontinuation
clinical trial branch
result category
substance use category
selenium
ann arbor stage iv adult t - cell leukemia / lymphoma
disease controlled
class code
loinc code
test code
reference comment
unplanned element description
element order
protocol test conditions met
life threatening
other action taken
recurrent adult t - cell leukemia / lymphoma
pre - specified
subsequent trial activity
test date
treatment dispense date
treatment return date
collection date time
observation end date time
observation start date time
reference date time
interruption duration
therapy - related acute myeloid leukemia
substance use duration
other medically important serious event
prior medication usage
subject continuance
subject unblinding
test occurrence
baseline flag
toxicity grade
group id
de novo myelodysplastic syndrome
sponsor id
reference id
normal range indicator
active ingredient
evaluation interval
test method
external filename
laboratory vendor name
parameter short name
planned time point name
recurrent renal pelvis and ureter urothelial carcinoma
standardized treatment name
test name
treatment name
adverse event line number
medical history line number
planned time point number
observation object
abnormal finding
occurs with overdose
outcome death
anal canal cloacogenic carcinoma
pattern of event
planned dose
causality
treatment vehicle amount
flow rate
dose adjustment reason
not - done reason
end relative to reference period
end relative to reference time point
start relative to reference period
anal basaloid carcinoma
start relative to reference time point
related to cancer
clinical significance
death relationship
non - study treatment relationship
end rule
start rule
transition rule
study medication completed
observation end day
adult anaplastic astrocytoma
observation start day
reported event term
elapsed time
end time
reference end time point end
reference start time point
reference time point
test time
serious event
flow rate unit
stage i uterine sarcoma ajcc v7
normal range lower limit original unit
planned dose unit
total volume administered unit
treatment vehicle amount unit
use duration unit
interruption duration unit
original result unit
standard result unit
lower limit of quantitation
stage ii uterine sarcoma ajcc v7
cdisc observation class terminology
myelodysplastic syndrome with single lineage dysplasia
unilineage dysplasia present
refractory neutropenia
refractory thrombocytopenia
myelodysplastic syndrome with excess blasts and fibrosis
refractory cytopenia of childhood
carbonate ion
carnitine
dl - selenomethionine
stage iii uterine sarcoma ajcc v7
deslorelin acetate
citrus pectin
fiducial marker
national institute on alcohol abuse and alcoholism
national institute on aging
national institute of arthritis and musculoskeletal and skin diseases
planning target volume
center for information technology
national institute on deafness and other communication disorders
national institute of biomedical imaging and bioengineering
recurrent uterine corpus sarcoma
national institute of environmental health sciences
national eye institute
ptpn11 gene mutation
national heart ,  lung ,  and blood institute
division of blood diseases and resources
division of epidemiology and clinical applications
myelodysplastic / myeloproliferative neoplasm with ring sideroblasts and thrombocytosis
national human genome research institute
division of lung diseases
division of cardiovascular diseases
national library of medicine
d - dimer measurement
national center on minority health and health disparities
botulinum toxin type a
gas measurement
partial pressure of carbon dioxide measurement
blueprint for neuroscience
national institute of neurological disorders and stroke
offices of research facilities development and operations
office of logistics and acquisition operations
adult acute monocytic leukemia
office of research services
center for scientific review
nih roadmap for medical research
superfund basic research program
fogarty international center
women's health initiative
worker education training program
crossover study
factorial study
parallel study
childhood meningioma
single group study
invitation
nedocromil calcium
adult cholangiocarcinoma
reject
live attenuated measles virus vaccine
feedback
ixazomib citrate
mrna - derived prostate cancer vaccine cv9103
afamelanotide
zirconium zr 89 bevacizumab
beta - glucan mm - 10 - 001
communication response
pegvorhyaluronidase alfa
enteric - coated trpm8 agonist d - 3263 hydrochloride
hla - a2 - restricted synthetic glioma antigen peptides vaccine
cancer diagnosis program
radiation research program
translational research program
investigational device exemption
center for biologics evaluation and research
center for drug evaluation and research
ovarian sarcoma
center for devices and radiological health
cottonseed oil
nocturia
aurora b serine / threonine kinase inhibitor tak - 901
mammaglobin - a dna vaccine
irinotecan sucrosofate
c - met inhibitor amg 208
diphenhydramine hydrochloride / dexamethasone / nystatin magic mouthwash
ionic silver - impregnated sodium carboxymethylcellulose antimicrobial dressing
sodium carboxymethylcellulose dressing
distilled water
irinotecan - eluting beads
dusigitumab
tovetumab
anti - ags - 16 monoclonal antibody ags - 16m18
anti - ags - 8 monoclonal antibody ags - 8m4
amifampridine
umbilical cord blood - derived mesenchymal stem cells
ribonuclease qbi - 139
adult anaplastic ependymoma
hdac inhibitor chr - 2845
hsp90 inhibitor ab - 010
rebastinib tosylate
eg5 kinesin - related motor protein inhibitor arq 621
trans sodium crocetinate
mek inhibitor ro4987655
radgocitabine
mir10a pre - mirna
mir10b pre - mirna
semustine
mir1 - 1 pre - mirna
mir1 - 2 pre - mirna
mir15a pre - mirna
mir15b pre - mirna
mir16 - 1 pre - mirna
mir16 - 2 pre - mirna
mir17 pre - mirna
mir18a pre - mirna
mir19a pre - mirna
mir19b1 pre -  mirna
mixed astrocytoma - ependymoma
mir19b2 pre - mirna
mir20a pre - mirna
mir20b pre - mirna
mir21 pre - mirna
mir23b pre - mirna
mir24 - 1 pre - mirna
mir24 - 2 pre - mirna
mir25 pre - mirna
mixed astrocytoma - ependymoma - oligodendroglioma
mir26a1 pre - mirna
mir26a2 pre - mirna
mir27a pre - mirna
mir29a pre - mirna
mir29b1 pre - mirna
mir29b2 pre - mirna
mir29c pre - mirna
mir30a pre - mirna
mir32 pre - mirna
adult pineal parenchymal cell neoplasm
mir34b pre - mirna
mir34c pre - mirna
mir7 - 1 pre - mirna
mir7 - 2 pre - mirna
mir7 - 3 pre - mirna
mir9 - 1 pre - mirna
mir9 - 2 pre - mirna
mir92a1 pre - mirna
mir9 - 3 pre - mirna
mirlet7a3 pre - mirna
mirlet7b pre - mirna
mirlet7c pre - mirna
mirlet7d pre - mirna
mirlet7e pre - mirna
mirlet7f1 pre - mirna
mirlet7f2 pre - mirna
mirlet7g pre - mirna
mirlet7a1 pre - mirna
mirlet7i pre - mirna
mir93 pre - mirna
adult anaplastic  ( malignant )  meningioma
mir101 - 1 pre - mirna
mir106a pre - mirna
mir106b pre - mirna
mir107 pre - mirna
mir122 pre - mirna
mir124 - 1 pre - mirna
mir125a pre - mirna
mir125b1 pre - mirna
mir125b2 pre - mirna
mir126 pre - mirna
mir127 pre - mirna
mir128 - 1 pre - mirna
mir128 - 2 pre - mirna
mir130a pre - mirna
mir130b pre - mirna
mir132 pre - mirna
mir133a1 pre - mirna
mir133a2 pre - mirna
mir133b pre - mirna
mir137 pre - mirna
localized unresectable neuroblastoma
mir138 - 1 pre - mirna
mir138 - 2 pre - mirna
mir141 pre - mirna
mir143 pre - mirna
mir144 pre - mirna
mir145 pre - mirna
mir146a pre - mirna
mir146b pre - mirna
mir148a pre - mirna
mir148b pre - mirna
cancer - related condition
mir152 pre - mirna
mir155 pre - mirna
mir181a1 pre - mirna
mir181a2 pre - mirna
mir181b1 pre - mirna
mir181b2 pre - mirna
mir182 pre - mirna
mir183 pre - mirna
mir184 pre - mirna
mir192 pre - mirna
mir193a pre - mirna
mir195 pre - mirna
mir196a1 pre - mirna
mir196a2 pre - mirna
mir197 pre - mirna
mir92a2 pre - mirna
mir198 pre - mirna
mir199a1 pre - mirna
mir199a2 pre - mirna
mir200a pre - mirna
mir200b pre - mirna
mir200c pre - mirna
mir203a pre - mirna
mir204 pre - mirna
mir205 pre - mirna
mir206 pre - mirna
mir208a pre - mirna
mir208b pre - mirna
mir210 pre - mirna
mir214 pre - mirna
poor vascular access
mir218 - 1 pre - mirna
mir218 - 2 pre - mirna
mir221 pre - mirna
mir222 pre - mirna
mir223 pre - mirna
mir224 pre - mirna
mir298 pre - mirna
mir320a pre - mirna
mir324 pre - mirna
mir326 pre - mirna
mir335 pre - mirna
mir337 pre - mirna
mir342 pre - mirna
mir346 pre - mirna
mir370 pre - mirna
mir372 pre - mirna
mir373 pre - mirna
mir376a1 pre - mirna
mir376b pre - mirna
mir377 pre - mirna
mir429 pre - mirna
mir432 pre - mirna
mir433 pre - mirna
polycystic liver disease
mir451a pre - mirna
mir510 pre - mirna
mir516a1 pre - mirna
mir516a2 pre - mirna
mir516b1 pre - mirna
mir516b2 pre - mirna
aids - related primary central nervous system lymphoma
mir520c pre - mirna
mir521 - 1 pre - mirna
mir521 - 2 pre - mirna
mir659 pre - mirna
parametric probability distribution
medical subject headings
has_a relationship
english language
icelandic language
btla gene
aids - related immunoblastic lymphoma
btla wt allele
b -  and t - lymphocyte attenuator
f2 gene
f2 wt allele
prothrombin
sirt6 gene
sirt6 wt allele
mono - adp - ribosyltransferase sirtuin - 6
fads1 gene
alopecia mucinosa
aids - related burkitt lymphoma
fads1 wt allele
fatty acid desaturase 1
meyerson nevus
leukocytoclastic vasculitis
desmoplastic spitz nevus
familial benign pemphigus
endpoint value derivation technique
minimum value derivation technique
maximum value derivation technique
lipc gene
bilateral breast carcinoma
lipc wt allele
acads gene
acads wt allele
acadm gene
acadm wt allele
hepatic triacylglycerol lipase
short - chain specific acyl - coa dehydrogenase ,  mitochondrial
medium - chain specific acyl - coa dehydrogenase ,  mitochondrial
international union of pure and applied chemistry
nrxn1 gene
bone marrow involvement
nrxn1 wt allele
canada drugbank
neurexin - 1
neurexin - 1 - beta
lupus panniculitis
dct gene
dct wt allele
chronic sclerosing sialadenitis
binding
focal fibrosis
adult infiltrating astrocytic tumor
cystic oncocytic neoplasm
hepatocellular large cell change
hemochromatosis
tonsillar cyst
astn2 gene
astn2 wt allele
astrotactin - 2
myt1l gene
myt1l wt allele
myelin transcription factor 1 - like protein
tobacco smoke
adult embryonal tumor with multilayered rosettes ,  c19mc - altered
chronic active inflammation
crypt abscess
biological drug neutralization
mild chronic inflammation
nitabuch's fibrinoid
mild anemia
adult pineocytoma
adult pineoblastoma
lincosamide antibiotic
megaloblastoid changes present
adult papillary meningioma
maturation asynchrony present
exclusion
nonanoic acid
pidolic acid
ischemic change
glomerular basement membrane wrinkling
mage - tab
chemical gastritis
viral inclusions present
pancreatic adenocarcinoma
adrenal vein
ctnnd2 gene
ctnnd2 wt allele
catenin delta - 2
rcan1 gene
rcan1 wt allele
dusky mucosa
calcipressin - 1
extract
lung papilloma
hyperchromasia
gestational sac
gubernaculum testis
orbital ridge
chronic active colitis
odontogenesis
complete odontogenesis
xage3 gene
xage3 wt allele
aids - related diffuse mixed cell lymphoma
g antigen family d member 4
eif4g1 gene
eif4g1 wt allele
eukaryotic translation initiation factor 4 gamma 1
computer job
interproscan
vascular regression
focal acute inflammation
hypersegmented neutrophils present
focal podocyte injury
aids - related diffuse small cleaved cell lymphoma
focal mammary duct ectasia
tissue congestion
duodenal extraskeletal osteosarcoma
subcapsular adrenal tumor
mucin depletion
intramucosal eosinophils present
dictionary - derived term
chronic hepatitis
chronic viral hepatitis
aids - related lymphoblastic lymphoma
fungal colonization
malassezia furfur infection
microvesicular steatosis
foregut cyst
gland distortion
architectural distortion
t - cell marker
s - 100 immunohistochemistry staining method
gland loss
primary systemic amyloidosis
macrovesicular steatosis
small lymphocytic lymphoma variant
regenerative epithelium present
gland branching
listeriosis
glandular hyperplasia
stigmata of chronic liver disease
hypocellular tissue
spicule
bone trabeculae
sodium
desmoplastic small round cell tumor
metallic object
peripheral blood vessel
condyle
substance use never current former
cdisc cdash substance use never / current / former classification terminology
osteoblastic rimming present
cholestasis
distortion
excrescence
myofibrillar myopathy
veno - occlusive disease
central core disease
ground glass hepatocyte
fentanyl citrate buccal tablet
adverse event action taken with study treatment
concomitant medication active ingredient
drug accountability record categorization
inclusion exclusion criterion category
laboratory test category
medical history category
electrocardiogram results clinically significant occurrence
graft - versus - tumor induction
laboratory test result clinically significant
physical examination clinically significant
vital signs clinical significance
physical examination abnormal finding
laboratory test specimen condition
concomitant medication daily dose
demographics date of collection
electrocardiogram date
laboratory test date
medical history completion date
adult acute myeloid leukemia with minimal differentiation
physical examination date
visit date
vital signs date
birth day
concomitant medication dose unit
exposure dose unit
exposure planned dose units
exposure total volume administration unit
substance use dose unit
exposure dose
childhood acute myeloid leukemia with minimal differentiation
exposure dose adjustment reason
substance use dose description
concomitant medication dose frequency
exposure dose frequency
substance use dose frequency
exposure interruption duration
adverse event end time
concomitant medication end time
protocol deviation end time
exposure end time
stage i childhood large cell lymphoma
physical examination evaluator
adverse event ongoing
adverse event associated with hospitalization
adverse event associated with serious medical event
concomitant medication ongoing
concomitant medication previous occurrence
concomitant medication yes no indicator
disposition continuation
site unblinding occurrence
protocol deviation yes no indicator
stage ii childhood large cell lymphoma
electrocardiogram performed
exposure dose adjustment
study treatment course completion occurrence
inclusion exclusion criteria yes no indicator
laboratory test protocol test conditions occurrence
laboratory test performed
medical history controlled
medical history occurrence
medical history ongoing
stage iii childhood large cell lymphoma
physical exam yes no indicator
exposure flow rate
exposure flow rate unit of measure
laboratory test reference range upper limit original unit
adverse event sponsor defined identifier
concomitant medication use sponsor defined identifier
next trial identification
protocol deviation sponsor defined identifier
investigator identifier
medical history sponsor defined identifier
stage iv childhood large cell lymphoma
physical examination sponsor defined identifier
study site identifier
study identifier
subject identifier
vital signs sponsor defined identifier
concomitant medication use indication
exposure interruption duration unit
exposure location
vital signs location
electrocardiogram method
recurrent childhood large cell lymphoma
birth month
exposure reported name of treatment
substance use reported name
visit name
laboratory test reference range indicator
laboratory test reference range lower limit original unit
laboratory test reference range for character results standard unit
concomitant medication adverse event number
concomitant medication medical history number
exposure lot number
etidronate disodium
childhood large cell lymphoma
study site number
visit number
drug accountability assessment original result
drug accountability assessment result original units
electrocardiogram original result
electrocardiogram original result unit of measure
laboratory test original result unit
subject characteristics original result
vital signs original result
other actions taken in response to adverse event
fibrous polyp
concomitant medication dose form
exposure dose form
exposure planned dose
electrocardiogram position
vital signs position
electrocardiogram reference identifier
laboratory test reference identifier
adverse event seriousness due to congenital anomaly
medical history reported term
leptomeningeal sarcoma
concomitant medication route of administration
exposure route of administration
disposition dictionary derived term
protocol deviation dictionary derived term
concomitant medication start date
disposition start date
protocol deviation start date
exposure start date
medical history start date
substance usage start date
concomitant medication start time
disposition start time
protocol deviation start time
exposure start time
vital signs completion status
concomitant medication end date
protocol deviation end date
exposure end date
medical history end date
substance use end date
drug accountability record subcategorization
laboratory test subcategory
medical history subcategory
inclusion exclusion criterion test code
drug accountability assessment test
electrocardiogram test
inclusion exclusion criterion test
physical examination test
subject characteristics test
electrocardiogram time
laboratory test time
physical examination time
visit time
vital signs time
electrocardiogram time point
exposure time point
laboratory test time point
vital signs time point
concomitant medication administration dose
vital signs original result unit
substance use duration units
exposure total volume administration
birth year
laboratory test original result
drug accountability treatment dispensation date
drug accountability treatment return date
duration of use
never current former classification
breast classic lobular carcinoma in situ type a
breast classic lobular carcinoma in situ type b
malignant cells with nuclei of various sizes and shapes present
glycogen - rich component present
cellular pleomorphic adenoma
superficial myometrium
colorectal serrated lesions and polyps
mucous cyst
membranous positivity present
ann arbor stage i lymphoma
cdisc variable terminology
cdisc cdash variable terminology
dermal papilla
ann arbor stage ii lymphoma
pediatrician
crypt epithelium
vasculostatin
orthokeratosis
tissue marking ink
crypt glandular lumen
perivascular space
adverse event body system or organ class
adverse event category
adverse event concomitant treatment
sodium fluoride
ann arbor stage iii lymphoma
adverse event duration
adverse event end date time
adverse event end day
adverse event end relative to reference period
adverse event group identifier
adverse event location
adverse event modified reported term
adverse event pattern
adverse event reference identifier
ann arbor stage iv lymphoma
adverse event relationship to non study treatment
adverse event involves cancer
adverse event subcategory
adverse event sequence number
adverse event occurred with overdose
adverse event start date time
planned arm code
birth date and time
concomitant medication category
concomitant medication class
intracranial colloid cyst
concomitant medication class code
concomitant medication dose
concomitant medication dose regimen
concomitant medication dose description
concomitant medication use duration
concomitant medication use end date time
concomitant medication use end day
concomitant medication use end relative to reference period
concomitant medication group identifier
concomitant medication modified reported term
soft tissue amyloid neoplasm
concomitant medication use occurrence
concomitant medication reason not collected
concomitant medication subcategory
concomitant medication sequence number
concomitant medication use completion status
concomitant medication use start date time
concomitant medication start day
concomitant medication use start relative to reference period
comment collection date time
comment evaluator
triploidy
comment sequence number
comment value
drug accountability assessment test code
demographics data collection date time
demographics data collection day
disposition category
disposition collection date time
disposition group identifier
disposition subcategory
disposition sequence number
dicentric chromosome
disposition sponsor defined identifier
disposition event start date time
disposition event start day
electrocardiogram baseline flag
electrocardiogram category
electrocardiogram derived flag
electrocardiogram collection date time
study day of electrocardiogram
electrocardiogram elapsed time
electrocardiogram evaluator
electrocardiogram group identifier
electrocardiogram loinc code
electrocardiogram vendor name
electrocardiogram reference range indicator
electrocardiogram reason not done
electrocardiogram subcategory
electrocardiogram sequence
electrocardiogram completion status
electrocardiogram character result in standard format
electrocardiogram numeric result in standard unit
electrocardiogram standard unit
electrocardiogram test code
electrocardiogram planned time point number
electrocardiogram time point reference
electrocardiogram external file name
subject element code
exposure category
exposure intended dose regimen
exposure daily dose
exposure dose description
exposure duration
exposure elapsed time
exposure end date time
exposure end day
exposure group identifier
exposure subcategory
exposure sequence number
exposure sponsor defined identifier
exposure start date time
exposure start day
exposure planned time point number
exposure time point reference
exposure treatment vehicle
identifying variable
identifying variable value
inclusion exclusion criterion collection date time
inclusion exclusion criterion data collection day
inclusion exclusion criterion original result
inclusion exclusion criterion subcategory
inclusion exclusion criterion sequence number
heparin sodium
inclusion exclusion criterion sponsor defined identifier
inclusion exclusion criterion character result in standard format
investigator name
laboratory test baseline flag
laboratory test derived flag
laboratory test collection date time
laboratory test data collection day
laboratory test elapsed time
laboratory test end date time
laboratory test fasting status
laboratory test group identifier
laboratory test loinc code
laboratory test method
laboratory test reason not done
laboratory test sequence number
laboratory specimen type
laboratory test sponsor defined identifier
laboratory test reference range upper limit standard unit
laboratory test reference range lower limit standard unit
laboratory test character result in standard unit
laboratory test numeric result in standard unit
laboratory test result standard unit
laboratory test code
laboratory test toxicity
laboratory test toxicity grade
laboratory test planned time point number
laboratory test time point reference
medical history body system or organ class
medical history data collection date time
medical history collection day
medical history event end date time
medical history end relative to reference period
medical history group identifier
medical history modified reported term
medical history reason not done
medical history reference identifier
medical history sequence number
medical history completion status
medical history event start date time
physical examination baseline flag
squamous cell intraepithelial neoplasia
physical examination body system or organ class
physical examination category
physical examination collection date time
adverse event start day
adverse event dictionary derived term
concomitant medication dictionary derived term
medical history dictionary derived term
adverse event yes no indicator
physical examination data collection day
physical examination group identifier
low grade squamous intraepithelial neoplasia
physical examination location
physical examination modified reported term
physical examination original result
physical examination original result unit
physical examination reason not done
physical examination subcategory
physical examination sequence number
physical examination severity
physical examination completion status
physical examination character result in standard unit
high grade squamous intraepithelial neoplasia
physical examination numeric result in standard unit
physical examination result standard unit
physical examination test code
qualifier evaluator
qualifier variable label
qualifier variable name
qualifier origin
questionnaire baseline flag
questionnaire category
questionnaire derived flag
questionnaire data collection date time
questionnaire data collection day
questionnaire elapsed time
questionnaire evaluation interval
questionnaire group identifier
questionnaire original result
questionnaire original result unit
questionnaire reason not done
questionnaire subcategory
questionnaire sequence number
questionnaire sponsor defined identifier
questionnaire completion status
questionnaire character result in standard unit
questionnaire numeric result in standard unit
questionnaire result standard unit
questionnaire test
questionnaire test code
questionnaire time point
questionnaire planned time point number
questionnaire time point reference
qualifier data value
related domain abbreviation
relationship identifier
relationship type
subject reference end date time
subject reference start date time
subject characteristics category
subject characteristics data collection date time
subject characteristics data collection day
subject characteristics group identifier
sodium salicylate
subject characteristics original result unit
subject characteristics reason not done
subject characteristics subcategory
subject characteristics sequence number
subject characteristics sponsor defined identifier
subject characteristics status
subject characteristics character result in standard unit
subject characteristics numeric result in standard unit
subject characteristics result standard unit
subject characteristics test code
subject element end date time
subject element start date time
unplanned subject element description
substance use class
substance use class code
substance usage dictionary derived substance term
substance use dose
substance use dose form
substance use daily dose
substance use end date time
substance use end day
substance use end relative to reference period
substance use group identifier
substance use modified reported term
substance use occurrence
substance use reason not collected
substance use route of administration
substance use subcategory
substance use sequence number
substance use sponsor defined identifier
substance use status
substance use start date time
substance use start day
substance use start relative to reference period
unplanned substance use description
subject visit end date time
subject visit start date time
trial arm branch
trial arm order
trial arm transition rule
trial element duration
trial element end rule
trial element start rule
trial inclusion exclusion criteria rule
trial inclusion exclusion criteria version
trial summary parameter code
trial summary sequence number
trial summary parameter value
trial visit end rule
trial visit start rule
visit day
vital signs baseline flag
vital signs category
vital signs derived flag
vital signs data collection date time
vital signs data collection day
vital signs elapsed time
vital signs group identifier
vital signs loinc code
vital signs reference range indicator
vital signs reason not done
vital signs subcategory
vital signs sequence number
vital signs character result in standard unit
vital signs numeric result in standard unit
vital signs result standard unit
vital signs test code
vital signs planned time point number
vital signs time point reference
villus tip
appendiceal tip
pyroninophilia
skin maceration
glomerular basement membrane spikes present
polyp tip
clinical laboratory improvement act
biomarker imaging quality of life studies funding program
occupancy
binary encoding
surface - active agent
non - cytotoxic agent
benign subcapsular adrenal tumor
malignant subcapsular adrenal tumor
microscopic finding
ejection fraction decreased
urinary tract pain
breast atrophy
accelerated growth
bcg solution
recombinant insulin - like growth factor
atypia suspicious for malignancy
qt interval
pr interval
statistic
infectious arteritis
respiratory tract aspiration
infectious conjunctivitis
koilocytotic atypia
berberine
berubicin
atypical glandular hyperplasia
bucillamine
glandular metaplasia
canfosfamide
canrenone
apocrine metaplasia
carbutamide
recombinant somatostatin
intestinal metaplasia
azamulin
saint barthelemy
saint martin  ( french part )
mild dysplasia
cilofungin
moderate dysplasia
clindamycin hydrochloride monohydrate
severe dysplasia
breast fibrocystic change ,  proliferative type with atypia
davalintide
davalintide acetate
intraepithelial neoplasia
low grade intraepithelial neoplasia
englitazone
enpromate
enviroxime
somatropin
connective tissue nevus
famphur
filibuvir
formic acid
hamartomatous polyp
fosamprenavir
fosbretabulin tromethamine
fosfonet sodium anhydrous
lymphangiomatosis
glibutimine
bowenoid papulosis
heptolamide
adenocarcinoma in situ in villous adenoma
hydrobentizide
hydrogenated castor oil
hydrogenated soybean oil
papillary serous cystadenocarcinoma
ibacitabine
idrapril
ifenprodil
imiglitazar
soybean oil
undifferentiated pleomorphic sarcoma with osteoclast - like giant cells
fenofibric acid
halofenate
florid cemento - osseous dysplasia
mobitz i
mobitz ii
corneal infection
eshophageal perforation
infectious mediastinitis
infectious cystitis
corrected prolonged qt interval by ecg finding
inecalcitol
efatutazone
intiquinatine
iobitridol
kidney adenoma
isepamicin
endometrioid stromal and related neoplasms
kethoxal
khelloside
lacosamide
ladirubicin
childhood cerebral diffuse astrocytoma
lersivirine
levofuraltadone
functioning pituitary gland adenoma
linagliptin
recurrent childhood cerebellar astrocytoma
lomitapide
lomitapide mesylate
spiramycin
anal leukoplakia
mannosulfan
mebutizide
tbxt gene duplication
upper gingival carcinoma
navuridine
nicofuranose
lisinopril anhydrous
lucanthone
lower gingival carcinoma
mespirenone
hard palate carcinoma
metamelfalan
soft palate carcinoma
submandibular gland carcinoma
moexipril
sublingual gland carcinoma
gastric fundus carcinoma
namirotene
gastric body carcinoma
nefopam hydrochloride
nemorubicin
spironolactone
gastric antrum carcinoma in situ ajcc v6 and v7
nemorubicin hydrochloride
jejunal neoplasm
nicomol
nicorandil
fibrohistiocytic neoplasm
malignant ovarian granulosa cell tumor
palm kernel oil
renal pelvis neoplasm
peppermint oil
phenethicillin potassium
benign choroid plexus neoplasm
phosphonoacetic acid
pine needle oil  ( pinus sylvestris )
pirlimycin
pivampicillin
posterior tongue carcinoma
malignant sternal neoplasm
malignant sebaceous neoplasm
polyoxyl 40 hydrogenated castor oil
fgfr4 gene mutation
stain
breast melanoma
potassium taurocholate
proflavine hemisulfate
metastatic malignant neoplasm in the colon
prorenoate
prorenoate potassium
stage iv rectal cancer ajcc v6
razaxaban
razupenem
benign supraglottis neoplasm
shark liver oil
sisomicin sulfate
sodium alginate
benign sternal neoplasm
benign ear neoplasm
sevelamer
spearmint oil
benign bartholin gland neoplasm
sulfamethazine sodium
sulfur hexafluoride
sulopenem
dysplastic cerebellar gangliocytoma
tafamidis meglumine
stanozolol
diffuse malignant mesothelioma
cervical condyloma
tocilizumab
cemento - ossifying fibroma
trichlorfon
stage 0 cutaneous melanoma ajcc v6 and v7
ustekinumab
zinc citrate
zinc gluconate
leukoplakia of buccal mucosa
vitamin d - binding protein
jak2 gene mutation
renal benign mesenchymoma
free immunoglobulin light chain
diffuse neurofibroma
serum free immunoglobulin light chain
urine free immunoglobulin light chain
ctcae v4 grade 1
ctcae v4 grade 2
ctcae v4 grade 3
life threatening adverse event
dosage form category
linguistic form
mastocytosis
myeloid / lymphoid neoplasms with eosinophilia and rearrangement of pdgfra ,  pdgfrb ,  or fgfr1 ,  or with pcm1 - jak2
pdgfra gene rearrangement
pdgfrb gene rearrangement
fgfr1 gene rearrangement
myeloid / lymphoid neoplasms with pdgfra rearrangement
myeloid / lymphoid neoplasms with pdgfrb rearrangement
myeloid / lymphoid neoplasms with fgfr1 rearrangement
daycare
attendance
tympanic paraganglioma
contaminant
dust
trisomy 9
trisomy 15
trisomy 19
thoracoabdominal
zfpm1 gene
zfpm1 wt allele
zinc finger protein zfpm1
klf1 gene
papillary epithelial neoplasm
klf1 wt allele
krueppel - like factor 1
hes1 gene
hes1 wt allele
transcription factor hes - 1
hes5 gene
hes5 wt allele
transcription factor hes - 5
hemgn gene
hemgn wt allele
steroid compound
ovarian papillary tumor
hemogen
ank1 gene
ank1 wt allele
ankyrin - 1
card8 gene
card8 wt allele
caspase recruitment domain - containing protein 8
jag2 gene
jag2 wt allele
arbitrary
ovarian serous tumor
protein jagged - 2
cd83 gene
cd83 wt allele
cd83 antigen
rps6kb1 gene
rps6kb1 wt allele
pancreatic insufficiency
ribosomal protein s6 kinase beta - 1
blast bit score
blast raw score
blast e - value
cd38 gene
cd38 wt allele
adp - ribosyl cyclase 1
cfd gene
cfd wt allele
complement factor d
freezer
rack
fancd2 nuclear foci present
microcalcification
fancd2 nuclear foci absent
serum ca19 - 9 abnormal
serum ca19 - 9 equal or less than 180 units / ml
serum ca19 - 9 more than 180 units / ml
ca19 - 9 measurement
scientific method
collaborator
scientific equipment
research material
primary data
processed data
discovery science
personalized medicine
genomics research
xenotropic murine leukemia virus - related virus
mammaprint
t1 translational research
anaplastic astroblastoma
phakomatosis
tumor suppressor arf
international prognostic scoring system  ( ipss )  for myelodysplastic syndromes
intracranial
craniospinal
vaginal infection
infectious otitis media
intraoperative
non - keratinizing epithelioma
yolk sac adenoma
intracranial leptomeningeal lesion
spinal leptomeningeal lesion
breast atypical ductal hyperplasia
distant intracranial metastasis
sexual orientation
heterosexuality
homosexuality
bisexuality
men who have sex with men
drug user
intravenous drug user
recreational drug
extraneural
radioactive instillation
patient - centered medicine
knee to heel length measurement
igf1r immunohistochemical expression
cmc4 gene
cmc4 wt allele
cx9c motif - containing protein 4
construct
theory
mathematical factor
spectral unmixing
sterilization
spectrum
imaging signal
profile
particle size reduction
feed milling
joint capsule
bullous pemphigoid
ectopic renin secretion syndrome
eisenmenger syndrome
age - related macular degeneration
mental retardation
simultanagnosia
acute liver failure
alpha - 1 antitrypsin deficiency
supersaturated calcium phosphate rinse
bariatric surgery
streptonigrin
ectopic growth hormone secretion syndrome
intrahepatic cholestasis
recurrent intrahepatic cholestasis
benign recurrent intrahepatic cholestasis
bile acid synthesis defect
rna - induced silencing complex
argonaute
tarbp2 gene
tarbp2 wt allele
risc - loading complex subunit tarbp2
ectopic prolactin secretion syndrome
six1 gene
cryptogenic cirrhosis
liver disease associated with cystic fibrosis
six1 wt allele
homeobox protein six1
diabetes complication
arid5b gene
diabetic nephropathy
arid5b wt allele
at - rich interactive domain - containing protein 5b
ectopic aldosterone secretion syndrome
diabetic eye disease
image quality
exemplary quality
diagnostic quality
dialysis access failure
limited quality
non - diagnostic quality
drug induced liver injury
end stage liver disease
clu gene
ectopic calcitonin secretion syndrome
clu wt allele
genetic study
clusterin
childhood diabetes mellitus
picalm gene
picalm wt allele
phosphatidylinositol - binding clathrin assembly protein
cr1 gene
cr1 wt allele
complement receptor type 1
ectopic chorionic gonadotropin secretion syndrome
kidney volume
liver study
metabolic syndrome
mitochondrial hepatopathy
nonalcoholic fatty liver disease
nonalcoholic steatohepatitis
neonatal hepatitis
childhood kidney disorder
childhood obesity
nfil3 gene
nfil3 wt allele
progressive familial intrahepatic cholestasis
nuclear factor interleukin - 3 - regulated protein
tbxt gene
tbxt wt allele
proliferative diabetic retinopathy
t - box transcription factor t
vascular access graft failure
mllt10 gene
mllt10 wt allele
protein af - 10
clip1 gene
clip1 wt allele
cap - gly domain - containing linker protein 1
vesicoureteral reflux
apoe gene
apoe wt allele
apolipoprotein e
central site
asbestos - related lung disorder
atrial septal defect
bronchiectasis
carotid artery disorder
congenital coronary artery abnormality
coronary microvascular disease
thrombophilia
heart murmur
hereditary hemochromatosis
congenital septal defect
iron - deficiency anemia
ago1 gene
ago1 wt allele
ago2 gene
narcolepsy
ago2 wt allele
ago3 gene
patent ductus arteriosus
ago3 wt allele
ago4 gene
peripheral arterial disorder
ago4 wt allele
protein argonaute - 1
streptozocin
protein argonaute - 2
restless leg syndrome
protein argonaute - 3
protein argonaute - 4
rh incompatibility
tetralogy of fallot
ventricular septal defect
buffy coat
primary malignant neoplasm
cannabinol
imetelstat sodium
cytoplasmic rna
whole bone marrow
fixed specimen
fixed slide
dried specimen
fresh specimen
touch prep slide
zinc - based fixative
glembatumumab
deletion 18p syndrome
deletion 18q syndrome
hmg - coa lyase deficiency
5' 10' methylenetetrahydrofolate reductase deficiency
abetalipoproteinemia
acatalasemia
achondrogenesis
achromatopsia
acquired hyperostosis syndrome
acrocallosal syndrome
acrodermatitis
acromegaly
actinomycetales infection
acute hemorrhagic leukoencephalitis
acute intermittent porphyria
long - chain acyl - coa dehydrogenase deficiency
medium - chain acyl - coa dehydrogenase deficiency
acyl - coa dehydrogenase ,  short - chain deficiency
adiposis dolorosa
african trypanosomiasis
agnosia
albinism
ainhum
alexander disease
alkaptonuria
allergic bronchopulmonary aspergillosis
alpha - mannosidosis
alstrom syndrome
amaurosis fugax
amebiasis
amniotic band syndrome
amyloid neuropathy
familial amyloid neuropathy
familial amyloidosis
pulp chamber
radiolucency
andersen syndrome
anencephaly
non - trisomic autosomal aneuploidy
anhidrotic ectodermal dysplasia 1
aniridia
ankylosing spondylitis
anthrax
anti - glomerular basement membrane disease
aortic coarctation
argininemia
argininosuccinic aciduria
arnold - chiari malformation
arrhythmogenic right ventricular dysplasia
arthrogryposis
asbestosis
atrophic muscular disorder
auditory perceptual disorder
autoimmune polyendocrinopathy syndrome
autosomal dominant optic atrophy
autosomal dominant polycystic kidney disease
autosomal recessive polycystic kidney disease
autosomal recessive hypohidrotic ectodermal dysplasia
babesiosis
balantidiasis
balkan endemic nephropathy
barth syndrome
bartonella infection
becker's muscular dystrophy
benign migratory glossitis
hepatosplenic t - cell lymphoma
silver
sulfabromomethazine sodium
benign neonatal epilepsy
berardinelli - seip congenital lipodystrophy
bernard - soulier syndrome
beta - mannosidosis
beta - methylcrotonylglycinuria
biotinidase deficiency
botulism
strontium
acute myeloid leukemia with minimal differentiation
brachial plexus neuritis
brown - sequard syndrome
brucellosis
bundle branch block by ecg finding
buruli ulcer
byssinosis
cadasil syndrome
calciphylaxis
tiotropium bromide
campomelic dysplasia
tibial adamantinoma
camurati - engelmann syndrome
canavan disease
carbamoyl - phosphate synthetase i deficiency
carbohydrate - deficient glycoprotein syndrome
cardiofaciocutaneous syndrome
cataplexy
caroli disease
cat - scratch disease
central nervous system cavernous hemangioma
central nervous system vasculitis
central pontine myelinolysis
cerebellar degeneration
cerebral amyloid angiopathy
cerebral cavernous malformation
cerebrospinal fluid rhinorrhea
cerebrotendinous xanthomatosis
chagas disease
palate carcinoma
cherubism
chilblains
chondrodysplasia punctata
chorea
medicated animal feed manufacture
chronic inflammatory demyelinating polyneuropathy
chronic pancreatitis
ciliary motility defect
citrullinemia
ann arbor stage i indolent adult non - hodgkin lymphoma
classical lissencephaly
clubfoot
coccidioidomycosis
coffin - lowry syndrome
cogan - reese syndrome
congenital cortical hyperostosis
congenital dyserythropoietic anemia
congenital myasthenic syndrome
congenital structural myopathy
congenital syphilis
ann arbor stage i mantle cell lymphoma
connexin 26 gene anomaly
cor triatriatum
costello syndrome
craniofacial dysostosis
craniomandibular disorder
craniosynostosis
crigler - najjar syndrome
cryopyrin - associated periodic syndrome
ann arbor stage ii contiguous adult non - hodgkin lymphoma
polyoxyl 60 hydrogenated castor oil
cutis laxa
cystinuria
darier disease
de sanctis - cacchione syndrome
dentinogenesis imperfecta
denys - drash syndrome
dextrocardia
ann arbor stage ii contiguous adult indolent non - hodgkin lymphoma
diffuse cerebral sclerosis of schilder
diffuse idiopathic skeletal hyperostosis
dihydropyrimidine dehydrogenase deficiency
dilated cardiomyopathy
distal muscular dystrophy
donohue syndrome
dracunculiasis
duane syndrome
dystrophia myotonica 1
ann arbor stage ii grade 1 contiguous follicular lymphoma
dystrophia myotonica 2
ebstein anomaly
echinococcosis
ectodermal dysplasia
ellis - van creveld syndrome
emery - dreifuss muscular dystrophy
empty sella syndrome
encephalocele
endemic typhus fever
epidemic louse - borne typhus
ann arbor stage ii grade 2 contiguous follicular lymphoma
epidermolysis bullosa acquisita
epidermolysis bullosa dystrophica
epidermolysis bullosa simplex
epidermolytic palmoplantar keratoderma
equine infectious anemia
erythema infectiosum
erythrokeratodermia variabilis
erythropoietic porphyria
erythropoietic protoporphyria
esophageal achalasia
substance p
ann arbor stage ii grade 3 contiguous follicular lymphoma
fabry disease
facial asymmetry
facial hemiatrophy
facioscapulohumeral muscular dystrophy
hereditary factor xi deficiency
familial dysautonomia
familial mediterranean fever
familial partial lipodystrophy
familial periodic paralysis
stage ii contiguous adult diffuse small cleaved cell lymphoma
farber lipogranulomatosis
fatal familial insomnia
felty syndrome
fetal alcohol syndrome
fibromuscular dysplasia
focal dermal hypoplasia
fox - fordyce disease
fragile x syndrome
friedreich ataxia
frontotemporal dementia
ann arbor stage ii contiguous adult aggressive non - hodgkin lymphoma
hereditary fructose intolerance
fuchs endothelial dystrophy
fusobacterium infection
galactosemia
gastric antral vascular ectasia
gastroschisis
genu varum
gerstmann - straussler - scheinker disease
giant axonal neuropathy
gilbert syndrome
ann arbor stage ii contiguous mantle cell lymphoma
gitelman syndrome
packing
labeling activity
glycogen storage disease type i
glycogen storage disease type ii
glycogen storage disease type iib
glycogen storage disease type iii
glycogen storage disease type iv
glycogen storage disease type v
gm1 gangliosidosis
stage ii contiguous adult diffuse mixed cell lymphoma
goldenhar syndrome
gray platelet syndrome
transposition of great vessels
gynatresia
gyrate atrophy
hajdu - cheney syndrome
hallermann syndrome
hantavirus pulmonary syndrome
hartnup disease
newborn examination
stage ii contiguous adult diffuse large cell lymphoma
hellp syndrome
helminthiasis
hemorrhagic fever with renal syndrome
hepatoerythropoietic porphyria
htert / survivin / melanoma tumor cell - derived mrna - transfected dendritic cell vaccine
hepatolenticular degeneration
hereditary angioedema types i and ii
hereditary angioedema
hereditary coproporphyria
ann arbor stage ii contiguous adult lymphoblastic lymphoma
hereditary mucosal leukokeratosis
hereditary hyperbilirubinemia
herpes simplex encephalitis
herpes zoster oticus
hfe - associated hereditary hemochromatosis
homocystinuria
hydroa vacciniforme
hydrops fetalis
hymenolepiasis
hyperargininemia
ann arbor stage ii non - contiguous adult non - hodgkin lymphoma
hyperhomocysteinemia
hyperostosis frontalis interna
familial hypertrophic cardiomyopathy
hypoalphalipoproteinemia
hypokalemic periodic paralysis
ichthyosis
ichthyosis bullosa of siemens
ichthyosis vulgaris
x - linked ichthyosis
ann arbor stage ii non - contiguous adult indolent non - hodgkin lymphoma
idiopathic cd4 - positive t - lymphocytopenia
idiopathic hypersomnolence
ileitis
immunodeficiency with hyper - igm
imperforate anus
urea cycle metabolism disorder
inclusion body myositis
incontinentia pigmenti
west syndrome
infantile refsum disease
ann arbor stage ii non - contiguous aggressive adult non - hodgkin lymphoma
intestinal atresia
intracranial hypertension
iridocorneal endothelial syndrome
jervell and lange nielsen syndrome
jeune syndrome
meesmann corneal dystrophy
juvenile myoclonic epilepsy
kartagener syndrome
kearns - sayre syndrome
kernicterus
sucralfate
stage ii non - contiguous adult diffuse large cell lymphoma
kleine - levin syndrome
klippel - trenaunay - weber syndrome
kluver - bucy syndrome
korsakoff syndrome
lafora disease
lamellar ichthyosis
landau - kleffner syndrome
lateral medullary syndrome
leber hereditary optic atrophy
beta amyloid 42 measurement
ann arbor stage ii non - contiguous adult lymphoblastic lymphoma
tau protein measurement
nonphosphorylated tau protein measurement
phosphorylated tau protein measurement
lecithin acyltransferase deficiency
leigh disease
lennox - gastaut syndrome
grace period
vitamin d measurement
eosinophilic metamyelocyte count
ann arbor stage iii indolent adult non - hodgkin lymphoma
leopard syndrome
eosinophilic myelocyte count
neutrophilic metamyelocyte count
neutrophilic myelocyte count
leprosy
leptospirosis
lewy body dementia
liddle syndrome
limb - girdle muscular dystrophy
lipoid proteinosis of urbach and wiethe
ann arbor stage iii mantle cell lymphoma
spinocerebellar ataxia type 3
summary 3 report
macroglossia
malakoplakia
malformations of cortical development
malignant atrophic papulosis
hsp90 inhibitor mpc - 3100
pi3k / mtor kinase inhibitor pf - 04691502
fulranumab
taxol analogue sid 530
ann arbor stage iii aggressive adult non - hodgkin lymphoma
oncolytic hsv1716
pak4 inhibitor pf - 03758309
dapatifagene navolactibac
montanide isa 51 vg
hla - a*0201 - restricted trp2 - gp100 - epha2 - her2 multipeptide vaccine
host dendritic cell vaccine - 001 mssm / biir
aurora kinase inhibitor ttp607
anti - pkn3 sirna atu027
glycerin enema
ann arbor stage iv indolent adult non - hodgkin lymphoma
16 , 16 - dimethyl prostaglandin e2
topoisomerase i inhibitor genz - 644282
sufentanil transdermal system
morphine sulfate sustained - release tablet
mage - a1 / mage - a3 / ny - eso - 1 peptides vaccine
anti - cd70 antibody - drug conjugate mdx - 1203
resminostat
camptothecin - 20 ( s )  - o - propionate hydrate
mek inhibitor tak - 733
dec - 205 / ny - eso - 1 fusion protein cdx - 1401
ann arbor stage iv mantle cell lymphoma
membrane - disrupting peptide ep - 100
dher2 vaccine + as15 adjuvant
glasdegib
menadione topical lotion
pimasertib
binimetinib
galeterone
combretastatin a1 diphosphate
ghrelin peptide analogue
malignant hyperthermia syndrome
ann arbor stage iv aggressive adult non - hodgkin lymphoma
uprosertib
igf - 1r / ir inhibitor kw - 2450
non - small cell lung cancer mrna - derived vaccine cv9201
recombinant human anti - tgf - beta monoclonal antibody
progesterone vaginal insert
estradiol / norethindrone acetate tablet
white wine
melphalan hydrochloride / sulfobutyl ether beta - cyclodextrin complex
phospholipid ether - drug conjugate clr 131
recurrent indolent adult non - hodgkin lymphoma
parp inhibitor cep - 9722
mallory - weiss syndrome
mansonelliasis
marburg virus disease
marek disease
melas syndrome
melkersson - rosenthal syndrome
melorheostosis
meningeal tuberculosis
recurrent mantle cell lymphoma
mevalonate kinase deficiency
microsporidiosis
mixed connective tissue disease
mobius syndrome
monilethrix
moyamoya disease
mucolipidosis type iv
mucopolysaccharidosis type iiia
mucopolysaccharidosis type iiib
mucopolysaccharidosis type iiic
sulfone anti - infective agent
recurrent aggressive adult non - hodgkin lymphoma
mucopolysaccharidosis type iiid
mucopolysaccharidosis type iva
mucopolysaccharidosis type ivb
sly syndrome
muenke syndrome
muir - torre syndrome
mulibrey nanism
multiple acyl - coa dehydrogenase deficiency
multiple sulfatase deficiency disease
multiple system atrophy
indolent adult non - hodgkin lymphoma
muscular dystrophy
myokymia
myotonia congenita
myotonic disorder
myotonic dystrophy
necrotizing enterocolitis
necrotizing fasciitis
nelson syndrome
nephrocalcinosis
nephrogenic diabetes insipidus
aggressive adult non - hodgkin lymphoma
nephrogenic fibrosing dermopathy
aldh2 gene
netherton syndrome
neural tube defect
aldh2 wt allele
neuroacanthocytosis
infantile neuroaxonal dystrophy
tnfaip3 gene
tnfaip3 wt allele
brca1 / 2 - associated hereditary breast and ovarian cancer syndrome
tnfrsf11a gene
tnfrsf11a wt allele
neurocysticercosis
neurogenic diabetes insipidus
neuromyelitis optica
neurosyphilis
noma
glycine encephalopathy
ochronosis
ocular cicatricial pemphigoid
lynch syndrome
oculocerebrorenal syndrome
oculocutaneous albinism
oculopharyngeal muscular dystrophy
st6galnac5 gene
st6galnac5 wt allele
palb2 gene
palb2 wt allele
olivopontocerebellar atrophy
idh2 gene
idh2 wt allele
hereditary retinoblastoma
optic neuritis
hbb gene
hbb wt allele
navigation
hbg1 gene
hbg1 wt allele
ornithine carbamoyltransferase deficiency disease
hbg2 gene
hbg2 wt allele
hereditary kidney wilms tumor
ornithine transcarbamylase deficiency
hbd gene
hbd wt allele
hbe1 gene
hbe1 wt allele
hbz gene
hbz wt allele
hbm gene
hbm wt allele
hbq1 gene
orthostatic hypotension
angiogenic squamous dysplasia
hbq1 wt allele
orthostatic intolerance
hemoglobin subunit theta - 1
ossification of posterior longitudinal ligament
hemoglobin subunit mu
hemoglobin subunit zeta
osteochondrodysplasia
hemoglobin subunit epsilon
hereditary melanoma
hemoglobin subunit delta
hemoglobin subunit gamma - 2
hemoglobin subunit gamma - 1
hemoglobin subunit beta
endotracheal
osteopoikilosis
pachyonychia congenita
pallister - hall syndrome
pantothenate kinase - associated neurodegeneration
panuveitis
isocitrate dehydrogenase  [ nadp ]  ,  mitochondrial
partner and localizer of brca2
papillon - lefevre syndrome
alpha - n - acetylgalactosaminide alpha - 2 , 6 - sialyltransferase 5 protein
tumor necrosis factor receptor superfamily member 11a
paragonimiasis
tumor necrosis factor alpha - induced protein 3
aldehyde dehydrogenase ,  mitochondrial
12q24 .2
6q23
sulindac
bilateral carcinoma
18q22 .1
1p31 .1
pelger - huet anomaly
pemphigoid gestationis
peritoneal panniculitis
peroxisomal disorder
persistent fetal circulation
pick's disease
piebaldism
brain stem glioma
pierre robin syndrome
pinta
piriformis muscle syndrome
pityriasis lichenoides
pityriasis rubra pilaris
plague
plummer - vinson syndrome
poland syndrome
polymyalgia rheumatica
porokeratosis
chronic lymphoblastic lymphoma
postural orthostatic tachycardia syndrome
preeclampsia
priapism
primary hypertrophic osteoarthropathy
primary progressive aphasia
primary progressive nonfluent aphasia
progressive bulbar palsy
progressive muscular atrophy
progressive supranuclear palsy
prolidase deficiency
propionic acidemia
prosopagnosia
proteus syndrome
prune belly syndrome
pseudohypoaldosteronism
pseudotumor cerebri
pseudoxanthoma elasticum
pulmonary alveolar proteinosis
infant failure to thrive
pulmonary veno - occlusive disease
indolent non - hodgkin lymphoma
pyruvate carboxylase deficiency
reflex epilepsy
complex regional pain syndrome i
refsum disease
renovascular hypertension
retinitis pigmentosa
retinoschisis
rhizomelic chondrodysplasia punctata
robinow syndrome
long qt syndrome 1
invasive malignant neoplasm
rubella infection
sandhoff disease
mucopolysaccharidosis type i
orofacial
malocclusion
scimitar syndrome
scleredema adultorum
beverage
dental fluorosis
malignant leptomeningeal neoplasm
natural
scleromyxedema
sea - blue histiocyte syndrome
septo - optic dysplasia
severe acute respiratory syndrome
short rib - polydactyly syndrome
sialic acid storage disease
russell - silver syndrome
sinus histiocytosis
measurable disease
sjogren - larsson syndrome
smith - lemli - opitz syndrome
spasmodic torticollis
selective antibody deficiency with normal immunoglobulins
spherocytosis
spinal muscular atrophy
spinal muscular atrophy of childhood
staphylococcal scalded skin syndrome
stargardt disease
status epilepticus
primary neoplasm
refractory carcinoma
malignant neoplasm with regional lymph node involvement
stage i colorectal cancer ajcc v6 and v7
stage ii colorectal cancer ajcc v6
stage iii colorectal cancer ajcc v6
stage iv colorectal cancer ajcc v6
ann arbor stage i hodgkin lymphoma
stiff person syndrome
subacute sclerosing panencephalitis
subvalvular aortic stenosis
sudden infant death syndrome
sunct syndrome
superior mesenteric artery syndrome
supravalvular aortic stenosis
sweet syndrome
swyer james syndrome
syringomyelia
ann arbor stage ii hodgkin lymphoma
taeniasis
takotsubo cardiomyopathy
tangier disease
tarsal tunnel syndrome
tay - sachs disease
tetanus
thalamic disease
thanatophoric dysplasia
thoracic outlet syndrome
thyroglossal duct cyst
ann arbor stage iv hodgkin lymphoma
thyroid dysgenesis
thyroid hormone resistance syndrome
togaviridae infection
tolosa - hunt syndrome
toxocariasis
tracheobronchomalacia
tracheobronchomegaly
treponemal infection
transient global amnesia
trichinosis
superoxide
ann arbor stage i non - hodgkin lymphoma
tricuspid valve atresia
trigger finger disorder
triploidy syndrome
true hermaphroditism
tularemia
ann arbor stage ii non - hodgkin lymphoma
xo syndrome
von willebrand disease ,  type 3
niemann - pick disease ,  type c
uniparental disomy
urachal cyst
usher syndrome
uveomeningoencephalitic syndrome
variegate porphyria
ann arbor stage iii non - hodgkin lymphoma
vitamin a deficiency
vitamin b6 deficiency
waardenburg syndrome
wallerian degeneration
wandering spleen
waterhouse - friderichsen syndrome
weill - marchesani syndrome
western equine encephalomyelitis
whipple disease
ann arbor stage iv non - hodgkin lymphoma
whooping cough
williams syndrome
spinal and bulbar muscular atrophy ,  x - linked 1
x - linked dominant hypophosphatemic rickets
computer configuration
xxxy and xxxxy syndrome
yellow nail syndrome
zellweger syndrome
locally advanced malignant neoplasm
upper case letter
lower case letter
helium
hydrogenated palm oil
jones test
xenon
benign sebaceous neoplasm
proteus vulgaris
low - dose rate brachytherapy
draft
central office
recovered from adverse event without sequelae
metastatic malignant neoplasm in the sternum
metastatic malignant neoplasm in the neck
benign chest wall neoplasm
suramin
metastatic malignant neoplasm in the chest wall
benign respiratory system neoplasm
benign paranasal sinus neoplasm
stage iv hypopharyngeal carcinoma ajcc v6
benign epicardial neoplasm
benign pericardial neoplasm
benign blood vessel neoplasm
malignant blood vessel neoplasm
benign great vessel neoplasm
disabilities of the arm shoulder and hand outcome measure
assessment of motor and process skills
jebsen - taylor hand function test
grooved pegboard test
manual ability measure - 36
skin prick test
spirometry
jogging
sport
talc
subcutaneous hemangioma
racquet sport
bicycling
imaging region of interest
cox - 2 immunohistochemical expression analysis
school age child
gross income
evans staging system
evans stage i
evans stage ii
splenic hemangioma
evans stage iii
evans stage iv
evans stage v
shimada classification system
favorable shimada classification
unfavorable shimada classification
international neuroblastoma staging system
inss stage 1
inss stage 2a
inss stage 2b
metastatic malignant neoplasm in the lip
inss stage 3
inss stage 4
inss stage 4s
pediatric oncology group neuroblastoma staging system
pog neuroblastoma stage a
pog neuroblastoma stage b
pog neuroblastoma stage c
pog neuroblastoma stage d
pog neuroblastoma stage ds
likert scale
metastatic malignant neoplasm in the pancreas
dichotomous response format
open - ended response format
close - ended response format
performing arts
data conversion
scalable vector graphics
kaplan meier survival plot
portable network graphics
spreadsheet
graphics visualization
metastatic malignant neoplasm in the epididymis
codec
clinical events domain
findings about events or interventions domain
tivozanib
autologous cd133 - positive btsc mrna - pulsed autologous dendritic cell vaccine
iodine i 131 - labeled anti - cea / anti - hsg bispecific monoclonal antibody tf2
alunacedase alfa
akt inhibitor sr13668
fluorine f 18 - vm4 - 037
benign placental neoplasm
autologous lymphoma cell / autologous dendritic cell electrofusion hybrid vaccine
autologous lymphoma cell / allogeneic dendritic cell electrofusion hybrid vaccine
autologous lymphoma cell lysate - pulsed autologous dendritic cell vaccine
anti - flt3 monoclonal antibody imc - eb10
onalespib
hla - a*2402 - restricted urlc10 - cdca1 - vegfr1 - vegfr2 multipeptide vaccine
dinitrophenyl - modified autologous renal cell carcinoma tumor cell vaccine
vinorelbine tartrate oral
technetium tc - 99m - nc100692
autologous tgfbeta - resistant her2 / ebv - specific cytotoxic t lymphocytes
metastatic malignant neoplasm in the placenta
silmitasertib sodium
iodine i 123 iodobenzamide
tarp 27 - 35 peptide vaccine
tarp 29 - 37 - 9v peptide vaccine
anti - gnrh vaccine pep223
eprenetapopt
natural killer cells zrx101
formoterol fumarate oral
pan - pi3k / mtor inhibitor sf1126
metastatic malignant neoplasm in the nervous system
multi - epitope tarp - pulsed autologous dendritic cell vaccine
stabilized sulphur hexafluoride microbubble - based contrast agent
carbon c 14 eribulin acetate
calcium - 41 chloride aqueous solution
calcium - 46 chloride aqueous solution
zolbetuximab
demplatin pegraglumer
ferumoxides injectable solution
anti - a5b1 integrin monoclonal antibody pf - 04605412
autologous renal cell carcinoma tumor lysate - pulsed dendritic cell vaccine
benign cerebral neoplasm
azurin:50 - 77 cell penetrating peptide p28
pexmetinib
2 - hydroxyflutamide depot
buprenorphine transdermal matrix patch
resveratrol formulation srt501
recombinant adenovirus encoding p53
anti - erbb2 / anti - erbb3 bispecific monoclonal antibody mm - 111
equipment operator
service occupation
digital clubbing
benign brain stem neoplasm
claustrophobia
cdisc sdtm microorganism terminology
cdisc sdtm method terminology
cdisc sdtm pharmacokinetic parameter long name terminology
cdisc sdtm pharmacokinetic parameter unit of measure terminology
cdisc sdtm microbiology susceptibility testing result category terminology
trait
chief complaint
immigration
clinician
tamoxifen citrate
metastatic malignant neoplasm in the brain stem
warmth
smear specimen
tuberculin
melanoblast
growth medium
mycetoma
in vitro route of administration
lowenstein - jensen medium
ogawa growth medium
middlebrook 7h10 growth medium
middlebrook 7h11 growth medium
microbacterium
anteroposterior orientation
lordotic position
posteroanterior orientation
intensive phase
immersion route of exposure
in beehive route of administration
in - ovo route of administration
intrafollicular route of administration
oculonasal route of administration
incarceration
medical history yes no indicator
thioacetazone
cdc mycobacterium quantitation scheme
1 +  score
2 +  score
3 +  score
4 +  score
mycobacterium tuberculosis complex
metastatic malignant neoplasm in the ciliary body
interim
division
upper limit of quantitation
excretion rate
mean residence time
area under first moment curve
area under urinary excretion rate curve
steady state volume of distribution
microbial susceptibility test result
metastatic malignant neoplasm in the choroid
microbial susceptibility test
volume of distribution of absorbed fraction
r squared
mycobacterium kansasii
mycobacterium africanum
mycobacterium bovis
mycobacterium bovis bcg
mycobacterium canetti
mycobacterium microti
unlikely
metastatic malignant neoplasm in the retina
likely
finger stick
five times weekly
adjusted r squared
acridine orange staining method
agar dilution method
aminoglycoside screening method
antibiotic agar screening method
antimicrobial combination testing method
antimicrobial dose dependent susceptibility result
metastatic malignant neoplasm in the orbit
antimicrobial intermediate susceptibility result
antimicrobial nonsusceptibility result
antimicrobial resistance result
antimicrobial susceptibility result
area under the curve all
area under the curve from dosing to last concentration
area under the curve from t1 to t2
area under the curve over dosing interval
area under the first moment curve all
area under the first moment curve from dosing to last concentration
metastatic malignant neoplasm in the parathyroid glands
area under the first moment curve over dosing interval
area under the urinary excretion rate curve from dosing to last concentration
area under the urinary excretion rate curve from t1 to t2
auscultation
atomic absorption spectroscopy
average concentration
beta lactamase screening method
calcofluor white staining method
cellulose tape method
cmin
collection interval midpoint
concentration variability between dose time and tau
current therapy
day times femtogram per milliliter
day times gram per milliliter
day times kilogram per milliliter
day times microgram per milliliter
day times micromole per milliliter
day times milligram per milliliter
day times millimole per milliliter
malignant paraganglioma
day times mole per milliliter
day times nanogram per milliliter
day times nanomole per milliliter
day times picogram per milliliter
day times picomole per milliliter
disk diffusion method
epsilometry
femtogram per milliliter
giemsa staining method
gradient diffusion method
technetium tc - 99m sulfur colloid
erythroleukemia in remission
gram per hour
gram per minute
gram per second
hour squared times microgram per milliliter
hour squared times micromole per milliliter
hour squared times milligram per milliliter
hour squared times millimole per milliliter
hour squared times nanogram per milliliter
hour squared times picogram per milliliter
malignant male reproductive system neoplasm
hour squared times picomole per milliliter
hour times femtogram per milliliter
hour times femtomole per milliliter
hour times gram per milliliter
hour times kilogram per milliliter
hour times microgram per milliliter
hour times microgram per milliliter per milligram
hour times micromole per milliliter
ocular melanoma
hour times milligram per liter per milligram
hour times milligram per milliliter
hour times millimole per milliliter
hour times mole per milliliter
hour times nanogram per milliliter
hour times nanogram per milliliter per gram
hour times nanogram per milliliter per kilogram
hour times nanogram per milliliter per milligram
hour times nanogram per milliliter per milligram per kilogram
hour times nanogram per milliliter per milligram per meter squared
undifferentiated high grade pleomorphic sarcoma of bone
hour times nanogram per milliliter times kilogram
hour times nanomole per liter per micromole
hour times nanomole per milliliter
hour times nanomole per milliliter per milligram
hour times picogram per milliliter
hour times picogram per milliliter per kilogram
hour times picogram per milliliter per microgram
hour times picogram per milliliter per milligram
hour times picomole per liter per microgram
ann arbor stage ii adult contiguous immunoblastic lymphoma
hour times picomole per milliliter
hour times picomole per milliliter per milligram
india ink staining method
infrared spectrometry
initial concentration
international unit per day
international unit per hour
international unit per minute
international unit per second
iodine staining method
ann arbor stage ii adult non - contiguous immunoblastic lymphoma
iron hematoxylin staining method
kinyoun staining method
lambda z
lambda z time lower limit
lambda z time upper limit
last concentration
last measurable observed excretion rate
liter per gram per day
liter per gram per hour
liter per gram per minute
metastatic malignant neoplasm of unknown primary
liter per gram per second
liter per microgram per hour
liter per kilogram per second
liter per microgram per day
liter per microgram per minute
liter per microgram per second
liter per micromole per day
liter per micromole per hour
visual pathway glioma
liter per micromole per minute
liter per micromole per second
liter per milligram per day
liter per milligram per hour
liter per milligram per minute
liter per milligram per second
liter per millimole per day
liter per millimole per hour
liter per millimole per minute
liter per millimole per second
adult choroid plexus neoplasm
liter per mole
liter per mole per day
liter per mole per hour
liter per mole per minute
liter per mole per second
liter per nanogram per day
liter per nanogram per hour
liter per nanogram per minute
liter per nanogram per second
liter per nanomole per day
liter per nanomole per hour
liter per nanomole per minute
liter per nanomole per second
liter per picogram per day
liter per picogram per hour
liter per picogram per minute
liter per picogram per second
macro broth dilution method
maximum concentration dose normalized
maximum observed excretion rate
teniposide
mean residence time last
micro broth dilution method
microbial concentration method
microgram per inhalation
microgram per puff
microgram per second
micromole per hour
micromole per minute
micromole per second
milligram per liter per milligram
milligram per milliliter per hour
milligram per second
milliliter per gram per second
milliliter per kilogram per second
milliliter per mole per day
milliliter per mole per hour
milliliter per mole per minute
milliliter per mole per second
millimole per hour
millimole per milliliter per hour
millimole per minute
millimole per second
minute times femtogram per milliliter
minute times gram per milliliter
minute times kilogram per milliliter
minute times microgram per milliliter
minute times micromole per milliliter
minute times milligram per milliliter
minute times millimole per milliliter
minute times mole per milliliter
minute times nanogram per milliliter
minute times nanomole per milliliter
minute times picogram per milliliter
minute times picomole per milliliter
modified acid fast staining method
mole per day
mole per hour
mole per minute
myelodysplastic syndrome with multilineage dysplasia
mole per second
nanogram per day
nanogram per hour
nanogram per kilogram per minute
nanogram per milligram of creatinine
nanogram per milliliter per kilogram
nanogram per milliliter per milligram
nanogram per milliliter times kilogram
nanogram per minute
nanogram per second
nanomole per day
nanomole per gram
nanomole per hour
nanomole per kilogram
nanomole per liter per micromole
nanomole per milliliter per hour
nanomole per minute
nanomole per second
localized malignant neoplasm
nanounit per milliliter
observed area under the curve infinity
observed area under the curve infinity by dose
observed area under the curve percent back extrapolation
observed area under the curve percent extrapolation
observed area under the first moment curve infinity
observed area under the first moment curve percent extrapolation
observed area under the urinary excretion rate curve infinity
observed area under the urinary excretion rate curve percent extrapolation
observed mean residence time infinity
infiltrating cervical carcinoma
observed steady state volume of distribution
observed steady state volume of distribution at terminal phase
observed total body clearance by fraction of dose absorbed
observed total body clearance rate
observed volume of distribution
observed volume of distribution of absorbed fraction
optical density measurement
percent recovered
picogram per day
picogram per hour
childhood ependymoma
picogram per milligram of creatinine
picogram per milliliter per microgram
picogram per minute
picogram per second
picomole per liter per microgram
predicted area under the curve infinity
predicted area under the curve infinity by dose
predicted area under the curve percent back extrapolation
predicted area under the curve percent extrapolation
predicted area under the first moment curve infinity
recurrent childhood ependymoma
predicted area under the first moment curve percent extrapolation
predicted area under the urinary excretion rate curve infinity
predicted area under the urinary excretion rate curve percent extrapolation
predicted mean residence time infinity
predicted steady state volume of distribution
predicted steady state volume of distribution at terminal phase
predicted total body clearance by fraction of dose absorbed
predicted total body clearance rate
predicted volume of distribution
predicted volume of distribution of absorbed fraction
tenuazonic acid
stage ib soft tissue sarcoma ajcc v7
previous and current therapy
ryan blue staining method
second times femtogram per milliliter
second times gram per milliliter
second times kilogram per milliliter
second times microgram per milliliter
second times micromole per milliliter
second times milligram per milliliter
second times millimole per milliliter
second times mole per milliliter
stage iia soft tissue sarcoma ajcc v7
second times nanogram per milliliter
second times nanomole per milliliter
second times picogram per milliliter
second times picomole per milliliter
steady state total body clearance by fraction of dose absorbed
steady state total body clearance rate
sum of lambda z timepoints
sum urine volume
terminal half life
thick smear technique
stage iib soft tissue sarcoma ajcc v7
thin smear technique
time and log concentration correlation
time of last nonzero concentration
time of maximum observed excretion rate
time until first nonzero concentration
tmin
trial primary objective
trial secondary objective
weber green staining method
wright staining method
stage ia soft tissue sarcoma ajcc v7
x - ray fluorescence spectrometry
ziehl neelsen acid fast staining method
amount recovered
work - up
stage ia breast cancer ajcc v7
stage ib breast cancer ajcc v7
dark field microscopy
clinical trial site
cdisc sdtm pharmacokinetic parameter short name terminology
breast tissue expander
area under urinary excretion rate curve all
mycobacterial interspersed repetitive unit typing
spacer oligonucleotide typing
color mapping function
grayscale image
grayscale color map
hot - cold color map
warm color map
cool color map
stage iii soft tissue sarcoma ajcc v7
undirected graph
graph layout
graph radial layout
graph circular layout
graph combinatorial layout
rounded rectangle
concentrate
evoked response audiometry
conditioning play audiometry
expectorate
stage iv soft tissue sarcoma ajcc v7
tenericutes
neuronal ceroid lipofuscinosis type 1
correctional institution
shelter
neuronal ceroid lipofuscinosis type 2
x - linked inherited disorder
autosomal recessive disorder
refugee camp
homeless
acquired
precancerous polyp
chromosome breakage
proprietary data format
open specification data format
plain text data format
microcephaly
aspergillus galactomannan antigen test
substrate deprivation therapy
migrant farm worker
refugee
3h - thymidine labeling index
childhood ovarian germ cell tumor
calcofluor white stain
fanconi anemia complementation group protein
fanconi anemia group a protein
burden
fanconi anemia group b protein
fanconi anemia group c protein
fanconi anemia group d2 protein
stage 0 merkel cell carcinoma ajcc v7
fanconi anemia group e protein
stage i merkel cell carcinoma ajcc v7
acute myelomonocytic leukemia in remission
stage ia merkel cell carcinoma ajcc v7
fanconi anemia group f protein
stage ib merkel cell carcinoma ajcc v7
stage ii merkel cell carcinoma ajcc v7
stage iia merkel cell carcinoma ajcc v7
stage iib merkel cell carcinoma ajcc v7
stage iic merkel cell carcinoma ajcc v7
stage iii merkel cell carcinoma ajcc v7
stage iiia merkel cell carcinoma ajcc v7
stage iiib merkel cell carcinoma ajcc v7
teratogen
lymphocyte predominant type hodgkin's disease
stage iv merkel cell carcinoma ajcc v7
consistent
suspicion
aeromonadaceae
bartonellaceae
brevibacteriaceae
campylobacteraceae
caulobacteraceae
paenibacillaceae
promicromonosporaceae
testicular germ cell tumor
thermomonosporaceae
acetobacteraceae
actinomycetaceae
aerococcaceae
alcaligenaceae
bacillaceae
bacillales xi
bacillales xii
bifidobacteriaceae
brucellaceae
benign chondrogenic neoplasm
burkholderiaceae
cardiobacteriaceae
carnobacteriaceae
cellulomonadaceae
clostridiales xi
clostridiales xiii
comamonadaceae
coriobacteriaceae
dermabacteraceae
dermacoccaceae
dermatophilaceae
desulfovibrionaceae
enterobacteriaceae
enterococcaceae
erysipelotrichaceae
eubacteriaceae
flavobacteriaceae
francisellaceae
fusobacteriaceae
gordoniaceae
leukemic phase of lymphoma
helicobacteraceae
intrasporangiaceae
lachnospiraceae
lactobacillaceae
methylobacteriaceae
microbacteriaceae
micrococcaceae
micrococcineae
moraxellaceae
mycoplasmataceae
postcricoid carcinoma
neisseriaceae
pasteurellaceae
peptococcaceae
peptostreptococcaceae
planococcaceae
porphyromonadaceae
prevotellaceae
propionibacteriaceae
pseudomonadaceae
rhizobiaceae
vulvar angiokeratoma
rhodospirillaceae
ruminococcaceae
shewanellaceae
sphingobacteriaceae
sphingomonadaceae
spirochaetaceae
staphylococcaceae
streptococcaceae
tsukamurellaceae
veillonellaceae
vibrionaceae
xanthomonadaceae
atopobium
avibacterium
cronobacter
dermacoccus
grimontia
histophilus
chlamydiaceae
aggravated epilepsy
tatlockia
corynebacteriaceae
mycobacteriaceae
nocardiaceae
streptomycetaceae
bacteroidaceae
clostridiaceae
leuconostocaceae
coarse
fine
listeriaceae
tuberculin skin test
fanca gene
heaf tuberculin skin test
mantoux tuberculin skin test
tine tuberculin skin test
fanca wt allele
terpene compound
leptospiraceae
ontario
manitoba
quebec
saskatchewan
newfoundland and labrador
coxiellaceae
rickettsiaceae
methemoglobin
moraxella
retinal melanoma
serratia
agrobacterium
alcaligenes
propionibacterium
leptotrichia
morganella morganii
nunavut
fancb gene
xanthomonas
proteus mirabilis
pleomorphic adenoma
uranium
exact
comprehension
fancb wt allele
ache
fancc gene
stage ia cutaneous melanoma ajcc v7
rhodotorula mucilaginosa
fancc wt allele
living quarters
renal pelvis papillary urothelial neoplasm
stage ib cutaneous melanoma ajcc v7
xy female
xx male
stage iia cutaneous melanoma ajcc v6 and v7
stage iic cutaneous melanoma ajcc v6 and v7
photograph
drink
shave
accomplishment
adjudication
recurrent lymphoplasmacytic lymphoma
navy
team
written documentation
upright
pipe
abate
abstracting
anesthesiology
asterixis
stage iiia cutaneous melanoma ajcc v7
anaplastic  ( malignant )  intraspinal meningioma
bathing
stage iiib cutaneous melanoma ajcc v7
bedridden
stage iiic cutaneous melanoma ajcc v7
brace
cardiology
causing
cavitec
check
complicated
stage ii testicular choriocarcinoma ajcc v6 and v7
crutch
dactylaria
cryoglobulin
densitometry
despondency
do
dycal
easy
eat
recurrent breast inflammatory carcinoma
endodontics
equivocal
esthesiometer
explanation
hemicolectomy
histoplasma
hypha
abiotrophia
abiotrophia defectiva
achromobacter
congenital epilepsy
achromobacter denitrificans
achromobacter piechaudii
achromobacter xylosoxidans
acidaminococcus
acidaminococcus fermentans
acidovorax
acidovorax delafieldii
acidovorax facilis
acidovorax temperans
acinetobacter anitratus
malignant hepatobiliary neoplasm
acinetobacter calcoaceticus
acinetobacter calcoaceticus / baumannii complex
acinetobacter haemolyticus
acinetobacter johnsonii
acinetobacter junii
acinetobacter lwoffii
acinetobacter radioresistens
actinobacillus
actinobacillus actinomycetemcomitans
actinobacillus equuli
metastatic malignant neoplasm in the adrenal gland
actinobacillus lignieresii
actinobacillus pleuropneumoniae
actinobacillus suis
actinobacillus ureae
actinomadura
actinomadura madurae
actinomadura pelletieri
actinomyces bovis
actinomyces israelii
actinomyces meyerii
actinomyces naeslundii
actinomyces neuii
actinomyces odontolyticus
actinomyces radingae
actinomyces turicensis
actinomyces viscosus
aerobic gram negative bacillus
aerobic gram negative coccus
aerobic gram positive bacillus
aerobic gram positive coccus
benign peritoneal neoplasm
aerobic streptococcus
aerococcus
aerococcus urinae
aerococcus viridans
aeromonas
aeromonas hydrophila
aeromonas jandaei
aeromonas punctata
aeromonas salmonicida
aeromonas schubertii
myeloid sarcoma in remission
aeromonas sobria
aeromonas veronii
aggregatibacter
aggregatibacter actinomycetemcomitans
aggregatibacter aphrophilus
aggregatibacter segnis
agrobacterium radiobacter
agrobacterium tumefaciens
hepatobiliary neoplasm
alcaligenes faecalis
alpha - hemolytic streptococcus
anaerobic gram negative bacillus
anaerobic gram negative coccus
anaerobic gram positive bacillus
anaerobic gram positive coccus
anaerobic streptococcus
arcanobacterium
arcanobacterium bernardiae
arcanobacterium haemolyticum
metastatic malignant neoplasm in the abdominal cavity
arcanobacterium pyogenes
arcobacter
arcobacter butzleri
arcobacter cryaerophilus
arthrobacter
atopobium minutum
atopobium parvulum
avibacterium paragallinarum
bacillus alvei
chronic myelomonocytic leukemia in remission
bacillus anthracis
bacillus cereus
bacillus lentus
bacillus licheniformis
bacillus megaterium
bacillus mycoides
bacillus polymyxa
bacillus subtilis
bacteroides caccae
bacteroides capillosus
pure erythroid leukemia in remission
bacteroides cellulosolvens
bacteroides eggerthii
bacteroides fragilis
bacteroides fragilis group
bacteroides nordii
bacteroides ovatus
bacteroides splanchnicus
bacteroides stercoris
bacteroides tectus
bacteroides thetaiotaomicron
bacteroides uniformis
bacteroides ureolyticus
bacteroides vulgatus
bartonella
bartonella elizabethae
bartonella henselae
bartonella quintana
bergeyella
bergeyella zoohelcum
intracranial tumor hemorrhage
beta - hemolytic streptococcus
beta streptococcus group c
beta streptococcus group f
beta streptococcus group g
bifidobacterium
bifidobacterium adolescentis
bifidobacterium angulatum
bifidobacterium bifidum
bifidobacterium dentium
bifidobacterium longum
therapeutic testosterone
bilophila
bilophila wadsworthia
bordetella
bordetella avium
bordetella bronchiseptica
bordetella parapertussis
borrelia
brevibacillus
brevibacillus laterosporus
brevibacterium
brevibacterium casei
brevibacterium epidermidis
brevundimonas
brevundimonas diminuta
brevundimonas vesicularis
brucella
brucella abortus
brucella canis
brucella melitensis
brucella suis
budvicia
budvicia aquatica
burkholderia
burkholderia cenocepacia
burkholderia cepacia complex
burkholderia gladioli
burkholderia mallei
burkholderia pseudomallei
buttiauxella
buttiauxella agrestis
campylobacter coli
campylobacter concisus
campylobacter curvus
campylobacter fetus
campylobacter gracilis
campylobacter jejuni
campylobacter lari
campylobacter rectus
campylobacter upsaliensis
capnocytophaga canimorsus
capnocytophaga gingivalis
capnocytophaga ochracea
capnocytophaga sputigena
cardiobacterium
cardiobacterium hominis
cedecea
cedecea davisae
cedecea lapagei
cedecea neteri
cellulomonas
recurrent colorectal carcinoma
cellulomonas hominis
cellulosimicrobium
cellulosimicrobium cellulans
chlamydia trachomatis
chlamydophila
chlamydophila psittaci
chromobacterium
chromobacterium violaceum
chryseobacterium
chryseobacterium gleum
stage iv gastric cancer with metastasis
chryseobacterium indologenes
chryseomonas
citrobacter amalonaticus
citrobacter braakii
citrobacter farmeri
citrobacter freundii
citrobacter freundii complex
citrobacter koseri
citrobacter youngae
clostridium acetobutylicum
recurrent esophageal adenocarcinoma
clostridium baratii
clostridium beijerinckii
clostridium bifermentans
clostridium butyricum
clostridium cadaveris
clostridium celatum
clostridium clostridioforme
clostridium cochlearium
clostridium cocleatum
clostridium fallax
stage ii esophageal adenocarcinoma ajcc v7
clostridium glycolicum
clostridium haemolyticum
clostridium histolyticum
clostridium innocuum
clostridium limosum
clostridium novyi
clostridium oceanicum
clostridium paraputrificum
clostridium perfringens
clostridium putrificum
stage 0 esophageal adenocarcinoma ajcc v7
clostridium ramosum
clostridium rectum
clostridium septicum
clostridium sordellii
clostridium sporogenes
clostridium subterminale
clostridium symbiosum
clostridium tertium
clostridium tetani
clostridium tyrobutyricum
testosterone propionate
stage i esophageal adenocarcinoma ajcc v7
collinsella
collinsella aerofaciens
collinsella intestinalis
comamonas
comamonas terrigena
comamonas testosteroni
corynebacterium accolens
corynebacterium afermentans
corynebacterium amycolatum
corynebacterium argentoratense
stage iii esophageal adenocarcinoma ajcc v7
corynebacterium auris
corynebacterium bovis
corynebacterium diphtheriae
corynebacterium genitalium
corynebacterium kutscheri
corynebacterium macginleyi
corynebacterium matruchotii
corynebacterium minutissimum
corynebacterium pilosum
corynebacterium propinquum
stage iv esophageal adenocarcinoma ajcc v7
corynebacterium pseudodiphtheriticum
corynebacterium pseudotuberculosis
corynebacterium renale
corynebacterium striatum
corynebacterium ulcerans
corynebacterium urealyticum
corynebacterium xerosis
coryneform gram positive bacillus
coxiella burnetii
cronobacter sakazakii
recurrent esophageal squamous cell carcinoma
cupriavidus
cupriavidus pauculus
delftia
delftia acidovorans
dermabacter
dermabacter hominis
dermacoccus nishinomiyaensis
dermatophilus
dermatophilus congolensis
desulfovibrio
recurrent rectosigmoid carcinoma
desulfovibrio desulfuricans
desulfovibrio fairfieldensis
desulfovibrio piger
diptheroid bacillus
edwardsiella
edwardsiella hoshinae
edwardsiella ictaluri
edwardsiella tarda
eggerthella
eggerthella lenta
stage iii rectosigmoid cancer ajcc v6
eikenella
eikenella corrodens
elizabethkingia
elizabethkingia meningoceptica
empedobacter
empedobacter brevis
enterobacter aerogenes
enterobacter amnigenus
enterobacter asburiae
enterobacter cancerogenus
stage iv rectosigmoid cancer ajcc v6
enterobacter cloacae
enterobacter gergoviae
enterobacter hormaechei
enterobacter taylorae
enterococcus avium
enterococcus casseliflavus
enterococcus dispar
enterococcus durans
enterococcus faecalis
enterococcus faecium
metastatic small intestinal carcinoma
enterococcus gallinarum
enterococcus hirae
enterococcus malodoratus
enterococcus mundtii
enterococcus pseudoavium
enterococcus raffinosus
erysipelothrix
erysipelothrix rhusiopathiae
escherichia albertii
escherichia blattae
unresectable small intestinal carcinoma
escherichia fergusonii
escherichia hermannii
escherichia vulneris
eubacterium
eubacterium alactolyticum
eubacterium contortum
eubacterium limosum
eubacterium nodatum
eubacterium rectale
eubacterium ventriosum
resectable small intestinal carcinoma
ewingella
ewingella americana
facklamia
faecalibacterium
faecalibacterium prausnitzii
fermentative gram negative bacillus
francisella
francisella tularensis
fusobacterium gonidiaformans
fusobacterium mortiferum
tetrachlorodibenzodioxin
resectable extrahepatic bile duct carcinoma
fusobacterium necrogenes
fusobacterium necrophorum
fusobacterium necrophorum subspecies funduliforme
fusobacterium necrophorum subspecies necrophorum
fusobacterium nucleatum
fusobacterium russii
fusobacterium ulcerans
fusobacterium varium
gamma - hemolytic streptococcus
gardnerella
unresectable hepatoblastoma
gardnerella vaginalis
globicatella
globicatella sanguinis
globicatella sulfidifaciens
gordonia
gordonia aichiensis
gordonia bronchialis
gordonia rubripertincta
gordonia sputi
gordonia terrae
resectable hepatoblastoma
gracilibacillus
gram negative bacillus
gram negative coccus
gram positive coccus
granulicatella
granulicatella adiacens
grimontia hollisae
haemophilus aegyptius
haemophilus haemoglobinophilus
recurrent hepatoblastoma
haemophilus haemolyticus
haemophilus influenzae
haemophilus parahaemolyticus
haemophilus parainfluenzae
hafnia
hafnia alvei
halobacillus
helicobacter cinaedi
helicobacter fennelliae
helicobacter mustelae
b acute lymphoblastic leukemia
helicobacter rappini
histophilus somni
holdemania
holdemania filiformis
inquilinus
inquilinus limosus
jeotgalibacillus
johnsonella
johnsonella ignava
kingella
recurrent chronic lymphocytic leukemia
kingella denitrificans
kingella kingae
kingella oralis
kingella potus
klebsiella granulomatis
klebsiella oxytoca
klebsiella ozaenae
klebsiella pneumoniae
klebsiella rhinoscleromatis
klebsiella singaporensis
stage iv chronic lymphocytic leukemia
klebsiella variicola
kluyvera
kluyvera ascorbata
kluyvera cryocrescens
kluyvera georgiana
kluyvera intermedia
knoellia
kocuria
kocuria kristinae
kocuria rosea
aggressive nk - cell leukemia
kocuria varians
kurthia
kytococcus
kytococcus sedentarius
lactobacillus acidophilus
lactobacillus brevis
lactobacillus casei
lactobacillus catenaformis
lactobacillus fermentum
lactobacillus gallinarum
myelodysplastic syndrome ,  unclassifiable
lactobacillus jensenii
lactobacillus johnsonii
lactobacillus salivarius
lactococcus
lactococcus garvieae
lactococcus lactis
leclercia
leclercia adecarboxylata
legionella longbeachae
legionella pneumophila
recurrent lymphocyte - depleted classic hodgkin lymphoma
leifsonia
leifsonia aquatica
leminorella
leminorella grimontii
leminorella richardii
leuconostoc citreum
leuconostoc lactis
leuconostoc mesenteroides
leuconostoc pseudomesenteroides
listeria grayi
tetracycline
refractory lymphocyte - depleted classic hodgkin lymphoma
listeria innocua
listeria ivanovii
listeria monocytogenes
listeria seeligeri
listeria welshimeri
macrococcus
macrococcus caseolyticus
mannheimia
mannheimia haemolytica
ann arbor stage iv lymphocyte - depleted classic hodgkin lymphoma
methylobacterium mesophilicum
microbacterium paraoxydans
micrococcus luteus
micrococcus lylae
mitsuokella
mitsuokella multacida
mobiluncus
mobiluncus curtisii
mobiluncus mulieris
refractory lymphoplasmacytic lymphoma
moellerella
moellerella wisconsensis
moraxella atlantae
moraxella bovis
moraxella canis
moraxella lacunata
moraxella lincolnii
moraxella nonliquefaciens
moraxella oblonga
ann arbor stage i lymphoplasmacytic lymphoma
moraxella osloensis
morganella
mycobacterium abscessus
mycobacterium avium
mycobacterium chelonae
mycobacterium flavescens
mycobacterium fortuitum
mycobacterium fortuitum complex
ann arbor stage ii lymphoplasmacytic lymphoma
mycobacterium gastri
mycobacterium gordonae
mycobacterium haemophilum
mycobacterium leprae
mycobacterium marinum
mycobacterium peregrinum
mycobacterium scrofulaceum
mycobacterium simiae
fancd2 gene
ann arbor stage iii lymphoplasmacytic lymphoma
fancd2 wt allele
fance gene
fance wt allele
fancf gene
fancf wt allele
illiterate
interpreter
inuit
inventory
ann arbor stage iv lymphoplasmacytic lymphoma
jamesdicksonia
judaism
kitchen
kneeling
lamiaceae
lawnmower
leisure time
lifting
literal
refractory adult t - cell leukemia / lymphoma
mask
melena
methodology
odor
orthodontics
paraparesis
pastry
photopsia
placentation
refractory anaplastic large cell lymphoma
pleasure
prisma vlc dycal
productivity
readiness
reasoning
recognition
recreation
algae
resultor
sedentary lifestyle
ann arbor stage i noncutaneous anaplastic large cell lymphoma
mycobacterium smegmatis
mycobacterium szulgai
mycobacterium terrae
mycobacterium thermoresistibile
mycobacterium ulcerans
mycoplasma hominis
mycoplasma orale
mycoplasma pneumoniae
tetradecanoylphorbol acetate
ann arbor stage ii noncutaneous anaplastic large cell lymphoma
neisseria canis
neisseria cinerea
neisseria flavescens
neisseria gonorrhoeae
neisseria lactamica
neisseria meningitidis
neisseria mucosa
neisseria polysaccharea
neisseria sicca
neisseria subflava
ann arbor stage iii noncutaneous anaplastic large cell lymphoma
neisseria weaverii
nocardia asteroides
nocardia asteroides complex
nocardia brasiliensis
nocardia dassonvillei
nocardia farcinica
nocardia nova
nocardia otitidiscaviarum
non - fermentative gram negative bacillus
ochrobactrum
ann arbor stage iv noncutaneous anaplastic large cell lymphoma
ochrobactrum anthropi
ochrobactrum intermedium
oerskovia
oerskovia turbata
oligella
oligella ureolytica
oligella urethralis
olsenella
olsenella uli
pandoraea
recurrent t - cell non - hodgkin lymphoma
pandoraea pnomenusa
pantoea
pantoea agglomerans
parabacteroides
parabacteroides distasonis
parabacteroides merdae
pasteurella
pasteurella aerogenes
pasteurella bettyae
pasteurella canis
refractory t - cell non - hodgkin lymphoma
pasteurella pneumotropica
pediococcus
peptococcus
peptococcus niger
peptostreptococcus
peptostreptococcus anaerobius
photobacterium
photobacterium damselae
photorhabdus
photorhabdus luminescens
ann arbor stage i t - cell non - hodgkin lymphoma
planococcus
plesiomonas
plesiomonas shigelloides
porphyromonas
porphyromonas asaccharolytica
porphyromonas catoniae
porphyromonas endodontalis
porphyromonas gingivalis
porphyromonas levii
porphyromonas somerae
ann arbor stage ii t - cell non - hodgkin lymphoma
prevotella
prevotella bivia
prevotella brevis
prevotella buccae
prevotella buccalis
prevotella corporis
prevotella dentalis
prevotella denticola
prevotella disiens
prevotella heparinolytica
ann arbor stage iii t - cell non - hodgkin lymphoma
prevotella intermedia
prevotella intermedia / nigrescens group
prevotella loescheii
prevotella melaninogenica
prevotella nigrescens
prevotella oralis
prevotella oris
prevotella ruminicola
prevotella tannerae
prevotella veroralis
ann arbor stage iv t - cell non - hodgkin lymphoma
propionibacterium avidum
propionibacterium granulosum
propionibacterium propionicum
proteus hauseri
proteus myxofaciens
proteus penneri
refractory nasal type extranodal nk / t - cell lymphoma
providencia
providencia alcalifaciens
providencia heimbachae
proteus rettgeri
providencia rustigianii
providencia stuartii
pseudomonas aeruginosa
pseudomonas alcaligenes
pseudomonas chlororaphis subspecies aureofaciens
pseudomonas chlororaphis
dronabinol
ann arbor stage i nasal type nk / t - cell lymphoma
pseudomonas fluorescens
pseudomonas luteola
pseudomonas mendocina
pseudomonas mosselii
pseudomonas pseudoalcaligenes
pseudomonas putida
pseudomonas stutzeri
psychrobacter
psychrobacter immobilis
psychrobacter phenylpyruvicus
refractory angioimmunoblastic t - cell lymphoma
rahnella
rahnella aquatilis
ralstonia
ralstonia pickettii
raoultella
raoultella ornithinolytica
raoultella planticola
raoultella terrigena
rhizobium
rhodococcus equi
ann arbor stage i angioimmunoblastic t - cell lymphoma
rickettsia africae
rickettsia felis
rickettsia japonica
rickettsia prowazekii
rickettsia rickettsii
rickettsia typhi
roseomonas
rothia
rothia dentocariosa
ruminococcus
ann arbor stage ii nasal type nk / t - cell lymphoma
ruminococcus productus
salmonella enterica
selenomonas
selenomonas noxia
selenomonas sputigena
serratia ficaria
serratia fonticola
serratia liquefaciens
serratia odorifera
ann arbor stage iii nasal type nk / t - cell lymphoma
serratia plymuthica
serratia rubidaea
shewanella
shewanella putrefaciens
shigella boydii
shigella dysenteriae
shigella flexneri
shigella sonnei
sphingomonas
sphingomonas paucimobilis
ann arbor stage iv nasal type nk / t - cell lymphoma
staphylococcus arlettae
staphylococcus auricularis
staphylococcus capitis
staphylococcus caprae
staphylococcus carnosus
staphylococcus chromogenes
staphylococcus cohnii
staphylococcus epidermidis
staphylococcus equorum
staphylococcus felis
recurrent angioimmunoblastic t - cell lymphoma
staphylococcus gallinarum
staphylococcus haemolyticus
staphylococcus hominis
staphylococcus hyicus
staphylococcus intermedius
staphylococcus kloosii
staphylococcus lentus
staphylococcus lugdunensis
staphylococcus pasteuri
staphylococcus saccharolyticus
ann arbor stage ii angioimmunoblastic t - cell lymphoma
staphylococcus saprophyticus
staphylococcus schleiferi
staphylococcus sciuri
staphylococcus simulans
staphylococcus warneri
staphylococcus xylosus
stenotrophomonas
streptobacillus
streptobacillus moniliformis
streptococcus acidominimus
ann arbor stage iii angioimmunoblastic t - cell lymphoma
streptococcus agalactiae
streptococcus alactolyticus
streptococcus anginosus
streptococcus anginosus group
streptococcus bovis
streptococcus bovis group
streptococcus canis
streptococcus constellatus
streptococcus cristatus
streptococcus equi
ann arbor stage iv angioimmunoblastic t - cell lymphoma
streptococcus equinus
streptococcus gallolyticus
streptococcus gordonii
streptococcus infantarius
streptococcus intermedius
streptococcus milleri
streptococcus milleri group
streptococcus mitis group
streptococcus mutans group
streptococcus oralis
tetrahydrouridine
recurrent enteropathy - associated t - cell lymphoma
streptococcus parasanguinis
streptococcus porcinus
streptococcus pyogenes
streptococcus salivarius
streptococcus salivarius group
streptococcus sanguinis
streptococcus suis
streptococcus thermophilus
streptococcus uberis
refractory enteropathy - associated t - cell lymphoma
streptococcus vestibularis
streptococcus viridans group
streptomyces albus
streptomyces griseus
streptomyces somaliensis
suttonella
suttonella indologenes
tatlockia micdadei
tatumella
tatumella ptyseos
ann arbor stage i enteropathy - associated t - cell lymphoma
tetragenococcus
tetragenococcus solitarius
trabulsiella
trabulsiella guamensis
treponema pallidum
tropheryma
tropheryma whipplei
tsukamurella
tsukamurella paurometabolum
ann arbor stage ii enteropathy - associated t - cell lymphoma
turicella
turicella otitidis
ureaplasma
ureaplasma urealyticum
vagococcus
varibaculum
varibaculum cambriense
veillonella
veillonella dispar
veillonella parvula
ann arbor stage iii enteropathy - associated t - cell lymphoma
vibrio alginolyticus
vibrio cholerae
vibrio fluvialis
vibrio furnissii
vibrio metschnikovii
vibrio mimicus
vibrio parahaemolyticus
vibrio vulnificus
weeksella
weeksella virosa
ann arbor stage iv enteropathy - associated t - cell lymphoma
wolinella
wolinella succinogenes
yersinia
yersinia aldovae
yersinia bercovieri
yersinia enterocolitica
yersinia frederiksenii
yersinia intermedia
yersinia kristensenii
yersinia mollaretii
recurrent mycosis fungoides
yersinia pestis
yersinia pseudotuberculosis
yersinia rohdei
yersinia ruckeri
yokenella
yokenella regensburgei
zimmermannella
zimmermannella alba
zimmermannella bifida
refractory mycosis fungoides
alistipes
alistipes putredinis
anaerococcus
helcococcus
anaerococcus hydrogenalis
anaerococcus prevotii
anaerococcus tetradius
anaerococcus vaginalis
helcococcus kunzii
helcococcus pyogenes
recurrent mature t - cell and nk - cell non - hodgkin lymphoma
helcococcus sueciensis
escherichia coli strain o111
escherichia coli strain o157
escherichia coli strain o157:h7
escherichia coli strain o26
exiguobacterium
exiguobacterium acetylicum
finegoldia
finegoldia magna
gemella
refractory mature t - cell and nk - cell non - hodgkin lymphoma
gemella bergeri
gemella haemolysans
gemella morbillorum
gemella sanguinis
lactococcus lactis subsp cremoris
megasphaera
megasphaera elsdenii
mobiluncus curtisii subsp holmesii
mogibacterium
mogibacterium timidum
thalicarpine
ann arbor stage i mature t -  and nk - cell lymphoma
parvimonas
parvimonas micra
peptoniphilus
peptoniphilus asaccharolyticus
peptoniphilus indolicus
streptococcus dysgalactiae
streptococcus dysgalactiae subsp equisimilis
tissierella
tissierella praeacuta
treponema pallidum subsp pertenue
ann arbor stage ii mature t -  and nk - cell lymphoma
salmonella enterica subsp arizonae
somatization
salmonella enterica subsp enterica
speak
salmonella serotype choleraesuis
steatorrhea
salmonella serotype dublin
salmonella serotype enteritidis
ann arbor stage iii mature t -  and nk - cell lymphoma
taboo
salmonella serotype newport
salmonella serotype paratyphi a
thoracoplasty
salmonella serotype paratyphi b
salmonella serotype paratyphi c
salmonella serotype typhi
salmonella serotype typhimurium
translator
transmural
ann arbor stage iv mature t -  and nk - cell lymphoma
clothing
other physical objects
undergarment
unresponsive
vitrebond
wedding
weekday
wet dream
t lymphoblastic leukemia / lymphoma
worry
lambda sutural junction
mental blocking
trisomy x
parosmia
recurrent t lymphoblastic leukemia / lymphoma
dysphonia
hypoaesthesia
dietary supplement marketing category
myroides
myroides odoratus
corynebacterium glucuronolyticum
sutterella
sphingobacterium
sphingobacterium mizutaii
sphingobacterium multivorum
refractory t lymphoblastic leukemia / lymphoma
sphingobacterium spiritivorum
sphingobacterium thalpophilum
pseudomonas fluorescens / putida group
medical food marketing category
cosmetic marketing category
diagnostic and statistical manual of mental disorders ,  4th edition
diagnostic and statistical manual of mental disorders ,  3rd edition
plastic
odontoid hypoplasia
stage i t lymphoblastic leukemia / lymphoma
odontoid process
modal chromosome number
dna index
stanford binet intelligence test
wechsler preschool and primary scale of intelligence
suboptimal image reason
glycophorin
glyoxylate dehydrogenase  ( acylating )
aliasing artifact
out of plane wrap around artifact
stage ii t lymphoblastic leukemia / lymphoma
phase wraparound artifact
spectral overlap artifact
data error artifact
nincds - adrda criteria for alzheimer's disease
edge or boundary artifact
edge smearing artifact
partial volume averaging
partial volume averaging between slices
vacuum cleaner artifact
motion related artifact
stage iii t lymphoblastic leukemia / lymphoma
flow separation with recirculation zones
gradient digitization error artifact
entry of unsaturated spins into the volume
exit of excited spins from the volume
non - uniform signal intensity artifact
off - resonance effect
gastric fluid
accentuation of pulsatile flow artifact
thalidomide
stage iv t lymphoblastic leukemia / lymphoma
banding artifact
parallel imaging artifact
half field - of - view ghost artifact
stage iiia vulvar cancer ajcc v7
stage iiib vulvar cancer ajcc v7
stage iiic vulvar cancer ajcc v7
pharmacological chaperone
stripe artifact
suboptimal gradient artifact
ct image artifact
refractory non - hodgkin lymphoma
metal artifact
helical interpolation artifact
cone - beam effect artifact
noise artifact
scatter artifact
partial volume artifact
beam hardening artifact
shading artifact
ring artifact
streaking artifact
recurrent transformed non - hodgkin lymphoma
image processing artifact
dose extravasation
abnormal uptake kinetics
activity at injection site
body substance contamination
grid artifact
object artifact
intervening foreign body
patient artifact
anatomic artifact
advanced pericardial malignant mesothelioma
body habitus artifact
large body habitus artifact
intervening anatomic structure
incorrect patient position
physiologic or metabolic artifact
arrhythmia artifact
left bundle branch block artifact
hyperglycemia artifact
patient motion artifact
faulty instrument or use of instrument artifact
advanced peritoneal malignant mesothelioma
plate - reader artifact
collimation error
inappropriate manual collimation
overcollimation
undercollimation
protocol error artifact
incomplete protocol artifact
incorrect protocol artifact
incorrect filter applied artifact
noisy image
recurrent peritoneal malignant mesothelioma
conclusive
p16 immunohistochemical expression analysis
in situ hybridization analysis of hpv 16 dna sequences
adrenergic agonist
sagittal abdominal diameter
oropharyngeal human papillomavirus - positive squamous cell carcinoma
belladonna / phenobarbital
brotizolam
neomycin / bacitracin zinc / polymyxin b / hydrocortisone
isoprostane
advanced pleural malignant mesothelioma
chlordiazepoxide hydrochloride / clidinium bromide
international classification of diseases for oncology ,  third edition
streptococcal infection
arm recoil result
barlow's maneuver result
cyanotic body
cyanotic limbs
caput succedaneum
male circumcision
cleft palate
recurrent pleural malignant mesothelioma
hypotonia
ear dimple
esophageal atresia
excessive sucking
eye prophylaxis
frenulum
congenital ankyloblepharon
galeazzi test result
general appearance
metastatic angiosarcoma
gestational age assessment result
heart rhythm
heel to ear measurement result
heterotaxy
hyperemesis gravidarum
hypertonia
palmar crease examination result
intercostal retractions
intrauterine growth restriction
irregular respiration
metastatic malignant hemangiopericytoma
labial fusion
labor and delivery complication
large for gestational age
meconium aspiration syndrome
micrognathism
mottling
movement of lip corners
multiple gestation
nasal flaring
thebaine
primary malignant hemangiopericytoma
neonatal abstinence syndrome assessment result
neonatal abstinence syndrome
newborn heart rate
newborn respiratory rate
newborn blood pressure
pupils equal round and reactive to light
pupils equal round and reactive to light and accommodation
non - cutaneous melanoma
polydactyly
poor feeding
premature rupture of membrane
proptosis
rhesus hemolytic disease of the newborn
rhonchi
risk factor assessment result
sacral dimple
scarf sign result
pineal region germinoma
single palmar crease
situs inversus
central nervous system signs and symptoms
syndactyly
umbilical cord prolapse
vasa previa
loose stool
weak breathing
bilateral retinoblastoma
pterygium colli
yawning
stage ia uterine sarcoma ajcc v7
stage ib uterine sarcoma ajcc v7
stage ic uterine sarcoma ajcc v7
stage iiia uterine sarcoma ajcc v7
prepuberty
stage iiib uterine sarcoma ajcc v7
stage iiic uterine sarcoma ajcc v7
forced
unilateral retinoblastoma
stage iva uterine sarcoma ajcc v7
contact biometry measurement
eyepatch
intraocular pressure
stage ivb uterine sarcoma ajcc v7
refractive error
tonometer
glasses
visual acuity
rhabdoid tumor of the kidney
stage i gestational trophoblastic tumor ajcc v7
stage ia gestational trophoblastic tumor ajcc v7
stage ib gestational trophoblastic tumor ajcc v7
stage ii gestational trophoblastic tumor ajcc v7
stage iia gestational trophoblastic tumor ajcc v7
stage iib gestational trophoblastic tumor ajcc v7
stage iii gestational trophoblastic tumor ajcc v7
stage iiia gestational trophoblastic tumor ajcc v7
stage iiib gestational trophoblastic tumor ajcc v7
stage iv gestational trophoblastic tumor ajcc v7
regional malignant ureter neoplasm
stage iva gestational trophoblastic tumor ajcc v7
stage ivb gestational trophoblastic tumor ajcc v7
cdisc sdtm common terminology criteria for adverse event grade terminology version 4 .0
ocular
eclampsia
group b streptococcal infection
high pitched cry
cleft lip
retinal
color vision
stage i bone cancer  ajcc v7
stage ia bone cancer  ajcc v7
stage ib bone cancer  ajcc v7
stage ii bone cancer  ajcc v7
stage iia bone cancer  ajcc v7
stage iib bone cancer  ajcc v7
stage iii bone cancer  ajcc v7
stage iv bone cancer  ajcc v7
stage iva bone cancer  ajcc v7
stage ivb bone cancer  ajcc v7
corrective lens
locality
endometrial squamous cell carcinoma
mailstop code
administrative district
story
subdivision
stage ia pleural malignant mesothelioma ajcc v7
stage ib pleural malignant mesothelioma ajcc v7
theophylline
stage i fallopian tube cancer ajcc v6 and v7
peretinoin
stage ii fallopian tube cancer ajcc v6 and v7
sulfabenzamide
sulfamethazine bisulfate
glucosulfone free acid
glucosulfone sodium
stage iii fallopian tube cancer ajcc v6
stage i ovarian dysgerminoma ajcc v6 and v7
deflazacort
dienogest
stage ii ovarian dysgerminoma ajcc v6 and v7
hydroxyprogesterone
stage ii ovarian embryonal carcinoma ajcc v6 and v7
stage iii ovarian dysgerminoma ajcc v6 and v7
stage iv ovarian dysgerminoma ajcc v6 and v7
hippuric acid
stage iii ovarian embryonal carcinoma ajcc v6 and v7
vinzolidine sulfate
stage iv ovarian embryonal carcinoma ajcc v6 and v7
albinterferon alfa - 2b
tinzaparin
boysenberry flavor
spl document type terminology
thiabendazole
stage i ovarian choriocarcinoma
spl unit of presentation terminology
stage iva lip and oral cavity cancer ajcc v6 and v7
stage ivb lip and oral cavity cancer ajcc v6 and v7
stage ivc lip and oral cavity cancer ajcc v6 and v7
ankle - brachial index
snellen fraction
quartile
cognitive abilities screening instrument
current procedural terminology
international classification of diseases for oncology ,  second edition
stage ii ovarian choriocarcinoma
vecuronium
stage iii ovarian choriocarcinoma
tolfenamic acid
stage iv ovarian choriocarcinoma
berberine chloride
nadide
stage i ovarian embryonal carcinoma ajcc v6 and v7
sodium selenite
stage i ovarian yolk sac tumor ajcc v6 and v7
zinc picolinate
stage ii ovarian yolk sac tumor ajcc v6 and v7
amoxicillin anhydrous
mezlocillin sodium monohydrate
stage iii ovarian yolk sac tumor ajcc v6 and v7
penicillin g procaine
propicillin potassium
laropiprant
stage iv ovarian yolk sac tumor ajcc v6 and v7
metronidazole benzoate
soraprazan
pseudoisocytidine
stage i ovarian polyembryoma ajcc v6 and v7
technetium tc - 99m albumin aggregated
thiamine
stage ii ovarian polyembryoma ajcc v6 and v7
stage iii ovarian polyembryoma ajcc v6 and v7
technetium tc - 99m tetrofosmin
stage iv ovarian polyembryoma ajcc v6 and v7
antimony triiodide
aprosulate
stage i ovarian teratoma ajcc v6 and v7
balapiravir
stage ii ovarian teratoma ajcc v6 and v7
balapiravir hydrochloride
bezafibrate
stage iii ovarian teratoma ajcc v6 and v7
bismuth subcitrate potassium
stage iv ovarian teratoma ajcc v6 and v7
cefpirome sulfate
recurrent lung adenosquamous carcinoma
ciprofibrate
citenazone
stage 0 lung adenosquamous carcinoma ajcc v6 and v7
demecarium
dextran 70
stage i lung adenosquamous carcinoma ajcc v7
dutogliptin
dutogliptin tartrate
fibromyalgia
stage 0 sinonasal cancer ajcc v6 ,  v7 ,  and v8
thiotepa
stage ii lung adenosquamous  carcinoma ajcc v7
stage iva sinonasal cancer ajcc v7
stage ivb sinonasal cancer ajcc v7
stage ivc sinonasal cancer ajcc v7
stage iii lung adenosquamous carcinoma ajcc v7
aspergillus terreus
aspergillus ustus
stage iv lung adenosquamous carcinoma ajcc v7
ustilago avenae
ustilago cynodontis
ustilago maydis
ustilago nuda hordei
ustilago tritici
recurrent lung large cell carcinoma
fulfill
stage iii mucosal melanoma of the head and neck ajcc v7
stage iva mucosal melanoma of the head and neck ajcc v7
stage ivb mucosal melanoma of the head and neck ajcc v7
stage ivc mucosal melanoma of the head and neck ajcc v7
smoke stick dosage form
smoke paper dosage form
extended release intraruminal device dosage form
tag dosage form
delayed release granule for suspension dosage form
lyophilized powder dosage form
pendant dosage form
stage i differentiated thyroid gland carcinoma ajcc v7
stage ii differentiated thyroid gland carcinoma ajcc v7
stage iii differentiated thyroid gland carcinoma ajcc v7
stage iva differentiated thyroid gland carcinoma ajcc v7
stage ivb differentiated thyroid gland carcinoma ajcc v7
stage ivc differentiated thyroid gland carcinoma ajcc v7
stage iva thyroid gland medullary carcinoma ajcc v7
stage i lung large cell carcinoma ajcc v7
stage ivb thyroid gland medullary carcinoma ajcc v7
stage ivc thyroid gland medullary carcinoma ajcc v7
stage iva thyroid gland anaplastic carcinoma ajcc v7
stage ivb thyroid gland anaplastic carcinoma ajcc v7
stage ivc thyroid gland anaplastic carcinoma ajcc v7
sample weight
decade
bee pollen
blue cohosh root
chaste berry
stage iv lung large cell carcinoma ajcc v7
chickweed tincture
chamaelirium luteum root
herbal tea
lachesis venom
glycyrrhiza lepidota root
motherwort
nux vomica seed
wild yam
royal jelly
recurrent lung adenocarcinoma
sage tea
sarsaparilla
sepia ink
hyaluronidase
stage 0 lung adenocarcinoma ajcc v6 and v7
stage i lung adenocarcinoma ajcc v7
medorubicin
thioguanine
stage ii lung adenocarcinoma ajcc v7
stage iii lung adenocarcinoma ajcc v7
gliclazide
linogliride fumarate
stage iv lung adenocarcinoma ajcc v7
melogliptin
pemaglitazar
sipoglitazar
teneligliptin
tibeglisene
stage 0 lung squamous cell carcinoma ajcc v6 and v7
glunicate
m - cresyl acetate
telavancin hydrochloride
stage i lung squamous cell carcinoma ajcc v7
stage ii lung squamous cell carcinoma ajcc v7
bedaquiline
stage iii lung squamous cell carcinoma ajcc v7
edoxudine
memotine
memotine hydrochloride
stage iv lung squamous cell carcinoma ajcc v7
sulopenem etzadroxil
stage i pharyngeal cancer
stage ii pharyngeal cancer
netazepide
mivobulin
thioinosine
stage iii pharyngeal cancer
ferumoxytol
oxprenoate
xipamide
stage iv pharyngeal cancer
stage i lung cancer ajcc v6
macitentan
stage iii lung cancer ajcc v6
picropodophyllin
stage iv lung cancer ajcc v6
pitavastatin
pitavastatin calcium
polyoxyl 50 hydrogenated castor oil
monophosphoryl lipid a
iobenguane
peripheral primitive neuroectodermal tumor of bone
efungumab
fezakinumab
fontolizumab
golimumab
lebrikizumab
stage iia gastric cancer ajcc v7
stage iib gastric cancer ajcc v7
stage iiic gastric cancer ajcc v7
institutional biosafety committee
localized chondrosarcoma
stage ia esophageal squamous cell carcinoma ajcc v7
stage ib esophageal squamous cell carcinoma ajcc v7
stage ia esophageal adenocarcinoma ajcc v7
stage ib esophageal adenocarcinoma ajcc v7
stage iiia esophageal adenocarcinoma ajcc v7
stage iiib esophageal adenocarcinoma ajcc v7
stage iiic esophageal adenocarcinoma ajcc v7
stage iiia esophageal squamous cell carcinoma ajcc v7
stage iiib esophageal squamous cell carcinoma ajcc v7
stage iiic esophageal squamous cell carcinoma ajcc v7
metastatic chondrosarcoma
stage iia small intestinal cancer ajcc v7
stage iib small intestinal cancer ajcc v7
stage iiia small intestinal cancer ajcc v7
stage iiib small intestinal cancer ajcc v7
pincers
secondary central nervous system lymphoma
stage i appendix carcinoma ajcc v7
stage iia appendix carcinoma ajcc v7
recombinant human thrombopoietin
recurrent chondrosarcoma
stage iib appendix carcinoma ajcc v7
stage iic appendix carcinoma ajcc v7
physical strength
stage iiia appendix carcinoma ajcc v7
stage iiib appendix carcinoma ajcc v7
stage iiic appendix carcinoma ajcc v7
stage iva appendix carcinoma ajcc v7
stage ivb appendix carcinoma ajcc v7
stage ivc appendix carcinoma ajcc v7
stage i appendix neuroendocrine tumor ajcc v7
stage i acral lentiginous melanoma ajcc v7
stage ii appendix neuroendocrine tumor ajcc v7
stage iii appendix neuroendocrine tumor ajcc v7
stage iv appendix neuroendocrine tumor ajcc v7
stage iia colorectal cancer ajcc v7
stage iib colorectal cancer ajcc v7
stage iic colorectal cancer ajcc v7
stage iiia colorectal cancer ajcc v7
stage iiib colorectal cancer ajcc v7
stage iiic colorectal cancer ajcc v7
stage iva colorectal cancer ajcc v7
stage ii acral lentiginous melanoma ajcc v6 and v7
stage ivb colorectal cancer ajcc v7
sarcomere
kit number
dispensed treatment label identifier reference
returned treatment label identifier reference
stage ia gastric gastrointestinal stromal tumor
stage ib gastric gastrointestinal stromal tumor
stage ii gastric gastrointestinal stromal tumor
stage iiia gastric gastrointestinal stromal tumor
stage iiib gastric gastrointestinal stromal tumor
stage iii acral lentiginous melanoma ajcc v7
stage iv gastric gastrointestinal stromal tumor
stage i small intestinal gastrointestinal stromal tumor
stage ii small intestinal gastrointestinal stromal tumor
stage iiia small intestinal gastrointestinal stromal tumor
stage iiib small intestinal gastrointestinal stromal tumor
stage iv small intestinal gastrointestinal stromal tumor
telatinib mesylate
adverse event end relative to reference time point
adverse event end timepoint
stage iv acral lentiginous melanoma ajcc v6 and v7
adverse event pre - specified
clinical event end date time
clinical events assessment reason not done
clinical events body system or organ class
clinical events category
study day of clinical events
clinical events dictionary derived term
clinical events end relative to reference period
clinical events end relative to reference time point
clinical events end timepoint
recurrent lentigo maligna melanoma
clinical events group identifier
clinical events occurrence
clinical events pre - specified
clinical events reference identifier
clinical events sequence number
clinical events severity
clinical events sponsor defined identifier
clinical events start date time
clinical events start relative to reference period
clinical events start relative to reference timepoint
stage i lentigo maligna melanoma ajcc v7
clinical events start timepoint
clinical events subcategory
concomitant medication end relative to reference time point
concomitant medication end timepoint
concomitant medication start relative to reference timepoint
concomitant medication start timepoint
disposition reference identifier
drug accountability assessment reason not done
drug accountability character result in standard format
study day of drug accountability
stage ii lentigo maligna melanoma ajcc v6 and v7
drug accountability dispensed treatment label identifier reference
drug accountability group identifier
drug accountability numeric result in standard unit
drug accountability performed
drug accountability reference identifier
drug accountability result standard unit
drug accountability returned treatment label identifier reference
drug accountability sequence number
drug accountability sponsor defined identifier
electrocardiogram date time of reference timepoint
stage iii lentigo maligna melanoma ajcc v7
electrocardiogram sponsor defined identifier
electrocardiograph lead placement location
exposure kit number
exposure treatment vehicle amount
exposure treatment vehicle amount unit
exposure yes no indicator
findings about events or interventions category
findings about events or interventions group identifier
findings about events or interventions observation object
findings about events or interventions sequence number
stage iv lentigo maligna melanoma ajcc v6 and v7
findings about events or interventions sponsor defined identifier
findings about events or interventions subcategory
finding about event or intervention test
findings about events or interventions test code
laboratory test date time of reference timepoint
medical history end relative to reference time point
medical history end timepoint
medical history pre - specified
microbiology specimen assessment reason not done
microbiology specimen category
thromboxane
stage i low - csd melanoma ajcc v7
microbiology specimen character result in standard format
microbiology specimen condition
microbiology specimen date time of reference timepoint
study day of microbiology specimen
microbiology specimen derived flag
microbiology specimen elapsed time
microbiology specimen examination baseline flag
microbiology specimen examination original result
microbiology specimen examination original result unit
microbiology specimen group identifier
stage ii low - csd melanoma ajcc v7
microbiology specimen vendor name
microbiology specimen loinc code
microbiology specimen method
microbiology specimen origin
microbiology specimen reference identifier
microbiology specimen numeric result in standard unit
microbiology specimen result standard unit
microbiology specimen sequence number
microbiology specimen sponsor defined identifier
microbiology specimen subcategory
stage iii low - csd melanoma ajcc v7
microbiology specimen test
microbiology specimen test code
microbiology specimen timepoint
microbiology specimen planned time point number
microbiology specimen time point reference
microbiology specimen type
microbiology susceptibility baseline flag
microbiology susceptibility category
microbiology susceptibility character result in standard format
study day of microbiology susceptibility
stage iv low - csd melanoma ajcc v7
microbiology susceptibility derived flag
microbiology susceptibility elapsed time
microbiology susceptibility group identifier
microbiology susceptibility loinc code
microbiology susceptibility method
microbiology susceptibility original result
microbiology susceptibility original result unit
microbiology susceptibility reason not done
microbiology susceptibility reference identifier
microbiology susceptibility numeric result in standard unit
microbiology susceptibility result standard unit
microbiology susceptibility sequence number
microbiology susceptibility sponsor defined identifier
microbiology susceptibility subcategory
microbiology susceptibility test
microbiology susceptibility test code
microbiology susceptibility timepoint
microbiology susceptibility planned time point number
microbiology susceptibility time point reference
pharmacokinetic concentration category
recurrent undifferentiated pleomorphic sarcoma
pharmacokinetic concentration character result in standard format
pharmacokinetic concentration date time of reference timepoint
study day of pharmacokinetic concentration
pharmacokinetic concentration derived flag
pharmacokinetic concentration elapsed time
pharmacokinetic concentration end date time
pharmacokinetic concentration evaluation interval
pharmacokinetic concentration fasting status
pharmacokinetic concentration group identifier
pharmacokinetic concentration lower limit of quantitation
metastatic alveolar soft part sarcoma
pharmacokinetic concentration method
pharmacokinetic concentration original result
pharmacokinetic concentration original result unit
pharmacokinetic concentration reason not done
pharmacokinetic concentration reference identifier
pharmacokinetic concentration numeric result in standard unit
pharmacokinetic concentration sequence number
pharmacokinetic concentration specimen type
pharmacokinetic concentration specimen condition
pharmacokinetic concentration sponsor defined identifier
localized alveolar soft part sarcoma
pharmacokinetic concentration standard result unit
pharmacokinetic concentration subcategory
pharmacokinetic concentration test
pharmacokinetic concentration test code
pharmacokinetic concentration timepoint
pharmacokinetic concentration planned time point number
pharmacokinetic concentration time point reference
pharmacokinetic parameter category
pharmacokinetic parameter character result in standard format
pharmacokinetic parameter date time of reference timepoint
recurrent alveolar soft part sarcoma
pharmacokinetic parameter group identifier
pharmacokinetic parameter original result
pharmacokinetic parameter original result unit
pharmacokinetic parameter reason not done
pharmacokinetic parameter numeric result in standard unit
pharmacokinetic parameter sequence number
pharmacokinetic parameter specimen type
pharmacokinetic parameter subcategory
pharmacokinetic parameter test
pharmacokinetic parameter test code
metastatic epithelioid sarcoma
protocol deviation category
protocol deviation code
protocol deviation end date time
protocol deviation reference identifier
protocol deviation sequence number
protocol deviation start date time
protocol deviation subcategory
questionnaire date time of reference timepoint
subject characteristics yes no indicator
subject elements sequence number
thymidine
localized epithelioid sarcoma
subject visit end day
subject visit start day
substance usage end relative to reference time point
substance usage end timepoint
substance usage pre - specified
substance usage start relative to reference timepoint
substance usage start timepoint
trial summary group identifier
unplanned subject visit description
metastatic extraskeletal ewing sarcoma
visit end date
vital signs date time of reference timepoint
vital signs performed
clinical events collection date time
drug accountability date time
microbiology specimen date time
microbiology susceptibility date time
pharmacokinetic concentration date time
pharmacokinetic parameter date time
microbiology susceptibility vendor name
localized extraskeletal ewing sarcoma
pharmacokinetic concentration vendor name
clinical events reported term
microbiology specimen result category
microbiology susceptibility result category
sacculus rotundus
cdisc send tumor findings results terminology
cdisc send body system terminology
stage 0 digestive system neuroendocrine tumor ajcc v7
stage i digestive system neuroendocrine tumor ajcc v7
stage iia digestive system neuroendocrine tumor ajcc v7
recurrent extraskeletal ewing sarcoma
stage iib digestive system neuroendocrine tumor ajcc v7
stage iiia digestive system neuroendocrine tumor ajcc v7
stage iiib digestive system neuroendocrine tumor ajcc v7
stage iv digestive system neuroendocrine tumor ajcc v7
dsp gene
dsp wt allele
clevidipine butyrate injectable emulsion
desmoplakin
nefh gene
nefh wt allele
metastatic extraskeletal myxoid chondrosarcoma
neurofilament heavy polypeptide
nefl gene
nefl wt allele
neurofilament light polypeptide
stage iiic hepatocellular carcinoma ajcc v7
nefm gene
nefm wt allele
neurofilament medium polypeptide
vineland adaptive behavior scales
stage 0 intrahepatic cholangiocarcinoma ajcc v7
stage i intrahepatic cholangiocarcinoma ajcc v7
stage ii intrahepatic cholangiocarcinoma ajcc v7
stage iii intrahepatic cholangiocarcinoma ajcc v7
stage iva intrahepatic cholangiocarcinoma ajcc v7
stage ivb intrahepatic cholangiocarcinoma ajcc v7
anti - cd19 - car retroviral vector - transduced autologous t cells
stage iiia gallbladder cancer ajcc v7
stage iiib gallbladder cancer ajcc v7
stage 0 hilar cholangiocarcinoma ajcc v7
stage i hilar cholangiocarcinoma ajcc v7
stage ii hilar cholangiocarcinoma ajcc v7
stage iiia hilar cholangiocarcinoma ajcc v7
stage iiib hilar cholangiocarcinoma ajcc v7
stage iva hilar cholangiocarcinoma ajcc v7
stage ivb hilar cholangiocarcinoma ajcc v7
recurrent extraskeletal myxoid chondrosarcoma
metastatic extraskeletal osteosarcoma
regulatory authority
observation icsr terminology
stage 0 distal bile duct cancer ajcc v7
localized extraskeletal osteosarcoma
stage ia distal bile duct cancer ajcc v7
stage ib distal bile duct cancer ajcc v7
stage iia distal bile duct cancer ajcc v7
stage iib distal bile duct cancer ajcc v7
stage iii distal bile duct cancer ajcc v7
stage iv distal bile duct cancer ajcc v7
stage ia ampulla of vater cancer ajcc v7
stage ib ampulla of vater cancer ajcc v7
stage iia ampulla of vater cancer ajcc v7
stage iib ampulla of vater cancer ajcc v7
extraskeletal osteosarcoma
stage ia pancreatic cancer ajcc v6 and v7
stage ib pancreatic cancer ajcc v6 and v7
stage iia pancreatic cancer ajcc v6 and v7
stage iib pancreatic cancer ajcc v6 and v7
stage iiia penile cancer ajcc v7
stage iiib penile cancer ajcc v7
stage iia prostate cancer ajcc v7
stage iib prostate cancer ajcc v7
quintamillesimal series of attenuation
centesimal series of attenuation
recurrent extraskeletal osteosarcoma
millesimal series of attenuation
decimal series of attenuation
photon
free cortisol measurement
esp culture system
mb / bact alert
12b and mgit
contagion contact
physical contagion contact
respiratory contagion contact
metastatic fibrosarcoma
stage 0 eyelid carcinoma ajcc v7
stage ia eyelid carcinoma ajcc v7
stage ib eyelid carcinoma ajcc v7
who mycobacterium quantitation scheme
scanty score
stage ic eyelid carcinoma ajcc v7
1 +  score ,  who
stage ii eyelid carcinoma ajcc v7
2 +  score ,  who
stage iiia eyelid carcinoma ajcc v7
metastatic leiomyosarcoma
3 +  score ,  who
stage iiib eyelid carcinoma ajcc v7
stage iiic eyelid carcinoma ajcc v7
stage iv eyelid carcinoma ajcc v7
steroid myopathy
stage iia uveal melanoma ajcc v7
stage iib uveal melanoma ajcc v7
stage iiia uveal melanoma ajcc v7
stage iiib uveal melanoma ajcc v7
stage iiic uveal melanoma ajcc v7
localized leiomyosarcoma
paced rhythm
obturator lymph node
internal iliac lymph node
external iliac lymph node
mosaic
ocular adnexal non - hodgkin lymphoma
unprotected sexual intercourse
cerebellar peduncle
milligram per square meter per week
meaning
recurrent leiomyosarcoma
stage i mycosis fungoides and sezary syndrome ajcc v7
stage ia mycosis fungoides and sezary syndrome ajcc v7
stage ib mycosis fungoides and sezary syndrome ajcc v7
stage ii mycosis fungoides and sezary syndrome ajcc v7
stage iia mycosis fungoides and sezary syndrome ajcc v7
stage iib mycosis fungoides and sezary syndrome ajcc v7
leukemia cutis
stage iii mycosis fungoides and sezary syndrome ajcc v7
stage iiia mycosis fungoides and sezary syndrome ajcc v7
stage iiib mycosis fungoides and sezary syndrome ajcc v7
metastatic liposarcoma
stage iv mycosis fungoides and sezary syndrome ajcc v7
stage iva mycosis fungoides and sezary syndrome ajcc v7
stage ivb mycosis fungoides and sezary syndrome ajcc v7
treadmill
cardiorespiratory fitness
pedometer
accelerometer
hrg gene
hrg wt allele
histidine - rich glycoprotein
localized liposarcoma
gpc5 gene
gpc5 wt allele
glypican - 5
gpc3 gene
gpc3 wt allele
glypican - 3
rb1cc1 gene
rb1cc1 wt allele
rb1 - inducible coiled - coil protein 1
ppm1d gene
recurrent liposarcoma
ppm1d wt allele
subjective
efficacy
self - efficacy
integrated fitness assessment
financial account
service item
inquiry
billing
protein phosphatase 1d
invoice
customer
quotation
mating
acp1 gene
acp1 wt allele
low molecular weight phosphotyrosine protein phosphatase
feeding
delta - x nomenclature
n - x nomenclature
poll
ywhaz gene
ventilation
desiccation
ywhaz wt allele
humidity
vaginal cuff
culdoscope
culdoscopy
14 - 3 - 3 protein zeta / delta
base number
operation
laptm4b gene
laptm4b wt allele
lysosomal - associated transmembrane protein 4b
mdm4 gene
mdm4 wt allele
metastatic malignant peripheral nerve sheath tumor
protein mdm4
carm1 gene
carm1 wt allele
histone - arginine methyltransferase carm1
serum cystatin c assay
urinary creatinine assay
urinary microalbumin assay
serum creatinine assay
primary cutaneous lymphoma tnm finding v7
mycosis fungoides and sezary syndrome tnm finding v7
recurrent malignant peripheral nerve sheath tumor
mycosis fungoides and sezary syndrome primary tumor - skin tnm finding v7
mycosis fungoides and sezary syndrome tx tnm finding v7
mycosis fungoides and sezary syndrome t1 tnm finding v7
mycosis fungoides and sezary syndrome t2 tnm finding v7
mycosis fungoides and sezary syndrome t3 tnm finding v7
mycosis fungoides and sezary syndrome t4 tnm finding v7
mycosis fungoides and sezary syndrome lymph nodes tnm finding v7
mycosis fungoides and sezary syndrome n0 tnm finding v7
mycosis fungoides and sezary syndrome n1 tnm finding v7
mycosis fungoides and sezary syndrome n1a tnm finding v7
recurrent rhabdomyosarcoma
mycosis fungoides and sezary syndrome n1b tnm finding v7
mycosis fungoides and sezary syndrome n2 tnm finding v7
mycosis fungoides and sezary syndrome n2a tnm finding v7
mycosis fungoides and sezary syndrome n2b tnm finding v7
mycosis fungoides and sezary syndrome n3 tnm finding v7
mycosis fungoides and sezary syndrome nx tnm finding v7
mycosis fungoides and sezary syndrome distant metastasis - visceral tnm finding v7
mycosis fungoides and sezary syndrome m0 tnm finding v7
mycosis fungoides and sezary syndrome m1 tnm finding v7
mycosis fungoides and sezary syndrome peripheral blood involvement tnm finding v7
metastatic synovial sarcoma
mycosis fungoides and sezary syndrome b0 tnm finding v7
mycosis fungoides and sezary syndrome b0a tnm finding v7
mycosis fungoides and sezary syndrome b0b tnm finding v7
mycosis fungoides and sezary syndrome b1 tnm finding v7
mycosis fungoides and sezary syndrome b1a tnm finding v7
mycosis fungoides and sezary syndrome b1b tnm finding v7
mycosis fungoides and sezary syndrome b2 tnm finding v7
breast cancer tnm finding v7
breast cancer pathologic tnm finding v7
resiquimod topical gel
localized synovial sarcoma
wt1 mrna - electroporated autologous dendritic cell vaccine
ad5 .sstr / tk .rgd
sodium bicarbonate solution
fluorine f 18 fluoro furanyl norprogesterone
c - visa bikdd:liposome
fluorine f 18 iso - 1
cd19car - cd3zeta - expressing autologous t lymphocytes
vegfr inhibitor krn951
agaricus blazei murill extract
high - selenium baker's yeast
recurrent synovial sarcoma
omipalisib
pdk1 inhibitor ar - 12
fgfr inhibitor azd4547
smac mimetic gdc - 0152
thl - p
technetium tc - 99m demobesin - 4
lutetium lu 177 - edotreotide
multikinase inhibitor sar103168
mva - fcu1 tg4023
recurrent hodgkin's disease lymphocyte predominance type
irinotecan / p - glycoprotein inhibitor hm30181ak combination tablet
necitumumab
antiperspirant cream f511
inebilizumab
iodine i - 124 fiau
pegylated recombinant human arginase i bct - 100
anti - cd45 bc8 monoclonal antibody - streptavidin conjugate
zoster vaccine recombinant ,  adjuvanted
pngvl4a - crt / e7 ( detox )  dna vaccine
refractory hodgkin's disease lymphocyte predominance type
short chain fatty acid hqk - 1004
egfr inhibitor pf - 00299804
indium in 111 capromab pendetide
fedratinib
bimatoprost ophthalmic solution
birinapant
dalantercept
carvedilol phosphate extended - release capsule
ramosetron hydrochloride
recombinant thymosin
stage iii hodgkin's disease lymphocyte predominance type
tomato - soy juice
ang2 / vegf - binding peptides - antibody fusion protein cvx - 241
infigratinib
pexidartinib
tasisulam sodium
quaternary ammonium polyethylenimine nanoparticles
anti - egfrviii immunotoxin mr1 - 1
plozalizumab
motixafortide
stage iv hodgkin's disease lymphocyte predominance type
allogeneic cmv / adv - specific cytotoxic t lymphocytes
momelotinib
milciclib maleate
polo - like kinase 1 inhibitor nms - 1286937
tepotinib
vorsetzumab mafodotin
cdc7 kinase inhibitor nms - 1116354
her2bi - armed activated t cells
canerpaturev
iodine i - 123 adam
recurrent mixed cellularity classic hodgkin lymphoma
as03 - adjuvanted h1n1 pandemic influenza vaccine
fumagillin - derived polymer conjugate xmt - 1107
burixafor
factor viia inhibitor pci - 27483
anti - il - 1 alpha monoclonal antibody mabp1
tipapkinogene sovacivec
bersanlimab
litronesib
vistusertib
refractory mixed cellularity classic hodgkin lymphoma
ad5 - ycd / muttk ( sr39 ) rep - adp
tph inhibitor lx1606
gamma - secretase inhibitor ro4929097
non - adjuvanted a ( h1n1 )  influenza vaccine
archexin
holmium ho 166 poly ( l - lactic acid )  microspheres
smoothened antagonist lde225 topical
vascular disrupting agent bnc105p
carbon c - 14 dacomitinib
ann arbor stage i mixed cellularity classic hodgkin lymphoma
topical pvdf / sirolimus
3' - aminomethyl nicotine - p . aeruginosa r - exoprotein a conjugate vaccine
cpg oligodeoxynucleotide gnkg168
fimaporfin a
dopamine - somatostatin chimeric molecule tbr - 760
fak inhibitor gsk2256098
breast cancer pathologic primary tumor tnm finding v7
breast cancer pathologic regional lymph nodes tnm finding v7
breast cancer pn0 tnm finding v7
ann arbor stage iv mixed cellularity classic hodgkin lymphoma
breast cancer pn0 ( i -  )  tnm finding v7
breast cancer pn0 ( i +  )  tnm finding v7
breast cancer pn1 tnm finding v7
breast cancer pn1mi tnm finding v7
breast cancer pn1b tnm finding v7
breast cancer pn1c tnm finding v7
cst3 gene
cst3 wt allele
breast cancer pn2 tnm finding v7
cystatin - c
refractory hodgkin lymphoma
breast cancer pn2b tnm finding v7
breast cancer pn3 tnm finding v7
breast cancer pn3b tnm finding v7
breast cancer pathologic distant metastasis tnm finding v7
breast cancer clinical tnm finding v7
breast cancer clinical primary tumor tnm finding v7
breast cancer clinical regional lymph nodes tnm finding v7
facility oncology registry data standards
breast cancer cn2 tnm finding v7
breast cancer cn2b tnm finding v7
recurrent nodular sclerosis classic hodgkin lymphoma
breast cancer cn3 tnm finding v7
breast cancer clinical distant metastasis tnm finding v7
breast cancer cm0 ( i +  )  tnm finding v7
breast cancer cm0 tnm finding v7
breast cancer cm1 tnm finding v7
stage i breast cancer ajcc v7
stage iii breast cancer ajcc v7
stage iiic breast cancer ajcc v7
cutaneous melanoma tnm finding v7
cutaneous melanoma pathologic tnm finding v7
refractory nodular sclerosis classic hodgkin lymphoma
cutaneous melanoma pathologic primary tumor tnm finding v7
cutaneous melanoma ptx tnm finding v7
cutaneous melanoma pt1 tnm finding v7
cutaneous melanoma pt1a tnm finding v7
cutaneous melanoma pt1b tnm finding v7
cutaneous melanoma pathologic regional lymph nodes tnm finding v7
cutaneous melanoma pnx tnm finding v7
cutaneous melanoma pn1 tnm finding v7
cutaneous melanoma pn1a tnm finding v7
cutaneous melanoma pn1b tnm finding v7
ann arbor stage i nodular sclerosis classic hodgkin lymphoma
cutaneous melanoma pn2 tnm finding v7
cutaneous melanoma pn2a tnm finding v7
cutaneous melanoma pn2b tnm finding v7
cutaneous melanoma pn2c tnm finding v7
cutaneous melanoma pathologic distant metastasis tnm finding v7
cutaneous melanoma pm1 tnm finding v7
cutaneous melanoma pm1a tnm finding v7
cutaneous melanoma pm1b tnm finding v7
cutaneous melanoma clinical tnm finding v7
cutaneous melanoma clinical regional lymph nodes tnm finding v7
recombinant thyroglobulin
ann arbor stage iv nodular sclerosis classic hodgkin lymphoma
cutaneous melanoma cnx tnm finding v7
cutaneous melanoma cn0 tnm finding v7
cutaneous melanoma cn1 tnm finding v7
cutaneous melanoma cn2c tnm finding v7
cutaneous melanoma cn3 tnm finding v7
cutaneous melanoma clinical distant metastasis tnm finding v7
cutaneous melanoma cm0 tnm finding v7
cutaneous melanoma cm1 tnm finding v7
cutaneous melanoma cm1a tnm finding v7
cutaneous melanoma cm1b tnm finding v7
recurrent b - cell non - hodgkin lymphoma
cutaneous melanoma cm1c tnm finding v7
obsessive compulsive disorder
autism spectrum disorder
antisocial personality disorder
stage i cutaneous melanoma ajcc v7
stage iii cutaneous melanoma ajcc v7
verbal memory
visual memory
working memory
executive function
refractory b - cell non - hodgkin lymphoma
gross motor skill
musculoskeletal system cancer tnm finding v7
bone cancer tnm finding v7
bone cancer pathologic tnm finding v7
bone cancer pathologic primary tumor tnm finding v7
bone cancer ptx tnm finding v7
bone cancer pt0 tnm finding v7
bone cancer pt1 tnm finding v7
bone cancer pt2 tnm finding v7
level of consciousness
ann arbor stage ii b - cell non - hodgkin lymphoma
bone cancer pt3 tnm finding v7
bone cancer pathologic regional lymph nodes tnm finding v7
bone cancer pnx tnm finding v7
bone cancer pn0 tnm finding v7
conscious state
unconscious state
bone cancer pn1 tnm finding v7
bone cancer pathologic distant metastasis tnm finding v7
bone cancer pm1 tnm finding v7
ann arbor stage iii b - cell non - hodgkin lymphoma
semi - conscious
bone cancer pm1a tnm finding v7
bone cancer pm1b tnm finding v7
bone cancer clinical tnm finding v7
bone cancer clinical distant metastasis tnm finding v7
bone cancer cm0 tnm finding v7
bone cancer cm1 tnm finding v7
bone cancer cm1a tnm finding v7
bone cancer cm1b tnm finding v7
soft tissue sarcoma tnm finding v7
ann arbor stage iv b - cell non - hodgkin lymphoma
soft tissue sarcoma pathologic tnm finding v7
soft tissue sarcoma pathologic primary tumor tnm finding v7
soft tissue sarcoma ptx tnm finding v7
soft tissue sarcoma pt0 tnm finding v7
soft tissue sarcoma pt1 tnm finding v7
soft tissue sarcoma pt1a tnm finding v7
soft tissue sarcoma pt1b tnm finding v7
soft tissue sarcoma pt2 tnm finding v7
soft tissue sarcoma pt2a tnm finding v7
soft tissue sarcoma pt2b tnm finding v7
refractory small lymphocytic lymphoma
soft tissue sarcoma pathologic regional lymph nodes tnm finding v7
soft tissue sarcoma pnx tnm finding v7
soft tissue sarcoma pn0 tnm finding v7
soft tissue sarcoma pn1 tnm finding v7
soft tissue sarcoma pathologic distant metastasis tnm finding v7
soft tissue sarcoma pm1 tnm finding v7
soft tissue sarcoma clinical tnm finding v7
soft tissue sarcoma clinical distant metastasis tnm finding v7
soft tissue sarcoma cm0 tnm finding v7
soft tissue sarcoma cm1 tnm finding v7
refractory burkitt lymphoma
ligand - independent ion channel activation
skin carcinoma tnm finding v7
skin squamous cell carcinoma or other skin carcinomas tnm finding v7
skin squamous cell carcinoma or other skin carcinomas pathologic tnm finding v7
skin squamous cell carcinoma or other skin carcinomas pathologic primary tumor tnm finding v7
skin squamous cell carcinoma or other skin carcinomas ptx tnm finding v7
skin squamous cell carcinoma or other skin carcinomas pt0 tnm finding v7
skin squamous cell carcinoma or other skin carcinomas ptis tnm finding v7
skin squamous cell carcinoma or other skin carcinomas pt1 tnm finding v7
skin squamous cell carcinoma or other skin carcinomas pt2 tnm finding v7
ann arbor stage i burkitt lymphoma
skin squamous cell carcinoma or other skin carcinomas pt3 tnm finding v7
skin squamous cell carcinoma or other skin carcinomas pt4 tnm finding v7
skin squamous cell carcinoma or other skin carcinomas pathologic regional lymph nodes tnm finding v7
skin squamous cell carcinoma or other skin carcinomas pnx tnm finding v7
skin squamous cell carcinoma or other skin carcinomas pn0 tnm finding v7
skin squamous cell carcinoma or other skin carcinomas pn1 tnm finding v7
skin squamous cell carcinoma or other skin carcinomas pn2 tnm finding v7
skin squamous cell carcinoma or other skin carcinomas pn2a tnm finding v7
skin squamous cell carcinoma or other skin carcinomas pn2b tnm finding v7
skin squamous cell carcinoma or other skin carcinomas pn2c tnm finding v7
ann arbor stage ii burkitt lymphoma
skin squamous cell carcinoma or other skin carcinomas pn3 tnm finding v7
skin squamous cell carcinoma or other skin carcinomas pathologic distant metastasis tnm finding v7
skin squamous cell carcinoma or other skin carcinomas pm1 tnm finding v7
skin squamous cell carcinoma or other skin carcinomas clinical tnm finding v7
skin squamous cell carcinoma or other skin carcinomas clinical distant metastasis tnm finding v7
skin squamous cell carcinoma or other skin carcinomas cm0 tnm finding v7
skin squamous cell carcinoma or other skin carcinomas cm1 tnm finding v7
merkel cell carcinoma tnm finding v7
merkel cell carcinoma pathologic tnm finding v7
merkel cell carcinoma pathologic primary tumor tnm finding v7
antithyroid agent
ann arbor stage iii burkitt lymphoma
merkel cell carcinoma ptx tnm finding v7
merkel cell carcinoma pt0 tnm finding v7
nerve conduction velocity test
merkel cell carcinoma ptis tnm finding v7
merkel cell carcinoma pt1 tnm finding v7
tympanometry
merkel cell carcinoma pt2 tnm finding v7
flat tympanometry result
retracted tympanometry result
merkel cell carcinoma pt3 tnm finding v7
diffuse large b - cell lymphoma
merkel cell carcinoma pt4 tnm finding v7
hypoproteinemia
socialization
nhej1 gene
nhej1 wt allele
nonhomologous end - joining factor 1
catecholamine
orai1 gene
orai1 wt allele
calcium release - activated calcium channel protein 1
recurrent diffuse large b - cell lymphoma
nppb gene
nppb wt allele
natriuretic peptides b
brain natriuretic peptide 32
n - terminal fragment brain natriuretic protein
merkel cell carcinoma pathologic regional lymph nodes tnm finding v7
merkel cell carcinoma pnx tnm finding v7
merkel cell carcinoma pn0 tnm finding v7
merkel cell carcinoma pn1 tnm finding v7
merkel cell carcinoma pn1a tnm finding v7
refractory diffuse large b - cell lymphoma
merkel cell carcinoma pn1b tnm finding v7
merkel cell carcinoma pn2 tnm finding v7
merkel cell carcinoma pathologic distant metastasis tnm finding v7
merkel cell carcinoma pm1 tnm finding v7
merkel cell carcinoma pm1a tnm finding v7
merkel cell carcinoma pm1b tnm finding v7
merkel cell carcinoma pm1c tnm finding v7
nephrogenic rest
perilobar nephrogenic rest
merkel cell carcinoma clinical tnm finding v7
ann arbor stage i diffuse large b - cell lymphoma
intralobar nephrogenic rest
hemihypertrophy
merkel cell carcinoma clinical regional lymph nodes tnm finding v7
merkel cell carcinoma cnx tnm finding v7
merkel cell carcinoma cn0 tnm finding v7
merkel cell carcinoma cn1 tnm finding v7
merkel cell carcinoma cn2 tnm finding v7
merkel cell carcinoma clinical distant metastasis tnm finding v7
merkel cell carcinoma cm0 tnm finding v7
ligand - independent chloride ion channel activation
ann arbor stage ii diffuse large b - cell lymphoma
voltage - gated potassium ion channel activation
voltage - gated sodium ion channel activation
merkel cell carcinoma cm1 tnm finding v7
merkel cell carcinoma cm1a tnm finding v7
merkel cell carcinoma cm1b tnm finding v7
merkel cell carcinoma cm1c tnm finding v7
ophthalmic sites cancer tnm finding v7
carcinoma of the eyelid tnm finding v7
carcinoma of the eyelid pathologic tnm finding v7
carcinoma of the eyelid pathologic primary tumor tnm finding v7
ann arbor stage iii diffuse large b - cell lymphoma
carcinoma of the eyelid ptx tnm finding v7
carcinoma of the eyelid pt0 tnm finding v7
carcinoma of the eyelid ptis tnm finding v7
carcinoma of the eyelid pt1 tnm finding v7
carcinoma of the eyelid pt2a tnm finding v7
carcinoma of the eyelid pt2b tnm finding v7
carcinoma of the eyelid pt3a tnm finding v7
carcinoma of the eyelid pt3b tnm finding v7
carcinoma of the eyelid pt4 tnm finding v7
carcinoma of the eyelid pathologic regional lymph nodes tnm finding v7
ann arbor stage iv diffuse large b - cell lymphoma
carcinoma of the eyelid pnx tnm finding v7
carcinoma of the eyelid pn0 tnm finding v7
carcinoma of the eyelid pn1 tnm finding v7
carcinoma of the eyelid pathologic distant metastasis tnm finding v7
carcinoma of the eyelid pm1 tnm finding v7
carcinoma of the eyelid clinical tnm finding v7
carcinoma of the eyelid clinical regional lymph nodes tnm finding v7
carcinoma of the eyelid cnx tnm finding v7
carcinoma of the eyelid cn0 tnm finding v7
carcinoma of the eyelid cn1 tnm finding v7
refractory follicular lymphoma
gantenerumab
carcinoma of the eyelid clinical distant metastasis tnm finding v7
carcinoma of the eyelid cm0 tnm finding v7
carcinoma of the eyelid cm1 tnm finding v7
motavizumab
solanezumab
carcinoma of the conjunctiva tnm finding v7
carcinoma of the conjunctiva pathologic tnm finding v7
carcinoma of the conjunctiva pathologic primary tumor tnm finding v7
carcinoma of the conjunctiva ptx tnm finding v7
ann arbor stage i follicular lymphoma
carcinoma of the conjunctiva pt0 tnm finding v7
carcinoma of the conjunctiva ptis tnm finding v7
carcinoma of the conjunctiva pt1 tnm finding v7
carcinoma of the conjunctiva pt2 tnm finding v7
benralizumab
carcinoma of the conjunctiva pt3 tnm finding v7
carcinoma of the conjunctiva pt4 tnm finding v7
carcinoma of the conjunctiva pt4a tnm finding v7
carcinoma of the conjunctiva pt4b tnm finding v7
carcinoma of the conjunctiva pt4c tnm finding v7
thyroid hormone
ann arbor stage ii follicular lymphoma
carcinoma of the conjunctiva pt4d tnm finding v7
carcinoma of the conjunctiva pathologic regional lymph nodes tnm finding v7
carcinoma of the conjunctiva pnx tnm finding v7
carcinoma of the conjunctiva pn0 tnm finding v7
carcinoma of the conjunctiva pn1 tnm finding v7
carcinoma of the conjunctiva pathologic distant metastasis tnm finding v7
carcinoma of the conjunctiva pm1 tnm finding v7
carcinoma of the conjunctiva clinical tnm finding v7
carcinoma of the conjunctiva clinical distant metastasis tnm finding v7
ann arbor stage iii follicular lymphoma
carcinoma of the conjunctiva cm0 tnm finding v7
carcinoma of the conjunctiva cm1 tnm finding v7
ibalizumab
melanoma of the conjunctiva tnm finding v7
melanoma of the conjunctiva pathologic tnm finding v7
melanoma of the conjunctiva pathologic primary tumor tnm finding v7
melanoma of the conjunctiva ptx tnm finding v7
melanoma of the conjunctiva pt0 tnm finding v7
refractory mantle cell lymphoma
melanoma of the conjunctiva pt ( is )  tnm finding v7
melanoma of the conjunctiva pt1a tnm finding v7
melanoma of the conjunctiva pt1b tnm finding v7
melanoma of the conjunctiva pt1c tnm finding v7
melanoma of the conjunctiva pt2a tnm finding v7
melanoma of the conjunctiva pt2b tnm finding v7
melanoma of the conjunctiva pt2c tnm finding v7
melanoma of the conjunctiva pt3 tnm finding v7
melanoma of the conjunctiva pt4 tnm finding v7
nodal marginal zone lymphoma
melanoma of the conjunctiva pathologic regional lymph nodes tnm finding v7
melanoma of the conjunctiva pnx tnm finding v7
melanoma of the conjunctiva pn0 tnm finding v7
melanoma of the conjunctiva pn1 tnm finding v7
melanoma of the conjunctiva pathologic distant metastasis tnm finding v7
melanoma of the conjunctiva pm1 tnm finding v7
melanoma of the conjunctiva clinical tnm finding v7
melanoma of the conjunctiva clinical primary tumor tnm finding v7
clivatuzumab
ann arbor stage i nodal marginal zone lymphoma
melanoma of the conjunctiva ctx tnm finding v7
melanoma of the conjunctiva ct0 tnm finding v7
melanoma of the conjunctiva ct ( is )  tnm finding v7
melanoma of the conjunctiva ct1a tnm finding v7
melanoma of the conjunctiva ct1b tnm finding v7
melanoma of the conjunctiva ct1c tnm finding v7
melanoma of the conjunctiva ct1d tnm finding v7
melanoma of the conjunctiva ct2a tnm finding v7
melanoma of the conjunctiva ct2b tnm finding v7
ann arbor stage ii nodal marginal zone lymphoma
melanoma of the conjunctiva ct2c tnm finding v7
melanoma of the conjunctiva ct2d tnm finding v7
melanoma of the conjunctiva ct3 tnm finding v7
melanoma of the conjunctiva ct3a tnm finding v7
melanoma of the conjunctiva ct3b tnm finding v7
melanoma of the conjunctiva ct3c tnm finding v7
melanoma of the conjunctiva ct3d tnm finding v7
melanoma of the conjunctiva ct4 tnm finding v7
melanoma of the conjunctiva clinical regional lymph nodes tnm finding v7
melanoma of the conjunctiva cnx tnm finding v7
ann arbor stage iii nodal marginal zone lymphoma
melanoma of the conjunctiva cn0a  ( biopsy )  tnm finding v7
melanoma of the conjunctiva cn0b  ( no biopsy )  tnm finding v7
melanoma of the conjunctiva cn1 tnm finding v7
melanoma of the conjunctiva clinical distant metastasis tnm finding v7
melanoma of the conjunctiva cm0 tnm finding v7
melanoma of the conjunctiva cm1 tnm finding v7
melanoma of the uvea tnm finding v7
melanoma of the uvea pathologic tnm finding v7
melanoma of the uvea pathologic primary tumor tnm finding v7
melanoma of the iris pathologic primary tumor tnm finding v7
ann arbor stage iv nodal marginal zone lymphoma
melanoma of the iris ptx tnm finding v7
melanoma of the iris pt0 tnm finding v7
melanoma of the iris pt1 tnm finding v7
melanoma of the iris pt1a tnm finding v7
melanoma of the iris pt1b tnm finding v7
melanoma of the iris pt1c tnm finding v7
melanoma of the iris pt2 tnm finding v7
melanoma of the iris pt2a tnm finding v7
melanoma of the iris pt3 tnm finding v7
melanoma of the iris pt3a tnm finding v7
b lymphoblastic lymphoma
melanoma of the iris pt4 tnm finding v7
melanoma of the iris pt4a tnm finding v7
melanoma of the iris pt4b tnm finding v7
melanoma of the ciliary body and choroid pathologic primary tumor tnm finding v7
melanoma of the ciliary body and choroid ptx tnm finding v7
melanoma of the ciliary body and choroid pt0 tnm finding v7
melanoma of the ciliary body and choroid pt1 tnm finding v7
melanoma of the ciliary body and choroid pt1a tnm finding v7
melanoma of the ciliary body and choroid pt1b tnm finding v7
melanoma of the ciliary body and choroid pt1c tnm finding v7
recurrent b lymphoblastic lymphoma
melanoma of the ciliary body and choroid pt1d tnm finding v7
melanoma of the ciliary body and choroid pt2 tnm finding v7
melanoma of the ciliary body and choroid pt2a tnm finding v7
melanoma of the ciliary body and choroid pt2b tnm finding v7
melanoma of the ciliary body and choroid pt2c tnm finding v7
melanoma of the ciliary body and choroid pt2d tnm finding v7
melanoma of the ciliary body and choroid pt3 tnm finding v7
melanoma of the ciliary body and choroid pt3a tnm finding v7
melanoma of the ciliary body and choroid pt3b tnm finding v7
melanoma of the ciliary body and choroid pt3c tnm finding v7
recombinant thyroid - stimulating hormone
refractory b lymphoblastic lymphoma
melanoma of the ciliary body and choroid pt3d tnm finding v7
melanoma of the ciliary body and choroid pt4 tnm finding v7
melanoma of the ciliary body and choroid pt4a tnm finding v7
melanoma of the ciliary body and choroid pt4b tnm finding v7
melanoma of the ciliary body and choroid pt4c tnm finding v7
melanoma of the ciliary body and choroid pt4d tnm finding v7
melanoma of the ciliary body and choroid pt4e tnm finding v7
melanoma of the uvea pathologic regional lymph nodes tnm finding v7
melanoma of the uvea pnx tnm finding v7
melanoma of the uvea pn0 tnm finding v7
ann arbor stage i b lymphoblastic lymphoma
melanoma of the uvea pn1 tnm finding v7
melanoma of the uvea pathologic distant metastasis tnm finding v7
melanoma of the uvea pm1 tnm finding v7
melanoma of the uvea pm1a tnm finding v7
melanoma of the uvea pm1b tnm finding v7
melanoma of the uvea pm1c tnm finding v7
melanoma of the uvea clinical tnm finding v7
united states immunodeficiency network
melanoma of the uvea clinical distant metastasis tnm finding v7
melanoma of the uvea cm0 tnm finding v7
ann arbor stage iii b lymphoblastic lymphoma
melanoma of the uvea cm1 tnm finding v7
melanoma of the uvea cm1a tnm finding v7
melanoma of the uvea cm1b tnm finding v7
melanoma of the uvea cm1c tnm finding v7
retinoblastoma tnm finding v7
retinoblastoma pathologic tnm finding v7
retinoblastoma pathologic primary tumor tnm finding v7
retinoblastoma ptx tnm finding v7
retinoblastoma pt0 tnm finding v7
retinoblastoma pt1 tnm finding v7
ann arbor stage iv b lymphoblastic lymphoma
retinoblastoma pt2 tnm finding v7
retinoblastoma pt2a tnm finding v7
retinoblastoma pt2b tnm finding v7
retinoblastoma pt3 tnm finding v7
retinoblastoma pt3a tnm finding v7
retinoblastoma pt3b tnm finding v7
retinoblastoma pt4 tnm finding v7
retinoblastoma pt4a tnm finding v7
retinoblastoma pt4b tnm finding v7
retinoblastoma pathologic regional lymph nodes tnm finding v7
recurrent primary mediastinal  ( thymic )  large b - cell lymphoma
retinoblastoma pnx tnm finding v7
retinoblastoma pn0 tnm finding v7
retinoblastoma pn1 tnm finding v7
retinoblastoma pathologic distant metastasis tnm finding v7
retinoblastoma pm1 tnm finding v7
retinoblastoma pm1a tnm finding v7
retinoblastoma pm1b tnm finding v7
retinoblastoma pm1c tnm finding v7
retinoblastoma pm1d tnm finding v7
retinoblastoma pm1e tnm finding v7
refractory primary mediastinal  ( thymic )  large b - cell lymphoma
retinoblastoma clinical tnm finding v7
retinoblastoma clinical primary tumor tnm finding v7
retinoblastoma ctx tnm finding v7
retinoblastoma ct0 tnm finding v7
retinoblastoma ct1 tnm finding v7
retinoblastoma ct1a tnm finding v7
retinoblastoma ct1b tnm finding v7
retinoblastoma ct1c tnm finding v7
retinoblastoma ct2 tnm finding v7
retinoblastoma ct2a tnm finding v7
ann arbor stage i primary mediastinal  ( thymic )  large b - cell lymphoma
retinoblastoma ct2b tnm finding v7
retinoblastoma ct3 tnm finding v7
retinoblastoma ct3a tnm finding v7
retinoblastoma ct3b tnm finding v7
retinoblastoma ct4 tnm finding v7
retinoblastoma ct4a tnm finding v7
retinoblastoma ct4b tnm finding v7
retinoblastoma ct4c tnm finding v7
retinoblastoma ct4d tnm finding v7
retinoblastoma clinical regional lymph nodes tnm finding v7
ann arbor stage ii primary mediastinal  ( thymic )  large b - cell lymphoma
retinoblastoma cnx tnm finding v7
retinoblastoma cn0 tnm finding v7
retinoblastoma cn1 tnm finding v7
retinoblastoma cn2 tnm finding v7
concanavalin a
retinoblastoma clinical distant metastasis tnm finding v7
retinoblastoma cm0 tnm finding v7
retinoblastoma cm1 tnm finding v7
retinoblastoma cm1a tnm finding v7
retinoblastoma cm1b tnm finding v7
ann arbor stage iii primary mediastinal  ( thymic )  large b - cell lymphoma
retinoblastoma cm1c tnm finding v7
retinoblastoma cm1d tnm finding v7
retinoblastoma cm1e tnm finding v7
carcinoma of the lacrimal gland tnm finding v7
carcinoma of the lacrimal gland pathologic tnm finding v7
carcinoma of the lacrimal gland pathologic primary tumor tnm finding v7
carcinoma of the lacrimal gland ptx tnm finding v7
carcinoma of the lacrimal gland pt0 tnm finding v7
pokeweed mitogen
ann arbor stage iv primary mediastinal  ( thymic )  large b - cell lymphoma
carcinoma of the lacrimal gland pt1 tnm finding v7
phytohemagglutinin
carcinoma of the lacrimal gland pt2 tnm finding v7
carcinoma of the lacrimal gland pt3 tnm finding v7
carcinoma of the lacrimal gland pt4 tnm finding v7
carcinoma of the lacrimal gland pt4a tnm finding v7
carcinoma of the lacrimal gland pt4b tnm finding v7
carcinoma of the lacrimal gland pt4c tnm finding v7
carcinoma of the lacrimal gland pathologic regional lymph nodes tnm finding v7
carcinoma of the lacrimal gland pnx tnm finding v7
levothyroxine sodium
extragonadal embryonal carcinoma
carcinoma of the lacrimal gland pn0 tnm finding v7
carcinoma of the lacrimal gland pn1 tnm finding v7
carcinoma of the lacrimal gland pathologic distant metastasis tnm finding v7
carcinoma of the lacrimal gland pm1 tnm finding v7
carcinoma of the lacrimal gland clinical tnm finding v7
carcinoma of the lacrimal gland clinical distant metastasis tnm finding v7
carcinoma of the lacrimal gland cm0 tnm finding v7
carcinoma of the lacrimal gland cm1 tnm finding v7
sarcoma of the orbit tnm finding v7
sarcoma of the orbit pathologic tnm finding v7
malignant extragonadal germ cell tumor
sarcoma of the orbit pathologic primary tumor tnm finding v7
sarcoma of the orbit ptx tnm finding v7
sarcoma of the orbit pt0 tnm finding v7
sarcoma of the orbit pt1 tnm finding v7
sarcoma of the orbit pt2 tnm finding v7
sarcoma of the orbit pt3 tnm finding v7
sarcoma of the orbit pt4 tnm finding v7
sarcoma of the orbit pathologic regional lymph nodes tnm finding v7
sarcoma of the orbit pnx tnm finding v7
sarcoma of the orbit pn0 tnm finding v7
sarcoma of the orbit pn1 tnm finding v7
sarcoma of the orbit pathologic distant metastasis tnm finding v7
sarcoma of the orbit pm1 tnm finding v7
sarcoma of the orbit clinical tnm finding v7
sarcoma of the orbit clinical distant metastasis tnm finding v7
sarcoma of the orbit cm0 tnm finding v7
sarcoma of the orbit cm1 tnm finding v7
ocular adnexal lymphoma tnm finding v7
ocular adnexal lymphoma pathologic tnm finding v7
ocular adnexal lymphoma pathologic primary tumor tnm finding v7
ocular adnexal lymphoma ptx tnm finding v7
ocular adnexal lymphoma pt0 tnm finding v7
ocular adnexal lymphoma pt1 tnm finding v7
ocular adnexal lymphoma pt1a tnm finding v7
ocular adnexal lymphoma pt1b tnm finding v7
ocular adnexal lymphoma pt1c tnm finding v7
ocular adnexal lymphoma pt2 tnm finding v7
ocular adnexal lymphoma pt2a tnm finding v7
ocular adnexal lymphoma pt2b tnm finding v7
ocular adnexal lymphoma pt2c tnm finding v7
immature extragonadal teratoma
ocular adnexal lymphoma pt2d tnm finding v7
ocular adnexal lymphoma pt3 tnm finding v7
ocular adnexal lymphoma pt4 tnm finding v7
ocular adnexal lymphoma pt4a tnm finding v7
ocular adnexal lymphoma pt4b tnm finding v7
ocular adnexal lymphoma pt4c tnm finding v7
ocular adnexal lymphoma pt4d tnm finding v7
ocular adnexal lymphoma pathologic regional lymph nodes tnm finding v7
ocular adnexal lymphoma pnx tnm finding v7
ocular adnexal lymphoma pn0 tnm finding v7
malignant extragonadal non - seminomatous germ cell tumor
ocular adnexal lymphoma pn1 tnm finding v7
ocular adnexal lymphoma pn2 tnm finding v7
ocular adnexal lymphoma pn3 tnm finding v7
ocular adnexal lymphoma pn4 tnm finding v7
ocular adnexal lymphoma pathologic distant metastasis tnm finding v7
ocular adnexal lymphoma pm1a tnm finding v7
ocular adnexal lymphoma pm1b tnm finding v7
ocular adnexal lymphoma pm1c tnm finding v7
ocular adnexal lymphoma clinical tnm finding v7
ocular adnexal lymphoma clinical distant metastasis tnm finding v7
ocular adnexal lymphoma cm0 tnm finding v7
ocular adnexal lymphoma cm1a tnm finding v7
ocular adnexal lymphoma cm1b tnm finding v7
ocular adnexal lymphoma cm1c tnm finding v7
thoracic cancer tnm finding v7
lung cancer tnm finding v7
lung cancer pathologic tnm finding v7
lung cancer pathologic primary tumor tnm finding v7
lung cancer pt1 tnm finding v7
lung cancer pt1a tnm finding v7
lung cancer pt1b tnm finding v7
lung cancer pt2 tnm finding v7
lung cancer pt2a tnm finding v7
lung cancer pt2b tnm finding v7
lung cancer pt3 tnm finding v7
lung cancer pt4 tnm finding v7
lung cancer pathologic regional lymph nodes tnm finding v7
lung cancer pn1 tnm finding v7
lung cancer pathologic distant metastasis tnm finding v7
lung cancer pm1 tnm finding v7
lung cancer pm1a tnm finding v7
lung cancer pm1b tnm finding v7
lung cancer clinical tnm finding v7
lung cancer clinical distant metastasis tnm finding v7
lung cancer cm0 tnm finding v7
lung cancer cm1 tnm finding v7
lung cancer cm1a tnm finding v7
lung cancer cm1b tnm finding v7
stage i lung cancer ajcc v7
stage ii lung cancer ajcc v7
stage iii lung cancer ajcc v7
stage iv lung cancer ajcc v7
primary care evaluation of mental disorders patient health questionnaire
generalized anxiety disorder questionnaire
serotype
pleural mesothelioma tnm finding v7
pleural mesothelioma pathologic tnm finding v7
pleural mesothelioma pathologic primary tumor tnm finding v7
pleural mesothelioma ptx tnm finding v7
pleural mesothelioma pt0 tnm finding v7
ticarcillin
pleural mesothelioma pt1 tnm finding v7
pleural mesothelioma pt1a tnm finding v7
pleural mesothelioma pt1b tnm finding v7
pleural mesothelioma pt2 tnm finding v7
pleural mesothelioma pt3 tnm finding v7
pleural mesothelioma pt4 tnm finding v7
pleural mesothelioma pathologic regional lymph nodes tnm finding v7
pleural mesothelioma pnx tnm finding v7
pleural mesothelioma pn0 tnm finding v7
pleural mesothelioma pn1 tnm finding v7
pleural mesothelioma pn2 tnm finding v7
pleural mesothelioma pn3 tnm finding v7
pleural mesothelioma pathologic distant metastasis tnm finding v7
pleural mesothelioma pm1 tnm finding v7
pleural mesothelioma clinical tnm finding v7
pleural mesothelioma clinical distant metastasis tnm finding v7
pleural mesothelioma cm0 tnm finding v7
pleural mesothelioma cm1 tnm finding v7
htt gene
htt wt allele
huntingtin
cd68 gene
cd68 wt allele
macrosialin
lincrna
tp53bp1 gene
tp53bp1 wt allele
tumor suppressor p53 - binding protein 1
tarp gene
tarp wt allele
placental choriocarcinoma
t - cell receptor gamma chain alternative reading frame protein isoform 1
csmd1 gene
csmd1 wt allele
cub and sushi domain - containing protein 1
nrk gene
nrk wt allele
nik - related protein kinase
head and neck cancer tnm finding v7
lip and oral cavity cancer tnm finding v7
lip and oral cavity cancer pathologic tnm finding v7
stage 0 bladder adenocarcinoma ajcc v6 and v7
lip and oral cavity cancer pathologic primary tumor tnm finding v7
mycbp2 gene
mycbp2 wt allele
probable e3 ubiquitin - protein ligase mycbp2
sned1 gene
sned1 wt allele
sushi ,  nidogen and egf - like domain - containing protein 1
lip and oral cavity cancer pt4a tnm finding v7
lip and oral cavity cancer pt4b tnm finding v7
lip and oral cavity cancer pathologic regional lymph nodes tnm finding v7
stage i bladder adenocarcinoma ajcc v6 and v7
lip and oral cavity cancer pn2 tnm finding v7
flnc gene
flnc wt allele
lip and oral cavity cancer pathologic distant metastasis tnm finding v7
filamin - c
lip and oral cavity cancer clinical tnm finding v7
lip and oral cavity cancer clinical distant metastasis tnm finding v7
stage ii bladder adenocarcinoma ajcc v6 and v7
lip and oral cavity cancer cm0 tnm finding v7
lip and oral cavity cancer cm1 tnm finding v7
pharyngeal cancer tnm finding v7
nasopharyngeal cancer tnm finding v7
nasopharyngeal cancer pathologic tnm finding v7
nasopharyngeal cancer pathologic primary tumor tnm finding v7
nasopharyngeal cancer pt1 tnm finding v7
nasopharyngeal cancer pt2 tnm finding v7
nasopharyngeal cancer pt3 tnm finding v7
stage iii bladder adenocarcinoma ajcc v6 and v7
nasopharyngeal cancer pt4 tnm finding v7
nasopharyngeal cancer pathologic regional lymph nodes tnm finding v7
nasopharyngeal cancer pn1 tnm finding v7
nasopharyngeal cancer pn2 tnm finding v7
nasopharyngeal cancer pn3 tnm finding v7
nasopharyngeal cancer pn3b tnm finding v7
nasopharyngeal cancer pathologic distant metastasis tnm finding v7
nasopharyngeal cancer clinical tnm finding v7
nasopharyngeal cancer clinical distant metastasis tnm finding v7
nasopharyngeal cancer cm0 tnm finding v7
stage iv bladder adenocarcinoma ajcc v7
nasopharyngeal cancer cm1 tnm finding v7
stage i nasopharyngeal carcinoma ajcc v7
stage ii nasopharyngeal carcinoma ajcc v7
stage iii nasopharyngeal carcinoma ajcc v7
stage iv nasopharyngeal carcinoma ajcc v7
ctnna1 gene
ctnna1 wt allele
catenin alpha - 1
lrrtm2 gene
lrrtm2 wt allele
stage i bladder cancer with carcinoma in situ
leucine - rich repeat transmembrane neuronal protein 2
matr3 gene
matr3 wt allele
matrin - 3
snora74a gene
snora74a wt allele
small nucleolar rna snora74a  ( u19 )
oropharyngeal cancer tnm finding v7
oropharyngeal cancer pathologic tnm finding v7
tinidazole
stage iii testicular choriocarcinoma ajcc v6 and v7
sil1 gene
oropharyngeal cancer pathologic primary tumor tnm finding v7
sil1 wt allele
nucleotide exchange factor sil1
oropharyngeal cancer pt3 tnm finding v7
oropharyngeal cancer pt4a tnm finding v7
oropharyngeal cancer pt4b tnm finding v7
oropharyngeal cancer pathologic regional lymph nodes tnm finding v7
mecr gene
mecr wt allele
stage i bladder cancer without carcinoma in situ
oropharyngeal cancer pn2 tnm finding v7
trans - 2 - enoyl - coa reductase ,  mitochondrial
oropharyngeal cancer pn3 tnm finding v7
oropharyngeal cancer pathologic distant metastasis tnm finding v7
oropharyngeal cancer clinical tnm finding v7
oropharyngeal cancer clinical distant metastasis tnm finding v7
oropharyngeal cancer cm0 tnm finding v7
recurrent bladder squamous cell carcinoma
oropharyngeal cancer cm1 tnm finding v7
stage iii oropharyngeal carcinoma ajcc v7
abca2 gene
stage iv oropharyngeal carcinoma ajcc v7
abca2 wt allele
atp - binding cassette sub - family a member 2
hypopharyngeal cancer tnm finding v7
znf496 gene
hypopharyngeal cancer pathologic tnm finding v7
znf496 wt allele
stage 0 bladder squamous cell carcinoma ajcc v6 and v7
hypopharyngeal cancer pathologic primary tumor tnm finding v7
zinc finger protein 496
hypopharyngeal cancer pt1 tnm finding v7
hypopharyngeal cancer pt3 tnm finding v7
slc2a4 gene
hypopharyngeal cancer pt4a tnm finding v7
hypopharyngeal cancer pt4b tnm finding v7
hypopharyngeal cancer pathologic regional lymph nodes tnm finding v7
hypopharyngeal cancer pn2 tnm finding v7
hypopharyngeal cancer pn3 tnm finding v7
stage i squamous cell carcinoma of the bladder ajcc v6 and v7
hypopharyngeal cancer pathologic distant metastasis tnm finding v7
hypopharyngeal cancer clinical tnm finding v7
hypopharyngeal cancer clinical distant metastasis tnm finding v7
hypopharyngeal cancer cm0 tnm finding v7
hypopharyngeal cancer cm1 tnm finding v7
stage i hypopharyngeal carcinoma ajcc v7
stage iii hypopharyngeal carcinoma ajcc v7
stage iv hypopharyngeal carcinoma ajcc v7
laryngeal cancer tnm finding v7
supraglottic cancer tnm finding v7
stage iii bladder squamous cell carcinoma ajcc v6 and v7
slc2a4 wt allele
supraglottic cancer pathologic tnm finding v7
supraglottic cancer pathologic primary tumor tnm finding v7
solute carrier family 2 ,  facilitated glucose transporter member 4
supraglottic cancer pt3 tnm finding v7
supraglottic cancer pt4a tnm finding v7
supraglottic cancer pt4b tnm finding v7
supraglottic cancer pathologic regional lymph nodes tnm finding v7
supraglottic cancer pn2 tnm finding v7
supraglottic cancer pathologic distant metastasis tnm finding v7
stage iv bladder squamous cell carcinoma ajcc v7
supraglottic cancer clinical tnm finding v7
supraglottic cancer clinical distant metastasis tnm finding v7
supraglottic cancer cm0 tnm finding v7
supraglottic cancer cm1 tnm finding v7
glottic cancer tnm finding v7
glottic cancer pathologic tnm finding v7
glottic cancer pathologic primary tumor tnm finding v7
glottic cancer pt3 tnm finding v7
glottic cancer pt4a tnm finding v7
glottic cancer pt4b tnm finding v7
stage i testicular choriocarcinoma ajcc v6 and v7
glottic cancer pathologic regional lymph nodes tnm finding v7
glottic cancer pn2 tnm finding v7
glottic cancer pathologic distant metastasis tnm finding v7
glottic cancer clinical tnm finding v7
glottic cancer clinical distant metastasis tnm finding v7
glottic cancer cm0 tnm finding v7
glottic cancer cm1 tnm finding v7
subglottic cancer tnm finding v7
subglottic cancer pathologic tnm finding v7
subglottic cancer pathologic primary tumor tnm finding v7
stage i testicular embryonal carcinoma ajcc v6 and v7
subglottic cancer pt4a tnm finding v7
dose frequency
subglottic cancer pt4b tnm finding v7
subglottic cancer pathologic regional lymph nodes tnm finding v7
subglottic cancer pn2 tnm finding v7
subglottic cancer pathologic distant metastasis tnm finding v7
subglottic cancer clinical tnm finding v7
subglottic cancer clinical distant metastasis tnm finding v7
subglottic cancer cm0 tnm finding v7
stage ii testicular embryonal carcinoma ajcc v6 and v7
subglottic cancer cm1 tnm finding v7
stage iv laryngeal cancer ajcc v7
nasal cavity and paranasal sinus cancer tnm finding v7
maxillary sinus cancer tnm finding v7
maxillary sinus cancer pathologic tnm finding v7
maxillary sinus cancer pathologic primary tumor tnm finding v7
maxillary sinus cancer pt4a tnm finding v7
maxillary sinus cancer pt4b tnm finding v7
maxillary sinus cancer pathologic regional lymph nodes tnm finding v7
maxillary sinus cancer pn2 tnm finding v7
tobacco
stage iii testicular embryonal carcinoma ajcc v6 and v7
maxillary sinus cancer pathologic distant metastasis tnm finding v7
maxillary sinus cancer clinical tnm finding v7
maxillary sinus cancer clinical distant metastasis tnm finding v7
maxillary sinus cancer cm0 tnm finding v7
maxillary sinus cancer cm1 tnm finding v7
nasal cavity and ethmoid sinus cancer tnm finding v7
nasal cavity and ethmoid sinus cancer pathologic tnm finding v7
nasal cavity and ethmoid sinus cancer pathologic primary tumor tnm finding v7
nasal cavity and ethmoid sinus cancer pt4a tnm finding v7
nasal cavity and ethmoid sinus cancer pt4b tnm finding v7
stage ii testicular mixed germ cell tumor ajcc v6 and v7
nasal cavity and ethmoid sinus cancer pathologic regional lymph nodes tnm finding v7
nasal cavity and ethmoid sinus cancer pn2 tnm finding v7
nasal cavity and ethmoid sinus cancer pathologic distant metastasis tnm finding v7
nasal cavity and ethmoid sinus cancer clinical tnm finding v7
nasal cavity and ethmoid sinus cancer clinical distant metastasis tnm finding v7
nasal cavity and ethmoid sinus cancer cm0 tnm finding v7
nasal cavity and ethmoid sinus cancer cm1 tnm finding v7
stage iv sinonasal cancer ajcc v7
major salivary gland cancer tnm finding v7
major salivary gland cancer pathologic tnm finding v7
stage i testicular mixed germ cell tumor ajcc v6 and v7
major salivary gland cancer pathologic primary tumor tnm finding v7
major salivary gland cancer pt4a tnm finding v7
major salivary gland cancer pt4b tnm finding v7
major salivary gland cancer pathologic regional lymph nodes tnm finding v7
major salivary gland cancer pathologic distant metastasis tnm finding v7
major salivary gland cancer clinical tnm finding v7
major salivary gland cancer clinical distant metastasis tnm finding v7
major salivary gland cancer cm0 tnm finding v7
major salivary gland cancer cm1 tnm finding v7
mucosal melanoma of the head and neck tnm finding v7
stage iii testicular mixed germ cell tumor ajcc v6 and v7
mucosal melanoma of the head and neck pathologic tnm finding v7
mucosal melanoma of the head and neck pathologic primary tumor tnm finding v7
mucosal melanoma of the head and neck pt3 tnm finding v7
mucosal melanoma of the head and neck pt4a tnm finding v7
mucosal melanoma of the head and neck pt4b tnm finding v7
mucosal melanoma of the head and neck pathologic regional lymph nodes tnm finding v7
mucosal melanoma of the head and neck pnx tnm finding v7
mucosal melanoma of the head and neck pn0 tnm finding v7
mucosal melanoma of the head and neck pn1 tnm finding v7
mucosal melanoma of the head and neck pathologic distant metastasis tnm finding v7
stage i immature testicular teratoma ajcc v6 and v7
mucosal melanoma of the head and neck pm1 tnm finding v7
mucosal melanoma of the head and neck clinical tnm finding v7
mucosal melanoma of the head and neck clinical distant metastasis tnm finding v7
mucosal melanoma of the head and neck cm0 tnm finding v7
mucosal melanoma of the head and neck cm1 tnm finding v7
thyroid cancer tnm finding v7
thyroid cancer pathologic tnm finding v7
thyroid cancer pathologic primary tumor tnm finding v7
thyroid cancer pt1a tnm finding v7
thyroid cancer pt1b tnm finding v7
stage ii immature testicular teratoma ajcc v6 and v7
thyroid cancer pt4a tnm finding v7
thyroid cancer pt4a anaplastic carcinoma tnm finding v7
thyroid cancer pt4b tnm finding v7
thyroid cancer pt4b anaplastic carcinoma tnm finding v7
thyroid cancer pathologic regional lymph nodes tnm finding v7
thyroid cancer pn1b tnm finding v7
thyroid cancer pathologic distant metastasis tnm finding v7
thyroid cancer clinical tnm finding v7
thyroid cancer clinical distant metastasis tnm finding v7
thyroid cancer cm0 tnm finding v7
stage iii immature testicular teratoma ajcc v6 and v7
thyroid cancer cm1 tnm finding v7
congenital amegakaryocytosis
genitourinary system cancer tnm finding v7
penile cancer tnm finding v7
penile cancer pathologic tnm finding v7
penile cancer pathologic primary tumor tnm finding v7
penile cancer ptx tnm finding v7
penile cancer pt0 tnm finding v7
penile cancer ptis tnm finding v7
penile cancer pta tnm finding v7
stage i testicular seminoma ajcc v6 and v7
penile cancer pt1 tnm finding v7
penile cancer pt1a tnm finding v7
penile cancer pt1b tnm finding v7
penile cancer pt2 tnm finding v7
penile cancer pt3 tnm finding v7
penile cancer pt4 tnm finding v7
penile cancer pathologic regional lymph nodes tnm finding v7
penile cancer pnx tnm finding v7
penile cancer pn0 tnm finding v7
penile cancer pn1 tnm finding v7
stage ii testicular seminoma ajcc v6 and v7
penile cancer pn2 tnm finding v7
penile cancer pn3 tnm finding v7
penile cancer pathologic distant metastasis tnm finding v7
penile cancer pm1 tnm finding v7
penile cancer clinical tnm finding v7
penile cancer clinical regional lymph nodes tnm finding v7
penile cancer cnx tnm finding v7
penile cancer cn0 tnm finding v7
penile cancer cn1 tnm finding v7
penile cancer cn2 tnm finding v7
stage iii testicular seminoma ajcc v6 and v7
penile cancer cn3 tnm finding v7
penile cancer clinical distant metastasis tnm finding v7
penile cancer cm0 tnm finding v7
penile cancer cm1 tnm finding v7
stage 0 penile cancer ajcc v7
stage i penile cancer ajcc v7
stage ii penile cancer ajcc v7
stage iii penile cancer ajcc v7
stage iv penile cancer ajcc v7
prostate cancer tnm finding v7
smokeless tobacco
stage i testicular yolk sac tumor ajcc v6 and v7
prostate cancer pathologic tnm finding v7
prostate cancer pathologic primary tumor tnm finding v7
prostate cancer pt3a tnm finding v7
prostate cancer pt4 tnm finding v7
prostate cancer pathologic regional lymph nodes tnm finding v7
prostate cancer pathologic distant metastasis tnm finding v7
prostate cancer clinical tnm finding v7
prostate cancer clinical primary tumor tnm finding v7
prostate cancer ctx tnm finding v7
prostate cancer ct0 tnm finding v7
stage ii testicular yolk sac tumor ajcc v6 and v7
prostate cancer ct1 tnm finding v7
prostate cancer ct1a tnm finding v7
prostate cancer ct1b tnm finding v7
prostate cancer ct1c tnm finding v7
prostate cancer ct2 tnm finding v7
prostate cancer ct2a tnm finding v7
prostate cancer ct2b tnm finding v7
prostate cancer ct2c tnm finding v7
prostate cancer ct3 tnm finding v7
prostate cancer ct3a tnm finding v7
stage iii testicular yolk sac tumor ajcc v6 and v7
prostate cancer ct3b tnm finding v7
prostate cancer ct4 tnm finding v7
prostate cancer clinical regional lymph nodes tnm finding v7
prostate cancer cnx tnm finding v7
prostate cancer cn0 tnm finding v7
prostate cancer cn1 tnm finding v7
prostate cancer clinical distant metastasis tnm finding v7
prostate cancer cm0 tnm finding v7
prostate cancer cm1 tnm finding v7
prostate cancer cm1a tnm finding v7
acute erythroid leukemia
prostate cancer cm1b tnm finding v7
prostate cancer cm1c tnm finding v7
stage i prostate cancer ajcc v7
stage ii prostate cancer ajcc v7
stage iii prostate cancer ajcc v7
stage iv prostate cancer ajcc v7
testicular cancer tnm finding v7
testicular cancer pathologic tnm finding v7
testicular cancer pathologic primary tumor tnm finding v7
testicular cancer ptx tnm finding v7
erythema multiforme minor
testicular cancer pt0 tnm finding v7
testicular cancer ptis tnm finding v7
testicular cancer pt1 tnm finding v7
testicular cancer pt2 tnm finding v7
testicular cancer pt3 tnm finding v7
testicular cancer pt4 tnm finding v7
testicular cancer pathologic regional lymph nodes tnm finding v7
testicular cancer pnx tnm finding v7
testicular cancer pn0 tnm finding v7
testicular cancer pn1 tnm finding v7
metastatic melanoma
testicular cancer pn2 tnm finding v7
testicular cancer pn3 tnm finding v7
rna sequence
testicular cancer pathologic distant metastasis tnm finding v7
testicular cancer pm1 tnm finding v7
testicular cancer pm1a tnm finding v7
testicular cancer pm1b tnm finding v7
testicular cancer clinical tnm finding v7
testicular cancer clinical regional lymph nodes tnm finding v7
testicular cancer cnx tnm finding v7
recurrent centroblastic lymphoma
testicular cancer cn0 tnm finding v7
testicular cancer cn1 tnm finding v7
testicular cancer cn2 tnm finding v7
testicular cancer cn3 tnm finding v7
testicular cancer clinical distant metastasis tnm finding v7
testicular cancer cm0 tnm finding v7
testicular cancer cm1 tnm finding v7
testicular cancer cm1a tnm finding v7
testicular cancer cm1b tnm finding v7
homework
refractory centroblastic lymphoma
classmate
assistance
due to
ontology concept
data context
comfort
endurance
possess
high school
reside
ann arbor stage i centroblastic lymphoma
kidney cancer tnm finding v7
boyfriend
girlfriend
kidney cancer pathologic tnm finding v7
kidney cancer pathologic primary tumor tnm finding v7
kidney cancer pt2a tnm finding v7
kidney cancer pt2b tnm finding v7
kidney cancer pt3 tnm finding v7
kidney cancer pt3a tnm finding v7
kidney cancer pt3b tnm finding v7
ann arbor stage ii centroblastic lymphoma
kidney cancer pt3c tnm finding v7
close relationship
intimacy
kidney cancer pt4 tnm finding v7
kidney cancer pathologic regional lymph nodes tnm finding v7
kidney cancer pn1 tnm finding v7
kidney cancer pathologic distant metastasis tnm finding v7
kidney cancer clinical tnm finding v7
kidney cancer clinical distant metastasis tnm finding v7
kidney cancer cm0 tnm finding v7
tobramycin sulfate
ann arbor stage iii centroblastic lymphoma
kidney cancer cm1 tnm finding v7
stage ii renal cell cancer ajcc v7
stage iii renal cell cancer ajcc v7
stage iv renal cell cancer ajcc v7
renal pelvis and ureter cancer tnm finding v7
renal pelvis and ureter cancer pathologic tnm finding v7
renal pelvis and ureter cancer pathologic primary tumor tnm finding v7
renal pelvis and ureter cancer ptx tnm finding v7
renal pelvis and ureter cancer pt0 tnm finding v7
renal pelvis and ureter cancer pta tnm finding v7
ann arbor stage iv centroblastic lymphoma
renal pelvis and ureter cancer ptis tnm finding v7
renal pelvis and ureter cancer pt1 tnm finding v7
renal pelvis and ureter cancer pt2 tnm finding v7
renal pelvis and ureter cancer pt3 tnm finding v7
renal pelvis and ureter cancer pt4 tnm finding v7
renal pelvis and ureter cancer pathologic regional lymph nodes tnm finding v7
renal pelvis and ureter cancer pnx tnm finding v7
renal pelvis and ureter cancer pn0 tnm finding v7
renal pelvis and ureter cancer pn1 tnm finding v7
renal pelvis and ureter cancer pn2 tnm finding v7
stage 0 colorectal cancer ajcc v6 and v7
renal pelvis and ureter cancer pn3 tnm finding v7
renal pelvis and ureter cancer pathologic distant metastasis tnm finding v7
renal pelvis and ureter cancer pm1 tnm finding v7
renal pelvis and ureter cancer clinical tnm finding v7
renal pelvis and ureter cancer clinical distant metastasis tnm finding v7
renal pelvis and ureter cancer cm0 tnm finding v7
renal pelvis and ureter cancer cm1 tnm finding v7
be
pediatric disorder
conduct disorder
metastatic pancreatic adenocarcinoma
developmental disorder
early adolescence
eating disorder
term infant
learning disorder
life stage
maternal
congenital musculoskeletal defect
neurodevelopmental disorder
neurological screening
metastatic small intestinal adenocarcinoma
obstetric procedure
preconception
toddler
finnegan score measurement
late adolescence
childhood
early childhood
middle childhood
bladder cancer tnm finding v7
bladder cancer pathologic tnm finding v7
bladder cancer pathologic primary tumor tnm finding v7
bladder cancer pt2 tnm finding v7
bladder cancer pt2a tnm finding v7
bladder cancer pt2b tnm finding v7
bladder cancer pt4 tnm finding v7
bladder cancer pt4a tnm finding v7
bladder cancer pathologic regional lymph nodes tnm finding v7
bladder cancer pn1 tnm finding v7
bladder cancer pn2 tnm finding v7
b lymphoblastic leukemia / lymphoma
bladder cancer pn3 tnm finding v7
bladder cancer pathologic distant metastasis tnm finding v7
bladder cancer clinical tnm finding v7
bladder cancer clinical distant metastasis tnm finding v7
bladder cancer cm0 tnm finding v7
bladder cancer cm1 tnm finding v7
stage iv bladder cancer ajcc v7
urethral cancer tnm finding v7
urethral cancer pathologic tnm finding v7
urethral cancer pathologic primary tumor tnm finding v7
ann arbor stage ii b lymphoblastic lymphoma
urethral cancer ptx tnm finding v7
urethral cancer pt0 tnm finding v7
urethral cancer pta tnm finding v7
urethral cancer ptis tnm finding v7
urethral cancer pt1 tnm finding v7
urethral cancer pt2 tnm finding v7
urethral cancer pt3 tnm finding v7
urethral cancer pt4 tnm finding v7
urothelial  ( transitional cell )  carcinoma of the prostate pathologic primary tumor tnm finding v7
urothelial  ( transitional cell )  carcinoma of the prostate ptis pu tnm finding v7
refractory primary cutaneous t - cell non - hodgkin lymphoma
urothelial  ( transitional cell )  carcinoma of the prostate ptis pd tnm finding v7
urothelial  ( transitional cell )  carcinoma of the prostate pt1 tnm finding v7
urothelial  ( transitional cell )  carcinoma of the prostate pt2 tnm finding v7
urothelial  ( transitional cell )  carcinoma of the prostate pt3 tnm finding v7
urothelial  ( transitional cell )  carcinoma of the prostate pt4 tnm finding v7
urethral cancer pathologic regional lymph nodes tnm finding v7
urethral cancer pnx tnm finding v7
urethral cancer pn0 tnm finding v7
urethral cancer pn1 tnm finding v7
urethral cancer pn2 tnm finding v7
stage ii bladder urothelial carcinoma ajcc v6 and v7
urethral cancer pathologic distant metastasis tnm finding v7
urethral cancer pm1 tnm finding v7
urethral cancer clinical tnm finding v7
urethral cancer clinical distant metastasis tnm finding v7
urethral cancer cm0 tnm finding v7
urethral cancer cm1 tnm finding v7
adrenal cancer tnm finding v7
adrenal cancer pathologic tnm finding v7
adrenal cancer pathologic primary tumor tnm finding v7
adrenal cancer ptx tnm finding v7
toxin
stage iii bladder urothelial carcinoma ajcc v6 and v7
adrenal cancer pt0 tnm finding v7
adrenal cancer pt1 tnm finding v7
adrenal cancer pt2 tnm finding v7
adrenal cancer pt3 tnm finding v7
adrenal cancer pt4 tnm finding v7
adrenal cancer pathologic regional lymph nodes tnm finding v7
adrenal cancer pnx tnm finding v7
adrenal cancer pn0 tnm finding v7
adrenal cancer pn1 tnm finding v7
adrenal cancer pathologic distant metastasis tnm finding v7
stage iv bladder urothelial carcinoma ajcc v7
adrenal cancer pm1 tnm finding v7
adrenal cancer clinical tnm finding v7
adrenal cancer clinical distant metastasis tnm finding v7
adrenal cancer cm0 tnm finding v7
adrenal cancer cm1 tnm finding v7
ncpdp terminology
female reproductive system cancer tnm finding v7
vulvar cancer tnm finding v7
vulvar cancer pathologic primary tumor tnm finding v7
vulvar cancer ptx tnm finding v7
metastatic endometrial adenocarcinoma
vulvar cancer pt0 tnm finding v7
vulvar cancer ptis tnm finding v7
vulvar cancer pt1 tnm finding v7
vulvar cancer pt1a tnm finding v7
vulvar cancer pt1b tnm finding v7
vulvar cancer pt2 tnm finding v7
vulvar cancer pt3 tnm finding v7
vulvar cancer pathologic regional lymph nodes tnm finding v7
vulvar cancer pnx tnm finding v7
vulvar cancer pn0 tnm finding v7
metastatic endometrioid adenocarcinoma
vulvar cancer pn1 tnm finding v7
vulvar cancer pn1a tnm finding v7
vulvar cancer pn1b tnm finding v7
vulvar cancer pn2 tnm finding v7
vulvar cancer pn2a tnm finding v7
vulvar cancer pn2b tnm finding v7
vulvar cancer pn2c tnm finding v7
vulvar cancer pn3 tnm finding v7
vulvar cancer pathologic tnm finding v7
vulvar cancer pathologic distant metastasis tnm finding v7
metastatic vaginal adenocarcinoma
vulvar cancer pm1 tnm finding v7
vulvar cancer clinical tnm finding v7
vulvar cancer clinical distant metastasis tnm finding v7
vulvar cancer cm0 tnm finding v7
vulvar cancer cm1 tnm finding v7
stage 0 vulvar cancer ajcc v7
stage i vulvar cancer ajcc v7
stage ia vulvar cancer ajcc v7
stage ib vulvar cancer ajcc v7
metastatic prostate adenocarcinoma
talpidae family mole
stage ii vulvar cancer ajcc v7
stage iii vulvar cancer ajcc v7
stage iv vulvar cancer ajcc v7
stage iva vulvar cancer ajcc v7
vaginal cancer tnm finding v7
vaginal cancer pathologic tnm finding v7
vaginal cancer pathologic primary tumor tnm finding v7
vaginal cancer ptx tnm finding v7
vaginal cancer pt0 tnm finding v7
metastatic prostate carcinoma
vaginal cancer ptis tnm finding v7
vaginal cancer pt1 tnm finding v7
vaginal cancer pt2 tnm finding v7
vaginal cancer pt3 tnm finding v7
vaginal cancer pt4 tnm finding v7
vaginal cancer pathologic regional lymph nodes tnm finding v7
vaginal cancer pnx tnm finding v7
vaginal cancer pn0 tnm finding v7
vaginal cancer pn1 tnm finding v7
stage i prostate adenocarcinoma ajcc v7
vaginal cancer pathologic distant metastasis tnm finding v7
vaginal cancer pm1 tnm finding v7
vaginal cancer clinical tnm finding v7
vaginal cancer clinical distant metastasis tnm finding v7
vaginal cancer cm0 tnm finding v7
vaginal cancer cm1 tnm finding v7
stage 0 vaginal cancer ajcc v7
cervical cancer tnm finding v7
cervical cancer clinical tnm finding v7
cervical cancer clinical primary tumor tnm finding v7
stage ii prostate adenocarcinoma ajcc v7
cervical cancer ctx tnm finding v7
cervical cancer ct0 tnm finding v7
cervical cancer ctis tnm finding v7
cervical cancer ct1 tnm finding v7
cervical cancer ct1b tnm finding v7
cervical cancer ct1b1 tnm finding v7
cervical cancer ct1b2 tnm finding v7
cervical cancer ct2 tnm finding v7
cervical cancer ct2a tnm finding v7
cervical cancer ct2a1 tnm finding v7
stage iii prostate adenocarcinoma ajcc v7
cervical cancer ct2a2 tnm finding v7
cervical cancer ct2b tnm finding v7
cervical cancer ct3 tnm finding v7
cervical cancer ct3a tnm finding v7
cervical cancer ct3b tnm finding v7
cervical cancer ct4 tnm finding v7
cervical cancer clinical regional lymph nodes tnm finding v7
cervical cancer cnx tnm finding v7
cervical cancer cn0 tnm finding v7
cervical cancer cn1 tnm finding v7
chromomycin a3
stage iv prostate adenocarcinoma ajcc v7
cervical cancer clinical distant metastasis tnm finding v7
cervical cancer cm0 tnm finding v7
cervical cancer cm1 tnm finding v7
cervical cancer pathologic tnm finding v7
cervical cancer pathologic primary tumor tnm finding v7
prenatal and pediatric terminology
newborn screening terminology
ncpdp dea schedule terminology
ncpdp strength form terminology
ncpdp strength unit of measure terminology
stage iiia lung adenosquamous carcinoma ajcc v7
ncpdp quantity unit of measure terminology
barlow's maneuver
heel to ear measurement
palmar crease examination
neonatal abstinence syndrome assessment
neuromuscular maturity assessment
ortolani maneuver
physical maturity assessment
popliteal angle measurement
stage iiib lung adenosquamous carcinoma ajcc v7
square window
scarf sign
cervical cancer ptx tnm finding v7
cervical cancer pt0 tnm finding v7
cervical cancer ptis tnm finding v7
cervical cancer pt1 tnm finding v7
cervical cancer pt1a tnm finding v7
cervical cancer pt1a1 tnm finding v7
adhesive device
cervical cancer pt1a2 tnm finding v7
recurrent lung carcinoma
cervical cancer pt1b tnm finding v7
weld device
cervical cancer pt1b1 tnm finding v7
cervical cancer pt1b2 tnm finding v7
cervical cancer pt2 tnm finding v7
cervical cancer pt2a tnm finding v7
cervical cancer pt2a1 tnm finding v7
cervical cancer pt2a2 tnm finding v7
cervical cancer pt2b tnm finding v7
stage ii lung cancer ajcc v6
cervical cancer pt3 tnm finding v7
cervical cancer pt3a tnm finding v7
cervical cancer pt3b tnm finding v7
cervical cancer pt4 tnm finding v7
cervical cancer pathologic regional lymph nodes tnm finding v7
cervical cancer pnx tnm finding v7
cervical cancer pn0 tnm finding v7
cervical cancer pn1 tnm finding v7
cervical cancer pathologic distant metastasis tnm finding v7
cervical cancer pm1 tnm finding v7
rete testis adenocarcinoma
stage 0 cervical cancer ajcc v7
stage ii cervical cancer ajcc v7
stage iia cervical cancer ajcc v7
uterine corpus cancer tnm finding v7
uterine corpus carcinoma tnm finding v7
uterine corpus carcinoma pathologic tnm finding v7
uterine corpus carcinoma pathologic primary tumor tnm finding v7
uterine corpus carcinoma ptx tnm finding v7
uterine corpus carcinoma pt0 tnm finding v7
uterine corpus carcinoma ptis tnm finding v7
stage iv gastric cancer without metastasis
uterine corpus carcinoma pt1 tnm finding v7
uterine corpus carcinoma pt1a tnm finding v7
uterine corpus carcinoma pt1b tnm finding v7
uterine corpus carcinoma pt2 tnm finding v7
uterine corpus carcinoma pt3 tnm finding v7
uterine corpus carcinoma pt3a tnm finding v7
uterine corpus carcinoma pt3b tnm finding v7
uterine corpus carcinoma pt4 tnm finding v7
uterine corpus carcinoma pathologic regional lymph nodes tnm finding v7
uterine corpus carcinoma pnx tnm finding v7
uterine corpus carcinoma pn0 tnm finding v7
uterine corpus carcinoma pn1 tnm finding v7
uterine corpus carcinoma pn2 tnm finding v7
uterine corpus carcinoma pathologic distant metastasis tnm finding v7
uterine corpus carcinoma pm1 tnm finding v7
uterine corpus carcinoma clinical tnm finding v7
uterine corpus carcinoma clinical distant metastasis tnm finding v7
uterine corpus carcinoma cm0 tnm finding v7
uterine corpus carcinoma cm1 tnm finding v7
fixed - point number
uterine corpus sarcoma tnm finding v7
leiomyosarcoma and endometrial stromal sarcoma tnm finding v7
leiomyosarcoma and endometrial stromal sarcoma pathologic tnm finding v7
leiomyosarcoma and endometrial stromal sarcoma pathologic primary tumor tnm finding v7
leiomyosarcoma and endometrial stromal sarcoma ptx tnm finding v7
leiomyosarcoma and endometrial stromal sarcoma pt0 tnm finding v7
leiomyosarcoma and endometrial stromal sarcoma pt1 tnm finding v7
leiomyosarcoma and endometrial stromal sarcoma pt1a tnm finding v7
leiomyosarcoma and endometrial stromal sarcoma pt1b tnm finding v7
leiomyosarcoma and endometrial stromal sarcoma pt2 tnm finding v7
stage iv penile cancer ajcc v6
leiomyosarcoma and endometrial stromal sarcoma pt2a tnm finding v7
leiomyosarcoma and endometrial stromal sarcoma pt2b tnm finding v7
leiomyosarcoma and endometrial stromal sarcoma pt3 tnm finding v7
leiomyosarcoma and endometrial stromal sarcoma pt3a tnm finding v7
leiomyosarcoma and endometrial stromal sarcoma pt3b tnm finding v7
leiomyosarcoma and endometrial stromal sarcoma pt4 tnm finding v7
leiomyosarcoma and endometrial stromal sarcoma pathologic regional lymph nodes tnm finding v7
leiomyosarcoma and endometrial stromal sarcoma pnx tnm finding v7
leiomyosarcoma and endometrial stromal sarcoma pn0 tnm finding v7
leiomyosarcoma and endometrial stromal sarcoma pn1 tnm finding v7
trace element
hereditary kidney oncocytoma
leiomyosarcoma and endometrial stromal sarcoma pathologic distant metastasis tnm finding v7
leiomyosarcoma and endometrial stromal sarcoma pm1 tnm finding v7
leiomyosarcoma and endometrial stromal sarcoma clinical tnm finding v7
leiomyosarcoma and endometrial stromal sarcoma clinical distant metastasis tnm finding v7
leiomyosarcoma and endometrial stromal sarcoma cm0 tnm finding v7
leiomyosarcoma and endometrial stromal sarcoma cm1 tnm finding v7
adenosarcoma tnm finding v7
adenosarcoma pathologic tnm finding v7
adenosarcoma pathologic primary tumor tnm finding v7
adenosarcoma ptx tnm finding v7
fundic gland polyp
adenosarcoma pt0 tnm finding v7
adenosarcoma pt1 tnm finding v7
adenosarcoma pt1a tnm finding v7
adenosarcoma pt1b tnm finding v7
adenosarcoma pt1c tnm finding v7
adenosarcoma pt2 tnm finding v7
adenosarcoma pt2a tnm finding v7
adenosarcoma pt2b tnm finding v7
adenosarcoma pt3 tnm finding v7
adenosarcoma pt3a tnm finding v7
digestive system intraepithelial neoplasia
adenosarcoma pt3b tnm finding v7
adenosarcoma pt4 tnm finding v7
adenosarcoma pathologic regional lymph nodes tnm finding v7
adenosarcoma pnx tnm finding v7
adenosarcoma pn0 tnm finding v7
adenosarcoma pn1 tnm finding v7
adenosarcoma pathologic distant metastasis tnm finding v7
adenosarcoma pm1 tnm finding v7
adenosarcoma clinical tnm finding v7
adenosarcoma clinical distant metastasis tnm finding v7
stage iv fallopian tube cancer ajcc v6 and v7
adenosarcoma cm0 tnm finding v7
adenosarcoma cm1 tnm finding v7
stage 0 uterine corpus cancer ajcc v7
stage i uterine corpus cancer ajcc v7
stage ii uterine corpus cancer ajcc v7
stage iii uterine corpus cancer ajcc v7
stage iv uterine corpus cancer ajcc v7
ovarian cancer and primary peritoneal carcinoma tnm finding v7
ovarian cancer and primary peritoneal carcinoma pathologic tnm finding v7
ovarian cancer and primary peritoneal carcinoma pathologic primary tumor tnm finding v7
synovial neoplasm
ovarian cancer and primary peritoneal carcinoma ptx tnm finding v7
ovarian cancer and primary peritoneal carcinoma pt0 tnm finding v7
ovarian cancer and primary peritoneal carcinoma pt1 tnm finding v7
ovarian cancer and primary peritoneal carcinoma pt1a tnm finding v7
ovarian cancer and primary peritoneal carcinoma pt1b tnm finding v7
ovarian cancer and primary peritoneal carcinoma pt1c tnm finding v7
ovarian cancer and primary peritoneal carcinoma pt2 tnm finding v7
ovarian cancer and primary peritoneal carcinoma pt2a tnm finding v7
ovarian cancer and primary peritoneal carcinoma pt2b tnm finding v7
ovarian cancer and primary peritoneal carcinoma pt2c tnm finding v7
lymphangioma
ovarian cancer and primary peritoneal carcinoma pt3 tnm finding v7
ovarian cancer and primary peritoneal carcinoma pt3a tnm finding v7
ovarian cancer and primary peritoneal carcinoma pt3b tnm finding v7
ovarian cancer and primary peritoneal carcinoma pt3c tnm finding v7
ovarian cancer and primary peritoneal carcinoma pathologic regional lymph nodes tnm finding v7
ovarian cancer and primary peritoneal carcinoma pnx tnm finding v7
ovarian cancer and primary peritoneal carcinoma pn0 tnm finding v7
ovarian cancer and primary peritoneal carcinoma pn1 tnm finding v7
ovarian cancer and primary peritoneal carcinoma pathologic distant metastasis tnm finding v7
ovarian cancer and primary peritoneal carcinoma pm1 tnm finding v7
paraneoplastic opsoclonus ataxia
ovarian cancer and primary peritoneal carcinoma clinical tnm finding v7
ovarian cancer and primary peritoneal carcinoma clinical distant metastasis tnm finding v7
ovarian cancer and primary peritoneal carcinoma cm0 tnm finding v7
ovarian cancer and primary peritoneal carcinoma cm1 tnm finding v7
fallopian tube cancer tnm finding v7
fallopian tube cancer pathologic tnm finding v7
fallopian tube cancer pathologic primary tumor tnm finding v7
fallopian tube cancer ptx tnm finding v7
fallopian tube cancer pt0 tnm finding v7
fallopian tube cancer ptis tnm finding v7
brain iron accumulation type i syndrome
fallopian tube cancer pt1 tnm finding v7
fallopian tube cancer pt1a tnm finding v7
fallopian tube cancer pt1b tnm finding v7
fallopian tube cancer pt1c tnm finding v7
fallopian tube cancer pt2 tnm finding v7
fallopian tube cancer pt2a tnm finding v7
fallopian tube cancer pt2b tnm finding v7
fallopian tube cancer pt2c tnm finding v7
fallopian tube cancer pt3 tnm finding v7
fallopian tube cancer pt3a tnm finding v7
grade 2 follicular lymphoma
fallopian tube cancer pt3b tnm finding v7
fallopian tube cancer pt3c tnm finding v7
fallopian tube cancer pathologic regional lymph nodes tnm finding v7
fallopian tube cancer pnx tnm finding v7
fallopian tube cancer pn0 tnm finding v7
fallopian tube cancer pn1 tnm finding v7
fallopian tube cancer pathologic distant metastasis tnm finding v7
fallopian tube cancer pm1 tnm finding v7
fallopian tube cancer clinical tnm finding v7
fallopian tube cancer clinical distant metastasis tnm finding v7
parosteal osteosarcoma
fallopian tube cancer cm0 tnm finding v7
fallopian tube cancer cm1 tnm finding v7
stage iii fallopian tube cancer ajcc v7
gestational trophoblastic tumor tnm finding v7
gestational trophoblastic tumor pathologic tnm finding v7
gestational trophoblastic tumor pathologic primary tumor tnm finding v7
gestational trophoblastic tumor ptx tnm finding v7
gestational trophoblastic tumor pt0 tnm finding v7
gestational trophoblastic tumor pt1 tnm finding v7
gestational trophoblastic tumor pt2 tnm finding v7
recombinant transforming growth factor - alpha
periosteal osteosarcoma
gestational trophoblastic tumor pathologic distant metastasis tnm finding v7
gestational trophoblastic tumor pm1 tnm finding v7
gestational trophoblastic tumor pm1a tnm finding v7
gestational trophoblastic tumor pm1b tnm finding v7
gestational trophoblastic tumor clinical tnm finding v7
gestational trophoblastic tumor clinical distant metastasis tnm finding v7
gestational trophoblastic tumor cm0 tnm finding v7
gestational trophoblastic tumor cm1 tnm finding v7
gestational trophoblastic tumor cm1a tnm finding v7
gestational trophoblastic tumor cm1b tnm finding v7
embryonal rhabdomyosarcoma
digestive system cancer tnm finding v7
gnaq gene expression analysis
gna11 gene expression analysis
gnaq gene mutation
gna11 gene mutation
migraine
gtf3c6 gene
gna11 gene
gna11 wt allele
guanine nucleotide - binding protein subunit alpha - 11
uterine corpus undifferentiated sarcoma
esophagus and esophagogastric junction cancer tnm finding v7
esophagus and esophagogastric junction cancer pathologic tnm finding v7
gtf3c6 wt allele
general transcription factor 3c polypeptide 6
esophagus and esophagogastric junction cancer pathologic primary tumor tnm finding v7
esophagus and esophagogastric junction cancer ptx tnm finding v7
esophagus and esophagogastric junction cancer pt0 tnm finding v7
esophagus and esophagogastric junction cancer ptis tnm finding v7
esophagus and esophagogastric junction cancer pt1 tnm finding v7
metabolic equivalent of task
endometrioid stromal sarcoma
esophagus and esophagogastric junction cancer pt1a tnm finding v7
esophagus and esophagogastric junction cancer pt1b tnm finding v7
esophagus and esophagogastric junction cancer pt2 tnm finding v7
esophagus and esophagogastric junction cancer pt3 tnm finding v7
esophagus and esophagogastric junction cancer pt4 tnm finding v7
esophagus and esophagogastric junction cancer pt4a tnm finding v7
esophagus and esophagogastric junction cancer pt4b tnm finding v7
esophagus and esophagogastric junction cancer pathologic regional lymph nodes tnm finding v7
esophagus and esophagogastric junction cancer pnx tnm finding v7
esophagus and esophagogastric junction cancer pn0 tnm finding v7
esophagus and esophagogastric junction cancer pn1 tnm finding v7
esophagus and esophagogastric junction cancer pn2 tnm finding v7
esophagus and esophagogastric junction cancer pn3 tnm finding v7
esophagus and esophagogastric junction cancer pathologic distant metastasis tnm finding v7
esophagus and esophagogastric junction cancer pm1 tnm finding v7
esophagus and esophagogastric junction cancer clinical tnm finding v7
esophagus and esophagogastric junction cancer clinical distant metastasis tnm finding v7
esophagus and esophagogastric junction cancer cm0 tnm finding v7
esophagus and esophagogastric junction cancer cm1 tnm finding v7
alveolar ridge
malignant mixed mesodermal  ( mullerian )  tumor
gtf2h2 gene
gtf2h2 wt allele
gtf2h3 gene
gtf2h3 wt allele
gtf2h4 gene
gtf2h4 wt allele
gtf2h5 gene
gtf2h5 wt allele
general transcription factor iih subunit 2
general transcription factor iih subunit 3
general transcription factor iih subunit 4
general transcription factor iih subunit 5
mnat1 gene
mnat1 wt allele
cdk7 gene
cdk7 wt allele
ccnh gene
ccnh wt allele
cdk - activating kinase assembly factor mat1
cyclin - dependent kinase 7
cyclin - h
stage 0 esophageal cancer ajcc v7
parvovirus b19
subcutaneous mastectomy
streptococcus mitis
bleeding time
biotene dental chewing gum
translocation
chromosomal inversion process
holliday junction
mucinous adenofibroma
scalene lymph node
azygos lobe
hepatitis g infection
fresh frozen plasma
fuji lining lc
sublingual
garcinia cambogia extract
paracolic gutter
every six weeks
every six months
mucinous cystadenofibroma
every forty - eight hours
every thirty - six hours
anise oil
stage i esophageal cancer ajcc v7
stage ii esophageal cancer ajcc v7
stage iii esophageal cancer ajcc v7
family practice
american dental association
hygiene
xxxy syndrome
recombinant transforming growth factor - beta
functional residual capacity
xxyy syndrome
penta x syndrome
forehead
stage iv esophageal cancer ajcc v7
chin
buttock
scalp
federation of gynecology and obstetrics
tumor suppressor gene inactivation process
milk of calcium
territory
british columbia
prince edward island
new brunswick
colon carcinoma metastatic in the lung
northwest territories
nova scotia
yukon
alberta
bk virus
transurethral needle ablation of the prostate
gastric cancer tnm finding v7
transurethral microwave thermotherapy of the prostate
osmolality
trichomonas
iron polysaccharide
gastric cancer pathologic tnm finding v7
gastric cancer pathologic primary tumor tnm finding v7
gram per week
microgram per kilogram per week
gastric cancer pt1 tnm finding v7
gastric cancer pt1a tnm finding v7
gastric cancer pt1b tnm finding v7
gastric cancer pt2 tnm finding v7
postgraduate
residual volume
gastric cancer pt3 tnm finding v7
gastric cancer pt4 tnm finding v7
female reproductive system adenofibroma
gastric cancer pt4a tnm finding v7
gastric cancer pt4b tnm finding v7
airway
gastric cancer pathologic regional lymph nodes tnm finding v7
gastric cancer pn0 tnm finding v7
gastric cancer pn1 tnm finding v7
gastric cancer pn2 tnm finding v7
gastric cancer pn3 tnm finding v7
gastric cancer pn3a tnm finding v7
gastric cancer pn3b tnm finding v7
cystadenofibroma
gastric cancer pathologic distant metastasis tnm finding v7
gastric cancer clinical tnm finding v7
gastric cancer clinical distant metastasis tnm finding v7
gastric cancer cm0 tnm finding v7
gastric cancer cm1 tnm finding v7
2 -  ( indol - 3 - ylmethyl )  - 3 , 3' - diindolylmethane
stage i gastric cancer ajcc v7
alpha - naphthyl butyrate esterase
alpha - naphthyl acetate esterase
stage ii gastric cancer ajcc v7
papillary adenofibroma
stage iii gastric cancer ajcc v7
stage iv gastric cancer ajcc v7
small intestine cancer tnm finding v7
small intestine cancer pathologic tnm finding v7
small intestine cancer pathologic primary tumor tnm finding v7
small intestine cancer ptx tnm finding v7
small intestine cancer pt0 tnm finding v7
small intestine cancer ptis tnm finding v7
small intestine cancer pt1 tnm finding v7
small intestine cancer pt1a tnm finding v7
clear cell adenofibroma
small intestine cancer pt1b tnm finding v7
small intestine cancer pt2 tnm finding v7
small intestine cancer pt3 tnm finding v7
small intestine cancer pt4 tnm finding v7
small intestine cancer pathologic regional lymph nodes tnm finding v7
small intestine cancer pnx tnm finding v7
small intestine cancer pn0 tnm finding v7
small intestine cancer pn1 tnm finding v7
small intestine cancer pn2 tnm finding v7
small intestine cancer pathologic distant metastasis tnm finding v7
clear cell cystadenofibroma
small intestine cancer pm1 tnm finding v7
small intestine cancer clinical tnm finding v7
small intestine cancer clinical distant metastasis tnm finding v7
small intestine cancer cm0 tnm finding v7
small intestine cancer cm1 tnm finding v7
fetal stage
full term neonatal stage
preterm neonatal stage
infancy
oral neoplasm
toddler stage
appendiceal cancer tnm finding v7
appendiceal carcinoma tnm finding v7
appendiceal carcinoma pathologic tnm finding v7
appendiceal carcinoma pathologic primary tumor tnm finding v7
appendiceal carcinoma ptx tnm finding v7
appendiceal carcinoma pt0 tnm finding v7
appendiceal carcinoma ptis tnm finding v7
appendiceal carcinoma pt1 tnm finding v7
appendiceal carcinoma pt2 tnm finding v7
recombinant transforming growth factor
oral cavity carcinoma
appendiceal carcinoma pt3 tnm finding v7
appendiceal carcinoma pt4 tnm finding v7
appendiceal carcinoma pt4a tnm finding v7
appendiceal carcinoma pt4b tnm finding v7
appendiceal carcinoma pathologic regional lymph nodes tnm finding v7
appendiceal carcinoma pnx tnm finding v7
appendiceal carcinoma pn0 tnm finding v7
appendiceal carcinoma pn1 tnm finding v7
appendiceal carcinoma pn2 tnm finding v7
appendiceal carcinoma pathologic distant metastasis tnm finding v7
malignant mastocytosis
appendiceal carcinoma pm1 tnm finding v7
appendiceal carcinoma pm1a tnm finding v7
appendiceal carcinoma pm1b tnm finding v7
appendiceal carcinoma clinical tnm finding v7
appendiceal carcinoma clinical distant metastasis tnm finding v7
appendiceal carcinoma cm0 tnm finding v7
appendiceal carcinoma cm1 tnm finding v7
appendiceal carcinoma cm1a tnm finding v7
appendiceal carcinoma cm1b tnm finding v7
annotation type
appendiceal carcinoid tnm finding v7
appendiceal carcinoid pathologic tnm finding v7
appendiceal carcinoid pathologic primary tumor tnm finding v7
appendiceal carcinoid ptx tnm finding v7
appendiceal carcinoid pt0 tnm finding v7
appendiceal carcinoid pt1 tnm finding v7
appendiceal carcinoid pt1a tnm finding v7
appendiceal carcinoid pt1b tnm finding v7
appendiceal carcinoid pt2 tnm finding v7
appendiceal carcinoid pt3 tnm finding v7
ureter carcinoma
appendiceal carcinoid pt4 tnm finding v7
appendiceal carcinoid pathologic regional lymph nodes tnm finding v7
appendiceal carcinoid pnx tnm finding v7
appendiceal carcinoid pn0 tnm finding v7
appendiceal carcinoid pn1 tnm finding v7
appendiceal carcinoid pathologic distant metastasis tnm finding v7
appendiceal carcinoid pm1 tnm finding v7
appendiceal carcinoid clinical tnm finding v7
appendiceal carcinoid clinical distant metastasis tnm finding v7
appendiceal carcinoid cm0 tnm finding v7
malignant lymphoma centroblastic ,  follicular
appendiceal carcinoid cm1 tnm finding v7
colorectal cancer tnm finding v7
colorectal cancer pathologic tnm finding v7
colorectal cancer pathologic primary tumor tnm finding v7
colorectal cancer ptis tnm finding v7
colorectal cancer pt3 tnm finding v7
colorectal cancer pt4a tnm finding v7
colorectal cancer pt4b tnm finding v7
colorectal cancer pathologic regional lymph nodes tnm finding v7
colorectal cancer pn1 tnm finding v7
colorectal cancer pn1a tnm finding v7
colorectal cancer pn1b tnm finding v7
colorectal cancer pn1c tnm finding v7
colorectal cancer pn2 tnm finding v7
colorectal cancer pn2a tnm finding v7
colorectal cancer pn2b tnm finding v7
colorectal cancer pathologic distant metastasis tnm finding v7
colorectal cancer pm1a tnm finding v7
colorectal cancer pm1b tnm finding v7
cdisc send body weight gain test name terminology
cdisc send body weight gain test code terminology
cdisc send body weight test name terminology
cdisc send body weight test code terminology
cdisc send category for clinical observation terminology
cdisc send death diagnosis object of measurement terminology
cdisc send death diagnosis test name terminology
cdisc send death diagnosis test code terminology
cdisc send study design terminology
cdisc send standardized disposition term terminology
cdisc send food and water consumption test name terminology
blastoma
cdisc send food and water consumption test code terminology
cdisc send macroscopic findings test name terminology
cdisc send macroscopic findings test code terminology
cdisc send microscopic findings test name terminology
cdisc send microscopic findings test code terminology
cdisc send method of termination terminology
cdisc send organ measurement test name terminology
cdisc send organ measurement test code terminology
cdisc send subject characteristic test name terminology
cdisc send subject characteristic test code terminology
cdisc send version terminology
colorectal cancer clinical tnm finding v7
colorectal cancer clinical distant metastasis tnm finding v7
colorectal cancer cm0 tnm finding v7
colorectal cancer cm1 tnm finding v7
colorectal cancer cm1a tnm finding v7
colorectal cancer cm1b tnm finding v7
stage ii colorectal cancer ajcc v7
stage ii colon cancer ajcc v7
stage ii rectal cancer ajcc v7
stage ii rectosigmoid cancer ajcc v7
perceived stress scale
stage iii colorectal cancer ajcc v7
stage iii colon cancer ajcc v7
stage iii rectal cancer ajcc v7
stage iii rectosigmoid cancer ajcc v7
stage iv colorectal cancer ajcc v7
stage iv colon cancer ajcc v7
tretinoin
cdisc send severity terminology
cdisc send specimen spatial organization terminology
cdisc send study category terminology
cdisc send study type terminology
cdisc send tumor findings histopathology result category terminology
cdisc send tumor findings test name terminology
cdisc send tumor findings test code terminology
cdisc send trial summary parameter long name terminology
cdisc send trial summary parameter short name terminology
cdisc send trial set parameter terminology
cdisc send trial set parameter code terminology
cdisc send electrocardiogram category terminology
cdisc sdtm electrocardiogram lead terminology
stage iv rectal cancer ajcc v7
cdisc send microscopic histopathology result category terminology
cdisc send consciousness state terminology
stage iv rectosigmoid cancer ajcc v7
anal cancer tnm finding v7
anal cancer pathologic tnm finding v7
anal cancer pathologic primary tumor tnm finding v7
responsibility
anal cancer pathologic regional lymph nodes tnm finding v7
sometimes
anal cancer pathologic distant metastasis tnm finding v7
anal cancer clinical tnm finding v7
anal cancer clinical distant metastasis tnm finding v7
anal cancer cm0 tnm finding v7
adrenal cortex adenoma
anal cancer cm1 tnm finding v7
zc2hc1b gene
zc2hc1b wt allele
zinc finger c2hc domain - containing protein 1b
ncam2 gene
ncam2 wt allele
overcome
going well
saimiriine herpesvirus 2
neural cell adhesion molecule 2
benign adrenal cortex neoplasm
dclre1c gene
dclre1c wt allele
protein artemis
gastrointestinal stromal tumor tnm finding v7
gastrointestinal stromal tumor pathologic tnm finding v7
gastrointestinal stromal tumor pathologic primary tumor tnm finding v7
gastrointestinal stromal tumor ptx tnm finding v7
gastrointestinal stromal tumor pt0 tnm finding v7
gastrointestinal stromal tumor pt1 tnm finding v7
gastrointestinal stromal tumor pt2 tnm finding v7
malignant pancreatic neoplasm
gastrointestinal stromal tumor pt3 tnm finding v7
gastrointestinal stromal tumor pt4 tnm finding v7
gastrointestinal stromal tumor pathologic regional lymph nodes tnm finding v7
gastrointestinal stromal tumor pnx tnm finding v7
gastrointestinal stromal tumor pn0 tnm finding v7
gastrointestinal stromal tumor pn1 tnm finding v7
gastrointestinal stromal tumor pathologic distant metastasis tnm finding v7
gastrointestinal stromal tumor pm1 tnm finding v7
gastrointestinal stromal tumor clinical tnm finding v7
gastrointestinal stromal tumor clinical distant metastasis tnm finding v7
seborrheic keratosis
gastrointestinal stromal tumor cm0 tnm finding v7
gastrointestinal stromal tumor cm1 tnm finding v7
gastrointestinal neuroendocrine tumor tnm finding v7
gastrointestinal neuroendocrine tumor pathologic tnm finding v7
gastric neuroendocrine tumor pathologic primary tumor tnm finding v7
basal
gastric neuroendocrine tumor ptx tnm finding v7
tip
inverted follicular keratosis
gastric neuroendocrine tumor pt0 tnm finding v7
gastric neuroendocrine tumor ptis tnm finding v7
gastric neuroendocrine tumor pt1 tnm finding v7
gastric neuroendocrine tumor pt2 tnm finding v7
gastric neuroendocrine tumor pt3 tnm finding v7
gastric neuroendocrine tumor pt4 tnm finding v7
gastric neuroendocrine tumor pathologic regional lymph nodes tnm finding v7
gastric neuroendocrine tumor pnx tnm finding v7
gastric neuroendocrine tumor pn0 tnm finding v7
gastric neuroendocrine tumor pn1 tnm finding v7
gastric neuroendocrine tumor pathologic distant metastasis tnm finding v7
gastric neuroendocrine tumor pm1 tnm finding v7
duodenum / ampulla / jejunum / ileum neuroendocrine tumor pathologic primary tumor tnm finding v7
duodenum / ampulla / jejunum / ileum neuroendocrine tumor ptx tnm finding v7
duodenum / ampulla / jejunum / ileum neuroendocrine tumor pt0 tnm finding v7
duodenum / ampulla / jejunum / ileum neuroendocrine tumor pt1 tnm finding v7
duodenum / ampulla / jejunum / ileum neuroendocrine tumor pt2 tnm finding v7
duodenum / ampulla / jejunum / ileum neuroendocrine tumor pt3 tnm finding v7
myd88 gene
squamous papillomatosis
duodenum / ampulla / jejunum / ileum neuroendocrine tumor pt4 tnm finding v7
duodenum / ampulla / jejunum / ileum neuroendocrine tumor pathologic regional lymph nodes tnm finding v7
duodenum / ampulla / jejunum / ileum neuroendocrine tumor pnx tnm finding v7
duodenum / ampulla / jejunum / ileum neuroendocrine tumor pn0 tnm finding v7
duodenum / ampulla / jejunum / ileum neuroendocrine tumor pn1 tnm finding v7
myd88 wt allele
duodenum / ampulla / jejunum / ileum neuroendocrine tumor pathologic distant metastasis tnm finding v7
duodenum / ampulla / jejunum / ileum neuroendocrine tumor pm1 tnm finding v7
colon or rectum neuroendocrine tumor pathologic primary tumor tnm finding v7
colon or rectum neuroendocrine tumor ptx tnm finding v7
triamcinolone
myeloid differentiation primary response protein myd88
snca gene
colon or rectum neuroendocrine tumor pt0 tnm finding v7
colon or rectum neuroendocrine tumor pt1 tnm finding v7
colon or rectum neuroendocrine tumor pt1a tnm finding v7
colon or rectum neuroendocrine tumor pt1b tnm finding v7
colon or rectum neuroendocrine tumor pt2 tnm finding v7
colon or rectum neuroendocrine tumor pt3 tnm finding v7
colon or rectum neuroendocrine tumor pt4 tnm finding v7
colon or rectum neuroendocrine tumor pathologic regional lymph nodes tnm finding v7
dermoid cyst
colon or rectum neuroendocrine tumor pnx tnm finding v7
colon or rectum neuroendocrine tumor pn0 tnm finding v7
colon or rectum neuroendocrine tumor pn1 tnm finding v7
snca wt allele
colon or rectum neuroendocrine tumor pathologic distant metastasis tnm finding v7
colon or rectum neuroendocrine tumor pm1 tnm finding v7
gastrointestinal neuroendocrine tumor clinical tnm finding v7
gastric neuroendocrine tumor clinical distant metastasis tnm finding v7
alpha - synuclein
gastric neuroendocrine tumor cm0 tnm finding v7
gastric neuroendocrine tumor cm1 tnm finding v7
duodenum / ampulla / jejunum / ileum neuroendocrine tumor clinical distant metastasis tnm finding v7
slitrk1 gene
duodenum / ampulla / jejunum / ileum neuroendocrine tumor cm0 tnm finding v7
slitrk1 wt allele
duodenum / ampulla / jejunum / ileum neuroendocrine tumor cm1 tnm finding v7
colon or rectum neuroendocrine tumor clinical distant metastasis tnm finding v7
slit and ntrk - like protein 1
colon or rectum neuroendocrine tumor cm0 tnm finding v7
colon or rectum neuroendocrine tumor cm1 tnm finding v7
hdc gene
hdc wt allele
histidine decarboxylase
slc4a7 gene
slc4a7 wt allele
sodium bicarbonate cotransporter 3
cox11 gene
cox11 wt allele
cytochrome c oxidase assembly protein cox11 ,  mitochondrial
rad51b gene
rad51b wt allele
dna repair protein rad51 homolog 2
nlk gene
liver cancer tnm finding v7
mature teratoma
nlk wt allele
liver cancer pathologic tnm finding v7
liver cancer pathologic primary tumor tnm finding v7
serine / threonine - protein kinase nlk
liver cancer ptx tnm finding v7
liver cancer pt0 tnm finding v7
liver cancer pt1 tnm finding v7
aids - related plasmablastic lymphoma of the oral mucosa
liver cancer pt2 tnm finding v7
liver cancer pt3a tnm finding v7
liver cancer pt3b tnm finding v7
liver cancer pt4 tnm finding v7
liver cancer pathologic regional lymph nodes tnm finding v7
liver cancer pnx tnm finding v7
liver cancer pn0 tnm finding v7
liver cancer pn1 tnm finding v7
liver cancer pathologic distant metastasis tnm finding v7
persistent disease
aids - related primary effusion lymphoma
liver cancer pm1 tnm finding v7
liver cancer clinical tnm finding v7
liver cancer clinical distant metastasis tnm finding v7
liver cancer cm0 tnm finding v7
liver cancer cm1 tnm finding v7
abtb2 gene
abtb2 wt allele
ankyrin repeat and btb / poz domain - containing protein 2
acute myeloid leukemia with inv ( 16 )  ( p13 .1q22 )  ;  cbfb - myh11
stage iii hepatocellular carcinoma ajcc v7
stage iv hepatocellular carcinoma ajcc v7
intrahepatic bile duct cancer tnm finding v7
intrahepatic bile duct cancer pathologic tnm finding v7
intrahepatic bile duct cancer pathologic primary tumor tnm finding v7
intrahepatic bile duct cancer ptx tnm finding v7
intrahepatic bile duct cancer pt0 tnm finding v7
intrahepatic bile duct cancer ptis tnm finding v7
intrahepatic bile duct cancer pt1 tnm finding v7
intrahepatic bile duct cancer pt2 tnm finding v7
acute myeloid leukemia with t ( 16 ; 16 )  ( p13 .1 ; q22 )  ;  cbfb - myh11
intrahepatic bile duct cancer pt2a tnm finding v7
intrahepatic bile duct cancer pt2b tnm finding v7
intrahepatic bile duct cancer pt3 tnm finding v7
intrahepatic bile duct cancer pt4 tnm finding v7
intrahepatic bile duct cancer pathologic regional lymph nodes tnm finding v7
intrahepatic bile duct cancer pnx tnm finding v7
intrahepatic bile duct cancer pn0 tnm finding v7
intrahepatic bile duct cancer pn1 tnm finding v7
intrahepatic bile duct cancer pathologic distant metastasis tnm finding v7
intrahepatic bile duct cancer pm1 tnm finding v7
triazene compound
acute myelomonocytic leukemia with abnormal eosinophils
intrahepatic bile duct cancer clinical tnm finding v7
intrahepatic bile duct cancer clinical distant metastasis tnm finding v7
intrahepatic bile duct cancer cm0 tnm finding v7
intrahepatic bile duct cancer cm1 tnm finding v7
gallbladder cancer tnm finding v7
gallbladder cancer pathologic tnm finding v7
gallbladder cancer pathologic primary tumor tnm finding v7
gallbladder cancer ptx tnm finding v7
gallbladder cancer pathologic regional lymph nodes tnm finding v7
gallbladder cancer pn1 tnm finding v7
gallbladder cancer pn2 tnm finding v7
gallbladder cancer pathologic distant metastasis tnm finding v7
gallbladder cancer clinical tnm finding v7
gallbladder cancer clinical distant metastasis tnm finding v7
gallbladder cancer cm0 tnm finding v7
gallbladder cancer cm1 tnm finding v7
stage i gallbladder cancer ajcc v7
stage ii gallbladder cancer ajcc v7
stage iii gallbladder cancer ajcc v7
stage iv gallbladder cancer ajcc v7
childhood astrocytic tumor
perihilar bile duct cancer tnm finding v7
perihilar bile duct cancer pathologic tnm finding v7
perihilar bile duct cancer pathologic primary tumor tnm finding v7
perihilar bile duct cancer ptx tnm finding v7
perihilar bile duct cancer pt0 tnm finding v7
perihilar bile duct cancer ptis tnm finding v7
perihilar bile duct cancer pt1 tnm finding v7
perihilar bile duct cancer pt2 tnm finding v7
perihilar bile duct cancer pt2a tnm finding v7
perihilar bile duct cancer pt2b tnm finding v7
sarcoma by fnclcc grade
perihilar bile duct cancer pt3 tnm finding v7
perihilar bile duct cancer pt4 tnm finding v7
perihilar bile duct cancer pathologic regional lymph nodes tnm finding v7
perihilar bile duct cancer pnx tnm finding v7
perihilar bile duct cancer pn0 tnm finding v7
perihilar bile duct cancer pn1 tnm finding v7
perihilar bile duct cancer pn2 tnm finding v7
perihilar bile duct cancer pathologic distant metastasis tnm finding v7
perihilar bile duct cancer pm1 tnm finding v7
perihilar bile duct cancer clinical tnm finding v7
fnclcc sarcoma grade 1
perihilar bile duct cancer clinical distant metastasis tnm finding v7
perihilar bile duct cancer cm0 tnm finding v7
perihilar bile duct cancer cm1 tnm finding v7
distal bile duct cancer tnm finding v7
distal bile duct cancer pathologic tnm finding v7
distal bile duct cancer pathologic primary tumor tnm finding v7
distal bile duct cancer ptx tnm finding v7
distal bile duct cancer pt0 tnm finding v7
distal bile duct cancer ptis tnm finding v7
distal bile duct cancer pt1 tnm finding v7
well differentiated fibrosarcoma
distal bile duct cancer pt2 tnm finding v7
distal bile duct cancer pt3 tnm finding v7
distal bile duct cancer pt4 tnm finding v7
distal bile duct cancer pathologic regional lymph nodes tnm finding v7
distal bile duct cancer pnx tnm finding v7
distal bile duct cancer pn0 tnm finding v7
distal bile duct cancer pn1 tnm finding v7
distal bile duct cancer pathologic distant metastasis tnm finding v7
distal bile duct cancer pm1 tnm finding v7
nichd terminology
low grade malignant peripheral nerve sheath tumor
distal bile duct cancer clinical tnm finding v7
distal bile duct cancer clinical distant metastasis tnm finding v7
distal bile duct cancer cm0 tnm finding v7
distal bile duct cancer cm1 tnm finding v7
ampulla of vater cancer tnm finding v7
ampulla of vater cancer pathologic tnm finding v7
ampulla of vater cancer pathologic primary tumor tnm finding v7
ampulla of vater cancer ptx tnm finding v7
ampulla of vater cancer pt0 tnm finding v7
ampulla of vater cancer ptis tnm finding v7
grade i chondrosarcoma
ampulla of vater cancer pt1 tnm finding v7
ampulla of vater cancer pt2 tnm finding v7
ampulla of vater cancer pt3 tnm finding v7
ampulla of vater cancer pt4 tnm finding v7
ampulla of vater cancer pathologic regional lymph nodes tnm finding v7
ampulla of vater cancer pnx tnm finding v7
ampulla of vater cancer pn0 tnm finding v7
ampulla of vater cancer pn1 tnm finding v7
ampulla of vater cancer pathologic distant metastasis tnm finding v7
ampulla of vater cancer pm1 tnm finding v7
fnclcc sarcoma grade 2
ampulla of vater cancer clinical tnm finding v7
ampulla of vater cancer clinical distant metastasis tnm finding v7
ampulla of vater cancer cm0 tnm finding v7
ampulla of vater cancer cm1 tnm finding v7
exocrine and endocrine pancreatic cancer tnm finding v7
exocrine and endocrine pancreatic cancer pathologic tnm finding v7
exocrine and endocrine pancreatic cancer pathologic primary tumor tnm finding v7
exocrine and endocrine pancreatic cancer ptx tnm finding v7
exocrine and endocrine pancreatic cancer pt0 tnm finding v7
exocrine and endocrine pancreatic cancer ptis tnm finding v7
fnclcc sarcoma grade 3
exocrine and endocrine pancreatic cancer pt1 tnm finding v7
pi3ka / mtor inhibitor pki - 179
exocrine and endocrine pancreatic cancer pt2 tnm finding v7
exocrine and endocrine pancreatic cancer pt3 tnm finding v7
exocrine and endocrine pancreatic cancer pt4 tnm finding v7
exocrine and endocrine pancreatic cancer pathologic regional lymph nodes tnm finding v7
exocrine and endocrine pancreatic cancer pnx tnm finding v7
exocrine and endocrine pancreatic cancer pn0 tnm finding v7
exocrine and endocrine pancreatic cancer pn1 tnm finding v7
exocrine and endocrine pancreatic cancer pathologic distant metastasis tnm finding v7
triaziquone
high grade malignant peripheral nerve sheath tumor
exocrine and endocrine pancreatic cancer pm1 tnm finding v7
exocrine and endocrine pancreatic cancer clinical tnm finding v7
exocrine and endocrine pancreatic cancer clinical distant metastasis tnm finding v7
exocrine and endocrine pancreatic cancer cm0 tnm finding v7
exocrine and endocrine pancreatic cancer cm1 tnm finding v7
plac8 gene
plac8 wt allele
placenta - specific gene 8 protein
fam13a gene
fam13a wt allele
poorly differentiated angiosarcoma
protein fam13a
prkn gene
prkn wt allele
e3 ubiquitin - protein ligase parkin
adam8 gene
adam8 wt allele
disintegrin and metalloproteinase domain - containing protein 8
dll4 gene
dll4 wt allele
delta - like protein 4
ann arbor stage i adult hodgkin lymphoma
ctsk gene
ctsk wt allele
cathepsin k
type of valve dysfunction
nek10 gene
nek10 wt allele
serine / threonine - protein kinase nek10
lgals7 gene
lgals7 wt allele
lgals7b gene
ann arbor stage ii adult hodgkin lymphoma
lgals7b wt allele
galectin - 7
muc5ac gene
muc5ac wt allele
mucin - 5ac
mass description
euthanasia method
maternal life stage
maternal postnatal stage
maternal prenatal stage
ann arbor stage iii adult hodgkin lymphoma
maternal preconception stage
pediatric intervention or procedure
developmental milestone
renal cell cancer by ajcc v6 stage
bladder cancer by ajcc v6 stage
vulvar cancer by ajcc v6 stage
behavior during childhood
vaginal cancer by ajcc v6 stage
prostate bed
10 lead standard
ann arbor stage iv adult hodgkin lymphoma
6 lead standard
accidental death
age text
alternate identifier
alternate study identifier
anesthesia and cervical dislocation euthanasia
anesthesia and decapitation euthanasia
anesthesia and exsanguination euthanasia
anesthesia and intravenous potassium chloride euthanasia
associated study
stage iv gastric cancer ajcc v6
augmented vector foot
augmented vector left
augmented vector right
average body weight gain
basal diet
bedding change
bedding material
bifurcation
blocked study
carbon dioxide euthanasia
stage i anal canal cancer ajcc v6 and v7
central nervous system pharmacology
cervical dislocation
class of trial agent
clinical trial agent
clinical trial quality assurance report
decapitation
dorsolateral
drinking water
duration of dosing
end date time of dose interval
occult lung non - small cell carcinoma
environmental temperature
environmental temperature units
experiment end date
feeding regimen
food consumption
food consumption relative to body weight
fore
found dead
gastrointestinal pharmacology
good laboratory practice type
cervical carcinoma
gross pathologic examination
group label
hair coat color
hind
housing group
housing humidity
housing humidity units
housing type
iacuc number
interim sacrifice period
trifluoperazine hydrochloride
adult angiosarcoma
intraperitoneal barbiturate overdose euthanasia
intravenous barbiturate overdose euthanasia
latin square study
lead site av6
lead site cm5
lead site cv5rl
lead site cv6ll
lead site cv6lu
lead site i
lead site ii
childhood infratentorial ependymoma
lead site iii
lead site rv2
lead site v1
lead site v10
lead site v2
lead site v3
lead site v4
lead site v5
lead site v6
light cycle
childhood brain stem glioma
mass consistency
mass hair cover
method of identification
method of termination of life
microscopic examination
moribund sacrifice
organ to body weight ratio
organ to brain weight ratio
organ to heart weight ratio
organ weight
childhood supratentorial ependymoma
p wave abnormality by ecg finding
p wave notched by ecg finding
partially blocked balanced study
partially blocked unbalanced study
percentage body weight gain
physical marking
interim sacrifice
planned number of female subjects
planned number of male subjects
project license number
metastatic parathyroid gland carcinoma
qrs complex abnormality by ecg finding
qrs complex absent by ecg finding
qtcv  -  van de water's correction formula
r wave abnormality by ecg finding
r wave notched by ecg finding
recovery sacrifice
recovery sacrifice period
removed from study alive
reproductive and developmental toxicology
respiratory pharmacology
recurrent childhood central nervous system neoplasm
respiratory sinus arrhythmia by ecg finding
s wave abnormality by ecg finding
safety pharmacology
send version 3 .0 draft a
send version 3 .0 draft b
set label
sponsor defined group code
sponsor reference identifier
standard for the exchange of nonclinical data implementation guide version
start date time of dose interval
recurrent childhood hepatocellular carcinoma
strain substrain details
study category
clinical study end date
study sponsor monitor
terminal body weight
terminal sacrifice
terminal sacrifice period
test facility country
test facility location
test facility name
childhood intraocular retinoblastoma
test site country
test site location
test site name
test subject supplier
test subject supplier site
titration study
total tissue
toxicokinetic description
toxicokinetics
tumor examination
childhood extraocular retinoblastoma
unconstrained body movement
unscheduled death
unspecified state of consciousness
ventricular escape beat by ecg finding
water consumption
water consumption relative to body weight
water delivery
experiment start date
commd1 gene
commd1 wt allele
extensive stage lung small cell carcinoma
comm domain - containing protein 1
pregnancy outcome
personal information
cervical cancer by ajcc v6 stage
uterine corpus cancer by ajcc v6 stage
elliptinium
arm recoil test
galeazzi test
risk factor assessment
fallopian tube cancer by ajcc v6 stage
trifluridine
recurrent lung small cell carcinoma
esophageal cancer by ajcc v6 stage
labored breathing
unlabored
subordinate
glomerular filtration rate
colorectal cancer by ajcc v6 stage
colon cancer by ajcc v6 stage
rectal cancer by ajcc v6 stage
rectosigmoid cancer by ajcc v6 stage
stage ii vulvar cancer ajcc v6
hepatocellular carcinoma by ajcc v6 stage
gallbladder cancer by ajcc v6 stage
breast cancer by ajcc v6 stage
cutaneous melanoma by ajcc v6 stage
citizen
us citizen
non - us citizen
lung cancer by ajcc v6 stage
stage iii vulvar cancer ajcc v6
penile cancer by ajcc v6 stage
prostate cancer by ajcc v6 stage
nasopharyngeal carcinoma by ajcc v6 stage
oropharyngeal carcinoma by ajcc v6 stage
hypopharyngeal carcinoma by ajcc v6 stage
pharyngeal carcinoma by ajcc v6 stage
laryngeal cancer by ajcc v6 stage
sinonasal cancer by ajcc v6 stage
ajcc v6 stage
stage iv vulvar cancer ajcc v6
ajcc v7 stage
nicotine lozenge
ensituximab
tlr9 agonist emd 1201081
protein stabilized liposomal docetaxel nanoparticles
photocyanine
purple grape juice
plasmid encoding antiangiogenic metargidin peptide
carrot / jilin ginseng / licorice root / tangerine peel / soy beverage
dm - choc - pen
recurrent vulvar carcinoma
allogeneic gm - csf - based myeloma cell vaccine
briciclib sodium
adenovirus - p53 transduced dendritic cell vaccine
dcr ligand - bearing liposome - encapsulated melanoma antigens vaccine
fluorouracil implant
opcs / green tea / spirullina / curcumin / antrodia camphorate / fermented soymilk extract capsule
darleukin
ruxotemitide
sapanisertib
lactobacillus plantarum strain 299v
bartholin gland carcinoma
lactobacillus plantarum strain 299
anti - egp - 2 immunotoxin moc31 - pe
bi - shrna - furin / gm - csf - expressing autologous tumor cell vaccine
multikinase inhibitor 4sc - 203
mipsagargin
cea / tetanus toxoid t helper epitope fusion protein - expressing dna plasmid vaccine
carbon c 14 ombrabulin
eg5 kinesin - related motor protein inhibitor 4sc - 205
alvac - eso - 1 vaccine
ny - eso - 1 reactive tcr retroviral vector transduced autologous pbl
ann arbor stage i childhood lymphoblastic lymphoma
autologous trimix - dc melanoma vaccine
calendula officinalis / plantago major / cochlearia armoracia / hamamelis virginiana herbal toothpaste
asunercept
oncolytic hsv - 1 rrp450
capmatinib
buparlisib
hla - a*2402 - restricted urlc10 - cdca1 - kif20a multipeptide vaccine
parsatuzumab
hla - a*2402 - restricted cdca1 - kif20a multipeptide vaccine
hla - a2 - binding tyr / mart - 1 / gp100 multipeptide - pulsed autologous dendritic cell vaccine
ann arbor stage ii childhood lymphoblastic lymphoma
hla - a1 - binding mage - 1 / mage - 3 multipeptide - pulsed autologous dendritic cell vaccine
autologous melanoma lysate - pulsed autologous dendritic cell vaccine
autologous melanoma lysate / klh - pulsed autologous dendritic cell vaccine
jak2 inhibitor xl019
xevinapant
zirconium zr 89 trastuzumab
copper cu 64 - dota - trastuzumab
allogeneic il13 - zetakine / hytk - expressing - glucocorticoid resistant cytotoxic t lymphocytes grm13z40 - 2
isatuximab
anti - her2 monoclonal antibody ct - p6
ann arbor stage iii childhood lymphoblastic lymphoma
fluorine f - 18 fluoropaclitaxel
akt inhibitor mk2206
orteronel
anti - a33 monoclonal antibody krn330
indole - 3 - carbinol / calcium / schizandra / vitamin d3 / milk thistle / stinging nettle / lignan - based nutritional capsule
aurora a kinase inhibitor mk5108
oleandrin
brincidofovir
stat3 inhibitor opb - 31121
egfr / her2 kinase inhibitor tak - 285
ann arbor stage iv childhood lymphoblastic lymphoma
anti - cd20 monoclonal antibody pro131921
c - met inhibitor mk2461
amolimogene bepiplasmid
idarubicin - eluting beads
topoisomerase i inhibitor lmp400
topoisomerase i inhibitor lmp776
multiplication
pustular rash
junctional epidermolysis bullosa
bronchopulmonary dysplasia
triglycerides
recurrent childhood lymphoblastic lymphoma
root eminence
abutment screw
central america
medication administered at birth
triceps brachii
leukemogenic
tumstatin
cert1 gene
cert1 wt allele
optic chiasm
penile carcinoma
gosogliptin
metronidazole phosphate
adult burkitt lymphoma
lometrexol sodium
malignant testicular germ cell tumor
mirabegron
bluensomycin
butikacin
micronomicin
ribostamycin
localized resectable adult hepatocellular carcinoma
localized unresectable adult hepatocellular carcinoma
beloranib
pegaptanib
recurrent adult hepatocellular carcinoma
recurrent childhood acute myeloid leukemia
pancreatic gastrin - producing neuroendocrine tumor
spectinomycin hydrochloride anhydrous
spectinomycin sulfate
spectinomycin sulfate tetrahydrate
liothyronine
recurrent chronic myelogenous leukemia ,  bcr - abl1 positive
dabigatran etexilate mesylate
otamixaban
stage 0 uterine corpus cancer ajcc v6
vilazodone
recurrent uterine corpus cancer
basifungin
stage ii testicular cancer ajcc v6 and v7
pyronaridine
stage iii testicular cancer ajcc v6 and v7
octapinol
teglarinad
stage iv prostate cancer ajcc v6
childhood diffuse large cell lymphoma
amithiozone
refractory malignant testicular germ cell tumor
opiniazide
rifametane
terizidone
amantadine sulfate
amenamevir
lagociclovir
omaciclovir
talviraline
valtorcitabine dihydrochloride
vidarabine phosphate
childhood immunoblastic lymphoma
trimethoprim
noninvasive malignant thymoma
stage i thyroid gland papillary carcinoma ajcc v7
stage ii thyroid gland papillary carcinoma ajcc v7
ceftazidime anhydrous
ceftizoxime alapivoxil
stage iv thyroid gland papillary carcinoma ajcc v7
ambuside
tizolemide
stage i thyroid gland follicular carcinoma ajcc v7
stage ii thyroid gland follicular carcinoma ajcc v7
anti - inhibitor coagulant complex
coagulation factor viia human
stage iv thyroid gland follicular carcinoma ajcc v7
crilvastatin
kaposi sarcoma
lincomycin hydrochloride anhydrous
iris melanoma
small size posterior uveal melanoma
trimethoprim - sulfamethoxazole
medium / large size posterior uveal melanoma
adult brain stem glioma
adult ependymoma
eptaplatin
adult meningioma
flutemetamol f 18
adult glioblastoma
motretinide
childhood burkitt lymphoma
stage iv cutaneous melanoma ajcc v6 and v7
recurrent cutaneous melanoma
tanexaban
stage 0 nasopharyngeal carcinoma ajcc v6 ,  v7 ,  and v8
nifurtoinol
trypan blue
stage 0 laryngeal cancer ajcc v6 ,  v7 ,  and v8
stage 0 hypopharyngeal carcinoma ajcc v6 ,  v7 ,  and v8
metenkefalin
niravoline
nifurquinazol
omiganan pentahydrochloride
atigliflozin
canagliflozin
canagliflozin anhydrous
stage iiia lung non - small cell cancer ajcc v7
gliamilide
lobeglitazone
metahexamide
remogliflozin etabonate
tifenazoxide
boxidine
boxidine hydrochloride
canosimibe
octimibate
stage iiib lung non - small cell cancer ajcc v7
oxfenicine
terbufibrol
aspirin dl - lysine
stage 0 lung non - small cell cancer ajcc v6 and v7
oropharyngeal carcinoma
ulipristal
ulipristal acetate
torcetrapib
urethral carcinoma
centimeters of water
segmentectomy
image quantification
video recording
suboptimal
macro
hsp90 inhibitor snx - 5422 mesylate
non - parameningeal head and neck area
childhood solid neoplasm
collagen type iv alpha - 3 - binding protein
fluorine f 18 choline
ipatasertib
ascrinvacumab
oxaliplatin - encapsulated transferrin - conjugated n - glutaryl phosphatidylethanolamine liposome
topical phenylephrine solution
mva - ebna1 / lmp2 vaccine
therapeutic breast / ovarian / prostate peptide cancer vaccine dpx - 0907
ublituximab
smac mimetic lcl161
cenp - e inhibitor gsk - 923295
aurora b / c kinase inhibitor gsk1070916a
maitake mushroom extract
uracil ointment
ferric carboxymaltose solution
heat - treated varicella - zoster virus vaccine v212
milatuzumab - doxorubicin antibody - drug conjugate immu - 110
docetaxel - pnp
autologous il - 21 - modulated cd8 +  mart1 - specific t cells
smoothened antagonist leq506
carboxyamidotriazole orotate
anti - her2 - car autologous cmv - specific cytotoxic t - lymphocytes
anti - melanin monoclonal antibody pti - 6d2
anti - cd123 monoclonal antibody csl360
balixafortide
allogeneic cytomegalovirus - specific cytotoxic t lymphocytes
recombinant attenuated salmonella typhimurium expressing il - 2
met tyrosine kinase inhibitor emd 1204831
sodium metaarsenite
deuterium oxide
tubercidin
blast phase chronic myelogenous leukemia ,  bcr - abl1 positive
emvododstat
ncpdp measurement unit code terminology
clinical or research assessment question
clinical or research assessment questionnaire
clinical or research assessment answer
young adult
middle adult
able to work
meningeal chronic myelogenous leukemia ,  bcr - abl1 positive
accepted illness
trouble meeting family needs because of physical condition
bothered by side effects of treatment
feel close to friends
content with quality of life
emotional support from family
able to enjoy life
enjoy things for fun
family accepts illness
satisfied with family communication
classic kaposi sarcoma
forced to be in bed
feel ill
lacks energy
losing hope against illness
have nausea
feel nervous
have pain
feel close to partner
satisfied with sex life
feel sad
kaposi sarcoma related to immunosuppressive treatment
satisfied with coping with illness
milligram per five milliliters
microgram per fifteen milliliters
microgram per three days
augmented gel dosage form
bar soap dosage form
buccal film dosage form
powder inhaler dosage form
extended release enteric coated capsule dosage form
extended release enteric coated tablet dosage form
inhalant powder dosage form
inhalant solution dosage form
medicated bar soap dosage form
medicated liquid soap dosage form
medicated shampoo dosage form
medicated tape dosage form
metered dose inhaler dosage form
mucosal spray dosage form
childhood acute myeloid leukemia in remission
mucous membrane topical solution dosage form
nasal cream dosage form
nasal gel dosage form
nasal inhalant dosage form
nasal inhaler dosage form
nasal ointment dosage form
nasal solution dosage form
nasal spray dosage form
nasal suspension dosage form
ophthalmic cream dosage form
ophthalmic gel dosage form
ophthalmic irrigation solution dosage form
ophthalmic ointment dosage form
ophthalmic solution dosage form
ophthalmic suspension dosage form
oral capsule dosage form
oral cream dosage form
oral foam dosage form
oral gel dosage form
oral ointment dosage form
recurrent neck squamous cell carcinoma of unknown primary
oral paste dosage form
oral powder dosage form
oral spray dosage form
oral strip dosage form
otic cream dosage form
otic ointment dosage form
otic solution dosage form
otic suspension dosage form
topical powder spray dosage form
prefilled applicator dosage form
sarcoma
prefilled syringe dosage form
rectal foam dosage form
rectal gel dosage form
rectal powder dosage form
rectal spray dosage form
toothpaste dosage form
topical cream dosage form
topical foam dosage form
topical gel dosage form
breast medullary carcinoma
topical lotion dosage form
topical oil dosage form
topical ointment dosage form
topical powder dosage form
topical spray dosage form
urethral gel dosage form
vaginal gel dosage form
vaginal powder dosage form
vaginal ring dosage form
tumor antigen
pancreatic ductal adenocarcinoma
vaginal spray dosage form
renal cell cancer by ajcc v7 stage
bladder cancer by ajcc v7 stage
vulvar cancer by ajcc v7 stage
vaginal cancer by ajcc v7 stage
sleeping well
receive support from friends
cervical cancer by ajcc v7 stage
work is fulfilling
stage iii thyroid gland follicular carcinoma ajcc v7
worry about worsening condition
worry about dying
not at all
a little bit
somewhat
quite a bit
very much
uterine corpus cancer by ajcc v7 stage
fallopian tube cancer by ajcc v7 stage
stage iii thyroid gland papillary carcinoma ajcc v7
french - american - british classification
esophageal cancer by ajcc v7 stage
gastric cancer by ajcc v7 stage
colorectal cancer by ajcc v7 stage
colon cancer by ajcc v7 stage
rectal cancer by ajcc v7 stage
rectosigmoid cancer by ajcc v7 stage
auto - injector dosage form
hepatocellular carcinoma by ajcc v7 stage
gallbladder cancer by ajcc v7 stage
breast cancer by ajcc v7 stage
cutaneous melanoma by ajcc v7 stage
lung cancer by ajcc v7 stage
prostate cancer by ajcc v7 stage
penile cancer by ajcc v7 stage
subjective numeracy scale
words or numbers for chance events
how good calculating 15 percent tip
how good calculating 25 percent off
how good at fractions
childhood lymphoblastic lymphoma
how good at percentages
how useful tables and graphs accompanying newspaper or other text
how useful numerical information
words or percentages for weather forecast
nasopharyngeal carcinoma by ajcc v7 stage
very often
oropharyngeal carcinoma by ajcc v7 stage
not at all good
adult lymphocyte - depleted classic hodgkin lymphoma
extremely good
hypopharyngeal carcinoma by ajcc v7 stage
pharyngeal carcinoma by ajcc v7 stage
always prefer words
always prefer numbers or percentages
sinonasal cancer by ajcc v7 stage
laryngeal cancer by ajcc v7 stage
plagl2 gene
plagl2 wt allele
zinc finger protein plagl2
adult nodular sclerosis classic hodgkin lymphoma
snai1 gene
snai1 wt allele
zinc finger protein snai1
lmo1 gene
lmo1 wt allele
rhombotin - 1
trip12 gene
trip12 wt allele
probable e3 ubiquitin - protein ligase trip12
lig1 gene
adult mixed cellularity classic hodgkin lymphoma
lig1 wt allele
dynamic extension
dynamic extension class
dna ligase 1
metaphone
hpse2 gene
hpse2 wt allele
heparanase - 2
dohh gene
philadelphia chromosome positive ,  bcr - abl1 positive chronic myelogenous leukemia
dohh wt allele
deoxyhypusine hydroxylase
siae gene
siae wt allele
sialate o - acetylesterase
polh gene
polh wt allele
dna polymerase eta
pnpt1 gene
pnpt1 wt allele
philadelphia chromosome negative ,  bcr - abl1 positive chronic myelogenous leukemia
polyribonucleotide nucleotidyltransferase 1 ,  mitochondrial
likert score 2
likert score 3
likert score 4
likert score 5
ace gene
ace wt allele
angiotensin - converting enzyme
dpp4 gene
dpp4 wt allele
recombinant tumor necrosis factor - alpha
adult rhabdomyosarcoma
dipeptidyl peptidase 4
breast mucinous carcinoma
invasive breast carcinoma of no special type with predominant intraductal component
lung adenosquamous carcinoma
f5 gene
f5 wt allele
f5 leiden allele
coagulation factor v
magea11 gene
magea11 wt allele
melanoma - associated antigen 11
date of first ever onset of angina pectoris
breast papillary  carcinoma
date of first ever onset of heart failure
date of heart failure prompting medical attention
date of most recent heart failure
date of resuscitated cardiac arrest
date time of angina pectoris prompting medical attention
date time of most recent angina pectoris
date time of onset of angina pectoris
eif4ebp1 gene
eif4ebp1 wt allele
eukaryotic translation initiation factor 4e - binding protein 1
breast tubular carcinoma
rps6 gene
rps6 wt allele
40s ribosomal protein s6
eif5a gene
eif5a wt allele
eukaryotic translation initiation factor 5a - 1
msi2 gene
msi2 wt allele
rna - binding protein musashi homolog 2
rad17 gene
invasive breast lobular carcinoma with predominant in situ component
rad17 wt allele
cell cycle checkpoint protein rad17
lalba gene
lalba wt allele
alpha - lactalbumin
zorubicin
fzd1 gene
fzd1 wt allele
frizzled - 1
ackr3 gene
combined lung small cell carcinoma
ackr3 wt allele
atypical chemokine receptor 3
indirect antiglobulin test
adenoviral vector ad5 - cea ( 6d )  vaccine
therapeutic allogeneic cytotoxic t - lymphocytes
ciclopirox olamine oral
anti - vegf anticalin prs - 050 - peg40
gm2 / gd2 / gd3 lactone - klh conjugate trivalent vaccine
alpha - fetoprotein peptide - pulsed autologous dendritic cell vaccine
leukemic apoptotic corpse - pulsed autologous dendritic cells
melanoma trp2 ctl epitope vaccine scib1
futuximab / modotuximab mixture
narnatumab
anti - gd2 monoclonal antibody morab - 028
flanvotumab
belimumab
anti - pgf monoclonal antibody ro5323441
parp inhibitor e7016
oprozomib
iodine i 131 anti - fibronectin antibody fragment l19 - sip
rhenium re - 188 ethiodized oil
deuterated 3 - methylhistidine
prexasertib
p70s6k inhibitor ly2584702
jak2 inhibitor azd1480
f16 - il2 fusion protein
medication error due to application program problem
data problem
patient data problem
bidi
tumor promoter
childhood b acute lymphoblastic leukemia
kretek
ginseng
ginseng root
positron emission tomography drug production
proximal muscle
distal muscle
inequality
piritrexim isethionate
mitoguazone dihydrochloride
non - t non - b calla positive childhood acute lymphoblastic leukemia
adult t acute lymphoblastic leukemia
adult b acute lymphoblastic leukemia
non - t non - b calla positive adult acute lymphoblastic leukemia
osteosarcoma
epithelial predominant kidney wilms tumor
blastema predominant kidney wilms tumor
stromal predominant kidney wilms tumor
mixed cell type kidney wilms tumor
l - tyrosine
botryoid - type embryonal rhabdomyosarcoma
lentigo maligna melanoma
low - csd melanoma
adult acute erythroid leukemia
adult acute myeloid leukemia
adult acute promyelocytic leukemia with pml - rara
adult acute monoblastic leukemia
gastric intestinal - type adenocarcinoma
childhood acute myeloid leukemia without maturation
gastric diffuse adenocarcinoma
coenzyme q10
childhood acute myeloid leukemia
anal squamous cell carcinoma
childhood acute monoblastic leukemia
childhood acute monocytic leukemia
childhood acute erythroid leukemia
childhood acute eosinophilic leukemia
gallbladder adenocarcinoma
gallbladder undifferentiated carcinoma
rectal signet ring cell adenocarcinoma
gallbladder adenocarcinoma with squamous metaplasia
gallbladder squamous cell carcinoma
oncolytic newcastle disease virus mth - 68h
zanolimumab
pegargiminase
galactomannan derivative
chinese herbal formulation phy906
kanglaite
fluorine f - 18 6 - fluorodopamine
autologous gm - csf - secreting lethally irradiated pancreatic cancer vaccine
dotap:cholesterol - fus1 liposome complex
urokinase - derived peptide a6
mage - a3 peptide vaccine
trebananib
donor lymphocytes
mouse renal adenocarcinoma cell - encapsulated agarose - agarose macrobeads
immunotherapeutic gsk1572932a
inactivated poliovirus vaccine
diphtheria toxoid / tetanus toxoid / acellular pertussis adsorbed ,  recombinant hepatitis b / inactivated poliovirus vaccine combined
diphtheria toxoid / tetanus toxoid / acellular pertussis vaccine adsorbed
diphtheria toxoid / tetanus toxoid vaccine adsorbed
ae37 peptide / gm - csf vaccine
testicular mixed embryonal carcinoma and yolk sac tumor with seminoma
gp2 peptide / gm - csf vaccine
anti - nucleolin aptamer as1411
4 - peptide melanoma vaccine
p - cadherin antagonist pf - 03732010
mdm2 antagonist ro5045337
adavosertib
saponin - based immunoadjuvant obi - 821
tabalumab
vesencumab
testicular mixed choriocarcinoma and seminoma
apitolisib
gedatolisib
margetuximab
vocimagene amiretrorepvec
simtuzumab
prexigebersen
technetium tc - 99m glycopeptide
nsclc antigen - loaded dendritic cell - derived exosomes
phaleria macrocarpa extract dlbs - 1425
childhood angiosarcoma
middle ear carcinoma in situ
mpo gene
mpo wt allele
zranb2 gene
zranb2 wt allele
rbl1 gene
rbl1 wt allele
retinoblastoma - like protein 1
ppara gene
bowel obstruction
ppara wt allele
peroxisome proliferator - activated receptor alpha
patient noncompliance
defb103a gene
defb103a wt allele
defb103b gene
defb103b wt allele
beta - defensin 103
asulacrine
eritoran tetrasodium
non - metastatic gestational trophoblastic tumor
transport pathway
extremely helpful
restrictive lung disease
siah2 gene
siah2 wt allele
e3 ubiquitin - protein ligase siah2
llgl1 gene
llgl1 wt allele
lethal ( 2 )  giant larvae protein homolog 1
arpc1b gene
good prognosis metastatic gestational trophoblastic tumor
arpc1b wt allele
actin - related protein 2 / 3 complex subunit 1b
bbc3 gene
bbc3 wt allele
bcl - 2 - binding component 3
rasa1 gene
rasa1 wt allele
ras gtpase - activating protein 1
emotional well - being
physical well - being
poor prognosis metastatic gestational trophoblastic tumor
functional well - being
how true
immune hemolytic anemia
tyrer - cuzick model
breast and ovarian analysis of disease incidence and carrier estimation algorithm
runx2 gene
runx2 wt allele
runt - related transcription factor 2
runx3 gene
runx3 wt allele
stage iv uterine sarcoma ajcc v7
runt - related transcription factor 3
tp63 gene
tp63 wt allele
tumor protein 63
tfap4 gene
tfap4 wt allele
transcription factor ap - 4
srf gene
srf wt allele
serum response factor
uracil mustard
uterine corpus carcinosarcoma
cdrh cause investigation  -  type of investigation terminology
cdrh cause investigation  -  investigation findings terminology
cdrh cause investigation  -  investigation conclusion terminology
globule unit
recurrent carcinoma of unknown primary
pigeon
quail
chinchillidae
chinchilla
mastomys
yucatan micropig
yucatan minipig
sinclair minipig
desmoid - type fibromatosis
thumbnail
drug pathway
homeostasis regulation pathway
pappa gene
pappa wt allele
pappalysin - 1
abdominoperineal resection
ampullectomy
bilobectomy
bland embolization
adult intracranial solitary fibrous tumor / hemangiopericytoma ,  grade 3
central hepatectomy
completion pneumonectomy
wire - guided localization
feeding tube
fundoplication
hyperthermic intraperitoneal chemotherapy
nasogastric intubation
pelvic exenteration
sigmoidectomy
supracricoid laryngectomy
primary intraocular non - hodgkin lymphoma
transoral laser microsurgery
urinary diversion
streptococcus dysgalactiae subsp dysgalactiae
ann arbor stage i childhood burkitt lymphoma
transoral laser surgery  ( glottis )
fus gene
fus wt allele
rna - binding protein fus
bcl11b gene
bcl11b wt allele
b - cell lymphoma / leukemia 11b
adam10 gene
adam10 wt allele
ann arbor stage ii childhood burkitt lymphoma
disintegrin and metalloproteinase domain - containing protein 10
dclre1b gene
dclre1b wt allele
5' exonuclease apollo
mknk2 gene
mknk2 wt allele
map kinase - interacting serine / threonine - protein kinase 2
conclusion not yet available
cause traced to device design
ann arbor stage iii childhood burkitt lymphoma
device difficult to operate
adverse event related to patient condition
failure to follow instructions
cause traced to user
cause traced to infrastructure
known inherent risk of device
cause traced to labeling
ann arbor stage iv childhood burkitt lymphoma
cause traced to maintenance
manufacturing deficiency
cause traced to manufacturing
cause traced to training
recurrent childhood burkitt lymphoma
cause traced to intentional off - label ,  unapproved ,  or contraindicated use
reuse of single use device
no problem detected
unintended use error caused or contributed to event
testing of actual / suspected device
recurrent childhood brain stem glioma
recurrent childhood cerebral astrocytoma
device electrical evaluation method
ovarian carcinosarcoma
ann arbor stage ii contiguous adult burkitt lymphoma
device from same lot evaluated evaluation method
ann arbor stage ii grade 1 non - contiguous follicular lymphoma
ann arbor stage ii grade 2 non - contiguous follicular lymphoma
ann arbor stage ii grade 3 non - contiguous follicular lymphoma
stage ii non - contiguous adult diffuse small cleaved cell lymphoma
analysis of production records
ann arbor stage ii non - contiguous mantle cell lymphoma
stage ii non - contiguous adult diffuse mixed cell lymphoma
device software verification evaluation method
urethane
ann arbor stage ii non - contiguous adult burkitt lymphoma
ann arbor stage ii mantle cell lymphoma
device agglutination problem
assembly problem identified
biocompatibility problem identified
breakthrough pain
biological problem identified
device carcinogenic problem
communications problem identified
complement activation problem
device migration problem identified
conducted interference
configuration issue
data compression error
stage i cervical cancer ajcc v6 and v7
deformation problem
degradation problem identified
design error
dust or dirt problem identified
current leakage problem
electrical problem identified
electromagnetic compatibility problem identified
electrostatic discharge problem
end of life problem identified
endotoxin contamination
stage iii cervical cancer ajcc v6 and v7
energy storage system problem
environment problem identified
failure to calibrate identified
device fatigue problem
biological contamination
device fracture problem
device friction problem identified
device genotoxicity problem identified
gradient induced field problem
hardware timing problem identified
stage iv cervical cancer ajcc v6 and v7
device hematologic problem identified
environmental humidity problem identified
image artifact
impedance problem identified
device improper composition / concentration
inappropriate device material
incompatible component / accessory
installation problem identified
insulation problem identified
interface design error
stage i uterine corpus cancer ajcc v6
interoperability problem identified
labeling and instructions for use / maintenance
loss of power identified
lubrication problem identified
magnetically induced
maintenance problem identified
manufacturing process problem identified
material or material leachate pyrogenic problem
material and / or chemistry problem identified
mechanical problem identified
stage ii uterine corpus cancer ajcc v6
mechanical shock problem
microbial contamination
mutagenic problem
no device problem found
no findings available
non - functional defect
open circuit
operational problem identified
optical problem identified
stage iii uterine corpus cancer ajcc v6
optical transmission problem identified
packaging compromised
packaging problem identified
platelet activation problem
power fluctuation
power source problem identified
protective system problem identified
quality control deficiency
uricosuric agent
stage i esophageal cancer ajcc v6
radiofrequency induced overheating
radiofrequency interference identified
clinical imaging problem identified
reactivity problem identified
reproductive toxicity problem identified
shelf life / expiration date exceeded
transport problem identified
short circuit
signal loss
stage ii esophageal cancer ajcc v6
software installation problem identified
software problem identified
software requirement error
software runtime error
software security vulnerability
software timing problem
stiffness problem identified
storage problem identified
stage iii esophageal cancer ajcc v6
stress problem identified
molecular structure problem
thermal problem
problem due to thrombosis activation
tolerance stack - up
vibration problem
stage iv esophageal cancer ajcc v6
wear problem
wired communication problem
wireless communication problem identified
improper physical structure
environmental temperature problem identified
inadequate device immunity
incorrect labeling and / or instructions for use
inadequate labeling and / or instructions for use
incompatible material
stage i adrenal cortex carcinoma ajcc v7
incorrect data definition
incorrect algorithm
results pending completion of investigation
dazap1 gene
dazap1 wt allele
daz - associated protein 1
tbx5 gene
tbx5 wt allele
stage ii adrenal cortex carcinoma ajcc v7
t - box transcription factor tbx5
pelp1 gene
pelp1 wt allele
proline -  ,  glutamic acid -  and leucine - rich protein 1
mef2a gene
mef2a wt allele
myocyte - specific enhancer factor 2a
mef2b gene
mef2b wt allele
myocyte - specific enhancer factor 2b
stage iii adrenal cortex carcinoma ajcc v7
activation of membrane attack complex
mef2c gene
mef2c wt allele
myocyte - specific enhancer factor 2c
mef2d gene
mef2d wt allele
clonal deletion
myocyte - specific enhancer factor 2d
cefozopran hydrochloride
stage iv adrenal cortex carcinoma ajcc v7
ciclopirox olamine lotion
egfr activating mutation
foxd3 gene
foxd3 wt allele
forkhead box protein d3
atf1 gene
atf1 wt allele
cyclic amp - dependent transcription factor atf - 1
stage iv oropharyngeal carcinoma ajcc v6
rat sertoliform tubular adenoma
benign adrenal gland composite pheochromocytoma
intraocular schwannoma
rat pars intermedia carcinoma
malignant adrenal gland composite pheochromocytoma
esophageal malignant peripheral nerve sheath tumor
intraocular malignant peripheral nerve sheath tumor
pericardial adenomatoid tumor
seasonal allergic rhinitis
perennial allergic rhinitis
pediatric psychiatric disorder
adjustment disorder
e - z notation
e isomer
z isomer
cognitive disorder
dissociative disorder
factitious disorder
mental disorder due to a general medical condition
uridine
stage iii renal cell cancer ajcc v6
mood disorder
schizophrenia and other psychotic disorders
sexual and gender identity disorders
substance - related disorder
modified rankin scale
trail making test
short limb dwarfism - saddle nose - spinal alterations - metaphyseal striation syndrome
stage unknown
extraperitoneal space
intercept
recurrent childhood malignant germ cell tumor
rescale
inferior cervical ganglion
middle cervical ganglion
superior cervical ganglion
trigeminal ganglion / trigeminal nerve
submandibular gland / sublingual gland
seminal vesicle / coagulating gland
rectum / anus
lung / bronchus
hereditary papillary renal cell carcinoma
brachial lymph node
gastric lymph node
best case imputation technique
best observation carried forward imputation technique
rsr' by ecg finding
borderline qtcb
borderline qtcf
left ventricular conduction delay by ecg finding
paced atrial and ventricular rhythm
paced atrial rhythm
paced ventricular rhythm
right ventricular conduction delay by ecg finding
sjogren's ss - a antibody measurement
sjogren's ss - b antibody measurement
trichomonas screening
yeast hyphae screening
esophagitis
protein to osmolality ratio measurement
mycobacterium tuberculosis interferon gamma response
myeloid to erythroid ratio measurement
amorphous phosphate crystals measurement
amorphous urate crystals measurement
erythrocyte cell clumps measurement
leukocyte cell clumps measurement
acetoacetic acid measurement
citrate measurement
cotinine measurement
oxalate measurement
transitional epithelial cells measurement
alpha - 1 globulin measurement
alpha - 1 globulin to total protein ratio measurement
alpha - 2 globulin measurement
alpha - 2 globulin to total protein ratio measurement
beta globulin measurement
gamma globulin measurement
hemoglobin a measurement
hemoglobin a2 measurement
non - hematologic malignancy
hemoglobin b measurement
hemoglobin c measurement
hemoglobin f measurement
hiv - 1 group m and o nucleic acid measurement
hiv - 1 group o antibody measurement
hiv - 1 p24 antigen measurement
hiv - 2 nucleic acid measurement
1 ,  25 - dihydroxyvitamin d measurement
25 - hydroxyvitamin d measurement
anti - single stranded dna igg measurement
hypogonadism
extractable nuclear antigen antibody measurement
hepatitis a virus antibody igm measurement
hepatitis g rna measurement
influenza a h1n1 viral load measurement
influenza a viral load measurement
legionella pneumophila antigen measurement
legionella pneumophila igg antibody measurement
legionella pneumophila igg igm antibody measurement
legionella pneumophila igm antibody measurement
mycobacterium tuberculosis nucleic acid measurement
terminal disease
myeloperoxidase antibody measurement
smith antibody measurement
streptolysin o antibody measurement
type i myeloblasts measurement
type ii myeloblasts measurement
type iii myeloblasts measurement
acyl coenzyme a oxidase measurement
bone specific alkaline phosphatase measurement
carnitine acetyl transferase measurement
cholinesterase measurement
systemic disease
cystatin c measurement
monoclonal protein measurement
tryptase measurement
apolipoprotein e4 measurement
beta globulin to total protein ratio measurement
gamma globulin to total protein ratio measurement
erythrocyte cell morphology
leukocyte cell morphology
alcian blue staining method
vaccine
myelosuppression
luxol fast blue and cresyl violet staining method
lead citrate staining method
toluidine blue staining method
uranyl acetate staining method
alcian blue and periodic acid schiff staining method
auc dosing to last concentration normalized by weight
auc all normalized by dose
auc all normalized by surface area
auc all normalized by weight
auc dosing to last concentration normalized by body mass index
merkel cell carcinoma
auc dosing to last concentration normalized by dose
auc dosing to last concentration normalized by surface area
auc from t1 to t2 normalized by body mass index
auc from t1 to t2 normalized by dose
auc from t1 to t2 normalized by surface area
auc from t1 to t2 normalized by weight
auc infinity observed normalized by body mass index
auc infinity observed normalized by surface area
auc infinity observed normalized by weight
auc infinity predicted normalized by body mass index
weight change
auc infinity predicted normalized by surface area
auc infinity predicted normalized by weight
auc over dosing interval normalized by body mass index
auc over dosing interval normalized by dose
auc over dosing interval normalized by surface area
auc over dosing interval normalized by weight
aumc dosing to last concentration normalized by body mass index
aumc dosing to last concentration normalized by dose
aumc dosing to last concentration normalized by surface area
aumc dosing to last concentration normalized by weight
juvenile myelomonocytic leukemia
aumc infinity observed normalized by body mass index
aumc infinity observed normalized by dose
aumc infinity observed normalized by surface area
aumc infinity observed normalized by weight
aumc infinity predicted normalized by body mass index
aumc infinity predicted normalized by dose
aumc infinity predicted normalized by surface area
aumc infinity predicted normalized by weight
aumc over dosing interval normalized by body mass index
aumc over dosing interval normalized by dose
childhood spinal cord neoplasm
aumc over dosing interval normalized by surface area
aumc over dosing interval normalized by weight
aurc all normalized by body mass index
aurc all normalized by dose
aurc all normalized by surface area
aurc all normalized by weight
aurc dosing to last concentration normalized by body mass index
aurc dosing to last concentration normalized by dose
aurc dosing to last concentration normalized by surface area
aurc dosing to last concentration normalized by weight
systemic mastocytosis
aurc from t1 to t2 normalized by body mass index
aurc from t1 to t2 normalized by dose
aurc from t1 to t2 normalized by surface area
aurc from t1 to t2 normalized by weight
aurc infinity observed normalized by body mass index
aurc infinity observed normalized by dose
aurc infinity observed normalized by surface area
aurc infinity observed normalized by weight
aurc infinity predicted normalized by body mass index
aurc infinity predicted normalized by dose
paroxysmal hypertension
aurc infinity predicted normalized by surface area
aurc infinity predicted normalized by weight
auc all normalized by body mass index
amount recovered normalized by body mass index
amount recovered normalized by dose
amount recovered normalized by surface area
amount recovered normalized by weight
average concentration normalized by body mass index
average concentration normalized by dose
average concentration normalized by surface area
recurrent gastric carcinoma
average concentration normalized by weight
maximum concentration normalized by body mass index
maximum concentration normalized by surface area
maximum concentration normalized by weight
minimum concentration normalized by body mass index
minimum concentration normalized by dose
minimum concentration normalized by surface area
minimum concentration normalized by weight
concentration after the nth dose
concentration after the nth dose by body mass index
recurrent rectal carcinoma
concentration after the nth dose by dose
concentration after the nth dose by surface area
concentration after the nth dose by weight
initial concentration normalized by body mass index
initial concentration normalized by dose
initial concentration normalized by surface area
initial concentration normalized by weight
last concentration normalized by body mass index
last concentration normalized by dose
last concentration normalized by surface area
localized malignant mesothelioma
last concentration normalized by weight
last measurable excretion rate normalized by body mass index
last measurable excretion rate normalized by dose
last measurable excretion rate normalized by surface area
last measurable excretion rate normalized by weight
maximum observed excretion rate normalized by body mass index
maximum observed excretion rate normalized by dose
maximum observed excretion rate normalized by surface area
maximum observed excretion rate normalized by weight
total clearance observed by fraction dose normalized by body mass index
valinomycin
recurrent nasopharyngeal carcinoma
total clearance observed by fraction dose normalized by dose
total clearance observed by fraction dose normalized by surface area
total clearance observed by fraction dose normalized by weight
total clearance observed normalized by body mass index
total clearance observed normalized by dose
total clearance observed normalized by surface area
total clearance observed normalized by weight
volume of distribution observed normalized by body mass index
volume of distribution observed normalized by surface area
volume of distribution observed normalized by weight
recurrent hypopharyngeal carcinoma
volume of distribution of fraction dose observed normalized by body mass index
volume of distribution of fraction dose observed normalized by surface area
volume of distribution of fraction dose observed normalized by weight
percent recovered normalized by body mass index
percent recovered normalized by dose
percent recovered normalized by surface area
percent recovered normalized by weight
total clearance predicted by fraction dose normalized by body mass index
total clearance predicted by fraction dose normalized by dose
total clearance predicted by fraction dose normalized by surface area
malignant colon neoplasm
total clearance predicted by fraction dose normalized by weight
total clearance predicted normalized by body mass index
total clearance predicted normalized by dose
total clearance predicted normalized by surface area
total clearance predicted normalized by weight
volume of distribution predicted normalized by body mass index
volume of distribution predicted normalized by surface area
volume of distribution predicted normalized by weight
volume of distribution of fraction dose predicted normalized by body mass index
volume of distribution of fraction dose predicted normalized by surface area
hypertension - associated pregnancy disorder
volume of distribution of fraction dose predicted normalized by weight
randomization ratio
chlamydia pneumoniae iga antibody measurement
chlamydia pneumoniae igm antibody measurement
sublingual lymph node
mesentery / peritoneum
uterus / cervix
small colon
spiral colon
large colon
aggressive non - hodgkin lymphoma
mesovarium
skin / subcutaneous tissue
vocabulary
receptive vocabulary
productive vocabulary
voice handicap index
phonation
audiogram
invasive breast carcinoma
discrimination
conflicts tactics scale ,  parent - child
conflicts tactics scale 2
organization
interpersonal relationship
healthy environment
healthy food environment
job decision latitude
concentrated disadvantage
psychological demand
stage iiib breast  inflammatory carcinoma
race / ethnic residential segregation
non - word repetition
grammatical impairment
receptive vocabulary assessment
word decoding
braf v600k mutation analysis
braf v600k mutation present
mir93 gene
mir93 wt allele
matched tissues
bladder granuloma
faap24 gene
faap24 wt allele
faap100 gene
faap100 wt allele
fanci gene
fanci wt allele
fancl gene
fancl wt allele
fan1 gene
fan1 wt allele
silicon granuloma
fanconi anemia core complex - associated protein 24
fanconi anemia core complex - associated protein 100
fanconi anemia group i protein
e3 ubiquitin - protein ligase fancl
fanconi - associated nuclease 1
endobronchial lesion
explanation of off label use
breed trait
length of time between product exposure and onset of adverse event symptom
recurrent aids - related anal canal carcinoma
tp53inp1 gene
tp53inp1 wt allele
tumor protein p53 - inducible nuclear protein 1
vash1 gene
vash1 wt allele
vasohibin - 1
cbx2 gene
cbx2 wt allele
chromobox protein homolog 2
ube2c gene
vancomycin
recurrent anaplastic large cell lymphoma
ube2c wt allele
ubiquitin - conjugating enzyme e2 c
nme5 gene
nme5 wt allele
nucleoside diphosphate kinase homolog 5
azgp1 gene
azgp1 wt allele
zinc - alpha - 2 - glycoprotein
pip gene
pip wt allele
recurrent non - hodgkin lymphoma
prolactin - inducible protein
sphk1 gene
sphk1 wt allele
sphingosine kinase 1
vascular endothelial growth factor measurement
mta1 gene
mta1 wt allele
metastasis - associated protein mta1
sik2 gene
sik2 wt allele
ann arbor stage i aggressive adult non - hodgkin lymphoma
serine / threonine - protein kinase sik2
aatf gene
aatf wt allele
protein aatf
denr gene
denr wt allele
density - regulated protein
lgtn gene
lgtn wt allele
ligatin
recurrent pericardial malignant mesothelioma
arid1a gene
arid1a wt allele
at - rich interactive domain - containing protein 1a
soluble vascular cell adhesion molecule 1
hepatitis a antibody measurement
hepatitis c antibody measurement
ppp2r1a gene
ppp2r1a wt allele
serine / threonine - protein phosphatase 2a 65 kda regulatory subunit a alpha isoform
ddit3 gene
recurrent malignant hemangiopericytoma
ddit3 wt allele
hepatitis a viral load measurement
hepatitis b viral load measurement
hepatitis c viral load measurement
hiv viral load measurement
dna damage - inducible transcript 3 protein
ffar4 gene
ffar4 wt allele
free fatty acid receptor 4
multifocal glioblastomas
recurrent ureter carcinoma
glioneuronal tumor with neuropil - like islands
islands of neuropil - like matrix present
angiocentric glioma
ependymal differentiation
papillary glioneuronal tumor
extraventricular neurocytoma
legally marketed unapproved new animal drugs for minor species
pca3 gene
pca3 wt allele
prostate cancer antigen 3
gastroesophageal reflux
developmental coordination disorder
expressive language disorder
mixed receptive - expressive language disorder
phonological disorder
oppositional defiant disorder
pica eating disorder
rumination disorder
encopresis
selective mutism
stage iii lung large cell carcinoma ajcc v7
unit of spread rate of substance by volume
measurement unit description
hsp90 inhibitor debio 0932
psa - pap / klh - pulsed autologous dendritic cell vaccine
apalutamide
onatasertib
 [ 18f ] l - fac
pamrevlumab
survivin mrna antagonist ezn - 3042
roniciclib
technetium tc 99m - labeled albumin microspheres
liposomal docetaxel
epacadostat
polyethylene glycol recombinant endostatin
iron isomaltoside 1000
e . coli cd - expressing genetically modified neural stem cells
recombinant prame protein plus as15 adjuvant gsk2302025a
plk1 inhibitor tak - 960
dna interference oligonucleotide pnt2258
thiarabine
aggravated granuloma annulare
anti - ags - 5 antibody - drug conjugate asg - 5me
braf ( v600e )  kinase inhibitor ro5212054
obex region
gill
subiliac lymph node
ovary / oviduct
catheter site
thoracolumbar region
caudal vein
8 - iso prostaglandin f2alpha  ( 8 - iso - pgf2a )
argipressin
actinomycotic granuloma
oropharyngeal tissue
common peroneal nerve
deep peroneal nerve
superficial peroneal nerve
patient in body sling
macelignan
fenoterol hydrobromide
nanomole per minute per milliliter
cells per millimeter squared
kilonewton per centimeter squared
milliequivalent per millimole
part per million per volume
unit per millimole
job strain
recurrent malignant oral neoplasm
panic attack
acute stress disorder
generalized anxiety disorder
substance - induced anxiety disorder
papillary tumor of the pineal region
anaplastic medulloblastoma
strand displacement amplification
cytokine panel 12
multi - analyte fluorescent detection
central nervous system ganglioneuroblastoma
recurrent malignant duodenal neoplasm
paranoid personality disorder
schizoid personality disorder
schizotypal personality disorder
borderline personality disorder
histrionic personality disorder
narcissistic personality disorder
avoidant personality disorder
dependent personality disorder
obsessive - compulsive personality disorder
delirium due to a general medical condition
recurrent hepatocellular carcinoma
substance intoxication delirium
substance withdrawal delirium
amnestic disorder due to a general medical condition
substance - induced persisting amnestic disorder
nonclinical study type
study agent cas registry number
study agent unique ingredient identifier
malignant peripheral nerve sheath tumor with mesenchymal differentiation
body weight measurement
mass color assessment
mycosis fungoides and sezary syndrome
observer
processor
meningeal solitary fibrous tumor / hemangiopericytoma ,  grade 3
other experiencer
footpad
cpq gene
cpq wt allele
carboxypeptidase q
mtdh gene
mtdh wt allele
recurrent malignant bladder neoplasm
protein lyric
microrna synthesis
dgcr8 gene
dgcr8 wt allele
microprocessor complex subunit dgcr8
sparc gene
sparc wt allele
sparc
slc1a2 gene
stage 0a bladder urothelial carcinoma ajcc v6 and v7
slc1a2 wt allele
excitatory amino acid transporter 2
zyx gene
zyx wt allele
zyxin
wee1 gene
wee1 wt allele
wee1 - like protein kinase
cyld gene
before breakfast
recurrent malignant nasopharyngeal neoplasm
cyld wt allele
before lunch
before dinner
ubiquitin carboxyl - terminal hydrolase cyld
between breakfast and lunch
between lunch and dinner
between dinner and bedtime
after breakfast
mta2 gene
mta2 wt allele
recurrent malignant endocervical neoplasm
metastasis - associated protein mta2
honorary title
voice
mthfd1l gene
mthfd1l wt allele
monofunctional c1 - tetrahydrofolate synthase ,  mitochondrial
malat1 gene
malat1 wt allele
metastasis - associated lung adenocarcinoma transcript 1
tcl1a gene
drug vehicle
advanced malignant neoplasm
tcl1a wt allele
t - cell leukemia / lymphoma protein 1a
brd4 gene
brd4 wt allele
bromodomain - containing protein 4
nutm1 gene
nutm1 wt allele
nut family member 1
capsule
postoperative hypertension
fetal finding
nichd pregnancy and childbirth terminology
fetal attitude
fetal examination
fetal heart finding
fetal heart rate
fetal station
finding during childbirth labor
fetal disorder
salivary gland carcinoma
pregnancy finding
pregnancy related screening test
qualitative concept
stage of labor
fetal presentation
abnormal fetal attitude
abnormal pregnancy
alcohol related birth defect
alcohol related neurodevelopmental disorder
amnioinfusion
angular pregnancy
antepartum
anterior occiput presentation
appropriate for gestational age
artificial rupture of membrane
assessment of fetal attitude
assessment of fetal heart condition
assessment of fetal presentation
assisted labor
back labor
cardiac granuloma
bacterial vaginosis screening
baseline fetal heart rate
bradley method
birthing labor
blood glucose measurement
blood protein measurement
breast engorgement
bulging perineum
cephalic presentation
cephalo - pelvic disproportion
localized angiosarcoma
cervical dilation
cervical effacement
cervical mucus plug
cesarean hysterectomy
change in uterine shape
chorionic villus sampling
compound fetal presentation
contraceptive cap
contraceptive coil
contraceptive implant
metastatic carcinoma in the adrenal medulla
contraceptive patch
cornual pregnancy
crash cesarean delivery
crowning during childbirth
cystic fibrosis carrier screening
deflexed fetal attitude
delivery of placenta
dilated anus
drug induced induction of labor
duration of uterine contraction
testicular leukemia
early deceleration
early pregnancy symptom
emergency cesarean delivery
enlarged uterus
episiotomy
extended fetal attitude
external fetal rotation
face presentation
threatened term labor
aids - related anal carcinoma
fetal alcohol spectrum disorder
fetal bradycardia
fetal descent
fetal engagement
fetal extension
fetal fibronectin test
fetal flexion
fetal heart acceleration
fetal heart deceleration
aids - related hodgkin lymphoma
fetal heart rate variability
fetal heart tone
fetal heart tone location
fetal malpresentation
fetal pulse oximetry
fetal restitution
fetal tachycardia
first movement
first stage of labor
first trimester
verapamil
primary mediastinal  ( thymic )  large b - cell lymphoma
flexed fetal attitude
food craving
fourth stage of labor
genetic screening
gestation
group b streptococcus screening
hepatitis b screening
high risk pregnancy
hormonal contraception
hormone imbalance
follicular dendritic cell sarcoma
hypnobirthing
hysterotomy
hysterotomy abortion
impending labor
induction of labor
intense uterine contraction
intermittent deceleration
internal fetal rotation
intrapartum
intrapartum process
interdigitating dendritic cell sarcoma
intrauterine cordocentesis
labor pain
late deceleration
late pregnancy bleeding
amniotic fluid leak
left occiput anterior presentation
longitudinal fetal presentation
lower uterine segment incision
maternal fever
maternal hypotension
lymphocyte - depleted classic hodgkin lymphoma
midline longitudinal uterine incision
mild uterine contraction
missed menstrual period
montgomery tubercle
morning sickness
neutral fetal attitude
non - stress test
nuchal translucency screen
oblique fetal presentation
oligohydramnios
systemic mastocytosis with an associated hematological neoplasm
passing of mucus plug
persistent fetal bradycardia
persistent fetal tachycardia
physiologic lightening
duncan mechanism
schultze mechanism
polycystic ovary syndrome
polyhydramnios
positive pregnancy test
aggressive systemic mastocytosis
posterior occiput presentation
postpartum
postpartum depression
postpartum hemorrhage
postpartum placental separation
pregnancy related breast soreness
pregnancy related skin change
pregnancy related stretch mark
pregnancy time period
prenatal hiv screening
indolent systemic mastocytosis
prenatal vitamin
preterm birth
preterm premature rupture of membrane
prolonged acceleration
prolonged deceleration
quad screen
recurrent deceleration
regular uterine contraction
regularity of uterine contraction
acute myeloid leukemia with inv ( 16 )  ( p13 .1q22 )  or t ( 16 ; 16 )  ( p13 .1 ; q22 )  ;  cbfb - myh11
rh immune globulin
right occiput anterior presentation
rubella immunization
rubella screening
rupture of membrane
second stage of labor
second trimester
sexual abstinence
sexually transmitted disease screening
short - term fetal heart rate variability
acute myeloid leukemia with t ( 8 ; 21 )  ;   ( q22 ;  q22 .1 )  ;  runx1 - runx1t1
shoulder presentation
signs of impending birth
sinciput presentation
spermicidal cream
spermicidal foam
spermicidal jelly
spermicide
spinal block
spontaneous rupture of membranes
st waveform analysis
acute myeloid leukemia with multilineage dysplasia
stripping of membrane
subdermal birth control implant
surgical contraception
surgical delivery procedure
therapeutic abortion procedure
third stage of labor
third trimester
tocodynamometry
transverse fetal presentation
transverse occiput presentation
vidarabine
myeloid neoplasm
triple screen
tubal ligation
umbilical cord compression
urge to push
uterine contraction
uterine contraction frequency
uterine contraction intensity
uterine contraction interval
uterine contraction stress test
uterine involution
anal carcinoma
uterine souffle
uterine tachysystole
vaginal birth mechanism
vaginal bleeding during pregnancy
variable deceleration
varicella zoster virus immunization
varicella zoster virus screening
vertex presentation
withdrawal contraception
solid neoplasm
assessment of fetal condition
abdominal pregnancy
intrapartum cardiotocography
corpus luteum development
early post - partum recovery
fetal biophysical profile
fetal position
fetal position above umbilicus
fetal position below umbilicus
fetal heart monitoring
central nervous system neoplasm
conception method
multiple pregnancy
natural birth
normal pregnancy
labor and delivery process
postpartum process
postpartum recovery
pregnancy related mood swing
teenage pregnancy
histiocytic and dendritic cell neoplasm
phase of labor
latent phase of labor
transition phase of labor
active phase of labor
central nervous system histiocytic and dendritic cell neoplasm
ovarian pregnancy
tubal pregnancy
rh immune globulin administration
rh factor measurement
pregnancy test
mast cell neoplasm
gonorrhea
structured product labeling unit of measure terminology
centesimal korsakovian series of attenuation
amb a 1 unit
induced abortion procedure
chronic bacterial prostatitis
acute bacterial prostatitis
gastroesophageal junction adenocarcinoma
spanxa1 gene
spanxa1 wt allele
spanxa2 gene
spanxa2 wt allele
spanxb1 gene
spanxb1 wt allele
spanxb2 gene
spanxb2 wt allele
spanxc gene
spanxc wt allele
malignant urinary system neoplasm
spanxd gene
spanxd wt allele
spanxe gene
spanxe wt allele
spanxf1 gene
spanxf1 wt allele
mosaicism
sperm protein associated with the nucleus on the x chromosome a
sperm protein associated with the nucleus on the x chromosome b / f
sperm protein associated with the nucleus on the x chromosome c
acute undifferentiated leukemia
sperm protein associated with the nucleus on the x chromosome d
sperm protein associated with the nucleus on the x chromosome e
sexuality
spanxn1 gene
spanxn1 wt allele
sperm protein associated with the nucleus on the x chromosome n1
spanxn2 gene
spanxn2 wt allele
systemic radiation therapy
sperm protein associated with the nucleus on the x chromosome n2
vegetarian
vegan
spanxn3 gene
spanxn3 wt allele
sperm protein associated with the nucleus on the x chromosome n3
spanxn4 gene
spanxn4 wt allele
vinblastine
acute leukemia
sperm protein associated with the nucleus on the x chromosome n4
spanxn5 gene
spanxn5 wt allele
sperm protein associated with the nucleus on the x chromosome n5
double - contrast barium enema
percutaneous transhepatic biliary drainage
central nervous system lymphoma
3 tesla magnetic resonance imaging
bronchial brush biopsy
anal pap smear
primary central nervous system lymphoma
whole genome association study
ultrasound - guided biopsy
newcastle disease virus
hepatic arterial occlusion
serum tumor marker test
calf
flank
inguinal canal
mastocytoma
parameningeal
paratesticular soft tissue
cation channel blocker
alcohol dependence
paralytic ileus
gigantism
hypoxemia
malignant neoplasm
soft tissue sarcoma
primary care provider
wood
cd276 gene
cd276 wt allele
cd276 antigen
cul4b gene
lymphadenopathy with polyclonal hypergammaglobulinemia
cul4b wt allele
cullin - 4b
ddb1 gene
ddb1 wt allele
dna damage - binding protein 1
ddb2 gene
ddb2 wt allele
dna damage - binding protein 2
lymphoproliferative disorder
rad21 gene
lassitude
rad21 wt allele
double - strand - break repair protein rad21 homolog
penile implant
seminoma
kmt2c gene
kmt2c wt allele
histone - lysine n - methyltransferase 2c
kmt2e gene
kmt2e wt allele
histone - lysine n - methyltransferase 2e
vinblastine sulfate
deleterious mutation
pycard gene
pycard wt allele
apoptosis - associated speck - like protein containing a card
malignant cervical neoplasm
mafk gene
mafk wt allele
transcription factor mafk
myod1 gene
myod1 wt allele
myoblast determination protein 1
nfe2 gene
nfe2 wt allele
transcription factor nf - e2 45 kda subunit
ybx1 gene
bone sarcoma
ybx1 wt allele
nuclease - sensitive element - binding protein 1
radiation - related sarcoma
testicular non - seminomatous germ cell tumor
nfat5 gene
nfat5 wt allele
nuclear factor of activated t - cells 5
nfatc1 gene
nfatc1 wt allele
nuclear factor of activated t - cells ,  cytoplasmic 1
nfatc2 gene
nfatc2 wt allele
malignant oral cavity neoplasm
nuclear factor of activated t - cells ,  cytoplasmic 2
human papillomavirus dna test
compression pump
nfatc3 gene
nfatc3 wt allele
lip and oral cavity carcinoma
nuclear factor of activated t - cells ,  cytoplasmic 3
nfatc4 gene
nfatc4 wt allele
invasive procedure
malignant oral neoplasm
nuclear factor of activated t - cells ,  cytoplasmic 4
aluminum
malignant gingival neoplasm
anti - vegfr monoclonal antibody
phlegm
exocrine pancreas cell
upper pole of kidney
malignant floor of the mouth neoplasm
lower pole of kidney
histoplasma capsulatum
pastoral counselor
mental health
floor of the mouth carcinoma
gonioscopy
transurethral prostate biopsy
malignant buccal mucosa neoplasm
f - 18 sodium fluoride positron emission tomography
chemical peel
cerebrospinal fluid diversion
social capital
malignant nasopharyngeal neoplasm
inflammatory disorder
acculturation
temperament
impulsive behavior
violence
crime
delinquency
perceived social support / conflict
intraesophageal impedance ph monitoring
malignant parathyroid gland neoplasm
coping style assessment tool
malignant postcricoid neoplasm
breast lobe
severe myelosuppression
methyl group
adrenal gland carcinoma
breast lobule
perfusion magnetic resonance imaging
acupuncture point
adrenal cortex carcinoma
regenerative medicine
vegfr tyrosine kinase inhibitor
adrenal cortex adenocarcinoma
anti - tag - 72 monoclonal antibody cc49 - streptavidin conjugate
chitinase - 3 - like protein 1
rhabdoid tumor predisposition syndrome
malignant adrenal cortex neoplasm
j - pouch coloanal anastomosis
malignant duodenal neoplasm
advanced stage
assisted reproductive technology
radiologic examination
malignant cecum neoplasm
breast duct
trophoblast
micelle
vincristine
appendix carcinoma
assistive device
electroconvulsive therapy
percutaneous endoscopic tube
malignant gastric neoplasm
nasogastric tube
maxillary sinus carcinoma
enteral tube feeding
hepatitis d virus
mindfulness relaxation
malignant appendix neoplasm
x - ray therapy
malignant bladder neoplasm
radioembolization
total skin electron beam radiation therapy
dermabrasion
family therapy
malignant breast neoplasm
microwave thermotherapy
targeted therapy
defined administrative activity
defined study activity
performed administrative activity
scheduled study activity
biologic entity part
study site research coordinator
registration center service
nasal cavity carcinoma
study condition
organizational contact
defined eligibility criterion
defined exclusion criterion
defined inclusion criterion
defined stratification criterion
performed eligibility criterion
performed exclusion criterion
performed inclusion criterion
defined experimental unit allocation
malignant ear neoplasm
defined imaging
defined observation
defined procedure
defined specimen collection
defined specimen storage
defined study administrative activity
defined study agent transfer
defined study subject milestone
defined substance administration
amendment change summary version document
malignant adrenal gland neoplasm
report version document
study protocol document
adverse event sub - domain
common sub - domain
protocol representation sub - domain
regulatory sub - domain
study conduct sub - domain
associated biologic entity
experimental unit
randomization book entry
refractory peripheral t - cell lymphoma ,  not otherwise specified
government funding
biologic entity group
defined criterion group
defined subject activity group
healthcare provider group
planned criterion group
product group
stratum group
biologic entity identifier
document identifier
vindesine
material identifier
organization identifier
package identifier
identifier source
study site investigator
collecting laboratory
study material
study outcome measurement
cooperative group member
healthcare provider group member
peripheral primitive neuroectodermal tumor
material name
defined notification
performed notification
planned notification
scheduled notification
study objective
adverse event outcome result
defined observation result
defined stratification criterion permissible result
performed clinical result
spindle cell intraocular melanoma
performed medical history result
performed observation result
performed product investigation result
reference result
product part
performed clinical interpretation
performed diagnosis
performed histopathology
performed imaging
performed lesion description
bone neoplasm
performed observation
performed procedure
performed product investigation
performed product problem discovery
performed protocol deviation
performed specimen collection
performed study administrative activity
performed study agent transfer
performed study subject milestone
performed substance administration
pineoblastoma
qualified person
study personnel
study site personnel
planned randomization book allocation
notification receiver
oversight authority
oversight committee
report submitter
research organization
resource provider
malignant tongue neoplasm
study oversight authority
reference to study results
study reference
study registry
assessed result relationship
companion study relationship
defined composition relationship
defined contingent on relationship
defined criterion group composition relationship
defined criterion group option relationship
malignant tracheal neoplasm
defined option relationship
document version relationship
evaluated activity relationship
evaluated result relationship
organization relationship
planned composition relationship
planned contingent on relationship
planned criterion group composition relationship
planned criterion group option relationship
planned option relationship
tracheal carcinoma
product action taken relationship
study resource relationship
study site protocol version relationship
study subject protocol version relationship
defined repeat activity until rule
planned repeat activity until rule
processing site
treating site
study legal sponsor
document version workflow status
mast cell sarcoma
study recruitment status
study site oversight status
study execution
planned study site
document version
expanded access study protocol version
interventional study protocol version
observational study protocol version
safety report
study protocol document version
plasmacytoma
study protocol version
abnormal indicator
accepts healthy volunteers indicator
accrual reporting method code
accrual status date
acronym
active indicator
active ingredient indicator
actual date range
actual duration
vindesine sulfate
peritoneal malignant mesothelioma
actual indicator
administrative gender code
adverse event coding system
allocation code
anatomic site code
anatomic site laterality code
appearance type code
approach anatomic site code
approach anatomic site laterality code
as collected indicator
pleural mesothelioma
assessment code
assessment date
assessment estimate anticipated indicator
available for evaluation indicator
baseline indicator
biomarker indicator
birth country code
birth order
blinded description
blinded role code
recurrent duodenal carcinoma
blinding schema code
body position code
body system code
breed code
category code
cell type code
cellular differentiation grade code
certificate license text
cessation pause quantity
change reason
recurrent malignant hypopharyngeal neoplasm
change type code
citation description
clinically significant indicator
communication mode code
companion code
completion required before starting indicator
condition code
condition coding system
confidentiality code
confidentiality indicator
recurrent malignant gastric neoplasm
contact anatomic site code
container cap type code
contrast agent enhancement indicator
control concurrency type code
control type code
date range
death indicator
defect type code
delay duration
delivery mechanism code
stage ivb vaginal cancer ajcc v6 and v7
derivation expression
deviation category code
device malfunction code
dimension product
disease amount status code
display order
dose frequency code
dose period code
due date
education level code
regional ureter carcinoma
effective date range
end relative to reference code
enhancement description
ethnic group code
evaluation conclusion code
expected indicator
fasting status indicator
focal date range
focal duration
form code
hodgkin lymphoma
function code
funding mechanism code
funding type code
grade code
group number
highlighted indicator
hospitalization required indicator
ideal date range
inactive comment
informed consent date
stage i colon cancer ajcc v6 and v7
intervention group quantity
involved surgical margin indicator
job title
jurisdiction authority code
jurisdiction territory code
keyword code
lead indicator
lesion number
link page description
location description
skin pigmented basal cell carcinoma
mandatory indicator
manufacture date
marital status code
measurable indicator
message title
method code
missed indicator
missed reason
mri enhancement rate value
multi - institution indicator
vinyl chloride
lymphoblastic lymphoma
name code
name code modified text
nih institute code
normal range comparison code
not applicable indicator
nullification indicator
nullification reason code
occupation date range
occurrence date range
occurrence pattern code
adult lymphoblastic lymphoma
off study date
off study reason code
official title
onset date
original quantity
over the counter product indicator
participating country code
participating organization type code
pause quantity
payment method code
clitoral carcinoma
period dose total
periodic target accrual number
phase code
physician sign off indicator
planned change indicator
planned duration
planned study subject experience
position filled indicator
position number
post report update date
labia majora carcinoma
pre - 1938 indicator
primary indicator
primary occupation code
primary purpose code
probability code
protocol amendment grace period
public description
public title
publication identifier
publication name
labia minora carcinoma
purpose statement
race code
randomization weight
reason code
receipt date
recurrence indicator
registration required indicator
repeat duration
repeat frequency code
repeat frequency ratio
repeat quantity
repetition number
reported date
reported result status code
reprocessed code
reproductive organs present indicator
required response
resolution date
responsible party code
result code modified text
result target coding system
returned to reprocessor date
review board approval number text
review board process code
review board process date
revision reason
role code
route of administration code
sampling method code
scientific description
stage iva bladder cancer
severity code
single use indicator
species code
start relative to reference code
status change reason code
status date
study accrual status code
study accrual threshold percent
study design configuration code
study focus indicator
stage ivb bladder cancer
study reference date range
study registration date
study schematic
study site accrual threshold percent
study stopped reason code
study subject type code
subcategory code
subgroup code
subtype code
target accrual number range
recurrent malignant testicular germ cell tumor
target anatomic site code
target anatomic site condition code
target anatomic site laterality code
time frame text
time perspective code
toxicity grade code
toxicity term code
treatment vehicle volume
type code
uncertainty code
virginiamycin
adult brain stem gliosarcoma
unexpected reason code
variance type code
version date
version number text
activity identifier
activity reason code
adverse event action taken relationship delay duration
adverse event action taken relationship type code
adverse event category code
adverse event end relative to reference code
adult brain stem mixed glioma
adverse event expected indicator
adverse event grade code
adverse event highlighted indicator
adverse event hospitalization required indicator
adverse event location description
adverse event occurrence pattern code
adverse event onset date
adverse event post report update date
adverse event resolution date
adverse event seriousness code
adult brain ependymoma
adverse event seriousness date
adverse event severity code
adverse event subcategory code
adverse event unexpected reason code
animal breed code
animal description
animal reproductive organs present indicator
animal species code
arm description
arm name
arm randomization weight
arm target accrual number range
arm type code
assessed result relationship type code
associated biologic entity type code
biologic entity actual indicator
biologic entity administrative gender code
biologic entity birth country code
biologic entity birth order
biologic entity group actual indicator
adult intracranial meningioma
biologic entity group name
biologic entity group quantity
biologic entity group type code
biologic entity identifier effective date range
biologic entity identifier with attribute identifier
biologic entity identifier type code
biologic entity part anatomic site code
biologic entity part anatomic site laterality code
biologic specimen accession number
biologic specimen condition code
adult brain glioblastoma
companion study relationship registration required indicator
defined activity category code
defined activity description
defined activity name code
defined activity repeat duration
defined activity repeat frequency code
defined activity repeat frequency ratio
defined activity repeat quantity
defined activity status date
defined activity subcategory code
defined composition relationship pause quantity
defined composition relationship sequence number
defined contingent on relationship completion required before starting indicator
defined contingent on relationship pause quantity
defined criterion group composition relationship pause quantity
defined criterion group composition relationship sequence number
defined criterion group option relationship pause quantity
defined criterion group option relationship priority number
defined eligibility criterion required response
defined experimental unit allocation method code
defined imaging contrast agent enhancement indicator
defined imaging enhancement description
defined notification delivery mechanism code
defined notification message
defined notification message title
defined observation body position code
defined observation focal date range
defined observation focal duration
defined observation method code
defined observation result confidentiality code
childhood myeloid leukemia in remission
defined observation result derivation expression
defined observation result outcome
defined observation result target anatomic site code
defined observation result target anatomic site laterality code
defined observation result target coding system
defined observation result type code
defined observation target anatomic site code
defined observation target anatomic site laterality code
defined option relationship pause quantity
defined option relationship priority number
combined lung small cell carcinoma and lung adenocarcinoma
defined procedure approach anatomic site code
defined procedure approach anatomic site laterality code
defined procedure method code
defined procedure target anatomic site code
defined procedure target anatomic site laterality code
defined repeat activity until rule cessation pause quantity
defined substance administration dose
defined substance administration dose frequency code
defined substance administration dose period code
defined substance administration dose regimen
vitamin a compound
adult acute myeloid leukemia without maturation
defined substance administration period dose total
defined substance administration route of administration code
device age
device available for evaluation indicator
device manufacture date
device over the counter product indicator
device reprocessed code
device returned to reprocessor date
device single use indicator
document identifier with attribute identifier
childhood acute myeloid leukemia with maturation
document identifier primary indicator
document identifier type code
document type code
document version date
document version keyword
document version keyword code
document version number text
document version official title
document version relationship type code
document version revision reason
rectal carcinoma
document version text
document version uniform resource locator
document version workflow status code
document version workflow status date
epoch description
epoch name
epoch sequence number
epoch target accrual number range
epoch type code
evaluated activity relationship probability
rectal adenocarcinoma
evaluated activity relationship probability code
evaluated activity relationship uncertainty code
evaluated result relationship probability
evaluated result relationship probability code
evaluated result relationship uncertainty code
experimental unit identifier
experimental unit status date
experimental unit subgroup code
government funding mechanism code
government funding nih institute code
kidney carcinoma
government funding serial number
government funding type code
health care provider effective date range
health care provider identifier
health care provider postal address
healthcare facility effective date range
healthcare facility identifier
healthcare facility postal address
healthcare provider group effective date range
healthcare provider group member effective date range
renal cell carcinoma
interventional study protocol version accepts healthy volunteers indicator
interventional study protocol version allocation code
interventional study protocol version blinded role code
interventional study protocol version blinding schema code
interventional study protocol version control concurrency type code
interventional study protocol version control type code
interventional study protocol version intervention group quantity
laboratory identifier
material actual indicator
material description
material effective date range
material form code
material identifier with attribute identifier
material identifier type code
material name code
material name with attribute name
material name type code
observational study protocol version sampling method code
observational study protocol version time perspective code
organization actual indicator
organization description
organization identifier with attribute identifier
organization identifier primary indicator
organization identifier type code
organization name
organization postal address
organization relationship effective date range
organization relationship type code
organization type code
organizational contact effective date range
organizational contact postal address
organizational contact primary indicator
organizational contact title
organizational contact type code
oversight committee effective date range
oversight committee type code
package cap type code
package capacity
package form code
package identifier with attribute identifier
well differentiated leiomyosarcoma
package identifier type code
package lot number
package name
package type code
performed activity actual date range
performed activity actual duration
performed activity delay duration
performed activity missed indicator
performed activity missed reason
performed activity repetition number
cobalamin
leiomyosarcoma nci grade 3
performed activity status date
performed administrative activity variance reason
performed administrative activity variance type code
performed clinical interpretation abnormal indicator
performed clinical interpretation clinically significant indicator
performed clinical interpretation severity code
performed clinical interpretation toxicity grade code
performed clinical interpretation toxicity term code
performed clinical result as collected indicator
performed clinical result biomarker indicator
leiomyosarcoma nci grade 2
performed clinical result inactive comment
performed clinical result normal range comparison code
performed clinical result reported result status code
performed diagnosis disease status code
performed diagnosis recurrence indicator
performed eligibility criterion display order
performed eligibility criterion not applicable indicator
performed histopathology cell type code
performed histopathology differentiation grade code
performed histopathology involved surgical margin indicator
well differentiated malignant hemangiopericytoma
performed imaging contrast agent enhancement indicator
performed imaging enhancement description
performed imaging image identifier
performed lesion description appearance type code
performed lesion description contact anatomic site code
performed lesion description dimension product
performed lesion description lesion number
performed lesion description measurable indicator
performed medical history result end relative to reference code
performed medical history result occurrence date range
performed notification message
performed notification message title
performed observation body position code
performed observation focal date range
performed observation focal duration
performed observation method code
performed observation result baseline indicator
performed observation result body system code
performed observation result confidentiality code
performed observation result identifier
performed observation result outcome
performed observation result reported date
performed observation result result code modified text
performed observation result target anatomic site code
performed observation result target anatomic site laterality code
performed observation result type code
performed observation result uncertainty code
performed observation target anatomic site code
performed observation target anatomic site laterality code
performed procedure approach anatomic site code
performed procedure approach anatomic site laterality code
performed procedure method code
performed procedure target anatomic site code
performed procedure target anatomic site condition code
performed procedure target anatomic site laterality code
performed product investigation result conclusion
performed product investigation result defect type code
performed product investigation result device malfunction code
performed product investigation result evaluation conclusion code
performed protocol deviation category code
performed protocol deviation date range
performed specimen collection fasting status indicator
performed study agent transfer original quantity
performed study agent transfer quantity
performed study subject milestone informed consent date
performed study subject milestone off study date
performed study subject milestone off study reason code
performed study subject milestone registration date
performed study subject milestone study reference date range
performed substance administration change reason
performed substance administration change type code
performed substance administration dose
performed substance administration dose description
performed substance administration dose frequency code
performed substance administration dose period code
performed substance administration end relative to reference code
performed substance administration period dose total
performed substance administration planned change indicator
performed substance administration route of administration code
performed substance administration start relative to reference code
performed substance administration treatment vehicle volume
performer effective date range
performer identifier
performer postal address
performer type code
person death indicator
person education level code
person ethnic group code
person marital status code
person occupation date range
person postal address
person primary occupation code
person race code
place identifier
place type code
planned activity blinded description
planned activity description
planned activity name
planned activity planned duration
planned activity purpose
vitamin b complex
sarcoma nci grade 2
planned activity repeat duration
planned activity repeat frequency code
planned activity repeat frequency ratio
planned activity repeat quantity
planned activity target accrual number range
planned composition relationship pause quantity
planned composition relationship sequence number
planned contingent on relationship completion required before starting indicator
planned contingent on relationship pause quantity
planned criterion group composition relationship pause quantity
planned criterion group composition relationship sequence number
planned criterion group option relationship pause quantity
planned criterion group option relationship priority number
planned notification study accrual threshold percent
planned notification study site accrual threshold percent
planned option relationship pause quantity
planned option relationship priority number
planned repeat activity until rule cessation pause quantity
planned study site lead indicator
planned study site planned duration
product action taken relationship delay duration
product class code
product group actual indicator
product group identifier
product group quantity
product lot number
product name code modified text
product part active ingredient indicator
product part pharmaceutical strength
product pharmaceutical product expiration date
product pre - 1938 indicator
product type code
qualified person certificate license text
qualified person effective date range
qualified person identifier
qualified person type code
randomization book entry position filled indicator
randomization book entry position number
reference result outcome
reference result target anatomic site code
poorly differentiated fibrosarcoma
reference result target anatomic site laterality code
reference result type code
reference to study results citation description
reference to study results link page description
reference to study results publication identifier
reference to study results publication name
reference to study results uniform resource locator
regulatory application identifier
regulatory application sponsor effective date range
regulatory application type code
regulatory assessment code
regulatory assessment date
regulatory assessment identifier
regulatory assessment reason code
regulatory authority effective date range
regulatory authority jurisdiction authority code
regulatory authority jurisdiction territory code
report version communication mode code
report version due date
report version physician sign off indicator
research organization effective date range
research organization type code
research staff effective date range
research staff identifier
research staff job title
research staff postal address
resource active indicator
resource inactive comment
resource provider effective date range
resource provider identifier
reviewable unit type code
safety report nullification indicator
safety report nullification reason code
safety report subtype code
scheduled activity date range
scheduled activity ideal date range
scheduled activity repetition number
scheduled activity status change reason code
scheduled activity status date
scheduled notification message
scheduled notification message title
service type code
stratum group number
study activity study focus indicator
study agent function code
study agent status date
study condition code
study condition lead indicator
unique study investigator identifier
study legal sponsor primary indicator
epithelioid sarcoma nci grade 2
study objective description
study objective primary indicator
study outcome measure name
study outcome measure primary indicator
study outcome measure time frame text
study outcome measure type code
study overall status anticipated indicator
study overall status code
study overall status date
study overall status study stopped reason code
d vitamin
epithelioid sarcoma nci grade 3
study personnel effective date range
study personnel postal address
study personnel primary indicator
study personnel role code
study protocol document version public description
study protocol document version public title
study protocol document version scientific description
study protocol version accrual reporting method code
study protocol version acronym
study protocol version adverse event coding system
angiosarcoma nci grade 2
study protocol version amendment grace period
study protocol version companion code
study protocol version condition coding system
study protocol version design configuration code
study protocol version mandatory indicator
study protocol version participating country code
study protocol version participating organization type code
study protocol version periodic target accrual number
study protocol version phase code
study protocol version planned duration
angiosarcoma nci grade 3
study protocol version planned study subject experience
study protocol version primary purpose code
study protocol version purpose statement
study protocol version responsible party code
study protocol version study schematic
study protocol version study subject type code
study protocol version target accrual number range
study protocol version target anatomic site code
study recruitment status code
study recruitment status date
kaposi sarcoma nci grade 2
study reference citation description
study reference link page description
study reference publication identifier
study reference publication name
study reference uniform resource locator
study registry acronym
study registry name
study resource effective date range
study resource primary indicator
study site accrual status code
kaposi sarcoma nci grade 3
study site accrual status date
study site date range
study site lead indicator
study site oversight status review board approval number text
study site oversight status review board process code
study site oversight status review board process date
study site personnel effective date range
study site personnel postal address
study site personnel primary indicator
study site personnel role code
sarcoma nci grade 3
study site planned duration
study site protocol version relationship effective date range
study site status date
study site target accrual number range
study subject confidentiality indicator
study subject payment method code
study subject protocol version relationship effective date range
study subject status date
subject identifier effective date range
subject identifier with attribute identifier
subject identifier primary indicator
subject identifier type code
submission receipt date
submission status date
submission type code
submission unit effective date range
submission unit receipt date
submission unit type code
system of record name
activity comment
adverse event summary
animal organism strain
assessed result relationship comment
biologic entity birth date
defined activity status code
defined composition relationship comment
defined contingent on relationship comment
defined criterion group composition relationship comment
defined criterion group option relationship comment
defined imaging enhancement rate value
high grade sarcoma
defined observation result comment
defined option relationship comment
defined repeat activity until rule comment
document version bibliographic designation
document version workflow status comment
biologic entity date of death
lesion identification
postmortem
ritual
vitamin e compound
ad5 - sge - reic / dkk - 3 mtg - 201
anti - cd20 monoclonal antibody tl011
lefitolimod
tebentafusp
allogeneic natural killer cell line mg4101
fibromun
glioblastoma multiforme multipeptide vaccine ima950
fluorodeoxygalactose f - 18
choline kinase alpha inhibitor tcd - 717
alpelisib
indoleamine 2 , 3 - dioxygenase peptide vaccine
gitrl rna - transfected autologous dendritic cell vaccine
anti - ctla4 moab rna - transfected autologous dendritic cell vaccine
anti - ctla4 moab rna / gitrl rna - transfected autologous dendritic cell vaccine
anti - cd30 / cd16a monoclonal antibody afm13
gatipotuzumab
anti - egfr monoclonal antibody gt - mab 5 .2 - gex
technetium tc - 99m hydroxydiphosphonate
hla - a*2402 - restricted cdca1 - a24 - 56 peptide vaccine
braf inhibitor arq 736
ivaltinostat
improvement
combined lung small cell and squamous cell carcinoma
resistant starch
compulsion
conventional malignant hemangiopericytoma
overweight
surgical menopause
expanded access study protocol intervention or procedure
experimental unit status code
conventional angiosarcoma
health care provider telecom address
healthcare facility telecom address
interventional study protocol version intervention or procedure
organization telecom address
organizational contact telecom address
performed activity status code
performed imaging enhancement rate value
performed lesion description x dimension
performed lesion description y dimension
performed lesion description z dimension
performed observation result comment
performer telecom address
person initials
person telecom address
place physical address
planned composition relationship comment
planned contingent on relationship comment
planned criterion group composition relationship comment
planned criterion group option relationship comment
planned option relationship comment
conventional leiomyosarcoma
planned repeat activity until rule comment
reference result comment
registration center telecom address
research staff telecom address
scheduled activity status code
study agent status code
study investigator signature text
study overall status comment
study personnel telecom address
study protocol version multi - institution indicator
conventional fibrosarcoma
study protocol version study population description
study site personnel telecom address
study site status code
study subject status code
submission status code
nfkb1 gene
antisocial behavior
androgen receptor positive
nfkb1 wt allele
receptor status
vitamin k
pigmented dermatofibrosarcoma protuberans
nuclear factor nf - kappa - b p105 subunit
vasoactive
ureteroscopy
rhinoscopy
organic food
malignant pleural effusion
dissociative amnesia
dissociative fugue
dissociative identity disorder
depersonalization disorder
intermittent explosive disorder
kleptomania
pyromania
pathological gambling
trichotillomania
hypoactive sexual desire disorder
sexual aversion disorder
female sexual arousal disorder
healthy control
premature ejaculation
substance - induced sexual dysfunction
exhibitionism
fetishism
frotteurism
pedophilia
sexual masochism
sexual sadism
transvestic fetishism
radiation fibrosis
voyeurism
gender identity disorder
informative
genetic hotspot
undifferentiated type schizophrenia
schizophreniform disorder
schizoaffective disorder
delusional disorder
chronic renal failure
erotomanic type delusional disorder
grandiose type delusional disorder
orthotopic
jealous type delusional disorder
persecutory type delusional disorder
somatic type delusional disorder
mixed type delusional disorder
unspecified type delusional disorder
chronic kidney disease ,  stage 5
brief psychotic disorder
shared psychotic disorder
psychotic disorder due to a general medical condition
rostral
cumulative dose
best practice
vitamin
abnormality
meridian
bursitis
folliculitis
duodenitis
asymptomatic inflammatory prostatitis
extraocular
deposit
sperm retrieval
nerve grafting
prior primary
stellate
panic
transoral robotic surgery
parietal cell vagotomy
nephrostomy
extrapleural pneumonectomy
rupture
prophylactic surgery
grade 1 colorectal adenocarcinoma
metastasectomy
vaginectomy
prostatocystectomy
cervicectomy
unilateral salpingo - oophorectomy
grade 2 colorectal adenocarcinoma
radical hysterectomy
respite care
urine cytology
cultural competency
retching
pretracheal space
radiation necrosis
grade 3 colorectal adenocarcinoma
stature
grade 3 rectal adenocarcinoma
papillary - reticular dermal interface
bisphosphonate - associated osteonecrosis
warfarin
grade 2 rectal adenocarcinoma
grade 1 rectal adenocarcinoma
seminal vesicle biopsy
tumor volume
dorsoventral
grade 1 colon adenocarcinoma
target lesion identification
non - target lesion identification
new lesion identification
tumor identification
pituicytoma
matted tumor mass present
tumor mass fragmentation
photography
panendoscopy
vulvovaginal region
grade 2 colon adenocarcinoma
radiologist 1
radiologist 2
reader 1
reader 2
response in target lesion
response in non - target lesion
best overall response
spindle cell oncocytoma
grade 3 colon adenocarcinoma
anterior pituitary gland endocrine neoplasm
limbic system
tooth socket
dental attrition
between
paranoia
lymphatic basin
bioactive glass product
bottom of gingival sulcus
orthodontic braces
neoplastic eosinophilic spindle cell
breath
buildup
business personnel
caries into dentin
caries restricted to enamel
caries ,  region unknown
chronic pericoronitis
jaw clicking or popping
breast ductal carcinoma in situ ,  intermediate grade
connect
crossbite
dental drilling
distobuccal
distolingual
lingual
decayed ,  missing ,  and filled teeth index
elastics
tooth cusp
tooth eruption
breast ductal carcinoma in situ ,  low grade
force - sensitive electronic probe
habit
lower lip
overeruption
panoramic
scarlet fever
scrape
scratch
stained appearance
tooth 1
tooth 15
tooth 16
tooth 17
tooth 18
tooth 2
tooth 31
tooth 32
incisal edge
tooth angulation
transparent
borderline ovarian brenner tumor / atypical proliferative ovarian brenner tumor
uprighting
dental whitening
zygomatic buttress
partial wave spectroscopic microscopy
pentosan polysulfate sodium
cockayne syndrome
bcr / abl1 fusion gene
steroid metabolism gene
c peptide
bladder small cell neuroendocrine carcinoma
protegrin
calbindin
b3 antigen
ras peptide
trpv6 gene
trpv6 wt allele
excretion
mitigate
laryngeal adenoid cystic carcinoma
transient receptor potential cation channel subfamily v member 6
anpep gene
oxygen therapy
thermotherapy
laryngeal mucoepidermoid carcinoma
antiretroviral therapy
base pair
dirty necrosis
grade 1 diffuse follicular lymphoma
hypopharyngeal carcinoma
level of evidence v
pharyngeal carcinoma
anpep wt allele
aminopeptidase n
trichophyton antigen
ltf gene
ltf wt allele
lactotransferrin
gast gene
gast wt allele
gastrin
becn1 gene
chronic cancer pain
becn1 wt allele
beclin - 1
intestinal villus
kcnk18 gene
kcnk18 wt allele
cervical intraepithelial neoplasia grade 2 / 3
potassium channel subfamily k member 18
grade 2 / 3
dysferlin
c3 deficiency
dysf gene
dysf wt allele
zfp42 gene
zfp42 wt allele
zinc finger protein 42 homolog
atp2c2 gene
atp2c2 wt allele
calcium - transporting atpase type 2c member 2
slc3a1 gene
slc3a1 wt allele
c5 deficiency
neutral and basic amino acid transport protein rbat
slc7a9 gene
slc7a9 wt allele
b ( 0 ,  +  )  - type amino acid transporter 1
autoimmune enteropathy
pdcd1 gene
pdcd1 wt allele
programmed cell death protein 1
pdcd4 gene
pdcd4 wt allele
zidovudine
systemic anaplastic large cell lymphoma
programmed cell death protein 4
5' - amp - activated protein kinase
myog gene
myog wt allele
myogenin
xrn1 gene
xrn1 wt allele
5' - 3' exoribonuclease 1
xrn2 gene
xrn2 wt allele
childhood systemic anaplastic large cell lymphoma
5' - 3' exoribonuclease 2
malondialdehyde
organic ester
organic phosphate
aldehyde
organic oxide
ketone
phytol
mpg gene
acetate
atypical gastric lymphoid hyperplasia
cyanogenic glucoside
mpg wt allele
glycopeptide
chlorotoxin
dna - 3 - methyladenine glycosylase
selective serotonin reuptake inhibitor
5 - ht3 receptor antagonist
tricyclic antidepressant
fluoropyrimidine
season
lactating adenoma
winter
spring
summer
autumn
mbd3 gene
mbd3 wt allele
methyl - cpg - binding domain protein 3
running
swimming
calisthenics
adenosarcoma
lrwd1 gene
weight lifting
baseball
lrwd1 wt allele
leucine - rich repeat and wd repeat - containing protein 1
prkaa2 gene
prkaa2 wt allele
5' - amp - activated protein kinase catalytic subunit alpha - 2
yard work
stk33 gene
cerebellar astrocytoma
stk33 wt allele
serine / threonine - protein kinase 33
trim21 gene
trim21 wt allele
meningeal leukemia
e3 ubiquitin - protein ligase trim21
meningeal lymphoma
nodular parenchymal tissue
low - dose aspirin
functioning endocrine neoplasm
desmoplastic infantile astrocytoma
non - functioning endocrine neoplasm
tfeb gene
tfeb wt allele
transcription factor eb
diffuse intrinsic pontine glioma
pain - relief medication
perp gene
perp wt allele
stage 0 paranasal sinus cancer ajcc v6 ,  v7 ,  and v8
p53 apoptosis effector related to pmp - 22
anaplastic astrocytoma
multifocal breast carcinoma
multicentric lesion
multicentric breast carcinoma
lower urinary tract symptoms
early - stage breast carcinoma
stage i adult liver cancer ajcc v7
stage ii adult liver cancer ajcc v7
stage iii adult liver cancer ajcc v7
clarify
stage iiia adult liver cancer ajcc v7
atypia
stage iiib adult liver cancer ajcc v7
stage iiic adult liver cancer ajcc v7
stage iv adult liver cancer ajcc v7
thank you
adipoq gene
adipoq wt allele
adiponectin
tnfsf13b gene
tnfsf13b wt allele
tumor necrosis factor ligand superfamily member 13b
hereditary malignant neoplasm
tumor necrosis factor receptor superfamily member 4
ann arbor stage i childhood non - hodgkin lymphoma
ann arbor stage ii childhood non - hodgkin lymphoma
ann arbor stage iii childhood non - hodgkin lymphoma
ann arbor stage iv childhood non - hodgkin lymphoma
drug for further processing
locally recurrent malignant neoplasm
ann arbor stage i aids - related lymphoma
ann arbor stage ii aids - related lymphoma
ann arbor stage iii aids - related lymphoma
zinc
invasive carcinoma
ann arbor stage iv aids - related lymphoma
icos gene
icos wt allele
inducible t - cell costimulator
elmo1 gene
elmo1 wt allele
engulfment and cell motility protein 1
fshr gene
fshr wt allele
follicle - stimulating hormone receptor
non - metastatic carcinoma
inherited bone marrow failure syndrome
clark level finding
clark level i
clark level ii
clark level iii
clark level iv
clark level v
food frequency questionnaire
reticular dermis
papillary dermis
soft tissue chondroma
mediastinal pleura
stage i borderline ovarian surface epithelial - stromal tumor
stage ii borderline ovarian surface epithelial - stromal tumor
booklet
stage iii borderline ovarian surface epithelial - stromal tumor
stage iv borderline ovarian surface epithelial - stromal tumor
paraganglion
erythrodysplasia
overgrowth syndrome
neuroleptic malignant syndrome
pineal gland cyst
familial isolated hyperparathyroidism
carney - stratakis syndrome
systemic inflammatory response syndrome
carney triad
muscle atrophy
normal spontaneous vaginal delivery
parasomnia
erythroleukoplakia
warm ischemia during surgery
cold ischemia during surgery
chromosomal deletion
atat1 gene
atat1 wt allele
alpha - tubulin n - acetyltransferase 1
paperwork
multidisciplinary
verbal
study position
quantity exactness
dose denominator qualifier icsr terminology
animal enclosure
quarter of the udder
living arrangement
anti - nmda receptor encephalitis
particle accelerator
concentration of radioactive activity
biological half - life
long axis
acquisition time frame
anger camera
asymmetry index
attenuation coefficient
attenuation correction
axial field of view
beta particle
blank radiographic scan
blood flow rate
blood volume fraction
brodmann's area
cerebral blood flow
intractable epilepsy
cine display mode
circumferential profile plot
color lookup table
compartmental model region
compartmental model
conjugate view
coronal plane
count per second
count rate
counting efficiency
ct number
cyclotron
decay constant
diagnostic imaging bull's eye
dicom header tag
disintegration per second
disintegration rate
dose calibrator
dual - time scan
dynamic range
genitourinary fistula
dynamic scan
electronic collimation
emission scan
end diastolic volume imaging
end systolic volume imaging
filter cutoff frequency
filtered backprojection
flood image
flood source
focal image
fourier analysis
fourth dimension
frame gate
full width at half maximum
fused image
gated scan
geometric mean
horizontal long axis of heart
hounsfield unit
hybrid imaging
image reorientation
image reslicing
image spill - in
image spillover
imaging cold spot
influx constant
infusion rate
injected dose
iterative reconstruction
least square
breast ductal hyperplasia
line of response
line pair
linear parameter identification
list mode
logan plot
logarithm
macroparameter
mathematic identifiability
mathematical integral
matrix size
hypochondriasis
maximum intensity projection
maximum pixel
maximum voxel
metabolic rate quantification
micropet
molecular imaging
monte carlo method
multi - planar reformatting
multiple time graphical analysis
myocardial blood flow
latent infection
national electrical manufacturers association
noise equivalent count rate
non - linear parameter identification
normalized time
nyquist frequency
parameter identification
parametric image
partial volume effect
percent injected dose
pet scanner 2d mode
radial scar / complex sclerosing lesion
pet scanner 3d mode
phase analysis
pinhole camera
pixel size
planar imaging
point spread function
polar map
positron
probability density
projection view
t - cell / histiocyte - rich large b - cell lymphoma
quantitative constraint
radioactive activity
radioactive label
radioactive source
radioactive tracer kinetic analysis
radioactivity cross calibration
radionuclide generator
rate constant
rebinning
rectilinear scan
medulloblastoma with melanotic differentiation
reference region
relative biological effectiveness
robust
sagittal plane
scan throughput
scan time frame
scanner camera center of rotation
scanner color scale
scanner patient bed position
scout scan
melanocytoma
semiquantitative method
septa
short axis
signal to noise ratio
sinogram
sokoloff model
specific radioactive activity
specific radioactive volume
statistical parameter mapping
stroke volume
melanomatosis
talairach space
topogram
tracer clearance
tracer extraction fraction
transaxial plane
transaxial field of view
transient ischemic dilation
transmission scan
tumor to normal
ventilation to perfusion ratio
anaxirone
visual interpretation
volume of interest
volume rendering
voxel size
whole body scan
zoom factor
binding potential
effective half - life
input function
ligand
mean life
scanner patient bed
standardized uptake value maximum
standardized uptake value peak
time activity curve
vertical long axis of the heart
volume curve
pregnancy and lactation status
myolipoma
lutetium lu 177 dotatate
cinobufagin
cesium cs - 131
anti - human gitr monoclonal antibody trx518
racotumomab
iodine i 131 monoclonal antibody f16sip
y - shape branched pegylated filgrastim
colorimetric cell viability assay
ppp1r13l gene
ppp1r13l wt allele
juvenile breast papillomatosis
rela - associated inhibitor
ppp1r13b gene
ppp1r13b wt allele
apoptosis - stimulating of p53 protein 1
mir194 - 1 gene
mir194 - 1 wt allele
mir215 gene
mir215 wt allele
thymoliposarcoma
mir194 - 1 pre - mirna
stage 4s neuroblastoma
mir215 pre - mirna
bmp4 gene
bmp4 wt allele
bone morphogenetic protein 4
thymus solitary fibrous tumor
tnfrsf4 gene
tnfrsf4 wt allele
lep gene
ectopic cervical thymoma
lep wt allele
dysembryoplastic neuroepithelial tumor
dppa3 gene
dppa3 wt allele
developmental pluripotency - associated protein 3
thymic hodgkin lymphoma
metrizoate meglumine
tegafur - uracil
cer1 gene
cer1 wt allele
cerberus
grpr gene
grpr wt allele
gastrin - releasing peptide receptor
bsg gene
bsg wt allele
cytarabine / doxorubicin regimen
basigin
circadian rhythm sleep disorder
delayed sleep phase type circadian rhythm sleep disorder
jet lag type circadian rhythm sleep disorder
shift work type circadian rhythm sleep disorder
nightmare disorder
sleep terror disorder
sleepwalking
substance - induced sleep disorder
rapamycin - polarized th1 / tc1 autologous t lymphocytes
nonclinical study design
body weight gain domain
behavioral domain
body weight domain
clinical observation domain
death diagnosis domain
developmental milestone domain
fertility domain
food and water consumption domain
fetal pathology findings domain
implantation classification domain
cesarean section and delivery litter results domain
macroscopic findings domain
microscopic findings domain
neuroscience domain
palpable masses domain
respiratory domain
subject stages domain
dibenzo [ a , h ] anthracene
tumor findings domain
trial paths domain
trial stages domain
trial sets domain
nonclinical randomization
nonclinical study length
planned number of nonclinical subjects
nonclinical study sponsor
nonclinical study title
hair or fur cover
acfucy regimen
consistency
inpp5d gene
inpp5d wt allele
phosphatidylinositol 3 , 4 , 5 - trisphosphate 5 - phosphatase 1
gamma secretase
psen1 gene
psen1 wt allele
presenilin - 1
psen2 gene
psen2 wt allele
cdisc sdtm physical properties test name terminology
cdisc sdtm physical properties test code terminology
presenilin - 2
macimorelin
lenvatinib
fenquizone potassium
neomycin c
interlaboratory
intralaboratory
immunoperoxidase procedure
how often upset by something unexpected in the last month
how often unable to control important things in the last month
how often felt nervous and stressed in the last month
how often felt confident about ability to handle problems in the last month
how often felt things going your way in the last month
how often could not cope with things that needed doing in the last month
how often able to control irritations in the last month
cytarabine / doxorubicin / prednisone / vincristine regimen
how often felt on top of things in the last month
how often angered by things outside your control in the last month
how often felt difficulties too high to overcome in the last month
almost never
fairly often
t ( 4 ; 14 )
t ( 14 ; 16 )
beta - 2 microglobulin greater than 5 .5 g / ml
vosaroxin
ishak score
ishak score 0
ishak score 1
ishak score 2
ishak score 3
ishak score 4
ishak score 5
ishak score 6
exponential function
line spread function
medical internal radiation dose
flood field
autoradiographic image
azidocillin potassium
germanium
life support
stage iia1 cervical cancer ajcc v7
stage iia2 cervical cancer ajcc v7
stage iiic1 uterine corpus cancer ajcc v7
mathematical derivative
stage iiic2 uterine corpus cancer ajcc v7
stage iia1
stage iia2
stage iiic1
stage iiic2
absorbed radiation dose
osmium
iridium
palladium
erbium
lithium
antimony
thallium
titanium
rhodium
rubidium
tellurium
bismuth
medactive oral product
actinomycin c2
carbon c - 13 dextromethorphan
sodium bicarbonate / potassium bicarbonate / anhydrous citric acid
parp inhibitor azd2461
pixatimod
c - met inhibitor amg 337
vegfr2 - targeted contrast agent br55
technetium tc - 99m dtpa
depatuxizumab
hla - a*2402 - restricted cdca1 - urlc10 - kif20a - depdc1 - mphosph1 multipeptide vaccine
triazene derivative trin2755
guadecitabine
clevudine
hla - a*2402 - restricted vegfr1 / 2 multipeptide vaccine
urlc10 - cdca1 - koc1 multipeptide vaccine
allogeneic renal cell carcinoma vaccine mgn1601
ozarelix
bleomycin / doxorubicin / lomustine / mechlorethamine / vincristine regimen
voglibose
fostamatinib
nilotinib hydrochloride anhydrous
saracatinib difumarate
selumetinib sulfate
varlitinib tosylate
fostamatinib disodium anhydrous
nilotinib hydrochloride monohydrate
bcd regimen
pegaptanib sodium
bcp regimen
ubiquitination regulation protein
dna replication initiation protein
elongin
regulated intramembrane proteolysis
glrx3 gene
glrx3 wt allele
glutaredoxin - 3
lrp8 gene
lrp8 wt allele
low - density lipoprotein receptor - related protein 8
tet2 gene
tet2 wt allele
methylcytosine dioxygenase tet2
ancrod
prkd1 gene
prkd1 wt allele
serine / threonine - protein kinase d1
prkd2 gene
prkd2 wt allele
serine / threonine - protein kinase d2
prkd3 gene
prkd3 wt allele
serine / threonine - protein kinase d3
aurkc gene
aurkc wt allele
aurora kinase c
fh gene
fh wt allele
fumarate hydratase ,  mitochondrial
apobec3f gene
apobec3f wt allele
dna dc to du - editing enzyme apobec - 3f
crtc3 gene
crtc3 wt allele
creb - regulated transcription coactivator 3
bip regimen
trim24 gene
trim24 wt allele
transcription intermediary factor 1 - alpha
tropisetron hydrochloride
klln gene
klln wt allele
killin
mobp regimen
prex1 gene
prex1 wt allele
phosphatidylinositol 3 , 4 , 5 - trisphosphate - dependent rac exchanger 1 protein
cdk8 gene
cdk8 wt allele
cyclin - dependent kinase 8
azp
bcvpp regimen
sfrp1 gene
sfrp1 wt allele
secreted frizzled - related protein 1
tmem127 gene
tmem127 wt allele
transmembrane protein 127
slamf7 gene
slamf7 wt allele
slam family member 7
lomustine / methotrexate / procarbazine regimen
calr gene
calr wt allele
calreticulin
pirarubicin hydrochloride
carboplatin / cyclophosphamide regimen
briakinumab
fanolesomab
enloplatin
nimustine hydrochloride
buformin
buformin hydrochloride
digestive system dysplasia
defined medical condition result
defined adverse event
planned subject activity group
service delivery location
scheduled substance administration
active ingredient dose
active ingredient dose description
handling code
cafvp regimen
local variable name
medical history indicator
period active ingredient dose total
population scope code
product dose
received indicator
reference type code
risk code
stability duration
study day range
value null flavor reason
biologic handling code
biologic risk code
biologic stability duration
cosmetic stability duration
defined adverse event category code
defined adverse event severity code
defined adverse event subcategory code
defined expression variable relationship local variable name
device handling code
device risk code
document version relationship priority number
drug handling code
drug risk code
drug stability duration
food product stability duration
package handling code
performed activity study day range
performed medical condition result medical history indicator
performed observation approach anatomic site code
performed observation approach anatomic site laterality code
performed observation result value null flavor reason
performed protocol deviation subcategory code
performed substance administration active ingredient dose
performed substance administration active ingredient dose description
performed substance administration flow rate
performed substance administration interruption duration
performed substance administration period active ingredient dose total
place name
planned activity study day range
camp regimen
planned subject activity group sequence number
processed product identifier
product relationship confidentiality code
product relationship effective date range
product relationship identifier
product relationship type code
reference result fasting status indicator
reference result population scope code
reference result reference type code
regulatory assessment type code
facp regimen
report receiver receipt date
report receiver received indicator
safety report confidentiality code
scheduled substance administration product dose
service delivery location code
service delivery location postal address
specimen type code
intramucosal adenocarcinoma
performed product transport
defined expression variable relationship
tauromustine
service delivery location telecom address
patient reported outcome
past week
developmental neuropsychological assessment
digestive system neuroendocrine tumor
digestive system neuroendocrine carcinoma
digestive system mixed adenoneuroendocrine carcinoma
core histone macro - h2a
anticardiolipin antibody
plasma kallikrein
lrp5 gene
lrp5 wt allele
lrp6 gene
lrp6 wt allele
low - density lipoprotein receptor - related protein 5
low - density lipoprotein receptor - related protein 6
dkk1 gene
dkk1 wt allele
dickkopf - related protein 1
dkk3 gene
dkk3 wt allele
dickkopf - related protein 3
tet1 gene
tet1 wt allele
methylcytosine dioxygenase tet1
pancreatic well differentiated ductal adenocarcinoma
pancreatic moderately differentiated ductal adenocarcinoma
pancreatic poorly differentiated ductal adenocarcinoma
pancreatic intraepithelial neoplasia - 1a
cyclophosphamide / lomustine / vincristine regimen
pancreatic intraepithelial neoplasia - 1b
pancreatic intraepithelial neoplasia / lesion - 1a
high grade pancreatic intraepithelial neoplasia
hspb8 gene
hspb8 wt allele
heat shock protein beta - 8
hereditary pancreatitis
acute pancreatitis
pbrm1 gene
pbrm1 wt allele
protein polybromo - 1
falcine
petrous
internal auditory canal
supraorbital
suprasellar
hspg2 gene
hspg2 wt allele
basement membrane - specific heparan sulfate proteoglycan core protein
crtc1 gene
crtc1 wt allele
creb - regulated transcription coactivator 1
crtc2 gene
crtc2 wt allele
creb - regulated transcription coactivator 2
maml2 gene
maml2 wt allele
pancreatic mixed acinar - ductal carcinoma
mastermind - like protein 2
pancreatic mixed acinar - ductal neuroendocrine carcinoma
aip gene
aip wt allele
ah receptor - interacting protein
inhalation
pancreatic hepatoid adenocarcinoma
pancreatic medullary carcinoma
pde5a gene
pde5a wt allele
cgmp - specific 3' , 5' - cyclic phosphodiesterase
pancreatic serous adenoma
pancreatic macrocystic serous cystadenoma
lrp1 gene
lrp1 wt allele
prolow - density lipoprotein receptor - related protein 1
pancreatic solid serous adenoma
von hippel - lindau syndrome - associated pancreatic serous adenoma
creb3l1 gene
creb3l1 wt allele
cyclic amp - responsive element - binding protein 3 - like protein 1
cfp regimen
creb3l2 gene
creb3l2 wt allele
cyclic amp - responsive element - binding protein 3 - like protein 2
pancreatic mucinous - cystic neoplasm ,  low grade
cyberknife
creb3l3 gene
creb3l3 wt allele
cyclic amp - responsive element - binding protein 3 - like protein 3
non - invasive pancreatic mucinous - cystic neoplasm
misfortune
ease
state - trait anxiety inventory
calm
pancreatic mucinous - cystic neoplasm ,  high grade
indecision
jittery
pleasant
secure
self - confidence
carmofur
bleomycin / cyclophosphamide / doxorubicin / prednisone / vincristine
steady
strain
tension
upset
hemoglobin h disease
pancreatic intraductal neoplasm
pancreatic intraductal tubulopapillary neoplasm
pancreatic intraductal tubulopapillary neoplasm with an associated invasive carcinoma
pancreatic intraductal papillary mucinous neoplasm ,  gastric - type
cellular changes resembling foveolar epithelium cells
chvp regimen
pancreatic intraductal papillary mucinous neoplasm ,  intestinal - type
tall papillae present
pancreatic intraductal papillary mucinous neoplasm ,  pancreatobiliary - type
thin - branching papillae present
pancreatic intraductal papillary mucinous neoplasm ,  oncocytic - type
bone marrow donors worldwide
centers for medicare and medicaid services
isbt - 128 donation identification number
prepacyte - cb
axp autoxpress platform
cisplatin / fluorouracil / methotrexate regimen
sepax cell separation device
bioarchive system
hepatitis b surface antigen neutralization
hiv1 p24 antigen neutralization
hiv western blot
hepatitis c virus recombinant immunoblot assay
anti - hiv2 enzyme immunoassay
fluorescent treponemal antibody absorption
mve freezer
taylor - wharton freezer
dry shipper
cryoguard thermal exposure indicator
neutralization
hemoglobin trait
alpha thalassemia trait
alpha thalassemia silent carrier
homozygous hemoglobin c or e ,  non - disease
beta thalassemia plus structural variants
sickle beta thalassemia
monomeric cyanine dye
rapid screening method for alpha thalassemia
pancreatic acinar cell neoplasm
stay out of bed
dressing
light work
acinar cystic transformation of the pancreas
hard work
driving
run errand
cooking
attend paid job
easy bleeding
people
better off
guilt
nail changes
vaginal bleeding
pancreatic teratoma
mature pancreatic teratoma
cmfpt regimen
prophylactic
deimmunization
wwp2 gene
wwp2 wt allele
nedd4 - like e3 ubiquitin - protein ligase wwp2
klkb1 gene
klkb1 wt allele
urod gene
urod wt allele
uroporphyrinogen decarboxylase
cmfvp regimen
spp1 gene
spp1 wt allele
pde4b gene
pde4b wt allele
camp - specific 3' , 5' - cyclic phosphodiesterase 4b
dmp1 gene
dmp1 wt allele
dentin matrix acidic phosphoprotein 1
cux1 gene
cux1 wt allele
protein casp
homeobox protein cut - like 1
pancreatic large cell neuroendocrine carcinoma
pancreatic small cell neuroendocrine carcinoma
pancreatic neuroendocrine tumor g1
non - functioning pancreatic neuroendocrine tumor g1
cdcp1 gene
cdcp1 wt allele
cub domain - containing protein 1
sirt3 gene
sirt3 wt allele
nad - dependent deacetylase sirtuin - 3 ,  mitochondrial
bub1b gene
bub1b wt allele
mitotic checkpoint serine / threonine - protein kinase bub1 beta
pancreatic somatostatinoma
pancreatic gastrinoma
pancreatic glucagonoma
pancreatic insulinoma
pancreatic vipoma
edelfosine
vcf regimen
marketed as approved drug product manufactured exclusively for private label distributor
marketed as otc monograph drug product manufactured exclusively for private label distributor
marketed as unapproved drug product manufactured exclusively for private label distributor
plaque
rifamycin sodium
second primary malignant neoplasm
esophageal spindle cell carcinoma
esophageal basal cell hyperplasia
comf regimen
esophageal well differentiated squamous cell carcinoma
esophageal moderately differentiated squamous cell carcinoma
esophageal poorly differentiated squamous cell carcinoma
intraepithelial neoplasia in barrett esophagus
barrett esophagus - negative for dysplasia
barrett esophagus - indefinite for dysplasia
esophageal neuroendocrine tumor
esophageal neuroendocrine tumor g2
review of systems
esophageal neuroendocrine carcinoma
comp regimen
esophageal large cell neuroendocrine carcinoma
esophageal mixed adenoneuroendocrine carcinoma
esophageal hemangioma
esophageal rhabdomyosarcoma
esophageal synovial sarcoma
esophageal diffuse large b - cell lymphoma
esophageal mucosa - associated lymphoid tissue lymphoma
address part data type
bag data type
bag telephone data type
cyclophosphamide / vincristine / prednisone / bleomycin regimen
boolean non - null data type
character string no translations data type
coded continuous set data type
coded ordinal data type
coded simple value data type
coded string data type
coded string no translations data type
coded value data type
continuous set data type
continuous set difference data type
bacopp regimen
continuous set intersection data type
continuous set periodic hull data type
continuous set set data type
continuous set union data type
discrete set code data type
discrete set coded string data type
discrete set data type
discrete set instance identifier data type
discrete set string data type
encapsulated data data type
encapsulated data image data type
encapsulated data signature data type
encapsulated data text data type
entity name data type
entity name organization data type
entity name part data type
entity name person data type
entity name trivial data type
event - related periodic interval of time data type
generated sequence data type
high interval data type
historical data type
instance identifier data type
integer to physical quantity time ratio data type
interval point in time date and time data type
interval point in time date data type
low interval data type
monetary amount data type
non - negative integer data type
non - parametric probability distribution data type
periodic interval data type
physical quantity data type
physical quantity representation data type
physical quantity time data type
physical quantity to physical quantity ratio data type
physical quantity to physical quantity time ratio data type
point in time date and time data type
point in time full date data type
positive integer data type
sampled sequence data type
simple character string data type
structured text data type
structured title data type
uncertain range non - negative integer data type
width interval data type
bag address data type
discrete set entity name data type
discrete set entity name organization data type
cisplatin / cyclophosphamide regimen
discrete set organization name data type
discrete set person name data type
interval point in time integer data type
non - negative integer to non - negative integer ratio data type
non - negative integer to physical quantity time ratio data type
trivial name data type
uncertain range physical quantity time data type
yttrium y 90 anti - cd45 monoclonal antibody bc8
tlr7 agonist ana773 tosylate
10 - deacetyltaxol
chad regimen
anticachexia agent mt - 102
ribociclib
jak2 inhibitor bms - 911543
palifosfamide tromethamine
anti - ang2 monoclonal antibody medi - 3617
svn53 - 67 / m57 - klh peptide vaccine
antibiotic sq109
anti - psma monoclonal antibody - mmae conjugate
bermekimab
prohibitin - targeting peptide 1
dvb regimen
labetuzumab govitecan
iodine i 124 - labeled hsp90 inhibitor puh71
nesvacumab
z - endoxifen hydrochloride
timolol maleate gel forming solution
autologous cd8 positive pbl sensitized to drosophila cell - presented melanoma peptides
cyl - 02 plasmid dna
liposomal sn - 38
liposomal c - raf antisense oligonucleotide
tarextumab
era36 modulator icaritin
anti - hb - egf monoclonal antibody khk2866
muc1 - targeted peptide go - 203 - 2c
pi3k inhibitor zstk474
mtf - 1 inhibitor apto - 253 hcl
carbon c 11 n - desmethyl - loperamide
lucitanib
pumvc3 - higfbp - 2 multi - epitope plasmid dna vaccine
anti - cea bite monoclonal antibody amg211
merestinib
mucoadhesive oral wound rinse
antrodia cinnamomea supplement
emibetuzumab
talazoparib
anti - vegfr3 monoclonal antibody imc - 3c5
herbal polysaccharide saliva substitute
anti - hbegf monoclonal antibody u3 - 1565
akt inhibitor ly2780301
mek inhibitor gdc - 0623
l - lysine
eif4e antisense oligonucleotide isis 183750
melitac 12 .1 peptide vaccine
egaptivon pegol
gastric poorly cohesive adenocarcinoma
poorly cohesive malignant cellular infiltrate
helplessness
sleepiness
gastric hepatoid adenocarcinoma
gastric carcinoma with lymphoid stroma
gastric choriocarcinoma
anti - cd3 x anti - cd20 bispecific antibody - armed activated t cells
autoimmune gastritis
gastric intestinal metaplasia
gastric dysplasia
ulocuplumab
negative for gastric dysplasia
artemisia absinthium
indefinite for gastric dysplasia
autologous ovarian tumor cell lysate - pulsed dendritic cell vaccine
anti - cd3 / anti - cd20 trifunctional bispecific monoclonal antibody fbta05
drug therapy
polyethylene glycol 1000 cetyl ether cream
gastric intramucosal adenocarcinoma
anti - ca6 - dm4 immunoconjugate sar566658
polyacrylamide hydrogel
fluorodopa f 18
gastric non - neoplastic polyp
tafasitamab
crystalline genistein formulation axp107 - 11
freeze - dried black raspberry bioadhesive gel
primary prostate cancer tissue / htert / survivin mrna - loaded autologous dendritic cell vaccine
sig12d loder
gastric adenoma ,  intestinal - type
gastric - type epithelial differentiation
gastric adenoma ,  gastric - type
amuvatinib hydrochloride
ponatinib
foveolar - type epithelium present
foveolar - type adenoma
datvp regimen
anrukinzumab
foralumab
foravirumab
itolizumab
mavrilimumab
naptumomab estafenatox
teprotumumab
vedolizumab
edatrexate
davh regimen
tofacitinib
ischemic cerebrovascular accident
hemorrhagic cerebrovascular accident
carotid artery stenosis
t1mi stage finding
break - induced replication
cpe gene
cpe wt allele
carboxypeptidase e
cytarabine / daunorubicin / mercaptopurine / prednisolone regimen
carboxypeptidase e - deltan
magi2 gene
magi2 wt allele
membrane - associated guanylate kinase ,  ww and pdz domain - containing protein 2
nedd8 activating enzyme
address data type
any data type
character string data type
collection data type
history data type
integer data type
interval data type
object identifier data type
quantity data type
ratio data type
real data type
sequence data type
telecommunication address data type
url data type
cisplatin / cytarabine / dexamethasone
mir34a gene
mir34a wt allele
mir34a pre - mirna
congenital heart disease
kcnj5 gene
kcnj5 wt allele
g protein - activated inward rectifier potassium channel 4
ube4b gene
ube4b wt allele
ubiquitin conjugation factor e4 b
cadm2 gene
cadm2 wt allele
cell adhesion molecule 2
nedd8 gene
nedd8 wt allele
nedd8
naa10 gene
naa10 wt allele
n - alpha - acetyltransferase 10 ,  nata catalytic subunit
nae1 gene
nae1 wt allele
nedd8 - activating enzyme e1 regulatory subunit
uba3 gene
uba3 wt allele
nedd8 - activating enzyme e1 catalytic subunit
npepps gene
ebap regimen
npepps wt allele
puromycin - sensitive aminopeptidase
psme3 gene
psme3 wt allele
proteasome activator complex subunit 3
pcbp1 gene
pcbp1 wt allele
poly ( rc )  - binding protein 1
znf703 gene
znf703 wt allele
zinc finger protein 703
gastric neuroendocrine tumor
loxl2 gene
loxl2 wt allele
lysyl oxidase homolog 2
high capture threshold
unstable capture threshold
no pacing
missing test results
device handling problem
voca regimen
gastric neuroendocrine tumor g2
tfdp1 gene
tfdp1 wt allele
transcription factor dp - 1
gastric neuroendocrine carcinoma
gastric large cell neuroendocrine carcinoma
gastric mixed adenoneuroendocrine carcinoma
carbon c 11 alpha - methyltryptophan
plocabulin
stat3 inhibitor opb - 51602
preimplantation factor pif - 1
pi3k - delta inhibitor amg 319
psma - targeted docetaxel nanoparticles bind - 014
g - quadruplex stabilizer bmvc
cbp / beta - catenin antagonist pri - 724
benign gastric gastrointestinal stromal tumor
vorolanib
malignant gastric gastrointestinal stromal tumor
gastric gastrointestinal stromal tumor of uncertain malignant potential
gastric synovial sarcoma
12 - hydroxy - 5 , 8 , 10 , 14 - eicosatetraenoic acid
gastric glomus tumor
gastric schwannoma
gastric plexiform fibromyxoma
metastatic malignant neoplasm in the stomach
protective clothing
preinvasive neoplasm of the ampullary region
vidarabine sodium phosphate
valtorcitabine
ampullary noninvasive papillary neoplasm ,  pancreatobiliary type
ampullary noninvasive pancreatobiliary papillary neoplasm with low grade dysplasia
ampullary noninvasive pancreatobiliary papillary neoplasm with high grade dysplasia
tezacitabine anhydrous
ampullary flat intraepithelial neoplasia ,  high grade
n0  ( i -  )  stage finding
n0  ( i +  )  stage finding
n0  ( mol -  )  stage finding
piga gene
n0  ( mol +  )  stage finding
piga wt allele
phosphatidylinositol n - acetylglucosaminyltransferase subunit a
cd55 gene
n1bi stage finding
cd55 wt allele
complement decay - accelerating factor
cd59 gene
cd59 wt allele
cd59 glycoprotein
n1bii stage finding
n1biii stage finding
n1biv stage finding
double - stranded rna
single - stranded rna
genomic dna
nuclear dna
transposon
ribosomal rna gene
dna - directed rna interference
viroid
ancient dna
rna polymerase i
rna polymerase ii
ribonucleoprotein
signal recognition particle rna
7sk small nuclear rna
guide rna
piwi - interacting rna
transfer - messenger rna
n1mi stage finding
cm0  ( i +  )  stage finding
stage x
ampulla of vater pancreatobiliary type adenocarcinoma
pancreatobiliary - type malignant cells present
ampulla of vater undifferentiated carcinoma with osteoclast - like giant cells
ampulla of vater hepatoid adenocarcinoma
ampulla of vater invasive papillary adenocarcinoma
androstenediol
hexa - caf regimen
ampulla of vater neuroendocrine neoplasm
ampulla of vater neuroendocrine tumor
ampulla of vater neuroendocrine tumor g1
ampulla of vater neuroendocrine tumor g2
ampulla of vater neuroendocrine carcinoma
ampulla of vater large cell neuroendocrine carcinoma
ampulla of vater mixed adenoneuroendocrine carcinoma
ampulla of vater enterochromaffin cell serotonin - producing neuroendocrine tumor
ampulla of vater somatostatin - producing neuroendocrine tumor
ampulla of vater gangliocytic paraganglioma
bleomycin / cytarabine / doxorubicin / prednisone / vincristine regimen
p16 - positive neoplastic cells present
dural extranodal marginal zone lymphoma of mucosa - associated lymphoid tissue
igg4 - related disease
di guglielmo syndrome
taf15 gene
taf15 wt allele
tata - binding protein - associated factor 2n
en2 gene
en2 wt allele
homeobox protein engrailed - 2
hydroxyprogesterone caproate
cisplatin / doxorubicin / ifosfamide regimen
e2f2 gene
tobacco use cessation
e2f2 wt allele
transcription factor e2f2
e2f3 gene
e2f3 wt allele
transcription factor e2f3
nr4a3 gene
nr4a3 wt allele
nuclear receptor subfamily 4 group a member 3
m - ei regimen
mir376c gene
mir376c wt allele
mir376c pre - mirna
ciita gene
ciita wt allele
mhc class ii transactivator
cflar gene
cflar wt allele
casp8 and fadd - like apoptosis regulator
acvr1c gene
lmf regimen
acvr1c wt allele
activin receptor type - 1c
cd274 gene
cd274 wt allele
programmed cell death 1 ligand 1
ta stage finding
n4 stage finding
rmi2 gene
rmi2 wt allele
recq - mediated genome instability protein 2
yap1 gene
yap1 wt allele
transcriptional coactivator yap1
facit fatigue scale
adam12 gene
adam12 wt allele
nutraceutical tbl - 12
paclitaxel injection concentrate for nanodispersion
her2 - targeted liposomal doxorubicin hydrochloride mm - 302
disintegrin and metalloproteinase domain - containing protein 12
anti - ox40 monoclonal antibody
melan - a / mage - 3 .dp4 peptide vaccine
na - 17 / mage - 3 .a2 / ny - eso - 1 peptide vaccine
nodal gene
nodal wt allele
nodal homolog
tlr9 gene
tlr9 wt allele
toll - like receptor 9
slc28a1 gene
slc28a1 wt allele
sodium / nucleoside cotransporter 1
juvenile polyp of the small intestine
small intestinal b - cell non - hodgkin lymphoma
small intestinal t - cell non - hodgkin lymphoma
small intestinal diffuse large b - cell lymphoma
small intestinal follicular lymphoma
small intestinal high grade b - cell lymphoma ,  not otherwise specified
monomorphic epitheliotropic intestinal t - cell lymphoma
small intestinal kaposi sarcoma
small intestinal angiosarcoma
small intestinal neuroendocrine tumor
intestinal neuroendocrine tumor
intestinal neuroendocrine carcinoma
small intestinal neuroendocrine carcinoma
small intestinal large cell neuroendocrine carcinoma
small intestinal mixed adenoneuroendocrine carcinoma
small intestinal neuroendocrine tumor g2
fda stability data standards terminology
macc regimen
stability study data file type terminology
stability study data file reason terminology
stability product identifier terminology
small intestinal gangliocytic paraganglioma
stability product form terminology
stability substance identifier terminology
stability study test terminology
stability study method type terminology
stability study interpretation terminology
stability study type terminology
stability container closure system terminology
stability container type terminology
stability study storage condition terminology
stability study pause description terminology
photostability drug study
bleomycin / cisplatin / methotrexate regimen
investigational new drug application
investigational new animal drug file
new active ingredient
gemcitabine hydrochloride
cmc regimen
compendial method
proprietary method
child resistant metal container closure
child resistant plastic container closure
continuous thread metal container closure
continuous thread plastic container closure
tamper evident metal container closure
tamper evident plastic container closure
vacuum sealed metal container closure
tamper evident composite container closure
vacuum sealed plastic container closure
vacuum sealed composite container closure
press - on / twist - off metal container closure
press - on composite container closure
crown metal container closure
lug metal container closure
roll on metal container closure
flip - top dispensing plastic container closure
hinged dispensing plastic container closure
copadm regimen
linerless plastic container closure
pump dispensing plastic container closure
push - pull dispensing plastic container closure
snap - on cap plastic container closure
snip - tip dispensing plastic container closure
toggle - swing dispensing plastic container closure
trigger spray dispensing plastic container closure
twist open / close dispensing plastic container closure
valved dispensing plastic container closure
stopper container closure
fluorouracil / leucovorin calcium / methotrexate regimen
tie container closure
petri dish
microwell plate
lined canister
flask
proprietary storage condition
etoposide / ifosfamide / methotrexate / mitoguazone
colorectal neuroendocrine neoplasm
colorectal neuroendocrine carcinoma
colorectal large cell neuroendocrine carcinoma
colorectal mixed adenoneuroendocrine carcinoma
colorectal neuroendocrine tumor
colorectal neuroendocrine tumor g1
colorectal l - cell glucagon - like peptide - producing neuroendocrine tumor
colorectal enterochromaffin cell serotonin - producing neuroendocrine tumor
colorectal neuroendocrine tumor g2
code of federal regulations method
intestinal neuroendocrine tumor g2
digestive system neuroendocrine tumor g2
diaper
occasional macrophages present
chronic acalculous cholecystitis
mof - strep regimen
intestinal metaplasia of columnar epithelium
bunionectomy
revision hammer toe surgery
darkly pigmented melanophages present
deep adventitial inked margin
arterial access port removal
parotid gland deep lobe
nerve regeneration
early regeneration
efferent arteriolar hyalinosis
endocervical glandular epithelium
epithelial damage
fibrillary glomerulonephritis
fibroblastic proliferation present
localized hemorrhagic and ulcerated lesion
gritty cut surface
hyaline arteriolosclerosis
intramucosal neutrophilic infiltrate
intrathyroidal parathyroid
invasion of muscularis mucosa present
ischemic glomerulopathy
trichlormethine
mopp - abv regimen
anagliptin
erythroid series cells decreased
mastopexy
meniscal cyst
anisopoikilocytosis
mild to moderate anisopoikilocytosis
negative for neoplasia
femoral shaft
neuropathic pain
serosal lesion
perimysial and endomysial inflammatory infiltrate
radical tympanomastoidectomy
scattered interstitial eosinophils present
stromal hemosiderin deposition
subepithelial collagen band present
cingulate gyrus
skin eschar
hyperparakeratosis
mechlorethamine / prednisone / procarbazine / vinblastine / vincristine regimen
tobacco induced hyperparakeratosis
adenovirus - encoding e .coli pnp
pepinemab
integrin receptor antagonist glpg0187
urethritis cystica and glandularis
urethritis cystica
urethritis glandularis
cfms tyrosine kinase inhibitor arry - 382
cystitis cystica and glandularis
parvovirus h - 1
cytarabine / mitoxantrone regimen
cystitis cystica
muscadine grape skin extract
ng - nitro - l - arginine
dexpanthenol mouthwash
fluorine f 18 dcfbc
fluorine f 18 fluoro - peg6 - ipqa
18 - f - fluoroacetate
widespread alveolar pneumocyte damage present
hyalinization
glomerular hypertrophy
oap regimen
stage ib cervix
stage ii cervix
stage iia cervix
figo stage 0
figo stage i
figo stage ia
figo stage ia1
figo stage ia2
figo stage ib
figo stage ib1
cyclophosphamide / doxorubicin / prednisone / procarbazine / vincristine regimen
figo stage ib2
figo stage ic
figo stage ii
figo stage iia
figo stage iib
figo stage iii
figo stage iiia
figo stage iiib
figo stage iiic
figo stage iiic1
bleomycin / cisplatin / cyclophosphamide / doxorubicin regimen
figo stage iiic2
figo stage iv
figo stage iva
figo stage ivb
hypogranularity
dual pack dosing unit
intramedullary
labial
intracytoplasmic lipofuscin present
malar
lomustine / procarbazine / vincristine
pten gene deletion
pik3ca gene mutation
microabscess
mottled skin
pedicle of vertebral arch
perigastric
perimysial
peroneal
plasmacytosis
polypoid
cfl regimen
remnant
semitransparent
mevastatin
lapaquistat
mononucleotide marker panel
mononucleotide and dinucleotide marker panel
pocc regimen
spongiosis
nafamostat
nafamostat mesylate
stump
submucosal
tan
tendon sheath
sarcnu
translucent
unremarkable
cytoplasmic vacuolation
vague
variegated
rosuvastatin zinc
prime regimen
mtorc1
mtorc2
tent5c gene
tent5c wt allele
terminal nucleotidyltransferase 5c
uri1 gene
uri1 wt allele
unconventional prefoldin rpb5 interactor 1
angptl4 gene
positive regulation of angiogenesis
angptl4 wt allele
angiopoietin - related protein 4
fgf19 gene
fgf19 wt allele
fibroblast growth factor 19
snd1 gene
snd1 wt allele
staphylococcal nuclease and tudor domain containing 1
kdm6a gene
kdm6a wt allele
lysine - specific demethylase 6a
alox12b gene
alox12b wt allele
arachidonate 12 - lipoxygenase ,  12r - type
asparaginase / daunorubicin / prednisone / vincristine regimen
event - free survival
nsd3 gene
nsd3 wt allele
histone - lysine n - methyltransferase nsd3
perinuclear halo present
mini - gemistocyte
circumferential endothelial hyperplasia
chicken - wire vasculature
multiple serpentine pseudopalisading pattern
zonal necrosis
perineuronal and / or perivascular satellitosis
entrapped gray matter present
entrapped white matter present
pnrc1 gene
pnrc1 wt allele
proline - rich nuclear receptor coactivator 1
microcyst
dis3 gene
dis3 wt allele
doap regimen
exosome complex exonuclease rrp44
small cell component present
oligodendroglioma - like component with perinuclear cytoplasmic halos present
epithelial metaplasia
camostat mesylate
micro - mineralization
conestat alfa
btrc gene
btrc wt allele
f - box / wd repeat - containing protein 1a
scab regimen
standard for the exchange of nonclinical data controlled terminology version
standard for the exchange of nonclinical data implementation guide version 3 .0
missing study animal
send test system strain
eif3b gene
eif3b wt allele
eukaryotic translation initiation factor 3 subunit b
traf3 gene
traf3 wt allele
tnf receptor - associated factor 3
vath regimen
ikbip gene
ikbip wt allele
inhibitor of nuclear factor kappa - b kinase - interacting protein
ikbkb gene
ikbkb wt allele
inhibitor of nuclear factor kappa - b kinase subunit beta
ripk4 gene
ripk4 wt allele
pediatric immunization terminology
receptor - interacting serine / threonine - protein kinase 4
bacterial vaccine
meningococcal conjugate vaccine mcv4
typhoid vaccine
streptococcus pneumoniae vaccine
rotavirus vaccine
varicella vaccine
yellow fever vaccine
meningococcal vaccine
toxoid vaccine
bordetella pertussis vaccine adsorbed
fludeoxyglucose f - 18
oral polio vaccine
live attenuated influenza vaccine
measles / mumps / rubella vaccine
viral vaccine
tetanus and diphtheria toxoids adsorbed
measles
varicella zoster infection
influenza vaccination
polio vaccination
dyslexia
pediatric viral infection
brain development abnormality
brain disorder
serrated lesions and polyps
appendix serrated lesions and polyps
appendix hyperplastic polyp
generalized dysplasia
appendix intraepithelial neoplasia
appendix low grade intraepithelial neoplasia
appendix high grade intraepithelial neoplasia
high grade appendix mucinous adenocarcinoma
appendix neuroendocrine tumor
appendix neuroendocrine tumor g2
appendix enterochromaffin cell serotonin - producing neuroendocrine tumor
appendix neuroendocrine carcinoma
appendix large cell neuroendocrine carcinoma
topical piperidine nitroxide mts - 01
napabucasin
vaca regimen
anti - tf monoclonal antibody alt - 836
ricolinostat
estrogen receptor agonist gtx - 758
send test system common name
appendix kaposi sarcoma
appendix leiomyosarcoma
appendix neuroma
transglutaminase
ptgis gene
ptgis wt allele
prostacyclin synthase
acox2 gene
acox2 wt allele
peroxisomal acyl - coenzyme a oxidase 2
krt7 gene
krt7 wt allele
keratin ,  type ii cytoskeletal 7
prelamin - a / c
des gene
des wt allele
desmin
ivl gene
ivl wt allele
involucrin
krt1 gene
krt1 wt allele
keratin ,  type ii cytoskeletal 1
krt20 gene
krt20 wt allele
keratin ,  type i cytoskeletal 20
ppard gene
ppard wt allele
peroxisome proliferator - activated receptor delta
rectal traditional serrated adenoma
colon serrated lesions and polyps
rectal serrated lesions and polyps
digestive system filiform serrated adenoma
villous projections of the neoplastic epithelium present
colorectal filiform serrated adenoma
colorectal sporadic serrated polyp
doxorubicin / prednisone / vincristine regimen
colon serrated polyposis
colorectal goblet cell rich hyperplastic polyp
colorectal mucin poor hyperplastic polyp
colorectal microvesicular hyperplastic polyp
colorectal hamartoma
gastrointestinal hamartoma
colorectal cowden - associated polyp
rectal tubular adenoma
colorectal adenomatous polyp
colon adenomatous polyp
rectal adenomatous polyp
simultaneous trisomies of chromosomes 4 and 10
cross reaction
calponin
serum interleukin - 2 receptor subunit alpha measurement
colorectal serrated adenocarcinoma
colon serrated adenocarcinoma
rectal serrated adenocarcinoma
colorectal cribriform comedo - type adenocarcinoma
colon cribriform comedo - type adenocarcinoma
rectal cribriform comedo - type adenocarcinoma
colorectal micropapillary adenocarcinoma
colon micropapillary adenocarcinoma
rectal micropapillary adenocarcinoma
colorectal sarcomatoid carcinoma
dysplasia - associated lesion or mass
ulcerative colitis - associated colorectal adenocarcinoma
crohn disease - associated colorectal adenocarcinoma
colorectal lymphoma
colorectal non - hodgkin lymphoma
2 - methoxyestradiol
colorectal hodgkin lymphoma
colorectal high grade b - cell lymphoma ,  not otherwise specified
colorectal burkitt lymphoma
colorectal diffuse large b - cell lymphoma
colon diffuse large b - cell lymphoma
colorectal mantle cell lymphoma
colorectal mucosa - associated lymphoid tissue lymphoma
tumor - associated antigen 43 - 9f
colorectal sarcoma
colorectal leiomyosarcoma
colorectal kaposi sarcoma
colorectal angiosarcoma
colorectal schwannoma
colorectal perineurioma
colorectal ganglioneuroma
single cell gel electrophoresis
colorectal benign granular cell tumor
microvascular density
taste bud
meningococcal polysaccharide vaccine mpsv4
mutyh - associated polyposis
mutyh gene mutation
bmpr1a gene mutation
orthopoxvirus
variola virus
surfomer
anal canal undifferentiated carcinoma
carmustine / doxorubicin / prednisone / vincristine regimen
losmapimod
ponesimod
edoxaban
anal canal neuroendocrine tumor
letaxaban
edoxaban tosylate
anal canal neuroendocrine tumor g1
anal canal neuroendocrine tumor g2
anal canal neuroendocrine carcinoma
anal canal large cell neuroendocrine carcinoma
anal canal small cell neuroendocrine carcinoma
anal canal mixed adenoneuroendocrine carcinoma
anal canal squamous cell papilloma
perpendicular
acetylcholine receptor antibody measurement
dvp regmen
acetylcholinesterase measurement
adjudicator
alpha fetoprotein l1 measurement
alpha fetoprotein l2 measurement
alpha fetoprotein l3 measurement
alpha fetoprotein l3 to total alpha fetoprotein ratio measurement
average metabolic standard uptake value
basophilic stippling measurement
beta - hydroxybutyrate measurement
biological aunt
biological brother
biological cousin
biological father
biological grandfather
biological grandmother
biological maternal aunt
biological maternal cousin
biological maternal grandfather
biological maternal grandmother
biological maternal uncle
biological mother
biological paternal aunt
biological paternal cousin
biological paternal grandfather
biological paternal grandmother
biological paternal uncle
biological sister
biological uncle
broad casts measurement
calcium clearance measurement
calcium sulphate measurement
carboxyhemoglobin measurement
circulating endothelial cell count
circulating tumor cell count
clarity measurement
cyclic citrullinated peptide antibody measurement
cytomegalovirus igg antibody measurement
cytomegalovirus igm antibody measurement
eccentrocyte count
ehrlich unit
dichloromethotrexate
epstein - barr capsid igg antibody measurement
epstein - barr capsid igm antibody measurement
epstein - barr early antigen measurement
epstein - barr nuclear antibody measurement
epstein - barr nuclear antigen measurement
erythrocyte ghost count
neurologist 2
stack
non - radiological progression
non - target response
vmcp regimen
n - terminal prob - type natriuretic peptide measurement
oncologist 1
oncologist 2
overall response
oxygen capacity measurement
oxyhemoglobin measurement
parvovirus b19 igg antibody measurement
parvovirus b19 igm antibody measurement
per high powered field
per low powered field
percent change from baseline
percent change from nadir
phospholipid measurement
platelet clumps count
procollagen 1 n - terminal propeptide measurement
prothrombin measurement
radiodensity
reptilase time measurement
sulfated dhea measurement
sum of areas
sum of diameters
sum of longest diameters
sum of longest perpendiculars
sum of viable diameters
sum of volumes
target cell count
target response
thyroperoxidase antibody measurement
thyroperoxidase measurement
total body radiography
toxic granulation measurement
tumor fragmentation
tumor status
unequivocal progression
urea to creatinine ratio measurement
viable tumor diameter
alexa fluor
fat measurement
fibrinogen equivalent unit
fibroblast growth factor 23 measurement
giant neutrophil count
glucose clearance measurement
glutamic acid decarboxylase antibody measurement
granulocyte count
half - brother with father as common parent
half - brother with mother as common parent
half - sister with father as common parent
half - sister with mother as common parent
hemosiderin measurement
abdic regimen
hepatitis b virus core antibody measurement
hepatitis b virus core igm antibody measurement
hepatitis b virus e antibody measurement
hepatitis b virus e antigen measurement
hepatitis d virus antibody measurement
hepatitis e virus igm antibody measurement
herpes simplex virus 1 igg antibody measurement
herpes simplex virus 2 igg antibody measurement
hexokinase measurement
hyperchromia measurement
cvad regimen
immature basophil count
immature basophil to leukocyte ratio measurement
immature cell count
immature eosinophil count
immature eosinophil to leukocyte ratio measurement
immature granulocyte count
immature monocyte count
immature monocyte to leukocyte ratio measurement
immature neutrophil count
immature plasma cell count
smf regimen
immature plasma cell to lymphocyte ratio measurement
inhibin b measurement
kurloff cells measurement
liver kidney microsomal type 1 antibody measurement
longest diameter
longest perpendicular
mean platelet component measurement
median fluorescence intensity unit
megakaryocyte count
methemoglobin measurement
methylmalonic acid measurement
molecule of equivalent soluble fluorochrome
neurologist 1
anal inflammatory cloacogenic polyp
auc infinity observed normalized by dose
dilute russell's viper venom time measurement
herpes simplex virus 1 / 2 igg antibody measurement
herpes simplex virus 1 / 2 igm antibody measurement
anal hidradenoma papilliferum
cordycepin triphosphate
vai regimen
non complete response / non progressive disease
ceftaroline fosamil acetate
etarotene
adarotene
activation failure including expansion failures
bile duct disorder
non - neoplastic gallbladder disorder
tromantadine hydrochloride
sulbactam pivoxil
muscarinic agonist apd515
recombinant b . pertussis adenylate cyclase toxin - tyrosinase a2 epitope vaccine
lymphoma taa - specific cytotoxic t lymphocytes
p .dom - wt1 - 37 dna vaccine
p .dom - wt1 - 126 dna vaccine
ovarian cancer stem cell / htert / survivin mrnas - loaded autologous dendritic cell vaccine dc - 006
cr2 - fh fusion protein tt30
allogeneic cd56 - positive cd3 - negative natural killer cells
androgen receptor antisense oligonucleotide ezn - 4176
citicoline
anti - prolactin receptor antibody lfa102
netupitant
cevipabulin succinate
verubulin
eribulin
amsacrine / azacitidine / etoposide regimen
benign liver and intrahepatic bile duct epithelial neoplasm
hnf1alpha - inactivated hepatocellular adenoma
beta - catenin - activated hepatocellular adenoma
inflammatory hepatocellular adenoma
unclassified hepatocellular adenoma
hnf1a gene mutation
valomaciclovir
hepatocellular small cell change
metastatic carcinoma in the liver
high grade liver dysplastic nodule
low grade liver dysplastic nodule
amsacrine lactate
early hepatocellular carcinoma
cdisc sdtm medical evaluator terminology
cdisc sdtm tumor or lesion properties test name terminology
cdisc sdtm tumor or lesion properties test code terminology
fluorouracil / methotrexate / mitoxantrone regimen
cdisc sdtm tumor and lesion identification result terminology
cdisc sdtm tumor response assessment test name terminology
cdisc sdtm tumor response assessment test code terminology
cdisc sdtm tumor identification test name terminology
cdisc sdtm tumor identification test code terminology
cdisc sdtm tumor response result terminology
liver neuroendocrine neoplasm
liver neuroendocrine carcinoma
lymphocyte - rich hepatocellular carcinoma
well differentiated hepatocellular carcinoma
promace - mopp regimen
moderately differentiated hepatocellular carcinoma
poorly differentiated hepatocellular carcinoma
liver undifferentiated carcinoma
bulk ingredient for human prescription compounding
bulk ingredient for animal prescription compounding
parp - 1 / 2 inhibitor abt - 767
copanlisib
domatinostat
vantictumab
dezaguanine
tpo receptor agonist ono - 7746
anti - csf1r monoclonal antibody imc - cs4
vitamin k1 - containing urea skin cream
intrahepatic large bile duct
large duct intrahepatic cholangiocarcinoma
small duct intrahepatic cholangiocarcinoma
intraductal papillary biliary neoplasm
bile duct intraductal papillary neoplasm ,  low grade
bile duct intraductal papillary neoplasm with intermediate grade intraepithelial neoplasia
bile duct intraductal papillary neoplasm ,  high grade
asparaginase / doxorubicin / prednisone / vincristine regimen
bile duct intraductal papillary neoplasm with an associated invasive carcinoma
extrahepatic bile duct tubulopapillary adenoma
obsolete molecular_abnormality_involves_gene
obsolete cytogenetic_abnormality_involves_chromosome
obsolete disease_mapped_to_chromosome
obsolete gene_involved_in_pathogenesis_of_disease
obsolete disease_mapped_to_gene
extensible_list
legacy_concept_name
mirbase_id
neoplastic_status
old_association
pid_id
has_cdrh_parent
has_nichd_parent
megakaryopoiesis
biliary adenofibroma
leukocyte differentiation
calcifying nested stromal - epithelial tumor of the liver
granulocyte differentiation
myeloid cell differentiation
erythrocyte differentiation
thrombocyte differentiation
intrahepatic bile duct mucinous cystic neoplasm
bile duct mucinous cystic neoplasm ,  low grade
bile duct mucinous cystic neoplasm with intermediate grade intraepithelial neoplasia
bile duct mucinous cystic neoplasm ,  high grade
liver cavernous hemangioma
liver infantile hemangioma
liver lymphangioma
liver lymphangiomatosis
liver diffuse large b - cell lymphoma
liver kaposi sarcoma
liver synovial sarcoma
liver epithelioid hemangioendothelioma
extrarenal rhabdoid tumor of the liver
liver carcinosarcoma
liver germ cell tumor
ctc regimen
liver teratoma
liver yolk sac tumor
non - neoplastic hepatobiliary disorder
egfr - tki sensitizing mutation
egfr - tki resistant mutation
pi3kca gene mutation
pik3ca gene amplification
akt family gene mutation
erbb2 gene mutation
pdgfra gene amplification
rosiglitazone cholinate
gallbladder intracholecystic papillary neoplasm ,  low grade
gallbladder intracholecystic papillary  ( tubular )  neoplasm with intermediate grade intraepithelial neoplasia
gallbladder intracholecystic papillary neoplasm ,  high grade
efp regimen
gallbladder mucinous cystic neoplasm
gallbladder mucinous cystic neoplasm ,  low grade
gallbladder mucinous cystic neoplasm with intermediate grade intraepithelial neoplasia
gallbladder mucinous cystic neoplasm ,  high grade
gallbladder mucinous cystic neoplasm with an associated invasive carcinoma
gallbladder carcinosarcoma
expand
gallbladder hepatoid adenocarcinoma
gallbladder cribriform carcinoma
clopidogrel hydrochloride
temanogrel hydrochloride
cd15 antigen
fcer2 gene
droloxifene
cnf regimen
fcer2 wt allele
auricular
low affinity immunoglobulin epsilon fc receptor
intrauterine
itgb1 gene
intraspinal
itgb1 wt allele
integrin beta - 1
sdc1 gene
sdc1 wt allele
syndecan - 1
gallbladder adenocarcinoma ,  biliary type
gallbladder adenocarcinoma ,  gastric foveolar type
gallbladder neuroendocrine neoplasm
gallbladder neuroendocrine tumor
gallbladder neuroendocrine carcinoma
maddoc regimen
gallbladder large cell neuroendocrine carcinoma
gallbladder neuroendocrine tumor g1
gallbladder neuroendocrine tumor g2
gallbladder mixed adenoneuroendocrine carcinoma
gallbladder goblet cell carcinoid
gallbladder tubular carcinoid
paclitaxel ceribate
hematospermia
extrahepatic bile duct adenocarcinoma ,  biliary type
extrahepatic bile duct adenocarcinoma ,  gastric foveolar type
extrahepatic bile duct adenocarcinoma ,  intestinal type
extrahepatic bile duct carcinosarcoma
extrahepatic bile duct biliary intraepithelial neoplasia
intrahepatic bile duct biliary intraepithelial neoplasia
bile duct biliary intraepithelial neoplasia
extrahepatic bile duct mucinous cystic neoplasm with an associated invasive carcinoma
intrahepatic bile duct mucinous cystic neoplasm with an associated invasive carcinoma
extrahepatic bile duct intraductal papillary neoplasm with an associated invasive carcinoma
intrahepatic bile duct intraductal papillary neoplasm with an associated invasive carcinoma
extrahepatic bile duct kaposi sarcoma
extrahepatic bile duct lymphoma
metastatic malignant neoplasm in the extrahepatic bile ducts
extrahepatic bile duct neuroendocrine neoplasm
extrahepatic bile duct neuroendocrine tumor
extrahepatic bile duct neuroendocrine carcinoma
extrahepatic bile duct neuroendocrine tumor g2
extrahepatic bile duct large cell neuroendocrine carcinoma
extrahepatic bile duct mixed adenoneuroendocrine carcinoma
clonal subgroup
business telephone number
digestive system carcinoma
drug sample
bacod regimen
brochure
fam - s regimen
iobenguane i - 131
cyclophosphamide / etoposide / methotrexate / vincristine regimen
internet social media
pave regimen
pentavalent klh conjugate vaccine
mage - a3 reactive t cell receptor - transduced autologous t cells
technetium tc 99m galactosyl human serum albumin
spebrutinib
anti - mesothelin cir mrna - electroporated autologous t cells
anti - pd - 1 fusion protein amp - 224
pce regimen
dna - pk / tor kinase inhibitor cc - 115
clear cell acanthoma
basal cells with pale cytoplasm present
alcoholic brain atrophy
age - related atrophy
metabolic bone disorder
human papillomavirus - related adenosquamous carcinoma
printed material other
internet other
invasive breast lobular carcinoma ,  alveolar variant
target audience
invasive breast lobular carcinoma ,  pleomorphic variant
invasive breast lobular carcinoma ,  solid variant
invasive breast lobular carcinoma ,  tubulolobular variant
generic name
giant cell myocarditis
colloid nodule
condyloma with dysplasia
mixed congenital mesoblastic nephroma
biliary cyst
metaplastic synovial cyst
laryngocele
hydatid cyst
cystic medial necrosis
periosteal desmoid tumor
acute esophagitis
chronic esophagitis
adult extramedullary hematopoiesis
extrahepatic biliary atresia
intrahepatic biliary atresia
congenital hepatic fibrosis
ductal plate malformation
hereditary neurodegenerative disorder
hereditary spherocytosis
hereditary connective tissue disorder
giant cell angioblastoma
funisitis
benign lymphoid hyperplasia
bronchial epithelial hyperplasia
denture - induced fibrous hyperplasia
diffuse hyperplasia
drug induced gingival hyperplasia
focal epithelial hyperplasia
lymph node follicular hyperplasia
aortitis
lithiasis
lymphangiectasia
carbohydrate metabolism disorder
amino acid metabolism disorder
intermediary metabolism disorder
lipid metabolism disorder
lipodystrophy
calcium oxalate crystal deposition
phosphorus metabolic disorder
porphyria
nephrogenic metaplasia
cadmium deposition
zinc deficiency disorder
4' - iodo - 4' - deoxydoxorubicin
muscle cell hypertrophy
antrum
established drug name
safety issue dossier
resubmission
regulatory report
blindness
cyclophosphamide / etoposide / lomustine / vincristine regimen
spinal cord disorder
ecchordosis physaliphora
aortic body
passive congestion
proliferative inflammatory atrophy
pseudoepitheliomatous hyperplasia
attenuated live vaccine
pseudocyst
pseudomonas - related vasculitis
idiopathic pulmonary hypertension
pneumococcal 10 - valent conjugate vaccine
pneumococcal 13 - valent conjugate vaccine
diphtheria toxoid / tetanus toxoid / inactivated pertussis vaccine
pneumococcal conjugate vaccine
bronchopulmonary sequestration
polysaccharide vaccine
ty21a typhoid vaccine
vi capsular polysaccharide typhoid vaccine
acute rejection
pedunculate
cyclophosphamide / etoposide regimen
radiosensitizer rrx - 001
5 - fluorouracil / salicylic acid topical solution
chicken pox
topical wound spray hp802 - 247
fluorine f 18 cp18 peptide
sclerosing polycystic adenosis
rosacea
squamous metaplasia without atypia
complex karyotype
proteomic profile
cope regimen
acute synovitis
tendonitis
acute tonsillitis
ureteritis cystica
arterionephrosclerosis
orchitis
unmutated immunoglobulin heavy chain variable region gene
associated pulmonary arterial hypertension
squamocolumnar junction
neurological development terminology
congenital systemic disorder
non - neoplastic brain disorder
language disorder
yellow fever virus
influenza c virus
genetically modified organism
asperger syndrome
attention deficit hyperactivity disorder
autism
binge eating
childhood depression
childhood disintegrative disorder
dyscalculia
echolalia
anemia of prematurity
ataxic cerebral palsy
athetoid cerebral palsy
mcv regimen
central auditory processing disorder
congenital digestive system disorder
congenital nervous system disorder
congenital respiratory system disorder
congenital skin disorder
low vision
maternal obesity
mixed cerebral palsy
pervasive developmental disorder
rasgrp1 / aptx ratio equal or greater than 5
fda ectd terminology
ectd applicant contact type terminology
ectd application type terminology
ectd form type terminology
ectd product name type terminology
ectd promotional material document type terminology
ectd promotional material type terminology
ectd promotional material audience type terminology
ectd submission sub - type terminology
ectd submission type terminology
ectd supplement effective date type terminology
ectd telephone number type terminology
panic disorder without agoraphobia
panic disorder with agoraphobia
crabp1 gene
crabp1 wt allele
caplet dosage form
cellular retinoic acid - binding protein 1
arhgef7 gene
esorubicin
arhgef7 wt allele
dimerization
rho guanine nucleotide exchange factor 7
sox8 gene
sox8 wt allele
transcription factor sox - 8
klk10 gene
klk10 wt allele
kallikrein - 10
cfh gene
cfh wt allele
complement factor h
dental - enamel junction
antral follicle count
pinx1 gene
pinx1 wt allele
pin2 / terf1 - interacting telomerase inhibitor 1
aldh1b1 gene
aldh1b1 wt allele
aldehyde dehydrogenase x ,  mitochondrial
ksr2 gene
ksr2 wt allele
kinase suppressor of ras 2
zfyve19 gene
zfyve19 wt allele
zinc finger fyve domain - containing protein 19
rasgrp1 gene
rasgrp1 wt allele
ras guanyl - releasing protein 1
embolic agent
mec regimen
embolic bead
bioresorbable embolic bead
drug - eluting embolic bead
plastic embolic bead
bach2 gene
bach2 wt allele
transcription regulator protein bach2
irgm gene
irgm wt allele
immunity - related gtpase family m protein
tp53*1 allele
aimp2 gene
aimp2 wt allele
aminoacyl trna synthase complex - interacting multifunctional protein 2
cd33 gene
cd33 wt allele
myeloid cell surface antigen cd33
cd2ap gene
cd2ap wt allele
cd2 - associated protein
intellectual disability
ppp1r15a gene
ppp1r15a wt allele
protein phosphatase 1 regulatory subunit 15a
pi3k / mtor kinase inhibitor ds - 7423
electrolyte - free parenteral nutrition emulsion
fkbpl gene
lactobacillus acidophilus / estriol vaginal tablet
fkbpl wt allele
fk506 - binding protein - like
tfpi gene
tfpi wt allele
tissue factor pathway inhibitor
tucidinostat
arhgef28 gene
allogeneic aml antigen - expressing dendritic cell vaccine
arhgef28 wt allele
rho guanine nucleotide exchange factor 28
arhgap35 gene
arhgap35 wt allele
rho gtpase - activating protein 35
quizartinib dihydrochloride
afatinib dimaleate
rodorubicin
arhgap5 gene
arhgap5 wt allele
rho gtpase - activating protein 5
promotional material document type
press release
cfl1 gene
cfl1 wt allele
cofilin - 1
lyve1 gene
lyve1 wt allele
lymphatic vessel endothelial hyaluronic acid receptor 1
rpn1 gene
rpn1 wt allele
dolichyl - diphosphooligosaccharide - protein glycosyltransferase subunit 1
rbm15 gene
rbm15 wt allele
putative rna - binding protein 15
mrtfa gene
mrtfa wt allele
myocardin - related transcription factor a
alendronate sodium
epithelial - to - mesenchymal transition
myelodysplastic syndrome with somatic mutations
ezh2 gene mutation
etv6 gene mutation
asxl1 gene mutation
laser cryo enrichment
pbx1 gene
pbx1 wt allele
pre - b - cell leukemia transcription factor 1
asxl1 gene
asxl1 wt allele
putative polycomb group protein asxl1
eif2ak1 gene
eif2ak1 wt allele
manufactured object
explanted organ
nickel metabolic disorder
polycystic
clonidine - containing mucoadhesive buccal tablet
montanide isa 720
intellectual property
iso - fludelone
locus coeruleus
18f - labeled mini - peg spacered rgd dimer
raphe nuclei
2 - fluoropropionyl - labeled pegylated dimeric rgd peptide
anti - tweak monoclonal antibody rg7212
entorhinal cortex
primary motor cortex
primary visual cortex
pars compacta
nucleus of diagonal band
milliampere
mvf - her - 2 ( 597 - 626 )  / mvf - her - 2  ( 266 - 296 )  peptide vaccine
hepatosplenomegaly
bacteriophage phi x 174
isohemagglutinin anti - a
isohemagglutinin anti - b
cd4 positive memory t - lymphocyte
cd4 positive naive t - lymphocyte
south sudan
cobicistat
acsl3 gene
hiv protease inhibitor
acsl3 wt allele
long - chain - fatty - acid - coa ligase 3
cars1 gene
cars1 wt allele
cysteinyl - trna synthetase ,  cytoplasmic
ccnb1ip1 gene
ccnb1ip1 wt allele
e3 ubiquitin - protein ligase ccnb1ip1
cant1 gene
cant1 wt allele
soluble calcium - activated nucleotidase 1
knl1 gene
knl1 wt allele
kinetochore scaffold 1
ccnd3 gene
ccnd3 wt allele
g1 / s - specific cyclin - d3
cdk6 gene
cdk6 wt allele
cyclin - dependent kinase 6
mllt11 gene
mllt11 wt allele
protein af1q
rnf213 gene
rnf213 wt allele
ring finger protein 213
bcl11a gene
bcl11a wt allele
b - cell lymphoma / leukemia 11a
brd3 gene
brd3 wt allele
bromodomain - containing protein 3
formestane
atic gene
atic wt allele
bifunctional purine biosynthesis protein purh
chchd7 gene
chchd7 wt allele
coiled - coil - helix - coiled - coil - helix domain - containing protein 7
chic2 gene
chic2 wt allele
cysteine - rich hydrophobic domain - containing protein 2
cltc gene
cltc wt allele
clathrin heavy chain 1
cltcl1 gene
cltcl1 wt allele
clathrin heavy chain 2
cd74 gene
cd74 wt allele
hla class ii histocompatibility antigen gamma chain
cd79a gene
cd79a wt allele
b - cell antigen receptor complex - associated protein alpha chain
cd79b gene
cd79b wt allele
b - cell antigen receptor complex - associated protein beta chain
cdh11 gene
cdh11 wt allele
cadherin - 11
crlf2 gene
crlf2 wt allele
cytokine receptor - like factor 2
nckipsd gene
nckipsd wt allele
nck - interacting protein with sh3 domain
arhgef12 gene
arhgef12 wt allele
rho guanine nucleotide exchange factor 12
cblc gene
cblc wt allele
e3 ubiquitin - protein ligase cbl - c
chn1 gene
chn1 wt allele
n - chimaerin
cbfa2t3 gene
cbfa2t3 wt allele
protein cbfa2t3
klf6 gene
klf6 wt allele
krueppel - like factor 6
eukaryotic translation initiation factor 2 - alpha kinase 1
nucleoside reverse transcriptase inhibitor
non - nucleoside reverse transcriptase inhibitor
fip1l1 gene
fip1l1 wt allele
pre - mrna 3' - end - processing factor fip1
ddx10 gene
ddx10 wt allele
probable atp - dependent rna helicase ddx10
ddx5 gene
ddx5 wt allele
probable atp - dependent rna helicase ddx5
dux4 gene
dux4 wt allele
double homeobox protein 4
pegloticase
eif4a2 gene
eif4a2 wt allele
eukaryotic initiation factor 4a - ii
elf4 gene
elf4 wt allele
ets - related transcription factor elf - 4
elk4 gene
elk4 wt allele
ets domain - containing protein elk - 4
etv5 gene
etv5 wt allele
ets translocation variant 5
fev gene
fev wt allele
protein fev
x inactive specific transcript
hook3 gene
hook3 wt allele
protein hook homolog 3
hnrnpa2b1 gene
hnrnpa2b1 wt allele
heterogeneous nuclear ribonucleoprotein a2 / b1
erc1 gene
afimoxifene
lead pb 212 tcmc - trastuzumab
erc1 wt allele
elks / rab6 - interacting / cast family member 1
recombinant interferon alpha 2b - like protein
arhgap26 gene
arhgap26 wt allele
naloxegol
ccr2 antagonist pf - 04136309
rho gtpase - activating protein 26
multi - subtype natural human leukocyte interferon alpha
enoblituzumab
met tyrosine kinase inhibitor sar125844
famitinib
remetinostat
green tea extract - based antioxidant supplement
sodium alginate microspheres
ell gene
ell wt allele
rna polymerase ii elongation factor ell
acsl6 gene
acsl6 wt allele
long - chain - fatty - acid - coa ligase 6
gmps gene
gmps wt allele
gmp synthase  [ glutamine - hydrolyzing ]
gphn gene
gphn wt allele
gephyrin
clp1 gene
clp1 wt allele
polyribonucleotide 5' - hydroxyl - kinase clp1
specc1 gene
specc1 wt allele
cytospin - b
herpud1 gene
herpud1 wt allele
homocysteine - responsive endoplasmic reticulum - resident ubiquitin - like domain member 1 protein
hip1 gene
hip1 wt allele
huntingtin - interacting protein 1
fnbp1 gene
fnbp1 wt allele
formin - binding protein 1
golga5 gene
golga5 wt allele
golgin subfamily a member 5
gopc gene
gopc wt allele
golgi - associated pdz and coiled - coil motif - containing protein
foxp1 gene
foxp1 wt allele
forkhead box protein p1
gata2 gene
gata2 wt allele
endothelial transcription factor gata - 2
leucovorin sodium
hlf gene
hlf wt allele
hepatic leukemia factor
mnx1 gene
mnx1 wt allele
motor neuron and pancreas homeobox protein 1
gas7 gene
gas7 wt allele
growth arrest - specific protein 7
fill out form
bone marrow cell count ratio measurement
hoxa11 gene
hoxa11 wt allele
homeobox protein hox - a11
hoxa13 gene
hoxa13 wt allele
homeobox protein hox - a13
hoxc11 gene
hoxc11 wt allele
homeobox protein hox - c11
hoxc13 gene
hoxc13 wt allele
homeobox protein hox - c13
hoxd11 gene
hoxd11 wt allele
homeobox protein hox - d11
hoxd13 gene
hoxd13 wt allele
homeobox protein hox - d13
hsp90aa1 gene
hsp90aa1 wt allele
heat shock protein hsp 90 - alpha
hsp90ab1 gene
hsp90ab1 wt allele
heat shock protein hsp 90 - beta
fcrl4 gene
fcrl4 wt allele
fc receptor - like protein 4
kdm5a gene
kdm5a wt allele
lysine - specific demethylase 5a
kdm5c gene
kdm5c wt allele
ipomeanol
lysine - specific demethylase 5c
ktn1 gene
ktn1 wt allele
kinectin
lasp1 gene
lasp1 wt allele
lim and sh3 domain protein 1
lhfpl6 gene
lhfpl6 wt allele
lhfpl tetraspan subfamily member 6 protein
lpp gene
lpp wt allele
lipoma - preferred partner
c12orf9 gene
c12orf9 wt allele
mds2 gene
mds2 wt allele
myelodysplastic syndrome 2 translocation - associated protein
mn1 gene
mn1 wt allele
transcriptional activator mn1
msn gene
msn wt allele
moesin
architecture and engineering occupations
arts ,  design ,  entertainment ,  sports and media occupations
building and grounds clearing and maintenance occupations
business and financial operations occupations
community and social services occupations
computer and mathematical occupations
construction and extraction occupations
education ,  training and library occupations
farming ,  fishing ,  and forestry occupations
food preparation and serving ,  related occupations
healthcare practitioners and technical occupations
healthcare support occupations
installation ,  maintenance and repair occupations
legal occupations
life ,  physical ,  and social science occupations
management occupations
office and administrative support occupations
personal care and service occupations
production occupations
protective service occupations
sales and related occupations
transportation and material moving occupations
myh9 gene
military occupation
myh9 wt allele
myosin - 9
mlf1 gene
mlf1 wt allele
myeloid leukemia factor 1
naca gene
naca wt allele
nascent polypeptide - associated complex subunit alpha
pcsk7 gene
pcsk7 wt allele
proprotein convertase subtilisin / kexin type 7
5 - fitc - labeled gi - heptapeptide
abemaciclib
gallium ga 68 - dotatate
pseudomonas aeruginosa preparation
sam68 modulator cwp232291
lisavanbulin
cyclin b1 peptide - pulsed autologous dendritic cell vaccine
brain tumor initiating cell vaccine
botanical extracts rinse izn - 6n4
nin gene
nin wt allele
ninein
mafb gene
mafb wt allele
transcription factor mafb
map2k4 gene
map2k4 wt allele
dual specificity mitogen - activated protein kinase kinase 4
notch2 gene
notch2 wt allele
neurogenic locus notch homolog protein 2
omd gene
omd wt allele
osteomodulin
p2ry8 gene
p2ry8 wt allele
p2y purinoceptor 8
pax8 gene
pax8 wt allele
paired box protein pax - 8
4 - nitroestrone 3 - methyl ether
promace regimen
ansamitomicin p - 3
pre - filled syringe
pre - filled pen syringe
pde4dip gene
pde4dip wt allele
myomegalin
per1 gene
per1 wt allele
period circadian protein homolog 1
phox2b gene
phox2b wt allele
paired mesoderm homeobox protein 2b
septin5 gene
septin5 wt allele
septin - 5
pou2af1 gene
pou2af1 wt allele
pou domain class 2 - associating factor 1
pik3r1 gene
pik3r1 wt allele
phosphatidylinositol 3 - kinase regulatory subunit alpha
prdm16 gene
prdm16 wt allele
pr domain zinc finger protein 16
prf1 gene
prf1 wt allele
perforin - 1
prkar1a gene
prkar1a wt allele
camp - dependent protein kinase type i - alpha regulatory subunit
integrin alpha4 / beta1
integrin alphal / beta2
itga4 gene
itga4 wt allele
integrin alpha - 4
disseminated tumor cell
rabep1 gene
rabep1 wt allele
rab gtpase - binding effector protein 1
ranbp17 gene
ranbp17 wt allele
ran - binding protein 17
vienna rectoscopy score
rap1gds1 gene
rap1gds1 wt allele
rap1 gtpase - gdp dissociation stimulator 1
rpl22 gene
rpl22 wt allele
60s ribosomal protein l22
snx29 gene
snx29 wt allele
sorting nexin - 29
sbds gene
sbds wt allele
ribosome maturation protein sbds
sdhaf2 gene
sdhaf2 wt allele
succinate dehydrogenase assembly factor 2 ,  mitochondrial
sdhb gene
sdhb wt allele
succinate dehydrogenase  [ ubiquinone ]  iron - sulfur subunit ,  mitochondrial
sdhc gene
sdhc wt allele
succinate dehydrogenase cytochrome b560 subunit ,  mitochondrial
sdhd gene
sdhd wt allele
succinate dehydrogenase  [ ubiquinone ]  cytochrome b small subunit ,  mitochondrial
septin6 gene
septin6 wt allele
septin - 6
srsf3 gene
srsf3 wt allele
serine / arginine - rich splicing factor 3
sh3gl1 gene
sh3gl1 wt allele
endophilin - a2
slc45a3 gene
slc45a3 wt allele
solute carrier family 45 member 3
socs1 gene
socs1 wt allele
suppressor of cytokine signaling 1
srgap3 gene
srgap3 wt allele
slit - robo rho gtpase - activating protein 3
doxifluridine
ss18 gene
ss18 wt allele
protein ssxt
ss18l1 gene
ss18l1 wt allele
calcium - responsive transactivator
ssx1 gene
ssx1 wt allele
protein ssx1
ssx2 gene
ssx2 wt allele
ssx2b gene
ssx2b wt allele
protein ssx2
ssx4 gene
ssx4 wt allele
ssx4b gene
ssx4b wt allele
protein ssx4
sufu gene
sufu wt allele
suppressor of fused homolog
tcea1 gene
tcea1 wt allele
transcription elongation factor a protein 1
hnf1a gene
hnf1a wt allele
hepatocyte nuclear factor 1 - alpha
tcf12 gene
tcf12 wt allele
cbp regimen
transcription factor 12
tcl6 gene
tcl6 wt allele
t - cell leukemia / lymphoma 6 long non - coding rna
tfg gene
tfg wt allele
protein tfg
tfpt gene
tfpt wt allele
tcf3 fusion partner
thrap3 gene
thrap3 wt allele
thyroid hormone receptor - associated protein 3
tnfrsf14 gene
tnfrsf14 wt allele
tumor necrosis factor receptor superfamily member 14
tnfrsf17 gene
tnfrsf17 wt allele
tumor necrosis factor receptor superfamily member 17
tpm3 gene
tpm3 wt allele
tropomyosin alpha - 3 chain
tpm4 gene
tpm4 wt allele
tropomyosin alpha - 4 chain
tpr gene
tpr wt allele
nucleoprotein tpr
trim33 gene
trim33 wt allele
e3 ubiquitin - protein ligase trim33
trip11 gene
trip11 wt allele
thyroid receptor - interacting protein 11
ttl gene
ttl wt allele
tubulin - tyrosine ligase
wif1 gene
wif1 wt allele
wnt inhibitory factor 1
xpc gene
xpc wt allele
dna repair protein complementing xp - c cells
zmym2 gene
zmym2 wt allele
zinc finger mym - type protein 2
patz1 gene
patz1 wt allele
poz -  ,  at hook -  ,  and zinc finger - containing protein 1
znf331 gene
mvpp regimen
znf331 wt allele
zinc finger protein 331
znf384 gene
znf384 wt allele
zinc finger protein 384
znf521 gene
znf521 wt allele
zinc finger protein 521
cnbp gene
cnbp wt allele
cellular nucleic acid - binding protein
cntrl gene
cntrl wt allele
centriolin
pafah1b2 gene
pafah1b2 wt allele
platelet - activating factor acetylhydrolase ib subunit beta
septin9 gene
septin9 wt allele
septin - 9
lometrexol
pcm1 gene
pcm1 wt allele
pericentriolar material 1 protein
rnf217 - as1 gene
rnf217 - as1 wt allele
six - twelve leukemia
tcf7 gene
tcf7 wt allele
transcription factor 7
akap10 gene
akap10 wt allele
a - kinase anchor protein 10 ,  mitochondrial
cic gene
cic wt allele
protein capicua homolog
pi3k alpha / mtor inhibitor pwt33597 mesylate
glycooptimized trastuzumab - gex
colloidal oatmeal cream
zinc oxide / aluminum starch octenylsuccinate / glycyrrhetinic phytosome / vitamin e / botanical extracts - based skin protectant paste
l - menthol preparation npo - 11
cd1a gene
cd1a wt allele
t - cell surface glycoprotein cd1a
para - spinal ganglion
molecular sequence variation
gene variant
gene product sequence variation
enokizumab
cdan1 gene
cdan1 wt allele
codanin - 1
sec23b gene
sec23b wt allele
protein transport protein sec23b
sulfonylurea antidiabetic agent
ruxolitinib phosphate
cabozantinib s - malate
ixazomib
ponezumab
atinumab
namilumab
etrolizumab
gevokizumab
certolizumab
ruthenium - based transferrin targeting agent nkp - 1339
henatinib maleate
vegfr2 tyrosine kinase inhibitor pf - 00337210
survivin antigen vaccine dpx - survivac
felzartamab
rolapitant hydrochloride
avadomide hydrochloride
il25 gene
il25 wt allele
adenovirus - mediated human interleukin - 12 inxn - 2001 plus activator ligand inxn - 1001
interleukin - 25
immunocytokine nhs - il12
breast solid neuroendocrine carcinoma
il17rb gene
il17rb wt allele
interleukin - 17 receptor b
socs3 gene
socs3 wt allele
suppressor of cytokine signaling 3
american college of rheumatology criteria for improvement in rheumatoid arthritis
systemic lupus erythematosus disease activity index
orconazole
american college of rheumatology improvement criteria
ythdf2 gene
dihydro - 5 - azacytidine
ythdf2 wt allele
yth domain family protein 2
has2 gene
has2 wt allele
hyaluronan synthase 2
sh3d19 gene
sh3d19 wt allele
sh3 domain - containing protein 19
znf687 gene
znf687 wt allele
zinc finger protein 687
sarnp gene
sarnp wt allele
sap domain - containing ribonucleoprotein
kiaa1549 gene
kiaa1549 wt allele
upf0606 protein kiaa1549
ighg1 gene
ighg1 wt allele
ig gamma - 1 chain c region
iglc1 gene
iglc1 wt allele
ig lambda - 1 chain c regions
myo18a gene
myo18a wt allele
unconventional myosin - xviiia
prrx1 gene
prrx1 wt allele
paired mesoderm homeobox protein 1
phf23 gene
phf23 wt allele
phd finger protein 23
sp3 gene
sp3 wt allele
transcription factor sp3
senp6 gene
senp6 wt allele
sentrin - specific protease 6
nkain2 gene
nkain2 wt allele
sodium / potassium - transporting atpase subunit beta - 1 - interacting protein 2
tmod3 gene
tmod3 wt allele
tropomodulin - 3
trpm7 gene
trpm7 wt allele
transient receptor potential cation channel subfamily m member 7
senp1 gene
senp1 wt allele
sentrin - specific protease 1
cgnl1 gene
cgnl1 wt allele
cingulin - like protein 1
dirc3 gene
dirc3 wt allele
hspbap1 gene
carboplatin / fluorouracil regimen
hspbap1 wt allele
hspb1 - associated protein 1
housework
chore
watch television
fgfr1op2 gene
fgfr1op2 wt allele
fgfr1 oncogene partner 2
schip1 gene
meglitinide antidiabetic agent
schip1 wt allele
schwannomin - interacting protein 1
cigarillo
sglt2 inhibitor
telephone script
glp - 1 mimetics
dipeptidyl peptidase - 4 inhibitor
mesd gene
mesd wt allele
ldlr chaperone mesd
uqcrh gene
uqcrh wt allele
cytochrome b - c1 complex subunit 6 ,  mitochondrial
hmgn2p46 gene
hmgn2p46 wt allele
dresden prostate carcinoma protein 2
c15orf65 gene
c15orf65 wt allele
uncharacterized protein c15orf65
tlx3 gene
decitabine
tlx3 wt allele
t - cell leukemia homeobox protein 3
lhx4 gene
lhx4 wt allele
lim / homeobox protein lhx4
iqcj gene
iqcj wt allele
iq domain - containing protein j
blueberry powder supplement
ilginatinib
mmp7 gene
mmp7 wt allele
matrilysin
kl gene
kl wt allele
klotho
wwp1 gene
wwp1 wt allele
nedd4 - like e3 ubiquitin - protein ligase wwp1
carboplatin / cisplatin / cyclophosphamide regimen
fen1 gene
fen1 wt allele
flap endonuclease 1
mia gene
mia wt allele
melanoma - derived growth regulatory protein
s100b gene
s100b wt allele
protein s100 - b
fluorouracil / leucovorin calcium / levamisole
afibrinogenemia
amot gene
amot wt allele
angiomotin
grin2a gene
grin2a wt allele
bile acid sequestrant
glutamate receptor ionotropic ,  nmda 2a
fibrate antilipidemic agent
niacin - based antilipidemic agent
hnrnpm gene
hnrnpm wt allele
heterogeneous nuclear ribonucleoprotein m
znf350 gene
znf350 wt allele
zinc finger protein 350
trim5 gene
trim5 wt allele
tripartite motif - containing protein 5
il1rn gene
il1rn wt allele
interleukin - 1 receptor antagonist protein
mre11 gene
mre11 wt allele
double - strand break repair protein mre11a
dyrk1a gene
dyrk1a wt allele
dual specificity tyrosine - phosphorylation - regulated kinase 1a
dynlrb1 gene
dynlrb1 wt allele
dynein light chain roadblock - type 1
mir211 gene
mir211 wt allele
mir211 pre - mirna
spry4 - it1 gene
spry4 - it1 wt allele
spry4 intronic transcript 1
epitrochlear lymph node
femoral lymph node
rasip1 gene
rasip1 wt allele
ras - interacting protein 1
pulmonary hilar lymph node
occipital lymph node
retroperitoneal lymph node
periorbital
mobile telephone number
rbfox1 gene
rbfox1 wt allele
rna binding protein fox - 1 homolog 1
pou3f2 gene
pou3f2 wt allele
pou domain ,  class 3 ,  transcription factor 2
chloroquinoxaline sulfonamide
neurod1 gene
neurod1 wt allele
neurogenic differentiation factor 1
samhd1 gene
samhd1 wt allele
sam domain and hd domain - containing protein 1
med12 gene
med12 wt allele
mediator of rna polymerase ii transcription subunit 12
cefalonium
cefatrizine propylene glycolate
cefazedone sodium
cefbuperazone sodium
cefcapene pivoxil
cefcapene pivoxil hydrochloride hydrate
cefclidin
cefetamet pivoxil
cefetamet pivoxil hydrochloride
cefminox sodium
cefodizime
cefodizime sodium
cefotiam hexetil hydrochloride
cefsulodin
cefsulodin sodium
ceftazidime dihydrochloride
cefteram pivoxil
ceftezole sodium
cefuzonam sodium
glitazar antidiabetic agent
biguanide antidiabetic agent
thiazolidinedione antidiabetic agent
frontal bossing
bardoxolone methyl
bulk ingredient for animal drug compounding
growth chart percentile
5th growth percentile
10th growth percentile
25th growth percentile
50th growth percentile
75th growth percentile
90th growth percentile
95th growth percentile
plasmodium
the cancer genome atlas
sulfamidochrysoidine
bone - in - bone sign
bat wing pulmonary opacities
cerebral atrophy
metaphyseal widening
tumor mass
opaganib
carbon c 13 sodium octanoate
hafnium oxide - containing nanoparticles nbtxr3
ccl21 - expressing h1944 cell vaccine
allogeneic gm - csf - secreting lethally irradiated whole melanoma cell vaccine
encorafenib
sf3b1 gene
sf3b1 wt allele
splicing factor 3b subunit 1
gm - csf - encoding oncolytic adenovirus cgtg - 102
sns01 - t nanoparticles
copper cu 64 tp3805
androgen antagonist apc - 100
gonadal teratoma
oxytocin antagonist
anetumab ravtansine
nagrestipen
anti - c - fms monoclonal antibody amg 820
monoclonal antibody cep - 37250 / khk2804
juvenile hyaline fibromatosis
pseudoprogression
acarbose
obsolete gene_mutant_encodes_gene_product_sequence_variation
obsolete gene_product_sequence_variation_encoded_by_gene_mutant
expanded disability status scale
akt1 protein variant
akt1 gene mutation
akt1 nm_001014431 .1:c .49g > a
akt1 np_001014431 .1:p .e17k
braf protein variant
braf np_004324 .2:p .g466a
braf nm_004333 .4:c .1397g > c
braf np_004324 .2:p .g466e
braf nm_004333 .4:c .1397g > a
braf np_004324 .2:p .g466r
braf nm_004333 .4:c .1396g > c
braf np_004324 .2:p .g466v
braf nm_004333 .4:c .1397g > t
braf np_004324 .2:p .g469a
braf nm_004333 .4:c .1406g > c
braf np_004324 .2:p .g469e
braf nm_004333 .4:c .1406g > a
braf np_004324 .2:p .g469r
braf nm_004333 .4:c .1405g > c
braf nm_004333 .4:c .1405g > a
braf np_004324 .2:p .g469s
braf nm_004333 .4:c .1405_1406delgginstc
braf nm_004333 .4:c .1405_1407delggainsagc
braf nm_004333 .4:c .1405_1407delggainsagt
braf np_004324 .2:p .g469v
braf nm_004333 .4:c .1406g > t
braf nm_004333 .4:c .1791a > g
braf np_004324 .2:p .l597q
braf nm_004333 .4:c .1790t > a
braf np_004324 .2:p .l597r
braf nm_004333 .4:c .1790t > g
braf np_004324 .2:p .l597s
braf nm_004333 .4:c .1789_1790delctinstc
braf np_004324 .2:p .l597v
braf nm_004333 .4:c .1789c > g
braf np_004324 .2:p .v600a
braf nm_004333 .4:c .1799t > c
braf np_004324 .2:p .v600d
braf nm_004333 .4:c .1799_1800deltginsat
braf np_004324 .2:p .v600e
braf nm_004333 .4:c .1799_1800deltginsaa
braf nm_004333 .4:c .1799t > a
braf np_004324 .2:p .v600g
braf nm_004333 .4:c .1799t > g
braf np_004324 .2:p .v600k
braf nm_004333 .4:c .1798_1799delgtinsaa
braf np_004324 .2:p .v600l
braf nm_004333 .4:c .1798g > t
braf np_004324 .2:p .v600m
braf nm_004333 .4:c .1798g > a
braf np_004324 .2:p .v600r
braf nm_004333 .4:c .1798_1799delgtinsag
braf nm_004333 .4:c .1797_1799delagtinsgag
egfr protein variant
egfr gene mutation
erbb2 protein variant
erbb2 np_004439 .2:p .a775_g776insyvma
erbb2 nm_004448 .2:c .2325_2326ins12
erbb2 nm_004448 .2:c .2324_2325ins12
kras protein variant
kras np_004976 .2:p .g12a
kras nm_004985 .3:c .35g > c
kras np_004976 .2:p .g12c
kras nm_004985 .3:c .34g > t
brief ataxia rating scale
kras nm_004985 .3:c .34_36delggtinstgc
kras np_004976 .2:p .g12d
kras nm_004985 .3:c .35g > a
kras nm_004985 .3:c .35_36delgtinsac
kras np_004976 .2:p .g12e
kras nm_004985 .3:c .35_36delgtinsag
kras nm_004985 .3:c .35_36delgtinsaa
kras np_004976 .2:p .g12f
kras nm_004985 .3:c .34_35delgginstt
kras nm_004985 .3:c .36t > c
kras np_004976 .2:p .g12i
kras nm_004985 .3:c .34_35delgginsat
kras np_004976 .2:p .g12l
kras nm_004985 .3:c .34_35delgginsct
perineuronal satellitosis
kras np_004976 .2:p .g12n
perivascular satellitosis
kras nm_004985 .3:c .34_35delgginsaa
kras np_004976 .2:p .g12r
kras nm_004985 .3:c .34g > c
interventional study
kras np_004976 .2:p .g12s
kras nm_004985 .3:c .34g > a
kras np_004976 .2:p .g12v
kras nm_004985 .3:c .35g > t
kras nm_004985 .3:c .35_36delgtinstc
kras np_004976 .2:p .g12w
kras nm_004985 .3:c .34_36delggtinstgg
kras np_004976 .2:p .g12y
kras nm_004985 .3:c .34_35delgginsta
ebselen - containing oral capsule spi - 1005
kras np_004976 .2:p .g13a
aceglatone
kras nm_004985 .3:c .38g > c
kras np_004976 .2:p .g13c
kras nm_004985 .3:c .37g > t
kras np_004976 .2:p .g13d
kras nm_004985 .3:c .38g > a
kras nm_004985 .3:c .38_39delgcinsat
kras np_004976 .2:p .g13e
kras nm_004985 .3:c .38_39delgcinsag
kras nm_004985 .3:c .38_39delgcinsaa
kras nm_004985 .3:c .39c > t
kras nm_004985 .3:c .39c > g
kras nm_004985 .3:c .39c > a
kras np_004976 .2:p .g13n
kras nm_004985 .3:c .37_38delgginsaa
kras np_004976 .2:p .g13r
kras nm_004985 .3:c .37g > c
kras nm_004985 .3:c .37_39delggcinscgt
kras np_004976 .2:p .g13s
kras nm_004985 .3:c .37g > a
kras np_004976 .2:p .g13v
kras nm_004985 .3:c .38g > t
kras nm_004985 .3:c .38_39delgcinstt
kras nm_004985 .3:c .38_39delgcinstg
kras np_004976 .2:p .q61d
kras np_004976 .2:p .q61e
kras nm_004985 .3:c .181c > g
kras np_004976 .2:p .q61h
kras nm_004985 .3:c .183a > t
kras nm_004985 .3:c .183a > c
kras np_004976 .2:p .q61k
kras nm_004985 .3:c .181c > a
kras nm_004985 .3:c .180_181deltcinsaa
kras nm_004985 .3:c .180_181deltcinsca
kras np_004976 .2:p .q61l
kras nm_004985 .3:c .182a > t
kras np_004976 .2:p .q61p
kras nm_004985 .3:c .182a > c
kras np_004976 .2:p .q61r
kras nm_004985 .3:c .182a > g
nras protein variant
nras np_002515 .1:p .q61e
nras nm_002524 .4:c .181c > g
nras np_002515 .1:p .q61h
nras nm_002524 .4:c .183a > c
nras nm_002524 .4:c .183a > t
nras np_002515 .1:p .q61k
nras nm_002524 .4:c .181c > a
nras nm_002524 .4:c .180_181delacinsta
nras nm_002524 .4:c .181_183delcaainsaag
nras np_002515 .1:p .q61l
nras nm_002524 .4:c .182a > t
nras nm_002524 .4:c .181_182delcainstt
nras nm_002524 .4:c .182_183delaainstg
nras np_002515 .1:p .q61p
nras nm_002524 .4:c .182a > c
nras nm_002524 .4:c .183a > g
nras np_002515 .1:p .q61r
nras nm_002524 .4:c .182a > g
nras nm_002524 .4:c .181_182delcainsag
nras nm_002524 .4:c .182_183delaainsgg
vie regimen
pik3ca protein variant
pik3ca np_006209 .2:p .e545a
pik3ca nm_006218 .1:c .1634a > c
pik3ca np_006209 .2:p .e545d
pik3ca nm_006218 .1:c .1635g > t
pik3ca nm_006218 .1:c .1635g > c
pik3ca np_006209 .2:p .e545g
pik3ca nm_006218 .1:c .1634a > g
pik3ca np_006209 .2:p .e545k
pik3ca nm_006218 .1:c .1633g > a
pik3ca np_006209 .2:p .e545q
pik3ca nm_006218 .1:c .1633g > c
pik3ca np_006209 .2:p .e545v
pik3ca nm_006218 .1:c .1634a > t
pik3ca np_006209 .2:p .e542k
pik3ca nm_006218 .1:c .1624g > a
pik3ca np_006209 .2:p .e542q
pik3ca nm_006218 .1:c .1624g > c
pik3ca np_006209 .2:p .e542v
pik3ca nm_006218 .1:c .1625a > t
pik3ca np_006209 .2:p .h1047l
pik3ca nm_006218 .1:c .3140a > t
pik3ca np_006209 .2:p .h1047q
pik3ca nm_006218 .1:c .3141t > g
pik3ca np_006209 .2:p .h1047r
pik3ca nm_006218 .1:c .3140a > g
pik3ca np_006209 .2:p .h1047t
pik3ca np_006209 .2:p .h1047y
pik3ca nm_006218 .1:c .3139c > t
pik3ca np_006209 .2:p .c420r
pik3ca nm_006218 .1:c .1258t > c
pik3ca np_006209 .2:p .e542g
pik3ca nm_006218 .1:c .1625a > g
differential leukocyte count
blood cell count with differential
egfr np_005219 .2:p .l861f
egfr np_005219 .2:p .l861p
egfr np_005219 .2:p .l861q
egfr nm_005228 .3:c .2582t > a
egfr np_005219 .2:p .l861r
acitretin
egfr nm_005228 .3:c .2582t > g
egfr np_005219 .2:p .l861v
egfr nm_005228 .3:c .2581c > g
egfr np_005219 .2:p .t790m
egfr nm_005228 .3:c .2369c > t
egfr np_005219 .2:p .l858a
egfr np_005219 .2:p .l858g
egfr np_005219 .2:p .l858k
egfr nm_005228 .3:c .2572_2573delctinsaa
egfr nm_005228 .3:c .2572c > t
egfr np_005219 .2:p .l858m
egfr nm_005228 .3:c .2572c > a
egfr np_005219 .2:p .l858p
egfr np_005219 .2:p .l858q
egfr nm_005228 .3:c .2573t > a
egfr np_005219 .2:p .l858r
egfr nm_005228 .3:c .2573t > g
egfr nm_005228 .3:c .2573_2574deltginsgt
egfr nm_005228 .3:c .2572_2573delctinsag
egfr np_005219 .2:p .l858w
egfr np_005219 .2:p .g719a
egfr nm_005228 .3:c .2156g > c
egfr np_005219 .2:p .g719c
egfr nm_005228 .3:c .2155g > t
egfr nm_005228 .3:c .2154_2155delgginstt
egfr np_005219 .2:p .g719d
egfr nm_005228 .3:c .2156g > a
egfr np_005219 .2:p .g719s
egfr nm_005228 .3:c .2155g > a
egfr np_005219 .2:p .g719v
egfr np_005219 .2:p .e709*
egfr nm_005228 .3:c .2125_2129delgaaac
egfr np_005219 .2:p .g719fs*29
egfr nm_005228 .3:c .2156delg
egfr np_005219 .2:p .k745_a750del
egfr np_005219 .2:p .k745_e749del
egfr nm_005228 .3:c .2233_2247del15
egfr np_005219 .2:p .e746_a750del
egfr np_005219 .2:p .k745_l747del
egfr nm_005228 .3:c .2236_2250del15
egfr nm_005228 .3:c .2235_2249del15
chronic lung disorder
egfr np_005219 .2:p .e746_e749del
egfr nm_005228 .3:c .2235_2246del12
egfr np_005219 .2:p .e746_p753del
egfr np_005219 .2:p .e746_r748del
egfr np_005219 .2:p .e746_s752del
egfr np_005219 .2:p .e746_t751del
egfr nm_005228 .3:c .2236_2253del18
egfr nm_005228 .3:c .2235_2252del18
egfr np_005219 .2:p .e746del
egfr nm_005228 .3:c .2234_2236delagg
egfr np_005219 .2:p .l747_a750del
egfr np_005219 .2:p .l747_a755del
egfr np_005219 .2:p .l747_e749del
egfr nm_005228 .3:c .2239_2247del9
egfr np_005219 .2:p .l747_k754del
egfr nm_005228 .3:c .2239_2262del24
egfr np_005219 .2:p .l747_p753del
egfr np_005219 .2:p .l747_s752del
egfr nm_005228 .3:c .2239_2256del18
egfr np_005219 .2:p .l747_t751del
egfr nm_005228 .3:c .2239_2253del15
egfr nm_005228 .3:c .2240_2254del15
egfr nm_005228 .3:c .2238_2252del15
egfr np_005219 .2:p .l747del
egfr np_005219 .2:p .r748_p753del
egfr np_005219 .2:p .r748_s752del
egfr np_005219 .2:p .a750_e758del
egfr nm_005228 .3:c .2247_2273del27
egfr np_005219 .2:p .a750_k754del
egfr nm_005228 .3:c .2246_2260del15
egfr np_005219 .2:p .a750_k757del
factor v leiden
egfr np_005219 .2:p .t751_e758del
egfr nm_005228 .3:c .2250_2273del24
osteogenesis imperfecta type iv
egfr np_005219 .2:p .s752_i759del
egfr nm_005228 .3:c .2254_2277del24
egfr nm_005228 .3:c .2253_2276del24
egfr np_005219 .2:p .s752_v769del
egfr np_005219 .2:p .p753_i759del
egfr nm_005228 .3:c .2257_2277del21
type 1 thanatophoric dysplasia
type 2 thanatophoric dysplasia
total anomalous pulmonary venous return
egfr np_005219 .2:p .n756_l760del
egfr np_005219 .2:p .v774del
egfr np_005219 .2:p .i789_l792del
egfr np_005219 .2:p .v834del
type i total anomalous pulmonary venous return
egfr np_005219 .2:p .i740_p741inspvaiki
type ii total anomalous pulmonary venous return
egfr nm_005228 .3:c .2219_2220ins18
egfr np_005219 .2:p .i744_k745inskipvai
egfr nm_005228 .3:c .2231_2232ins18
egfr nm_005228 .3:c .2232_2233ins18
type iii total anomalous pulmonary venous return
type iv total anomalous pulmonary venous return
egfr np_005219 .2:p .k745_e746insvpvaik
acivicin
egfr nm_005228 .3:c .2236_2237ins18
egfr np_005219 .2:p .d761_e762inseafq
torch antibody measurement
egfr nm_005228 .3:c .2283_2284ins12
egfr np_005219 .2:p .y764_v765inshh
egfr np_005219 .2:p .v765_m766insmas
egfr np_005219 .2:p .m766_a767insai
egfr nm_005228 .3:c .2298_2299insgccata
egfr np_005219 .2:p .a767_s768instla
torch syndrome
egfr nm_005228 .3:c .2302_2303ins9
egfr np_005219 .2:p .a763_y764insfqea
egfr nm_005228 .3:c .2290_2291ins12
egfr np_005219 .2:p .s768_v769insawt
egfr np_005219 .2:p .s768_v769insvas
egfr nm_005228 .3:c .2303_2304ins9
egfr np_005219 .2:p .v769_d770insasv
egfr nm_005228 .3:c .2307_2308ins9
egfr nm_005228 .3:c .2308_2309ins9
parenteral nutrition  -  associated cholestasis
egfr nm_005228 .3:c .2309_2310delacinsccagcgtggat
egfr np_005219 .2:p .v769_d770inscv
larnygeotracheoesophageal cleft
egfr nm_005228 .3:c .2307_2308instgcgtg
egfr np_005219 .2:p .v769_d770insdnv
egfr nm_005228 .3:c .2307_2308insgacaacgtg
egfr np_005219 .2:p .v769_d770insgsv
egfr nm_005228 .3:c .2308_2309insgcagcgtgg
egfr np_005219 .2:p .v769_d770insgv
tracheal web
etoposide / mitoxantrone regimen
egfr np_005219 .2:p .v769_d770insgvv
egfr nm_005228 .3:c .2308_2309insgggtcgtgg
egfr np_005219 .2:p .v769_d770insmasvd
egfr nm_005228 .3:c .2307_2308ins15
tracheomalacia
egfr np_005219 .2:p .d770_n771insapw
egfr nm_005228 .3:c .2310_2311ins9
egfr np_005219 .2:p .d770_n771insd
egfr np_005219 .2:p .d770_n771insdg
egfr nm_005228 .3:c .2308_2309insacggcg
tyrosinemia
tyrosinemia type i
vein of galen malformation
venous stenosis
egfr np_005219 .2:p .d770_n771insg
egfr nm_005228 .3:c .2310_2311insggt
egfr nm_005228 .3:c .2310_2311insggc
very long - chain acyl - coa dehydrogenase deficiency
egfr np_005219 .2:p .d770_n771insgd
egfr nm_005228 .3:c .2310_2311insggggac
egfr np_005219 .2:p .d770_n771insgl
egfr nm_005228 .3:c .2310_2311insgggtta
egfr np_005219 .2:p .d770_n771insmatp
egfr nm_005228 .3:c .2311_2312ins12
egfr np_005219 .2:p .d770_n771insn
egfr nm_005228 .3:c .2310_2311insaac
egfr np_005219 .2:p .d770_n771insnph
egfr nm_005228 .3:c .2310_2311insaacccccac
egfr np_005219 .2:p .d770_n771inssvd
egfr nm_005228 .3:c .2311_2312ins9
egfr nm_005228 .3:c .2310_2311insagcgtggac
grade i vesicoureteral reflux
grade ii vesicoureteral reflux
grade iii vesicoureteral reflux
grade iv vesicoureteral reflux
grade v vesicoureteral reflux
egfr np_005219 .2:p .d770_n771inssvp
egfr np_005219 .2:p .d770_n771inssvq
egfr np_005219 .2:p .d770fs*61
egfr nm_005228 .3:c .2309_2310ins14
werdnig - hoffmann disease
egfr np_005219 .2:p .n771_p772insh
egfr np_005219 .2:p .n771_p772insn
egfr nm_005228 .3:c .2313_2314insaac
methylcrotonyl - coa carboxylase deficiency
egfr np_005219 .2:p .p772_h773insdhp
egfr np_005219 .2:p .p772_h773inspr
egfr np_005219 .2:p .p772_h773insdnp
3 - methylglutaconic aciduria
egfr np_005219 .2:p .p772_h773insqv
egfr np_005219 .2:p .p772_h773insynp
egfr np_005219 .2:p .p772_h773insthp
egfr nm_005228 .3:c .2315_2316insgacacaccc
3 - methylglutaconic aciduria type 1
egfr np_005219 .2:p .h773_v774insg
egfr np_005219 .2:p .h773_v774insgh
egfr np_005219 .2:p .h773_v774insgnph
egfr nm_005228 .3:c .2320_2321ins12
egfr np_005219 .2:p .h773_v774insh
egfr nm_005228 .3:c .2319_2320inscac
asparaginase / cyclophosphamide / daunorubicin / prednisone / vincristine regimen
egfr np_005219 .2:p .h773_v774insnph
egfr nm_005228 .3:c .2319_2320ins9
egfr np_005219 .2:p .h773_v774insph
egfr nm_005228 .3:c .2318_2319insccccca
egfr nm_005228 .3:c .2319_2320insccccac
egfr np_005219 .2:p .v774_c775inshv
egfr nm_005228 .3:c .2322_2323inscacgtg
egfr nm_005228 .3:c .2321_2322insccacgt
egfr nm_005228 .3:c .2322delginsccacgtg
5 alpha steroid reductase 2 deficiency
aclacinomycin antitumor antibiotic
abdominal hernia
abdominal aorta thrombosis
abomasum
actual subject number
adaptive design
adenovirus viral load measurement
anti - factor xa activity measurement
b6 .129 - trp53tm1brd n5
benign histiocytoma
experimental organism benign melanocytoma
bk virus viral load measurement
cb6f1 - tgn  ( rash2 )
cerebral subcortex
cervical ganglia
clinical trial registry identifier
confirmed response minimum duration
cytomegalovirus viral load measurement
data cutoff date
data cutoff date description
dna copies per milliliter
eosinophils to total cell ratio measurement
epstein - barr virus viral load measurement
expanded access study
experimental organism pituitary gland adenoma
exploratory outcome measure
factor ix measurement
factor v measurement
factor x measurement
fat droplet measurement
food effect study
free kappa light chain measurement
free kappa light chain to free lambda light chain ratio measurement
free lambda light chain measurement
fvb / ntac - tg ( hba - x - v - ha - ras ) tg .acled
glomerular filtration rate adjusted for bsa
glomerular filtration rate from creatinine adjusted for bsa
glomerular filtration rate from cystatin c adjusted for bsa
healthy subject indicator
herpes simplex virus 1 igm antibody measurement
herpes simplex virus 2 igm antibody measurement
human anti - sheep ige antibody measurement
human anti - sheep igg antibody measurement
human anti - sheep igm antibody measurement
hundred thousand per high powered field
icteric specimen
immunoglobulin d measurement
intervention model
intervention type
inulin clearance
iothalamate clearance
iothalamate clearance adjusted for bsa
lymphocyte to total cell ratio measurement
megakaryoblast cell count
megakaryoblast to total cell ratio measurement
metamyelocyte to total cell ratio measurement
milliliter per centimeter of water
million dna copies per milliliter
million international units per milliliter
million per gram
million per high powered field
million rna copies per milliliter
myeloblast to total cell ratio measurement
natural killer cell count
neutrophil to total cell ratio measurement
normoblast to total cell ratio measurement
olfactory region
omasum
pancreatic amylase measurement
pharmacological class of investigational therapy
physical medical procedure
planned country of investigational site
planned number of arms
primary outcome measure
promyelocyte to total cell ratio measurement
prothrombin activity measurement
randomization quotient
reticulocyte corpuscular hemoglobin content
reticulum
rumen
run - in period
carboplatin / cyclophosphamide / etoposide regimen
salivary amylase measurement
secondary outcome measure
skh1 - hr hr
stable disease minimum duration
stifle joint
subscapular skinfold thickness
ten million per liter
ten thousand per high powered field
thousand dna copies per milliliter
thousand per high powered field
thousand rna copies per milliliter
tolerability study
transferrin saturation measurement
triceps skinfold thickness
undetermined sertoli cell tumor
varicella zoster virus iga antibody measurement
varicella zoster virus igg antibody measurement
varicella zoster virus igm antibody measurement
ventrolateral
von willebrand factor measurement
acodazole
zymbal's gland adenoma
zymbal's gland carcinoma
acquired cataract
acquired hydrocephalus
acquired chylothorax
acquired methemoglobinemia
acquired rickets
acrocyanosis
adrenal hemorrhage
alveolar capillary dysplasia
ambiguous genitalia
anasarca
annular pancreas
anophthalmos
antithrombin iii deficiency
apgar score at one minute
apgar score at ten minutes
aortic valve atresia
apgar score at fifteen minutes
apgar score at twenty minutes
apgar score at five minutes
aplasia cutis congenita
apnea of prematurity
aprosencephaly
arterial thrombosis
large intestine atresia
small intestine atresia
autosomal dominant disorder
ladd band
brigatinib
mek 1 / 2 inhibitor as703988 / msc2015103b
carbon c 13 phytoene
carbon c 13 phytofluene
sickle beta 0 thalassemia
filgrastim - primed peripheral blood progenitor cells
sickle beta plus thalassemia
poziotinib
endometrioid tissue present
benign congenital hypotonia
beta - ketothiolase deficiency
holocarboxylase synthetase deficiency
blood type determination
serabelisib
brachial plexus palsy
breast milk jaundice
bronchomalacia
congenital bundle of his tachycardia
five times daily
five times monthly
five times yearly
four times monthly
four times yearly
seven times weekly
six times daily
six times monthly
six times weekly
six times yearly
three times monthly
m - bacos regimen
three times yearly
two times yearly
activated ptt / standard ratio measurement
butyryl - coa dehydrogenase deficiency
primary carnitine deficiency
basophil to total cell ratio measurement
granulocyte to total cell ratio measurement
megakaryocyte to total cell ratio measurement
myelocyte to total cell ratio measurement
plasma cell to total cell ratio measurement
pronormoblast to total cell ratio measurement
carnitine palmitoyltransferase i deficiency
monocytes to total cell ratio measurement
type ii acrocephalopolysyndactyly
myelocele
cervical myelocele
congenital hydrocephalus
coloboma of the eye
coloboma of the eyelid
coloboma of the iris
persistent truncus arteriosus
congenital abnormality of the large intestine
congenital lung malformation
icatibant
icatibant acetate
congenital urinary system abnormality
congenital vena cava abnormality
congenital eye disorder
congenital cataract
congenital central hypoventilation
congenital cerebellar hypoplasia
congenital chylothorax
congenital cystic adenomatoid malformation of the lung
congenital diaphragmatic hernia
hypoplastic left heart syndrome
congenital lobar emphysema
congenital hand and foot deformity
thumb hypoplasia
congenital methemoglobinemia
postural scoliosis
recombinant activin
sacral myelocele
ureterovesical obstruction
levo - transposition of the great arteries
conjoined twins
connective and soft tissue injury
corpus callosum agenesis
fetal warfarin syndrome
craniorachischisis
cryptophthalmos syndrome
cyanotic attacks in children
cytochrome - c oxidase deficiency
decreased bone density
diaphragmatic eventration
diastematomyelia
discordant ventriculoarterial connection
duplex kidney
double outlet right ventricle
duplicated ureter
duodenal web
ear tag
encephalomalacia
endemic cretinism
endocardial fibroelastosis
epispadias
esophageal duplication
esophageal web
fetal heart rhythm
fetal hydantoin syndrome
fetal methotrexate syndrome
fetal retinoid syndrome
fetal valproate syndrome
freeman - sheldon syndrome
fryns syndrome
glucose - 6 - phosphate dehydrogenase deficiency
harlequin ichthyosis
cardiac monitoring
hematochezia
hereditary factor i deficiency
hereditary factor v deficiency
hereditary factor vii deficiency
hereditary factor x deficiency
hereditary factor xiii deficiency
hereditary coagulation factor deficiency
hereditary pyropoikilocytosis
hereditary orotic aciduria
hiatal hernia
high molecular weight kininogen deficiency
horseshoe kidney
congenital h - type tracheoesophageal fistula
hydranencephaly
hyperammonemia
hyperextension
hypertrophic pyloric stenosis
ileal web
in utero drug exposure
infant of diabetic mother
inspissated bile syndrome
cutaneous fistula
interrupted aortic arch
mericitabine
intestinal duplication
intestinal malrotation
intestinal stricture
intestinal volvulus
isovaleric acidemia
chebi_id
jejunal web
klippel - feil syndrome
lacrimal mucocele
lactic acidosis
laryngeal web
laryngomalacia
laryngeal atresia
lithium induced birth defect
low anorectal malformation
lumbar myelocele
maternal transmission
meckel - gruber syndrome
meconium ileus
meconium plug syndrome
pneumomediastinum
mmih syndrome
melnick - fraser syndrome
metabolic myopathy
methylmalonic acidemia
microcolon
microgyria
microphthalmos
neuronal migration disorder
mitochondrial trifunctional protein deficiency
mitral valve atresia
monosomy 13q syndrome
nadh dehydrogenase deficiency
neonatal thrombocytopenia
neonatal disorder
omphalocele
opiate withdrawal syndrome
optic nerve hypoplasia
corynebacterium granulosum p40
orbital cellulitis
osteogenesis imperfecta type ii
osteogenesis imperfecta type iii
osteogenesis imperfecta type i
partial anomalous pulmonary venous return
patent urachus
pelvic kidney
pelviureteric junction obstruction
pena - shokeir syndrome
penile agenesis
penoscrotal transposition
pentalogy of cantrell
pneumoperitoneum
periventricular leukomalacia
persistent cloaca
phosphoenolpyruvate carboxykinase deficiency
phrenic nerve injury
phrenic nerve palsy
plethoric face
pneumopericardium
porencephalic cyst
posterior urethral valve
prekallikrein deficiency
content identifier
premature closure of ductus arteriosus
protein c deficiency disease
protein s deficiency disease
pseudohypoparathyroidism
pulmonary agenesis
pulmonary arteriovenous fistula
pulmonary artery stenosis
pulmonary valve atresia
pulmonary valve atresia with intact ventricular septum
pulmonary valve atresia with ventricular septal defect
congenital pulmonary lymphangiectasia
pulmonary hypoplasia
pulmonary vein stenosis
pyruvate kinase deficiency
radial aplasia - thrombocytopenia syndrome
radius fracture
recto - vesico - vaginal fistula
renal agenesis
renal vein thrombosis
retinopathy of prematurity in zone 1
retinopathy of prematurity in zone 2
retinopathy of prematurity in zone 3
retinopathy of prematurity stage 1 demarcation line
retinopathy of prematurity stage 2 intraretinal ridge
retinopathy of prematurity stage 3 ridge with extraretinal fibroblastic proliferation
retinopathy of prematurity stage 4 subtotal retinal detachment
retinopathy of prematurity stage 5 total retinal detachment
rh titer measurement
hypoplastic right heart syndrome
sacral agenesis
sacrococcygeal teratoma
schizencephaly
severe bronchopulmonary dysplasia
shone syndrome
short bowel syndrome
single ventricle defect
situs inversus thoracis
skin injury
spinal cord infarction
spinal deformity
subependymal hemorrhage
supravalvular pulmonary artery stenosis
surfactant protein deficiency
pulmonary surfactant metabolism dysfunction - 1
surfactant protein c deficiency
pulmonary surfactant metabolism dysfunction - 3
surfactant protein d deficiency
surfactant protein a deficiency
cdisc sdtm laterality terminology
cdisc sdtm directionality terminology
cdisc sdtm portion / totality terminology
cdisc sdtm intervention model terminology
cdisc sdtm study type terminology
cdisc sdtm intervention type terminology
cdisc sdtm epoch terminology
tethered spinal cord syndrome
arakawa syndrome ii
thalidomide embryopathy syndrome
tibia fracture
ovarian torsion
townes - brocks syndrome
airway infantile hemangioma
furuncle
impetigo
liver abscess
lung abscess
lymph node abscess
perianal abscess
skin abscess
electronic content
content item
dextro - transposition of the great arteries
reason for narrative
type i acrocephalosyndactyly
type v acrocephalosyndactyly
glutaric acidemia type 1
uterine agenesis
utp - hexose - 1 - phosphate uridylyltransferase deficiency
vacterl association
vascular ring
venous thrombosis
vitamin k deficiency
walker - warburg syndrome
drug induced thrombocytopenia
heparin induced thrombocytopenia
cystic periventricular leukomalacia
ectopic atrial tachycardia
trp2 mrna - electroporated autologous langerhans - type dendritic cell vaccine
immature retinal vasculature
htert mrna / survivin peptide - double - loaded autologous dendritic cell vaccine
immature retinal vasculature in zone 1
immature retinal vasculature in zone 2
immature retinal vasculature in zone 3
carbon c 13 lycopene
in utero bowel perforation
north american ginseng extract afx - 2
increased bone density
cis - urocanic acid
left ventricular outflow tract obstruction
varlilumab
thoracic myelocele
aim2 (  - 1 )  / ht001 (  - 1 )  / taf1b (  - 1 )  frameshift peptide vaccine
dociparstat sodium
idasanutlin
tri - virus / gd2 - specific allogeneic cytotoxic t - lymphocytes
fluorine f 18 rgd - k5
p38 mapk inhibitor ly3007113
embryonic stage
normal pupillary response
great vessels abnormality
germinal matrix hemorrhage of the newborn
intraventricular hemorrhage of the newborn without ventricular dilatation
intraventricular hemorrhage of the newborn with ventricular dilatation
radial hypoplasia
oeis complex
subgaleal area
branch pulmonary artery stenosis
spontaneous perforation
beta - lapachone prodrug arq 761
neonatal research network terminology
perianal region
bayley scale of infant development ii
moad regimen
bayley scale of infant development iii
nonclinical study end date
nonclinical study start date
clinical study follow - up
honey - containing mouthwash
icotinib hydrochloride
tropomyosin receptor kinase inhibitor azd7451
monoclonal antibody abgn - 7
lyophilized black raspberry lozenge
lyophilized black raspberry saliva substitute
dna - dependent protein kinase - targeting sidna dt01
entolimod
yttrium y 90 basiliximab
yttrium y 90 tabituximab barzuxetan
indium in 111 anti - egfr monoclonal antibody abt - 806
beta - glucan / alginate / hyaluronic acid / squalene / avocado oil - containing emulsion
dexamethasone intravitreal implant
miransertib
device evaluation icsr terminology
product characteristic icsr terminology
substance administration icsr terminology
pre - 1938 product
liquid - based cytology
human papillomavirus - 11
audible device noise
lipofibromatosis
acp5 gene
acp5 wt allele
acp5 gene product
tartrate - resistant acid phosphatase type 5
tartrate - resistant acid phosphatase type 5b
pml / rara fusion gene
apoa1 / apoc3 fusion gene
bcl6 / lcp1 fusion gene
lcp1 / bcl6 fusion gene
nup214 / abl1 fusion gene variant 1
nup214 / abl1 310 - 333 kda fusion protein
nup214 / abl1 fusion gene variant 2
nup214 / abl1 239 kda fusion protein
cltc / tfe3 fusion gene
cltc / tfe3 fusion protein
col1a1 / pdgfb fusion gene
col1a1 / pdgfb fusion protein
dek / nup214 fusion gene
dek / nup214 fusion protein
monobenzone
ewsr1 / ddit3 fusion gene
ewsr1 / ddit3 fusion protein
ewsr1 / fli1 fusion gene
ewsr1 / fli1 fusion gene type 1
ewsr1 / fli1 fusion gene type 2
ewsr1 / fli1 fusion protein
ewsr1 / fli1 fusion protein type 1
ewsr1 / fli1 fusion protein type 2
eye finding
ear finding
congenital
ewsr1 / erg fusion gene
ewsr1 / erg fusion protein
ewsr1 / wt1 fusion gene
ewsr1 / wt1 fusion protein
allogeneic cd19 - specific car - modified cd8 plus central memory - derived virus - specific t cells
ewsr1 / atf1 fusion gene
copper cu 64 - dota - anti - her3 monoclonal antibody u3 - 1287
ewsr1 / atf1 fusion protein
ewsr1 / atf1 fusion gene type 1
ewsr1 / atf1 fusion gene type 2
ewsr1 / atf1 fusion protein type 1
anti - egfrviii antibody drug conjugate amg 595
ewsr1 / atf1 fusion protein type 2
bi - functional alkylating agent val - 083
duvelisib
ewsr1 / fev fusion gene
beta - glucan / lactobacillus casei / bifidobacterium lactis - based supplement
nelipepimut - s plus gm - csf vaccine
lactobacillus brevis cd2 lozenge
synbiotic supplement
neonatal infectious disorder
neonatal respiratory system disorder
neonatal rickets
ewsr1 / fev fusion protein
neonatal hyperbilirubinemia
neonatal lupus erythematosus
neonatal hypoglycemia
ewsr1 / patz1 fusion gene
ewsr1 / patz1 fusion gene short isoform
ewsr1 / patz1 fusion gene long a isoform
ewsr1 / patz1 fusion gene long b isoform
ewsr1 / patz1 fusion protein
ewsr1 / patz1 fusion protein short isoform
ewsr1 / patz1 fusion protein long a isoform
ewsr1 / patz1 fusion protein long b isoform
neonatal jaundice
neonatal holocarboxylase synthetase deficiency
neonatal diabetes mellitus
ewsr1 / creb1 fusion gene
ewsr1 / creb1 fusion protein
neonatal adrenoleukodystrophy
ewsr1 / nr4a3 fusion gene
neonatal acrocyanosis
ewsr1 / nr4a3 fusion protein
neonatal opiate withdrawal syndrome
ewsr1 / pou5f1 fusion gene
ewsr1 / pou5f1 fusion protein
perinatal drug withdrawal
ewsr1 / etv1 fusion gene
ewsr1 / etv1 fusion protein
perinatal intracranial hemorrhage
ewsr1 / etv4 fusion gene
ewsr1 / etv4 fusion protein
cephalhematoma
congenital complete atrioventricular block
breath alcohol test device
congenital malformation syndrome
participant case or control status
true case status
true control status
probable case status
probable control status
neither case or control status
unable to assess case or control status
core specimen
tissue scroll
fus / atf1 fusion gene
fus / atf1 fusion protein
fus / ddit3 fusion gene
fus / ddit3 fusion protein
fus / erg fusion gene
fus / erg fusion protein
fus / creb3l2 fusion gene
fus / creb3l2 fusion protein
model number
catalog number
product reference number
spl miscellaneous identifier types terminology
tcf3 / hlf fusion gene
tcf3 / hlf fusion protein
tcf3 / pbx1 fusion gene
tcf3 / pbx1 fusion protein
tcf3 / tfpt fusion gene
runx1 / runx1t1 fusion gene
runx1 / mecom fusion gene
runx1 / mecom fusion protein
functional assessment of human immunodeficiency virus infection
runx1 / zfpm2 fusion gene
runx1 / zfpm2 fusion protein
al721
runx1 / ythdf2 fusion gene
runx1 / sh3d19 fusion gene
runx1 / sh3d19 fusion protein
runx1 / znf687 fusion gene
runx1 / znf687 fusion protein
bcr / abl1 fusion gene p190
bcr / abl1 fusion gene p210
bcr / abl1 fusion gene p230
bcr / abl1 fusion protein p190
bcr / abl1 fusion protein p210
bcr / abl1 fusion protein p230
bcr / fgfr1 fusion gene
bcr / fgfr1 fusion protein
bcr / pdgfra fusion gene
bcr / pdgfra fusion protein
mn1 / etv6 fusion gene
mn1 / etv6 fusion protein
histologic progression
mll / aff1 fusion gene
bleomycin / cytarabine / prednisone / vincristine regimen
mll / aff1 fusion protein
mll / mllt1 fusion gene
mll / mllt1 fusion protein
mll / mllt3 fusion gene
mll / mllt3 fusion protein
mll / gmps fusion gene
mll / gmps fusion protein
mll / fnbp1 fusion gene
mll / fnbp1 fusion protein
mll / lpp fusion gene
chlorambucil / dacarbazine / dactinomycin / doxorubicin / methotrexate / vincristine regimen
mll / lpp fusion protein
mll / gphn fusion gene
mll / gphn fusion protein
mll / sept5 fusion gene
mll / sept5 fusion protein
mll / lasp1 fusion gene
mll / lasp1 fusion protein
mll / arhgap26 fusion gene
mll / arhgap26 fusion protein
mll / abi1 fusion gene
mll / abi1 fusion protein
mll / aff3 fusion gene
mll / aff3 fusion protein
mll / cbl fusion gene
mll / cbl fusion protein
mll / arhgef12 fusion gene
mll / arhgef12 fusion protein
mll / mllt10 fusion gene
mll / mllt10 fusion protein
mll / casc5 fusion gene
mll / casc5 fusion protein
mll / mllt4 fusion gene
mll / mllt4 fusion protein
mll / sarnp fusion gene
mll / sarnp fusion protein
mll / sept6 fusion gene
mll / sept6 fusion protein
mll / maml2 fusion gene
mll / maml2 fusion protein
numa1 / rara fusion gene
opp regimen
numa1 / rara fusion protein
npm1 / alk fusion gene
npm1 / alk fusion protein
pax7 / foxo1 fusion gene
pax7 / foxo1 fusion protein
pax8 / pparg fusion gene
pax8 / pparg fusion protein
ccnd1 / ighg1 fusion gene
ccnd1 / pth fusion gene
ccnd1 / iglc1 fusion gene
ccnd1 / fstl3 fusion gene
zbtb16 / rara fusion gene
rara / zbtb16 fusion gene
rara / zbtb16 fusion protein
nup98 / rap1gds1 fusion gene
nup98 / rap1gds1 fusion protein
prcc / tfe3 fusion gene
prcc / tfe3 fusion protein
vegfr - 2 dna vaccine vxm01
olaptesed pegol
bleomycin / doxorubicin / lomustine / vincristine regimen
pan - pim kinase inhibitor azd1208
dexanabinol
autoimmune cytopenia
autoimmune nervous system disorder
prkar1a / rara fusion gene
prkar1a / rara fusion protein
tpm3 / ntrk1 fusion gene
polysaccharide hydrolase
il1rapl1 / dmd fusion gene
p2ry8 / crlf2 fusion gene
contralateral breast carcinoma
tfe3 / prcc fusion gene
tfe3 / prcc fusion protein
ss18 / ssx1 fusion gene
ss18 / ssx1 fusion protein
ss18 / ssx2 fusion gene
ss18 / ssx2 fusion protein
ss18 / ssx4 fusion gene
ss18 / ssx4 fusion protein
pcm1 / ret fusion gene
alanosine
pcm1 / ret fusion protein
tcf12 / nr4a3 fusion gene
tcf12 / nr4a3 fusion protein
etv6 / pdgfrb fusion gene
etv6 / pdgfrb fusion protein
etv6 / arnt fusion gene
ercc1 protein expression
etv6 / arnt fusion protein
figo staging system and modified world health organization  [ who ]  prognostic scoring system for gestational trophoblastic neoplasms
etv6 / mds2 fusion gene
etv6 / abl2 fusion gene
etv6 / abl2 fusion protein
etv6 / per1 fusion gene
etv6 / ntrk3 fusion gene
etv6 / ntrk3 fusion protein
etv6 / acsl6 fusion gene
etv6 / jak2 fusion gene
etv6 / jak2 fusion protein
t ( 1 ; 19 )  ( q10 ; p10 )
hmga2 / lpp short fusion gene
bap regimen
hmga2 / lpp long fusion gene
hmga2 / lpp short fusion protein
hmga2 / lpp long fusion protein
hmga2 / lhfp fusion gene
hmga2 / rad51b fusion gene
hmga2 / rad51b fusion protein
hmga2 / ccnb1ip1 fusion gene
hmga2 / ccnb1ip1 fusion protein
hmga2 / aldh2 fusion gene
hmga2 / aldh2 fusion protein
pft regimen
hmga2 / cox6c fusion gene
hmga2 / cox6c fusion protein
lpp / mll fusion gene
lpp / mll fusion protein
nup98 / nsd1 fusion gene
nup98 / nsd1 fusion protein
nup98 / whsc1l1 fusion gene
nup98 / whsc1l1 fusion protein
nup98 / prrx1 fusion gene
nup98 / prrx1 fusion protein
bamon regimen
nup98 / hoxa9 fusion gene
nup98 / hoxa9 fusion protein
nup98 / top1 fusion gene
nup98 / top1 fusion protein
nup98 / ddx10 fusion gene
ddx10 / nup98 fusion gene
nup98 / ddx10 fusion protein
nup98 / hoxd13 fusion gene
nup98 / hoxd13 fusion protein
nup98 / hoxd11 fusion gene
nup98 / hoxd11 fusion protein
nup98 / hoxc13 fusion gene
nup98 / hoxc13 fusion protein
nup98 / add3 fusion gene
nup98 / add3 fusion protein
nup98 / setbp1 fusion gene
nup98 / setbp1 fusion protein
nup98 / phf23 fusion gene
nup98 / phf23 fusion protein
recombinant oncolytic poliovirus pvs - ripo
abos regimen
sr - t100 gel
paclitaxel trevatide
vti1a gene
vti1a wt allele
vesicle transport through interaction with t - snares homolog 1a
rnf146 gene
rnf146 wt allele
e3 ubiquitin - protein ligase rnf146
fto gene
fto wt allele
alpha - ketoglutarate - dependent dioxygenase fto
cpt1c gene
cpt1c wt allele
carnitine o - palmitoyltransferase 1 ,  brain isoform
phgdh gene
phgdh wt allele
d - 3 - phosphoglycerate dehydrogenase
stk3 gene
stk3 wt allele
serine / threonine - protein kinase 3
stk4 gene
pyrosequencing
stk4 wt allele
serine / threonine - protein kinase 4
xpo1 gene
xpo1 wt allele
cold - pcr
peptide nucleic acid clamping
exportin - 1
proficiency testing
proficiency testing challenge
next - generation technology
isotope dilution mass spectrometry
cognitive flexibility
delayed reward discounting
inhibitory nerve control
kat6a / crebbp fusion gene
kat6a / crebbp fusion protein
kat6a / ncoa2 fusion gene
alizapride
kat6a / ncoa2 fusion protein
taf15 / nr4a3 fusion gene
taf15 / nr4a3 fusion protein
hip1 / pdgfrb fusion gene
hip1 / pdgfrb fusion protein
mll / sh3gl1 fusion gene
mll / sh3gl1 fusion protein
mildly abnormal ejection fraction
moderately abnormal ejection fraction
severely abnormal ventricular ejection fraction
carmustine / dacarbazine / hydroxyurea regimen
ewsr1 / sp3 fusion gene
ewsr1 / sp3 fusion protein
hyperdynamic ventricular ejection fraction
normal ventricular ejection fraction
ccdc6 / pdgfrb fusion gene
ccdc6 / pdgfrb fusion protein
home oxygen therapy
tmprss2 / etv1 fusion gene
lhx4 / ighg1 fusion gene
zmym2 / fgfr1 fusion gene
zmym2 / fgfr1 fusion protein
percutaneous coronary intervention
ventricular tachycardia / ventricular fibrillation arrest
left ventricular ejection fraction
commence
failure of cardiac pacemaker to capture
failure of cardiac pacemaker to pace
cardiac pacemaker oversensing
cyclophosphamide / doxorubicin / fluorouracil / fluoxymesterone / tamoxifen regimen
bradycardia arrest
primary cause of death
diabetes therapy
fractional flow reserve of vessel
fractional flow reserve ratio of vessel
intravascular ultrasound
hemodynamic instability
venous thromboembolism
structural heart abnormality
mechanical circulatory support placement timing
mechanical circulatory support
cardiac pacemaker undersensing
common ventricle disorder
abnormal intraventricular conduction by ecg finding
left ventricular non - compaction syndrome
primary valvular disorder
cardiac valve procedure
life expectancy of an individual
imidapril hydrochloride
patient condition delay
permanent cardiac pacemaker
sleep study
disease presentation
paraoxon
actinomycin c3
levonordefrin hydrochloride
lymphomatous involvement of extranodal site
competency
retain
mllt10 / clp1 fusion gene
tfg / ntrk1 fusion gene
tfg / ntrk1 fusion protein
tfg / nr4a3 fusion gene
tfg / nr4a3 fusion protein
hist1h4i / bcl6 fusion gene
lasp1 / mll fusion gene
lasp1 / mll fusion protein
rad51b / hmga2 fusion gene
rad51b / hmga2 fusion protein
ikzf1 / bcl6 fusion gene
picalm / mllt10 fusion gene
picalm / mllt10 fusion protein
mllt10 / picalm fusion gene
mllt10 / picalm fusion protein
pik3r2 / usp8 fusion gene
pik3r2 / usp8 fusion protein
cdk6 / mll fusion gene
bleomycin / mechlorethamine / prednisone / procarbazine / vincristine regimen
cdk6 / mll fusion protein
rabep1 / pdgfrb fusion gene
rabep1 / pdgfrb fusion protein
akap9 / braf fusion gene
index colonoscopy
akap9 / braf fusion protein
znf652 gene
znf652 wt allele
zinc finger protein 652
egr1 gene
allocolchicine
egr1 wt allele
early growth response protein 1
klhl6 gene
klhl6 wt allele
kelch - like protein 6
s100a6 gene
s100a6 wt allele
protein s100 - a6
s100a1 gene
s100a1 wt allele
protein s100 - a1
sh3pxd2a gene
sh3pxd2a wt allele
sh3 and px domain - containing protein 2a
fubp1 gene
fubp1 wt allele
far upstream element - binding protein 1
tle3 gene
tle3 wt allele
transducin - like enhancer protein 3
zbtb38 gene
zbtb38 wt allele
zinc finger and btb domain - containing protein 38
cchcr1 gene
cchcr1 wt allele
coiled - coil alpha - helical rod protein 1
tctn1 gene
tctn1 wt allele
tectonic - 1
capecitabine rapidly disintegrating tablet
ccl28 gene
ccl28 wt allele
iodine i 124 monoclonal antibody 8h9
c - c motif chemokine 28
rhubarb / licorice herbal supplement
iodine i 124 nm404
iodine i 131 nm404
pbi - shrna stmn1 lipoplex
doxorubicin / semustine / streptozocin regimen
landogrozumab
rbm38 gene
rbm38 wt allele
rna - binding protein 38
radotinib hydrochloride
vps35 gene
vps35 wt allele
vacuolar protein sorting - associated protein 35
id1 gene
id1 wt allele
dna - binding protein inhibitor id - 1
spib gene
spib wt allele
transcription factor spi - b
dmrt1 gene
dmrt1 wt allele
doublesex -  and mab - 3 - related transcription factor 1
adgrg1 gene
adgrg1 wt allele
adhesion g - protein coupled receptor g1
dlk1 gene
dlk1 wt allele
protein delta homolog 1
rac1 gene
rac1 wt allele
ras - related c3 botulinum toxin substrate 1
stat5b / rara fusion gene
stat5b / rara fusion protein
chic2 / etv6 fusion gene
chic2 / etv6 fusion protein
autolysis
reason for denial
psychological denial
acsl6 / etv6 fusion gene
acsl6 / etv6 fusion protein
etv6 / mn1 fusion gene
add3 / nup98 fusion gene
zfpm2 / runx1 fusion gene
pdgfrb / myo18a fusion gene
rara / pml fusion gene
abl1 / bcr fusion gene
ntrk1 / tpm3 fusion gene
tfe3 / aspscr1 fusion gene
trip11 / pdgfrb fusion gene
trip11 / pdgfrb fusion protein
senp6 / nkain2 fusion gene
tmod3 / cyp19a1 fusion gene
sfpq / tfe3 fusion gene
sfpq / tfe3 fusion protein
il21r / bcl6 fusion gene
fgfr1op / fgfr1 fusion gene
fgfr1 / fgfr1op fusion gene
fgfr1op / fgfr1 fusion protein
m - bacop regimen
f - machop regimen
cntrl / fgfr1 fusion gene
cntrl / fgfr1 fusion protein
linolenic acid
trpm7 / cyp19a1 fusion gene
rbm15 / mkl1 fusion gene
rbm15 / mkl1 fusion protein
mkl1 / rbm15 fusion gene
arterial dissection
aspscr1 / tfe3 fusion gene
aspscr1 / tfe3 fusion protein
jazf1 / suz12 fusion gene
jazf1 / suz12 fusion protein
significant arterial dissection
srgap3 / raf1 fusion gene
srgap3 / raf1 fusion protein
pax3 / foxo1 fusion gene
fgfr1 / zmym2 fusion gene
foxo1 / pax7 fusion gene
foxo1 / pax3 fusion gene
nsd1 / nup98 fusion gene
nsd1 / nup98 fusion protein
gopc / ros1 fusion gene
gopc / ros1 fusion protein
erc1 / ret fusion gene
erc1 / ret fusion protein
london deauville criteria point scale
eml4 / alk fusion gene
eml4 / alk fusion gene variant 1
eml4 / alk fusion gene variant 2
eml4 / alk fusion gene variant 3a
london deauville criteria point scale 1
eml4 / alk fusion gene variant 3b
eml4 / alk fusion gene variant 4
eml4 / alk fusion gene variant 5a
eml4 / alk fusion gene variant 5b
eml4 / alk fusion protein
eml4 / alk fusion protein variant 1
eml4 / alk fusion protein variant 2
eml4 / alk fusion protein variant 3a
eml4 / alk fusion protein variant 3b
eml4 / alk fusion protein variant 4
eml4 / alk fusion protein variant 5a
eml4 / alk fusion protein variant 5b
crtc1 / maml2 fusion gene
crtc1 / maml2 fusion protein
fip1l1 / pdgfra fusion gene
fip1l1 / pdgfra fusion protein
mesdc2 / senp1 fusion gene
mesdc2 / senp1 fusion protein
london deauville criteria point scale 2
london deauville criteria point scale 3
london deauville criteria point scale 4
london deauville criteria point scale 5
fecal dna test
indel mutation
disruptive behavior disorder
reward
punishment
disapproval
unmet
retail environment
clcf1 gene
clcf1 wt allele
antiangiogenic drug combination tl - 118
conditionally replicative adenovirus 5 / 3 - delta24
oral aminolevulinic acid hydrochloride
liposome - encapsulated recombinant human cu / zn superoxide - dismutase
anti - vegfc monoclonal antibody vgx - 100
adagloxad simolenin
erythrocyte - encapsulated l - asparaginase suspension
victimization
ventriculostomy
have shortness of breath
bothered by change in weight
get tired easily
feel fatigue
feel weak all over
have been coughing
unhappy with appearance
hard to tell other people about infection
worry about spreading infection
concern about future
worry about effect of stress on illness
embarrassed by illness
pain has interfered with normal work or activities
satisfied with physical appearance
have swelling in face arms or legs
feel sexually attractive
have good appetite
feel motivated to do things
hopeful about future
have people to help if needed
thinking clear
have trouble concentrating
have trouble remembering things
prosector
time of death
presumed dead
pronounced dead
metyrosine
year of onset
month - year
decedent
last time seen alive
fluorouracil / levamisole regimen
cgnl1 / cyp19a1 fusion gene
msi2 / hoxa9 fusion gene
msi2 / hoxa9 fusion protein
malat1 / tfeb fusion gene
dirc3 / hspbap1 fusion gene
brd4 / nutm1 fusion gene
brd4 / nutm1 fusion protein
specc1 / pdgfrb fusion gene
specc1 / pdgfrb fusion protein
fgfr1op2 / fgfr1 fusion gene
fgfr1op2 / fgfr1 fusion protein
myo18a / pdgfrb fusion gene
myo18a / pdgfrb fusion protein
iqcj / schip1 fusion gene
lomustine / prednisone / vincristine regimen
iqcj / schip1 fusion protein
senp1 / mesdc2 fusion gene
senp1 / mesdc2 fusion protein
kiaa1549 / braf fusion gene
kiaa1549 / braf fusion protein
prkar1a / ret fusion gene
prkar1a / ret fusion protein
ncoa4 / ret fusion gene
ncoa4 / ret fusion protein
ret / ncoa4 fusion gene
trim24 / ret fusion gene
trim24 / ret fusion protein
ret / trim24 fusion gene
trim33 / ret fusion gene
trim33 / ret fusion protein
ret / trim33 fusion gene
golga5 / ret fusion gene
golga5 / ret fusion protein
tpr / ntrk1 fusion gene trkt1
tpr / ntrk1 fusion gene trkt2
tpr / ntrk1 fusion protein trkt1
tpr / ntrk1 fusion protein trkt2
tpr / met fusion gene
tpr / met fusion protein
patz1 / uqcrh fusion gene
uqcrh / ewsr1 fusion gene
ctnnb1 / plag1 fusion gene
chchd7 / plag1 fusion gene
tcea1 / plag1 fusion gene
rnf213 / alk fusion gene
rnf213 / alk fusion protein
cars / alk fusion gene
cars / alk fusion protein
cltc / alk fusion gene
cltc / alk fusion protein
birc3 / malt1 fusion gene
birc3 / malt1 fusion protein
problem with teeth ,  denture or mouth
trouble pronouncing words due to problem with teeth ,  denture or mouth
feel sense of taste has worsened
painful ache in mouth due problem with teeth ,  denture or mouth
uncomfortable eating food due to problem with teeth ,  denture or mouth
self - conscious due to problems with teeth ,  dentures or mouth
feel tense due to mouth problems
unsatisfactory diet due to problem with teeth ,  denture or mouth
meal interruptions due to problems with teeth ,  denture or mouth
difficulty relaxing due to problem with teeth ,  denture or mouth
have embarrassment due to problem with teeth ,  denture or mouth
irritable with other people due to problems with teeth ,  dentures or mouth
difficulty doing usual jobs due to problem with teeth ,  denture or mouth
feel life in general was less satisfying
unable to function due to problems with teeth ,  dentures or mouth
hardly ever
cardiac lead event finding
congenital pulmonary artery stenosis
cndo - 109 - activated allogeneic natural killer cells
anti - egfr monoclonal antibody mixture mm - 151
amonafide dihydrochloride
copper cu 64 - dota - rituximab
acai berry juice
ilixadencel
her2 ecd + tm virus - like replicon particles vaccine avx901
gallium ga 68 - labeled bnota - prgd2
rociletinib
abandoned lead
ablation of cardiac accessory pathway
ablation of cardiac atrioventricular node
federal health care facility
hospice care at medical facility
inpatient rehabilitation facility including rehabilitation distinct part units of a hospital
intermediate care facility
nursing facility certified under medicaid but not certified under medicare
skilled nursing facility with medicare certification in anticipation of covered skilled care
aortic anastomosis of graft
aortic balloon valvotomy
atypical coronary artery disease symptom
body of graft
candidate to receive cardiac transplant
cardiac arrest prior to percutaneous coronary intervention
cardiac atrial pacing malfunction
cardiac defibrillator issue
cardiac defibrillator malfunction
cardiac device conductor failure
cardiac device generator is being replaced at time of lead revision
cardiac device oversensing
cardiac device oversensing with shock or anti - tachycardia pacing
cardiac device oversensing without shock or anti - tachycardia pacing
cardiac device set screw problem
cardiac device undersensing
cardiac lead erosion
cardiac lead insulation failure
cardiac lead position results in undesirable stimulation of diaphragm
cardiac lead procedure
cardiac tricuspid valve repair
catecholaminergic polymorphic ventricular tachycardia by ecg finding
chemical cardioversion
chronic total occlusion vessel
closure of cardiac atrial septum
closure of cardiac ventricle septum
co - dominant artery
coronary artery right dominance
device generator malfunction
died in a medical facility
difficult vascular access
difficulty crossing culprit lesion during percutaneous coronary intervention
donor for cardiac transplant
electric cardioversion
end of expected battery life
endotracheal intubation before percutaneous coronary intervention
extracardiac stimulation
extracted cardiac lead
failure to capture with acceptable safety margin
failure to shock with inadequate defibrillator threshold safety margin
high coronary artery disease risk
high ischemic risk
home care
home hospice
home under care of organized home health service organization in anticipation of covered skilled care
hospital with medicare approved swing bed
immediate percutaneous coronary intervention for st elevation myocardial infarction
inserted during a non - percutaneous coronary intervention
inserted during a procedure but prior to percutaneous coronary intervention
inserted during procedure and after percutaneous coronary intervention began
intentional left cardiac atrial appendage occlusion procedure
intermediate coronary artery disease risk
intermediate ischemic risk
known coronary artery disease
left against medical advice
left atrium dimension
left cardiac artery dominance
left cardiac ventricular assist device procedure
left cardiac ventricular pacing malfunction
left cardiac ventricular systolic dysfunction
left cardiac ventricular systolic dysfunction evaluation
left ventricle dimension at end - diastole
left ventricular dimension at end - systole
low coronary artery disease risk
low ischemic risk
manufacturer recognized a recurring performance failure
mechanical circulatory support in place at start of procedure
medical condition or procedure affects implantation site
medical or surgical procedure requiring relocation of lead
medicare certified long term care hospital
mild cardiac valve regurgitation
mild cardiac valve stenosis
mitral balloon valvotomy
mitral commissurotomy
moderate cardiac valve regurgitation
cmfpth regimen
moderate cardiac valve stenosis
no cardiac valve regurgitation
no cardiac valve stenosis
no evidence of coronary artery disease
no treatment for diabetes
non - cardiovascular surgery
number of diseased coronary artery vessels
one vessel coronary disease
pacemaker procedure
percutaneous coronary intervention for high risk non - st elevation myocardial infarction or unstable angina
